Citrus Sinensis ID: 040702

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680-------690-------700-------710-------720-------730-------740-------750-------760-------770-------780-------790-------
Protein Sequence
MPSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMPNLQVLSCRTKIHHTLGKNDLLIGIVLPLSTIFMMVVVLLILKYRKGRKSQLKDVNMPSVADQRRFTYLELFQATNRFSENNLIGRGGFGPVYKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYTISSSTFNAVILALAEIVA
Secondary Structure (PSIPRED)
cccccccccEEcccccccccccccEEEccccccccccccccccccccccccccccccEEcccccccccccHHHHccccccccccccccccccccHHHHcccccccEEEccccEEEEcccHHHHHHccccEEEcccccccccccccccccccccEEEccccccccccccccccccccccccccEEEcccccccccccHHHHcccccccEEEccccEEEEccccccccccccccccEEcccccccccccHHHHccccccEEEccccEEEEEcccccccccccccEEccccccccccHHHHccccccccccccccccccccHHHHccccccccccccccccccccHHHHccccccccccccccccccccHHHHccccccccccccccccccccHHHHcccccccEEccccccEEccccccccccccHHHHcccccccccccccccccccccccccccccEEEHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccHHHHHHHHcccccccEEEcccccEEEccccEEEEEEEEcccccccccHHHHHHHHccccccccccEEEEEEcccccEEEEccccccccccccccccccccHHHHHHHHHHHHHHHHHHccccccccEEccccccccccccccEEEEcccccccccccccccEEcccccccccccccccccccccccHHHHHHHHHHHHHHHHccccHHHHHHHccccccccHHcccccccccccccccHHHHHHHHHHHccccccccccccccccccccccccccccccccHHHHHHHHHHHHc
Secondary Structure Prediction (SSPRO)
ccccccccccccccHHHcccccccEEEcccccccccccccccccccHHHccccccEEEEEccccccccccHHHcccccccEEEcccccccccccHHHHHccccccEEEcccccccccccHHHccccccEEEEcccccccccccHHHcccccccEEEEcccccccccccccccHHHccccccEEEEEccccccccccHHHHccHHHccEEEcccccccccccHHHcccccEEEEEEEcccccccccccHHHccccccEEEEEccccccccccHHHcccccccEEEccccccccccHHHcccccccEEEEccccEEccccHHHHHcccccEEEEEEEccEEEccHHHHHcccccEEEccccEEEccccHHHHHcccccEEEccccccEEEccHHHHHcccccEEEccccEEEEEccccccHHHccHHHcccccEEEccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHcHHHHcccccccccccccccccHHHHHHHHHHcccccEEEccccEEEEccccEEEEEEccccccccccHHHHHHHHHHHcHHHHHHHHHEEcccccccEEEEEccccccHHHHHccccccccHHHHHHHHHHHHHHHHHHHccccccEEEEEcccccEEcccccHHHHHHHcHHHHEcccccccccEEEccccccccccHEEEEEEcccccHHHHHHHHHHHHccccccccccccHHHHHHHHHHccccccHEHHHHHccccccccHccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHHcc
Coil and Loop (DISEMBL)
MPSLTNDFLRGIILSqlgnpsslqtlylsynppsgsipsfilceipheidnlhnMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHsnslsgrlpssadvrlpnlkelhlwgnnfigtiPSFIFNAsklselglqknsfsgsipntfgnlrnlkwlglndnyltsstpelsslsslsnckyleyfsfsnnplggilpraignlSQSMEDFWmdncnisgsipEEINNLTNLILQLLSLEgnqlegsipDDLCRLAALFQLdlggnklsgfvpacsgnltnlrklylgsnlltsipstlwNLKDILhlnlssnfftgplplkignLNVLVQLDLSmnnfscviptkigglkdLQYLFLEYNrlqgsipnsigDLISLkslnlsnnnlsgtipisLEKLLDLKDINVSFNrlegeipregpfrnlsaesfkgnellcgmpnlqvlsCRTKIHHTLGKNDLLIGIVLPLSTIFMMVVVLLILKYRKGrksqlkdvnmpsvadqRRFTYLELFQATnrfsennligrggfgpvykdGMEVAIKVFNLqyggafksfdieCGMMKRIRHRNLIKIISSCSNDDFKALVLEymplgslekclysgnYILDIFQGLNIMIDVASALEYLhfgysvpiihcdlkpsnvllddnmvahlsdfgmakplleedqsLTQTQTLAtigymapdeifsgemrlkcwvndSLLISVMIVVDANLLIREEKhlmtkeqpmvrmgtdlslgqfpasysISKYLVYIRELErgkvgitsvaafpivhhyLYRTVDYTISSSTFNAVILALAEIVA
Flexible Loop (DISEMBL)
MPSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRlegeipregpfrNLSAESFKGNELLCGMPNLQVLSCRTKIHHTLGKNDLLIGIVLPLSTIFMMVVVLLILKYRKgrksqlkdvnmpsvadqRRFTYLELFQAtnrfsennligRGGFGPVYKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYTISSSTFNAVILALAEIVA
Low Complexity Region (SEG)
MPSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYltsstpelsslsslsNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSipeeinnltnlilqllsleGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLIslkslnlsnnnlsGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMPNLQVLSCRTKIHHTLGKNDLLIGIVLPLSTIFMMVVVLLILKYRKGRKSQLKDVNMPSVADQRRFTYLELFQATNRFSENNLIGRGGFGPVYKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYTISSSTFNAVILALAEIVA
Disordered region (IsUnstruct)
******DFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSG*****ADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSST**L*SLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMPNLQVLSCRTKIHHTLGKNDLLIGIVLPLSTIFMMVVVLLILKYRKGRKSQLKDVNMPSVADQRRFTYLELFQATNRFSENNLIGRGGFGPVYKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYTISSSTFNAVILALAEI**
Disordered Region (DISOPRED)
MPSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMP*********************IGIVLPLSTIFMMVVVLLILK*********************RFTYLELFQATNRFSENNLIGRGGFGPVYKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE******QTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEKHLMTKEQPMVRMGTDLSLGQFP**YSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTV******ST*NAVILALAEIVA
Disordered Region (DISEMBL)
MPSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMPNLQVLSCRTKIHHTLGKNDLLIGIVLPLSTIFMMVVVLLILKYRKGRKSQLKDVNMPSVADQRRFTYLELFQATNRFSENNLIGRGGFGPVYKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYTISSSTFNAVILALAEIVA
Disordered Region (DISPRO)
MPSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMPNLQVLSCRTKIHHTLGKNDLLIGIVLPLSTIFMMVVVLLILKYRKGRKSQLKDVNMPSVADQRRFTYLELFQATNRFSENNLIGRGGFGPVYKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEKHLMTKEQPMVRMGTDLSLGQFPASYSI*KYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYTISSSTFNAVILALAEIVA
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MPSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMPNLQVLSCRTKIHHTLGKNDLLIGIVLPLSTIFMMVVVLLILKYRKGRKSQLKDVNMPSVADQRRFTYLELFQATNRFSENNLIGRGGFGPVYKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYTISSSTFNAVILALAEIVA
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	797	2.2.26 [Sep-21-2011]
C0LGT6	1031	LRR receptor-like serine/	yes	no	0.843	0.651	0.380	1e-115
C0LGP4	1010	Probable LRR receptor-lik	no	no	0.835	0.659	0.379	1e-115
Q9SD62	1025	Putative receptor-like pr	no	no	0.836	0.650	0.388	2e-99
Q9ZUI0	980	Putative leucine-rich rep	no	no	0.818	0.665	0.371	1e-94
Q9FL28	1173	LRR receptor-like serine/	no	no	0.869	0.590	0.322	1e-85
Q8VZG8	1045	Probable LRR receptor-lik	no	no	0.855	0.652	0.308	4e-83
C0LGQ5	1249	LRR receptor-like serine/	no	no	0.831	0.530	0.329	9e-82
Q9FIZ3	1252	LRR receptor-like serine/	no	no	0.879	0.559	0.318	6e-80
Q9SHI2	1101	Leucine-rich repeat recep	no	no	0.846	0.613	0.316	1e-79
Q9LP24	1120	Probable leucine-rich rep	no	no	0.819	0.583	0.315	9e-77

>sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1

 Score =  417 bits (1071), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 283/743 (38%), Positives = 405/743 (54%), Gaps = 71/743 (9%)

Query: 4   LTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFN 63
           L+ + L G   + LGN +SLQ L  +YN   G        EIP E+  L  M +   + N
Sbjct: 176 LSKNNLTGNFPASLGNLTSLQKLDFAYNQMRG--------EIPDEVARLTQMVFFQIALN 227

Query: 64  KVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIF 123
              G  P  ++N+S+L+SL L  NS SG L +     LPNL+ L L  N F G IP  + 
Sbjct: 228 SFSGGFPPALYNISSLESLSLADNSFSGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTLA 287

Query: 124 NASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSS-LSSLSNCKYLE 182
           N S L    +  N  SGSIP +FG LRNL WLG+ +N L +++      + +++NC  LE
Sbjct: 288 NISSLERFDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQLE 347

Query: 183 YFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQL 242
           Y     N LGG LP +I NLS ++   ++    ISG+IP +I NL +  LQ LSLE N L
Sbjct: 348 YLDVGYNRLGGELPASIANLSTTLTSLFLGQNLISGTIPHDIGNLVS--LQELSLETNML 405

Query: 243 EGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSN-------------- 288
            G +P    +L  L  +DL  N +SG +P+  GN+T L+KL+L SN              
Sbjct: 406 SGELPVSFGKLLNLQVVDLYSNAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCR 465

Query: 289 -----------LLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNF 337
                      L  +IP  +  +  + +++LS+NF TG  P ++G L +LV L  S N  
Sbjct: 466 YLLDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFPEEVGKLELLVGLGASYNKL 525

Query: 338 SCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLL 397
           S  +P  IGG   +++LF++ N   G+IP+ I  L+SLK+++ SNNNLSG IP  L  L 
Sbjct: 526 SGKMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKNVDFSNNNLSGRIPRYLASLP 584

Query: 398 DLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLC-GMPNLQVLSCRTKIHHTLGK-- 454
            L+++N+S N+ EG +P  G FRN +A S  GN  +C G+  +Q+  C  +      K  
Sbjct: 585 SLRNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPL 644

Query: 455 ---NDLLIGIVLPLSTIFMMVVVLLILKYRKGRKSQLKDVNMPSVAD-----QRRFTYLE 506
                ++ GI + ++++ ++++V  +  + K +K        PS +        + +Y E
Sbjct: 645 SVRKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEE 704

Query: 507 LFQATNRFSENNLIGRGGFGPVYKD--GME---VAIKVFNLQYGGAFKSFDIECGMMKRI 561
           L  AT+RFS  NLIG G FG V+K   G E   VA+KV NL   GA KSF  EC   K I
Sbjct: 705 LHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGI 764

Query: 562 RHRNLIKIISSCSN-----DDFKALVLEYMPLGSLEKCLY--------SGNYILDIFQGL 608
           RHRNL+K+I+ CS+     +DF+ALV E+MP GSL+  L           +  L   + L
Sbjct: 765 RHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTPAEKL 824

Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ----- 663
           NI IDVASALEYLH     P+ HCD+KPSN+LLDD++ AH+SDFG+A+ L + D+     
Sbjct: 825 NIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRESFLN 884

Query: 664 SLTQTQTLATIGYMAPDEIFSGE 686
             +      TIGY AP+    G+
Sbjct: 885 QFSSAGVRGTIGYAAPEYGMGGQ 907

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1

 Score =  416 bits (1068), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 279/736 (37%), Positives = 410/736 (55%), Gaps = 70/736 (9%)

Query: 9   LRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGV 68
           +RG + + LGN + L+ L LS+N   G        EIP ++  L  +  +    N   GV
Sbjct: 174 MRGKLPTSLGNLTLLEQLALSHNNLEG--------EIPSDVAQLTQIWSLQLVANNFSGV 225

Query: 69  VPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKL 128
            P  ++N+S+LK L +  N  SGRL     + LPNL   ++ GN F G+IP+ + N S L
Sbjct: 226 FPPALYNLSSLKLLGIGYNHFSGRLRPDLGILLPNLLSFNMGGNYFTGSIPTTLSNISTL 285

Query: 129 SELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTS-STPELSSLSSLSNCKYLEYFSFS 187
             LG+ +N+ +GSIP TFGN+ NLK L L+ N L S S+ +L  L+SL+NC  LE     
Sbjct: 286 ERLGMNENNLTGSIP-TFGNVPNLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQLETLGIG 344

Query: 188 NNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIP 247
            N LGG LP +I NLS  +    +    ISGSIP +I NL NL  Q L L+ N L G +P
Sbjct: 345 RNRLGGDLPISIANLSAKLVTLDLGGTLISGSIPYDIGNLINL--QKLILDQNMLSGPLP 402

Query: 248 DDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSI-PSTLWNLKDILHL 306
             L +L  L  L L  N+LSG +PA  GN+T L  L L +N    I P++L N   +L L
Sbjct: 403 TSLGKLLNLRYLSLFSNRLSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLEL 462

Query: 307 NLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIP 366
            +  N   G +PL+I  +  L++LD+S N+    +P  IG L++L  L L  N+L G +P
Sbjct: 463 WIGDNKLNGTIPLEIMKIQQLLRLDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLP 522

Query: 367 NSIGD-----------------------LISLKSLNLSNNNLSGTIPISLEKLLDLKDIN 403
            ++G+                       L+ +K ++LSNN+LSG+IP        L+ +N
Sbjct: 523 QTLGNCLTMESLFLEGNLFYGDIPDLKGLVGVKEVDLSNNDLSGSIPEYFASFSKLEYLN 582

Query: 404 VSFNRLEGEIPREGPFRNLSAESFKGNELLCG-MPNLQVLSCRTKIHHTLGKND-----L 457
           +SFN LEG++P +G F N +  S  GN  LCG +   Q+  C ++    + K+      +
Sbjct: 583 LSFNNLEGKVPVKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKV 642

Query: 458 LIGIVLPLSTIFMMVVVLLILKYRKGRKSQLKDVNMPSVAD----QRRFTYLELFQATNR 513
           +IG+ + ++ + ++ +  + L + + RK   K+ N P+ +       + +Y +L  ATN 
Sbjct: 643 VIGVSVGITLLLLLFMASVTLIWLRKRKKN-KETNNPTPSTLEVLHEKISYGDLRNATNG 701

Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIK 568
           FS +N++G G FG VYK     +   VA+KV N+Q  GA KSF  EC  +K IRHRNL+K
Sbjct: 702 FSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVK 761

Query: 569 IISSCSNDDF-----KALVLEYMPLGSLEKCLY--------SGNYILDIFQGLNIMIDVA 615
           ++++CS+ DF     +AL+ E+MP GSL+  L+          +  L + + LNI IDVA
Sbjct: 762 LLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTLLERLNIAIDVA 821

Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ-----SLTQTQT 670
           S L+YLH     PI HCDLKPSNVLLDD++ AH+SDFG+A+ LL+ D+      L+    
Sbjct: 822 SVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEESFFNQLSSAGV 881

Query: 671 LATIGYMAPDEIFSGE 686
             TIGY AP+    G+
Sbjct: 882 RGTIGYAAPEYGVGGQ 897

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1

 Score =  363 bits (933), Expect = 2e-99,   Method: Compositional matrix adjust.
 Identities = 286/737 (38%), Positives = 397/737 (53%), Gaps = 70/737 (9%)

Query: 9   LRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGV 68
           L G   + LGN +SLQ L   YN   G        EIP +I  L  M +   + NK  GV
Sbjct: 189 LTGKFPASLGNLTSLQMLDFIYNQIEG--------EIPGDIARLKQMIFFRIALNKFNGV 240

Query: 69  VPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKL 128
            P  I+N+S+L  L +  NS SG L       LPNL+ L++  N+F GTIP  + N S L
Sbjct: 241 FPPPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPNLQILYMGINSFTGTIPETLSNISSL 300

Query: 129 SELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTS-STPELSSLSSLSNCKYLEYFSFS 187
            +L +  N  +G IP +FG L+NL  LGLN+N L + S+ +L  L +L+NC  L+Y +  
Sbjct: 301 RQLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGNYSSGDLDFLGALTNCSQLQYLNVG 360

Query: 188 NNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIP 247
            N LGG LP  I NLS  + +  +    ISGSIP  I NL +L  Q L L  N L G +P
Sbjct: 361 FNKLGGQLPVFIANLSTQLTELSLGGNLISGSIPHGIGNLVSL--QTLDLGENLLTGKLP 418

Query: 248 DDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYL---------------------- 285
             L  L+ L ++ L  N LSG +P+  GN++ L  LYL                      
Sbjct: 419 PSLGELSELRKVLLYSNGLSGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLGSCSYLLDL 478

Query: 286 --GSNLLT-SIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIP 342
             G+N L  SIP  L  L  ++ LN+S N   GPL   IG L  L+ LD+S N  S  IP
Sbjct: 479 NLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSGQIP 538

Query: 343 TKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDI 402
             +     L++L L+ N   G IP+ I  L  L+ L+LS NNLSGTIP  +     L+++
Sbjct: 539 QTLANCLSLEFLLLQGNSFVGPIPD-IRGLTGLRFLDLSKNNLSGTIPEYMANFSKLQNL 597

Query: 403 NVSFNRLEGEIPREGPFRNLSAESFKGNELLCG-MPNLQVLSCRTKI--HHTLGKNDLLI 459
           N+S N  +G +P EG FRN SA S  GN  LCG +P+LQ+  C  ++   H+  +  + I
Sbjct: 598 NLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKIITI 657

Query: 460 GIVLPLSTIFMMVVVLLILKYRKGRKSQLKDVN-------MPSVADQRRFTYLELFQATN 512
            +   ++ + ++ + ++ L + K R   ++  N        P  +   + +Y EL++ T 
Sbjct: 658 CVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYKTTG 717

Query: 513 RFSENNLIGRGGFGPVYKDGM-----EVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLI 567
            FS +NLIG G FG V+K  +      VAIKV NL   GA KSF  EC  +  IRHRNL+
Sbjct: 718 GFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHRNLV 777

Query: 568 KIISSCSN-----DDFKALVLEYMPLGSLEKCLY------SGN--YILDIFQGLNIMIDV 614
           K+++ CS+     +DF+ALV E+MP G+L+  L+      +GN    L +F  LNI IDV
Sbjct: 778 KLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGLFARLNIAIDV 837

Query: 615 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ----- 669
           ASAL YLH     PI HCD+KPSN+LLD ++ AH+SDFG+A+ LL+ D+     Q     
Sbjct: 838 ASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRDTFHIQFSSAG 897

Query: 670 TLATIGYMAPDEIFSGE 686
              TIGY AP+    G 
Sbjct: 898 VRGTIGYAAPEYGMGGH 914

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1

 Score =  348 bits (893), Expect = 1e-94,   Method: Compositional matrix adjust.
 Identities = 269/725 (37%), Positives = 405/725 (55%), Gaps = 73/725 (10%)

Query: 4   LTNDFLRGIILSQL---GNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAF 60
           L ++ L G I  QL   G+ SSLQ + LS N  +G IP    C       +L  + ++  
Sbjct: 146 LGSNRLNGSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLNYHC-------HLKELRFLLL 198

Query: 61  SFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGT--- 117
             NK+ G VP+++ N + LK + L SN LSG LPS    ++P L+ L+L  N+F+     
Sbjct: 199 WSNKLTGTVPSSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQFLYLSYNHFVSHNNN 258

Query: 118 ---IPSF--IFNASKLSELGLQKNSFSGSIPNTFGNLR-NLKWLGLNDNYLTSSTPELSS 171
               P F  + N+S L EL L  NS  G I ++  +L  NL  + L+ N +  S P    
Sbjct: 259 TNLEPFFASLANSSDLQELELAGNSLGGEITSSVRHLSVNLVQIHLDQNRIHGSIP---- 314

Query: 172 LSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLI 231
              +SN   L   + S+N L G +PR +  LS+ +E  ++ N +++G IP E+ ++  L 
Sbjct: 315 -PEISNLLNLTLLNLSSNLLSGPIPRELCKLSK-LERVYLSNNHLTGEIPMELGDIPRL- 371

Query: 232 LQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLT 291
             LL +  N L GSIPD    L+ L +L L GN LSG VP   G   NL  L L  N LT
Sbjct: 372 -GLLDVSRNNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNLT 430

Query: 292 -SIP----STLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIG 346
            +IP    S L NLK  L+LNLSSN  +GP+PL++  +++++ +DLS N  S  IP ++G
Sbjct: 431 GTIPVEVVSNLRNLK--LYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLG 488

Query: 347 GLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSF 406
               L++L L  N    ++P+S+G L  LK L++S N L+G IP S ++   LK +N SF
Sbjct: 489 SCIALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSF 548

Query: 407 NRLEGEIPREGPFRNLSAESFKGNELLCG-MPNLQVLSCRTKIHH-TLGKNDLLIGIVLP 464
           N L G +  +G F  L+ ESF G+ LLCG +  +Q  +C+ K  + ++    LL  I  P
Sbjct: 549 NLLSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQ--ACKKKHKYPSVLLPVLLSLIATP 606

Query: 465 LSTIFMMVVVLLILKYRKGR------KSQLKDVNMPSVADQR--RFTYLELFQATNRFSE 516
           +  +F      L+ + R G+      K +++D    +  D +  R +Y +L  AT  F+ 
Sbjct: 607 VLCVFGYP---LVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYPRISYQQLIAATGGFNA 663

Query: 517 NNLIGRGGFGPVYK----DGMEVAIKVFN----LQYGGAFKSFDIECGMMKRIRHRNLIK 568
           ++LIG G FG VYK    +  +VA+KV +    L++ G+FK    EC ++KR RHRNLI+
Sbjct: 664 SSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKR---ECQILKRTRHRNLIR 720

Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCLYSGNYI---LDIFQGLNIMIDVASALEYLHFGY 625
           II++CS   F ALVL  MP GSLE+ LY G Y    LD+ Q +NI  DVA  + YLH   
Sbjct: 721 IITTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHHYS 780

Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA----------TIG 675
            V ++HCDLKPSN+LLDD M A ++DFG+++ +   +++++   +++          ++G
Sbjct: 781 PVKVVHCDLKPSNILLDDEMTALVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLCGSVG 840

Query: 676 YMAPD 680
           Y+AP+
Sbjct: 841 YIAPE 845

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1

 Score =  318 bits (815), Expect = 1e-85,   Method: Compositional matrix adjust.
 Identities = 269/833 (32%), Positives = 399/833 (47%), Gaps = 140/833 (16%)

Query: 4    LTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPS--FILCEIPH-------------- 47
            L ++ L G I ++LGN   LQ L +  N  + SIPS  F L ++ H              
Sbjct: 271  LYDNQLTGKIPAELGNLVQLQALRIYKNKLTSSIPSSLFRLTQLTHLGLSENHLVGPISE 330

Query: 48   EIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKEL 107
            EI  L ++E +    N   G  P +I N+  L  L +  N++SG LP+   + L NL+ L
Sbjct: 331  EIGFLESLEVLTLHSNNFTGEFPQSITNLRNLTVLTVGFNNISGELPADLGL-LTNLRNL 389

Query: 108  HLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTP 167
                N   G IPS I N + L  L L  N  +G IP  FG + NL ++ +  N+ T   P
Sbjct: 390  SAHDNLLTGPIPSSISNCTGLKLLDLSHNQMTGEIPRGFGRM-NLTFISIGRNHFTGEIP 448

Query: 168  ELSSLSSLSNCKYLEYFSFSNNPLGGIL------------------------PRAIGNLS 203
            +      + NC  LE  S ++N L G L                        PR IGNL 
Sbjct: 449  D-----DIFNCSNLETLSVADNNLTGTLKPLIGKLQKLRILQVSYNSLTGPIPREIGNL- 502

Query: 204  QSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGG 263
            + +   ++ +   +G IP E++NLT  +LQ L +  N LEG IP+++  +  L  LDL  
Sbjct: 503  KDLNILYLHSNGFTGRIPREMSNLT--LLQGLRMYSNDLEGPIPEEMFDMKLLSVLDLSN 560

Query: 264  NKLSGFVPACSGNLTNLRKLYLGSNLLT-SIPSTLWNLK-----DI-------------- 303
            NK SG +PA    L +L  L L  N    SIP++L +L      DI              
Sbjct: 561  NKFSGQIPALFSKLESLTYLSLQGNKFNGSIPASLKSLSLLNTFDISDNLLTGTIPGELL 620

Query: 304  -------LHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFL 356
                   L+LN S+N  TG +P ++G L ++ ++DLS N FS  IP  +   K++  L  
Sbjct: 621  ASLKNMQLYLNFSNNLLTGTIPKELGKLEMVQEIDLSNNLFSGSIPRSLQACKNVFTLDF 680

Query: 357  EYNRLQGSIPN-------------------------SIGDLISLKSLNLSNNNLSGTIPI 391
              N L G IP+                         S G++  L SL+LS+NNL+G IP 
Sbjct: 681  SQNNLSGHIPDEVFQGMDMIISLNLSRNSFSGEIPQSFGNMTHLVSLDLSSNNLTGEIPE 740

Query: 392  SLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMPN-LQVLSCRTKIHH 450
            SL  L  LK + ++ N L+G +P  G F+N++A    GN  LCG    L+  + + K  H
Sbjct: 741  SLANLSTLKHLKLASNNLKGHVPESGVFKNINASDLMGNTDLCGSKKPLKPCTIKQKSSH 800

Query: 451  TLGKNDLLIGIVL---------PLSTIFMMVVVLLILKYRKGRKSQLKDVNMPSVADQRR 501
               K   +I I+L          L  + +        K     +S L D++  S    +R
Sbjct: 801  -FSKRTRVILIILGSAAALLLVLLLVLILTCCKKKEKKIENSSESSLPDLD--SALKLKR 857

Query: 502  FTYLELFQATNRFSENNLIGRGGFGPVYK----DGMEVAIKVFNLQYGGAF--KSFDIEC 555
            F   EL QAT+ F+  N+IG      VYK    DG  +A+KV NL+   A   K F  E 
Sbjct: 858  FEPKELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEA 917

Query: 556  GMMKRIRHRNLIKIIS-SCSNDDFKALVLEYMPLGSLEKCLY-SGNYILDIFQGLNIMID 613
              + +++HRNL+KI+  +  +   KALVL +M  G+LE  ++ S   I  + + +++ + 
Sbjct: 918  KTLSQLKHRNLVKILGFAWESGKTKALVLPFMENGNLEDTIHGSAAPIGSLLEKIDLCVH 977

Query: 614  VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTL- 671
            +AS ++YLH GY  PI+HCDLKP+N+LLD + VAH+SDFG A+ L   ED S T + +  
Sbjct: 978  IASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGSTTASTSAF 1037

Query: 672  -ATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEKHLMTKEQP 723
              TIGY+AP+  +   MR      D     ++++            LMTK++P
Sbjct: 1038 EGTIGYLAPEFAY---MRKVTTKADVFSFGIIMM-----------ELMTKQRP 1076

Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8VZG8|Y4885_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g08850 OS=Arabidopsis thaliana GN=At4g08850 PE=1 SV=3

 Score =  310 bits (793), Expect = 4e-83,   Method: Compositional matrix adjust.
 Identities = 240/777 (30%), Positives = 373/777 (48%), Gaps = 95/777 (12%)

Query: 3   SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFI--------LC--------EIP 46
           ++ ++ L G I S  GN + L  LYL  N  SGSIPS I        LC        +IP
Sbjct: 196 AIYDNLLTGPIPSSFGNLTKLVNLYLFINSLSGSIPSEIGNLPNLRELCLDRNNLTGKIP 255

Query: 47  HEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKE 106
               NL N+  +    N++ G +P  I N++ L +L LH+N L+G +PS+    +  L  
Sbjct: 256 SSFGNLKNVTLLNMFENQLSGEIPPEIGNMTALDTLSLHTNKLTGPIPSTLG-NIKTLAV 314

Query: 107 LHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSST 166
           LHL+ N   G+IP  +     + +L + +N  +G +P++FG L  L+WL L DN L+   
Sbjct: 315 LHLYLNQLNGSIPPELGEMESMIDLEISENKLTGPVPDSFGKLTALEWLFLRDNQLSGPI 374

Query: 167 PELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINN 226
           P       ++N   L       N   G LP  I    + +E+  +D+ +  G +P+ + +
Sbjct: 375 P-----PGIANSTELTVLQLDTNNFTGFLPDTICRGGK-LENLTLDDNHFEGPVPKSLRD 428

Query: 227 LTNLI----------------------------------------------LQLLSLEGN 240
             +LI                                              L    L  N
Sbjct: 429 CKSLIRVRFKGNSFSGDISEAFGVYPTLNFIDLSNNNFHGQLSANWEQSQKLVAFILSNN 488

Query: 241 QLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLT-SIPSTLWN 299
            + G+IP ++  +  L QLDL  N+++G +P    N+  + KL L  N L+  IPS +  
Sbjct: 489 SITGAIPPEIWNMTQLSQLDLSSNRITGELPESISNINRISKLQLNGNRLSGKIPSGIRL 548

Query: 300 LKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYN 359
           L ++ +L+LSSN F+  +P  + NL  L  ++LS N+    IP  +  L  LQ L L YN
Sbjct: 549 LTNLEYLDLSSNRFSSEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYN 608

Query: 360 RLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPF 419
           +L G I +    L +L+ L+LS+NNLSG IP S + +L L  ++VS N L+G IP    F
Sbjct: 609 QLDGEISSQFRSLQNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPIPDNAAF 668

Query: 420 RNLSAESFKGNELLCGMPNLQ--VLSCR-TKIHHTLGKNDLLIGIVLPL--STIFMMVVV 474
           RN   ++F+GN+ LCG  N    +  C  T    +    +L+I I++P+  + I + V  
Sbjct: 669 RNAPPDAFEGNKDLCGSVNTTQGLKPCSITSSKKSHKDRNLIIYILVPIIGAIIILSVCA 728

Query: 475 LLILKYRKGRKSQLKDVNMPSVAD-------QRRFTYLELFQATNRFSENNLIGRGGFGP 527
            + + +RK  K   +  +  S  +         +  Y E+ +AT  F    LIG GG G 
Sbjct: 729 GIFICFRKRTKQIEEHTDSESGGETLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGK 788

Query: 528 VYKDGME---VAIKVFNLQYGGAF------KSFDIECGMMKRIRHRNLIKIISSCSNDDF 578
           VYK  +    +A+K  N     +       + F  E   +  IRHRN++K+   CS+   
Sbjct: 789 VYKAKLPNAIMAVKKLNETTDSSISNPSTKQEFLNEIRALTEIRHRNVVKLFGFCSHRRN 848

Query: 579 KALVLEYMPLGSLEKCLYSGNYI--LDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKP 636
             LV EYM  GSL K L + +    LD  + +N++  VA AL Y+H   S  I+H D+  
Sbjct: 849 TFLVYEYMERGSLRKVLENDDEAKKLDWGKRINVVKGVAHALSYMHHDRSPAIVHRDISS 908

Query: 637 SNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWV 693
            N+LL ++  A +SDFG AK LL+ D S   +    T GY+AP+  ++ ++  KC V
Sbjct: 909 GNILLGEDYEAKISDFGTAK-LLKPDSS-NWSAVAGTYGYVAPELAYAMKVTEKCDV 963

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1

 Score =  305 bits (781), Expect = 9e-82,   Method: Compositional matrix adjust.
 Identities = 252/765 (32%), Positives = 373/765 (48%), Gaps = 102/765 (13%)

Query: 4    LTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFN 63
            L N+ L G +   + N ++LQ L L +N   G        ++P EI  L  +E +    N
Sbjct: 391  LHNNTLEGTLSPSISNLTNLQWLVLYHNNLEG--------KLPKEISALRKLEVLFLYEN 442

Query: 64   KVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIF 123
            +  G +P  I N ++LK + +  N   G +P S   RL  L  LHL  N  +G +P+ + 
Sbjct: 443  RFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIG-RLKELNLLHLRQNELVGGLPASLG 501

Query: 124  NASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSN------ 177
            N  +L+ L L  N  SGSIP++FG L+ L+ L L +N L  + P+  SL SL N      
Sbjct: 502  NCHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPD--SLISLRNLTRINL 559

Query: 178  ------------CKYLEYFSF--SNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEE 223
                        C    Y SF  +NN     +P  +GN SQ+++   +    ++G IP  
Sbjct: 560  SHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLELGN-SQNLDRLRLGKNQLTGKIPWT 618

Query: 224  INNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKL 283
            +  +  L   LL +  N L G+IP  L     L  +DL  N LSG +P   G L+ L +L
Sbjct: 619  LGKIREL--SLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGEL 676

Query: 284  YLGSN-------------------------LLTSIPSTLWNLKDILHLNLSSNFFTGPLP 318
             L SN                         L  SIP  + NL  +  LNL  N F+G LP
Sbjct: 677  KLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLP 736

Query: 319  LKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQ-YLFLEYNRLQGSIPNSIGDLISLKS 377
              +G L+ L +L LS N+ +  IP +IG L+DLQ  L L YN   G IP++IG L  L++
Sbjct: 737  QAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLET 796

Query: 378  LNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMP 437
            L+LS+N L+G +P S+  +  L  +NVSFN L G++ ++  F    A+SF GN  LCG P
Sbjct: 797  LDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQ--FSRWPADSFLGNTGLCGSP 854

Query: 438  NLQVLSCRT--KIHHTLGKNDLLIGIVLPLSTIFMMVVVLLILKYRKGRKSQLKDVNMPS 495
              +    R+  K      ++ ++I  +  L+ I +M++V+ +  + K R    K V   S
Sbjct: 855  LSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIAL--FFKQRHDFFKKVGHGS 912

Query: 496  VA--------------------DQRRFTYLELFQATNRFSENNLIGRGGFGPVYK----D 531
             A                     +    + ++ +AT+  SE  +IG GG G VYK    +
Sbjct: 913  TAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELEN 972

Query: 532  GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSN--DDFKALVLEYMPL 588
            G  VA+K    +    + KSF  E   + RIRHR+L+K++  CS+  +    L+ EYM  
Sbjct: 973  GETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKN 1032

Query: 589  GSLEKCLYSGNYIL-------DIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL 641
            GS+   L+    +L       D    L I + +A  +EYLH     PI+H D+K SNVLL
Sbjct: 1033 GSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLL 1092

Query: 642  DDNMVAHLSDFGMAKPLLEEDQSLTQTQTL--ATIGYMAPDEIFS 684
            D NM AHL DFG+AK L E   + T + T    + GY+AP+  +S
Sbjct: 1093 DSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYAYS 1137

Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2

 Score =  299 bits (766), Expect = 6e-80,   Method: Compositional matrix adjust.
 Identities = 255/801 (31%), Positives = 389/801 (48%), Gaps = 100/801 (12%)

Query: 4    LTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFN 63
            L N+ L G + S + N ++LQ   L +N   G        ++P EI  L  +E M    N
Sbjct: 392  LNNNSLEGTLSSSISNLTNLQEFTLYHNNLEG--------KVPKEIGFLGKLEIMYLYEN 443

Query: 64   KVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIF 123
            +  G +P  I N + L+ +  + N LSG +PSS   RL +L  LHL  N  +G IP+ + 
Sbjct: 444  RFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIG-RLKDLTRLHLRENELVGNIPASLG 502

Query: 124  NASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEY 183
            N  +++ + L  N  SGSIP++FG L  L+   + +N L  + P+     SL N K L  
Sbjct: 503  NCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPD-----SLINLKNLTR 557

Query: 184  FSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLI------------ 231
             +FS+N   G +    G  S S   F +      G IP E+   TNL             
Sbjct: 558  INFSSNKFNGSISPLCG--SSSYLSFDVTENGFEGDIPLELGKSTNLDRLRLGKNQFTGR 615

Query: 232  ----------LQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSG------ 275
                      L LL +  N L G IP +L     L  +DL  N LSG +P   G      
Sbjct: 616  IPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGKLPLLG 675

Query: 276  ------------------NLTNLRKLYL-GSNLLTSIPSTLWNLKDILHLNLSSNFFTGP 316
                              +LTN+  L+L G++L  SIP  + NL+ +  LNL  N  +GP
Sbjct: 676  ELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEENQLSGP 735

Query: 317  LPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQ-YLFLEYNRLQGSIPNSIGDLISL 375
            LP  IG L+ L +L LS N  +  IP +IG L+DLQ  L L YN   G IP++I  L  L
Sbjct: 736  LPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTISTLPKL 795

Query: 376  KSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCG 435
            +SL+LS+N L G +P  +  +  L  +N+S+N LEG++ ++  F    A++F GN  LCG
Sbjct: 796  ESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKKQ--FSRWQADAFVGNAGLCG 853

Query: 436  MPNLQVLSCRTKIHHTLG-KNDLLIGIVLPLSTIFMMVVVLLIL---------KYRKGRK 485
             P        +K   +L  K  ++I  +  L+ I +MV+V+++          K R G  
Sbjct: 854  SPLSHCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDLFKKVRGGNS 913

Query: 486  SQLKDVNMPSV------ADQRRFTYLELFQATNRFSENNLIGRGGFGPVYK----DGMEV 535
            +   + +            +    + ++ +AT+  +E  +IG GG G VYK    +G  +
Sbjct: 914  AFSSNSSSSQAPLFSNGGAKSDIKWDDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETI 973

Query: 536  AIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSN--DDFKALVLEYMPLGSLE 592
            A+K    +    + KSF+ E   +  IRHR+L+K++  CS+  D    L+ EYM  GS+ 
Sbjct: 974  AVKKILWKDDLMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVW 1033

Query: 593  KCLYSG-----NYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVA 647
              L++        +L     L I + +A  +EYLH+    PI+H D+K SNVLLD N+ A
Sbjct: 1034 DWLHANENTKKKEVLGWETRLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEA 1093

Query: 648  HLSDFGMAKPLLEEDQSLTQTQTL--ATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV 705
            HL DFG+AK L     + T++ T+   + GY+AP+  +S +   K  V  S+ I +M +V
Sbjct: 1094 HLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKATEKSDVY-SMGIVLMEIV 1152

Query: 706  DANLLIREEKHLMTKEQPMVR 726
               +     + +  +E  MVR
Sbjct: 1153 TGKM---PTEAMFDEETDMVR 1170

Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2

 Score =  298 bits (762), Expect = 1e-79,   Method: Compositional matrix adjust.
 Identities = 269/851 (31%), Positives = 382/851 (44%), Gaps = 176/851 (20%)

Query: 4   LTNDFLRGIILSQLGNPSSLQTLYLSYN------PPS------------------GSIPS 39
           L  ++L G I  Q+GN SSLQ L +  N      PPS                  G IPS
Sbjct: 146 LCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGFSGVIPS 205

Query: 40  FIL-CE---------------IPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLY 83
            I  CE               +P +++ L N+  +    N++ G +P ++ N+S L+ L 
Sbjct: 206 EISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNISRLEVLA 265

Query: 84  LHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIP 143
           LH N  +G +P     +L  +K L+L+ N   G IP  I N    +E+   +N  +G IP
Sbjct: 266 LHENYFTGSIPREIG-KLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGFIP 324

Query: 144 NTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLS 203
             FG++ NLK L L +N L    P       L     LE    S N L G +P+ +  L 
Sbjct: 325 KEFGHILNLKLLHLFENILLGPIPR-----ELGELTLLEKLDLSINRLNGTIPQELQFLP 379

Query: 204 QSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGG 263
             ++    DN  + G IP  I   +N    +L +  N L G IP   CR   L  L LG 
Sbjct: 380 YLVDLQLFDN-QLEGKIPPLIGFYSNF--SVLDMSANSLSGPIPAHFCRFQTLILLSLGS 436

Query: 264 NKLSGFVPACSGNLTNLRKLYLGSNLLT-SIPSTLWNLKDI----LH------------- 305
           NKLSG +P       +L KL LG N LT S+P  L+NL+++    LH             
Sbjct: 437 NKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLG 496

Query: 306 -------LNLSSNFFTGPLPLKIGNLNVLV------------------------QLDLSM 334
                  L L++N FTG +P +IGNL  +V                        +LDLS 
Sbjct: 497 KLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSG 556

Query: 335 NNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLK------------------ 376
           N FS  I  ++G L  L+ L L  NRL G IP+S GDL  L                   
Sbjct: 557 NKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELG 616

Query: 377 -------SLNLSNNNLSGTIPISLEKL-----LDLKD-------------------INVS 405
                  SLN+S+NNLSGTIP SL  L     L L D                    N+S
Sbjct: 617 KLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNIS 676

Query: 406 FNRLEGEIPREGPFRNLSAESFKGNELLCGMPNLQVLSCRTKIHHTLGKNDLLIG----- 460
            N L G +P    F+ + + +F GN  LC   N Q   C+  + H+  K + LI      
Sbjct: 677 NNNLVGTVPDTAVFQRMDSSNFAGNHGLC---NSQRSHCQPLVPHSDSKLNWLINGSQRQ 733

Query: 461 IVLPLSTIFMMVVVLL-------ILKYRKGRKSQLKDVNMPSVAD-----QRRFTYLELF 508
            +L ++ I +  V L+        +K R+     L+D   P V D     ++ FTY  L 
Sbjct: 734 KILTITCIVIGSVFLITFLGLCWTIKRREPAFVALEDQTKPDVMDSYYFPKKGFTYQGLV 793

Query: 509 QATNRFSENNLIGRGGFGPVYKDGME----VAIKVFNLQYGGAFK--SFDIECGMMKRIR 562
            AT  FSE+ ++GRG  G VYK  M     +A+K  N +  GA    SF  E   + +IR
Sbjct: 794 DATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSDNSFRAEISTLGKIR 853

Query: 563 HRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSG--NYILDIFQGLNIMIDVASALEY 620
           HRN++K+   C + +   L+ EYM  GSL + L  G  N +LD      I +  A  L Y
Sbjct: 854 HRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCY 913

Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH      I+H D+K +N+LLD+   AH+ DFG+AK L++   S + +    + GY+AP+
Sbjct: 914 LHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAK-LIDLSYSKSMSAVAGSYGYIAPE 972

Query: 681 EIFSGEMRLKC 691
             ++ ++  KC
Sbjct: 973 YAYTMKVTEKC 983

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LP24|Y1571_ARATH Probable leucine-rich repeat receptor-like protein kinase At1g35710 OS=Arabidopsis thaliana GN=At1g35710 PE=2 SV=1

 Score =  288 bits (738), Expect = 9e-77,   Method: Compositional matrix adjust.
 Identities = 230/728 (31%), Positives = 358/728 (49%), Gaps = 75/728 (10%)

Query: 4    LTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPS----------------FILCEIPH 47
            L  ++L G+I  +LGN  S+  L L+ N  +GSIPS                ++   IP 
Sbjct: 349  LYENYLTGVIPPELGNMESMIDLQLNNNKLTGSIPSSFGNLKNLTYLYLYLNYLTGVIPQ 408

Query: 48   EIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKEL 107
            E+ N+ +M  +  S NK+ G VP +  N + L+SLYL  N LSG +P        +L  L
Sbjct: 409  ELGNMESMINLDLSQNKLTGSVPDSFGNFTKLESLYLRVNHLSGAIPPGV-ANSSHLTTL 467

Query: 108  HLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTP 167
             L  NNF G  P  +    KL  + L  N   G IP +  + ++L       N  T    
Sbjct: 468  ILDTNNFTGFFPETVCKGRKLQNISLDYNHLEGPIPKSLRDCKSLIRARFLGNKFTGDIF 527

Query: 168  ELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNL 227
            E     +      L +  FS+N   G +  +    S  +    M N NI+G+IP EI N+
Sbjct: 528  E-----AFGIYPDLNFIDFSHNKFHGEI-SSNWEKSPKLGALIMSNNNITGAIPTEIWNM 581

Query: 228  TNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGS 287
            T L+   L L  N L G +P+ +  L  L +L L GN+LSG VPA    LTNL  L L S
Sbjct: 582  TQLVE--LDLSTNNLFGELPEAIGNLTNLSRLRLNGNQLSGRVPAGLSFLTNLESLDLSS 639

Query: 288  NLLTS-IPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIG 346
            N  +S IP T  +   +  +NLS N F G +P ++  L  L QLDLS             
Sbjct: 640  NNFSSEIPQTFDSFLKLHDMNLSRNKFDGSIP-RLSKLTQLTQLDLS------------- 685

Query: 347  GLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSF 406
                       +N+L G IP+ +  L SL  L+LS+NNLSG IP + E ++ L ++++S 
Sbjct: 686  -----------HNQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIALTNVDISN 734

Query: 407  NRLEGEIPREGPFRNLSAESFKGNELLCG-MPNLQVLSCRTKIHHTLGKNDLLIGIVLPL 465
            N+LEG +P    FR  +A++ + N  LC  +P  ++  CR ++       +L++ I++P+
Sbjct: 735  NKLEGPLPDTPTFRKATADALEENIGLCSNIPKQRLKPCR-ELKKPKKNGNLVVWILVPI 793

Query: 466  STIFMMVVV-----LLILKYRKGRKSQLKD----VNMPSVADQRRFTYLELFQATNRFSE 516
              + +++ +        ++ RK +  +  D     NM   +   +F Y ++ ++TN F  
Sbjct: 794  LGVLVILSICANTFTYCIRKRKLQNGRNTDPETGENMSIFSVDGKFKYQDIIESTNEFDP 853

Query: 517  NNLIGRGGFGPVYKDGME---VAIKVFN------LQYGGAFKSFDIECGMMKRIRHRNLI 567
             +LIG GG+  VY+  ++   +A+K  +      +      + F  E   +  IRHRN++
Sbjct: 854  THLIGTGGYSKVYRANLQDTIIAVKRLHDTIDEEISKPVVKQEFLNEVKALTEIRHRNVV 913

Query: 568  KIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYI--LDIFQGLNIMIDVASALEYLHFGY 625
            K+   CS+     L+ EYM  GSL K L +      L   + +N++  VA AL Y+H   
Sbjct: 914  KLFGFCSHRRHTFLIYEYMEKGSLNKLLANDEEAKRLTWTKRINVVKGVAHALSYMHHDR 973

Query: 626  SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG 685
              PI+H D+   N+LLD++  A +SDFG AK LL+ D S   +    T GY+AP+  ++ 
Sbjct: 974  ITPIVHRDISSGNILLDNDYTAKISDFGTAK-LLKTDSS-NWSAVAGTYGYVAPEFAYTM 1031

Query: 686  EMRLKCWV 693
            ++  KC V
Sbjct: 1032 KVTEKCDV 1039

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	797
359497186	1140	PREDICTED: LRR receptor-like serine/thre	0.885	0.619	0.476	1e-177
359483677	1229	PREDICTED: LRR receptor-like serine/thre	0.885	0.574	0.475	1e-177
359485453	1202	PREDICTED: probable LRR receptor-like se	0.879	0.583	0.483	1e-177
224116832	1061	predicted protein [Populus trichocarpa]	0.883	0.663	0.467	1e-176
147776333	1205	hypothetical protein VITISV_000078 [Viti	0.885	0.585	0.474	1e-175
255572272	1089	serine-threonine protein kinase, plant-t	0.903	0.661	0.464	1e-174
147852480	1229	hypothetical protein VITISV_039533 [Viti	0.877	0.568	0.472	1e-174
359483683	1228	PREDICTED: LRR receptor-like serine/thre	0.875	0.568	0.471	1e-174
359483675	1250	PREDICTED: LRR receptor-like serine/thre	0.883	0.563	0.471	1e-173
147769371	1241	hypothetical protein VITISV_010511 [Viti	0.885	0.568	0.465	1e-173

>gi|359497186|ref|XP_003635448.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera]

 Score =  630 bits (1625), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 373/782 (47%), Positives = 488/782 (62%), Gaps = 76/782 (9%)

Query: 3    SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSF 62
            SL+ +  RG I  ++GN S L+ +YL  N   GSIP+           NL  ++++    
Sbjct: 330  SLSFNKFRGSIPKEIGNLSKLEEIYLGTNSLIGSIPT--------SFGNLKALKFLNLGI 381

Query: 63   NKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFI 122
            N + G VP  IFN+S L+SL +  N LSG LPSS    LP+L+ L + GN F G IP  I
Sbjct: 382  NNLTGTVPEAIFNISKLQSLAMVKNHLSGSLPSSIGTWLPDLEGLFIAGNEFSGIIPMSI 441

Query: 123  FNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSS--TPELSSLSSLSNCKY 180
             N SKL+ LGL  NSF+G++P   GNL  LK L L  N LT      E+  L+SL+NCK+
Sbjct: 442  SNMSKLTVLGLSANSFTGNVPKDLGNLTKLKVLDLAGNQLTDEHVASEVGFLTSLTNCKF 501

Query: 181  LEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLI--------- 231
            L+     N P  G LP ++GNL  ++E F    C   G+IP  I NLTNLI         
Sbjct: 502  LKNLWIGNIPFKGTLPNSLGNLPIALESFIASACQFRGTIPTGIGNLTNLIRLDLGANDL 561

Query: 232  -------------LQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLT 278
                         LQ L + GN++ GSIP+DLC L  L  L L  NKLSG +P+C G+L 
Sbjct: 562  TGSIPTTLGQLQKLQWLYIAGNRIRGSIPNDLCHLKDLGYLFLSSNKLSGSIPSCFGDLL 621

Query: 279  NLRKLYLGSNLLT-SIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNF 337
             L++L+L SN+L  +IP++LW+L+D+L LNLSSNF TG LP ++GN+  +  LDLS N  
Sbjct: 622  ALQELFLDSNVLAFNIPTSLWSLRDLLALNLSSNFLTGNLPPEVGNMKSITTLDLSKNLV 681

Query: 338  SCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLL 397
            S  IP+K+G L+ L  L L  NRLQG IP   GDL+SL+SL+LS NNLSGTIP SLE L+
Sbjct: 682  SGYIPSKMGKLQSLITLSLSQNRLQGPIPIEFGDLVSLESLDLSQNNLSGTIPKSLEALI 741

Query: 398  DLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMPNLQVLSC----RTKIHHTLG 453
             LK +NVS N+L+GEIP  GPF N +AESF  NE LCG P+ QV++C    RT+   T  
Sbjct: 742  YLKYLNVSLNKLQGEIPNGGPFINFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKT-- 799

Query: 454  KNDLLIGIVLPLSTIFMMVVVLLILKYRKGRKSQLKDVNMPSVADQRRFTYLELFQATNR 513
            K+ +L  I+LP+ +I  +VV +++   R+        ++        + ++ +L  ATN 
Sbjct: 800  KSFILKYILLPVGSIVTLVVFIVLWIRRRDNMEIPTPIDSWLPGTHEKISHQQLLYATND 859

Query: 514  FSENNLIGRGGFGPVYK----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKI 569
            F E+NLIG+G  G VYK    +G+ VAIKVFNL++ GA +SFD EC +M+ IRHRNL++I
Sbjct: 860  FGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRI 919

Query: 570  ISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPI 629
            I+ CSN DFKALVLEYMP GSLEK LYS NY LD+ Q LNIMIDVASALEYLH   S  +
Sbjct: 920  ITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSSLV 979

Query: 630  IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP---------- 679
            +HCDLKP+NVLLDD+MVAH++DFG+ K LL + +S+ QT+TL TIGYMAP          
Sbjct: 980  VHCDLKPNNVLLDDDMVAHVADFGITK-LLTKTESMQQTKTLGTIGYMAPEHGSDGIVST 1038

Query: 680  ---------------------DEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEKHLM 718
                                 DE+F+G + LK WV +SL  SV+ VVDANLL RE++ L 
Sbjct: 1039 KSDVYSYGILLMEVFSRKKPMDEMFTGGLTLKTWV-ESLSNSVIQVVDANLLRREDEDLA 1097

Query: 719  TK 720
            TK
Sbjct: 1098 TK 1099

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483677|ref|XP_003633000.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO2-like [Vitis vinifera]

 Score =  629 bits (1622), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 372/782 (47%), Positives = 488/782 (62%), Gaps = 76/782 (9%)

Query: 3    SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSF 62
            SL+ +  RG I  ++GN S L+ +YL  N   GSIP+           NL  ++++    
Sbjct: 419  SLSFNKFRGSIPKEIGNLSKLEKIYLGTNSLIGSIPT--------SFGNLKALKFLNLGI 470

Query: 63   NKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFI 122
            N + G VP  IFN+S L+SL +  N LSG LPSS    L +L+ L + GN F G IP  I
Sbjct: 471  NNLTGTVPEAIFNISKLQSLAMVKNHLSGSLPSSIGTWLSDLEGLFIAGNEFSGIIPMSI 530

Query: 123  FNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSS--TPELSSLSSLSNCKY 180
             N SKL+ LGL  NSF+G++P   GNL  LK L L  N LT      E+  L+SL+NCK+
Sbjct: 531  SNMSKLTVLGLSANSFTGNVPKDLGNLTKLKVLDLAGNQLTDEHVASEVGFLTSLTNCKF 590

Query: 181  LEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLI--------- 231
            L+     NNP  G LP ++GNL  ++E F    C   G+IP  I NLTNLI         
Sbjct: 591  LKNLWIGNNPFKGTLPNSLGNLPIALESFIASACQFRGTIPTRIGNLTNLIWLDLGANDL 650

Query: 232  -------------LQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLT 278
                         LQ L + GN+L GSIP+DLC L  L  L L  NKLSG +P+C G+L 
Sbjct: 651  TGSIPTTLGRLKKLQKLHIVGNRLRGSIPNDLCHLKNLGYLHLSSNKLSGSIPSCFGDLP 710

Query: 279  NLRKLYLGSNLLT-SIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNF 337
             L++L+L SN+L  +IP++LW+L+D+L LNLSSNF TG LP ++GN+  +  LDLS N  
Sbjct: 711  ALQELFLDSNVLAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLV 770

Query: 338  SCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLL 397
            S  IP K+G  ++L  L L  N+LQG IP   GDL+SL+SL+LS NNLSGTIP SLE L+
Sbjct: 771  SGHIPRKMGEQQNLAKLSLSQNKLQGPIPIEFGDLVSLESLDLSQNNLSGTIPKSLEALI 830

Query: 398  DLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMPNLQVLSC----RTKIHHTLG 453
             LK +NVS N+L+GEIP  GPF N +AESF  NE LCG P+ QV++C    RT+   T  
Sbjct: 831  YLKYLNVSLNKLQGEIPNGGPFINFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKT-- 888

Query: 454  KNDLLIGIVLPLSTIFMMVVVLLILKYRKGRKSQLKDVNMPSVADQRRFTYLELFQATNR 513
            K+ +L  I+LP+ +I  +VV +++   R+        ++        + ++ +L  ATN 
Sbjct: 889  KSFILKYILLPVGSIVTLVVFIVLWIRRRDNMEIPTPIDSWLPGTHEKISHQQLLYATND 948

Query: 514  FSENNLIGRGGFGPVYK----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKI 569
            F E+NLIG+G  G VYK    +G+ VAIKVFNL++ GA +SFD EC +M+ IRHRNL++I
Sbjct: 949  FGEDNLIGKGSQGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRI 1008

Query: 570  ISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPI 629
            I+ CSN DFKALVLEYMP GSLEK LYS NY LD+ Q LNIMIDVASALEYLH   S  +
Sbjct: 1009 ITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSSLV 1068

Query: 630  IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP---------- 679
            +HCDLKP+NVLLDD+MVAH++DFG+ K LL + +S+ QT+TL TIGYMAP          
Sbjct: 1069 VHCDLKPNNVLLDDDMVAHVADFGITK-LLTKTESMQQTKTLGTIGYMAPEHGSDGIVST 1127

Query: 680  ---------------------DEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEKHLM 718
                                 DE+F+G++ LK WV +SL  SV+ VVDANLL RE++ L 
Sbjct: 1128 KSDVYSYGILLMEVFSRKKPMDEMFTGDLTLKTWV-ESLSNSVIQVVDANLLRREDEDLA 1186

Query: 719  TK 720
            TK
Sbjct: 1187 TK 1188

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359485453|ref|XP_003633276.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera]

 Score =  628 bits (1620), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 378/781 (48%), Positives = 491/781 (62%), Gaps = 80/781 (10%)

Query: 6    NDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKV 65
            N+F  G I  ++GN S L+ +Y   +  +G+IP         E+ NL N+++++ + N +
Sbjct: 393  NNF-TGSIPREIGNLSKLEQIYFRRSSFTGNIPK--------ELGNLVNLQFLSLNVNNL 443

Query: 66   VGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNA 125
             G+VP  IFN+S L+ L L  N LSG LPSS    LPNL++L + GN F G IP  I N 
Sbjct: 444  TGIVPEAIFNISKLQVLSLAGNHLSGSLPSSIGSWLPNLEQLLIGGNEFSGIIPMSISNM 503

Query: 126  SKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTS--STPELSSLSSLSNCKYLEY 183
            S L  L +  N F G++P   GNLR L+ LGL+ N LT+  S  EL+ L+SL+NC +L  
Sbjct: 504  SNLISLDISDNFFIGNVPKDLGNLRQLQLLGLSHNQLTNEHSASELAFLTSLTNCIFLRT 563

Query: 184  FSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLI------------ 231
             S S+NPL G++P ++GNLS S+E  +  +C + G+IP  I+NLTNLI            
Sbjct: 564  LSISDNPLKGMIPNSLGNLSISLEIIYASDCQLRGTIPTGISNLTNLIGLRLDDNDLTGL 623

Query: 232  ----------LQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLR 281
                      LQ+LS+  N++ GSIP  LC L  L  LDL  NKLSG +P+CSGNLT LR
Sbjct: 624  IPTPFGRLQKLQMLSISQNRIHGSIPSGLCHLTNLAFLDLSSNKLSGTIPSCSGNLTGLR 683

Query: 282  KLYLGSNLLTS-IPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCV 340
             +YL SN L S IPS+L NL+ +L LNLSSNF    LPL++GN+  LV LDLS N FS  
Sbjct: 684  NVYLHSNGLASEIPSSLCNLRGLLVLNLSSNFLNSQLPLQVGNMKSLVALDLSKNQFSGN 743

Query: 341  IPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLK 400
            IP+ I  L++L  L+L +N+LQG IP + GDL+SL+SL+LS NNLSGTIP SLE L  L+
Sbjct: 744  IPSTISLLQNLLQLYLSHNKLQGHIPPNFGDLVSLESLDLSGNNLSGTIPKSLEHLKYLE 803

Query: 401  DINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMPNLQVLSCRTKIHHTLGKNDLLIG 460
             +NVSFN+L+GEIP  GPF N +AESF  N  LCG P  QV++C            LL+ 
Sbjct: 804  YLNVSFNKLQGEIPNGGPFANFTAESFISNLALCGAPRFQVMACEKDSRKN--TKSLLLK 861

Query: 461  IVLPLSTIF--MMVVVLLILKYRKGRKSQLK---DVNMPSVADQRRFTYLELFQATNRFS 515
             ++PLS     +++VVL +   R+  KS+     D+++P +   R   + EL  ATN F 
Sbjct: 862  CIVPLSVSLSTIILVVLFVQWKRRQTKSETPIQVDLSLPRM--HRMIPHQELLYATNYFG 919

Query: 516  ENNLIGRGGFGPVYK----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIIS 571
            E+NLIG+G  G VYK    DG+ VA+KVFNL+  GAFKSF++EC +M+ IRHRNL KIIS
Sbjct: 920  EDNLIGKGSLGMVYKGVLSDGLIVAVKVFNLELQGAFKSFEVECEVMRNIRHRNLAKIIS 979

Query: 572  SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
            SCSN DFKALVLEYMP GSLEK LYS NY LD  Q L IMIDVAS LEYLH  YS P++H
Sbjct: 980  SCSNLDFKALVLEYMPNGSLEKWLYSHNYYLDFVQRLKIMIDVASGLEYLHHYYSNPVVH 1039

Query: 632  CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP------------ 679
            CDLKPSNVLLDD+MVAH+SDFG+AK LL   + + +T+TL T+GYMAP            
Sbjct: 1040 CDLKPSNVLLDDDMVAHISDFGIAK-LLMGSEFMKRTKTLGTVGYMAPEYGSEGIVSTKG 1098

Query: 680  -------------------DEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEKHLMTK 720
                               DE+F  E+ LK WV  S   ++M V+DANLL  E++    K
Sbjct: 1099 DIYSYGILLMETFVRKKPTDEMFVEELTLKSWVESS-TNNIMEVIDANLLTEEDESFALK 1157

Query: 721  E 721
             
Sbjct: 1158 R 1158

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224116832|ref|XP_002317405.1| predicted protein [Populus trichocarpa] gi|222860470|gb|EEE98017.1| predicted protein [Populus trichocarpa]

 Score =  625 bits (1611), Expect = e-176,   Method: Compositional matrix adjust.
 Identities = 362/775 (46%), Positives = 477/775 (61%), Gaps = 71/775 (9%)

Query: 9    LRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGV 68
            L G I  ++GN + L  +++  N  +G IP        +E+ NLH ++ +   FN + G 
Sbjct: 247  LNGNIPREIGNCTYLMEIHVENNNLTGVIP--------NEMGNLHTLQELDLGFNNITGS 298

Query: 69   VPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKL 128
            +P+T FN S L+ + +  N LSG LPS+  + LPNL+EL+L  N   G IP  I NASKL
Sbjct: 299  IPSTFFNFSILRRVNMAYNYLSGHLPSNTGLGLPNLEELYLEKNELSGPIPDSIGNASKL 358

Query: 129  SELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLS--NCKYLEYFSF 186
              L L  NSFSG IP+  GNLRNL+ L L +N LTS +         S  NC+ L Y  F
Sbjct: 359  IVLDLSYNSFSGRIPDLLGNLRNLQKLNLAENILTSKSLRSELSFLSSLSNCRSLAYLRF 418

Query: 187  SNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLI--------------- 231
            + NPL G LP +IGNLS S+E+ +  +C I G+IP  I NL+NLI               
Sbjct: 419  NGNPLRGRLPVSIGNLSASLEELYAFDCRIIGNIPRGIGNLSNLIGLILQQNELTGAIPS 478

Query: 232  -------LQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLY 284
                   LQ  SL  N+L+G IP+++C L  L  L L  N  SG +PAC  N+T+LR+LY
Sbjct: 479  EIGRLKHLQDFSLASNKLQGHIPNEICHLERLSYLYLLENGFSGSLPACLSNITSLRELY 538

Query: 285  LGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTK 344
            LGSN  TSIP+T W+LKD+L +NLS N  TG LPL+IGNL V+  +D S N  S  IPT 
Sbjct: 539  LGSNRFTSIPTTFWSLKDLLQINLSFNSLTGTLPLEIGNLKVVTVIDFSSNQLSGDIPTS 598

Query: 345  IGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINV 404
            I  L++L +  L  NR+QG IP+S GDL+SL+ L+LS N+LSG IP SLEKL+ LK  NV
Sbjct: 599  IADLQNLAHFSLSDNRMQGPIPSSFGDLVSLEFLDLSRNSLSGAIPKSLEKLVHLKTFNV 658

Query: 405  SFNRLEGEIPREGPFRNLSAESFKGNELLCGMPNLQVLSCRTKIHHTLGK--NDLLIGIV 462
            SFNRL+GEI   GPF N S  SF  NE LCG   +QV  C++   H   K   + +I  +
Sbjct: 659  SFNRLQGEILDGGPFANFSFRSFMDNEALCGPIRMQVPPCKSISTHRQSKRPREFVIRYI 718

Query: 463  LPLSTIFMMVVVLLILKYRKGRKSQLKDVNMP-SVADQRRFTYLELFQATNRFSENNLIG 521
            +P     ++V+ L ++ +R+  K +L     P   A  R+ +Y EL++AT  F+E NL+G
Sbjct: 719  VPAIAFIILVLALAVIIFRRSHKRKLSTQEDPLPPATWRKISYHELYRATEGFNETNLLG 778

Query: 522  RGGFGPVYK----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDD 577
             G  G VYK    DG+ +A+KVF+LQ  G    FD EC +++ +RHRNL+KIISSC N D
Sbjct: 779  TGSCGSVYKGTLSDGLCIAVKVFHLQLEGELMRFDSECEVLRMLRHRNLVKIISSCCNLD 838

Query: 578  FKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPS 637
            FKAL+LE++P GSLEK LYS NY LDI Q LNIMIDVASALEYLH G + P++HCDLKPS
Sbjct: 839  FKALILEFIPHGSLEKWLYSHNYYLDILQRLNIMIDVASALEYLHHGCTRPVVHCDLKPS 898

Query: 638  NVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP------------------ 679
            NVL++++MVAH+SDFG+++ LL E  ++TQT TLATIGYMAP                  
Sbjct: 899  NVLINEDMVAHVSDFGISR-LLGEGDAVTQTLTLATIGYMAPEYGLEGIVSVKGDVYSYG 957

Query: 680  -------------DEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEKHLMTKE 721
                         D++F GEM LK WV  SL  ++  V+DANLLI EE  +  K+
Sbjct: 958  IFLMETFTRKKPTDDMFGGEMSLKNWVKQSLPKAITEVIDANLLIEEEHFVAKKD 1012

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147776333|emb|CAN72034.1| hypothetical protein VITISV_000078 [Vitis vinifera]

 Score =  621 bits (1601), Expect = e-175,   Method: Compositional matrix adjust.
 Identities = 371/782 (47%), Positives = 486/782 (62%), Gaps = 76/782 (9%)

Query: 3    SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSF 62
            SL+ +  RG I  ++GN S L+ + L  N   GSIP+           NL  ++++    
Sbjct: 395  SLSFNKFRGSIPREIGNLSKLEHIDLRSNSLVGSIPT--------SFGNLKALKFLNLGI 446

Query: 63   NKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFI 122
            N + G VP  IFN+S L++L L  N LSG LPSS    LP+L+ L++  N F GTIP  I
Sbjct: 447  NFLTGTVPEAIFNISELQNLALVQNHLSGSLPSSIGTWLPDLEGLYIGANEFSGTIPMSI 506

Query: 123  FNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSS--TPELSSLSSLSNCKY 180
             N SKL+ L L  NSF+G++P    NL  LK+L L  N LT       +  L+SL+NCK+
Sbjct: 507  SNMSKLTVLSLSDNSFTGNVPKDLCNLTKLKFLNLAHNQLTDEHLASGVGFLTSLTNCKF 566

Query: 181  LEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLI--------- 231
            L Y     NPL G LP ++GNL  ++E F    C   G+IP  I NLTNLI         
Sbjct: 567  LRYLWIGYNPLKGTLPNSLGNLPIALESFTAYACQFRGTIPTGIGNLTNLIWLDLGANDL 626

Query: 232  -------------LQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLT 278
                         LQ L + GN++ GSIP+DLC L  L  L L  NKLSG  P+C G+L 
Sbjct: 627  TGSIPTTLGRLQKLQRLHIAGNRIRGSIPNDLCHLKNLGYLGLSSNKLSGSTPSCFGDLL 686

Query: 279  NLRKLYLGSNLLT-SIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNF 337
             LR+L+L SN L  +IP++LW+L+D+L LNLSSNF TG LP ++GN+  +  LDLS N  
Sbjct: 687  ALRELFLDSNALAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLV 746

Query: 338  SCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLL 397
            S  IP+++G L+ L  L L  NRLQG I    GDL+SL+SL+LS+NNLSGTIP SLE L+
Sbjct: 747  SGYIPSRMGKLQYLITLSLSQNRLQGPIXVEFGDLVSLESLDLSHNNLSGTIPKSLEALI 806

Query: 398  DLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMPNLQVLSC----RTKIHHTLG 453
             LK +NVSFN+L+GEIP  GPF   +AESF  NE LCG P+ QV++C    RT+   T  
Sbjct: 807  YLKYLNVSFNKLQGEIPNGGPFVKFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKT-- 864

Query: 454  KNDLLIGIVLPLSTIFMMVVVLLILKYRKGRKSQLKDVNMPSVADQRRFTYLELFQATNR 513
            K+ +L  I+LP+ +   +VV +++   R+        ++   +    + ++ +L  ATN 
Sbjct: 865  KSFILKYILLPVGSTVTLVVFIVLWIRRRDNMEIPTPIDSWLLGTHEKISHQQLLYATND 924

Query: 514  FSENNLIGRGGFGPVYK----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKI 569
            F E+NLIG+G  G VYK    +G+ VAIKVFNL++ GA +SFD EC +M+ IRHRNL++I
Sbjct: 925  FGEDNLIGKGSQGMVYKGVLSNGLNVAIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRI 984

Query: 570  ISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPI 629
            I+ CSN DFKALVLEYMP GSLEK LYS NY LD+ Q LNIMIDVASALEYLH   S  +
Sbjct: 985  ITCCSNLDFKALVLEYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSSLV 1044

Query: 630  IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP---------- 679
            +HCDLKPSNVLLDD+MVAH++DFG+AK LL E +S+ QT+TL TIGYMAP          
Sbjct: 1045 VHCDLKPSNVLLDDDMVAHVADFGIAK-LLTETESMQQTKTLGTIGYMAPEHGSAGIVST 1103

Query: 680  ---------------------DEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEKHLM 718
                                 DE+F+G++ LK WV +SL  SV+ VVD NLL RE++ L 
Sbjct: 1104 KSDVYSYGILLMEVFARKKPMDEMFTGDLTLKTWV-ESLSNSVIQVVDVNLLRREDEDLA 1162

Query: 719  TK 720
            TK
Sbjct: 1163 TK 1164

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255572272|ref|XP_002527075.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223533580|gb|EEF35319.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  618 bits (1594), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 375/807 (46%), Positives = 496/807 (61%), Gaps = 87/807 (10%)

Query: 4    LTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFI----------------LCEIPH 47
            L  + L G I S L     L++L L  N  +GSIP  I                   IP 
Sbjct: 247  LAGNQLYGQIPSDLYKCKELRSLALHANKFTGSIPRTIGNLTKLKWLSLGRNNLTGRIPL 306

Query: 48   EIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKEL 107
            EI NL N++ +  SFN + G +P  +FN+ST+K + + SN+L G LP+S  + LPNL  L
Sbjct: 307  EIGNLQNLQIVHLSFNNLNGSIPHALFNISTMKWIAMTSNNLLGNLPTSLGLHLPNLIWL 366

Query: 108  HLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTS--S 165
            +L  N   G IPS+I NASKL+ L L  NSF+G IP++ G+LRNL+ L L  N L+S  +
Sbjct: 367  YLGINKLSGPIPSYISNASKLTILELPSNSFTGFIPDSLGDLRNLQTLKLGANLLSSKKT 426

Query: 166  TPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEIN 225
            + EL+  SSL NC+ L+Y   S NPL G LP ++GNLS S+E F   +  I GS+ E I 
Sbjct: 427  SQELTIFSSLKNCQNLKYLWLSYNPLDGYLPHSVGNLSNSLESFLASDGLIKGSVHESIG 486

Query: 226  NLTNLI----------------------LQLLSLEGNQLEGSIPDDLCRLAALFQLDLGG 263
            NL++L                       LQ L L GN L+GSIP +LC L  L+ L+L G
Sbjct: 487  NLSSLTRLNLGNNDLTGRIPTTIGTLKHLQGLYLHGNDLDGSIPSELCDLRTLYNLELTG 546

Query: 264  NKLSGFVPACSGNLTNLRKLYLGSN-LLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIG 322
            NKLSG +P C  NLT+LR L+L SN  +++I STLW LKDIL +NL+SN+ TG LP +I 
Sbjct: 547  NKLSGSIPTCFSNLTSLRNLFLASNRFVSTISSTLWTLKDILQVNLASNYLTGSLPSEIE 606

Query: 323  NLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSN 382
            NL  +  +++S N  S  IP  IGGL+DL  L+L  N+LQG IP S+GD+ SL+ L+LS+
Sbjct: 607  NLRAVYMINISKNQLSGEIPISIGGLQDLAQLYLSGNKLQGPIPQSVGDIKSLEFLDLSS 666

Query: 383  NNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMPNLQVL 442
            NNLSG IP SL+ LL LK  NVSFN L+GEIP  G F N SA+SF GNE LCG   LQV 
Sbjct: 667  NNLSGMIPKSLDNLLYLKYFNVSFNYLQGEIPEGGSFSNFSAQSFIGNEALCGSARLQVS 726

Query: 443  SCR---TKIHHTLGKNDLLIGIVLP--LSTIFMMVVVLLILKY--RKGRKSQLKDVNMPS 495
             C+   ++   T G + +++  VLP  +  +F++  V+++ +Y  RK + S   D    +
Sbjct: 727  PCKDDNSRATETPG-SKIVLRYVLPAIVFAVFVLAFVIMLKRYCERKAKFSIEDD--FLA 783

Query: 496  VADQRRFTYLELFQATNRFSENNLIGRGGFGPVYK----DGMEVAIKVFNLQYGGAFKSF 551
            +   RR +Y EL  ATN F E+N +G G FG VYK    DG  +A KVFNLQ   AFKSF
Sbjct: 784  LTTIRRISYHELQLATNGFQESNFLGMGSFGSVYKGTLSDGTVIAAKVFNLQLERAFKSF 843

Query: 552  DIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIM 611
            D EC +++ +RHRNL+KII+SCS  +FKALVLE+MP  SLEK LYS +Y L+  Q LNIM
Sbjct: 844  DTECEVLRNLRHRNLVKIITSCSGPNFKALVLEFMPNWSLEKWLYSDDYFLNNLQRLNIM 903

Query: 612  IDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL 671
            +DVAS LEYLH GY++P+ HCD+KPSNVLL+++MVA L+DFG++K LL E+ S+ QT TL
Sbjct: 904  LDVASVLEYLHHGYTIPMAHCDIKPSNVLLNEDMVAFLADFGISK-LLGEEGSVMQTMTL 962

Query: 672  ATIGYMAP-------------------------------DEIFSGEMRLKCWVNDSLLIS 700
            ATIGYMAP                               D++F+ ++ LK WV  SL   
Sbjct: 963  ATIGYMAPEYGSEGIVSVRGDVYSYGVLLMETFTQKKPTDKMFTEQLSLKSWVEQSLSCE 1022

Query: 701  VMIVVDANLLIREEKHLMTKEQPMVRM 727
            V  V+DANLL  EE HL  K+  +V +
Sbjct: 1023 VTQVIDANLLGIEEDHLAAKKDCIVSI 1049

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147852480|emb|CAN78527.1| hypothetical protein VITISV_039533 [Vitis vinifera]

 Score =  617 bits (1592), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 373/789 (47%), Positives = 494/789 (62%), Gaps = 90/789 (11%)

Query: 3    SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSF 62
            SL+ +  RG I  ++GN S L+ + LS N   GSIP+           NL  ++++    
Sbjct: 419  SLSFNKFRGSIPREIGNLSKLEWIDLSSNSLVGSIPT--------SFGNLMALKFLNLGI 470

Query: 63   NKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFI 122
            N + G VP  IFN+S L+SL +  N LSG LPSS    LP+L+ L + GN F G IP  I
Sbjct: 471  NNLTGTVPEAIFNISKLQSLAMAINHLSGSLPSSIGTWLPDLEGLFIGGNEFSGIIPVSI 530

Query: 123  FNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSS--TPELSSLSSLSNCKY 180
             N SKL++L + +NSF G++P   GNL  L+ L L  N  T+     E+S L+SL+NCK+
Sbjct: 531  SNMSKLTQLDVSRNSFIGNVPKDLGNLTKLEVLNLAGNQFTNEHLASEVSFLTSLTNCKF 590

Query: 181  LEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLI--------- 231
            L+     NNP  G LP ++GNL  ++E F    C   G+IP  I NLTNLI         
Sbjct: 591  LKNLWIGNNPFKGTLPNSLGNLPIALESFIASACQFRGTIPTGIGNLTNLIWLDLGANDL 650

Query: 232  -------------LQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLT 278
                         LQ L + GN+L GSIP+DLC L  L  L L  NKLSG +P+C G+L 
Sbjct: 651  TGSIPTILGRLKKLQRLHIAGNRLRGSIPNDLCHLKNLGYLHLSSNKLSGSIPSCFGDLP 710

Query: 279  NLRKLYLGSNLLT-SIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNF 337
             L++L+L SN+L  +IP++LW+L+D+L LNLSSNF TG LP ++GN+  +  LDLS N  
Sbjct: 711  ALQELFLDSNVLAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLV 770

Query: 338  SCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLL 397
            S  IP ++G  ++L  L L  NRLQG IP   GDL+SL+SL+LS NNLSGTIP SLE L+
Sbjct: 771  SGYIPRRMGEQQNLAKLSLSQNRLQGPIPVEFGDLVSLESLDLSQNNLSGTIPKSLEALI 830

Query: 398  DLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMPNLQVLSC----RTKIHHTLG 453
             LK +NVS N+L+GEIP  GPF N +AESF  NE LCG P+ QV++C    RT+   T  
Sbjct: 831  YLKYLNVSSNKLQGEIPNGGPFVNFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKT-- 888

Query: 454  KNDLLIGIVLPL-STIFMMVVVLLILKYRKGRKSQLKDVNMPSVAD------QRRFTYLE 506
            K+ +L  I+LP+ STI ++V ++L ++ R        ++ +P+  D        + ++  
Sbjct: 889  KSFILKYILLPVGSTITLVVFIVLWIRRRD-------NMEIPTPIDSWLPGTHEKISHQR 941

Query: 507  LFQATNRFSENNLIGRGGFGPVYK----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIR 562
            L  ATN F E+NLIG+G  G VYK    +G+ VAIKVFNL++ GA +SFD EC +M+ IR
Sbjct: 942  LLYATNDFGEDNLIGKGSQGMVYKGVLSNGLIVAIKVFNLEFQGALRSFDSECEVMQGIR 1001

Query: 563  HRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
            HRNL++II+ CSN DFKALVL+YMP GSLEK LYS NY LD+ Q LNIMIDVASALEYLH
Sbjct: 1002 HRNLVRIITCCSNLDFKALVLKYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLH 1061

Query: 623  FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP--- 679
               S  ++HCDLKPSNVLLDD+MVAH++DFG+ K LL + +S+ QT+TL TIGYMAP   
Sbjct: 1062 HDCSSLVVHCDLKPSNVLLDDDMVAHVADFGITK-LLTKTESMQQTKTLGTIGYMAPEHG 1120

Query: 680  ----------------------------DEIFSGEMRLKCWVNDSLLISVMIVVDANLLI 711
                                        DE+F+G++ LK WV +SL  SV+ VVD NLL 
Sbjct: 1121 SDGIVSTKSDVYSYGILLMEVFARKKPMDEMFTGDLTLKTWV-ESLSNSVIQVVDVNLLR 1179

Query: 712  REEKHLMTK 720
            RE++ L TK
Sbjct: 1180 REDEDLATK 1188

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483683|ref|XP_003633001.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera]

 Score =  617 bits (1590), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 365/774 (47%), Positives = 482/774 (62%), Gaps = 76/774 (9%)

Query: 11   GIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVP 70
            G I   +GN S L+ +YLS N   GSIP+           NL  ++++    N + G +P
Sbjct: 426  GSIPRDIGNLSKLEKIYLSTNSLIGSIPT--------SFGNLKALKFLQLGSNNLTGTIP 477

Query: 71   TTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSE 130
              IFN+S L++L L  N LSG LPSS    LP+L+ L + GN F GTIP  I N SKL  
Sbjct: 478  EDIFNISKLQTLALAQNHLSGGLPSSIGTWLPDLEGLFIGGNEFSGTIPVSISNMSKLIR 537

Query: 131  LGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSS--TPELSSLSSLSNCKYLEYFSFSN 188
            L +  N F+G++P    NLR L+ L L  N LT    T E+  L+SL+NCK+L       
Sbjct: 538  LHISDNYFTGNVPKDLSNLRKLEVLNLAGNQLTDEHLTSEVGFLTSLTNCKFLRTLWIDY 597

Query: 189  NPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLI----------------- 231
            NPL G LP ++GNLS ++E F    C+  G+IP  I NLTNLI                 
Sbjct: 598  NPLKGTLPNSLGNLSVALESFTASACHFRGTIPTGIGNLTNLIWLDLGANDLTGSIPTTL 657

Query: 232  -----LQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLG 286
                 LQ L + GN+++GSIP+DLC L  L  L L  NKLSG +P+C G+L  LR+L L 
Sbjct: 658  GHLQKLQRLYIAGNRIQGSIPNDLCHLKNLGYLHLSSNKLSGSIPSCFGDLPALRELSLD 717

Query: 287  SNLLT-SIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKI 345
            SN+L  +IP + W+L+D++ L+LSSNF TG LP ++GN+  +  LDLS N  S  IP ++
Sbjct: 718  SNVLAFNIPMSFWSLRDLMVLSLSSNFLTGNLPPEVGNMKSITTLDLSKNLISGYIPRRM 777

Query: 346  GGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVS 405
            G L++L  L L  N+LQGSIP   GDL+SL+S++LS NNL GTIP SLE L+ LK +NVS
Sbjct: 778  GELQNLVNLCLSQNKLQGSIPVEFGDLLSLESMDLSQNNLFGTIPKSLEALIYLKHLNVS 837

Query: 406  FNRLEGEIPREGPFRNLSAESFKGNELLCGMPNLQVLSC----RTKIHHTLGKNDLLIGI 461
            FN+L+GEIP  GPF N +AESF  NE LCG P+ QV++C    RT+   T  K+ +L  I
Sbjct: 838  FNKLQGEIPNGGPFVNFTAESFIFNEALCGAPHFQVIACDKNNRTQSWKT--KSFILKYI 895

Query: 462  VLPLSTIFMMVVVLLILKYRKGRKSQLKDVNMPSVADQRRFTYLELFQATNRFSENNLIG 521
            +LP+ +   +V  +++   R+        ++        + +  +L  ATN F E+NLIG
Sbjct: 896  LLPVGSAVTLVAFIVLWIRRRDNTEIPAPIDSWLPGAHEKISQQQLLYATNGFGEDNLIG 955

Query: 522  RGGFGPVYK----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDD 577
            +G  G VYK    +G+ VAIKVFNL++ GA +SFD EC +M+ I HRNLI+II+ CSN D
Sbjct: 956  KGSLGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVMQGICHRNLIRIITCCSNLD 1015

Query: 578  FKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPS 637
            FKALVLEYMP GSL+K LYS NY LD+FQ LNIMIDVASALEYLH   S  ++HCDLKPS
Sbjct: 1016 FKALVLEYMPKGSLDKWLYSHNYFLDLFQRLNIMIDVASALEYLHHDCSSLVVHCDLKPS 1075

Query: 638  NVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP------------------ 679
            NVLLD+NMVAH++DFG+A+ LL E +S+ QT+TL TIGYMAP                  
Sbjct: 1076 NVLLDNNMVAHVADFGIAR-LLTETESMQQTKTLGTIGYMAPEYGSDGIVSTKGDVYSYG 1134

Query: 680  -------------DEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEKHLMTK 720
                         DE+F+G++ LK WV +SL  SV+ VVDANLL R+++ L TK
Sbjct: 1135 ILLMEVFARKKPMDEMFTGDVTLKTWV-ESLSSSVIEVVDANLLRRDDEDLATK 1187

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359483675|ref|XP_003632999.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase GSO1-like [Vitis vinifera]

 Score =  615 bits (1585), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 366/777 (47%), Positives = 479/777 (61%), Gaps = 73/777 (9%)

Query: 6    NDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKV 65
            N F R I    +GN S L+ +YLS N   GSIP+           NL  ++++    N +
Sbjct: 422  NKFTRSIP-RDIGNLSKLKKIYLSTNSLIGSIPT--------SFGNLKALKFLQLGSNNL 472

Query: 66   VGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNA 125
            +G +P  IFN+S L++L L  N LSG LPSS    LP+L+ L + GN F GTIP  I N 
Sbjct: 473  IGTIPEDIFNISKLQTLALAQNHLSGGLPSSISTWLPDLEGLFIGGNEFSGTIPVSISNM 532

Query: 126  SKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSS--TPELSSLSSLSNCKYLEY 183
            SKL  L +  N F G++P    NLR L+ L L  N LT    T E+  L+SL+NCK+L  
Sbjct: 533  SKLIRLHISDNYFIGNVPKDLSNLRKLEVLNLAGNQLTDEHLTSEVGFLTSLTNCKFLRT 592

Query: 184  FSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLI------------ 231
                 NPL G LP ++GNLS ++E F    C+  G+IP  I NLTNLI            
Sbjct: 593  LWIDYNPLKGTLPNSLGNLSVALESFTASACHFRGTIPTGIGNLTNLIWLDLGANDLTGS 652

Query: 232  ----------LQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLR 281
                      LQ L + GN+++GSIP+DL  L  L  L L  NKLSG +P+C G+L  LR
Sbjct: 653  IPTTLGQLQKLQRLYIAGNRIQGSIPNDLFHLKNLGYLHLSSNKLSGSIPSCFGDLPALR 712

Query: 282  KLYLGSNLLT-SIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCV 340
            +L L SN+L  +IP + W+L+D+L L+LSSNF TG LP ++GN+  +  LDLS N  S  
Sbjct: 713  ELSLDSNVLAFNIPMSFWSLRDLLVLSLSSNFLTGNLPPEVGNMKSITTLDLSKNLISGY 772

Query: 341  IPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLK 400
            IP ++G L++L  L L  N+LQGSIP   GDL+SL+S++LS NNLSGTIP SLE L+ LK
Sbjct: 773  IPRRMGELQNLVNLCLSQNKLQGSIPVEFGDLLSLESMDLSQNNLSGTIPKSLEALIYLK 832

Query: 401  DINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMPNLQVLSCRTKIHHTLGKND--LL 458
             +NVSFN+L+GEIP  GPF N +AESF  NE LCG P+ QV++C    H    K    +L
Sbjct: 833  HLNVSFNKLQGEIPDGGPFVNFTAESFIFNEALCGAPHFQVIACDKNNHTQSWKTKSFIL 892

Query: 459  IGIVLPLSTIFMMVVVLLILKYRKGRKSQLKDVNMPSVADQRRFTYLELFQATNRFSENN 518
              I+LP+ +I  +V  +++   R+        ++        + +  +L  ATN F E+N
Sbjct: 893  KYILLPVGSIVTLVAFIVLWIRRQDNTEIPAPIDSWLPGAHEKISQQQLLYATNDFGEDN 952

Query: 519  LIGRGGFGPVYK----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
            LIG+G  G VYK    +G+ VAIKVFNL++ GA +SFD EC +M+ I HRNLI+II+ CS
Sbjct: 953  LIGKGSLGMVYKGVLSNGLTVAIKVFNLEFQGALRSFDSECEVMQGICHRNLIRIITCCS 1012

Query: 575  NDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDL 634
            N DFKALVLEYMP GSL+K LYS NY LD+FQ LNIMIDVA ALEYLH   S  ++HCDL
Sbjct: 1013 NLDFKALVLEYMPKGSLDKWLYSHNYFLDLFQRLNIMIDVALALEYLHHDCSSLVVHCDL 1072

Query: 635  KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP--------------- 679
            KPSNVLLD+NMVAH++DFG+A+ LL E +S+ QT+TL TIGYMAP               
Sbjct: 1073 KPSNVLLDNNMVAHVADFGIAR-LLTETESMQQTKTLGTIGYMAPEYGSDGIVSTKGDVY 1131

Query: 680  ----------------DEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEKHLMTK 720
                            DE+F+G++ LK WV +SL  SV+ VVDANLL R+ + L TK
Sbjct: 1132 SYGILLMEVFARKKPMDEMFTGDVTLKTWV-ESLSSSVIEVVDANLLRRDNEDLATK 1187

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147769371|emb|CAN72496.1| hypothetical protein VITISV_010511 [Vitis vinifera]

 Score =  614 bits (1583), Expect = e-173,   Method: Compositional matrix adjust.
 Identities = 364/782 (46%), Positives = 484/782 (61%), Gaps = 76/782 (9%)

Query: 3    SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSF 62
            SL  +  RG I  ++GN S L+ + L  N   GSIP+           NL  ++++    
Sbjct: 431  SLAVNKFRGSIPREIGNLSKLEDISLRSNSLVGSIPT--------SFGNLMALKYLDLGM 482

Query: 63   NKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFI 122
            N + G VP  IFN+S L+ L L  N LSG LP S    LP+L+ L++  N F GTIP  I
Sbjct: 483  NFLTGTVPEAIFNISELQILVLVQNHLSGSLPPSIGTWLPDLEGLYIGSNKFSGTIPMSI 542

Query: 123  FNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSS--TPELSSLSSLSNCKY 180
             N SKL +L +  NSF+G++P   GNL  L+ L L  N LT+      +  L+SL+NCK+
Sbjct: 543  SNMSKLIQLQVWDNSFTGNVPKDLGNLTKLEVLNLAANQLTNEHLASGVGFLTSLTNCKF 602

Query: 181  LEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLI--------- 231
            L +    +NP  G LP ++GNL  ++E F    C   G+IP  I NLTNLI         
Sbjct: 603  LRHLWIDDNPFKGTLPNSLGNLPIALESFTASACQFRGTIPTGIGNLTNLIELDLGANDL 662

Query: 232  -------------LQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLT 278
                         LQ L + GN++ GSIP+DLC L  L  L L  NKLSG +P+C G+L 
Sbjct: 663  TRSIPTTLGRLQKLQRLHIAGNRIRGSIPNDLCHLKNLGYLHLXSNKLSGSIPSCFGDLP 722

Query: 279  NLRKLYLGSNLLT-SIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNF 337
             L++L+L SN+L  +IP++LW+L+D+L LNLSSNF TG LP ++GN+  +  LDLS N  
Sbjct: 723  ALQELFLDSNVLAFNIPTSLWSLRDLLVLNLSSNFLTGNLPPEVGNMKSITTLDLSKNLV 782

Query: 338  SCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLL 397
            S  IP ++G  ++L  L L  NRLQG IP   GDL+SL+SL+LS NNLSGTIP SLE L+
Sbjct: 783  SGYIPRRMGEQQNLAKLSLSQNRLQGPIPXEFGDLVSLESLDLSQNNLSGTIPKSLEALI 842

Query: 398  DLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMPNLQVLSC----RTKIHHTLG 453
             LK +NVS N+L+GEIP  GPF N +AESF  NE LCG P+ QV++C    RT+   T  
Sbjct: 843  YLKYLNVSSNKLQGEIPNGGPFXNFTAESFMFNEALCGAPHFQVMACDKNNRTQSWKT-- 900

Query: 454  KNDLLIGIVLPLSTIFMMVVVLLILKYRKGRKSQLKDVNMPSVADQRRFTYLELFQATNR 513
            K+ +L  I+LP+ +   +VV +++   R+        ++        + ++ +L  ATN 
Sbjct: 901  KSFILKYILLPVGSTITLVVFIVLWIRRRDNMEIXTPIDSWLPGTHEKISHQQLLYATND 960

Query: 514  FSENNLIGRGGFGPVYK----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKI 569
            F E+NLIG+G  G VYK    +G+ VAIKVFNL++ GA +SFD EC +M+ IRHRNL++I
Sbjct: 961  FGEDNLIGKGSQGMVYKGVLSNGLIVAIKVFNLEFQGALRSFDSECEVMQGIRHRNLVRI 1020

Query: 570  ISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPI 629
            I+ CSN DFKALVL+YMP GSLEK LYS NY LD+ Q LNIMIDVASALEYLH   S  +
Sbjct: 1021 ITCCSNLDFKALVLKYMPNGSLEKWLYSHNYFLDLIQRLNIMIDVASALEYLHHDCSSLV 1080

Query: 630  IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP---------- 679
            +HCDLKPSNVLLDDBMVAH++DFG+AK LL + +S+ QT+TL TIGYMAP          
Sbjct: 1081 VHCDLKPSNVLLDDBMVAHVTDFGIAK-LLTKTESMQQTKTLGTIGYMAPEHGSDGIVST 1139

Query: 680  ---------------------DEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEKHLM 718
                                 DE+F+G++ LK WV +SL  SV+ VVD NLL RE++ L 
Sbjct: 1140 KSDVYSYGILLMEVFARKKPMDEMFTGDLTLKTWV-ESLSNSVIQVVDVNLLRREDEDLA 1198

Query: 719  TK 720
            TK
Sbjct: 1199 TK 1200

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	797
TAIR|locus:2079142	1010	AT3G47570 [Arabidopsis thalian	0.721	0.569	0.290	2.5e-93
TAIR|locus:2075661	1025	AT3G47110 [Arabidopsis thalian	0.713	0.555	0.307	6e-88
TAIR|locus:2149922	1031	EFR "EF-TU receptor" [Arabidop	0.708	0.548	0.283	2.5e-87
TAIR|locus:2047525	980	AT2G24130 [Arabidopsis thalian	0.825	0.671	0.347	1.3e-86
UNIPROTKB|Q40640	1025	Xa21 "Receptor kinase-like pro	0.813	0.632	0.332	4.4e-86
TAIR|locus:2075631	1009	AT3G47090 [Arabidopsis thalian	0.693	0.548	0.286	1.8e-81
TAIR|locus:2079157	1011	AT3G47580 [Arabidopsis thalian	0.702	0.553	0.276	2.6e-75
TAIR|locus:2011339	1120	AT1G35710 [Arabidopsis thalian	0.656	0.466	0.282	6.5e-71
TAIR|locus:2138268	1045	AT4G08850 [Arabidopsis thalian	0.642	0.489	0.293	7.9e-70
TAIR|locus:2020417	1101	AT1G17230 [Arabidopsis thalian	0.651	0.471	0.287	1.4e-69

TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)]

 Score = 587 (211.7 bits), Expect = 2.5e-93, Sum P(3) = 2.5e-93
 Identities = 181/622 (29%), Positives = 290/622 (46%)

Query:     3 SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSF 62
             +L+++ L G I S +   + + +L L  N  SG  P  +         NL +++ +   +
Sbjct:   192 ALSHNNLEGEIPSDVAQLTQIWSLQLVANNFSGVFPPALY--------NLSSLKLLGIGY 243

Query:    63 NKVVGVV-PTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSF 121
             N   G + P     +  L S  +  N  +G +P++    +  L+ L +  NN  G+IP+F
Sbjct:   244 NHFSGRLRPDLGILLPNLLSFNMGGNYFTGSIPTTLS-NISTLERLGMNENNLTGSIPTF 302

Query:   122 IFNASKLSELGLQKNSFSGSIPN------TFGNLRNLKWLGLNDNYXXXXXXXXXXXXXX 175
               N   L  L L  NS             +  N   L+ LG+  N               
Sbjct:   303 -GNVPNLKLLFLHTNSLGSDSSRDLEFLTSLTNCTQLETLGIGRN---RLGGDLPISIAN 358

Query:   176 XNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSXXXXXXXXXXXXXXXX 235
              + K L         + G +P  IGNL  +++   +D   +SG                 
Sbjct:   359 LSAK-LVTLDLGGTLISGSIPYDIGNLI-NLQKLILDQNMLSGPLPTSLGKLLNLRYLSL 416

Query:   236 XXXGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLT-SIP 294
                 N+L G IP  +  +  L  LDL  N   G VP   GN ++L +L++G N L  +IP
Sbjct:   417 FS--NRLSGGIPAFIGNMTMLETLDLSNNGFEGIVPTSLGNCSHLLELWIGDNKLNGTIP 474

Query:   295 STLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYL 354
               +  ++ +L L++S N   G LP  IG L  L  L L  N  S  +P  +G    ++ L
Sbjct:   475 LEIMKIQQLLRLDMSGNSLIGSLPQDIGALQNLGTLSLGDNKLSGKLPQTLGNCLTMESL 534

Query:   355 FLEYNRLQGSIPNSIGDLIXXXXXXXXXXXXXGTIPISLEKLLDLKDINVSFNRLEGEIP 414
             FLE N   G IP+  G L+             G+IP        L+ +N+SFN LEG++P
Sbjct:   535 FLEGNLFYGDIPDLKG-LVGVKEVDLSNNDLSGSIPEYFASFSKLEYLNLSFNNLEGKVP 593

Query:   415 REGPFRNLSAESFKGNELLCG-MPNLQVLSCRTKIHHTLGKND-----LLIGIVLPLSTI 468
              +G F N +  S  GN  LCG +   Q+  C ++    + K+      ++IG+ + ++ +
Sbjct:   594 VKGIFENATTVSIVGNNDLCGGIMGFQLKPCLSQAPSVVKKHSSRLKKVVIGVSVGITLL 653

Query:   469 FMMVVVLLILKYRKGRKSQLKDVNMPSVAD----QRRFTYLELFQATNRFSENNLIGRGG 524
              ++ +  + L + + RK   K+ N P+ +       + +Y +L  ATN FS +N++G G 
Sbjct:   654 LLLFMASVTLIWLRKRKKN-KETNNPTPSTLEVLHEKISYGDLRNATNGFSSSNMVGSGS 712

Query:   525 FGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDF- 578
             FG VYK     +   VA+KV N+Q  GA KSF  EC  +K IRHRNL+K++++CS+ DF 
Sbjct:   713 FGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACSSIDFQ 772

Query:   579 ----KALVLEYMPLGSLEKCLY 596
                 +AL+ E+MP GSL+  L+
Sbjct:   773 GNEFRALIYEFMPNGSLDMWLH 794

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)]

 Score = 577 (208.2 bits), Expect = 6.0e-88, Sum P(2) = 6.0e-88
 Identities = 189/615 (30%), Positives = 280/615 (45%)

Query:     3 SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPS-------FILCEI---------P 46
             SL  + L G   + LGN +SLQ L   YN   G IP         I   I         P
Sbjct:   183 SLGRNNLTGKFPASLGNLTSLQMLDFIYNQIEGEIPGDIARLKQMIFFRIALNKFNGVFP 242

Query:    47 HEIDNLHNMEWMAFSFNKVVGVV-PTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLK 105
               I NL ++ +++ + N   G + P     +  L+ LY+  NS +G +P +    + +L+
Sbjct:   243 PPIYNLSSLIFLSITGNSFSGTLRPDFGSLLPNLQILYMGINSFTGTIPETLS-NISSLR 301

Query:   106 ELHLWGNNFIGTIPSFIFNASKLSELGLQKNSF----SGSIPNTFGNLRNLKWLG-LNDN 160
             +L +  N+  G IP        L  LGL  NS     SG + +  G L N   L  LN  
Sbjct:   302 QLDIPSNHLTGKIPLSFGRLQNLLLLGLNNNSLGNYSSGDL-DFLGALTNCSQLQYLNVG 360

Query:   161 YXXXXXXXXXXXXXXXNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSX 220
             +                   L   S   N + G +P  IGNL  S++   +    ++G  
Sbjct:   361 FNKLGGQLPVFIANLST--QLTELSLGGNLISGSIPHGIGNLV-SLQTLDLGENLLTGKL 417

Query:   221 XXXXXXXXXXXXXXXXXXGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNL 280
                               G  L G IP  L  ++ L  L L  N   G +P+  G+ + L
Sbjct:   418 PPSLGELSELRKVLLYSNG--LSGEIPSSLGNISGLTYLYLLNNSFEGSIPSSLGSCSYL 475

Query:   281 RKLYLGSNLLT-SIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSC 339
               L LG+N L  SIP  L  L  ++ LN+S N   GPL   IG L  L+ LD+S N  S 
Sbjct:   476 LDLNLGTNKLNGSIPHELMELPSLVVLNVSFNLLVGPLRQDIGKLKFLLALDVSYNKLSG 535

Query:   340 VIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLIXXXXXXXXXXXXXGTIPISLEKLLDL 399
              IP  +     L++L L+ N   G IP+  G L              GTIP  +     L
Sbjct:   536 QIPQTLANCLSLEFLLLQGNSFVGPIPDIRG-LTGLRFLDLSKNNLSGTIPEYMANFSKL 594

Query:   400 KDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCG-MPNLQVLSCRTKI--HHTLGKND 456
             +++N+S N  +G +P EG FRN SA S  GN  LCG +P+LQ+  C  ++   H+  +  
Sbjct:   595 QNLNLSLNNFDGAVPTEGVFRNTSAMSVFGNINLCGGIPSLQLQPCSVELPRRHSSVRKI 654

Query:   457 LLIGIVLPLSTIFMMVVVLLILKYRKGRKSQLKDVN-------MPSVADQRRFTYLELFQ 509
             + I +   ++ + ++ + ++ L + K R   ++  N        P  +   + +Y EL++
Sbjct:   655 ITICVSAVMAALLLLCLCVVYLCWYKLRVKSVRANNNENDRSFSPVKSFYEKISYDELYK 714

Query:   510 ATNRFSENNLIGRGGFGPVYKD--GME---VAIKVFNLQYGGAFKSFDIECGMMKRIRHR 564
              T  FS +NLIG G FG V+K   G +   VAIKV NL   GA KSF  EC  +  IRHR
Sbjct:   715 TTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEALGGIRHR 774

Query:   565 NLIKIISSCSNDDFK 579
             NL+K+++ CS+ DF+
Sbjct:   775 NLVKLVTICSSSDFE 789

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)]

 Score = 560 (202.2 bits), Expect = 2.5e-87, Sum P(2) = 2.5e-87
 Identities = 174/614 (28%), Positives = 277/614 (45%)

Query:     4 LTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPS-------FILCEI---------PH 47
             L+ + L G   + LGN +SLQ L  +YN   G IP         +  +I         P 
Sbjct:   176 LSKNNLTGNFPASLGNLTSLQKLDFAYNQMRGEIPDEVARLTQMVFFQIALNSFSGGFPP 235

Query:    48 EIDNLHNMEWMAFSFNKVVGVVPTTI-FNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKE 106
              + N+ ++E ++ + N   G +     + +  L+ L L +N  +G +P +    + +L+ 
Sbjct:   236 ALYNISSLESLSLADNSFSGNLRADFGYLLPNLRRLLLGTNQFTGAIPKTL-ANISSLER 294

Query:   107 LHLWGNNFIGTIPSFIFNASKLSELGLQKNSF-----SG-SIPNTFGNLRNLKWLGLNDN 160
               +  N   G+IP        L  LG++ NS      SG        N   L++L +  N
Sbjct:   295 FDISSNYLSGSIPLSFGKLRNLWWLGIRNNSLGNNSSSGLEFIGAVANCTQLEYLDVGYN 354

Query:   161 YXXXXXXXXXXXXXXXNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSX 220
                                 L       N + G +P  IGNL  S+++  ++   +SG  
Sbjct:   355 RLGGELPASIANLSTT----LTSLFLGQNLISGTIPHDIGNLV-SLQELSLETNMLSGEL 409

Query:   221 XXXXXXXXXXXXXXXXXXGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNL 280
                                N + G IP     +  L +L L  N   G +P   G    L
Sbjct:   410 PVSFGKLLNLQVVDLYS--NAISGEIPSYFGNMTRLQKLHLNSNSFHGRIPQSLGRCRYL 467

Query:   281 RKLYLGSNLLT-SIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSC 339
               L++ +N L  +IP  +  +  + +++LS+NF TG  P ++G L +LV L  S N  S 
Sbjct:   468 LDLWMDTNRLNGTIPQEILQIPSLAYIDLSNNFLTGHFPEEVGKLELLVGLGASYNKLSG 527

Query:   340 VIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLIXXXXXXXXXXXXXGTIPISLEKLLDL 399
              +P  IGG   +++LF++ N   G+IP+ I  L+             G IP  L  L  L
Sbjct:   528 KMPQAIGGCLSMEFLFMQGNSFDGAIPD-ISRLVSLKNVDFSNNNLSGRIPRYLASLPSL 586

Query:   400 KDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCG-MPNLQVLSCRTKIHHTLGK---- 454
             +++N+S N+ EG +P  G FRN +A S  GN  +CG +  +Q+  C  +      K    
Sbjct:   587 RNLNLSMNKFEGRVPTTGVFRNATAVSVFGNTNICGGVREMQLKPCIVQASPRKRKPLSV 646

Query:   455 -NDLLIGIVLPLSTIFMMVVVLLILKYRKGRKSQLKDVNMPSVAD-----QRRFTYLELF 508
                ++ GI + ++++ ++++V  +  + K +K        PS +        + +Y EL 
Sbjct:   647 RKKVVSGICIGIASLLLIIIVASLCWFMKRKKKNNASDGNPSDSTTLGMFHEKVSYEELH 706

Query:   509 QATNRFSENNLIGRGGFGPVYKD--GME---VAIKVFNLQYGGAFKSFDIECGMMKRIRH 563
              AT+RFS  NLIG G FG V+K   G E   VA+KV NL   GA KSF  EC   K IRH
Sbjct:   707 SATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECETFKGIRH 766

Query:   564 RNLIKIISSCSNDD 577
             RNL+K+I+ CS+ D
Sbjct:   767 RNLVKLITVCSSLD 780

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010204 "defense response signaling pathway, resistance gene-independent" evidence=IMP

GO:0016045 "detection of bacterium" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0002764 "immune response-regulating signaling pathway" evidence=IMP

GO:0009626 "plant-type hypersensitive response" evidence=IMP

GO:0019199 "transmembrane receptor protein kinase activity" evidence=TAS

GO:0010359 "regulation of anion channel activity" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050776 "regulation of immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)]

 Score = 866 (309.9 bits), Expect = 1.3e-86, P = 1.3e-86
 Identities = 250/720 (34%), Positives = 377/720 (52%)

Query:     4 LTNDFLRGIILSQL---GNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAF 60
             L ++ L G I  QL   G+ SSLQ + LS N  +G IP    C       +L  + ++  
Sbjct:   146 LGSNRLNGSIPVQLFCNGSSSSLQYIDLSNNSLTGEIPLNYHC-------HLKELRFLLL 198

Query:    61 SFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIG---- 116
               NK+ G VP+++ N + LK + L SN LSG LPS    ++P L+ L+L  N+F+     
Sbjct:   199 WSNKLTGTVPSSLSNSTNLKWMDLESNMLSGELPSQVISKMPQLQFLYLSYNHFVSHNNN 258

Query:   117 --TIPSF--IFNASKLSELGLQKNSFSGSIPNTFGNLR-NLKWLGLNDNYXXXXXXXXXX 171
                 P F  + N+S L EL L  NS  G I ++  +L  NL  + L+ N           
Sbjct:   259 TNLEPFFASLANSSDLQELELAGNSLGGEITSSVRHLSVNLVQIHLDQN-----RIHGSI 313

Query:   172 XXXXXNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSXXXXXXXXXXXX 231
                  N   L   + S+N L G +PR +  LS+ +E  ++ N +++G             
Sbjct:   314 PPEISNLLNLTLLNLSSNLLSGPIPRELCKLSK-LERVYLSNNHLTGEIPMELGDIPRLG 372

Query:   232 XXXXXXXGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLT 291
                     N L GSIPD    L+ L +L L GN LSG VP   G   NL  L L  N LT
Sbjct:   373 LLDVSR--NNLSGSIPDSFGNLSQLRRLLLYGNHLSGTVPQSLGKCINLEILDLSHNNLT 430

Query:   292 -SIP-STLWNLKDI-LHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGL 348
              +IP   + NL+++ L+LNLSSN  +GP+PL++  +++++ +DLS N  S  IP ++G  
Sbjct:   431 GTIPVEVVSNLRNLKLYLNLSSNHLSGPIPLELSKMDMVLSVDLSSNELSGKIPPQLGSC 490

Query:   349 KDLQYLFLEYNRLQGSIPNSIGDLIXXXXXXXXXXXXXGTIPISLEKLLDLKDINVSFNR 408
               L++L L  N    ++P+S+G L              G IP S ++   LK +N SFN 
Sbjct:   491 IALEHLNLSRNGFSSTLPSSLGQLPYLKELDVSFNRLTGAIPPSFQQSSTLKHLNFSFNL 550

Query:   409 LEGEIPREGPFRNLSAESFKGNELLCG-MPNLQVLSCRTKIHHTLGKNDLLIGIVL-PLS 466
             L G +  +G F  L+ ESF G+ LLCG +  +Q  +C+ K  +      +L+ ++  P+ 
Sbjct:   551 LSGNVSDKGSFSKLTIESFLGDSLLCGSIKGMQ--ACKKKHKYPSVLLPVLLSLIATPVL 608

Query:   467 TIFMMVVVLLILKYRKGR------KSQLKDVNMPSVADQR--RFTYLELFQATNRFSENN 518
              +F      L+ + R G+      K +++D    +  D +  R +Y +L  AT  F+ ++
Sbjct:   609 CVFGYP---LVQRSRFGKNLTVYAKEEVEDEEKQNQNDPKYPRISYQQLIAATGGFNASS 665

Query:   519 LIGRGGFGPVYK----DGMEVAIKVFN----LQYGGAFKSFDIECGMMKRIRHRNLIKII 570
             LIG G FG VYK    +  +VA+KV +    L++ G+FK    EC ++KR RHRNLI+II
Sbjct:   666 LIGSGRFGHVYKGVLRNNTKVAVKVLDPKTALEFSGSFKR---ECQILKRTRHRNLIRII 722

Query:   571 SSCSNDDFKALVLEYMPLGSLEKCLYSGNYI---LDIFQGLNIMIDVASALEYLHFGYSV 627
             ++CS   F ALVL  MP GSLE+ LY G Y    LD+ Q +NI  DVA  + YLH    V
Sbjct:   723 TTCSKPGFNALVLPLMPNGSLERHLYPGEYSSKNLDLIQLVNICSDVAEGIAYLHHYSPV 782

Query:   628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEM 687
              ++HCDLKPSN+LLDD M A ++DFG+++ L++  +    T    + G  + D +  G +
Sbjct:   783 KVVHCDLKPSNILLDDEMTALVTDFGISR-LVQGVEETVSTDDSVSFG--STDGLLCGSV 839

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)]

 Score = 837 (299.7 bits), Expect = 4.4e-86, Sum P(2) = 4.4e-86
 Identities = 231/694 (33%), Positives = 354/694 (51%)

Query:     9 LRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGV 68
             L G I S LG  SSL T+ L  N  SG IP+ I         NL ++   +   NK+ G+
Sbjct:   212 LSGAIPSSLGQLSSLLTMNLGQNNLSGMIPNSIW--------NLSSLRAFSVRENKLGGM 263

Query:    69 VPTTIFN-VSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASK 127
             +PT  F  +  L+ + + +N   G++P+S      +L  + ++GN F G I S       
Sbjct:   264 IPTNAFKTLHLLEVIDMGTNRFHGKIPASV-ANASHLTVIQIYGNLFSGIITSGFGRLRN 322

Query:   128 LSELGLQKNSFSGSIPNTFG------NLRNLKWLGLNDNYXXXXXXXXXXXXXXXNCKYL 181
             L+EL L +N F     + +G      N   L+ L L +N                    L
Sbjct:   323 LTELYLWRNLFQTREQDDWGFISDLTNCSKLQTLNLGENNLGGVLPNSFSNLSTS----L 378

Query:   182 EYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSXXXXXXXXXXXXXXXXXXXGNQ 241
              + +   N + G +P+ IGNL   ++  ++ N N  GS                    N 
Sbjct:   379 SFLALELNKITGSIPKDIGNLI-GLQHLYLCNNNFRGSLPSSLGRLKNLGILLAYE--NN 435

Query:   242 LEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTS-IPSTLWNL 300
             L GSIP  +  L  L  L LG NK SG++P    NLTNL  L L +N L+  IPS L+N+
Sbjct:   436 LSGSIPLAIGNLTELNILLLGTNKFSGWIPYTLSNLTNLLSLGLSTNNLSGPIPSELFNI 495

Query:   301 KDI-LHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYN 359
             + + + +N+S N   G +P +IG+L  LV+     N  S  IP  +G  + L+YL+L+ N
Sbjct:   496 QTLSIMINVSKNNLEGSIPQEIGHLKNLVEFHAESNRLSGKIPNTLGDCQLLRYLYLQNN 555

Query:   360 RLQGSIPNSIGDLIXXXXXXXXXXXXXGTIPISLEKLLDLKDINVSFNRLEGEIPREGPF 419
              L GSIP+++G L              G IP SL  +  L  +N+SFN   GE+P  G F
Sbjct:   556 LLSGSIPSALGQLKGLETLDLSSNNLSGQIPTSLADITMLHSLNLSFNSFVGEVPTIGAF 615

Query:   420 RNLSAESFKGNELLCG-MPNLQVLSCRTKIHHTLGKNDLLIGIVLPLSTIFMMVVVLLIL 478
                S  S +GN  LCG +P+L +  C   + +      L I + L  +   +  + LLI 
Sbjct:   616 AAASGISIQGNAKLCGGIPDLHLPRCCPLLENRKHFPVLPISVSLAAALAILSSLYLLIT 675

Query:   479 KYRKGRKSQLKDVNMPSVADQRRFTYLELFQATNRFSENNLIGRGGFGPVYKDGME---- 534
              +++ +K      +M         +Y +L +AT+ F+  NL+G G FG VYK  +     
Sbjct:   676 WHKRTKKGAPSRTSMKG---HPLVSYSQLVKATDGFAPTNLLGSGSFGSVYKGKLNIQDH 732

Query:   535 VAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN-----DDFKALVLEYMPLG 589
             VA+KV  L+   A KSF  EC  ++ +RHRNL+KI++ CS+     +DFKA+V ++MP G
Sbjct:   733 VAVKVLKLENPKALKSFTAECEALRNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNG 792

Query:   590 SLEKCLY------SGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD 643
             SLE  ++      +    L++ + + I++DVA AL+YLH     P++HCD+K SNVLLD 
Sbjct:   793 SLEDWIHPETNDQADQRHLNLHRRVTILLDVACALDYLHRHGPEPVVHCDIKSSNVLLDS 852

Query:   644 NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 677
             +MVAH+ DFG+A+ +L +  SL Q Q+ +++G++
Sbjct:   853 DMVAHVGDFGLAR-ILVDGTSLIQ-QSTSSMGFI 884

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)]

 Score = 523 (189.2 bits), Expect = 1.8e-81, Sum P(3) = 1.8e-81
 Identities = 173/604 (28%), Positives = 282/604 (46%)

Query:     3 SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSF 62
             +L  + L G I   +   S + +L L+ N  SG  P        + + +L N+  +   F
Sbjct:   192 NLGYNHLEGEIPDDIAMLSQMVSLTLTMNNFSGVFPPAF-----YNLSSLENLYLLGNGF 246

Query:    63 NKVVGVVPTTIFNV-STLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWG---NNFIGTI 118
             +   G +     N+   +  L LH N L+G +P++    L N+  L ++G   N   G+I
Sbjct:   247 S---GNLKPDFGNLLPNIHELSLHGNFLTGAIPTT----LANISTLEMFGIGKNRMTGSI 299

Query:   119 -PSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWL-------GLNDNYXXXXXXXXX 170
              P+F      L  L L  NS  GS   +FG+L  L  L       GL+ +Y         
Sbjct:   300 SPNF-GKLENLHYLELANNSL-GSY--SFGDLAFLDALTNCSHLHGLSVSYNRLGGALPT 355

Query:   171 XXXXXXNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSXXXXXXXXXXX 230
                       L   +   N + G +P  IGNL         DN  ++G            
Sbjct:   356 SIVNMST--ELTVLNLKGNLIYGSIPHDIGNLIGLQSLLLADNL-LTGPLPTSLGNLVGL 412

Query:   231 XXXXXXXXGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLL 290
                      N+  G IP  +  L  L +L L  N   G VP   G+ +++  L +G N L
Sbjct:   413 GELILFS--NRFSGEIPSFIGNLTQLVKLYLSNNSFEGIVPPSLGDCSHMLDLQIGYNKL 470

Query:   291 T-SIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLK 349
               +IP  +  +  ++HLN+ SN  +G LP  IG L  LV+L L  NN S  +P  +G   
Sbjct:   471 NGTIPKEIMQIPTLVHLNMESNSLSGSLPNDIGRLQNLVELLLGNNNLSGHLPQTLGKCL 530

Query:   350 DLQYLFLEYNRLQGSIPNSIGDLIXXXXXXXXXXXXXGTIPISLEKLLDLKDINVSFNRL 409
              ++ ++L+ N   G+IP+  G L+             G+I    E    L+ +N+S N  
Sbjct:   531 SMEVIYLQENHFDGTIPDIKG-LMGVKNVDLSNNNLSGSISEYFENFSKLEYLNLSDNNF 589

Query:   410 EGEIPREGPFRNLSAESFKGNELLCG-MPNLQVLSCRTKI------HHTLGKNDLLIGIV 462
             EG +P EG F+N +  S  GN+ LCG +  L++  C  +       H +L K  + IG+ 
Sbjct:   590 EGRVPTEGIFQNATLVSVFGNKNLCGSIKELKLKPCIAQAPPVETRHPSLLKK-VAIGVS 648

Query:   463 LPLSTIFMMVVVLLILKYRKGRKSQLKDVNMPSVAD--QRRFTYLELFQATNRFSENNLI 520
             + ++ + ++ +V L   ++K + +Q  + + P   +    + +Y +L  AT+ FS +N++
Sbjct:   649 VGIALLLLLFIVSLSW-FKKRKNNQKINNSAPFTLEIFHEKLSYGDLRNATDGFSSSNIV 707

Query:   521 GRGGFGPVYKDGME-----VAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
             G G FG V+K  ++     VA+KV N+Q  GA KSF  EC  +K IRHRNL+K++++C++
Sbjct:   708 GSGSFGTVFKALLQTENKIVAVKVLNMQRRGAMKSFMAECESLKDIRHRNLVKLLTACAS 767

Query:   576 DDFK 579
              DF+
Sbjct:   768 IDFQ 771

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009507 "chloroplast" evidence=IDA

TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)]

 Score = 490 (177.5 bits), Expect = 2.6e-75, Sum P(3) = 2.6e-75
 Identities = 169/611 (27%), Positives = 279/611 (45%)

Query:     9 LRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFI--LCEI--------------PHEIDNL 52
             L+G +   LGN +SL++L  + N   G +P  +  L ++              P  I NL
Sbjct:   174 LKGKLPRSLGNLTSLKSLGFTDNNIEGEVPDELARLSQMVGLGLSMNKFFGVFPPAIYNL 233

Query:    53 HNMEWMAFSFNKVVGVVPTTIFNV-STLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWG 111
               +E +    +   G +     N+   ++ L L  N L G +P++    +  L++  +  
Sbjct:   234 SALEDLFLFGSGFSGSLKPDFGNLLPNIRELNLGENDLVGAIPTTLS-NISTLQKFGINK 292

Query:   112 NNFIGTI-PSFIFNASKLSELGLQKNSFSGSIPNTFGNLR------NLKWLGLNDNYXXX 164
             N   G I P+F      L  L L +N   GS   TFG+L       N   L L       
Sbjct:   293 NMMTGGIYPNF-GKVPSLQYLDLSENPL-GSY--TFGDLEFIDSLTNCTHLQLLSVGYTR 348

Query:   165 XXXXXXXXXXXXNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSXXXXX 224
                         + + +      N+  G I P+ IGNL   ++   +    ++G      
Sbjct:   349 LGGALPTSIANMSTELISLNLIGNHFFGSI-PQDIGNLI-GLQRLQLGKNMLTGPLPTSL 406

Query:   225 XXXXXXXXXXXXXXGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLY 284
                            N++ G IP  +  L  L  L L  N   G VP   G  +++  L 
Sbjct:   407 GKLLRLGLLSLYS--NRMSGEIPSFIGNLTQLEILYLSNNSFEGIVPPSLGKCSHMLDLR 464

Query:   285 LGSNLLT-SIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPT 343
             +G N L  +IP  +  +  +++L++  N  +G LP  IG+L  LV+L L  N FS  +P 
Sbjct:   465 IGYNKLNGTIPKEIMQIPTLVNLSMEGNSLSGSLPNDIGSLQNLVKLSLENNKFSGHLPQ 524

Query:   344 KIGGLKDLQYLFLEYNRLQGSIPNSIGDLIXXXXXXXXXXXXXGTIPISLEKLLDLKDIN 403
              +G    ++ LFL+ N   G+IPN  G L+             G+IP        L+ +N
Sbjct:   525 TLGNCLAMEQLFLQGNSFDGAIPNIRG-LMGVRRVDLSNNDLSGSIPEYFANFSKLEYLN 583

Query:   404 VSFNRLEGEIPREGPFRNLSAESFKGNELLCG-MPNLQVLSC-------RTKIHHTLGKN 455
             +S N   G++P +G F+N +     GN+ LCG + +L++  C        TK    L K 
Sbjct:   584 LSINNFTGKVPSKGNFQNSTIVFVFGNKNLCGGIKDLKLKPCLAQEPPVETKHSSHLKKV 643

Query:   456 DLLIGIVLPLSTIFMMVVVLLILKYRKGRKSQLKDVNMPSVAD--QRRFTYLELFQATNR 513
              +L+ I + L  + +++  +++  +RK RK+Q  +  +PS  +    + +Y +L  ATN 
Sbjct:   644 AILVSIGIAL-LLLLVIASMVLCWFRKRRKNQQTNNLVPSKLEIFHEKISYGDLRNATNG 702

Query:   514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIK 568
             FS +N++G G FG V+K     +   VA+KV N+Q  GA KSF  EC  +K  RHRNL+K
Sbjct:   703 FSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNMQRRGAMKSFMAECESLKDTRHRNLVK 762

Query:   569 IISSCSNDDFK 579
             ++++C++ DF+
Sbjct:   763 LLTACASTDFQ 773

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)]

 Score = 507 (183.5 bits), Expect = 6.5e-71, Sum P(2) = 6.5e-71
 Identities = 160/566 (28%), Positives = 265/566 (46%)

Query:     4 LTNDFLRGIILSQLGNPSSLQTLYLSYN------PPS-GSIPSFILCE---------IPH 47
             L+N+ L G I S LGN  +L  LYL  N      PP  G++ S I  +         IP 
Sbjct:   325 LSNNKLTGSIPSSLGNLKNLTILYLYENYLTGVIPPELGNMESMIDLQLNNNKLTGSIPS 384

Query:    48 EIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKEL 107
                NL N+ ++    N + GV+P  + N+ ++ +L L  N L+G +P S       L+ L
Sbjct:   385 SFGNLKNLTYLYLYLNYLTGVIPQELGNMESMINLDLSQNKLTGSVPDSFG-NFTKLESL 443

Query:   108 HLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYXXXXXX 167
             +L  N+  G IP  + N+S L+ L L  N+F+G  P T    R L+ + L+ N+      
Sbjct:   444 YLRVNHLSGAIPPGVANSSHLTTLILDTNNFTGFFPETVCKGRKLQNISLDYNHLEGPIP 503

Query:   168 XXXXXXXXXNCKYLEYFSFSNNPLGGILPRAIGNLSQ-SMEDFWMDNCNISGSXXXXXXX 226
                      +CK L    F  N   G +  A G     +  DF   +    G        
Sbjct:   504 KSLR-----DCKSLIRARFLGNKFTGDIFEAFGIYPDLNFIDF--SHNKFHGEISSNWEK 556

Query:   227 XXXXXXXXXXXXGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLG 286
                          N + G+IP ++  +  L +LDL  N L G +P   GNLTNL +L L 
Sbjct:   557 SPKLGALIMS--NNNITGAIPTEIWNMTQLVELDLSTNNLFGELPEAIGNLTNLSRLRLN 614

Query:   287 SNLLTS-IPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKI 345
              N L+  +P+ L  L ++  L+LSSN F+  +P    +   L  ++LS N F   IP ++
Sbjct:   615 GNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLSRNKFDGSIP-RL 673

Query:   346 GGLKDLQYLFLEYNRLQGSIPNSIGDLIXXXXXXXXXXXXXGTIPISLEKLLDLKDINVS 405
               L  L  L L +N+L G IP+ +  L              G IP + E ++ L ++++S
Sbjct:   674 SKLTQLTQLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIALTNVDIS 733

Query:   406 FNRLEGEIPREGPFRNLSAESFKGNELLCG-MPNLQVLSCRTKIHHTLGKNDLLIGIVLP 464
              N+LEG +P    FR  +A++ + N  LC  +P  ++  CR ++       +L++ I++P
Sbjct:   734 NNKLEGPLPDTPTFRKATADALEENIGLCSNIPKQRLKPCR-ELKKPKKNGNLVVWILVP 792

Query:   465 LSTIFMMVVVLL-----ILKYRK---GRKSQLKD-VNMPSVADQRRFTYLELFQATNRFS 515
             +  + +++ +        ++ RK   GR +  +   NM   +   +F Y ++ ++TN F 
Sbjct:   793 ILGVLVILSICANTFTYCIRKRKLQNGRNTDPETGENMSIFSVDGKFKYQDIIESTNEFD 852

Query:   516 ENNLIGRGGFGPVYKDGME---VAIK 538
               +LIG GG+  VY+  ++   +A+K
Sbjct:   853 PTHLIGTGGYSKVYRANLQDTIIAVK 878

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

TAIR|locus:2138268 AT4G08850 [Arabidopsis thaliana (taxid:3702)]

 Score = 512 (185.3 bits), Expect = 7.9e-70, Sum P(2) = 7.9e-70
 Identities = 159/542 (29%), Positives = 250/542 (46%)

Query:     9 LRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGV 68
             L G I  ++GN ++L TL L  N  +G IPS         + N+  +  +    N++ G 
Sbjct:   274 LSGEIPPEIGNMTALDTLSLHTNKLTGPIPS--------TLGNIKTLAVLHLYLNQLNGS 325

Query:    69 VPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKL 128
             +P  +  + ++  L +  N L+G +P S   +L  L+ L L  N   G IP  I N+++L
Sbjct:   326 IPPELGEMESMIDLEISENKLTGPVPDSFG-KLTALEWLFLRDNQLSGPIPPGIANSTEL 384

Query:   129 SELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYXXXXXXXXXXXXXXXNCKYLEYFSFSN 188
             + L L  N+F+G +P+T      L+ L L+DN+               +CK L    F  
Sbjct:   385 TVLQLDTNNFTGFLPDTICRGGKLENLTLDDNHFEGPVPKSLR-----DCKSLIRVRFKG 439

Query:   189 NPLGGILPRAIGNLSQSMEDFWMDNCNISGSXXXXXXXXXXXXXXXXXXXGNQLEGSIPD 248
             N   G +  A G +  ++    + N N  G                     N + G+IP 
Sbjct:   440 NSFSGDISEAFG-VYPTLNFIDLSNNNFHGQLSANWEQSQKLVAFILS--NNSITGAIPP 496

Query:   249 DLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTS-IPSTLWNLKDILHLN 307
             ++  +  L QLDL  N+++G +P    N+  + KL L  N L+  IPS +  L ++ +L+
Sbjct:   497 EIWNMTQLSQLDLSSNRITGELPESISNINRISKLQLNGNRLSGKIPSGIRLLTNLEYLD 556

Query:   308 LSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPN 367
             LSSN F+  +P  + NL  L  ++LS N+    IP  +  L  LQ L L YN+L G I +
Sbjct:   557 LSSNRFSSEIPPTLNNLPRLYYMNLSRNDLDQTIPEGLTKLSQLQMLDLSYNQLDGEISS 616

Query:   368 SIGDLIXXXXXXXXXXXXXGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESF 427
                 L              G IP S + +L L  ++VS N L+G IP    FRN   ++F
Sbjct:   617 QFRSLQNLERLDLSHNNLSGQIPPSFKDMLALTHVDVSHNNLQGPIPDNAAFRNAPPDAF 676

Query:   428 KGNELLCGMPNL-QVLS-CR-TKIHHTLGKNDLLIGIVLPL--STIFMMVVVLLILKYRK 482
             +GN+ LCG  N  Q L  C  T    +    +L+I I++P+  + I + V   + + +RK
Sbjct:   677 EGNKDLCGSVNTTQGLKPCSITSSKKSHKDRNLIIYILVPIIGAIIILSVCAGIFICFRK 736

Query:   483 GRKSQLKDVNMPSVAD-------QRRFTYLELFQATNRFSENNLIGRGGFGPVYKDGMEV 535
               K   +  +  S  +         +  Y E+ +AT  F    LIG GG G VYK  +  
Sbjct:   737 RTKQIEEHTDSESGGETLSIFSFDGKVRYQEIIKATGEFDPKYLIGTGGHGKVYKAKLPN 796

Query:   536 AI 537
             AI
Sbjct:   797 AI 798

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0006857 "oligopeptide transport" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)]

 Score = 467 (169.5 bits), Expect = 1.4e-69, Sum P(2) = 1.4e-69
 Identities = 163/566 (28%), Positives = 249/566 (43%)

Query:     3 SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFI--LCE--------------IP 46
             +L  ++  G I  ++G  + ++ LYL  N  +G IP  I  L +              IP
Sbjct:   265 ALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGFIP 324

Query:    47 HEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKE 106
              E  ++ N++ +    N ++G +P  +  ++ L+ L L  N L+G +P      LP L +
Sbjct:   325 KEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQF-LPYLVD 383

Query:   107 LHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYXXXXX 166
             L L+ N   G IP  I   S  S L +  NS SG IP  F   + L  L L  N      
Sbjct:   384 LQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSN-----K 438

Query:   167 XXXXXXXXXXNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSXXXXXXX 226
                        CK L      +N L G LP  + NL Q++    +    +SG+       
Sbjct:   439 LSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNL-QNLTALELHQNWLSGNISADLGK 497

Query:   227 XXXXXXXXXXXXGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLG 286
                          N   G IP ++  L  +   ++  N+L+G +P   G+   +++L L 
Sbjct:   498 LKNLERLRLA--NNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLS 555

Query:   287 SNLLTS-IPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKI 345
              N  +  I   L  L  +  L LS N  TG +P   G+L  L++L L  N  S  IP ++
Sbjct:   556 GNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVEL 615

Query:   346 GGLKDLQY-LFLEYNRLQGSIPNSIGDLIXXXXXXXXXXXXXGTIPISLEKLLDLKDINV 404
             G L  LQ  L + +N L G+IP+S+G+L              G IP S+  L+ L   N+
Sbjct:   616 GKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNI 675

Query:   405 SFNRLEGEIPREGPFRNLSAESFKGNELLCGMPNLQVLSCRTKIHHTLGK-NDLLIGI-- 461
             S N L G +P    F+ + + +F GN  LC   N Q   C+  + H+  K N L+ G   
Sbjct:   676 SNNNLVGTVPDTAVFQRMDSSNFAGNHGLC---NSQRSHCQPLVPHSDSKLNWLINGSQR 732

Query:   462 --VLPLSTIFMMVVVLLI-------LKYRKGRKSQLKDVNMPSVAD-----QRRFTYLEL 507
               +L ++ I +  V L+        +K R+     L+D   P V D     ++ FTY  L
Sbjct:   733 QKILTITCIVIGSVFLITFLGLCWTIKRREPAFVALEDQTKPDVMDSYYFPKKGFTYQGL 792

Query:   508 FQATNRFSENNLIGRGGFGPVYKDGM 533
               AT  FSE+ ++GRG  G VYK  M
Sbjct:   793 VDATRNFSEDVVLGRGACGTVYKAEM 818

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002237 "response to molecule of bacterial origin" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0010103 "stomatal complex morphogenesis" evidence=RCA

GO:0048443 "stamen development" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: eugene3.00110705 hypothetical protein (1061 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	797
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-66
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-52
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	8e-45
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-43
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-41
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	6e-37
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	9e-35
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	8e-34
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-27
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-27
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	7e-27
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	7e-27
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-23
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	8e-23
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-21
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-21
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	5e-19
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-18
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	8e-18
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-17
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-16
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-16
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	8e-16
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-15
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-15
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-15
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-15
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-15
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-15
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-15
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-15
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	7e-15
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	7e-15
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	8e-15
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-14
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-14
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-14
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-14
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	6e-14
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-13
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-13
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-13
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-13
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-13
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-13
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-13
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-13
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-13
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	5e-13
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	7e-13
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-13
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-12
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-12
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-12
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-12
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-12
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-12
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	3e-12
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-12
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-12
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-12
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	3e-12
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-12
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	5e-12
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	8e-12
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-11
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-11
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-11
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-11
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-11
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-11
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-11
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-11
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-11
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	4e-11
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-11
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	5e-11
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	6e-11
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	7e-11
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	9e-11
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-10
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-10
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-10
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-10
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-10
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-10
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-10
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-10
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-10
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-10
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-10
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-10
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-10
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	5e-10
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	5e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	5e-10
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-10
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	5e-10
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	5e-10
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	6e-10
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	6e-10
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	8e-10
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	9e-10
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	1e-09
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-09
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-09
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-09
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-09
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-09
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-09
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-09
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-09
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-09
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-09
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-09
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-09
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-09
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-09
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-09
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-09
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-09
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-09
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	6e-09
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	7e-09
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	7e-09
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	7e-09
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	8e-09
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	8e-09
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	8e-09
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-08
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-08
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-08
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-08
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-08
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-08
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-08
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-08
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-08
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-08
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-08
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-08
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-08
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-08
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-08
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-08
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-08
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-08
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-08
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	5e-08
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	6e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	6e-08
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	6e-08
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	6e-08
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	7e-08
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	7e-08
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	7e-08
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	8e-08
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	8e-08
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	9e-08
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-07
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-07
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-07
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-07
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-07
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-07
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-07
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-07
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-07
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-07
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-07
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-07
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-07
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-07
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-07
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-07
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-07
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-07
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-07
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	5e-07
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	5e-07
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	6e-07
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	8e-07
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	9e-07
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	9e-07
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	9e-07
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-06
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-06
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-06
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-06
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-06
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-06
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-06
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-06
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-06
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-06
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-06
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-06
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-06
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-06
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-06
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-06
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	4e-06
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-06
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-06
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-06
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-06
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	5e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	7e-06
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	8e-06
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	9e-06
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	9e-06
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	9e-06
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-05
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	2e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-05
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-05
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-05
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-05
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-05
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-05
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-05
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-05
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-05
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-05
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-05
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-05
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-05
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-05
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-05
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-05
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	7e-05
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	7e-05
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	7e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	8e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	8e-05
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	8e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	9e-05
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-04
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-04
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-04
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-04
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-04
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	1e-04
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-04
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-04
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-04
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-04
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-04
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-04
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-04
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-04
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	4e-04
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-04
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	5e-04
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-04
PRK15370	754	PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl	5e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	6e-04
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-04
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	6e-04
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	6e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	7e-04
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	0.001
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	0.001
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	0.001
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	0.001
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	0.001
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	0.001
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.002
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.002
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	0.002
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	0.002
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	0.002
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	0.002
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	0.002
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.003
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	0.003
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	0.003
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	0.003
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	0.004
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	0.004
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	0.004

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  236 bits (604), Expect = 6e-66
 Identities = 213/716 (29%), Positives = 327/716 (45%), Gaps = 99/716 (13%)

Query: 3   SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFI----------------LCEIP 46
           +L ++ L G I  +LG   SL+ +YL YN  SG IP  I                   IP
Sbjct: 194 TLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIP 253

Query: 47  HEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKE 106
             + NL N++++    NK+ G +P +IF++  L SL L  NSLSG +P    ++L NL+ 
Sbjct: 254 SSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELV-IQLQNLEI 312

Query: 107 LHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSST 166
           LHL+ NNF G IP  + +  +L  L L  N FSG IP   G   NL  L L+ N LT   
Sbjct: 313 LHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEI 372

Query: 167 PELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINN 226
           PE   L S  N   L  FS   N L G +P+++G   +S+    + + + SG +P E   
Sbjct: 373 PE--GLCSSGNLFKLILFS---NSLEGEIPKSLGA-CRSLRRVRLQDNSFSGELPSEFTK 426

Query: 227 LTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLG 286
           L   ++  L +  N L+G I      + +L  L L  NK  G +P   G+          
Sbjct: 427 LP--LVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS---------- 474

Query: 287 SNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIG 346
                         K + +L+LS N F+G +P K+G+L+ L+QL LS N  S  IP ++ 
Sbjct: 475 --------------KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELS 520

Query: 347 GLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSF 406
             K L  L L +N+L G IP S  ++  L  L+LS N LSG IP +L  +  L  +N+S 
Sbjct: 521 SCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISH 580

Query: 407 NRLEGEIPREGPFRNLSAESFKGNELLCGMPNLQVLS-CRTKIHHTLGKNDLLIGIVLPL 465
           N L G +P  G F  ++A +  GN  LCG      L  C+      + K       +   
Sbjct: 581 NHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCK-----RVRKTPSWWFYITCT 635

Query: 466 STIFMMV-VVLLILKYRKGRK-SQLKDVNMPSVADQRRFTY-LELFQATNRFS------- 515
              F+++ +V     + +GR   +LK V      +    T+ L+ F +  + S       
Sbjct: 636 LGAFLVLALVAFGFVFIRGRNNLELKRV------ENEDGTWELQFFDS--KVSKSITIND 687

Query: 516 ------ENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHR 564
                 E N+I RG  G  YK     +GM+  +K  N        S   +   M +++H 
Sbjct: 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIN-DVNSIPSSEIAD---MGKLQHP 743

Query: 565 NLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFG 624
           N++K+I  C ++    L+ EY+   +L + L +    L   +   I I +A AL +LH  
Sbjct: 744 NIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCR 799

Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
            S  ++  +L P  +++D     HL    +   L       T T+   +  Y+AP+
Sbjct: 800 CSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL------CTDTKCFISSAYVAPE 848

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  197 bits (502), Expect = 2e-52
 Identities = 139/411 (33%), Positives = 216/411 (52%), Gaps = 25/411 (6%)

Query: 21  SSLQTLYLSYNPPSGSIPS-FILC-------------EIPHEIDNLHNMEWMAFSFNKVV 66
           SSL+ L LS N  +GSIP   I               EIP++I +  +++ +    N +V
Sbjct: 118 SSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLV 177

Query: 67  GVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNAS 126
           G +P ++ N+++L+ L L SN L G++P     ++ +LK ++L  NN  G IP  I   +
Sbjct: 178 GKIPNSLTNLTSLEFLTLASNQLVGQIPRELG-QMKSLKWIYLGYNNLSGEIPYEIGGLT 236

Query: 127 KLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSF 186
            L+ L L  N+ +G IP++ GNL+NL++L L  N L+   P      S+ + + L     
Sbjct: 237 SLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPP-----SIFSLQKLISLDL 291

Query: 187 SNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSI 246
           S+N L G +P  +  L Q++E   + + N +G IP  + +L    LQ+L L  N+  G I
Sbjct: 292 SDNSLSGEIPELVIQL-QNLEILHLFSNNFTGKIPVALTSLPR--LQVLQLWSNKFSGEI 348

Query: 247 PDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTS-IPSTLWNLKDILH 305
           P +L +   L  LDL  N L+G +P    +  NL KL L SN L   IP +L   + +  
Sbjct: 349 PKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRR 408

Query: 306 LNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSI 365
           + L  N F+G LP +   L ++  LD+S NN    I ++   +  LQ L L  N+  G +
Sbjct: 409 VRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGL 468

Query: 366 PNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPRE 416
           P+S G    L++L+LS N  SG +P  L  L +L  + +S N+L GEIP E
Sbjct: 469 PDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDE 518

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  173 bits (441), Expect = 8e-45
 Identities = 138/387 (35%), Positives = 197/387 (50%), Gaps = 21/387 (5%)

Query: 67  GVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPS-FIFNA 125
           G + + IF +  ++++ L +N LSG +P        +L+ L+L  NNF G+IP   I N 
Sbjct: 83  GKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPN- 141

Query: 126 SKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFS 185
             L  L L  N  SG IPN  G+  +LK L L  N L    P     +SL+N   LE+ +
Sbjct: 142 --LETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP-----NSLTNLTSLEFLT 194

Query: 186 FSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGS 245
            ++N L G +PR +G + +S++  ++   N+SG IP EI  LT+  L  L L  N L G 
Sbjct: 195 LASNQLVGQIPRELGQM-KSLKWIYLGYNNLSGEIPYEIGGLTS--LNHLDLVYNNLTGP 251

Query: 246 IPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLT-SIPSTLWNLKDIL 304
           IP  L  L  L  L L  NKLSG +P    +L  L  L L  N L+  IP  +  L+++ 
Sbjct: 252 IPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLE 311

Query: 305 HLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGS 364
            L+L SN FTG +P+ + +L  L  L L  N FS  IP  +G   +L  L L  N L G 
Sbjct: 312 ILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGE 371

Query: 365 IPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGP------ 418
           IP  +    +L  L L +N+L G IP SL     L+ + +  N   GE+P E        
Sbjct: 372 IPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVY 431

Query: 419 FRNLSAESFKG--NELLCGMPNLQVLS 443
           F ++S  + +G  N     MP+LQ+LS
Sbjct: 432 FLDISNNNLQGRINSRKWDMPSLQMLS 458

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  168 bits (426), Expect = 6e-43
 Identities = 140/421 (33%), Positives = 199/421 (47%), Gaps = 48/421 (11%)

Query: 23  LQTLYLSYNPPSGSIPS--FILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLK 80
           +QT+ LS N  SG IP   F             ++ ++  S N   G +P    ++  L+
Sbjct: 95  IQTINLSNNQLSGPIPDDIFTTS---------SSLRYLNLSNNNFTGSIPRG--SIPNLE 143

Query: 81  SLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSG 140
           +L L +N LSG +P+       +LK L L GN  +G IP+ + N + L  L L  N   G
Sbjct: 144 TLDLSNNMLSGEIPNDIGS-FSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVG 202

Query: 141 SIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIG 200
            IP   G +++LKW+                        YL Y     N L G +P  IG
Sbjct: 203 QIPRELGQMKSLKWI------------------------YLGY-----NNLSGEIPYEIG 233

Query: 201 NLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLD 260
            L+ S+    +   N++G IP  + NL N  LQ L L  N+L G IP  +  L  L  LD
Sbjct: 234 GLT-SLNHLDLVYNNLTGPIPSSLGNLKN--LQYLFLYQNKLSGPIPPSIFSLQKLISLD 290

Query: 261 LGGNKLSGFVPACSGNLTNLRKLYLGSNLLT-SIPSTLWNLKDILHLNLSSNFFTGPLPL 319
           L  N LSG +P     L NL  L+L SN  T  IP  L +L  +  L L SN F+G +P 
Sbjct: 291 LSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPK 350

Query: 320 KIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLN 379
            +G  N L  LDLS NN +  IP  +    +L  L L  N L+G IP S+G   SL+ + 
Sbjct: 351 NLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVR 410

Query: 380 LSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEI-PREGPFRNLSAESFKGNELLCGMPN 438
           L +N+ SG +P    KL  +  +++S N L+G I  R+    +L   S   N+   G+P+
Sbjct: 411 LQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPD 470

Query: 439 L 439
            
Sbjct: 471 S 471

Length = 968

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  163 bits (415), Expect = 1e-41
 Identities = 126/352 (35%), Positives = 176/352 (50%), Gaps = 43/352 (12%)

Query: 137 SFSGSIPNTFGNLRN-------LKWLGLN-DNYLTSSTPELSS-------LSSLSNCKYL 181
           SF  SI +    L N         W G+  +N     + +LS         S++    Y+
Sbjct: 36  SFKSSINDPLKYLSNWNSSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYI 95

Query: 182 EYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQ 241
           +  + SNN L G +P  I   S S+    + N N +GSIP    ++ NL  + L L  N 
Sbjct: 96  QTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNL--ETLDLSNNM 151

Query: 242 LEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLT-SIPSTLWNL 300
           L G IP+D+   ++L  LDLGGN L G +P    NLT+L  L L SN L   IP  L  +
Sbjct: 152 LSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQM 211

Query: 301 KDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNR 360
           K +  + L  N  +G +P +IG L  L  LDL  NN +  IP+ +G LK+LQYLFL  N+
Sbjct: 212 KSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNK 271

Query: 361 LQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFR 420
           L G IP SI  L  L SL+LS+N+LSG IP  + +L +L+ +++  N   G+IP      
Sbjct: 272 LSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVA---- 327

Query: 421 NLSAESFKGNELLCGMPNLQVLSCRT-----KIHHTLGKNDLLIGIVLPLST 467
                       L  +P LQVL   +     +I   LGK++ L   VL LST
Sbjct: 328 ------------LTSLPRLQVLQLWSNKFSGEIPKNLGKHNNL--TVLDLST 365

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  137 bits (348), Expect = 6e-37
 Identities = 60/175 (34%), Positives = 88/175 (50%), Gaps = 13/175 (7%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLIKIISSC 573
           +G GGFG VY       G +VAIK+   +      +    E  ++K++ H N++K+    
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
            +++   LV+EY   GSL+  L      L   + L I++ +   LEYLH   S  IIH D
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRD 117

Query: 634 LKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEM 687
           LKP N+LLD DN    L+DFG++K L            + T  YMAP E+  G+ 
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLL--TSDKSLLKTIVGTPAYMAP-EVLLGKG 169

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  133 bits (336), Expect = 9e-35
 Identities = 64/177 (36%), Positives = 90/177 (50%), Gaps = 17/177 (9%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI----ECGMMKRIRHRNLIKII 570
           +G G FG VYK      G  VA+K+   +        D     E  +++R+ H N++++I
Sbjct: 7   LGSGSFGTVYKAKHKGTGKIVAVKILKKR--SEKSKKDQTARREIRILRRLSHPNIVRLI 64

Query: 571 SSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPII 630
            +  + D   LV+EY   G L   L  G   L   +   I + +   LEYLH   S  II
Sbjct: 65  DAFEDKDHLYLVMEYCEGGDLFDYLSRGG-PLSEDEAKKIALQILRGLEYLH---SNGII 120

Query: 631 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEM 687
           H DLKP N+LLD+N V  ++DFG+AK LL+   SLT T    T  YMAP+ +  G  
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLT-TFV-GTPWYMAPEVLLGGNG 175

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  129 bits (328), Expect = 8e-34
 Identities = 57/175 (32%), Positives = 86/175 (49%), Gaps = 14/175 (8%)

Query: 518 NLIGRGGFGPVYK-----DGMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIIS 571
             +G G FG VY       G  VAIKV   +      +    E  ++K+++H N++++  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
              ++D   LV+EY   G L   L      L   +    +  + SALEYLH   S  I+H
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLH---SKGIVH 120

Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGE 686
            DLKP N+LLD++    L+DFG+A+   + D     T  + T  YMAP E+  G+
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLAR---QLDPGEKLTTFVGTPEYMAP-EVLLGK 171

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  112 bits (283), Expect = 1e-27
 Identities = 50/177 (28%), Positives = 85/177 (48%), Gaps = 13/177 (7%)

Query: 520 IGRGGFGPVYK---------DGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKI 569
           +G G FG VYK            +VA+K           + F  E  +MK++ H N++++
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 570 ISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPI 629
           +  C+  +   +V EYMP G L   L      L +   L + + +A  +EYL    S   
Sbjct: 67  LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKNF 123

Query: 630 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGE 686
           +H DL   N L+ +N+V  +SDFG+++ + E+D    +      I +MAP+ +  G+
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGK 180

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  110 bits (278), Expect = 5e-27
 Identities = 51/180 (28%), Positives = 86/180 (47%), Gaps = 14/180 (7%)

Query: 517 NNLIGRGGFGPVYK---------DGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNL 566
              +G G FG VYK           +EVA+K           + F  E  +M+++ H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
           +K++  C+ ++   +V+EYM  G L   L      L +   L+  + +A  +EYL    S
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---S 120

Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGE 686
              IH DL   N L+ +N+V  +SDFG+++  L +D    +      I +MAP+ +  G+
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYRKRGGKLPIRWMAPESLKEGK 179

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  110 bits (277), Expect = 7e-27
 Identities = 54/190 (28%), Positives = 89/190 (46%), Gaps = 28/190 (14%)

Query: 513 RFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGA--FKSFDIECGMMKRIRHRN 565
            ++   L+GRG FG VY       G  +A+K   L        ++ + E  ++  ++H N
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 566 LIKIISSCSNDDFKAL--VLEYMPLGSLEKCLYSGNYILDIFQGLNI------MIDVASA 617
           +++   S  +++   L   LEY+  GSL         +L  F  L           +   
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSS-------LLKKFGKLPEPVIRKYTRQILEG 113

Query: 618 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGY 676
           L YLH   S  I+H D+K +N+L+D + V  L+DFG AK  L + ++   T ++  T  +
Sbjct: 114 LAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAK-RLGDIETGEGTGSVRGTPYW 169

Query: 677 MAPDEIFSGE 686
           MAP E+  GE
Sbjct: 170 MAP-EVIRGE 178

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  109 bits (276), Expect = 7e-27
 Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 15/181 (8%)

Query: 517 NNLIGRGGFGPVYK---------DGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNL 566
              +G G FG VYK           +EVA+K           + F  E  +M+++ H N+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCL-YSGNYILDIFQGLNIMIDVASALEYLHFGY 625
           +K++  C+ ++   +V+EYMP G L   L  +    L +   L+  + +A  +EYL    
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--- 120

Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG 685
           S   IH DL   N L+ +N+V  +SDFG+++  L +D           I +MAP+ +  G
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYKVKGGKLPIRWMAPESLKEG 179

Query: 686 E 686
           +
Sbjct: 180 K 180

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 99.5 bits (249), Expect = 4e-23
 Identities = 54/188 (28%), Positives = 87/188 (46%), Gaps = 24/188 (12%)

Query: 518 NLIGRGGFGPVYK--------DGMEVAIKVFNLQYGGAFKS-FDIECGMMKRIRHRNLIK 568
             +G G FG VYK           EVA+K          +  F  E  +MK++ H N+++
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCL--------YSGNYILDIFQGLNIMIDVASALEY 620
           ++  C+ ++   LVLEYM  G L   L              L +   L+  I +A  +EY
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP- 679
           L    S   +H DL   N L+ +++V  +SDFG+++ + ++D    +T     I +MAP 
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177

Query: 680 ---DEIFS 684
              D IF+
Sbjct: 178 SLKDGIFT 185

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 98.0 bits (245), Expect = 8e-23
 Identities = 60/173 (34%), Positives = 87/173 (50%), Gaps = 14/173 (8%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           IG+GGFG VYK      G EVAIKV  L+     +    E  ++K+ +H N++K   S  
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67

Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDL 634
             D   +V+E+   GSL+  L S N  L   Q   +  ++   LEYLH   S  IIH D+
Sbjct: 68  KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDI 124

Query: 635 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGYMAPDEIFSGE 686
           K +N+LL  +    L DFG++  L           T+  T  +MAP E+ +G+
Sbjct: 125 KAANILLTSDGEVKLIDFGLSAQL----SDTKARNTMVGTPYWMAP-EVINGK 172

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 92.9 bits (232), Expect = 5e-21
 Identities = 53/180 (29%), Positives = 84/180 (46%), Gaps = 18/180 (10%)

Query: 518 NLIGRGGFGPVYK-----DGMEVAIKVFNL-QYGGAFKSFDI-ECGMMKRIRHRNLIKII 570
             IG+G FG VY      DG    +K  +L       +   + E  ++K++ H N+IK  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 571 SSCSNDDFKALVLEYMPLGSL----EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
            S        +V+EY   G L    +K    G    +  Q L+  + +  AL+YLH   S
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPE-EQILDWFVQLCLALKYLH---S 121

Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGE 686
             I+H D+KP N+ L  N +  L DFG++K +L     L +T  + T  Y++P E+   +
Sbjct: 122 RKILHRDIKPQNIFLTSNGLVKLGDFGISK-VLSSTVDLAKTV-VGTPYYLSP-ELCQNK 178

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 92.8 bits (231), Expect = 6e-21
 Identities = 53/168 (31%), Positives = 83/168 (49%), Gaps = 13/168 (7%)

Query: 519 LIGRGGFGPVYK---DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
            IG+G FG V      G +VA+K        A ++F  E  +M  +RH NL++++     
Sbjct: 13  TIGKGEFGDVMLGDYRGQKVAVKCLK-DDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 576 DDFKALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDL 634
            +   +V EYM  GSL   L S G  ++ + Q L   +DV   +EYL        +H DL
Sbjct: 72  GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDL 128

Query: 635 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              NVL+ +++VA +SDFG+AK     + S  Q      + + AP+ +
Sbjct: 129 AARNVLVSEDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEAL 171

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 89.8 bits (221), Expect = 5e-19
 Identities = 61/198 (30%), Positives = 93/198 (46%), Gaps = 16/198 (8%)

Query: 519 LIGRGGFGPVY--KDGMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRH-RNLIKIISS 572
            +G G FG VY  +D   VA+KV   +        + F  E  ++  + H  N++K+   
Sbjct: 7   KLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDF 66

Query: 573 CSNDDFKALVLEYMPLGSLEK--CLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPII 630
             ++    LV+EY+  GSLE           L   + L I+  + SALEYLH   S  II
Sbjct: 67  FQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGII 123

Query: 631 HCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLA----TIGYMAPDEIFSG 685
           H D+KP N+LLD D  V  L DFG+AK L +   + +     +    T GYMAP+ +   
Sbjct: 124 HRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGL 183

Query: 686 EMRLKCWVNDSLLISVMI 703
            +      +D   + + +
Sbjct: 184 SLAYASSSSDIWSLGITL 201

Length = 384

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 60/183 (32%), Positives = 85/183 (46%), Gaps = 25/183 (13%)

Query: 513 RFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQ--YGGAFKSFDIECGMMKRIRHRN 565
            +   +LIGRG FG VYK      G  VAIK  +L+     A KS   E  ++K ++H N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLN------IMIDVASALE 619
           ++K I S    D   ++LEY   GSL +       I+  F           +  V   L 
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQ-------IIKKFGPFPESLVAVYVYQVLQGLA 113

Query: 620 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
           YLH      +IH D+K +N+L   + V  L+DFG+A  L   D S      + T  +MAP
Sbjct: 114 YLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKL--NDVSKDDASVVGTPYWMAP 168

Query: 680 DEI 682
           + I
Sbjct: 169 EVI 171

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 83.3 bits (207), Expect = 8e-18
 Identities = 57/183 (31%), Positives = 81/183 (44%), Gaps = 31/183 (16%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGM----------MKRIRHR 564
           +G+G FG V        G   A+KV         K   I+             + RI H 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLK-------KKKIIKRKEVEHTLTERNILSRINHP 53

Query: 565 NLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFG 624
            ++K+  +   ++   LVLEY P G L   L          +      ++  ALEYLH  
Sbjct: 54  FIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSK-EGRFSEERARFYAAEIVLALEYLH-- 110

Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGYMAPDEIF 683
            S+ II+ DLKP N+LLD +    L+DFG+AK L  E     +T T   T  Y+AP E+ 
Sbjct: 111 -SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS---RTNTFCGTPEYLAP-EVL 165

Query: 684 SGE 686
            G+
Sbjct: 166 LGK 168

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 82.3 bits (204), Expect = 3e-17
 Identities = 54/186 (29%), Positives = 83/186 (44%), Gaps = 36/186 (19%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G+G  G VYK      G   A+K  +          D +    K++     +K + SC 
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIH---------VDGDEEFRKQLL--RELKTLRSCE 57

Query: 575 NDD--------FK----ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
           +          +K    ++VLEYM  GSL   L     I +      I   +   L+YLH
Sbjct: 58  SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY-IARQILKGLDYLH 116

Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT-LATIGYMAPDE 681
                 IIH D+KPSN+L++      ++DFG++K L   + +L Q  T + T+ YM+P E
Sbjct: 117 --TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVL---ENTLDQCNTFVGTVTYMSP-E 170

Query: 682 IFSGEM 687
              GE 
Sbjct: 171 RIQGES 176

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 80.3 bits (199), Expect = 2e-16
 Identities = 55/168 (32%), Positives = 78/168 (46%), Gaps = 11/168 (6%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           IG G  G VYK      G EVAIK   L+     +    E  +MK  +H N++    S  
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLR-KQNKELIINEILIMKDCKHPNIVDYYDSYL 85

Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDL 634
             D   +V+EYM  GSL   +      ++  Q   +  +V   LEYLH   S  +IH D+
Sbjct: 86  VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDI 142

Query: 635 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
           K  N+LL  +    L+DFG A  L +E     +   + T  +MAP+ I
Sbjct: 143 KSDNILLSKDGSVKLADFGFAAQLTKEKS--KRNSVVGTPYWMAPEVI 188

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 80.1 bits (198), Expect = 2e-16
 Identities = 62/188 (32%), Positives = 90/188 (47%), Gaps = 24/188 (12%)

Query: 513 RFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRN 565
           R+   N IG G FG VY       G  +A+K   +Q       K    E  +++ ++H N
Sbjct: 1   RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60

Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVAS-----ALEY 620
           L+K      + +   + +EY   G+LE+ L  G  ILD       +I V +      L Y
Sbjct: 61  LVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGR-ILD-----EHVIRVYTLQLLEGLAY 114

Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL-TQTQTLA-TIGYMA 678
           LH   S  I+H D+KP+N+ LD N V  L DFG A  L     ++  + Q+LA T  YMA
Sbjct: 115 LH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMA 171

Query: 679 PDEIFSGE 686
           P E+ +G 
Sbjct: 172 P-EVITGG 178

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 78.3 bits (193), Expect = 8e-16
 Identities = 53/190 (27%), Positives = 79/190 (41%), Gaps = 33/190 (17%)

Query: 520 IGRGGFGPVYK----------DGMEVAIKVF-NLQYGGAFKSFDIECGMMKRIRHRNLIK 568
           +G G FG V+           D   VA+K         A K F+ E  ++   +H N++K
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCLYSGN-------------YILDIFQGLNIMIDVA 615
               C+  D   +V EYM  G L K L S                 L + Q L I + +A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 616 SALEYL---HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA 672
           S + YL   HF      +H DL   N L+  ++V  + DFGM++ +   D       T+ 
Sbjct: 133 SGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML 186

Query: 673 TIGYMAPDEI 682
            I +M P+ I
Sbjct: 187 PIRWMPPESI 196

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 77.4 bits (191), Expect = 1e-15
 Identities = 56/178 (31%), Positives = 95/178 (53%), Gaps = 14/178 (7%)

Query: 520 IGRGGFGPVYKDGM-----EVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSC 573
           +G G FG V+  G      +VA+K   L+ G  + ++F  E  +MK++RH  L+++ + C
Sbjct: 14  LGAGQFGEVWM-GTWNGTTKVAVKT--LKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70

Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYI-LDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
           S ++   +V EYM  GSL   L SG    L + Q +++   +A  + YL    S   IH 
Sbjct: 71  SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHR 127

Query: 633 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           DL   N+L+ +N+V  ++DFG+A+ L+E+D+   +      I + AP+    G   +K
Sbjct: 128 DLAARNILVGENLVCKIADFGLAR-LIEDDEYTAREGAKFPIKWTAPEAANYGRFTIK 184

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 57/192 (29%), Positives = 87/192 (45%), Gaps = 41/192 (21%)

Query: 513 RFSENNLIGRGGFGPVY-----KDGMEVAIKVFNL-----QYGGAFKSFDIECGMMKRIR 562
           R+ +  L+G G FG VY      DG   A+K  +L         A K  + E  ++ +++
Sbjct: 1   RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60

Query: 563 HRNLIKIISSCSNDDFKALVLEYMPLGSLEKCL--YSG-------NYILDIFQGLNIMID 613
           H N+++ + +   +D   + LE +P GSL K L  Y          Y   I  GL     
Sbjct: 61  HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGL----- 115

Query: 614 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 673
                EYLH       +H D+K +N+L+D N V  L+DFGMAK      Q +  +   + 
Sbjct: 116 -----EYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAK------QVVEFSFAKSF 161

Query: 674 IG---YMAPDEI 682
            G   +MAP+ I
Sbjct: 162 KGSPYWMAPEVI 173

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 77.6 bits (192), Expect = 2e-15
 Identities = 46/157 (29%), Positives = 76/157 (48%), Gaps = 20/157 (12%)

Query: 513 RFSENNLIGRGGFGPVYK-----DGMEVAIK-VFNLQYGGAFKSFDI----ECGMMKRIR 562
           R+ +   +G G +  VYK      G  VAIK +   +   A    +     E  +++ ++
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 563 HRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYIL---DIFQGLNIMIDVASALE 619
           H N+I ++    +     LV E+M    LEK +   + +L   DI      M+     LE
Sbjct: 61  HPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKS---YMLMTLRGLE 116

Query: 620 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK 656
           YLH  +   I+H DLKP+N+L+  + V  L+DFG+A+
Sbjct: 117 YLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLAR 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 76.8 bits (190), Expect = 2e-15
 Identities = 55/184 (29%), Positives = 86/184 (46%), Gaps = 31/184 (16%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYG--GAFKSFDI----ECGMMKRIRHRNLIK 568
           IG G +G VYK      G  VA+K   ++    G    F I    E  +++++RH N+++
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEG----FPITAIREIKLLQKLRHPNIVR 62

Query: 569 II----SSCSNDDFKALVLEYMP--LGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
           +     S      +  +V EYM   L  L   L S        Q    M  +   L+YLH
Sbjct: 63  LKEIVTSKGKGSIY--MVFEYMDHDLTGL---LDSPEVKFTESQIKCYMKQLLEGLQYLH 117

Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              S  I+H D+K SN+L++++ V  L+DFG+A+P   +  S   T  + T+ Y  P E+
Sbjct: 118 ---SNGILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSADYTNRVITLWYRPP-EL 172

Query: 683 FSGE 686
             G 
Sbjct: 173 LLGA 176

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 77.6 bits (192), Expect = 3e-15
 Identities = 55/188 (29%), Positives = 86/188 (45%), Gaps = 29/188 (15%)

Query: 513 RFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKS-FDI-----ECGMMKRI 561
           R+     IG G +G V      + G +VAIK  +      F    D      E  +++ +
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISN----VFDDLIDAKRILREIKLLRHL 56

Query: 562 RHRNLIK---IISSCSNDDFKAL--VLEYMPLGSLEKCLYSGNYI-LDIFQGLNIMIDVA 615
           RH N+I    I+   S +DF  +  V E M    L K + S   +  D  Q    +  + 
Sbjct: 57  RHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQ--YFLYQIL 113

Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ-TQTLATI 674
             L+YLH   S  +IH DLKPSN+L++ N    + DFG+A+ +  ++      T+ + T 
Sbjct: 114 RGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTR 170

Query: 675 GYMAPDEI 682
            Y AP E+
Sbjct: 171 WYRAP-EL 177

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 76.7 bits (189), Expect = 3e-15
 Identities = 44/157 (28%), Positives = 74/157 (47%), Gaps = 16/157 (10%)

Query: 518 NLIGRGGFGPVY---------KDGMEVAIKVFNLQYGGAFKS-FDIECGMMKRIRHRNLI 567
             +G G FG V            G +VA+K  N       +S F+ E  +++ + H N++
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 568 KIISSCSNDDFKA--LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY 625
           K    C     ++  L++EY+P GSL   L      +++ + L     +   ++YL    
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG--- 126

Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED 662
           S   IH DL   N+L++   +  +SDFG+AK +L ED
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLAK-VLPED 162

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 75.8 bits (187), Expect = 4e-15
 Identities = 54/180 (30%), Positives = 86/180 (47%), Gaps = 16/180 (8%)

Query: 514 FSENNLIGRGGFGPVYKDGMEVAIKVFNLQY--------GGAFKSFDIECGMMKRIRHRN 565
           F    +IG+G FG V         K+F ++Y         G+ ++   E  +++ + H  
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY 625
           L+ +  S  +++   LV++ +  G L   L S        Q    + ++  ALEYLH   
Sbjct: 62  LVNLWYSFQDEENMYLVVDLLLGGDLRYHL-SQKVKFSEEQVKFWICEIVLALEYLH--- 117

Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG 685
           S  IIH D+KP N+LLD+    H++DF +A  +     +LT T T  T GYMAP E+   
Sbjct: 118 SKGIIHRDIKPDNILLDEQGHVHITDFNIATKV--TPDTLT-TSTSGTPGYMAP-EVLCR 173

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 75.6 bits (187), Expect = 5e-15
 Identities = 50/168 (29%), Positives = 80/168 (47%), Gaps = 13/168 (7%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISS 572
           +G G +G VYK      G  VA+K   L     G   +   E  ++K ++H N++K++  
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66

Query: 573 CSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
              +    LV EY  +  L+K L      L      +IM  +   L Y H   S  I+H 
Sbjct: 67  IHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHR 122

Query: 633 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           DLKP N+L++ + V  L+DFG+A+      ++   T  + T+ Y AP+
Sbjct: 123 DLKPQNILINRDGVLKLADFGLARAFGIPLRTY--THEVVTLWYRAPE 168

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 75.2 bits (185), Expect = 7e-15
 Identities = 52/182 (28%), Positives = 90/182 (49%), Gaps = 10/182 (5%)

Query: 514 FSENNLIGRGGFGPVY----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKI 569
           F+    +G G FG V+    K+ + VAIK+         + F  E   +KR+RH++LI +
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 570 ISSCSNDDFKALVLEYMPLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVP 628
            + CS  +   ++ E M  GSL   L S    +L +   +++   VA  + YL       
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQN 124

Query: 629 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMR 688
            IH DL   N+L+ +++V  ++DFG+A+ L++ED  L+  + +    + AP+    G   
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLAR-LIKEDVYLSSDKKIP-YKWTAPEAASHGTFS 182

Query: 689 LK 690
            K
Sbjct: 183 TK 184

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 74.8 bits (184), Expect = 7e-15
 Identities = 51/149 (34%), Positives = 74/149 (49%), Gaps = 11/149 (7%)

Query: 519 LIGRGGFGPVY----KDGMEVAIKVFNLQYGGAFK-SFDIECGMMKRIRHRNLIKIISSC 573
            IG+G FG VY    K   EVA+K          K  F  E  ++K+  H N++K+I  C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
                  +V+E +P GSL   L      L + + L + +D A+ +EYL    S   IH D
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRD 118

Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEED 662
           L   N L+ +N V  +SDFGM++   EE+
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR---EEE 144

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 75.0 bits (185), Expect = 8e-15
 Identities = 52/177 (29%), Positives = 78/177 (44%), Gaps = 18/177 (10%)

Query: 520 IGRGGFGPVY-----KDGMEVAIKVFN---LQYGGAFKSFDIECGMMKRIRHRNLIKIIS 571
           I +G +G V+       G   AIKV     +           E  ++ + +   ++K+  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
           S        LV+EY+P G L   L +    LD       + ++  ALEYLH   S  IIH
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGS-LDEDVARIYIAEIVLALEYLH---SNGIIH 116

Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ------TQTLATIGYMAPDEI 682
            DLKP N+L+D N    L+DFG++K  L   Q           + + T  Y+AP+ I
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 74.2 bits (183), Expect = 1e-14
 Identities = 56/181 (30%), Positives = 87/181 (48%), Gaps = 24/181 (13%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGG---AFKSFDI-ECGMMKRIRHRNLIKII 570
           IG+G FG V K     DG  +  K  +  YG      K   + E  +++ ++H N+++  
Sbjct: 8   IGKGSFGTVRKVRRKSDGKILVWKEID--YGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 571 SSCSNDDFKAL--VLEYMPLGSL----EKCLYSGNYILDIFQGLNIMIDVASALEYLHFG 624
               +   + L  V+EY   G L    +KC     YI + F    I+  +  AL   H  
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI-WRILTQLLLALYECHNR 124

Query: 625 YSVP---IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
            S P   ++H DLKP+N+ LD N    L DFG+AK +L  D S  +T  + T  YM+P++
Sbjct: 125 -SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK-ILGHDSSFAKT-YVGTPYYMSPEQ 181

Query: 682 I 682
           +
Sbjct: 182 L 182

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 77.2 bits (190), Expect = 1e-14
 Identities = 56/169 (33%), Positives = 80/169 (47%), Gaps = 29/169 (17%)

Query: 306 LNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSI 365
           L L +    G +P  I  L  L  ++LS N+    IP  +G +  L+ L L YN   GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 366 PNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAE 425
           P S+G L SL+ LNL+ N+LSG +P +L   L  +    SFN                  
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHR---ASFN------------------ 521

Query: 426 SFKGNELLCGMPNLQVLSCRTKIHHTLGKNDLLIGIVLPLSTIFMMVVV 474
            F  N  LCG+P L+  +C    H ++G     IGI   +S  F+ +V+
Sbjct: 522 -FTDNAGLCGIPGLR--ACGP--HLSVGAK---IGIAFGVSVAFLFLVI 562

Length = 623

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 73.8 bits (182), Expect = 2e-14
 Identities = 52/187 (27%), Positives = 80/187 (42%), Gaps = 38/187 (20%)

Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIK 568
           F     +G G +G VYK      G  VAIKV  +      +    E  ++K+     ++K
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVK 62

Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLN----------IMIDVASAL 618
              S   +    +V+EY   GS          + DI +  N          I+      L
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGS----------VSDIMKITNKTLTEEEIAAILYQTLKGL 112

Query: 619 EYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG--- 675
           EYLH   S   IH D+K  N+LL++   A L+DFG++  L     ++ +  T+  IG   
Sbjct: 113 EYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQL---TDTMAKRNTV--IGTPF 164

Query: 676 YMAPDEI 682
           +MAP+ I
Sbjct: 165 WMAPEVI 171

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 74.2 bits (183), Expect = 2e-14
 Identities = 54/165 (32%), Positives = 80/165 (48%), Gaps = 16/165 (9%)

Query: 519 LIGRGGFGPVYK-----DGMEVAIKVFNLQY---GGAFKSFDIECGMMKRI-RHRNLIKI 569
           +IG G F  V          E AIK+ + +        K   IE  ++ R+  H  +IK+
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL 67

Query: 570 ISSCSNDDFKALVLEYMPLGSLEKCL-YSGNYILDIFQGLNIMIDVASALEYLHFGYSVP 628
             +  +++    VLEY P G L + +   G+  LD         ++  ALEYLH   S  
Sbjct: 68  YYTFQDEENLYFVLEYAPNGELLQYIRKYGS--LDEKCTRFYAAEILLALEYLH---SKG 122

Query: 629 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 673
           IIH DLKP N+LLD +M   ++DFG AK +L+ + S    +  AT
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAK-VLDPNSSPESNKGDAT 166

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 72.9 bits (179), Expect = 6e-14
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 31/206 (15%)

Query: 506 ELFQATNRFSENNLIGRGGFGPVYK------DGME----VAIKVFNLQYGGAFKS-FDIE 554
           E+  +  RF E   +G G FG VYK      +       VAIK          +  F  E
Sbjct: 1   EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58

Query: 555 CGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYS---------------GN 599
             +M  ++H N++ ++  C+ +    ++ EY+  G L + L                   
Sbjct: 59  AELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK 118

Query: 600 YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL 659
             LD    L+I I +A+ +EYL    S   +H DL   N L+ + +   +SDFG+++ + 
Sbjct: 119 SSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIY 175

Query: 660 EEDQSLTQTQTLATIGYMAPDEIFSG 685
             D    Q+++L  + +M P+ I  G
Sbjct: 176 SADYYRVQSKSLLPVRWMPPEAILYG 201

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 48/171 (28%), Positives = 77/171 (45%), Gaps = 13/171 (7%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNL-QYGGAFKSFDIECGMMKRIRHRNLIKIISSC 573
           IG G    VY      +  +VAIK  +L +   +      E   M +  H N++K  +S 
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNY--ILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
              D   LV+ Y+  GSL   + S      LD      ++ +V   LEYLH   S   IH
Sbjct: 69  VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIH 125

Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLE--EDQSLTQTQTLATIGYMAPD 680
            D+K  N+LL ++    ++DFG++  L +  +     +   + T  +MAP+
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 53/191 (27%), Positives = 81/191 (42%), Gaps = 34/191 (17%)

Query: 520 IGRGGFGPVY----------KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKI 569
           +G G FG V+          KD M VA+K        A K F  E  ++  ++H +++K 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 570 ISSCSNDDFKALVLEYMPLGSLEKCLYS---------------GNYILDIFQGLNIMIDV 614
              C + D   +V EYM  G L K L +                   L + Q L+I   +
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 615 ASALEYL---HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL 671
           AS + YL   HF      +H DL   N L+  N++  + DFGM++ +   D       T+
Sbjct: 133 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186

Query: 672 ATIGYMAPDEI 682
             I +M P+ I
Sbjct: 187 LPIRWMPPESI 197

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 54/169 (31%), Positives = 86/169 (50%), Gaps = 17/169 (10%)

Query: 520 IGRGGFGPV----YKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           IG+G FG V    Y+ G +VA+K   ++     ++F  E  +M ++RH NL++++     
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 576 DDFKA-LVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
           +     +V EYM  GSL   L S G  +L     L   +DV  A+EYL    +   +H D
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRD 127

Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
           L   NVL+ ++ VA +SDFG+ K     + S TQ      + + AP+ +
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEAL 171

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 52/177 (29%), Positives = 89/177 (50%), Gaps = 12/177 (6%)

Query: 520 IGRGGFGPVYK----DGMEVAIKVFNLQYGGA-FKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G FG V++    +   VA+K   L+ G    K F  E  +MK++RH  LI++ + C+
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVK--TLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 575 NDDFKALVLEYMPLGSLEKCLY-SGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
            ++   +V E M  GSL + L       L + Q +++   VAS + YL    +   IH D
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRD 128

Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           L   NVL+ +N +  ++DFG+A+ +++ED    +      I + AP+        +K
Sbjct: 129 LAARNVLVGENNICKVADFGLAR-VIKEDIYEAREGAKFPIKWTAPEAALYNRFSIK 184

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 48/188 (25%), Positives = 80/188 (42%), Gaps = 27/188 (14%)

Query: 520 IGRGGFGPVY----------KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKI 569
           +G G FG V+          +D M VA+K        A + F  E  ++  ++H+++++ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 570 ISSCSNDDFKALVLEYMPLGSLEKCLYSGN---YILDIFQG-----------LNIMIDVA 615
              C+      +V EYM  G L + L S      IL   +            L I   +A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 675
           S + YL    S+  +H DL   N L+   +V  + DFGM++ +   D      +T+  I 
Sbjct: 133 SGMVYLA---SLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 676 YMAPDEIF 683
           +M P+ I 
Sbjct: 190 WMPPESIL 197

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 70.4 bits (172), Expect = 3e-13
 Identities = 45/141 (31%), Positives = 80/141 (56%), Gaps = 10/141 (7%)

Query: 520 IGRGGFGPVYKD---GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSND 576
           IG G FG V +    G +VA+K  N++     ++F  E  +M ++ H+NL++++    ++
Sbjct: 14  IGEGEFGAVLQGEYTGQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN 71

Query: 577 DFKALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLK 635
               +V+E M  G+L   L + G  ++ + Q L   +DVA  +EYL    S  ++H DL 
Sbjct: 72  GLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLA 127

Query: 636 PSNVLLDDNMVAHLSDFGMAK 656
             N+L+ ++ VA +SDFG+A+
Sbjct: 128 ARNILVSEDGVAKVSDFGLAR 148

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 70.4 bits (173), Expect = 3e-13
 Identities = 48/171 (28%), Positives = 73/171 (42%), Gaps = 13/171 (7%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNL-QYGGAFKSFDI-ECGMMKRIRHRNLIKIISS 572
           IG G +G VYK      G  VAIK   L           + E  ++K + H N+IK++  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 573 CSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
             +     LV E+M    L K +      L      + +  +   L + H   S  I+H 
Sbjct: 67  FRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHR 122

Query: 633 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIF 683
           DLKP N+L++   V  L+DFG+A+           T  + T  Y AP+ + 
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSF--GSPVRPYTHYVVTRWYRAPELLL 171

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 70.4 bits (172), Expect = 3e-13
 Identities = 48/182 (26%), Positives = 92/182 (50%), Gaps = 15/182 (8%)

Query: 512 NRFSENNLIGRGGFGPVYKDGM------EVAIKVFNLQYGGAFKS---FDIECGMMKRIR 562
           +  ++  +IG G FG V++  +      EVA+ +  L+ G   K    F  E  +M +  
Sbjct: 5   SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64

Query: 563 HRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
           H N+I++    +      ++ EYM  G+L+K L   +     +Q + ++  +A+ ++YL 
Sbjct: 65  HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS 124

Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG--YMAPD 680
               +  +H DL   N+L++ N+   +SDFG+++ +LE+D   T T +   I   + AP+
Sbjct: 125 ---DMNYVHRDLAARNILVNSNLECKVSDFGLSR-VLEDDPEGTYTTSGGKIPIRWTAPE 180

Query: 681 EI 682
            I
Sbjct: 181 AI 182

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 69.8 bits (171), Expect = 4e-13
 Identities = 54/171 (31%), Positives = 83/171 (48%), Gaps = 14/171 (8%)

Query: 520 IGRGGFGPV----YKDGMEVAIKVFNLQYGGAFKSFDI--ECGMMKRIRHRNLIKIISSC 573
           +G G FG V    ++  ++VAIK+      GA    D   E  +M ++ H NL+++   C
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIR---EGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68

Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
           +      +V EYM  G L   L      L     L++  DV  A+EYL    S   IH D
Sbjct: 69  TKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRD 125

Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS 684
           L   N L+ ++ V  +SDFG+A+ +L +DQ  +   T   + + AP E+F 
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVL-DDQYTSSQGTKFPVKW-APPEVFD 174

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 69.8 bits (171), Expect = 5e-13
 Identities = 52/192 (27%), Positives = 87/192 (45%), Gaps = 42/192 (21%)

Query: 519 LIGRGGFGPVY-----KDGMEVAIKVFNL-----QYGGAFKSFDIECGMMKRIRHRNLIK 568
           L+G+G FG VY       G E+A+K         +      + + E  ++K ++H  +++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68

Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCL---------YSGNYILDIFQGLNIMIDVASALE 619
                 +D+  ++ +EYMP GS++  L          +  Y   I +G+          E
Sbjct: 69  YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGV----------E 118

Query: 620 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT-----LATI 674
           YLH   S  I+H D+K +N+L D      L DFG +K L    Q++  + T       T 
Sbjct: 119 YLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL----QTICSSGTGMKSVTGTP 171

Query: 675 GYMAPDEIFSGE 686
            +M+P E+ SGE
Sbjct: 172 YWMSP-EVISGE 182

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 69.4 bits (170), Expect = 7e-13
 Identities = 47/175 (26%), Positives = 82/175 (46%), Gaps = 14/175 (8%)

Query: 517 NNLIGRGGFGPVYK--------DGMEVAIKVFNLQYGGAFKS-FDIECGMMKRIRHRNLI 567
              IG G FG VY+        + + VA+K        + +  F  E  +M++  H +++
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 568 KIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
           K+I   + ++   +V+E  PLG L   L    Y LD+   +     +++AL YL    S 
Sbjct: 71  KLIGVIT-ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SK 126

Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
             +H D+   NVL+       L DFG+++  LE++     ++    I +MAP+ I
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDESYYKASKGKLPIKWMAPESI 180

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 69.5 bits (170), Expect = 7e-13
 Identities = 56/187 (29%), Positives = 89/187 (47%), Gaps = 24/187 (12%)

Query: 514 FSENN---LIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRN 565
           + EN    ++G+G +G VY        + +AIK    +     +    E  +   ++HRN
Sbjct: 7   YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66

Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYS------GNYILDIFQGLNIMIDVASALE 619
           +++ + S S + F  + +E +P GSL   L S       N    IF    I+      L+
Sbjct: 67  IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL----EGLK 122

Query: 620 YLHFGYSVPIIHCDLKPSNVLLDD-NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 678
           YLH      I+H D+K  NVL++  + V  +SDFG +K L   +   T+T T  T+ YMA
Sbjct: 123 YLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN-PCTETFT-GTLQYMA 177

Query: 679 PDEIFSG 685
           P+ I  G
Sbjct: 178 PEVIDKG 184

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 69.0 bits (169), Expect = 1e-12
 Identities = 53/183 (28%), Positives = 89/183 (48%), Gaps = 26/183 (14%)

Query: 519 LIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI-----ECGMMKRIRH---RN 565
           LIGRG +G VY+      G  VA+K+ NL         D+     E  ++ ++R     N
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDT----PDDDVSDIQREVALLSQLRQSQPPN 63

Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY 625
           + K   S        +++EY   GS+   + +G  I + +  + I+ +V  AL+Y+H   
Sbjct: 64  ITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP-IAEKYISV-IIREVLVALKYIH--- 118

Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGY-MAPDEIFS 684
            V +IH D+K +N+L+ +     L DFG+A  L   +Q+ ++  T     Y MAP+ I  
Sbjct: 119 KVGVIHRDIKAANILVTNTGNVKLCDFGVAALL---NQNSSKRSTFVGTPYWMAPEVITE 175

Query: 685 GEM 687
           G+ 
Sbjct: 176 GKY 178

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 70.4 bits (172), Expect = 1e-12
 Identities = 88/264 (33%), Positives = 130/264 (49%), Gaps = 13/264 (4%)

Query: 163 TSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPE 222
            SS   L   SSLS    L+  S S           + NL          N N   S   
Sbjct: 54  LSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGS-ENLLNLLPLPSLD--LNLNRLRSNIS 110

Query: 223 EINNLTNLILQLLSLEGNQLEGSIPDDLCRLAA-LFQLDLGGNKLSGFVPACSGNLTNLR 281
           E+  LTNL    L L+ N +   IP  +  L + L +LDL  NK+   +P+   NL NL+
Sbjct: 111 ELLELTNL--TSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLK 166

Query: 282 KLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVI 341
            L L  N L+ +P  L NL ++ +L+LS N  +  LP +I  L+ L +LDLS NN    +
Sbjct: 167 NLDLSFNDLSDLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLS-NNSIIEL 224

Query: 342 PTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKD 401
            + +  LK+L  L L  N+L+  +P SIG+L +L++L+LSNN +S     SL  L +L++
Sbjct: 225 LSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLRE 281

Query: 402 INVSFNRLEGEIPREGPFRNLSAE 425
           +++S N L   +P       L   
Sbjct: 282 LDLSGNSLSNALPLIALLLLLLEL 305

Length = 394

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 68.6 bits (167), Expect = 1e-12
 Identities = 51/189 (26%), Positives = 83/189 (43%), Gaps = 31/189 (16%)

Query: 520 IGRGGFGPVY----------KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKI 569
           +G G FG V+          +D + VA+K        A K F  E  ++  ++H +++K 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 570 ISSCSNDDFKALVLEYMPLGSLEKCLYS----------GNYILDIFQG--LNIMIDVASA 617
              C   D   +V EYM  G L K L +          GN   ++ Q   L+I   +A+ 
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 618 LEYL---HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI 674
           + YL   HF      +H DL   N L+ +N++  + DFGM++ +   D       T+  I
Sbjct: 133 MVYLASQHF------VHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186

Query: 675 GYMAPDEIF 683
            +M P+ I 
Sbjct: 187 RWMPPESIM 195

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 46/172 (26%), Positives = 83/172 (48%), Gaps = 17/172 (9%)

Query: 518 NLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISS 572
           + +G G +G VY     K  + VA+K    +     + F  E  +MK I+H NL++++  
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 573 CSNDDFKALVLEYMPLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYL---HFGYSVP 628
           C+ +    ++ E+M  G+L   L   N   ++    L +   ++SA+EYL   +F     
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF----- 125

Query: 629 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
            IH DL   N L+ +N +  ++DFG+++ L+  D           I + AP+
Sbjct: 126 -IHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPE 175

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 51/171 (29%), Positives = 83/171 (48%), Gaps = 12/171 (7%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQ--YGGAFKSFDIECGMMKRIRHRNLIKIISS 572
           IG G  G V+K      G  VA+K   L+   GG       E   ++  +H  ++K++  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 573 CSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
             +     LV+EYMP   L + L      L   Q  + M  +   + Y+H   +  I+H 
Sbjct: 68  FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHR 123

Query: 633 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIF 683
           DLKP+N+L+  + V  ++DFG+A+   EE+  L   Q +AT  Y AP+ ++
Sbjct: 124 DLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPELLY 173

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 67.6 bits (165), Expect = 3e-12
 Identities = 54/196 (27%), Positives = 88/196 (44%), Gaps = 36/196 (18%)

Query: 518 NLIGRGGFGPVYK--------DGME---VAIKVFNLQYGGA---FKSFDIECGMMKRIRH 563
           N +G G FG VY+         G     VA+K   L+ G      K F  E  +M    H
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVK--TLRKGATDQEKKEFLKEAHLMSNFNH 58

Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSL------EKCLYSGNYILDIFQGLNIMIDVASA 617
            N++K++  C  ++ + +++E M  G L       +    G  +L + + L+I +DVA  
Sbjct: 59  PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118

Query: 618 LEYL---HFGYSVPIIHCDLKPSNVLL-----DDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
             YL   HF      IH DL   N L+     D + V  + DFG+A+ + + D    + +
Sbjct: 119 CVYLEQMHF------IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGE 172

Query: 670 TLATIGYMAPDEIFSG 685
            L  + +MAP+ +  G
Sbjct: 173 GLLPVRWMAPESLLDG 188

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 67.4 bits (164), Expect = 3e-12
 Identities = 51/178 (28%), Positives = 94/178 (52%), Gaps = 15/178 (8%)

Query: 520 IGRGGFGPVYKDG----MEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G+G FG V+         VAIK   L+ G  + ++F  E  +MK++RH  L+++ +  S
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNY--ILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
            +    +V EYM  GSL   L  G     L + Q +++   +AS + Y+     +  +H 
Sbjct: 72  EEPI-YIVTEYMSKGSLLDFL-KGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126

Query: 633 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           DL+ +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + AP+    G   +K
Sbjct: 127 DLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 67.2 bits (164), Expect = 3e-12
 Identities = 50/171 (29%), Positives = 87/171 (50%), Gaps = 15/171 (8%)

Query: 519 LIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI--ECGMMKRIRHRNLIKIIS 571
           ++GRG FG V+      D   V IK   ++     +      EC ++K + H N+I+   
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFGYSVPII 630
           +   D    +V+EY P G+L + +    N +LD    L+  + +  AL ++H   +  I+
Sbjct: 67  NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLIL 123

Query: 631 HCDLKPSNVLLDDN-MVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           H DLK  N+LLD + MV  + DFG++K L  + ++ T    + T  Y++P+
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT---VVGTPCYISPE 171

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 67.4 bits (165), Expect = 3e-12
 Identities = 46/177 (25%), Positives = 78/177 (44%), Gaps = 14/177 (7%)

Query: 520 IGRGGFGPVYK-----DG----MEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKI 569
           +G G FG VYK     +G    + VAIKV   +    A K    E  +M  + H +++++
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 570 ISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPI 629
           +  C +     L+ + MPLG L   + +    +     LN  + +A  + YL       +
Sbjct: 75  LGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRL 130

Query: 630 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGE 686
           +H DL   NVL+       ++DFG+AK L  +++          I +MA + I    
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRI 187

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 67.3 bits (165), Expect = 3e-12
 Identities = 50/169 (29%), Positives = 77/169 (45%), Gaps = 12/169 (7%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGA-FKSFDIECGMMKRIRHRNLIKIISSC 573
           +G G  G V K      G  +A+K   L+   A  K    E  ++ +     ++    + 
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68

Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
            N+   ++ +EYM  GSL+K L      +       I + V   L YLH  +   IIH D
Sbjct: 69  YNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK--IIHRD 126

Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
           +KPSN+L++      L DFG++  L+    SL +T    T  YMAP+ I
Sbjct: 127 VKPSNILVNSRGQIKLCDFGVSGQLVN---SLAKTFV-GTSSYMAPERI 171

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 68.1 bits (167), Expect = 3e-12
 Identities = 57/202 (28%), Positives = 90/202 (44%), Gaps = 42/202 (20%)

Query: 508 FQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAFKSFDI------ECG 556
           F   +R+     IG G +G V      + G +VAIK    +   AF    +      E  
Sbjct: 1   FDVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIK----KIPHAFDVPTLAKRTLRELK 56

Query: 557 MMKRIRHRNLIKI--ISSCSNDDFKA--LVLEYMPLGSLEKCLYSG--------NYILDI 604
           +++  +H N+I I  I      DFK   +V++ M    L   ++S          Y L  
Sbjct: 57  ILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFL-- 113

Query: 605 FQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE--ED 662
           +Q L         L+Y+H   S  +IH DLKPSN+L++++    + DFGMA+ L     +
Sbjct: 114 YQLLR-------GLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163

Query: 663 QSLTQTQTLATIGYMAPDEIFS 684
                T+ +AT  Y AP+ + S
Sbjct: 164 HKYFMTEYVATRWYRAPELLLS 185

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 66.9 bits (164), Expect = 4e-12
 Identities = 54/181 (29%), Positives = 81/181 (44%), Gaps = 36/181 (19%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           IG G +G VYK      G  VAIKV  L+ G  F+    E  M+K  RH N++    S  
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLN----------IMIDVASALEYLHFG 624
             D   +V+EY   GSL+          DI+Q             +  +    L YLH  
Sbjct: 71  RRDKLWIVMEYCGGGSLQ----------DIYQVTRGPLSELQIAYVCRETLKGLAYLH-- 118

Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG---YMAPDE 681
                IH D+K +N+LL ++    L+DFG++  L     ++ + ++   IG   +MAP+ 
Sbjct: 119 -ETGKIHRDIKGANILLTEDGDVKLADFGVSAQL---TATIAKRKSF--IGTPYWMAPEV 172

Query: 682 I 682
            
Sbjct: 173 A 173

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 66.6 bits (162), Expect = 5e-12
 Identities = 52/174 (29%), Positives = 81/174 (46%), Gaps = 13/174 (7%)

Query: 519 LIGRGGFGPVYK----DGMEVAIKVFNLQYGGAFK-SFDIECGMMKRIRHRNLIKIISSC 573
           L+G+G FG V+K    D   VA+K          K  F  E  ++K+  H N++K+I  C
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
           +      +V+E +P G     L      L   Q +   +D A+ + YL    S   IH D
Sbjct: 62  TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRD 118

Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPDEIFSG 685
           L   N L+ +N V  +SDFGM++   +ED  +  +  L    I + AP+ +  G
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR---QEDDGIYSSSGLKQIPIKWTAPEALNYG 169

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 65.9 bits (161), Expect = 8e-12
 Identities = 50/175 (28%), Positives = 82/175 (46%), Gaps = 18/175 (10%)

Query: 520 IGRGGFGPVYK-----DGMEVA---IKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIIS 571
           IG+G F  VYK     DG  VA   +++F +    A +    E  ++K++ H N+IK ++
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 572 SCSNDDFKALVLEYMPLGSLE---KCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVP 628
           S   ++   +VLE    G L    K       ++         + + SALE++H   S  
Sbjct: 70  SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKR 126

Query: 629 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL-ATIGYMAPDEI 682
           I+H D+KP+NV +    V  L D G+ +    +    T   +L  T  YM+P+ I
Sbjct: 127 IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT---TAAHSLVGTPYYMSPERI 178

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 65.8 bits (161), Expect = 1e-11
 Identities = 52/183 (28%), Positives = 81/183 (44%), Gaps = 26/183 (14%)

Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGG--AFKSFDIECGMMKRIRHR 564
           N++    ++G G +G V K      G  VAIK F          K+   E  +++++RH 
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60

Query: 565 NLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQ-GLN------IMIDVASA 617
           N++ +  +        LV EY+    LE        +L+    GL        +  +  A
Sbjct: 61  NIVNLKEAFRRKGRLYLVFEYVERTLLE--------LLEASPGGLPPDAVRSYIWQLLQA 112

Query: 618 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 677
           + Y H   S  IIH D+KP N+L+ ++ V  L DFG A+ L     S   T  +AT  Y 
Sbjct: 113 IAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYVATRWYR 168

Query: 678 APD 680
           AP+
Sbjct: 169 APE 171

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 65.7 bits (160), Expect = 1e-11
 Identities = 51/153 (33%), Positives = 73/153 (47%), Gaps = 17/153 (11%)

Query: 520 IGRGGFGPV--YK-------DGMEVAIKVFNLQYGGAFKS-FDIECGMMKRIRHRNLIKI 569
           +G G FG V  Y         G  VA+K    + G    S +  E  ++K + H N++K 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 570 ISSCSNDDFKA--LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
              CS    K   L++EY+PLGSL   L      L++ Q L     +   + YLH   S 
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLH---SQ 126

Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE 660
             IH DL   NVLLD++ +  + DFG+AK + E
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 65.3 bits (160), Expect = 2e-11
 Identities = 55/200 (27%), Positives = 83/200 (41%), Gaps = 41/200 (20%)

Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNL 566
             F+    IG+G FG VYK         VAIKV +L+        +IE  + + I     
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA----EDEIE-DIQQEI----- 50

Query: 567 IKIISSCSN-----------DDFK-ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDV 614
            + +S C +              K  +++EY   GS    L  G   LD      I+ +V
Sbjct: 51  -QFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREV 107

Query: 615 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI 674
              LEYLH       IH D+K +N+LL +     L+DFG++  L     + T ++    +
Sbjct: 108 LLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQL-----TSTMSKRNTFV 159

Query: 675 G---YMAPDEIFSGEMRLKC 691
           G   +MAP+ I       K 
Sbjct: 160 GTPFWMAPEVIKQSGYDEKA 179

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 51/177 (28%), Positives = 92/177 (51%), Gaps = 13/177 (7%)

Query: 520 IGRGGFGPVYKD----GMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G FG V+        +VA+K   L+ G  + +SF  E  +MK++RH  L+++ +  S
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVK--TLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71

Query: 575 NDDFKALVLEYMPLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
            +    +V EYM  GSL   L  G    L +   +++   VA+ + Y+     +  IH D
Sbjct: 72  EEPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRD 127

Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           L+ +N+L+ D +V  ++DFG+A+ L+E+++   +      I + AP+    G   +K
Sbjct: 128 LRSANILVGDGLVCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 42/175 (24%), Positives = 69/175 (39%), Gaps = 15/175 (8%)

Query: 519 LIGRGGFGPVYKDG--------MEVAIKVF-NLQYGGAFKSFDIECGMMKRIRHRNLIKI 569
            +G G FG V +          + VA+K   + +       F  E  +M  + H NLI++
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 570 ISSCSNDDFKALVLEYMPLGSLEKCLY-SGNYILDIFQGLNIMIDVASALEYLHFGYSVP 628
                      +V E  PLGSL   L         I    +  + +A+ + YL    S  
Sbjct: 62  YGVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKR 117

Query: 629 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT-IGYMAPDEI 682
            IH DL   N+LL  +    + DFG+ + L + +      + L     + AP+ +
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESL 172

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 50/183 (27%), Positives = 82/183 (44%), Gaps = 18/183 (9%)

Query: 513 RFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI--ECGMMKRIRHRN 565
            F     +G+G +G VYK     D    A+K  +L      +  D   E  ++  + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQG---LNIMIDVASALEYLH 622
           +I    +  + +   +V+EY P G L K +        +        I I +   L+ LH
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
                 I+H DLK +N+LL  N +  + D G++K L    +++ +TQ   T  YMAP E+
Sbjct: 121 ---EQKILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQI-GTPHYMAP-EV 172

Query: 683 FSG 685
           + G
Sbjct: 173 WKG 175

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 53/171 (30%), Positives = 81/171 (47%), Gaps = 14/171 (8%)

Query: 520 IGRGGFGPVYK----DGMEVAIKVFNLQYGGAF--KSFDIECGMMKRIRHRNLIKIISSC 573
           IG G FG V+     +  +VAIK       GA   + F  E  +M ++ H  L+++   C
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIR---EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68

Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
           +      LV E+M  G L   L +          L + +DV   + YL    S  +IH D
Sbjct: 69  TERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRD 125

Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS 684
           L   N L+ +N V  +SDFGM + +L +DQ  + T T   + + +P E+FS
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVL-DDQYTSSTGTKFPVKWSSP-EVFS 174

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 51/177 (28%), Positives = 93/177 (52%), Gaps = 13/177 (7%)

Query: 520 IGRGGFGPVY----KDGMEVAIKVFNLQYGGAF-KSFDIECGMMKRIRHRNLIKIISSCS 574
           +G+G FG V+        +VAIK   L+ G    ++F  E  +MK++RH  L+ + +  S
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIK--TLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 575 NDDFKALVLEYMPLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
            +    +V E+M  GSL   L  G+   L + Q +++   +A  + Y+     +  IH D
Sbjct: 72  EEPI-YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRD 127

Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           L+ +N+L+ DN+V  ++DFG+A+ L+E+++   +      I + AP+    G   +K
Sbjct: 128 LRAANILVGDNLVCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 64.4 bits (157), Expect = 3e-11
 Identities = 42/172 (24%), Positives = 81/172 (47%), Gaps = 22/172 (12%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G FG VYK      G+  A K+  ++     + F +E  ++   +H N++ +  +  
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLN------IMIDVASALEYLHFGYSVP 628
            ++   +++E+   G+L       + +L++ +GL       +   +  AL +LH   S  
Sbjct: 73  YENKLWILIEFCDGGAL------DSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHK 123

Query: 629 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           +IH DLK  N+LL  +    L+DFG++       Q   +   + T  +MAP+
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK--RDTFIGTPYWMAPE 173

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 64.1 bits (156), Expect = 4e-11
 Identities = 56/191 (29%), Positives = 88/191 (46%), Gaps = 44/191 (23%)

Query: 519 LIGRGGFGPVY-----KDGMEVAIKVFNLQYGGA---------FKSFDIECGMMKRIRHR 564
           LIG G FG VY       G  +A+K   L    A           +   E  ++K ++H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 565 NLIKIISSCSNDDFKALVLEYMPLGSLEKCL--YSG-------NYILDIFQGLNIMIDVA 615
           N+++ + S  + D   + LEY+P GS+   L  Y         N++  I +GLN      
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLN------ 120

Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA--- 672
               YLH   +  IIH D+K +N+L+D+     +SDFG++K L  E  SL+     A   
Sbjct: 121 ----YLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL--EANSLSTKTNGARPS 171

Query: 673 ---TIGYMAPD 680
              ++ +MAP+
Sbjct: 172 LQGSVFWMAPE 182

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 64.2 bits (156), Expect = 5e-11
 Identities = 53/171 (30%), Positives = 79/171 (46%), Gaps = 22/171 (12%)

Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           IG+G  G VY       G EVAIK  NLQ     +    E  +M+  +H N++  + S  
Sbjct: 27  IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86

Query: 575 NDDFKALVLEYMPLGSL-----EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPI 629
             D   +V+EY+  GSL     E C+  G       Q   +  +   ALE+LH   S  +
Sbjct: 87  VGDELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECLQALEFLH---SNQV 136

Query: 630 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           IH D+K  N+LL  +    L+DFG    +  E     ++  + T  +MAP+
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPE 185

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 63.9 bits (155), Expect = 5e-11
 Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 41/212 (19%)

Query: 506 ELFQATNRFSENNLIGRGGFGPVYKD-----GME----VAIKVF----NLQYGGAFKSFD 552
           EL  +  RF E   +G   FG +YK      GM+    VAIK      N Q  G F+   
Sbjct: 1   ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQ-- 56

Query: 553 IECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLY---------------- 596
            E  +M  + H N++ ++   + +    ++ EY+  G L + L                 
Sbjct: 57  -EASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDG 115

Query: 597 SGNYILDIFQGLNIMIDVASALEYL--HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGM 654
           +    LD    L+I I +A+ +EYL  HF      +H DL   N+L+ + +   +SD G+
Sbjct: 116 TVKSSLDHGDFLHIAIQIAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDLGL 170

Query: 655 AKPLLEEDQSLTQTQTLATIGYMAPDEIFSGE 686
           ++ +   D    Q ++L  I +M P+ I  G+
Sbjct: 171 SREIYSADYYRVQPKSLLPIRWMPPEAIMYGK 202

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 63.8 bits (155), Expect = 6e-11
 Identities = 52/176 (29%), Positives = 83/176 (47%), Gaps = 17/176 (9%)

Query: 519 LIGRGGFGPVY--------KDGMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKI 569
           +IG G FG V         K  + VAIK     Y     + F  E  +M +  H N+I +
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 570 ISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH-FGYSVP 628
               +      +V EYM  GSL+  L   +    + Q + ++  +AS ++YL   GY   
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGY--- 127

Query: 629 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG--YMAPDEI 682
            +H DL   N+L++ N+V  +SDFG+++ +LE+D     T     I   + AP+ I
Sbjct: 128 -VHRDLAARNILVNSNLVCKVSDFGLSR-VLEDDPEAAYTTRGGKIPIRWTAPEAI 181

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 64.1 bits (156), Expect = 7e-11
 Identities = 58/187 (31%), Positives = 85/187 (45%), Gaps = 32/187 (17%)

Query: 513 RFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAF---KSFDI--ECGMMKRIR 562
            F++   IG G FG VY     +    VAIK   + Y G     K  DI  E   ++++R
Sbjct: 16  LFTDLREIGHGSFGAVYFARDVRTNEVVAIK--KMSYSGKQSNEKWQDIIKEVRFLQQLR 73

Query: 563 HRNLIKIISSCSNDDFKA-LVLEYMPLGSLEKCLYSGNYILDI----FQGLNIMIDVASA 617
           H N I+    C   +  A LV+EY        CL S + IL++     Q + I      A
Sbjct: 74  HPNTIEY-KGCYLREHTAWLVMEY--------CLGSASDILEVHKKPLQEVEIAAICHGA 124

Query: 618 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 677
           L+ L + +S   IH D+K  N+LL +     L+DFG A  L+    S      + T  +M
Sbjct: 125 LQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSAS-LVSPANSF-----VGTPYWM 178

Query: 678 APDEIFS 684
           AP+ I +
Sbjct: 179 APEVILA 185

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 63.1 bits (154), Expect = 9e-11
 Identities = 47/176 (26%), Positives = 83/176 (47%), Gaps = 14/176 (7%)

Query: 517 NNLIGRGGFGPVYKDGME--------VAIKVFNLQYGGAFKS-FDIECGMMKRIRHRNLI 567
             +IG G FG V +  ++        VAIK          +  F  E  +M +  H N+I
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 568 KIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL-HFGYS 626
           ++    +      ++ EYM  GSL+K L   +    + Q + ++  +AS ++YL    Y 
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNY- 127

Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              +H DL   N+L++ N+V  +SDFG+++ L + + + T       I + AP+ I
Sbjct: 128 ---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAI 180

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 42/147 (28%), Positives = 68/147 (46%), Gaps = 8/147 (5%)

Query: 520 IGRGGFGPV----YKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           +G G FG V    ++   +VAIK+   +   +   F  E  +M ++ H  L+++   C+ 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70

Query: 576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLK 635
                +V EYM  G L   L          Q L +  DV   + YL    S   IH DL 
Sbjct: 71  QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLA 127

Query: 636 PSNVLLDDNMVAHLSDFGMAKPLLEED 662
             N L+DD     +SDFG+++ +L+++
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSRYVLDDE 154

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 51/191 (26%), Positives = 81/191 (42%), Gaps = 37/191 (19%)

Query: 519 LIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI------ECGMMKRIRHRNLI 567
            +G G F   Y     K G  +A+K        + +  ++      E  +M R+ H ++I
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 568 KIISSCSNDDFKALVLEYMPLGSLEKCLY---------SGNYILDIFQGLNIMIDVASAL 618
           +++ +   D    L +E+M  GS+   L            NY   + +GL+         
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLS--------- 117

Query: 619 EYLHFGYSVPIIHCDLKPSNVLLDDN-MVAHLSDFGMAKPLLEE--DQSLTQTQTLATIG 675
            YLH      IIH D+K +N+L+D       ++DFG A  L  +       Q Q L TI 
Sbjct: 118 -YLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIA 173

Query: 676 YMAPDEIFSGE 686
           +MAP E+  GE
Sbjct: 174 FMAP-EVLRGE 183

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 62.6 bits (153), Expect = 1e-10
 Identities = 50/172 (29%), Positives = 76/172 (44%), Gaps = 17/172 (9%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIIS 571
           +G GGFG V            A+K    ++    G  +    E  +++   H  ++K+  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
           +  +  +  +++EY   G L   L       D +     +  V  A EYLH   +  II+
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGL-FDEYTARFYIACVVLAFEYLH---NRGIIY 116

Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL-ATIGYMAPDEI 682
            DLKP N+LLD N    L DFG AK L    +S  +T T   T  Y+AP+ I
Sbjct: 117 RDLKPENLLLDSNGYVKLVDFGFAKKL----KSGQKTWTFCGTPEYVAPEII 164

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 60/199 (30%), Positives = 91/199 (45%), Gaps = 26/199 (13%)

Query: 519 LIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFD---IECGMMKRIRHRNLIKII 570
            +G G FG V+           A+KV  +      K       E  ++K + H  +I++ 
Sbjct: 8   TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF 67

Query: 571 SSCSNDDFKALVLEYMPLGSLEKCLYSG---NYILDIFQGLNIMIDVASALEYLHFGYSV 627
            +  +  F  +++EY+P G L   L +    +    +F    I+     ALEYLH   S 
Sbjct: 68  WTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIV----CALEYLH---SK 120

Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL-ATIGYMAPDEIFS-G 685
            I++ DLKP N+LLD      L+DFG AK L +      +T TL  T  Y+AP+ I S G
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD------RTWTLCGTPEYLAPEVIQSKG 174

Query: 686 EMRLKCWVNDSLLISVMIV 704
             +   W    +LI  M+V
Sbjct: 175 HNKAVDWWALGILIYEMLV 193

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 2e-10
 Identities = 51/184 (27%), Positives = 85/184 (46%), Gaps = 27/184 (14%)

Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIK--VFNLQYGGAFKSFDIECGMMKRIR---H 563
           + E   IG G +G VYK      G  VA+K     L   G   S   E  ++K++    H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 564 RNLIKIISSCSNDDFK-----ALVLEYMP--LGS-LEKCLYSGNYILDIFQGLNIMIDVA 615
            N+++++  C            LV E++   L + L KC   G   L      ++M  + 
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG---LPPETIKDLMRQLL 117

Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 675
             +++LH   S  I+H DLKP N+L+  +    ++DFG+A+ +   + +L  T  + T+ 
Sbjct: 118 RGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLAR-IYSFEMAL--TSVVVTLW 171

Query: 676 YMAP 679
           Y AP
Sbjct: 172 YRAP 175

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 58/187 (31%), Positives = 83/187 (44%), Gaps = 34/187 (18%)

Query: 519 LIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI---------ECGMMKRIRHR 564
           L+G G +G V K      G  VAIK F        +S D          E  M+K++RH 
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKF-------LESEDDKMVKKIAMREIRMLKQLRHE 60

Query: 565 NLIKIISSCSNDDFKALVLEYMP---LGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
           NL+ +I          LV E++    L  LEK  Y     LD  +    +  +   +E+ 
Sbjct: 61  NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEK--YPNG--LDESRVRKYLFQILRGIEFC 116

Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
           H   S  IIH D+KP N+L+  + V  L DFG A+ L    +    T  +AT  Y AP E
Sbjct: 117 H---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--TDYVATRWYRAP-E 170

Query: 682 IFSGEMR 688
           +  G+ +
Sbjct: 171 LLVGDTK 177

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 45/189 (23%), Positives = 90/189 (47%), Gaps = 30/189 (15%)

Query: 514 FSENNLIGRGGFGPVY----KDGMEVAIKVFNLQYGGA------FKSFDIECGMMKRIRH 563
           +++  ++G+G +G VY      G  +A+K   L           ++    E  ++K ++H
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61

Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMI------DVASA 617
            N+++ + +C +D+  ++ +E++P GS+         IL+ F  L   +       +   
Sbjct: 62  VNIVQYLGTCLDDNTISIFMEFVPGGSISS-------ILNRFGPLPEPVFCKYTKQILDG 114

Query: 618 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG-- 675
           + YLH   +  ++H D+K +NV+L  N +  L DFG A+ L       T +  L ++   
Sbjct: 115 VAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGT 171

Query: 676 --YMAPDEI 682
             +MAP+ I
Sbjct: 172 PYWMAPEVI 180

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 61.2 bits (149), Expect = 3e-10
 Identities = 47/148 (31%), Positives = 70/148 (47%), Gaps = 14/148 (9%)

Query: 520 IGRGGFGPVY------KDG--MEVAIKVFNLQYGGAFKS-FDIECGMMKRIRHRNLIKII 570
           +G G FG V       K G  +EVA+K    ++  A K  F  E  +M ++ H  ++++I
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 571 SSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPII 630
             C  +    LV+E  PLG L K L      + +     +   VA  + YL    S   +
Sbjct: 63  GVCKGEPL-MLVMELAPLGPLLKYL-KKRREIPVSDLKELAHQVAMGMAYLE---SKHFV 117

Query: 631 HCDLKPSNVLLDDNMVAHLSDFGMAKPL 658
           H DL   NVLL +   A +SDFGM++ L
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRAL 145

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 61.4 bits (149), Expect = 3e-10
 Identities = 45/176 (25%), Positives = 84/176 (47%), Gaps = 15/176 (8%)

Query: 519 LIGRGGFGPVYKDGME--------VAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKI 569
           +IG G FG V +  ++        VAIK     Y     + F  E  +M +  H N+I +
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 570 ISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPI 629
               +      ++ E+M  G+L+  L   +    + Q + ++  +A+ ++YL     +  
Sbjct: 71  EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNY 127

Query: 630 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA---TIGYMAPDEI 682
           +H DL   N+L++ N+V  +SDFG+++ L ++    T T +L     I + AP+ I
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 47/178 (26%), Positives = 95/178 (53%), Gaps = 14/178 (7%)

Query: 520 IGRGGFGPV----YKDGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G FG V    Y +  +VA+K   L+ G  + ++F  E  +MK ++H  L+++ +  +
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVK--TLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 575 NDDFKALVLEYMPLGSLEKCLYS--GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
            ++   ++ EYM  GSL   L S  G  +L + + ++    +A  + Y+        IH 
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIE---RKNYIHR 127

Query: 633 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           DL+ +NVL+ ++++  ++DFG+A+ ++E+++   +      I + AP+ I  G   +K
Sbjct: 128 DLRAANVLVSESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 184

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 62.1 bits (151), Expect = 4e-10
 Identities = 42/169 (24%), Positives = 72/169 (42%), Gaps = 25/169 (14%)

Query: 508 FQATNRFSE-NNLIGRGGFGPVYK-----DGMEVAIK-VFNLQYGGAFKSFDIECGM--- 557
           F  + R+ +    +G G +G V K      G  VAIK V  ++            GM   
Sbjct: 4   FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGI 63

Query: 558 ----------MKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQG 607
                     M  I+H N++ ++      DF  LV++ M    L+K +      L   Q 
Sbjct: 64  HFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDR-KIRLTESQV 121

Query: 608 LNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK 656
             I++ + + L  LH  Y    +H DL P+N+ ++   +  ++DFG+A+
Sbjct: 122 KCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLAR 167

Length = 335

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 61.4 bits (150), Expect = 4e-10
 Identities = 56/196 (28%), Positives = 83/196 (42%), Gaps = 60/196 (30%)

Query: 520 IGRGGFGPV----YKDGMEV-AIKVFNLQYGGAFKSFDI-----------ECGMMKRIRH 563
           +G G FG V    +K   +  A+K+ +           I           E  +++ IRH
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKA--------KIVKLKQVEHVLNEKRILQSIRH 60

Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIM----IDVA---- 615
             L+ +  S  +D    LV+EY+P G             ++F  L         VA    
Sbjct: 61  PFLVNLYGSFQDDSNLYLVMEYVPGG-------------ELFSHLRKSGRFPEPVARFYA 107

Query: 616 ----SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL 671
                ALEYLH   S+ I++ DLKP N+LLD +    ++DFG AK +        +T TL
Sbjct: 108 AQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG------RTYTL 158

Query: 672 -ATIGYMAPDEIFSGE 686
             T  Y+AP EI   +
Sbjct: 159 CGTPEYLAP-EIILSK 173

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 60.6 bits (147), Expect = 4e-10
 Identities = 47/177 (26%), Positives = 93/177 (52%), Gaps = 13/177 (7%)

Query: 520 IGRGGFGPV----YKDGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G FG V    Y    +VAIK  +L+ G  + ++F  E  +MK+++H  L+++ +  +
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIK--SLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT 71

Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYI-LDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
            +    ++ EYM  GSL   L +   I L I + +++   +A  + ++        IH D
Sbjct: 72  QEPI-YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY---IHRD 127

Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           L+ +N+L+ + +   ++DFG+A+ L+E+++   +      I + AP+ I  G   +K
Sbjct: 128 LRAANILVSETLCCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 61.0 bits (148), Expect = 5e-10
 Identities = 44/165 (26%), Positives = 71/165 (43%), Gaps = 24/165 (14%)

Query: 519 LIGRGGFGPVYK------DGMEVAIKVFNLQYGGAFKS----FDIECGMMKRIRHRNLIK 568
           ++G G FG V +      DG ++ + V  ++      S    F  E   MK   H N++K
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 569 IISSC----SNDDFKA--LVLEYMPLGSLEKCLYS-----GNYILDIFQGLNIMIDVASA 617
           +I  C    S        ++L +M  G L   L           L +   L  M+D+A  
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 618 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED 662
           +EYL    +   IH DL   N +L ++M   ++DFG++K +   D
Sbjct: 126 MEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGD 167

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 61.0 bits (148), Expect = 5e-10
 Identities = 50/176 (28%), Positives = 78/176 (44%), Gaps = 16/176 (9%)

Query: 520 IGRGGFGPVY----KD-GMEVAIKVFN---LQYGGAFKSFDIECGMMKRIRHRNLIKIIS 571
           +G+GGFG V     K  G   A K  +   L+     +    E  +++++  R ++ +  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFGYSVPII 630
           +    D   LV+  M  G L+  +Y+ G       + +     +   LE+LH      I+
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIV 117

Query: 631 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGE 686
           + DLKP NVLLDD+    +SD G+A  L              T GYMAP E+  GE
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGRAGTPGYMAP-EVLQGE 169

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 61.1 bits (148), Expect = 5e-10
 Identities = 50/177 (28%), Positives = 84/177 (47%), Gaps = 17/177 (9%)

Query: 524 GFGPVYKDGMEVAIKVFNLQ---YGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKA 580
           G G    DG  V + V  L+      A   F  E  +M R+++ N+I+++  C +DD   
Sbjct: 34  GEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLC 93

Query: 581 LVLEYMPLGSLEKCL-----YS----GNYI--LDIFQGLNIMIDVASALEYLHFGYSVPI 629
           ++ EYM  G L + L      S     N I  + I   L + + +AS ++YL    S+  
Sbjct: 94  MITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNF 150

Query: 630 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGE 686
           +H DL   N L+ ++    ++DFGM++ L   D    Q + +  I +MA + I  G+
Sbjct: 151 VHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK 207

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 61.2 bits (149), Expect = 5e-10
 Identities = 47/186 (25%), Positives = 85/186 (45%), Gaps = 26/186 (13%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI----ECGMMKRIRHRNLIKII 570
           IG+G FG V+K         VA+K   +      + F I    E  +++ ++H N++ +I
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALK--KVLMENEKEGFPITALREIKILQLLKHENVVNLI 77

Query: 571 SSCSN-----DDFKA---LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
             C       + +K    LV E+     L   L + N    + +   +M  + + L Y+H
Sbjct: 78  EICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH 136

Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP--LLEEDQSLTQTQTLATIGYMAPD 680
                 I+H D+K +N+L+  + +  L+DFG+A+   L +  +    T  + T+ Y  P 
Sbjct: 137 RN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPP- 192

Query: 681 EIFSGE 686
           E+  GE
Sbjct: 193 ELLLGE 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 61.0 bits (148), Expect = 5e-10
 Identities = 49/182 (26%), Positives = 87/182 (47%), Gaps = 21/182 (11%)

Query: 519 LIGRGGFGPVY-----KDGMEVAIKVFNL----------QYGGAFKSFDIECGMMKRIRH 563
           LIG+G +G VY       G  +A+K   L          +     K+   E   +K + H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLH 622
            N+++ +   + +++ ++ LEY+P GS+  CL + G +   + +       V   L YLH
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFF--TEQVLEGLAYLH 125

Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              S  I+H DLK  N+L+D + +  +SDFG++K   +   +        ++ +MAP+ I
Sbjct: 126 ---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI 182

Query: 683 FS 684
            S
Sbjct: 183 HS 184

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 61.3 bits (149), Expect = 5e-10
 Identities = 50/176 (28%), Positives = 87/176 (49%), Gaps = 20/176 (11%)

Query: 520 IGRGGFGPVY----KDGME-VAIKVFN---LQYGGAFKSFDIECGMMKRIRHRNLIKIIS 571
           +G+GG+G V+    KD  E VA+K      L      +    E  ++   +   L+K++ 
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH-FGYSVPII 630
           +  +D++  L +EY+P G   + L +   +L        M ++  A++ LH  GY    I
Sbjct: 69  AFQDDEYLYLAMEYVPGGDF-RTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY----I 123

Query: 631 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGE 686
           H DLKP N L+D +    L+DFG++K ++    S+     + +  YMAP E+  G+
Sbjct: 124 HRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV-----VGSPDYMAP-EVLRGK 173

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 61.2 bits (148), Expect = 5e-10
 Identities = 45/164 (27%), Positives = 76/164 (46%), Gaps = 29/164 (17%)

Query: 518 NLIGRGGFGPVY-----KDG--MEVAIKVFNLQYGGA--FKSFDIECGMMKRI-RHRNLI 567
           ++IG G FG V      KDG  M  AIK+   ++      + F  E  ++ ++  H N+I
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLK-EFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 568 KIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYI---------------LDIFQGLNIMI 612
            ++ +C N  +  + +EY P G+L   L     +               L   Q L    
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 613 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK 656
           DVA+ ++YL        IH DL   NVL+ +N+ + ++DFG+++
Sbjct: 127 DVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSR 167

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 60.8 bits (148), Expect = 6e-10
 Identities = 42/186 (22%), Positives = 77/186 (41%), Gaps = 23/186 (12%)

Query: 520 IGRGGFGPVYK----------DGMEVAIK-VFNLQYGGAFKSFDIECGMMKRIRHRNLIK 568
           +G+G FG VY+              VAIK V           F  E  +MK     ++++
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCLYS---------GNYILDIFQGLNIMIDVASALE 619
           ++   S      +V+E M  G L+  L S         G     + + + +  ++A  + 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 620 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
           YL    +   +H DL   N ++ +++   + DFGM + + E D      + L  + +MAP
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 680 DEIFSG 685
           + +  G
Sbjct: 191 ESLKDG 196

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 60.5 bits (146), Expect = 6e-10
 Identities = 53/169 (31%), Positives = 78/169 (46%), Gaps = 17/169 (10%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           IG G +G VYK      G   AIKV  L+ G  F     E  MMK  +H N++    S  
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDL 634
             D   + +E+   GSL+  +Y     L   Q   +  +    L YLH   S   +H D+
Sbjct: 77  RRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAYVSRETLQGLYYLH---SKGKMHRDI 132

Query: 635 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG---YMAPD 680
           K +N+LL DN    L+DFG++  +     + T  +  + IG   +MAP+
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQI-----TATIAKRKSFIGTPYWMAPE 176

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 61.0 bits (148), Expect = 8e-10
 Identities = 55/190 (28%), Positives = 87/190 (45%), Gaps = 35/190 (18%)

Query: 510 ATNRFSE---NNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI----ECGM 557
           A    SE    N IG G  G VYK      G   A+KV    YG    +       E  +
Sbjct: 69  AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVI---YGNHEDTVRRQICREIEI 125

Query: 558 MKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASA 617
           ++ + H N++K      ++    ++LE+M  GSLE     G +I D     ++   + S 
Sbjct: 126 LRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE-----GTHIADEQFLADVARQILSG 180

Query: 618 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT-----QTLA 672
           + YLH      I+H D+KPSN+L++      ++DFG+++        L QT      ++ 
Sbjct: 181 IAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSR-------ILAQTMDPCNSSVG 230

Query: 673 TIGYMAPDEI 682
           TI YM+P+ I
Sbjct: 231 TIAYMSPERI 240

Length = 353

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 60.0 bits (145), Expect = 9e-10
 Identities = 50/180 (27%), Positives = 83/180 (46%), Gaps = 16/180 (8%)

Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIK---VFNLQYGGAFKSFDIECGMMKRIRHRN 565
           F     IGRG F  VY+     DG+ VA+K   +F+L    A      E  ++K++ H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNI---MIDVASALEYLH 622
           +IK  +S   D+   +VLE    G L + +        +     +    + + SALE++H
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123

Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              S  ++H D+KP+NV +    V  L D G+ +      ++      + T  YM+P+ I
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGR--FFSSKTTAAHSLVGTPYYMSPERI 178

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 61.8 bits (150), Expect = 1e-09
 Identities = 34/88 (38%), Positives = 51/88 (57%), Gaps = 3/88 (3%)

Query: 211 MDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFV 270
           +DN  + G IP +I+ L +L  Q ++L GN + G+IP  L  + +L  LDL  N  +G +
Sbjct: 425 LDNQGLRGFIPNDISKLRHL--QSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482

Query: 271 PACSGNLTNLRKLYLGSNLLTS-IPSTL 297
           P   G LT+LR L L  N L+  +P+ L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 61.4 bits (149), Expect = 1e-09
 Identities = 39/114 (34%), Positives = 62/114 (54%), Gaps = 6/114 (5%)

Query: 82  LYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGS 141
           L L +  L G +P+    +L +L+ ++L GN+  G IP  + + + L  L L  NSF+GS
Sbjct: 423 LGLDNQGLRGFIPNDIS-KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481

Query: 142 IPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNP-LGGI 194
           IP + G L +L+ L LN N L+   P  ++L       +   F+F++N  L GI
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVP--AALGGRL--LHRASFNFTDNAGLCGI 531

Length = 623

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 61.1 bits (148), Expect = 1e-09
 Identities = 85/326 (26%), Positives = 135/326 (41%), Gaps = 44/326 (13%)

Query: 70  PTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLS 129
            + +  ++ L SL L +N+++  +P    +   NLKEL L  +N I ++PS + N   L 
Sbjct: 109 ISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDL-SDNKIESLPSPLRNLPNLK 166

Query: 130 ELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNN 189
            L L  N  S  +P    NL NL  L L+ N   S  P    L S      LE    SNN
Sbjct: 167 NLDLSFNDLS-DLPKLLSNLSNLNNLDLSGN-KISDLPPEIELLSA-----LEELDLSNN 219

Query: 190 PLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDD 249
            +                            +   ++NL N  L  L L  N+LE  +P+ 
Sbjct: 220 SI--------------------------IELLSSLSNLKN--LSGLELSNNKLE-DLPES 250

Query: 250 LCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLS 309
           +  L+ L  LDL  N++S       G+LTNLR+L L  N L++    +  L  +L L L+
Sbjct: 251 IGNLSNLETLDLSNNQISSISSL--GSLTNLRELDLSGNSLSNALPLIALLLLLLELLLN 308

Query: 310 SNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSI 369
                  L LK+ ++ +   +    +N     P  +  L+ L  L+   N L  S  N  
Sbjct: 309 LLLTLKALELKLNSILLNNNIL---SNGETSSPEALSILESLNNLWTLDNALDESNLNRY 365

Query: 370 GDLISLKSLNLSNNNLSGTIPISLEK 395
             + +  ++    + +   +   LEK
Sbjct: 366 -IVKNPNAIGSLLDLVKKHVNQLLEK 390

Length = 394

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 60.6 bits (147), Expect = 1e-09
 Identities = 54/183 (29%), Positives = 83/183 (45%), Gaps = 23/183 (12%)

Query: 508 FQATNRFSENNLIGRGGFGPV--YKD---GMEVAIKVFNLQYGGAF--KSFDIECGMMKR 560
           F+ TNR+ +   +G G FG V   +D   G  VAIK     +      K    E  ++K 
Sbjct: 6   FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKH 65

Query: 561 IRHRNLI---KIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASA 617
           +RH N+I    I  S   D +   V E +    L + L S        Q    +  +   
Sbjct: 66  LRHENIISLSDIFISPLEDIY--FVTELLGT-DLHRLLTSRPLEKQFIQ--YFLYQILRG 120

Query: 618 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 677
           L+Y+H   S  ++H DLKPSN+L+++N    + DFG+A+      Q    T  ++T  Y 
Sbjct: 121 LKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYVSTRYYR 172

Query: 678 APD 680
           AP+
Sbjct: 173 APE 175

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 49/174 (28%), Positives = 81/174 (46%), Gaps = 13/174 (7%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKS-FDIECGMMKRIRHRNLIKIISSC 573
           IGRG FG V+      D   VA+K          K+ F  E  ++K+  H N++++I  C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
           +      +V+E +  G     L +    L + + + ++ + A+ +EYL    S   IH D
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRD 119

Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI--GYMAPDEIFSG 685
           L   N L+ +  V  +SDFGM++   EED     T  +  I   + AP+ +  G
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSRE--EEDGVYASTGGMKQIPVKWTAPEALNYG 171

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 60.4 bits (146), Expect = 2e-09
 Identities = 63/216 (29%), Positives = 93/216 (43%), Gaps = 21/216 (9%)

Query: 19  NPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVST 78
             S+L+ L LS N          +  +P  + NL N++ +  SFN +   +P  + N+S 
Sbjct: 138 LKSNLKELDLSDN---------KIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSN 187

Query: 79  LKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSF 138
           L +L L  N +S  LP   +  L  L+EL L  NN I  + S + N   LS L L  N  
Sbjct: 188 LNNLDLSGNKIS-DLPPEIE-LLSALEELDL-SNNSIIELLSSLSNLKNLSGLELSNNKL 244

Query: 139 SGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRA 198
              +P + GNL NL+ L L++N       ++SS+SSL +   L     S N L   LP  
Sbjct: 245 E-DLPESIGNLSNLETLDLSNN-------QISSISSLGSLTNLRELDLSGNSLSNALPLI 296

Query: 199 IGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQL 234
              L        +     +  +      L N IL  
Sbjct: 297 ALLLLLLELLLNLLLTLKALELKLNSILLNNNILSN 332

Length = 394

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 59.5 bits (144), Expect = 2e-09
 Identities = 51/201 (25%), Positives = 80/201 (39%), Gaps = 45/201 (22%)

Query: 520 IGRGGFGPV----------YKDGMEVAIKVFNLQYGGAF---KSFDIECGMMKRIRHRNL 566
           IG+G FG V          Y+    VA+K+  L+   +      F  E  +M    H N+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKM--LKEEASADMQADFQREAALMAEFDHPNI 70

Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCL--------------------YSGNYI-LDIF 605
           +K++  C+      L+ EYM  G L + L                       N + L   
Sbjct: 71  VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130

Query: 606 QGLNIMIDVASALEYL---HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED 662
           + L I   VA+ + YL    F      +H DL   N L+ +NMV  ++DFG+++ +   D
Sbjct: 131 EQLCIAKQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 184

Query: 663 QSLTQTQTLATIGYMAPDEIF 683
                      I +M P+ IF
Sbjct: 185 YYKASENDAIPIRWMPPESIF 205

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 58.9 bits (143), Expect = 2e-09
 Identities = 36/150 (24%), Positives = 64/150 (42%), Gaps = 13/150 (8%)

Query: 546 GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLY--------S 597
            A + F  E  ++ R+   N+ +++  C+ D    +++EYM  G L + L          
Sbjct: 61  NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL 120

Query: 598 GNYILDIFQG--LNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMA 655
                 +     L +   +AS + YL    S+  +H DL   N L+  N    ++DFGM+
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMS 177

Query: 656 KPLLEEDQSLTQTQTLATIGYMAPDEIFSG 685
           + L   D    Q +    I +MA + +  G
Sbjct: 178 RNLYSSDYYRVQGRAPLPIRWMAWESVLLG 207

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 59.5 bits (145), Expect = 2e-09
 Identities = 58/182 (31%), Positives = 91/182 (50%), Gaps = 32/182 (17%)

Query: 520 IGRGGFGPVYK-----DGMEVAIK-VFNLQYGGAF-------KSFDIECGMMKRIR-HRN 565
           +G+G +G V+K         VA+K +F      AF       ++F  E   ++ +  H N
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIF-----DAFRNATDAQRTFR-EIMFLQELGDHPN 68

Query: 566 LIKIIS--SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHF 623
           ++K+++     ND    LV EYM    L   + +   IL+      IM  +  AL+Y+H 
Sbjct: 69  IVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH- 124

Query: 624 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ---TQTLATIGYMAPD 680
             S  +IH DLKPSN+LL+ +    L+DFG+A+ L E +++      T  +AT  Y AP 
Sbjct: 125 --SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAP- 181

Query: 681 EI 682
           EI
Sbjct: 182 EI 183

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 58.9 bits (142), Expect = 3e-09
 Identities = 46/177 (25%), Positives = 85/177 (48%), Gaps = 16/177 (9%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G FG VYK      G   A KV   +     + + +E  ++    H  ++K++ +  
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLN---IMIDVASALEYLHFGYSVPIIH 631
            D    +++E+ P G+++  +      L++ +GL    I +     LE L + +S+ IIH
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIM------LELDRGLTEPQIQVICRQMLEALQYLHSMKIIH 133

Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMR 688
            DLK  NVLL  +    L+DFG++   ++  Q   +   + T  +MAP+ +    M+
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR--RDSFIGTPYWMAPEVVMCETMK 188

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 58.9 bits (142), Expect = 3e-09
 Identities = 45/146 (30%), Positives = 72/146 (49%), Gaps = 19/146 (13%)

Query: 554 ECGMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----NYILDI--- 604
           E  MMK I +H+N+I ++ +C+ D    +++EY   G+L + L +       Y  DI   
Sbjct: 70  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARV 129

Query: 605 ------FQGL-NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP 657
                 F+ L +    VA  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ 
Sbjct: 130 PDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARD 186

Query: 658 LLEEDQSLTQTQTLATIGYMAPDEIF 683
           +   D     T     + +MAP+ +F
Sbjct: 187 VNNIDYYKKTTNGRLPVKWMAPEALF 212

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 66/282 (23%), Positives = 126/282 (44%), Gaps = 31/282 (10%)

Query: 514 FSENNLIGRGGFGPVYKDGMEVAIKVFNLQ---------YGGAFKSFDIECGMMKRIRHR 564
           F +  ++G+GGFG V    +    K++  +           G   + + E  +++++  R
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALN-EKQILEKVNSR 60

Query: 565 NLIKIISSCSNDDFKALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHF 623
            ++ +  +    D   LVL  M  G L+  +Y  G    +  + +    ++   LE LH 
Sbjct: 61  FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH- 119

Query: 624 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI- 682
                I++ DLKP N+LLDD+    +SD G+A   + E Q++     + T+GYMAP+ + 
Sbjct: 120 --QERIVYRDLKPENILLDDHGHIRISDLGLAVH-VPEGQTI--KGRVGTVGYMAPEVVK 174

Query: 683 -----FSGEMRLKCWVNDSLLISVMIVVDANLLIREEKHLMTKEQPMVRMGTDLSLGQF- 736
                FS +     W     L+  MI   +    R++K    + + +V+   +    +F 
Sbjct: 175 NERYTFSPD-----WWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFS 229

Query: 737 PASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDY 778
           P + S+ K L+     ER  +G     A  +  H L++ +++
Sbjct: 230 PDARSLCKMLLCKDPKER--LGCQGGGAREVKEHPLFKQINF 269

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 58.4 bits (141), Expect = 3e-09
 Identities = 50/176 (28%), Positives = 82/176 (46%), Gaps = 27/176 (15%)

Query: 520 IGRGGFGPVYKDGMEVAIKVFNLQYGGAFKSFDIE-----CGMMKRIRHRNLIKIISSC- 573
           +G+GGFG V       A++V N     A K  D +      G    +  + +++ ++S  
Sbjct: 1   LGKGGFGEV------CAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPF 54

Query: 574 --------SNDDFKALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFG 624
                    +     LV+  M  G L+  +Y+ G   L++ + ++    +   + +LH  
Sbjct: 55  IVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH-- 112

Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
            S+ I++ D+KP NVLLDD     LSD G+A   +E     T TQ   T GYMAP+
Sbjct: 113 -SMDIVYRDMKPENVLLDDQGNCRLSDLGLA---VELKDGKTITQRAGTNGYMAPE 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 58.8 bits (143), Expect = 3e-09
 Identities = 49/186 (26%), Positives = 81/186 (43%), Gaps = 35/186 (18%)

Query: 520 IGRGGFGPVYK-------DGMEVAIKVF---NLQYGGAFKSFDIECGMMKRIRHRNLIKI 569
           IGRG +G VYK       DG E AIK F     QY G  +S   E  +++ ++H N++ +
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 570 ISSCSNDDFKA--LVLEYMPLGSLEKCLYSGNYILDIFQGL---NIMIDVASALEYLHFG 624
           +        K+  L+ +Y      +   +               +++  + + + YLH  
Sbjct: 68  VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH-- 125

Query: 625 YSVPIIHCDLKPSNVLL----DDNMVAHLSDFGMA-------KPLLEEDQSLTQTQTLAT 673
            S  ++H DLKP+N+L+     +  V  + D G+A       KPL + D        + T
Sbjct: 126 -SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD------PVVVT 178

Query: 674 IGYMAP 679
           I Y AP
Sbjct: 179 IWYRAP 184

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 58.1 bits (140), Expect = 4e-09
 Identities = 49/180 (27%), Positives = 81/180 (45%), Gaps = 28/180 (15%)

Query: 520 IGRGGFGPVYK-----DGMEVAIK---VFNLQYGGAFKSFDIECGMMKRIRHRNLIKIIS 571
           IGRG F  VY+     D   VA+K   +F +    A +    E  ++K++ H N+IK + 
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 572 SCSNDDFKALVLEYMPLGSL---------EKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
           S   D+   +VLE    G L         +K L     +   F      + + SA+E++H
Sbjct: 70  SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYF------VQLCSAVEHMH 123

Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              S  ++H D+KP+NV +    V  L D G+ +      ++      + T  YM+P+ I
Sbjct: 124 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGR--FFSSKTTAAHSLVGTPYYMSPERI 178

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 58.1 bits (140), Expect = 4e-09
 Identities = 54/189 (28%), Positives = 83/189 (43%), Gaps = 34/189 (17%)

Query: 519 LIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---EC--GMMKRIRHRNLIK 568
           L+GRG FG VY       G E+A+K           S ++   EC   ++K +RH  +++
Sbjct: 9   LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68

Query: 569 IISSCSNDDFKALVL--EYMPLGSLEKCL---------YSGNYILDIFQGLNIMIDVASA 617
                 + + K L +  EYMP GS++  L          +  Y   I QG++        
Sbjct: 69  YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVS-------- 120

Query: 618 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 677
             YLH   S  I+H D+K +N+L D      L DFG +K +     S T  +++    Y 
Sbjct: 121 --YLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175

Query: 678 APDEIFSGE 686
              E+ SGE
Sbjct: 176 MSPEVISGE 184

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 58.1 bits (140), Expect = 4e-09
 Identities = 51/176 (28%), Positives = 86/176 (48%), Gaps = 15/176 (8%)

Query: 514 FSENNLIGRGGFGPVYKDGME------VAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNL 566
           F++   IG+G FG V+K G++      VAIK+ +L+      +    E  ++ +     +
Sbjct: 6   FTKLERIGKGSFGEVFK-GIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64

Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
            K   S        +++EY+  GS    L +G +  D FQ   ++ ++   L+YLH   S
Sbjct: 65  TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKGLDYLH---S 119

Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              IH D+K +NVLL +     L+DFG+A  L   D  + +   + T  +MAP+ I
Sbjct: 120 EKKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVI 173

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 58.2 bits (141), Expect = 5e-09
 Identities = 48/196 (24%), Positives = 79/196 (40%), Gaps = 36/196 (18%)

Query: 519 LIGRGGFGPVYK----------DGMEVAIKVFNLQYGGA----FKSFDIECGMMKRI-RH 563
            +G G FG V K          +   VA+K+       A          E  MMK I +H
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGKH 75

Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYS-------GNYILDIFQGLNIMI---- 612
           +N+I ++  C+ +    +V+EY   G+L   L +        +          +      
Sbjct: 76  KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135

Query: 613 ----DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
                VA  +E+L    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     T
Sbjct: 136 SFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTT 192

Query: 669 QTLATIGYMAPDEIFS 684
                + +MAP+ +F 
Sbjct: 193 NGRLPVKWMAPEALFD 208

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 58.5 bits (142), Expect = 5e-09
 Identities = 60/198 (30%), Positives = 90/198 (45%), Gaps = 41/198 (20%)

Query: 508 FQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKV---FNLQYGGAFKSFDI----EC 555
           F    R+   + IG G +G V        G++VAIK    F  Q      +F      E 
Sbjct: 1   FDVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ------TFCQRTLREI 54

Query: 556 GMMKRIRHRNLIKI---ISSCSNDDFKA--LVLEYMPLGSLEKCLYSGNYILD-----IF 605
            +++R +H N+I I   I   S + F    +V E M    L K + + +   D     ++
Sbjct: 55  KILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLY 113

Query: 606 QGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK-PLLEEDQS 664
           Q L         L+Y+H   S  ++H DLKPSN+LL+ N    + DFG+A+    E D +
Sbjct: 114 QILR-------GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHT 163

Query: 665 LTQTQTLATIGYMAPDEI 682
              T+ +AT  Y AP EI
Sbjct: 164 GFLTEYVATRWYRAP-EI 180

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 57.7 bits (139), Expect = 6e-09
 Identities = 34/153 (22%), Positives = 70/153 (45%), Gaps = 26/153 (16%)

Query: 554 ECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYI------------ 601
           E  ++K++ H ++IK+  +CS D    L++EY   GSL   L     +            
Sbjct: 53  EFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRN 112

Query: 602 -----------LDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLS 650
                      L +   ++    ++  ++YL     + ++H DL   NVL+ +     +S
Sbjct: 113 SSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKIS 169

Query: 651 DFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIF 683
           DFG+++ + EED  + +++    + +MA + +F
Sbjct: 170 DFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLF 202

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 57.5 bits (140), Expect = 6e-09
 Identities = 43/159 (27%), Positives = 68/159 (42%), Gaps = 36/159 (22%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIR-------HRNLI 567
           +G G FG VY       G  VAIK         F S++ EC  ++ ++       H N++
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMK----KKFYSWE-ECMNLREVKSLRKLNEHPNIV 61

Query: 568 KIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGL-------NIMIDVASALEY 620
           K+      +D    V EYM     E  LY    + D            +I+  +   L +
Sbjct: 62  KLKEVFRENDELYFVFEYM-----EGNLY--QLMKDRKGKPFSESVIRSIIYQILQGLAH 114

Query: 621 LH-FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL 658
           +H  G+     H DLKP N+L+    V  ++DFG+A+ +
Sbjct: 115 IHKHGF----FHRDLKPENLLVSGPEVVKIADFGLAREI 149

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 59.1 bits (143), Expect = 7e-09
 Identities = 33/91 (36%), Positives = 50/91 (54%), Gaps = 3/91 (3%)

Query: 185 SFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEG 244
              N  L G +P  I  L + ++   +   +I G+IP  + ++T+L  ++L L  N   G
Sbjct: 424 GLDNQGLRGFIPNDISKL-RHLQSINLSGNSIRGNIPPSLGSITSL--EVLDLSYNSFNG 480

Query: 245 SIPDDLCRLAALFQLDLGGNKLSGFVPACSG 275
           SIP+ L +L +L  L+L GN LSG VPA  G
Sbjct: 481 SIPESLGQLTSLRILNLNGNSLSGRVPAALG 511

Length = 623

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 57.3 bits (138), Expect = 7e-09
 Identities = 48/207 (23%), Positives = 88/207 (42%), Gaps = 31/207 (14%)

Query: 506 ELFQATNRFSENNLIGRGGFGPVYKDGM----------EVAIKVFNLQYGGAFKS-FDIE 554
           E+  +T RF E   +G   FG VYK  +           VAIK    +  G  +  F  E
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 555 CGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLY---------------SGN 599
             M  R++H N++ ++   + +   +++  Y     L + L                +  
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 600 YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL 659
             L+    ++I+  +A+ +E+L    S  ++H DL   NVL+ D +   +SD G+ + + 
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175

Query: 660 EEDQSLTQTQTLATIGYMAPDEIFSGE 686
             D       +L  I +M+P+ I  G+
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGK 202

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 57.8 bits (139), Expect = 7e-09
 Identities = 53/186 (28%), Positives = 84/186 (45%), Gaps = 26/186 (13%)

Query: 508 FQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQY--GGAFKSFDIECGMMKR 560
           F   + + +   +G G +  VYK     +G  VA+KV  LQ   G  F +   E  ++K 
Sbjct: 1   FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKG 59

Query: 561 IRHRNLIKIISSCSNDDFKALVLEYMP------LGSLEKCLYSGNYILDIFQGLNIMIDV 614
           ++H N++ +       +   LV EY+       +      L+  N  L +FQ L      
Sbjct: 60  LKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR----- 114

Query: 615 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI 674
              L Y+H  Y   I+H DLKP N+L+ D     L+DFG+A+   +   S T +  + T+
Sbjct: 115 --GLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARA--KSVPSHTYSNEVVTL 167

Query: 675 GYMAPD 680
            Y  PD
Sbjct: 168 WYRPPD 173

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 57.4 bits (138), Expect = 8e-09
 Identities = 53/176 (30%), Positives = 86/176 (48%), Gaps = 15/176 (8%)

Query: 514 FSENNLIGRGGFGPVYKDGME------VAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNL 566
           F++   IG+G FG V+K G++      VAIK+ +L+      +    E  ++ +     +
Sbjct: 6   FTKLEKIGKGSFGEVFK-GIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64

Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
            K   S   D    +++EY+  GS    L  G   LD  Q   I+ ++   L+YLH   S
Sbjct: 65  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---S 119

Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              IH D+K +NVLL ++    L+DFG+A  L   D  + +   + T  +MAP+ I
Sbjct: 120 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVI 173

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 57.0 bits (137), Expect = 8e-09
 Identities = 50/169 (29%), Positives = 79/169 (46%), Gaps = 17/169 (10%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G +G VYK      G   A+K+  L+ G  F     E  M+K  +H N++    S  
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDL 634
           + +   + +EY   GSL+  +Y     L   Q   +  +    L YLH   S   +H D+
Sbjct: 77  SREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAYVCRETLQGLAYLH---SKGKMHRDI 132

Query: 635 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG---YMAPD 680
           K +N+LL DN    L+DFG+A  +     + T  +  + IG   +MAP+
Sbjct: 133 KGANILLTDNGDVKLADFGVAAKI-----TATIAKRKSFIGTPYWMAPE 176

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 57.4 bits (138), Expect = 8e-09
 Identities = 51/180 (28%), Positives = 83/180 (46%), Gaps = 22/180 (12%)

Query: 513 RFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLI 567
           +++    IG+G  G VY       G EVAI+  NLQ     +    E  +M+  ++ N++
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80

Query: 568 KIISSCSNDDFKALVLEYMPLGSL-----EKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
             + S    D   +V+EY+  GSL     E C+  G       Q   +  +   ALE+LH
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECLQALEFLH 133

Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              S  +IH D+K  N+LL  +    L+DFG    +  E     ++  + T  +MAP+ +
Sbjct: 134 ---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVV 188

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 57.0 bits (137), Expect = 1e-08
 Identities = 51/185 (27%), Positives = 86/185 (46%), Gaps = 12/185 (6%)

Query: 503 TYLELFQATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGM 557
           T + +     +++    IG+G  G V+       G EVAIK  NLQ     +    E  +
Sbjct: 10  TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILV 69

Query: 558 MKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASA 617
           MK +++ N++  + S    D   +V+EY+  GSL   +      +D  Q   +  +   A
Sbjct: 70  MKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET--CMDEAQIAAVCRECLQA 127

Query: 618 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 677
           LE+LH   +  +IH D+K  NVLL  +    L+DFG    +  E     ++  + T  +M
Sbjct: 128 LEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWM 182

Query: 678 APDEI 682
           AP+ +
Sbjct: 183 APEVV 187

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 57.1 bits (138), Expect = 1e-08
 Identities = 45/132 (34%), Positives = 60/132 (45%), Gaps = 17/132 (12%)

Query: 580 ALVLEYMPLGSLE----KCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLK 635
            + +EY   GSL+    K    G  I +   G  I   V   L YLH   S  IIH D+K
Sbjct: 77  GIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG-KIAESVLKGLSYLH---SRKIIHRDIK 132

Query: 636 PSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKC--WV 693
           PSN+LL       L DFG++  L+    SL  T T  T  YMAP+ I      +    W 
Sbjct: 133 PSNILLTRKGQVKLCDFGVSGELVN---SLAGTFT-GTSFYMAPERIQGKPYSITSDVW- 187

Query: 694 NDSLLISVMIVV 705
             SL ++++ V 
Sbjct: 188 --SLGLTLLEVA 197

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 49/172 (28%), Positives = 78/172 (45%), Gaps = 18/172 (10%)

Query: 520 IGRGGFGPV----YKDGMEVAIKVFNLQYGGAFKSFDI--ECGMMKRIRHRNLIKIISSC 573
           +G G FG V    ++  ++VAIK  N    GA    D   E  +M ++ H  L+++   C
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAIN---EGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68

Query: 574 SNDDFKALVLEYMPLGSLEKCLYS--GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
           +      +V E+M  G L   L    G    D+   L++  DV   +EYL        IH
Sbjct: 69  TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDML--LSMCQDVCEGMEYLE---RNSFIH 123

Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIF 683
            DL   N L+    V  +SDFGM + +L +D+  + +     + +  P E+F
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVL-DDEYTSSSGAKFPVKWSPP-EVF 173

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 57.1 bits (138), Expect = 1e-08
 Identities = 56/174 (32%), Positives = 81/174 (46%), Gaps = 19/174 (10%)

Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKR------IRHRNLIK 568
           IG+G FG V       DG   A+KV  LQ     K  + +  M +R      ++H  L+ 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKV--LQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVP 628
           +  S    D    VL+Y+  G L   L       +  +      ++ASAL YLH   S+ 
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP-RARFYAAEIASALGYLH---SLN 116

Query: 629 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
           II+ DLKP N+LLD      L+DFG+ K  +E   S T +    T  Y+AP+ +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTTSTFCGTPEYLAPEVL 168

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 57.0 bits (138), Expect = 1e-08
 Identities = 52/181 (28%), Positives = 84/181 (46%), Gaps = 19/181 (10%)

Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKV--FNLQYGGAFKSFDIECGMMKRIRHRNL 566
           F + N IG G +G VY+      G  VA+K    + +  G   S   E  ++  +RH N+
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68

Query: 567 IKIISSCSNDDFKA--LVLEY--MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
           +++          +  LV+EY    L SL   L +        Q   +M+ +   L+YLH
Sbjct: 69  VELKEVVVGKHLDSIFLVMEYCEQDLASL---LDNMPTPFSESQVKCLMLQLLRGLQYLH 125

Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
             +   IIH DLK SN+LL D     ++DFG+A+      + +  T  + T+ Y AP+ +
Sbjct: 126 ENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM--TPKVVTLWYRAPELL 180

Query: 683 F 683
            
Sbjct: 181 L 181

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 56.7 bits (137), Expect = 1e-08
 Identities = 58/195 (29%), Positives = 92/195 (47%), Gaps = 37/195 (18%)

Query: 518 NLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI----ECGMMKRIRHRNLIK 568
             IG G +G VYK      G  VA+K   L      + F I    E  +++++ HRN++ 
Sbjct: 13  GQIGEGTYGQVYKARDKDTGELVALKKVRLD--NEKEGFPITAIREIKILRQLNHRNIVN 70

Query: 569 IISSCSND----DFKA------LVLEYMP---LGSLEKCL--YSGNYILDIFQGLNIMID 613
           +    ++     DFK       LV EYM    +G LE  L  +S ++I    + L     
Sbjct: 71  LKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL----- 125

Query: 614 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 673
               LE L++ +    +H D+K SN+LL++     L+DFG+A+ L   ++S   T  + T
Sbjct: 126 ----LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR-LYNSEESRPYTNKVIT 180

Query: 674 IGYMAPDEIFSGEMR 688
           + Y  P E+  GE R
Sbjct: 181 LWYRPP-ELLLGEER 194

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 50/173 (28%), Positives = 76/173 (43%), Gaps = 30/173 (17%)

Query: 514 FSENNLIGRGGFGPVYK--------DGMEVAIKVFNLQYGGAFKSFDIE-----CGMMKR 560
           F+   ++G+G FG V +           +VA+K+        F S DIE        MK 
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKAD---IFSSSDIEEFLREAACMKE 57

Query: 561 IRHRNLIKIISSCSNDDFKA------LVLEYMPLGSLEKCLYSGN-----YILDIFQGLN 609
             H N+IK+I        K       ++L +M  G L   L         + L +   + 
Sbjct: 58  FDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR 117

Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED 662
            MID+AS +EYL    S   IH DL   N +L++NM   ++DFG++K +   D
Sbjct: 118 FMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD 167

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 56.9 bits (138), Expect = 2e-08
 Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 44/208 (21%)

Query: 502 FTYLELFQAT----NRFSENNLIGRGGFGPVYK-----DGMEVAIK-----VFNLQYG-G 546
           F   EL +      +R+   + +G G +G V        G +VAIK       +  +   
Sbjct: 1   FYRQELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKR 60

Query: 547 AFKSFDIECGMMKRIRHRNLIKIIS----SCSNDDFKA--LVLEYM--PLGSLEKC-LYS 597
            ++    E  ++K + H N+I ++     + S +DF+   LV   M   L ++ KC   S
Sbjct: 61  TYR----ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLS 116

Query: 598 GNYI-LDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK 656
            ++I   ++Q L         L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+
Sbjct: 117 DDHIQFLVYQILR-------GLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLAR 166

Query: 657 PLLEEDQSLTQTQTLATIGYMAPDEIFS 684
              +E      T  +AT  Y AP+ + +
Sbjct: 167 HTDDE-----MTGYVATRWYRAPEIMLN 189

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 31/73 (42%), Positives = 43/73 (58%), Gaps = 5/73 (6%)

Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
           I + +  ALEYLH   SV  IH D+KPSNVL++ N    L DFG++  L++   S+ +T 
Sbjct: 108 IAVSIVKALEYLHSKLSV--IHRDVKPSNVLINRNGQVKLCDFGISGYLVD---SVAKTI 162

Query: 670 TLATIGYMAPDEI 682
                 YMAP+ I
Sbjct: 163 DAGCKPYMAPERI 175

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 47/178 (26%), Positives = 81/178 (45%), Gaps = 14/178 (7%)

Query: 519 LIGRGGFGPVYK-----DG----MEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIK 568
           L+G G FG V+K     +G    + VAIK    + G   F+        M  + H  +++
Sbjct: 14  LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73

Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVP 628
           ++  C     + LV +  PLGSL   +      LD  + LN  + +A  + YL       
Sbjct: 74  LLGICPGASLQ-LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHR 129

Query: 629 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGE 686
           ++H +L   N+LL  + +  ++DFG+A  L  +D+    ++    I +MA + I  G 
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR 187

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 55.6 bits (134), Expect = 3e-08
 Identities = 49/179 (27%), Positives = 82/179 (45%), Gaps = 19/179 (10%)

Query: 520 IGRGGFGPVYKDGMEVAIKVF--------NLQYGGAFKSFDIECGMMKRIRHRNLIKIIS 571
           +G+GGFG V    M    K++         L+    ++   +E  ++ ++  R ++ +  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYS---GNYILDIFQGLNIMIDVASALEYLHFGYSVP 628
           +        LV+  M  G L   +Y+    N      +       + S LE+LH      
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRR 117

Query: 629 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGYMAPDEIFSGE 686
           II+ DLKP NVLLD++    +SD G+A  L +     ++T+  A T G+MAP E+  GE
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ---SKTKGYAGTPGFMAP-ELLQGE 172

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 56.2 bits (135), Expect = 3e-08
 Identities = 43/146 (29%), Positives = 72/146 (49%), Gaps = 19/146 (13%)

Query: 554 ECGMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----NYILD---- 603
           E  MMK I +H+N+I ++ +C+ D    +++EY   G+L + L +      +Y  D    
Sbjct: 67  EMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKL 126

Query: 604 -----IFQGL-NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP 657
                 F+ L +    VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ 
Sbjct: 127 PEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGLARD 183

Query: 658 LLEEDQSLTQTQTLATIGYMAPDEIF 683
           +   D     T     + +MAP+ +F
Sbjct: 184 VHNIDYYKKTTNGRLPVKWMAPEALF 209

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 55.9 bits (134), Expect = 3e-08
 Identities = 51/180 (28%), Positives = 83/180 (46%), Gaps = 22/180 (12%)

Query: 513 RFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLI 567
           +++    IG+G  G VY       G EVAIK  NLQ     +    E  +M+  ++ N++
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIV 79

Query: 568 KIISSCSNDDFKALVLEYMPLGSL-----EKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
             + S    D   +V+EY+  GSL     E C+  G       Q   +  +   AL++LH
Sbjct: 80  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECLQALDFLH 132

Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              S  +IH D+K  N+LL  +    L+DFG    +  E     ++  + T  +MAP+ +
Sbjct: 133 ---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEVV 187

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 55.2 bits (133), Expect = 3e-08
 Identities = 52/188 (27%), Positives = 83/188 (44%), Gaps = 43/188 (22%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRNLIKIISS 572
           IG G +G VYK      G  VA+K   L  +  G   +   E  ++K + H N++K++  
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 573 CSNDDFKALVLEYM-----------PLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
              ++   LV E++           PL  +   L   +Y+  + QGL             
Sbjct: 68  IHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIK-SYLFQLLQGLA------------ 114

Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK----PLLEEDQSLTQTQTLATIGYM 677
            F +S  ++H DLKP N+L++      L+DFG+A+    P+       T T  + T+ Y 
Sbjct: 115 -FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV------RTYTHEVVTLWYR 167

Query: 678 APDEIFSG 685
           AP EI  G
Sbjct: 168 AP-EILLG 174

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 55.1 bits (132), Expect = 4e-08
 Identities = 47/164 (28%), Positives = 76/164 (46%), Gaps = 29/164 (17%)

Query: 518 NLIGRGGFGPVY-----KDG--MEVAIKVFNLQYGGA--FKSFDIECGMMKRI-RHRNLI 567
           ++IG G FG V      KDG  M+ AIK    +Y      + F  E  ++ ++  H N+I
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNII 59

Query: 568 KIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYI---------------LDIFQGLNIMI 612
            ++ +C +  +  L +EY P G+L   L     +               L   Q L+   
Sbjct: 60  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119

Query: 613 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK 656
           DVA  ++YL        IH DL   N+L+ +N VA ++DFG+++
Sbjct: 120 DVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR 160

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 55.4 bits (133), Expect = 4e-08
 Identities = 42/146 (28%), Positives = 69/146 (47%), Gaps = 19/146 (13%)

Query: 554 ECGMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCL---------YSGN---- 599
           E  MMK I +H+N+I ++ +C+ D    +++EY   G+L + L         Y  N    
Sbjct: 73  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQV 132

Query: 600 --YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP 657
               L     ++    VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ 
Sbjct: 133 PEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARD 189

Query: 658 LLEEDQSLTQTQTLATIGYMAPDEIF 683
           +   D     T     + +MAP+ +F
Sbjct: 190 IHHIDYYKKTTNGRLPVKWMAPEALF 215

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 54.8 bits (132), Expect = 4e-08
 Identities = 45/181 (24%), Positives = 74/181 (40%), Gaps = 25/181 (13%)

Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI--ECGMMKRIRHRNL 566
           F   N IG+G FG V+K     D    A+K  +L      +  +   E  ++ ++    +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-------NYILDIFQGLNIMIDVASALE 619
           I+   S  +     +V+EY   G L K L          + +   F      I +   L 
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFF------IQILLGLA 115

Query: 620 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
           +LH   S  I+H D+K  N+ LD      + D G+AK L   D +      + T  Y++P
Sbjct: 116 HLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL--SDNTNFANTIVGTPYYLSP 170

Query: 680 D 680
           +
Sbjct: 171 E 171

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 55.2 bits (133), Expect = 5e-08
 Identities = 39/113 (34%), Positives = 51/113 (45%), Gaps = 32/113 (28%)

Query: 581 LVLEYMPLGSL----EK---------CLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
           L+LEY+  G L    E+         C Y     L              ALE+LH     
Sbjct: 77  LILEYLSGGELFMHLEREGIFMEDTACFYLSEISL--------------ALEHLH---QQ 119

Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
            II+ DLKP N+LLD      L+DFG+ K  + E  ++T T    TI YMAP+
Sbjct: 120 GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVTHT-FCGTIEYMAPE 170

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 54.4 bits (131), Expect = 5e-08
 Identities = 47/172 (27%), Positives = 74/172 (43%), Gaps = 19/172 (11%)

Query: 520 IGRGGFGPVY-----KDGMEVAIKVF---NLQYGGAFKSFDIE-CGMMKRIRHRNLIKII 570
           I +G FG VY       G   AIKV    ++       +   E   MM +     + K+ 
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 571 SSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPII 630
            S  + D+  LV+EY+  G     + +    L        + +V   +E LH      II
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCASLIKTLGG-LPEDWAKQYIAEVVLGVEDLH---QRGII 119

Query: 631 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
           H D+KP N+L+D      L+DFG+++  LE        + + T  Y+AP+ I
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVGTPDYLAPETI 165

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 54.7 bits (132), Expect = 5e-08
 Identities = 57/197 (28%), Positives = 87/197 (44%), Gaps = 46/197 (23%)

Query: 514 FSENNL-----IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRH 563
           F+  +L     IGRG FG V K      G  +A+K          K         KR+  
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KE-------QKRLLM 51

Query: 564 R-NLIKIISSCSN--DDFKAL--------VLEYMPLGSLEKCLYSGNYILDIFQGL---N 609
             +++   S C      + AL         +E M + SL+K  Y   Y+ ++ + +    
Sbjct: 52  DLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDK-FY--KYVYEVLKSVIPEE 107

Query: 610 IMIDVA----SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL 665
           I+  +A     AL YL     + IIH D+KPSN+LLD N    L DFG++  L++   S+
Sbjct: 108 ILGKIAVATVKALNYLK--EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD---SI 162

Query: 666 TQTQTLATIGYMAPDEI 682
            +T+      YMAP+ I
Sbjct: 163 AKTRDAGCRPYMAPERI 179

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 55.4 bits (133), Expect = 6e-08
 Identities = 92/307 (29%), Positives = 134/307 (43%), Gaps = 20/307 (6%)

Query: 75  NVSTLKSLYLHSNSLSGRLP-SSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGL 133
           ++S L SL L S S    L  S   + L  L  L L  N     I S +   + L+ L L
Sbjct: 65  SLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNI-SELLELTNLTSLDL 123

Query: 134 QKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGG 193
             N+ +   P       NLK L L+DN +       S  S L N   L+    S N L  
Sbjct: 124 DNNNITDIPPLIGLLKSNLKELDLSDNKIE------SLPSPLRNLPNLKNLDLSFNDL-S 176

Query: 194 ILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRL 253
            LP+ + NLS ++ +  +    IS  +P EI  L+   L+ L L  N +   +   L  L
Sbjct: 177 DLPKLLSNLS-NLNNLDLSGNKIS-DLPPEIELLSA--LEELDLSNNSII-ELLSSLSNL 231

Query: 254 AALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFF 313
             L  L+L  NKL   +P   GNL+NL  L L +N ++SI S L +L ++  L+LS N  
Sbjct: 232 KNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSISS-LGSLTNLRELDLSGNSL 289

Query: 314 TGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLI 373
           +  LPL    L +L  L    N    +   ++     L    +  N  + S P ++  L 
Sbjct: 290 SNALPLIALLLLLLELLL---NLLLTLKALELKLNSILLNNNILSN-GETSSPEALSILE 345

Query: 374 SLKSLNL 380
           SL +L  
Sbjct: 346 SLNNLWT 352

Length = 394

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 55.0 bits (132), Expect = 6e-08
 Identities = 55/179 (30%), Positives = 82/179 (45%), Gaps = 31/179 (17%)

Query: 519 LIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGM------MKRIRHRNLI 567
           +IG+G FG V       DG   A+KV  LQ     K  +    M      +K ++H  L+
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKV--LQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59

Query: 568 KIISSCSNDDFKALVLEYMPLGSL------EKCLYSGNYILDIFQGLNIMIDVASALEYL 621
            +  S    +    VL+Y+  G L      E+C           +      +VASA+ YL
Sbjct: 60  GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEP-------RARFYAAEVASAIGYL 112

Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           H   S+ II+ DLKP N+LLD      L+DFG+ K  +E ++  T +    T  Y+AP+
Sbjct: 113 H---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTSTFCGTPEYLAPE 166

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 54.2 bits (130), Expect = 6e-08
 Identities = 49/174 (28%), Positives = 83/174 (47%), Gaps = 15/174 (8%)

Query: 520 IGRGGFGPV-----YKDGMEVAIKVFNLQYGGAF--KSFDIECGMMKRIRHRNLIKIISS 572
           +G+G +G V       DG +  IK  NL+       K+ + E  ++ +++H N++    S
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 573 CSNDD-FKALVLEYMPLGSL-EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPII 630
              +D    +V+ +   G L  K       +L   Q +   + +A AL+YLH  +   I+
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---IL 124

Query: 631 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS 684
           H DLK  NV L    +  + D G+A+ L  E+Q    +  + T  YM+P E+FS
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVL--ENQCDMASTLIGTPYYMSP-ELFS 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 54.4 bits (131), Expect = 6e-08
 Identities = 53/196 (27%), Positives = 92/196 (46%), Gaps = 21/196 (10%)

Query: 520 IGRGGFGPV-----YKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           IG G  G V        G +VA+K  +L+     +    E  +M+  +H N++++ SS  
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86

Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDL 634
             D   +V+E++  G+L   +      ++  Q   + + V  AL +LH   +  +IH D+
Sbjct: 87  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLAVLKALSFLH---AQGVIHRDI 141

Query: 635 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGY-MAPDEIFSGE---MRLK 690
           K  ++LL  +    LSDFG    + +E   + + ++L    Y MAP E+ S       + 
Sbjct: 142 KSDSILLTSDGRVKLSDFGFCAQVSKE---VPRRKSLVGTPYWMAP-EVISRLPYGTEVD 197

Query: 691 CWVNDSLLISVMIVVD 706
            W   SL I V+ +VD
Sbjct: 198 IW---SLGIMVIEMVD 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 54.6 bits (131), Expect = 7e-08
 Identities = 48/162 (29%), Positives = 76/162 (46%), Gaps = 25/162 (15%)

Query: 518 NLIGRGGFGPVYK-----DG--MEVAIKVFNLQYGGA--FKSFDIECGMMKRI-RHRNLI 567
           ++IG G FG V K     DG  M+ AIK    +Y      + F  E  ++ ++  H N+I
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 568 KIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASAL---EYLHFG 624
            ++ +C +  +  L +EY P G+L   L     +L+      I    AS L   + LHF 
Sbjct: 72  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSR-VLETDPAFAIANSTASTLSSQQLLHFA 130

Query: 625 YSVP----------IIHCDLKPSNVLLDDNMVAHLSDFGMAK 656
             V            IH DL   N+L+ +N VA ++DFG+++
Sbjct: 131 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 172

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 54.5 bits (131), Expect = 7e-08
 Identities = 42/173 (24%), Positives = 75/173 (43%), Gaps = 14/173 (8%)

Query: 525 FGPVYKDGMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL 583
                   + VA+K+        A   F  E  +M R++  N+I++++ C   D   ++ 
Sbjct: 39  LDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMIT 98

Query: 584 EYMPLGSLEKCL---------YSGNYILDIFQGLNIM-IDVASALEYLHFGYSVPIIHCD 633
           EYM  G L + L            + +   +  L  M   +AS ++YL    S+  +H D
Sbjct: 99  EYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRD 155

Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGE 686
           L   N L+  N    ++DFGM++ L   D    Q + +  I +M+ + I  G+
Sbjct: 156 LATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK 208

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 54.4 bits (131), Expect = 7e-08
 Identities = 50/191 (26%), Positives = 79/191 (41%), Gaps = 29/191 (15%)

Query: 518 NLIGRGGFGPVY------KDG----MEVAIKVFNLQYGGAFKS-FDIECGMMKRIRHRNL 566
             +G G FG VY      +DG    ++VA+K          +S F +E  +M +  H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSGN------YILDIFQGLNIMIDVASALEY 620
           +++I        + ++LE M  G L+  L            L +   L    DVA   +Y
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 621 L---HFGYSVPIIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLLEEDQSLTQTQTLATI 674
           L   HF      IH D+   N LL       VA ++DFGMA+ +          + +  I
Sbjct: 132 LEENHF------IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185

Query: 675 GYMAPDEIFSG 685
            +M P+    G
Sbjct: 186 KWMPPEAFLDG 196

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 54.7 bits (132), Expect = 8e-08
 Identities = 59/186 (31%), Positives = 87/186 (46%), Gaps = 35/186 (18%)

Query: 520 IGRGGFGPVY-----KDGMEVAIK----VF-NLQYGGAFKSFDIECGMMKRIRHRN---L 566
           IG G FG V+     +DG  VA+K    VF NL    + K    E  M+   +H N    
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLV---SCKRVFRELKMLCFFKHDNVLSA 64

Query: 567 IKIISSCSNDDFKAL-VLEYMPLGSLEKCLYSGNYILD------IFQGLNIMIDVASALE 619
           + I+     D F+ + V+  +    L K + S   +        ++Q L         L+
Sbjct: 65  LDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILR-------GLK 117

Query: 620 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
           YLH   S  I+H D+KP N+L++ N V  + DFG+A+ + E D+S   TQ + T  Y AP
Sbjct: 118 YLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR-VEEPDESKHMTQEVVTQYYRAP 173

Query: 680 DEIFSG 685
            EI  G
Sbjct: 174 -EILMG 178

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 53.9 bits (129), Expect = 8e-08
 Identities = 50/189 (26%), Positives = 80/189 (42%), Gaps = 34/189 (17%)

Query: 519 LIGRGGFGPVY-----KDGMEVAIKVFNL-----QYGGAFKSFDIECGMMKRIRHRNLIK 568
           L+G+G FG VY       G E+A K         +      + + E  ++K ++H  +++
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68

Query: 569 IISSCSNDDFKALV--LEYMPLGSLEKCL---------YSGNYILDIFQGLNIMIDVASA 617
                 +   K L   +EYMP GS++  L          +  Y   I +G++        
Sbjct: 69  YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMS-------- 120

Query: 618 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 677
             YLH   S  I+H D+K +N+L D      L DFG +K L     S T  +++    Y 
Sbjct: 121 --YLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175

Query: 678 APDEIFSGE 686
              E+ SGE
Sbjct: 176 MSPEVISGE 184

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 54.0 bits (130), Expect = 9e-08
 Identities = 52/188 (27%), Positives = 84/188 (44%), Gaps = 26/188 (13%)

Query: 519 LIGRGGFGPVYK------DGMEVAIK---VFNLQYGGAFKSFD-------IECGMMK-RI 561
            +G G FG VYK          +A+K   V N  +G   +  D        E  ++K ++
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 562 RHRNLIKIISSCSNDDFKALVLEYM---PLGSLEKCLYSGNYILDIFQGLNIMIDVASAL 618
           RH N+++   +   +D   +V++ +   PLG     L          +  NI + +  AL
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126

Query: 619 EYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 678
            YLH      I+H DL P+N++L ++    ++DFG+AK    E +    T  + TI Y  
Sbjct: 127 RYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK---LTSVVGTILYSC 181

Query: 679 PDEIFSGE 686
           P EI   E
Sbjct: 182 P-EIVKNE 188

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 54.4 bits (131), Expect = 1e-07
 Identities = 55/202 (27%), Positives = 89/202 (44%), Gaps = 22/202 (10%)

Query: 514 FSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFD---IECGMMKRIRHRN 565
           F     +G G FG V        G   AIK    +     K       E  ++  + H  
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79

Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFG 624
           ++ ++ S  +++    +LE++  G L   L   G +  D+ +  +   ++  A EYLH  
Sbjct: 80  IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHA--ELVLAFEYLH-- 135

Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL-ATIGYMAPDEIF 683
            S  II+ DLKP N+LLD+     ++DFG AK + +      +T TL  T  Y+AP+ I 
Sbjct: 136 -SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD------RTFTLCGTPEYLAPEVIQ 188

Query: 684 S-GEMRLKCWVNDSLLISVMIV 704
           S G  +   W    +L+   I 
Sbjct: 189 SKGHGKAVDWWTMGVLLYEFIA 210

Length = 329

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 53.8 bits (129), Expect = 1e-07
 Identities = 45/179 (25%), Positives = 84/179 (46%), Gaps = 17/179 (9%)

Query: 514 FSENNLIGRGGFGPVYKDGMEVAIKVFNLQ---------YGGAFKSFDIECGMMKRIRHR 564
           F +  ++G+GGFG V    +    K++  +           G   + + E  +++++  +
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALN-EKQILEKVNSQ 60

Query: 565 NLIKIISSCSNDDFKALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHF 623
            ++ +  +    D   LVL  M  G L+  +Y+ GN   +  + L    ++   LE LH 
Sbjct: 61  FVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH- 119

Query: 624 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
                 ++ DLKP N+LLDD     +SD G+A  + E +    +   + T+GYMAP+ +
Sbjct: 120 --RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR---VGTVGYMAPEVL 173

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 53.4 bits (128), Expect = 1e-07
 Identities = 40/159 (25%), Positives = 72/159 (45%), Gaps = 15/159 (9%)

Query: 520 IGRGGFGPVY---------KDGMEVAIKVFNLQYGGA-FKSFDIECGMMKRIRHRNLIKI 569
           +G G FG V            G +VA+K    + GG        E  +++ + H N++K 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 570 ISSCSNDDFKA--LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
              C+ D      L++E++P GSL++ L      +++ Q L   + +   ++YL    S 
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SR 128

Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT 666
             +H DL   NVL++      + DFG+ K +  + +  T
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT 167

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 53.9 bits (130), Expect = 1e-07
 Identities = 54/180 (30%), Positives = 82/180 (45%), Gaps = 22/180 (12%)

Query: 519 LIGRGGFGPV----YKDGMEV-AIKVFNLQYGGAFKSFDIECGMM-KRI-----RHRNLI 567
           ++G+G FG V     K   E+ A+KV  L+     +  D+EC M  KR+     +H  L 
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKV--LKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59

Query: 568 KIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
           ++ S     D    V+EY+  G L   +   +   D  +      ++   L++LH     
Sbjct: 60  QLHSCFQTKDRLFFVMEYVNGGDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLH---ER 115

Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL-ATIGYMAPDEIFSGE 686
            II+ DLK  NVLLD      ++DFGM K  +    +   T T   T  Y+AP EI S +
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TSTFCGTPDYIAP-EILSYQ 171

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 54.1 bits (130), Expect = 2e-07
 Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 8/99 (8%)

Query: 3   SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSF 62
            L N  LRG I + +     LQ++ LS N         I   IP  + ++ ++E +  S+
Sbjct: 424 GLDNQGLRGFIPNDISKLRHLQSINLSGN--------SIRGNIPPSLGSITSLEVLDLSY 475

Query: 63  NKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRL 101
           N   G +P ++  +++L+ L L+ NSLSGR+P++   RL
Sbjct: 476 NSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRL 514

Length = 623

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 54.1 bits (130), Expect = 2e-07
 Identities = 34/114 (29%), Positives = 53/114 (46%), Gaps = 23/114 (20%)

Query: 235 LSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIP 294
           L L+   L G IP+D+ +L  L  ++L GN + G +P   G++T+L  L           
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVL----------- 471

Query: 295 STLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGL 348
                       +LS N F G +P  +G L  L  L+L+ N+ S  +P  +GG 
Sbjct: 472 ------------DLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGR 513

Length = 623

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 53.1 bits (128), Expect = 2e-07
 Identities = 27/73 (36%), Positives = 42/73 (57%), Gaps = 5/73 (6%)

Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
           + + +  AL YL   + V  IH D+KPSN+LLD +    L DFG++  L++   S  +T+
Sbjct: 119 MTVAIVKALHYLKEKHGV--IHRDVKPSNILLDASGNVKLCDFGISGRLVD---SKAKTR 173

Query: 670 TLATIGYMAPDEI 682
           +     YMAP+ I
Sbjct: 174 SAGCAAYMAPERI 186

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 53.4 bits (128), Expect = 2e-07
 Identities = 36/110 (32%), Positives = 58/110 (52%), Gaps = 14/110 (12%)

Query: 581 LVLEYMPLGSLEKCLYSGNYI----LDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKP 636
           L+L+Y+  G +   LY  +      +  + G     ++  ALE+LH    + I++ D+K 
Sbjct: 82  LILDYVSGGEMFTHLYQRDNFSEDEVRFYSG-----EIILALEHLH---KLGIVYRDIKL 133

Query: 637 SNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGE 686
            N+LLD      L+DFG++K  L E++  T +    TI YMAP EI  G+
Sbjct: 134 ENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYMAP-EIIRGK 181

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 53.4 bits (128), Expect = 2e-07
 Identities = 41/146 (28%), Positives = 73/146 (50%), Gaps = 19/146 (13%)

Query: 554 ECGMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYS-----GNYILDI--- 604
           E  +MK I +H+N+I ++  C+ +    +++EY   G+L + L +      +Y  DI   
Sbjct: 67  EMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKV 126

Query: 605 ------FQGL-NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP 657
                 F+ L +    VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ 
Sbjct: 127 PEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARG 183

Query: 658 LLEEDQSLTQTQTLATIGYMAPDEIF 683
           + + D     +     + +MAP+ +F
Sbjct: 184 VHDIDYYKKTSNGRLPVKWMAPEALF 209

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 53.5 bits (129), Expect = 2e-07
 Identities = 52/205 (25%), Positives = 88/205 (42%), Gaps = 51/205 (24%)

Query: 508 FQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAF------KSFDIECG 556
           F+   ++     IGRG +G V      +   +VAIK    +   AF      K    E  
Sbjct: 1   FEVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIK----KIANAFDNRIDAKRTLREIK 56

Query: 557 MMKRIRHRNLIK---IISSCSNDDFKA--LVLEYM------------PLGSLEKCLYSGN 599
           +++ + H N+I    I+     + F    +V E M             L S + C Y   
Sbjct: 57  LLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTL-SDDHCQY--- 112

Query: 600 YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL 659
           ++  + +GL          +Y+H   S  ++H DLKPSN+LL+ N    + DFG+A+   
Sbjct: 113 FLYQLLRGL----------KYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTS 159

Query: 660 EEDQSLTQTQTLATIGYMAPDEIFS 684
           E+   +  T+ + T  Y AP+ + +
Sbjct: 160 EKGDFM--TEYVVTRWYRAPELLLN 182

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 52.9 bits (127), Expect = 2e-07
 Identities = 43/155 (27%), Positives = 74/155 (47%), Gaps = 13/155 (8%)

Query: 518 NLIGRGGFGPVY------KDGMEV--AIKVFN-LQYGGAFKSFDIECGMMKRIRHRNLIK 568
            +IG+G FG VY       DG ++  A+K  N +      + F  E  +MK   H N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 569 IISSCSNDDFKALV-LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
           ++  C   +   LV L YM  G L   + S  +   +   +   + VA  +EYL    S 
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SK 117

Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED 662
             +H DL   N +LD++    ++DFG+A+ + +++
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 52.8 bits (127), Expect = 2e-07
 Identities = 52/193 (26%), Positives = 85/193 (44%), Gaps = 34/193 (17%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISS 572
           IG G +G VYK      G  VA+K   L+    G   +   E  ++K ++H N++ +   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 573 CSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH-------FGY 625
              +    L+ E++ +  L+K L S              +D      YL+       F +
Sbjct: 68  LMQESRLYLIFEFLSM-DLKKYLDS--------LPKGQYMDAELVKSYLYQILQGILFCH 118

Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK----PLLEEDQSLTQTQTLATIGYMAPDE 681
           S  ++H DLKP N+L+D+  V  L+DFG+A+    P+         T  + T+ Y AP E
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV------RVYTHEVVTLWYRAP-E 171

Query: 682 IFSGEMRLKCWVN 694
           +  G  R    V+
Sbjct: 172 VLLGSPRYSTPVD 184

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 52.9 bits (127), Expect = 2e-07
 Identities = 71/289 (24%), Positives = 122/289 (42%), Gaps = 45/289 (15%)

Query: 514 FSENNLIGRGGFGPVYKDGMEVAIKVFNLQ---------YGGAFKSFDIECGMMKRIRHR 564
           F    ++G+GGFG V    +    K++  +           G   + + E  +++++  R
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN-EKQILEKVNSR 60

Query: 565 NLIKIISSCSNDDFKALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHF 623
            ++ +  +    D   LVL  M  G L+  +Y+ GN   D  + +    ++   LE LH 
Sbjct: 61  FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH- 119

Query: 624 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI- 682
                I++ DLKP N+LLDD     +SD G+A  + E +   T    + T+GYMAP+ + 
Sbjct: 120 --RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE---TIRGRVGTVGYMAPEVVK 174

Query: 683 -----FSGEMRLKCWVNDSLLISVMIVVDANLLIREEKHLMTKEQPMVRMGTDLSLGQFP 737
                FS +     W     LI  MI   +    R+EK  + +E+   R+  D       
Sbjct: 175 NERYTFSPD-----WWGLGCLIYEMIEGKSPFRQRKEK--VKREEVERRVKED------Q 221

Query: 738 ASYSISKYLVYIRELERG--------KVGITSVAAFPIVHHYLYRTVDY 778
             YS  K+    R + R         ++G     A  +  H  +RT ++
Sbjct: 222 EEYS-EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANF 269

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 49/179 (27%), Positives = 93/179 (51%), Gaps = 17/179 (9%)

Query: 520 IGRGGFGPV----YKDGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G FG V    Y    +VA+K   ++ G  + ++F  E  +MK ++H  L+K+ +  +
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVK--TMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 71

Query: 575 NDDFKALVLEYMPLGSLEKCLYS--GNYILDIFQGLNIMIDVASAL-EYLHFGYSVPIIH 631
            +    ++ E+M  GSL   L S  G+      Q L  +ID ++ + E + F      IH
Sbjct: 72  KEPI-YIITEFMAKGSLLDFLKSDEGSK-----QPLPKLIDFSAQIAEGMAFIEQRNYIH 125

Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
            DL+ +N+L+  ++V  ++DFG+A+ ++E+++   +      I + AP+ I  G   +K
Sbjct: 126 RDLRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 183

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 46/174 (26%), Positives = 83/174 (47%), Gaps = 14/174 (8%)

Query: 520 IGRGGFGP--VYK---DGMEVAIKVFNLQYGGAFKSFDI--ECGMMKRIRHRNLIKIISS 572
           +G+G FG   +Y+   D   V  K  NL      +  D   E  ++  ++H N+I   + 
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67

Query: 573 CSNDDFKALVLEYMPLGSL-EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
             +D+   + +EY   G+L +K +     + +    L  +  + SA+ Y+H      I+H
Sbjct: 68  FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILH 124

Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG 685
            D+K  N+ L    +  L DFG++K +L  + S+ +T  + T  YM+P E+  G
Sbjct: 125 RDIKTLNIFLTKAGLIKLGDFGISK-ILGSEYSMAET-VVGTPYYMSP-ELCQG 175

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 53.1 bits (128), Expect = 2e-07
 Identities = 38/160 (23%), Positives = 65/160 (40%), Gaps = 17/160 (10%)

Query: 519 LIGR----GGFGPVYK---DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRNLIKI 569
           LIG+         + K       VA+K  NL        K    E    ++++H N++  
Sbjct: 5   LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPY 64

Query: 570 ISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGL---NIMIDVASALEYLHFGYS 626
           ++S   D    +V   M  GS E  L    +  +    L    I+ DV +AL+Y+H   S
Sbjct: 65  VTSFIVDSELYVVSPLMAYGSCEDLL--KTHFPEGLPELAIAFILKDVLNALDYIH---S 119

Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT 666
              IH  +K S++LL  +    LS    +  +++  +   
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR 159

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 52.8 bits (127), Expect = 3e-07
 Identities = 54/185 (29%), Positives = 74/185 (40%), Gaps = 34/185 (18%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFD------I---ECGMMKRIRHRN 565
           IG G +G V+K      G  VAIK F        +S D      I   E  M+K+++H N
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKF-------VESEDDPVIKKIALREIRMLKQLKHPN 61

Query: 566 LIKIISSCSNDDFKALVLEYMP---LGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
           L+ +I          LV EY     L  LEK        +       I+     A+ + H
Sbjct: 62  LVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG----VPEHLIKKIIWQTLQAVNFCH 117

Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
                  IH D+KP N+L+       L DFG A+ L         T  +AT  Y AP E+
Sbjct: 118 ---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY--TDYVATRWYRAP-EL 171

Query: 683 FSGEM 687
             G+ 
Sbjct: 172 LVGDT 176

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 52.7 bits (126), Expect = 3e-07
 Identities = 51/180 (28%), Positives = 83/180 (46%), Gaps = 23/180 (12%)

Query: 514 FSENNLIGRGGFGPVYKDGME------VAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNL 566
           F++   IG+G FG VYK G++      VAIK+ +L+      +    E  ++ +     +
Sbjct: 6   FTKLERIGKGSFGEVYK-GIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI 64

Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSG----NYILDIFQGLNIMIDVASALEYLH 622
            +   S        +++EY+  GS    L  G     YI  I +      ++   L+YLH
Sbjct: 65  TRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILR------EILKGLDYLH 118

Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              S   IH D+K +NVLL +     L+DFG+A  L   D  + +   + T  +MAP+ I
Sbjct: 119 ---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQL--TDTQIKRNTFVGTPFWMAPEVI 173

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 52.5 bits (126), Expect = 3e-07
 Identities = 36/109 (33%), Positives = 56/109 (51%), Gaps = 11/109 (10%)

Query: 581 LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVAS---ALEYLHFGYSVPIIHCDLKPS 637
           L+L+Y+  G L   LY   +    F    + + +A    AL++LH    + II+ D+K  
Sbjct: 82  LILDYVNGGELFTHLYQREH----FTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLE 134

Query: 638 NVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGE 686
           N+LLD      L+DFG++K  L E++    +    TI YMAP+ I  G 
Sbjct: 135 NILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTIEYMAPEVIRGGS 182

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 53/183 (28%), Positives = 87/183 (47%), Gaps = 23/183 (12%)

Query: 519 LIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRI-RHRNLIKII-- 570
           ++G G +G VYK      G   AIKV ++      +   +E  M+K+   HRN+      
Sbjct: 23  VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIATYYGA 81

Query: 571 ----SSCSNDDFKALVLEYMPLGSLEKCLYS--GNYILDIFQGLNIMIDVASALEYLHFG 624
               S   +DD   LV+E+   GS+   + +  GN + + +    I  ++   L +LH  
Sbjct: 82  FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY-ICREILRGLAHLHAH 140

Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT-LATIGYMAPDEIF 683
               +IH D+K  NVLL +N    L DFG++  L   D+++ +  T + T  +MAP+ I 
Sbjct: 141 K---VIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPEVIA 194

Query: 684 SGE 686
             E
Sbjct: 195 CDE 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 52.3 bits (126), Expect = 4e-07
 Identities = 56/191 (29%), Positives = 80/191 (41%), Gaps = 27/191 (14%)

Query: 510 ATNRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRI-RH 563
            T  F    +IG G +G VY     K G  VAIK+ ++      +    E  ++++   H
Sbjct: 4   PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-EDEEEEIKEEYNILRKYSNH 62

Query: 564 RNLIKII------SSCSNDDFKALVLEYMPLGS---LEKCLYSGNYILDIFQGLNIMIDV 614
            N+          +   NDD   LV+E    GS   L K L      L       I+ + 
Sbjct: 63  PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122

Query: 615 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI 674
              L YLH      +IH D+K  N+LL  N    L DFG++  L   D +L +  T   I
Sbjct: 123 LRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL---DSTLGRRNT--FI 174

Query: 675 G---YMAPDEI 682
           G   +MAP+ I
Sbjct: 175 GTPYWMAPEVI 185

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 51.9 bits (124), Expect = 4e-07
 Identities = 49/183 (26%), Positives = 83/183 (45%), Gaps = 26/183 (14%)

Query: 513 RFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGA--FKSFDIECGMMKRIRHRN 565
           R+     IG G FG +Y      D     IK  +L        ++   E  ++ +++H N
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEK-------CLYSGNYILDIFQGLNIMIDVASAL 618
           ++   +S   +    +V+EY   G L K        L+S + IL  F      + ++  L
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF------VQISLGL 114

Query: 619 EYLHFGYSVPIIHCDLKPSNVLLDDN-MVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 677
           +++H      I+H D+K  N+ L  N MVA L DFG+A+  L +   L  T  + T  Y+
Sbjct: 115 KHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIAR-QLNDSMELAYT-CVGTPYYL 169

Query: 678 APD 680
           +P+
Sbjct: 170 SPE 172

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 51.9 bits (124), Expect = 5e-07
 Identities = 48/179 (26%), Positives = 83/179 (46%), Gaps = 17/179 (9%)

Query: 514 FSENNLIGRGGFGPVYKDGMEVAIKVFNLQ---------YGGAFKSFDIECGMMKRIRHR 564
           F    ++G+GGFG V    +    K++  +           G   + + E  +++++  R
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALN-EKRILEKVNSR 60

Query: 565 NLIKIISSCSNDDFKALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHF 623
            ++ +  +    D   LVL  M  G L+  +Y+ GN   D  + +    ++   LE L  
Sbjct: 61  FVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ- 119

Query: 624 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
                I++ DLKP N+LLDD     +SD G+A  + E +   T    + T+GYMAP+ I
Sbjct: 120 --RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVRGRVGTVGYMAPEVI 173

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 51.6 bits (123), Expect = 5e-07
 Identities = 48/182 (26%), Positives = 83/182 (45%), Gaps = 20/182 (10%)

Query: 519 LIGRGGFGPVY-----KDGMEVAIKVFNL-----QYGGAFKSFDIECGMMKRIRHRNLIK 568
           L+G+G FG VY       G E+A+K         +      + + E  ++K + H  +++
Sbjct: 9   LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68

Query: 569 IISSCSNDDFK---ALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFG 624
               C  D  +   ++ +E+MP GS++  L S G    ++ +     I     LE + + 
Sbjct: 69  YYG-CLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI-----LEGVSYL 122

Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS 684
           +S  I+H D+K +N+L D      L DFG +K L     S T  +++    Y    E+ S
Sbjct: 123 HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVIS 182

Query: 685 GE 686
           GE
Sbjct: 183 GE 184

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 51.9 bits (124), Expect = 6e-07
 Identities = 40/159 (25%), Positives = 77/159 (48%), Gaps = 23/159 (14%)

Query: 547 AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD--- 603
           A   F  E  ++ R++  N+I+++  C ++D   ++ EYM  G L + L S +++ D   
Sbjct: 62  ARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL-SSHHLDDKEE 120

Query: 604 ---------------IFQGL-NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVA 647
                           +  L ++ + +AS ++YL    S+  +H DL   N L+ +N+  
Sbjct: 121 NGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGENLTI 177

Query: 648 HLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGE 686
            ++DFGM++ L   D    Q + +  I +MA + I  G+
Sbjct: 178 KIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK 216

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 51.5 bits (124), Expect = 8e-07
 Identities = 44/158 (27%), Positives = 74/158 (46%), Gaps = 29/158 (18%)

Query: 520 IGRGGFGPVYK-----DGMEVAIK---VFNLQYGGAFKSFDI----ECGMMKRIRHRNLI 567
           +G G FG VYK      G  VA+K   + N + G     F I    E  ++K+++H N++
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-----FPITALREIKILKKLKHPNVV 70

Query: 568 KII------SSCSNDDFKA--LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALE 619
            +I         S     +  +V  YM    L   L + +  L   Q    M+ +   + 
Sbjct: 71  PLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGIN 129

Query: 620 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP 657
           YLH      I+H D+K +N+L+D+  +  ++DFG+A+P
Sbjct: 130 YLH---ENHILHRDIKAANILIDNQGILKIADFGLARP 164

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 51.5 bits (124), Expect = 9e-07
 Identities = 46/182 (25%), Positives = 73/182 (40%), Gaps = 68/182 (37%)

Query: 519 LIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKR--IRH----RNLI 567
           +IGRG FG V+       G   A+KV              +  M+KR  I H    R+++
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLR------------KSDMIKRNQIAHVRAERDIL 55

Query: 568 KIISS-------CS--NDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMID----- 613
               S        S  +++   LV+EYMP G L                +N++I      
Sbjct: 56  ADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDL----------------MNLLIRKDVFP 99

Query: 614 ----------VASALEYLH-FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED 662
                     +  AL+ +H  G+    IH D+KP N+L+D +    L+DFG+ K + +  
Sbjct: 100 EETARFYIAELVLALDSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155

Query: 663 QS 664
             
Sbjct: 156 DR 157

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 51.1 bits (123), Expect = 9e-07
 Identities = 52/194 (26%), Positives = 92/194 (47%), Gaps = 30/194 (15%)

Query: 506 ELFQATNRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI----ECG 556
           + ++  NR  E      G +G VY     K G  VA+K   L+     + F I    E  
Sbjct: 5   DEYEKLNRIEE------GTYGVVYRARDKKTGEIVALK--KLKMEKEKEGFPITSLREIN 56

Query: 557 MMKRIRHRNLIKI--ISSCSNDDFKALVLEYMP--LGSLEKCLYSGNYILDIFQGLNIMI 612
           ++ +++H N++ +  +   SN D   +V+EY+   L SL   + +        +   +M+
Sbjct: 57  ILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSL---METMKQPFLQSEVKCLML 113

Query: 613 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA 672
            + S + +LH  +   I+H DLK SN+LL++  +  + DFG+A+      +    TQ + 
Sbjct: 114 QLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY--TQLVV 168

Query: 673 TIGYMAPDEIFSGE 686
           T+ Y AP E+  G 
Sbjct: 169 TLWYRAP-ELLLGA 181

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 50.8 bits (121), Expect = 9e-07
 Identities = 46/163 (28%), Positives = 76/163 (46%), Gaps = 23/163 (14%)

Query: 520 IGRGGFGPVYKDGM-------EVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKII 570
           +G G FG V +  +       +VA+K   +        + F  E   MK   H N++++I
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 571 SSC----SNDDFKA--LVLEYMPLGSLEK-CLYS--GN--YILDIFQGLNIMIDVASALE 619
             C     ++ + +  ++L +M  G L    LYS  G+    L     +  M D+AS +E
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 620 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED 662
           YL    S   IH DL   N +L++NM   ++DFG++K +   D
Sbjct: 127 YLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGD 166

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 50.8 bits (121), Expect = 1e-06
 Identities = 47/160 (29%), Positives = 76/160 (47%), Gaps = 25/160 (15%)

Query: 519 LIGRGGFGPVYKD---------GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIK 568
           ++G G FG VYK           + VAIK+ N   G  A   F  E  +M  + H +L++
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCLYS-----GNYILDIFQGLNIMIDVASALEYLHF 623
           ++  C +   + LV + MP G L   ++      G+ +L     LN  + +A  + YL  
Sbjct: 74  LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLL-----LNWCVQIAKGMMYLE- 126

Query: 624 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ 663
                ++H DL   NVL+       ++DFG+A+ LLE D+
Sbjct: 127 --ERRLVHRDLAARNVLVKSPNHVKITDFGLAR-LLEGDE 163

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 50.7 bits (121), Expect = 1e-06
 Identities = 44/180 (24%), Positives = 75/180 (41%), Gaps = 18/180 (10%)

Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKS---FDIECGMMKRIRHRNLIKIIS 571
           IG G FG V             + V  L+   + +    F  E    + ++H NL++ + 
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 572 SCSNDDFKALVLEYMPLGSLEK----CLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
            C+      LV+E+ PLG L+     C  +     D      +  ++A  L +LH     
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KN 119

Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP---DEIFS 684
             IH DL   N LL  ++   + D+G++    +ED  +T  Q    + ++AP   DE+  
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 50.6 bits (121), Expect = 1e-06
 Identities = 44/152 (28%), Positives = 75/152 (49%), Gaps = 14/152 (9%)

Query: 554 ECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYI-LDIFQGLNIMI 612
           E  +M   R   ++    +  N++   + +E+M  GSL++    G  I ++I     I +
Sbjct: 53  ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG--KIAV 110

Query: 613 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA 672
            V   L YL+      I+H D+KPSN+L++      L DFG++  L+    S+  T  + 
Sbjct: 111 AVVEGLTYLY--NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI---NSIADT-FVG 164

Query: 673 TIGYMAPDEIFSGEMRLKC--WVNDSLLISVM 702
           T  YM+P+ I  G+  +K   W   SL IS++
Sbjct: 165 TSTYMSPERIQGGKYTVKSDVW---SLGISII 193

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 50.5 bits (121), Expect = 1e-06
 Identities = 43/145 (29%), Positives = 69/145 (47%), Gaps = 11/145 (7%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISS 572
           IG G +G V+K         VA+K   L     G   S   E  ++K ++H+N++++   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 573 CSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
             +D    LV EY     L+K   S N  +D     + M  +   L + H   S  ++H 
Sbjct: 68  LHSDKKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHR 123

Query: 633 DLKPSNVLLDDNMVAHLSDFGMAKP 657
           DLKP N+L++ N    L+DFG+A+ 
Sbjct: 124 DLKPQNLLINKNGELKLADFGLARA 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 51.2 bits (122), Expect = 1e-06
 Identities = 66/272 (24%), Positives = 116/272 (42%), Gaps = 40/272 (14%)

Query: 519 LIGRGGFGPVYKDGMEVAIKVFNLQYGGAFKS--------FDIECGMMKRIRHRNLIKII 570
           +IGRG FG V     + + KV+ ++    F+         F  E  +M       ++++ 
Sbjct: 50  VIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 571 SSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPII 630
            +  +D +  +V+EYMP G L   +   NY +          +V  AL+ +H   S+ +I
Sbjct: 110 CAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAKFYTAEVVLALDAIH---SMGLI 164

Query: 631 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS----GE 686
           H D+KP N+LLD +    L+DFG    + E       T  + T  Y++P+ + S    G 
Sbjct: 165 HRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDT-AVGTPDYISPEVLKSQGGDGY 223

Query: 687 MRLKC-WVNDSLLISVMIVVD----ANLLIREEKHLMTKEQPMVRMGTDLSLGQFPASYS 741
              +C W +  + +  M+V D    A+ L+     +M  +  +           FP    
Sbjct: 224 YGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL----------NFPEDVE 273

Query: 742 ISKY-------LVYIRELERGKVGITSVAAFP 766
           ISK+        +  RE+  G+ G+  +   P
Sbjct: 274 ISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 50.5 bits (120), Expect = 1e-06
 Identities = 54/183 (29%), Positives = 86/183 (46%), Gaps = 23/183 (12%)

Query: 519 LIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRI-RHRNLIKIISS 572
           L+G G +G VYK      G   AIKV ++  G   +    E  M+K+   HRN+     +
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGA 71

Query: 573 C------SNDDFKALVLEYMPLGSLEKCLYS--GNYILDIFQGLNIMIDVASALEYLHFG 624
                    DD   LV+E+   GS+   + +  GN + + +    I  ++   L +LH  
Sbjct: 72  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-ICREILRGLSHLH-- 128

Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT-LATIGYMAPDEIF 683
               +IH D+K  NVLL +N    L DFG++  L   D+++ +  T + T  +MAP+ I 
Sbjct: 129 -QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPEVIA 184

Query: 684 SGE 686
             E
Sbjct: 185 CDE 187

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 50.5 bits (120), Expect = 1e-06
 Identities = 61/221 (27%), Positives = 92/221 (41%), Gaps = 50/221 (22%)

Query: 484 RKSQLKDVNMPSVADQRRFTYLELF---QATNRFSENNLIGRGGFGPVY-----KDGMEV 535
           R   LKD   P +A        ELF        F++   IG G FG VY     +    V
Sbjct: 5   RAGSLKD---PEIA--------ELFFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVV 53

Query: 536 AIKVFNLQYGGA-----FKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGS 590
           AIK   + Y G      ++    E   ++RI+H N I+       +    LV+EY     
Sbjct: 54  AIK--KMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY----- 106

Query: 591 LEKCLYSGNYILDI----FQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV 646
              CL S + +L++     Q + I      AL+ L + +S  +IH D+K  N+LL +   
Sbjct: 107 ---CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ 163

Query: 647 AHLSDFG---MAKPLLEEDQSLTQTQTLATIGYMAPDEIFS 684
             L+DFG   +A P             + T  +MAP+ I +
Sbjct: 164 VKLADFGSASIASP---------ANSFVGTPYWMAPEVILA 195

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 50.2 bits (120), Expect = 2e-06
 Identities = 50/178 (28%), Positives = 81/178 (45%), Gaps = 22/178 (12%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNL-QYGGAFKSFDI-ECGMMKRIRHRNLIKIISS 572
           IG G +G VYK         +A+K   L Q      S  I E  ++K ++H N++++   
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 573 CSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
             ++    LV EY+ L   +    S ++  +       +  +   + Y H   S  ++H 
Sbjct: 70  VHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHR 126

Query: 633 DLKPSNVLLDDNMVA-HLSDFGMAK----PLLEEDQSLTQTQTLATIGYMAPDEIFSG 685
           DLKP N+L+D    A  L+DFG+A+    P+       T T  + T+ Y AP EI  G
Sbjct: 127 DLKPQNLLIDRRTNALKLADFGLARAFGIPV------RTFTHEVVTLWYRAP-EILLG 177

Length = 294

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 50.4 bits (120), Expect = 2e-06
 Identities = 53/179 (29%), Positives = 81/179 (45%), Gaps = 31/179 (17%)

Query: 519 LIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGM------MKRIRHRNLI 567
           +IG+G FG V       +    A+KV  LQ     K  + +  M      +K ++H  L+
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59

Query: 568 KIISSCSNDDFKALVLEYMPLGSL------EKCLYSGNYILDIFQGLNIMIDVASALEYL 621
            +  S    D    VL+Y+  G L      E+C           +      ++ASAL YL
Sbjct: 60  GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP-------RARFYAAEIASALGYL 112

Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           H   S+ I++ DLKP N+LLD      L+DFG+ K  +E +   T +    T  Y+AP+
Sbjct: 113 H---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAPE 166

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 50.1 bits (120), Expect = 2e-06
 Identities = 45/153 (29%), Positives = 70/153 (45%), Gaps = 18/153 (11%)

Query: 519 LIGRGGFGPVYK---------DGMEVAIKVFNLQYGGA--FKSFDIECGMMKRIRHRNLI 567
            +G+G FG V            G  VA+K   LQ+  A   + F+ E  ++K ++H N++
Sbjct: 11  QLGKGNFGSVELCRYDPLQDNTGEVVAVK--KLQHSTAEHLRDFEREIEILKSLQHDNIV 68

Query: 568 KIISSCSNDDFKA--LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY 625
           K    C +   +   LV+EY+P GSL   L      LD  + L     +   +EYL    
Sbjct: 69  KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG--- 125

Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL 658
           S   +H DL   N+L++      + DFG+ K L
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 51.4 bits (123), Expect = 2e-06
 Identities = 44/163 (26%), Positives = 72/163 (44%), Gaps = 16/163 (9%)

Query: 532 GMEVAIKVF-NLQYGGA--FKSFDIECGMMKRIRHRNLIKIISS-CSNDDFKALVLEYMP 587
           G EVAIK+              F  E  +  R+ H N++ ++ S  +       V EY+P
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 588 LGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL---DDN 644
             +L + L +   +     G  +M+ V  AL   H   +  I+H DLKP N+++      
Sbjct: 63  GRTLREVLAADGALPAGETG-RLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGVR 118

Query: 645 MVAHLSDFGMAK--PLLEEDQSLTQTQT---LATIGYMAPDEI 682
             A + DFG+    P + +    T T+T   L T  Y AP+++
Sbjct: 119 PHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL 161

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 53/194 (27%), Positives = 81/194 (41%), Gaps = 44/194 (22%)

Query: 519 LIGRGGFGPVY--------KDGMEVAIKVFN----LQYGGAFKSFDIECGMMKRIRHRNL 566
           ++G G +G V+          G   A+KV      +Q     +    E  +++ IR    
Sbjct: 7   VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66

Query: 567 IKIISSCSNDDFKA-LVLEYMPLGSL-------------EKCLYSGNYILDIFQGLNIMI 612
           +  +      D K  L+L+Y+  G L             E  +YSG  +L          
Sbjct: 67  LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVL---------- 116

Query: 613 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA 672
               ALE+LH    + II+ D+K  N+LLD N    L+DFG++K    ED+         
Sbjct: 117 ----ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH-EDEVERAYSFCG 168

Query: 673 TIGYMAPDEIFSGE 686
           TI YMAPD +  G+
Sbjct: 169 TIEYMAPDIVRGGD 182

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 49.8 bits (119), Expect = 3e-06
 Identities = 53/173 (30%), Positives = 76/173 (43%), Gaps = 19/173 (10%)

Query: 519 LIGRGGFGPVY----KDGMEV-AIKVFNLQYGGAFKSFDIECGMM-KRI-----RHRNLI 567
           ++G+G FG V     K   EV AIKV  L+     +  D++C M  KRI     +H  L 
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKV--LKKDVILQDDDVDCTMTEKRILALAAKHPFLT 59

Query: 568 KIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
            +       D    V+EY+  G L   +       D  +      +V  AL +LH     
Sbjct: 60  ALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK-FDEPRSRFYAAEVTLALMFLH---RH 115

Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
            +I+ DLK  N+LLD      L+DFGM K  +     +T T    T  Y+AP+
Sbjct: 116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VTTTTFCGTPDYIAPE 166

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 49.7 bits (118), Expect = 3e-06
 Identities = 49/191 (25%), Positives = 87/191 (45%), Gaps = 32/191 (16%)

Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAF--KSFDIECGMMK 559
           +++   R+   + +G G +G V      K G+ VA+K  +  +      K    E  ++K
Sbjct: 12  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 71

Query: 560 RIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGLN 609
            ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q   
Sbjct: 72  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--- 128

Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
               +   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T 
Sbjct: 129 ----ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTG 176

Query: 670 TLATIGYMAPD 680
            +AT  Y AP+
Sbjct: 177 YVATRWYRAPE 187

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 49.4 bits (118), Expect = 3e-06
 Identities = 26/69 (37%), Positives = 45/69 (65%), Gaps = 7/69 (10%)

Query: 613 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL- 671
           ++A AL++LH   S+ II+ DLKP N+LLD+     L+DFG++K  ++ ++   +  +  
Sbjct: 106 ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK---KAYSFC 159

Query: 672 ATIGYMAPD 680
            T+ YMAP+
Sbjct: 160 GTVEYMAPE 168

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 49.5 bits (118), Expect = 3e-06
 Identities = 52/179 (29%), Positives = 86/179 (48%), Gaps = 20/179 (11%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGA-FKSFDIECGMMKRIRHRNLIKIISSC 573
           +G+G +G VYK      G+ +A+K   L+   + F    +E  ++ +     ++    + 
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGL--NIMIDVASALEYLHFGYSVPIIH 631
             +    + +EYM  GSL+K    G     I + +   I   V   L++L   ++  IIH
Sbjct: 69  FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIH 126

Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG---YMAPDEIFSGEM 687
            D+KP+NVL++ N    L DFG++  L+    SL +T     IG   YMAP+ I SG  
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSGNLV---ASLAKTN----IGCQSYMAPERIKSGGP 178

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 49.6 bits (118), Expect = 3e-06
 Identities = 54/175 (30%), Positives = 80/175 (45%), Gaps = 19/175 (10%)

Query: 519 LIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGM------MKRIRHRNLI 567
           +IG+G FG V       DG   A+KV  LQ        + +  M      +K ++H  L+
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKV--LQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59

Query: 568 KIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
            +  S    +    VL+++  G L   L       +         ++ASAL YLH   S+
Sbjct: 60  GLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---SI 115

Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
            I++ DLKP N+LLD      L+DFG+ K  +   QS T T    T  Y+AP+ I
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCGTPEYLAPEVI 168

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 49.2 bits (117), Expect = 4e-06
 Identities = 50/179 (27%), Positives = 80/179 (44%), Gaps = 36/179 (20%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRNLIKIISS 572
           +G G +  VYK     +G  VA+KV ++  + G  F +   E  ++K ++H N++ +   
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR-EASLLKGLKHANIVLLHDI 71

Query: 573 CSNDDFKALVLEYM-----------PLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
               +    V EYM           P G     L+  N  L +FQ L         L Y+
Sbjct: 72  IHTKETLTFVFEYMHTDLAQYMIQHPGG-----LHPYNVRLFMFQLLR-------GLAYI 119

Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           H  +   I+H DLKP N+L+       L+DFG+A+   +   S T +  + T+ Y  PD
Sbjct: 120 HGQH---ILHRDLKPQNLLISYLGELKLADFGLARA--KSIPSQTYSSEVVTLWYRPPD 173

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 49.3 bits (117), Expect = 4e-06
 Identities = 51/185 (27%), Positives = 82/185 (44%), Gaps = 30/185 (16%)

Query: 514 FSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGA-----FKSFDIECGMMKRIRH 563
           FS+   IG G FG VY     ++   VAIK   + Y G      ++    E   ++++RH
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIK--KMSYSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDI----FQGLNIMIDVASALE 619
            N I+       +    LV+EY        CL S + +L++     Q + I      AL+
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQ 126

Query: 620 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
            L + +S  +IH D+K  N+LL +  +  L DFG A  ++        T       +MAP
Sbjct: 127 GLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS-IMAPANXFVGTPY-----WMAP 180

Query: 680 DEIFS 684
           + I +
Sbjct: 181 EVILA 185

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 49.0 bits (117), Expect = 4e-06
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 22/173 (12%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI-ECGMMKRIRHRNLIKIISSC 573
           +G G +  VYK      G  VA+K  +L       S  I E  +MK ++H N++++    
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 574 SNDDFKALVLEYMPLGSLEKCL--YSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
             ++   LV EYM    L+K +  +     LD     +    +   + + H      ++H
Sbjct: 68  HTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLH 123

Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAK----PLLEEDQSLTQTQTLATIGYMAPD 680
            DLKP N+L++      L+DFG+A+    P+       T +  + T+ Y APD
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAFGIPV------NTFSNEVVTLWYRAPD 170

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 48.8 bits (117), Expect = 4e-06
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 23/178 (12%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNL-QYGGAFKSFDI-ECGMMKRIRHRNLIKIISS 572
           IG G +G VYK      G  VA+K   L        S  I E  ++K + H N+++++  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 573 CSNDDFKALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
             +++   LV E++ L  L+K + S     LD     + +  +   + Y H   S  ++H
Sbjct: 67  VHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLH 122

Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAK----PLLEEDQSLTQTQTLATIGYMAPDEIFSG 685
            DLKP N+L+D      L+DFG+A+    P+       T T  + T+ Y AP EI  G
Sbjct: 123 RDLKPQNLLIDREGALKLADFGLARAFGVPV------RTYTHEVVTLWYRAP-EILLG 173

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 48.8 bits (116), Expect = 4e-06
 Identities = 41/151 (27%), Positives = 71/151 (47%), Gaps = 12/151 (7%)

Query: 520 IGRGGFGPVYK-------DGMEVAIKVFNLQYGGAFKSFDI-ECGMMKRIRHRNLIKIIS 571
           +G G FG V K         ++VAIKV   +   + +   + E  +M ++ +  ++++I 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
            C  +    LV+E    G L K L      + +   + +M  V+  ++YL        +H
Sbjct: 63  VCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVH 118

Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEED 662
            DL   NVLL +   A +SDFG++K L  +D
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADD 149

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 49.0 bits (117), Expect = 5e-06
 Identities = 48/193 (24%), Positives = 81/193 (41%), Gaps = 27/193 (13%)

Query: 514 FSENNL-----IGRGGFGPVYK----------DGMEVAIKVF----NLQYGGAFKSFDIE 554
           F  NNL     +G G FG V +            M+VA+K+     +     A  S   E
Sbjct: 32  FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS---E 88

Query: 555 CGMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNY-ILDIFQGLNIMI 612
             +M  +  H N++ ++ +C+      ++ EY   G L   L       L +   L+   
Sbjct: 89  LKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSY 148

Query: 613 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA 672
            VA  + +L    S   IH DL   NVLL    +  + DFG+A+ ++ +   + +     
Sbjct: 149 QVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL 205

Query: 673 TIGYMAPDEIFSG 685
            + +MAP+ IF+ 
Sbjct: 206 PVKWMAPESIFNC 218

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 48.9 bits (116), Expect = 7e-06
 Identities = 65/272 (23%), Positives = 113/272 (41%), Gaps = 40/272 (14%)

Query: 519 LIGRGGFGPVYKDGMEVAIKVFNLQYGGAFKS--------FDIECGMMKRIRHRNLIKII 570
           +IGRG FG V     +   KV+ ++    F+         F  E  +M       ++++ 
Sbjct: 50  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109

Query: 571 SSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPII 630
            +  +D +  +V+EYMP G L   +   NY +          +V  AL+ +H   S+  I
Sbjct: 110 YAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFYTAEVVLALDAIH---SMGFI 164

Query: 631 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS----GE 686
           H D+KP N+LLD +    L+DFG    + +E      T  + T  Y++P+ + S    G 
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGDGY 223

Query: 687 MRLKC-WVNDSLLISVMIVVD----ANLLIREEKHLMTKEQPMVRMGTDLSLGQFPASYS 741
              +C W +  + +  M+V D    A+ L+     +M  +  +           FP    
Sbjct: 224 YGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT----------FPDDND 273

Query: 742 ISK-------YLVYIRELERGKVGITSVAAFP 766
           ISK         +  RE+  G+ G+  +    
Sbjct: 274 ISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 48.6 bits (116), Expect = 8e-06
 Identities = 48/162 (29%), Positives = 76/162 (46%), Gaps = 41/162 (25%)

Query: 514 FSENNLIGRGGFGPV----YKDGMEV-AIKVFNLQYGGAFKSFDIECGMMKR-------- 560
           F    +IGRG FG V    +K   +V A+K+ +         F+    M+KR        
Sbjct: 45  FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS--------KFE----MIKRSDSAFFWE 92

Query: 561 ----IRHRN---LIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIM-- 611
               + H N   ++++  +  +D +  +V+EYMP G L   +   NY  DI +       
Sbjct: 93  ERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM--SNY--DIPEKWARFYT 148

Query: 612 IDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFG 653
            +V  AL+ +H   S+  IH D+KP N+LLD +    L+DFG
Sbjct: 149 AEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFG 187

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 48.0 bits (114), Expect = 9e-06
 Identities = 50/179 (27%), Positives = 81/179 (45%), Gaps = 27/179 (15%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYG--GAFKSFDIECGMMKRIR---HRNLIKI 569
           IG G +G VYK      G  VA+K   +Q    G   S   E  ++KR+    H N++++
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 570 ISSC----SNDDFK-ALVLEYMPL---GSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
           +  C    ++ + K  LV E++       L+K    G   L      ++M      L++L
Sbjct: 68  MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG---LPAETIKDLMRQFLRGLDFL 124

Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           H      I+H DLKP N+L+       L+DFG+A+        +  T  + T+ Y AP+
Sbjct: 125 HANC---IVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPE 177

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 47.6 bits (113), Expect = 9e-06
 Identities = 47/183 (25%), Positives = 74/183 (40%), Gaps = 15/183 (8%)

Query: 520 IGRGGFGPVYK----DGMEVA-IKVFNLQYGGAFK---SFDIECGMMKRIRHRNLIKIIS 571
           IG G FG V       GM  A + V  L+          F  E    + + H N+++ + 
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYIL----DIFQGLNIMIDVASALEYLHFGYSV 627
            C       LVLE+ PLG L+  L S   ++           +  +VAS L +LH     
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QA 119

Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEM 687
             IH DL   N  L  ++   + D+G+A     ED  +T+      + ++AP+ +     
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179

Query: 688 RLK 690
            L 
Sbjct: 180 DLL 182

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 48.1 bits (114), Expect = 9e-06
 Identities = 42/167 (25%), Positives = 81/167 (48%), Gaps = 12/167 (7%)

Query: 520 IGRGGFGPVYKDGME-----VAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSC 573
           +G G +  V+K   +     VA+K   L++  GA  +   E  ++K ++H N++ +    
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73

Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
             D    LV EY+    L++ +     I+ +    N+ I +   L  L + +   ++H D
Sbjct: 74  HTDKSLTLVFEYLD-KDLKQYMDDCGNIMSMH---NVKIFLYQILRGLAYCHRRKVLHRD 129

Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LKP N+L+++     L+DFG+A+   +   + T +  + T+ Y  PD
Sbjct: 130 LKPQNLLINERGELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPD 174

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 42/167 (25%), Positives = 78/167 (46%), Gaps = 12/167 (7%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSC 573
           +G G +  V+K         VA+K   L++  GA  +   E  ++K ++H N++ +    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
             +    LV EY+    L++ L +   ++ +      M  +   L Y H      I+H D
Sbjct: 73  HTERCLTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRD 128

Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LKP N+L+++     L+DFG+A+   +   + T +  + T+ Y  PD
Sbjct: 129 LKPQNLLINEKGELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPD 173

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 48.1 bits (114), Expect = 1e-05
 Identities = 54/188 (28%), Positives = 88/188 (46%), Gaps = 28/188 (14%)

Query: 498 DQRRFTYLELFQATNR-FSENNLIGRGGFGPVYK-----DGMEVAIK--VFNLQYGGAFK 549
           D+ +    ++ ++ N+ +   N+IG G FG VY+        +VAIK  + + QY     
Sbjct: 51  DEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYK---- 106

Query: 550 SFDIECGMMKRIRHRNLIKIISSCSNDDFKA--------LVLEYMP--LGSLEKCLYSGN 599
             + E  +MK + H N+I +      + FK         +V+E++P  +    K     N
Sbjct: 107 --NRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNN 164

Query: 600 YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM-VAHLSDFGMAKPL 658
           + L +F        +  AL Y+H  +   I H DLKP N+L+D N     L DFG AK L
Sbjct: 165 HALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221

Query: 659 LEEDQSLT 666
           L   +S++
Sbjct: 222 LAGQRSVS 229

Length = 440

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 42.9 bits (102), Expect = 2e-05
 Identities = 23/56 (41%), Positives = 30/56 (53%)

Query: 330 LDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNL 385
           LDLS N  + +      GL +L+ L L  N L    P +   L SL+SL+LS NNL
Sbjct: 5   LDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 47.9 bits (114), Expect = 2e-05
 Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 26/158 (16%)

Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIR-HRN-------- 565
           I RG FG VY      +    A+KV         K+  I   M+ +++  R+        
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVK-------KADMINKNMVHQVQAERDALALSKSP 64

Query: 566 -LIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFG 624
            ++ +  S  + +   LV+EY+  G ++  L+   Y  D    +  + +VA AL+YLH  
Sbjct: 65  FIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY-FDEEMAVKYISEVALALDYLH-- 121

Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED 662
               IIH DLKP N+L+ +     L+DFG++K  L  +
Sbjct: 122 -RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 47.2 bits (112), Expect = 2e-05
 Identities = 54/178 (30%), Positives = 77/178 (43%), Gaps = 29/178 (16%)

Query: 519 LIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMM-KRI-----RHRNLI 567
           ++G+G FG V      + G   A+KV  L+     +  D+EC M  KRI      H  L 
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 59

Query: 568 KIISSCSNDDFKALVLEYMPLGSL----EKCLYSGNYILDIFQGLNIMIDVASALEYLHF 623
           ++       D    V+E++  G L    +K         D  +      ++ SAL +LH 
Sbjct: 60  QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR-----FDEARARFYAAEITSALMFLH- 113

Query: 624 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL-ATIGYMAPD 680
                II+ DLK  NVLLD      L+DFGM K   E   +   T T   T  Y+AP+
Sbjct: 114 --DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTFCGTPDYIAPE 166

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 46.7 bits (111), Expect = 2e-05
 Identities = 37/195 (18%), Positives = 77/195 (39%), Gaps = 23/195 (11%)

Query: 515 SENNLIGRGGFGPVYKDGME----------VAIKVFN-LQYGGAFKSFDIECGMMKRIRH 563
            E   +GRG FG V+    +          V +K     +       F  E  M +++ H
Sbjct: 8   QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSH 67

Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCL--------YSGNYILDIFQGLNIMIDVA 615
           +N+++++  C   +   ++LEY  LG L++ L              L   Q + +   +A
Sbjct: 68  KNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIA 127

Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 675
             +++L    +   +H DL   N L+       +S   ++K +   +    +   L  + 
Sbjct: 128 LGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLR-NALIPLR 183

Query: 676 YMAPDEIFSGEMRLK 690
           ++AP+ +   +   K
Sbjct: 184 WLAPEAVQEDDFSTK 198

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 41/167 (24%), Positives = 82/167 (49%), Gaps = 12/167 (7%)

Query: 520 IGRGGFGPVYKDGME-----VAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSC 573
           +G G +  VYK   +     VA+K   L++  GA  +   E  ++K ++H N++ +    
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73

Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
             +    LV EY+    L++ L      +++    N+ + +   L  L++ +   ++H D
Sbjct: 74  HTEKSLTLVFEYLD-KDLKQYLDDCGNSINMH---NVKLFLFQLLRGLNYCHRRKVLHRD 129

Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LKP N+L+++     L+DFG+A+   +   + T +  + T+ Y  PD
Sbjct: 130 LKPQNLLINERGELKLADFGLARA--KSIPTKTYSNEVVTLWYRPPD 174

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 47.0 bits (111), Expect = 2e-05
 Identities = 44/175 (25%), Positives = 83/175 (47%), Gaps = 13/175 (7%)

Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI-ECGMMKRIRHRNLI 567
           F + + +G G  G V+K      G+ +A K+ +L+   A ++  I E  ++       ++
Sbjct: 7   FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 568 KIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
               +  +D   ++ +E+M  GSL++ L     I +   G  + I V   L YL   +  
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKGLTYLREKHK- 124

Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
            I+H D+KPSN+L++      L DFG++  L++          + T  YM+P+ +
Sbjct: 125 -IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERL 174

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 46.7 bits (111), Expect = 2e-05
 Identities = 47/177 (26%), Positives = 76/177 (42%), Gaps = 12/177 (6%)

Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKS---FDIECGMMKRIRH 563
             F   +L+GRG FG V        G   A+KV       A ++   F+ E  ++     
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHF 623
             + ++  +  + D   LV+EY P G L   L   N   D F        +A  +  +H 
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL---NRYEDQFDEDMAQFYLAELVLAIHS 117

Query: 624 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
            + +  +H D+KP NVL+D      L+DFG A   L  ++ +     + T  Y+AP+
Sbjct: 118 VHQMGYVHRDIKPENVLIDRTGHIKLADFGSAAR-LTANKMVNSKLPVGTPDYIAPE 173

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 46.7 bits (111), Expect = 3e-05
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 7/98 (7%)

Query: 583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD 642
           +E+M  GSL++ L     I +   G  I I V   L YL   +   I+H D+KPSN+L++
Sbjct: 78  MEHMDGGSLDQVLKKAGRIPENILG-KISIAVLRGLTYLREKHK--IMHRDVKPSNILVN 134

Query: 643 DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
                 L DFG++  L++   S+  +  + T  YM+P+
Sbjct: 135 SRGEIKLCDFGVSGQLID---SMANS-FVGTRSYMSPE 168

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 46.6 bits (111), Expect = 3e-05
 Identities = 46/159 (28%), Positives = 72/159 (45%), Gaps = 34/159 (21%)

Query: 519 LIGRGGFGPV----YKD-GMEVAIKVFNLQYGGAFKSFDIECGMMKRIR-HRNL------ 566
           +IGRG FG V     KD G   A+K          KS  +E   +  +R  R++      
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMKKLR-------KSEMLEKEQVAHVRAERDILAEADN 60

Query: 567 ---IKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIF---QGLNIMIDVASALEY 620
              +K+  S  ++++  L++EY+P G +   L       D F   +    + +   A++ 
Sbjct: 61  PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDS 116

Query: 621 LH-FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL 658
           +H  GY    IH D+KP N+LLD      LSDFG+   L
Sbjct: 117 IHKLGY----IHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 46.2 bits (109), Expect = 3e-05
 Identities = 51/179 (28%), Positives = 79/179 (44%), Gaps = 30/179 (16%)

Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYGGAF---KSFDI--ECGMMKRIRHRNLIKI 569
           IG G FG VY          VA+K   + Y G     K  DI  E   +++++H N I+ 
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVK--KMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEY 86

Query: 570 ISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDI----FQGLNIMIDVASALEYLHFGY 625
                 +    LV+EY        CL S + +L++     Q + I      AL+ L + +
Sbjct: 87  KGCYLKEHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH 138

Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS 684
           S  +IH D+K  N+LL +     L+DFG A       +S      + T  +MAP+ I +
Sbjct: 139 SHNMIHRDIKAGNILLTEPGQVKLADFGSAS------KSSPANSFVGTPYWMAPEVILA 191

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 46.2 bits (109), Expect = 3e-05
 Identities = 46/192 (23%), Positives = 82/192 (42%), Gaps = 47/192 (24%)

Query: 519 LIGRGGFGPVYKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHR-------NLIKIIS 571
           +IGRGGFG VY             +     K + ++C   KRI+ +       N   ++S
Sbjct: 1   IIGRGGFGEVY-----------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 49

Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNI------------------MID 613
             S  D   +V       + +K  +    ILD+  G ++                    +
Sbjct: 50  LVSTGDCPFIVCMTYAFHTPDKLCF----ILDLMNGGDLHYHLSQHGVFSEKEMRFYATE 105

Query: 614 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 673
           +   LE++H  +   +++ DLKP+N+LLD++    +SD G+A    ++        ++ T
Sbjct: 106 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASVGT 158

Query: 674 IGYMAPDEIFSG 685
            GYMAP+ +  G
Sbjct: 159 HGYMAPEVLQKG 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 52/184 (28%), Positives = 84/184 (45%), Gaps = 41/184 (22%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G  G VYK         +A+KV  L         DI   + K+I     ++I+  C 
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPL---------DITVELQKQIMSE--LEILYKCD 57

Query: 575 N------------DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
           +            ++  ++  E+M  GSL+       ++L       I + V   L YL 
Sbjct: 58  SPYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLG-----RIAVAVVKGLTYL- 111

Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
             +S+ I+H D+KPSN+L++      L DFG++  L+    S+ +T  + T  YMAP+ I
Sbjct: 112 --WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV---NSIAKTY-VGTNAYMAPERI 165

Query: 683 FSGE 686
            SGE
Sbjct: 166 -SGE 168

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 46.4 bits (110), Expect = 4e-05
 Identities = 52/192 (27%), Positives = 94/192 (48%), Gaps = 39/192 (20%)

Query: 513 RFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGG---AFKSFDIECGMMKRIRHR 564
           R++    +G G +G V      + G +VAIK  +  +     A +++  E  ++K ++H 
Sbjct: 16  RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHE 74

Query: 565 NLIKII----SSCSNDDFKA--LVLEYMPLGSLEKCLYSGNYILD------IFQGLNIMI 612
           N+I ++    S+ S D+F+   LV+ YM    L+K +  G+ + +      ++Q L    
Sbjct: 75  NVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQML---- 127

Query: 613 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA 672
                L+Y+H   S  IIH DLKP N+ ++++    + DFG+A+    E      T  + 
Sbjct: 128 ---CGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVV 176

Query: 673 TIGYMAPDEIFS 684
           T  Y AP+ I +
Sbjct: 177 TRWYRAPEVILN 188

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 46.1 bits (109), Expect = 4e-05
 Identities = 26/65 (40%), Positives = 38/65 (58%), Gaps = 7/65 (10%)

Query: 617 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL-ATIG 675
           ALE+LH      I++ DLKP N+LLD      L DFG++K  L ++++   T T   T  
Sbjct: 108 ALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT---TNTFCGTTE 161

Query: 676 YMAPD 680
           Y+AP+
Sbjct: 162 YLAPE 166

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 46.3 bits (110), Expect = 4e-05
 Identities = 50/198 (25%), Positives = 89/198 (44%), Gaps = 37/198 (18%)

Query: 513 RFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLI 567
           R+ +   +G G  G V+          VA+K   L    + K    E  +++R+ H N++
Sbjct: 6   RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIV 65

Query: 568 KII------SSCSNDDFKAL--------VLEYMPLG---SLEKCLYSGNYI-LDIFQGLN 609
           K+        S   +D  +L        V EYM       LE+   S  +  L ++Q L 
Sbjct: 66  KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR 125

Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQ- 667
                   L+Y+H   S  ++H DLKP+NV ++ +++V  + DFG+A+ +++   S    
Sbjct: 126 -------GLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLAR-IVDPHYSHKGY 174

Query: 668 -TQTLATIGYMAPDEIFS 684
            ++ L T  Y +P  + S
Sbjct: 175 LSEGLVTKWYRSPRLLLS 192

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 46.2 bits (109), Expect = 4e-05
 Identities = 50/191 (26%), Positives = 88/191 (46%), Gaps = 32/191 (16%)

Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAFKSFDI--ECGMMK 559
           +++   R+     +G G +G V      +   +VA+K  +  +     +     E  ++K
Sbjct: 10  VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLK 69

Query: 560 RIRHRNLIKIIS----SCSNDDFKA--LVLEYM--PLGSLEKC--LYSGNYILDIFQGLN 609
            ++H N+I ++     + S ++F    LV   M   L ++ KC  L   +    I+Q L 
Sbjct: 70  HMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLR 129

Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
                   L+Y+H   S  IIH DLKPSNV ++++    + DFG+A+   +E      T 
Sbjct: 130 -------GLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTG 174

Query: 670 TLATIGYMAPD 680
            +AT  Y AP+
Sbjct: 175 YVATRWYRAPE 185

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 45.7 bits (108), Expect = 4e-05
 Identities = 50/193 (25%), Positives = 85/193 (44%), Gaps = 49/193 (25%)

Query: 519 LIGRGGFGPVYKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHR-------NLIKIIS 571
           +IGRGGFG VY             +     K + ++C   KRI+ +       N   ++S
Sbjct: 1   IIGRGGFGEVY-----------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 49

Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNI--------------MIDVAS- 616
             S  D   +V       + +K     ++ILD+  G ++              M   A+ 
Sbjct: 50  LVSTGDCPFIVCMSYAFHTPDKL----SFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAE 105

Query: 617 ---ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ-TLA 672
               LE++H  +   +++ DLKP+N+LLD++    +SD G+A      D S  +   ++ 
Sbjct: 106 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC-----DFSKKKPHASVG 157

Query: 673 TIGYMAPDEIFSG 685
           T GYMAP+ +  G
Sbjct: 158 THGYMAPEVLQKG 170

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 45.4 bits (107), Expect = 6e-05
 Identities = 46/187 (24%), Positives = 80/187 (42%), Gaps = 25/187 (13%)

Query: 520 IGRGGFGPVY--------KDGME--VAIKVFNLQYGGAFK-SFDIECGMMKRIRHRNLIK 568
           +G+G FG VY        KD  E  VAIK  N       +  F  E  +MK     ++++
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCLYS------GNYILDIFQGLNIMI----DVASAL 618
           ++   S      +++E M  G L+  L S       N +      L  MI    ++A  +
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAP-PSLKKMIQMAGEIADGM 132

Query: 619 EYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 678
            YL+   +   +H DL   N ++ ++    + DFGM + + E D      + L  + +M+
Sbjct: 133 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 189

Query: 679 PDEIFSG 685
           P+ +  G
Sbjct: 190 PESLKDG 196

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 45.7 bits (108), Expect = 7e-05
 Identities = 51/193 (26%), Positives = 89/193 (46%), Gaps = 28/193 (14%)

Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAF--KSFDIECGMMK 559
           +++  +R+ +   +G G +G V      + G +VAIK     +      K    E  ++K
Sbjct: 10  IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLK 69

Query: 560 RIRHRNLIKII----SSCSNDDFKA--LVLEYM--PLGSLEKCLYSGNYILDIFQGLNIM 611
            ++H N+I ++       S D F    LV+ +M   LG L K         D  Q L  +
Sbjct: 70  HMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSE---DRIQFL--V 124

Query: 612 IDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL 671
             +   L+Y+H   +  IIH DLKP N+ ++++    + DFG+A+   + D  +  T  +
Sbjct: 125 YQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEM--TGYV 176

Query: 672 ATIGYMAPDEIFS 684
            T  Y AP+ I +
Sbjct: 177 VTRWYRAPEVILN 189

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 45.0 bits (106), Expect = 7e-05
 Identities = 40/167 (23%), Positives = 79/167 (47%), Gaps = 12/167 (7%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G FG VYK      G+  A KV + +     + + +E  ++    H N++K++ +  
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDL 634
            ++   +++E+   G+++  +      L   Q   +      AL YLH      IIH DL
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDL 129

Query: 635 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT-LATIGYMAPD 680
           K  N+L   +    L+DFG++    +  +++ +  + + T  +MAP+
Sbjct: 130 KAGNILFTLDGDIKLADFGVSA---KNTRTIQRRDSFIGTPYWMAPE 173

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 45.4 bits (107), Expect = 7e-05
 Identities = 44/179 (24%), Positives = 76/179 (42%), Gaps = 14/179 (7%)

Query: 514 FSENNLIGRGGFGPVYK-----DG----MEVAIKVFNLQYG-GAFKSFDIECGMMKRIRH 563
           F +  ++G G FG VYK     +G    + VAIK         A K    E  +M  + +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHF 623
            ++ +++  C     + L+ + MP G L   +      +     LN  + +A  + YL  
Sbjct: 69  PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 126

Query: 624 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
                ++H DL   NVL+       ++DFG+AK L  +++          I +MA + I
Sbjct: 127 --ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESI 183

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 40.6 bits (96), Expect = 8e-05
 Identities = 21/59 (35%), Positives = 31/59 (52%)

Query: 351 LQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRL 409
           L+ L L  NRL      +   L +LK L+LS NNL+   P +   L  L+ +++S N L
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 45.4 bits (107), Expect = 8e-05
 Identities = 25/87 (28%), Positives = 43/87 (49%), Gaps = 9/87 (10%)

Query: 603 DIFQGLNIM------IDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK 656
           D  +GL  +        VA  +E+L    S   +H DL   NVLL    +  + DFG+A+
Sbjct: 229 DGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKIVKICDFGLAR 285

Query: 657 PLLEEDQSLTQTQTLATIGYMAPDEIF 683
            ++ +   +++  T   + +MAP+ IF
Sbjct: 286 DIMHDSNYVSKGSTFLPVKWMAPESIF 312

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 45.0 bits (106), Expect = 8e-05
 Identities = 49/187 (26%), Positives = 82/187 (43%), Gaps = 34/187 (18%)

Query: 512 NRFSENNLIGRGGFGPV----YKDGME-VAIKVFNLQYGGA-FKSFDI-ECGMMKRIRHR 564
           N+F    ++G G +G V    +K+  E VAIK F         K   + E  M++ ++  
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 565 NLIKIISSCSNDDFKALVLEY-----------MPLGSLEKCLYSGNYILDIFQGLNIMID 613
           N++++  +        LV EY           MP G   + + S  YI  + + +     
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRS--YIYQLIKAI----- 113

Query: 614 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 673
                   H+ +   I+H D+KP N+L+  N V  L DFG A+  L E  +   T+ +AT
Sbjct: 114 --------HWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARN-LSEGSNANYTEYVAT 164

Query: 674 IGYMAPD 680
             Y +P+
Sbjct: 165 RWYRSPE 171

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 45.2 bits (107), Expect = 9e-05
 Identities = 27/96 (28%), Positives = 47/96 (48%), Gaps = 3/96 (3%)

Query: 588 LGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVA 647
             S ++     ++ LD+   L     VA  +++L    S   IH D+   NVLL D  VA
Sbjct: 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVA 251

Query: 648 HLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIF 683
            + DFG+A+ ++ +   + +      + +MAP+ IF
Sbjct: 252 KICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIF 287

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 40.6 bits (96), Expect = 1e-04
 Identities = 18/60 (30%), Positives = 23/60 (38%)

Query: 103 NLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYL 162
           NLK L L  N               L  L L  N+ +   P  F  L +L+ L L+ N L
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 45.0 bits (106), Expect = 1e-04
 Identities = 69/247 (27%), Positives = 100/247 (40%), Gaps = 69/247 (27%)

Query: 520 IGRGGFGPV----YKDG--MEVAIKVFNLQYGGAFKSFD---IECGMMKRIRHRNLIKII 570
           +G G FG V    YK+     VAIK F        K  D    E  ++  I H   + + 
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97

Query: 571 SSCSNDDFKALVLEYMPLGSLEK-------------CLYSGNYILDIFQGLNIMIDVASA 617
            S  ++ +  LVLE++  G                 C Y+   +L IF            
Sbjct: 98  GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL-IF------------ 144

Query: 618 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL-ATIGY 676
            EYL    S+ I++ DLKP N+LLD +    ++DFG AK +++     T+T TL  T  Y
Sbjct: 145 -EYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAK-VVD-----TRTYTLCGTPEY 194

Query: 677 MAPD----------------EIFSGEMRLKC---WVNDSLLISVM----IVVDANLLIRE 713
           +AP+                 IF  E+ + C   + N+ LLI       I+     L   
Sbjct: 195 IAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNN 254

Query: 714 EKHLMTK 720
            KHLM K
Sbjct: 255 CKHLMKK 261

Length = 340

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 44.3 bits (105), Expect = 1e-04
 Identities = 28/117 (23%), Positives = 53/117 (45%), Gaps = 11/117 (9%)

Query: 554 ECGMMKRIRHRNLIKIISSCSNDDFKALVLE-YMPLGSLEKCLYSGNYI-------LDIF 605
           E  ++  + H+N++ I+  C  D     VL  YM  G+L+  L             L   
Sbjct: 58  ESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQ 117

Query: 606 QGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED 662
           Q +++ I +A  + YLH      +IH D+   N ++D+ +   ++D  +++ L   D
Sbjct: 118 QLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD 171

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 44.6 bits (105), Expect = 1e-04
 Identities = 51/180 (28%), Positives = 82/180 (45%), Gaps = 22/180 (12%)

Query: 519 LIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMM-KRI-----RHRNLI 567
           ++G+G FG V+           AIK   L+        D+EC M+ KR+      H  L 
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59

Query: 568 KIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
            +  +    +    V+EY+  G L   + S  +  D+ +      ++   L++LH   S 
Sbjct: 60  HLYCTFQTKENLFFVMEYLNGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLH---SK 115

Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL-ATIGYMAPDEIFSGE 686
            I++ DLK  N+LLD +    ++DFGM K  +  D    +T T   T  Y+AP EI  G+
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD---AKTCTFCGTPDYIAP-EILLGQ 171

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 44.4 bits (105), Expect = 1e-04
 Identities = 51/180 (28%), Positives = 79/180 (43%), Gaps = 22/180 (12%)

Query: 519 LIGRGGFGPVY----KDGMEV-AIKVFNLQYGGAFKSFDIECGMMKR------IRHRNLI 567
           ++G+G FG V     K   E  AIK   L+     +  D+EC M++R        H  L 
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKA--LKKDVVLEDDDVECTMVERRVLALAWEHPFLT 59

Query: 568 KIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
            +  +    +    V+EY+  G L   + S     D  +      ++   L++LH     
Sbjct: 60  HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR-FDEARARFYAAEIICGLQFLH---KK 115

Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL-ATIGYMAPDEIFSGE 686
            II+ DLK  NVLLD +    ++DFGM K  +  +    +  T   T  Y+AP EI  G+
Sbjct: 116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE---GKASTFCGTPDYIAP-EILKGQ 171

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 44.3 bits (104), Expect = 1e-04
 Identities = 43/169 (25%), Positives = 79/169 (46%), Gaps = 13/169 (7%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI-ECGMMKRIRHRNLIKIISSC 573
           +G G  G V K      G+ +A K+ +L+   A ++  I E  ++       ++    + 
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
            +D   ++ +E+M  GSL++ L     I +   G  + I V   L YL   +   I+H D
Sbjct: 73  YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-KVSIAVLRGLAYLREKHQ--IMHRD 129

Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
           +KPSN+L++      L DFG++  L++          + T  YM+P+ +
Sbjct: 130 VKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERL 174

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 44/163 (26%), Positives = 73/163 (44%), Gaps = 34/163 (20%)

Query: 519 LIGRGGFGPVYK--------DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKII 570
           LIG GGFG VY+           +   K+ NL+     ++  +E  +   I   + I + 
Sbjct: 19  LIGCGGFGCVYETQCASDHCINNQAVAKIENLEN----ETIVMETLVYNNIYDIDKIALW 74

Query: 571 SSCSNDDFKALVLEYMPLGSLEKCLYSGNYIL---------DIFQGL---------NIMI 612
            +  N D   +   Y   GS ++C     +IL         +IF+ +         NIM 
Sbjct: 75  KNIHNIDHLGIPK-YYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMK 133

Query: 613 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMA 655
           D+ + LEY+H      I H D+KP N+++D N   ++ D+G+A
Sbjct: 134 DMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIA 173

Length = 294

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 44.2 bits (104), Expect = 2e-04
 Identities = 23/70 (32%), Positives = 38/70 (54%), Gaps = 3/70 (4%)

Query: 614 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 673
           VA  +E+L    S   IH DL   N+LL +N V  + DFG+A+ + ++   + +      
Sbjct: 188 VAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 674 IGYMAPDEIF 683
           + +MAP+ IF
Sbjct: 245 LKWMAPETIF 254

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 44.1 bits (104), Expect = 2e-04
 Identities = 23/70 (32%), Positives = 38/70 (54%), Gaps = 3/70 (4%)

Query: 614 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 673
           VA  +E+L    S   IH DL   N+LL +N V  + DFG+A+ + ++   + +      
Sbjct: 182 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238

Query: 674 IGYMAPDEIF 683
           + +MAP+ IF
Sbjct: 239 LKWMAPESIF 248

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 43.8 bits (103), Expect = 2e-04
 Identities = 48/185 (25%), Positives = 83/185 (44%), Gaps = 20/185 (10%)

Query: 505 LELFQATNRFSENNLIGRGGFGPVYKDGMEVAIKVFNLQYGGAFK---SFDIECGMMKRI 561
           +E    T RF E   + RG      K  + VAI    L+ G + K    F  E   + + 
Sbjct: 9   IERILGTGRFGE---LCRGCLKLPSKRELPVAIHT--LRAGCSDKQRRGFLAEALTLGQF 63

Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
            H N++++    +  +   +V EYM  G+L+  L      L   Q + ++  +AS ++YL
Sbjct: 64  DHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL 123

Query: 622 -HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL---ATIGYM 677
              GY    +H  L    VL++ ++V  +S F      L+ED+S     T+   + + + 
Sbjct: 124 SEMGY----VHKGLAAHKVLVNSDLVCKISGFRR----LQEDKSEAIYTTMSGKSPVLWA 175

Query: 678 APDEI 682
           AP+ I
Sbjct: 176 APEAI 180

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 43.9 bits (103), Expect = 2e-04
 Identities = 50/179 (27%), Positives = 79/179 (44%), Gaps = 32/179 (17%)

Query: 519 LIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFD---IECGMMKRIRHRNLIKII 570
           L+G+G FG V        G   A+K+   +   A         E  ++K  RH  L  + 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 571 SSCSNDDFKALVLEYMPLGSL-----EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY 625
            S    D    V+EY+  G L      + ++S +     F G  I+    SAL+YLH G 
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTR--FYGAEIV----SALDYLHSG- 114

Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI----GYMAPD 680
              I++ DLK  N++LD +    ++DFG+ K      + +T   T+ T      Y+AP+
Sbjct: 115 --KIVYRDLKLENLMLDKDGHIKITDFGLCK------EGITDAATMKTFCGTPEYLAPE 165

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 43.4 bits (102), Expect = 2e-04
 Identities = 45/161 (27%), Positives = 77/161 (47%), Gaps = 17/161 (10%)

Query: 520 IGRGGFGPVYKDGM--------EVAIKVF-NLQYGGAFKSFDI-ECGMMKRIRHRNLIKI 569
           +G G FG V K GM         VA+K+  N     A K   + E  +M+++ +  ++++
Sbjct: 3   LGSGNFGTV-KKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 570 ISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPI 629
           I  C  + +  LV+E   LG L K L    ++ +      ++  V+  ++YL        
Sbjct: 62  IGICEAESW-MLVMELAELGPLNKFLQKNKHVTE-KNITELVHQVSMGMKYLE---ETNF 116

Query: 630 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 670
           +H DL   NVLL     A +SDFG++K  L  D++  + +T
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKA-LGADENYYKAKT 156

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 44/168 (26%), Positives = 77/168 (45%), Gaps = 12/168 (7%)

Query: 520 IGRGGFGPV-----YKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           IG G  G V        G +VA+K  +L+     +    E  +M+   H N++ + +S  
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDL 634
             D   +V+E++  G+L   +      ++  Q   + + V  AL YLH   +  +IH D+
Sbjct: 90  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLH---NQGVIHRDI 144

Query: 635 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
           K  ++LL  +    LSDFG    + +E     +   + T  +MAP+ I
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVI 190

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 43.9 bits (104), Expect = 2e-04
 Identities = 23/70 (32%), Positives = 40/70 (57%), Gaps = 5/70 (7%)

Query: 617 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE--EDQSLTQTQTLATI 674
            L+Y+H   S  ++H DLKP N+L++ +    + DFG+A+   E   + +   T+ +AT 
Sbjct: 117 GLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173

Query: 675 GYMAPDEIFS 684
            Y AP+ + S
Sbjct: 174 WYRAPEIMLS 183

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 43.2 bits (102), Expect = 3e-04
 Identities = 49/186 (26%), Positives = 87/186 (46%), Gaps = 28/186 (15%)

Query: 513 RFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAFKSFDI--ECGMMKRIRHRN 565
           R+    +IG+G +G V        G +VAIK  N  +     +  I  E  +++ +RH +
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60

Query: 566 LIK---IISSCSNDDFKAL--VLEYMP--LGSLEKC---LYSGNYILDIFQGLNIMIDVA 615
           +++   I+   S  +FK +  V E M   L  + K    L   ++   ++Q L       
Sbjct: 61  IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLR------ 114

Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP-LLEEDQSLTQTQTLATI 674
            AL+Y+H   +  + H DLKP N+L + +    + DFG+A+    +   ++  T  +AT 
Sbjct: 115 -ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 675 GYMAPD 680
            Y AP+
Sbjct: 171 WYRAPE 176

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 43.1 bits (102), Expect = 3e-04
 Identities = 43/150 (28%), Positives = 68/150 (45%), Gaps = 24/150 (16%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISS 572
           +G G +  VYK      G  VA+K   L++  G  F +   E  ++K ++H N++ +   
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLHDI 71

Query: 573 CSNDDFKALVLEYM--PLGS-LEKC---LYSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
                   LV EY+   L   ++ C   L   N  L +FQ L         L Y H    
Sbjct: 72  IHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLR-------GLAYCHQRR- 123

Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAK 656
             ++H DLKP N+L+ +     L+DFG+A+
Sbjct: 124 --VLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 38.7 bits (91), Expect = 4e-04
 Identities = 20/54 (37%), Positives = 25/54 (46%), Gaps = 1/54 (1%)

Query: 259 LDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPS-TLWNLKDILHLNLSSN 311
           LDL  N+L+         L NL+ L L  N LTSI       L  +  L+LS N
Sbjct: 5   LDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGN 58

Length = 60

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 43.1 bits (101), Expect = 4e-04
 Identities = 50/180 (27%), Positives = 83/180 (46%), Gaps = 28/180 (15%)

Query: 520 IGRGGFGPVYK------DGMEVAIKVFNLQYG--GAFKSFDIECGMMKRIR---HRNLIK 568
           IG G +G V+K       G  VA+K   +Q G  G   S   E  +++ +    H N+++
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 569 IISSC--SNDDFKA---LVLEYMP---LGSLEKCLYSGNYILDIFQGLNIMIDVASALEY 620
           +   C  S  D +    LV E++       L+K    G     I    ++M  +   L++
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI---KDMMFQLLRGLDF 125

Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S  ++H DLKP N+L+  +    L+DFG+A+  +   Q    T  + T+ Y AP+
Sbjct: 126 LH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR--IYSFQMAL-TSVVVTLWYRAPE 179

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 43.1 bits (101), Expect = 4e-04
 Identities = 23/70 (32%), Positives = 38/70 (54%), Gaps = 3/70 (4%)

Query: 614 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 673
           VA  +E+L    S   IH DL   N+LL +N V  + DFG+A+ + ++   + +      
Sbjct: 183 VARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239

Query: 674 IGYMAPDEIF 683
           + +MAP+ IF
Sbjct: 240 LKWMAPESIF 249

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 42.5 bits (100), Expect = 5e-04
 Identities = 35/134 (26%), Positives = 60/134 (44%), Gaps = 15/134 (11%)

Query: 520 IGRGGFGPVYK-------DG-----MEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLI 567
           +G+G F  ++K       D       EV +KV +  +    +SF     MM ++ H++L+
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 568 KIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
                C   D   +V EY+  GSL+  L     +++I   L +   +A AL +L      
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DK 119

Query: 628 PIIHCDLKPSNVLL 641
            + H ++   NVLL
Sbjct: 120 GLTHGNVCAKNVLL 133

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 42.3 bits (99), Expect = 5e-04
 Identities = 44/156 (28%), Positives = 70/156 (44%), Gaps = 15/156 (9%)

Query: 519 LIGRGGFGPVYK-----DG----MEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIK 568
           ++G G FG VYK     DG    + VAIKV        A K    E  +M  +    + +
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVP 628
           ++  C     + LV + MP G L   +      +     LN  + +A  + YL     V 
Sbjct: 74  LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVR 129

Query: 629 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS 664
           ++H DL   NVL+       ++DFG+A+ LL+ D++
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLAR-LLDIDET 164

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional

 Score = 43.1 bits (101), Expect = 5e-04
 Identities = 57/203 (28%), Positives = 87/203 (42%), Gaps = 40/203 (19%)

Query: 225 NNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLY 284
           NN T L L++L L    +   IP+ +  L       L  N+L        GN+   + LY
Sbjct: 178 NNKTELRLKILGL--TTIPACIPEQITTLI------LDNNELKSLPENLQGNI---KTLY 226

Query: 285 LGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTK 344
             SN LTSIP+TL +   I  + LS N  T  LP ++   + L  LDL  N  SC+    
Sbjct: 227 ANSNQLTSIPATLPD--TIQEMELSINRIT-ELPERLP--SALQSLDLFHNKISCLPENL 281

Query: 345 IGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLS---GTIPISLEKLL---- 397
              L+ L         L   +P+ I        LN+ +N+L+    T+P  L+ L     
Sbjct: 282 PEELRYLSVYDNSIRTLPAHLPSGITH------LNVQSNSLTALPETLPPGLKTLEAGEN 335

Query: 398 -----------DLKDINVSFNRL 409
                      +L+ ++VS N++
Sbjct: 336 ALTSLPASLPPELQVLDVSKNQI 358

Length = 754

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 40.9 bits (96), Expect = 6e-04
 Identities = 29/141 (20%), Positives = 64/141 (45%), Gaps = 17/141 (12%)

Query: 519 LIGRGGFGPVYK---DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLI--KIISSC 573
           L+  G    VY       +  +K+   +  GA +  ++   +++ +  + L   K+++S 
Sbjct: 5   LLKGGLTNRVYLLGTKDEDYVLKINPSREKGADREREVA--ILQLLARKGLPVPKVLASG 62

Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH-FGYSVPIIHC 632
            +D +  L++E++   +L++        +   +  +I   +A  L  LH     V + H 
Sbjct: 63  ESDGWSYLLMEWIEGETLDE--------VSEEEKEDIAEQLAELLAKLHQLPLLV-LCHG 113

Query: 633 DLKPSNVLLDDNMVAHLSDFG 653
           DL P N+L+DD  +  + D+ 
Sbjct: 114 DLHPGNILVDDGKILGIIDWE 134

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 42.5 bits (100), Expect = 6e-04
 Identities = 51/182 (28%), Positives = 82/182 (45%), Gaps = 33/182 (18%)

Query: 519 LIGRGGFGPVY---KDGME--VAIKVFNLQYGGAFKSFDIECGMM-KRI-----RHRNLI 567
           ++G+G FG V    + G +   AIK+  L+     +  D+EC M+ KR+     +   L 
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKI--LKKDVIIQDDDVECTMVEKRVLALPGKPPFLT 64

Query: 568 KIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIF------QGLNIMIDVASALEYL 621
           ++ S     D    V+EY+  G L        Y +           +    ++A  L +L
Sbjct: 65  QLHSCFQTMDRLYFVMEYVNGGDLM-------YHIQQVGKFKEPHAVFYAAEIAIGLFFL 117

Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL-ATIGYMAPD 680
           H   S  II+ DLK  NV+LD      ++DFGM K  +   ++   T+T   T  Y+AP+
Sbjct: 118 H---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGTPDYIAPE 171

Query: 681 EI 682
            I
Sbjct: 172 II 173

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 42.6 bits (100), Expect = 6e-04
 Identities = 27/104 (25%), Positives = 48/104 (46%), Gaps = 4/104 (3%)

Query: 553 IECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMI 612
           IE  +++ + H ++I++  +  +     +VL +     L   L   +  L I Q L I  
Sbjct: 106 IEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEK 164

Query: 613 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK 656
            +   L YLH   +  IIH D+K  N+ ++D     + D G A+
Sbjct: 165 QILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205

Length = 357

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 42.3 bits (99), Expect = 6e-04
 Identities = 40/186 (21%), Positives = 77/186 (41%), Gaps = 23/186 (12%)

Query: 520 IGRGGFGPVY--------KDGMEVAIKVFNLQYGGAFKS---FDIECGMMKRIRHRNLIK 568
           +G+G FG VY        K   E  + V  +    + +    F  E  +MK     ++++
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCLYS---------GNYILDIFQGLNIMIDVASALE 619
           ++   S      +V+E M  G L+  L S         G     + + + +  ++A  + 
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 620 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
           YL+   +   +H DL   N ++  +    + DFGM + + E D      + L  + +MAP
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 680 DEIFSG 685
           + +  G
Sbjct: 191 ESLKDG 196

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 42.3 bits (99), Expect = 7e-04
 Identities = 21/70 (30%), Positives = 40/70 (57%), Gaps = 3/70 (4%)

Query: 614 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 673
           VA+ +E+L    S   +H DL   NVL+ +  +  + DFG+A+ ++ +   +++  T   
Sbjct: 248 VANGMEFLA---SKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304

Query: 674 IGYMAPDEIF 683
           + +MAP+ IF
Sbjct: 305 LKWMAPESIF 314

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 41.6 bits (98), Expect = 0.001
 Identities = 52/199 (26%), Positives = 85/199 (42%), Gaps = 45/199 (22%)

Query: 508 FQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGG------AFKSFDIECG 556
           F    R+     IG G  G V        G  VAIK  +  +        A++       
Sbjct: 12  FTVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELV---- 67

Query: 557 MMKRIRHRNLIKIIS----SCSNDDFKA--LVLEYMPLGSLEKCLYSGNYILD------- 603
           +MK + H+N+I +++      S ++F+   LV+E M   +L + +      LD       
Sbjct: 68  LMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVI---QMDLDHERMSYL 123

Query: 604 IFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ 663
           ++Q L         +++LH   S  IIH DLKPSN+++  +    + DFG+A+       
Sbjct: 124 LYQML-------CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGT 170

Query: 664 SLTQTQTLATIGYMAPDEI 682
           S   T  + T  Y AP+ I
Sbjct: 171 SFMMTPYVVTRYYRAPEVI 189

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 41.5 bits (98), Expect = 0.001
 Identities = 43/156 (27%), Positives = 68/156 (43%), Gaps = 26/156 (16%)

Query: 519 LIGRGGFGPVY-----KDGMEVAIKV---FNLQYGGAFKSFDIECGMMKRIRHRNLIKII 570
           L+G+G  G V+       G   A+KV     +      K    E  ++  + H  L  + 
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLY 67

Query: 571 SSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVAS--------ALEYLH 622
           +S   + +  LV++Y P G L         +L    G  +  +VA         ALEYLH
Sbjct: 68  ASFQTETYLCLVMDYCPGGEL-------FRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120

Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL 658
               + I++ DLKP N+LL ++    LSDF ++K  
Sbjct: 121 ---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQS 153

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 41.6 bits (97), Expect = 0.001
 Identities = 40/170 (23%), Positives = 79/170 (46%), Gaps = 12/170 (7%)

Query: 519 LIGRGGFGPVYKDGMEVAIKVFNLQYGGAFK--------SFDIECGMMKRIRHRNLIKII 570
           +IGRG FG V    ++ A KVF ++    ++         F  E  ++    ++ +  + 
Sbjct: 8   VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67

Query: 571 SSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPII 630
            +  +++   LV++Y   G L   L      L        + ++  A++ +H    +  +
Sbjct: 68  YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYV 124

Query: 631 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           H D+KP N+L+D N    L+DFG    L+ ED ++  +  + T  Y++P+
Sbjct: 125 HRDIKPDNILMDMNGHIRLADFGSCLKLM-EDGTVQSSVAVGTPDYISPE 173

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 41.3 bits (97), Expect = 0.001
 Identities = 26/66 (39%), Positives = 34/66 (51%), Gaps = 3/66 (4%)

Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           L+F +   II+ DLK  NVLLD      L+D+GM K  +      T +    T  Y+AP 
Sbjct: 109 LNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTSTFCGTPNYIAP- 165

Query: 681 EIFSGE 686
           EI  GE
Sbjct: 166 EILRGE 171

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 41.6 bits (97), Expect = 0.001
 Identities = 49/189 (25%), Positives = 87/189 (46%), Gaps = 23/189 (12%)

Query: 508 FQATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFN--LQYGGAFKSFDIECGMMKR 560
           F    R+ +   IG G  G V        G+ VA+K  +   Q     K    E  ++K 
Sbjct: 17  FTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKC 76

Query: 561 IRHRNLIKIIS----SCSNDDFKA--LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDV 614
           + H+N+I +++      S ++F+   LV+E M   +L + ++     LD  +   ++  +
Sbjct: 77  VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHME---LDHERMSYLLYQM 132

Query: 615 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI 674
              +++LH   S  IIH DLKPSN+++  +    + DFG+A+       +   T  + T 
Sbjct: 133 LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTR 186

Query: 675 GYMAPDEIF 683
            Y AP+ I 
Sbjct: 187 YYRAPEVIL 195

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 44/169 (26%), Positives = 80/169 (47%), Gaps = 14/169 (8%)

Query: 520 IGRGGFGPV-----YKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           IG G  G V        G +VA+K+ +L+     +    E  +M+  +H+N++++  S  
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDL 634
             +   +++E++  G+L   +      L+  Q   +   V  AL YLH   S  +IH D+
Sbjct: 89  VGEELWVLMEFLQGGALTDIV--SQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDI 143

Query: 635 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGY-MAPDEI 682
           K  ++LL  +    LSDFG    +    + + + ++L    Y MAP+ I
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSLVGTPYWMAPEVI 189

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.1 bits (87), Expect = 0.002
 Identities = 24/60 (40%), Positives = 29/60 (48%), Gaps = 2/60 (3%)

Query: 232 LQLLSLEGNQLEGSIPDDLCR-LAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLL 290
           L+ L L  N+L   IPD   + L  L  LDL GN L+   P     L +LR L L  N L
Sbjct: 2   LKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 36.8 bits (86), Expect = 0.002
 Identities = 25/83 (30%), Positives = 30/83 (36%), Gaps = 23/83 (27%)

Query: 279 NLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFS 338
           NL+ L L +N LT IP                             L  L  LDLS NN +
Sbjct: 1   NLKSLDLSNNRLTVIPDGA-----------------------FKGLPNLKVLDLSGNNLT 37

Query: 339 CVIPTKIGGLKDLQYLFLEYNRL 361
            + P    GL  L+ L L  N L
Sbjct: 38  SISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 40.9 bits (96), Expect = 0.002
 Identities = 26/80 (32%), Positives = 38/80 (47%), Gaps = 16/80 (20%)

Query: 617 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL-------------EEDQ 663
           ALEYLH   +  I+H DLKP N+L+       L+DFG++K  L             ++ +
Sbjct: 113 ALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169

Query: 664 SLTQTQTLATIGYMAPDEIF 683
                Q   T  Y+AP+ I 
Sbjct: 170 EFLDKQVCGTPEYIAPEVIL 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 40.9 bits (96), Expect = 0.002
 Identities = 38/133 (28%), Positives = 60/133 (45%), Gaps = 18/133 (13%)

Query: 554 ECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSL----EKC-LYSGNYILDIFQGL 608
           E  +++  RH  L  +  S    D    V+EY   G L     +  ++S +     F G 
Sbjct: 45  ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR--FYGA 102

Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
            I+    SAL YLH   S  +++ DLK  N++LD +    ++DFG+ K   E        
Sbjct: 103 EIV----SALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATM 152

Query: 669 QTL-ATIGYMAPD 680
           +T   T  Y+AP+
Sbjct: 153 KTFCGTPEYLAPE 165

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 41.1 bits (96), Expect = 0.002
 Identities = 32/90 (35%), Positives = 45/90 (50%), Gaps = 10/90 (11%)

Query: 617 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL-ATIG 675
           ALE LH      +I+ DLKP N+LLD      L DFG+ K  +++D    +T T   T  
Sbjct: 105 ALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD---KTNTFCGTPE 158

Query: 676 YMAPDEIFSGEMRLKC--WVNDSLLISVMI 703
           Y+AP E+  G    K   W    +L+  M+
Sbjct: 159 YLAP-ELLLGHGYTKAVDWWTLGVLLYEML 187

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 43/168 (25%), Positives = 77/168 (45%), Gaps = 12/168 (7%)

Query: 520 IGRGGFG-----PVYKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           IG G  G      V   G  VA+K  +L+     +    E  +M+  +H N++++ +S  
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDL 634
             D   +V+E++  G+L   +      ++  Q   + + V  AL  LH   +  +IH D+
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIAAVCLAVLKALSVLH---AQGVIHRDI 142

Query: 635 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
           K  ++LL  +    LSDFG    + +E     +   + T  +MAP+ I
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPELI 188

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 41.0 bits (96), Expect = 0.002
 Identities = 38/117 (32%), Positives = 54/117 (46%), Gaps = 17/117 (14%)

Query: 554 ECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKC-LYSGNYI-----LDIFQG 607
           E  ++K I HR +I +I +      K+ V   MP     KC L++  Y+     L + Q 
Sbjct: 136 EIDILKTISHRAIINLIHAYRW---KSTVCMVMPK---YKCDLFT--YVDRSGPLPLEQA 187

Query: 608 LNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS 664
           + I   +  AL YLH      IIH D+K  N+ LD+   A L DFG A  L     +
Sbjct: 188 ITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241

Length = 392

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 40.6 bits (95), Expect = 0.003
 Identities = 23/82 (28%), Positives = 38/82 (46%), Gaps = 3/82 (3%)

Query: 602 LDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE 661
           LD    L+    VA  + +L    S   IH DL   N+LL    +  + DFG+A+ +  +
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRND 267

Query: 662 DQSLTQTQTLATIGYMAPDEIF 683
              + +      + +MAP+ IF
Sbjct: 268 SNYVVKGNARLPVKWMAPESIF 289

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 40.1 bits (94), Expect = 0.003
 Identities = 32/136 (23%), Positives = 60/136 (44%), Gaps = 12/136 (8%)

Query: 534 EVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEK 593
            V +KV          +F     +M ++ H++L+K+   C  D+   +V EY+  G L+ 
Sbjct: 32  SVVLKVLG-SDHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDV 89

Query: 594 CLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL---DDNM----V 646
            L+     + +   L++   +ASAL YL       ++H ++   N+L+     N      
Sbjct: 90  FLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPF 146

Query: 647 AHLSDFGMAKPLLEED 662
             LSD G+   +L  +
Sbjct: 147 IKLSDPGIPITVLSRE 162

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 40.3 bits (94), Expect = 0.003
 Identities = 47/178 (26%), Positives = 78/178 (43%), Gaps = 20/178 (11%)

Query: 519 LIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMM-KRI-----RHRNLI 567
           ++G+G FG V        G   A+K   L+        D+EC M+ KR+      +  L 
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKA--LKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59

Query: 568 KIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
            +  +    +    V+E++  G L   +       D+++      ++   L++LH   S 
Sbjct: 60  HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR-FDLYRATFYAAEIVCGLQFLH---SK 115

Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG 685
            II+ DLK  NV+LD +    ++DFGM K  +  D     +    T  Y+AP EI  G
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIAP-EILQG 170

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 40.0 bits (93), Expect = 0.003
 Identities = 30/74 (40%), Positives = 38/74 (51%), Gaps = 6/74 (8%)

Query: 613 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA 672
           +++ AL YLH      II+ DLK  NVLLD      L+D+GM K  L      T +    
Sbjct: 104 EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCG 158

Query: 673 TIGYMAPDEIFSGE 686
           T  Y+AP EI  GE
Sbjct: 159 TPNYIAP-EILRGE 171

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 40.0 bits (93), Expect = 0.004
 Identities = 46/173 (26%), Positives = 73/173 (42%), Gaps = 20/173 (11%)

Query: 519 LIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFD---IECGMMKRIRHRNLIKII 570
           L+G+G FG V        G   A+K+   +   A         E  +++  RH  L  + 
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61

Query: 571 SSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEYLHFGYSV 627
            +    D    V+EY   G L   L       +    F G  I+    SALEYLH   S 
Sbjct: 62  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIV----SALEYLH---SR 114

Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
            +++ D+K  N++LD +    ++DFG+ K  + +    T      T  Y+AP+
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPE 165

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 39.9 bits (94), Expect = 0.004
 Identities = 47/182 (25%), Positives = 78/182 (42%), Gaps = 41/182 (22%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFD-------IECGMMKRIR-HRNL 566
           IG G F  V K      G   AIK         FKS +       I+   ++R+  H N+
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKH----FKSLEQVNNLREIQA--LRRLSPHPNI 60

Query: 567 IKIISSCSNDDFK--ALVLEYMPLGSLEKCLYSGNYILDIFQGL------NIMIDVASAL 618
           +++I    +      ALV E M     +  LY    I    + L      + M  +  +L
Sbjct: 61  LRLIEVLFDRKTGRLALVFELM-----DMNLY--ELIKGRKRPLPEKRVKSYMYQLLKSL 113

Query: 619 EYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 678
           +++H      I H D+KP N+L+ D+++  L+DFG  + +         T+ ++T  Y A
Sbjct: 114 DHMH---RNGIFHRDIKPENILIKDDIL-KLADFGSCRGI---YSKPPYTEYISTRWYRA 166

Query: 679 PD 680
           P+
Sbjct: 167 PE 168

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 39.5 bits (93), Expect = 0.004
 Identities = 30/101 (29%), Positives = 45/101 (44%), Gaps = 7/101 (6%)

Query: 557 MMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVAS 616
           +MK   + N IK+  S +      L+++Y+  G L   L      L   +   I+  +  
Sbjct: 64  LMKD--NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGK-LSEAEVKKIIRQLVE 120

Query: 617 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMV-AHLSDFGMAK 656
           AL  LH      IIH D+K  NVL D      +L D+G+ K
Sbjct: 121 ALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK 158

Length = 267

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	797
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	100.0
KOG0472	565	consensus Leucine-rich repeat protein [Function un	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.98
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.98
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.98
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.98
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.98
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.98
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.98
PTZ00283	496	serine/threonine protein kinase; Provisional	99.98
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.98
PHA03212	391	serine/threonine kinase US3; Provisional	99.98
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.98
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.98
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.98
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.98
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.98
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.98
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.98
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.98
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.98
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.98
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.98
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.98
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.98
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.98
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.98
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.98
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.98
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.98
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.98
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.98
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.98
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.98
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.98
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.98
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.98
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.98
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.98
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.98
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.97
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.97
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.97
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.97
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.97
PHA03211	461	serine/threonine kinase US3; Provisional	99.97
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.97
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.97
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.97
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.97
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.97
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.97
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.97
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.97
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.97
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.97
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.97
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.97
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.97
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.97
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.97
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.97
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.97
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.97
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.97
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.97
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.97
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.97
PHA03209	357	serine/threonine kinase US3; Provisional	99.97
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.97
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.97
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.97
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.97
PHA03207	392	serine/threonine kinase US3; Provisional	99.97
PTZ00036	440	glycogen synthase kinase; Provisional	99.97
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.97
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.97
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.97
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.97
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.97
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.97
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.97
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.97
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.97
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.97
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.97
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.97
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.97
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.97
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.97
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.97
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.97
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.97
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.97
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.97
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.97
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.97
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.97
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.97
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.97
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.97
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.97
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.97
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.97
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.97
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.97
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.97
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.97
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.97
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.97
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.97
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.97
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.97
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.97
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.97
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.97
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.97
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.97
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.97
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.97
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.97
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.97
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.97
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.97
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.97
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.97
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.97
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.97
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.97
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.97
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.97
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.97
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.97
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.97
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.97
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.97
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.97
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.97
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.97
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.97
PTZ00284	467	protein kinase; Provisional	99.97
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.97
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.97
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.97
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.97
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.97
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.97
KOG0586	596	consensus Serine/threonine protein kinase [General	99.97
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.97
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.97
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.97
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.97
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.97
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.97
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.97
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.97
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.97
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.97
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.97
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.97
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.97
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.97
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.97
KOG0584	632	consensus Serine/threonine protein kinase [General	99.97
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.97
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.97
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.97
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.97
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.97
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.97
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.96
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.96
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.96
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.96
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.96
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.96
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.96
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.96
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.96
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.96
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.96
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.96
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.96
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.96
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.96
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.96
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.96
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.96
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.96
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.96
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.96
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.96
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.96
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.96
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.96
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.96
PHA03210	501	serine/threonine kinase US3; Provisional	99.96
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.96
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.96
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.96
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.96
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.96
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.96
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.96
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.96
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.96
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.96
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.96
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.96
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.96
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.96
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.96
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	99.96
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.96
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.96
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.96
PLN00009	294	cyclin-dependent kinase A; Provisional	99.96
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.96
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.96
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.96
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.96
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.96
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.96
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.96
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.96
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.96
PHA02882	294	putative serine/threonine kinase; Provisional	99.96
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.96
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.96
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.96
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.96
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.96
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.96
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.96
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.96
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.96
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.95
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.95
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.95
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.95
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.95
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.95
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.95
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.95
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.95
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.95
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.95
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.95
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.95
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.95
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.95
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.95
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.95
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.95
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.95
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.95
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.95
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.95
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.95
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.95
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.95
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.95
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.94
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.94
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.93
KOG4237	498	consensus Extracellular matrix protein slit, conta	99.93
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.93
KOG1152	772	consensus Signal transduction serine/threonine kin	99.93
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.93
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.93
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.92
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.92
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.92
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	99.92
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.92
PLN03210	1153	Resistant to P. syringae 6; Provisional	99.91
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.9
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.9
PRK09188	365	serine/threonine protein kinase; Provisional	99.89
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.88
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.87
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.87
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.87
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	99.87
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.86
PLN00181	793	protein SPA1-RELATED; Provisional	99.85
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.84
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.82
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.81
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.81
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.79
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.79
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.79
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.78
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.78
PRK10345	210	hypothetical protein; Provisional	99.77
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.77
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.76
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.76
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.75
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	99.75
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.73
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.73
PRK14879	211	serine/threonine protein kinase; Provisional	99.69
PRK12274	218	serine/threonine protein kinase; Provisional	99.69
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.69
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.68
smart00090	237	RIO RIO-like kinase.	99.68
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.65
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.62
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.6
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.6
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.59
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.56
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.55
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.55
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.54
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.52
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.51
PLN03150	623	hypothetical protein; Provisional	99.5
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	99.48
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.48
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.42
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.4
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	99.4
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.36
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.32
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.28
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	99.28
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.26
PLN03150	623	hypothetical protein; Provisional	99.25
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.24
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.21
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	99.19
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.17
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	99.17
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.15
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.13
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.11
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.08
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	99.06
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.04
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	99.02
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.98
KOG3087	229	consensus Serine/threonine protein kinase [General	98.98
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.97
KOG1909	382	consensus Ran GTPase-activating protein [RNA proce	98.97
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.96
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.94
KOG1243	690	consensus Protein kinase [General function predict	98.85
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.8
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.74
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.72
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.71
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.69
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.68
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.65
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.47
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.46
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.4
PRK09902	216	hypothetical protein; Provisional	98.39
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.38
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.37
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.32
KOG2982	418	consensus Uncharacterized conserved protein [Funct	98.32

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=6.6e-87  Score=820.40  Aligned_cols=721  Identities=28%  Similarity=0.442  Sum_probs=519.4

Q ss_pred             CCCCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCcc----------------ccCCCccccCCCCCCEEEcccCcc
Q 040702            2 PSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFI----------------LCEIPHEIDNLHNMEWMAFSFNKV   65 (797)
Q Consensus         2 ~~l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~----------------l~~ip~~~~~l~~L~~L~ls~N~i   65 (797)
                      +||++|.+.+.+|..++++++|++|||++|.+.+.+|..+                ...+|..++.+++|++|++++|++
T Consensus       145 L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l  224 (968)
T PLN00113        145 LDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNL  224 (968)
T ss_pred             EECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCcc
Confidence            4677777777777777777777777777777766666542                124567777778888888888888


Q ss_pred             cccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCcc
Q 040702           66 VGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNT  145 (797)
Q Consensus        66 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  145 (797)
                      .+.+|..|+++++|++|+|++|.+++.+|.. +..+++|++|+|++|++++..|..+.++++|++|+|++|++.+..|..
T Consensus       225 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~-l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~  303 (968)
T PLN00113        225 SGEIPYEIGGLTSLNHLDLVYNNLTGPIPSS-LGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPEL  303 (968)
T ss_pred             CCcCChhHhcCCCCCEEECcCceeccccChh-HhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChh
Confidence            7777877888888888888888877666654 357777888888877777777777777777777777777777777777


Q ss_pred             ccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhh
Q 040702          146 FGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEIN  225 (797)
Q Consensus       146 f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~  225 (797)
                      |.++++|++|++++|.++...+.     .+.++++|+.|++++|++.+..|..++.++ +|+.|++++|++.+.+|..++
T Consensus       304 ~~~l~~L~~L~l~~n~~~~~~~~-----~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~-~L~~L~Ls~n~l~~~~p~~~~  377 (968)
T PLN00113        304 VIQLQNLEILHLFSNNFTGKIPV-----ALTSLPRLQVLQLWSNKFSGEIPKNLGKHN-NLTVLDLSTNNLTGEIPEGLC  377 (968)
T ss_pred             HcCCCCCcEEECCCCccCCcCCh-----hHhcCCCCCEEECcCCCCcCcCChHHhCCC-CCcEEECCCCeeEeeCChhHh
Confidence            77777777777777777655443     255566666666666666666666666554 566666666666555555554


Q ss_pred             hhhhh----------------------HhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCcccccc
Q 040702          226 NLTNL----------------------ILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKL  283 (797)
Q Consensus       226 ~l~~L----------------------~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  283 (797)
                      .+++|                      .|+.|++++|++++..|..|..+++|+.|++++|.+++..|..+..+++|+.|
T Consensus       378 ~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  457 (968)
T PLN00113        378 SSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQML  457 (968)
T ss_pred             CcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEE
Confidence            44443                      00555555555555555555555555555555555555555555556666666


Q ss_pred             ccCCCCCC-CCCCCCCCCCcccEEEccCCcCCCCCCccccccccccEEeccCcccccccCccccCCcccceecccCcccc
Q 040702          284 YLGSNLLT-SIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQ  362 (797)
Q Consensus       284 ~L~~N~l~-~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  362 (797)
                      ++++|.+. .+|. ....++|+.|++++|++++..|..|.++++|+.|++++|++.+.+|..+.++++|++|+|++|.++
T Consensus       458 ~L~~n~~~~~~p~-~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  536 (968)
T PLN00113        458 SLARNKFFGGLPD-SFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLS  536 (968)
T ss_pred             ECcCceeeeecCc-ccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCccc
Confidence            66666663 3333 334577888888888888888888999999999999999999999999999999999999999999


Q ss_pred             CCCChhhhccccCCeeeecCCcCCCCCChhhhccCCCCeEEccCCcCcccCCCCCCCCCCCcccccCCccccCCCCc-cc
Q 040702          363 GSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMPNL-QV  441 (797)
Q Consensus       363 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~~~~~~n~~~c~~~~~-~~  441 (797)
                      +.+|..|..+++|+.|+|++|++++.+|..+.++++|+.|++++|++++.+|..+.+..+....+.||+.+|+.+.. ..
T Consensus       537 ~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~  616 (968)
T PLN00113        537 GQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGL  616 (968)
T ss_pred             ccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCC
Confidence            99999999999999999999999999999999999999999999999999999888888888899999999985432 22


Q ss_pred             ccccccccccccCCcceEEEeccchhhH-HHHHHHHHhhhhcCccccccccC--CCCc-------cccCccCHHHHHHHh
Q 040702          442 LSCRTKIHHTLGKNDLLIGIVLPLSTIF-MMVVVLLILKYRKGRKSQLKDVN--MPSV-------ADQRRFTYLELFQAT  511 (797)
Q Consensus       442 ~~~~~~~~~~~~~~~~~i~i~~~~~~~~-~~~~~~~~~~~r~~r~~~~~~~~--~~~~-------~~~~~~~~~~l~~~~  511 (797)
                      ..|....    .....++.+++++++++ +++++++++++|++++...+...  ....       ...+.++++++   .
T Consensus       617 ~~c~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~  689 (968)
T PLN00113        617 PPCKRVR----KTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDI---L  689 (968)
T ss_pred             CCCcccc----ccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHHH---H
Confidence            2353211    11112222222222222 22222222333322211111100  0000       01122344444   3


Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      ..|...+.||+|+||.||+|     +..||||+++....    ....|++.+++++|||||+++|+|.+++..|+||||+
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~  765 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI  765 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence            46778889999999999985     57899998864322    2235688999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccc
Q 040702          587 PLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  666 (797)
Q Consensus       587 ~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  666 (797)
                      ++|+|.++++.    ++|..+.+++.|+|+|++|||+.++++|+|||+||+||+++.++.+++. ||.+.....      
T Consensus       766 ~~g~L~~~l~~----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------  834 (968)
T PLN00113        766 EGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------  834 (968)
T ss_pred             CCCcHHHHHhc----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------
Confidence            99999999963    7899999999999999999997767899999999999999999888876 776653321      


Q ss_pred             ccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccch----------------------------------
Q 040702          667 QTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIR----------------------------------  712 (797)
Q Consensus       667 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~----------------------------------  712 (797)
                      .....||+.|||||.+.+..++.++|||++|+..++.+.+..++..                                  
T Consensus       835 ~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  914 (968)
T PLN00113        835 DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS  914 (968)
T ss_pred             CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCC
Confidence            1223689999999999999999999999999987665544333210                                  


Q ss_pred             hhhhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          713 EEKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       713 ~~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                      .+.+....+.+++..|++.||++||+|.|+++.++.+.+.
T Consensus       915 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  954 (968)
T PLN00113        915 VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS  954 (968)
T ss_pred             ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence            0001122344677789999999999999999999877553

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.6e-50  Score=497.78  Aligned_cols=425  Identities=36%  Similarity=0.544  Sum_probs=362.9

Q ss_pred             CCCCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCcc----------------ccCCCccccCCCCCCEEEcccCcc
Q 040702            2 PSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFI----------------LCEIPHEIDNLHNMEWMAFSFNKV   65 (797)
Q Consensus         2 ~~l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~----------------l~~ip~~~~~l~~L~~L~ls~N~i   65 (797)
                      +||++|.+.|.+|.  +.+++|++|||++|.+++.+|..+                ...+|..++++++|++|++++|++
T Consensus       123 L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l  200 (968)
T PLN00113        123 LNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQL  200 (968)
T ss_pred             EECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCC
Confidence            68999999999884  679999999999999998888643                246788899999999999999999


Q ss_pred             cccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCcc
Q 040702           66 VGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNT  145 (797)
Q Consensus        66 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~  145 (797)
                      .+..|..|+++++|+.|+|++|++++.+|..+ ..+++|++|+|++|++++..|..|.++++|++|+|++|++.+..|..
T Consensus       201 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l-~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~  279 (968)
T PLN00113        201 VGQIPRELGQMKSLKWIYLGYNNLSGEIPYEI-GGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPS  279 (968)
T ss_pred             cCcCChHHcCcCCccEEECcCCccCCcCChhH-hcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchh
Confidence            99999999999999999999999997788765 58999999999999999999999999999999999999999999999


Q ss_pred             ccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhh
Q 040702          146 FGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEIN  225 (797)
Q Consensus       146 f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~  225 (797)
                      |.++++|++|+|++|.++...+.     .+.++++|+.|++++|.+.+..|..+..++ +|+.|++++|.+.+.+|..++
T Consensus       280 l~~l~~L~~L~Ls~n~l~~~~p~-----~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~-~L~~L~L~~n~l~~~~p~~l~  353 (968)
T PLN00113        280 IFSLQKLISLDLSDNSLSGEIPE-----LVIQLQNLEILHLFSNNFTGKIPVALTSLP-RLQVLQLWSNKFSGEIPKNLG  353 (968)
T ss_pred             HhhccCcCEEECcCCeeccCCCh-----hHcCCCCCcEEECCCCccCCcCChhHhcCC-CCCEEECcCCCCcCcCChHHh
Confidence            99999999999999999876654     378899999999999999999999999998 899999999999999999999


Q ss_pred             hhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCC-CCCCCCCCC----
Q 040702          226 NLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLT-SIPSTLWNL----  300 (797)
Q Consensus       226 ~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l----  300 (797)
                      .+++|  +.|++++|++.+..|..++.+++|+.|++++|.+.+..|..+..+++|+.|++++|.++ .+|..+..+    
T Consensus       354 ~~~~L--~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~  431 (968)
T PLN00113        354 KHNNL--TVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVY  431 (968)
T ss_pred             CCCCC--cEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCC
Confidence            99998  99999999998888887777777777777776666666666666666666666666552 344444444    


Q ss_pred             --------------------CcccEEEccCCcCCCCCCccccccccccEEeccCcccccccCccccCCcccceecccCcc
Q 040702          301 --------------------KDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNR  360 (797)
Q Consensus       301 --------------------~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  360 (797)
                                          ++|+.|++++|.+.+..|..+ ..++|+.|++++|++++..|..|.++++|+.|+|++|+
T Consensus       432 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~  510 (968)
T PLN00113        432 FLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENK  510 (968)
T ss_pred             EEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCc
Confidence                                455555555555544444433 23567778888888888888888899999999999999


Q ss_pred             ccCCCChhhhccccCCeeeecCCcCCCCCChhhhccCCCCeEEccCCcCcccCCCC-CCCCCCCcccccCCccccCCCC
Q 040702          361 LQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPRE-GPFRNLSAESFKGNELLCGMPN  438 (797)
Q Consensus       361 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~l~~~~~~~n~~~c~~~~  438 (797)
                      +.+.+|..+..+++|++|+|++|.+++.+|..|..+++|+.|++++|++++.+|.. ..+..+..+++++|++.+..|.
T Consensus       511 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~  589 (968)
T PLN00113        511 LSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPS  589 (968)
T ss_pred             ceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCC
Confidence            99999999999999999999999999999999999999999999999999988874 5678899999999998876664

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-46  Score=390.53  Aligned_cols=362  Identities=23%  Similarity=0.264  Sum_probs=260.8

Q ss_pred             CCCCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCE
Q 040702            2 PSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKS   81 (797)
Q Consensus         2 ~~l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~   81 (797)
                      ||||||+|+.+.++.|.++++|+.++|.+|.         ++.||.......+|+.|+|.+|.|+++-.+++..++.|++
T Consensus        83 LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~---------Lt~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrs  153 (873)
T KOG4194|consen   83 LDLSNNKLSHIDFEFFYNLPNLQEVNLNKNE---------LTRIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRS  153 (873)
T ss_pred             eeccccccccCcHHHHhcCCcceeeeeccch---------hhhcccccccccceeEEeeeccccccccHHHHHhHhhhhh
Confidence            6777777777777777777777777777776         5566766666667777777777777777777777777777


Q ss_pred             EEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCcc
Q 040702           82 LYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNY  161 (797)
Q Consensus        82 L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~  161 (797)
                      ||||+|.|+ .+|...|..-.++++|+|++|.|+....+.|.++.+|..|.|++|+|+.+++.+|.+|++|+.|+|..|+
T Consensus       154 lDLSrN~is-~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~  232 (873)
T KOG4194|consen  154 LDLSRNLIS-EIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNR  232 (873)
T ss_pred             hhhhhchhh-cccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccc
Confidence            777777777 7777777666777777777777777777777777777777777777777777777777777777777777


Q ss_pred             CcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhccccccc
Q 040702          162 LTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQ  241 (797)
Q Consensus       162 l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~  241 (797)
                      |..+..-     .|.+|++|+.|.|..|.|.....++|..+. .++.|+|+.|+++.....++.+|+.|  +.|+||+|.
T Consensus       233 irive~l-----tFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~-kme~l~L~~N~l~~vn~g~lfgLt~L--~~L~lS~Na  304 (873)
T KOG4194|consen  233 IRIVEGL-----TFQGLPSLQNLKLQRNDISKLDDGAFYGLE-KMEHLNLETNRLQAVNEGWLFGLTSL--EQLDLSYNA  304 (873)
T ss_pred             eeeehhh-----hhcCchhhhhhhhhhcCcccccCcceeeec-ccceeecccchhhhhhcccccccchh--hhhccchhh
Confidence            7665321     477777777777777777777777777776 67777777777777777777777766  777777777


Q ss_pred             ccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCC-CCCCCCcccEEEccCCcCCCCCC--
Q 040702          242 LEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPS-TLWNLKDILHLNLSSNFFTGPLP--  318 (797)
Q Consensus       242 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~-~~~~l~~L~~L~l~~N~l~~~~~--  318 (797)
                      |..+.+++....++|++|||++|+|+...+..|..+..|++|.|++|.+..+.+ .|.++++|+.|||++|.++..+.  
T Consensus       305 I~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDa  384 (873)
T KOG4194|consen  305 IQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDA  384 (873)
T ss_pred             hheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecc
Confidence            777777766666777777777777777767777777777777777777766655 45566777777777777664433  


Q ss_pred             -ccccccccccEEeccCcccccccCccccCCcccceecccCccccCCCChhhhccccCCeeeecC
Q 040702          319 -LKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSN  382 (797)
Q Consensus       319 -~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~  382 (797)
                       ..|.++++|+.|++.+|+|..+...+|.++++|+.|||.+|.|..+.|.+|..+ .|+.|.++.
T Consensus       385 a~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nS  448 (873)
T KOG4194|consen  385 AVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNS  448 (873)
T ss_pred             hhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcc
Confidence             245666777777777777766666667777777777777777766666677666 666666543

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-45  Score=383.53  Aligned_cols=400  Identities=22%  Similarity=0.225  Sum_probs=354.4

Q ss_pred             CCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCC
Q 040702           23 LQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLP  102 (797)
Q Consensus        23 L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~  102 (797)
                      -..||.|.+.++-.-...+    +..+.  +.-+.||+|+|+++.+.+..|.++++|+.++|.+|.++ .||... ....
T Consensus        54 ~~lldcs~~~lea~~~~~l----~g~lp--~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~-~~sg  125 (873)
T KOG4194|consen   54 TRLLDCSDRELEAIDKSRL----KGFLP--SQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFG-HESG  125 (873)
T ss_pred             ceeeecCcccccccccccc----CCcCc--cceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hccccc-cccc
Confidence            4568999998654321111    11111  24567999999999999999999999999999999998 999865 2456


Q ss_pred             CccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCc
Q 040702          103 NLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLE  182 (797)
Q Consensus       103 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~  182 (797)
                      +|+.|+|.+|.|+.+-.+.+..++.|+.||||.|.|+.+.-..|..-.++++|+|++|.|+.+..+     .|.++.+|.
T Consensus       126 hl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~-----~F~~lnsL~  200 (873)
T KOG4194|consen  126 HLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETG-----HFDSLNSLL  200 (873)
T ss_pred             ceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccc-----cccccchhe
Confidence            699999999999988888999999999999999999999989999999999999999999999876     588888999


Q ss_pred             EEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEcc
Q 040702          183 YFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLG  262 (797)
Q Consensus       183 ~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  262 (797)
                      .|.|+.|+|+.+++..|..++ .|+.|+|..|.|...-.-+|.+|++|  +.|.|..|.+.....++|..+.++++|+|+
T Consensus       201 tlkLsrNrittLp~r~Fk~L~-~L~~LdLnrN~irive~ltFqgL~Sl--~nlklqrN~I~kL~DG~Fy~l~kme~l~L~  277 (873)
T KOG4194|consen  201 TLKLSRNRITTLPQRSFKRLP-KLESLDLNRNRIRIVEGLTFQGLPSL--QNLKLQRNDISKLDDGAFYGLEKMEHLNLE  277 (873)
T ss_pred             eeecccCcccccCHHHhhhcc-hhhhhhccccceeeehhhhhcCchhh--hhhhhhhcCcccccCcceeeecccceeecc
Confidence            999999999999999999998 89999999999997767889999998  999999999999999999999999999999


Q ss_pred             CCcCcccCCCCccCCccccccccCCCCCCCCC-CCCCCCCcccEEEccCCcCCCCCCccccccccccEEeccCccccccc
Q 040702          263 GNKLSGFVPACSGNLTNLRKLYLGSNLLTSIP-STLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVI  341 (797)
Q Consensus       263 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  341 (797)
                      .|+++.+....+-++++|+.|+||+|.|..|. +.....++|++|+|++|+|+...++.|..+..|++|+|++|++..+.
T Consensus       278 ~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~  357 (873)
T KOG4194|consen  278 TNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLA  357 (873)
T ss_pred             cchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHH
Confidence            99999998899999999999999999998874 45556789999999999999999999999999999999999999988


Q ss_pred             CccccCCcccceecccCccccCCCC---hhhhccccCCeeeecCCcCCCCCChhhhccCCCCeEEccCCcCcccCCCC-C
Q 040702          342 PTKIGGLKDLQYLFLEYNRLQGSIP---NSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPRE-G  417 (797)
Q Consensus       342 ~~~~~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~  417 (797)
                      ..+|.++.+|++|||++|.|...+.   ..|..|++|+.|+|.+|+|..+.-.+|.++..|+.|||.+|.+...-|.. .
T Consensus       358 e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe  437 (873)
T KOG4194|consen  358 EGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFE  437 (873)
T ss_pred             hhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccc
Confidence            9999999999999999999876543   46888999999999999999888889999999999999999998887765 3


Q ss_pred             CCCCCCcccccCCccccCCCCc
Q 040702          418 PFRNLSAESFKGNELLCGMPNL  439 (797)
Q Consensus       418 ~~~~l~~~~~~~n~~~c~~~~~  439 (797)
                      ++ .++.+.+....++|+|...
T Consensus       438 ~m-~Lk~Lv~nSssflCDCql~  458 (873)
T KOG4194|consen  438 PM-ELKELVMNSSSFLCDCQLK  458 (873)
T ss_pred             cc-hhhhhhhcccceEEeccHH
Confidence            44 7888888888899999743

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-43  Score=378.04  Aligned_cols=253  Identities=38%  Similarity=0.514  Sum_probs=211.8

Q ss_pred             ccCccCHHHHHHHhcCCCccccccccCCcceeec----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeee
Q 040702          498 DQRRFTYLELFQATNRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSC  573 (797)
Q Consensus       498 ~~~~~~~~~l~~~~~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~  573 (797)
                      ..+.|++.++..||++|.....||+|+||.||||    +..||||++........++|.+|++++.+++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            5678999999999999999999999999999986    478999987765432146699999999999999999999999


Q ss_pred             ecCC-eEEEEEEccCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEe
Q 040702          574 SNDD-FKALVLEYMPLGSLEKCLYSGNY-ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSD  651 (797)
Q Consensus       574 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  651 (797)
                      .+.+ ..++|+|||++|+|+++++.... .++|..+++||.++|+||+|||+.+.++|+||||||+|||+|+++++||+|
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD  220 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD  220 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence            9998 59999999999999999998776 799999999999999999999988888999999999999999999999999


Q ss_pred             ecCCccCCccCcccccccc-ccCcccccccccccCccchHHHHHHHhhhhh-----------------------------
Q 040702          652 FGMAKPLLEEDQSLTQTQT-LATIGYMAPDEIFSGEMRLKCWVNDSLLISV-----------------------------  701 (797)
Q Consensus       652 FGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~-----------------------------  701 (797)
                      ||+|+..+....  ..... .||.+|+|||.+..+..+.++||||+|+..+                             
T Consensus       221 FGLa~~~~~~~~--~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~  298 (361)
T KOG1187|consen  221 FGLAKLGPEGDT--SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE  298 (361)
T ss_pred             ccCcccCCcccc--ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence            999976543111  11112 7999999999999999999999999997432                             


Q ss_pred             ----hhhcccccc-chhhh-hhhcccccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          702 ----MIVVDANLL-IREEK-HLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       702 ----~~~~~~~~~-~~~~~-~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                          .+++|+.+. +.++. +.+..+..+..+|++.+|.+||+|.||++.++.+...
T Consensus       299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence                223344443 23332 3455566777779999999999999998888555433

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-42  Score=347.06  Aligned_cols=259  Identities=23%  Similarity=0.292  Sum_probs=209.4

Q ss_pred             HhcCCCccccccccCCcceee-----cceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk-----~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l  581 (797)
                      ..++|+..++||+|+||+||.     +++.||+|++++..   ....+....|..+|.+++||.||+++..|++++..|+
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            357899999999999999995     47899999998763   2345678899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCcc
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  661 (797)
                      |+||+.||.|..++...+. +++..+..++.+|+.||.|||   +++|||||+||+|||+|.+|+++|+|||+++.....
T Consensus       103 Vld~~~GGeLf~hL~~eg~-F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~  178 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQREGR-FSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD  178 (357)
T ss_pred             EEeccCCccHHHHHHhcCC-cchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence            9999999999999987664 899999999999999999999   999999999999999999999999999999965433


Q ss_pred             CccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhhhhhcccccchhccccCC-CCCCC-Ch
Q 040702          662 DQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEKHLMTKEQPMVRMGTDLS-LGQFP-AS  739 (797)
Q Consensus       662 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~d-p~~RP-s~  739 (797)
                      +.  .+.+++||+.|||||.+.+.+|+..+|+|++|+..++++.+.+++......      ++.+...... +...+ -.
T Consensus       179 ~~--~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~------~~~~~I~~~k~~~~p~~ls  250 (357)
T KOG0598|consen  179 GD--ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK------KMYDKILKGKLPLPPGYLS  250 (357)
T ss_pred             CC--ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH------HHHHHHhcCcCCCCCccCC
Confidence            32  456689999999999999999999999999999998887777665543322      1122211111 11111 11


Q ss_pred             HHHHHhHHH-HHHHhccccccccccCCcccccceeeeeeeeec
Q 040702          740 YSISKYLVY-IRELERGKVGITSVAAFPIVHHYLYRTVDYTIS  781 (797)
Q Consensus       740 ~~i~~~l~~-i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~  781 (797)
                      .+..+.++. +...++.|.| .+.++..+.+|+||++++|+--
T Consensus       251 ~~ardll~~LL~rdp~~RLg-~~~d~~~ik~HpfF~~inW~~l  292 (357)
T KOG0598|consen  251 EEARDLLKKLLKRDPRQRLG-GPGDAEEIKRHPFFKGINWEKL  292 (357)
T ss_pred             HHHHHHHHHHhccCHHHhcC-CCCChHHhhcCcccccCCHHHH
Confidence            333444444 4455667777 7778889999999999999843

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=9e-42  Score=342.95  Aligned_cols=226  Identities=21%  Similarity=0.252  Sum_probs=192.2

Q ss_pred             CCCccccccccCCcceee-----cceEEEEEEEEeccCC-cchhHHHHHHHhhhccCCceeEeeeeeecCC-eEEEEEEc
Q 040702          513 RFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCSNDD-FKALVLEY  585 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk-----~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~-~~~lv~e~  585 (797)
                      +.+..+.||+|..|+|||     +++.+|+|++....+. ..+++.+|+++++.++||+||++||+|+..+ ..+|+|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            445568899999999998     4789999999655433 3578999999999999999999999999998 59999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      |++|+|++++...+ .+++...-+|+.+|++||.|||+  .++||||||||+|||+...|++||||||.++.+...    
T Consensus       160 MDgGSLd~~~k~~g-~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----  232 (364)
T KOG0581|consen  160 MDGGSLDDILKRVG-RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----  232 (364)
T ss_pred             cCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----
Confidence            99999999998764 48999999999999999999993  389999999999999999999999999999976433    


Q ss_pred             cccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccch----------------------hhh-hhhcccc
Q 040702          666 TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIR----------------------EEK-HLMTKEQ  722 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~----------------------~~~-~~~~~~~  722 (797)
                      ...+++||..|||||.+.++.|+.++||||+|...++...+..+...                      .+. ...+.++
T Consensus       233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~  312 (364)
T KOG0581|consen  233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFR  312 (364)
T ss_pred             hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHH
Confidence            45678999999999999999999999999999887666555332222                      111 1334578


Q ss_pred             cchhccccCCCCCCCChHHHHHh
Q 040702          723 PMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       723 ~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                      .++..|+++||.+||+++|+++.
T Consensus       313 ~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  313 SFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             HHHHHHhcCCcccCCCHHHHhcC
Confidence            89999999999999999998864

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.3e-41  Score=356.46  Aligned_cols=228  Identities=22%  Similarity=0.324  Sum_probs=201.1

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEec---cCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQ---YGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      .+|...+.||+|||+.||++     |+.||+|++.+.   .....+.+.+|+++.+.++|||||+++++|++.+.+|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            57999999999999999974     689999999875   3345678999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      |+|+.|+|.++++. ++.+++.+++.+++||+.||.|||   +.+|+|||||-.|++++++.++||+|||+|..+..++ 
T Consensus        98 ELC~~~sL~el~Kr-rk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~-  172 (592)
T KOG0575|consen   98 ELCHRGSLMELLKR-RKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG-  172 (592)
T ss_pred             EecCCccHHHHHHh-cCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeecCcc-
Confidence            99999999999984 456999999999999999999999   9999999999999999999999999999999875432 


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh----------------hhhhcccccchhc
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE----------------KHLMTKEQPMVRM  727 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~l~~~  727 (797)
                       ....+.+|||.|+|||++...++++.+||||+|++.+..+++.+++....                .......+++++.
T Consensus       173 -Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~  251 (592)
T KOG0575|consen  173 -ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRK  251 (592)
T ss_pred             -cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHH
Confidence             24567899999999999999999999999999999987777666555421                1233456799999


Q ss_pred             cccCCCCCCCChHHHHHh
Q 040702          728 GTDLSLGQFPASYSISKY  745 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~~  745 (797)
                      .+++||.+||++.+|+..
T Consensus       252 lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  252 LLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             HhcCCcccCCCHHHHhcC
Confidence            999999999999999874

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-41  Score=338.82  Aligned_cols=195  Identities=30%  Similarity=0.410  Sum_probs=174.8

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEec--cCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQ--YGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      ..++|...+.||+|+||+||+|     +.+||||.+.+.  .....+.+..|+++|+.++|||||++++++++++.+|+|
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            3468988999999999999986     589999999877  333456788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCC------CcEEEEeecCCc
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN------MVAHLSDFGMAK  656 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~------~~~kl~DFGla~  656 (797)
                      ||||.||+|.++++.++. +++..++.++.|+|.|+++||   +++||||||||+|||++..      -.+||+|||+|+
T Consensus        88 MEyC~gGDLs~yi~~~~~-l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRRGR-LPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EEeCCCCCHHHHHHHcCC-CCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            999999999999998764 899999999999999999999   9999999999999999764      458999999999


Q ss_pred             cCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccc
Q 040702          657 PLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLI  711 (797)
Q Consensus       657 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~  711 (797)
                      .+.+..   ...+.+|++.|||||++....|+.++|.|++|.+.+..+.+..++.
T Consensus       164 ~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~  215 (429)
T KOG0595|consen  164 FLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFD  215 (429)
T ss_pred             hCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcc
Confidence            875332   4567899999999999999999999999999999988887777666

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-40  Score=321.01  Aligned_cols=257  Identities=22%  Similarity=0.253  Sum_probs=206.6

Q ss_pred             cCCCccccccccCCcceee-----cceEEEEEEEEeccCC---cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGG---AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk-----~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ++|+..+.||.|+||.|..     +|..+|+|+++++.--   ..+...+|..+|+.+.||.++++++.|.+.+..|+||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            6788899999999999984     5789999999876432   2345678999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      ||++||.|..++++.++ +++..++.+|.||+.|++|||   +.+|++||+||+|||+|.+|.+||+|||+|+.+..   
T Consensus       124 eyv~GGElFS~Lrk~~r-F~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~---  196 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSGR-FSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG---  196 (355)
T ss_pred             eccCCccHHHHHHhcCC-CCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecC---
Confidence            99999999999988765 999999999999999999999   99999999999999999999999999999997632   


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhhhhhcccccchhccccCCCCCCCChHHHH
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEKHLMTKEQPMVRMGTDLSLGQFPASYSIS  743 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~  743 (797)
                        .+.+.||||.|+|||.+...+|...+|+|++|+..++++.+.+++.....  +.....++..-+...+---|.+++++
T Consensus       197 --rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--~~iY~KI~~~~v~fP~~fs~~~kdLl  272 (355)
T KOG0616|consen  197 --RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--IQIYEKILEGKVKFPSYFSSDAKDLL  272 (355)
T ss_pred             --cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--HHHHHHHHhCcccCCcccCHHHHHHH
Confidence              24568999999999999999999999999999998766665554433322  22222333333333222223334444


Q ss_pred             HhHHHHHHHhc-cccccccccCCcccccceeeeeeeeecc
Q 040702          744 KYLVYIRELER-GKVGITSVAAFPIVHHYLYRTVDYTISS  782 (797)
Q Consensus       744 ~~l~~i~~~~~-~~~~~~~~~~~~~~~~~~f~~~~~~~~~  782 (797)
                         +.+-+... .|.|.......++..|+||++|+|+.-+
T Consensus       273 ---~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~  309 (355)
T KOG0616|consen  273 ---KKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAIL  309 (355)
T ss_pred             ---HHHHhhhhHhhhcCcCCCccccccCcccccccHHHHh
Confidence               44444433 3457777789999999999999998643

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-40  Score=348.31  Aligned_cols=233  Identities=27%  Similarity=0.364  Sum_probs=194.9

Q ss_pred             CccccccccCCcceeec---ceE-EEEEEEEeccCCc--chhHHHHHHHhhhccCCceeEeeeeeecCC-eEEEEEEccC
Q 040702          515 SENNLIGRGGFGPVYKD---GME-VAIKVFNLQYGGA--FKSFDIECGMMKRIRHRNLIKIISSCSNDD-FKALVLEYMP  587 (797)
Q Consensus       515 ~~~~~lg~G~~g~Vyk~---~~~-vAvK~~~~~~~~~--~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~-~~~lv~e~~~  587 (797)
                      ...+.+|+|+||+||+|   |+. ||||++.......  .++|.+|+.+|++++|||||+++|+|.++. ..++||||++
T Consensus        44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~  123 (362)
T KOG0192|consen   44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP  123 (362)
T ss_pred             hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence            33455999999999985   455 9999998664332  458999999999999999999999999887 7999999999


Q ss_pred             CCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCC-eEEcCCCCCceEEcCCC-cEEEEeecCCccCCccCcc
Q 040702          588 LGSLEKCLYSG-NYILDIFQGLNIMIDVASALEYLHFGYSVP-IIHCDLKPSNVLLDDNM-VAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       588 ~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~yLH~~~~~~-ivHrDlkp~NIll~~~~-~~kl~DFGla~~~~~~~~~  664 (797)
                      +|+|.++++.. +..+++..+.+|+.|||+||.|||   +.+ ||||||||+|||++.++ ++||+|||+++......  
T Consensus       124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--  198 (362)
T KOG0192|consen  124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--  198 (362)
T ss_pred             CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--
Confidence            99999999883 557999999999999999999999   888 99999999999999997 99999999998654321  


Q ss_pred             ccccccccCcccccccccc--cCccchHHHHHHHhhhhhhhhccccccchh------------------hhhhhcccccc
Q 040702          665 LTQTQTLATIGYMAPDEIF--SGEMRLKCWVNDSLLISVMIVVDANLLIRE------------------EKHLMTKEQPM  724 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~l  724 (797)
                      ...+...||+.|||||++.  ...|+.++||||+|+..++.+....++...                  +......+..+
T Consensus       199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l  278 (362)
T KOG0192|consen  199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSL  278 (362)
T ss_pred             ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHH
Confidence            2334468999999999999  568999999999999876655554333221                  11234467788


Q ss_pred             hhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          725 VRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       725 ~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                      +..||+.||++||++.++...++.+...
T Consensus       279 ~~~CW~~dp~~RP~f~ei~~~l~~~~~~  306 (362)
T KOG0192|consen  279 MERCWLVDPSRRPSFLEIVSRLESIMSH  306 (362)
T ss_pred             HHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence            8889999999999999999999988664

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-40  Score=336.56  Aligned_cols=228  Identities=23%  Similarity=0.313  Sum_probs=187.0

Q ss_pred             hcCCCccccccccCCcceee-----cceEEEEEEEEeccCC-------cchhHHHHHHHhhhccCCceeEeeeeeecCCe
Q 040702          511 TNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGG-------AFKSFDIECGMMKRIRHRNLIKIISSCSNDDF  578 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk-----~~~~vAvK~~~~~~~~-------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~  578 (797)
                      .+.|...+.||+|+||.|-.     +++.||||++.++...       ....+.+|+++|++++|||||+++++|..++.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            45678889999999999975     5799999999876321       12345799999999999999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCC---CcEEEEeecCC
Q 040702          579 KALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN---MVAHLSDFGMA  655 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~---~~~kl~DFGla  655 (797)
                      .||||||++||+|.+.+-..+. +.+...+.+++|++.|+.|||   +.||+||||||+|||+..+   ..+||+|||+|
T Consensus       251 ~YmVlE~v~GGeLfd~vv~nk~-l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFGlA  326 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVANKY-LREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFGLA  326 (475)
T ss_pred             eEEEEEEecCccHHHHHHhccc-cccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccchh
Confidence            9999999999999999877664 777788899999999999999   9999999999999999765   78999999999


Q ss_pred             ccCCccCccccccccccCcccccccccccCccc---hHHHHHHHhhhhhhhhccccccch--------------------
Q 040702          656 KPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMR---LKCWVNDSLLISVMIVVDANLLIR--------------------  712 (797)
Q Consensus       656 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~dv~s~~~~~~~~~~~~~~~~~--------------------  712 (797)
                      +....   .....+.|||+.|.|||++.++++.   -++|+||+|+..+..+.+..++..                    
T Consensus       327 K~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p  403 (475)
T KOG0615|consen  327 KVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGP  403 (475)
T ss_pred             hcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccC
Confidence            98753   2356779999999999999887654   466999999976433332222211                    


Q ss_pred             -hhhhhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          713 -EEKHLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       713 -~~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                       .-..+.....+++.+++..||++||++.|.++.
T Consensus       404 ~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  404 LQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence             111234466789999999999999999888764

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.8e-40  Score=344.32  Aligned_cols=274  Identities=20%  Similarity=0.245  Sum_probs=222.4

Q ss_pred             HHHhcCCCccccccccCCcceee-----cceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeE
Q 040702          508 FQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFK  579 (797)
Q Consensus       508 ~~~~~~f~~~~~lg~G~~g~Vyk-----~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~  579 (797)
                      ....++|+....||+|+||+||.     +|..+|+|++++..   .+..+-+..|-.+|...++|+||+++..|++.+..
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            33568999999999999999995     47999999998773   34456678899999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCC
Q 040702          580 ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  659 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  659 (797)
                      |+||||++||++..++...+. +++..+..++.+.+-|++.+|   ..|+|||||||+|+|||..|++||+|||+++.+.
T Consensus       217 YLiMEylPGGD~mTLL~~~~~-L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLMRKDT-LTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEEEecCCccHHHHHHhcCc-CchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhh
Confidence            999999999999999988764 899999999999999999999   9999999999999999999999999999985331


Q ss_pred             cc---------------------Cccc------------------------cccccccCcccccccccccCccchHHHHH
Q 040702          660 EE---------------------DQSL------------------------TQTQTLATIGYMAPDEIFSGEMRLKCWVN  694 (797)
Q Consensus       660 ~~---------------------~~~~------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~dv~  694 (797)
                      ..                     ....                        .....+|||.|||||++.+.+|+..+|+|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            10                     0000                        01234799999999999999999999999


Q ss_pred             HHhhhhhhhhccccccc-hhhhhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHHhccccccccccCCccccccee
Q 040702          695 DSLLISVMIVVDANLLI-REEKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLY  773 (797)
Q Consensus       695 s~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f  773 (797)
                      |+|++.++++++-+++- ..+.+....+ .--+.||..-++.+.+ .|..+.+.++-..+..|.|  ...++++..||||
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI-~nwr~~l~fP~~~~~s-~eA~DLI~rll~d~~~RLG--~~G~~EIK~HPfF  448 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETPQETYRKI-VNWRETLKFPEEVDLS-DEAKDLITRLLCDPENRLG--SKGAEEIKKHPFF  448 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHH-HHHhhhccCCCcCccc-HHHHHHHHHHhcCHHHhcC--cccHHHHhcCCcc
Confidence            99999987777665544 4443333322 1233478776666665 6677777777677778888  7788999999999


Q ss_pred             eeeeeeecccchhHHH
Q 040702          774 RTVDYTISSSTFNAVI  789 (797)
Q Consensus       774 ~~~~~~~~~~~~~~~~  789 (797)
                      ++|+|+---+..-+++
T Consensus       449 ~~v~W~~l~~~~apfv  464 (550)
T KOG0605|consen  449 KGVDWDHLREMPAPFV  464 (550)
T ss_pred             ccCCcchhhcCCCCCC
Confidence            9999997655554443

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-40  Score=344.58  Aligned_cols=260  Identities=23%  Similarity=0.301  Sum_probs=207.1

Q ss_pred             HHHhcCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhc-cCCceeEeeeeeecCCe
Q 040702          508 FQATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDF  578 (797)
Q Consensus       508 ~~~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~  578 (797)
                      ....++|..++.||+|+|++|+++     +++||||++.+..   +...+-+.+|-.+|.++ .||.|++++..|.++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            445689999999999999999985     6899999998763   33456788899999999 79999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccC
Q 040702          579 KALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  658 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  658 (797)
                      .|+|+||+++|+|.+++++.+. +++..++.++.||+.|++|||   ++|||||||||+|||+|++|++||.|||.|+.+
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gs-fde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGsAK~l  224 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGS-FDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGSAKIL  224 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCc-chHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccccccC
Confidence            9999999999999999988764 999999999999999999999   999999999999999999999999999999987


Q ss_pred             CccCcc---------cc--ccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhhhhhcccccchhc
Q 040702          659 LEEDQS---------LT--QTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEKHLMTKEQPMVRM  727 (797)
Q Consensus       659 ~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  727 (797)
                      .+....         ..  ...++||..|.+||.+..+..+..+|+|++|++.+.++.+.+++....+.  ...+.++..
T Consensus       225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney--liFqkI~~l  302 (604)
T KOG0592|consen  225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY--LIFQKIQAL  302 (604)
T ss_pred             ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH--HHHHHHHHh
Confidence            543211         11  25589999999999999999999999999999998887776665543322  122333433


Q ss_pred             cccCCCCCCCChHHHHHhHHHHHHHhccccccccccCCcccccceeeeeeeee
Q 040702          728 GTDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYTI  780 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~  780 (797)
                      -...-|.-+|-++++++.|  +...+.+|++.     .++..|+||.+|+|+.
T Consensus       303 ~y~fp~~fp~~a~dLv~KL--Lv~dp~~Rlt~-----~qIk~HpFF~~Vdw~n  348 (604)
T KOG0592|consen  303 DYEFPEGFPEDARDLIKKL--LVRDPSDRLTS-----QQIKAHPFFEGVDWEN  348 (604)
T ss_pred             cccCCCCCCHHHHHHHHHH--HccCccccccH-----HHHhhCcccccCChhh
Confidence            3444444444444444432  22234444442     6677899999999985

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-41  Score=324.56  Aligned_cols=225  Identities=22%  Similarity=0.314  Sum_probs=185.7

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEecc--CCcchhHHHHHHHhhhccCCceeEeeee-eecCCe-EEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISS-CSNDDF-KALV  582 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~~~-~~~~~~-~~lv  582 (797)
                      .+|++.++||+|+||+|||+     |..||.|.+.-..  ....++...|+.+|++++|||||+++++ +.++.. .+||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            56888999999999999984     7889999887442  3345678899999999999999999994 444444 8999


Q ss_pred             EEccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCC--eEEcCCCCCceEEcCCCcEEEEeecCCcc
Q 040702          583 LEYMPLGSLEKCLYS---GNYILDIFQGLNIMIDVASALEYLHFGYSVP--IIHCDLKPSNVLLDDNMVAHLSDFGMAKP  657 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~--ivHrDlkp~NIll~~~~~~kl~DFGla~~  657 (797)
                      ||||.+|+|...++.   .++.+++..+++++.|++.||..+|... +.  |+||||||.||+++.+|.+|++|||+++.
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            999999999998853   3447999999999999999999999321 44  99999999999999999999999999998


Q ss_pred             CCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccch-------------h---h-hhhhc
Q 040702          658 LLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIR-------------E---E-KHLMT  719 (797)
Q Consensus       658 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~-------------~---~-~~~~~  719 (797)
                      +....  ......+|||.||+||.+.+.+|+.++|+|++|+..+++.. .+++.+.             +   + .....
T Consensus       178 l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~~YS~  255 (375)
T KOG0591|consen  178 LSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDEHYST  255 (375)
T ss_pred             hcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHHHhhh
Confidence            74433  34567899999999999999999999999999998854443 3333332             1   1 23455


Q ss_pred             ccccchhccccCCCCCCCCh
Q 040702          720 KEQPMVRMGTDLSLGQFPAS  739 (797)
Q Consensus       720 ~~~~l~~~cl~~dp~~RPs~  739 (797)
                      .+.+++..|+..||+.||+.
T Consensus       256 ~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  256 DLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             HHHHHHHHHccCCcccCCCc
Confidence            78899999999999999985

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.8e-39  Score=313.60  Aligned_cols=227  Identities=21%  Similarity=0.237  Sum_probs=187.9

Q ss_pred             cCCCccccccccCCcceee-----cceEEEEEEEEeccCC--cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGG--AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk-----~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      +.|+...++|+|+||+|||     +|+.||||++....++  ..+-..+|+++|++++|||+|.++++|......++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            4688889999999999997     5899999999765432  23567899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      ||+. ++-+-+......++.....+++.|++.|+.|+|   +++++||||||+|||++.+|.+||||||+|+.+...+  
T Consensus        82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg--  155 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG--  155 (396)
T ss_pred             ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCCc--
Confidence            9987 555555555555899999999999999999999   9999999999999999999999999999999875332  


Q ss_pred             ccccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchhhh-h--------------------------
Q 040702          665 LTQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIREEK-H--------------------------  716 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~-~--------------------------  716 (797)
                      ...+..+.|+||+|||.+.+ -.|...+|||++|+...+++.+.++.++.+. +                          
T Consensus       156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F  235 (396)
T KOG0593|consen  156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF  235 (396)
T ss_pred             chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence            24567889999999999987 5799999999999987555555554433221 1                          


Q ss_pred             --------------------hhcccccchhccccCCCCCCCChHHHHH
Q 040702          717 --------------------LMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       717 --------------------~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                          ......++++.|++.||.+|++.+|++.
T Consensus       236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence                                1113456777799999999999998875

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=4.6e-41  Score=352.56  Aligned_cols=364  Identities=26%  Similarity=0.393  Sum_probs=261.2

Q ss_pred             CCCCCCCcc-ccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCC
Q 040702            2 PSLTNDFLR-GIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLK   80 (797)
Q Consensus         2 ~~l~~~~~~-~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~   80 (797)
                      +|+|+|-++ +..|.....+++++.|-|.+.+         ++++|++++.+.+|++|.+++|++.+ +...+..++.|+
T Consensus        12 vDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~---------L~~vPeEL~~lqkLEHLs~~HN~L~~-vhGELs~Lp~LR   81 (1255)
T KOG0444|consen   12 VDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTK---------LEQVPEELSRLQKLEHLSMAHNQLIS-VHGELSDLPRLR   81 (1255)
T ss_pred             ccccCCcCCCCcCchhHHHhhheeEEEechhh---------hhhChHHHHHHhhhhhhhhhhhhhHh-hhhhhccchhhH
Confidence            578888777 6788888899999999988877         78999999999999999999999986 567789999999


Q ss_pred             EEEccCCcCcc-cCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccC
Q 040702           81 SLYLHSNSLSG-RLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLND  159 (797)
Q Consensus        81 ~L~Ls~N~l~~-~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~  159 (797)
                      .+++.+|+++. -||..+| ++..|+.||||+|++. ..|..+....++-.|+||+|+|..|+...|-+|+.|-.||||+
T Consensus        82 sv~~R~N~LKnsGiP~diF-~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~  159 (1255)
T KOG0444|consen   82 SVIVRDNNLKNSGIPTDIF-RLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSN  159 (1255)
T ss_pred             HHhhhccccccCCCCchhc-ccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhcccc
Confidence            99999999973 4899998 8999999999999998 7899999999999999999999999888999999999999999


Q ss_pred             ccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCccc-ccCChhhhhhhhhHhhhcccc
Q 040702          160 NYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNIS-GSIPEEINNLTNLILQLLSLE  238 (797)
Q Consensus       160 N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~-~~~p~~~~~l~~L~L~~L~Ls  238 (797)
                      |++..+||+      ...+..|++|+|++|++...--..+..+. +|..|.+++.+-+ ..+|.++..+.+|  ..+|||
T Consensus       160 NrLe~LPPQ------~RRL~~LqtL~Ls~NPL~hfQLrQLPsmt-sL~vLhms~TqRTl~N~Ptsld~l~NL--~dvDlS  230 (1255)
T KOG0444|consen  160 NRLEMLPPQ------IRRLSMLQTLKLSNNPLNHFQLRQLPSMT-SLSVLHMSNTQRTLDNIPTSLDDLHNL--RDVDLS  230 (1255)
T ss_pred             chhhhcCHH------HHHHhhhhhhhcCCChhhHHHHhcCccch-hhhhhhcccccchhhcCCCchhhhhhh--hhcccc
Confidence            999999997      45667799999999998754333333333 4555555554322 2344445555544  455555


Q ss_pred             cccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEccCCcCCCCCC
Q 040702          239 GNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLP  318 (797)
Q Consensus       239 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~  318 (797)
                      .|.+. +.|+.+..+.+|                        +.|+||+|.|+++......+.+|+.|++|+|+++ .+|
T Consensus       231 ~N~Lp-~vPecly~l~~L------------------------rrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~LP  284 (1255)
T KOG0444|consen  231 ENNLP-IVPECLYKLRNL------------------------RRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-VLP  284 (1255)
T ss_pred             ccCCC-cchHHHhhhhhh------------------------heeccCcCceeeeeccHHHHhhhhhhccccchhc-cch
Confidence            55554 444444444444                        4445555544444444444445555555555554 445


Q ss_pred             ccccccccccEEeccCccccc-ccCccccCCcccceecccCccccCCCChhhhccccCCeeeecCCcCCCCCChhhhccC
Q 040702          319 LKIGNLNVLVQLDLSMNNFSC-VIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLL  397 (797)
Q Consensus       319 ~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  397 (797)
                      .+++.++.|+.|++.+|+++- -+|+.++.+.+|+.+..++|.+. ..|..++.+..|+.|.|++|++. ++|+++.-++
T Consensus       285 ~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~  362 (1255)
T KOG0444|consen  285 DAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLP  362 (1255)
T ss_pred             HHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcC
Confidence            555555555555555555431 14666666777777777777666 66777777777777777777766 5677777777


Q ss_pred             CCCeEEccCCcCcccCC
Q 040702          398 DLKDINVSFNRLEGEIP  414 (797)
Q Consensus       398 ~L~~L~l~~N~l~~~~p  414 (797)
                      .|+.||+..|+=---+|
T Consensus       363 ~l~vLDlreNpnLVMPP  379 (1255)
T KOG0444|consen  363 DLKVLDLRENPNLVMPP  379 (1255)
T ss_pred             CcceeeccCCcCccCCC
Confidence            77777777776443333

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-40  Score=335.53  Aligned_cols=229  Identities=22%  Similarity=0.282  Sum_probs=191.0

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcch-hHHHHHHHhhhcc-CCceeEeeeeeecCC-eEEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFK-SFDIECGMMKRIR-HRNLIKIISSCSNDD-FKAL  581 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~-~~~~E~~~l~~l~-Hpniv~l~~~~~~~~-~~~l  581 (797)
                      ..++|...++||.|.||.||+|     +..||||+++.+.....+ .=.+|++.|++++ |||||++.+++.+.+ ..|+
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            4578999999999999999986     578999999877543222 3458999999999 999999999999888 9999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCcc
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  661 (797)
                      |||||+. +|+++++++++.+++..++.|+.||++||+|+|   .+|+.|||+||+|||+.....+||+|||+|+.+.+.
T Consensus        88 VfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk  163 (538)
T KOG0661|consen   88 VFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK  163 (538)
T ss_pred             eHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccccccC
Confidence            9999976 999999999889999999999999999999999   999999999999999999999999999999987544


Q ss_pred             CccccccccccCcccccccccc-cCccchHHHHHHHhhhhhhhhc-cccccchhhhh-----------------------
Q 040702          662 DQSLTQTQTLATIGYMAPDEIF-SGEMRLKCWVNDSLLISVMIVV-DANLLIREEKH-----------------------  716 (797)
Q Consensus       662 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~~~~-----------------------  716 (797)
                      .   ..+..+.|+||+|||+++ .+-|+.+.|+|++|++..+... .|-+.+..+.|                       
T Consensus       164 p---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L  240 (538)
T KOG0661|consen  164 P---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL  240 (538)
T ss_pred             C---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence            3   446688999999999876 5668999999999998744333 22222222222                       


Q ss_pred             ----------------------hhcccccchhccccCCCCCCCChHHHHHh
Q 040702          717 ----------------------LMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       717 ----------------------~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                                            ......+++..|++.||++|||+.|.++.
T Consensus       241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence                                  12245567777999999999999998874

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=6.4e-42  Score=343.19  Aligned_cols=408  Identities=28%  Similarity=0.413  Sum_probs=255.5

Q ss_pred             CCCCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCE
Q 040702            2 PSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKS   81 (797)
Q Consensus         2 ~~l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~   81 (797)
                      ++|++|.++...+ .+.++..|++|++++|+         +.++|.+++.+..++.|+.|+|+++. +|..+.++.+|+.
T Consensus        50 lils~N~l~~l~~-dl~nL~~l~vl~~~~n~---------l~~lp~aig~l~~l~~l~vs~n~ls~-lp~~i~s~~~l~~  118 (565)
T KOG0472|consen   50 LILSHNDLEVLRE-DLKNLACLTVLNVHDNK---------LSQLPAAIGELEALKSLNVSHNKLSE-LPEQIGSLISLVK  118 (565)
T ss_pred             hhhccCchhhccH-hhhcccceeEEEeccch---------hhhCCHHHHHHHHHHHhhcccchHhh-ccHHHhhhhhhhh
Confidence            5788998876555 58899999999999998         44556666666666666666666653 5566666666666


Q ss_pred             EEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCcc
Q 040702           82 LYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNY  161 (797)
Q Consensus        82 L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~  161 (797)
                      |++++|.+. .+|++++ .+..|+.|+..+|+++ ..|.++..+.+|..|++.+|++....|.... ++.|+.||..+|.
T Consensus       119 l~~s~n~~~-el~~~i~-~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~  194 (565)
T KOG0472|consen  119 LDCSSNELK-ELPDSIG-RLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNL  194 (565)
T ss_pred             hhcccccee-ecCchHH-HHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhh
Confidence            666666665 5555554 5556666666666665 4555555566666666666666544444443 5555666665555


Q ss_pred             CcCCCCCcccc----------------ccCCCCCCCcEEEccCCCCCCCCChhhh-ccccCCcEEEccCCcccccCChhh
Q 040702          162 LTSSTPELSSL----------------SSLSNCKYLEYFSFSNNPLGGILPRAIG-NLSQSMEDFWMDNCNISGSIPEEI  224 (797)
Q Consensus       162 l~~~~~~~~~~----------------~~l~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~~L~~L~L~~n~i~~~~p~~~  224 (797)
                      ++.+|++++.+                +.|.++..|+.|.++.|+|..+ |.... +++ ++..|||.+|++. ..|+.+
T Consensus       195 L~tlP~~lg~l~~L~~LyL~~Nki~~lPef~gcs~L~Elh~g~N~i~~l-pae~~~~L~-~l~vLDLRdNklk-e~Pde~  271 (565)
T KOG0472|consen  195 LETLPPELGGLESLELLYLRRNKIRFLPEFPGCSLLKELHVGENQIEML-PAEHLKHLN-SLLVLDLRDNKLK-EVPDEI  271 (565)
T ss_pred             hhcCChhhcchhhhHHHHhhhcccccCCCCCccHHHHHHHhcccHHHhh-HHHHhcccc-cceeeeccccccc-cCchHH
Confidence            55555542110                0144444444444444444422 22222 333 4555555555554 345555


Q ss_pred             hhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccC----------------------------------
Q 040702          225 NNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFV----------------------------------  270 (797)
Q Consensus       225 ~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~----------------------------------  270 (797)
                      +-+.+|  .+||+|+|.|+ ..|.+++++ .|+.|-+.+|.+.++-                                  
T Consensus       272 clLrsL--~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~  347 (565)
T KOG0472|consen  272 CLLRSL--ERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETA  347 (565)
T ss_pred             HHhhhh--hhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCccccccc
Confidence            555544  55555555555 234444444 4555555555433210                                  


Q ss_pred             ----CCC---ccCCccccccccCCCCCCCCCCCCCCCCc---ccEEEccCCcCC-----------------------CCC
Q 040702          271 ----PAC---SGNLTNLRKLYLGSNLLTSIPSTLWNLKD---ILHLNLSSNFFT-----------------------GPL  317 (797)
Q Consensus       271 ----~~~---~~~l~~L~~L~L~~N~l~~lp~~~~~l~~---L~~L~l~~N~l~-----------------------~~~  317 (797)
                          +..   ...+.+.+.|+++.-+++.+|+..|...+   ....+++.|++.                       +.+
T Consensus       348 ~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv  427 (565)
T KOG0472|consen  348 MTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFV  427 (565)
T ss_pred             CCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccc
Confidence                000   00122334444444445555544433222   344555555543                       245


Q ss_pred             CccccccccccEEeccCcccccccCccccCCcccceecccCccccCCCChhhhccccCCeeeecCCcCCCCCChhhhccC
Q 040702          318 PLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLL  397 (797)
Q Consensus       318 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  397 (797)
                      |..++.+++|..|+|++|.+. .+|..++.+..|+.|++|+|++. ..|..+..+..++.+-.++|++....|+.+.++.
T Consensus       428 ~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~  505 (565)
T KOG0472|consen  428 PLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMR  505 (565)
T ss_pred             hHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhh
Confidence            556677788888888888887 56777888888888888888887 7788877777788777788888877777799999


Q ss_pred             CCCeEEccCCcCcccCCCCCCCCCCCcccccCCccc
Q 040702          398 DLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELL  433 (797)
Q Consensus       398 ~L~~L~l~~N~l~~~~p~~~~~~~l~~~~~~~n~~~  433 (797)
                      +|..||+.+|.+...+|..+.+++++.+.+.|||+.
T Consensus       506 nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  506 NLTTLDLQNNDLQQIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             hcceeccCCCchhhCChhhccccceeEEEecCCccC
Confidence            999999999999999999999999999999999986

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-38  Score=337.96  Aligned_cols=258  Identities=20%  Similarity=0.256  Sum_probs=216.8

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhcc-CCceeEeeeeeecCCeEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIR-HRNLIKIISSCSNDDFKA  580 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~  580 (797)
                      ..++|...++||+|.||+|+.+     ++.||||++++..   .++.+..+.|.+++.... ||.++.++..|+.+++.|
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            4578999999999999999963     5899999999873   456778889999988885 999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCc
Q 040702          581 LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  660 (797)
Q Consensus       581 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  660 (797)
                      +||||+.||++..+.+.  ..+++..+..++++|+.||+|||   .++||+||||-+|||+|.+|++||+|||++|....
T Consensus       446 fvmey~~Ggdm~~~~~~--~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~  520 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHIHT--DVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG  520 (694)
T ss_pred             EEEEecCCCcEEEEEec--ccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccCC
Confidence            99999999995444332  35899999999999999999999   99999999999999999999999999999996542


Q ss_pred             cCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhhhhhcccccchhccccCCCCCCCC--
Q 040702          661 EDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEKHLMTKEQPMVRMGTDLSLGQFPA--  738 (797)
Q Consensus       661 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPs--  738 (797)
                      .  ...+++++||+.|||||.+.+..|+..+|+|++|+..++++++..++.+...+      ++....+..|| .-|.  
T Consensus       521 ~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe------e~FdsI~~d~~-~yP~~l  591 (694)
T KOG0694|consen  521 Q--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE------EVFDSIVNDEV-RYPRFL  591 (694)
T ss_pred             C--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHhcCCC-CCCCcc
Confidence            2  23567899999999999999999999999999999998888887777654433      33344444444 2332  


Q ss_pred             hHHHHHhHHH-HHHHhccccccccccCCcccccceeeeeeeeec
Q 040702          739 SYSISKYLVY-IRELERGKVGITSVAAFPIVHHYLYRTVDYTIS  781 (797)
Q Consensus       739 ~~~i~~~l~~-i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~  781 (797)
                      .+|.+..++. +.+.+..|.|..+.++.++..||||++|+|+.-
T Consensus       592 s~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L  635 (694)
T KOG0694|consen  592 SKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDL  635 (694)
T ss_pred             cHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHH
Confidence            3677777776 466688889999999999999999999999854

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-38  Score=333.93  Aligned_cols=236  Identities=23%  Similarity=0.324  Sum_probs=196.2

Q ss_pred             cCCCccccccccCCcceeec----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccC
Q 040702          512 NRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  587 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~  587 (797)
                      +.+..++.||+|-||+||.|    ...||||.++.... ..++|.+|+.+|++++|++||+++|+|..++.+|||||||+
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~  284 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP  284 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence            44556688999999999875    46999999987632 34789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccc
Q 040702          588 LGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  666 (797)
Q Consensus       588 ~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  666 (797)
                      .|+|.++++. .+..+...+.+.++.|||+|++||+   ++++|||||.++||||+++..+||+|||+|+.. .++.+..
T Consensus       285 ~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~-~d~~Y~~  360 (468)
T KOG0197|consen  285 KGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLI-GDDEYTA  360 (468)
T ss_pred             cCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEccccccccc-CCCceee
Confidence            9999999987 4447889999999999999999999   999999999999999999999999999999944 3344444


Q ss_pred             ccccccCcccccccccccCccchHHHHHHHhhhhhhhhcccccc-ch-----------------hhhhhhcccccchhcc
Q 040702          667 QTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLL-IR-----------------EEKHLMTKEQPMVRMG  728 (797)
Q Consensus       667 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~-~~-----------------~~~~~~~~~~~l~~~c  728 (797)
                      .....-...|+|||.+..+.++.++||||+|+..++.+...... +.                 .|......+.++++.|
T Consensus       361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~C  440 (468)
T KOG0197|consen  361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSC  440 (468)
T ss_pred             cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHH
Confidence            44445567899999999999999999999999874444332211 22                 1222344677889999


Q ss_pred             ccCCCCCCCChHHHHHhHHHHHHH
Q 040702          729 TDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       729 l~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                      |+.+|++|||+..+...++++...
T Consensus       441 W~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  441 WHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             hhCCcccCCCHHHHHHHHHHhhhc
Confidence            999999999999988888776543

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.3e-37  Score=341.56  Aligned_cols=239  Identities=23%  Similarity=0.336  Sum_probs=199.7

Q ss_pred             hcCCCccccccccCCcceeec----------ceEEEEEEEEeccCC-cchhHHHHHHHhhhccCCceeEeeeeeecCCeE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD----------GMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFK  579 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~----------~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~  579 (797)
                      ..+....+.||+|+||+||+|          ...||||.++..... ..++|.+|+++++.++|||||+++|+|..++..
T Consensus       485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            345566789999999999985          278999999887665 678999999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCc
Q 040702          580 ALVLEYMPLGSLEKCLYSGN-------------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV  646 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~-------------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~  646 (797)
                      |+|+|||..|||.+++....             .+++..+.+.||.|||.|++||-   ++.+|||||..+|+||.++..
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLV  641 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceE
Confidence            99999999999999996432             13788899999999999999999   999999999999999999999


Q ss_pred             EEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccch-------------
Q 040702          647 AHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIR-------------  712 (797)
Q Consensus       647 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~-------------  712 (797)
                      |||+|||+++.....+.+.......-..+|||||.|+.++++.++|||++|+..++.+- +..+..+             
T Consensus       642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g  721 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG  721 (774)
T ss_pred             EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC
Confidence            99999999998766555443334445779999999999999999999999987633221 1111111             


Q ss_pred             ----hhhhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          713 ----EEKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       713 ----~~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                          .+......+.++++.||+..|.+||+++||..+|+.+.+.
T Consensus       722 ~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  722 QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence                2223445778889999999999999999999999987654

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.4e-37  Score=297.04  Aligned_cols=191  Identities=28%  Similarity=0.420  Sum_probs=167.6

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      .+|...+++|+|.||.||+|     ++.||||.++....  +......+|++.|+.++||||+.++++|...+...+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            47888899999999999985     68999999987732  234578899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      ||+. +|+..++.....++..+++.++.++++|++|||   ++.|+|||+||.|+|++.+|.+||+|||+|+.+.+....
T Consensus        82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~  157 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI  157 (318)
T ss_pred             eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence            9986 999999998888999999999999999999999   999999999999999999999999999999988765443


Q ss_pred             ccccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhcccc
Q 040702          665 LTQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDAN  708 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~  708 (797)
                        .+..+-|.+|+|||.+++. .|+..+|+|+.|++..+.+...+
T Consensus       158 --~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P  200 (318)
T KOG0659|consen  158 --QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVP  200 (318)
T ss_pred             --cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCC
Confidence              2334889999999988865 58999999999998744443333

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-37  Score=321.51  Aligned_cols=195  Identities=28%  Similarity=0.359  Sum_probs=169.7

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEecc--CCcchhHHHHHHHhhhccCCceeEeeeeeecC--CeEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISSCSND--DFKAL  581 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~--~~~~l  581 (797)
                      .+.|+..++||+|.||.|||+     |+.||+|+++...  .+...-..+||.+|++++||||+++.+...+.  +.+|+
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            467888999999999999985     6889999998775  34456678999999999999999999998776  68999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCcc
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  661 (797)
                      |+|||++ +|.-++....-.++..+++.++.|++.||+|||   .++|+|||||.+|||||.+|.+||+|||+|+++...
T Consensus       196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            9999987 999988877667999999999999999999999   999999999999999999999999999999977544


Q ss_pred             CccccccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhcccccc
Q 040702          662 DQSLTQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANLL  710 (797)
Q Consensus       662 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~~  710 (797)
                      . ....+..+-|.+|+|||.+++. .|+...|+|++|++..+.+.+.+++
T Consensus       272 ~-~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~  320 (560)
T KOG0600|consen  272 G-SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPIL  320 (560)
T ss_pred             C-CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCc
Confidence            3 2345778899999999999875 5999999999999985555554443

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-37  Score=328.85  Aligned_cols=226  Identities=23%  Similarity=0.308  Sum_probs=197.7

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      ..|....+||+|+.|.||-+     ++.||||++........+-+.+|+.+|+..+|+|||.+++.|...+..|+|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            46777889999999999964     6889999999888777788999999999999999999999999899999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccc
Q 040702          587 PLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  666 (797)
Q Consensus       587 ~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  666 (797)
                      +||+|.+.+....  +++.++..|++++++||+|||   .++|+|||||.+|||++.+|.+||+|||++..+.....  .
T Consensus       353 ~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--K  425 (550)
T KOG0578|consen  353 EGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--K  425 (550)
T ss_pred             CCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC--c
Confidence            9999999987664  899999999999999999999   99999999999999999999999999999987754433  4


Q ss_pred             ccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccc-hhh------------------hhhhcccccchhc
Q 040702          667 QTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLI-REE------------------KHLMTKEQPMVRM  727 (797)
Q Consensus       667 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~-~~~------------------~~~~~~~~~l~~~  727 (797)
                      ..+.+||+.|||||++....|+.++||||+|++.++++-+.+++- +.+                  ......+++++.+
T Consensus       426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~  505 (550)
T KOG0578|consen  426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDR  505 (550)
T ss_pred             cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHH
Confidence            567899999999999999999999999999999866654443322 222                  2244578899999


Q ss_pred             cccCCCCCCCChHHHHH
Q 040702          728 GTDLSLGQFPASYSISK  744 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~  744 (797)
                      |+..|+++||++.|+++
T Consensus       506 cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  506 CLVVDVEQRASAKELLE  522 (550)
T ss_pred             HhhcchhcCCCHHHHhc
Confidence            99999999999998875

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-37  Score=314.46  Aligned_cols=231  Identities=23%  Similarity=0.286  Sum_probs=195.3

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCC-cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      .++|+..+.||.|..+.||+|     ++.||||++...... ..+.+.+|+..|+.++||||++++..|..+...|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            478999999999999999986     589999999877543 35889999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          585 YMPLGSLEKCLYSGNY-ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      ||.+|++.++++..-. .+++..+..|.+++++||.|||   .+|.||||||+.||||+++|.+||+|||.+..+.+.+.
T Consensus       105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~  181 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD  181 (516)
T ss_pred             hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence            9999999999976432 5899999999999999999999   99999999999999999999999999998766554332


Q ss_pred             c-ccc-cccccCccccccccccc--CccchHHHHHHHhhhhhhhhccccccchhhhh-----------------------
Q 040702          664 S-LTQ-TQTLATIGYMAPDEIFS--GEMRLKCWVNDSLLISVMIVVDANLLIREEKH-----------------------  716 (797)
Q Consensus       664 ~-~~~-~~~~gt~~y~aPE~~~~--~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~~-----------------------  716 (797)
                      . ... ..++||+.|||||++.+  .+|+.++|||++|+...+..-+..++..+++-                       
T Consensus       182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~  261 (516)
T KOG0582|consen  182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDE  261 (516)
T ss_pred             eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHH
Confidence            1 122 56799999999999653  56999999999999876665555554444421                       


Q ss_pred             ---hhcccccchhccccCCCCCCCChHHHHH
Q 040702          717 ---LMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       717 ---~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                         ....+.+++..|+..||.+|||+.++++
T Consensus       262 ~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  262 DKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             hhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence               1225568889999999999999999876

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-37  Score=314.44  Aligned_cols=235  Identities=27%  Similarity=0.373  Sum_probs=191.8

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCC--eEEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDD--FKALVL  583 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~--~~~lv~  583 (797)
                      ..++...+.||+|+||.||.+     |..+|||.+........+.+.+|+.+|++++|||||+++|.....+  .+++.|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            346777899999999999974     5789999998764333567899999999999999999999854444  689999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcC-CCcEEEEeecCCccCCccC
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD-NMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl~DFGla~~~~~~~  662 (797)
                      ||+++|+|.+++...+..+++..++++++||++||+|||   +++|+||||||+|||++. ++.+||+|||+++......
T Consensus        96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            999999999999886646999999999999999999999   999999999999999999 7999999999998764311


Q ss_pred             -ccccccccccCcccccccccccCcc-chHHHHHHHhhhhhhhhccccccch-------------------hhhhhhccc
Q 040702          663 -QSLTQTQTLATIGYMAPDEIFSGEM-RLKCWVNDSLLISVMIVVDANLLIR-------------------EEKHLMTKE  721 (797)
Q Consensus       663 -~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~dv~s~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~  721 (797)
                       .........||+.|||||++..+.. ...+|+|++|+..++++....+...                   .+.......
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a  252 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA  252 (313)
T ss_pred             ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence             1122345789999999999986433 3599999999988666665443332                   111233367


Q ss_pred             ccchhccccCCCCCCCChHHHHHhHHH
Q 040702          722 QPMVRMGTDLSLGQFPASYSISKYLVY  748 (797)
Q Consensus       722 ~~l~~~cl~~dp~~RPs~~~i~~~l~~  748 (797)
                      +++++.|+..||++|||+.++++..-.
T Consensus       253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~  279 (313)
T KOG0198|consen  253 KDFLRKCFKRDPEKRPTAEELLEHPFL  279 (313)
T ss_pred             HHHHHHHhhcCcccCcCHHHHhhChhh
Confidence            889999999999999999999986544

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-36  Score=322.33  Aligned_cols=236  Identities=21%  Similarity=0.254  Sum_probs=197.5

Q ss_pred             HHhcCCCccccccccCCcceeec-----ceEEEEEEEEec----cC-CcchhHHHHHHHhhhcc-CCceeEeeeeeecCC
Q 040702          509 QATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQ----YG-GAFKSFDIECGMMKRIR-HRNLIKIISSCSNDD  577 (797)
Q Consensus       509 ~~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~----~~-~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~  577 (797)
                      ...+.|...+.||+|+||.|+.+     +..||||+++..    .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            45678999999999999999975     689999977654    11 23456678999999999 999999999999999


Q ss_pred             eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCC-CcEEEEeecCCc
Q 040702          578 FKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN-MVAHLSDFGMAK  656 (797)
Q Consensus       578 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~DFGla~  656 (797)
                      ..|+||||+.||+|.+++.. ..++.+..+.++++|+++|++|||   +++|+||||||+||++|.+ +++||+|||++.
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~  169 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSA  169 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence            99999999999999999998 445888999999999999999999   9999999999999999999 999999999999


Q ss_pred             cCCccCccccccccccCcccccccccccCc-cc-hHHHHHHHhhhhhhhhccccccchhh----------------hhh-
Q 040702          657 PLLEEDQSLTQTQTLATIGYMAPDEIFSGE-MR-LKCWVNDSLLISVMIVVDANLLIREE----------------KHL-  717 (797)
Q Consensus       657 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~dv~s~~~~~~~~~~~~~~~~~~~----------------~~~-  717 (797)
                      ...  .........+||+.|+|||++.+.. |+ .++|+||+|++.+.++.+.-++....                ... 
T Consensus       170 ~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~  247 (370)
T KOG0583|consen  170 ISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLL  247 (370)
T ss_pred             ccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcC
Confidence            763  2223456789999999999999877 75 99999999999866665554444311                112 


Q ss_pred             hcccccchhccccCCCCCCCChHHHHHhHHHHHH
Q 040702          718 MTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRE  751 (797)
Q Consensus       718 ~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~  751 (797)
                      ......++++|+..||.+|+++.+++ ....++.
T Consensus       248 S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~  280 (370)
T KOG0583|consen  248 SPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK  280 (370)
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence            44557889999999999999999999 4444443

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=317.11  Aligned_cols=228  Identities=26%  Similarity=0.320  Sum_probs=196.5

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEecc-CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      ...|...+.||+|+||.||||     ++.||+|+++... ....+++.+|+.++.+++++||.++|+.+..+...|++||
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe   91 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME   91 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence            346777799999999999996     5899999998774 4456889999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      ||.||++.+.++.... +++..+.-|++++..|+.|+|   ..+.+|||||+.||++..+|.+|++|||.+..+....  
T Consensus        92 y~~gGsv~~lL~~~~~-~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~--  165 (467)
T KOG0201|consen   92 YCGGGSVLDLLKSGNI-LDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV--  165 (467)
T ss_pred             HhcCcchhhhhccCCC-CccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechh--
Confidence            9999999999987653 577788889999999999999   9999999999999999999999999999998764332  


Q ss_pred             ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh-----------------hhhhcccccchhc
Q 040702          665 LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE-----------------KHLMTKEQPMVRM  727 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~l~~~  727 (797)
                      ....+++||+.|||||++...+|+.++|+|++|+..+++..+.++.....                 .+..+.+++++..
T Consensus       166 ~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~  245 (467)
T KOG0201|consen  166 KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEA  245 (467)
T ss_pred             hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHH
Confidence            23477899999999999998899999999999999877666554433211                 1344568899999


Q ss_pred             cccCCCCCCCChHHHHH
Q 040702          728 GTDLSLGQFPASYSISK  744 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~  744 (797)
                      |+..||+.||++.++++
T Consensus       246 CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  246 CLDKNPEFRPSAKELLK  262 (467)
T ss_pred             HhhcCcccCcCHHHHhh
Confidence            99999999999998876

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-37  Score=322.98  Aligned_cols=243  Identities=21%  Similarity=0.302  Sum_probs=201.6

Q ss_pred             HHHHHHhcCCCccccccccCCcceeecc--eEEEEEEEEeccCC--cchhHHHHHHHhhhccCCceeEeeeeeecCCeEE
Q 040702          505 LELFQATNRFSENNLIGRGGFGPVYKDG--MEVAIKVFNLQYGG--AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKA  580 (797)
Q Consensus       505 ~~l~~~~~~f~~~~~lg~G~~g~Vyk~~--~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~  580 (797)
                      .++..-.+.+.....||+|+||+||||.  ..||||++......  ..+.|.+|+.++++-+|.||+-+.|||..+.. .
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A  463 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A  463 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence            4444455667778899999999999995  78999999877533  45789999999999999999999999998887 9


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCc
Q 040702          581 LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  660 (797)
Q Consensus       581 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  660 (797)
                      ||+.+|+|.+|+.+++..+..++..+...|+.|||+|+.|||   .++|||||||..||++.++++|||+|||++..-..
T Consensus       464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~  540 (678)
T KOG0193|consen  464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR  540 (678)
T ss_pred             eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecccceeeeee
Confidence            999999999999999988888999999999999999999999   99999999999999999999999999999864221


Q ss_pred             cCccccccccccCccccccccccc---CccchHHHHHHHhhhhhhhhccccccchhhhh---------------------
Q 040702          661 EDQSLTQTQTLATIGYMAPDEIFS---GEMRLKCWVNDSLLISVMIVVDANLLIREEKH---------------------  716 (797)
Q Consensus       661 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~~---------------------  716 (797)
                      -..........|...|||||++..   .+|+..+|||++|+..|+.+.+.-++.....+                     
T Consensus       541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~  620 (678)
T KOG0193|consen  541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSN  620 (678)
T ss_pred             eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhcc
Confidence            111223345668889999998863   46899999999999887766554443332222                     


Q ss_pred             hhcccccchhccccCCCCCCCChHHHHHhHHHHHH
Q 040702          717 LMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRE  751 (797)
Q Consensus       717 ~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~  751 (797)
                      ....+++++..||..++++||.+.+++..|+++..
T Consensus       621 ~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  621 CPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             CHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            22367788888999999999999999998777655

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=100.00  E-value=1.4e-38  Score=334.05  Aligned_cols=375  Identities=28%  Similarity=0.419  Sum_probs=312.4

Q ss_pred             CCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCc
Q 040702           17 LGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSS   96 (797)
Q Consensus        17 ~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~   96 (797)
                      -+-|+-.+-.|+|+|.++|.       ..|+++..+++++||-|...++.. +|+.++.+.+|++|.+++|++. .+-..
T Consensus         3 tgVLpFVrGvDfsgNDFsg~-------~FP~~v~qMt~~~WLkLnrt~L~~-vPeEL~~lqkLEHLs~~HN~L~-~vhGE   73 (1255)
T KOG0444|consen    3 TGVLPFVRGVDFSGNDFSGD-------RFPHDVEQMTQMTWLKLNRTKLEQ-VPEELSRLQKLEHLSMAHNQLI-SVHGE   73 (1255)
T ss_pred             ccccceeecccccCCcCCCC-------cCchhHHHhhheeEEEechhhhhh-ChHHHHHHhhhhhhhhhhhhhH-hhhhh
Confidence            45677888899999998854       468889999999999999999975 7999999999999999999997 55544


Q ss_pred             cccCCCCccEEEccCccccc-cCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccC
Q 040702           97 ADVRLPNLKELHLWGNNFIG-TIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSL  175 (797)
Q Consensus        97 ~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l  175 (797)
                      . +.++.|+.+++.+|++.. -+|..++.+..|+.|+||+|+++ ..|..+..-+++-+|+||+|+|.++|..+     |
T Consensus        74 L-s~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~l-----f  146 (1255)
T KOG0444|consen   74 L-SDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSL-----F  146 (1255)
T ss_pred             h-ccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchH-----H
Confidence            4 478899999999998853 36777888888888888888888 56777888888888888888888888764     7


Q ss_pred             CCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCC
Q 040702          176 SNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAA  255 (797)
Q Consensus       176 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~  255 (797)
                      .+++.|-+||||+|++...                          |..+..+.+|  ++|+|++|.+....-..+..+++
T Consensus       147 inLtDLLfLDLS~NrLe~L--------------------------PPQ~RRL~~L--qtL~Ls~NPL~hfQLrQLPsmts  198 (1255)
T KOG0444|consen  147 INLTDLLFLDLSNNRLEML--------------------------PPQIRRLSML--QTLKLSNNPLNHFQLRQLPSMTS  198 (1255)
T ss_pred             HhhHhHhhhccccchhhhc--------------------------CHHHHHHhhh--hhhhcCCChhhHHHHhcCccchh
Confidence            7788888888888887633                          3333444444  66667766665333344556788


Q ss_pred             CcEEEccCCcCc-ccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEccCCcCCCCCCccccccccccEEeccC
Q 040702          256 LFQLDLGGNKLS-GFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSM  334 (797)
Q Consensus       256 L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~  334 (797)
                      |++|.+++.+-+ .-+|..+..+.+|..+|||.|.+..+|+.+..+++|+.|+||+|+|+ .+....+...+|++|+||.
T Consensus       199 L~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSr  277 (1255)
T KOG0444|consen  199 LSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLPIVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSR  277 (1255)
T ss_pred             hhhhhcccccchhhcCCCchhhhhhhhhccccccCCCcchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhcccc
Confidence            889999886543 34688899999999999999999999999999999999999999999 4555667788999999999


Q ss_pred             cccccccCccccCCcccceecccCccccC-CCChhhhccccCCeeeecCCcCCCCCChhhhccCCCCeEEccCCcCcccC
Q 040702          335 NNFSCVIPTKIGGLKDLQYLFLEYNRLQG-SIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEI  413 (797)
Q Consensus       335 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  413 (797)
                      |+++ ..|+++..++.|+.|++.+|+++. -+|..++.+..|+++..++|.+. ..|..++.+..|+.|.|+.|++-+.+
T Consensus       278 NQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLiTLP  355 (1255)
T KOG0444|consen  278 NQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLITLP  355 (1255)
T ss_pred             chhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccccceeech
Confidence            9999 789999999999999999999874 37999999999999999999997 89999999999999999999998877


Q ss_pred             CCCCCCCCCCcccccCCccccCCCC
Q 040702          414 PREGPFRNLSAESFKGNELLCGMPN  438 (797)
Q Consensus       414 p~~~~~~~l~~~~~~~n~~~c~~~~  438 (797)
                      ....-++.+..+++..||.+.-.|.
T Consensus       356 eaIHlL~~l~vLDlreNpnLVMPPK  380 (1255)
T KOG0444|consen  356 EAIHLLPDLKVLDLRENPNLVMPPK  380 (1255)
T ss_pred             hhhhhcCCcceeeccCCcCccCCCC
Confidence            6666788899999999998765553

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=100.00  E-value=4.7e-39  Score=322.64  Aligned_cols=378  Identities=28%  Similarity=0.411  Sum_probs=280.0

Q ss_pred             CCCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEE
Q 040702            3 SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSL   82 (797)
Q Consensus         3 ~l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L   82 (797)
                      +-|+|.++ .+|++.+++.+|..||.|+|.         +.++|++++.+..++.|+..+|+|++ .|..++++.+|..|
T Consensus        97 ~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~---------~~el~~~i~~~~~l~dl~~~~N~i~s-lp~~~~~~~~l~~l  165 (565)
T KOG0472|consen   97 NVSHNKLS-ELPEQIGSLISLVKLDCSSNE---------LKELPDSIGRLLDLEDLDATNNQISS-LPEDMVNLSKLSKL  165 (565)
T ss_pred             hcccchHh-hccHHHhhhhhhhhhhccccc---------eeecCchHHHHhhhhhhhcccccccc-CchHHHHHHHHHHh
Confidence            45667754 567788888888888888887         56777788888888888888888875 56777777888888


Q ss_pred             EccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccC
Q 040702           83 YLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYL  162 (797)
Q Consensus        83 ~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l  162 (797)
                      ++.+|+++ .+|.... +++.|++||...|-+. .+|..++.+.+|+-|+|.+|+|.. .| .|.++..|+.|+++.|.|
T Consensus       166 ~~~~n~l~-~l~~~~i-~m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~-lP-ef~gcs~L~Elh~g~N~i  240 (565)
T KOG0472|consen  166 DLEGNKLK-ALPENHI-AMKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIRF-LP-EFPGCSLLKELHVGENQI  240 (565)
T ss_pred             hccccchh-hCCHHHH-HHHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhccccc-CC-CCCccHHHHHHHhcccHH
Confidence            88888887 6665554 3777777777777765 667777777777777777777773 34 677776677777777766


Q ss_pred             cCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhh------------
Q 040702          163 TSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNL------------  230 (797)
Q Consensus       163 ~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L------------  230 (797)
                      ..+|.+.     ++++.+|..|||.+|+++ ..|+.+.-+. +|+.||+++|.|+ ..|..++++ .|            
T Consensus       241 ~~lpae~-----~~~L~~l~vLDLRdNklk-e~Pde~clLr-sL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrT  311 (565)
T KOG0472|consen  241 EMLPAEH-----LKHLNSLLVLDLRDNKLK-EVPDEICLLR-SLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRT  311 (565)
T ss_pred             HhhHHHH-----hcccccceeeeccccccc-cCchHHHHhh-hhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHH
Confidence            6666653     556666666777777766 3355555554 6666666666666 345555554 33            


Q ss_pred             ---------------------------------------------------HhhhcccccccccCCCchhhcCCCC---C
Q 040702          231 ---------------------------------------------------ILQLLSLEGNQLEGSIPDDLCRLAA---L  256 (797)
Q Consensus       231 ---------------------------------------------------~L~~L~Ls~N~l~~~~~~~~~~l~~---L  256 (797)
                                                                         ..++|+++.-+++. +|+..+....   .
T Consensus       312 iRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~-VPdEVfea~~~~~V  390 (565)
T KOG0472|consen  312 IRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTL-VPDEVFEAAKSEIV  390 (565)
T ss_pred             HHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhccccccccc-CCHHHHHHhhhcce
Confidence                                                               01334444444442 2222222222   4


Q ss_pred             cEEEccCCcCcccCCCCccCCcccc-ccccCCCCCCCCCCCCCCCCcccEEEccCCcCCCCCCccccccccccEEeccCc
Q 040702          257 FQLDLGGNKLSGFVPACSGNLTNLR-KLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMN  335 (797)
Q Consensus       257 ~~L~Ls~N~l~~~~~~~~~~l~~L~-~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N  335 (797)
                      +..+++.|++. ..|..+..++.+. .+.+++|.+.-+|..+..+++|..|++++|.+. .+|..++.+..|+.||+|.|
T Consensus       391 t~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~N  468 (565)
T KOG0472|consen  391 TSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFN  468 (565)
T ss_pred             EEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheeccccc
Confidence            55677777776 3455555555544 467777778888888889999999999999998 67889999999999999999


Q ss_pred             ccccccCccccCCcccceecccCccccCCCChhhhccccCCeeeecCCcCCCCCChhhhccCCCCeEEccCCcCc
Q 040702          336 NFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLE  410 (797)
Q Consensus       336 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  410 (797)
                      ++. ..|.++..+..|+.+-.++|++....|..+.+|.+|..|||.+|.+. .+|..++++++|+.|++++|+|.
T Consensus       469 rFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  469 RFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             ccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence            998 57888888888998888999999888888999999999999999998 88889999999999999999998

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.3e-35  Score=321.70  Aligned_cols=238  Identities=20%  Similarity=0.299  Sum_probs=190.6

Q ss_pred             hcCCCccccccccCCcceeecc----------eEEEEEEEEeccC-CcchhHHHHHHHhhhc-cCCceeEeeeeeecCC-
Q 040702          511 TNRFSENNLIGRGGFGPVYKDG----------MEVAIKVFNLQYG-GAFKSFDIECGMMKRI-RHRNLIKIISSCSNDD-  577 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~~----------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~-  577 (797)
                      .++|...+.||+|+||.||++.          ..||||+++.... ...+.+.+|+.+++.+ +||||++++++|...+ 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            4689999999999999999852          5799999875432 2345788999999999 8999999999887654 


Q ss_pred             eEEEEEEccCCCCHHHHHhcCC----------------------------------------------------------
Q 040702          578 FKALVLEYMPLGSLEKCLYSGN----------------------------------------------------------  599 (797)
Q Consensus       578 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  599 (797)
                      ..++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            6899999999999999986532                                                          


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccccccccccCccc
Q 040702          600 ---YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGY  676 (797)
Q Consensus       600 ---~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y  676 (797)
                         ..+++..+..++.||++||+|||   +++|+||||||+||+++.++.+||+|||+++...............++..|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence               13677888999999999999999   999999999999999999999999999999865433322222334567889


Q ss_pred             ccccccccCccchHHHHHHHhhhhhhhhc-cccccchh------------------hhhhhcccccchhccccCCCCCCC
Q 040702          677 MAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE------------------EKHLMTKEQPMVRMGTDLSLGQFP  737 (797)
Q Consensus       677 ~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~------------------~~~~~~~~~~l~~~cl~~dp~~RP  737 (797)
                      ||||.+.+..++.++|+|++|+..++.+. +..++...                  +......+.+++..|++.||++||
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP  322 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERP  322 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence            99999999999999999999998765542 32222110                  011223567899999999999999


Q ss_pred             ChHHHHHhHHHHHH
Q 040702          738 ASYSISKYLVYIRE  751 (797)
Q Consensus       738 s~~~i~~~l~~i~~  751 (797)
                      ++.++++.|+.+.+
T Consensus       323 s~~el~~~l~~~~~  336 (338)
T cd05102         323 TFSALVEILGDLLQ  336 (338)
T ss_pred             CHHHHHHHHHHHHh
Confidence            99999999987643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-36  Score=325.52  Aligned_cols=257  Identities=22%  Similarity=0.289  Sum_probs=211.3

Q ss_pred             CccCHHHHHHHhcCC---------CccccccccCCcceeecc--------eEEEEEEEEeccC-CcchhHHHHHHHhhhc
Q 040702          500 RRFTYLELFQATNRF---------SENNLIGRGGFGPVYKDG--------MEVAIKVFNLQYG-GAFKSFDIECGMMKRI  561 (797)
Q Consensus       500 ~~~~~~~l~~~~~~f---------~~~~~lg~G~~g~Vyk~~--------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l  561 (797)
                      ..+||++--+|...|         .+.++||.|.||+||+|.        ..||||.++.... ....+|..|+.||.++
T Consensus       608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF  687 (996)
T KOG0196|consen  608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF  687 (996)
T ss_pred             CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence            456777766665544         456899999999999863        6899999998753 3467899999999999


Q ss_pred             cCCceeEeeeeeecCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEE
Q 040702          562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL  641 (797)
Q Consensus       562 ~Hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll  641 (797)
                      +||||+++.|+.......+||+|||++|+|+.+++.+...+++.+...+.++||.|++||-   +.++|||||.++|||+
T Consensus       688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILV  764 (996)
T KOG0196|consen  688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILV  764 (996)
T ss_pred             CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheee
Confidence            9999999999999999999999999999999999998888999999999999999999999   9999999999999999


Q ss_pred             cCCCcEEEEeecCCccCCccC-ccccccccccCcccccccccccCccchHHHHHHHhhhhh-hhhccccccchhhh----
Q 040702          642 DDNMVAHLSDFGMAKPLLEED-QSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISV-MIVVDANLLIREEK----  715 (797)
Q Consensus       642 ~~~~~~kl~DFGla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~-~~~~~~~~~~~~~~----  715 (797)
                      +.+..+|++|||+++.+.++. ......+..-..+|.|||.|...+++..+||||+|+.++ -+-++.+++.+...    
T Consensus       765 NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI  844 (996)
T KOG0196|consen  765 NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI  844 (996)
T ss_pred             ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH
Confidence            999999999999999764433 112222223356899999999999999999999998862 22233333333222    


Q ss_pred             -------------hhhcccccchhccccCCCCCCCChHHHHHhHHHHHHHhcccccc
Q 040702          716 -------------HLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRELERGKVGI  759 (797)
Q Consensus       716 -------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~  759 (797)
                                   +....+.+++..||++|..+||++.||+..|+++...+..-...
T Consensus       845 kaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~  901 (996)
T KOG0196|consen  845 KAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTI  901 (996)
T ss_pred             HHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhccc
Confidence                         23446778888899999999999999999999987766554433

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.8e-35  Score=298.18  Aligned_cols=261  Identities=20%  Similarity=0.223  Sum_probs=199.6

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      -++|+..+.||+|.-|.||.+     +..+|+|++.+..   +....+...|.+||+.++||.++.+|+.++.+...|+|
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            357788899999999999963     4889999998763   23345778899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCc-
Q 040702          583 LEYMPLGSLEKCLYSGNY-ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE-  660 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~-  660 (797)
                      ||||+||+|....+++.. .+++..++.++.+|+-||+|||   -.|||.|||||+||||-++|++-|+||.++..... 
T Consensus       156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            999999999999887654 7999999999999999999999   99999999999999999999999999998753210 


Q ss_pred             --------------------------------c-C--------------------ccccccccccCcccccccccccCcc
Q 040702          661 --------------------------------E-D--------------------QSLTQTQTLATIGYMAPDEIFSGEM  687 (797)
Q Consensus       661 --------------------------------~-~--------------------~~~~~~~~~gt~~y~aPE~~~~~~~  687 (797)
                                                      . .                    .......++||-.|.|||++.+++.
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            0 0                    0011234689999999999999999


Q ss_pred             chHHHHHHHhhhhhhhhccccccchhhhhhhcccccchhcccc--CCCCCCCChHHHHHhHHHHHHHhccccccccccCC
Q 040702          688 RLKCWVNDSLLISVMIVVDANLLIREEKHLMTKEQPMVRMGTD--LSLGQFPASYSISKYLVYIRELERGKVGITSVAAF  765 (797)
Q Consensus       688 ~~~~dv~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~--~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~  765 (797)
                      +.++|+|++|+..++++.+..++.+...++.  +..++..-+.  ..|.---.++++.+.|  +.+.+..|+| ....|.
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~T--l~NIv~~~l~Fp~~~~vs~~akDLIr~L--LvKdP~kRlg-~~rGA~  387 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKET--LRNIVGQPLKFPEEPEVSSAAKDLIRKL--LVKDPSKRLG-SKRGAA  387 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhh--HHHHhcCCCcCCCCCcchhHHHHHHHHH--hccChhhhhc-cccchH
Confidence            9999999999999998888877766543311  1111211111  1110001122222211  3334444454 345678


Q ss_pred             cccccceeeeeeee
Q 040702          766 PIVHHYLYRTVDYT  779 (797)
Q Consensus       766 ~~~~~~~f~~~~~~  779 (797)
                      ++..|+||+||+|+
T Consensus       388 eIK~HpFF~gVnWa  401 (459)
T KOG0610|consen  388 EIKRHPFFEGVNWA  401 (459)
T ss_pred             HhhcCccccCCChh
Confidence            89999999999997

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.6e-36  Score=298.82  Aligned_cols=228  Identities=20%  Similarity=0.260  Sum_probs=197.1

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCC---cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG---AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      ..+|+..+.||+|.||.|-++     |+.||||.+++..-.   +.-.+.+|+++|+.++||||+.+|.+|+..+.+.+|
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            457888999999999999764     789999999876433   334577899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      |||..+|.|++|+.+++. +++.+++++++||.+|+.|+|   .++++|||+|.+|||+|+++++||+|||++-.+..+.
T Consensus       132 MEYaS~GeLYDYiSer~~-LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k  207 (668)
T KOG0611|consen  132 MEYASGGELYDYISERGS-LSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK  207 (668)
T ss_pred             EEecCCccHHHHHHHhcc-ccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence            999999999999998775 999999999999999999999   9999999999999999999999999999998765433


Q ss_pred             ccccccccccCcccccccccccCccc-hHHHHHHHhhhhhhhhccccccchhhh---------------hhhcccccchh
Q 040702          663 QSLTQTQTLATIGYMAPDEIFSGEMR-LKCWVNDSLLISVMIVVDANLLIREEK---------------HLMTKEQPMVR  726 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~dv~s~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~l~~  726 (797)
                         ...+++|++-|.+||.+-+..|. ..+|.|++|+..+..+.+.-++++...               ........+++
T Consensus       208 ---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~PSdA~gLIR  284 (668)
T KOG0611|consen  208 ---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPETPSDASGLIR  284 (668)
T ss_pred             ---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCCCchHHHHHH
Confidence               45779999999999999888874 889999999988766666555554322               22335567899


Q ss_pred             ccccCCCCCCCChHHHHHh
Q 040702          727 MGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       727 ~cl~~dp~~RPs~~~i~~~  745 (797)
                      +++-.+|++|-|+.+|+..
T Consensus       285 wmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  285 WMLMVNPERRATIEDIASH  303 (668)
T ss_pred             HHHhcCcccchhHHHHhhh
Confidence            9999999999999999875

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.1e-35  Score=309.90  Aligned_cols=193  Identities=28%  Similarity=0.356  Sum_probs=172.3

Q ss_pred             cCCCccccccccCCcceeecc-----eEEEEEEEEeccCC--cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKDG-----MEVAIKVFNLQYGG--AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~~-----~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      ++|.+.+.||+|+||.||||.     +.||+|.+.+..+.  ..+.+.+|++++++++|||||.++++|+...+.|+|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            578888999999999999973     78999999876443  34678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      |+.| +|..++..... ++++.+..++.|+++||.|||   +.+|+|||+||.|||++..|.+|+||||+|+.+....  
T Consensus        82 ~a~g-~L~~il~~d~~-lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t--  154 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDGK-LPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT--  154 (808)
T ss_pred             hhhh-hHHHHHHhccC-CCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccCc--
Confidence            9976 99999987664 999999999999999999999   9999999999999999999999999999999775432  


Q ss_pred             ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccc
Q 040702          665 LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLI  711 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~  711 (797)
                      ...+...|||.|||||.+.+..|+..+|.|++|++.|+..++.+++-
T Consensus       155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~  201 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY  201 (808)
T ss_pred             eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch
Confidence            24466789999999999999999999999999999988777666543

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.1e-35  Score=311.88  Aligned_cols=241  Identities=21%  Similarity=0.280  Sum_probs=191.5

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEeccC---CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG---GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      .|+..+.||+|+||.||++     ++.||||.+.....   .....+.+|+.++++++|++|+++++++.+.+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            3777899999999999974     68899999875431   223467889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          585 YMPLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      |+++|+|.+++.... ..+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+||+|||++....... 
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-  156 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence            999999988876433 35899999999999999999999   9999999999999999999999999999998653222 


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh--------------------hhhhccccc
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE--------------------KHLMTKEQP  723 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~  723 (797)
                        ......||..|||||.+.+..++.++|+|++|+..+..+.+..++....                    ......+.+
T Consensus       157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (285)
T cd05631         157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKS  234 (285)
T ss_pred             --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHH
Confidence              2234579999999999999999999999999998866665544432210                    112234556


Q ss_pred             chhccccCCCCCCCChHHHHHhHHHHHHHhccccccccccCCcccccceeeeeeee
Q 040702          724 MVRMGTDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYT  779 (797)
Q Consensus       724 l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~  779 (797)
                      +++.|+..||.+||++.+                    ..+.++++|+||++++|+
T Consensus       235 li~~~l~~~P~~R~~~~~--------------------~~~~~~~~h~~~~~~~~~  270 (285)
T cd05631         235 ICRMLLTKNPKERLGCRG--------------------NGAAGVKQHPIFKNINFK  270 (285)
T ss_pred             HHHHHhhcCHHHhcCCCC--------------------CCHHHHhcCHhhcCCCHH
Confidence            777788888888877332                    234556677777777664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=8.9e-35  Score=310.25  Aligned_cols=233  Identities=22%  Similarity=0.312  Sum_probs=187.7

Q ss_pred             cCCCccccccccCCcceeec---------------------ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEe
Q 040702          512 NRFSENNLIGRGGFGPVYKD---------------------GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKI  569 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~---------------------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l  569 (797)
                      ++|...+.||+|+||.||++                     +..||+|.+..... ....++.+|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            57888999999999999974                     23699999876432 234578999999999999999999


Q ss_pred             eeeeecCCeEEEEEEccCCCCHHHHHhcCC------------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEE
Q 040702          570 ISSCSNDDFKALVLEYMPLGSLEKCLYSGN------------------YILDIFQGLNIMIDVASALEYLHFGYSVPIIH  631 (797)
Q Consensus       570 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivH  631 (797)
                      ++++.+.+..++||||+++|+|.+++....                  ..+++..+.+++.|++.|++|||   +.+|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccc
Confidence            999999999999999999999999886432                  13677888999999999999999   999999


Q ss_pred             cCCCCCceEEcCCCcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc--cccc
Q 040702          632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV--DANL  709 (797)
Q Consensus       632 rDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~--~~~~  709 (797)
                      |||||+||+++.++.+||+|||+++...............++..|||||.+..+.++.++|+|++|+..++.+.  .+.+
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999986543332222233456889999999998899999999999998754432  2222


Q ss_pred             cchhh------------------------hhhhcccccchhccccCCCCCCCChHHHHHhHH
Q 040702          710 LIREE------------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISKYLV  747 (797)
Q Consensus       710 ~~~~~------------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~  747 (797)
                      +....                        ......+.+++..||+.||++||++.++.+.|+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         242 YGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            21110                        011234678999999999999999999988765

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=292.99  Aligned_cols=226  Identities=21%  Similarity=0.275  Sum_probs=195.6

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      +-|++.++||+|+||.|||+     |+.||||.+....  +.+++..|+.++++++.|+||++||.+......|+|||||
T Consensus        33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC  110 (502)
T KOG0574|consen   33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC  110 (502)
T ss_pred             HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence            34677789999999999984     7999999987664  4689999999999999999999999998888999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccc
Q 040702          587 PLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  666 (797)
Q Consensus       587 ~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  666 (797)
                      ..|+..++++-+++.+.+.++..+++..++||+|||   ...-+|||||+-|||+..+|.+|++|||.|..+.  ++...
T Consensus       111 GAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT--DTMAK  185 (502)
T KOG0574|consen  111 GAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLT--DTMAK  185 (502)
T ss_pred             CCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhh--hhHHh
Confidence            999999999988888999999999999999999999   7788999999999999999999999999998663  23335


Q ss_pred             ccccccCcccccccccccCccchHHHHHHHhhhhhhhhccc-------------------cccchhhhhhhcccccchhc
Q 040702          667 QTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDA-------------------NLLIREEKHLMTKEQPMVRM  727 (797)
Q Consensus       667 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~l~~~  727 (797)
                      ..+..||+.|||||++..-+|+.++|+|++|+..+++.-+.                   ++.-.-+........++++.
T Consensus       186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~  265 (502)
T KOG0574|consen  186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRS  265 (502)
T ss_pred             hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHH
Confidence            56788999999999999999999999999998764433222                   22223444566788899999


Q ss_pred             cccCCCCCCCChHHHHH
Q 040702          728 GTDLSLGQFPASYSISK  744 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~  744 (797)
                      |+...|++|-++-++++
T Consensus       266 CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  266 CLIKKPEERKTALRLCE  282 (502)
T ss_pred             HhcCCHHHHHHHHHHhh
Confidence            99999999999887765

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=301.99  Aligned_cols=269  Identities=20%  Similarity=0.266  Sum_probs=219.6

Q ss_pred             cCHHHHHHHh-cCCCccccccccCCcceee-----cceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeee
Q 040702          502 FTYLELFQAT-NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISS  572 (797)
Q Consensus       502 ~~~~~l~~~~-~~f~~~~~lg~G~~g~Vyk-----~~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~  572 (797)
                      +.+-|++..| +.|..-++||+||||+||-     +|+.||.|.+.+..   +.......+|-.+|.+++.|.||.+-.+
T Consensus       174 WK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA  253 (591)
T KOG0986|consen  174 WKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA  253 (591)
T ss_pred             HHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee
Confidence            3444544444 5678889999999999994     57889999886542   2334667889999999999999999999


Q ss_pred             eecCCeEEEEEEccCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEe
Q 040702          573 CSNDDFKALVLEYMPLGSLEKCLYSGNY-ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSD  651 (797)
Q Consensus       573 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  651 (797)
                      |+..+..|+|+..|.||+|..++...+. .+++..+..++.+|+.||++||   ..+||.||+||+|||+|+.|+++|+|
T Consensus       254 feTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISD  330 (591)
T KOG0986|consen  254 FETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISD  330 (591)
T ss_pred             ecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeec
Confidence            9999999999999999999998876553 5899999999999999999999   99999999999999999999999999


Q ss_pred             ecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhhhhhcccccchhccccC
Q 040702          652 FGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEKHLMTKEQPMVRMGTDL  731 (797)
Q Consensus       652 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~  731 (797)
                      .|+|..+....   ...+.+||.+|||||++..+.|+...|+|++|+..++++.+..++..+....-.   +-+.+....
T Consensus       331 LGLAvei~~g~---~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~---eEvdrr~~~  404 (591)
T KOG0986|consen  331 LGLAVEIPEGK---PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR---EEVDRRTLE  404 (591)
T ss_pred             cceEEecCCCC---ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH---HHHHHHHhc
Confidence            99999876544   345569999999999999999999999999999999888888877665543222   234555556


Q ss_pred             CCCCCCC-h-HHHHHhHHH-HHHHhccccccccccCCcccccceeeeeeee
Q 040702          732 SLGQFPA-S-YSISKYLVY-IRELERGKVGITSVAAFPIVHHYLYRTVDYT  779 (797)
Q Consensus       732 dp~~RPs-~-~~i~~~l~~-i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~  779 (797)
                      ||.+-|. + .+.-..++. +.+.+..|.|-.-..+....+||||++++|.
T Consensus       405 ~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~  455 (591)
T KOG0986|consen  405 DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWR  455 (591)
T ss_pred             chhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHh
Confidence            7777763 2 223333333 4556777788888899999999999999995

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.2e-34  Score=276.99  Aligned_cols=237  Identities=23%  Similarity=0.306  Sum_probs=198.3

Q ss_pred             HHHHHHhcCCCccccccccCCcceee-----cceEEEEEEEEeccCCc--------chhHHHHHHHhhhc-cCCceeEee
Q 040702          505 LELFQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGA--------FKSFDIECGMMKRI-RHRNLIKII  570 (797)
Q Consensus       505 ~~l~~~~~~f~~~~~lg~G~~g~Vyk-----~~~~vAvK~~~~~~~~~--------~~~~~~E~~~l~~l-~Hpniv~l~  570 (797)
                      .+-...-..|...+.+|.|..+.|.+     +++++|+|++.......        .++..+|+.+|+++ .||+|+++.
T Consensus        10 ~aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~   89 (411)
T KOG0599|consen   10 DAAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQ   89 (411)
T ss_pred             hhHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEee
Confidence            34445556788889999999998864     68999999997653211        23456799999998 599999999


Q ss_pred             eeeecCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEE
Q 040702          571 SSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLS  650 (797)
Q Consensus       571 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~  650 (797)
                      ++++.+.+.++|+|.|+.|.|.+++...-. +++....+|++|+..|++|||   ...|||||+||+|||+|++.++||+
T Consensus        90 D~yes~sF~FlVFdl~prGELFDyLts~Vt-lSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~is  165 (411)
T KOG0599|consen   90 DVYESDAFVFLVFDLMPRGELFDYLTSKVT-LSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKIS  165 (411)
T ss_pred             eeccCcchhhhhhhhcccchHHHHhhhhee-ecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEe
Confidence            999999999999999999999999987654 899999999999999999999   9999999999999999999999999


Q ss_pred             eecCCccCCccCccccccccccCcccccccccc------cCccchHHHHHHHhhhhhhhhccccccchhhh---------
Q 040702          651 DFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIF------SGEMRLKCWVNDSLLISVMIVVDANLLIREEK---------  715 (797)
Q Consensus       651 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~---------  715 (797)
                      |||+|+.+..+.   .....+|||+|.|||.+.      ..+|+..+|.|++|++.+..+.+.+++.....         
T Consensus       166 DFGFa~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Ime  242 (411)
T KOG0599|consen  166 DFGFACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIME  242 (411)
T ss_pred             ccceeeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHh
Confidence            999999875433   456789999999999774      45789999999999988766666555443222         


Q ss_pred             -----------hhhcccccchhccccCCCCCCCChHHHHHhHHH
Q 040702          716 -----------HLMTKEQPMVRMGTDLSLGQFPASYSISKYLVY  748 (797)
Q Consensus       716 -----------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~  748 (797)
                                 +.....++++.+|++.||.+|-|++|.+..=..
T Consensus       243 GkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff  286 (411)
T KOG0599|consen  243 GKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFF  286 (411)
T ss_pred             cccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence                       345578899999999999999999999875433

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=6e-35  Score=313.98  Aligned_cols=214  Identities=21%  Similarity=0.240  Sum_probs=176.9

Q ss_pred             ccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccCCC
Q 040702          518 NLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLG  589 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~g  589 (797)
                      +.||+|+||.||++     ++.||||+++...   ......+.+|++++++++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999964     6889999998653   223456788999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccccccc
Q 040702          590 SLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ  669 (797)
Q Consensus       590 ~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  669 (797)
                      +|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  .....
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~  154 (323)
T cd05571          81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT  154 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccccc
Confidence            9999987654 4899999999999999999999   9999999999999999999999999999998542221  12344


Q ss_pred             cccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh----------------hhhhcccccchhccccCCC
Q 040702          670 TLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE----------------KHLMTKEQPMVRMGTDLSL  733 (797)
Q Consensus       670 ~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~l~~~cl~~dp  733 (797)
                      .+||+.|||||.+.+..++.++|+|++|+..++.+.+..++....                ......+.++++.|+..||
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP  234 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP  234 (323)
T ss_pred             eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCH
Confidence            679999999999998899999999999999866665544432211                1123355678888999999


Q ss_pred             CCCC
Q 040702          734 GQFP  737 (797)
Q Consensus       734 ~~RP  737 (797)
                      ++||
T Consensus       235 ~~R~  238 (323)
T cd05571         235 KQRL  238 (323)
T ss_pred             HHcC
Confidence            9998

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.5e-35  Score=310.16  Aligned_cols=229  Identities=23%  Similarity=0.269  Sum_probs=199.3

Q ss_pred             cCCCccccccccCCcceee-----cceEEEEEEEEeccC---CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYG---GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk-----~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      +-|+.++.||.|+-|.|..     +|+.+|||++.+...   .....+.+|+.+|+-+.||||+++|++|++..+.|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            5578889999999999975     589999999987632   23467889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      ||+++|.|++++-.++. +++.++.++++||+.|+.|+|   ..+|+|||+||+|+|+|..+++||+|||+|..-.++  
T Consensus        92 Eyv~gGELFdylv~kG~-l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g--  165 (786)
T KOG0588|consen   92 EYVPGGELFDYLVRKGP-LPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG--  165 (786)
T ss_pred             EecCCchhHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCC--
Confidence            99999999999987764 888999999999999999999   999999999999999999999999999999854322  


Q ss_pred             cccccccccCcccccccccccCccc-hHHHHHHHhhhhhhhhccccccchhh----------------hhhhcccccchh
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMR-LKCWVNDSLLISVMIVVDANLLIREE----------------KHLMTKEQPMVR  726 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~dv~s~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~l~~  726 (797)
                       ....+.||++.|.|||.+.+..|. .++|||++|++.+..+.+.-++++..                ..+....+++++
T Consensus       166 -klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr  244 (786)
T KOG0588|consen  166 -KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLR  244 (786)
T ss_pred             -ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHH
Confidence             244668999999999999999985 99999999999988777766665432                234557889999


Q ss_pred             ccccCCCCCCCChHHHHHhHH
Q 040702          727 MGTDLSLGQFPASYSISKYLV  747 (797)
Q Consensus       727 ~cl~~dp~~RPs~~~i~~~l~  747 (797)
                      +++..||++|-|++||.+.-.
T Consensus       245 ~ml~VDp~~RiT~~eI~kHP~  265 (786)
T KOG0588|consen  245 RMLDVDPSTRITTEEILKHPF  265 (786)
T ss_pred             HHhccCccccccHHHHhhCch
Confidence            999999999999999998653

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1e-34  Score=285.75  Aligned_cols=192  Identities=22%  Similarity=0.270  Sum_probs=164.2

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCC--cchhHHHHHHHhhhccCCceeEeeeeeecC--CeEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG--AFKSFDIECGMMKRIRHRNLIKIISSCSND--DFKAL  581 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~--~~~~l  581 (797)
                      .+.|+..+.|++|+||.||||     ++.||+|+++...+.  -.-.-.+|+.+|.+++|||||.+..+....  +.+|+
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            457888899999999999986     488999999877432  223467899999999999999999987654  57999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCcc
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  661 (797)
                      |||||++ +|...+..-+.++...+++.++.|+++|++|||   ...|+|||+||+|+|+...|.+||+|||+|+.+.+.
T Consensus       155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp  230 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP  230 (419)
T ss_pred             eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence            9999987 999999887778999999999999999999999   999999999999999999999999999999987544


Q ss_pred             CccccccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhcccc
Q 040702          662 DQSLTQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDAN  708 (797)
Q Consensus       662 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~  708 (797)
                        ....+..+-|.+|+|||.+++. .|+...|+||+|++..+.+...+
T Consensus       231 --~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kP  276 (419)
T KOG0663|consen  231 --LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKP  276 (419)
T ss_pred             --cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCC
Confidence              2245667889999999998865 58999999999998744443333

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4e-36  Score=282.95  Aligned_cols=228  Identities=20%  Similarity=0.339  Sum_probs=189.4

Q ss_pred             HhcCCCccccccccCCcceee-----cceEEEEEEEEec--cCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQ--YGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk-----~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      .++.|+..+.||+|+|+.||+     +|+.+|+|++...  .....+++.+|+++.+.++|||||++.+.....+..|+|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            356788889999999999997     5788999988654  234568899999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcC---CCcEEEEeecCCccCC
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLL  659 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~DFGla~~~~  659 (797)
                      +|+|.||+|..-+-.+ ..+++..+-.+++||++||.|+|   .++|||||+||+|+++..   ..-+|++|||+|..+.
T Consensus        89 Fe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             EecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            9999999996655443 34788889999999999999999   999999999999999953   3468999999999775


Q ss_pred             ccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccch-hhh-------------------hhhc
Q 040702          660 EEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIR-EEK-------------------HLMT  719 (797)
Q Consensus       660 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~-~~~-------------------~~~~  719 (797)
                         ......+++|||+|||||++...+|+..+|+|+.|++.+..+++..++.+ ...                   ...+
T Consensus       165 ---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~  241 (355)
T KOG0033|consen  165 ---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTP  241 (355)
T ss_pred             ---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCH
Confidence               22356778999999999999999999999999999998555554444333 111                   1233


Q ss_pred             ccccchhccccCCCCCCCChHHHHH
Q 040702          720 KEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       720 ~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      ..++++++|+..||.+|.|+.|.++
T Consensus       242 ~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  242 EAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             HHHHHHHHHhccChhhhccHHHHhC
Confidence            5678899999999999999988765

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-35  Score=304.62  Aligned_cols=234  Identities=23%  Similarity=0.320  Sum_probs=193.8

Q ss_pred             CCCccccccccCCcceee----cceEEEEEEEEeccCC-cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccC
Q 040702          513 RFSENNLIGRGGFGPVYK----DGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  587 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk----~~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~  587 (797)
                      ....+++||+|-||+|..    +...||||.++..... ...+|..|+++|.+++|||||+++|+|..++.+++|+|||+
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmE  618 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYME  618 (807)
T ss_pred             heehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHh
Confidence            345578999999999986    4589999999877543 35899999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccc
Q 040702          588 LGSLEKCLYSGNYI-LDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  666 (797)
Q Consensus       588 ~g~L~~~l~~~~~~-l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  666 (797)
                      +|+|.+++..+..+ .......+|+.|||+|++||.   +.++||||+.+.|+|+|.++++||+|||.++-+...+.+..
T Consensus       619 nGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v  695 (807)
T KOG1094|consen  619 NGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV  695 (807)
T ss_pred             cCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCceee
Confidence            99999999877432 355567789999999999999   99999999999999999999999999999997776665555


Q ss_pred             ccccccCcccccccccccCccchHHHHHHHhhhhhh--hhccccccchhhh------------------------hhhcc
Q 040702          667 QTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVM--IVVDANLLIREEK------------------------HLMTK  720 (797)
Q Consensus       667 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~--~~~~~~~~~~~~~------------------------~~~~~  720 (797)
                      ....+-..+|||||.+.-++++.++|||++|...++  ..-..+++.....                        -....
T Consensus       696 qgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~  775 (807)
T KOG1094|consen  696 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQG  775 (807)
T ss_pred             ecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHH
Confidence            555667789999999999999999999999987632  2222222222111                        11224


Q ss_pred             cccchhccccCCCCCCCChHHHHHhHHHH
Q 040702          721 EQPMVRMGTDLSLGQFPASYSISKYLVYI  749 (797)
Q Consensus       721 ~~~l~~~cl~~dp~~RPs~~~i~~~l~~i  749 (797)
                      +.+++..||..|.++||+++++...+++.
T Consensus       776 lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  776 LYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             HHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            55788889999999999999999888653

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2e-34  Score=315.83  Aligned_cols=235  Identities=21%  Similarity=0.294  Sum_probs=189.2

Q ss_pred             hcCCCccccccccCCcceeec----------ceEEEEEEEEecc-CCcchhHHHHHHHhhhc-cCCceeEeeeeeecCCe
Q 040702          511 TNRFSENNLIGRGGFGPVYKD----------GMEVAIKVFNLQY-GGAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDF  578 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~----------~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~  578 (797)
                      .++|+..+.||+|+||.||++          +..||||+++... ....+.+.+|+.+++.+ +||||++++++|...+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            457888999999999999975          3579999987543 22346788999999999 89999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCC-----------------------------------------------------------
Q 040702          579 KALVLEYMPLGSLEKCLYSGN-----------------------------------------------------------  599 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  599 (797)
                      .++||||+++|+|.+++....                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999999886432                                                           


Q ss_pred             ---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          600 ---------------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       600 ---------------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                                     ..+++..+.+++.||++||+|||   +++|+||||||+||+++.++.+||+|||+++........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                           13678889999999999999999   999999999999999999999999999999865433222


Q ss_pred             ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchhh------------------hhhhcccccch
Q 040702          665 LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIREE------------------KHLMTKEQPMV  725 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~~------------------~~~~~~~~~l~  725 (797)
                      .......++..|||||.+.+..++.++|+|++|+..++.+. +..++....                  ......+.+++
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  350 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIM  350 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHH
Confidence            22222345678999999999999999999999998755442 222221110                  01123567899


Q ss_pred             hccccCCCCCCCChHHHHHhHHH
Q 040702          726 RMGTDLSLGQFPASYSISKYLVY  748 (797)
Q Consensus       726 ~~cl~~dp~~RPs~~~i~~~l~~  748 (797)
                      +.|++.||++||++.|+++.+++
T Consensus       351 ~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         351 KSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             HHHccCChhHCcCHHHHHHHHHh
Confidence            99999999999999999998875

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-34  Score=310.29  Aligned_cols=240  Identities=23%  Similarity=0.287  Sum_probs=194.7

Q ss_pred             HhcCCCccccccccCCcceeecc--------eE-EEEEEEEec---cCCcchhHHHHHHHhhhccCCceeEeeeeeecCC
Q 040702          510 ATNRFSENNLIGRGGFGPVYKDG--------ME-VAIKVFNLQ---YGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDD  577 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~~--------~~-vAvK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~  577 (797)
                      ..++-...++||+|+||+||+|.        .. ||||..+..   ......+|.+|+++|+.++|||||++||++....
T Consensus       155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~  234 (474)
T KOG0194|consen  155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE  234 (474)
T ss_pred             eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence            34455566899999999999852        23 899998853   2345678999999999999999999999999999


Q ss_pred             eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCcc
Q 040702          578 FKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  657 (797)
Q Consensus       578 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  657 (797)
                      ..++|||+|.||+|.+++++.+..++..+...++.+.|.||+|||   +++++||||-++|+|++.++.+||+|||+++.
T Consensus       235 Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~  311 (474)
T KOG0194|consen  235 PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSRA  311 (474)
T ss_pred             ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCccccccC
Confidence            999999999999999999988767999999999999999999999   99999999999999999999999999999885


Q ss_pred             CCccCcccccc-ccccCcccccccccccCccchHHHHHHHhhhhhhhhcc--ccccchh-----------------hhhh
Q 040702          658 LLEEDQSLTQT-QTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVD--ANLLIRE-----------------EKHL  717 (797)
Q Consensus       658 ~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~--~~~~~~~-----------------~~~~  717 (797)
                      ..   .+.... ...-...|+|||.+..+.|+.++|||++|+..++...+  .++.+..                 +...
T Consensus       312 ~~---~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~  388 (474)
T KOG0194|consen  312 GS---QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKT  388 (474)
T ss_pred             Cc---ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCC
Confidence            32   111111 22356789999999999999999999999876333322  2221111                 1112


Q ss_pred             hcccccchhccccCCCCCCCChHHHHHhHHHHHHHhcc
Q 040702          718 MTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRELERG  755 (797)
Q Consensus       718 ~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~~  755 (797)
                      ...+..++..||..||++||+|.++.+.++.+..-...
T Consensus       389 p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  389 PKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             HHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence            23556677789999999999999999999998777554

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=2.4e-34  Score=314.95  Aligned_cols=236  Identities=21%  Similarity=0.334  Sum_probs=190.3

Q ss_pred             hcCCCccccccccCCcceeecc----------eEEEEEEEEeccC-CcchhHHHHHHHhhhc-cCCceeEeeeeeecCCe
Q 040702          511 TNRFSENNLIGRGGFGPVYKDG----------MEVAIKVFNLQYG-GAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDF  578 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~~----------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~  578 (797)
                      .++|+..+.||+|+||.||++.          ..||||+++.... .....+.+|+.+++.+ +|||||+++++|...+.
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            3579999999999999999742          4799999975532 2345688999999999 89999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCC-----------------------------------------------------------
Q 040702          579 KALVLEYMPLGSLEKCLYSGN-----------------------------------------------------------  599 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  599 (797)
                      .++||||+++|+|.+++....                                                           
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999999885421                                                           


Q ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccccccc
Q 040702          600 ----------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ  669 (797)
Q Consensus       600 ----------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  669 (797)
                                ..+++..+.+++.||++||+|||   +++|+||||||+||++++++.+||+|||+++.............
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~  273 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN  273 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence                      13678889999999999999999   99999999999999999999999999999986543322222223


Q ss_pred             cccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchhh------------------hhhhcccccchhcccc
Q 040702          670 TLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIREE------------------KHLMTKEQPMVRMGTD  730 (797)
Q Consensus       670 ~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~~------------------~~~~~~~~~l~~~cl~  730 (797)
                      ..++..|||||.+.+..++.++|+|++|+..+..+. +..++....                  ......+.++++.|++
T Consensus       274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  353 (374)
T cd05106         274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWN  353 (374)
T ss_pred             CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcC
Confidence            345678999999998999999999999998865543 332221100                  0123456788999999


Q ss_pred             CCCCCCCChHHHHHhHHHH
Q 040702          731 LSLGQFPASYSISKYLVYI  749 (797)
Q Consensus       731 ~dp~~RPs~~~i~~~l~~i  749 (797)
                      .||.+||++.++.+.++++
T Consensus       354 ~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         354 LEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             CChhhCcCHHHHHHHHHHH
Confidence            9999999999999998875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.3e-35  Score=275.62  Aligned_cols=228  Identities=21%  Similarity=0.246  Sum_probs=196.3

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      -++|+.++.||+|-||.||.+     +-.||+|++.+..   .+..+++.+|+++-+.++||||.++|++|.+....|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            378999999999999999965     4689999997663   33457899999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCcc
Q 040702          583 LEYMPLGSLEKCLYSGNY-ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  661 (797)
                      +||.+.|++...+...+. .+++..+..++.|+|.|+.|+|   .++|+||||||+|+|++.++..||+|||.+-.-+  
T Consensus       101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--  175 (281)
T ss_pred             EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence            999999999999985443 5888999999999999999999   9999999999999999999999999999986432  


Q ss_pred             CccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh----------------hhhcccccch
Q 040702          662 DQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK----------------HLMTKEQPMV  725 (797)
Q Consensus       662 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~l~  725 (797)
                        .....+.+||..|.|||++.+..++..+|+|++|+..++.+++.+++.....                ......++++
T Consensus       176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a~dlI  253 (281)
T KOG0580|consen  176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGAADLI  253 (281)
T ss_pred             --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhHHHHH
Confidence              2345678999999999999999999999999999998777776665544222                2234667888


Q ss_pred             hccccCCCCCCCChHHHHHh
Q 040702          726 RMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       726 ~~cl~~dp~~RPs~~~i~~~  745 (797)
                      ..|+..+|.+|.+..|+++.
T Consensus       254 ~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  254 SRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             HHHhccCccccccHHHHhhh
Confidence            88999999999998888764

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-35  Score=307.95  Aligned_cols=218  Identities=24%  Similarity=0.298  Sum_probs=181.8

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccC---CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG---GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ++|+..+.||+|+||.||++     ++.||+|++.....   ...+.+.+|++++++++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888999999999999974     58899999975432   23456888999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      ||+++|+|.+++...+ .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.....  
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--  154 (291)
T cd05612          81 EYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--  154 (291)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence            9999999999997655 4888999999999999999999   999999999999999999999999999999865321  


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh----------------hhhhcccccchhc
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE----------------KHLMTKEQPMVRM  727 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~l~~~  727 (797)
                         .....||+.|+|||.+.+..++.++|+|++|+..+..+.+..++....                ......+.++++.
T Consensus       155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~  231 (291)
T cd05612         155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKK  231 (291)
T ss_pred             ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHH
Confidence               223579999999999988889999999999999866665544432211                1122345678888


Q ss_pred             cccCCCCCCCC
Q 040702          728 GTDLSLGQFPA  738 (797)
Q Consensus       728 cl~~dp~~RPs  738 (797)
                      |+..||.+||+
T Consensus       232 ~l~~dp~~R~~  242 (291)
T cd05612         232 LLVVDRTRRLG  242 (291)
T ss_pred             HcCCCHHHccC
Confidence            89999999885

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=6.8e-35  Score=314.28  Aligned_cols=218  Identities=21%  Similarity=0.243  Sum_probs=182.3

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ++|...+.||+|+||.||++     ++.||||+++...   ....+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            67899999999999999974     5789999997653   223457889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....  
T Consensus        98 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--  171 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--  171 (329)
T ss_pred             cCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--
Confidence            9999999999997655 4788899999999999999999   999999999999999999999999999999865322  


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh-h---------------hhcccccchhc
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK-H---------------LMTKEQPMVRM  727 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~-~---------------~~~~~~~l~~~  727 (797)
                         .....||+.|+|||.+.+..++.++|+|++|+..+..+.+..++..... +               ......++++.
T Consensus       172 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~  248 (329)
T PTZ00263        172 ---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKG  248 (329)
T ss_pred             ---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHH
Confidence               1235799999999999988899999999999998666655444322111 0               12245577888


Q ss_pred             cccCCCCCCCC
Q 040702          728 GTDLSLGQFPA  738 (797)
Q Consensus       728 cl~~dp~~RPs  738 (797)
                      |+..||.+||+
T Consensus       249 ~L~~dP~~R~~  259 (329)
T PTZ00263        249 LLQTDHTKRLG  259 (329)
T ss_pred             HhhcCHHHcCC
Confidence            88888888886

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.7e-34  Score=311.84  Aligned_cols=218  Identities=22%  Similarity=0.235  Sum_probs=179.9

Q ss_pred             hcCCCccccccccCCcceeec------ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD------GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~------~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l  581 (797)
                      .++|+..+.||+|+||.||++      +..||+|++....   ....+.+.+|+++++.++||||+++++++.+++..|+
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            357999999999999999975      2579999997542   2234578889999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCcc
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  661 (797)
                      ||||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       109 v~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence            999999999999997655 4889999999999999999999   999999999999999999999999999999865321


Q ss_pred             CccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh----------------hhhcccccch
Q 040702          662 DQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK----------------HLMTKEQPMV  725 (797)
Q Consensus       662 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~l~  725 (797)
                           .....||+.|||||.+.+..++.++|+|++|+..+..+.+..++.....                .......+++
T Consensus       185 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li  259 (340)
T PTZ00426        185 -----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLM  259 (340)
T ss_pred             -----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence                 2345799999999999888899999999999998666655544332211                1122345666


Q ss_pred             hccccCCCCCCC
Q 040702          726 RMGTDLSLGQFP  737 (797)
Q Consensus       726 ~~cl~~dp~~RP  737 (797)
                      +.|++.||.+|+
T Consensus       260 ~~~l~~dp~~R~  271 (340)
T PTZ00426        260 KKLLSHDLTKRY  271 (340)
T ss_pred             HHHcccCHHHcC
Confidence            777777777775

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.2e-34  Score=287.97  Aligned_cols=198  Identities=26%  Similarity=0.346  Sum_probs=169.3

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCc-eeEeeeeeecCC-----
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRN-LIKIISSCSNDD-----  577 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpn-iv~l~~~~~~~~-----  577 (797)
                      ...|+..++||+|+||+||+|     |+.||+|.++...+  +......+|+.+++.++|+| ||++++++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            456777889999999999985     68999999987744  45567889999999999999 999999998877     


Q ss_pred             -eEEEEEEccCCCCHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeec
Q 040702          578 -FKALVLEYMPLGSLEKCLYSGN---YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFG  653 (797)
Q Consensus       578 -~~~lv~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG  653 (797)
                       ..++|+||++. +|..++....   ..++...++.+++||+.||+|||   +++|+||||||+||+++.+|.+||+|||
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccc
Confidence             89999999965 9999998765   34777889999999999999999   9999999999999999999999999999


Q ss_pred             CCccCCccCccccccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccccccchhh
Q 040702          654 MAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANLLIREE  714 (797)
Q Consensus       654 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~~~~~~  714 (797)
                      +|+...-+.  ...+..++|.+|+|||++++. .|+...|+|++|++..+++...+++.+..
T Consensus       166 lAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~s  225 (323)
T KOG0594|consen  166 LARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDS  225 (323)
T ss_pred             hHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCc
Confidence            999654222  234567899999999999877 68999999999999866666666655433

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5.3e-34  Score=304.07  Aligned_cols=193  Identities=25%  Similarity=0.334  Sum_probs=161.5

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      .++|+..+.||+|+||.||++     ++.||||+++.... .....+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            478999999999999999975     57899999975532 223467889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      |++ +++.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++......  
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--  157 (303)
T cd07869          84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS--  157 (303)
T ss_pred             CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--
Confidence            996 5888888766556888999999999999999999   9999999999999999999999999999997542221  


Q ss_pred             ccccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccc
Q 040702          665 LTQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANL  709 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~  709 (797)
                      .......||+.|+|||.+.+ ..++.++|+|++|+..+..+.+..+
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p  203 (303)
T cd07869         158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAA  203 (303)
T ss_pred             ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            12234568999999998865 4578899999999987655554433

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-35  Score=308.82  Aligned_cols=223  Identities=26%  Similarity=0.288  Sum_probs=188.0

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCC---cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG---AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      +.|...+.||.|+||.||-+     .+.||||.+.-...+   ..+++..|++.|.+++|||++.+.|+|..+...|+||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            45777789999999999953     589999998655433   2467899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      |||- |+-.+++.-.++++.+.++..|..+.+.||+|||   +.+.||||||+-|||+++.|.||++|||.|....    
T Consensus       106 EYCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~----  177 (948)
T KOG0577|consen  106 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA----  177 (948)
T ss_pred             HHHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcC----
Confidence            9995 5889998877778889999999999999999999   9999999999999999999999999999998653    


Q ss_pred             cccccccccCcccccccccc---cCccchHHHHHHHhhhhhhhhc-cccccchh-----------------hhhhhcccc
Q 040702          664 SLTQTQTLATIGYMAPDEIF---SGEMRLKCWVNDSLLISVMIVV-DANLLIRE-----------------EKHLMTKEQ  722 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-----------------~~~~~~~~~  722 (797)
                        ....++|||.|||||+|+   .|.|+-++||||+|+..++..- .|+++...                 ..++...+.
T Consensus       178 --PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~  255 (948)
T KOG0577|consen  178 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFR  255 (948)
T ss_pred             --chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHH
Confidence              345689999999999886   6889999999999998744332 33333321                 123445677


Q ss_pred             cchhccccCCCCCCCChHHHHH
Q 040702          723 PMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       723 ~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      .++..|+..-|.+|||..++++
T Consensus       256 ~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  256 NFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             HHHHHHHhhCcccCCcHHHHhh
Confidence            8899999999999999988765

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.1e-33  Score=298.04  Aligned_cols=239  Identities=18%  Similarity=0.134  Sum_probs=192.9

Q ss_pred             cCccCHHHHHHHhcCCCccccccccCCcceeec---ceEEEEEEEEeccCCc---chhHHHHHHHhhhccCCceeEeeee
Q 040702          499 QRRFTYLELFQATNRFSENNLIGRGGFGPVYKD---GMEVAIKVFNLQYGGA---FKSFDIECGMMKRIRHRNLIKIISS  572 (797)
Q Consensus       499 ~~~~~~~~l~~~~~~f~~~~~lg~G~~g~Vyk~---~~~vAvK~~~~~~~~~---~~~~~~E~~~l~~l~Hpniv~l~~~  572 (797)
                      .+.++.+++     +......+|+|++|.||+|   ++.||||+++......   .+.+.+|+.++++++||||++++|+
T Consensus        12 ~~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~   86 (283)
T PHA02988         12 IKCIESDDI-----DKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGF   86 (283)
T ss_pred             ceecCHHHc-----CCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeee
Confidence            344555555     2233367999999999986   6899999997654333   4677899999999999999999999


Q ss_pred             eec----CCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCceEEcCCCcE
Q 040702          573 CSN----DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS-VPIIHCDLKPSNVLLDDNMVA  647 (797)
Q Consensus       573 ~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~-~~ivHrDlkp~NIll~~~~~~  647 (797)
                      +.+    ....++||||+++|+|.+++...+ .+++....+++.|++.|+.|||   . .+++||||||+||++++++.+
T Consensus        87 ~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~  162 (283)
T PHA02988         87 IIDIVDDLPRLSLILEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKL  162 (283)
T ss_pred             EEecccCCCceEEEEEeCCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcE
Confidence            876    346899999999999999998755 4889999999999999999999   6 488899999999999999999


Q ss_pred             EEEeecCCccCCccCccccccccccCccccccccccc--CccchHHHHHHHhhhhhhhhccccccchhhh----------
Q 040702          648 HLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS--GEMRLKCWVNDSLLISVMIVVDANLLIREEK----------  715 (797)
Q Consensus       648 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~----------  715 (797)
                      ||+|||+++.....     .....||..|+|||.+.+  ..++.++|+||+|+..++.+.+..++.....          
T Consensus       163 kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~  237 (283)
T PHA02988        163 KIICHGLEKILSSP-----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINK  237 (283)
T ss_pred             EEcccchHhhhccc-----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhc
Confidence            99999999865322     123568999999999875  6789999999999988665554444332111          


Q ss_pred             --------hhhcccccchhccccCCCCCCCChHHHHHhHHHHHH
Q 040702          716 --------HLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRE  751 (797)
Q Consensus       716 --------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~  751 (797)
                              .....+++++++||+.||++||++.|+++.|+..+.
T Consensus       238 ~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        238 NNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             CCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence                    123456789999999999999999999999987754

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-34  Score=310.95  Aligned_cols=225  Identities=20%  Similarity=0.297  Sum_probs=188.2

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ++|+..+.||+|+||.||++     ++.||||+++...   ....+.+..|++++..++||||+++++++..++..|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            46889999999999999975     5789999998653   223456888999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      ||+++|+|.+++.... .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++....   
T Consensus        81 e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---  153 (333)
T cd05600          81 EYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---  153 (333)
T ss_pred             eCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence            9999999999997654 4888999999999999999999   99999999999999999999999999999985532   


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh------------------------hhhc
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK------------------------HLMT  719 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~------------------------~~~~  719 (797)
                        ......||+.|+|||.+.+..++.++|+|++|+..++.+.+..++.....                        ....
T Consensus       154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~  231 (333)
T cd05600         154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSD  231 (333)
T ss_pred             --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCH
Confidence              23446799999999999988999999999999988666555444322110                        1123


Q ss_pred             ccccchhccccCCCCCCCChHHHHHh
Q 040702          720 KEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       720 ~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                      .+.++++.|+..+|.+||++.++++.
T Consensus       232 ~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         232 EAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             HHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            45668888999999999998888764

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-34  Score=294.76  Aligned_cols=239  Identities=25%  Similarity=0.256  Sum_probs=187.9

Q ss_pred             cCCCccccccccCCcceeec---ceEEEEEEEEeccCCcchhHHHHHHHhhh--ccCCceeEeeeeeecCC----eEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD---GMEVAIKVFNLQYGGAFKSFDIECGMMKR--IRHRNLIKIISSCSNDD----FKALV  582 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~---~~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~Hpniv~l~~~~~~~~----~~~lv  582 (797)
                      ......+.+|+|+||.||||   ++.||||++....   .+.|.+|-.+.+.  ++|+||++++++-....    .+++|
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV  286 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV  286 (534)
T ss_pred             CchhhHHHhhcCccceeehhhccCceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence            34455678999999999997   5999999998553   4678888888765  47999999999876655    89999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcc------CCCCeEEcCCCCCceEEcCCCcEEEEeecCCc
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFG------YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  656 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~------~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  656 (797)
                      +||.+.|+|.+++....  ++|....+|+.-+++||+|||+.      ++++|+|||||+.|||+..|+++.|+|||+|.
T Consensus       287 t~fh~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl  364 (534)
T KOG3653|consen  287 TEFHPKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLAL  364 (534)
T ss_pred             eeeccCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeE
Confidence            99999999999998774  89999999999999999999953      57789999999999999999999999999998


Q ss_pred             cCCccCccccccccccCcccccccccccC------ccchHHHHHHHhhhhhhhhcc---c--cc----cchhhh------
Q 040702          657 PLLEEDQSLTQTQTLATIGYMAPDEIFSG------EMRLKCWVNDSLLISVMIVVD---A--NL----LIREEK------  715 (797)
Q Consensus       657 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~dv~s~~~~~~~~~~~---~--~~----~~~~~~------  715 (797)
                      .+............+||.+|||||++.+.      .--...|||++|....+.+..   -  ..    .-.++.      
T Consensus       365 ~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hP  444 (534)
T KOG3653|consen  365 RLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHP  444 (534)
T ss_pred             EecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCC
Confidence            87655444445568999999999987532      122467999999765332211   1  00    001110      


Q ss_pred             -------------------------hhhcccccchhccccCCCCCCCChHHHHHhHHHHHHHhcc
Q 040702          716 -------------------------HLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRELERG  755 (797)
Q Consensus       716 -------------------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~~  755 (797)
                                               ..+..+.+.+..||+.||+.|-|+.=+.+++.++.....+
T Consensus       445 t~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~  509 (534)
T KOG3653|consen  445 TLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED  509 (534)
T ss_pred             CHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence                                     0122455666679999999999999999999998887654

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=8.7e-34  Score=310.07  Aligned_cols=261  Identities=20%  Similarity=0.260  Sum_probs=194.8

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ++|+..+.||+|+||.||++     ++.||||+++...   ......+..|+.++.+++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47889999999999999974     5799999997643   222356788999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.......
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~  156 (363)
T cd05628          81 EFLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR  156 (363)
T ss_pred             cCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence            9999999999997654 4899999999999999999999   99999999999999999999999999999975432110


Q ss_pred             c---------------------------------ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhcccccc
Q 040702          664 S---------------------------------LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLL  710 (797)
Q Consensus       664 ~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~  710 (797)
                      .                                 ......+||+.|||||.+.+..++.++|+|++|+..++++.+..++
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf  236 (363)
T cd05628         157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (363)
T ss_pred             ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence            0                                 0012457999999999999999999999999999987777666555


Q ss_pred             chhh-hhhhcccccchhccc-cCCCCCCCChHHHHHhHHHHHHHhccccccccccCCcccccceeeeeeeeec
Q 040702          711 IREE-KHLMTKEQPMVRMGT-DLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYTIS  781 (797)
Q Consensus       711 ~~~~-~~~~~~~~~l~~~cl-~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~  781 (797)
                      .... .+...   .+....- ...|...|-..+..+.+..+...+..+.+  ...+.++++|+||++++|+--
T Consensus       237 ~~~~~~~~~~---~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~--r~~~~ei~~hp~f~~~~~~~~  304 (363)
T cd05628         237 CSETPQETYK---KVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIG--APGVEEIKTNPFFEGVDWEHI  304 (363)
T ss_pred             CCCCHHHHHH---HHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCC--CCCHHHHhCCCCCCCCCHHHH
Confidence            4322 11111   1111100 01122333233444444443222222222  124577899999999999753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=4.5e-34  Score=307.44  Aligned_cols=221  Identities=20%  Similarity=0.175  Sum_probs=179.1

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccC-CceeEeeeeeecCCeEEEEE
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRH-RNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~H-pniv~l~~~~~~~~~~~lv~  583 (797)
                      +|+..+.||+|+||.||++     ++.||||+++...   ....+.+..|.++++.++| ++|+++++++...+..|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            5788899999999999985     4689999998652   2334667889999999976 56889999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.......
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05587          81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK  156 (324)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence            9999999999987654 4889999999999999999999   99999999999999999999999999999875322111


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh----------------hhhcccccchhc
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK----------------HLMTKEQPMVRM  727 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~l~~~  727 (797)
                        ......||+.|+|||.+.+..++.++|+|++|+..+..+.+..++.....                .......++++.
T Consensus       157 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~  234 (324)
T cd05587         157 --TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKG  234 (324)
T ss_pred             --ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence              23345799999999999988899999999999998666655544332111                122234567778


Q ss_pred             cccCCCCCCCCh
Q 040702          728 GTDLSLGQFPAS  739 (797)
Q Consensus       728 cl~~dp~~RPs~  739 (797)
                      |+..||.+||+.
T Consensus       235 ~l~~~P~~R~~~  246 (324)
T cd05587         235 LLTKHPAKRLGC  246 (324)
T ss_pred             HhhcCHHHcCCC
Confidence            888888888875

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-34  Score=305.60  Aligned_cols=217  Identities=19%  Similarity=0.185  Sum_probs=178.9

Q ss_pred             ccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccCCCCH
Q 040702          520 IGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSL  591 (797)
Q Consensus       520 lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~g~L  591 (797)
                      ||+|+||.||++     ++.||+|+++...   ......+.+|+.++++++||||+++++++..++..|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            699999999974     5789999997542   23345678899999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccccccccc
Q 040702          592 EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL  671 (797)
Q Consensus       592 ~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  671 (797)
                      .+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++......  .......
T Consensus        81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~  154 (312)
T cd05585          81 FHHLQREG-RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFC  154 (312)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccccc
Confidence            99997654 4899999999999999999999   9999999999999999999999999999998543222  1234467


Q ss_pred             cCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh----------------hhhhhcccccchhccccCCCCC
Q 040702          672 ATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE----------------EKHLMTKEQPMVRMGTDLSLGQ  735 (797)
Q Consensus       672 gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~l~~~cl~~dp~~  735 (797)
                      ||+.|||||.+.+..++.++|+|++|+..+..+.+..++...                +......+.++++.|+..||.+
T Consensus       155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~  234 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTR  234 (312)
T ss_pred             CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHH
Confidence            999999999999989999999999999986665554443221                1112235678899999999999


Q ss_pred             CCChHHH
Q 040702          736 FPASYSI  742 (797)
Q Consensus       736 RPs~~~i  742 (797)
                      ||+..++
T Consensus       235 R~~~~~~  241 (312)
T cd05585         235 RLGYNGA  241 (312)
T ss_pred             cCCCCCH
Confidence            9864333

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.7e-34  Score=308.30  Aligned_cols=221  Identities=21%  Similarity=0.235  Sum_probs=180.0

Q ss_pred             ccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccCCC
Q 040702          518 NLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLG  589 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~g  589 (797)
                      +.||+|+||.||++     ++.||||++....   ......+.+|+++++.++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999974     6899999997652   223457788999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccccccc
Q 040702          590 SLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ  669 (797)
Q Consensus       590 ~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  669 (797)
                      +|..++.... .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++......  .....
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~  154 (328)
T cd05593          81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKT  154 (328)
T ss_pred             CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccccc
Confidence            9998887654 4899999999999999999999   9999999999999999999999999999997542221  12234


Q ss_pred             cccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh----------------hhhcccccchhccccCCC
Q 040702          670 TLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK----------------HLMTKEQPMVRMGTDLSL  733 (797)
Q Consensus       670 ~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~l~~~cl~~dp  733 (797)
                      ..||+.|+|||.+.+..++.++|+|++|+..+..+.+..++.....                .....+.++++.|+..||
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP  234 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDP  234 (328)
T ss_pred             ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCH
Confidence            6799999999999988999999999999998666655444322111                112345677888888888


Q ss_pred             CCCC-----ChHHHHH
Q 040702          734 GQFP-----ASYSISK  744 (797)
Q Consensus       734 ~~RP-----s~~~i~~  744 (797)
                      ++||     ++.++++
T Consensus       235 ~~R~~~~~~~~~~il~  250 (328)
T cd05593         235 NKRLGGGPDDAKEIMR  250 (328)
T ss_pred             HHcCCCCCCCHHHHhc
Confidence            8887     5566554

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=5.3e-34  Score=306.51  Aligned_cols=221  Identities=20%  Similarity=0.236  Sum_probs=178.7

Q ss_pred             ccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccCCC
Q 040702          518 NLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLG  589 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~g  589 (797)
                      +.||+|+||.||++     +..||+|+++...   ......+.+|+++++.++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46899999999974     5889999998653   223456778999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccccccc
Q 040702          590 SLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ  669 (797)
Q Consensus       590 ~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  669 (797)
                      +|..++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  .....
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~~  154 (323)
T cd05595          81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKT  154 (323)
T ss_pred             cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccccc
Confidence            9998887654 4899999999999999999999   9999999999999999999999999999987532221  12234


Q ss_pred             cccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh----------------hhhhcccccchhccccCCC
Q 040702          670 TLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE----------------KHLMTKEQPMVRMGTDLSL  733 (797)
Q Consensus       670 ~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~l~~~cl~~dp  733 (797)
                      ..||+.|||||.+.++.++.++|+|++|+..+..+.+..++....                ......+.++++.|+..||
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP  234 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP  234 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCH
Confidence            679999999999999999999999999999866665544332211                1122345677788888888


Q ss_pred             CCCC-----ChHHHHH
Q 040702          734 GQFP-----ASYSISK  744 (797)
Q Consensus       734 ~~RP-----s~~~i~~  744 (797)
                      ++||     ++.++++
T Consensus       235 ~~R~~~~~~~~~~~l~  250 (323)
T cd05595         235 KQRLGGGPSDAKEVME  250 (323)
T ss_pred             HHhCCCCCCCHHHHHc
Confidence            8887     4555443

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.5e-33  Score=294.74  Aligned_cols=235  Identities=17%  Similarity=0.218  Sum_probs=190.2

Q ss_pred             hcCCCccccccccCCcceeec--------ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD--------GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~--------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l  581 (797)
                      .++|+..+.||+|+||.||++        +..||+|.++.... .....+.+|+.++++++||||+++++++...+..++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            357888999999999999975        36899999876532 223578899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCcc
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  661 (797)
                      ||||+++|+|.+++......+++..++.++.|++.|++|||   +.+++||||||+||+++.++.+|++|||.+......
T Consensus        84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            99999999999999876556899999999999999999999   999999999999999999999999999987653221


Q ss_pred             CccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-----------------hhhhhccccc
Q 040702          662 DQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-----------------EKHLMTKEQP  723 (797)
Q Consensus       662 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-----------------~~~~~~~~~~  723 (797)
                      .. .......++..|+|||.+..+.++.++|+|++|+..++.+. +..++...                 +......+.+
T Consensus       161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (266)
T cd05064         161 AI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQ  239 (266)
T ss_pred             ch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence            11 11122345678999999999999999999999998755332 22222111                 1112345667


Q ss_pred             chhccccCCCCCCCChHHHHHhHHHH
Q 040702          724 MVRMGTDLSLGQFPASYSISKYLVYI  749 (797)
Q Consensus       724 l~~~cl~~dp~~RPs~~~i~~~l~~i  749 (797)
                      ++..||+.+|++||++.++.+.++.+
T Consensus       240 li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         240 LMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             HHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            88899999999999999999987654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.6e-33  Score=309.42  Aligned_cols=236  Identities=20%  Similarity=0.315  Sum_probs=190.7

Q ss_pred             hcCCCccccccccCCcceeecc----------eEEEEEEEEeccC-CcchhHHHHHHHhhhcc-CCceeEeeeeeecCCe
Q 040702          511 TNRFSENNLIGRGGFGPVYKDG----------MEVAIKVFNLQYG-GAFKSFDIECGMMKRIR-HRNLIKIISSCSNDDF  578 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~~----------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~  578 (797)
                      .++|.+.+.||+|+||.||++.          ..||||+++.... ...+.+.+|+++++++. ||||++++++|...+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            5688999999999999999752          4699999975432 23467899999999996 9999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCC-----------------------------------------------------------
Q 040702          579 KALVLEYMPLGSLEKCLYSGN-----------------------------------------------------------  599 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~~~-----------------------------------------------------------  599 (797)
                      .|+||||+++|+|.+++....                                                           
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            999999999999999886421                                                           


Q ss_pred             ------------------------------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcC
Q 040702          600 ------------------------------------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD  643 (797)
Q Consensus       600 ------------------------------------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~  643 (797)
                                                          ..+++..+..++.|+++|++|||   +.+|+||||||+||+++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeC
Confidence                                                13677888899999999999999   999999999999999999


Q ss_pred             CCcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh---------
Q 040702          644 NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE---------  713 (797)
Q Consensus       644 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~---------  713 (797)
                      ++.+||+|||+++...............++..|||||.+.+..++.++|+|++|+..++.+. ...++...         
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~  352 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK  352 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH
Confidence            99999999999986543332222334457788999999998889999999999998755442 22221110         


Q ss_pred             ---------hhhhhcccccchhccccCCCCCCCChHHHHHhHHHH
Q 040702          714 ---------EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYI  749 (797)
Q Consensus       714 ---------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i  749 (797)
                               +......+.+++..||+.||++||++.++.+.++.+
T Consensus       353 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l  397 (400)
T cd05105         353 IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL  397 (400)
T ss_pred             HhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence                     111233567899999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.1e-34  Score=301.71  Aligned_cols=230  Identities=20%  Similarity=0.271  Sum_probs=195.5

Q ss_pred             hcCCCccccccccCCcceee-----cceEEEEEEEEecc--CCcchhHHHHHHHhhhccCCceeEeeeeeecCCe-EEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDF-KALV  582 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk-----~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~-~~lv  582 (797)
                      .++|..++++|+|+||.++.     ..+.||+|.+....  ....+...+|+.++++++|||||.+.+.|..++. .+||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            36799999999999999973     25789999998664  2334578899999999999999999999999988 9999


Q ss_pred             EEccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCcc
Q 040702          583 LEYMPLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  661 (797)
                      |+||+||++.+.+.+.+ ..+++..+..|+.|++.|+.|||   +..|+|||||+.||+++.++.+||+|||+|+.+.++
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            99999999999998766 47899999999999999999999   999999999999999999999999999999988655


Q ss_pred             CccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccch----------------hhhhhhcccccc
Q 040702          662 DQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIR----------------EEKHLMTKEQPM  724 (797)
Q Consensus       662 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~----------------~~~~~~~~~~~l  724 (797)
                      ..  ...+.+||+.||.||.+.+.+|..++|+|++|+..+++.. .+.+...                .+......++.+
T Consensus       160 ~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~l  237 (426)
T KOG0589|consen  160 DS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSL  237 (426)
T ss_pred             hh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHH
Confidence            42  4566889999999999999999999999999998744432 2222221                222334567788


Q ss_pred             hhccccCCCCCCCChHHHHHh
Q 040702          725 VRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       725 ~~~cl~~dp~~RPs~~~i~~~  745 (797)
                      ++.|+..+|..||++.+++..
T Consensus       238 v~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  238 VKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             HHHHhhcCCccCCCHHHHhhC
Confidence            999999999999999999875

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-34  Score=292.05  Aligned_cols=235  Identities=23%  Similarity=0.268  Sum_probs=184.6

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEeccC---------C-----cchhHHHHHHHhhhccCCceeEee
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG---------G-----AFKSFDIECGMMKRIRHRNLIKII  570 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~---------~-----~~~~~~~E~~~l~~l~Hpniv~l~  570 (797)
                      .-+.|+..+.||+|.||.|-++     ++.||||++.+...         .     ..+...+|+.+|++++|||||+++
T Consensus        95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li  174 (576)
T KOG0585|consen   95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI  174 (576)
T ss_pred             ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence            4578999999999999999864     68999999975421         1     124788999999999999999999


Q ss_pred             eeeecC--CeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEE
Q 040702          571 SSCSND--DFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAH  648 (797)
Q Consensus       571 ~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~k  648 (797)
                      .+..++  +..|||+|||..|.+...-.... .++..++++|++++..||+|||   .++|+||||||+|+|++++|++|
T Consensus       175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~-els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~VK  250 (576)
T KOG0585|consen  175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKP-ELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGTVK  250 (576)
T ss_pred             EeecCcccCceEEEEEeccCCccccCCCCcc-cccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCcEE
Confidence            998765  47999999999988765432222 3889999999999999999999   99999999999999999999999


Q ss_pred             EEeecCCccCCccC---ccccccccccCcccccccccccCc----cchHHHHHHHhhhhhhhhcccccc-chhhh-----
Q 040702          649 LSDFGMAKPLLEED---QSLTQTQTLATIGYMAPDEIFSGE----MRLKCWVNDSLLISVMIVVDANLL-IREEK-----  715 (797)
Q Consensus       649 l~DFGla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~dv~s~~~~~~~~~~~~~~~-~~~~~-----  715 (797)
                      |+|||.+.......   ........+|||.|||||...++.    .+.+-|+|++|++.+-.+++.-++ +.+..     
T Consensus       251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~K  330 (576)
T KOG0585|consen  251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDK  330 (576)
T ss_pred             eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHH
Confidence            99999987653221   111224468999999999888743    358889999999875555444322 22111     


Q ss_pred             ------------hhhcccccchhccccCCCCCCCChHHHHHhHHH
Q 040702          716 ------------HLMTKEQPMVRMGTDLSLGQFPASYSISKYLVY  748 (797)
Q Consensus       716 ------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~  748 (797)
                                  ++.+..++++.+++.+||++|-+..+|......
T Consensus       331 Ivn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv  375 (576)
T KOG0585|consen  331 IVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV  375 (576)
T ss_pred             HhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence                        234567788888999999999998887765543

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=6e-34  Score=305.14  Aligned_cols=217  Identities=19%  Similarity=0.229  Sum_probs=177.0

Q ss_pred             ccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhc-cCCceeEeeeeeecCCeEEEEEEccCC
Q 040702          518 NLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPL  588 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~  588 (797)
                      +.||+|+||.||++     ++.||||+++...   ....+.+..|..++... +||||+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999975     5789999998652   22344566677777654 799999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccccc
Q 040702          589 GSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  668 (797)
Q Consensus       589 g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  668 (797)
                      |+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~  154 (316)
T cd05592          81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKAS  154 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cccc
Confidence            99999987654 4889999999999999999999   9999999999999999999999999999997543222  2234


Q ss_pred             ccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh----------------hhhcccccchhccccCC
Q 040702          669 QTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK----------------HLMTKEQPMVRMGTDLS  732 (797)
Q Consensus       669 ~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~l~~~cl~~d  732 (797)
                      ...||+.|||||.+.+..++.++|+|++|+..++.+.+..++.....                .......++++.|++.|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~  234 (316)
T cd05592         155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERD  234 (316)
T ss_pred             cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCC
Confidence            56799999999999988899999999999998666655544332111                12234568889999999


Q ss_pred             CCCCCChH
Q 040702          733 LGQFPASY  740 (797)
Q Consensus       733 p~~RPs~~  740 (797)
                      |.+||++.
T Consensus       235 P~~R~~~~  242 (316)
T cd05592         235 PTKRLGVD  242 (316)
T ss_pred             HHHcCCCh
Confidence            99999874

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=5.3e-34  Score=306.79  Aligned_cols=221  Identities=20%  Similarity=0.195  Sum_probs=178.3

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhc-cCCceeEeeeeeecCCeEEEEE
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      +|...+.||+|+||.||++     +..||||++++..   ....+.+..|..++... +||+|+++++++...+..|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            5788899999999999974     4789999998653   22234567788888777 5899999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~-  155 (323)
T cd05616          81 EYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG-  155 (323)
T ss_pred             cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC-
Confidence            9999999999887654 4889999999999999999999   9999999999999999999999999999997543221 


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh----------------hhhcccccchhc
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK----------------HLMTKEQPMVRM  727 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~l~~~  727 (797)
                       .......||+.|||||.+.+..++.++|+|++|+..++.+.+..++.....                .......++++.
T Consensus       156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  234 (323)
T cd05616         156 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKG  234 (323)
T ss_pred             -CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHH
Confidence             123446799999999999999999999999999998666665554433221                122344566777


Q ss_pred             cccCCCCCCCCh
Q 040702          728 GTDLSLGQFPAS  739 (797)
Q Consensus       728 cl~~dp~~RPs~  739 (797)
                      |++.||.+|++.
T Consensus       235 ~l~~~p~~R~~~  246 (323)
T cd05616         235 LMTKHPGKRLGC  246 (323)
T ss_pred             HcccCHHhcCCC
Confidence            777777777764

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.9e-33  Score=297.60  Aligned_cols=247  Identities=19%  Similarity=0.282  Sum_probs=196.7

Q ss_pred             HhcCCCccccccccCCcceeec----------ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCe
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD----------GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDF  578 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~----------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~  578 (797)
                      ..++|++.+.||+|+||.||++          +..||+|.+..... .....+.+|+.++++++||||+++++++...+.
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4678999999999999999975          24799998764432 123467889999999999999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEE
Q 040702          579 KALVLEYMPLGSLEKCLYSGN---------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHL  649 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl  649 (797)
                      .|+||||+++|+|.+++....         ...++..+..++.|++.|++|||   +++|+||||||+||++++++.+|+
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEE
Confidence            999999999999999996522         13466788899999999999999   999999999999999999999999


Q ss_pred             EeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc--cccccchh--------------
Q 040702          650 SDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV--DANLLIRE--------------  713 (797)
Q Consensus       650 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~--~~~~~~~~--------------  713 (797)
                      +|||+++...............++..|+|||.+.++.++.++|+|++|+..++.+.  .+++.+..              
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~  240 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL  240 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence            99999986543322222223345778999999998899999999999998754432  22211110              


Q ss_pred             --hhhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHHhccccccccccCCcccccceeeeeee
Q 040702          714 --EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDY  778 (797)
Q Consensus       714 --~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~  778 (797)
                        +......+.++++.|++.||++||++.++++.++..                   -|++|++|+|
T Consensus       241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~-------------------~~~~~~~~~~  288 (288)
T cd05061         241 DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD-------------------LHPSFPEVSF  288 (288)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh-------------------cCCCCCCCCC
Confidence              111234577899999999999999999998877654                   2778999988

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=4.8e-34  Score=306.43  Aligned_cols=218  Identities=22%  Similarity=0.213  Sum_probs=178.1

Q ss_pred             ccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhc-cCCceeEeeeeeecCCeEEEEEEccCC
Q 040702          518 NLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPL  588 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~  588 (797)
                      +.||+|+||.||++     ++.||||+++...   ....+.+..|..++... +||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999974     5789999997542   23345677888888876 699999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccccc
Q 040702          589 GSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  668 (797)
Q Consensus       589 g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  668 (797)
                      |+|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~  154 (320)
T cd05590          81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTS  154 (320)
T ss_pred             chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cccc
Confidence            99999887654 4889999999999999999999   9999999999999999999999999999987532221  1234


Q ss_pred             ccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh----------------hhhcccccchhccccCC
Q 040702          669 QTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK----------------HLMTKEQPMVRMGTDLS  732 (797)
Q Consensus       669 ~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~l~~~cl~~d  732 (797)
                      ...||+.|||||.+.+..++.++|+|++|+..+..+.+..++.....                .......++++.|+..|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~d  234 (320)
T cd05590         155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKN  234 (320)
T ss_pred             ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccC
Confidence            46799999999999888899999999999998666655544332211                12234567888899999


Q ss_pred             CCCCCChHH
Q 040702          733 LGQFPASYS  741 (797)
Q Consensus       733 p~~RPs~~~  741 (797)
                      |++||++.+
T Consensus       235 P~~R~~~~~  243 (320)
T cd05590         235 PTMRLGSLT  243 (320)
T ss_pred             HHHCCCCCC
Confidence            999998744

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.3e-34  Score=307.62  Aligned_cols=219  Identities=21%  Similarity=0.249  Sum_probs=177.9

Q ss_pred             CCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHh---hhccCCceeEeeeeeecCCeEEEE
Q 040702          514 FSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMM---KRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       514 f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l---~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      |...+.||+|+||.||++     ++.||||+++...   ....+.+..|++++   +.++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            667889999999999974     5889999998653   22335566776665   456799999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      |||+++|+|...+...  .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus        81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence            9999999999888654  4899999999999999999999   9999999999999999999999999999987532221


Q ss_pred             ccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh----------------hhhcccccchh
Q 040702          663 QSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK----------------HLMTKEQPMVR  726 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~l~~  726 (797)
                        .......||+.|||||.+.+..++.++|+|++|+..+..+.+..++.....                .....+.++++
T Consensus       156 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~  233 (324)
T cd05589         156 --DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMR  233 (324)
T ss_pred             --CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence              123446799999999999988899999999999998666655544332111                12234567888


Q ss_pred             ccccCCCCCCCCh
Q 040702          727 MGTDLSLGQFPAS  739 (797)
Q Consensus       727 ~cl~~dp~~RPs~  739 (797)
                      .|+..||.+||++
T Consensus       234 ~~L~~dP~~R~~~  246 (324)
T cd05589         234 RLLRRNPERRLGS  246 (324)
T ss_pred             HHhhcCHhHcCCC
Confidence            8999999999964

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-34  Score=300.43  Aligned_cols=219  Identities=21%  Similarity=0.276  Sum_probs=187.6

Q ss_pred             CccccccccCCcceeec---ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccCCCCH
Q 040702          515 SENNLIGRGGFGPVYKD---GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSL  591 (797)
Q Consensus       515 ~~~~~lg~G~~g~Vyk~---~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~g~L  591 (797)
                      ...+-||.|+-|.||.|   ++.||||.++..       -..+++-|++++||||+.+.|+|.....+|||||||+.|-|
T Consensus       127 sELeWlGSGaQGAVF~Grl~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL  199 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRLHNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL  199 (904)
T ss_pred             hhhhhhccCcccceeeeeccCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence            34578999999999997   589999988633       23478889999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccccccccc
Q 040702          592 EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL  671 (797)
Q Consensus       592 ~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  671 (797)
                      ...++..+. +.......|..+||.|+.|||   .+.|||||||.-||||..+..+||+|||.++...+.   .+...++
T Consensus       200 ~~VLka~~~-itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFa  272 (904)
T KOG4721|consen  200 YEVLKAGRP-ITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSFA  272 (904)
T ss_pred             HHHHhccCc-cCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhhh
Confidence            999988765 777788899999999999999   999999999999999999999999999999865433   2345689


Q ss_pred             cCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh------------------hhhhhcccccchhccccCCC
Q 040702          672 ATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE------------------EKHLMTKEQPMVRMGTDLSL  733 (797)
Q Consensus       672 gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~l~~~cl~~dp  733 (797)
                      ||..|||||+|.....+.++|||++|+..++++....++...                  +.....-++-+++.||...|
T Consensus       273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKp  352 (904)
T KOG4721|consen  273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKP  352 (904)
T ss_pred             hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCC
Confidence            999999999999999999999999999887766655544332                  22234466778999999999


Q ss_pred             CCCCChHHHHHhHH
Q 040702          734 GQFPASYSISKYLV  747 (797)
Q Consensus       734 ~~RPs~~~i~~~l~  747 (797)
                      ..||++++++..++
T Consensus       353 RNRPSFrqil~Hld  366 (904)
T KOG4721|consen  353 RNRPSFRQILLHLD  366 (904)
T ss_pred             CCCccHHHHHHHHh
Confidence            99999999988764

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=4.7e-34  Score=307.42  Aligned_cols=221  Identities=21%  Similarity=0.235  Sum_probs=178.0

Q ss_pred             ccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccCCC
Q 040702          518 NLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLG  589 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~g  589 (797)
                      +.||+|+||.||++     +..||+|+++...   ......+..|+++++.++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46899999999963     5789999998653   223456778999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccccc
Q 040702          590 SLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS-VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  668 (797)
Q Consensus       590 ~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~-~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  668 (797)
                      +|..++.... .+++..+..++.||+.||+|||   + .+|+||||||+||+++.++.+||+|||+++.......  ...
T Consensus        81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~  154 (325)
T cd05594          81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMK  154 (325)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccc
Confidence            9999887654 4899999999999999999999   7 7999999999999999999999999999875432221  223


Q ss_pred             ccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh----------------hhhcccccchhccccCC
Q 040702          669 QTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK----------------HLMTKEQPMVRMGTDLS  732 (797)
Q Consensus       669 ~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~l~~~cl~~d  732 (797)
                      ...||+.|||||.+.++.++.++|+|++|+..+..+.+..++.....                .....+.++++.|++.|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~d  234 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKD  234 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence            45799999999999988999999999999988665555444322111                12234567777788888


Q ss_pred             CCCCC-----ChHHHHH
Q 040702          733 LGQFP-----ASYSISK  744 (797)
Q Consensus       733 p~~RP-----s~~~i~~  744 (797)
                      |++|+     ++.++++
T Consensus       235 P~~R~~~~~~~~~~il~  251 (325)
T cd05594         235 PKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             HHHhCCCCCCCHHHHhc
Confidence            88886     5666554

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=7.3e-34  Score=306.00  Aligned_cols=238  Identities=21%  Similarity=0.211  Sum_probs=187.8

Q ss_pred             ccccccCCcceeec-----ceEEEEEEEEeccC---CcchhHHHHHHHhhhc-cCCceeEeeeeeecCCeEEEEEEccCC
Q 040702          518 NLIGRGGFGPVYKD-----GMEVAIKVFNLQYG---GAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPL  588 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~  588 (797)
                      +.||+|+||.||++     ++.||||+++....   ...+.+..|+.++.++ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999974     57899999986532   2345678899999888 699999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccccc
Q 040702          589 GSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  668 (797)
Q Consensus       589 g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  668 (797)
                      |+|..++.... .+++..+..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (327)
T cd05617          81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTS  154 (327)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Ccee
Confidence            99998887654 4899999999999999999999   9999999999999999999999999999997532211  1234


Q ss_pred             ccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh-----------------------hhhhhcccccch
Q 040702          669 QTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE-----------------------EKHLMTKEQPMV  725 (797)
Q Consensus       669 ~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~l~  725 (797)
                      ..+||+.|+|||.+.+..++.++|+|++|+..+..+.+..++...                       +........+++
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li  234 (327)
T cd05617         155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVL  234 (327)
T ss_pred             cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            467999999999999999999999999999986666555544210                       001122356777


Q ss_pred             hccccCCCCCCCChHHHHHhHHHHHHHhccccccccccCCcccccceeeeeeeee
Q 040702          726 RMGTDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYTI  780 (797)
Q Consensus       726 ~~cl~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~  780 (797)
                      +.|+..||++||++.+                   ......+++|+||++++|+.
T Consensus       235 ~~~L~~dP~~R~~~~~-------------------~~~~~~i~~h~~f~~~~~~~  270 (327)
T cd05617         235 KGFLNKDPKERLGCQP-------------------QTGFSDIKSHTFFRSIDWDL  270 (327)
T ss_pred             HHHhccCHHHcCCCCC-------------------CCCHHHHHcCCCCCCCCHHH
Confidence            7788888888887531                   11123456777788777764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.8e-33  Score=295.11  Aligned_cols=228  Identities=21%  Similarity=0.280  Sum_probs=183.5

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      .++|...+.||+|+||.||++     +..||+|.++.... .....+.+|+.++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            357999999999999999985     58899999975532 234577899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      |+++ +|.+++......+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++......  
T Consensus        84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~--  157 (288)
T cd07871          84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--  157 (288)
T ss_pred             CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--
Confidence            9975 999988766556789999999999999999999   9999999999999999999999999999997543221  


Q ss_pred             ccccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchhh-h---------------------------
Q 040702          665 LTQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIREE-K---------------------------  715 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-~---------------------------  715 (797)
                      .......||+.|+|||.+.+ ..++.++|+|++|+..+..+.+..++.... .                           
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07871         158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF  237 (288)
T ss_pred             ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence            12234568999999998875 458899999999998755554433221100 0                           


Q ss_pred             ------------------hhhcccccchhccccCCCCCCCChHHHHH
Q 040702          716 ------------------HLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       716 ------------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                        .......++++.|+..||.+|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                              01123456888899999999999888764

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=6.2e-34  Score=306.67  Aligned_cols=216  Identities=21%  Similarity=0.212  Sum_probs=175.7

Q ss_pred             ccccccCCcceeec-----ceEEEEEEEEeccC---CcchhHHHHHHHhhhc-cCCceeEeeeeeecCCeEEEEEEccCC
Q 040702          518 NLIGRGGFGPVYKD-----GMEVAIKVFNLQYG---GAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPL  588 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~  588 (797)
                      +.||+|+||.||++     ++.||+|++++...   ...+.+..|+.++.++ +||||+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999974     57899999986532   2335677888888877 799999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccccc
Q 040702          589 GSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  668 (797)
Q Consensus       589 g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  668 (797)
                      |+|..++.... .+++..+..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||+++.......  ...
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~~  154 (329)
T cd05618          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTS  154 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--ccc
Confidence            99998887654 4899999999999999999999   99999999999999999999999999999975322211  233


Q ss_pred             ccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccch-------------------------hhhhhhccccc
Q 040702          669 QTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIR-------------------------EEKHLMTKEQP  723 (797)
Q Consensus       669 ~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~  723 (797)
                      ...||+.|+|||.+.+..++.++|+|++|+..+..+.+..++..                         .+........+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~  234 (329)
T cd05618         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAAS  234 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHH
Confidence            46799999999999999999999999999998666555444320                         00111223457


Q ss_pred             chhccccCCCCCCCCh
Q 040702          724 MVRMGTDLSLGQFPAS  739 (797)
Q Consensus       724 l~~~cl~~dp~~RPs~  739 (797)
                      +++.|+..||++||++
T Consensus       235 ll~~~L~~dP~~R~~~  250 (329)
T cd05618         235 VLKSFLNKDPKERLGC  250 (329)
T ss_pred             HHHHHhcCCHHHcCCC
Confidence            8888999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-33  Score=313.94  Aligned_cols=249  Identities=22%  Similarity=0.253  Sum_probs=198.5

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhcc-CCceeEeeeeee-cC------C
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIR-HRNLIKIISSCS-ND------D  577 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~-~~------~  577 (797)
                      ..++.+.+.|.+|||+.||.+     +..||+|++-..++.+.+.+.+|+++|+.+. |+|||.++|.+. ..      -
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            456778899999999999963     4899999998777777889999999999996 999999999432 11      2


Q ss_pred             eEEEEEEccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCc
Q 040702          578 FKALVLEYMPLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  656 (797)
Q Consensus       578 ~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  656 (797)
                      ++++.||||.||.|-+++..+. ..+++.++++|+.|+++|+.+|| .+..+|||||||.||||++.+++.||||||.|.
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH-~~~pPiIHRDLKiENvLls~~g~~KLCDFGSat  194 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMH-YLKPPIIHRDLKIENVLLSADGNYKLCDFGSAT  194 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHh-cCCCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence            5789999999999999997542 25999999999999999999999 446779999999999999999999999999886


Q ss_pred             cCCccC-ccc------cccccccCccccccccc---ccCccchHHHHHHHhhhhhhhhccccccchh-------------
Q 040702          657 PLLEED-QSL------TQTQTLATIGYMAPDEI---FSGEMRLKCWVNDSLLISVMIVVDANLLIRE-------------  713 (797)
Q Consensus       657 ~~~~~~-~~~------~~~~~~gt~~y~aPE~~---~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~-------------  713 (797)
                      -..... ...      ..-...-|+.|+|||++   .+..++.|+|||++|+..|..++...+++..             
T Consensus       195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIlng~Y~~P  274 (738)
T KOG1989|consen  195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILNGNYSFP  274 (738)
T ss_pred             cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEeccccCC
Confidence            432111 110      00122468999999976   3567899999999999986666554444332             


Q ss_pred             -hhhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHHhccccccc
Q 040702          714 -EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRELERGKVGIT  760 (797)
Q Consensus       714 -~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~  760 (797)
                       ...+...++.+|+.||++||++||++.|++..+-++..-+.....++
T Consensus       275 ~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~  322 (738)
T KOG1989|consen  275 PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY  322 (738)
T ss_pred             CCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence             12455678899999999999999999999999888876655544444

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-34  Score=287.65  Aligned_cols=234  Identities=24%  Similarity=0.250  Sum_probs=189.0

Q ss_pred             HHHHhcCCCccccccccCCcceee-----cceEEEEEEEEec--cCCcchhHHHHHHHhhhccCCceeEeeeeeecC---
Q 040702          507 LFQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQ--YGGAFKSFDIECGMMKRIRHRNLIKIISSCSND---  576 (797)
Q Consensus       507 l~~~~~~f~~~~~lg~G~~g~Vyk-----~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~---  576 (797)
                      .+.....|...+.||+|+||.|++     +|+.||||.+...  ..-..++..+|+++|+.++|+||+.+.+++..+   
T Consensus        17 ~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~   96 (359)
T KOG0660|consen   17 LFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD   96 (359)
T ss_pred             EEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence            344556777789999999999997     3699999998733  333457889999999999999999999998662   


Q ss_pred             --CeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecC
Q 040702          577 --DFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGM  654 (797)
Q Consensus       577 --~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl  654 (797)
                        ...|+|+|+|+ -+|...++..+. ++...+.-++.|+++||+|+|   +.+|+|||+||+|++++.+..+||+|||+
T Consensus        97 ~f~DvYiV~elMe-tDL~~iik~~~~-L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGL  171 (359)
T KOG0660|consen   97 KFNDVYLVFELME-TDLHQIIKSQQD-LTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGL  171 (359)
T ss_pred             ccceeEEehhHHh-hHHHHHHHcCcc-ccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccc
Confidence              37899999995 499999987764 888999999999999999999   99999999999999999999999999999


Q ss_pred             CccCCccCccccccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchhhh-h----------------
Q 040702          655 AKPLLEEDQSLTQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIREEK-H----------------  716 (797)
Q Consensus       655 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~-~----------------  716 (797)
                      |+...........+..+.|.+|+|||.+.. ..|+...|+||+|++..+++.+.+++.+... +                
T Consensus       172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~  251 (359)
T KOG0660|consen  172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED  251 (359)
T ss_pred             eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence            997754322334477889999999998764 5699999999999987665555554433111 0                


Q ss_pred             ------------------------------hhcccccchhccccCCCCCCCChHHHHHh
Q 040702          717 ------------------------------LMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       717 ------------------------------~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                                                    ..+...+++++++..||.+|+|++|.++.
T Consensus       252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence                                          11234567777999999999999888763

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=7.7e-34  Score=306.67  Aligned_cols=227  Identities=21%  Similarity=0.249  Sum_probs=181.0

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccC---CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG---GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ++|...+.||+|+||.||++     ++.||||+++....   ...+.+..|+.+++.++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            47889999999999999974     68899999986532   23456888999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      ||+++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~  157 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM  157 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence            999999999999876556899999999999999999999   99999999999999999999999999999986543322


Q ss_pred             cccccccccCcccccccccc------cCccchHHHHHHHhhhhhhhhccccccchhhh--------------------hh
Q 040702          664 SLTQTQTLATIGYMAPDEIF------SGEMRLKCWVNDSLLISVMIVVDANLLIREEK--------------------HL  717 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~------~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~--------------------~~  717 (797)
                      . ......||+.|+|||.+.      ...++.++|+|++|+..++.+.+..++.....                    ..
T Consensus       158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (330)
T cd05601         158 V-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKV  236 (330)
T ss_pred             e-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCC
Confidence            1 223457999999999886      45678999999999988665555444322110                    11


Q ss_pred             hcccccchhccccCCCCCCCChHHHH
Q 040702          718 MTKEQPMVRMGTDLSLGQFPASYSIS  743 (797)
Q Consensus       718 ~~~~~~l~~~cl~~dp~~RPs~~~i~  743 (797)
                      .....++++.|+. +|.+||++.+++
T Consensus       237 ~~~~~~li~~ll~-~p~~R~t~~~l~  261 (330)
T cd05601         237 SSDFLDLIQSLLC-GQKERLGYEGLC  261 (330)
T ss_pred             CHHHHHHHHHHcc-ChhhCCCHHHHh
Confidence            2233455666665 677777665554

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=7.6e-34  Score=305.28  Aligned_cols=215  Identities=21%  Similarity=0.214  Sum_probs=174.7

Q ss_pred             ccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhc-cCCceeEeeeeeecCCeEEEEEEccCC
Q 040702          518 NLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPL  588 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~  588 (797)
                      +.||+|+||.||++     ++.||||+++...   ....+.+..|.+++..+ +||||+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46899999999975     5789999998652   23345677888888866 799999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccccc
Q 040702          589 GSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  668 (797)
Q Consensus       589 g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  668 (797)
                      |+|..++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.......  ...
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~  154 (321)
T cd05591          81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTT  154 (321)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--ccc
Confidence            99999887654 4889999999999999999999   99999999999999999999999999999875432221  234


Q ss_pred             ccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh-h---------------hhcccccchhccccCC
Q 040702          669 QTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK-H---------------LMTKEQPMVRMGTDLS  732 (797)
Q Consensus       669 ~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~-~---------------~~~~~~~l~~~cl~~d  732 (797)
                      ...||+.|+|||.+.+..++.++|+|++|+..+..+.+..++..... +               ......++++.|+..|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~d  234 (321)
T cd05591         155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKN  234 (321)
T ss_pred             ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccC
Confidence            46799999999999888899999999999998666655544332111 1               1234557778888888


Q ss_pred             CCCCCC
Q 040702          733 LGQFPA  738 (797)
Q Consensus       733 p~~RPs  738 (797)
                      |++||+
T Consensus       235 p~~R~~  240 (321)
T cd05591         235 PNKRLG  240 (321)
T ss_pred             HHHcCC
Confidence            888883

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=303.95  Aligned_cols=228  Identities=20%  Similarity=0.243  Sum_probs=192.4

Q ss_pred             cCCCccccccccCCcceeecc-----eEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          512 NRFSENNLIGRGGFGPVYKDG-----MEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~~-----~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      +.|.++..||.|+||.|||+.     -..|.|++....+...+++.-|+++|+.+.||+||++++.|+.++..||..|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            456677889999999999963     456789998888878899999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccc
Q 040702          587 PLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  666 (797)
Q Consensus       587 ~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  666 (797)
                      .||-.+.++-.-+..+.+.++.-+++|++.||.|||   +..|||||+|+.|||++-+|.++++|||.+....  .+...
T Consensus       112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~--~t~qk  186 (1187)
T KOG0579|consen  112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK--STRQK  186 (1187)
T ss_pred             CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccch--hHHhh
Confidence            999999998877778999999999999999999999   9999999999999999999999999999875432  22224


Q ss_pred             ccccccCcccccccccc-----cCccchHHHHHHHhhhhhhhhccccccch-------------------hhhhhhcccc
Q 040702          667 QTQTLATIGYMAPDEIF-----SGEMRLKCWVNDSLLISVMIVVDANLLIR-------------------EEKHLMTKEQ  722 (797)
Q Consensus       667 ~~~~~gt~~y~aPE~~~-----~~~~~~~~dv~s~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~  722 (797)
                      ...+.|||+|||||++.     ..+|++++||||+|+..+++.-..++...                   .+..+.....
T Consensus       187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~  266 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFS  266 (1187)
T ss_pred             hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHH
Confidence            45689999999999764     56799999999999987544332222111                   2234555778


Q ss_pred             cchhccccCCCCCCCChHHHHH
Q 040702          723 PMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       723 ~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      +++.+|+..||..||++.++++
T Consensus       267 DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  267 DFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             HHHHHHHhcCCccCCCHHHHhh
Confidence            9999999999999999988875

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.5e-33  Score=315.26  Aligned_cols=229  Identities=17%  Similarity=0.157  Sum_probs=188.6

Q ss_pred             CCCccccccccCCcceeec------ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          513 RFSENNLIGRGGFGPVYKD------GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      .|...+.||+|+||.||++      +..||+|.+..........+.+|+.+++.++|||||++++++..++..|+||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4888999999999999974      4678889876554444456788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          587 PLGSLEKCLYSG---NYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       587 ~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      ++|+|.+++...   ...+++..+..++.|++.||.|||   +++|+||||||+||+++.++.+||+|||+++.......
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999887542   235888999999999999999999   99999999999999999999999999999986643322


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh-----------------hhhhhcccccchh
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE-----------------EKHLMTKEQPMVR  726 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~l~~  726 (797)
                      .......+||+.|||||.+.+..++.++|+|++|+..+..+....++...                 +......+.+++.
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  304 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLD  304 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHHH
Confidence            22334567999999999999889999999999999886555543332211                 1112335678899


Q ss_pred             ccccCCCCCCCChHHHHH
Q 040702          727 MGTDLSLGQFPASYSISK  744 (797)
Q Consensus       727 ~cl~~dp~~RPs~~~i~~  744 (797)
                      .|+..||++||++.+++.
T Consensus       305 ~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        305 PLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             HHhccChhhCcCHHHHHh
Confidence            999999999999988864

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9.7e-34  Score=304.63  Aligned_cols=221  Identities=23%  Similarity=0.289  Sum_probs=179.0

Q ss_pred             ccccccCCcceeec--------ceEEEEEEEEecc----CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          518 NLIGRGGFGPVYKD--------GMEVAIKVFNLQY----GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~--------~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      +.||+|+||.||++        ++.||||+++...    ......+..|+.++++++||||+++++++..++..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            67999999999963        4789999997542    12234677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      +++|+|.+++.... .+.+..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.......  
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  155 (323)
T cd05584          82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--  155 (323)
T ss_pred             CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--
Confidence            99999999987654 4788888999999999999999   99999999999999999999999999999975432221  


Q ss_pred             cccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh----------------hhhhcccccchhccc
Q 040702          666 TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE----------------KHLMTKEQPMVRMGT  729 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~l~~~cl  729 (797)
                      ......||+.|+|||.+.+..++.++|+|++|+..++.+.+..++....                ......+.++++.|+
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  235 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLL  235 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHc
Confidence            2234579999999999988889999999999999866665544432211                112234567888899


Q ss_pred             cCCCCCCC-----ChHHHHH
Q 040702          730 DLSLGQFP-----ASYSISK  744 (797)
Q Consensus       730 ~~dp~~RP-----s~~~i~~  744 (797)
                      +.||++||     ++.++.+
T Consensus       236 ~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         236 KRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             ccCHhHcCCCCCCCHHHHhc
Confidence            99999998     5555544

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=4.7e-33  Score=298.56  Aligned_cols=239  Identities=19%  Similarity=0.219  Sum_probs=192.8

Q ss_pred             cCCCccccccccCCcceeecc---------eEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKDG---------MEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~~---------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l  581 (797)
                      .+|+..+.||+|+||.||++.         ..||||.++.... ...+++..|+.+++.++||||++++|+|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            579999999999999999862         2489999875432 3346788999999999999999999999765 5679


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCcc
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  661 (797)
                      |+||+++|+|.+++......+++..+++++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~  162 (316)
T cd05108          86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD  162 (316)
T ss_pred             eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence            99999999999999876656889999999999999999999   999999999999999999999999999999876443


Q ss_pred             CccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchhhh-----------------hhhccccc
Q 040702          662 DQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIREEK-----------------HLMTKEQP  723 (797)
Q Consensus       662 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~~~-----------------~~~~~~~~  723 (797)
                      ..........++..|||||.+.+..++.++|+|++|+..++.+. +..++...+.                 .....+.+
T Consensus       163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (316)
T cd05108         163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM  242 (316)
T ss_pred             CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence            32222233345678999999999999999999999998765443 3333222111                 11224567


Q ss_pred             chhccccCCCCCCCChHHHHHhHHHHHHHhc
Q 040702          724 MVRMGTDLSLGQFPASYSISKYLVYIRELER  754 (797)
Q Consensus       724 l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~  754 (797)
                      ++..|+..+|++||++.+++..+..+...+.
T Consensus       243 li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~  273 (316)
T cd05108         243 IMVKCWMIDADSRPKFRELIIEFSKMARDPQ  273 (316)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence            8889999999999999999998888765543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=5e-33  Score=290.78  Aligned_cols=236  Identities=21%  Similarity=0.290  Sum_probs=193.3

Q ss_pred             hcCCCccccccccCCcceeec--------ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD--------GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~--------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l  581 (797)
                      .++|+..+.||+|+||.||+|        ...||||.++.... ....++.+|+.++++++||||+++++++...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            357899999999999999985        24799999875533 234678899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCcc
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  661 (797)
                      ||||+++|+|.+++......+++..+.+++.|++.|++|||   +.+|+||||||+||++++++.+||+|||+++.....
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            99999999999999776556899999999999999999999   999999999999999999999999999999876422


Q ss_pred             CccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccch-----------------hhhhhhccccc
Q 040702          662 DQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIR-----------------EEKHLMTKEQP  723 (797)
Q Consensus       662 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~-----------------~~~~~~~~~~~  723 (797)
                      ..........++..|+|||.+....++.++|+|++|+..+..+. +..++..                 .+......+.+
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  239 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQ  239 (266)
T ss_pred             ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            22222223345678999999988889999999999998755432 2222111                 01122346678


Q ss_pred             chhccccCCCCCCCChHHHHHhHHHH
Q 040702          724 MVRMGTDLSLGQFPASYSISKYLVYI  749 (797)
Q Consensus       724 l~~~cl~~dp~~RPs~~~i~~~l~~i  749 (797)
                      +++.|++.+|++||++.++++.++.+
T Consensus       240 li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         240 LMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             HHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            99999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=282.37  Aligned_cols=260  Identities=21%  Similarity=0.232  Sum_probs=211.9

Q ss_pred             hcCCCccccccccCCcceee-----cceEEEEEEEEeccC---CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYG---GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk-----~~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      .++|+..++||+|.||+|-.     +++.||+|++++.--   +....-..|-++|+..+||.+..+-..|+..++.|+|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            47899999999999999963     479999999987633   2334456789999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      |||+.||.|.-++...+ .+++...+.+..+|..||.|||   +++||.||+|.+|.|+|.+|++||.|||+++.-...+
T Consensus       247 MeyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g  322 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYG  322 (516)
T ss_pred             EEEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhccccc
Confidence            99999999998887655 4888889999999999999999   9999999999999999999999999999998643332


Q ss_pred             ccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhhhhhcccccchhccccCCCC-CCCChHH
Q 040702          663 QSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEKHLMTKEQPMVRMGTDLSLG-QFPASYS  741 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~-~RPs~~~  741 (797)
                        ....+++|||.|.|||++....|...+|+|+.|+.+++++.+.-++-....   ..+.+++..|=-.=|. --|-++.
T Consensus       323 --~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh---~kLFeLIl~ed~kFPr~ls~eAkt  397 (516)
T KOG0690|consen  323 --DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH---EKLFELILMEDLKFPRTLSPEAKT  397 (516)
T ss_pred             --ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch---hHHHHHHHhhhccCCccCCHHHHH
Confidence              356789999999999999999999999999999998776655544332222   2444666665333332 1223333


Q ss_pred             HHHhHHHHHHHhccccccccccCCcccccceeeeeeeeec
Q 040702          742 ISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYTIS  781 (797)
Q Consensus       742 i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~  781 (797)
                      ++.  -.+.+.+..+.|..+.+|.++..|.||++|+|+.-
T Consensus       398 LLs--GLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~  435 (516)
T KOG0690|consen  398 LLS--GLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEAT  435 (516)
T ss_pred             HHH--HHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHH
Confidence            333  23677899999999999999999999999999853

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=5.7e-33  Score=293.91  Aligned_cols=238  Identities=22%  Similarity=0.303  Sum_probs=195.2

Q ss_pred             cCCCccccccccCCcceeecc----------eEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKDG----------MEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~~----------~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l  581 (797)
                      ++|...+.||+|+||.||++.          ..||+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            578889999999999999742          5689999876554445679999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCC------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEE
Q 040702          582 VLEYMPLGSLEKCLYSGN------------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHL  649 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~------------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl  649 (797)
                      ||||+++++|.+++....            ..+++..++.++.|++.||+|||   +++++||||||+||++++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEe
Confidence            999999999999987432            24899999999999999999999   999999999999999999999999


Q ss_pred             EeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccch-hh-------------
Q 040702          650 SDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIR-EE-------------  714 (797)
Q Consensus       650 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~-~~-------------  714 (797)
                      +|||+++...............++..|+|||.+....++.++|+|++|+..+..+. +..++.. ..             
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~  241 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL  241 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcC
Confidence            99999986543322222233456788999999988889999999999998765553 3322211 11             


Q ss_pred             ---hhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          715 ---KHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       715 ---~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                         ......+.+++.+|++.||.+||++.++.+.++.+.+.
T Consensus       242 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         242 QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence               11233567899999999999999999999999888654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=4.8e-33  Score=300.33  Aligned_cols=228  Identities=19%  Similarity=0.224  Sum_probs=188.5

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      .++|+..+.||+|+||.||++     +..||+|.++.... ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            368999999999999999974     57899999876532 234678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCC-CeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV-PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~-~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      |+++|+|.+++.... .+++..+..++.|++.|+.|||   +. +|+||||||+||+++.++.+||+|||+++.....  
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  157 (331)
T cd06649          84 HMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (331)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence            999999999997655 4888999999999999999999   64 6999999999999999999999999999865322  


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh----------------------------
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK----------------------------  715 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~----------------------------  715 (797)
                        ......||+.|+|||.+.+..++.++|+|++|+..++.+.+..++.....                            
T Consensus       158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (331)
T cd06649         158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP  235 (331)
T ss_pred             --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccc
Confidence              22345799999999999988899999999999987555443332211000                            


Q ss_pred             ------------------------------------hhhcccccchhccccCCCCCCCChHHHHHhH
Q 040702          716 ------------------------------------HLMTKEQPMVRMGTDLSLGQFPASYSISKYL  746 (797)
Q Consensus       716 ------------------------------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l  746 (797)
                                                          .....+.+++++|+..||++||++.++++.-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                                                0122456889999999999999999998753

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.5e-33  Score=303.85  Aligned_cols=216  Identities=20%  Similarity=0.192  Sum_probs=175.8

Q ss_pred             ccccccCCcceeec-----ceEEEEEEEEeccC---CcchhHHHHHHHhhhc-cCCceeEeeeeeecCCeEEEEEEccCC
Q 040702          518 NLIGRGGFGPVYKD-----GMEVAIKVFNLQYG---GAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPL  588 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~  588 (797)
                      +.||+|+||.||++     ++.||||+++....   ...+.+..|..+++.+ +||||+++++++.+++..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46899999999974     57899999986532   2345678899999988 699999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccccc
Q 040702          589 GSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  668 (797)
Q Consensus       589 g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  668 (797)
                      |+|.+++...+ .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~  154 (329)
T cd05588          81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTS  154 (329)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCC--Cccc
Confidence            99999887654 4899999999999999999999   9999999999999999999999999999997532211  1234


Q ss_pred             ccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh-------------------------hhhhhccccc
Q 040702          669 QTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE-------------------------EKHLMTKEQP  723 (797)
Q Consensus       669 ~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~  723 (797)
                      ...||+.|+|||.+.+..++.++|+|++|+..+..+.+..++...                         +........+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  234 (329)
T cd05588         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASS  234 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            467999999999999989999999999999986655554443210                         0011223457


Q ss_pred             chhccccCCCCCCCCh
Q 040702          724 MVRMGTDLSLGQFPAS  739 (797)
Q Consensus       724 l~~~cl~~dp~~RPs~  739 (797)
                      +++.|+..||.+||++
T Consensus       235 li~~~L~~dP~~R~~~  250 (329)
T cd05588         235 VLKGFLNKDPKERLGC  250 (329)
T ss_pred             HHHHHhccCHHHcCCC
Confidence            8888999999999873

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.2e-33  Score=308.84  Aligned_cols=195  Identities=20%  Similarity=0.297  Sum_probs=164.5

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      .|...+.||+|+||.||++     +..||||+++...   ......+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5888999999999999985     5789999997653   2234568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc-
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ-  663 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~-  663 (797)
                      |+++|+|.+++.... .+++..+..++.|++.||+|||   ..+|+||||||+||+++.++.+||+|||+++....... 
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~  157 (381)
T cd05626          82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS  157 (381)
T ss_pred             cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence            999999999987655 4888899999999999999999   99999999999999999999999999999864311000 


Q ss_pred             --------------------------------------------cccccccccCcccccccccccCccchHHHHHHHhhh
Q 040702          664 --------------------------------------------SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLI  699 (797)
Q Consensus       664 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~  699 (797)
                                                                  .......+||+.|||||.+.+..++.++|+|++|++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i  237 (381)
T cd05626         158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI  237 (381)
T ss_pred             ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence                                                        000123579999999999998889999999999999


Q ss_pred             hhhhhccccccc
Q 040702          700 SVMIVVDANLLI  711 (797)
Q Consensus       700 ~~~~~~~~~~~~  711 (797)
                      .++.+.+..++.
T Consensus       238 l~elltG~~Pf~  249 (381)
T cd05626         238 LFEMLVGQPPFL  249 (381)
T ss_pred             HHHHHhCCCCCc
Confidence            877666655543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-33  Score=297.88  Aligned_cols=227  Identities=22%  Similarity=0.289  Sum_probs=193.6

Q ss_pred             HhcCCCccccccccCCcceee-----cceEEEEEEEEeccCC---cchhHHHHHHHhhhcc-CCceeEeeeeeecCCeEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGG---AFKSFDIECGMMKRIR-HRNLIKIISSCSNDDFKA  580 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk-----~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~  580 (797)
                      ....|+..+.||+|.||.||+     +|+.+|+|.+.+....   ....+.+|+.+|+++. |||||.++++|++.+..+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            346788889999999999996     4789999999877443   3468999999999998 999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCC----CcEEEEeecCCc
Q 040702          581 LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN----MVAHLSDFGMAK  656 (797)
Q Consensus       581 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~----~~~kl~DFGla~  656 (797)
                      +|||++.||.|.+.+... . +++..+..++.|++.|++|||   +.||+|||+||+|+|+...    +.+|++|||+|+
T Consensus       113 lvmEL~~GGeLfd~i~~~-~-~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK-H-YSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             EEEEecCCchHHHHHHHc-c-CCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            999999999999999776 3 899999999999999999999   9999999999999999633    579999999999


Q ss_pred             cCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh--------------------hh
Q 040702          657 PLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE--------------------KH  716 (797)
Q Consensus       657 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------------~~  716 (797)
                      ....   .......+||+.|+|||++....|+..+|+|++|+..+..+.+..++....                    ..
T Consensus       188 ~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~  264 (382)
T KOG0032|consen  188 FIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDD  264 (382)
T ss_pred             EccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccc
Confidence            7654   335577899999999999999999999999999998854444433332221                    12


Q ss_pred             hhcccccchhccccCCCCCCCChHHHHH
Q 040702          717 LMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       717 ~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      .....+++++.++..||.+|+++.++++
T Consensus       265 is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  265 ISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             cCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            3446778999999999999999999887

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=4.1e-33  Score=294.28  Aligned_cols=234  Identities=22%  Similarity=0.345  Sum_probs=191.4

Q ss_pred             cCCCccccccccCCcceeecc----------eEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEE
Q 040702          512 NRFSENNLIGRGGFGPVYKDG----------MEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKA  580 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~~----------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~  580 (797)
                      ++|+..+.||+|+||.||++.          ..||+|.++.... ....++.+|++++++++||||+++++++...+..|
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            478889999999999999752          5799999875432 22457889999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCC
Q 040702          581 LVLEYMPLGSLEKCLYSGN---------------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM  645 (797)
Q Consensus       581 lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~  645 (797)
                      ++|||+++|+|.+++....               ..+++..+..++.|++.|+.|||   +.+++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence            9999999999999986532               24788889999999999999999   99999999999999999999


Q ss_pred             cEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-ccccc-chh----------
Q 040702          646 VAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLL-IRE----------  713 (797)
Q Consensus       646 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~-~~~----------  713 (797)
                      .+||+|||+++...............+++.|||||.+..+.++.++|+|++|+..++.+. +..++ +..          
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~  241 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRS  241 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            999999999986543332223344567889999999998999999999999998765543 22221 111          


Q ss_pred             ------hhhhhcccccchhccccCCCCCCCChHHHHHhHHH
Q 040702          714 ------EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVY  748 (797)
Q Consensus       714 ------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~  748 (797)
                            +......+.+++..||+.||++||++.++.+.|+.
T Consensus       242 ~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         242 RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence                  11223466789999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-33  Score=323.30  Aligned_cols=240  Identities=23%  Similarity=0.309  Sum_probs=195.3

Q ss_pred             cCCCccccccccCCcceeecc----------eEEEEEEEEecc-CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEE
Q 040702          512 NRFSENNLIGRGGFGPVYKDG----------MEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKA  580 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~~----------~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~  580 (797)
                      +.-+..+.||+|.||+||+|.          ..||||.++... .+...+|.+|..+|+.++|||||+++|+|.+.+..+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            344566899999999999862          459999987663 445679999999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecC
Q 040702          581 LVLEYMPLGSLEKCLYSG------NYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGM  654 (797)
Q Consensus       581 lv~e~~~~g~L~~~l~~~------~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl  654 (797)
                      |++|||++|+|..++++.      ...+...+...++.|||+|+.||+   ++++|||||.++|+|++....+||+|||+
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccch
Confidence            999999999999999887      457889999999999999999999   99999999999999999999999999999


Q ss_pred             CccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhh--hhccccccchh----------------hhh
Q 040702          655 AKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVM--IVVDANLLIRE----------------EKH  716 (797)
Q Consensus       655 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~--~~~~~~~~~~~----------------~~~  716 (797)
                      |+.+...+.+.......-...|||||.+..+.++.++|||++|+..++  .+...+.....                +..
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~  928 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSY  928 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCC
Confidence            996544443322222233468999999999999999999999987633  22222222211                112


Q ss_pred             hhcccccchhccccCCCCCCCChHHHHHhHHHHHHHhc
Q 040702          717 LMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRELER  754 (797)
Q Consensus       717 ~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~  754 (797)
                      ....+.+++..||+.+|++||++..+++.+..+.....
T Consensus       929 CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~  966 (1025)
T KOG1095|consen  929 CPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL  966 (1025)
T ss_pred             CChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence            23466688999999999999999999998877755533

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-33  Score=308.28  Aligned_cols=228  Identities=21%  Similarity=0.305  Sum_probs=184.6

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ++|...+.||+|+||.||++     ++.||||+++...   ......+..|+++++.++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47889999999999999974     5889999998653   233467888999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC-
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED-  662 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~-  662 (797)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++...... 
T Consensus        81 e~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  156 (350)
T cd05573          81 EYMPGGDLMNLLIRKD-VFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD  156 (350)
T ss_pred             cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence            9999999999998763 5899999999999999999999   9999999999999999999999999999998654332 


Q ss_pred             --------------------------ccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhhh
Q 040702          663 --------------------------QSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEKH  716 (797)
Q Consensus       663 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~~  716 (797)
                                                .........||+.|+|||.+.+..++.++|+|++|+..+..+.+..++......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~  236 (350)
T cd05573         157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ  236 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence                                      001223457999999999999999999999999999986666554443221110


Q ss_pred             --------------------hhcccccchhccccCCCCCCCC-hHHHHH
Q 040702          717 --------------------LMTKEQPMVRMGTDLSLGQFPA-SYSISK  744 (797)
Q Consensus       717 --------------------~~~~~~~l~~~cl~~dp~~RPs-~~~i~~  744 (797)
                                          ....+.++++.|+. ||.+||+ +.++++
T Consensus       237 ~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~  284 (350)
T cd05573         237 ETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS  284 (350)
T ss_pred             HHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence                                12334566666775 7777777 666654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-33  Score=297.11  Aligned_cols=222  Identities=22%  Similarity=0.260  Sum_probs=180.4

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEeccC---CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG---GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      .|+..+.||+|+||.||++     ++.||||.+.....   .....+.+|+.++++++||||+++++++..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4778899999999999984     57899999975421   223457789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          585 YMPLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      |+++|+|.+++.... ..+++..+..++.|++.|++|||   +.+|+||||||+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-  156 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence            999999998886543 35899999999999999999999   9999999999999999999999999999998653222 


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh--------------------hhhhccccc
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE--------------------KHLMTKEQP  723 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~  723 (797)
                        ......|++.|+|||.+.+..++.++|+|++|+..+..+.+..++....                    ......+.+
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd05605         157 --TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARS  234 (285)
T ss_pred             --ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHH
Confidence              2234578999999999988889999999999998755554444332211                    112334567


Q ss_pred             chhccccCCCCCCCChH
Q 040702          724 MVRMGTDLSLGQFPASY  740 (797)
Q Consensus       724 l~~~cl~~dp~~RPs~~  740 (797)
                      ++..|++.||++||+..
T Consensus       235 li~~~l~~~P~~R~~~~  251 (285)
T cd05605         235 ICRQLLTKDPGFRLGCR  251 (285)
T ss_pred             HHHHHccCCHHHhcCCC
Confidence            88889999999999543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.3e-33  Score=294.36  Aligned_cols=236  Identities=21%  Similarity=0.239  Sum_probs=185.3

Q ss_pred             ccccCCcceeec-----ceEEEEEEEEeccC---CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccCCCCH
Q 040702          520 IGRGGFGPVYKD-----GMEVAIKVFNLQYG---GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSL  591 (797)
Q Consensus       520 lg~G~~g~Vyk~-----~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~g~L  591 (797)
                      ||+|+||+||++     ++.||||.+.....   ...+.+..|++++++++||||+++.+++..++..|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999974     57899999875422   2235677899999999999999999999999999999999999999


Q ss_pred             HHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccccc
Q 040702          592 EKCLYS---GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  668 (797)
Q Consensus       592 ~~~l~~---~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  668 (797)
                      ..++..   ....+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++........  ...
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~  155 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK  155 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence            888753   2235899999999999999999999   99999999999999999999999999999976543222  223


Q ss_pred             ccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh--------------------hhhhhcccccchhcc
Q 040702          669 QTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE--------------------EKHLMTKEQPMVRMG  728 (797)
Q Consensus       669 ~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~l~~~c  728 (797)
                      ...||+.|+|||.+.+..++.++|+|++|+..++.+.+..++...                    +......+.++++.|
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  235 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEAL  235 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHH
Confidence            457999999999999999999999999999886655544333211                    011223455677778


Q ss_pred             ccCCCCCCCChHHHHHhHHHHHHHhccccccccccCCcccccceeeeeeeee
Q 040702          729 TDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYTI  780 (797)
Q Consensus       729 l~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~  780 (797)
                      ++.||++||+.+                    ...+..+++|+||++++|+.
T Consensus       236 l~~~P~~R~~~~--------------------~~~~~~~l~h~~~~~~~~~~  267 (280)
T cd05608         236 LAKDPEKRLGFR--------------------DGNCDGLRTHPLFRDLNWRQ  267 (280)
T ss_pred             hcCCHHHhcCCC--------------------CCCHHHHhcChhhhcCCHhH
Confidence            888888887532                    22234455678888888874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.1e-33  Score=299.47  Aligned_cols=217  Identities=19%  Similarity=0.243  Sum_probs=176.9

Q ss_pred             ccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhc-cCCceeEeeeeeecCCeEEEEEEccCC
Q 040702          518 NLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPL  588 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~  588 (797)
                      +.||+|+||.||++     ++.||||+++...   ......+..|..++... +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46899999999975     5789999998652   23345567788888764 899999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccccc
Q 040702          589 GSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  668 (797)
Q Consensus       589 g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  668 (797)
                      |+|.+++.... .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.......  ...
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~  154 (316)
T cd05619          81 GDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTC  154 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--cee
Confidence            99999987654 4888999999999999999999   99999999999999999999999999999875322211  223


Q ss_pred             ccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh----------------hhhcccccchhccccCC
Q 040702          669 QTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK----------------HLMTKEQPMVRMGTDLS  732 (797)
Q Consensus       669 ~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~l~~~cl~~d  732 (797)
                      ...||+.|||||.+.+..++.++|+|++|+..++.+.+..++.....                .......+++..|+..|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~  234 (316)
T cd05619         155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVRE  234 (316)
T ss_pred             eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccC
Confidence            45799999999999988899999999999998666655544322111                11223567888999999


Q ss_pred             CCCCCChH
Q 040702          733 LGQFPASY  740 (797)
Q Consensus       733 p~~RPs~~  740 (797)
                      |++||++.
T Consensus       235 P~~R~~~~  242 (316)
T cd05619         235 PERRLGVK  242 (316)
T ss_pred             HhhcCCCh
Confidence            99999986

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.9e-34  Score=288.17  Aligned_cols=191  Identities=28%  Similarity=0.405  Sum_probs=156.1

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCC-----eEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDD-----FKA  580 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~-----~~~  580 (797)
                      +-.|...+++|+|+||.||+|     ++.||||.+....+    ---+|+.+|+.++|||||++..+|....     ...
T Consensus        23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln   98 (364)
T KOG0658|consen   23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN   98 (364)
T ss_pred             EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence            346778899999999999986     48999999865432    2236999999999999999998876432     234


Q ss_pred             EEEEccCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCC-CcEEEEeecCCc
Q 040702          581 LVLEYMPLGSLEKCLYSG---NYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN-MVAHLSDFGMAK  656 (797)
Q Consensus       581 lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~DFGla~  656 (797)
                      +|||||+. +|.+.++.-   +..++...++-+++||.+|++|||   +.+|+||||||+|+|+|.+ |.+||||||.|+
T Consensus        99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen   99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence            89999976 999998742   235788888999999999999999   8999999999999999965 999999999999


Q ss_pred             cCCccCccccccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccccccch
Q 040702          657 PLLEEDQSLTQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANLLIR  712 (797)
Q Consensus       657 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~~~~  712 (797)
                      .+...+.   ......|+.|+|||.+++. .|+.+.|+||.|+...+.+.+.+++.+
T Consensus       175 ~L~~~ep---niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG  228 (364)
T KOG0658|consen  175 VLVKGEP---NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG  228 (364)
T ss_pred             eeccCCC---ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC
Confidence            8754432   3456789999999998864 589999999999987666655555444

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.9e-33  Score=302.23  Aligned_cols=221  Identities=20%  Similarity=0.186  Sum_probs=176.5

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhcc-CCceeEeeeeeecCCeEEEEE
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIR-HRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      +|...+.||+|+||.||++     ++.||||+++...   ....+.+..|..+++.+. |++|+++++++.+.+..|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4777899999999999974     5789999998642   223456778888988886 578889999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      ||+++|+|.+++.... .+++.++..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++...... 
T Consensus        81 Ey~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~-  155 (323)
T cd05615          81 EYVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG-  155 (323)
T ss_pred             cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC-
Confidence            9999999999987654 4899999999999999999999   9999999999999999999999999999997543222 


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh----------------hhhcccccchhc
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK----------------HLMTKEQPMVRM  727 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~l~~~  727 (797)
                       .......||+.|||||.+.+..++.++|+|++|+..+..+.+..++.....                .......++++.
T Consensus       156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~  234 (323)
T cd05615         156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKG  234 (323)
T ss_pred             -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHH
Confidence             123345799999999999988899999999999998666655554433221                112233456666


Q ss_pred             cccCCCCCCCCh
Q 040702          728 GTDLSLGQFPAS  739 (797)
Q Consensus       728 cl~~dp~~RPs~  739 (797)
                      |++.+|.+|++.
T Consensus       235 ~l~~~p~~R~~~  246 (323)
T cd05615         235 LMTKHPSKRLGC  246 (323)
T ss_pred             HcccCHhhCCCC
Confidence            777777777764

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.1e-32  Score=290.11  Aligned_cols=237  Identities=21%  Similarity=0.262  Sum_probs=188.3

Q ss_pred             cCCCccccccccCCcceeecc-----e----EEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKDG-----M----EVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~~-----~----~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l  581 (797)
                      ++|+..+.||+|+||.||++.     .    .||+|.+..... ....++..|+..+++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            578888999999999999852     2    477887754322 223567788889999999999999998764 45789


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCcc
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  661 (797)
                      |+||+++|+|.+++......+++..+..++.||+.|++|||   +++++||||||+||++++++.+||+|||+++.....
T Consensus        86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~  162 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD  162 (279)
T ss_pred             EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence            99999999999999876666899999999999999999999   999999999999999999999999999999865433


Q ss_pred             CccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-hhh----------------hhccccc
Q 040702          662 DQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-EKH----------------LMTKEQP  723 (797)
Q Consensus       662 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-~~~----------------~~~~~~~  723 (797)
                      ..........++..|+|||.+.++.++.++|+|++|+..++.+. +..++... +..                ....+.+
T Consensus       163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (279)
T cd05111         163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYM  242 (279)
T ss_pred             CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHH
Confidence            32222334557789999999998999999999999998765543 33222211 110                1113445


Q ss_pred             chhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          724 MVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       724 l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                      ++..|+..||++||++.|+++.+..+.+.
T Consensus       243 li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         243 VMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             HHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence            77889999999999999999988876653

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-33  Score=307.75  Aligned_cols=261  Identities=20%  Similarity=0.285  Sum_probs=193.1

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ++|+..+.||+|+||.||++     ++.||||+++...   ......+.+|+.+++.++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47899999999999999974     5789999998642   223456788999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus        81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  156 (364)
T cd05599          81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR  156 (364)
T ss_pred             CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence            9999999999987655 4899999999999999999999   99999999999999999999999999999875432110


Q ss_pred             cc------------------------------------cccccccCcccccccccccCccchHHHHHHHhhhhhhhhccc
Q 040702          664 SL------------------------------------TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDA  707 (797)
Q Consensus       664 ~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~  707 (797)
                      ..                                    .....+||+.|||||.+....++.++|+|++|+..++.+.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~  236 (364)
T cd05599         157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY  236 (364)
T ss_pred             ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence            00                                    011246999999999999889999999999999987766655


Q ss_pred             cccchhhhhhhcccccchhc--cccCCCCCCCChHHHHHhHHHHHHHhccccccccccCCcccccceeeeeeeeec
Q 040702          708 NLLIREEKHLMTKEQPMVRM--GTDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYTIS  781 (797)
Q Consensus       708 ~~~~~~~~~~~~~~~~l~~~--cl~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~  781 (797)
                      .++........  ...+...  -+. .|...+-..++.+.++.+...+..+...  ..+.+.+.|+||++++|+..
T Consensus       237 ~Pf~~~~~~~~--~~~i~~~~~~~~-~~~~~~~s~~~~~li~~ll~~p~~R~~~--~~~~~ll~h~~~~~~~~~~~  307 (364)
T cd05599         237 PPFCSDNPQET--YRKIINWKETLQ-FPDEVPLSPEAKDLIKRLCCEAERRLGN--NGVNEIKSHPFFKGVDWEHI  307 (364)
T ss_pred             CCCCCCCHHHH--HHHHHcCCCccC-CCCCCCCCHHHHHHHHHHccCHhhcCCC--CCHHHHhcCCCcCCCCHHHH
Confidence            55433221110  0111110  011 1222122234444444443333334332  35667788888888888653

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=5.4e-33  Score=292.17  Aligned_cols=233  Identities=22%  Similarity=0.275  Sum_probs=187.0

Q ss_pred             ccccCCcceeec-----ceEEEEEEEEeccC---CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccCCCCH
Q 040702          520 IGRGGFGPVYKD-----GMEVAIKVFNLQYG---GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSL  591 (797)
Q Consensus       520 lg~G~~g~Vyk~-----~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~g~L  591 (797)
                      ||+|+||.||++     ++.||+|.+.....   ...+.+..|++++++++||||+++++++..+...|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999974     68899999875321   2234566799999999999999999999999999999999999999


Q ss_pred             HHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccccccc
Q 040702          592 EKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT  670 (797)
Q Consensus       592 ~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~  670 (797)
                      .+++.... ..+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.++|+|||++.......   .....
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~  154 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR  154 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence            98876543 25888999999999999999999   9999999999999999999999999999997653322   22345


Q ss_pred             ccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh---------------------hhhhcccccchhccc
Q 040702          671 LATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE---------------------KHLMTKEQPMVRMGT  729 (797)
Q Consensus       671 ~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~l~~~cl  729 (797)
                      .||..|+|||.+.+..++.++|+|++|+..++.+.+..++....                     ........++++.|+
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  234 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFL  234 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHh
Confidence            68999999999998889999999999998766555444332110                     012234578888899


Q ss_pred             cCCCCCCCChHHHHHhHHHHHHHhccccccccccCCcccccceeeeeeee
Q 040702          730 DLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYT  779 (797)
Q Consensus       730 ~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~  779 (797)
                      +.||++||+++|+.+.                     .+.|+||++++|.
T Consensus       235 ~~~P~~R~~~~~~~~~---------------------~~~h~~f~~~~~~  263 (277)
T cd05607         235 AKKPEDRLGSREKNDD---------------------PRKHEFFKTINFP  263 (277)
T ss_pred             ccCHhhCCCCccchhh---------------------hhcChhhcCCCHH
Confidence            9999999998776532                     2358888888773

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=3e-33  Score=299.66  Aligned_cols=217  Identities=18%  Similarity=0.249  Sum_probs=177.2

Q ss_pred             ccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhc-cCCceeEeeeeeecCCeEEEEEEccCC
Q 040702          518 NLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPL  588 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~  588 (797)
                      +.||+|+||.||++     +..||||.++...   ......+..|.+++... +||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999974     5789999998652   23345667788888765 899999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccccc
Q 040702          589 GSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  668 (797)
Q Consensus       589 g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  668 (797)
                      |+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (316)
T cd05620          81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRAS  154 (316)
T ss_pred             CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Ccee
Confidence            99999887654 4889999999999999999999   9999999999999999999999999999987432111  1234


Q ss_pred             ccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh----------------hhhcccccchhccccCC
Q 040702          669 QTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK----------------HLMTKEQPMVRMGTDLS  732 (797)
Q Consensus       669 ~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~l~~~cl~~d  732 (797)
                      ...||+.|+|||.+.+..++.++|+|++|+..++.+.+..++.....                .......++++.|++.|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d  234 (316)
T cd05620         155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERD  234 (316)
T ss_pred             ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCC
Confidence            56799999999999988999999999999998666655544332111                11224567889999999


Q ss_pred             CCCCCChH
Q 040702          733 LGQFPASY  740 (797)
Q Consensus       733 p~~RPs~~  740 (797)
                      |++||++.
T Consensus       235 P~~R~~~~  242 (316)
T cd05620         235 PTRRLGVV  242 (316)
T ss_pred             HHHcCCCh
Confidence            99999874

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=6e-33  Score=293.64  Aligned_cols=228  Identities=21%  Similarity=0.212  Sum_probs=184.8

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      ++|+..+.||+|+||.||++     ++.||||+++....  ...+.+.+|++++++++||||+++++++..++..|+|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            36889999999999999974     57899999976532  234678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      |++++.+..+... ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....... 
T Consensus        81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  155 (287)
T cd07848          81 YVEKNMLELLEEM-PNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN-  155 (287)
T ss_pred             cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc-
Confidence            9998777655433 335889999999999999999999   99999999999999999999999999999986533221 


Q ss_pred             ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh-----------------------------
Q 040702          665 LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK-----------------------------  715 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~-----------------------------  715 (797)
                      .......||+.|+|||.+.+..++.++|+|++|+..++.+.+..++.....                             
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH  235 (287)
T ss_pred             ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence            122345789999999999888899999999999987555544433221100                             


Q ss_pred             -------------------hhhcccccchhccccCCCCCCCChHHHHH
Q 040702          716 -------------------HLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       716 -------------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                         .....+.++++.|+..||++||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                               01123668999999999999999988764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2e-33  Score=303.66  Aligned_cols=221  Identities=21%  Similarity=0.244  Sum_probs=178.6

Q ss_pred             CCCccccccccCCcceeec--------ceEEEEEEEEecc----CCcchhHHHHHHHhhhc-cCCceeEeeeeeecCCeE
Q 040702          513 RFSENNLIGRGGFGPVYKD--------GMEVAIKVFNLQY----GGAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDFK  579 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~--------~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~  579 (797)
                      +|+..+.||+|+||.||++        ++.||+|++++..    ....+.+..|+.+++.+ +||+|+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4788899999999999952        5789999997542    12235678899999999 499999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCC
Q 040702          580 ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  659 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  659 (797)
                      ++||||+++|+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            99999999999999987654 4889999999999999999999   9999999999999999999999999999998653


Q ss_pred             ccCccccccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccccccchh--------------------hhhhh
Q 040702          660 EEDQSLTQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANLLIRE--------------------EKHLM  718 (797)
Q Consensus       660 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~~~~~--------------------~~~~~  718 (797)
                      .... .......||+.|||||.+.+. .++.++|+|++|+..++.+.+..++...                    +....
T Consensus       157 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T cd05614         157 SEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIG  235 (332)
T ss_pred             ccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Confidence            3222 123346799999999998764 4788999999999986665554443210                    00122


Q ss_pred             cccccchhccccCCCCCCCC
Q 040702          719 TKEQPMVRMGTDLSLGQFPA  738 (797)
Q Consensus       719 ~~~~~l~~~cl~~dp~~RPs  738 (797)
                      ..+.++++.|++.||++||+
T Consensus       236 ~~~~~li~~~l~~dp~~R~~  255 (332)
T cd05614         236 PEAQDLLHKLLRKDPKKRLG  255 (332)
T ss_pred             HHHHHHHHHHcCCCHHHcCC
Confidence            34567888899999999994

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=9.9e-33  Score=297.87  Aligned_cols=188  Identities=22%  Similarity=0.320  Sum_probs=161.9

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      .++|+..+.||+|+||.||++     +..||+|.+..... .....+.+|++++++++||||++++++|...+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            368999999999999999974     57899999876532 234578899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS-VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~-~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      |+++|+|.+++.... .+++..+..++.|++.|+.|||   . .+|+||||||+||+++.++.+||+|||++......  
T Consensus        84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--  157 (333)
T cd06650          84 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (333)
T ss_pred             cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence            999999999997654 4788899999999999999999   6 47999999999999999999999999999755322  


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhcc
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVD  706 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~  706 (797)
                        ......||..|+|||.+.+..++.++|+|++|+..+..+.+
T Consensus       158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g  198 (333)
T cd06650         158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIG  198 (333)
T ss_pred             --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHC
Confidence              12345789999999999888899999999999887555443

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.6e-33  Score=302.43  Aligned_cols=218  Identities=21%  Similarity=0.269  Sum_probs=179.9

Q ss_pred             ccccccCCcceee--------cceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccC
Q 040702          518 NLIGRGGFGPVYK--------DGMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  587 (797)
Q Consensus       518 ~~lg~G~~g~Vyk--------~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~  587 (797)
                      +.||+|+||.||+        .++.||+|+++....  .....+..|++++++++||||+++++++..++..|+||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999995        357899999986532  223467789999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccccc
Q 040702          588 LGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ  667 (797)
Q Consensus       588 ~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  667 (797)
                      +|+|.+++.... .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++......  ...
T Consensus        82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~~~  155 (318)
T cd05582          82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKA  155 (318)
T ss_pred             CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--Cce
Confidence            999999987654 4899999999999999999999   9999999999999999999999999999998653321  123


Q ss_pred             cccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh----------------hhhhcccccchhccccC
Q 040702          668 TQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE----------------KHLMTKEQPMVRMGTDL  731 (797)
Q Consensus       668 ~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~l~~~cl~~  731 (797)
                      ....||+.|+|||.+.+..++.++|+|++|+..++.+.+..++....                ......+.++++.|++.
T Consensus       156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~  235 (318)
T cd05582         156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKR  235 (318)
T ss_pred             ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhc
Confidence            34679999999999988888999999999998766555444332211                11233557888999999


Q ss_pred             CCCCCCChHH
Q 040702          732 SLGQFPASYS  741 (797)
Q Consensus       732 dp~~RPs~~~  741 (797)
                      ||++||++.+
T Consensus       236 ~P~~R~~a~~  245 (318)
T cd05582         236 NPANRLGAGP  245 (318)
T ss_pred             CHhHcCCCCC
Confidence            9999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1e-32  Score=292.43  Aligned_cols=237  Identities=24%  Similarity=0.311  Sum_probs=194.1

Q ss_pred             cCCCccccccccCCcceeecc----------eEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKDG----------MEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~~----------~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l  581 (797)
                      ++|...+.||+|+||.||++.          ..+|+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            468888999999999999752          4688998875544445678999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCc
Q 040702          582 VLEYMPLGSLEKCLYSGN---------------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV  646 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~  646 (797)
                      ||||+++++|.+++....               ..+++..++.++.|++.|++|||   +++|+||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCc
Confidence            999999999999986532               24788999999999999999999   999999999999999999999


Q ss_pred             EEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccch-hh----------
Q 040702          647 AHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIR-EE----------  714 (797)
Q Consensus       647 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~-~~----------  714 (797)
                      +||+|||+++...............++..|+|||.+.+..++.++|+|++|+..++.+. +..++.. ..          
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~  241 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG  241 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCC
Confidence            99999999986543322222334557889999999998889999999999998765543 3333211 11          


Q ss_pred             ------hhhhcccccchhccccCCCCCCCChHHHHHhHHHHHH
Q 040702          715 ------KHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRE  751 (797)
Q Consensus       715 ------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~  751 (797)
                            ......+.+++.+|++.||++||++.++.+.++.+..
T Consensus       242 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         242 RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             CCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence                  1122356788999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=6.8e-33  Score=299.34  Aligned_cols=238  Identities=21%  Similarity=0.315  Sum_probs=189.7

Q ss_pred             hcCCCccccccccCCcceeec----------ceEEEEEEEEeccC-CcchhHHHHHHHhhhc-cCCceeEeeeeeecC-C
Q 040702          511 TNRFSENNLIGRGGFGPVYKD----------GMEVAIKVFNLQYG-GAFKSFDIECGMMKRI-RHRNLIKIISSCSND-D  577 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~----------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~-~  577 (797)
                      .++|++.+.||+|+||.||++          ++.||+|+++.... ...+.+..|+.++.++ +||||++++++|... .
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            357999999999999999975          26799999875432 2235678899999999 799999999988654 5


Q ss_pred             eEEEEEEccCCCCHHHHHhcCC----------------------------------------------------------
Q 040702          578 FKALVLEYMPLGSLEKCLYSGN----------------------------------------------------------  599 (797)
Q Consensus       578 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  599 (797)
                      ..++||||+++|+|.+++....                                                          
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            7889999999999999885421                                                          


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccccccccccCcccc
Q 040702          600 --YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM  677 (797)
Q Consensus       600 --~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~  677 (797)
                        ..+++..+..++.||+.||+|||   +.+|+||||||+||++++++.+||+|||+++.+.............++..||
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence              14788999999999999999999   9999999999999999999999999999998764333222233345677899


Q ss_pred             cccccccCccchHHHHHHHhhhhhhhhc-cccccch-h-----------------hhhhhcccccchhccccCCCCCCCC
Q 040702          678 APDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIR-E-----------------EKHLMTKEQPMVRMGTDLSLGQFPA  738 (797)
Q Consensus       678 aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~-~-----------------~~~~~~~~~~l~~~cl~~dp~~RPs  738 (797)
                      |||.+.+..++.++|+|++|+..++.+. +..++.. .                 +......+.+++..|++.+|++||+
T Consensus       243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs  322 (337)
T cd05054         243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPT  322 (337)
T ss_pred             CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcC
Confidence            9999999999999999999998865543 2222211 0                 0011234567888899999999999


Q ss_pred             hHHHHHhHHHHHH
Q 040702          739 SYSISKYLVYIRE  751 (797)
Q Consensus       739 ~~~i~~~l~~i~~  751 (797)
                      +.|+++.|+.+.+
T Consensus       323 ~~ell~~l~~~~~  335 (337)
T cd05054         323 FSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHHHHHHHh
Confidence            9999999987643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.2e-32  Score=290.78  Aligned_cols=234  Identities=21%  Similarity=0.306  Sum_probs=188.6

Q ss_pred             cCCCccccccccCCcceeecc---------eEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKDG---------MEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~~---------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l  581 (797)
                      ++|+..+.||+|+||.||+|.         ..||+|.+..... ...+.+.+|++++++++||||+++++++..++..|+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            568888999999999999852         6799999875432 223678899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCC
Q 040702          582 VLEYMPLGSLEKCLYSGN----------------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM  645 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~----------------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~  645 (797)
                      ||||+++|+|.+++....                ..+++.....++.|++.|++|||   +++|+||||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence            999999999999985321                14678888999999999999999   99999999999999999999


Q ss_pred             cEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccch-hh---------
Q 040702          646 VAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIR-EE---------  714 (797)
Q Consensus       646 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~-~~---------  714 (797)
                      .+||+|||+++...............++..|+|||.+.++.++.++|+|++|+..++.+. +..++.. .+         
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~  241 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK  241 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            999999999986543332222334456778999999988889999999999998755543 3222211 11         


Q ss_pred             -------hhhhcccccchhccccCCCCCCCChHHHHHhHHH
Q 040702          715 -------KHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVY  748 (797)
Q Consensus       715 -------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~  748 (797)
                             ......+.+++..|++.||++||++.++.+.++.
T Consensus       242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         242 RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence                   1123356678899999999999999999888753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-34  Score=319.99  Aligned_cols=266  Identities=21%  Similarity=0.258  Sum_probs=206.2

Q ss_pred             HHHHHHHhcCCCccccccccCCcceee-----cceEEEEEEEEec---cCCcchhHHHHHHHhhhccCCceeEeeeeeec
Q 040702          504 YLELFQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQ---YGGAFKSFDIECGMMKRIRHRNLIKIISSCSN  575 (797)
Q Consensus       504 ~~~l~~~~~~f~~~~~lg~G~~g~Vyk-----~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~  575 (797)
                      ..++.-..++|.+.++||+|+||+|..     +++.||+|++.+.   .......|..|-.+|.--+.+.|+.++.+|.+
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            344555668999999999999999984     4789999999875   23445678889999999999999999999999


Q ss_pred             CCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCC
Q 040702          576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMA  655 (797)
Q Consensus       576 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla  655 (797)
                      +...|+|||||+||+|-.++.... .+++..++.++.+|+-||..+|   +.|+|||||||+|||+|..|++||+|||.+
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsC  222 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSC  222 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhH
Confidence            999999999999999999998877 6999999999999999999999   999999999999999999999999999988


Q ss_pred             ccCCccCccccccccccCcccccccccc----c-CccchHHHHHHHhhhhhhhhccccccchhhhh--hhcccccchhcc
Q 040702          656 KPLLEEDQSLTQTQTLATIGYMAPDEIF----S-GEMRLKCWVNDSLLISVMIVVDANLLIREEKH--LMTKEQPMVRMG  728 (797)
Q Consensus       656 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~c  728 (797)
                      -.+..++. ......+|||.|++||++.    + |.|+..+|+||+|+.+|+++++..++-...-.  +..++..--..+
T Consensus       223 lkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~  301 (1317)
T KOG0612|consen  223 LKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLS  301 (1317)
T ss_pred             HhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcC
Confidence            76654443 3456689999999999885    2 67899999999999998888877765332211  111111111112


Q ss_pred             ccCCCCCCCChHHHHHhHHHHHHHhccccccccccCCcccccceeeeeeee
Q 040702          729 TDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYT  779 (797)
Q Consensus       729 l~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~  779 (797)
                      +..++.--+.++++...+---.+..-++-|     ..+|..||||.|++|+
T Consensus       302 FP~~~~VSeeakdLI~~ll~~~e~RLgrng-----iedik~HpFF~g~~W~  347 (1317)
T KOG0612|consen  302 FPDETDVSEEAKDLIEALLCDREVRLGRNG-----IEDIKNHPFFEGIDWD  347 (1317)
T ss_pred             CCcccccCHHHHHHHHHHhcChhhhccccc-----HHHHHhCccccCCChh
Confidence            322333333344444444333333333333     5788999999999995

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-33  Score=306.67  Aligned_cols=260  Identities=20%  Similarity=0.265  Sum_probs=192.3

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ++|...+.||+|+||.||++     ++.||||++....   ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47889999999999999974     5789999987542   223456888999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      ||+++|+|.+++...+ .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+.....
T Consensus        81 E~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~  156 (377)
T cd05629          81 EFLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD  156 (377)
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            9999999999987654 4888899999999999999999   99999999999999999999999999999964321000


Q ss_pred             c------------c---------------------------------cccccccCcccccccccccCccchHHHHHHHhh
Q 040702          664 S------------L---------------------------------TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLL  698 (797)
Q Consensus       664 ~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~  698 (797)
                      .            .                                 .....+||+.|||||.+.+..++.++|+|++|+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  236 (377)
T cd05629         157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA  236 (377)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence            0            0                                 001246999999999999888999999999999


Q ss_pred             hhhhhhccccccchhh-hhhhcccccchhc--cccCCCCCCCChHHHHHhHHHHHHHhccccccccccCCcccccceeee
Q 040702          699 ISVMIVVDANLLIREE-KHLMTKEQPMVRM--GTDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRT  775 (797)
Q Consensus       699 ~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~--cl~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~  775 (797)
                      ..++.+.+..++.... .+...   .+...  -+. -|....-..++.+.+..+...+..+.+.  ..+.+.+.|+||++
T Consensus       237 il~elltG~~Pf~~~~~~~~~~---~i~~~~~~~~-~p~~~~~s~~~~dli~~lL~~~~~r~~r--~~~~~~l~hp~~~~  310 (377)
T cd05629         237 IMFECLIGWPPFCSENSHETYR---KIINWRETLY-FPDDIHLSVEAEDLIRRLITNAENRLGR--GGAHEIKSHPFFRG  310 (377)
T ss_pred             hhhhhhcCCCCCCCCCHHHHHH---HHHccCCccC-CCCCCCCCHHHHHHHHHHhcCHhhcCCC--CCHHHHhcCCCcCC
Confidence            9877666555443221 11111   11111  011 1221111234555555554433333321  35677888999998


Q ss_pred             eeeeec
Q 040702          776 VDYTIS  781 (797)
Q Consensus       776 ~~~~~~  781 (797)
                      ++|+..
T Consensus       311 ~~~~~~  316 (377)
T cd05629         311 VDWDTI  316 (377)
T ss_pred             CCHHHH
Confidence            888653

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.6e-32  Score=284.48  Aligned_cols=227  Identities=22%  Similarity=0.273  Sum_probs=182.5

Q ss_pred             ccccccCCcceeec-----ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccCCCCH
Q 040702          518 NLIGRGGFGPVYKD-----GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSL  591 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~g~L  591 (797)
                      +.||+|+||.||++     ++.||+|.+..... .....+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            46899999999974     57899998764432 2346789999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccccccccc
Q 040702          592 EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL  671 (797)
Q Consensus       592 ~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  671 (797)
                      .+++......+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++................
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  157 (252)
T cd05084          81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ  157 (252)
T ss_pred             HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence            9999765556899999999999999999999   9999999999999999999999999999997543221111111123


Q ss_pred             cCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccch-----------------hhhhhhcccccchhccccCCC
Q 040702          672 ATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIR-----------------EEKHLMTKEQPMVRMGTDLSL  733 (797)
Q Consensus       672 gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~-----------------~~~~~~~~~~~l~~~cl~~dp  733 (797)
                      ++..|+|||.+.++.++.++|+|++|+..++.+. +..++..                 .+......+.+++++|+..+|
T Consensus       158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  237 (252)
T cd05084         158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP  237 (252)
T ss_pred             CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence            3567999999998899999999999998755443 2222211                 011123456778999999999


Q ss_pred             CCCCChHHHHHhHH
Q 040702          734 GQFPASYSISKYLV  747 (797)
Q Consensus       734 ~~RPs~~~i~~~l~  747 (797)
                      ++||++.++.+.++
T Consensus       238 ~~Rps~~~~~~~l~  251 (252)
T cd05084         238 GQRPSFSTVHQELQ  251 (252)
T ss_pred             hhCcCHHHHHHHHh
Confidence            99999999998764

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=6.4e-33  Score=288.53  Aligned_cols=228  Identities=30%  Similarity=0.417  Sum_probs=179.7

Q ss_pred             ccccccccCCcceeec---------ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          516 ENNLIGRGGFGPVYKD---------GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       516 ~~~~lg~G~~g~Vyk~---------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      ..+.||+|+||.||+|         +..||||.+..... ...+.+.+|++.+++++||||++++|++...+..++||||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3578999999999984         36799999955332 2357899999999999999999999999988889999999


Q ss_pred             cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          586 MPLGSLEKCLYSG-NYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       586 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      +++|+|.+++... ...+++..+..|+.||++||.|||   +.+++|+||+++||++++++.+||+|||++.........
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999887 446899999999999999999999   889999999999999999999999999999866322222


Q ss_pred             ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-----------------hhhhhcccccchh
Q 040702          665 LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-----------------EKHLMTKEQPMVR  726 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-----------------~~~~~~~~~~l~~  726 (797)
                      .......+...|+|||.+..+.++.++|||++|+..++.+. ...+....                 +......+.++++
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  239 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQ  239 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHHH
Confidence            23344557788999999999999999999999998755554 22222211                 1112335678899


Q ss_pred             ccccCCCCCCCChHHHHHhH
Q 040702          727 MGTDLSLGQFPASYSISKYL  746 (797)
Q Consensus       727 ~cl~~dp~~RPs~~~i~~~l  746 (797)
                      .||+.||++||++.++.+.|
T Consensus       240 ~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  240 QCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             HHT-SSGGGS--HHHHHHHH
T ss_pred             HHcCCChhhCcCHHHHHhcC
Confidence            99999999999999998765

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=5.7e-33  Score=303.42  Aligned_cols=261  Identities=21%  Similarity=0.280  Sum_probs=195.1

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ++|+..+.||+|+||.||++     ++.||||+++...   ......+..|+.++..++||+|+++++++.+++..|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999974     6889999997542   223456788999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        81 E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~  156 (360)
T cd05627          81 EFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR  156 (360)
T ss_pred             eCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence            9999999999987654 4889999999999999999999   99999999999999999999999999999875432110


Q ss_pred             c---------------------------------ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhcccccc
Q 040702          664 S---------------------------------LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLL  710 (797)
Q Consensus       664 ~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~  710 (797)
                      .                                 ......+||+.|||||.+.+..++.++|+|++|+..++.+.+..++
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf  236 (360)
T cd05627         157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF  236 (360)
T ss_pred             cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence            0                                 0012357999999999999999999999999999987766655554


Q ss_pred             chhhh-hhhcccccchhc-cccCCCCCCCChHHHHHhHHHHHHHhccccccccccCCcccccceeeeeeeeec
Q 040702          711 IREEK-HLMTKEQPMVRM-GTDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYTIS  781 (797)
Q Consensus       711 ~~~~~-~~~~~~~~l~~~-cl~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~  781 (797)
                      ..... ....   .+... --..-|...|-..+..+.+..+...+..|.+  ...+..+++|+||++++|+.-
T Consensus       237 ~~~~~~~~~~---~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~--~~~~~ei~~hp~f~~~~~~~~  304 (360)
T cd05627         237 CSETPQETYR---KVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIG--SNGVEEIKSHPFFEGVDWGHI  304 (360)
T ss_pred             CCCCHHHHHH---HHHcCCCceecCCCCCCCHHHHHHHHHhccChhhcCC--CCCHHHHhcCCCCCCCCHHHH
Confidence            33221 1111   11110 0001133333334444444444323333333  224568899999999999753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.5e-32  Score=301.63  Aligned_cols=237  Identities=19%  Similarity=0.304  Sum_probs=190.6

Q ss_pred             HhcCCCccccccccCCcceeecc----------eEEEEEEEEeccC-CcchhHHHHHHHhhhcc-CCceeEeeeeeecCC
Q 040702          510 ATNRFSENNLIGRGGFGPVYKDG----------MEVAIKVFNLQYG-GAFKSFDIECGMMKRIR-HRNLIKIISSCSNDD  577 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~~----------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~  577 (797)
                      ..++|...+.||+|+||.||++.          ..||||+++.... ...+.+.+|++++.++. ||||++++++|...+
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~  114 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG  114 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence            44678888999999999999752          5799999975532 22357889999999997 999999999999999


Q ss_pred             eEEEEEEccCCCCHHHHHhcCC----------------------------------------------------------
Q 040702          578 FKALVLEYMPLGSLEKCLYSGN----------------------------------------------------------  599 (797)
Q Consensus       578 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  599 (797)
                      ..++||||+++|+|.++++..+                                                          
T Consensus       115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (401)
T cd05107         115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD  194 (401)
T ss_pred             CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence            9999999999999999986432                                                          


Q ss_pred             ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceE
Q 040702          600 ---------------------------------------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL  640 (797)
Q Consensus       600 ---------------------------------------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIl  640 (797)
                                                             ..+++.....++.|++.||+|||   +.+|+||||||+||+
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiL  271 (401)
T cd05107         195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVL  271 (401)
T ss_pred             chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEE
Confidence                                                   13567778899999999999999   999999999999999


Q ss_pred             EcCCCcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh------
Q 040702          641 LDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE------  713 (797)
Q Consensus       641 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~------  713 (797)
                      +++++.+||+|||+++...............++..|||||.+....++.++|+|++|+..++.+. +..++...      
T Consensus       272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~  351 (401)
T cd05107         272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF  351 (401)
T ss_pred             EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence            99999999999999986543322222233457889999999998889999999999998755443 22222110      


Q ss_pred             ------------hhhhhcccccchhccccCCCCCCCChHHHHHhHHHH
Q 040702          714 ------------EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYI  749 (797)
Q Consensus       714 ------------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i  749 (797)
                                  +......+.+++..||..+|.+||+++++++.|+.+
T Consensus       352 ~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         352 YNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                        011223566889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.5e-32  Score=289.45  Aligned_cols=234  Identities=24%  Similarity=0.318  Sum_probs=191.4

Q ss_pred             hcCCCccccccccCCcceeecc----------eEEEEEEEEeccCC-cchhHHHHHHHhhhccCCceeEeeeeeecCCeE
Q 040702          511 TNRFSENNLIGRGGFGPVYKDG----------MEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFK  579 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~~----------~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~  579 (797)
                      .++|...+.||+|+||.||++.          ..||||.++..... ..+.+.+|++++++++||||+++++++...+..
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            3568888999999999999752          57999998765443 357899999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCc
Q 040702          580 ALVLEYMPLGSLEKCLYSGN-------------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV  646 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~-------------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~  646 (797)
                      ++||||+++|+|.+++....             ..+++..+..++.|++.|++|||   +++++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCe
Confidence            99999999999999997542             24788899999999999999999   999999999999999999999


Q ss_pred             EEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccch-h-----------
Q 040702          647 AHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIR-E-----------  713 (797)
Q Consensus       647 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~-~-----------  713 (797)
                      +||+|||+++...............+++.|+|||.+.++.++.++|+|++|+..++.+. +..++.. .           
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~  240 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG  240 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence            99999999976533322222233456788999999999999999999999998765553 3332211 1           


Q ss_pred             -----hhhhhcccccchhccccCCCCCCCChHHHHHhHH
Q 040702          714 -----EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLV  747 (797)
Q Consensus       714 -----~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~  747 (797)
                           +......+.++++.||..||++||++.|+++.++
T Consensus       241 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         241 RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence                 1112346678999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.9e-33  Score=300.06  Aligned_cols=217  Identities=24%  Similarity=0.249  Sum_probs=174.5

Q ss_pred             ccccccCCcceeec-----ceEEEEEEEEeccC---CcchhHHHHHH-HhhhccCCceeEeeeeeecCCeEEEEEEccCC
Q 040702          518 NLIGRGGFGPVYKD-----GMEVAIKVFNLQYG---GAFKSFDIECG-MMKRIRHRNLIKIISSCSNDDFKALVLEYMPL  588 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~---~~~~~~~~E~~-~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~  588 (797)
                      +.||+|+||.||++     ++.||||++.....   .....+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46899999999974     68899999976521   22334555554 46788999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccccc
Q 040702          589 GSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  668 (797)
Q Consensus       589 g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  668 (797)
                      |+|..++.... .+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (323)
T cd05575          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTTS  154 (323)
T ss_pred             CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Cccc
Confidence            99999887654 4888999999999999999999   9999999999999999999999999999997542221  1234


Q ss_pred             ccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh----------------hhhcccccchhccccCC
Q 040702          669 QTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK----------------HLMTKEQPMVRMGTDLS  732 (797)
Q Consensus       669 ~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~l~~~cl~~d  732 (797)
                      ...||+.|||||.+.+..++.++|+|++|+..+..+.+..++.....                .......++++.|++.|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~  234 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKD  234 (323)
T ss_pred             cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence            45799999999999998999999999999998666655444322111                12334567888899999


Q ss_pred             CCCCCChH
Q 040702          733 LGQFPASY  740 (797)
Q Consensus       733 p~~RPs~~  740 (797)
                      |.+||+++
T Consensus       235 p~~R~~~~  242 (323)
T cd05575         235 RTKRLGAK  242 (323)
T ss_pred             HHhCCCCC
Confidence            99999875

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.7e-32  Score=288.84  Aligned_cols=241  Identities=20%  Similarity=0.219  Sum_probs=192.5

Q ss_pred             hcCCCccccccccCCcceeecc---------eEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKDG---------MEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKA  580 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~~---------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~  580 (797)
                      .++|+..+.||+|+||.||++.         ..||+|+++.... .....+.+|+.+++.++||||+++++++... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            4678889999999999999862         2589999875432 2346788999999999999999999998754 467


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCc
Q 040702          581 LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  660 (797)
Q Consensus       581 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  660 (797)
                      ++|||+++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++....
T Consensus        85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            999999999999999876556899999999999999999999   99999999999999999999999999999986643


Q ss_pred             cCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchhhh-----------------hhhcccc
Q 040702          661 EDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIREEK-----------------HLMTKEQ  722 (797)
Q Consensus       661 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~~~-----------------~~~~~~~  722 (797)
                      ...........++..|+|||.+.+..++.++|+|++|+..++.+. +..++.....                 .....+.
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVY  241 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHH
Confidence            322212222345678999999998889999999999998765443 3333221111                 1122445


Q ss_pred             cchhccccCCCCCCCChHHHHHhHHHHHHHhcc
Q 040702          723 PMVRMGTDLSLGQFPASYSISKYLVYIRELERG  755 (797)
Q Consensus       723 ~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~~  755 (797)
                      +++..|+..||++||++.++++.++.+...+.+
T Consensus       242 ~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~~  274 (279)
T cd05109         242 MIMVKCWMIDSECRPRFRELVDEFSRMARDPSR  274 (279)
T ss_pred             HHHHHHcCCChhhCcCHHHHHHHHHHhhcCCcC
Confidence            788899999999999999999998887666533

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.2e-32  Score=284.12  Aligned_cols=230  Identities=20%  Similarity=0.227  Sum_probs=187.3

Q ss_pred             cCCCccccccccCCcceeec----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccC
Q 040702          512 NRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  587 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~  587 (797)
                      ++|+..+.||+|+||.||++    +..+|+|.+.... ...+++.+|+.++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            56888899999999999975    4589999876432 234678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccccc
Q 040702          588 LGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ  667 (797)
Q Consensus       588 ~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  667 (797)
                      +|+|.+++......+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+||+|||.++....... ...
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~-~~~  158 (256)
T cd05114          83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY-TSS  158 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-ecc
Confidence            99999999765556899999999999999999999   99999999999999999999999999999986532221 122


Q ss_pred             cccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccc-hhhh----------------hhhcccccchhccc
Q 040702          668 TQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLI-REEK----------------HLMTKEQPMVRMGT  729 (797)
Q Consensus       668 ~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~-~~~~----------------~~~~~~~~l~~~cl  729 (797)
                      ....++..|+|||.+....++.++|+|++|+..+..+. +..++. ....                .....+.+++++|+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~  238 (256)
T cd05114         159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCW  238 (256)
T ss_pred             CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHc
Confidence            23345678999999988889999999999998766554 222211 1111                11224678888999


Q ss_pred             cCCCCCCCChHHHHHhH
Q 040702          730 DLSLGQFPASYSISKYL  746 (797)
Q Consensus       730 ~~dp~~RPs~~~i~~~l  746 (797)
                      +.+|.+||++.++++.|
T Consensus       239 ~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         239 HEKPEGRPTFAELLRAI  255 (256)
T ss_pred             cCCcccCcCHHHHHHhh
Confidence            99999999999998865

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.1e-32  Score=291.98  Aligned_cols=240  Identities=23%  Similarity=0.303  Sum_probs=193.9

Q ss_pred             hcCCCccccccccCCcceeecc------------eEEEEEEEEecc-CCcchhHHHHHHHhhhc-cCCceeEeeeeeecC
Q 040702          511 TNRFSENNLIGRGGFGPVYKDG------------MEVAIKVFNLQY-GGAFKSFDIECGMMKRI-RHRNLIKIISSCSND  576 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~~------------~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~  576 (797)
                      .++|...+.||+|+||.||++.            ..||+|.++... ....+.+.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            4688899999999999999652            369999887542 23346788999999999 899999999999999


Q ss_pred             CeEEEEEEccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEE
Q 040702          577 DFKALVLEYMPLGSLEKCLYSGN---------------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL  641 (797)
Q Consensus       577 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll  641 (797)
                      +..|+||||+++|+|.+++....               ..+++..+..++.|+++|++|||   +++|+||||||+||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili  170 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLV  170 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEE
Confidence            99999999999999999987532               24778889999999999999999   9999999999999999


Q ss_pred             cCCCcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-------
Q 040702          642 DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-------  713 (797)
Q Consensus       642 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-------  713 (797)
                      ++++.+||+|||.++...............+++.|+|||.+.+..++.++|+|++|+..+..+. ...++...       
T Consensus       171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~  250 (304)
T cd05101         171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK  250 (304)
T ss_pred             cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence            9999999999999987643332222333456788999999988889999999999998754443 21111110       


Q ss_pred             ----------hhhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHHh
Q 040702          714 ----------EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRELE  753 (797)
Q Consensus       714 ----------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~  753 (797)
                                +......+.+++.+|++.+|++||++.++++.|+++....
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~  300 (304)
T cd05101         251 LLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLT  300 (304)
T ss_pred             HHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhh
Confidence                      0112235677899999999999999999999999887664

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.1e-32  Score=289.93  Aligned_cols=235  Identities=20%  Similarity=0.278  Sum_probs=188.0

Q ss_pred             HhcCCCccccccccCCcceeec----------ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCe
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD----------GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDF  578 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~----------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~  578 (797)
                      .+++|+..+.||+|+||.||++          +..||||.+..... ....++.+|+.+++.++||||+++++++...+.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            4678999999999999999964          25799998864322 234568899999999999999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEE
Q 040702          579 KALVLEYMPLGSLEKCLYSGN---------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHL  649 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl  649 (797)
                      .++||||+++|+|.+++....         ...++..+..++.|+++|++|||   +.+++||||||+||++++++.+||
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEE
Confidence            999999999999999986532         13577888999999999999999   899999999999999999999999


Q ss_pred             EeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc--cccccchh--------------
Q 040702          650 SDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV--DANLLIRE--------------  713 (797)
Q Consensus       650 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~--~~~~~~~~--------------  713 (797)
                      +|||+++...............++..|||||.+.++.++.++|+|++|+..++.+.  .+++.+..              
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~  240 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL  240 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence            99999986543322222223456788999999998889999999999998755443  22221111              


Q ss_pred             --hhhhhcccccchhccccCCCCCCCChHHHHHhHH
Q 040702          714 --EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLV  747 (797)
Q Consensus       714 --~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~  747 (797)
                        +......+.+++.+|++.||++||++.|+++.++
T Consensus       241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         241 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence              1112234667999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.6e-32  Score=288.31  Aligned_cols=236  Identities=21%  Similarity=0.286  Sum_probs=189.1

Q ss_pred             hcCCCccccccccCCcceeec---------ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecC--CeE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD---------GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSND--DFK  579 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~---------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~--~~~  579 (797)
                      ..+|+..+.||+|+||.||++         +..||+|.+........+.+.+|++++++++||||+++++++...  ...
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            357888999999999999974         468999998765544456889999999999999999999987543  468


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCC
Q 040702          580 ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  659 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  659 (797)
                      ++||||+++|+|.+++......+++..+..++.|++.||+|||   ..+|+||||||+||+++.++.+||+|||+++...
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~  159 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLP  159 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence            9999999999999999765556899999999999999999999   9999999999999999999999999999998764


Q ss_pred             ccCcccc-ccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccch--------------------------
Q 040702          660 EEDQSLT-QTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIR--------------------------  712 (797)
Q Consensus       660 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~--------------------------  712 (797)
                      ....... .....++..|+|||.+.+..++.++|+|++|+..++.+........                          
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05081         160 QDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL  239 (284)
T ss_pred             CCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence            3322111 1122345569999999888899999999999887444332111000                          


Q ss_pred             -------hhhhhhcccccchhccccCCCCCCCChHHHHHhHHHH
Q 040702          713 -------EEKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYI  749 (797)
Q Consensus       713 -------~~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i  749 (797)
                             .+......+.+++.+|++.+|++|||+.++.+.++.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence                   0011223577899999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.4e-32  Score=298.01  Aligned_cols=228  Identities=20%  Similarity=0.262  Sum_probs=181.5

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeecCC-----eEE
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSNDD-----FKA  580 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~-----~~~  580 (797)
                      +|+..+.||+|+||.||++     +..||||++.....  .....+.+|++++++++||||+++++++...+     ..|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4788899999999999974     58899999875422  22356889999999999999999999886432     479


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCc
Q 040702          581 LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  660 (797)
Q Consensus       581 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  660 (797)
                      +||||++ ++|.+++.... .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        81 lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          81 VVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            9999995 68999887654 4899999999999999999999   99999999999999999999999999999986432


Q ss_pred             cCcc-ccccccccCccccccccccc--CccchHHHHHHHhhhhhhhhccccccchhh-----------------------
Q 040702          661 EDQS-LTQTQTLATIGYMAPDEIFS--GEMRLKCWVNDSLLISVMIVVDANLLIREE-----------------------  714 (797)
Q Consensus       661 ~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-----------------------  714 (797)
                      .... .......||+.|+|||.+.+  ..++.++|+|++|+..+..+.+..++....                       
T Consensus       156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i  235 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV  235 (338)
T ss_pred             ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            2211 12234679999999998865  678899999999998866555443331100                       


Q ss_pred             ------------------------hhhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          715 ------------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       715 ------------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                                              ......+.++++.|+..||++||++.|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                                    0011234578999999999999999998864

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.98  E-value=1.6e-32  Score=291.48  Aligned_cols=233  Identities=22%  Similarity=0.307  Sum_probs=186.3

Q ss_pred             cCCCccccccccCCcceeecc-------------------eEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeee
Q 040702          512 NRFSENNLIGRGGFGPVYKDG-------------------MEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIIS  571 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~~-------------------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~  571 (797)
                      ++|+..+.||+|+||.||++.                   ..||+|.++.... .....+.+|++++++++||||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            578999999999999999641                   2589999875422 23457889999999999999999999


Q ss_pred             eeecCCeEEEEEEccCCCCHHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceE
Q 040702          572 SCSNDDFKALVLEYMPLGSLEKCLYSGN-----------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL  640 (797)
Q Consensus       572 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIl  640 (797)
                      ++...+..++||||+++++|.+++....           ..+++..+..++.|++.|++|||   +.+++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEE
Confidence            9999999999999999999999986532           13678889999999999999999   999999999999999


Q ss_pred             EcCCCcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc--cccccchh-----
Q 040702          641 LDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV--DANLLIRE-----  713 (797)
Q Consensus       641 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~--~~~~~~~~-----  713 (797)
                      +++++.+||+|||++................++..|+|||.+..+.++.++|+|++|+..+..+.  ...++...     
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~  241 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV  241 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence            99999999999999986543322222233445778999999998999999999999988744432  22111110     


Q ss_pred             -------------------hhhhhcccccchhccccCCCCCCCChHHHHHhHH
Q 040702          714 -------------------EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLV  747 (797)
Q Consensus       714 -------------------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~  747 (797)
                                         +......+.+++++|++.||++||++.++.+.|+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         242 IENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence                               0011234678999999999999999999988775

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.98  E-value=2.9e-32  Score=288.82  Aligned_cols=235  Identities=22%  Similarity=0.323  Sum_probs=189.8

Q ss_pred             CCCccccccccCCcceeecc----------eEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEE
Q 040702          513 RFSENNLIGRGGFGPVYKDG----------MEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~~----------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l  581 (797)
                      +|...+.||+|+||.||++.          ..+|+|.+..... ...+++.+|+.+++.++||||+++++.+...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            47788999999999999852          4688888865432 234678899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCc
Q 040702          582 VLEYMPLGSLEKCLYSGN-----------------------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSN  638 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~N  638 (797)
                      ||||+.+|+|.+++....                       ..+++..+..++.|++.|++|||   +.+|+||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence            999999999999886421                       24788899999999999999999   9999999999999


Q ss_pred             eEEcCCCcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh----
Q 040702          639 VLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE----  713 (797)
Q Consensus       639 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~----  713 (797)
                      |++++++.+||+|||+++...............++..|+|||.+.+..++.++|+|++|+..+..+. +..++...    
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999986543333222333456778999999988889999999999998755543 32221111    


Q ss_pred             -------------hhhhhcccccchhccccCCCCCCCChHHHHHhHHHHH
Q 040702          714 -------------EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIR  750 (797)
Q Consensus       714 -------------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~  750 (797)
                                   +......+.++++.|++.+|++||++.++++.++.+-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence                         1112235668899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.98  E-value=6.4e-33  Score=305.54  Aligned_cols=260  Identities=19%  Similarity=0.261  Sum_probs=189.6

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      +|+..+.||+|+||.||++     ++.||||++....   ....+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5888999999999999985     5789999997653   2234578889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc-
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ-  663 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~-  663 (797)
                      |+++|+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+..... 
T Consensus        82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence            999999999987654 4788899999999999999999   99999999999999999999999999999753210000 


Q ss_pred             --------------------------------------------cccccccccCcccccccccccCccchHHHHHHHhhh
Q 040702          664 --------------------------------------------SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLI  699 (797)
Q Consensus       664 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~  699 (797)
                                                                  .......+||+.|||||.+.+..++.++|+|++|++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi  237 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  237 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence                                                        000123479999999999999999999999999999


Q ss_pred             hhhhhccccccchhhhhhhcccccchhcccc-CCCCCCCChHHHHHhHHHHHHHhccccccccccCCcccccceeeeeee
Q 040702          700 SVMIVVDANLLIREEKHLMTKEQPMVRMGTD-LSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDY  778 (797)
Q Consensus       700 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~-~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~  778 (797)
                      .++.+.+..++........  ...++..-.. ..|....-..+..+.+..+...+..|.+  ...+.++++|+||++++|
T Consensus       238 l~elltG~~Pf~~~~~~~~--~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~--~~~~~ei~~hp~f~~~~~  313 (382)
T cd05625         238 LYEMLVGQPPFLAQTPLET--QMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLG--KNGADEIKAHPFFKTIDF  313 (382)
T ss_pred             HHHHHhCCCCCCCCCHHHH--HHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHhHcCC--CCCHHHHhcCCCcCCcCh
Confidence            8777666555443221110  0011110000 0111000113334444444333344433  233567888888988887


Q ss_pred             ee
Q 040702          779 TI  780 (797)
Q Consensus       779 ~~  780 (797)
                      ..
T Consensus       314 ~~  315 (382)
T cd05625         314 SS  315 (382)
T ss_pred             HH
Confidence            64

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.98  E-value=1.4e-32  Score=291.78  Aligned_cols=237  Identities=23%  Similarity=0.306  Sum_probs=191.2

Q ss_pred             HhcCCCccccccccCCcceeecc----------eEEEEEEEEeccC-CcchhHHHHHHHhhhc-cCCceeEeeeeeecCC
Q 040702          510 ATNRFSENNLIGRGGFGPVYKDG----------MEVAIKVFNLQYG-GAFKSFDIECGMMKRI-RHRNLIKIISSCSNDD  577 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~~----------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~  577 (797)
                      ..++|+..+.||+|+||.||++.          ..||+|.+..... .....+.+|+.+++++ +||||+++++++..++
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            45678899999999999999753          5799999875422 2335688999999999 7999999999999999


Q ss_pred             eEEEEEEccCCCCHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEc
Q 040702          578 FKALVLEYMPLGSLEKCLYSG---------------NYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD  642 (797)
Q Consensus       578 ~~~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~  642 (797)
                      ..++||||+++|+|.+++...               ...+++..++.++.|++.|++|||   ..+|+||||||+||+++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEc
Confidence            999999999999999998642               235889999999999999999999   99999999999999999


Q ss_pred             CCCcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh--------
Q 040702          643 DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE--------  713 (797)
Q Consensus       643 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~--------  713 (797)
                      +++.+||+|||+++.+.............++..|+|||.+.+..++.++|+|++|+..++.+. +..++...        
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  246 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL  246 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHH
Confidence            999999999999987644332222223345678999999988889999999999998755432 22221111        


Q ss_pred             ---------hhhhhcccccchhccccCCCCCCCChHHHHHhHHHH
Q 040702          714 ---------EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYI  749 (797)
Q Consensus       714 ---------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i  749 (797)
                               +......+.+++..|+..||++||++.++++.++.+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         247 LKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence                     111223567789999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.98  E-value=3.2e-32  Score=290.95  Aligned_cols=239  Identities=24%  Similarity=0.313  Sum_probs=192.8

Q ss_pred             hcCCCccccccccCCcceeecc------------eEEEEEEEEecc-CCcchhHHHHHHHhhhc-cCCceeEeeeeeecC
Q 040702          511 TNRFSENNLIGRGGFGPVYKDG------------MEVAIKVFNLQY-GGAFKSFDIECGMMKRI-RHRNLIKIISSCSND  576 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~~------------~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~  576 (797)
                      .++|.+.+.||+|+||.||++.            ..||+|.++... ......+..|+++++++ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            3679999999999999999752            369999987542 22345788899999999 799999999999999


Q ss_pred             CeEEEEEEccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEE
Q 040702          577 DFKALVLEYMPLGSLEKCLYSGN---------------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL  641 (797)
Q Consensus       577 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll  641 (797)
                      +..|+||||+++|+|.+++....               ..+++.++.+++.|++.||+|||   +.+++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEE
Confidence            99999999999999999997542               24788999999999999999999   9999999999999999


Q ss_pred             cCCCcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccch--------
Q 040702          642 DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIR--------  712 (797)
Q Consensus       642 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~--------  712 (797)
                      +.++.+||+|||.++...............++..|||||.+.+..++.++|+|++|+..++.+. +..++..        
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~  253 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK  253 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence            9999999999999986543222111222334578999999988889999999999998765543 2222111        


Q ss_pred             ---------hhhhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          713 ---------EEKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       713 ---------~~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                               .+......+.++++.|+..+|.+||++.++++.++++...
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         254 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             HHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence                     1111234667888999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.98  E-value=1.3e-32  Score=290.55  Aligned_cols=234  Identities=20%  Similarity=0.267  Sum_probs=188.2

Q ss_pred             cCCCccccccccCCcceeec----------ceEEEEEEEEeccCC-cchhHHHHHHHhhhccCCceeEeeeeeecCCeEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD----------GMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKA  580 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~----------~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~  580 (797)
                      .+|...+.||+|+||.||++          +..||||+++..... ..+.+.+|+.+++.++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            35777889999999999985          267999999755332 2356888999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCC
Q 040702          581 LVLEYMPLGSLEKCLYSG---------------NYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM  645 (797)
Q Consensus       581 lv~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~  645 (797)
                      +++||+++++|.+++...               ...+++..+..++.|++.||+|+|   +++|+||||||+||++++++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCC
Confidence            999999999999998532               124788889999999999999999   99999999999999999999


Q ss_pred             cEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccch-hh---------
Q 040702          646 VAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIR-EE---------  714 (797)
Q Consensus       646 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~-~~---------  714 (797)
                      .+||+|||+++...............+++.|+|||.+..+.++.++|+|++|+..++.+. +..++.. ..         
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~  241 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN  241 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            999999999986543322222233456789999999998899999999999998765543 2222111 11         


Q ss_pred             -------hhhhcccccchhccccCCCCCCCChHHHHHhHHH
Q 040702          715 -------KHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVY  748 (797)
Q Consensus       715 -------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~  748 (797)
                             .+....+.++++.|++.+|++||++.++...|+.
T Consensus       242 ~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         242 RQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence                   1122346688889999999999999999988753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.98  E-value=1.2e-32  Score=295.39  Aligned_cols=216  Identities=20%  Similarity=0.215  Sum_probs=177.9

Q ss_pred             ccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhc-cCCceeEeeeeeecCCeEEEEEEccCC
Q 040702          518 NLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPL  588 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~  588 (797)
                      +.||+|+||.||++     +..||||+++...   ......+..|.++++.+ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46899999999974     5789999998652   23345677899999888 699999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccccc
Q 040702          589 GSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  668 (797)
Q Consensus       589 g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  668 (797)
                      |+|..++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.......  ...
T Consensus        81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~  154 (318)
T cd05570          81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTS  154 (318)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--ccc
Confidence            99999887654 4899999999999999999999   99999999999999999999999999999875322211  223


Q ss_pred             ccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh----------------hhhhcccccchhccccCC
Q 040702          669 QTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE----------------KHLMTKEQPMVRMGTDLS  732 (797)
Q Consensus       669 ~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~l~~~cl~~d  732 (797)
                      ..+||+.|+|||.+.+..++.++|+|++|+..+..+.+..++....                ........++++.|+..|
T Consensus       155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~d  234 (318)
T cd05570         155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKN  234 (318)
T ss_pred             ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCC
Confidence            4579999999999999999999999999998866555444432211                112335568889999999


Q ss_pred             CCCCCCh
Q 040702          733 LGQFPAS  739 (797)
Q Consensus       733 p~~RPs~  739 (797)
                      |++||++
T Consensus       235 P~~R~s~  241 (318)
T cd05570         235 PEKRLGC  241 (318)
T ss_pred             HHHcCCC
Confidence            9999998

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.98  E-value=1.2e-32  Score=310.89  Aligned_cols=234  Identities=20%  Similarity=0.209  Sum_probs=190.0

Q ss_pred             HHhcCCCccccccccCCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeecCC----
Q 040702          509 QATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSNDD----  577 (797)
Q Consensus       509 ~~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~----  577 (797)
                      ...++|...+.||+|+||.||++     ++.||||++.....  .....+.+|+..+..++|+||+++++.+...+    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            34579999999999999999974     58999999976532  23456788999999999999999988765432    


Q ss_pred             ----eEEEEEEccCCCCHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEE
Q 040702          578 ----FKALVLEYMPLGSLEKCLYSGN---YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLS  650 (797)
Q Consensus       578 ----~~~lv~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~  650 (797)
                          ..++||||+++|+|.+++....   ..+++..+..++.|++.||.|+|   +++|+||||||+||+++.++.+||+
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~  185 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLG  185 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEE
Confidence                3689999999999999986532   35889999999999999999999   9999999999999999999999999


Q ss_pred             eecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh-----------------
Q 040702          651 DFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE-----------------  713 (797)
Q Consensus       651 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~-----------------  713 (797)
                      |||+++.+.............||+.|||||.+.+..++.++|+|++|+..++.+....++...                 
T Consensus       186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~  265 (496)
T PTZ00283        186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPL  265 (496)
T ss_pred             ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence            999998654332222334567999999999999989999999999999886655544433211                 


Q ss_pred             hhhhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          714 EKHLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       714 ~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                      +......+.++++.|++.||.+||++.++++.
T Consensus       266 ~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        266 PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            11223457788999999999999999998763

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.98  E-value=5.4e-33  Score=304.00  Aligned_cols=195  Identities=23%  Similarity=0.298  Sum_probs=163.8

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l  581 (797)
                      ..++|+..+.||+|+||.||++     +..||+|++....   ....+.+..|+.+++.++||||+++++++.+++..|+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            4578999999999999999974     5789999997542   2223457789999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCcc
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  661 (797)
                      ||||+++|+|.+++....  ++...+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus       121 v~Ey~~gg~L~~~l~~~~--l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         121 VMEYMPGGDLVNLMSNYD--IPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence            999999999999987653  788889999999999999999   999999999999999999999999999999865322


Q ss_pred             CccccccccccCcccccccccccC----ccchHHHHHHHhhhhhhhhcccccc
Q 040702          662 DQSLTQTQTLATIGYMAPDEIFSG----EMRLKCWVNDSLLISVMIVVDANLL  710 (797)
Q Consensus       662 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~dv~s~~~~~~~~~~~~~~~  710 (797)
                      .. .......||+.|||||.+.+.    .++.++|+|++|+..++.+.+..++
T Consensus       196 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf  247 (370)
T cd05596         196 GM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF  247 (370)
T ss_pred             Cc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCc
Confidence            21 122346799999999988643    4788999999999986666554443

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.98  E-value=2.3e-32  Score=300.27  Aligned_cols=183  Identities=21%  Similarity=0.224  Sum_probs=157.2

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      ..+|+..+.||+|+||.||++     ++.||+|...      .+.+.+|++++++++||||+++++++...+..++|||+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            357999999999999999974     5889999643      24578899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      +. ++|..++.... .+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+|+...... ..
T Consensus       165 ~~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~  238 (391)
T PHA03212        165 YK-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-AN  238 (391)
T ss_pred             CC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-cc
Confidence            95 68988886654 4889999999999999999999   9999999999999999999999999999997532211 11


Q ss_pred             cccccccCcccccccccccCccchHHHHHHHhhhhhhhhc
Q 040702          666 TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV  705 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~  705 (797)
                      ......||+.|+|||.+.+..++.++|+|++|+..++.+.
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt  278 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT  278 (391)
T ss_pred             ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHH
Confidence            2334679999999999999899999999999998755543

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.98  E-value=2.5e-32  Score=290.25  Aligned_cols=234  Identities=22%  Similarity=0.274  Sum_probs=189.8

Q ss_pred             hcCCCccccccccCCcceeecc---------------------eEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeE
Q 040702          511 TNRFSENNLIGRGGFGPVYKDG---------------------MEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIK  568 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~~---------------------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~  568 (797)
                      .++|+..+.||+|+||.||++.                     ..||+|.+..... ...+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4688999999999999999732                     4689999875532 23567889999999999999999


Q ss_pred             eeeeeecCCeEEEEEEccCCCCHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCc
Q 040702          569 IISSCSNDDFKALVLEYMPLGSLEKCLYSGN----------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSN  638 (797)
Q Consensus       569 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~N  638 (797)
                      +++++..++..++||||+++++|.+++....          ..+++..++.++.|++.|++|||   +.+|+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence            9999999999999999999999999987654          15889999999999999999999   9999999999999


Q ss_pred             eEEcCCCcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc--cccccchh---
Q 040702          639 VLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV--DANLLIRE---  713 (797)
Q Consensus       639 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~--~~~~~~~~---  713 (797)
                      |+++.++.++|+|||+++...............++..|||||.+..+.++.++|+|++|+..++.+.  ...++...   
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            9999999999999999986543332222334557789999999988889999999999988754332  22111110   


Q ss_pred             ---------------------hhhhhcccccchhccccCCCCCCCChHHHHHhHH
Q 040702          714 ---------------------EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLV  747 (797)
Q Consensus       714 ---------------------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~  747 (797)
                                           +......+.+++..|++.||.+||++.++.+.|+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence                                 0011235788999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.98  E-value=2.7e-32  Score=287.42  Aligned_cols=233  Identities=22%  Similarity=0.301  Sum_probs=190.2

Q ss_pred             cCCCccccccccCCcceeec----------ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD----------GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~----------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l  581 (797)
                      .+|...++||+|+||.||++          +..||+|.+........+.+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            46778899999999999975          35789998876555556789999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcE
Q 040702          582 VLEYMPLGSLEKCLYSGN--------------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVA  647 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~--------------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~  647 (797)
                      ||||+++|+|.+++....              ..+++..+..++.|++.|++|||   +.+++||||||+||++++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCE
Confidence            999999999999987543              24788999999999999999999   9999999999999999999999


Q ss_pred             EEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-ccccc-chhh-----------
Q 040702          648 HLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLL-IREE-----------  714 (797)
Q Consensus       648 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~-~~~~-----------  714 (797)
                      ||+|||+++...............+++.|+|||.+.+..++.++|+|++|+..++.+. +..++ ....           
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  241 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR  241 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc
Confidence            9999999976543222222233446788999999998899999999999998765543 22222 1100           


Q ss_pred             -----hhhhcccccchhccccCCCCCCCChHHHHHhHH
Q 040702          715 -----KHLMTKEQPMVRMGTDLSLGQFPASYSISKYLV  747 (797)
Q Consensus       715 -----~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~  747 (797)
                           ......+.+++..||+.||.+||++.++.+.++
T Consensus       242 ~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         242 ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence                 112345678999999999999999999998775

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.98  E-value=7.1e-33  Score=298.26  Aligned_cols=218  Identities=23%  Similarity=0.244  Sum_probs=174.7

Q ss_pred             ccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHH-HhhhccCCceeEeeeeeecCCeEEEEEEccCC
Q 040702          518 NLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECG-MMKRIRHRNLIKIISSCSNDDFKALVLEYMPL  588 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~-~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~  588 (797)
                      +.||+|+||.||++     ++.||+|++....   ......+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999975     4789999997542   122234444443 56778999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccccc
Q 040702          589 GSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  668 (797)
Q Consensus       589 g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  668 (797)
                      |+|.+++.... .+.+..+..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+++.......  ...
T Consensus        81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~~  154 (325)
T cd05602          81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTS  154 (325)
T ss_pred             CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--Ccc
Confidence            99999987654 3778888899999999999999   99999999999999999999999999999975432221  234


Q ss_pred             ccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh----------------hhhhcccccchhccccCC
Q 040702          669 QTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE----------------KHLMTKEQPMVRMGTDLS  732 (797)
Q Consensus       669 ~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~l~~~cl~~d  732 (797)
                      ..+||+.|||||.+.+..++.++|+|++|+..+..+.+..++....                ........++++.|++.|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~  234 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKD  234 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccC
Confidence            4679999999999998889999999999999866665544432211                122335567888899999


Q ss_pred             CCCCCChHH
Q 040702          733 LGQFPASYS  741 (797)
Q Consensus       733 p~~RPs~~~  741 (797)
                      |.+||++.+
T Consensus       235 p~~R~~~~~  243 (325)
T cd05602         235 RTKRLGAKD  243 (325)
T ss_pred             HHHCCCCCC
Confidence            999998764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.98  E-value=3.1e-32  Score=288.66  Aligned_cols=226  Identities=22%  Similarity=0.304  Sum_probs=179.0

Q ss_pred             cCCCccccccccCCcceeec------ceEEEEEEEEeccC--CcchhHHHHHHHhhhc---cCCceeEeeeeeec-----
Q 040702          512 NRFSENNLIGRGGFGPVYKD------GMEVAIKVFNLQYG--GAFKSFDIECGMMKRI---RHRNLIKIISSCSN-----  575 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~------~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l---~Hpniv~l~~~~~~-----  575 (797)
                      ++|...+.||+|+||.||++      +..||||+++....  .....+.+|+.+++.+   +||||++++++|..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36888999999999999974      47799999876532  2234567788877766   69999999998852     


Q ss_pred             CCeEEEEEEccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecC
Q 040702          576 DDFKALVLEYMPLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGM  654 (797)
Q Consensus       576 ~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl  654 (797)
                      ....++||||++ ++|.+++.... ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            346899999996 59999887543 35889999999999999999999   99999999999999999999999999999


Q ss_pred             CccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh--------------------
Q 040702          655 AKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE--------------------  714 (797)
Q Consensus       655 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------------  714 (797)
                      ++.....   .......||+.|+|||.+.+..++.++|+|++|+..++.+....++....                    
T Consensus       157 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~  233 (290)
T cd07862         157 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  233 (290)
T ss_pred             eEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence            9865322   12344578999999999988889999999999998765554433322110                    


Q ss_pred             -----------------------hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          715 -----------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       715 -----------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                             .+......+++.+|++.||++||++.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence                                   011123457888999999999999988874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.98  E-value=2.4e-34  Score=316.65  Aligned_cols=405  Identities=28%  Similarity=0.354  Sum_probs=283.1

Q ss_pred             CCCCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCE
Q 040702            2 PSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKS   81 (797)
Q Consensus         2 ~~l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~   81 (797)
                      +|||||++ +..|.+++.+..|+.|.+|.|-         +.+.|.+..++.+|++|+|.+|++.. .|..+..+.+|+.
T Consensus        50 l~lsnn~~-~~fp~~it~l~~L~~ln~s~n~---------i~~vp~s~~~~~~l~~lnL~~n~l~~-lP~~~~~lknl~~  118 (1081)
T KOG0618|consen   50 LDLSNNQI-SSFPIQITLLSHLRQLNLSRNY---------IRSVPSSCSNMRNLQYLNLKNNRLQS-LPASISELKNLQY  118 (1081)
T ss_pred             eecccccc-ccCCchhhhHHHHhhcccchhh---------HhhCchhhhhhhcchhheeccchhhc-CchhHHhhhcccc
Confidence            46677764 3456667777777777777775         55666677777777777777777754 6777777777777


Q ss_pred             EEccCCcCcccCCCccccCCCCc-------------------cEEEccCccccccCCchhhCCCCCCEEEccCCcCcccC
Q 040702           82 LYLHSNSLSGRLPSSADVRLPNL-------------------KELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSI  142 (797)
Q Consensus        82 L~Ls~N~l~~~l~~~~~~~l~~L-------------------~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~  142 (797)
                      |++|.|.+. .+|..++ .++.+                   +.++|..|.+.+.++..+..++.  .|+|.+|.+... 
T Consensus       119 LdlS~N~f~-~~Pl~i~-~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~~~-  193 (1081)
T KOG0618|consen  119 LDLSFNHFG-PIPLVIE-VLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEMEVL-  193 (1081)
T ss_pred             cccchhccC-CCchhHH-hhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhhe--eeecccchhhhh-
Confidence            777777775 6665443 33333                   33333333333333444433433  466666665511 


Q ss_pred             CccccCCCCCCeeeccCccCcCCCCCcccc-------------ccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEE
Q 040702          143 PNTFGNLRNLKWLGLNDNYLTSSTPELSSL-------------SSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDF  209 (797)
Q Consensus       143 ~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~-------------~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L  209 (797)
                        .+.++.+|+.|..+.|+++.+.-.-..+             ..-.--.+|+++++++|+++..+ .+++.+. +++.+
T Consensus       194 --dls~~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~~p~p~nl~~~dis~n~l~~lp-~wi~~~~-nle~l  269 (1081)
T KOG0618|consen  194 --DLSNLANLEVLHCERNQLSELEISGPSLTALYADHNPLTTLDVHPVPLNLQYLDISHNNLSNLP-EWIGACA-NLEAL  269 (1081)
T ss_pred             --hhhhccchhhhhhhhcccceEEecCcchheeeeccCcceeeccccccccceeeecchhhhhcch-HHHHhcc-cceEe
Confidence              1333334444444444333221100000             00112346777888888877554 7777776 78888


Q ss_pred             EccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCcc-ccccccCCC
Q 040702          210 WMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTN-LRKLYLGSN  288 (797)
Q Consensus       210 ~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~-L~~L~L~~N  288 (797)
                      ...+|.++ .+|..+...++|  +.|+..+|.+. -+|....+++.|++|||..|+|...++..+.-+.. |..|+.+.|
T Consensus       270 ~~n~N~l~-~lp~ri~~~~~L--~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n  345 (1081)
T KOG0618|consen  270 NANHNRLV-ALPLRISRITSL--VSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSN  345 (1081)
T ss_pred             cccchhHH-hhHHHHhhhhhH--HHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhc
Confidence            88888884 677777777777  78888888887 45556667888888888888887655544444443 777777888


Q ss_pred             CCCCCCC-CCCCCCcccEEEccCCcCCCCCCccccccccccEEeccCcccccccCccccCCcccceecccCccccCCCCh
Q 040702          289 LLTSIPS-TLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPN  367 (797)
Q Consensus       289 ~l~~lp~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~  367 (797)
                      .+...|. .=..++.|+.|++.+|.++...-..+.+...|+.|+|++|+|...+...+.++..|++|+||+|+++ .+|.
T Consensus       346 ~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~  424 (1081)
T KOG0618|consen  346 KLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPD  424 (1081)
T ss_pred             cccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhH
Confidence            8877774 2223678999999999999877778889999999999999999776778899999999999999999 7889


Q ss_pred             hhhccccCCeeeecCCcCCCCCChhhhccCCCCeEEccCCcCcccC-CCCCCCCCCCcccccCCccc
Q 040702          368 SIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEI-PREGPFRNLSAESFKGNELL  433 (797)
Q Consensus       368 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-p~~~~~~~l~~~~~~~n~~~  433 (797)
                      ++..++.|++|...+|++. ..| .+..+++|+.+|+|.|+++-.. |...++++|+.++++||.+.
T Consensus       425 tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l  489 (1081)
T KOG0618|consen  425 TVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRL  489 (1081)
T ss_pred             HHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCccc
Confidence            9999999999999999998 677 8999999999999999998553 55567789999999999963

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.98  E-value=1.4e-32  Score=302.26  Aligned_cols=260  Identities=20%  Similarity=0.261  Sum_probs=188.2

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      .+|+..+.||+|+||.||++     ++.||||++....   ......+.+|++++++++||||+++++.+.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36889999999999999974     5889999997542   223456888999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC-
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED-  662 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~-  662 (797)
                      ||+++|+|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+|..+.... 
T Consensus        81 E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~  156 (376)
T cd05598          81 DYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (376)
T ss_pred             eCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence            9999999999997754 4788889999999999999999   9999999999999999999999999999985321000 


Q ss_pred             ----------------------------------------ccccccccccCcccccccccccCccchHHHHHHHhhhhhh
Q 040702          663 ----------------------------------------QSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVM  702 (797)
Q Consensus       663 ----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~  702 (797)
                                                              ........+||+.|||||.+.+..++.++|+|++|++.++
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye  236 (376)
T cd05598         157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  236 (376)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence                                                    0001123579999999999999899999999999999866


Q ss_pred             hhccccccchhhh-hhhcccccchhcccc-CCCCCCCChHHHHHhHHHHHHHhccccccccccCCcccccceeeeeeeee
Q 040702          703 IVVDANLLIREEK-HLMTKEQPMVRMGTD-LSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYTI  780 (797)
Q Consensus       703 ~~~~~~~~~~~~~-~~~~~~~~l~~~cl~-~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~  780 (797)
                      .+.+..++..... +...   .+....-. ..|....-..+..+.+..+...+..|.+  ...+.+.++|+||++++|..
T Consensus       237 ll~G~~Pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~--~~t~~ell~h~~~~~~~~~~  311 (376)
T cd05598         237 MLVGQPPFLADTPAETQL---KVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLG--KNGADEIKAHPFFKGIDFAS  311 (376)
T ss_pred             hhhCCCCCCCCCHHHHHH---HHhccCccccCCCCCCCCHHHHHHHHHHhcCHhhcCC--CCCHHHHhCCCCcCCCCHHH
Confidence            6665555433221 1111   11110000 0111111123334444443333333332  11456677788888877644

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.98  E-value=3.9e-32  Score=289.34  Aligned_cols=236  Identities=22%  Similarity=0.310  Sum_probs=191.0

Q ss_pred             hcCCCccccccccCCcceeec----------ceEEEEEEEEeccC-CcchhHHHHHHHhhhc-cCCceeEeeeeeecCCe
Q 040702          511 TNRFSENNLIGRGGFGPVYKD----------GMEVAIKVFNLQYG-GAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDF  578 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~----------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~  578 (797)
                      .++|...+.||+|+||.||++          +..||||.++.... ...+.+.+|+.+++++ +||||+++++++...+.
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  113 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP  113 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence            357999999999999999975          24799998875432 2345788999999999 79999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCcc
Q 040702          579 KALVLEYMPLGSLEKCLYSGNY-ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  657 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  657 (797)
                      .|+||||+++|+|.+++..... .+++.++..++.|++.|++|||   +.+|+|+||||+||+++.++.+|++|||+++.
T Consensus       114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~  190 (302)
T cd05055         114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARD  190 (302)
T ss_pred             eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence            9999999999999999975432 4799999999999999999999   99999999999999999999999999999986


Q ss_pred             CCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccch-h-----------------hhhhh
Q 040702          658 LLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIR-E-----------------EKHLM  718 (797)
Q Consensus       658 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~-~-----------------~~~~~  718 (797)
                      ..............++..|+|||.+.++.++.++|+|++|+..++.+. +..++.. .                 +....
T Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (302)
T cd05055         191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAP  270 (302)
T ss_pred             ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCC
Confidence            543322212223346788999999999999999999999998755442 2222111 0                 00122


Q ss_pred             cccccchhccccCCCCCCCChHHHHHhHHHH
Q 040702          719 TKEQPMVRMGTDLSLGQFPASYSISKYLVYI  749 (797)
Q Consensus       719 ~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i  749 (797)
                      ..+.+++++|++++|++||++.++++.++.+
T Consensus       271 ~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         271 AEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             HHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            3566899999999999999999999988763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.98  E-value=3.3e-32  Score=283.71  Aligned_cols=233  Identities=20%  Similarity=0.286  Sum_probs=191.0

Q ss_pred             hcCCCccccccccCCcceeec----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          511 TNRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      .++|+..++||+|+||.||++    +..||+|.+..... ..+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            467899999999999999985    47799998765432 3468899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          587 PLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       587 ~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      ++|+|.+++.... ..+++..+..++.|+++|++|||   ..+++||||||+||+++.++.+||+|||++........ .
T Consensus        84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~  159 (261)
T cd05072          84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY-T  159 (261)
T ss_pred             CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCce-e
Confidence            9999999987542 35788899999999999999999   89999999999999999999999999999986543221 1


Q ss_pred             cccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchhh-----------------hhhhcccccchhc
Q 040702          666 TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIREE-----------------KHLMTKEQPMVRM  727 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~~-----------------~~~~~~~~~l~~~  727 (797)
                      ......++..|+|||.+..+.++.++|+|++|+..+..+. +..++....                 ......+.+++.+
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (261)
T cd05072         160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKT  239 (261)
T ss_pred             ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence            2223446778999999988889999999999998866553 333221110                 0122356788999


Q ss_pred             cccCCCCCCCChHHHHHhHHH
Q 040702          728 GTDLSLGQFPASYSISKYLVY  748 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~~l~~  748 (797)
                      |+..+|++||++.++.+.|+.
T Consensus       240 ~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         240 CWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             HccCCcccCcCHHHHHHHHhc
Confidence            999999999999999998875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.98  E-value=8.4e-33  Score=297.25  Aligned_cols=216  Identities=23%  Similarity=0.219  Sum_probs=172.1

Q ss_pred             ccccccCCcceeec-----ceEEEEEEEEeccC---CcchhHHHHHH-HhhhccCCceeEeeeeeecCCeEEEEEEccCC
Q 040702          518 NLIGRGGFGPVYKD-----GMEVAIKVFNLQYG---GAFKSFDIECG-MMKRIRHRNLIKIISSCSNDDFKALVLEYMPL  588 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~---~~~~~~~~E~~-~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~  588 (797)
                      +.||+|+||.||++     ++.||+|++.....   .....+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999975     57899999975421   22344555554 57888999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccccc
Q 040702          589 GSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  668 (797)
Q Consensus       589 g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  668 (797)
                      |+|...+.... .+++..+..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~  154 (321)
T cd05603          81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTS  154 (321)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cccc
Confidence            99998887644 4788889999999999999999   9999999999999999999999999999987532221  1234


Q ss_pred             ccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh----------------hhhcccccchhccccCC
Q 040702          669 QTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK----------------HLMTKEQPMVRMGTDLS  732 (797)
Q Consensus       669 ~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~l~~~cl~~d  732 (797)
                      ...||+.|+|||.+.+..++.++|+|++|+..++.+.+..++.....                .....+.+++..|++.|
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~  234 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKD  234 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCC
Confidence            46799999999999888899999999999998666655444322111                11223556778888888


Q ss_pred             CCCCCCh
Q 040702          733 LGQFPAS  739 (797)
Q Consensus       733 p~~RPs~  739 (797)
                      |.+||++
T Consensus       235 p~~R~~~  241 (321)
T cd05603         235 QRRRLGA  241 (321)
T ss_pred             HhhcCCC
Confidence            8888875

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.98  E-value=2.5e-32  Score=284.61  Aligned_cols=234  Identities=22%  Similarity=0.292  Sum_probs=194.1

Q ss_pred             HhcCCCccccccccCCcceeec----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      ...+|+..+.||+|+||.||++    +..||+|.+.........++..|+.+++.++||||+++++++...+..++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            4567999999999999999975    588999999876554567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          586 MPLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       586 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      +++|+|.+++.... ..+++..+.+++.|++.|++|||   +.+|+||||||+||++++++.+||+|||.+.....+.. 
T Consensus        84 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~-  159 (261)
T cd05148          84 MEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY-  159 (261)
T ss_pred             cccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCccc-
Confidence            99999999997643 35899999999999999999999   99999999999999999999999999999986543221 


Q ss_pred             ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-----------------hhhhhcccccchh
Q 040702          665 LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-----------------EKHLMTKEQPMVR  726 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-----------------~~~~~~~~~~l~~  726 (797)
                       ......++..|+|||.+..+.++.++|+|++|+..+..+. +..++...                 +......+.+++.
T Consensus       160 -~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  238 (261)
T cd05148         160 -LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIML  238 (261)
T ss_pred             -cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHH
Confidence             1223456778999999988889999999999988755543 22222111                 1112245678889


Q ss_pred             ccccCCCCCCCChHHHHHhHHH
Q 040702          727 MGTDLSLGQFPASYSISKYLVY  748 (797)
Q Consensus       727 ~cl~~dp~~RPs~~~i~~~l~~  748 (797)
                      +|+..||.+||++.++.+.|+.
T Consensus       239 ~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         239 ECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             HHcCCCchhCcCHHHHHHHHhc
Confidence            9999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.98  E-value=6e-32  Score=282.77  Aligned_cols=234  Identities=22%  Similarity=0.293  Sum_probs=191.3

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccC---CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG---GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ++|+..+.||+|+||.||++     ++.||||.++....   .....+.+|+++++.++||||+++++++.+.+..++||
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            57899999999999999975     58999998865322   22356888999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCc
Q 040702          584 EYMPLGSLEKCLYS---GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  660 (797)
Q Consensus       584 e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  660 (797)
                      ||+++|+|.+++..   ....+++..+..++.|+++|++|||   +.+++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999988753   2235788899999999999999999   99999999999999999999999999999986543


Q ss_pred             cCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh--------------------hhhhhcc
Q 040702          661 EDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE--------------------EKHLMTK  720 (797)
Q Consensus       661 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~--------------------~~~~~~~  720 (797)
                      ...  ......|++.|+|||.+.+..++.++|+|++|+..+..+....++...                    .......
T Consensus       159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08228         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEK  236 (267)
T ss_pred             hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHH
Confidence            221  223456889999999998888899999999998875544333221110                    0122345


Q ss_pred             cccchhccccCCCCCCCChHHHHHhHHHHH
Q 040702          721 EQPMVRMGTDLSLGQFPASYSISKYLVYIR  750 (797)
Q Consensus       721 ~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~  750 (797)
                      +.+++++||..+|++||++.++++.++.++
T Consensus       237 ~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         237 LRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             HHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            788999999999999999999999988763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.98  E-value=4.8e-32  Score=281.59  Aligned_cols=230  Identities=21%  Similarity=0.254  Sum_probs=187.6

Q ss_pred             cCCCccccccccCCcceeec----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccC
Q 040702          512 NRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  587 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~  587 (797)
                      ++|...+.||+|+||.||++    +..||||.++... ...+++.+|+.++++++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            46888899999999999975    3569999987443 234678999999999999999999999998889999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccccc
Q 040702          588 LGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ  667 (797)
Q Consensus       588 ~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  667 (797)
                      +|+|.+++......+++..++.++.|++.|++|||   +.+++|+||||+||+++.++.+||+|||.++....... ...
T Consensus        83 ~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~  158 (256)
T cd05113          83 NGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSS  158 (256)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-eec
Confidence            99999999765546899999999999999999999   99999999999999999999999999999986543221 122


Q ss_pred             cccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchhhh-----------------hhhcccccchhccc
Q 040702          668 TQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIREEK-----------------HLMTKEQPMVRMGT  729 (797)
Q Consensus       668 ~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~~~-----------------~~~~~~~~l~~~cl  729 (797)
                      ....++..|+|||.+..+.++.++|+|++|+..++.+. +..++.....                 .....+.+++..||
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  238 (256)
T cd05113         159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCW  238 (256)
T ss_pred             CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHc
Confidence            23346678999999988889999999999998865543 3322211110                 11234678888999


Q ss_pred             cCCCCCCCChHHHHHhH
Q 040702          730 DLSLGQFPASYSISKYL  746 (797)
Q Consensus       730 ~~dp~~RPs~~~i~~~l  746 (797)
                      +.+|.+||++.++++.+
T Consensus       239 ~~~p~~Rp~~~~ll~~~  255 (256)
T cd05113         239 HEKAEERPTFQQLLSSI  255 (256)
T ss_pred             CCCcccCCCHHHHHHhh
Confidence            99999999999998765

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.98  E-value=4.5e-32  Score=289.17  Aligned_cols=263  Identities=20%  Similarity=0.247  Sum_probs=200.8

Q ss_pred             hcCCCccccccccCCcceeec-----c----eEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----G----MEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKA  580 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~----~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~  580 (797)
                      .++|+..+.||+|+||.||++     +    ..||+|.+..... ....++.+|+.++++++||||++++++|... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            457888899999999999985     2    2578888865432 2234688999999999999999999998754 467


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCc
Q 040702          581 LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  660 (797)
Q Consensus       581 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  660 (797)
                      +|+||+++|+|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++....
T Consensus        85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccC
Confidence            999999999999999876556889999999999999999999   99999999999999999999999999999986543


Q ss_pred             cCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-hh----------------hhhcccc
Q 040702          661 EDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-EK----------------HLMTKEQ  722 (797)
Q Consensus       661 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-~~----------------~~~~~~~  722 (797)
                      ...........++..|+|||.+.+..++.++|+|++|+..++.+. +..++... ..                .....+.
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVY  241 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence            322222233456778999999988889999999999988755442 22222111 11                1122446


Q ss_pred             cchhccccCCCCCCCChHHHHHhHHHHHHHhcccccccccc----CCcccccceeeeee
Q 040702          723 PMVRMGTDLSLGQFPASYSISKYLVYIRELERGKVGITSVA----AFPIVHHYLYRTVD  777 (797)
Q Consensus       723 ~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~----~~~~~~~~~f~~~~  777 (797)
                      +++..|+..+|++||++.++++.++.+.+.+....-+++..    ..|..+.+|.+.+|
T Consensus       242 ~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (303)
T cd05110         242 MVMVKCWMIDADSRPKFKELAAEFSRMARDPQRYLVIQGDDRMKLPSPNDSKFFQNLLD  300 (303)
T ss_pred             HHHHHHcCCChhhCcCHHHHHHHHHHHHhchhhheeeccCCcCCCCCCchhhHHhcccc
Confidence            67888999999999999999999998876655444333222    34555555555443

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.98  E-value=1.1e-32  Score=301.07  Aligned_cols=197  Identities=23%  Similarity=0.293  Sum_probs=165.5

Q ss_pred             HHHhcCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeE
Q 040702          508 FQATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFK  579 (797)
Q Consensus       508 ~~~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~  579 (797)
                      ....++|+..+.||+|+||.||++     ++.||+|++.+..   ....+.+.+|+.+++.++||||+++++++.+++..
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~  118 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL  118 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence            334578999999999999999974     5789999997542   22235678899999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCC
Q 040702          580 ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  659 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  659 (797)
                      |+||||+++|+|.+++....  +++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+...
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~~--~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSNYD--VPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            99999999999999997653  788899999999999999999   9999999999999999999999999999998653


Q ss_pred             ccCccccccccccCcccccccccccC----ccchHHHHHHHhhhhhhhhcccccc
Q 040702          660 EEDQSLTQTQTLATIGYMAPDEIFSG----EMRLKCWVNDSLLISVMIVVDANLL  710 (797)
Q Consensus       660 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~dv~s~~~~~~~~~~~~~~~  710 (797)
                      .... ......+||+.|||||.+...    .++.++|+|++|+..+..+.+..++
T Consensus       194 ~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf  247 (370)
T cd05621         194 ETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF  247 (370)
T ss_pred             cCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCC
Confidence            2221 122456799999999998653    3778999999999986666555444

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.98  E-value=4.6e-32  Score=294.05  Aligned_cols=238  Identities=21%  Similarity=0.306  Sum_probs=186.5

Q ss_pred             hcCCCccccccccCCcceeec----------ceEEEEEEEEeccC-CcchhHHHHHHHhhhc-cCCceeEeeeeeecC-C
Q 040702          511 TNRFSENNLIGRGGFGPVYKD----------GMEVAIKVFNLQYG-GAFKSFDIECGMMKRI-RHRNLIKIISSCSND-D  577 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~----------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~-~  577 (797)
                      .++|+..+.||+|+||.||++          ++.||||+++.... ...+.+.+|+.++.++ +||||+++++++... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            368999999999999999975          36899999975432 2245688999999999 689999999988654 4


Q ss_pred             eEEEEEEccCCCCHHHHHhcCC----------------------------------------------------------
Q 040702          578 FKALVLEYMPLGSLEKCLYSGN----------------------------------------------------------  599 (797)
Q Consensus       578 ~~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------  599 (797)
                      ..++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            6789999999999999986431                                                          


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccccccccc
Q 040702          600 --------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL  671 (797)
Q Consensus       600 --------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  671 (797)
                              ..+++..+.+++.|+++|++|||   +++|+||||||+||+++.++.+||+|||+++...............
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                    13677888899999999999999   9999999999999999999999999999998654332222222334


Q ss_pred             cCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchhh------------------hhhhcccccchhccccCC
Q 040702          672 ATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIREE------------------KHLMTKEQPMVRMGTDLS  732 (797)
Q Consensus       672 gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~~------------------~~~~~~~~~l~~~cl~~d  732 (797)
                      ++..|+|||.+....++.++|+|++|+..+..+. +..+.....                  ......+.+++..|++.|
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~  322 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE  322 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCC
Confidence            5678999999988889999999999988754432 222111100                  001224567788899999


Q ss_pred             CCCCCChHHHHHhHHHHHH
Q 040702          733 LGQFPASYSISKYLVYIRE  751 (797)
Q Consensus       733 p~~RPs~~~i~~~l~~i~~  751 (797)
                      |++||++.++++.++.+.+
T Consensus       323 p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         323 PSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             hhhCcCHHHHHHHHHHHHh
Confidence            9999999999999887643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.98  E-value=6.2e-32  Score=289.65  Aligned_cols=239  Identities=22%  Similarity=0.293  Sum_probs=190.9

Q ss_pred             hcCCCccccccccCCcceeecc------------eEEEEEEEEeccC-CcchhHHHHHHHhhhc-cCCceeEeeeeeecC
Q 040702          511 TNRFSENNLIGRGGFGPVYKDG------------MEVAIKVFNLQYG-GAFKSFDIECGMMKRI-RHRNLIKIISSCSND  576 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~~------------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~  576 (797)
                      .++|...+.||+|+||.||++.            ..||+|.++.... .....+..|+++++++ +||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            3688899999999999999752            4699999875432 2345688999999999 699999999999999


Q ss_pred             CeEEEEEEccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEE
Q 040702          577 DFKALVLEYMPLGSLEKCLYSGN---------------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL  641 (797)
Q Consensus       577 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll  641 (797)
                      +..|+||||+++|+|.+++....               ..+++.++.+++.|++.|++|||   +++|+||||||+||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEE
Confidence            99999999999999999996532               24788899999999999999999   9999999999999999


Q ss_pred             cCCCcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-------
Q 040702          642 DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-------  713 (797)
Q Consensus       642 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-------  713 (797)
                      +.++.+||+|||+++...............++..|||||.+.++.++.++|+|++|+..+..+. +..++...       
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~  247 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK  247 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            9999999999999986543222111222234567999999988889999999999988755443 22211111       


Q ss_pred             ----------hhhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          714 ----------EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       714 ----------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                                +......+.+++++|+..+|++||++.++++.++.+...
T Consensus       248 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~  296 (314)
T cd05099         248 LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA  296 (314)
T ss_pred             HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence                      111123566889999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.98  E-value=5.3e-32  Score=282.50  Aligned_cols=233  Identities=21%  Similarity=0.323  Sum_probs=190.0

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      .+|...+.||+|+||.||++     ++.||+|.+.... ...+++.+|++++++++||||+++++++..++..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            45788899999999999985     5789999987442 23467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          587 PLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       587 ~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      ++++|.+++.... ..+++..++.++.|+++||+|||   +.+++||||||+||++++++.+||+|||.+........ .
T Consensus        85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-~  160 (263)
T cd05052          85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-T  160 (263)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCcccccccccee-e
Confidence            9999999987543 35899999999999999999999   99999999999999999999999999999986543221 1


Q ss_pred             cccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccch-----------------hhhhhhcccccchhc
Q 040702          666 TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIR-----------------EEKHLMTKEQPMVRM  727 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~-----------------~~~~~~~~~~~l~~~  727 (797)
                      ......++..|+|||.+.+..++.++|+|++|+..+..+. +..++..                 .+......+.+++++
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  240 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRA  240 (263)
T ss_pred             ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence            1122334678999999988889999999999998866553 3222211                 111122356779999


Q ss_pred             cccCCCCCCCChHHHHHhHHHH
Q 040702          728 GTDLSLGQFPASYSISKYLVYI  749 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~~l~~i  749 (797)
                      |+..||++||++.++.+.++.+
T Consensus       241 cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         241 CWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             HccCCcccCCCHHHHHHHHHhh
Confidence            9999999999999999988764

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.98  E-value=6.1e-32  Score=281.68  Aligned_cols=233  Identities=24%  Similarity=0.279  Sum_probs=190.1

Q ss_pred             hcCCCccccccccCCcceeec----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          511 TNRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      .++|...+.||+|+||.||++    ++.||||.++.... ..+++.+|++++++++||||+++++++...+..|+||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM   83 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence            467889999999999999974    47899999875432 3467899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          587 PLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       587 ~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      ++++|.+++.... ..+++..+..++.|++.|+.|||   +.+|+||||||+||+++.++.+||+|||+++....... .
T Consensus        84 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~  159 (261)
T cd05068          84 KYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-E  159 (261)
T ss_pred             cCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-c
Confidence            9999999997654 35899999999999999999999   99999999999999999999999999999987642211 1


Q ss_pred             cccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccch-----------------hhhhhhcccccchhc
Q 040702          666 TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIR-----------------EEKHLMTKEQPMVRM  727 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~-----------------~~~~~~~~~~~l~~~  727 (797)
                      ......++..|+|||.+....++.++|+|++|+..++.+. +..++..                 .+......+.+++..
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  239 (261)
T cd05068         160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLD  239 (261)
T ss_pred             ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHH
Confidence            1122233467999999988889999999999998755443 2221111                 011223466788899


Q ss_pred             cccCCCCCCCChHHHHHhHHH
Q 040702          728 GTDLSLGQFPASYSISKYLVY  748 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~~l~~  748 (797)
                      |+..+|++||++.++.+.|++
T Consensus       240 ~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         240 CWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             HhhcCcccCCCHHHHHHHHhc
Confidence            999999999999999998864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=2.3e-32  Score=294.82  Aligned_cols=263  Identities=19%  Similarity=0.224  Sum_probs=191.2

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ++|+..+.||+|+||.||++     ++.||||++.+..   ....+.+.+|+.++..++||||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47889999999999999974     5789999997532   223456888999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      ||+++|+|.+++......+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||++........
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  157 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT  157 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence            999999999999765556899999999999999999999   99999999999999999999999999999876533221


Q ss_pred             cccccccccCccccccccccc-----CccchHHHHHHHhhhhhhhhccccccchhh-hhhhcccccchhccccCCCCCCC
Q 040702          664 SLTQTQTLATIGYMAPDEIFS-----GEMRLKCWVNDSLLISVMIVVDANLLIREE-KHLMTKEQPMVRMGTDLSLGQFP  737 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~cl~~dp~~RP  737 (797)
                       .......||+.|||||.+..     +.++.++|+|++|+..+..+.+..++.... .+....+.. ...+....+....
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~  235 (331)
T cd05597         158 -VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN-HKEHFQFPPDVTD  235 (331)
T ss_pred             -ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHc-CCCcccCCCccCC
Confidence             12233569999999998863     457789999999999876666555443221 111110000 0112222221111


Q ss_pred             ChHHHHHhHHHHHHHhccccccccccCCcccccceeeeeeeeec
Q 040702          738 ASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYTIS  781 (797)
Q Consensus       738 s~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~  781 (797)
                      -..++.+.++.+...+..+.+  ...+.++++|+||.+++|+..
T Consensus       236 ~~~~~~~li~~ll~~~~~r~~--r~~~~~~l~hp~~~~~~~~~~  277 (331)
T cd05597         236 VSEEAKDLIRRLICSPETRLG--RNGLQDFKDHPFFEGIDWDNI  277 (331)
T ss_pred             CCHHHHHHHHHHccCcccccC--CCCHHHHhcCCCCCCCCHHHH
Confidence            123444444444332222211  224577888899988888654

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=9.2e-33  Score=293.40  Aligned_cols=222  Identities=23%  Similarity=0.306  Sum_probs=188.9

Q ss_pred             ccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccCCCCHH
Q 040702          518 NLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLE  592 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~g~L~  592 (797)
                      -++|+|.||+||.|     ...+|||-+..++....+.+..|+.+-++++|.|||+++|.+.+.++.-|.||-++||+|.
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            47999999999975     4678999998887777788999999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCC--CHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEc-CCCcEEEEeecCCccCCccCccccccc
Q 040702          593 KCLYSGNYIL--DIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQ  669 (797)
Q Consensus       593 ~~l~~~~~~l--~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~~  669 (797)
                      +++...=+++  ++...-.+.+||++||.|||   ...|||||||-+|||+. -.|.+||+|||.++.+..-.  ..+.+
T Consensus       661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TET  735 (1226)
T KOG4279|consen  661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTET  735 (1226)
T ss_pred             HHHHhccCCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCC--ccccc
Confidence            9998765555  77788889999999999999   99999999999999996 67999999999999774322  24456


Q ss_pred             cccCcccccccccccCc--cchHHHHHHHhhhhhhhhccccccch-------------------hhhhhhcccccchhcc
Q 040702          670 TLATIGYMAPDEIFSGE--MRLKCWVNDSLLISVMIVVDANLLIR-------------------EEKHLMTKEQPMVRMG  728 (797)
Q Consensus       670 ~~gt~~y~aPE~~~~~~--~~~~~dv~s~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~l~~~c  728 (797)
                      +.||..|||||++..|.  |..++|+||+|+..+++..+.+++..                   .+.+.....+.++.+|
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Filrc  815 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRC  815 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHH
Confidence            78999999999998764  88999999999988655554443322                   2233445677889999


Q ss_pred             ccCCCCCCCChHHHHH
Q 040702          729 TDLSLGQFPASYSISK  744 (797)
Q Consensus       729 l~~dp~~RPs~~~i~~  744 (797)
                      +.+||.+||++.+++.
T Consensus       816 Fepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  816 FEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             cCCCcccCccHHHhcc
Confidence            9999999999999875

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.98  E-value=6.5e-32  Score=282.50  Aligned_cols=235  Identities=22%  Similarity=0.300  Sum_probs=190.5

Q ss_pred             cCCCccccccccCCcceeecc--------eEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKDG--------MEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~~--------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      ++|+..+.||+|+||.||++.        ..||+|.++.... ...+.+..|+.++++++||||+++++++..++..|+|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            578889999999999999752        3699998865432 2346788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      |||+++|+|.+++......+++.++..++.|++.|++|||   +.+++||||||+||+++.++.++++|||+++......
T Consensus        84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd05066          84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  160 (267)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence            9999999999999876556899999999999999999999   9999999999999999999999999999998664332


Q ss_pred             ccc-cccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-h----------------hhhhccccc
Q 040702          663 QSL-TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-E----------------KHLMTKEQP  723 (797)
Q Consensus       663 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-~----------------~~~~~~~~~  723 (797)
                      ... ......++..|+|||.+..+.++.++|+|++|+..+..+. +..++... .                ......+.+
T Consensus       161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (267)
T cd05066         161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQ  240 (267)
T ss_pred             ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHHH
Confidence            211 1122334568999999988889999999999988755442 22222111 0                012235678


Q ss_pred             chhccccCCCCCCCChHHHHHhHHHH
Q 040702          724 MVRMGTDLSLGQFPASYSISKYLVYI  749 (797)
Q Consensus       724 l~~~cl~~dp~~RPs~~~i~~~l~~i  749 (797)
                      ++.+|++.+|.+||++.++++.++++
T Consensus       241 li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         241 LMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             HHHHHcccCchhCCCHHHHHHHHHhh
Confidence            99999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.98  E-value=5.6e-32  Score=283.91  Aligned_cols=219  Identities=19%  Similarity=0.240  Sum_probs=175.2

Q ss_pred             cccccCCcceeecc-----------------------------eEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEe
Q 040702          519 LIGRGGFGPVYKDG-----------------------------MEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKI  569 (797)
Q Consensus       519 ~lg~G~~g~Vyk~~-----------------------------~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l  569 (797)
                      .||+|+||.||+|.                             ..||+|++..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999753                             3588998875544334678889999999999999999


Q ss_pred             eeeeecCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCC----
Q 040702          570 ISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM----  645 (797)
Q Consensus       570 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~----  645 (797)
                      +++|...+..++||||+++|+|..++......+++..+..++.|+++||+|||   +++|+||||||+||+++..+    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccC
Confidence            99999999999999999999999998765556899999999999999999999   99999999999999997543    


Q ss_pred             ---cEEEEeecCCccCCccCccccccccccCccccccccccc-CccchHHHHHHHhhhhhhhhc-cccccchh-------
Q 040702          646 ---VAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVV-DANLLIRE-------  713 (797)
Q Consensus       646 ---~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-------  713 (797)
                         .+|++|||.+......      ....++..|+|||.+.+ ..++.++|+|++|+..++.+. +..++...       
T Consensus       159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~  232 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER  232 (274)
T ss_pred             ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence               3899999998643221      22357888999998875 457899999999998755432 11111110       


Q ss_pred             --------hhhhhcccccchhccccCCCCCCCChHHHHHhH
Q 040702          714 --------EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYL  746 (797)
Q Consensus       714 --------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l  746 (797)
                              +......+.++++.||+.+|++||++.++++.|
T Consensus       233 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         233 FYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             HHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence                    001123467889999999999999999998765

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.98  E-value=5.4e-32  Score=287.60  Aligned_cols=233  Identities=22%  Similarity=0.287  Sum_probs=186.6

Q ss_pred             cCCCccccccccCCcceeec---------------------ceEEEEEEEEecc-CCcchhHHHHHHHhhhccCCceeEe
Q 040702          512 NRFSENNLIGRGGFGPVYKD---------------------GMEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLIKI  569 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~---------------------~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l  569 (797)
                      ++|+..+.||+|+||.||++                     ...||+|++.... ....+++.+|+.+++.++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            57899999999999999974                     2468999987543 2234678999999999999999999


Q ss_pred             eeeeecCCeEEEEEEccCCCCHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCce
Q 040702          570 ISSCSNDDFKALVLEYMPLGSLEKCLYSGN----------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNV  639 (797)
Q Consensus       570 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NI  639 (797)
                      ++++...+..++||||+++|+|.+++....          ..+++..+..++.|++.|++|||   +.+++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheE
Confidence            999999999999999999999999987542          13677889999999999999999   99999999999999


Q ss_pred             EEcCCCcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc--cccccchh----
Q 040702          640 LLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV--DANLLIRE----  713 (797)
Q Consensus       640 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~--~~~~~~~~----  713 (797)
                      +++.++.++|+|||+++.+.............++..|+|||....+.++.++|+||+|+..++.+.  ...++...    
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            999999999999999986543322112222345678999999888899999999999988754432  11111110    


Q ss_pred             --------------------hhhhhcccccchhccccCCCCCCCChHHHHHhHH
Q 040702          714 --------------------EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLV  747 (797)
Q Consensus       714 --------------------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~  747 (797)
                                          +......+.+++..|+..||.+||++.++.+.|+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         242 VIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                                0111235568899999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.98  E-value=2.5e-32  Score=297.50  Aligned_cols=224  Identities=21%  Similarity=0.250  Sum_probs=179.6

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCC-cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      ++|+..+.||+|+||.||++     ++.||||++...... ..+.+.+|+++++.++|+||+++++++...+..|+||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            45667789999999999975     588999998654322 246788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      +++|+|....     ..++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  .
T Consensus       154 ~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~  223 (353)
T PLN00034        154 MDGGSLEGTH-----IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM--D  223 (353)
T ss_pred             CCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc--c
Confidence            9999986432     2566778899999999999999   9999999999999999999999999999998653221  1


Q ss_pred             cccccccCccccccccccc----C-ccchHHHHHHHhhhhhhhhccccccchh--------------------hhhhhcc
Q 040702          666 TQTQTLATIGYMAPDEIFS----G-EMRLKCWVNDSLLISVMIVVDANLLIRE--------------------EKHLMTK  720 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~----~-~~~~~~dv~s~~~~~~~~~~~~~~~~~~--------------------~~~~~~~  720 (797)
                      ......||..|+|||.+..    + ..+.++|||++|+..++.+.+..++...                    +......
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASRE  303 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHH
Confidence            2234579999999998743    2 2356899999999886655554433210                    1112235


Q ss_pred             cccchhccccCCCCCCCChHHHHHh
Q 040702          721 EQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       721 ~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                      +.++++.||..||++||++.|+++.
T Consensus       304 l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        304 FRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcC
Confidence            6789999999999999999999875

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.98  E-value=1.2e-32  Score=260.91  Aligned_cols=239  Identities=20%  Similarity=0.204  Sum_probs=193.1

Q ss_pred             HhcCCCccccccccCCcceee-----cceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCC-----eE
Q 040702          510 ATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDD-----FK  579 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk-----~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~-----~~  579 (797)
                      ..++|.+.+.+|+|||+.||.     +++.||+|++.....+..+...+|++..++++||||++++++...+.     ..
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            346899999999999999996     36899999998887777889999999999999999999999875443     59


Q ss_pred             EEEEEccCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCc
Q 040702          580 ALVLEYMPLGSLEKCLYSG---NYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  656 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  656 (797)
                      |++++|...|+|.+.+...   +..+++.+++.|+.+|++||++||.. ..+++||||||.||++.+.+.+++.|||.+.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence            9999999999999988643   33689999999999999999999922 3349999999999999999999999999987


Q ss_pred             cCCccCcc-------ccccccccCcccccccccc---cCccchHHHHHHHhhhhhhhhccccccchhhh-----------
Q 040702          657 PLLEEDQS-------LTQTQTLATIGYMAPDEIF---SGEMRLKCWVNDSLLISVMIVVDANLLIREEK-----------  715 (797)
Q Consensus       657 ~~~~~~~~-------~~~~~~~gt~~y~aPE~~~---~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~-----------  715 (797)
                      ...-.-..       .......+|..|+|||.+-   +...+.+.||||+|+..+..++...++.....           
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n  257 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQN  257 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeec
Confidence            54311100       0112345899999999774   34568999999999998777666555443221           


Q ss_pred             ---------hhhcccccchhccccCCCCCCCChHHHHHhHHHH
Q 040702          716 ---------HLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYI  749 (797)
Q Consensus       716 ---------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i  749 (797)
                               ...+.+.++++.|++.||.+||++.+++..++.+
T Consensus       258 ~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  258 AQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             cccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                     1344677899999999999999999999887654

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=9.3e-33  Score=298.12  Aligned_cols=214  Identities=23%  Similarity=0.239  Sum_probs=170.3

Q ss_pred             ccccCCcceeec-----ceEEEEEEEEeccC---CcchhHHHHHHHhhhc---cCCceeEeeeeeecCCeEEEEEEccCC
Q 040702          520 IGRGGFGPVYKD-----GMEVAIKVFNLQYG---GAFKSFDIECGMMKRI---RHRNLIKIISSCSNDDFKALVLEYMPL  588 (797)
Q Consensus       520 lg~G~~g~Vyk~-----~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l---~Hpniv~l~~~~~~~~~~~lv~e~~~~  588 (797)
                      ||+|+||.||++     ++.||||++.....   .....+..|..++.+.   +||||+++++++..++..|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999974     58899999975422   1223455677777665   699999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccccc
Q 040702          589 GSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  668 (797)
Q Consensus       589 g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  668 (797)
                      |+|.+++.... .+++..+..++.||++||+|||   +++|+||||||+||+++.++.+||+|||+++.......  ...
T Consensus        81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~  154 (330)
T cd05586          81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTN  154 (330)
T ss_pred             ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--Ccc
Confidence            99999887654 4899999999999999999999   99999999999999999999999999999975432221  234


Q ss_pred             ccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccccccchhh-h----------------hhhcccccchhcccc
Q 040702          669 QTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANLLIREE-K----------------HLMTKEQPMVRMGTD  730 (797)
Q Consensus       669 ~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-~----------------~~~~~~~~l~~~cl~  730 (797)
                      ..+||+.|||||.+.+. .++.++|+|++|+..+..+.+..++.... .                .......++++.|+.
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~  234 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLN  234 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcC
Confidence            46799999999998754 47899999999998766555443322111 0                112345678899999


Q ss_pred             CCCCCCCCh
Q 040702          731 LSLGQFPAS  739 (797)
Q Consensus       731 ~dp~~RPs~  739 (797)
                      .||.+||++
T Consensus       235 ~~P~~R~~~  243 (330)
T cd05586         235 RNPQHRLGA  243 (330)
T ss_pred             CCHHHCCCC
Confidence            999999964

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.98  E-value=6.7e-32  Score=283.29  Aligned_cols=233  Identities=21%  Similarity=0.304  Sum_probs=186.6

Q ss_pred             CCccccccccCCcceeecc--------eEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeecCCe-----
Q 040702          514 FSENNLIGRGGFGPVYKDG--------MEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDF-----  578 (797)
Q Consensus       514 f~~~~~lg~G~~g~Vyk~~--------~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~-----  578 (797)
                      |...+.||+|+||.||++.        ..||||+++....  ...+.+.+|++.++.++||||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5677899999999999752        5699999875432  224578899999999999999999998866554     


Q ss_pred             -EEEEEEccCCCCHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEee
Q 040702          579 -KALVLEYMPLGSLEKCLYSG-----NYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDF  652 (797)
Q Consensus       579 -~~lv~e~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF  652 (797)
                       .++||||+++|+|..++...     ...+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence             79999999999999888542     125889999999999999999999   899999999999999999999999999


Q ss_pred             cCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccch-----------------hh
Q 040702          653 GMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIR-----------------EE  714 (797)
Q Consensus       653 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~-----------------~~  714 (797)
                      |+++...............++..|+|||.+....++.++|+|++|+..++.+. ...++..                 .+
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  237 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQP  237 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence            99987644333222223345678999999988889999999999998866543 2222211                 11


Q ss_pred             hhhhcccccchhccccCCCCCCCChHHHHHhHHHH
Q 040702          715 KHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYI  749 (797)
Q Consensus       715 ~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i  749 (797)
                      ......+.++++.|++.||++||++.|+.+.++++
T Consensus       238 ~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         238 EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            12234667889999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.98  E-value=7.8e-32  Score=282.73  Aligned_cols=233  Identities=21%  Similarity=0.277  Sum_probs=182.8

Q ss_pred             CCccccccccCCcceeecc-------eEEEEEEEEecc--CCcchhHHHHHHHhhhccCCceeEeeeeeecC------Ce
Q 040702          514 FSENNLIGRGGFGPVYKDG-------MEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISSCSND------DF  578 (797)
Q Consensus       514 f~~~~~lg~G~~g~Vyk~~-------~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~------~~  578 (797)
                      |.+.+.||+|+||.||++.       ..||+|.++...  ....+.+..|+++++.++||||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3567899999999999852       369999887542  22346788999999999999999999987532      24


Q ss_pred             EEEEEEccCCCCHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeec
Q 040702          579 KALVLEYMPLGSLEKCLYS-----GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFG  653 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~-----~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG  653 (797)
                      .++||||+++|+|.+++..     ....+++..+..++.|++.|++|||   .++|+||||||+||+++.++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence            6899999999999988742     1225789999999999999999999   8999999999999999999999999999


Q ss_pred             CCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-----------------hh
Q 040702          654 MAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-----------------EK  715 (797)
Q Consensus       654 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-----------------~~  715 (797)
                      +++...............+++.|+|||...+..++.++|+|++|+..+..+. ...++...                 +.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  237 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPP  237 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCC
Confidence            9987643322212233346778999999998889999999999998755543 22221110                 11


Q ss_pred             hhhcccccchhccccCCCCCCCChHHHHHhHHHH
Q 040702          716 HLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYI  749 (797)
Q Consensus       716 ~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i  749 (797)
                      .....+.++++.|++.||++||++.++++.++.+
T Consensus       238 ~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         238 DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            1223567789999999999999999999988763

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=8.1e-32  Score=284.36  Aligned_cols=234  Identities=24%  Similarity=0.334  Sum_probs=187.2

Q ss_pred             cCC-CccccccccCCcceee---------cceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecC--Ce
Q 040702          512 NRF-SENNLIGRGGFGPVYK---------DGMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSND--DF  578 (797)
Q Consensus       512 ~~f-~~~~~lg~G~~g~Vyk---------~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~--~~  578 (797)
                      ++| +..+.||+|+||.||.         .+..||+|.++.... .....+.+|++++++++||||+++++++...  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            345 8889999999999964         247899999876532 2346788999999999999999999988654  36


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccC
Q 040702          579 KALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  658 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  658 (797)
                      .++||||+++|+|.+++....  +++.++..++.|++.|++|||   +++|+||||||+||+++.++.+||+|||+++..
T Consensus        83 ~~lv~e~~~~~~l~~~~~~~~--l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  157 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPKHK--LNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  157 (283)
T ss_pred             EEEEecCCCCCCHHHHHHHcC--CCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence            899999999999999997653  899999999999999999999   999999999999999999999999999999866


Q ss_pred             CccCccc-cccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh------------------------
Q 040702          659 LEEDQSL-TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE------------------------  713 (797)
Q Consensus       659 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~------------------------  713 (797)
                      ....... ......++..|+|||.+..+.++.++|+|++|+..++.+.+..+....                        
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05080         158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL  237 (283)
T ss_pred             CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence            4332211 112234567799999998888999999999998875554432211100                        


Q ss_pred             --------hhhhhcccccchhccccCCCCCCCChHHHHHhHHHHH
Q 040702          714 --------EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIR  750 (797)
Q Consensus       714 --------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~  750 (797)
                              +......+.+++..|++.+|++||++.++++.++.+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence                    1112346678899999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.97  E-value=3.4e-32  Score=287.28  Aligned_cols=219  Identities=21%  Similarity=0.264  Sum_probs=177.5

Q ss_pred             CCccccccccCCcceeec-----ceEEEEEEEEeccCC---cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          514 FSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG---AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       514 f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      |+..+.||+|+||.||++     ++.||||.+......   ..+.+..|+.++++++|++|+.+++.+.+.+..|+||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            677789999999999974     578999998754321   234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          586 MPLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       586 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      +++|+|.+++.... ..+++..+..++.|++.|+.|||   +.+|+||||||+||+++.++.++|+|||++.......  
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~--  156 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ--  156 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence            99999999886533 25889999999999999999999   9999999999999999999999999999987543222  


Q ss_pred             ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh--------------------hhhhcccccc
Q 040702          665 LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE--------------------KHLMTKEQPM  724 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~l  724 (797)
                       ......||..|||||.+.+..++.++|+|++|+..+..+.+..++....                    ........++
T Consensus       157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (285)
T cd05630         157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSL  235 (285)
T ss_pred             -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHH
Confidence             1234579999999999998889999999999998765555444332110                    0122245677


Q ss_pred             hhccccCCCCCCCC
Q 040702          725 VRMGTDLSLGQFPA  738 (797)
Q Consensus       725 ~~~cl~~dp~~RPs  738 (797)
                      ++.|++.||++||+
T Consensus       236 i~~~l~~~p~~R~s  249 (285)
T cd05630         236 CKMLLCKDPKERLG  249 (285)
T ss_pred             HHHHhhcCHHHccC
Confidence            77788888888887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.97  E-value=9.8e-32  Score=279.30  Aligned_cols=230  Identities=24%  Similarity=0.254  Sum_probs=186.8

Q ss_pred             cCCCccccccccCCcceeec----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccC
Q 040702          512 NRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  587 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~  587 (797)
                      .+|...+.||+|+||.||++    +..+|+|.+..... ..+.+.+|++++++++||||+++++++...+..|+||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            35788899999999999975    46799999864432 24578899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccccc
Q 040702          588 LGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ  667 (797)
Q Consensus       588 ~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  667 (797)
                      +++|.+++......+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++....... ...
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~~  158 (256)
T cd05059          83 NGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TSS  158 (256)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccccc-ccc
Confidence            99999999765556899999999999999999999   99999999999999999999999999999986543211 111


Q ss_pred             cccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-----------------hhhhhcccccchhccc
Q 040702          668 TQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-----------------EKHLMTKEQPMVRMGT  729 (797)
Q Consensus       668 ~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-----------------~~~~~~~~~~l~~~cl  729 (797)
                      ....++..|+|||.+.+..++.++|+|++|+..+..+. ...++...                 +......+.+++.+|+
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  238 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCW  238 (256)
T ss_pred             CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHh
Confidence            22234567999999998899999999999998755543 22221110                 1112345778999999


Q ss_pred             cCCCCCCCChHHHHHhH
Q 040702          730 DLSLGQFPASYSISKYL  746 (797)
Q Consensus       730 ~~dp~~RPs~~~i~~~l  746 (797)
                      ..+|++||++.++++.+
T Consensus       239 ~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         239 HEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             cCChhhCcCHHHHHHHh
Confidence            99999999999998765

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.97  E-value=7.5e-32  Score=281.07  Aligned_cols=220  Identities=19%  Similarity=0.258  Sum_probs=177.8

Q ss_pred             ccccccCCcceeecc-----------------eEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEE
Q 040702          518 NLIGRGGFGPVYKDG-----------------MEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKA  580 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~~-----------------~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~  580 (797)
                      +.||+|+||.||+|.                 ..||+|.+..........+..|+.+++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999863                 258889877655444567888999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCc-------EEEEeec
Q 040702          581 LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV-------AHLSDFG  653 (797)
Q Consensus       581 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~-------~kl~DFG  653 (797)
                      +||||+++|+|..++......+++..+..++.||++|++|||   +++|+||||||+||+++.++.       +|++|||
T Consensus        81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            999999999999988766556899999999999999999999   999999999999999986654       8999999


Q ss_pred             CCccCCccCccccccccccCcccccccccc-cCccchHHHHHHHhhhhhhhhc-cccccchhhh---------------h
Q 040702          654 MAKPLLEEDQSLTQTQTLATIGYMAPDEIF-SGEMRLKCWVNDSLLISVMIVV-DANLLIREEK---------------H  716 (797)
Q Consensus       654 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~~~---------------~  716 (797)
                      ++......      ....|+..|||||.+. ...++.++|+|++|+..+..+. +..+......               .
T Consensus       158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  231 (262)
T cd05077         158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQCMLVTP  231 (262)
T ss_pred             CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcCccCCCC
Confidence            98754321      2345888999999886 4568899999999998765543 2222111100               0


Q ss_pred             hhcccccchhccccCCCCCCCChHHHHHhH
Q 040702          717 LMTKEQPMVRMGTDLSLGQFPASYSISKYL  746 (797)
Q Consensus       717 ~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l  746 (797)
                      ....+.+++..||+.||.+||++.++++.+
T Consensus       232 ~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         232 SCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             ChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            123456889999999999999999998754

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.97  E-value=7.9e-32  Score=281.86  Aligned_cols=229  Identities=22%  Similarity=0.295  Sum_probs=186.4

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      .++|+..+.||+|+||.||++     ++.||+|++..........+.+|+.++++++||||+++++++..++..|+||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            357999999999999999985     578999999766544456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      +++++|.+++.... .+++..+..++.|++.|++|||   +.+|+|||+||+||+++.++.+||+|||+++......  .
T Consensus        88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~--~  161 (267)
T cd06646          88 CGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI--A  161 (267)
T ss_pred             CCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecccc--c
Confidence            99999999887554 4889999999999999999999   8999999999999999999999999999998653221  1


Q ss_pred             cccccccCcccccccccc---cCccchHHHHHHHhhhhhhhhccccccc-hhh--------------------hhhhccc
Q 040702          666 TQTQTLATIGYMAPDEIF---SGEMRLKCWVNDSLLISVMIVVDANLLI-REE--------------------KHLMTKE  721 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~---~~~~~~~~dv~s~~~~~~~~~~~~~~~~-~~~--------------------~~~~~~~  721 (797)
                      ......|+..|+|||.+.   ...++.++|+|++|+..++.+....++. ..+                    ......+
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTF  241 (267)
T ss_pred             ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHH
Confidence            223456889999999874   3457789999999987754433322211 100                    0112355


Q ss_pred             ccchhccccCCCCCCCChHHHHHh
Q 040702          722 QPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       722 ~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                      .+++++|+..+|++||++.++++.
T Consensus       242 ~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         242 HNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             HHHHHHHhhCChhhCcCHHHHhcC
Confidence            688999999999999999998764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=7.2e-32  Score=299.65  Aligned_cols=184  Identities=21%  Similarity=0.207  Sum_probs=158.7

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      ..+|.+.+.||+|+||.||++     ++.||||...      ...+.+|++++++++|||||++++++..++..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            457999999999999999985     4779999532      24567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      +. ++|.+++......+++..+..|+.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.........
T Consensus       242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            95 6998888765556899999999999999999999   9999999999999999999999999999998653322222


Q ss_pred             cccccccCcccccccccccCccchHHHHHHHhhhhhhhh
Q 040702          666 TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIV  704 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~  704 (797)
                      ......||+.|||||.+.+..++.++|+|++|++.++.+
T Consensus       318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~  356 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAA  356 (461)
T ss_pred             cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHH
Confidence            233467999999999999999999999999999875543

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.97  E-value=8e-32  Score=284.55  Aligned_cols=235  Identities=18%  Similarity=0.304  Sum_probs=189.0

Q ss_pred             cCCCccccccccCCcceeec---------ceEEEEEEEEecc-CCcchhHHHHHHHhhhccCCceeEeeeeeecC--CeE
Q 040702          512 NRFSENNLIGRGGFGPVYKD---------GMEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLIKIISSCSND--DFK  579 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~---------~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~--~~~  579 (797)
                      ..|+..+.||+|+||.||.+         +..||+|.++... ....+.+.+|+.++++++||||+++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            45788899999999999853         5789999987553 22346789999999999999999999998775  568


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCC
Q 040702          580 ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  659 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  659 (797)
                      ++||||+++++|.+++......+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++...
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  160 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence            9999999999999999765556899999999999999999999   9999999999999999999999999999998664


Q ss_pred             ccCccc-cccccccCcccccccccccCccchHHHHHHHhhhhhhhhcccccc----------------------------
Q 040702          660 EEDQSL-TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLL----------------------------  710 (797)
Q Consensus       660 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~----------------------------  710 (797)
                      ...... ......++..|+|||.+.+..++.++|+|++|+..+..+....+.                            
T Consensus       161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05079         161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLE  240 (284)
T ss_pred             cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHH
Confidence            332211 122345777899999998888999999999998875443211000                            


Q ss_pred             ----chhhhhhhcccccchhccccCCCCCCCChHHHHHhHHHH
Q 040702          711 ----IREEKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYI  749 (797)
Q Consensus       711 ----~~~~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i  749 (797)
                          ...+......+.++++.|++.+|++||++.++++.++.+
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         241 EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence                000112234567899999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.97  E-value=9.8e-32  Score=287.45  Aligned_cols=227  Identities=21%  Similarity=0.290  Sum_probs=183.8

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      ++|...+.||+|+||.||++     +..||+|.++.... .....+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            57899999999999999985     57899999975532 2345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      +++ ++.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.......  
T Consensus        86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--  159 (309)
T cd07872          86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK--  159 (309)
T ss_pred             CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc--
Confidence            975 888888766556889999999999999999999   99999999999999999999999999999975432211  


Q ss_pred             cccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchhh------------------------------
Q 040702          666 TQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIREE------------------------------  714 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~------------------------------  714 (797)
                      ......+|+.|+|||.+.+ ..++.++|+|++|+..+..+.+..++....                              
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07872         160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK  239 (309)
T ss_pred             ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence            2233568999999998865 457899999999998755554433321100                              


Q ss_pred             ----------------hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          715 ----------------KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       715 ----------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                      ........+++++|+..||.+|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence                            001224457899999999999999988876

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.4e-31  Score=278.11  Aligned_cols=229  Identities=25%  Similarity=0.346  Sum_probs=190.3

Q ss_pred             hcCCCccccccccCCcceeec---ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccC
Q 040702          511 TNRFSENNLIGRGGFGPVYKD---GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  587 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~---~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~  587 (797)
                      .++|+..+.||+|+||.||++   ++.||||.++.... ..+++.+|+.++++++|+||+++++++.+.+..++||||++
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   83 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA   83 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence            357888999999999999985   68899999975543 45788999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccc
Q 040702          588 LGSLEKCLYSGNY-ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  666 (797)
Q Consensus       588 ~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  666 (797)
                      +++|.+++..... .+++..+..++.|++.|+.|||   ..+++||||||+||+++.++.+||+|||.++......    
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~----  156 (256)
T cd05039          84 KGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ----  156 (256)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccccc----
Confidence            9999999976543 5899999999999999999999   9999999999999999999999999999998653221    


Q ss_pred             ccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-----------------hhhhhcccccchhcc
Q 040702          667 QTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-----------------EKHLMTKEQPMVRMG  728 (797)
Q Consensus       667 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-----------------~~~~~~~~~~l~~~c  728 (797)
                       ....++..|+|||.+..+.++.++|+|++|+..+..+. +..++...                 +......+.+++++|
T Consensus       157 -~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  235 (256)
T cd05039         157 -DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDC  235 (256)
T ss_pred             -ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHH
Confidence             12345668999999988889999999999988754432 22111111                 111234667899999


Q ss_pred             ccCCCCCCCChHHHHHhHHH
Q 040702          729 TDLSLGQFPASYSISKYLVY  748 (797)
Q Consensus       729 l~~dp~~RPs~~~i~~~l~~  748 (797)
                      +..+|++||++.++++.|+.
T Consensus       236 l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         236 WELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             hccChhhCcCHHHHHHHHhc
Confidence            99999999999999998864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.97  E-value=1.7e-31  Score=277.54  Aligned_cols=227  Identities=20%  Similarity=0.259  Sum_probs=181.5

Q ss_pred             cccccCCcceeec-------ceEEEEEEEEeccCC-cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccCCCC
Q 040702          519 LIGRGGFGPVYKD-------GMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGS  590 (797)
Q Consensus       519 ~lg~G~~g~Vyk~-------~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~g~  590 (797)
                      .||+|+||.||++       +..||+|++...... ..+.+.+|+.++++++||||+++++++.. +..++||||+++|+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCC
Confidence            3899999999974       356999998755332 24578899999999999999999998864 46899999999999


Q ss_pred             HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc-cccc
Q 040702          591 LEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL-TQTQ  669 (797)
Q Consensus       591 L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~-~~~~  669 (797)
                      |.+++......+++..+.+++.|++.|++|||   +++++||||||+||+++.++.+||+|||+++......... ....
T Consensus        81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05115          81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA  157 (257)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence            99999765556899999999999999999999   8999999999999999999999999999998654332211 1122


Q ss_pred             cccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchhh-----------------hhhhcccccchhccccC
Q 040702          670 TLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIREE-----------------KHLMTKEQPMVRMGTDL  731 (797)
Q Consensus       670 ~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~~-----------------~~~~~~~~~l~~~cl~~  731 (797)
                      ..++..|+|||.+....++.++|+|++|+..++.+. +..++....                 ......+.+++..||..
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~  237 (257)
T cd05115         158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY  237 (257)
T ss_pred             CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence            234678999999988888999999999998765543 333322111                 11234566789999999


Q ss_pred             CCCCCCChHHHHHhHHHH
Q 040702          732 SLGQFPASYSISKYLVYI  749 (797)
Q Consensus       732 dp~~RPs~~~i~~~l~~i  749 (797)
                      +|++||++.++.+.++.+
T Consensus       238 ~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         238 KWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             ChhhCcCHHHHHHHHhhh
Confidence            999999999999887654

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.97  E-value=1.2e-31  Score=284.28  Aligned_cols=227  Identities=21%  Similarity=0.264  Sum_probs=185.2

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      +.|+..+.||+|+||.||++     +..||+|.+........+.+.+|+.+++.++||||+++++++..++..|+||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            56888999999999999975     5889999997665555677889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccc
Q 040702          587 PLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  666 (797)
Q Consensus       587 ~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  666 (797)
                      +++++..++......+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||++......  ...
T Consensus        92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--~~~  166 (292)
T cd06644          92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--LQR  166 (292)
T ss_pred             CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceecccc--ccc
Confidence            999999887665556899999999999999999999   999999999999999999999999999998754221  112


Q ss_pred             ccccccCcccccccccc-----cCccchHHHHHHHhhhhhhhhccccccchhh-------------------hhhhcccc
Q 040702          667 QTQTLATIGYMAPDEIF-----SGEMRLKCWVNDSLLISVMIVVDANLLIREE-------------------KHLMTKEQ  722 (797)
Q Consensus       667 ~~~~~gt~~y~aPE~~~-----~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~  722 (797)
                      .....+++.|+|||.+.     ...++.++|+|++|+..+..+....++....                   ......+.
T Consensus       167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (292)
T cd06644         167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFR  246 (292)
T ss_pred             cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHH
Confidence            23456889999999885     3446789999999998765554444432211                   01122456


Q ss_pred             cchhccccCCCCCCCChHHHH
Q 040702          723 PMVRMGTDLSLGQFPASYSIS  743 (797)
Q Consensus       723 ~l~~~cl~~dp~~RPs~~~i~  743 (797)
                      ++++.|+..+|++||++.+++
T Consensus       247 ~li~~~l~~~p~~Rp~~~~il  267 (292)
T cd06644         247 DFLKTALDKHPETRPSAAQLL  267 (292)
T ss_pred             HHHHHHhcCCcccCcCHHHHh
Confidence            788999999999999987763

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.7e-32  Score=279.43  Aligned_cols=228  Identities=19%  Similarity=0.253  Sum_probs=196.5

Q ss_pred             cCCCccccccccCCcceee-----cceEEEEEEEEeccCC--cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGG--AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk-----~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      +-|+..+.||+|-|++|-.     +|..||||++++..-+  ....+.+|++.|+-++|||||++|.+.......|+|.|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            5688889999999999975     4799999999877433  34678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEE-cCCCcEEEEeecCCccCCccCc
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL-DDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll-~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      .-.+|+|++|+.++...+.+..+.+++.||+.|+.|+|   ...+||||+||+||.+ ..-|-+|+.|||++-.+.+.. 
T Consensus        98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~-  173 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK-  173 (864)
T ss_pred             ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc-
Confidence            99999999999888777999999999999999999999   8889999999999976 567899999999997764433 


Q ss_pred             cccccccccCcccccccccccCccc-hHHHHHHHhhhhhhhhccccccchhh----------------hhhhcccccchh
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMR-LKCWVNDSLLISVMIVVDANLLIREE----------------KHLMTKEQPMVR  726 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~dv~s~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~l~~  726 (797)
                        ..++.+|+..|-|||.+++..|+ .++|||++|++.+|.+.+..++....                .......+++++
T Consensus       174 --kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrdLI~  251 (864)
T KOG4717|consen  174 --KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRDLIQ  251 (864)
T ss_pred             --hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHHHHH
Confidence              45678999999999999999996 88999999999987776666554422                123446678999


Q ss_pred             ccccCCCCCCCChHHHHHh
Q 040702          727 MGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       727 ~cl~~dp~~RPs~~~i~~~  745 (797)
                      .|+..||.+|-+.+||...
T Consensus       252 sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  252 SMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             HHHhcCchhhccHHHHhcc
Confidence            9999999999998888764

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.97  E-value=1.1e-31  Score=310.14  Aligned_cols=237  Identities=21%  Similarity=0.236  Sum_probs=188.8

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCC---cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG---AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ++|+..++||+|+||.||++     ++.||||+++.....   ..+++.+|++++++++||||+++++++.+++..|+||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            57999999999999999985     688999999754322   2457899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcC----------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeec
Q 040702          584 EYMPLGSLEKCLYSG----------NYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFG  653 (797)
Q Consensus       584 e~~~~g~L~~~l~~~----------~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG  653 (797)
                      ||++||+|.+++...          ....++..+.+++.||++||+|||   +.+|+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence            999999999988642          113566778899999999999999   9999999999999999999999999999


Q ss_pred             CCccCCccCc----------------cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh---
Q 040702          654 MAKPLLEEDQ----------------SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE---  714 (797)
Q Consensus       654 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~---  714 (797)
                      +++.......                .......+||+.|||||.+.+..++.++|+|++|+..++.+.+..++....   
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9986521110                001123579999999999999999999999999999866555443332110   


Q ss_pred             ----------------hhhhcccccchhccccCCCCCCCC-hHHHHHhHHHHHH
Q 040702          715 ----------------KHLMTKEQPMVRMGTDLSLGQFPA-SYSISKYLVYIRE  751 (797)
Q Consensus       715 ----------------~~~~~~~~~l~~~cl~~dp~~RPs-~~~i~~~l~~i~~  751 (797)
                                      .+....+.+++.+|++.||++||+ +.++.+.++.+.+
T Consensus       239 i~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        239 ISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             hhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                            012234668889999999999975 5667666666543

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.97  E-value=3.5e-32  Score=293.50  Aligned_cols=259  Identities=18%  Similarity=0.222  Sum_probs=190.4

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ++|...+.||+|+||.||++     ++.||+|++.+..   ......+..|..++..++|++|+++++++.+++..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47889999999999999974     5789999997532   222355788999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      ||+++|+|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.......
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  157 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT  157 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            999999999999875456899999999999999999999   99999999999999999999999999999986543222


Q ss_pred             cccccccccCccccccccccc-----CccchHHHHHHHhhhhhhhhccccccchhhh-hhhcccccchhc--cccCCCCC
Q 040702          664 SLTQTQTLATIGYMAPDEIFS-----GEMRLKCWVNDSLLISVMIVVDANLLIREEK-HLMTKEQPMVRM--GTDLSLGQ  735 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~--cl~~dp~~  735 (797)
                       .......||+.|||||.+.+     +.++.++|+|++|+..+..+.+..++..... +...   .+...  -.. -|..
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~---~i~~~~~~~~-~p~~  232 (331)
T cd05624         158 -VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG---KIMNHEERFQ-FPSH  232 (331)
T ss_pred             -eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHH---HHHcCCCccc-CCCc
Confidence             12234579999999998865     5678899999999998766665554432211 1111   11100  000 0111


Q ss_pred             CCC-hHHHHHhHHHHHHHhccccccccccCCcccccceeeeeeeee
Q 040702          736 FPA-SYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYTI  780 (797)
Q Consensus       736 RPs-~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~  780 (797)
                      .+. ..++.+.+..+...+..+.+  ......+++|+||++++|+.
T Consensus       233 ~~~~~~~~~~li~~ll~~~~~~~~--~~~~~~~~~h~~f~~~~~~~  276 (331)
T cd05624         233 ITDVSEEAKDLIQRLICSRERRLG--QNGIEDFKKHAFFEGIDWEN  276 (331)
T ss_pred             cccCCHHHHHHHHHHccCchhhcC--CCCHHHHhcCCCcCCCCHHH
Confidence            111 23444555544333222222  22346788899999988864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.97  E-value=3.5e-32  Score=287.32  Aligned_cols=221  Identities=21%  Similarity=0.251  Sum_probs=179.1

Q ss_pred             CCccccccccCCcceeec-----ceEEEEEEEEeccC---CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          514 FSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG---GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       514 f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      |...+.||+|+||.||++     ++.||+|.+.....   .....+.+|++++++++|+||+++.+++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            667789999999999984     57899999875432   2234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          586 MPLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       586 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      +++|+|.+++.... ..+++..+..++.|++.||.|||   +.+|+||||||+||++++++.+||+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--  156 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence            99999998886543 35899999999999999999999   9999999999999999999999999999997543221  


Q ss_pred             ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh--------------------hhhhcccccc
Q 040702          665 LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE--------------------KHLMTKEQPM  724 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~l  724 (797)
                       ......|+..|+|||.+.+..++.++|+|++|+..+..+.+..++....                    ........++
T Consensus       157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (285)
T cd05632         157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSI  235 (285)
T ss_pred             -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHH
Confidence             1234578999999999988889999999999988755544443332111                    1122345677


Q ss_pred             hhccccCCCCCCCChH
Q 040702          725 VRMGTDLSLGQFPASY  740 (797)
Q Consensus       725 ~~~cl~~dp~~RPs~~  740 (797)
                      +..|++.||++||++.
T Consensus       236 i~~~l~~~P~~R~~~~  251 (285)
T cd05632         236 CKMLLTKDPKQRLGCQ  251 (285)
T ss_pred             HHHHccCCHhHcCCCc
Confidence            8889999999999843

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.97  E-value=8e-32  Score=285.18  Aligned_cols=234  Identities=24%  Similarity=0.341  Sum_probs=188.9

Q ss_pred             hcCCCccccccccCCcceeec----------ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD----------GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFK  579 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~----------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~  579 (797)
                      .++|+..+.||+|+||.||++          +..||+|.+..... ...+++.+|+.++++++||||+++++++..++..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            468999999999999999974          47899999875432 2346788999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCC---------------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCc
Q 040702          580 ALVLEYMPLGSLEKCLYSGN---------------------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSN  638 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~---------------------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~N  638 (797)
                      ++||||+++|+|.+++....                     ..+++..++.++.|++.||+|||   ..+++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhh
Confidence            99999999999999986431                     13678888999999999999999   9999999999999


Q ss_pred             eEEcCCCcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cc-cccchh---
Q 040702          639 VLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DA-NLLIRE---  713 (797)
Q Consensus       639 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~-~~~~~~---  713 (797)
                      |++++++.+||+|||++................++..|+|||.+.+..++.++|+|++|+..+..+. .. ++.+..   
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999876533322222223345678999999988889999999999998755442 21 211111   


Q ss_pred             -------------hhhhhcccccchhccccCCCCCCCChHHHHHhHH
Q 040702          714 -------------EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLV  747 (797)
Q Consensus       714 -------------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~  747 (797)
                                   +......+.+++.+|+..||++||++.|+.+.|+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         241 VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence                         1112346778999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.97  E-value=1e-31  Score=281.27  Aligned_cols=235  Identities=21%  Similarity=0.285  Sum_probs=188.3

Q ss_pred             cCCCccccccccCCcceeecc--------eEEEEEEEEecc-CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKDG--------MEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~~--------~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      .+|+..+.||+|+||.||++.        ..||||.+.... ....++|..|+.++++++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            457888999999999999752        369999987542 22346799999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      |||+++|+|.+++......+++.+++.++.|++.|++|||   +.+++||||||+||+++.++.+|++|||+++......
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            9999999999999876556899999999999999999999   9999999999999999999999999999997654322


Q ss_pred             ccccccc-c--ccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccch-h----------------hhhhhccc
Q 040702          663 QSLTQTQ-T--LATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIR-E----------------EKHLMTKE  721 (797)
Q Consensus       663 ~~~~~~~-~--~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~-~----------------~~~~~~~~  721 (797)
                      ....... .  .++..|+|||.+..+.++.++|+|++|+..++.+. +..++.. .                +.+....+
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  240 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTAL  240 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHH
Confidence            1111111 1  12457999999998899999999999998755332 2222111 1                01123356


Q ss_pred             ccchhccccCCCCCCCChHHHHHhHHHH
Q 040702          722 QPMVRMGTDLSLGQFPASYSISKYLVYI  749 (797)
Q Consensus       722 ~~l~~~cl~~dp~~RPs~~~i~~~l~~i  749 (797)
                      .+++..|+..+|.+||++.++...++.+
T Consensus       241 ~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         241 HQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            7788999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.97  E-value=1.7e-31  Score=279.50  Aligned_cols=236  Identities=20%  Similarity=0.308  Sum_probs=190.1

Q ss_pred             hcCCCccccccccCCcceeecc--------eEEEEEEEEecc-CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKDG--------MEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~~--------~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l  581 (797)
                      .++|+..+.||+|+||.||++.        ..+|+|.++... ....+.+..|++++++++||||+++++++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            4578888999999999999752        369999987553 2234678899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCcc
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  661 (797)
                      ||||+++++|.+++......+++..+..++.|++.|++|||   +.+++||||||+||++++++.+|++|||++......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            99999999999999776556899999999999999999999   999999999999999999999999999999765432


Q ss_pred             Ccccc-ccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccc-hhh----------------hhhhcccc
Q 040702          662 DQSLT-QTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLI-REE----------------KHLMTKEQ  722 (797)
Q Consensus       662 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~-~~~----------------~~~~~~~~  722 (797)
                      ..... ......+..|+|||.+....++.++|+|++|+..++.+. +..++. ...                .+....+.
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  240 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVY  240 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence            21111 112223567999999988889999999999998765443 322221 111                11223556


Q ss_pred             cchhccccCCCCCCCChHHHHHhHHHH
Q 040702          723 PMVRMGTDLSLGQFPASYSISKYLVYI  749 (797)
Q Consensus       723 ~l~~~cl~~dp~~RPs~~~i~~~l~~i  749 (797)
                      +++..|+..+|++||++.++.+.++++
T Consensus       241 ~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         241 QLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             HHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            888899999999999999999988764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=2.1e-31  Score=280.55  Aligned_cols=238  Identities=21%  Similarity=0.248  Sum_probs=191.6

Q ss_pred             cCCCccccccccCCcceeecc---------eEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKDG---------MEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~~---------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l  581 (797)
                      .+|+..+.||+|+||.||++.         ..||+|....... ....++.+|+.++++++||||+++++++.. +..++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            578888999999999999852         3689998865532 234678899999999999999999999987 78899


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCcc
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  661 (797)
                      ||||+++|+|.+++......+++..+..++.|++.|++|||   +.+|+||||||+||++++++.+||+|||.++.....
T Consensus        86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~  162 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD  162 (279)
T ss_pred             EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence            99999999999999876656899999999999999999999   899999999999999999999999999999876433


Q ss_pred             CccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchhhh-h----------------hhccccc
Q 040702          662 DQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIREEK-H----------------LMTKEQP  723 (797)
Q Consensus       662 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~~~-~----------------~~~~~~~  723 (797)
                      ..........++..|+|||.+....++.++|+|++|+..++.+. +..++..... +                ....+.+
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (279)
T cd05057         163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYM  242 (279)
T ss_pred             ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHH
Confidence            32222222334678999999988889999999999988755443 3322222111 0                1124557


Q ss_pred             chhccccCCCCCCCChHHHHHhHHHHHHHh
Q 040702          724 MVRMGTDLSLGQFPASYSISKYLVYIRELE  753 (797)
Q Consensus       724 l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~  753 (797)
                      ++..|+..||++||++.++++.++.+.+.+
T Consensus       243 ~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05057         243 VLVKCWMIDAESRPTFKELINEFSKMARDP  272 (279)
T ss_pred             HHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence            788899999999999999999998876543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.97  E-value=1.9e-31  Score=283.60  Aligned_cols=236  Identities=24%  Similarity=0.313  Sum_probs=187.4

Q ss_pred             cCCCccccccccCCcceeec-----c--eEEEEEEEEecc-CCcchhHHHHHHHhhhc-cCCceeEeeeeeecCCeEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----G--MEVAIKVFNLQY-GGAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~--~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      ++|+..+.||+|+||.||++     +  ..+|+|.++... ....+.+.+|+++++++ +||||+++++++...+..|+|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            47888999999999999975     2  347888876432 22346788999999999 799999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcE
Q 040702          583 LEYMPLGSLEKCLYSGN---------------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVA  647 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~  647 (797)
                      |||+++|+|.+++....               ..+++..+..++.|++.|++|||   +++|+||||||+||++++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence            99999999999986532               24788899999999999999999   9999999999999999999999


Q ss_pred             EEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-ccccc-chhh-----------
Q 040702          648 HLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLL-IREE-----------  714 (797)
Q Consensus       648 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~-~~~~-----------  714 (797)
                      ||+|||++......   ........+..|+|||.+....++.++|+|++|+..++.+. +..++ ....           
T Consensus       159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~  235 (297)
T cd05089         159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  235 (297)
T ss_pred             EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence            99999998643211   11112233567999999988889999999999998865543 32221 1111           


Q ss_pred             -----hhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHHh
Q 040702          715 -----KHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRELE  753 (797)
Q Consensus       715 -----~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~  753 (797)
                           ......+.+++..|+..+|.+||++.++++.++.+.+-.
T Consensus       236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence                 112235668899999999999999999999888776543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.97  E-value=2.3e-31  Score=277.54  Aligned_cols=233  Identities=21%  Similarity=0.298  Sum_probs=188.3

Q ss_pred             hcCCCccccccccCCcceeec----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          511 TNRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      .++|...++||+|+||.||++    ...||+|.++.... ..+.+.+|+.++++++||||+++++++. .+..++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence            467999999999999999985    35799999875332 3467899999999999999999999875 45679999999


Q ss_pred             CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          587 PLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       587 ~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      ++|+|.+++.... ..+++..+..++.|+++||+|+|   +.+++||||||+||++++++.+||+|||.++....... .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~-~  158 (262)
T cd05071          83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-T  158 (262)
T ss_pred             CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccccc-c
Confidence            9999999997533 35789999999999999999999   99999999999999999999999999999976543221 1


Q ss_pred             cccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-----------------hhhhhcccccchhc
Q 040702          666 TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-----------------EKHLMTKEQPMVRM  727 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-----------------~~~~~~~~~~l~~~  727 (797)
                      ......++..|+|||....+.++.++|+|++|+..+..+. +..++...                 ..+....+.+++++
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  238 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ  238 (262)
T ss_pred             cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHH
Confidence            1223446778999999988889999999999998866554 22221110                 11233456789999


Q ss_pred             cccCCCCCCCChHHHHHhHHHH
Q 040702          728 GTDLSLGQFPASYSISKYLVYI  749 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~~l~~i  749 (797)
                      |++.||++||++.++.+.++..
T Consensus       239 ~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         239 CWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             HccCCcccCCCHHHHHHHHHHh
Confidence            9999999999999999988753

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.97  E-value=4.8e-32  Score=296.41  Aligned_cols=201  Identities=23%  Similarity=0.286  Sum_probs=167.8

Q ss_pred             HHHHHHHhcCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeec
Q 040702          504 YLELFQATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSN  575 (797)
Q Consensus       504 ~~~l~~~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~  575 (797)
                      +.++....++|+..+.||+|+||.||++     ++.||+|++....   ....+.+.+|+.+++.++||||+++++++.+
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            3445556689999999999999999974     5789999997532   2223557789999999999999999999999


Q ss_pred             CCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCC
Q 040702          576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMA  655 (797)
Q Consensus       576 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla  655 (797)
                      ++..|+||||+++|+|.+++....  ++...+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||++
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~~~--~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a  189 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTC  189 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence            999999999999999999987653  788889999999999999999   999999999999999999999999999999


Q ss_pred             ccCCccCccccccccccCcccccccccccC----ccchHHHHHHHhhhhhhhhcccccc
Q 040702          656 KPLLEEDQSLTQTQTLATIGYMAPDEIFSG----EMRLKCWVNDSLLISVMIVVDANLL  710 (797)
Q Consensus       656 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~dv~s~~~~~~~~~~~~~~~  710 (797)
                      +....... .......||+.|||||.+...    .++.++|+|++|+..++++.+..++
T Consensus       190 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf  247 (371)
T cd05622         190 MKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF  247 (371)
T ss_pred             eEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCC
Confidence            86543221 123456799999999988643    3788999999999987666555444

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.97  E-value=5.7e-32  Score=292.05  Aligned_cols=260  Identities=18%  Similarity=0.225  Sum_probs=190.5

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ++|...+.||+|+||.||++     ++.||+|++.+..   ......+..|+.++..++|++|+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47889999999999999974     5789999997532   222345788999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      ||+++|+|.+++......+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~  157 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT  157 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence            999999999999875556899999999999999999999   99999999999999999999999999999976533222


Q ss_pred             cccccccccCcccccccccc-----cCccchHHHHHHHhhhhhhhhccccccchhh-hhhhcccccchhcccc-CCCCCC
Q 040702          664 SLTQTQTLATIGYMAPDEIF-----SGEMRLKCWVNDSLLISVMIVVDANLLIREE-KHLMTKEQPMVRMGTD-LSLGQF  736 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~cl~-~dp~~R  736 (797)
                       ......+||+.|||||.+.     .+.++.++|+|++|+..++.+.+..++.... .+...   .+...-.. .-|..-
T Consensus       158 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~---~i~~~~~~~~~p~~~  233 (332)
T cd05623         158 -VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG---KIMNHKERFQFPAQV  233 (332)
T ss_pred             -ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHH---HHhCCCccccCCCcc
Confidence             1223457999999999886     3457889999999999877666555443221 11111   11110000 001110


Q ss_pred             C-ChHHHHHhHHHHHHHhccccccccccCCcccccceeeeeeeee
Q 040702          737 P-ASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYTI  780 (797)
Q Consensus       737 P-s~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~  780 (797)
                      . -..++.+.++.+...+..+.+  ...+..+++|+||++++|+.
T Consensus       234 ~~~s~~~~~li~~ll~~~~~r~~--r~~~~~~~~h~~f~~~~~~~  276 (332)
T cd05623         234 TDVSEDAKDLIRRLICSREHRLG--QNGIEDFKQHPFFTGIDWDN  276 (332)
T ss_pred             ccCCHHHHHHHHHHccChhhhcC--CCCHHHHhCCCCcCCCCHHH
Confidence            0 123445555554333222222  22356788999999999864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=9.2e-32  Score=282.98  Aligned_cols=234  Identities=21%  Similarity=0.292  Sum_probs=189.7

Q ss_pred             hcCCCccccccccCCcceeec----------ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD----------GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFK  579 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~----------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~  579 (797)
                      .++|.+.+.||+|+||.||++          +..||+|.+..... .....+.+|+.+++.++||||+++++++...+..
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            467888999999999999974          26799999864432 2245788999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEE
Q 040702          580 ALVLEYMPLGSLEKCLYSGN---------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLS  650 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~  650 (797)
                      ++||||+++|+|.+++....         ..+++..+..++.|++.|+.|||   +.+|+||||||+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEEC
Confidence            99999999999999986432         13678899999999999999999   9999999999999999999999999


Q ss_pred             eecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccch-----------------
Q 040702          651 DFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIR-----------------  712 (797)
Q Consensus       651 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~-----------------  712 (797)
                      |||+++...............++..|+|||.+.++.++.++|+|++|+..++.+. +..++..                 
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~  241 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLD  241 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCC
Confidence            9999986544332222334557889999999988889999999999998755442 2222111                 


Q ss_pred             hhhhhhcccccchhccccCCCCCCCChHHHHHhHH
Q 040702          713 EEKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLV  747 (797)
Q Consensus       713 ~~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~  747 (797)
                      .+......+.++++.|+..+|++||++.++++.++
T Consensus       242 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         242 LPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            11122345678999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.97  E-value=4.7e-32  Score=285.33  Aligned_cols=236  Identities=22%  Similarity=0.273  Sum_probs=194.4

Q ss_pred             hcCCCccccccccCCcceeecc---------eEEEEEEEEec-cCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKDG---------MEVAIKVFNLQ-YGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKA  580 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~~---------~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~  580 (797)
                      .+.....++||+|-||.||+|.         -.||||.-+.. ..+..+.|..|..+|+.++|||||+++|+|.+. ..|
T Consensus       388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~W  466 (974)
T KOG4257|consen  388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMW  466 (974)
T ss_pred             hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-cee
Confidence            3445556899999999999862         56999998875 334578899999999999999999999999754 589


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCc
Q 040702          581 LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  660 (797)
Q Consensus       581 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  660 (797)
                      ||||.++-|.|..+++..+..++......++.||+.||.|||   ++.+|||||..+|||+....-+|++|||+++.+.+
T Consensus       467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed  543 (974)
T KOG4257|consen  467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLED  543 (974)
T ss_pred             EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccc
Confidence            999999999999999998888999999999999999999999   99999999999999999999999999999998755


Q ss_pred             cCccccccccccCcccccccccccCccchHHHHHHHhhhh--hhhhccccccch----------------hhhhhhcccc
Q 040702          661 EDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLIS--VMIVVDANLLIR----------------EEKHLMTKEQ  722 (797)
Q Consensus       661 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~--~~~~~~~~~~~~----------------~~~~~~~~~~  722 (797)
                      +.. ...+...-...|||||.+--..++.++|||.+|+-.  +.+....++.+-                .++...+.+.
T Consensus       544 ~~y-YkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LY  622 (974)
T KOG4257|consen  544 DAY-YKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALY  622 (974)
T ss_pred             cch-hhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHH
Confidence            443 333444456689999999999999999999999755  333333332222                2223345666


Q ss_pred             cchhccccCCCCCCCChHHHHHhHHHHHH
Q 040702          723 PMVRMGTDLSLGQFPASYSISKYLVYIRE  751 (797)
Q Consensus       723 ~l~~~cl~~dp~~RPs~~~i~~~l~~i~~  751 (797)
                      .++.+||+.||.+||++.++...|..+.+
T Consensus       623 slmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  623 SLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             HHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            78889999999999999999888887755

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.97  E-value=1.8e-31  Score=278.07  Aligned_cols=232  Identities=22%  Similarity=0.326  Sum_probs=187.1

Q ss_pred             hcCCCccccccccCCcceeec----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          511 TNRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      .++|+..+.||+|+||.||++    +..||+|.++.... ..+.+.+|+.++++++|||++++++++. .+..++||||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            357888999999999999975    46799999875433 3467899999999999999999999875 45688999999


Q ss_pred             CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          587 PLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       587 ~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      ++++|.+++.... ..+++..+..++.|++.|++|||   +.+|+||||||+||++++++.++|+|||++........ .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~-~  158 (260)
T cd05070          83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY-T  158 (260)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc-c
Confidence            9999999987643 35899999999999999999999   89999999999999999999999999999986533221 1


Q ss_pred             cccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccch-----------------hhhhhhcccccchhc
Q 040702          666 TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIR-----------------EEKHLMTKEQPMVRM  727 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~-----------------~~~~~~~~~~~l~~~  727 (797)
                      ......++..|+|||.+....++.++|+|++|+..+..+. +..++..                 .+.+....+.+++++
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  238 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQ  238 (260)
T ss_pred             cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHH
Confidence            1222345678999999988889999999999998755543 2222111                 111223456788999


Q ss_pred             cccCCCCCCCChHHHHHhHHH
Q 040702          728 GTDLSLGQFPASYSISKYLVY  748 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~~l~~  748 (797)
                      |+..+|++|||+.++.+.++.
T Consensus       239 ~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         239 CWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             HcccCcccCcCHHHHHHHHhc
Confidence            999999999999999988764

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.97  E-value=2.4e-31  Score=287.63  Aligned_cols=238  Identities=23%  Similarity=0.301  Sum_probs=190.5

Q ss_pred             cCCCccccccccCCcceeecc------------eEEEEEEEEeccC-CcchhHHHHHHHhhhc-cCCceeEeeeeeecCC
Q 040702          512 NRFSENNLIGRGGFGPVYKDG------------MEVAIKVFNLQYG-GAFKSFDIECGMMKRI-RHRNLIKIISSCSNDD  577 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~~------------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~  577 (797)
                      .+|.+.+.||+|+||.||++.            ..||+|.++.... ...+++.+|+.+++++ +||||++++++|...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            478899999999999999752            3689998875432 2346788999999999 7999999999999999


Q ss_pred             eEEEEEEccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEc
Q 040702          578 FKALVLEYMPLGSLEKCLYSGN---------------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD  642 (797)
Q Consensus       578 ~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~  642 (797)
                      ..++||||+++|+|.+++....               ..+++..+..++.|+++|++|||   .++|+||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEc
Confidence            9999999999999999987532               24788899999999999999999   99999999999999999


Q ss_pred             CCCcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh--------
Q 040702          643 DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE--------  713 (797)
Q Consensus       643 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~--------  713 (797)
                      .++.+||+|||+++...............++..|||||.+.+..++.++|+|++|+..++.+. +..++...        
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  248 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL  248 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            999999999999986543222212223345678999999999999999999999988755443 22211110        


Q ss_pred             ---------hhhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          714 ---------EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       714 ---------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                               +......+.++++.|++.+|++||++.++++.++.+...
T Consensus       249 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~  296 (334)
T cd05100         249 LKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV  296 (334)
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence                     001123456789999999999999999999999888654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.97  E-value=2e-31  Score=276.91  Aligned_cols=227  Identities=25%  Similarity=0.298  Sum_probs=185.2

Q ss_pred             cCCCccccccccCCcceeec---ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeee-cCCeEEEEEEccC
Q 040702          512 NRFSENNLIGRGGFGPVYKD---GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS-NDDFKALVLEYMP  587 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~---~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~-~~~~~~lv~e~~~  587 (797)
                      ++|+..+.||+|+||.||++   +..||+|.++...  ..+.+.+|+.++++++|+|++++++++. .++..++||||++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~   83 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA   83 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence            57888999999999999985   5789999886432  2467899999999999999999999764 4567899999999


Q ss_pred             CCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccc
Q 040702          588 LGSLEKCLYSGNY-ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  666 (797)
Q Consensus       588 ~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  666 (797)
                      +|+|.+++..... .+++..+..++.|++.|++|||   +++++||||||+||++++++.+|++|||+++......    
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----  156 (256)
T cd05082          84 KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----  156 (256)
T ss_pred             CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccC----
Confidence            9999999876543 4789999999999999999999   9999999999999999999999999999998543221    


Q ss_pred             ccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccch-hh----------------hhhhcccccchhcc
Q 040702          667 QTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIR-EE----------------KHLMTKEQPMVRMG  728 (797)
Q Consensus       667 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~-~~----------------~~~~~~~~~l~~~c  728 (797)
                       ....++..|+|||.+....++.++|+|++|+..+..+. +..++.. ..                ......+.+++.+|
T Consensus       157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  235 (256)
T cd05082         157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQC  235 (256)
T ss_pred             -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHH
Confidence             22345678999999988889999999999998755542 2222111 00                11234567889999


Q ss_pred             ccCCCCCCCChHHHHHhHHH
Q 040702          729 TDLSLGQFPASYSISKYLVY  748 (797)
Q Consensus       729 l~~dp~~RPs~~~i~~~l~~  748 (797)
                      +..+|++||++.++.+.|+.
T Consensus       236 l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         236 WHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             hcCChhhCcCHHHHHHHHhc
Confidence            99999999999999988765

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=1.3e-31  Score=291.91  Aligned_cols=182  Identities=20%  Similarity=0.249  Sum_probs=156.7

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      ...+|...+.||+|+||.||++     +..||+|+...      .....|+.++++++||||+++++++...+..++|||
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            4468999999999999999985     46899997432      334579999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      |+. |+|.+++......+++..+..|+.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++......  
T Consensus       138 ~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--  211 (357)
T PHA03209        138 HYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--  211 (357)
T ss_pred             ccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccCc--
Confidence            995 5898888766667899999999999999999999   9999999999999999999999999999997532211  


Q ss_pred             ccccccccCcccccccccccCccchHHHHHHHhhhhhhhh
Q 040702          665 LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIV  704 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~  704 (797)
                       ......||+.|+|||.+.+..++.++|+|++|+..++.+
T Consensus       212 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell  250 (357)
T PHA03209        212 -AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML  250 (357)
T ss_pred             -ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHH
Confidence             223457999999999999999999999999999875544

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.97  E-value=2.4e-31  Score=277.33  Aligned_cols=230  Identities=21%  Similarity=0.275  Sum_probs=182.1

Q ss_pred             ccccccCCcceeecc--------eEEEEEEEEecc-CCcchhHHHHHHHhhhccCCceeEeeeeee-cCCeEEEEEEccC
Q 040702          518 NLIGRGGFGPVYKDG--------MEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLIKIISSCS-NDDFKALVLEYMP  587 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~~--------~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~-~~~~~~lv~e~~~  587 (797)
                      +.||+|+||.||++.        ..||+|.+.... ....+.+.+|+.+++.++||||+++++++. .++..++||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999752        579999885432 223467888999999999999999999876 4556899999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc--c
Q 040702          588 LGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS--L  665 (797)
Q Consensus       588 ~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~--~  665 (797)
                      +|+|.+++.......++..+..++.|+++|++|||   ..+++||||||+||++++++.+||+|||+++........  .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            99999999776555778888899999999999999   899999999999999999999999999999865332111  1


Q ss_pred             cccccccCcccccccccccCccchHHHHHHHhhhhhhhhcc-ccccch-h----------------hhhhhcccccchhc
Q 040702          666 TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVD-ANLLIR-E----------------EKHLMTKEQPMVRM  727 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~-~~~~~~-~----------------~~~~~~~~~~l~~~  727 (797)
                      ......++..|+|||.+....++.++|+|++|+..++.+.. ..++.. .                +......+.+++..
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  237 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLS  237 (262)
T ss_pred             ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence            11233467789999999888899999999999987655442 221111 0                11123456788999


Q ss_pred             cccCCCCCCCChHHHHHhHHHHH
Q 040702          728 GTDLSLGQFPASYSISKYLVYIR  750 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~~l~~i~  750 (797)
                      |+..+|++||++.++++.++.+.
T Consensus       238 cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         238 CWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             HcCCChhhCCCHHHHHHHHHHHh
Confidence            99999999999999999888763

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.97  E-value=2.9e-31  Score=275.97  Aligned_cols=225  Identities=20%  Similarity=0.258  Sum_probs=181.6

Q ss_pred             cccccCCcceeec-------ceEEEEEEEEeccCC--cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccCCC
Q 040702          519 LIGRGGFGPVYKD-------GMEVAIKVFNLQYGG--AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLG  589 (797)
Q Consensus       519 ~lg~G~~g~Vyk~-------~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~g  589 (797)
                      .||+|+||.||++       +..||+|+++.....  ..+++.+|+.++++++||||+++++++.. +..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            5899999999974       478999998754322  34678899999999999999999998864 4678999999999


Q ss_pred             CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc-ccc
Q 040702          590 SLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL-TQT  668 (797)
Q Consensus       590 ~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~-~~~  668 (797)
                      +|.+++.... .+++..+.+++.|++.|++|+|   +++|+||||||+||+++.++.+||+|||+++......... ...
T Consensus        81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence            9999997654 4889999999999999999999   9999999999999999999999999999998664332211 112


Q ss_pred             ccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccch-----------------hhhhhhcccccchhcccc
Q 040702          669 QTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIR-----------------EEKHLMTKEQPMVRMGTD  730 (797)
Q Consensus       669 ~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~-----------------~~~~~~~~~~~l~~~cl~  730 (797)
                      ...++..|+|||.+..+.++.++|+|++|+..++.+. +..++..                 .+......++++++.|+.
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~  236 (257)
T cd05116         157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWT  236 (257)
T ss_pred             CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhc
Confidence            2345678999999988888999999999998765553 3322221                 111234467789999999


Q ss_pred             CCCCCCCChHHHHHhHHH
Q 040702          731 LSLGQFPASYSISKYLVY  748 (797)
Q Consensus       731 ~dp~~RPs~~~i~~~l~~  748 (797)
                      .||++||++.+|.+.|+.
T Consensus       237 ~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         237 YGVDERPGFAVVELRLRN  254 (257)
T ss_pred             cCchhCcCHHHHHHHHhc
Confidence            999999999999988764

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.97  E-value=9.6e-32  Score=289.48  Aligned_cols=217  Identities=23%  Similarity=0.227  Sum_probs=173.5

Q ss_pred             ccccccCCcceeec-----ceEEEEEEEEeccC---CcchhHHHHHH-HhhhccCCceeEeeeeeecCCeEEEEEEccCC
Q 040702          518 NLIGRGGFGPVYKD-----GMEVAIKVFNLQYG---GAFKSFDIECG-MMKRIRHRNLIKIISSCSNDDFKALVLEYMPL  588 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~---~~~~~~~~E~~-~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~  588 (797)
                      +.||+|+||.||++     ++.||||++.....   .....+..|.. +++.++||||+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46899999999974     67899999976521   22345555654 46778999999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccccc
Q 040702          589 GSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  668 (797)
Q Consensus       589 g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  668 (797)
                      |+|..++.... .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  ....
T Consensus        81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~  154 (325)
T cd05604          81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTTT  154 (325)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CCcc
Confidence            99998887654 4899999999999999999999   9999999999999999999999999999987532221  1234


Q ss_pred             ccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh----------------hhhcccccchhccccCC
Q 040702          669 QTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK----------------HLMTKEQPMVRMGTDLS  732 (797)
Q Consensus       669 ~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~l~~~cl~~d  732 (797)
                      ...||+.|||||.+.+..++.++|+|++|+..+..+.+..++.....                .......++++.|+..+
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~  234 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKD  234 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccC
Confidence            46799999999999999999999999999998666655444322111                11223446778888888


Q ss_pred             CCCCCChH
Q 040702          733 LGQFPASY  740 (797)
Q Consensus       733 p~~RPs~~  740 (797)
                      |.+||+++
T Consensus       235 p~~R~~~~  242 (325)
T cd05604         235 RQRRLGAK  242 (325)
T ss_pred             HHhcCCCC
Confidence            88888875

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.97  E-value=3.4e-31  Score=276.98  Aligned_cols=234  Identities=22%  Similarity=0.282  Sum_probs=191.8

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ++|+..+.||+|+||.||++     ++.||+|.++...   ....+.+.+|++++++++|+||+++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57899999999999999975     6889999987532   223467889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCc
Q 040702          584 EYMPLGSLEKCLYSG---NYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  660 (797)
Q Consensus       584 e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  660 (797)
                      ||+++|+|.+++...   ...+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999988642   235789999999999999999999   99999999999999999999999999999876532


Q ss_pred             cCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccch-------------------hh-hhhhcc
Q 040702          661 EDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIR-------------------EE-KHLMTK  720 (797)
Q Consensus       661 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~-------------------~~-~~~~~~  720 (797)
                      ...  ......|+..|+|||.+.+..++.++|+|++|+..+..+....++..                   .+ ......
T Consensus       159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08224         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEE  236 (267)
T ss_pred             CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHH
Confidence            221  12335688999999999888899999999999987544433222110                   00 022235


Q ss_pred             cccchhccccCCCCCCCChHHHHHhHHHHH
Q 040702          721 EQPMVRMGTDLSLGQFPASYSISKYLVYIR  750 (797)
Q Consensus       721 ~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~  750 (797)
                      +.+++..|+..+|++||++.++++.++.+.
T Consensus       237 ~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         237 LRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             HHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            678899999999999999999999988764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.97  E-value=1.2e-31  Score=295.87  Aligned_cols=186  Identities=23%  Similarity=0.232  Sum_probs=159.5

Q ss_pred             hcCCCccccccccCCcceeec-------ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-------GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ..+|...+.||+|+||.||++       +..||||.+...     +...+|++++++++||||+++++++...+..|+||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            357999999999999999974       367899987532     34568999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      |++. +++.+++... ..+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.......
T Consensus       166 e~~~-~~l~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~  240 (392)
T PHA03207        166 PKYK-CDLFTYVDRS-GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD  240 (392)
T ss_pred             hhcC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence            9996 6888888544 35899999999999999999999   99999999999999999999999999999986544333


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhcc
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVD  706 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~  706 (797)
                      ........||+.|+|||.+....++.++|+|++|+..++.+.+
T Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g  283 (392)
T PHA03207        241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVK  283 (392)
T ss_pred             cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHC
Confidence            2233456799999999999988999999999999988665543

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.97  E-value=1.5e-31  Score=298.57  Aligned_cols=224  Identities=24%  Similarity=0.295  Sum_probs=176.0

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecC--------C
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSND--------D  577 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~--------~  577 (797)
                      .++|...+.||+|+||.||++     ++.||||++....    ....+|+.+++.++||||+++++++...        .
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~  140 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI  140 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence            467999999999999999975     5789999885432    3455799999999999999999876432        2


Q ss_pred             eEEEEEEccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCC-cEEEEeec
Q 040702          578 FKALVLEYMPLGSLEKCLYS---GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM-VAHLSDFG  653 (797)
Q Consensus       578 ~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DFG  653 (797)
                      ..++||||+++ ++.+++..   ....+++..++.++.|++.||+|||   +++|+||||||+||+++.++ .+||+|||
T Consensus       141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence            46799999975 77776643   2336899999999999999999999   99999999999999999664 79999999


Q ss_pred             CCccCCccCccccccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccccccchhh------------------
Q 040702          654 MAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANLLIREE------------------  714 (797)
Q Consensus       654 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~~~~~~------------------  714 (797)
                      +|+......   ......||+.|||||.+.+. .++.++|+||+|++.++.+.+..++....                  
T Consensus       217 la~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~  293 (440)
T PTZ00036        217 SAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED  293 (440)
T ss_pred             cchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            998654322   22345789999999998764 68999999999998765554433322110                  


Q ss_pred             ---------------------------hhhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          715 ---------------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       715 ---------------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                                                 ........++++.|+..||.+||++.|+++.
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence                                       0012345688999999999999999998864

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.97  E-value=2.2e-31  Score=280.05  Aligned_cols=235  Identities=22%  Similarity=0.255  Sum_probs=186.2

Q ss_pred             HhcCCCccccccccCCcceeec----------ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCe
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD----------GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDF  578 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~----------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~  578 (797)
                      .+++|...+.||+|+||.||++          +..||+|.+..... .....+.+|+.++++++||||+++++++.+.+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            3567999999999999999974          24688998764432 234568999999999999999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCCC------CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCC---cEEE
Q 040702          579 KALVLEYMPLGSLEKCLYSGNY------ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM---VAHL  649 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~~~~------~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~---~~kl  649 (797)
                      .++||||+++|+|.+++.....      .+++..+.+++.||+.|++|||   +.+++||||||+||+++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEe
Confidence            9999999999999999876431      4889999999999999999999   89999999999999998654   5999


Q ss_pred             EeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh---------------
Q 040702          650 SDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE---------------  713 (797)
Q Consensus       650 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~---------------  713 (797)
                      +|||+++................+..|||||.+.++.++.++|+|++|+..+..+. +..++...               
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~  240 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL  240 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence            99999986532221111222334568999999998999999999999998755442 22221110               


Q ss_pred             --hhhhhcccccchhccccCCCCCCCChHHHHHhHH
Q 040702          714 --EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLV  747 (797)
Q Consensus       714 --~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~  747 (797)
                        +......+.++++.|++.+|++||++.++++.++
T Consensus       241 ~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence              1112235568899999999999999999998774

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.97  E-value=6e-32  Score=281.21  Aligned_cols=220  Identities=23%  Similarity=0.273  Sum_probs=179.0

Q ss_pred             ccccccCCcceeecc------------eEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          518 NLIGRGGFGPVYKDG------------MEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~~------------~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      +.||+|+||.||++.            ..||+|.+........+.+..|+.+++.++||||+++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            468999999999863            24888888655444456788999999999999999999999998999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCc--------EEEEeecCCcc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV--------AHLSDFGMAKP  657 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~--------~kl~DFGla~~  657 (797)
                      +++|+|.+++...+..+++..+..++.||+.|++|||   +++|+||||||+||+++.++.        ++++|||.+..
T Consensus        81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            9999999999876656899999999999999999999   999999999999999987765        69999999875


Q ss_pred             CCccCccccccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccc-cccchhhh---------------hhhcc
Q 040702          658 LLEEDQSLTQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDA-NLLIREEK---------------HLMTK  720 (797)
Q Consensus       658 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~-~~~~~~~~---------------~~~~~  720 (797)
                      ...      .....++..|+|||.+.+. .++.++|+|++|+..+..+.+. .+......               .....
T Consensus       158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (258)
T cd05078         158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAPKWTE  231 (258)
T ss_pred             cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHccccCCCCCcHH
Confidence            432      1234688899999999764 4789999999999876555542 22111100               11134


Q ss_pred             cccchhccccCCCCCCCChHHHHHhH
Q 040702          721 EQPMVRMGTDLSLGQFPASYSISKYL  746 (797)
Q Consensus       721 ~~~l~~~cl~~dp~~RPs~~~i~~~l  746 (797)
                      +.+++..|++.||++||+++++++.|
T Consensus       232 ~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         232 LANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             HHHHHHHHhccChhhCCCHHHHHHhc
Confidence            66889999999999999999998765

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=2.5e-31  Score=280.69  Aligned_cols=235  Identities=20%  Similarity=0.271  Sum_probs=190.4

Q ss_pred             cCCCccccccccCCcceeec---------ceEEEEEEEEeccCC-cchhHHHHHHHhhhccCCceeEeeeeeec--CCeE
Q 040702          512 NRFSENNLIGRGGFGPVYKD---------GMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCSN--DDFK  579 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~---------~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~Hpniv~l~~~~~~--~~~~  579 (797)
                      ++|+..+.||+|+||.||++         +..||||.+...... ..+.+.+|+++++.++||||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            46777899999999999975         468999999766443 35689999999999999999999999887  5578


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCC
Q 040702          580 ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  659 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  659 (797)
                      ++||||+++++|.+++......+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||.+....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            9999999999999999876656899999999999999999999   8999999999999999999999999999998765


Q ss_pred             ccCccc-cccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh-------------------------
Q 040702          660 EEDQSL-TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE-------------------------  713 (797)
Q Consensus       660 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~-------------------------  713 (797)
                      ...... ......++..|+|||.+.+..++.++|+|++|+..++.+....+....                         
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK  240 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence            332211 112234566799999998888999999999998875444322211110                         


Q ss_pred             -------hhhhhcccccchhccccCCCCCCCChHHHHHhHHHH
Q 040702          714 -------EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYI  749 (797)
Q Consensus       714 -------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i  749 (797)
                             +......+.+++.+|+..+|++||++.|+++.++.+
T Consensus       241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence                   001123566889999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.97  E-value=2.1e-31  Score=278.62  Aligned_cols=233  Identities=22%  Similarity=0.308  Sum_probs=191.1

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccC---CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG---GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ++|+..+.||+|+||.||++     +..||||.+.....   ...+++.+|+.+++.++||||+++++++..++..++||
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            46888899999999999974     58999998875432   22457889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCc
Q 040702          584 EYMPLGSLEKCLYS---GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  660 (797)
Q Consensus       584 e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  660 (797)
                      ||+++++|.+++..   ....+++..++.++.|++.|++|||   +.+++|+||||+||+++.++.++++|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999998863   2235899999999999999999999   99999999999999999999999999999876533


Q ss_pred             cCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh--------------------hhhhcc
Q 040702          661 EDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE--------------------KHLMTK  720 (797)
Q Consensus       661 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------------~~~~~~  720 (797)
                      ...  ......|+..|+|||.+.+..++.++|+|++|+..+..+.+..++....                    ......
T Consensus       159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08229         159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE  236 (267)
T ss_pred             CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHH
Confidence            221  2234568999999999988889999999999988755444332221100                    112235


Q ss_pred             cccchhccccCCCCCCCChHHHHHhHHHH
Q 040702          721 EQPMVRMGTDLSLGQFPASYSISKYLVYI  749 (797)
Q Consensus       721 ~~~l~~~cl~~dp~~RPs~~~i~~~l~~i  749 (797)
                      +.+++.+|+..||++||++.++.+.++++
T Consensus       237 ~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         237 LRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             HHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            77889999999999999999999988775

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.97  E-value=2.4e-31  Score=278.50  Aligned_cols=225  Identities=21%  Similarity=0.263  Sum_probs=172.9

Q ss_pred             ccccccCCcceeecc-------eEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccCCC
Q 040702          518 NLIGRGGFGPVYKDG-------MEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLG  589 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~~-------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~g  589 (797)
                      +.||+|+||.||+|.       ..+|+|.+..... .....+.+|+++++.++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            368999999999852       4688887754422 22456889999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          590 SLEKCLYSGNY----ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       590 ~L~~~l~~~~~----~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      +|.+++.....    ..++.....++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999876432    3467788899999999999999   9999999999999999999999999999987543322222


Q ss_pred             cccccccCccccccccccc-------CccchHHHHHHHhhhhhhhhc-cccccchh-hh---------------------
Q 040702          666 TQTQTLATIGYMAPDEIFS-------GEMRLKCWVNDSLLISVMIVV-DANLLIRE-EK---------------------  715 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-~~---------------------  715 (797)
                      ......++..|+|||.+..       ..++.++|+|++|+..++.+. +..++... +.                     
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDL  237 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccc
Confidence            2233456778999998643       356789999999998765554 22222111 10                     


Q ss_pred             hhhcccccchhccccCCCCCCCChHHHHHhH
Q 040702          716 HLMTKEQPMVRMGTDLSLGQFPASYSISKYL  746 (797)
Q Consensus       716 ~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l  746 (797)
                      .......++++.|+ .||++||+++++.+.+
T Consensus       238 ~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         238 KYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             cCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            11123345777788 5999999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-31  Score=261.82  Aligned_cols=272  Identities=20%  Similarity=0.253  Sum_probs=200.1

Q ss_pred             cCHHHHHHHhcCCCccccccccCCccee-----ecceEEEEEEEEeccCCcchhHHHHHHHhhhcc-CCceeEeeeeeec
Q 040702          502 FTYLELFQATNRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIR-HRNLIKIISSCSN  575 (797)
Q Consensus       502 ~~~~~l~~~~~~f~~~~~lg~G~~g~Vy-----k~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~  575 (797)
                      -++.++.+-|+     +.||+|+|+.|-     +++.+||||++.+.......++.+|++++..++ |+||+++++||++
T Consensus        73 g~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd  147 (463)
T KOG0607|consen   73 GKFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED  147 (463)
T ss_pred             chHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence            45778888776     799999999996     368999999999987777889999999999995 9999999999999


Q ss_pred             CCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCC---cEEEEee
Q 040702          576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM---VAHLSDF  652 (797)
Q Consensus       576 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~---~~kl~DF  652 (797)
                      +...|+|||-|.||.|..++.++.. +++.++.++..+|+.||.|||   .+||.|||+||+|||..+..   -+|||||
T Consensus       148 d~~FYLVfEKm~GGplLshI~~~~~-F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDf  223 (463)
T KOG0607|consen  148 DTRFYLVFEKMRGGPLLSHIQKRKH-FNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDF  223 (463)
T ss_pred             cceEEEEEecccCchHHHHHHHhhh-ccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeecc
Confidence            9999999999999999999988764 899999999999999999999   99999999999999997654   4899999


Q ss_pred             cCCccCCcc-----CccccccccccCcccccccccc-----cCccchHHHHHHHhhhhh-hhhccccccchhhhhhh---
Q 040702          653 GMAKPLLEE-----DQSLTQTQTLATIGYMAPDEIF-----SGEMRLKCWVNDSLLISV-MIVVDANLLIREEKHLM---  718 (797)
Q Consensus       653 Gla~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~dv~s~~~~~~-~~~~~~~~~~~~~~~~~---  718 (797)
                      .++.-+...     .......+.+|+..|||||++.     ...|+-.+|.||+|++.+ +....+++.+.+..+.-   
T Consensus       224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr  303 (463)
T KOG0607|consen  224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR  303 (463)
T ss_pred             ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence            998643211     1122335678999999999653     234889999999999984 44444555555443210   


Q ss_pred             --------cccccchhcc-ccCCCCCCCChHHHHHhHHHHHHHhccccccccccCCcccccceeeeeeeeecccch
Q 040702          719 --------TKEQPMVRMG-TDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYTISSSTF  785 (797)
Q Consensus       719 --------~~~~~l~~~c-l~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~  785 (797)
                              ..+.+-++.- ....-++.-.+.+.++.+  +..+ ..+...+...|..++.|||++++..|-++++.
T Consensus       304 Ge~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdl--isnL-lvrda~~rlsa~~vlnhPw~~~~~~ekalptp  376 (463)
T KOG0607|consen  304 GEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDL--ISNL-LVRDAKQRLSAAQVLNHPWVQRCAPEKALPTP  376 (463)
T ss_pred             CCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHH--HHHH-HhccHHhhhhhhhccCCccccccchhccCCCC
Confidence                    1111111111 111111111222222211  1222 22445556667889999999999888776653

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.97  E-value=2.5e-31  Score=290.48  Aligned_cols=226  Identities=21%  Similarity=0.247  Sum_probs=181.5

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEecc--CCcchhHHHHHHHhhhccCCceeEeeeeeecCC-----
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDD-----  577 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~-----  577 (797)
                      ..++|+..+.||+|+||.||++     +..||||.+....  ......+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            4578999999999999999974     6889999987542  223467889999999999999999999986543     


Q ss_pred             -eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCc
Q 040702          578 -FKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  656 (797)
Q Consensus       578 -~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  656 (797)
                       ..|+||||+++ ++.+.+..   .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~  171 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  171 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence             47999999975 66666543   3788889999999999999999   9999999999999999999999999999997


Q ss_pred             cCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh---------------------
Q 040702          657 PLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK---------------------  715 (797)
Q Consensus       657 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~---------------------  715 (797)
                      ......   ......||+.|+|||.+.+..++.++|+|++|+..+..+.+..++.....                     
T Consensus       172 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (359)
T cd07876         172 TACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR  248 (359)
T ss_pred             ccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence            543221   22345789999999999988999999999999987655544333221000                     


Q ss_pred             -------------------------------------hhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          716 -------------------------------------HLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       716 -------------------------------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                                                           .......+++..|+..||++|||+.|+++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                                                 001235688999999999999999999875

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=5.1e-31  Score=274.99  Aligned_cols=230  Identities=23%  Similarity=0.310  Sum_probs=188.0

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCC-----cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG-----AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~-----~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l  581 (797)
                      ++|+..+.||+|++|.||++     ++.||+|.++.....     ..+.+.+|++++++++||||+++++++..++..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57899999999999999974     588999998754321     23568889999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCcc
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  661 (797)
                      ||||+++++|.+++.... .+++..+..++.|++.|+.|||   +.+|+||||||+||+++.++.++|+|||+++.....
T Consensus        82 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~  157 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  157 (263)
T ss_pred             EEEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence            999999999999987654 4788899999999999999999   999999999999999999999999999999765322


Q ss_pred             Ccccc-ccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccch------------------hhhhhhcccc
Q 040702          662 DQSLT-QTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIR------------------EEKHLMTKEQ  722 (797)
Q Consensus       662 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~  722 (797)
                      ..... .....|+..|+|||.+.+..++.++|+|++|+..++.+.+..++..                  .+......+.
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (263)
T cd06625         158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDAR  237 (263)
T ss_pred             ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHH
Confidence            11111 1335688899999999988899999999999987555554333211                  1111233566


Q ss_pred             cchhccccCCCCCCCChHHHHHh
Q 040702          723 PMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       723 ~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                      ++++.|+..+|.+||++.++++.
T Consensus       238 ~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         238 NFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             HHHHHHhhcCcccCCCHHHHhhC
Confidence            88899999999999999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.97  E-value=2.1e-31  Score=278.59  Aligned_cols=228  Identities=25%  Similarity=0.292  Sum_probs=185.7

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      .++|...+.||+|+||.||++     ++.||+|.++.........+.+|+.+++.++||||+++++++...+..|+||||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            357888899999999999974     588999999866544456788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      +++++|.+++...+ .+++.++..++.|++.|+.|||   ..+++|+||||+||+++.++.+||+|||++......  ..
T Consensus        88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~--~~  161 (267)
T cd06645          88 CGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT--IA  161 (267)
T ss_pred             cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc--cc
Confidence            99999999987655 4899999999999999999999   899999999999999999999999999998755322  11


Q ss_pred             cccccccCcccccccccc---cCccchHHHHHHHhhhhhhhhcccccc-chhhh--------------------hhhccc
Q 040702          666 TQTQTLATIGYMAPDEIF---SGEMRLKCWVNDSLLISVMIVVDANLL-IREEK--------------------HLMTKE  721 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~---~~~~~~~~dv~s~~~~~~~~~~~~~~~-~~~~~--------------------~~~~~~  721 (797)
                      ......|+..|+|||.+.   .+.++.++|+|++|+..+.......++ ...+.                    .....+
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (267)
T cd06645         162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSF  241 (267)
T ss_pred             ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHH
Confidence            223457999999999874   456789999999999875544433221 11000                    011235


Q ss_pred             ccchhccccCCCCCCCChHHHHH
Q 040702          722 QPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       722 ~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      .+++++|+..+|++||++.++++
T Consensus       242 ~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         242 HHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             HHHHHHHccCCchhCcCHHHHhc
Confidence            57899999999999999988765

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.97  E-value=3e-31  Score=281.71  Aligned_cols=227  Identities=23%  Similarity=0.315  Sum_probs=189.3

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      .+|+..+.||+|+||.||++     +..||+|.+........+.+.+|+.+++.++||||+++++.+..++..|+||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            57888999999999999985     5789999998765555577889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccc
Q 040702          587 PLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  666 (797)
Q Consensus       587 ~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  666 (797)
                      ++++|.+++...  .+++.++..++.|++.|++|||   ..+|+||||||+||+++.++.+||+|||++........  .
T Consensus       100 ~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~  172 (296)
T cd06654         100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K  172 (296)
T ss_pred             CCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc--c
Confidence            999999998654  3788999999999999999999   99999999999999999999999999999876533221  1


Q ss_pred             ccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh-------------------hhhhhcccccchhc
Q 040702          667 QTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE-------------------EKHLMTKEQPMVRM  727 (797)
Q Consensus       667 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~l~~~  727 (797)
                      .....|++.|+|||.+.+..++.++|+|++|+..+..+.+..++...                   +......+.+++++
T Consensus       173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  252 (296)
T cd06654         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR  252 (296)
T ss_pred             cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHH
Confidence            23356899999999998888899999999999875555444332111                   11122346678889


Q ss_pred             cccCCCCCCCChHHHHHh
Q 040702          728 GTDLSLGQFPASYSISKY  745 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~~  745 (797)
                      |+..||++||++.++++.
T Consensus       253 ~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         253 CLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             HCcCCcccCcCHHHHhhC
Confidence            999999999999998873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.9e-32  Score=273.21  Aligned_cols=258  Identities=19%  Similarity=0.190  Sum_probs=209.0

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEec---cCCcchhHHHHHHHhhhc-cCCceeEeeeeeecCCeEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQ---YGGAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~l  581 (797)
                      ..+|....+||+|+||.|..+     .+.||||++++.   ..++.+--+.|-++|+-- +-|.++++..+|+..++.|+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            347888999999999999864     377999999876   233455566788888776 46899999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCcc
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  661 (797)
                      ||||+.||+|..+++.-++ +.+..+..+|.+||-||-+||   ++||+.||+|.+|||+|.+|++||+|||+++.-..+
T Consensus       428 VMEyvnGGDLMyhiQQ~Gk-FKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQVGK-FKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD  503 (683)
T ss_pred             EEEEecCchhhhHHHHhcc-cCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence            9999999999988887664 788899999999999999999   999999999999999999999999999999864333


Q ss_pred             CccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhhhhhcccccchhccccCCCCCCCCh-H
Q 040702          662 DQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEKHLMTKEQPMVRMGTDLSLGQFPAS-Y  740 (797)
Q Consensus       662 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPs~-~  740 (797)
                      +  .++.+++||+.|+|||.+...+|...+|+|++|+..++++.+.+++++...+      ++.+..++.+..---++ +
T Consensus       504 ~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~------elF~aI~ehnvsyPKslSk  575 (683)
T KOG0696|consen  504 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED------ELFQAIMEHNVSYPKSLSK  575 (683)
T ss_pred             C--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHHccCcCcccccH
Confidence            3  2567799999999999999999999999999999998888777776655443      23333333333222222 4


Q ss_pred             HHHHhHHH-HHHHhccccccccccCCcccccceeeeeeeee
Q 040702          741 SISKYLVY-IRELERGKVGITSVAAFPIVHHYLYRTVDYTI  780 (797)
Q Consensus       741 ~i~~~l~~-i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~  780 (797)
                      |.++...- +.+.+.-|.|-.+....++.+|+||+.||||-
T Consensus       576 EAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek  616 (683)
T KOG0696|consen  576 EAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEK  616 (683)
T ss_pred             HHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHH
Confidence            44444433 56678888898899999999999999999974

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.97  E-value=3.6e-31  Score=274.85  Aligned_cols=228  Identities=18%  Similarity=0.218  Sum_probs=186.9

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEecc-CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      +|+..+.||+|+||.||++     +..||+|.++... ....+.+.+|+.+++.++||||+++++++.+++..|+||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4788899999999999974     6889999987542 234567888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          587 PLGSLEKCLYSG-NYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       587 ~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      ++|++.+++... ...++...+..++.|++.|++|||   +.+|+|+||||+||++++++.++++|||.+........  
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--  155 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--  155 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc--
Confidence            999999988653 335788999999999999999999   99999999999999999999999999999976533221  


Q ss_pred             cccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh-----------------hhhhcccccchhcc
Q 040702          666 TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE-----------------KHLMTKEQPMVRMG  728 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~l~~~c  728 (797)
                      ......|++.|+|||.+.+..++.++|+|++|+..+..+.+..++....                 ......+.+++++|
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  235 (255)
T cd08219         156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM  235 (255)
T ss_pred             ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHH
Confidence            2234568999999999988889999999999998755444333322111                 11223456789999


Q ss_pred             ccCCCCCCCChHHHHHh
Q 040702          729 TDLSLGQFPASYSISKY  745 (797)
Q Consensus       729 l~~dp~~RPs~~~i~~~  745 (797)
                      ++.||++||++.+++..
T Consensus       236 l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         236 FKRNPRSRPSATTILSR  252 (255)
T ss_pred             HhCCcccCCCHHHHhhc
Confidence            99999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.97  E-value=3e-31  Score=279.55  Aligned_cols=239  Identities=17%  Similarity=0.253  Sum_probs=191.3

Q ss_pred             HhcCCCccccccccCCcceeec---------ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeec-CCe
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD---------GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSN-DDF  578 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~---------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~-~~~  578 (797)
                      ..++|...+.||+|+||.||++         +..||+|++..... ...+.+.+|+.++++++||||+++++++.. +..
T Consensus         4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP   83 (280)
T ss_pred             chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            3568889999999999999974         37789998864422 234668899999999999999999998766 467


Q ss_pred             EEEEEEccCCCCHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEe
Q 040702          579 KALVLEYMPLGSLEKCLYSGN-------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSD  651 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~~~-------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  651 (797)
                      .++++||+++|+|.+++....       ..+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECC
Confidence            899999999999999986532       34889999999999999999999   99999999999999999999999999


Q ss_pred             ecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccch-h----------------
Q 040702          652 FGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIR-E----------------  713 (797)
Q Consensus       652 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~-~----------------  713 (797)
                      ||+++.+.............++..|+|||.+....++.++|+|++|+..++.+. +..++.. .                
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~  240 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQ  240 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCC
Confidence            999986643332222223456778999999988889999999999988755443 2222111 0                


Q ss_pred             hhhhhcccccchhccccCCCCCCCChHHHHHhHHHHHH
Q 040702          714 EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRE  751 (797)
Q Consensus       714 ~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~  751 (797)
                      .......+.+++.+|+..||++||++.++++.|+.+.+
T Consensus       241 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         241 PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            01112356789999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.97  E-value=4e-31  Score=275.27  Aligned_cols=226  Identities=27%  Similarity=0.375  Sum_probs=188.4

Q ss_pred             ccccccCCcceeec--------ceEEEEEEEEeccCCc-chhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccCC
Q 040702          518 NLIGRGGFGPVYKD--------GMEVAIKVFNLQYGGA-FKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPL  588 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~--------~~~vAvK~~~~~~~~~-~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~  588 (797)
                      +.||+|+||.||++        +..||+|.++...... .+.+.+|++.++.++|+||+++++++...+..++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            46899999999974        5689999997664433 57889999999999999999999999999999999999999


Q ss_pred             CCHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCc
Q 040702          589 GSLEKCLYSG--------NYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  660 (797)
Q Consensus       589 g~L~~~l~~~--------~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  660 (797)
                      ++|.+++...        ...+++..+..++.|+++|++|||   +++++||||||+||+++.++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999876        346899999999999999999999   99999999999999999999999999999987654


Q ss_pred             cCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhcc-ccccch-----------------hhhhhhcccc
Q 040702          661 EDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVD-ANLLIR-----------------EEKHLMTKEQ  722 (797)
Q Consensus       661 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~-~~~~~~-----------------~~~~~~~~~~  722 (797)
                      ...........++..|+|||.+....++.++|+|++|+..+..+.. ..++..                 .+......+.
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY  237 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence            4322334455688899999999888899999999999987554432 222111                 1112234677


Q ss_pred             cchhccccCCCCCCCChHHHHHhH
Q 040702          723 PMVRMGTDLSLGQFPASYSISKYL  746 (797)
Q Consensus       723 ~l~~~cl~~dp~~RPs~~~i~~~l  746 (797)
                      ++++.|+..+|.+||++.|+++.+
T Consensus       238 ~li~~~l~~~p~~Rps~~~l~~~l  261 (262)
T cd00192         238 ELMLSCWQLDPEDRPTFSELVERL  261 (262)
T ss_pred             HHHHHHccCCcccCcCHHHHHHhh
Confidence            888999999999999999998876

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.97  E-value=3.4e-31  Score=275.09  Aligned_cols=227  Identities=21%  Similarity=0.229  Sum_probs=188.7

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEecc--CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      +|+..+.||+|+||.||++     ++.||+|.+....  ....+++.+|++++++++||||+++++++...+..|+||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4777899999999999985     5889999987542  23456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          586 MPLGSLEKCLYSG-NYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       586 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      +++++|.+++... ...+++..+..++.|++.|+.|||   ..+++|+||||+||+++.++.+||+|||+++....... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-  156 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-  156 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence            9999999999764 346889999999999999999999   99999999999999999999999999999986643322 


Q ss_pred             ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh-----------------hhhhcccccchhc
Q 040702          665 LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE-----------------KHLMTKEQPMVRM  727 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~l~~~  727 (797)
                       ......|++.|+|||.+.++.++.++|+|++|+..+..+.+..++....                 ......+.+++++
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  235 (256)
T cd08529         157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQ  235 (256)
T ss_pred             -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHH
Confidence             2234568899999999998889999999999998755554433322111                 1123356788999


Q ss_pred             cccCCCCCCCChHHHHH
Q 040702          728 GTDLSLGQFPASYSISK  744 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~  744 (797)
                      |++.+|++||++.++++
T Consensus       236 ~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         236 CLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             HccCCcccCcCHHHHhh
Confidence            99999999999998875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.97  E-value=2.5e-31  Score=283.33  Aligned_cols=237  Identities=24%  Similarity=0.290  Sum_probs=186.9

Q ss_pred             hcCCCccccccccCCcceeecc-------eEEEEEEEEecc-CCcchhHHHHHHHhhhc-cCCceeEeeeeeecCCeEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKDG-------MEVAIKVFNLQY-GGAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~~-------~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~l  581 (797)
                      .++|+..+.||+|+||.||++.       ..+|+|.++... ....+.+.+|++++.++ +||||+++++++..++..|+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            3678889999999999999862       346777765432 22345788899999999 89999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCc
Q 040702          582 VLEYMPLGSLEKCLYSGN---------------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV  646 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~  646 (797)
                      ||||+++|+|.+++....               ..+++.+++.++.|++.|++|||   +.+|+||||||+||+++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCc
Confidence            999999999999987532               24788999999999999999999   999999999999999999999


Q ss_pred             EEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-ccccc-ch------------
Q 040702          647 AHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLL-IR------------  712 (797)
Q Consensus       647 ~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~-~~------------  712 (797)
                      +||+|||+++....   ........++..|+|||.+....++.++|+|++|+..+..+. +..++ ..            
T Consensus       163 ~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~  239 (303)
T cd05088         163 AKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  239 (303)
T ss_pred             EEeCccccCcccch---hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC
Confidence            99999999874211   111122234678999999888888999999999998755542 22211 11            


Q ss_pred             ----hhhhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHHh
Q 040702          713 ----EEKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRELE  753 (797)
Q Consensus       713 ----~~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~  753 (797)
                          .+......+.+++..|++.+|++||++.+++..++.+....
T Consensus       240 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~  284 (303)
T cd05088         240 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  284 (303)
T ss_pred             CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence                00012235567899999999999999999999888775543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.8e-32  Score=284.56  Aligned_cols=235  Identities=22%  Similarity=0.332  Sum_probs=194.6

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      ...+.....+||-|.||+||.|     .-.||||.++.... ..++|..|+.+|+.++|||+|+++|+|..+..+|||+|
T Consensus       265 eRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE  343 (1157)
T KOG4278|consen  265 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE  343 (1157)
T ss_pred             cchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence            3345566689999999999976     36799999975542 46899999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          585 YMPLGSLEKCLYSGNY-ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      ||..|+|.+|+++..+ .++.-..+.++.||++|++||.   .+++|||||.+.|+|+.++..+|++|||+++.+.. ++
T Consensus       344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg-DT  419 (1157)
T KOG4278|consen  344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG-DT  419 (1157)
T ss_pred             cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcC-Cc
Confidence            9999999999988655 5666677889999999999999   99999999999999999999999999999998753 34


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhh------------------ccccccchhhhhhhcccccch
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIV------------------VDANLLIREEKHLMTKEQPMV  725 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~~l~  725 (797)
                      +....+..-...|.|||.+....++.++|||++|+..++..                  ....+....+....+.+.+++
T Consensus       420 YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLM  499 (1157)
T KOG4278|consen  420 YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELM  499 (1157)
T ss_pred             eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHH
Confidence            44444445567899999999999999999999998652211                  111122222333456788999


Q ss_pred             hccccCCCCCCCChHHHHHhHHHH
Q 040702          726 RMGTDLSLGQFPASYSISKYLVYI  749 (797)
Q Consensus       726 ~~cl~~dp~~RPs~~~i~~~l~~i  749 (797)
                      +.||+..|.+||+++|+.+.++.|
T Consensus       500 raCW~WsPsDRPsFaeiHqafEtm  523 (1157)
T KOG4278|consen  500 RACWNWSPSDRPSFAEIHQAFETM  523 (1157)
T ss_pred             HHHhcCCcccCccHHHHHHHHHHH
Confidence            999999999999999999988876

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.97  E-value=2.1e-31  Score=292.45  Aligned_cols=227  Identities=22%  Similarity=0.239  Sum_probs=181.6

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeecCC-----eEE
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSNDD-----FKA  580 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~-----~~~  580 (797)
                      +|+..+.||+|+||.||++     ++.||||.+.....  ...+.+.+|+++++.++||||+++++++..++     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4788899999999999974     58899999865422  23467889999999999999999999998776     789


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCc
Q 040702          581 LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  660 (797)
Q Consensus       581 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  660 (797)
                      +||||+. ++|.+.+.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        81 lv~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             EEeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            9999996 58888776544 4899999999999999999999   99999999999999999999999999999985432


Q ss_pred             cCccccccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccccccchhh-------------------------
Q 040702          661 EDQSLTQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANLLIREE-------------------------  714 (797)
Q Consensus       661 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-------------------------  714 (797)
                      .. ........+|+.|+|||.+.+. .++.++|+|++|+..++.+.+..++....                         
T Consensus       156 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  234 (372)
T cd07853         156 DE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE  234 (372)
T ss_pred             Cc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence            22 1122345689999999988764 47899999999998765554443321100                         


Q ss_pred             -----------------------hhhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          715 -----------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       715 -----------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                                             ........+++..|++.||++||++.|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                                   0012234578899999999999999998874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1e-31  Score=280.57  Aligned_cols=228  Identities=19%  Similarity=0.230  Sum_probs=192.1

Q ss_pred             cCCCccccccccCCcceeec----ceEEEEEEEEec--cCCcchhHHHHHHHhhhcc-CCceeEeeeeeecCCeEEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQ--YGGAFKSFDIECGMMKRIR-HRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      ..|++.++||+||.+.||+.    .+.||+|++...  +....+.|.+|+..|.+++ |.+||++++|-..++..|||||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE  440 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME  440 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence            56899999999999999983    477888876543  3334578999999999995 9999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      |-+. +|..+++.+....+...++.+..|++.|+.++|   .+||||.||||.|+|+- .|.+||+|||+|+.+..+.+.
T Consensus       441 ~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTs  515 (677)
T KOG0596|consen  441 CGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTS  515 (677)
T ss_pred             cccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeeechhcccCccccc
Confidence            8754 999999887764553378899999999999999   99999999999999986 469999999999998877776


Q ss_pred             ccccccccCcccccccccccC-----------ccchHHHHHHHhhhhhhhhccccccchhhhhhh---------------
Q 040702          665 LTQTQTLATIGYMAPDEIFSG-----------EMRLKCWVNDSLLISVMIVVDANLLIREEKHLM---------------  718 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~~~~---------------  718 (797)
                      ......+||+.||+||.+...           ..+.++||||+|++.|.++.+..+++.+...+.               
T Consensus       516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp  595 (677)
T KOG0596|consen  516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFP  595 (677)
T ss_pred             eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccccc
Confidence            666778999999999977532           256899999999999888888888777663211               


Q ss_pred             ----c-ccccchhccccCCCCCCCChHHHHH
Q 040702          719 ----T-KEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       719 ----~-~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                          . .+.++++.|++.||.+||++.++++
T Consensus       596 ~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  596 DIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             CCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence                1 2678888999999999999998876

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.97  E-value=4.2e-31  Score=279.62  Aligned_cols=225  Identities=22%  Similarity=0.285  Sum_probs=177.2

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEeccCC--cchhHHHHHHHhhhc---cCCceeEeeeeeec-----CC
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG--AFKSFDIECGMMKRI---RHRNLIKIISSCSN-----DD  577 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l---~Hpniv~l~~~~~~-----~~  577 (797)
                      +|+..+.||+|+||.||++     ++.||+|.++.....  ....+.+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4888899999999999985     578999998765322  234566788877766   69999999998864     24


Q ss_pred             eEEEEEEccCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCc
Q 040702          578 FKALVLEYMPLGSLEKCLYSGNY-ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  656 (797)
Q Consensus       578 ~~~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  656 (797)
                      ..++||||+++ ++.+++..... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            58999999974 89888865432 4899999999999999999999   9999999999999999999999999999998


Q ss_pred             cCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh----------------------
Q 040702          657 PLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE----------------------  714 (797)
Q Consensus       657 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------------  714 (797)
                      ......   ......||..|+|||.+.+..++.++|+|++|+..+..+....++....                      
T Consensus       157 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07863         157 IYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  233 (288)
T ss_pred             cccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            653221   2234568999999999998899999999999998755544333221100                      


Q ss_pred             ---------------------hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          715 ---------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       715 ---------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                           ........+++..|++.||++||++.|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                                 011223457889999999999999888764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.97  E-value=4.2e-31  Score=278.77  Aligned_cols=227  Identities=19%  Similarity=0.232  Sum_probs=183.7

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccC
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  587 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~  587 (797)
                      .|+..+.||+|+||.||++     +..+|+|.+........+.+.+|+++++.++||||+++++++..++..|+||||++
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            3577789999999999985     57889999876544445678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccccc
Q 040702          588 LGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ  667 (797)
Q Consensus       588 ~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  667 (797)
                      +|++..++......+++..+..++.|+++||.|||   +.+++||||||+||+++.++.+||+|||++.......  ...
T Consensus        86 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~~~  160 (282)
T cd06643          86 GGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--QRR  160 (282)
T ss_pred             CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccc--ccc
Confidence            99999988765556899999999999999999999   9999999999999999999999999999987543221  122


Q ss_pred             cccccCcccccccccc-----cCccchHHHHHHHhhhhhhhhccccccchh-------------------hhhhhccccc
Q 040702          668 TQTLATIGYMAPDEIF-----SGEMRLKCWVNDSLLISVMIVVDANLLIRE-------------------EKHLMTKEQP  723 (797)
Q Consensus       668 ~~~~gt~~y~aPE~~~-----~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~  723 (797)
                      ....|+..|+|||.+.     ...++.++|+|++|+..+..+....++...                   +......+.+
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (282)
T cd06643         161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKD  240 (282)
T ss_pred             ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHH
Confidence            3456899999999874     345778999999998875544433332211                   0112235778


Q ss_pred             chhccccCCCCCCCChHHHHH
Q 040702          724 MVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       724 l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      +++.|++.||.+||++.++++
T Consensus       241 li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         241 FLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             HHHHHccCChhhCcCHHHHhc
Confidence            899999999999999877654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.97  E-value=4.6e-31  Score=276.27  Aligned_cols=232  Identities=22%  Similarity=0.283  Sum_probs=186.3

Q ss_pred             HHHhcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          508 FQATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       508 ~~~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      ..+++.+.....||+|+||.||++     +..||+|.+........+.+.+|++++++++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   83 (268)
T cd06624           4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF   83 (268)
T ss_pred             ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence            446677777789999999999986     467999998766554557889999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcC-CCcEEEEeecCCccCC
Q 040702          583 LEYMPLGSLEKCLYSGNYIL--DIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD-NMVAHLSDFGMAKPLL  659 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l--~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl~DFGla~~~~  659 (797)
                      |||+++++|.+++......+  ++..+..++.|++.|++|||   +.+|+||||||+||+++. ++.+||+|||.+....
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            99999999999997653334  78888899999999999999   999999999999999986 6799999999987653


Q ss_pred             ccCccccccccccCcccccccccccCc--cchHHHHHHHhhhhhhhhccccccchh-------------------hhhhh
Q 040702          660 EEDQSLTQTQTLATIGYMAPDEIFSGE--MRLKCWVNDSLLISVMIVVDANLLIRE-------------------EKHLM  718 (797)
Q Consensus       660 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~dv~s~~~~~~~~~~~~~~~~~~-------------------~~~~~  718 (797)
                      ....  ......|++.|+|||.+..+.  ++.++|+|++|+..+..+....++...                   +....
T Consensus       161 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (268)
T cd06624         161 GINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLS  238 (268)
T ss_pred             cCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccC
Confidence            2221  223345889999999986644  788999999998875554433332110                   11122


Q ss_pred             cccccchhccccCCCCCCCChHHHHH
Q 040702          719 TKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       719 ~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      ..+.+++++|++.+|++||++.|+++
T Consensus       239 ~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         239 AEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             HHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            34567899999999999999988875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=5.2e-31  Score=274.00  Aligned_cols=227  Identities=24%  Similarity=0.272  Sum_probs=183.2

Q ss_pred             ccccccCCcceeecc--------eEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccCC
Q 040702          518 NLIGRGGFGPVYKDG--------MEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPL  588 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~~--------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~  588 (797)
                      +.||+|+||.||++.        ..||+|.++.... ...+++.+|+.+++++.||||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            469999999999752        6899999875543 23467889999999999999999999876 4467999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc-cc
Q 040702          589 GSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL-TQ  667 (797)
Q Consensus       589 g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~-~~  667 (797)
                      |+|.+++.... .+++..+..++.|++.|++|||   ..+++||||||+||+++.++.+||+|||+++......... ..
T Consensus        80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~  155 (257)
T cd05060          80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT  155 (257)
T ss_pred             CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence            99999998765 4899999999999999999999   8999999999999999999999999999998664332211 11


Q ss_pred             cccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccch-h----------------hhhhhcccccchhccc
Q 040702          668 TQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIR-E----------------EKHLMTKEQPMVRMGT  729 (797)
Q Consensus       668 ~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~-~----------------~~~~~~~~~~l~~~cl  729 (797)
                      ....++..|+|||.+....++.++|+|++|+..+..+. ...++.. .                +......+.+++.+|+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  235 (257)
T cd05060         156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCW  235 (257)
T ss_pred             cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHh
Confidence            22234568999999988889999999999998865553 2322211 1                1112345678999999


Q ss_pred             cCCCCCCCChHHHHHhHHHH
Q 040702          730 DLSLGQFPASYSISKYLVYI  749 (797)
Q Consensus       730 ~~dp~~RPs~~~i~~~l~~i  749 (797)
                      ..+|++||++.++.+.++.+
T Consensus       236 ~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         236 KYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             cCChhhCcCHHHHHHHHHhc
Confidence            99999999999999988765

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.5e-31  Score=280.13  Aligned_cols=230  Identities=19%  Similarity=0.236  Sum_probs=189.3

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      .++|++.+.||+|+||.||++     +..||+|+++.......+.+..|++++++++||||+++++++..++..|+||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            457899999999999999985     578999999866554557888999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      +++++|.+++......+++..+..++.|++.|+.|||   +.+|+|+||||+||+++.++.++|+|||++.......  .
T Consensus        84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~--~  158 (280)
T cd06611          84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--Q  158 (280)
T ss_pred             cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcccc--c
Confidence            9999999998776556899999999999999999999   9999999999999999999999999999987543221  1


Q ss_pred             cccccccCcccccccccc-----cCccchHHHHHHHhhhhhhhhccccccchhh-------------------hhhhccc
Q 040702          666 TQTQTLATIGYMAPDEIF-----SGEMRLKCWVNDSLLISVMIVVDANLLIREE-------------------KHLMTKE  721 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~  721 (797)
                      ......|++.|+|||.+.     ...++.++|+|++|+..+..+.+..++....                   ......+
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (280)
T cd06611         159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSF  238 (280)
T ss_pred             ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHH
Confidence            223456899999999875     3346789999999998755555444332211                   1122356


Q ss_pred             ccchhccccCCCCCCCChHHHHHh
Q 040702          722 QPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       722 ~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                      .++++.|+..+|.+||++.++++.
T Consensus       239 ~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         239 NDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             HHHHHHHhccChhhCcCHHHHhcC
Confidence            678899999999999999888653

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.97  E-value=6.3e-31  Score=272.13  Aligned_cols=226  Identities=23%  Similarity=0.276  Sum_probs=181.9

Q ss_pred             ccccccCCcceeec----ceEEEEEEEEeccCC-cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccCCCCHH
Q 040702          518 NLIGRGGFGPVYKD----GMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLE  592 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~g~L~  592 (797)
                      +.||+|+||.||++    +..||+|.+...... ....+.+|++++++++||||+++++++...+..++||||+++|+|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            46899999999985    578999988755322 2346889999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccccccccc
Q 040702          593 KCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA  672 (797)
Q Consensus       593 ~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g  672 (797)
                      +++......+++..+..++.|++.|+.|+|   +++++||||||+||+++.++.+|++|||++........ .......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~  156 (250)
T cd05085          81 SFLRKKKDELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGLKQI  156 (250)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceecccccc-ccCCCCCC
Confidence            998765556889999999999999999999   99999999999999999999999999999875432211 11122344


Q ss_pred             CcccccccccccCccchHHHHHHHhhhhhhhhc-cccccch-----------------hhhhhhcccccchhccccCCCC
Q 040702          673 TIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIR-----------------EEKHLMTKEQPMVRMGTDLSLG  734 (797)
Q Consensus       673 t~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~-----------------~~~~~~~~~~~l~~~cl~~dp~  734 (797)
                      +..|+|||.+..+.++.++|+|++|+..+..+. +..++..                 .+......+.+++..|+..+|+
T Consensus       157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  236 (250)
T cd05085         157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPE  236 (250)
T ss_pred             cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcc
Confidence            678999999988889999999999988754443 2211111                 1112334667889999999999


Q ss_pred             CCCChHHHHHhHH
Q 040702          735 QFPASYSISKYLV  747 (797)
Q Consensus       735 ~RPs~~~i~~~l~  747 (797)
                      +||++.++.+.+.
T Consensus       237 ~Rp~~~~l~~~l~  249 (250)
T cd05085         237 NRPKFSELQKELA  249 (250)
T ss_pred             cCCCHHHHHHHhc
Confidence            9999999988763

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.97  E-value=8.2e-31  Score=273.03  Aligned_cols=231  Identities=23%  Similarity=0.339  Sum_probs=186.1

Q ss_pred             cCCCccccccccCCcceeec----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccC
Q 040702          512 NRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  587 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~  587 (797)
                      ++|...+.||+|+||.||++    +..||+|.+..... ..+.+.+|++++++++|||++++++++. .+..++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            56888899999999999975    35799998865432 3467889999999999999999999875 456889999999


Q ss_pred             CCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccc
Q 040702          588 LGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  666 (797)
Q Consensus       588 ~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  666 (797)
                      +|+|.+++.... ..+++..+..++.|++.|++|||   +.+++||||||+||++++++.+||+|||+++....... ..
T Consensus        84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~-~~  159 (260)
T cd05069          84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY-TA  159 (260)
T ss_pred             CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-cc
Confidence            999999997643 35789999999999999999999   99999999999999999999999999999976532221 12


Q ss_pred             ccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-----------------hhhhhcccccchhcc
Q 040702          667 QTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-----------------EKHLMTKEQPMVRMG  728 (797)
Q Consensus       667 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-----------------~~~~~~~~~~l~~~c  728 (797)
                      .....++..|+|||.+.++.++.++|+|++|+..++.+. +..++...                 +......+.+++++|
T Consensus       160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  239 (260)
T cd05069         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLC  239 (260)
T ss_pred             cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHH
Confidence            223346778999999988889999999999998766554 22222111                 111234567889999


Q ss_pred             ccCCCCCCCChHHHHHhHHH
Q 040702          729 TDLSLGQFPASYSISKYLVY  748 (797)
Q Consensus       729 l~~dp~~RPs~~~i~~~l~~  748 (797)
                      +..||++||++.++.+.+++
T Consensus       240 l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         240 WKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ccCCcccCcCHHHHHHHHhc
Confidence            99999999999999998864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.97  E-value=5.1e-31  Score=280.09  Aligned_cols=227  Identities=23%  Similarity=0.317  Sum_probs=188.6

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      .++|...+.||+|+||.||++     ++.||+|.+........+.+.+|+.+++.++||||+++++++..++..|+||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            368999999999999999974     588999999766555556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      +++++|.+++...  .+++.++..++.|++.|+.|||   +.+++||||||+||+++.++.++|+|||++........  
T Consensus        98 ~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~--  170 (297)
T cd06656          98 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  170 (297)
T ss_pred             cCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc--
Confidence            9999999998654  3788899999999999999999   99999999999999999999999999999876533221  


Q ss_pred             cccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh-------------------hhhhhcccccchh
Q 040702          666 TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE-------------------EKHLMTKEQPMVR  726 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~l~~  726 (797)
                      ......|++.|+|||.+.+..++.++|+|++|+..+..+.+..++...                   +......+.+++.
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  250 (297)
T cd06656         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLN  250 (297)
T ss_pred             CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHH
Confidence            123356889999999998888899999999998875544443332111                   1112234567889


Q ss_pred             ccccCCCCCCCChHHHHH
Q 040702          727 MGTDLSLGQFPASYSISK  744 (797)
Q Consensus       727 ~cl~~dp~~RPs~~~i~~  744 (797)
                      +|+..+|++||++.++++
T Consensus       251 ~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         251 RCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             HHccCChhhCcCHHHHhc
Confidence            999999999999988876

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.97  E-value=5.3e-31  Score=275.94  Aligned_cols=226  Identities=22%  Similarity=0.279  Sum_probs=174.8

Q ss_pred             ccccccCCcceeecc-------eEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccCCC
Q 040702          518 NLIGRGGFGPVYKDG-------MEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLG  589 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~~-------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~g  589 (797)
                      +.||+|+||.||++.       ..+|+|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999852       5689998875542 22357888999999999999999999999989999999999999


Q ss_pred             CHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          590 SLEKCLYSGN----YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       590 ~L~~~l~~~~----~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      +|.+++....    ...++..+..++.|++.|++|||   +.+++||||||+||+++.++.+|++|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999986532    14567778899999999999999   9999999999999999999999999999997544332222


Q ss_pred             cccccccCcccccccccccC-------ccchHHHHHHHhhhhhhhhc-cccccchh-hhh--------------------
Q 040702          666 TQTQTLATIGYMAPDEIFSG-------EMRLKCWVNDSLLISVMIVV-DANLLIRE-EKH--------------------  716 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-~~~--------------------  716 (797)
                      ......|+..|+|||.+...       .++.++|+|++|+..++.+. +..++... ..+                    
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKL  237 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCC
Confidence            22345678899999987532       35779999999998755442 33222111 000                    


Q ss_pred             -hhcccccchhccccCCCCCCCChHHHHHhHH
Q 040702          717 -LMTKEQPMVRMGTDLSLGQFPASYSISKYLV  747 (797)
Q Consensus       717 -~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~  747 (797)
                       ......++++.|+ .+|++||++.++...|+
T Consensus       238 ~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         238 PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence             1123345788898 68999999999997764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.97  E-value=5.9e-31  Score=279.41  Aligned_cols=227  Identities=24%  Similarity=0.325  Sum_probs=189.8

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      .+|+..+.||.|+||.||++     ++.||+|.+........+.+.+|+.+++.++||||+++++++...+..|+||||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            46899999999999999974     5889999997665555678889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccc
Q 040702          587 PLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  666 (797)
Q Consensus       587 ~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  666 (797)
                      ++++|.+++...  .+++.++..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||++........  .
T Consensus        99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~  171 (296)
T cd06655          99 AGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--K  171 (296)
T ss_pred             CCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc--c
Confidence            999999988754  3799999999999999999999   99999999999999999999999999999876533221  1


Q ss_pred             ccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh-------------------hhhhhcccccchhc
Q 040702          667 QTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE-------------------EKHLMTKEQPMVRM  727 (797)
Q Consensus       667 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~l~~~  727 (797)
                      .....|+..|+|||.+.+..++.++|+|++|+..+..+.+..++...                   +......+.+++++
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  251 (296)
T cd06655         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNR  251 (296)
T ss_pred             CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHH
Confidence            23346889999999998888999999999999876555544432211                   11122346678899


Q ss_pred             cccCCCCCCCChHHHHHh
Q 040702          728 GTDLSLGQFPASYSISKY  745 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~~  745 (797)
                      |+..||.+||++.+++..
T Consensus       252 ~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         252 CLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             HhhcChhhCCCHHHHhhC
Confidence            999999999999988763

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.5e-31  Score=269.53  Aligned_cols=236  Identities=23%  Similarity=0.310  Sum_probs=182.5

Q ss_pred             cCCCccccccccCCcceeec---ceEEEEEEEEeccCCcchhHHHHHHHhhhc--cCCceeEeeeeeecCC----eEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD---GMEVAIKVFNLQYGGAFKSFDIECGMMKRI--RHRNLIKIISSCSNDD----FKALV  582 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~---~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l--~Hpniv~l~~~~~~~~----~~~lv  582 (797)
                      +.....+.||+|.||+||+|   |+.||||++...+   .+.+.+|.++.+..  +|+||..+++.-..+.    +.|+|
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv  287 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV  287 (513)
T ss_pred             heeEEEEEecCccccceeeccccCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence            45677899999999999997   7999999997554   36788888888764  9999999998865433    68999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHc-----cCCCCeEEcCCCCCceEEcCCCcEEEEeecCCcc
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHF-----GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  657 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~-----~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  657 (797)
                      ++|.+.|+|++++...  .++.....+++.-+|.||++||.     ..++.|.|||||+.|||+..++.+.|+|+|+|-.
T Consensus       288 TdYHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~  365 (513)
T KOG2052|consen  288 TDYHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  365 (513)
T ss_pred             eecccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEE
Confidence            9999999999999875  48999999999999999999993     2467899999999999999999999999999976


Q ss_pred             CCccCc--cccccccccCcccccccccccCc----c--chHHHHHHHhhhhhhh-------------------hc--ccc
Q 040702          658 LLEEDQ--SLTQTQTLATIGYMAPDEIFSGE----M--RLKCWVNDSLLISVMI-------------------VV--DAN  708 (797)
Q Consensus       658 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~----~--~~~~dv~s~~~~~~~~-------------------~~--~~~  708 (797)
                      ...+..  .......+||.+|||||++.+.-    +  -.-+|||++|...++.                   ++  ||.
T Consensus       366 h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs  445 (513)
T KOG2052|consen  366 HDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS  445 (513)
T ss_pred             ecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC
Confidence            544322  23456789999999999875321    1  2457999999653211                   11  111


Q ss_pred             ccch-----------------hhhhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          709 LLIR-----------------EEKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       709 ~~~~-----------------~~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                      +...                 .....+..+.++++.||..+|..|-|+-.+-+.+.++.+.
T Consensus       446 ~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~  506 (513)
T KOG2052|consen  446 FEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS  506 (513)
T ss_pred             HHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence            1000                 0112344667788889999999999998888888777653

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.97  E-value=6.2e-31  Score=280.22  Aligned_cols=227  Identities=20%  Similarity=0.287  Sum_probs=182.7

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      ++|...+.||+|+||.||++     +..||+|.++.... .....+.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            57899999999999999975     57899999975532 2345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      ++ ++|.+++......+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||++........  
T Consensus        86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--  159 (301)
T cd07873          86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--  159 (301)
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--
Confidence            97 5999988776556889999999999999999999   99999999999999999999999999999975432211  


Q ss_pred             cccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccccccchhh------------------------------
Q 040702          666 TQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANLLIREE------------------------------  714 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~~~~~~------------------------------  714 (797)
                      ......+++.|+|||.+.+. .++.++|+|++|+..+..+.+..++....                              
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (301)
T cd07873         160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  239 (301)
T ss_pred             cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence            22334678999999988654 47889999999998755554433321100                              


Q ss_pred             ----------------hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          715 ----------------KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       715 ----------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                      .......+++++.|+..||.+|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                            001223457888999999999999887765

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.97  E-value=4.2e-31  Score=277.18  Aligned_cols=230  Identities=25%  Similarity=0.295  Sum_probs=185.3

Q ss_pred             HHhcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhc-cCCceeEeeeeeecC------
Q 040702          509 QATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRI-RHRNLIKIISSCSND------  576 (797)
Q Consensus       509 ~~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~------  576 (797)
                      .+++.|+..+.||+|+||.||++     ++.||+|++.... .....+..|+.+++++ +||||+++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            46778999999999999999985     5789999987553 2346788999999998 699999999998753      


Q ss_pred             CeEEEEEEccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCC
Q 040702          577 DFKALVLEYMPLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMA  655 (797)
Q Consensus       577 ~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla  655 (797)
                      ...|+||||+++|+|.+++.... ..+++..+..++.|++.|++|||   +++|+|||+||+||++++++.+||+|||++
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~  158 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS  158 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCc
Confidence            46899999999999999987643 35889999999999999999999   899999999999999999999999999999


Q ss_pred             ccCCccCccccccccccCcccccccccc-----cCccchHHHHHHHhhhhhhhhccccccchhh----------------
Q 040702          656 KPLLEEDQSLTQTQTLATIGYMAPDEIF-----SGEMRLKCWVNDSLLISVMIVVDANLLIREE----------------  714 (797)
Q Consensus       656 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------  714 (797)
                      +......  .......|+..|+|||.+.     ...++.++|+|++|+..++.+....++....                
T Consensus       159 ~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  236 (272)
T cd06637         159 AQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL  236 (272)
T ss_pred             eeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCC
Confidence            7543211  1234457899999999886     3457889999999998755554443322110                


Q ss_pred             --hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          715 --KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       715 --~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                        ......+.++++.|+..||.+||++.++++
T Consensus       237 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         237 KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence              012235678889999999999999988865

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.97  E-value=6.1e-31  Score=281.08  Aligned_cols=226  Identities=20%  Similarity=0.237  Sum_probs=184.8

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCC-cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      ++|+..+.||+|+||.||++     +..||+|.+...... ...++.+|++++++++||||+++++++..++..|+||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36889999999999999974     578999988754322 235688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS-VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~-~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      +++++|.+++.... .+++..+..++.|+++||.|||   + .+++||||||+||+++.++.+||+|||++......   
T Consensus        81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---  153 (308)
T cd06615          81 MDGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  153 (308)
T ss_pred             cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence            99999999997654 4889999999999999999999   6 58999999999999999999999999998755322   


Q ss_pred             ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh------------------------------
Q 040702          665 LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE------------------------------  714 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~------------------------------  714 (797)
                       ......|+..|+|||.+.+..++.++|+|++|+..+..+.+..++....                              
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (308)
T cd06615         154 -MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD  232 (308)
T ss_pred             -ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCC
Confidence             1234578999999999888788999999999988755554432211000                              


Q ss_pred             ------------------------hhhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          715 ------------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       715 ------------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                                              ......+.+++.+|+..+|++||++.++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             ccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                                    0011235688999999999999998888765

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.97  E-value=6.8e-31  Score=276.66  Aligned_cols=222  Identities=21%  Similarity=0.251  Sum_probs=182.1

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEecc-CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      ++|+..+.||+|+||.||++     +..||+|.+.... ....+++.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            36788899999999999985     5889999987553 22345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      +++|++..+.     .+++..+..++.|++.|++|||   +.+|+|+||||+||+++.++.+||+|||++......    
T Consensus        81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~----  148 (279)
T cd06619          81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----  148 (279)
T ss_pred             CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----
Confidence            9999997542     3678888999999999999999   999999999999999999999999999999865322    


Q ss_pred             cccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh-------------------------hhhhcc
Q 040702          666 TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE-------------------------KHLMTK  720 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~  720 (797)
                      ......||..|+|||.+.+..++.++|+|++|+..+..+.+..++....                         ......
T Consensus       149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (279)
T cd06619         149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEK  228 (279)
T ss_pred             cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHH
Confidence            2234579999999999998889999999999988755544333321100                         011224


Q ss_pred             cccchhccccCCCCCCCChHHHHHh
Q 040702          721 EQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       721 ~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                      +.+++..|++.+|++||++.++++.
T Consensus       229 ~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         229 FVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             HHHHHHHHhhCChhhCCCHHHHhcC
Confidence            5678889999999999999888764

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.97  E-value=3.1e-31  Score=289.37  Aligned_cols=227  Identities=22%  Similarity=0.238  Sum_probs=181.1

Q ss_pred             HHhcCCCccccccccCCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeecC-----
Q 040702          509 QATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSND-----  576 (797)
Q Consensus       509 ~~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~-----  576 (797)
                      ...++|...+.||+|+||.||++     ++.||||.+.....  ...+.+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            34579999999999999999974     58899999875432  2345778899999999999999999988643     


Q ss_pred             -CeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCC
Q 040702          577 -DFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMA  655 (797)
Q Consensus       577 -~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla  655 (797)
                       ...|+||||+++ ++.+.+..   .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~  166 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence             357999999975 67666643   3788899999999999999999   999999999999999999999999999999


Q ss_pred             ccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh---------------------
Q 040702          656 KPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE---------------------  714 (797)
Q Consensus       656 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~---------------------  714 (797)
                      +.....   .......||+.|+|||.+.+..++.++|+|++|+..+..+.+..++....                     
T Consensus       167 ~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (355)
T cd07874         167 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  243 (355)
T ss_pred             ccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            864322   12344578999999999988889999999999998755544332221100                     


Q ss_pred             -------------------------------------hhhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          715 -------------------------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       715 -------------------------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                                                           ......+.+++..|+..||++|||+.|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                                                 0001234678999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.97  E-value=4.5e-31  Score=277.39  Aligned_cols=232  Identities=17%  Similarity=0.274  Sum_probs=188.3

Q ss_pred             cCCCccccccccCCcceeecc----------eEEEEEEEEeccCC-cchhHHHHHHHhhhccCCceeEeeeeeecCCeEE
Q 040702          512 NRFSENNLIGRGGFGPVYKDG----------MEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKA  580 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~~----------~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~  580 (797)
                      ++|+..+.||+|+||.||++.          ..||+|.+...... ..+.+.+|++++++++||||+++++++.+.+..|
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            678899999999999999742          57999988655433 3467999999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEee
Q 040702          581 LVLEYMPLGSLEKCLYSGN--------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDF  652 (797)
Q Consensus       581 lv~e~~~~g~L~~~l~~~~--------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF  652 (797)
                      +||||+++|+|.+++....        ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++++||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999987544        14899999999999999999999   999999999999999999999999999


Q ss_pred             cCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccch------------------h
Q 040702          653 GMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIR------------------E  713 (797)
Q Consensus       653 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~------------------~  713 (797)
                      |+++...... ........++..|+|||.+.+...+.++|+|++|+..+..+. ...++..                  .
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  240 (275)
T cd05046         162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV  240 (275)
T ss_pred             ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCC
Confidence            9987543221 222334467788999999988888999999999988754443 1111110                  0


Q ss_pred             hhhhhcccccchhccccCCCCCCCChHHHHHhHH
Q 040702          714 EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLV  747 (797)
Q Consensus       714 ~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~  747 (797)
                      +......+.+++.+|+..+|.+||++.++++.++
T Consensus       241 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            1112235678999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=8e-31  Score=273.35  Aligned_cols=229  Identities=24%  Similarity=0.300  Sum_probs=190.1

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      .++|+..+.+|+|+||.||++     ++.+|+|.+........+.+.+|++++++++||||+++++++...+..|++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            367889999999999999975     478999999876555567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      +++++|.+++......+++..+..++.|++.|++|||   ..+|+|+||||+||+++.++.+||+|||.+.......  .
T Consensus        82 ~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~  156 (262)
T cd06613          82 CGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI--A  156 (262)
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhh--h
Confidence            9999999998776456899999999999999999999   9999999999999999999999999999997653221  1


Q ss_pred             cccccccCcccccccccccC---ccchHHHHHHHhhhhhhhhccccccchh---------------------hhhhhccc
Q 040702          666 TQTQTLATIGYMAPDEIFSG---EMRLKCWVNDSLLISVMIVVDANLLIRE---------------------EKHLMTKE  721 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~~---~~~~~~dv~s~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~  721 (797)
                      ......++..|+|||.+...   .++.++|+|++|+..+..+....++...                     .......+
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (262)
T cd06613         157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVF  236 (262)
T ss_pred             ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHH
Confidence            22345688899999998776   7889999999998875544333322111                     11112346


Q ss_pred             ccchhccccCCCCCCCChHHHHH
Q 040702          722 QPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       722 ~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      .+++++|+..+|.+||++.++++
T Consensus       237 ~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         237 HDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             HHHHHHHcCCChhhCCCHHHHhc
Confidence            78999999999999999988874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=6.3e-31  Score=273.59  Aligned_cols=218  Identities=21%  Similarity=0.303  Sum_probs=176.8

Q ss_pred             ccccccCCcceeecc---------------eEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          518 NLIGRGGFGPVYKDG---------------MEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~~---------------~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      +.||+|+||.||++.               ..||+|.+...... ...+.+|+.++++++||||+++++++.. +..++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            468999999999752               24778877654433 5788999999999999999999999988 778999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCC-------cEEEEeecCC
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM-------VAHLSDFGMA  655 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~-------~~kl~DFGla  655 (797)
                      |||+++|+|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++       .+||+|||++
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            9999999999999876546899999999999999999999   99999999999999999887       7999999999


Q ss_pred             ccCCccCccccccccccCcccccccccccC--ccchHHHHHHHhhhhhhhhcc-ccccchh-h--------------hhh
Q 040702          656 KPLLEEDQSLTQTQTLATIGYMAPDEIFSG--EMRLKCWVNDSLLISVMIVVD-ANLLIRE-E--------------KHL  717 (797)
Q Consensus       656 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~dv~s~~~~~~~~~~~-~~~~~~~-~--------------~~~  717 (797)
                      .....      .....++..|+|||.+...  .++.++|+|++|+..+..+.. ..+.... .              ...
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  229 (259)
T cd05037         156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPMPD  229 (259)
T ss_pred             ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCCCCCC
Confidence            86532      1234577789999998776  789999999999887554432 2211111 0              011


Q ss_pred             hcccccchhccccCCCCCCCChHHHHHhH
Q 040702          718 MTKEQPMVRMGTDLSLGQFPASYSISKYL  746 (797)
Q Consensus       718 ~~~~~~l~~~cl~~dp~~RPs~~~i~~~l  746 (797)
                      ...+.++++.|+..+|.+||++.++++.|
T Consensus       230 ~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         230 CAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             chHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            23566889999999999999999998765

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.97  E-value=7.4e-31  Score=272.84  Aligned_cols=226  Identities=19%  Similarity=0.252  Sum_probs=184.9

Q ss_pred             ccccccCCcceeecc--------eEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccCC
Q 040702          518 NLIGRGGFGPVYKDG--------MEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPL  588 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~~--------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~  588 (797)
                      +.||+|+||.||++.        ..||||.+..... ...+.+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999852        3699999987654 445789999999999999999999999988 889999999999


Q ss_pred             CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc-cc
Q 040702          589 GSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS-LT  666 (797)
Q Consensus       589 g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~  666 (797)
                      |+|.+++.... ..+++..++.++.|++.||+|||   ..+++||||||+||+++.++.+||+|||+++........ ..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            99999997765 46899999999999999999999   999999999999999999999999999999876442221 12


Q ss_pred             ccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccc-hh-----------------hhhhhcccccchhc
Q 040702          667 QTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLI-RE-----------------EKHLMTKEQPMVRM  727 (797)
Q Consensus       667 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~-~~-----------------~~~~~~~~~~l~~~  727 (797)
                      .....++..|+|||.+....++.++|+|++|+..++.+. +..++. ..                 +......+.+++..
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  236 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ  236 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence            223457889999999988889999999999998755543 222211 00                 01122456678999


Q ss_pred             cccCCCCCCCChHHHHHhHH
Q 040702          728 GTDLSLGQFPASYSISKYLV  747 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~~l~  747 (797)
                      |+..+|++||++.++.+.+.
T Consensus       237 ~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         237 CWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             HCCCCcccCCCHHHHHHHhc
Confidence            99999999999999998764

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.97  E-value=6.9e-31  Score=275.22  Aligned_cols=235  Identities=22%  Similarity=0.273  Sum_probs=189.7

Q ss_pred             cCCCccccccccCCcceeecc--------eEEEEEEEEecc-CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKDG--------MEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~~--------~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      ++|...+.||+|+||.||++.        ..||||...... ....+.+.+|+.++++++||||+++++++.+ +..|+|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            568888999999999999852        368999886554 2334678999999999999999999999875 457899


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      |||+++|+|.+++......+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+|++|||+++......
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  161 (270)
T cd05056          85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES  161 (270)
T ss_pred             EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence            9999999999999876556899999999999999999999   9999999999999999999999999999998654332


Q ss_pred             ccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccch-----------------hhhhhhcccccc
Q 040702          663 QSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIR-----------------EEKHLMTKEQPM  724 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~-----------------~~~~~~~~~~~l  724 (797)
                      .. ......++..|+|||.+....++.++|+|++|+..++.+. +..++..                 .+......+.++
T Consensus       162 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  240 (270)
T cd05056         162 YY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSL  240 (270)
T ss_pred             ce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHH
Confidence            11 1223345568999999988889999999999988755442 2222111                 011223467788


Q ss_pred             hhccccCCCCCCCChHHHHHhHHHHHH
Q 040702          725 VRMGTDLSLGQFPASYSISKYLVYIRE  751 (797)
Q Consensus       725 ~~~cl~~dp~~RPs~~~i~~~l~~i~~  751 (797)
                      +.+|+..+|++||++.++.+.++.+..
T Consensus       241 i~~~l~~~P~~Rpt~~~~~~~l~~~~~  267 (270)
T cd05056         241 MTKCWAYDPSKRPRFTELKAQLSDILQ  267 (270)
T ss_pred             HHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=4.5e-31  Score=283.40  Aligned_cols=225  Identities=23%  Similarity=0.256  Sum_probs=183.5

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCC---cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG---AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ++|+..+.||+|+||.||++     ++.||+|.+......   ..+.+..|++++++++||||+++++.+...+..|+||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888999999999999974     589999999765322   3457889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          584 EYMPLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      ||+.+++|.+++.... ..+++..+..++.|+++||+|||   +.+++|+||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            9999999999987543 36899999999999999999999   9999999999999999999999999999987543211


Q ss_pred             cc---------------------------ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh
Q 040702          663 QS---------------------------LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK  715 (797)
Q Consensus       663 ~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~  715 (797)
                      ..                           .......||..|+|||.+.+..++.++|+|++|+..+..+.+..++.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            10                           011234689999999999988899999999999987555544443221110


Q ss_pred             ------------------hhhcccccchhccccCCCCCCCCh
Q 040702          716 ------------------HLMTKEQPMVRMGTDLSLGQFPAS  739 (797)
Q Consensus       716 ------------------~~~~~~~~l~~~cl~~dp~~RPs~  739 (797)
                                        .....+.++++.|+..||++||+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~  279 (316)
T cd05574         238 DETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGS  279 (316)
T ss_pred             HHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCc
Confidence                              023457889999999999999993

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.97  E-value=9.5e-31  Score=276.49  Aligned_cols=226  Identities=22%  Similarity=0.285  Sum_probs=180.9

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      +|+..+.||+|+||.||++     +..||||.++....  ...+.+.+|+.++++++||||+++++++.+++..|+||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4788899999999999985     57899999875432  2346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          586 MPLGSLEKCLYSGN--YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       586 ~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      ++ +++.+++....  ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 58988876532  35899999999999999999999   9999999999999999999999999999997553221 


Q ss_pred             cccccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccccccchhh----------------------------
Q 040702          664 SLTQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANLLIREE----------------------------  714 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------------------  714 (797)
                       .......+++.|+|||.+.+. .++.++|+|++|+..+..+.+..++....                            
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         156 -RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             -ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence             122334678999999988654 46889999999998755544433221100                            


Q ss_pred             -----------------hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          715 -----------------KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       715 -----------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                       ........++++.|+..||.+||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                             001223347999999999999999998875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.97  E-value=9.1e-31  Score=281.15  Aligned_cols=185  Identities=20%  Similarity=0.256  Sum_probs=148.5

Q ss_pred             cccccccCCcceeec-------ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeec--CCeEEEEEEccC
Q 040702          517 NNLIGRGGFGPVYKD-------GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN--DDFKALVLEYMP  587 (797)
Q Consensus       517 ~~~lg~G~~g~Vyk~-------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~--~~~~~lv~e~~~  587 (797)
                      .++||+|+||.||++       +..||+|.+....  ....+.+|++++++++||||+++++++..  +...|+||||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999985       2679999886432  23567889999999999999999998854  456899999996


Q ss_pred             CCCHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEE----cCCCcEEEEeecCC
Q 040702          588 LGSLEKCLYSG--------NYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL----DDNMVAHLSDFGMA  655 (797)
Q Consensus       588 ~g~L~~~l~~~--------~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll----~~~~~~kl~DFGla  655 (797)
                       +++.+++...        ...+++..+..++.|++.||+|||   +.+|+||||||+|||+    +.++.+||+|||+|
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             4888877532        124788899999999999999999   9999999999999999    45678999999999


Q ss_pred             ccCCccCc-cccccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccc
Q 040702          656 KPLLEEDQ-SLTQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDA  707 (797)
Q Consensus       656 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~  707 (797)
                      +....... ........||+.|||||.+.+. .++.++|+|++|+..+..+.+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~  213 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE  213 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCC
Confidence            86543221 1122446789999999998764 5889999999999875555443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.97  E-value=1e-30  Score=272.34  Aligned_cols=232  Identities=20%  Similarity=0.297  Sum_probs=188.0

Q ss_pred             hcCCCccccccccCCcceeec----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          511 TNRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      .++|+..++||+|+||.||++    ++.||+|.+..... ...++.+|+.++++++||||+++++++. .+..++||||+
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            467888999999999999974    58899999875432 3468899999999999999999999874 45689999999


Q ss_pred             CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          587 PLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       587 ~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      ++|+|.+++.... ..+++.++..++.|++.|++|||   +.+++||||||+||++++++.++|+|||++........ .
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~  158 (260)
T cd05067          83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-T  158 (260)
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-c
Confidence            9999999986543 36889999999999999999999   99999999999999999999999999999976542211 1


Q ss_pred             cccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-h----------------hhhhcccccchhc
Q 040702          666 TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-E----------------KHLMTKEQPMVRM  727 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-~----------------~~~~~~~~~l~~~  727 (797)
                      ......++..|+|||.+..+.++.++|+|++|+..++.+. +..++... .                ......+.+++++
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  238 (260)
T cd05067         159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRL  238 (260)
T ss_pred             cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence            2223456778999999988889999999999998765553 33222111 0                1122357889999


Q ss_pred             cccCCCCCCCChHHHHHhHHH
Q 040702          728 GTDLSLGQFPASYSISKYLVY  748 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~~l~~  748 (797)
                      |+..+|++||++.++.+.|+.
T Consensus       239 ~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         239 CWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             HccCChhhCCCHHHHHHHhhc
Confidence            999999999999999988764

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.2e-30  Score=270.15  Aligned_cols=227  Identities=25%  Similarity=0.296  Sum_probs=184.3

Q ss_pred             ccccccCCcceeec----ceEEEEEEEEeccCC-cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccCCCCHH
Q 040702          518 NLIGRGGFGPVYKD----GMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLE  592 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~g~L~  592 (797)
                      ++||+|+||.||++    ++.||+|.+...... ....+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            46899999999974    688999998765433 3467899999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccccccccc
Q 040702          593 KCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA  672 (797)
Q Consensus       593 ~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g  672 (797)
                      +++......+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||.++...............+
T Consensus        81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             HHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            999765556888999999999999999999   99999999999999999999999999999986532211111122334


Q ss_pred             CcccccccccccCccchHHHHHHHhhhhhhhhc-cccccch-----------------hhhhhhcccccchhccccCCCC
Q 040702          673 TIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIR-----------------EEKHLMTKEQPMVRMGTDLSLG  734 (797)
Q Consensus       673 t~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~-----------------~~~~~~~~~~~l~~~cl~~dp~  734 (797)
                      +..|+|||.+.++.++.++|+|++|+..++.+. ...++..                 .+......+.+++++|+..+|.
T Consensus       158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~  237 (251)
T cd05041         158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPE  237 (251)
T ss_pred             eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChh
Confidence            667999999988889999999999998755543 2222111                 1112234677899999999999


Q ss_pred             CCCChHHHHHhHH
Q 040702          735 QFPASYSISKYLV  747 (797)
Q Consensus       735 ~RPs~~~i~~~l~  747 (797)
                      +||++.|+++.|+
T Consensus       238 ~Rp~~~ell~~l~  250 (251)
T cd05041         238 NRPSFSEIYNELQ  250 (251)
T ss_pred             hCcCHHHHHHHhh
Confidence            9999999998774

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.97  E-value=6.8e-31  Score=280.39  Aligned_cols=230  Identities=21%  Similarity=0.233  Sum_probs=183.1

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccC---CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG---GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ++|+..+.||+|+||.||++     ++.||+|.+.....   ...+.+.+|+++++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36888999999999999974     47899999876532   23457889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC-
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED-  662 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~-  662 (797)
                      ||+++++|.+++.... .+++..+..++.|+++|++|||   +.+++||||||+||+++.++.+|++|||+++...... 
T Consensus        81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~  156 (305)
T cd05609          81 EYVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT  156 (305)
T ss_pred             ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence            9999999999997654 4888999999999999999999   8999999999999999999999999999987421100 


Q ss_pred             ------------ccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh-h--------------
Q 040702          663 ------------QSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE-K--------------  715 (797)
Q Consensus       663 ------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-~--------------  715 (797)
                                  .........|+..|+|||.+....++.++|+|++|+..++.+.+..++.... .              
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  236 (305)
T cd05609         157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP  236 (305)
T ss_pred             ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCC
Confidence                        0001123457889999999988889999999999988755544433322110 0              


Q ss_pred             ----hhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          716 ----HLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       716 ----~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                          .....+.++++.|++.||++||++.++.+.
T Consensus       237 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~l  270 (305)
T cd05609         237 EGDEALPADAQDLISRLLRQNPLERLGTGGAFEV  270 (305)
T ss_pred             CccccCCHHHHHHHHHHhccChhhccCccCHHHH
Confidence                112346788999999999999986544443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.97  E-value=3.5e-31  Score=275.63  Aligned_cols=225  Identities=27%  Similarity=0.392  Sum_probs=185.1

Q ss_pred             CCccccccccCCcceeec-----ceEEEEEEEEeccCCcc--hhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          514 FSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAF--KSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       514 f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~--~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      |+..+.||+|+||.||++     ++.||+|++........  ....+|+.++++++||||+++++++...+..++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            567899999999999984     57899999987743322  23456999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccc
Q 040702          587 PLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  666 (797)
Q Consensus       587 ~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  666 (797)
                      ++++|.+++.... .+++..+..++.|+++||.|||   +.+|+|+||||+||+++.++.++|+|||.+....  .....
T Consensus        81 ~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~~~  154 (260)
T PF00069_consen   81 PGGSLQDYLQKNK-PLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENNEN  154 (260)
T ss_dssp             TTEBHHHHHHHHS-SBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEEST--STTSE
T ss_pred             ccccccccccccc-cccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--ccccc
Confidence            9999999998333 4899999999999999999999   8999999999999999999999999999997541  11223


Q ss_pred             ccccccCcccccccccc-cCccchHHHHHHHhhhhhhhhccccccchh---hh--------------h------hhcccc
Q 040702          667 QTQTLATIGYMAPDEIF-SGEMRLKCWVNDSLLISVMIVVDANLLIRE---EK--------------H------LMTKEQ  722 (797)
Q Consensus       667 ~~~~~gt~~y~aPE~~~-~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~---~~--------------~------~~~~~~  722 (797)
                      .....++..|+|||.+. ...++.++|+|++|+..+..+....+....   ..              .      ....+.
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  234 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELR  234 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHH
Confidence            44567899999999988 788999999999999875555443332221   00              0      014677


Q ss_pred             cchhccccCCCCCCCChHHHHH
Q 040702          723 PMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       723 ~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      ++++.|++.||++||++.++++
T Consensus       235 ~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  235 DLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HHHHHHSSSSGGGSTTHHHHHT
T ss_pred             HHHHHHccCChhHCcCHHHHhc
Confidence            8899999999999999998875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.97  E-value=1.2e-30  Score=271.14  Aligned_cols=230  Identities=22%  Similarity=0.277  Sum_probs=187.2

Q ss_pred             cCCCccccccccCCcceeec----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccC
Q 040702          512 NRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  587 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~  587 (797)
                      .+|+..+.||+|+||.||++    +..+|+|.++.... ...++.+|++++++++||||+++++++......++||||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            46788899999999999985    57899998864432 24678999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccccc
Q 040702          588 LGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ  667 (797)
Q Consensus       588 ~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  667 (797)
                      +++|.+++......+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||.+....... ....
T Consensus        83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~~~  158 (256)
T cd05112          83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSS  158 (256)
T ss_pred             CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCc-cccc
Confidence            99999999776556889999999999999999999   9999999999999999999999999999987553321 1112


Q ss_pred             cccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccc-hh----------------hhhhhcccccchhccc
Q 040702          668 TQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLI-RE----------------EKHLMTKEQPMVRMGT  729 (797)
Q Consensus       668 ~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~-~~----------------~~~~~~~~~~l~~~cl  729 (797)
                      ....++..|+|||.+.++.++.++|+|++|+..++.+. +..++. ..                +......+.++++.|+
T Consensus       159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l  238 (256)
T cd05112         159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCW  238 (256)
T ss_pred             CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHc
Confidence            23345678999999988889999999999988755443 222211 11                0012234667899999


Q ss_pred             cCCCCCCCChHHHHHhH
Q 040702          730 DLSLGQFPASYSISKYL  746 (797)
Q Consensus       730 ~~dp~~RPs~~~i~~~l  746 (797)
                      +.+|++||++.++++.+
T Consensus       239 ~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         239 KERPEDRPSFSLLLHQL  255 (256)
T ss_pred             ccChhhCCCHHHHHHhh
Confidence            99999999999998865

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.97  E-value=6.2e-31  Score=275.37  Aligned_cols=227  Identities=24%  Similarity=0.364  Sum_probs=182.5

Q ss_pred             ccccccCCcceeecc-----------eEEEEEEEEecc-CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          518 NLIGRGGFGPVYKDG-----------MEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~~-----------~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      +.||+|+||.||++.           ..||||.+.... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            368999999999753           578999886543 23456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCC-----cEEEEeecC
Q 040702          586 MPLGSLEKCLYSG------NYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM-----VAHLSDFGM  654 (797)
Q Consensus       586 ~~~g~L~~~l~~~------~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~-----~~kl~DFGl  654 (797)
                      +++|+|.+++...      ...+++.++..++.|++.|++|||   +.+++|+||||+||+++.++     .+|++|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999998642      124788899999999999999999   89999999999999999877     899999999


Q ss_pred             CccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccch-----------------hhhh
Q 040702          655 AKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIR-----------------EEKH  716 (797)
Q Consensus       655 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~-----------------~~~~  716 (797)
                      ++...............++..|+|||.+.++.++.++|+|++|+..+..+. +..++..                 .+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN  237 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCccc
Confidence            986543322222233456788999999999999999999999998755443 2222111                 1112


Q ss_pred             hhcccccchhccccCCCCCCCChHHHHHhHH
Q 040702          717 LMTKEQPMVRMGTDLSLGQFPASYSISKYLV  747 (797)
Q Consensus       717 ~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~  747 (797)
                      ....+.+++++|+..+|.+||++.++.+.|+
T Consensus       238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         238 CPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             chHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            2335678999999999999999999998775

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.97  E-value=1.5e-30  Score=274.97  Aligned_cols=227  Identities=23%  Similarity=0.283  Sum_probs=186.0

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEecc--CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      +|+..+.||+|+||.||++     +..||||++....  ....+.+.+|+.++++++||||+++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4788899999999999984     5789999987654  23346789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      + +++|.+++......+++.++..++.|+++||+|||   +.+++|+||||+||+++.++.++|+|||++........ .
T Consensus        81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~  155 (286)
T cd07832          81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-R  155 (286)
T ss_pred             c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-C
Confidence            9 99999998766566899999999999999999999   99999999999999999999999999999986643321 1


Q ss_pred             cccccccCcccccccccccCc-cchHHHHHHHhhhhhhhhccccccchhh------------------------------
Q 040702          666 TQTQTLATIGYMAPDEIFSGE-MRLKCWVNDSLLISVMIVVDANLLIREE------------------------------  714 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~~~-~~~~~dv~s~~~~~~~~~~~~~~~~~~~------------------------------  714 (797)
                      ......|+..|+|||.+.+.. ++.++|+|++|+..+..+....++....                              
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN  235 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence            223456899999999886544 6899999999988755554433221100                              


Q ss_pred             ----------------hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          715 ----------------KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       715 ----------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                      .+....+.++++.|+..+|++||+++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                            011234567889999999999999988875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.5e-30  Score=271.18  Aligned_cols=233  Identities=24%  Similarity=0.342  Sum_probs=190.0

Q ss_pred             hcCCCccccccccCCcceeec----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          511 TNRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      .++|...+.||+|+||.||++    +..||||.+..... ..+++.+|+.++++++||||+++++++......++||||+
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            468899999999999999975    46799999875432 3467999999999999999999999999888999999999


Q ss_pred             CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          587 PLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       587 ~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      ++++|.+++.... ..+++..+..++.|++.|++|||   +.+++|+||||+||++++++.+|++|||.++...... ..
T Consensus        84 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~-~~  159 (261)
T cd05034          84 SKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE-YT  159 (261)
T ss_pred             CCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchh-hh
Confidence            9999999997654 35899999999999999999999   9999999999999999999999999999998664321 11


Q ss_pred             cccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccch-----------------hhhhhhcccccchhc
Q 040702          666 TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIR-----------------EEKHLMTKEQPMVRM  727 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~-----------------~~~~~~~~~~~l~~~  727 (797)
                      ......++..|+|||.+.+..++.++|+|++|+..++.+. +..++..                 .+......+.+++.+
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  239 (261)
T cd05034         160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLMLQ  239 (261)
T ss_pred             hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHH
Confidence            1222335678999999988889999999999988755443 2222111                 011123356788999


Q ss_pred             cccCCCCCCCChHHHHHhHHH
Q 040702          728 GTDLSLGQFPASYSISKYLVY  748 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~~l~~  748 (797)
                      |+..+|++||++.++.+.++.
T Consensus       240 ~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         240 CWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             HcccCcccCCCHHHHHHHHhc
Confidence            999999999999999988764

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=3.7e-31  Score=278.89  Aligned_cols=271  Identities=18%  Similarity=0.241  Sum_probs=200.3

Q ss_pred             cCHHHHHHHh---cCCCccccccccCCcceeec-----ceEEEEEEEEeccC---CcchhHHHHHHHhhhccCCceeEee
Q 040702          502 FTYLELFQAT---NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG---GAFKSFDIECGMMKRIRHRNLIKII  570 (797)
Q Consensus       502 ~~~~~l~~~~---~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~l~  570 (797)
                      -.|-.+..+.   .-|..++.||-|+||+|..+     ...||.|.+++.+.   ....-+..|-.||+....+.||++|
T Consensus       616 SnYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLy  695 (1034)
T KOG0608|consen  616 SNYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLY  695 (1034)
T ss_pred             hhHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEE
Confidence            3444555543   46888999999999999863     46799999987642   2334567799999999999999999


Q ss_pred             eeeecCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEE
Q 040702          571 SSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLS  650 (797)
Q Consensus       571 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~  650 (797)
                      ..|.+++..|+||||++||++..++-..+ .+++..++.++.+++.|+++.|   ..|+|||||||+|||||.+|++||.
T Consensus       696 ySFQDkdnLYFVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLT  771 (1034)
T KOG0608|consen  696 YSFQDKDNLYFVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLT  771 (1034)
T ss_pred             EEeccCCceEEEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeee
Confidence            99999999999999999999999887655 4889999999999999999999   9999999999999999999999999


Q ss_pred             eecCCccCCc--------cCcc--------------------------------ccccccccCcccccccccccCccchH
Q 040702          651 DFGMAKPLLE--------EDQS--------------------------------LTQTQTLATIGYMAPDEIFSGEMRLK  690 (797)
Q Consensus       651 DFGla~~~~~--------~~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~  690 (797)
                      |||++.-+..        .+..                                ......+||+.|+|||++...+|+..
T Consensus       772 DFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~  851 (1034)
T KOG0608|consen  772 DFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL  851 (1034)
T ss_pred             eccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc
Confidence            9999853210        0000                                01123479999999999999999999


Q ss_pred             HHHHHHhhhhhhhhccccccchhhhhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHHhccccccccccCCccccc
Q 040702          691 CWVNDSLLISVMIVVDANLLIREEKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHH  770 (797)
Q Consensus       691 ~dv~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~  770 (797)
                      +|+|+.|++.++++++..++-............-.+.-++.-+.---+ .|.+.+++++-.-...|.|  ...+..+..|
T Consensus       852 cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls-~e~~~li~kLc~sad~RLG--kng~d~vKaH  928 (1034)
T KOG0608|consen  852 CDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLS-KEALDLIQKLCCSADSRLG--KNGADQVKAH  928 (1034)
T ss_pred             chhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccC-HHHHHHHHHHhcChhhhhc--ccchhhhhcC
Confidence            999999999988777766544333222111111112223332222221 3455555554444444444  2334578999


Q ss_pred             ceeeeeeee
Q 040702          771 YLYRTVDYT  779 (797)
Q Consensus       771 ~~f~~~~~~  779 (797)
                      +||++|||-
T Consensus       929 pfFkgIDfs  937 (1034)
T KOG0608|consen  929 PFFKGIDFS  937 (1034)
T ss_pred             ccccccchH
Confidence            999999984

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.97  E-value=1.3e-30  Score=270.68  Aligned_cols=227  Identities=23%  Similarity=0.275  Sum_probs=189.8

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      .++|+..+.||+|+||.||++     +..||+|.+.....  .+++.+|++++++++||||+++++++......|+++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            367899999999999999975     57899999876543  57899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      +++++|.+++......+++..+..++.|++.|+.|||   ..+++||||+|+||+++.++.+||+|||++........  
T Consensus        80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--  154 (256)
T cd06612          80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--  154 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence            9999999999766566899999999999999999999   89999999999999999999999999999986543221  


Q ss_pred             cccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh-------------------hhhhhcccccchh
Q 040702          666 TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE-------------------EKHLMTKEQPMVR  726 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~l~~  726 (797)
                      ......|+..|+|||.+.+..++.++|+|++|+..+..+....++...                   +......+.++++
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  234 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVK  234 (256)
T ss_pred             ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHH
Confidence            223355889999999998888999999999999875554443332211                   0111234567899


Q ss_pred             ccccCCCCCCCChHHHHH
Q 040702          727 MGTDLSLGQFPASYSISK  744 (797)
Q Consensus       727 ~cl~~dp~~RPs~~~i~~  744 (797)
                      .|++.||++||++.|+++
T Consensus       235 ~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         235 KCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             HHHhcChhhCcCHHHHhc
Confidence            999999999999998875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.97  E-value=1.5e-30  Score=272.07  Aligned_cols=228  Identities=23%  Similarity=0.365  Sum_probs=185.2

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEeccCCc---------chhHHHHHHHhhhccCCceeEeeeeeecCCe
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGA---------FKSFDIECGMMKRIRHRNLIKIISSCSNDDF  578 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~---------~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~  578 (797)
                      +|.....||+|+||.||++     ++.||+|.+.......         .+.+.+|+.++++++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            3677789999999999985     4789999987543221         2467889999999999999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccC
Q 040702          579 KALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  658 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  658 (797)
                      .++||||+++++|.+++.... .+++..+..++.|++.|++|||   +.+++||||+|+||++++++.+||+|||.++..
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            999999999999999997654 4788899999999999999999   899999999999999999999999999999866


Q ss_pred             CccCccc----cccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccch-----------------hhhhh
Q 040702          659 LEEDQSL----TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIR-----------------EEKHL  717 (797)
Q Consensus       659 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~-----------------~~~~~  717 (797)
                      .......    ......|+..|+|||.+.++.++.++|+|++|+..+..+.+..++..                 .+...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNI  236 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCccc
Confidence            4221111    11234588999999999888889999999999987555544333221                 11122


Q ss_pred             hcccccchhccccCCCCCCCChHHHHH
Q 040702          718 MTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       718 ~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      ...+.++++.|+++||.+||++.++++
T Consensus       237 ~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         237 SSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             CHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            345678899999999999999988875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.97  E-value=8.9e-31  Score=276.57  Aligned_cols=226  Identities=23%  Similarity=0.288  Sum_probs=180.9

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      +|+..+.||+|+||.||++     |..||+|+++....  .....+.+|++++++++||||+++++++.+.+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4788899999999999974     67899999975432  2245678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      ++ +++.+++......+++..++.++.||++||+|||   ..+|+||||||+||+++.++.+||+|||+++.......  
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--  154 (284)
T cd07839          81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--  154 (284)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--
Confidence            97 5888887665556899999999999999999999   99999999999999999999999999999986532221  


Q ss_pred             cccccccCcccccccccccCc-cchHHHHHHHhhhhhhhhccccc-cchhh-----------------------------
Q 040702          666 TQTQTLATIGYMAPDEIFSGE-MRLKCWVNDSLLISVMIVVDANL-LIREE-----------------------------  714 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~~~-~~~~~dv~s~~~~~~~~~~~~~~-~~~~~-----------------------------  714 (797)
                      ......++..|+|||.+.+.. ++.++|+|++|+..+..+....+ .....                             
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY  234 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence            123346789999999887644 68999999999987555432221 11000                             


Q ss_pred             ----------------hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          715 ----------------KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       715 ----------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                      ........++++.|++.||.+|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence                            011234457899999999999999988865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.97  E-value=9.5e-31  Score=286.42  Aligned_cols=226  Identities=21%  Similarity=0.233  Sum_probs=181.3

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEecc--CCcchhHHHHHHHhhhccCCceeEeeeeeecC------
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISSCSND------  576 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~------  576 (797)
                      ..++|...+.||+|+||.||++     ++.||||++....  ....+.+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3578999999999999999974     5789999987543  22345788899999999999999999987543      


Q ss_pred             CeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCc
Q 040702          577 DFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  656 (797)
Q Consensus       577 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  656 (797)
                      ...|+||||+++ ++.+.+..   .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  174 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  174 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence            357999999965 77777653   3788899999999999999999   9999999999999999999999999999998


Q ss_pred             cCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh---------------------
Q 040702          657 PLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK---------------------  715 (797)
Q Consensus       657 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~---------------------  715 (797)
                      .....   .......||+.|+|||.+.+..++.++|+|++|+..+..+.+..++.....                     
T Consensus       175 ~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (364)
T cd07875         175 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  251 (364)
T ss_pred             ccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence            64322   122445789999999999998999999999999987655544332211000                     


Q ss_pred             -------------------------------------hhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          716 -------------------------------------HLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       716 -------------------------------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                                                           .......+++..|+..||.+|||+.|+++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                                                 001134578999999999999999998874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.97  E-value=9.7e-31  Score=276.58  Aligned_cols=238  Identities=20%  Similarity=0.246  Sum_probs=187.3

Q ss_pred             cCHHHHHHHhcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhc-cCCceeEeeeeee-
Q 040702          502 FTYLELFQATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRI-RHRNLIKIISSCS-  574 (797)
Q Consensus       502 ~~~~~l~~~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~-  574 (797)
                      +.++++..++++|+..+.||+|+||.||++     ++.||+|++.... .....+.+|+.+++++ +||||+++++++. 
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            455666778899999999999999999974     5789999876432 2235688899999999 6999999999874 


Q ss_pred             ----cCCeEEEEEEccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcE
Q 040702          575 ----NDDFKALVLEYMPLGSLEKCLYS---GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVA  647 (797)
Q Consensus       575 ----~~~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~  647 (797)
                          .++..++||||+++|+|.+++..   ....+++..+..++.|+++|+.|||   +.+|+||||||+||+++.++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCE
Confidence                34578999999999999998753   2235788899999999999999999   9999999999999999999999


Q ss_pred             EEEeecCCccCCccCccccccccccCccccccccccc-----CccchHHHHHHHhhhhhhhhccccccchhh--------
Q 040702          648 HLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS-----GEMRLKCWVNDSLLISVMIVVDANLLIREE--------  714 (797)
Q Consensus       648 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------  714 (797)
                      ||+|||+++.......  ......|++.|+|||.+..     ..++.++|+|++|+..+.......++....        
T Consensus       164 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~  241 (286)
T cd06638         164 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKI  241 (286)
T ss_pred             EEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhc
Confidence            9999999976532221  2234568999999998753     447889999999988755443332211110        


Q ss_pred             -----------hhhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          715 -----------KHLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       715 -----------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                                 ......+.++++.|++.||++||++.|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         242 PRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             cccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence                       0012246678899999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=6.5e-31  Score=285.43  Aligned_cols=228  Identities=20%  Similarity=0.248  Sum_probs=181.9

Q ss_pred             HHHHhcCCCccccccccCCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeecC---
Q 040702          507 LFQATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSND---  576 (797)
Q Consensus       507 l~~~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~---  576 (797)
                      .....++|...+.||+|+||.||++     +..||||.+.....  ...+.+.+|++++++++||||+++++++...   
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07878          10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI   89 (343)
T ss_pred             HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence            3445688999999999999999975     57899999875422  2235677899999999999999999987543   


Q ss_pred             ---CeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeec
Q 040702          577 ---DFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFG  653 (797)
Q Consensus       577 ---~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG  653 (797)
                         ...|++||++ +++|.+++...  .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||
T Consensus        90 ~~~~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          90 ENFNEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             cccCcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCc
Confidence               3578999998 67998887654  3899999999999999999999   9999999999999999999999999999


Q ss_pred             CCccCCccCccccccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchhh-h----------------
Q 040702          654 MAKPLLEEDQSLTQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIREE-K----------------  715 (797)
Q Consensus       654 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-~----------------  715 (797)
                      +++.....     .....||+.|+|||.+.+ ..++.++|+|++|+..+..+.+..++.... .                
T Consensus       164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  238 (343)
T cd07878         164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE  238 (343)
T ss_pred             cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            99865321     234578999999999876 468899999999998755544433221100 0                


Q ss_pred             ------------------------------hhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          716 ------------------------------HLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       716 ------------------------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                                                    .......++++.|+..||++|||+.|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         239 VLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                                          001124578889999999999999998864

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.97  E-value=1.5e-30  Score=272.26  Aligned_cols=225  Identities=18%  Similarity=0.252  Sum_probs=171.3

Q ss_pred             cccccCCcceeecc-------eEEEEEEEEecc-CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccCCCC
Q 040702          519 LIGRGGFGPVYKDG-------MEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGS  590 (797)
Q Consensus       519 ~lg~G~~g~Vyk~~-------~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~g~  590 (797)
                      .||+|+||.||++.       ..+++|.+.... ....+.+.+|+.+++.++||||++++++|......|+||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            58999999999852       345666665433 2235689999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccccc
Q 040702          591 LEKCLYSGN---YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ  667 (797)
Q Consensus       591 L~~~l~~~~---~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  667 (797)
                      |.+++....   ...++..+..++.||++||+|||   +.+++||||||+||+++.++.+||+|||++............
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            999987542   23566778899999999999999   899999999999999999999999999998643222211222


Q ss_pred             cccccCccccccccccc-------CccchHHHHHHHhhhhhhhhcc-ccccch-hhh---------------------hh
Q 040702          668 TQTLATIGYMAPDEIFS-------GEMRLKCWVNDSLLISVMIVVD-ANLLIR-EEK---------------------HL  717 (797)
Q Consensus       668 ~~~~gt~~y~aPE~~~~-------~~~~~~~dv~s~~~~~~~~~~~-~~~~~~-~~~---------------------~~  717 (797)
                      ....|+..|+|||.+..       ..++.++|+|++|+..++.+.. ..++.. .+.                     ..
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY  238 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence            34568899999998743       2356789999999987554432 111111 100                     11


Q ss_pred             hcccccchhccccCCCCCCCChHHHHHhHH
Q 040702          718 MTKEQPMVRMGTDLSLGQFPASYSISKYLV  747 (797)
Q Consensus       718 ~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~  747 (797)
                      ...+.++++.|+ .+|++||++.++++.|.
T Consensus       239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         239 SERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            223456778899 67999999999988763

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.97  E-value=1.6e-30  Score=269.83  Aligned_cols=225  Identities=22%  Similarity=0.329  Sum_probs=183.1

Q ss_pred             cCCCccccccccCCcceeec---ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccCC
Q 040702          512 NRFSENNLIGRGGFGPVYKD---GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPL  588 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~---~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~  588 (797)
                      ++|...+.||+|+||.||++   ++.||+|.++...  ..+.+.+|+.++++++||||+++++++...+ .++||||+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~-~~~v~e~~~~   82 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMSK   82 (254)
T ss_pred             HHceeeeeeccCCCCceEecccCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC-cEEEEECCCC
Confidence            56888999999999999985   5789999986432  2367889999999999999999999987654 7999999999


Q ss_pred             CCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccccc
Q 040702          589 GSLEKCLYSGNY-ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ  667 (797)
Q Consensus       589 g~L~~~l~~~~~-~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  667 (797)
                      |+|.+++..... .+++..+..++.|++.|+.|||   +.+++||||||+||+++.++.+||+|||+++.....     .
T Consensus        83 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-----~  154 (254)
T cd05083          83 GNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----V  154 (254)
T ss_pred             CCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceecccc-----C
Confidence            999999976543 5789999999999999999999   999999999999999999999999999998754221     1


Q ss_pred             cccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-h----------------hhhhcccccchhccc
Q 040702          668 TQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-E----------------KHLMTKEQPMVRMGT  729 (797)
Q Consensus       668 ~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-~----------------~~~~~~~~~l~~~cl  729 (797)
                      .....+..|+|||.+.++.++.++|+|++|+..++.+. +..++... .                ......+.+++++|+
T Consensus       155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  234 (254)
T cd05083         155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCW  234 (254)
T ss_pred             CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHc
Confidence            12234568999999988889999999999998755543 22221111 0                112234567999999


Q ss_pred             cCCCCCCCChHHHHHhHH
Q 040702          730 DLSLGQFPASYSISKYLV  747 (797)
Q Consensus       730 ~~dp~~RPs~~~i~~~l~  747 (797)
                      +.+|++||++.++.+.++
T Consensus       235 ~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         235 ETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             CCChhhCcCHHHHHHHHc
Confidence            999999999999998775

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.97  E-value=1.9e-30  Score=271.87  Aligned_cols=227  Identities=24%  Similarity=0.305  Sum_probs=179.7

Q ss_pred             ccccccCCcceeecc-------eEEEEEEEEecc-CCcchhHHHHHHHhhhc-cCCceeEeeeeeecCCeEEEEEEccCC
Q 040702          518 NLIGRGGFGPVYKDG-------MEVAIKVFNLQY-GGAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPL  588 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~~-------~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~  588 (797)
                      +.||+|+||.||++.       ..+|+|.++... ....+.+.+|++++.++ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999852       357888887432 23346788999999999 799999999999999999999999999


Q ss_pred             CCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeec
Q 040702          589 GSLEKCLYSGN---------------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFG  653 (797)
Q Consensus       589 g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG  653 (797)
                      |+|.+++....               ..+++.++..++.|++.|++|||   +.+++||||||+||++++++.+|++|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence            99999987532               14788899999999999999999   8999999999999999999999999999


Q ss_pred             CCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-----------------hh
Q 040702          654 MAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-----------------EK  715 (797)
Q Consensus       654 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-----------------~~  715 (797)
                      ++.....   .........+..|+|||.+....++.++|+|++|+..++.+. +..++...                 +.
T Consensus       158 l~~~~~~---~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  234 (270)
T cd05047         158 LSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL  234 (270)
T ss_pred             Cccccch---hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCC
Confidence            9863211   111122234667999999988889999999999988755542 22222110                 00


Q ss_pred             hhhcccccchhccccCCCCCCCChHHHHHhHHHHH
Q 040702          716 HLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIR  750 (797)
Q Consensus       716 ~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~  750 (797)
                      .....+.+++..|+..+|.+||++.++++.|+.+.
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         235 NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             cCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            11234667889999999999999999999988763

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.97  E-value=6.8e-31  Score=278.29  Aligned_cols=218  Identities=25%  Similarity=0.293  Sum_probs=180.0

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ++|...+.||+|+||.||++     ++.||+|.+....   ....+.+.+|++++++++||||+++++++..++..|+||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36888999999999999974     5889999987542   223467889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      ||+++++|.+++.... .+++..+..++.|+++||+|||   +.+|+||||+|+||+++.++.+||+|||+++.....  
T Consensus        81 e~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--  154 (290)
T cd05580          81 EYVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--  154 (290)
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence            9999999999987764 4889999999999999999999   999999999999999999999999999999865432  


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh----------------hhhhcccccchhc
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE----------------KHLMTKEQPMVRM  727 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~l~~~  727 (797)
                         .....|++.|+|||.+.+..++.++|+|++|+..+..+.+..++....                ......++++++.
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  231 (290)
T cd05580         155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRN  231 (290)
T ss_pred             ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHH
Confidence               234568999999999988888899999999998755554444322111                1112355677888


Q ss_pred             cccCCCCCCCC
Q 040702          728 GTDLSLGQFPA  738 (797)
Q Consensus       728 cl~~dp~~RPs  738 (797)
                      |+..||.+||+
T Consensus       232 ~l~~~p~~R~~  242 (290)
T cd05580         232 LLQVDLTKRLG  242 (290)
T ss_pred             HccCCHHHccC
Confidence            88888888873

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=8.2e-31  Score=276.83  Aligned_cols=230  Identities=21%  Similarity=0.276  Sum_probs=189.0

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      ++|+..+.||+|+||.||++     ++.||+|++..... ...+.+.+|+++++.++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            57888899999999999974     57899998876532 2346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS-VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~-~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      +++|+|.+++...+ .+++..+..++.|++.|+.|||   . .+++||||||+||+++.++.++|+|||++......   
T Consensus        85 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~---  157 (284)
T cd06620          85 MDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLY---NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---  157 (284)
T ss_pred             CCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHH---HhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh---
Confidence            99999999887654 4899999999999999999999   5 58999999999999999999999999998754221   


Q ss_pred             ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh-----------------------------
Q 040702          665 LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK-----------------------------  715 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~-----------------------------  715 (797)
                       ......|+..|+|||.+.++.++.++|+|++|+..+..+.+..++.....                             
T Consensus       158 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd06620         158 -IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSS  236 (284)
T ss_pred             -ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCch
Confidence             12345789999999999888899999999999887555543333221100                             


Q ss_pred             hhhcccccchhccccCCCCCCCChHHHHHhHHHH
Q 040702          716 HLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYI  749 (797)
Q Consensus       716 ~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i  749 (797)
                      .....+.++++.|+..||++||++.|+.+....+
T Consensus       237 ~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~  270 (284)
T cd06620         237 DFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI  270 (284)
T ss_pred             hcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence            1223466789999999999999999998865443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.97  E-value=3e-30  Score=273.57  Aligned_cols=229  Identities=21%  Similarity=0.267  Sum_probs=181.9

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ++++|...+.||+|+||.||++     +..||+|++..... .....+.+|+.+++.++|+||+++++++..++..|+||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4678999999999999999975     67899999976533 22346788999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      ||+. +++.+++......+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            9996 6787777654445788889999999999999999   89999999999999999999999999999975432221


Q ss_pred             cccccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccccccchhhh---------------------------
Q 040702          664 SLTQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANLLIREEK---------------------------  715 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~---------------------------  715 (797)
                        ......+++.|+|||.+.+. .++.++|+|++|+..++.+.+..++.....                           
T Consensus       159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07870         159 --TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP  236 (291)
T ss_pred             --CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence              22334578999999988754 478899999999887555444333211000                           


Q ss_pred             ----------------------hhhcccccchhccccCCCCCCCChHHHHH
Q 040702          716 ----------------------HLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       716 ----------------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                            .......++++.|+..||.+|||+.|++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence                                  01124457888899999999999988764

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.97  E-value=2.5e-30  Score=273.39  Aligned_cols=227  Identities=22%  Similarity=0.238  Sum_probs=183.5

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      ++|+..+.||+|+||.||++     ++.||+|++.....  ...+.+.+|+.++++++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888999999999999985     58899999875432  223567899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      |++++++..+..... .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++........ 
T Consensus        81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07847          81 YCDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-  155 (286)
T ss_pred             ccCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence            999988887765443 4899999999999999999999   89999999999999999999999999999986543321 


Q ss_pred             ccccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchhh-----------------------------
Q 040702          665 LTQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIREE-----------------------------  714 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-----------------------------  714 (797)
                       ......++..|+|||.+.+ ..++.++|+|++|+..+..+.+..++....                             
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07847         156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF  234 (286)
T ss_pred             -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence             1233467889999999876 457889999999998755554443321100                             


Q ss_pred             ------------------hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          715 ------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       715 ------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                        ......+.+++..|+..+|++||++.|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence                              011223557889999999999999988864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.97  E-value=1.8e-30  Score=279.87  Aligned_cols=227  Identities=16%  Similarity=0.175  Sum_probs=177.4

Q ss_pred             cccccccc--CCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          516 ENNLIGRG--GFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       516 ~~~~lg~G--~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      ..++||+|  +||+||++     ++.||||+++....  ...+.+.+|+++++.++||||++++++|..++..|+||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            45789999  67889874     58899999976532  22356778999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          587 PLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       587 ~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      ++|+|.+++.... ..+++..+..++.|++.||+|||   +++|+||||||+||+++.++.++++|||.+..........
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            9999999986532 34889999999999999999999   9999999999999999999999999998764332111100


Q ss_pred             -----cccccccCccccccccccc--CccchHHHHHHHhhhhhhhhccccccchhhh-----------------------
Q 040702          666 -----TQTQTLATIGYMAPDEIFS--GEMRLKCWVNDSLLISVMIVVDANLLIREEK-----------------------  715 (797)
Q Consensus       666 -----~~~~~~gt~~y~aPE~~~~--~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~-----------------------  715 (797)
                           ......++..|+|||.+.+  ..++.++|+|++|+..++.+.+..++.....                       
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA  238 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence                 1122357788999999876  3588999999999987555544433321100                       


Q ss_pred             ---------------------------------------hhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          716 ---------------------------------------HLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       716 ---------------------------------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                                                             .....+.++++.|++.||++|||+.|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence                                                   011234578999999999999999998863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.97  E-value=3.2e-30  Score=267.84  Aligned_cols=228  Identities=19%  Similarity=0.215  Sum_probs=187.6

Q ss_pred             CCCccccccccCCcceee-----cceEEEEEEEEecc--CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          513 RFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk-----~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      +|+..+.||+|+||.||.     .+..||+|.+....  ....+++.+|+.++++++|+||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            588899999999998875     36889999987653  23356788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          586 MPLGSLEKCLYSG-NYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       586 ~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      +++|+|.+++... ...+++..+..++.|++.|++|||   +.+++|+||||+||+++.++.+||+|||.++....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            9999999999765 335899999999999999999999   89999999999999999999999999999986543321 


Q ss_pred             ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccch-h----------------hhhhhcccccchhc
Q 040702          665 LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIR-E----------------EKHLMTKEQPMVRM  727 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~-~----------------~~~~~~~~~~l~~~  727 (797)
                       ......|++.|+|||.+.+..++.++|+|++|+..+..+....++.. .                .......+.+++..
T Consensus       157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  235 (256)
T cd08221         157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHS  235 (256)
T ss_pred             -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHH
Confidence             23445689999999999888888999999999887544433222111 0                01123356788899


Q ss_pred             cccCCCCCCCChHHHHHh
Q 040702          728 GTDLSLGQFPASYSISKY  745 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~~  745 (797)
                      |+..+|++||++.++++.
T Consensus       236 ~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         236 LLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             HcccCcccCCCHHHHhhC
Confidence            999999999999998864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.97  E-value=2.7e-30  Score=268.58  Aligned_cols=228  Identities=24%  Similarity=0.373  Sum_probs=185.9

Q ss_pred             CCccccccccCCcceeec---------ceEEEEEEEEeccCC-cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          514 FSENNLIGRGGFGPVYKD---------GMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       514 f~~~~~lg~G~~g~Vyk~---------~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      |+..+.||+|+||.||++         +..||+|.++..... ..+.+..|+++++.++||||+++++++.+.+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            356789999999999974         277999999755433 4568899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          584 EYMPLGSLEKCLYSGNYI-LDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~-l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      ||+++++|.+++...... +++..+..++.|++.|++|||   +.+++||||||+||++++++.++|+|||+++......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            999999999999765543 899999999999999999999   9999999999999999999999999999998665432


Q ss_pred             ccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchhh-----------------hhhhcccccc
Q 040702          663 QSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIREE-----------------KHLMTKEQPM  724 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~~-----------------~~~~~~~~~l  724 (797)
                      .... ....++..|+|||.+.+..++.++|+|++|+..+..+. ...++....                 ......+.++
T Consensus       158 ~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (258)
T smart00219      158 YYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKL  236 (258)
T ss_pred             cccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHH
Confidence            2211 12347889999999988889999999999998755443 222221110                 0123456678


Q ss_pred             hhccccCCCCCCCChHHHHHh
Q 040702          725 VRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       725 ~~~cl~~dp~~RPs~~~i~~~  745 (797)
                      +..|+..||++||++.++++.
T Consensus       237 i~~~l~~~p~~Rpt~~~ll~~  257 (258)
T smart00219      237 MLQCWAEDPEDRPTFSELVEI  257 (258)
T ss_pred             HHHHCcCChhhCcCHHHHHhh
Confidence            999999999999999998865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.97  E-value=3.1e-30  Score=273.41  Aligned_cols=227  Identities=20%  Similarity=0.277  Sum_probs=181.5

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCC-cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      ++|+..+.||+|+||.||++     ++.||||.+...... ....+.+|++++++++||||+++++++.+.+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            67899999999999999974     588999998765322 235677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      +++ +|.+++......+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+++.......  
T Consensus        85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--  158 (291)
T cd07844          85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--  158 (291)
T ss_pred             CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc--
Confidence            975 999988776556899999999999999999999   99999999999999999999999999999875422111  


Q ss_pred             cccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchhh------------------------------
Q 040702          666 TQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIREE------------------------------  714 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~------------------------------  714 (797)
                      ......++..|+|||.+.+ ..++.++|+|++|+..+..+.+..++....                              
T Consensus       159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07844         159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF  238 (291)
T ss_pred             cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence            1223357889999998875 457889999999988755444333321110                              


Q ss_pred             ----------h-------hhh--cccccchhccccCCCCCCCChHHHHH
Q 040702          715 ----------K-------HLM--TKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       715 ----------~-------~~~--~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                .       ...  ....++++.|+..+|.+||++.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                      0       000  23347888899999999999988764

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>PTZ00284 protein kinase; Provisional

Probab=99.97  E-value=1.3e-30  Score=294.41  Aligned_cols=227  Identities=18%  Similarity=0.195  Sum_probs=178.0

Q ss_pred             HHHHhcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccC------CceeEeeeeeec
Q 040702          507 LFQATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRH------RNLIKIISSCSN  575 (797)
Q Consensus       507 l~~~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H------pniv~l~~~~~~  575 (797)
                      +...+++|...+.||+|+||.||++     ++.||||+++.... ....+..|+.+++.++|      ++++++++++..
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            3345688999999999999999985     57899999974322 23456678888877754      458999998876


Q ss_pred             C-CeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCceEEcCCC--------
Q 040702          576 D-DFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS-VPIIHCDLKPSNVLLDDNM--------  645 (797)
Q Consensus       576 ~-~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~-~~ivHrDlkp~NIll~~~~--------  645 (797)
                      + +..|+|||++ +++|.+++.... .+++..+..|+.||+.||+|||   + .+|+||||||+|||++.++        
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~~~~~~~~  277 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDTVVDPVTN  277 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCcccccccc
Confidence            5 4789999998 678988887654 4899999999999999999999   7 5999999999999998665        


Q ss_pred             --------cEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhhh-
Q 040702          646 --------VAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEKH-  716 (797)
Q Consensus       646 --------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~~-  716 (797)
                              .+||+|||.+....     ......+||+.|||||.+.+..++.++|+|++|+..++.+.+..++...... 
T Consensus       278 ~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~  352 (467)
T PTZ00284        278 RALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE  352 (467)
T ss_pred             cccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence                    49999999886421     1234568999999999999999999999999999886666555443211000 


Q ss_pred             ---------------------------------------------------------hhcccccchhccccCCCCCCCCh
Q 040702          717 ---------------------------------------------------------LMTKEQPMVRMGTDLSLGQFPAS  739 (797)
Q Consensus       717 ---------------------------------------------------------~~~~~~~l~~~cl~~dp~~RPs~  739 (797)
                                                                               ....+.++++.|+..||.+||++
T Consensus       353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta  432 (467)
T PTZ00284        353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA  432 (467)
T ss_pred             HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence                                                                     00123478889999999999999


Q ss_pred             HHHHH
Q 040702          740 YSISK  744 (797)
Q Consensus       740 ~~i~~  744 (797)
                      .|+++
T Consensus       433 ~e~L~  437 (467)
T PTZ00284        433 RQMTT  437 (467)
T ss_pred             HHHhc
Confidence            99886

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.97  E-value=3.7e-30  Score=267.57  Aligned_cols=227  Identities=22%  Similarity=0.286  Sum_probs=183.9

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeec-CCeEEEEEE
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSN-DDFKALVLE  584 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~-~~~~~lv~e  584 (797)
                      +|+..+.||+|++|.||++     ++.||+|.+.....  ...+.+.+|++++++++|||++++++.+.. +...|+|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            5888999999999999964     57899999975432  234578889999999999999999998764 446899999


Q ss_pred             ccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          585 YMPLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      |+++++|.+++.... ..+++.++..++.|++.|++|||   +.+++||||||+||+++.++.++|+|||+++.......
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            999999999987643 35899999999999999999999   99999999999999999999999999999986532221


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh-----------------hhhhcccccchh
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE-----------------KHLMTKEQPMVR  726 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~l~~  726 (797)
                        ......|++.|+|||.+.+..++.++|+|++|+..+..+....++....                 ......+.+++.
T Consensus       158 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  235 (257)
T cd08223         158 --MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIA  235 (257)
T ss_pred             --ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHH
Confidence              2234568999999999998889999999999988754443333221110                 112235677889


Q ss_pred             ccccCCCCCCCChHHHHH
Q 040702          727 MGTDLSLGQFPASYSISK  744 (797)
Q Consensus       727 ~cl~~dp~~RPs~~~i~~  744 (797)
                      .|++.+|++||++.++++
T Consensus       236 ~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         236 TMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             HHhccCcccCCCHHHHhc
Confidence            999999999999988875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.97  E-value=3.2e-30  Score=269.32  Aligned_cols=228  Identities=21%  Similarity=0.311  Sum_probs=184.5

Q ss_pred             CCCccccccccCCcceeec----ceEEEEEEEEeccCC------cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          513 RFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGG------AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      +|...+.||+|+||.||++    ++.+|||.++.....      ..+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            4778899999999999984    578999998754321      134688899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      |||+++++|.+++.... .+++..+..++.|++.|++|||   +.+|+|+||||+||++++++.+||+|||+++......
T Consensus        81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence            99999999999997654 4788999999999999999999   8999999999999999999999999999987543211


Q ss_pred             c----cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh-------------------hhhhc
Q 040702          663 Q----SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE-------------------KHLMT  719 (797)
Q Consensus       663 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-------------------~~~~~  719 (797)
                      .    ........|+..|+|||.+.+..++.++|+|++|+..+..+.+..++....                   .....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSA  236 (265)
T ss_pred             ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCH
Confidence            1    111234568999999999988888999999999988755554443322110                   01122


Q ss_pred             ccccchhccccCCCCCCCChHHHHH
Q 040702          720 KEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       720 ~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      .+.++++.|+..+|++||++.++++
T Consensus       237 ~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         237 AAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             HHHHHHHHHhcCCcccCCCHHHHhc
Confidence            4567899999999999999988764

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3e-30  Score=271.00  Aligned_cols=226  Identities=25%  Similarity=0.285  Sum_probs=188.8

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEecc-CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      ++|+..+.||.|+||.||++     ++.||+|.+.... ......+.+|+.+++.++||||+++++++.++...|+|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36888899999999999984     5889999987553 33346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      +++++|.+++...  .+++..+..++.|++.|+.|||   +.+++||||+|+||++++++.++|+|||+++......  .
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~  153 (274)
T cd06609          81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--S  153 (274)
T ss_pred             eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--c
Confidence            9999999998765  4899999999999999999999   9999999999999999999999999999998764322  1


Q ss_pred             cccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh-----------------h-hhcccccchhc
Q 040702          666 TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK-----------------H-LMTKEQPMVRM  727 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~-----------------~-~~~~~~~l~~~  727 (797)
                      ......|+..|+|||.+.+..++.++|+|++|+..+..+.+..++.....                 . ....+.++++.
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  233 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSL  233 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHH
Confidence            23445788999999999988899999999999987555544333221100                 0 22346788899


Q ss_pred             cccCCCCCCCChHHHHH
Q 040702          728 GTDLSLGQFPASYSISK  744 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~  744 (797)
                      |+..+|++||+++++++
T Consensus       234 ~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         234 CLNKDPKERPSAKELLK  250 (274)
T ss_pred             HhhCChhhCcCHHHHhh
Confidence            99999999999988876

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.97  E-value=1e-30  Score=275.03  Aligned_cols=216  Identities=20%  Similarity=0.222  Sum_probs=174.4

Q ss_pred             ccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccCCCCH
Q 040702          520 IGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSL  591 (797)
Q Consensus       520 lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~g~L  591 (797)
                      ||+|+||.||++     ++.||+|.+....   ......+..|++++++++||||+++++++...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999974     6889999987542   22345677899999999999999999999999999999999999999


Q ss_pred             HHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccccccc
Q 040702          592 EKCLYSGNY-ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT  670 (797)
Q Consensus       592 ~~~l~~~~~-~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~  670 (797)
                      .+++..... .+++..+..++.|+++|+.|||   ..+++||||+|+||+++.++.+||+|||.+......   ......
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~~  154 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKGR  154 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC---Cccccc
Confidence            999876542 5899999999999999999999   999999999999999999999999999998765321   122345


Q ss_pred             ccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh--------------------hhhhcccccchhcccc
Q 040702          671 LATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE--------------------KHLMTKEQPMVRMGTD  730 (797)
Q Consensus       671 ~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~l~~~cl~  730 (797)
                      .++..|+|||.+.++.++.++|+|++|+..+..+.+..++....                    ......+.++++.|++
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  234 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQ  234 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHcc
Confidence            68889999999988889999999999998755554443332111                    1123345678888888


Q ss_pred             CCCCCCCChHH
Q 040702          731 LSLGQFPASYS  741 (797)
Q Consensus       731 ~dp~~RPs~~~  741 (797)
                      .||++||+..+
T Consensus       235 ~~p~~R~~~~~  245 (277)
T cd05577         235 KDPEKRLGCRG  245 (277)
T ss_pred             CChhHccCCCc
Confidence            88888886544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.97  E-value=3.6e-30  Score=270.19  Aligned_cols=233  Identities=23%  Similarity=0.312  Sum_probs=183.8

Q ss_pred             CCccccccccCCcceeec--------ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeecCC------
Q 040702          514 FSENNLIGRGGFGPVYKD--------GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSNDD------  577 (797)
Q Consensus       514 f~~~~~lg~G~~g~Vyk~--------~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~------  577 (797)
                      |...+.||+|+||.||++        +..||||++.....  ...+++.+|++++++++||||+++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            566789999999999975        47899999875432  23457889999999999999999999886542      


Q ss_pred             eEEEEEEccCCCCHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEee
Q 040702          578 FKALVLEYMPLGSLEKCLYSG-----NYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDF  652 (797)
Q Consensus       578 ~~~lv~e~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF  652 (797)
                      ..++++||+.+|+|.+++...     ...+++.....++.|++.|++|||   +.+|+||||||+||+++.++.+|++||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence            347899999999998887432     124788899999999999999999   899999999999999999999999999


Q ss_pred             cCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccc-hhh----------------
Q 040702          653 GMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLI-REE----------------  714 (797)
Q Consensus       653 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~-~~~----------------  714 (797)
                      |+++...............+++.|++||.+....++.++|+|++|+..++.+. ...++. ...                
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  237 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQP  237 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCC
Confidence            99986643332222233456778999999988889999999999998755443 211111 100                


Q ss_pred             hhhhcccccchhccccCCCCCCCChHHHHHhHHHH
Q 040702          715 KHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYI  749 (797)
Q Consensus       715 ~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i  749 (797)
                      ......+.+++..|++.+|++||++.++.+.++.+
T Consensus       238 ~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         238 PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            11224567788899999999999999999988765

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.97  E-value=3.1e-30  Score=270.55  Aligned_cols=228  Identities=23%  Similarity=0.338  Sum_probs=182.9

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEeccCC----------cchhHHHHHHHhhhccCCceeEeeeeeecCC
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG----------AFKSFDIECGMMKRIRHRNLIKIISSCSNDD  577 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~----------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~  577 (797)
                      +|...+.||+|+||.||++     ++.||+|.++.....          ..+.+..|+.++++++||||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4677889999999999985     578999988643211          1245778999999999999999999999999


Q ss_pred             eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCcc
Q 040702          578 FKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  657 (797)
Q Consensus       578 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  657 (797)
                      ..++||||+++|+|.+++.... .+++..+..++.|++.|+.|||   +.+++||||+|+||+++.++.++++|||+++.
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecccccc
Confidence            9999999999999999987764 5888999999999999999999   89999999999999999999999999999986


Q ss_pred             CCccCccccccccccCcccccccccccCc--cchHHHHHHHhhhhhhhhccccccchhh---------------------
Q 040702          658 LLEEDQSLTQTQTLATIGYMAPDEIFSGE--MRLKCWVNDSLLISVMIVVDANLLIREE---------------------  714 (797)
Q Consensus       658 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~dv~s~~~~~~~~~~~~~~~~~~~---------------------  714 (797)
                      ..............|+..|+|||.+....  ++.++|+|++|+..+..+.+..+.....                     
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDV  237 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccc
Confidence            53222222223456889999999887654  7899999999988744444333221100                     


Q ss_pred             -hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          715 -KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       715 -~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                       .+....+.+++..|+.++|++||++.++++
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         238 SMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             cccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence             011335677888899999999999998875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=9.8e-31  Score=278.61  Aligned_cols=232  Identities=23%  Similarity=0.253  Sum_probs=194.6

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCc--chhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGA--FKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~--~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      .+..|...+.||+|.|+.|..+     +..||||.+++..-..  .+.+.+|+++|+.++|||||+++.+...+...|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            4678999999999999999864     6899999998775432  35588999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      |||+.+|.+++++...+. ..+..+..++.|+.+|++|||   ++.|+|||||++||+++.+.++||+|||++..+... 
T Consensus       134 ~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~-  208 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG-  208 (596)
T ss_pred             EEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeeccc-
Confidence            999999999999988775 455889999999999999999   999999999999999999999999999999876422 


Q ss_pred             ccccccccccCcccccccccccCcc-chHHHHHHHhhhhhhhhccccccchhhh----------------hhhcccccch
Q 040702          663 QSLTQTQTLATIGYMAPDEIFSGEM-RLKCWVNDSLLISVMIVVDANLLIREEK----------------HLMTKEQPMV  725 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~dv~s~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~l~  725 (797)
                        ....+.+|++.|.|||.+.+..| ...+|+|++|...+..+.+.-++++..-                ......++++
T Consensus       209 --~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lL  286 (596)
T KOG0586|consen  209 --LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDLL  286 (596)
T ss_pred             --ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHHH
Confidence              24567899999999999998887 4899999999987655443333332111                1223567888


Q ss_pred             hccccCCCCCCCChHHHHHhHHH
Q 040702          726 RMGTDLSLGQFPASYSISKYLVY  748 (797)
Q Consensus       726 ~~cl~~dp~~RPs~~~i~~~l~~  748 (797)
                      ++.+..+|.+|+++.++.+.-+.
T Consensus       287 rk~lvl~Pskr~~~dqim~~~W~  309 (596)
T KOG0586|consen  287 RKFLVLNPSKRGPCDQIMKDRWR  309 (596)
T ss_pred             HHhhccCccccCCHHHhhhhccc
Confidence            88999999999999999875433

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.97  E-value=4.2e-30  Score=276.03  Aligned_cols=187  Identities=20%  Similarity=0.266  Sum_probs=148.8

Q ss_pred             cccccccCCcceeecc-------eEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeec--CCeEEEEEEccC
Q 040702          517 NNLIGRGGFGPVYKDG-------MEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN--DDFKALVLEYMP  587 (797)
Q Consensus       517 ~~~lg~G~~g~Vyk~~-------~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~--~~~~~lv~e~~~  587 (797)
                      ..+||+|+||.||++.       ..||+|.+....  ....+.+|++++++++||||+++++++..  +...++||||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            3689999999999852       679999886432  23567889999999999999999998854  457899999986


Q ss_pred             CCCHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEE----cCCCcEEEEeecCC
Q 040702          588 LGSLEKCLYSG--------NYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL----DDNMVAHLSDFGMA  655 (797)
Q Consensus       588 ~g~L~~~l~~~--------~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll----~~~~~~kl~DFGla  655 (797)
                      + ++.+++...        ...+++..+..++.|++.||+|||   +.+|+||||||+||++    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 787776421        124788899999999999999999   9999999999999999    46678999999999


Q ss_pred             ccCCccCcc-ccccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccccc
Q 040702          656 KPLLEEDQS-LTQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANL  709 (797)
Q Consensus       656 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~  709 (797)
                      +........ .......||+.|+|||.+.+. .++.++|+|++|+..++.+.+..+
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~  215 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI  215 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCC
Confidence            865432211 122345789999999998764 578999999999987655554433

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.6e-31  Score=287.89  Aligned_cols=243  Identities=21%  Similarity=0.233  Sum_probs=203.6

Q ss_pred             CCccccccccCCcceeecc---------eEEEEEEEEecc-CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          514 FSENNLIGRGGFGPVYKDG---------MEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       514 f~~~~~lg~G~~g~Vyk~~---------~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ....++||+|+||.||||.         .+||||++.... ....+++..|+-+|.+++|||+++++|+|.... ..||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            3456899999999999973         689999987653 344678999999999999999999999998776 78999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      +||+.|+|.++++..+..+.....+.|..|||+|+.|||   .++++||||.++|||+.....+||.|||+|+....++.
T Consensus       777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            999999999999988878888999999999999999999   99999999999999999999999999999998876665


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhh-hhccccccchhhhhhhc-----------------ccccch
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVM-IVVDANLLIREEKHLMT-----------------KEQPMV  725 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~-~~~~~~~~~~~~~~~~~-----------------~~~~l~  725 (797)
                      ........-.+.|||=|.+....|+.++|||++|+..++ +.++..+..+.+.+...                 .+..++
T Consensus       854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~m  933 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVM  933 (1177)
T ss_pred             cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHH
Confidence            555555556778999999999999999999999998732 23344443433332221                 334455


Q ss_pred             hccccCCCCCCCChHHHHHhHHHHHHHhccccccc
Q 040702          726 RMGTDLSLGQFPASYSISKYLVYIRELERGKVGIT  760 (797)
Q Consensus       726 ~~cl~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~  760 (797)
                      -+||..|++.||+++++.+.+.++.+.+..-..++
T Consensus       934 vkCwmid~~~rp~fkel~~~fs~~ardpqryl~i~  968 (1177)
T KOG1025|consen  934 VKCWMIDADSRPTFKELAEEFSRMARDPQRYLVIQ  968 (1177)
T ss_pred             HHHhccCcccCccHHHHHHHHHHHhcCcceEeeeh
Confidence            56999999999999999999999988887777766

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.97  E-value=1.5e-30  Score=273.69  Aligned_cols=226  Identities=23%  Similarity=0.288  Sum_probs=185.8

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEecc-CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      .|+..+.||+|+||.||++     +..||+|.++... ....+.+.+|+.++++++||||+++++++...+..|+||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            4666788999999999985     5789999987543 233467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccc
Q 040702          587 PLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  666 (797)
Q Consensus       587 ~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  666 (797)
                      ++++|.+++...  .+++..+..++.|++.|+.|||   ..+++|+||+|+||+++.++.++++|||+++......  ..
T Consensus        85 ~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~  157 (277)
T cd06642          85 GGGSALDLLKPG--PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IK  157 (277)
T ss_pred             CCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcc--hh
Confidence            999999988654  4788999999999999999999   8999999999999999999999999999998654322  12


Q ss_pred             ccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh-----------------hhhhcccccchhccc
Q 040702          667 QTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE-----------------KHLMTKEQPMVRMGT  729 (797)
Q Consensus       667 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~l~~~cl  729 (797)
                      .....|+..|+|||.+.+..++.++|+|++|+..++.+.+..+.....                 ......+.+++..|+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  237 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACL  237 (277)
T ss_pred             hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHc
Confidence            233568899999999988889999999999998755554433321100                 012234678899999


Q ss_pred             cCCCCCCCChHHHHHh
Q 040702          730 DLSLGQFPASYSISKY  745 (797)
Q Consensus       730 ~~dp~~RPs~~~i~~~  745 (797)
                      ..+|++||++.++++.
T Consensus       238 ~~~p~~Rp~~~~il~~  253 (277)
T cd06642         238 NKDPRFRPTAKELLKH  253 (277)
T ss_pred             cCCcccCcCHHHHHHh
Confidence            9999999999999873

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.97  E-value=8.1e-31  Score=282.39  Aligned_cols=189  Identities=24%  Similarity=0.345  Sum_probs=161.1

Q ss_pred             CCCccccccccCCcceee-----cceEEEEEEEEeccCCcchhHHHHHHHhhhcc-C-----CceeEeeeeeecCCeEEE
Q 040702          513 RFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIR-H-----RNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk-----~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H-----pniv~l~~~~~~~~~~~l  581 (797)
                      +|.+.+.||+|+||.|-|     +++.||||+++.... -..+...|+++|+.++ |     -|+|+++++|...++.||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            889999999999999986     479999999985532 2456677999999997 4     399999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCC--CcEEEEeecCCccC
Q 040702          582 VLEYMPLGSLEKCLYSGNY-ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN--MVAHLSDFGMAKPL  658 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~--~~~kl~DFGla~~~  658 (797)
                      |+|.+.. +|+++++..+. .++...++.++.||+.||.+||   ..+|||+||||||||+.+.  ..+||+|||.|+..
T Consensus       266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            9999964 99999987665 6889999999999999999999   9999999999999999643  47999999999864


Q ss_pred             CccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccc
Q 040702          659 LEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLI  711 (797)
Q Consensus       659 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~  711 (797)
                      ..     .....+-++.|+|||+|++.+|+.+.|+||+|++..++..+.+++.
T Consensus       342 ~q-----~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp  389 (586)
T KOG0667|consen  342 SQ-----RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP  389 (586)
T ss_pred             CC-----cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence            22     1225667889999999999999999999999998766555555443

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.97  E-value=9e-31  Score=277.43  Aligned_cols=227  Identities=20%  Similarity=0.230  Sum_probs=185.5

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      +.|.....||+|+||.||++     +..||||.+........+.+.+|+.+++.++||||+++++.+...+..|+||||+
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~  101 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL  101 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence            34444577999999999974     5789999987655445567889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccc
Q 040702          587 PLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  666 (797)
Q Consensus       587 ~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  666 (797)
                      ++++|.+++...  .+++..+..++.||+.|++|||   +.+|+||||||+||+++.++.+||+|||++........  .
T Consensus       102 ~~~~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~  174 (292)
T cd06658         102 EGGALTDIVTHT--RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--K  174 (292)
T ss_pred             CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--c
Confidence            999999988654  3788999999999999999999   99999999999999999999999999999875432221  2


Q ss_pred             ccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh-------------------hhhcccccchhc
Q 040702          667 QTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK-------------------HLMTKEQPMVRM  727 (797)
Q Consensus       667 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~l~~~  727 (797)
                      .....|+..|+|||.+.+..++.++|+|++|+..++.+.+..++.....                   .....+..+++.
T Consensus       175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  254 (292)
T cd06658         175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDL  254 (292)
T ss_pred             CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHH
Confidence            2345689999999999888899999999999887555544433221100                   112245678889


Q ss_pred             cccCCCCCCCChHHHHHh
Q 040702          728 GTDLSLGQFPASYSISKY  745 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~~  745 (797)
                      |+..||.+||++.++++.
T Consensus       255 ~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         255 MLVREPSQRATAQELLQH  272 (292)
T ss_pred             HccCChhHCcCHHHHhhC
Confidence            999999999999998864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.97  E-value=1.4e-30  Score=302.18  Aligned_cols=233  Identities=20%  Similarity=0.264  Sum_probs=183.7

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEecc--CCcchhHHHHHHHhhhccCCceeEeeeeeec--CCeEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISSCSN--DDFKA  580 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~--~~~~~  580 (797)
                      ..++|.+.+.||+|+||.||++     +..||+|.+....  ......+..|+.++++++|||||+++++|..  .+..|
T Consensus        11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly   90 (1021)
T PTZ00266         11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY   90 (1021)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence            4578999999999999999974     5789999987542  2234678899999999999999999998854  35789


Q ss_pred             EEEEccCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHccC----CCCeEEcCCCCCceEEcC----------
Q 040702          581 LVLEYMPLGSLEKCLYSG---NYILDIFQGLNIMIDVASALEYLHFGY----SVPIIHCDLKPSNVLLDD----------  643 (797)
Q Consensus       581 lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~al~yLH~~~----~~~ivHrDlkp~NIll~~----------  643 (797)
                      +||||+++|+|.+++...   ...+++..++.|+.||+.||.|||...    .++|+||||||+|||++.          
T Consensus        91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~  170 (1021)
T PTZ00266         91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA  170 (1021)
T ss_pred             EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence            999999999999998652   235899999999999999999999321    146999999999999964          


Q ss_pred             -------CCcEEEEeecCCccCCccCccccccccccCccccccccccc--CccchHHHHHHHhhhhhhhhccccccchhh
Q 040702          644 -------NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS--GEMRLKCWVNDSLLISVMIVVDANLLIREE  714 (797)
Q Consensus       644 -------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~  714 (797)
                             .+.+||+|||+++......   ......||+.|+|||.+..  ..++.++|||++|++.+..+....++....
T Consensus       171 ~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        171 QANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             cccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                   2348999999998653221   2234579999999999864  347899999999999866665544432110


Q ss_pred             -----------------hhhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          715 -----------------KHLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       715 -----------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                                       ......+.+++..||..+|.+||++.|++..
T Consensus       248 ~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        248 NFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             cHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence                             0112356788999999999999999998853

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.97  E-value=3e-30  Score=268.82  Aligned_cols=232  Identities=20%  Similarity=0.273  Sum_probs=187.6

Q ss_pred             hcCCCccccccccCCcceeec----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          511 TNRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      .++|...+.||+|+||.||++    +..+|+|.+.... ...+.+.+|++++++++|+||+++++++.. ...++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            467899999999999999975    3679999886442 234678899999999999999999999887 7789999999


Q ss_pred             CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          587 PLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       587 ~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      ++|+|.+++.... ...++..+..++.|++.|++|||   ..+++||||||+||+++.++.+||+|||.+....... ..
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-~~  158 (260)
T cd05073          83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-YT  158 (260)
T ss_pred             CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCC-cc
Confidence            9999999997643 35788899999999999999999   8999999999999999999999999999997653322 11


Q ss_pred             cccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-h----------------hhhhcccccchhc
Q 040702          666 TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-E----------------KHLMTKEQPMVRM  727 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-~----------------~~~~~~~~~l~~~  727 (797)
                      ......++..|+|||.+..+.++.++|+|++|+..+..+. +..++... .                ......+.+++.+
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  238 (260)
T cd05073         159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMR  238 (260)
T ss_pred             cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHHH
Confidence            2233446678999999988889999999999998755553 33222111 0                1122356778999


Q ss_pred             cccCCCCCCCChHHHHHhHHH
Q 040702          728 GTDLSLGQFPASYSISKYLVY  748 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~~l~~  748 (797)
                      |++.+|++||++.++.+.|+.
T Consensus       239 ~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         239 CWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             HcccCcccCcCHHHHHHHHhc
Confidence            999999999999999988864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.97  E-value=4.8e-30  Score=269.93  Aligned_cols=227  Identities=23%  Similarity=0.297  Sum_probs=188.1

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEecc-CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      ..|+..+.||+|+||.||++     +..||+|.+.... ....+.+.+|+.++++++||||+++++++.+++..|+||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            46778889999999999985     5789999987543 23356788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      +++|+|.+++...  .+++.....++.|++.|++|+|   +.+++|+||+|+||+++.++.++++|||++........  
T Consensus        84 ~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--  156 (277)
T cd06640          84 LGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--  156 (277)
T ss_pred             CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--
Confidence            9999999998754  3788899999999999999999   99999999999999999999999999999976533221  


Q ss_pred             cccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh-----------------hhhhcccccchhcc
Q 040702          666 TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE-----------------KHLMTKEQPMVRMG  728 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~l~~~c  728 (797)
                      ......++..|+|||.+.+..++.++|+|++|+..+..+.+..++....                 ......+.++++.|
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  236 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDAC  236 (277)
T ss_pred             ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHH
Confidence            2233468889999999988889999999999998866555544332111                 01223466889999


Q ss_pred             ccCCCCCCCChHHHHHh
Q 040702          729 TDLSLGQFPASYSISKY  745 (797)
Q Consensus       729 l~~dp~~RPs~~~i~~~  745 (797)
                      +..+|++||++.+++..
T Consensus       237 l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         237 LNKDPSFRPTAKELLKH  253 (277)
T ss_pred             cccCcccCcCHHHHHhC
Confidence            99999999999999775

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.97  E-value=1.6e-30  Score=271.28  Aligned_cols=233  Identities=25%  Similarity=0.298  Sum_probs=188.4

Q ss_pred             ccccCCcceeec-----ceEEEEEEEEeccC---CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccCCCCH
Q 040702          520 IGRGGFGPVYKD-----GMEVAIKVFNLQYG---GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSL  591 (797)
Q Consensus       520 lg~G~~g~Vyk~-----~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~g~L  591 (797)
                      ||+|+||.||++     ++.||+|.+.....   ...+.+.+|++++++++||||+++++.+..++..|+||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999973     68899999875533   3356788899999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc------cc
Q 040702          592 EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ------SL  665 (797)
Q Consensus       592 ~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~------~~  665 (797)
                      .+++.... .+++..+..++.|+++||+|||   ..+++|+||+|+||+++.++.++|+|||++........      ..
T Consensus        81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  156 (265)
T cd05579          81 ASLLENVG-SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK  156 (265)
T ss_pred             HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence            99997755 4899999999999999999999   99999999999999999999999999999875433211      11


Q ss_pred             cccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh----------------h--hhcccccchhc
Q 040702          666 TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK----------------H--LMTKEQPMVRM  727 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~----------------~--~~~~~~~l~~~  727 (797)
                      ......++..|+|||.......+.++|+|++|+..+..+.+..++.....                .  ....+.++++.
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  236 (265)
T cd05579         157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISK  236 (265)
T ss_pred             cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHH
Confidence            22345688899999999888889999999999887554443333211100                0  13456788888


Q ss_pred             cccCCCCCCCChHHHHHhHHHHHHHhccccccccccCCcccccceeeeeee
Q 040702          728 GTDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDY  778 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~  778 (797)
                      |++.+|++||++.++.+.                      ++|+||++++|
T Consensus       237 ~l~~~p~~Rpt~~~~~~~----------------------l~~~~~~~~~~  265 (265)
T cd05579         237 LLVPDPEKRLGAKSIEEI----------------------KNHPFFKGIDW  265 (265)
T ss_pred             HhcCCHhhcCCCccHHHH----------------------hcCccccCCCC
Confidence            999999999998666643                      45889999888

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.97  E-value=3.7e-30  Score=273.86  Aligned_cols=226  Identities=24%  Similarity=0.316  Sum_probs=181.4

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEeccCC-----cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG-----AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~-----~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      +|+..+.||+|+||.||++     ++.||||.++.....     ....+..|++++++++||||+++++++.+.+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            4778889999999999985     578999999765322     234567899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      |||+ +|+|.+++......+++..+..++.||++||+|||   +++|+|+||||+||+++.++.+||+|||+++......
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence            9999 88999999776545899999999999999999999   9999999999999999999999999999998654332


Q ss_pred             ccccccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccch-hh--------------------------
Q 040702          663 QSLTQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIR-EE--------------------------  714 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~-~~--------------------------  714 (797)
                      .  ......+++.|+|||.+.+ ..++.++|+|++|+..+..+....++.. .+                          
T Consensus       157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (298)
T cd07841         157 R--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP  234 (298)
T ss_pred             c--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence            1  2233457889999998865 4578999999999887544433221110 00                          


Q ss_pred             -----------------hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          715 -----------------KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       715 -----------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                       ......+.++++.|+..||++||++.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence                             001223456889999999999999988886

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.97  E-value=2.1e-30  Score=275.25  Aligned_cols=226  Identities=19%  Similarity=0.222  Sum_probs=186.1

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccC
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  587 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~  587 (797)
                      .|+....||+|+||.||++     +..||+|.+........+.+.+|+.+++.++||||+++++++..++..|+||||++
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~  101 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ  101 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence            3444568999999999975     57899999976655555678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccccc
Q 040702          588 LGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ  667 (797)
Q Consensus       588 ~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  667 (797)
                      +++|..++...  .+++..+..++.|++.|++|||   +.+++||||||+||+++.++.+||+|||++........  ..
T Consensus       102 ~~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~  174 (297)
T cd06659         102 GGALTDIVSQT--RLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KR  174 (297)
T ss_pred             CCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cc
Confidence            99999987654  3789999999999999999999   99999999999999999999999999999875533221  22


Q ss_pred             cccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh-------------------hhhhcccccchhcc
Q 040702          668 TQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE-------------------KHLMTKEQPMVRMG  728 (797)
Q Consensus       668 ~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~l~~~c  728 (797)
                      ....|+..|+|||.+.+..++.++|+|++|+..++.+.+..++....                   ......+.++++.|
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~  254 (297)
T cd06659         175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERM  254 (297)
T ss_pred             cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHH
Confidence            34568999999999988889999999999998765554443321110                   01123457789999


Q ss_pred             ccCCCCCCCChHHHHHh
Q 040702          729 TDLSLGQFPASYSISKY  745 (797)
Q Consensus       729 l~~dp~~RPs~~~i~~~  745 (797)
                      +..+|++||++.++++.
T Consensus       255 l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         255 LTREPQERATAQELLDH  271 (297)
T ss_pred             hcCCcccCcCHHHHhhC
Confidence            99999999999998874

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.97  E-value=2.7e-30  Score=272.65  Aligned_cols=237  Identities=23%  Similarity=0.270  Sum_probs=189.5

Q ss_pred             cCHHHHHHHhcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhc-cCCceeEeeeeeec
Q 040702          502 FTYLELFQATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRI-RHRNLIKIISSCSN  575 (797)
Q Consensus       502 ~~~~~l~~~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~  575 (797)
                      .+..++..+.+.|+..+.+|+|+||.||++     ++.||+|++..... ...++..|+.+++++ +||||+++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            466777778899999999999999999974     57899999865432 345788899999998 69999999999853


Q ss_pred             ------CCeEEEEEEccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEE
Q 040702          576 ------DDFKALVLEYMPLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAH  648 (797)
Q Consensus       576 ------~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~k  648 (797)
                            .+..|+||||+++|+|.+++.... ..+++..+..++.|+++|++|||   +.+|+|||+||+||++++++.++
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEE
Confidence                  457899999999999999987643 35788889999999999999999   99999999999999999999999


Q ss_pred             EEeecCCccCCccCccccccccccCcccccccccc-----cCccchHHHHHHHhhhhhhhhccccccchhhh--------
Q 040702          649 LSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIF-----SGEMRLKCWVNDSLLISVMIVVDANLLIREEK--------  715 (797)
Q Consensus       649 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~--------  715 (797)
                      |+|||++.......  .......|++.|+|||.+.     ...++.++|+|++|+..++.+....++.....        
T Consensus       162 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~  239 (282)
T cd06636         162 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIP  239 (282)
T ss_pred             EeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHh
Confidence            99999987543211  1223456899999999876     34578899999999987555544433221110        


Q ss_pred             ----------hhhcccccchhccccCCCCCCCChHHHHH
Q 040702          716 ----------HLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       716 ----------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                .....+.++++.|+..||.+||++.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         240 RNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             hCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence                      12235678999999999999999998864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.97  E-value=3.9e-30  Score=268.86  Aligned_cols=230  Identities=23%  Similarity=0.281  Sum_probs=189.2

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEecc-CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      ++|+..+.||+|+||.||++     +..||+|++.... ....+.+.+|++.++.++|+||+++++.+..++..|+||||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            47889999999999999975     4789999987543 22457789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          586 MPLGSLEKCLYSGN--YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       586 ~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      +++++|.+++....  ..+++..+..++.|++.|++|||   +.+++||||||+||++++++.+||+|||++........
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            99999999987532  35899999999999999999999   99999999999999999999999999999976654332


Q ss_pred             cc--cccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccccccchhhh----------------------hhh
Q 040702          664 SL--TQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANLLIREEK----------------------HLM  718 (797)
Q Consensus       664 ~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~----------------------~~~  718 (797)
                      ..  ......|+..|+|||.+... .++.++|+|++|+..+..+.+..++.....                      ...
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYS  237 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCcccccccc
Confidence            21  22345689999999998877 788999999999887655554443322110                      122


Q ss_pred             cccccchhccccCCCCCCCChHHHHH
Q 040702          719 TKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       719 ~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      ..+.++++.|+..||++||++.++++
T Consensus       238 ~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         238 KSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            34578999999999999999988875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.1e-30  Score=268.71  Aligned_cols=230  Identities=21%  Similarity=0.254  Sum_probs=182.3

Q ss_pred             ccccccCCcceeec-----ceEEEEEEEEeccCC---cchhHHHHHHHh-hhccCCceeEeeeeeecCCeEEEEEEccCC
Q 040702          518 NLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG---AFKSFDIECGMM-KRIRHRNLIKIISSCSNDDFKALVLEYMPL  588 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~---~~~~~~~E~~~l-~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~  588 (797)
                      +.||+|+||.||++     ++.||||+++.....   ....+..|..++ ...+|||++++++++..++..|+||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57899999999985     578999998754321   123344555544 445899999999999999999999999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccccc
Q 040702          589 GSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  668 (797)
Q Consensus       589 g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  668 (797)
                      ++|.+++.... .+++..+..++.|+++||.|||   +.+++||||+|+||+++.++.+||+|||+++....      ..
T Consensus        82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~  151 (260)
T cd05611          82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NK  151 (260)
T ss_pred             CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cc
Confidence            99999997654 4788999999999999999999   89999999999999999999999999999875432      22


Q ss_pred             ccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh--------------------hhhhcccccchhcc
Q 040702          669 QTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE--------------------KHLMTKEQPMVRMG  728 (797)
Q Consensus       669 ~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~l~~~c  728 (797)
                      ...|+..|+|||.+.+..++.++|+|++|+..++.+.+..++....                    ......+.+++..|
T Consensus       152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  231 (260)
T cd05611         152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRL  231 (260)
T ss_pred             cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHH
Confidence            3468899999999988888999999999998755554333221100                    01234567788889


Q ss_pred             ccCCCCCCCChHHHHHhHHHHHHHhccccccccccCCcccccceeeeeeee
Q 040702          729 TDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYT  779 (797)
Q Consensus       729 l~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~  779 (797)
                      +..+|++||++.++.+                      +++|+||+.++||
T Consensus       232 l~~~p~~R~~~~~~~~----------------------~l~~~~~~~~~~~  260 (260)
T cd05611         232 LCMDPAKRLGANGYQE----------------------IKSHPFFKSINWD  260 (260)
T ss_pred             ccCCHHHccCCCcHHH----------------------HHcChHhhcCCCC
Confidence            9999999998766643                      4678899999996

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.97  E-value=2.1e-30  Score=273.97  Aligned_cols=227  Identities=25%  Similarity=0.312  Sum_probs=182.9

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCC--cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG--AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      ++|+..+.||+|+||.||++     ++.||+|++......  ..+.+.+|+++++.++||||+++++++..++..|+|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46888899999999999984     578999987654322  24568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      |++++++.++..... .+++..+..++.|+++|++|||   +.+++|+|++|+||++++++.++|+|||++........ 
T Consensus        81 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-  155 (286)
T cd07846          81 FVDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-  155 (286)
T ss_pred             cCCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-
Confidence            999999988765543 4899999999999999999999   89999999999999999999999999999986533221 


Q ss_pred             ccccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchhh-----------------------------
Q 040702          665 LTQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIREE-----------------------------  714 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-----------------------------  714 (797)
                       ......++..|+|||.+.+ ..++.++|+|++|+..++.+.+..++....                             
T Consensus       156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07846         156 -VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF  234 (286)
T ss_pred             -ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence             2234568899999998865 346789999999998755554433221100                             


Q ss_pred             ------------------hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          715 ------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       715 ------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                        ......+.++++.|+..+|++||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence                              011234667899999999999999998875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=4.6e-31  Score=281.32  Aligned_cols=222  Identities=20%  Similarity=0.257  Sum_probs=180.0

Q ss_pred             CccccccccCCcceeec-----ceEEEEEEEEec----cCCcchhHHHHHHHhhhccCCceeEeeeeeecCCe--EEEEE
Q 040702          515 SENNLIGRGGFGPVYKD-----GMEVAIKVFNLQ----YGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDF--KALVL  583 (797)
Q Consensus       515 ~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~----~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~--~~lv~  583 (797)
                      .....||+|+|-+||||     |.+||--.++..    .....++|..|+++|+.++|||||++|++|.+...  .-+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            34478999999999996     566774333222    22335789999999999999999999999988765  77999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcC-CCcEEEEeecCCccCCccC
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD-NMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl~DFGla~~~~~~~  662 (797)
                      |.+..|+|..|.++.+. ++....+.|++||++||.|||+ +.++|+|||||-+||+|++ .|.|||+|.|+|...... 
T Consensus       123 EL~TSGtLr~Y~kk~~~-vn~kaik~W~RQILkGL~yLHs-~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s-  199 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHRR-VNIKAIKSWCRQILKGLVYLHS-QDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS-  199 (632)
T ss_pred             ecccCCcHHHHHHHhcc-CCHHHHHHHHHHHHHHhhhhhc-CCCCccccccccceEEEcCCcCceeecchhHHHHhhcc-
Confidence            99999999999988775 8889999999999999999994 4789999999999999975 589999999999865322 


Q ss_pred             ccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh-------------------hhhccccc
Q 040702          663 QSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK-------------------HLMTKEQP  723 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~  723 (797)
                         .....+|||.|||||... ..|+..+|||++|+-.++++....++..+..                   -.-+.+++
T Consensus       200 ---~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~  275 (632)
T KOG0584|consen  200 ---HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVRE  275 (632)
T ss_pred             ---ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHH
Confidence               233478999999999665 8899999999999876666554444333211                   11236789


Q ss_pred             chhccccCCCCCCCChHHHHH
Q 040702          724 MVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       724 l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      +|..|+.. .++||++.|+++
T Consensus       276 fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  276 FIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             HHHHHhcC-chhccCHHHHhh
Confidence            99999999 999999999887

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.97  E-value=4.4e-30  Score=271.83  Aligned_cols=228  Identities=23%  Similarity=0.259  Sum_probs=184.7

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEecc--CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      ++|+..+.||+|+||.||++     ++.||||.++...  ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888999999999999984     5789999987542  2334678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      |++++.+..+.... ..+++..+..++.|++.|++|||   ..+++|||++|+||++++++.+||+|||++........ 
T Consensus        81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-  155 (288)
T cd07833          81 YVERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-  155 (288)
T ss_pred             cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-
Confidence            99987776655443 34899999999999999999999   89999999999999999999999999999987643322 


Q ss_pred             ccccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccccccchh------------------------------
Q 040702          665 LTQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANLLIRE------------------------------  713 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~~~~~------------------------------  713 (797)
                      .......++..|+|||.+.+. .++.++|+|++|+..+..+.+..++...                              
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF  235 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence            122345688999999999888 7899999999998875444433222110                              


Q ss_pred             ------------------hhhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          714 ------------------EKHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       714 ------------------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                        +......+.++++.|+..+|++||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                              0011345678899999999999999988875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.97  E-value=7e-30  Score=266.97  Aligned_cols=228  Identities=21%  Similarity=0.281  Sum_probs=179.2

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccC-----CcchhHHHHHHHhhhccCCceeEeeeeeecC--CeE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG-----GAFKSFDIECGMMKRIRHRNLIKIISSCSND--DFK  579 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~-----~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~--~~~  579 (797)
                      .+|+..+.||+|+||.||++     +..||+|.+.....     ...+.+.+|+.++++++||||+++++++...  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            36888999999999999985     57899999875432     1234678899999999999999999988753  578


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCC
Q 040702          580 ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  659 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  659 (797)
                      +++|||+++++|.+++.... .+++.....++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            89999999999999987654 3788899999999999999999   9999999999999999999999999999997653


Q ss_pred             ccCc-cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh------------------hhhhcc
Q 040702          660 EEDQ-SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE------------------KHLMTK  720 (797)
Q Consensus       660 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~------------------~~~~~~  720 (797)
                      .... ........++..|+|||.+.+..++.++|+|++|+..++.+.+..++....                  ......
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEH  237 (266)
T ss_pred             cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHH
Confidence            2111 111223468899999999988888999999999998766555444332111                  111223


Q ss_pred             cccchhccccCCCCCCCChHHHHH
Q 040702          721 EQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       721 ~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      ++.++ .|+..+|++||+++|+++
T Consensus       238 ~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         238 ARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             HHHHH-HHhcCChhhCcCHHHHhc
Confidence            34455 477789999999888764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.97  E-value=4.4e-30  Score=267.83  Aligned_cols=233  Identities=21%  Similarity=0.265  Sum_probs=186.0

Q ss_pred             ccccCCcceeec-----ceEEEEEEEEeccC---CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccCCCCH
Q 040702          520 IGRGGFGPVYKD-----GMEVAIKVFNLQYG---GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSL  591 (797)
Q Consensus       520 lg~G~~g~Vyk~-----~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~g~L  591 (797)
                      ||.|+||.||++     ++.||+|++.....   ...+.+.+|+.++++++||||+++++++.+++..|+||||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999974     57899999975432   2346789999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccccccccc
Q 040702          592 EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL  671 (797)
Q Consensus       592 ~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  671 (797)
                      .+++.... .+++..+..++.|+++|++|+|   +.+++|+||||+||+++.++.+||+|||+++......   ......
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~  153 (262)
T cd05572          81 WTILRDRG-LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFC  153 (262)
T ss_pred             HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccccc
Confidence            99997754 3788999999999999999999   9999999999999999999999999999998664332   223356


Q ss_pred             cCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh---h-----------------hhhcccccchhccccC
Q 040702          672 ATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE---K-----------------HLMTKEQPMVRMGTDL  731 (797)
Q Consensus       672 gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~---~-----------------~~~~~~~~l~~~cl~~  731 (797)
                      |+..|+|||.+....++.++|+|++|+..+..+.+..++....   .                 .....+.+++..|+..
T Consensus       154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  233 (262)
T cd05572         154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRR  233 (262)
T ss_pred             CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccC
Confidence            8899999999888889999999999988755554444332222   0                 0113445677777877


Q ss_pred             CCCCCCChHHHHHhHHHHHHHhccccccccccCCcccccceeeeeeee
Q 040702          732 SLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYT  779 (797)
Q Consensus       732 dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~  779 (797)
                      +|++||++.+                    ..+.++++|+||++.+|+
T Consensus       234 ~p~~R~~~~~--------------------~~~~~l~~~~~~~~~~~~  261 (262)
T cd05572         234 NPEERLGNLK--------------------GGIKDIKKHKWFNGFDWE  261 (262)
T ss_pred             ChhhCcCCcc--------------------cCHHHHhcChhhhCCCCC
Confidence            8888877322                    223445668999998886

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.97  E-value=9.8e-30  Score=266.32  Aligned_cols=229  Identities=21%  Similarity=0.277  Sum_probs=184.4

Q ss_pred             CCCccccccccCCcceeec------ceEEEEEEEEecc----------CCcchhHHHHHHHhhh-ccCCceeEeeeeeec
Q 040702          513 RFSENNLIGRGGFGPVYKD------GMEVAIKVFNLQY----------GGAFKSFDIECGMMKR-IRHRNLIKIISSCSN  575 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~------~~~vAvK~~~~~~----------~~~~~~~~~E~~~l~~-l~Hpniv~l~~~~~~  575 (797)
                      +|+..+.||+|+||.||++      ++.+|+|.+....          .....++..|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            4788899999999999973      4789999886432          1123456778888865 799999999999999


Q ss_pred             CCeEEEEEEccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCceEEcCCCcEEEEe
Q 040702          576 DDFKALVLEYMPLGSLEKCLYS---GNYILDIFQGLNIMIDVASALEYLHFGYS-VPIIHCDLKPSNVLLDDNMVAHLSD  651 (797)
Q Consensus       576 ~~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~al~yLH~~~~-~~ivHrDlkp~NIll~~~~~~kl~D  651 (797)
                      ++..++||||+++++|.+++..   ....+++..++.++.|++.|+.|||   . .+++|+||||+||+++.++.+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEEec
Confidence            9999999999999999988743   3335889999999999999999999   5 6799999999999999999999999


Q ss_pred             ecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh-----------------
Q 040702          652 FGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE-----------------  714 (797)
Q Consensus       652 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-----------------  714 (797)
                      ||.+.......   ......|+..|+|||.+.++.++.++|+|++|+..+..+....++....                 
T Consensus       158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  234 (269)
T cd08528         158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP  234 (269)
T ss_pred             ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCC
Confidence            99998653322   2344568999999999998889999999999988755544333321100                 


Q ss_pred             -hhhhcccccchhccccCCCCCCCChHHHHHhHH
Q 040702          715 -KHLMTKEQPMVRMGTDLSLGQFPASYSISKYLV  747 (797)
Q Consensus       715 -~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~  747 (797)
                       ......+.+++++|++.||++||++.|+.+.++
T Consensus       235 ~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         235 EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence             012345678889999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.97  E-value=8.4e-30  Score=270.41  Aligned_cols=227  Identities=20%  Similarity=0.236  Sum_probs=182.4

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCC--cchhHHHHHHHhhhccCCceeEeeeeeecC--CeEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG--AFKSFDIECGMMKRIRHRNLIKIISSCSND--DFKALV  582 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~--~~~~lv  582 (797)
                      ++|+..+.||+|+||.||++     ++.||+|.++.....  ....+.+|+.++++++||||+++++++..+  +..|+|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            57888999999999999984     578999999765322  234567899999999999999999998877  889999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      |||++ ++|.+++......+++..+..++.|+++||+|||   +.+++|+||||+||+++.++.+||+|||+++......
T Consensus        85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            99997 4999988765556899999999999999999999   9999999999999999999999999999998664332


Q ss_pred             ccccccccccCcccccccccccCc-cchHHHHHHHhhhhhhhhccccccchh----------------------------
Q 040702          663 QSLTQTQTLATIGYMAPDEIFSGE-MRLKCWVNDSLLISVMIVVDANLLIRE----------------------------  713 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~dv~s~~~~~~~~~~~~~~~~~~----------------------------  713 (797)
                      .  ......+++.|+|||.+.+.. ++.++|+|++|+..+..+.+..++...                            
T Consensus       161 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
T cd07843         161 K--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP  238 (293)
T ss_pred             c--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence            1  223345788999999887544 588999999998875544432221100                            


Q ss_pred             -------------------hhh-hhcccccchhccccCCCCCCCChHHHHH
Q 040702          714 -------------------EKH-LMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       714 -------------------~~~-~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                         +.. ......++++.|++.||++||++.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                               000 1334567899999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-30  Score=233.49  Aligned_cols=220  Identities=24%  Similarity=0.308  Sum_probs=177.0

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      ..|+..++||+|.||+|||+     ++.||+|+++....  +......+|+.+++.++|.|||++++....+....+|+|
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            35777899999999999986     48899999987643  335678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      ||.. +|..+.....+.++...++.++.|+++|+.++|   ++++.|||+||.|.++..+|+.|++|||+|+.++-.-  
T Consensus        82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgipv--  155 (292)
T KOG0662|consen   82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV--  155 (292)
T ss_pred             HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCce--
Confidence            9964 999999887777999999999999999999999   9999999999999999999999999999999764321  


Q ss_pred             ccccccccCcccccccccccCc-cchHHHHHHHhhhh--hhhhccccccchhhhhhhcccccchhccccCCCCCCCChH
Q 040702          665 LTQTQTLATIGYMAPDEIFSGE-MRLKCWVNDSLLIS--VMIVVDANLLIREEKHLMTKEQPMVRMGTDLSLGQFPASY  740 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~dv~s~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPs~~  740 (797)
                      .-.+..+-|.+|++|.++++.. |+..-|+||.|++.  +.....|-+.+....++..   .+.+..=.+..++.|+|.
T Consensus       156 rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlk---rif~~lg~p~ed~wps~t  231 (292)
T KOG0662|consen  156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK---RIFRLLGTPTEDQWPSMT  231 (292)
T ss_pred             EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHH---HHHHHhCCCccccCCccc
Confidence            1234457899999999998765 78999999999986  4444444444444444333   444443334444555543

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.97  E-value=5.8e-30  Score=271.45  Aligned_cols=227  Identities=24%  Similarity=0.321  Sum_probs=187.7

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      ++|...+.||+|+||.||++     +..||+|.+........+.+.+|+.++++++||||+++++++..++..|+|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            68889999999999999985     4789999987655444577889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccc
Q 040702          587 PLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  666 (797)
Q Consensus       587 ~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  666 (797)
                      ++++|.+++....  +++..+..++.|++.|+.|||   +.+++||||||+||+++.++.+||+|||++........  .
T Consensus        99 ~~~~L~~~~~~~~--l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~--~  171 (293)
T cd06647          99 AGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K  171 (293)
T ss_pred             CCCcHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc--c
Confidence            9999999987643  788899999999999999999   99999999999999999999999999998875533221  2


Q ss_pred             ccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh-------------------hhhhcccccchhc
Q 040702          667 QTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE-------------------KHLMTKEQPMVRM  727 (797)
Q Consensus       667 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~l~~~  727 (797)
                      .....|++.|+|||.+..+.++.++|+|++|+..+..+.+..++....                   ......+.++++.
T Consensus       172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  251 (293)
T cd06647         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR  251 (293)
T ss_pred             cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHH
Confidence            233468899999999988888999999999988755554443322110                   0112346688999


Q ss_pred             cccCCCCCCCChHHHHHh
Q 040702          728 GTDLSLGQFPASYSISKY  745 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~~  745 (797)
                      |+..+|++||++.+++..
T Consensus       252 ~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         252 CLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             HccCChhhCcCHHHHhcC
Confidence            999999999998887753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.97  E-value=6e-30  Score=265.82  Aligned_cols=227  Identities=20%  Similarity=0.248  Sum_probs=186.5

Q ss_pred             CCCccccccccCCcceee-----cceEEEEEEEEecc--CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          513 RFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk-----~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      +|+..+.||+|+||.||+     +++.||+|.+....  ....+++.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            478889999999999997     36889999987542  22345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          586 MPLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       586 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      +++++|.+++.... ..+++..+..++.|++.|+.|||   +.+++|+||+|+||+++.++.++++|||.+........ 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  156 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-  156 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence            99999999987643 25788999999999999999999   89999999999999999999999999999976533221 


Q ss_pred             ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccch-----------------hhhhhhcccccchhc
Q 040702          665 LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIR-----------------EEKHLMTKEQPMVRM  727 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~l~~~  727 (797)
                       ......|++.|+|||.+.+..++.++|+|++|+..+..+....++..                 .+......+.++++.
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  235 (256)
T cd08218         157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQ  235 (256)
T ss_pred             -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHH
Confidence             12334688999999999888889999999999887554444332211                 011123356788999


Q ss_pred             cccCCCCCCCChHHHHH
Q 040702          728 GTDLSLGQFPASYSISK  744 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~  744 (797)
                      |++.+|++||++.++++
T Consensus       236 ~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         236 LFKRNPRDRPSVNSILE  252 (256)
T ss_pred             HhhCChhhCcCHHHHhh
Confidence            99999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.96  E-value=4.2e-30  Score=271.69  Aligned_cols=227  Identities=22%  Similarity=0.308  Sum_probs=183.5

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      ++|+..+.||+|+||.||++     +..||+|.++.... ...+.+.+|+.++++++||||+++++++...+..|+||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            36888899999999999974     58899999875422 2346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          586 MPLGSLEKCLYSG--NYILDIFQGLNIMIDVASALEYLHFGYS-VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       586 ~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~al~yLH~~~~-~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      +++++|..++...  ...+++..+..++.|+++|+.|||   . .+|+||||||+||+++.++.+||+|||++...... 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  156 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK---EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-  156 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence            9999999988764  225899999999999999999999   5 58999999999999999999999999999765322 


Q ss_pred             ccccccccccCcccccccccccC------ccchHHHHHHHhhhhhhhhccccccch--------------------hhhh
Q 040702          663 QSLTQTQTLATIGYMAPDEIFSG------EMRLKCWVNDSLLISVMIVVDANLLIR--------------------EEKH  716 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~dv~s~~~~~~~~~~~~~~~~~--------------------~~~~  716 (797)
                         ......|+..|+|||.+.+.      .++.++|+|++|+..+..+.+..++..                    .+..
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd06622         157 ---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG  233 (286)
T ss_pred             ---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcc
Confidence               12334688899999988543      347899999999987555544333211                    0011


Q ss_pred             hhcccccchhccccCCCCCCCChHHHHHh
Q 040702          717 LMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       717 ~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                      ....+.++++.|+..+|++||++.++.+.
T Consensus       234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             cCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            22345678899999999999999988874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.96  E-value=1.3e-30  Score=294.94  Aligned_cols=233  Identities=23%  Similarity=0.330  Sum_probs=180.8

Q ss_pred             HHhcCCCccccccccCCcceee-----cceEEEEEEEEecc-CCcchhHHHHHHHhhhccCCceeEeeeeeec-------
Q 040702          509 QATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLIKIISSCSN-------  575 (797)
Q Consensus       509 ~~~~~f~~~~~lg~G~~g~Vyk-----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~-------  575 (797)
                      .-..+|+..+.||+||||.|||     +|..||||++.... ......+.+|++++++++|||||+++..|.+       
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            3456899999999999999998     47999999998664 2234678899999999999999999865511       


Q ss_pred             ------------------------------------------------C-------------------------------
Q 040702          576 ------------------------------------------------D-------------------------------  576 (797)
Q Consensus       576 ------------------------------------------------~-------------------------------  576 (797)
                                                                      .                               
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                            0                               


Q ss_pred             ---------------------------------CeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHc
Q 040702          577 ---------------------------------DFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHF  623 (797)
Q Consensus       577 ---------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~  623 (797)
                                                       -..||-||||+.-++.++++.....-.....+++++||++||.|+| 
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH-  714 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH-  714 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH-
Confidence                                             1247899999987777777665432146678999999999999999 


Q ss_pred             cCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCC----------------ccCccccccccccCcccccccccccC--
Q 040702          624 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL----------------EEDQSLTQTQTLATIGYMAPDEIFSG--  685 (797)
Q Consensus       624 ~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~--  685 (797)
                        ..|||||||||.||++|++..+||+|||+|+...                ........++.+||.-|+|||.+.+.  
T Consensus       715 --~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~  792 (1351)
T KOG1035|consen  715 --DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS  792 (1351)
T ss_pred             --hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence              9999999999999999999999999999998621                01111234678899999999988654  


Q ss_pred             -ccchHHHHHHHhhhhhhhhcc----------------cccc--chhhhhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          686 -EMRLKCWVNDSLLISVMIVVD----------------ANLL--IREEKHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       686 -~~~~~~dv~s~~~~~~~~~~~----------------~~~~--~~~~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                       .|+.+.|+||+|++.++++..                +.+.  ..+....+.....+++++++.||.+|||+.|++.
T Consensus       793 ~~Yn~KiDmYSLGIVlFEM~yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  793 NKYNSKIDMYSLGIVLFEMLYPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             ccccchhhhHHHHHHHHHHhccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence             499999999999976443321                1111  1122334456678899999999999999999875

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.96  E-value=3.7e-30  Score=268.88  Aligned_cols=226  Identities=23%  Similarity=0.254  Sum_probs=187.2

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      ++|+..+.||+|+||.||++     ++.||+|++..... ...+++.+|++++++++||||+++++++..++..++|+||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            36788899999999999985     57899999876532 3346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS-VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~-~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      +++++|.+++......+++..+..++.|+++|++|+|   + .+++|+||||+||+++.++.+||+|||.+.......  
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~--  155 (265)
T cd06605          81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--  155 (265)
T ss_pred             cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH--
Confidence            9999999999876456889999999999999999999   8 999999999999999999999999999987553221  


Q ss_pred             ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh------h----------------hh-hhccc
Q 040702          665 LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE------E----------------KH-LMTKE  721 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~------~----------------~~-~~~~~  721 (797)
                        .....|+..|+|||.+.+..++.++|+|++|+..+..+....++...      .                .. ....+
T Consensus       156 --~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (265)
T cd06605         156 --AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF  233 (265)
T ss_pred             --hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence              11267889999999998888999999999999875555433322111      0                00 22346


Q ss_pred             ccchhccccCCCCCCCChHHHHH
Q 040702          722 QPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       722 ~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      .+++..|+..||++||++.+++.
T Consensus       234 ~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         234 QDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             HHHHHHHcCCCchhCcCHHHHhh
Confidence            77889999999999999988864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.96  E-value=4.5e-30  Score=272.18  Aligned_cols=237  Identities=21%  Similarity=0.239  Sum_probs=187.0

Q ss_pred             cCHHHHHHHhcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhc-cCCceeEeeeeeec
Q 040702          502 FTYLELFQATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRI-RHRNLIKIISSCSN  575 (797)
Q Consensus       502 ~~~~~l~~~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~  575 (797)
                      +++.++..++++|...+.||+|+||.||++     ++.||+|++..... ....+.+|+.+++++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            455666777899999999999999999974     57899999865422 235678899999999 79999999999875


Q ss_pred             C-----CeEEEEEEccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcE
Q 040702          576 D-----DFKALVLEYMPLGSLEKCLYS---GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVA  647 (797)
Q Consensus       576 ~-----~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~  647 (797)
                      .     +..|+||||+++|+|.++++.   ....+++..++.++.|++.|++|||   ..+++||||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCE
Confidence            4     358999999999999998763   2335889999999999999999999   9999999999999999999999


Q ss_pred             EEEeecCCccCCccCccccccccccCcccccccccccC-----ccchHHHHHHHhhhhhhhhccccccchh-h-------
Q 040702          648 HLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG-----EMRLKCWVNDSLLISVMIVVDANLLIRE-E-------  714 (797)
Q Consensus       648 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~dv~s~~~~~~~~~~~~~~~~~~-~-------  714 (797)
                      ||+|||++........  ......|+..|+|||.+..+     .++.++|+|++|+..+....+..++... +       
T Consensus       168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~  245 (291)
T cd06639         168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI  245 (291)
T ss_pred             EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHH
Confidence            9999999986533221  12335688999999987543     2678999999998875554433322111 0       


Q ss_pred             -----------hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          715 -----------KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       715 -----------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                 ......+.++++.|++.+|++||++.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         246 PRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             hcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                       011123557899999999999999998875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.96  E-value=7.2e-30  Score=265.14  Aligned_cols=226  Identities=23%  Similarity=0.300  Sum_probs=184.9

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEecc--CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      +|+..+.||+|+||.||++     +..+|||.+....  ....+.+.+|++++++++||||+++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4788899999999999973     5889999987553  22346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCC-CcEEEEeecCCccCCccCc
Q 040702          586 MPLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN-MVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       586 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~DFGla~~~~~~~~  663 (797)
                      +++++|.+++.... ..+++..+..++.|+++|++|||   +++++|+||||+||+++.+ +.+|++|||.+....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-  156 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-  156 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence            99999999997643 35889999999999999999999   9999999999999999855 468999999998654322 


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh-----------------hhhhhcccccchh
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE-----------------EKHLMTKEQPMVR  726 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~l~~  726 (797)
                        ......|+..|+|||.+.+..++.++|+|++|+..+..+....++...                 +......+.+++.
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  234 (256)
T cd08220         157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLIL  234 (256)
T ss_pred             --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHH
Confidence              223356889999999998888899999999998875544433322211                 1112335678899


Q ss_pred             ccccCCCCCCCChHHHHH
Q 040702          727 MGTDLSLGQFPASYSISK  744 (797)
Q Consensus       727 ~cl~~dp~~RPs~~~i~~  744 (797)
                      .|+..+|++||++.|++.
T Consensus       235 ~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         235 SMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             HHccCChhhCCCHHHHhh
Confidence            999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.96  E-value=2.7e-30  Score=267.06  Aligned_cols=191  Identities=25%  Similarity=0.340  Sum_probs=163.0

Q ss_pred             cccccccCCcceee-----cceEEEEEEEEecc--CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccCCC
Q 040702          517 NNLIGRGGFGPVYK-----DGMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLG  589 (797)
Q Consensus       517 ~~~lg~G~~g~Vyk-----~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~g  589 (797)
                      .+.||+|.||.||-     +|+.||||++++-.  ......+.+|+.+|+.++||.||.+-..|+.+++.++|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            48999999999994     58999999998653  223467889999999999999999999999999999999999665


Q ss_pred             CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCC---CcEEEEeecCCccCCccCcccc
Q 040702          590 SLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN---MVAHLSDFGMAKPLLEEDQSLT  666 (797)
Q Consensus       590 ~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~---~~~kl~DFGla~~~~~~~~~~~  666 (797)
                      =|+-++....+.+++...+.++.||+.||+|||   .++|+|+|+||+|||+.+.   -.+||||||+|+.+++..   .
T Consensus       649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks---F  722 (888)
T KOG4236|consen  649 MLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS---F  722 (888)
T ss_pred             HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhh---h
Confidence            555566665667999888899999999999999   9999999999999999643   369999999999886543   3


Q ss_pred             ccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh
Q 040702          667 QTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE  713 (797)
Q Consensus       667 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~  713 (797)
                      ....+||+.|.|||++...+|.-.-|+||+|++.+..+-+..++...
T Consensus       723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd  769 (888)
T KOG4236|consen  723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED  769 (888)
T ss_pred             hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc
Confidence            45689999999999999999999999999999987766666555443

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.96  E-value=9.9e-30  Score=264.38  Aligned_cols=225  Identities=25%  Similarity=0.326  Sum_probs=184.8

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEeccC-----CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG-----GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~-----~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      +|+..+.||+|+||.||++     +..||+|.+.....     ...+.+.+|+.++++++||||+++++++..++..++|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4777899999999999984     57899999876532     2346788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      |||+++++|.+++.... .+++..+..++.|+++|++|||   +.+|+|+||+|+||+++.++.+||+|||.+.......
T Consensus        81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence            99999999999997654 4789999999999999999999   9999999999999999999999999999987653322


Q ss_pred             ccccccccccCcccccccccccCc-cchHHHHHHHhhhhhhhhccccccchhh------------------hhhhccccc
Q 040702          663 QSLTQTQTLATIGYMAPDEIFSGE-MRLKCWVNDSLLISVMIVVDANLLIREE------------------KHLMTKEQP  723 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~dv~s~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~  723 (797)
                         ......|+..|+|||.+.... ++.++|+|++|+..+..+.+..++....                  ......+.+
T Consensus       157 ---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (258)
T cd06632         157 ---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKD  233 (258)
T ss_pred             ---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHH
Confidence               223456899999999987766 8899999999988755554433322111                  011234567


Q ss_pred             chhccccCCCCCCCChHHHHH
Q 040702          724 MVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       724 l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      ++++|+..+|++||++.+++.
T Consensus       234 li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         234 FILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             HHHHHhhcCcccCcCHHHHhc
Confidence            888999999999999998875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.96  E-value=1.6e-29  Score=265.94  Aligned_cols=226  Identities=24%  Similarity=0.296  Sum_probs=185.6

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEecc-CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      -|+..+.||+|+||.||++     +..||||.+.... ....+.+.+|+.++++++||||+++++++..++..|+||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            4677789999999999975     4789999886443 223467889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccc
Q 040702          587 PLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  666 (797)
Q Consensus       587 ~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  666 (797)
                      ++++|.+++...  .+++..+..++.|++.|+.|||   ..+++|+||||+||+++.++.++|+|||++........  .
T Consensus        85 ~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~--~  157 (277)
T cd06641          85 GGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--K  157 (277)
T ss_pred             CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchh--h
Confidence            999999998754  4789999999999999999999   99999999999999999999999999999876533211  2


Q ss_pred             ccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh-----------------hhhcccccchhccc
Q 040702          667 QTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK-----------------HLMTKEQPMVRMGT  729 (797)
Q Consensus       667 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~l~~~cl  729 (797)
                      .....|+..|+|||.+.....+.++|+|++|+..+..+.+..++.....                 .....+.+++..|+
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  237 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACL  237 (277)
T ss_pred             hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHc
Confidence            2335688899999999888888999999999887555544443321110                 11234677899999


Q ss_pred             cCCCCCCCChHHHHHh
Q 040702          730 DLSLGQFPASYSISKY  745 (797)
Q Consensus       730 ~~dp~~RPs~~~i~~~  745 (797)
                      ..+|.+||++.++++.
T Consensus       238 ~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         238 NKEPSFRPTAKELLKH  253 (277)
T ss_pred             cCChhhCcCHHHHHhC
Confidence            9999999999999884

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.96  E-value=7.4e-30  Score=267.04  Aligned_cols=228  Identities=24%  Similarity=0.335  Sum_probs=184.4

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEeccCC------cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEE
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG------AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l  581 (797)
                      +|+..+.||+|+||.||++     ++.||+|.+......      ..+.+.+|++++++++||||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            4778899999999999974     588999998754311      23578899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCC-cEEEEeecCCccCCc
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM-VAHLSDFGMAKPLLE  660 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DFGla~~~~~  660 (797)
                      ||||+++++|.+++.... .+++..+..++.|++.|++|||   +.+++|+||||+||+++.++ .+||+|||.+.....
T Consensus        81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence            999999999999997654 4888999999999999999999   99999999999999998775 599999999976643


Q ss_pred             cCcc--ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh---------------------hhh
Q 040702          661 EDQS--LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE---------------------KHL  717 (797)
Q Consensus       661 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~---------------------~~~  717 (797)
                      ....  .......||..|+|||.+.+..++.++|+|++|+..+..+.+..++....                     ...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (268)
T cd06630         157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHL  236 (268)
T ss_pred             ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhh
Confidence            2111  11223468899999999988888999999999988755544443322110                     112


Q ss_pred             hcccccchhccccCCCCCCCChHHHHH
Q 040702          718 MTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       718 ~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      ...+.+++..|+..+|++||++.++++
T Consensus       237 ~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         237 SPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            235567888999999999999988875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.96  E-value=1.4e-30  Score=253.78  Aligned_cols=230  Identities=21%  Similarity=0.264  Sum_probs=178.5

Q ss_pred             HhcCCCccccccccCCcceeec---------ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeec-CC
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD---------GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSN-DD  577 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~---------~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~-~~  577 (797)
                      .-..|+....||+|.||.|||+         ...+|+|.++....  +.-....+|+.+++.++||||+.+..++.. +.
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            3457899999999999999986         24899999976533  234578899999999999999999999877 77


Q ss_pred             eEEEEEEccCCCCHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCC----CcEEE
Q 040702          578 FKALVLEYMPLGSLEKCLYSGN----YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN----MVAHL  649 (797)
Q Consensus       578 ~~~lv~e~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~----~~~kl  649 (797)
                      ..++++||.+. +|.++++-++    +.++....+.|++||+.|+.|||   +.=|+|||+||.|||+..+    |.+||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEe
Confidence            89999999987 9999886432    26888899999999999999999   8889999999999999877    89999


Q ss_pred             EeecCCccCCccCcc-ccccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccccccchhhhhh-------hcc
Q 040702          650 SDFGMAKPLLEEDQS-LTQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANLLIREEKHL-------MTK  720 (797)
Q Consensus       650 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~~~-------~~~  720 (797)
                      +|||+|+.+...-.. ......+-|.+|+|||.+++. .|+.+.|+|++|++..+.+.-.+++...+.+.       ..+
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ  257 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ  257 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence            999999977543222 133456789999999998875 58999999999999755555555544444332       123


Q ss_pred             cccchhccccCCCCCCCChHHHH
Q 040702          721 EQPMVRMGTDLSLGQFPASYSIS  743 (797)
Q Consensus       721 ~~~l~~~cl~~dp~~RPs~~~i~  743 (797)
                      +..++...=.++-++.|.++..-
T Consensus       258 l~rIf~vLG~Pt~~~Wp~lkk~P  280 (438)
T KOG0666|consen  258 LDRIFEVLGTPTDKDWPDLKKMP  280 (438)
T ss_pred             HHHHHHHcCCCccccchhhhhCc
Confidence            34444444455555666554433

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.96  E-value=1.3e-29  Score=264.56  Aligned_cols=228  Identities=26%  Similarity=0.365  Sum_probs=187.3

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEeccCC--cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG--AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      +|+..+.||+|+||.||++     +..||+|.++.....  ..+.+..|+.++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            5788899999999999985     578999999866443  457889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      +++++|.+++.... .+++..+..++.|++.|++|||   +.+|+|+||+|+||++++++.+||+|||.+..........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            99999999997754 3788899999999999999999   9999999999999999999999999999998764332211


Q ss_pred             c--ccccccCcccccccccccCc---cchHHHHHHHhhhhhhhhccccccchhh------------------h--hhhcc
Q 040702          666 T--QTQTLATIGYMAPDEIFSGE---MRLKCWVNDSLLISVMIVVDANLLIREE------------------K--HLMTK  720 (797)
Q Consensus       666 ~--~~~~~gt~~y~aPE~~~~~~---~~~~~dv~s~~~~~~~~~~~~~~~~~~~------------------~--~~~~~  720 (797)
                      .  .....++..|+|||.+....   ++.++|+|++|+..+..+.+..++....                  .  .....
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPE  236 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHH
Confidence            1  12356888999999988766   8899999999988755554443332110                  0  01234


Q ss_pred             cccchhccccCCCCCCCChHHHHH
Q 040702          721 EQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       721 ~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      +.++++.|++.+|++||++.+++.
T Consensus       237 ~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         237 GKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             HHHHHHHHccCCcccCCCHHHHhc
Confidence            568899999999999999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.96  E-value=1.4e-29  Score=264.23  Aligned_cols=231  Identities=19%  Similarity=0.240  Sum_probs=185.6

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeec--CCeEEEEE
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSN--DDFKALVL  583 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~--~~~~~lv~  583 (797)
                      +|+..+.||+|+||.||++     +..||+|.+.....  ...+++..|+.++++++||||+++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4788899999999999974     57899999875432  234578889999999999999999998764  45689999


Q ss_pred             EccCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHccC--CCCeEEcCCCCCceEEcCCCcEEEEeecCCccC
Q 040702          584 EYMPLGSLEKCLYSG---NYILDIFQGLNIMIDVASALEYLHFGY--SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  658 (797)
Q Consensus       584 e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~al~yLH~~~--~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  658 (797)
                      ||+++++|.+++...   ...+++..++.++.|++.|++|||..+  +.+++|+||||+||+++.++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998653   336899999999999999999999443  678999999999999999999999999999866


Q ss_pred             CccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh-----------------hhhhhccc
Q 040702          659 LEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE-----------------EKHLMTKE  721 (797)
Q Consensus       659 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~  721 (797)
                      .....  ......|++.|+|||.+....++.++|+|++|+..+..+.+..++...                 +......+
T Consensus       161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (265)
T cd08217         161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSEL  238 (265)
T ss_pred             cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCHHH
Confidence            43321  123456899999999998888999999999998875444433322211                 11223456


Q ss_pred             ccchhccccCCCCCCCChHHHHHh
Q 040702          722 QPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       722 ~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                      .++++.|+..+|++||++.++++.
T Consensus       239 ~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         239 NEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             HHHHHHHccCCcccCCCHHHHhhC
Confidence            788999999999999999998863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.96  E-value=1.4e-29  Score=264.53  Aligned_cols=228  Identities=21%  Similarity=0.261  Sum_probs=178.6

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCC-----cchhHHHHHHHhhhccCCceeEeeeeeecC--CeE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG-----AFKSFDIECGMMKRIRHRNLIKIISSCSND--DFK  579 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~-----~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~--~~~  579 (797)
                      .+|...+.||+|+||.||++     +..||||.+......     ..+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            47888999999999999974     588999998643211     234678899999999999999999988764  468


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCC
Q 040702          580 ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  659 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  659 (797)
                      ++||||+++++|.+++.... .+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||+++...
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence            89999999999999987654 3788889999999999999999   9999999999999999999999999999997643


Q ss_pred             ccCcc-ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh------------------hhhhhcc
Q 040702          660 EEDQS-LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE------------------EKHLMTK  720 (797)
Q Consensus       660 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~------------------~~~~~~~  720 (797)
                      ..... .......|+..|+|||.+.+..++.++|+|++|+..+..+.+..++...                  +......
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDH  237 (265)
T ss_pred             cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHH
Confidence            21111 1123356899999999998888899999999999875555444433211                  1112223


Q ss_pred             cccchhccccCCCCCCCChHHHHH
Q 040702          721 EQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       721 ~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      ..++++.|+ .+|++||++.++++
T Consensus       238 ~~~~i~~~l-~~p~~Rp~~~~il~  260 (265)
T cd06652         238 CRDFLKRIF-VEAKLRPSADELLR  260 (265)
T ss_pred             HHHHHHHHh-cChhhCCCHHHHhc
Confidence            456677777 47888888777764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.96  E-value=1.2e-29  Score=267.96  Aligned_cols=226  Identities=22%  Similarity=0.305  Sum_probs=180.2

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      +|+..+.||+|++|.||++     ++.||||.++....  ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788899999999999985     57899999875432  2335788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          586 MPLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       586 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      +. ++|..++.... ..+++..+..++.|++.|++|||   +.+++||||+|+||+++.++.+||+|||+++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-  155 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  155 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence            96 58988886543 35899999999999999999999   99999999999999999999999999999876532211 


Q ss_pred             ccccccccCcccccccccccCc-cchHHHHHHHhhhhhhhhccccccchhh-----------------------------
Q 040702          665 LTQTQTLATIGYMAPDEIFSGE-MRLKCWVNDSLLISVMIVVDANLLIREE-----------------------------  714 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~dv~s~~~~~~~~~~~~~~~~~~~-----------------------------  714 (797)
                       ......++..|+|||.+.+.. ++.++|+|++|+..+..+.+..++....                             
T Consensus       156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07860         156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY  234 (284)
T ss_pred             -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence             223345788999999887654 5789999999998755554433221100                             


Q ss_pred             ----------------hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          715 ----------------KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       715 ----------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                      ......+.++++.|++.||.+||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence                            001123346899999999999999988875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.96  E-value=1.9e-29  Score=261.02  Aligned_cols=226  Identities=27%  Similarity=0.340  Sum_probs=190.5

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccC
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  587 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~  587 (797)
                      +|...+.||+|++|.||++     +..||+|++........+.+.+|++.+++++||||+++++++...+..++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4778899999999999985     57899999987655456789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccccc
Q 040702          588 LGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ  667 (797)
Q Consensus       588 ~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  667 (797)
                      +++|.+++......+++..+..++.|+++|++|||   ..+++|+||+|+||++++++.++|+|||.+........   .
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~  154 (253)
T cd05122          81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R  154 (253)
T ss_pred             CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence            99999999876456899999999999999999999   89999999999999999999999999999986543321   2


Q ss_pred             cccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh-------------------hhhhhcccccchhcc
Q 040702          668 TQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE-------------------EKHLMTKEQPMVRMG  728 (797)
Q Consensus       668 ~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~l~~~c  728 (797)
                      ....|+..|+|||.+....++.++|+|++|+..+..+.+..++...                   .......+.++++.|
T Consensus       155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  234 (253)
T cd05122         155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKC  234 (253)
T ss_pred             cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHH
Confidence            3456889999999998888899999999999876555444332221                   000134567899999


Q ss_pred             ccCCCCCCCChHHHHH
Q 040702          729 TDLSLGQFPASYSISK  744 (797)
Q Consensus       729 l~~dp~~RPs~~~i~~  744 (797)
                      +..||++||++.++++
T Consensus       235 l~~~p~~R~t~~~~l~  250 (253)
T cd05122         235 LQKNPEKRPTAEQLLK  250 (253)
T ss_pred             ccCChhhCCCHHHHhc
Confidence            9999999999998875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.8e-29  Score=265.53  Aligned_cols=226  Identities=23%  Similarity=0.312  Sum_probs=185.1

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEecc-CCcchhHHHHHHHhhhcc---CCceeEeeeeeecCCeEEEEE
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY-GGAFKSFDIECGMMKRIR---HRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~---Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      .|+..+.||+|+||.||++     +..||+|.++... ....+++.+|+.++++++   |||++++++++..++..|+||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            4777889999999999974     5889999987553 233467889999999997   999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      ||+++++|.+++...  .+++..+..++.|+++|+.|||   ..+|+|+||+|+||+++.++.++|+|||++........
T Consensus        82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06917          82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS  156 (277)
T ss_pred             ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence            999999999998664  4889999999999999999999   99999999999999999999999999999986643321


Q ss_pred             cccccccccCcccccccccccCc-cchHHHHHHHhhhhhhhhccccccchhhh------------------hhhcccccc
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGE-MRLKCWVNDSLLISVMIVVDANLLIREEK------------------HLMTKEQPM  724 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~dv~s~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~l  724 (797)
                        ......|+..|+|||.+.++. ++.++|+|++|+..+..+.+..++.....                  .....+.++
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (277)
T cd06917         157 --KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREF  234 (277)
T ss_pred             --ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHH
Confidence              223456899999999887654 58899999999887555444333221110                  123356778


Q ss_pred             hhccccCCCCCCCChHHHHHh
Q 040702          725 VRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       725 ~~~cl~~dp~~RPs~~~i~~~  745 (797)
                      ++.|+..||++||++.++++.
T Consensus       235 i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         235 VAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             HHHHcCCCcccCcCHHHHhhC
Confidence            899999999999999998763

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=8.2e-30  Score=267.61  Aligned_cols=230  Identities=22%  Similarity=0.242  Sum_probs=184.3

Q ss_pred             HHhcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhc-cCCceeEeeeeeecCC-----
Q 040702          509 QATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRI-RHRNLIKIISSCSNDD-----  577 (797)
Q Consensus       509 ~~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~-----  577 (797)
                      .++++|+..+.||+|+||.||++     ++.||+|++..... ..+++.+|+.+++++ +||||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            35689999999999999999974     47899999875543 346789999999999 6999999999997644     


Q ss_pred             -eEEEEEEccCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeec
Q 040702          578 -FKALVLEYMPLGSLEKCLYSG---NYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFG  653 (797)
Q Consensus       578 -~~~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG  653 (797)
                       ..|+||||+++++|.+++...   ...+++..+..++.|++.|++|||   +.+++|+||+|+||+++.++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCc
Confidence             589999999999999988653   246899999999999999999999   9999999999999999999999999999


Q ss_pred             CCccCCccCccccccccccCccccccccccc-----CccchHHHHHHHhhhhhhhhccccccchh---------------
Q 040702          654 MAKPLLEEDQSLTQTQTLATIGYMAPDEIFS-----GEMRLKCWVNDSLLISVMIVVDANLLIRE---------------  713 (797)
Q Consensus       654 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~dv~s~~~~~~~~~~~~~~~~~~---------------  713 (797)
                      ++.......  .......|+..|+|||.+..     ..++.++|+|++|+..+..+.+..++...               
T Consensus       159 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  236 (275)
T cd06608         159 VSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPP  236 (275)
T ss_pred             cceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCC
Confidence            987653221  12334568999999998753     34678899999998875544433332211               


Q ss_pred             ----hhhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          714 ----EKHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       714 ----~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                          +......+.+++++|+..||++||++.++++
T Consensus       237 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         237 TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                0112235678999999999999999999875

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.96  E-value=2.9e-29  Score=264.95  Aligned_cols=226  Identities=22%  Similarity=0.287  Sum_probs=181.4

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      +|+..+.||+|++|.||++     +..||||.++.... ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5888999999999999984     57899999976543 23467788999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          587 PLGSLEKCLYSGN--YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       587 ~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      ++ ++.+++....  ..+++..+..++.|++.|++|||   +.+++||||||+||++++++.+|++|||++........ 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            85 8888876543  35899999999999999999999   89999999999999999999999999999975432211 


Q ss_pred             ccccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccccccchh------------------------------
Q 040702          665 LTQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANLLIRE------------------------------  713 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~~~~~------------------------------  713 (797)
                       ......++..|+|||.+.+. .++.++|+|++|+..+..+.+..++...                              
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence             22334678899999988654 4688999999998875444333222100                              


Q ss_pred             ---------------hhhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          714 ---------------EKHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       714 ---------------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                     .........++++.|++.||.+||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                           0012334568889999999999999988875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.96  E-value=1e-29  Score=269.00  Aligned_cols=241  Identities=21%  Similarity=0.297  Sum_probs=189.6

Q ss_pred             CCCccccccccCCcceeec--------ceEEEEEEEEecc----CCcchhHHHHHHHhhhc-cCCceeEeeeeeecCCeE
Q 040702          513 RFSENNLIGRGGFGPVYKD--------GMEVAIKVFNLQY----GGAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDFK  579 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~--------~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~  579 (797)
                      +|+..+.||+|+||.||++        +..||||+++...    ....+.+.+|+.++.++ +||||+++++++..++..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4778899999999999963        4679999987542    12245688899999999 599999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCC
Q 040702          580 ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  659 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  659 (797)
                      ++||||+++|+|.+++.... .+++..+..++.|+++||+|||   ..+++||||||+||+++.++.++|+|||+++...
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          81 HLILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence            99999999999999987654 4888899999999999999999   9999999999999999999999999999987654


Q ss_pred             ccCccccccccccCcccccccccccCc--cchHHHHHHHhhhhhhhhccccccchh-----h---------------hhh
Q 040702          660 EEDQSLTQTQTLATIGYMAPDEIFSGE--MRLKCWVNDSLLISVMIVVDANLLIRE-----E---------------KHL  717 (797)
Q Consensus       660 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~dv~s~~~~~~~~~~~~~~~~~~-----~---------------~~~  717 (797)
                      ..... ......|+..|+|||.+.+..  .+.++|+|++|+..++.+.+..++...     .               ...
T Consensus       157 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd05583         157 AEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTM  235 (288)
T ss_pred             ccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCccc
Confidence            33211 223356899999999887654  678999999998875555433332100     0               011


Q ss_pred             hcccccchhccccCCCCCCCChHHHHHhHHHHHHHhccccccccccCCcccccceeeeeeeee
Q 040702          718 MTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYTI  780 (797)
Q Consensus       718 ~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~  780 (797)
                      ...+.++++.|++.||++|||+.++.+.                      ++|+||+.++|+.
T Consensus       236 ~~~l~~li~~~l~~~p~~R~t~~~~~~~----------------------l~~~~~~~~~~~~  276 (288)
T cd05583         236 SAEARDFIQKLLEKDPKKRLGANGADEI----------------------KNHPFFQGIDWDD  276 (288)
T ss_pred             CHHHHHHHHHHhcCCHhhccCcchHHHH----------------------hcCcccccCCHHH
Confidence            2345677788899999999987766554                      4567899998853

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.96  E-value=2.4e-29  Score=262.43  Aligned_cols=228  Identities=21%  Similarity=0.254  Sum_probs=191.2

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      ++|+..+.||+|++|.||++     ++.||||++..... ...+.+.+|++.+++++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36888899999999999985     68899999876643 3357899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS-VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~-~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      +++++|.+++.... .+++..+..++.|+++|++|||   + .+++||||+|+||+++.++.++|+|||.+........ 
T Consensus        81 ~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~-  155 (264)
T cd06623          81 MDGGSLADLLKKVG-KIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD-  155 (264)
T ss_pred             cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC-
Confidence            99999999997653 4899999999999999999999   8 9999999999999999999999999999986643322 


Q ss_pred             ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh--------------------hh-hhccccc
Q 040702          665 LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE--------------------KH-LMTKEQP  723 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------------~~-~~~~~~~  723 (797)
                       ......++..|+|||.+....++.++|+|++|+..+..+.+..++....                    .. ....+.+
T Consensus       156 -~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  234 (264)
T cd06623         156 -QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRD  234 (264)
T ss_pred             -cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHH
Confidence             1224568899999999988889999999999998765555433322211                    01 2345778


Q ss_pred             chhccccCCCCCCCChHHHHHh
Q 040702          724 MVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       724 l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                      +++.|+.++|++||++.++++.
T Consensus       235 li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         235 FISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             HHHHHccCChhhCCCHHHHHhC
Confidence            8999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.96  E-value=1.8e-29  Score=266.61  Aligned_cols=225  Identities=20%  Similarity=0.228  Sum_probs=184.8

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccC
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  587 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~  587 (797)
                      .|...+.||+|++|.||++     +..||+|.++.......+.+.+|+.++++++||||+++++++...+..++|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            4555679999999999975     47899999876544445678899999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccccc
Q 040702          588 LGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ  667 (797)
Q Consensus       588 ~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  667 (797)
                      +++|.+++...  .+++..+..++.|++.|++|||   +.+|+||||+|+||+++.++.++|+|||.+........  ..
T Consensus       100 ~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~  172 (285)
T cd06648         100 GGALTDIVTHT--RMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RR  172 (285)
T ss_pred             CCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--cc
Confidence            99999998773  4788999999999999999999   99999999999999999999999999998875432211  22


Q ss_pred             cccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccch-h------------------hhhhhcccccchhcc
Q 040702          668 TQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIR-E------------------EKHLMTKEQPMVRMG  728 (797)
Q Consensus       668 ~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~-~------------------~~~~~~~~~~l~~~c  728 (797)
                      ....|++.|+|||.+.+..++.++|+|++|+..+..+.+..++.. .                  .......+.++++.|
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  252 (285)
T cd06648         173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRM  252 (285)
T ss_pred             ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHH
Confidence            335689999999999888899999999999987555443332111 0                  001223567889999


Q ss_pred             ccCCCCCCCChHHHHH
Q 040702          729 TDLSLGQFPASYSISK  744 (797)
Q Consensus       729 l~~dp~~RPs~~~i~~  744 (797)
                      +..+|++||++.++++
T Consensus       253 l~~~p~~Rpt~~~il~  268 (285)
T cd06648         253 LVRDPAQRATAAELLN  268 (285)
T ss_pred             cccChhhCcCHHHHcc
Confidence            9999999999988875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=3.8e-30  Score=274.45  Aligned_cols=227  Identities=21%  Similarity=0.275  Sum_probs=187.2

Q ss_pred             CCccccccccCCcceeecc--------eEEEEEEEEeccCC-cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          514 FSENNLIGRGGFGPVYKDG--------MEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       514 f~~~~~lg~G~~g~Vyk~~--------~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      ....++||+|.||.|++|+        ..||||.++..... ..++|.+|+.+|.+++|||++++||+..+ ....+|||
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E  190 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE  190 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence            3445789999999999863        67999999877554 57899999999999999999999999887 67889999


Q ss_pred             ccCCCCHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          585 YMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       585 ~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      .++.|+|.+.+++ .+..+-......++.|||.|+.||.   +++.||||+...|+++.....+||+|||+.+.++..+.
T Consensus       191 LaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned  267 (1039)
T KOG0199|consen  191 LAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED  267 (1039)
T ss_pred             hcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence            9999999999988 3336777888899999999999999   99999999999999999999999999999998876544


Q ss_pred             cc-cccccccCcccccccccccCccchHHHHHHHhhhhhhhhccc-cccch-----------------hhhhhhcccccc
Q 040702          664 SL-TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDA-NLLIR-----------------EEKHLMTKEQPM  724 (797)
Q Consensus       664 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~-~~~~~-----------------~~~~~~~~~~~l  724 (797)
                      .. ......-...|.|||.+....++-++|||++|+..++++... .+..+                 .++...+.+.++
T Consensus       268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY~i  347 (1039)
T KOG0199|consen  268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIYQI  347 (1039)
T ss_pred             ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHHHHHH
Confidence            33 333444566899999999999999999999999875444322 11111                 112233466678


Q ss_pred             hhccccCCCCCCCChHHHHH
Q 040702          725 VRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       725 ~~~cl~~dp~~RPs~~~i~~  744 (797)
                      +..||...|.+||++..+.+
T Consensus       348 mk~cWah~paDRptFsair~  367 (1039)
T KOG0199|consen  348 MKNCWAHNPADRPTFSAIRE  367 (1039)
T ss_pred             HHHhccCCccccccHHHHHH
Confidence            88899999999999999874

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.96  E-value=2.5e-29  Score=268.65  Aligned_cols=225  Identities=25%  Similarity=0.269  Sum_probs=182.8

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCC---cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG---AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      .+.|+..+.||+|+||.||++     ++.||+|.+......   ..+++.+|+++++.++||||++++++|.+.+..|+|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            356888899999999999975     688999998654322   235688999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      |||++ |++.+++......+++..+..++.|++.|+.|||   +.+|+||||+|+||++++++.+||+|||++...... 
T Consensus        94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-  168 (307)
T cd06607          94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-  168 (307)
T ss_pred             HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence            99997 5777777654446899999999999999999999   999999999999999999999999999998754321 


Q ss_pred             ccccccccccCcccccccccc---cCccchHHHHHHHhhhhhhhhccccccchh------------------hhhhhccc
Q 040702          663 QSLTQTQTLATIGYMAPDEIF---SGEMRLKCWVNDSLLISVMIVVDANLLIRE------------------EKHLMTKE  721 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~------------------~~~~~~~~  721 (797)
                           ....|+..|+|||.+.   .+.++.++|+|++|+..+..+.+..++...                  .......+
T Consensus       169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (307)
T cd06607         169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYF  243 (307)
T ss_pred             -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHH
Confidence                 2346888999999874   456788999999998875554443322110                  11123356


Q ss_pred             ccchhccccCCCCCCCChHHHHHh
Q 040702          722 QPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       722 ~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                      .++++.||..||++||++.+++..
T Consensus       244 ~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         244 RNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             HHHHHHHhcCChhhCcCHHHHhcC
Confidence            788999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.96  E-value=2.4e-29  Score=265.86  Aligned_cols=230  Identities=26%  Similarity=0.304  Sum_probs=190.7

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      .++.|+..+.+|+|+||.||++     +..||+|+++.... ..+.+.+|++++++++|+||+++++++...+..|+|+|
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   95 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME   95 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence            4567888899999999999984     57899999976544 45678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      |+++++|.+++......+++..+..++.|++.|++|||   ..+++|+|++|+||+++.++.++|+|||++........ 
T Consensus        96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  171 (286)
T cd06614          96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-  171 (286)
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh-
Confidence            99999999999876545899999999999999999999   89999999999999999999999999999875432221 


Q ss_pred             ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh-------------------hhhhcccccch
Q 040702          665 LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE-------------------KHLMTKEQPMV  725 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~l~  725 (797)
                       ......++..|+|||.+.+..++.++|+|++|+..+..+.+..++....                   ......+.+++
T Consensus       172 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  250 (286)
T cd06614         172 -KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFL  250 (286)
T ss_pred             -hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHH
Confidence             2233457889999999988888999999999998755544332211110                   01233577889


Q ss_pred             hccccCCCCCCCChHHHHHh
Q 040702          726 RMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       726 ~~cl~~dp~~RPs~~~i~~~  745 (797)
                      +.|++.+|.+||++.++++.
T Consensus       251 ~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         251 NKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             HHHhccChhhCcCHHHHhhC
Confidence            99999999999999998764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.96  E-value=1.9e-29  Score=266.27  Aligned_cols=227  Identities=22%  Similarity=0.245  Sum_probs=178.2

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccC-CcchhHHHHHHH-hhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG-GAFKSFDIECGM-MKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~-~~~~~~~~E~~~-l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      ++|+..+.||+|+||.||++     ++.||+|+++.... ....++..|+.. ++..+||||+++++++..++..|+|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46888999999999999984     68999999976532 223456667665 556689999999999999999999999


Q ss_pred             ccCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHccCCC-CeEEcCCCCCceEEcCCCcEEEEeecCCccCCc
Q 040702          585 YMPLGSLEKCLYSG---NYILDIFQGLNIMIDVASALEYLHFGYSV-PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  660 (797)
Q Consensus       585 ~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~al~yLH~~~~~-~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  660 (797)
                      |++ |+|.+++...   ...+++..++.++.|++.|++|||   ++ +++||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 6888777542   235899999999999999999999   76 999999999999999999999999999986532


Q ss_pred             cCccccccccccCccccccccccc----CccchHHHHHHHhhhhhhhhccccccchh----h---------------hhh
Q 040702          661 EDQSLTQTQTLATIGYMAPDEIFS----GEMRLKCWVNDSLLISVMIVVDANLLIRE----E---------------KHL  717 (797)
Q Consensus       661 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~dv~s~~~~~~~~~~~~~~~~~~----~---------------~~~  717 (797)
                      ..   ......|+..|+|||.+.+    ..++.++|+|++|+..+..+.+..++...    .               ...
T Consensus       157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd06617         157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKF  233 (283)
T ss_pred             cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCcccc
Confidence            21   2233568899999998754    44688999999999875555443332210    0               011


Q ss_pred             hcccccchhccccCCCCCCCChHHHHHh
Q 040702          718 MTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       718 ~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                      ...+.++++.|+..+|++||++.++++.
T Consensus       234 ~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         234 SPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            2345678899999999999999888763

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.2e-31  Score=273.33  Aligned_cols=257  Identities=19%  Similarity=0.204  Sum_probs=206.0

Q ss_pred             cCCCccccccccCCcceee---cce--EEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYK---DGM--EVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk---~~~--~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      .+++.+..||-||||.|=.   .++  .+|+|++++..   ....+.+..|-.+|..++.|.||++|..|.+....|+.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            4566677899999999953   222  37888887653   223456778999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      |-|-||.+...+.+++. ++...++.++..+.+|++|||   +++||.||+||+|.++|.+|.+||.|||+|+.+.... 
T Consensus       500 EaClGGElWTiLrdRg~-Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~-  574 (732)
T KOG0614|consen  500 EACLGGELWTILRDRGS-FDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR-  574 (732)
T ss_pred             HhhcCchhhhhhhhcCC-cccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhccCC-
Confidence            99999999999988775 888999999999999999999   9999999999999999999999999999999886554 


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh-hhhhhc-ccccchhccccCCCCCCCChHH
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE-EKHLMT-KEQPMVRMGTDLSLGQFPASYS  741 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~l~~~cl~~dp~~RPs~~~  741 (797)
                        .+-+++||+.|.|||.++..+.+..+|.|++|+..++.+.+.+++... +..... .++-+-  .++. | +|-+-.-
T Consensus       575 --KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid--~i~~-P-r~I~k~a  648 (732)
T KOG0614|consen  575 --KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID--KIEF-P-RRITKTA  648 (732)
T ss_pred             --ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh--hhhc-c-cccchhH
Confidence              445689999999999999999999999999999997777666655443 222111 111111  1222 3 4443222


Q ss_pred             HHHhHHHHHHHhccccccccccCCcccccceeeeeeee
Q 040702          742 ISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYT  779 (797)
Q Consensus       742 i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~  779 (797)
                      ..-...-.++.|.+|.|.+...-.++.+|.||.+.||+
T Consensus       649 ~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwe  686 (732)
T KOG0614|consen  649 TDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWE  686 (732)
T ss_pred             HHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChh
Confidence            22233447888999999999999999999999999997

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=9.9e-30  Score=288.15  Aligned_cols=191  Identities=20%  Similarity=0.219  Sum_probs=150.3

Q ss_pred             HhcCCCccccccccCCcceeecc------eEEEEEEE--------------Eec---cCCcchhHHHHHHHhhhccCCce
Q 040702          510 ATNRFSENNLIGRGGFGPVYKDG------MEVAIKVF--------------NLQ---YGGAFKSFDIECGMMKRIRHRNL  566 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~~------~~vAvK~~--------------~~~---~~~~~~~~~~E~~~l~~l~Hpni  566 (797)
                      ..++|++.+.||+|+||.||++.      ..+++|.+              .+.   .......+.+|+.++++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            35789999999999999999642      11222211              100   11123467899999999999999


Q ss_pred             eEeeeeeecCCeEEEEEEccCCCCHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEc
Q 040702          567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNY----ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD  642 (797)
Q Consensus       567 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~  642 (797)
                      +++++++...+..|+|+|++. +++.+++.....    ......+..++.|++.||+|||   +++|+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEC
Confidence            999999999999999999995 578777654321    2335567789999999999999   99999999999999999


Q ss_pred             CCCcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc
Q 040702          643 DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV  705 (797)
Q Consensus       643 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~  705 (797)
                      .++.+||+|||+++.+..... .......||..|+|||.+.+..++.++|+|++|+..++.+.
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~  363 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS  363 (501)
T ss_pred             CCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHH
Confidence            999999999999986643222 12234679999999999999999999999999998755543

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.96  E-value=1.6e-29  Score=267.82  Aligned_cols=243  Identities=21%  Similarity=0.244  Sum_probs=184.6

Q ss_pred             CCCccccccccCCcceee--------cceEEEEEEEEeccC----CcchhHHHHHHHhhhc-cCCceeEeeeeeecCCeE
Q 040702          513 RFSENNLIGRGGFGPVYK--------DGMEVAIKVFNLQYG----GAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDFK  579 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk--------~~~~vAvK~~~~~~~----~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~  579 (797)
                      +|+..+.||+|+||.||+        .+..||+|+++....    ...+.+.+|+.+++++ +||||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477889999999999995        357899999975421    2235678899999999 599999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCC
Q 040702          580 ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  659 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  659 (797)
                      |+||||+++++|.+++.... .+++..+..++.|+++||.|||   +.+++||||||+||+++.++.+||+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          81 HLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence            99999999999999987654 4788899999999999999999   9999999999999999999999999999998653


Q ss_pred             ccCccccccccccCcccccccccccC--ccchHHHHHHHhhhhhhhhccccccchhh--------------------hhh
Q 040702          660 EEDQSLTQTQTLATIGYMAPDEIFSG--EMRLKCWVNDSLLISVMIVVDANLLIREE--------------------KHL  717 (797)
Q Consensus       660 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------------~~~  717 (797)
                      .... .......|+..|+|||.+..+  .++.++|+|++|+..+..+.+..++....                    ...
T Consensus       157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (290)
T cd05613         157 EDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM  235 (290)
T ss_pred             cccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccC
Confidence            3221 122345689999999998753  46788999999998765555443332100                    001


Q ss_pred             hcccccchhccccCCCCCCCChHHHHHhHHHHHHHhccccccccccCCcccccceeeeeeeee
Q 040702          718 MTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYTI  780 (797)
Q Consensus       718 ~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~  780 (797)
                      ...+.++++.|++.||++||                    ...+..+.+.++|+||+.++|+-
T Consensus       236 ~~~~~~ll~~~l~~~p~~R~--------------------~~~~~~~~~l~~~~~~~~~~~~~  278 (290)
T cd05613         236 SALAKDIIQRLLMKDPKKRL--------------------GCGPSDADEIKKHPFFQKINWDD  278 (290)
T ss_pred             CHHHHHHHHHHhcCCHHHhc--------------------CCCCCCHHHHHcCcccccCCHHH
Confidence            11233444555555555554                    33344556678888888888853

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.96  E-value=3.3e-29  Score=268.91  Aligned_cols=189  Identities=23%  Similarity=0.331  Sum_probs=154.5

Q ss_pred             CCCccccccccCCcceeec-------ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecC--CeEE
Q 040702          513 RFSENNLIGRGGFGPVYKD-------GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSND--DFKA  580 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-------~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~--~~~~  580 (797)
                      +|+..+.||+|+||.||++       +..||+|.+....   ....+.+.+|+.++++++||||+++++++.+.  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4778899999999999974       4789999998643   33346778899999999999999999999988  7899


Q ss_pred             EEEEccCCCCHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcC----CCcEEEEee
Q 040702          581 LVLEYMPLGSLEKCLYSGN----YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD----NMVAHLSDF  652 (797)
Q Consensus       581 lv~e~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~----~~~~kl~DF  652 (797)
                      +||||+++ ++.+.+....    ..+++..++.++.|++.|++|||   +.+|+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 6766654321    25788899999999999999999   999999999999999999    899999999


Q ss_pred             cCCccCCccCc-cccccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhc
Q 040702          653 GMAKPLLEEDQ-SLTQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVV  705 (797)
Q Consensus       653 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~  705 (797)
                      |+++....... ........+|..|+|||.+.+. .++.++|+|++|+..+..+.
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~  211 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT  211 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence            99986543322 1123345689999999988664 47899999999988744443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.96  E-value=3.7e-29  Score=263.15  Aligned_cols=211  Identities=20%  Similarity=0.225  Sum_probs=162.1

Q ss_pred             cccccCCcceeec-----ceEEEEEEEEeccCC---cchhHHHHHHH---hhhccCCceeEeeeeeecCCeEEEEEEccC
Q 040702          519 LIGRGGFGPVYKD-----GMEVAIKVFNLQYGG---AFKSFDIECGM---MKRIRHRNLIKIISSCSNDDFKALVLEYMP  587 (797)
Q Consensus       519 ~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~---~~~~~~~E~~~---l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~  587 (797)
                      .||+|+||.||++     ++.||+|.+......   ....+..|..+   ++...||+|+++++++..++..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999964     578999998764321   11234444443   344579999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccccc
Q 040702          588 LGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ  667 (797)
Q Consensus       588 ~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  667 (797)
                      +|+|.+++.... .+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||+++.....    ..
T Consensus        81 g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----~~  152 (278)
T cd05606          81 GGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KP  152 (278)
T ss_pred             CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----CC
Confidence            999999887654 5899999999999999999999   899999999999999999999999999999755322    12


Q ss_pred             cccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccccccchhhh-------------------hhhcccccchhc
Q 040702          668 TQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANLLIREEK-------------------HLMTKEQPMVRM  727 (797)
Q Consensus       668 ~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~l~~~  727 (797)
                      ....|+..|+|||.+.++ .++.++|+|++|+..+..+.+..++.....                   .....+.++++.
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  232 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG  232 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHH
Confidence            345799999999998755 578999999999987555544433322100                   012344566666


Q ss_pred             cccCCCCCCC
Q 040702          728 GTDLSLGQFP  737 (797)
Q Consensus       728 cl~~dp~~RP  737 (797)
                      |+..+|.+||
T Consensus       233 ~l~~~p~~R~  242 (278)
T cd05606         233 LLQRDVNRRL  242 (278)
T ss_pred             HhhcCHHhcc
Confidence            7777777777

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.96  E-value=3.5e-29  Score=265.94  Aligned_cols=227  Identities=19%  Similarity=0.253  Sum_probs=178.4

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhcc-CCceeEeeeeeecCCe-----
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIR-HRNLIKIISSCSNDDF-----  578 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~-----  578 (797)
                      ++|+..+.||+|+||.||++     ++.||||.++....  .....+.+|+.++++++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888999999999999985     58899999865532  23467888999999995 6999999999887665     


Q ss_pred             EEEEEEccCCCCHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcC-CCcEEEEeec
Q 040702          579 KALVLEYMPLGSLEKCLYSGN----YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD-NMVAHLSDFG  653 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl~DFG  653 (797)
                      .|+||||+++ ++.+++....    ..+++..++.++.||++||+|||   +++|+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999985 8888875432    25799999999999999999999   999999999999999998 8899999999


Q ss_pred             CCccCCccCccccccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchhh------------------
Q 040702          654 MAKPLLEEDQSLTQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIREE------------------  714 (797)
Q Consensus       654 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~------------------  714 (797)
                      +++.......  ......+++.|+|||.+.+ ..++.++|+|++|+..+..+.+..++....                  
T Consensus       157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (295)
T cd07837         157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQ  234 (295)
T ss_pred             cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            9986532211  1223457889999998865 446899999999998755444433221100                  


Q ss_pred             --------------------------hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          715 --------------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       715 --------------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                                ......+.++++.|+.+||.+||++.|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                                      112334667889999999999999888764

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.96  E-value=2.1e-29  Score=261.74  Aligned_cols=227  Identities=21%  Similarity=0.272  Sum_probs=184.6

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      +|+..+.||+|+||.||++     +..||+|.+.....  ...+.+.+|+.+++.++||||+++++++...+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4788899999999999974     57899999876421  2346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCC-cEEEEeecCCccCCccCc
Q 040702          586 MPLGSLEKCLYSGNY-ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM-VAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DFGla~~~~~~~~  663 (797)
                      +++++|.+++..... .+++..+..++.|+++|++|||   +.+++|+||||+||++++++ .+|++|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            999999999876433 5789999999999999999999   89999999999999999875 469999999986543221


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh-----------------hhhhcccccchh
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE-----------------KHLMTKEQPMVR  726 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~l~~  726 (797)
                        ......|++.|+|||.+....++.++|+|++|+..+..+....++....                 ......+.++++
T Consensus       158 --~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  235 (257)
T cd08225         158 --LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLIS  235 (257)
T ss_pred             --cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHH
Confidence              2233468999999999988889999999999988755444333222110                 011235678889


Q ss_pred             ccccCCCCCCCChHHHHH
Q 040702          727 MGTDLSLGQFPASYSISK  744 (797)
Q Consensus       727 ~cl~~dp~~RPs~~~i~~  744 (797)
                      +|+..+|++||++.++++
T Consensus       236 ~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         236 QLFKVSPRDRPSITSILK  253 (257)
T ss_pred             HHhccChhhCcCHHHHhh
Confidence            999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.96  E-value=4.7e-29  Score=263.08  Aligned_cols=223  Identities=21%  Similarity=0.236  Sum_probs=176.8

Q ss_pred             CCccccccccCCcceeec-----ceEEEEEEEEeccC-CcchhHHHHHHHhhhcc-CCceeEeeeeeecC--CeEEEEEE
Q 040702          514 FSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIR-HRNLIKIISSCSND--DFKALVLE  584 (797)
Q Consensus       514 f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~--~~~~lv~e  584 (797)
                      |+..+.||+|+||.||++     +..||+|.++.... .......+|+.+++++. ||||+++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            567789999999999985     57899999875432 22234557888999885 99999999999987  88999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      |++ |++.+.+......+++..+..++.|++.||+|||   ..+++||||||+||+++. +.+||+|||+++....... 
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-  154 (282)
T cd07831          81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-  154 (282)
T ss_pred             cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence            997 5888888765556899999999999999999999   999999999999999999 9999999999986543221 


Q ss_pred             ccccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchh-h----------------------------
Q 040702          665 LTQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIRE-E----------------------------  714 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~-~----------------------------  714 (797)
                        .....++..|+|||.+.. +.++.++|+|++|+..++.+....++... +                            
T Consensus       155 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07831         155 --YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM  232 (282)
T ss_pred             --cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence              123468899999998754 45688999999998875554432222110 0                            


Q ss_pred             ----------------hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          715 ----------------KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       715 ----------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                      ......+.+++.+|+.++|++||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence                            012345668889999999999999988875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.96  E-value=4.5e-30  Score=246.00  Aligned_cols=226  Identities=19%  Similarity=0.212  Sum_probs=180.2

Q ss_pred             CCCccccccccCCcceee-----cceEEEEEEEEecc-CCcchhHHHHHHHhhhcc-CCceeEeeeeeecCCeEEEEEEc
Q 040702          513 RFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQY-GGAFKSFDIECGMMKRIR-HRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk-----~~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      +.+....+|.|+.|.|++     .+...|||.++... ....+++...+.++...+ +|+||+.+|||......++.||.
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel  172 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL  172 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence            344456799999999997     46899999997663 334567777888776665 89999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      |.. -.+.+++.-..++++..+-++..-+.+||.||.+  .++|+|||+||+|||+|+.|++|+||||++..+.+..   
T Consensus       173 Ms~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk---  246 (391)
T KOG0983|consen  173 MST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK---  246 (391)
T ss_pred             HHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc---
Confidence            843 5666666666678888888899999999999985  6799999999999999999999999999998775443   


Q ss_pred             cccccccCcccccccccc---cCccchHHHHHHHhhhhhhhhccccccchhhh--------------------hhhcccc
Q 040702          666 TQTQTLATIGYMAPDEIF---SGEMRLKCWVNDSLLISVMIVVDANLLIREEK--------------------HLMTKEQ  722 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~---~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~  722 (797)
                      ..+...|.+.|||||.+.   ...|++.+||||+|+..++...+..++.....                    ...+..+
T Consensus       247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~  326 (391)
T KOG0983|consen  247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQ  326 (391)
T ss_pred             ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHH
Confidence            234457899999999885   45699999999999876555544443333111                    1344677


Q ss_pred             cchhccccCCCCCCCChHHHHH
Q 040702          723 PMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       723 ~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      +++..|+..|+.+||...++++
T Consensus       327 ~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  327 SFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             HHHHHHhhcCcccCcchHHHhc
Confidence            8899999999999999888875

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.96  E-value=3.9e-29  Score=267.51  Aligned_cols=230  Identities=19%  Similarity=0.250  Sum_probs=178.5

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCC--cchhHHHHHHHhhhccCCceeEeeeeeecCC------
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG--AFKSFDIECGMMKRIRHRNLIKIISSCSNDD------  577 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~------  577 (797)
                      .++|+..+.||+|+||.||++     ++.||||.+......  ....+.+|++++++++||||+++++++...+      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            467999999999999999975     589999998754322  2345678999999999999999999987654      


Q ss_pred             --eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCC
Q 040702          578 --FKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMA  655 (797)
Q Consensus       578 --~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla  655 (797)
                        ..++||||+. +++.+.+......+++.+++.++.|+++|++|||   +.+++|+||||+||+++.++.+||+|||++
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~  166 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLA  166 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence              4599999996 4888888766556899999999999999999999   899999999999999999999999999999


Q ss_pred             ccCCccCcc--ccccccccCcccccccccccCc-cchHHHHHHHhhhhhhhhccccccchhhh----------------h
Q 040702          656 KPLLEEDQS--LTQTQTLATIGYMAPDEIFSGE-MRLKCWVNDSLLISVMIVVDANLLIREEK----------------H  716 (797)
Q Consensus       656 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~dv~s~~~~~~~~~~~~~~~~~~~~----------------~  716 (797)
                      .........  .......++..|+|||.+.+.. ++.++|+|++|+..+..+.+..++.....                +
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE  246 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            865432211  1223456788999999876543 67899999999887554433222110000                0


Q ss_pred             --------------------------------hhcccccchhccccCCCCCCCChHHHHH
Q 040702          717 --------------------------------LMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       717 --------------------------------~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                                      ......++++.|+..||++||++.|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence                                            0112346899999999999999988874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.96  E-value=5.5e-29  Score=263.28  Aligned_cols=227  Identities=22%  Similarity=0.233  Sum_probs=183.1

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecC--CeEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSND--DFKALVL  583 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~--~~~~lv~  583 (797)
                      ++|+..+.||.|++|.||++     ++.||+|.+..... ....++.+|++++++++||||++++++|...  +..|+||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            46888899999999999974     58899999875533 2346789999999999999999999998654  4789999


Q ss_pred             EccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCc
Q 040702          584 EYMPLGSLEKCLYS---GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  660 (797)
Q Consensus       584 e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  660 (797)
                      ||+++++|.+++..   ....++...+..++.|++.|+.|||   ..+++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999988653   2335788899999999999999999   99999999999999999999999999999875532


Q ss_pred             cCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh------h-------------------
Q 040702          661 EDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE------K-------------------  715 (797)
Q Consensus       661 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~------~-------------------  715 (797)
                      ..    .....++..|+|||.+.+..++.++|+|++|+..+..+.+..++....      .                   
T Consensus       158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd06621         158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG  233 (287)
T ss_pred             cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence            21    123457889999999988889999999999988755554433322110      0                   


Q ss_pred             ---hhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          716 ---HLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       716 ---~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                         .....+.++++.|+..+|++||++.|+++.
T Consensus       234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence               011235688889999999999999998874

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.96  E-value=4.5e-29  Score=266.93  Aligned_cols=228  Identities=24%  Similarity=0.258  Sum_probs=180.9

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCC--cchhHHHHHHHhhhccCCceeEeeeeeecC--CeEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG--AFKSFDIECGMMKRIRHRNLIKIISSCSND--DFKAL  581 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~--~~~~l  581 (797)
                      .++|+..+.||+|+||.||++     ++.||+|.++.....  ....+.+|+.++++++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            468999999999999999985     688999998765322  234567899999999999999999998765  46899


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCcc
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  661 (797)
                      ||||+.+ +|.+++......+++.++..++.|+++|++|||   +.+++||||||+||+++.++.+||+|||.+......
T Consensus        86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            9999964 888888765556899999999999999999999   999999999999999999999999999999865432


Q ss_pred             CccccccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchhh-h------------------------
Q 040702          662 DQSLTQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIREE-K------------------------  715 (797)
Q Consensus       662 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-~------------------------  715 (797)
                      ..  ......++..|+|||.+.+ ..++.++|+|++|+..+..+.+..++.... .                        
T Consensus       162 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07845         162 AK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL  239 (309)
T ss_pred             cC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence            21  2223346888999998875 457899999999998755544333221000 0                        


Q ss_pred             ---------------------hhhcccccchhccccCCCCCCCChHHHHH
Q 040702          716 ---------------------HLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       716 ---------------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                           .......++++.|+..||++||++.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                                 01223456889999999999999888875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.96  E-value=4.6e-29  Score=263.31  Aligned_cols=225  Identities=23%  Similarity=0.300  Sum_probs=180.4

Q ss_pred             CCccccccccCCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          514 FSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       514 f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      |+..+.||+|++|.||++     +..||+|++.....  ...+.+.+|++++++++|||++++++++.+++..|+||||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            667789999999999984     68899999876532  22356888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          587 PLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       587 ~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      + ++|.+++.... ..+++..+..++.|+++||+|||   +.+++||||+|+||+++.++.++|+|||+++.......  
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--  154 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--  154 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--
Confidence            5 68999887654 35899999999999999999999   89999999999999999999999999999975432211  


Q ss_pred             cccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccccccchh-------------------------------
Q 040702          666 TQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANLLIRE-------------------------------  713 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~~~~~-------------------------------  713 (797)
                      ......++..|+|||.+.+. .++.++|+|++|+..+..+....++...                               
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK  234 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence            12234578899999988664 4688999999999875554443322100                               


Q ss_pred             --------------hhhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          714 --------------EKHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       714 --------------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                    .......+.++++.|++.||.+||++.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                          0011124567889999999999999998875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.96  E-value=2e-29  Score=272.87  Aligned_cols=229  Identities=22%  Similarity=0.235  Sum_probs=181.0

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEecc-CCcchhHHHHHHHhhhccCCceeEeeeeeecCC-----eE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDD-----FK  579 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~-----~~  579 (797)
                      .++|+..+.||+|+||.||++     ++.||||.+.... ......+.+|+.++++++||||+++++++...+     ..
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999985     5889999986432 223456788999999999999999999876543     57


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCC
Q 040702          580 ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  659 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  659 (797)
                      |+||||+++ ++.+.+...  .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        84 ~lv~e~~~~-~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          84 YIVQELMET-DLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             EEEehhccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence            999999964 888877654  4899999999999999999999   9999999999999999999999999999997653


Q ss_pred             ccCccc-cccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchh------------------------
Q 040702          660 EEDQSL-TQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIRE------------------------  713 (797)
Q Consensus       660 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~------------------------  713 (797)
                      ...... ......||+.|||||.+.+ ..++.++|+|++|+..+..+.+..++...                        
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI  237 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            322111 1233568999999998765 45789999999998875554443322110                        


Q ss_pred             -----------------------hhhhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          714 -----------------------EKHLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       714 -----------------------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                                             .......+.+++++|++.||++||++.|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                                   00112345678999999999999999998875

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-30  Score=296.43  Aligned_cols=231  Identities=23%  Similarity=0.288  Sum_probs=188.8

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      .+-+++...+||.|.||.||-+     |.-.|||-++.+..  ...+.+.+|..++..++|||+|+++|+-.+.+..+|.
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence            4457788899999999999974     68899998876533  3457888999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      ||||++|+|.+.+...+. .++.....+..|++.|+.|||   ..|||||||||+||+++.+|.+|.+|||.|..+....
T Consensus      1313 MEyC~~GsLa~ll~~gri-~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGRI-EDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred             HHHhccCcHHHHHHhcch-hhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCch
Confidence            999999999999876653 666677788999999999999   9999999999999999999999999999998765432


Q ss_pred             c--cccccccccCccccccccccc---CccchHHHHHHHhhhhhhhhccccccchhhhh------------------hhc
Q 040702          663 Q--SLTQTQTLATIGYMAPDEIFS---GEMRLKCWVNDSLLISVMIVVDANLLIREEKH------------------LMT  719 (797)
Q Consensus       663 ~--~~~~~~~~gt~~y~aPE~~~~---~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~~------------------~~~  719 (797)
                      .  ........||+.|||||++.+   .+..-+.|||++|+..++++.+.++...+..+                  ...
T Consensus      1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~ 1468 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSS 1468 (1509)
T ss_pred             hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhH
Confidence            1  122356689999999999974   34567899999999877766666654443322                  233


Q ss_pred             ccccchhccccCCCCCCCChHHHHH
Q 040702          720 KEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       720 ~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      .=.+++..|+..||..|-++.|+++
T Consensus      1469 ~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1469 EGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             hHHHHHHHHHhcCchhhhHHHHHHH
Confidence            4567888899999999977766654

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.96  E-value=1.3e-29  Score=263.77  Aligned_cols=220  Identities=24%  Similarity=0.268  Sum_probs=183.7

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEeccC---CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG---GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      +|+..+.||+|+||.||++     +..||+|.+.....   ...+.+.+|++++++++||||+++++++..++..++|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5788899999999999974     68899999976532   335688999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      |+.+++|.+++... ..+++..+..++.|+++|+.|||   ..+++|+||+|+||++++++.++|+|||.+.......  
T Consensus        81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--  154 (258)
T cd05578          81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--  154 (258)
T ss_pred             CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence            99999999999766 35889999999999999999999   9999999999999999999999999999987654332  


Q ss_pred             ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh-------------------hhhhcccccch
Q 040702          665 LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE-------------------KHLMTKEQPMV  725 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~l~  725 (797)
                       ......|+..|+|||.+....++.++|+|++|+..+..+.+..++....                   ......+.+++
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  233 (258)
T cd05578         155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAI  233 (258)
T ss_pred             -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHH
Confidence             2234568889999999988888999999999988755554443322211                   11234667888


Q ss_pred             hccccCCCCCCCCh
Q 040702          726 RMGTDLSLGQFPAS  739 (797)
Q Consensus       726 ~~cl~~dp~~RPs~  739 (797)
                      ++|+..||.+||++
T Consensus       234 ~~~l~~~p~~R~~~  247 (258)
T cd05578         234 NKLLERDPQKRLGD  247 (258)
T ss_pred             HHHccCChhHcCCc
Confidence            88999999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.96  E-value=8.2e-29  Score=261.82  Aligned_cols=227  Identities=23%  Similarity=0.312  Sum_probs=181.9

Q ss_pred             CCccccccccCCcceeec-----ceEEEEEEEEecc--CCcchhHHHHHHHhhhccCCceeEeeeeeecC--CeEEEEEE
Q 040702          514 FSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISSCSND--DFKALVLE  584 (797)
Q Consensus       514 f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~--~~~~lv~e  584 (797)
                      |+..+.||+|+||.||++     ++.||+|++....  ....+.+.+|++++++++|||++++++++...  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            667789999999999985     5889999998763  23345788999999999999999999999888  78999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      |+++ +|.+++......+++..+..++.|+++|++|||   ..+++|+||||+||++++++.+||+|||.+........ 
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-  155 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-  155 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-
Confidence            9975 899888766456899999999999999999999   89999999999999999999999999999986643321 


Q ss_pred             ccccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchhh-----------------------------
Q 040702          665 LTQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIREE-----------------------------  714 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-----------------------------  714 (797)
                      .......++..|+|||.+.+ ..++.++|+|++|+..+..+....++....                             
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07840         156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF  235 (287)
T ss_pred             ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence            12233467889999998765 357899999999988754443332221100                             


Q ss_pred             -----------------hh-hhcccccchhccccCCCCCCCChHHHHHh
Q 040702          715 -----------------KH-LMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       715 -----------------~~-~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                                       .. ....+.++++.|+..+|.+||++.++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                             00 13345678899999999999999988753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=99.96  E-value=8.3e-32  Score=296.76  Aligned_cols=394  Identities=28%  Similarity=0.307  Sum_probs=248.5

Q ss_pred             CCCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEE
Q 040702            3 SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSL   82 (797)
Q Consensus         3 ~l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L   82 (797)
                      +++.|.+-....+.......|+.||||.|+         +...|..+..+.+|+.|+++.|-|.. .|.+..++.+|++|
T Consensus        27 n~~~N~~l~~pl~~~~~~v~L~~l~lsnn~---------~~~fp~~it~l~~L~~ln~s~n~i~~-vp~s~~~~~~l~~l   96 (1081)
T KOG0618|consen   27 NLRRNSLLSRPLEFVEKRVKLKSLDLSNNQ---------ISSFPIQITLLSHLRQLNLSRNYIRS-VPSSCSNMRNLQYL   96 (1081)
T ss_pred             hccccccccCchHHhhheeeeEEeeccccc---------cccCCchhhhHHHHhhcccchhhHhh-Cchhhhhhhcchhh
Confidence            444454433333334444457777777776         33445666667777777777777765 45666777777777


Q ss_pred             EccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCC-------------------cCcccCC
Q 040702           83 YLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKN-------------------SFSGSIP  143 (797)
Q Consensus        83 ~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-------------------~l~~~~~  143 (797)
                      .|.+|.+. .+|.++ ..+.+|++|++++|++. ..|..+..++.++.+..++|                   .+.+..+
T Consensus        97 nL~~n~l~-~lP~~~-~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~  173 (1081)
T KOG0618|consen   97 NLKNNRLQ-SLPASI-SELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFL  173 (1081)
T ss_pred             eeccchhh-cCchhH-HhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchh
Confidence            77777776 667665 36777777777777765 45555555444444444444                   3333333


Q ss_pred             ccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChh
Q 040702          144 NTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEE  223 (797)
Q Consensus       144 ~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~  223 (797)
                      .....++.  .|+|++|.+..+        .+.++.+|+.|....|++....-     ...+++.|+.++|.++...+..
T Consensus       174 ~~i~~l~~--~ldLr~N~~~~~--------dls~~~~l~~l~c~rn~ls~l~~-----~g~~l~~L~a~~n~l~~~~~~p  238 (1081)
T KOG0618|consen  174 IDIYNLTH--QLDLRYNEMEVL--------DLSNLANLEVLHCERNQLSELEI-----SGPSLTALYADHNPLTTLDVHP  238 (1081)
T ss_pred             cchhhhhe--eeecccchhhhh--------hhhhccchhhhhhhhcccceEEe-----cCcchheeeeccCcceeecccc
Confidence            33333333  477777766622        14455555555555555543211     1125556666666665332221


Q ss_pred             hhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcc
Q 040702          224 INNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDI  303 (797)
Q Consensus       224 ~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L  303 (797)
                      ..  .+  ++++++++|+++. .|++++.+.+|+.++..+|+++ ..|..+...++|+.|++.+|.+..+|+...+++.|
T Consensus       239 ~p--~n--l~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL  312 (1081)
T KOG0618|consen  239 VP--LN--LQYLDISHNNLSN-LPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSL  312 (1081)
T ss_pred             cc--cc--ceeeecchhhhhc-chHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhhhCCCccccccee
Confidence            11  12  2666666666663 3366666666666666666664 34445555566666666666666666655556666


Q ss_pred             cEEEccCCcCCCCCCccc-------------------------cccccccEEeccCcccccccCccccCCcccceecccC
Q 040702          304 LHLNLSSNFFTGPLPLKI-------------------------GNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEY  358 (797)
Q Consensus       304 ~~L~l~~N~l~~~~~~~~-------------------------~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  358 (797)
                      ++|+|..|.|...++..|                         .....|+.|++.+|.++...-..+.+..+|+.|+|++
T Consensus       313 ~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsy  392 (1081)
T KOG0618|consen  313 RTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSY  392 (1081)
T ss_pred             eeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecc
Confidence            666666666653222111                         1235578888888888876666788888999999999


Q ss_pred             ccccCCCChhhhccccCCeeeecCCcCCCCCChhhhccCCCCeEEccCCcCcccCCCCCCCCCCCcccccCCcc
Q 040702          359 NRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNEL  432 (797)
Q Consensus       359 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~~~~~~n~~  432 (797)
                      |+|.......+.++..|+.|+||+|.++ .+|..+.++..|+.|...+|++...+ ....+..++.++++.|.+
T Consensus       393 NrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~~fP-e~~~l~qL~~lDlS~N~L  464 (1081)
T KOG0618|consen  393 NRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLLSFP-ELAQLPQLKVLDLSCNNL  464 (1081)
T ss_pred             cccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCceeech-hhhhcCcceEEecccchh
Confidence            9998555557788899999999999998 77888999999999999999988654 667788888888888865

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.7e-30  Score=260.24  Aligned_cols=232  Identities=24%  Similarity=0.330  Sum_probs=188.1

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEec--cCCc-----chhHHHHHHHhhhccCCceeEeeeeee-cCC
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQ--YGGA-----FKSFDIECGMMKRIRHRNLIKIISSCS-NDD  577 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~--~~~~-----~~~~~~E~~~l~~l~Hpniv~l~~~~~-~~~  577 (797)
                      .++|-....||+|||++|||+     .+.||||+-...  +++.     .+-..+|.++-+.+.||.||++|+++. +.+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            357777889999999999996     488999986433  2222     244678999999999999999999986 557


Q ss_pred             eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEc---CCCcEEEEeecC
Q 040702          578 FKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD---DNMVAHLSDFGM  654 (797)
Q Consensus       578 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~---~~~~~kl~DFGl  654 (797)
                      .+|-|.|||+|.+|+.+++..+. +++.+++.|+.||+.||.||... +.+|+|-|+||.|||+.   ..|.+||.|||+
T Consensus       542 sFCTVLEYceGNDLDFYLKQhkl-mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGL  619 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQHKL-MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGL  619 (775)
T ss_pred             cceeeeeecCCCchhHHHHhhhh-hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecch
Confidence            89999999999999999988764 89999999999999999999944 78999999999999995   568999999999


Q ss_pred             CccCCccCcc-----ccccccccCcccccccccccC----ccchHHHHHHHhhhhhhhhccccccchhhhh---------
Q 040702          655 AKPLLEEDQS-----LTQTQTLATIGYMAPDEIFSG----EMRLKCWVNDSLLISVMIVVDANLLIREEKH---------  716 (797)
Q Consensus       655 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~~---------  716 (797)
                      ++.+.++...     ..++...||.||.+||.+.-+    .++.++|||++|++.+..+.+..+++..-.+         
T Consensus       620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI  699 (775)
T KOG1151|consen  620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI  699 (775)
T ss_pred             hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch
Confidence            9988654322     234667899999999998755    4688999999999988888777776653221         


Q ss_pred             -------------hhcccccchhccccCCCCCCCChHHHHH
Q 040702          717 -------------LMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       717 -------------~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                   .....+.++++|+++.-++|-...+++.
T Consensus       700 lkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  700 LKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             hcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence                         2235677888899888888887666654

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.96  E-value=7.6e-29  Score=264.30  Aligned_cols=231  Identities=23%  Similarity=0.270  Sum_probs=182.2

Q ss_pred             HHhcCCCccccccccCCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeecCC----
Q 040702          509 QATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSNDD----  577 (797)
Q Consensus       509 ~~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~----  577 (797)
                      ...++|+..+.||+|+||.||++     ++.||||+++....  .....+.+|++++++++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            35678999999999999999985     57899999976532  22356778999999999999999999987654    


Q ss_pred             ------eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEe
Q 040702          578 ------FKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSD  651 (797)
Q Consensus       578 ------~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  651 (797)
                            ..++|+||+++ ++...+......+++..+..++.|++.||+|||   ..+|+||||||+||++++++.+||+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCc
Confidence                  78999999976 777777665546899999999999999999999   99999999999999999999999999


Q ss_pred             ecCCccCCccCccccccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccccccchh-----------------
Q 040702          652 FGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANLLIRE-----------------  713 (797)
Q Consensus       652 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~~~~~-----------------  713 (797)
                      ||.+........ .......++..|+|||.+.+. .++.++|+|++|+..+..+.+..++...                 
T Consensus       160 fg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~  238 (302)
T cd07864         160 FGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC  238 (302)
T ss_pred             ccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            999986543321 122234567889999988653 4688999999998875444332221100                 


Q ss_pred             -----------------------------hhhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          714 -----------------------------EKHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       714 -----------------------------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                                   .......+.+++..|+..||.+||++.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         239 PAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             hhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                                         0012345678899999999999999988875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.96  E-value=8.3e-29  Score=265.72  Aligned_cols=227  Identities=25%  Similarity=0.274  Sum_probs=183.3

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEeccCC---cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG---AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      .|+..+.||+|+||.||++     +..||+|.+......   ....+.+|++++++++|||++++++++..++..++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3677789999999999974     578999998754322   23568889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      |+. |++.+.+......+++.++..++.|++.|+.|||   ..+|+||||+|+||+++.++.+||+|||++.....    
T Consensus       106 ~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----  177 (317)
T cd06635         106 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----  177 (317)
T ss_pred             CCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence            997 5888877665556899999999999999999999   99999999999999999999999999999875422    


Q ss_pred             ccccccccCcccccccccc---cCccchHHHHHHHhhhhhhhhccccccchhh------------------hhhhccccc
Q 040702          665 LTQTQTLATIGYMAPDEIF---SGEMRLKCWVNDSLLISVMIVVDANLLIREE------------------KHLMTKEQP  723 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~  723 (797)
                        .....|+..|+|||.+.   .+.++.++|+|++|+..++.+.+..++....                  ......+.+
T Consensus       178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  255 (317)
T cd06635         178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRN  255 (317)
T ss_pred             --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHH
Confidence              22346889999999874   4568899999999998755544433221110                  012234678


Q ss_pred             chhccccCCCCCCCChHHHHHhHHHH
Q 040702          724 MVRMGTDLSLGQFPASYSISKYLVYI  749 (797)
Q Consensus       724 l~~~cl~~dp~~RPs~~~i~~~l~~i  749 (797)
                      +++.|++.+|.+||++.++++.....
T Consensus       256 li~~~l~~~p~~Rpt~~~il~~~~~~  281 (317)
T cd06635         256 FVDSCLQKIPQDRPTSEELLKHMFVL  281 (317)
T ss_pred             HHHHHccCCcccCcCHHHHHhChhhh
Confidence            88999999999999999998865443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.96  E-value=8.3e-29  Score=262.90  Aligned_cols=227  Identities=22%  Similarity=0.295  Sum_probs=178.8

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      ++|+..+.||+|++|.||++     ++.||+|.++....  ...+.+.+|++++++++||||+++++++...+..|+|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            57889999999999999985     57899999865432  223578899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcC-CCcEEEEeecCCccCCccC
Q 040702          585 YMPLGSLEKCLYSGNY-ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD-NMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl~DFGla~~~~~~~  662 (797)
                      |++ +++.+++..... ..++..+..++.||+.||+|||   +++++||||||+||+++. ++.+||+|||++.......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            996 588887765433 3678888899999999999999   999999999999999985 5679999999997543221


Q ss_pred             ccccccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccccccchh-h--------------------------
Q 040702          663 QSLTQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANLLIRE-E--------------------------  714 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~~~~~-~--------------------------  714 (797)
                        .......|++.|+|||.+.+. .++.++|+|++|+..+..+.+..++... .                          
T Consensus       158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (294)
T PLN00009        158 --RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP  235 (294)
T ss_pred             --cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence              122334678999999988664 4788999999998875554443322110 0                          


Q ss_pred             ------------------hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          715 ------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       715 ------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                        ........+++++|++.+|++||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence                              011233457888999999999999998886

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.96  E-value=7e-29  Score=261.16  Aligned_cols=234  Identities=19%  Similarity=0.226  Sum_probs=176.3

Q ss_pred             cccccCCcceeec-----ceEEEEEEEEeccCC---cchhHHHHHHHhhh---ccCCceeEeeeeeecCCeEEEEEEccC
Q 040702          519 LIGRGGFGPVYKD-----GMEVAIKVFNLQYGG---AFKSFDIECGMMKR---IRHRNLIKIISSCSNDDFKALVLEYMP  587 (797)
Q Consensus       519 ~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~---l~Hpniv~l~~~~~~~~~~~lv~e~~~  587 (797)
                      .||+|+||.||++     ++.||+|.+......   ....+.+|..+++.   .+||+|+.+++++..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999973     588999998755321   12234455444443   369999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccccc
Q 040702          588 LGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ  667 (797)
Q Consensus       588 ~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  667 (797)
                      +|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++++|||++......    ..
T Consensus        81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~~  152 (279)
T cd05633          81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KP  152 (279)
T ss_pred             CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----Cc
Confidence            999999887654 4899999999999999999999   999999999999999999999999999998754322    12


Q ss_pred             cccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchhh-------------------hhhhcccccchhc
Q 040702          668 TQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIREE-------------------KHLMTKEQPMVRM  727 (797)
Q Consensus       668 ~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~l~~~  727 (797)
                      ....||..|+|||.+.. ..++.++|+|++|+..+..+.+..++....                   ......+.++++.
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  232 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEG  232 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHH
Confidence            33569999999998864 457899999999998765555444332110                   0112244567777


Q ss_pred             cccCCCCCCCChHHHHHhHHHHHHHhccccccccccCCcccccceeeeeeeee
Q 040702          728 GTDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYTI  780 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~  780 (797)
                      |+..||.+||+...                    ..+..+++|+||++++|.-
T Consensus       233 ~l~~~p~~R~~~~~--------------------~~~~~~~~h~~~~~~~~~~  265 (279)
T cd05633         233 LLQRDVSKRLGCLG--------------------RGAQEVKEHVFFKGIDWQQ  265 (279)
T ss_pred             HhcCCHHHhcCCCC--------------------CCHHHHHhCccccCCCHhH
Confidence            88888888875211                    1234557788888887654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.96  E-value=4.7e-29  Score=264.21  Aligned_cols=222  Identities=21%  Similarity=0.213  Sum_probs=181.1

Q ss_pred             ccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccCCCC
Q 040702          516 ENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGS  590 (797)
Q Consensus       516 ~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~g~  590 (797)
                      ...+||+|+||.||++     +..||||.+..........+.+|+.+++.++||||+++++++...+..++||||+++++
T Consensus        24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  103 (292)
T cd06657          24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA  103 (292)
T ss_pred             hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence            3467999999999974     58899999865544445678899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccccccc
Q 040702          591 LEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT  670 (797)
Q Consensus       591 L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~  670 (797)
                      |.+++...  .+++..+..++.|++.|++|||   +.+++|+||||+||+++.++.++|+|||.+........  .....
T Consensus       104 L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~  176 (292)
T cd06657         104 LTDIVTHT--RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSL  176 (292)
T ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccc--ccccc
Confidence            99987654  3788999999999999999999   89999999999999999999999999999875533221  12335


Q ss_pred             ccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh-------------------hhhhcccccchhccccC
Q 040702          671 LATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE-------------------KHLMTKEQPMVRMGTDL  731 (797)
Q Consensus       671 ~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~l~~~cl~~  731 (797)
                      .|++.|+|||.+.+..++.++|+|++|+..+..+.+..++....                   ......+.+++.+|+..
T Consensus       177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  256 (292)
T cd06657         177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVR  256 (292)
T ss_pred             ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhC
Confidence            68999999999888888999999999988755554333221100                   01123456778899999


Q ss_pred             CCCCCCChHHHHH
Q 040702          732 SLGQFPASYSISK  744 (797)
Q Consensus       732 dp~~RPs~~~i~~  744 (797)
                      +|.+||++.++++
T Consensus       257 ~P~~R~~~~~ll~  269 (292)
T cd06657         257 DPAQRATAAELLK  269 (292)
T ss_pred             CcccCcCHHHHhc
Confidence            9999999998876

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.96  E-value=9.1e-29  Score=257.00  Aligned_cols=228  Identities=24%  Similarity=0.312  Sum_probs=190.1

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeecC--CeEEEEE
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSND--DFKALVL  583 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~--~~~~lv~  583 (797)
                      +|...+.||+|++|.||++     +..|++|++.....  ...+.+.+|+.++++++||||+++++.+...  +..++||
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4778899999999999985     67899999876643  3457889999999999999999999999988  8899999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      ||+++++|.+++.... .+++..+..++.|++.|++|||   +.+++|+|++|+||+++.++.++|+|||.+........
T Consensus        81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence            9999999999998765 5899999999999999999999   89999999999999999999999999999986644332


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccch-------------------hhhhhhcccccc
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIR-------------------EEKHLMTKEQPM  724 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~l  724 (797)
                      ........++..|+|||.+.....+.++|+|++|+..+..+.+..++..                   .+......+.++
T Consensus       157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  236 (260)
T cd06606         157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDF  236 (260)
T ss_pred             cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHH
Confidence            1113345688999999999888899999999999987555543322211                   111223467888


Q ss_pred             hhccccCCCCCCCChHHHHH
Q 040702          725 VRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       725 ~~~cl~~dp~~RPs~~~i~~  744 (797)
                      +.+|+..+|++||++.+++.
T Consensus       237 i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         237 LRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             HHHhCcCChhhCCCHHHHhh
Confidence            99999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.96  E-value=5e-29  Score=271.60  Aligned_cols=226  Identities=22%  Similarity=0.241  Sum_probs=180.7

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEecc--CCcchhHHHHHHHhhhccCCceeEeeeeeecC------
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISSCSND------  576 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~------  576 (797)
                      ..++|+..+.||+|+||.||++     ++.||||++....  ....+.+.+|+.++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999999999974     5889999986532  22345677899999999999999999988643      


Q ss_pred             CeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCc
Q 040702          577 DFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  656 (797)
Q Consensus       577 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  656 (797)
                      ...|+||||+. +++.+.+...   ++...+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~  166 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQMD---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  166 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccce
Confidence            35799999996 4888877643   788899999999999999999   9999999999999999999999999999998


Q ss_pred             cCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh----------------------
Q 040702          657 PLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE----------------------  714 (797)
Q Consensus       657 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------------  714 (797)
                      ......   ......|+..|+|||.+.+..++.++|+|++|+..+..+.+..++....                      
T Consensus       167 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
T cd07850         167 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR  243 (353)
T ss_pred             eCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            653221   2234568899999999998899999999999988754443322211000                      


Q ss_pred             -------------------------------------hhhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          715 -------------------------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       715 -------------------------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                                                           ........++++.|+..||++||++.|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                                                 0011234679999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.96  E-value=1.7e-30  Score=248.20  Aligned_cols=226  Identities=23%  Similarity=0.254  Sum_probs=175.9

Q ss_pred             CCCccccccccCCcceee-----cceEEEEEEEEeccC-CcchhHHHHHHHhhhc-cCCceeEeeeeeecCCeEEEEEEc
Q 040702          513 RFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYG-GAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk-----~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      +.+....||.|+||.|+|     .|+..|||+++.... .+.+++..|.++..+- +.||||++||++..++..|+.||.
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL  144 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL  144 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence            334457799999999997     579999999987643 4567888888876555 699999999999999999999999


Q ss_pred             cCCCCHHHHHh---c-CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCcc
Q 040702          586 MPLGSLEKCLY---S-GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       586 ~~~g~L~~~l~---~-~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  661 (797)
                      |.- ++..+.+   . .+..+++...-+|+.....||.||..  ...|+|||+||+|||+|..|.+|+||||++..+.+ 
T Consensus       145 Md~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~-  220 (361)
T KOG1006|consen  145 MDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD-  220 (361)
T ss_pred             Hhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHH-
Confidence            964 6655432   1 22257887777888889999999985  56899999999999999999999999999976532 


Q ss_pred             CccccccccccCcccccccccc--cCccchHHHHHHHhhhhhhhhccccccchhhh-----------------------h
Q 040702          662 DQSLTQTQTLATIGYMAPDEIF--SGEMRLKCWVNDSLLISVMIVVDANLLIREEK-----------------------H  716 (797)
Q Consensus       662 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~-----------------------~  716 (797)
                        +...+...|...|||||.+.  ..+|+..+||||+|+..++...+..+......                       +
T Consensus       221 --SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~  298 (361)
T KOG1006|consen  221 --SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVH  298 (361)
T ss_pred             --HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccc
Confidence              22445578999999999885  34699999999999876554444433332221                       1


Q ss_pred             hhcccccchhccccCCCCCCCChHHHHH
Q 040702          717 LMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       717 ~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      ....+..++..|+.+|.+.||...++.+
T Consensus       299 ~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  299 YSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             cCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            2335567778899999999999888765

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=9.9e-29  Score=256.14  Aligned_cols=226  Identities=26%  Similarity=0.318  Sum_probs=187.3

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      +|+..+.||+|++|.||++     ++.||+|.+.....  ...+.+.+|++++++++|||++++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4778899999999999984     57899999976643  3456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      +++++|.+++.... .+++..+..++.|++.|+.|||   +.+|+||||||+||+++.++.++|+|||.+........  
T Consensus        81 ~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  154 (254)
T cd06627          81 AENGSLRQIIKKFG-PFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--  154 (254)
T ss_pred             CCCCcHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc--
Confidence            99999999987654 4899999999999999999999   99999999999999999999999999999986643322  


Q ss_pred             cccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh-----------------hhhhhcccccchhcc
Q 040702          666 TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE-----------------EKHLMTKEQPMVRMG  728 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~l~~~c  728 (797)
                      ......++..|+|||......++.++|+|++|+..+..+.+..++...                 +......+.+++..|
T Consensus       155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  234 (254)
T cd06627         155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQC  234 (254)
T ss_pred             cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHH
Confidence            123456889999999988777889999999998875544433322110                 111234567889999


Q ss_pred             ccCCCCCCCChHHHHH
Q 040702          729 TDLSLGQFPASYSISK  744 (797)
Q Consensus       729 l~~dp~~RPs~~~i~~  744 (797)
                      +..+|++||++.+++.
T Consensus       235 l~~~p~~R~~~~~~l~  250 (254)
T cd06627         235 FQKDPNLRPTAKQLLK  250 (254)
T ss_pred             HhCChhhCcCHHHHhc
Confidence            9999999999988874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.3e-29  Score=248.64  Aligned_cols=262  Identities=20%  Similarity=0.218  Sum_probs=198.3

Q ss_pred             hcCCCccccccccCCcceee-----cceEEEEEEEEec---cCCcchhHHHHHHHhhhc-cCCceeEeeeeeecCCeEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQ---YGGAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk-----~~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~l  581 (797)
                      -++|...++||+|+|++|..     +.+.||+|++++.   ...+.+....|-.+..+. +||.+|.+..+|..+.+.++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            46899999999999999974     5689999999876   234456778888888776 69999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCcc
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  661 (797)
                      |.||++||+|..+++..++ ++++.++.+..+|.-||.|||   ++||+.||+|.+|||+|..|++|+.|||.++.-..+
T Consensus       329 vieyv~ggdlmfhmqrqrk-lpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~~  404 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQRQRK-LPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP  404 (593)
T ss_pred             EEEEecCcceeeehhhhhc-CcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence            9999999999888877664 999999999999999999999   999999999999999999999999999999864333


Q ss_pred             CccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhhhhhc--ccccchhccccCCCCCCC--
Q 040702          662 DQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEKHLMT--KEQPMVRMGTDLSLGQFP--  737 (797)
Q Consensus       662 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~~cl~~dp~~RP--  737 (797)
                      +  ..+++++||+.|+|||.+.+..|.+.+|+|++|+.+++++.+..+++....+...  ...-+.+..+... -+-|  
T Consensus       405 g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq-iriprs  481 (593)
T KOG0695|consen  405 G--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ-IRIPRS  481 (593)
T ss_pred             C--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc-ccccce
Confidence            2  2567799999999999999999999999999999987777776655432211110  0001111111110 0111  


Q ss_pred             ---ChHHHHHhHHHHHHHhccccccccc-cCCcccccceeeeeeeeec
Q 040702          738 ---ASYSISKYLVYIRELERGKVGITSV-AAFPIVHHYLYRTVDYTIS  781 (797)
Q Consensus       738 ---s~~~i~~~l~~i~~~~~~~~~~~~~-~~~~~~~~~~f~~~~~~~~  781 (797)
                         .+..+++-  .+.+.+..+.|-.+. .-.++.+|+||+.|+||.-
T Consensus       482 lsvkas~vlkg--flnkdp~erlgc~~~~g~~dik~h~ffr~idwd~l  527 (593)
T KOG0695|consen  482 LSVKASHVLKG--FLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLL  527 (593)
T ss_pred             eehhhHHHHHH--hhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHH
Confidence               11223321  133444445543332 3468899999999999863

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.96  E-value=8.1e-29  Score=257.24  Aligned_cols=227  Identities=23%  Similarity=0.274  Sum_probs=187.9

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      +|+..+.||+|+||.||++     +..||+|++.....  ...+.+..|++++++++|||++++++.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            5788899999999999974     58899999976543  3456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          586 MPLGSLEKCLYSGN---YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       586 ~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      +++++|.+++....   ..+++..+..++.|++.|+.|||   +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999997652   46899999999999999999999   8999999999999999999999999999998654332


Q ss_pred             ccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh-h----------------hhhhcccccch
Q 040702          663 QSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE-E----------------KHLMTKEQPMV  725 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~-~----------------~~~~~~~~~l~  725 (797)
                        .......|++.|+|||......++.++|+|++|...+..+....++... .                ......+.+++
T Consensus       158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  235 (258)
T cd08215         158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLV  235 (258)
T ss_pred             --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence              1223456899999999998888999999999998864444333322111 0                11224567788


Q ss_pred             hccccCCCCCCCChHHHHH
Q 040702          726 RMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       726 ~~cl~~dp~~RPs~~~i~~  744 (797)
                      +.|+..+|++||++.++++
T Consensus       236 ~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         236 SSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             HHHcCCChhhCcCHHHHhc
Confidence            9999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.96  E-value=3.6e-29  Score=270.62  Aligned_cols=230  Identities=22%  Similarity=0.247  Sum_probs=182.7

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeec----CCeE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSN----DDFK  579 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~----~~~~  579 (797)
                      .++|+..+.||+|+||.||++     +..||+|++.....  ...+.+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            478999999999999999974     68899999875432  234667889999999999999999998763    3468


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCC
Q 040702          580 ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  659 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  659 (797)
                      ++||||+. |+|.+++.... .+++..+..++.|++.||+|||   ..+|+||||||+||++++++.+||+|||+++...
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             EEEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            99999995 68999887654 3899999999999999999999   8999999999999999999999999999997653


Q ss_pred             ccCcc--ccccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchh-----------------------
Q 040702          660 EEDQS--LTQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIRE-----------------------  713 (797)
Q Consensus       660 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~-----------------------  713 (797)
                      .....  .......|+..|+|||.+.+ ..++.++|+|++|+..+..+.+..++...                       
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~  238 (334)
T cd07855         159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR  238 (334)
T ss_pred             ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence            32211  11234578999999998865 45789999999998875544433332110                       


Q ss_pred             ------------------------hhhhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          714 ------------------------EKHLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       714 ------------------------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                                              .......+.++++.|++.+|.+||++.+++..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                                    01123456689999999999999999988774

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.96  E-value=8.5e-29  Score=268.15  Aligned_cols=230  Identities=23%  Similarity=0.293  Sum_probs=181.8

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEecc--CCcchhHHHHHHHhhhc-cCCceeEeeeeeecC--CeE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY--GGAFKSFDIECGMMKRI-RHRNLIKIISSCSND--DFK  579 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~--~~~  579 (797)
                      ..++|+..+.||+|+||.||++     +..||||++....  ......+.+|+.+++++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3568999999999999999974     5789999886432  22345677899999999 999999999998654  368


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCC
Q 040702          580 ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  659 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  659 (797)
                      |+||||++ ++|..++...  .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++...
T Consensus        85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~  158 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS  158 (337)
T ss_pred             EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence            99999997 5999988765  4788899999999999999999   9999999999999999999999999999998664


Q ss_pred             ccCcc---ccccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchhh---------------------
Q 040702          660 EEDQS---LTQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIREE---------------------  714 (797)
Q Consensus       660 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~---------------------  714 (797)
                      .....   .......||..|+|||.+.+ ..++.++|+|++|+..+..+.+..++....                     
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07852         159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE  238 (337)
T ss_pred             cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            33221   12234568999999998765 457889999999988755444332221100                     


Q ss_pred             --------------------------hhhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          715 --------------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       715 --------------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                                                ......+.+++..|++.||++||++.++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                                      0012335678889999999999999999874

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.96  E-value=2.4e-28  Score=255.34  Aligned_cols=226  Identities=20%  Similarity=0.193  Sum_probs=175.7

Q ss_pred             CHHHHHHHhcCCCccccc--cccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhc-cCCceeEeeeeee
Q 040702          503 TYLELFQATNRFSENNLI--GRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRI-RHRNLIKIISSCS  574 (797)
Q Consensus       503 ~~~~l~~~~~~f~~~~~l--g~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~  574 (797)
                      +..++....++|+..+.+  |+|+||.||++     +..+|+|.+.......   .  |+.....+ +||||+++++++.
T Consensus         5 ~~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~   79 (267)
T PHA03390          5 SLSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVT   79 (267)
T ss_pred             HHHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEe
Confidence            445566667788887777  99999999973     5789999987543211   1  22222222 6999999999999


Q ss_pred             cCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCC-cEEEEeec
Q 040702          575 NDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM-VAHLSDFG  653 (797)
Q Consensus       575 ~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DFG  653 (797)
                      ..+..|+||||+++|+|.+++.... .+++..+..++.|+++|++|||   +.+++||||||+||+++.++ .++|+|||
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg  155 (267)
T PHA03390         80 TLKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYG  155 (267)
T ss_pred             cCCeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCc
Confidence            9999999999999999999997765 5899999999999999999999   99999999999999999888 99999999


Q ss_pred             CCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh------------------
Q 040702          654 MAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK------------------  715 (797)
Q Consensus       654 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~------------------  715 (797)
                      +++.....      ....|+..|+|||.+.+..++.++|+|++|+..+..+.+..++.....                  
T Consensus       156 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  229 (267)
T PHA03390        156 LCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPF  229 (267)
T ss_pred             cceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCc
Confidence            98755322      224689999999999988899999999999987555544333221100                  


Q ss_pred             --hhhcccccchhccccCCCCCCCC-hHHHH
Q 040702          716 --HLMTKEQPMVRMGTDLSLGQFPA-SYSIS  743 (797)
Q Consensus       716 --~~~~~~~~l~~~cl~~dp~~RPs-~~~i~  743 (797)
                        .....+.+++..|++.+|.+||+ +.+++
T Consensus       230 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l  260 (267)
T PHA03390        230 IKNVSKNANDFVQSMLKYNINYRLTNYNEII  260 (267)
T ss_pred             ccccCHHHHHHHHHHhccChhhCCchHHHHh
Confidence              12234566778888888888885 35554

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.96  E-value=1.1e-28  Score=261.63  Aligned_cols=230  Identities=20%  Similarity=0.184  Sum_probs=170.0

Q ss_pred             cCCCccccccccCCcceeec--------ceEEEEEEEEeccCCcc-----------hhHHHHHHHhhhccCCceeEeeee
Q 040702          512 NRFSENNLIGRGGFGPVYKD--------GMEVAIKVFNLQYGGAF-----------KSFDIECGMMKRIRHRNLIKIISS  572 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~--------~~~vAvK~~~~~~~~~~-----------~~~~~E~~~l~~l~Hpniv~l~~~  572 (797)
                      ++|.+.+.||+|+||.||++        +..+|+|..........           .....+...+..+.|++|++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            68999999999999999985        24566665433321110           011223344556689999999997


Q ss_pred             eecCC----eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEE
Q 040702          573 CSNDD----FKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAH  648 (797)
Q Consensus       573 ~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~k  648 (797)
                      +....    ..++++|++.. ++.+.+.... ..++..+..++.|++.|++|||   +.+|+||||||+|||++.++.++
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~~  166 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGY  166 (294)
T ss_pred             eeEecCCceEEEEEEehhcc-CHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcEE
Confidence            66543    45788888754 6766665432 3577888999999999999999   99999999999999999999999


Q ss_pred             EEeecCCccCCccCcc-----ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh--------
Q 040702          649 LSDFGMAKPLLEEDQS-----LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK--------  715 (797)
Q Consensus       649 l~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~--------  715 (797)
                      |+|||+|+.+......     .......||+.|+|||...+..++.++|+||+|+..++.+.+..++.....        
T Consensus       167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~  246 (294)
T PHA02882        167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA  246 (294)
T ss_pred             EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence            9999999865432211     112334699999999999988999999999999988665554444322210        


Q ss_pred             ----------------hhhcccccchhccccCCCCCCCChHHHHHhH
Q 040702          716 ----------------HLMTKEQPMVRMGTDLSLGQFPASYSISKYL  746 (797)
Q Consensus       716 ----------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l  746 (797)
                                      .....+.++++.|+..+|++||++.++.+.+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        247 KCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence                            1123456788889999999999999998765

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.96  E-value=1.3e-28  Score=265.14  Aligned_cols=229  Identities=23%  Similarity=0.271  Sum_probs=182.4

Q ss_pred             HHHHHhcCCCccccccccCCcceeec-----ceEEEEEEEEecc--CCcchhHHHHHHHhhhccCCceeEeeeeeec-CC
Q 040702          506 ELFQATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISSCSN-DD  577 (797)
Q Consensus       506 ~l~~~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~-~~  577 (797)
                      ++...+++|+..+.||+|+||.||++     ++.||||++....  ....+.+..|++++++++||||+++++++.. .+
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   83 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE   83 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence            44567889999999999999999974     5789999886532  2234678889999999999999999999875 45


Q ss_pred             eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCcc
Q 040702          578 FKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  657 (797)
Q Consensus       578 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  657 (797)
                      ..|+||||+ +++|.+++...  .+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||.+..
T Consensus        84 ~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~  157 (328)
T cd07856          84 DIYFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI  157 (328)
T ss_pred             cEEEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccc
Confidence            789999998 56899888654  3788888899999999999999   99999999999999999999999999999875


Q ss_pred             CCccCccccccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchhh----------------------
Q 040702          658 LLEEDQSLTQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIREE----------------------  714 (797)
Q Consensus       658 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------------  714 (797)
                      ...     ......++..|+|||.+.+ ..++.++|+|++|+..+..+.+..++....                      
T Consensus       158 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (328)
T cd07856         158 QDP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT  232 (328)
T ss_pred             cCC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            422     1223467889999998866 468899999999988744443332221100                      


Q ss_pred             -------------------------hhhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          715 -------------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       715 -------------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                                               ......+.+++++|+..+|++||++.+++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                                     0122456788999999999999999888654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.96  E-value=6.1e-29  Score=269.12  Aligned_cols=228  Identities=22%  Similarity=0.233  Sum_probs=182.3

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEecc--CCcchhHHHHHHHhhhccCCceeEeeeeeecCC-----e
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDD-----F  578 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~-----~  578 (797)
                      .++|...+.||+|+||.||++     +..||||.++...  ......+.+|+.+++.++||||+++++++....     .
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            457999999999999999974     5889999987542  223456778999999999999999999886542     4


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccC
Q 040702          579 KALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  658 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  658 (797)
                      .|+||||+. ++|.+++.... .+++..+..++.|++.||.|||   +++++||||||+||+++.++.+||+|||+++..
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTT  158 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence            799999996 68988887654 4899999999999999999999   999999999999999999999999999999865


Q ss_pred             CccCccccccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchh------------------------
Q 040702          659 LEEDQSLTQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIRE------------------------  713 (797)
Q Consensus       659 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~------------------------  713 (797)
                      ....  .......++..|+|||.+.. ..++.++|+|++|+..+..+....++...                        
T Consensus       159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07858         159 SEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI  236 (337)
T ss_pred             CCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence            4322  12234568899999998865 45889999999998875544433322110                        


Q ss_pred             -----------------------hhhhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          714 -----------------------EKHLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       714 -----------------------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                                             .......+.+++++|+..+|++||++.++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence                                   01123345688999999999999999999876

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.96  E-value=9.6e-29  Score=265.09  Aligned_cols=228  Identities=17%  Similarity=0.155  Sum_probs=177.5

Q ss_pred             CccccccccCCcceee---cceEEEEEEEEec--cCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccCCC
Q 040702          515 SENNLIGRGGFGPVYK---DGMEVAIKVFNLQ--YGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLG  589 (797)
Q Consensus       515 ~~~~~lg~G~~g~Vyk---~~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~g  589 (797)
                      ...+.+|.|+++.||+   .++.||||++...  .....+.+.+|++++++++||||+++++++...+..+++|||+++|
T Consensus         5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            3445566667777776   3689999999765  2334568999999999999999999999999999999999999999


Q ss_pred             CHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc----
Q 040702          590 SLEKCLYSG-NYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS----  664 (797)
Q Consensus       590 ~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~----  664 (797)
                      ++.+++... ...+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+|++|||.+.........    
T Consensus        85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            999998754 235788899999999999999999   999999999999999999999999999988755322111    


Q ss_pred             -ccccccccCccccccccccc--CccchHHHHHHHhhhhhhhhccccccchhhh--------------------------
Q 040702          665 -LTQTQTLATIGYMAPDEIFS--GEMRLKCWVNDSLLISVMIVVDANLLIREEK--------------------------  715 (797)
Q Consensus       665 -~~~~~~~gt~~y~aPE~~~~--~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~--------------------------  715 (797)
                       .......++..|+|||.+..  ..++.++|+|++|+..+....+..++.....                          
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED  241 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence             11233457888999998865  3578899999999887554443333221100                          


Q ss_pred             ------------------------hhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          716 ------------------------HLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       716 ------------------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                                              .......++++.||..||++||++.++++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence                                    001234568889999999999999988873

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.96  E-value=5.6e-29  Score=263.40  Aligned_cols=227  Identities=22%  Similarity=0.259  Sum_probs=177.2

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccC-CcchhHHHHHHHhhhcc-CCceeEeeeeeecCCeEEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIR-HRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      ++|...+.||+|+||.||++     ++.||+|.+..... .....+.+|+.++.++. ||||+++++++..++..+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            35666789999999999973     58899999875532 23467889999999996 9999999999999999999999


Q ss_pred             ccCCCCHHHHH---hc-CCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCceEEcCCCcEEEEeecCCccCC
Q 040702          585 YMPLGSLEKCL---YS-GNYILDIFQGLNIMIDVASALEYLHFGYS-VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  659 (797)
Q Consensus       585 ~~~~g~L~~~l---~~-~~~~l~~~~~~~i~~qi~~al~yLH~~~~-~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  659 (797)
                      |+.. ++.++.   .. ....+++..+..++.|++.|++|||   + .+|+||||||+||+++.++.+||+|||+++...
T Consensus        84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK---EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            9864 655433   22 2235899999999999999999999   5 489999999999999999999999999997653


Q ss_pred             ccCccccccccccCcccccccccccC---ccchHHHHHHHhhhhhhhhccccccchhhh---------------------
Q 040702          660 EEDQSLTQTQTLATIGYMAPDEIFSG---EMRLKCWVNDSLLISVMIVVDANLLIREEK---------------------  715 (797)
Q Consensus       660 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~---------------------  715 (797)
                      ...   ......|+..|+|||.+...   .++.++|+|++|+..+..+.+..++.....                     
T Consensus       160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd06616         160 DSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEE  236 (288)
T ss_pred             cCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCC
Confidence            322   12334688999999998766   688999999999887555444333221110                     


Q ss_pred             -hhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          716 -HLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       716 -~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                       .....+.++++.|++.||++||++.++++.
T Consensus       237 ~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         237 REFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             112235678899999999999998887763

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.96  E-value=1.4e-28  Score=259.49  Aligned_cols=225  Identities=23%  Similarity=0.257  Sum_probs=183.4

Q ss_pred             CCccccccccCCcceeec-----ceEEEEEEEEeccCC--cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          514 FSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG--AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       514 f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      |+..+.||+|++|.||++     ++.+|+|.++.....  ....+..|++++++++||||+++++++..++..++||||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            567789999999999984     688999998755322  3467888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccc
Q 040702          587 PLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  666 (797)
Q Consensus       587 ~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  666 (797)
                      ++ ++.+++......+++..+..++.|+++|++|||   ..+|+|+||||+||+++.++.+||+|||.+.......  ..
T Consensus        81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~  154 (283)
T cd05118          81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RP  154 (283)
T ss_pred             CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cc
Confidence            75 888888775556899999999999999999999   9999999999999999999999999999997664332  12


Q ss_pred             ccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccccccchh--------------------------------
Q 040702          667 QTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANLLIRE--------------------------------  713 (797)
Q Consensus       667 ~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~~~~~--------------------------------  713 (797)
                      .....++..|+|||.+.+. .++.++|+|++|+..+..+.+..++...                                
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK  234 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence            2334688899999998776 6889999999998875554443322110                                


Q ss_pred             --------------hhhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          714 --------------EKHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       714 --------------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                    .......+.++++.|+.+||.+||++.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                          0012235668899999999999999998875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.96  E-value=2.9e-29  Score=270.77  Aligned_cols=192  Identities=28%  Similarity=0.375  Sum_probs=162.1

Q ss_pred             CCccccccccCCcceeec-----ceEEEEEEEEecc-CCcchhHHHHHHHhhhccCCceeEeeeeeecCC------eEEE
Q 040702          514 FSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDD------FKAL  581 (797)
Q Consensus       514 f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~------~~~l  581 (797)
                      +...+.||+||||.||++     |+.||||.++... ....+...+|++++++++|||||+++++=++..      ...+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            345588999999999985     6899999998653 344577889999999999999999999865543      4679


Q ss_pred             EEEccCCCCHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEc--CCC--cEEEEeecCC
Q 040702          582 VLEYMPLGSLEKCLYSGNY--ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD--DNM--VAHLSDFGMA  655 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~--~~~--~~kl~DFGla  655 (797)
                      |||||.||+|...+.....  .+++.+.+.+..+++.||.|||   .++|+||||||.||++-  .+|  --||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            9999999999999976543  6999999999999999999999   99999999999999983  334  4799999999


Q ss_pred             ccCCccCccccccccccCcccccccccc-cCccchHHHHHHHhhhhhhhhccccccc
Q 040702          656 KPLLEEDQSLTQTQTLATIGYMAPDEIF-SGEMRLKCWVNDSLLISVMIVVDANLLI  711 (797)
Q Consensus       656 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~dv~s~~~~~~~~~~~~~~~~  711 (797)
                      +...+..   .....+||..|.+||.+. ++.|+..+|.||+|++.+....+..++.
T Consensus       172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~  225 (732)
T KOG4250|consen  172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFI  225 (732)
T ss_pred             ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCC
Confidence            9875443   456789999999999988 4889999999999999877766655443

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.96  E-value=8e-29  Score=260.91  Aligned_cols=229  Identities=24%  Similarity=0.299  Sum_probs=186.5

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhcc-CCceeEeeeeeecCCeEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIR-HRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~lv  582 (797)
                      ++|...+.||+|+||.||++     +..||+|++....   ....+.+..|++++++++ ||||+++++++..++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888999999999999974     5889999987542   223467888999999998 99999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      |||+++++|.+++.... .+++..+..++.|++.|+.|||   +.+++|+||||+||+++.++.++++|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~  156 (280)
T cd05581          81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS  156 (280)
T ss_pred             EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence            99999999999998765 4899999999999999999999   9999999999999999999999999999998654322


Q ss_pred             cc------------------ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh-----------
Q 040702          663 QS------------------LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE-----------  713 (797)
Q Consensus       663 ~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~-----------  713 (797)
                      ..                  .......|+..|+|||.+....++.++|+|++|+..+..+.+..++...           
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~  236 (280)
T cd05581         157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILK  236 (280)
T ss_pred             ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh
Confidence            11                  1223456789999999998888999999999998875544433332211           


Q ss_pred             -----hhhhhcccccchhccccCCCCCCCCh----HHHHH
Q 040702          714 -----EKHLMTKEQPMVRMGTDLSLGQFPAS----YSISK  744 (797)
Q Consensus       714 -----~~~~~~~~~~l~~~cl~~dp~~RPs~----~~i~~  744 (797)
                           +......+.++++.|+..+|++||++    .++++
T Consensus       237 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         237 LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence                 11122356788999999999999999    55543

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.96  E-value=1.5e-28  Score=266.57  Aligned_cols=227  Identities=21%  Similarity=0.280  Sum_probs=179.4

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEecc--CCcchhHHHHHHHhhhccCCceeEeeeeeecCC------
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDD------  577 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~------  577 (797)
                      .++|...+.||+|+||.||++     ++.||||.+....  ......+.+|+.++++++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            478999999999999999975     5889999987542  222356789999999999999999999986543      


Q ss_pred             eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCcc
Q 040702          578 FKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  657 (797)
Q Consensus       578 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  657 (797)
                      ..|+||||+.. ++..+...   .+++..+..++.|++.|++|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus        94 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~  166 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMGH---PLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARH  166 (342)
T ss_pred             eEEEEeccccc-CHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence            46899999964 77776532   3788999999999999999999   99999999999999999999999999999985


Q ss_pred             CCccCccccccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchhh----------------------
Q 040702          658 LLEEDQSLTQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIREE----------------------  714 (797)
Q Consensus       658 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------------  714 (797)
                      ...     ......++..|+|||.+.+ ..++.++|+|++|+..++.+.+..++....                      
T Consensus       167 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (342)
T cd07879         167 ADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK  241 (342)
T ss_pred             CCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            422     1233568889999999876 457899999999998755554443322110                      


Q ss_pred             -------------------------hhhhcccccchhccccCCCCCCCChHHHHHh--HHHH
Q 040702          715 -------------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISKY--LVYI  749 (797)
Q Consensus       715 -------------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~--l~~i  749 (797)
                                               ......+.++++.|++.||++||++.+++..  ++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~  303 (342)
T cd07879         242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF  303 (342)
T ss_pred             hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence                                     0112235689999999999999999999853  4444

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=8.9e-29  Score=271.91  Aligned_cols=233  Identities=23%  Similarity=0.274  Sum_probs=190.3

Q ss_pred             HHHHHhcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhc-cCCceeEeeeeeec----
Q 040702          506 ELFQATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRI-RHRNLIKIISSCSN----  575 (797)
Q Consensus       506 ~l~~~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~----  575 (797)
                      .+...++-|++.+.||.|.+|.||++     ++.+|||+...... ..+++..|.++++.. .|||++.++|++..    
T Consensus        13 ~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~   91 (953)
T KOG0587|consen   13 SLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG   91 (953)
T ss_pred             hCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence            33445678899999999999999974     57899999876543 347788899999887 59999999999853    


Q ss_pred             -CCeEEEEEEccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeec
Q 040702          576 -DDFKALVLEYMPLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFG  653 (797)
Q Consensus       576 -~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG  653 (797)
                       +++.|+|||||.+|+..++++.-. ..+.|..+.-|+++++.|+.+||   ...++|||||-.|||++.++.+|++|||
T Consensus        92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFG  168 (953)
T KOG0587|consen   92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFG  168 (953)
T ss_pred             CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeee
Confidence             468999999999999999987643 36899999999999999999999   9999999999999999999999999999


Q ss_pred             CCccCCccCccccccccccCccccccccccc-----CccchHHHHHHHhhhhhhhh-ccccccch---------------
Q 040702          654 MAKPLLEEDQSLTQTQTLATIGYMAPDEIFS-----GEMRLKCWVNDSLLISVMIV-VDANLLIR---------------  712 (797)
Q Consensus       654 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~dv~s~~~~~~~~~-~~~~~~~~---------------  712 (797)
                      .+..+.  .+.....+.+||+.|||||++.-     ..|+..+|+|++|++.+++. .+|++.+.               
T Consensus       169 vSaQld--sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPP  246 (953)
T KOG0587|consen  169 VSAQLD--STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPP  246 (953)
T ss_pred             eeeeee--cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCc
Confidence            997652  33335567899999999998853     45889999999999875443 23333322               


Q ss_pred             ---hhhhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          713 ---EEKHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       713 ---~~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                         .+....++..+++..|+..|-++||++.++++
T Consensus       247 kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  247 KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             cccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence               23345567788999999999999999987765

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.95  E-value=1.8e-28  Score=262.60  Aligned_cols=230  Identities=20%  Similarity=0.245  Sum_probs=179.4

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCC--cchhHHHHHHHhhhccCCceeEeeeeeecCC------
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG--AFKSFDIECGMMKRIRHRNLIKIISSCSNDD------  577 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~------  577 (797)
                      .++|...+.||+|+||.||++     ++.||||++......  ....+.+|++++++++||||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            578999999999999999974     578999998765322  2346788999999999999999999875433      


Q ss_pred             --eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCC
Q 040702          578 --FKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMA  655 (797)
Q Consensus       578 --~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla  655 (797)
                        ..++||||+++ ++...+......+++..+..++.|+++||+|||   +.+|+||||||+||++++++.+||+|||++
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence              46999999965 777777665556899999999999999999999   999999999999999999999999999999


Q ss_pred             ccCCccCcc---------ccccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccccccchhh-----------
Q 040702          656 KPLLEEDQS---------LTQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANLLIREE-----------  714 (797)
Q Consensus       656 ~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-----------  714 (797)
                      +........         .......|++.|+|||.+.+. .++.++|+|++|+..++.+.+..++....           
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~  242 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL  242 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            765322111         111334678899999988654 47889999999998755554433221100           


Q ss_pred             -----------------------------------hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          715 -----------------------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       715 -----------------------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                                         ......+.++++.|+..||++||++.|++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence                                               001124458899999999999999888764

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.95  E-value=4.1e-28  Score=259.77  Aligned_cols=222  Identities=24%  Similarity=0.275  Sum_probs=179.8

Q ss_pred             CCccccccccCCcceeec-----ceEEEEEEEEeccCC---cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          514 FSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG---AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       514 f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      |...+.||+|+||.||++     +..||+|.+......   ..+.+..|++++++++|||++++++++.+.+..|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            566678999999999985     578999998754322   235678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      +. |++.+++......+++.++..++.|++.|+.|||   +.+++||||||+||+++.++.+||+|||++....      
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------  172 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------  172 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccC------
Confidence            96 5888877665556899999999999999999999   8999999999999999999999999999986432      


Q ss_pred             cccccccCcccccccccc---cCccchHHHHHHHhhhhhhhhccccccchhh------------------hhhhcccccc
Q 040702          666 TQTQTLATIGYMAPDEIF---SGEMRLKCWVNDSLLISVMIVVDANLLIREE------------------KHLMTKEQPM  724 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~---~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~l  724 (797)
                      ......|+..|+|||.+.   .+.++.++|+|++|+..+....+..++....                  ......++++
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  252 (313)
T cd06633         173 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGF  252 (313)
T ss_pred             CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHH
Confidence            123456899999999874   4567889999999998755544433221100                  0112346788


Q ss_pred             hhccccCCCCCCCChHHHHHh
Q 040702          725 VRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       725 ~~~cl~~dp~~RPs~~~i~~~  745 (797)
                      +..|++.+|.+||++.+++..
T Consensus       253 i~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         253 VDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             HHHHccCChhhCcCHHHHhcC
Confidence            999999999999999988853

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.95  E-value=1.9e-28  Score=254.48  Aligned_cols=225  Identities=22%  Similarity=0.274  Sum_probs=185.0

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEecc--CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      +|+..+.||+|+||.||++     ++.+|+|.+....  .....++.+|++++++++||||+++++++.+....|+||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4788899999999999974     5789999987643  22345778899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          586 MPLGSLEKCLYSG---NYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       586 ~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      +++++|.+++...   ...+++..++.++.|+++|++|||   +.+++|+||+|+||++++++.+|++|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            9999999988652   235889999999999999999999   999999999999999999999999999999866433 


Q ss_pred             ccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh-----------------hhhhcccccch
Q 040702          663 QSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE-----------------KHLMTKEQPMV  725 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~l~  725 (797)
                         ......|+..|+|||.+.+..++.++|+|++|...+..+....++....                 ......+.+++
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  233 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFI  233 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHH
Confidence               2223568889999999988888999999999988754443332221111                 11223467888


Q ss_pred             hccccCCCCCCCChHHHHH
Q 040702          726 RMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       726 ~~cl~~dp~~RPs~~~i~~  744 (797)
                      ..|+..+|++||++.++++
T Consensus       234 ~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         234 RSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             HHHcCCCcccCCCHHHHhc
Confidence            9999999999999998875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.95  E-value=4.2e-28  Score=262.57  Aligned_cols=229  Identities=21%  Similarity=0.281  Sum_probs=178.6

Q ss_pred             hcCCCc-cccccccCCcceeec-----ceEEEEEEEEeccCCc--------------chhHHHHHHHhhhccCCceeEee
Q 040702          511 TNRFSE-NNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGA--------------FKSFDIECGMMKRIRHRNLIKII  570 (797)
Q Consensus       511 ~~~f~~-~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~--------------~~~~~~E~~~l~~l~Hpniv~l~  570 (797)
                      .++|.. .+.||+|+||.||++     ++.||||.++......              ...+.+|++++++++||||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            356654 577999999999985     5789999986543211              12577899999999999999999


Q ss_pred             eeeecCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEE
Q 040702          571 SSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLS  650 (797)
Q Consensus       571 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~  650 (797)
                      +++..++..++||||+. |+|.+++.... .+++.....++.|++.|++|||   +.+|+||||||+||+++.++.+||+
T Consensus        87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         87 DVYVEGDFINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             EEEecCCcEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEEC
Confidence            99999999999999997 59999886544 4889999999999999999999   9999999999999999999999999


Q ss_pred             eecCCccCCccCc------------cccccccccCcccccccccccCc-cchHHHHHHHhhhhhhhhccccccchhh---
Q 040702          651 DFGMAKPLLEEDQ------------SLTQTQTLATIGYMAPDEIFSGE-MRLKCWVNDSLLISVMIVVDANLLIREE---  714 (797)
Q Consensus       651 DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~~-~~~~~dv~s~~~~~~~~~~~~~~~~~~~---  714 (797)
                      |||+++.......            ........++..|+|||.+.+.. ++.++|+|++|+..+..+.+..++....   
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  241 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID  241 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            9999976541110            01112345688999999987643 6899999999988755544433221100   


Q ss_pred             -----------------------------------------hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          715 -----------------------------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       715 -----------------------------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                                               ......+.++++.|++.+|++||++.|++.
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        242 QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence                                                     011234567888999999999999988885

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.95  E-value=1.9e-28  Score=261.87  Aligned_cols=225  Identities=25%  Similarity=0.281  Sum_probs=181.2

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccC---CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG---GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ..|+..+.||+|+||.||++     +..||+|.+.....   ...+++.+|+++++.++|||++++++++...+..++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            45777889999999999975     47899999874322   22356788999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      ||+. |++.+.+......+++..+..++.|++.|+.|||   +.+++||||||+||+++.++.+||+|||++......  
T Consensus        95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--  168 (308)
T cd06634          95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (308)
T ss_pred             EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence            9996 5888877655556899999999999999999999   899999999999999999999999999998754321  


Q ss_pred             cccccccccCcccccccccc---cCccchHHHHHHHhhhhhhhhccccccchhh------------------hhhhcccc
Q 040702          664 SLTQTQTLATIGYMAPDEIF---SGEMRLKCWVNDSLLISVMIVVDANLLIREE------------------KHLMTKEQ  722 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~  722 (797)
                          ....|+..|+|||.+.   .+.++.++|+|++|+..+..+.+..++....                  ......+.
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (308)
T cd06634         169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFR  244 (308)
T ss_pred             ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHH
Confidence                2346889999999875   3567889999999998755544443321111                  01223466


Q ss_pred             cchhccccCCCCCCCChHHHHHhH
Q 040702          723 PMVRMGTDLSLGQFPASYSISKYL  746 (797)
Q Consensus       723 ~l~~~cl~~dp~~RPs~~~i~~~l  746 (797)
                      +++++|+..+|++||++.++++.-
T Consensus       245 ~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         245 NFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             HHHHHHhhCCcccCCCHHHHhhCc
Confidence            888999999999999999888754

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.95  E-value=2.3e-28  Score=259.71  Aligned_cols=228  Identities=21%  Similarity=0.228  Sum_probs=180.7

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccC-CcchhHHHHHHHhhhcc-CCceeEeeeeeecCCeEEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIR-HRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      -++|+..+.||+|+||.||++     ++.||||.++.... .....+..|+.++.+.. ||||+++++++.++...|+||
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            367888999999999999974     68899999975532 23355677887776665 999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS-VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~-~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      ||+. +++..+.......+++..+..++.|+++|++|||   + .+|+||||+|+||++++++.+||+|||++.......
T Consensus        94 e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          94 ELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             eccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence            9985 4787777664556899999999999999999999   6 599999999999999999999999999997653322


Q ss_pred             ccccccccccCcccccccccccC----ccchHHHHHHHhhhhhhhhccccccchhhh--------------------hhh
Q 040702          663 QSLTQTQTLATIGYMAPDEIFSG----EMRLKCWVNDSLLISVMIVVDANLLIREEK--------------------HLM  718 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~--------------------~~~  718 (797)
                      .   .....++..|+|||.+...    .++.++|+|++|+..+..+.+..++.....                    ...
T Consensus       170 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (296)
T cd06618         170 A---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFS  246 (296)
T ss_pred             c---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCC
Confidence            1   2234578899999988654    378899999999987555544443322110                    012


Q ss_pred             cccccchhccccCCCCCCCChHHHHHh
Q 040702          719 TKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       719 ~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                      ..+.+++.+|+..||.+||++.+++..
T Consensus       247 ~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         247 PDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            245788889999999999999998865

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.95  E-value=2.4e-28  Score=264.96  Aligned_cols=226  Identities=21%  Similarity=0.259  Sum_probs=179.7

Q ss_pred             HHHhcCCCccccccccCCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeecCC---
Q 040702          508 FQATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSNDD---  577 (797)
Q Consensus       508 ~~~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~---  577 (797)
                      ....++|+..+.||+|+||.||++     +..||||++.....  ...+.+.+|+.++++++||||+++++++....   
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            335678999999999999999975     58899999864322  12356789999999999999999999987553   


Q ss_pred             ---eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecC
Q 040702          578 ---FKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGM  654 (797)
Q Consensus       578 ---~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl  654 (797)
                         ..++||||+ +++|.+++...  .+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+|++|||+
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence               458999999 67999888654  4899999999999999999999   99999999999999999999999999999


Q ss_pred             CccCCccCccccccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchhh-------------------
Q 040702          655 AKPLLEEDQSLTQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIREE-------------------  714 (797)
Q Consensus       655 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-------------------  714 (797)
                      +......     .....+++.|+|||.+.+ ..++.++|+|++|+..+..+.+..++....                   
T Consensus       165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (343)
T cd07880         165 ARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF  239 (343)
T ss_pred             ccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            9854321     223467899999998875 357899999999988755444433221100                   


Q ss_pred             ----------------------------hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          715 ----------------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       715 ----------------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                                  ......+.++++.|+..||.+||++.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                                        011223457888899999999999998874

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.95  E-value=3.7e-28  Score=262.04  Aligned_cols=225  Identities=18%  Similarity=0.228  Sum_probs=173.9

Q ss_pred             cccccc--CCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccCC
Q 040702          518 NLIGRG--GFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPL  588 (797)
Q Consensus       518 ~~lg~G--~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~  588 (797)
                      ..||+|  +||.||++     ++.||||++.....  ...+.+.+|+.+++.++||||++++++|..++..++||||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456766  88999974     68999999875432  2246788899999999999999999999999999999999999


Q ss_pred             CCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc--
Q 040702          589 GSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL--  665 (797)
Q Consensus       589 g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~--  665 (797)
                      |++.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+|++|||.+..........  
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            99999987643 24888899999999999999999   9999999999999999999999999998654322111100  


Q ss_pred             ---cccccccCcccccccccccC--ccchHHHHHHHhhhhhhhhccccccchh---------------------------
Q 040702          666 ---TQTQTLATIGYMAPDEIFSG--EMRLKCWVNDSLLISVMIVVDANLLIRE---------------------------  713 (797)
Q Consensus       666 ---~~~~~~gt~~y~aPE~~~~~--~~~~~~dv~s~~~~~~~~~~~~~~~~~~---------------------------  713 (797)
                         ......++..|||||.+.++  .++.++|+|++|+..++.+.+..++...                           
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE  240 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence               01112356679999998764  4789999999998875544333322110                           


Q ss_pred             ------------------------------------hhhhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          714 ------------------------------------EKHLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       714 ------------------------------------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                                                          .......+.++++.|+..||++|||+.|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                                                00112345689999999999999999999764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.95  E-value=2.7e-28  Score=264.78  Aligned_cols=235  Identities=20%  Similarity=0.238  Sum_probs=185.6

Q ss_pred             ccCHHHHHHHhcCCCccccccccCCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeee
Q 040702          501 RFTYLELFQATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSC  573 (797)
Q Consensus       501 ~~~~~~l~~~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~  573 (797)
                      +....++...+++|...+.||+|+||.||++     ++.||+|++.....  ...+.+.+|+.++++++||||+++++++
T Consensus         6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~   85 (345)
T cd07877           6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF   85 (345)
T ss_pred             hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence            4456677888999999999999999999974     58899999875422  2235678899999999999999999987


Q ss_pred             ecC------CeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcE
Q 040702          574 SND------DFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVA  647 (797)
Q Consensus       574 ~~~------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~  647 (797)
                      ...      ...|++++++ +++|.+++...  .+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+
T Consensus        86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~  159 (345)
T cd07877          86 TPARSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCEL  159 (345)
T ss_pred             eecccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCE
Confidence            543      3478888887 77998887654  3889999999999999999999   9999999999999999999999


Q ss_pred             EEEeecCCccCCccCccccccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccch-hhh----------
Q 040702          648 HLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIR-EEK----------  715 (797)
Q Consensus       648 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~-~~~----------  715 (797)
                      ||+|||+++....     ......|+..|+|||.+.+ ..++.++|+|++|+..+..+.+..++.. ...          
T Consensus       160 kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  234 (345)
T cd07877         160 KILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV  234 (345)
T ss_pred             EEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            9999999985422     1233568899999998765 4678899999999887554433322210 000          


Q ss_pred             ------------------------------------hhhcccccchhccccCCCCCCCChHHHHHhH
Q 040702          716 ------------------------------------HLMTKEQPMVRMGTDLSLGQFPASYSISKYL  746 (797)
Q Consensus       716 ------------------------------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l  746 (797)
                                                          .....+.+++..|+..||.+||++.+++..-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~  301 (345)
T cd07877         235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA  301 (345)
T ss_pred             CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence                                                0122345788899999999999999888753

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.95  E-value=1.8e-28  Score=264.86  Aligned_cols=228  Identities=22%  Similarity=0.249  Sum_probs=184.8

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEecc--CCcchhHHHHHHHhhhccCCceeEeeeeeecCC-----eEE
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDD-----FKA  580 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~-----~~~  580 (797)
                      +|.+.+.||+|+||.||++     ++.||||.+....  ....+.+.+|+++++.++||||+++++++...+     ..|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5888899999999999975     5889999987653  334568899999999999999999999988775     789


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCc
Q 040702          581 LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  660 (797)
Q Consensus       581 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  660 (797)
                      +||||++ ++|.+++.... .+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.++|+|||++.....
T Consensus        81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            9999997 48988887655 5899999999999999999999   99999999999999999999999999999986543


Q ss_pred             cCcc-ccccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccccccchhh------------------------
Q 040702          661 EDQS-LTQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANLLIREE------------------------  714 (797)
Q Consensus       661 ~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~~~~~~------------------------  714 (797)
                      .... .......++..|+|||.+.+. .++.++|+|++|+..+..+....++....                        
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  235 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT  235 (330)
T ss_pred             cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence            3210 112345688999999999887 78999999999988755444332221100                        


Q ss_pred             -----------------------hhhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          715 -----------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       715 -----------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                                             ......+.++++.|++.+|++||++.+++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                                   0112345679999999999999999999874

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.95  E-value=1.7e-29  Score=245.28  Aligned_cols=225  Identities=22%  Similarity=0.232  Sum_probs=179.9

Q ss_pred             HhcCCCcc-ccccccCCccee-----ecceEEEEEEEEeccCCcchhHHHHHHHhhhc-cCCceeEeeeeeecC----Ce
Q 040702          510 ATNRFSEN-NLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRI-RHRNLIKIISSCSND----DF  578 (797)
Q Consensus       510 ~~~~f~~~-~~lg~G~~g~Vy-----k~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~----~~  578 (797)
                      .|++|.+. ++||-|-.|.|.     ++++.+|+|++...     ....+|++.--.. .|||||.++++|+..    ..
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            46677654 789999999985     36889999988633     5567888875555 699999999998643    35


Q ss_pred             EEEEEEccCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcC---CCcEEEEeecC
Q 040702          579 KALVLEYMPLGSLEKCLYSGNY-ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD---NMVAHLSDFGM  654 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~DFGl  654 (797)
                      ..+|||.|+||.|...+.+++. .+++.++..|++||+.|++|||   +.+|.||||||+|+|...   +..+||+|||+
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEeccccc
Confidence            6799999999999999987654 7899999999999999999999   999999999999999964   45799999999


Q ss_pred             CccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhh-hhhhccccccchhhh------------------
Q 040702          655 AKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLIS-VMIVVDANLLIREEK------------------  715 (797)
Q Consensus       655 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~-~~~~~~~~~~~~~~~------------------  715 (797)
                      |+....   .....+.+.|+.|.|||++-..+|+..+|+|++|++. +....-|+++.....                  
T Consensus       211 AK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP  287 (400)
T KOG0604|consen  211 AKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFP  287 (400)
T ss_pred             ccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCC
Confidence            996432   2345668899999999999999999999999999987 444444443322111                  


Q ss_pred             -----hhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          716 -----HLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       716 -----~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                           ...+..+++++..+..+|.+|-|+.++++.
T Consensus       288 ~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  288 EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence                 123456788888999999999998888763

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=4.6e-28  Score=252.95  Aligned_cols=194  Identities=24%  Similarity=0.327  Sum_probs=160.1

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEecc-----CCcchhHHHHHHHhhhccCCceeEeeeeeecC--CeE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY-----GGAFKSFDIECGMMKRIRHRNLIKIISSCSND--DFK  579 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~--~~~  579 (797)
                      .+|...+.||+|+||.||++     +..||+|.+....     ......+.+|++++++++||||+++++++.+.  +..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47888999999999999985     5789999886432     12235788899999999999999999998764  468


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCC
Q 040702          580 ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  659 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  659 (797)
                      ++||||+++++|.+++.... .+++..+..++.|++.|+.|||   +.+++|+||||+||+++.++.++|+|||+++...
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence            89999999999999987654 3788899999999999999999   9999999999999999999999999999998653


Q ss_pred             ccCc-cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccc
Q 040702          660 EEDQ-SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANL  709 (797)
Q Consensus       660 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~  709 (797)
                      .... ........|+..|+|||.+.+...+.++|+|++|+..+..+.+..+
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p  208 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP  208 (264)
T ss_pred             cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCC
Confidence            2111 1112345689999999999888889999999999987655544433

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.95  E-value=3.2e-28  Score=256.84  Aligned_cols=224  Identities=20%  Similarity=0.242  Sum_probs=178.8

Q ss_pred             CCccccccccCCcceeec-----ceEEEEEEEEeccCC-cchhHHHHHHHhhhcc-CCceeEeeeeeecCCeEEEEEEcc
Q 040702          514 FSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG-AFKSFDIECGMMKRIR-HRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       514 f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      |...+.||+|+||.||+|     ++.||||++...... ......+|+..+++++ ||||+++++++.+++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567789999999999985     478999998755332 2234567999999999 999999999999999999999999


Q ss_pred             CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          587 PLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       587 ~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                       +|++.+++.... ..+++..+..++.|++.|+.|||   +.+++|+||+|+||++++++.++|+|||.++......   
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~---  153 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP---  153 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC---
Confidence             789999887654 35899999999999999999999   8999999999999999999999999999998654322   


Q ss_pred             cccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchh-------------------------------
Q 040702          666 TQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIRE-------------------------------  713 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~-------------------------------  713 (797)
                      ......|+..|+|||.+.. ..++.++|+|++|+..++.+....++...                               
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07830         154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL  233 (283)
T ss_pred             CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence            1233568889999998854 44789999999998874444332221100                               


Q ss_pred             ---------------hhhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          714 ---------------EKHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       714 ---------------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                     .......+.++++.|+..||++||++.|++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence                           0011234668899999999999999998865

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.95  E-value=5.6e-28  Score=255.51  Aligned_cols=224  Identities=21%  Similarity=0.292  Sum_probs=177.2

Q ss_pred             CCccccccccCCcceeec-----ceEEEEEEEEeccCC--cchhHHHHHHHhhhc---cCCceeEeeeeeecCCe-----
Q 040702          514 FSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG--AFKSFDIECGMMKRI---RHRNLIKIISSCSNDDF-----  578 (797)
Q Consensus       514 f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l---~Hpniv~l~~~~~~~~~-----  578 (797)
                      |+..+.||+|+||.||++     ++.||+|+++.....  ....+.+|+.+++++   +||||+++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            667889999999999974     578999999754322  234566788877766   59999999999988776     


Q ss_pred             EEEEEEccCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCcc
Q 040702          579 KALVLEYMPLGSLEKCLYSGNY-ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  657 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  657 (797)
                      .+++|||+.+ ++.+++..... .+++..++.++.|+++||+|||   +.+++|+||+|+||+++.++.+||+|||++..
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            9999999974 89888866432 5899999999999999999999   89999999999999999999999999999986


Q ss_pred             CCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh-----------------------
Q 040702          658 LLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE-----------------------  714 (797)
Q Consensus       658 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-----------------------  714 (797)
                      .....   ......++..|+|||.+.+..++.++|+|++|+..+..+....++....                       
T Consensus       157 ~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07838         157 YSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN  233 (287)
T ss_pred             ccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCC
Confidence            53322   1223457889999999998889999999999988755443322211100                       


Q ss_pred             --------------------hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          715 --------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       715 --------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                          .+......++++.|++.||++||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                                011234457889999999999999998874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.95  E-value=3.9e-28  Score=283.66  Aligned_cols=142  Identities=29%  Similarity=0.392  Sum_probs=127.6

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccC---CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG---GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      .++|.+.++||+|+||.||++     ++.||||+++....   .....+..|+.+++.++||||+++++++...+..|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            368999999999999999985     58899999975432   1236788899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCc
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  656 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  656 (797)
                      |||+.+++|.+++.... .+++..++.|+.||+.||+|||   .++|+||||||+|||++.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999997654 4788899999999999999999   8999999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.95  E-value=4.4e-28  Score=255.58  Aligned_cols=225  Identities=24%  Similarity=0.312  Sum_probs=183.0

Q ss_pred             CCccccccccCCcceeec-----ceEEEEEEEEecc--CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          514 FSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       514 f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      |+..+.||+|+||.||++     ++.||+|.+....  ....+.+..|+.++++++||||+++++++...+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            566788999999999974     6889999998663  233467888999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccc
Q 040702          587 PLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  666 (797)
Q Consensus       587 ~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  666 (797)
                      + ++|.+++......+++..+..++.|++.|++|||   ..+|+||||+|+||++++++.+||+|||+++.......  .
T Consensus        81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~  154 (282)
T cd07829          81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--T  154 (282)
T ss_pred             C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--c
Confidence            7 5999999876445899999999999999999999   89999999999999999999999999999986543221  2


Q ss_pred             ccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccccccchhh-------------------------------
Q 040702          667 QTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANLLIREE-------------------------------  714 (797)
Q Consensus       667 ~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-------------------------------  714 (797)
                      .....++..|+|||.+.+. .++.++|+|++|+..++.+....++....                               
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP  234 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence            2234567889999998776 78899999999988755544433221100                               


Q ss_pred             --------------hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          715 --------------KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       715 --------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                    ......+.++++.|+..||++||++.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence                          001234677899999999999999988875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.95  E-value=5e-28  Score=275.51  Aligned_cols=227  Identities=18%  Similarity=0.170  Sum_probs=154.0

Q ss_pred             HhcCCCccccccccCCcceeec---------ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeee------ee
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD---------GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISS------CS  574 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~---------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~------~~  574 (797)
                      ..++|+..+.||+|+||.||++         +..||||++.....  .+....|  .+....+.+++.+...      +.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            5678999999999999999985         57899998753321  1111111  1112222222222221      24


Q ss_pred             cCCeEEEEEEccCCCCHHHHHhcCCCCC-------------------CHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCC
Q 040702          575 NDDFKALVLEYMPLGSLEKCLYSGNYIL-------------------DIFQGLNIMIDVASALEYLHFGYSVPIIHCDLK  635 (797)
Q Consensus       575 ~~~~~~lv~e~~~~g~L~~~l~~~~~~l-------------------~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlk  635 (797)
                      .++..++||||+++++|.+++.......                   ....+..++.|++.||+|||   +++|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence            5567999999999999999987543211                   12345679999999999999   9999999999


Q ss_pred             CCceEEcC-CCcEEEEeecCCccCCccCccccccccccCcccccccccccC----------------------ccchHHH
Q 040702          636 PSNVLLDD-NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG----------------------EMRLKCW  692 (797)
Q Consensus       636 p~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~d  692 (797)
                      |+|||++. ++.+||+|||+|+.+..... .......||+.|||||.+...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999985 57999999999986533222 223456799999999965422                      2334569


Q ss_pred             HHHHhhhhhhhhccccccchhh----------------------hhhhc--------------ccccchhccccCCCCCC
Q 040702          693 VNDSLLISVMIVVDANLLIREE----------------------KHLMT--------------KEQPMVRMGTDLSLGQF  736 (797)
Q Consensus       693 v~s~~~~~~~~~~~~~~~~~~~----------------------~~~~~--------------~~~~l~~~cl~~dp~~R  736 (797)
                      +||+|+..++.+..+.......                      .....              ...++++.|+..||++|
T Consensus       362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR  441 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR  441 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence            9999998765554221111000                      00000              01268999999999999


Q ss_pred             CChHHHHH
Q 040702          737 PASYSISK  744 (797)
Q Consensus       737 Ps~~~i~~  744 (797)
                      ||+.++++
T Consensus       442 ~ta~e~L~  449 (566)
T PLN03225        442 ISAKAALA  449 (566)
T ss_pred             CCHHHHhC
Confidence            99888774

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.95  E-value=3.7e-30  Score=258.79  Aligned_cols=262  Identities=23%  Similarity=0.256  Sum_probs=135.6

Q ss_pred             ccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccC-ccccccCCc
Q 040702           42 LCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWG-NNFIGTIPS  120 (797)
Q Consensus        42 l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~-N~l~~~~~~  120 (797)
                      ++++|.++..  .-+.++|..|+|+.+.|.+|+.+.+|+.||||+|.|+ .|...+|.++++|.+|-+.+ |+|+.+..+
T Consensus        58 L~eVP~~LP~--~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is-~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~  134 (498)
T KOG4237|consen   58 LTEVPANLPP--ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNIS-FIAPDAFKGLASLLSLVLYGNNKITDLPKG  134 (498)
T ss_pred             cccCcccCCC--cceEEEeccCCcccCChhhccchhhhceecccccchh-hcChHhhhhhHhhhHHHhhcCCchhhhhhh
Confidence            3444544432  3445555555555555555555555555555555555 55555555555555555444 555544445


Q ss_pred             hhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCC----------
Q 040702          121 FIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNP----------  190 (797)
Q Consensus       121 ~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~----------  190 (797)
                      .|.++..|+.|.+.-|++..+..++|..|++|..|.|.+|.+..+...     +|..+..++.+.+..|.          
T Consensus       135 ~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~-----tf~~l~~i~tlhlA~np~icdCnL~wl  209 (498)
T KOG4237|consen  135 AFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKG-----TFQGLAAIKTLHLAQNPFICDCNLPWL  209 (498)
T ss_pred             HhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccc-----cccchhccchHhhhcCccccccccchh
Confidence            555555555555555555555555555555555555555555555543     35555555555555555          


Q ss_pred             --------------------------CCCCCChhhhccccCCcEEEccCCcccccCC-hhhhhhhhhHhhhccccccccc
Q 040702          191 --------------------------LGGILPRAIGNLSQSMEDFWMDNCNISGSIP-EEINNLTNLILQLLSLEGNQLE  243 (797)
Q Consensus       191 --------------------------l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p-~~~~~l~~L~L~~L~Ls~N~l~  243 (797)
                                                +..+.+..|....+++..-..+.+...+..| ..|..+++|  +.|+|++|+|+
T Consensus       210 a~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L--~~lnlsnN~i~  287 (498)
T KOG4237|consen  210 ADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNL--RKLNLSNNKIT  287 (498)
T ss_pred             hhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccc--eEeccCCCccc
Confidence                                      3333333332211111111122222222222 235555555  55555555555


Q ss_pred             CCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCC-CCCCCCCCcccEEEccCCcC
Q 040702          244 GSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSI-PSTLWNLKDILHLNLSSNFF  313 (797)
Q Consensus       244 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l-p~~~~~l~~L~~L~l~~N~l  313 (797)
                      ++-+.+|.++..+++|.|..|+|..+....|.++..|++|+|.+|+|+.+ |.+|..+.+|..|+|-.|.+
T Consensus       288 ~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~  358 (498)
T KOG4237|consen  288 RIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPF  358 (498)
T ss_pred             hhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcc
Confidence            55555555555555555555555555555555555555555555555444 33444455555555555543

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=7.7e-30  Score=241.55  Aligned_cols=193  Identities=22%  Similarity=0.359  Sum_probs=158.7

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEec--cCCcchhHHHHHHHhhhccCCceeEeeeeeecC--------
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQ--YGGAFKSFDIECGMMKRIRHRNLIKIISSCSND--------  576 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~--------  576 (797)
                      ..|....++|+|.||+||++     ++.||+|++-..  .++-.....+|+++|..++|+|++.+++.|...        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            45666789999999999974     577898875433  333345678999999999999999999988542        


Q ss_pred             CeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCc
Q 040702          577 DFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  656 (797)
Q Consensus       577 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  656 (797)
                      ...|+||++|+. +|.-++......++..++.+++.++..||.|+|   +..|+|||+||+|+||+.+|.+||+|||+|+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence            358999999987 999999877667999999999999999999999   9999999999999999999999999999998


Q ss_pred             cCCccCc--cccccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhcccc
Q 040702          657 PLLEEDQ--SLTQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDAN  708 (797)
Q Consensus       657 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~  708 (797)
                      .+...+.  ....+..+-|.+|++||.+.+. .|+.+.|+|+.|++..+++...+
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrsp  227 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSP  227 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCc
Confidence            7644332  2234566789999999998875 58899999999998744444433

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.95  E-value=8.2e-28  Score=259.80  Aligned_cols=228  Identities=20%  Similarity=0.204  Sum_probs=176.6

Q ss_pred             CCCccccccccCCcceeec-------ceEEEEEEEEeccCC--cchhHHHHHHHhhhc-cCCceeEeeeeeecC----Ce
Q 040702          513 RFSENNLIGRGGFGPVYKD-------GMEVAIKVFNLQYGG--AFKSFDIECGMMKRI-RHRNLIKIISSCSND----DF  578 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-------~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~----~~  578 (797)
                      +|...+.||+|+||.||++       +..||||++......  ..+.+.+|+++++++ +||||+++++++...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4778899999999999973       468999998754222  245678899999999 599999999875432    45


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccC
Q 040702          579 KALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  658 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  658 (797)
                      .|+++||+. ++|.+++.... .+++..++.++.|++.||+|||   ..+|+||||||+||+++.++.+||+|||+++..
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            789999986 58999886554 4899999999999999999999   999999999999999999999999999999865


Q ss_pred             CccCcc--ccccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchhh---------------------
Q 040702          659 LEEDQS--LTQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIREE---------------------  714 (797)
Q Consensus       659 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~---------------------  714 (797)
                      ......  .......||..|+|||.+.+ ..++.++|+|++|+..+..+.+..++....                     
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS  235 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            432211  11234578999999998765 457899999999988754443332221100                     


Q ss_pred             --------------------------hhhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          715 --------------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       715 --------------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                                                ......+.+++.+|++.||.+||++.++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                      0012356688899999999999999998753

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.9e-28  Score=261.23  Aligned_cols=221  Identities=19%  Similarity=0.231  Sum_probs=182.9

Q ss_pred             HhcCCCccccccccCCcceee-----cceEEEEEEEEeccCCcchhHHHHHHHhhhc-cCCceeEeeeeeecCCeEEEEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk-----~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      .++.|.....+|.|+|+.|.+     ..+..|||++.+..    .+..+|+.++... +||||+++.+.+.+....|+||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            356788888899999999976     35889999998662    3445677666665 6999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEE-cCCCcEEEEeecCCccCCccC
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL-DDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll-~~~~~~kl~DFGla~~~~~~~  662 (797)
                      |++.||-+.+.+...+. .. ..+..|+.+|+.|+.|||   ++||||||+||+|||+ ++.++++|+|||.++....+ 
T Consensus       396 e~l~g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-  469 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKPE-FC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-  469 (612)
T ss_pred             hhccccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence            99999988777766543 22 677789999999999999   9999999999999999 58999999999999865432 


Q ss_pred             ccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhhh---------------hhcccccchhc
Q 040702          663 QSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEKH---------------LMTKEQPMVRM  727 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~l~~~  727 (797)
                          ..+.+-|..|.|||++...+|+..+|+||+|+..+.++.+..++...+.+               .....+++++.
T Consensus       470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s~~vS~~AKdLl~~  545 (612)
T KOG0603|consen  470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFSECVSDEAKDLLQQ  545 (612)
T ss_pred             ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccccccCHHHHHHHHH
Confidence                23456788999999999999999999999999998888777765554443               23356788999


Q ss_pred             cccCCCCCCCChHHHHH
Q 040702          728 GTDLSLGQFPASYSISK  744 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~  744 (797)
                      |++.||.+||++.++..
T Consensus       546 LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  546 LLQVDPALRLGADEIGA  562 (612)
T ss_pred             hccCChhhCcChhhhcc
Confidence            99999999999888764

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.95  E-value=4.2e-28  Score=263.04  Aligned_cols=229  Identities=21%  Similarity=0.262  Sum_probs=178.6

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecC---------
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSND---------  576 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~---------  576 (797)
                      ..+|...+.||+|+||.||++     +..||+|.+........+.+.+|++++++++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            368999999999999999975     579999999776555567788999999999999999999876544         


Q ss_pred             -----CeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEc-CCCcEEEE
Q 040702          577 -----DFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD-DNMVAHLS  650 (797)
Q Consensus       577 -----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~-~~~~~kl~  650 (797)
                           ...|+||||++ ++|.+++...  .+++..++.++.||++|++|||   ..+|+||||||+||+++ .++.+|++
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG--PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEEC
Confidence                 35789999997 5898888654  3789999999999999999999   99999999999999997 45678999


Q ss_pred             eecCCccCCccCccc-cccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchhh--------------
Q 040702          651 DFGMAKPLLEEDQSL-TQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIREE--------------  714 (797)
Q Consensus       651 DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------  714 (797)
                      |||.++......... ......|+..|+|||.+.. ..++.++|+|++|+..+..+.+..++....              
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  237 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV  237 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            999997643221111 1123467889999998755 457789999999998755444333221000              


Q ss_pred             --------------------------------hhhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          715 --------------------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       715 --------------------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                                                      ........++++.|+..||++||++.++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence                                            0112234578999999999999999998863

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.95  E-value=5e-28  Score=252.02  Aligned_cols=226  Identities=20%  Similarity=0.237  Sum_probs=177.2

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEecc-----CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY-----GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      +|...+.||+|+||.||++     +..+++|.++...     .....++..|+.++++++||||+++++++.+.+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            5788899999999999974     2345566654321     12234567899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCC
Q 040702          583 LEYMPLGSLEKCLYS---GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  659 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  659 (797)
                      |||+++++|.+++..   ....+++..++.++.|+++|+.|||   +.+++|+|+||+||++++ +.+||+|||.++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999988864   2235899999999999999999999   999999999999999975 569999999997654


Q ss_pred             ccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccch-----------------hhhhhhcccc
Q 040702          660 EEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIR-----------------EEKHLMTKEQ  722 (797)
Q Consensus       660 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~  722 (797)
                      ....  ......|++.|+|||.+....++.++|+|++|+..+..+....++..                 .+......+.
T Consensus       157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (260)
T cd08222         157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLN  234 (260)
T ss_pred             CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHH
Confidence            3322  22345688999999998888888999999999887544333322111                 1112234566


Q ss_pred             cchhccccCCCCCCCChHHHHH
Q 040702          723 PMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       723 ~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      ++++.|+..+|++||++.++++
T Consensus       235 ~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         235 SIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             HHHHHHhcCChhhCcCHHHHhh
Confidence            7899999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=8.2e-28  Score=276.47  Aligned_cols=236  Identities=22%  Similarity=0.337  Sum_probs=190.0

Q ss_pred             HhcCCCccccccccCCcceeec------------ceEEEEEEEEeccC-CcchhHHHHHHHhhhcc-CCceeEeeeeeec
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD------------GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIR-HRNLIKIISSCSN  575 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~------------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~  575 (797)
                      ..++....+.+|+|.||.|++|            ...||||.++.... ...+.+..|+++|+.+. ||||+.++|+|..
T Consensus       294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~  373 (609)
T KOG0200|consen  294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ  373 (609)
T ss_pred             chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence            3445556679999999999975            36799999986643 34678999999999994 9999999999999


Q ss_pred             CCeEEEEEEccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceE
Q 040702          576 DDFKALVLEYMPLGSLEKCLYSGN---------------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL  640 (797)
Q Consensus       576 ~~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIl  640 (797)
                      ++..++|+||++.|+|.++++..+               ..+...+...++.|||.|++||+   +.+++|||+-++|||
T Consensus       374 ~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVL  450 (609)
T KOG0200|consen  374 DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVL  450 (609)
T ss_pred             CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEE
Confidence            999999999999999999998877               23788899999999999999999   999999999999999


Q ss_pred             EcCCCcEEEEeecCCccCCccCcccccccccc--CcccccccccccCccchHHHHHHHhhhh--hhhhccccccch----
Q 040702          641 LDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA--TIGYMAPDEIFSGEMRLKCWVNDSLLIS--VMIVVDANLLIR----  712 (797)
Q Consensus       641 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~dv~s~~~~~--~~~~~~~~~~~~----  712 (797)
                      +..+..+||+|||+|+.....+.+.. ....|  ...|||||.+....|+.++||||+|+..  +..+.+.+..+.    
T Consensus       451 i~~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~  529 (609)
T KOG0200|consen  451 ITKNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE  529 (609)
T ss_pred             ecCCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH
Confidence            99999999999999996654443321 22222  3459999999999999999999999965  233333333221    


Q ss_pred             -------------hhhhhhcccccchhccccCCCCCCCChHHHHHhHHHH
Q 040702          713 -------------EEKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYI  749 (797)
Q Consensus       713 -------------~~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i  749 (797)
                                   .|......+.++++.||+.+|++||++.++.+.++..
T Consensus       530 ~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  530 ELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence                         0111223455778889999999999999999998884

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.95  E-value=3e-28  Score=264.25  Aligned_cols=226  Identities=21%  Similarity=0.252  Sum_probs=181.2

Q ss_pred             HHhcCCCccccccccCCcceeec-----ceEEEEEEEEecc--CCcchhHHHHHHHhhhccCCceeEeeeeeecCCe---
Q 040702          509 QATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDF---  578 (797)
Q Consensus       509 ~~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~---  578 (797)
                      ...++|+..+.||+|+||.||++     +..||||++....  ....+.+.+|+.++++++||||+++++++...+.   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            34678999999999999999974     5789999986542  2223567789999999999999999998876554   


Q ss_pred             ---EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCC
Q 040702          579 ---KALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMA  655 (797)
Q Consensus       579 ---~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla  655 (797)
                         .++|+||+ +++|.+++...  .+++..+..++.|+++|++|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~  165 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLA  165 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence               89999999 56999988764  4899999999999999999999   999999999999999999999999999999


Q ss_pred             ccCCccCccccccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchhh--------------------
Q 040702          656 KPLLEEDQSLTQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIREE--------------------  714 (797)
Q Consensus       656 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------------  714 (797)
                      ......     .....++..|+|||.+.+ ..++.++|+|++|+..+..+.+..++....                    
T Consensus       166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  240 (343)
T cd07851         166 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL  240 (343)
T ss_pred             cccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence            865322     233568889999998865 357899999999988755544433221000                    


Q ss_pred             ---------------------------hhhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          715 ---------------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       715 ---------------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                                                 ......+.++++.|+..||++||++.++++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence                                       0113345678999999999999999998763

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.95  E-value=2.3e-27  Score=245.34  Aligned_cols=216  Identities=25%  Similarity=0.284  Sum_probs=178.0

Q ss_pred             ccccCCcceeec-----ceEEEEEEEEeccCC---cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccCCCCH
Q 040702          520 IGRGGFGPVYKD-----GMEVAIKVFNLQYGG---AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSL  591 (797)
Q Consensus       520 lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~g~L  591 (797)
                      ||+|+||.||++     ++.||+|+++.....   ..+.+..|+.++++++||||+++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999974     588999998765322   345788999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccccccccc
Q 040702          592 EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL  671 (797)
Q Consensus       592 ~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  671 (797)
                      .+++.... .+++..+..++.|+++|+.|+|   +.+++|+||+|+||+++.++.++|+|||.+.......  .......
T Consensus        81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~  154 (250)
T cd05123          81 FSHLSKEG-RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFC  154 (250)
T ss_pred             HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCc
Confidence            99997664 4899999999999999999999   8999999999999999999999999999998654321  1233456


Q ss_pred             cCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh----------------hhhhcccccchhccccCCCCC
Q 040702          672 ATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE----------------KHLMTKEQPMVRMGTDLSLGQ  735 (797)
Q Consensus       672 gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~l~~~cl~~dp~~  735 (797)
                      ++..|+|||.+.+...+.++|+|++|+..+..+.+..++...+                ......+.++++.|+..||++
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~  234 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTK  234 (250)
T ss_pred             CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhh
Confidence            8889999999988888999999999988755554443332111                111235578889999999999


Q ss_pred             CCChHH
Q 040702          736 FPASYS  741 (797)
Q Consensus       736 RPs~~~  741 (797)
                      ||++.+
T Consensus       235 R~~~~~  240 (250)
T cd05123         235 RLGSGG  240 (250)
T ss_pred             CCCccc
Confidence            999854

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.94  E-value=4.6e-27  Score=241.06  Aligned_cols=204  Identities=16%  Similarity=0.067  Sum_probs=163.3

Q ss_pred             cCCcceee-----cceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccCCCCHHHHHhc
Q 040702          523 GGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYS  597 (797)
Q Consensus       523 G~~g~Vyk-----~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  597 (797)
                      |.||.||+     +++.||+|.++...     .+..|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            88999996     46889999997553     233455555666799999999999999999999999999999999876


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccccccccccCcccc
Q 040702          598 GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM  677 (797)
Q Consensus       598 ~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~  677 (797)
                      .. .+++..+..++.|+++|++|+|   +.+|+||||||+||+++.++.++++|||.+......     .....++..|+
T Consensus        79 ~~-~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~~y~  149 (237)
T cd05576          79 FL-NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVENMYC  149 (237)
T ss_pred             hc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCcccc
Confidence            54 4899999999999999999999   999999999999999999999999999988654321     12345677899


Q ss_pred             cccccccCccchHHHHHHHhhhhhhhhccccccchh------------hhhhhcccccchhccccCCCCCCCChH
Q 040702          678 APDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE------------EKHLMTKEQPMVRMGTDLSLGQFPASY  740 (797)
Q Consensus       678 aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~l~~~cl~~dp~~RPs~~  740 (797)
                      |||.+..+.++.++|+|++|+..+..+.+..+....            +......+.++++.|++.||++||++.
T Consensus       150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcccccccCCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence            999998888899999999999875555443221111            111233456788899999999999863

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=1.5e-28  Score=261.88  Aligned_cols=228  Identities=24%  Similarity=0.312  Sum_probs=191.1

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      .++|+....+|.|.||.|||+     ++..|||+++........-...|+-+++.++|||||.++|.+...+..|++|||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy   93 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY   93 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence            468999999999999999986     578999999988877788888999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      |.+|+|.+.-+..+ ++++.++..+.++..+|++|+|   +.+-+|||||-.||++++.|.+|++|||.+..+.  ....
T Consensus        94 cgggslQdiy~~Tg-plselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqit--ati~  167 (829)
T KOG0576|consen   94 CGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQIT--ATIA  167 (829)
T ss_pred             cCCCcccceeeecc-cchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhh--hhhh
Confidence            99999999766544 5889999999999999999999   9999999999999999999999999999987553  2233


Q ss_pred             cccccccCccccccccc---ccCccchHHHHHHHhhhhhh-hhccccccchhh--------------------hhhhccc
Q 040702          666 TQTQTLATIGYMAPDEI---FSGEMRLKCWVNDSLLISVM-IVVDANLLIREE--------------------KHLMTKE  721 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~---~~~~~~~~~dv~s~~~~~~~-~~~~~~~~~~~~--------------------~~~~~~~  721 (797)
                      ....+.||+.|||||+.   ..++|...+|+|+.|+..++ .-..|++++-.+                    ....+.+
T Consensus       168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~f  247 (829)
T KOG0576|consen  168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFF  247 (829)
T ss_pred             hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHH
Confidence            45678999999999965   46889999999999976522 112233222222                    2234467


Q ss_pred             ccchhccccCCCCCCCChHHHHH
Q 040702          722 QPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       722 ~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      .++++.|+-.+|.+||++..++.
T Consensus       248 h~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  248 HNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             HHHHHHHhcCCCccCCChhhhee
Confidence            78999999999999999976654

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.94  E-value=3.1e-27  Score=217.92  Aligned_cols=196  Identities=22%  Similarity=0.277  Sum_probs=156.8

Q ss_pred             HhcCCCccccccccCCcceee-----cceEEEEEEEEeccC-CcchhHHHHHHHhhhc-cCCceeEeeeeeecCCeEEEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYG-GAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk-----~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      ..++......||+|+||.|-+     .|+..|||+++..-. +..++..+|+.+..+. .+|.+|++||...++...|+.
T Consensus        44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc  123 (282)
T KOG0984|consen   44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC  123 (282)
T ss_pred             chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence            345556678899999998843     579999999986632 3456778888876655 699999999999999999999


Q ss_pred             EEccCCCCHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCC
Q 040702          583 LEYMPLGSLEKCLY---SGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  659 (797)
Q Consensus       583 ~e~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  659 (797)
                      ||.|.. +|+.+-.   ..+..+++...-+|+.-+.+||.|||+  ...++|||+||+|||++.+|.+|+||||++..+.
T Consensus       124 ME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~  200 (282)
T KOG0984|consen  124 MELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLV  200 (282)
T ss_pred             HHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence            999965 7766643   234468888888999999999999995  5689999999999999999999999999998764


Q ss_pred             ccCccccccccccCcccccccccc----cCccchHHHHHHHhhhhhhhhccccccc
Q 040702          660 EEDQSLTQTQTLATIGYMAPDEIF----SGEMRLKCWVNDSLLISVMIVVDANLLI  711 (797)
Q Consensus       660 ~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~dv~s~~~~~~~~~~~~~~~~  711 (797)
                      ++   ...+...|...|||||.+.    ..+|+.++|+||+|+..++......+++
T Consensus       201 dS---iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~  253 (282)
T KOG0984|consen  201 DS---IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYE  253 (282)
T ss_pred             hh---hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccc
Confidence            32   2334467889999999764    4579999999999999866655554433

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.94  E-value=2.1e-27  Score=239.03  Aligned_cols=188  Identities=24%  Similarity=0.294  Sum_probs=156.3

Q ss_pred             hcCCCccccccccCCcceee-----cceEEEEEEEEeccCCcchhHHHHHHHhhhcc-C-C----ceeEeeeeeecCCeE
Q 040702          511 TNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIR-H-R----NLIKIISSCSNDDFK  579 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk-----~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H-p----niv~l~~~~~~~~~~  579 (797)
                      +++|.+.+.+|+|.||.|-+     .+..||||+++.-.. -.++...|+++++++. + |    -+|.+.+||...++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            68999999999999999974     468999999874432 2356777999999994 2 3    478899999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcC---------------
Q 040702          580 ALVLEYMPLGSLEKCLYSGNY-ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD---------------  643 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~---------------  643 (797)
                      |+|+|.+ |-++.+++..+.. +++...++.|+.|++++++|||   +.+++|-|+||+||++.+               
T Consensus       167 Civfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~  242 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF  242 (415)
T ss_pred             EEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCccce
Confidence            9999998 5599999988655 7899999999999999999999   999999999999999832               


Q ss_pred             -----CCcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhcccc
Q 040702          644 -----NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDAN  708 (797)
Q Consensus       644 -----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~  708 (797)
                           +..+|++|||.|....+.     .+..+.|..|+|||++++-+++..+||||+|++..+...+..
T Consensus       243 ~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~  307 (415)
T KOG0671|consen  243 IRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGET  307 (415)
T ss_pred             eccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccce
Confidence                 235899999999864322     245688999999999999999999999999986544443333

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.93  E-value=8.4e-27  Score=233.87  Aligned_cols=245  Identities=16%  Similarity=0.146  Sum_probs=194.4

Q ss_pred             CHHHHHHHhcCCCccccccccCCcceeec----------ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeee
Q 040702          503 TYLELFQATNRFSENNLIGRGGFGPVYKD----------GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIIS  571 (797)
Q Consensus       503 ~~~~l~~~~~~f~~~~~lg~G~~g~Vyk~----------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~  571 (797)
                      ..+++.....++.....+-+|.||.||+|          .+.|-||.++.... -....+..|...+..+.|||+..+.+
T Consensus       275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            45566667778888899999999999987          25566777765432 23467888999999999999999999


Q ss_pred             eeec-CCeEEEEEEccCCCCHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcC
Q 040702          572 SCSN-DDFKALVLEYMPLGSLEKCLYSGN-------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD  643 (797)
Q Consensus       572 ~~~~-~~~~~lv~e~~~~g~L~~~l~~~~-------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~  643 (797)
                      ++.+ .+..++++.++.-|+|..++...+       ..++..+...++.|++.|++|||   +++|||.||.++|.+||+
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd  431 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDD  431 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehh
Confidence            8865 457889999999999999997221       14666778899999999999999   999999999999999999


Q ss_pred             CCcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhh--hhccccccchhhhh-----
Q 040702          644 NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVM--IVVDANLLIREEKH-----  716 (797)
Q Consensus       644 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~--~~~~~~~~~~~~~~-----  716 (797)
                      ...+||+|=.+++.+.+.+.............||+||.+....|+..+|+|++|+..++  .....+.....+.+     
T Consensus       432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl  511 (563)
T KOG1024|consen  432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL  511 (563)
T ss_pred             heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH
Confidence            99999999999998877666555555556778999999999999999999999998633  33222222222211     


Q ss_pred             -----------hhcccccchhccccCCCCCCCChHHHHHhHHHHH
Q 040702          717 -----------LMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIR  750 (797)
Q Consensus       717 -----------~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~  750 (797)
                                 ...++..++.-||+.+|++||+..|+...|.+..
T Consensus       512 kdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~  556 (563)
T KOG1024|consen  512 KDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH  556 (563)
T ss_pred             hccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence                       2335556677799999999999999999988753

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=99.93  E-value=5.3e-29  Score=250.51  Aligned_cols=369  Identities=24%  Similarity=0.259  Sum_probs=281.2

Q ss_pred             CCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccC-CcCcccCCCccc
Q 040702           20 PSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHS-NSLSGRLPSSAD   98 (797)
Q Consensus        20 l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~-N~l~~~l~~~~~   98 (797)
                      +..-..++|..|+|+.+.        |..|+.+++|+.||||+|+|+.+.|++|.++.+|.+|-+-+ |+|+ .+|..+|
T Consensus        66 P~~tveirLdqN~I~~iP--------~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F  136 (498)
T KOG4237|consen   66 PPETVEIRLDQNQISSIP--------PGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAF  136 (498)
T ss_pred             CCcceEEEeccCCcccCC--------hhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHh
Confidence            466788999999955332        24689999999999999999999999999999988887666 9998 9999999


Q ss_pred             cCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCC-------------
Q 040702           99 VRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSS-------------  165 (797)
Q Consensus        99 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~-------------  165 (797)
                      .++..|+.|.+.-|++.-+..++|..+++|..|.|.+|.+..+..++|.++.+++.+.+..|.+-..             
T Consensus       137 ~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~  216 (498)
T KOG4237|consen  137 GGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMN  216 (498)
T ss_pred             hhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhc
Confidence            9999999999999999988889999999999999999999988778999999999999999983221             


Q ss_pred             CCCcccccc-------------C---CCCCCCc----EEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhh
Q 040702          166 TPELSSLSS-------------L---SNCKYLE----YFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEIN  225 (797)
Q Consensus       166 ~~~~~~~~~-------------l---~~l~~L~----~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~  225 (797)
                      +.+.+.+..             .   .....++    .+....+....-+...|..++ +|+.|+|++|+|+.+-+.+|.
T Consensus       217 ~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~-~L~~lnlsnN~i~~i~~~aFe  295 (498)
T KOG4237|consen  217 PIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLP-NLRKLNLSNNKITRIEDGAFE  295 (498)
T ss_pred             hhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcc-cceEeccCCCccchhhhhhhc
Confidence            111000000             0   0011122    223333444433446788998 899999999999999999999


Q ss_pred             hhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCC-C--C---CCCC--
Q 040702          226 NLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLT-S--I---PSTL--  297 (797)
Q Consensus       226 ~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~--l---p~~~--  297 (797)
                      .+..+  ++|.|..|+|..+....|.++..|+.|+|.+|+|+.+.|.+|..+.+|.+|.|-.|.+. .  +   -+|+  
T Consensus       296 ~~a~l--~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~  373 (498)
T KOG4237|consen  296 GAAEL--QELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRK  373 (498)
T ss_pred             chhhh--hhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhh
Confidence            99998  99999999999888999999999999999999999999999999999999999998762 1  1   0011  


Q ss_pred             ---------CCCCcccEEEccCCcCCCC---CCcccc---------ccccccEE-eccCcccccccCccccCCcccceec
Q 040702          298 ---------WNLKDILHLNLSSNFFTGP---LPLKIG---------NLNVLVQL-DLSMNNFSCVIPTKIGGLKDLQYLF  355 (797)
Q Consensus       298 ---------~~l~~L~~L~l~~N~l~~~---~~~~~~---------~l~~L~~L-~Ls~N~l~~~~~~~~~~l~~L~~L~  355 (797)
                               .....++.+.++.+.+...   .|...+         ..+.+.+. .-|++.++ .+|..+-  ..-++|+
T Consensus       374 ~~~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~tely  450 (498)
T KOG4237|consen  374 KSVVGNPRCQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP--VDVTELY  450 (498)
T ss_pred             CCCCCCCCCCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCC--chhHHHh
Confidence                     1122455666666655421   111111         11222222 22333333 3443221  3568899


Q ss_pred             ccCccccCCCChhhhccccCCeeeecCCcCCCCCChhhhccCCCCeEEccCC
Q 040702          356 LEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFN  407 (797)
Q Consensus       356 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N  407 (797)
                      +.+|.++ .+|..  .+.+| .+|+++|+++......|.++++|..|-+++|
T Consensus       451 l~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn  498 (498)
T KOG4237|consen  451 LDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN  498 (498)
T ss_pred             cccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence            9999998 67776  67788 9999999999888888999999999999887

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.93  E-value=7.5e-27  Score=255.64  Aligned_cols=225  Identities=23%  Similarity=0.354  Sum_probs=176.6

Q ss_pred             CCCccccccccCCcc-eeec---ceEEEEEEEEeccCCcchhHHHHHHHhhhc-cCCceeEeeeeeecCCeEEEEEEccC
Q 040702          513 RFSENNLIGRGGFGP-VYKD---GMEVAIKVFNLQYGGAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDFKALVLEYMP  587 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~-Vyk~---~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~  587 (797)
                      -|...+.+|.|+-|. ||+|   +++||||++-...   .+-..+|+..|+.- +|||||++++.-.++++.||..|.|.
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEeeCCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            345567889998885 5886   7999999986442   35667899999888 59999999999999999999999997


Q ss_pred             CCCHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcC---C--CcEEEEeecCCccCC
Q 040702          588 LGSLEKCLYSGNY---ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD---N--MVAHLSDFGMAKPLL  659 (797)
Q Consensus       588 ~g~L~~~l~~~~~---~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~---~--~~~kl~DFGla~~~~  659 (797)
                      . +|.+++.....   .......+.+..|+++||++||   +.+||||||||.||||+.   +  ..++|+|||+++.+.
T Consensus       587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            6 99999987421   1111345778999999999999   899999999999999975   3  479999999999886


Q ss_pred             ccCccc-cccccccCcccccccccccCccchHHHHHHHhhhhhhhhcc-ccccch-hhhh--------------hhc--c
Q 040702          660 EEDQSL-TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVD-ANLLIR-EEKH--------------LMT--K  720 (797)
Q Consensus       660 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~-~~~~~~-~~~~--------------~~~--~  720 (797)
                      .+.... ...+..||-+|+|||++.....+..+|++++|+..+..+.+ ..+++. ..++              ...  .
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~~~d~e  742 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEPLPDCE  742 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeeccCchHH
Confidence            554432 34667899999999999998888899999999987433332 334333 2221              011  4


Q ss_pred             cccchhccccCCCCCCCChHHHHH
Q 040702          721 EQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       721 ~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      ..+++..++++||..||++.+|+.
T Consensus       743 A~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  743 AKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             HHHHHHHhcCCCcccCCCHHHHhC
Confidence            468889999999999999999864

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.93  E-value=1.7e-26  Score=242.29  Aligned_cols=190  Identities=22%  Similarity=0.265  Sum_probs=161.3

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEecc--------CCcchhHHHHHHHhhhcc---CCceeEeeeeee
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY--------GGAFKSFDIECGMMKRIR---HRNLIKIISSCS  574 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l~---Hpniv~l~~~~~  574 (797)
                      ..+|...+.+|+|+||.|+.+     ..+|+||.+.+..        ......+-.|+.+|+.++   |+||++++++|+
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            357888999999999999854     4789999987652        112335667999999997   999999999999


Q ss_pred             cCCeEEEEEEcc-CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeec
Q 040702          575 NDDFKALVLEYM-PLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFG  653 (797)
Q Consensus       575 ~~~~~~lv~e~~-~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG  653 (797)
                      +.+.+|++||-. ++-+|.+++..++. +++.++.-|++||+.|+++||   +.+|||||||-+||.+|.+|-+||+|||
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~kp~-m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klidfg  715 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEFKPR-MDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLIDFG  715 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhccCc-cchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEeecc
Confidence            999999999975 56699999987664 899999999999999999999   9999999999999999999999999999


Q ss_pred             CCccCCccCccccccccccCcccccccccccCcc-chHHHHHHHhhhhhhhhcccc
Q 040702          654 MAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEM-RLKCWVNDSLLISVMIVVDAN  708 (797)
Q Consensus       654 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~dv~s~~~~~~~~~~~~~  708 (797)
                      .|......    ....++||..|.|||++.+..| .-..|+|++|+..+..+....
T Consensus       716 saa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivyken  767 (772)
T KOG1152|consen  716 SAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKEN  767 (772)
T ss_pred             chhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccC
Confidence            99765433    2345789999999999988887 477899999998766555443

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.93  E-value=7.6e-26  Score=250.84  Aligned_cols=192  Identities=20%  Similarity=0.264  Sum_probs=144.4

Q ss_pred             HhcCCCccccccccCCcceeec---------------------ceEEEEEEEEeccCCcc--------------hhHHHH
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD---------------------GMEVAIKVFNLQYGGAF--------------KSFDIE  554 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~---------------------~~~vAvK~~~~~~~~~~--------------~~~~~E  554 (797)
                      ..++|+..++||+|+||.||+|                     ++.||||++........              +....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            4679999999999999999975                     24799999875432222              234457


Q ss_pred             HHHhhhccCCce-----eEeeeeeec--------CCeEEEEEEccCCCCHHHHHhcCCC---------------------
Q 040702          555 CGMMKRIRHRNL-----IKIISSCSN--------DDFKALVLEYMPLGSLEKCLYSGNY---------------------  600 (797)
Q Consensus       555 ~~~l~~l~Hpni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~---------------------  600 (797)
                      +.++.+++|.++     ++++++|..        .+..|+||||+++|+|.++++....                     
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777778876554     677777653        3468999999999999998864311                     


Q ss_pred             --CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccccccccccCccccc
Q 040702          601 --ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA  678 (797)
Q Consensus       601 --~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~a  678 (797)
                        .+++..+..++.|++.||.|+|   +.+|+||||||+||+++.++.+||+|||+++....... .......+|+.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence              2456778899999999999999   89999999999999999999999999999975533221 11122345889999


Q ss_pred             ccccccCc--------------------c--chHHHHHHHhhhhhhhhc
Q 040702          679 PDEIFSGE--------------------M--RLKCWVNDSLLISVMIVV  705 (797)
Q Consensus       679 PE~~~~~~--------------------~--~~~~dv~s~~~~~~~~~~  705 (797)
                      ||.+....                    |  ....|+|++|++.+.++.
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~  427 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCV  427 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHh
Confidence            99875432                    1  123699999998866554

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.93  E-value=1.5e-25  Score=230.17  Aligned_cols=214  Identities=27%  Similarity=0.304  Sum_probs=177.6

Q ss_pred             CCcceeec-----ceEEEEEEEEeccCCc-chhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccCCCCHHHHHhc
Q 040702          524 GFGPVYKD-----GMEVAIKVFNLQYGGA-FKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYS  597 (797)
Q Consensus       524 ~~g~Vyk~-----~~~vAvK~~~~~~~~~-~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~  597 (797)
                      +||.||++     ++.||+|++....... .+.+.+|++.+++++|+||+++++++......++||||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            57889874     5789999998765444 67899999999999999999999999999999999999999999999876


Q ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccccccccccCcccc
Q 040702          598 GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM  677 (797)
Q Consensus       598 ~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~  677 (797)
                      ... +++..+..++.+++.|+.|||   ..+++|+||+|+||++++++.++++|||.+.......   ......++..|+
T Consensus        81 ~~~-~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~  153 (244)
T smart00220       81 RGR-LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYM  153 (244)
T ss_pred             ccC-CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCC
Confidence            554 788999999999999999999   8999999999999999999999999999998664332   223456888999


Q ss_pred             cccccccCccchHHHHHHHhhhhhhhhccccccch-hhhh-------------------hhcccccchhccccCCCCCCC
Q 040702          678 APDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIR-EEKH-------------------LMTKEQPMVRMGTDLSLGQFP  737 (797)
Q Consensus       678 aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~-~~~~-------------------~~~~~~~l~~~cl~~dp~~RP  737 (797)
                      |||......++.++|+|++|...+..+....++.. ...+                   ....+.++++.|+..+|++||
T Consensus       154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp  233 (244)
T smart00220      154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRL  233 (244)
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhcc
Confidence            99999888889999999999887554444332221 0000                   234567899999999999999


Q ss_pred             ChHHHHH
Q 040702          738 ASYSISK  744 (797)
Q Consensus       738 s~~~i~~  744 (797)
                      ++.++++
T Consensus       234 ~~~~~~~  240 (244)
T smart00220      234 TAEEALQ  240 (244)
T ss_pred             CHHHHhh
Confidence            9999886

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.92  E-value=7.7e-26  Score=211.63  Aligned_cols=185  Identities=19%  Similarity=0.316  Sum_probs=154.0

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhcc-CCceeEeeeeeecCC--eEEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIR-HRNLIKIISSCSNDD--FKAL  581 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~--~~~l  581 (797)
                      ..++|++.+++|+|.|++||.|     .+.++||++++-.   .+.+.+|+.+|+.++ ||||+++++...++.  ...+
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            3578999999999999999975     4889999997553   378899999999997 999999999988765  5679


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCC-CcEEEEeecCCccCCc
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN-MVAHLSDFGMAKPLLE  660 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~DFGla~~~~~  660 (797)
                      |+||+.+.+...+...    ++...+..++.|+++||.|+|   +.||+|||+||.|+++|.. -.++++|+|+|.++.+
T Consensus       113 iFE~v~n~Dfk~ly~t----l~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp  185 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLYPT----LTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP  185 (338)
T ss_pred             HhhhhccccHHHHhhh----hchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence            9999988776655432    666788899999999999999   9999999999999999954 5799999999998765


Q ss_pred             cCccccccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccc
Q 040702          661 EDQSLTQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDA  707 (797)
Q Consensus       661 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~  707 (797)
                      ...   ..-.+.+..|--||.+..- .|+..-|+||+|++...+++..
T Consensus       186 ~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrk  230 (338)
T KOG0668|consen  186 GKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRK  230 (338)
T ss_pred             Cce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhcc
Confidence            543   3446788889999988754 4788999999999875554433

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.92  E-value=1.5e-24  Score=217.17  Aligned_cols=206  Identities=30%  Similarity=0.442  Sum_probs=176.8

Q ss_pred             ccccCCcceeec-----ceEEEEEEEEeccCC-cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccCCCCHHH
Q 040702          520 IGRGGFGPVYKD-----GMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEK  593 (797)
Q Consensus       520 lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~  593 (797)
                      ||+|++|.||++     ++.+++|++...... ..+.+.+|++.++.++|++|+++++++...+..+++|||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999984     678999998765432 34679999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcC-CCcEEEEeecCCccCCccCcccccccccc
Q 040702          594 CLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD-NMVAHLSDFGMAKPLLEEDQSLTQTQTLA  672 (797)
Q Consensus       594 ~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~g  672 (797)
                      ++......+++..+..++.+++++++|||   ..+++|+||+|.||+++. ++.++|+|||.+........  ......+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~  155 (215)
T cd00180          81 LLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVG  155 (215)
T ss_pred             HHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccC
Confidence            99876335889999999999999999999   899999999999999999 89999999999986543221  1233557


Q ss_pred             CcccccccccccC-ccchHHHHHHHhhhhhhhhccccccchhhhhhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          673 TIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANLLIREEKHLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       673 t~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                      ...|++||.+... .++.+.|+|++|...+..               ..+.+++..|+..+|++||++.++++.
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             CCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence            8899999998877 788999999999887444               456689999999999999999988764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.92  E-value=2e-24  Score=247.24  Aligned_cols=267  Identities=27%  Similarity=0.330  Sum_probs=149.4

Q ss_pred             CCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEc
Q 040702           54 NMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGL  133 (797)
Q Consensus        54 ~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  133 (797)
                      +-..|+++.|+++. +|..+.  ++|+.|++++|+|+ .+|..    +++|++|+|++|+|+. +|..   .++|++|+|
T Consensus       202 ~~~~LdLs~~~Lts-LP~~l~--~~L~~L~L~~N~Lt-~LP~l----p~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~L  269 (788)
T PRK15387        202 GNAVLNVGESGLTT-LPDCLP--AHITTLVIPDNNLT-SLPAL----PPELRTLEVSGNQLTS-LPVL---PPGLLELSI  269 (788)
T ss_pred             CCcEEEcCCCCCCc-CCcchh--cCCCEEEccCCcCC-CCCCC----CCCCcEEEecCCccCc-ccCc---ccccceeec
Confidence            34556666666653 444443  25666666666665 45532    3556666666666553 3321   245555566


Q ss_pred             cCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccC
Q 040702          134 QKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDN  213 (797)
Q Consensus       134 ~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~  213 (797)
                      ++|.|+.+. ..+   ++|+.|+|++|+|+.+|..         +++|+.|+|++|+|.++ |.    ++.+|       
T Consensus       270 s~N~L~~Lp-~lp---~~L~~L~Ls~N~Lt~LP~~---------p~~L~~LdLS~N~L~~L-p~----lp~~L-------  324 (788)
T PRK15387        270 FSNPLTHLP-ALP---SGLCKLWIFGNQLTSLPVL---------PPGLQELSVSDNQLASL-PA----LPSEL-------  324 (788)
T ss_pred             cCCchhhhh-hch---hhcCEEECcCCcccccccc---------ccccceeECCCCccccC-CC----Ccccc-------
Confidence            666555322 211   3455555555555554431         13455555555555532 11    11122       


Q ss_pred             CcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCC
Q 040702          214 CNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSI  293 (797)
Q Consensus       214 n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l  293 (797)
                                         +.|++++|+|++ +|..   ..+|+.|+|++|+|+.+ |..   ..+|+.|++++|.|+.+
T Consensus       325 -------------------~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~L-P~l---p~~L~~L~Ls~N~L~~L  377 (788)
T PRK15387        325 -------------------CKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLASL-PTL---PSELYKLWAYNNRLTSL  377 (788)
T ss_pred             -------------------cccccccCcccc-cccc---ccccceEecCCCccCCC-CCC---CcccceehhhccccccC
Confidence                               445555565553 2221   13577777777777753 332   24566777777777777


Q ss_pred             CCCCCCCCcccEEEccCCcCCCCCCccccccccccEEeccCcccccccCccccCCcccceecccCccccCCCChhhhccc
Q 040702          294 PSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLI  373 (797)
Q Consensus       294 p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  373 (797)
                      |..   ..+|+.|++++|.|++ +|..   .++|+.|++++|+|+. +|..   ..+|+.|++++|+|+ .+|..+..++
T Consensus       378 P~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~LP~sl~~L~  445 (788)
T PRK15387        378 PAL---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-RLPESLIHLS  445 (788)
T ss_pred             ccc---ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-ccChHHhhcc
Confidence            653   2457777777777764 3322   2457777777777764 3432   235667777777776 5677777777


Q ss_pred             cCCeeeecCCcCCCCCChhhhcc
Q 040702          374 SLKSLNLSNNNLSGTIPISLEKL  396 (797)
Q Consensus       374 ~L~~L~Ls~N~l~~~~p~~~~~l  396 (797)
                      +|+.|+|++|+|++..|..+..+
T Consensus       446 ~L~~LdLs~N~Ls~~~~~~L~~l  468 (788)
T PRK15387        446 SETTVNLEGNPLSERTLQALREI  468 (788)
T ss_pred             CCCeEECCCCCCCchHHHHHHHH
Confidence            77777777777777666665443

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=99.92  E-value=1.1e-24  Score=249.28  Aligned_cols=268  Identities=23%  Similarity=0.319  Sum_probs=178.6

Q ss_pred             CCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccC
Q 040702           21 SSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVR  100 (797)
Q Consensus        21 ~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~  100 (797)
                      ..-..|||+.|.+         +++|+.+.  ++|+.|++++|+++. +|.   ..++|++|+|++|+|+ .+|..    
T Consensus       201 ~~~~~LdLs~~~L---------tsLP~~l~--~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lt-sLP~l----  260 (788)
T PRK15387        201 NGNAVLNVGESGL---------TTLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPVL----  260 (788)
T ss_pred             CCCcEEEcCCCCC---------CcCCcchh--cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccC-cccCc----
Confidence            3456789999984         44555554  378899999999986 453   2578999999999998 77753    


Q ss_pred             CCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCC
Q 040702          101 LPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKY  180 (797)
Q Consensus       101 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~  180 (797)
                      .++|+.|+|++|.++ .+|..   .++|+.|+|++|+|+.+. .   .+++|+.|+|++|+|+.++..      .   .+
T Consensus       261 p~sL~~L~Ls~N~L~-~Lp~l---p~~L~~L~Ls~N~Lt~LP-~---~p~~L~~LdLS~N~L~~Lp~l------p---~~  323 (788)
T PRK15387        261 PPGLLELSIFSNPLT-HLPAL---PSGLCKLWIFGNQLTSLP-V---LPPGLQELSVSDNQLASLPAL------P---SE  323 (788)
T ss_pred             ccccceeeccCCchh-hhhhc---hhhcCEEECcCCcccccc-c---cccccceeECCCCccccCCCC------c---cc
Confidence            468899999999987 34443   367888999999998653 3   247899999999999887642      1   34


Q ss_pred             CcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEE
Q 040702          181 LEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLD  260 (797)
Q Consensus       181 L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  260 (797)
                      |+.|++++|+|+++ |.    ++.+|+.|+|++|+|++ +|..                             ..+|+.|+
T Consensus       324 L~~L~Ls~N~L~~L-P~----lp~~Lq~LdLS~N~Ls~-LP~l-----------------------------p~~L~~L~  368 (788)
T PRK15387        324 LCKLWAYNNQLTSL-PT----LPSGLQELSVSDNQLAS-LPTL-----------------------------PSELYKLW  368 (788)
T ss_pred             ccccccccCccccc-cc----cccccceEecCCCccCC-CCCC-----------------------------Ccccceeh
Confidence            77888999998754 32    23355555555555552 2221                             12344455


Q ss_pred             ccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEccCCcCCCCCCccccccccccEEeccCcccccc
Q 040702          261 LGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCV  340 (797)
Q Consensus       261 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  340 (797)
                      +++|+|+.+ |..   ..+|+.|++++|.|+.+|..   .++|+.|++++|+++. +|..   ..+|+.|++++|+|+ .
T Consensus       369 Ls~N~L~~L-P~l---~~~L~~LdLs~N~Lt~LP~l---~s~L~~LdLS~N~Lss-IP~l---~~~L~~L~Ls~NqLt-~  436 (788)
T PRK15387        369 AYNNRLTSL-PAL---PSGLKELIVSGNRLTSLPVL---PSELKELMVSGNRLTS-LPML---PSGLLSLSVYRNQLT-R  436 (788)
T ss_pred             hhccccccC-ccc---ccccceEEecCCcccCCCCc---ccCCCEEEccCCcCCC-CCcc---hhhhhhhhhccCccc-c
Confidence            555555532 222   13466666666666666543   2456667777777764 3432   235667788888887 4


Q ss_pred             cCccccCCcccceecccCccccCCCChhhhcc
Q 040702          341 IPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDL  372 (797)
Q Consensus       341 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  372 (797)
                      +|..+..+++|+.|+|++|++++..|..+..+
T Consensus       437 LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l  468 (788)
T PRK15387        437 LPESLIHLSSETTVNLEGNPLSERTLQALREI  468 (788)
T ss_pred             cChHHhhccCCCeEECCCCCCCchHHHHHHHH
Confidence            67777788888888888888887766665443

>PLN03210 Resistant to P

Probab=99.92  E-value=8.8e-24  Score=260.89  Aligned_cols=334  Identities=26%  Similarity=0.337  Sum_probs=159.2

Q ss_pred             cccCCCCCCEEEcccCc------ccccCCccccCCC-CCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCc
Q 040702           48 EIDNLHNMEWMAFSFNK------VVGVVPTTIFNVS-TLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPS  120 (797)
Q Consensus        48 ~~~~l~~L~~L~ls~N~------i~~~~p~~~~~l~-~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~  120 (797)
                      .|..+++|+.|.+..+.      +...+|..|..++ +|+.|++.+|.++ .+|..+  ...+|++|+|++|++. .++.
T Consensus       553 aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f--~~~~L~~L~L~~s~l~-~L~~  628 (1153)
T PLN03210        553 AFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF--RPENLVKLQMQGSKLE-KLWD  628 (1153)
T ss_pred             HHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC--CccCCcEEECcCcccc-cccc
Confidence            35555666666554432      2223444554443 4666666666555 555543  3455666666666554 3445


Q ss_pred             hhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCcc-CcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhh
Q 040702          121 FIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNY-LTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAI  199 (797)
Q Consensus       121 ~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~-l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~  199 (797)
                      .+..+++|+.|+|++|.....+|. +..+++|++|+|++|. +..+|.      .+.++++|+.|++++|..-+.+|..+
T Consensus       629 ~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~------si~~L~~L~~L~L~~c~~L~~Lp~~i  701 (1153)
T PLN03210        629 GVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPS------SIQYLNKLEDLDMSRCENLEILPTGI  701 (1153)
T ss_pred             ccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccch------hhhccCCCCEEeCCCCCCcCccCCcC
Confidence            555556666666655432223332 5555566666665543 333332      24455556666665543322333332


Q ss_pred             hccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccCCcCc-------ccCCC
Q 040702          200 GNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLS-------GFVPA  272 (797)
Q Consensus       200 ~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-------~~~~~  272 (797)
                       +++ +|+.|++++|...+.+|...   .+|  ++|++++|.+.. .|..+ .+++|+.|++.++...       ...+.
T Consensus       702 -~l~-sL~~L~Lsgc~~L~~~p~~~---~nL--~~L~L~~n~i~~-lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~  772 (1153)
T PLN03210        702 -NLK-SLYRLNLSGCSRLKSFPDIS---TNI--SWLDLDETAIEE-FPSNL-RLENLDELILCEMKSEKLWERVQPLTPL  772 (1153)
T ss_pred             -CCC-CCCEEeCCCCCCcccccccc---CCc--CeeecCCCcccc-ccccc-cccccccccccccchhhccccccccchh
Confidence             333 55555555554444444322   223  555555555542 33322 3455555555442211       11111


Q ss_pred             CccCCccccccccCCCCC-CCCCCCCCCCCcccEEEccCCcCCCCCCccccccccccEEeccCcccccccCccccCCccc
Q 040702          273 CSGNLTNLRKLYLGSNLL-TSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDL  351 (797)
Q Consensus       273 ~~~~l~~L~~L~L~~N~l-~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  351 (797)
                      .+...++|+.|+|++|.. ..+|..+.++++|+.|++++|...+.+|..+ ++++|+.|++++|..-...|..   ..+|
T Consensus       773 ~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL  848 (1153)
T PLN03210        773 MTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNI  848 (1153)
T ss_pred             hhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---cccc
Confidence            122234555555555533 4455555555555555555543322334333 4555555555554332222321   2345


Q ss_pred             ceecccCccccCCCChhhhccccCCeeeecC-CcCCCCCChhhhccCCCCeEEccCC
Q 040702          352 QYLFLEYNRLQGSIPNSIGDLISLKSLNLSN-NNLSGTIPISLEKLLDLKDINVSFN  407 (797)
Q Consensus       352 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~l~~N  407 (797)
                      +.|+|++|.++ .+|..+..+++|+.|+|++ |++. .+|..+..+++|+.++++++
T Consensus       849 ~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C  903 (1153)
T PLN03210        849 SDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDC  903 (1153)
T ss_pred             CEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCC
Confidence            55555555554 3455555555555555555 2333 34444555555555555554

syringae 6; Provisional

>PLN03210 Resistant to P

Probab=99.91  E-value=8.1e-24  Score=261.20  Aligned_cols=344  Identities=20%  Similarity=0.226  Sum_probs=245.2

Q ss_pred             CCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCC-CCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcc
Q 040702           13 ILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLH-NMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSG   91 (797)
Q Consensus        13 ~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~-~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~   91 (797)
                      .+.+|..+.+|+.|.+..+.....  ..+...+|+++..++ +|++|++.+|.+.. +|..| ...+|+.|+|++|+|. 
T Consensus       550 ~~~aF~~m~~L~~L~~~~~~~~~~--~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~~-lP~~f-~~~~L~~L~L~~s~l~-  624 (1153)
T PLN03210        550 HENAFKGMRNLLFLKFYTKKWDQK--KEVRWHLPEGFDYLPPKLRLLRWDKYPLRC-MPSNF-RPENLVKLQMQGSKLE-  624 (1153)
T ss_pred             cHHHHhcCccccEEEEeccccccc--ccceeecCcchhhcCcccEEEEecCCCCCC-CCCcC-CccCCcEEECcCcccc-
Confidence            345688888888888876642210  111234566666653 58888888888865 56666 5678888888888887 


Q ss_pred             cCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCc-cCcCCCCCcc
Q 040702           92 RLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDN-YLTSSTPELS  170 (797)
Q Consensus        92 ~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N-~l~~~~~~~~  170 (797)
                      .++.+. ..+++|++|+|++|.....+|. +..+++|++|+|++|..-...|..+.++++|+.|++++| .++.+|..  
T Consensus       625 ~L~~~~-~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~--  700 (1153)
T PLN03210        625 KLWDGV-HSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTG--  700 (1153)
T ss_pred             cccccc-ccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCc--
Confidence            777665 4788888888888764445664 777888888888887655567888888888888888885 56666543  


Q ss_pred             ccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccc-------c
Q 040702          171 SLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQL-------E  243 (797)
Q Consensus       171 ~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l-------~  243 (797)
                           .++++|+.|++++|......|..    +.+|+.|++++|.+. .+|..+ .+++|  ++|++.++..       .
T Consensus       701 -----i~l~sL~~L~Lsgc~~L~~~p~~----~~nL~~L~L~~n~i~-~lP~~~-~l~~L--~~L~l~~~~~~~l~~~~~  767 (1153)
T PLN03210        701 -----INLKSLYRLNLSGCSRLKSFPDI----STNISWLDLDETAIE-EFPSNL-RLENL--DELILCEMKSEKLWERVQ  767 (1153)
T ss_pred             -----CCCCCCCEEeCCCCCCccccccc----cCCcCeeecCCCccc-cccccc-ccccc--ccccccccchhhcccccc
Confidence                 25778888888888655444432    347888888888876 455544 45565  7777766332       1


Q ss_pred             CCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCC-CCCCCCCCCCCCCcccEEEccCCcCCCCCCcccc
Q 040702          244 GSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSN-LLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIG  322 (797)
Q Consensus       244 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~  322 (797)
                      ...+..+...++|+.|+|++|.....+|..++++++|+.|++++| .++.+|..+ .+++|+.|++++|......|..  
T Consensus       768 ~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~--  844 (1153)
T PLN03210        768 PLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI--  844 (1153)
T ss_pred             ccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc--
Confidence            122223334568888888888776677888888888888888886 467888765 6788888888887655444433  


Q ss_pred             ccccccEEeccCcccccccCccccCCcccceecccCc-cccCCCChhhhccccCCeeeecCCc
Q 040702          323 NLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYN-RLQGSIPNSIGDLISLKSLNLSNNN  384 (797)
Q Consensus       323 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~  384 (797)
                       ..+|+.|+|++|.++ .+|..+..+++|+.|+|++| ++. .+|..+..+++|+.|++++|.
T Consensus       845 -~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~  904 (1153)
T PLN03210        845 -STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG  904 (1153)
T ss_pred             -ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence             357888888888887 46778888888888888884 455 566677888888888888774

syringae 6; Provisional

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.90  E-value=2.1e-24  Score=212.45  Aligned_cols=183  Identities=26%  Similarity=0.296  Sum_probs=151.7

Q ss_pred             hcCCCccccccccCCcceee----cceEEEEEEEEecc--CCcchhHHHHHHHhhhccCCceeEeeeeeecCC------e
Q 040702          511 TNRFSENNLIGRGGFGPVYK----DGMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDD------F  578 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk----~~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~------~  578 (797)
                      ..+|.....+|.|.-..|-.    .+++||+|.+....  ....++..+|...+..++|+||++++.++....      .
T Consensus        16 ~~Ry~nL~p~~~g~~~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQIVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeeecccCCCCceEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            46788888899888733332    36899999875442  233577889999999999999999999986443      5


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccC
Q 040702          579 KALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  658 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  658 (797)
                      .|+|||||.. +|...+..   .++......+..|++.|++|+|   +.+|+||||||+||++..++.+||.|||+|+.-
T Consensus        96 ~y~v~e~m~~-nl~~vi~~---elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e  168 (369)
T KOG0665|consen   96 VYLVMELMDA-NLCQVILM---ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE  168 (369)
T ss_pred             HHHHHHhhhh-HHHHHHHH---hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhccc
Confidence            7999999964 89888773   3788889999999999999999   999999999999999999999999999999853


Q ss_pred             CccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhh
Q 040702          659 LEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMI  703 (797)
Q Consensus       659 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~  703 (797)
                      .   .....+..+.|+.|.|||++.+-+|...+|+|+.|++..++
T Consensus       169 ~---~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEl  210 (369)
T KOG0665|consen  169 D---TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL  210 (369)
T ss_pred             C---cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHH
Confidence            2   22355678899999999999999999999999999975333

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=7.3e-26  Score=216.79  Aligned_cols=182  Identities=25%  Similarity=0.374  Sum_probs=150.8

Q ss_pred             CCCccccccccCCccee-----ecceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeecCC-----eEE
Q 040702          513 RFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSNDD-----FKA  580 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vy-----k~~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~-----~~~  580 (797)
                      +.+..+.||-|+||+||     +.|+.||.|.+..-..  ...+.+.+|++++..++|.|+...+++.....     +.|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            44556899999999999     4689999998864432  23578899999999999999999998876553     578


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCc
Q 040702          581 LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  660 (797)
Q Consensus       581 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  660 (797)
                      +|+|.|.. +|..++-... .++...++-+..||++||+|||   +.+|.||||||.|.|++.+...||||||+|+.-..
T Consensus       134 V~TELmQS-DLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  134 VLTELMQS-DLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHHHHh-hhhheeccCC-CCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccch
Confidence            99999954 8888876554 4777888889999999999999   99999999999999999999999999999996433


Q ss_pred             cCccccccccccCcccccccccccC-ccchHHHHHHHhhhh
Q 040702          661 EDQSLTQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLIS  700 (797)
Q Consensus       661 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~  700 (797)
                      ++ ....+..+-|..|+|||.+.+. .|+-..|+||.|++.
T Consensus       209 d~-~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIF  248 (449)
T KOG0664|consen  209 RD-RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIF  248 (449)
T ss_pred             hh-hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHH
Confidence            32 2334566789999999998865 589999999999875

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=4.7e-23  Score=219.12  Aligned_cols=160  Identities=22%  Similarity=0.221  Sum_probs=125.3

Q ss_pred             HHhcCCCccccccccCCcceeec------ceEEEEEEEEecc-----CCcchhHHHHHHHhhhccCCceeE-eeeeeecC
Q 040702          509 QATNRFSENNLIGRGGFGPVYKD------GMEVAIKVFNLQY-----GGAFKSFDIECGMMKRIRHRNLIK-IISSCSND  576 (797)
Q Consensus       509 ~~~~~f~~~~~lg~G~~g~Vyk~------~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~Hpniv~-l~~~~~~~  576 (797)
                      ...++|...+.||+|+||+||++      ++.||||++....     ....+.+.+|++++++++|+|++. ++++    
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence            45678999999999999999975      4668999875331     112456899999999999999985 5442    


Q ss_pred             CeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCC-CCCceEEcCCCcEEEEeecCC
Q 040702          577 DFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDL-KPSNVLLDDNMVAHLSDFGMA  655 (797)
Q Consensus       577 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDl-kp~NIll~~~~~~kl~DFGla  655 (797)
                      +..|+||||++|++|... ..    ..   ...++.|+++||.|||   +++|+|||| ||+|||++.++.+||+|||+|
T Consensus        91 ~~~~LVmE~~~G~~L~~~-~~----~~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA  159 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHLA-RP----HG---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLA  159 (365)
T ss_pred             CCcEEEEEccCCCCHHHh-Cc----cc---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence            457999999999999732 11    11   1467899999999999   999999999 999999999999999999999


Q ss_pred             ccCCccCcccc------ccccccCcccccccccc
Q 040702          656 KPLLEEDQSLT------QTQTLATIGYMAPDEIF  683 (797)
Q Consensus       656 ~~~~~~~~~~~------~~~~~gt~~y~aPE~~~  683 (797)
                      +.+........      .+...+++.|+|||.+.
T Consensus       160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             eecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            87654332111      14567889999999764

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=3e-22  Score=207.16  Aligned_cols=127  Identities=28%  Similarity=0.385  Sum_probs=106.4

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhcc-----C---CceeEeeeeeecC-
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIR-----H---RNLIKIISSCSND-  576 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----H---pniv~l~~~~~~~-  576 (797)
                      .++|.+.++||-|-|++||.+     .+.||+|+.+... .-.+....|+++|++++     |   ..||++++.|... 
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            368999999999999999963     6899999987442 22466778999999984     3   3799999999754 


Q ss_pred             ---CeEEEEEEccCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEE
Q 040702          577 ---DFKALVLEYMPLGSLEKCLYSGNY-ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL  641 (797)
Q Consensus       577 ---~~~~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll  641 (797)
                         .++|||+|+. |-+|..++..... .++...+++|++||+.||.|||.  ..+|||-||||+|||+
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL  221 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence               4899999999 5588888765443 68999999999999999999996  4599999999999998

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.87  E-value=1.6e-22  Score=233.45  Aligned_cols=247  Identities=21%  Similarity=0.350  Sum_probs=144.9

Q ss_pred             CCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccC
Q 040702           21 SSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVR  100 (797)
Q Consensus        21 ~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~  100 (797)
                      .+...|+|+++.+         +++|..+.  ++|+.|+|++|+|+. +|..+.  ++|+.|+|++|+|+ .+|....  
T Consensus       178 ~~~~~L~L~~~~L---------tsLP~~Ip--~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--  240 (754)
T PRK15370        178 NNKTELRLKILGL---------TTIPACIP--EQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLT-SIPATLP--  240 (754)
T ss_pred             cCceEEEeCCCCc---------CcCCcccc--cCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccc-cCChhhh--
Confidence            4567788888874         34454443  467888888888875 454443  47888888888887 7776543  


Q ss_pred             CCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCC
Q 040702          101 LPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKY  180 (797)
Q Consensus       101 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~  180 (797)
                       ++|+.|+|++|++. .+|..+.  ++|+.|+|++|+|+. +|..+.  ++|++|+|++|+|+.+|..+      .  ++
T Consensus       241 -~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~LP~~l------p--~s  305 (754)
T PRK15370        241 -DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIRTLPAHL------P--SG  305 (754)
T ss_pred             -ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccCc-cccccC--CCCcEEECCCCccccCcccc------h--hh
Confidence             46888888888877 5565553  468888888888874 344443  47888888888877766532      1  35


Q ss_pred             CcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEE
Q 040702          181 LEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLD  260 (797)
Q Consensus       181 L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  260 (797)
                      |+.|++++|++..+ |..+   +.+|+.|++++|.+++ +|..+.                            ++|+.|+
T Consensus       306 L~~L~Ls~N~Lt~L-P~~l---~~sL~~L~Ls~N~Lt~-LP~~l~----------------------------~sL~~L~  352 (754)
T PRK15370        306 ITHLNVQSNSLTAL-PETL---PPGLKTLEAGENALTS-LPASLP----------------------------PELQVLD  352 (754)
T ss_pred             HHHHHhcCCccccC-Cccc---cccceeccccCCcccc-CChhhc----------------------------CcccEEE
Confidence            77777777777743 3222   1255566666665553 333222                            3444444


Q ss_pred             ccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEccCCcCCCCCCcc----ccccccccEEeccCcc
Q 040702          261 LGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLK----IGNLNVLVQLDLSMNN  336 (797)
Q Consensus       261 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~----~~~l~~L~~L~Ls~N~  336 (797)
                      +++|+|+. +|..+.  ++|+.|+|++|.|+.+|..+.  .+|+.|++++|++. .+|..    ++.++.+..|++.+|.
T Consensus       353 Ls~N~L~~-LP~~lp--~~L~~LdLs~N~Lt~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Np  426 (754)
T PRK15370        353 VSKNQITV-LPETLP--PTITTLDVSRNALTNLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNP  426 (754)
T ss_pred             CCCCCCCc-CChhhc--CCcCEEECCCCcCCCCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCC
Confidence            44444442 222221  344555555555544444332  23445555555554 22222    2234556667777776


Q ss_pred             cc
Q 040702          337 FS  338 (797)
Q Consensus       337 l~  338 (797)
                      ++
T Consensus       427 ls  428 (754)
T PRK15370        427 FS  428 (754)
T ss_pred             cc
Confidence            65

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.87  E-value=3.8e-23  Score=214.55  Aligned_cols=198  Identities=23%  Similarity=0.259  Sum_probs=160.2

Q ss_pred             cCccCHHHHHHHhcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhcc------CCcee
Q 040702          499 QRRFTYLELFQATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIR------HRNLI  567 (797)
Q Consensus       499 ~~~~~~~~l~~~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~------Hpniv  567 (797)
                      ...+.+.|+.  ..+|.+....|+|-|+.|.++     +..||||+|+... -..+.=..|+++|++++      --+++
T Consensus       421 YYrv~igE~L--D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hcl  497 (752)
T KOG0670|consen  421 YYRVRIGELL--DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCL  497 (752)
T ss_pred             eEEEehhhhh--cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHH
Confidence            3444555543  468999999999999999975     5799999998542 22345567999999995      34899


Q ss_pred             EeeeeeecCCeEEEEEEccCCCCHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCC-
Q 040702          568 KIISSCSNDDFKALVLEYMPLGSLEKCLYSGNY--ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN-  644 (797)
Q Consensus       568 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~-  644 (797)
                      +++..|...++.|+|+|-+. .+|.+.+++-+.  .+....+..++.|+.-||..|.   ..+|+|.||||.|||+.+. 
T Consensus       498 rl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k  573 (752)
T KOG0670|consen  498 RLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESK  573 (752)
T ss_pred             HHHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCc
Confidence            99999999999999999884 599999986544  5777888999999999999999   9999999999999999865 


Q ss_pred             CcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccc
Q 040702          645 MVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDA  707 (797)
Q Consensus       645 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~  707 (797)
                      ..+||||||.|....+..    .+.+.-+..|.|||.|++-.|+..-|+||+|+..|+...+.
T Consensus       574 ~iLKLCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGk  632 (752)
T KOG0670|consen  574 NILKLCDFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGK  632 (752)
T ss_pred             ceeeeccCcccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccc
Confidence            468999999998654322    23445677899999999999999999999998665444333

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.87  E-value=1.1e-21  Score=198.91  Aligned_cols=193  Identities=26%  Similarity=0.349  Sum_probs=162.4

Q ss_pred             CCccccccccCCcceeec-----ceEEEEEEEEeccCC-cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccC
Q 040702          514 FSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  587 (797)
Q Consensus       514 f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~  587 (797)
                      |...+.||+|++|.||++     ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++...+..++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            566789999999999985     588999999876544 56788999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccccc
Q 040702          588 LGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ  667 (797)
Q Consensus       588 ~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  667 (797)
                      +++|.+++......+++.....++.+++.++.|||   ..+++|+|++|+||+++.++.++|+|||.+......... ..
T Consensus        81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~  156 (225)
T smart00221       81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LL  156 (225)
T ss_pred             CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cc
Confidence            99999998765433788999999999999999999   889999999999999999999999999999876443211 22


Q ss_pred             cccccCccccccccc-ccCccchHHHHHHHhhhhhhhhcccccc
Q 040702          668 TQTLATIGYMAPDEI-FSGEMRLKCWVNDSLLISVMIVVDANLL  710 (797)
Q Consensus       668 ~~~~gt~~y~aPE~~-~~~~~~~~~dv~s~~~~~~~~~~~~~~~  710 (797)
                      ....++..|++||.. ....++.++|+|++|+..+..+.+..++
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf  200 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPF  200 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCc
Confidence            335678899999988 5566778999999999875555544444

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=99.87  E-value=6.5e-22  Score=228.43  Aligned_cols=202  Identities=22%  Similarity=0.354  Sum_probs=108.4

Q ss_pred             CCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeec
Q 040702           78 TLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGL  157 (797)
Q Consensus        78 ~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L  157 (797)
                      +.+.|+++++.++ .+|..+.   ++|+.|+|++|+|+ .+|..+.  ++|++|+|++|+|+.+ |..+.  .+|+.|+|
T Consensus       179 ~~~~L~L~~~~Lt-sLP~~Ip---~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~LtsL-P~~l~--~~L~~L~L  248 (754)
T PRK15370        179 NKTELRLKILGLT-TIPACIP---EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLTSI-PATLP--DTIQEMEL  248 (754)
T ss_pred             CceEEEeCCCCcC-cCCcccc---cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccccC-Chhhh--ccccEEEC
Confidence            4566777777766 5665442   45667777777766 3444332  4667777777776643 33332  35677777


Q ss_pred             cCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhccc
Q 040702          158 NDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSL  237 (797)
Q Consensus       158 ~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~L  237 (797)
                      ++|+++.+|..+      .  .+|+.|++++|+|..+ |..+.   .+|+.|++++|++++ +|..+.  ++|  +.|++
T Consensus       249 s~N~L~~LP~~l------~--s~L~~L~Ls~N~L~~L-P~~l~---~sL~~L~Ls~N~Lt~-LP~~lp--~sL--~~L~L  311 (754)
T PRK15370        249 SINRITELPERL------P--SALQSLDLFHNKISCL-PENLP---EELRYLSVYDNSIRT-LPAHLP--SGI--THLNV  311 (754)
T ss_pred             cCCccCcCChhH------h--CCCCEEECcCCccCcc-ccccC---CCCcEEECCCCcccc-Ccccch--hhH--HHHHh
Confidence            777776665432      1  3566777777777643 43332   256666666666663 333222  223  66677


Q ss_pred             ccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEccCCcCC
Q 040702          238 EGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFT  314 (797)
Q Consensus       238 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~  314 (797)
                      ++|+++. +|..+.  ++|+.|++++|.++.+ |..+.  ++|+.|++++|+|+.+|..+.  ++|+.|++++|.++
T Consensus       312 s~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~L-P~~l~--~sL~~L~Ls~N~L~~LP~~lp--~~L~~LdLs~N~Lt  380 (754)
T PRK15370        312 QSNSLTA-LPETLP--PGLKTLEAGENALTSL-PASLP--PELQVLDVSKNQITVLPETLP--PTITTLDVSRNALT  380 (754)
T ss_pred             cCCcccc-CCcccc--ccceeccccCCccccC-Chhhc--CcccEEECCCCCCCcCChhhc--CCcCEEECCCCcCC
Confidence            7777663 232221  3555555666555542 32221  345555555555554544331  34444444444444

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.86  E-value=8.4e-22  Score=201.66  Aligned_cols=183  Identities=27%  Similarity=0.335  Sum_probs=151.1

Q ss_pred             HhcCCCccccccccCCcceeec--------ceEEEEEEEEeccCCcchhHHHHHHHhhhcc-CCceeEeeeeeecCCeEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD--------GMEVAIKVFNLQYGGAFKSFDIECGMMKRIR-HRNLIKIISSCSNDDFKA  580 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~--------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~  580 (797)
                      -.+.|..+++||+|.|+.||++        .+.||+|.+....  ...++.+|+++|..+. +.||+++.+++...+...
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~  111 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA  111 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence            4467889999999999999974        3789999987553  3467999999999995 999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEc-CCCcEEEEeecCCccCC
Q 040702          581 LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLL  659 (797)
Q Consensus       581 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~-~~~~~kl~DFGla~~~~  659 (797)
                      +|+||+++-.-.++...    ++..++..+++.+..||+++|   ..|||||||||+|++.+ ..+.-.|+|||+|....
T Consensus       112 ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d  184 (418)
T KOG1167|consen  112 IVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD  184 (418)
T ss_pred             EEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHHHH
Confidence            99999999888887765    567889999999999999999   99999999999999998 45678999999996211


Q ss_pred             cc-------C-----------------------------------ccccccccccCcccccccccccC-ccchHHHHHHH
Q 040702          660 EE-------D-----------------------------------QSLTQTQTLATIGYMAPDEIFSG-EMRLKCWVNDS  696 (797)
Q Consensus       660 ~~-------~-----------------------------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~  696 (797)
                      ..       .                                   .........||++|+|||++..- ..+.+.|+|+.
T Consensus       185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~  264 (418)
T KOG1167|consen  185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA  264 (418)
T ss_pred             hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence            00       0                                   00011234699999999998764 46889999999


Q ss_pred             hhhhh
Q 040702          697 LLISV  701 (797)
Q Consensus       697 ~~~~~  701 (797)
                      |++.+
T Consensus       265 GVI~L  269 (418)
T KOG1167|consen  265 GVILL  269 (418)
T ss_pred             cceee
Confidence            99863

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.85  E-value=6.6e-22  Score=237.30  Aligned_cols=183  Identities=14%  Similarity=0.115  Sum_probs=131.5

Q ss_pred             hhccC-CceeEeeeee-------ecCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeE
Q 040702          559 KRIRH-RNLIKIISSC-------SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPII  630 (797)
Q Consensus       559 ~~l~H-pniv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~iv  630 (797)
                      +.++| +||++++++|       ...+..+.++||+ +++|.+++......+++.+++.++.||++||+|||   +++|+
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~gIv  102 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAH---SQGIV  102 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            44566 6888888887       2234567888987 56999999765556899999999999999999999   99999


Q ss_pred             EcCCCCCceEEcCCC-------------------cEEEEeecCCccCCccCc--------------cccccccccCcccc
Q 040702          631 HCDLKPSNVLLDDNM-------------------VAHLSDFGMAKPLLEEDQ--------------SLTQTQTLATIGYM  677 (797)
Q Consensus       631 HrDlkp~NIll~~~~-------------------~~kl~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~  677 (797)
                      ||||||+|||++..+                   .+|++|||+++.......              .......+||+.||
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            999999999996544                   455666666543210000              00011246899999


Q ss_pred             cccccccCccchHHHHHHHhhhhhhhhccccccchhh------------h---hhhcccccchhccccCCCCCCCChHHH
Q 040702          678 APDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE------------K---HLMTKEQPMVRMGTDLSLGQFPASYSI  742 (797)
Q Consensus       678 aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~------------~---~~~~~~~~l~~~cl~~dp~~RPs~~~i  742 (797)
                      |||++.+..|+.++|||++|+..++.+..........            .   ........++..|+.++|.+||++.|+
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~ei  262 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSEL  262 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHH
Confidence            9999999999999999999998765553222211100            0   011233456677999999999999999


Q ss_pred             HHh
Q 040702          743 SKY  745 (797)
Q Consensus       743 ~~~  745 (797)
                      ++.
T Consensus       263 l~h  265 (793)
T PLN00181        263 LQS  265 (793)
T ss_pred             hhc
Confidence            763

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.84  E-value=1.6e-21  Score=187.47  Aligned_cols=223  Identities=18%  Similarity=0.224  Sum_probs=162.4

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhc-cCCceeEeeee-eecCCeEEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRI-RHRNLIKIISS-CSNDDFKALVL  583 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~-~~~~~~~~lv~  583 (797)
                      .+.|.+.+.+|+|.||.+-.+     .+.+|+|.++.... ..++|.+|...--.+ .|.||+.-|+. |+..+.+.+++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            457888899999999999742     58899999875542 357899988765555 48999988874 67778888999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEc--CCCcEEEEeecCCccCCcc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD--DNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~--~~~~~kl~DFGla~~~~~~  661 (797)
                      ||++.|+|..-+...+  +.+....+++.|+++|+.|||   ++++||||||.+||||-  +..++|+||||..+..+. 
T Consensus       102 E~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~-  175 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT-  175 (378)
T ss_pred             ccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccccCc-
Confidence            9999999998876654  778888999999999999999   99999999999999993  334899999999985422 


Q ss_pred             CccccccccccCcccccccccc---cCc--cchHHHHHHHhhhhhhhhccccccc----------hhhh-----------
Q 040702          662 DQSLTQTQTLATIGYMAPDEIF---SGE--MRLKCWVNDSLLISVMIVVDANLLI----------REEK-----------  715 (797)
Q Consensus       662 ~~~~~~~~~~gt~~y~aPE~~~---~~~--~~~~~dv~s~~~~~~~~~~~~~~~~----------~~~~-----------  715 (797)
                          .......+..|-|||+..   .+.  .....|+|.+|+..+..+.+..+..          .+..           
T Consensus       176 ----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~  251 (378)
T KOG1345|consen  176 ----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPK  251 (378)
T ss_pred             ----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCch
Confidence                112233566789999654   333  3678899999987533332222111          1000           


Q ss_pred             ---hhhcccccchhccccCCCCCCCChHHHHH
Q 040702          716 ---HLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       716 ---~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                         ...+....+.++-+.+++++|-...+..+
T Consensus       252 ~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk  283 (378)
T KOG1345|consen  252 KFNPFSEKALRLFKKSLTPRFKDRCKIWTAKK  283 (378)
T ss_pred             hhcccCHHHHHHHHHhcCCcccccchhHHHHH
Confidence               01123445566678899988855555444

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.82  E-value=4.6e-20  Score=180.66  Aligned_cols=135  Identities=19%  Similarity=0.162  Sum_probs=104.1

Q ss_pred             cccccccCCcceeec----ceEEEEEEEEeccCCc---------chh-----------------HHHHHHHhhhccCCce
Q 040702          517 NNLIGRGGFGPVYKD----GMEVAIKVFNLQYGGA---------FKS-----------------FDIECGMMKRIRHRNL  566 (797)
Q Consensus       517 ~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~~---------~~~-----------------~~~E~~~l~~l~Hpni  566 (797)
                      .+.||+|+||.||++    |+.||||+++......         ...                 ...|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            468999999999985    6899999998653211         112                 2349999999988776


Q ss_pred             eEeeeeeecCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HccCCCCeEEcCCCCCceEEcCCC
Q 040702          567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL-HFGYSVPIIHCDLKPSNVLLDDNM  645 (797)
Q Consensus       567 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yL-H~~~~~~ivHrDlkp~NIll~~~~  645 (797)
                      .....+..  ...++||||++++++....... ..++...+..++.|++.+|.|+ |   +.+|+||||||+||+++ ++
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-~~  154 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-DG  154 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-CC
Confidence            44333322  2238999999988776543222 2478889999999999999999 7   88999999999999998 47


Q ss_pred             cEEEEeecCCccC
Q 040702          646 VAHLSDFGMAKPL  658 (797)
Q Consensus       646 ~~kl~DFGla~~~  658 (797)
                      .++|+|||+|...
T Consensus       155 ~v~LiDFG~a~~~  167 (190)
T cd05147         155 KLYIIDVSQSVEH  167 (190)
T ss_pred             cEEEEEccccccC
Confidence            8999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.81  E-value=1.1e-19  Score=171.95  Aligned_cols=185  Identities=22%  Similarity=0.269  Sum_probs=153.8

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccC-CceeEeeeeeecCCeEEEEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRH-RNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H-pniv~l~~~~~~~~~~~lv~  583 (797)
                      ..+.|..+++||+|+||.+|.|     |.+||||+-.....  ..++..|.++.+.++| ..|..+..+..+.+...+||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            3468999999999999999975     79999998765443  3678889999999975 78889999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEc---CCCcEEEEeecCCccCCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLE  660 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~---~~~~~kl~DFGla~~~~~  660 (797)
                      |.. |.+|++++.-....++..+.+-.+-|++.-++|+|   .++++||||||+|.|..   ....+.++|||+|+.+.+
T Consensus        91 dLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             ecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            998 67999999877777999999999999999999999   99999999999999986   345789999999998754


Q ss_pred             cCcc-----ccccccccCcccccccccccCccchHHHHHHHhhhh
Q 040702          661 EDQS-----LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLIS  700 (797)
Q Consensus       661 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~  700 (797)
                      ..+.     .......||.+|.+--...+-..+-..|.-|+|-..
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvL  211 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVL  211 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhccee
Confidence            3221     223456799999988776666677778888888553

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.81  E-value=2.5e-19  Score=177.26  Aligned_cols=183  Identities=21%  Similarity=0.250  Sum_probs=157.9

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhcc-CCceeEeeeeeecCCeEEEEEEc
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIR-HRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      -+|.++++||+|+||+.+.|     +++||||.-....+  ..++..|.+..+.+. .++|...+.+..++-.-.+|||.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL  105 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL  105 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence            37999999999999999986     59999998766544  367888999998885 69999999988888888999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCC-----CcEEEEeecCCccCCc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN-----MVAHLSDFGMAKPLLE  660 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~-----~~~kl~DFGla~~~~~  660 (797)
                      . |.+|++++.-+++.++..+...+|.|++.-++|+|   ++..|.|||||+|.||...     ..+.++|||+|+.+.+
T Consensus       106 L-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  106 L-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             h-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence            8 67999999988888999999999999999999999   9999999999999999743     3589999999998866


Q ss_pred             cCcc-----ccccccccCcccccccccccCccchHHHHHHHhhhh
Q 040702          661 EDQS-----LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLIS  700 (797)
Q Consensus       661 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~  700 (797)
                      ..+.     .......||.+||+--.-++.+.+-..|.-++|-+.
T Consensus       182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvF  226 (449)
T KOG1165|consen  182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVF  226 (449)
T ss_pred             ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhh
Confidence            5432     223456799999999888888889999999999765

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.79  E-value=9.9e-19  Score=187.14  Aligned_cols=234  Identities=23%  Similarity=0.277  Sum_probs=172.9

Q ss_pred             CCCccccccccCCcceeecc------eEEEEEEEEeccCCcchhHHHHHHHhhhccC----CceeEeeeee-ecCCeEEE
Q 040702          513 RFSENNLIGRGGFGPVYKDG------MEVAIKVFNLQYGGAFKSFDIECGMMKRIRH----RNLIKIISSC-SNDDFKAL  581 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~~------~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H----pniv~l~~~~-~~~~~~~l  581 (797)
                      +|.+.+.||+|+||.||.+.      ..+|+|............+..|+.++..+..    +++.++++.. ..++..|+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            89999999999999999742      4789998876544333378889999999873    6899999998 57788999


Q ss_pred             EEEccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCC-----CcEEEEeecCC
Q 040702          582 VLEYMPLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN-----MVAHLSDFGMA  655 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~-----~~~kl~DFGla  655 (797)
                      ||+.+ |.+|.++..... ..++..++.+|+.|++.||+++|   +.|++||||||+|++++..     ..+.+.|||+|
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99988 679999886554 57999999999999999999999   9999999999999999855     46999999999


Q ss_pred             c--cCCccCcc----c-c-ccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccc-hhh----hh------
Q 040702          656 K--PLLEEDQS----L-T-QTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLI-REE----KH------  716 (797)
Q Consensus       656 ~--~~~~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~-~~~----~~------  716 (797)
                      +  .+......    . . ...+.||..|+++..-.+...+.+.|+|+++-..+...... +.. ...    ..      
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~-LPW~~~~~~~~~~~~~~~~  253 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGS-LPWEALEMTDLKSKFEKDP  253 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCC-CCCccccccchHHHHHHHh
Confidence            8  43222211    1 1 23456999999999998888999999999765543333221 111 100    00      


Q ss_pred             -----------hhcccccchhccccCCCCCCCChHHHHHhHHHHHH
Q 040702          717 -----------LMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRE  751 (797)
Q Consensus       717 -----------~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~  751 (797)
                                 .......+...+-..+..++|....+.+.++....
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~  299 (322)
T KOG1164|consen  254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD  299 (322)
T ss_pred             hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence                       01122333333455677888887777777655433

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.79  E-value=6.3e-19  Score=173.43  Aligned_cols=135  Identities=21%  Similarity=0.204  Sum_probs=106.0

Q ss_pred             cccccccCCcceeec----ceEEEEEEEEeccCCc--------------------------chhHHHHHHHhhhccCCce
Q 040702          517 NNLIGRGGFGPVYKD----GMEVAIKVFNLQYGGA--------------------------FKSFDIECGMMKRIRHRNL  566 (797)
Q Consensus       517 ~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~Hpni  566 (797)
                      .+.||+|+||.||++    |+.||||+++......                          ...+..|.+.+.++.|++|
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            468999999999984    6899999998653210                          1123578899999999987


Q ss_pred             eEeeeeeecCCeEEEEEEccCCCCHHHH-HhcCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCceEEcCC
Q 040702          567 IKIISSCSNDDFKALVLEYMPLGSLEKC-LYSGNYILDIFQGLNIMIDVASALEYLHFGYS-VPIIHCDLKPSNVLLDDN  644 (797)
Q Consensus       567 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~-~~ivHrDlkp~NIll~~~  644 (797)
                      .....+....  .++||||++|+++... +...  .++......++.|++.++.|+|   . .||+||||||+||+++ +
T Consensus        82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~--~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-~  153 (190)
T cd05145          82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLKDV--PLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCceEEEecC--CEEEEEEecCCCchhhhhhhc--cCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-C
Confidence            5444443332  4899999998755433 3332  4677888999999999999999   7 8999999999999999 7


Q ss_pred             CcEEEEeecCCccCC
Q 040702          645 MVAHLSDFGMAKPLL  659 (797)
Q Consensus       645 ~~~kl~DFGla~~~~  659 (797)
                      +.++|+|||+|+...
T Consensus       154 ~~~~liDFG~a~~~~  168 (190)
T cd05145         154 GKPYIIDVSQAVELD  168 (190)
T ss_pred             CCEEEEEcccceecC
Confidence            899999999998653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.79  E-value=1.7e-19  Score=178.08  Aligned_cols=170  Identities=13%  Similarity=0.101  Sum_probs=131.2

Q ss_pred             HHHHHH--HhcCCCccccccccCCcceeec---ceEEEEEEEEeccCCcchh---------HHHHHHHhhhccCCceeEe
Q 040702          504 YLELFQ--ATNRFSENNLIGRGGFGPVYKD---GMEVAIKVFNLQYGGAFKS---------FDIECGMMKRIRHRNLIKI  569 (797)
Q Consensus       504 ~~~l~~--~~~~f~~~~~lg~G~~g~Vyk~---~~~vAvK~~~~~~~~~~~~---------~~~E~~~l~~l~Hpniv~l  569 (797)
                      +.++..  -.++|...+.+|.|+||.||..   +..+|||.++.........         +.+|+..+.+++||+|..+
T Consensus        21 ~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~  100 (232)
T PRK10359         21 YKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASL  100 (232)
T ss_pred             HHHHHHHHhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcc
Confidence            344443  3478999999999999999973   4689999997664332222         6789999999999999999


Q ss_pred             eeeeecC--------CeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEE
Q 040702          570 ISSCSND--------DFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL  641 (797)
Q Consensus       570 ~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll  641 (797)
                      .+++...        +..++||||++|.+|.++..     ++.    ....+++.++..+|   ..|++|||+||+||++
T Consensus       101 ~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili  168 (232)
T PRK10359        101 NDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIV  168 (232)
T ss_pred             eEeeeecccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEE
Confidence            9886543        35889999999999988631     222    34669999999999   9999999999999999


Q ss_pred             cCCCcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhh
Q 040702          642 DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLIS  700 (797)
Q Consensus       642 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~  700 (797)
                      +.++ ++++|||..+....+...              ...+....|..+.|+|++|...
T Consensus       169 ~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~  212 (232)
T PRK10359        169 SKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYL  212 (232)
T ss_pred             eCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEee
Confidence            9988 999999988754222110              0034455567899999999875

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.78  E-value=5.5e-19  Score=172.17  Aligned_cols=145  Identities=17%  Similarity=0.019  Sum_probs=116.2

Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccccc
Q 040702          589 GSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT  668 (797)
Q Consensus       589 g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~  668 (797)
                      |+|.+++...+..+++.+++.|+.|+++||+|||   +.+      ||+||+++.++.+|+  ||+++.....       
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-------   62 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPE-------   62 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeeccc-------
Confidence            6899999876556999999999999999999999   666      999999999999999  9999865321       


Q ss_pred             ccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh------------------------hhhhc--ccc
Q 040702          669 QTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE------------------------KHLMT--KEQ  722 (797)
Q Consensus       669 ~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~------------------------~~~~~--~~~  722 (797)
                      ...||+.|||||.+.+..++.++||||+|++.++.+....++....                        .....  .+.
T Consensus        63 ~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  142 (176)
T smart00750       63 QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFA  142 (176)
T ss_pred             cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHH
Confidence            1268999999999999999999999999998766554433321100                        01111  477


Q ss_pred             cchhccccCCCCCCCChHHHHHhHHHHHH
Q 040702          723 PMVRMGTDLSLGQFPASYSISKYLVYIRE  751 (797)
Q Consensus       723 ~l~~~cl~~dp~~RPs~~~i~~~l~~i~~  751 (797)
                      +++++|+..+|.+||++.|+++....+..
T Consensus       143 ~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      143 DFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             HHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            89999999999999999999998766543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.78  E-value=9.6e-21  Score=169.93  Aligned_cols=179  Identities=27%  Similarity=0.428  Sum_probs=150.9

Q ss_pred             cCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEccCCcCCCCCCccccccccccEE
Q 040702          251 CRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQL  330 (797)
Q Consensus       251 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L  330 (797)
                      ..+...+.|.||+|+++. .|..+..+.+|+.|++++|+++++|..+..+++|++|+++-|++. ..|..|+.++.|+.|
T Consensus        30 f~~s~ITrLtLSHNKl~~-vppnia~l~nlevln~~nnqie~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl  107 (264)
T KOG0617|consen   30 FNMSNITRLTLSHNKLTV-VPPNIAELKNLEVLNLSNNQIEELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL  107 (264)
T ss_pred             cchhhhhhhhcccCceee-cCCcHHHhhhhhhhhcccchhhhcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence            345677788899999984 566788899999999999999999999999999999999999998 788899999999999


Q ss_pred             eccCcccc-cccCccccCCcccceecccCccccCCCChhhhccccCCeeeecCCcCCCCCChhhhccCCCCeEEccCCcC
Q 040702          331 DLSMNNFS-CVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRL  409 (797)
Q Consensus       331 ~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l  409 (797)
                      ||++|+++ ...|+.|..+..|+.|+|++|.+. .+|..++.+++|+.|.+..|.+- ..|..++.++.|++|.+.+|++
T Consensus       108 dltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl  185 (264)
T KOG0617|consen  108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRL  185 (264)
T ss_pred             hccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccccee
Confidence            99999885 457889999999999999999998 88889999999999999999987 7899999999999999999999


Q ss_pred             cccCCCCCCCCCC---CcccccCCccc
Q 040702          410 EGEIPREGPFRNL---SAESFKGNELL  433 (797)
Q Consensus       410 ~~~~p~~~~~~~l---~~~~~~~n~~~  433 (797)
                      +-.+|..+.+...   .......|||.
T Consensus       186 ~vlppel~~l~l~~~k~v~r~E~NPwv  212 (264)
T KOG0617|consen  186 TVLPPELANLDLVGNKQVMRMEENPWV  212 (264)
T ss_pred             eecChhhhhhhhhhhHHHHhhhhCCCC
Confidence            9888876443221   22334556664

>PRK10345 hypothetical protein; Provisional

Probab=99.77  E-value=2.4e-18  Score=169.85  Aligned_cols=136  Identities=17%  Similarity=0.248  Sum_probs=107.0

Q ss_pred             CCccccccccCCcceeec--ceEEEEEEEEeccCCcchhHHHHHHHhhhc-----cCCceeEeeeeeecCC---e-EEEE
Q 040702          514 FSENNLIGRGGFGPVYKD--GMEVAIKVFNLQYGGAFKSFDIECGMMKRI-----RHRNLIKIISSCSNDD---F-KALV  582 (797)
Q Consensus       514 f~~~~~lg~G~~g~Vyk~--~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-----~Hpniv~l~~~~~~~~---~-~~lv  582 (797)
                      ....+.||+|+||.||..  ....+||++........+.+.+|+++++.+     .||||++++|+++++.   . ..+|
T Consensus         4 L~~~~~LG~G~~~~Vy~hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I   83 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYAHPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI   83 (210)
T ss_pred             cCCcceecCCCceEEEECCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence            345689999999999972  122368887765444567899999999999     5799999999998863   3 3489


Q ss_pred             EEc--cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHH-HHHHccCCCCeEEcCCCCCceEEcC----CCcEEEEeecCC
Q 040702          583 LEY--MPLGSLEKCLYSGNYILDIFQGLNIMIDVASAL-EYLHFGYSVPIIHCDLKPSNVLLDD----NMVAHLSDFGMA  655 (797)
Q Consensus       583 ~e~--~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al-~yLH~~~~~~ivHrDlkp~NIll~~----~~~~kl~DFGla  655 (797)
                      |||  +.+|+|.+++....  +++.  ..++.|++.++ +|||   +.+|+||||||+||+++.    ++.++|+||+-+
T Consensus        84 ~e~~G~~~~tL~~~l~~~~--~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         84 ADFDGKPSITLTEFAEQCR--YEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             ecCCCCcchhHHHHHHccc--ccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            999  55799999997643  5544  35678888887 9999   999999999999999973    347999995544


Q ss_pred             c
Q 040702          656 K  656 (797)
Q Consensus       656 ~  656 (797)
                      +
T Consensus       157 ~  157 (210)
T PRK10345        157 S  157 (210)
T ss_pred             c
Confidence            3

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.77  E-value=5.8e-20  Score=197.75  Aligned_cols=240  Identities=19%  Similarity=0.220  Sum_probs=189.2

Q ss_pred             cccccCCcceee--------cceEEEEEEEEeccCC--cchhHHHHHHHhhhcc-CCceeEeeeeeecCCeEEEEEEccC
Q 040702          519 LIGRGGFGPVYK--------DGMEVAIKVFNLQYGG--AFKSFDIECGMMKRIR-HRNLIKIISSCSNDDFKALVLEYMP  587 (797)
Q Consensus       519 ~lg~G~~g~Vyk--------~~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~lv~e~~~  587 (797)
                      .+|+|+||.|+.        ++.-||.|+.++....  .......|-.++..++ ||.+|++...++.+...+++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999984        3578999988765321  1224455778888887 9999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccccc
Q 040702          588 LGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ  667 (797)
Q Consensus       588 ~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  667 (797)
                      +|++...+..... ++......+...++-|++++|   +.+|+|||+|++||+++.+|++++.|||+++...+..     
T Consensus        81 gg~lft~l~~~~~-f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~-----  151 (612)
T KOG0603|consen   81 GGDLFTRLSKEVM-FDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK-----  151 (612)
T ss_pred             cchhhhccccCCc-hHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhh-----
Confidence            9999988877654 677777788899999999999   9999999999999999999999999999998654332     


Q ss_pred             cccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhhhhhcccccchhccccCCCCCCCChHHHHHhHH
Q 040702          668 TQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLV  747 (797)
Q Consensus       668 ~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~  747 (797)
                       ..+||..|||||.+.  +.....|+|++|...+.++.+..++..   +   ....+.+.|+- -|.++-+  +....+.
T Consensus       152 -~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---~---~~~~Il~~~~~-~p~~l~~--~a~~~~~  219 (612)
T KOG0603|consen  152 -IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---D---TMKRILKAELE-MPRELSA--EARSLFR  219 (612)
T ss_pred             -hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---H---HHHHHhhhccC-CchhhhH--HHHHHHH
Confidence             228999999999887  667889999999999888888887666   2   22233443443 3434333  2233333


Q ss_pred             H-HHHHhccccccccccCCcccccceeeeeeee
Q 040702          748 Y-IRELERGKVGITSVAAFPIVHHYLYRTVDYT  779 (797)
Q Consensus       748 ~-i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~  779 (797)
                      + ..+.+.-+.+..+.....+.+|.||..++|.
T Consensus       220 ~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~  252 (612)
T KOG0603|consen  220 QLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN  252 (612)
T ss_pred             HHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence            3 3455677788888899999999999999998

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.76  E-value=2.2e-19  Score=172.43  Aligned_cols=227  Identities=16%  Similarity=0.250  Sum_probs=174.8

Q ss_pred             ccccccccCCcceeec---ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccCCCC
Q 040702          516 ENNLIGRGGFGPVYKD---GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGS  590 (797)
Q Consensus       516 ~~~~lg~G~~g~Vyk~---~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~g~  590 (797)
                      ...+|.+...|+.|||   |..+++|++..+..  ...++|..|.-.++-+.||||..++|.|..+....++..||+.|+
T Consensus       194 l~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs  273 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS  273 (448)
T ss_pred             hhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence            3456788889999997   46788888866532  234689999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccccccc
Q 040702          591 LEKCLYSGNY-ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ  669 (797)
Q Consensus       591 L~~~l~~~~~-~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  669 (797)
                      |+..+++... ..+..++.+++.++|+|++|||+. .+-|.---+.+..+++|++.+++|+ .+-+++..      ...+
T Consensus       274 lynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris-mad~kfsf------qe~g  345 (448)
T KOG0195|consen  274 LYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSF------QEVG  345 (448)
T ss_pred             HHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee-cccceeee------eccc
Confidence            9999998765 678889999999999999999953 3445555688999999999998875 22233211      2234


Q ss_pred             cccCcccccccccccCcc---chHHHHHHHhhhhhhhhcccc------------------ccchhhhhhhcccccchhcc
Q 040702          670 TLATIGYMAPDEIFSGEM---RLKCWVNDSLLISVMIVVDAN------------------LLIREEKHLMTKEQPMVRMG  728 (797)
Q Consensus       670 ~~gt~~y~aPE~~~~~~~---~~~~dv~s~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~l~~~c  728 (797)
                      ....+.||+||.+...+-   -..+|+||+.+...+.....-                  +....++.....+..++..|
T Consensus       346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm~ic  425 (448)
T KOG0195|consen  346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNIC  425 (448)
T ss_pred             cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHHHHH
Confidence            456889999999876543   367899999876533322222                  22223344555777888999


Q ss_pred             ccCCCCCCCChHHHHHhHHHHH
Q 040702          729 TDLSLGQFPASYSISKYLVYIR  750 (797)
Q Consensus       729 l~~dp~~RPs~~~i~~~l~~i~  750 (797)
                      +..||.+||.+..++-.|+++.
T Consensus       426 mnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  426 MNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             hcCCCCcCCCcceehhhHHHhc
Confidence            9999999999999999998864

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.76  E-value=2.6e-20  Score=200.22  Aligned_cols=282  Identities=22%  Similarity=0.222  Sum_probs=165.8

Q ss_pred             EEEccCcccc-ccCCchhhCCCCCCEEEccCCcCccc----CCccccCCCCCCeeeccCccCcCCCCCccc-cccCCCCC
Q 040702          106 ELHLWGNNFI-GTIPSFIFNASKLSELGLQKNSFSGS----IPNTFGNLRNLKWLGLNDNYLTSSTPELSS-LSSLSNCK  179 (797)
Q Consensus       106 ~L~L~~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~----~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~-~~~l~~l~  179 (797)
                      .|+|..+.++ ...+..|..+.+|++|++++|.++..    ++..+...++|++|++++|.+...+..+.. ...+..++
T Consensus         2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~   81 (319)
T cd00116           2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC   81 (319)
T ss_pred             ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence            5788888887 34455667788899999999988532    344566777888898888887642222111 11245567


Q ss_pred             CCcEEEccCCCCCCCCChhhhcccc--CCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCC-CCC
Q 040702          180 YLEYFSFSNNPLGGILPRAIGNLSQ--SMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRL-AAL  256 (797)
Q Consensus       180 ~L~~L~Ls~N~l~~~~~~~~~~l~~--~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l-~~L  256 (797)
                      +|+.|++++|.+....+..+..+..  +|+.|++++|.++.....                      .+...+..+ ++|
T Consensus        82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~----------------------~l~~~l~~~~~~L  139 (319)
T cd00116          82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLR----------------------LLAKGLKDLPPAL  139 (319)
T ss_pred             ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHH----------------------HHHHHHHhCCCCc
Confidence            7888888888777655555555542  266666666655421111                      111223334 566


Q ss_pred             cEEEccCCcCccc----CCCCccCCccccccccCCCCCCC-----CCCCCCCCCcccEEEccCCcCCCCC----Cccccc
Q 040702          257 FQLDLGGNKLSGF----VPACSGNLTNLRKLYLGSNLLTS-----IPSTLWNLKDILHLNLSSNFFTGPL----PLKIGN  323 (797)
Q Consensus       257 ~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~-----lp~~~~~l~~L~~L~l~~N~l~~~~----~~~~~~  323 (797)
                      +.|++++|.+++.    .+..+..+++|++|++++|.++.     ++..+...++|++|++++|.+++..    ...+..
T Consensus       140 ~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~  219 (319)
T cd00116         140 EKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLAS  219 (319)
T ss_pred             eEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcc
Confidence            6666666666521    12234445566666666666642     2223334456777777777665322    223445


Q ss_pred             cccccEEeccCcccccccCcccc-----CCcccceecccCccccC----CCChhhhccccCCeeeecCCcCCCC----CC
Q 040702          324 LNVLVQLDLSMNNFSCVIPTKIG-----GLKDLQYLFLEYNRLQG----SIPNSIGDLISLKSLNLSNNNLSGT----IP  390 (797)
Q Consensus       324 l~~L~~L~Ls~N~l~~~~~~~~~-----~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p  390 (797)
                      +++|+.|++++|.+++.....+.     ..+.|+.|++++|.++.    .+...+..+++|+.+++++|.++..    ..
T Consensus       220 ~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~  299 (319)
T cd00116         220 LKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLA  299 (319)
T ss_pred             cCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHH
Confidence            66677777777776642222221     23677777777777752    2234455567777788888877744    33


Q ss_pred             hhhhcc-CCCCeEEccCCcC
Q 040702          391 ISLEKL-LDLKDINVSFNRL  409 (797)
Q Consensus       391 ~~~~~l-~~L~~L~l~~N~l  409 (797)
                      ..+... +.|+.+++.+|++
T Consensus       300 ~~~~~~~~~~~~~~~~~~~~  319 (319)
T cd00116         300 ESLLEPGNELESLWVKDDSF  319 (319)
T ss_pred             HHHhhcCCchhhcccCCCCC
Confidence            334444 5677777777754

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.75  E-value=6.8e-19  Score=199.91  Aligned_cols=226  Identities=18%  Similarity=0.186  Sum_probs=168.1

Q ss_pred             CccccccccCCcceeec-----ceEEEEEEEEe---ccCCc---chhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          515 SENNLIGRGGFGPVYKD-----GMEVAIKVFNL---QYGGA---FKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       515 ~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~---~~~~~---~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      .....+|.|++|.|+..     ....+.|.++.   .....   ...+..|+.+-..+.|||++..+..+.+....+-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            34578999999966642     23333333221   11111   122566788888889999999888887776666669


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      |||++ +|..++.... .+...++..++.|+..|++|+|   ..||.|||+|++|++++.+|.+||+|||.+..+.-+..
T Consensus       401 E~~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             hcccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence            99999 9999987763 3778889999999999999999   99999999999999999999999999999876543322


Q ss_pred             --cccccccccCcccccccccccCccc-hHHHHHHHhhhhhhhhccccccch-------------------------hhh
Q 040702          664 --SLTQTQTLATIGYMAPDEIFSGEMR-LKCWVNDSLLISVMIVVDANLLIR-------------------------EEK  715 (797)
Q Consensus       664 --~~~~~~~~gt~~y~aPE~~~~~~~~-~~~dv~s~~~~~~~~~~~~~~~~~-------------------------~~~  715 (797)
                        .....+.+|+..|+|||++....|+ ...|+|+.|++.+.+.....+...                         -..
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~  555 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLS  555 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHH
Confidence              2456778999999999999998885 789999999876443333221110                         000


Q ss_pred             hhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          716 HLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       716 ~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                      ......+.++.++++.||.+|-++.+|++-
T Consensus       556 ~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  556 LLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             hchhhHHHHHHHHccCChhheecHHHHhhC
Confidence            123355667777999999999999999874

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=99.75  E-value=6e-20  Score=197.33  Aligned_cols=283  Identities=19%  Similarity=0.181  Sum_probs=147.1

Q ss_pred             CCCCCCCcc-ccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccc------cCCcccc
Q 040702            2 PSLTNDFLR-GIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVG------VVPTTIF   74 (797)
Q Consensus         2 ~~l~~~~~~-~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~------~~p~~~~   74 (797)
                      ++|.++.++ +.....|..+.+|++|+|++|.+++.-    ...+++.+...++++.|+++++.+.+      .++..+.
T Consensus         3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~----~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~   78 (319)
T cd00116           3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEA----AKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLT   78 (319)
T ss_pred             cccccCcccccchHHHHHHHhhccEEeecCCCCcHHH----HHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHH
Confidence            466666665 344455666677777777777654321    23345556666677777777776652      2344566


Q ss_pred             CCCCCCEEEccCCcCcccCCCccccCCC---CccEEEccCccccc----cCCchhhCC-CCCCEEEccCCcCccc----C
Q 040702           75 NVSTLKSLYLHSNSLSGRLPSSADVRLP---NLKELHLWGNNFIG----TIPSFIFNA-SKLSELGLQKNSFSGS----I  142 (797)
Q Consensus        75 ~l~~L~~L~Ls~N~l~~~l~~~~~~~l~---~L~~L~L~~N~l~~----~~~~~~~~l-~~L~~L~L~~N~l~~~----~  142 (797)
                      .+++|+.|+|++|.+.+..+ ..+..+.   +|++|++++|++++    .+...+..+ ++|++|+|++|.+++.    .
T Consensus        79 ~~~~L~~L~l~~~~~~~~~~-~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~  157 (319)
T cd00116          79 KGCGLQELDLSDNALGPDGC-GVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEAL  157 (319)
T ss_pred             hcCceeEEEccCCCCChhHH-HHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHH
Confidence            66677777777777752222 2222233   37777777776652    222344455 6677777777776621    2


Q ss_pred             CccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChh----hhccccCCcEEEccCCcccc
Q 040702          143 PNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRA----IGNLSQSMEDFWMDNCNISG  218 (797)
Q Consensus       143 ~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~----~~~l~~~L~~L~L~~n~i~~  218 (797)
                      +..|..+++|++|+|++|.++...... -...+..+++|+.|++++|.+.+.....    +..++ +|+.|++++|.++.
T Consensus       158 ~~~~~~~~~L~~L~l~~n~l~~~~~~~-l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~-~L~~L~ls~n~l~~  235 (319)
T cd00116         158 AKALRANRDLKELNLANNGIGDAGIRA-LAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLK-SLEVLNLGDNNLTD  235 (319)
T ss_pred             HHHHHhCCCcCEEECcCCCCchHHHHH-HHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccC-CCCEEecCCCcCch
Confidence            334555666777777766665311000 0011333456666666666665332222    22232 45555555554443


Q ss_pred             cCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccCCcCccc----CCCCccCCccccccccCCCCCCCCC
Q 040702          219 SIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGF----VPACSGNLTNLRKLYLGSNLLTSIP  294 (797)
Q Consensus       219 ~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~lp  294 (797)
                      .....+...                     .....+.|+.|++++|.++..    ....+..+++|+.+++++|.++.-+
T Consensus       236 ~~~~~l~~~---------------------~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~  294 (319)
T cd00116         236 AGAAALASA---------------------LLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEG  294 (319)
T ss_pred             HHHHHHHHH---------------------HhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHH
Confidence            111111110                     000125666666666666411    1223344466777777777765332


Q ss_pred             -----CCCCCC-CcccEEEccCCc
Q 040702          295 -----STLWNL-KDILHLNLSSNF  312 (797)
Q Consensus       295 -----~~~~~l-~~L~~L~l~~N~  312 (797)
                           ..+... +.|+.|++.+|.
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~  318 (319)
T cd00116         295 AQLLAESLLEPGNELESLWVKDDS  318 (319)
T ss_pred             HHHHHHHHhhcCCchhhcccCCCC
Confidence                 222233 466677766664

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.73  E-value=1.1e-19  Score=163.16  Aligned_cols=176  Identities=30%  Similarity=0.463  Sum_probs=135.7

Q ss_pred             hhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEccCCc
Q 040702          233 QLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNF  312 (797)
Q Consensus       233 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~  312 (797)
                      +.|.||+|+++ ..|..+..+.+|+.|++++|+|. ..|..++.+++|+.|+++-|++..+|..|+.++.|+.||+..|.
T Consensus        36 TrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~~lprgfgs~p~levldltynn  113 (264)
T KOG0617|consen   36 TRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLNILPRGFGSFPALEVLDLTYNN  113 (264)
T ss_pred             hhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhhcCccccCCCchhhhhhccccc
Confidence            67777888887 45556777778888888888887 45667778888888888888888888888888888888888887


Q ss_pred             CC-CCCCccccccccccEEeccCcccccccCccccCCcccceecccCccccCCCChhhhccccCCeeeecCCcCCCCCCh
Q 040702          313 FT-GPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPI  391 (797)
Q Consensus       313 l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~  391 (797)
                      +. ...|+.|..+..|+.|+|+.|.+. .+|..++.+++|+.|.+.+|.+. ..|..++.+..|++|++.+|+++ .+|.
T Consensus       114 l~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~-vlpp  190 (264)
T KOG0617|consen  114 LNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT-VLPP  190 (264)
T ss_pred             cccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee-ecCh
Confidence            76 356788888888888888888887 66777888888888888888887 67888888888888888888888 6666


Q ss_pred             hhhccC---CCCeEEccCCcCcccC
Q 040702          392 SLEKLL---DLKDINVSFNRLEGEI  413 (797)
Q Consensus       392 ~~~~l~---~L~~L~l~~N~l~~~~  413 (797)
                      .+.++.   +=+.+.+.+|++...|
T Consensus       191 el~~l~l~~~k~v~r~E~NPwv~pI  215 (264)
T KOG0617|consen  191 ELANLDLVGNKQVMRMEENPWVNPI  215 (264)
T ss_pred             hhhhhhhhhhHHHHhhhhCCCCChH
Confidence            666543   3355667777765443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.73  E-value=4.9e-17  Score=175.11  Aligned_cols=184  Identities=32%  Similarity=0.443  Sum_probs=155.6

Q ss_pred             CCccccccccCCcceeecc--eEEEEEEEEeccCC---cchhHHHHHHHhhhccCC-ceeEeeeeeecCCeEEEEEEccC
Q 040702          514 FSENNLIGRGGFGPVYKDG--MEVAIKVFNLQYGG---AFKSFDIECGMMKRIRHR-NLIKIISSCSNDDFKALVLEYMP  587 (797)
Q Consensus       514 f~~~~~lg~G~~g~Vyk~~--~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~Hp-niv~l~~~~~~~~~~~lv~e~~~  587 (797)
                      |...+.+|.|+||.||++.  ..+|+|.+......   ....+.+|+.+++.+.|+ +|+++.+.+......+++++|+.
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~   81 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD   81 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEeccEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence            6677899999999999875  56899998766433   357899999999999988 79999999987778899999999


Q ss_pred             CCCHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCC-cEEEEeecCCccCCccCcc
Q 040702          588 LGSLEKCLYSGNY--ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM-VAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       588 ~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DFGla~~~~~~~~~  664 (797)
                      ++++.+++.....  .+.......++.|++.+++|+|   ..+++|||+||+||+++..+ .++++|||.++........
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          82 GGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             CCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            9999977766541  4788899999999999999999   99999999999999999888 7999999999855433322


Q ss_pred             c----cccccccCccccccccccc---CccchHHHHHHHhhhh
Q 040702          665 L----TQTQTLATIGYMAPDEIFS---GEMRLKCWVNDSLLIS  700 (797)
Q Consensus       665 ~----~~~~~~gt~~y~aPE~~~~---~~~~~~~dv~s~~~~~  700 (797)
                      .    ......||..|+|||.+..   ..+....|+|++|+..
T Consensus       159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~  201 (384)
T COG0515         159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITL  201 (384)
T ss_pred             ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHH
Confidence            1    2356789999999999987   5788999999999654

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.69  E-value=1.1e-16  Score=160.76  Aligned_cols=131  Identities=26%  Similarity=0.313  Sum_probs=111.3

Q ss_pred             ccccccCCcceeec---ceEEEEEEEEeccCC--------cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          518 NLIGRGGFGPVYKD---GMEVAIKVFNLQYGG--------AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~---~~~vAvK~~~~~~~~--------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      +.||+|++|.||++   +..|+||+.......        ....+.+|++++..++|++|+....++.+.+..++||||+
T Consensus         2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   81 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI   81 (211)
T ss_pred             cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence            57999999999986   678999986543211        1235778999999999999888777777778889999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCcc
Q 040702          587 PLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  657 (797)
Q Consensus       587 ~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  657 (797)
                      +|++|.+++....    . ....++.+++.++.++|   ..+++|+|++|.||+++ ++.++++|||.++.
T Consensus        82 ~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         82 EGEPLKDLINSNG----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999986542    2 77889999999999999   99999999999999999 78999999999874

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.69  E-value=1.1e-16  Score=154.40  Aligned_cols=154  Identities=15%  Similarity=0.105  Sum_probs=113.6

Q ss_pred             CCccccccccCCcceeec---ceEEEEEEEEeccCC----cchhHHHHHHHhhhcc-CCceeEeeeeeecCCeEEEEEEc
Q 040702          514 FSENNLIGRGGFGPVYKD---GMEVAIKVFNLQYGG----AFKSFDIECGMMKRIR-HRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       514 f~~~~~lg~G~~g~Vyk~---~~~vAvK~~~~~~~~----~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      +.+...|++|+||+||.+   +.+++.+.+......    ....+.+|+++|++++ |++|++++++    +..+++|||
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             cccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            345678999999999963   567776666533221    1125789999999995 5889999886    346999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCC-CCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDL-KPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDl-kp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      ++|.+|.+....        ....++.|++.+++++|   ..||+|||| ||+|||++.++.++|+|||+|........-
T Consensus        80 I~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         80 LAGAAMYQRPPR--------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             ecCccHHhhhhh--------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence            999998754321        12357889999999999   999999999 799999999999999999999854322210


Q ss_pred             ----c-------cccccccCccccccccc
Q 040702          665 ----L-------TQTQTLATIGYMAPDEI  682 (797)
Q Consensus       665 ----~-------~~~~~~gt~~y~aPE~~  682 (797)
                          .       ...-..+++.|++|++-
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~  177 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVER  177 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHH
Confidence                0       01112367788888754

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.69  E-value=9.4e-17  Score=159.76  Aligned_cols=128  Identities=24%  Similarity=0.339  Sum_probs=104.2

Q ss_pred             cccccCCcceeec---ceEEEEEEEEeccC-C-------cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccC
Q 040702          519 LIGRGGFGPVYKD---GMEVAIKVFNLQYG-G-------AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  587 (797)
Q Consensus       519 ~lg~G~~g~Vyk~---~~~vAvK~~~~~~~-~-------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~  587 (797)
                      .||+|+||.||++   +..|++|....... .       ....+.+|++++..++|+++.....++...+..++||||++
T Consensus         1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~   80 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE   80 (199)
T ss_pred             CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence            4899999999986   57899998654321 1       12456789999999998876655555556667799999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccC
Q 040702          588 LGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  658 (797)
Q Consensus       588 ~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  658 (797)
                      |++|.+.+.....        .++.+++.++.++|   ..+++|+|++|.||+++ ++.++++|||+++..
T Consensus        81 g~~l~~~~~~~~~--------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        81 GKPLKDVIEEGND--------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CccHHHHHhhcHH--------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            9999988754321        78999999999999   99999999999999999 789999999998753

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.68  E-value=1.6e-16  Score=181.70  Aligned_cols=144  Identities=23%  Similarity=0.306  Sum_probs=114.5

Q ss_pred             cCHHHHHHHhcCCCccccccccCCcceeec---ceEEEEEEEEec-cCC-------cchhHHHHHHHhhhccCCceeEee
Q 040702          502 FTYLELFQATNRFSENNLIGRGGFGPVYKD---GMEVAIKVFNLQ-YGG-------AFKSFDIECGMMKRIRHRNLIKII  570 (797)
Q Consensus       502 ~~~~~l~~~~~~f~~~~~lg~G~~g~Vyk~---~~~vAvK~~~~~-~~~-------~~~~~~~E~~~l~~l~Hpniv~l~  570 (797)
                      .++.........|...+.||+|+||.||++   +..+++|+.... ...       ..+.+.+|+++++.++|++++...
T Consensus       323 ~~~~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~  402 (535)
T PRK09605        323 VTWIKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPV  402 (535)
T ss_pred             eeeccccccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeE
Confidence            344444444556677899999999999994   344555543221 111       124678899999999999999888


Q ss_pred             eeeecCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEE
Q 040702          571 SSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLS  650 (797)
Q Consensus       571 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~  650 (797)
                      .++..++..++||||+++++|.+++.         ....++.|+++++.|||   ..+++|||+||+||++ +++.++|+
T Consensus       403 ~~~~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~li  469 (535)
T PRK09605        403 IYDVDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLI  469 (535)
T ss_pred             EEEEeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEE
Confidence            88877778899999999999998875         35678999999999999   9999999999999999 57799999


Q ss_pred             eecCCccC
Q 040702          651 DFGMAKPL  658 (797)
Q Consensus       651 DFGla~~~  658 (797)
                      |||+++..
T Consensus       470 DFGla~~~  477 (535)
T PRK09605        470 DFGLGKYS  477 (535)
T ss_pred             eCcccccC
Confidence            99999853

>smart00090 RIO RIO-like kinase

Probab=99.68  E-value=1.4e-16  Score=161.54  Aligned_cols=137  Identities=18%  Similarity=0.162  Sum_probs=106.9

Q ss_pred             CCCccccccccCCcceeec------ceEEEEEEEEeccCC------------------------cchhHHHHHHHhhhcc
Q 040702          513 RFSENNLIGRGGFGPVYKD------GMEVAIKVFNLQYGG------------------------AFKSFDIECGMMKRIR  562 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~------~~~vAvK~~~~~~~~------------------------~~~~~~~E~~~l~~l~  562 (797)
                      .|+..+.||+|+||.||++      |+.||||+++.....                        ....+..|++.+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            5788899999999999976      479999999754210                        0123567999999997


Q ss_pred             CC--ceeEeeeeeecCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC-eEEcCCCCCce
Q 040702          563 HR--NLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVP-IIHCDLKPSNV  639 (797)
Q Consensus       563 Hp--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~-ivHrDlkp~NI  639 (797)
                      +.  .+++++++    ...++||||++++++........ .........++.|++.++.|||   ..+ |+||||||+||
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NI  180 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-EPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNI  180 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccC-CcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhE
Confidence            53  34455543    23589999999988876543322 3555667889999999999999   999 99999999999


Q ss_pred             EEcCCCcEEEEeecCCccC
Q 040702          640 LLDDNMVAHLSDFGMAKPL  658 (797)
Q Consensus       640 ll~~~~~~kl~DFGla~~~  658 (797)
                      +++ ++.++|+|||.|+..
T Consensus       181 li~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      181 LVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             EEE-CCCEEEEEChhhhcc
Confidence            999 889999999998854

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.65  E-value=6.3e-16  Score=153.45  Aligned_cols=138  Identities=23%  Similarity=0.198  Sum_probs=106.9

Q ss_pred             HHHHhcCCCccccccccCCcceeec----ceEEEEEEEEeccCC----------------------cchhHHHHHHHhhh
Q 040702          507 LFQATNRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGG----------------------AFKSFDIECGMMKR  560 (797)
Q Consensus       507 l~~~~~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~----------------------~~~~~~~E~~~l~~  560 (797)
                      +.....-|...+.||+|+||.||++    ++.||||+++.....                      ....+..|..++..
T Consensus        10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   89 (198)
T cd05144          10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA   89 (198)
T ss_pred             HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence            3333334788899999999999974    689999998754210                      01135678889999


Q ss_pred             ccCC--ceeEeeeeeecCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCc
Q 040702          561 IRHR--NLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSN  638 (797)
Q Consensus       561 l~Hp--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~N  638 (797)
                      +.|+  .+++.++.    +..++||||++|+++......       .....++.++++++.++|   ..+|+||||||+|
T Consensus        90 l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~N  155 (198)
T cd05144          90 LYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFN  155 (198)
T ss_pred             HHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCccc
Confidence            9887  44444443    345899999999998765321       245678899999999999   8999999999999


Q ss_pred             eEEcCCCcEEEEeecCCccC
Q 040702          639 VLLDDNMVAHLSDFGMAKPL  658 (797)
Q Consensus       639 Ill~~~~~~kl~DFGla~~~  658 (797)
                      |++++++.++|+|||.+...
T Consensus       156 ill~~~~~~~liDfg~~~~~  175 (198)
T cd05144         156 ILVDDDEKIYIIDWPQMVST  175 (198)
T ss_pred             EEEcCCCcEEEEECCccccC
Confidence            99999999999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.62  E-value=1.1e-15  Score=176.80  Aligned_cols=236  Identities=19%  Similarity=0.197  Sum_probs=170.8

Q ss_pred             HHhcCCCccccccccCCcceeec----ceEEEEEEEEeccCCcchhHHHHHHHhhhcc---CCceeEeeeeeecCCeEEE
Q 040702          509 QATNRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIR---HRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       509 ~~~~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---Hpniv~l~~~~~~~~~~~l  581 (797)
                      ..-+.|.+.+.+|+|+||.||+|    |+.||+|+-+.....   +|..-.+++.+++   -+.|+.+..++...+.-++
T Consensus       695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l  771 (974)
T KOG1166|consen  695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL  771 (974)
T ss_pred             ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence            34467888899999999999986    689999987755432   2333334455554   2456666666677777899


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEc-------CCCcEEEEeecC
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD-------DNMVAHLSDFGM  654 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~-------~~~~~kl~DFGl  654 (797)
                      |+||.+.|+|.+++...+ .++|...+.++.|++.-+++||   ..+|||+||||+|.|+.       +...++|+|||.
T Consensus       772 v~ey~~~Gtlld~~N~~~-~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~  847 (974)
T KOG1166|consen  772 VSEYSPYGTLLDLINTNK-VMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGR  847 (974)
T ss_pred             eeeccccccHHHhhccCC-CCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEeccc
Confidence            999999999999998544 5899999999999999999999   99999999999999994       234689999999


Q ss_pred             CccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhcccccc--ch--------hhhhh-hccccc
Q 040702          655 AKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLL--IR--------EEKHL-MTKEQP  723 (797)
Q Consensus       655 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~--~~--------~~~~~-~~~~~~  723 (797)
                      +-.+.--.........++|-.+-.+|+..+..+++..|.+++..+...++++..+.  ++        .++.. ......
T Consensus       848 siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~~~g~~~~~~~~~~Ry~~~~~W~~  927 (974)
T KOG1166|consen  848 SIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEVKNGSSWMVKTNFPRYWKRDMWNK  927 (974)
T ss_pred             ceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHhcCCcceeccccchhhhhHHHHHH
Confidence            96543222333556678899999999999999999999999887653333332221  00        01000 012234


Q ss_pred             chhccccCCCCCCCChHHHHHhHHHHHH
Q 040702          724 MVRMGTDLSLGQFPASYSISKYLVYIRE  751 (797)
Q Consensus       724 l~~~cl~~dp~~RPs~~~i~~~l~~i~~  751 (797)
                      ++...+.+|...=|...++...++.+..
T Consensus       928 ~F~~lLN~~~~~~p~l~~lr~~~~~~~~  955 (974)
T KOG1166|consen  928 FFDLLLNPDCDTLPNLQELRTELEEVLA  955 (974)
T ss_pred             HHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence            5555777777777777777776666533

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.60  E-value=4.8e-16  Score=175.64  Aligned_cols=228  Identities=17%  Similarity=0.154  Sum_probs=168.6

Q ss_pred             CCCccccccccCCcceeecc---eEEEEEEEEecc-CCcchhHHHHHHH--hhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          513 RFSENNLIGRGGFGPVYKDG---MEVAIKVFNLQY-GGAFKSFDIECGM--MKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~~---~~vAvK~~~~~~-~~~~~~~~~E~~~--l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      +|...+.+|++.|=+|.|+.   ..|+||++-++. .-..+.|.++++-  ....+|||++.+.-+-......|+|=+|.
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyv  103 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYV  103 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHH
Confidence            67778999999999999863   459999987765 3344555544433  44458999999988877777788999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCc-cCccc
Q 040702          587 PLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE-EDQSL  665 (797)
Q Consensus       587 ~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~-~~~~~  665 (797)
                      .+ +|++.+..++. +...+.+-|+.|++.|+.-+|   ..||+|+|||.+|||++.-..+.|+||.--|+..- ++...
T Consensus       104 kh-nLyDRlSTRPF-L~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa  178 (1431)
T KOG1240|consen  104 KH-NLYDRLSTRPF-LVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA  178 (1431)
T ss_pred             hh-hhhhhhccchH-HHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence            66 99999988875 666777889999999999999   99999999999999999999999999997775421 11111


Q ss_pred             cccccc----cCcccccccccccC----------c-cchHHHHHHHhhhhhhhhccccccchh-------------hhh-
Q 040702          666 TQTQTL----ATIGYMAPDEIFSG----------E-MRLKCWVNDSLLISVMIVVDANLLIRE-------------EKH-  716 (797)
Q Consensus       666 ~~~~~~----gt~~y~aPE~~~~~----------~-~~~~~dv~s~~~~~~~~~~~~~~~~~~-------------~~~-  716 (797)
                      ...-+.    .-..|.|||.+...          . .+.+.|+++.|+...+.+.+..+.-..             +.. 
T Consensus       179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~  258 (1431)
T KOG1240|consen  179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQL  258 (1431)
T ss_pred             cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHH
Confidence            111111    22369999977542          2 578899999999875555553321111             111 


Q ss_pred             ----hhcccccchhccccCCCCCCCChHHHHHh
Q 040702          717 ----LMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       717 ----~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                          .-..++.++..|++.||++|-++.+.++.
T Consensus       259 Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  259 LEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence                11256678888999999999999998874

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.60  E-value=4.2e-15  Score=140.61  Aligned_cols=132  Identities=21%  Similarity=0.264  Sum_probs=111.0

Q ss_pred             ccccccccCCcceeecc---eEEEEEEEEeccCCcchhHHHHHHHhhhccC--CceeEeeeeeecCCeEEEEEEccCCCC
Q 040702          516 ENNLIGRGGFGPVYKDG---MEVAIKVFNLQYGGAFKSFDIECGMMKRIRH--RNLIKIISSCSNDDFKALVLEYMPLGS  590 (797)
Q Consensus       516 ~~~~lg~G~~g~Vyk~~---~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H--pniv~l~~~~~~~~~~~lv~e~~~~g~  590 (797)
                      ..+.+|+|.++.||+..   ..+++|.......  ...+..|+.+++.++|  +.++++++++...+..+++|||++++.
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~   79 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET   79 (155)
T ss_pred             cceecccccccceEEEEecCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence            35789999999999854   5899998865433  4678999999999986  599999999888888999999999877


Q ss_pred             HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCcc
Q 040702          591 LEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  657 (797)
Q Consensus       591 L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  657 (797)
                      +..+        +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.++.
T Consensus        80 ~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          80 LDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             cccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            7543        4456678899999999999944335899999999999999989999999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.59  E-value=1e-15  Score=173.05  Aligned_cols=224  Identities=21%  Similarity=0.279  Sum_probs=150.8

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      ...+|..++.+..|+||.||..     .+.+|+|+ .++     ..+.+-  ++.....|.+|                 
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq-----~lilRn--ilt~a~npfvv-----------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQ-----NLILRN--ILTFAGNPFVV-----------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhcc-ccc-----chhhhc--cccccCCccee-----------------
Confidence            4578999999999999999953     46677743 211     111111  23333344443                 


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCcc---
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE---  661 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~---  661 (797)
                          |+-...++.-+. ++...        +.|++|+|   +.+|+|||+||+|.+|+.-|++|+.|||+++...-.   
T Consensus       136 ----gDc~tllk~~g~-lPvdm--------vla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at  199 (1205)
T KOG0606|consen  136 ----GDCATLLKNIGP-LPVDM--------VLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT  199 (1205)
T ss_pred             ----chhhhhcccCCC-Ccchh--------hHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence                454454544332 33322        77999999   999999999999999999999999999998753110   


Q ss_pred             ----------CccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh-hhhhhcccccchhcccc
Q 040702          662 ----------DQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE-EKHLMTKEQPMVRMGTD  730 (797)
Q Consensus       662 ----------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~cl~  730 (797)
                                .......+.+||+.|+|||++...+|.-.+|+|++|++.++..+...++.+. +.+...   .++..-..
T Consensus       200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg---~visd~i~  276 (1205)
T KOG0606|consen  200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG---QVISDDIE  276 (1205)
T ss_pred             hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh---hhhhhhcc
Confidence                      0111235668999999999999999999999999999987666665554443 333322   23333222


Q ss_pred             CCCCCCCChHHHHHhHHHHHHH-hccccccccccCCcccccceeeeeeee
Q 040702          731 LSLGQFPASYSISKYLVYIREL-ERGKVGITSVAAFPIVHHYLYRTVDYT  779 (797)
Q Consensus       731 ~dp~~RPs~~~i~~~l~~i~~~-~~~~~~~~~~~~~~~~~~~~f~~~~~~  779 (797)
                      ..-++-|...|....++++.+. +..+.+..  .+.....|.||+++||.
T Consensus       277 wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~--ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  277 WPEEDEALPPEAQDLIEQLLRQNPLCRLGTG--GALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             ccccCcCCCHHHHHHHHHHHHhChHhhcccc--hhhhhhhccceeecccc
Confidence            3333445556666666665444 44444433  88899999999999998

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.56  E-value=3.3e-15  Score=161.78  Aligned_cols=192  Identities=25%  Similarity=0.291  Sum_probs=146.4

Q ss_pred             hhhccCCceeEeeeeeecCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCe-EEcCCCC
Q 040702          558 MKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPI-IHCDLKP  636 (797)
Q Consensus       558 l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~i-vHrDlkp  636 (797)
                      |+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+......+++.....+.++|++|++|+|   ..+| .|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLH---NSPIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHh---cCcceeeeeecc
Confidence            45788999999999999999999999999999999999987767999999999999999999999   4444 9999999


Q ss_pred             CceEEcCCCcEEEEeecCCccCCccCccccccccccCcccccccccccC-------ccchHHHHHHHhhhhhhhhccccc
Q 040702          637 SNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG-------EMRLKCWVNDSLLISVMIVVDANL  709 (797)
Q Consensus       637 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~dv~s~~~~~~~~~~~~~~  709 (797)
                      .|.++|....+|++|||+.................-..-|.|||.+...       ..+.+.|+|++|++.++.+....+
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            9999999999999999998865321111111222234569999987653       146779999999876443332221


Q ss_pred             cch--------------------------hhh-hhhcccccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          710 LIR--------------------------EEK-HLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       710 ~~~--------------------------~~~-~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                      ++.                          ... +....+..+++.||..+|.+||++.++...++.+...
T Consensus       158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            111                          000 1222466778889999999999999998877666443

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.55  E-value=3e-14  Score=144.76  Aligned_cols=132  Identities=17%  Similarity=0.187  Sum_probs=100.3

Q ss_pred             cccc-ccCCcceee---cceEEEEEEEEecc------C-------CcchhHHHHHHHhhhccCCce--eEeeeeeecCC-
Q 040702          518 NLIG-RGGFGPVYK---DGMEVAIKVFNLQY------G-------GAFKSFDIECGMMKRIRHRNL--IKIISSCSNDD-  577 (797)
Q Consensus       518 ~~lg-~G~~g~Vyk---~~~~vAvK~~~~~~------~-------~~~~~~~~E~~~l~~l~Hpni--v~l~~~~~~~~-  577 (797)
                      ..+| .||.|.||+   ++..+|||++....      .       .....+.+|++++.+++|++|  ++.+++...+. 
T Consensus        37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~  116 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG  116 (239)
T ss_pred             ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence            3455 566666654   67889999886421      0       123467889999999998875  67777654332 


Q ss_pred             ---eEEEEEEccCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeec
Q 040702          578 ---FKALVLEYMPL-GSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFG  653 (797)
Q Consensus       578 ---~~~lv~e~~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG  653 (797)
                         ..++||||++| .+|.+++....  ++..    .+.+++.++.+||   ..||+||||||+|||++.++.++|+|||
T Consensus       117 ~~~~~~lV~e~l~G~~~L~~~l~~~~--l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LIDfg  187 (239)
T PRK01723        117 LFYRADILIERIEGARDLVALLQEAP--LSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLIDFD  187 (239)
T ss_pred             cceeeeEEEEecCCCCCHHHHHhcCC--CCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEECC
Confidence               23599999997 69998886542  4433    3678999999999   9999999999999999998899999999


Q ss_pred             CCccC
Q 040702          654 MAKPL  658 (797)
Q Consensus       654 la~~~  658 (797)
                      .+...
T Consensus       188 ~~~~~  192 (239)
T PRK01723        188 RGELR  192 (239)
T ss_pred             CcccC
Confidence            98753

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.55  E-value=1.4e-14  Score=147.02  Aligned_cols=179  Identities=17%  Similarity=0.160  Sum_probs=124.9

Q ss_pred             cCCceeEeeeeeecC---------------------------CeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHH
Q 040702          562 RHRNLIKIISSCSND---------------------------DFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDV  614 (797)
Q Consensus       562 ~Hpniv~l~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi  614 (797)
                      +|||||++.++|.++                           ...|+||...+. +|.+++..+.  .+...+.-++.|+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl  350 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL  350 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence            599999999887441                           247899998865 9999998765  3555677799999


Q ss_pred             HHHHHHHHccCCCCeEEcCCCCCceEEc--CCC--cEEEEeecCCccCCccC---ccc-cccccccCcccccccccccC-
Q 040702          615 ASALEYLHFGYSVPIIHCDLKPSNVLLD--DNM--VAHLSDFGMAKPLLEED---QSL-TQTQTLATIGYMAPDEIFSG-  685 (797)
Q Consensus       615 ~~al~yLH~~~~~~ivHrDlkp~NIll~--~~~--~~kl~DFGla~~~~~~~---~~~-~~~~~~gt~~y~aPE~~~~~-  685 (797)
                      ++|+.|||   .+||.|||+|++|||+.  +++  ...|+|||++-.....+   .+. .....-|...-||||....- 
T Consensus       351 LEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  351 LEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            99999999   99999999999999993  443  57899999885321100   000 11223467789999976432 


Q ss_pred             -c----cchHHHHHHHhhhhhhhhccccccch----------hhh--------hhhcccccchhccccCCCCCCCChHHH
Q 040702          686 -E----MRLKCWVNDSLLISVMIVVDANLLIR----------EEK--------HLMTKEQPMVRMGTDLSLGQFPASYSI  742 (797)
Q Consensus       686 -~----~~~~~dv~s~~~~~~~~~~~~~~~~~----------~~~--------~~~~~~~~l~~~cl~~dp~~RPs~~~i  742 (797)
                       +    --.+.|.|+.|...++.+....++-.          |..        ......++++...++.||++||++.-.
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iA  507 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIA  507 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHH
Confidence             2    23688999999887554433222111          111        223356677888999999999997655


Q ss_pred             HHhH
Q 040702          743 SKYL  746 (797)
Q Consensus       743 ~~~l  746 (797)
                      +..+
T Consensus       508 ANvl  511 (598)
T KOG4158|consen  508 ANVL  511 (598)
T ss_pred             HhHH
Confidence            5544

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.54  E-value=2.9e-14  Score=140.35  Aligned_cols=131  Identities=22%  Similarity=0.239  Sum_probs=93.4

Q ss_pred             cccccccCCcceeec----ceEEEEEEEEeccCCc--chh----------------------HHHHHHHhhhccCCc--e
Q 040702          517 NNLIGRGGFGPVYKD----GMEVAIKVFNLQYGGA--FKS----------------------FDIECGMMKRIRHRN--L  566 (797)
Q Consensus       517 ~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~Hpn--i  566 (797)
                      .+.||+|+||.||++    ++.||||+++......  ...                      ...|.+.+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            467999999999984    6889999987542211  111                      134566666665432  4


Q ss_pred             eEeeeeeecCCeEEEEEEccCCCCHHH-HHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCceEEcCC
Q 040702          567 IKIISSCSNDDFKALVLEYMPLGSLEK-CLYSGNYILDIFQGLNIMIDVASALEYLHFGYS-VPIIHCDLKPSNVLLDDN  644 (797)
Q Consensus       567 v~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~-~~ivHrDlkp~NIll~~~  644 (797)
                      .+.+++    ...++||||++++.+.. .+....  .. ..+..++.+++.++.++|   . .+|+|||+||+||+++ +
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~  150 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-D  150 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-C
Confidence            444443    23589999999854321 111111  11 567789999999999999   7 9999999999999999 8


Q ss_pred             CcEEEEeecCCccC
Q 040702          645 MVAHLSDFGMAKPL  658 (797)
Q Consensus       645 ~~~kl~DFGla~~~  658 (797)
                      +.++++|||.+...
T Consensus       151 ~~~~liDfg~a~~~  164 (187)
T cd05119         151 GKVYIIDVPQAVEI  164 (187)
T ss_pred             CcEEEEECcccccc
Confidence            89999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.52  E-value=2.4e-15  Score=159.44  Aligned_cols=157  Identities=22%  Similarity=0.294  Sum_probs=121.8

Q ss_pred             eEEEEEEccCCCCHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCC
Q 040702          578 FKALVLEYMPLGSLEKCLYSGNY--ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMA  655 (797)
Q Consensus       578 ~~~lv~e~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla  655 (797)
                      ..||.|++|...+|.+++..++.  ..++.....++.|++.|++|      ++.+|||+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence            57899999999999999975443  56778889999999999999      57899999999999999999999999998


Q ss_pred             ccCCccC----ccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc--ccc--------------ccchhhh
Q 040702          656 KPLLEED----QSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV--DAN--------------LLIREEK  715 (797)
Q Consensus       656 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~--~~~--------------~~~~~~~  715 (797)
                      .......    .....+..+||.+||+||++.+..|+.++|+|++|.+.++...  ...              +....- 
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~~d~r~g~ip~~~~-  482 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATLTDIRDGIIPPEFL-  482 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhhhhhhcCCCChHHh-
Confidence            7665443    1224466789999999999999999999999999987633322  111              111111 


Q ss_pred             hhhcccccchhccccCCCCCCCChHH
Q 040702          716 HLMTKEQPMVRMGTDLSLGQFPASYS  741 (797)
Q Consensus       716 ~~~~~~~~l~~~cl~~dp~~RPs~~~  741 (797)
                      ...+....+++..+.+.|.+||++.+
T Consensus       483 ~d~p~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  483 QDYPEEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             hcCcHHHHHHHHhcCCCcccCchHHH
Confidence            11123447888999999999995443

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.51  E-value=2.7e-15  Score=158.80  Aligned_cols=215  Identities=33%  Similarity=0.427  Sum_probs=166.1

Q ss_pred             eeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhh
Q 040702          154 WLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQ  233 (797)
Q Consensus       154 ~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~  233 (797)
                      .|.|++=++...|..-.   . ..+..-...||+.|++. .+|..+..+. .|+.+.|..|.+. .+|..++++..|  .
T Consensus        54 ~l~Ls~rrlk~fpr~a~---~-~~ltdt~~aDlsrNR~~-elp~~~~~f~-~Le~liLy~n~~r-~ip~~i~~L~~l--t  124 (722)
T KOG0532|consen   54 RLLLSGRRLKEFPRGAA---S-YDLTDTVFADLSRNRFS-ELPEEACAFV-SLESLILYHNCIR-TIPEAICNLEAL--T  124 (722)
T ss_pred             ccccccchhhcCCCccc---c-ccccchhhhhccccccc-cCchHHHHHH-HHHHHHHHhccce-ecchhhhhhhHH--H
Confidence            34555555555544311   1 33444556777778777 4455555555 6777888888887 788888999888  9


Q ss_pred             hcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEccCCcC
Q 040702          234 LLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFF  313 (797)
Q Consensus       234 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l  313 (797)
                      +|||+.|++. ..|..+|.++ |+.|-+++|+++ ..|..++.+..|..||.+.|.+.++|+.+.++.+|+.|++..|++
T Consensus       125 ~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l  201 (722)
T KOG0532|consen  125 FLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHL  201 (722)
T ss_pred             Hhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhh
Confidence            9999999998 6788888887 999999999998 467778888999999999999999999999999999999999999


Q ss_pred             CCCCCccccccccccEEeccCcccccccCccccCCcccceecccCccccCCCChhhhcc---ccCCeeeecCCc
Q 040702          314 TGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDL---ISLKSLNLSNNN  384 (797)
Q Consensus       314 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l---~~L~~L~Ls~N~  384 (797)
                      . .+|..++.|+ |.+||+|.|+++ .+|-.|..++.|++|-|.+|+++ ..|..++..   .-.++|+..-++
T Consensus       202 ~-~lp~El~~Lp-Li~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q  271 (722)
T KOG0532|consen  202 E-DLPEELCSLP-LIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ  271 (722)
T ss_pred             h-hCCHHHhCCc-eeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence            8 4566677654 889999999998 67889999999999999999998 667666443   334566665553

>PLN03150 hypothetical protein; Provisional

Probab=99.50  E-value=4.6e-14  Score=163.16  Aligned_cols=139  Identities=33%  Similarity=0.556  Sum_probs=112.4

Q ss_pred             cccEEeccCcccccccCccccCCcccceecccCccccCCCChhhhccccCCeeeecCCcCCCCCChhhhccCCCCeEEcc
Q 040702          326 VLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVS  405 (797)
Q Consensus       326 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~  405 (797)
                      .++.|+|++|.+++.+|..+..+++|+.|+|++|++.+.+|..++.+++|+.|+|++|++++.+|..+.++++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            37889999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCcCcccCCCCC--CCCCCCcccccCCccccCCCCcccccccccccccccCCcceEEEeccchhhHHH
Q 040702          406 FNRLEGEIPREG--PFRNLSAESFKGNELLCGMPNLQVLSCRTKIHHTLGKNDLLIGIVLPLSTIFMM  471 (797)
Q Consensus       406 ~N~l~~~~p~~~--~~~~l~~~~~~~n~~~c~~~~~~~~~~~~~~~~~~~~~~~~i~i~~~~~~~~~~  471 (797)
                      +|+++|.+|..-  ....+..+++.+|+.+|+.|..  ..|....     ....++++++++++++++
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l--~~C~~~~-----~~~~~i~~~~~~~~~~l~  559 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGL--RACGPHL-----SVGAKIGIAFGVSVAFLF  559 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCCCC--CCCcccC-----CCceEEEEEhHHHHHHHH
Confidence            999999998742  2234567789999999998753  3564221     123455555555544333

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=99.48  E-value=3e-15  Score=158.48  Aligned_cols=201  Identities=31%  Similarity=0.471  Sum_probs=160.7

Q ss_pred             EEEccCCcCcccCCCccc-cCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccC
Q 040702           81 SLYLHSNSLSGRLPSSAD-VRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLND  159 (797)
Q Consensus        81 ~L~Ls~N~l~~~l~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~  159 (797)
                      .|.|++-+++ .+|...+ ..+..-...||+.|++. .+|..+..+..|+.|.|.+|.|. .+|.++++|..|++|||+.
T Consensus        54 ~l~Ls~rrlk-~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~  130 (722)
T KOG0532|consen   54 RLLLSGRRLK-EFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSS  130 (722)
T ss_pred             ccccccchhh-cCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhcc
Confidence            4566666676 6666554 34666778899999987 78888888888999999999998 6788899999999999999


Q ss_pred             ccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhccccc
Q 040702          160 NYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEG  239 (797)
Q Consensus       160 N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~  239 (797)
                      |+++.+|..++      .|+ |+.|-+++|+++ .+|..++.++ .|..|+.+.|+|. .+|..++++.+|  +.|.+..
T Consensus       131 NqlS~lp~~lC------~lp-Lkvli~sNNkl~-~lp~~ig~~~-tl~~ld~s~nei~-slpsql~~l~sl--r~l~vrR  198 (722)
T KOG0532|consen  131 NQLSHLPDGLC------DLP-LKVLIVSNNKLT-SLPEEIGLLP-TLAHLDVSKNEIQ-SLPSQLGYLTSL--RDLNVRR  198 (722)
T ss_pred             chhhcCChhhh------cCc-ceeEEEecCccc-cCCcccccch-hHHHhhhhhhhhh-hchHHhhhHHHH--HHHHHhh
Confidence            99999988743      333 888999999998 4566677544 7888888888887 678888888888  8999999


Q ss_pred             ccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCC
Q 040702          240 NQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWN  299 (797)
Q Consensus       240 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~  299 (797)
                      |++. ..|..++.|+ |..||+|.|+++ .+|-.|.+|+.|++|-|.+|.+.+-|..++.
T Consensus       199 n~l~-~lp~El~~Lp-Li~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSPPAqIC~  255 (722)
T KOG0532|consen  199 NHLE-DLPEELCSLP-LIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSPPAQICE  255 (722)
T ss_pred             hhhh-hCCHHHhCCc-eeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCChHHHHh
Confidence            9998 4566677554 888999999998 5688899999999999999998887776653

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.48  E-value=7.9e-14  Score=142.19  Aligned_cols=214  Identities=18%  Similarity=0.209  Sum_probs=127.6

Q ss_pred             CCCccccccccCCcceee-----cceEEEEEEEEeccCC---cchhHHHHHHHhhhcc----------CCceeEeeeeee
Q 040702          513 RFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGG---AFKSFDIECGMMKRIR----------HRNLIKIISSCS  574 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk-----~~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~----------Hpniv~l~~~~~  574 (797)
                      .+..++.||.|+++.||.     +++++|||++......   ..+++.+|.-....+.          |-.++.-++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            445678999999999997     3699999998766432   2455666554333321          222222222221


Q ss_pred             ---------cC---C-----eEEEEEEccCCCCHHHHHhc---CCC---CCCHHHHHHHHHHHHHHHHHHHccCCCCeEE
Q 040702          575 ---------ND---D-----FKALVLEYMPLGSLEKCLYS---GNY---ILDIFQGLNIMIDVASALEYLHFGYSVPIIH  631 (797)
Q Consensus       575 ---------~~---~-----~~~lv~e~~~~g~L~~~l~~---~~~---~l~~~~~~~i~~qi~~al~yLH~~~~~~ivH  631 (797)
                               ..   .     ..+++|+-+. ++|.+++..   ...   .+....+..+..|+++.++++|   +.|++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEe
Confidence                     11   1     1357888874 588887542   211   2334445667799999999999   999999


Q ss_pred             cCCCCCceEEcCCCcEEEEeecCCccCCccCccccccccccCccccccccccc--------CccchHHHHHHHhhhhhhh
Q 040702          632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS--------GEMRLKCWVNDSLLISVMI  703 (797)
Q Consensus       632 rDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~dv~s~~~~~~~~  703 (797)
                      +||||+|++++.+|.++|+||+.....++..   .  ....+..|.|||....        -.++.+.|+|++|+..+..
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~---~--~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l  243 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRY---R--CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL  243 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEEE---E--GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCcee---e--ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence            9999999999999999999999776543211   1  1335577999996533        2478999999999876443


Q ss_pred             hcccccc-------------chhhhhhhcccccchhccccCCCCCC
Q 040702          704 VVDANLL-------------IREEKHLMTKEQPMVRMGTDLSLGQF  736 (797)
Q Consensus       704 ~~~~~~~-------------~~~~~~~~~~~~~l~~~cl~~dp~~R  736 (797)
                      +-..-++             ..+. +..+.++.+++..++.+|.+|
T Consensus       244 WC~~lPf~~~~~~~~~~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  244 WCGRLPFGLSSPEADPEWDFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHSS-STCCCGGGSTSGGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHccCCCCCCCccccccccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            3322222             2222 444556666777777777665

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.42  E-value=4.9e-13  Score=148.02  Aligned_cols=197  Identities=33%  Similarity=0.446  Sum_probs=94.0

Q ss_pred             EEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCC-CCCeeeccCccCcCCCCCccccccCCCCCCCcEE
Q 040702          106 ELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLR-NLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYF  184 (797)
Q Consensus       106 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~-~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L  184 (797)
                      .|+++.|.+. .....+..++.++.|++.+|.++.+. .....++ +|+.|++++|.+..++..      ...+++|+.|
T Consensus        97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~~i~-~~~~~~~~nL~~L~l~~N~i~~l~~~------~~~l~~L~~L  168 (394)
T COG4886          97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNITDIP-PLIGLLKSNLKELDLSDNKIESLPSP------LRNLPNLKNL  168 (394)
T ss_pred             eeeccccccc-cCchhhhcccceeEEecCCcccccCc-cccccchhhcccccccccchhhhhhh------hhcccccccc
Confidence            4555555543 12223334455555555555555332 2333332 555555555555555321      4455555555


Q ss_pred             EccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccCC
Q 040702          185 SFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGN  264 (797)
Q Consensus       185 ~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  264 (797)
                      ++++|++..+.+ ..+..+ .|+.|++++|++. .+|........|  ++|++++|.+. ..+..+..+.++..+.+.+|
T Consensus       169 ~l~~N~l~~l~~-~~~~~~-~L~~L~ls~N~i~-~l~~~~~~~~~L--~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n  242 (394)
T COG4886         169 DLSFNDLSDLPK-LLSNLS-NLNNLDLSGNKIS-DLPPEIELLSAL--EELDLSNNSII-ELLSSLSNLKNLSGLELSNN  242 (394)
T ss_pred             ccCCchhhhhhh-hhhhhh-hhhheeccCCccc-cCchhhhhhhhh--hhhhhcCCcce-ecchhhhhcccccccccCCc
Confidence            555555553322 111222 4444444444444 223222222223  55555555422 23344555555555555555


Q ss_pred             cCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEccCCcCCCCCC
Q 040702          265 KLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLP  318 (797)
Q Consensus       265 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~  318 (797)
                      ++... +..++.++++++|++++|.++.++. +..+.+++.|++++|.+....+
T Consensus       243 ~~~~~-~~~~~~l~~l~~L~~s~n~i~~i~~-~~~~~~l~~L~~s~n~~~~~~~  294 (394)
T COG4886         243 KLEDL-PESIGNLSNLETLDLSNNQISSISS-LGSLTNLRELDLSGNSLSNALP  294 (394)
T ss_pred             eeeec-cchhccccccceecccccccccccc-ccccCccCEEeccCccccccch
Confidence            55432 3445555555555555555555554 4455555555555555554443

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.40  E-value=1.5e-13  Score=130.39  Aligned_cols=124  Identities=29%  Similarity=0.370  Sum_probs=29.2

Q ss_pred             CCCCCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCcccc-CCCCCCEEEcccCcccccCCccccCCCCC
Q 040702            1 MPSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEID-NLHNMEWMAFSFNKVVGVVPTTIFNVSTL   79 (797)
Q Consensus         1 ~~~l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~-~l~~L~~L~ls~N~i~~~~p~~~~~l~~L   79 (797)
                      |+.|+.+.|+....  +.++..+++|+|++|+++         .| +.++ .+.+|+.||||+|+|+.+.  .+..+++|
T Consensus         1 ~~~lt~~~i~~~~~--~~n~~~~~~L~L~~n~I~---------~I-e~L~~~l~~L~~L~Ls~N~I~~l~--~l~~L~~L   66 (175)
T PF14580_consen    1 MVRLTANMIEQIAQ--YNNPVKLRELNLRGNQIS---------TI-ENLGATLDKLEVLDLSNNQITKLE--GLPGLPRL   66 (175)
T ss_dssp             -----------------------------------------------S--TT-TT--EEE-TTS--S--T--T----TT-
T ss_pred             Cccccccccccccc--cccccccccccccccccc---------cc-cchhhhhcCCCEEECCCCCCcccc--CccChhhh
Confidence            55677777765443  677777788888888743         22 2343 4566777777777776542  35566666


Q ss_pred             CEEEccCCcCcccCCCccccCCCCccEEEccCccccccCC-chhhCCCCCCEEEccCCcCc
Q 040702           80 KSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIP-SFIFNASKLSELGLQKNSFS  139 (797)
Q Consensus        80 ~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~  139 (797)
                      ++|++++|+|+ .++......+++|++|+|++|+|..... ..+..+++|++|+|.+|.+.
T Consensus        67 ~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~  126 (175)
T PF14580_consen   67 KTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC  126 (175)
T ss_dssp             -EEE--SS----S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred             hhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence            66666666666 5543333345666666666666653211 23444555555555555554

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=99.40  E-value=7.5e-13  Score=146.52  Aligned_cols=200  Identities=31%  Similarity=0.456  Sum_probs=123.2

Q ss_pred             CEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCC-CCCcEEEccCCCCCCCCChhhhccccCCc
Q 040702          129 SELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNC-KYLEYFSFSNNPLGGILPRAIGNLSQSME  207 (797)
Q Consensus       129 ~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~  207 (797)
                      ..|.++.|.+. ........++.++.|++.+|.++.+++.      ...+ .+|+.|++++|++..+ |..+..++ +|+
T Consensus        96 ~~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~~i~~~------~~~~~~nL~~L~l~~N~i~~l-~~~~~~l~-~L~  166 (394)
T COG4886          96 PSLDLNLNRLR-SNISELLELTNLTSLDLDNNNITDIPPL------IGLLKSNLKELDLSDNKIESL-PSPLRNLP-NLK  166 (394)
T ss_pred             ceeeccccccc-cCchhhhcccceeEEecCCcccccCccc------cccchhhcccccccccchhhh-hhhhhccc-ccc
Confidence            46888888885 2344566668899999999999998875      2333 2788889999988844 34556665 677


Q ss_pred             EEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCC
Q 040702          208 DFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGS  287 (797)
Q Consensus       208 ~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  287 (797)
                      .|++++|++. .+|...+.+++|  +.|++++|+++ .+|........|++|++++|.+. ..+..+..+.++..+.+++
T Consensus       167 ~L~l~~N~l~-~l~~~~~~~~~L--~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~  241 (394)
T COG4886         167 NLDLSFNDLS-DLPKLLSNLSNL--NNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSN  241 (394)
T ss_pred             ccccCCchhh-hhhhhhhhhhhh--hheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCC
Confidence            7777777776 344443345555  66666666666 33333334444666666666432 2344455566666666666


Q ss_pred             CCCCCCCCCCCCCCcccEEEccCCcCCCCCCccccccccccEEeccCcccccccCcc
Q 040702          288 NLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTK  344 (797)
Q Consensus       288 N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~  344 (797)
                      |++..++..+..+++++.|++++|.++....  ++.+.+++.|++++|.+....|..
T Consensus       242 n~~~~~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~  296 (394)
T COG4886         242 NKLEDLPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLI  296 (394)
T ss_pred             ceeeeccchhccccccceecccccccccccc--ccccCccCEEeccCccccccchhh
Confidence            6665555555555556666666666653322  555555666666666555444433

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.36  E-value=1.8e-12  Score=143.31  Aligned_cols=136  Identities=17%  Similarity=0.182  Sum_probs=97.1

Q ss_pred             cccccccCCcceeec----ceEEEEEEEEeccCCc----------------------------------------chhHH
Q 040702          517 NNLIGRGGFGPVYKD----GMEVAIKVFNLQYGGA----------------------------------------FKSFD  552 (797)
Q Consensus       517 ~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~~----------------------------------------~~~~~  552 (797)
                      .+.||.|++|.||+|    |+.||||+.++.....                                        .-+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            378999999999985    7899999986542100                                        01355


Q ss_pred             HHHHHhhhcc-----CCceeEeeee-eecCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHH-HHHHHHccC
Q 040702          553 IECGMMKRIR-----HRNLIKIISS-CSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVAS-ALEYLHFGY  625 (797)
Q Consensus       553 ~E~~~l~~l~-----Hpniv~l~~~-~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~-al~yLH~~~  625 (797)
                      +|++.+.+++     +++| .+-.+ +...+..++||||++|+++.+.........   ...+++.+++. .+..+|   
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~---  274 (437)
T TIGR01982       202 REAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVL---  274 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHH---
Confidence            5666666663     3443 32222 223445799999999999988765322112   23456666666 467888   


Q ss_pred             CCCeEEcCCCCCceEEcCCCcEEEEeecCCccCC
Q 040702          626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  659 (797)
Q Consensus       626 ~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  659 (797)
                      ..|++|+|+||.||+++.++.++++|||+++.+.
T Consensus       275 ~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       275 RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             hCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            8999999999999999999999999999998764

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.32  E-value=1.8e-13  Score=155.90  Aligned_cols=232  Identities=18%  Similarity=0.183  Sum_probs=169.6

Q ss_pred             hcCCCccccccccCCcceeec------ceEEEEEEEEecc--CCcchhHHHHHHHhhhcc-CCceeEeeeeeecCCeEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD------GMEVAIKVFNLQY--GGAFKSFDIECGMMKRIR-HRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~------~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~l  581 (797)
                      ...|...+.||+|+|+.|-..      ...+|+|.+....  .........|..+-+.+. |+|++++++.....+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            346777788999999999742      2556667665442  222334445777777776 9999999999999999999


Q ss_pred             EEEccCCCCHHHHH-hcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCC-cEEEEeecCCccCC
Q 040702          582 VLEYMPLGSLEKCL-YSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM-VAHLSDFGMAKPLL  659 (797)
Q Consensus       582 v~e~~~~g~L~~~l-~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DFGla~~~~  659 (797)
                      ++||..+|++.+.+ .......+...+..+..|+..|+.|+|.  ..++.|||+||+|.+++..+ ..+++|||+|..+.
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            99999999998888 4433245666788899999999999995  56899999999999999999 99999999998776


Q ss_pred             c-cCcccccccccc-CcccccccccccC-ccchHHHHHHHhhhhhhhhccccccch---------------------hhh
Q 040702          660 E-EDQSLTQTQTLA-TIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANLLIR---------------------EEK  715 (797)
Q Consensus       660 ~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~~~~---------------------~~~  715 (797)
                      . .+........+| ++.|+|||...+. ......|+|+.|+..............                     .-.
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWN  256 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccc
Confidence            5 444445566788 9999999988874 446788999999876443332221110                     000


Q ss_pred             hhhcccccchhccccCCCCCCCChHHHHH
Q 040702          716 HLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       716 ~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      ........+...++..+|+.|.+.+++..
T Consensus       257 ~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  257 SISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             cCChhhhhcccccccCCchhccccccccc
Confidence            11223445555566677777777665543

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.28  E-value=6.8e-13  Score=147.01  Aligned_cols=196  Identities=30%  Similarity=0.388  Sum_probs=84.2

Q ss_pred             CCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCee
Q 040702           76 VSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWL  155 (797)
Q Consensus        76 l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L  155 (797)
                      +..++.+++..|.|. .+.... ..+.+|+.|++.+|+|..+ ...+..+++|++|+|++|+|+.+.+  +..++.|+.|
T Consensus        71 l~~l~~l~l~~n~i~-~~~~~l-~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L  145 (414)
T KOG0531|consen   71 LTSLKELNLRQNLIA-KILNHL-SKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKEL  145 (414)
T ss_pred             hHhHHhhccchhhhh-hhhccc-ccccceeeeeccccchhhc-ccchhhhhcchheeccccccccccc--hhhccchhhh
Confidence            344444445555554 211111 2344555555555555422 1123444555555555555544322  3344445555


Q ss_pred             eccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhc
Q 040702          156 GLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLL  235 (797)
Q Consensus       156 ~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L  235 (797)
                      ++++|.|+.+..       +..++.|+.+++++|++..+.+.                        . ...+.++  +.+
T Consensus       146 ~l~~N~i~~~~~-------~~~l~~L~~l~l~~n~i~~ie~~------------------------~-~~~~~~l--~~l  191 (414)
T KOG0531|consen  146 NLSGNLISDISG-------LESLKSLKLLDLSYNRIVDIEND------------------------E-LSELISL--EEL  191 (414)
T ss_pred             eeccCcchhccC-------CccchhhhcccCCcchhhhhhhh------------------------h-hhhccch--HHH
Confidence            555555544432       33344444445555444433221                        1 1222222  444


Q ss_pred             ccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCc--cccccccCCCCCCCCCCCCCCCCcccEEEccCCcC
Q 040702          236 SLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLT--NLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFF  313 (797)
Q Consensus       236 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~--~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l  313 (797)
                      ++.+|.+..+  ..+..+..+..+++..|.++.+.+  +..+.  .|+.+++++|.+..++..+..+..+..|++.+|++
T Consensus       192 ~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~~~~~~~~~~~~l~~l~~~~n~~  267 (414)
T KOG0531|consen  192 DLGGNSIREI--EGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRISRSPEGLENLKNLPVLDLSSNRI  267 (414)
T ss_pred             hccCCchhcc--cchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccccccccccccccccccchhhccc
Confidence            4444444422  222223333333555555543322  11122  25666666666655544444444555555555554


Q ss_pred             C
Q 040702          314 T  314 (797)
Q Consensus       314 ~  314 (797)
                      .
T Consensus       268 ~  268 (414)
T KOG0531|consen  268 S  268 (414)
T ss_pred             c
Confidence            4

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=99.28  E-value=8.4e-13  Score=146.30  Aligned_cols=220  Identities=26%  Similarity=0.280  Sum_probs=145.8

Q ss_pred             cCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCC
Q 040702           50 DNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLS  129 (797)
Q Consensus        50 ~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  129 (797)
                      ..+..++.+++..|.|.. .-..+..+.+|+.|++..|+|. .+... ...+++|++|+|++|.|+.+.  .+..++.|+
T Consensus        69 ~~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~-~i~~~-l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~  143 (414)
T KOG0531|consen   69 ESLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIE-KIENL-LSSLVNLQVLDLSFNKITKLE--GLSTLTLLK  143 (414)
T ss_pred             HHhHhHHhhccchhhhhh-hhcccccccceeeeeccccchh-hcccc-hhhhhcchheecccccccccc--chhhccchh
Confidence            356778888899999986 2344778899999999999998 55552 246899999999999998653  467788899


Q ss_pred             EEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEE
Q 040702          130 ELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDF  209 (797)
Q Consensus       130 ~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L  209 (797)
                      .|++++|.|+.+  ..|..+++|+.+++++|.++.+...    . ...+.+|+.+.+.+|.+..+..-....   .+   
T Consensus       144 ~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~----~-~~~~~~l~~l~l~~n~i~~i~~~~~~~---~l---  210 (414)
T KOG0531|consen  144 ELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIEND----E-LSELISLEELDLGGNSIREIEGLDLLK---KL---  210 (414)
T ss_pred             hheeccCcchhc--cCCccchhhhcccCCcchhhhhhhh----h-hhhccchHHHhccCCchhcccchHHHH---HH---
Confidence            999999999965  4577799999999999999988752    0 256778888888888887543221111   22   


Q ss_pred             EccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCC--CCcEEEccCCcCcccCCCCccCCccccccccCC
Q 040702          210 WMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLA--ALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGS  287 (797)
Q Consensus       210 ~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~--~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  287 (797)
                                             ..+++..|.+..+.+  +..+.  .|+.+++++|++... +..+..+..+..|++.+
T Consensus       211 -----------------------~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~~~-~~~~~~~~~l~~l~~~~  264 (414)
T KOG0531|consen  211 -----------------------VLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRISRS-PEGLENLKNLPVLDLSS  264 (414)
T ss_pred             -----------------------HHhhcccccceeccC--cccchhHHHHHHhcccCccccc-cccccccccccccchhh
Confidence                                   233444444442211  11111  255555666655532 13455556666666666


Q ss_pred             CCCCCCCCCCCCCCcccEEEccCCcCC
Q 040702          288 NLLTSIPSTLWNLKDILHLNLSSNFFT  314 (797)
Q Consensus       288 N~l~~lp~~~~~l~~L~~L~l~~N~l~  314 (797)
                      |++..+. .+...+.+..+....|.+.
T Consensus       265 n~~~~~~-~~~~~~~~~~~~~~~~~~~  290 (414)
T KOG0531|consen  265 NRISNLE-GLERLPKLSELWLNDNKLA  290 (414)
T ss_pred             ccccccc-cccccchHHHhccCcchhc
Confidence            6665442 2333344444555555443

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.26  E-value=3e-12  Score=121.51  Aligned_cols=110  Identities=27%  Similarity=0.305  Sum_probs=29.1

Q ss_pred             CCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCe
Q 040702           75 NVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKW  154 (797)
Q Consensus        75 ~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~  154 (797)
                      +..+++.|+|++|.|+ .|.. ....+.+|+.|+|++|.|+.+  +.+..+++|++|++++|+|+.+.+.....+++|+.
T Consensus        17 n~~~~~~L~L~~n~I~-~Ie~-L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~   92 (175)
T PF14580_consen   17 NPVKLRELNLRGNQIS-TIEN-LGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQE   92 (175)
T ss_dssp             --------------------S---TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S-CHHHHHH-TT--E
T ss_pred             cccccccccccccccc-cccc-hhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccccchHHhCCcCCE
Confidence            3344555555555555 4432 212345555666666655532  23555566666666666666443322234566666


Q ss_pred             eeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCC
Q 040702          155 LGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLG  192 (797)
Q Consensus       155 L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~  192 (797)
                      |+|++|+|.++..    +..++.+++|+.|+|.+|+++
T Consensus        93 L~L~~N~I~~l~~----l~~L~~l~~L~~L~L~~NPv~  126 (175)
T PF14580_consen   93 LYLSNNKISDLNE----LEPLSSLPKLRVLSLEGNPVC  126 (175)
T ss_dssp             EE-TTS---SCCC----CGGGGG-TT--EEE-TT-GGG
T ss_pred             EECcCCcCCChHH----hHHHHcCCCcceeeccCCccc
Confidence            6666666655432    223455566666666666665

>PLN03150 hypothetical protein; Provisional

Probab=99.25  E-value=1.4e-11  Score=142.68  Aligned_cols=113  Identities=37%  Similarity=0.511  Sum_probs=105.4

Q ss_pred             cccEEEccCCcCCCCCCccccccccccEEeccCcccccccCccccCCcccceecccCccccCCCChhhhccccCCeeeec
Q 040702          302 DILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLS  381 (797)
Q Consensus       302 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls  381 (797)
                      .+..|+|++|.+.+..|..++.+++|+.|+|++|.+++.+|..++.+++|+.|+|++|++++.+|..++.+++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            37889999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCcCCCCCChhhhcc-CCCCeEEccCCcCcccCC
Q 040702          382 NNNLSGTIPISLEKL-LDLKDINVSFNRLEGEIP  414 (797)
Q Consensus       382 ~N~l~~~~p~~~~~l-~~L~~L~l~~N~l~~~~p  414 (797)
                      +|+++|.+|..+..+ .++..+++++|+..|..|
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p  532 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP  532 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCC
Confidence            999999999998764 577899999998776554

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.24  E-value=2.5e-11  Score=117.31  Aligned_cols=125  Identities=20%  Similarity=0.187  Sum_probs=93.8

Q ss_pred             cccccccCCcceee---cceEEEEEEEEeccCCcchhHHHHHHHhhhccCCce-eEeeeeeecCCeEEEEEEccCCCCHH
Q 040702          517 NNLIGRGGFGPVYK---DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNL-IKIISSCSNDDFKALVLEYMPLGSLE  592 (797)
Q Consensus       517 ~~~lg~G~~g~Vyk---~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpni-v~l~~~~~~~~~~~lv~e~~~~g~L~  592 (797)
                      .+.++.|.++.||+   ++..|++|+...... ....+..|+++++.+.+.++ ++++++..  +..++||||++|.++.
T Consensus         3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l~   79 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSELL   79 (170)
T ss_pred             eeecCCcccCceEEEEECCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCccc
Confidence            36789999999997   468899998754432 23457889999999875544 45555433  3458999999998775


Q ss_pred             HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC-----eEEcCCCCCceEEcCCCcEEEEeecCCcc
Q 040702          593 KCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVP-----IIHCDLKPSNVLLDDNMVAHLSDFGMAKP  657 (797)
Q Consensus       593 ~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~-----ivHrDlkp~NIll~~~~~~kl~DFGla~~  657 (797)
                      ..    .  .   ....++.+++++++.||   ..+     ++|+|++|.||+++ ++.++++|||.+..
T Consensus        80 ~~----~--~---~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          80 TE----D--F---SDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cc----c--c---cCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            43    0  1   12346679999999999   655     59999999999999 66899999999874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.21  E-value=4e-12  Score=124.67  Aligned_cols=132  Identities=27%  Similarity=0.363  Sum_probs=81.2

Q ss_pred             CCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEccCCcCCCCCCccccccccccEEec
Q 040702          253 LAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDL  332 (797)
Q Consensus       253 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L  332 (797)
                      +..|+++|||+|.|+. +.....-++.++.|++|+|.|..+.. +..+++|++||||+|.++. ..+.-..+-+.++|.|
T Consensus       283 Wq~LtelDLS~N~I~~-iDESvKL~Pkir~L~lS~N~i~~v~n-La~L~~L~~LDLS~N~Ls~-~~Gwh~KLGNIKtL~L  359 (490)
T KOG1259|consen  283 WQELTELDLSGNLITQ-IDESVKLAPKLRRLILSQNRIRTVQN-LAELPQLQLLDLSGNLLAE-CVGWHLKLGNIKTLKL  359 (490)
T ss_pred             Hhhhhhccccccchhh-hhhhhhhccceeEEeccccceeeehh-hhhcccceEeecccchhHh-hhhhHhhhcCEeeeeh
Confidence            4445555555555553 23344455556666666666655543 5556666666666666652 2233344556677777


Q ss_pred             cCcccccccCccccCCcccceecccCccccCC-CChhhhccccCCeeeecCCcCCCCC
Q 040702          333 SMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGS-IPNSIGDLISLKSLNLSNNNLSGTI  389 (797)
Q Consensus       333 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~  389 (797)
                      ++|.|...  ..++.+.+|..||+++|+|... --..++++|.|+.|.|.+|.+.+..
T Consensus       360 a~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v  415 (490)
T KOG1259|consen  360 AQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV  415 (490)
T ss_pred             hhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence            77776532  3466677788888888877632 1246788888888888888888543

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=99.19  E-value=2.2e-12  Score=126.55  Aligned_cols=131  Identities=21%  Similarity=0.322  Sum_probs=88.7

Q ss_pred             CCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEc
Q 040702           54 NMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGL  133 (797)
Q Consensus        54 ~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  133 (797)
                      .|+.||||+|.|+. +..+..-.++++.|++|+|+|+ .+..-  ..+++|++||||+|.++ .+.+.-..+-+.++|.|
T Consensus       285 ~LtelDLS~N~I~~-iDESvKL~Pkir~L~lS~N~i~-~v~nL--a~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L  359 (490)
T KOG1259|consen  285 ELTELDLSGNLITQ-IDESVKLAPKLRRLILSQNRIR-TVQNL--AELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL  359 (490)
T ss_pred             hhhhccccccchhh-hhhhhhhccceeEEecccccee-eehhh--hhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence            46677777777764 4455566677777777777776 55542  35777777777777776 44445556777777777


Q ss_pred             cCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCC
Q 040702          134 QKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGIL  195 (797)
Q Consensus       134 ~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~  195 (797)
                      +.|.|...  ..+..|-+|..||+++|+|..+..    ....++++.|+.+.|.+|+++++.
T Consensus       360 a~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~lde----V~~IG~LPCLE~l~L~~NPl~~~v  415 (490)
T KOG1259|consen  360 AQNKIETL--SGLRKLYSLVNLDLSSNQIEELDE----VNHIGNLPCLETLRLTGNPLAGSV  415 (490)
T ss_pred             hhhhHhhh--hhhHhhhhheeccccccchhhHHH----hcccccccHHHHHhhcCCCccccc
Confidence            77777643  335666677778888887765433    235777888888888888887553

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.17  E-value=5e-12  Score=130.56  Aligned_cols=165  Identities=25%  Similarity=0.275  Sum_probs=92.5

Q ss_pred             CCCCCCEEEccCCcCcccCC-ccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhcc
Q 040702          124 NASKLSELGLQKNSFSGSIP-NTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNL  202 (797)
Q Consensus       124 ~l~~L~~L~L~~N~l~~~~~-~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l  202 (797)
                      ++.+|++..|.+........ +....+++++.||||+|-+....+-.   .-...+++|+.|+|+.|++...........
T Consensus       119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~---~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~  195 (505)
T KOG3207|consen  119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVL---KIAEQLPSLENLNLSSNRLSNFISSNTTLL  195 (505)
T ss_pred             hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHH---HHHHhcccchhcccccccccCCccccchhh
Confidence            46777888888877763222 35667888888888888776543311   114567788888888888775444333333


Q ss_pred             ccCCcEEEccCCcccccCChh-hhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCC-CCccCCccc
Q 040702          203 SQSMEDFWMDNCNISGSIPEE-INNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVP-ACSGNLTNL  280 (797)
Q Consensus       203 ~~~L~~L~L~~n~i~~~~p~~-~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L  280 (797)
                      ..+++.|.|+.|.++...-.+ +...++|  +.|+|+.|....+......-+..|++|||++|++-...- ...+.++.|
T Consensus       196 l~~lK~L~l~~CGls~k~V~~~~~~fPsl--~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L  273 (505)
T KOG3207|consen  196 LSHLKQLVLNSCGLSWKDVQWILLTFPSL--EVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGL  273 (505)
T ss_pred             hhhhheEEeccCCCCHHHHHHHHHhCCcH--HHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccch
Confidence            336777777777766221111 2223444  556666664322333333445555566666655543221 234455555


Q ss_pred             cccccCCCCCCCC
Q 040702          281 RKLYLGSNLLTSI  293 (797)
Q Consensus       281 ~~L~L~~N~l~~l  293 (797)
                      ..|+++.+.+.++
T Consensus       274 ~~Lnls~tgi~si  286 (505)
T KOG3207|consen  274 NQLNLSSTGIASI  286 (505)
T ss_pred             hhhhccccCcchh
Confidence            5556655555443

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=99.17  E-value=8.4e-12  Score=128.95  Aligned_cols=135  Identities=20%  Similarity=0.243  Sum_probs=85.4

Q ss_pred             CCCCcEEEccCCCCCCCCCh-hhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCc-hhhcCCCC
Q 040702          178 CKYLEYFSFSNNPLGGILPR-AIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIP-DDLCRLAA  255 (797)
Q Consensus       178 l~~L~~L~Ls~N~l~~~~~~-~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~-~~~~~l~~  255 (797)
                      +++|+.|.|+.|.++-..-. ....+| +++.|+|..|.....-......+..|  +.|||++|++....- .....++.
T Consensus       196 l~~lK~L~l~~CGls~k~V~~~~~~fP-sl~~L~L~~N~~~~~~~~~~~i~~~L--~~LdLs~N~li~~~~~~~~~~l~~  272 (505)
T KOG3207|consen  196 LSHLKQLVLNSCGLSWKDVQWILLTFP-SLEVLYLEANEIILIKATSTKILQTL--QELDLSNNNLIDFDQGYKVGTLPG  272 (505)
T ss_pred             hhhhheEEeccCCCCHHHHHHHHHhCC-cHHHhhhhcccccceecchhhhhhHH--hhccccCCcccccccccccccccc
Confidence            34556666666666522211 122333 67777777775333333334445555  889999998874321 34566888


Q ss_pred             CcEEEccCCcCcccC-CCC-----ccCCccccccccCCCCCCCCCC--CCCCCCcccEEEccCCcCCC
Q 040702          256 LFQLDLGGNKLSGFV-PAC-----SGNLTNLRKLYLGSNLLTSIPS--TLWNLKDILHLNLSSNFFTG  315 (797)
Q Consensus       256 L~~L~Ls~N~l~~~~-~~~-----~~~l~~L~~L~L~~N~l~~lp~--~~~~l~~L~~L~l~~N~l~~  315 (797)
                      |..|+++.+.+..+. |++     ...+++|++|+++.|++.++++  .+..+++|+.|.+..|.++.
T Consensus       273 L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~  340 (505)
T KOG3207|consen  273 LNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK  340 (505)
T ss_pred             hhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence            889999999887653 222     3456788888888888877765  45566777777777777763

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.15  E-value=5.5e-11  Score=132.83  Aligned_cols=140  Identities=15%  Similarity=0.153  Sum_probs=91.0

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCCc----------------------------------c----
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGA----------------------------------F----  548 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~----------------------------------~----  548 (797)
                      .+|+. +.+|+|++|.||++     |+.||||+.++.-...                                  .    
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            35666 79999999999973     7899999997552100                                  0    


Q ss_pred             --hhHHHHHHHhhhcc----CCceeEeeeeee-cCCeEEEEEEccCCCCHHHHH--hcCCCCCCHHHHHHHHHHHHHH-H
Q 040702          549 --KSFDIECGMMKRIR----HRNLIKIISSCS-NDDFKALVLEYMPLGSLEKCL--YSGNYILDIFQGLNIMIDVASA-L  618 (797)
Q Consensus       549 --~~~~~E~~~l~~l~----Hpniv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l--~~~~~~l~~~~~~~i~~qi~~a-l  618 (797)
                        -++.+|+..+.+++    +...+.+-.++. .....++||||++|+.+.+.-  ...+  .+..   .++...+.. +
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g--~d~~---~la~~~v~~~~  273 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG--TDMK---LLAERGVEVFF  273 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC--CCHH---HHHHHHHHHHH
Confidence              12445555555553    333333333332 234678999999999997742  2222  2211   222222221 2


Q ss_pred             HHHHccCCCCeEEcCCCCCceEEcCCC----cEEEEeecCCccCCc
Q 040702          619 EYLHFGYSVPIIHCDLKPSNVLLDDNM----VAHLSDFGMAKPLLE  660 (797)
Q Consensus       619 ~yLH~~~~~~ivHrDlkp~NIll~~~~----~~kl~DFGla~~~~~  660 (797)
                      .-+.   ..|++|+|+||.||+++.++    .++++|||++..+..
T Consensus       274 ~Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        274 TQVF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            2234   67999999999999999888    999999999987643

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.13  E-value=6.2e-11  Score=118.21  Aligned_cols=187  Identities=16%  Similarity=0.135  Sum_probs=129.2

Q ss_pred             HhhhccCCceeEeeeeeecC-----CeEEEEEEccCCCCHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHccCCCC
Q 040702          557 MMKRIRHRNLIKIISSCSND-----DFKALVLEYMPLGSLEKCLYSGNY---ILDIFQGLNIMIDVASALEYLHFGYSVP  628 (797)
Q Consensus       557 ~l~~l~Hpniv~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~---~l~~~~~~~i~~qi~~al~yLH~~~~~~  628 (797)
                      -+-++-|.|+|+++.||.+.     .+..+++|||..|++..++++.++   .+....-.+|+.||..||.||| .|+++
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLh-s~~Pp  198 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLH-SCDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhh-ccCCc
Confidence            34556799999999998654     357899999999999999976432   5666677789999999999999 56899


Q ss_pred             eEEcCCCCCceEEcCCCcEEEEeecCCccCCccC--ccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhcc
Q 040702          629 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED--QSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVD  706 (797)
Q Consensus       629 ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~  706 (797)
                      |+|+++.-+-|++..+|-+|+.--.-......-.  .........+-++|-|||.=.....+..+|+|++|.-.+.+.+.
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence            9999999999999999888875321111100000  00011123467789999976666677889999999554333222


Q ss_pred             ccccch----hhhh----------hhcccccchhccccCCCCCCCChHHHHH
Q 040702          707 ANLLIR----EEKH----------LMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       707 ~~~~~~----~~~~----------~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      .--...    ...+          ......+.++.|+...|..||+|++++-
T Consensus       279 Eiq~tnseS~~~~ee~ia~~i~~len~lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  279 EIQSTNSESKVEVEENIANVIIGLENGLQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             eeccCCCcceeehhhhhhhheeeccCccccCcCcccccCCCCCCcchhhhhc
Confidence            111010    0000          1124567888899999999999988754

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.11  E-value=5.6e-10  Score=103.91  Aligned_cols=129  Identities=22%  Similarity=0.319  Sum_probs=98.9

Q ss_pred             ccccccCCcceeec---ceEEEEEEE-EeccCCc-------chhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          518 NLIGRGGFGPVYKD---GMEVAIKVF-NLQYGGA-------FKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~---~~~vAvK~~-~~~~~~~-------~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      ..+++|+=+.+|.+   +.++++|.- ++.....       .....+|++++.+++--.|....=+..+++...|+|||+
T Consensus         2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            46789999999987   667777753 3333221       245678999999987666655555666777788999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccC
Q 040702          587 PLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  658 (797)
Q Consensus       587 ~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  658 (797)
                      +|..|.+.+...        ...++..+-.-+.-||   ..+|+|+|+.++||++.++. +.++|||++...
T Consensus        82 ~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          82 EGELLKDALEEA--------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             CChhHHHHHHhc--------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            998888888665        2346666777778899   99999999999999998764 999999999853

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.08  E-value=9e-10  Score=106.81  Aligned_cols=131  Identities=21%  Similarity=0.229  Sum_probs=94.9

Q ss_pred             ccccccCCcceeec--c---------eEEEEEEEEeccC----------Cc------------chhH----HHHHHHhhh
Q 040702          518 NLIGRGGFGPVYKD--G---------MEVAIKVFNLQYG----------GA------------FKSF----DIECGMMKR  560 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~--~---------~~vAvK~~~~~~~----------~~------------~~~~----~~E~~~l~~  560 (797)
                      ..||.|-=+.||.+  .         ..+|||+.+....          +.            .+.+    .+|.+.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            57899999999974  1         5899998864310          00            1122    379999999


Q ss_pred             ccC--CceeEeeeeeecCCeEEEEEEccCCCCHH-HHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HccCCCCeEEcCCCC
Q 040702          561 IRH--RNLIKIISSCSNDDFKALVLEYMPLGSLE-KCLYSGNYILDIFQGLNIMIDVASALEYL-HFGYSVPIIHCDLKP  636 (797)
Q Consensus       561 l~H--pniv~l~~~~~~~~~~~lv~e~~~~g~L~-~~l~~~~~~l~~~~~~~i~~qi~~al~yL-H~~~~~~ivHrDlkp  636 (797)
                      +..  -++++.+++    ...++||||+.++.+. ..++..  .++..+...+..+++.++.++ |   ..+++|+|+++
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~--~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs~  153 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA--KLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLSE  153 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc--ccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCCH
Confidence            853  466677765    4568999999764332 123222  245556677889999999999 8   88999999999


Q ss_pred             CceEEcCCCcEEEEeecCCccC
Q 040702          637 SNVLLDDNMVAHLSDFGMAKPL  658 (797)
Q Consensus       637 ~NIll~~~~~~kl~DFGla~~~  658 (797)
                      .||+++ ++.+.|+|||.|-..
T Consensus       154 ~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         154 YNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             HHEEEE-CCcEEEEECCCceeC
Confidence            999997 468999999988643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=99.06  E-value=1.1e-11  Score=124.98  Aligned_cols=203  Identities=21%  Similarity=0.260  Sum_probs=93.7

Q ss_pred             CCCCCCCcEEEccCCCCCCCCChhhhcccc---CCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhc
Q 040702          175 LSNCKYLEYFSFSNNPLGGILPRAIGNLSQ---SMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLC  251 (797)
Q Consensus       175 l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~---~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~  251 (797)
                      +..+++|++||||+|.+....++.|..+-.   +|+.|+|.+|.+...-...++.-    |..|.  .|+.       ..
T Consensus        88 L~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~a----l~~l~--~~kk-------~~  154 (382)
T KOG1909|consen   88 LLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRA----LFELA--VNKK-------AA  154 (382)
T ss_pred             HhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHH----HHHHH--HHhc-------cC
Confidence            556678888888888887665555544321   34444454444432222222110    01111  1111       11


Q ss_pred             CCCCCcEEEccCCcCcccCC----CCccCCccccccccCCCCCCCCCCCCCCCCcccEEEccCCcCCCCCCccccccccc
Q 040702          252 RLAALFQLDLGGNKLSGFVP----ACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVL  327 (797)
Q Consensus       252 ~l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L  327 (797)
                      .-+.|++++.++|++.....    ..|...+.|+.+.++.|.|..=--                   ......|..+++|
T Consensus       155 ~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~-------------------~al~eal~~~~~L  215 (382)
T KOG1909|consen  155 SKPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGV-------------------TALAEALEHCPHL  215 (382)
T ss_pred             CCcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchh-------------------HHHHHHHHhCCcc
Confidence            22345555555555543221    123333444444444444421000                   0011234444555


Q ss_pred             cEEeccCcccccc----cCccccCCcccceecccCccccCCCChhh-----hccccCCeeeecCCcCCCC----CChhhh
Q 040702          328 VQLDLSMNNFSCV----IPTKIGGLKDLQYLFLEYNRLQGSIPNSI-----GDLISLKSLNLSNNNLSGT----IPISLE  394 (797)
Q Consensus       328 ~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~~----~p~~~~  394 (797)
                      +.|||..|-++..    ...++..+++|++|+++++.+...-..+|     ...++|++|.|.+|.++..    +.....
T Consensus       216 evLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~  295 (382)
T KOG1909|consen  216 EVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMA  295 (382)
T ss_pred             eeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHh
Confidence            5555555554421    22334455556666666665554322222     1245666666666666532    122334


Q ss_pred             ccCCCCeEEccCCcC
Q 040702          395 KLLDLKDINVSFNRL  409 (797)
Q Consensus       395 ~l~~L~~L~l~~N~l  409 (797)
                      ..+.|..|+|++|++
T Consensus       296 ek~dL~kLnLngN~l  310 (382)
T KOG1909|consen  296 EKPDLEKLNLNGNRL  310 (382)
T ss_pred             cchhhHHhcCCcccc
Confidence            456677777777766

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.04  E-value=2e-10  Score=124.85  Aligned_cols=228  Identities=19%  Similarity=0.158  Sum_probs=165.0

Q ss_pred             cCCCccccccc--cCCcceeec-------ceEEEEEEEEeccC--CcchhHHHHHHHhhhcc-CCceeEeeeeeecCCeE
Q 040702          512 NRFSENNLIGR--GGFGPVYKD-------GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIR-HRNLIKIISSCSNDDFK  579 (797)
Q Consensus       512 ~~f~~~~~lg~--G~~g~Vyk~-------~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~  579 (797)
                      ..|.....+|.  |.+|.||++       +..+|+|.-+....  .....=.+|+...++++ |++.++.+..+...+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            35666688899  999999975       36789887543322  22233445676677774 99999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHH----HHHHHHccCCCCeEEcCCCCCceEEcCC-CcEEEEeecC
Q 040702          580 ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVAS----ALEYLHFGYSVPIIHCDLKPSNVLLDDN-MVAHLSDFGM  654 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~----al~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~DFGl  654 (797)
                      ++-+|++. .++..+.+.....++....+.+..+..+    |+.++|   +.+++|-|+||+||+...+ ...+++|||+
T Consensus       194 fiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  194 FIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             eeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCcce
Confidence            99999995 6888887766555788888889889888    999999   9999999999999999988 8899999999


Q ss_pred             CccCCccCccc---cccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccc--cc----------h-----hh
Q 040702          655 AKPLLEEDQSL---TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANL--LI----------R-----EE  714 (797)
Q Consensus       655 a~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~--~~----------~-----~~  714 (797)
                      ...+.+..-..   ......|...|++||.. .+.++...|++++|...+....+...  .+          .     +-
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~  348 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFC  348 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhh
Confidence            98775543211   11223577789999855 67788999999999765332222111  11          0     00


Q ss_pred             hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          715 KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       715 ~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      ......+...+..+++.+|-.|++.+.+..
T Consensus       349 ~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  349 EGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             cCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            011123333566689999999998665543

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=99.02  E-value=2.1e-10  Score=89.54  Aligned_cols=60  Identities=35%  Similarity=0.547  Sum_probs=33.5

Q ss_pred             CccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccC
Q 040702          103 NLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYL  162 (797)
Q Consensus       103 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l  162 (797)
                      +|++|++++|+|+.+.+..|.++++|++|++++|+|+.+.+++|.++++|++|++++|+|
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            455555555555544445555555555555555555555555555555555555555543

...

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.98  E-value=1.5e-09  Score=128.35  Aligned_cols=293  Identities=25%  Similarity=0.318  Sum_probs=154.8

Q ss_pred             CCCCEEEcccCcccccCCccccCCCCCCEEEccCCc--CcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCE
Q 040702           53 HNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNS--LSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSE  130 (797)
Q Consensus        53 ~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~--l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  130 (797)
                      ...+...+-+|++.. ++.... .++|++|-+..|.  +. .++..+|..++.|++|||++|.=.+.+|..++++-+|++
T Consensus       523 ~~~rr~s~~~~~~~~-~~~~~~-~~~L~tLll~~n~~~l~-~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lry  599 (889)
T KOG4658|consen  523 NSVRRMSLMNNKIEH-IAGSSE-NPKLRTLLLQRNSDWLL-EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRY  599 (889)
T ss_pred             hheeEEEEeccchhh-ccCCCC-CCccceEEEeecchhhh-hcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhc
Confidence            445556666666653 222222 2356666666665  44 566666666777777777766554566677777777777


Q ss_pred             EEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCC--CCCChhhhccccCCcE
Q 040702          131 LGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLG--GILPRAIGNLSQSMED  208 (797)
Q Consensus       131 L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~--~~~~~~~~~l~~~L~~  208 (797)
                      |+|++..|+ ..|..|.+|+.|.+|++..+.-....+.+     ...+++|++|.+..-...  ...-..+..+. +|+.
T Consensus       600 L~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i-----~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le-~L~~  672 (889)
T KOG4658|consen  600 LDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGI-----LLELQSLRVLRLPRSALSNDKLLLKELENLE-HLEN  672 (889)
T ss_pred             ccccCCCcc-ccchHHHHHHhhheeccccccccccccch-----hhhcccccEEEeeccccccchhhHHhhhccc-chhh
Confidence            777777766 45666777777777777666544443332     444666666666554311  11112222221 2333


Q ss_pred             EEccCCcccccCChhhhhhhhhH--hhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccC------Cccc
Q 040702          209 FWMDNCNISGSIPEEINNLTNLI--LQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGN------LTNL  280 (797)
Q Consensus       209 L~L~~n~i~~~~p~~~~~l~~L~--L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~------l~~L  280 (797)
                      +.......  .+-..+..++.|.  .+.+.+.++... ..+..+..+.+|+.|.+.++.+..........      ++++
T Consensus       673 ls~~~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l  749 (889)
T KOG4658|consen  673 LSITISSV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNL  749 (889)
T ss_pred             heeecchh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHH
Confidence            32222111  0111112222220  234444343333 45566778889999999888886443322221      2233


Q ss_pred             cccccCCCCCCCCCCCCCCCCcccEEEccCCcCCCCCCccccccccccEEeccCcccccc-cCccccCCcccceecccC
Q 040702          281 RKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCV-IPTKIGGLKDLQYLFLEY  358 (797)
Q Consensus       281 ~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~  358 (797)
                      ..+...++..-..+.+....++|+.|.+..+.....+......+..++.+-+..+.+.+. .-...++++++..+.+++
T Consensus       750 ~~~~~~~~~~~r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~~~l~~  828 (889)
T KOG4658|consen  750 SKVSILNCHMLRDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLYWLPLSF  828 (889)
T ss_pred             HHHHhhccccccccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeEecccCc
Confidence            333333333333333344567888888888777655555556666666656666666554 233444555555544433

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.98  E-value=4.8e-09  Score=97.07  Aligned_cols=139  Identities=21%  Similarity=0.215  Sum_probs=102.4

Q ss_pred             ccccccccCCcceeec---ceEEEEEE-EEeccCC-------cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          516 ENNLIGRGGFGPVYKD---GMEVAIKV-FNLQYGG-------AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       516 ~~~~lg~G~~g~Vyk~---~~~vAvK~-~~~~~~~-------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      ....+-+|+=+.|+++   |+.+.||. +.+..+.       ..++..+|++.+.+++--.|.-..=++.+...-.++||
T Consensus        11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME   90 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME   90 (229)
T ss_pred             cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence            5678889999999985   57777774 4443322       13567789999999875555555556666667789999


Q ss_pred             ccCC-CCHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCC---cEEEEeecCCcc
Q 040702          585 YMPL-GSLEKCLYSGNYI-LDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM---VAHLSDFGMAKP  657 (797)
Q Consensus       585 ~~~~-g~L~~~l~~~~~~-l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~---~~kl~DFGla~~  657 (797)
                      |++| .++.+++...... .+.......+.+|-+.+.-||   ..+|+|+||..+||++..++   .+.++|||++..
T Consensus        91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            9976 4777777654331 222222678888999999999   99999999999999996554   468999999874

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.97  E-value=4.7e-10  Score=87.59  Aligned_cols=60  Identities=35%  Similarity=0.488  Sum_probs=33.9

Q ss_pred             CCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcC
Q 040702           78 TLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSF  138 (797)
Q Consensus        78 ~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  138 (797)
                      +|++|++++|+|+ .+|..+|.++++|++|++++|+++.+.+..|.++++|++|++++|+|
T Consensus         2 ~L~~L~l~~n~l~-~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    2 NLESLDLSNNKLT-EIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TESEEEETSSTES-EECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             cCcEEECCCCCCC-ccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            4555555555555 55555555555555555555555555555555555555555555543

...

>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms]

Probab=98.97  E-value=2.6e-11  Score=122.13  Aligned_cols=96  Identities=19%  Similarity=0.152  Sum_probs=49.0

Q ss_pred             CCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccC---cccccCCc-------cccCCCCCCEEEcc
Q 040702           16 QLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFN---KVVGVVPT-------TIFNVSTLKSLYLH   85 (797)
Q Consensus        16 ~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N---~i~~~~p~-------~~~~l~~L~~L~Ls   85 (797)
                      .+..+.++++||||+|.+-..-    -..|-..+.+.++|+..++|+=   ++...+|.       ++...++|+.||||
T Consensus        25 ~~~~~~s~~~l~lsgnt~G~EA----a~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLS  100 (382)
T KOG1909|consen   25 ELEPMDSLTKLDLSGNTFGTEA----ARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLS  100 (382)
T ss_pred             HhcccCceEEEeccCCchhHHH----HHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeecc
Confidence            3556778888888888632110    1223334556667777776652   22222232       33444566666666


Q ss_pred             CCcCcccCCCc---cccCCCCccEEEccCcccc
Q 040702           86 SNSLSGRLPSS---ADVRLPNLKELHLWGNNFI  115 (797)
Q Consensus        86 ~N~l~~~l~~~---~~~~l~~L~~L~L~~N~l~  115 (797)
                      .|.+...-+..   ..+.+.+|++|.|.+|.+.
T Consensus       101 DNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg  133 (382)
T KOG1909|consen  101 DNAFGPKGIRGLEELLSSCTDLEELYLNNCGLG  133 (382)
T ss_pred             ccccCccchHHHHHHHHhccCHHHHhhhcCCCC
Confidence            66664111111   1223556666666666553

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.96  E-value=2.6e-10  Score=124.01  Aligned_cols=233  Identities=19%  Similarity=0.096  Sum_probs=163.0

Q ss_pred             HHHHhcCCCccccccccCCcceee------cceEEEEEEEEeccCCcch--hHHHHHHHhhhc-cCCceeEeeeeeecCC
Q 040702          507 LFQATNRFSENNLIGRGGFGPVYK------DGMEVAIKVFNLQYGGAFK--SFDIECGMMKRI-RHRNLIKIISSCSNDD  577 (797)
Q Consensus       507 l~~~~~~f~~~~~lg~G~~g~Vyk------~~~~vAvK~~~~~~~~~~~--~~~~E~~~l~~l-~Hpniv~l~~~~~~~~  577 (797)
                      ...-+.+|..+..||.|.|+.|++      ++..||+|...........  .-..|+-+...+ .|.++++.+..|..-.
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r  339 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR  339 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence            344567899999999999999986      5688999987655322222  223466666666 4899999988888888


Q ss_pred             eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCC-CcEEEEeecCCc
Q 040702          578 FKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN-MVAHLSDFGMAK  656 (797)
Q Consensus       578 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~DFGla~  656 (797)
                      ..|+--|||++++......... .++....+++..|++.|+.++|   ++.++|+|+||+||++..+ +..++.|||++.
T Consensus       340 ~~~ip~e~~~~~s~~l~~~~~~-~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t  415 (524)
T KOG0601|consen  340 QGYIPLEFCEGGSSSLRSVTSQ-MLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWT  415 (524)
T ss_pred             cccCchhhhcCcchhhhhHHHH-hcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcccccccc
Confidence            8889999999998877663322 3677788899999999999999   9999999999999999876 888999999997


Q ss_pred             cCCccCccccccccccCcccc--cccccccCccchHHHHHHHhhhhhhhhccccccch-----------hh--hhhhccc
Q 040702          657 PLLEEDQSLTQTQTLATIGYM--APDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIR-----------EE--KHLMTKE  721 (797)
Q Consensus       657 ~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~-----------~~--~~~~~~~  721 (797)
                      .+.-..     ....++-+++  +|+......+..+.|+++++........+..+...           .+  .....+.
T Consensus       416 ~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i~~~~~p~~~~~~~~~  490 (524)
T KOG0601|consen  416 RLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTIRSGDTPNLPGLKLQL  490 (524)
T ss_pred             ccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCcccccceeeecccccCCCchHHhh
Confidence            532111     1122333445  44444455667888889998654333333222111           00  0111456


Q ss_pred             ccchhccccCCCCCCCChHHHHHhHHH
Q 040702          722 QPMVRMGTDLSLGQFPASYSISKYLVY  748 (797)
Q Consensus       722 ~~l~~~cl~~dp~~RPs~~~i~~~l~~  748 (797)
                      +.+.+....+|+..||.+.+.....+.
T Consensus       491 q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  491 QVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             hhhhhhhcCCccccchhhhhhcccchh
Confidence            677788888999999987776654433

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.94  E-value=4.1e-09  Score=106.63  Aligned_cols=138  Identities=17%  Similarity=0.147  Sum_probs=106.8

Q ss_pred             ccccccCCcceeec----ceEEEEEEEEeccC-CcchhHHHHHHHhhhccC--CceeEeeeeeecC---CeEEEEEEccC
Q 040702          518 NLIGRGGFGPVYKD----GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRH--RNLIKIISSCSND---DFKALVLEYMP  587 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H--pniv~l~~~~~~~---~~~~lv~e~~~  587 (797)
                      +.+|.|..+.||+.    |..+++|....... .....+..|+++++.+++  ..+++++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            57899999999983    37899998765432 235678999999999975  4467777777654   36789999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcc-------------------------------------------
Q 040702          588 LGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFG-------------------------------------------  624 (797)
Q Consensus       588 ~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~-------------------------------------------  624 (797)
                      |+++.+.+..  ..++..+...++.++++++.+||..                                           
T Consensus        84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (223)
T cd05154          84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL  161 (223)
T ss_pred             CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence            9888765432  2367777788899999999999832                                           


Q ss_pred             ----------CCCCeEEcCCCCCceEEcC--CCcEEEEeecCCcc
Q 040702          625 ----------YSVPIIHCDLKPSNVLLDD--NMVAHLSDFGMAKP  657 (797)
Q Consensus       625 ----------~~~~ivHrDlkp~NIll~~--~~~~kl~DFGla~~  657 (797)
                                ....++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                      0246799999999999998  66789999998874

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=98.85  E-value=3.1e-08  Score=109.00  Aligned_cols=159  Identities=16%  Similarity=0.158  Sum_probs=118.1

Q ss_pred             ecceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHH
Q 040702          530 KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLN  609 (797)
Q Consensus       530 k~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~  609 (797)
                      ..+.+|.|...+...........+.++.|+.++||||+++++.++.++..|+|+|.+.  .|..++++..    .....-
T Consensus        35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v~~  108 (690)
T KOG1243|consen   35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEVCL  108 (690)
T ss_pred             ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHHHH
Confidence            3468889888876655444567788899999999999999999999999999999984  5777776543    344445


Q ss_pred             HHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccccccccccCcccccccccccCccch
Q 040702          610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRL  689 (797)
Q Consensus       610 i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  689 (797)
                      .+.||+.||.|||+  +.+++|++|.-..|+++..|+-||++|-.+........  ......---.|..|+.+....  .
T Consensus       109 Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~  182 (690)
T KOG1243|consen  109 GLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--W  182 (690)
T ss_pred             HHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--c
Confidence            67899999999985  67899999999999999999999999998864321111  111111222477887765554  3


Q ss_pred             HHHHHHHhhhh
Q 040702          690 KCWVNDSLLIS  700 (797)
Q Consensus       690 ~~dv~s~~~~~  700 (797)
                      ..|.|.+|+..
T Consensus       183 s~D~~~Lg~li  193 (690)
T KOG1243|consen  183 SIDSWGLGCLI  193 (690)
T ss_pred             chhhhhHHHHH
Confidence            44666666654

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.80  E-value=6.8e-09  Score=122.90  Aligned_cols=131  Identities=22%  Similarity=0.334  Sum_probs=100.6

Q ss_pred             CCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCcc--ccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCC
Q 040702           75 NVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNN--FIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNL  152 (797)
Q Consensus        75 ~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~--l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L  152 (797)
                      +....+...+-+|.+. .++...  ..++|++|-+.+|.  +.......|..++.|+.|||++|.=-+..|..+++|-+|
T Consensus       521 ~~~~~rr~s~~~~~~~-~~~~~~--~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~L  597 (889)
T KOG4658|consen  521 SWNSVRRMSLMNNKIE-HIAGSS--ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHL  597 (889)
T ss_pred             chhheeEEEEeccchh-hccCCC--CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhh
Confidence            3457788888888886 666554  45689999998886  554445557779999999999887666788889999999


Q ss_pred             CeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCc
Q 040702          153 KWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCN  215 (797)
Q Consensus       153 ~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~  215 (797)
                      ++|+|++..++.+|..      +.++++|.+||+..+.-...+|.....+. +|++|.+..-.
T Consensus       598 ryL~L~~t~I~~LP~~------l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~-~Lr~L~l~~s~  653 (889)
T KOG4658|consen  598 RYLDLSDTGISHLPSG------LGNLKKLIYLNLEVTGRLESIPGILLELQ-SLRVLRLPRSA  653 (889)
T ss_pred             hcccccCCCccccchH------HHHHHhhheeccccccccccccchhhhcc-cccEEEeeccc
Confidence            9999999999988875      67788888999988776555566666676 78877766543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.74  E-value=5e-09  Score=119.80  Aligned_cols=263  Identities=16%  Similarity=0.176  Sum_probs=168.5

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEec---cCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQ---YGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l  581 (797)
                      ..++|...+.+-+|+++.++-+     +...++|.....   .....+....+-.++-..+||-+++...-+......++
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            3467777788889999999842     333344433222   11122333333333333456777777666667788999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCcc
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  661 (797)
                      |++|..+|++...++..+. .+..-+......+.++.+|||   ...+.|||++|.|++...++..++.|||......--
T Consensus       882 ~~~~~~~~~~~Skl~~~~~-~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~  957 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSGC-LSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI  957 (1205)
T ss_pred             hhHHhccCCchhhhhcCCC-cccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccccccccc
Confidence            9999999999999887653 555556667778899999999   777999999999999999999999999844322100


Q ss_pred             -----------------------------CccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccch
Q 040702          662 -----------------------------DQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIR  712 (797)
Q Consensus       662 -----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~  712 (797)
                                                   +.........||+.|.+||...+......+|+|+.|...+........+..
T Consensus       958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen  958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred             cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence                                         000112345689999999999999888999999999988766666554443


Q ss_pred             -hhhhhhcccccchhc--cccCCC-CCCCChHHHHHhHHHHHHHhccccccccccCCcccccceeeeeeeeeccc
Q 040702          713 -EEKHLMTKEQPMVRM--GTDLSL-GQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYTISSS  783 (797)
Q Consensus       713 -~~~~~~~~~~~l~~~--cl~~dp-~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~  783 (797)
                       .+.+...   .++.+  -|..-| ..-|.+++....+....  +..+.+  ...+.....|+||++++|+...-
T Consensus      1038 ~tpq~~f~---ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~--~~qr~~--a~~~~e~k~~~~~~~~~~~~l~~ 1105 (1205)
T KOG0606|consen 1038 ETPQQIFE---NILNRDIPWPEGPEEGSYEAQDLINRLLTEE--PTQRLG--AKGAAEVKGHPFFQDVDWENLAL 1105 (1205)
T ss_pred             cchhhhhh---ccccCCCCCCCCccccChhhhhhhhhhhccC--chhccC--cccccccccCCccCCCCcccccc
Confidence             3322222   22222  121112 12233444443332211  111111  22345788999999999997653

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.72  E-value=4.9e-10  Score=122.38  Aligned_cols=131  Identities=33%  Similarity=0.244  Sum_probs=104.1

Q ss_pred             ccccccccCCCCCCCCCCCCCCCCcccEEEccCCcCCCCCCccccccccccEEeccCcccccccCccccCCcccceeccc
Q 040702          278 TNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLE  357 (797)
Q Consensus       278 ~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  357 (797)
                      ..|...+.++|.+..+...+.-++.|+.|+|++|+++...  .+..++.|++|||++|+++.++--...++. |+.|.++
T Consensus       164 n~L~~a~fsyN~L~~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lr  240 (1096)
T KOG1859|consen  164 NKLATASFSYNRLVLMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLR  240 (1096)
T ss_pred             hhHhhhhcchhhHHhHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeec
Confidence            4677888899999888888888899999999999998543  778889999999999999865444444555 9999999


Q ss_pred             CccccCCCChhhhccccCCeeeecCCcCCCCCC-hhhhccCCCCeEEccCCcCcccC
Q 040702          358 YNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIP-ISLEKLLDLKDINVSFNRLEGEI  413 (797)
Q Consensus       358 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~  413 (797)
                      +|.++..  ..+.++.+|+.||+++|-|.+--. ..+..+..|+.|+|.+|++.|.+
T Consensus       241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~p  295 (1096)
T KOG1859|consen  241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCAP  295 (1096)
T ss_pred             ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccCH
Confidence            9998743  357889999999999998875322 23566788899999999987664

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.71  E-value=1.5e-07  Score=96.70  Aligned_cols=124  Identities=16%  Similarity=0.059  Sum_probs=90.7

Q ss_pred             cceEEEEEEEEeccC-----------CcchhHHHHHHHhhhccCCce--eEeeeeeec-----CCeEEEEEEccCCC-CH
Q 040702          531 DGMEVAIKVFNLQYG-----------GAFKSFDIECGMMKRIRHRNL--IKIISSCSN-----DDFKALVLEYMPLG-SL  591 (797)
Q Consensus       531 ~~~~vAvK~~~~~~~-----------~~~~~~~~E~~~l~~l~Hpni--v~l~~~~~~-----~~~~~lv~e~~~~g-~L  591 (797)
                      +|+.|.||+......           .....+.+|...+.++...+|  ++.+++.+.     ....++|||++++- +|
T Consensus        44 ~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL  123 (268)
T PRK15123         44 AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISL  123 (268)
T ss_pred             CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccH
Confidence            567899997643220           111247899999988853333  344445432     23578999999875 79


Q ss_pred             HHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcC-------CCcEEEEeecCCcc
Q 040702          592 EKCLYSG-NYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD-------NMVAHLSDFGMAKP  657 (797)
Q Consensus       592 ~~~l~~~-~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~-------~~~~kl~DFGla~~  657 (797)
                      .+++... ....+......++.+++..+.-||   ..||+|+|+++.|||++.       +..+.++||+.+..
T Consensus       124 ~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        124 EDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            8887532 123455677789999999999999   999999999999999975       46899999998863

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.69  E-value=6.4e-09  Score=102.58  Aligned_cols=209  Identities=25%  Similarity=0.285  Sum_probs=136.8

Q ss_pred             CCCEEEccCCcCcccCCC--ccccCCCCccEEEccCccccc--cCCchhhCCCCCCEEEccCCcCcccCCccc-cCCCCC
Q 040702           78 TLKSLYLHSNSLSGRLPS--SADVRLPNLKELHLWGNNFIG--TIPSFIFNASKLSELGLQKNSFSGSIPNTF-GNLRNL  152 (797)
Q Consensus        78 ~L~~L~Ls~N~l~~~l~~--~~~~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f-~~l~~L  152 (797)
                      -+.-|.+.++.|. ....  .+....+.+++|||.+|.|+.  .+..-+.+++.|+.|+|+.|++...+ +.+ ..+.+|
T Consensus        46 a~ellvln~~~id-~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I-~~lp~p~~nl  123 (418)
T KOG2982|consen   46 ALELLVLNGSIID-NEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDI-KSLPLPLKNL  123 (418)
T ss_pred             chhhheecCCCCC-cchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCcc-ccCcccccce
Confidence            4455666666664 2221  122356789999999999873  33345678999999999999998444 333 467799


Q ss_pred             CeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCCh--hhhhhhhh
Q 040702          153 KWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPE--EINNLTNL  230 (797)
Q Consensus       153 ~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~--~~~~l~~L  230 (797)
                      ++|-|.+-.+.-...+    +.++.++.++.|.+|.|.+...               .+..|.+...-|+  .+.-++.+
T Consensus       124 ~~lVLNgT~L~w~~~~----s~l~~lP~vtelHmS~N~~rq~---------------n~Dd~c~e~~s~~v~tlh~~~c~  184 (418)
T KOG2982|consen  124 RVLVLNGTGLSWTQST----SSLDDLPKVTELHMSDNSLRQL---------------NLDDNCIEDWSTEVLTLHQLPCL  184 (418)
T ss_pred             EEEEEcCCCCChhhhh----hhhhcchhhhhhhhccchhhhh---------------ccccccccccchhhhhhhcCCcH
Confidence            9999998877544332    3477888899999998865422               2233333221111  11112222


Q ss_pred             HhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccC-CCCccCCccccccccCCCCCCCCCC--CCCCCCcccEEE
Q 040702          231 ILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFV-PACSGNLTNLRKLYLGSNLLTSIPS--TLWNLKDILHLN  307 (797)
Q Consensus       231 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~lp~--~~~~l~~L~~L~  307 (797)
                        ..++++-|++..+       ++++..+-+..|.|.... ...+..++.+-.|+|+.|+|.++.+  ++.++++|..|.
T Consensus       185 --~~~w~~~~~l~r~-------Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlR  255 (418)
T KOG2982|consen  185 --EQLWLNKNKLSRI-------FPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLR  255 (418)
T ss_pred             --HHHHHHHHhHHhh-------cccchheeeecCcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheee
Confidence              4455556666543       456777888888876442 3456677788899999999987754  677889999999


Q ss_pred             ccCCcCCCC
Q 040702          308 LSSNFFTGP  316 (797)
Q Consensus       308 l~~N~l~~~  316 (797)
                      +++|.+...
T Consensus       256 v~~~Pl~d~  264 (418)
T KOG2982|consen  256 VSENPLSDP  264 (418)
T ss_pred             ccCCccccc
Confidence            999988754

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.68  E-value=2.9e-09  Score=116.46  Aligned_cols=128  Identities=28%  Similarity=0.341  Sum_probs=97.5

Q ss_pred             CCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCC
Q 040702          102 PNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYL  181 (797)
Q Consensus       102 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L  181 (797)
                      ..|..-+.+.|.+. ....++.-++.|+.|+|++|+++...  .+..|+.|++|||++|.++.+|.-     +..++. |
T Consensus       164 n~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l-----~~~gc~-L  234 (1096)
T KOG1859|consen  164 NKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQL-----SMVGCK-L  234 (1096)
T ss_pred             hhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhcccccc-----chhhhh-h
Confidence            45777788888887 66777888889999999999998653  788899999999999999888752     234444 8


Q ss_pred             cEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCC-hhhhhhhhhHhhhccccccccc
Q 040702          182 EYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIP-EEINNLTNLILQLLSLEGNQLE  243 (797)
Q Consensus       182 ~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p-~~~~~l~~L~L~~L~Ls~N~l~  243 (797)
                      +.|.+++|.++..  ..+.++. +|.-||++.|-|.+--- ..+..|..|  +.|+|.+|.+-
T Consensus       235 ~~L~lrnN~l~tL--~gie~Lk-sL~~LDlsyNll~~hseL~pLwsLs~L--~~L~LeGNPl~  292 (1096)
T KOG1859|consen  235 QLLNLRNNALTTL--RGIENLK-SLYGLDLSYNLLSEHSELEPLWSLSSL--IVLWLEGNPLC  292 (1096)
T ss_pred             eeeeecccHHHhh--hhHHhhh-hhhccchhHhhhhcchhhhHHHHHHHH--HHHhhcCCccc
Confidence            8999999988755  4566776 78888999888874322 334556666  88899998886

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.65  E-value=6.8e-08  Score=93.45  Aligned_cols=98  Identities=23%  Similarity=0.250  Sum_probs=65.4

Q ss_pred             hHHHHHHHhhhccCC--ceeEeeeeeecCCeEEEEEEccC--CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH-HHcc
Q 040702          550 SFDIECGMMKRIRHR--NLIKIISSCSNDDFKALVLEYMP--LGSLEKCLYSGNYILDIFQGLNIMIDVASALEY-LHFG  624 (797)
Q Consensus       550 ~~~~E~~~l~~l~Hp--niv~l~~~~~~~~~~~lv~e~~~--~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~y-LH~~  624 (797)
                      ...+|.+.|.++..-  ++++.+++.    ..++||||++  |..+..+....   ++......++.+++..+.. +|  
T Consensus        54 ~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~--  124 (188)
T PF01163_consen   54 WAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLH--  124 (188)
T ss_dssp             HHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHH--
T ss_pred             HHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHH--
Confidence            456799999999755  567776553    3479999998  54454433221   1123456677888886555 57  


Q ss_pred             CCCCeEEcCCCCCceEEcCCCcEEEEeecCCccC
Q 040702          625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  658 (797)
Q Consensus       625 ~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  658 (797)
                       ..||+|+|+.+.||+++++ .+.++|||.|...
T Consensus       125 -~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~  156 (188)
T PF01163_consen  125 -KAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDS  156 (188)
T ss_dssp             -CTTEEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred             -hcCceecCCChhhEEeecc-eEEEEecCcceec
Confidence             8999999999999999987 9999999988643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.47  E-value=1.1e-08  Score=89.59  Aligned_cols=104  Identities=25%  Similarity=0.263  Sum_probs=60.8

Q ss_pred             hhcccccccccCCCchhhcC---CCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEcc
Q 040702          233 QLLSLEGNQLEGSIPDDLCR---LAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLS  309 (797)
Q Consensus       233 ~~L~Ls~N~l~~~~~~~~~~---l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~  309 (797)
                      ..++|+.+++. .++++...   ...|+..+|++|.+..+++..-...+.++.|+|++|.|.++|..+..++.|+.|+++
T Consensus        30 h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neisdvPeE~Aam~aLr~lNl~  108 (177)
T KOG4579|consen   30 HFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEISDVPEELAAMPALRSLNLR  108 (177)
T ss_pred             hhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhhhchHHHhhhHHhhhcccc
Confidence            55666666665 33444333   344555567777776555444444456666666666666666666666666666666


Q ss_pred             CCcCCCCCCccccccccccEEeccCcccc
Q 040702          310 SNFFTGPLPLKIGNLNVLVQLDLSMNNFS  338 (797)
Q Consensus       310 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  338 (797)
                      .|.+. ..|..+..+.+|-.||..+|.+.
T Consensus       109 ~N~l~-~~p~vi~~L~~l~~Lds~~na~~  136 (177)
T KOG4579|consen  109 FNPLN-AEPRVIAPLIKLDMLDSPENARA  136 (177)
T ss_pred             cCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence            66665 34444444555556666555554

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.46  E-value=1.4e-08  Score=88.98  Aligned_cols=131  Identities=26%  Similarity=0.319  Sum_probs=65.0

Q ss_pred             ccccccCCCCCCCCCCCCC---CCCcccEEEccCCcCCCCCCcccc-ccccccEEeccCcccccccCccccCCcccceec
Q 040702          280 LRKLYLGSNLLTSIPSTLW---NLKDILHLNLSSNFFTGPLPLKIG-NLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLF  355 (797)
Q Consensus       280 L~~L~L~~N~l~~lp~~~~---~l~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  355 (797)
                      +..++|+.+.+..+++...   ....|...+|++|.+.. .|..|. ..+.++.|+|++|.|+ .+|..+..++.|+.|+
T Consensus        29 ~h~ldLssc~lm~i~davy~l~~~~el~~i~ls~N~fk~-fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lN  106 (177)
T KOG4579|consen   29 LHFLDLSSCQLMYIADAVYMLSKGYELTKISLSDNGFKK-FPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLN  106 (177)
T ss_pred             hhhcccccchhhHHHHHHHHHhCCceEEEEecccchhhh-CCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcc
Confidence            4445555555544443322   22334444555555552 222232 2335555666666665 3444466666666666


Q ss_pred             ccCccccCCCChhhhccccCCeeeecCCcCCCCCChhhhccCCCCeEEccCCcCcccCC
Q 040702          356 LEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIP  414 (797)
Q Consensus       356 Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  414 (797)
                      ++.|++. ..|..+..+.++..||..+|.+. .+|..+---+.....++.++++.+..+
T Consensus       107 l~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~  163 (177)
T KOG4579|consen  107 LRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETK  163 (177)
T ss_pred             cccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCc
Confidence            6666665 45666666666666666666665 233222222223333444555544433

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.40  E-value=2.7e-06  Score=85.70  Aligned_cols=132  Identities=14%  Similarity=0.139  Sum_probs=87.8

Q ss_pred             ccccccCCcceeec-ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCc--eeEeeeeeecCCeEEEEEEccCCCC-HHH
Q 040702          518 NLIGRGGFGPVYKD-GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRN--LIKIISSCSNDDFKALVLEYMPLGS-LEK  593 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpn--iv~l~~~~~~~~~~~lv~e~~~~g~-L~~  593 (797)
                      ..||+|..+.||+. +..+++|..+...  ......+|.++++.+..-.  +.+.+++....+..++|||+++|.+ +..
T Consensus         7 ~~i~~G~t~~~y~~~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~   84 (226)
T TIGR02172         7 TQTGEGGNGESYTHKTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSR   84 (226)
T ss_pred             eeecCCCCcceeEecCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhh
Confidence            67899999999983 4567888876433  2356788999999986433  4677888878888889999998863 221


Q ss_pred             HHhcCCCCCCHHHHHHHHHHHHHHHHHHHc----------------------------------------cCCCCeEEcC
Q 040702          594 CLYSGNYILDIFQGLNIMIDVASALEYLHF----------------------------------------GYSVPIIHCD  633 (797)
Q Consensus       594 ~l~~~~~~l~~~~~~~i~~qi~~al~yLH~----------------------------------------~~~~~ivHrD  633 (797)
                      .+..     +......++.++++.+.-+|.                                        .....++|+|
T Consensus        85 ~~~~-----~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD  159 (226)
T TIGR02172        85 IISD-----NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD  159 (226)
T ss_pred             hhcC-----CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence            1110     111111222222222222221                                        1134578999


Q ss_pred             CCCCceEEcCCCcEEEEeecCCcc
Q 040702          634 LKPSNVLLDDNMVAHLSDFGMAKP  657 (797)
Q Consensus       634 lkp~NIll~~~~~~kl~DFGla~~  657 (797)
                      +.|.||++++++ +.++||+.+..
T Consensus       160 ~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       160 FQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCCCcEEEcCCC-cEEEechhcCc
Confidence            999999999888 99999998863

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PRK09902 hypothetical protein; Provisional

Probab=98.39  E-value=6.1e-06  Score=80.31  Aligned_cols=151  Identities=16%  Similarity=0.087  Sum_probs=107.2

Q ss_pred             HHHHHHHhcCCCccccccccCCcceee---cceEEEEEEEEecc------CCcchhHHHHHHHhhhccCC--ceeEeeee
Q 040702          504 YLELFQATNRFSENNLIGRGGFGPVYK---DGMEVAIKVFNLQY------GGAFKSFDIECGMMKRIRHR--NLIKIISS  572 (797)
Q Consensus       504 ~~~l~~~~~~f~~~~~lg~G~~g~Vyk---~~~~vAvK~~~~~~------~~~~~~~~~E~~~l~~l~Hp--niv~l~~~  572 (797)
                      ++.+.....++...---|+||.+-|++   .|..+=+|+-...-      ......|.+|...+.++...  .+++...+
T Consensus        10 f~~~w~~~~~wve~pN~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~   89 (216)
T PRK09902         10 FNHWWATEGDWVEEPNYRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFG   89 (216)
T ss_pred             HHHHHhCCCceecCCCcCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCcccee
Confidence            444444444554444457788888886   34667788764221      22356899999999998632  24555522


Q ss_pred             eecC----CeEEEEEEccCC-CCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCc
Q 040702          573 CSND----DFKALVLEYMPL-GSLEKCLYSGNY-ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV  646 (797)
Q Consensus       573 ~~~~----~~~~lv~e~~~~-g~L~~~l~~~~~-~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~  646 (797)
                      ....    -..+||+|-+++ .+|.+++..... ..+......+..+++++++-||   ..|+.|+|+-+.||+++.++.
T Consensus        90 ~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~  166 (216)
T PRK09902         90 EAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGK  166 (216)
T ss_pred             eeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCC
Confidence            2111    246799997753 589888865432 3566777899999999999999   999999999999999986666


Q ss_pred             --EEEEeecCCcc
Q 040702          647 --AHLSDFGMAKP  657 (797)
Q Consensus       647 --~kl~DFGla~~  657 (797)
                        ++++||--++.
T Consensus       167 ~~v~lIDlEk~r~  179 (216)
T PRK09902        167 AEAGFLDLEKSRR  179 (216)
T ss_pred             eeEEEEEhhccch
Confidence              99999987764

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.38  E-value=1.2e-06  Score=86.94  Aligned_cols=131  Identities=24%  Similarity=0.264  Sum_probs=95.9

Q ss_pred             CCccccccccCCcceeec----ceEEEEEEEEeccC-----------------C-----cchhHHHHHHHhhhccCC--c
Q 040702          514 FSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYG-----------------G-----AFKSFDIECGMMKRIRHR--N  565 (797)
Q Consensus       514 f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~-----------------~-----~~~~~~~E~~~l~~l~Hp--n  565 (797)
                      ...+..||-|-=+.||.+    |.++|||.=+.+..                 .     +.....+|.++|.++.-.  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            345689999999999974    68999996543210                 0     123466799999998654  6


Q ss_pred             eeEeeeeeecCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCC
Q 040702          566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM  645 (797)
Q Consensus       566 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~  645 (797)
                      |++.+++    +.-.+||||++|-.|...-      ++......++..|+.-+.-.-   ..||||+|+.+-||+++++|
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg  239 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDG  239 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCC
Confidence            7777776    5678999999986654421      233445556666666666666   67899999999999999999


Q ss_pred             cEEEEeecCCcc
Q 040702          646 VAHLSDFGMAKP  657 (797)
Q Consensus       646 ~~kl~DFGla~~  657 (797)
                      .+.++||--+..
T Consensus       240 ~~~vIDwPQ~v~  251 (304)
T COG0478         240 DIVVIDWPQAVP  251 (304)
T ss_pred             CEEEEeCccccc
Confidence            999999976653

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.37  E-value=2.7e-06  Score=90.95  Aligned_cols=129  Identities=19%  Similarity=0.192  Sum_probs=101.5

Q ss_pred             cceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeec----CCeEEEEEEccCC-CCHHHHHhcC-------
Q 040702          531 DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN----DDFKALVLEYMPL-GSLEKCLYSG-------  598 (797)
Q Consensus       531 ~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~----~~~~~lv~e~~~~-g~L~~~l~~~-------  598 (797)
                      +|..|+.|+++............-++.++++.|+|||++.+++..    +...++|++|.++ ++|.++....       
T Consensus       300 DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~  379 (655)
T KOG3741|consen  300 DGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRT  379 (655)
T ss_pred             CCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCcccccc
Confidence            478999999954433333344456788999999999999998863    3478999999875 5777765321       


Q ss_pred             -------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          599 -------NYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       599 -------~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                             +...++...|.++.|++.||.++|   +.|..-+-+.+.+|+++++.+++|+..|.......+.
T Consensus       380 n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~  447 (655)
T KOG3741|consen  380 NSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP  447 (655)
T ss_pred             ccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecCCC
Confidence                   114677899999999999999999   8999999999999999999999998888776654443

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.32  E-value=2.8e-06  Score=84.54  Aligned_cols=107  Identities=23%  Similarity=0.224  Sum_probs=84.2

Q ss_pred             chhHHHHHHHhhhccCC--ceeEeeeeeecCC----eEEEEEEccCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH
Q 040702          548 FKSFDIECGMMKRIRHR--NLIKIISSCSNDD----FKALVLEYMPLG-SLEKCLYSGNYILDIFQGLNIMIDVASALEY  620 (797)
Q Consensus       548 ~~~~~~E~~~l~~l~Hp--niv~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~al~y  620 (797)
                      .....+|...+.++...  .+++.+++.+...    ..++|+|++++. +|.+++..... .+......++.++++.++-
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAK  133 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHH
Confidence            34678888888887533  3455566655432    458999999874 79998876433 4556778899999999999


Q ss_pred             HHccCCCCeEEcCCCCCceEEcCCC---cEEEEeecCCccC
Q 040702          621 LHFGYSVPIIHCDLKPSNVLLDDNM---VAHLSDFGMAKPL  658 (797)
Q Consensus       621 LH~~~~~~ivHrDlkp~NIll~~~~---~~kl~DFGla~~~  658 (797)
                      ||   ..||+|+|+++.|||++.+.   .+.++||+-++..
T Consensus       134 lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  134 LH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99   99999999999999999876   8999999988743

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG2982 consensus Uncharacterized conserved protein [Function unknown]

Probab=98.32  E-value=7.9e-08  Score=95.04  Aligned_cols=87  Identities=25%  Similarity=0.301  Sum_probs=49.5

Q ss_pred             CCCCCEEEcccCccccc--CCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCcccccc-CCchhhCCCCC
Q 040702           52 LHNMEWMAFSFNKVVGV--VPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGT-IPSFIFNASKL  128 (797)
Q Consensus        52 l~~L~~L~ls~N~i~~~--~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L  128 (797)
                      .+.++.|||.+|+|+.-  +-..+.+++.|+.|+|++|++...|.... ..+.+|++|-|.+-.+.-. ....+..++.+
T Consensus        70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp-~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~v  148 (418)
T KOG2982|consen   70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLP-LPLKNLRVLVLNGTGLSWTQSTSSLDDLPKV  148 (418)
T ss_pred             hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCc-ccccceEEEEEcCCCCChhhhhhhhhcchhh
Confidence            45566677777777632  23345566777777777777664333222 2456677777766655422 22344556666


Q ss_pred             CEEEccCCcCc
Q 040702          129 SELGLQKNSFS  139 (797)
Q Consensus       129 ~~L~L~~N~l~  139 (797)
                      ++|++|.|.+.
T Consensus       149 telHmS~N~~r  159 (418)
T KOG2982|consen  149 TELHMSDNSLR  159 (418)
T ss_pred             hhhhhccchhh
Confidence            66666666433

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	797
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		4e-25
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		6e-25
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-22
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		8e-21
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		4e-20
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		3e-19
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		9e-19
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-18
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-18
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		5e-16
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-15
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-15
1ogq_A	313	The Crystal Structure Of Pgip (Polygalacturonase In		2e-13
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-13
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		5e-13
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-12
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-12
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		7e-12
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-11
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-11
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-11
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-11
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-11
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-11
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-11
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-11
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-11
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-11
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-11
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-11
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-11
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-11
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		4e-11
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-11
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-11
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-11
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-11
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-11
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-11
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-11
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-11
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-11
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-11
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-11
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-11
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-11
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		6e-11
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		6e-11
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		6e-11
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-11
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-11
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-11
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-11
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		6e-11
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		7e-11
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		7e-11
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		7e-11
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		7e-11
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		7e-11
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		8e-11
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		8e-11
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-10
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-10
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-10
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-10
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-10
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-10
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-10
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-10
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-10
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		4e-10
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		4e-10
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-10
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-10
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-10
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		5e-10
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-10
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-10
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		6e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-10
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		6e-10
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-10
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		7e-10
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		7e-10
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		7e-10
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		7e-10
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		7e-10
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		8e-10
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		8e-10
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		8e-10
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		8e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		8e-10
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		8e-10
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		8e-10
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		8e-10
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		8e-10
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		9e-10
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		9e-10
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-09
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-09
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-09
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-09
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-09
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-09
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-09
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-09
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-09
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-09
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-09
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-09
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-09
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-09
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-09
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		4e-09
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-09
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-09
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-09
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-09
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-09
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-09
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-09
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-09
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		5e-09
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-09
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-09
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-09
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-09
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-09
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		5e-09
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		6e-09
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		6e-09
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		6e-09
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		6e-09
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		6e-09
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-09
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		6e-09
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		6e-09
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		7e-09
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		7e-09
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		8e-09
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		8e-09
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		8e-09
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		8e-09
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		8e-09
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		8e-09
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		8e-09
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		8e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		9e-09
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		9e-09
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		9e-09
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		9e-09
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		9e-09
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-08
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-08
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-08
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-08
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-08
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-08
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-08
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-08
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-08
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-08
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-08
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-08
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-08
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-08
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-08
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-08
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-08
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-08
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-08
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-08
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-08
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-08
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-08
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-08
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-08
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-08
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-08
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-08
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-08
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-08
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-08
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-08
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-08
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-08
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-08
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-08
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-08
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-08
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-08
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-08
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-08
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-08
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-08
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-08
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-08
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-08
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-08
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-08
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-08
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-08
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-08
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-08
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-08
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-08
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-08
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-08
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-08
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-08
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-08
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-08
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-08
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-08
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-08
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-08
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-08
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-08
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-08
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-08
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-08
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-08
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-08
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-08
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-08
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-08
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-08
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-08
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-08
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-08
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-08
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-08
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-08
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-08
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-08
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-08
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-08
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-08
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-08
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-08
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-08
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-08
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-08
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-08
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-08
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-08
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-08
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		3e-08
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-08
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-08
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		3e-08
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-08
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-08
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-08
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-08
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		3e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-08
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-08
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-08
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-08
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-08
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-08
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-08
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		4e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-08
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-08
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		4e-08
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-08
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-08
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		4e-08
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-08
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-08
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-08
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-08
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-08
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-08
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-08
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		4e-08
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-08
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-08
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-08
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-08
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		5e-08
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-08
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-08
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		5e-08
3b2t_A	311	Structure Of Phosphotransferase Length = 311		5e-08
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-08
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-08
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-08
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-08
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		6e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		6e-08
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-08
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		6e-08
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		6e-08
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		6e-08
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		7e-08
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		7e-08
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		7e-08
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		7e-08
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		7e-08
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		7e-08
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		7e-08
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		7e-08
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-08
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		7e-08
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-08
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		8e-08
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		8e-08
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		8e-08
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		8e-08
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		9e-08
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		9e-08
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		9e-08
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-07
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-07
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-07
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-07
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-07
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-07
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-07
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-07
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-07
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-07
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-07
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-07
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-07
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-07
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-07
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-07
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-07
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-07
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-07
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-07
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-07
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-07
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-07
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-07
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-07
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-07
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-07
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-07
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-07
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-07
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-07
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-07
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-07
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-07
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-07
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-07
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-07
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-07
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-07
2o6q_A	270	Structural Diversity Of The Hagfish Variable Lympho		5e-07
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-07
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		5e-07
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		6e-07
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		6e-07
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		6e-07
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		6e-07
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-07
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-07
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		7e-07
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		7e-07
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		7e-07
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		7e-07
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-07
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-07
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		8e-07
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		8e-07
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		9e-07
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-06
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-06
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-06
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-06
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-06
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-06
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-06
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-06
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-06
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-06
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-06
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-06
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-06
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-06
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-06
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-06
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-06
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-06
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-06
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-06
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-06
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-06
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-06
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-06
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-06
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-06
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-06
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-06
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-06
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-06
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-06
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-06
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-06
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-06
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-06
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-06
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-06
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-06
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-06
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-06
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-06
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-06
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-06
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-06
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-06
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-06
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-06
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-06
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-06
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-06
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-06
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-06
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-06
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-06
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-06
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-06
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-06
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-06
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-06
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-06
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-06
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-06
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-06
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-06
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		3e-06
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-06
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-06
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-06
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		3e-06
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		3e-06
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-06
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		3e-06
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-06
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-06
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-06
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-06
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		4e-06
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		4e-06
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-06
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-06
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-06
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-06
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-06
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-06
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-06
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-06
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-06
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-06
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-06
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-06
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-06
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-06
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-06
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-06
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		4e-06
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		4e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-06
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-06
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-06
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-06
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-06
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-06
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-06
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-06
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-06
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-06
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		4e-06
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-06
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-06
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-06
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-06
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-06
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-06
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-06
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-06
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-06
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-06
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		5e-06
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-06
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		5e-06
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		5e-06
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		5e-06
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-06
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		5e-06
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		5e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-06
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-06
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		5e-06
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-06
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-06
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		5e-06
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-06
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-06
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		6e-06
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		6e-06
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		6e-06
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-06
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		6e-06
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		7e-06
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-06
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		7e-06
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		7e-06
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		8e-06
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		8e-06
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		8e-06
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		8e-06
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		8e-06
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		9e-06
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		9e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		9e-06
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		9e-06
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-05
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-05
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-05
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-05
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-05
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-05
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-05
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-05
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-05
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-05
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-05
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-05
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-05
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-05
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-05
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-05
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-05
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-05
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-05
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-05
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-05
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-05
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-05
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-05
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-05
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-05
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-05
3v47_A	455	Crystal Structure Of The N-Tetminal Fragment Of Zeb		2e-05
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-05
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-05
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-05
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-05
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-05
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-05
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-05
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-05
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-05
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-05
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-05
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-05
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-05
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-05
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-05
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-05
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-05
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-05
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-05
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-05
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-05
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-05
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-05
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-05
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-05
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-05
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-05
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		3e-05
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-05
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-05
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-05
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-05
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-05
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-05
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-05
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-05
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-05
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-05
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-05
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-05
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-05
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-05
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-05
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		4e-05
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-05
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-05
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-05
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		4e-05
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-05
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-05
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-05
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-05
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-05
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-05
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-05
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		5e-05
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		5e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		5e-05
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		5e-05
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		5e-05
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		5e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-05
4ae9_A	343	Structure And Function Of The Human Sperm-specific		6e-05
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-05
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		6e-05
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		6e-05
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-05
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		7e-05
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		7e-05
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		7e-05
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		7e-05
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		7e-05
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		7e-05
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		7e-05
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		8e-05
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-05
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		8e-05
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		8e-05
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-05
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-05
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		8e-05
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-05
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		9e-05
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		9e-05
4ae6_A	343	Structure And Function Of The Human Sperm-specific		9e-05
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		9e-05
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		9e-05
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-04
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-04
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-04
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-04
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-04
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-04
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-04
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-04
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-04
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-04
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-04
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-04
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-04
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-04
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-04
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-04
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-04
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-04
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-04
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-04
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-04
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-04
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-04
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-04
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-04
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-04
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-04
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-04
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-04
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-04
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-04
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-04
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-04
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-04
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-04
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-04
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-04
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-04
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-04
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-04
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		2e-04
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-04
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-04
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-04
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-04
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-04
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-04
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-04
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-04
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-04
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-04
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-04
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-04
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-04
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-04
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-04
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-04
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-04
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-04
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-04
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-04
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-04
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-04
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-04
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-04
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-04
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-04
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-04
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-04
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-04
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-04
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		2e-04
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-04
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-04
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-04
3soa_A	444	Full-Length Human Camkii Length = 444		2e-04
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-04
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-04
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-04
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-04
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-04
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-04
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		3e-04
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-04
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-04
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		3e-04
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-04
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-04
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-04
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-04
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-04
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-04
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-04
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-04
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		4e-04
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		5e-04
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		5e-04
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		5e-04
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		5e-04
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		5e-04
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-04
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		5e-04
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		5e-04
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		5e-04
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		5e-04
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		6e-04
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-04
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		6e-04
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		6e-04
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		6e-04
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		6e-04
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		6e-04
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		6e-04
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		6e-04
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		6e-04
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		6e-04
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		6e-04
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		6e-04
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		7e-04
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		7e-04
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		7e-04
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		7e-04
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-04
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		7e-04
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		7e-04
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		7e-04
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		7e-04
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		7e-04
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-04
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		8e-04
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-04
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		8e-04
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-04
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		8e-04
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		8e-04
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		8e-04
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		8e-04
1w8a_A	192	Third Lrr Domain Of Drosophila Slit Length = 192		8e-04
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		8e-04
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		9e-04
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		9e-04
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-04
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		9e-04
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		9e-04
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		9e-04
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		9e-04
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		9e-04
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		9e-04

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score =  113 bits (283), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 125/441 (28%), Positives = 178/441 (40%), Gaps = 88/441 (19%)
Query: 21  SSLQTLYLSYNPPSGSI-PSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTL 79
           +SL TL LS N  SG I P+  LC+ P      + ++ +    N   G +P T+ N S L
Sbjct: 365 ASLLTLDLSSNNFSGPILPN--LCQNPK-----NTLQELYLQNNGFTGKIPPTLSNCSEL 417
Query: 80  KSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFS 139
            SL+L  N LSG +PSS    L  L++L LW N   G IP  +     L  L L  N  +
Sbjct: 418 VSLHLSFNYLSGTIPSSLG-SLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLT 476
Query: 140 GSIPNTFGNLRNLKWLGLNDNYXXXXXXXXXXXXXXXNCKYLEYFSFSNNPLGGILPRAI 199
           G IP+   N  NL W+                             S SNN L G +P+ I
Sbjct: 477 GEIPSGLSNCTNLNWI-----------------------------SLSNNRLTGEIPKWI 507
Query: 200 GNLSQSMEDFWMDNCNISGSXXXXXXXXXXXXXXXXXXXGNQLEGSIPDDLCRLAALFQL 259
           G L +++    + N                          N   G+IP +L    +L  L
Sbjct: 508 GRL-ENLAILKLSN--------------------------NSFSGNIPAELGDCRSLIWL 540
Query: 260 DLGGNKLSGFVPAC----SGN-----LTNLRKLYLGSNLLTSIPSTLWNLKDILHL---- 306
           DL  N  +G +PA     SG      +   R +Y+ ++ +        NL +   +    
Sbjct: 541 DLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQ 600
Query: 307 ----------NLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFL 356
                     N++S  + G       N   ++ LD+S N  S  IP +IG +  L  L L
Sbjct: 601 LNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNL 660
Query: 357 EYNRLQGSIPNSIGDLIXXXXXXXXXXXXXGTIPISLEKLLDLKDINVSFNRLEGEIPRE 416
            +N + GSIP+ +GDL              G IP ++  L  L +I++S N L G IP  
Sbjct: 661 GHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM 720
Query: 417 GPFRNLSAESFKGNELLCGMP 437
           G F       F  N  LCG P
Sbjct: 721 GQFETFPPAKFLNNPGLCGYP 741

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score =  112 bits (281), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 125/441 (28%), Positives = 178/441 (40%), Gaps = 88/441 (19%)
Query: 21  SSLQTLYLSYNPPSGSI-PSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTL 79
           +SL TL LS N  SG I P+  LC+ P      + ++ +    N   G +P T+ N S L
Sbjct: 368 ASLLTLDLSSNNFSGPILPN--LCQNPK-----NTLQELYLQNNGFTGKIPPTLSNCSEL 420
Query: 80  KSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFS 139
            SL+L  N LSG +PSS    L  L++L LW N   G IP  +     L  L L  N  +
Sbjct: 421 VSLHLSFNYLSGTIPSSLG-SLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLT 479
Query: 140 GSIPNTFGNLRNLKWLGLNDNYXXXXXXXXXXXXXXXNCKYLEYFSFSNNPLGGILPRAI 199
           G IP+   N  NL W+                             S SNN L G +P+ I
Sbjct: 480 GEIPSGLSNCTNLNWI-----------------------------SLSNNRLTGEIPKWI 510
Query: 200 GNLSQSMEDFWMDNCNISGSXXXXXXXXXXXXXXXXXXXGNQLEGSIPDDLCRLAALFQL 259
           G L +++    + N                          N   G+IP +L    +L  L
Sbjct: 511 GRL-ENLAILKLSN--------------------------NSFSGNIPAELGDCRSLIWL 543
Query: 260 DLGGNKLSGFVPAC----SGN-----LTNLRKLYLGSNLLTSIPSTLWNLKDILHL---- 306
           DL  N  +G +PA     SG      +   R +Y+ ++ +        NL +   +    
Sbjct: 544 DLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQ 603
Query: 307 ----------NLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFL 356
                     N++S  + G       N   ++ LD+S N  S  IP +IG +  L  L L
Sbjct: 604 LNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNL 663
Query: 357 EYNRLQGSIPNSIGDLIXXXXXXXXXXXXXGTIPISLEKLLDLKDINVSFNRLEGEIPRE 416
            +N + GSIP+ +GDL              G IP ++  L  L +I++S N L G IP  
Sbjct: 664 GHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEM 723
Query: 417 GPFRNLSAESFKGNELLCGMP 437
           G F       F  N  LCG P
Sbjct: 724 GQFETFPPAKFLNNPGLCGYP 744

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  103 bits (256), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 70/196 (35%), Positives = 101/196 (51%), Gaps = 11/196 (5%)
Query: 500 RRFTYLELFQATNRFSENNLIGRGGFGPVYK----DGMEVAIKVFNLQ--YGGAFKSFDI 553
           +RF+  EL  A++ FS  N++GRGGFG VYK    DG  VA+K    +   GG  + F  
Sbjct: 26  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQ-FQT 84
Query: 554 ECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYS---GNYILDIFQGLNI 610
           E  M+    HRNL+++   C     + LV  YM  GS+  CL         LD  +   I
Sbjct: 85  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 144
Query: 611 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 670
            +  A  L YLH      IIH D+K +N+LLD+   A + DFG+AK L++          
Sbjct: 145 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDXHVXXAV 203
Query: 671 LATIGYMAPDEIFSGE 686
             TIG++AP+ + +G+
Sbjct: 204 RGTIGHIAPEYLSTGK 219

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 68/196 (34%), Positives = 99/196 (50%), Gaps = 11/196 (5%)
Query: 500 RRFTYLELFQATNRFSENNLIGRGGFGPVYK----DGMEVAIKVFNLQ--YGGAFKSFDI 553
           +RF+  EL  A++ F   N++GRGGFG VYK    DG  VA+K    +   GG  + F  
Sbjct: 18  KRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQ-FQT 76
Query: 554 ECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYS---GNYILDIFQGLNI 610
           E  M+    HRNL+++   C     + LV  YM  GS+  CL         LD  +   I
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 611 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 670
            +  A  L YLH      IIH D+K +N+LLD+   A + DFG+AK L++          
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDXHVXXAV 195
Query: 671 LATIGYMAPDEIFSGE 686
              IG++AP+ + +G+
Sbjct: 196 RGXIGHIAPEYLSTGK 211

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 67/197 (34%), Positives = 100/197 (50%), Gaps = 10/197 (5%)
Query: 501 RFTYLELFQATNRFSENNLIGRGGFGPVYK----DGMEVAIKVFNLQYGGAFKSFDIECG 556
           R   ++L +ATN F    LIG G FG VYK    DG +VA+K    +     + F+ E  
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 557 MMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGN---YILDIFQGLNIMID 613
            +   RH +L+ +I  C   +   L+ +YM  G+L++ LY  +     +   Q L I I 
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 614 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 673
            A  L YLH   +  IIH D+K  N+LLD+N V  ++DFG++K   E DQ+        T
Sbjct: 148 AARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGT 204
Query: 674 IGYMAPDEIFSGEMRLK 690
           +GY+ P+    G +  K
Sbjct: 205 LGYIDPEYFIKGRLTEK 221

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/197 (33%), Positives = 99/197 (50%), Gaps = 10/197 (5%)
Query: 501 RFTYLELFQATNRFSENNLIGRGGFGPVYK----DGMEVAIKVFNLQYGGAFKSFDIECG 556
           R   ++L +ATN F    LIG G FG VYK    DG +VA+K    +     + F+ E  
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 557 MMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGN---YILDIFQGLNIMID 613
            +   RH +L+ +I  C   +   L+ +YM  G+L++ LY  +     +   Q L I I 
Sbjct: 88  TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 614 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 673
            A  L YLH   +  IIH D+K  N+LLD+N V  ++DFG++K   E  Q+        T
Sbjct: 148 AARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGT 204
Query: 674 IGYMAPDEIFSGEMRLK 690
           +GY+ P+    G +  K
Sbjct: 205 LGYIDPEYFIKGRLTEK 221

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 92.4 bits (228), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 71/214 (33%), Positives = 107/214 (50%), Gaps = 23/214 (10%)
Query: 495 SVADQR--RFTYLELFQATNRFSEN------NLIGRGGFGPVYK---DGMEVAIK----V 539
            V+D R   F++ EL   TN F E       N +G GGFG VYK   +   VA+K    +
Sbjct: 6   EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAM 65
Query: 540 FNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLE---KCLY 596
            ++      + FD E  +M + +H NL++++   S+ D   LV  YMP GSL     CL 
Sbjct: 66  VDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL- 124
Query: 597 SGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK 656
            G   L       I    A+ + +LH  +    IH D+K +N+LLD+   A +SDFG+A+
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 657 PLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
              +  Q++  ++ + T  YMAP E   GE+  K
Sbjct: 182 ASEKFAQTVMXSRIVGTTAYMAP-EALRGEITPK 214

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 91.7 bits (226), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/214 (33%), Positives = 106/214 (49%), Gaps = 23/214 (10%)
Query: 495 SVADQR--RFTYLELFQATNRFSEN------NLIGRGGFGPVYK---DGMEVAIK----V 539
            V+D R   F++ EL   TN F E       N +G GGFG VYK   +   VA+K    +
Sbjct: 6   EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAM 65
Query: 540 FNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLE---KCLY 596
            ++      + FD E  +M + +H NL++++   S+ D   LV  YMP GSL     CL 
Sbjct: 66  VDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL- 124
Query: 597 SGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK 656
            G   L       I    A+ + +LH  +    IH D+K +N+LLD+   A +SDFG+A+
Sbjct: 125 DGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLAR 181
Query: 657 PLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
              +  Q++   + + T  YMAP E   GE+  K
Sbjct: 182 ASEKFAQTVMXXRIVGTTAYMAP-EALRGEITPK 214

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 71/213 (33%), Positives = 105/213 (49%), Gaps = 23/213 (10%)
Query: 496 VADQR--RFTYLELFQATNRFSEN------NLIGRGGFGPVYK---DGMEVAIK----VF 540
           V+D R   F++ EL   TN F E       N +G GGFG VYK   +   VA+K    + 
Sbjct: 1   VSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMV 60
Query: 541 NLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLE---KCLYS 597
           ++      + FD E  +M + +H NL++++   S+ D   LV  YMP GSL     CL  
Sbjct: 61  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-D 119
Query: 598 GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP 657
           G   L       I    A+ + +LH  +    IH D+K +N+LLD+   A +SDFG+A+ 
Sbjct: 120 GTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARA 176
Query: 658 LLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
             +  Q +   + + T  YMAP E   GE+  K
Sbjct: 177 SEKFAQXVMXXRIVGTTAYMAP-EALRGEITPK 208

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 502 FTYLELFQATNRFSEN------NLIGRGGFGPVYK---DGMEVAIK----VFNLQYGGAF 548
           F++ EL   TN F E       N  G GGFG VYK   +   VA+K    + ++      
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 65
Query: 549 KSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLE---KCLYSGNYILDIF 605
           + FD E  +  + +H NL++++   S+ D   LV  Y P GSL     CL  G   L   
Sbjct: 66  QQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCL-DGTPPLSWH 124
Query: 606 QGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL 665
               I    A+ + +LH  +    IH D+K +N+LLD+   A +SDFG+A+   +  Q +
Sbjct: 125 XRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 666 TQTQTLATIGYMAPDEIFSGEMRLK 690
             ++ + T  Y AP E   GE+  K
Sbjct: 182 XXSRIVGTTAYXAP-EALRGEITPK 205

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 86/168 (51%), Gaps = 10/168 (5%)
Query: 520 IGRGGFGPVYK---DGMEVAIKVFNLQ--YGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           IG G FG V++    G +VA+K+   Q  +      F  E  +MKR+RH N++  + + +
Sbjct: 45  IGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104
Query: 575 NDDFKALVLEYMPLGSLEKCLYS--GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
                ++V EY+  GSL + L+       LD  + L++  DVA  + YLH   + PI+H 
Sbjct: 105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHR 163
Query: 633 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           DLK  N+L+D      + DFG+++  L+    L       T  +MAP+
Sbjct: 164 DLKSPNLLVDKKYTVKVCDFGLSR--LKASXFLXSKXAAGTPEWMAPE 209

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/168 (30%), Positives = 87/168 (51%), Gaps = 10/168 (5%)
Query: 520 IGRGGFGPVYK---DGMEVAIKVFNLQ--YGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           IG G FG V++    G +VA+K+   Q  +      F  E  +MKR+RH N++  + + +
Sbjct: 45  IGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104
Query: 575 NDDFKALVLEYMPLGSLEKCLYS--GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
                ++V EY+  GSL + L+       LD  + L++  DVA  + YLH   + PI+H 
Sbjct: 105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHR 163
Query: 633 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           +LK  N+L+D      + DFG+++  L+    L+      T  +MAP+
Sbjct: 164 NLKSPNLLVDKKYTVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAPE 209

>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 90/198 (45%), Gaps = 4/198 (2%)
Query: 242 LEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLT-SIPSTLWNL 300
           + G+IPD L ++  L  LD   N LSG +P    +L NL  +    N ++ +IP +  + 
Sbjct: 113 VSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSF 172
Query: 301 KDIL-HLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYN 359
             +   + +S N  TG +P    NLN L  +DLS N          G  K+ Q + L  N
Sbjct: 173 SKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN 231
Query: 360 RLQGSIPNSIGDLIXXXXXXXXXXXXXGTIPISLEKLLDLKDINVSFNRLEGEIPREGPF 419
            L   +   +G                GT+P  L +L  L  +NVSFN L GEIP+ G  
Sbjct: 232 SLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNL 290
Query: 420 RNLSAESFKGNELLCGMP 437
           +     ++  N+ LCG P
Sbjct: 291 QRFDVSAYANNKCLCGSP 308

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 84/167 (50%), Gaps = 8/167 (4%)
Query: 520 IGRGGFGPVYKDGM--EVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           IG G FG VYK     +VA+K+  +       F++F  E  ++++ RH N++  +   + 
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK 103
Query: 576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLK 635
           D+  A+V ++    SL K L+       +FQ ++I    A  ++YLH   +  IIH D+K
Sbjct: 104 DNL-AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMK 159
Query: 636 PSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
            +N+ L + +   + DFG+A        S    Q   ++ +MAP+ I
Sbjct: 160 SNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVI 206

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 93/181 (51%), Gaps = 18/181 (9%)
Query: 515 SENNLIGRGGFGPVYKDGM--------EVAIKVFNLQYGGAFKS---FDIECGMMKRIRH 563
           +   +IG G FG VYK GM        EV + +  L+ G   K    F  E G+M +  H
Sbjct: 47  TRQKVIGAGEFGEVYK-GMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 105
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHF 623
            N+I++    S      ++ EYM  G+L+K L   +    + Q + ++  +A+ ++YL  
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA- 164
Query: 624 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPDE 681
             ++  +H DL   N+L++ N+V  +SDFG+++ +LE+D   T T +     I + AP+ 
Sbjct: 165 --NMNYVHRDLAARNILVNSNLVCKVSDFGLSR-VLEDDPEATYTTSGGKIPIRWTAPEA 221
Query: 682 I 682
           I
Sbjct: 222 I 222

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/188 (29%), Positives = 94/188 (50%), Gaps = 16/188 (8%)
Query: 513 RFSENNLIGRGGFGPVY--KD---GMEVAIKVFNL---QYGGAFKSFDIECGMMKRIRHR 564
           R+   + +G GG   VY  +D    ++VAIK   +   +     K F+ E     ++ H+
Sbjct: 12  RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQ 71
Query: 565 NLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFG 624
           N++ +I     DD   LV+EY+   +L + + S    L +   +N    +   +++ H  
Sbjct: 72  NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP-LSVDTAINFTNQILDGIKHAH-- 128
Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT-QTLATIGYMAPDEIF 683
             + I+H D+KP N+L+D N    + DFG+AK L E   SLTQT   L T+ Y +P++  
Sbjct: 129 -DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE--TSLTQTNHVLGTVQYFSPEQA- 184
Query: 684 SGEMRLKC 691
            GE   +C
Sbjct: 185 KGEATDEC 192

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 82/181 (45%), Gaps = 21/181 (11%)
Query: 517 NNLIGRGGFGPVYKD---GMEVAIKVF----NLQYGGAFKSFDIECGMMKRIRHRNLIKI 569
             +IG GGFG VY+    G EVA+K      +       ++   E  +   ++H N+I +
Sbjct: 12  EEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 570 ISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPI 629
              C  +    LV+E+   G L + L       DI   +N  + +A  + YLH    VPI
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDIL--VNWAVQIARGMNYLHDEAIVPI 129
Query: 630 IHCDLKPSNVLLDD--------NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
           IH DLK SN+L+          N +  ++DFG+A+    E    T+        +MAP+ 
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAAGAYAWMAPEV 185
Query: 682 I 682
           I
Sbjct: 186 I 186

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/188 (27%), Positives = 80/188 (42%), Gaps = 28/188 (14%)
Query: 520 IGRGGFGPVY----------KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKI 569
           +G G FG V+          KD M VA+K        A K F  E  ++  ++H +++K 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 570 ISSCSNDDFKALVLEYMPLGSLEKCLYS---------------GNYILDIFQGLNIMIDV 614
              C + D   +V EYM  G L K L +                   L + Q L+I   +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 615 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI 674
           AS + YL    S   +H DL   N L+  N++  + DFGM++ +   D       T+  I
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 675 GYMAPDEI 682
            +M P+ I
Sbjct: 200 RWMPPESI 207

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 82/185 (44%), Gaps = 25/185 (13%)
Query: 520 IGRGGFGPVY----------KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKI 569
           +G G FG V+          +D + VA+K        A K F  E  ++  ++H +++K 
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 570 ISSCSNDDFKALVLEYMPLGSLEKCLYS----------GNYILDIFQG--LNIMIDVASA 617
              C   D   +V EYM  G L K L +          GN   ++ Q   L+I   +A+ 
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 618 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 677
           + YL    S   +H DL   N L+ +N++  + DFGM++ +   D       T+  I +M
Sbjct: 141 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197
Query: 678 APDEI 682
            P+ I
Sbjct: 198 PPESI 202

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 96/178 (53%), Gaps = 15/178 (8%)
Query: 520 IGRGGFGPVY----KDGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G+G FG V+         VAIK   L+ G  + ++F  E  +MK++RH  L+++ +  S
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 575 NDDFKALVLEYMPLGSLEKCLY--SGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
            +    +V EYM  GSL   L   +G Y L + Q +++   +AS + Y+     +  +H 
Sbjct: 74  EEPI-XIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 128
Query: 633 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           DL+ +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + AP+    G   +K
Sbjct: 129 DLRAANILVGENLVCKVADFGLAR-LIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 185

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 18/202 (8%)
Query: 493 MPSVADQRRFTYLELFQATNRFSENNLIGRGGFGPV--------YKDGMEVAIKVFNLQY 544
           +P  + Q    + +   ATN  S + ++G G FG V         K  + VAIK   + Y
Sbjct: 15  VPRGSTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY 73
Query: 545 G-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD 603
                + F  E  +M +  H N+I++    +      +V EYM  GSL+  L   +    
Sbjct: 74  TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFT 133
Query: 604 IFQGLNIMIDVASALEYL-HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED 662
           + Q + ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDFG+++ +LE+D
Sbjct: 134 VIQLVGMLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSR-VLEDD 188
Query: 663 QSLTQTQTLAT--IGYMAPDEI 682
                T       I + +P+ I
Sbjct: 189 PEAAYTTRGGKIPIRWTSPEAI 210

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 19/214 (8%)
Query: 505 LELFQATNRFSENNLIGRGGFGPVYKDGME-----VAIKVFNLQY-----GGAFKSFDIE 554
           L++     R+ + + +G G F  VYK   +     VAIK   L +      G  ++   E
Sbjct: 3   LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE 62
Query: 555 CGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDV 614
             +++ + H N+I ++ +  +    +LV ++M    LE  +   + +L        M+  
Sbjct: 63  IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMT 121
Query: 615 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI 674
              LEYLH  +   I+H DLKP+N+LLD+N V  L+DFG+AK     +++      + T 
Sbjct: 122 LQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--XHQVVTR 176
Query: 675 GYMAPDEIFSGEMR---LKCWVNDSLLISVMIVV 705
            Y AP+ +F   M    +  W    +L  +++ V
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 96/178 (53%), Gaps = 15/178 (8%)
Query: 520 IGRGGFGPVY----KDGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G+G FG V+         VAIK   L+ G  + ++F  E  +MK++RH  L+++ +  S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 575 NDDFKALVLEYMPLGSLEKCLY--SGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
            +    +V EYM  GSL   L   +G Y L + Q +++   +AS + Y+     +  +H 
Sbjct: 250 EEPI-YIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 633 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           DL+ +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + AP+    G   +K
Sbjct: 305 DLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 96/178 (53%), Gaps = 15/178 (8%)
Query: 520 IGRGGFGPVY----KDGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G+G FG V+         VAIK   L+ G  + ++F  E  +MK++RH  L+++ +  S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 575 NDDFKALVLEYMPLGSLEKCLY--SGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
            +    +V EYM  GSL   L   +G Y L + Q +++   +AS + Y+     +  +H 
Sbjct: 250 EEPI-YIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 633 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           DL+ +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + AP+    G   +K
Sbjct: 305 DLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 96/178 (53%), Gaps = 15/178 (8%)
Query: 520 IGRGGFGPVY----KDGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G+G FG V+         VAIK   L+ G  + ++F  E  +MK++RH  L+++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 575 NDDFKALVLEYMPLGSLEKCLYS--GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
            +    +V+EYM  GSL   L    G Y L + Q +++   +AS + Y+     +  +H 
Sbjct: 84  EEPI-YIVIEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 633 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           DL+ +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + AP+    G   +K
Sbjct: 139 DLRAANILVGENLVCKVADFGLAR-LIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 195

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 93/196 (47%), Gaps = 18/196 (9%)
Query: 499 QRRFTYLELFQATNRFSENNLIGRGGFGPV--------YKDGMEVAIKVFNLQYG-GAFK 549
           Q    + +   ATN  S + ++G G FG V         K  + VAIK   + Y     +
Sbjct: 33  QTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 550 SFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLN 609
            F  E  +M +  H N+I++    +      +V EYM  GSL+  L   +    + Q + 
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 610 IMIDVASALEYL-HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
           ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDFG+A+ +LE+D     T
Sbjct: 152 MLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLAR-VLEDDPEAAYT 206
Query: 669 QTLAT--IGYMAPDEI 682
                  I + +P+ I
Sbjct: 207 TRGGKIPIRWTSPEAI 222

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 83/167 (49%), Gaps = 8/167 (4%)
Query: 520 IGRGGFGPVYKDGM--EVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           IG G FG VYK     +VA+K+ N+        ++F  E G++++ RH N++  +   + 
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 91
Query: 576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLK 635
               A+V ++    SL   L++     ++ + ++I    A  ++YLH   +  IIH DLK
Sbjct: 92  PQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLK 147
Query: 636 PSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
            +N+ L ++    + DFG+A        S    Q   +I +MAP+ I
Sbjct: 148 SNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 83/167 (49%), Gaps = 8/167 (4%)
Query: 520 IGRGGFGPVYKDGM--EVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           IG G FG VYK     +VA+K+ N+        ++F  E G++++ RH N++  +   + 
Sbjct: 36  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 95
Query: 576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLK 635
               A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH DLK
Sbjct: 96  PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 151
Query: 636 PSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
            +N+ L +++   + DFG+A        S    Q   +I +MAP+ I
Sbjct: 152 SNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 198

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 96/178 (53%), Gaps = 15/178 (8%)
Query: 520 IGRGGFGPVY----KDGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G+G FG V+         VAIK   L+ G  + ++F  E  +MK++RH  L+++ +  S
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 575 NDDFKALVLEYMPLGSLEKCLY--SGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
            +    +V EYM  GSL   L   +G Y L + Q +++   +AS + Y+     +  +H 
Sbjct: 333 EEPI-YIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 387
Query: 633 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           DL+ +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + AP+    G   +K
Sbjct: 388 DLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 96/178 (53%), Gaps = 15/178 (8%)
Query: 520 IGRGGFGPVY----KDGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G+G FG V+         VAIK   L+ G  + ++F  E  +MK++RH  L+++ +  S
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 575 NDDFKALVLEYMPLGSLEKCLY--SGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
            +    +V EYM  GSL   L   +G Y L + Q +++   +AS + Y+     +  +H 
Sbjct: 77  EEPI-YIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 131
Query: 633 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           DL+ +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + AP+    G   +K
Sbjct: 132 DLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 188

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 95/178 (53%), Gaps = 15/178 (8%)
Query: 520 IGRGGFGPVY----KDGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G+G FG V+         VAIK   L+ G  + ++F  E  +MK+IRH  L+++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 575 NDDFKALVLEYMPLGSLEKCLYS--GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
            +    +V EYM  GSL   L    G Y L + Q +++   +AS + Y+     +  +H 
Sbjct: 84  EEPI-YIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 633 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           DL+ +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + AP+    G   +K
Sbjct: 139 DLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 83/167 (49%), Gaps = 8/167 (4%)
Query: 520 IGRGGFGPVYKDGM--EVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           IG G FG VYK     +VA+K+ N+        ++F  E G++++ RH N++  +   + 
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLK 635
               A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH DLK
Sbjct: 76  PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 131
Query: 636 PSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
            +N+ L +++   + DFG+A        S    Q   +I +MAP+ I
Sbjct: 132 SNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 178

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 96/178 (53%), Gaps = 15/178 (8%)
Query: 520 IGRGGFGPVY----KDGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G+G FG V+         VAIK   L+ G  + ++F  E  +MK++RH  L+++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 575 NDDFKALVLEYMPLGSLEKCLYS--GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
            +    +V+EYM  GSL   L    G Y L + Q +++   +AS + Y+     +  +H 
Sbjct: 84  EEPI-YIVIEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 633 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           DL+ +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + AP+    G   +K
Sbjct: 139 DLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/176 (31%), Positives = 82/176 (46%), Gaps = 18/176 (10%)
Query: 517 NNLIGRGGFGPVYK---DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSC 573
             ++GRG FG V K      +VAIK   ++     K+F +E   + R+ H N++K+  +C
Sbjct: 13  EEVVGRGAFGVVCKAKWRAKDVAIK--QIESESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIM---IDVASALEYLHFGYSVPII 630
            N     LV+EY   GSL   L+ G   L  +   + M   +  +  + YLH      +I
Sbjct: 71  LNP--VCLVMEYAEGGSLYNVLH-GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 631 HCDLKPSNVLL-DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG 685
           H DLKP N+LL     V  + DFG A      D     T    +  +MAP E+F G
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAP-EVFEG 177

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/176 (31%), Positives = 82/176 (46%), Gaps = 18/176 (10%)
Query: 517 NNLIGRGGFGPVYK---DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSC 573
             ++GRG FG V K      +VAIK   ++     K+F +E   + R+ H N++K+  +C
Sbjct: 14  EEVVGRGAFGVVCKAKWRAKDVAIK--QIESESERKAFIVELRQLSRVNHPNIVKLYGAC 71
Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIM---IDVASALEYLHFGYSVPII 630
            N     LV+EY   GSL   L+ G   L  +   + M   +  +  + YLH      +I
Sbjct: 72  LNP--VCLVMEYAEGGSLYNVLH-GAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 128
Query: 631 HCDLKPSNVLL-DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG 685
           H DLKP N+LL     V  + DFG A      D     T    +  +MAP E+F G
Sbjct: 129 HRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAP-EVFEG 178

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 83/167 (49%), Gaps = 8/167 (4%)
Query: 520 IGRGGFGPVYKDGM--EVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           IG G FG VYK     +VA+K+ N+        ++F  E G++++ RH N++  +   + 
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLK 635
               A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH DLK
Sbjct: 104 PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 159
Query: 636 PSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
            +N+ L +++   + DFG+A        S    Q   +I +MAP+ I
Sbjct: 160 SNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 206

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 83/167 (49%), Gaps = 8/167 (4%)
Query: 520 IGRGGFGPVYKDGM--EVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           IG G FG VYK     +VA+K+ N+        ++F  E G++++ RH N++  +   + 
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 79
Query: 576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLK 635
               A+V ++    SL   L++     ++ + ++I    A  ++YLH   +  IIH DLK
Sbjct: 80  PQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLK 135
Query: 636 PSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
            +N+ L ++    + DFG+A        S    Q   +I +MAP+ I
Sbjct: 136 SNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 182

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 83/167 (49%), Gaps = 8/167 (4%)
Query: 520 IGRGGFGPVYKDGM--EVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           IG G FG VYK     +VA+K+ N+        ++F  E G++++ RH N++  +   + 
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 77
Query: 576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLK 635
               A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH DLK
Sbjct: 78  PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 133
Query: 636 PSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
            +N+ L +++   + DFG+A        S    Q   +I +MAP+ I
Sbjct: 134 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 180

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 17/184 (9%)
Query: 511 TNRFSENNLIGRGGFG---------PVYKDGMEVAIKVFNLQYGG-AFKSFDIECGMMKR 560
            +R     +IG G  G         P  +D + VAIK     Y     + F  E  +M +
Sbjct: 48  ASRIHIEKIIGSGDSGEVCYGRLRVPGQRD-VPVAIKALKAGYTERQRRDFLSEASIMGQ 106
Query: 561 IRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEY 620
             H N+I++    +      +V EYM  GSL+  L + +    I Q + ++  V + + Y
Sbjct: 107 FDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRY 166
Query: 621 L-HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE-DQSLTQTQTLATIGYMA 678
           L   GY    +H DL   NVL+D N+V  +SDFG+++ L ++ D + T T     I + A
Sbjct: 167 LSDLGY----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTA 222
Query: 679 PDEI 682
           P+ I
Sbjct: 223 PEAI 226

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 96/178 (53%), Gaps = 15/178 (8%)
Query: 520 IGRGGFGPVY----KDGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G+G FG V+         VAIK   L+ G  + ++F  E  +MK++RH  L+++ +  S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 575 NDDFKALVLEYMPLGSLEKCLY--SGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
            +    +V EYM  GSL   L   +G Y L + Q +++   +AS + Y+     +  +H 
Sbjct: 250 EEPI-YIVGEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 304
Query: 633 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           DL+ +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + AP+    G   +K
Sbjct: 305 DLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 83/167 (49%), Gaps = 8/167 (4%)
Query: 520 IGRGGFGPVYKDGM--EVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           IG G FG VYK     +VA+K+ N+        ++F  E G++++ RH N++  +   + 
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLK 635
               A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH DLK
Sbjct: 81  PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 136
Query: 636 PSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
            +N+ L +++   + DFG+A        S    Q   +I +MAP+ I
Sbjct: 137 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 183

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 83/167 (49%), Gaps = 8/167 (4%)
Query: 520 IGRGGFGPVYKDGM--EVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           IG G FG VYK     +VA+K+ N+        ++F  E G++++ RH N++  +   + 
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLK 635
               A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH DLK
Sbjct: 81  PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 136
Query: 636 PSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
            +N+ L +++   + DFG+A        S    Q   +I +MAP+ I
Sbjct: 137 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 183

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 83/167 (49%), Gaps = 8/167 (4%)
Query: 520 IGRGGFGPVYKDGM--EVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           IG G FG VYK     +VA+K+ N+        ++F  E G++++ RH N++  +   + 
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLK 635
               A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH DLK
Sbjct: 76  PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 131
Query: 636 PSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
            +N+ L +++   + DFG+A        S    Q   +I +MAP+ I
Sbjct: 132 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 83/167 (49%), Gaps = 8/167 (4%)
Query: 520 IGRGGFGPVYKDGM--EVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           IG G FG VYK     +VA+K+ N+        ++F  E G++++ RH N++  +   + 
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 91
Query: 576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLK 635
               A+V ++    SL   L++     ++ + ++I    A  ++YLH   +  IIH DLK
Sbjct: 92  PQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLK 147
Query: 636 PSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
            +N+ L ++    + DFG+A        S    Q   +I +MAP+ I
Sbjct: 148 SNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 86/184 (46%), Gaps = 17/184 (9%)
Query: 511 TNRFSENNLIGRGGFG---------PVYKDGMEVAIKVFNLQYGG-AFKSFDIECGMMKR 560
            +R     +IG G  G         P  +D + VAIK     Y     + F  E  +M +
Sbjct: 48  ASRIHIEKIIGSGDSGEVCYGRLRVPGQRD-VPVAIKALKAGYTERQRRDFLSEASIMGQ 106
Query: 561 IRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEY 620
             H N+I++    +      +V EYM  GSL+  L + +    I Q + ++  V + + Y
Sbjct: 107 FDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRY 166
Query: 621 L-HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE-DQSLTQTQTLATIGYMA 678
           L   GY    +H DL   NVL+D N+V  +SDFG+++ L ++ D + T T     I + A
Sbjct: 167 LSDLGY----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTA 222
Query: 679 PDEI 682
           P+ I
Sbjct: 223 PEAI 226

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 93/196 (47%), Gaps = 18/196 (9%)
Query: 499 QRRFTYLELFQATNRFSENNLIGRGGFGPV--------YKDGMEVAIKVFNLQYG-GAFK 549
           Q    + +   ATN  S + ++G G FG V         K  + VAIK   + Y     +
Sbjct: 4   QTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 62
Query: 550 SFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLN 609
            F  E  +M +  H N+I++    +      +V EYM  GSL+  L   +    + Q + 
Sbjct: 63  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 122
Query: 610 IMIDVASALEYL-HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
           ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDFG+++ +LE+D     T
Sbjct: 123 MLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAYT 177
Query: 669 QTLAT--IGYMAPDEI 682
                  I + +P+ I
Sbjct: 178 TRGGKIPIRWTSPEAI 193

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 95/178 (53%), Gaps = 15/178 (8%)
Query: 520 IGRGGFGPVY----KDGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G+G FG V+         VAIK   L+ G  + ++F  E  +MK++RH  L+++ +  S
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 575 NDDFKALVLEYMPLGSLEKCLYS--GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
            +    +V EYM  GSL   L    G Y L + Q +++   +AS + Y+     +  +H 
Sbjct: 73  EEPI-YIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 127
Query: 633 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           DL+ +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + AP+    G   +K
Sbjct: 128 DLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 184

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 96/178 (53%), Gaps = 15/178 (8%)
Query: 520 IGRGGFGPVY----KDGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G+G FG V+         VAIK   L+ G  + ++F  E  +MK++RH  L+++ +  S
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 575 NDDFKALVLEYMPLGSLEKCLY--SGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
            +    +V EYM  GSL   L   +G Y L + Q +++   +AS + Y+     +  +H 
Sbjct: 81  EEPI-YIVTEYMNKGSLLDFLKGETGKY-LRLPQLVDMSAQIASGMAYVE---RMNYVHR 135
Query: 633 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           DL+ +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + AP+    G   +K
Sbjct: 136 DLRAANILVGENLVCKVADFGLAR-LIEDNEWTARQGAKFPIKWTAPEAALYGRFTIK 192

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 83/167 (49%), Gaps = 8/167 (4%)
Query: 520 IGRGGFGPVYKDGM--EVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           IG G FG VYK     +VA+K+ N+        ++F  E G++++ RH N++  +   + 
Sbjct: 43  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 102
Query: 576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLK 635
               A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH DLK
Sbjct: 103 PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 158
Query: 636 PSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
            +N+ L +++   + DFG+A        S    Q   +I +MAP+ I
Sbjct: 159 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 205

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 83/167 (49%), Gaps = 8/167 (4%)
Query: 520 IGRGGFGPVYKDGM--EVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           IG G FG VYK     +VA+K+ N+        ++F  E G++++ RH N++  +   + 
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLK 635
               A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH DLK
Sbjct: 104 PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 159
Query: 636 PSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
            +N+ L +++   + DFG+A        S    Q   +I +MAP+ I
Sbjct: 160 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 206

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 93/196 (47%), Gaps = 18/196 (9%)
Query: 499 QRRFTYLELFQATNRFSENNLIGRGGFGPV--------YKDGMEVAIKVFNLQYG-GAFK 549
           Q    + +   ATN  S + ++G G FG V         K  + VAIK   + Y     +
Sbjct: 33  QTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 550 SFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLN 609
            F  E  +M +  H N+I++    +      +V EYM  GSL+  L   +    + Q + 
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 610 IMIDVASALEYL-HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
           ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDFG+++ +LE+D     T
Sbjct: 152 MLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAYT 206
Query: 669 QTLAT--IGYMAPDEI 682
                  I + +P+ I
Sbjct: 207 TRGGKIPIRWTSPEAI 222

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 95/178 (53%), Gaps = 15/178 (8%)
Query: 520 IGRGGFGPVY----KDGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G+G FG V+         VAIK   L+ G  + ++F  E  +MK++RH  L+++ +  S
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 575 NDDFKALVLEYMPLGSLEKCLYS--GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
            +    +V EYM  GSL   L    G Y L + Q +++   +AS + Y+     +  +H 
Sbjct: 75  EEPI-YIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 129
Query: 633 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           DL+ +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + AP+    G   +K
Sbjct: 130 DLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 186

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 93/196 (47%), Gaps = 18/196 (9%)
Query: 499 QRRFTYLELFQATNRFSENNLIGRGGFGPV--------YKDGMEVAIKVFNLQYG-GAFK 549
           Q    + +   ATN  S + ++G G FG V         K  + VAIK   + Y     +
Sbjct: 33  QTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 550 SFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLN 609
            F  E  +M +  H N+I++    +      +V EYM  GSL+  L   +    + Q + 
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 610 IMIDVASALEYL-HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
           ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDFG+++ +LE+D     T
Sbjct: 152 MLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAYT 206
Query: 669 QTLAT--IGYMAPDEI 682
                  I + +P+ I
Sbjct: 207 TRGGKIPIRWTSPEAI 222

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 93/196 (47%), Gaps = 18/196 (9%)
Query: 499 QRRFTYLELFQATNRFSENNLIGRGGFGPV--------YKDGMEVAIKVFNLQYG-GAFK 549
           Q    + +   ATN  S + ++G G FG V         K  + VAIK   + Y     +
Sbjct: 33  QTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 550 SFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLN 609
            F  E  +M +  H N+I++    +      +V EYM  GSL+  L   +    + Q + 
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 610 IMIDVASALEYL-HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
           ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDFG+++ +LE+D     T
Sbjct: 152 MLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAYT 206
Query: 669 QTLAT--IGYMAPDEI 682
                  I + +P+ I
Sbjct: 207 TRGGKIPIRWTSPEAI 222

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 96/178 (53%), Gaps = 15/178 (8%)
Query: 520 IGRGGFGPVY----KDGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G+G FG V+         VAIK   L+ G  + ++F  E  +MK++RH  L+++ +  S
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 575 NDDFKALVLEYMPLGSLEKCLY--SGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
            +    +V EYM  GSL   L   +G Y L + Q +++   +AS + Y+     +  +H 
Sbjct: 81  EEPI-YIVTEYMNKGSLLDFLKGETGKY-LRLPQLVDMSAQIASGMAYVE---RMNYVHR 135
Query: 633 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           DL+ +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + AP+    G   +K
Sbjct: 136 DLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 192

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 93/196 (47%), Gaps = 18/196 (9%)
Query: 499 QRRFTYLELFQATNRFSENNLIGRGGFGPV--------YKDGMEVAIKVFNLQYG-GAFK 549
           Q    + +   ATN  S + ++G G FG V         K  + VAIK   + Y     +
Sbjct: 33  QTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 550 SFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLN 609
            F  E  +M +  H N+I++    +      +V EYM  GSL+  L   +    + Q + 
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 610 IMIDVASALEYL-HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
           ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDFG+++ +LE+D     T
Sbjct: 152 MLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAYT 206
Query: 669 QTLAT--IGYMAPDEI 682
                  I + +P+ I
Sbjct: 207 TRGGKIPIRWTSPEAI 222

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 93/196 (47%), Gaps = 18/196 (9%)
Query: 499 QRRFTYLELFQATNRFSENNLIGRGGFGPV--------YKDGMEVAIKVFNLQYG-GAFK 549
           Q    + +   ATN  S + ++G G FG V         K  + VAIK   + Y     +
Sbjct: 31  QTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 89
Query: 550 SFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLN 609
            F  E  +M +  H N+I++    +      +V EYM  GSL+  L   +    + Q + 
Sbjct: 90  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 149
Query: 610 IMIDVASALEYL-HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
           ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDFG+++ +LE+D     T
Sbjct: 150 MLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAYT 204
Query: 669 QTLAT--IGYMAPDEI 682
                  I + +P+ I
Sbjct: 205 TRGGKIPIRWTSPEAI 220

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 95/178 (53%), Gaps = 15/178 (8%)
Query: 520 IGRGGFGPVY----KDGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G+G FG V+         VAIK   L+ G  + ++F  E  +MK++RH  L+++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 575 NDDFKALVLEYMPLGSLEKCLYS--GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
            +    +V EYM  GSL   L    G Y L + Q +++   +AS + Y+     +  +H 
Sbjct: 84  EEPI-YIVCEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 633 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           DL+ +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + AP+    G   +K
Sbjct: 139 DLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 83/167 (49%), Gaps = 8/167 (4%)
Query: 520 IGRGGFGPVYKDGM--EVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           IG G FG VYK     +VA+K+ N+        ++F  E G++++ RH N++  +   + 
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75
Query: 576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLK 635
               A+V ++    SL   L+      ++ + ++I    A  ++YLH   +  IIH DLK
Sbjct: 76  PQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLK 131
Query: 636 PSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
            +N+ L +++   + DFG+A        S    Q   +I +MAP+ I
Sbjct: 132 SNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 95/178 (53%), Gaps = 15/178 (8%)
Query: 520 IGRGGFGPVY----KDGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G+G FG V+         VAIK   L+ G  + ++F  E  +MK++RH  L+++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 575 NDDFKALVLEYMPLGSLEKCLYS--GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
            +    +V EYM  GSL   L    G Y L + Q +++   +AS + Y+     +  +H 
Sbjct: 84  EEPI-YIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 633 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           DL+ +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + AP+    G   +K
Sbjct: 139 DLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 92/196 (46%), Gaps = 18/196 (9%)
Query: 499 QRRFTYLELFQATNRFSENNLIGRGGFGPV--------YKDGMEVAIKVFNLQYG-GAFK 549
           Q    + +   ATN  S + ++G G FG V         K  + VAIK   + Y     +
Sbjct: 33  QTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 550 SFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLN 609
            F  E  +M +  H N+I++    +      +V EYM  GSL+  L   +    + Q + 
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 610 IMIDVASALEYL-HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
           ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDFG+ + +LE+D     T
Sbjct: 152 MLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLGR-VLEDDPEAAYT 206
Query: 669 QTLAT--IGYMAPDEI 682
                  I + +P+ I
Sbjct: 207 TRGGKIPIRWTSPEAI 222

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 91/194 (46%), Gaps = 25/194 (12%)
Query: 510 ATNRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNL-------QYGGAFKSFDIECGM 557
           A N       IG+GGFG V+     KD   VAIK   L       +    F+ F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 558 MKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASA 617
           M  + H N++K+     N     +V+E++P G L   L    + +     L +M+D+A  
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 618 LEYLHFGYSVPIIHCDLKPSNVL---LDDN--MVAHLSDFGMAKPLLEEDQSLTQTQTLA 672
           +EY+    + PI+H DL+  N+    LD+N  + A ++DFG+++  +     L     L 
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGL-----LG 188
Query: 673 TIGYMAPDEIFSGE 686
              +MAP+ I + E
Sbjct: 189 NFQWMAPETIGAEE 202

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 94/178 (52%), Gaps = 15/178 (8%)
Query: 520 IGRGGFGPVY----KDGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G+G FG V+         VAIK   L+ G  + ++F  E  +MK++RH  L+++ +  S
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKT--LKPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 575 NDDFKALVLEYMPLGSLEKCLYS--GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
            +    +V EYM  GSL   L    G Y L + Q +++   +AS + Y+     +  +H 
Sbjct: 251 EEPI-YIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 305
Query: 633 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           DL+ +N+L+ +N+V  ++DFG+ + L+E+++   +      I + AP+    G   +K
Sbjct: 306 DLRAANILVGENLVCKVADFGLGR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 362

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 95/178 (53%), Gaps = 15/178 (8%)
Query: 520 IGRGGFGPVY----KDGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G+G FG V+         VAIK   L+ G  + ++F  E  +MK++RH  L+++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 575 NDDFKALVLEYMPLGSLEKCLYS--GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
            +    +V+EYM  G L   L    G Y L + Q +++   +AS + Y+     +  +H 
Sbjct: 84  EEPI-YIVMEYMSKGCLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 633 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           DL+ +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + AP+    G   +K
Sbjct: 139 DLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/195 (27%), Positives = 92/195 (47%), Gaps = 16/195 (8%)
Query: 499 QRRFTYLELFQATNRFSENNLIGRGGFGPV--------YKDGMEVAIKVFNLQYG-GAFK 549
           Q    + +   ATN  S + ++G G FG V         K  + VAIK   + Y     +
Sbjct: 33  QTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 550 SFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLN 609
            F  E  +M +  H N+I++    +      +V EYM  GSL+  L   +    + Q + 
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
           ++  +AS ++YL     +  +H DL   N+L++ N+V  +SDFG+++ +LE+D     T 
Sbjct: 152 MLRGIASGMKYLS---DMGFVHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAYTT 207
Query: 670 TLAT--IGYMAPDEI 682
                 I + +P+ I
Sbjct: 208 RGGKIPIRWTSPEAI 222

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 87/189 (46%), Gaps = 23/189 (12%)
Query: 509 QATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKS-FDIECGMMKRIR 562
           Q    +     +G GGFG V +      G +VAIK    +     +  + +E  +MK++ 
Sbjct: 12  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 71
Query: 563 HRNLIKI------ISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQG--LNIMIDV 614
           H N++        +   + +D   L +EY   G L K L        + +G    ++ D+
Sbjct: 72  HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 131
Query: 615 ASALEYLHFGYSVPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEEDQSLTQTQTL 671
           +SAL YLH      IIH DLKP N++L      ++  + D G AK L   DQ    T+ +
Sbjct: 132 SSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFV 185
Query: 672 ATIGYMAPD 680
            T+ Y+AP+
Sbjct: 186 GTLQYLAPE 194

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/194 (28%), Positives = 90/194 (46%), Gaps = 25/194 (12%)
Query: 510 ATNRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNL-------QYGGAFKSFDIECGM 557
           A N       IG+GGFG V+     KD   VAIK   L       +    F+ F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 558 MKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASA 617
           M  + H N++K+     N     +V+E++P G L   L    + +     L +M+D+A  
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 618 LEYLHFGYSVPIIHCDLKPSNVL---LDDN--MVAHLSDFGMAKPLLEEDQSLTQTQTLA 672
           +EY+    + PI+H DL+  N+    LD+N  + A ++DFG ++  +     L     L 
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSGL-----LG 188
Query: 673 TIGYMAPDEIFSGE 686
              +MAP+ I + E
Sbjct: 189 NFQWMAPETIGAEE 202

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 94/178 (52%), Gaps = 15/178 (8%)
Query: 520 IGRGGFGPVY----KDGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G+G FG V+         VAIK   L+ G  + ++F  E  +MK++RH  L+++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 575 NDDFKALVLEYMPLGSLEKCLYS--GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
            +    +V EYM  GSL   L    G Y L + Q +++   +AS + Y+     +  +H 
Sbjct: 84  EEPI-YIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 633 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           DL  +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + AP+    G   +K
Sbjct: 139 DLAAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 87/189 (46%), Gaps = 23/189 (12%)
Query: 509 QATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKS-FDIECGMMKRIR 562
           Q    +     +G GGFG V +      G +VAIK    +     +  + +E  +MK++ 
Sbjct: 11  QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70
Query: 563 HRNLIKI------ISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQG--LNIMIDV 614
           H N++        +   + +D   L +EY   G L K L        + +G    ++ D+
Sbjct: 71  HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130
Query: 615 ASALEYLHFGYSVPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEEDQSLTQTQTL 671
           +SAL YLH      IIH DLKP N++L      ++  + D G AK L   DQ    T+ +
Sbjct: 131 SSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL---DQGELCTEFV 184
Query: 672 ATIGYMAPD 680
            T+ Y+AP+
Sbjct: 185 GTLQYLAPE 193

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 94/178 (52%), Gaps = 15/178 (8%)
Query: 520 IGRGGFGPVY----KDGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G+G FG V+         VAIK   L+ G  + ++F  E  +MK++RH  L+++ +  S
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIK--TLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 575 NDDFKALVLEYMPLGSLEKCLYS--GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
            +    +V EYM  G L   L    G Y L + Q +++   +AS + Y+     +  +H 
Sbjct: 84  EEPI-YIVTEYMSKGCLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHR 138
Query: 633 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           DL+ +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + AP+    G   +K
Sbjct: 139 DLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 85/169 (50%), Gaps = 17/169 (10%)
Query: 520 IGRGGFGPV----YKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           IG+G FG V    Y+ G +VA+K   ++     ++F  E  +M ++RH NL++++     
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 576 DDFK-ALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
           +     +V EYM  GSL   L S G  +L     L   +DV  A+EYL        +H D
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 133
Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
           L   NVL+ ++ VA +SDFG+ K     + S TQ      + + AP+ +
Sbjct: 134 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEAL 177

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 85/169 (50%), Gaps = 17/169 (10%)
Query: 520 IGRGGFGPV----YKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           IG+G FG V    Y+ G +VA+K   ++     ++F  E  +M ++RH NL++++     
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 576 DDFK-ALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
           +     +V EYM  GSL   L S G  +L     L   +DV  A+EYL        +H D
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 127
Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
           L   NVL+ ++ VA +SDFG+ K     + S TQ      + + AP+ +
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEAL 171

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 85/169 (50%), Gaps = 17/169 (10%)
Query: 520 IGRGGFGPV----YKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           IG+G FG V    Y+ G +VA+K   ++     ++F  E  +M ++RH NL++++     
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 576 DDFK-ALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
           +     +V EYM  GSL   L S G  +L     L   +DV  A+EYL        +H D
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 142
Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
           L   NVL+ ++ VA +SDFG+ K     + S TQ      + + AP+ +
Sbjct: 143 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEAL 186

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 80/173 (46%), Gaps = 18/173 (10%)
Query: 520 IGRGGFGPVY------KDGMEVAIKVFNLQYGGAFKSFDI--ECGMMKRIRHRNLIKIIS 571
           IG G FG V+      KD  +VAIK       GA    D   E  +M ++ H  L+++  
Sbjct: 15  IGSGQFGLVHLGYWLNKD--KVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
            C       LV E+M  G L   L +   +      L + +DV   + YL       +IH
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EASVIH 126
Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS 684
            DL   N L+ +N V  +SDFGM + +L +DQ  + T T   + + +P E+FS
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASP-EVFS 177

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 92/196 (46%), Gaps = 18/196 (9%)
Query: 499 QRRFTYLELFQATNRFSENNLIGRGGFGPV--------YKDGMEVAIKVFNLQYG-GAFK 549
           Q    + +   ATN  S + ++G G FG V         K  + VAIK   + Y     +
Sbjct: 4   QTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 62
Query: 550 SFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLN 609
            F  E  +M +  H N+I++    +      +V E M  GSL+  L   +    + Q + 
Sbjct: 63  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVG 122
Query: 610 IMIDVASALEYL-HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
           ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDFG+++ +LE+D     T
Sbjct: 123 MLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAYT 177
Query: 669 QTLAT--IGYMAPDEI 682
                  I + +P+ I
Sbjct: 178 TRGGKIPIRWTSPEAI 193

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 25/194 (12%)
Query: 510 ATNRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNL-------QYGGAFKSFDIECGM 557
           A N       IG+GGFG V+     KD   VAIK   L       +    F+ F  E  +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 558 MKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASA 617
           M  + H N++K+     N     +V+E++P G L   L    + +     L +M+D+A  
Sbjct: 77  MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 618 LEYLHFGYSVPIIHCDLKPSNVL---LDDN--MVAHLSDFGMAKPLLEEDQSLTQTQTLA 672
           +EY+    + PI+H DL+  N+    LD+N  + A ++DF +++  +     L     L 
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSGL-----LG 188
Query: 673 TIGYMAPDEIFSGE 686
              +MAP+ I + E
Sbjct: 189 NFQWMAPETIGAEE 202

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/169 (31%), Positives = 85/169 (50%), Gaps = 17/169 (10%)
Query: 520 IGRGGFGPV----YKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           IG+G FG V    Y+ G +VA+K   ++     ++F  E  +M ++RH NL++++     
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 576 DDFK-ALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
           +     +V EYM  GSL   L S G  +L     L   +DV  A+EYL        +H D
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 314
Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
           L   NVL+ ++ VA +SDFG+ K     + S TQ      + + AP+ +
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEAL 358

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 80/173 (46%), Gaps = 18/173 (10%)
Query: 520 IGRGGFGPVY------KDGMEVAIKVFNLQYGGAFKSFDI--ECGMMKRIRHRNLIKIIS 571
           IG G FG V+      KD  +VAIK       GA    D   E  +M ++ H  L+++  
Sbjct: 15  IGSGQFGLVHLGYWLNKD--KVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYG 69
Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
            C       LV E+M  G L   L +   +      L + +DV   + YL       +IH
Sbjct: 70  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIH 126
Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS 684
            DL   N L+ +N V  +SDFGM + +L +DQ  + T T   + + +P E+FS
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASP-EVFS 177

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 80/173 (46%), Gaps = 18/173 (10%)
Query: 520 IGRGGFGPVY------KDGMEVAIKVFNLQYGGAFKSFDI--ECGMMKRIRHRNLIKIIS 571
           IG G FG V+      KD  +VAIK       GA    D   E  +M ++ H  L+++  
Sbjct: 18  IGSGQFGLVHLGYWLNKD--KVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYG 72
Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
            C       LV E+M  G L   L +   +      L + +DV   + YL       +IH
Sbjct: 73  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIH 129
Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS 684
            DL   N L+ +N V  +SDFGM + +L +DQ  + T T   + + +P E+FS
Sbjct: 130 RDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASP-EVFS 180

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 92/196 (46%), Gaps = 18/196 (9%)
Query: 499 QRRFTYLELFQATNRFSENNLIGRGGFGPV--------YKDGMEVAIKVFNLQYG-GAFK 549
           Q    + +   ATN  S + ++G G FG V         K  + VAIK   + Y     +
Sbjct: 33  QTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 550 SFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLN 609
            F  E  +M +  H N+I++    +      +V E M  GSL+  L   +    + Q + 
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 610 IMIDVASALEYL-HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
           ++  +AS ++YL   GY    +H DL   N+L++ N+V  +SDFG+++ +LE+D     T
Sbjct: 152 MLRGIASGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAYT 206
Query: 669 QTLAT--IGYMAPDEI 682
                  I + +P+ I
Sbjct: 207 TRGGKIPIRWTSPEAI 222

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 95/187 (50%), Gaps = 26/187 (13%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIK 568
           +++  +IG G FG VY+      G  VAIK   +  G AFK+ +++  +M+++ H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFKNRELQ--IMRKLDHCNIVR 77
Query: 569 I----ISSCSNDD--FKALVLEYMP--LGSLEKCLYSGNYILDIFQGLNIMIDVASALEY 620
           +     SS    D  +  LVL+Y+P  +  + +        L +      M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 621 LH-FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 678
           +H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 190
Query: 679 PDEIFSG 685
           P+ IF  
Sbjct: 191 PELIFGA 197

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 85/178 (47%), Gaps = 15/178 (8%)
Query: 517 NNLIGRGGFGPVYKDGME--------VAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLI 567
             +IG G FG V +  ++        VAIK     Y     + F  E  +M +  H N+I
Sbjct: 21  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 568 KIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
           ++    +N     ++ E+M  G+L+  L   +    + Q + ++  +AS + YL     +
Sbjct: 81  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLA---EM 137
Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA---TIGYMAPDEI 682
             +H DL   N+L++ N+V  +SDFG+++ L E     T+T +L     I + AP+ I
Sbjct: 138 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAI 195

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 83/176 (47%), Gaps = 17/176 (9%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVF---NLQYGGAFKSFDIECGMMKRIRHRNLIKIIS 571
           +G+G FG VY     +    +A+KV     L+  G       E  +   +RH N++++  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
              +     L+LEY PLG++ + L   +   D  +    + ++A+AL Y H   S  +IH
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSR-FDEQRTATYITELANALSYCH---SKRVIH 135
Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEM 687
            D+KP N+LL  N    ++DFG +        S  +T    T+ Y+ P E+  G M
Sbjct: 136 RDIKPENLLLGSNGELKIADFGWSV----HAPSSRRTTLCGTLDYLPP-EMIEGRM 186

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 80/173 (46%), Gaps = 18/173 (10%)
Query: 520 IGRGGFGPVY------KDGMEVAIKVFNLQYGGAFKSFDI--ECGMMKRIRHRNLIKIIS 571
           IG G FG V+      KD  +VAIK       GA    D   E  +M ++ H  L+++  
Sbjct: 13  IGSGQFGLVHLGYWLNKD--KVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYG 67
Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
            C       LV E+M  G L   L +   +      L + +DV   + YL       +IH
Sbjct: 68  VCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIH 124
Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS 684
            DL   N L+ +N V  +SDFGM + +L +DQ  + T T   + + +P E+FS
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASP-EVFS 175

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 26/201 (12%)
Query: 503 TYLELFQATNRFSEN---------NLIGRGGFGPVY--------KDGMEVAIKVFNLQYG 545
           TY +  QA + F++           +IG G FG V         K  + VAIK   + Y 
Sbjct: 4   TYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYT 63
Query: 546 -GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDI 604
               + F  E  +M +  H N+I +    +      +V EYM  GSL+  L   +    +
Sbjct: 64  EKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTV 123
Query: 605 FQGLNIMIDVASALEYL-HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ 663
            Q + ++  +++ ++YL   GY    +H DL   N+L++ N+V  +SDFG+++ +LE+D 
Sbjct: 124 IQLVGMLRGISAGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSR-VLEDDP 178
Query: 664 SLTQTQTLAT--IGYMAPDEI 682
               T       I + AP+ I
Sbjct: 179 EAAYTTRGGKIPIRWTAPEAI 199

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 92/176 (52%), Gaps = 11/176 (6%)
Query: 520 IGRGGFGPV----YKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           +G G FG V    Y    +VA+K    Q   +  +F  E  +MK+++H+ L+++ +  + 
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 81
Query: 576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASAL-EYLHFGYSVPIIHCDL 634
           +    ++ EYM  GSL   L + +    I   +N ++D+A+ + E + F      IH DL
Sbjct: 82  EPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 137
Query: 635 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           + +N+L+ D +   ++DFG+A+ L+E+++   +      I + AP+ I  G   +K
Sbjct: 138 RAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 192

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 92/176 (52%), Gaps = 11/176 (6%)
Query: 520 IGRGGFGPV----YKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           +G G FG V    Y    +VA+K    Q   +  +F  E  +MK+++H+ L+++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASAL-EYLHFGYSVPIIHCDL 634
           +    ++ EYM  GSL   L + +    I   +N ++D+A+ + E + F      IH DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 135
Query: 635 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           + +N+L+ D +   ++DFG+A+ L+E+++   +      I + AP+ I  G   +K
Sbjct: 136 RAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 190

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 62.8 bits (151), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 92/176 (52%), Gaps = 11/176 (6%)
Query: 520 IGRGGFGPV----YKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           +G G FG V    Y    +VA+K    Q   +  +F  E  +MK+++H+ L+++ +  + 
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 80
Query: 576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASAL-EYLHFGYSVPIIHCDL 634
           +    ++ EYM  GSL   L + +    I   +N ++D+A+ + E + F      IH DL
Sbjct: 81  EPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 136
Query: 635 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           + +N+L+ D +   ++DFG+A+ L+E+++   +      I + AP+ I  G   +K
Sbjct: 137 RAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 191

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 82/191 (42%), Gaps = 33/191 (17%)
Query: 520 IGRGGFGPVY----------KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKI 569
           +G G FG V+          +D M VA+K        A + F  E  ++  ++H+++++ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 570 ISSCSNDDFKALVLEYMPLGSLEKCLYS----------GNYI----LDIFQGLNIMIDVA 615
              C+      +V EYM  G L + L S          G  +    L + Q L +   VA
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 616 SALEYL---HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA 672
           + + YL   HF      +H DL   N L+   +V  + DFGM++ +   D      +T+ 
Sbjct: 140 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 193
Query: 673 TIGYMAPDEIF 683
            I +M P+ I 
Sbjct: 194 PIRWMPPESIL 204

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 80/173 (46%), Gaps = 18/173 (10%)
Query: 520 IGRGGFGPVY------KDGMEVAIKVFNLQYGGAFKSFDI--ECGMMKRIRHRNLIKIIS 571
           IG G FG V+      KD  +VAIK       GA    D   E  +M ++ H  L+++  
Sbjct: 16  IGSGQFGLVHLGYWLNKD--KVAIKTIR---EGAMSEEDFIEEAEVMMKLSHPKLVQLYG 70
Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
            C       LV E+M  G L   L +   +      L + +DV   + YL       +IH
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIH 127
Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS 684
            DL   N L+ +N V  +SDFGM + +L +DQ  + T T   + + +P E+FS
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASP-EVFS 178

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 95/187 (50%), Gaps = 26/187 (13%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIK 568
           +++  +IG G FG VY+      G  VAIK   +  G AFK+ +++  +M+++ H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFKNRELQ--IMRKLDHCNIVR 77
Query: 569 I----ISSCSNDD--FKALVLEYMP--LGSLEKCLYSGNYILDIFQGLNIMIDVASALEY 620
           +     SS    D  +  LVL+Y+P  +  + +        L +      M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 621 LH-FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 678
           +H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 190
Query: 679 PDEIFSG 685
           P+ IF  
Sbjct: 191 PELIFGA 197

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 92/176 (52%), Gaps = 11/176 (6%)
Query: 520 IGRGGFGPV----YKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           +G G FG V    Y    +VA+K    Q   +  +F  E  +MK+++H+ L+++ +  + 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASAL-EYLHFGYSVPIIHCDL 634
           +    ++ EYM  GSL   L + +    I   +N ++D+A+ + E + F      IH DL
Sbjct: 86  EPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 141
Query: 635 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           + +N+L+ D +   ++DFG+A+ L+E+++   +      I + AP+ I  G   +K
Sbjct: 142 RAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 196

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 95/187 (50%), Gaps = 26/187 (13%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIK 568
           +++  +IG G FG VY+      G  VAIK   +  G AFK+ +++  +M+++ H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFKNRELQ--IMRKLDHCNIVR 77
Query: 569 I----ISSCSNDD--FKALVLEYMP--LGSLEKCLYSGNYILDIFQGLNIMIDVASALEY 620
           +     SS    D  +  LVL+Y+P  +  + +        L +      M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 621 LH-FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 678
           +H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 190
Query: 679 PDEIFSG 685
           P+ IF  
Sbjct: 191 PELIFGA 197

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 92/176 (52%), Gaps = 11/176 (6%)
Query: 520 IGRGGFGPV----YKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           +G G FG V    Y    +VA+K    Q   +  +F  E  +MK+++H+ L+++ +  + 
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 88
Query: 576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASAL-EYLHFGYSVPIIHCDL 634
           +    ++ EYM  GSL   L + +    I   +N ++D+A+ + E + F      IH DL
Sbjct: 89  EPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 144
Query: 635 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           + +N+L+ D +   ++DFG+A+ L+E+++   +      I + AP+ I  G   +K
Sbjct: 145 RAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 199

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 92/176 (52%), Gaps = 11/176 (6%)
Query: 520 IGRGGFGPV----YKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           +G G FG V    Y    +VA+K    Q   +  +F  E  +MK+++H+ L+++ +  + 
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 87
Query: 576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASAL-EYLHFGYSVPIIHCDL 634
           +    ++ EYM  GSL   L + +    I   +N ++D+A+ + E + F      IH DL
Sbjct: 88  EPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 143
Query: 635 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           + +N+L+ D +   ++DFG+A+ L+E+++   +      I + AP+ I  G   +K
Sbjct: 144 RAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 198

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 82/191 (42%), Gaps = 33/191 (17%)
Query: 520 IGRGGFGPVY----------KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKI 569
           +G G FG V+          +D M VA+K        A + F  E  ++  ++H+++++ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 570 ISSCSNDDFKALVLEYMPLGSLEKCLYS----------GNYI----LDIFQGLNIMIDVA 615
              C+      +V EYM  G L + L S          G  +    L + Q L +   VA
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 616 SALEYL---HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA 672
           + + YL   HF      +H DL   N L+   +V  + DFGM++ +   D      +T+ 
Sbjct: 146 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 199
Query: 673 TIGYMAPDEIF 683
            I +M P+ I 
Sbjct: 200 PIRWMPPESIL 210

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 82/191 (42%), Gaps = 33/191 (17%)
Query: 520 IGRGGFGPVY----------KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKI 569
           +G G FG V+          +D M VA+K        A + F  E  ++  ++H+++++ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 570 ISSCSNDDFKALVLEYMPLGSLEKCLYS----------GNYI----LDIFQGLNIMIDVA 615
              C+      +V EYM  G L + L S          G  +    L + Q L +   VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 616 SALEYL---HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA 672
           + + YL   HF      +H DL   N L+   +V  + DFGM++ +   D      +T+ 
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 673 TIGYMAPDEIF 683
            I +M P+ I 
Sbjct: 223 PIRWMPPESIL 233

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 92/176 (52%), Gaps = 11/176 (6%)
Query: 520 IGRGGFGPV----YKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           +G G FG V    Y    +VA+K    Q   +  +F  E  +MK+++H+ L+++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASAL-EYLHFGYSVPIIHCDL 634
           +    ++ EYM  GSL   L + +    I   +N ++D+A+ + E + F      IH DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 135
Query: 635 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           + +N+L+ D +   ++DFG+A+ L+E+++   +      I + AP+ I  G   +K
Sbjct: 136 RAANILVSDTLSCKIADFGLAR-LIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 190

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 62.4 bits (150), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 92/176 (52%), Gaps = 11/176 (6%)
Query: 520 IGRGGFGPV----YKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           +G G FG V    Y    +VA+K    Q   +  +F  E  +MK+++H+ L+++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASAL-EYLHFGYSVPIIHCDL 634
           +    ++ EYM  GSL   L + +    I   +N ++D+A+ + E + F      IH DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 135
Query: 635 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           + +N+L+ D +   ++DFG+A+ L+E+++   +      I + AP+ I  G   +K
Sbjct: 136 RAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 81/169 (47%), Gaps = 11/169 (6%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G +G VY     K  + VA+K    +     + F  E  +MK I+H NL++++  C+
Sbjct: 40  LGGGQYGEVYVGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNY-ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
            +    +V EYMP G+L   L   N   +     L +   ++SA+EYL        IH D
Sbjct: 99  LEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE---KKNFIHRD 155
Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
           L   N L+ +N V  ++DFG+++ L+  D           I + AP+ +
Sbjct: 156 LAARNCLVGENHVVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESL 203

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 92/176 (52%), Gaps = 11/176 (6%)
Query: 520 IGRGGFGPV----YKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           +G G FG V    Y    +VA+K    Q   +  +F  E  +MK+++H+ L+++ +  + 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASAL-EYLHFGYSVPIIHCDL 634
           +    ++ EYM  GSL   L + +    I   +N ++D+A+ + E + F      IH DL
Sbjct: 86  EPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 141
Query: 635 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           + +N+L+ D +   ++DFG+A+ L+E+++   +      I + AP+ I  G   +K
Sbjct: 142 RAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 196

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 92/176 (52%), Gaps = 11/176 (6%)
Query: 520 IGRGGFGPV----YKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           +G G FG V    Y    +VA+K    Q   +  +F  E  +MK+++H+ L+++ +  + 
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 84
Query: 576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASAL-EYLHFGYSVPIIHCDL 634
           +    ++ EYM  GSL   L + +    I   +N ++D+A+ + E + F      IH DL
Sbjct: 85  EPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 140
Query: 635 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           + +N+L+ D +   ++DFG+A+ L+E+++   +      I + AP+ I  G   +K
Sbjct: 141 RAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 195

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 92/176 (52%), Gaps = 11/176 (6%)
Query: 520 IGRGGFGPV----YKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           +G G FG V    Y    +VA+K    Q   +  +F  E  +MK+++H+ L+++ +  + 
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 74
Query: 576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASAL-EYLHFGYSVPIIHCDL 634
           +    ++ EYM  GSL   L + +    I   +N ++D+A+ + E + F      IH DL
Sbjct: 75  EPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 130
Query: 635 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           + +N+L+ D +   ++DFG+A+ L+E+++   +      I + AP+ I  G   +K
Sbjct: 131 RAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 185

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 92/176 (52%), Gaps = 11/176 (6%)
Query: 520 IGRGGFGPV----YKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           +G G FG V    Y    +VA+K    Q   +  +F  E  +MK+++H+ L+++ +  + 
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 89
Query: 576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASAL-EYLHFGYSVPIIHCDL 634
           +    ++ EYM  GSL   L + +    I   +N ++D+A+ + E + F      IH DL
Sbjct: 90  EPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 145
Query: 635 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           + +N+L+ D +   ++DFG+A+ L+E+++   +      I + AP+ I  G   +K
Sbjct: 146 RAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 200

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/195 (26%), Positives = 91/195 (46%), Gaps = 16/195 (8%)
Query: 499 QRRFTYLELFQATNRFSENNLIGRGGFGPV--------YKDGMEVAIKVFNLQYG-GAFK 549
           Q    + +   ATN  S + ++G G FG V         K  + VAIK   + Y     +
Sbjct: 33  QTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91
Query: 550 SFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLN 609
            F  E  +M +  H N+I++    +      +V E M  GSL+  L   +    + Q + 
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVG 151
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
           ++  +AS ++YL     +  +H DL   N+L++ N+V  +SDFG+++ +LE+D     T 
Sbjct: 152 MLRGIASGMKYLS---DMGAVHRDLAARNILINSNLVCKVSDFGLSR-VLEDDPEAAYTT 207
Query: 670 TLAT--IGYMAPDEI 682
                 I + +P+ I
Sbjct: 208 RGGKIPIRWTSPEAI 222

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/239 (23%), Positives = 104/239 (43%), Gaps = 38/239 (15%)
Query: 479 KYRKGRKSQLK-------DVNMPSVADQRRFTYLELFQATNRFSENNL-----IGRGGFG 526
           KY++  K Q++       + N  +  D  +  Y E ++    F  NNL     +G G FG
Sbjct: 5   KYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWE----FPRNNLQFGKTLGAGAFG 60
Query: 527 PVYKDG----------MEVAIKVF-NLQYGGAFKSFDIECGMMKRI-RHRNLIKIISSCS 574
            V +            ++VA+K+  +  +    ++   E  +M  + +H N++ ++ +C+
Sbjct: 61  KVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120
Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVP------ 628
           +     ++ EY   G L   L   + +L+      I    AS  + LHF   V       
Sbjct: 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL 180
Query: 629 ----IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIF 683
                IH D+   NVLL +  VA + DFG+A+ ++ +   + +      + +MAP+ IF
Sbjct: 181 ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF 239

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 92/177 (51%), Gaps = 13/177 (7%)
Query: 520 IGRGGFGPVY----KDGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G FG V+        +VAIK   L+ G  + +SF  E  +MK+++H  L+++ +  S
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKT--LKPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 575 NDDFKALVLEYMPLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
            +    +V EYM  GSL   L  G    L +   +++   VA+ + Y+     +  IH D
Sbjct: 75  EEPI-YIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRD 130
Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           L+ +N+L+ + ++  ++DFG+A+ L+E+++   +      I + AP+    G   +K
Sbjct: 131 LRSANILVGNGLICKIADFGLAR-LIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 186

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/178 (26%), Positives = 84/178 (47%), Gaps = 15/178 (8%)
Query: 517 NNLIGRGGFGPVYKDGME--------VAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLI 567
             +IG G FG V +  ++        VAIK     Y     + F  E  +M +  H N+I
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 568 KIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
           ++    +N     ++ E+M  G+L+  L   +    + Q + ++  +AS + YL     +
Sbjct: 79  RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLA---EM 135
Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA---TIGYMAPDEI 682
             +H DL   N+L++ N+V  +SDFG+++ L E     T T +L     I + AP+ I
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAI 193

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 83/180 (46%), Gaps = 16/180 (8%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIK---VFNLQYGGAFKSFDIECGMMKRIRHRN 565
           F     IGRG F  VY+     DG+ VA+K   +F+L    A      E  ++K++ H N
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNI---MIDVASALEYLH 622
           +IK  +S   D+   +VLE    G L + +        +     +    + + SALE++H
Sbjct: 94  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153
Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              S  ++H D+KP+NV +    V  L D G+ +      ++      + T  YM+P+ I
Sbjct: 154 ---SRRVMHRDIKPANVFITATGVVKLGDLGLGR--FFSSKTTAAHSLVGTPYYMSPERI 208

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 80/171 (46%), Gaps = 14/171 (8%)
Query: 520 IGRGGFGPVY------KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSC 573
           IG G FG V+      KD  +VAIK    +   +   F  E  +M ++ H  L+++   C
Sbjct: 35  IGSGQFGLVHLGYWLNKD--KVAIKTIK-EGSMSEDDFIEEAEVMMKLSHPKLVQLYGVC 91
Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
                  LV E+M  G L   L +   +      L + +DV   + YL       +IH D
Sbjct: 92  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRD 148
Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS 684
           L   N L+ +N V  +SDFGM + +L +DQ  + T T   + + +P E+FS
Sbjct: 149 LAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASP-EVFS 197

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 90/201 (44%), Gaps = 24/201 (11%)
Query: 502 FTYLELFQATNRFSEN---------NLIGRGGFGPVY--------KDGMEVAIKVFNLQY 544
           FT+ +  QA   F++           +IG G FG V         K  + VAIK     Y
Sbjct: 10  FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGY 69
Query: 545 -GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD 603
                + F  E  +M +  H N+I +    +      ++ EYM  GSL+  L   +    
Sbjct: 70  TDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFT 129
Query: 604 IFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ 663
           + Q + ++  + S ++YL     +  +H DL   N+L++ N+V  +SDFGM++ +LE+D 
Sbjct: 130 VIQLVGMLRGIGSGMKYLS---DMSAVHRDLAARNILVNSNLVCKVSDFGMSR-VLEDDP 185
Query: 664 SLTQTQTLAT--IGYMAPDEI 682
               T       I + AP+ I
Sbjct: 186 EAAYTTRGGKIPIRWTAPEAI 206

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 83/176 (47%), Gaps = 17/176 (9%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVF---NLQYGGAFKSFDIECGMMKRIRHRNLIKIIS 571
           +G+G FG VY     +    +A+KV     L+  G       E  +   +RH N++++  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
              +     L+LEY PLG++ + L   +   D  +    + ++A+AL Y H   S  +IH
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIH 131
Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEM 687
            D+KP N+LL       ++DFG +        S  +T+   T+ Y+ P E+  G M
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTELCGTLDYLPP-EMIEGRM 182

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 28/199 (14%)
Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNL--------QYGGAFKSFDIECGMM 558
            ++   ++IGRG    V +      G E A+K+  +        Q     ++   E  ++
Sbjct: 94  QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 559 KRIR-HRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASA 617
           +++  H ++I +I S  +  F  LV + M  G L   L +    L   +  +IM  +  A
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL-TEKVALSEKETRSIMRSLLEA 212
Query: 618 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 677
           + +LH      I+H DLKP N+LLDDNM   LSDFG +   LE  + L   +   T GY+
Sbjct: 213 VSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFS-CHLEPGEKL--RELCGTPGYL 266
Query: 678 APDEIFSGEMRLKCWVNDS 696
           AP EI      LKC ++++
Sbjct: 267 AP-EI------LKCSMDET 278

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 95/201 (47%), Gaps = 26/201 (12%)
Query: 503 TYLELFQATNRFSEN---------NLIGRGGFGPVY--------KDGMEVAIKVFNLQYG 545
           TY +  +A ++F++           +IG G FG V         K  + VAIK   + Y 
Sbjct: 25  TYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYT 84
Query: 546 -GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDI 604
               + F  E  +M +  H N++ +    +      +V+E+M  G+L+  L   +    +
Sbjct: 85  EKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTV 144
Query: 605 FQGLNIMIDVASALEYL-HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ 663
            Q + ++  +A+ + YL   GY    +H DL   N+L++ N+V  +SDFG+++ ++E+D 
Sbjct: 145 IQLVGMLRGIAAGMRYLADMGY----VHRDLAARNILVNSNLVCKVSDFGLSR-VIEDDP 199
Query: 664 SLTQTQTLATI--GYMAPDEI 682
               T T   I   + AP+ I
Sbjct: 200 EAVYTTTGGKIPVRWTAPEAI 220

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/168 (30%), Positives = 80/168 (47%), Gaps = 10/168 (5%)
Query: 520 IGRGGFGPV----YKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           +G G FG V    +K   +VA+K+   +   +   F  E   M ++ H  L+K    CS 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74
Query: 576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLK 635
           +    +V EY+  G L   L S    L+  Q L +  DV   + +L    S   IH DL 
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLA 131
Query: 636 PSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIF 683
             N L+D ++   +SDFGM + +L +DQ ++   T   + + AP E+F
Sbjct: 132 ARNCLVDRDLCVKVSDFGMTRYVL-DDQYVSSVGTKFPVKWSAP-EVF 177

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 69/141 (48%), Gaps = 8/141 (5%)
Query: 518 NLIGRGGFGPVYKDGM--EVAIKVFNLQYGGA--FKSFDIECGMMKRIRHRNLIKIISSC 573
            LIG+G FG VY      EVAI++ +++       K+F  E    ++ RH N++  + +C
Sbjct: 39  ELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
            +    A++       +L   +     +LD+ +   I  ++   + YLH   +  I+H D
Sbjct: 99  MSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKD 155
Query: 634 LKPSNVLLDDNMVAHLSDFGM 654
           LK  NV  D+  V  ++DFG+
Sbjct: 156 LKSKNVFYDNGKVV-ITDFGL 175

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 90/201 (44%), Gaps = 40/201 (19%)
Query: 518 NLIGRGGFGPVYK---DGMEVAIKVFNLQYGGAFKSFDIECGMMKRI---RHRNLIKIIS 571
            LIGRG +G VYK   D   VA+KVF+      F    I    + R+    H N+ + I 
Sbjct: 19  ELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNF----INEKNIYRVPLMEHDNIARFI- 73
Query: 572 SCSNDDFKA-------LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFG 624
              ++   A       LV+EY P GSL K  Y   +  D      +   V   L YLH  
Sbjct: 74  -VGDERVTADGRMEYLLVMEYYPNGSLXK--YLSLHTSDWVSSCRLAHSVTRGLAYLHTE 130
Query: 625 ------YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMA---------KPLLEEDQSLTQTQ 669
                 Y   I H DL   NVL+ ++    +SDFG++         +P  E++ ++++  
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE-- 188
Query: 670 TLATIGYMAPDEIFSGEMRLK 690
            + TI YMAP E+  G + L+
Sbjct: 189 -VGTIRYMAP-EVLEGAVNLR 207

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 17/176 (9%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVF---NLQYGGAFKSFDIECGMMKRIRHRNLIKIIS 571
           +G+G FG VY     +    +A+KV     L+  G       E  +   +RH N++++  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
              +     L+LEY PLG++ + L   +   D  +    + ++A+AL Y H   S  +IH
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSR-FDEQRTATYITELANALSYCH---SKRVIH 135
Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEM 687
            D+KP N+LL  N    ++DFG +        S  +     T+ Y+ P E+  G M
Sbjct: 136 RDIKPENLLLGSNGELKIADFGWSV----HAPSSRRDTLCGTLDYLPP-EMIEGRM 186

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 92/176 (52%), Gaps = 11/176 (6%)
Query: 520 IGRGGFGPV----YKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           +G G FG V    Y    +VA+K    Q   +  +F  E  +MK+++H+ L+++ +  + 
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 75
Query: 576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASAL-EYLHFGYSVPIIHCDL 634
           +    ++ EYM  GSL   L + +    I   +N ++D+A+ + E + F      IH +L
Sbjct: 76  EPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRNL 131
Query: 635 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           + +N+L+ D +   ++DFG+A+ L+E+++   +      I + AP+ I  G   +K
Sbjct: 132 RAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 186

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 73/153 (47%), Gaps = 17/153 (11%)
Query: 520 IGRGGFGPVY---------KDGMEVAIKVFNLQYGGAFKS-FDIECGMMKRIRHRNLIKI 569
           +G G FG V            G  VA+K      G   +S +  E  +++ + H ++IK 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 570 ISSCSNDDFKAL--VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
              C +   K+L  V+EY+PLGSL    Y   + + + Q L     +   + YLH   S 
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRD--YLPRHSIGLAQLLLFAQQICEGMAYLH---SQ 136
Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE 660
             IH +L   NVLLD++ +  + DFG+AK + E
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPE 169

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 84/186 (45%), Gaps = 17/186 (9%)
Query: 510 ATNRFSENNLIGRGGFGPVY-----KDGMEVAIKVF---NLQYGGAFKSFDIECGMMKRI 561
           A   F     +G+G FG VY     +    +A+KV     L+  G       E  +   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
           RH N++++     +     L+LEY PLG++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P E
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTXLCGTLDYLPP-E 176
Query: 682 IFSGEM 687
           +  G M
Sbjct: 177 MIEGRM 182

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 43/212 (20%)
Query: 509 QATNRFSEN----NLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI------ 553
            +T+ F EN     ++GRG    V +        E A+K+ ++  GG+F + ++      
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 554 ---ECGMMKRIR-HRNLIKIISSCSNDDFKALVLEYMPLGSL-----EKCLYSGNYILDI 604
              E  +++++  H N+I++  +   + F  LV + M  G L     EK   S      I
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI 129
Query: 605 FQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS 664
            + L   ++V  AL  L+      I+H DLKP N+LLDD+M   L+DFG +  L   D  
Sbjct: 130 MRAL---LEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPG 177
Query: 665 LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDS 696
               +   T  Y+AP+ I       +C +ND+
Sbjct: 178 EKLREVCGTPSYLAPEII-------ECSMNDN 202

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 84/186 (45%), Gaps = 17/186 (9%)
Query: 510 ATNRFSENNLIGRGGFGPVY-----KDGMEVAIKVF---NLQYGGAFKSFDIECGMMKRI 561
           A   F     +G+G FG VY     +    +A+KV     L+  G       E  +   +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
           RH N++++     +     L+LEY PLG++ + L   +   D  +    + ++A+AL Y 
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 123
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P E
Sbjct: 124 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPP-E 175
Query: 682 IFSGEM 687
           +  G M
Sbjct: 176 MIEGRM 181

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 84/186 (45%), Gaps = 17/186 (9%)
Query: 510 ATNRFSENNLIGRGGFGPVY-----KDGMEVAIKVF---NLQYGGAFKSFDIECGMMKRI 561
           A   F     +G+G FG VY     +    +A+KV     L+  G       E  +   +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
           RH N++++     +     L+LEY PLG++ + L   +   D  +    + ++A+AL Y 
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 128
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P E
Sbjct: 129 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPP-E 180
Query: 682 IFSGEM 687
           +  G M
Sbjct: 181 MIEGRM 186

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 17/176 (9%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVF---NLQYGGAFKSFDIECGMMKRIRHRNLIKIIS 571
           +G+G FG VY     +    +A+KV     L+  G       E  +   +RH N++++  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
              +     L+LEY PLG++ + L   +   D  +    + ++A+AL Y H   S  +IH
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIH 131
Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEM 687
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ P E+  G M
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPP-EMIEGRM 182

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 517 NNLIGRGGFGPVYK------DGMEV--AIKVFN-LQYGGAFKSFDIECGMMKRIRHRNLI 567
           N +IGRG FG VY       DG ++  A+K  N +   G    F  E  +MK   H N++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 568 KIISSCSNDDFKALV-LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
            ++  C   +   LV L YM  G L   + +  +   +   +   + VA  ++YL    S
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 150
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPDEIFS 684
              +H DL   N +LD+     ++DFG+A+ + +++      +T A   + +MA + + +
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQT 210
Query: 685 GEMRLK--CWVNDSLLISVM 702
            +   K   W    LL  +M
Sbjct: 211 QKFTTKSDVWSFGVLLWELM 230

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 17/176 (9%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVF---NLQYGGAFKSFDIECGMMKRIRHRNLIKIIS 571
           +G+G FG VY     +    +A+KV     L+  G       E  +   +RH N++++  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
              +     L+LEY PLG++ + L   +   D  +    + ++A+AL Y H   S  +IH
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIH 132
Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEM 687
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ P E+  G M
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTDLCGTLDYLPP-EMIEGRM 183

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 17/176 (9%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVF---NLQYGGAFKSFDIECGMMKRIRHRNLIKIIS 571
           +G+G FG VY     +    +A+KV     L+  G       E  +   +RH N++++  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
              +     L+LEY PLG++ + L   +   D  +    + ++A+AL Y H   S  +IH
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIH 131
Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEM 687
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ P E+  G M
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTDLCGTLDYLPP-EMIEGRM 182

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 17/176 (9%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVF---NLQYGGAFKSFDIECGMMKRIRHRNLIKIIS 571
           +G+G FG VY     +    +A+KV     L+  G       E  +   +RH N++++  
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
              +     L+LEY PLG++ + L   +   D  +    + ++A+AL Y H   S  +IH
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIH 157
Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEM 687
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ P E+  G M
Sbjct: 158 RDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPP-EMIEGRM 208

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 17/176 (9%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVF---NLQYGGAFKSFDIECGMMKRIRHRNLIKIIS 571
           +G+G FG VY     +    +A+KV     L+  G       E  +   +RH N++++  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
              +     L+LEY PLG++ + L   +   D  +    + ++A+AL Y H   S  +IH
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIH 131
Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEM 687
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ P E+  G M
Sbjct: 132 RDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTDLCGTLDYLPP-EMIEGRM 182

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 84/186 (45%), Gaps = 17/186 (9%)
Query: 510 ATNRFSENNLIGRGGFGPVY-----KDGMEVAIKVF---NLQYGGAFKSFDIECGMMKRI 561
           A   F     +G+G FG VY     +    +A+KV     L+  G       E  +   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
           RH N++++     +     L+LEY PLG++ + L   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
           H   S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P E
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPP-E 179
Query: 682 IFSGEM 687
           +  G M
Sbjct: 180 MIEGRM 185

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 73/149 (48%), Gaps = 8/149 (5%)
Query: 520 IGRGGFGPV----YKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           +G G FG V    ++   +VAIK+   +   +   F  E  +M  + H  L+++   C+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLK 635
                ++ EYM  G L   L    +     Q L +  DV  A+EYL    S   +H DL 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 147
Query: 636 PSNVLLDDNMVAHLSDFGMAKPLLEEDQS 664
             N L++D  V  +SDFG+++ +L+++++
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVLDDEET 176

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 17/176 (9%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVF---NLQYGGAFKSFDIECGMMKRIRHRNLIKIIS 571
           +G+G FG VY     +    +A+KV     L+  G       E  +   +RH N++++  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
              +     L+LEY PLG++ + L   +   D  +    + ++A+AL Y H   S  +IH
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIH 136
Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEM 687
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ P E+  G M
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTDLCGTLDYLPP-EMIEGRM 187

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 17/176 (9%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVF---NLQYGGAFKSFDIECGMMKRIRHRNLIKIIS 571
           +G+G FG VY     +    +A+KV     L+  G       E  +   +RH N++++  
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
              +     L+LEY PLG++ + L   +   D  +    + ++A+AL Y H   S  +IH
Sbjct: 93  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIH 148
Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEM 687
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ P E+  G M
Sbjct: 149 RDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPP-EMIEGRM 199

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 17/176 (9%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVF---NLQYGGAFKSFDIECGMMKRIRHRNLIKIIS 571
           +G+G FG VY     +    +A+KV     L+  G       E  +   +RH N++++  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
              +     L+LEY PLG++ + L   +   D  +    + ++A+AL Y H   S  +IH
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIH 134
Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEM 687
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ P E+  G M
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPP-EMIEGRM 185

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 17/200 (8%)
Query: 517 NNLIGRGGFGPVYK------DGMEV--AIKVFN-LQYGGAFKSFDIECGMMKRIRHRNLI 567
           N +IGRG FG VY       DG ++  A+K  N +   G    F  E  +MK   H N++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 568 KIISSCSNDDFKALV-LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
            ++  C   +   LV L YM  G L   + +  +   +   +   + VA  +++L    S
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 152
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPDEIFS 684
              +H DL   N +LD+     ++DFG+A+ +L+++      +T A   + +MA + + +
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 685 GEMRLK--CWVNDSLLISVM 702
            +   K   W    LL  +M
Sbjct: 213 QKFTTKSDVWSFGVLLWELM 232

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 72/153 (47%), Gaps = 17/153 (11%)
Query: 520 IGRGGFGPVY---------KDGMEVAIKVFNLQYGGAFKS-FDIECGMMKRIRHRNLIKI 569
           +G G FG V            G  VA+K      G   +S +  E  +++ + H ++IK 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 570 ISSCSNDDFKAL--VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
              C +    +L  V+EY+PLGSL    Y   + + + Q L     +   + YLH  +  
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRD--YLPRHSIGLAQLLLFAQQICEGMAYLHAQH-- 154
Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE 660
             IH DL   NVLLD++ +  + DFG+AK + E
Sbjct: 155 -YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 80/171 (46%), Gaps = 16/171 (9%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVF---NLQYGGAFKSFDIECGMMKRIRHRNLIKIIS 571
           +G+G FG VY     +    +A+KV     L+  G       E  +   +RH N++++  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
              +     L+LEY PLG++ + L   +   D  +    + ++A+AL Y H   S  +IH
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIH 136
Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ P+ I
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEXI 183

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 17/176 (9%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVF---NLQYGGAFKSFDIECGMMKRIRHRNLIKIIS 571
           +G+G FG VY     +    +A+KV     L+  G       E  +   +RH N++++  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
              +     L+LEY PLG++ + L   +   D  +    + ++A+AL Y H   S  +IH
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIH 136
Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEM 687
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ P E+  G M
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPP-EMIEGRM 187

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 73/153 (47%), Gaps = 17/153 (11%)
Query: 520 IGRGGFGPVY---------KDGMEVAIKVFNLQYGGAFKS-FDIECGMMKRIRHRNLIKI 569
           +G G FG V            G  VA+K      G   +S +  E  +++ + H ++IK 
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 570 ISSCSNDDFKAL--VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
              C +   K+L  V+EY+PLGSL    Y   + + + Q L     +   + YLH  +  
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRD--YLPRHSIGLAQLLLFAQQICEGMAYLHAQH-- 137
Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE 660
             IH +L   NVLLD++ +  + DFG+AK + E
Sbjct: 138 -YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPE 169

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 89/190 (46%), Gaps = 13/190 (6%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G +G VY     K  + VA+K    +     + F  E  +MK I+H NL++++  C+
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYI-LDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
            +    +++E+M  G+L   L   N   ++    L +   ++SA+EYL        IH D
Sbjct: 81  REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 137
Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK--C 691
           L   N L+ +N +  ++DFG+++ L+  D           I + AP+ +   +  +K   
Sbjct: 138 LAARNCLVGENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 196
Query: 692 WVNDSLLISV 701
           W    LL  +
Sbjct: 197 WAFGVLLWEI 206

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/239 (23%), Positives = 103/239 (43%), Gaps = 38/239 (15%)
Query: 479 KYRKGRKSQLK-------DVNMPSVADQRRFTYLELFQATNRFSENNL-----IGRGGFG 526
           KY++  K Q++       + N  +  D  +  Y E ++    F  NNL     +G G FG
Sbjct: 5   KYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWE----FPRNNLQFGKTLGAGAFG 60
Query: 527 PVYKDG----------MEVAIKVF-NLQYGGAFKSFDIECGMMKRI-RHRNLIKIISSCS 574
            V +            ++VA+K+  +  +    ++   E  +M  + +H N++ ++ +C+
Sbjct: 61  KVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120
Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVP------ 628
           +     ++ EY   G L   L   + +L+      I     S  + LHF   V       
Sbjct: 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFL 180
Query: 629 ----IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIF 683
                IH D+   NVLL +  VA + DFG+A+ ++ +   + +      + +MAP+ IF
Sbjct: 181 ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF 239

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 517 NNLIGRGGFGPVYK------DGMEV--AIKVFN-LQYGGAFKSFDIECGMMKRIRHRNLI 567
           N +IGRG FG VY       DG ++  A+K  N +   G    F  E  +MK   H N++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 568 KIISSCSNDDFKALV-LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
            ++  C   +   LV L YM  G L   + +  +   +   +   + VA  ++YL    S
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 149
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPDEIFS 684
              +H DL   N +LD+     ++DFG+A+ + +++      +T A   + +MA + + +
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 209
Query: 685 GEMRLK--CWVNDSLLISVM 702
            +   K   W    LL  +M
Sbjct: 210 QKFTTKSDVWSFGVLLWELM 229

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 517 NNLIGRGGFGPVYK------DGMEV--AIKVFN-LQYGGAFKSFDIECGMMKRIRHRNLI 567
           N +IGRG FG VY       DG ++  A+K  N +   G    F  E  +MK   H N++
Sbjct: 54  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 113
Query: 568 KIISSCSNDDFKALV-LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
            ++  C   +   LV L YM  G L   + +  +   +   +   + VA  ++YL    S
Sbjct: 114 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 170
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPDEIFS 684
              +H DL   N +LD+     ++DFG+A+ + +++      +T A   + +MA + + +
Sbjct: 171 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 230
Query: 685 GEMRLK--CWVNDSLLISVM 702
            +   K   W    LL  +M
Sbjct: 231 QKFTTKSDVWSFGVLLWELM 250

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 517 NNLIGRGGFGPVYK------DGMEV--AIKVFN-LQYGGAFKSFDIECGMMKRIRHRNLI 567
           N +IGRG FG VY       DG ++  A+K  N +   G    F  E  +MK   H N++
Sbjct: 34  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 93
Query: 568 KIISSCSNDDFKALV-LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
            ++  C   +   LV L YM  G L   + +  +   +   +   + VA  ++YL    S
Sbjct: 94  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 150
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPDEIFS 684
              +H DL   N +LD+     ++DFG+A+ + +++      +T A   + +MA + + +
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 210
Query: 685 GEMRLK--CWVNDSLLISVM 702
            +   K   W    LL  +M
Sbjct: 211 QKFTTKSDVWSFGVLLWELM 230

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 89/190 (46%), Gaps = 13/190 (6%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G +G VY     K  + VA+K    +     + F  E  +MK I+H NL++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYI-LDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
            +    +++E+M  G+L   L   N   ++    L +   ++SA+EYL        IH D
Sbjct: 85  REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK--C 691
           L   N L+ +N +  ++DFG+++ L+  D           I + AP+ +   +  +K   
Sbjct: 142 LAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 692 WVNDSLLISV 701
           W    LL  +
Sbjct: 201 WAFGVLLWEI 210

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 86/195 (44%), Gaps = 28/195 (14%)
Query: 508 FQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVF-NLQYGGAFKSFDI-ECGMMKR 560
           FQ+  ++    L+G G +G V K      G  VAIK F         K   + E  ++K+
Sbjct: 21  FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80
Query: 561 IRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEY 620
           +RH NL+ ++  C       LV E++            + ILD  +     +D     +Y
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFV-----------DHTILDDLELFPNGLDYQVVQKY 129
Query: 621 LH-------FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 673
           L        F +S  IIH D+KP N+L+  + V  L DFG A+ L    +       +AT
Sbjct: 130 LFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVAT 187
Query: 674 IGYMAPDEIFSGEMR 688
             Y AP E+  G+++
Sbjct: 188 RWYRAP-ELLVGDVK 201

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 517 NNLIGRGGFGPVYK------DGMEV--AIKVFN-LQYGGAFKSFDIECGMMKRIRHRNLI 567
           N +IGRG FG VY       DG ++  A+K  N +   G    F  E  +MK   H N++
Sbjct: 27  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 86
Query: 568 KIISSCSNDDFKALV-LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
            ++  C   +   LV L YM  G L   + +  +   +   +   + VA  ++YL    S
Sbjct: 87  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 143
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPDEIFS 684
              +H DL   N +LD+     ++DFG+A+ + +++      +T A   + +MA + + +
Sbjct: 144 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 203
Query: 685 GEMRLK--CWVNDSLLISVM 702
            +   K   W    LL  +M
Sbjct: 204 QKFTTKSDVWSFGVLLWELM 223

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 17/176 (9%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVF---NLQYGGAFKSFDIECGMMKRIRHRNLIKIIS 571
           +G+G FG VY     +    +A+KV     L+  G       E  +   +RH N++++  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
              +     L+LEY PLG++ + L   +   D  +    + ++A+AL Y H   S  +IH
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIH 132
Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEM 687
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ P E+  G M
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWSC----HAPSSRRTTLSGTLDYLPP-EMIEGRM 183

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 517 NNLIGRGGFGPVYK------DGMEV--AIKVFN-LQYGGAFKSFDIECGMMKRIRHRNLI 567
           N +IGRG FG VY       DG ++  A+K  N +   G    F  E  +MK   H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 568 KIISSCSNDDFKALV-LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
            ++  C   +   LV L YM  G L   + +  +   +   +   + VA  ++YL    S
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 151
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPDEIFS 684
              +H DL   N +LD+     ++DFG+A+ + +++      +T A   + +MA + + +
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 685 GEMRLK--CWVNDSLLISVM 702
            +   K   W    LL  +M
Sbjct: 212 QKFTTKSDVWSFGVLLWELM 231

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 43/212 (20%)
Query: 509 QATNRFSEN----NLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI------ 553
            +T+ F EN     ++GRG    V +        E A+K+ ++  GG+F + ++      
Sbjct: 10  HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 554 ---ECGMMKRIR-HRNLIKIISSCSNDDFKALVLEYMPLGSL-----EKCLYSGNYILDI 604
              E  +++++  H N+I++  +   + F  LV + M  G L     EK   S      I
Sbjct: 70  TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKI 129
Query: 605 FQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS 664
            + L   ++V  AL  L+      I+H DLKP N+LLDD+M   L+DFG +  L   D  
Sbjct: 130 MRAL---LEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPG 177
Query: 665 LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDS 696
                   T  Y+AP+ I       +C +ND+
Sbjct: 178 EKLRSVCGTPSYLAPEII-------ECSMNDN 202

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 517 NNLIGRGGFGPVYK------DGMEV--AIKVFN-LQYGGAFKSFDIECGMMKRIRHRNLI 567
           N +IGRG FG VY       DG ++  A+K  N +   G    F  E  +MK   H N++
Sbjct: 53  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 112
Query: 568 KIISSCSNDDFKALV-LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
            ++  C   +   LV L YM  G L   + +  +   +   +   + VA  ++YL    S
Sbjct: 113 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 169
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPDEIFS 684
              +H DL   N +LD+     ++DFG+A+ + +++      +T A   + +MA + + +
Sbjct: 170 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 229
Query: 685 GEMRLK--CWVNDSLLISVM 702
            +   K   W    LL  +M
Sbjct: 230 QKFTTKSDVWSFGVLLWELM 249

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 517 NNLIGRGGFGPVYK------DGMEV--AIKVFN-LQYGGAFKSFDIECGMMKRIRHRNLI 567
           N +IGRG FG VY       DG ++  A+K  N +   G    F  E  +MK   H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 568 KIISSCSNDDFKALV-LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
            ++  C   +   LV L YM  G L   + +  +   +   +   + VA  ++YL    S
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 148
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPDEIFS 684
              +H DL   N +LD+     ++DFG+A+ + +++      +T A   + +MA + + +
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 208
Query: 685 GEMRLK--CWVNDSLLISVM 702
            +   K   W    LL  +M
Sbjct: 209 QKFTTKSDVWSFGVLLWELM 228

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 517 NNLIGRGGFGPVYK------DGMEV--AIKVFN-LQYGGAFKSFDIECGMMKRIRHRNLI 567
           N +IGRG FG VY       DG ++  A+K  N +   G    F  E  +MK   H N++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 568 KIISSCSNDDFKALV-LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
            ++  C   +   LV L YM  G L   + +  +   +   +   + VA  ++YL    S
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 146
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPDEIFS 684
              +H DL   N +LD+     ++DFG+A+ + +++      +T A   + +MA + + +
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 685 GEMRLK--CWVNDSLLISVM 702
            +   K   W    LL  +M
Sbjct: 207 QKFTTKSDVWSFGVLLWELM 226

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 517 NNLIGRGGFGPVYK------DGMEV--AIKVFN-LQYGGAFKSFDIECGMMKRIRHRNLI 567
           N +IGRG FG VY       DG ++  A+K  N +   G    F  E  +MK   H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 568 KIISSCSNDDFKALV-LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
            ++  C   +   LV L YM  G L   + +  +   +   +   + VA  ++YL    S
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---AS 151
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPDEIFS 684
              +H DL   N +LD+     ++DFG+A+ + +++      +T A   + +MA + + +
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 685 GEMRLK--CWVNDSLLISVM 702
            +   K   W    LL  +M
Sbjct: 212 QKFTTKSDVWSFGVLLWELM 231

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 87/190 (45%), Gaps = 13/190 (6%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G FG VY     K  + VA+K    +     + F  E  +MK I+H NL++++  C+
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYI-LDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
            +    ++ E+M  G+L   L   N   +     L +   ++SA+EYL        IH D
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK--C 691
           L   N L+ +N +  ++DFG+++ L+  D           I + AP+ +   +  +K   
Sbjct: 135 LAARNCLVGENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 692 WVNDSLLISV 701
           W    LL  +
Sbjct: 194 WAFGVLLWEI 203

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 89/182 (48%), Gaps = 24/182 (13%)
Query: 518 NLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAFKSFDIECGMMKR-------IRHRN 565
           + +G G FG V        G +VA+K+ N Q     +S D+  G +KR        RH +
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQ---KIRSLDV-VGKIKREIQNLKLFRHPH 72
Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY 625
           +IK+    S      +V+EY+  G L   +     + ++ +   +   + SA++Y H   
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEM-EARRLFQQILSAVDYCHRHM 131
Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG 685
              ++H DLKP NVLLD +M A ++DFG++   +  D    +T +  +  Y AP E+ SG
Sbjct: 132 ---VVHRDLKPENVLLDAHMNAKIADFGLSN--MMSDGEFLRT-SCGSPNYAAP-EVISG 184
Query: 686 EM 687
            +
Sbjct: 185 RL 186

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 88/181 (48%), Gaps = 22/181 (12%)
Query: 518 NLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI------ECGMMKRIRHRNL 566
           + +G G FG V        G +VA+K+ N Q     +S D+      E   +K  RH ++
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQ---KIRSLDVVGKIRREIQNLKLFRHPHI 78
Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
           IK+    S      +V+EY+  G L   +   N  LD  +   +   + S ++Y H    
Sbjct: 79  IKLYQVISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCHRHM- 136
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGE 686
             ++H DLKP NVLLD +M A ++DFG++  ++ + + L    +  +  Y AP E+ SG 
Sbjct: 137 --VVHRDLKPENVLLDAHMNAKIADFGLSN-MMSDGEFL--RXSCGSPNYAAP-EVISGR 190
Query: 687 M 687
           +
Sbjct: 191 L 191

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 85/188 (45%), Gaps = 22/188 (11%)
Query: 513 RFSENNL-----IGRGGFGPVY---------KDGMEVAIKVFNLQYGGAFKSFDIECGMM 558
           +F E +L     +G+G FG V            G  VA+K          + F+ E  ++
Sbjct: 24  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 83
Query: 559 KRIRHRNLIKIISSCSNDDFK--ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVAS 616
           K ++H N++K    C +   +   L++EY+P GSL   L      +D  + L     +  
Sbjct: 84  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 143
Query: 617 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT--LATI 674
            +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I
Sbjct: 144 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPI 199
Query: 675 GYMAPDEI 682
            + AP+ +
Sbjct: 200 FWYAPESL 207

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 88/190 (46%), Gaps = 13/190 (6%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G +G VY     K  + VA+K    +     + F  E  +MK I+H NL++++  C+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYI-LDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
            +    +++E+M  G+L   L   N   +     L +   ++SA+EYL        IH D
Sbjct: 78  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK--C 691
           L   N L+ +N +  ++DFG+++ L+  D           I + AP+ +   +  +K   
Sbjct: 135 LAARNCLVGENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 692 WVNDSLLISV 701
           W    LL  +
Sbjct: 194 WAFGVLLWEI 203

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 83/179 (46%), Gaps = 22/179 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNL 566
            +++    IG+G  G VY       G EVAI+  NLQ     +    E  +M+  ++ N+
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 567 IKIISSCSNDDFKALVLEYMPLGSL-----EKCLYSGNYILDIFQGLNIMIDVASALEYL 621
           +  + S    D   +V+EY+  GSL     E C+  G       Q   +  +   ALE+L
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECLQALEFL 132
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           H   S  +IH D+K  N+LL  +    L+DFG    +  E     +++ + T  +MAP+
Sbjct: 133 H---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSEMVGTPYWMAPE 186

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 85/188 (45%), Gaps = 22/188 (11%)
Query: 513 RFSENNL-----IGRGGFGPVY---------KDGMEVAIKVFNLQYGGAFKSFDIECGMM 558
           +F E +L     +G+G FG V            G  VA+K          + F+ E  ++
Sbjct: 5   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 64
Query: 559 KRIRHRNLIKIISSCSNDDFK--ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVAS 616
           K ++H N++K    C +   +   L++EY+P GSL   L      +D  + L     +  
Sbjct: 65  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 124
Query: 617 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT--LATI 674
            +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I
Sbjct: 125 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPI 180
Query: 675 GYMAPDEI 682
            + AP+ +
Sbjct: 181 FWYAPESL 188

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 85/188 (45%), Gaps = 22/188 (11%)
Query: 513 RFSENNL-----IGRGGFGPVY---------KDGMEVAIKVFNLQYGGAFKSFDIECGMM 558
           +F E +L     +G+G FG V            G  VA+K          + F+ E  ++
Sbjct: 24  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 83
Query: 559 KRIRHRNLIKIISSCSNDDFK--ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVAS 616
           K ++H N++K    C +   +   L++EY+P GSL   L      +D  + L     +  
Sbjct: 84  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 143
Query: 617 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT--LATI 674
            +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I
Sbjct: 144 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPI 199
Query: 675 GYMAPDEI 682
            + AP+ +
Sbjct: 200 FWYAPESL 207

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 95/178 (53%), Gaps = 14/178 (7%)
Query: 520 IGRGGFGPV----YKDGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G FG V    Y +  +VA+K   L+ G  + ++F  E  +MK ++H  L+++ +  +
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVK--TLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 575 NDDFKALVLEYMPLGSLEKCLYS--GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
            ++   ++ EYM  GSL   L S  G  +L + + ++    +A  + Y+        IH 
Sbjct: 79  REEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIE---RKNYIHR 134
Query: 633 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           DL+ +NVL+ ++++  ++DFG+A+ ++E+++   +      I + AP+ I  G   +K
Sbjct: 135 DLRAANVLVSESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGCFTIK 191

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 88/190 (46%), Gaps = 13/190 (6%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G +G VY     K  + VA+K    +     + F  E  +MK I+H NL++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYI-LDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
            +    ++ E+M  G+L   L   N   ++    L +   ++SA+EYL        IH D
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK--C 691
           L   N L+ +N +  ++DFG+++ L+  D           I + AP+ +   +  +K   
Sbjct: 142 LAARNCLVGENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 692 WVNDSLLISV 701
           W    LL  +
Sbjct: 201 WAFGVLLWEI 210

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 85/178 (47%), Gaps = 34/178 (19%)
Query: 534 EVAIKVFNLQYGGAFKSFDI---------ECGMMKRIR-HRNLIKIISSCSNDDFKALVL 583
           E A+K+ ++  GG+F + ++         E  +++++  H N+I++  +   + F  LV 
Sbjct: 31  EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVF 90
Query: 584 EYMPLGSL-----EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSN 638
           + M  G L     EK   S      I + L   ++V  AL  L+      I+H DLKP N
Sbjct: 91  DLMKKGELFDYLTEKVTLSEKETRKIMRAL---LEVICALHKLN------IVHRDLKPEN 141
Query: 639 VLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDS 696
           +LLDD+M   L+DFG +  L   D      +   T  Y+AP+ I       +C +ND+
Sbjct: 142 ILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTPSYLAPEII-------ECSMNDN 189

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 85/188 (45%), Gaps = 22/188 (11%)
Query: 513 RFSENNL-----IGRGGFGPVY---------KDGMEVAIKVFNLQYGGAFKSFDIECGMM 558
           +F E +L     +G+G FG V            G  VA+K          + F+ E  ++
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 559 KRIRHRNLIKIISSCSNDDFK--ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVAS 616
           K ++H N++K    C +   +   L++EY+P GSL   L      +D  + L     +  
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 617 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT--LATI 674
            +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I
Sbjct: 126 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPI 181
Query: 675 GYMAPDEI 682
            + AP+ +
Sbjct: 182 FWYAPESL 189

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 85/188 (45%), Gaps = 22/188 (11%)
Query: 513 RFSENNL-----IGRGGFGPVY---------KDGMEVAIKVFNLQYGGAFKSFDIECGMM 558
           +F E +L     +G+G FG V            G  VA+K          + F+ E  ++
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 559 KRIRHRNLIKIISSCSNDDFK--ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVAS 616
           K ++H N++K    C +   +   L++EY+P GSL   L      +D  + L     +  
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 617 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT--LATI 674
            +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I
Sbjct: 126 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPI 181
Query: 675 GYMAPDEI 682
            + AP+ +
Sbjct: 182 FWYAPESL 189

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 85/188 (45%), Gaps = 22/188 (11%)
Query: 513 RFSENNL-----IGRGGFGPVY---------KDGMEVAIKVFNLQYGGAFKSFDIECGMM 558
           +F E +L     +G+G FG V            G  VA+K          + F+ E  ++
Sbjct: 37  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 96
Query: 559 KRIRHRNLIKIISSCSNDDFK--ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVAS 616
           K ++H N++K    C +   +   L++EY+P GSL   L      +D  + L     +  
Sbjct: 97  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 156
Query: 617 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT--LATI 674
            +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I
Sbjct: 157 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPI 212
Query: 675 GYMAPDEI 682
            + AP+ +
Sbjct: 213 FWYAPESL 220

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 85/188 (45%), Gaps = 22/188 (11%)
Query: 513 RFSENNL-----IGRGGFGPVY---------KDGMEVAIKVFNLQYGGAFKSFDIECGMM 558
           +F E +L     +G+G FG V            G  VA+K          + F+ E  ++
Sbjct: 11  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 70
Query: 559 KRIRHRNLIKIISSCSNDDFK--ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVAS 616
           K ++H N++K    C +   +   L++EY+P GSL   L      +D  + L     +  
Sbjct: 71  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 130
Query: 617 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT--LATI 674
            +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I
Sbjct: 131 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPI 186
Query: 675 GYMAPDEI 682
            + AP+ +
Sbjct: 187 FWYAPESL 194

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 85/188 (45%), Gaps = 22/188 (11%)
Query: 513 RFSENNL-----IGRGGFGPVY---------KDGMEVAIKVFNLQYGGAFKSFDIECGMM 558
           +F E +L     +G+G FG V            G  VA+K          + F+ E  ++
Sbjct: 12  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 71
Query: 559 KRIRHRNLIKIISSCSNDDFK--ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVAS 616
           K ++H N++K    C +   +   L++EY+P GSL   L      +D  + L     +  
Sbjct: 72  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 131
Query: 617 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT--LATI 674
            +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I
Sbjct: 132 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPI 187
Query: 675 GYMAPDEI 682
            + AP+ +
Sbjct: 188 FWYAPESL 195

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 85/188 (45%), Gaps = 22/188 (11%)
Query: 513 RFSENNL-----IGRGGFGPVY---------KDGMEVAIKVFNLQYGGAFKSFDIECGMM 558
           +F E +L     +G+G FG V            G  VA+K          + F+ E  ++
Sbjct: 9   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 68
Query: 559 KRIRHRNLIKIISSCSNDDFK--ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVAS 616
           K ++H N++K    C +   +   L++EY+P GSL   L      +D  + L     +  
Sbjct: 69  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 128
Query: 617 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT--LATI 674
            +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I
Sbjct: 129 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPI 184
Query: 675 GYMAPDEI 682
            + AP+ +
Sbjct: 185 FWYAPESL 192

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 85/188 (45%), Gaps = 22/188 (11%)
Query: 513 RFSENNL-----IGRGGFGPVY---------KDGMEVAIKVFNLQYGGAFKSFDIECGMM 558
           +F E +L     +G+G FG V            G  VA+K          + F+ E  ++
Sbjct: 4   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 63
Query: 559 KRIRHRNLIKIISSCSNDDFK--ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVAS 616
           K ++H N++K    C +   +   L++EY+P GSL   L      +D  + L     +  
Sbjct: 64  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 123
Query: 617 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT--LATI 674
            +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I
Sbjct: 124 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPI 179
Query: 675 GYMAPDEI 682
            + AP+ +
Sbjct: 180 FWYAPESL 187

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 85/188 (45%), Gaps = 22/188 (11%)
Query: 513 RFSENNL-----IGRGGFGPVY---------KDGMEVAIKVFNLQYGGAFKSFDIECGMM 558
           +F E +L     +G+G FG V            G  VA+K          + F+ E  ++
Sbjct: 13  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 72
Query: 559 KRIRHRNLIKIISSCSNDDFK--ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVAS 616
           K ++H N++K    C +   +   L++EY+P GSL   L      +D  + L     +  
Sbjct: 73  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 132
Query: 617 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT--LATI 674
            +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I
Sbjct: 133 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPI 188
Query: 675 GYMAPDEI 682
            + AP+ +
Sbjct: 189 FWYAPESL 196

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 85/188 (45%), Gaps = 22/188 (11%)
Query: 513 RFSENNL-----IGRGGFGPVY---------KDGMEVAIKVFNLQYGGAFKSFDIECGMM 558
           +F E +L     +G+G FG V            G  VA+K          + F+ E  ++
Sbjct: 10  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 69
Query: 559 KRIRHRNLIKIISSCSNDDFK--ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVAS 616
           K ++H N++K    C +   +   L++EY+P GSL   L      +D  + L     +  
Sbjct: 70  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 129
Query: 617 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT--LATI 674
            +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I
Sbjct: 130 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPI 185
Query: 675 GYMAPDEI 682
            + AP+ +
Sbjct: 186 FWYAPESL 193

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 81/177 (45%), Gaps = 15/177 (8%)
Query: 517 NNLIGRGGFGPVY--------KDGMEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLI 567
             +IG G FG V         K  + VAIK     Y     + F  E  +M +  H N+I
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 568 KIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
            +    +      ++ EYM  GSL+  L   +    + Q + ++  + S ++YL     +
Sbjct: 79  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DM 135
Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPDEI 682
             +H DL   N+L++ N+V  +SDFGM++ +LE+D     T       I + AP+ I
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGMSR-VLEDDPEAAYTTRGGKIPIRWTAPEAI 191

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 85/188 (45%), Gaps = 22/188 (11%)
Query: 513 RFSENNL-----IGRGGFGPVY---------KDGMEVAIKVFNLQYGGAFKSFDIECGMM 558
           +F E +L     +G+G FG V            G  VA+K          + F+ E  ++
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 559 KRIRHRNLIKIISSCSNDDFK--ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVAS 616
           K ++H N++K    C +   +   L++EY+P GSL   L      +D  + L     +  
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 617 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT--LATI 674
            +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I
Sbjct: 126 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEFFKVKEPGESPI 181
Query: 675 GYMAPDEI 682
            + AP+ +
Sbjct: 182 FWYAPESL 189

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 24/202 (11%)
Query: 502 FTYLELFQATNRFSEN---------NLIGRGGFGPVY--------KDGMEVAIKVFNLQY 544
           FT+ +  +A   F++           +IG G FG V         K  + VAIK     Y
Sbjct: 14  FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 73
Query: 545 G-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD 603
                + F  E  +M +  H N+I +    +      ++ E+M  GSL+  L   +    
Sbjct: 74  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 133
Query: 604 IFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ 663
           + Q + ++  +A+ ++YL     +  +H DL   N+L++ N+V  +SDFG+++ L ++  
Sbjct: 134 VIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 190
Query: 664 SLTQTQTLA---TIGYMAPDEI 682
             T T  L     I + AP+ I
Sbjct: 191 DPTYTSALGGKIPIRWTAPEAI 212

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 89/196 (45%), Gaps = 36/196 (18%)
Query: 520 IGRGGFGPVY------------KDGMEVAIKVFNLQYGGAFKSFD---IECGMMKRI-RH 563
           +G G FG V             K+ + VA+K+  L+     K       E  MMK I +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----NYILDI---------FQGL- 608
           +N+I ++ +C+ D    +++EY   G+L + L +       Y  DI         F+ L 
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
           +    +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T
Sbjct: 161 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 669 QTLATIGYMAPDEIFS 684
                + +MAP+ +F 
Sbjct: 218 NGRLPVKWMAPEALFD 233

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 71/147 (48%), Gaps = 8/147 (5%)
Query: 520 IGRGGFGPV----YKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           +G G FG V    ++   +VAIK+   +   +   F  E  +M  + H  L+++   C+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90
Query: 576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLK 635
                ++ EYM  G L   L    +     Q L +  DV  A+EYL    S   +H DL 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 147
Query: 636 PSNVLLDDNMVAHLSDFGMAKPLLEED 662
             N L++D  V  +SDFG+++ +L+++
Sbjct: 148 ARNCLVNDQGVVKVSDFGLSRYVLDDE 174

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 71/147 (48%), Gaps = 8/147 (5%)
Query: 520 IGRGGFGPV----YKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           +G G FG V    ++   +VAIK+   +   +   F  E  +M  + H  L+++   C+ 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLK 635
                ++ EYM  G L   L    +     Q L +  DV  A+EYL    S   +H DL 
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 132
Query: 636 PSNVLLDDNMVAHLSDFGMAKPLLEED 662
             N L++D  V  +SDFG+++ +L+++
Sbjct: 133 ARNCLVNDQGVVKVSDFGLSRYVLDDE 159

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 78/176 (44%), Gaps = 14/176 (7%)
Query: 514 FSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRN 565
           F    ++G G F  V          E AIK+   ++            E  +M R+ H  
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 70
Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFG 624
            +K+  +  +D+     L Y   G L K +   G++  D         ++ SALEYLH  
Sbjct: 71  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF--DETCTRFYTAEIVSALEYLH-- 126
Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
               IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P+
Sbjct: 127 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 181

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 88/190 (46%), Gaps = 13/190 (6%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G +G VY     K  + VA+K    +     + F  E  +MK I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYI-LDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
            +    +++E+M  G+L   L   N   +     L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK--C 691
           L   N L+ +N +  ++DFG+++ L+  D           I + AP+ +   +  +K   
Sbjct: 137 LAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 692 WVNDSLLISV 701
           W    LL  +
Sbjct: 196 WAFGVLLWEI 205

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 88/190 (46%), Gaps = 13/190 (6%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G +G VY     K  + VA+K    +     + F  E  +MK I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYI-LDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
            +    +++E+M  G+L   L   N   +     L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK--C 691
           L   N L+ +N +  ++DFG+++ L+  D           I + AP+ +   +  +K   
Sbjct: 137 LAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 692 WVNDSLLISV 701
           W    LL  +
Sbjct: 196 WAFGVLLWEI 205

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 78/176 (44%), Gaps = 14/176 (7%)
Query: 514 FSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRN 565
           F    ++G G F  V          E AIK+   ++            E  +M R+ H  
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 68
Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFG 624
            +K+  +  +D+     L Y   G L K +   G++  D         ++ SALEYLH  
Sbjct: 69  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF--DETCTRFYTAEIVSALEYLH-- 124
Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
               IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P+
Sbjct: 125 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 179

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 90/199 (45%), Gaps = 17/199 (8%)
Query: 496 VADQRRFTYLELFQATNRFSEN-NLIGRGGFGPVY---------KDGMEVAIKVFNLQYG 545
           V++++  T ++      RF +    +G G FG V            G +VA+K    + G
Sbjct: 4   VSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG 63
Query: 546 G-AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKA--LVLEYMPLGSLEKCLYSGNYIL 602
           G        E  +++ + H N++K    C+ D      L++E++P GSL++ L      +
Sbjct: 64  GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKI 123
Query: 603 DIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED 662
           ++ Q L   + +   ++YL    S   +H DL   NVL++      + DFG+ K +  + 
Sbjct: 124 NLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 180
Query: 663 QSLT-QTQTLATIGYMAPD 680
           +  T +    + + + AP+
Sbjct: 181 EXXTVKDDRDSPVFWYAPE 199

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 78/176 (44%), Gaps = 14/176 (7%)
Query: 514 FSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRN 565
           F    ++G G F  V          E AIK+   ++            E  +M R+ H  
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFG 624
            +K+  +  +D+     L Y   G L K +   G++  D         ++ SALEYLH  
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF--DETCTRFYTAEIVSALEYLH-- 125
Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
               IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P+
Sbjct: 126 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 180

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 71/147 (48%), Gaps = 8/147 (5%)
Query: 520 IGRGGFGPV----YKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           +G G FG V    ++   +VAIK+   +   +   F  E  +M  + H  L+++   C+ 
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 74
Query: 576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLK 635
                ++ EYM  G L   L    +     Q L +  DV  A+EYL    S   +H DL 
Sbjct: 75  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 131
Query: 636 PSNVLLDDNMVAHLSDFGMAKPLLEED 662
             N L++D  V  +SDFG+++ +L+++
Sbjct: 132 ARNCLVNDQGVVKVSDFGLSRYVLDDE 158

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 90/176 (51%), Gaps = 11/176 (6%)
Query: 520 IGRGGFGPV----YKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           +G G  G V    Y    +VA+K    Q   +  +F  E  +MK+++H+ L+++ +  + 
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASAL-EYLHFGYSVPIIHCDL 634
           +    ++ EYM  GSL   L + +    I   +N ++D+A+ + E + F      IH DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 135
Query: 635 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           + +N+L+ D +   ++DFG+A+ L+E+ +   +      I + AP+ I  G   +K
Sbjct: 136 RAANILVSDTLSCKIADFGLAR-LIEDAEXTAREGAKFPIKWTAPEAINYGTFTIK 190

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 78/176 (44%), Gaps = 14/176 (7%)
Query: 514 FSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRN 565
           F    ++G G F  V          E AIK+   ++            E  +M R+ H  
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFG 624
            +K+  +  +D+     L Y   G L K +   G++  D         ++ SALEYLH  
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF--DETCTRFYTAEIVSALEYLH-- 146
Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
               IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P+
Sbjct: 147 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 201

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 71/147 (48%), Gaps = 8/147 (5%)
Query: 520 IGRGGFGPV----YKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           +G G FG V    ++   +VAIK+   +   +   F  E  +M  + H  L+++   C+ 
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 75
Query: 576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLK 635
                ++ EYM  G L   L    +     Q L +  DV  A+EYL    S   +H DL 
Sbjct: 76  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 132
Query: 636 PSNVLLDDNMVAHLSDFGMAKPLLEED 662
             N L++D  V  +SDFG+++ +L+++
Sbjct: 133 ARNCLVNDQGVVKVSDFGLSRYVLDDE 159

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 78/176 (44%), Gaps = 14/176 (7%)
Query: 514 FSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRN 565
           F    ++G G F  V          E AIK+   ++            E  +M R+ H  
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 71
Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFG 624
            +K+  +  +D+     L Y   G L K +   G++  D         ++ SALEYLH  
Sbjct: 72  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF--DETCTRFYTAEIVSALEYLH-- 127
Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
               IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P+
Sbjct: 128 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 182

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 88/190 (46%), Gaps = 13/190 (6%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G +G VY     K  + VA+K    +     + F  E  +MK I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYI-LDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
            +    ++ E+M  G+L   L   N   ++    L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK--C 691
           L   N L+ +N +  ++DFG+++ L+  D           I + AP+ +   +  +K   
Sbjct: 137 LAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 692 WVNDSLLISV 701
           W    LL  +
Sbjct: 196 WAFGVLLWEI 205

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 88/190 (46%), Gaps = 13/190 (6%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G +G VY     K  + VA+K    +     + F  E  +MK I+H NL++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYI-LDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
            +    ++ E+M  G+L   L   N   ++    L +   ++SA+EYL        IH D
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK--C 691
           L   N L+ +N +  ++DFG+++ L+  D           I + AP+ +   +  +K   
Sbjct: 142 LAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 692 WVNDSLLISV 701
           W    LL  +
Sbjct: 201 WAFGVLLWEI 210

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 71/147 (48%), Gaps = 8/147 (5%)
Query: 520 IGRGGFGPV----YKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           +G G FG V    ++   +VAIK+   +   +   F  E  +M  + H  L+++   C+ 
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLK 635
                ++ EYM  G L   L    +     Q L +  DV  A+EYL    S   +H DL 
Sbjct: 71  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 127
Query: 636 PSNVLLDDNMVAHLSDFGMAKPLLEED 662
             N L++D  V  +SDFG+++ +L+++
Sbjct: 128 ARNCLVNDQGVVKVSDFGLSRYVLDDE 154

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 88/188 (46%), Gaps = 21/188 (11%)
Query: 507 LFQATNRFSEN----NLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGA--FKSFDIEC 555
           +  A+ +FS+N      +G+G F  V +      G+E A K+ N +   A  F+  + E 
Sbjct: 20  MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79
Query: 556 GMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVA 615
            + ++++H N++++  S   + F  LV + +  G     L+      + +   +    + 
Sbjct: 80  RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQ 135
Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDN---MVAHLSDFGMAKPLLEEDQSLTQTQTLA 672
             LE + + +S  I+H +LKP N+LL          L+DFG+A   +E + S        
Sbjct: 136 QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAG 192
Query: 673 TIGYMAPD 680
           T GY++P+
Sbjct: 193 TPGYLSPE 200

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 86/188 (45%), Gaps = 22/188 (11%)
Query: 513 RFSENNL-----IGRGGFGPVY---------KDGMEVAIKVFNLQYGGAFKSFDIECGMM 558
           +F E +L     +G+G FG V            G  VA+K          + F+ E  ++
Sbjct: 9   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 68
Query: 559 KRIRHRNLIKIISSCSNDDFK--ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVAS 616
           K ++H N++K    C +   +   L++EY+P GSL   L +    +D  + L     +  
Sbjct: 69  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICK 128
Query: 617 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT--LATI 674
            +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I
Sbjct: 129 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPI 184
Query: 675 GYMAPDEI 682
            + AP+ +
Sbjct: 185 FWYAPESL 192

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 81/177 (45%), Gaps = 15/177 (8%)
Query: 517 NNLIGRGGFGPVY--------KDGMEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLI 567
             +IG G FG V         K  + VAIK     Y     + F  E  +M +  H N+I
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 568 KIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
            +    +      ++ EYM  GSL+  L   +    + Q + ++  + S ++YL     +
Sbjct: 73  HLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DM 129
Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPDEI 682
             +H DL   N+L++ N+V  +SDFGM++ +LE+D     T       I + AP+ I
Sbjct: 130 SYVHRDLAARNILVNSNLVCKVSDFGMSR-VLEDDPEAAYTTRGGKIPIRWTAPEAI 185

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 71/147 (48%), Gaps = 8/147 (5%)
Query: 520 IGRGGFGPV----YKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           +G G FG V    ++   +VAIK+   +   +   F  E  +M  + H  L+++   C+ 
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTK 81
Query: 576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLK 635
                ++ EYM  G L   L    +     Q L +  DV  A+EYL    S   +H DL 
Sbjct: 82  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLA 138
Query: 636 PSNVLLDDNMVAHLSDFGMAKPLLEED 662
             N L++D  V  +SDFG+++ +L+++
Sbjct: 139 ARNCLVNDQGVVKVSDFGLSRYVLDDE 165

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 26/187 (13%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIK 568
           +++  +IG G FG VY+      G  VAIK   +     FK+ +++  +M+++ H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKNRELQ--IMRKLDHCNIVR 77
Query: 569 I----ISSCSNDD--FKALVLEYMP--LGSLEKCLYSGNYILDIFQGLNIMIDVASALEY 620
           +     SS    D  +  LVL+Y+P  +  + +        L +      M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 621 LH-FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 678
           +H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 190
Query: 679 PDEIFSG 685
           P+ IF  
Sbjct: 191 PELIFGA 197

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 26/187 (13%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIK 568
           +++  +IG G FG VY+      G  VAIK   +     FK+ +++  +M+++ H N+++
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKNRELQ--IMRKLDHCNIVR 78
Query: 569 I----ISSCSNDD--FKALVLEYMP--LGSLEKCLYSGNYILDIFQGLNIMIDVASALEY 620
           +     SS    D  +  LVL+Y+P  +  + +        L +      M  +  +L Y
Sbjct: 79  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 138
Query: 621 LH-FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 678
           +H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 139 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 191
Query: 679 PDEIFSG 685
           P+ IF  
Sbjct: 192 PELIFGA 198

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 26/187 (13%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIK 568
           +++  +IG G FG VY+      G  VAIK   +     FK+ +++  +M+++ H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKNRELQ--IMRKLDHCNIVR 77
Query: 569 I----ISSCSNDD--FKALVLEYMP--LGSLEKCLYSGNYILDIFQGLNIMIDVASALEY 620
           +     SS    D  +  LVL+Y+P  +  + +        L +      M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 621 LH-FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 678
           +H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 190
Query: 679 PDEIFSG 685
           P+ IF  
Sbjct: 191 PELIFGA 197

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 78/176 (44%), Gaps = 14/176 (7%)
Query: 514 FSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRN 565
           F    ++G G F  V          E AIK+   ++            E  +M R+ H  
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFG 624
            +K+  +  +D+     L Y   G L K +   G++  D         ++ SALEYLH  
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF--DETCTRFYTAEIVSALEYLH-- 150
Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
               IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P+
Sbjct: 151 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 205

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 26/187 (13%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIK 568
           +++  +IG G FG VY+      G  VAIK   +     FK+ +++  +M+++ H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKNRELQ--IMRKLDHCNIVR 77
Query: 569 I----ISSCSNDD--FKALVLEYMP--LGSLEKCLYSGNYILDIFQGLNIMIDVASALEY 620
           +     SS    D  +  LVL+Y+P  +  + +        L +      M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 621 LH-FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 678
           +H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 190
Query: 679 PDEIFSG 685
           P+ IF  
Sbjct: 191 PELIFGA 197

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 17/153 (11%)
Query: 520 IGRGGFGPVY---------KDGMEVAIKVFNLQYGGAFKS-FDIECGMMKRIRHRNLIKI 569
           +G G FG V            G  VA+K      G   +S +  E  +++ + H +++K 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 570 ISSCSNDDFKA--LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
              C +   K+  LV+EY+PLGSL    Y   + + + Q L     +   + YLH  +  
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRD--YLPRHCVGLAQLLLFAQQICEGMAYLHAQH-- 132
Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE 660
             IH  L   NVLLD++ +  + DFG+AK + E
Sbjct: 133 -YIHRALAARNVLLDNDRLVKIGDFGLAKAVPE 164

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 78/176 (44%), Gaps = 14/176 (7%)
Query: 514 FSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRN 565
           F    ++G G F  V          E AIK+   ++            E  +M R+ H  
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 75
Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFG 624
            +K+  +  +D+     L Y   G L K +   G++  D         ++ SALEYLH  
Sbjct: 76  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF--DETCTRFYTAEIVSALEYLH-- 131
Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
               IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P+
Sbjct: 132 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 186

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 78/176 (44%), Gaps = 14/176 (7%)
Query: 514 FSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRN 565
           F    ++G G F  V          E AIK+   ++            E  +M R+ H  
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFG 624
            +K+  +  +D+     L Y   G L K +   G++  D         ++ SALEYLH  
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF--DETCTRFYTAEIVSALEYLH-- 146
Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
               IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P+
Sbjct: 147 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 201

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 83/186 (44%), Gaps = 17/186 (9%)
Query: 510 ATNRFSENNLIGRGGFGPVY-----KDGMEVAIKVF---NLQYGGAFKSFDIECGMMKRI 561
           A   F     +G+G FG VY     +    +A+KV     L+  G       E  +   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
           RH N++++     +     L+LEY PLG++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
           H   S  +IH D+KP N+LL       ++DFG +        S  +     T+ Y+ P E
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRAALCGTLDYLPP-E 176
Query: 682 IFSGEM 687
           +  G M
Sbjct: 177 MIEGRM 182

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 88/190 (46%), Gaps = 13/190 (6%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G +G VY     K  + VA+K    +     + F  E  +MK I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYI-LDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
            +    ++ E+M  G+L   L   N   ++    L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK--C 691
           L   N L+ +N +  ++DFG+++ L+  D           I + AP+ +   +  +K   
Sbjct: 137 LAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 692 WVNDSLLISV 701
           W    LL  +
Sbjct: 196 WAFGVLLWEI 205

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 78/176 (44%), Gaps = 14/176 (7%)
Query: 514 FSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRN 565
           F    ++G G F  V          E AIK+   ++            E  +M R+ H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFG 624
            +K+  +  +D+     L Y   G L K +   G++  D         ++ SALEYLH  
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF--DETCTRFYTAEIVSALEYLH-- 149
Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
               IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P+
Sbjct: 150 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 88/190 (46%), Gaps = 13/190 (6%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G +G VY     K  + VA+K    +     + F  E  +MK I+H NL++++  C+
Sbjct: 25  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYI-LDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
            +    ++ E+M  G+L   L   N   ++    L +   ++SA+EYL        IH D
Sbjct: 84  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 140
Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK--C 691
           L   N L+ +N +  ++DFG+++ L+  D           I + AP+ +   +  +K   
Sbjct: 141 LAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 199
Query: 692 WVNDSLLISV 701
           W    LL  +
Sbjct: 200 WAFGVLLWEI 209

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 78/176 (44%), Gaps = 14/176 (7%)
Query: 514 FSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRN 565
           F    ++G G F  V          E AIK+   ++            E  +M R+ H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFG 624
            +K+  +  +D+     L Y   G L K +   G++  D         ++ SALEYLH  
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF--DETCTRFYTAEIVSALEYLH-- 147
Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
               IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P+
Sbjct: 148 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPE 202

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 79/174 (45%), Gaps = 16/174 (9%)
Query: 520 IGRGGFGPVY---------KDGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKI 569
           +G G FG V            G +VA+K    + GG        E  +++ + H N++K 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 570 ISSCSNDDFKA--LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
              C+ D      L++E++P GSL++ L      +++ Q L   + +   ++YL    S 
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 133
Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT-QTQTLATIGYMAPD 680
             +H DL   NVL++      + DFG+ K +  + +  T +    + + + AP+
Sbjct: 134 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPE 187

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 78/176 (44%), Gaps = 14/176 (7%)
Query: 514 FSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRN 565
           F    ++G G F  V          E AIK+   ++            E  +M R+ H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFG 624
            +K+  +  +D+     L Y   G L K +   G++  D         ++ SALEYLH  
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF--DETCTRFYTAEIVSALEYLH-- 149
Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
               IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P+
Sbjct: 150 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 17/176 (9%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVF---NLQYGGAFKSFDIECGMMKRIRHRNLIKIIS 571
           +G+G FG VY     +    +A+KV     L+  G       E  +   +RH N++++  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
              +     L+LEY PLG++ + L   +   D  +    + ++A+AL Y H   S  +IH
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIH 134
Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEM 687
            D+KP N+LL       +++FG +        S  +T    T+ Y+ P E+  G M
Sbjct: 135 RDIKPENLLLGSAGELKIANFGWSV----HAPSSRRTTLCGTLDYLPP-EMIEGRM 185

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 78/176 (44%), Gaps = 14/176 (7%)
Query: 514 FSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRN 565
           F    ++G G F  V          E AIK+   ++            E  +M R+ H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFG 624
            +K+  +  +D+     L Y   G L K +   G++  D         ++ SALEYLH  
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF--DETCTRFYTAEIVSALEYLH-- 147
Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
               IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P+
Sbjct: 148 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 17/153 (11%)
Query: 520 IGRGGFGPVY---------KDGMEVAIKVFNLQYGGAFKS-FDIECGMMKRIRHRNLIKI 569
           +G G FG V            G  VA+K      G   +S +  E  +++ + H +++K 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 570 ISSCSNDDFKA--LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
              C +   K+  LV+EY+PLGSL    Y   + + + Q L     +   + YLH  +  
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRD--YLPRHCVGLAQLLLFAQQICEGMAYLHAQH-- 131
Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE 660
             IH  L   NVLLD++ +  + DFG+AK + E
Sbjct: 132 -YIHRALAARNVLLDNDRLVKIGDFGLAKAVPE 163

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 26/187 (13%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIK 568
           +++  +IG G FG VY+      G  VAIK   +     FK+ +++  +M+++ H N+++
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKNRELQ--IMRKLDHCNIVR 85
Query: 569 I----ISSCSNDD--FKALVLEYMP--LGSLEKCLYSGNYILDIFQGLNIMIDVASALEY 620
           +     SS    D  +  LVL+Y+P  +  + +        L +      M  +  +L Y
Sbjct: 86  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 145
Query: 621 LH-FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 678
           +H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 146 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 198
Query: 679 PDEIFSG 685
           P+ IF  
Sbjct: 199 PELIFGA 205

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 78/176 (44%), Gaps = 14/176 (7%)
Query: 514 FSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRN 565
           F    ++G G F  V          E AIK+   ++            E  +M R+ H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFG 624
            +K+  +  +D+     L Y   G L K +   G++  D         ++ SALEYLH  
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF--DETCTRFYTAEIVSALEYLH-- 149
Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
               IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P+
Sbjct: 150 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 26/187 (13%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIK 568
           +++  +IG G FG VY+      G  VAIK   +     FK+ +++  +M+++ H N+++
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKNRELQ--IMRKLDHCNIVR 81
Query: 569 I----ISSCSNDD--FKALVLEYMP--LGSLEKCLYSGNYILDIFQGLNIMIDVASALEY 620
           +     SS    D  +  LVL+Y+P  +  + +        L +      M  +  +L Y
Sbjct: 82  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 141
Query: 621 LH-FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 678
           +H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 142 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 194
Query: 679 PDEIFSG 685
           P+ IF  
Sbjct: 195 PELIFGA 201

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 83/186 (44%), Gaps = 17/186 (9%)
Query: 510 ATNRFSENNLIGRGGFGPVY-----KDGMEVAIKVF---NLQYGGAFKSFDIECGMMKRI 561
           A   F     +G+G FG VY     +    +A+KV     L+  G       E  +   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
           RH N++++     +     L+LEY PLG++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
           H   S  +IH D+KP N+LL       ++DFG +        S  +     T+ Y+ P E
Sbjct: 125 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRXXLCGTLDYLPP-E 176
Query: 682 IFSGEM 687
           +  G M
Sbjct: 177 MIEGRM 182

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 88/190 (46%), Gaps = 13/190 (6%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G +G VY     K  + VA+K    +     + F  E  +MK I+H NL++++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYI-LDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
            +    ++ E+M  G+L   L   N   ++    L +   ++SA+EYL        IH D
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 138
Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK--C 691
           L   N L+ +N +  ++DFG+++ L+  D           I + AP+ +   +  +K   
Sbjct: 139 LAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 197
Query: 692 WVNDSLLISV 701
           W    LL  +
Sbjct: 198 WAFGVLLWEI 207

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 82/186 (44%), Gaps = 17/186 (9%)
Query: 510 ATNRFSENNLIGRGGFGPVY-----KDGMEVAIKVF---NLQYGGAFKSFDIECGMMKRI 561
           A   F     +G+G FG VY          +A+KV     L+  G       E  +   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
           RH N++++     +     L+LEY PLG++ + L   +   D  +    + ++A+AL Y 
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 124
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
           H   S  +IH D+KP N+LL       ++DFG +        S  +     T+ Y+ P E
Sbjct: 125 H---SKKVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRAALCGTLDYLPP-E 176
Query: 682 IFSGEM 687
           +  G M
Sbjct: 177 MIEGRM 182

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 26/187 (13%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIK 568
           +++  +IG G FG VY+      G  VAIK   +     FK+ +++  +M+++ H N+++
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKNRELQ--IMRKLDHCNIVR 89
Query: 569 I----ISSCSNDD--FKALVLEYMP--LGSLEKCLYSGNYILDIFQGLNIMIDVASALEY 620
           +     SS    D  +  LVL+Y+P  +  + +        L +      M  +  +L Y
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 149
Query: 621 LH-FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 678
           +H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 150 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 202
Query: 679 PDEIFSG 685
           P+ IF  
Sbjct: 203 PELIFGA 209

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 78/176 (44%), Gaps = 14/176 (7%)
Query: 514 FSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRN 565
           F    ++G G F  V          E AIK+   ++            E  +M R+ H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFG 624
            +K+  +  +D+     L Y   G L K +   G++  D         ++ SALEYLH  
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSF--DETCTRFYTAEIVSALEYLH-- 149
Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
               IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P+
Sbjct: 150 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 204

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 88/190 (46%), Gaps = 13/190 (6%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G +G VY     K  + VA+K    +     + F  E  +MK I+H NL++++  C+
Sbjct: 34  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYI-LDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
            +    ++ E+M  G+L   L   N   ++    L +   ++SA+EYL        IH D
Sbjct: 93  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 149
Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK--C 691
           L   N L+ +N +  ++DFG+++ L+  D           I + AP+ +   +  +K   
Sbjct: 150 LAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 208
Query: 692 WVNDSLLISV 701
           W    LL  +
Sbjct: 209 WAFGVLLWEI 218

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 78/176 (44%), Gaps = 14/176 (7%)
Query: 514 FSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRN 565
           F    ++G G F  V          E AIK+   ++            E  +M R+ H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFG 624
            +K+  +  +D+     L Y   G L K +   G++  D         ++ SALEYLH  
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF--DETCTRFYTAEIVSALEYLH-- 149
Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
               IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P+
Sbjct: 150 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 26/187 (13%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIK 568
           +++  +IG G FG VY+      G  VAIK   +     FK+ +++  +M+++ H N+++
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKNRELQ--IMRKLDHCNIVR 96
Query: 569 I----ISSCSNDD--FKALVLEYMP--LGSLEKCLYSGNYILDIFQGLNIMIDVASALEY 620
           +     SS    D  +  LVL+Y+P  +  + +        L +      M  +  +L Y
Sbjct: 97  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 156
Query: 621 LH-FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 678
           +H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 157 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 209
Query: 679 PDEIFSG 685
           P+ IF  
Sbjct: 210 PELIFGA 216

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 83/186 (44%), Gaps = 17/186 (9%)
Query: 510 ATNRFSENNLIGRGGFGPVY-----KDGMEVAIKVF---NLQYGGAFKSFDIECGMMKRI 561
           A   F     +G+G FG VY     +    +A+KV     L+  G       E  +   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
           RH N++++     +     L+LEY PLG++ + L   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
           H   S  +IH D+KP N+LL       ++DFG +        S  +     T+ Y+ P E
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRDDLCGTLDYLPP-E 179
Query: 682 IFSGEM 687
           +  G M
Sbjct: 180 MIEGRM 185

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 78/176 (44%), Gaps = 14/176 (7%)
Query: 514 FSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRN 565
           F    ++G G F  V          E AIK+   ++            E  +M R+ H  
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 96
Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFG 624
            +K+  +  +D+     L Y   G L K +   G++  D         ++ SALEYLH  
Sbjct: 97  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF--DETCTRFYTAEIVSALEYLH-- 152
Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
               IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P+
Sbjct: 153 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 207

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 78/176 (44%), Gaps = 14/176 (7%)
Query: 514 FSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRN 565
           F    ++G G F  V          E AIK+   ++            E  +M R+ H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFG 624
            +K+  +  +D+     L Y   G L K +   G++  D         ++ SALEYLH  
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF--DETCTRFYTAEIVSALEYLH-- 147
Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
               IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P+
Sbjct: 148 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 202

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 78/176 (44%), Gaps = 14/176 (7%)
Query: 514 FSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRN 565
           F    ++G G F  V          E AIK+   ++            E  +M R+ H  
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFG 624
            +K+  +  +D+     L Y   G L K +   G++  D         ++ SALEYLH  
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF--DETCTRFYTAEIVSALEYLH-- 150
Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
               IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P+
Sbjct: 151 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 205

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 80/176 (45%), Gaps = 17/176 (9%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVF---NLQYGGAFKSFDIECGMMKRIRHRNLIKIIS 571
           +G+G FG VY     +    +A+KV     L+  G       E  +   +RH N++++  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
              +     L+LEY P G + K L   +   D  +    + ++A+AL Y H   S  +IH
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSK-FDEQRTATYITELANALSYCH---SKRVIH 136
Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEM 687
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ P E+  G M
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPP-EMIEGRM 187

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 26/187 (13%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIK 568
           +++  +IG G FG VY+      G  VAIK   +     FK+ +++  +M+++ H N+++
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKNRELQ--IMRKLDHCNIVR 89
Query: 569 I----ISSCSNDD--FKALVLEYMP--LGSLEKCLYSGNYILDIFQGLNIMIDVASALEY 620
           +     SS    D  +  LVL+Y+P  +  + +        L +      M  +  +L Y
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 149
Query: 621 LH-FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 678
           +H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 150 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 202
Query: 679 PDEIFSG 685
           P+ IF  
Sbjct: 203 PELIFGA 209

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 82/176 (46%), Gaps = 17/176 (9%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVF---NLQYGGAFKSFDIECGMMKRIRHRNLIKIIS 571
           +G+G FG VY     +    +A+KV     L+  G       E  +   +RH N++++  
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
              +     L+LEY PLG++ + L   +   D  +    + ++A+AL Y H   S  +IH
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIH 133
Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEM 687
            D+KP N+LL       +++FG +        S  +T    T+ Y+ P E+  G M
Sbjct: 134 RDIKPENLLLGSAGELKIANFGWSV----HAPSSRRTTLCGTLDYLPP-EMIEGRM 184

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 86/188 (45%), Gaps = 22/188 (11%)
Query: 513 RFSENNL-----IGRGGFGPVY---------KDGMEVAIKVFNLQYGGAFKSFDIECGMM 558
           +F E +L     +G+G FG V            G  VA+K          + F+ E  ++
Sbjct: 9   QFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 68
Query: 559 KRIRHRNLIKIISSCSNDDFK--ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVAS 616
           K ++H N++K    C +   +   L++E++P GSL + L      +D  + L     +  
Sbjct: 69  KSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICK 128
Query: 617 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT--LATI 674
            +EYL    +   IH DL   N+L+++     + DFG+ K +L +D+   + +    + I
Sbjct: 129 GMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEXXKVKEPGESPI 184
Query: 675 GYMAPDEI 682
            + AP+ +
Sbjct: 185 FWYAPESL 192

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 78/176 (44%), Gaps = 14/176 (7%)
Query: 514 FSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRN 565
           F    ++G G F  V          E AIK+   ++            E  +M R+ H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFG 624
            +K+  +  +D+     L Y   G L K +   G++  D         ++ SALEYLH  
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF--DETCTRFYTAEIVSALEYLH-- 149
Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
               IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P+
Sbjct: 150 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 204

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 82/179 (45%), Gaps = 22/179 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNL 566
            +++    IG+G  G VY       G EVAI+  NLQ     +    E  +M+  ++ N+
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 567 IKIISSCSNDDFKALVLEYMPLGSL-----EKCLYSGNYILDIFQGLNIMIDVASALEYL 621
           +  + S    D   +V+EY+  GSL     E C+  G       Q   +  +   ALE+L
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECLQALEFL 132
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           H   S  +IH D+K  N+LL  +    L+DFG    +  E     ++  + T  +MAP+
Sbjct: 133 H---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMAPE 186

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 90/182 (49%), Gaps = 24/182 (13%)
Query: 518 NLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAFKSFDIECGMMKR-------IRHRN 565
           + +G G FG V        G +VA+K+ N Q     +S D+  G +KR        RH +
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQ---KIRSLDV-VGKIKREIQNLKLFRHPH 72
Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY 625
           +IK+    S      +V+EY+  G L   +     + ++ +   +   + SA++Y H   
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEM-EARRLFQQILSAVDYCHRHM 131
Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG 685
              ++H DLKP NVLLD +M A ++DFG++  ++ + + L    +  +  Y AP E+ SG
Sbjct: 132 ---VVHRDLKPENVLLDAHMNAKIADFGLSN-MMSDGEFL--RDSCGSPNYAAP-EVISG 184
Query: 686 EM 687
            +
Sbjct: 185 RL 186

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 77/153 (50%), Gaps = 11/153 (7%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFN---LQYGGAFKSFDIECGMMKRIRHRN 565
           F   NL+G+G F  VY+      G+EVAIK+ +   +   G  +    E  +  +++H +
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY 625
           ++++ +   + ++  LVLE    G + + L +        +  + M  + + + YLH   
Sbjct: 73  ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH--- 129
Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL 658
           S  I+H DL  SN+LL  NM   ++DFG+A  L
Sbjct: 130 SHGILHRDLTLSNLLLTRNMNIKIADFGLATQL 162

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 82/179 (45%), Gaps = 22/179 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNL 566
            +++    IG+G  G VY       G EVAI+  NLQ     +    E  +M+  ++ N+
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 567 IKIISSCSNDDFKALVLEYMPLGSL-----EKCLYSGNYILDIFQGLNIMIDVASALEYL 621
           +  + S    D   +V+EY+  GSL     E C+  G       Q   +  +   ALE+L
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECLQALEFL 132
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           H   S  +IH D+K  N+LL  +    L+DFG    +  E     ++  + T  +MAP+
Sbjct: 133 H---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPE 186

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 81/176 (46%), Gaps = 17/176 (9%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVF---NLQYGGAFKSFDIECGMMKRIRHRNLIKIIS 571
           +G+G FG VY     +    +A+KV     L+  G       E  +   +RH N++++  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
              +     L+LEY PLG++ + L   +   D  +    + ++A+AL Y H   S  +IH
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIH 134
Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEM 687
            D+KP N+LL       ++DFG +        S  +     T+ Y+ P E+  G M
Sbjct: 135 RDIKPENLLLGSAGELKIADFGWSV----HAPSSRRAALCGTLDYLPP-EMIEGRM 185

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 88/190 (46%), Gaps = 13/190 (6%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G +G VY     K  + VA+K    +     + F  E  +MK I+H NL++++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYI-LDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
            +    ++ E+M  G+L   L   N   ++    L +   ++SA+EYL        IH D
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 138
Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK--C 691
           L   N L+ +N +  ++DFG+++ L+  D           I + AP+ +   +  +K   
Sbjct: 139 LAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 197
Query: 692 WVNDSLLISV 701
           W    LL  +
Sbjct: 198 WAFGVLLWEI 207

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/128 (32%), Positives = 64/128 (50%), Gaps = 6/128 (4%)
Query: 554 ECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMI 612
           E  +M R+ H   +K+  +  +D+     L Y   G L K +   G++  D         
Sbjct: 80  ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSF--DETCTRFYTA 137
Query: 613 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA 672
           ++ SALEYLH      IIH DLKP N+LL+++M   ++DFG AK L  E +       + 
Sbjct: 138 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 673 TIGYMAPD 680
           T  Y++P+
Sbjct: 195 TAQYVSPE 202

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 82/179 (45%), Gaps = 22/179 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNL 566
            +++    IG+G  G VY       G EVAI+  NLQ     +    E  +M+  ++ N+
Sbjct: 21  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 80
Query: 567 IKIISSCSNDDFKALVLEYMPLGSL-----EKCLYSGNYILDIFQGLNIMIDVASALEYL 621
           +  + S    D   +V+EY+  GSL     E C+  G       Q   +  +   ALE+L
Sbjct: 81  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECLQALEFL 133
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           H   S  +IH D+K  N+LL  +    L+DFG    +  E     ++  + T  +MAP+
Sbjct: 134 H---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSXMVGTPYWMAPE 187

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 26/187 (13%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIK 568
           +++  +IG G FG VY+      G  VAIK   +     FK+ +++  +M+++ H N+++
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKNRELQ--IMRKLDHCNIVR 77
Query: 569 I----ISSCSNDD--FKALVLEYMP--LGSLEKCLYSGNYILDIFQGLNIMIDVASALEY 620
           +     SS    D  +  LVL+Y+P  +  + +        L +      M  +  +L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 621 LH-FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 678
           +H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 138 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 190
Query: 679 PDEIFSG 685
           P+ IF  
Sbjct: 191 PELIFGA 197

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 517 NNLIGRGGFGPVYK------DGMEV--AIKVFN-LQYGGAFKSFDIECGMMKRIRHRNLI 567
           N +IGRG FG VY       DG ++  A+K  N +   G    F  E  +MK   H N++
Sbjct: 40  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 99
Query: 568 KIISSCSNDDFKALV-LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
            ++  C   +   LV L YM  G L   + +  +   +   +   + VA  +++L    S
Sbjct: 100 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 156
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPDEIFS 684
              +H DL   N +LD+     ++DFG+A+ + +++      +T A   + +MA + + +
Sbjct: 157 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 216
Query: 685 GEMRLK--CWVNDSLLISVM 702
            +   K   W    LL  +M
Sbjct: 217 QKFTTKSDVWSFGVLLWELM 236

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 517 NNLIGRGGFGPVYK------DGMEV--AIKVFN-LQYGGAFKSFDIECGMMKRIRHRNLI 567
           N +IGRG FG VY       DG ++  A+K  N +   G    F  E  +MK   H N++
Sbjct: 36  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 95
Query: 568 KIISSCSNDDFKALV-LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
            ++  C   +   LV L YM  G L   + +  +   +   +   + VA  +++L    S
Sbjct: 96  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 152
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPDEIFS 684
              +H DL   N +LD+     ++DFG+A+ + +++      +T A   + +MA + + +
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 685 GEMRLK--CWVNDSLLISVM 702
            +   K   W    LL  +M
Sbjct: 213 QKFTTKSDVWSFGVLLWELM 232

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 88/190 (46%), Gaps = 13/190 (6%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G +G VY     K  + VA+K    +     + F  E  +MK I+H NL++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYI-LDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
            +    ++ E+M  G+L   L   N   ++    L +   ++SA+EYL        IH D
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK--C 691
           L   N L+ +N +  ++DFG+++ L+  D           I + AP+ +   +  +K   
Sbjct: 142 LAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 692 WVNDSLLISV 701
           W    LL  +
Sbjct: 201 WAFGVLLWEI 210

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 517 NNLIGRGGFGPVYK------DGMEV--AIKVFN-LQYGGAFKSFDIECGMMKRIRHRNLI 567
           N +IGRG FG VY       DG ++  A+K  N +   G    F  E  +MK   H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 568 KIISSCSNDDFKALV-LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
            ++  C   +   LV L YM  G L   + +  +   +   +   + VA  +++L    S
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 151
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPDEIFS 684
              +H DL   N +LD+     ++DFG+A+ + +++      +T A   + +MA + + +
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 685 GEMRLK--CWVNDSLLISVM 702
            +   K   W    LL  +M
Sbjct: 212 QKFTTKSDVWSFGVLLWELM 231

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 83/186 (44%), Gaps = 17/186 (9%)
Query: 510 ATNRFSENNLIGRGGFGPVY-----KDGMEVAIKVF---NLQYGGAFKSFDIECGMMKRI 561
           A   F     +G+G FG VY     +    +A+KV     L+  G       E  +   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
           RH N++++     +     L+LEY PLG++ + L   +   D  +    + ++A+AL Y 
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYC 127
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
           H   S  +IH D+KP N+LL       ++DFG +        S  +     T+ Y+ P E
Sbjct: 128 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRXXLCGTLDYLPP-E 179
Query: 682 IFSGEM 687
           +  G M
Sbjct: 180 MIEGRM 185

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 517 NNLIGRGGFGPVYK------DGMEV--AIKVFN-LQYGGAFKSFDIECGMMKRIRHRNLI 567
           N +IGRG FG VY       DG ++  A+K  N +   G    F  E  +MK   H N++
Sbjct: 33  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 92
Query: 568 KIISSCSNDDFKALV-LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
            ++  C   +   LV L YM  G L   + +  +   +   +   + VA  +++L    S
Sbjct: 93  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 149
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPDEIFS 684
              +H DL   N +LD+     ++DFG+A+ + +++      +T A   + +MA + + +
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 209
Query: 685 GEMRLK--CWVNDSLLISVM 702
            +   K   W    LL  +M
Sbjct: 210 QKFTTKSDVWSFGVLLWELM 229

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 89/196 (45%), Gaps = 36/196 (18%)
Query: 520 IGRGGFGPVY------------KDGMEVAIKVFNLQYGGAFKSFD---IECGMMKRI-RH 563
           +G G FG V             K+ + VA+K+  L+     K       E  MMK I +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----NYILDI---------FQGL- 608
           +N+I ++ +C+ D    +++EY   G+L + L +       Y  DI         F+ L 
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
           +    +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T
Sbjct: 161 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTT 217
Query: 669 QTLATIGYMAPDEIFS 684
                + +MAP+ +F 
Sbjct: 218 NGRLPVKWMAPEALFD 233

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 26/187 (13%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIK 568
           +++  +IG G FG VY+      G  VAIK   +     FK+ +++  +M+++ H N+++
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKNRELQ--IMRKLDHCNIVR 111
Query: 569 I----ISSCSNDD--FKALVLEYMP--LGSLEKCLYSGNYILDIFQGLNIMIDVASALEY 620
           +     SS    D  +  LVL+Y+P  +  + +        L +      M  +  +L Y
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 621 LH-FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 678
           +H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 172 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---XICSRYYRA 224
Query: 679 PDEIFSG 685
           P+ IF  
Sbjct: 225 PELIFGA 231

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 81/176 (46%), Gaps = 17/176 (9%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVF---NLQYGGAFKSFDIECGMMKRIRHRNLIKIIS 571
           +G+G FG VY     +    +A+KV     L+  G       E  +   +RH N++++  
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
              +     L+LEY PLG++ + L   +   D  +    + ++A+AL Y H   S  +IH
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIH 133
Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEM 687
            D+KP N+LL       ++DFG +        S  +     T+ Y+ P E+  G M
Sbjct: 134 RDIKPENLLLGSAGELKIADFGWSV----HAPSSRRXXLCGTLDYLPP-EMIEGRM 184

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 517 NNLIGRGGFGPVYK------DGMEV--AIKVFN-LQYGGAFKSFDIECGMMKRIRHRNLI 567
           N +IGRG FG VY       DG ++  A+K  N +   G    F  E  +MK   H N++
Sbjct: 35  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 94
Query: 568 KIISSCSNDDFKALV-LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
            ++  C   +   LV L YM  G L   + +  +   +   +   + VA  +++L    S
Sbjct: 95  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 151
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPDEIFS 684
              +H DL   N +LD+     ++DFG+A+ + +++      +T A   + +MA + + +
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 685 GEMRLK--CWVNDSLLISVM 702
            +   K   W    LL  +M
Sbjct: 212 QKFTTKSDVWSFGVLLWELM 231

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 89/198 (44%), Gaps = 21/198 (10%)
Query: 508 FQAT--NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGA-FKSFDIECGMMK 559
           FQ T  + F     +G G FG V+       G+E  IK  N        +  + E  ++K
Sbjct: 16  FQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLK 75
Query: 560 RIRHRNLIKIISSCSNDDFKALVLEYMPLGSL-EKCLYSGNYILDIFQGL--NIMIDVAS 616
            + H N+IKI     +     +V+E    G L E+ + +      + +G    +M  + +
Sbjct: 76  SLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMN 135
Query: 617 ALEYLHFGYSVPIIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 673
           AL Y H   S  ++H DLKP N+L  D   +    + DFG+A+    ++ S   T    T
Sbjct: 136 ALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS---TNAAGT 189
Query: 674 IGYMAPDEIFSGEMRLKC 691
             YMAP E+F  ++  KC
Sbjct: 190 ALYMAP-EVFKRDVTFKC 206

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 26/187 (13%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIK 568
           +++  +IG G FG VY+      G  VAIK   +     FK+ +++  +M+++ H N+++
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKNRELQ--IMRKLDHCNIVR 90
Query: 569 I----ISSCSNDD--FKALVLEYMP--LGSLEKCLYSGNYILDIFQGLNIMIDVASALEY 620
           +     SS    D  +  LVL+Y+P  +  + +        L +      M  +  +L Y
Sbjct: 91  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 150
Query: 621 LH-FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 678
           +H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 151 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 203
Query: 679 PDEIFSG 685
           P+ IF  
Sbjct: 204 PELIFGA 210

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 81/176 (46%), Gaps = 17/176 (9%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVF---NLQYGGAFKSFDIECGMMKRIRHRNLIKIIS 571
           +G+G FG VY     +    +A+KV     L+  G       E  +   +RH N++++  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
              +     L+LEY PLG++ + L   +   D  +    + ++A+AL Y H   S  +IH
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIH 132
Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEM 687
            D+KP N+LL       ++DFG +        S  +     T+ Y+ P E+  G M
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWSV----HAPSSRRDTLCGTLDYLPP-EMIEGRM 183

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 89/196 (45%), Gaps = 36/196 (18%)
Query: 520 IGRGGFGPVY------------KDGMEVAIKVFNLQYGGAFKSFD---IECGMMKRI-RH 563
           +G G FG V             K+ + VA+K+  L+     K       E  MMK I +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----NYILDI---------FQGL- 608
           +N+I ++ +C+ D    +++EY   G+L + L +       Y  DI         F+ L 
Sbjct: 101 KNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
           +    +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T
Sbjct: 161 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 669 QTLATIGYMAPDEIFS 684
                + +MAP+ +F 
Sbjct: 218 NGRLPVKWMAPEALFD 233

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 87/190 (45%), Gaps = 13/190 (6%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G +G VY     K  + VA+K    +     + F  E  +MK I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYI-LDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
            +    ++ E+M  G+L   L   N   +     L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK--C 691
           L   N L+ +N +  ++DFG+++ L+  D           I + AP+ +   +  +K   
Sbjct: 137 LAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 692 WVNDSLLISV 701
           W    LL  +
Sbjct: 196 WAFGVLLWEI 205

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 90/190 (47%), Gaps = 26/190 (13%)
Query: 520 IGRGGFGPVYK---DGMEVAIKVFNLQYGGA-FKSFDIECGMMKRIRHRNLIKIISSCSN 575
           +G+G +G V++    G  VA+K+F+ +   + F+  ++   +M  +RH N++  I+S   
Sbjct: 45  VGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVM--LRHENILGFIASDMT 102
Query: 576 DDFKA----LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH---FGYS-- 626
               +    L+  Y  +GSL    Y     LD    L I++ +AS L +LH   FG    
Sbjct: 103 SRHSSTQLWLITHYHEMGSLYD--YLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK 160
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT-----LATIGYMAPDE 681
             I H DLK  N+L+  N    ++D G+A   +   QS  Q        + T  YMAP E
Sbjct: 161 PAIAHRDLKSKNILVKKNGQCCIADLGLA---VMHSQSTNQLDVGNNPRVGTKRYMAP-E 216
Query: 682 IFSGEMRLKC 691
           +    +++ C
Sbjct: 217 VLDETIQVDC 226

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 89/196 (45%), Gaps = 36/196 (18%)
Query: 520 IGRGGFGPVY------------KDGMEVAIKVFNLQYGGAFKSFD---IECGMMKRI-RH 563
           +G G FG V             K+ + VA+K+  L+     K       E  MMK I +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----NYILDI---------FQGL- 608
           +N+I ++ +C+ D    +++EY   G+L + L +       Y  DI         F+ L 
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
           +    +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T
Sbjct: 161 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTT 217
Query: 669 QTLATIGYMAPDEIFS 684
                + +MAP+ +F 
Sbjct: 218 NGRLPVKWMAPEALFD 233

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 30/206 (14%)
Query: 492 NMPSVADQRR---FTYLELFQATNRFSENNLIGRGGFGPVYKDGMEVAIKVFNLQYGGAF 548
           +MP V D+     F + E+ +A         IG+G FG V         K++ ++Y    
Sbjct: 1   SMPPVFDENEDVNFDHFEILRA---------IGKGSFGKVCIVQKNDTKKMYAMKYMNKQ 51
Query: 549 KSFD--------IECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNY 600
           K  +         E  +M+ + H  L+ +  S  +++   +V++ +  G L   L    +
Sbjct: 52  KCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVH 111
Query: 601 ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE 660
             +    L  + ++  AL+YL    +  IIH D+KP N+LLD++   H++DF +A  L  
Sbjct: 112 FKEETVKL-FICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167
Query: 661 EDQSLTQTQTLA-TIGYMAPDEIFSG 685
           E    TQ  T+A T  YMAP E+FS 
Sbjct: 168 E----TQITTMAGTKPYMAP-EMFSS 188

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 95/178 (53%), Gaps = 14/178 (7%)
Query: 520 IGRGGFGPV----YKDGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G FG V    Y +  +VA+K   L+ G  + ++F  E  +MK ++H  L+++ +  +
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVK--TLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 575 NDDFKALVLEYMPLGSLEKCLYS--GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
            ++   ++ E+M  GSL   L S  G  +L + + ++    +A  + Y+        IH 
Sbjct: 78  KEEPIYIITEFMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIE---RKNYIHR 133
Query: 633 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           DL+ +NVL+ ++++  ++DFG+A+ ++E+++   +      I + AP+ I  G   +K
Sbjct: 134 DLRAANVLVSESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGCFTIK 190

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 87/190 (45%), Gaps = 13/190 (6%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G +G VY     K  + VA+K    +     + F  E  +MK I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYI-LDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
            +    ++ E+M  G+L   L   N   +     L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136
Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK--C 691
           L   N L+ +N +  ++DFG+++ L+  D           I + AP+ +   +  +K   
Sbjct: 137 LAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 195
Query: 692 WVNDSLLISV 701
           W    LL  +
Sbjct: 196 WAFGVLLWEI 205

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 89/190 (46%), Gaps = 26/190 (13%)
Query: 520 IGRGGFGPVYK---DGMEVAIKVFNLQ-YGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           +G+G +G V++    G  VA+K+F+ +     F+  ++   +M  +RH N++  I+S   
Sbjct: 16  VGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVM--LRHENILGFIASDMT 73
Query: 576 DDFKA----LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH---FGYS-- 626
               +    L+  Y  +GSL    Y     LD    L I++ +AS L +LH   FG    
Sbjct: 74  SRHSSTQLWLITHYHEMGSLYD--YLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK 131
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT-----LATIGYMAPDE 681
             I H DLK  N+L+  N    ++D G+A   +   QS  Q        + T  YMAP E
Sbjct: 132 PAIAHRDLKSKNILVKKNGQCCIADLGLA---VMHSQSTNQLDVGNNPRVGTKRYMAP-E 187
Query: 682 IFSGEMRLKC 691
           +    +++ C
Sbjct: 188 VLDETIQVDC 197

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 89/189 (47%), Gaps = 27/189 (14%)
Query: 514 FSENNLIGRGGFGPVYKDGMEVAIKVFNLQ------------YGGAFKSFDIECGMMKRI 561
           F +  ++GRGGFG V+   M+   K++  +            Y GA     +E  ++ ++
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM----VEKKILAKV 242
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQ---GLNIMIDVASAL 618
             R ++ +  +        LV+  M  G +   +Y+ +     FQ    +     + S L
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 619 EYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGYM 677
           E+LH      II+ DLKP NVLLDD+    +SD G+A   +E     T+T+  A T G+M
Sbjct: 303 EHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLA---VELKAGQTKTKGYAGTPGFM 356
Query: 678 APDEIFSGE 686
           AP E+  GE
Sbjct: 357 AP-ELLLGE 364

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 517 NNLIGRGGFGPVYK------DGMEV--AIKVFN-LQYGGAFKSFDIECGMMKRIRHRNLI 567
           N +IGRG FG VY       DG ++  A+K  N +   G    F  E  +MK   H N++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 568 KIISSCSNDDFKALV-LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
            ++  C   +   LV L YM  G L   + +  +   +   +   + VA  +++L    S
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---AS 210
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPDEIFS 684
              +H DL   N +LD+     ++DFG+A+ + +++      +T A   + +MA + + +
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270
Query: 685 GEMRLK--CWVNDSLLISVM 702
            +   K   W    LL  +M
Sbjct: 271 QKFTTKSDVWSFGVLLWELM 290

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 26/187 (13%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIK 568
           +++  +IG G FG VY+      G  VAIK   +     FK+ +++  +M+++ H N+++
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKNRELQ--IMRKLDHCNIVR 105
Query: 569 I----ISSCSNDD--FKALVLEYMP--LGSLEKCLYSGNYILDIFQGLNIMIDVASALEY 620
           +     SS    D  +  LVL+Y+P  +  + +        L +      M  +  +L Y
Sbjct: 106 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 165
Query: 621 LH-FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 678
           +H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 166 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 218
Query: 679 PDEIFSG 685
           P+ IF  
Sbjct: 219 PELIFGA 225

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 89/190 (46%), Gaps = 26/190 (13%)
Query: 520 IGRGGFGPVYK---DGMEVAIKVFNLQ-YGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           +G+G +G V++    G  VA+K+F+ +     F+  ++   +M  +RH N++  I+S   
Sbjct: 16  VGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVM--LRHENILGFIASDMT 73
Query: 576 DDFKA----LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH---FGYS-- 626
               +    L+  Y  +GSL    Y     LD    L I++ +AS L +LH   FG    
Sbjct: 74  SRHSSTQLWLITHYHEMGSLYD--YLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK 131
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT-----LATIGYMAPDE 681
             I H DLK  N+L+  N    ++D G+A   +   QS  Q        + T  YMAP E
Sbjct: 132 PAIAHRDLKSKNILVKKNGQCCIADLGLA---VMHSQSTNQLDVGNNPRVGTKRYMAP-E 187
Query: 682 IFSGEMRLKC 691
           +    +++ C
Sbjct: 188 VLDETIQVDC 197

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 89/196 (45%), Gaps = 36/196 (18%)
Query: 520 IGRGGFGPVY------------KDGMEVAIKVFNLQYGGAFKSFD---IECGMMKRI-RH 563
           +G G FG V             K+ + VA+K+  L+     K       E  MMK I +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----NYILDI---------FQGL- 608
           +N+I ++ +C+ D    +++EY   G+L + L +       Y  DI         F+ L 
Sbjct: 101 KNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
           +    +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T
Sbjct: 161 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 669 QTLATIGYMAPDEIFS 684
                + +MAP+ +F 
Sbjct: 218 NGRLPVKWMAPEALFD 233

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 81/176 (46%), Gaps = 17/176 (9%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVF---NLQYGGAFKSFDIECGMMKRIRHRNLIKIIS 571
           +G+G FG VY     +    +A+KV     L+  G       E  +   +RH N++++  
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
              +     L+LEY PLG++ + L   +   D  +    + ++A+AL Y H   S  +IH
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIH 157
Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEM 687
            D+KP N+LL       ++DFG +        S  +     T+ Y+ P E+  G M
Sbjct: 158 RDIKPENLLLGSAGELKIADFGWSV----HAPSSRRDDLCGTLDYLPP-EMIEGRM 208

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 89/189 (47%), Gaps = 27/189 (14%)
Query: 514 FSENNLIGRGGFGPVYKDGMEVAIKVFNLQ------------YGGAFKSFDIECGMMKRI 561
           F +  ++GRGGFG V+   M+   K++  +            Y GA     +E  ++ ++
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM----VEKKILAKV 242
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQ---GLNIMIDVASAL 618
             R ++ +  +        LV+  M  G +   +Y+ +     FQ    +     + S L
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 619 EYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGYM 677
           E+LH      II+ DLKP NVLLDD+    +SD G+A   +E     T+T+  A T G+M
Sbjct: 303 EHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLA---VELKAGQTKTKGYAGTPGFM 356
Query: 678 APDEIFSGE 686
           AP E+  GE
Sbjct: 357 AP-ELLLGE 364

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 26/187 (13%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIK 568
           +++  +IG G FG VY+      G  VAIK   +     FK+ +++  +M+++ H N+++
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKNRELQ--IMRKLDHCNIVR 82
Query: 569 I----ISSCSNDD--FKALVLEYMP--LGSLEKCLYSGNYILDIFQGLNIMIDVASALEY 620
           +     SS    D  +  LVL+Y+P  +  + +        L +      M  +  +L Y
Sbjct: 83  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 142
Query: 621 LH-FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 678
           +H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 143 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 195
Query: 679 PDEIFSG 685
           P+ IF  
Sbjct: 196 PELIFGA 202

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 89/189 (47%), Gaps = 27/189 (14%)
Query: 514 FSENNLIGRGGFGPVYKDGMEVAIKVFNLQ------------YGGAFKSFDIECGMMKRI 561
           F +  ++GRGGFG V+   M+   K++  +            Y GA     +E  ++ ++
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM----VEKKILAKV 242
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQ---GLNIMIDVASAL 618
             R ++ +  +        LV+  M  G +   +Y+ +     FQ    +     + S L
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 619 EYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGYM 677
           E+LH      II+ DLKP NVLLDD+    +SD G+A   +E     T+T+  A T G+M
Sbjct: 303 EHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLA---VELKAGQTKTKGYAGTPGFM 356
Query: 678 APDEIFSGE 686
           AP E+  GE
Sbjct: 357 AP-ELLLGE 364

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 126/290 (43%), Gaps = 20/290 (6%)
Query: 501 RFTYLELFQAT-NRFSENNLIGRGGFGPVYKDGMEVAIKVFNLQYGGAFKSFDI------ 553
           ++ +LE    T N F +  ++G+GGFG V    +    K++  +     +          
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA 231
Query: 554 --ECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYS-GNYILDIFQGLNI 610
             E  +++++  R ++ +  +    D   LVL  M  G L+  +Y  G       + +  
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY 291
Query: 611 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 670
             ++   LE LH      I++ DLKP N+LLDD+    +SD G+A  + E     T    
Sbjct: 292 AAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQTIKGR 345
Query: 671 LATIGYMAPDEIFSGEMRLKC-WVNDSLLISVMIVVDANLLIREEKHLMTKEQPMVRMGT 729
           + T+GYMAP+ + +        W     L+  MI   +    R++K    + + +V+   
Sbjct: 346 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP 405
Query: 730 DLSLGQF-PASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDY 778
           +    +F P + S+   L+     ER  +G    +A  +  H L++ +++
Sbjct: 406 EEYSERFSPQARSLCSQLLCKDPAER--LGCRGGSAREVKEHPLFKKLNF 453

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 87/190 (45%), Gaps = 13/190 (6%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G +G VY     K  + VA+K    +     + F  E  +MK I+H NL++++  C+
Sbjct: 26  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYI-LDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
            +    ++ E+M  G+L   L   N   +     L +   ++SA+EYL        IH D
Sbjct: 85  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 141
Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK--C 691
           L   N L+ +N +  ++DFG+++ L+  D           I + AP+ +   +  +K   
Sbjct: 142 LAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 200
Query: 692 WVNDSLLISV 701
           W    LL  +
Sbjct: 201 WAFGVLLWEI 210

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 88/190 (46%), Gaps = 13/190 (6%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G +G VY     K  + VA+K    +     + F  E  +MK I+H NL++++  C+
Sbjct: 22  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYI-LDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
            +    ++ E+M  G+L   L   N   ++    L +   ++SA+EYL        IH D
Sbjct: 81  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 137
Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK--C 691
           L   N L+ +N +  ++DFG+++ L+  D           I + AP+ +   +  +K   
Sbjct: 138 LAARNCLVGENHLVKVADFGLSR-LMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDV 196
Query: 692 WVNDSLLISV 701
           W    LL  +
Sbjct: 197 WAFGVLLWEI 206

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 26/187 (13%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIK 568
           +++  +IG G FG VY+      G  VAIK   +     FK+ +++  +M+++ H N+++
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKNRELQ--IMRKLDHCNIVR 111
Query: 569 I----ISSCSNDD--FKALVLEYMP--LGSLEKCLYSGNYILDIFQGLNIMIDVASALEY 620
           +     SS    D  +  LVL+Y+P  +  + +        L +      M  +  +L Y
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 621 LH-FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 678
           +H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 172 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 224
Query: 679 PDEIFSG 685
           P+ IF  
Sbjct: 225 PELIFGA 231

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 88/190 (46%), Gaps = 13/190 (6%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G +G VY     K  + VA+K    +     + F  E  +MK I+H NL++++  C+
Sbjct: 23  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYI-LDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
            +    ++ E+M  G+L   L   N   ++    L +   ++SA+EYL        IH D
Sbjct: 82  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRD 138
Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK--C 691
           L   N L+ +N +  ++DFG+++ L+  D           I + AP+ +   +  +K   
Sbjct: 139 LAARNCLVGENHLVKVADFGLSR-LMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDV 197
Query: 692 WVNDSLLISV 701
           W    LL  +
Sbjct: 198 WAFGVLLWEI 207

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/194 (27%), Positives = 86/194 (44%), Gaps = 32/194 (16%)
Query: 520 IGRGGFGPVY------------KDGMEVAIKVFNLQYGGA-FKSFDIECGMMKRI-RHRN 565
           +G G FG V             K+ + VA+K+               E  MMK I +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----NYILDI---------FQGL-NI 610
           +I ++ +C+ D    +++EY   G+L + L +       Y  DI         F+ L + 
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 611 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 670
              +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T  
Sbjct: 163 TYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 671 LATIGYMAPDEIFS 684
              + +MAP+ +F 
Sbjct: 220 RLPVKWMAPEALFD 233

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 22/213 (10%)
Query: 475 LLILKYRKGRKSQLKDVNMPSVADQRRFTYLELFQATNRFSENNLIGRGGFGPVYK---- 530
           L  ++ R   + QLK ++  S+  Q      E+F    +      +G G +G VYK    
Sbjct: 2   LETVQLRNPPRRQLKKLDEDSLTKQPE----EVFDVLEK------LGEGSYGSVYKAIHK 51
Query: 531 -DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLG 589
             G  VAIK   ++     +    E  +M++    +++K   S   +    +V+EY   G
Sbjct: 52  ETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAG 109
Query: 590 SLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHL 649
           S+   +   N  L   +   I+      LEYLHF      IH D+K  N+LL+    A L
Sbjct: 110 SVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK---IHRDIKAGNILLNTEGHAKL 166
Query: 650 SDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
           +DFG+A  L   D    +   + T  +MAP+ I
Sbjct: 167 ADFGVAGQLT--DXMAKRNXVIGTPFWMAPEVI 197

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/172 (26%), Positives = 78/172 (45%), Gaps = 9/172 (5%)
Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKS-FDIECGMMKRIRHRNLIKIISSC 573
           IGRG FG V+      D   VA+K          K+ F  E  ++K+  H N++++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
           +      +V+E +  G     L +    L +   L ++ D A+ +EYL    S   IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG 685
           L   N L+ +  V  +SDFGM++   +   + +       + + AP+ +  G
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYG 290

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 36/196 (18%)
Query: 520 IGRGGFGPVY------------KDGMEVAIKVFNLQYGGAFKSFD---IECGMMKRI-RH 563
           +G G FG V             K+ + VA+K+  L+     K       E  MMK I +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCL-----------YSGNYILD---IFQGL- 608
           +N+I ++ +C+ D    +++EY   G+L + L           Y  N + +    F+ L 
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLV 160
Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
           +    +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T
Sbjct: 161 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 669 QTLATIGYMAPDEIFS 684
                + +MAP+ +F 
Sbjct: 218 NGRLPVKWMAPEALFD 233

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 26/187 (13%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIK 568
           +++  +IG G FG VY+      G  VAIK   +     FK+ +++  +M+++ H N+++
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKNRELQ--IMRKLDHCNIVR 115
Query: 569 I----ISSCSNDD--FKALVLEYMP--LGSLEKCLYSGNYILDIFQGLNIMIDVASALEY 620
           +     SS    D  +  LVL+Y+P  +  + +        L +      M  +  +L Y
Sbjct: 116 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 175
Query: 621 LH-FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 678
           +H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 176 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 228
Query: 679 PDEIFSG 685
           P+ IF  
Sbjct: 229 PELIFGA 235

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 89/189 (47%), Gaps = 27/189 (14%)
Query: 514 FSENNLIGRGGFGPVYKDGMEVAIKVFNLQ------------YGGAFKSFDIECGMMKRI 561
           F +  ++GRGGFG V+   M+   K++  +            Y GA     +E  ++ ++
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAM----VEKKILAKV 242
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQ---GLNIMIDVASAL 618
             R ++ +  +        LV+  M  G +   +Y+ +     FQ    +     + S L
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 619 EYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGYM 677
           E+LH      II+ DLKP NVLLDD+    +SD G+A   +E     T+T+  A T G+M
Sbjct: 303 EHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLA---VELKAGQTKTKGYAGTPGFM 356
Query: 678 APDEIFSGE 686
           AP E+  GE
Sbjct: 357 AP-ELLLGE 364

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 26/187 (13%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIK 568
           +++  +IG G FG VY+      G  VAIK   +     FK+ +++  +M+++ H N+++
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKNRELQ--IMRKLDHCNIVR 113
Query: 569 I----ISSCSNDD--FKALVLEYMP--LGSLEKCLYSGNYILDIFQGLNIMIDVASALEY 620
           +     SS    D  +  LVL+Y+P  +  + +        L +      M  +  +L Y
Sbjct: 114 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 173
Query: 621 LH-FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 678
           +H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 174 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 226
Query: 679 PDEIFSG 685
           P+ IF  
Sbjct: 227 PELIFGA 233

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 78/198 (39%), Gaps = 37/198 (18%)
Query: 520 IGRGGFGPV----------YKDGMEVAIKVFNLQYGGAFKS-FDIECGMMKRIRHRNLIK 568
           IG G FG V          Y+    VA+K+   +     ++ F  E  +M    + N++K
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCLYS-----------------------GNYILDIF 605
           ++  C+      L+ EYM  G L + L S                       G   L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 606 QGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL 665
           + L I   VA+ + YL        +H DL   N L+ +NMV  ++DFG+++ +   D   
Sbjct: 175 EQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 666 TQTQTLATIGYMAPDEIF 683
                   I +M P+ IF
Sbjct: 232 ADGNDAIPIRWMPPESIF 249

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 26/187 (13%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIK 568
           +++  +IG G FG VY+      G  VAIK   +     FK+ +++  +M+++ H N+++
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFKNRELQ--IMRKLDHCNIVR 156
Query: 569 I----ISSCSNDD--FKALVLEYMP--LGSLEKCLYSGNYILDIFQGLNIMIDVASALEY 620
           +     SS    D  +  LVL+Y+P  +  + +        L +      M  +  +L Y
Sbjct: 157 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 216
Query: 621 LH-FGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 678
           +H FG    I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 217 IHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY---ICSRYYRA 269
Query: 679 PDEIFSG 685
           P+ IF  
Sbjct: 270 PELIFGA 276

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 88/190 (46%), Gaps = 13/190 (6%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G +G VY     K  + VA+K    +     + F  E  +MK I+H NL++++  C+
Sbjct: 267 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYI-LDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
            +    ++ E+M  G+L   L   N   ++    L +   ++SA+EYL        IH +
Sbjct: 326 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRN 382
Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKC-- 691
           L   N L+ +N +  ++DFG+++ L+  D           I + AP+ +   +  +K   
Sbjct: 383 LAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 441
Query: 692 WVNDSLLISV 701
           W    LL  +
Sbjct: 442 WAFGVLLWEI 451

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 68/143 (47%), Gaps = 9/143 (6%)
Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKS-FDIECGMMKRIRHRNLIKIISSC 573
           IGRG FG V+      D   VA+K          K+ F  E  ++K+  H N++++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
           +      +V+E +  G     L +    L +   L ++ D A+ +EYL    S   IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 634 LKPSNVLLDDNMVAHLSDFGMAK 656
           L   N L+ +  V  +SDFGM++
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSR 261

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/124 (26%), Positives = 65/124 (52%), Gaps = 6/124 (4%)
Query: 532 GMEVAIKVFNLQYGGAFKS--FDIECGMMKRIRHRNLIKIISSCSND--DFKALVLEYMP 587
           G ++ +KV  ++     KS  F+ EC  ++   H N++ ++ +C +       L+  +MP
Sbjct: 33  GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMP 92
Query: 588 LGSLEKCLYSG-NYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV 646
            GSL   L+ G N+++D  Q +   +D+A  + +LH    +   H  L   +V++D++M 
Sbjct: 93  YGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHA-LNSRSVMIDEDMT 151
Query: 647 AHLS 650
           A +S
Sbjct: 152 ARIS 155

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 85/177 (48%), Gaps = 16/177 (9%)
Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G FG VYK      G   A KV   +     + + +E  ++    H  ++K++ +  
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGL---NIMIDVASALEYLHFGYSVPIIH 631
           +D    +++E+ P G+++  +      L++ +GL    I +     LE L+F +S  IIH
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIM------LELDRGLTEPQIQVVCRQMLEALNFLHSKRIIH 132
Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMR 688
            DLK  NVL+       L+DFG++   L+  Q   +   + T  +MAP+ +    M+
Sbjct: 133 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK--RDSFIGTPYWMAPEVVMCETMK 187

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 79/180 (43%), Gaps = 14/180 (7%)
Query: 512 NRFSENNLIGRGGFGPVYKD--------GMEVAIKVF-NLQYGGAFKSFDIECGMMKRIR 562
            R      IG G FG V++          M VAIK   N       + F  E   M++  
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 563 HRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
           H +++K+I   + +    +++E   LG L   L    Y LD+   +     +++AL YL 
Sbjct: 70  HPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 128
Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              S   +H D+   NVL+  N    L DFG+++  +E+      ++    I +MAP+ I
Sbjct: 129 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESI 184

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 91/181 (50%), Gaps = 26/181 (14%)
Query: 517 NNLIGRGGFGPVY-----KDGMEVAIKVFN-LQYGGAFKSFDI---ECGMMKRIRHRNLI 567
           ++++G+G    V+     K G   AIKVFN + +    +  D+   E  ++K++ H+N++
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISF---LRPVDVQMREFEVLKKLNHKNIV 70
Query: 568 KI--ISSCSNDDFKALVLEYMPLGSLEKCLY--SGNYILDIFQGLNIMIDVASALEYLHF 623
           K+  I   +    K L++E+ P GSL   L   S  Y L   + L ++ DV   + +L  
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR- 129
Query: 624 GYSVPIIHCDLKPSNVLL----DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
                I+H ++KP N++     D   V  L+DFG A+ L +++Q ++      T  Y+ P
Sbjct: 130 --ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS---LYGTEEYLHP 184
Query: 680 D 680
           D
Sbjct: 185 D 185

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 66/290 (22%), Positives = 126/290 (43%), Gaps = 20/290 (6%)
Query: 501 RFTYLELFQAT-NRFSENNLIGRGGFGPVYKDGMEVAIKVFNLQYGGAFKSFDI------ 553
           ++ +LE    T N F +  ++G+GGFG V    +    K++  +     +          
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA 231
Query: 554 --ECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYS-GNYILDIFQGLNI 610
             E  +++++  R ++ +  +    D   LVL  M  G L+  +Y  G       + +  
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY 291
Query: 611 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 670
             ++   LE LH      I++ DLKP N+LLDD+    +SD G+A  + E     T    
Sbjct: 292 AAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQTIKGR 345
Query: 671 LATIGYMAPDEIFSGEMRLKC-WVNDSLLISVMIVVDANLLIREEKHLMTKEQPMVRMGT 729
           + T+GYMAP+ + +        W     L+  MI   +    R++K    + + +V+   
Sbjct: 346 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP 405
Query: 730 DLSLGQF-PASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDY 778
           +    +F P + S+   L+     ER  +G    +A  +  H L++ +++
Sbjct: 406 EEYSERFSPQARSLCSQLLCKDPAER--LGCRGGSAREVKEHPLFKKLNF 453

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 83/176 (47%), Gaps = 17/176 (9%)
Query: 520 IGRGGFGPV-----YKDGMEVAIKVFN---LQYGGAFKSFDIECGMMKRIRHRNLIKIIS 571
           +G G FG V     YK   +VA+K  +   L+        + E   +K +RH ++IK+  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
             +      +V+EY      +  +       D  +G      +  A+EY H      I+H
Sbjct: 77  VITTPTDIVMVIEYAGGELFDYIVEKKRMTED--EGRRFFQQIICAIEYCH---RHKIVH 131
Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEM 687
            DLKP N+LLDDN+   ++DFG++  +   D +  +T +  +  Y AP E+ +G++
Sbjct: 132 RDLKPENLLLDDNLNVKIADFGLSNIMT--DGNFLKT-SCGSPNYAAP-EVINGKL 183

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/190 (25%), Positives = 87/190 (45%), Gaps = 13/190 (6%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G +G VY     K  + VA+K    +     + F  E  +MK I+H NL++++  C+
Sbjct: 19  LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYI-LDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
            +    ++ E+M  G+L   L   N   +     L +   ++SA+EYL        IH D
Sbjct: 78  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 134
Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK--C 691
           L   N L+ +N +  ++DFG+++ L+  D           I + AP+ +   +  +K   
Sbjct: 135 LAARNCLVGENHLVKVADFGLSR-LMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDV 193
Query: 692 WVNDSLLISV 701
           W    LL  +
Sbjct: 194 WAFGVLLWEI 203

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 117/238 (49%), Gaps = 19/238 (7%)
Query: 476 LILKYRKGRKSQLKDVNMPSVADQRRFTYLELFQATNRFS---ENNLIGRGGFGPV---- 528
           L+  Y+KG     + +++P ++ + +  + +      R S   E  L G G FG V    
Sbjct: 150 LVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKL-GAGQFGEVWMAT 208
Query: 529 YKDGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMP 587
           Y    +VA+K   ++ G  + ++F  E  +MK ++H  L+K+ +  + +    ++ E+M 
Sbjct: 209 YNKHTKVAVKT--MKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMA 265
Query: 588 LGSLEKCLYSGNYILDIFQGLNIMIDVASAL-EYLHFGYSVPIIHCDLKPSNVLLDDNMV 646
            GSL   L S        Q L  +ID ++ + E + F      IH DL+ +N+L+  ++V
Sbjct: 266 KGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV 322
Query: 647 AHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK--CWVNDSLLISVM 702
             ++DFG+A+ ++E+++   +      I + AP+ I  G   +K   W    LL+ ++
Sbjct: 323 CKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 379

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/198 (25%), Positives = 82/198 (41%), Gaps = 42/198 (21%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFN---------------------LQYGGA 547
           F E  LIG GGFG V+K     DG    IK                        + Y G 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 548 FKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGN-YILDIFQ 606
           +  FD +     +   R+  K +          + +E+   G+LE+ +       LD   
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCL---------FIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 607 GLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT 666
            L +   +   ++Y+H   S  +I+ DLKPSN+ L D     + DFG+   L  + +   
Sbjct: 124 ALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK--- 177
Query: 667 QTQTLATIGYMAPDEIFS 684
           + ++  T+ YM+P++I S
Sbjct: 178 RXRSKGTLRYMSPEQISS 195

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 77/176 (43%), Gaps = 14/176 (7%)
Query: 514 FSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRN 565
           F    ++G G F  V          E AIK+   ++            E  +M R+ H  
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 98
Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFG 624
            +K+     +D+     L Y   G L K +   G++  D         ++ SALEYLH  
Sbjct: 99  FVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSF--DETCTRFYTAEIVSALEYLH-- 154
Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
               IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P+
Sbjct: 155 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPE 209

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 89/196 (45%), Gaps = 36/196 (18%)
Query: 520 IGRGGFGPVY------------KDGMEVAIKVFNLQYGGAFKSFD---IECGMMKRI-RH 563
           +G G FG V             K+ + VA+K+  L+     K       E  MMK I +H
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----NYILDI---------FQGL- 608
           +N+I ++ +C+ D    +++EY   G+L + L +       Y  DI         F+ L 
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
           +    +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T
Sbjct: 207 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 669 QTLATIGYMAPDEIFS 684
                + +MAP+ +F 
Sbjct: 264 NGRLPVKWMAPEALFD 279

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Composition-based stats.
 Identities = 49/176 (27%), Positives = 82/176 (46%), Gaps = 17/176 (9%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVF---NLQYGGAFKSFDIECGMMKRIRHRNLIKIIS 571
           +G+G FG VY     +    +A+KV     L+  G       E  +   +RH N++++  
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
              +     L+LEY PLG++ + L   +   D  +    + ++A+AL Y H   S  +IH
Sbjct: 73  YFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVIH 128
Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEM 687
            D+KP N+LL       ++DFG +        S  +T    T+ Y+ P E+  G M
Sbjct: 129 RDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPP-EMIEGRM 179

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 94/191 (49%), Gaps = 16/191 (8%)
Query: 506 ELFQATNRFSENN---LIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGM 557
           +L +    + EN    ++G+G +G VY      + + +AIK    +     +    E  +
Sbjct: 13  DLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIAL 72
Query: 558 MKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-NYILDIFQGLNIMI-DVA 615
            K ++H+N+++ + S S + F  + +E +P GSL   L S    + D  Q +      + 
Sbjct: 73  HKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL 132
Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDD-NMVAHLSDFGMAKPLLEEDQSLTQTQTLATI 674
             L+YLH      I+H D+K  NVL++  + V  +SDFG +K L   +   T+T T  T+
Sbjct: 133 EGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTETFT-GTL 187
Query: 675 GYMAPDEIFSG 685
            YMAP+ I  G
Sbjct: 188 QYMAPEIIDKG 198

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 85/177 (48%), Gaps = 16/177 (9%)
Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G FG VYK      G   A KV   +     + + +E  ++    H  ++K++ +  
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGL---NIMIDVASALEYLHFGYSVPIIH 631
           +D    +++E+ P G+++  +      L++ +GL    I +     LE L+F +S  IIH
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIM------LELDRGLTEPQIQVVCRQMLEALNFLHSKRIIH 140
Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMR 688
            DLK  NVL+       L+DFG++   L+  Q   +   + T  +MAP+ +    M+
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK--RDSFIGTPYWMAPEVVMCETMK 195

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 87/186 (46%), Gaps = 15/186 (8%)
Query: 504 YLELFQATNRFSENNLIGRGGFGPVYKDGME------VAIKVFNLQYGGAFKSF-DIECG 556
           Y +       F++   IG+G FG V+K G++      VAIK+ +L+           E  
Sbjct: 19  YFQSMDPEELFTKLEKIGKGSFGEVFK-GIDNRTQKVVAIKIIDLEEAEDEIEDIQQEIT 77
Query: 557 MMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVAS 616
           ++ +     + K   S   D    +++EY+  GS    L  G   LD  Q   I+ ++  
Sbjct: 78  VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILK 135
Query: 617 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGY 676
            L+YLH   S   IH D+K +NVLL ++    L+DFG+A  L   D  + +   + T  +
Sbjct: 136 GLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFW 190
Query: 677 MAPDEI 682
           MAP+ I
Sbjct: 191 MAPEVI 196

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 86/180 (47%), Gaps = 27/180 (15%)
Query: 520 IGRGGFGPVYK---DGMEVAIKVFN-LQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           IG+G FG V++    G EVA+K+F+  +    F+  +I   +M  +RH N++  I++ + 
Sbjct: 37  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAADNK 94
Query: 576 DDFKA----LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY-----S 626
           D+       LV +Y   GSL    Y   Y + +   + + +  AS L +LH         
Sbjct: 95  DNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 152
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA------TIGYMAPD 680
             I H DLK  N+L+  N    ++D G+A   +  D S T T  +A      T  YMAP+
Sbjct: 153 PAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHD-SATDTIDIAPNHRVGTKRYMAPE 208

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 79/176 (44%), Gaps = 17/176 (9%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVF---NLQYGGAFKSFDIECGMMKRIRHRNLIKIIS 571
           +G+G FG VY     K    VA+KV     ++  G       E  +   + H N++++ +
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYN 90
Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
              +     L+LEY P G L K L   +   D  +   IM ++A AL Y H      +IH
Sbjct: 91  YFYDRRRIYLILEYAPRGELYKEL-QKSCTFDEQRTATIMEELADALMYCH---GKKVIH 146
Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEM 687
            D+KP N+LL       ++DFG +        SL +     T+ Y+ P E+  G M
Sbjct: 147 RDIKPENLLLGLKGELKIADFGWSV----HAPSLRRKTMCGTLDYLPP-EMIEGRM 197

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 90/205 (43%), Gaps = 43/205 (20%)
Query: 514 FSENNLIGRGGFGPVYKDGMEVAIKVF---NLQYGGAFKSFDIECGMMKRIRHRNLIKII 570
           F E  LIG GGFG V+K    +  K +    ++Y    +  + E   + ++ H N++   
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNN--EKAEREVKALAKLDHVNIVHY- 70
Query: 571 SSC----------SNDDFKA--------------------LVLEYMPLGSLEKCLYSGN- 599
           + C          S+D  ++                    + +E+   G+LE+ +     
Sbjct: 71  NGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 130
Query: 600 YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL 659
             LD    L +   +   ++Y+H   S  +IH DLKPSN+ L D     + DFG+   L 
Sbjct: 131 EKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLK 187
Query: 660 EEDQSLTQTQTLATIGYMAPDEIFS 684
            + +   +T++  T+ YM+P++I S
Sbjct: 188 NDGK---RTRSKGTLRYMSPEQISS 209

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 97/191 (50%), Gaps = 15/191 (7%)
Query: 520 IGRGGFGPV----YKDGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G FG V    Y    +VA+K   ++ G  + ++F  E  +MK ++H  L+K+ +  +
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVK--TMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 80
Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASAL-EYLHFGYSVPIIHCD 633
            +    ++ E+M  GSL   L S        Q L  +ID ++ + E + F      IH D
Sbjct: 81  KEPI-YIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 136
Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK--C 691
           L+ +N+L+  ++V  ++DFG+A+ ++E+++   +      I + AP+ I  G   +K   
Sbjct: 137 LRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 195
Query: 692 WVNDSLLISVM 702
           W    LL+ ++
Sbjct: 196 WSFGILLMEIV 206

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 86/180 (47%), Gaps = 27/180 (15%)
Query: 520 IGRGGFGPVYK---DGMEVAIKVFN-LQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           IG+G FG V++    G EVA+K+F+  +    F+  +I   +M  +RH N++  I++ + 
Sbjct: 11  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAADNK 68
Query: 576 DDFKA----LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY-----S 626
           D+       LV +Y   GSL    Y   Y + +   + + +  AS L +LH         
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA------TIGYMAPD 680
             I H DLK  N+L+  N    ++D G+A   +  D S T T  +A      T  YMAP+
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHD-SATDTIDIAPNHRVGTKRYMAPE 182

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 89/196 (45%), Gaps = 36/196 (18%)
Query: 520 IGRGGFGPVY------------KDGMEVAIKVFNLQYGGAFKSFD---IECGMMKRI-RH 563
           +G G FG V             K+ + VA+K+  L+     K       E  MMK I +H
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 87
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----NYILDI---------FQGL- 608
           +N+I ++ +C+ D    +++EY   G+L + L +       Y  DI         F+ L 
Sbjct: 88  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 147
Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
           +    +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T
Sbjct: 148 SCTYQLARGMEYLA---SQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTT 204
Query: 669 QTLATIGYMAPDEIFS 684
                + +MAP+ +F 
Sbjct: 205 NGRLPVKWMAPEALFD 220

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 86/180 (47%), Gaps = 27/180 (15%)
Query: 520 IGRGGFGPVYK---DGMEVAIKVFN-LQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           IG+G FG V++    G EVA+K+F+  +    F+  +I   +M  +RH N++  I++ + 
Sbjct: 12  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAADNK 69
Query: 576 DDFKA----LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY-----S 626
           D+       LV +Y   GSL    Y   Y + +   + + +  AS L +LH         
Sbjct: 70  DNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 127
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA------TIGYMAPD 680
             I H DLK  N+L+  N    ++D G+A   +  D S T T  +A      T  YMAP+
Sbjct: 128 PAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHD-SATDTIDIAPNHRVGTKRYMAPE 183

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 87/190 (45%), Gaps = 13/190 (6%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G +G VY     K  + VA+K    +     + F  E  +MK I+H NL++++  C+
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYI-LDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
            +    ++ E+M  G+L   L   N   +     L +   ++SA+EYL        IH +
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRN 343
Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKC-- 691
           L   N L+ +N +  ++DFG+++ L+  D           I + AP+ +   +  +K   
Sbjct: 344 LAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 402
Query: 692 WVNDSLLISV 701
           W    LL  +
Sbjct: 403 WAFGVLLWEI 412

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 89/196 (45%), Gaps = 36/196 (18%)
Query: 520 IGRGGFGPVY------------KDGMEVAIKVFNLQYGGAFKSFD---IECGMMKRI-RH 563
           +G G FG V             K+ + VA+K+  L+     K       E  MMK I +H
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 89
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----NYILDI---------FQGL- 608
           +N+I ++ +C+ D    +++EY   G+L + L +       Y  DI         F+ L 
Sbjct: 90  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 149
Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
           +    +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T
Sbjct: 150 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 206
Query: 669 QTLATIGYMAPDEIFS 684
                + +MAP+ +F 
Sbjct: 207 NGRLPVKWMAPEALFD 222

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 85/188 (45%), Gaps = 22/188 (11%)
Query: 513 RFSENNL-----IGRGGFGPVY---------KDGMEVAIKVFNLQYGGAFKSFDIECGMM 558
           +F E +L     +G+G FG V            G  VA+K          + F+ E  ++
Sbjct: 7   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 66
Query: 559 KRIRHRNLIKIISSCSNDDFK--ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVAS 616
           K ++H N++K    C +   +   L++EY+P GSL   L      +D  + L     +  
Sbjct: 67  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 126
Query: 617 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT--LATI 674
            +EYL    +   IH +L   N+L+++     + DFG+ K +L +D+   + +    + I
Sbjct: 127 GMEYLG---TKRYIHRNLATRNILVENENRVKIGDFGLTK-VLPQDKEYYKVKEPGESPI 182
Query: 675 GYMAPDEI 682
            + AP+ +
Sbjct: 183 FWYAPESL 190

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 84/179 (46%), Gaps = 25/179 (13%)
Query: 520 IGRGGFGPVYK---DGMEVAIKVFN-LQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           IG+G FG V++    G EVA+K+F+  +    F+  +I   +M  +RH N++  I++ + 
Sbjct: 14  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAADNK 71
Query: 576 DDFKA----LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY-----S 626
           D+       LV +Y   GSL    Y   Y + +   + + +  AS L +LH         
Sbjct: 72  DNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 129
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS-----LTQTQTLATIGYMAPD 680
             I H DLK  N+L+  N    ++D G+A   +  D +     +     + T  YMAP+
Sbjct: 130 PAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHDSATDTIDIAPNHRVGTKRYMAPE 185

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 116/274 (42%), Gaps = 40/274 (14%)
Query: 518 NLIGRGGFGPVYKDGMEVAIKVFNLQYGGAFKS--------FDIECGMMKRIRHRNLIKI 569
            +IGRG FG V     + + KV+ ++    F+         F  E  +M       ++++
Sbjct: 81  KVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 140
Query: 570 ISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPI 629
             +  +D +  +V+EYMP G L   +   NY +          +V  AL+ +H   S+ +
Sbjct: 141 FCAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWAKFYTAEVVLALDAIH---SMGL 195
Query: 630 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS----G 685
           IH D+KP N+LLD +    L+DFG    + E       T  + T  Y++P+ + S    G
Sbjct: 196 IHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDT-AVGTPDYISPEVLKSQGGDG 254
Query: 686 EMRLKC-WVNDSLLISVMIVVD----ANLLIREEKHLMTKEQPMVRMGTDLSLGQFPASY 740
               +C W +  + +  M+V D    A+ L+     +M  +  +           FP   
Sbjct: 255 YYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLC----------FPEDA 304
Query: 741 SISKY-------LVYIRELERGKVGITSVAAFPI 767
            ISK+        +  RE+  G+ G+  +   P 
Sbjct: 305 EISKHAKNLICAFLTDREVRLGRNGVEEIKQHPF 338

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 86/180 (47%), Gaps = 27/180 (15%)
Query: 520 IGRGGFGPVYK---DGMEVAIKVFN-LQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           IG+G FG V++    G EVA+K+F+  +    F+  +I   +M  +RH N++  I++ + 
Sbjct: 50  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAADNK 107
Query: 576 DDFKA----LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY-----S 626
           D+       LV +Y   GSL    Y   Y + +   + + +  AS L +LH         
Sbjct: 108 DNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 165
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA------TIGYMAPD 680
             I H DLK  N+L+  N    ++D G+A   +  D S T T  +A      T  YMAP+
Sbjct: 166 PAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHD-SATDTIDIAPNHRVGTKRYMAPE 221

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 86/180 (47%), Gaps = 27/180 (15%)
Query: 520 IGRGGFGPVYK---DGMEVAIKVFN-LQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           IG+G FG V++    G EVA+K+F+  +    F+  +I   +M  +RH N++  I++ + 
Sbjct: 17  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVM--LRHENILGFIAADNK 74
Query: 576 DDFKA----LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY-----S 626
           D+       LV +Y   GSL    Y   Y + +   + + +  AS L +LH         
Sbjct: 75  DNGTWTQLWLVSDYHEHGSLFD--YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 132
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA------TIGYMAPD 680
             I H DLK  N+L+  N    ++D G+A   +  D S T T  +A      T  YMAP+
Sbjct: 133 PAIAHRDLKSKNILVKKNGTCCIADLGLA---VRHD-SATDTIDIAPNHRVGTKRYMAPE 188

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 89/196 (45%), Gaps = 36/196 (18%)
Query: 520 IGRGGFGPVY------------KDGMEVAIKVFNLQYGGAFKSFD---IECGMMKRI-RH 563
           +G G FG V             K+ + VA+K+  L+     K       E  MMK I +H
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 92
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----NYILDI---------FQGL- 608
           +N+I ++ +C+ D    +++EY   G+L + L +       Y  DI         F+ L 
Sbjct: 93  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 152
Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
           +    +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T
Sbjct: 153 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 209
Query: 669 QTLATIGYMAPDEIFS 684
                + +MAP+ +F 
Sbjct: 210 NGRLPVKWMAPEALFD 225

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 80/170 (47%), Gaps = 27/170 (15%)
Query: 518 NLIGRGGFGPVYKDGMEVAIKVFNLQYGGAF-------------KSFDIECGMMKRIRHR 564
            ++G+G FG         AIKV + + G                ++F  E  +M+ + H 
Sbjct: 16  EVLGKGCFGQ--------AIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHP 67
Query: 565 NLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFG 624
           N++K I     D     + EY+  G+L   + S +      Q ++   D+AS + YLH  
Sbjct: 68  NVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH-- 125
Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI 674
            S+ IIH DL   N L+ +N    ++DFG+A+ +++E    TQ + L ++
Sbjct: 126 -SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK---TQPEGLRSL 171

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 87/185 (47%), Gaps = 35/185 (18%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFN---LQYGGAFKSFDIECGMMKRIRHRNLIKIIS 571
           +G G FG V        G +VA+K+ N   L         + E   ++ +RH ++IK+  
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMID---------VASALEYLH 622
              + D   +V+EY           +GN + D     + M +         + SA+EY H
Sbjct: 81  VIKSKDEIIMVIEY-----------AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 129
Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
                 I+H DLKP N+LLD+++   ++DFG++   +  D +  +T +  +  Y AP E+
Sbjct: 130 ---RHKIVHRDLKPENLLLDEHLNVKIADFGLSN--IMTDGNFLKT-SCGSPNYAAP-EV 182
Query: 683 FSGEM 687
            SG++
Sbjct: 183 ISGKL 187

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 87/185 (47%), Gaps = 35/185 (18%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFN---LQYGGAFKSFDIECGMMKRIRHRNLIKIIS 571
           +G G FG V        G +VA+K+ N   L         + E   ++ +RH ++IK+  
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMID---------VASALEYLH 622
              + D   +V+EY           +GN + D     + M +         + SA+EY H
Sbjct: 72  VIKSKDEIIMVIEY-----------AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 120
Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
                 I+H DLKP N+LLD+++   ++DFG++   +  D +  +T +  +  Y AP E+
Sbjct: 121 ---RHKIVHRDLKPENLLLDEHLNVKIADFGLSN--IMTDGNFLKT-SCGSPNYAAP-EV 173
Query: 683 FSGEM 687
            SG++
Sbjct: 174 ISGKL 178

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 87/185 (47%), Gaps = 35/185 (18%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFN---LQYGGAFKSFDIECGMMKRIRHRNLIKIIS 571
           +G G FG V        G +VA+K+ N   L         + E   ++ +RH ++IK+  
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMID---------VASALEYLH 622
              + D   +V+EY           +GN + D     + M +         + SA+EY H
Sbjct: 82  VIKSKDEIIMVIEY-----------AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 130
Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
                 I+H DLKP N+LLD+++   ++DFG++   +  D +  +T +  +  Y AP E+
Sbjct: 131 ---RHKIVHRDLKPENLLLDEHLNVKIADFGLSN--IMTDGNFLKT-SCGSPNYAAP-EV 183
Query: 683 FSGEM 687
            SG++
Sbjct: 184 ISGKL 188

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 84/192 (43%), Gaps = 23/192 (11%)
Query: 499 QRRFTYLELFQATNRFSENNLIGRGGFGPVY-----KDGMEVAIKVF---NLQYGGAFKS 550
           +R+FT        + F     +G+G FG VY     ++   +A+KV     L+  G    
Sbjct: 9   KRKFT-------IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 61
Query: 551 FDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNI 610
              E  +   +RH N++++ +   +     L+LE+ P G L K L       D  +    
Sbjct: 62  LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR-FDEQRSATF 120
Query: 611 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 670
           M ++A AL Y H      +IH D+KP N+L+       ++DFG +        SL +   
Sbjct: 121 MEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSV----HAPSLRRRXM 173
Query: 671 LATIGYMAPDEI 682
             T+ Y+ P+ I
Sbjct: 174 CGTLDYLPPEMI 185

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 79/176 (44%), Gaps = 17/176 (9%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVF---NLQYGGAFKSFDIECGMMKRIRHRNLIKIIS 571
           +G+G FG VY     +    +A+KV     L+  G       E  +   +RH N++++  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
              +     L+LEY P G + K L   +   D  +    + ++A+AL Y H   S  +IH
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSK-FDEQRTATYITELANALSYCH---SKRVIH 136
Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEM 687
            D+KP N+LL       ++DFG +        S  +     T+ Y+ P E+  G M
Sbjct: 137 RDIKPENLLLGSAGELKIADFGWSV----HAPSSRRXXLXGTLDYLPP-EMIEGRM 187

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 87/185 (47%), Gaps = 35/185 (18%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFN---LQYGGAFKSFDIECGMMKRIRHRNLIKIIS 571
           +G G FG V        G +VA+K+ N   L         + E   ++ +RH ++IK+  
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMID---------VASALEYLH 622
              + D   +V+EY           +GN + D     + M +         + SA+EY H
Sbjct: 76  VIKSKDEIIMVIEY-----------AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 124
Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
                 I+H DLKP N+LLD+++   ++DFG++   +  D +  +T +  +  Y AP E+
Sbjct: 125 ---RHKIVHRDLKPENLLLDEHLNVKIADFGLSN--IMTDGNFLKT-SCGSPNYAAP-EV 177
Query: 683 FSGEM 687
            SG++
Sbjct: 178 ISGKL 182

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 79/180 (43%), Gaps = 14/180 (7%)
Query: 512 NRFSENNLIGRGGFGPVYKD--------GMEVAIKVF-NLQYGGAFKSFDIECGMMKRIR 562
            R      IG G FG V++          M VAIK   N       + F  E   M++  
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 563 HRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
           H +++K+I   + +    +++E   LG L   L    + LD+   +     +++AL YL 
Sbjct: 70  HPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 128
Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              S   +H D+   NVL+  N    L DFG+++  +E+      ++    I +MAP+ I
Sbjct: 129 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTXXKASKGKLPIKWMAPESI 184

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 81/173 (46%), Gaps = 15/173 (8%)
Query: 494 PSVADQRRFTYLELFQATNRF---SENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYG 545
           P+  D R  T  +   A N F   S+  ++G G FG V+K      G+++A K+   +  
Sbjct: 70  PAPFDHRIVTAKQ--GAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM 127
Query: 546 GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIF 605
              +    E  +M ++ H NLI++  +  + +   LV+EY+  G L   +   +Y L   
Sbjct: 128 KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTEL 187
Query: 606 QGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL--DDNMVAHLSDFGMAK 656
             +  M  +   + ++H  Y   I+H DLKP N+L    D     + DFG+A+
Sbjct: 188 DTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLAR 237

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 85/176 (48%), Gaps = 15/176 (8%)
Query: 514 FSENNLIGRGGFGPVYKDGME------VAIKVFNLQYGGAFKSF-DIECGMMKRIRHRNL 566
           F++   IG+G FG V+K G++      VAIK+ +L+           E  ++ +     +
Sbjct: 9   FTKLEKIGKGSFGEVFK-GIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 67
Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
            K   S   D    +++EY+  GS    L  G   LD  Q   I+ ++   L+YLH   S
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---S 122
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              IH D+K +NVLL ++    L+DFG+A  L   D  + +   + T  +MAP+ I
Sbjct: 123 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVI 176

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 90/181 (49%), Gaps = 26/181 (14%)
Query: 517 NNLIGRGGFGPVY-----KDGMEVAIKVFN-LQYGGAFKSFDI---ECGMMKRIRHRNLI 567
           ++++G+G    V+     K G   AIKVFN + +    +  D+   E  ++K++ H+N++
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISF---LRPVDVQMREFEVLKKLNHKNIV 70
Query: 568 KI--ISSCSNDDFKALVLEYMPLGSLEKCLY--SGNYILDIFQGLNIMIDVASALEYLHF 623
           K+  I   +    K L++E+ P GSL   L   S  Y L   + L ++ DV   + +L  
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR- 129
Query: 624 GYSVPIIHCDLKPSNVLL----DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
                I+H ++KP N++     D   V  L+DFG A+ L +++Q +       T  Y+ P
Sbjct: 130 --ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVX---LYGTEEYLHP 184
Query: 680 D 680
           D
Sbjct: 185 D 185

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 85/176 (48%), Gaps = 15/176 (8%)
Query: 514 FSENNLIGRGGFGPVYKDGME------VAIKVFNLQYGGAFKSF-DIECGMMKRIRHRNL 566
           F++   IG+G FG V+K G++      VAIK+ +L+           E  ++ +     +
Sbjct: 9   FTKLEKIGKGSFGEVFK-GIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 67
Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
            K   S   D    +++EY+  GS    L  G   LD  Q   I+ ++   L+YLH   S
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---S 122
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              IH D+K +NVLL ++    L+DFG+A  L   D  + +   + T  +MAP+ I
Sbjct: 123 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVI 176

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 46/171 (26%), Positives = 77/171 (45%), Gaps = 16/171 (9%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVF---NLQYGGAFKSFDIECGMMKRIRHRNLIKIIS 571
           +G+G FG VY     ++   +A+KV     L+  G       E  +   +RH N++++ +
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
              +     L+LE+ P G L K L       D  +    M ++A AL Y H      +IH
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHGR-FDEQRSATFMEELADALHYCH---ERKVIH 137
Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
            D+KP N+L+       ++DFG +        SL +     T+ Y+ P+ I
Sbjct: 138 RDIKPENLLMGYKGELKIADFGWSV----HAPSLRRRXMCGTLDYLPPEMI 184

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 91/184 (49%), Gaps = 16/184 (8%)
Query: 513 RFSENN---LIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHR 564
            + EN    ++G+G +G VY      + + +AIK    +     +    E  + K ++H+
Sbjct: 6   EYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHK 65
Query: 565 NLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-NYILDIFQGLNIMI-DVASALEYLH 622
           N+++ + S S + F  + +E +P GSL   L S    + D  Q +      +   L+YLH
Sbjct: 66  NIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH 125
Query: 623 FGYSVPIIHCDLKPSNVLLDD-NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
                 I+H D+K  NVL++  + V  +SDFG +K L   +   T+T T  T+ YMAP+ 
Sbjct: 126 ---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-PCTETFT-GTLQYMAPEI 180
Query: 682 IFSG 685
           I  G
Sbjct: 181 IDKG 184

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 511 TNRFSEN----NLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGA--FKSFDIECGMMK 559
           + +FS+N      +G+G F  V +      G+E A K+ N +   A  F+  + E  + +
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 560 RIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALE 619
           +++H N++++  S   + F  LV + +  G     L+      + +   +    +   LE
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILE 116
Query: 620 YLHFGYSVPIIHCDLKPSNVLLDDN---MVAHLSDFGMAKPLLEEDQSLTQTQTLATIGY 676
            + + +S  I+H +LKP N+LL          L+DFG+A   +E + S        T GY
Sbjct: 117 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGY 173
Query: 677 MAPD 680
           ++P+
Sbjct: 174 LSPE 177

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 85/176 (48%), Gaps = 15/176 (8%)
Query: 514 FSENNLIGRGGFGPVYKDGME------VAIKVFNLQYGGAFKSF-DIECGMMKRIRHRNL 566
           F++   IG+G FG V+K G++      VAIK+ +L+           E  ++ +     +
Sbjct: 25  FTKLERIGKGSFGEVFK-GIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYV 83
Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
            K   S        +++EY+  GS    L +G +  D FQ   ++ ++   L+YLH   S
Sbjct: 84  TKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPF--DEFQIATMLKEILKGLDYLH---S 138
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              IH D+K +NVLL +     L+DFG+A  L   D  + +   + T  +MAP+ I
Sbjct: 139 EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNTFVGTPFWMAPEVI 192

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 79/180 (43%), Gaps = 14/180 (7%)
Query: 512 NRFSENNLIGRGGFGPVYKD--------GMEVAIKVF-NLQYGGAFKSFDIECGMMKRIR 562
            R      IG G FG V++          + VAIK   N       + F  E   M++  
Sbjct: 38  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 97
Query: 563 HRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
           H +++K+I   + +    +++E   LG L   L    Y LD+   +     +++AL YL 
Sbjct: 98  HPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 156
Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              S   +H D+   NVL+  N    L DFG+++  +E+      ++    I +MAP+ I
Sbjct: 157 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESI 212

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 82/179 (45%), Gaps = 22/179 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNL 566
            +++    IG+G  G VY       G EVAI+  NLQ     +    E  +M+  ++ N+
Sbjct: 21  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 80
Query: 567 IKIISSCSNDDFKALVLEYMPLGSL-----EKCLYSGNYILDIFQGLNIMIDVASALEYL 621
           +  + S    D   +V+EY+  GSL     E C+  G       Q   +  +   ALE+L
Sbjct: 81  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG-------QIAAVCRECLQALEFL 133
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           H   S  +IH ++K  N+LL  +    L+DFG    +  E     ++  + T  +MAP+
Sbjct: 134 H---SNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPE 187

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 86/184 (46%), Gaps = 21/184 (11%)
Query: 511 TNRFSEN----NLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGA--FKSFDIECGMMK 559
           + +FS+N      +G+G F  V +      G+E A K+ N +   A  F+  + E  + +
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 560 RIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALE 619
           +++H N++++  S   + F  LV + +  G     L+      + +   +    +   LE
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILE 116
Query: 620 YLHFGYSVPIIHCDLKPSNVLLDDN---MVAHLSDFGMAKPLLEEDQSLTQTQTLATIGY 676
            + + +S  I+H +LKP N+LL          L+DFG+A   +E + S        T GY
Sbjct: 117 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGY 173
Query: 677 MAPD 680
           ++P+
Sbjct: 174 LSPE 177

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/176 (30%), Positives = 85/176 (48%), Gaps = 15/176 (8%)
Query: 514 FSENNLIGRGGFGPVYKDGME------VAIKVFNLQYGGAFKSF-DIECGMMKRIRHRNL 566
           F++   IG+G FG V+K G++      VAIK+ +L+           E  ++ +     +
Sbjct: 24  FTKLEKIGKGSFGEVFK-GIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
            K   S   D    +++EY+  GS    L  G   LD  Q   I+ ++   L+YLH   S
Sbjct: 83  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLH---S 137
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              IH D+K +NVLL ++    L+DFG+A  L   D  + +   + T  +MAP+ I
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVI 191

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 79/180 (43%), Gaps = 14/180 (7%)
Query: 512 NRFSENNLIGRGGFGPVYKD--------GMEVAIKVF-NLQYGGAFKSFDIECGMMKRIR 562
            R      IG G FG V++          + VAIK   N       + F  E   M++  
Sbjct: 15  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 563 HRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
           H +++K+I   + +    +++E   LG L   L    Y LD+   +     +++AL YL 
Sbjct: 75  HPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 133
Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              S   +H D+   NVL+  N    L DFG+++  +E+      ++    I +MAP+ I
Sbjct: 134 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESI 189

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/222 (22%), Positives = 94/222 (42%), Gaps = 31/222 (13%)
Query: 491 VNMPSVADQRRFTYLELFQATNRFSENNLIGRGGFGPVYKDGM----------EVAIKVF 540
           + MP +   ++    E+  +  RF E   +G   FG VYK  +           VAIK  
Sbjct: 7   MEMPLINQHKQAKLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL 64
Query: 541 NLQYGGAFKS-FDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGN 599
             +  G  +  F  E  +  R++H N++ ++   + D   +++  Y   G L + L   +
Sbjct: 65  KDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRS 124
Query: 600 YILDIFQG---------------LNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN 644
              D+                  ++++  +A+ +EYL    S  ++H DL   NVL+ D 
Sbjct: 125 PHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDK 181
Query: 645 MVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGE 686
           +   +SD G+ + +   D       +L  I +MAP+ I  G+
Sbjct: 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK 223

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 79/180 (43%), Gaps = 14/180 (7%)
Query: 512 NRFSENNLIGRGGFGPVYKD--------GMEVAIKVF-NLQYGGAFKSFDIECGMMKRIR 562
            R      IG G FG V++          + VAIK   N       + F  E   M++  
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 563 HRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
           H +++K+I   + +    +++E   LG L   L    Y LD+   +     +++AL YL 
Sbjct: 70  HPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 128
Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              S   +H D+   NVL+  N    L DFG+++  +E+      ++    I +MAP+ I
Sbjct: 129 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESI 184

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 79/180 (43%), Gaps = 14/180 (7%)
Query: 512 NRFSENNLIGRGGFGPVYKD--------GMEVAIKVF-NLQYGGAFKSFDIECGMMKRIR 562
            R      IG G FG V++          + VAIK   N       + F  E   M++  
Sbjct: 13  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 72
Query: 563 HRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
           H +++K+I   + +    +++E   LG L   L    Y LD+   +     +++AL YL 
Sbjct: 73  HPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 131
Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              S   +H D+   NVL+  N    L DFG+++  +E+      ++    I +MAP+ I
Sbjct: 132 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESI 187

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 79/180 (43%), Gaps = 14/180 (7%)
Query: 512 NRFSENNLIGRGGFGPVYKD--------GMEVAIKVF-NLQYGGAFKSFDIECGMMKRIR 562
            R      IG G FG V++          + VAIK   N       + F  E   M++  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 563 HRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
           H +++K+I   + +    +++E   LG L   L    Y LD+   +     +++AL YL 
Sbjct: 67  HPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              S   +H D+   NVL+  N    L DFG+++  +E+      ++    I +MAP+ I
Sbjct: 126 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESI 181

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 79/180 (43%), Gaps = 14/180 (7%)
Query: 512 NRFSENNLIGRGGFGPVYKD--------GMEVAIKVF-NLQYGGAFKSFDIECGMMKRIR 562
            R      IG G FG V++          + VAIK   N       + F  E   M++  
Sbjct: 12  ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 71
Query: 563 HRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
           H +++K+I   + +    +++E   LG L   L    Y LD+   +     +++AL YL 
Sbjct: 72  HPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 130
Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              S   +H D+   NVL+  N    L DFG+++  +E+      ++    I +MAP+ I
Sbjct: 131 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESI 186

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 71/147 (48%), Gaps = 19/147 (12%)
Query: 554 ECGMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCL---------YSGNYILD 603
           E  MMK I +H+N+I ++ +C+ D    +++EY   G+L + L         YS N   +
Sbjct: 124 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183
Query: 604 IFQGLN------IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP 657
             + L+          VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ 
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARD 240
Query: 658 LLEEDQSLTQTQTLATIGYMAPDEIFS 684
           +   D     T     + +MAP+ +F 
Sbjct: 241 IHHIDYYKKTTNGRLPVKWMAPEALFD 267

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 88/196 (44%), Gaps = 36/196 (18%)
Query: 520 IGRGGFGPVY------------KDGMEVAIKVFNLQYGGAFKSFD---IECGMMKRI-RH 563
           +G G FG V             K+ + VA+K+  L+     K       E  MMK I +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----NYILDI---------FQGL- 608
           +N+I ++ +C+ D    +++ Y   G+L + L +       Y  DI         F+ L 
Sbjct: 101 KNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
           +    +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T
Sbjct: 161 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 669 QTLATIGYMAPDEIFS 684
                + +MAP+ +F 
Sbjct: 218 NGRLPVKWMAPEALFD 233

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 81/175 (46%), Gaps = 12/175 (6%)
Query: 512 NRFSENNLIGRGGFGPVYK----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRN 565
            ++ +   +G G +G VYK     G  VA+K   L  +  G   +   E  ++K + H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY 625
           ++ +I    ++    LV E+M    L+K L      L   Q   I I +   L  +   +
Sbjct: 81  IVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCH 136
Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
              I+H DLKP N+L++ +    L+DFG+A+      +S   T  + T+ Y APD
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPD 189

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/175 (28%), Positives = 81/175 (46%), Gaps = 12/175 (6%)
Query: 512 NRFSENNLIGRGGFGPVYK----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRN 565
            ++ +   +G G +G VYK     G  VA+K   L  +  G   +   E  ++K + H N
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY 625
           ++ +I    ++    LV E+M    L+K L      L   Q   I I +   L  +   +
Sbjct: 81  IVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKTGL---QDSQIKIYLYQLLRGVAHCH 136
Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
              I+H DLKP N+L++ +    L+DFG+A+      +S   T  + T+ Y APD
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPD 189

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 85/183 (46%), Gaps = 21/183 (11%)
Query: 512 NRFSEN----NLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGA--FKSFDIECGMMKR 560
            +FS+N      +G+G F  V +      G+E A K+ N +   A  F+  + E  + ++
Sbjct: 1   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 60
Query: 561 IRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEY 620
           ++H N++++  S   + F  LV + +  G     L+      + +   +    +   LE 
Sbjct: 61  LQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILES 116
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDN---MVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 677
           + + +S  I+H +LKP N+LL          L+DFG+A   +E + S        T GY+
Sbjct: 117 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGYL 173
Query: 678 APD 680
           +P+
Sbjct: 174 SPE 176

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 76/163 (46%), Gaps = 25/163 (15%)
Query: 517 NNLIGRGGFGPV-----YKDG--MEVAIKVFNLQYGGA--FKSFDIECGMMKRIRHR-NL 566
            ++IG G FG V      KDG  M+ AIK    +Y      + F  E  ++ ++ H  N+
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNI 78
Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASAL---EYLHF 623
           I ++ +C +  +  L +EY P G+L   L     +L+      I    AS L   + LHF
Sbjct: 79  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSR-VLETDPAFAIANSTASTLSSQQLLHF 137
Query: 624 GYSVP----------IIHCDLKPSNVLLDDNMVAHLSDFGMAK 656
              V            IH DL   N+L+ +N VA ++DFG+++
Sbjct: 138 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 180

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 79/172 (45%), Gaps = 15/172 (8%)
Query: 518 NLIGRGGFGPV---YKDGMEVAIKVFNLQYGGAFKSFDIECGM------MKRIRHRNLIK 568
            +IG+G FG V        EV   V  LQ     K  + +  M      +K ++H  L+ 
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVP 628
           +  S    D    VL+Y+  G L   L      L+  +      ++ASAL YLH   S+ 
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP-RARFYAAEIASALGYLH---SLN 159
Query: 629 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           I++ DLKP N+LLD      L+DFG+ K  +E +   T +    T  Y+AP+
Sbjct: 160 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS--TTSTFCGTPEYLAPE 209

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 83/190 (43%), Gaps = 38/190 (20%)
Query: 483 GRKSQLKDVNMPSVADQRRFTYLELF---QATNRFSENNLIGRGGFGPVY-----KDGME 534
           GR   LKD   P VA        ELF        FS+   IG G FG VY     ++   
Sbjct: 33  GRAGSLKD---PDVA--------ELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEV 81
Query: 535 VAIKVFNLQYGGA-----FKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLG 589
           VAIK   + Y G      ++    E   ++++RH N I+       +    LV+EY    
Sbjct: 82  VAIK--KMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY---- 135
Query: 590 SLEKCLYSGNYILDI----FQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM 645
               CL S + +L++     Q + I      AL+ L + +S  +IH D+K  N+LL +  
Sbjct: 136 ----CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG 191
Query: 646 VAHLSDFGMA 655
           +  L DFG A
Sbjct: 192 LVKLGDFGSA 201

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 76/163 (46%), Gaps = 25/163 (15%)
Query: 517 NNLIGRGGFGPV-----YKDG--MEVAIKVFNLQYGGA--FKSFDIECGMMKRIRHR-NL 566
            ++IG G FG V      KDG  M+ AIK    +Y      + F  E  ++ ++ H  N+
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNI 88
Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASAL---EYLHF 623
           I ++ +C +  +  L +EY P G+L   L     +L+      I    AS L   + LHF
Sbjct: 89  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSR-VLETDPAFAIANSTASTLSSQQLLHF 147
Query: 624 GYSVP----------IIHCDLKPSNVLLDDNMVAHLSDFGMAK 656
              V            IH DL   N+L+ +N VA ++DFG+++
Sbjct: 148 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 190

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 85/180 (47%), Gaps = 13/180 (7%)
Query: 510 ATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI-ECGMMKRIRH 563
           ++++F +   +G G +  VYK      G+ VA+K   L       S  I E  +MK ++H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLN---IMIDVASALEY 620
            N++++      ++   LV E+M    L+K + S   + +  +GL    +       L+ 
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDS-RTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           L F +   I+H DLKP N+L++      L DFG+A+       +   +  + T+ Y APD
Sbjct: 121 LAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--SSEVVTLWYRAPD 178

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/209 (22%), Positives = 86/209 (41%), Gaps = 42/209 (20%)
Query: 514 FSENNLI-----GRGGFGPVYKDGM----------EVAIKVFNLQYG-GAFKSFDIECGM 557
           F   NL+     G G FG V K              VA+K+          +    E  +
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNV 79
Query: 558 MKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYI---------------- 601
           +K++ H ++IK+  +CS D    L++EY   GSL   L     +                
Sbjct: 80  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 602 -------LDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGM 654
                  L +   ++    ++  ++YL     + ++H DL   N+L+ +     +SDFG+
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 655 AKPLLEEDQSLTQTQTLATIGYMAPDEIF 683
           ++ + EED  + ++Q    + +MA + +F
Sbjct: 197 SRDVYEEDSXVKRSQGRIPVKWMAIESLF 225

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/287 (23%), Positives = 118/287 (41%), Gaps = 60/287 (20%)
Query: 479 KYRKGRK--SQLKDVNMPSVADQRRFTYLEL----FQATNRFSENNL-----IGRGGFGP 527
           KY+K  +  SQL+ V +   +D   F Y++     +     F   NL     +G G FG 
Sbjct: 2   KYKKQFRYESQLQMVQVTGSSDNEYF-YVDFREYEYDLKWEFPRENLEFGKVLGSGAFGK 60
Query: 528 VY--------KDG--MEVAIKVFNLQYGGAFK-SFDIECGMMKRI-RHRNLIKIISSCSN 575
           V         K G  ++VA+K+   +   + + +   E  MM ++  H N++ ++ +C+ 
Sbjct: 61  VMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120
Query: 576 DDFKALVLEYMPLGSL-------------EKCLYSGNYILDIFQGLNIMI---------D 613
                L+ EY   G L             ++  Y     L+  + LN++           
Sbjct: 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQ 180
Query: 614 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 673
           VA  +E+L F      +H DL   NVL+    V  + DFG+A+ ++ +   + +      
Sbjct: 181 VAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLP 237
Query: 674 IGYMAPDEIFSGEMRLK--CWVNDSLLISVM---------IVVDANL 709
           + +MAP+ +F G   +K   W    LL  +          I VDAN 
Sbjct: 238 VKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF 284

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 81/178 (45%), Gaps = 15/178 (8%)
Query: 517 NNLIGRGGFGPVY--------KDGMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLI 567
             +IG G FG V         K  + VAIK     Y     + F  E  +M +  H N+I
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 568 KIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
            +    +      ++ E+M  GSL+  L   +    + Q + ++  +A+ ++YL     +
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DM 128
Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA---TIGYMAPDEI 682
             +H  L   N+L++ N+V  +SDFG+++ L ++    T T  L     I + AP+ I
Sbjct: 129 NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 186

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/209 (22%), Positives = 86/209 (41%), Gaps = 42/209 (20%)
Query: 514 FSENNLI-----GRGGFGPVYKDGM----------EVAIKVFNLQYG-GAFKSFDIECGM 557
           F   NL+     G G FG V K              VA+K+          +    E  +
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNV 79
Query: 558 MKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYI---------------- 601
           +K++ H ++IK+  +CS D    L++EY   GSL   L     +                
Sbjct: 80  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 602 -------LDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGM 654
                  L +   ++    ++  ++YL     + ++H DL   N+L+ +     +SDFG+
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLA---EMSLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 655 AKPLLEEDQSLTQTQTLATIGYMAPDEIF 683
           ++ + EED  + ++Q    + +MA + +F
Sbjct: 197 SRDVYEEDSXVKRSQGRIPVKWMAIESLF 225

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 71/147 (48%), Gaps = 19/147 (12%)
Query: 554 ECGMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCL---------YSGNYILD 603
           E  MMK I +H+N+I ++ +C+ D    +++EY   G+L + L         YS N   +
Sbjct: 72  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 131
Query: 604 IFQGLN------IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP 657
             + L+          VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ 
Sbjct: 132 PEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARD 188
Query: 658 LLEEDQSLTQTQTLATIGYMAPDEIFS 684
           +   D     T     + +MAP+ +F 
Sbjct: 189 IHHIDYYKKTTNGRLPVKWMAPEALFD 215

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 71/147 (48%), Gaps = 19/147 (12%)
Query: 554 ECGMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCL---------YSGNYILD 603
           E  MMK I +H+N+I ++ +C+ D    +++EY   G+L + L         YS N   +
Sbjct: 75  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 134
Query: 604 IFQGLN------IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP 657
             + L+          VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ 
Sbjct: 135 PEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARD 191
Query: 658 LLEEDQSLTQTQTLATIGYMAPDEIFS 684
           +   D     T     + +MAP+ +F 
Sbjct: 192 IHHIDYYKKTTNGRLPVKWMAPEALFD 218

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 79/180 (43%), Gaps = 14/180 (7%)
Query: 512 NRFSENNLIGRGGFGPVYKD--------GMEVAIKVF-NLQYGGAFKSFDIECGMMKRIR 562
            R      IG G FG V++          M VAIK   N       + F  E   M++  
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 563 HRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
           H +++K+I   + +    +++E   LG L   L    + LD+   +     +++AL YL 
Sbjct: 450 HPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              S   +H D+   NVL+  N    L DFG+++  +E+      ++    I +MAP+ I
Sbjct: 509 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESI 564

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 71/147 (48%), Gaps = 19/147 (12%)
Query: 554 ECGMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCL---------YSGNYILD 603
           E  MMK I +H+N+I ++ +C+ D    +++EY   G+L + L         YS N   +
Sbjct: 83  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 142
Query: 604 IFQGLN------IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP 657
             + L+          VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ 
Sbjct: 143 PEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARD 199
Query: 658 LLEEDQSLTQTQTLATIGYMAPDEIFS 684
           +   D     T     + +MAP+ +F 
Sbjct: 200 IHHIDYYKKTTNGRLPVKWMAPEALFD 226

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 71/147 (48%), Gaps = 19/147 (12%)
Query: 554 ECGMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCL---------YSGNYILD 603
           E  MMK I +H+N+I ++ +C+ D    +++EY   G+L + L         YS N   +
Sbjct: 83  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHN 142
Query: 604 IFQGLN------IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP 657
             + L+          VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ 
Sbjct: 143 PEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARD 199
Query: 658 LLEEDQSLTQTQTLATIGYMAPDEIFS 684
           +   D     T     + +MAP+ +F 
Sbjct: 200 IHHIDYYKKTTNGRLPVKWMAPEALFD 226

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 71/147 (48%), Gaps = 19/147 (12%)
Query: 554 ECGMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCL---------YSGNYILD 603
           E  MMK I +H+N+I ++ +C+ D    +++EY   G+L + L         YS N   +
Sbjct: 76  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 135
Query: 604 IFQGLN------IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP 657
             + L+          VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ 
Sbjct: 136 PEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARD 192
Query: 658 LLEEDQSLTQTQTLATIGYMAPDEIFS 684
           +   D     T     + +MAP+ +F 
Sbjct: 193 IHHIDYYKKTTNGRLPVKWMAPEALFD 219

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 86/194 (44%), Gaps = 16/194 (8%)
Query: 508 FQATNRFSENNLIGRGGFGPVYKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLI 567
           + A    S+  LI + GF                +Q  G  +    E  ++K++ H N++
Sbjct: 40  YYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVV 99
Query: 568 KIISSCS--NDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY 625
           K++      N+D   +V E +  G + +         D  Q      D+   +EYLH+  
Sbjct: 100 KLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED--QARFYFQDLIKGIEYLHYQ- 156
Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD----- 680
              IIH D+KPSN+L+ ++    ++DFG++      D  L  + T+ T  +MAP+     
Sbjct: 157 --KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALL--SNTVGTPAFMAPESLSET 212
Query: 681 -EIFSGEMRLKCWV 693
            +IFSG+  L  W 
Sbjct: 213 RKIFSGKA-LDVWA 225

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 84/185 (45%), Gaps = 34/185 (18%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRNL 566
           F +   IG G +G VYK      G  VA+K   L  +  G   +   E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----------NYILDIFQGLNIMIDVA 615
           +K++     ++   LV E++    L+K + +            +Y+  + QGL+      
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLS------ 117
Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 675
                  F +S  ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ 
Sbjct: 118 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLW 168
Query: 676 YMAPD 680
           Y AP+
Sbjct: 169 YRAPE 173

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 88/196 (44%), Gaps = 36/196 (18%)
Query: 520 IGRGGFGPVY------------KDGMEVAIKVFNLQYGGAFKSFD---IECGMMKRI-RH 563
           +G G FG V             K+ + VA+K+  L+     K       E  MMK I +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----NYILDI---------FQGL- 608
           +N+I ++ +C+ D    +++ Y   G+L + L +       Y  DI         F+ L 
Sbjct: 101 KNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
           +    +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     T
Sbjct: 161 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 669 QTLATIGYMAPDEIFS 684
                + +MAP+ +F 
Sbjct: 218 NGRLPVKWMAPEALFD 233

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/209 (22%), Positives = 86/209 (41%), Gaps = 42/209 (20%)
Query: 514 FSENNLI-----GRGGFGPVYKDGM----------EVAIKVFNLQYG-GAFKSFDIECGM 557
           F   NL+     G G FG V K              VA+K+          +    E  +
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNV 79
Query: 558 MKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYI---------------- 601
           +K++ H ++IK+  +CS D    L++EY   GSL   L     +                
Sbjct: 80  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 602 -------LDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGM 654
                  L +   ++    ++  ++YL     + ++H DL   N+L+ +     +SDFG+
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 655 AKPLLEEDQSLTQTQTLATIGYMAPDEIF 683
           ++ + EED  + ++Q    + +MA + +F
Sbjct: 197 SRDVYEEDSYVKRSQGRIPVKWMAIESLF 225

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 90/185 (48%), Gaps = 20/185 (10%)
Query: 521 GRGGFGPVYKDGM---EVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISS----C 573
            RG FG V+K  +    VA+K+F +Q   ++++ + E   +  ++H N+++ I +     
Sbjct: 33  ARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIGAEKRGT 91
Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHF-------GYS 626
           S D    L+  +   GSL   L +   ++   +  +I   +A  L YLH        G+ 
Sbjct: 92  SVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHK 149
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ-TLATIGYMAPDEIFSG 685
             I H D+K  NVLL +N+ A ++DFG+A    E  +S   T   + T  YMAP E+  G
Sbjct: 150 PAISHRDIKSKNVLLKNNLTACIADFGLALK-FEAGKSAGDTHGQVGTRRYMAP-EVLEG 207
Query: 686 EMRLK 690
            +  +
Sbjct: 208 AINFQ 212

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 69/147 (46%), Gaps = 19/147 (12%)
Query: 554 ECGMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCL---------------YS 597
           E  MMK I +H+N+I ++ +C+ D    +++EY   G+L + L               ++
Sbjct: 83  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHN 142
Query: 598 GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP 657
               L     ++    VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ 
Sbjct: 143 PEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 199
Query: 658 LLEEDQSLTQTQTLATIGYMAPDEIFS 684
           +   D     T     + +MAP+ +F 
Sbjct: 200 IHHIDXXKKTTNGRLPVKWMAPEALFD 226

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 83/185 (44%), Gaps = 34/185 (18%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRNL 566
           F +   IG G +G VYK      G  VA+K   L  +  G   +   E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----------NYILDIFQGLNIMIDVA 615
           +K++     ++   LV E++    L+K + +            +Y+  + QGL       
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 117
Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 675
                  F +S  ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ 
Sbjct: 118 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLW 168
Query: 676 YMAPD 680
           Y AP+
Sbjct: 169 YRAPE 173

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 83/185 (44%), Gaps = 34/185 (18%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRNL 566
           F +   IG G +G VYK      G  VA+K   L  +  G   +   E  ++K + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----------NYILDIFQGLNIMIDVA 615
           +K++     ++   LV E++    L+K + +            +Y+  + QGL       
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 116
Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 675
                  F +S  ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ 
Sbjct: 117 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLW 167
Query: 676 YMAPD 680
           Y AP+
Sbjct: 168 YRAPE 172

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 87/195 (44%), Gaps = 40/195 (20%)
Query: 504 YLELFQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNL--QYGGAFKSFDIECG 556
           ++E FQ   +      IG G +G VYK      G  VA+K   L  +  G   +   E  
Sbjct: 8   FMENFQKVEK------IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS 61
Query: 557 MMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----------NYILDIF 605
           ++K + H N++K++     ++   LV E++    L+K + +            +Y+  + 
Sbjct: 62  LLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL 120
Query: 606 QGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL 665
           QGL              F +S  ++H DLKP N+L++      L+DFG+A+      +  
Sbjct: 121 QGLA-------------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-- 165
Query: 666 TQTQTLATIGYMAPD 680
           T T  + T+ Y AP+
Sbjct: 166 TYTHEVVTLWYRAPE 180

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 83/185 (44%), Gaps = 34/185 (18%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRNL 566
           F +   IG G +G VYK      G  VA+K   L  +  G   +   E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----------NYILDIFQGLNIMIDVA 615
           +K++     ++   LV E++    L+K + +            +Y+  + QGL       
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 117
Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 675
                  F +S  ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ 
Sbjct: 118 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLW 168
Query: 676 YMAPD 680
           Y AP+
Sbjct: 169 YRAPE 173

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 87/195 (44%), Gaps = 40/195 (20%)
Query: 504 YLELFQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNL--QYGGAFKSFDIECG 556
           ++E FQ   +      IG G +G VYK      G  VA+K   L  +  G   +   E  
Sbjct: 8   FMENFQKVEK------IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREIS 61
Query: 557 MMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----------NYILDIF 605
           ++K + H N++K++     ++   LV E++    L+K + +            +Y+  + 
Sbjct: 62  LLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLL 120
Query: 606 QGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL 665
           QGL              F +S  ++H DLKP N+L++      L+DFG+A+      +  
Sbjct: 121 QGLA-------------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-- 165
Query: 666 TQTQTLATIGYMAPD 680
           T T  + T+ Y AP+
Sbjct: 166 TYTHEVVTLWYRAPE 180

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 83/185 (44%), Gaps = 34/185 (18%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRNL 566
           F +   IG G +G VYK      G  VA+K   L  +  G   +   E  ++K + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----------NYILDIFQGLNIMIDVA 615
           +K++     ++   LV E++    L+K + +            +Y+  + QGL       
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 116
Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 675
                  F +S  ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ 
Sbjct: 117 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLW 167
Query: 676 YMAPD 680
           Y AP+
Sbjct: 168 YRAPE 172

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 83/185 (44%), Gaps = 34/185 (18%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRNL 566
           F +   IG G +G VYK      G  VA+K   L  +  G   +   E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----------NYILDIFQGLNIMIDVA 615
           +K++     ++   LV E++    L+K + +            +Y+  + QGL       
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 117
Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 675
                  F +S  ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ 
Sbjct: 118 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLW 168
Query: 676 YMAPD 680
           Y AP+
Sbjct: 169 YRAPE 173

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 83/185 (44%), Gaps = 34/185 (18%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRNL 566
           F +   IG G +G VYK      G  VA+K   L  +  G   +   E  ++K + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----------NYILDIFQGLNIMIDVA 615
           +K++     ++   LV E++    L+K + +            +Y+  + QGL       
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 118
Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 675
                  F +S  ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ 
Sbjct: 119 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLW 169
Query: 676 YMAPD 680
           Y AP+
Sbjct: 170 YRAPE 174

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/185 (25%), Positives = 83/185 (44%), Gaps = 34/185 (18%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRNL 566
           F +   IG G +G VYK      G  VA+K   L  +  G   +   E  ++K + H N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----------NYILDIFQGLNIMIDVA 615
           +K++     ++   LV E++    L+K + +            +Y+  + QGL       
Sbjct: 69  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 121
Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 675
                  F +S  ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ 
Sbjct: 122 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLW 172
Query: 676 YMAPD 680
           Y AP+
Sbjct: 173 YRAPE 177

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 88/192 (45%), Gaps = 19/192 (9%)
Query: 511 TNRFSENNLIGRGGFGPVY--KD---GMEVAIKVFN---LQYGGAFKSFDIECGMMKRIR 562
           ++R+    ++G+G FG V   KD   G E A+KV +   ++     +S   E  ++K++ 
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 90
Query: 563 HRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
           H N++K+     +  +  LV E    G L   + S     ++     I+  V S + Y+H
Sbjct: 91  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYMH 149
Query: 623 FGYSVPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
                 I+H DLKP N+LL+    +    + DFG++      + S      + T  Y+AP
Sbjct: 150 ---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYIAP 203
Query: 680 DEIFSGEMRLKC 691
            E+  G    KC
Sbjct: 204 -EVLHGTYDEKC 214

>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/173 (31%), Positives = 81/173 (46%), Gaps = 7/173 (4%)
Query: 254 AALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWN-LKDILHLNLSSNF 312
           A   +LDL  NKLS         LT LR LYL  N L ++P+ ++  LK++  L ++ N 
Sbjct: 37  ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNK 96
Query: 313 FTGPLPLKI-GNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGD 371
               LP+ +   L  L +L L  N    + P     L  L YL L YN LQ S+P  + D
Sbjct: 97  LQA-LPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFD 154
Query: 372 LIXXXXXXXXXXXXXGTIPI-SLEKLLDLKDINVSFNRLEGEIPREGPFRNLS 423
            +               +P  + +KL +LK + +  N+L+  +P EG F +L 
Sbjct: 155 KLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVP-EGAFDSLE 205

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/195 (27%), Positives = 89/195 (45%), Gaps = 34/195 (17%)
Query: 506 ELFQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFN-LQYGGAFKSFDIECGMMK 559
           ++F    R++  + IG G +G V       + + VAIK  +  ++    +    E  ++ 
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 80
Query: 560 RIRHRNLIKIISSCSNDDFKALVLEYMP------------LGSLEKCLYSGNYILDIFQG 607
           R RH N+I I     ND  +A  +E M             L  L KC +  N  +  F  
Sbjct: 81  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYF-- 133
Query: 608 LNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ 667
              +  +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+ + + D   T 
Sbjct: 134 ---LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTG 186
Query: 668 --TQTLATIGYMAPD 680
             T+ +AT  Y AP+
Sbjct: 187 FLTEYVATRWYRAPE 201

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 89/186 (47%), Gaps = 20/186 (10%)
Query: 518 NLIGRGGFGPVYKDGMEVAIKVFNLQ---YGGAFK--SFDIECGMMKRIRHRNLIKIISS 572
            ++G G F  V+     +  K+F L+      AF+  S + E  ++K+I+H N++ +   
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 573 CSNDDFKALVLEYMPLGSL-EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
             +     LV++ +  G L ++ L  G Y         ++  V SA++YLH      I+H
Sbjct: 75  YESTTHYYLVMQLVSGGELFDRILERGVYTEK--DASLVIQQVLSAVKYLH---ENGIVH 129
Query: 632 CDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG--E 686
            DLKP N+L    ++N    ++DFG++K     +Q+   +    T GY+AP+ +      
Sbjct: 130 RDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTPGYVAPEVLAQKPYS 185
Query: 687 MRLKCW 692
             + CW
Sbjct: 186 KAVDCW 191

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 76/163 (46%), Gaps = 25/163 (15%)
Query: 517 NNLIGRGGFGPV-----YKDG--MEVAIKVFNLQYGGA--FKSFDIECGMMKRIRHR-NL 566
            ++IG G FG V      KDG  M+ AIK    +Y      + F  E  ++ ++ H  N+
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNI 85
Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASAL---EYLHF 623
           I ++ +C +  +  L +EY P G+L   L     +L+      I    AS L   + LHF
Sbjct: 86  INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSR-VLETDPAFAIANSTASTLSSQQLLHF 144
Query: 624 GYSVP----------IIHCDLKPSNVLLDDNMVAHLSDFGMAK 656
              V            IH +L   N+L+ +N VA ++DFG+++
Sbjct: 145 AADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSR 187

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 69/147 (46%), Gaps = 19/147 (12%)
Query: 554 ECGMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCL---------------YS 597
           E  MMK I +H+N+I ++ +C+ D    +++EY   G+L + L               ++
Sbjct: 68  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHN 127
Query: 598 GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP 657
               L     ++    VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ 
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARD 184
Query: 658 LLEEDQSLTQTQTLATIGYMAPDEIFS 684
           +   D     T     + +MAP+ +F 
Sbjct: 185 IHHIDYYKKTTNGRLPVKWMAPEALFD 211

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 89/194 (45%), Gaps = 19/194 (9%)
Query: 511 TNRFSENNLIGRGGFGPVY--KD---GMEVAIKVFN---LQYGGAFKSFDIECGMMKRIR 562
           ++R+    ++G+G FG V   KD   G E A+KV +   ++     +S   E  ++K++ 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 563 HRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
           H N++K+     +  +  LV E    G L   + S     ++     I+  V S + Y+H
Sbjct: 85  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYMH 143
Query: 623 FGYSVPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
                 I+H DLKP N+LL+    +    + DFG++      + S      + T  Y+AP
Sbjct: 144 ---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYIAP 197
Query: 680 DEIFSGEMRLKCWV 693
            E+  G    KC V
Sbjct: 198 -EVLHGTYDEKCDV 210

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 95/189 (50%), Gaps = 31/189 (16%)
Query: 514 FSENNLIGRGGFGPVYKDGM----EVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKI 569
           ++   +IG G FG V++  +    EVAIK   +     FK+ +++  +M+ ++H N++ +
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIK--KVLQDKRFKNRELQ--IMRIVKHPNVVDL 97
Query: 570 ISS-CSNDD-----FKALVLEYMPLGSLEKCLYSGNYILDIFQGLNI------MIDVASA 617
            +   SN D     F  LVLEY+P    E    +  +   + Q + +      M  +  +
Sbjct: 98  KAFFYSNGDKKDEVFLNLVLEYVP----ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRS 153
Query: 618 LEYLHFGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGY 676
           L Y+H   S+ I H D+KP N+LLD  + V  L DFG AK L+  + +++    + +  Y
Sbjct: 154 LAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS---XICSRYY 207
Query: 677 MAPDEIFSG 685
            AP+ IF  
Sbjct: 208 RAPELIFGA 216

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 68/143 (47%), Gaps = 11/143 (7%)
Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISS 572
           IG+G F  V        G EVA+K+ +       + +    E  +MK + H N++K+   
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 573 CSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
              +    LV+EY   G +   L +  ++ +  +       + SA++Y H  +   I+H 
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLVAHGWMKEK-EARAKFRQIVSAVQYCHQKF---IVHR 130
Query: 633 DLKPSNVLLDDNMVAHLSDFGMA 655
           DLK  N+LLD +M   ++DFG +
Sbjct: 131 DLKAENLLLDADMNIKIADFGFS 153

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 78/180 (43%), Gaps = 14/180 (7%)
Query: 512 NRFSENNLIGRGGFGPVYKD--------GMEVAIKVF-NLQYGGAFKSFDIECGMMKRIR 562
            R      IG G FG V++          M VAIK   N       + F  E   M++  
Sbjct: 10  ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 563 HRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
           H +++K+I   + +    +++E   LG L   L    + LD+   +     +++AL YL 
Sbjct: 70  HPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 128
Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              S   +H D+   NVL+       L DFG+++  +E+      ++    I +MAP+ I
Sbjct: 129 ---SKRFVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESI 184

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 83/185 (44%), Gaps = 34/185 (18%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRNL 566
           F +   IG G +G VYK      G  VA+K   L  +  G   +   E  ++K + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----------NYILDIFQGLNIMIDVA 615
           +K++     ++   LV E++ +  L+K + +            +Y+  + QGL       
Sbjct: 66  VKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 118
Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 675
                  F +S  ++H DLKP N+L++      L+DFG+A+      +  T    + T+ 
Sbjct: 119 -------FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLW 169
Query: 676 YMAPD 680
           Y AP+
Sbjct: 170 YRAPE 174

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 118/273 (43%), Gaps = 24/273 (8%)
Query: 518 NLIGRGGFGPVY--------KDGMEVAIKVFN---LQYGGAFKSFDIECGMMKRIRHRNL 566
            ++G+G FG V+          G   A+KV     L+     ++  +E  ++  + H  +
Sbjct: 34  KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRT-KMERDILADVNHPFV 92
Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
           +K+  +   +    L+L+++  G L   L S   +         + ++A  L++LH   S
Sbjct: 93  VKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALGLDHLH---S 148
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI-FSG 685
           + II+ DLKP N+LLD+     L+DFG++K  +  D          T+ YMAP+ +   G
Sbjct: 149 LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAI--DHEKKAYSFCGTVEYMAPEVVNRQG 206
Query: 686 EMRLKCWVNDSLLISVMIVVDANLLIREEKHLMTKEQPMVRMGTDLSLGQFPASYSISKY 745
                 W +  +L+  M+        ++ K  MT     + +   L + QF ++ + S  
Sbjct: 207 HSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMT-----LILKAKLGMPQFLSTEAQSLL 261
Query: 746 LVYIRELERGKVGITSVAAFPIVHHYLYRTVDY 778
               +     ++G     A  I  H  Y T+D+
Sbjct: 262 RALFKRNPANRLGSGPDGAEEIKRHVFYSTIDW 294

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 89/194 (45%), Gaps = 19/194 (9%)
Query: 511 TNRFSENNLIGRGGFGPVY--KD---GMEVAIKVFN---LQYGGAFKSFDIECGMMKRIR 562
           ++R+    ++G+G FG V   KD   G E A+KV +   ++     +S   E  ++K++ 
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 107
Query: 563 HRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
           H N++K+     +  +  LV E    G L   + S     ++     I+  V S + Y+H
Sbjct: 108 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYMH 166
Query: 623 FGYSVPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
                 I+H DLKP N+LL+    +    + DFG++      + S      + T  Y+AP
Sbjct: 167 ---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYIAP 220
Query: 680 DEIFSGEMRLKCWV 693
            E+  G    KC V
Sbjct: 221 -EVLHGTYDEKCDV 233

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 89/194 (45%), Gaps = 19/194 (9%)
Query: 511 TNRFSENNLIGRGGFGPVY--KD---GMEVAIKVFN---LQYGGAFKSFDIECGMMKRIR 562
           ++R+    ++G+G FG V   KD   G E A+KV +   ++     +S   E  ++K++ 
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 108
Query: 563 HRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
           H N++K+     +  +  LV E    G L   + S     ++     I+  V S + Y+H
Sbjct: 109 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYMH 167
Query: 623 FGYSVPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
                 I+H DLKP N+LL+    +    + DFG++      + S      + T  Y+AP
Sbjct: 168 ---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYIAP 221
Query: 680 DEIFSGEMRLKCWV 693
            E+  G    KC V
Sbjct: 222 -EVLHGTYDEKCDV 234

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/190 (25%), Positives = 87/190 (45%), Gaps = 15/190 (7%)
Query: 507 LFQATNRFSENNLIGRGGFGPVYKD---------GMEVAIKVFNLQYG-GAFKSFDIECG 556
           +F+ T    +  ++G G FG V+K           + V IKV   + G  +F++      
Sbjct: 9   IFKETE-LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHML 67
Query: 557 MMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVAS 616
            +  + H ++++++  C     + LV +Y+PLGSL   +      L     LN  + +A 
Sbjct: 68  AIGSLDHAHIVRLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAK 126
Query: 617 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGY 676
            + YL       ++H +L   NVLL       ++DFG+A  L  +D+ L  ++    I +
Sbjct: 127 GMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 183
Query: 677 MAPDEIFSGE 686
           MA + I  G+
Sbjct: 184 MALESIHFGK 193

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 83/185 (44%), Gaps = 34/185 (18%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRNL 566
           F +   IG G +G VYK      G  VA+K   L  +  G   +   E  ++K + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----------NYILDIFQGLNIMIDVA 615
           +K++     ++   LV E++ +  L+K + +            +Y+  + QGL       
Sbjct: 68  VKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 120
Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 675
                  F +S  ++H DLKP N+L++      L+DFG+A+      +  T    + T+ 
Sbjct: 121 -------FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLW 171
Query: 676 YMAPD 680
           Y AP+
Sbjct: 172 YRAPE 176

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 69/147 (46%), Gaps = 19/147 (12%)
Query: 554 ECGMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCL---------------YS 597
           E  MMK I +H+N+I ++ +C+ D    +++EY   G+L + L               ++
Sbjct: 83  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHN 142
Query: 598 GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP 657
               L     ++    VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ 
Sbjct: 143 PEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARD 199
Query: 658 LLEEDQSLTQTQTLATIGYMAPDEIFS 684
           +   D     T     + +MAP+ +F 
Sbjct: 200 IHHIDYYKKTTNGRLPVKWMAPEALFD 226

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 82/179 (45%), Gaps = 14/179 (7%)
Query: 518 NLIGRGGFGPVYKD---------GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLI 567
            ++G G FG V+K           + V IKV   + G  +F++       +  + H +++
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 568 KIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
           +++  C     + LV +Y+PLGSL   +      L     LN  + +A  + YL      
Sbjct: 97  RLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EH 152
Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGE 686
            ++H +L   NVLL       ++DFG+A  L  +D+ L  ++    I +MA + I  G+
Sbjct: 153 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 211

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 72/156 (46%), Gaps = 24/156 (15%)
Query: 514 FSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGA-----FKSFDIECGMMKRIRH 563
           FS+   IG G FG VY     ++   VAIK   + Y G      ++    E   ++++RH
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIK--KMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDI----FQGLNIMIDVASALE 619
            N I+       +    LV+EY        CL S + +L++     Q + I      AL+
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEY--------CLGSASDLLEVHKKPLQEVEIAAVTHGALQ 126
Query: 620 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMA 655
            L + +S  +IH D+K  N+LL +  +  L DFG A
Sbjct: 127 GLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA 162

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 21/201 (10%)
Query: 518 NLIGRGGFGPVYKD------------GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRN 565
            ++G+GG+G V++              M+V  K   ++          E  +++ ++H  
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCL-YSGNYILDIFQGLNIMIDVASALEYLHFG 624
           ++ +I +        L+LEY+  G L   L   G ++ D       + +++ AL +LH  
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDT--ACFYLAEISMALGHLH-- 138
Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIF- 683
               II+ DLKP N++L+      L+DFG+ K  +  D ++T T    TI YMAP+ +  
Sbjct: 139 -QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI-HDGTVTHT-FCGTIEYMAPEILMR 195
Query: 684 SGEMRLKCWVNDSLLISVMIV 704
           SG  R   W +   L+  M+ 
Sbjct: 196 SGHNRAVDWWSLGALMYDMLT 216

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 82/184 (44%), Gaps = 32/184 (17%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRNL 566
           F +   IG G +G VYK      G  VA+K   L  +  G   +   E  ++K + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 567 IKIISSCSNDDFKALVLEYMPLG---SLEKCLYSG-------NYILDIFQGLNIMIDVAS 616
           +K++     ++   LV E++ +     ++    +G       +Y+  + QGL        
Sbjct: 68  VKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA------- 120
Query: 617 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGY 676
                 F +S  ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y
Sbjct: 121 ------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWY 172
Query: 677 MAPD 680
            AP+
Sbjct: 173 RAPE 176

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 89/210 (42%), Gaps = 31/210 (14%)
Query: 506 ELFQATNRFSENNLIGRGGFGPVYKDGM----------EVAIKVFNLQYGGAFKS-FDIE 554
           E+  +  RF E   +G   FG VYK  +           VAIK    +  G  +  F  E
Sbjct: 5   EISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHE 62
Query: 555 CGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQG------- 607
             +  R++H N++ ++   + D   +++  Y   G L + L   +   D+          
Sbjct: 63  AMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK 122
Query: 608 --------LNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL 659
                   ++++  +A+ +EYL    S  ++H DL   NVL+ D +   +SD G+ + + 
Sbjct: 123 SALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVY 179
Query: 660 EEDQSLTQTQTLATIGYMAPDEIFSGEMRL 689
             D       +L  I +MAP+ I  G+  +
Sbjct: 180 AADYYKLLGNSLLPIRWMAPEAIMYGKFSI 209

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 82/184 (44%), Gaps = 32/184 (17%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRNL 566
           F +   IG G +G VYK      G  VA+K   L  +  G   +   E  ++K + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 567 IKIISSCSNDDFKALVLEYMPLG---SLEKCLYSG-------NYILDIFQGLNIMIDVAS 616
           +K++     ++   LV E++ +     ++    +G       +Y+  + QGL        
Sbjct: 67  VKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA------- 119
Query: 617 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGY 676
                 F +S  ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y
Sbjct: 120 ------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWY 171
Query: 677 MAPD 680
            AP+
Sbjct: 172 RAPE 175

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 82/184 (44%), Gaps = 32/184 (17%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRNL 566
           F +   IG G +G VYK      G  VA+K   L  +  G   +   E  ++K + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 567 IKIISSCSNDDFKALVLEYMPLG---SLEKCLYSG-------NYILDIFQGLNIMIDVAS 616
           +K++     ++   LV E++       ++    +G       +Y+  + QGL        
Sbjct: 64  VKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLA------- 116
Query: 617 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGY 676
                 F +S  ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y
Sbjct: 117 ------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWY 168
Query: 677 MAPD 680
            AP+
Sbjct: 169 RAPE 172

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/184 (29%), Positives = 85/184 (46%), Gaps = 23/184 (12%)
Query: 518 NLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRI-RHRNLIKIIS 571
            L+G G +G VYK      G   AIKV ++  G   +    E  M+K+   HRN+     
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYG 88
Query: 572 SCSN------DDFKALVLEYMPLGSLEKCLY--SGNYILDIFQGLNIMIDVASALEYLHF 623
           +         DD   LV+E+   GS+   +    GN + + +    I  ++   L +LH 
Sbjct: 89  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-ICREILRGLSHLH- 146
Query: 624 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT-LATIGYMAPDEI 682
                +IH D+K  NVLL +N    L DFG++  L   D+++ +  T + T  +MAP+ I
Sbjct: 147 --QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---DRTVGRRNTFIGTPYWMAPEVI 201
Query: 683 FSGE 686
              E
Sbjct: 202 ACDE 205

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 78/180 (43%), Gaps = 14/180 (7%)
Query: 512 NRFSENNLIGRGGFGPVYKD--------GMEVAIKVF-NLQYGGAFKSFDIECGMMKRIR 562
            R      IG G FG V++          M VAIK   N       + F  E   M++  
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 563 HRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
           H +++K+I   + +    +++E   LG L   L    + LD+   +     +++AL YL 
Sbjct: 450 HPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE 508
Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              S   +H D+   NVL+       L DFG+++  +E+      ++    I +MAP+ I
Sbjct: 509 ---SKRFVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESI 564

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 89/190 (46%), Gaps = 24/190 (12%)
Query: 506 ELFQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFN-LQYGGAFKSFDIECGMMK 559
           ++F    R++  + IG G +G V       + + VAIK  +  ++    +    E  ++ 
Sbjct: 37  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 96
Query: 560 RIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGN-YILDIFQGLN------IMI 612
           R RH N+I I     ND  +A  +E M    L   L   + Y L   Q L+       + 
Sbjct: 97  RFRHENIIGI-----NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLY 151
Query: 613 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ--TQT 670
            +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+ + + D   T   T+ 
Sbjct: 152 QILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEY 207
Query: 671 LATIGYMAPD 680
           +AT  Y AP+
Sbjct: 208 VATRWYRAPE 217

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/184 (22%), Positives = 89/184 (48%), Gaps = 17/184 (9%)
Query: 511 TNRFSENNLIGRGGFGPVY-----KDGMEVAIKVF--NLQYGGAFK-SFDIECGMMKRIR 562
           ++R+    ++G GG   V+     +D  +VA+KV   +L    +F   F  E      + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 563 HRNLIKIISSCSNDD----FKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASAL 618
           H  ++ +  +   +        +V+EY+   +L   +++   +    + + ++ D   A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP-KRAIEVIAD---AC 126
Query: 619 EYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT-LATIGYM 677
           + L+F +   IIH D+KP+N+++       + DFG+A+ + +   S+TQT   + T  Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 678 APDE 681
           +P++
Sbjct: 187 SPEQ 190

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 84/181 (46%), Gaps = 24/181 (13%)
Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGG---AFKSFDI-ECGMMKRIRHRNLIKII 570
           IG G +G   K     DG  +  K   L YG    A K   + E  +++ ++H N+++  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWK--ELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 571 SSCSNDDFKAL--VLEYMPLGSLEKCLYSG---NYILDIFQGLNIMIDVASALEYLHF-- 623
               +     L  V+EY   G L   +  G      LD    L +M  +  AL+  H   
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 624 --GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
             G++V  +H DLKP+NV LD      L DFG+A+ +L  D S  +T  + T  YM+P++
Sbjct: 132 DGGHTV--LHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKT-FVGTPYYMSPEQ 187
Query: 682 I 682
           +
Sbjct: 188 M 188

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 92/217 (42%), Gaps = 31/217 (14%)
Query: 486 SQLKDVNMPSVADQRRFTYLELFQATNRFSENNLIGRGGFGPVY-------KDGMEVAIK 538
           +QL     P++ ++R   Y+            + +G+G FG V         D     + 
Sbjct: 9   AQLYACQDPTIFEERHLKYI------------SQLGKGNFGSVELCRYDPLGDNTGALVA 56
Query: 539 VFNLQYGG--AFKSFDIECGMMKRIRHRNLIKI--ISSCSNDDFKALVLEYMPLGSLEKC 594
           V  LQ+ G    + F  E  ++K +    ++K   +S         LV+EY+P G L   
Sbjct: 57  VKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDF 116
Query: 595 LYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGM 654
           L      LD  + L     +   +EYL    S   +H DL   N+L++      ++DFG+
Sbjct: 117 LQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGL 173
Query: 655 AKPL-LEEDQSLTQTQTLATIGYMAP----DEIFSGE 686
           AK L L++D  + +    + I + AP    D IFS +
Sbjct: 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQ 210

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/184 (22%), Positives = 89/184 (48%), Gaps = 17/184 (9%)
Query: 511 TNRFSENNLIGRGGFGPVY-----KDGMEVAIKVF--NLQYGGAFK-SFDIECGMMKRIR 562
           ++R+    ++G GG   V+     +D  +VA+KV   +L    +F   F  E      + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 563 HRNLIKIISSCSNDD----FKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASAL 618
           H  ++ +  +   +        +V+EY+   +L   +++    +   + + ++ D   A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIAD---AC 126
Query: 619 EYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT-LATIGYM 677
           + L+F +   IIH D+KP+N+++       + DFG+A+ + +   S+TQT   + T  Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 678 APDE 681
           +P++
Sbjct: 187 SPEQ 190

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 91/190 (47%), Gaps = 24/190 (12%)
Query: 506 ELFQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFN-LQYGGAFKSFDIECGMMK 559
           ++F    R++  + IG G +G V       + + VAIK  +  ++    +    E  ++ 
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILL 80
Query: 560 RIRHRNLIKIISSCSNDDFKALVLEYMP-LGSLEKCLYSGNYILDIFQGLN------IMI 612
           R RH N+I I     ND  +A  +E M  +  ++  + +  Y L   Q L+       + 
Sbjct: 81  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 135
Query: 613 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ--TQT 670
            +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+ + + D   T   T+ 
Sbjct: 136 QILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEY 191
Query: 671 LATIGYMAPD 680
           +AT  Y AP+
Sbjct: 192 VATRWYRAPE 201

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 113/268 (42%), Gaps = 40/268 (14%)
Query: 519 LIGRGGFGPVYKDGMEVAIKVFNLQYGGAFKS--------FDIECGMMKRIRHRNLIKII 570
           +IGRG FG V     +   KV+ ++    F+         F  E  +M       ++++ 
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 140
Query: 571 SSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPII 630
            +  +D +  +V+EYMP G L   +   NY +          +V  AL+ +H   S+  I
Sbjct: 141 YAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFYTAEVVLALDAIH---SMGFI 195
Query: 631 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS----GE 686
           H D+KP N+LLD +    L+DFG    + +E      T  + T  Y++P+ + S    G 
Sbjct: 196 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGDGY 254
Query: 687 MRLKC-WVNDSLLISVMIVVD----ANLLIREEKHLMTKEQPMVRMGTDLSLGQFPASYS 741
              +C W +  + +  M+V D    A+ L+     +M  +  +           FP    
Sbjct: 255 YGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT----------FPDDND 304
Query: 742 ISK-------YLVYIRELERGKVGITSV 762
           ISK         +  RE+  G+ G+  +
Sbjct: 305 ISKEAKNLICAFLTDREVRLGRNGVEEI 332

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 34/185 (18%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRNL 566
           F +   IG G +G VYK      G  VA+K   L  +  G   +   E  ++K + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----------NYILDIFQGLNIMIDVA 615
           +K++     ++   LV E++    L+K + +            +Y+  + QGL       
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 116
Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 675
                  F +S  ++H DLKP N+L++      L+DFG+A+      +  T    + T+ 
Sbjct: 117 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLW 167
Query: 676 YMAPD 680
           Y AP+
Sbjct: 168 YRAPE 172

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 34/185 (18%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRNL 566
           F +   IG G +G VYK      G  VA+K   L  +  G   +   E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----------NYILDIFQGLNIMIDVA 615
           +K++     ++   LV E++    L+K + +            +Y+  + QGL       
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 117
Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 675
                  F +S  ++H DLKP N+L++      L+DFG+A+      +  T    + T+ 
Sbjct: 118 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLW 168
Query: 676 YMAPD 680
           Y AP+
Sbjct: 169 YRAPE 173

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 34/185 (18%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRNL 566
           F +   IG G +G VYK      G  VA+K   L  +  G   +   E  ++K + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----------NYILDIFQGLNIMIDVA 615
           +K++     ++   LV E++    L+K + +            +Y+  + QGL       
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 116
Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 675
                  F +S  ++H DLKP N+L++      L+DFG+A+      +  T    + T+ 
Sbjct: 117 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLW 167
Query: 676 YMAPD 680
           Y AP+
Sbjct: 168 YRAPE 172

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 34/185 (18%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRNL 566
           F +   IG G +G VYK      G  VA+K   L  +  G   +   E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----------NYILDIFQGLNIMIDVA 615
           +K++     ++   LV E++    L+K + +            +Y+  + QGL       
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 117
Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 675
                  F +S  ++H DLKP N+L++      L+DFG+A+      +  T    + T+ 
Sbjct: 118 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLW 168
Query: 676 YMAPD 680
           Y AP+
Sbjct: 169 YRAPE 173

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 34/185 (18%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRNL 566
           F +   IG G +G VYK      G  VA+K   L  +  G   +   E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----------NYILDIFQGLNIMIDVA 615
           +K++     ++   LV E++    L+K + +            +Y+  + QGL       
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 117
Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 675
                  F +S  ++H DLKP N+L++      L+DFG+A+      +  T    + T+ 
Sbjct: 118 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLW 168
Query: 676 YMAPD 680
           Y AP+
Sbjct: 169 YRAPE 173

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 113/268 (42%), Gaps = 40/268 (14%)
Query: 519 LIGRGGFGPVYKDGMEVAIKVFNLQYGGAFKS--------FDIECGMMKRIRHRNLIKII 570
           +IGRG FG V     +   KV+ ++    F+         F  E  +M       ++++ 
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135
Query: 571 SSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPII 630
            +  +D +  +V+EYMP G L   +   NY +          +V  AL+ +H   S+  I
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFYTAEVVLALDAIH---SMGFI 190
Query: 631 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS----GE 686
           H D+KP N+LLD +    L+DFG    + +E      T  + T  Y++P+ + S    G 
Sbjct: 191 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGDGY 249
Query: 687 MRLKC-WVNDSLLISVMIVVD----ANLLIREEKHLMTKEQPMVRMGTDLSLGQFPASYS 741
              +C W +  + +  M+V D    A+ L+     +M  +  +           FP    
Sbjct: 250 YGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT----------FPDDND 299
Query: 742 ISK-------YLVYIRELERGKVGITSV 762
           ISK         +  RE+  G+ G+  +
Sbjct: 300 ISKEAKNLICAFLTDREVRLGRNGVEEI 327

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 91/190 (47%), Gaps = 24/190 (12%)
Query: 506 ELFQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFN-LQYGGAFKSFDIECGMMK 559
           ++F    R++  + IG G +G V       + + VAIK  +  ++    +    E  ++ 
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 80
Query: 560 RIRHRNLIKIISSCSNDDFKALVLEYMP-LGSLEKCLYSGNYILDIFQGLN------IMI 612
           R RH N+I I     ND  +A  +E M  +  ++  + +  Y L   Q L+       + 
Sbjct: 81  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 135
Query: 613 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ--TQT 670
            +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+ + + D   T   T+ 
Sbjct: 136 QILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEY 191
Query: 671 LATIGYMAPD 680
           +AT  Y AP+
Sbjct: 192 VATRWYRAPE 201

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 67/143 (46%), Gaps = 11/143 (7%)
Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISS 572
           IG+G F  V        G EVA+K+ +       + +    E  +MK + H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 573 CSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
              +    LV+EY   G +   L +   + +  +       + SA++Y H  +   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-EARAKFRQIVSAVQYCHQKF---IVHR 137
Query: 633 DLKPSNVLLDDNMVAHLSDFGMA 655
           DLK  N+LLD +M   ++DFG +
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS 160

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 91/190 (47%), Gaps = 24/190 (12%)
Query: 506 ELFQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFN-LQYGGAFKSFDIECGMMK 559
           ++F    R++  + IG G +G V       + + VAIK  +  ++    +    E  ++ 
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 76
Query: 560 RIRHRNLIKIISSCSNDDFKALVLEYMP-LGSLEKCLYSGNYILDIFQGLN------IMI 612
           R RH N+I I     ND  +A  +E M  +  ++  + +  Y L   Q L+       + 
Sbjct: 77  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 131
Query: 613 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ--TQT 670
            +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+ + + D   T   T+ 
Sbjct: 132 QILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKIXDFGLAR-VADPDHDHTGFLTEY 187
Query: 671 LATIGYMAPD 680
           +AT  Y AP+
Sbjct: 188 VATRWYRAPE 197

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 91/190 (47%), Gaps = 24/190 (12%)
Query: 506 ELFQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFN-LQYGGAFKSFDIECGMMK 559
           ++F    R++  + IG G +G V       + + VAIK  +  ++    +    E  ++ 
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 76
Query: 560 RIRHRNLIKIISSCSNDDFKALVLEYMP-LGSLEKCLYSGNYILDIFQGLN------IMI 612
           R RH N+I I     ND  +A  +E M  +  ++  + +  Y L   Q L+       + 
Sbjct: 77  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 131
Query: 613 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ--TQT 670
            +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+ + + D   T   T+ 
Sbjct: 132 QILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEY 187
Query: 671 LATIGYMAPD 680
           +AT  Y AP+
Sbjct: 188 VATRWYRAPE 197

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 34/185 (18%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRNL 566
           F +   IG G +G VYK      G  VA+K   L  +  G   +   E  ++K + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----------NYILDIFQGLNIMIDVA 615
           +K++     ++   LV E++    L+K + +            +Y+  + QGL       
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 120
Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 675
                  F +S  ++H DLKP N+L++      L+DFG+A+      +  T    + T+ 
Sbjct: 121 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLW 171
Query: 676 YMAPD 680
           Y AP+
Sbjct: 172 YRAPE 176

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 34/185 (18%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRNL 566
           F +   IG G +G VYK      G  VA+K   L  +  G   +   E  ++K + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----------NYILDIFQGLNIMIDVA 615
           +K++     ++   LV E++    L+K + +            +Y+  + QGL       
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 119
Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 675
                  F +S  ++H DLKP N+L++      L+DFG+A+      +  T    + T+ 
Sbjct: 120 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLW 170
Query: 676 YMAPD 680
           Y AP+
Sbjct: 171 YRAPE 175

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 87/194 (44%), Gaps = 19/194 (9%)
Query: 511 TNRFSENNLIGRGGFGPVY--KD---GMEVAIKVFN---LQYGGAFKSFDIECGMMKRIR 562
           ++R+    ++G+G FG V   KD   G E A+KV +   ++     +S   E  ++K++ 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 563 HRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
           H N+ K+     +  +  LV E    G L   + S     ++     I+  V S + Y H
Sbjct: 85  HPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-DAARIIRQVLSGITYXH 143
Query: 623 FGYSVPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
                 I+H DLKP N+LL+    +    + DFG++      + S      + T  Y+AP
Sbjct: 144 ---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKXKDKIGTAYYIAP 197
Query: 680 DEIFSGEMRLKCWV 693
            E+  G    KC V
Sbjct: 198 -EVLHGTYDEKCDV 210

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 67/143 (46%), Gaps = 11/143 (7%)
Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISS 572
           IG+G F  V        G EVA+K+ +       + +    E  +MK + H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 573 CSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
              +    LV+EY   G +   L +   + +  +       + SA++Y H  +   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-EARAKFRQIVSAVQYCHQKF---IVHR 137
Query: 633 DLKPSNVLLDDNMVAHLSDFGMA 655
           DLK  N+LLD +M   ++DFG +
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS 160

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 34/185 (18%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRNL 566
           F +   IG G +G VYK      G  VA+K   L  +  G   +   E  ++K + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----------NYILDIFQGLNIMIDVA 615
           +K++     ++   LV E++    L+K + +            +Y+  + QGL       
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 119
Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 675
                  F +S  ++H DLKP N+L++      L+DFG+A+      +  T    + T+ 
Sbjct: 120 -------FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLW 170
Query: 676 YMAPD 680
           Y AP+
Sbjct: 171 YRAPE 175

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 34/185 (18%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRNL 566
           F +   IG G +G VYK      G  VA+K   L  +  G   +   E  ++K + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----------NYILDIFQGLNIMIDVA 615
           +K++     ++   LV E++    L+K + +            +Y+  + QGL       
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 118
Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 675
                  F +S  ++H DLKP N+L++      L+DFG+A+      +  T    + T+ 
Sbjct: 119 -------FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLW 169
Query: 676 YMAPD 680
           Y AP+
Sbjct: 170 YRAPE 174

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 34/185 (18%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRNL 566
           F +   IG G +G VYK      G  VA+K   L  +  G   +   E  ++K + H N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----------NYILDIFQGLNIMIDVA 615
           +K++     ++   LV E++    L+K + +            +Y+  + QGL       
Sbjct: 69  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 121
Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 675
                  F +S  ++H DLKP N+L++      L+DFG+A+      +  T    + T+ 
Sbjct: 122 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLW 172
Query: 676 YMAPD 680
           Y AP+
Sbjct: 173 YRAPE 177

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 34/185 (18%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRNL 566
           F +   IG G +G VYK      G  VA+    L  +  G   +   E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----------NYILDIFQGLNIMIDVA 615
           +K++     ++   LV E++    L+K + +            +Y+  + QGL       
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 117
Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 675
                  F +S  ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ 
Sbjct: 118 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLW 168
Query: 676 YMAPD 680
           Y AP+
Sbjct: 169 YRAPE 173

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 34/185 (18%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRNL 566
           F +   IG G +G VYK      G  VA+    L  +  G   +   E  ++K + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----------NYILDIFQGLNIMIDVA 615
           +K++     ++   LV E++    L+K + +            +Y+  + QGL       
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 116
Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 675
                  F +S  ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ 
Sbjct: 117 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLW 167
Query: 676 YMAPD 680
           Y AP+
Sbjct: 168 YRAPE 172

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 34/185 (18%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRNL 566
           F +   IG G +G VYK      G  VA+K   L  +  G   +   E  ++K + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----------NYILDIFQGLNIMIDVA 615
           +K++     ++   LV E++    L+K + +            +Y+  + QGL       
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 118
Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 675
                  F +S  ++H DLKP N+L++      L+DFG+A+      +  T    + T+ 
Sbjct: 119 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLW 169
Query: 676 YMAPD 680
           Y AP+
Sbjct: 170 YRAPE 174

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 34/185 (18%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRNL 566
           F +   IG G +G VYK      G  VA+K   L  +  G   +   E  ++K + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----------NYILDIFQGLNIMIDVA 615
           +K++     ++   LV E++    L+K + +            +Y+  + QGL       
Sbjct: 68  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 120
Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 675
                  F +S  ++H DLKP N+L++      L+DFG+A+      +  T    + T+ 
Sbjct: 121 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLW 171
Query: 676 YMAPD 680
           Y AP+
Sbjct: 172 YRAPE 176

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 34/185 (18%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRNL 566
           F +   IG G +G VYK      G  VA+K   L  +  G   +   E  ++K + H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----------NYILDIFQGLNIMIDVA 615
           +K++     ++   LV E++    L+K + +            +Y+  + QGL       
Sbjct: 67  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 119
Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 675
                  F +S  ++H DLKP N+L++      L+DFG+A+      +  T    + T+ 
Sbjct: 120 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLW 170
Query: 676 YMAPD 680
           Y AP+
Sbjct: 171 YRAPE 175

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 34/185 (18%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRNL 566
           F +   IG G +G VYK      G  VA+K   L  +  G   +   E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----------NYILDIFQGLNIMIDVA 615
           +K++     ++   LV E++    L+K + +            +Y+  + QGL       
Sbjct: 65  VKLLDVIHTENKLYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 117
Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 675
                  F +S  ++H DLKP N+L++      L+DFG+A+      +  T    + T+ 
Sbjct: 118 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLW 168
Query: 676 YMAPD 680
           Y AP+
Sbjct: 169 YRAPE 173

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 67/143 (46%), Gaps = 11/143 (7%)
Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISS 572
           IG+G F  V        G EVA+K+ +       + +    E  +MK + H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 573 CSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
              +    LV+EY   G +   L +   + +  +       + SA++Y H  +   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-EARAKFRQIVSAVQYCHQKF---IVHR 137
Query: 633 DLKPSNVLLDDNMVAHLSDFGMA 655
           DLK  N+LLD +M   ++DFG +
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS 160

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 91/190 (47%), Gaps = 24/190 (12%)
Query: 506 ELFQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFN-LQYGGAFKSFDIECGMMK 559
           ++F    R++  + IG G +G V       + + VAIK  +  ++    +    E  ++ 
Sbjct: 15  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 74
Query: 560 RIRHRNLIKIISSCSNDDFKALVLEYMP-LGSLEKCLYSGNYILDIFQGLN------IMI 612
           R RH N+I I     ND  +A  +E M  +  ++  + +  Y L   Q L+       + 
Sbjct: 75  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 129
Query: 613 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ--TQT 670
            +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+ + + D   T   T+ 
Sbjct: 130 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 185
Query: 671 LATIGYMAPD 680
           +AT  Y AP+
Sbjct: 186 VATRWYRAPE 195

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 91/190 (47%), Gaps = 24/190 (12%)
Query: 506 ELFQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFN-LQYGGAFKSFDIECGMMK 559
           ++F    R++  + IG G +G V       + + VAIK  +  ++    +    E  ++ 
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 76
Query: 560 RIRHRNLIKIISSCSNDDFKALVLEYMP-LGSLEKCLYSGNYILDIFQGLN------IMI 612
           R RH N+I I     ND  +A  +E M  +  ++  + +  Y L   Q L+       + 
Sbjct: 77  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 131
Query: 613 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ--TQT 670
            +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+ + + D   T   T+ 
Sbjct: 132 QILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLAR-VADPDHDHTGFLTEY 187
Query: 671 LATIGYMAPD 680
           +AT  Y AP+
Sbjct: 188 VATRWYRAPE 197

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 91/190 (47%), Gaps = 24/190 (12%)
Query: 506 ELFQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFN-LQYGGAFKSFDIECGMMK 559
           ++F    R++  + IG G +G V       + + VAIK  +  ++    +    E  ++ 
Sbjct: 19  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 78
Query: 560 RIRHRNLIKIISSCSNDDFKALVLEYMP-LGSLEKCLYSGNYILDIFQGLN------IMI 612
           R RH N+I I     ND  +A  +E M  +  ++  + +  Y L   Q L+       + 
Sbjct: 79  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 133
Query: 613 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ--TQT 670
            +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+ + + D   T   T+ 
Sbjct: 134 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 189
Query: 671 LATIGYMAPD 680
           +AT  Y AP+
Sbjct: 190 VATRWYRAPE 199

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 91/190 (47%), Gaps = 24/190 (12%)
Query: 506 ELFQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFN-LQYGGAFKSFDIECGMMK 559
           ++F    R++  + IG G +G V       + + VAIK  +  ++    +    E  ++ 
Sbjct: 22  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 81
Query: 560 RIRHRNLIKIISSCSNDDFKALVLEYMP-LGSLEKCLYSGNYILDIFQGLN------IMI 612
           R RH N+I I     ND  +A  +E M  +  ++  + +  Y L   Q L+       + 
Sbjct: 82  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 136
Query: 613 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ--TQT 670
            +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+ + + D   T   T+ 
Sbjct: 137 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 192
Query: 671 LATIGYMAPD 680
           +AT  Y AP+
Sbjct: 193 VATRWYRAPE 202

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 91/190 (47%), Gaps = 24/190 (12%)
Query: 506 ELFQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFN-LQYGGAFKSFDIECGMMK 559
           ++F    R++  + IG G +G V       + + VAIK  +  ++    +    E  ++ 
Sbjct: 23  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 82
Query: 560 RIRHRNLIKIISSCSNDDFKALVLEYMP-LGSLEKCLYSGNYILDIFQGLN------IMI 612
           R RH N+I I     ND  +A  +E M  +  ++  + +  Y L   Q L+       + 
Sbjct: 83  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 137
Query: 613 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ--TQT 670
            +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+ + + D   T   T+ 
Sbjct: 138 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 193
Query: 671 LATIGYMAPD 680
           +AT  Y AP+
Sbjct: 194 VATRWYRAPE 203

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 91/190 (47%), Gaps = 24/190 (12%)
Query: 506 ELFQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFN-LQYGGAFKSFDIECGMMK 559
           ++F    R++  + IG G +G V       + + VAIK  +  ++    +    E  ++ 
Sbjct: 14  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 73
Query: 560 RIRHRNLIKIISSCSNDDFKALVLEYMP-LGSLEKCLYSGNYILDIFQGLN------IMI 612
           R RH N+I I     ND  +A  +E M  +  ++  + +  Y L   Q L+       + 
Sbjct: 74  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 128
Query: 613 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ--TQT 670
            +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+ + + D   T   T+ 
Sbjct: 129 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 184
Query: 671 LATIGYMAPD 680
           +AT  Y AP+
Sbjct: 185 VATRWYRAPE 194

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 91/190 (47%), Gaps = 24/190 (12%)
Query: 506 ELFQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFN-LQYGGAFKSFDIECGMMK 559
           ++F    R++  + IG G +G V       + + VAIK  +  ++    +    E  ++ 
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 80
Query: 560 RIRHRNLIKIISSCSNDDFKALVLEYMP-LGSLEKCLYSGNYILDIFQGLN------IMI 612
           R RH N+I I     ND  +A  +E M  +  ++  + +  Y L   Q L+       + 
Sbjct: 81  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 135
Query: 613 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ--TQT 670
            +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+ + + D   T   T+ 
Sbjct: 136 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 191
Query: 671 LATIGYMAPD 680
           +AT  Y AP+
Sbjct: 192 VATRWYRAPE 201

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 91/190 (47%), Gaps = 24/190 (12%)
Query: 506 ELFQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFN-LQYGGAFKSFDIECGMMK 559
           ++F    R++  + IG G +G V       + + VAIK  +  ++    +    E  ++ 
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 76
Query: 560 RIRHRNLIKIISSCSNDDFKALVLEYMP-LGSLEKCLYSGNYILDIFQGLN------IMI 612
           R RH N+I I     ND  +A  +E M  +  ++  + +  Y L   Q L+       + 
Sbjct: 77  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 131
Query: 613 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ--TQT 670
            +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+ + + D   T   T+ 
Sbjct: 132 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 187
Query: 671 LATIGYMAPD 680
           +AT  Y AP+
Sbjct: 188 VATRWYRAPE 197

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/143 (27%), Positives = 67/143 (46%), Gaps = 11/143 (7%)
Query: 520 IGRGGFGPV-----YKDGMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISS 572
           IG+G F  V        G EVA+K+ +       + +    E  +MK + H N++K+   
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 573 CSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
              +    LV+EY   G +   L +   + +  +       + SA++Y H  Y   I+H 
Sbjct: 83  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-EARAKFRQIVSAVQYCHQKY---IVHR 138
Query: 633 DLKPSNVLLDDNMVAHLSDFGMA 655
           DLK  N+LLD +M   ++DFG +
Sbjct: 139 DLKAENLLLDGDMNIKIADFGFS 161

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 91/190 (47%), Gaps = 24/190 (12%)
Query: 506 ELFQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFN-LQYGGAFKSFDIECGMMK 559
           ++F    R++  + IG G +G V       + + VAIK  +  ++    +    E  ++ 
Sbjct: 37  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 96
Query: 560 RIRHRNLIKIISSCSNDDFKALVLEYMP-LGSLEKCLYSGNYILDIFQGLN------IMI 612
           R RH N+I I     ND  +A  +E M  +  ++  + +  Y L   Q L+       + 
Sbjct: 97  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 151
Query: 613 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ--TQT 670
            +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+ + + D   T   T+ 
Sbjct: 152 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 207
Query: 671 LATIGYMAPD 680
           +AT  Y AP+
Sbjct: 208 VATRWYRAPE 217

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 34/185 (18%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRNL 566
           F +   IG G +G VYK      G  VA+K   L  +  G   +   E  ++K + H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----------NYILDIFQGLNIMIDVA 615
           +K++     ++   LV E++    L+K + +            +Y+  + QGL       
Sbjct: 66  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 118
Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 675
                  F +S  ++H DLKP N+L++      L+DFG+A+      +  T    + T+ 
Sbjct: 119 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLW 169
Query: 676 YMAPD 680
           Y AP+
Sbjct: 170 YRAPE 174

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 80/171 (46%), Gaps = 15/171 (8%)
Query: 611 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 670
           + ++A AL++LH   S+ II+ DLKP N+LLD+     L+DFG++K  +  D        
Sbjct: 132 LAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI--DHEKKAYSF 186
Query: 671 LATIGYMAPDEI-FSGEMRLKCWVNDSLLISVMIVVDANLLIREEKHLMTKEQPMVRMGT 729
             T+ YMAP+ +   G  +   W +  +L+  M+        ++ K  MT    M+ +  
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT----MI-LKA 241
Query: 730 DLSLGQF--PASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDY 778
            L + QF  P + S+ + L       R   G   V    I  H  + T+D+
Sbjct: 242 KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEE--IKRHSFFSTIDW 290

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 91/190 (47%), Gaps = 24/190 (12%)
Query: 506 ELFQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFN-LQYGGAFKSFDIECGMMK 559
           ++F    R++  + IG G +G V       + + VAIK  +  ++    +    E  ++ 
Sbjct: 15  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 74
Query: 560 RIRHRNLIKIISSCSNDDFKALVLEYMP-LGSLEKCLYSGNYILDIFQGLN------IMI 612
           R RH N+I I     ND  +A  +E M  +  ++  + +  Y L   Q L+       + 
Sbjct: 75  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 129
Query: 613 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ--TQT 670
            +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+ + + D   T   T+ 
Sbjct: 130 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 185
Query: 671 LATIGYMAPD 680
           +AT  Y AP+
Sbjct: 186 VATRWYRAPE 195

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/240 (19%), Positives = 106/240 (44%), Gaps = 29/240 (12%)
Query: 472 VVVLLILKYRKGRKSQLKDVNMPSVADQRRFTYLELFQ------ATNRFSENNLIGRGGF 525
           +V++L + +RK   S+L +  + +  +   F+  +++       A  + + +  +G+G F
Sbjct: 1   LVIMLYVFHRKRNNSRLGNGVLYASVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSF 60
Query: 526 GPVY--------KDGMEVAIKVFNLQYGGAFKS---FDIECGMMKRIRHRNLIKIISSCS 574
           G VY        KD  E  + +  +    + +    F  E  +MK     ++++++   S
Sbjct: 61  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 120
Query: 575 NDDFKALVLEYMPLGSLEKCLYS------GNYIL---DIFQGLNIMIDVASALEYLHFGY 625
                 +++E M  G L+  L S       N +L    + + + +  ++A  + YL+   
Sbjct: 121 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLN--- 177
Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG 685
           +   +H DL   N ++ ++    + DFGM + + E D      + L  + +M+P+ +  G
Sbjct: 178 ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG 237

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 91/190 (47%), Gaps = 24/190 (12%)
Query: 506 ELFQATNRFSENNLIGRGGFGPVYK-----DGMEVAI-KVFNLQYGGAFKSFDIECGMMK 559
           ++F    R++  + IG G +G V       + + VAI K+   ++    +    E  ++ 
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILL 80
Query: 560 RIRHRNLIKIISSCSNDDFKALVLEYMP-LGSLEKCLYSGNYILDIFQGLN------IMI 612
           R RH N+I I     ND  +A  +E M  +  ++  + +  Y L   Q L+       + 
Sbjct: 81  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 135
Query: 613 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ--TQT 670
            +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+ + + D   T   T+ 
Sbjct: 136 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 191
Query: 671 LATIGYMAPD 680
           +AT  Y AP+
Sbjct: 192 VATRWYRAPE 201

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 34/199 (17%)
Query: 508 FQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI--------- 553
           F   + +     IG G +G V        G +VAIK           +FD+         
Sbjct: 50  FDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIP-------NAFDVVTNAKRTLR 102
Query: 554 ECGMMKRIRHRNLIKIIS----SCSNDDFKAL--VLEYMPLGSLEKCLYSGNYILDIFQG 607
           E  ++K  +H N+I I      +    +FK++  VL+ M    L + ++S    L +   
Sbjct: 103 ELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQ-PLTLEHV 160
Query: 608 LNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE--DQSL 665
              +  +   L+Y+H   S  +IH DLKPSN+L+++N    + DFGMA+ L     +   
Sbjct: 161 RYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQY 217
Query: 666 TQTQTLATIGYMAPDEIFS 684
             T+ +AT  Y AP+ + S
Sbjct: 218 FMTEYVATRWYRAPELMLS 236

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 87/191 (45%), Gaps = 32/191 (16%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAF--KSFDIECGMMK 559
           +++   R+   + +G G +G V      K G+ VA+K  +  +      K    E  ++K
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 560 RIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGLN 609
            ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q L 
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 143
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
                   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T 
Sbjct: 144 -------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTG 188
Query: 670 TLATIGYMAPD 680
            +AT  Y AP+
Sbjct: 189 YVATRWYRAPE 199

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 90/192 (46%), Gaps = 34/192 (17%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGG---AFKSFDIECGMM 558
           +++   R+   + +G G +G V      K G+ VA+K  +  +     A +++  E  ++
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 82
Query: 559 KRIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGL 608
           K ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q L
Sbjct: 83  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 142
Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
                    L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T
Sbjct: 143 R-------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MT 187
Query: 669 QTLATIGYMAPD 680
             +AT  Y AP+
Sbjct: 188 GYVATRWYRAPE 199

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 80/171 (46%), Gaps = 15/171 (8%)
Query: 611 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 670
           + ++A AL++LH   S+ II+ DLKP N+LLD+     L+DFG++K  +  D        
Sbjct: 133 LAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI--DHEKKAYSF 187
Query: 671 LATIGYMAPDEI-FSGEMRLKCWVNDSLLISVMIVVDANLLIREEKHLMTKEQPMVRMGT 729
             T+ YMAP+ +   G  +   W +  +L+  M+        ++ K  MT    M+ +  
Sbjct: 188 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT----MI-LKA 242
Query: 730 DLSLGQF--PASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDY 778
            L + QF  P + S+ + L       R   G   V    I  H  + T+D+
Sbjct: 243 KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEE--IKRHSFFSTIDW 291

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 80/171 (46%), Gaps = 15/171 (8%)
Query: 611 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 670
           + ++A AL++LH   S+ II+ DLKP N+LLD+     L+DFG++K  +  D        
Sbjct: 132 LAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI--DHEKKAYSF 186
Query: 671 LATIGYMAPDEI-FSGEMRLKCWVNDSLLISVMIVVDANLLIREEKHLMTKEQPMVRMGT 729
             T+ YMAP+ +   G  +   W +  +L+  M+        ++ K  MT    M+ +  
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT----MI-LKA 241
Query: 730 DLSLGQF--PASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDY 778
            L + QF  P + S+ + L       R   G   V    I  H  + T+D+
Sbjct: 242 KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEE--IKRHSFFSTIDW 290

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 65/268 (24%), Positives = 113/268 (42%), Gaps = 40/268 (14%)
Query: 519 LIGRGGFGPVYKDGMEVAIKVFNLQYGGAFKS--------FDIECGMMKRIRHRNLIKII 570
           +IGRG FG V     +   KV+ ++    F+         F  E  +M       ++++ 
Sbjct: 81  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 140
Query: 571 SSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPII 630
            +  +D +  +V+EYMP G L   +   NY +          +V  AL+ +H   S+  I
Sbjct: 141 YAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFYTAEVVLALDAIH---SMGFI 195
Query: 631 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS----GE 686
           H D+KP N+LLD +    L+DFG    + +E      T  + T  Y++P+ + S    G 
Sbjct: 196 HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISPEVLKSQGGDGY 254
Query: 687 MRLKC-WVNDSLLISVMIVVD----ANLLIREEKHLMTKEQPMVRMGTDLSLGQFPASYS 741
              +C W +  + +  M+V D    A+ L+     +M  +  +           FP    
Sbjct: 255 YGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT----------FPDDND 304
Query: 742 ISK-------YLVYIRELERGKVGITSV 762
           ISK         +  RE+  G+ G+  +
Sbjct: 305 ISKEAKNLICAFLTDREVRLGRNGVEEI 332

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 91/190 (47%), Gaps = 24/190 (12%)
Query: 506 ELFQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFN-LQYGGAFKSFDIECGMMK 559
           ++F    R++  + IG G +G V       + + VAIK  +  ++    +    E  ++ 
Sbjct: 25  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 84
Query: 560 RIRHRNLIKIISSCSNDDFKALVLEYMP-LGSLEKCLYSGNYILDIFQGLN------IMI 612
           R RH N+I I     ND  +A  +E M  +  ++  + +  Y L   Q L+       + 
Sbjct: 85  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 139
Query: 613 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ--TQT 670
            +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+ + + D   T   T+ 
Sbjct: 140 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 195
Query: 671 LATIGYMAPD 680
           +AT  Y AP+
Sbjct: 196 VATRWYRAPE 205

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 91/190 (47%), Gaps = 24/190 (12%)
Query: 506 ELFQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFN-LQYGGAFKSFDIECGMMK 559
           ++F    R++  + IG G +G V       + + VAIK  +  ++    +    E  ++ 
Sbjct: 17  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 76
Query: 560 RIRHRNLIKIISSCSNDDFKALVLEYMP-LGSLEKCLYSGNYILDIFQGLN------IMI 612
           R RH N+I I     ND  +A  +E M  +  ++  + +  Y L   Q L+       + 
Sbjct: 77  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 131
Query: 613 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ--TQT 670
            +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+ + + D   T   T+ 
Sbjct: 132 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 187
Query: 671 LATIGYMAPD 680
           +AT  Y AP+
Sbjct: 188 VATRWYRAPE 197

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 74/177 (41%), Gaps = 20/177 (11%)
Query: 520 IGRGGFGPVYK--------DGMEVAIKVFN---LQYGGAFKSFDIECGMMKRIRHRNLIK 568
           +G G FG V +          + VA+K      L    A   F  E   M  + HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCL--YSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
           +         K +V E  PLGSL   L  + G+++L         + VA  + YL    S
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLS--RYAVQVAEGMGYLE---S 129
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE-EDQSLTQTQTLATIGYMAPDEI 682
              IH DL   N+LL    +  + DFG+ + L + +D  + Q        + AP+ +
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESL 186

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/192 (26%), Positives = 90/192 (46%), Gaps = 34/192 (17%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGG---AFKSFDIECGMM 558
           +++   R+   + IG G +G V      K G+ VA+K  +  +     A +++  E  ++
Sbjct: 22  IWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 80
Query: 559 KRIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGL 608
           K ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q L
Sbjct: 81  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 140
Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
                    L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T
Sbjct: 141 R-------GLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MT 185
Query: 669 QTLATIGYMAPD 680
             +AT  Y AP+
Sbjct: 186 GYVATRWYRAPE 197

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 85/180 (47%), Gaps = 19/180 (10%)
Query: 521 GRGGFGPVYKDGME---VAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISS---CS 574
            RG FG V+K  +    VA+K+F LQ   +++S + E      ++H NL++ I++    S
Sbjct: 24  ARGRFGCVWKAQLMNDFVAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAAEKRGS 82
Query: 575 NDDFK-ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHF--------GY 625
           N + +  L+  +   GSL   L  GN I+   +  ++   ++  L YLH         G+
Sbjct: 83  NLEVELWLITAFHDKGSLTDYL-KGN-IITWNELCHVAETMSRGLSYLHEDVPWCRGEGH 140
Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG 685
              I H D K  NVLL  ++ A L+DFG+A               + T  YMAP E+  G
Sbjct: 141 KPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAP-EVLEG 199

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 74/177 (41%), Gaps = 20/177 (11%)
Query: 520 IGRGGFGPVYK--------DGMEVAIKVFN---LQYGGAFKSFDIECGMMKRIRHRNLIK 568
           +G G FG V +          + VA+K      L    A   F  E   M  + HRNLI+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCL--YSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
           +         K +V E  PLGSL   L  + G+++L         + VA  + YL    S
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLS--RYAVQVAEGMGYLE---S 139
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE-EDQSLTQTQTLATIGYMAPDEI 682
              IH DL   N+LL    +  + DFG+ + L + +D  + Q        + AP+ +
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESL 196

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 84/183 (45%), Gaps = 13/183 (7%)
Query: 512 NRFSENNLIGRGGFGPVYKDGME-----VAIKVFNLQYG--GAFKSFDIECGMMKRIRHR 564
            ++ +   IG G +G V+K         VA+K   L     G   S   E  ++K ++H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 565 NLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFG 624
           N++++     +D    LV E+     L+K   S N  LD     + +  +   L + H  
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH-- 118
Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS 684
            S  ++H DLKP N+L++ N    L+DFG+A+      +    +  + T+ Y  PD +F 
Sbjct: 119 -SRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFG 175
Query: 685 GEM 687
            ++
Sbjct: 176 AKL 178

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 75/165 (45%), Gaps = 23/165 (13%)
Query: 518 NLIGRGGFGPV------YKDG--MEVAIKVFNLQYGG--AFKSFDIECGMMKRIRHRNLI 567
            ++G G FG V       +DG  ++VA+K   L        + F  E   MK   H N+I
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 568 KIISSCSNDDFKAL-----VLEYMPLGSLEK-CLYS----GNYILDIFQGLNIMIDVASA 617
           +++  C     + +     +L +M  G L    LYS    G   + +   L  M+D+A  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 618 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED 662
           +EYL    +   +H DL   N +L D+M   ++DFG++K +   D
Sbjct: 160 MEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD 201

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 87/191 (45%), Gaps = 32/191 (16%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAF--KSFDIECGMMK 559
           +++   R+   + +G G +G V      K G+ VA+K  +  +      K    E  ++K
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 560 RIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGLN 609
            ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q L 
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 143
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
                   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T 
Sbjct: 144 -------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTG 188
Query: 670 TLATIGYMAPD 680
            +AT  Y AP+
Sbjct: 189 YVATRWYRAPE 199

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/187 (24%), Positives = 84/187 (44%), Gaps = 25/187 (13%)
Query: 508 FQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAFKSFDI--ECGMMKR 560
           FQ+  ++     IG G FG        +DG +  IK  N+    + +  +   E  ++  
Sbjct: 20  FQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLAN 79
Query: 561 IRHRNLIKIISSCSNDDFKALVLEYMPLGSLEK-------CLYSGNYILDIFQGLNIMID 613
           ++H N+++   S   +    +V++Y   G L K        L+  + ILD F      + 
Sbjct: 80  MKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWF------VQ 133
Query: 614 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 673
           +  AL+++H      I+H D+K  N+ L  +    L DFG+A+ +L     L +   + T
Sbjct: 134 ICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIAR-VLNSTVELARA-CIGT 188
Query: 674 IGYMAPD 680
             Y++P+
Sbjct: 189 PYYLSPE 195

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 87/199 (43%), Gaps = 18/199 (9%)
Query: 494 PSVADQRRFTYLELFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFN-LQYGGA 547
           P V  +      + F    R+++   IG G +G V     +     VAIK  +  ++   
Sbjct: 25  PGVPGEVEMVKGQPFDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTY 84
Query: 548 FKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQG 607
            +    E  ++ R RH N+I I         +A+   Y+    +E  LY    +L   Q 
Sbjct: 85  CQRTLREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYK---LLKSQQL 141
Query: 608 LN-----IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK-PLLEE 661
            N      +  +   L+Y+H   S  ++H DLKPSN+L++      + DFG+A+    E 
Sbjct: 142 SNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEH 198
Query: 662 DQSLTQTQTLATIGYMAPD 680
           D +   T+ +AT  Y AP+
Sbjct: 199 DHTGFLTEXVATRWYRAPE 217

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 15/157 (9%)
Query: 518 NLIGRGGFGPVYKD---------GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLI 567
            ++G G FG VYK           + VAIK+ N   G  A   F  E  +M  + H +L+
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 568 KIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
           +++  C +   + LV + MP G L + ++     +     LN  + +A  + YL      
Sbjct: 104 RLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ER 159
Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS 664
            ++H DL   NVL+       ++DFG+A+ LLE D+ 
Sbjct: 160 RLVHRDLAARNVLVKSPNHVKITDFGLAR-LLEGDEK 195

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 89/199 (44%), Gaps = 34/199 (17%)
Query: 508 FQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI--------- 553
           F   + +     IG G +G V        G +VAIK           +FD+         
Sbjct: 51  FDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIP-------NAFDVVTNAKRTLR 103
Query: 554 ECGMMKRIRHRNLIKIIS----SCSNDDFKAL--VLEYMPLGSLEKCLYSGNYILDIFQG 607
           E  ++K  +H N+I I      +    +FK++  VL+ M    L + ++S    L +   
Sbjct: 104 ELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQ-PLTLEHV 161
Query: 608 LNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE--DQSL 665
              +  +   L+Y+H   S  +IH DLKPSN+L+++N    + DFGMA+ L     +   
Sbjct: 162 RYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQY 218
Query: 666 TQTQTLATIGYMAPDEIFS 684
             T+ +AT  Y AP+ + S
Sbjct: 219 FMTEYVATRWYRAPELMLS 237

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 66/146 (45%), Gaps = 22/146 (15%)
Query: 511 TNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRI---- 561
           T  F E   IG G FG V+K     DG   AIK       G+      E   ++ +    
Sbjct: 6   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD----EQNALREVYAHA 61
Query: 562 ---RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGL---NIMIDVA 615
              +H ++++  S+ + DD   +  EY   GSL   +     I+  F+     ++++ V 
Sbjct: 62  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 121
Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLL 641
             L Y+H   S+ ++H D+KPSN+ +
Sbjct: 122 RGLRYIH---SMSLVHMDIKPSNIFI 144

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 87/191 (45%), Gaps = 32/191 (16%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAF--KSFDIECGMMK 559
           +++   R+   + +G G +G V      K G+ VA+K  +  +      K    E  ++K
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 560 RIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGLN 609
            ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q L 
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
                   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T 
Sbjct: 137 -------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTG 181
Query: 670 TLATIGYMAPD 680
            +AT  Y AP+
Sbjct: 182 XVATRWYRAPE 192

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 82/185 (44%), Gaps = 34/185 (18%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRNL 566
           F +   IG G +G VYK      G  VA+K   L  +  G   +   E  ++K + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSG-----------NYILDIFQGLNIMIDVA 615
           +K++     ++   LV E++    L+K + +            +Y+  + QGL       
Sbjct: 68  VKLLDVIHTENKLYLVFEHVD-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLA------ 120
Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 675
                  F +S  ++H DLKP N+L++      L+DFG+A+      +  T    + T+ 
Sbjct: 121 -------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLW 171
Query: 676 YMAPD 680
           Y AP+
Sbjct: 172 YRAPE 176

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 92/187 (49%), Gaps = 24/187 (12%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGG---AFKSFDIECGMM 558
           +++   R+   + +G G +G V      K G+++A+K  +  +     A +++  E  ++
Sbjct: 46  IWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYR-ELRLL 104
Query: 559 KRIRHRNLIKIIS----SCSNDDFKALVLEYMPLGS-LEKCLYSGNYILDIFQGLNIMID 613
           K ++H N+I ++     + S ++F  + L    +G+ L   +       D  Q L  +  
Sbjct: 105 KHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL--IYQ 162
Query: 614 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 673
           +   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT
Sbjct: 163 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 214
Query: 674 IGYMAPD 680
             Y AP+
Sbjct: 215 RWYRAPE 221

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 66/146 (45%), Gaps = 22/146 (15%)
Query: 511 TNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRI---- 561
           T  F E   IG G FG V+K     DG   AIK       G+      E   ++ +    
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD----EQNALREVYAHA 63
Query: 562 ---RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGL---NIMIDVA 615
              +H ++++  S+ + DD   +  EY   GSL   +     I+  F+     ++++ V 
Sbjct: 64  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 123
Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLL 641
             L Y+H   S+ ++H D+KPSN+ +
Sbjct: 124 RGLRYIH---SMSLVHMDIKPSNIFI 146

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 66/146 (45%), Gaps = 22/146 (15%)
Query: 511 TNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRI---- 561
           T  F E   IG G FG V+K     DG   AIK       G+      E   ++ +    
Sbjct: 8   TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD----EQNALREVYAHA 63
Query: 562 ---RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGL---NIMIDVA 615
              +H ++++  S+ + DD   +  EY   GSL   +     I+  F+     ++++ V 
Sbjct: 64  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 123
Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLL 641
             L Y+H   S+ ++H D+KPSN+ +
Sbjct: 124 RGLRYIH---SMSLVHMDIKPSNIFI 146

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 74/177 (41%), Gaps = 20/177 (11%)
Query: 520 IGRGGFGPVYK--------DGMEVAIKVFN---LQYGGAFKSFDIECGMMKRIRHRNLIK 568
           +G G FG V +          + VA+K      L    A   F  E   M  + HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCL--YSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
           +         K +V E  PLGSL   L  + G+++L         + VA  + YL    S
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLS--RYAVQVAEGMGYLE---S 129
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE-EDQSLTQTQTLATIGYMAPDEI 682
              IH DL   N+LL    +  + DFG+ + L + +D  + Q        + AP+ +
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 90/192 (46%), Gaps = 34/192 (17%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGG---AFKSFDIECGMM 558
           +++   R+   + +G G +G V      K G+ VA+K  +  +     A +++  E  ++
Sbjct: 22  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 80
Query: 559 KRIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGL 608
           K ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q L
Sbjct: 81  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 140
Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
                    L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T
Sbjct: 141 R-------GLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MT 185
Query: 669 QTLATIGYMAPD 680
             +AT  Y AP+
Sbjct: 186 GYVATRWYRAPE 197

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 74/177 (41%), Gaps = 20/177 (11%)
Query: 520 IGRGGFGPVYK--------DGMEVAIKVFN---LQYGGAFKSFDIECGMMKRIRHRNLIK 568
           +G G FG V +          + VA+K      L    A   F  E   M  + HRNLI+
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCL--YSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
           +         K +V E  PLGSL   L  + G+++L         + VA  + YL    S
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLS--RYAVQVAEGMGYLE---S 133
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE-EDQSLTQTQTLATIGYMAPDEI 682
              IH DL   N+LL    +  + DFG+ + L + +D  + Q        + AP+ +
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 190

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/184 (22%), Positives = 88/184 (47%), Gaps = 17/184 (9%)
Query: 511 TNRFSENNLIGRGGFGPVY-----KDGMEVAIKVF--NLQYGGAFK-SFDIECGMMKRIR 562
           ++R+    ++G GG   V+     +D  +VA+KV   +L    +F   F  E      + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 563 HRNLIKIISSCSNDD----FKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASAL 618
           H  ++ +  +   +        +V+EY+   +L   +++   +    + + ++ D   A 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP-KRAIEVIAD---AC 126
Query: 619 EYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT-LATIGYM 677
           + L+F +   IIH D+KP+N+L+       + DFG+A+ + +   S+ QT   + T  Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYL 186
Query: 678 APDE 681
           +P++
Sbjct: 187 SPEQ 190

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 67/143 (46%), Gaps = 11/143 (7%)
Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISS 572
           IG+G F  V        G EVA+++ +       + +    E  +MK + H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 573 CSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
              +    LV+EY   G +   L +   + +  +       + SA++Y H  +   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-EARAKFRQIVSAVQYCHQKF---IVHR 137
Query: 633 DLKPSNVLLDDNMVAHLSDFGMA 655
           DLK  N+LLD +M   ++DFG +
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS 160

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 74/177 (41%), Gaps = 20/177 (11%)
Query: 520 IGRGGFGPVYK--------DGMEVAIKVFN---LQYGGAFKSFDIECGMMKRIRHRNLIK 568
           +G G FG V +          + VA+K      L    A   F  E   M  + HRNLI+
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCL--YSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
           +         K +V E  PLGSL   L  + G+++L         + VA  + YL    S
Sbjct: 80  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLS--RYAVQVAEGMGYLE---S 133
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE-EDQSLTQTQTLATIGYMAPDEI 682
              IH DL   N+LL    +  + DFG+ + L + +D  + Q        + AP+ +
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 190

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/143 (26%), Positives = 67/143 (46%), Gaps = 11/143 (7%)
Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISS 572
           IG+G F  V        G EVA+++ +       + +    E  +MK + H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 573 CSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
              +    LV+EY   G +   L +   + +  +       + SA++Y H  +   I+H 
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGRMKEK-EARAKFRQIVSAVQYCHQKF---IVHR 137
Query: 633 DLKPSNVLLDDNMVAHLSDFGMA 655
           DLK  N+LLD +M   ++DFG +
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS 160

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/146 (26%), Positives = 66/146 (45%), Gaps = 22/146 (15%)
Query: 511 TNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRI---- 561
           T  F E   IG G FG V+K     DG   AIK       G+      E   ++ +    
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVD----EQNALREVYAHA 65
Query: 562 ---RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGL---NIMIDVA 615
              +H ++++  S+ + DD   +  EY   GSL   +     I+  F+     ++++ V 
Sbjct: 66  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 125
Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLL 641
             L Y+H   S+ ++H D+KPSN+ +
Sbjct: 126 RGLRYIH---SMSLVHMDIKPSNIFI 148

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 103/238 (43%), Gaps = 40/238 (16%)
Query: 479 KYRKGRKSQLK-------DVNMPSVADQRRFTYLELFQATNRFSENNL-----IGRGGFG 526
           KY++  K Q++       + N  +  D  +  Y E ++    F  NNL     +G G FG
Sbjct: 5   KYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWE----FPRNNLQFGKTLGAGAFG 60
Query: 527 PVYKDG----------MEVAIKVF-NLQYGGAFKSFDIECGMMKRI-RHRNLIKIISSCS 574
            V +            ++VA+K+  +  +    ++   E  +M  + +H N++ ++ +C+
Sbjct: 61  KVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120
Query: 575 NDDFKALVLEYMPLGSLEKCLY-SGNYILDIFQG--------LNIMIDVASALEYLHFGY 625
           +     ++ EY   G L   L       LD   G        L+    VA  + +L    
Sbjct: 121 HGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLA--- 177
Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIF 683
           S   IH D+   NVLL +  VA + DFG+A+ ++ +   + +      + +MAP+ IF
Sbjct: 178 SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF 235

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 87/191 (45%), Gaps = 32/191 (16%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAF--KSFDIECGMMK 559
           +++   R+   + +G G +G V      K G+ VA+K  +  +      K    E  ++K
Sbjct: 15  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 74
Query: 560 RIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGLN 609
            ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q   
Sbjct: 75  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--- 131
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
               +   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T 
Sbjct: 132 ----ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTG 179
Query: 670 TLATIGYMAPD 680
            +AT  Y AP+
Sbjct: 180 YVATRWYRAPE 190

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 87/191 (45%), Gaps = 32/191 (16%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAF--KSFDIECGMMK 559
           +++   R+   + +G G +G V      K G+ VA+K  +  +      K    E  ++K
Sbjct: 28  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 87
Query: 560 RIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGLN 609
            ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q   
Sbjct: 88  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--- 144
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
               +   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T 
Sbjct: 145 ----ILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTG 192
Query: 670 TLATIGYMAPD 680
            +AT  Y AP+
Sbjct: 193 YVATRWYRAPE 203

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 91/187 (48%), Gaps = 24/187 (12%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGG---AFKSFDIECGMM 558
           +++   R+   + +G G +G V      K G+ VA+K  +  +     A +++  E  ++
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 75
Query: 559 KRIRHRNLIKIIS----SCSNDDFKALVLEYMPLGS-LEKCLYSGNYILDIFQGLNIMID 613
           K ++H N+I ++     + S ++F  + L    +G+ L   +       D  Q L  +  
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL--IYQ 133
Query: 614 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 673
           +   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDE-----MTGYVAT 185
Query: 674 IGYMAPD 680
             Y AP+
Sbjct: 186 RWYRAPE 192

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/180 (23%), Positives = 82/180 (45%), Gaps = 16/180 (8%)
Query: 511 TNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGA--FKSFDIECGMMKRIRH 563
           T+ +     IG+G F  V +      G E A K+ N +   A   +  + E  + + ++H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHF 623
            N++++  S S + F  LV + +  G L + + +  Y    +   +    +   LE +  
Sbjct: 63  SNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIQQILEAVLH 118
Query: 624 GYSVPIIHCDLKPSNVLLDDN---MVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
            + + ++H DLKP N+LL          L+DFG+A  +  + Q+        T GY++P+
Sbjct: 119 CHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAW--FGFAGTPGYLSPE 176

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 76/167 (45%), Gaps = 12/167 (7%)
Query: 520 IGRGGFGPVYKD----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSC 573
           IG G +G VYK     G   A+K   L+    G   +   E  ++K ++H N++K+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
                  LV E++    L+K L      L+     + ++ + + + Y H      ++H D
Sbjct: 70  HTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LKP N+L++      ++DFG+A+      +    T  + T+ Y APD
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYRAPD 170

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 81/184 (44%), Gaps = 32/184 (17%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRNL 566
           F +   IG G +G VYK      G  VA+K   L  +  G   +   E  ++K + H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 567 IKIISSCSNDDFKALVLEYMPLG---SLEKCLYSG-------NYILDIFQGLNIMIDVAS 616
           +K++     ++   LV E++       ++    +G       +Y+  + QGL        
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLA------- 117
Query: 617 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGY 676
                 F +S  ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y
Sbjct: 118 ------FCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWY 169
Query: 677 MAPD 680
            AP+
Sbjct: 170 RAPE 173

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/184 (25%), Positives = 81/184 (44%), Gaps = 32/184 (17%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRNL 566
           F +   IG G +G VYK      G  VA+K   L  +  G   +   E  ++K + H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 567 IKIISSCSNDDFKALVLEYMPLG---SLEKCLYSG-------NYILDIFQGLNIMIDVAS 616
           +K++     ++   LV E++       ++    +G       +Y+  + QGL        
Sbjct: 68  VKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLA------- 120
Query: 617 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGY 676
                 F +S  ++H DLKP N+L++      L+DFG+A+      +  T    + T+ Y
Sbjct: 121 ------FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYXHEVVTLWY 172
Query: 677 MAPD 680
            AP+
Sbjct: 173 RAPE 176

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 74/177 (41%), Gaps = 20/177 (11%)
Query: 520 IGRGGFGPVYK--------DGMEVAIKVFN---LQYGGAFKSFDIECGMMKRIRHRNLIK 568
           +G G FG V +          + VA+K      L    A   F  E   M  + HRNLI+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCL--YSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
           +         K +V E  PLGSL   L  + G+++L         + VA  + YL    S
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLS--RYAVQVAEGMGYLE---S 139
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE-EDQSLTQTQTLATIGYMAPDEI 682
              IH DL   N+LL    +  + DFG+ + L + +D  + Q        + AP+ +
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 196

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 87/191 (45%), Gaps = 32/191 (16%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAF--KSFDIECGMMK 559
           +++   R+   + +G G +G V      K G+ VA+K  +  +      K    E  ++K
Sbjct: 14  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 73
Query: 560 RIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGLN 609
            ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q L 
Sbjct: 74  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 133
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
                   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T 
Sbjct: 134 -------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTG 178
Query: 670 TLATIGYMAPD 680
            +AT  Y AP+
Sbjct: 179 YVATRWYRAPE 189

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 21/201 (10%)
Query: 518 NLIGRGGFGPVYKD------------GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRN 565
            ++G+GG+G V++              M+V  K   ++          E  +++ ++H  
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCL-YSGNYILDIFQGLNIMIDVASALEYLHFG 624
           ++ +I +        L+LEY+  G L   L   G ++ D       + +++ AL +LH  
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDT--ACFYLAEISMALGHLH-- 138
Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIF- 683
               II+ DLKP N++L+      L+DFG+ K  +  D ++T      TI YMAP+ +  
Sbjct: 139 -QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI-HDGTVTHX-FCGTIEYMAPEILMR 195
Query: 684 SGEMRLKCWVNDSLLISVMIV 704
           SG  R   W +   L+  M+ 
Sbjct: 196 SGHNRAVDWWSLGALMYDMLT 216

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 90/192 (46%), Gaps = 34/192 (17%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGG---AFKSFDIECGMM 558
           +++   R+   + +G G +G V      K G+ VA+K  +  +     A +++  E  ++
Sbjct: 22  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 80
Query: 559 KRIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGL 608
           K ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q L
Sbjct: 81  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 140
Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
                    L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T
Sbjct: 141 R-------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MT 185
Query: 669 QTLATIGYMAPD 680
             +AT  Y AP+
Sbjct: 186 GYVATRWYRAPE 197

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 87/191 (45%), Gaps = 32/191 (16%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAF--KSFDIECGMMK 559
           +++   R+   + +G G +G V      K G+ VA+K  +  +      K    E  ++K
Sbjct: 14  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 73
Query: 560 RIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGLN 609
            ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q   
Sbjct: 74  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--- 130
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
               +   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T 
Sbjct: 131 ----ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTG 178
Query: 670 TLATIGYMAPD 680
            +AT  Y AP+
Sbjct: 179 YVATRWYRAPE 189

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 90/192 (46%), Gaps = 34/192 (17%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGG---AFKSFDIECGMM 558
           +++   R+   + +G G +G V      K G+ VA+K  +  +     A +++  E  ++
Sbjct: 16  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 74
Query: 559 KRIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGL 608
           K ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q L
Sbjct: 75  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 134
Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
                    L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T
Sbjct: 135 R-------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MT 179
Query: 669 QTLATIGYMAPD 680
             +AT  Y AP+
Sbjct: 180 GYVATRWYRAPE 191

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 87/191 (45%), Gaps = 32/191 (16%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAF--KSFDIECGMMK 559
           +++   R+   + +G G +G V      K G+ VA+K  +  +      K    E  ++K
Sbjct: 22  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 560 RIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGLN 609
            ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q L 
Sbjct: 82  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 141
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
                   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T 
Sbjct: 142 -------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTG 186
Query: 670 TLATIGYMAPD 680
            +AT  Y AP+
Sbjct: 187 YVATRWYRAPE 197

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 63/137 (45%), Gaps = 12/137 (8%)
Query: 554 ECGMMKRIRHRNLIKIISSCSNDDFKAL--VLEYMPLGSLEKCLYSGNYILDIFQGLNIM 611
           E  +++R+RH+N+I+++    N++ + +  V+EY   G  E           + Q     
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYF 115
Query: 612 IDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK---PLLEEDQSLTQT 668
             +   LEYLH   S  I+H D+KP N+LL       +S  G+A+   P   +D   T  
Sbjct: 116 CQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172
Query: 669 QTLATIGYMAPDEIFSG 685
            + A      P EI +G
Sbjct: 173 GSPA----FQPPEIANG 185

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 87/191 (45%), Gaps = 32/191 (16%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAF--KSFDIECGMMK 559
           +++   R+   + +G G +G V      K G+ VA+K  +  +      K    E  ++K
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 560 RIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGLN 609
            ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q L 
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 132
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
                   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T 
Sbjct: 133 -------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTG 177
Query: 670 TLATIGYMAPD 680
            +AT  Y AP+
Sbjct: 178 YVATRWYRAPE 188

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 74/177 (41%), Gaps = 20/177 (11%)
Query: 520 IGRGGFGPVYK--------DGMEVAIKVFN---LQYGGAFKSFDIECGMMKRIRHRNLIK 568
           +G G FG V +          + VA+K      L    A   F  E   M  + HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCL--YSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
           +         K +V E  PLGSL   L  + G+++L         + VA  + YL    S
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLS--RYAVQVAEGMGYLE---S 129
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE-EDQSLTQTQTLATIGYMAPDEI 682
              IH DL   N+LL    +  + DFG+ + L + +D  + Q        + AP+ +
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/124 (25%), Positives = 60/124 (48%), Gaps = 6/124 (4%)
Query: 532 GMEVAIKVFNLQYGGAFKS--FDIECGMMKRIRHRNLIKIISSCSND--DFKALVLEYMP 587
           G ++ +KV  ++     KS  F+ EC  ++   H N++ ++ +C +       L+  + P
Sbjct: 33  GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWXP 92
Query: 588 LGSLEKCLYSG-NYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV 646
            GSL   L+ G N+++D  Q +   +D A    +LH    +   H  L   +V +D++  
Sbjct: 93  YGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLHTLEPLIPRHA-LNSRSVXIDEDXT 151
Query: 647 AHLS 650
           A +S
Sbjct: 152 ARIS 155

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/191 (23%), Positives = 85/191 (44%), Gaps = 20/191 (10%)
Query: 504 YLELFQATNRFSEN----NLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGA--FKSFD 552
           Y +      RF+++      +G+G F  V +        E A K+ N +   A   +  +
Sbjct: 19  YFQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLE 78
Query: 553 IECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMI 612
            E  + + ++H N++++  S S + F  LV + +  G L + + +  Y    +   +   
Sbjct: 79  REARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASH 134
Query: 613 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDN---MVAHLSDFGMAKPLLEEDQSLTQTQ 669
            +   LE ++  +   I+H DLKP N+LL          L+DFG+A  +  E Q+     
Sbjct: 135 CIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAW--FG 192
Query: 670 TLATIGYMAPD 680
              T GY++P+
Sbjct: 193 FAGTPGYLSPE 203

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 87/191 (45%), Gaps = 32/191 (16%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAF--KSFDIECGMMK 559
           +++   R+   + +G G +G V      K G+ VA+K  +  +      K    E  ++K
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 560 RIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGLN 609
            ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q L 
Sbjct: 79  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 138
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
                   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T 
Sbjct: 139 -------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTG 183
Query: 670 TLATIGYMAPD 680
            +AT  Y AP+
Sbjct: 184 YVATRWYRAPE 194

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 87/191 (45%), Gaps = 32/191 (16%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAF--KSFDIECGMMK 559
           +++   R+   + +G G +G V      K G+ VA+K  +  +      K    E  ++K
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 560 RIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGLN 609
            ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q   
Sbjct: 79  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--- 135
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
               +   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T 
Sbjct: 136 ----ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTG 183
Query: 670 TLATIGYMAPD 680
            +AT  Y AP+
Sbjct: 184 YVATRWYRAPE 194

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 87/191 (45%), Gaps = 32/191 (16%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAF--KSFDIECGMMK 559
           +++   R+   + +G G +G V      K G+ VA+K  +  +      K    E  ++K
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 560 RIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGLN 609
            ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q L 
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
                   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T 
Sbjct: 137 -------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTG 181
Query: 670 TLATIGYMAPD 680
            +AT  Y AP+
Sbjct: 182 YVATRWYRAPE 192

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 87/191 (45%), Gaps = 32/191 (16%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAF--KSFDIECGMMK 559
           +++   R+   + +G G +G V      K G+ VA+K  +  +      K    E  ++K
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 560 RIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGLN 609
            ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q L 
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
                   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T 
Sbjct: 137 -------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTG 181
Query: 670 TLATIGYMAPD 680
            +AT  Y AP+
Sbjct: 182 YVATRWYRAPE 192

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 87/191 (45%), Gaps = 32/191 (16%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAF--KSFDIECGMMK 559
           +++   R+   + +G G +G V      K G+ VA+K  +  +      K    E  ++K
Sbjct: 36  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 95
Query: 560 RIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGLN 609
            ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q   
Sbjct: 96  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--- 152
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
               +   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T 
Sbjct: 153 ----ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTG 200
Query: 670 TLATIGYMAPD 680
            +AT  Y AP+
Sbjct: 201 YVATRWYRAPE 211

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 31/209 (14%)
Query: 494 PSVADQRRFTYLELFQATNRFSENNLIGRGGFGPV-------YKDGMEVAIKVFNLQYGG 546
           P++ ++R   Y+            + +G+G FG V         D     + V  LQ+ G
Sbjct: 1   PTIFEERHLKYI------------SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG 48
Query: 547 A--FKSFDIECGMMKRIRHRNLIKI--ISSCSNDDFKALVLEYMPLGSLEKCLYSGNYIL 602
               + F  E  ++K +    ++K   +S         LV+EY+P G L   L      L
Sbjct: 49  PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARL 108
Query: 603 DIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEE 661
           D  + L     +   +EYL    S   +H DL   N+L++      ++DFG+AK L L++
Sbjct: 109 DASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 165
Query: 662 DQSLTQTQTLATIGYMAP----DEIFSGE 686
           D  + +    + I + AP    D IFS +
Sbjct: 166 DXXVVREPGQSPIFWYAPESLSDNIFSRQ 194

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 76/167 (45%), Gaps = 12/167 (7%)
Query: 520 IGRGGFGPVYKD----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSC 573
           IG G +G VYK     G   A+K   L+    G   +   E  ++K ++H N++K+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
                  LV E++    L+K L      L+     + ++ + + + Y H      ++H D
Sbjct: 70  HTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LKP N+L++      ++DFG+A+      +    T  + T+ Y APD
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYRAPD 170

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/190 (26%), Positives = 95/190 (50%), Gaps = 16/190 (8%)
Query: 476 LILKYRKGRKSQLKDVNMPSVADQRRFTYLELFQATNRFS---ENNLIGRGGFGPV---- 528
           L+  Y+KG     + +++P ++ + +  + +      R S   E  L G G FG V    
Sbjct: 144 LVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKL-GAGQFGEVWMAT 202
Query: 529 YKDGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMP 587
           Y    +VA+K   ++ G  + ++F  E  +MK ++H  L+K+ +  + +    ++ E+M 
Sbjct: 203 YNKHTKVAVKT--MKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMA 259
Query: 588 LGSLEKCLYSGNYILDIFQGLNIMIDVASAL-EYLHFGYSVPIIHCDLKPSNVLLDDNMV 646
            GSL   L S        Q L  +ID ++ + E + F      IH DL+ +N+L+  ++V
Sbjct: 260 KGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV 316
Query: 647 AHLSDFGMAK 656
             ++DFG+A+
Sbjct: 317 CKIADFGLAR 326

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 86/177 (48%), Gaps = 13/177 (7%)
Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI-ECGMMKRIRHRN 565
           + F + + +G G  G V+K      G+ +A K+ +L+   A ++  I E  ++       
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY 625
           ++    +  +D   ++ +E+M  GSL++ L     I +   G  + I V   L YL   +
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKGLTYLREKH 127
Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              I+H D+KPSN+L++      L DFG++  L++E       + + T  YM+P+ +
Sbjct: 128 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDE----MANEFVGTRSYMSPERL 178

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/196 (20%), Positives = 85/196 (43%), Gaps = 23/196 (11%)
Query: 510 ATNRFSENNLIGRGGFGPVY--------KDGMEVAIKVFNLQYGGAFKS---FDIECGMM 558
           A  + + +  +G+G FG VY        KD  E  + +  +    + +    F  E  +M
Sbjct: 8   AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 67
Query: 559 KRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYS------GNYIL---DIFQGLN 609
           K     ++++++   S      +++E M  G L+  L S       N +L    + + + 
Sbjct: 68  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 127
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
           +  ++A  + YL+   +   +H DL   N ++ ++    + DFGM + + E D      +
Sbjct: 128 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGK 184
Query: 670 TLATIGYMAPDEIFSG 685
            L  + +M+P+ +  G
Sbjct: 185 GLLPVRWMSPESLKDG 200

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 84/181 (46%), Gaps = 24/181 (13%)
Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGG---AFKSFDI-ECGMMKRIRHRNLIKII 570
           IG G +G   K     DG  +  K   L YG    A K   + E  +++ ++H N+++  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWK--ELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 571 SSCSNDDFKAL--VLEYMPLGSLEKCLYSG---NYILDIFQGLNIMIDVASALEYLHF-- 623
               +     L  V+EY   G L   +  G      LD    L +M  +  AL+  H   
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 624 --GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
             G++V  +H DLKP+NV LD      L DFG+A+ +L  D+   + + + T  YM+P++
Sbjct: 132 DGGHTV--LHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDEDFAK-EFVGTPYYMSPEQ 187
Query: 682 I 682
           +
Sbjct: 188 M 188

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 90/192 (46%), Gaps = 34/192 (17%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGG---AFKSFDIECGMM 558
           +++   R+   + +G G +G V      K G+ VA+K  +  +     A +++  E  ++
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 75
Query: 559 KRIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGL 608
           K ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q L
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
                    L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T
Sbjct: 136 R-------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MT 180
Query: 669 QTLATIGYMAPD 680
             +AT  Y AP+
Sbjct: 181 GYVATRWYRAPE 192

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 90/192 (46%), Gaps = 34/192 (17%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGG---AFKSFDIECGMM 558
           +++   R+   + +G G +G V      K G+ VA+K  +  +     A +++  E  ++
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 75
Query: 559 KRIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGL 608
           K ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q L
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
                    L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T
Sbjct: 136 R-------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MT 180
Query: 669 QTLATIGYMAPD 680
             +AT  Y AP+
Sbjct: 181 GYVATRWYRAPE 192

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 87/191 (45%), Gaps = 32/191 (16%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAF--KSFDIECGMMK 559
           +++   R+   + +G G +G V      K G+ VA+K  +  +      K    E  ++K
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 560 RIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGLN 609
            ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q L 
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
                   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T 
Sbjct: 137 -------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTG 181
Query: 670 TLATIGYMAPD 680
            +AT  Y AP+
Sbjct: 182 YVATRWYRAPE 192

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 87/191 (45%), Gaps = 32/191 (16%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAF--KSFDIECGMMK 559
           +++   R+   + +G G +G V      K G+ VA+K  +  +      K    E  ++K
Sbjct: 29  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 88
Query: 560 RIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGLN 609
            ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q   
Sbjct: 89  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--- 145
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
               +   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T 
Sbjct: 146 ----ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTG 193
Query: 670 TLATIGYMAPD 680
            +AT  Y AP+
Sbjct: 194 YVATRWYRAPE 204

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 87/191 (45%), Gaps = 32/191 (16%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAF--KSFDIECGMMK 559
           +++   R+   + +G G +G V      K G+ VA+K  +  +      K    E  ++K
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 560 RIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGLN 609
            ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q   
Sbjct: 79  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--- 135
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
               +   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T 
Sbjct: 136 ----ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTG 183
Query: 670 TLATIGYMAPD 680
            +AT  Y AP+
Sbjct: 184 YVATRWYRAPE 194

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 87/191 (45%), Gaps = 32/191 (16%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAF--KSFDIECGMMK 559
           +++   R+   + +G G +G V      K G+ VA+K  +  +      K    E  ++K
Sbjct: 37  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 96
Query: 560 RIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGLN 609
            ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q   
Sbjct: 97  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--- 153
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
               +   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T 
Sbjct: 154 ----ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTG 201
Query: 670 TLATIGYMAPD 680
            +AT  Y AP+
Sbjct: 202 YVATRWYRAPE 212

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 87/191 (45%), Gaps = 32/191 (16%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAF--KSFDIECGMMK 559
           +++   R+   + +G G +G V      K G+ VA+K  +  +      K    E  ++K
Sbjct: 40  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 99
Query: 560 RIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGLN 609
            ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q   
Sbjct: 100 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--- 156
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
               +   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T 
Sbjct: 157 ----ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTG 204
Query: 670 TLATIGYMAPD 680
            +AT  Y AP+
Sbjct: 205 YVATRWYRAPE 215

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 87/191 (45%), Gaps = 32/191 (16%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAF--KSFDIECGMMK 559
           +++   R+   + +G G +G V      K G+ VA+K  +  +      K    E  ++K
Sbjct: 29  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 88
Query: 560 RIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGLN 609
            ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q   
Sbjct: 89  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--- 145
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
               +   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T 
Sbjct: 146 ----ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTG 193
Query: 670 TLATIGYMAPD 680
            +AT  Y AP+
Sbjct: 194 YVATRWYRAPE 204

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 90/192 (46%), Gaps = 34/192 (17%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGG---AFKSFDIECGMM 558
           +++   R+   + +G G +G V      K G+ VA+K  +  +     A +++  E  ++
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 77
Query: 559 KRIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGL 608
           K ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q L
Sbjct: 78  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 137
Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
                    L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T
Sbjct: 138 R-------GLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----MT 182
Query: 669 QTLATIGYMAPD 680
             +AT  Y AP+
Sbjct: 183 GYVATRWYRAPE 194

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 90/192 (46%), Gaps = 34/192 (17%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGG---AFKSFDIECGMM 558
           +++   R+   + +G G +G V      K G+ VA+K  +  +     A +++  E  ++
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 82
Query: 559 KRIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGL 608
           K ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q L
Sbjct: 83  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 142
Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
                    L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T
Sbjct: 143 R-------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MT 187
Query: 669 QTLATIGYMAPD 680
             +AT  Y AP+
Sbjct: 188 GYVATRWYRAPE 199

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 76/167 (45%), Gaps = 12/167 (7%)
Query: 520 IGRGGFGPVYKD----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSC 573
           IG G +G VYK     G   A+K   L+    G   +   E  ++K ++H N++K+    
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
                  LV E++    L+K L      L+     + ++ + + + Y H      ++H D
Sbjct: 70  HTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LKP N+L++      ++DFG+A+      +    T  + T+ Y APD
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKY--THEVVTLWYRAPD 170

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 87/191 (45%), Gaps = 32/191 (16%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAF--KSFDIECGMMK 559
           +++   R+   + +G G +G V      K G+ VA+K  +  +      K    E  ++K
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 560 RIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGLN 609
            ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q L 
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
                   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T 
Sbjct: 137 -------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTG 181
Query: 670 TLATIGYMAPD 680
            +AT  Y AP+
Sbjct: 182 YVATRWYRAPE 192

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 15/157 (9%)
Query: 518 NLIGRGGFGPVYKD---------GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLI 567
            ++G G FG VYK           + VAIK+ N   G  A   F  E  +M  + H +L+
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 568 KIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
           +++  C +   + LV + MP G L + ++     +     LN  + +A  + YL      
Sbjct: 81  RLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ER 136
Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS 664
            ++H DL   NVL+       ++DFG+A+ LLE D+ 
Sbjct: 137 RLVHRDLAARNVLVKSPNHVKITDFGLAR-LLEGDEK 172

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 87/191 (45%), Gaps = 32/191 (16%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAF--KSFDIECGMMK 559
           +++   R+   + +G G +G V      K G+ VA+K  +  +      K    E  ++K
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 560 RIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGLN 609
            ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q L 
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
                   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T 
Sbjct: 137 -------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTG 181
Query: 670 TLATIGYMAPD 680
            +AT  Y AP+
Sbjct: 182 YVATRWYRAPE 192

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 90/192 (46%), Gaps = 34/192 (17%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGG---AFKSFDIECGMM 558
           +++   R+   + +G G +G V      K G+ VA+K  +  +     A +++  E  ++
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 81
Query: 559 KRIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGL 608
           K ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q L
Sbjct: 82  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 141
Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
                    L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T
Sbjct: 142 R-------GLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDE-----MT 186
Query: 669 QTLATIGYMAPD 680
             +AT  Y AP+
Sbjct: 187 GYVATRWYRAPE 198

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 90/192 (46%), Gaps = 34/192 (17%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGG---AFKSFDIECGMM 558
           +++   R+   + +G G +G V      K G+ VA+K  +  +     A +++  E  ++
Sbjct: 28  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 86
Query: 559 KRIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGL 608
           K ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q  
Sbjct: 87  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ-- 144
Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
                +   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T
Sbjct: 145 -----ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MT 191
Query: 669 QTLATIGYMAPD 680
             +AT  Y AP+
Sbjct: 192 GYVATRWYRAPE 203

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 32/217 (14%)
Query: 493 MPSVADQRRFTYLELFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIK-VFNLQYGG 546
           MP   +  R+   E  +    F   +++G G F  V      +    VAIK +      G
Sbjct: 1   MPGAVEGPRWKQAEDIRDIYDF--RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG 58
Query: 547 AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSL-----EKCLYSGNYI 601
              S + E  ++ +I+H N++ +     +     L+++ +  G L     EK  Y+    
Sbjct: 59  KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER-- 116
Query: 602 LDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVL---LDDNMVAHLSDFGMAKPL 658
                   ++  V  A++YLH    + I+H DLKP N+L   LD++    +SDFG++K  
Sbjct: 117 ----DASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-- 167
Query: 659 LEEDQSLTQTQTLATIGYMAPDEIFSGE---MRLKCW 692
           +E+  S+  T    T GY+AP E+ + +     + CW
Sbjct: 168 MEDPGSVLST-ACGTPGYVAP-EVLAQKPYSKAVDCW 202

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 40/196 (20%), Positives = 85/196 (43%), Gaps = 23/196 (11%)
Query: 510 ATNRFSENNLIGRGGFGPVY--------KDGMEVAIKVFNLQYGGAFKS---FDIECGMM 558
           A  + + +  +G+G FG VY        KD  E  + +  +    + +    F  E  +M
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 559 KRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYS------GNYIL---DIFQGLN 609
           K     ++++++   S      +++E M  G L+  L S       N +L    + + + 
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
           +  ++A  + YL+   +   +H DL   N ++ ++    + DFGM + + E D      +
Sbjct: 137 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGK 193
Query: 670 TLATIGYMAPDEIFSG 685
            L  + +M+P+ +  G
Sbjct: 194 GLLPVRWMSPESLKDG 209

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 91/187 (48%), Gaps = 24/187 (12%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGG---AFKSFDIECGMM 558
           +++   R+   + +G G +G V      K G+ VA+K  +  +     A +++  E  ++
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 75
Query: 559 KRIRHRNLIKIIS----SCSNDDFKALVLEYMPLGS-LEKCLYSGNYILDIFQGLNIMID 613
           K ++H N+I ++     + S ++F  + L    +G+ L   + S     D  Q L  +  
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFL--IYQ 133
Query: 614 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 673
           +   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+ +   +E      T  +AT
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDE-----MTGYVAT 185
Query: 674 IGYMAPD 680
             Y AP+
Sbjct: 186 RWYRAPE 192

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 91/187 (48%), Gaps = 24/187 (12%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGG---AFKSFDIECGMM 558
           +++   R+   + +G G +G V      K G+ VA+K  +  +     A +++  E  ++
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 75
Query: 559 KRIRHRNLIKIIS----SCSNDDFKALVLEYMPLGS-LEKCLYSGNYILDIFQGLNIMID 613
           K ++H N+I ++     + S ++F  + L    +G+ L   +       D  Q L  +  
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFL--IYQ 133
Query: 614 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 673
           +   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 185
Query: 674 IGYMAPD 680
             Y AP+
Sbjct: 186 RWYRAPE 192

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 31/209 (14%)
Query: 494 PSVADQRRFTYLELFQATNRFSENNLIGRGGFGPVY-------KDGMEVAIKVFNLQYGG 546
           P++ ++R   Y+            + +G+G FG V         D     + V  LQ+ G
Sbjct: 4   PTIFEERHLKYI------------SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG 51
Query: 547 --AFKSFDIECGMMKRIRHRNLIKI--ISSCSNDDFKALVLEYMPLGSLEKCLYSGNYIL 602
               + F  E  ++K +    ++K   +S         LV+EY+P G L   L      L
Sbjct: 52  PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARL 111
Query: 603 DIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEE 661
           D  + L     +   +EYL    S   +H DL   N+L++      ++DFG+AK L L++
Sbjct: 112 DASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 168
Query: 662 DQSLTQTQTLATIGYMAP----DEIFSGE 686
           D  + +    + I + AP    D IFS +
Sbjct: 169 DYYVVREPGQSPIFWYAPESLSDNIFSRQ 197

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 86/197 (43%), Gaps = 29/197 (14%)
Query: 513 RFSENNL-----IGRGGFGPVYKDG----------MEVAIKVF-NLQYGGAFKSFDIECG 556
            F  NNL     +G G FG V +            ++VA+K+  +  +    ++   E  
Sbjct: 34  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 93
Query: 557 MMKRI-RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLY-SGNYILDIFQG------- 607
           +M  + +H N++ ++ +C++     ++ EY   G L   L       LD   G       
Sbjct: 94  IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRD 153
Query: 608 -LNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT 666
            L+    VA  + +L    S   IH D+   NVLL +  VA + DFG+A+ ++ +   + 
Sbjct: 154 LLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 210
Query: 667 QTQTLATIGYMAPDEIF 683
           +      + +MAP+ IF
Sbjct: 211 KGNARLPVKWMAPESIF 227

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 87/191 (45%), Gaps = 32/191 (16%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAF--KSFDIECGMMK 559
           +++   R+   + +G G +G V      K G+ VA+K  +  +      K    E  ++K
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 82
Query: 560 RIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGLN 609
            ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q   
Sbjct: 83  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--- 139
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
               +   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T 
Sbjct: 140 ----ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTG 187
Query: 670 TLATIGYMAPD 680
            +AT  Y AP+
Sbjct: 188 YVATRWYRAPE 198

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 85/182 (46%), Gaps = 26/182 (14%)
Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGG---AFKSFDI-ECGMMKRIRHRNLIKII 570
           IG G +G   K     DG  +  K   L YG    A K   + E  +++ ++H N+++  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWK--ELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 571 SSCSNDDFKAL--VLEYMPLGSLEKCLYSG----NYILDIFQGLNIMIDVASALEYLHF- 623
               +     L  V+EY   G L   +  G     Y+ + F  L +M  +  AL+  H  
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFV-LRVMTQLTLALKECHRR 130
Query: 624 ---GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
              G++V  +H DLKP+NV LD      L DFG+A+ +L  D S  +   + T  YM+P+
Sbjct: 131 SDGGHTV--LHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKA-FVGTPYYMSPE 186
Query: 681 EI 682
           ++
Sbjct: 187 QM 188

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 90/192 (46%), Gaps = 34/192 (17%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGG---AFKSFDIECGMM 558
           +++   R+   + +G G +G V      K G+ VA+K  +  +     A +++  E  ++
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 81
Query: 559 KRIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGL 608
           K ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q L
Sbjct: 82  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 141
Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
                    L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T
Sbjct: 142 R-------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MT 186
Query: 669 QTLATIGYMAPD 680
             +AT  Y AP+
Sbjct: 187 GYVATRWYRAPE 198

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 90/192 (46%), Gaps = 34/192 (17%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGG---AFKSFDIECGMM 558
           +++   R+   + +G G +G V      K G+ VA+K  +  +     A +++  E  ++
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 75
Query: 559 KRIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGL 608
           K ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q L
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
                    L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T
Sbjct: 136 R-------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MT 180
Query: 669 QTLATIGYMAPD 680
             +AT  Y AP+
Sbjct: 181 GYVATRWYRAPE 192

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 90/192 (46%), Gaps = 34/192 (17%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGG---AFKSFDIECGMM 558
           +++   R+   + +G G +G V      K G+ VA+K  +  +     A +++  E  ++
Sbjct: 29  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYR-ELRLL 87
Query: 559 KRIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGL 608
           K ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q  
Sbjct: 88  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ-- 145
Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
                +   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T
Sbjct: 146 -----ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MT 192
Query: 669 QTLATIGYMAPD 680
             +AT  Y AP+
Sbjct: 193 GYVATRWYRAPE 204

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 50.1 bits (118), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/167 (25%), Positives = 81/167 (48%), Gaps = 12/167 (7%)
Query: 520 IGRGGFGPVYKDGME-----VAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSC 573
           +G G +  VYK   +     VA+K   L++  GA  +   E  ++K ++H N++ +    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
             +    LV EY+    L++ L     I+++    N+ + +   L  L + +   ++H D
Sbjct: 70  HTEKSLTLVFEYLD-KDLKQYLDDCGNIINMH---NVKLFLFQLLRGLAYCHRQKVLHRD 125
Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LKP N+L+++     L+DFG+A+   +   + T    + T+ Y  PD
Sbjct: 126 LKPQNLLINERGELKLADFGLARA--KSIPTKTYDNEVVTLWYRPPD 170

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 89/209 (42%), Gaps = 31/209 (14%)
Query: 494 PSVADQRRFTYLELFQATNRFSENNLIGRGGFGPVY-------KDGMEVAIKVFNLQYGG 546
           P++ ++R   Y+            + +G+G FG V         D     + V  LQ+ G
Sbjct: 5   PTIFEERHLKYI------------SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG 52
Query: 547 --AFKSFDIECGMMKRIRHRNLIKI--ISSCSNDDFKALVLEYMPLGSLEKCLYSGNYIL 602
               + F  E  ++K +    ++K   +S         LV+EY+P G L   L      L
Sbjct: 53  PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARL 112
Query: 603 DIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEE 661
           D  + L     +   +EYL    S   +H DL   N+L++      ++DFG+AK L L++
Sbjct: 113 DASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 169
Query: 662 DQSLTQTQTLATIGYMAP----DEIFSGE 686
           D  + +    + I + AP    D IFS +
Sbjct: 170 DYYVVREPGQSPIFWYAPESLSDNIFSRQ 198

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 67/143 (46%), Gaps = 11/143 (7%)
Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISS 572
           IG+G F  V        G EVAIK+ +       + +    E  +MK + H N++K+   
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 573 CSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
              +    L++EY   G +   L +   + +  +  +    + SA++Y H      I+H 
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEK-EARSKFRQIVSAVQYCH---QKRIVHR 135
Query: 633 DLKPSNVLLDDNMVAHLSDFGMA 655
           DLK  N+LLD +M   ++DFG +
Sbjct: 136 DLKAENLLLDADMNIKIADFGFS 158

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 68/161 (42%), Gaps = 22/161 (13%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRH----- 563
           F E  ++G+G FG V K     D    AIK           +   E  ++  + H     
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 564 --------RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVA 615
                   RN +K +++        + +EY   G+L   ++S N      +   +   + 
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK 656
            AL Y+H   S  IIH DLKP N+ +D++    + DFG+AK
Sbjct: 127 EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 49.7 bits (117), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 83/176 (47%), Gaps = 15/176 (8%)
Query: 514 FSENNLIGRGGFGPVYKDGME------VAIKVFNLQYGGAFKSF-DIECGMMKRIRHRNL 566
           F++ + IG+G FG VYK G++      VAIK+ +L+           E  ++ +     +
Sbjct: 21  FTKLDRIGKGSFGEVYK-GIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYI 79
Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
            +   S        +++EY+  GS    L  G   L+      I+ ++   L+YLH   S
Sbjct: 80  TRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGP--LEETYIATILREILKGLDYLH---S 134
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              IH D+K +NVLL +     L+DFG+A  L   D  + +   + T  +MAP+ I
Sbjct: 135 ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT--DTQIKRNXFVGTPFWMAPEVI 188

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 39/143 (27%), Positives = 67/143 (46%), Gaps = 11/143 (7%)
Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISS 572
           IG+G F  V        G EVAIK+ +       + +    E  +MK + H N++K+   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 573 CSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
              +    L++EY   G +   L +   + +  +  +    + SA++Y H      I+H 
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEK-EARSKFRQIVSAVQYCH---QKRIVHR 138
Query: 633 DLKPSNVLLDDNMVAHLSDFGMA 655
           DLK  N+LLD +M   ++DFG +
Sbjct: 139 DLKAENLLLDADMNIKIADFGFS 161

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/187 (25%), Positives = 90/187 (48%), Gaps = 24/187 (12%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGG---AFKSFDIECGMM 558
           +++   R+   + +G G +G V      K G  VA+K  +  +     A +++  E  ++
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLL 71
Query: 559 KRIRHRNLIKIIS----SCSNDDFKALVLEYMPLGS-LEKCLYSGNYILDIFQGLNIMID 613
           K ++H N+I ++     + S ++F  + L    +G+ L   +       D  Q L  +  
Sbjct: 72  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFL--IYQ 129
Query: 614 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 673
           +   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T  +AT
Sbjct: 130 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVAT 181
Query: 674 IGYMAPD 680
             Y AP+
Sbjct: 182 RWYRAPE 188

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 90/190 (47%), Gaps = 24/190 (12%)
Query: 506 ELFQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFN-LQYGGAFKSFDIECGMMK 559
           ++F    R++  + IG G +G V       + + VAIK  +  ++    +    E  ++ 
Sbjct: 21  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 80
Query: 560 RIRHRNLIKIISSCSNDDFKALVLEYMP-LGSLEKCLYSGNYILDIFQGLN------IMI 612
           R RH N+I I     ND  +A  +E M  +  ++  + +  Y L   Q L+       + 
Sbjct: 81  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 135
Query: 613 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ--TQT 670
            +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+ + + D   T    + 
Sbjct: 136 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLXEX 191
Query: 671 LATIGYMAPD 680
           +AT  Y AP+
Sbjct: 192 VATRWYRAPE 201

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 90/190 (47%), Gaps = 24/190 (12%)
Query: 506 ELFQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFN-LQYGGAFKSFDIECGMMK 559
           ++F    R++  + IG G +G V       + + VAIK  +  ++    +    E  ++ 
Sbjct: 22  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILL 81
Query: 560 RIRHRNLIKIISSCSNDDFKALVLEYMP-LGSLEKCLYSGNYILDIFQGLN------IMI 612
           R RH N+I I     ND  +A  +E M  +  ++  + +  Y L   Q L+       + 
Sbjct: 82  RFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 136
Query: 613 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ--TQT 670
            +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+ + + D   T    + 
Sbjct: 137 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLXEX 192
Query: 671 LATIGYMAPD 680
           +AT  Y AP+
Sbjct: 193 VATRWYRAPE 202

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 41/175 (23%), Positives = 77/175 (44%), Gaps = 14/175 (8%)
Query: 517 NNLIGRGGFGPVYK------DGMEVAIKVFNLQYGGAF---KSFDIECGMMKRIRHRNLI 567
           N ++G G FG VY+       G ++ + V   +        + F  E  +MK + H +++
Sbjct: 29  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 88
Query: 568 KIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
           K+I     +    +++E  P G L   L      L +   +   + +  A+ YL    S+
Sbjct: 89  KLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SI 144
Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
             +H D+   N+L+       L DFG+++ + +ED        L  I +M+P+ I
Sbjct: 145 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSPESI 198

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 87/199 (43%), Gaps = 47/199 (23%)
Query: 512 NRFSENNLIGRGGFGPVYKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHR------- 564
           N FS + +IGRGGFG VY             +     K + ++C   KRI+ +       
Sbjct: 189 NDFSVHRIIGRGGFGEVY-----------GCRKADTGKMYAMKCLDKKRIKMKQGETLAL 237
Query: 565 NLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVAS-------- 616
           N   ++S  S  D   +V       + +K     ++ILD+  G ++   ++         
Sbjct: 238 NERIMLSLVSTGDCPFIVCMSYAFHTPDKL----SFILDLMNGGDLHYHLSQHGVFSEAD 293
Query: 617 ----------ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT 666
                      LE++H  +   +++ DLKP+N+LLD++    +SD G+A    ++     
Sbjct: 294 MRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA- 349
Query: 667 QTQTLATIGYMAPDEIFSG 685
              ++ T GYMAP+ +  G
Sbjct: 350 ---SVGTHGYMAPEVLQKG 365

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 87/199 (43%), Gaps = 47/199 (23%)
Query: 512 NRFSENNLIGRGGFGPVYKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHR------- 564
           N FS + +IGRGGFG VY             +     K + ++C   KRI+ +       
Sbjct: 189 NDFSVHRIIGRGGFGEVY-----------GCRKADTGKMYAMKCLDKKRIKMKQGETLAL 237
Query: 565 NLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVAS-------- 616
           N   ++S  S  D   +V       + +K     ++ILD+  G ++   ++         
Sbjct: 238 NERIMLSLVSTGDCPFIVCMSYAFHTPDKL----SFILDLMNGGDLHYHLSQHGVFSEAD 293
Query: 617 ----------ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT 666
                      LE++H  +   +++ DLKP+N+LLD++    +SD G+A    ++     
Sbjct: 294 MRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA- 349
Query: 667 QTQTLATIGYMAPDEIFSG 685
              ++ T GYMAP+ +  G
Sbjct: 350 ---SVGTHGYMAPEVLQKG 365

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 87/199 (43%), Gaps = 47/199 (23%)
Query: 512 NRFSENNLIGRGGFGPVYKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHR------- 564
           N FS + +IGRGGFG VY             +     K + ++C   KRI+ +       
Sbjct: 188 NDFSVHRIIGRGGFGEVY-----------GCRKADTGKMYAMKCLDKKRIKMKQGETLAL 236
Query: 565 NLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVAS-------- 616
           N   ++S  S  D   +V       + +K     ++ILD+  G ++   ++         
Sbjct: 237 NERIMLSLVSTGDCPFIVCMSYAFHTPDKL----SFILDLMNGGDLHYHLSQHGVFSEAD 292
Query: 617 ----------ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT 666
                      LE++H  +   +++ DLKP+N+LLD++    +SD G+A    ++     
Sbjct: 293 MRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA- 348
Query: 667 QTQTLATIGYMAPDEIFSG 685
              ++ T GYMAP+ +  G
Sbjct: 349 ---SVGTHGYMAPEVLQKG 364

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 49.3 bits (116), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 87/199 (43%), Gaps = 47/199 (23%)
Query: 512 NRFSENNLIGRGGFGPVYKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHR------- 564
           N FS + +IGRGGFG VY             +     K + ++C   KRI+ +       
Sbjct: 189 NDFSVHRIIGRGGFGEVY-----------GCRKADTGKMYAMKCLDKKRIKMKQGETLAL 237
Query: 565 NLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVAS-------- 616
           N   ++S  S  D   +V       + +K     ++ILD+  G ++   ++         
Sbjct: 238 NERIMLSLVSTGDCPFIVCMSYAFHTPDKL----SFILDLMNGGDLHYHLSQHGVFSEAD 293
Query: 617 ----------ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT 666
                      LE++H  +   +++ DLKP+N+LLD++    +SD G+A    ++     
Sbjct: 294 MRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA- 349
Query: 667 QTQTLATIGYMAPDEIFSG 685
              ++ T GYMAP+ +  G
Sbjct: 350 ---SVGTHGYMAPEVLQKG 365

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 86/191 (45%), Gaps = 32/191 (16%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAF--KSFDIECGMMK 559
           +++   R+   + +G G +G V      K G  VA+K  +  +      K    E  ++K
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 560 RIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGLN 609
            ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q L 
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 132
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
                   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T 
Sbjct: 133 -------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTG 177
Query: 670 TLATIGYMAPD 680
            +AT  Y AP+
Sbjct: 178 YVATRWYRAPE 188

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 41/175 (23%), Positives = 77/175 (44%), Gaps = 14/175 (8%)
Query: 517 NNLIGRGGFGPVYK------DGMEVAIKVFNLQYGGAF---KSFDIECGMMKRIRHRNLI 567
           N ++G G FG VY+       G ++ + V   +        + F  E  +MK + H +++
Sbjct: 13  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 72
Query: 568 KIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
           K+I     +    +++E  P G L   L      L +   +   + +  A+ YL    S+
Sbjct: 73  KLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SI 128
Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
             +H D+   N+L+       L DFG+++ + +ED        L  I +M+P+ I
Sbjct: 129 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSPESI 182

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 84/183 (45%), Gaps = 13/183 (7%)
Query: 512 NRFSENNLIGRGGFGPVYKDGME-----VAIKVFNLQYG--GAFKSFDIECGMMKRIRHR 564
            ++ +   IG G +G V+K         VA+K   L     G   S   E  ++K ++H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 565 NLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFG 624
           N++++     +D    LV E+     L+K   S N  LD     + +  +   L + H  
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH-- 118
Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS 684
            S  ++H DLKP N+L++ N    L++FG+A+      +    +  + T+ Y  PD +F 
Sbjct: 119 -SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPDVLFG 175
Query: 685 GEM 687
            ++
Sbjct: 176 AKL 178

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 40/196 (20%), Positives = 85/196 (43%), Gaps = 23/196 (11%)
Query: 510 ATNRFSENNLIGRGGFGPVY--------KDGMEVAIKVFNLQYGGAFKS---FDIECGMM 558
           A  + + +  +G+G FG VY        KD  E  + +  +    + +    F  E  +M
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 559 KRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYS------GNYIL---DIFQGLN 609
           K     ++++++   S      +++E M  G L+  L S       N +L    + + + 
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
           +  ++A  + YL+   +   +H DL   N ++ ++    + DFGM + + E D      +
Sbjct: 130 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 186
Query: 670 TLATIGYMAPDEIFSG 685
            L  + +M+P+ +  G
Sbjct: 187 GLLPVRWMSPESLKDG 202

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 87/191 (45%), Gaps = 32/191 (16%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAF--KSFDIECGMMK 559
           +++   R+   + +G G +G V      K G+ VA+K  +  +      K    E  ++K
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 560 RIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGLN 609
            ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q L 
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
                   L+Y+H   S  IIH DLKPSN+ ++++    + D+G+A+   +E      T 
Sbjct: 137 -------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDE-----MTG 181
Query: 670 TLATIGYMAPD 680
            +AT  Y AP+
Sbjct: 182 YVATRWYRAPE 192

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/196 (20%), Positives = 85/196 (43%), Gaps = 23/196 (11%)
Query: 510 ATNRFSENNLIGRGGFGPVY--------KDGMEVAIKVFNLQYGGAFKS---FDIECGMM 558
           A  + + +  +G+G FG VY        KD  E  + +  +    + +    F  E  +M
Sbjct: 17  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 76
Query: 559 KRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYS------GNYIL---DIFQGLN 609
           K     ++++++   S      +++E M  G L+  L S       N +L    + + + 
Sbjct: 77  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 136
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
           +  ++A  + YL+   +   +H DL   N ++ ++    + DFGM + + E D      +
Sbjct: 137 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 193
Query: 670 TLATIGYMAPDEIFSG 685
            L  + +M+P+ +  G
Sbjct: 194 GLLPVRWMSPESLKDG 209

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 86/191 (45%), Gaps = 32/191 (16%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAF--KSFDIECGMMK 559
           +++   R+   + +G G +G V      K G  VA+K  +  +      K    E  ++K
Sbjct: 37  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 96
Query: 560 RIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGLN 609
            ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q   
Sbjct: 97  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--- 153
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
               +   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T 
Sbjct: 154 ----ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTG 201
Query: 670 TLATIGYMAPD 680
            +AT  Y AP+
Sbjct: 202 YVATRWYRAPE 212

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/196 (20%), Positives = 85/196 (43%), Gaps = 23/196 (11%)
Query: 510 ATNRFSENNLIGRGGFGPVY--------KDGMEVAIKVFNLQYGGAFKS---FDIECGMM 558
           A  + + +  +G+G FG VY        KD  E  + +  +    + +    F  E  +M
Sbjct: 14  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 73
Query: 559 KRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYS------GNYIL---DIFQGLN 609
           K     ++++++   S      +++E M  G L+  L S       N +L    + + + 
Sbjct: 74  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 133
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
           +  ++A  + YL+   +   +H DL   N ++ ++    + DFGM + + E D      +
Sbjct: 134 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 190
Query: 670 TLATIGYMAPDEIFSG 685
            L  + +M+P+ +  G
Sbjct: 191 GLLPVRWMSPESLKDG 206

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 89/192 (46%), Gaps = 34/192 (17%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGG---AFKSFDIECGMM 558
           +++   R+   + +G G +G V      K G  VA+K  +  +     A +++  E  ++
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLL 75
Query: 559 KRIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGL 608
           K ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q L
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
                    L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T
Sbjct: 136 R-------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MT 180
Query: 669 QTLATIGYMAPD 680
             +AT  Y AP+
Sbjct: 181 GYVATRWYRAPE 192

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 89/192 (46%), Gaps = 34/192 (17%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGG---AFKSFDIECGMM 558
           +++   R+   + +G G +G V      K G  VA+K  +  +     A +++  E  ++
Sbjct: 36  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLL 94
Query: 559 KRIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGL 608
           K ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q  
Sbjct: 95  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ-- 152
Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
                +   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T
Sbjct: 153 -----ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MT 199
Query: 669 QTLATIGYMAPD 680
             +AT  Y AP+
Sbjct: 200 GYVATRWYRAPE 211

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/175 (23%), Positives = 77/175 (44%), Gaps = 14/175 (8%)
Query: 517 NNLIGRGGFGPVYK------DGMEVAIKVFNLQYGGAF---KSFDIECGMMKRIRHRNLI 567
           N ++G G FG VY+       G ++ + V   +        + F  E  +MK + H +++
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 568 KIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
           K+I     +    +++E  P G L   L      L +   +   + +  A+ YL    S+
Sbjct: 77  KLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SI 132
Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
             +H D+   N+L+       L DFG+++ + +ED        L  I +M+P+ I
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLP-IKWMSPESI 186

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/196 (20%), Positives = 85/196 (43%), Gaps = 23/196 (11%)
Query: 510 ATNRFSENNLIGRGGFGPVY--------KDGMEVAIKVFNLQYGGAFKS---FDIECGMM 558
           A  + + +  +G+G FG VY        KD  E  + +  +    + +    F  E  +M
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 559 KRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYS------GNYIL---DIFQGLN 609
           K     ++++++   S      +++E M  G L+  L S       N +L    + + + 
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 135
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
           +  ++A  + YL+   +   +H DL   N ++ ++    + DFGM + + E D      +
Sbjct: 136 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 192
Query: 670 TLATIGYMAPDEIFSG 685
            L  + +M+P+ +  G
Sbjct: 193 GLLPVRWMSPESLKDG 208

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/196 (20%), Positives = 85/196 (43%), Gaps = 23/196 (11%)
Query: 510 ATNRFSENNLIGRGGFGPVY--------KDGMEVAIKVFNLQYGGAFKS---FDIECGMM 558
           A  + + +  +G+G FG VY        KD  E  + +  +    + +    F  E  +M
Sbjct: 13  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 72
Query: 559 KRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYS------GNYIL---DIFQGLN 609
           K     ++++++   S      +++E M  G L+  L S       N +L    + + + 
Sbjct: 73  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 132
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
           +  ++A  + YL+   +   +H DL   N ++ ++    + DFGM + + E D      +
Sbjct: 133 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 189
Query: 670 TLATIGYMAPDEIFSG 685
            L  + +M+P+ +  G
Sbjct: 190 GLLPVRWMSPESLKDG 205

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 92/209 (44%), Gaps = 38/209 (18%)
Query: 495 SVADQRRFTYLE------LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQ 543
           S A Q R T+        +++   R+   + +G G +G V      K G+ VA+K  +  
Sbjct: 22  SNASQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP 81
Query: 544 YGGAF--KSFDIECGMMKRIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEK 593
           +      K    E  ++K ++H N+I ++   +        ND +    L    L ++ K
Sbjct: 82  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK 141
Query: 594 C--LYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSD 651
           C  L   +    I+Q       +   L+Y+H   S  IIH DLKPSN+ ++++    + D
Sbjct: 142 CQKLTDDHVQFLIYQ-------ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILD 191
Query: 652 FGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           FG+A+   +E         +AT  Y AP+
Sbjct: 192 FGLARHTDDE-----MXGYVATRWYRAPE 215

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/196 (20%), Positives = 85/196 (43%), Gaps = 23/196 (11%)
Query: 510 ATNRFSENNLIGRGGFGPVY--------KDGMEVAIKVFNLQYGGAFKS---FDIECGMM 558
           A  + + +  +G+G FG VY        KD  E  + +  +    + +    F  E  +M
Sbjct: 16  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 75
Query: 559 KRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYS------GNYIL---DIFQGLN 609
           K     ++++++   S      +++E M  G L+  L S       N +L    + + + 
Sbjct: 76  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 135
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
           +  ++A  + YL+   +   +H DL   N ++ ++    + DFGM + + E D      +
Sbjct: 136 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 192
Query: 670 TLATIGYMAPDEIFSG 685
            L  + +M+P+ +  G
Sbjct: 193 GLLPVRWMSPESLKDG 208

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/188 (22%), Positives = 85/188 (45%), Gaps = 24/188 (12%)
Query: 496 VADQRRFTYLELFQATNRFSENNLIGRGGFGPV------YKDG--MEVAIKVF--NLQYG 545
           ++D+ +    ++     +F+   ++G+G FG V       +DG  ++VA+K+   ++   
Sbjct: 7   ISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIAS 66
Query: 546 GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKA------LVLEYMPLGSLEKCLYSGN 599
              + F  E   MK   H ++ K++        K       ++L +M  G L   L +  
Sbjct: 67  SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASR 126
Query: 600 -----YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGM 654
                + L +   +  M+D+A  +EYL    S   IH DL   N +L ++M   ++DFG+
Sbjct: 127 IGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGL 183
Query: 655 AKPLLEED 662
           ++ +   D
Sbjct: 184 SRKIYSGD 191

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 68/143 (47%), Gaps = 11/143 (7%)
Query: 554 ECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMID 613
           E  ++K + H N+IK+     +  +  LV E+   G L + + +  +  D     NIM  
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQ 154
Query: 614 VASALEYLHFGYSVPIIHCDLKPSNVLLDDN---MVAHLSDFGMAKPLLEEDQSLTQTQT 670
           + S + YLH      I+H D+KP N+LL++    +   + DFG++     +D  L     
Sbjct: 155 ILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLS-SFFSKDYKL--RDR 208
Query: 671 LATIGYMAPDEIFSGEMRLKCWV 693
           L T  Y+AP E+   +   KC V
Sbjct: 209 LGTAYYIAP-EVLKKKYNEKCDV 230

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/180 (23%), Positives = 82/180 (45%), Gaps = 16/180 (8%)
Query: 511 TNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGA--FKSFDIECGMMKRIRH 563
           T+ +     +G+G F  V +      G E A K+ N +   A   +  + E  + + ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHF 623
            N++++  S S + F  LV + +  G L + + +  Y    +   +    +   LE ++ 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIQQILESVNH 118
Query: 624 GYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
            +   I+H DLKP N+LL          L+DFG+A  +  + Q+        T GY++P+
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAW--FGFAGTPGYLSPE 176

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/180 (23%), Positives = 82/180 (45%), Gaps = 16/180 (8%)
Query: 511 TNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGA--FKSFDIECGMMKRIRH 563
           T+ +     +G+G F  V +      G E A K+ N +   A   +  + E  + + ++H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHF 623
            N++++  S S + F  LV + +  G L + + +  Y    +   +    +   LE ++ 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIQQILESVNH 118
Query: 624 GYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
            +   I+H DLKP N+LL          L+DFG+A  +  + Q+        T GY++P+
Sbjct: 119 CHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAW--FGFAGTPGYLSPE 176

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/196 (20%), Positives = 85/196 (43%), Gaps = 23/196 (11%)
Query: 510 ATNRFSENNLIGRGGFGPVY--------KDGMEVAIKVFNLQYGGAFKS---FDIECGMM 558
           A  + + +  +G+G FG VY        KD  E  + +  +    + +    F  E  +M
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 559 KRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYS------GNYIL---DIFQGLN 609
           K     ++++++   S      +++E M  G L+  L S       N +L    + + + 
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 142
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
           +  ++A  + YL+   +   +H DL   N ++ ++    + DFGM + + E D      +
Sbjct: 143 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 199
Query: 670 TLATIGYMAPDEIFSG 685
            L  + +M+P+ +  G
Sbjct: 200 GLLPVRWMSPESLKDG 215

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/196 (20%), Positives = 85/196 (43%), Gaps = 23/196 (11%)
Query: 510 ATNRFSENNLIGRGGFGPVY--------KDGMEVAIKVFNLQYGGAFKS---FDIECGMM 558
           A  + + +  +G+G FG VY        KD  E  + +  +    + +    F  E  +M
Sbjct: 23  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 82
Query: 559 KRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYS------GNYIL---DIFQGLN 609
           K     ++++++   S      +++E M  G L+  L S       N +L    + + + 
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
           +  ++A  + YL+   +   +H DL   N ++ ++    + DFGM + + E D      +
Sbjct: 143 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 199
Query: 670 TLATIGYMAPDEIFSG 685
            L  + +M+P+ +  G
Sbjct: 200 GLLPVRWMSPESLKDG 215

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/184 (22%), Positives = 90/184 (48%), Gaps = 17/184 (9%)
Query: 511 TNRFSENNLIGRGGFGPVY--KD---GMEVAIKVF--NLQYGGAFK-SFDIECGMMKRIR 562
           ++R+    ++G GG   V+  +D     +VA+KV   +L    +F   F  E      + 
Sbjct: 11  SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 70
Query: 563 HRNLIKIISSCSNDD----FKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASAL 618
           H  ++ + ++   +        +V+EY+   +L   +++   +    + + ++ D   A 
Sbjct: 71  HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTP-KRAIEVIAD---AC 126
Query: 619 EYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT-LATIGYM 677
           + L+F +   IIH D+KP+N+++       + DFG+A+ + +   S+TQT   + T  Y+
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186
Query: 678 APDE 681
           +P++
Sbjct: 187 SPEQ 190

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/186 (21%), Positives = 77/186 (41%), Gaps = 23/186 (12%)
Query: 520 IGRGGFGPVY--------KDGMEVAIKVFNLQYGGAFKS---FDIECGMMKRIRHRNLIK 568
           +G+G FG VY        K   E  + V  +    + +    F  E  +MK     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCLYS---------GNYILDIFQGLNIMIDVASALE 619
           ++   S      +V+E M  G L+  L S         G     + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 620 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
           YL+   +   +H DL   N ++  +    + DFGM + + E D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 680 DEIFSG 685
           + +  G
Sbjct: 202 ESLKDG 207

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 94/216 (43%), Gaps = 29/216 (13%)
Query: 485 KSQLKDVNMPSVADQRRFTYLELFQATNRFSENNLIGRGGFGPVY--------KDGMEVA 536
           K +L+  N+   A++      EL +         ++G G +G V+          G   A
Sbjct: 36  KHELRTANLTGHAEKVGIENFELLK---------VLGTGAYGKVFLVRKISGHDTGKLYA 86
Query: 537 IKVFN----LQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFK-ALVLEYMPLGSL 591
           +KV      +Q     +    E  +++ IR    +  +      + K  L+L+Y+  G L
Sbjct: 87  MKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGEL 146
Query: 592 EKCLYSGNYILDIFQGLNIMI-DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLS 650
              L       +    + I + ++  ALE+LH    + II+ D+K  N+LLD N    L+
Sbjct: 147 FTHLSQRERFTE--HEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLT 201
Query: 651 DFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGE 686
           DFG++K  +  D++        TI YMAPD +  G+
Sbjct: 202 DFGLSKEFV-ADETERAYDFCGTIEYMAPDIVRGGD 236

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 89/192 (46%), Gaps = 34/192 (17%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGG---AFKSFDIECGMM 558
           +++   R+   + +G G +G V      K G  VA+K  +  +     A +++  E  ++
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLL 81
Query: 559 KRIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGL 608
           K ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q L
Sbjct: 82  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 141
Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
                    L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T
Sbjct: 142 R-------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MT 186
Query: 669 QTLATIGYMAPD 680
             +AT  Y AP+
Sbjct: 187 GYVATRWYRAPE 198

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/186 (21%), Positives = 77/186 (41%), Gaps = 23/186 (12%)
Query: 520 IGRGGFGPVY--------KDGMEVAIKVFNLQYGGAFKS---FDIECGMMKRIRHRNLIK 568
           +G+G FG VY        K   E  + V  +    + +    F  E  +MK     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCLYS---------GNYILDIFQGLNIMIDVASALE 619
           ++   S      +V+E M  G L+  L S         G     + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 620 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
           YL+   +   +H DL   N ++  +    + DFGM + + E D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 680 DEIFSG 685
           + +  G
Sbjct: 202 ESLKDG 207

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/168 (23%), Positives = 74/168 (44%), Gaps = 13/168 (7%)
Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G FG V++      G     K  N  Y     +   E  +M ++ H  LI +  +  
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDL 634
           +     L+LE++  G L   + + +Y +   + +N M      L+++H      I+H D+
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDI 175
Query: 635 KPSNVLLDDNMVAHLS--DFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           KP N++ +    + +   DFG+A  L  ++       T AT  + AP+
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPE 220

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/186 (21%), Positives = 77/186 (41%), Gaps = 23/186 (12%)
Query: 520 IGRGGFGPVY--------KDGMEVAIKVFNLQYGGAFKS---FDIECGMMKRIRHRNLIK 568
           +G+G FG VY        K   E  + V  +    + +    F  E  +MK     ++++
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCLYS---------GNYILDIFQGLNIMIDVASALE 619
           ++   S      +V+E M  G L+  L S         G     + + + +  ++A  + 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 620 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
           YL+   +   +H DL   N ++  +    + DFGM + + E D      + L  + +MAP
Sbjct: 142 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198
Query: 680 DEIFSG 685
           + +  G
Sbjct: 199 ESLKDG 204

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 65/130 (50%), Gaps = 6/130 (4%)
Query: 554 ECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMID 613
           E  +M+++ +  ++++I  C  + +  LV+E   LG L K L    ++ D    + ++  
Sbjct: 62  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 119
Query: 614 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLA 672
           V+  ++YL        +H DL   NVLL     A +SDFG++K L  +E+    QT    
Sbjct: 120 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKW 176
Query: 673 TIGYMAPDEI 682
            + + AP+ I
Sbjct: 177 PVKWYAPECI 186

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 119/278 (42%), Gaps = 31/278 (11%)
Query: 514 FSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMM-KRI-----R 562
           F  + ++G+G FG V+     K     AIK   L+        D+EC M+ KR+      
Sbjct: 20  FELHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWE 77
Query: 563 HRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
           H  L  +  +    +    V+EY+  G L   + S  +  D+ +      ++   L++LH
Sbjct: 78  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLH 136
Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              S  I++ DLK  N+LLD +    ++DFGM K  +  D      +   T  Y+AP EI
Sbjct: 137 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNEFCGTPDYIAP-EI 190
Query: 683 FSGEMRLKC--WVNDSLLISVMIVVDANLLIREEKHLMTKEQPMVRMGTDLSLGQFPASY 740
             G+       W +  +L+  M++  +    ++E+ L       +RM             
Sbjct: 191 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS----IRMDNPFYPRWLEKEA 246
Query: 741 SISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDY 778
                 +++RE E+ ++G+       I  H L+R +++
Sbjct: 247 KDLLVKLFVREPEK-RLGVRG----DIRQHPLFREINW 279

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 90/190 (47%), Gaps = 24/190 (12%)
Query: 506 ELFQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFN-LQYGGAFKSFDIECGMMK 559
           ++F    R++  + IG G +G V       + + VAIK  +  ++    +    E  ++ 
Sbjct: 19  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 78
Query: 560 RIRHRNLIKIISSCSNDDFKALVLEYMP-LGSLEKCLYSGNYILDIFQGLN------IMI 612
             RH N+I I     ND  +A  +E M  +  ++  + +  Y L   Q L+       + 
Sbjct: 79  AFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 133
Query: 613 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ--TQT 670
            +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+ + + D   T   T+ 
Sbjct: 134 QILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLAR-VADPDHDHTGFLTEY 189
Query: 671 LATIGYMAPD 680
           +AT  Y AP+
Sbjct: 190 VATRWYRAPE 199

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 65/130 (50%), Gaps = 6/130 (4%)
Query: 554 ECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMID 613
           E  +M+++ +  ++++I  C  + +  LV+E   LG L K L    ++ D    + ++  
Sbjct: 420 EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 477
Query: 614 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLA 672
           V+  ++YL        +H DL   NVLL     A +SDFG++K L  +E+    QT    
Sbjct: 478 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 534
Query: 673 TIGYMAPDEI 682
            + + AP+ I
Sbjct: 535 PVKWYAPECI 544

>pdb|3V47|A Chain A, Crystal Structure Of The N-Tetminal Fragment Of Zebrafish Tlr5 In Complex With Salmonella Flagellin Length = 455

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/113 (32%), Positives = 57/113 (50%), Gaps = 2/113 (1%)
Query: 260 DLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIP-STLWNLKDILHLNLSSNFFTGPLP 318
           DL  +K+   + +   + T+L +L L  N +  I  +  W L  +L LNLS NF      
Sbjct: 281 DLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDS 340
Query: 319 LKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGD 371
               NL+ L  LDLS N+   +      GL +L+ L L+ N+L+ S+P+ I D
Sbjct: 341 RMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SVPDGIFD 392

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 105/248 (42%), Gaps = 54/248 (21%)
Query: 479 KYRKGRKSQLK-------DVNMPSVADQRRFTYLELFQATNRFSENNL-----IGRGGFG 526
           KY++  K Q++       + N  +  D  +  Y E ++    F  NNL     +G G FG
Sbjct: 5   KYKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWE----FPRNNLQFGKTLGAGAFG 60
Query: 527 PVYKDG----------MEVAIKVF-NLQYGGAFKSFDIECGMMKRI-RHRNLIKIISSCS 574
            V +            ++VA+K+  +  +    ++   E  +M  + +H N++ ++ +C+
Sbjct: 61  KVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT 120
Query: 575 NDDFKALVLEYMPLGSLEKCL---------YSGNYILDIFQGLNIMIDVASALEYLHFGY 625
           +     ++ EY   G L   L         YS N   +  + L       S+ + LHF  
Sbjct: 121 HGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQL-------SSRDLLHFSS 173
Query: 626 SVP----------IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 675
            V            IH D+   NVLL +  VA + DFG+A+ ++ +   + +      + 
Sbjct: 174 QVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVK 233
Query: 676 YMAPDEIF 683
           +MAP+ IF
Sbjct: 234 WMAPESIF 241

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 65/130 (50%), Gaps = 6/130 (4%)
Query: 554 ECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMID 613
           E  +M+++ +  ++++I  C  + +  LV+E   LG L K L    ++ D    + ++  
Sbjct: 421 EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 478
Query: 614 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLA 672
           V+  ++YL        +H DL   NVLL     A +SDFG++K L  +E+    QT    
Sbjct: 479 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 535
Query: 673 TIGYMAPDEI 682
            + + AP+ I
Sbjct: 536 PVKWYAPECI 545

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 22/69 (31%), Positives = 42/69 (60%), Gaps = 1/69 (1%)
Query: 614 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT-LA 672
           +A A + L+F +   IIH D+KP+N+++       + DFG+A+ + +   S+TQT   + 
Sbjct: 139 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 198
Query: 673 TIGYMAPDE 681
           T  Y++P++
Sbjct: 199 TAQYLSPEQ 207

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 65/130 (50%), Gaps = 6/130 (4%)
Query: 554 ECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMID 613
           E  +M+++ +  ++++I  C  + +  LV+E   LG L K L    ++ D    + ++  
Sbjct: 58  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 115
Query: 614 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLA 672
           V+  ++YL        +H DL   NVLL     A +SDFG++K L  +E+    QT    
Sbjct: 116 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 172
Query: 673 TIGYMAPDEI 682
            + + AP+ I
Sbjct: 173 PVKWYAPECI 182

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 65/130 (50%), Gaps = 6/130 (4%)
Query: 554 ECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMID 613
           E  +M+++ +  ++++I  C  + +  LV+E   LG L K L    ++ D    + ++  
Sbjct: 56  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 113
Query: 614 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLA 672
           V+  ++YL        +H DL   NVLL     A +SDFG++K L  +E+    QT    
Sbjct: 114 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 170
Query: 673 TIGYMAPDEI 682
            + + AP+ I
Sbjct: 171 PVKWYAPECI 180

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/191 (26%), Positives = 85/191 (44%), Gaps = 32/191 (16%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAF--KSFDIECGMMK 559
           +++   R+     +G G +G V      K G  VA+K  +  +      K    E  ++K
Sbjct: 27  IWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 86
Query: 560 RIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGLN 609
            ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q L 
Sbjct: 87  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 146
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
                   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T 
Sbjct: 147 -------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTG 191
Query: 670 TLATIGYMAPD 680
            +AT  Y AP+
Sbjct: 192 YVATRWYRAPE 202

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 81/180 (45%), Gaps = 21/180 (11%)
Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVF-NLQYGGAFKSFDI-ECGMMKRIRHR 564
            ++ +   IG G +G V+K      G  VAIK F   +     K   + E  M+K+++H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 565 NLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQ-GLN---IMIDVASALEY 620
           NL+ ++          LV EY        C ++  + LD +Q G+    +       L+ 
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEY--------CDHTVLHELDRYQRGVPEHLVKSITWQTLQA 114
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           ++F +    IH D+KP N+L+  + V  L DFG A+ L     S      +AT  Y +P+
Sbjct: 115 VNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLT--GPSDYYDDEVATRWYRSPE 172

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 65/130 (50%), Gaps = 6/130 (4%)
Query: 554 ECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMID 613
           E  +M+++ +  ++++I  C  + +  LV+E   LG L K L    ++ D    + ++  
Sbjct: 62  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 119
Query: 614 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLA 672
           V+  ++YL        +H DL   NVLL     A +SDFG++K L  +E+    QT    
Sbjct: 120 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 176
Query: 673 TIGYMAPDEI 682
            + + AP+ I
Sbjct: 177 PVKWYAPECI 186

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 80/183 (43%), Gaps = 24/183 (13%)
Query: 514 FSENNLIGRGGFGPVYK---DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKII 570
           F   + +GRG    VY+    G +    +  L+     K    E G++ R+ H N+IK+ 
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLK 114
Query: 571 SSCSNDDFKALVLEYMPLGSL-----EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY 625
                    +LVLE +  G L     EK  YS     D  +       +  A+ YLH   
Sbjct: 115 EIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVK------QILEAVAYLH--- 165
Query: 626 SVPIIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              I+H DLKP N+L      +    ++DFG++K  + E Q L +T    T GY AP EI
Sbjct: 166 ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK--IVEHQVLMKT-VCGTPGYCAP-EI 221
Query: 683 FSG 685
             G
Sbjct: 222 LRG 224

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/190 (26%), Positives = 90/190 (47%), Gaps = 24/190 (12%)
Query: 506 ELFQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFN-LQYGGAFKSFDIECGMMK 559
           ++F    R++  + IG G +G V       + + VAIK  +  ++    +    E  ++ 
Sbjct: 19  QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 78
Query: 560 RIRHRNLIKIISSCSNDDFKALVLEYMP-LGSLEKCLYSGNYILDIFQGLN------IMI 612
             RH N+I I     ND  +A  +E M  +  ++  + +  Y L   Q L+       + 
Sbjct: 79  AFRHENIIGI-----NDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLY 133
Query: 613 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ--TQT 670
            +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+ + + D   T   T+ 
Sbjct: 134 QILRGLKYIH---SANVLHRDLKPSNLLLNTTSDLKICDFGLAR-VADPDHDHTGFLTEY 189
Query: 671 LATIGYMAPD 680
           +AT  Y AP+
Sbjct: 190 VATRWYRAPE 199

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/183 (23%), Positives = 84/183 (45%), Gaps = 18/183 (9%)
Query: 508 FQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGA--FKSFDIECGMMKR 560
           FQ+  +  E   +G+G F  V +      G E A K+ N +   A   +  + E  + + 
Sbjct: 20  FQSMYQLFEE--LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRL 77
Query: 561 IRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEY 620
           ++H N++++  S S +    L+ + +  G L + + +  Y    +   +    +   LE 
Sbjct: 78  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY----YSEADASHCIQQILEA 133
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNM---VAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 677
           +   + + ++H DLKP N+LL   +      L+DFG+A  +  E Q+        T GY+
Sbjct: 134 VLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA--GTPGYL 191
Query: 678 APD 680
           +P+
Sbjct: 192 SPE 194

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 86/189 (45%), Gaps = 24/189 (12%)
Query: 520 IGRGGFGPVYK---DGMEVAIKVFNLQ-YGGAFKSFDIECGMMKRIRHRNLIKIISS--- 572
           +G+G +G V++    G  VA+K+F+ +     F+  +I   ++  +RH N++  I+S   
Sbjct: 16  VGKGRYGEVWRGLWHGESVAVKIFSSRDEQSWFRETEIYNTVL--LRHDNILGFIASDMT 73
Query: 573 CSNDDFK-ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH---FGYS-- 626
             N   +  L+  Y   GSL   L      L+    L + +  A  L +LH   FG    
Sbjct: 74  SRNSSTQLWLITHYHEHGSLYDFLQ--RQTLEPHLALRLAVSAACGLAHLHVEIFGTQGK 131
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS----LTQTQTLATIGYMAPDEI 682
             I H D K  NVL+  N+   ++D G+A  ++    S    +     + T  YMAP E+
Sbjct: 132 PAIAHRDFKSRNVLVKSNLQCCIADLGLA--VMHSQGSDYLDIGNNPRVGTKRYMAP-EV 188
Query: 683 FSGEMRLKC 691
              ++R  C
Sbjct: 189 LDEQIRTDC 197

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 85/178 (47%), Gaps = 18/178 (10%)
Query: 514 FSENNLIGRGGFGPVYKDGM----EVAIKVFNLQYGGAFKSFDIECGMMKRI-RHRNLIK 568
           F   +++G G  G +   GM    +VA+K    +    F   D E  +++    H N+I+
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE---CFSFADREVQLLRESDEHPNVIR 82
Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVP 628
              +  +  F+ + +E +   +L++ +   ++     + + ++    S L +LH   S+ 
Sbjct: 83  YFCTEKDRQFQYIAIE-LCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLN 138
Query: 629 IIHCDLKPSNVLLD-----DNMVAHLSDFGMAKPLLEEDQSLTQTQTL-ATIGYMAPD 680
           I+H DLKP N+L+        + A +SDFG+ K L     S ++   +  T G++AP+
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 65/130 (50%), Gaps = 6/130 (4%)
Query: 554 ECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMID 613
           E  +M+++ +  ++++I  C  + +  LV+E   LG L K L    ++ D    + ++  
Sbjct: 68  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 125
Query: 614 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLA 672
           V+  ++YL        +H DL   NVLL     A +SDFG++K L  +E+    QT    
Sbjct: 126 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 182
Query: 673 TIGYMAPDEI 682
            + + AP+ I
Sbjct: 183 PVKWYAPECI 192

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 83/192 (43%), Gaps = 27/192 (14%)
Query: 507 LFQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKV-----FNLQYGGAFKSFDIECG 556
           LF+      E  +IG+G F  V +      G + A+K+     F    G + +    E  
Sbjct: 21  LFEDVYELCE--VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREAS 78
Query: 557 MMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCL-----YSGNYILDIFQGLNIM 611
           +   ++H ++++++ + S+D    +V E+M    L  C          ++       + M
Sbjct: 79  ICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADL--CFEIVKRADAGFVYSEAVASHYM 136
Query: 612 IDVASALEYLHFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQT 668
             +  AL Y H      IIH D+KP NVLL   +++    L DFG+A  L E    L   
Sbjct: 137 RQILEALRYCH---DNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGE--SGLVAG 191
Query: 669 QTLATIGYMAPD 680
             + T  +MAP+
Sbjct: 192 GRVGTPHFMAPE 203

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 90/192 (46%), Gaps = 34/192 (17%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGG---AFKSFDIECGMM 558
           +++   R      +G G +G V      +   +VA+K  +  +     A +++  E  ++
Sbjct: 23  VWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYR-ELRLL 81
Query: 559 KRIRHRNLIKIIS----SCSNDDFKALVLEYMPLGS----LEKC--LYSGNYILDIFQGL 608
           K ++H N+I ++     + S +DF  + L    +G+    + KC  L   +    ++Q L
Sbjct: 82  KHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLL 141
Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
                    L+Y+H   S  IIH DLKPSNV ++++    + DFG+A+   EE      T
Sbjct: 142 R-------GLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE-----MT 186
Query: 669 QTLATIGYMAPD 680
             +AT  Y AP+
Sbjct: 187 GYVATRWYRAPE 198

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/196 (20%), Positives = 84/196 (42%), Gaps = 23/196 (11%)
Query: 510 ATNRFSENNLIGRGGFGPVY--------KDGMEVAIKVFNLQYGGAFKS---FDIECGMM 558
           A  + + +  +G+G FG VY        KD  E  + +  +    + +    F  E  +M
Sbjct: 10  AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 69
Query: 559 KRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYS------GNYIL---DIFQGLN 609
           K     ++++++   S      +++E M  G L+  L S       N +L    + + + 
Sbjct: 70  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQ 129
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
           +  ++A  + YL+   +   +H DL   N  + ++    + DFGM + + E D      +
Sbjct: 130 MAGEIADGMAYLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGK 186
Query: 670 TLATIGYMAPDEIFSG 685
            L  + +M+P+ +  G
Sbjct: 187 GLLPVRWMSPESLKDG 202

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 22/69 (31%), Positives = 42/69 (60%), Gaps = 1/69 (1%)
Query: 614 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT-LA 672
           +A A + L+F +   IIH D+KP+N+++       + DFG+A+ + +   S+TQT   + 
Sbjct: 122 IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIG 181
Query: 673 TIGYMAPDE 681
           T  Y++P++
Sbjct: 182 TAQYLSPEQ 190

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 90/192 (46%), Gaps = 34/192 (17%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGG---AFKSFDIECGMM 558
           +++   R      +G G +G V      +   +VA+K  +  +     A +++  E  ++
Sbjct: 15  VWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYR-ELRLL 73
Query: 559 KRIRHRNLIKIIS----SCSNDDFKALVLEYMPLGS----LEKC--LYSGNYILDIFQGL 608
           K ++H N+I ++     + S +DF  + L    +G+    + KC  L   +    ++Q L
Sbjct: 74  KHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLL 133
Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
                    L+Y+H   S  IIH DLKPSNV ++++    + DFG+A+   EE      T
Sbjct: 134 R-------GLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEE-----MT 178
Query: 669 QTLATIGYMAPD 680
             +AT  Y AP+
Sbjct: 179 GYVATRWYRAPE 190

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 65/130 (50%), Gaps = 6/130 (4%)
Query: 554 ECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMID 613
           E  +M+++ +  ++++I  C  + +  LV+E   LG L K L    ++ D    + ++  
Sbjct: 76  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 133
Query: 614 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLA 672
           V+  ++YL        +H DL   NVLL     A +SDFG++K L  +E+    QT    
Sbjct: 134 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 190
Query: 673 TIGYMAPDEI 682
            + + AP+ I
Sbjct: 191 PVKWYAPECI 200

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 86/186 (46%), Gaps = 22/186 (11%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGG---AFKSFDIECGMM 558
           +++   R      +G G +G V      +   +VA+K  +  +     A +++  E  ++
Sbjct: 23  VWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYR-ELRLL 81
Query: 559 KRIRHRNLIKIIS----SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDV 614
           K ++H N+I ++     + S +DF  + L    +G+    +     + D     ++   V
Sbjct: 82  KHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSD----EHVQFLV 137
Query: 615 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI 674
              L  L + +S  IIH DLKPSNV ++++    + DFG+A+   EE      T  +AT 
Sbjct: 138 YQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE-----MTGYVATR 192
Query: 675 GYMAPD 680
            Y AP+
Sbjct: 193 WYRAPE 198

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 92/211 (43%), Gaps = 25/211 (11%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRHRNLIKIIS 571
           +G G FG V+      +G   A+KV   +     K  +    E  M+  + H  +I++  
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
           +  +     ++++Y+  G L   L       +         +V  ALEYLH   S  II+
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF-YAAEVCLALEYLH---SKDIIY 129
Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKC 691
            DLKP N+LLD N    ++DFG AK + +    L       T  Y+AP E+ S +   K 
Sbjct: 130 RDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLC-----GTPDYIAP-EVVSTKPYNKS 183
Query: 692 --WVNDSLLISVMIV-----VDANLLIREEK 715
             W +  +LI  M+       D+N +   EK
Sbjct: 184 IDWWSFGILIYEMLAGYTPFYDSNTMKTYEK 214

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 85/189 (44%), Gaps = 27/189 (14%)
Query: 510 ATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYG--GAFKSFDIECGMMKRIR 562
           AT+R+     IG G +G VYK      G  VA+K   +  G  G   S   E  +++R+ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 563 ---HRNLIKIISSCS----NDDFK-ALVLEYMPLG---SLEKCLYSGNYILDIFQGLNIM 611
              H N+++++  C+    + + K  LV E++       L+K    G   L      ++M
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG---LPAETIKDLM 118
Query: 612 IDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL 671
                 L++LH      I+H DLKP N+L+       L+DFG+A+        +     +
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALAPVV 172
Query: 672 ATIGYMAPD 680
            T+ Y AP+
Sbjct: 173 VTLWYRAPE 181

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 86/207 (41%), Gaps = 38/207 (18%)
Query: 508 FQAT--NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI--ECGMM 558
           FQ T   R++   ++G+G FG V K        E A+KV N        +  I  E  ++
Sbjct: 16  FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELL 75
Query: 559 KRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIF---------QGLN 609
           K++ H N++K+     +     +V E          LY+G  + D               
Sbjct: 76  KKLDHPNIMKLFEILEDSSSFYIVGE----------LYTGGELFDEIIKRKRFSEHDAAR 125
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLT 666
           I+  V S + Y+H      I+H DLKP N+LL   + +    + DFG++       Q+  
Sbjct: 126 IIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTK 179
Query: 667 QTQTLATIGYMAPDEIFSGEMRLKCWV 693
               + T  Y+AP E+  G    KC V
Sbjct: 180 MKDRIGTAYYIAP-EVLRGTYDEKCDV 205

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 81/184 (44%), Gaps = 23/184 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     IG G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EYMP G +   L       +    F    I++      EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVL----TFEY 156
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP+
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPE 208
Query: 681 EIFS 684
            I S
Sbjct: 209 IILS 212

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 65/130 (50%), Gaps = 6/130 (4%)
Query: 554 ECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMID 613
           E  +M+++ +  ++++I  C  + +  LV+E   LG L K L    ++ D    + ++  
Sbjct: 78  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 135
Query: 614 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLA 672
           V+  ++YL        +H DL   NVLL     A +SDFG++K L  +E+    QT    
Sbjct: 136 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 192
Query: 673 TIGYMAPDEI 682
            + + AP+ I
Sbjct: 193 PVKWYAPECI 202

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 65/130 (50%), Gaps = 6/130 (4%)
Query: 554 ECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMID 613
           E  +M+++ +  ++++I  C  + +  LV+E   LG L K L    ++ D    + ++  
Sbjct: 78  EANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDK-NIIELVHQ 135
Query: 614 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLA 672
           V+  ++YL        +H DL   NVLL     A +SDFG++K L  +E+    QT    
Sbjct: 136 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 192
Query: 673 TIGYMAPDEI 682
            + + AP+ I
Sbjct: 193 PVKWYAPECI 202

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 81/184 (44%), Gaps = 23/184 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     IG G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EYMP G +   L       +    F    I++      EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVL----TFEY 156
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP+
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPE 208
Query: 681 EIFS 684
            I S
Sbjct: 209 IILS 212

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 85/205 (41%), Gaps = 38/205 (18%)
Query: 508 FQAT--NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI--ECGMM 558
           FQ T   R++   ++G+G FG V K        E A+KV N        +  I  E  ++
Sbjct: 16  FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELL 75
Query: 559 KRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIF---------QGLN 609
           K++ H N++K+     +     +V E          LY+G  + D               
Sbjct: 76  KKLDHPNIMKLFEILEDSSSFYIVGE----------LYTGGELFDEIIKRKRFSEHDAAR 125
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLT 666
           I+  V S + Y+H      I+H DLKP N+LL   + +    + DFG++       Q+  
Sbjct: 126 IIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTK 179
Query: 667 QTQTLATIGYMAPDEIFSGEMRLKC 691
               + T  Y+AP E+  G    KC
Sbjct: 180 MKDRIGTAYYIAP-EVLRGTYDEKC 203

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/190 (29%), Positives = 90/190 (47%), Gaps = 20/190 (10%)
Query: 516 ENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIR-HRNLIKI 569
           + +++G G    V          E A+K+   Q G        E  M+ + + HRN++++
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 570 ISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPI 629
           I     +D   LV E M  GS+   ++   +  ++   + ++ DVASAL++LH   +  I
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV-VVQDVASALDFLH---NKGI 132
Query: 630 IHCDLKPSNVLLDD-NMVA--HLSDFGMAKPL-LEEDQSLTQTQTLAT----IGYMAPD- 680
            H DLKP N+L +  N V+   + DFG+   + L  D S   T  L T      YMAP+ 
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192
Query: 681 -EIFSGEMRL 689
            E FS E  +
Sbjct: 193 VEAFSEEASI 202

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 85/205 (41%), Gaps = 38/205 (18%)
Query: 508 FQAT--NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI--ECGMM 558
           FQ T   R++   ++G+G FG V K        E A+KV N        +  I  E  ++
Sbjct: 16  FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELL 75
Query: 559 KRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIF---------QGLN 609
           K++ H N++K+     +     +V E          LY+G  + D               
Sbjct: 76  KKLDHPNIMKLFEILEDSSSFYIVGE----------LYTGGELFDEIIKRKRFSEHDAAR 125
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLT 666
           I+  V S + Y+H      I+H DLKP N+LL   + +    + DFG++       Q+  
Sbjct: 126 IIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTK 179
Query: 667 QTQTLATIGYMAPDEIFSGEMRLKC 691
               + T  Y+AP E+  G    KC
Sbjct: 180 MKDRIGTAYYIAP-EVLRGTYDEKC 203

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 90/193 (46%), Gaps = 30/193 (15%)
Query: 517 NNLIGRGGFGPV-----YKDGMEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLIKII 570
            +++G G F  V      +    VAIK    +   G   S + E  ++ +I+H N++ + 
Sbjct: 23  RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALD 82
Query: 571 SSCSNDDFKALVLEYMPLGSL-----EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY 625
               +     L+++ +  G L     EK  Y+            ++  V  A++YLH   
Sbjct: 83  DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER------DASRLIFQVLDAVKYLH--- 133
Query: 626 SVPIIHCDLKPSNVL---LDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
            + I+H DLKP N+L   LD++    +SDFG++K  +E+  S+  T    T GY+AP E+
Sbjct: 134 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLST-ACGTPGYVAP-EV 189
Query: 683 FSGE---MRLKCW 692
            + +     + CW
Sbjct: 190 LAQKPYSKAVDCW 202

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/168 (23%), Positives = 79/168 (47%), Gaps = 13/168 (7%)
Query: 517 NNLIGRGGFGPVY--------KDGMEVAIKVFN-LQYGGAFKSFDIECGMMKRIRHRNLI 567
           + +IG+G FG VY        ++ ++ AIK  + +      ++F  E  +M+ + H N++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 568 KIIS-SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
            +I      +    ++L YM  G L + + S      +   ++  + VA  +EYL     
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL---AE 142
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI 674
              +H DL   N +LD++    ++DFG+A+ +L+ +    Q    A +
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL 190

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 90/193 (46%), Gaps = 30/193 (15%)
Query: 517 NNLIGRGGFGPV-----YKDGMEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLIKII 570
            +++G G F  V      +    VAIK    +   G   S + E  ++ +I+H N++ + 
Sbjct: 23  RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALD 82
Query: 571 SSCSNDDFKALVLEYMPLGSL-----EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY 625
               +     L+++ +  G L     EK  Y+            ++  V  A++YLH   
Sbjct: 83  DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER------DASRLIFQVLDAVKYLH--- 133
Query: 626 SVPIIHCDLKPSNVL---LDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
            + I+H DLKP N+L   LD++    +SDFG++K  +E+  S+  T    T GY+AP E+
Sbjct: 134 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK--MEDPGSVLST-ACGTPGYVAP-EV 189
Query: 683 FSGE---MRLKCW 692
            + +     + CW
Sbjct: 190 LAQKPYSKAVDCW 202

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/186 (21%), Positives = 77/186 (41%), Gaps = 23/186 (12%)
Query: 520 IGRGGFGPVY--------KDGMEVAIKVFNLQYGGAFKS---FDIECGMMKRIRHRNLIK 568
           +G+G FG VY        K   E  + V  +    + +    F  E  +MK     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCLYS---------GNYILDIFQGLNIMIDVASALE 619
           ++   S      +V+E M  G L+  L S         G     + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 620 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
           YL+   +   +H DL   N ++  +    + DFGM + + E D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 680 DEIFSG 685
           + +  G
Sbjct: 202 ESLKDG 207

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 77/165 (46%), Gaps = 24/165 (14%)
Query: 510 ATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYG--GAFKSFDIECGMMKRIR 562
           AT+R+     IG G +G VYK      G  VA+K   +  G  G   S   E  +++R+ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 563 ---HRNLIKIISSCS----NDDFK-ALVLEYMPLG---SLEKCLYSGNYILDIFQGLNIM 611
              H N+++++  C+    + + K  LV E++       L+K    G   L      ++M
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG---LPAETIKDLM 118
Query: 612 IDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK 656
                 L++LH      I+H DLKP N+L+       L+DFG+A+
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR 160

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/193 (25%), Positives = 87/193 (45%), Gaps = 30/193 (15%)
Query: 517 NNLIGRGGFGPV-----YKDGMEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLIKII 570
            +++G G F  V      +    VAIK    +   G   S + E  ++ +I+H N++ + 
Sbjct: 23  RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALD 82
Query: 571 SSCSNDDFKALVLEYMPLGSL-----EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY 625
               +     L+++ +  G L     EK  Y+            ++  V  A++YLH   
Sbjct: 83  DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTER------DASRLIFQVLDAVKYLH--- 133
Query: 626 SVPIIHCDLKPSNVL---LDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
            + I+H DLKP N+L   LD++    +SDFG++K    ED     +    T GY+AP E+
Sbjct: 134 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAP-EV 189
Query: 683 FSGE---MRLKCW 692
            + +     + CW
Sbjct: 190 LAQKPYSKAVDCW 202

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/186 (21%), Positives = 77/186 (41%), Gaps = 23/186 (12%)
Query: 520 IGRGGFGPVY--------KDGMEVAIKVFNLQYGGAFKS---FDIECGMMKRIRHRNLIK 568
           +G+G FG VY        K   E  + V  +    + +    F  E  +MK     ++++
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCLYS---------GNYILDIFQGLNIMIDVASALE 619
           ++   S      +V+E M  G L+  L S         G     + + + +  ++A  + 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 620 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
           YL+   +   +H DL   N ++  +    + DFGM + + E D      + L  + +MAP
Sbjct: 144 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200
Query: 680 DEIFSG 685
           + +  G
Sbjct: 201 ESLKDG 206

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 77/165 (46%), Gaps = 24/165 (14%)
Query: 510 ATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYG--GAFKSFDIECGMMKRIR 562
           AT+R+     IG G +G VYK      G  VA+K   +  G  G   S   E  +++R+ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 563 ---HRNLIKIISSC----SNDDFK-ALVLEYMPLG---SLEKCLYSGNYILDIFQGLNIM 611
              H N+++++  C    ++ + K  LV E++       L+K    G   L      ++M
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG---LPAETIKDLM 118
Query: 612 IDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK 656
                 L++LH      I+H DLKP N+L+       L+DFG+A+
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR 160

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 85/191 (44%), Gaps = 32/191 (16%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAF--KSFDIECGMMK 559
           +++   R+   + +G G +G V      K G  VA+K  +  +      K    E  ++K
Sbjct: 37  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 96
Query: 560 RIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGLN 609
            ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q   
Sbjct: 97  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--- 153
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
               +   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E        
Sbjct: 154 ----ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MXG 201
Query: 670 TLATIGYMAPD 680
            +AT  Y AP+
Sbjct: 202 XVATRWYRAPE 212

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 94/208 (45%), Gaps = 18/208 (8%)
Query: 486 SQLKDVNMPSVADQRRFTYLELFQATNRFSENNL-----IGRGGFGPVYK-----DGMEV 535
            +L+++ +     +R   +L   Q      +++      +G G  G V+K      G+ +
Sbjct: 2   KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVM 61
Query: 536 AIKVFNLQYGGAFKSFDI-ECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKC 594
           A K+ +L+   A ++  I E  ++       ++    +  +D   ++ +E+M  GSL++ 
Sbjct: 62  ARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV 121
Query: 595 LYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGM 654
           L     I +   G  + I V   L YL   +   I+H D+KPSN+L++      L DFG+
Sbjct: 122 LKKAGRIPEQILG-KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGV 178
Query: 655 AKPLLEEDQSLTQTQTLATIGYMAPDEI 682
           +  L++          + T  YM+P+ +
Sbjct: 179 SGQLIDS----MANSFVGTRSYMSPERL 202

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 86/191 (45%), Gaps = 32/191 (16%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAF--KSFDIECGMMK 559
           +++   R+   + +G G +G V      K G+ VA+K  +  +      K    E  ++K
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 560 RIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGLN 609
            ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q   
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ--- 133
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
               +   L+Y+H   S  IIH DLKPSN+ ++++    +  FG+A+   +E      T 
Sbjct: 134 ----ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDE-----MTG 181
Query: 670 TLATIGYMAPD 680
            +AT  Y AP+
Sbjct: 182 YVATRWYRAPE 192

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 84/177 (47%), Gaps = 13/177 (7%)
Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI-ECGMMKRIRHRN 565
           + F + + +G G  G V+K      G+ +A K+ +L+   A ++  I E  ++       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY 625
           ++    +  +D   ++ +E+M  GSL++ L     I +   G  + I V   L YL   +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKGLTYLREKH 124
Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              I+H D+KPSN+L++      L DFG++  L++          + T  YM+P+ +
Sbjct: 125 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERL 175

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 85/191 (44%), Gaps = 32/191 (16%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAF--KSFDIECGMMK 559
           +++   R+   + +G G +G V      K G  VA+K  +  +      K    E  ++K
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 560 RIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGLN 609
            ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q L 
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
                   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E        
Sbjct: 137 -------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGF---- 182
Query: 670 TLATIGYMAPD 680
            +AT  Y AP+
Sbjct: 183 -VATRWYRAPE 192

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 85/191 (44%), Gaps = 32/191 (16%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAF--KSFDIECGMMK 559
           +++   R+   + +G G +G V      K G  VA+K  +  +      K    E  ++K
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 560 RIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGLN 609
            ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q L 
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 132
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
                   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E        
Sbjct: 133 -------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGF---- 178
Query: 670 TLATIGYMAPD 680
            +AT  Y AP+
Sbjct: 179 -VATRWYRAPE 188

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 84/185 (45%), Gaps = 25/185 (13%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EY+P G +   L       +    F    I++      EY
Sbjct: 87  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEY 142
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL-ATIGYMAP 679
           LH   S+ +I+ DLKP N+L+D      ++DFG AK      +   +T TL  T  Y+AP
Sbjct: 143 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGRTWTLCGTPEYLAP 193
Query: 680 DEIFS 684
           + I S
Sbjct: 194 EIILS 198

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 89/192 (46%), Gaps = 34/192 (17%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGG---AFKSFDIECGMM 558
           +++   R+   + +G G +G V      K G+ VA+K  +  +     A +++  E  ++
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 75
Query: 559 KRIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGL 608
           K ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q L
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
                    L+Y+H   S  IIH DLKPSN+ ++++    + D G+A+   +E      T
Sbjct: 136 R-------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDE-----MT 180
Query: 669 QTLATIGYMAPD 680
             +AT  Y AP+
Sbjct: 181 GYVATRWYRAPE 192

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 86/192 (44%), Gaps = 22/192 (11%)
Query: 514 FSENNLIGRGGFGPVYKDGMEVAIKVFNLQ------YGGAFKSFDIECGMMKRIRHRNLI 567
           F     +G G F  V     +   K+F ++        G   S + E  ++++I+H N++
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIV 83
Query: 568 KIISSCSNDDFKALVLEYMPLGSL-EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
            +     + +   LV++ +  G L ++ +  G Y         ++  V  A+ YLH    
Sbjct: 84  ALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEK--DASTLIRQVLDAVYYLH---R 138
Query: 627 VPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIF 683
           + I+H DLKP N+L    D+     +SDFG++K    E +    +    T GY+AP E+ 
Sbjct: 139 MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM---EGKGDVMSTACGTPGYVAP-EVL 194
Query: 684 SGE---MRLKCW 692
           + +     + CW
Sbjct: 195 AQKPYSKAVDCW 206

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 86/191 (45%), Gaps = 32/191 (16%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAF--KSFDIECGMMK 559
           +++   R+   + +G G +G V      K G+ VA+K  +  +      K    E  ++K
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 560 RIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGLN 609
            ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q L 
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
                   L+Y+H   S  IIH DLKPSN+ ++++    + D G+A+   +E      T 
Sbjct: 137 -------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDE-----MTG 181
Query: 670 TLATIGYMAPD 680
            +AT  Y AP+
Sbjct: 182 YVATRWYRAPE 192

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 85/191 (44%), Gaps = 32/191 (16%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAF--KSFDIECGMMK 559
           +++   R+   + +G G +G V      K G  VA+K  +  +      K    E  ++K
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 560 RIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGLN 609
            ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q L 
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 136
Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
                   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E        
Sbjct: 137 -------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGF---- 182
Query: 670 TLATIGYMAPD 680
            +AT  Y AP+
Sbjct: 183 -VATRWYRAPE 192

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 84/177 (47%), Gaps = 13/177 (7%)
Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI-ECGMMKRIRHRN 565
           + F + + +G G  G V+K      G+ +A K+ +L+   A ++  I E  ++       
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY 625
           ++    +  +D   ++ +E+M  GSL++ L     I +   G  + I V   L YL   +
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKGLTYLREKH 143
Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              I+H D+KPSN+L++      L DFG++  L++          + T  YM+P+ +
Sbjct: 144 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERL 194

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 24/65 (36%), Positives = 38/65 (58%), Gaps = 1/65 (1%)
Query: 618 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 677
           LE +H  +   I+H DLKP+N L+ D M+  L DFG+A  +  +  S+ +   + T+ YM
Sbjct: 118 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 678 APDEI 682
            P+ I
Sbjct: 177 PPEAI 181

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 22/200 (11%)
Query: 498 DQRRFTYLELFQATNR---------FSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQ 543
           D+++   LE F    +         F + + +G G  G V+K      G+ +A K+ +L+
Sbjct: 45  DEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE 104
Query: 544 YGGAFKSFDI-ECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYIL 602
              A ++  I E  ++       ++    +  +D   ++ +E+M  GSL++ L     I 
Sbjct: 105 IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIP 164
Query: 603 DIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED 662
           +   G  + I V   L YL   +   I+H D+KPSN+L++      L DFG++  L++  
Sbjct: 165 EQILG-KVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 220
Query: 663 QSLTQTQTLATIGYMAPDEI 682
                   + T  YM+P+ +
Sbjct: 221 ---MANSFVGTRSYMSPERL 237

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 70/151 (46%), Gaps = 14/151 (9%)
Query: 514 FSENNLIGRGGFGPV---YKDGMEV--AIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIK 568
           ++  N IGRG +G V    + G  +  A K     +      F  E  +MK + H N+I+
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 569 IISSCSNDDFKALVLEYMPLGSL-EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
           +  +  ++    LV+E    G L E+ ++    +        IM DV SA+ Y H    +
Sbjct: 71  LYETFEDNTDIYLVMELCTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCH---KL 125
Query: 628 PIIHCDLKPSNVL-LDDNMVAHLS--DFGMA 655
            + H DLKP N L L D+  + L   DFG+A
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 156

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 70/151 (46%), Gaps = 14/151 (9%)
Query: 514 FSENNLIGRGGFGPV---YKDGMEV--AIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIK 568
           ++  N IGRG +G V    + G  +  A K     +      F  E  +MK + H N+I+
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 87
Query: 569 IISSCSNDDFKALVLEYMPLGSL-EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
           +  +  ++    LV+E    G L E+ ++    +        IM DV SA+ Y H    +
Sbjct: 88  LYETFEDNTDIYLVMELCTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCH---KL 142
Query: 628 PIIHCDLKPSNVL-LDDNMVAHLS--DFGMA 655
            + H DLKP N L L D+  + L   DFG+A
Sbjct: 143 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 173

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 84/185 (45%), Gaps = 25/185 (13%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EY+P G +   L       +    F    I++      EY
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEY 157
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL-ATIGYMAP 679
           LH   S+ +I+ DLKP N+L+D      ++DFG AK +        +T TL  T  Y+AP
Sbjct: 158 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWTLCGTPEYLAP 208
Query: 680 DEIFS 684
           + I S
Sbjct: 209 EIILS 213

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 67/161 (41%), Gaps = 22/161 (13%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRH----- 563
           F E  ++G+G FG V K     D    AIK           +   E  ++  + H     
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 564 --------RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVA 615
                   RN +K +++        + +EY    +L   ++S N      +   +   + 
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK 656
            AL Y+H   S  IIH DLKP N+ +D++    + DFG+AK
Sbjct: 127 EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAK 164

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 65/275 (23%), Positives = 117/275 (42%), Gaps = 31/275 (11%)
Query: 517 NNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMM-KRI-----RHRN 565
           + ++G+G FG V+     K     AIK   L+        D+EC M+ KR+      H  
Sbjct: 22  HKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPF 79
Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY 625
           L  +  +    +    V+EY+  G L   + S  +  D+ +      ++   L++LH   
Sbjct: 80  LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLH--- 135
Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG 685
           S  I++ DLK  N+LLD +    ++DFGM K  +  D          T  Y+AP EI  G
Sbjct: 136 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNXFCGTPDYIAP-EILLG 192
Query: 686 EMRLKC--WVNDSLLISVMIVVDANLLIREEKHLMTKEQPMVRMGTDLSLGQFPASYSIS 743
           +       W +  +L+  M++  +    ++E+ L       +RM                
Sbjct: 193 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS----IRMDNPFYPRWLEKEAKDL 248
Query: 744 KYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDY 778
              +++RE E+ ++G+       I  H L+R +++
Sbjct: 249 LVKLFVREPEK-RLGVRG----DIRQHPLFREINW 278

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 84/177 (47%), Gaps = 13/177 (7%)
Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI-ECGMMKRIRHRN 565
           + F + + +G G  G V+K      G+ +A K+ +L+   A ++  I E  ++       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY 625
           ++    +  +D   ++ +E+M  GSL++ L     I +   G  + I V   L YL   +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKGLTYLREKH 124
Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              I+H D+KPSN+L++      L DFG++  L++          + T  YM+P+ +
Sbjct: 125 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERL 175

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 84/177 (47%), Gaps = 13/177 (7%)
Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI-ECGMMKRIRHRN 565
           + F + + +G G  G V+K      G+ +A K+ +L+   A ++  I E  ++       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY 625
           ++    +  +D   ++ +E+M  GSL++ L     I +   G  + I V   L YL   +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKGLTYLREKH 124
Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              I+H D+KPSN+L++      L DFG++  L++          + T  YM+P+ +
Sbjct: 125 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERL 175

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 24/65 (36%), Positives = 38/65 (58%), Gaps = 1/65 (1%)
Query: 618 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 677
           LE +H  +   I+H DLKP+N L+ D M+  L DFG+A  +  +  S+ +   + T+ YM
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 223
Query: 678 APDEI 682
            P+ I
Sbjct: 224 PPEAI 228

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 74/166 (44%), Gaps = 23/166 (13%)
Query: 517 NNLIGRGGFGPVYK------------DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHR 564
           N  +G+G F  ++K               EV +KV +  +    +SF     MM ++ H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 565 NLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFG 624
           +L+     C   D   LV E++  GSL+  L      ++I   L +   +A+A   +HF 
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAA---MHFL 129
Query: 625 YSVPIIHCDLKPSNVLL---DDNMVAH-----LSDFGMAKPLLEED 662
               +IH ++   N+LL   +D    +     LSD G++  +L +D
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 24/65 (36%), Positives = 38/65 (58%), Gaps = 1/65 (1%)
Query: 618 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 677
           LE +H  +   I+H DLKP+N L+ D M+  L DFG+A  +  +  S+ +   + T+ YM
Sbjct: 117 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 175
Query: 678 APDEI 682
            P+ I
Sbjct: 176 PPEAI 180

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 24/65 (36%), Positives = 38/65 (58%), Gaps = 1/65 (1%)
Query: 618 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 677
           LE +H  +   I+H DLKP+N L+ D M+  L DFG+A  +  +  S+ +   + T+ YM
Sbjct: 121 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 179
Query: 678 APDEI 682
            P+ I
Sbjct: 180 PPEAI 184

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 77/182 (42%), Gaps = 14/182 (7%)
Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAF-----KSFDIECGMMKRI 561
             F +  ++G G FG VYK     +G +V I V  ++   A      K    E  +M  +
Sbjct: 49  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASV 108
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
            + ++ +++  C     + L+ + MP G L   +      +     LN  + +A  + YL
Sbjct: 109 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 167
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
                  ++H DL   NVL+       ++DFG+AK L  E++          I +MA + 
Sbjct: 168 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 224
Query: 682 IF 683
           I 
Sbjct: 225 IL 226

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 84/177 (47%), Gaps = 13/177 (7%)
Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI-ECGMMKRIRHRN 565
           + F + + +G G  G V+K      G+ +A K+ +L+   A ++  I E  ++       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY 625
           ++    +  +D   ++ +E+M  GSL++ L     I +   G  + I V   L YL   +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKGLTYLREKH 124
Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              I+H D+KPSN+L++      L DFG++  L++          + T  YM+P+ +
Sbjct: 125 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERL 175

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 84/177 (47%), Gaps = 13/177 (7%)
Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI-ECGMMKRIRHRN 565
           + F + + +G G  G V+K      G+ +A K+ +L+   A ++  I E  ++       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY 625
           ++    +  +D   ++ +E+M  GSL++ L     I +   G  + I V   L YL   +
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-KVSIAVIKGLTYLREKH 124
Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              I+H D+KPSN+L++      L DFG++  L++          + T  YM+P+ +
Sbjct: 125 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERL 175

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 24/65 (36%), Positives = 38/65 (58%), Gaps = 1/65 (1%)
Query: 618 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 677
           LE +H  +   I+H DLKP+N L+ D M+  L DFG+A  +  +  S+ +   + T+ YM
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 195
Query: 678 APDEI 682
            P+ I
Sbjct: 196 PPEAI 200

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 81/184 (44%), Gaps = 23/184 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EY+P G +   L       +    F    I++      EY
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL----TFEY 149
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP+
Sbjct: 150 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPE 201
Query: 681 EIFS 684
            I S
Sbjct: 202 IILS 205

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 89/192 (46%), Gaps = 34/192 (17%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGG---AFKSFDIECGMM 558
           +++   R+   + +G G +G V      K G+ VA+K  +  +     A +++  E  ++
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLL 75
Query: 559 KRIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGL 608
           K ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q L
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
                    L+Y+H   S  IIH DLKPSN+ ++++    + D G+A+   +E      T
Sbjct: 136 R-------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDE-----MT 180
Query: 669 QTLATIGYMAPD 680
             +AT  Y AP+
Sbjct: 181 GYVATRWYRAPE 192

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 24/203 (11%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EY+P G +   L       +    F    I++      EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL----TFEY 156
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP+
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPE 208
Query: 681 EIFS-GEMRLKCWVNDSLLISVM 702
            I S G  +   W    +LI  M
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEM 231

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 95/198 (47%), Gaps = 31/198 (15%)
Query: 517 NNLIGRGGFGPV-----YKDGMEVAIKVFN---LQYGGAFKS-----FDIECGMMKRIRH 563
           +  +G G  G V      K   +VAIK+ +      G A ++      + E  ++K++ H
Sbjct: 14  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 73
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSL-EKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
             +IKI +    +D+  +VLE M  G L +K +  GN  L           +  A++YLH
Sbjct: 74  PCIIKIKNFFDAEDY-YIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLH 130
Query: 623 FGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
                 IIH DLKP NVLL   +++ +  ++DFG +K L E   SL +T    T  Y+AP
Sbjct: 131 EN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRT-LCGTPTYLAP 184
Query: 680 DEIFS----GEMR-LKCW 692
           + + S    G  R + CW
Sbjct: 185 EVLVSVGTAGYNRAVDCW 202

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 95/198 (47%), Gaps = 31/198 (15%)
Query: 517 NNLIGRGGFGPV-----YKDGMEVAIKVFN---LQYGGAFKS-----FDIECGMMKRIRH 563
           +  +G G  G V      K   +VAIK+ +      G A ++      + E  ++K++ H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSL-EKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
             +IKI +    +D+  +VLE M  G L +K +  GN  L           +  A++YLH
Sbjct: 75  PCIIKIKNFFDAEDY-YIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLH 131
Query: 623 FGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
                 IIH DLKP NVLL   +++ +  ++DFG +K L E   SL +T    T  Y+AP
Sbjct: 132 EN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRT-LCGTPTYLAP 185
Query: 680 DEIFS----GEMR-LKCW 692
           + + S    G  R + CW
Sbjct: 186 EVLVSVGTAGYNRAVDCW 203

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 81/184 (44%), Gaps = 23/184 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EY+P G +   L       +    F    I++      EY
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL----TFEY 157
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP+
Sbjct: 158 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPE 209
Query: 681 EIFS 684
            I S
Sbjct: 210 IILS 213

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 24/203 (11%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EY+P G +   L       +    F    I++      EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL----TFEY 156
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP+
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPE 208
Query: 681 EIFS-GEMRLKCWVNDSLLISVM 702
            I S G  +   W    +LI  M
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEM 231

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 95/198 (47%), Gaps = 31/198 (15%)
Query: 517 NNLIGRGGFGPV-----YKDGMEVAIKVFN---LQYGGAFKS-----FDIECGMMKRIRH 563
           +  +G G  G V      K   +VAIK+ +      G A ++      + E  ++K++ H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSL-EKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
             +IKI +    +D+  +VLE M  G L +K +  GN  L           +  A++YLH
Sbjct: 75  PCIIKIKNFFDAEDY-YIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLH 131
Query: 623 FGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
                 IIH DLKP NVLL   +++ +  ++DFG +K L E   SL +T    T  Y+AP
Sbjct: 132 EN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRT-LCGTPTYLAP 185
Query: 680 DEIFS----GEMR-LKCW 692
           + + S    G  R + CW
Sbjct: 186 EVLVSVGTAGYNRAVDCW 203

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 24/65 (36%), Positives = 38/65 (58%), Gaps = 1/65 (1%)
Query: 618 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 677
           LE +H  +   I+H DLKP+N L+ D M+  L DFG+A  +  +  S+ +   + T+ YM
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYM 223
Query: 678 APDEI 682
            P+ I
Sbjct: 224 PPEAI 228

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 95/198 (47%), Gaps = 31/198 (15%)
Query: 517 NNLIGRGGFGPV-----YKDGMEVAIKVFN---LQYGGAFKS-----FDIECGMMKRIRH 563
           +  +G G  G V      K   +VAIK+ +      G A ++      + E  ++K++ H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSL-EKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
             +IKI +    +D+  +VLE M  G L +K +  GN  L           +  A++YLH
Sbjct: 75  PCIIKIKNFFDAEDY-YIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLH 131
Query: 623 FGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
                 IIH DLKP NVLL   +++ +  ++DFG +K L E   SL +T    T  Y+AP
Sbjct: 132 EN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRT-LCGTPTYLAP 185
Query: 680 DEIFS----GEMR-LKCW 692
           + + S    G  R + CW
Sbjct: 186 EVLVSVGTAGYNRAVDCW 203

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 81/184 (44%), Gaps = 23/184 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EY+P G +   L       +    F    I++      EY
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEY 156
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP+
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPE 208
Query: 681 EIFS 684
            I S
Sbjct: 209 IILS 212

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 81/184 (44%), Gaps = 23/184 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     IG G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EY+P G +   L       +    F    I++      EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEY 156
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP+
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPE 208
Query: 681 EIFS 684
            I S
Sbjct: 209 IILS 212

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 95/198 (47%), Gaps = 31/198 (15%)
Query: 517 NNLIGRGGFGPV-----YKDGMEVAIKVFN---LQYGGAFKS-----FDIECGMMKRIRH 563
           +  +G G  G V      K   +VAIK+ +      G A ++      + E  ++K++ H
Sbjct: 21  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 80
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSL-EKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
             +IKI +    +D+  +VLE M  G L +K +  GN  L           +  A++YLH
Sbjct: 81  PCIIKIKNFFDAEDY-YIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLH 137
Query: 623 FGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
                 IIH DLKP NVLL   +++ +  ++DFG +K L E   SL +T    T  Y+AP
Sbjct: 138 EN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRT-LCGTPTYLAP 191
Query: 680 DEIFS----GEMR-LKCW 692
           + + S    G  R + CW
Sbjct: 192 EVLVSVGTAGYNRAVDCW 209

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/182 (22%), Positives = 78/182 (42%), Gaps = 14/182 (7%)
Query: 512 NRFSENNLIGRGGFGPVYK-------DGMEVAIKVFNLQYG---GAFKSFDIECGMMKRI 561
             F +  ++G G FG VYK       + +++ + +  L+      A K    E  +M  +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
            + ++ +++  C     + L+++ MP G L   +      +     LN  + +A  + YL
Sbjct: 79  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 137
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
                  ++H DL   NVL+       ++DFG+AK L  E++          I +MA + 
Sbjct: 138 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 194
Query: 682 IF 683
           I 
Sbjct: 195 IL 196

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 26/85 (30%), Positives = 46/85 (54%), Gaps = 13/85 (15%)
Query: 608 LNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT- 666
           L+I + +A A+E+LH   S  ++H DLKPSN+    + V  + DFG+   + ++++  T 
Sbjct: 121 LHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 667 ---------QTQTLATIGYMAPDEI 682
                     T  + T  YM+P++I
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQI 202

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 41/182 (22%), Positives = 78/182 (42%), Gaps = 14/182 (7%)
Query: 512 NRFSENNLIGRGGFGPVYK-------DGMEVAIKVFNLQYG---GAFKSFDIECGMMKRI 561
             F +  ++G G FG VYK       + +++ + +  L+      A K    E  +M  +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
            + ++ +++  C     + L+++ MP G L   +      +     LN  + +A  + YL
Sbjct: 76  DNPHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 134
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
                  ++H DL   NVL+       ++DFG+AK L  E++          I +MA + 
Sbjct: 135 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 191
Query: 682 IF 683
           I 
Sbjct: 192 IL 193

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 41/182 (22%), Positives = 78/182 (42%), Gaps = 14/182 (7%)
Query: 512 NRFSENNLIGRGGFGPVYK-------DGMEVAIKVFNLQYG---GAFKSFDIECGMMKRI 561
             F +  ++G G FG VYK       + +++ + +  L+      A K    E  +M  +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
            + ++ +++  C     + L+++ MP G L   +      +     LN  + +A  + YL
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
                  ++H DL   NVL+       ++DFG+AK L  E++          I +MA + 
Sbjct: 136 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 682 IF 683
           I 
Sbjct: 193 IL 194

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 41/182 (22%), Positives = 78/182 (42%), Gaps = 14/182 (7%)
Query: 512 NRFSENNLIGRGGFGPVYK-------DGMEVAIKVFNLQYG---GAFKSFDIECGMMKRI 561
             F +  ++G G FG VYK       + +++ + +  L+      A K    E  +M  +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
            + ++ +++  C     + L+++ MP G L   +      +     LN  + +A  + YL
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 136
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
                  ++H DL   NVL+       ++DFG+AK L  E++          I +MA + 
Sbjct: 137 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 193
Query: 682 IF 683
           I 
Sbjct: 194 IL 195

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 41/182 (22%), Positives = 78/182 (42%), Gaps = 14/182 (7%)
Query: 512 NRFSENNLIGRGGFGPVYK-------DGMEVAIKVFNLQYG---GAFKSFDIECGMMKRI 561
             F +  ++G G FG VYK       + +++ + +  L+      A K    E  +M  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
            + ++ +++  C     + L+++ MP G L   +      +     LN  + +A  + YL
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
                  ++H DL   NVL+       ++DFG+AK L  E++          I +MA + 
Sbjct: 134 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 682 IF 683
           I 
Sbjct: 191 IL 192

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 41/182 (22%), Positives = 78/182 (42%), Gaps = 14/182 (7%)
Query: 512 NRFSENNLIGRGGFGPVYK-------DGMEVAIKVFNLQYG---GAFKSFDIECGMMKRI 561
             F +  ++G G FG VYK       + +++ + +  L+      A K    E  +M  +
Sbjct: 16  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 75
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
            + ++ +++  C     + L+++ MP G L   +      +     LN  + +A  + YL
Sbjct: 76  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 134
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
                  ++H DL   NVL+       ++DFG+AK L  E++          I +MA + 
Sbjct: 135 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 191
Query: 682 IF 683
           I 
Sbjct: 192 IL 193

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 81/184 (44%), Gaps = 23/184 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EY+P G +   L       +    F    I++      EY
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEY 156
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP+
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPE 208
Query: 681 EIFS 684
            I S
Sbjct: 209 IILS 212

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 82/177 (46%), Gaps = 16/177 (9%)
Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI-ECGMMKRIRHRN 565
            R SE   +G G  G V K      G+ +A K+ +L+   A ++  I E  ++       
Sbjct: 19  ERISE---LGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY 625
           ++    +  +D   ++ +E+M  GSL++ L     I +   G  + I V   L YL   +
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-KVSIAVLRGLAYLREKH 134
Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              I+H D+KPSN+L++      L DFG++  L++          + T  YMAP+ +
Sbjct: 135 Q--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMAPERL 185

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 81/184 (44%), Gaps = 23/184 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EY+P G +   L       +    F    I++      EY
Sbjct: 101 PFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEY 156
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP+
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPE 208
Query: 681 EIFS 684
            I S
Sbjct: 209 IILS 212

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 25/74 (33%), Positives = 41/74 (55%), Gaps = 5/74 (6%)
Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
            + + +  AL YL   + V  IH D+KPSN+LLD+     L DFG++  L+++     + 
Sbjct: 128 KMTVAIVKALYYLKEKHGV--IHRDVKPSNILLDERGQIKLCDFGISGRLVDDK---AKD 182
Query: 669 QTLATIGYMAPDEI 682
           ++     YMAP+ I
Sbjct: 183 RSAGCAAYMAPERI 196

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 81/184 (44%), Gaps = 23/184 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 93
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EY+P G +   L       +    F    I++      EY
Sbjct: 94  PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEY 149
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP+
Sbjct: 150 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPE 201
Query: 681 EIFS 684
            I S
Sbjct: 202 IILS 205

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 81/184 (44%), Gaps = 23/184 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EY+P G +   L       +    F    I++      EY
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEY 157
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP+
Sbjct: 158 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPE 209
Query: 681 EIFS 684
            I S
Sbjct: 210 IILS 213

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 45.8 bits (107), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 46/186 (24%), Positives = 77/186 (41%), Gaps = 23/186 (12%)
Query: 520 IGRGGFGPVYK---DGM-------EVAIKVFNLQYGGAFK-SFDIECGMMKRIRHRNLIK 568
           +G G FG VY+    GM       +VA+K     Y    +  F +E  ++ +  H+N+++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCLY------SGNYILDIFQGLNIMIDVASALEYLH 622
            I        + ++LE M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 623 FGYSVPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
             +    IH D+   N LL       VA + DFGMA+ +            +  + +M P
Sbjct: 173 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 680 DEIFSG 685
           +    G
Sbjct: 230 EAFMEG 235

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 81/184 (44%), Gaps = 23/184 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EY+P G +   L       +    F    I++      EY
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEY 157
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP+
Sbjct: 158 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPE 209
Query: 681 EIFS 684
            I S
Sbjct: 210 IILS 213

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 34/215 (15%)
Query: 491 VNMPSVADQRRFTYLELFQATNRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYG 545
           +N  + AD+R    ++ FQ         + G+G FG V        GM VAIK   +   
Sbjct: 8   LNAAAAADERSRKEMDRFQV------ERMAGQGTFGTVQLGKEKSTGMSVAIK--KVIQD 59
Query: 546 GAFKSFDIECGM-MKRIRHRNLIKIIS-------SCSNDDFKALVLEYMPLGSLEKCLYS 597
             F++ +++    +  + H N++++ S           D +  +V+EY+P  +L +C   
Sbjct: 60  PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRC--C 116
Query: 598 GNYILDIFQGLNIMIDV-----ASALEYLHFGYSVPIIHCDLKPSNVLLDD-NMVAHLSD 651
            NY         I+I V       ++  LH   SV + H D+KP NVL+++ +    L D
Sbjct: 117 RNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCD 175
Query: 652 FGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGE 686
           FG AK L   + ++     + +  Y AP+ IF  +
Sbjct: 176 FGSAKKLSPSEPNVA---YICSRYYRAPELIFGNQ 207

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 81/184 (44%), Gaps = 23/184 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EY+P G +   L       +    F    I++      EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEY 156
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP+
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPE 208
Query: 681 EIFS 684
            I S
Sbjct: 209 IILS 212

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 81/184 (44%), Gaps = 23/184 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EY+P G +   L       +    F    I++      EY
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEY 157
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP+
Sbjct: 158 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPE 209
Query: 681 EIFS 684
            I S
Sbjct: 210 IILS 213

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/141 (24%), Positives = 65/141 (46%), Gaps = 8/141 (5%)
Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G FG VYK       +  A KV + +     + + +E  ++    H N++K++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDL 634
            ++   +++E+   G+++  +      L   Q   +      AL YLH      IIH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDL 161
Query: 635 KPSNVLLDDNMVAHLSDFGMA 655
           K  N+L   +    L+DFG++
Sbjct: 162 KAGNILFTLDGDIKLADFGVS 182

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/141 (24%), Positives = 65/141 (46%), Gaps = 8/141 (5%)
Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G FG VYK       +  A KV + +     + + +E  ++    H N++K++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDL 634
            ++   +++E+   G+++  +      L   Q   +      AL YLH      IIH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDL 161
Query: 635 KPSNVLLDDNMVAHLSDFGMA 655
           K  N+L   +    L+DFG++
Sbjct: 162 KAGNILFTLDGDIKLADFGVS 182

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 88/203 (43%), Gaps = 24/203 (11%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EY+P G +   L       +    F    I++      EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEY 156
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP+
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPE 208
Query: 681 EIFS-GEMRLKCWVNDSLLISVM 702
            I S G  +   W    +LI  M
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEM 231

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 81/184 (44%), Gaps = 23/184 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EY+P G +   L       +    F    I++      EY
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEY 177
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP+
Sbjct: 178 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPE 229
Query: 681 EIFS 684
            I S
Sbjct: 230 IILS 233

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 76/166 (45%), Gaps = 35/166 (21%)
Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQY------GGAFKSFDIECGMMKR 560
           +R+     +G G +G VYK         VAIK   L++      G A +    E  ++K 
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR----EVSLLKE 89
Query: 561 IRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEY 620
           ++HRN+I++ S   ++    L+ EY     L+K +          +  ++ + V  +  Y
Sbjct: 90  LQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMD---------KNPDVSMRVIKSFLY 139
Query: 621 -----LHFGYSVPIIHCDLKPSNVLL-----DDNMVAHLSDFGMAK 656
                ++F +S   +H DLKP N+LL      +  V  + DFG+A+
Sbjct: 140 QLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/141 (24%), Positives = 65/141 (46%), Gaps = 8/141 (5%)
Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G FG VYK       +  A KV + +     + + +E  ++    H N++K++ +  
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDL 634
            ++   +++E+   G+++  +      L   Q   +      AL YLH      IIH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDL 161
Query: 635 KPSNVLLDDNMVAHLSDFGMA 655
           K  N+L   +    L+DFG++
Sbjct: 162 KAGNILFTLDGDIKLADFGVS 182

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/85 (34%), Positives = 47/85 (55%), Gaps = 13/85 (15%)
Query: 608 LNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL--LEEDQSL 665
           L+I I +A A+E+LH   S  ++H DLKPSN+    + V  + DFG+   +   EE+Q++
Sbjct: 167 LHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 666 --------TQTQTLATIGYMAPDEI 682
                   T    + T  YM+P++I
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQI 248

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 81/184 (44%), Gaps = 23/184 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EY+P G +   L       +    F    I++      EY
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEY 157
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP+
Sbjct: 158 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPE 209
Query: 681 EIFS 684
            I S
Sbjct: 210 IILS 213

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/186 (20%), Positives = 77/186 (41%), Gaps = 23/186 (12%)
Query: 520 IGRGGFGPVY--------KDGMEVAIKVFNLQYGGAFKS---FDIECGMMKRIRHRNLIK 568
           +G+G FG VY        K   E  + V  +    + +    F  E  +MK     ++++
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCLYS---------GNYILDIFQGLNIMIDVASALE 619
           ++   S      +V+E M  G L+  L S         G     + + + +  ++A  + 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 620 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
           YL+   +   +H +L   N ++  +    + DFGM + + E D      + L  + +MAP
Sbjct: 146 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 202
Query: 680 DEIFSG 685
           + +  G
Sbjct: 203 ESLKDG 208

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 48/184 (26%), Positives = 81/184 (44%), Gaps = 23/184 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EY+P G +   L       +    F    I++      EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEY 156
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP+
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPE 208
Query: 681 EIFS 684
            I S
Sbjct: 209 IILS 212

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 94/195 (48%), Gaps = 31/195 (15%)
Query: 520 IGRGGFGPV-----YKDGMEVAIKVFN---LQYGGAFKS-----FDIECGMMKRIRHRNL 566
           +G G  G V      K   +VAI++ +      G A ++      + E  ++K++ H  +
Sbjct: 157 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 216
Query: 567 IKIISSCSNDDFKALVLEYMPLGSL-EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY 625
           IKI +    +D+  +VLE M  G L +K +  GN  L           +  A++YLH   
Sbjct: 217 IKIKNFFDAEDY-YIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLH--- 270
Query: 626 SVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              IIH DLKP NVLL   +++ +  ++DFG +K L E   SL +T    T  Y+AP+ +
Sbjct: 271 ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRT-LCGTPTYLAPEVL 327
Query: 683 FS----GEMR-LKCW 692
            S    G  R + CW
Sbjct: 328 VSVGTAGYNRAVDCW 342

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/186 (20%), Positives = 77/186 (41%), Gaps = 23/186 (12%)
Query: 520 IGRGGFGPVY--------KDGMEVAIKVFNLQYGGAFKS---FDIECGMMKRIRHRNLIK 568
           +G+G FG VY        K   E  + V  +    + +    F  E  +MK     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCLYS---------GNYILDIFQGLNIMIDVASALE 619
           ++   S      +V+E M  G L+  L S         G     + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 620 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
           YL+   +   +H +L   N ++  +    + DFGM + + E D      + L  + +MAP
Sbjct: 145 YLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 680 DEIFSG 685
           + +  G
Sbjct: 202 ESLKDG 207

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 88/192 (45%), Gaps = 34/192 (17%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGG---AFKSFDIECGMM 558
           +++   R+   + +G G +G V      K G  VA+K  +  +     A +++  E  ++
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLL 75
Query: 559 KRIRHRNLIKIISSCS--------NDDFKALVLEYMPLGSLEKC--LYSGNYILDIFQGL 608
           K ++H N+I ++   +        ND +    L    L ++ KC  L   +    I+Q L
Sbjct: 76  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
                    L+Y+H   S  IIH DLKPSN+ ++++    + DF +A+   +E      T
Sbjct: 136 R-------GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDE-----MT 180
Query: 669 QTLATIGYMAPD 680
             +AT  Y AP+
Sbjct: 181 GYVATRWYRAPE 192

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 75/174 (43%), Gaps = 24/174 (13%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSC 573
           +G G +G V           VA+K+ +++      ++   E  + K + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH-------FGYS 626
              + + L LEY        C  SG  + D  +  +I +    A  + H       + + 
Sbjct: 74  REGNIQYLFLEY--------C--SGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP+
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSC 573
           +G G +G V           VA+K+ +++      ++   E  + K + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH-------FGYS 626
              + + L LEY           SG  + D  +  +I +    A  + H       + + 
Sbjct: 74  REGNIQYLFLEYC----------SGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP+
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSC 573
           +G G +G V           VA+K+ +++      ++   E  + K + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH-------FGYS 626
              + + L LEY           SG  + D  +  +I +    A  + H       + + 
Sbjct: 75  REGNIQYLFLEYC----------SGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP+
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSC 573
           +G G +G V           VA+K+ +++      ++   E  + K + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH-------FGYS 626
              + + L LEY           SG  + D  +  +I +    A  + H       + + 
Sbjct: 74  REGNIQYLFLEYC----------SGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP+
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/199 (23%), Positives = 79/199 (39%), Gaps = 29/199 (14%)
Query: 512 NRFSENNLIGRGGFGPVY--------KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRI-- 561
           +R      +GRG FG V         K      + V  L+ G            +K +  
Sbjct: 29  DRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 88
Query: 562 --RHRNLIKIISSCSNDDFKALVL-EYMPLGSLEKCL---------YSGNYILDIFQGLN 609
              H N++ ++ +C+      +V+ E+   G+L   L         Y    +   F  L 
Sbjct: 89  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLE 148
Query: 610 IMI----DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL 665
            +I     VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ + ++   +
Sbjct: 149 HLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXV 205
Query: 666 TQTQTLATIGYMAPDEIFS 684
            +      + +MAP+ IF 
Sbjct: 206 RKGDARLPLKWMAPETIFD 224

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 75/174 (43%), Gaps = 24/174 (13%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSC 573
           +G G +G V           VA+K+ +++      ++   E  + K + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH-------FGYS 626
              + + L LEY        C  SG  + D  +  +I +    A  + H       + + 
Sbjct: 75  REGNIQYLFLEY--------C--SGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP+
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 177

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 26/71 (36%), Positives = 41/71 (57%), Gaps = 3/71 (4%)
Query: 612 IDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL 671
           I +A+     H   ++ IIH D+KPSN+LLD +    L DFG++  L++   S+ +T+  
Sbjct: 130 ITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD---SIAKTRDA 186
Query: 672 ATIGYMAPDEI 682
               YMAP+ I
Sbjct: 187 GCRPYMAPERI 197

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/210 (21%), Positives = 86/210 (40%), Gaps = 42/210 (20%)
Query: 513 RFSENNL-----IGRGGFGPVYKDG----------MEVAIKVF-NLQYGGAFKSFDIECG 556
            F  NNL     +G G FG V +            ++VA+K+  +  +    ++   E  
Sbjct: 27  EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELK 86
Query: 557 MMKRI-RHRNLIKIISSCSNDDFKALVLEYMPLGSL----------------------EK 593
           +M  + +H N++ ++ +C++     ++ EY   G L                      E 
Sbjct: 87  IMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEG 146
Query: 594 CLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFG 653
                   L++   L+    VA  + +L    S   IH D+   NVLL +  VA + DFG
Sbjct: 147 LDKEDGRPLELRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFG 203
Query: 654 MAKPLLEEDQSLTQTQTLATIGYMAPDEIF 683
           +A+ ++ +   + +      + +MAP+ IF
Sbjct: 204 LARDIMNDSNYIVKGNARLPVKWMAPESIF 233

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 81/200 (40%), Gaps = 22/200 (11%)
Query: 509 QATNRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQY--------GGAFKSFDIEC 555
           + + ++S  + +G G FG V+     +   EV +K    +                 +E 
Sbjct: 21  EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEI 80
Query: 556 GMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVA 615
            ++ R+ H N+IK++    N  F  LV+E    G         +  LD      I   + 
Sbjct: 81  AILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLV 140
Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 675
           SA+ YL       IIH D+K  N+++ ++    L DFG A  L  E   L  T    TI 
Sbjct: 141 SAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYT-FCGTIE 194
Query: 676 YMAPDEIFSGEMR---LKCW 692
           Y AP+ +     R   L+ W
Sbjct: 195 YCAPEVLMGNPYRGPELEMW 214

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/168 (26%), Positives = 77/168 (45%), Gaps = 12/168 (7%)
Query: 520 IGRGGFGPV-----YKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           IG G  G V        G +VA+K  +L+     +    E  +M+   H N++ + SS  
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDL 634
             D   +V+E++  G+L   +      ++  Q   + + V  AL YLH   +  +IH D+
Sbjct: 113 VGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLSVLRALSYLH---NQGVIHRDI 167
Query: 635 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
           K  ++LL  +    LSDFG    + +E     +   + T  +MAP+ I
Sbjct: 168 KSDSILLTSDGRIKLSDFGFCAQVSKE--VPKRKXLVGTPYWMAPEVI 213

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/174 (23%), Positives = 75/174 (43%), Gaps = 24/174 (13%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSC 573
           +G G +G V           VA+K+ +++      ++   E  + K + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH-------FGYS 626
              + + L LEY        C  SG  + D  +  +I +    A  + H       + + 
Sbjct: 74  REGNIQYLFLEY--------C--SGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP+
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSC 573
           +G G +G V           VA+K+ +++      ++   E  + K + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH-------FGYS 626
              + + L LEY           SG  + D  +  +I +    A  + H       + + 
Sbjct: 74  REGNIQYLFLEYC----------SGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP+
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSC 573
           +G G +G V           VA+K+ +++      ++   E  + K + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH-------FGYS 626
              + + L LEY           SG  + D  +  +I +    A  + H       + + 
Sbjct: 74  REGNIQYLFLEYC----------SGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP+
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 94/195 (48%), Gaps = 31/195 (15%)
Query: 520 IGRGGFGPV-----YKDGMEVAIKVFN---LQYGGAFKS-----FDIECGMMKRIRHRNL 566
           +G G  G V      K   +VAI++ +      G A ++      + E  ++K++ H  +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 567 IKIISSCSNDDFKALVLEYMPLGSL-EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY 625
           IKI +    +D+  +VLE M  G L +K +  GN  L           +  A++YLH   
Sbjct: 203 IKIKNFFDAEDY-YIVLELMEGGELFDKVV--GNKRLKEATCKLYFYQMLLAVQYLH--- 256
Query: 626 SVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              IIH DLKP NVLL   +++ +  ++DFG +K L E   SL +T    T  Y+AP+ +
Sbjct: 257 ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRT-LCGTPTYLAPEVL 313
Query: 683 FS----GEMR-LKCW 692
            S    G  R + CW
Sbjct: 314 VSVGTAGYNRAVDCW 328

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/74 (37%), Positives = 42/74 (56%), Gaps = 5/74 (6%)
Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
            I + +  ALE+LH   SV  IH D+KPSNVL++      + DFG++  L++   S+ +T
Sbjct: 157 KIAVSIVKALEHLHSKLSV--IHRDVKPSNVLINALGQVKMCDFGISGYLVD---SVAKT 211
Query: 669 QTLATIGYMAPDEI 682
                  YMAP+ I
Sbjct: 212 IDAGCKPYMAPERI 225

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSC 573
           +G G +G V           VA+K+ +++      ++   E  + K + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH-------FGYS 626
              + + L LEY           SG  + D  +  +I +    A  + H       + + 
Sbjct: 75  REGNIQYLFLEYC----------SGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP+
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSC 573
           +G G +G V           VA+K+ +++      ++   E  + K + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH-------FGYS 626
              + + L LEY           SG  + D  +  +I +    A  + H       + + 
Sbjct: 75  REGNIQYLFLEYC----------SGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP+
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSC 573
           +G G +G V           VA+K+ +++      ++   E  + K + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH-------FGYS 626
              + + L LEY           SG  + D  +  +I +    A  + H       + + 
Sbjct: 74  REGNIQYLFLEYC----------SGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP+
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSC 573
           +G G +G V           VA+K+ +++      ++   E  + K + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH-------FGYS 626
              + + L LEY           SG  + D  +  +I +    A  + H       + + 
Sbjct: 75  REGNIQYLFLEYC----------SGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP+
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 86/192 (44%), Gaps = 30/192 (15%)
Query: 510 ATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFK-----SFDIECGMMK 559
           AT+R+     IG G +G VYK      G  VA+K   +  GG        S   E  +++
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 560 RIR---HRNLIKIISSCS----NDDFK-ALVLEYMPLG---SLEKCLYSGNYILDIFQGL 608
           R+    H N+++++  C+    + + K  LV E++       L+K    G   L      
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG---LPAETIK 123
Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
           ++M      L++LH      I+H DLKP N+L+       L+DFG+A+        +  T
Sbjct: 124 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALT 177
Query: 669 QTLATIGYMAPD 680
             + T+ Y AP+
Sbjct: 178 PVVVTLWYRAPE 189

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 81/184 (44%), Gaps = 23/184 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EY P G +   L       +    F    I++      EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEY 156
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+++D      ++DFG+AK +      L       T  Y+AP+
Sbjct: 157 LH---SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC-----GTPEYLAPE 208
Query: 681 EIFS 684
            I S
Sbjct: 209 IILS 212

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSC 573
           +G G +G V           VA+K+ +++      ++   E  + K + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH-------FGYS 626
              + + L LEY           SG  + D  +  +I +    A  + H       + + 
Sbjct: 75  REGNIQYLFLEYC----------SGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP+
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSC 573
           +G G +G V           VA+K+ +++      ++   E  + K + H N++K     
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH-------FGYS 626
              + + L LEY           SG  + D  +  +I +    A  + H       + + 
Sbjct: 73  REGNIQYLFLEYC----------SGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP+
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSC 573
           +G G +G V           VA+K+ +++      ++   E  + K + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH-------FGYS 626
              + + L LEY           SG  + D  +  +I +    A  + H       + + 
Sbjct: 74  REGNIQYLFLEYC----------SGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP+
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/182 (22%), Positives = 77/182 (42%), Gaps = 14/182 (7%)
Query: 512 NRFSENNLIGRGGFGPVYK-------DGMEVAIKVFNLQYG---GAFKSFDIECGMMKRI 561
             F +  ++G G FG VYK       + +++ + +  L+      A K    E  +M  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
            + ++ +++  C     + L+ + MP G L   +      +     LN  + +A  + YL
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
                  ++H DL   NVL+       ++DFG+AK L  E++          I +MA + 
Sbjct: 134 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 682 IF 683
           I 
Sbjct: 191 IL 192

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSC 573
           +G G +G V           VA+K+ +++      ++   E  + K + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH-------FGYS 626
              + + L LEY           SG  + D  +  +I +    A  + H       + + 
Sbjct: 74  REGNIQYLFLEYC----------SGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP+
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSC 573
           +G G +G V           VA+K+ +++      ++   E  + K + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH-------FGYS 626
              + + L LEY           SG  + D  +  +I +    A  + H       + + 
Sbjct: 74  REGNIQYLFLEYC----------SGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP+
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/182 (22%), Positives = 77/182 (42%), Gaps = 14/182 (7%)
Query: 512 NRFSENNLIGRGGFGPVYK-------DGMEVAIKVFNLQYG---GAFKSFDIECGMMKRI 561
             F +  ++G G FG VYK       + +++ + +  L+      A K    E  +M  +
Sbjct: 19  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 78
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
            + ++ +++  C     + L+++ MP G L   +      +     LN  + +A  + YL
Sbjct: 79  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 137
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
                  ++H DL   NVL+       ++DFG AK L  E++          I +MA + 
Sbjct: 138 E---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 194
Query: 682 IF 683
           I 
Sbjct: 195 IL 196

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSC 573
           +G G +G V           VA+K+ +++      ++   E  + K + H N++K     
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH-------FGYS 626
              + + L LEY           SG  + D  +  +I +    A  + H       + + 
Sbjct: 74  REGNIQYLFLEYC----------SGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG 122
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP+
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPE 176

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 73/166 (43%), Gaps = 23/166 (13%)
Query: 517 NNLIGRGGFGPVYK------------DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHR 564
           N  +G+G F  ++K               EV +KV +  +    +SF     MM ++ H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 565 NLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFG 624
           +L+     C   D   LV E++  GSL+  L      ++I   L +   +A A   +HF 
Sbjct: 73  HLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAWA---MHFL 129
Query: 625 YSVPIIHCDLKPSNVLL---DDNMVAH-----LSDFGMAKPLLEED 662
               +IH ++   N+LL   +D    +     LSD G++  +L +D
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 74/174 (42%), Gaps = 24/174 (13%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSC 573
           +G G +G V           VA+K+ +++      ++   E  + K + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH-------FGYS 626
              + + L LEY           SG  + D  +  +I +    A  + H       + + 
Sbjct: 75  REGNIQYLFLEYC----------SGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP+
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/182 (22%), Positives = 77/182 (42%), Gaps = 14/182 (7%)
Query: 512 NRFSENNLIGRGGFGPVYK-------DGMEVAIKVFNLQYG---GAFKSFDIECGMMKRI 561
             F +  ++G G FG VYK       + +++ + +  L+      A K    E  +M  +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
            + ++ +++  C     + L+ + MP G L   +      +     LN  + +A  + YL
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
                  ++H DL   NVL+       ++DFG+AK L  E++          I +MA + 
Sbjct: 136 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 682 IF 683
           I 
Sbjct: 193 IL 194

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/182 (22%), Positives = 77/182 (42%), Gaps = 14/182 (7%)
Query: 512 NRFSENNLIGRGGFGPVYK-------DGMEVAIKVFNLQYG---GAFKSFDIECGMMKRI 561
             F +  ++G G FG VYK       + +++ + +  L+      A K    E  +M  +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
            + ++ +++  C     + L+++ MP G L   +      +     LN  + +A  + YL
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
                  ++H DL   NVL+       ++DFG AK L  E++          I +MA + 
Sbjct: 136 E---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 682 IF 683
           I 
Sbjct: 193 IL 194

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/182 (22%), Positives = 77/182 (42%), Gaps = 14/182 (7%)
Query: 512 NRFSENNLIGRGGFGPVYK-------DGMEVAIKVFNLQYG---GAFKSFDIECGMMKRI 561
             F +  ++G G FG VYK       + +++ + +  L+      A K    E  +M  +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
            + ++ +++  C     + L+++ MP G L   +      +     LN  + +A  + YL
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
                  ++H DL   NVL+       ++DFG AK L  E++          I +MA + 
Sbjct: 136 E---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 682 IF 683
           I 
Sbjct: 193 IL 194

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/182 (22%), Positives = 77/182 (42%), Gaps = 14/182 (7%)
Query: 512 NRFSENNLIGRGGFGPVYK-------DGMEVAIKVFNLQYG---GAFKSFDIECGMMKRI 561
             F +  ++G G FG VYK       + +++ + +  L+      A K    E  +M  +
Sbjct: 21  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 80
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
            + ++ +++  C     + L+ + MP G L   +      +     LN  + +A  + YL
Sbjct: 81  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 139
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
                  ++H DL   NVL+       ++DFG+AK L  E++          I +MA + 
Sbjct: 140 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 196
Query: 682 IF 683
           I 
Sbjct: 197 IL 198

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/197 (22%), Positives = 80/197 (40%), Gaps = 27/197 (13%)
Query: 512 NRFSENNLIGRGGFGPVY--------KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRI-- 561
           +R +    +GRG FG V         K      + V  L+ G            +K +  
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 562 --RHRNLIKIISSCSNDDFKALVL-EYMPLGSLEKCLYSGNYIL----DIFQG------- 607
              H N++ ++ +C+      +V+ E+   G+L   L S         D+++        
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHL 146
Query: 608 LNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ 667
           +     VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ + ++   + +
Sbjct: 147 IXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRK 203
Query: 668 TQTLATIGYMAPDEIFS 684
                 + +MAP+ IF 
Sbjct: 204 GDARLPLKWMAPETIFD 220

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/182 (22%), Positives = 77/182 (42%), Gaps = 14/182 (7%)
Query: 512 NRFSENNLIGRGGFGPVYK-------DGMEVAIKVFNLQYG---GAFKSFDIECGMMKRI 561
             F +  ++G G FG VYK       + +++ + +  L+      A K    E  +M  +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
            + ++ +++  C     + L+ + MP G L   +      +     LN  + +A  + YL
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 140
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
                  ++H DL   NVL+       ++DFG+AK L  E++          I +MA + 
Sbjct: 141 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 197
Query: 682 IF 683
           I 
Sbjct: 198 IL 199

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 80/180 (44%), Gaps = 27/180 (15%)
Query: 520 IGRGGFGPVYK---DGMEVAIKVF-NLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           IG+G +G V+     G +VA+KVF   +    F+  +I   ++  +RH N++  I++   
Sbjct: 45  IGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVL--MRHENILGFIAA--- 99
Query: 576 DDFKA--------LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFG-YS 626
            D K         L+ +Y   GSL   L S    LD    L +     S L +LH   +S
Sbjct: 100 -DIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 627 V----PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE--DQSLTQTQTLATIGYMAPD 680
                 I H DLK  N+L+  N    ++D G+A   + +  +  +     + T  YM P+
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/182 (22%), Positives = 77/182 (42%), Gaps = 14/182 (7%)
Query: 512 NRFSENNLIGRGGFGPVYK-------DGMEVAIKVFNLQYG---GAFKSFDIECGMMKRI 561
             F +  ++G G FG VYK       + +++ + +  L+      A K    E  +M  +
Sbjct: 12  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 71
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
            + ++ +++  C     + L+ + MP G L   +      +     LN  + +A  + YL
Sbjct: 72  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYL 130
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
                  ++H DL   NVL+       ++DFG+AK L  E++          I +MA + 
Sbjct: 131 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 187
Query: 682 IF 683
           I 
Sbjct: 188 IL 189

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/182 (22%), Positives = 77/182 (42%), Gaps = 14/182 (7%)
Query: 512 NRFSENNLIGRGGFGPVYK-------DGMEVAIKVFNLQYG---GAFKSFDIECGMMKRI 561
             F +  ++G G FG VYK       + +++ + +  L+      A K    E  +M  +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
            + ++ +++  C     + L+ + MP G L   +      +     LN  + +A  + YL
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 136
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
                  ++H DL   NVL+       ++DFG+AK L  E++          I +MA + 
Sbjct: 137 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 193
Query: 682 IF 683
           I 
Sbjct: 194 IL 195

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 87/193 (45%), Gaps = 28/193 (14%)
Query: 507 LFQATNRFSENNLIGRGGFGPVYK------DGMEVAIKVFNLQYG--GAFKSFDIECGMM 558
           L +A  ++     IG G +G V+K       G  VA+K   +Q G  G   S   E  ++
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 559 KRIR---HRNLIKIISSC--SNDDFKA---LVLEYMP---LGSLEKCLYSGNYILDIFQG 607
           + +    H N++++   C  S  D +    LV E++       L+K    G     I   
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI--- 122
Query: 608 LNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ 667
            ++M  +   L++LH   S  ++H DLKP N+L+  +    L+DFG+A+        +  
Sbjct: 123 KDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMAL 176
Query: 668 TQTLATIGYMAPD 680
           T  + T+ Y AP+
Sbjct: 177 TSVVVTLWYRAPE 189

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 89/190 (46%), Gaps = 20/190 (10%)
Query: 516 ENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIR-HRNLIKI 569
           + +++G G    V          E A+K+   Q G        E  M+ + + HRN++++
Sbjct: 17  QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 570 ISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPI 629
           I     +D   LV E M  GS+   ++   +  ++   + ++ DVASAL++LH   +  I
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV-VVQDVASALDFLH---NKGI 132
Query: 630 IHCDLKPSNVLLDD-NMVA--HLSDFGMAKPL-LEEDQSLTQTQTLAT----IGYMAPD- 680
            H DLKP N+L +  N V+   + DF +   + L  D S   T  L T      YMAP+ 
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192
Query: 681 -EIFSGEMRL 689
            E FS E  +
Sbjct: 193 VEAFSEEASI 202

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/65 (35%), Positives = 37/65 (56%), Gaps = 1/65 (1%)
Query: 618 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 677
           LE +H  +   I+H DLKP+N L+ D M+  L DFG+A  +  +  S+ +   +  + YM
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGAVNYM 223
Query: 678 APDEI 682
            P+ I
Sbjct: 224 PPEAI 228

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/182 (22%), Positives = 77/182 (42%), Gaps = 14/182 (7%)
Query: 512 NRFSENNLIGRGGFGPVYK-------DGMEVAIKVFNLQYG---GAFKSFDIECGMMKRI 561
             F +  ++G G FG VYK       + +++ + +  L+      A K    E  +M  +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
            + ++ +++  C     + L+ + MP G L   +      +     LN  + +A  + YL
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 136
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
                  ++H DL   NVL+       ++DFG+AK L  E++          I +MA + 
Sbjct: 137 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 193
Query: 682 IF 683
           I 
Sbjct: 194 IL 195

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 63/143 (44%), Gaps = 11/143 (7%)
Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISS 572
           IG+G F  V        G EVA+K+ +       + +    E  + K + H N++K+   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 573 CSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
              +    LV EY   G +   L +     +  +       + SA++Y H  +   I+H 
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGRXKEK-EARAKFRQIVSAVQYCHQKF---IVHR 137
Query: 633 DLKPSNVLLDDNMVAHLSDFGMA 655
           DLK  N+LLD +    ++DFG +
Sbjct: 138 DLKAENLLLDADXNIKIADFGFS 160

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/182 (22%), Positives = 77/182 (42%), Gaps = 14/182 (7%)
Query: 512 NRFSENNLIGRGGFGPVYK-------DGMEVAIKVFNLQYG---GAFKSFDIECGMMKRI 561
             F +  ++G G FG VYK       + +++ + +  L+      A K    E  +M  +
Sbjct: 25  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 84
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
            + ++ +++  C     + L+ + MP G L   +      +     LN  + +A  + YL
Sbjct: 85  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 143
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
                  ++H DL   NVL+       ++DFG+AK L  E++          I +MA + 
Sbjct: 144 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 200
Query: 682 IF 683
           I 
Sbjct: 201 IL 202

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/182 (22%), Positives = 77/182 (42%), Gaps = 14/182 (7%)
Query: 512 NRFSENNLIGRGGFGPVYK-------DGMEVAIKVFNLQYG---GAFKSFDIECGMMKRI 561
             F +  ++G G FG VYK       + +++ + +  L+      A K    E  +M  +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
            + ++ +++  C     + L+ + MP G L   +      +     LN  + +A  + YL
Sbjct: 69  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
                  ++H DL   NVL+       ++DFG+AK L  E++          I +MA + 
Sbjct: 128 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 682 IF 683
           I 
Sbjct: 185 IL 186

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/182 (22%), Positives = 77/182 (42%), Gaps = 14/182 (7%)
Query: 512 NRFSENNLIGRGGFGPVYK-------DGMEVAIKVFNLQYG---GAFKSFDIECGMMKRI 561
             F +  ++G G FG VYK       + +++ + +  L+      A K    E  +M  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
            + ++ +++  C     + L+ + MP G L   +      +     LN  + +A  + YL
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
                  ++H DL   NVL+       ++DFG+AK L  E++          I +MA + 
Sbjct: 134 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 682 IF 683
           I 
Sbjct: 191 IL 192

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/182 (22%), Positives = 77/182 (42%), Gaps = 14/182 (7%)
Query: 512 NRFSENNLIGRGGFGPVYK-------DGMEVAIKVFNLQYG---GAFKSFDIECGMMKRI 561
             F +  ++G G FG VYK       + +++ + +  L+      A K    E  +M  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
            + ++ +++  C     + L+ + MP G L   +      +     LN  + +A  + YL
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
                  ++H DL   NVL+       ++DFG+AK L  E++          I +MA + 
Sbjct: 134 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 682 IF 683
           I 
Sbjct: 191 IL 192

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/154 (23%), Positives = 68/154 (44%), Gaps = 19/154 (12%)
Query: 535 VAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEK 593
           VA+K+ +++      ++   E  + K + H N++K        + + L LEY        
Sbjct: 34  VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC------- 86
Query: 594 CLYSGNYILDIFQGLNIMIDVASALEYLH-------FGYSVPIIHCDLKPSNVLLDDNMV 646
              SG  + D  +  +I +    A  + H       + + + I H D+KP N+LLD+   
Sbjct: 87  ---SGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN 142
Query: 647 AHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
             +SDFG+A      ++     +   T+ Y+AP+
Sbjct: 143 LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 176

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 23/65 (35%), Positives = 37/65 (56%), Gaps = 1/65 (1%)
Query: 618 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 677
           LE +H  +   I+H DLKP+N L+ D M+  L DFG+A  +  +   + +   + T+ YM
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFLIVDGMLK-LIDFGIANQMQPDXXXVVKDSQVGTVNYM 195
Query: 678 APDEI 682
            P+ I
Sbjct: 196 PPEAI 200

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/182 (22%), Positives = 77/182 (42%), Gaps = 14/182 (7%)
Query: 512 NRFSENNLIGRGGFGPVYK-------DGMEVAIKVFNLQYG---GAFKSFDIECGMMKRI 561
             F +  ++G G FG VYK       + +++ + +  L+      A K    E  +M  +
Sbjct: 18  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 77
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
            + ++ +++  C     + L+ + MP G L   +      +     LN  + +A  + YL
Sbjct: 78  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 136
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
                  ++H DL   NVL+       ++DFG+AK L  E++          I +MA + 
Sbjct: 137 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 193
Query: 682 IF 683
           I 
Sbjct: 194 IL 195

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/182 (22%), Positives = 77/182 (42%), Gaps = 14/182 (7%)
Query: 512 NRFSENNLIGRGGFGPVYK-------DGMEVAIKVFNLQYG---GAFKSFDIECGMMKRI 561
             F +  ++G G FG VYK       + +++ + +  L+      A K    E  +M  +
Sbjct: 40  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 99
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
            + ++ +++  C     + L+ + MP G L   +      +     LN  + +A  + YL
Sbjct: 100 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 158
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
                  ++H DL   NVL+       ++DFG+AK L  E++          I +MA + 
Sbjct: 159 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 215
Query: 682 IF 683
           I 
Sbjct: 216 IL 217

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 87/193 (45%), Gaps = 28/193 (14%)
Query: 507 LFQATNRFSENNLIGRGGFGPVYKD------GMEVAIKVFNLQYG--GAFKSFDIECGMM 558
           L +A  ++     IG G +G V+K       G  VA+K   +Q G  G   S   E  ++
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 559 KRIR---HRNLIKIISSC--SNDDFKA---LVLEYMP---LGSLEKCLYSGNYILDIFQG 607
           + +    H N++++   C  S  D +    LV E++       L+K    G     I   
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI--- 122
Query: 608 LNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ 667
            ++M  +   L++LH   S  ++H DLKP N+L+  +    L+DFG+A+        +  
Sbjct: 123 KDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMAL 176
Query: 668 TQTLATIGYMAPD 680
           T  + T+ Y AP+
Sbjct: 177 TSVVVTLWYRAPE 189

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 87/193 (45%), Gaps = 28/193 (14%)
Query: 507 LFQATNRFSENNLIGRGGFGPVYKD------GMEVAIKVFNLQYG--GAFKSFDIECGMM 558
           L +A  ++     IG G +G V+K       G  VA+K   +Q G  G   S   E  ++
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 559 KRIR---HRNLIKIISSC--SNDDFKA---LVLEYMP---LGSLEKCLYSGNYILDIFQG 607
           + +    H N++++   C  S  D +    LV E++       L+K    G     I   
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI--- 122
Query: 608 LNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ 667
            ++M  +   L++LH   S  ++H DLKP N+L+  +    L+DFG+A+        +  
Sbjct: 123 KDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMAL 176
Query: 668 TQTLATIGYMAPD 680
           T  + T+ Y AP+
Sbjct: 177 TSVVVTLWYRAPE 189

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/70 (34%), Positives = 38/70 (54%), Gaps = 3/70 (4%)
Query: 614 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 673
           VA  +E+L    S   IH DL   N+LL +N V  + DFG+A+ + +    + +  T   
Sbjct: 208 VARGMEFLS---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 674 IGYMAPDEIF 683
           + +MAP+ IF
Sbjct: 265 LKWMAPESIF 274

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 81/184 (44%), Gaps = 23/184 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EY P G +   L       +    F    I++      EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEY 156
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+++D      ++DFG+AK +      L       T  Y+AP+
Sbjct: 157 LH---SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC-----GTPEYLAPE 208
Query: 681 EIFS 684
            I S
Sbjct: 209 IILS 212

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 49/184 (26%), Positives = 79/184 (42%), Gaps = 23/184 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  + + +  
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF 101
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +VLEY P G +   L       +    F    I++      EY
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEY 157
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP+
Sbjct: 158 LH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLC-----GTPEYLAPE 209
Query: 681 EIFS 684
            I S
Sbjct: 210 IILS 213

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/197 (22%), Positives = 80/197 (40%), Gaps = 27/197 (13%)
Query: 512 NRFSENNLIGRGGFGPVY--------KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRI-- 561
           +R +    +GRG FG V         K      + V  L+ G            +K +  
Sbjct: 27  DRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 562 --RHRNLIKIISSCSNDDFKALVL-EYMPLGSLEKCLYSGNYIL----DIFQGLNIM--- 611
              H N++ ++ +C+      +V+ E+   G+L   L S         D+++    +   
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHL 146
Query: 612 ----IDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ 667
                 VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ + ++   + +
Sbjct: 147 ICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 203
Query: 668 TQTLATIGYMAPDEIFS 684
                 + +MAP+ IF 
Sbjct: 204 GDARLPLKWMAPETIFD 220

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/183 (22%), Positives = 82/183 (44%), Gaps = 20/183 (10%)
Query: 512 NRFSEN----NLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGA--FKSFDIECGMMKR 560
            RF+E       +G+G F  V +      G E A  + N +   A   +  + E  + + 
Sbjct: 7   TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRL 66
Query: 561 IRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEY 620
           ++H N++++  S S +    L+ + +  G L + + +  Y    +   +    +   LE 
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY----YSEADASHCIQQILEA 122
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNM---VAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 677
           +   + + ++H +LKP N+LL   +      L+DFG+A  +  E Q+        T GY+
Sbjct: 123 VLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW--FGFAGTPGYL 180
Query: 678 APD 680
           +P+
Sbjct: 181 SPE 183

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 78/180 (43%), Gaps = 14/180 (7%)
Query: 509 QATNRFSENNLIGRGGFGPVYK----DGMEV-AIKVFN---LQYGGAFKSFDIECGMMKR 560
           +   R+     +G+GGF   Y+    D  EV A KV     L      +    E  + K 
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 561 IRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEY 620
           + + +++       +DDF  +VLE     SL + L+     +   +    M      ++Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQY 157
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH      +IH DLK  N+ L+D+M   + DFG+A   +E D    +T    T  Y+AP+
Sbjct: 158 LHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLAT-KIEFDGERKKT-LCGTPNYIAPE 212

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 39/186 (20%), Positives = 76/186 (40%), Gaps = 23/186 (12%)
Query: 520 IGRGGFGPVY--------KDGMEVAIKVFNLQYGGAFKS---FDIECGMMKRIRHRNLIK 568
           +G+G FG VY        K   E  + V  +    + +    F  E  +MK     ++++
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCLYS---------GNYILDIFQGLNIMIDVASALE 619
           ++   S      +V+E M  G L+  L S         G     + + + +  ++A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 620 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
           YL+   +   +H DL   N ++  +    + DFGM + + E        + L  + +MAP
Sbjct: 145 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAP 201
Query: 680 DEIFSG 685
           + +  G
Sbjct: 202 ESLKDG 207

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 76/180 (42%), Gaps = 14/180 (7%)
Query: 509 QATNRFSENNLIGRGGFGPVYK----DGMEV-AIKVFN---LQYGGAFKSFDIECGMMKR 560
           +   R+     +G+GGF   Y+    D  EV A KV     L      +    E  + K 
Sbjct: 23  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 82
Query: 561 IRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEY 620
           + + +++       +DDF  +VLE     SL + L+     +   +    M      ++Y
Sbjct: 83  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQY 141
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH      +IH DLK  N+ L+D+M   + DFG+A  +  E     +     T  Y+AP+
Sbjct: 142 LHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKDLCGTPNYIAPE 196

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 80/184 (43%), Gaps = 23/184 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EY P G +   L       +    F    I++      EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVL----TFEY 156
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+++D      ++DFG AK +      L       T  Y+AP+
Sbjct: 157 LH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPE 208
Query: 681 EIFS 684
            I S
Sbjct: 209 IILS 212

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 80/184 (43%), Gaps = 23/184 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EY P G +   L       +    F    I++      EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEY 156
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+++D      ++DFG AK +      L       T  Y+AP+
Sbjct: 157 LH---SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPE 208
Query: 681 EIFS 684
            I S
Sbjct: 209 IILS 212

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 76/180 (42%), Gaps = 14/180 (7%)
Query: 509 QATNRFSENNLIGRGGFGPVYK----DGMEV-AIKVFN---LQYGGAFKSFDIECGMMKR 560
           +   R+     +G+GGF   Y+    D  EV A KV     L      +    E  + K 
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 561 IRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEY 620
           + + +++       +DDF  +VLE     SL + L+     +   +    M      ++Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQY 157
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH      +IH DLK  N+ L+D+M   + DFG+A  +  E     +     T  Y+AP+
Sbjct: 158 LHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKDLCGTPNYIAPE 212

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 84/186 (45%), Gaps = 27/186 (14%)
Query: 520 IGRGGFGPV-----YKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G GGF  V       DG   A+K          +    E  M +   H N++++++ C 
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 575 NDDFKA----LVLEYMPLGSL----EKCLYSGNYILDIFQGLNIMIDVASALEYLHF-GY 625
            +        L+L +   G+L    E+    GN++ +  Q L +++ +   LE +H  GY
Sbjct: 97  RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTED-QILWLLLGICRGLEAIHAKGY 155
Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFG-MAKPLLEED---QSLTQTQTLA---TIGYMA 678
           +    H DLKP+N+LL D     L D G M +  +  +   Q+LT     A   TI Y A
Sbjct: 156 A----HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 679 PDEIFS 684
           P E+FS
Sbjct: 212 P-ELFS 216

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/161 (24%), Positives = 65/161 (40%), Gaps = 22/161 (13%)
Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRH----- 563
           F E  ++G+G FG V K     D    AIK           +   E  ++  + H     
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVXLLASLNHQYVVR 66
Query: 564 --------RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVA 615
                   RN +K  ++        +  EY    +L   ++S N      +   +   + 
Sbjct: 67  YYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK 656
            AL Y+H   S  IIH +LKP N+ +D++    + DFG+AK
Sbjct: 127 EALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAK 164

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 76/180 (42%), Gaps = 14/180 (7%)
Query: 509 QATNRFSENNLIGRGGFGPVYK----DGMEV-AIKVFN---LQYGGAFKSFDIECGMMKR 560
           +   R+     +G+GGF   Y+    D  EV A KV     L      +    E  + K 
Sbjct: 39  RTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKS 98
Query: 561 IRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEY 620
           + + +++       +DDF  +VLE     SL + L+     +   +    M      ++Y
Sbjct: 99  LDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQY 157
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH      +IH DLK  N+ L+D+M   + DFG+A  +  E     +     T  Y+AP+
Sbjct: 158 LHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKXLCGTPNYIAPE 212

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 13/159 (8%)
Query: 508 FQATNRFSENNLIGRGGFGPVYK--DGME---VAIKVFNLQYGGAFKSFDI--ECGMMKR 560
           +Q  +R+   +LIG G +G V +  D +E   VAIK     +        I  E  ++ R
Sbjct: 49  WQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNR 108
Query: 561 IRHRNLIKIISSCSNDDFKALVLEYMPLGSLE---KCLYSGNYILDIFQGLNIMIDVASA 617
           + H +++K++      D +     Y+ L   +   K L+     L       ++ ++   
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 618 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK 656
           ++Y+H   S  I+H DLKP+N L++ +    + DFG+A+
Sbjct: 169 VKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLAR 204

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 81/187 (43%), Gaps = 24/187 (12%)
Query: 510 ATNRFSENN-----LIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMM- 558
           ++NR   +N     ++G+G FG V      + G   A+KV  L+     +  D+EC M  
Sbjct: 16  SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTE 73
Query: 559 KRI-----RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMID 613
           KRI      H  L ++       D    V+E++  G L   +       D  +      +
Sbjct: 74  KRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR-FDEARARFYAAE 132
Query: 614 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 673
           + SAL +LH      II+ DLK  NVLLD      L+DFGM K  +     +T      T
Sbjct: 133 IISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI--CNGVTTATFCGT 187
Query: 674 IGYMAPD 680
             Y+AP+
Sbjct: 188 PDYIAPE 194

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/182 (22%), Positives = 76/182 (41%), Gaps = 14/182 (7%)
Query: 512 NRFSENNLIGRGGFGPVYK-------DGMEVAIKVFNLQYG---GAFKSFDIECGMMKRI 561
             F +  ++G G FG VYK       + +++ + +  L+      A K    E  +M  +
Sbjct: 17  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 76
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
            + ++ +++  C     + L+ + MP G L   +      +     LN  + +A  + YL
Sbjct: 77  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
                  ++H DL   NVL+       ++DFG AK L  E++          I +MA + 
Sbjct: 136 E---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 682 IF 683
           I 
Sbjct: 193 IL 194

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 80/184 (43%), Gaps = 23/184 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EY P G +   L       +    F    I++      EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEY 156
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+++D      ++DFG AK +      L       T  Y+AP+
Sbjct: 157 LH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPE 208
Query: 681 EIFS 684
            I S
Sbjct: 209 IILS 212

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 85/192 (44%), Gaps = 23/192 (11%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAFKSFDI-ECGMMKR 560
           ++  ++ F   +L+G G +G V        G  VAIK         F    + E  ++K 
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKH 65
Query: 561 IRHRNLIKIISSCSNDDFK----ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVAS 616
            +H N+I I +    D F+      +++ +    L + + +     D  Q    +     
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF--IYQTLR 123
Query: 617 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED--------QSLTQT 668
           A++ LH G +V  IH DLKPSN+L++ N    + DFG+A+ + E          Q    T
Sbjct: 124 AVKVLH-GSNV--IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMT 180
Query: 669 QTLATIGYMAPD 680
           + +AT  Y AP+
Sbjct: 181 EXVATRWYRAPE 192

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 87/206 (42%), Gaps = 52/206 (25%)
Query: 520 IGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIR----------HR 564
           +G+G +G V+K      G  VA+K         F +F       +  R          H 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVK-------KIFDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 565 NLIKIIS--SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
           N++ +++     ND    LV +YM    L   + +   IL+      ++  +   ++YLH
Sbjct: 70  NIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH 126
Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK------------PL--------LEED 662
            G    ++H D+KPSN+LL+      ++DFG+++            PL         ++D
Sbjct: 127 SG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 663 QSLTQTQTLATIGYMAPDEIFSGEMR 688
           Q +  T  +AT  Y AP EI  G  +
Sbjct: 184 QPIL-TDYVATRWYRAP-EILLGSTK 207

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/182 (22%), Positives = 76/182 (41%), Gaps = 14/182 (7%)
Query: 512 NRFSENNLIGRGGFGPVYK-------DGMEVAIKVFNLQYG---GAFKSFDIECGMMKRI 561
             F +  ++G G FG VYK       + +++ + +  L+      A K    E  +M  +
Sbjct: 22  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
            + ++ +++  C     + L+ + MP G L   +      +     LN  + +A  + YL
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 140
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
                  ++H DL   NVL+       ++DFG AK L  E++          I +MA + 
Sbjct: 141 E---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 197
Query: 682 IF 683
           I 
Sbjct: 198 IL 199

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/182 (22%), Positives = 76/182 (41%), Gaps = 14/182 (7%)
Query: 512 NRFSENNLIGRGGFGPVYK-------DGMEVAIKVFNLQYG---GAFKSFDIECGMMKRI 561
             F +  ++G G FG VYK       + +++ + +  L+      A K    E  +M  +
Sbjct: 15  TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
            + ++ +++  C     + L+ + MP G L   +      +     LN  + +A  + YL
Sbjct: 75  DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
                  ++H DL   NVL+       ++DFG AK L  E++          I +MA + 
Sbjct: 134 E---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 682 IF 683
           I 
Sbjct: 191 IL 192

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 80/184 (43%), Gaps = 23/184 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EY P G +   L       +    F    I++      EY
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEY 157
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+++D      ++DFG AK +      L       T  Y+AP+
Sbjct: 158 LH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPE 209
Query: 681 EIFS 684
            I S
Sbjct: 210 IILS 213

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 81/184 (44%), Gaps = 23/184 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EY+  G +   L       +    F    I++      EY
Sbjct: 88  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEY 143
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+L+D+     ++DFG AK +      L       T  Y+AP+
Sbjct: 144 LH---SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPE 195
Query: 681 EIFS 684
            I S
Sbjct: 196 IILS 199

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 50/192 (26%), Positives = 85/192 (44%), Gaps = 23/192 (11%)
Query: 507 LFQATNRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAFKSFDI-ECGMMKR 560
           ++  ++ F   +L+G G +G V        G  VAIK         F    + E  ++K 
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKH 65
Query: 561 IRHRNLIKIISSCSNDDFK----ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVAS 616
            +H N+I I +    D F+      +++ +    L + + +     D  Q    +     
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF--IYQTLR 123
Query: 617 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED--------QSLTQT 668
           A++ LH G +V  IH DLKPSN+L++ N    + DFG+A+ + E          Q    T
Sbjct: 124 AVKVLH-GSNV--IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMT 180
Query: 669 QTLATIGYMAPD 680
           + +AT  Y AP+
Sbjct: 181 EYVATRWYRAPE 192

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 34/132 (25%), Positives = 66/132 (50%), Gaps = 10/132 (7%)
Query: 517 NNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIR-HRNLIKII 570
           + L+G G +  V      ++G E A+K+   Q G +      E   + + + ++N++++I
Sbjct: 18  SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELI 77
Query: 571 SSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPII 630
               +D    LV E +  GS+   +    +  +  +   ++ DVA+AL++LH   +  I 
Sbjct: 78  EFFEDDTRFYLVFEKLQGGSILAHIQKQKH-FNEREASRVVRDVAAALDFLH---TKGIA 133
Query: 631 HCDLKPSNVLLD 642
           H DLKP N+L +
Sbjct: 134 HRDLKPENILCE 145

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 40/182 (21%), Positives = 77/182 (42%), Gaps = 14/182 (7%)
Query: 512 NRFSENNLIGRGGFGPVYK-------DGMEVAIKVFNLQYG---GAFKSFDIECGMMKRI 561
             F +  ++  G FG VYK       + +++ + +  L+      A K    E  +M  +
Sbjct: 22  TEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 81
Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
            + ++ +++  C     + L+++ MP G L   +      +     LN  + +A  + YL
Sbjct: 82  DNPHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 140
Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
                  ++H DL   NVL+       ++DFG+AK L  E++          I +MA + 
Sbjct: 141 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 197
Query: 682 IF 683
           I 
Sbjct: 198 IL 199

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 65/154 (42%), Gaps = 19/154 (12%)
Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQY------GGAFKSFDIECGMMKRIRHRNLIK 568
           +G G F  V K      G E A K    +       G + +  + E  +++ IRH N+I 
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 79
Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVP 628
           +     N     L+LE +  G L   L     + +  +    +  +   + YLH   S  
Sbjct: 80  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTED-EATQFLKQILDGVHYLH---SKR 135
Query: 629 IIHCDLKPSNVLLDDNMVAH----LSDFGMAKPL 658
           I H DLKP N++L D  V +    L DFG+A  +
Sbjct: 136 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 169

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/185 (26%), Positives = 83/185 (44%), Gaps = 25/185 (13%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EY+  G +   L       +    F    I++      EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEY 156
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGYMAP 679
           LH   S+ +I+ DLKP N+L+D      ++DFG AK +        +T  LA T  Y+AP
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV------KGRTWXLAGTPEYLAP 207
Query: 680 DEIFS 684
           + I S
Sbjct: 208 EIILS 212

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 80/184 (43%), Gaps = 23/184 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EY+  G +   L       +    F    I++      EY
Sbjct: 96  PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVL----TFEY 151
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP+
Sbjct: 152 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPE 203
Query: 681 EIFS 684
            I S
Sbjct: 204 IILS 207

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 45/186 (24%), Positives = 77/186 (41%), Gaps = 23/186 (12%)
Query: 520 IGRGGFGPVYK---DGM-------EVAIKVFNLQYGGAFK-SFDIECGMMKRIRHRNLIK 568
           +G G FG VY+    GM       +VA+K          +  F +E  ++ ++ H+N+++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCLY------SGNYILDIFQGLNIMIDVASALEYLH 622
            I        + ++LE M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 623 FGYSVPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
             +    IH D+   N LL       VA + DFGMA+ +            +  + +M P
Sbjct: 159 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 680 DEIFSG 685
           +    G
Sbjct: 216 EAFMEG 221

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 65/154 (42%), Gaps = 19/154 (12%)
Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQY------GGAFKSFDIECGMMKRIRHRNLIK 568
           +G G F  V K      G E A K    +       G + +  + E  +++ IRH N+I 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVP 628
           +     N     L+LE +  G L   L     + +  +    +  +   + YLH   S  
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTED-EATQFLKQILDGVHYLH---SKR 128
Query: 629 IIHCDLKPSNVLLDDNMVAH----LSDFGMAKPL 658
           I H DLKP N++L D  V +    L DFG+A  +
Sbjct: 129 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 93/209 (44%), Gaps = 26/209 (12%)
Query: 506 ELFQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI-ECGMMK 559
           E+  AT++      +GRG FG V++      G + A+K   L+    F++ ++  C  + 
Sbjct: 91  EVHWATHQLR----LGRGSFGEVHRMEDKQTGFQCAVKKVRLE---VFRAEELMACAGLT 143
Query: 560 RIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALE 619
             R   ++ +  +     +  + +E +  GSL + L      L   + L  +      LE
Sbjct: 144 SPR---IVPLYGAVREGPWVNIFMELLEGGSLGQ-LVKEQGCLPEDRALYYLGQALEGLE 199
Query: 620 YLHFGYSVPIIHCDLKPSNVLL-DDNMVAHLSDFGMAKPLLEE---DQSLTQTQTLATIG 675
           YLH   S  I+H D+K  NVLL  D   A L DFG A  L  +      LT      T  
Sbjct: 200 YLH---SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTET 256
Query: 676 YMAPDEIF--SGEMRLKCWVNDSLLISVM 702
           +MAP+ +   S + ++  W +  +++ ++
Sbjct: 257 HMAPEVVLGRSCDAKVDVWSSCCMMLHML 285

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 80/184 (43%), Gaps = 23/184 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EY+  G +   L       +    F    I++      EY
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVL----TFEY 177
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP+
Sbjct: 178 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPE 229
Query: 681 EIFS 684
            I S
Sbjct: 230 IILS 233

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 80/184 (43%), Gaps = 23/184 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EY+  G +   L       +    F    I++      EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVL----TFEY 156
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP+
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPE 208
Query: 681 EIFS 684
            I S
Sbjct: 209 IILS 212

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 96/221 (43%), Gaps = 29/221 (13%)
Query: 479 KYRKGRKSQLKDVNMPSVADQRRFTYLELFQATNRFS-----ENNLIGRG-GFGPVYKDG 532
           KY K +   + D  +    +Q +F  + L +  N+F      E +L+ +   F     D 
Sbjct: 21  KYVKEKDKYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDK 80
Query: 533 MEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLE 592
           + +  K         +  F  E  ++  I++   +      +N D   ++ EYM   S+ 
Sbjct: 81  ISIKSK---------YDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSIL 131
Query: 593 KC-----LYSGNYILDI-FQGLNIMID-VASALEYLHFGYSVPIIHCDLKPSNVLLDDNM 645
           K      +   NY   I  Q +  +I  V ++  Y+H      I H D+KPSN+L+D N 
Sbjct: 132 KFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNG 189
Query: 646 VAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGE 686
              LSDFG ++ ++  D+ +  ++   T  +M P E FS E
Sbjct: 190 RVKLSDFGESEYMV--DKKIKGSR--GTYEFMPP-EFFSNE 225

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 81/185 (43%), Gaps = 25/185 (13%)
Query: 509 QATNRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRH 563
           +  NR+     IG G FG +Y       G EVAIK+  ++         IE  + K ++ 
Sbjct: 4   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQG 61
Query: 564 RNLIKIISSCSND-DFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
              I  I  C  + D+  +V+E +   SLE      +    +   L +   + S +EY+H
Sbjct: 62  GVGIPTIRWCGAEGDYNVMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 623 FGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLE----------EDQSLTQTQ 669
              S   IH D+KP N L+       + ++ DFG+AK   +          E+++LT T 
Sbjct: 121 ---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 670 TLATI 674
             A+I
Sbjct: 178 RYASI 182

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 80/184 (43%), Gaps = 23/184 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EY+  G +   L       +    F    I++      EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVL----TFEY 156
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP+
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPE 208
Query: 681 EIFS 684
            I S
Sbjct: 209 IILS 212

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 79/184 (42%), Gaps = 23/184 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L K+  S  ++    +V+EY P G +   L       +    F    I++      EY
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVL----TFEY 157
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+++D      ++DFG AK +      L       T  Y+AP+
Sbjct: 158 LH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPE 209
Query: 681 EIFS 684
            I S
Sbjct: 210 IILS 213

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 81/185 (43%), Gaps = 25/185 (13%)
Query: 509 QATNRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRH 563
           +  NR+     IG G FG +Y       G EVAIK+  ++         IE  + K ++ 
Sbjct: 6   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQG 63
Query: 564 RNLIKIISSCSND-DFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
              I  I  C  + D+  +V+E +   SLE      +    +   L +   + S +EY+H
Sbjct: 64  GVGIPTIRWCGAEGDYNVMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 122
Query: 623 FGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLE----------EDQSLTQTQ 669
              S   IH D+KP N L+       + ++ DFG+AK   +          E+++LT T 
Sbjct: 123 ---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 179
Query: 670 TLATI 674
             A+I
Sbjct: 180 RYASI 184

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 65/154 (42%), Gaps = 19/154 (12%)
Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQY------GGAFKSFDIECGMMKRIRHRNLIK 568
           +G G F  V K      G E A K    +       G + +  + E  +++ IRH N+I 
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIIT 93
Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVP 628
           +     N     L+LE +  G L   L     + +  +    +  +   + YLH   S  
Sbjct: 94  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTED-EATQFLKQILDGVHYLH---SKR 149
Query: 629 IIHCDLKPSNVLLDDNMVAH----LSDFGMAKPL 658
           I H DLKP N++L D  V +    L DFG+A  +
Sbjct: 150 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 183

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 80/184 (43%), Gaps = 23/184 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EY+  G +   L       +    F    I++      EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVL----TFEY 156
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP+
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPE 208
Query: 681 EIFS 684
            I S
Sbjct: 209 IILS 212

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 71/152 (46%), Gaps = 23/152 (15%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYGGAF--KSFDIECGMMKRIRHRNLIKIISS 572
           +G G +G V      + G +VAIK     +      K    E  ++K +RH N+I ++  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 573 CSND----DFKA--LVLEYM--PLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFG 624
            + D    DF    LV+ +M   LG L K    G    D  Q L     V   L+ L + 
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGE---DRIQFL-----VYQMLKGLRYI 144
Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK 656
           ++  IIH DLKP N+ ++++    + DFG+A+
Sbjct: 145 HAAGIIHRDLKPGNLAVNEDCELKILDFGLAR 176

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 81/184 (44%), Gaps = 23/184 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EY+  G +   L       +    F    I++      EY
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEY 177
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+L+D      ++DFG AK +     +L       T  Y+AP+
Sbjct: 178 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLC-----GTPEYLAPE 229
Query: 681 EIFS 684
            I S
Sbjct: 230 IILS 233

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 45/186 (24%), Positives = 77/186 (41%), Gaps = 23/186 (12%)
Query: 520 IGRGGFGPVYK---DGM-------EVAIKVFNLQYGGAFK-SFDIECGMMKRIRHRNLIK 568
           +G G FG VY+    GM       +VA+K          +  F +E  ++ ++ H+N+++
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCLY------SGNYILDIFQGLNIMIDVASALEYLH 622
            I        + ++LE M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 172
Query: 623 FGYSVPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
             +    IH D+   N LL       VA + DFGMA+ +            +  + +M P
Sbjct: 173 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 680 DEIFSG 685
           +    G
Sbjct: 230 EAFMEG 235

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 80/184 (43%), Gaps = 23/184 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EY+  G +   L       +    F    I++      EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVL----TFEY 156
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP+
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPE 208
Query: 681 EIFS 684
            I S
Sbjct: 209 IILS 212

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 44/200 (22%), Positives = 80/200 (40%), Gaps = 30/200 (15%)
Query: 512 NRFSENNLIGRGGFGPVY--------KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRI-- 561
           +R +    +GRG FG V         K      + V  L+ G            +K +  
Sbjct: 28  DRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 87
Query: 562 --RHRNLIKIISSCSNDDFKALVL-EYMPLGSLEKCLYSGNYIL-------DIFQGLNIM 611
              H N++ ++ +C+      +V+ E+   G+L   L S            D+++    +
Sbjct: 88  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTL 147
Query: 612 -------IDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS 664
                    VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ + ++   
Sbjct: 148 EHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 204
Query: 665 LTQTQTLATIGYMAPDEIFS 684
           + +      + +MAP+ IF 
Sbjct: 205 VRKGDARLPLKWMAPETIFD 224

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 88/198 (44%), Gaps = 33/198 (16%)
Query: 505 LELFQATNRFSENNLIGRGGFG--PVYKDGME---VAIKVFNLQYGGAF-KSFDIECGMM 558
           + +   ++R+     IG G FG   + +D +    VA+K   ++ G A  ++   E    
Sbjct: 13  MPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKY--IERGAAIDENVQREIINH 70
Query: 559 KRIRHRNLIKIISSCSNDDFKALVLEYMPLGSL-EKCLYSGNYILD----IFQGLNIMID 613
           + +RH N+++           A+++EY   G L E+   +G +  D     FQ L     
Sbjct: 71  RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL----- 125
Query: 614 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLS--DFGMAKPLLEEDQSLTQTQTL 671
             S + Y H   S+ I H DLK  N LLD +    L   DFG +K       S+  +Q  
Sbjct: 126 -LSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQPK 175
Query: 672 ATIG---YMAPDEIFSGE 686
           +T+G   Y+AP+ +   E
Sbjct: 176 STVGTPAYIAPEVLLRQE 193

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 93/209 (44%), Gaps = 26/209 (12%)
Query: 506 ELFQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI-ECGMMK 559
           E+  AT++      +GRG FG V++      G + A+K   L+    F++ ++  C  + 
Sbjct: 72  EVHWATHQLR----LGRGSFGEVHRMEDKQTGFQCAVKKVRLE---VFRAEELMACAGLT 124
Query: 560 RIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALE 619
             R   ++ +  +     +  + +E +  GSL + L      L   + L  +      LE
Sbjct: 125 SPR---IVPLYGAVREGPWVNIFMELLEGGSLGQ-LVKEQGCLPEDRALYYLGQALEGLE 180
Query: 620 YLHFGYSVPIIHCDLKPSNVLL-DDNMVAHLSDFGMAKPLLEE---DQSLTQTQTLATIG 675
           YLH   S  I+H D+K  NVLL  D   A L DFG A  L  +      LT      T  
Sbjct: 181 YLH---SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTET 237
Query: 676 YMAPDEIF--SGEMRLKCWVNDSLLISVM 702
           +MAP+ +   S + ++  W +  +++ ++
Sbjct: 238 HMAPEVVLGRSCDAKVDVWSSCCMMLHML 266

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 77/172 (44%), Gaps = 13/172 (7%)
Query: 520 IGRGGFGPVY-------KDGMEVAIKVFNLQYGGA-FKSFDIECGMMKRIRHRNLIKIIS 571
           +G G FG V        K  ++VAIKV       A  +    E  +M ++ +  ++++I 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
            C  +    LV+E    G L K L      + +     ++  V+  ++YL        +H
Sbjct: 78  VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVH 133
Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT-QTQTLATIGYMAPDEI 682
            DL   NVLL +   A +SDFG++K L  +D   T ++     + + AP+ I
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 185

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 45/186 (24%), Positives = 76/186 (40%), Gaps = 23/186 (12%)
Query: 520 IGRGGFGPVYK---DGM-------EVAIKVFNLQYGGAFK-SFDIECGMMKRIRHRNLIK 568
           +G G FG VY+    GM       +VA+K          +  F +E  ++ +  H+N+++
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCLY------SGNYILDIFQGLNIMIDVASALEYLH 622
            I        + ++LE M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 164
Query: 623 FGYSVPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
             +    IH D+   N LL       VA + DFGMA+ +            +  + +M P
Sbjct: 165 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 221
Query: 680 DEIFSG 685
           +    G
Sbjct: 222 EAFMEG 227

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 75/177 (42%), Gaps = 14/177 (7%)
Query: 512 NRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAFKSFD---IECGMMKRIRH 563
           N F    L+G+G FG V        G   A+K+   +   A         E  +++  RH
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHF 623
             L  +  +    D    V+EY   G L   L S   +    +      ++ SALEYLH 
Sbjct: 68  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEYLH- 125
Query: 624 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
             S  +++ D+K  N++LD +    ++DFG+ K  + +    T      T  Y+AP+
Sbjct: 126 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPE 178

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 75/177 (42%), Gaps = 14/177 (7%)
Query: 512 NRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAFKSFD---IECGMMKRIRH 563
           N F    L+G+G FG V        G   A+K+   +   A         E  +++  RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHF 623
             L  +  +    D    V+EY   G L   L S   +    +      ++ SALEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEYLH- 122
Query: 624 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
             S  +++ D+K  N++LD +    ++DFG+ K  + +    T      T  Y+AP+
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPE 175

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 80/184 (43%), Gaps = 23/184 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EY+  G +   L       +    F    I++      EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEY 156
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP+
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLX-----GTPEYLAPE 208
Query: 681 EIFS 684
            I S
Sbjct: 209 IILS 212

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 76/169 (44%), Gaps = 26/169 (15%)
Query: 508 FQATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIR 562
           F   +R+ +   +G GG G V+          VAIK   L    + K    E  +++R+ 
Sbjct: 7   FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLD 66
Query: 563 HRNLIKIIS------SCSNDDFKAL--------VLEYMPLGSLEKCLYSGNYILDIFQGL 608
           H N++K+        S   DD  +L        V EYM    L   L  G  + +     
Sbjct: 67  HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEE--HAR 123
Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAK 656
             M  +   L+Y+H   S  ++H DLKP+N+ ++ +++V  + DFG+A+
Sbjct: 124 LFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLAR 169

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 39/174 (22%), Positives = 73/174 (41%), Gaps = 24/174 (13%)
Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSC 573
           +G G +G V           VA+K+ +++      ++   E  +   + H N++K     
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH-------FGYS 626
              + + L LEY           SG  + D  +  +I +    A  + H       + + 
Sbjct: 75  REGNIQYLFLEYC----------SGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP+
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 44/200 (22%), Positives = 79/200 (39%), Gaps = 31/200 (15%)
Query: 512 NRFSENNLIGRGGFGPVY--------KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRI-- 561
           +R      +GRG FG V         K      + V  L+ G            +K +  
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 562 --RHRNLIKIISSCSNDDFKALVL-EYMPLGSLEKCLYSGNYIL--------DIFQGLNI 610
              H N++ ++ +C+      +V+ E+   G+L   L S             D+++    
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 611 M-------IDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ 663
           +         VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ + ++  
Sbjct: 138 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 194
Query: 664 SLTQTQTLATIGYMAPDEIF 683
            + +      + +MAP+ IF
Sbjct: 195 XVRKGDARLPLKWMAPETIF 214

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 75/177 (42%), Gaps = 14/177 (7%)
Query: 512 NRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAFKSFD---IECGMMKRIRH 563
           N F    L+G+G FG V        G   A+K+   +   A         E  +++  RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHF 623
             L  +  +    D    V+EY   G L   L S   +    +      ++ SALEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEYLH- 122
Query: 624 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
             S  +++ D+K  N++LD +    ++DFG+ K  + +    T      T  Y+AP+
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKXFCGTPEYLAPE 175

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 44/200 (22%), Positives = 79/200 (39%), Gaps = 31/200 (15%)
Query: 512 NRFSENNLIGRGGFGPVY--------KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRI-- 561
           +R      +GRG FG V         K      + V  L+ G            +K +  
Sbjct: 18  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 77
Query: 562 --RHRNLIKIISSCSNDDFKALVL-EYMPLGSLEKCLYSGNYIL--------DIFQGLNI 610
              H N++ ++ +C+      +V+ E+   G+L   L S             D+++    
Sbjct: 78  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 137
Query: 611 M-------IDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ 663
           +         VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ + ++  
Sbjct: 138 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 194
Query: 664 SLTQTQTLATIGYMAPDEIF 683
            + +      + +MAP+ IF
Sbjct: 195 XVRKGDARLPLKWMAPETIF 214

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 80/184 (43%), Gaps = 23/184 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EY+  G +   L       +    F    I++      EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEY 156
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP+
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPE 208
Query: 681 EIFS 684
            I S
Sbjct: 209 IILS 212

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 45/186 (24%), Positives = 76/186 (40%), Gaps = 23/186 (12%)
Query: 520 IGRGGFGPVYK---DGM-------EVAIKVFNLQYGGAFK-SFDIECGMMKRIRHRNLIK 568
           +G G FG VY+    GM       +VA+K          +  F +E  ++ +  H+N+++
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCLY------SGNYILDIFQGLNIMIDVASALEYLH 622
            I        + ++LE M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 158
Query: 623 FGYSVPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
             +    IH D+   N LL       VA + DFGMA+ +            +  + +M P
Sbjct: 159 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 680 DEIFSG 685
           +    G
Sbjct: 216 EAFMEG 221

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 75/177 (42%), Gaps = 14/177 (7%)
Query: 512 NRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAFKSFD---IECGMMKRIRH 563
           N F    L+G+G FG V        G   A+K+   +   A         E  +++  RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHF 623
             L  +  +    D    V+EY   G L   L S   +    +      ++ SALEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEYLH- 122
Query: 624 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
             S  +++ D+K  N++LD +    ++DFG+ K  + +    T      T  Y+AP+
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLAPE 175

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 80/184 (43%), Gaps = 23/184 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EY+  G +   L       +    F    I++      EY
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEY 157
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP+
Sbjct: 158 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPE 209
Query: 681 EIFS 684
            I S
Sbjct: 210 IILS 213

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 42/171 (24%), Positives = 78/171 (45%), Gaps = 12/171 (7%)
Query: 518 NLIGRGGFGPVYKDGMEVAIKVFNLQYGGAF---KSFDIECGMMKRI-----RHRNLIKI 569
            +IGRG FG V    ++ A KVF ++    +   K  +  C   +R        + +  +
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 570 ISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPI 629
             +  +D+   LV++Y   G L   L      L        + ++  A++ +H    +  
Sbjct: 140 HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHY 196
Query: 630 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           +H D+KP N+L+D N    L+DFG    L+ ED ++  +  + T  Y++P+
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFGSCLKLM-EDGTVQSSVAVGTPDYISPE 246

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 46/177 (25%), Positives = 75/177 (42%), Gaps = 14/177 (7%)
Query: 512 NRFSENNLIGRGGFGPV-----YKDGMEVAIKVFNLQYGGAFKSFD---IECGMMKRIRH 563
           N F    L+G+G FG V        G   A+K+   +   A         E  +++  RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHF 623
             L  +  +    D    V+EY   G L   L S   +    +      ++ SALEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVSALEYLH- 122
Query: 624 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
             S  +++ D+K  N++LD +    ++DFG+ K  + +    T      T  Y+AP+
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKXFCGTPEYLAPE 175

>pdb|1W8A|A Chain A, Third Lrr Domain Of Drosophila Slit Length = 192

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 28/89 (31%), Positives = 48/89 (53%), Gaps = 1/89 (1%)
Query: 252 RLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLW-NLKDILHLNLSS 310
           RL  L +L+L  N+L+G  P      +++++L LG N +  I + ++  L  +  LNL  
Sbjct: 52  RLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYD 111
Query: 311 NFFTGPLPLKIGNLNVLVQLDLSMNNFSC 339
           N  +  +P    +LN L  L+L+ N F+C
Sbjct: 112 NQISCVMPGSFEHLNSLTSLNLASNPFNC 140

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 80/184 (43%), Gaps = 23/184 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EY+  G +   L       +    F    I++      EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEY 156
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP+
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPE 208
Query: 681 EIFS 684
            I S
Sbjct: 209 IILS 212

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 44/201 (21%), Positives = 79/201 (39%), Gaps = 31/201 (15%)
Query: 512 NRFSENNLIGRGGFGPVY--------KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRI-- 561
           +R      +GRG FG V         K      + V  L+ G            +K +  
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 562 --RHRNLIKIISSCSNDDFKALVL-EYMPLGSLEKCLYSGNYIL--------DIFQGLNI 610
              H N++ ++ +C+      +V+ E+   G+L   L S             D+++    
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 611 M-------IDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ 663
           +         VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ + ++  
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 203
Query: 664 SLTQTQTLATIGYMAPDEIFS 684
            + +      + +MAP+ IF 
Sbjct: 204 XVRKGDARLPLKWMAPETIFD 224

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 79/184 (42%), Gaps = 23/184 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L K+  S  ++    +V+EY P G +   L       +    F    I++      EY
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEY 157
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+++D      ++DFG AK +      L       T  Y+AP+
Sbjct: 158 LH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLC-----GTPEYLAPE 209
Query: 681 EIFS 684
            I S
Sbjct: 210 IILS 213

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 45/186 (24%), Positives = 76/186 (40%), Gaps = 23/186 (12%)
Query: 520 IGRGGFGPVYK---DGM-------EVAIKVFNLQYGGAFK-SFDIECGMMKRIRHRNLIK 568
           +G G FG VY+    GM       +VA+K          +  F +E  ++ +  H+N+++
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCLY------SGNYILDIFQGLNIMIDVASALEYLH 622
            I        + ++LE M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 184
Query: 623 FGYSVPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
             +    IH D+   N LL       VA + DFGMA+ +            +  + +M P
Sbjct: 185 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 241
Query: 680 DEIFSG 685
           +    G
Sbjct: 242 EAFMEG 247

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 44/201 (21%), Positives = 79/201 (39%), Gaps = 31/201 (15%)
Query: 512 NRFSENNLIGRGGFGPVY--------KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRI-- 561
           +R      +GRG FG V         K      + V  L+ G            +K +  
Sbjct: 27  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 562 --RHRNLIKIISSCSNDDFKALVL-EYMPLGSLEKCLYSGNYIL--------DIFQGLNI 610
              H N++ ++ +C+      +V+ E+   G+L   L S             D+++    
Sbjct: 87  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 611 M-------IDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ 663
           +         VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ + ++  
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 664 SLTQTQTLATIGYMAPDEIFS 684
            + +      + +MAP+ IF 
Sbjct: 204 XVRKGDARLPLKWMAPETIFD 224

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 80/184 (43%), Gaps = 23/184 (12%)
Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRH 563
           ++F     +G G FG V      + G   A+K+ + Q     K  +    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD---IFQGLNIMIDVASALEY 620
             L+K+  S  ++    +V+EY+  G +   L       +    F    I++      EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL----TFEY 156
Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           LH   S+ +I+ DLKP N+L+D      ++DFG AK +      L       T  Y+AP+
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLC-----GTPEYLAPE 208
Query: 681 EIFS 684
            I S
Sbjct: 209 IILS 212

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 44/195 (22%), Positives = 80/195 (41%), Gaps = 25/195 (12%)
Query: 508 FQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIR 562
            Q T+ +     IG G +    +       ME A+K+ +       +  +I   +++  +
Sbjct: 18  IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI---LLRYGQ 74
Query: 563 HRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
           H N+I +     +  +  +V E M  G L   +    +  +  +   ++  +   +EYLH
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE-REASAVLFTITKTVEYLH 133
Query: 623 FGYSVPIIHCDLKPSNVLLDDNM----VAHLSDFGMAKPLLEED---------QSLTQTQ 669
              +  ++H DLKPSN+L  D         + DFG AK L  E+          +    +
Sbjct: 134 ---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE 190
Query: 670 TLATIGYMAPDEIFS 684
            L   GY A  +I+S
Sbjct: 191 VLERQGYDAACDIWS 205

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 45/186 (24%), Positives = 76/186 (40%), Gaps = 23/186 (12%)
Query: 520 IGRGGFGPVYK---DGM-------EVAIKVFNLQYGGAFK-SFDIECGMMKRIRHRNLIK 568
           +G G FG VY+    GM       +VA+K          +  F +E  ++ +  H+N+++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCLY------SGNYILDIFQGLNIMIDVASALEYLH 622
            I        + ++LE M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 623 FGYSVPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
             +    IH D+   N LL       VA + DFGMA+ +            +  + +M P
Sbjct: 158 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 680 DEIFSG 685
           +    G
Sbjct: 215 EAFMEG 220

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 71/174 (40%), Gaps = 14/174 (8%)
Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G FG V++      G   A K     +    ++   E   M  +RH  L+ +  +  
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 118
Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDL 634
           +D+   ++ E+M  G L + +   +  +   + +  M  V   L ++H       +H DL
Sbjct: 119 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDL 175
Query: 635 KPSNVLLDDNMVAHLS--DFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGE 686
           KP N++        L   DFG+   L   D   +   T  T  + AP E+  G+
Sbjct: 176 KPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAP-EVAEGK 225

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 42.4 bits (98), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 45/186 (24%), Positives = 76/186 (40%), Gaps = 23/186 (12%)
Query: 520 IGRGGFGPVYK---DGM-------EVAIKVFNLQYGGAFK-SFDIECGMMKRIRHRNLIK 568
           +G G FG VY+    GM       +VA+K          +  F +E  ++ +  H+N+++
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCLY------SGNYILDIFQGLNIMIDVASALEYLH 622
            I        + ++LE M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 149
Query: 623 FGYSVPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
             +    IH D+   N LL       VA + DFGMA+ +            +  + +M P
Sbjct: 150 ENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 206
Query: 680 DEIFSG 685
           +    G
Sbjct: 207 EAFMEG 212

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	797
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-118
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-97
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-96
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-60
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-31
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-04
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	5e-85
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	5e-39
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-70
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-65
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-65
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-59
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-50
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-68
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-66
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	6e-66
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-37
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-24
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	3e-62
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-56
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-54
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-54
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-46
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-46
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-29
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-21
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-59
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	3e-57
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-56
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-50
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	7e-31
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	2e-23
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-57
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-57
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-55
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-49
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-44
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-28
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-57
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	4e-57
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-51
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	4e-49
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-42
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-42
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	9e-27
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	7e-51
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-49
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-45
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	4e-44
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	1e-32
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-48
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	3e-45
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-39
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	6e-22
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	2e-13
1o6v_A	466	Internalin A; bacterial infection, extracellular r	7e-47
1o6v_A	466	Internalin A; bacterial infection, extracellular r	8e-46
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-43
1o6v_A	466	Internalin A; bacterial infection, extracellular r	6e-40
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-28
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-45
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-45
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-40
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	7e-24
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	7e-18
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-13
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-43
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	9e-42
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-41
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-35
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-34
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-30
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-27
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-27
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-19
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-41
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	6e-41
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-31
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-13
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	9e-41
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-39
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-39
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	3e-35
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-29
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-40
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	5e-40
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	8e-36
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	8e-36
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-29
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-24
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	4e-13
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	6e-40
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	6e-40
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-39
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-39
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-39
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	9e-34
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	6e-16
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	3e-06
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	3e-39
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-31
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	2e-28
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	6e-20
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	6e-15
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-38
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-38
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-38
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-37
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	5e-37
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	7e-37
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	8e-25
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	3e-05
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	5e-37
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-36
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-36
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-33
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-30
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	3e-30
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	1e-19
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-37
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-36
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	2e-34
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-34
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-28
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-35
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	9e-32
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-31
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	1e-26
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-22
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	9e-20
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-35
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-34
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	5e-33
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-13
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	7e-34
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-33
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	4e-31
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-28
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-19
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	8e-13
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	3e-06
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-31
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	5e-27
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	5e-26
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-21
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-15
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-31
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	8e-30
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	2e-11
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	6e-08
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-30
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-28
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	6e-26
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	3e-24
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-15
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-30
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	7e-29
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	6e-23
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	5e-22
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-16
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-29
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-26
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	5e-23
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	9e-12
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-29
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-28
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-24
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-22
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-19
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	4e-29
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	9e-22
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	7e-20
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-17
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	4e-29
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	8e-27
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	3e-20
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	6e-10
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	5e-28
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-26
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-26
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-24
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-15
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	4e-13
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-27
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-27
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-26
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	2e-25
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-25
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	6e-25
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	6e-25
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-25
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	7e-25
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	8e-16
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-12
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	3e-11
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-24
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-24
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-24
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-24
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-24
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-24
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-21
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	6e-19
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	9e-16
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	1e-15
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	3e-14
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-24
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-24
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-24
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-24
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	6e-24
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	6e-24
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	6e-24
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	6e-24
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	7e-24
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	7e-24
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	8e-24
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	9e-24
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	9e-24
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-23
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-23
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-23
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-23
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-23
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-23
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-23
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-23
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-23
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-23
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-23
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-23
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-23
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-23
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	5e-23
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	5e-23
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-23
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	6e-23
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	7e-23
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	8e-23
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-21
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	5e-21
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	6e-18
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-13
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	6e-12
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-22
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-22
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-22
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-22
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-22
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-22
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	8e-18
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-22
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-22
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	2e-22
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	5e-17
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	6e-15
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-22
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-22
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-22
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-22
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-22
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-19
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-15
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	5e-10
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-22
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-22
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-22
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	7e-22
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-19
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	6e-16
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	6e-13
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	7e-22
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-21
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-21
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-21
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-21
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-21
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-21
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-21
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-21
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-19
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-12
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	5e-12
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	2e-11
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-21
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	5e-21
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	7e-21
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	8e-21
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-20
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-20
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-20
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-20
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-20
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-18
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-16
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	8e-16
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	6e-14
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	2e-09
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	5e-20
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-20
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-20
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	7e-20
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	7e-20
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-19
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-19
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-19
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-19
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-19
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-19
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	7e-19
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	5e-17
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-16
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-12
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-10
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-19
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-19
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-19
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-19
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-19
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-19
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-19
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	4e-19
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-19
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-19
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-19
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	6e-19
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	9e-19
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-18
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-18
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-18
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-18
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-18
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-18
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-18
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-18
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-18
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-18
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-18
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-18
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-18
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-18
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-18
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-18
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-18
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-18
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-18
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-18
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-18
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	6e-18
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	6e-18
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	7e-18
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	7e-18
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	4e-16
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	9e-16
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	7e-06
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	7e-18
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-17
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-17
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-17
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-17
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-17
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-17
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-17
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-17
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-17
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	5e-17
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-15
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-15
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-09
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-17
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	6e-17
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-16
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-16
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-16
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-16
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	3e-16
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-10
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-09
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	9e-08
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-16
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-16
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	8e-16
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	9e-16
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-15
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-15
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-15
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-15
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-04
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-15
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-15
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-15
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	3e-15
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-12
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	1e-04
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-15
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-15
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-15
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	5e-15
2dyl_A	318	Dual specificity mitogen-activated protein kinase	6e-15
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	7e-15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	7e-15
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	8e-15
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	8e-15
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	9e-15
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	9e-15
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-14
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-14
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-14
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-14
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-14
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	6e-13
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	2e-10
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	9e-05
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	1e-04
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-14
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-14
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-14
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-14
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-14
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-14
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	6e-14
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-13
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-11
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-10
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	6e-08
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	3e-05
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-13
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-13
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-13
3m19_A	251	Variable lymphocyte receptor A diversity region; a	5e-13
3m19_A	251	Variable lymphocyte receptor A diversity region; a	1e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	5e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-06
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-13
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-13
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-13
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-13
3o0g_A	292	Cell division protein kinase 5; kinase activator c	6e-13
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	7e-13
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	9e-13
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-12
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-12
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-12
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-12
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-12
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	2e-10
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-09
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	1e-09
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	6e-06
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	8e-05
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-12
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-12
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-12
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	3e-12
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	5e-12
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-09
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	9e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-12
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-12
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-12
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-12
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-12
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-12
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-12
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	5e-12
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	6e-12
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	4e-10
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	1e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	7e-06
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	3e-05
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	8e-12
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	9e-12
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-11
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-11
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-11
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-11
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	9e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-08
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	3e-07
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-05
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-11
3e6j_A	229	Variable lymphocyte receptor diversity region; var	6e-11
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-08
3e6j_A	229	Variable lymphocyte receptor diversity region; var	1e-08
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	6e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	8e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-05
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	1e-10
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	8e-08
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	2e-07
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-10
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-10
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	6e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	7e-10
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-10
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	8e-10
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	1e-09
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	9e-09
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	3e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	4e-07
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	7e-04
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	1e-09
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	1e-07
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	3e-07
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	1e-06
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	2e-05
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	5e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-09
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-09
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-09
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	2e-05
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-09
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-09
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-07
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	5e-07
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-05
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	4e-04
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	5e-09
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	4e-06
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	2e-04
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	6e-09
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	1e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	2e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	4e-06
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	7e-09
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-08
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	3e-07
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-06
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-05
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	2e-04
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	3e-08
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	4e-07
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	2e-06
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	1e-04
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-08
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-07
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-07
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	5e-07
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	5e-04
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	5e-04
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	5e-07
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	3e-04
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	7e-04
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-06
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-06
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-06
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	9e-06
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-05
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	1e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	3e-05
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	3e-05
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	6e-04

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  374 bits (963), Expect = e-118
 Identities = 141/460 (30%), Positives = 208/460 (45%), Gaps = 40/460 (8%)

Query: 3   SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSF 62
            L+ +   G +    G+ S L++L LS N  SG +P          +  +  ++ +  SF
Sbjct: 300 DLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELP-------MDTLLKMRGLKVLDLSF 352

Query: 63  NKVVGVVPTTIFNVST-LKSLYLHSNSLSGRLPSS-ADVRLPNLKELHLWGNNFIGTIPS 120
           N+  G +P ++ N+S  L +L L SN+ SG +  +        L+EL+L  N F G IP 
Sbjct: 353 NEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPP 412

Query: 121 FIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKY 180
            + N S+L  L L  N  SG+IP++ G+L  L+ L L  N L    P       L   K 
Sbjct: 413 TLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIP-----QELMYVKT 467

Query: 181 LEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGN 240
           LE      N L G +P  + N + ++    + N  ++G IP+ I  L NL   +L L  N
Sbjct: 468 LETLILDFNDLTGEIPSGLSNCT-NLNWISLSNNRLTGEIPKWIGRLENL--AILKLSNN 524

Query: 241 QLEGSIPDDLCRLAALFQLDLGGNKLSGFVPAC--------------------SGNLTNL 280
              G+IP +L    +L  LDL  N  +G +PA                       N    
Sbjct: 525 SFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMK 584

Query: 281 RKLYLGSNLLT---SIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNF 337
           ++ +   NLL         L  L      N++S  + G       N   ++ LD+S N  
Sbjct: 585 KECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNML 644

Query: 338 SCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLL 397
           S  IP +IG +  L  L L +N + GSIP+ +GDL  L  L+LS+N L G IP ++  L 
Sbjct: 645 SGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALT 704

Query: 398 DLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMP 437
            L +I++S N L G IP  G F       F  N  LCG P
Sbjct: 705 MLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYP 744

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  319 bits (819), Expect = 2e-97
 Identities = 142/461 (30%), Positives = 211/461 (45%), Gaps = 41/461 (8%)

Query: 2   PSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFS 61
            S   +     + S L + + L++L+LS +  +GS+  F             ++  +  S
Sbjct: 58  SSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFK---------CSASLTSLDLS 108

Query: 62  FNKVVGVVPT--TIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIP 119
            N + G V T  ++ + S LK L + SN+L      S  ++L +L+ L L  N+  G   
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANV 168

Query: 120 SFIF---NASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLS 176
                     +L  L +  N  SG +        NL++L ++ N  ++  P L   S+  
Sbjct: 169 VGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPFLGDCSA-- 224

Query: 177 NCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLS 236
               L++   S N L G   RAI   +  ++   + +    G IP     L +  LQ LS
Sbjct: 225 ----LQHLDISGNKLSGDFSRAISTCT-ELKLLNISSNQFVGPIPPL--PLKS--LQYLS 275

Query: 237 LEGNQLEGSIPDDLC-RLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLT-SIP 294
           L  N+  G IPD L      L  LDL GN   G VP   G+ + L  L L SN  +  +P
Sbjct: 276 LAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELP 335

Query: 295 -STLWNLKDILHLNLSSNFFTGPLPLKIGNLNV-LVQLDLSMNNFSCVIPTKIGG--LKD 350
             TL  ++ +  L+LS N F+G LP  + NL+  L+ LDLS NNFS  I   +       
Sbjct: 336 MDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNT 395

Query: 351 LQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLE 410
           LQ L+L+ N   G IP ++ +   L SL+LS N LSGTIP SL  L  L+D+ +  N LE
Sbjct: 396 LQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLE 455

Query: 411 GEIPRE-GPFRNLSAESFKGNEL-------LCGMPNLQVLS 443
           GEIP+E    + L       N+L       L    NL  +S
Sbjct: 456 GEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWIS 496

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  316 bits (811), Expect = 2e-96
 Identities = 119/416 (28%), Positives = 174/416 (41%), Gaps = 50/416 (12%)

Query: 17  LGNPSSLQTLYLSYNPPSGSIPSFILC---------------EIPHEIDNLHNMEWMAFS 61
           +    +L+ L +S N  S  IP    C               +    I     ++ +  S
Sbjct: 196 VSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNIS 255

Query: 62  FNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSF 121
            N+ VG +P     + +L+ L L  N  +G +P         L  L L GN+F G +P F
Sbjct: 256 SNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPF 313

Query: 122 IFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYL 181
             + S L  L L  N+FSG +P                              +L   + L
Sbjct: 314 FGSCSLLESLALSSNNFSGELPM----------------------------DTLLKMRGL 345

Query: 182 EYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQ 241
           +    S N   G LP ++ NLS S+    + + N SG I   +       LQ L L+ N 
Sbjct: 346 KVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNG 405

Query: 242 LEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLT-SIPSTLWNL 300
             G IP  L   + L  L L  N LSG +P+  G+L+ LR L L  N+L   IP  L  +
Sbjct: 406 FTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYV 465

Query: 301 KDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNR 360
           K +  L L  N  TG +P  + N   L  + LS N  +  IP  IG L++L  L L  N 
Sbjct: 466 KTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNS 525

Query: 361 LQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPRE 416
             G+IP  +GD  SL  L+L+ N  +GTIP ++ K        ++ N + G+    
Sbjct: 526 FSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVY 577

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  217 bits (554), Expect = 3e-60
 Identities = 79/327 (24%), Positives = 129/327 (39%), Gaps = 40/327 (12%)

Query: 103 NLKELHLWGNNF---IGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLND 159
            +  + L           + S + + + L  L L  +  +GS+   F    +L  L L+ 
Sbjct: 51  KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSR 109

Query: 160 NYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGS 219
           N L+     L+SL S S    L++ + S+N L      + G    S+E   +   +ISG+
Sbjct: 110 NSLSGPVTTLTSLGSCSG---LKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166

Query: 220 IPEEINNLTNLI-LQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLT 278
                        L+ L++ GN++ G +                                
Sbjct: 167 NVVGWVLSDGCGELKHLAISGNKISGDVD--------------------------VSRCV 200

Query: 279 NLRKLYLGSNLLT-SIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNF 337
           NL  L + SN  +  IP  L +   + HL++S N  +G     I     L  L++S N F
Sbjct: 201 NLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQF 259

Query: 338 SCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSI-GDLISLKSLNLSNNNLSGTIPISLEKL 396
              IP     LK LQYL L  N+  G IP+ + G   +L  L+LS N+  G +P      
Sbjct: 260 VGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSC 317

Query: 397 LDLKDINVSFNRLEGEIPREGPFRNLS 423
             L+ + +S N   GE+P +     + 
Sbjct: 318 SLLESLALSSNNFSGELPMDT-LLKMR 343

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  130 bits (330), Expect = 2e-31
 Identities = 51/209 (24%), Positives = 87/209 (41%), Gaps = 18/209 (8%)

Query: 251 CRLAALFQLDLGGNKLSGF---VPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLN 307
           CR   +  +DL    L+     V +   +LT L  L+L ++ +    S       +  L+
Sbjct: 47  CRDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLD 106

Query: 308 LSSNFFTGPLPLK--IGNLNVLVQLDLSMNNFSCVIPTKIG-GLKDLQYLFLEYNRLQGS 364
           LS N  +GP+     +G+ + L  L++S N          G  L  L+ L L  N + G+
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166

Query: 365 IPNSI---GDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRN 421
                        LK L +S N +SG + +S  + ++L+ ++VS N     IP  G    
Sbjct: 167 NVVGWVLSDGCGELKHLAISGNKISGDVDVS--RCVNLEFLDVSSNNFSTGIPFLGDCSA 224

Query: 422 LSAESFKGNEL-------LCGMPNLQVLS 443
           L      GN+L       +     L++L+
Sbjct: 225 LQHLDISGNKLSGDFSRAISTCTELKLLN 253

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 43.0 bits (102), Expect = 4e-04
 Identities = 18/105 (17%), Positives = 37/105 (35%), Gaps = 20/105 (19%)

Query: 374 SLKSLNLSNNNLS---GTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGN 430
            + S++LS+  L+     +  SL  L  L+ + +S + + G +       +L++     N
Sbjct: 51  KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRN 110

Query: 431 EL---------LCGMPNLQVLSCRTKIHHTLGKNDLLIGIVLPLS 466
            L         L     L+ L+        +  N L     +   
Sbjct: 111 SLSGPVTTLTSLGSCSGLKFLN--------VSSNTLDFPGKVSGG 147

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  271 bits (696), Expect = 5e-85
 Identities = 87/304 (28%), Positives = 129/304 (42%), Gaps = 33/304 (10%)

Query: 136 NSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGIL 195
            ++ G + +T      +  L L+   L    P     SSL+N  YL +            
Sbjct: 36  RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYP---IPSSLANLPYLNFLYIGGIN----- 87

Query: 196 PRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAA 255
                              N+ G IP  I  LT L    L +    + G+IPD L ++  
Sbjct: 88  -------------------NLVGPIPPAIAKLTQL--HYLYITHTNVSGAIPDFLSQIKT 126

Query: 256 LFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLT-SIPSTLWNLKDIL-HLNLSSNFF 313
           L  LD   N LSG +P    +L NL  +    N ++ +IP +  +   +   + +S N  
Sbjct: 127 LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRL 186

Query: 314 TGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLI 373
           TG +P    NLN L  +DLS N          G  K+ Q + L  N L   +   +G   
Sbjct: 187 TGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSK 244

Query: 374 SLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELL 433
           +L  L+L NN + GT+P  L +L  L  +NVSFN L GEIP+ G  +     ++  N+ L
Sbjct: 245 NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCL 304

Query: 434 CGMP 437
           CG P
Sbjct: 305 CGSP 308

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  146 bits (370), Expect = 5e-39
 Identities = 53/170 (31%), Positives = 72/170 (42%), Gaps = 7/170 (4%)

Query: 259 LDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLT---SIPSTLWNLKDILHLNLSS-NFFT 314
            D       G +         +  L L    L     IPS+L NL  +  L +   N   
Sbjct: 31  TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90

Query: 315 GPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLIS 374
           GP+P  I  L  L  L ++  N S  IP  +  +K L  L   YN L G++P SI  L +
Sbjct: 91  GPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPN 150

Query: 375 LKSLNLSNNNLSGTIPISLEKLLDL-KDINVSFNRLEGEIPREGPFRNLS 423
           L  +    N +SG IP S      L   + +S NRL G+IP    F NL+
Sbjct: 151 LVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPT--FANLN 198

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  242 bits (619), Expect = 3e-70
 Identities = 67/440 (15%), Positives = 138/440 (31%), Gaps = 55/440 (12%)

Query: 13  ILSQLGNPSSLQTLYLSYNPPSGSIPSFI-----------LCEIPHEIDNLHNMEWMAFS 61
           +   +   + L+  Y+  +P                          + DNL ++  +   
Sbjct: 198 VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVY 257

Query: 62  FNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSAD-------VRLPNLKELHLWGNNF 114
               +  +PT +  +  ++ + +  N          D            ++ +++  NN 
Sbjct: 258 NCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNL 317

Query: 115 I-GTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLS 173
               + + +    KL  L    N   G +P  FG+   L  L L  N +T          
Sbjct: 318 KTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANF---- 372

Query: 174 SLSNCKYLEYFSFSNNPLGGILPRA-IGNLSQSMEDFWMDNCNISG-------SIPEEIN 225
                + +E  SF++N L  I       ++S  M         I          +     
Sbjct: 373 -CGFTEQVENLSFAHNKLKYIPNIFDAKSVS-VMSAIDFSYNEIGSVDGKNFDPLDPTPF 430

Query: 226 NLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGF-------VPACSGNLT 278
              N+    ++L  NQ+     +     + L  ++L GN L+               N  
Sbjct: 431 KGINV--SSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTY 488

Query: 279 NLRKLYLGSNLLTSIPSTL--WNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQL------ 330
            L  + L  N LT +        L  ++ ++LS N F+   P +  N + L         
Sbjct: 489 LLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQR 547

Query: 331 DLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIP 390
           D   N      P  I     L  L +  N ++  +   I    ++  L++ +N       
Sbjct: 548 DAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDL 604

Query: 391 ISLEKLLDLKDINVSFNRLE 410
             +   ++     + +++ +
Sbjct: 605 SYVCPYIEAGMYMLFYDKTQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  228 bits (584), Expect = 2e-65
 Identities = 67/475 (14%), Positives = 130/475 (27%), Gaps = 80/475 (16%)

Query: 3   SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSF 62
                F+           S L    ++ +P   SI                    +    
Sbjct: 144 HYQKTFVDYDPREDF---SDLIKDCINSDPQQKSIKKSSR--------ITLKDTQIGQLS 192

Query: 63  NKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFI 122
           N +  V    +  ++ L+  Y+ ++                 +  +        T     
Sbjct: 193 NNITFV-SKAVMRLTKLRQFYMGNSPFVAENICE------AWENENSEYAQQYKTEDLKW 245

Query: 123 FNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTP---ELSSLSSLSNCK 179
            N   L+++ +        +P     L  ++ + +  N   S      +  +L+     +
Sbjct: 246 DNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGE 305

Query: 180 YLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEG 239
            ++      N           NL              +  +   +  +    L +L    
Sbjct: 306 KIQIIYIGYN-----------NLK-------------TFPVETSLQKMKK--LGMLECLY 339

Query: 240 NQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTL-- 297
           NQLEG +P        L  L+L  N+++       G    +  L    N L  IP+    
Sbjct: 340 NQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDA 398

Query: 298 WNLKDILHLNLSSNFFTG-------PLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKD 350
            ++  +  ++ S N           PL         +  ++LS N  S            
Sbjct: 399 KSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSP 458

Query: 351 LQYLFLEYNRLQG-------SIPNSIGDLISLKSLNLSNNNLSGTIP-ISLEKLLDLKDI 402
           L  + L  N L             +  +   L S++L  N L+          L  L  I
Sbjct: 459 LSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGI 518

Query: 403 NVSFNRLEGEIPRE------------GPFRNLSAESFKGN--ELLCGMPNLQVLS 443
           ++S+N      P +               R+           E +   P+L  L 
Sbjct: 519 DLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQ 572

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  228 bits (584), Expect = 3e-65
 Identities = 74/446 (16%), Positives = 140/446 (31%), Gaps = 44/446 (9%)

Query: 3   SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSF 62
           SL      G +   +G  + L+ L L  +    +   F     P  I    + E      
Sbjct: 87  SLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLF----GPKGISANMSDEQKQKMR 142

Query: 63  NKVVGVVPTTIF--NVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPS 120
                         + S L    ++S+     +  S         ++    NN I  +  
Sbjct: 143 MHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKS-SRITLKDTQIGQLSNN-ITFVSK 200

Query: 121 FIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKY 180
            +   +KL +  +  + F            N ++                      N K 
Sbjct: 201 AVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT----------EDLKWDNLKD 250

Query: 181 LEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISG--SIPEEINNLTNLI----LQL 234
           L      N P    LP  +  L   M+   +          + ++   L +      +Q+
Sbjct: 251 LTDVEVYNCPNLTKLPTFLKALP-EMQLINVACNRGISGEQLKDDWQALADAPVGEKIQI 309

Query: 235 LSLEGNQL-EGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSI 293
           + +  N L    +   L ++  L  L+   N+L G +PA  G+   L  L L  N +T I
Sbjct: 310 IYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYNQITEI 368

Query: 294 PSTLW-NLKDILHLNLSSNFFTG-PLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGL--- 348
           P+      + + +L+ + N     P      +++V+  +D S N    V       L   
Sbjct: 369 PANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPT 428

Query: 349 ----KDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSG-------TIPISLEKLL 397
                ++  + L  N++             L S+NL  N L+            + +   
Sbjct: 429 PFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTY 488

Query: 398 DLKDINVSFNRLEGEIPREGPFRNLS 423
            L  I++ FN+L   +  +     L 
Sbjct: 489 LLTSIDLRFNKLTK-LSDDFRATTLP 513

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  212 bits (542), Expect = 2e-59
 Identities = 59/391 (15%), Positives = 134/391 (34%), Gaps = 40/391 (10%)

Query: 48  EIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPN---L 104
            +++   +  ++       G VP  I  ++ L+ L L S+             +      
Sbjct: 76  SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135

Query: 105 KELHLWGNNFIGTIPSFIFNA--SKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYL 162
           ++      ++  T   +      S L +  +  +    SI  +         +G   N +
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI 195

Query: 163 TSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPE 222
           T  +  +  L+       L  F   N+P                     +      +   
Sbjct: 196 TFVSKAVMRLTK------LRQFYMGNSPFVAENICEAWENEN------SEYAQQYKTEDL 243

Query: 223 EINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKL--------SGFVPACS 274
           + +NL +  L  + +        +P  L  L  +  +++  N+              A +
Sbjct: 244 KWDNLKD--LTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADA 301

Query: 275 GNLTNLRKLYLGSNLLTS--IPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDL 332
                ++ +Y+G N L +  + ++L  +K +  L    N   G LP   G+   L  L+L
Sbjct: 302 PVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNL 360

Query: 333 SMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPN--SIGDLISLKSLNLSNNNLSG--- 387
           + N  + +     G  + ++ L   +N+L+  IPN      +  + +++ S N +     
Sbjct: 361 AYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDG 419

Query: 388 ----TIPISLEKLLDLKDINVSFNRLEGEIP 414
                +  +  K +++  IN+S N++     
Sbjct: 420 KNFDPLDPTPFKGINVSSINLSNNQISKFPK 450

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  187 bits (476), Expect = 1e-50
 Identities = 52/340 (15%), Positives = 109/340 (32%), Gaps = 30/340 (8%)

Query: 124 NASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEY 183
           +  +++ L L+    SG +P+  G L  L+ L L  +    +   L     +S     E 
Sbjct: 79  SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER-LFGPKGISANMSDEQ 137

Query: 184 FSFSNNPLGGILPRAIGNLSQS-MEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQL 242
                                S +    +++     SI +            +    N +
Sbjct: 138 KQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLK--DTQIGQLSNNI 195

Query: 243 EGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKD 302
              +   + RL  L Q  +G +         +    N            +      NLKD
Sbjct: 196 T-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYA----QQYKTEDLKWDNLKD 250

Query: 303 ILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNF--------SCVIPTKIGGLKDLQYL 354
           +  + + +      LP  +  L  +  ++++ N                     + +Q +
Sbjct: 251 LTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQII 310

Query: 355 FLEYNRLQ-GSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEI 413
           ++ YN L+   +  S+  +  L  L    N L G +P +    + L  +N+++N++   I
Sbjct: 311 YIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITE-I 368

Query: 414 PRE--GPFRNLSAESFKGNEL--------LCGMPNLQVLS 443
           P    G    +   SF  N+L           +  +  + 
Sbjct: 369 PANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAID 408

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  236 bits (605), Expect = 8e-68
 Identities = 96/483 (19%), Positives = 172/483 (35%), Gaps = 53/483 (10%)

Query: 3   SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCE------------------ 44
            L+++ ++            L  L+L+      S+   +  E                  
Sbjct: 177 ELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLST 236

Query: 45  -IPHEIDNLH--NMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRL 101
                   L   N+  +  S+N +  V   +   +  L+  +L  N++   L S +   L
Sbjct: 237 TSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQH-LFSHSLHGL 295

Query: 102 PNLKELHLWGN--------NFIGTIPSFIF-NASKLSELGLQKNSFSGSIPNTFGNLRNL 152
            N++ L+L  +          +  I  F F     L  L ++ N   G   N F  L NL
Sbjct: 296 FNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINL 355

Query: 153 KWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMD 212
           K+L L++++ +  T    +  SL++   L   + + N +  I   A   L   +E   + 
Sbjct: 356 KYLSLSNSFTSLRTLTNETFVSLAH-SPLHILNLTKNKISKIESDAFSWLG-HLEVLDLG 413

Query: 213 NCNISGSIP-EEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGF-- 269
              I   +  +E   L N+    + L  N+      +    + +L +L L    L     
Sbjct: 414 LNEIGQELTGQEWRGLENI--FEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDS 471

Query: 270 VPACSGNLTNLRKLYLGSNLLTSIP-STLWNLKDILHLNLSSN--------FFTGPLPLK 320
            P+    L NL  L L +N + +I    L  L+ +  L+L  N           G     
Sbjct: 472 SPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYF 531

Query: 321 IGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNL 380
           +  L+ L  L+L  N F  +       L +L+ + L  N L     +   + +SLKSLNL
Sbjct: 532 LKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNL 591

Query: 381 SNNNLSGTIPISLEKLLD-LKDINVSFNRLEGEIPREGPFRNLSAESFK-----GNELLC 434
             N ++             L ++++ FN  +        F N   E+        +  LC
Sbjct: 592 QKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLC 651

Query: 435 GMP 437
             P
Sbjct: 652 NTP 654

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  232 bits (593), Expect = 3e-66
 Identities = 92/450 (20%), Positives = 163/450 (36%), Gaps = 39/450 (8%)

Query: 20  PSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTL 79
           P+++  L L++N     +                 +  +   FN +  + P     +  L
Sbjct: 24  PTNITVLNLTHN----QLRRLP----AANFTRYSQLTSLDVGFNTISKLEPELCQKLPML 75

Query: 80  KSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFS 139
           K L L  N LS  L         NL ELHL  N+      +       L  L L  N  S
Sbjct: 76  KVLNLQHNELSQ-LSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLS 134

Query: 140 GSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAI 199
            +   T   L NL+ L L++N + +   E   + + S+   L+    S+N +    P   
Sbjct: 135 STKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSS---LKKLELSSNQIKEFSPGCF 191

Query: 200 GNLSQSMEDFWMDNCNISGSIPEEI-NNLTNLILQLLSLEGNQLEGSIPDDL--CRLAAL 256
             +   +   +++N  +  S+ E++   L N  ++ LSL  +QL  +        +   L
Sbjct: 192 HAIG-RLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNL 250

Query: 257 FQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSI-PSTLWNLKDILHLNLSSNFFTG 315
             LDL  N L+         L  L   +L  N +  +   +L  L ++ +LNL  +F   
Sbjct: 251 TMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQ 310

Query: 316 PL---------PLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIP 366
            +               L  L  L++  N+   +      GL +L+YL L  +       
Sbjct: 311 SISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTL 370

Query: 367 NSIG----DLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPRE--GPFR 420
            +          L  LNL+ N +S     +   L  L+ +++  N +  E+  +      
Sbjct: 371 TNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLE 430

Query: 421 NLSAESFKGNEL-------LCGMPNLQVLS 443
           N+       N+           +P+LQ L 
Sbjct: 431 NIFEIYLSYNKYLQLTRNSFALVPSLQRLM 460

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  231 bits (591), Expect = 6e-66
 Identities = 92/486 (18%), Positives = 159/486 (32%), Gaps = 51/486 (10%)

Query: 3   SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSF----------------ILCEIP 46
           +LT++ LR +  +     S L +L + +N  S   P                  +     
Sbjct: 31  NLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSD 90

Query: 47  HEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKE 106
                  N+  +    N +  +          L +L L  N LS        V+L NL+E
Sbjct: 91  KTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSS-TKLGTQVQLENLQE 149

Query: 107 LHLWGNNFIGTIPSFI--FNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTS 164
           L L  N         +  F  S L +L L  N      P  F  +  L  L LN+  L  
Sbjct: 150 LLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGP 209

Query: 165 STPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQ-SMEDFWMDNCNISGSIPEE 223
           S  E   L        +   S SN+ L          L   ++    +   N++    + 
Sbjct: 210 SLTE--KLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDS 267

Query: 224 INNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGN---------KLSGFVPACS 274
              L  L  +   LE N ++      L  L  +  L+L  +          L        
Sbjct: 268 FAWLPQL--EYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSF 325

Query: 275 GNLTNLRKLYLGSNLLTSI-PSTLWNLKDILHLNLSSNFFTG----PLPLKIGNLNVLVQ 329
             L  L  L +  N +  I  +    L ++ +L+LS++F +              + L  
Sbjct: 326 QWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHI 385

Query: 330 LDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIP-NSIGDLISLKSLNLSNNNLSGT 388
           L+L+ N  S +       L  L+ L L  N +   +       L ++  + LS N     
Sbjct: 386 LNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQL 445

Query: 389 IPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSA-----------ESFKGNELLCGMP 437
              S   +  L+ + +    L+       PF+ L              +   +++L G+ 
Sbjct: 446 TRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANIN-DDMLEGLE 504

Query: 438 NLQVLS 443
            L++L 
Sbjct: 505 KLEILD 510

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  147 bits (373), Expect = 4e-37
 Identities = 54/282 (19%), Positives = 99/282 (35%), Gaps = 26/282 (9%)

Query: 180 YLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEG 239
             E    S+  L  +      +L  ++    + +  +           +   L  L +  
Sbjct: 5   SHEVADCSHLKLTQVPD----DLPTNITVLNLTHNQLRRLPAANFTRYSQ--LTSLDVGF 58

Query: 240 NQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSI-PSTLW 298
           N +    P+   +L  L  L+L  N+LS          TNL +L+L SN +  I  +   
Sbjct: 59  NTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFV 118

Query: 299 NLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPT--KIGGLKDLQYLFL 356
             K+++ L+LS N  +         L  L +L LS N    +      I     L+ L L
Sbjct: 119 KQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLEL 178

Query: 357 EYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISL---EKLLDLKDINVSFNRLEGEI 413
             N+++   P     +  L  L L+N  L  ++   L        ++++++S ++L    
Sbjct: 179 SSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTS 238

Query: 414 PREGPFRNLSAESFK-----GNEL-------LCGMPNLQVLS 443
                F  L   +        N L          +P L+   
Sbjct: 239 N--TTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFF 278

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  108 bits (273), Expect = 1e-24
 Identities = 34/166 (20%), Positives = 55/166 (33%), Gaps = 18/166 (10%)

Query: 278 TNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNF 337
            +          LT +P  L    +I  LNL+ N             + L  LD+  N  
Sbjct: 4   VSHEVADCSHLKLTQVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61

Query: 338 SCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLL 397
           S + P     L  L+ L L++N L      +     +L  L+L +N++         K  
Sbjct: 62  SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121

Query: 398 DLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMPNLQVLS 443
           +L  +++S N L                          + NLQ L 
Sbjct: 122 NLITLDLSHNGLSSTKLG----------------TQVQLENLQELL 151

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  219 bits (560), Expect = 3e-62
 Identities = 94/439 (21%), Positives = 164/439 (37%), Gaps = 30/439 (6%)

Query: 20  PSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTL 79
           P+S + L  S+N     +P+            L N+ ++  +  ++  +   T  +   L
Sbjct: 32  PNSTECLEFSFN----VLPTIQ----NTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRL 83

Query: 80  KSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFS 139
            +L L +N L   +  +A      LK L              + N   L  L L  N  S
Sbjct: 84  DTLVLTANPLIF-MAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHIS 142

Query: 140 GSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAI 199
                       LK L   +N +   + E   +SSL     L   + + N + GI P A 
Sbjct: 143 SIKLPKGFPTEKLKVLDFQNNAIHYLSKE--DMSSLQQATNL-SLNLNGNDIAGIEPGAF 199

Query: 200 GNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAA--LF 257
            +      +F          I + + N T   L L + E    E   P     L    + 
Sbjct: 200 DSAVFQSLNF--GGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVE 257

Query: 258 QLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPL 317
            ++L  +             + L++L L +  L+ +PS L  L  +  L LS+N F    
Sbjct: 258 SINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLC 317

Query: 318 PLKIGNLNVLVQLDLSMNNFSCVIPTK-IGGLKDLQYLFLEYNRLQGS--IPNSIGDLIS 374
            +   N   L  L +  N     + T  +  L++L+ L L ++ ++ S      + +L  
Sbjct: 318 QISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSH 377

Query: 375 LKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSA---------- 424
           L+SLNLS N        + ++   L+ ++++F RL+     + PF+NL            
Sbjct: 378 LQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKV-KDAQSPFQNLHLLKVLNLSHSL 436

Query: 425 ESFKGNELLCGMPNLQVLS 443
                 +L  G+P LQ L+
Sbjct: 437 LDISSEQLFDGLPALQHLN 455

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  203 bits (519), Expect = 1e-56
 Identities = 84/432 (19%), Positives = 142/432 (32%), Gaps = 29/432 (6%)

Query: 3   SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSF 62
            LT + L  +  + L  P +L+ L+             I       + N   +E +    
Sbjct: 87  VLTANPLIFMAETALSGPKALKHLFFIQT--------GISSIDFIPLHNQKTLESLYLGS 138

Query: 63  NKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLW-GNNFIGTIPSF 121
           N +  +     F    LK L   +N++   L       L     L L    N I  I   
Sbjct: 139 NHISSIKLPKGFPTEKLKVLDFQNNAIHY-LSKEDMSSLQQATNLSLNLNGNDIAGIEPG 197

Query: 122 IFNASKLSELGLQKNSFSGSIPN--TFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCK 179
            F+++    L          I        +++L      D      +P +       +  
Sbjct: 198 AFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMS-- 255

Query: 180 YLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEG 239
            +E  +   +    I        S  +++  +   ++S  +P  +  L+ L  + L L  
Sbjct: 256 -VESINLQKHYFFNISSNTFHCFS-GLQELDLTATHLS-ELPSGLVGLSTL--KKLVLSA 310

Query: 240 NQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACS-GNLTNLRKLYLGSNLLTSIPS--- 295
           N+ E           +L  L + GN     +      NL NLR+L L  + + +      
Sbjct: 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNL 370

Query: 296 TLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIP-TKIGGLKDLQYL 354
            L NL  +  LNLS N               L  LDL+          +    L  L+ L
Sbjct: 371 QLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVL 430

Query: 355 FLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPI---SLEKLLDLKDINVSFNRLEG 411
            L ++ L  S       L +L+ LNL  N+          SL+ L  L+ + +SF  L  
Sbjct: 431 NLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSS 490

Query: 412 EIPREGPFRNLS 423
                  F +L 
Sbjct: 491 IDQ--HAFTSLK 500

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  197 bits (504), Expect = 1e-54
 Identities = 84/446 (18%), Positives = 150/446 (33%), Gaps = 33/446 (7%)

Query: 3   SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSF 62
            L ++ +  I L +      L+ L    N         I      ++ +L     ++ + 
Sbjct: 135 YLGSNHISSIKLPKGFPTEKLKVLDFQNN--------AIHYLSKEDMSSLQQATNLSLNL 186

Query: 63  NK-VVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSS-ADVRLPNLKELHLWGNNFIGTIPS 120
           N   +  +    F+ +  +SL          +     +  + +L        +    I  
Sbjct: 187 NGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMD-DEDISP 245

Query: 121 FIFN---ASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSN 177
            +F       +  + LQK+ F     NTF     L+ L L   +L+     L  LS+L  
Sbjct: 246 AVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTL-- 303

Query: 178 CKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEE-INNLTNLILQLLS 236
               +    S N    +   +  N   S+    +        +    + NL NL  + L 
Sbjct: 304 ----KKLVLSANKFENLCQISASNFP-SLTHLSIKGNTKRLELGTGCLENLENL--RELD 356

Query: 237 LEGNQLEGS--IPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSI- 293
           L  + +E S      L  L+ L  L+L  N+              L  L L    L    
Sbjct: 357 LSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKD 416

Query: 294 -PSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKD-- 350
             S   NL  +  LNLS +            L  L  L+L  N+F      K   L+   
Sbjct: 417 AQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLG 476

Query: 351 -LQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRL 409
            L+ L L +  L     ++   L  +  ++LS+N L+ +   +L  L  +  +N++ N +
Sbjct: 477 RLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHI 535

Query: 410 EGEIPRE-GPFRNLSAESFKGNELLC 434
              +P            + + N L C
Sbjct: 536 SIILPSLLPILSQQRTINLRQNPLDC 561

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  197 bits (504), Expect = 1e-54
 Identities = 88/430 (20%), Positives = 151/430 (35%), Gaps = 25/430 (5%)

Query: 3   SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSF 62
            LT   +  I      +   L TL L+ NP        ++      +     ++ + F  
Sbjct: 63  DLTRCQIYWIHEDTFQSQHRLDTLVLTANP--------LIFMAETALSGPKALKHLFFIQ 114

Query: 63  NKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFI 122
             +  +    + N  TL+SLYL SN +S  +          LK L    N         +
Sbjct: 115 TGISSIDFIPLHNQKTLESLYLGSNHISS-IKLPKGFPTEKLKVLDFQNNAIHYLSKEDM 173

Query: 123 FNASKLS--ELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKY 180
            +  + +   L L  N  +  I     +    + L            +    S++ +   
Sbjct: 174 SSLQQATNLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQS--- 229

Query: 181 LEYFSFSNNPLGGILPRAIGNLSQ-SMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEG 239
           L   +F +     I P     L + S+E   +             +  +   LQ L L  
Sbjct: 230 LWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSG--LQELDLTA 287

Query: 240 NQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSN--LLTSIPSTL 297
             L   +P  L  L+ L +L L  NK        + N  +L  L +  N   L      L
Sbjct: 288 THLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCL 346

Query: 298 WNLKDILHLNLSSNFFT--GPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLF 355
            NL+++  L+LS +         L++ NL+ L  L+LS N    +          L+ L 
Sbjct: 347 ENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLD 406

Query: 356 LEYNRLQGSIPNSI-GDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIP 414
           L + RL+     S   +L  LK LNLS++ L  +     + L  L+ +N+  N       
Sbjct: 407 LAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNI 466

Query: 415 RE-GPFRNLS 423
           ++    + L 
Sbjct: 467 QKTNSLQTLG 476

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  174 bits (444), Expect = 2e-46
 Identities = 71/385 (18%), Positives = 129/385 (33%), Gaps = 25/385 (6%)

Query: 13  ILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTT 72
           I     + +  Q+L          I   +      +   + ++    F       + P  
Sbjct: 194 IEPGAFDSAVFQSLNFGGTQNLLVIFKGL------KNSTIQSLWLGTFEDMDDEDISPAV 247

Query: 73  IFNVS--TLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSE 130
              +   +++S+ L  +     + S+       L+EL L   + +  +PS +   S L +
Sbjct: 248 FEGLCEMSVESINLQKHYFFN-ISSNTFHCFSGLQELDLTATH-LSELPSGLVGLSTLKK 305

Query: 131 LGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNP 190
           L L  N F      +  N  +L  L +  N              L N + L     S++ 
Sbjct: 306 LVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGT----GCLENLENLRELDLSHDD 361

Query: 191 LGGI--LPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPD 248
           +         + NLS  ++   +          E       L  +LL L   +L+     
Sbjct: 362 IETSDCCNLQLRNLS-HLQSLNLSYNEPLSLKTEAFKECPQL--ELLDLAFTRLKVKDAQ 418

Query: 249 D-LCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSI----PSTLWNLKDI 303
                L  L  L+L  + L          L  L+ L L  N          ++L  L  +
Sbjct: 419 SPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRL 478

Query: 304 LHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQG 363
             L LS    +        +L ++  +DLS N  +      +  LK + YL L  N +  
Sbjct: 479 EILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISI 537

Query: 364 SIPNSIGDLISLKSLNLSNNNLSGT 388
            +P+ +  L   +++NL  N L  T
Sbjct: 538 ILPSLLPILSQQRTINLRQNPLDCT 562

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  173 bits (440), Expect = 6e-46
 Identities = 72/373 (19%), Positives = 133/373 (35%), Gaps = 29/373 (7%)

Query: 21  SSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLK 80
            S++++ L  +        +      +       ++ +  +   +  + P+ +  +STLK
Sbjct: 254 MSVESINLQKH--------YFFNISSNTFHCFSGLQELDLTATHLSEL-PSGLVGLSTLK 304

Query: 81  SLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIF-NASKLSELGLQKN--S 137
            L L +N     L   +    P+L  L + GN     + +    N   L EL L  +   
Sbjct: 305 KLVLSANKFEN-LCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIE 363

Query: 138 FSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPR 197
            S        NL +L+ L L+ N   S   E     +   C  LE    +   L     +
Sbjct: 364 TSDCCNLQLRNLSHLQSLNLSYNEPLSLKTE-----AFKECPQLELLDLAFTRLKVKDAQ 418

Query: 198 AIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSI---PDDLCRLA 254
           +       ++   + +  +  S  +  + L  L  Q L+L+GN          + L  L 
Sbjct: 419 SPFQNLHLLKVLNLSHSLLDISSEQLFDGLPAL--QHLNLQGNHFPKGNIQKTNSLQTLG 476

Query: 255 ALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFT 314
            L  L L    LS        +L  +  + L  N LTS      +    ++LNL+SN  +
Sbjct: 477 RLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIYLNLASNHIS 536

Query: 315 GPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDL-QYLFLEYNRLQGSIPNSIGDLI 373
             LP  +  L+    ++L  N   C             ++      +L+ +      +  
Sbjct: 537 IILPSLLPILSQQRTINLRQNPLDCTC-----SNIYFLEWYKENMQKLEDTEDTLCENPP 591

Query: 374 SLKSLNLSNNNLS 386
            L+ + LS+  LS
Sbjct: 592 LLRGVRLSDVTLS 604

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score =  123 bits (311), Expect = 2e-29
 Identities = 51/260 (19%), Positives = 68/260 (26%), Gaps = 20/260 (7%)

Query: 200 GNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQL 259
           G L  S E        +        + L N  L  L L   Q+     D       L  L
Sbjct: 29  GTLPNSTECLEFSFNVLPTIQNTTFSRLIN--LTFLDLTRCQIYWIHEDTFQSQHRLDTL 86

Query: 260 DLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSI-PSTLWNLKDILHLNLSSNFFTGPLP 318
            L  N L             L+ L+     ++SI    L N K +  L L SN  +    
Sbjct: 87  VLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKL 146

Query: 319 LKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQ-GSIPNSIGDLISLKS 377
            K      L  LD   N    +    +  L+    L L  N      I     D    +S
Sbjct: 147 PKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQS 206

Query: 378 LNLSNNNLSGTIPISLE--KLLDLKDINVSFNRLEGEIPREGPFRNLSAESFK------- 428
           LN         I   L+   +  L          E        F  L   S +       
Sbjct: 207 LNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDED--ISPAVFEGLCEMSVESINLQKH 264

Query: 429 -----GNELLCGMPNLQVLS 443
                 +        LQ L 
Sbjct: 265 YFFNISSNTFHCFSGLQELD 284

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 98.5 bits (246), Expect = 2e-21
 Identities = 30/166 (18%), Positives = 60/166 (36%), Gaps = 6/166 (3%)

Query: 259 LDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSI-PSTLWNLKDILHLNLSSNFFTGPL 317
            +     L+  +P       +   L    N+L +I  +T   L ++  L+L+        
Sbjct: 17  YNCENLGLNE-IP--GTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIH 73

Query: 318 PLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKS 377
                + + L  L L+ N    +  T + G K L++LF     +       + +  +L+S
Sbjct: 74  EDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLES 133

Query: 378 LNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLS 423
           L L +N++S            LK ++   N +           +L 
Sbjct: 134 LYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSK--EDMSSLQ 177

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  211 bits (540), Expect = 2e-59
 Identities = 83/436 (19%), Positives = 152/436 (34%), Gaps = 38/436 (8%)

Query: 3   SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSF 62
                 L  +    +G+  +L+ L +++N            ++P    NL N+E +  S 
Sbjct: 106 VAVETNLASLENFPIGHLKTLKELNVAHNLIQSF-------KLPEYFSNLTNLEHLDLSS 158

Query: 63  NKVVGVVPTTIFNVSTLK----SLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTI 118
           NK+  +  T +  +  +     SL L  N ++   P +   +   L +L L  N     +
Sbjct: 159 NKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGA--FKEIRLHKLTLRNNFDSLNV 216

Query: 119 PSFIFNA-SKLSELGLQKNSFSGS------IPNTFGNLRNLKWLGLNDNYLTSSTPELSS 171
                   + L    L    F           +    L NL        YL     ++  
Sbjct: 217 MKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIID 276

Query: 172 LSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLI 231
           L   +    +  FS  +  +  +   +    +   +   + NC        ++ +L  L 
Sbjct: 277 L--FNCLTNVSSFSLVSVTIERVKDFS---YNFGWQHLELVNCKFGQFPTLKLKSLKRLT 331

Query: 232 LQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLS--GFVPACSGNLTNLRKLYLGSNL 289
                      +G        L +L  LDL  N LS  G         T+L+ L L  N 
Sbjct: 332 F-------TSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNG 384

Query: 290 LTSIPSTLWNLKDILHLNLSSNFFTGPLPLKI-GNLNVLVQLDLSMNNFSCVIPTKIGGL 348
           + ++ S    L+ + HL+   +         +  +L  L+ LD+S  +          GL
Sbjct: 385 VITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL 444

Query: 349 KDLQYLFLEYNRLQGSI-PNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFN 407
             L+ L +  N  Q +  P+   +L +L  L+LS   L    P +   L  L+ +N+S N
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHN 504

Query: 408 RLEGEIPREGPFRNLS 423
                     P++ L+
Sbjct: 505 NFFSLDT--FPYKCLN 518

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  205 bits (524), Expect = 3e-57
 Identities = 84/473 (17%), Positives = 144/473 (30%), Gaps = 61/473 (12%)

Query: 6   NDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAF----S 61
           N      +     N ++L+ L LS N       +        ++  LH M  +      S
Sbjct: 134 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT--------DLRVLHQMPLLNLSLDLS 185

Query: 62  FNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNF--IGTIP 119
            N +  + P   F    L  L L +N  S  +  +    L  L+   L    F   G + 
Sbjct: 186 LNPMNFIQPG-AFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLE 244

Query: 120 SFIFNA-SKLSELGLQKNSFS------GSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSL 172
            F  +A   L  L +++   +        I + F  L N+    L    +         +
Sbjct: 245 KFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTI-------ERV 297

Query: 173 SSLSNCKYLEYFSFSNNPLGGILPRAIGNLS-------QSMEDFWMDNC----------- 214
              S     ++    N   G      + +L        +    F   +            
Sbjct: 298 KDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRN 357

Query: 215 --NISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPA 272
             +  G   +     T+L  + L L  N +   +  +   L  L  LD   + L      
Sbjct: 358 GLSFKGCCSQSDFGTTSL--KYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEF 414

Query: 273 -CSGNLTNLRKLYLGSNLLTSI-PSTLWNLKDILHLNLSSNFFTGPL-PLKIGNLNVLVQ 329
               +L NL  L +               L  +  L ++ N F     P     L  L  
Sbjct: 415 SVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 474

Query: 330 LDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTI 389
           LDLS      + PT    L  LQ L + +N            L SL+ L+ S N++  + 
Sbjct: 475 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSK 534

Query: 390 PISLEKLLD-LKDINVSFNRLEGEIPREGPF----RNLSAESFKGNELLCGMP 437
              L+     L  +N++ N        +  F    ++      +   + C  P
Sbjct: 535 KQELQHFPSSLAFLNLTQNDFACTCEHQ-SFLQWIKDQRQLLVEVERMECATP 586

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  202 bits (515), Expect = 5e-56
 Identities = 78/475 (16%), Positives = 144/475 (30%), Gaps = 68/475 (14%)

Query: 4   LTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFN 63
           L+ + LR +      +   LQ L LS                     +L ++  +  + N
Sbjct: 35  LSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDG--------AYQSLSHLSTLILTGN 86

Query: 64  KVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGT-IPSFI 122
            +  +       +S+L+ L     +L+  L +     L  LKEL++  N      +P + 
Sbjct: 87  PIQSLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEYF 145

Query: 123 FNASKLSELGLQKNSFSGSIPNTFGNLRNLK----WLGLNDNYLTSSTPELSSLSSLSNC 178
            N + L  L L  N            L  +      L L+ N +    P           
Sbjct: 146 SNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR---- 201

Query: 179 KYLEYFSFSNNPL-GGILPRAIGNLSQSMEDFWMDN-----CNISGSIPEEINNLTNLIL 232
             L   +  NN     ++   I  L+       +        N+       +  L NL +
Sbjct: 202 --LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 259

Query: 233 QLLSLEGNQL-EGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLT 291
           +   L         I D    L  +    L    +              + L L +    
Sbjct: 260 EEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFG 317

Query: 292 SIPS--------------------TLWNLKDILHLNLSSNF--FTGPLPLKIGNLNVLVQ 329
             P+                    +  +L  +  L+LS N   F G           L  
Sbjct: 318 QFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKY 377

Query: 330 LDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSI-GDLISLKSLNLSNNNLSGT 388
           LDLS N     + +   GL+ L++L  +++ L+     S+   L +L  L++S+ +    
Sbjct: 378 LDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA 436

Query: 389 IPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMPNLQVLS 443
                  L  L+ + ++ N  +                    ++   + NL  L 
Sbjct: 437 FNGIFNGLSSLEVLKMAGNSFQENFLP---------------DIFTELRNLTFLD 476

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  186 bits (475), Expect = 1e-50
 Identities = 84/426 (19%), Positives = 134/426 (31%), Gaps = 41/426 (9%)

Query: 42  LCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRL 101
             +IP  +    + + +  SFN +  +   + F+   L+ L L    +   +   A   L
Sbjct: 19  FYKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSL 75

Query: 102 PNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNY 161
            +L  L L GN             S L +L   + + +       G+L+ LK L +  N 
Sbjct: 76  SHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNL 135

Query: 162 LTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFW---MDNCNISG 218
           + S           SN   LE+   S+N +  I    +  L Q         +    ++ 
Sbjct: 136 IQS----FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF 191

Query: 219 SIPEEINNLTNLILQLLSLEGNQLEGSIPDDLC-RLAALFQLDLGGNKLSGF---VPACS 274
             P     +    L  L+L  N    ++       LA L    L   +            
Sbjct: 192 IQPGAFKEIR---LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK 248

Query: 275 GNLTNLRKLYLGSNLLTS-------IPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVL 327
             L  L  L +    L         I      L ++   +L S                 
Sbjct: 249 SALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDF--SYNFGW 306

Query: 328 VQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLS- 386
             L+L    F      K+  LK L      +   +G    S  DL SL+ L+LS N LS 
Sbjct: 307 QHLELVNCKFGQFPTLKLKSLKRLT-----FTSNKGGNAFSEVDLPSLEFLDLSRNGLSF 361

Query: 387 -GTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNEL--------LCGMP 437
            G    S      LK +++SFN +            L    F+ + L           + 
Sbjct: 362 KGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 421

Query: 438 NLQVLS 443
           NL  L 
Sbjct: 422 NLIYLD 427

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  127 bits (322), Expect = 7e-31
 Identities = 57/314 (18%), Positives = 101/314 (32%), Gaps = 45/314 (14%)

Query: 1   MPSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAF 60
           +  LT    +G       +  SL+ L LS N                             
Sbjct: 327 LKRLTFTSNKGGNAFSEVDLPSLEFLDLSRN----------------------------- 357

Query: 61  SFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPS 120
                 G    + F  ++LK L L  N +     +     L  L+ L    +N       
Sbjct: 358 -GLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFL--GLEQLEHLDFQHSNLKQMSEF 414

Query: 121 FIF-NASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCK 179
            +F +   L  L +       +    F  L +L+ L +  N    +          +  +
Sbjct: 415 SVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP----DIFTELR 470

Query: 180 YLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEG 239
            L +   S   L  + P A  +LS S++   M + N           L +  LQ+L    
Sbjct: 471 NLTFLDLSQCQLEQLSPTAFNSLS-SLQVLNMSHNNFFSLDTFPYKCLNS--LQVLDYSL 527

Query: 240 NQLEGSIPDDLCRLA-ALFQLDLGGNKLSGFVPACS--GNLTNLRKLYLGSNLLT-SIPS 295
           N +  S   +L     +L  L+L  N  +      S    + + R+L +    +  + PS
Sbjct: 528 NHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPS 587

Query: 296 TLWNLKDILHLNLS 309
               +  +L LN++
Sbjct: 588 DKQGMP-VLSLNIT 600

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  104 bits (261), Expect = 2e-23
 Identities = 36/151 (23%), Positives = 54/151 (35%), Gaps = 4/151 (2%)

Query: 273 CSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDL 332
           C   + N+    +  N    IP  L       +L+LS N           +   L  LDL
Sbjct: 3   CVEVVPNITYQCMELNF-YKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59

Query: 333 SMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPIS 392
           S      +       L  L  L L  N +Q     +   L SL+ L     NL+      
Sbjct: 60  SRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP 119

Query: 393 LEKLLDLKDINVSFNRLEGEIPREGPFRNLS 423
           +  L  LK++NV+ N ++        F NL+
Sbjct: 120 IGHLKTLKELNVAHNLIQS-FKLPEYFSNLT 149

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  210 bits (537), Expect = 1e-57
 Identities = 61/456 (13%), Positives = 130/456 (28%), Gaps = 63/456 (13%)

Query: 1   MPSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAF 60
           +  L   +      +        +     Y     +              NL ++  +  
Sbjct: 447 LTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEEL--------SWSNLKDLTDVEL 498

Query: 61  SFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPS 120
                +  +P  ++++  L+SL +  N                              +  
Sbjct: 499 YNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQL----------------KADWTRLAD 542

Query: 121 FIFNASKLSELGLQKNSFSG-SIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCK 179
                 K+    +  N+        +   +  L  L    N       ++  L +     
Sbjct: 543 DEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHN-------KVRHLEAFGTNV 595

Query: 180 YLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPE--EINNLTNLILQLLSL 237
            L       N +  I P      +  +E     +  +   IP      ++    +  +  
Sbjct: 596 KLTDLKLDYNQIEEI-PEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYV--MGSVDF 651

Query: 238 EGNQLEGSIPD-----DLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTS 292
             N++     +     D  +      + L  N++  F        + +  + L +NL+TS
Sbjct: 652 SYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTS 711

Query: 293 IPS--------TLWNLKDILHLNLSSNFFTG-PLPLKIGNLNVLVQLDLSMNNFSCVIPT 343
           IP            N   +  ++L  N  T      +   L  L  +D+S N FS   PT
Sbjct: 712 IPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFS-SFPT 770

Query: 344 KIGGLKDLQYL------FLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLL 397
           +      L+          E NR+    P  I    SL  L + +N++   +   L    
Sbjct: 771 QPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TP 827

Query: 398 DLKDINVSFNRL-EGEIPREGPFRNLSAESFKGNEL 432
            L  ++++ N     ++    P+          ++ 
Sbjct: 828 QLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKT 863

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  210 bits (536), Expect = 2e-57
 Identities = 62/459 (13%), Positives = 122/459 (26%), Gaps = 55/459 (11%)

Query: 7   DFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVV 66
           D         L N   +  L L+     G +P          I  L  ++ ++F  +   
Sbjct: 309 DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPD--------AIGQLTELKVLSFGTHSET 360

Query: 67  GVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNF-----IGTIPSF 121
                      T        + +              L    L  +       +  I   
Sbjct: 361 VSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKD 420

Query: 122 IFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYL 181
              + K +++G   N  +  I      L  L+ +   ++  T     +    +       
Sbjct: 421 SRISLKDTQIGNLTNRIT-FISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDAN------ 473

Query: 182 EYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQ 241
                           +  NL   + D  + NC     +P+ + +L    LQ L++  N+
Sbjct: 474 ----SDYAKQYENEELSWSNLK-DLTDVELYNCPNMTQLPDFLYDLPE--LQSLNIACNR 526

Query: 242 LEG---------SIPDDLCRLAALFQLDLGGNKLSGFVPACS-GNLTNLRKLYLGSNLLT 291
                        + DD      +    +G N L  F  + S   +  L  L    N + 
Sbjct: 527 GISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR 586

Query: 292 SIPSTLWNLKDILHLNLSSNFFTGPLPLKIG-NLNVLVQLDLSMNNFSCVIPT-KIGGLK 349
            + +       +  L L  N     +P       + +  L  S N    +        + 
Sbjct: 587 HLEA-FGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVY 644

Query: 350 DLQYLFLEYNRLQGSIPN-----SIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINV 404
            +  +   YN++     N          I+  ++ LS N +             +  I +
Sbjct: 645 VMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIIL 704

Query: 405 SFNRLEGEIPREGPFRNLSAESFKGNELLCGMPNLQVLS 443
           S N +   IP               +        L  + 
Sbjct: 705 SNNLMT-SIPEN--------SLKPKDGNYKNTYLLTTID 734

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  205 bits (522), Expect = 1e-55
 Identities = 69/460 (15%), Positives = 141/460 (30%), Gaps = 69/460 (15%)

Query: 12  IILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPH-EIDNLHNMEWMAFSFNKVVGVVP 70
           +   Q  N S L    ++ NP    I       +   +I NL N           +  + 
Sbjct: 392 LDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNR----------ITFIS 441

Query: 71  TTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSE 130
             I  ++ L+ +Y  ++  +    +       + ++ +               N   L++
Sbjct: 442 KAIQRLTKLQIIYFANSPFTYDNIAV------DWEDANSDYAKQYENEELSWSNLKDLTD 495

Query: 131 LGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSL----SNCKYLEYFSF 186
           + L        +P+   +L  L+ L +  N   S+    +  + L         ++ F  
Sbjct: 496 VELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYM 555

Query: 187 SNNPLGGI-LPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGS 245
             N L       ++  +   +      +  +     E         L  L L+ NQ+E  
Sbjct: 556 GYNNLEEFPASASLQKMV-KLGLLDCVHNKV--RHLEAFGTNVK--LTDLKLDYNQIE-E 609

Query: 246 IPDDLCRLA-ALFQLDLGGNKLSGFVPACS-GNLTNLRKLYLGSNLLTSIPSTL------ 297
           IP+D C     +  L    NKL       +  ++  +  +    N + S    +      
Sbjct: 610 IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDD 669

Query: 298 WNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCV-------IPTKIGGLKD 350
           +   +   + LS N             + +  + LS N  + +                 
Sbjct: 670 YKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYL 729

Query: 351 LQYLFLEYNRLQGSIPNSI--GDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSF-- 406
           L  + L +N+L  S+ +      L  L ++++S N  S + P        LK   +    
Sbjct: 730 LTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQR 787

Query: 407 ----NRLEGEIPREGPFRNLSAESFKGNELLCGMPNLQVL 442
               NR+  + P                  +   P+L  L
Sbjct: 788 DAEGNRILRQWPTG----------------ITTCPSLIQL 811

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  187 bits (477), Expect = 1e-49
 Identities = 64/420 (15%), Positives = 125/420 (29%), Gaps = 62/420 (14%)

Query: 61  SFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPS 120
             +         + N   +  L L      GR+P +   +L  LK L    ++   +   
Sbjct: 307 ELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIG-QLTELKVLSFGTHSETVSGRL 365

Query: 121 FIFNASKLSELGLQKNSFSGSIPNTFG-NLRNLKWLGLNDNYLTSSTPELSSLSSLSNCK 179
           F            +K+         F    + L    L  + +  + PE+  +   S   
Sbjct: 366 FGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN-PEMKPIKKDSRIS 424

Query: 180 -YLEYFSFSNNPLGGILPRAIGNLSQ------------------SMEDFWMDNCNISGSI 220
                     N +  I  +AI  L++                    ED   D      + 
Sbjct: 425 LKDTQIGNLTNRITFI-SKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENE 483

Query: 221 PEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGF---------VP 271
               +NL +  L  + L        +PD L  L  L  L++  N+             + 
Sbjct: 484 ELSWSNLKD--LTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLA 541

Query: 272 ACSGNLTNLRKLYLGSNLLTSIPS--TLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQ 329
                   ++  Y+G N L   P+  +L  +  +  L+   N          G    L  
Sbjct: 542 DDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHLEA--FGTNVKLTD 599

Query: 330 LDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPN--SIGDLISLKSLNLSNNNLSG 387
           L L  N    +          ++ L   +N+L+  IPN  +   +  + S++ S N +  
Sbjct: 600 LKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGS 658

Query: 388 -----TIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMPNLQVL 442
                +  +   K ++   + +S+N ++                    EL      +  +
Sbjct: 659 EGRNISCSMDDYKGINASTVTLSYNEIQKFPT----------------ELFATGSPISTI 702

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  171 bits (435), Expect = 2e-44
 Identities = 60/368 (16%), Positives = 112/368 (30%), Gaps = 56/368 (15%)

Query: 94  PSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLK 153
            +   +     KEL +WG+         + N  +++ L L      G +P+  G L  LK
Sbjct: 295 NTIHSLNWNFNKELDMWGDQ----PGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELK 350

Query: 154 WLGLNDNYLTSSTPE--------------------------LSSLSSLSNCKYLEYFSFS 187
            L    +  T S                             L     L+    L+     
Sbjct: 351 VLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINR 410

Query: 188 NNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIP 247
           N  +  I   +  +L  +      +  N    I + I  LT   LQ++    +       
Sbjct: 411 NPEMKPIKKDSRISLKDTQIG---NLTNRITFISKAIQRLTK--LQIIYFANSPFTYDNI 465

Query: 248 DDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGS-NLLTSIPSTLWNLKDILHL 306
                       +    K          NL +L  + L +   +T +P  L++L ++  L
Sbjct: 466 AVDWED-----ANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSL 520

Query: 307 NLSSNFFTGP---------LPLKIGNLNVLVQLDLSMNNFSCV-IPTKIGGLKDLQYLFL 356
           N++ N              L         +    +  NN         +  +  L  L  
Sbjct: 521 NIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDC 580

Query: 357 EYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLL-DLKDINVSFNRLEGEIPR 415
            +N++      + G  + L  L L  N +   IP         ++ +  S N+L+  IP 
Sbjct: 581 VHNKV--RHLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPN 636

Query: 416 EGPFRNLS 423
               +++ 
Sbjct: 637 IFNAKSVY 644

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score =  121 bits (305), Expect = 2e-28
 Identities = 39/263 (14%), Positives = 79/263 (30%), Gaps = 34/263 (12%)

Query: 208 DFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLS 267
           +F  +          +++N   +    LSL G   +G +PD + +L  L  L  G +  +
Sbjct: 303 NFNKELDMWGDQPGVDLDNNGRVTG--LSLAGFGAKGRVPDAIGQLTELKVLSFGTHSET 360

Query: 268 GFVPACSGNLTNLRKLYLGSNLLTSI--PSTLWNLKDILHLNLSSNFFTG---PLPLKIG 322
                               + +        L   + +   +L  +         P+K  
Sbjct: 361 VSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKD 420

Query: 323 NLNVLVQLDLS-MNNFSCVIPTKIGGLKDLQYLFLEYNRLQG------------------ 363
           +   L    +  + N    I   I  L  LQ ++   +                      
Sbjct: 421 SRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQY 480

Query: 364 -SIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNL 422
            +   S  +L  L  + L N      +P  L  L +L+ +N++ NR       +  +  L
Sbjct: 481 ENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRL 540

Query: 423 SAESFKGNELLCGMPNLQVLSCR 445
           + +           P +Q+    
Sbjct: 541 ADD-------EDTGPKIQIFYMG 556

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  198 bits (506), Expect = 2e-57
 Identities = 66/187 (35%), Positives = 95/187 (50%), Gaps = 10/187 (5%)

Query: 500 RRFTYLELFQATNRFSENNLIGRGGFGPVYK----DGMEVAIKVFNLQYGGAFKSFDIEC 555
            R   ++L +ATN F    LIG G FG VYK    DG +VA+K    +     + F+ E 
Sbjct: 27  YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEI 86

Query: 556 GMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLY---SGNYILDIFQGLNIMI 612
             +   RH +L+ +I  C   +   L+ +YM  G+L++ LY        +   Q L I I
Sbjct: 87  ETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICI 146

Query: 613 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA 672
             A  L YLH      IIH D+K  N+LLD+N V  ++DFG++K   E DQ+   T    
Sbjct: 147 GAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKG 203

Query: 673 TIGYMAP 679
           T+GY+ P
Sbjct: 204 TLGYIDP 210

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  197 bits (503), Expect = 4e-57
 Identities = 71/200 (35%), Positives = 102/200 (51%), Gaps = 9/200 (4%)

Query: 500 RRFTYLELFQATNRFSENNLIGRGGFGPVYK----DGMEVAIKVFNLQYG-GAFKSFDIE 554
           +RF+  EL  A++ FS  N++GRGGFG VYK    DG  VA+K    +   G    F  E
Sbjct: 18  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTE 77

Query: 555 CGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLY---SGNYILDIFQGLNIM 611
             M+    HRNL+++   C     + LV  YM  GS+  CL         LD  +   I 
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137

Query: 612 IDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL 671
           +  A  L YLH      IIH D+K +N+LLD+   A + DFG+AK L++   +   T   
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVR 196

Query: 672 ATIGYMAPDEIFSGEMRLKC 691
            TIG++AP+ + +G+   K 
Sbjct: 197 GTIGHIAPEYLSTGKSSEKT 216

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  189 bits (482), Expect = 1e-51
 Identities = 79/459 (17%), Positives = 134/459 (29%), Gaps = 63/459 (13%)

Query: 3   SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSF 62
                 L  +    +G   +L+ L +++N            ++P    NL N+  +  S+
Sbjct: 110 VAVETKLASLESFPIGQLITLKKLNVAHNFIHSC-------KLPAYFSNLTNLVHVDLSY 162

Query: 63  NKVVGV---------------------------VPTTIFNVSTLKSLYLHSNSLSGRLPS 95
           N +  +                           +    F    L  L L  N  S  +  
Sbjct: 163 NYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMK 222

Query: 96  SADVRLPNLKELHLWGNNFIGTIPSFIFNASKLS--------ELGLQKNSFSGSIPNTFG 147
           +    L  L    L    F       IF  S +         E  L   +        F 
Sbjct: 223 TCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFH 282

Query: 148 NLRNLKWLGLNDNYLTS--STPELSSLSSLS------------NCKYLEYFSFSNNPLGG 193
            L N+  + L    +      P+     SLS            +  +L+  + + N    
Sbjct: 283 CLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLTLTMNKGSI 342

Query: 194 ILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRL 253
                   L  S+    +    +S S     ++L    L+ L L  N     +  +   L
Sbjct: 343 SFK--KVALP-SLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGL 398

Query: 254 AALFQLDLGGNKLSGFVPACS-GNLTNLRKLYLGSNLLTSIP-STLWNLKDILHLNLSSN 311
             L  LD   + L       +  +L  L  L +               L  +  L ++ N
Sbjct: 399 EELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGN 458

Query: 312 FFTGPLPLKI-GNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIG 370
            F       +  N   L  LDLS      +       L  LQ L + +N L     +   
Sbjct: 459 SFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYN 518

Query: 371 DLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRL 409
            L SL +L+ S N +  +  I       L   N++ N +
Sbjct: 519 QLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSV 557

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  182 bits (463), Expect = 4e-49
 Identities = 87/452 (19%), Positives = 151/452 (33%), Gaps = 45/452 (9%)

Query: 3   SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSF 62
            L+   +  I          L  L L+ NP        I    P     L ++E +    
Sbjct: 62  DLSRCEIETIEDKAWHGLHHLSNLILTGNP--------IQSFSPGSFSGLTSLENLVAVE 113

Query: 63  NKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFI 122
            K+  +    I  + TLK L +  N +      +    L NL  + L   N+I TI    
Sbjct: 114 TKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDL-SYNYIQTITVND 172

Query: 123 FNA-----SKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPE--LSSLSSL 175
                        L +  N         F  +  L  L L  N+ +S+  +  L +L+ L
Sbjct: 173 LQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGL 231

Query: 176 SNCKYLEYFSFSNNPLGGILPRAIGNLSQ-SMEDFWMDNCNISGSIPEEINNLTNLILQL 234
              + +         L    P  +  L   ++++F +   N       + + L N  +  
Sbjct: 232 HVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLAN--VSA 289

Query: 235 LSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIP 294
           +SL G  +     +D+ +      L +   +L  F      +L  L+ L L  N  +   
Sbjct: 290 MSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQFPTL---DLPFLKSLTLTMNKGSISF 344

Query: 295 STLWNLKDILHLNLSSNFFT--GPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQ 352
                L  + +L+LS N  +  G         N L  LDLS N    ++     GL++LQ
Sbjct: 345 K-KVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQ 402

Query: 353 YLFLEYNRLQGSIPNS-IGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEG 411
           +L  +++ L+     S    L  L  L++S  N           L  L  + ++ N  + 
Sbjct: 403 HLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKD 462

Query: 412 EIPREGPFRNLSAESFKGNELLCGMPNLQVLS 443
                             + +     NL  L 
Sbjct: 463 NTL---------------SNVFANTTNLTFLD 479

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  162 bits (413), Expect = 2e-42
 Identities = 66/388 (17%), Positives = 116/388 (29%), Gaps = 22/388 (5%)

Query: 4   LTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFN 63
           ++ + +  I          L  L L  N  S +I    L  +   +     +        
Sbjct: 188 MSLNPIDFIQDQAFQGIK-LHELTLRGNFNSSNIMKTCLQNLAG-LHVHRLILGEFKDER 245

Query: 64  KVVGVVPTTIFNVSTLKSLYLHSNSLSGR-LPSSADVRLPNLKELHLWGNNFIGTIPSFI 122
            +    P+ +  +  +          +           L N+  + L G + I  +    
Sbjct: 246 NLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVS-IKYLEDVP 304

Query: 123 FNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLE 182
            +  K   L + +            +L  LK L L  N       + S          L 
Sbjct: 305 KH-FKWQSLSIIRCQLKQ---FPTLDLPFLKSLTLTMN-------KGSISFKKVALPSLS 353

Query: 183 YFSFSNNPLGGILPRAIGNLS-QSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQ 241
           Y   S N L      +  +L   S+    +        +      L  L  Q L  + + 
Sbjct: 354 YLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEEL--QHLDFQHST 410

Query: 242 LEGSIP-DDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSI--PSTLW 298
           L+          L  L  LD+               LT+L  L +  N        +   
Sbjct: 411 LKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFA 470

Query: 299 NLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEY 358
           N  ++  L+LS              L+ L  L++S NN   +  +    L  L  L   +
Sbjct: 471 NTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSF 530

Query: 359 NRLQGSIPNSIGDLISLKSLNLSNNNLS 386
           NR++ S         SL   NL+NN+++
Sbjct: 531 NRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  162 bits (411), Expect = 3e-42
 Identities = 80/425 (18%), Positives = 134/425 (31%), Gaps = 40/425 (9%)

Query: 42  LCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRL 101
           L ++P +I    + + +  SFN +  +   +  N S L+ L L    +   +   A   L
Sbjct: 23  LSKVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIET-IEDKAWHGL 79

Query: 102 PNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNY 161
            +L  L L GN      P      + L  L   +   +       G L  LK L +  N+
Sbjct: 80  HHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNF 139

Query: 162 LTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQ---SMEDFWMDNCNISG 218
           + S        +  SN   L +   S N +  I    +  L +         M    I  
Sbjct: 140 IHS----CKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID- 194

Query: 219 SIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCR-LAALFQLDLGGNKLSGFV------P 271
            I ++      + L  L+L GN    +I     + LA L    L   +           P
Sbjct: 195 FIQDQA--FQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEP 252

Query: 272 ACSGNLTNLRKLYL---GSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLV 328
           +    L ++         +N  +        L ++  ++L+         +         
Sbjct: 253 SIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVP--KHFKWQ 310

Query: 329 QLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGT 388
            L +               L  L+ L L  N+   SI      L SL  L+LS N LS +
Sbjct: 311 SLSIIRCQLKQFPT---LDLPFLKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFS 365

Query: 389 IPISLE--KLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNEL--------LCGMPN 438
              S        L+ +++SFN              L    F+ + L           +  
Sbjct: 366 GCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEK 425

Query: 439 LQVLS 443
           L  L 
Sbjct: 426 LLYLD 430

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score =  115 bits (289), Expect = 9e-27
 Identities = 46/230 (20%), Positives = 80/230 (34%), Gaps = 26/230 (11%)

Query: 218 GSIPEEINNLTNLILQL------------------LSLEGNQLEGSIPDDLCRLAALFQL 259
           GS+   I  + N+  Q                   + L  N L+          + L  L
Sbjct: 2   GSLNPCIEVVPNITYQCMDQKLSKVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWL 61

Query: 260 DLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSI-PSTLWNLKDILHLNLSSNFFTGPLP 318
           DL   ++          L +L  L L  N + S  P +   L  + +L            
Sbjct: 62  DLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLES 121

Query: 319 LKIGNLNVLVQLDLSMNNFSCV-IPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDL----I 373
             IG L  L +L+++ N      +P     L +L ++ L YN +Q    N +  L     
Sbjct: 122 FPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQ 181

Query: 374 SLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLS 423
              SL++S N +   I     + + L ++ +  N     I +    +NL+
Sbjct: 182 VNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTC-LQNLA 229

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  179 bits (457), Expect = 7e-51
 Identities = 64/197 (32%), Positives = 94/197 (47%), Gaps = 22/197 (11%)

Query: 500 RRFTYLELFQATNRFSE------NNLIGRGGFGPVYK---DGMEVAIKVFNLQYGGAFKS 550
             F++ EL   TN F E       N +G GGFG VYK   +   VA+K   L       +
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKK--LAAMVDITT 70

Query: 551 ------FDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLY--SGNYIL 602
                 FD E  +M + +H NL++++   S+ D   LV  YMP GSL   L    G   L
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130

Query: 603 DIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED 662
                  I    A+ + +LH       IH D+K +N+LLD+   A +SDFG+A+   +  
Sbjct: 131 SWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187

Query: 663 QSLTQTQTLATIGYMAP 679
           Q++  ++ + T  YMAP
Sbjct: 188 QTVMTSRIVGTTAYMAP 204

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  176 bits (448), Expect = 3e-49
 Identities = 87/388 (22%), Positives = 151/388 (38%), Gaps = 43/388 (11%)

Query: 23  LQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSL 82
             TL     P +   P            +L            V  VV      + ++  L
Sbjct: 2   AATLATLPAPINQIFP----------DADLAEGIRAVLQKASVTDVVT--QEELESITKL 49

Query: 83  YLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSI 142
            +    ++          L NL+ L+L GN      P  + N  KL+ L +  N  +   
Sbjct: 50  VVAGEKVASI---QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--D 102

Query: 143 PNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNL 202
            +   NL NL+ L LN++ ++        +S L+N   +   +   N     L   + N+
Sbjct: 103 ISALQNLTNLRELYLNEDNISD-------ISPLANLTKMYSLNLGANHNLSDLS-PLSNM 154

Query: 203 SQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLG 262
           +  +    +    +    P  I NLT+L    LSL  NQ+E   P  L  L +L      
Sbjct: 155 T-GLNYLTVTESKVKDVTP--IANLTDL--YSLSLNYNQIEDISP--LASLTSLHYFTAY 207

Query: 263 GNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIG 322
            N+++   P    N+T L  L +G+N +T +   L NL  +  L + +N  +    +   
Sbjct: 208 VNQITDITP--VANMTRLNSLKIGNNKITDLSP-LANLSQLTWLEIGTNQISDINAV--K 262

Query: 323 NLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSN 382
           +L  L  L++  N  S +    +  L  L  LFL  N+L       IG L +L +L LS 
Sbjct: 263 DLTKLKMLNVGSNQISDISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQ 320

Query: 383 NNLSGTIPISLEKLLDLKDINVSFNRLE 410
           N+++   P++   L  +   + +   ++
Sbjct: 321 NHITDIRPLA--SLSKMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  165 bits (420), Expect = 2e-45
 Identities = 74/344 (21%), Positives = 141/344 (40%), Gaps = 31/344 (9%)

Query: 71  TTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSE 130
               +++      L   S++  +       L ++ +L + G   + +I   I   + L  
Sbjct: 16  FPDADLAEGIRAVLQKASVTDVVTQE---ELESITKLVVAGEK-VASIQG-IEYLTNLEY 70

Query: 131 LGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNP 190
           L L  N  +   P    NL  L  L +  N       +++ +S+L N   L     + + 
Sbjct: 71  LNLNGNQITDISP--LSNLVKLTNLYIGTN-------KITDISALQNLTNLRELYLNEDN 121

Query: 191 LGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDL 250
           +  I P  + NL++ M    +   +   S    ++N+T L    L++  ++++   P  +
Sbjct: 122 ISDISP--LANLTK-MYSLNLGANHNL-SDLSPLSNMTGL--NYLTVTESKVKDVTP--I 173

Query: 251 CRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSS 310
             L  L+ L L  N++    P    +LT+L       N +T I   + N+  +  L + +
Sbjct: 174 ANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP-VANMTRLNSLKIGN 230

Query: 311 NFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIG 370
           N  T   PL   NL+ L  L++  N  S +    +  L  L+ L +  N++  S  + + 
Sbjct: 231 NKITDLSPL--ANLSQLTWLEIGTNQISDINA--VKDLTKLKMLNVGSNQI--SDISVLN 284

Query: 371 DLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIP 414
           +L  L SL L+NN L       +  L +L  + +S N +    P
Sbjct: 285 NLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  161 bits (411), Expect = 4e-44
 Identities = 84/373 (22%), Positives = 146/373 (39%), Gaps = 63/373 (16%)

Query: 14  LSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTI 73
           +       S+  L ++    + SI           I+ L N                   
Sbjct: 37  VVTQEELESITKLVVAGEKVA-SIQ---------GIEYLTN------------------- 67

Query: 74  FNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGL 133
                L+ L L+ N ++     S    L  L  L++  N    T  S + N + L EL L
Sbjct: 68  -----LEYLNLNGNQITD---ISPLSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYL 117

Query: 134 QKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGG 193
            +++ S   P    NL  +  L L  N+  S    LS+++       L Y + + + +  
Sbjct: 118 NEDNISDISP--LANLTKMYSLNLGANHNLSDLSPLSNMTG------LNYLTVTESKVKD 169

Query: 194 ILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRL 253
           + P  I NL+  +    ++   I    P  + +LT+  L   +   NQ+    P  +  +
Sbjct: 170 VTP--IANLTD-LYSLSLNYNQIEDISP--LASLTS--LHYFTAYVNQITDITP--VANM 220

Query: 254 AALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFF 313
             L  L +G NK++   P    NL+ L  L +G+N ++ I + + +L  +  LN+ SN  
Sbjct: 221 TRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDINA-VKDLTKLKMLNVGSNQI 277

Query: 314 TGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLI 373
           +      + NL+ L  L L+ N         IGGL +L  LFL  N +    P  +  L 
Sbjct: 278 SDISV--LNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLS 333

Query: 374 SLKSLNLSNNNLS 386
            + S + +N  + 
Sbjct: 334 KMDSADFANQVIK 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score =  128 bits (325), Expect = 1e-32
 Identities = 58/279 (20%), Positives = 106/279 (37%), Gaps = 34/279 (12%)

Query: 13  ILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTT 72
            +S L N ++L+ LYL+ +  S   P          + NL  M  +    N  +    + 
Sbjct: 102 DISALQNLTNLRELYLNEDNISDISP----------LANLTKMYSLNLGANHNLS-DLSP 150

Query: 73  IFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELG 132
           + N++ L  L +  + +      +    L +L  L L   N I  I     + + L    
Sbjct: 151 LSNMTGLNYLTVTESKVKD---VTPIANLTDLYSLSL-NYNQIEDISPL-ASLTSLHYFT 205

Query: 133 LQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLG 192
              N  +   P    N+  L  L + +N +T        LS L+N   L +     N + 
Sbjct: 206 AYVNQITDITP--VANMTRLNSLKIGNNKIT-------DLSPLANLSQLTWLEIGTNQIS 256

Query: 193 GILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCR 252
            I   A+ +L++ ++   + +  IS      +NNL+   L  L L  NQL     + +  
Sbjct: 257 DI--NAVKDLTK-LKMLNVGSNQISD--ISVLNNLSQ--LNSLFLNNNQLGNEDMEVIGG 309

Query: 253 LAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLT 291
           L  L  L L  N ++   P    +L+ +      + ++ 
Sbjct: 310 LTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  173 bits (442), Expect = 1e-48
 Identities = 59/329 (17%), Positives = 117/329 (35%), Gaps = 27/329 (8%)

Query: 101 LPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDN 160
               + L+  G+  +      +    +       +   +    N      N +       
Sbjct: 11  SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN----SNNPQIETRTGR 66

Query: 161 YLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSI 220
            L ++   L   +              + PL    P     L   ++   +D   +   +
Sbjct: 67  ALKATADLLEDATQPG----RVALELRSVPLP-QFPDQAFRL-SHLQHMTIDAAGLM-EL 119

Query: 221 PEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGG-NKL--------SGFVP 271
           P+ +     L  + L+L  N L  ++P  +  L  L +L +    +L        S    
Sbjct: 120 PDTMQQFAGL--ETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDAS 176

Query: 272 ACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLD 331
                L NL+ L L    + S+P+++ NL+++  L + ++  +  L   I +L  L +LD
Sbjct: 177 GEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELD 235

Query: 332 LSMNNFSCVIPTKIGGLKDLQYLFL-EYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIP 390
           L         P   GG   L+ L L + + L  ++P  I  L  L+ L+L        +P
Sbjct: 236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLP 294

Query: 391 ISLEKLLDLKDINVSFNRLEGEIPREGPF 419
             + +L     I V  + L+ ++ +  P 
Sbjct: 295 SLIAQLPANCIILVPPH-LQAQLDQHRPV 322

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  164 bits (417), Expect = 3e-45
 Identities = 59/380 (15%), Positives = 108/380 (28%), Gaps = 66/380 (17%)

Query: 17  LGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNV 76
             + S  + LY   +          L      +           +             N 
Sbjct: 8   HHHSSGRENLYFQGSTA--------LRPYHDVLSQWQRHYNADRNRWH----SAWRQANS 55

Query: 77  STLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKN 136
           +  +       +L        D   P    L L     +   P   F  S L  + +   
Sbjct: 56  NNPQIETRTGRALKATADLLEDATQPGRVALELRSVP-LPQFPDQAFRLSHLQHMTIDAA 114

Query: 137 SFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILP 196
                +P+T      L+ L L  N L +                              LP
Sbjct: 115 GLM-ELPDTMQQFAGLETLTLARNPLRA------------------------------LP 143

Query: 197 RAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAAL 256
            +I +L   + +  +  C     +PE + +                      +   L  L
Sbjct: 144 ASIASL-NRLRELSIRACPELTELPEPLAST-----------------DASGEHQGLVNL 185

Query: 257 FQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGP 316
             L L    +   +PA   NL NL+ L + ++ L+++   + +L  +  L+L        
Sbjct: 186 QSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDLRGCTALRN 244

Query: 317 LPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLK 376
            P   G    L +L L   +    +P  I  L  L+ L L        +P+ I  L +  
Sbjct: 245 YPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANC 304

Query: 377 SLNLSNN---NLSGTIPISL 393
            + +  +    L    P++ 
Sbjct: 305 IILVPPHLQAQLDQHRPVAR 324

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score =  148 bits (375), Expect = 1e-39
 Identities = 50/359 (13%), Positives = 107/359 (29%), Gaps = 58/359 (16%)

Query: 115 IGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSS 174
           +G+      ++S    L  Q ++      +     +       N  +        ++   
Sbjct: 1   MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQI 60

Query: 175 LSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQL 234
            +                                          +  + + + T      
Sbjct: 61  ETR-----------------------------------TGRALKATADLLEDATQPGRVA 85

Query: 235 LSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIP 294
           L L    L    PD   RL+ L  + +    L   +P        L  L L  N L ++P
Sbjct: 86  LELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLRALP 143

Query: 295 STLWNLKDILHLNLSSNFFTGPLPLKIGNLNV---------LVQLDLSMNNFSCVIPTKI 345
           +++ +L  +  L++ +      LP  + + +          L  L L        +P  I
Sbjct: 144 ASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASI 202

Query: 346 GGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVS 405
             L++L+ L +  + L  ++  +I  L  L+ L+L         P        LK + + 
Sbjct: 203 ANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILK 261

Query: 406 -FNRLEGEIPRE-GPFRNLSAESFKGN-------ELLCGMPNLQVLSCRTKIHHTLGKN 455
             + L   +P +      L     +G         L+  +P   ++     +   L ++
Sbjct: 262 DCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQH 319

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 96.9 bits (242), Expect = 6e-22
 Identities = 38/185 (20%), Positives = 70/185 (37%), Gaps = 11/185 (5%)

Query: 15  SQLGNPSSLQTLYLSYNPPSGSIPSFI-LCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTI 73
           + + + + L+ L +   P    +P  +   +   E   L N++ +   +  +   +P +I
Sbjct: 144 ASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASI 202

Query: 74  FNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGL 133
            N+  LKSL + ++ LS  L  +    LP L+EL L G   +   P      + L  L L
Sbjct: 203 ANLQNLKSLKIRNSPLSA-LGPAIH-HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLIL 260

Query: 134 QKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSL-SSLSNCKYLEYFSFSNNPLG 192
           +  S   ++P     L  L+ L L           LS L S ++            +   
Sbjct: 261 KDCSNLLTLPLDIHRLTQLEKLDLRGC------VNLSRLPSLIAQLPANCIILVPPHLQA 314

Query: 193 GILPR 197
            +   
Sbjct: 315 QLDQH 319

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 71.1 bits (175), Expect = 2e-13
 Identities = 26/173 (15%), Positives = 51/173 (29%), Gaps = 38/173 (21%)

Query: 1   MPSLTNDFLRGIILSQL----GNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNME 56
           + +L +  L    +  L     N  +L++L +  +P         L  +   I +L    
Sbjct: 182 LVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSP---------LSALGPAIHHLPK-- 230

Query: 57  WMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIG 116
                                 L+ L L   +     P         LK L L   + + 
Sbjct: 231 ----------------------LEELDLRGCTALRNYPPIFG-GRAPLKRLILKDCSNLL 267

Query: 117 TIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPEL 169
           T+P  I   ++L +L L+       +P+    L     + +  +         
Sbjct: 268 TLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHR 320

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  172 bits (439), Expect = 7e-47
 Identities = 87/419 (20%), Positives = 165/419 (39%), Gaps = 46/419 (10%)

Query: 14  LSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTI 73
           +  +   ++L  +  S N  +   P          + NL  +  +  + N++  + P  +
Sbjct: 61  IDGVEYLNNLTQINFSNNQLTDITP----------LKNLTKLVDILMNNNQIADITP--L 108

Query: 74  FNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGL 133
            N++ L  L L +N ++          L NL  L L  N    +  S +   + L +L  
Sbjct: 109 ANLTNLTGLTLFNNQITD---IDPLKNLTNLNRLELSSNTI--SDISALSGLTSLQQLSF 163

Query: 134 QKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGG 193
             N  +   P    NL  L+ L ++ N ++        +S L+    LE    +NN +  
Sbjct: 164 G-NQVTDLKP--LANLTTLERLDISSNKVS-------DISVLAKLTNLESLIATNNQISD 213

Query: 194 ILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRL 253
           I P  +G L+ ++++  ++   +       + +LTN  L  L L  NQ+    P  L  L
Sbjct: 214 ITP--LGILT-NLDELSLNGNQLKD--IGTLASLTN--LTDLDLANNQISNLAP--LSGL 264

Query: 254 AALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFF 313
             L +L LG N++S   P     LT L  L L  N L  I   + NLK++ +L L  N  
Sbjct: 265 TKLTELKLGANQISNISPL--AGLTALTNLELNENQLEDISP-ISNLKNLTYLTLYFNNI 321

Query: 314 TGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLI 373
           +   P+   +L  L +L    N  S V    +  L ++ +L   +N++    P  + +L 
Sbjct: 322 SDISPV--SSLTKLQRLFFYNNKVSDVSS--LANLTNINWLSAGHNQISDLTP--LANLT 375

Query: 374 SLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNEL 432
            +  L L++   +   P++ +  + + +   +               + +      N  
Sbjct: 376 RITQLGLNDQAWT-NAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLP 433

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  169 bits (431), Expect = 8e-46
 Identities = 91/401 (22%), Positives = 156/401 (38%), Gaps = 47/401 (11%)

Query: 14  LSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTI 73
           +      +      L     + ++             +L  +  +      +  +    +
Sbjct: 17  IFTDTALAEKMKTVLGKTNVTDTVS----------QTDLDQVTTLQADRLGIKSIDG--V 64

Query: 74  FNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGL 133
             ++ L  +   +N L+   P      L  L ++ +  N      P  + N + L+ L L
Sbjct: 65  EYLNNLTQINFSNNQLTDITPLK---NLTKLVDILMNNNQIADITP--LANLTNLTGLTL 119

Query: 134 QKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGG 193
             N  +   P    NL NL  L L+ N        +S +S+LS    L+  SF N     
Sbjct: 120 FNNQITDIDP--LKNLTNLNRLELSSN-------TISDISALSGLTSLQQLSFGNQVTD- 169

Query: 194 ILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRL 253
              + + NL+ ++E   + +  +S      +  LTN  L+ L    NQ+    P  L  L
Sbjct: 170 --LKPLANLT-TLERLDISSNKVSD--ISVLAKLTN--LESLIATNNQISDITP--LGIL 220

Query: 254 AALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFF 313
             L +L L GN+L         +LTNL  L L +N ++++   L  L  +  L L +N  
Sbjct: 221 TNLDELSLNGNQLKDIGTL--ASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQI 277

Query: 314 TGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLI 373
           +   PL    L  L  L+L+ N    + P  I  LK+L YL L +N +    P  +  L 
Sbjct: 278 SNISPL--AGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLT 331

Query: 374 SLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIP 414
            L+ L   NN +S     SL  L ++  ++   N++    P
Sbjct: 332 KLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP 370

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  162 bits (413), Expect = 2e-43
 Identities = 91/416 (21%), Positives = 164/416 (39%), Gaps = 52/416 (12%)

Query: 14  LSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTI 73
           ++ L N + L  + ++ N  +   P          + NL N+  +    N++  + P  +
Sbjct: 83  ITPLKNLTKLVDILMNNNQIADITP----------LANLTNLTGLTLFNNQITDIDP--L 130

Query: 74  FNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGL 133
            N++ L  L L SN++S  + + +   L +L++L   GN      P  + N + L  L +
Sbjct: 131 KNLTNLNRLELSSNTISD-ISALSG--LTSLQQLSF-GNQVTDLKP--LANLTTLERLDI 184

Query: 134 QKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTP---------------ELSSLSSLSNC 178
             N  S    +    L NL+ L   +N ++  TP               +L  + +L++ 
Sbjct: 185 SSNKVSD--ISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASL 242

Query: 179 KYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLE 238
             L     +NN +  + P  +  L+  + +  +    IS   P  +  LT L    L L 
Sbjct: 243 TNLTDLDLANNQISNLAP--LSGLT-KLTELKLGANQISNISP--LAGLTAL--TNLELN 295

Query: 239 GNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLW 298
            NQLE   P  +  L  L  L L  N +S   P    +LT L++L+  +N ++ + S L 
Sbjct: 296 ENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSS-LA 350

Query: 299 NLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEY 358
           NL +I  L+   N  +   P  + NL  + QL L+   ++         +     +    
Sbjct: 351 NLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVT 408

Query: 359 NRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIP 414
             L    P +I D  S    +++ N  S T  +S      +  I        G + 
Sbjct: 409 GAL--IAPATISDGGSYTEPDITWNLPSYTNEVSYTFSQPVT-IGKGTTTFSGTVT 461

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  152 bits (387), Expect = 6e-40
 Identities = 94/389 (24%), Positives = 152/389 (39%), Gaps = 49/389 (12%)

Query: 77  STLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKN 136
               +       ++       D  L    +  L   N   T+     +  +++ L   + 
Sbjct: 2   PLGSATITQDTPINQ---IFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRL 56

Query: 137 SFSGSIPNTFGNLRNLKWLGLNDNYLTSSTP---------------ELSSLSSLSNCKYL 181
               SI      L NL  +  ++N LT  TP               +++ ++ L+N   L
Sbjct: 57  GIK-SIDG-VEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNL 114

Query: 182 EYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQ 241
              +  NN +  I P  + NL+  +    + +  IS      ++ LT+  LQ LS  GNQ
Sbjct: 115 TGLTLFNNQITDIDP--LKNLTN-LNRLELSSNTISD--ISALSGLTS--LQQLSF-GNQ 166

Query: 242 LEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLK 301
           +    P  L  L  L +LD+  NK+S         LTNL  L   +N ++ I   L  L 
Sbjct: 167 VTDLKP--LANLTTLERLDISSNKVSDISV--LAKLTNLESLIATNNQISDITP-LGILT 221

Query: 302 DILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRL 361
           ++  L+L+ N       L   +L  L  LDL+ N  S + P  + GL  L  L L  N++
Sbjct: 222 NLDELSLNGNQLKDIGTL--ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQI 277

Query: 362 QGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRN 421
               P  +  L +L +L L+ N L    PIS   L +L  + + FN +    P       
Sbjct: 278 SNISP--LAGLTALTNLELNENQLEDISPIS--NLKNLTYLTLYFNNISDISPVSS-LTK 332

Query: 422 LSAESFKGNEL-----LCGMPNLQVLSCR 445
           L    F  N++     L  + N+  LS  
Sbjct: 333 LQRLFFYNNKVSDVSSLANLTNINWLSAG 361

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score =  117 bits (296), Expect = 3e-28
 Identities = 75/346 (21%), Positives = 126/346 (36%), Gaps = 68/346 (19%)

Query: 14  LSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTI 73
           +S L   +SLQ L       +   P          + NL  +E +  S NKV     + +
Sbjct: 149 ISALSGLTSLQQLSFGNQV-TDLKP----------LANLTTLERLDISSNKVSD--ISVL 195

Query: 74  FNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGL 133
             ++ L+SL   +N +S     +    L NL EL L GN         + + + L++L L
Sbjct: 196 AKLTNLESLIATNNQISD---ITPLGILTNLDELSLNGNQL--KDIGTLASLTNLTDLDL 250

Query: 134 QKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTP---------------ELSSLSSLSNC 178
             N  S   P     L  L  L L  N +++ +P               +L  +S +SN 
Sbjct: 251 ANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNL 308

Query: 179 KYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLE 238
           K L Y +   N +  I P  + +L++ ++  +  N  +S      + NLTN+    LS  
Sbjct: 309 KNLTYLTLYFNNISDISP--VSSLTK-LQRLFFYNNKVSD--VSSLANLTNI--NWLSAG 361

Query: 239 GNQLEGSIPDDLCRLAALFQLDLGGNKLSGF----------------------VPACSGN 276
            NQ+    P  L  L  + QL L     +                         PA   +
Sbjct: 362 HNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATISD 419

Query: 277 LTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTG--PLPLK 320
             +  +  +  NL +      +     + +   +  F+G    PLK
Sbjct: 420 GGSYTEPDITWNLPSYTNEVSYTFSQPVTIGKGTTTFSGTVTQPLK 465

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  165 bits (420), Expect = 1e-45
 Identities = 49/203 (24%), Positives = 86/203 (42%), Gaps = 18/203 (8%)

Query: 502 FTYLELFQATNRFSENNLIGRGGFGPVYK---DGMEVAIKVFNLQYGGAFKSFDIECGMM 558
                L+  +       +  RG FG V+K       VA+K+F +Q   +++  + E   +
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQ-NEYEVYSL 72

Query: 559 KRIRHRNLIKIISSCSNDDFKA----LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDV 614
             ++H N+++ I +            L+  +   GSL   L     ++   +  +I   +
Sbjct: 73  PGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK--ANVVSWNELCHIAETM 130

Query: 615 ASALEYLH-------FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ 667
           A  L YLH        G+   I H D+K  NVLL +N+ A ++DFG+A        +   
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDT 190

Query: 668 TQTLATIGYMAPDEIFSGEMRLK 690
              + T  YMAP E+  G +  +
Sbjct: 191 HGQVGTRRYMAP-EVLEGAINFQ 212

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  169 bits (430), Expect = 6e-45
 Identities = 92/450 (20%), Positives = 166/450 (36%), Gaps = 42/450 (9%)

Query: 3   SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSF 62
            LT + ++ + L      SSLQ L              +       I +L  ++ +  + 
Sbjct: 82  ILTGNPIQSLALGAFSGLSSLQKLVAVET--------NLASLENFPIGHLKTLKELNVAH 133

Query: 63  NKVVGV-VPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLW---GNNFIGTI 118
           N +    +P    N++ L+ L L SN +   +  +    L  +  L+L      N +  I
Sbjct: 134 NLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNFI 192

Query: 119 PSFIFNASKLSELGLQKNSFSGSIP-NTFGNLRNLKWLGLNDNYLTS----STPELSSLS 173
               F   +L +L L+ N  S ++       L  L+   L      +       + S+L 
Sbjct: 193 QPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALE 252

Query: 174 SLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQ 233
            L N   +E F  +           + N   ++  F + +  I   + +   N     L+
Sbjct: 253 GLCNL-TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLE 310

Query: 234 LLSLEGNQLEGSIPDDL----------------CRLAALFQLDLGGNKLS--GFVPACSG 275
           L++ +  Q        L                  L +L  LDL  N LS  G       
Sbjct: 311 LVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDF 370

Query: 276 NLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKI-GNLNVLVQLDLSM 334
             T+L+ L L  N + ++ S    L+ + HL+   +         +  +L  L+ LD+S 
Sbjct: 371 GTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 430

Query: 335 NNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSI-GDLISLKSLNLSNNNLSGTIPISL 393
            +          GL  L+ L +  N  Q +    I  +L +L  L+LS   L    P + 
Sbjct: 431 THTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 490

Query: 394 EKLLDLKDINVSFNRLEGEIPREGPFRNLS 423
             L  L+ +N++ N+L+  +P +G F  L+
Sbjct: 491 NSLSSLQVLNMASNQLK-SVP-DGIFDRLT 518

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  155 bits (393), Expect = 5e-40
 Identities = 94/449 (20%), Positives = 157/449 (34%), Gaps = 49/449 (10%)

Query: 20  PSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTL 79
           P S + L LS+NP    +         +   +   ++ +  S  ++  +      ++S L
Sbjct: 27  PFSTKNLDLSFNPLR-HLG-------SYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78

Query: 80  KSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSF- 138
            +L L  N +   L   A   L +L++L     N        I +   L EL +  N   
Sbjct: 79  STLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137

Query: 139 SGSIPNTFGNLRNLKWLGLNDNYLTSSTPE-LSSLSSLSNCKYLEYFSFSNNPLGGILPR 197
           S  +P  F NL NL+ L L+ N + S     L  L  +           S NP+  I P 
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPL--LNLSLDLSLNPMNFIQPG 195

Query: 198 AIGNLSQSMEDFWMDNCNISGSIPEE-INNLTNLILQLLSLEG----NQLEGSIPDDLCR 252
           A   +   +    + N   S ++ +  I  L  L +  L L        LE      L  
Sbjct: 196 AFKEI--RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEG 253

Query: 253 LAALFQLDLGGNKLSGF---VPACSGNLTNLRKLYLGSNLLTSIP--STLWNLKDILHLN 307
           L  L   +     L  +   +      LTN+    L S  +  +   S  +  + +  +N
Sbjct: 254 LCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVN 313

Query: 308 LSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQ--GSI 365
                F          L  L +L  + N            L  L++L L  N L   G  
Sbjct: 314 CKFGQFPT------LKLKSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCC 365

Query: 366 PNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSA- 424
             S     SLK L+LS N +  T+  +   L  L+ ++   + L+ ++     F +L   
Sbjct: 366 SQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNL 423

Query: 425 ----------ESFKGNELLCGMPNLQVLS 443
                          N +  G+ +L+VL 
Sbjct: 424 IYLDISHTHTRVA-FNGIFNGLSSLEVLK 451

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score =  105 bits (264), Expect = 7e-24
 Identities = 59/286 (20%), Positives = 104/286 (36%), Gaps = 26/286 (9%)

Query: 181 LEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGN 240
            +    S NPL  +   +  +  + ++   +  C I         +L++L    L L GN
Sbjct: 30  TKNLDLSFNPLRHLGSYSFFSFPE-LQVLDLSRCEIQTIEDGAYQSLSHL--STLILTGN 86

Query: 241 QLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSI--PSTLW 298
            ++         L++L +L      L+       G+L  L++L +  NL+ S   P    
Sbjct: 87  PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146

Query: 299 NLKDILHLNLSSNFFTGPLPLKIGNLNVL----VQLDLSMNNFSCVIPTKIGGLKDLQYL 354
           NL ++ HL+LSSN         +  L+ +    + LDLS+N  + + P     ++ L  L
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKL 205

Query: 355 FLEYNRLQGSIP-NSIGDLISLKSLNL------SNNNLSGTIPISLEKLLDLKDINVSFN 407
            L  N    ++    I  L  L+   L      +  NL      +LE L +L        
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265

Query: 408 RLEGEIPRE----GPFRNLSAESFKGNEL-----LCGMPNLQVLSC 444
            L+  +           N+S+ S     +            Q L  
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLEL 311

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 86.7 bits (215), Expect = 7e-18
 Identities = 35/151 (23%), Positives = 52/151 (34%), Gaps = 4/151 (2%)

Query: 273 CSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDL 332
           C   + N+            IP  L       +L+LS N           +   L  LDL
Sbjct: 3   CVEVVPNI-TYQCMELNFYKIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDL 59

Query: 333 SMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPIS 392
           S      +       L  L  L L  N +Q     +   L SL+ L     NL+      
Sbjct: 60  SRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP 119

Query: 393 LEKLLDLKDINVSFNRLEGEIPREGPFRNLS 423
           +  L  LK++NV+ N ++        F NL+
Sbjct: 120 IGHLKTLKELNVAHNLIQ-SFKLPEYFSNLT 149

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 71.3 bits (175), Expect = 6e-13
 Identities = 27/149 (18%), Positives = 48/149 (32%), Gaps = 13/149 (8%)

Query: 15  SQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEI--DNLHNMEWMAFSFNKVVGVVPTT 72
           S       L+ L   ++          L ++       +L N+ ++  S           
Sbjct: 390 SNFLGLEQLEHLDFQHSN---------LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 440

Query: 73  IFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIF-NASKLSEL 131
              +S+L+ L +  NS            L NL  L L     +  +    F + S L  L
Sbjct: 441 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL-SQCQLEQLSPTAFNSLSSLQVL 499

Query: 132 GLQKNSFSGSIPNTFGNLRNLKWLGLNDN 160
            +  N         F  L +L+ + L+ N
Sbjct: 500 NMASNQLKSVPDGIFDRLTSLQKIWLHTN 528

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  159 bits (404), Expect = 1e-43
 Identities = 54/174 (31%), Positives = 88/174 (50%), Gaps = 11/174 (6%)

Query: 520 IGRGGFGPVYK---DGMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           IG G FG V++    G +VA+K+   Q         F  E  +MKR+RH N++  + + +
Sbjct: 45  IGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104

Query: 575 NDDFKALVLEYMPLGSLEKCLYSGN--YILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
                ++V EY+  GSL + L+       LD  + L++  DVA  + YLH   + PI+H 
Sbjct: 105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHR 163

Query: 633 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGE 686
           +LK  N+L+D      + DFG+++  L+    L+      T  +MAP E+   E
Sbjct: 164 NLKSPNLLVDKKYTVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAP-EVLRDE 214

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  154 bits (392), Expect = 9e-42
 Identities = 60/212 (28%), Positives = 84/212 (39%), Gaps = 28/212 (13%)

Query: 502 FTYLELFQATNRFSENNLIGRGGFGPVYK---DGMEVAIKVFNLQYGGAFKSFDIECGMM 558
               E     +      LIGRG +G VYK   D   VA+KVF+       ++F  E  + 
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFA---NRQNFINEKNIY 59

Query: 559 K--RIRHRNLIKIISSCSNDDFKA-----LVLEYMPLGSLEKCLYSGNYILDIFQGLNIM 611
           +   + H N+ + I               LV+EY P GSL K L    +  D      + 
Sbjct: 60  RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS--LHTSDWVSSCRLA 117

Query: 612 IDVASALEYLH------FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL 665
             V   L YLH        Y   I H DL   NVL+ ++    +SDFG++  L       
Sbjct: 118 HSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177

Query: 666 TQTQTLA------TIGYMAPDEIFSGEMRLKC 691
              +  A      TI YMAP E+  G + L+ 
Sbjct: 178 PGEEDNAAISEVGTIRYMAP-EVLEGAVNLRD 208

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  158 bits (401), Expect = 3e-41
 Identities = 87/488 (17%), Positives = 174/488 (35%), Gaps = 67/488 (13%)

Query: 4   LTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEI-DNLHNMEWMAFSF 62
           L+ + +  I    L   ++LQ L L  +  +          I  +   +L ++E +  S 
Sbjct: 33  LSFNKITYIGHGDLRACANLQVLILKSSRIN---------TIEGDAFYSLGSLEHLDLSD 83

Query: 63  NKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFI 122
           N +  +  +    +S+LK L L  N       +S    L NL+ L +        I    
Sbjct: 84  NHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRID 143

Query: 123 F-NASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPE----LSSLSSL-- 175
           F   + L+EL ++  S       +  ++R++  L L+ +            LSS+  L  
Sbjct: 144 FAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLEL 203

Query: 176 -------------SNCKYLEYFSFSNNPLGGILPRAIGNLSQ------SMEDFWMDNCNI 216
                           +              +   +   L +       + +   D+C +
Sbjct: 204 RDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTL 263

Query: 217 SG---------SIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLS 267
           +G          +  E+  +  + ++ L +    L   +      L  + ++ +  +K+ 
Sbjct: 264 NGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF 323

Query: 268 GFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDIL----HLNLSSNFFT--GPLPLKI 321
               + S +L +L  L L  NL+          K        L LS N           +
Sbjct: 324 LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEIL 383

Query: 322 GNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLS 381
             L  L  LD+S N F   +P      + +++L L    ++  +   I    +L+ L++S
Sbjct: 384 LTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVS 439

Query: 382 NNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNEL-------LC 434
           NNNL  +  + L +   L+++ +S N+L+  +P    F  L       N+L         
Sbjct: 440 NNNLD-SFSLFLPR---LQELYISRNKLK-TLPDASLFPVLLVMKISRNQLKSVPDGIFD 494

Query: 435 GMPNLQVL 442
            + +LQ +
Sbjct: 495 RLTSLQKI 502

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  141 bits (358), Expect = 1e-35
 Identities = 84/453 (18%), Positives = 158/453 (34%), Gaps = 47/453 (10%)

Query: 18  GNPSSLQTLYLSYNPPSGSIPSFILCEIPHE-IDNLHNMEWMAFSFNKVVGVVPTTIFNV 76
           G  +++++L LS+N          +  I H  +    N++ +    +++  +     +++
Sbjct: 23  GLTAAMKSLDLSFNK---------ITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSL 73

Query: 77  STLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIG-TIPSFIFNASKLSELGLQK 135
            +L+ L L  N LS  L SS    L +LK L+L GN +    + S   N + L  L +  
Sbjct: 74  GSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGN 132

Query: 136 NSFSGSIP-NTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGI 194
                 I    F  L +L  L +    L +   +  SL S+ +   + + +   +    +
Sbjct: 133 VETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQ--SLKSIRD---IHHLTLHLSESAFL 187

Query: 195 LPRAIGNLSQSMEDFWMDNCNISG---------SIPEEINNLTNLILQLLSLEGNQLEGS 245
           L      LS S+    + + N++           +   +  L      L     N+L   
Sbjct: 188 LEIFADILS-SVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKL 246

Query: 246 IPDDLC-------RLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPS-TL 297
           +   L                D   ++              +R+L++    L    S   
Sbjct: 247 LRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVY 306

Query: 298 WNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFS---CVIPTKIGGLKDLQYL 354
             L+ +  + + ++           +L  L  LDLS N             G    LQ L
Sbjct: 307 SLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTL 366

Query: 355 FLEYNRLQ--GSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGE 412
            L  N L+        +  L +L SL++S N     +P S +    ++ +N+S   +   
Sbjct: 367 VLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-V 424

Query: 413 IPREGPFRNLSAESFKGNELLC---GMPNLQVL 442
           +      + L       N L      +P LQ L
Sbjct: 425 VKT-CIPQTLEVLDVSNNNLDSFSLFLPRLQEL 456

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  137 bits (348), Expect = 2e-34
 Identities = 73/422 (17%), Positives = 134/422 (31%), Gaps = 38/422 (9%)

Query: 6   NDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKV 65
           N +    + S   N ++LQTL +        I          +   L ++  +      +
Sbjct: 108 NPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIR-------RIDFAGLTSLNELEIKALSL 160

Query: 66  VGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNA 125
                 ++ ++  +  L LH +  +  L       L +++ L L   N      S +   
Sbjct: 161 RNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVD 219

Query: 126 SKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSN-------- 177
              S +       S     +F  L  L    L  + +      L+ L   +         
Sbjct: 220 EVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSE 279

Query: 178 -----CKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLIL 232
                   +         L   L      L + ++   ++N  +         +L +L  
Sbjct: 280 LGKVETVTIRRLHIPQFYLFYDLSTVYSLLEK-VKRITVENSKVFLVPCSFSQHLKSL-- 336

Query: 233 QLLSLEGNQLEGSIPDD---LCRLAALFQLDLGGNKLSGFVPACS--GNLTNLRKLYLGS 287
           + L L  N +      +        +L  L L  N L            L NL  L +  
Sbjct: 337 EFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISR 396

Query: 288 NLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGG 347
           N    +P +    + +  LNLSS        +K      L  LD+S NN           
Sbjct: 397 NTFHPMPDSCQWPEKMRFLNLSSTGIRV---VKTCIPQTLEVLDVSNNNLD-SFSL---F 449

Query: 348 LKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFN 407
           L  LQ L++  N+L+ ++P++      L  + +S N L        ++L  L+ I +  N
Sbjct: 450 LPRLQELYISRNKLK-TLPDASL-FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507

Query: 408 RL 409
             
Sbjct: 508 PW 509

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  126 bits (318), Expect = 1e-30
 Identities = 66/403 (16%), Positives = 133/403 (33%), Gaps = 46/403 (11%)

Query: 74  FNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIF-NASKLSELG 132
            +          S S +  +PS        +K L L  N  I  I        + L  L 
Sbjct: 2   LSCDASGVCDGRSRSFT-SIPSGL---TAAMKSLDLSFNK-ITYIGHGDLRACANLQVLI 56

Query: 133 LQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLG 192
           L+ +  +    + F +L +L+ L L+DN+L+S +              L+Y +   NP  
Sbjct: 57  LKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSW-----FGPLSSLKYLNLMGNPYQ 111

Query: 193 GILPRAIGNLSQSMEDFWMDNCNISGSIPEE-INNLTNLILQLLSLEGNQLEGSIPDDLC 251
            +   ++     +++   + N      I       LT+  L  L ++   L       L 
Sbjct: 112 TLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTS--LNELEIKALSLRNYQSQSLK 169

Query: 252 RLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIP----STLWNLKDILHLN 307
            +  +  L L  ++ +  +   +  L+++R L L    L                +  L 
Sbjct: 170 SIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLA 229

Query: 308 LSSNFFTGP-------LPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKD--------LQ 352
              +  T         L   I  L+ +   D ++N      P++   + +        ++
Sbjct: 230 FRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIR 289

Query: 353 YLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGE 412
            L +    L   +      L  +K + + N+ +        + L  L+ +++S N +  E
Sbjct: 290 RLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEE 349

Query: 413 IPREGPFR----NLSAESFKGNEL---------LCGMPNLQVL 442
             +    +    +L       N L         L  + NL  L
Sbjct: 350 YLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSL 392

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  115 bits (291), Expect = 4e-27
 Identities = 58/381 (15%), Positives = 113/381 (29%), Gaps = 45/381 (11%)

Query: 3   SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSF 62
            +    LR      L +   +  L L  +  +  +            D L ++ ++    
Sbjct: 154 EIKALSLRNYQSQSLKSIRDIHHLTLHLSESA-FLLEIFA-------DILSSVRYLELRD 205

Query: 63  NKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSAD------VRLPNLKELHLWGN--NF 114
             +     + +        +   +   S     S +        +  L E+       N 
Sbjct: 206 TNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNG 265

Query: 115 IGTIPSFIFNA---------SKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSS 165
           +G       +            +  L + +      +   +  L  +K + + ++ +   
Sbjct: 266 LGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLV 325

Query: 166 TPELSSLSSLSNCKYLEYFSFSNNPLGGIL---PRAIGNLSQSMEDFWMDNCNISGSIPE 222
                  S   + K LE+   S N +           G    S++   +   ++  S+ +
Sbjct: 326 PC-----SFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWP-SLQTLVLSQNHLR-SMQK 378

Query: 223 EINNLTNLI-LQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLR 281
               L  L  L  L +  N     +PD       +  L+L    +   V  C      L 
Sbjct: 379 TGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTC--IPQTLE 434

Query: 282 KLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVI 341
            L + +N L S    L  L+    L +S N     LP       VL+ + +S N    V 
Sbjct: 435 VLDVSNNNLDSFSLFLPRLQ---ELYISRNKLKT-LP-DASLFPVLLVMKISRNQLKSVP 489

Query: 342 PTKIGGLKDLQYLFLEYNRLQ 362
                 L  LQ ++L  N   
Sbjct: 490 DGIFDRLTSLQKIWLHTNPWD 510

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score =  115 bits (290), Expect = 4e-27
 Identities = 46/349 (13%), Positives = 112/349 (32%), Gaps = 27/349 (7%)

Query: 3   SLTNDFLRGIILSQLGNPSSLQTLYLSYNP----PSGSIPSFILCEIPHEIDNLHN---- 54
           +L       ++       SS++ L L            +P   +     ++    +    
Sbjct: 178 TLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTD 237

Query: 55  --MEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGN 112
                +      ++ +      + +       + +     +     V    ++ LH+   
Sbjct: 238 ESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESD-VVSELGKVETVTIRRLHIPQF 296

Query: 113 NFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSL 172
                + +      K+  + ++ +       +   +L++L++L L++N +      L + 
Sbjct: 297 YLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEY--LKNS 354

Query: 173 SSLSNCKYLEYFSFSNNPLGGI--LPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNL 230
           +       L+    S N L  +      +  L  ++    +        +P+       +
Sbjct: 355 ACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLK-NLTSLDISRNTFH-PMPDSCQWPEKM 412

Query: 231 ILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLL 290
             + L+L    +   +   +     L  LD+  N L  F    S  L  L++LY+  N L
Sbjct: 413 --RFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLDSF----SLFLPRLQELYISRNKL 463

Query: 291 TSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSC 339
            ++P        +L + +S N            L  L ++ L  N + C
Sbjct: 464 KTLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 511

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 91.7 bits (228), Expect = 2e-19
 Identities = 42/254 (16%), Positives = 87/254 (34%), Gaps = 26/254 (10%)

Query: 60  FSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTI- 118
                +   + T    +  +K + + ++ +   +P S    L +L+ L L   N +    
Sbjct: 293 IPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDL-SENLMVEEY 350

Query: 119 ---PSFIFNASKLSELGLQKNSFS--GSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLS 173
               +       L  L L +N              L+NL  L ++ N             
Sbjct: 351 LKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPE 410

Query: 174 SLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQ 233
            +       + + S+  +  +       + Q++E   + N N+  S    +  L  L + 
Sbjct: 411 KM------RFLNLSSTGIRVVKT----CIPQTLEVLDVSNNNLD-SFSLFLPRLQELYIS 459

Query: 234 LLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSI 293
                 N+L+ ++PD       L  + +  N+L          LT+L+K++L +N     
Sbjct: 460 -----RNKLK-TLPDASL-FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 512

Query: 294 PSTLWNLKDILHLN 307
              +  L   L+ N
Sbjct: 513 CPRIDYLSRWLNKN 526

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  150 bits (381), Expect = 5e-41
 Identities = 37/175 (21%), Positives = 77/175 (44%), Gaps = 17/175 (9%)

Query: 520 IGRGGFGPVYK---DGMEVAIKVFNLQYGGA--FKSFDIECGMMKRIRHRNLIKIISSCS 574
           +     G ++K    G ++ +KV  ++       + F+ EC  ++   H N++ ++ +C 
Sbjct: 18  LNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQ 77

Query: 575 N--DDFKALVLEYMPLGSLEKCLYSG-NYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
           +       L+  +MP GSL   L+ G N+++D  Q +   +D+A  + +LH      I  
Sbjct: 78  SPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIPR 136

Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGE 686
             L   +V++D++M A +S   +         S      +    ++AP E    +
Sbjct: 137 HALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAP-EALQKK 183

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  154 bits (390), Expect = 6e-41
 Identities = 73/398 (18%), Positives = 141/398 (35%), Gaps = 55/398 (13%)

Query: 51  NLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLW 110
            L+N + + F  + +  +    + +   ++ L L+   +   + + A      +++L++ 
Sbjct: 43  TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMG 101

Query: 111 GNNFIGTIPSFIF-NASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPEL 169
            N  I  +P  +F N   L+ L L++N  S      F N   L  L +++N L     + 
Sbjct: 102 FNA-IRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDT 160

Query: 170 SSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTN 229
                      L+    S+N L  +    I +                            
Sbjct: 161 -----FQATTSLQNLQLSSNRLTHVDLSLIPS---------------------------- 187

Query: 230 LILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNL 289
             L   ++  N L       L    A+ +LD   N ++  V         L  L L  N 
Sbjct: 188 --LFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNN 237

Query: 290 LTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLK 349
           LT     L N   ++ ++LS N     +      +  L +L +S N     +      + 
Sbjct: 238 LTDTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIP 295

Query: 350 DLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRL 409
            L+ L L +N L   +  +      L++L L +N++  T+ +S      LK++ +S N  
Sbjct: 296 TLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST--HHTLKNLTLSHNDW 351

Query: 410 EGEIPREGPFRNLSAESFKGNELLC--GMPNLQVLSCR 445
           +        FRN++  +    +  C         L C+
Sbjct: 352 D-CNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCK 388

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score =  125 bits (315), Expect = 4e-31
 Identities = 67/342 (19%), Positives = 120/342 (35%), Gaps = 34/342 (9%)

Query: 112 NNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSS 171
                 I S +       ++ +   +           L N K +   ++ +      L  
Sbjct: 7   QPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAAL-- 64

Query: 172 LSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEI-NNLTNL 230
              L + + +E  + ++  +  I   A      +++  +M    I   +P  +  N+   
Sbjct: 65  ---LDSFRQVELLNLNDLQIEEIDTYAFAYAH-TIQKLYMGFNAIR-YLPPHVFQNVPL- 118

Query: 231 ILQLLSLEGNQLEGSIPDDL-CRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNL 289
            L +L LE N L  S+P  +      L  L +  N L           T+L+ L L SN 
Sbjct: 119 -LTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNR 176

Query: 290 LTSIP-STLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGL 348
           LT +  S + +L    H N+S N  +      +     + +LD S N+ + V        
Sbjct: 177 LTHVDLSLIPSLF---HANVSYNLLS-----TLAIPIAVEELDASHNSINVVRG---PVN 225

Query: 349 KDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNR 408
            +L  L L++N L       + +   L  ++LS N L   +     K+  L+ + +S NR
Sbjct: 226 VELTILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR 283

Query: 409 LEGEIPRE-GPFRNLSAESFKGNEL------LCGMPNLQVLS 443
           L   +     P   L       N L            L+ L 
Sbjct: 284 LV-ALNLYGQPIPTLKVLDLSHNHLLHVERNQPQFDRLENLY 324

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 71.6 bits (176), Expect = 2e-13
 Identities = 32/191 (16%), Positives = 66/191 (34%), Gaps = 26/191 (13%)

Query: 2   PSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFS 61
           PSL +  +   +LS L  P +++ L  S+N          +  +   +     +  +   
Sbjct: 186 PSLFHANVSYNLLSTLAIPIAVEELDASHNS---------INVVRGPV--NVELTILKLQ 234

Query: 62  FNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSF 121
            N +       + N   L  + L  N L  ++     V++  L+ L++  N  +  +  +
Sbjct: 235 HNNLTDT--AWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNR-LVALNLY 290

Query: 122 IFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTS-STPELSSLSSLSNCKY 180
                 L  L L  N     +         L+ L L+ N + +       +L +L     
Sbjct: 291 GQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNL----- 344

Query: 181 LEYFSFSNNPL 191
               + S+N  
Sbjct: 345 ----TLSHNDW 351

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  159 bits (405), Expect = 9e-41
 Identities = 84/423 (19%), Positives = 145/423 (34%), Gaps = 55/423 (13%)

Query: 71  TTIF-NVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIF-NASKL 128
           T +   ++T + L L  N +   + +S+   L  L+ L L       TI    F N   L
Sbjct: 17  TQVPQVLNTTERLLLSFNYIR-TVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNL 75

Query: 129 SELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSN 188
             L L  +      P+ F  L +L  L L    L+ +  +     +L     L     S 
Sbjct: 76  RILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKA---LTRLDLSK 132

Query: 189 NPLGGI-LPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIP 247
           N +  + L  + G L+ S++     +  I      E+  L    L   SL  N L   + 
Sbjct: 133 NQIRSLYLHPSFGKLN-SLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVS 191

Query: 248 DDLCRLAALFQ------LDLGGNKLSGFVPACSGN------------LTNLRKLYLGSNL 289
            D  +    F+      LD+ GN  +  +     N              ++     G + 
Sbjct: 192 VDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHN 251

Query: 290 LTSIP-STLWNLKD--ILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIG 346
           +     +T   L    + HL+LS  F           L  L  L+L+ N  + +      
Sbjct: 252 IKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFY 311

Query: 347 GLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSF 406
           GL +LQ L L YN L     ++   L  +  ++L  N+++     + + L  L+ +++  
Sbjct: 312 GLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRD 371

Query: 407 NRLEGEIP----------REGPFRNLSAESFKGNEL---------------LCGMPNLQV 441
           N L   I                  L   +   N +               L  +P+LQ+
Sbjct: 372 NALT-TIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQI 430

Query: 442 LSC 444
           L  
Sbjct: 431 LIL 433

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  155 bits (393), Expect = 3e-39
 Identities = 89/472 (18%), Positives = 147/472 (31%), Gaps = 50/472 (10%)

Query: 4   LTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFN 63
           L+ +++R +  S       LQ L L       +I             NL N+  +    +
Sbjct: 31  LSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTID-------KEAFRNLPNLRILDLGSS 83

Query: 64  KVVGVVPTTIFNVSTLKSLYLHSNSLSGR-LPSSADVRLPNLKELHLWGNNFIGTIPSFI 122
           K+  + P     +  L  L L+   LS   L       L  L  L L  N          
Sbjct: 84  KIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPS 143

Query: 123 F-NASKLSELGLQKNSFSGSIPNTFGNLR--NLKWLGLNDNYLTSSTPE-LSSLSSLSNC 178
           F   + L  +    N       +    L+   L +  L  N L S          +    
Sbjct: 144 FGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRN 203

Query: 179 KYLEYFSFSNNPLGGILPRAIGN-----------LSQSMEDFWMDNCNISGSIPEEINNL 227
             LE    S N     +     N           L+  +        NI          L
Sbjct: 204 MVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGL 263

Query: 228 TNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGS 287
               ++ L L    +          L  L  L+L  NK++         L NL+ L L  
Sbjct: 264 ARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSY 323

Query: 288 NLLTSIPS-TLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIG 346
           NLL  + S   + L  + +++L  N            L  L  LDL  N  +      I 
Sbjct: 324 NLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT-----IH 378

Query: 347 GLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSG-TIPISLEKLLDLKDINVS 405
            +  +  +FL  N+L  ++P      ++   ++LS N L    I   L ++  L+ + ++
Sbjct: 379 FIPSIPDIFLSGNKLV-TLPK---INLTANLIHLSENRLENLDILYFLLRVPHLQILILN 434

Query: 406 FNRLEGEIPREGPFRNLS---------------AESFKGNELLCGMPNLQVL 442
            NR       +                       E+    ++  G+ +LQVL
Sbjct: 435 QNRFS-SCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVL 485

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  154 bits (390), Expect = 7e-39
 Identities = 87/474 (18%), Positives = 159/474 (33%), Gaps = 58/474 (12%)

Query: 3   SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSF 62
            L +  +  +          L  L L +      +   +L        NL  +  +  S 
Sbjct: 79  DLGSSKIYFLHPDAFQGLFHLFELRLYFC----GLSDAVLK--DGYFRNLKALTRLDLSK 132

Query: 63  NKVVGVVPTTIF-NVSTLKSLYLHSNSLSGRLPSS-ADVRLPNLKELHLWGNNFIGTIPS 120
           N++  +     F  +++LKS+   SN +          ++   L    L  N+    +  
Sbjct: 133 NQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSV 192

Query: 121 FIFNASK------LSELGLQKNSFSGSIPNTFGN------------LRNLKWLGLNDNYL 162
                        L  L +  N ++  I   F N              ++   G   + +
Sbjct: 193 DWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNI 252

Query: 163 TSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPE 222
               P+ ++ + L+    + +   S+  +  +  R    L   ++   +    I+    E
Sbjct: 253 K--DPDQNTFAGLARS-SVRHLDLSHGFVFSLNSRVFETLK-DLKVLNLAYNKINKIADE 308

Query: 223 EINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRK 282
               L N  LQ+L+L  N L      +   L  +  +DL  N ++         L  L+ 
Sbjct: 309 AFYGLDN--LQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQT 366

Query: 283 LYLGSNLLTSIPSTLWNLKDIL-----------------HLNLSSNFFTGPLPLKI-GNL 324
           L L  N LT+I   + ++ DI                   ++LS N       L     +
Sbjct: 367 LDLRDNALTTIHF-IPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRV 425

Query: 325 NVLVQLDLSMNNFSCVIPTKI-GGLKDLQYLFLEYNRLQGSIPNSI-----GDLISLKSL 378
             L  L L+ N FS     +       L+ LFL  N LQ +    +       L  L+ L
Sbjct: 426 PHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVL 485

Query: 379 NLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNEL 432
            L++N L+   P     L  L+ ++++ NRL   +       NL       N+L
Sbjct: 486 YLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPANLEILDISRNQL 538

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  142 bits (360), Expect = 3e-35
 Identities = 84/464 (18%), Positives = 151/464 (32%), Gaps = 62/464 (13%)

Query: 6   NDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHE-IDNLHNM--EWMAFSF 62
           N      +    G  +SL+++  S N          +  +    ++ L      + + + 
Sbjct: 133 NQIRSLYLHPSFGKLNSLKSIDFSSNQ---------IFLVCEHELEPLQGKTLSFFSLAA 183

Query: 63  NKVVGVVPTTIFNVS------TLKSLYLHSNSLS-----------GRLPSSADVRLPNLK 105
           N +   V               L+ L +  N  +            +  + + +   ++ 
Sbjct: 184 NSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIM 243

Query: 106 ELHLWGNNFIGTIPSFIF---NASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYL 162
                 +N I       F     S +  L L            F  L++LK L L  N +
Sbjct: 244 GAGFGFHN-IKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKI 302

Query: 163 TSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPE 222
                      +      L+  + S N LG +       L   +    +   +I+    +
Sbjct: 303 NKIAD-----EAFYGLDNLQVLNLSYNLLGELYSSNFYGL-PKVAYIDLQKNHIAIIQDQ 356

Query: 223 EINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRK 282
               L  L  Q L L  N L       +  + ++  + L GNKL                
Sbjct: 357 TFKFLEKL--QTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVTL----PKINLTANL 405

Query: 283 LYLGSNLLTSIP--STLWNLKDILHLNLSSNFFTG-PLPLKIGNLNVLVQLDLSMNNFSC 339
           ++L  N L ++     L  +  +  L L+ N F+             L QL L  N    
Sbjct: 406 IHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQL 465

Query: 340 VIPTKI-----GGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLE 394
              T++      GL  LQ L+L +N L    P     L +L+ L+L++N L+      L 
Sbjct: 466 AWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP 525

Query: 395 KLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMPN 438
               L+ +++S N+L    P    F +LS      N+ +C    
Sbjct: 526 AN--LEILDISRNQL--LAPNPDVFVSLSVLDITHNKFICECEL 565

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score =  122 bits (308), Expect = 7e-29
 Identities = 81/403 (20%), Positives = 143/403 (35%), Gaps = 39/403 (9%)

Query: 1   MPSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAF 60
           +    ++ +       L     +      ++             +        ++  +  
Sbjct: 220 ITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIK-DPDQNTFAGLAR-----SSVRHLDL 273

Query: 61  SFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPS 120
           S   V  +       +  LK L L  N ++ ++   A   L NL+ L+L   N +G + S
Sbjct: 274 SHGFVFSLNSRVFETLKDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNL-SYNLLGELYS 331

Query: 121 FIF-NASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTS--STPELSSLS-SLS 176
             F    K++ + LQKN  +     TF  L  L+ L L DN LT+    P +  +  S +
Sbjct: 332 SNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGN 391

Query: 177 NCKYLEYFSF-------SNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEI-NNLT 228
               L   +        S N L  +           ++   ++    S    ++  +   
Sbjct: 392 KLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENP 451

Query: 229 NLILQLLSLEGNQLEGSIPDDLCR-----LAALFQLDLGGNKLSGFVPACSGNLTNLRKL 283
           +L  + L L  N L+ +   +LC      L+ L  L L  N L+   P    +LT LR L
Sbjct: 452 SL--EQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGL 509

Query: 284 YLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPT 343
            L SN LT +        ++  L++S N    P P    +L+    LD++ N F C    
Sbjct: 510 SLNSNRLTVLSHN-DLPANLEILDISRNQLLAPNPDVFVSLS---VLDITHNKFICEC-- 563

Query: 344 KIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLS 386
                 +L       N    +I     D+  +   + S  +L 
Sbjct: 564 ------ELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLF 600

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  149 bits (379), Expect = 3e-40
 Identities = 53/173 (30%), Positives = 77/173 (44%), Gaps = 16/173 (9%)

Query: 520 IGRGGFGPVYK---DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSND 576
           +GRG FG V K      +VAIK    +     K+F +E   + R+ H N++K+  +C N 
Sbjct: 16  VGRGAFGVVCKAKWRAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLNP 73

Query: 577 DFKALVLEYMPLGSLEKCLYSGN--YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDL 634
               LV+EY   GSL   L+             ++  +  +  + YLH      +IH DL
Sbjct: 74  --VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDL 131

Query: 635 KPSNVLLDDNM-VAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGE 686
           KP N+LL     V  + DFG A      D     T    +  +MAP E+F G 
Sbjct: 132 KPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAP-EVFEGS 178

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  155 bits (393), Expect = 5e-40
 Identities = 63/368 (17%), Positives = 132/368 (35%), Gaps = 29/368 (7%)

Query: 69  VPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIF-NASK 127
           + + +        +++   +         D+ L N K +    +  +  +P+ +  +  +
Sbjct: 19  IDSNLQYDCVFYDVHIDMQTQD-VYFGFEDITLNNQKIVTFKNST-MRKLPAALLDSFRQ 76

Query: 128 LSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFS 187
           +  L L            F     ++ L +  N +    P +       N   L      
Sbjct: 77  VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHV-----FQNVPLLTVLVLE 131

Query: 188 NNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEI-NNLTNLILQLLSLEGNQLEGSI 246
            N L  +      N    +    M N N+   I ++     T+  LQ L L  N+L   +
Sbjct: 132 RNDLSSLPRGIFHNTP-KLTTLSMSNNNLE-RIEDDTFQATTS--LQNLQLSSNRLT-HV 186

Query: 247 PDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHL 306
              L  + +LF  ++  N LS            + +L    N +  +   +    ++  L
Sbjct: 187 DLSL--IPSLFHANVSYNLLSTL-----AIPIAVEELDASHNSINVVRGPV--NVELTIL 237

Query: 307 NLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIP 366
            L  N  T      + N   LV++DLS N    ++      ++ L+ L++  NRL  ++ 
Sbjct: 238 KLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALN 294

Query: 367 NSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAES 426
                + +LK L+LS+N+L   +  +  +   L+++ +  N +   +        L   +
Sbjct: 295 LYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK-LSTHHTLKNLT 351

Query: 427 FKGNELLC 434
              N+  C
Sbjct: 352 LSHNDWDC 359

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  143 bits (361), Expect = 8e-36
 Identities = 71/382 (18%), Positives = 146/382 (38%), Gaps = 42/382 (10%)

Query: 19  NPSSLQTLYLSYNPPSGSIPSFILCEIPHEI-DNLHNMEWMAFSFNKVVGVVPTTIFNVS 77
             ++ + +    +          + ++P  + D+   +E +  +  ++  +         
Sbjct: 49  TLNNQKIVTFKNST---------MRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAH 99

Query: 78  TLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIF-NASKLSELGLQKN 136
           T++ LY+  N++   LP      +P L  L L  N+ + ++P  IF N  KL+ L +  N
Sbjct: 100 TIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERND-LSSLPRGIFHNTPKLTTLSMSNN 157

Query: 137 SFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPE-LSSLSSLSNCKYLEYFSFSNNPLGGIL 195
           +      +TF    +L+ L L+ N LT      + SL   +          S N L  + 
Sbjct: 158 NLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHAN---------VSYNLLSTL- 207

Query: 196 PRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAA 255
                 +  ++E+    + +I+      +    N+ L +L L+ N L  +    L     
Sbjct: 208 -----AIPIAVEELDASHNSIN-----VVRGPVNVELTILKLQHNNL--TDTAWLLNYPG 255

Query: 256 LFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTG 315
           L ++DL  N+L   +      +  L +LY+ +N L ++      +  +  L+LS N    
Sbjct: 256 LVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLLH 315

Query: 316 PLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISL 375
            +       + L  L L  N+   +   K+     L+ L L +N    +  +      ++
Sbjct: 316 -VERNQPQFDRLENLYLDHNSIVTL---KLSTHHTLKNLTLSHNDWDCN--SLRALFRNV 369

Query: 376 KSLNLSNNNLSGTIPISLEKLL 397
               + + +    I   LE  L
Sbjct: 370 ARPAVDDADQHCKIDYQLEHGL 391

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  142 bits (360), Expect = 8e-36
 Identities = 78/437 (17%), Positives = 147/437 (33%), Gaps = 45/437 (10%)

Query: 3   SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEI-DNLHNMEWMAFS 61
           +  N  +R +  + L +   ++ L L+            + EI        H ++ +   
Sbjct: 57  TFKNSTMRKLPAALLDSFRQVELLNLNDLQ---------IEEIDTYAFAYAHTIQKLYMG 107

Query: 62  FNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSF 121
           FN +  + P    NV  L  L L  N LS  LP       P L  L +  NN +  I   
Sbjct: 108 FNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSM-SNNNLERIEDD 165

Query: 122 IF-NASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKY 180
            F   + L  L L  N  +  +      + +L    ++ N           LS+L+    
Sbjct: 166 TFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYN----------LLSTLAIPIA 212

Query: 181 LEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLI-LQLLSLEG 239
           +E    S+N +  +       L        + + N++     +   L N   L  + L  
Sbjct: 213 VEELDASHNSINVVRGPVNVEL----TILKLQHNNLT-----DTAWLLNYPGLVEVDLSY 263

Query: 240 NQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWN 299
           N+LE  +     ++  L +L +  N+L   +      +  L+ L L  N L  +      
Sbjct: 264 NELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLLHVERNQPQ 322

Query: 300 LKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYN 359
              + +L L  N       LK+   + L  L LS N++ C     +   +++    ++  
Sbjct: 323 FDRLENLYLDHNSIV---TLKLSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDA 377

Query: 360 RLQGSIPNSIGDLISLKSLN---LSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPRE 416
                I   +   +  K  +   L        +   +EK+   +    + + +       
Sbjct: 378 DQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSATDTINSVQSLS 437

Query: 417 GPFRNLSAESFKGNELL 433
                      +GNE L
Sbjct: 438 HYITQQGGVPLQGNEQL 454

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  123 bits (311), Expect = 1e-29
 Identities = 69/355 (19%), Positives = 125/355 (35%), Gaps = 47/355 (13%)

Query: 115 IGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSS 174
              I S +       ++ +   +           L N K +   ++ +      L     
Sbjct: 16  YKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAAL----- 70

Query: 175 LSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEI-NNLTNLILQ 233
           L + + +E  + ++  +  I   A      +++  +M    I   +P  +  N+    L 
Sbjct: 71  LDSFRQVELLNLNDLQIEEIDTYAFAYAH-TIQKLYMGFNAIR-YLPPHVFQNVPL--LT 126

Query: 234 LLSLEGNQLEGSIPDDL-CRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTS 292
           +L LE N L  S+P  +      L  L +  N L           T+L+ L L SN LT 
Sbjct: 127 VLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH 185

Query: 293 IP-STLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIP--------- 342
           +  S + +L    H N+S N  +      +     + +LD S N+ + V           
Sbjct: 186 VDLSLIPSLF---HANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELTIL 237

Query: 343 -------TKIG---GLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPIS 392
                  T          L  + L YN L+  + +    +  L+ L +SNN L   + + 
Sbjct: 238 KLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLY 296

Query: 393 LEKLLDLKDINVSFNRLEGEIPRE-GPFRNLSAESFKGNEL----LCGMPNLQVL 442
            + +  LK +++S N L   + R    F  L       N +    L     L+ L
Sbjct: 297 GQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNL 350

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score =  107 bits (269), Expect = 2e-24
 Identities = 47/237 (19%), Positives = 89/237 (37%), Gaps = 20/237 (8%)

Query: 215 NISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDD-LCRLAALFQLDLGGNKLSGFVPAC 273
             +  +     ++T    ++++ + + +   +P   L     +  L+L   ++       
Sbjct: 36  MQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYA 94

Query: 274 SGNLTNLRKLYLGSNLLTSIP-STLWNLKDILHLNLSSNFFTGPLPLKI-GNLNVLVQLD 331
                 ++KLY+G N +  +P     N+  +  L L  N  +  LP  I  N   L  L 
Sbjct: 95  FAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLS 153

Query: 332 LSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPI 391
           +S NN   +          LQ L L  NRL   +   +  + SL   N+S N LS     
Sbjct: 154 MSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS----- 205

Query: 392 SLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNEL-----LCGMPNLQVLS 443
           +L   + +++++ S N +   +        L+    + N L     L   P L  + 
Sbjct: 206 TLAIPIAVEELDASHNSIN-VVR-GPVNVELTILKLQHNNLTDTAWLLNYPGLVEVD 260

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 71.9 bits (176), Expect = 4e-13
 Identities = 65/433 (15%), Positives = 127/433 (29%), Gaps = 47/433 (10%)

Query: 2   PSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFS 61
           PSL +  +   +LS L  P +++ L  S+N          +  +   +     +  +   
Sbjct: 192 PSLFHANVSYNLLSTLAIPIAVEELDASHNS---------INVVRGPV--NVELTILKLQ 240

Query: 62  FNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSF 121
            N +       + N   L  + L  N L  ++     V++  L+ L++  NN +  +  +
Sbjct: 241 HNNLTDT--AWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYI-SNNRLVALNLY 296

Query: 122 IFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTS-STPELSSLSSLSNCKY 180
                 L  L L  N     +         L+ L L+ N + +       +L +L     
Sbjct: 297 GQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNL----T 351

Query: 181 LEYFSFSNNPLGGIL-----PRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLL 235
           L +  +  N L  +      P           D+ +++        +   +     + L 
Sbjct: 352 LSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALT 411

Query: 236 SLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPS 295
           S+                    Q         G VP             L + +      
Sbjct: 412 SVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNE 471

Query: 296 TLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLF 355
            +   + +  L+   +           NL         +   S  +      LK+ Q   
Sbjct: 472 QIQQEQLLQGLHAEID----------TNLRRYRLPKDGLARSSDNLNKVFTHLKERQAFK 521

Query: 356 LEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPR 415
           L     Q     +       + L   N         +LEK LD K    +  R E  + R
Sbjct: 522 LRET--QARRTEADAKQKETEDLEQENI--------ALEKQLDNKRAKQAELRQETSLKR 571

Query: 416 EGPFRNLSAESFK 428
           +   + L A+  +
Sbjct: 572 Q-KVKQLEAKKNR 583

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  148 bits (375), Expect = 6e-40
 Identities = 48/177 (27%), Positives = 85/177 (48%), Gaps = 11/177 (6%)

Query: 520 IGRGGFGPVYKDGM---EVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           IG G FG VYK G    +VA+K+ N+        ++F  E G++++ RH N++  +   +
Sbjct: 32  IGSGSFGTVYK-GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 90

Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDL 634
                A+V ++    SL   L++     ++ + ++I    A  ++YLH   +  IIH DL
Sbjct: 91  APQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDL 146

Query: 635 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKC 691
           K +N+ L ++    + DFG+A        S    Q   +I +MAP E+   +     
Sbjct: 147 KSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP-EVIRMQDSNPY 202

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  147 bits (374), Expect = 6e-40
 Identities = 51/184 (27%), Positives = 83/184 (45%), Gaps = 26/184 (14%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQ-------YGGAFKSFDIECGMMKRIRHRNLI 567
           IG+GGFG V+K     D   VAIK   L            F+ F  E  +M  + H N++
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86

Query: 568 KIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
           K+     N     +V+E++P G L   L    + +     L +M+D+A  +EY+    + 
Sbjct: 87  KLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNP 143

Query: 628 PIIHCDLKPSNVLLD-----DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
           PI+H DL+  N+ L        + A ++DFG+++         + +  L    +MAP E 
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAP-ET 197

Query: 683 FSGE 686
              E
Sbjct: 198 IGAE 201

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  148 bits (375), Expect = 1e-39
 Identities = 45/177 (25%), Positives = 79/177 (44%), Gaps = 14/177 (7%)

Query: 518 NLIGRGGFGPVYKDGM---EVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISS 572
            LIG+G FG VY  G    EVAI++ +++       K+F  E    ++ RH N++  + +
Sbjct: 39  ELIGKGRFGQVYH-GRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97

Query: 573 CSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
           C +    A++       +L   +     +LD+ +   I  ++   + YLH   +  I+H 
Sbjct: 98  CMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHK 154

Query: 633 DLKPSNVLLDDNMVAHLSDFGMAK---PLLEEDQSLTQTQTLATIGYMAPDEIFSGE 686
           DLK  NV  D+  V  ++DFG+      L    +          + ++AP EI    
Sbjct: 155 DLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAP-EIIRQL 209

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  151 bits (383), Expect = 2e-39
 Identities = 84/419 (20%), Positives = 143/419 (34%), Gaps = 83/419 (19%)

Query: 19  NPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVST 78
            P  L++L  S N          L E+P    +L ++     +   +  + P        
Sbjct: 89  LPPHLESLVASCNS---------LTELPELPQSLKSLLVDNNNLKALSDLPPL------- 132

Query: 79  LKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSF 138
           L+ L + +N L  +LP         LK + +  NN +  +P    +   L  +    N  
Sbjct: 133 LEYLGVSNNQLE-KLPELQ--NSSFLKIIDVD-NNSLKKLPDLPPS---LEFIAAGNNQL 185

Query: 139 SGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSL-------------SNCKYLEYFS 185
              +P    NL  L  +  ++N L        SL S+              N  +L    
Sbjct: 186 E-ELPE-LQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIY 243

Query: 186 FSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLI-------------- 231
             NN L   LP    +L    E   + +  ++  +PE   +LT L               
Sbjct: 244 ADNNLLK-TLPDLPPSL----EALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSELPP 297

Query: 232 -LQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLL 290
            L  L+   N++  S+ D    L    +L++  NKL             L +L    N L
Sbjct: 298 NLYYLNASSNEIR-SLCDLPPSLE---ELNVSNNKLIEL----PALPPRLERLIASFNHL 349

Query: 291 TSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKD 350
             +P    NLK    L++  N      P    ++      DL MN+    +P     LK 
Sbjct: 350 AEVPELPQNLK---QLHVEYNPLRE-FPDIPESVE-----DLRMNSHLAEVPELPQNLK- 399

Query: 351 LQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRL 409
              L +E N L+   P+      S++ L +++  +      + E    L+D     +  
Sbjct: 400 --QLHVETNPLR-EFPDIPE---SVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  150 bits (380), Expect = 4e-39
 Identities = 91/449 (20%), Positives = 153/449 (34%), Gaps = 79/449 (17%)

Query: 21  SSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLK 80
           + LQ      +          L E+P E +N+ +      ++++     P        + 
Sbjct: 11  TFLQEPLRHSSN---------LTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 81  SLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSG 140
              L                     EL L     + ++P    +   L  L    NS + 
Sbjct: 62  VSRLRDC------------LDRQAHELELNNLG-LSSLPELPPH---LESLVASCNSLT- 104

Query: 141 SIPNTFGNLRNLKWLGLNDNYLTSSTP----------ELSSLSSLSNCKYLEYFSFSNNP 190
            +P    +L++L     N   L+   P          +L  L  L N  +L+     NN 
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNS 164

Query: 191 LGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDL 250
           L   LP    +L    E     N  +   +P E+ NL    L  +  + N L+  +PD  
Sbjct: 165 L-KKLPDLPPSL----EFIAAGNNQLE-ELP-ELQNLPF--LTAIYADNNSLK-KLPDLP 214

Query: 251 CRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSS 310
             L     +  G N L         NL  L  +Y  +NLL ++P    +L+    LN+  
Sbjct: 215 LSLE---SIVAGNNILE--ELPELQNLPFLTTIYADNNLLKTLPDLPPSLE---ALNVRD 266

Query: 311 NFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIP-------------TKIGGLKDLQYLFLE 357
           N+ T  LP    +L  L   +   +  S + P             +       L+ L + 
Sbjct: 267 NYLTD-LPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVS 325

Query: 358 YNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPRE- 416
            N+L   +P        L+ L  S N+L+  +P   +    LK ++V +N L  E P   
Sbjct: 326 NNKLI-ELPALPP---RLERLIASFNHLA-EVPELPQN---LKQLHVEYNPLR-EFPDIP 376

Query: 417 GPFRNLSAESFKGNELLCGMPNLQVLSCR 445
               +L   +    E+     NL+ L   
Sbjct: 377 ESVEDLRM-NSHLAEVPELPQNLKQLHVE 404

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score =  134 bits (339), Expect = 9e-34
 Identities = 71/363 (19%), Positives = 128/363 (35%), Gaps = 59/363 (16%)

Query: 97  ADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLG 156
            +V    L+E     +N +  +P    N    +E     + +  + P   G  R +    
Sbjct: 6   RNVSNTFLQEPLRHSSN-LTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSR 64

Query: 157 LNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNI 216
           L D                           +N  L   LP    +L    E       ++
Sbjct: 65  LRDCLDRQ----------------AHELELNNLGL-SSLPELPPHL----ESLVASCNSL 103

Query: 217 SGSIPEEINNLTNLI---------------LQLLSLEGNQLEGSIPDDLCRLAALFQLDL 261
           +  +PE   +L +L+               L+ L +  NQLE  +P +L   + L  +D+
Sbjct: 104 T-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLE-KLP-ELQNSSFLKIIDV 160

Query: 262 GGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKI 321
             N L            +L  +  G+N L  +P  L NL  +  +   +N     LP   
Sbjct: 161 DNNSLKKL----PDLPPSLEFIAAGNNQLEELPE-LQNLPFLTAIYADNNSLKK-LPDLP 214

Query: 322 GNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLS 381
            +L     +    N        ++  L  L  ++ + N L+ ++P+      SL++LN+ 
Sbjct: 215 LSLE---SIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPP---SLEALNVR 265

Query: 382 NNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMPNLQV 441
           +N L+  +P   + L  L      F+ L    P       L+A S +   L    P+L+ 
Sbjct: 266 DNYLT-DLPELPQSLTFLDVSENIFSGLSELPPN---LYYLNASSNEIRSLCDLPPSLEE 321

Query: 442 LSC 444
           L+ 
Sbjct: 322 LNV 324

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 80.0 bits (198), Expect = 6e-16
 Identities = 41/193 (21%), Positives = 68/193 (35%), Gaps = 29/193 (15%)

Query: 269 FVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNL---- 324
           F+   + + T L++    S+ LT +P    N+K       + + +    P   G      
Sbjct: 2   FINPRNVSNTFLQEPLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61

Query: 325 ---------NVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISL 375
                        +L+L+    S  +P        L+ L    N L   +P     L SL
Sbjct: 62  VSRLRDCLDRQAHELELNNLGLSS-LPELPP---HLESLVASCNSLT-ELPELPQSLKSL 116

Query: 376 KSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGN---EL 432
              N +   LS  +P  LE L       VS N+LE ++P       L       N   +L
Sbjct: 117 LVDNNNLKALSD-LPPLLEYL------GVSNNQLE-KLPELQNSSFLKIIDVDNNSLKKL 168

Query: 433 LCGMPNLQVLSCR 445
               P+L+ ++  
Sbjct: 169 PDLPPSLEFIAAG 181

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 49.6 bits (119), Expect = 3e-06
 Identities = 33/171 (19%), Positives = 60/171 (35%), Gaps = 30/171 (17%)

Query: 18  GNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVS 77
             P SL+ L +S N          L E+P     L   E +  SFN +   VP    N  
Sbjct: 314 DLPPSLEELNVSNNK---------LIELPALPPRL---ERLIASFNHLA-EVPELPQN-- 358

Query: 78  TLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNS 137
            LK L++  N L    P        ++++L +  N+ +  +P        L +L ++ N 
Sbjct: 359 -LKQLHVEYNPLR-EFPDI----PESVEDLRM--NSHLAEVPELP---QNLKQLHVETNP 407

Query: 138 FSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSN 188
                P+   ++ +L    +N   +          +        E+    +
Sbjct: 408 LR-EFPDIPESVEDL---RMNSERVVDPYEFAHETTDKLEDDVFEHHHHHH 454

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  153 bits (389), Expect = 3e-39
 Identities = 74/338 (21%), Positives = 126/338 (37%), Gaps = 52/338 (15%)

Query: 77  STLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKN 136
           +    L +  + L+  LP        ++  L +  NN + ++P+      +L  L +  N
Sbjct: 40  NGNAVLNVGESGLT-TLPDCL---PAHITTLVIPDNN-LTSLPALP---PELRTLEVSGN 91

Query: 137 SFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILP 196
             + S+P     L  L        +L +    L  L                N L   LP
Sbjct: 92  QLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLW------------IFGNQLTS-LP 137

Query: 197 RAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAAL 256
                L    ++  + +  ++ S+P   + L  L         NQL  S+P     L   
Sbjct: 138 VLPPGL----QELSVSDNQLA-SLPALPSELCKL-----WAYNNQLT-SLPMLPSGLQ-- 184

Query: 257 FQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGP 316
            +L +  N+L+   P      + L KL+  +N LTS+P+    LK    L +S N  T  
Sbjct: 185 -ELSVSDNQLASL-PT---LPSELYKLWAYNNRLTSLPALPSGLK---ELIVSGNRLTS- 235

Query: 317 LPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLK 376
           LP+    L    +L +S N  +  +P    GL     L +  N+L   +P S+  L S  
Sbjct: 236 LPVLPSELK---ELMVSGNRLTS-LPMLPSGL---LSLSVYRNQLT-RLPESLIHLSSET 287

Query: 377 SLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIP 414
           ++NL  N LS     +L ++      +    R +    
Sbjct: 288 TVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGA 325

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  130 bits (327), Expect = 1e-31
 Identities = 78/383 (20%), Positives = 135/383 (35%), Gaps = 63/383 (16%)

Query: 20  PSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTL 79
           P+ + TL +  N          L  +P     L  +E    S N++   +P     +  L
Sbjct: 60  PAHITTLVIPDNN---------LTSLPALPPELRTLE---VSGNQLT-SLPVLPPGLLEL 106

Query: 80  KSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFS 139
                    L   LPS        L +L ++GN  + ++P        L EL +  N  +
Sbjct: 107 SIFSNPLTHLP-ALPS-------GLCKLWIFGNQ-LTSLPVLPPG---LQELSVSDNQLA 154

Query: 140 GSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAI 199
            S+P     L  L      +N LTS     S L  LS          S+N L   LP   
Sbjct: 155 -SLPALPSELCKLW---AYNNQLTSLPMLPSGLQELS---------VSDNQLA-SLPTLP 200

Query: 200 GNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQL 259
             L +     W  N  ++ S+P   + L  LI+      GN+L  S+P     L    +L
Sbjct: 201 SELYK----LWAYNNRLT-SLPALPSGLKELIV-----SGNRLT-SLPVLPSELK---EL 246

Query: 260 DLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPL 319
            + GN+L+  +P      + L  L +  N LT +P +L +L     +NL  N  +     
Sbjct: 247 MVSGNRLTS-LPM---LPSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLSERTLQ 302

Query: 320 KIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSL- 378
            +  +         +  F     +     + L     ++      +P   G+        
Sbjct: 303 ALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADW-----LVPAREGEPAPADRWH 357

Query: 379 NLSNNNLSGTIPISLEKLLDLKD 401
                + +    + L++L + ++
Sbjct: 358 MFGQEDNADAFSLFLDRLSETEN 380

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score =  120 bits (302), Expect = 2e-28
 Identities = 67/303 (22%), Positives = 112/303 (36%), Gaps = 55/303 (18%)

Query: 149 LRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMED 208
                 L + ++ LT+    L          ++      +N L   LP     L      
Sbjct: 39  NNGNAVLNVGESGLTTLPDCL--------PAHITTLVIPDNNL-TSLPALPPEL----RT 85

Query: 209 FWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSG 268
             +    ++ S+P     L    L + S     L  ++P  LC+      L + GN+L+ 
Sbjct: 86  LEVSGNQLT-SLPVLPPGLLE--LSIFSNPLTHLP-ALPSGLCK------LWIFGNQLTS 135

Query: 269 FVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLV 328
                      L++L +  N L S+P+    L     L   +N  T  LP+       L 
Sbjct: 136 L----PVLPPGLQELSVSDNQLASLPALPSELC---KLWAYNNQLTS-LPMLPSG---LQ 184

Query: 329 QLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGT 388
           +L +S N  +  +PT       L  L+   NRL  S+P        LK L +S N L+ +
Sbjct: 185 ELSVSDNQLAS-LPTLPSE---LYKLWAYNNRLT-SLPALPS---GLKELIVSGNRLT-S 235

Query: 389 IPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNEL------LCGMPNLQVL 442
           +P+   +L +L    VS NRL   +P       L + S   N+L      L  + +   +
Sbjct: 236 LPVLPSELKEL---MVSGNRLT-SLPML--PSGLLSLSVYRNQLTRLPESLIHLSSETTV 289

Query: 443 SCR 445
           +  
Sbjct: 290 NLE 292

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 93.8 bits (233), Expect = 6e-20
 Identities = 47/208 (22%), Positives = 78/208 (37%), Gaps = 30/208 (14%)

Query: 251 CRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSS 310
           C       L++G + L+  +P C     ++  L +  N LTS+P+    L+    L +S 
Sbjct: 37  CLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPALPPELR---TLEVSG 90

Query: 311 NFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIP------------TKI-GGLKDLQYLFLE 357
           N  T  LP+    L  L      + +   +              T +      LQ L + 
Sbjct: 91  NQLTS-LPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVLPPGLQELSVS 149

Query: 358 YNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPRE- 416
            N+L  S+P        L  L   NN L+ ++P+    L +L   +VS N+L   +P   
Sbjct: 150 DNQLA-SLPALPS---ELCKLWAYNNQLT-SLPMLPSGLQEL---SVSDNQLA-SLPTLP 200

Query: 417 GPFRNLSAESFKGNELLCGMPNLQVLSC 444
                L A + +   L      L+ L  
Sbjct: 201 SELYKLWAYNNRLTSLPALPSGLKELIV 228

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 77.6 bits (191), Expect = 6e-15
 Identities = 42/263 (15%), Positives = 80/263 (30%), Gaps = 36/263 (13%)

Query: 19  NPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVST 78
            PS LQ L +S N          L  +P     L+ +             +P        
Sbjct: 179 LPSGLQELSVSDNQ---------LASLPTLPSELYKLWAYNNRLTS----LPALPSG--- 222

Query: 79  LKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSF 138
           LK L +  N L+  LP         LKEL +   N + ++P      S L  L + +N  
Sbjct: 223 LKELIVSGNRLT-SLPVL----PSELKELMV-SGNRLTSLPMLP---SGLLSLSVYRNQL 273

Query: 139 SGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRA 198
           +  +P +  +L +   + L  N L+  T +          + +      + P+      A
Sbjct: 274 T-RLPESLIHLSSETTVNLEGNPLSERTLQ--------ALREITSAPGYSGPI-IRFDMA 323

Query: 199 IGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQ 258
             +  +      +   +      E      +        +         D L       +
Sbjct: 324 GASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLSETENFIK 383

Query: 259 LDLGGNKLSGFVPACSGNLTNLR 281
                 ++S ++   + +   LR
Sbjct: 384 DAGFKAQISSWLAQLAED-EALR 405

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  142 bits (361), Expect = 3e-38
 Identities = 50/182 (27%), Positives = 80/182 (43%), Gaps = 22/182 (12%)

Query: 520 IGRGGFGPVYK---DGMEVAIKVFNLQ----YGGAFKSFDIECGMMKRIRHRNLIKIISS 572
           IG GGFG VY+    G EVA+K              ++   E  +   ++H N+I +   
Sbjct: 15  IGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGV 74

Query: 573 CSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
           C  +    LV+E+   G L + L      +     +N  + +A  + YLH    VPIIH 
Sbjct: 75  CLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGMNYLHDEAIVPIIHR 132

Query: 633 DLKPSNVLLD--------DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS 684
           DLK SN+L+          N +  ++DFG+A+   E  ++   +       +MAP E+  
Sbjct: 133 DLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTTKMSAA-GAYAWMAP-EVIR 187

Query: 685 GE 686
             
Sbjct: 188 AS 189

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  143 bits (362), Expect = 4e-38
 Identities = 49/188 (26%), Positives = 82/188 (43%), Gaps = 18/188 (9%)

Query: 518 NLIGRGGFGPVYK---DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
             +G+G +G V++    G  VA+K+F+ +   ++   + E      +RH N++  I+S  
Sbjct: 14  ECVGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWF-RETELYNTVMLRHENILGFIASDM 72

Query: 575 NDDFKA----LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH-----FGY 625
                +    L+  Y  +GSL   L      LD    L I++ +AS L +LH        
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQG 130

Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA--TIGYMAPDEIF 683
              I H DLK  N+L+  N    ++D G+A    +    L         T  YMAP E+ 
Sbjct: 131 KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP-EVL 189

Query: 684 SGEMRLKC 691
              +++ C
Sbjct: 190 DETIQVDC 197

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  144 bits (365), Expect = 5e-37
 Identities = 80/363 (22%), Positives = 126/363 (34%), Gaps = 44/363 (12%)

Query: 77  STLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIF-NASKLSELGLQK 135
           +  +++  H       +P          + L L G N I T+    F +   L EL L +
Sbjct: 11  AQDRAVLCHRKRFV-AVPEGIP---TETRLLDL-GKNRIKTLNQDEFASFPHLEELELNE 65

Query: 136 NSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGIL 195
           N  S   P  F NL NL+ LGL  N L      +   + LSN   L     S N +  +L
Sbjct: 66  NIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGV--FTGLSN---LTKLDISENKIVILL 120

Query: 196 PRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDD-LCRLA 254
                +L                             L+ L +  N L   I       L 
Sbjct: 121 DYMFQDLYN---------------------------LKSLEVGDNDLV-YISHRAFSGLN 152

Query: 255 ALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPS-TLWNLKDILHLNLSSNFF 313
           +L QL L    L+        +L  L  L L    + +I   +   L  +  L +S   +
Sbjct: 153 SLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPY 212

Query: 314 TGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLI 373
              +         L  L ++  N + V    +  L  L++L L YN +     + + +L+
Sbjct: 213 LDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELL 272

Query: 374 SLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPRE--GPFRNLSAESFKGNE 431
            L+ + L    L+   P +   L  L+ +NVS N+L   +         NL       N 
Sbjct: 273 RLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNP 331

Query: 432 LLC 434
           L C
Sbjct: 332 LAC 334

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  144 bits (364), Expect = 7e-37
 Identities = 70/324 (21%), Positives = 119/324 (36%), Gaps = 24/324 (7%)

Query: 20  PSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTL 79
           P+  + L L  N    ++             +  ++E +  + N V  V P    N+  L
Sbjct: 31  PTETRLLDLGKNRIK-TLNQDEF-------ASFPHLEELELNENIVSAVEPGAFNNLFNL 82

Query: 80  KSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIF-NASKLSELGLQKNSF 138
           ++L L SN L   +P      L NL +L +   N I  +  ++F +   L  L +  N  
Sbjct: 83  RTLGLRSNRLK-LIPLGVFTGLSNLTKLDI-SENKIVILLDYMFQDLYNLKSLEVGDNDL 140

Query: 139 SGSIP-NTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPR 197
              I    F  L +L+ L L    LTS   E     +LS+   L      +  +  I   
Sbjct: 141 V-YISHRAFSGLNSLEQLTLEKCNLTSIPTE-----ALSHLHGLIVLRLRHLNINAIRDY 194

Query: 198 AIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCR-LAAL 256
           +   L + ++   + +     ++        N  L  LS+    L  ++P    R L  L
Sbjct: 195 SFKRLYR-LKVLEISHWPYLDTMTPNCLYGLN--LTSLSITHCNLT-AVPYLAVRHLVYL 250

Query: 257 FQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPS-TLWNLKDILHLNLSSNFFTG 315
             L+L  N +S    +    L  L+++ L    L  +       L  +  LN+S N  T 
Sbjct: 251 RFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTT 310

Query: 316 PLPLKIGNLNVLVQLDLSMNNFSC 339
                  ++  L  L L  N  +C
Sbjct: 311 LEESVFHSVGNLETLILDSNPLAC 334

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score =  107 bits (270), Expect = 8e-25
 Identities = 53/268 (19%), Positives = 109/268 (40%), Gaps = 25/268 (9%)

Query: 4   LTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEI-DNLHNMEWMAFSF 62
           L ++ L+ I L      S+L  L +S N          +  +   +  +L+N++ +    
Sbjct: 87  LRSNRLKLIPLGVFTGLSNLTKLDISENK---------IVILLDYMFQDLYNLKSLEVGD 137

Query: 63  NKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFI 122
           N +V +       +++L+ L L   +L+  +P+ A   L  L  L L   N I  I  + 
Sbjct: 138 NDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLN-INAIRDYS 195

Query: 123 FNA-SKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYL 181
           F    +L  L +    +  ++        NL  L +    LT+         ++ +  YL
Sbjct: 196 FKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYL-----AVRHLVYL 250

Query: 182 EYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEI-NNLTNLILQLLSLEGN 240
            + + S NP+  I    +  L + +++  +    ++  +       L    L++L++ GN
Sbjct: 251 RFLNLSYNPISTIEGSMLHELLR-LQEIQLVGGQLA-VVEPYAFRGLNY--LRVLNVSGN 306

Query: 241 QLEGSIPDDLCR-LAALFQLDLGGNKLS 267
           QL  ++ + +   +  L  L L  N L+
Sbjct: 307 QLT-TLEESVFHSVGNLETLILDSNPLA 333

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 46.2 bits (110), Expect = 3e-05
 Identities = 27/113 (23%), Positives = 47/113 (41%), Gaps = 9/113 (7%)

Query: 3   SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSF 62
           S+T+  L  +    + +   L+ L LSYNP S +I   +L         L  ++ +    
Sbjct: 230 SITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-TIEGSML-------HELLRLQEIQLVG 281

Query: 63  NKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFI 115
            ++  V P     ++ L+ L +  N L+  L  S    + NL+ L L  N   
Sbjct: 282 GQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  140 bits (355), Expect = 5e-37
 Identities = 47/294 (15%), Positives = 101/294 (34%), Gaps = 24/294 (8%)

Query: 141 SIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIG 200
           +I     N    K   + D+ L  +   L       +   ++    S NPL  I    + 
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASL-----RQSAWNVKELDLSGNPLSQISAADLA 55

Query: 201 NLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLD 260
             +  +E   + +  +      ++ +L+   L+ L L  N ++     +L    ++  L 
Sbjct: 56  PFT-KLELLNLSSNVLY-ETL-DLESLST--LRTLDLNNNYVQ-----ELLVGPSIETLH 105

Query: 261 LGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPS-TLWNLKDILHLNLSSNFFTG-PLP 318
              N +S             + +YL +N +T +          + +L+L  N        
Sbjct: 106 AANNNISRVSC---SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA 162

Query: 319 LKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSL 378
               + + L  L+L  N     +  ++     L+ L L  N+L   +         +  +
Sbjct: 163 ELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWI 219

Query: 379 NLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNEL 432
           +L NN L   I  +L    +L+  ++  N       R+   +N   ++     +
Sbjct: 220 SLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTV 272

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  139 bits (352), Expect = 1e-36
 Identities = 55/314 (17%), Positives = 116/314 (36%), Gaps = 26/314 (8%)

Query: 118 IPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSN 177
           I     N ++     +  +S   ++ +   +  N+K L L+ N L+  +        L+ 
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAA-----DLAP 56

Query: 178 CKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSL 237
              LE  + S+N L   L   + +LS ++    ++N  +      E+    +  ++ L  
Sbjct: 57  FTKLELLNLSSNVLYETLD--LESLS-TLRTLDLNNNYVQ-----ELLVGPS--IETLHA 106

Query: 238 EGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIP--S 295
             N +   +            + L  NK++       G  + ++ L L  N + ++    
Sbjct: 107 ANNNIS-RVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAE 163

Query: 296 TLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLF 355
              +   + HLNL  NF    +  ++     L  LDLS N  +  +  +      + ++ 
Sbjct: 164 LAASSDTLEHLNLQYNFIYD-VKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWIS 220

Query: 356 LEYNRLQGSIPNSIGDLISLKSLNLSNNNLS-GTIPISLEKLLDLKDINV-SFNRLEGEI 413
           L  N+L   I  ++    +L+  +L  N    GT+     K   ++ +   +  +L G+ 
Sbjct: 221 LRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQN 279

Query: 414 PREGPFRNLSAESF 427
             E     L     
Sbjct: 280 EEECTVPTLGHYGA 293

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  139 bits (352), Expect = 1e-36
 Identities = 51/305 (16%), Positives = 98/305 (32%), Gaps = 23/305 (7%)

Query: 101 LPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDN 160
               K   +  ++    + S   +A  + EL L  N  S            L+ L L+ N
Sbjct: 9   GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68

Query: 161 YLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSI 220
            L     E   L SLS    L     +NN +     + +     S+E     N NIS  +
Sbjct: 69  VLY----ETLDLESLST---LRTLDLNNNYV-----QELLVGP-SIETLHAANNNIS-RV 114

Query: 221 PEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGF-VPACSGNLTN 279
                       + + L  N++      D    + +  LDL  N++        + +   
Sbjct: 115 SCSRGQG----KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170

Query: 280 LRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSC 339
           L  L L  N +  +         +  L+LSSN     +  +  +   +  + L  N    
Sbjct: 171 LEHLNLQYNFIYDVKG-QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV- 227

Query: 340 VIPTKIGGLKDLQYLFLEYNRLQ-GSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLD 398
           +I   +   ++L++  L  N    G++ +       ++++                 +  
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPT 287

Query: 399 LKDIN 403
           L    
Sbjct: 288 LGHYG 292

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  129 bits (326), Expect = 4e-33
 Identities = 52/363 (14%), Positives = 117/363 (32%), Gaps = 50/363 (13%)

Query: 45  IPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNL 104
           I     N +  +    + + +   + +   +   +K L L  N LS ++ ++       L
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKL 60

Query: 105 KELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTS 164
           + L+L  N  +                                +L  L+ L LN+NY+  
Sbjct: 61  ELLNLSSNV-LYETLD-------------------------LESLSTLRTLDLNNNYVQ- 93

Query: 165 STPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEI 224
                     L     +E    +NN +  +            ++ ++ N  I+     + 
Sbjct: 94  ---------ELLVGPSIETLHAANNNISRVSCSRGQGK----KNIYLANNKITMLRDLDE 140

Query: 225 NNLTNLILQLLSLEGNQLEG-SIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKL 283
              +   +Q L L+ N+++  +  +       L  L+L  N +             L+ L
Sbjct: 141 GCRSR--VQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTL 196

Query: 284 YLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPT 343
            L SN L  +     +   +  ++L +N     +   +     L   DL  N F C    
Sbjct: 197 DLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHC-GTL 254

Query: 344 KIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPI-SLEKLLDLKDI 402
           +    K+ +   +    ++  +     +  ++ +L          +P    ++L+ L   
Sbjct: 255 RDFFSKNQRVQTVAKQTVK-KLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALGHH 313

Query: 403 NVS 405
           +  
Sbjct: 314 HHH 316

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  121 bits (306), Expect = 2e-30
 Identities = 43/232 (18%), Positives = 85/232 (36%), Gaps = 19/232 (8%)

Query: 219 SIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLT 278
           +I E   N      ++  +  + L+ ++         + +LDL GN LS    A     T
Sbjct: 1   AIHEIKQNGNRY--KIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFT 58

Query: 279 NLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFS 338
            L  L L SN+L      L +L  +  L+L++N+       ++     +  L  + NN S
Sbjct: 59  KLELLNLSSNVLYETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS 112

Query: 339 CVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSG-TIPISLEKLL 397
            V        +  + ++L  N++        G    ++ L+L  N +             
Sbjct: 113 RV---SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169

Query: 398 DLKDINVSFNRLEGEIPREGPFRNLSAESFKGNEL------LCGMPNLQVLS 443
            L+ +N+ +N +  ++  +  F  L       N+L            +  +S
Sbjct: 170 TLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWIS 220

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score =  121 bits (305), Expect = 3e-30
 Identities = 53/350 (15%), Positives = 112/350 (32%), Gaps = 56/350 (16%)

Query: 3   SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSF 62
            +T+  L+  + S   +  +++ L LS NP S  I          ++     +E +  S 
Sbjct: 16  KVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QIS-------AADLAPFTKLELLNLSS 67

Query: 63  NKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFI 122
           N +   +   + ++STL++L L++N +   L        P+++ LH   NN I  +    
Sbjct: 68  NVLYETLD--LESLSTLRTLDLNNNYVQ-ELLV-----GPSIETLHA-ANNNISRVSCSR 118

Query: 123 FNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLE 182
                   + L  N  +       G    +++L L  N + +    ++     ++   LE
Sbjct: 119 G--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDT----VNFAELAASSDTLE 172

Query: 183 YFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQL 242
           + +   N +                            +  ++       L+ L L  N+L
Sbjct: 173 HLNLQYNFI--------------------------YDVKGQV-VFAK--LKTLDLSSNKL 203

Query: 243 EGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKD 302
              +  +    A +  + L  NKL   +        NL    L  N         +  K+
Sbjct: 204 A-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKN 261

Query: 303 ILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQ 352
                ++       L  +      +  L      + C         + + 
Sbjct: 262 QRVQTVAKQTVKK-LTGQNEEECTVPTL-GHYGAYCCEDLPAPFADRLIA 309

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 89.7 bits (223), Expect = 1e-19
 Identities = 40/246 (16%), Positives = 82/246 (33%), Gaps = 30/246 (12%)

Query: 1   MPSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAF 60
           + +L    L    + +L    S++TL+ + N          +  +          + +  
Sbjct: 79  LSTLRTLDLNNNYVQELLVGPSIETLHAANNN---------ISRVS--CSRGQGKKNIYL 127

Query: 61  SFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPS 120
           + NK+  +        S ++ L L  N +     +        L+ L+L   NFI  +  
Sbjct: 128 ANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL-QYNFIYDVKG 186

Query: 121 FIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKY 180
            +   +KL  L L  N  +  +   F +   + W+ L +N L      L    +      
Sbjct: 187 QVVF-AKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQN------ 238

Query: 181 LEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGN 240
           LE+F    N               ++ DF+  N  +     + +  LT    +  ++   
Sbjct: 239 LEHFDLRGNGFHCG----------TLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTL 288

Query: 241 QLEGSI 246
              G+ 
Sbjct: 289 GHYGAY 294

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  141 bits (356), Expect = 6e-37
 Identities = 45/189 (23%), Positives = 74/189 (39%), Gaps = 18/189 (9%)

Query: 518 NLIGRGGFGPVYK---DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
             IG+G +G V+     G +VA+KVF      ++   + E      +RH N++  I++  
Sbjct: 43  KQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWF-RETEIYQTVLMRHENILGFIAADI 101

Query: 575 NDDFK----ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH-----FGY 625
                     L+ +Y   GSL   L   +  LD    L +     S L +LH        
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYLK--STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQG 159

Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA--TIGYMAPDEIF 683
              I H DLK  N+L+  N    ++D G+A   + +   +         T  YM P E+ 
Sbjct: 160 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP-EVL 218

Query: 684 SGEMRLKCW 692
              +    +
Sbjct: 219 DESLNRNHF 227

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  143 bits (362), Expect = 2e-36
 Identities = 52/401 (12%), Positives = 113/401 (28%), Gaps = 34/401 (8%)

Query: 18  GNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVS 77
            N +  +   ++ +    S+       +     +  N++ +  S N +  +    +   +
Sbjct: 7   QNGNRYKIEKVTDS----SLKQA----LASLRQSAWNVKELDLSGNPLSQISAADLAPFT 58

Query: 78  TLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNS 137
            L+ L L SN L           L  L+ L L  NN++  +         +  L    N+
Sbjct: 59  KLELLNLSSNVLYE-TLDLES--LSTLRTLDL-NNNYVQELL----VGPSIETLHAANNN 110

Query: 138 FSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPR 197
            S  +       +  K + L +N +T                 ++Y     N +  +   
Sbjct: 111 IS-RVS--CSRGQGKKNIYLANNKITMLRDL-----DEGCRSRVQYLDLKLNEIDTVNFA 162

Query: 198 AIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALF 257
            +   S ++E   +    I   +  ++       L+ L L  N+L   +  +    A + 
Sbjct: 163 ELAASSDTLEHLNLQYNFIY-DVKGQV-VFAK--LKTLDLSSNKLA-FMGPEFQSAAGVT 217

Query: 258 QLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPL 317
            + L  NKL   +        NL    L  N         +  K+     ++        
Sbjct: 218 WISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLT 276

Query: 318 PLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGS----IPNSIGDLI 373
                   V             +       L  L+         QGS    +     +  
Sbjct: 277 GQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQA 336

Query: 374 SLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIP 414
             + ++         I     +      +      L+ ++ 
Sbjct: 337 RQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVS 377

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  136 bits (345), Expect = 2e-34
 Identities = 49/319 (15%), Positives = 104/319 (32%), Gaps = 25/319 (7%)

Query: 141 SIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIG 200
           +I     N    K   + D+ L  +   L       +   ++    S NPL  I    + 
Sbjct: 1   AIHEIKQNGNRYKIEKVTDSSLKQALASL-----RQSAWNVKELDLSGNPLSQISAADLA 55

Query: 201 NLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLD 260
             +  +E   + +  +      ++ +L+   L+ L L  N ++     +L    ++  L 
Sbjct: 56  PFT-KLELLNLSSNVLYE--TLDLESLST--LRTLDLNNNYVQ-----ELLVGPSIETLH 105

Query: 261 LGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPS-TLWNLKDILHLNLSSNFFTG-PLP 318
              N +S             + +YL +N +T +          + +L+L  N        
Sbjct: 106 AANNNISRVSC---SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA 162

Query: 319 LKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSL 378
               + + L  L+L  N     +  ++     L+ L L  N+L   +         +  +
Sbjct: 163 ELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWI 219

Query: 379 NLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMPN 438
           +L NN L   I  +L    +L+  ++  N       R+   +N   ++      +  +  
Sbjct: 220 SLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQT-VKKLTG 277

Query: 439 LQVLSCRTKIHHTLGKNDL 457
                C        G    
Sbjct: 278 QNEEECTVPTLGHYGAYCC 296

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  136 bits (343), Expect = 5e-34
 Identities = 56/395 (14%), Positives = 123/395 (31%), Gaps = 40/395 (10%)

Query: 45  IPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNL 104
           I     N +  +    + + +   + +   +   +K L L  N LS ++ ++       L
Sbjct: 2   IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLS-QISAADLAPFTKL 60

Query: 105 KELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTS 164
           + L+L  +N +        + S L  L L  N              +++ L   +N ++ 
Sbjct: 61  ELLNL-SSNVLYETLDL-ESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR 113

Query: 165 STPE-LSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISG-SIPE 222
            +        ++           +NN +  +     G  S  ++   +    I   +  E
Sbjct: 114 VSCSRGQGKKNI---------YLANNKITMLRDLDEGCRS-RVQYLDLKLNEIDTVNFAE 163

Query: 223 EINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRK 282
              +     L+ L+L+ N +   +   +   A L  LDL  NKL+ F+     +   +  
Sbjct: 164 LAASSDT--LEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTW 218

Query: 283 LYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIP 342
           + L +N L  I   L   +++ H +L  N F     L+           ++      +  
Sbjct: 219 ISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHC-GTLRDFFSKNQRVQTVAKQTVKKLTG 277

Query: 343 TKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSG----TIPISLEKLLD 398
                              +         LI+LK    +  +  G     +    E    
Sbjct: 278 QNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQAR 337

Query: 399 LKDINVSFNRLEGEIPREGPFRNLSAESFKGNELL 433
            ++I+    +           R +  +     +  
Sbjct: 338 QREIDALKEQY----------RTVIDQVTLRKQAK 362

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score =  119 bits (300), Expect = 1e-28
 Identities = 61/426 (14%), Positives = 117/426 (27%), Gaps = 40/426 (9%)

Query: 14  LSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTI 73
           + +L    S++TL+ + N          +  +          + +  + NK+  +     
Sbjct: 92  VQELLVGPSIETLHAANNN---------ISRVS--CSRGQGKKNIYLANNKITMLRDLDE 140

Query: 74  FNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGL 133
              S ++ L L  N +     +        L+ L+L   NFI  +   +   +KL  L L
Sbjct: 141 GCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL-QYNFIYDVKGQVVF-AKLKTLDL 198

Query: 134 QKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGG 193
             N  +  +   F +   + W+ L +N L      L    +      LE+F    N    
Sbjct: 199 SSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKALRFSQN------LEHFDLRGNGFHC 251

Query: 194 ILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRL 253
              R   + +Q ++            +  +      +   L        E        RL
Sbjct: 252 GTLRDFFSKNQRVQTV---AKQTVKKLTGQNEEECTV-PTLGHYGAYCCEDLPAPFADRL 307

Query: 254 AALFQLDLGGNKLSG----FVPACSGNLTNLRKLYLGSNLLTSIPSTLW-NLKDILHLNL 308
            AL + +       G     +     N    R++        ++   +    +  + L  
Sbjct: 308 IALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQ 367

Query: 309 SSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNS 368
                   +         L                   G  +LQ+   E + LQ      
Sbjct: 368 KKKALDEQVSNGRRAHAELDGTLQQAV-----------GQIELQHATEEQSPLQLLRAIV 416

Query: 369 IGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFK 428
                         NN      +   K   L + N    +L GE        N + +   
Sbjct: 417 KRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLALASANATLQELV 476

Query: 429 GNELLC 434
             E   
Sbjct: 477 VREQNL 482

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  136 bits (344), Expect = 2e-35
 Identities = 49/189 (25%), Positives = 84/189 (44%), Gaps = 18/189 (9%)

Query: 518 NLIGRGGFGPVYK---DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
             IG+G FG V++    G EVA+K+F+ +   ++   + E      +RH N++  I++ +
Sbjct: 48  ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADN 106

Query: 575 NDDFKA----LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH-----FGY 625
            D+       LV +Y   GSL   L    Y + +   + + +  AS L +LH        
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQG 164

Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA--TIGYMAPDEIF 683
              I H DLK  N+L+  N    ++D G+A        ++         T  YMAP E+ 
Sbjct: 165 KPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP-EVL 223

Query: 684 SGEMRLKCW 692
              + +K +
Sbjct: 224 DDSINMKHF 232

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  136 bits (343), Expect = 3e-34
 Identities = 88/393 (22%), Positives = 151/393 (38%), Gaps = 41/393 (10%)

Query: 20  PSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIF-NVST 78
           P+ +  + LS N  +  +              L +++++         V+    F  +S+
Sbjct: 29  PAHVNYVDLSLNSIA-ELN-------ETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS 80

Query: 79  LKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGT-IPSFIF-NASKLSELGLQKN 136
           L  L L  N    +L + A   L NL+ L L   N  G  +    F   + L  L L+ N
Sbjct: 81  LIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDN 139

Query: 137 SFSGSIPNT-FGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGIL 195
           +     P + F N+R    L L  N + S   E   L +    K+      S+  L  + 
Sbjct: 140 NIKKIQPASFFLNMRRFHVLDLTFNKVKSICEE--DLLNFQG-KHFTLLRLSSITLQDMN 196

Query: 196 PRAIGNLS-------QSMEDFWMDNCNISGSIPEEINNLTNLI-LQLLSLEGNQLEG--- 244
              +G           S+    +       S+ +   +      +Q L L  +   G   
Sbjct: 197 EYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF 256

Query: 245 ------SIPDDLCR---LAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPS 295
                    +   +    + +   DL  +K+   + +   + T+L +L L  N +  I  
Sbjct: 257 GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDD 316

Query: 296 -TLWNLKDILHLNLSSNFFTGPLPLKI-GNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQY 353
              W L  +L LNLS NF    +  ++  NL+ L  LDLS N+   +      GL +L+ 
Sbjct: 317 NAFWGLTHLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKE 375

Query: 354 LFLEYNRLQGSIPNSIGD-LISLKSLNLSNNNL 385
           L L+ N+L+ S+P+ I D L SL+ + L  N  
Sbjct: 376 LALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score =  132 bits (333), Expect = 5e-33
 Identities = 71/403 (17%), Positives = 142/403 (35%), Gaps = 52/403 (12%)

Query: 36  SIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPS 95
            +P      +P  ++ +        S N +  +  T+   +  L+ L +   +    + +
Sbjct: 24  QVPE-----LPAHVNYVD------LSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRN 72

Query: 96  SADVRLPNLKELHLWGNNFIGTIPSFIFNA-SKLSELGLQKNSFSGSI--PNTFGNLRNL 152
           +    L +L  L L  N     + +  FN  + L  L L + +  G++   N F  L +L
Sbjct: 73  NTFRGLSSLIILKLDYNQ-FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSL 131

Query: 153 KWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLS--------- 203
           + L L DN +    P  S   ++           + N +  I    + N           
Sbjct: 132 EMLVLRDNNIKKIQPA-SFFLNMRR---FHVLDLTFNKVKSICEEDLLNFQGKHFTLLRL 187

Query: 204 QSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQL---- 259
            S+    M+   +           T+  +  L L GN  + S+        A  ++    
Sbjct: 188 SSITLQDMNEYWLGWEKCGNPFKNTS--ITTLDLSGNGFKESMAKRFFDAIAGTKIQSLI 245

Query: 260 ---------DLGGNKLSGFVPACSGNL--TNLRKLYLGSNLLTSIPSTLW-NLKDILHLN 307
                      G              L  + ++   L  + + ++  +++ +  D+  L 
Sbjct: 246 LSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLT 305

Query: 308 LSSNFFTGPLPLKI-GNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIP 366
           L+ N     +       L  L++L+LS N    +       L  L+ L L YN ++ ++ 
Sbjct: 306 LAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALG 363

Query: 367 NSIGD-LISLKSLNLSNNNLSGTIPIS-LEKLLDLKDINVSFN 407
           +     L +LK L L  N L  ++P    ++L  L+ I +  N
Sbjct: 364 DQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 72.1 bits (177), Expect = 2e-13
 Identities = 44/219 (20%), Positives = 75/219 (34%), Gaps = 16/219 (7%)

Query: 3   SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILC-----EIPHEIDNLHNMEW 57
            +   +L           +S+ TL LS N    S+           +I   I +      
Sbjct: 194 DMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMG 253

Query: 58  MAFSFNKVVGVVPTTIFN--VSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFI 115
            +F           T      S +K+  L  + +   L  S      +L++L L  N  I
Sbjct: 254 SSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNE-I 311

Query: 116 GTIPSFIF-NASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSS 174
             I    F   + L +L L +N         F NL  L+ L L+ N++ +   +  S   
Sbjct: 312 NKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQ--SFLG 369

Query: 175 LSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDN 213
           L N   L+  +   N L  +       L+ S++  W+  
Sbjct: 370 LPN---LKELALDTNQLKSVPDGIFDRLT-SLQKIWLHT 404

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  131 bits (331), Expect = 7e-34
 Identities = 47/184 (25%), Positives = 82/184 (44%), Gaps = 21/184 (11%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G+G FG   K      G  + +K          ++F  E  +M+ + H N++K I    
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77

Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDL 634
            D     + EY+  G+L   + S +      Q ++   D+AS + YLH   S+ IIH DL
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDL 134

Query: 635 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA------------TIGYMAPDEI 682
              N L+ +N    ++DFG+A+ +++E       ++L                +MAP E+
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP-EM 193

Query: 683 FSGE 686
            +G 
Sbjct: 194 INGR 197

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  130 bits (328), Expect = 3e-33
 Identities = 71/320 (22%), Positives = 117/320 (36%), Gaps = 41/320 (12%)

Query: 69  VPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIF-NASK 127
           VP  +        L L +N ++  +       L NL  L L  N  I  I    F    K
Sbjct: 46  VPKDLP--PDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNK-ISKISPGAFAPLVK 101

Query: 128 LSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFS 187
           L  L L KN     +P      + L+ L +++N +T      S  + L+    +      
Sbjct: 102 LERLYLSKNQLK-ELPE--KMPKTLQELRVHENEITKVRK--SVFNGLNQ---MIVVELG 153

Query: 188 NNPL--GGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGS 245
            NPL   GI   A   +   +    + + NI+ +IP+      +L    L L+GN++   
Sbjct: 154 TNPLKSSGIENGAFQGMK-KLSYIRIADTNIT-TIPQ--GLPPSL--TELHLDGNKITKV 207

Query: 246 IPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILH 305
               L  L  L +L L  N +S        N  +LR+L+L +N L  +P  L + K I  
Sbjct: 208 DAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQV 267

Query: 306 LNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSI 365
           + L +N  +                 +  N+F    P           + L  N +Q   
Sbjct: 268 VYLHNNNIS----------------AIGSNDFC--PPGYNTKKASYSGVSLFSNPVQYWE 309

Query: 366 --PNSIGDLISLKSLNLSNN 383
             P++   +    ++ L N 
Sbjct: 310 IQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  123 bits (312), Expect = 4e-31
 Identities = 66/344 (19%), Positives = 118/344 (34%), Gaps = 60/344 (17%)

Query: 79  LKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIF-NASKLSELGLQKNS 137
           L+ +      L  ++P       P+   L L  NN I  I    F N   L  L L  N 
Sbjct: 33  LRVVQCSDLGLE-KVPKDLP---PDTALLDL-QNNKITEIKDGDFKNLKNLHTLILINNK 87

Query: 138 FSGSIPNTFGNLRNLKWLGLNDNYLTSSTPEL-SSLSSLSNCKYLEYFSFSNNPLGGILP 196
            S   P  F  L  L+ L L+ N L     ++  +L  L             N +  +  
Sbjct: 88  ISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELR---------VHENEITKVRK 138

Query: 197 RAIGNLSQSMEDFWMDNCNI-SGSIPEEI-NNLTNLILQLLSLEGNQLEGSIPDDLCRLA 254
                L+Q M    +    + S  I       +  L    + +    +  +IP  L    
Sbjct: 139 SVFNGLNQ-MIVVELGTNPLKSSGIENGAFQGMKKL--SYIRIADTNIT-TIPQGL--PP 192

Query: 255 ALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPS-TLWNLKDILHLNLSSNFF 313
           +L +L L GNK++    A    L NL KL L  N ++++ + +L N   +  L+L++N  
Sbjct: 193 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 252

Query: 314 TGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNS----- 368
                                      +P  +   K +Q ++L  N +  +I ++     
Sbjct: 253 V-------------------------KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPP 286

Query: 369 --IGDLISLKSLNLSNNNLSGTI--PISLEKLLDLKDINVSFNR 408
                  S   ++L +N +      P +   +     + +   +
Sbjct: 287 GYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score =  115 bits (290), Expect = 3e-28
 Identities = 60/344 (17%), Positives = 114/344 (33%), Gaps = 79/344 (22%)

Query: 103 NLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYL 162
           +L+ +          +P  +      + L LQ N  +      F NL+NL  L L +N +
Sbjct: 32  HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88

Query: 163 TSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPE 222
           +                              I P A   L +                  
Sbjct: 89  SK-----------------------------ISPGAFAPLVK------------------ 101

Query: 223 EINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRK 282
                    L+ L L  NQL+  +P+ +     L +L +  N+++    +    L  +  
Sbjct: 102 ---------LERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIV 149

Query: 283 LYLGSNLLTSI---PSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSC 339
           + LG+N L S          +K + ++ ++    T    +  G    L +L L  N  + 
Sbjct: 150 VELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT---IPQGLPPSLTELHLDGNKITK 206

Query: 340 VIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDL 399
           V    + GL +L  L L +N +      S+ +   L+ L+L+NN L   +P  L     +
Sbjct: 207 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYI 265

Query: 400 KDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMPNLQVLS 443
           + + +  N +            + +  F          +   +S
Sbjct: 266 QVVYLHNNNI----------SAIGSNDFCPPGYNTKKASYSGVS 299

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 89.3 bits (222), Expect = 2e-19
 Identities = 49/251 (19%), Positives = 85/251 (33%), Gaps = 45/251 (17%)

Query: 20  PSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNK--VVGVVPTTIFNVS 77
           P +LQ L +  N  +  +   +        + L+ M  +    N     G+       + 
Sbjct: 120 PKTLQELRVHENEIT-KVRKSVF-------NGLNQMIVVELGTNPLKSSGIENGAFQGMK 171

Query: 78  TLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNA-SKLSELGLQKN 136
            L  + +   +++  +P       P+L ELHL GN  I  + +      + L++LGL  N
Sbjct: 172 KLSYIRIADTNIT-TIPQGL---PPSLTELHLDGNK-ITKVDAASLKGLNNLAKLGLSFN 226

Query: 137 SFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILP 196
           S S     +  N  +L+ L LN+N L      L+        KY++     NN +  I  
Sbjct: 227 SISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADH------KYIQVVYLHNNNISAIGS 280

Query: 197 RAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLE-GSIPDDLCR-LA 254
                                   P       +     +SL  N ++   I     R + 
Sbjct: 281 NDFCP-------------------PGYNTKKAS--YSGVSLFSNPVQYWEIQPSTFRCVY 319

Query: 255 ALFQLDLGGNK 265
               + LG  K
Sbjct: 320 VRAAVQLGNYK 330

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 69.3 bits (170), Expect = 8e-13
 Identities = 35/152 (23%), Positives = 61/152 (40%), Gaps = 20/152 (13%)

Query: 18  GNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVS 77
           G P SL  L+L  N  +  + +  L         L+N+  +  SFN +  V   ++ N  
Sbjct: 189 GLPPSLTELHLDGNKIT-KVDAASL-------KGLNNLAKLGLSFNSISAVDNGSLANTP 240

Query: 78  TLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIF-------NASKLSE 130
            L+ L+L++N L  ++P         ++ ++L  NN I  I S  F         +  S 
Sbjct: 241 HLRELHLNNNKLV-KVPGGLAD-HKYIQVVYL-HNNNISAIGSNDFCPPGYNTKKASYSG 297

Query: 131 LGLQKNSFSGSI--PNTFGNLRNLKWLGLNDN 160
           + L  N        P+TF  +     + L + 
Sbjct: 298 VSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 48.8 bits (117), Expect = 3e-06
 Identities = 32/138 (23%), Positives = 55/138 (39%), Gaps = 20/138 (14%)

Query: 327 LVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLS 386
           L  +  S       +P  +    D   L L+ N++         +L +L +L L NN +S
Sbjct: 33  LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89

Query: 387 GTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNEL-------LCGMPNL 439
              P +   L+ L+ + +S N+L+ E+P E   + L       NE+         G+  +
Sbjct: 90  KISPGAFAPLVKLERLYLSKNQLK-ELP-EKMPKTLQELRVHENEITKVRKSVFNGLNQM 147

Query: 440 QVLSCRTKIHHTLGKNDL 457
            V+         LG N L
Sbjct: 148 IVVE--------LGTNPL 157

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  124 bits (314), Expect = 1e-31
 Identities = 61/276 (22%), Positives = 94/276 (34%), Gaps = 40/276 (14%)

Query: 69  VPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNF-IGTIPSFIF-NAS 126
           VPT I   S+   L L SN L   LP     +L  L +L L  N        S      +
Sbjct: 22  VPTGIP--SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78

Query: 127 KLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSF 186
            L  L L  N    ++ + F  L  L+ L    + L      +S  S   + + L Y   
Sbjct: 79  SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQ----MSEFSVFLSLRNLIYLDI 133

Query: 187 SNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSI 246
           S+             LS                            L++L + GN  + + 
Sbjct: 134 SHTHTRVAFNGIFNGLSS---------------------------LEVLKMAGNSFQENF 166

Query: 247 PDD-LCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPS-TLWNLKDIL 304
             D    L  L  LDL   +L    P    +L++L+ L +  N   S+ +     L  + 
Sbjct: 167 LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQ 226

Query: 305 HLNLSSNFFTG-PLPLKIGNLNVLVQLDLSMNNFSC 339
            L+ S N              + L  L+L+ N+F+C
Sbjct: 227 VLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFAC 262

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  111 bits (279), Expect = 5e-27
 Identities = 57/290 (19%), Positives = 92/290 (31%), Gaps = 42/290 (14%)

Query: 103 NLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYL 162
           +  E+         ++P+ I   S  + L L+ N         F  L  L  L L+ N L
Sbjct: 8   SGTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGL 64

Query: 163 TSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPE 222
           +       S    ++   L+Y   S N +   +      L   +E     + N+   + E
Sbjct: 65  SFKGCCSQSDFGTTS---LKYLDLSFNGV-ITMSSNFLGLE-QLEHLDFQHSNLK-QMSE 118

Query: 223 E--INNLTNLILQLLSLEGNQLEGSIPDDLCR-LAALFQLDLGGNKLSGFVPACS-GNLT 278
                +L N  L  L +          + +   L++L  L + GN             L 
Sbjct: 119 FSVFLSLRN--LIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELR 175

Query: 279 NLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFS 338
           NL  L L    L  +                   F          L+ L  L++S NNF 
Sbjct: 176 NLTFLDLSQCQLEQLS---------------PTAFNS--------LSSLQVLNMSHNNFF 212

Query: 339 CVIPTKIGGLKDLQYLFLEYNRLQGSIPNSI--GDLISLKSLNLSNNNLS 386
            +       L  LQ L    N +  +           SL  LNL+ N+ +
Sbjct: 213 SLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score =  108 bits (271), Expect = 5e-26
 Identities = 49/235 (20%), Positives = 82/235 (34%), Gaps = 10/235 (4%)

Query: 181 LEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNIS--GSIPEEINNLTNLILQLLSLE 238
                  +N L  +       L+Q +    + +  +S  G   +     T+L  + L L 
Sbjct: 30  ATRLELESNKLQSLPHGVFDKLTQ-LTKLSLSSNGLSFKGCCSQSDFGTTSL--KYLDLS 86

Query: 239 GNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACS-GNLTNLRKLYLGSNLLTSIPS-T 296
            N +  ++  +   L  L  LD   + L          +L NL  L +         +  
Sbjct: 87  FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 145

Query: 297 LWNLKDILHLNLSSN-FFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLF 355
              L  +  L ++ N F    LP     L  L  LDLS      + PT    L  LQ L 
Sbjct: 146 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 205

Query: 356 LEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLD-LKDINVSFNRL 409
           + +N            L SL+ L+ S N++  +    L+     L  +N++ N  
Sbjct: 206 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 95.5 bits (238), Expect = 1e-21
 Identities = 52/244 (21%), Positives = 96/244 (39%), Gaps = 21/244 (8%)

Query: 3   SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSF 62
            L ++ L+ +        + L  L LS N     +     C          +++++  SF
Sbjct: 34  ELESNKLQSLPHGVFDKLTQLTKLSLSSN----GLSFKGCC--SQSDFGTTSLKYLDLSF 87

Query: 63  NKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFI 122
           N V+  + +    +  L+ L    ++L      S  + L NL  L +  +       + I
Sbjct: 88  NGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI-SHTHTRVAFNGI 145

Query: 123 F-NASKLSELGLQKNSFSGSI-PNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKY 180
           F   S L  L +  NSF  +  P+ F  LRNL +L L+   L   +P   + +SLS+   
Sbjct: 146 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT--AFNSLSS--- 200

Query: 181 LEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLI--LQLLSLE 238
           L+  + S+N    +       L+ S++       +I  +  ++   L +    L  L+L 
Sbjct: 201 LQVLNMSHNNFFSLDTFPYKCLN-SLQVLDYSLNHIM-TSKKQE--LQHFPSSLAFLNLT 256

Query: 239 GNQL 242
            N  
Sbjct: 257 QNDF 260

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 77.7 bits (192), Expect = 1e-15
 Identities = 39/170 (22%), Positives = 70/170 (41%), Gaps = 9/170 (5%)

Query: 258 QLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPS-TLWNLKDILHLNLSSNFFT-- 314
           ++      L+  VP  +G  ++  +L L SN L S+P      L  +  L+LSSN  +  
Sbjct: 11  EIRCNSKGLTS-VP--TGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK 67

Query: 315 GPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSI-GDLI 373
           G           L  LDLS N     + +   GL+ L++L  +++ L+     S+   L 
Sbjct: 68  GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 126

Query: 374 SLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLS 423
           +L  L++S+ +           L  L+ + ++ N  +        F  L 
Sbjct: 127 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFL-PDIFTELR 175

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  124 bits (314), Expect = 2e-31
 Identities = 71/345 (20%), Positives = 126/345 (36%), Gaps = 62/345 (17%)

Query: 42  LCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRL 101
           L  +P EI    +   +    N +  +       +  L +L L +N +S ++   A   L
Sbjct: 45  LKAVPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPL 101

Query: 102 PNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNY 161
             L++L++  N+ +  IP  +   S L EL +  N         F  LRN+  + +  N 
Sbjct: 102 RKLQKLYISKNH-LVEIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNP 158

Query: 162 LTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIP 221
           L +S  E  +   L     L Y   S   L GI       L++                 
Sbjct: 159 LENSGFEPGAFDGLK----LNYLRISEAKLTGIPKDLPETLNE----------------- 197

Query: 222 EEINNLTNLILQLLSLEGNQLEGSIPD-DLCRLAALFQLDLGGNKLSGFVPACSGNLTNL 280
                        L L+ N+++ +I   DL R + L++L LG N++          L  L
Sbjct: 198 -------------LHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTL 243

Query: 281 RKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCV 340
           R+L+L +N L+ +P+ L +LK +  + L +N  T                 + +N+F  V
Sbjct: 244 RELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNIT----------------KVGVNDFCPV 287

Query: 341 IPTKIGGLKDLQYLFLEYNRLQGSI--PNSIGDLISLKSLNLSNN 383
                        + L  N +      P +   +    ++   N 
Sbjct: 288 GFG--VKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score =  120 bits (302), Expect = 8e-30
 Identities = 64/330 (19%), Positives = 117/330 (35%), Gaps = 52/330 (15%)

Query: 103 NLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYL 162
           +L+ +          +P  I      + L LQ N  S    + F  L++L  L L +N +
Sbjct: 34  HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90

Query: 163 TSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPE 222
           +    +  + S L     L+    S N L  I P    NL  S+ +  + +  I   +P+
Sbjct: 91  SKIHEK--AFSPLRK---LQKLYISKNHLVEIPP----NLPSSLVELRIHDNRIR-KVPK 140

Query: 223 EI-NNLTNLILQLLSLEGNQL-EGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNL 280
            + + L N+    + + GN L              L  L +   KL+G           L
Sbjct: 141 GVFSGLRNM--NCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTGI---PKDLPETL 195

Query: 281 RKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCV 340
            +L+L  N + +I                               + L +L L  N    +
Sbjct: 196 NELHLDHNKIQAIEL---------------EDLLR--------YSKLYRLGLGHNQIRMI 232

Query: 341 IPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPIS-------L 393
               +  L  L+ L L+ N+L   +P  + DL  L+ + L  NN++  + ++        
Sbjct: 233 ENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFG 290

Query: 394 EKLLDLKDINVSFNRLEGEIPREGPFRNLS 423
            K      I++  N +     +   FR ++
Sbjct: 291 VKRAYYNGISLFNNPVPYWEVQPATFRCVT 320

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 65.0 bits (159), Expect = 2e-11
 Identities = 28/152 (18%), Positives = 57/152 (37%), Gaps = 20/152 (13%)

Query: 18  GNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVS 77
             P +L  L+L +N    +I    L            +  +    N++  +   ++  + 
Sbjct: 190 DLPETLNELHLDHNKIQ-AIELEDL-------LRYSKLYRLGLGHNQIRMIENGSLSFLP 241

Query: 78  TLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIF-------NASKLSE 130
           TL+ L+L +N LS R+P+     L  L+ ++L   N I  +    F         +  + 
Sbjct: 242 TLRELHLDNNKLS-RVPAGLP-DLKLLQVVYL-HTNNITKVGVNDFCPVGFGVKRAYYNG 298

Query: 131 LGLQKN--SFSGSIPNTFGNLRNLKWLGLNDN 160
           + L  N   +    P TF  + +   +   + 
Sbjct: 299 ISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 54.3 bits (131), Expect = 6e-08
 Identities = 37/201 (18%), Positives = 64/201 (31%), Gaps = 52/201 (25%)

Query: 243 EGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLT-NLRKLYLGSNLLTSIPSTLWNLK 301
           E S  +    +  L  L    +        C      +LR +      L ++P       
Sbjct: 3   EASGAETTSGIPDLDSLPPTYS------AMCPFGCHCHLRVVQCSDLGLKAVPK------ 50

Query: 302 DILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRL 361
                 +S +                  LDL  N+ S +      GL+ L  L L  N++
Sbjct: 51  -----EISPD---------------TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90

Query: 362 QGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRN 421
                 +   L  L+ L +S N+L   IP +L     L ++ +  NR+          R 
Sbjct: 91  SKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRI----------RK 137

Query: 422 LSAESFKGNELLCGMPNLQVL 442
           +    F       G+ N+  +
Sbjct: 138 VPKGVFS------GLRNMNCI 152

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  123 bits (311), Expect = 3e-30
 Identities = 66/267 (24%), Positives = 107/267 (40%), Gaps = 20/267 (7%)

Query: 77  STLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIF-NASKLSELGLQK 135
           +    +      LS  +P        N + L+L   N I  I +  F +   L  L L +
Sbjct: 54  NQFSKVVCTRRGLS-EVPQGIP---SNTRYLNL-MENNIQMIQADTFRHLHHLEVLQLGR 108

Query: 136 NSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGIL 195
           NS        F  L +L  L L DN+LT       +   LS    L      NNP+  I 
Sbjct: 109 NSIRQIEVGAFNGLASLNTLELFDNWLTVIPSG--AFEYLSK---LRELWLRNNPIESIP 163

Query: 196 PRAIGNLSQSMEDFWMDNCNISGSIPEEI-NNLTNLILQLLSLEGNQLEGSIPDDLCRLA 254
             A   +   +    +        I E     L NL  + L+L    ++  +P+ L  L 
Sbjct: 164 SYAFNRVPS-LMRLDLGELKKLEYISEGAFEGLFNL--KYLNLGMCNIK-DMPN-LTPLV 218

Query: 255 ALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPS-TLWNLKDILHLNLSSNFF 313
            L +L++ GN      P     L++L+KL++ ++ ++ I       L  ++ LNL+ N  
Sbjct: 219 GLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNL 278

Query: 314 TGPLPLKI-GNLNVLVQLDLSMNNFSC 339
           +  LP  +   L  LV+L L  N ++C
Sbjct: 279 SS-LPHDLFTPLRYLVELHLHHNPWNC 304

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  117 bits (295), Expect = 4e-28
 Identities = 67/286 (23%), Positives = 102/286 (35%), Gaps = 39/286 (13%)

Query: 102 PNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNY 161
               ++          +P  I   S    L L +N+      +TF +L +L+ L L  N 
Sbjct: 54  NQFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110

Query: 162 LTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIP 221
           +        + + L++   L      +N L  I   A   LS+                 
Sbjct: 111 IRQIEVG--AFNGLAS---LNTLELFDNWLTVIPSGAFEYLSK----------------- 148

Query: 222 EEINNLTNLILQLLSLEGNQLEGSIPDD-LCRLAALFQLDLGG-NKLSGFVPACSGNLTN 279
                     L+ L L  N +E SIP     R+ +L +LDLG   KL          L N
Sbjct: 149 ----------LRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFN 197

Query: 280 LRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSC 339
           L+ L LG   +  +P  L  L  +  L +S N F    P     L+ L +L +  +  S 
Sbjct: 198 LKYLNLGMCNIKDMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSL 256

Query: 340 VIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNL 385
           +      GL  L  L L +N L     +    L  L  L+L +N  
Sbjct: 257 IERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  110 bits (278), Expect = 6e-26
 Identities = 71/249 (28%), Positives = 105/249 (42%), Gaps = 26/249 (10%)

Query: 20  PSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTL 79
           PS+ + L L  N     I +           +LH++E +    N +  +       +++L
Sbjct: 74  PSNTRYLNLMENNIQ-MIQADTF-------RHLHHLEVLQLGRNSIRQIEVGAFNGLASL 125

Query: 80  KSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNA-SKLSELGLQKNSF 138
            +L L  N L+  +PS A   L  L+EL L  NN I +IPS+ FN    L  L L +   
Sbjct: 126 NTLELFDNWLT-VIPSGAFEYLSKLRELWL-RNNPIESIPSYAFNRVPSLMRLDLGELKK 183

Query: 139 SGSIP-NTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPR 197
              I    F  L NLK+L L           +  + +L+    LE    S N    I P 
Sbjct: 184 LEYISEGAFEGLFNLKYLNLGMC-------NIKDMPNLTPLVGLEELEMSGNHFPEIRPG 236

Query: 198 AIGNLSQSMEDFWMDNCNISGSIPEE-INNLTNLILQLLSLEGNQLEGSIPDDLCR-LAA 255
           +   LS S++  W+ N  +S  I     + L +  L  L+L  N L  S+P DL   L  
Sbjct: 237 SFHGLS-SLKKLWVMNSQVS-LIERNAFDGLAS--LVELNLAHNNLS-SLPHDLFTPLRY 291

Query: 256 LFQLDLGGN 264
           L +L L  N
Sbjct: 292 LVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score =  105 bits (265), Expect = 3e-24
 Identities = 53/208 (25%), Positives = 84/208 (40%), Gaps = 10/208 (4%)

Query: 219 SIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLT 278
            +P+ I + T    + L+L  N ++    D    L  L  L LG N +          L 
Sbjct: 68  EVPQGIPSNT----RYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLA 123

Query: 279 NLRKLYLGSNLLTSIPS-TLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNF 337
           +L  L L  N LT IPS     L  +  L L +N            +  L++LDL     
Sbjct: 124 SLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKK 183

Query: 338 SCVIPTKI-GGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKL 396
              I      GL +L+YL L    ++  +P ++  L+ L+ L +S N+     P S   L
Sbjct: 184 LEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGL 241

Query: 397 LDLKDINVSFNRLEGEIPREGPFRNLSA 424
             LK + V  +++   I     F  L++
Sbjct: 242 SSLKKLWVMNSQVS-LIE-RNAFDGLAS 267

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 78.6 bits (194), Expect = 2e-15
 Identities = 39/226 (17%), Positives = 73/226 (32%), Gaps = 39/226 (17%)

Query: 3   SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSF 62
           +L  + ++ I      +   L+ L L  N     I            + L ++  +    
Sbjct: 81  NLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAF-------NGLASLNTLELFD 132

Query: 63  NKVVGVVPTTIFNVSTLKSLYLHSNSLS------------------------GRLPSSAD 98
           N +  +       +S L+ L+L +N +                           +   A 
Sbjct: 133 NWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAF 192

Query: 99  VRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLN 158
             L NLK L+L   N I  +P+       L EL +  N F    P +F  L +LK L + 
Sbjct: 193 EGLFNLKYLNLGMCN-IKDMPNLT-PLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVM 250

Query: 159 DNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQ 204
           ++ ++          +      L   + ++N L  +       L  
Sbjct: 251 NSQVSLIERN-----AFDGLASLVELNLAHNNLSSLPHDLFTPLRY 291

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  124 bits (312), Expect = 3e-30
 Identities = 63/377 (16%), Positives = 124/377 (32%), Gaps = 50/377 (13%)

Query: 70  PTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLS 129
             +   ++TL SL  H++S++  +       L  L +L    NN I T+   +   + L+
Sbjct: 35  TISEEQLATLTSLDCHNSSITD-MTGIEK--LTGLTKLICTSNN-ITTLD--LSQNTNLT 88

Query: 130 ELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLT----SSTPELSSLS---------SLS 176
            L    N  + ++      L  L +L  + N LT    S  P L+ L+          +S
Sbjct: 89  YLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKLDVSQNPLLTYLNCARNTLTEIDVS 145

Query: 177 NCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLS 236
           +   L       N     L   +   +  +         I+     +++      L  L+
Sbjct: 146 HNTQLTELDCHLNKKITKLD--VTPQT-QLTTLDCSFNKITEL---DVSQNKL--LNRLN 197

Query: 237 LEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPST 296
            + N +   +  DL +   L  LD   NKL+         LT L       N LT +   
Sbjct: 198 CDTNNIT-KL--DLNQNIQLTFLDCSSNKLTEI---DVTPLTQLTYFDCSVNPLTELD-- 249

Query: 297 LWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFL 356
           +  L  +  L+           + + +   L+            +   +     L  L  
Sbjct: 250 VSTLSKLTTLHCIQTDLLE---IDLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDC 304

Query: 357 EYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPRE 416
           +   +   +   +     L  L L+N  L+  + +S      LK ++     ++ +    
Sbjct: 305 QAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELDVS--HNTKLKSLSCVNAHIQ-DFSSV 357

Query: 417 GPFRNLSAESFKGNELL 433
           G    L+       + +
Sbjct: 358 GKIPALNNNFEAEGQTI 374

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  119 bits (301), Expect = 7e-29
 Identities = 63/399 (15%), Positives = 125/399 (31%), Gaps = 57/399 (14%)

Query: 11  GIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVP 70
                     ++L +L    +          + ++   I+ L  +  +  + N +  +  
Sbjct: 32  ATDTISEEQLATLTSLDCHNSS---------ITDMT-GIEKLTGLTKLICTSNNITTL-- 79

Query: 71  TTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSE 130
             +   + L  L   SN L+  L  +    L  L  L+   N  +  +   +     L+ 
Sbjct: 80  -DLSQNTNLTYLACDSNKLT-NLDVT---PLTKLTYLNCDTNK-LTKLD--VSQNPLLTY 131

Query: 131 LGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNP 190
           L   +N+ +  I     +   L  L  + N   +          ++    L     S N 
Sbjct: 132 LNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD-------VTPQTQLTTLDCSFNK 181

Query: 191 LGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDL 250
           +  +    +      +     D  NI+  +   +N      L  L    N+L   I  D+
Sbjct: 182 ITEL---DVSQNK-LLNRLNCDTNNIT-KLD--LNQNIQ--LTFLDCSSNKLT-EI--DV 229

Query: 251 CRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSS 310
             L  L   D   N L+         L+ L  L+     L  I   L +   +++     
Sbjct: 230 TPLTQLTYFDCSVNPLTEL---DVSTLSKLTTLHCIQTDLLEID--LTHNTQLIYFQAEG 284

Query: 311 NFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIG 370
                 L   + +   L  LD      + +    +     L YL+L    L   +   + 
Sbjct: 285 CRKIKELD--VTHNTQLYLLDCQAAGITEL---DLSQNPKLVYLYLNNTELT-ELD--VS 336

Query: 371 DLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRL 409
               LKSL+  N ++      S+ K+  L +   +  + 
Sbjct: 337 HNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQT 373

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score =  102 bits (255), Expect = 6e-23
 Identities = 65/404 (16%), Positives = 125/404 (30%), Gaps = 60/404 (14%)

Query: 3   SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSF 62
             T++ +  + LSQ  N   L  L    N          L  +   +  L  + ++    
Sbjct: 70  ICTSNNITTLDLSQNTN---LTYLACDSNK---------LTNLD--VTPLTKLTYLNCDT 115

Query: 63  NKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFI 122
           NK+  +    +     L  L    N+L+  +  S       L EL    N  I  +   +
Sbjct: 116 NKLTKL---DVSQNPLLTYLNCARNTLT-EIDVS---HNTQLTELDCHLNKKITKLD--V 166

Query: 123 FNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLT----SSTPELSSLS----- 173
              ++L+ L    N  +  +       + L  L  + N +T    +   +L+ L      
Sbjct: 167 TPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNITKLDLNQNIQLTFLDCSSNK 223

Query: 174 ----SLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTN 229
                ++    L YF  S NPL  +    +  L            ++      EI+   N
Sbjct: 224 LTEIDVTPLTQLTYFDCSVNPLTELDVSTLSKL----TTLHCIQTDLL-----EIDLTHN 274

Query: 230 LILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNL 289
             L     EG +    +  D+     L+ LD     ++            L  LYL +  
Sbjct: 275 TQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGITELDL---SQNPKLVYLYLNNTE 329

Query: 290 LTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLK 349
           LT +   + +   +  L+  +          +G +  L     +      +    +    
Sbjct: 330 LTELD--VSHNTKLKSLSCVNAHIQD-FSS-VGKIPALNNNFEAEGQTITMPKETLTNNS 385

Query: 350 DLQYLFLEYNRLQG---SIPNSIGDLISLKSLNLSNNNLSGTIP 390
               +  +     G   +I    G +    +  ++  NLS   P
Sbjct: 386 LTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNP 429

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 99.0 bits (247), Expect = 5e-22
 Identities = 53/327 (16%), Positives = 100/327 (30%), Gaps = 62/327 (18%)

Query: 122 IFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYL 181
            F     +           +   +   L  L  L  +++        ++ ++ +     L
Sbjct: 14  WFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNS-------SITDMTGIEKLTGL 66

Query: 182 EYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQ 241
                ++N +  +                            +++  TN  L  L+ + N+
Sbjct: 67  TKLICTSNNITTL----------------------------DLSQNTN--LTYLACDSNK 96

Query: 242 LEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLK 301
           L  ++   +  L  L  L+   NKL+            L  L    N LT I   + +  
Sbjct: 97  LT-NLD--VTPLTKLTYLNCDTNKLTKLDV---SQNPLLTYLNCARNTLTEID--VSHNT 148

Query: 302 DILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRL 361
            +  L+   N     L   +     L  LD S N  + +    +   K L  L  + N +
Sbjct: 149 QLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNI 203

Query: 362 QGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRN 421
              +   +   I L  L+ S+N L+  I ++   L  L   + S N L  E+        
Sbjct: 204 T-KLD--LNQNIQLTFLDCSSNKLT-EIDVT--PLTQLTYFDCSVNPLT-ELD-VSTLSK 255

Query: 422 LSAESFKGNEL----LCGMPNLQVLSC 444
           L+       +L    L     L     
Sbjct: 256 LTTLHCIQTDLLEIDLTHNTQLIYFQA 282

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 81.3 bits (201), Expect = 3e-16
 Identities = 43/218 (19%), Positives = 76/218 (34%), Gaps = 21/218 (9%)

Query: 232 LQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLT 291
                    +++ +      +LA L  LD   + ++         LT L KL   SN +T
Sbjct: 20  FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTG--IEKLTGLTKLICTSNNIT 77

Query: 292 SIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDL 351
           ++   L    ++ +L   SN  T    L +  L  L  L+   N  + +    +     L
Sbjct: 78  TLD--LSQNTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKLTKL---DVSQNPLL 129

Query: 352 QYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEG 411
            YL    N L   I   +     L  L+   N     + ++      L  ++ SFN++  
Sbjct: 130 TYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLDVT--PQTQLTTLDCSFNKIT- 183

Query: 412 EIPREGPFRNLSAESFKGNEL----LCGMPNLQVLSCR 445
           E+      + L+  +   N +    L     L  L C 
Sbjct: 184 ELD-VSQNKLLNRLNCDTNNITKLDLNQNIQLTFLDCS 220

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  122 bits (308), Expect = 2e-29
 Identities = 54/298 (18%), Positives = 98/298 (32%), Gaps = 38/298 (12%)

Query: 134 QKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGG 193
             +       + +         G N N   S   E      ++          +   L  
Sbjct: 21  TISGTYADYFSAWDKWEKQALPGENRNEAVSLLKE----CLINQ---FSELQLNRLNLS- 72

Query: 194 ILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRL 253
            LP  +      +    +    +  S+PE   +L  L         N+L  ++P+    L
Sbjct: 73  SLPDNLP---PQITVLEITQNALI-SLPELPASLEYLDAC-----DNRLS-TLPELPASL 122

Query: 254 AALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFF 313
                LD+  N+L+  +P        L  +   +N LT +P    +L+    L++ +N  
Sbjct: 123 K---HLDVDNNQLT-MLPEL---PALLEYINADNNQLTMLPELPTSLE---VLSVRNNQL 172

Query: 314 TGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQ----YLFLEYNRLQGSIPNSI 369
           T  LP    +L     LD+S N     +P         +    +     NR+   IP +I
Sbjct: 173 TF-LPELPESLE---ALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENI 226

Query: 370 GDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESF 427
             L    ++ L +N LS  I  SL +     D +           ++       A++ 
Sbjct: 227 LSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAV 284

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  114 bits (287), Expect = 1e-26
 Identities = 57/302 (18%), Positives = 104/302 (34%), Gaps = 37/302 (12%)

Query: 45  IPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNL 104
           I   I+N  ++   +F  N + G            +   L   + +  +    +  +   
Sbjct: 3   IMLPINNNFSLSQNSFY-NTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQF 61

Query: 105 KELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTS 164
            EL L     + ++P  +    +++ L + +N+   S+P    +L  L      DN L++
Sbjct: 62  SELQL-NRLNLSSLPDNLP--PQITVLEITQNALI-SLPELPASLEYLD---ACDNRLST 114

Query: 165 STPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEI 224
                +SL  L            NN L  +LP     L    E    DN  ++  +PE  
Sbjct: 115 LPELPASLKHLD---------VDNNQLT-MLPELPALL----EYINADNNQLT-MLPELP 159

Query: 225 NNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRK-- 282
            +L     ++LS+  NQL   +P+    L     LD+  N L   +PA      +  +  
Sbjct: 160 TSL-----EVLSVRNNQLT-FLPELPESLE---ALDVSTNLLES-LPAVPVRNHHSEETE 209

Query: 283 --LYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCV 340
                  N +T IP  + +L     + L  N  +  +   +               FS  
Sbjct: 210 IFFRCRENRITHIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMS 269

Query: 341 IP 342
             
Sbjct: 270 DG 271

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score =  103 bits (257), Expect = 5e-23
 Identities = 64/405 (15%), Positives = 113/405 (27%), Gaps = 91/405 (22%)

Query: 21  SSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLK 80
           +    L L+            L  +P  +                             + 
Sbjct: 59  NQFSELQLNRLN---------LSSLPDNL--------------------------PPQIT 83

Query: 81  SLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSG 140
            L +  N+L   LP        +L+ L    +N + T+P    +   L  L +  N  + 
Sbjct: 84  VLEITQNALI-SLPEL----PASLEYLDA-CDNRLSTLPELPAS---LKHLDVDNNQLT- 133

Query: 141 SIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIG 200
            +P     L    ++  ++N LT      +SL  L         S  NN L   LP    
Sbjct: 134 MLPELPALLE---YINADNNQLTMLPELPTSLEVL---------SVRNNQLTF-LPELPE 180

Query: 201 NLSQSMEDFWMDNCNISGSIPEEINNLTNL--ILQLLSLEGNQLEGSIPDDLCRLAALFQ 258
           +L    E   +    +  S+P       +            N++   IP+++  L     
Sbjct: 181 SL----EALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCT 234

Query: 259 LDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLP 318
           + L  N LS      S +    +  Y G  +  S+     N       +  + +F     
Sbjct: 235 IILEDNPLSSR-IRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQ 293

Query: 319 LKIGNLNVLVQLDLSMNNFSCV-------------------IPTKIGGLKDLQYLFLEYN 359
             +  +    + +   N FS                     +   +  L     L  +  
Sbjct: 294 SDVSQIWHAFEHEEHANTFSAFLDRLSDTVSARNTSGFREQVAAWLEKLSASAELRQQSF 353

Query: 360 RLQGSIPNSIGDLISLKSLNLSNNNL-----SGTIPISLEKLLDL 399
            +      S  D ++L   NL    L      G        LL L
Sbjct: 354 AVAADATESCEDRVALTWNNLRKTLLVHQASEGLFDNDTGALLSL 398

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 67.3 bits (164), Expect = 9e-12
 Identities = 34/267 (12%), Positives = 74/267 (27%), Gaps = 61/267 (22%)

Query: 20  PSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTL 79
           P+ L+ +    N          L  +P    +                           L
Sbjct: 139 PALLEYINADNNQ---------LTMLPELPTS---------------------------L 162

Query: 80  KSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSE----LGLQK 135
           + L + +N L+  LP        +L+ L +   N + ++P+         E       ++
Sbjct: 163 EVLSVRNNQLT-FLPEL----PESLEALDV-STNLLESLPAVPVRNHHSEETEIFFRCRE 216

Query: 136 NSFSGSIPNTFGNLRNLKWLGLNDNYLTSST-PELSSLSSLSNCKYLEYFSFSNNPLGGI 194
           N  +  IP    +L     + L DN L+S     LS  ++  +          + P    
Sbjct: 217 NRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPD---------YHGPRIYF 266

Query: 195 LPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLA 254
                   +               +   +++ + +        E      +  D L    
Sbjct: 267 SMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWH---AFEHEEHANTFSAFLDRLSDTV 323

Query: 255 ALFQLDLGGNKLSGFVPACSGNLTNLR 281
           +         +++ ++   S     LR
Sbjct: 324 SARNTSGFREQVAAWLEKLS-ASAELR 349

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  121 bits (306), Expect = 3e-29
 Identities = 77/404 (19%), Positives = 146/404 (36%), Gaps = 32/404 (7%)

Query: 21  SSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLK 80
            +L+ L LS+N    ++P      I  E  N+  ++++  S   +       I +++  K
Sbjct: 90  VNLKHLDLSFNAFD-ALP------ICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISK 142

Query: 81  SLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQ------ 134
            L +   +   +        L +     L           FI + S  +   L+      
Sbjct: 143 VLLVLGETYGEKEDPEG---LQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKC 199

Query: 135 ---KNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPL 191
               N  S  +        N K   L  N + ++      +  L     + YFS SN  L
Sbjct: 200 VLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKL 259

Query: 192 GGILPRAIGNLS-QSMEDFWMDNC--NISGSIPEEI-NNLTNLILQLLSLEGNQLEGSIP 247
            G L     + S  S++   +     ++ G     I    +N+   + +   +       
Sbjct: 260 QGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNM--NIKNFTVSGTRMVHM 317

Query: 248 DDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPST---LWNLKDIL 304
               +++    LD   N L+  V    G+LT L  L L  N L  +         +K + 
Sbjct: 318 LCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQ 377

Query: 305 HLNLSSNFFTGPLPLKI-GNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQG 363
            L++S N  +             L+ L++S N  +  I   +     ++ L L  N+++ 
Sbjct: 378 QLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK- 434

Query: 364 SIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFN 407
           SIP  +  L +L+ LN+++N L        ++L  L+ I +  N
Sbjct: 435 SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  119 bits (301), Expect = 1e-28
 Identities = 84/418 (20%), Positives = 146/418 (34%), Gaps = 33/418 (7%)

Query: 21  SSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIF-NVSTL 79
             L+ L LS+N          L +I        N++ +  SFN    +     F N+S L
Sbjct: 69  QELEYLDLSHNK---------LVKIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQL 117

Query: 80  KSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPS---FIFNASKLSELGLQKN 136
           K L L +  L  +        L   K L + G  +           FN   L  +     
Sbjct: 118 KFLGLSTTHLE-KSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNK 176

Query: 137 SFSGSIPNTFGNLRNLKWLGLNDN-YLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGIL 195
            F   +  +   + NL+   +         +  LS L+ L     L   + +N       
Sbjct: 177 EFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNS 236

Query: 196 PRAIGNLSQ--SMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEG---NQLEGSIPDDL 250
              I  L    ++  F + N  + G +     + +   L+ LS+     +          
Sbjct: 237 FIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIY 296

Query: 251 CRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPST-LWNLKDILHLNLS 309
              + +   +   +        C   ++    L   +NLLT        +L ++  L L 
Sbjct: 297 EIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQ 356

Query: 310 SNFFTGPLPLKIG---NLNVLVQLDLSMNNFSCVIPTKI-GGLKDLQYLFLEYNRLQGSI 365
            N     L         +  L QLD+S N+ S           K L  L +  N L  +I
Sbjct: 357 MNQLKE-LSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTI 415

Query: 366 PNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLS 423
              +     +K L+L +N +  +IP  + KL  L+++NV+ N+L+  +P  G F  L+
Sbjct: 416 FRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPD-GIFDRLT 468

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  106 bits (266), Expect = 3e-24
 Identities = 66/398 (16%), Positives = 124/398 (31%), Gaps = 56/398 (14%)

Query: 69  VPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNA-SK 127
           VP  +        L +  N +S  L +S  + L  L+ L +  N  I  +   +F    +
Sbjct: 15  VPKDLS--QKTTILNISQNYIS-ELWTSDILSLSKLRILIISHNR-IQYLDISVFKFNQE 70

Query: 128 LSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFS 187
           L  L L  N     I        NLK L L+ N   +  P      ++S    L++   S
Sbjct: 71  LEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDAL-PICKEFGNMSQ---LKFLGLS 123

Query: 188 NNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIP 247
              L       I +L+ S     +         PE + +     L ++     +    + 
Sbjct: 124 TTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILD 183

Query: 248 DDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWN-------- 299
             +  +A L   ++               L  L+     SNL  +   T WN        
Sbjct: 184 VSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQL 243

Query: 300 --LKDILHLNLSSNFFTGPLP-------------LKIGNLNVLVQ--------------- 329
                + + ++S+    G L              L I  +   V                
Sbjct: 244 VWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMN 303

Query: 330 -LDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGT 388
             + +++    V       +    +L    N L  ++  + G L  L++L L  N L   
Sbjct: 304 IKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-E 362

Query: 389 IPIS---LEKLLDLKDINVSFNRLEGEIPREGPFRNLS 423
           +        ++  L+ +++S N +  +   +G      
Sbjct: 363 LSKIAEMTTQMKSLQQLDISQNSVSYDEK-KGDCSWTK 399

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score =  100 bits (251), Expect = 2e-22
 Identities = 57/339 (16%), Positives = 107/339 (31%), Gaps = 27/339 (7%)

Query: 16  QLGNPSSLQTLYLSYNPPSGSIPSFILCEI--------PHEIDNLHNMEWMAFSFNKVVG 67
                    T  L    P+     FIL              I  +      ++  + +  
Sbjct: 156 DPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAK 215

Query: 68  VVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNAS- 126
           +      +  TL ++    NS    L     V    +    +      G +    F+ S 
Sbjct: 216 LQTNPKLSNLTLNNIETTWNSFIRILQL---VWHTTVWYFSISNVKLQGQLDFRDFDYSG 272

Query: 127 ----KLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLE 182
                LS   +  + F       +    N+       +        +  +   S      
Sbjct: 273 TSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTR-----MVHMLCPSKISPFL 327

Query: 183 YFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLI-LQLLSLEGNQ 241
           +  FSNN L   +    G+L++ +E   +    +   + +     T +  LQ L +  N 
Sbjct: 328 HLDFSNNLLTDTVFENCGHLTE-LETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNS 385

Query: 242 LEGSIPDDLC-RLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNL 300
           +        C    +L  L++  N L+  +  C      ++ L L SN + SIP  +  L
Sbjct: 386 VSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRC--LPPRIKVLDLHSNKIKSIPKQVVKL 443

Query: 301 KDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSC 339
           + +  LN++SN            L  L ++ L  N + C
Sbjct: 444 EALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 482

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 92.6 bits (230), Expect = 1e-19
 Identities = 47/277 (16%), Positives = 104/277 (37%), Gaps = 11/277 (3%)

Query: 13  ILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTT 72
           IL++L     L  L L+    + +    IL  + H      ++  +             +
Sbjct: 212 ILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYS 271

Query: 73  IFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNA-SKLSEL 131
             ++  L    + S+       S       N+   +   +     +     +  S    L
Sbjct: 272 GTSLKALSIHQVVSDVFGF-PQSYIYEIFSNMNIKNFTVSG-TRMVHMLCPSKISPFLHL 329

Query: 132 GLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPL 191
               N  + ++    G+L  L+ L L  N L   +      + + +   L+    S N +
Sbjct: 330 DFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKS---LQQLDISQNSV 386

Query: 192 GGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLC 251
                +   + ++S+    M +  ++ +I   +       +++L L  N+++ SIP  + 
Sbjct: 387 SYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPR----IKVLDLHSNKIK-SIPKQVV 441

Query: 252 RLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSN 288
           +L AL +L++  N+L          LT+L+K++L +N
Sbjct: 442 KLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score =  117 bits (294), Expect = 4e-29
 Identities = 59/247 (23%), Positives = 98/247 (39%), Gaps = 41/247 (16%)

Query: 69  VPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNA-SK 127
           VP  I   +  + ++LH N +S  +P+++     NL  L L  N  +  I +  F   + 
Sbjct: 26  VPVGIP--AASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNV-LARIDAAAFTGLAL 81

Query: 128 LSELGLQKNSFSGSIP-NTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSF 186
           L +L L  N+   S+   TF  L  L  L L+   L    P L           L+Y   
Sbjct: 82  LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGL-----FRGLAALQYLYL 136

Query: 187 SNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSI 246
            +N L  +      +L                             L  L L GN++  S+
Sbjct: 137 QDNALQALPDDTFRDLGN---------------------------LTHLFLHGNRIS-SV 168

Query: 247 PDD-LCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLW-NLKDIL 304
           P+     L +L +L L  N+++   P    +L  L  LYL +N L+++P+     L+ + 
Sbjct: 169 PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQ 228

Query: 305 HLNLSSN 311
           +L L+ N
Sbjct: 229 YLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 95.4 bits (238), Expect = 9e-22
 Identities = 56/210 (26%), Positives = 77/210 (36%), Gaps = 6/210 (2%)

Query: 201 NLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLD 260
            +  + +  ++    IS           NL   +L L  N L          LA L QLD
Sbjct: 29  GIPAASQRIFLHGNRISHVPAASFRACRNL--TILWLHSNVLARIDAAAFTGLALLEQLD 86

Query: 261 LGGNKLSGFVPACS-GNLTNLRKLYLGSNLLTSIPS-TLWNLKDILHLNLSSNFFTGPLP 318
           L  N     V   +   L  L  L+L    L  +       L  + +L L  N     LP
Sbjct: 87  LSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA-LP 145

Query: 319 LKI-GNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKS 377
                +L  L  L L  N  S V      GL  L  L L  NR+    P++  DL  L +
Sbjct: 146 DDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMT 205

Query: 378 LNLSNNNLSGTIPISLEKLLDLKDINVSFN 407
           L L  NNLS     +L  L  L+ + ++ N
Sbjct: 206 LYLFANNLSALPTEALAPLRALQYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 89.7 bits (223), Expect = 7e-20
 Identities = 52/248 (20%), Positives = 90/248 (36%), Gaps = 46/248 (18%)

Query: 20  PSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTL 79
           P++ Q ++L  N  S  +P+              N+  +    N +  +       ++ L
Sbjct: 31  PAASQRIFLHGNRIS-HVPAASF-------RACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 80  KSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIF-NASKLSELGLQKNSF 138
           + L L  N+    +  +    L  L  LHL     +  +   +F   + L  L LQ N+ 
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHL-DRCGLQELGPGLFRGLAALQYLYLQDNAL 141

Query: 139 SGSIP-NTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPR 197
             ++P +TF +L NL  L L+ N ++S      +   L +   L+      N +  + P 
Sbjct: 142 Q-ALPDDTFRDLGNLTHLFLHGNRISSVPER--AFRGLHS---LDRLLLHQNRVAHVHPH 195

Query: 198 AIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDD-LCRLAAL 256
           A  +L +                           L  L L  N L  ++P + L  L AL
Sbjct: 196 AFRDLGR---------------------------LMTLYLFANNLS-ALPTEALAPLRAL 227

Query: 257 FQLDLGGN 264
             L L  N
Sbjct: 228 QYLRLNDN 235

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 41/204 (20%), Positives = 69/204 (33%), Gaps = 17/204 (8%)

Query: 3   SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSF 62
            L  + +  +  +      +L  L+L  N  +  I +            L  +E +  S 
Sbjct: 38  FLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAF-------TGLALLEQLDLSD 89

Query: 63  NKVVGVVPTTIF-NVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSF 121
           N  +  V    F  +  L +L+L    L   L       L  L+ L+L  +N +  +P  
Sbjct: 90  NAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYL-QDNALQALPDD 147

Query: 122 IF-NASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKY 180
            F +   L+ L L  N  S      F  L +L  L L+ N +    P      +  +   
Sbjct: 148 TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPH-----AFRDLGR 202

Query: 181 LEYFSFSNNPLGGILPRAIGNLSQ 204
           L       N L  +   A+  L  
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRA 226

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  118 bits (298), Expect = 4e-29
 Identities = 57/319 (17%), Positives = 117/319 (36%), Gaps = 53/319 (16%)

Query: 69  VPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKL 128
           +P+ +     +KSL L +N ++  + +S   R  NL+ L L  N  I TI          
Sbjct: 46  IPSGLT--EAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNG-INTIE--------- 92

Query: 129 SELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSN 188
                          ++F +L +L+ L L+ NYL++ +        LS+   L + +   
Sbjct: 93  --------------EDSFSSLGSLEHLDLSYNYLSNLSSSW--FKPLSS---LTFLNLLG 133

Query: 189 NPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEI-NNLTNLILQLLSLEGNQLEGSIP 247
           NP   +   ++ +    ++   + N +    I  +    LT L  + L ++ + L+   P
Sbjct: 134 NPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFL--EELEIDASDLQSYEP 191

Query: 248 DDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLN 307
             L  +  +  L L   +    +       +++  L L    L +   +           
Sbjct: 192 KSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFS----------E 241

Query: 308 LSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPN 367
           LS+      +            + ++  +    +   +  +  L  L    N+L+ S+P+
Sbjct: 242 LSTGETNSLI-----KKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPD 294

Query: 368 SI-GDLISLKSLNLSNNNL 385
            I   L SL+ + L  N  
Sbjct: 295 GIFDRLTSLQKIWLHTNPW 313

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score =  111 bits (280), Expect = 8e-27
 Identities = 56/300 (18%), Positives = 107/300 (35%), Gaps = 43/300 (14%)

Query: 18  GNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVS 77
           G   ++++L LS N  +  I +  L           N++ +  + N +  +   +  ++ 
Sbjct: 49  GLTEAVKSLDLSNNRIT-YISNSDL-------QRCVNLQALVLTSNGINTIEEDSFSSLG 100

Query: 78  TLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNA-SKLSELGLQKN 136
           +L+ L L  N LS  L SS    L +L  L+L GN +     + +F+  +KL  L +   
Sbjct: 101 SLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNM 159

Query: 137 SFSGSIP-NTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGIL 195
                I    F  L  L+ L ++ + L S  P+     SL + + + +          +L
Sbjct: 160 DTFTKIQRKDFAGLTFLEELEIDASDLQSYEPK-----SLKSIQNVSHLILHMKQHILLL 214

Query: 196 PRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQ---LEGSIPDDLCR 252
              +   S                      ++  L L+   L+      L     + L +
Sbjct: 215 EIFVDVTS----------------------SVECLELRDTDLDTFHFSELSTGETNSLIK 252

Query: 253 LAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIP-STLWNLKDILHLNLSSN 311
                 + +    L   V      ++ L +L    N L S+P      L  +  + L +N
Sbjct: 253 KFTFRNVKITDESLFQ-VMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 92.1 bits (229), Expect = 3e-20
 Identities = 49/263 (18%), Positives = 99/263 (37%), Gaps = 24/263 (9%)

Query: 201 NLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDL-CRLAALFQL 259
            L+++++   + N  I+     ++    NL  Q L L  N +  +I +D    L +L  L
Sbjct: 49  GLTEAVKSLDLSNNRITYISNSDLQRCVNL--QALVLTSNGIN-TIEEDSFSSLGSLEHL 105

Query: 260 DLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIP--STLWNLKDILHLNLSSNFFTGPL 317
           DL  N LS    +    L++L  L L  N   ++   S   +L  +  L + +      +
Sbjct: 106 DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKI 165

Query: 318 PLKI-GNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGD-LISL 375
             K    L  L +L++  ++     P  +  ++++ +L L   +    +     D   S+
Sbjct: 166 QRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSV 224

Query: 376 KSLNLSNNNLSGT--------IPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESF 427
           + L L + +L              SL K    +++ ++   L   +        L    F
Sbjct: 225 ECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEF 284

Query: 428 KGNEL-------LCGMPNLQVLS 443
             N+L          + +LQ + 
Sbjct: 285 SRNQLKSVPDGIFDRLTSLQKIW 307

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 60.5 bits (147), Expect = 6e-10
 Identities = 22/169 (13%), Positives = 58/169 (34%), Gaps = 20/169 (11%)

Query: 1   MPSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEI-DNLHNMEWMA 59
           +     D    I        + L+ L +  +          L     +   ++ N+  + 
Sbjct: 154 LRVGNMDTFTKIQRKDFAGLTFLEELEIDASD---------LQSYEPKSLKSIQNVSHLI 204

Query: 60  FSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSG-------RLPSSADVRLPNLKELHLWGN 112
               + + ++   +   S+++ L L    L            +++ ++    + + +   
Sbjct: 205 LHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDE 264

Query: 113 NFIGTIPSFIFNASKLSELGLQKNSFSGSIP-NTFGNLRNLKWLGLNDN 160
           + +  +   +   S L EL   +N    S+P   F  L +L+ + L+ N
Sbjct: 265 S-LFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTN 311

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  117 bits (294), Expect = 5e-28
 Identities = 67/286 (23%), Positives = 107/286 (37%), Gaps = 39/286 (13%)

Query: 102 PNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNY 161
               ++     N    +P  I   +    L L +N       N+F +LR+L+ L L+ N+
Sbjct: 43  NQFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99

Query: 162 LTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIP 221
           + +      + + L+N   L      +N L  I   A   LS+                 
Sbjct: 100 IRTIEIG--AFNGLAN---LNTLELFDNRLTTIPNGAFVYLSK----------------- 137

Query: 222 EEINNLTNLILQLLSLEGNQLEGSIPDDL-CRLAALFQLDLGG-NKLSGFVPACSGNLTN 279
                     L+ L L  N +E SIP     R+ +L +LDLG   +LS         L+N
Sbjct: 138 ----------LKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSN 186

Query: 280 LRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSC 339
           LR L L    L  IP  L  L  +  L+LS N  +   P     L  L +L +  +    
Sbjct: 187 LRYLNLAMCNLREIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQV 245

Query: 340 VIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNL 385
           +       L+ L  + L +N L     +    L  L+ ++L +N  
Sbjct: 246 IERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  113 bits (284), Expect = 1e-26
 Identities = 72/295 (24%), Positives = 108/295 (36%), Gaps = 61/295 (20%)

Query: 69  VPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKL 128
           VP  I   +  + L LH N +   +  ++   L +L+ L L  N+ I TI          
Sbjct: 58  VPDGIS--TNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNH-IRTIE--------- 104

Query: 129 SELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSN 188
                            F  L NL  L L DN LT+      +   LS    L+     N
Sbjct: 105 --------------IGAFNGLANLNTLELFDNRLTTIPNG--AFVYLSK---LKELWLRN 145

Query: 189 NPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEI-NNLTNLILQLLSLEGNQLEGSIP 247
           NP+  I   A   +  S+    +        I E     L+NL  + L+L    L   IP
Sbjct: 146 NPIESIPSYAFNRI-PSLRRLDLGELKRLSYISEGAFEGLSNL--RYLNLAMCNLR-EIP 201

Query: 248 DDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLN 307
           + L  L  L +LDL GN LS   P     L +L+KL++  + +  I              
Sbjct: 202 N-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIER------------ 248

Query: 308 LSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQ 362
              N F          L  LV+++L+ NN + +       L  L+ + L +N   
Sbjct: 249 ---NAFDN--------LQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN 292

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  111 bits (279), Expect = 4e-26
 Identities = 73/329 (22%), Positives = 117/329 (35%), Gaps = 53/329 (16%)

Query: 20  PSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTL 79
            ++ + L L  N     I             +L ++E +  S N +  +       ++ L
Sbjct: 63  STNTRLLNLHENQIQ-IIKVNSF-------KHLRHLEILQLSRNHIRTIEIGAFNGLANL 114

Query: 80  KSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNA-SKLSELGLQKNSF 138
            +L L  N L+  +P+ A V L  LKEL L  NN I +IPS+ FN    L  L L +   
Sbjct: 115 NTLELFDNRLT-TIPNGAFVYLSKLKELWL-RNNPIESIPSYAFNRIPSLRRLDLGELKR 172

Query: 139 SGSIP-NTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPR 197
              I    F  L NL++L L           L  + +L+    L+    S N L  I P 
Sbjct: 173 LSYISEGAFEGLSNLRYLNLAMC-------NLREIPNLTPLIKLDELDLSGNHLSAIRPG 225

Query: 198 AIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALF 257
           +   L                             LQ L +  +Q++    +    L +L 
Sbjct: 226 SFQGLMH---------------------------LQKLWMIQSQIQVIERNAFDNLQSLV 258

Query: 258 QLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPL 317
           +++L  N L+         L +L +++L  N        LW L   +     SN      
Sbjct: 259 EINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCDILW-LSWWIKDMAPSNTACCAR 317

Query: 318 ---PLKIGNLNVLVQLDLSMNNFSCVIPT 343
              P  +    +    +L  N F+C  P 
Sbjct: 318 CNTPPNLKGRYI---GELDQNYFTCYAPV 343

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score =  107 bits (268), Expect = 1e-24
 Identities = 58/208 (27%), Positives = 90/208 (43%), Gaps = 10/208 (4%)

Query: 219 SIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLT 278
            +P+ I+  T    +LL+L  NQ++    +    L  L  L L  N +          L 
Sbjct: 57  EVPDGISTNT----RLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLA 112

Query: 279 NLRKLYLGSNLLTSIPS-TLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNF 337
           NL  L L  N LT+IP+     L  +  L L +N            +  L +LDL     
Sbjct: 113 NLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKR 172

Query: 338 SCVIPTKI-GGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKL 396
              I      GL +L+YL L    L+  IP ++  LI L  L+LS N+LS   P S + L
Sbjct: 173 LSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAIRPGSFQGL 230

Query: 397 LDLKDINVSFNRLEGEIPREGPFRNLSA 424
           + L+ + +  ++++  I     F NL +
Sbjct: 231 MHLQKLWMIQSQIQ-VIE-RNAFDNLQS 256

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 78.6 bits (194), Expect = 2e-15
 Identities = 42/226 (18%), Positives = 78/226 (34%), Gaps = 39/226 (17%)

Query: 3   SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSF 62
           +L  + ++ I ++   +   L+ L LS N    +I            + L N+  +    
Sbjct: 70  NLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAF-------NGLANLNTLELFD 121

Query: 63  NKVVGVVPTTIFNVSTLKSLYLHSNSLS------------------------GRLPSSAD 98
           N++  +       +S LK L+L +N +                           +   A 
Sbjct: 122 NRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAF 181

Query: 99  VRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLN 158
             L NL+ L+L     +  IP+      KL EL L  N  S   P +F  L +L+ L + 
Sbjct: 182 EGLSNLRYLNL-AMCNLREIPNLT-PLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMI 239

Query: 159 DNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQ 204
            + +           +  N + L   + ++N L  +       L  
Sbjct: 240 QSQIQVIERN-----AFDNLQSLVEINLAHNNLTLLPHDLFTPLHH 280

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 71.3 bits (175), Expect = 4e-13
 Identities = 47/178 (26%), Positives = 66/178 (37%), Gaps = 34/178 (19%)

Query: 273 CSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDL 332
           CS       K+      L  +P  +    +   LNL  N           +L  L  L L
Sbjct: 41  CSNQF---SKVICVRKNLREVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQL 95

Query: 333 SMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSI-GDLISLKSLNLSNNNLSGTIPI 391
           S N+   +      GL +L  L L  NRL  +IPN     L  LK L L NN +  +IP 
Sbjct: 96  SRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPS 153

Query: 392 S----LEKL--LDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMPNLQVLS 443
                +  L  LDL +      RL            +S  +F+      G+ NL+ L+
Sbjct: 154 YAFNRIPSLRRLDLGE----LKRL----------SYISEGAFE------GLSNLRYLN 191

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  115 bits (290), Expect = 1e-27
 Identities = 44/187 (23%), Positives = 87/187 (46%), Gaps = 19/187 (10%)

Query: 513 RFSENNLIGRGGFGPVYK----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRI-RHRNLI 567
            F   +++G G  G +      D  +VA+K    +    F   D E  +++    H N+I
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVI 81

Query: 568 KIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
           +   +  +  F+ + +E     +L++ +   ++     + + ++    S L +LH   S+
Sbjct: 82  RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SL 137

Query: 628 PIIHCDLKPSNVLL-----DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGYMAPDE 681
            I+H DLKP N+L+        + A +SDFG+ K L     S ++   +  T G++AP E
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP-E 196

Query: 682 IFSGEMR 688
           + S + +
Sbjct: 197 MLSEDCK 203

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  112 bits (282), Expect = 3e-27
 Identities = 50/194 (25%), Positives = 78/194 (40%), Gaps = 25/194 (12%)

Query: 513 RFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLI 567
            +     +G GGF  V       DG   A+K          +    E  M +   H N++
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89

Query: 568 KIISSCSNDDFKA----LVLEYMPLGSL----EKCLYSGNYILDIFQGLNIMIDVASALE 619
           ++++ C  +        L+L +   G+L    E+    GN+ L   Q L +++ +   LE
Sbjct: 90  RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF-LTEDQILWLLLGICRGLE 148

Query: 620 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA------- 672
            +H   +    H DLKP+N+LL D     L D G         +   Q  TL        
Sbjct: 149 AIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205

Query: 673 TIGYMAPDEIFSGE 686
           TI Y AP E+FS +
Sbjct: 206 TISYRAP-ELFSVQ 218

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  109 bits (274), Expect = 4e-26
 Identities = 43/207 (20%), Positives = 79/207 (38%), Gaps = 18/207 (8%)

Query: 482 KGRKSQLKDVNMPSVADQRRFTYLELFQATNRFSENNLIGRGGFGPVYK-----DGMEVA 536
           +    + +D     + ++ +    E  +  +  +    +GRG FG V++      G + A
Sbjct: 28  QRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCA 87

Query: 537 IKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLY 596
           +K   L+          E      +    ++ +  +     +  + +E +  GSL + + 
Sbjct: 88  VKKVRLE-----VFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK 142

Query: 597 SGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN-MVAHLSDFGMA 655
                L   + L  +      LEYLH   +  I+H D+K  NVLL  +   A L DFG A
Sbjct: 143 QMG-CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHA 198

Query: 656 KPLLEEDQSLTQTQTLATIG---YMAP 679
             L  +    +        G   +MAP
Sbjct: 199 LCLQPDGLGKSLLTGDYIPGTETHMAP 225

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  106 bits (266), Expect = 2e-25
 Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 36/197 (18%)

Query: 511 TNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRN 565
            +   +  ++G+G +G VY      + + +AIK    +     +    E  + K ++H+N
Sbjct: 21  YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKN 80

Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYS------------GNYILDIFQGLNIMID 613
           +++ + S S + F  + +E +P GSL   L S            G Y   I +G      
Sbjct: 81  IVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEG------ 134

Query: 614 VASALEYLHFGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLA 672
               L+YLH      I+H D+K  NVL++  + V  +SDFG +K L   +     T+T  
Sbjct: 135 ----LKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN---PCTETFT 184

Query: 673 -TIGYMAPDEIFSGEMR 688
            T+ YMAP EI     R
Sbjct: 185 GTLQYMAP-EIIDKGPR 200

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  106 bits (266), Expect = 3e-25
 Identities = 43/183 (23%), Positives = 77/183 (42%), Gaps = 15/183 (8%)

Query: 512 NRFSENNLIGRGGFGPVYK----DGMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRN 565
             +S    IG GG   V++         AIK  NL+        S+  E   + +++  +
Sbjct: 28  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87

Query: 566 L--IKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHF 623
              I++      D +  +V+E      L   L      +D ++  +   ++  A+  +H 
Sbjct: 88  DKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH- 144

Query: 624 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIF 683
                I+H DLKP+N L+ D M+  L DFG+A  +  +  S+ +   + T+ YM P E  
Sbjct: 145 --QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP-EAI 200

Query: 684 SGE 686
              
Sbjct: 201 KDM 203

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  105 bits (264), Expect = 6e-25
 Identities = 49/178 (27%), Positives = 79/178 (44%), Gaps = 16/178 (8%)

Query: 519 LIGRGGFGPVYK--D---GMEVAIKVFNLQYGG--AFKS-FDIECGMMKRIRHRNLIKII 570
           L+GRGG G VY+  D      VA+K+ +        F++    E     R++  +++ I 
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100

Query: 571 SSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPII 630
                D    + +  +    L   L      L   + + I+  + SAL+  H   +    
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAH---AAGAT 156

Query: 631 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT-LATIGYMAPDEIFSGEM 687
           H D+KP N+L+  +  A+L DFG+A      D+ LTQ    + T+ YMAP E FS   
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYYMAP-ERFSESH 211

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  106 bits (267), Expect = 6e-25
 Identities = 42/183 (22%), Positives = 76/183 (41%), Gaps = 15/183 (8%)

Query: 512 NRFSENNLIGRGGFGPVYK----DGMEVAIKVFNLQYGG--AFKSFDIECGMMKRIRHRN 565
             +S    IG GG   V++         AIK  NL+        S+  E   + +++  +
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115

Query: 566 L--IKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHF 623
              I++      D +  +V+E      L   L      +D ++  +   ++  A+  +H 
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIH- 172

Query: 624 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIF 683
                I+H DLKP+N L+ D M+  L DFG+A  +  +  S+ +   +  + YM P E  
Sbjct: 173 --QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPP-EAI 228

Query: 684 SGE 686
              
Sbjct: 229 KDM 231

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  105 bits (264), Expect = 6e-25
 Identities = 43/179 (24%), Positives = 70/179 (39%), Gaps = 20/179 (11%)

Query: 520 IGRGGFGPVYK---------DGMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKI 569
           +G G FG VYK           + VAIK         A K    E  +M  + + ++ ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 570 ISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL---HFGYS 626
           +  C     + L+ + MP G L   +      +     LN  + +A  + YL        
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL--- 138

Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG 685
              +H DL   NVL+       ++DFG+AK L  E++          I +MA + I   
Sbjct: 139 ---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score =  104 bits (262), Expect = 7e-25
 Identities = 49/287 (17%), Positives = 106/287 (36%), Gaps = 27/287 (9%)

Query: 124 NASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEY 183
             +   ++   K++ +     T  +L  +  L      +T+       +  +     L  
Sbjct: 17  ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTT-------IEGVQYLNNLIG 67

Query: 184 FSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLE 243
               +N +  + P  + NL++ + +  +    +       I  L ++  + L L   Q+ 
Sbjct: 68  LELKDNQITDLAP--LKNLTK-ITELELSGNPLK--NVSAIAGLQSI--KTLDLTSTQIT 120

Query: 244 GSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDI 303
              P  L  L+ L  L L  N+++   P     LTNL+ L +G+  ++ + + L NL  +
Sbjct: 121 DVTP--LAGLSNLQVLYLDLNQITNISPL--AGLTNLQYLSIGNAQVSDL-TPLANLSKL 175

Query: 304 LHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQG 363
             L    N  +   PL   +L  L+++ L  N  S V P  +    +L  + L    +  
Sbjct: 176 TTLKADDNKISDISPLA--SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITN 231

Query: 364 SIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLE 410
                  +L+      +   + +   P ++         N+++N   
Sbjct: 232 QPVFYNNNLVVP--NVVKGPSGAPIAPATISDNGTYASPNLTWNLTS 276

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 78.2 bits (193), Expect = 8e-16
 Identities = 53/324 (16%), Positives = 105/324 (32%), Gaps = 84/324 (25%)

Query: 14  LSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTI 73
                +   + TL                      +  +  ++                 
Sbjct: 34  TVTQADLDGITTLSAFGT----------------GVTTIEGVQ----------------- 60

Query: 74  FNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGL 133
             ++ L  L L  N ++  L    +  L  + EL L GN  +  + +       +  L L
Sbjct: 61  -YLNNLIGLELKDNQIT-DLAPLKN--LTKITELELSGNP-LKNVSAI-AGLQSIKTLDL 114

Query: 134 QKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGG 193
                +   P     L NL+ L L+ N       +++++S L+    L+Y S  N  +  
Sbjct: 115 TSTQITDVTP--LAGLSNLQVLYLDLN-------QITNISPLAGLTNLQYLSIGNAQVSD 165

Query: 194 ILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRL 253
           +                             + NL+   L  L  + N++   I   L  L
Sbjct: 166 L---------------------------TPLANLSK--LTTLKADDNKIS-DIS-PLASL 194

Query: 254 AALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFF 313
             L ++ L  N++S   P    N +NL  + L +  +T+ P  ++   +++  N+     
Sbjct: 195 PNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQP--VFYNNNLVVPNVVKGPS 250

Query: 314 TGPL-PLKIGNLNVLVQLDLSMNN 336
             P+ P  I +       +L+ N 
Sbjct: 251 GAPIAPATISDNGTYASPNLTWNL 274

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 42/169 (24%), Positives = 71/169 (42%), Gaps = 27/169 (15%)

Query: 276 NLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMN 335
            L N  K+  G + +T    T  +L  I  L+      T    +    LN L+ L+L  N
Sbjct: 17  ALANAIKIAAGKSNVTDT-VTQADLDGITTLSAFGTGVTTIEGV--QYLNNLIGLELKDN 73

Query: 336 NFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEK 395
             + + P  +  L  +  L L  N L     ++I  L S+K+L+L++  ++   P  L  
Sbjct: 74  QITDLAP--LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTP--LAG 127

Query: 396 LLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMPNLQVLSC 444
           L +L+ + +  N++           N+S         L G+ NLQ LS 
Sbjct: 128 LSNLQVLYLDLNQI----------TNISP--------LAGLTNLQYLSI 158

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 64.3 bits (157), Expect = 3e-11
 Identities = 53/230 (23%), Positives = 90/230 (39%), Gaps = 31/230 (13%)

Query: 14  LSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTI 73
           L+ L N + +  L LS NP         L  +   I  L +++ +  +  ++  V P  +
Sbjct: 78  LAPLKNLTKITELELSGNP---------LKNVS-AIAGLQSIKTLDLTSTQITDVTP--L 125

Query: 74  FNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGL 133
             +S L+ LYL  N ++     S    L NL+ L + GN  +  + + + N SKL+ L  
Sbjct: 126 AGLSNLQVLYLDLNQITN---ISPLAGLTNLQYLSI-GNAQVSDL-TPLANLSKLTTLKA 180

Query: 134 QKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGG 193
             N  S  I     +L NL  + L +N       ++S +S L+N   L   + +N  +  
Sbjct: 181 DDNKIS-DISP-LASLPNLIEVHLKNN-------QISDVSPLANTSNLFIVTLTNQTITN 231

Query: 194 ILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLE 243
                  NL             I+   P  I++  N      +L  N   
Sbjct: 232 QPVFYNNNLVVPNVVKGPSGAPIA---PATISD--NGTYASPNLTWNLTS 276

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  108 bits (272), Expect = 1e-24
 Identities = 39/181 (21%), Positives = 74/181 (40%), Gaps = 28/181 (15%)

Query: 519 LIGRGGFGPVYK------DGMEVAIKVFNLQYGGAFKS-FDIECGMMKRIRHRNLIKIIS 571
            I  GG G +Y       +G  V +K          ++    E   +  + H ++++I +
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 572 SCSNDDFKA-----LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
              + D        +V+EY+   SL++        L + + +  ++++  AL YLH   S
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH---S 200

Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT-LATIGYMAPDEIFSG 685
           + +++ DLKP N++L +  +  L D G           +        T G+ AP EI   
Sbjct: 201 IGLVYNDLKPENIMLTEEQLK-LIDLGAVS-------RINSFGYLYGTPGFQAP-EIVRT 251

Query: 686 E 686
            
Sbjct: 252 G 252

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  104 bits (262), Expect = 2e-24
 Identities = 43/182 (23%), Positives = 77/182 (42%), Gaps = 15/182 (8%)

Query: 512 NRFSENNLIGRGGFGPVYK----DGMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRN 565
             +S    IG GG   V++         AIK  NL+        S+  E   + +++  +
Sbjct: 9   RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68

Query: 566 L--IKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHF 623
              I++      D +  +V+E      L   L      +D ++  +   ++  A+  +H 
Sbjct: 69  DKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKKKS-IDPWERKSYWKNMLEAVHTIH- 125

Query: 624 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIF 683
                I+H DLKP+N L+ D M+  L DFG+A  +  +  S+ +   + T+ YM P E  
Sbjct: 126 --QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPP-EAI 181

Query: 684 SG 685
             
Sbjct: 182 KD 183

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  103 bits (258), Expect = 2e-24
 Identities = 43/164 (26%), Positives = 61/164 (37%), Gaps = 21/164 (12%)

Query: 520 IGRGGFGPVYK--------DGMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIK 568
           +G G FG V +          + VA+K           A   F  E   M  + HRNLI+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85

Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL---HFGY 625
           +         K +V E  PLGSL   L        +       + VA  + YL    F  
Sbjct: 86  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRF-- 142

Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
               IH DL   N+LL    +  + DFG+ + L + D      +
Sbjct: 143 ----IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE 182

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  104 bits (262), Expect = 3e-24
 Identities = 45/175 (25%), Positives = 75/175 (42%), Gaps = 13/175 (7%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSC 573
           IGRG FG V+      D   VA+K             F  E  ++K+  H N++++I  C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181

Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
           +      +V+E +  G     L +    L +   L ++ D A+ +EYL    S   IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238

Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP----DEIFS 684
           L   N L+ +  V  +SDFGM++   +   + +       + + AP       +S
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYS 293

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  102 bits (257), Expect = 3e-24
 Identities = 50/197 (25%), Positives = 80/197 (40%), Gaps = 33/197 (16%)

Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNL 566
             F E  LIG GGFG V+K     DG    IK        A +    E   + ++ H N+
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNI 66

Query: 567 IKIISSCSNDDFKA----------------LVLEYMPLGSLEKCL-YSGNYILDIFQGLN 609
           +         D+                  + +E+   G+LE+ +       LD    L 
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126

Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
           +   +   ++Y+H   S  +I+ DLKPSN+ L D     + DFG+   L        +T+
Sbjct: 127 LFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRTR 180

Query: 670 TLATIGYMAPDEIFSGE 686
           +  T+ YM+P E  S +
Sbjct: 181 SKGTLRYMSP-EQISSQ 196

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score =  102 bits (256), Expect = 3e-24
 Identities = 53/241 (21%), Positives = 83/241 (34%), Gaps = 47/241 (19%)

Query: 75  NVSTLKSLYLHSNSLSGRLPSSADVRLP-NLKELHLWGNNFIGTIPSFIF-NASKLSELG 132
            V++   +     +L+  LP      LP +   LHL  N  + T         ++L++L 
Sbjct: 8   KVASHLEVNCDKRNLT-ALPPD----LPKDTTILHLSENL-LYTFSLATLMPYTRLTQLN 61

Query: 133 LQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLG 192
           L +   +  +    G L  L  L L+ N L S                            
Sbjct: 62  LDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQS---------------------------- 91

Query: 193 GILPRAIGNLSQSMEDFWMDNCNISGSIPEEI-NNLTNLILQLLSLEGNQLEGSIPDDLC 251
             LP     L   +    +    ++ S+P      L  L  Q L L+GN+L+ ++P  L 
Sbjct: 92  --LPLLGQTLPA-LTVLDVSFNRLT-SLPLGALRGLGEL--QELYLKGNELK-TLPPGLL 144

Query: 252 -RLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSS 310
                L +L L  N L+         L NL  L L  N L +IP   +    +    L  
Sbjct: 145 TPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHG 204

Query: 311 N 311
           N
Sbjct: 205 N 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 95.2 bits (237), Expect = 1e-21
 Identities = 51/191 (26%), Positives = 76/191 (39%), Gaps = 11/191 (5%)

Query: 219 SIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLT 278
           ++P ++    +    +L L  N L       L     L QL+L   +L+  +    G L 
Sbjct: 24  ALPPDL--PKDT--TILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQV-DGTLP 77

Query: 279 NLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKI-GNLNVLVQLDLSMNNF 337
            L  L L  N L S+P     L  +  L++S N  T  LPL     L  L +L L  N  
Sbjct: 78  VLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQELYLKGNEL 136

Query: 338 SCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGD-LISLKSLNLSNNNLSGTIPISLEKL 396
             + P  +     L+ L L  N L   +P  + + L +L +L L  N+L  TIP      
Sbjct: 137 KTLPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGS 194

Query: 397 LDLKDINVSFN 407
             L    +  N
Sbjct: 195 HLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 87.1 bits (216), Expect = 6e-19
 Identities = 57/284 (20%), Positives = 83/284 (29%), Gaps = 88/284 (30%)

Query: 101 LPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDN 160
           + +  E++    N +  +P  +      + L L +N        T      L  L L+  
Sbjct: 9   VASHLEVNCDKRN-LTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65

Query: 161 YLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSI 220
            LT     L    +L     L     S+N L                           S+
Sbjct: 66  ELTK----LQVDGTLPV---LGTLDLSHNQLQ--------------------------SL 92

Query: 221 PEEINNLTNLILQLLSLEGNQLEGSIPDDL-CRLAALFQLDLGGNKLSGFVPACSGNLTN 279
           P     L  L   +L +  N+L  S+P      L  L +L L GN+L    P        
Sbjct: 93  PLLGQTLPAL--TVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPK 149

Query: 280 LRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSC 339
           L KL L +N LT +P+ L N                                        
Sbjct: 150 LEKLSLANNNLTELPAGLLN---------------------------------------- 169

Query: 340 VIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNN 383
                  GL++L  L L+ N L  +IP        L    L  N
Sbjct: 170 -------GLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 77.5 bits (191), Expect = 9e-16
 Identities = 47/169 (27%), Positives = 68/169 (40%), Gaps = 13/169 (7%)

Query: 259 LDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPST-LWNLKDILHLNLSSNFFTGPL 317
           ++     L+  +P       +   L+L  NLL +     L     +  LNL     T  L
Sbjct: 15  VNCDKRNLTA-LP--PDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-L 70

Query: 318 PLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGD-LISLK 376
            +  G L VL  LDLS N     +P     L  L  L + +NRL  S+P      L  L+
Sbjct: 71  QVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQ 127

Query: 377 SLNLSNNNLSGTIPISL-EKLLDLKDINVSFNRLEGEIPREGPFRNLSA 424
            L L  N L  T+P  L      L+ ++++ N L  E+P  G    L  
Sbjct: 128 ELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELP-AGLLNGLEN 173

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 77.5 bits (191), Expect = 1e-15
 Identities = 39/172 (22%), Positives = 62/172 (36%), Gaps = 22/172 (12%)

Query: 21  SSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLK 80
           + L  L L     +  +              L  +  +  S N++   +P     +  L 
Sbjct: 55  TRLTQLNLDRAELT-KLQVD---------GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALT 103

Query: 81  SLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNA-SKLSELGLQKNSFS 139
            L +  N L+  LP  A   L  L+EL+L GN  + T+P  +     KL +L L  N+ +
Sbjct: 104 VLDVSFNRLT-SLPLGALRGLGELQELYLKGNE-LKTLPPGLLTPTPKLEKLSLANNNLT 161

Query: 140 GSIP-NTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNP 190
             +P      L NL  L L +N L +                L +     NP
Sbjct: 162 -ELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHL------LPFAFLHGNP 206

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 72.8 bits (179), Expect = 3e-14
 Identities = 39/156 (25%), Positives = 67/156 (42%), Gaps = 10/156 (6%)

Query: 271 PAC-SGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQ 329
           P C    + +  ++      LT++P  L   KD   L+LS N         +     L Q
Sbjct: 2   PICEVSKVASHLEVNCDKRNLTALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQ 59

Query: 330 LDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTI 389
           L+L     +  +    G L  L  L L +N+LQ S+P     L +L  L++S N L+ ++
Sbjct: 60  LNLDRAELT-KLQVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SL 115

Query: 390 PISL-EKLLDLKDINVSFNRLEGEIPREGPFRNLSA 424
           P+     L +L+++ +  N L+  +P  G       
Sbjct: 116 PLGALRGLGELQELYLKGNELK-TLP-PGLLTPTPK 149

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  105 bits (264), Expect = 4e-24
 Identities = 49/181 (27%), Positives = 90/181 (49%), Gaps = 11/181 (6%)

Query: 518 NLIGRGGFGPVY----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSC 573
             +G+G FG V+         VAIK          ++F  E  +MK++RH  L+++ +  
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
           S +    +V EYM  GSL   L       L + Q +++   +AS + Y+     +  +H 
Sbjct: 249 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 304

Query: 633 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCW 692
           DL+ +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + AP+    G   +K  
Sbjct: 305 DLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363

Query: 693 V 693
           V
Sbjct: 364 V 364

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  102 bits (257), Expect = 4e-24
 Identities = 50/187 (26%), Positives = 89/187 (47%), Gaps = 23/187 (12%)

Query: 519 LIGRGGFGPVYK-----DGMEVAIKVFN-LQYGGAFKSFDIECGMMKRIRHRNLIKI--I 570
           ++G+G    V++      G   AIKVFN + +         E  ++K++ H+N++K+  I
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 571 SSCSNDDFKALVLEYMPLGSLEKCLYS--GNYILDIFQGLNIMIDVASALEYLHFGYSVP 628
              +    K L++E+ P GSL   L      Y L   + L ++ DV   + +L       
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132

Query: 629 IIHCDLKPSNVLL----DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGYMAPDEIF 683
           I+H ++KP N++     D   V  L+DFG A+  LE+D+      +L  T  Y+ P +++
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR-ELEDDEQFV---SLYGTEEYLHP-DMY 187

Query: 684 SGEMRLK 690
              +  K
Sbjct: 188 ERAVLRK 194

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  102 bits (256), Expect = 5e-24
 Identities = 47/188 (25%), Positives = 77/188 (40%), Gaps = 21/188 (11%)

Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI-----ECGMMKRI 561
             F     IGRG F  VY+     DG+ VA+K   +       +        E  ++K++
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQI--FDLMDAKARADCIKEIDLLKQL 89

Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIF---QGLNIMIDVASAL 618
            H N+IK  +S   D+   +VLE    G L + +        +          + + SAL
Sbjct: 90  NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149

Query: 619 EYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 678
           E++H   S  ++H D+KP+NV +    V  L D G+ +       +   +    T  YM+
Sbjct: 150 EHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLV-GTPYYMS 204

Query: 679 PDEIFSGE 686
           P E     
Sbjct: 205 P-ERIHEN 211

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  102 bits (256), Expect = 5e-24
 Identities = 43/181 (23%), Positives = 66/181 (36%), Gaps = 16/181 (8%)

Query: 513 RFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIRHR 564
            F   + +G G +G V+K     DG   A+K     + G               K  +H 
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 565 NLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFG 624
             +++  +        L  E     SL++   +    L   Q    + D   AL +LH  
Sbjct: 118 CCVRLEQAWEEGGILYLQTELCG-PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH-- 174

Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS 684
            S  ++H D+KP+N+ L       L DFG+   L        Q        YMAP E+  
Sbjct: 175 -SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE---GDPRYMAP-ELLQ 229

Query: 685 G 685
           G
Sbjct: 230 G 230

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  102 bits (257), Expect = 6e-24
 Identities = 46/176 (26%), Positives = 80/176 (45%), Gaps = 14/176 (7%)

Query: 520 IGRGGFGPVYK---------DGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKI 569
           +G G FG V+K           + V IKV   + G  +F++       +  + H +++++
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80

Query: 570 ISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPI 629
           +  C     + LV +Y+PLGSL   +      L     LN  + +A  + YL       +
Sbjct: 81  LGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGM 136

Query: 630 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG 685
           +H +L   NVLL       ++DFG+A  L  +D+ L  ++    I +MA + I  G
Sbjct: 137 VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 192

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  103 bits (258), Expect = 6e-24
 Identities = 41/183 (22%), Positives = 77/183 (42%), Gaps = 14/183 (7%)

Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHR 564
            ++     IG G FG         DG +  IK  N+        +    E  ++  ++H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 565 NLIKIISSCSNDDFKALVLEYMPLGSL-EKCLYSGNYILDIFQGLNIMIDVASALEYLHF 623
           N+++   S   +    +V++Y   G L ++       +    Q L+  + +  AL+++H 
Sbjct: 84  NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH- 142

Query: 624 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIF 683
                I+H D+K  N+ L  +    L DFG+A+ +L     L +     T  Y++P EI 
Sbjct: 143 --DRKILHRDIKSQNIFLTKDGTVQLGDFGIAR-VLNSTVELARACI-GTPYYLSP-EIC 197

Query: 684 SGE 686
             +
Sbjct: 198 ENK 200

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  101 bits (255), Expect = 6e-24
 Identities = 42/156 (26%), Positives = 71/156 (45%), Gaps = 22/156 (14%)

Query: 520 IGRGGFGPVYK-------DGMEVAIKVFNLQYGGAFKS---FDIECGMMKRIRHRNLIKI 569
           +G G FG V +         ++VAIKV  L+ G           E  +M ++ +  ++++
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75

Query: 570 ISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL---HFGYS 626
           I  C  +    LV+E    G L K L      + +     ++  V+  ++YL   +F   
Sbjct: 76  IGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF--- 131

Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED 662
              +H DL   NVLL +   A +SDFG++K L  +D
Sbjct: 132 ---VHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  101 bits (253), Expect = 6e-24
 Identities = 47/168 (27%), Positives = 76/168 (45%), Gaps = 17/168 (10%)

Query: 520 IGRGGFGPVY----KDGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCS 574
           IG G FG V+     +  +VAIK   ++ G  + + F  E  +M ++ H  L+++   C 
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKT--IREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73

Query: 575 NDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL---HFGYSVPIIH 631
                 LV E+M  G L   L +   +      L + +DV   + YL           IH
Sbjct: 74  EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV------IH 127

Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
            DL   N L+ +N V  +SDFGM +  + +DQ  + T T   + + +P
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASP 174

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  101 bits (253), Expect = 7e-24
 Identities = 53/209 (25%), Positives = 83/209 (39%), Gaps = 33/209 (15%)

Query: 493 MPSVADQRRFTYLELFQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQY--G 545
           MPS A+   +  L              IG G +G   K     DG  +  K  +      
Sbjct: 1   MPSRAED--YEVLYT------------IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE 46

Query: 546 GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKAL--VLEYMPLGSL----EKCLYSGN 599
              +    E  +++ ++H N+++      +     L  V+EY   G L     K      
Sbjct: 47  AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ 106

Query: 600 YILDIFQGLNIMIDVASALEYLH--FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP 657
           Y+ D    L +M  +  AL+  H        ++H DLKP+NV LD      L DFG+A+ 
Sbjct: 107 YL-DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR- 164

Query: 658 LLEEDQSLTQTQTLATIGYMAPDEIFSGE 686
           +L  D S  +T  + T  YM+P E  +  
Sbjct: 165 ILNHDTSFAKTF-VGTPYYMSP-EQMNRM 191

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  101 bits (254), Expect = 7e-24
 Identities = 44/183 (24%), Positives = 78/183 (42%), Gaps = 21/183 (11%)

Query: 518 NLIGRGGFGPVYK--------DGMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIK 568
            +IGRG FG VY           +  A+K  N     G    F  E  +MK   H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 569 IISSCSNDDFKAL-VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL---HFG 624
           ++  C   +   L VL YM  G L   + +  +   +   +   + VA  ++YL    F 
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF- 149

Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED--QSLTQTQTLATIGYMAPDEI 682
                +H DL   N +LD+     ++DFG+A+ + +++      +T     + +MA + +
Sbjct: 150 -----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204

Query: 683 FSG 685
            + 
Sbjct: 205 QTQ 207

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  101 bits (254), Expect = 8e-24
 Identities = 43/180 (23%), Positives = 79/180 (43%), Gaps = 18/180 (10%)

Query: 520 IGRGGFGPVYK---------DGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKI 569
           +G G FG V            G +VA+K    + GG        E  +++ + H N++K 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88

Query: 570 ISSCSNDDFKA--LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
              C+ D      L++E++P GSL++ L      +++ Q L   + +   ++YL    S 
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 145

Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAPDEIFSG 685
             +H DL   NVL++      + DFG+ K  +E D+     +      + + AP+ +   
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDDRDSPVFWYAPECLMQS 204

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  104 bits (262), Expect = 9e-24
 Identities = 43/174 (24%), Positives = 80/174 (45%), Gaps = 11/174 (6%)

Query: 518 NLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISS 572
           + +G G +G VY+       + VA+K          + F  E  +MK I+H NL++++  
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 573 CSNDDFKALVLEYMPLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
           C+ +    ++ E+M  G+L   L   N   +     L +   ++SA+EYL        IH
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIH 341

Query: 632 CDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG 685
            +L   N L+ +N +  ++DFG+++ L+  D           I + AP+ +   
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYN 394

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  104 bits (260), Expect = 9e-24
 Identities = 46/201 (22%), Positives = 78/201 (38%), Gaps = 34/201 (16%)

Query: 512 NRFSENNLIGRGGFGPVY----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRI-RHRNL 566
           N      ++G G  G V       G  VA+K   + +        +E  ++     H N+
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNV 71

Query: 567 IKIISSCSNDDFKALVLEYMPLGSLE------KCLYSGNYILDIFQGLNIMIDVASALEY 620
           I+   S + D F  + LE     +L+              +   +  ++++  +AS + +
Sbjct: 72  IRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 621 LHFGYSVPIIHCDLKPSNVLLD-------------DNMVAHLSDFGMAKPLLEEDQSLTQ 667
           LH   S+ IIH DLKP N+L+              +N+   +SDFG+ K L     S   
Sbjct: 131 LH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187

Query: 668 TQTLA--TIGYMAPDEIFSGE 686
                  T G+ AP E+    
Sbjct: 188 NLNNPSGTSGWRAP-ELLEES 207

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  103 bits (258), Expect = 1e-23
 Identities = 50/186 (26%), Positives = 87/186 (46%), Gaps = 21/186 (11%)

Query: 519 LIGRGGFGPVYK-----DGMEVAIKVFN-LQYGGAFKSFDIECGMMKRIRHRNLIKI--I 570
           ++G+G    V++      G   AIKVFN + +         E  ++K++ H+N++K+  I
Sbjct: 16  ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75

Query: 571 SSCSNDDFKALVLEYMPLGSLEKCLYS-GN-YILDIFQGLNIMIDVASALEYLHFGYSVP 628
              +    K L++E+ P GSL   L    N Y L   + L ++ DV   + +L       
Sbjct: 76  EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENG 132

Query: 629 IIHCDLKPSNVLL----DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS 684
           I+H ++KP N++     D   V  L+DFG A+ L  ED     +    T  Y+ P +++ 
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL--EDDEQFVSL-YGTEEYLHP-DMYE 188

Query: 685 GEMRLK 690
             +  K
Sbjct: 189 RAVLRK 194

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  101 bits (253), Expect = 1e-23
 Identities = 47/205 (22%), Positives = 82/205 (40%), Gaps = 35/205 (17%)

Query: 511 TNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRN 565
            + F E  ++G+G FG V K     D    AIK           +   E  ++  + H+ 
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQY 63

Query: 566 LIKIISSCSNDDFKA-------------LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMI 612
           +++  ++                     + +EY   G+L   ++S N      +   +  
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123

Query: 613 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL--------LEEDQS 664
            +  AL Y+H   S  IIH DLKP N+ +D++    + DFG+AK +        L+    
Sbjct: 124 QILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180

Query: 665 LTQTQTLAT-IG---YMAPDEIFSG 685
              +  L + IG   Y+A  E+  G
Sbjct: 181 PGSSDNLTSAIGTAMYVAT-EVLDG 204

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  104 bits (262), Expect = 1e-23
 Identities = 49/181 (27%), Positives = 90/181 (49%), Gaps = 11/181 (6%)

Query: 518 NLIGRGGFGPVY----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSC 573
             +G+G FG V+         VAIK          ++F  E  +MK++RH  L+++ +  
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 574 SNDDFKALVLEYMPLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
           S +    +V EYM  GSL   L       L + Q +++   +AS + Y+     +  +H 
Sbjct: 332 SEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 387

Query: 633 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCW 692
           DL+ +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + AP+    G   +K  
Sbjct: 388 DLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446

Query: 693 V 693
           V
Sbjct: 447 V 447

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  101 bits (253), Expect = 1e-23
 Identities = 46/182 (25%), Positives = 80/182 (43%), Gaps = 21/182 (11%)

Query: 520 IGRGGFGPVYK---------DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKII 570
           +G+G FG V            G  VA+K          + F+ E  ++K ++H N++K  
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77

Query: 571 SSCSNDDFKA--LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVP 628
             C +   +   L++EY+P GSL   L      +D  + L     +   +EYL    +  
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 134

Query: 629 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAP----DEI 682
            IH DL   N+L+++     + DFG+ K +L +D+   + +      I + AP    +  
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEFFKVKEPGESPIFWYAPESLTESK 193

Query: 683 FS 684
           FS
Sbjct: 194 FS 195

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  101 bits (254), Expect = 1e-23
 Identities = 46/182 (25%), Positives = 80/182 (43%), Gaps = 21/182 (11%)

Query: 520 IGRGGFGPVYK---------DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKII 570
           +G+G FG V            G  VA+K          + F+ E  ++K ++H N++K  
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108

Query: 571 SSCSNDDFKA--LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVP 628
             C +   +   L++EY+P GSL   L      +D  + L     +   +EYL    +  
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 165

Query: 629 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAP----DEI 682
            IH DL   N+L+++     + DFG+ K +L +D+   + +      I + AP    +  
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEYYKVKEPGESPIFWYAPESLTESK 224

Query: 683 FS 684
           FS
Sbjct: 225 FS 226

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  101 bits (254), Expect = 1e-23
 Identities = 39/154 (25%), Positives = 63/154 (40%), Gaps = 14/154 (9%)

Query: 520 IGRGGFGPVYK---------DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKII 570
           +G+G FG V            G  VA+K          + F  E  ++K +    ++K  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90

Query: 571 SSCSNDDFKA--LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVP 628
                   ++  LV+EY+P G L   L      LD  + L     +   +EYL    S  
Sbjct: 91  GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 147

Query: 629 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED 662
            +H DL   N+L++      ++DFG+AK L  + 
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDK 181

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  100 bits (251), Expect = 1e-23
 Identities = 43/167 (25%), Positives = 73/167 (43%), Gaps = 15/167 (8%)

Query: 520 IGRGGFGPVY----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           +G G FG V     +   +VAIK+       +   F  E  +M  + H  L+++   C+ 
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90

Query: 576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL---HFGYSVPIIHC 632
                ++ EYM  G L   L    +     Q L +  DV  A+EYL    F      +H 
Sbjct: 91  QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF------LHR 144

Query: 633 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
           DL   N L++D  V  +SDFG+++  + +D+  +   +   + +  P
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPP 190

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =   99 bits (250), Expect = 2e-23
 Identities = 49/176 (27%), Positives = 76/176 (43%), Gaps = 19/176 (10%)

Query: 520 IGRGGFGPVY----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           +G G FG V     K   +VA+K+       +   F  E   M ++ H  L+K    CS 
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSK 74

Query: 576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL---HFGYSVPIIHC 632
           +    +V EY+  G L   L S    L+  Q L +  DV   + +L    F      IH 
Sbjct: 75  EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF------IHR 128

Query: 633 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP----DEIFS 684
           DL   N L+D ++   +SDFGM +  + +DQ ++   T   + + AP       +S
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPEVFHYFKYS 183

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  105 bits (262), Expect = 2e-23
 Identities = 52/184 (28%), Positives = 83/184 (45%), Gaps = 24/184 (13%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQ-YGGAFKSFDIECGMMKRIRHRNLIKII--- 570
           +G GGFG V +      G +VAIK    +      + + +E  +MK++ H N++      
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81

Query: 571 ---SSCSNDDFKALVLEYMPLGSLEKCL--YSGNYILDIFQGLNIMIDVASALEYLHFGY 625
                 + +D   L +EY   G L K L  +     L       ++ D++SAL YLH   
Sbjct: 82  DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH--- 138

Query: 626 SVPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              IIH DLKP N++L      ++  + D G AK L  +   L     + T+ Y+AP E+
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEF-VGTLQYLAP-EL 194

Query: 683 FSGE 686
              +
Sbjct: 195 LEQK 198

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  100 bits (251), Expect = 2e-23
 Identities = 50/177 (28%), Positives = 83/177 (46%), Gaps = 15/177 (8%)

Query: 512 NRFSENNLIGRGGFGPVYK--D---GMEVAIKVFNLQYGG--AFKS-FDIECGMMKRIRH 563
            R+   + +G GG   VY   D    ++VAIK   +           F+ E     ++ H
Sbjct: 11  ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70

Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHF 623
           +N++ +I     DD   LV+EY+   +L       +  L +   +N    +   +++ H 
Sbjct: 71  QNIVSMIDVDEEDDCYYLVMEYIEGPTL-SEYIESHGPLSVDTAINFTNQILDGIKHAH- 128

Query: 624 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT-LATIGYMAP 679
              + I+H D+KP N+L+D N    + DFG+AK L   + SLTQT   L T+ Y +P
Sbjct: 129 --DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSP 181

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  100 bits (250), Expect = 2e-23
 Identities = 45/176 (25%), Positives = 79/176 (44%), Gaps = 27/176 (15%)

Query: 520 IGRGGFGPVYK-------DGMEVAIKVFNLQYG----GAFKSFDIECGMMKRIRHRNLIK 568
           +G G FG V K           VA+K+  L+              E  +M+++ +  +++
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKI--LKNEANDPALKDELLAEANVMQQLDNPYIVR 82

Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL---HFGY 625
           +I  C  + +  LV+E   LG L K L    + +     + ++  V+  ++YL   +F  
Sbjct: 83  MIGICEAESWM-LVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEESNF-- 138

Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAP 679
               +H DL   NVLL     A +SDFG++K  L  D++  + QT     + + AP
Sbjct: 139 ----VHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAP 189

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  101 bits (254), Expect = 2e-23
 Identities = 45/186 (24%), Positives = 79/186 (42%), Gaps = 25/186 (13%)

Query: 518 NLIGRGGFGPVYK--------DGMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIK 568
            +IGRG FG VY           +  A+K  N     G    F  E  +MK   H N++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 569 IISSCSNDDFKAL-VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL---HFG 624
           ++  C   +   L VL YM  G L   + +  +   +   +   + VA  +++L    F 
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF- 213

Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAP--- 679
                +H DL   N +LD+     ++DFG+A+ + +++      +T A   + +MA    
Sbjct: 214 -----VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268

Query: 680 -DEIFS 684
             + F+
Sbjct: 269 QTQKFT 274

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  103 bits (258), Expect = 2e-23
 Identities = 47/142 (33%), Positives = 72/142 (50%), Gaps = 10/142 (7%)

Query: 520 IGRGGFGPVYK---DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSND 576
           IG+G FG V      G +VA+K   ++     ++F  E  +M ++RH NL++++     +
Sbjct: 201 IGKGEFGDVMLGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 258

Query: 577 DFKA-LVLEYMPLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDL 634
                +V EYM  GSL   L S    +L     L   +DV  A+EYL        +H DL
Sbjct: 259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDL 315

Query: 635 KPSNVLLDDNMVAHLSDFGMAK 656
              NVL+ ++ VA +SDFG+ K
Sbjct: 316 AARNVLVSEDNVAKVSDFGLTK 337

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  100 bits (251), Expect = 4e-23
 Identities = 43/179 (24%), Positives = 70/179 (39%), Gaps = 20/179 (11%)

Query: 520 IGRGGFGPVYK---------DGMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKI 569
           +G G FG VYK           + VAIK         A K    E  +M  + + ++ ++
Sbjct: 23  LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82

Query: 570 ISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL---HFGYS 626
           +  C     + L+ + MP G L   +      +     LN  + +A  + YL        
Sbjct: 83  LGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRL--- 138

Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG 685
              +H DL   NVL+       ++DFG+AK L  E++          I +MA + I   
Sbjct: 139 ---VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 98.8 bits (247), Expect = 5e-23
 Identities = 36/155 (23%), Positives = 66/155 (42%), Gaps = 19/155 (12%)

Query: 520 IGRGGFGPVYK--------DGMEVAIKVFNLQYGGAFKS-FDIECGMMKRIRHRNLIKII 570
           +G G FG VY+        + + VA+K          K  F  E  +MK + H +++K+I
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79

Query: 571 SSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL---HFGYSV 627
                +    +++E  P G L   L      L +   +   + +  A+ YL   +     
Sbjct: 80  GIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINC---- 134

Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED 662
             +H D+   N+L+       L DFG+++ + +ED
Sbjct: 135 --VHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 98.9 bits (247), Expect = 5e-23
 Identities = 39/166 (23%), Positives = 70/166 (42%), Gaps = 29/166 (17%)

Query: 520 IGRGGFGPVYK------------DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLI 567
           +G+G F  ++K               EV +KV +  +    +SF     MM ++ H++L+
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75

Query: 568 KIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL---HFG 624
                C   D   LV E++  GSL+  L      ++I   L +   +A+A+ +L      
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTL- 134

Query: 625 YSVPIIHCDLKPSNVLLD--------DNMVAHLSDFGMAKPLLEED 662
                IH ++   N+LL         +     LSD G++  +L +D
Sbjct: 135 -----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  102 bits (255), Expect = 5e-23
 Identities = 40/173 (23%), Positives = 83/173 (47%), Gaps = 11/173 (6%)

Query: 518 NLIGRGGFGPVY----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSC 573
             +G G FG V+        +VA+K          ++F  E  +MK ++H  L+K+ +  
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 574 SNDDFKALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
           + +    ++ E+M  GSL   L S       + + ++    +A  + ++        IH 
Sbjct: 253 TKEPI-YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHR 308

Query: 633 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG 685
           DL+ +N+L+  ++V  ++DFG+A+ ++E+++   +      I + AP+ I  G
Sbjct: 309 DLRAANILVSASLVCKIADFGLAR-VIEDNEYTAREGAKFPIKWTAPEAINFG 360

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  103 bits (257), Expect = 6e-23
 Identities = 40/154 (25%), Positives = 69/154 (44%), Gaps = 18/154 (11%)

Query: 520 IGRGGFGPVYK-------DGMEVAIKVFNLQYGGAFKS-FDIECGMMKRIRHRNLIKIIS 571
           +G G FG V +         ++VAIKV       A       E  +M ++ +  ++++I 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403

Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL---HFGYSVP 628
            C  +    LV+E    G L K L      + +     ++  V+  ++YL   +F     
Sbjct: 404 VCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNF----- 457

Query: 629 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED 662
            +H +L   NVLL +   A +SDFG++K L  +D
Sbjct: 458 -VHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 98.5 bits (246), Expect = 7e-23
 Identities = 46/175 (26%), Positives = 79/175 (45%), Gaps = 15/175 (8%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G +G VY+       + VA+K          + F  E  +MK I+H NL++++  C+
Sbjct: 21  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCT 79

Query: 575 NDDFKALVLEYMPLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
            +    ++ E+M  G+L   L   N   +     L +   ++SA+EYL        IH D
Sbjct: 80  REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRD 136

Query: 634 LKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP----DEIFS 684
           L   N L+ +N +  ++DFG+++ L+  D           I + AP       FS
Sbjct: 137 LAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 98.1 bits (245), Expect = 8e-23
 Identities = 61/251 (24%), Positives = 97/251 (38%), Gaps = 46/251 (18%)

Query: 69  VPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIF-NASK 127
           +P  +    + K+L L  N L   L S +    P L+ L L     I TI    + + S 
Sbjct: 22  IPDNLP--FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCE-IQTIEDGAYQSLSH 77

Query: 128 LSELGLQKNSFSGSIP-NTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSF 186
           LS L L  N    S+    F  L +L+ L   +  L S       +  L     L+  + 
Sbjct: 78  LSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLEN--FPIGHLKT---LKELNV 131

Query: 187 SNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSI 246
           ++N +            +  E F               +NLTN  L+ L L  N+++ SI
Sbjct: 132 AHNLIQSF---------KLPEYF---------------SNLTN--LEHLDLSSNKIQ-SI 164

Query: 247 P-DDLCRLAAL----FQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPS-TLWNL 300
              DL  L  +      LDL  N ++ F+   +     L++L L +N L S+P      L
Sbjct: 165 YCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRL 223

Query: 301 KDILHLNLSSN 311
             +  + L +N
Sbjct: 224 TSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 93.5 bits (233), Expect = 3e-21
 Identities = 53/214 (24%), Positives = 82/214 (38%), Gaps = 11/214 (5%)

Query: 201 NLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLC-RLAALFQL 259
           NL  S ++  +    +         +   L  Q+L L   +++ +I D     L+ L  L
Sbjct: 25  NLPFSTKNLDLSFNPLRHLGSYSFFSFPEL--QVLDLSRCEIQ-TIEDGAYQSLSHLSTL 81

Query: 260 DLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLW-NLKDILHLNLSSNFFTG-PL 317
            L GN +          L++L+KL      L S+ +    +LK +  LN++ N      L
Sbjct: 82  ILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKL 141

Query: 318 PLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQY----LFLEYNRLQGSIPNSIGDLI 373
           P    NL  L  LDLS N    +  T +  L  +      L L  N +   I       I
Sbjct: 142 PEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEI 200

Query: 374 SLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFN 407
            LK L L  N L        ++L  L+ I +  N
Sbjct: 201 RLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 92.7 bits (231), Expect = 5e-21
 Identities = 56/251 (22%), Positives = 96/251 (38%), Gaps = 49/251 (19%)

Query: 20  PSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTL 79
           P S + L LS+N                    L ++   +F              +   L
Sbjct: 27  PFSTKNLDLSFN-------------------PLRHLGSYSFF-------------SFPEL 54

Query: 80  KSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNA-SKLSELGLQKNSF 138
           + L L    +   +   A   L +L  L L GN  I ++    F+  S L +L   + + 
Sbjct: 55  QVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP-IQSLALGAFSGLSSLQKLVAVETNL 112

Query: 139 SGSIP-NTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPR 197
           + S+     G+L+ LK L +  N +  S       S+L+N   LE+   S+N +  I   
Sbjct: 113 A-SLENFPIGHLKTLKELNVAHNLIQ-SFKLPEYFSNLTN---LEHLDLSSNKIQSIYCT 167

Query: 198 AIGNLSQ---SMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDD-LCRL 253
            +  L Q         +    ++  I         + L+ L+L+ NQL+ S+PD    RL
Sbjct: 168 DLRVLHQMPLLNLSLDLSLNPMN-FIQPGA--FKEIRLKELALDTNQLK-SVPDGIFDRL 223

Query: 254 AALFQLDLGGN 264
            +L ++ L  N
Sbjct: 224 TSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 83.9 bits (208), Expect = 6e-18
 Identities = 61/268 (22%), Positives = 98/268 (36%), Gaps = 57/268 (21%)

Query: 118 IPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSN 177
           IP  +  ++K   L L  N        +F +   L+ L L+   + +      +  SLS+
Sbjct: 22  IPDNLPFSTK--NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED--GAYQSLSH 77

Query: 178 CKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEI-NNLTNLILQLLS 236
              L     + NP+  +   A   LS   +       N++ S+      +L    L+ L+
Sbjct: 78  ---LSTLILTGNPIQSLALGAFSGLSSL-QKLVAVETNLA-SLENFPIGHLKT--LKELN 130

Query: 237 LEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPST 296
           +  N ++ S       L   F                  NLTNL  L L SN + SI   
Sbjct: 131 VAHNLIQ-SFK-----LPEYFS-----------------NLTNLEHLDLSSNKIQSIY-- 165

Query: 297 LWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFL 356
                                 + + NL     LDLS+N  +  I         L+ L L
Sbjct: 166 -------------CTDLRVLHQMPLLNL----SLDLSLNPMN-FIQPGAFKEIRLKELAL 207

Query: 357 EYNRLQGSIPNSIGD-LISLKSLNLSNN 383
           + N+L+ S+P+ I D L SL+ + L  N
Sbjct: 208 DTNQLK-SVPDGIFDRLTSLQKIWLHTN 234

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 70.0 bits (172), Expect = 3e-13
 Identities = 37/178 (20%), Positives = 60/178 (33%), Gaps = 26/178 (14%)

Query: 21  SSLQTLYLSYNPPSGSIPSFILCEIPHEI-DNLHNMEWMAFSFNKVVGVVPTTIFNVSTL 79
           S L TL L+ NP         +  +       L +++ +      +  +    I ++ TL
Sbjct: 76  SHLSTLILTGNP---------IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126

Query: 80  KSLYLHSNSLSGRLPSSADV--RLPNLKELHLWGNNFIGTIPSFIF-NASKL----SELG 132
           K L +  N +        +    L NL+ L L  N  I +I         ++      L 
Sbjct: 127 KELNVAHNLIQ-SFK-LPEYFSNLTNLEHLDLSSNK-IQSIYCTDLRVLHQMPLLNLSLD 183

Query: 133 LQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNP 190
           L  N  +   P  F  +  LK L L+ N L S    +           L+      NP
Sbjct: 184 LSLNPMNFIQPGAFKEI-RLKELALDTNQLKSVPDGI-----FDRLTSLQKIWLHTNP 235

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 66.1 bits (162), Expect = 6e-12
 Identities = 33/147 (22%), Positives = 54/147 (36%), Gaps = 15/147 (10%)

Query: 19  NPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIF-NVS 77
             SSLQ L         S+ +F        I +L  ++ +  + N +        F N++
Sbjct: 98  GLSSLQKLVAVETN-LASLENFP-------IGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149

Query: 78  TLKSLYLHSNSLSGRLPSSADVRLPNLK----ELHLWGNNFIGTIPSFIFNASKLSELGL 133
            L+ L L SN +   +  +    L  +      L L  N  +  I    F   +L EL L
Sbjct: 150 NLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNP-MNFIQPGAFKEIRLKELAL 207

Query: 134 QKNSFSGSIPNTFGNLRNLKWLGLNDN 160
             N         F  L +L+ + L+ N
Sbjct: 208 DTNQLKSVPDGIFDRLTSLQKIWLHTN 234

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 98.9 bits (247), Expect = 1e-22
 Identities = 44/194 (22%), Positives = 82/194 (42%), Gaps = 37/194 (19%)

Query: 520 IGRGGFGPVYK--------DGMEVAIKVFNLQYGGA----FKSFDIECGMMKRIRHRNLI 567
           +G G FG V +          ++VA+K   ++   +     + F  E   MK   H N+I
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKT--MKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 568 KIISSCSNDDFKA-----LVLEYMPLGSL-----EKCLYSGNYILDIFQGLNIMIDVASA 617
           +++  C     +      ++L +M  G L        L +G   + +   L  M+D+A  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 618 LEYL---HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI 674
           +EYL   +F      +H DL   N +L D+M   ++DFG++K +   D           +
Sbjct: 160 MEYLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 213

Query: 675 GYMAP----DEIFS 684
            ++A     D +++
Sbjct: 214 KWIAIESLADRVYT 227

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 98.9 bits (247), Expect = 1e-22
 Identities = 49/173 (28%), Positives = 77/173 (44%), Gaps = 19/173 (10%)

Query: 520 IGRGGFGPVYK--------DGMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKII 570
           IG G  G V            + VAIK     Y     + F  E  +M +  H N+I++ 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116

Query: 571 SSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL---HFGYSV 627
              +      +V EYM  GSL+  L + +    I Q + ++  V + + YL    +    
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY---- 172

Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL-EEDQSLTQTQTLATIGYMAP 679
             +H DL   NVL+D N+V  +SDFG+++ L  + D + T T     I + AP
Sbjct: 173 --VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAP 223

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 98.1 bits (245), Expect = 1e-22
 Identities = 40/185 (21%), Positives = 81/185 (43%), Gaps = 21/185 (11%)

Query: 516 ENNLIGRGGFGPVYK--------DGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNL 566
            + +IG+G FG VY         + ++ AIK  +        ++F  E  +M+ + H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84

Query: 567 IKIISSCSNDD-FKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL---H 622
           + +I      +    ++L YM  G L + + S      +   ++  + VA  +EYL    
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK 144

Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED--QSLTQTQTLATIGYMAPD 680
           F      +H DL   N +LD++    ++DFG+A+ +L+ +             + + A +
Sbjct: 145 F------VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198

Query: 681 EIFSG 685
            + + 
Sbjct: 199 SLQTY 203

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 97.8 bits (244), Expect = 1e-22
 Identities = 46/178 (25%), Positives = 71/178 (39%), Gaps = 24/178 (13%)

Query: 517 NNLIGRGGFGPVYK-----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRNLIKI 569
           +  IGRG F  VYK       +EVA              + F  E  M+K ++H N+++ 
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 570 ISSCSNDDFKA----LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY 625
             S  +         LV E M  G+L+  L     ++ I    +    +   L++LH   
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH-TR 148

Query: 626 SVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG---YMAP 679
           + PIIH DLK  N+ +        + D G+A            +   A IG   +MAP
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-------LKRASFAKAVIGTPEFMAP 199

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  101 bits (252), Expect = 2e-22
 Identities = 54/372 (14%), Positives = 105/372 (28%), Gaps = 50/372 (13%)

Query: 77  STLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNA-SKLSELGLQK 135
              K+L L  NS+S  L       L  L+ L L  N  I ++   +F     L  L +  
Sbjct: 52  PRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNR-IRSLDFHVFLFNQDLEYLDVSH 109

Query: 136 NSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGIL 195
           N    +I      + +L+ L L+ N      P      +L+    L +   S      + 
Sbjct: 110 NRLQ-NIS--CCPMASLRHLDLSFNDFDV-LPVCKEFGNLTK---LTFLGLSAAKFRQLD 162

Query: 196 PRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAA 255
              + +L  S     + + +I G   E +      +L L+    +     +   +  L  
Sbjct: 163 LLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGH 222

Query: 256 L--FQLDLGGNKLSGFVPACSGNLTN-------LRKLYLGSNLLTSIPSTLWNLKDILHL 306
           L    + L        +   S            L+ +         +    W  + + +L
Sbjct: 223 LQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWP-RPVEYL 281

Query: 307 NLSSNFFTGPLPLKIGN-----------------------------LNVLVQLDLSMNNF 337
           N+ +   T  +  +                                   +    LS+++ 
Sbjct: 282 NIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDT 341

Query: 338 SCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLL 397
             +            +L    N    S+      L  L++L L  N L            
Sbjct: 342 PFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-NFFKVALMTK 400

Query: 398 DLKDINVSFNRL 409
           ++  +      L
Sbjct: 401 NMSSLETLDVSL 412

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score =  100 bits (251), Expect = 3e-22
 Identities = 71/403 (17%), Positives = 141/403 (34%), Gaps = 48/403 (11%)

Query: 18  GNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVS 77
              +SL+ L LS+N     +P      +  E  NL  + ++  S  K   +         
Sbjct: 118 CPMASLRHLDLSFNDFD-VLP------VCKEFGNLTKLTFLGLSAAKFRQL-DLLPVAHL 169

Query: 78  TLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGN-NFIGTIPSFIFNAS----KLSELG 132
            L  + L   S   +   +  +++PN   LHL  + N + ++   +   +    +LS + 
Sbjct: 170 HLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIK 229

Query: 133 LQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLG 192
           L   +    +       R    L +   ++ ++      L      + +EY +  N  + 
Sbjct: 230 LNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTIT 289

Query: 193 GILPRAIGNLSQSMEDF----WMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPD 248
             + R     S++         + N     S     +    + +++LS+        +  
Sbjct: 290 ERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCP 349

Query: 249 DLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPST---LWNLKDILH 305
                ++   L+   N  +  V      L  L+ L L  N L +         N+  +  
Sbjct: 350 P--SPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLET 407

Query: 306 LNLSSN---------FFTGPLPLKIGNLNV--------------LVQLDLSMNNFSCVIP 342
           L++S N                + + NL+               +  LDL  N     IP
Sbjct: 408 LDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIM-SIP 466

Query: 343 TKIGGLKDLQYLFLEYNRLQGSIPNSIGD-LISLKSLNLSNNN 384
             +  L+ LQ L +  N+L+ S+P+ + D L SL+ + L +N 
Sbjct: 467 KDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNP 508

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 86.8 bits (215), Expect = 8e-18
 Identities = 52/335 (15%), Positives = 110/335 (32%), Gaps = 21/335 (6%)

Query: 16  QLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLH--NMEWMAFSFNKVVGVVPTTI 73
           +  +     T  L       S+ S  +    + + +L   N++    +  +++  +    
Sbjct: 187 ETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELT 246

Query: 74  FNVSTLKSLYLHSNSLSGRLPSS-ADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSE-- 130
              + L     H  +                ++ L+++       I    F  S+ +   
Sbjct: 247 RGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKS 306

Query: 131 ---LGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFS 187
                ++   F  S    +     +    L+ +             S S+     + +F+
Sbjct: 307 LMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPP--SPSS---FTFLNFT 361

Query: 188 NNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNL-ILQLLSLEGNQLEGSI 246
            N     + +    L +      +    +  +  +      N+  L+ L +  N L    
Sbjct: 362 QNVFTDSVFQGCSTLKRLQT-LILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHA 419

Query: 247 PDDLCRLAA-LFQLDLGGNKLSGFVPACSGNLT-NLRKLYLGSNLLTSIPSTLWNLKDIL 304
            D  C  A  +  L+L  N L+G V  C   L   ++ L L +N + SIP  + +L+ + 
Sbjct: 420 YDRTCAWAESILVLNLSSNMLTGSVFRC---LPPKVKVLDLHNNRIMSIPKDVTHLQALQ 476

Query: 305 HLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSC 339
            LN++SN            L  L  + L  N + C
Sbjct: 477 ELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWDC 511

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 96.9 bits (242), Expect = 2e-22
 Identities = 44/172 (25%), Positives = 76/172 (44%), Gaps = 20/172 (11%)

Query: 520 IGRGGFGPVYK--------DGMEVAIKVFNLQYGGAFKS-FDIECGMMKRIRHRNLIKII 570
           IG G FG V++          + VAIK        + +  F  E   M++  H +++K+I
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82

Query: 571 SSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL---HFGYSV 627
              + +    +++E   LG L   L    Y LD+   +     +++AL YL    F    
Sbjct: 83  GVITENPVW-IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRF---- 137

Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
             +H D+   NVL+  N    L DFG+++  +E+      ++    I +MAP
Sbjct: 138 --VHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAP 186

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 96.9 bits (242), Expect = 2e-22
 Identities = 42/174 (24%), Positives = 85/174 (48%), Gaps = 15/174 (8%)

Query: 520 IGRGGFGPVY----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN 575
           +G G FG V+        +VA+K           +F  E  +MK+++H+ L+++ +  + 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVVTQ 79

Query: 576 DDFKALVLEYMPLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDL 634
           +    ++ EYM  GSL   L + +   L I + L++   +A  + ++        IH DL
Sbjct: 80  EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDL 135

Query: 635 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP----DEIFS 684
           + +N+L+ D +   ++DFG+A+ L+E+++   +      I + AP       F+
Sbjct: 136 RAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGTFT 188

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score =  101 bits (252), Expect = 2e-22
 Identities = 55/242 (22%), Positives = 89/242 (36%), Gaps = 18/242 (7%)

Query: 168 ELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNL 227
            +  +            +     +   +      L  S++    +N +I  S+ + I  L
Sbjct: 10  PIKQIFPDDAFAETIKDNLKKKSVTDAVT--QNEL-NSIDQIIANNSDIK-SV-QGIQYL 64

Query: 228 TNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGS 287
            N+    L L GN+L   I   L  L  L  L L  NK+         +L  L+ L L  
Sbjct: 65  PNV--TKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKIKDLSSLK--DLKKLKSLSLEH 118

Query: 288 NLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGG 347
           N ++ I + L +L  +  L L +N  T    L    L  L  L L  N  S ++P  + G
Sbjct: 119 NGISDI-NGLVHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQISDIVP--LAG 173

Query: 348 LKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFN 407
           L  LQ L+L  N +  S   ++  L +L  L L +             L+    +  +  
Sbjct: 174 LTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDG 231

Query: 408 RL 409
            L
Sbjct: 232 SL 233

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 84.4 bits (208), Expect = 5e-17
 Identities = 57/370 (15%), Positives = 109/370 (29%), Gaps = 39/370 (10%)

Query: 49  IDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELH 108
            D              V   V      ++++  +  +++ +   +       LPN+ +L 
Sbjct: 17  DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQGIQY--LPNVTKLF 71

Query: 109 LWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPE 168
           L GN  +  I   + N   L  L L +N     + +   +L+ LK L L  N        
Sbjct: 72  LNGNK-LTDI-KPLTNLKNLGWLFLDENKIK-DLSS-LKDLKKLKSLSLEHN-------G 120

Query: 169 LSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLT 228
           +S ++ L +   LE     NN +  I    +  L+  ++   +++  IS     +I  L 
Sbjct: 121 ISDINGLVHLPQLESLYLGNNKITDITV--LSRLT-KLDTLSLEDNQIS-----DIVPLA 172

Query: 229 NLI-LQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGS 287
            L  LQ L L  N +  S    L  L  L  L+L   +          NL     +    
Sbjct: 173 GLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTD 230

Query: 288 NLLT-----SIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIP 342
             L      S            HL   +N  +      +       +    +      + 
Sbjct: 231 GSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVY 290

Query: 343 TKIGGLKDLQYL-------FLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEK 395
           T    +              +   +             + K+     N  +  +  +   
Sbjct: 291 TVSYDVDGTVIKTKVEAGTRITAPKPPTKQGYVFKGWYTEKNGGHEWNFNTDYMSGNDFT 350

Query: 396 LLDLKDINVS 405
           L  +     +
Sbjct: 351 LYAVFKAETT 360

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 77.8 bits (191), Expect = 6e-15
 Identities = 52/301 (17%), Positives = 92/301 (30%), Gaps = 57/301 (18%)

Query: 14  LSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTI 73
                  +S+  +  + +     I S         I  L N+  +  + NK+  + P  +
Sbjct: 36  AVTQNELNSIDQIIANNS----DIKSV------QGIQYLPNVTKLFLNGNKLTDIKP--L 83

Query: 74  FNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGL 133
            N+  L  L+L  N +   L S  D  L  LK L L  +N I  I + + +  +L  L L
Sbjct: 84  TNLKNLGWLFLDENKIK-DLSSLKD--LKKLKSLSL-EHNGISDI-NGLVHLPQLESLYL 138

Query: 134 QKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGG 193
             N  +  I      L  L  L L DN       ++S +  L+    L+    S N +  
Sbjct: 139 GNNKIT-DITV-LSRLTKLDTLSLEDN-------QISDIVPLAGLTKLQNLYLSKNHISD 189

Query: 194 ILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRL 253
           +                             +  L N  L +L L   +      +    L
Sbjct: 190 L---------------------------RALAGLKN--LDVLELFSQECLNKPINHQSNL 220

Query: 254 AALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFF 313
                +      L    P    +  +  K  +  +L        +     + +  +   F
Sbjct: 221 VVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARF 278

Query: 314 T 314
            
Sbjct: 279 H 279

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 98.3 bits (245), Expect = 2e-22
 Identities = 42/194 (21%), Positives = 72/194 (37%), Gaps = 34/194 (17%)

Query: 520 IGRGGFGPVY---KDGMEVAIKVFN-----------------LQYGGAFKSFDIECGMMK 559
           + +G F  +    KD    A+K +                  +     +  F  E  ++ 
Sbjct: 39  LNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98

Query: 560 RIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGL-------NIMI 612
            I++   +      +N D   ++ EYM   S+ K       +   +           I+ 
Sbjct: 99  DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIK 158

Query: 613 DVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA 672
            V ++  Y+H      I H D+KPSN+L+D N    LSDFG ++          +  +  
Sbjct: 159 SVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESE---YMVDKKIKG-SRG 212

Query: 673 TIGYMAPDEIFSGE 686
           T  +M P E FS E
Sbjct: 213 TYEFMPP-EFFSNE 225

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 96.5 bits (241), Expect = 3e-22
 Identities = 48/144 (33%), Positives = 73/144 (50%), Gaps = 10/144 (6%)

Query: 518 NLIGRGGFGPVYK---DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
             IG+G FG V      G +VA+K   ++     ++F  E  +M ++RH NL++++    
Sbjct: 27  QTIGKGEFGDVMLGDYRGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 84

Query: 575 NDDFKA-LVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
            +     +V EYM  GSL   L S G  +L     L   +DV  A+EYL        +H 
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHR 141

Query: 633 DLKPSNVLLDDNMVAHLSDFGMAK 656
           DL   NVL+ ++ VA +SDFG+ K
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTK 165

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 97.4 bits (243), Expect = 3e-22
 Identities = 48/183 (26%), Positives = 78/183 (42%), Gaps = 24/183 (13%)

Query: 520 IGRGGFGPVYK---------DGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKI 569
           +G G FG V            G  VA+K      G      +  E  +++ + H ++IK 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98

Query: 570 ISSCSNDDFKA--LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
              C +    +  LV+EY+PLGSL   L   +  + + Q L     +   + YLH   + 
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQ 153

Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT--IGYMAP----DE 681
             IH DL   NVLLD++ +  + DFG+AK  + E     + +      + + AP    + 
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAK-AVPEGHEYYRVREDGDSPVFWYAPECLKEY 212

Query: 682 IFS 684
            F 
Sbjct: 213 KFY 215

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 97.0 bits (242), Expect = 3e-22
 Identities = 42/206 (20%), Positives = 78/206 (37%), Gaps = 36/206 (17%)

Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFK-SFDIECGMMKRIRHRN 565
             F     +GRGGFG V++     D    AIK   L      +     E   + ++ H  
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64

Query: 566 LIKIISSCSNDDFKA------------LVLEYMPLGSLEKCL--YSGNYILDIFQGLNIM 611
           +++  ++    +               + ++     +L+  +         +    L+I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 612 IDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL 671
           + +A A+E+LH   S  ++H DLKPSN+    + V  + DFG+    +++D+      T 
Sbjct: 125 LQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVT-AMDQDEEEQTVLTP 180

Query: 672 ATIG-----------YMAPDEIFSGE 686
                          YM+P E   G 
Sbjct: 181 MPAYARHTGQVGTKLYMSP-EQIHGN 205

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 97.3 bits (242), Expect = 3e-22
 Identities = 53/320 (16%), Positives = 95/320 (29%), Gaps = 46/320 (14%)

Query: 113 NFIGTIPSF--IFNASKLSELGLQKNSFS--------GSIPNTFGNLRNLKWLGLNDNYL 162
           NF    P +   FN    +++ L     S         +  +       +K L L    +
Sbjct: 16  NFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTV 75

Query: 163 TS---STPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLS-QSMEDFWMDNCNISG 218
            +    +  L     +     L+  +  N  + G  P  +   +   +    + N + + 
Sbjct: 76  RAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT 135

Query: 219 --SIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVP----A 272
             +   E+       L++LS+          + +    AL  LDL  N   G        
Sbjct: 136 RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISAL 195

Query: 273 CSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDL 332
           C      L+ L L +  + +       L                          L  LDL
Sbjct: 196 CPLKFPTLQVLALRNAGMETPSGVCSAL--------------------AAARVQLQGLDL 235

Query: 333 SMNNFSCVIPTKI-GGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPI 391
           S N+               L  L L +  L+  +P  +     L  L+LS N L    P 
Sbjct: 236 SHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPA--KLSVLDLSYNRLD-RNPS 291

Query: 392 SLEKLLDLKDINVSFNRLEG 411
             E L  + ++++  N    
Sbjct: 292 PDE-LPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 88.4 bits (219), Expect = 3e-19
 Identities = 53/321 (16%), Positives = 87/321 (27%), Gaps = 67/321 (20%)

Query: 79  LKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPS---FIFNASKLSELGLQK 135
           L+ L    ++ +     +  ++  +LK L +        I      +   S L EL L+ 
Sbjct: 45  LEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLEN 104

Query: 136 NSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGIL 195
              +G+ P                                     L   +  N       
Sbjct: 105 LEVTGTAPPPLLEATGPD---------------------------LNILNLRNVSWATR- 136

Query: 196 PRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAA 255
                                  +   E+       L++LS+          + +    A
Sbjct: 137 ----------------------DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPA 174

Query: 256 LFQLDLGGNKLSGFVP----ACSGNLTNLRKLYLGSNLLTSIP----STLWNLKDILHLN 307
           L  LDL  N   G        C      L+ L L +  + +      +       +  L+
Sbjct: 175 LSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLD 234

Query: 308 LSSNFFTG-PLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIP 366
           LS N              + L  L+LS      V     G    L  L L YNRL    P
Sbjct: 235 LSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPK---GLPAKLSVLDLSYNRLD-RNP 290

Query: 367 NSIGDLISLKSLNLSNNNLSG 387
            S  +L  + +L+L  N    
Sbjct: 291 -SPDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 77.6 bits (191), Expect = 1e-15
 Identities = 54/320 (16%), Positives = 85/320 (26%), Gaps = 64/320 (20%)

Query: 3   SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSF 62
              +        + +    SL+ L +        I    L      +  +  ++ +    
Sbjct: 50  KRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGAL-----RVLGISGLQELTLEN 104

Query: 63  NKVVGVVPTTIFNVS--TLKSLYLHSNSLSGRLPSSADVR---LPNLKELHLWGNNFIGT 117
            +V G  P  +   +   L  L L + S + R    A+++    P LK L +        
Sbjct: 105 LEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSI-AQAHSLN 163

Query: 118 IPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSN 177
                                             L  L L+DN        +S+L     
Sbjct: 164 FS-----------------------CEQVRVFPALSTLDLSDNPELGERGLISAL-CPLK 199

Query: 178 CKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSL 237
              L+  +  N  +                         SG             LQ L L
Sbjct: 200 FPTLQVLALRNAGM----------------------ETPSGVCSALAAARVQ--LQGLDL 235

Query: 238 EGNQLEGSIPDDLCR-LAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPST 296
             N L  +     C   + L  L+L    L   VP        L  L L  N L   PS 
Sbjct: 236 SHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGL--PAKLSVLDLSYNRLDRNPS- 291

Query: 297 LWNLKDILHLNLSSNFFTGP 316
              L  + +L+L  N F   
Sbjct: 292 PDELPQVGNLSLKGNPFLDS 311

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 60.7 bits (147), Expect = 5e-10
 Identities = 36/250 (14%), Positives = 68/250 (27%), Gaps = 40/250 (16%)

Query: 208 DFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGN-KL 266
           D    +CN S   P+  +    L    + L G                L  L    + + 
Sbjct: 9   DEESCSCNFSDPKPDWSSAFNCLGAADVELYGGGRS------------LEYLLKRVDTEA 56

Query: 267 SGFVPACSGNLTNLRKLYLGSNLLTSIPST----LWNLKDILHLNLSSNFFTGPLPLKIG 322
                       +L++L + +  + S        +  +  +  L L +   TG  P  + 
Sbjct: 57  DLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLL 116

Query: 323 NLNVLVQLDLSMNNFSCVIPTKIGG------LKDLQYLFLEYNRLQGSIPNSIGDLISLK 376
                    L++ N S                  L+ L +            +    +L 
Sbjct: 117 EATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALS 176

Query: 377 SLNLSNNNLSGTIPIS----LEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNEL 432
           +L+LS+N   G   +       K   L+ + +                 +   S   + L
Sbjct: 177 TLDLSDNPELGERGLISALCPLKFPTLQVLALRNA-------------GMETPSGVCSAL 223

Query: 433 LCGMPNLQVL 442
                 LQ L
Sbjct: 224 AAARVQLQGL 233

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 96.6 bits (241), Expect = 4e-22
 Identities = 51/188 (27%), Positives = 85/188 (45%), Gaps = 33/188 (17%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI---------ECGMMKRI-RHR 564
           +GRG    V +        E A+K+ ++  GG+F + ++         E  +++++  H 
Sbjct: 25  LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84

Query: 565 NLIKIISSCSNDDFKALVLEYMPLGSL-----EKCLYSGNYILDIFQGLNIMIDVASALE 619
           N+I++  +   + F  LV + M  G L     EK   S      I +       +   + 
Sbjct: 85  NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMR------ALLEVIC 138

Query: 620 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
            LH    + I+H DLKP N+LLDD+M   L+DFG +   L+  + L   +   T  Y+AP
Sbjct: 139 ALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC-QLDPGEKL--REVCGTPSYLAP 192

Query: 680 DEIFSGEM 687
            EI    M
Sbjct: 193 -EIIECSM 199

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 96.6 bits (241), Expect = 5e-22
 Identities = 40/181 (22%), Positives = 80/181 (44%), Gaps = 17/181 (9%)

Query: 512 NRFSENNLIGRGGFGPVYK--D---GMEVAIKVFNLQYGG--AFKS-FDIECGMMKRIRH 563
           +R+    ++G GG   V+   D     +VA+KV         +F   F  E      + H
Sbjct: 12  DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71

Query: 564 RNLIKIISSCSNDDFKA----LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALE 619
             ++ +  +   +        +V+EY+   +L + +      +   + + ++ D   AL 
Sbjct: 72  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL-RDIVHTEGPMTPKRAIEVIADACQALN 130

Query: 620 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT-LATIGYMA 678
           + H      IIH D+KP+N+++       + DFG+A+ + +   S+TQT   + T  Y++
Sbjct: 131 FSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187

Query: 679 P 679
           P
Sbjct: 188 P 188

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 97.8 bits (244), Expect = 6e-22
 Identities = 45/176 (25%), Positives = 80/176 (45%), Gaps = 19/176 (10%)

Query: 520 IGRGGFGPVYK--------DGMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKII 570
           +G G FG V            + VAIK   + Y     + F  E  +M +  H N+I++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112

Query: 571 SSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL---HFGYSV 627
              +      +V EYM  GSL+  L   +    + Q + ++  +AS ++YL    +    
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY---- 168

Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL-EEDQSLTQTQTLATIGYMAPDEI 682
             +H DL   N+L++ N+V  +SDFG+ + L  + + + T       I + +P+ I
Sbjct: 169 --VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 97.2 bits (242), Expect = 7e-22
 Identities = 51/271 (18%), Positives = 92/271 (33%), Gaps = 34/271 (12%)

Query: 42  LCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRL 101
           + EIP ++    N   + F   K+  +          L+ + +  N +   + +     L
Sbjct: 21  VTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNL 78

Query: 102 PNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNY 161
           P L E+ +   N +  I                        P  F NL NL++L +++  
Sbjct: 79  PKLHEIRIEKANNLLYIN-----------------------PEAFQNLPNLQYLLISNTG 115

Query: 162 LTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIP 221
           +    P++  + SL     L+     N  +  I   +   LS      W++   I   I 
Sbjct: 116 IKHL-PDVHKIHSLQK-VLLDI--QDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIH 170

Query: 222 EEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLR 281
               N T L  +L   + N LE    D     +    LD+   ++         NL  LR
Sbjct: 171 NSAFNGTQL-DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLR 229

Query: 282 KLYLGSNLLTSIPSTLWNLKDILHLNLSSNF 312
                   L  +P+ L  L  ++  +L+   
Sbjct: 230 ARST--YNLKKLPT-LEKLVALMEASLTYPS 257

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 89.9 bits (223), Expect = 2e-19
 Identities = 50/286 (17%), Positives = 91/286 (31%), Gaps = 44/286 (15%)

Query: 103 NLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYL 162
           + +      +  +  IPS +       EL              F    +L+ + ++ N +
Sbjct: 10  SNRVFLCQESK-VTEIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDV 66

Query: 163 TSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPE 222
                E    S+L     +                             ++  N    I  
Sbjct: 67  LE-VIEADVFSNLPKLHEIR----------------------------IEKANNLLYINP 97

Query: 223 EI-NNLTNLILQLLSLEGNQLEGSIPDDL-CRLAALFQLDLGGNKLSGFVPACS--GNLT 278
           E   NL NL  Q L +    ++  +PD           LD+  N     +   S  G   
Sbjct: 98  EAFQNLPNL--QYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSF 154

Query: 279 NLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKI-GNLNVLVQLDLSMNNF 337
               L+L  N +  I ++ +N   +  LNLS N     LP  +    +  V LD+S    
Sbjct: 155 ESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRI 214

Query: 338 SCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNN 383
             +    +  LK L+       +    +P ++  L++L   +L+  
Sbjct: 215 HSLPSYGLENLKKLRARSTYNLK---KLP-TLEKLVALMEASLTYP 256

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 79.1 bits (195), Expect = 6e-16
 Identities = 33/209 (15%), Positives = 71/209 (33%), Gaps = 9/209 (4%)

Query: 201 NLSQSMEDFWMDNCNISGSIPEEI-NNLTNLILQLLSLEGNQLEGSIPDD-LCRLAALFQ 258
           +L ++  +       +   I +   +   +L  + + +  N +   I  D    L  L +
Sbjct: 27  DLPRNAIELRFVLTKLR-VIQKGAFSGFGDL--EKIEISQNDVLEVIEADVFSNLPKLHE 83

Query: 259 LDL-GGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPS-TLWNLKDILHLNLSSNFFTGP 316
           + +   N L    P    NL NL+ L + +  +  +P     +    + L++  N     
Sbjct: 84  IRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHT 143

Query: 317 LPLKI--GNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLIS 374
           +      G     V L L+ N    +  +   G +  +    + N L+    +       
Sbjct: 144 IERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASG 203

Query: 375 LKSLNLSNNNLSGTIPISLEKLLDLKDIN 403
              L++S   +       LE L  L+  +
Sbjct: 204 PVILDISRTRIHSLPSYGLENLKKLRARS 232

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 70.2 bits (172), Expect = 6e-13
 Identities = 41/222 (18%), Positives = 68/222 (30%), Gaps = 36/222 (16%)

Query: 3   SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFI-----------------LCEI 45
                 LR I          L+ + +S N     I + +                 L  I
Sbjct: 36  RFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYI 95

Query: 46  PHEI-DNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLP-N 103
             E   NL N++++  S   +  +      +      L +  N     +  ++ V L   
Sbjct: 96  NPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFE 155

Query: 104 LKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIP-NTFGNLRNLKWLGLNDNYL 162
              L L  N  I  I +  FN ++L EL L  N+    +P + F        L ++   +
Sbjct: 156 SVILWLNKNG-IQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRI 214

Query: 163 TS---------------STPELSSLSSLSNCKYLEYFSFSNN 189
            S               ST  L  L +L     L   S +  
Sbjct: 215 HSLPSYGLENLKKLRARSTYNLKKLPTLEKLVALMEASLTYP 256

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 97.4 bits (242), Expect = 7e-22
 Identities = 35/201 (17%), Positives = 67/201 (33%), Gaps = 29/201 (14%)

Query: 511 TNRFSENNLIGRGGFGPVYK----------DGMEVAIKVFNLQYGGAFKSFDIECGMMKR 560
           +     ++L+G G F  VY+          +  +  +KV        F         +K 
Sbjct: 64  SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123

Query: 561 IRHRNLIKIISSCSNDDFKALVLEYMPLGSL----EKCLYSGNYILDIFQGLNIMIDVAS 616
                 +K  S+    +   LV E    G+L         +   ++     ++  + +  
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183

Query: 617 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAH-----------LSDFGMAKPLLEEDQSL 665
            +E +H      IIH D+KP N +L +  +             L D G +  +    +  
Sbjct: 184 MIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240

Query: 666 TQTQTLATIGYMAPDEIFSGE 686
             T    T G+    E+ S +
Sbjct: 241 IFTAKCETSGFQCV-EMLSNK 260

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 99.2 bits (247), Expect = 1e-21
 Identities = 45/178 (25%), Positives = 78/178 (43%), Gaps = 20/178 (11%)

Query: 520 IGRGGFGPVYK--------DGMEVAIKVFNLQYGGAFKS-FDIECGMMKRIRHRNLIKII 570
           IG G FG V++          M VAIK        + +  F  E   M++  H +++K+I
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457

Query: 571 SSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL---HFGYSV 627
              + +    +++E   LG L   L    + LD+   +     +++AL YL    F    
Sbjct: 458 GVITENPV-WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRF---- 512

Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG 685
             +H D+   NVL+  N    L DFG+++  +E+      ++    I +MAP+ I   
Sbjct: 513 --VHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFR 567

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 95.9 bits (239), Expect = 1e-21
 Identities = 40/193 (20%), Positives = 80/193 (41%), Gaps = 34/193 (17%)

Query: 520 IGRGGFGPVYK--------DGMEVAIKVFNLQYGGA--FKSFDIECGMMKRIRHRNLIKI 569
           +G+G FG V +          ++VA+K+       +   + F  E   MK   H ++ K+
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90

Query: 570 ISSCSNDDFKA------LVLEYMPLGSL-----EKCLYSGNYILDIFQGLNIMIDVASAL 618
           +        K       ++L +M  G L        +    + L +   +  M+D+A  +
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150

Query: 619 EYL---HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 675
           EYL   +F      IH DL   N +L ++M   ++DFG+++ +   D       +   + 
Sbjct: 151 EYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVK 204

Query: 676 YMAP----DEIFS 684
           ++A     D +++
Sbjct: 205 WLALESLADNLYT 217

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 95.9 bits (239), Expect = 1e-21
 Identities = 45/163 (27%), Positives = 79/163 (48%), Gaps = 19/163 (11%)

Query: 520 IGRGGFGPVYK---------DGMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKI 569
           IG G FG VYK           + VAIK     Y       F  E G+M +  H N+I++
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111

Query: 570 ISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL---HFGYS 626
               S      ++ EYM  G+L+K L   +    + Q + ++  +A+ ++YL   ++   
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNY--- 168

Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
              +H DL   N+L++ N+V  +SDFG+++ L ++ ++   T 
Sbjct: 169 ---VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS 208

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 94.5 bits (236), Expect = 1e-21
 Identities = 47/175 (26%), Positives = 84/175 (48%), Gaps = 14/175 (8%)

Query: 519 LIGRGGFGPVY-----KDGMEVAIKVFN---LQYGGAFKSFDIECGMMKRIRHRNLIKII 570
           L+G+G F  VY       G+EVAIK+ +   +   G  +    E  +  +++H +++++ 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77

Query: 571 SSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPII 630
           +   + ++  LVLE    G + + L +        +  + M  + + + YLH   S  I+
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGIL 134

Query: 631 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG 685
           H DL  SN+LL  NM   ++DFG+A   L+       T    T  Y++P EI + 
Sbjct: 135 HRDLTLSNLLLTRNMNIKIADFGLAT-QLKMPHEKHYT-LCGTPNYISP-EIATR 186

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 95.1 bits (237), Expect = 2e-21
 Identities = 54/202 (26%), Positives = 86/202 (42%), Gaps = 23/202 (11%)

Query: 511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRN 565
              F     +G G +G VYK      G  VAIK   ++     +    E  +M++    +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85

Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY 625
           ++K   S   +    +V+EY   GS+   +   N  L   +   I+      LEYLH   
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH--- 142

Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG---YMAPDEI 682
            +  IH D+K  N+LL+    A L+DFG+A  L     ++ +  T+  IG   +MAP+ I
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL---TDTMAKRNTV--IGTPFWMAPEVI 197

Query: 683 FSGEMRLKC--WVNDSLLISVM 702
                      W   SL I+ +
Sbjct: 198 QEIGYNCVADIW---SLGITAI 216

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 95.6 bits (238), Expect = 2e-21
 Identities = 49/197 (24%), Positives = 72/197 (36%), Gaps = 27/197 (13%)

Query: 513 RFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIR-HRNL 566
           R     ++  GGF  VY+      G E A+K          ++   E   MK++  H N+
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88

Query: 567 IKIISSCS-------NDDFKALVLEYMPLGSLEKCL--YSGNYILDIFQGLNIMIDVASA 617
           ++  S+ S           + L+L  +  G L + L        L     L I      A
Sbjct: 89  VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148

Query: 618 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA----- 672
           ++++H     PIIH DLK  N+LL +     L DFG A  +          Q  A     
Sbjct: 149 VQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207

Query: 673 -----TIGYMAPDEIFS 684
                T  Y  P EI  
Sbjct: 208 ITRNTTPMYRTP-EIID 223

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 93.9 bits (234), Expect = 3e-21
 Identities = 45/186 (24%), Positives = 83/186 (44%), Gaps = 16/186 (8%)

Query: 511 TNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRN 565
              +     +G G FG VYK      G   A KV   +     + + +E  ++    H  
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77

Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY 625
           ++K++ +  +D    +++E+ P G+++  +   +  L   Q   +   +  AL +LH   
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH--- 134

Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG---YMAPDEI 682
           S  IIH DLK  NVL+       L+DFG++       ++L +  +   IG   +MAP+ +
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN---LKTLQKRDSF--IGTPYWMAPEVV 189

Query: 683 FSGEMR 688
               M+
Sbjct: 190 MCETMK 195

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 93.6 bits (233), Expect = 4e-21
 Identities = 57/289 (19%), Positives = 114/289 (39%), Gaps = 49/289 (16%)

Query: 126 SKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFS 185
           ++  +  L+K S + ++      L ++  +  N++       ++ S+  +     +    
Sbjct: 24  AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNS-------DIKSVQGIQYLPNVTKLF 74

Query: 186 FSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLI-LQLLSLEGNQLEG 244
            + N L  I P  + NL  ++   ++D   +      ++++L +L  L+ LSLE N +  
Sbjct: 75  LNGNKLTDIKP--LANLK-NLGWLFLDENKVK-----DLSSLKDLKKLKSLSLEHNGIS- 125

Query: 245 SIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDIL 304
                                ++G       +L  L  LYLG+N +T I + L  L  + 
Sbjct: 126 --------------------DINGL-----VHLPQLESLYLGNNKITDI-TVLSRLTKLD 159

Query: 305 HLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGS 364
            L+L  N  +  +PL    L  L  L LS N+ S +    + GLK+L  L L        
Sbjct: 160 TLSLEDNQISDIVPLA--GLTKLQNLYLSKNHISDLRA--LAGLKNLDVLELFSQECLNK 215

Query: 365 IPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEI 413
             N   +L+   ++  ++ +L     IS +   +  ++         E+
Sbjct: 216 PINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEV 264

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 88.6 bits (220), Expect = 2e-19
 Identities = 55/241 (22%), Positives = 88/241 (36%), Gaps = 18/241 (7%)

Query: 169 LSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLT 228
           +  + S          +     +   +      L  S++    +N +I  S+ + I  L 
Sbjct: 14  IKQIFSDDAFAETIKDNLKKKSVTDAVT--QNEL-NSIDQIIANNSDIK-SV-QGIQYLP 68

Query: 229 NLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSN 288
           N  +  L L GN+L   I   L  L  L  L L  NK+         +L  L+ L L  N
Sbjct: 69  N--VTKLFLNGNKLT-DI-KPLANLKNLGWLFLDENKVKDLSSLK--DLKKLKSLSLEHN 122

Query: 289 LLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGL 348
            ++ I   L +L  +  L L +N  T    L    L  L  L L  N  S ++P  + GL
Sbjct: 123 GISDING-LVHLPQLESLYLGNNKITDITVLS--RLTKLDTLSLEDNQISDIVP--LAGL 177

Query: 349 KDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNR 408
             LQ L+L  N +   +   +  L +L  L L +             L+    +  +   
Sbjct: 178 TKLQNLYLSKNHIS-DLRA-LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGS 235

Query: 409 L 409
           L
Sbjct: 236 L 236

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 66.6 bits (163), Expect = 5e-12
 Identities = 41/174 (23%), Positives = 76/174 (43%), Gaps = 15/174 (8%)

Query: 276 NLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMN 335
                 K  L    +T    T   L  I  +  +++       ++   L  + +L L+ N
Sbjct: 22  AFAETIKDNLKKKSVTDA-VTQNELNSIDQIIANNSDIKSVQGIQ--YLPNVTKLFLNGN 78

Query: 336 NFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEK 395
             + + P  +  LK+L +LFL+ N+++  + + + DL  LKSL+L +N +S  I   L  
Sbjct: 79  KLTDIKP--LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DIN-GLVH 132

Query: 396 LLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNEL-----LCGMPNLQVLSC 444
           L  L+ + +  N++  +I        L   S + N++     L G+  LQ L  
Sbjct: 133 LPQLESLYLGNNKIT-DITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYL 185

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 66.2 bits (162), Expect = 5e-12
 Identities = 52/233 (22%), Positives = 89/233 (38%), Gaps = 29/233 (12%)

Query: 14  LSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTI 73
           +  +    ++  L+L+ N          L +I   + NL N+ W+    NKV  +    +
Sbjct: 61  VQGIQYLPNVTKLFLNGNK---------LTDIK-PLANLKNLGWLFLDENKVKDLSS--L 108

Query: 74  FNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGL 133
            ++  LKSL L  N +S  +       LP L+ L+L GNN I  I + +   +KL  L L
Sbjct: 109 KDLKKLKSLSLEHNGIS-DINGLVH--LPQLESLYL-GNNKITDI-TVLSRLTKLDTLSL 163

Query: 134 QKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGG 193
           + N  S  I      L  L+ L L+ N        +S L +L+  K L+     +     
Sbjct: 164 EDNQIS-DIVP-LAGLTKLQNLYLSKN-------HISDLRALAGLKNLDVLELFSQECLN 214

Query: 194 ILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSI 246
                  NL         D   ++   PE I++  +     +     +    +
Sbjct: 215 KPINHQSNLVVPNTVKNTDGSLVT---PEIISDDGDYEKPNVKWHLPEFTNEV 264

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 53/302 (17%), Positives = 92/302 (30%), Gaps = 57/302 (18%)

Query: 14  LSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTI 73
                  +S+  +  + +     I S         I  L N+  +  + NK+  + P  +
Sbjct: 39  AVTQNELNSIDQIIANNS----DIKSV------QGIQYLPNVTKLFLNGNKLTDIKP--L 86

Query: 74  FNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGL 133
            N+  L  L+L  N +   L S  D  L  LK L L  N  I  I + + +  +L  L L
Sbjct: 87  ANLKNLGWLFLDENKVK-DLSSLKD--LKKLKSLSLEHNG-ISDI-NGLVHLPQLESLYL 141

Query: 134 QKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGG 193
             N  +  I      L  L  L L DN       ++S +  L+    L+    S N +  
Sbjct: 142 GNNKIT-DITV-LSRLTKLDTLSLEDN-------QISDIVPLAGLTKLQNLYLSKNHISD 192

Query: 194 ILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRL 253
           +                             +  L N  L +L L   +      +    L
Sbjct: 193 L---------------------------RALAGLKN--LDVLELFSQECLNKPINHQSNL 223

Query: 254 AALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFF 313
                +      L    P    +  +  K  +  +L        +     + +  +   F
Sbjct: 224 VVPNTVKNTDGSLV--TPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARF 281

Query: 314 TG 315
            G
Sbjct: 282 HG 283

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 94.3 bits (235), Expect = 4e-21
 Identities = 37/186 (19%), Positives = 73/186 (39%), Gaps = 23/186 (12%)

Query: 520 IGRGGFGPVYK----------DGMEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLIK 568
           +G+G FG VY+              VAIK  N          F  E  +MK     ++++
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92

Query: 569 IISSCSNDDFKALVLEYMPLGSL---------EKCLYSGNYILDIFQGLNIMIDVASALE 619
           ++   S      +++E M  G L                     + + + +  ++A  + 
Sbjct: 93  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152

Query: 620 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
           YL+   +   +H DL   N ++ ++    + DFGM + + E D      + L  + +M+P
Sbjct: 153 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209

Query: 680 DEIFSG 685
           + +  G
Sbjct: 210 ESLKDG 215

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 95.5 bits (238), Expect = 5e-21
 Identities = 57/239 (23%), Positives = 97/239 (40%), Gaps = 46/239 (19%)

Query: 482 KGRKSQLKDVNMPSVADQRR--FTYLELFQATNRFSENNL---------IGRGGFGPVYK 530
           KG++  L + +  +++  R   F + +L           L         +G G  G V  
Sbjct: 94  KGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKL 153

Query: 531 -----DGMEVAIKVFN---LQYGGAFKSFDI-----ECGMMKRIRHRNLIKIISSCSNDD 577
                   +VAI++ +      G A ++        E  ++K++ H  +IKI +    +D
Sbjct: 154 AFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 213

Query: 578 FKALVLEYMPLGSL-----EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
           +  +VLE M  G L                  F        +  A++YLH      IIH 
Sbjct: 214 Y-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY------QMLLAVQYLH---ENGIIHR 263

Query: 633 DLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMR 688
           DLKP NVLL   +++ +  ++DFG +K  +  + SL +T    T  Y+AP E+      
Sbjct: 264 DLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRT-LCGTPTYLAP-EVLVSVGT 318

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 94.4 bits (235), Expect = 7e-21
 Identities = 64/231 (27%), Positives = 96/231 (41%), Gaps = 38/231 (16%)

Query: 481 RKGRKSQLKDVNMPSVADQRRFTYLELFQATNRFSEN----NLIGRGGFGPVYK-----D 531
           +K   +Q K               L  + A   F +     ++IGRG    V +      
Sbjct: 59  KKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRAT 118

Query: 532 GMEVAIKVFNL--------QYGGAFKSFDIECGMMKRIR-HRNLIKIISSCSNDDFKALV 582
           G E A+K+  +        Q     ++   E  +++++  H ++I +I S  +  F  LV
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178

Query: 583 LEYMPLGSL-----EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPS 637
            + M  G L     EK   S      I +       +  A+ +LH   +  I+H DLKP 
Sbjct: 179 FDLMRKGELFDYLTEKVALSEKETRSIMR------SLLEAVSFLH---ANNIVHRDLKPE 229

Query: 638 NVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGYMAPDEIFSGEM 687
           N+LLDDNM   LSDFG +   LE  + L     L  T GY+AP EI    M
Sbjct: 230 NILLDDNMQIRLSDFGFSC-HLEPGEKLR---ELCGTPGYLAP-EILKCSM 275

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 92.8 bits (231), Expect = 8e-21
 Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 19/200 (9%)

Query: 511 TNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRN 565
             +++    IG+G  G VY       G EVAI+  NLQ     +    E  +M+  ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY 625
           ++  + S    D   +V+EY+  GSL   +      +D  Q   +  +   ALE+LH   
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH--- 133

Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGYMAPDEIFS 684
           S  +IH D+K  N+LL  +    L+DFG    +       ++  T+  T  +MAP+ +  
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGTPYWMAPEVVTR 190

Query: 685 GEMRLKC--WVNDSLLISVM 702
                K   W   SL I  +
Sbjct: 191 KAYGPKVDIW---SLGIMAI 207

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 92.2 bits (230), Expect = 1e-20
 Identities = 47/182 (25%), Positives = 86/182 (47%), Gaps = 29/182 (15%)

Query: 519 LIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSC 573
           ++G G F  V+       G   A+K           S + E  ++K+I+H N++ +    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 574 SNDDFKALVLEYMPLGSL-----EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVP 628
            +     LV++ +  G L     E+ +Y+      + Q       V SA++YLH      
Sbjct: 76  ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQ------QVLSAVKYLH---ENG 126

Query: 629 IIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGYMAPDEIFS 684
           I+H DLKP N+L    ++N    ++DFG++K  +E++  ++   T   T GY+AP E+ +
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMS---TACGTPGYVAP-EVLA 180

Query: 685 GE 686
            +
Sbjct: 181 QK 182

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 91.6 bits (228), Expect = 2e-20
 Identities = 43/208 (20%), Positives = 76/208 (36%), Gaps = 42/208 (20%)

Query: 511 TNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI---ECGMMKRIR 562
           T  F E   IG G FG V+K     DG   AIK       G+    +            +
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 563 HRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIF---QGLNIMIDVASALE 619
           H ++++  S+ + DD   +  EY   GSL   +     I+  F   +  ++++ V   L 
Sbjct: 70  HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129

Query: 620 YLHFGYSVPIIHCDLKPSNVLLDDN-------------------MVAHLSDFGMAKPLLE 660
           Y+H   S+ ++H D+KPSN+ +                      ++  + D G       
Sbjct: 130 YIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT---- 182

Query: 661 EDQSLTQTQTLA-TIGYMAPDEIFSGEM 687
               ++  Q       ++A  E+     
Sbjct: 183 ---RISSPQVEEGDSRFLAN-EVLQENY 206

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 91.3 bits (227), Expect = 4e-20
 Identities = 42/177 (23%), Positives = 79/177 (44%), Gaps = 18/177 (10%)

Query: 511 TNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRN 565
                    IG G  G V        G +VA+K+ +L+     +    E  +M+  +H N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY 625
           ++++  S    +   +++E++  G+L   +      L+  Q   +   V  AL YLH   
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLH--- 158

Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG---YMAP 679
           +  +IH D+K  ++LL  +    LSDFG    +    + + + ++L  +G   +MAP
Sbjct: 159 AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSL--VGTPYWMAP 210

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 90.8 bits (226), Expect = 4e-20
 Identities = 50/194 (25%), Positives = 78/194 (40%), Gaps = 34/194 (17%)

Query: 520 IGRGGFGPVYK----------DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKI 569
           +G G FG V+           D M VA+K        A K F  E  ++  ++H +++K 
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82

Query: 570 ISSCSNDDFKALVLEYMPLGSL---------------EKCLYSGNYILDIFQGLNIMIDV 614
              C + D   +V EYM  G L               +         L + Q L+I   +
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142

Query: 615 ASALEYL---HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL 671
           AS + YL   HF      +H DL   N L+  N++  + DFGM++ +   D       T+
Sbjct: 143 ASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196

Query: 672 ATIGYMAPDEIFSG 685
             I +M P+ I   
Sbjct: 197 LPIRWMPPESIMYR 210

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 90.0 bits (224), Expect = 4e-20
 Identities = 66/247 (26%), Positives = 96/247 (38%), Gaps = 66/247 (26%)

Query: 69  VPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNA-SK 127
           +P+ I   +  K L L SN LS  LPS A  RL  L+ L+L  N  + T+P+ IF     
Sbjct: 31  IPSNIP--ADTKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNK-LQTLPAGIFKELKN 86

Query: 128 LSELGLQKNSFSGSIP-NTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSF 186
           L  L +  N    ++P   F  L NL  L L+ N L S                      
Sbjct: 87  LETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKS---------------------- 123

Query: 187 SNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSI 246
                  + PR   +L++                      LT L     SL  N+L+ S+
Sbjct: 124 -------LPPRVFDSLTK----------------------LTYL-----SLGYNELQ-SL 148

Query: 247 PDDLC-RLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIP-STLWNLKDIL 304
           P  +  +L +L +L L  N+L          LT L+ L L +N L  +P     +L+ + 
Sbjct: 149 PKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLK 208

Query: 305 HLNLSSN 311
            L L  N
Sbjct: 209 MLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 84.3 bits (209), Expect = 4e-18
 Identities = 54/193 (27%), Positives = 76/193 (39%), Gaps = 11/193 (5%)

Query: 219 SIPEEI-NNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNL 277
           +IP  I  +   L LQ      N+L         RL  L  L L  NKL          L
Sbjct: 30  AIPSNIPADTKKLDLQ-----SNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKEL 84

Query: 278 TNLRKLYLGSNLLTSIPS-TLWNLKDILHLNLSSNFFTGPLPLKI-GNLNVLVQLDLSMN 335
            NL  L++  N L ++P      L ++  L L  N     LP ++  +L  L  L L  N
Sbjct: 85  KNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYN 143

Query: 336 NFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGD-LISLKSLNLSNNNLSGTIPISLE 394
               +       L  L+ L L  N+L+  +P    D L  LK+L L NN L      + +
Sbjct: 144 ELQSLPKGVFDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFD 202

Query: 395 KLLDLKDINVSFN 407
            L  LK + +  N
Sbjct: 203 SLEKLKMLQLQEN 215

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 64/185 (34%), Positives = 86/185 (46%), Gaps = 19/185 (10%)

Query: 246 IPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPST----LWNLK 301
           IP D  +L      DL  NKLS         LT LR LYL  N L ++P+     L NL+
Sbjct: 35  IPADTKKL------DLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLE 88

Query: 302 DILHLNLSSNFFTGPLPLKI-GNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNR 360
               L ++ N     LP+ +   L  L +L L  N    + P     L  L YL L YN 
Sbjct: 89  ---TLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNE 144

Query: 361 LQGSIPNSIGD-LISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPF 419
           LQ S+P  + D L SLK L L NN L      + +KL +LK + +  N+L+  +P  G F
Sbjct: 145 LQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPE-GAF 201

Query: 420 RNLSA 424
            +L  
Sbjct: 202 DSLEK 206

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 77.3 bits (191), Expect = 8e-16
 Identities = 51/197 (25%), Positives = 83/197 (42%), Gaps = 21/197 (10%)

Query: 20  PSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFN-VST 78
           P+  + L L  N  S S+PS            L  +  +  + NK+   +P  IF  +  
Sbjct: 36  PADTKKLDLQSNKLS-SLPSKAF-------HRLTKLRLLYLNDNKLQ-TLPAGIFKELKN 86

Query: 79  LKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNA-SKLSELGLQKNS 137
           L++L++  N L   LP     +L NL EL L   N + ++P  +F++ +KL+ L L  N 
Sbjct: 87  LETLWVTDNKLQ-ALPIGVFDQLVNLAELRL-DRNQLKSLPPRVFDSLTKLTYLSLGYNE 144

Query: 138 FSGSIP-NTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILP 196
              S+P   F  L +LK L L +N L            L+    L+     NN L  +  
Sbjct: 145 LQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGA--FDKLTE---LKTLKLDNNQLKRVPE 198

Query: 197 RAIGNLSQSMEDFWMDN 213
            A  +L   ++   +  
Sbjct: 199 GAFDSLE-KLKMLQLQE 214

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 71.9 bits (177), Expect = 6e-14
 Identities = 46/174 (26%), Positives = 70/174 (40%), Gaps = 22/174 (12%)

Query: 21  SSLQTLYLSYNPPSGSIPSFILCEIPHEI-DNLHNMEWMAFSFNKVVGVVPTTIF-NVST 78
           + L+ LYL+ N          L  +P  I   L N+E +  + NK+   +P  +F  +  
Sbjct: 61  TKLRLLYLNDNK---------LQTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVN 110

Query: 79  LKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNA-SKLSELGLQKNS 137
           L  L L  N L   LP      L  L  L L  N  + ++P  +F+  + L EL L  N 
Sbjct: 111 LAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNE-LQSLPKGVFDKLTSLKELRLYNNQ 168

Query: 138 FSGSIP-NTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNP 190
               +P   F  L  LK L L++N L           +  + + L+      NP
Sbjct: 169 LK-RVPEGAFDKLTELKTLKLDNNQLKR-----VPEGAFDSLEKLKMLQLQENP 216

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 35/143 (24%), Positives = 48/143 (33%), Gaps = 35/143 (24%)

Query: 19  NPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVST 78
              +L  L L  N    S+P  +        D+L                          
Sbjct: 107 QLVNLAELRLDRNQLK-SLPPRVF-------DSLTK------------------------ 134

Query: 79  LKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIF-NASKLSELGLQKNS 137
           L  L L  N L   LP     +L +LKEL L+ N  +  +P   F   ++L  L L  N 
Sbjct: 135 LTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQ-LKRVPEGAFDKLTELKTLKLDNNQ 192

Query: 138 FSGSIPNTFGNLRNLKWLGLNDN 160
                   F +L  LK L L +N
Sbjct: 193 LKRVPEGAFDSLEKLKMLQLQEN 215

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 91.2 bits (227), Expect = 5e-20
 Identities = 39/182 (21%), Positives = 71/182 (39%), Gaps = 29/182 (15%)

Query: 519 LIGRGGFGPVY-----KDGMEVAIKVFN---LQYGGAFKSFDIECGMMKRIRHRNLIKII 570
            +G+GGF   +           A K+     L      +   +E  + + + H++++   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 571 SSCSNDDFKALVLEYMPLGSLEKCLYSGNYI-----LDIFQGLNIMIDVASALEYLHFGY 625
               ++DF  +VLE     SL               L   +    +  +    +YLH   
Sbjct: 108 GFFEDNDFVFVVLELCRRRSL------LELHKRRKALTEPEARYYLRQIVLGCQYLH--- 158

Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ--TLATIGYMAPDEIF 683
              +IH DLK  N+ L++++   + DFG+A   +E D    +    T     Y+AP E+ 
Sbjct: 159 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT-KVEYDGERKKVLCGTPN---YIAP-EVL 213

Query: 684 SG 685
           S 
Sbjct: 214 SK 215

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 90.3 bits (225), Expect = 5e-20
 Identities = 39/177 (22%), Positives = 72/177 (40%), Gaps = 19/177 (10%)

Query: 519 LIGRGGFGPVY-----KDGMEVAIKVFN---LQYGGAFKSFDIECGMMKRIRHRNLIKII 570
            +G+GGF   +           A K+     L      +   +E  + + + H++++   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 571 SSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPII 630
               ++DF  +VLE     SL +        L   +    +  +    +YLH      +I
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRRKA-LTEPEARYYLRQIVLGCQYLH---RNRVI 137

Query: 631 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ--TLATIGYMAPDEIFSG 685
           H DLK  N+ L++++   + DFG+A   +E D    +    T     Y+AP E+ S 
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLAT-KVEYDGERKKVLCGTPN---YIAP-EVLSK 189

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 90.0 bits (224), Expect = 5e-20
 Identities = 47/176 (26%), Positives = 79/176 (44%), Gaps = 17/176 (9%)

Query: 518 NLIGRGGFGPVY-----KDGMEVAIKVFN---LQYGGAFKSFDIECGMMKRIRHRNLIKI 569
             +G+G FG VY     +    +A+KV     L+  G       E  +   +RH N++++
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 570 ISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPI 629
                +     L+LEY PLG++ + L   +   D  +    + ++A+AL Y H   S  +
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRV 130

Query: 630 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG 685
           IH D+KP N+LL       ++DFG +        S        T+ Y+ P E+  G
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTD-LCGTLDYLPP-EMIEG 181

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 90.8 bits (226), Expect = 7e-20
 Identities = 45/185 (24%), Positives = 77/185 (41%), Gaps = 26/185 (14%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKV-----FNLQYGGAFKSFDIECGMMKRIRHRNLIKI 569
           IG+G F  V +      G + A+K+     F    G + +    E  +   ++H +++++
Sbjct: 32  IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91

Query: 570 ISSCSNDDFKALVLEYMPLGSL-----EKCLYSGNYILDIFQGLNIMIDVASALEYLHFG 624
           + + S+D    +V E+M    L     ++      Y        + M  +  AL Y H  
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA--VASHYMRQILEALRYCH-- 147

Query: 625 YSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
               IIH D+KP  VLL   +++    L  FG+A  L E          + T  +MAP E
Sbjct: 148 -DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA--GGRVGTPHFMAP-E 203

Query: 682 IFSGE 686
           +   E
Sbjct: 204 VVKRE 208

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 90.4 bits (225), Expect = 7e-20
 Identities = 52/191 (27%), Positives = 81/191 (42%), Gaps = 37/191 (19%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFN---LQYGGAFKSFDI-----ECGMMKRIRHRNL 566
           +G G  G V          +VAIK+ +      G A ++        E  ++K++ H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77

Query: 567 IKIISSCSNDDFKALVLEYMPLGSL-----EKCLYSGNYILDIFQGLNIMIDVASALEYL 621
           IKI +    +D+  +VLE M  G L                  F        +  A++YL
Sbjct: 78  IKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFY------QMLLAVQYL 130

Query: 622 HFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGYM 677
           H      IIH DLKP NVLL   +++ +  ++DFG +K +L E   +    TL  T  Y+
Sbjct: 131 H---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-ILGETSLMR---TLCGTPTYL 183

Query: 678 APDEIFSGEMR 688
           AP E+      
Sbjct: 184 AP-EVLVSVGT 193

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 90.0 bits (224), Expect = 1e-19
 Identities = 46/193 (23%), Positives = 76/193 (39%), Gaps = 33/193 (17%)

Query: 520 IGRGGFGPVYK----------DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKI 569
           +G G FG V+           D M VA+K        A + F  E  ++  ++H+++++ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108

Query: 570 ISSCSNDDFKALVLEYMPLGSL--------------EKCLYSGNYILDIFQGLNIMIDVA 615
              C+      +V EYM  G L                        L + Q L +   VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168

Query: 616 SALEYL---HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA 672
           + + YL   HF      +H DL   N L+   +V  + DFGM++ +   D      +T+ 
Sbjct: 169 AGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222

Query: 673 TIGYMAPDEIFSG 685
            I +M P+ I   
Sbjct: 223 PIRWMPPESILYR 235

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 89.2 bits (222), Expect = 1e-19
 Identities = 46/195 (23%), Positives = 86/195 (44%), Gaps = 32/195 (16%)

Query: 511 TNRFSEN----NLIGRGGFGPVYK-----DGMEVAIKVFNLQ--YGGAFKSFDIECGMMK 559
           + +FS+N      +G+G F  V +      G+E A K+ N +      F+  + E  + +
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 560 RIRHRNLIKIISSCSNDDFKALVLEYMPLGSL-----EKCLYSGNYILDIFQGLNIMIDV 614
           +++H N++++  S   + F  LV + +  G L      +  YS        Q       +
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ------QI 114

Query: 615 ASALEYLHFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTL 671
             ++ Y H   S  I+H +LKP N+LL          L+DFG+A   + + ++       
Sbjct: 115 LESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVNDSEAW--HGFA 168

Query: 672 ATIGYMAPDEIFSGE 686
            T GY++P E+   +
Sbjct: 169 GTPGYLSP-EVLKKD 182

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 89.7 bits (223), Expect = 2e-19
 Identities = 45/192 (23%), Positives = 77/192 (40%), Gaps = 33/192 (17%)

Query: 520 IGRGGFGPVYK----------DGMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIK 568
           +G G FG VY+            ++VA+K             F +E  ++ +  H+N+++
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97

Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCL------YSGNYILDIFQGLNIMIDVASALEYL- 621
            I        + +++E M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157

Query: 622 --HFGYSVPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGY 676
             HF      IH D+   N LL       VA + DFGMA+ +            +  + +
Sbjct: 158 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211

Query: 677 MAP----DEIFS 684
           M P    + IF+
Sbjct: 212 MPPEAFMEGIFT 223

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 91.2 bits (227), Expect = 2e-19
 Identities = 42/183 (22%), Positives = 77/183 (42%), Gaps = 29/183 (15%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI--ECGMMKRIRHRNLIKIISS 572
           +G+G F  V +      G E A  + N +   A     +  E  + + ++H N++++  S
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78

Query: 573 CSNDDFKALVLEYMPLGSL-----EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
            S +    L+ + +  G L      +  YS        Q       +  A+ + H    +
Sbjct: 79  ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQ------QILEAVLHCH---QM 129

Query: 628 PIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGYMAPDEIF 683
            ++H +LKP N+LL          L+DFG+A  +  E Q+       A T GY++P E+ 
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWF---GFAGTPGYLSP-EVL 185

Query: 684 SGE 686
             +
Sbjct: 186 RKD 188

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 90.1 bits (223), Expect = 2e-19
 Identities = 24/207 (11%), Positives = 47/207 (22%), Gaps = 48/207 (23%)

Query: 519 LIGRGGFGPVYK-----DGMEVAIKVFN---LQYGGAFKSFDIECGMMKRIRHRNLIKII 570
            +  G    V+         + A+KVF           +          R+   +  +  
Sbjct: 69  PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128

Query: 571 SSC----------------------SNDDFKA----LVLEYM-----PLGSLEKCLYSGN 599
                                      DD+      L++         L S    +Y   
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188

Query: 600 YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL 659
               I     +   +      L    S  ++H    P N+ +  +    L D      + 
Sbjct: 189 GDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG 245

Query: 660 EEDQSLTQTQTLATIGYMAPDEIFSGE 686
                  +    +     AP E  +  
Sbjct: 246 T------RGPASSVPVTYAPREFLNAS 266

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 86.2 bits (214), Expect = 2e-19
 Identities = 38/174 (21%), Positives = 74/174 (42%), Gaps = 9/174 (5%)

Query: 236 SLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPS 295
            L+ +Q   +IPD      A     LG +  +    A    + +L  + L +  +T + +
Sbjct: 7   GLKASQDNVNIPDS--TFKAYLNGLLGQSSTANITEA---QMNSLTYITLANINVTDL-T 60

Query: 296 TLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLF 355
            +    +I  L +++   T   P+    L+ L +L +   + +      + GL  L  L 
Sbjct: 61  GIEYAHNIKDLTINNIHATNYNPIS--GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD 118

Query: 356 LEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRL 409
           + ++    SI   I  L  + S++LS N     I   L+ L +LK +N+ F+ +
Sbjct: 119 ISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGV 171

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 84.6 bits (210), Expect = 7e-19
 Identities = 28/190 (14%), Positives = 64/190 (33%), Gaps = 14/190 (7%)

Query: 122 IFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYL 181
               S            S +   T   + +L ++ L +         ++ L+ +     +
Sbjct: 16  NIPDSTFKAYLNGLLGQSSTANITEAQMNSLTYITLANI-------NVTDLTGIEYAHNI 68

Query: 182 EYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQ 241
           +  + +N       P  I  LS  +E   +   +++      ++ LT+  L LL +  + 
Sbjct: 69  KDLTINNIHATNYNP--ISGLSN-LERLRIMGKDVTSDKIPNLSGLTS--LTLLDISHSA 123

Query: 242 LEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLK 301
            + SI   +  L  +  +DL  N     +      L  L+ L +  + +      + +  
Sbjct: 124 HDDSILTKINTLPKVNSIDLSYNGAITDIMPLK-TLPELKSLNIQFDGVHDY-RGIEDFP 181

Query: 302 DILHLNLSSN 311
            +  L   S 
Sbjct: 182 KLNQLYAFSQ 191

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 79.2 bits (196), Expect = 5e-17
 Identities = 30/196 (15%), Positives = 61/196 (31%), Gaps = 18/196 (9%)

Query: 98  DVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGL 157
           D          L G +    I       + L+ + L   + +  +        N+K L +
Sbjct: 19  DSTFKAYLNGLL-GQSSTANIT--EAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTI 73

Query: 158 NDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNIS 217
           N+          ++ + +S    LE        +       +  L+  +    + +    
Sbjct: 74  NNI-------HATNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTS-LTLLDISHSAHD 125

Query: 218 GSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNL 277
            SI  +IN L  +    + L  N     I   L  L  L  L++  + +  +      + 
Sbjct: 126 DSILTKINTLPKV--NSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRGI--EDF 180

Query: 278 TNLRKLYLGSNLLTSI 293
             L +LY  S  +   
Sbjct: 181 PKLNQLYAFSQTIGGK 196

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 77.3 bits (191), Expect = 2e-16
 Identities = 34/182 (18%), Positives = 68/182 (37%), Gaps = 19/182 (10%)

Query: 210 WMDNCNISGSIPEEINNLTNLIL---QLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKL 266
            +   + +     ++N+LT + L    +  L G          +     +  L +     
Sbjct: 29  LLGQSSTANITEAQMNSLTYITLANINVTDLTG----------IEYAHNIKDLTINNIHA 78

Query: 267 SGFVPACSGNLTNLRKLYLGSNLLTSI-PSTLWNLKDILHLNLSSNFFTGPLPLKIGNLN 325
           + + P     L+NL +L +    +TS     L  L  +  L++S +     +  KI  L 
Sbjct: 79  TNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLP 136

Query: 326 VLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNL 385
            +  +DLS N     I   +  L +L+ L ++++ +       I D   L  L   +  +
Sbjct: 137 KVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTI 193

Query: 386 SG 387
            G
Sbjct: 194 GG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 66.1 bits (162), Expect = 1e-12
 Identities = 22/140 (15%), Positives = 51/140 (36%), Gaps = 12/140 (8%)

Query: 79  LKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSF 138
           +K L +++   +   P S    L NL+ L + G +        +   + L+ L +  ++ 
Sbjct: 68  IKDLTINNIHATNYNPISG---LSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAH 124

Query: 139 SGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRA 198
             SI      L  +  + L+ N        ++ +  L     L+  +   + +     R 
Sbjct: 125 DDSILTKINTLPKVNSIDLSYN------GAITDIMPLKTLPELKSLNIQFDGVHDY--RG 176

Query: 199 IGNLSQSMEDFWMDNCNISG 218
           I +  + +   +  +  I G
Sbjct: 177 IEDFPK-LNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 60.0 bits (146), Expect = 2e-10
 Identities = 21/151 (13%), Positives = 49/151 (32%), Gaps = 14/151 (9%)

Query: 14  LSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTI 73
           L+ +    +++ L ++    +   P          I  L N+E +      V       +
Sbjct: 59  LTGIEYAHNIKDLTINNIHATNYNP----------ISGLSNLERLRIMGKDVTSDKIPNL 108

Query: 74  FNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGL 133
             +++L  L +  ++    + +  +  LP +  + L  N  I  I   +    +L  L +
Sbjct: 109 SGLTSLTLLDISHSAHDDSILTKIN-TLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNI 166

Query: 134 QKNSFSGSIPNTFGNLRNLKWLGLNDNYLTS 164
           Q +           +   L  L      +  
Sbjct: 167 QFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 91.3 bits (227), Expect = 2e-19
 Identities = 45/183 (24%), Positives = 82/183 (44%), Gaps = 20/183 (10%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI--ECGMMKRIRHRNLIKIISS 572
           +G G +G V         +E AIK+          +  +  E  ++K + H N++K+   
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104

Query: 573 CSNDDFKALVLEYMPLGSL-EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
             +     LV+E    G L ++ ++   +  +      I+  V S + YLH      I+H
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMKF--NEVDAAVIIKQVLSGVTYLH---KHNIVH 159

Query: 632 CDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMR 688
            DLKP N+LL   + + +  + DFG++  + E  + +   + L T  Y+AP E+   +  
Sbjct: 160 RDLKPENLLLESKEKDALIKIVDFGLSA-VFENQKKM--KERLGTAYYIAP-EVLRKKYD 215

Query: 689 LKC 691
            KC
Sbjct: 216 EKC 218

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 88.0 bits (219), Expect = 3e-19
 Identities = 44/195 (22%), Positives = 77/195 (39%), Gaps = 35/195 (17%)

Query: 520 IGRGGFGPVYK----------DGMEVAIKVFNLQYGGAFKS-FDIECGMMKRIRHRNLIK 568
           +G   FG VYK              VAIK    +  G  +  F  E  +  R++H N++ 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76

Query: 569 IISSCSNDDFKALVLEYMPLGSL---------------EKCLYSGNYILDIFQGLNIMID 613
           ++   + D   +++  Y   G L                    +    L+    ++++  
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136

Query: 614 VASALEYL---HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 670
           +A+ +EYL   H       +H DL   NVL+ D +   +SD G+ + +   D       +
Sbjct: 137 IAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190

Query: 671 LATIGYMAPDEIFSG 685
           L  I +MAP+ I  G
Sbjct: 191 LLPIRWMAPEAIMYG 205

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 90.5 bits (225), Expect = 3e-19
 Identities = 47/184 (25%), Positives = 81/184 (44%), Gaps = 21/184 (11%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFN---LQYGGAFKSFDIECGMMKRIRHRNLIKIIS 571
           +G+G FG V        G E A+KV +   ++     +S   E  ++K++ H N++K+  
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93

Query: 572 SCSNDDFKALVLEYMPLGSL-EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPII 630
              +  +  LV E    G L ++ +    +         I+  V S + Y+H      I+
Sbjct: 94  FFEDKGYFYLVGEVYTGGELFDEIISRKRF--SEVDAARIIRQVLSGITYMH---KNKIV 148

Query: 631 HCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEM 687
           H DLKP N+LL     +    + DFG++    E  + +     + T  Y+AP E+  G  
Sbjct: 149 HRDLKPENLLLESKSKDANIRIIDFGLST-HFEASKKM--KDKIGTAYYIAP-EVLHGTY 204

Query: 688 RLKC 691
             KC
Sbjct: 205 DEKC 208

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 88.4 bits (220), Expect = 3e-19
 Identities = 43/203 (21%), Positives = 83/203 (40%), Gaps = 43/203 (21%)

Query: 520 IGRGGFGPVYK----------DGMEVAIKVFNLQYGGA----FKSFDIECGMMKRIRHRN 565
           +G G FG V K              VA+K+       A     +    E  ++K++ H +
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK---ENASPSELRDLLSEFNVLKQVNHPH 87

Query: 566 LIKIISSCSNDDFKALVLEYMPLGSL-----------------------EKCLYSGNYIL 602
           +IK+  +CS D    L++EY   GSL                           +     L
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 603 DIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED 662
            +   ++    ++  ++YL     + ++H DL   N+L+ +     +SDFG+++ + EED
Sbjct: 148 TMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204

Query: 663 QSLTQTQTLATIGYMAPDEIFSG 685
             + ++Q    + +MA + +F  
Sbjct: 205 SYVKRSQGRIPVKWMAIESLFDH 227

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 89.4 bits (222), Expect = 3e-19
 Identities = 45/180 (25%), Positives = 74/180 (41%), Gaps = 26/180 (14%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           +G G FG V++      G     K  N  Y     +   E  +M ++ H  LI +  +  
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118

Query: 575 NDDFKALVLEYMPLGSL------EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVP 628
           +     L+LE++  G L      E    S   +      +N M      L+++H      
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEV------INYMRQACEGLKHMH---EHS 169

Query: 629 IIHCDLKPSNVLLDDNMVAHL--SDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGE 686
           I+H D+KP N++ +    + +   DFG+A   L  D+ +    T AT  + AP EI   E
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLAT-KLNPDEIV--KVTTATAEFAAP-EIVDRE 225

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 88.9 bits (221), Expect = 4e-19
 Identities = 43/182 (23%), Positives = 79/182 (43%), Gaps = 28/182 (15%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFN--LQYGGAFKSFDIECGMMKRIRHRNLIKIISS 572
           +G+G F  V +      G+E A K+ N        F+  + E  + ++++H N++++  S
Sbjct: 37  LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96

Query: 573 CSNDDFKALVLEYMPLGSL-----EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
              + F  LV + +  G L      +  YS        Q       +  ++ Y H   S 
Sbjct: 97  IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ------QILESIAYCH---SN 147

Query: 628 PIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS 684
            I+H +LKP N+LL          L+DFG+A   + + ++        T GY++P E+  
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVNDSEAW--HGFAGTPGYLSP-EVLK 203

Query: 685 GE 686
            +
Sbjct: 204 KD 205

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 87.7 bits (218), Expect = 4e-19
 Identities = 46/186 (24%), Positives = 80/186 (43%), Gaps = 22/186 (11%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISS 572
           +G+G FG V K        E A+KV N          +   E  ++K++ H N++K+   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 573 CSNDDFKALVLEYMPLGSL-EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
             +     +V E    G L ++ +    +         I+  V S + Y+H      I+H
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFSEH--DAARIIKQVFSGITYMH---KHNIVH 144

Query: 632 CDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMR 688
            DLKP N+LL   + +    + DFG++    +++  +     + T  Y+AP E+  G   
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLST-CFQQNTKM--KDRIGTAYYIAP-EVLRGTYD 200

Query: 689 LKC--W 692
            KC  W
Sbjct: 201 EKCDVW 206

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 89.7 bits (222), Expect = 4e-19
 Identities = 28/209 (13%), Positives = 58/209 (27%), Gaps = 50/209 (23%)

Query: 519 LIGRGGFGPVYK-----DGMEVAIKVFNLQYG---GAFKSFDIECGMMKRIR-------- 562
           ++G+       +      G    + V          A K    E   ++ +R        
Sbjct: 85  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144

Query: 563 --------------HRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYS-GNYILDIFQ- 606
                              K+I    ++    ++  +     ++  L + G  +L     
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204

Query: 607 --------GLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL 658
                    L + + V   L  LH      ++H  L+P +++LD      L+ F      
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261

Query: 659 LEEDQSLTQTQTLATIGYMAPDEIFSGEM 687
                      +    G+  P E  +  M
Sbjct: 262 GAS------AVSPIGRGFAPP-ETTAERM 283

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 87.7 bits (218), Expect = 4e-19
 Identities = 43/188 (22%), Positives = 74/188 (39%), Gaps = 33/188 (17%)

Query: 519 LIGRGGFGPVY-----KDGMEVAIKVFN----LQYGGAFKSFDIECGMMKRIRHRNLIK- 568
           L+G G +G V      +     A+K+       +      +   E  +++R+RH+N+I+ 
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 569 --IISSCSNDDFKALVLEYMPLGSLEKCLYSGNYI----LDIFQGLNIMIDVASALEYLH 622
             ++ +        +V+EY   G  E  +   + +      + Q       +   LEYLH
Sbjct: 72  VDVLYNEEKQKM-YMVMEYCVCGMQE--ML--DSVPEKRFPVCQAHGYFCQLIDGLEYLH 126

Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI----GYMA 678
              S  I+H D+KP N+LL       +S  G+A    E         T  T      +  
Sbjct: 127 ---SQGIVHKDIKPGNLLLTTGGTLKISALGVA----EALHPFAADDTCRTSQGSPAFQP 179

Query: 679 PDEIFSGE 686
           P EI +G 
Sbjct: 180 P-EIANGL 186

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 87.3 bits (217), Expect = 4e-19
 Identities = 46/175 (26%), Positives = 77/175 (44%), Gaps = 17/175 (9%)

Query: 519 LIGRGGFGPVY-----KDGMEVAIKVFN---LQYGGAFKSFDIECGMMKRIRHRNLIKII 570
            +G+G FG VY     ++   +A+KV     L+  G       E  +   +RH N++++ 
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 571 SSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPII 630
           +   +     L+LE+ P G L K L       D  +    M ++A AL Y H      +I
Sbjct: 81  NYFHDRKRIYLMLEFAPRGELYKELQKHGR-FDEQRSATFMEELADALHYCH---ERKVI 136

Query: 631 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG 685
           H D+KP N+L+       ++DFG +           +T    T+ Y+ P E+  G
Sbjct: 137 HRDIKPENLLMGYKGELKIADFGWSV---HAPSLRRRT-MCGTLDYLPP-EMIEG 186

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 89.0 bits (221), Expect = 5e-19
 Identities = 45/189 (23%), Positives = 76/189 (40%), Gaps = 29/189 (15%)

Query: 520 IGRGGFGPVYK----------DGMEVAIKVFNLQYGGAFKS-FDIECGMMKRIRHRNLIK 568
           +G G FG VY+            ++VA+K          +  F +E  ++ +  H+N+++
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138

Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCL------YSGNYILDIFQGLNIMIDVASALEYL- 621
            I        + ++LE M  G L+  L       S    L +   L++  D+A   +YL 
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198

Query: 622 --HFGYSVPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGY 676
             HF      IH D+   N LL       VA + DFGMA+ +            +  + +
Sbjct: 199 ENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252

Query: 677 MAPDEIFSG 685
           M P+    G
Sbjct: 253 MPPEAFMEG 261

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 88.0 bits (218), Expect = 6e-19
 Identities = 49/222 (22%), Positives = 78/222 (35%), Gaps = 57/222 (25%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI-----ECGMMKRIRHRNLIKI 569
           IG+G +G V            AIK+ N          D+     E  +MK++ H N+ ++
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 570 ISSCSNDDFKALVLEYMPLGSL------EKCLYSGNYILDIFQGL--------------- 608
                ++ +  LV+E    G L           +G   +D+ +                 
Sbjct: 94  YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153

Query: 609 ------------------NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHL- 649
                             NIM  + SAL YLH   +  I H D+KP N L   N    + 
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210

Query: 650 -SDFGMAK--PLLEEDQSLTQTQTLATIGYMAPDEIFSGEMR 688
             DFG++K    L   +    T    T  ++AP E+ +    
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP-EVLNTTNE 251

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 87.4 bits (217), Expect = 9e-19
 Identities = 47/203 (23%), Positives = 75/203 (36%), Gaps = 43/203 (21%)

Query: 520 IGRGGFGPVYK----------DGMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIK 568
           IG G FG V++              VA+K+   +        F  E  +M    + N++K
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114

Query: 569 IISSCSNDDFKALVLEYMPLGSL-----------------------EKCLYSGNYILDIF 605
           ++  C+      L+ EYM  G L                        +    G   L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174

Query: 606 QGLNIMIDVASALEYL---HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED 662
           + L I   VA+ + YL    F      +H DL   N L+ +NMV  ++DFG+++ +   D
Sbjct: 175 EQLCIARQVAAGMAYLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228

Query: 663 QSLTQTQTLATIGYMAPDEIFSG 685
                      I +M P+ IF  
Sbjct: 229 YYKADGNDAIPIRWMPPESIFYN 251

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 87.5 bits (217), Expect = 1e-18
 Identities = 52/210 (24%), Positives = 80/210 (38%), Gaps = 32/210 (15%)

Query: 481 RKGRKSQLKDVNMPSVADQRRFTYLELFQATNRFSENNLIGRGGFGPVYK-----DGMEV 535
             GR   LKD ++  +  +              FS+   IG G FG VY      +   V
Sbjct: 31  AGGRAGSLKDPDVAELFFKD--------DPEKLFSDLREIGHGSFGAVYFARDVRNSEVV 82

Query: 536 AIKVFNLQYGGAFKSFDI---ECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLE 592
           AIK  +     + + +     E   ++++RH N I+       +    LV+EY   GS  
Sbjct: 83  AIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSAS 141

Query: 593 KCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDF 652
             L      L   +   +       L YLH   S  +IH D+K  N+LL +  +  L DF
Sbjct: 142 DLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDF 198

Query: 653 GMAKPLLEEDQSLTQTQTLATIG---YMAP 679
           G A         +    +   +G   +MAP
Sbjct: 199 GSA-------SIMAPANSF--VGTPYWMAP 219

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 86.1 bits (214), Expect = 1e-18
 Identities = 47/184 (25%), Positives = 77/184 (41%), Gaps = 20/184 (10%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS 574
           IGRG +G V         +  A K     +      F  E  +MK + H N+I++  +  
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76

Query: 575 NDDFKALVLEYMPLGSL-EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCD 633
           ++    LV+E    G L E+ ++   +         IM DV SA+ Y H    + + H D
Sbjct: 77  DNTDIYLVMELCTGGELFERVVHKRVFRES--DAARIMKDVLSAVAYCH---KLNVAHRD 131

Query: 634 LKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           LKP N L      +    L DFG+A    +  + +     + T  Y++P ++  G    +
Sbjct: 132 LKPENFLFLTDSPDSPLKLIDFGLAA-RFKPGKMM--RTKVGTPYYVSP-QVLEGLYGPE 187

Query: 691 C--W 692
           C  W
Sbjct: 188 CDEW 191

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 89.0 bits (221), Expect = 1e-18
 Identities = 46/186 (24%), Positives = 80/186 (43%), Gaps = 22/186 (11%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISS 572
           +G+G FG V K        E A+KV N          +   E  ++K++ H N++K+   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89

Query: 573 CSNDDFKALVLEYMPLGSL-EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIH 631
             +     +V E    G L ++ +    +         I+  V S + Y+H      I+H
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRF--SEHDAARIIKQVFSGITYMH---KHNIVH 144

Query: 632 CDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMR 688
            DLKP N+LL   + +    + DFG++    +++  +     + T  Y+AP E+  G   
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLST-CFQQNTKM--KDRIGTAYYIAP-EVLRGTYD 200

Query: 689 LKC--W 692
            KC  W
Sbjct: 201 EKCDVW 206

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 48/208 (23%), Positives = 81/208 (38%), Gaps = 49/208 (23%)

Query: 519 LIGRGGFGPVY-----KDGMEVAIKVFN----------------LQYGGAFKSFDIECGM 557
            IG+G +G V       D    A+KV +                     A        G 
Sbjct: 20  EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79

Query: 558 ----------MKRIRHRNLIKIIS--SCSNDDFKALVLEYMPLGSLEKCLYSGNYILD-- 603
                     +K++ H N++K++      N+D   +V E +  G + +         D  
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQA 139

Query: 604 --IFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE 661
              FQ      D+   +EYLH      IIH D+KPSN+L+ ++    ++DFG++    + 
Sbjct: 140 RFYFQ------DLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSN-EFKG 189

Query: 662 DQSLTQTQTLATIGYMAPDEIFSGEMRL 689
             +L    T+ T  +MAP E  S   ++
Sbjct: 190 SDALLSN-TVGTPAFMAP-ESLSETRKI 215

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 43/188 (22%), Positives = 75/188 (39%), Gaps = 21/188 (11%)

Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI--ECGMMKRIRHR 564
           + +    +IG G    V          +VAIK  NL+        ++  E   M +  H 
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMD-ELLKEIQAMSQCHHP 73

Query: 565 NLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGL-------NIMIDVASA 617
           N++   +S    D   LV++ +  GS+   +       +   G+        I+ +V   
Sbjct: 74  NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133

Query: 618 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG-- 675
           LEYLH       IH D+K  N+LL ++    ++DFG++  L               +G  
Sbjct: 134 LEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190

Query: 676 -YMAPDEI 682
            +MAP+ +
Sbjct: 191 CWMAPEVM 198

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 86.2 bits (214), Expect = 2e-18
 Identities = 50/186 (26%), Positives = 79/186 (42%), Gaps = 29/186 (15%)

Query: 519 LIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIR-HRNLIKIISS 572
           ++G G    V          E A+K+   Q G        E  M+ + + HRN++++I  
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79

Query: 573 CSNDDFKALVLEYMPLGSL-----EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
              +D   LV E M  GS+     ++  ++        +   ++ DVASAL++LH   + 
Sbjct: 80  FEEEDRFYLVFEKMRGGSILSHIHKRRHFNEL------EASVVVQDVASALDFLH---NK 130

Query: 628 PIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPL-LEEDQSLTQTQTLATI----GYMAP 679
            I H DLKP N+L    +      + DF +   + L  D S   T  L T      YMAP
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190

Query: 680 DEIFSG 685
            E+   
Sbjct: 191 -EVVEA 195

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 87.1 bits (216), Expect = 2e-18
 Identities = 43/186 (23%), Positives = 82/186 (44%), Gaps = 26/186 (13%)

Query: 514 FSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIK 568
            S+  ++G G FG V+K      G+++A K+   +     +    E  +M ++ H NLI+
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150

Query: 569 IISSCSNDDFKALVLEYMPLGSL------EKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
           +  +  + +   LV+EY+  G L      E    +    +        M  +   + ++H
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTIL------FMKQICEGIRHMH 204

Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHL--SDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
             Y   I+H DLKP N+L  +     +   DFG+A+   +  + L       T  ++AP 
Sbjct: 205 QMY---ILHLDLKPENILCVNRDAKQIKIIDFGLAR-RYKPREKL--KVNFGTPEFLAP- 257

Query: 681 EIFSGE 686
           E+ + +
Sbjct: 258 EVVNYD 263

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 86.6 bits (215), Expect = 2e-18
 Identities = 44/200 (22%), Positives = 84/200 (42%), Gaps = 35/200 (17%)

Query: 506 ELFQATNRFSEN----NLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECG 556
           +L + + +F++       IG G +    +       ME A+K+ +       +  +I   
Sbjct: 12  QLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI--- 68

Query: 557 MMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSL-----EKCLYSGNYILDIFQGLNIM 611
           +++  +H N+I +     +  +  +V E M  G L      +  +S        +   ++
Sbjct: 69  LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSER------EASAVL 122

Query: 612 IDVASALEYLHFGYSVPIIHCDLKPSNVLL----DDNMVAHLSDFGMAKPLLEEDQSLTQ 667
             +   +EYLH   +  ++H DLKPSN+L      +     + DFG AK L  E+  L  
Sbjct: 123 FTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM- 178

Query: 668 TQTLA-TIGYMAPDEIFSGE 686
             T   T  ++AP E+   +
Sbjct: 179 --TPCYTANFVAP-EVLERQ 195

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 85.8 bits (213), Expect = 2e-18
 Identities = 43/197 (21%), Positives = 78/197 (39%), Gaps = 37/197 (18%)

Query: 520 IGRGGFGPVYK----------DGMEVAIKVFNLQYGGA----FKSFDIECGMMKRI-RHR 564
           +GRG FG V +              VA+K+      GA     ++   E  ++  I  H 
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLK---EGATHSEHRALMSELKILIHIGHHL 91

Query: 565 NLIKIISSCSNDDFKALV-LEYMPLGSL---------------EKCLYSGNYILDIFQGL 608
           N++ ++ +C+      +V +E+   G+L                         L +   +
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151

Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
                VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ + ++   + + 
Sbjct: 152 CYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208

Query: 669 QTLATIGYMAPDEIFSG 685
                + +MAP+ IF  
Sbjct: 209 DARLPLKWMAPETIFDR 225

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 85.9 bits (213), Expect = 2e-18
 Identities = 57/217 (26%), Positives = 89/217 (41%), Gaps = 48/217 (22%)

Query: 492 NMPSVADQRRFTYLELFQATN---RFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQ 543
           +M S +  R    ++L    +    F    L+G G +G VYK      G   AIKV ++ 
Sbjct: 1   SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60

Query: 544 YGGAFKSFDIECGMMKRI-RHRNLIKIISS------CSNDDFKALVLEYMPLGSLEKCLY 596
            G   +    E  M+K+   HRN+     +         DD   LV+E+   GS+     
Sbjct: 61  -GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV----- 114

Query: 597 SGNYILDIFQGLN-----------IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM 645
                 D+ +              I  ++   L +LH      +IH D+K  NVLL +N 
Sbjct: 115 -----TDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENA 166

Query: 646 VAHLSDFGMAKPLLEEDQSLTQTQTLATIG---YMAP 679
              L DFG++  L   D+++ +  T   IG   +MAP
Sbjct: 167 EVKLVDFGVSAQL---DRTVGRRNTF--IGTPYWMAP 198

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 88.4 bits (219), Expect = 3e-18
 Identities = 45/225 (20%), Positives = 85/225 (37%), Gaps = 30/225 (13%)

Query: 479 KYRKGRKSQLKDVNMPSVADQRRFTYLELFQATNRFSE----NNLIGRGGFGPVYK---- 530
           K  +G+ +   + +       +++    +    +   +    +  +G G FG V++    
Sbjct: 120 KIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTER 179

Query: 531 -DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLG 589
             G   A K     +    ++   E   M  +RH  L+ +  +  +D+   ++ E+M  G
Sbjct: 180 ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGG 239

Query: 590 SL------EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD 643
            L      E    S +        +  M  V   L ++H       +H DLKP N++   
Sbjct: 240 ELFEKVADEHNKMSEDEA------VEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTT 290

Query: 644 NMVAHL--SDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGE 686
                L   DFG+    L+  QS+    T  T  + AP E+  G+
Sbjct: 291 KRSNELKLIDFGLTA-HLDPKQSV--KVTTGTAEFAAP-EVAEGK 331

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 85.1 bits (211), Expect = 3e-18
 Identities = 53/177 (29%), Positives = 82/177 (46%), Gaps = 21/177 (11%)

Query: 513 RFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI--ECGMMKRIRHRN 565
            F++   IG+G FG V+K         VAIK+ +L+        DI  E  ++ +     
Sbjct: 23  LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPY 81

Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY 625
           + K   S   D    +++EY+  GS    L  G   LD  Q   I+ ++   L+YLH   
Sbjct: 82  VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH--- 136

Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG---YMAP 679
           S   IH D+K +NVLL ++    L+DFG+A  L     +  +  T   +G   +MAP
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL---TDTQIKRNTF--VGTPFWMAP 188

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 85.8 bits (213), Expect = 3e-18
 Identities = 41/199 (20%), Positives = 79/199 (39%), Gaps = 40/199 (20%)

Query: 518 NLIGRGGFGPVYK----------DGMEVAIKVFNLQYGGA----FKSFDIECGMMKRI-R 562
             +G G FG V +            ++VA+K+       A     ++   E  +M  + +
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK---STAHADEKEALMSELKIMSHLGQ 108

Query: 563 HRNLIKIISSCSNDDFKALVLEYMPLGSL-------------EKCLYSGNYILDIFQGLN 609
           H N++ ++ +C++     ++ EY   G L             +      N        L+
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168

Query: 610 IMIDVASALEYL---HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT 666
               VA  + +L   +       IH D+   NVLL +  VA + DFG+A+ ++ +   + 
Sbjct: 169 FSSQVAQGMAFLASKNC------IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222

Query: 667 QTQTLATIGYMAPDEIFSG 685
           +      + +MAP+ IF  
Sbjct: 223 KGNARLPVKWMAPESIFDC 241

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 85.4 bits (212), Expect = 3e-18
 Identities = 40/195 (20%), Positives = 75/195 (38%), Gaps = 32/195 (16%)

Query: 520 IGRGGFGPVYK----------DGMEVAIKVFNLQYGGA-FKSFDIECGMMKRI-RHRNLI 567
           +G G FG V +            M VA+K+          ++   E  ++  +  H N++
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90

Query: 568 KIISSCSNDDFKALVLEYMPLGSL-----------------EKCLYSGNYILDIFQGLNI 610
            ++ +C+      ++ EY   G L                    +      LD+   L+ 
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150

Query: 611 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 670
              VA  + +L    S   IH DL   N+LL    +  + DFG+A+ +  +   + +   
Sbjct: 151 SYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207

Query: 671 LATIGYMAPDEIFSG 685
              + +MAP+ IF+ 
Sbjct: 208 RLPVKWMAPESIFNC 222

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 85.5 bits (212), Expect = 4e-18
 Identities = 51/191 (26%), Positives = 78/191 (40%), Gaps = 42/191 (21%)

Query: 520 IGRGGFGPVY-----KDGMEVAIKVFN---LQYGGAFKSFDI-----ECGMMKRIRHRNL 566
           +G G FG V+     +   EV +K      +      +   +     E  ++ R+ H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD-----------IFQGLNIMIDVA 615
           IK++    N  F  LV+E    G L+  L+   +I             IF+       + 
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSG-LD--LF--AFIDRHPRLDEPLASYIFR------QLV 140

Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 675
           SA+ YL       IIH D+K  N+++ ++    L DFG A  L  E   L  T    TI 
Sbjct: 141 SAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYT-FCGTIE 194

Query: 676 YMAPDEIFSGE 686
           Y AP E+  G 
Sbjct: 195 YCAP-EVLMGN 204

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 85.4 bits (212), Expect = 4e-18
 Identities = 43/184 (23%), Positives = 72/184 (39%), Gaps = 27/184 (14%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNL-QYGGAFKSFDI-----ECGMMKRIRHRNLIK 568
           +G G F  V K      G+E A K     Q   + +         E  +++++ H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79

Query: 569 IISSCSNDDFKALVLEYMPLGSL-EKCLYSGNYI-LDIFQGLNIMIDVASALEYLHFGYS 626
           +     N     L+LE +  G L +      +    +     + +  +   + YLH   +
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA---TSFIKQILDGVNYLH---T 133

Query: 627 VPIIHCDLKPSNVLL----DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
             I H DLKP N++L           L DFG+A   +E+           T  ++AP EI
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEF--KNIFGTPEFVAP-EI 189

Query: 683 FSGE 686
            + E
Sbjct: 190 VNYE 193

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 84.2 bits (209), Expect = 4e-18
 Identities = 47/184 (25%), Positives = 72/184 (39%), Gaps = 27/184 (14%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNL-QYGGAFKSFDI-----ECGMMKRIRHRNLIK 568
           +G G F  V K      G E A K     +   + +         E  +++ IRH N+I 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 569 IISSCSNDDFKALVLEYMPLGSL-EKCLYSGNYI-LDIFQGLNIMIDVASALEYLHFGYS 626
           +     N     L+LE +  G L +      +    +       +  +   + YLH   S
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEA---TQFLKQILDGVHYLH---S 126

Query: 627 VPIIHCDLKPSNVLLDDNMVAH----LSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
             I H DLKP N++L D  V +    L DFG+A   +E            T  ++AP EI
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH-KIEAGNEF--KNIFGTPEFVAP-EI 182

Query: 683 FSGE 686
            + E
Sbjct: 183 VNYE 186

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 85.4 bits (212), Expect = 5e-18
 Identities = 47/198 (23%), Positives = 79/198 (39%), Gaps = 38/198 (19%)

Query: 520 IGRGGFGPVYK------------DGMEVAIKVFNLQYGGA----FKSFDIECGMMKRI-R 562
           +G G FG V              + + VA+K+       A          E  MMK I +
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGK 99

Query: 563 HRNLIKIISSCSNDDFKALVLEYMPLGSL---------------EKCLYSGNYILDIFQG 607
           H+N+I ++ +C+ D    +++EY   G+L                         +     
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 608 LNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ 667
           ++    +A  +EYL    S   IH DL   NVL+ +N V  ++DFG+A+ +   D     
Sbjct: 160 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKT 216

Query: 668 TQTLATIGYMAPDEIFSG 685
           T     + +MAP+ +F  
Sbjct: 217 TNGRLPVKWMAPEALFDR 234

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 85.0 bits (211), Expect = 5e-18
 Identities = 44/181 (24%), Positives = 76/181 (41%), Gaps = 29/181 (16%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIR-HRNLIKIISSC 573
           +G G F    K          A+K+ + +      +   E   +K    H N++K+    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVF 75

Query: 574 SNDDFKALVLEYMPLGSL-----EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVP 628
            +     LV+E +  G L     +K  +S        +   IM  + SA+ ++H    V 
Sbjct: 76  HDQLHTFLVMELLNGGELFERIKKKKHFSET------EASYIMRKLVSAVSHMH---DVG 126

Query: 629 IIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG 685
           ++H DLKP N+L    +DN+   + DFG A+    ++Q L       T+ Y AP E+ + 
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL--KTPCFTLHYAAP-ELLNQ 183

Query: 686 E 686
            
Sbjct: 184 N 184

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 85.5 bits (212), Expect = 6e-18
 Identities = 43/184 (23%), Positives = 73/184 (39%), Gaps = 27/184 (14%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFN------LQYGGAFKSFDIECGMMKRIRHRNLIK 568
           +G G F  V K      G+E A K          + G   +  + E  +++++ H N+I 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 569 IISSCSNDDFKALVLEYMPLGSL-EKCLYSGNYI-LDIFQGLNIMIDVASALEYLHFGYS 626
           +     N     L+LE +  G L +      +    +     + +  +   + YLH   +
Sbjct: 80  LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEA---TSFIKQILDGVNYLH---T 133

Query: 627 VPIIHCDLKPSNVLL----DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
             I H DLKP N++L           L DFG+A   +E+           T  ++AP EI
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH-EIEDGVEF--KNIFGTPEFVAP-EI 189

Query: 683 FSGE 686
            + E
Sbjct: 190 VNYE 193

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 85.7 bits (212), Expect = 6e-18
 Identities = 31/175 (17%), Positives = 67/175 (38%), Gaps = 18/175 (10%)

Query: 520 IGRG--GFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI--ECGMMKRIRHRNLIKII 570
           IG+G      V        G  V ++  NL+         +  E  + K   H N++   
Sbjct: 33  IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92

Query: 571 SSCSNDDFKALVLEYMPLGSLEKCL-YSGNYILDIFQGLNIMIDVASALEYLHFGYSVPI 629
           ++   D+   +V  +M  GS +  +       ++      I+  V  AL+Y+H    +  
Sbjct: 93  ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGY 149

Query: 630 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED--QSLTQTQTLATIG---YMAP 679
           +H  +K S++L+  +   +LS       ++     Q +       ++    +++P
Sbjct: 150 VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 85.4 bits (212), Expect = 6e-18
 Identities = 45/197 (22%), Positives = 71/197 (36%), Gaps = 28/197 (14%)

Query: 506 ELFQATNRFSENNLIGRGGFGPV----YKDGMEVAIK-VFNLQYGGAFKS-FDI------ 553
           EL    + ++    I  G +G V      +G+ VAIK VFN    G   +          
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75

Query: 554 ---ECGMMKRIRHRNLIK---IISSCSNDDFKA--LVLEYMPLGSLEKCLYSGNYILDIF 605
              E  ++    H N++    I             LV E M    L + ++    ++   
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQ 134

Query: 606 QGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL 665
                M  +   L  LH      ++H DL P N+LL DN    + DF +A+    +    
Sbjct: 135 HIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK- 190

Query: 666 TQTQTLATIGYMAPDEI 682
             T  +    Y AP E+
Sbjct: 191 --THYVTHRWYRAP-EL 204

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 83.8 bits (208), Expect = 6e-18
 Identities = 51/189 (26%), Positives = 79/189 (41%), Gaps = 25/189 (13%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFN-LQYGGAFKSFDIECGMMKRIRHRNLIKIISSC 573
           +G G FG V+       G+E  IK  N  +     +  + E  ++K + H N+IKI    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89

Query: 574 SNDDFKALVLEYMPLGSL-----EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVP 628
            +     +V+E    G L                       +M  + +AL Y H   S  
Sbjct: 90  EDYHNMYIVMETCEGGELLERIVSAQARGKALSEG--YVAELMKQMMNALAYFH---SQH 144

Query: 629 IIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG 685
           ++H DLKP N+L      +    + DFG+A+ L + D+    T    T  YMAP E+F  
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAE-LFKSDEHS--TNAAGTALYMAP-EVFKR 200

Query: 686 EMRLKC--W 692
           ++  KC  W
Sbjct: 201 DVTFKCDIW 209

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 85.1 bits (211), Expect = 7e-18
 Identities = 54/187 (28%), Positives = 79/187 (42%), Gaps = 40/187 (21%)

Query: 519 LIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI-----ECGMMKRIRHRNLIK 568
            +GRG    VY+          A+KV         K+ D      E G++ R+ H N+IK
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLK-------KTVDKKIVRTEIGVLLRLSHPNIIK 112

Query: 569 IISSCSNDDFKALVLEYMPLGSL-----EKCLYSGNYILDIFQGLNIMIDVASALEYLHF 623
           +          +LVLE +  G L     EK  YS     D  +       +  A+ YLH 
Sbjct: 113 LKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVK------QILEAVAYLH- 165

Query: 624 GYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGYMAP 679
                I+H DLKP N+L      +    ++DFG++K ++E    +    T+  T GY AP
Sbjct: 166 --ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK-IVEHQVLMK---TVCGTPGYCAP 219

Query: 680 DEIFSGE 686
            EI  G 
Sbjct: 220 -EILRGC 225

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 82.7 bits (205), Expect = 7e-18
 Identities = 51/296 (17%), Positives = 85/296 (28%), Gaps = 91/296 (30%)

Query: 20  PSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTL 79
           P S QTL L                      +L  +   AFS             N+  +
Sbjct: 30  PPSTQTLKLIET-------------------HLRTIPSHAFS-------------NLPNI 57

Query: 80  KSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFS 139
             +Y+  +    +L S +   L  +  + +     +  I                     
Sbjct: 58  SRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYID-------------------- 97

Query: 140 GSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAI 199
              P+    L  LK+LG+ +  L    P+L+ + S      LE                 
Sbjct: 98  ---PDALKELPLLKFLGIFNTGLKMF-PDLTKVYSTDIFFILE----------------- 136

Query: 200 GNLSQSMEDFWMDNCNISGSIPEEI-NNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQ 258
                       DN  ++ SIP      L N     L L  N    S+         L  
Sbjct: 137 ----------ITDNPYMT-SIPVNAFQGLCNE-TLTLKLYNNGFT-SVQGYAFNGTKLDA 183

Query: 259 LDLGGNKLSGFVP--ACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNF 312
           + L  NK    +   A  G  +    L +    +T++PS    L+ +  L   + +
Sbjct: 184 VYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKG--LEHLKELIARNTW 237

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 77.4 bits (191), Expect = 4e-16
 Identities = 44/289 (15%), Positives = 88/289 (30%), Gaps = 89/289 (30%)

Query: 77  STLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKN 136
            + ++L L    L   +PS A   LPN+  +++  +  +  +                  
Sbjct: 31  PSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLE----------------- 72

Query: 137 SFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILP 196
                  ++F NL  +  + + +         L+ +                       P
Sbjct: 73  ------SHSFYNLSKVTHIEIRNT------RNLTYID----------------------P 98

Query: 197 RAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDD--LCRLA 254
            A+  L                             L+ L +    L+   PD   +    
Sbjct: 99  DALKELPL---------------------------LKFLGIFNTGLK-MFPDLTKVYSTD 130

Query: 255 ALFQLDLGGNKLSGFVPACS-GNLTN-LRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNF 312
             F L++  N     +P  +   L N    L L +N  TS+    +N   +  + L+ N 
Sbjct: 131 IFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNK 190

Query: 313 FTGPLPLKI--GNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYN 359
           +   +      G  +    LD+S  + +  +P+   GL+ L+ L     
Sbjct: 191 YLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPS--KGLEHLKELIARNT 236

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 76.6 bits (189), Expect = 9e-16
 Identities = 37/202 (18%), Positives = 75/202 (37%), Gaps = 13/202 (6%)

Query: 232 LQLLSLEGNQLEGSIPDD-LCRLAALFQLDLGGNKLSGFVPACS-GNLTNLRKLYLGSN- 288
            Q L L    L  +IP      L  + ++ +  +     + + S  NL+ +  + + +  
Sbjct: 33  TQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91

Query: 289 LLTSIPS-TLWNLKDILHLNLSSNFFTG-PLPLKIGNLNVLVQLDLSMNNFSCVIPTKI- 345
            LT I    L  L  +  L + +      P   K+ + ++   L+++ N +   IP    
Sbjct: 92  NLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNAF 151

Query: 346 GGL-KDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPI-SLEKLL-DLKDI 402
            GL  +   L L  N    S+     +   L ++ L+ N     I   +   +      +
Sbjct: 152 QGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLL 210

Query: 403 NVSFNRLEGEIPREGPFRNLSA 424
           +VS   +   +P +G   +L  
Sbjct: 211 DVSQTSVT-ALPSKG-LEHLKE 230

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 47.3 bits (113), Expect = 7e-06
 Identities = 25/143 (17%), Positives = 48/143 (33%), Gaps = 36/143 (25%)

Query: 14  LSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTI 73
           L+++ +      L ++ NP   SIP        +    L N                   
Sbjct: 123 LTKVYSTDIFFILEITDNPYMTSIP-------VNAFQGLCNE------------------ 157

Query: 74  FNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFN--ASKLSEL 131
                  +L L++N  +  +   A      L  ++L  N ++  I    F    S  S L
Sbjct: 158 -----TLTLKLYNNGFT-SVQGYA-FNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLL 210

Query: 132 GLQKNSFSGSIP-NTFGNLRNLK 153
            + + S + ++P     +L+ L 
Sbjct: 211 DVSQTSVT-ALPSKGLEHLKELI 232

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 85.1 bits (211), Expect = 7e-18
 Identities = 46/201 (22%), Positives = 78/201 (38%), Gaps = 44/201 (21%)

Query: 520 IGRGGFGPVYK------------DGMEVAIKVFNLQYGGA----FKSFDIECGMMKRI-R 562
           +G G FG V              + + VA+K+       A          E  MMK I +
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLK---DDATEKDLSDLVSEMEMMKMIGK 145

Query: 563 HRNLIKIISSCSNDDFKALVLEYMPLGSL---------------EKCLYSGNYILDIFQG 607
           H+N+I ++ +C+ D    +++EY   G+L                         +     
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 608 LNIMIDVASALEYL---HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS 664
           ++    +A  +EYL           IH DL   NVL+ +N V  ++DFG+A+ +   D  
Sbjct: 206 VSCTYQLARGMEYLASQKC------IHRDLAARNVLVTENNVMKIADFGLARDINNIDYY 259

Query: 665 LTQTQTLATIGYMAPDEIFSG 685
              T     + +MAP+ +F  
Sbjct: 260 KKTTNGRLPVKWMAPEALFDR 280

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 86.3 bits (214), Expect = 1e-17
 Identities = 51/196 (26%), Positives = 79/196 (40%), Gaps = 31/196 (15%)

Query: 518 NLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI-------------ECGMMK 559
             +G G +G V          E AIKV         +  D              E  ++K
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 560 RIRHRNLIKIISSCSNDDFKALVLEYMPLGSL-EKCLYSGNYILDIFQGLNIMIDVASAL 618
            + H N+IK+     +  +  LV E+   G L E+ +    +  D     NIM  + S +
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKF--DECDAANIMKQILSGI 159

Query: 619 EYLHFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG 675
            YLH      I+H D+KP N+LL   +  +   + DFG++     +D  L     L T  
Sbjct: 160 CYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS-FFSKDYKL--RDRLGTAY 213

Query: 676 YMAPDEIFSGEMRLKC 691
           Y+AP E+   +   KC
Sbjct: 214 YIAP-EVLKKKYNEKC 228

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 84.2 bits (209), Expect = 1e-17
 Identities = 42/184 (22%), Positives = 72/184 (39%), Gaps = 27/184 (14%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFN-LQYGGAFKSFDI-----ECGMMKRIRHRNLIK 568
           +G G F  V K      G++ A K     +   + +         E  ++K I+H N+I 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 569 IISSCSNDDFKALVLEYMPLGSL-EKCLYSGNYI-LDIFQGLNIMIDVASALEYLHFGYS 626
           +     N     L+LE +  G L +      +    +       +  + + + YLH   S
Sbjct: 79  LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA---TEFLKQILNGVYYLH---S 132

Query: 627 VPIIHCDLKPSNVLL----DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
           + I H DLKP N++L           + DFG+A   ++            T  ++AP EI
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH-KIDFGNEF--KNIFGTPEFVAP-EI 188

Query: 683 FSGE 686
            + E
Sbjct: 189 VNYE 192

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 84.7 bits (210), Expect = 1e-17
 Identities = 49/201 (24%), Positives = 81/201 (40%), Gaps = 42/201 (20%)

Query: 520 IGRGGFGPVYK------------DGMEVAIKVFNLQYGGA----FKSFDIECGMMKRI-R 562
           +G G FG V                 +VA+K+       A          E  MMK I +
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK---SDATEKDLSDLISEMEMMKMIGK 133

Query: 563 HRNLIKIISSCSNDDFKALVLEYMPLGSL---------------EKCLYSGNYILDIFQG 607
           H+N+I ++ +C+ D    +++EY   G+L                   ++    L     
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 608 LNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ 667
           ++    VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D     
Sbjct: 194 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKT 250

Query: 668 TQTLATIGYMAP----DEIFS 684
           T     + +MAP    D I++
Sbjct: 251 TNGRLPVKWMAPEALFDRIYT 271

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 84.3 bits (208), Expect = 2e-17
 Identities = 26/209 (12%), Positives = 58/209 (27%), Gaps = 50/209 (23%)

Query: 519 LIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKS----------------------- 550
           ++G+            + G    + V          +                       
Sbjct: 80  VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139

Query: 551 -----FDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMP-------LGSLEKCLYSG 598
                F     ++K  + + +I++     +    +    Y          G +     S 
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199

Query: 599 NYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL 658
           +  L     L + + V   L  LH      ++H  L+P +++LD      L+ F      
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR- 255

Query: 659 LEEDQSLTQTQTLATIGYMAPDEIFSGEM 687
              D +   +    + G+  P E+ +   
Sbjct: 256 ---DGARVVSSV--SRGFEPP-ELEARRA 278

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 85.2 bits (211), Expect = 2e-17
 Identities = 56/188 (29%), Positives = 86/188 (45%), Gaps = 25/188 (13%)

Query: 514 FSENNLIGRGGFGPVY----KDGMEV-AIKVFNLQYGGAFKSFDIECGMMKR-----IRH 563
           F +  ++GRGGFG V+    K   ++ A K   L      K    +  M+++     +  
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKK--LNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMI----DVASALE 619
           R ++ +  +        LV+  M  G +   +Y+ +     FQ     I     + S LE
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFYTAQIVSGLE 303

Query: 620 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGYMA 678
           +LH      II+ DLKP NVLLDD+    +SD G+A  L       T+T+  A T G+MA
Sbjct: 304 HLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ---TKTKGYAGTPGFMA 357

Query: 679 PDEIFSGE 686
           P E+  GE
Sbjct: 358 P-ELLLGE 364

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 83.0 bits (205), Expect = 3e-17
 Identities = 47/210 (22%), Positives = 95/210 (45%), Gaps = 22/210 (10%)

Query: 486 SQLKDVNMPSVADQRRFTYLELFQATNRFSENNL-----IGRGGFGPVYK-----DGMEV 535
            +L+++ +     +R   +L   Q      +++      +G G  G V+K      G+ +
Sbjct: 2   KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVM 61

Query: 536 AIKVFNLQYGGAFKSFDI--ECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEK 593
           A K+ +L+   A ++  I  E  ++       ++    +  +D   ++ +E+M  GSL++
Sbjct: 62  ARKLIHLEIKPAIRN-QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 120

Query: 594 CLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFG 653
            L     I +   G  + I V   L YL   +   I+H D+KPSN+L++      L DFG
Sbjct: 121 VLKKAGRIPEQILGK-VSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFG 177

Query: 654 MAKPLLEEDQSLTQTQTLA-TIGYMAPDEI 682
           ++  L++     +   +   T  YM+P+ +
Sbjct: 178 VSGQLID-----SMANSFVGTRSYMSPERL 202

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 82.7 bits (205), Expect = 3e-17
 Identities = 47/195 (24%), Positives = 83/195 (42%), Gaps = 34/195 (17%)

Query: 518 NLIGRGGFGPVYK-------DGMEVAIKVFNLQYG-GAFKSFDIECGMMKRI-RHRNLIK 568
           ++IG G FG V K         M+ AIK           + F  E  ++ ++  H N+I 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 569 IISSCSNDDFKALVLEYMPLGSL---------------EKCLYSGNYILDIFQGLNIMID 613
           ++ +C +  +  L +EY P G+L                    S    L   Q L+   D
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 614 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 673
           VA  ++YL        IH DL   N+L+ +N VA ++DFG+++    ++  + +T     
Sbjct: 151 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRLP 204

Query: 674 IGYMAP----DEIFS 684
           + +MA       +++
Sbjct: 205 VRWMAIESLNYSVYT 219

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 84.8 bits (210), Expect = 3e-17
 Identities = 54/224 (24%), Positives = 92/224 (41%), Gaps = 24/224 (10%)

Query: 476 LILKYRKGRKSQLKDVNMPSVADQRRFTYLELFQAT-NRFSENNLIGRGGFGPVY----K 530
           L  +Y          ++        ++ +LE    T N F +  ++G+GGFG V     +
Sbjct: 148 LTHEYLSVAPFA-DYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVR 206

Query: 531 DGMEV-AIKVFNLQYGGAFKSFDIECGMMKR-----IRHRNLIKIISSCSNDDFKALVLE 584
              ++ A K   L+     K       + ++     +  R ++ +  +    D   LVL 
Sbjct: 207 ATGKMYACKK--LEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 264

Query: 585 YMPLGSLEKCLY-SGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD 643
            M  G L+  +Y  G       + +    ++   LE LH      I++ DLKP N+LLDD
Sbjct: 265 LMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDD 321

Query: 644 NMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGYMAPDEIFSGE 686
           +    +SD G+A  + E        +    T+GYMAP E+   E
Sbjct: 322 HGHIRISDLGLAVHVPEGQ----TIKGRVGTVGYMAP-EVVKNE 360

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 82.3 bits (204), Expect = 3e-17
 Identities = 37/182 (20%), Positives = 73/182 (40%), Gaps = 31/182 (17%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI-----ECGMMKRIRHRNLIKI 569
           +GRG FG V++            K   +      K  D      E  ++   RHRN++ +
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKV------KGTDQVLVKKEISILNIARHRNILHL 66

Query: 570 ISSCSNDDFKALVLEYMPLGSL-EKCLYSGNYI--LDIFQGLNIMIDVASALEYLHFGYS 626
             S  + +   ++ E++    + E+   S   +   +I   ++ +  V  AL++LH    
Sbjct: 67  HESFESMEELVMIFEFISGLDIFERINTSAFELNEREI---VSYVHQVCEALQFLHSHN- 122

Query: 627 VPIIHCDLKPSNVLLDDNMVAHL--SDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS 684
             I H D++P N++      + +   +FG A+  L+   +           Y AP E+  
Sbjct: 123 --IGHFDIRPENIIYQTRRSSTIKIIEFGQAR-QLKPGDNF--RLLFTAPEYYAP-EVHQ 176

Query: 685 GE 686
            +
Sbjct: 177 HD 178

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 82.6 bits (204), Expect = 5e-17
 Identities = 44/210 (20%), Positives = 73/210 (34%), Gaps = 19/210 (9%)

Query: 69  VPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIF-NASK 127
           VP ++   S    L L  N+LS         RL NL  L L  N+ +  I S  F     
Sbjct: 33  VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNH-LNFISSEAFVPVPN 89

Query: 128 LSELGLQKNSFSGSIP-NTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSF 186
           L  L L  N    ++    F +L+ L+ L L +N++           +  +   L+    
Sbjct: 90  LRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRN-----AFEDMAQLQKLYL 143

Query: 187 SNNPLGGILPRAIGNLS--QSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEG 244
           S N +       I + +    +    + +  +      ++  L   +   L L  N LE 
Sbjct: 144 SQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLEC 203

Query: 245 SIPDDLCRLAALFQLDLGGNKLSGFVPACS 274
                 C+L  LF       +LS  +    
Sbjct: 204 D-----CKLYQLFS-HWQYRQLSSVMDFQE 227

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 78.0 bits (192), Expect = 2e-15
 Identities = 45/177 (25%), Positives = 70/177 (39%), Gaps = 17/177 (9%)

Query: 219 SIPEEINNLTNLILQLLSLEGNQLEGSIP--DDLCRLAALFQLDLGGNKLSGFVPACS-G 275
           ++P+ + + T     LL L  N L   +       RL  L  L L  N L+ F+ + +  
Sbjct: 32  NVPQSLPSYT----ALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFV 85

Query: 276 NLTNLRKLYLGSNLLTSIPS-TLWNLKDILHLNLSSNFFTGPLPLKI-GNLNVLVQLDLS 333
            + NLR L L SN L ++      +L+ +  L L +N     +      ++  L +L LS
Sbjct: 86  PVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLS 144

Query: 334 MNNFSCVIP---TKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLK--SLNLSNNNL 385
            N  S            L  L  L L  N+L+      +  L +     L L NN L
Sbjct: 145 QNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 77.6 bits (191), Expect = 2e-15
 Identities = 44/179 (24%), Positives = 63/179 (35%), Gaps = 22/179 (12%)

Query: 20  PSSLQTLYLSYNPPSGSIPSFILCEIPHEID--NLHNMEWMAFSFNKVVGVVPTTIFNVS 77
           PS    L LS+N          L  +  E     L N+  +  S N +  +       V 
Sbjct: 38  PSYTALLDLSHNN---------LSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVP 88

Query: 78  TLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIF-NASKLSELGLQKN 136
            L+ L L SN L   L       L  L+ L L+ N+ I  +    F + ++L +L L +N
Sbjct: 89  NLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNH-IVVVDRNAFEDMAQLQKLYLSQN 146

Query: 137 SFSGSIPNTFGN---LRNLKWLGLNDNYLTSSTPE-LSSLSSLSNCKYLEYFSFSNNPL 191
             S        +   L  L  L L+ N L       L  L +             NNPL
Sbjct: 147 QISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWV----KNGLYLHNNPL 201

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 59.5 bits (144), Expect = 2e-09
 Identities = 36/156 (23%), Positives = 68/156 (43%), Gaps = 16/156 (10%)

Query: 273 CSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKI--GNLNVLVQL 330
           C+ N+     L      L ++P +L        L+LS N  +  L  +     L  L  L
Sbjct: 18  CASNI-----LSCSKQQLPNVPQSL--PSYTALLDLSHNNLSR-LRAEWTPTRLTNLHSL 69

Query: 331 DLSMNNFSCVIPTKI-GGLKDLQYLFLEYNRLQGSIPNSI-GDLISLKSLNLSNNNLSGT 388
            LS N+ +  I ++    + +L+YL L  N L  ++   +  DL +L+ L L NN++   
Sbjct: 70  LLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVV 127

Query: 389 IPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSA 424
              + E +  L+ + +S N++    P     ++ + 
Sbjct: 128 DRNAFEDMAQLQKLYLSQNQIS-RFP-VELIKDGNK 161

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 82.4 bits (204), Expect = 5e-17
 Identities = 54/255 (21%), Positives = 96/255 (37%), Gaps = 55/255 (21%)

Query: 479 KYRKGRK--SQLKDVNMPSVADQRRFTYLELFQATNR----FSENNL-----IGRGGFGP 527
           KY+K  +  SQL+ V +   +D   + Y++  +        F   NL     +G G FG 
Sbjct: 2   KYKKQFRYESQLQMVQVTGSSDNE-YFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGK 60

Query: 528 VYK----------DGMEVAIKVFNLQYGGA----FKSFDIECGMMKRI-RHRNLIKIISS 572
           V              ++VA+K+       A     ++   E  MM ++  H N++ ++ +
Sbjct: 61  VMNATAYGISKTGVSIQVAVKMLK---EKADSSEREALMSELKMMTQLGSHENIVNLLGA 117

Query: 573 CSNDDFKALVLEYMPLGSL----------------------EKCLYSGNYILDIFQGLNI 610
           C+      L+ EY   G L                               +L     L  
Sbjct: 118 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCF 177

Query: 611 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT 670
              VA  +E+L        +H DL   NVL+    V  + DFG+A+ ++ +   + +   
Sbjct: 178 AYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNA 234

Query: 671 LATIGYMAPDEIFSG 685
              + +MAP+ +F G
Sbjct: 235 RLPVKWMAPESLFEG 249

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 83.3 bits (206), Expect = 6e-17
 Identities = 43/222 (19%), Positives = 81/222 (36%), Gaps = 39/222 (17%)

Query: 489 KDVNMPSVADQRRFTYLELFQATNRFSENNLIGRGGFGPVYK-----DGMEVAIK-VFNL 542
              +  S  +   F  ++     + +   +LIGRG +G VY          VAIK V   
Sbjct: 3   HHHHHSSGRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNR- 61

Query: 543 QYGGAFKSFDI------ECGMMKRIRHRNLIK---IISSCSNDDFKA--LVLEYMPLGSL 591
                F+          E  ++ R++   +I+   +I       F    +VLE      L
Sbjct: 62  ----MFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DL 116

Query: 592 EKCLYSGNYILD------IFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM 645
           +K   +  ++ +      ++  L           ++H      IIH DLKP+N LL+ + 
Sbjct: 117 KKLFKTPIFLTEEHIKTILYNLLL-------GENFIH---ESGIIHRDLKPANCLLNQDC 166

Query: 646 VAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEM 687
              + DFG+A+ +  E  +               ++    ++
Sbjct: 167 SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQL 208

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 82.2 bits (203), Expect = 2e-16
 Identities = 45/229 (19%), Positives = 93/229 (40%), Gaps = 42/229 (18%)

Query: 481 RKGRKSQLKDVNMPSVADQRRFTYLELFQATNRFSENNLIGRGGFGPVYK-----DGMEV 535
           ++G++ +    + P+ +  R  +    +Q  +R+   +LIG G +G V +     +   V
Sbjct: 25  QEGQQRKQHHSSKPTASMPRPHS---DWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVV 81

Query: 536 AIK-VFNLQYGGAFKSFDI------ECGMMKRIRHRNLIK---IISSCSNDDFKA--LVL 583
           AIK +        F+          E  ++ R+ H +++K   I+     + F    +VL
Sbjct: 82  AIKKILR-----VFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVL 136

Query: 584 EYMPLGSLEKCLYSGNYILD------IFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPS 637
           E       +K   +  Y+ +      ++  L         ++Y+H   S  I+H DLKP+
Sbjct: 137 EIADS-DFKKLFRTPVYLTELHIKTLLYNLLV-------GVKYVH---SAGILHRDLKPA 185

Query: 638 NVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGE 686
           N L++ +    + DFG+A+ +   +   +Q         M        +
Sbjct: 186 NCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTK 234

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 80.4 bits (199), Expect = 2e-16
 Identities = 44/179 (24%), Positives = 74/179 (41%), Gaps = 19/179 (10%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI--ECGMMKRIRHR-NLIKIIS 571
           +GRG F  V +      G E A K    +  G     +I  E  +++  +    +I +  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 572 SCSNDDFKALVLEYMPLGSL-EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPII 630
              N     L+LEY   G +   CL     ++     + ++  +   + YLH      I+
Sbjct: 97  VYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IV 153

Query: 631 HCDLKPSNVLLDDNMVAH---LSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGE 686
           H DLKP N+LL          + DFGM++  +     L   + + T  Y+AP EI + +
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSR-KIGHACEL--REIMGTPEYLAP-EILNYD 208

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 47/190 (24%), Positives = 77/190 (40%), Gaps = 41/190 (21%)

Query: 519 LIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFD---IECGMMKRIRHRNLIKII 570
           ++G G F  V          E AIK+   ++            E  +M R+ H   +K+ 
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96

Query: 571 SSCSNDDFKALVLEYMPLGSL------EKCL-------YSGNYILDIFQGLNIMIDVASA 617
            +  +D+     L Y   G L                 Y+               ++ SA
Sbjct: 97  FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA--------------EIVSA 142

Query: 618 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL-ATIGY 676
           LEYLH      IIH DLKP N+LL+++M   ++DFG AK +L  +    +  +   T  Y
Sbjct: 143 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAK-VLSPESKQARANSFVGTAQY 198

Query: 677 MAPDEIFSGE 686
           ++P E+ + +
Sbjct: 199 VSP-ELLTEK 207

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 79.7 bits (197), Expect = 3e-16
 Identities = 45/177 (25%), Positives = 74/177 (41%), Gaps = 23/177 (12%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSF---DIECGMMKRIRHRNLIKIIS 571
           IGRG +G V K      G  +A+K          +     D++  +M+      +++   
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDV-VMRSSDCPYIVQFYG 88

Query: 572 SCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLN------IMIDVASALEYLHFGY 625
           +   +    + +E M   S +K       +LD    +       I +    AL +L    
Sbjct: 89  ALFREGDCWICMELMS-TSFDKFYKYVYSVLD--DVIPEEILGKITLATVKALNHLKENL 145

Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              IIH D+KPSN+LLD +    L DFG++  L     S+ +T+      YMAP+ I
Sbjct: 146 K--IIHRDIKPSNILLDRSGNIKLCDFGISGQL---VDSIAKTRDAGCRPYMAPERI 197

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 78.5 bits (194), Expect = 3e-16
 Identities = 44/260 (16%), Positives = 83/260 (31%), Gaps = 48/260 (18%)

Query: 148 NLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSME 207
            L N     L           ++ L S      ++ F+  N+ +  +             
Sbjct: 17  GLANAVKQNLGKQ-------SVTDLVSQKELSGVQNFNGDNSNIQSL------------- 56

Query: 208 DFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLS 267
                           +   TNL  + L L  NQ+   +   L  L  L +L +  N+L 
Sbjct: 57  --------------AGMQFFTNL--KELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLK 98

Query: 268 GFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVL 327
                       L +L+L +N L     +L +LK++  L++ +N     + L    L+ L
Sbjct: 99  NLNG---IPSACLSRLFLDNNELRDT-DSLIHLKNLEILSIRNNKLKSIVMLG--FLSKL 152

Query: 328 VQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSG 387
             LDL  N  +      +  LK + ++ L   +          +L    ++   +     
Sbjct: 153 EVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRW-- 208

Query: 388 TIPISLEKLLDLKDINVSFN 407
             P  +       D  V + 
Sbjct: 209 ISPYYISNGGSYVDGCVLWE 228

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 52/289 (17%), Positives = 88/289 (30%), Gaps = 75/289 (25%)

Query: 49  IDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELH 108
              L N          V  +V      +S +++    ++++   L         NLKELH
Sbjct: 15  DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAGMQF--FTNLKELH 69

Query: 109 LWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPE 168
           L  N  I  + S + + +KL EL + +N    ++         L  L L++N       E
Sbjct: 70  LSHNQ-ISDL-SPLKDLTKLEELSVNRNRLK-NLNG--IPSACLSRLFLDNN-------E 117

Query: 169 LSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLT 228
           L    SL + K LE  S  NN L  I                             +  L+
Sbjct: 118 LRDTDSLIHLKNLEILSIRNNKLKSI---------------------------VMLGFLS 150

Query: 229 NLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSN 288
              L++L L GN++      +   L                       L  +  + L   
Sbjct: 151 K--LEVLDLHGNEIT-----NTGGLT---------------------RLKKVNWIDLTGQ 182

Query: 289 LLTSIPSTLWNLKDILHLNLSSNFFTGPL-PLKIGNLNVLVQLDLSMNN 336
              + P  +    ++   N   +     + P  I N    V   +    
Sbjct: 183 KCVNEP--VKYQPELYITNTVKDPDGRWISPYYISNGGSYVDGCVLWEL 229

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 34/230 (14%), Positives = 69/230 (30%), Gaps = 31/230 (13%)

Query: 14  LSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTI 73
           +      ++     L     +  +              L  ++      + +  +    +
Sbjct: 12  VFPDPGLANAVKQNLGKQSVTDLVS----------QKELSGVQNFNGDNSNIQSLAG--M 59

Query: 74  FNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGL 133
              + LK L+L  N +S  L    D  L  L+EL +   N +  +      ++ LS L L
Sbjct: 60  QFFTNLKELHLSHNQIS-DLSPLKD--LTKLEELSV-NRNRLKNLNG--IPSACLSRLFL 113

Query: 134 QKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGG 193
             N       +   +L+NL+ L + +N L        S+  L     LE      N +  
Sbjct: 114 DNNELR-DTDS-LIHLKNLEILSIRNNKLK-------SIVMLGFLSKLEVLDLHGNEITN 164

Query: 194 ILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLE 243
                +  L   +    +          +    L      +   +G  + 
Sbjct: 165 TGG--LTRLK-KVNWIDLTGQKCVNEPVKYQPELYITNT-VKDPDGRWIS 210

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 53.1 bits (128), Expect = 9e-08
 Identities = 26/164 (15%), Positives = 58/164 (35%), Gaps = 28/164 (17%)

Query: 282 KLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVI 341
           +       +  +      L + +  NL     T  +  K   L+ +   +   +N   + 
Sbjct: 1   ESIQRPTPINQV-FPDPGLANAVKQNLGKQSVTDLVSQK--ELSGVQNFNGDNSNIQSLA 57

Query: 342 PTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKD 401
              +    +L+ L L +N++   +   + DL  L+ L+++ N L     ++      L  
Sbjct: 58  G--MQFFTNLKELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLKN---LNGIPSACLSR 110

Query: 402 INVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMPNLQVLSCR 445
           + +  N L           +  +        L  + NL++LS R
Sbjct: 111 LFLDNNELR----------DTDS--------LIHLKNLEILSIR 136

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 79.0 bits (195), Expect = 3e-16
 Identities = 20/147 (13%), Positives = 44/147 (29%), Gaps = 14/147 (9%)

Query: 519 LIGRGGFGPVYK--D---GMEVAIKVFNLQYGGA--FKS-FDIECGMMKRIRHRNLIKII 570
             G       ++  D     +VA+   + Q                 + RI    + +++
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97

Query: 571 SSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPII 630
                     +V E++  GSL++   +          +  M  +A+A +  H      + 
Sbjct: 98  DVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVA 151

Query: 631 HCDLKPSNVLLDDNMVAHLSDFGMAKP 657
                PS V +  +    L+       
Sbjct: 152 LSIDHPSRVRVSIDGDVVLAYPATMPD 178

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 80.5 bits (199), Expect = 3e-16
 Identities = 53/193 (27%), Positives = 86/193 (44%), Gaps = 28/193 (14%)

Query: 508 FQATNRFSENNLIGRGGFGPVYK-----DGMEVAIK-VFNLQYGGAFKSFDI-ECGMMKR 560
                 +++  +IG G FG VY+      G  VAIK V         K F   E  +M++
Sbjct: 50  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRK 103

Query: 561 IRHRNLIKII------SSCSNDDFKALVLEYMP--LGSLEKCLYSGNYILDIFQGLNIMI 612
           + H N++++           ++ +  LVL+Y+P  +  + +        L +      M 
Sbjct: 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 163

Query: 613 DVASALEYLHFGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTL 671
            +  +L Y+H   S  I H D+KP N+LLD D  V  L DFG AK L+  + +      +
Sbjct: 164 QLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN---VSYI 217

Query: 672 ATIGYMAPDEIFS 684
            +  Y AP+ IF 
Sbjct: 218 CSRYYRAPELIFG 230

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 77.6 bits (192), Expect = 8e-16
 Identities = 51/181 (28%), Positives = 84/181 (46%), Gaps = 26/181 (14%)

Query: 519 LIGRGGFGPVY-----KDGMEVAIKVFN---LQYGGAFKSFDIECGMMKRIRHRNLIKII 570
            +G G FG V        G +VA+K+ N   ++          E   +K  RH ++IK+ 
Sbjct: 18  TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77

Query: 571 SSCSNDDFKALVLEYMPLGSLEKCLYSGNYI-----LDIFQGLNIMIDVASALEYLHFGY 625
              S      +V+EY+  G L       +YI     ++  +   +   + SA++Y H   
Sbjct: 78  QVISTPTDFFMVMEYVSGGEL------FDYICKHGRVEEMEARRLFQQILSAVDYCH--- 128

Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG 685
              ++H DLKP NVLLD +M A ++DFG++   +  D    +T +  +  Y AP E+ SG
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSN--MMSDGEFLRT-SCGSPNYAAP-EVISG 184

Query: 686 E 686
            
Sbjct: 185 R 185

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 78.9 bits (195), Expect = 9e-16
 Identities = 53/188 (28%), Positives = 84/188 (44%), Gaps = 44/188 (23%)

Query: 519 LIGRGGFGPVY----KDGMEV-AIKVFNLQYGGAFKSFD---IECGMMKRIRHRNLIKII 570
            IG+G FG V      D  ++ A+K  N Q             E  +M+ + H  L+ + 
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81

Query: 571 SSCSNDDFKALVLEYMPLGSL-----------EK--CLYSGNYILDIFQGLNIMIDVASA 617
            S  +++   +V++ +  G L           E+   L+                ++  A
Sbjct: 82  YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFIC--------------ELVMA 127

Query: 618 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGY 676
           L+YL    +  IIH D+KP N+LLD++   H++DF +A  L  E    TQ  T+A T  Y
Sbjct: 128 LDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE----TQITTMAGTKPY 180

Query: 677 MAPDEIFS 684
           MAP E+FS
Sbjct: 181 MAP-EMFS 187

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 78.1 bits (193), Expect = 1e-15
 Identities = 43/184 (23%), Positives = 74/184 (40%), Gaps = 31/184 (16%)

Query: 519 LIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI--ECGMMKRI-RHRNLIKII 570
           ++G G  G V +      G + A+K+          S     E     +     +++ I+
Sbjct: 36  VLGLGVNGKVLECFHRRTGQKCALKLLY-------DSPKARQEVDHHWQASGGPHIVCIL 88

Query: 571 ----SSCSNDDFKALVLEYMPLGSL-EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY 625
               +         +++E M  G L  +    G+      +   IM D+ +A+++LH   
Sbjct: 89  DVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH--- 145

Query: 626 SVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
           S  I H D+KP N+L    + + V  L+DFG AK       +L       T  Y+AP E+
Sbjct: 146 SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET--TQNAL--QTPCYTPYYVAP-EV 200

Query: 683 FSGE 686
              E
Sbjct: 201 LGPE 204

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 78.9 bits (195), Expect = 1e-15
 Identities = 54/191 (28%), Positives = 85/191 (44%), Gaps = 27/191 (14%)

Query: 508 FQATNRFSENNLIGRGGFGPVYK----DGMEVAIK-VFNLQYGGAFKSFDI-ECGMMKRI 561
            Q    ++   +IG G FG V++    +  EVAIK V         K F   E  +M+ +
Sbjct: 36  EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ------DKRFKNRELQIMRIV 89

Query: 562 RHRNLIK----IISSCSNDDFKA--LVLEYMP--LGSLEKCLYSGNYILDIFQGLNIMID 613
           +H N++       S+    D     LVLEY+P  +    +        + +      M  
Sbjct: 90  KHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ 149

Query: 614 VASALEYLHFGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLA 672
           +  +L Y+H   S+ I H D+KP N+LLD  + V  L DFG AK L+  + +      + 
Sbjct: 150 LLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN---VSYIC 203

Query: 673 TIGYMAPDEIF 683
           +  Y AP+ IF
Sbjct: 204 SRYYRAPELIF 214

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 76.9 bits (190), Expect = 1e-15
 Identities = 43/185 (23%), Positives = 71/185 (38%), Gaps = 35/185 (18%)

Query: 519 LIGRGGFGPVY-----KDGMEVAIKVFNL-QYGGAFKSFDIECGMMKRIRHRNLIKIISS 572
            +G G +G V           VA+K+ ++ +     ++   E  + K + H N++K    
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 573 CSNDDFKALVLEYMPLGSLEKCLYSGNYILD-----------IFQGLNIMIDVASALEYL 621
               + + L LEY   G L       + I              F  L       + + YL
Sbjct: 74  RREGNIQYLFLEYCSGGELF------DRIEPDIGMPEPDAQRFFHQL------MAGVVYL 121

Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGM-AKPLLEEDQSLTQTQTLATIGYMAPD 680
           H    + I H D+KP N+LLD+     +SDFG+         + L       T+ Y+AP 
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP- 176

Query: 681 EIFSG 685
           E+   
Sbjct: 177 ELLKR 181

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 77.7 bits (192), Expect = 2e-15
 Identities = 53/193 (27%), Positives = 87/193 (45%), Gaps = 29/193 (15%)

Query: 507 LFQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI------EC 555
           +F    R++  + IG G +G V       + + VAIK  +      F+          E 
Sbjct: 22  VFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKIS-----PFEHQTYCQRTLREI 76

Query: 556 GMMKRIRHRNLIK---IISSCSNDDFKA--LVLEYMPLGSLEKCLYSGNYILDIFQGLNI 610
            ++ R RH N+I    II + + +  K   +V + M    L K L + +   D       
Sbjct: 77  KILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHIC--YF 133

Query: 611 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL-LEEDQSLTQTQ 669
           +  +   L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+    + D +   T+
Sbjct: 134 LYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTE 190

Query: 670 TLATIGYMAPDEI 682
            +AT  Y AP EI
Sbjct: 191 YVATRWYRAP-EI 202

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 77.2 bits (190), Expect = 2e-15
 Identities = 37/235 (15%), Positives = 76/235 (32%), Gaps = 25/235 (10%)

Query: 473 VVLLILKYRKGRKSQLKDVNMPSVADQRRFTYLELFQATNRFSENNLIGRGGFGPVYKDG 532
           VV             +K + +P+    R     E+           +     +     + 
Sbjct: 21  VVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEK 80

Query: 533 MEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKA---------LVL 583
            +  +    L+             M         +   S+ +               + +
Sbjct: 81  WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQM 140

Query: 584 EYMPLGSLEKCLYSGNYI--LDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL 641
           +     +L+  +     +   +    L+I I +A A+E+LH   S  ++H DLKPSN+  
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFF 197

Query: 642 DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA----------TIGYMAPDEIFSGE 686
             + V  + DFG+   + ++++  T    +           T  YM+P E   G 
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP-EQIHGN 251

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 16/73 (21%), Positives = 28/73 (38%), Gaps = 6/73 (8%)

Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRN 565
             F     +GRGGFG V++     D    AIK   L     A +    E   + ++ H  
Sbjct: 6   TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65

Query: 566 LIKIISSCSNDDF 578
           +++  ++      
Sbjct: 66  IVRYFNAWLETPP 78

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 77.7 bits (192), Expect = 2e-15
 Identities = 50/208 (24%), Positives = 79/208 (37%), Gaps = 52/208 (25%)

Query: 508 FQATNRFSENNLIGRGGFGPVYK-----DGMEVAIK-VFN--------LQYGGAFKSFDI 553
            +  +RF    + G+G FG V        GM VAIK V          LQ          
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ---------- 68

Query: 554 ECGMMKRIRHRNLIK---IISSCSNDDFK----ALVLEYMP--LGSLEKCLYSGNYILD- 603
               +  + H N+++      +    D +     +V+EY+P  L    +  Y        
Sbjct: 69  IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPP 128

Query: 604 ------IFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAK 656
                 +FQ +        ++  LH   SV + H D+KP NVL++  +    L DFG AK
Sbjct: 129 ILIKVFLFQLI-------RSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180

Query: 657 PLLEEDQSLTQTQTLATIGYMAPDEIFS 684
            L   + +      + +  Y AP+ IF 
Sbjct: 181 KLSPSEPN---VAYICSRYYRAPELIFG 205

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 77.0 bits (190), Expect = 2e-15
 Identities = 43/191 (22%), Positives = 71/191 (37%), Gaps = 40/191 (20%)

Query: 519 LIGRGGFGPVY-----KDGMEVAIKVFN----LQYGGAFKSFDI--ECGMMKRIRHR--N 565
           L+G GGFG VY      D + VAIK         +G       +  E  ++K++      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYI-----LDIFQGLNIMIDVASALEY 620
           +I+++      D   L+LE  P    +  L+  ++I     L      +    V  A+ +
Sbjct: 110 VIRLLDWFERPDSFVLILER-PEPVQD--LF--DFITERGALQEELARSFFWQVLEAVRH 164

Query: 621 LHFGYSVPIIHCDLKPSNVLLDDN-MVAHLSDFGMAKPLLEEDQSLTQTQTLAT----IG 675
            H   +  ++H D+K  N+L+D N     L DFG          +L +            
Sbjct: 165 CH---NCGVLHRDIKDENILIDLNRGELKLIDFGSG--------ALLKDTVYTDFDGTRV 213

Query: 676 YMAPDEIFSGE 686
           Y  P E     
Sbjct: 214 YSPP-EWIRYH 223

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 77.8 bits (192), Expect = 2e-15
 Identities = 46/186 (24%), Positives = 79/186 (42%), Gaps = 35/186 (18%)

Query: 519 LIGRGGFGPVY----KDGMEV-AIKVFNLQYGGAFKSFDIECGM-----MKRIRHRNLIK 568
           +IGRG FG V     K   +V A+K+ +       K  D          M       +++
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE--MIKRSDSAFFWEERDIMAFANSPWVVQ 133

Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCLYSGN--------YILDIFQGLNIMIDVASALEY 620
           +  +  +D +  +V+EYMP G L   + + +        Y  ++            AL+ 
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEV----------VLALDA 183

Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           +H   S+  IH D+KP N+LLD +    L+DFG    + +E      T  + T  Y++P 
Sbjct: 184 IH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT-AVGTPDYISP- 238

Query: 681 EIFSGE 686
           E+   +
Sbjct: 239 EVLKSQ 244

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 78.6 bits (193), Expect = 3e-15
 Identities = 53/288 (18%), Positives = 82/288 (28%), Gaps = 29/288 (10%)

Query: 94  PSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLK 153
              + V L +L    L       T       +    E  L K+       +       L 
Sbjct: 294 NRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRD-SATDEQLF 352

Query: 154 WLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDN 213
              L+    T    EL S   L     LE  +        +L RA+  L    E      
Sbjct: 353 RCELSVEKSTVLQSELESCKELQE---LEPENKWCLLTIILLMRALDPLLYEKE------ 403

Query: 214 CNISGSIPEEINNLTNLI---LQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFV 270
                   +  + L  +       L    ++            A +  L L    L+  V
Sbjct: 404 ------TLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT--V 455

Query: 271 PACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQL 330
                 L  +  L L  N L ++P  L  L+ +  L  S N     +   + NL  L +L
Sbjct: 456 LCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQEL 513

Query: 331 DLSMN---NFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISL 375
            L  N     + + P  +     L  L L+ N L          L  +
Sbjct: 514 LLCNNRLQQSAAIQP--LVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 70.2 bits (171), Expect = 1e-12
 Identities = 35/223 (15%), Positives = 78/223 (34%), Gaps = 25/223 (11%)

Query: 221 PEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNL 280
             +      L    LS+E + +   +  +L     L +L+         +      L  L
Sbjct: 342 CRDSATDEQLFRCELSVEKSTV---LQSELESCKELQELEPENKWCLLTIILLMRALDPL 398

Query: 281 RKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCV 340
                     +++     +     +L+   + F     +       +  L L+  + + +
Sbjct: 399 LYEKETLQYFSTL--KAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVL 456

Query: 341 IPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLK 400
               +  L  + +L L +NRL+ ++P ++  L  L+ L  S+N L   +   +  L  L+
Sbjct: 457 CH--LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQ 511

Query: 401 DINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMPNLQVLS 443
           ++ +  NRL               +     + L   P L +L+
Sbjct: 512 ELLLCNNRL---------------QQSAAIQPLVSCPRLVLLN 539

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 44.7 bits (105), Expect = 1e-04
 Identities = 24/103 (23%), Positives = 37/103 (35%), Gaps = 19/103 (18%)

Query: 14  LSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTI 73
           L  L     +  L LS+N          L  +P  +  L  +E +  S N +       +
Sbjct: 456 LCHLEQLLLVTHLDLSHNR---------LRALPPALAALRCLEVLQASDNAL-----ENV 501

Query: 74  FNVSTLKSL---YLHSNSLSGRLPSSADVR-LPNLKELHLWGN 112
             V+ L  L    L +N L     +   +   P L  L+L GN
Sbjct: 502 DGVANLPRLQELLLCNNRLQQ-SAAIQPLVSCPRLVLLNLQGN 543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 77.0 bits (190), Expect = 3e-15
 Identities = 47/191 (24%), Positives = 67/191 (35%), Gaps = 50/191 (26%)

Query: 519 LIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI------ECGMMKRIRHRNLI 567
            IG G FG             VA+K          +   I      E    + +RH N++
Sbjct: 27  DIGSGNFGVARLMRDKLTKELVAVKYIE-------RGAAIDENVQREIINHRSLRHPNIV 79

Query: 568 KIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD-----------IFQGLNIMIDVAS 616
           +           A+++EY   G L         I +            FQ L       S
Sbjct: 80  RFKEVILTPTHLAIIMEYASGGELY------ERICNAGRFSEDEARFFFQQL------LS 127

Query: 617 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHL--SDFGMAKPLLEEDQSLTQTQTLATI 674
            + Y H   S+ I H DLK  N LLD +    L   DFG +K       S  ++ T+ T 
Sbjct: 128 GVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKS-TVGTP 181

Query: 675 GYMAPDEIFSG 685
            Y+AP E+   
Sbjct: 182 AYIAP-EVLLR 191

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 76.1 bits (188), Expect = 5e-15
 Identities = 50/180 (27%), Positives = 80/180 (44%), Gaps = 13/180 (7%)

Query: 508 FQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNL-QYGGAFKSFDI-ECGMMKR 560
           FQ+  ++    L+G G +G V K      G  VAIK F         K   + E  ++K+
Sbjct: 21  FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80

Query: 561 IRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEY 620
           +RH NL+ ++  C       LV E++   ++   L      LD       +  + + + +
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGF 139

Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
            H   S  IIH D+KP N+L+  + V  L DFG A+ L    +       +AT  Y AP+
Sbjct: 140 CH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY--DDEVATRWYRAPE 194

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 75.8 bits (187), Expect = 5e-15
 Identities = 43/186 (23%), Positives = 71/186 (38%), Gaps = 35/186 (18%)

Query: 519 LIGRGGFGPVY-----KDGMEVAIKVFNL-QYGGAFKSFDIECGMMKRIRHRNLIKIISS 572
            +G G +G V           VA+K+ ++ +     ++   E  + K + H N++K    
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 573 CSNDDFKALVLEYMPLGSLEKCLYSGNYILD-----------IFQGLNIMIDVASALEYL 621
               + + L LEY   G L       + I              F  L       + + YL
Sbjct: 74  RREGNIQYLFLEYCSGGELF------DRIEPDIGMPEPDAQRFFHQL------MAGVVYL 121

Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGM-AKPLLEEDQSLTQTQTLATIGYMAPD 680
           H    + I H D+KP N+LLD+     +SDFG+         + L       T+ Y+AP 
Sbjct: 122 H---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK-MCGTLPYVAP- 176

Query: 681 EIFSGE 686
           E+    
Sbjct: 177 ELLKRR 182

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 75.9 bits (187), Expect = 6e-15
 Identities = 38/173 (21%), Positives = 67/173 (38%), Gaps = 19/173 (10%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKS-----FDIECGMMKRIRHRNLIKI 569
           +G G  G V+K      G  +A+K                  D+   ++K      +++ 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDV---VLKSHDCPYIVQC 89

Query: 570 ISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPI 629
             +   +    + +E M     EK        +       + + +  AL YL   +   +
Sbjct: 90  FGTFITNTDVFIAMELMG-TCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG--V 146

Query: 630 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
           IH D+KPSN+LLD+     L DFG++  L        + ++     YMAP+ I
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGISGRL---VDDKAKDRSAGCAAYMAPERI 196

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 77.6 bits (191), Expect = 7e-15
 Identities = 46/192 (23%), Positives = 79/192 (41%), Gaps = 32/192 (16%)

Query: 514 FSENNLIGRGGFGPVY----KDGMEV-AIKVFNLQYGGAFKSFDIECGMM-KRI------ 561
           FS + +IGRGGFG VY     D  ++ A+K   L              +  + +      
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIKMKQGETLALNERIMLSLVST 248

Query: 562 -RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLY-SGNYILD--IFQGLNIMIDVASA 617
                ++ +  +    D  + +L+ M  G L   L   G +      F    I       
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI----ILG 304

Query: 618 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGY 676
           LE++H   +  +++ DLKP+N+LLD++    +SD G+A    ++     +      T GY
Sbjct: 305 LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-----KPHASVGTHGY 356

Query: 677 MAPDEIFSGEMR 688
           MAP E+    + 
Sbjct: 357 MAP-EVLQKGVA 367

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 75.8 bits (187), Expect = 7e-15
 Identities = 50/222 (22%), Positives = 92/222 (41%), Gaps = 52/222 (23%)

Query: 495 SVADQRRFTYLEL----FQATNRFSENNLIGRGGFGPVYK-----DGMEVAIK-VFNLQY 544
           S+  ++ F   ++    ++    +     +G G +G V        G +VAIK +     
Sbjct: 3   SLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR--- 59

Query: 545 GGAFKSFDI------ECGMMKRIRHRNLIKI----ISSCSNDDFKA--LVLEYMPLGSLE 592
              F+S         E  ++K ++H N+I +      + S  +F    LV+ +M    L+
Sbjct: 60  --PFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQ 116

Query: 593 KCLYSG------NYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV 646
           K +          Y+  ++Q L         L+Y+H   S  ++H DLKP N+ ++++  
Sbjct: 117 KIMGLKFSEEKIQYL--VYQMLK-------GLKYIH---SAGVVHRDLKPGNLAVNEDCE 164

Query: 647 AHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMR 688
             + DFG+A+    E      T  + T  Y AP E+    M 
Sbjct: 165 LKILDFGLARHADAE-----MTGYVVTRWYRAP-EVILSWMH 200

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 76.7 bits (189), Expect = 8e-15
 Identities = 53/184 (28%), Positives = 83/184 (45%), Gaps = 32/184 (17%)

Query: 519 LIGRGGFGPVY-----KDGMEVAIKVFN---LQYGGAFKSFDIECGMMKRIRHRNLIKII 570
            +G G FG V        G +VA+K+ N   ++          E   +K  RH ++IK+ 
Sbjct: 23  TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82

Query: 571 SSCSNDDFKALVLEYMPLGSLEKCLYSGNYI-----LDIFQGLNIMIDVASALEYLHFGY 625
              S      +V+EY+  G L       +YI     LD  +   +   + S ++Y H   
Sbjct: 83  QVISTPSDIFMVMEYVSGGELF------DYICKNGRLDEKESRRLFQQILSGVDYCH--- 133

Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIG---YMAPDEI 682
              ++H DLKP NVLLD +M A ++DFG++   +  D    +T    + G   Y AP E+
Sbjct: 134 RHMVVHRDLKPENVLLDAHMNAKIADFGLSN--MMSDGEFLRT----SCGSPNYAAP-EV 186

Query: 683 FSGE 686
            SG 
Sbjct: 187 ISGR 190

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 75.9 bits (187), Expect = 8e-15
 Identities = 55/221 (24%), Positives = 90/221 (40%), Gaps = 50/221 (22%)

Query: 493 MPSVA-DQRRFTYLEL----FQATNRFSENNLIGRGGFGPVYK-----DGMEVAIK-VFN 541
           M S +     F  +E+    F    R+     IG G  G V           VAIK +  
Sbjct: 1   MGSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR 60

Query: 542 LQYGGAFKSFDI------ECGMMKRIRHRNLIKI----ISSCSNDDFKA--LVLEYMPLG 589
                 F++         E  +MK + H+N+I +        S ++F+   +V+E M   
Sbjct: 61  -----PFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-A 114

Query: 590 SLEKCLYSG------NYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD 643
           +L + +         +Y+L  +Q L         +++LH   S  IIH DLKPSN+++  
Sbjct: 115 NLCQVIQMELDHERMSYLL--YQMLC-------GIKHLH---SAGIIHRDLKPSNIVVKS 162

Query: 644 NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS 684
           +    + DFG+A+       S   T  + T  Y AP+ I  
Sbjct: 163 DCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILG 200

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 74.9 bits (185), Expect = 9e-15
 Identities = 45/176 (25%), Positives = 73/176 (41%), Gaps = 13/176 (7%)

Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNL-QYGGAFKSFDI-ECGMMKRIRHR 564
            ++ +   IG G +G V+K      G  VAIK F   +     K   + E  M+K+++H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62

Query: 565 NLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFG 624
           NL+ ++          LV EY    ++   L      +      +I      A+ + H  
Sbjct: 63  NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH-- 119

Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
                IH D+KP N+L+  + V  L DFG A+ L            +AT  Y +P+
Sbjct: 120 -KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY--DDEVATRWYRSPE 172

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 76.3 bits (188), Expect = 9e-15
 Identities = 44/180 (24%), Positives = 77/180 (42%), Gaps = 21/180 (11%)

Query: 519 LIGRGGFGPVY----KDGMEV-AIKVFNLQYGGAFKSFDIECGM-----MKRIRHRNLIK 568
           +IGRG FG V     K+  +V A+K+  L      K  +  C       +     + +  
Sbjct: 81  VIGRGAFGEVAVVKLKNADKVFAMKI--LNKWEMLKRAETACFREERDVLVNGDSKWITT 138

Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVP 628
           +  +  +D+   LV++Y   G L   L      L        + ++  A++ +H    + 
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLH 195

Query: 629 IIHCDLKPSNVLLDDNMVAH--LSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGE 686
            +H D+KP N+L+D N   H  L+DFG    L+E+    +    + T  Y++P EI    
Sbjct: 196 YVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSV-AVGTPDYISP-EILQAM 251

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 75.0 bits (185), Expect = 1e-14
 Identities = 48/192 (25%), Positives = 76/192 (39%), Gaps = 51/192 (26%)

Query: 520 IGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI-----ECGMMKRIRHRNLIKI 569
           IG+G F  V        G EVAIK+ +           +     E  +MK + H N++K+
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKT---QLNPTSLQKLFREVRIMKILNHPNIVKL 79

Query: 570 ISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD-----------IFQGLNIMIDVASAL 618
                 +    L++EY   G +       +Y++             F+       + SA+
Sbjct: 80  FEVIETEKTLYLIMEYASGGEV------FDYLVAHGRMKEKEARSKFR------QIVSAV 127

Query: 619 EYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI---- 674
           +Y H      I+H DLK  N+LLD +M   ++DFG +          T    L       
Sbjct: 128 QYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFS-------NEFTVGGKLDAFCGAP 177

Query: 675 GYMAPDEIFSGE 686
            Y AP E+F G+
Sbjct: 178 PYAAP-ELFQGK 188

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 75.4 bits (186), Expect = 1e-14
 Identities = 51/199 (25%), Positives = 87/199 (43%), Gaps = 33/199 (16%)

Query: 507 LFQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI------EC 555
           +++   R+   + +G G +G V        G+ VA+K    +    F+S         E 
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK----KLSRPFQSIIHAKRTYREL 79

Query: 556 GMMKRIRHRNLIKI----ISSCSNDDFKA--LVLEYMPLGSLEKCLYSGNYILDIFQGLN 609
            ++K ++H N+I +      + S ++F    LV   M    L   +       D  Q   
Sbjct: 80  RLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQ--F 136

Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
           ++  +   L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+   +E      T 
Sbjct: 137 LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTG 188

Query: 670 TLATIGYMAPDEIFSGEMR 688
            +AT  Y AP EI    M 
Sbjct: 189 YVATRWYRAP-EIMLNWMH 206

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 74.7 bits (184), Expect = 1e-14
 Identities = 47/186 (25%), Positives = 73/186 (39%), Gaps = 28/186 (15%)

Query: 519 LIGRGGFGPVY-----KDGMEVAIKVFN----LQYGGAFKSFDI--ECGMMKRIR----H 563
           L+G+GGFG V+      D ++VAIKV      L +     S     E  ++ ++     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGS--LEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
             +I+++      +   LVLE         +     G   L           V +A+++ 
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP--LGEGPSRCFFGQVVAAIQHC 155

Query: 622 HFGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           H   S  ++H D+K  N+L+D     A L DFG     L  D+  T      T  Y  P 
Sbjct: 156 H---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGA--LLHDEPYTDFD--GTRVYSPP- 207

Query: 681 EIFSGE 686
           E  S  
Sbjct: 208 EWISRH 213

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 74.2 bits (183), Expect = 1e-14
 Identities = 45/185 (24%), Positives = 75/185 (40%), Gaps = 29/185 (15%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKS-----FDIECGMMKRIRHRNLIKI 569
           +GRG +G V K      G  +A+K          +       DI    M+ +     +  
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDI---SMRTVDCPFTVTF 71

Query: 570 ISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLN------IMIDVASALEYLHF 623
             +   +    + +E M   SL+K       ++D  Q +       I + +  ALE+LH 
Sbjct: 72  YGALFREGDVWICMELMD-TSLDKFY---KQVIDKGQTIPEDILGKIAVSIVKALEHLHS 127

Query: 624 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIF 683
             S  +IH D+KPSNVL++      + DFG++  L      + +        YMAP E  
Sbjct: 128 KLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL---VDDVAKDIDAGCKPYMAP-ERI 181

Query: 684 SGEMR 688
           + E+ 
Sbjct: 182 NPELN 186

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 75.8 bits (187), Expect = 2e-14
 Identities = 73/387 (18%), Positives = 143/387 (36%), Gaps = 54/387 (13%)

Query: 76  VSTLKSLYLHSNSLSG---RLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNA-----SK 127
           +   + + L    L+    +  SSA    P L EL+L  N         +         K
Sbjct: 27  LQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCK 86

Query: 128 LSELGLQKNSFS----GSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEY 183
           + +L LQ    +    G + +T   L  L+ L L+DN L  +  +L     L     LE 
Sbjct: 87  IQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEK 146

Query: 184 FSFSNNPLGGILPRAIGNL---SQSMEDFWMDNCNISGS----IPEEINNLTNLILQLLS 236
                  L       + ++       ++  + N +I+ +    + + + + +   L+ L 
Sbjct: 147 LQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKD-SPCQLEALK 205

Query: 237 LEGNQL--EG--SIPDDLCRLAALFQLDLGGNKL--SGFVPACSGNL---TNLRKLYLGS 287
           LE   +  +    +   +   A+L +L LG NKL   G    C G L   + LR L++  
Sbjct: 206 LESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWE 265

Query: 288 NLLTS-----IPSTLWNLKDILHLNLSSNFFTGP------LPLKIGNLNVLVQLDLSMNN 336
             +T+     +   L   + +  L+L+ N             L       L  L +   +
Sbjct: 266 CGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQ-LESLWVKSCS 324

Query: 337 FSCV----IPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLI-----SLKSLNLSNNNLS- 386
           F+        + +   + L  L +  NRL+ +    +   +      L+ L L++ ++S 
Sbjct: 325 FTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSD 384

Query: 387 -GTIPIS--LEKLLDLKDINVSFNRLE 410
                ++  L     L+++++S N L 
Sbjct: 385 SSCSSLAATLLANHSLRELDLSNNCLG 411

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 70.8 bits (174), Expect = 6e-13
 Identities = 65/383 (16%), Positives = 116/383 (30%), Gaps = 76/383 (19%)

Query: 77  STLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNF----IGTIPSFIFNASKLSELG 132
             ++SL +    LS    +     L   + + L            I S +     L+EL 
Sbjct: 3   LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62

Query: 133 LQKNSFSGS----------IPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSS-LSNCKYL 181
           L+ N                P+       ++ L L +  LT +      LSS L     L
Sbjct: 63  LRSNELGDVGVHCVLQGLQTPSC-----KIQKLSLQNCCLTGA--GCGVLSSTLRTLPTL 115

Query: 182 EYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQ 241
           +    S+N LG      +  L + + D                       L+ L LE   
Sbjct: 116 QELHLSDNLLG---DAGLQLLCEGLLD-------------------PQCRLEKLQLEYCS 153

Query: 242 L--EG--SIPDDLCRLAALFQLDLGGNKLSG-----FVPACSGNLTNLRKLYLGSNLLT- 291
           L       +   L       +L +  N ++             +   L  L L S  +T 
Sbjct: 154 LSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTS 213

Query: 292 ----SIPSTLWNLKDILHLNLSSNFFTGP-----LPLKIGNLNVLVQLDLSMNNFSCV-- 340
                +   + +   +  L L SN           P  +   + L  L +     +    
Sbjct: 214 DNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGC 273

Query: 341 --IPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLI-----SLKSLNLSNNNLS--GTIPI 391
             +   +   + L+ L L  N L       + + +      L+SL + + + +       
Sbjct: 274 GDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHF 333

Query: 392 S--LEKLLDLKDINVSFNRLEGE 412
           S  L +   L ++ +S NRLE  
Sbjct: 334 SSVLAQNRFLLELQISNNRLEDA 356

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 63.1 bits (154), Expect = 2e-10
 Identities = 53/300 (17%), Positives = 96/300 (32%), Gaps = 39/300 (13%)

Query: 77  STLKSLYLHSNSLS---GRLPSSADVRLPNLKELHLWGNNFIGT-----IPSFIFNASKL 128
             L+ L L   SLS       +S     P+ KEL +  N+               +  +L
Sbjct: 142 CRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQL 201

Query: 129 SELGLQKNSFS----GSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYF 184
             L L+    +      +     +  +L+ L L  N L            L     L   
Sbjct: 202 EALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTL 261

Query: 185 SFSNNPLGGILPRAIGNL---SQSMEDFWMDNCNISGS----IPEEINNLTNLILQLLSL 237
                 +       +  +    +S+++  +    +       + E +       L+ L +
Sbjct: 262 WIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLE-PGCQLESLWV 320

Query: 238 EGNQL--EG--SIPDDLCRLAALFQLDLGGNKL--SGFVPACSG---NLTNLRKLYLGSN 288
           +               L +   L +L +  N+L  +G    C G     + LR L+L   
Sbjct: 321 KSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADC 380

Query: 289 LLT-----SIPSTLWNLKDILHLNLSSNFFT--GPLPLKIG---NLNVLVQLDLSMNNFS 338
            ++     S+ +TL     +  L+LS+N     G L L         +L QL L    +S
Sbjct: 381 DVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 45.0 bits (107), Expect = 9e-05
 Identities = 50/271 (18%), Positives = 92/271 (33%), Gaps = 49/271 (18%)

Query: 19  NPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNK-----VVGVVPTTI 73
           +P  L+ L L        + S    ++   + +  ++  +A   NK     +  + P  +
Sbjct: 197 SPCQLEALKLESC----GVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLL 252

Query: 74  FNVSTLKSLYLHSNSLS---GRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSE 130
              S L++L++    ++               +LKEL L GN               L +
Sbjct: 253 HPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNE--------------LGD 298

Query: 131 LGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTS-STPELSSLSSLSNCKYLEYFSFSNN 189
            G +    +   P        L+ L +     T+      SS+  L+  ++L     SNN
Sbjct: 299 EGARLLCETLLEPGC-----QLESLWVKSCSFTAACCSHFSSV--LAQNRFLLELQISNN 351

Query: 190 PLGG----ILPRAIGNLSQSMEDFWMDNCNIS----GSIPEEINNLTNLILQLLSLEGNQ 241
            L       L + +G     +   W+ +C++S     S+   +    +  L+ L L  N 
Sbjct: 352 RLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHS--LRELDLSNNC 409

Query: 242 LEGSIPDDLCRLAA-----LFQLDLGGNKLS 267
           L  +    L          L QL L     S
Sbjct: 410 LGDAGILQLVESVRQPGCLLEQLVLYDIYWS 440

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461

 Score = 44.2 bits (105), Expect = 1e-04
 Identities = 44/204 (21%), Positives = 73/204 (35%), Gaps = 40/204 (19%)

Query: 202 LSQSMEDFWMDNCNIS-GSIPEEINNLTNLILQLLSLEGNQL--EG--SIPDDLCRLAAL 256
           +S  ++   +    +S     E +  L     Q++ L+   L       I   L    AL
Sbjct: 1   MSLDIQSLDIQCEELSDARWAELLPLLQQC--QVVRLDDCGLTEARCKDISSALRVNPAL 58

Query: 257 FQLDLGGNKL--SGFVPACSG---NLTNLRKLYLGSNLLT-----SIPSTLWNLKDILHL 306
            +L+L  N+L   G      G       ++KL L +  LT      + STL  L  +  L
Sbjct: 59  AELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQEL 118

Query: 307 NLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIP 366
           +LS N            L +L +  L                  L+ L LEY  L  +  
Sbjct: 119 HLSDNLLGDA------GLQLLCEGLLDPQ-------------CRLEKLQLEYCSLSAASC 159

Query: 367 NSIGDLI----SLKSLNLSNNNLS 386
             +  ++      K L +SNN+++
Sbjct: 160 EPLASVLRAKPDFKELTVSNNDIN 183

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 74.2 bits (183), Expect = 2e-14
 Identities = 49/184 (26%), Positives = 83/184 (45%), Gaps = 33/184 (17%)

Query: 519 LIGRGGFGPVY-----KDGMEVAIKVFN---LQYGGAFKSFDIECGMMKRIRHRNLIKII 570
            +G G FG V      K   +VA+K  +   L+        + E   +K +RH ++IK+ 
Sbjct: 16  TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75

Query: 571 SSCSNDDFKALVLEYMPLGSLEKCLYSG---NYI-----LDIFQGLNIMIDVASALEYLH 622
              +      +V+EY            G   +YI     +   +G      +  A+EY H
Sbjct: 76  DVITTPTDIVMVIEYA----------GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCH 125

Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
                 I+H DLKP N+LLDDN+   ++DFG++   +  D +  +T +  +  Y AP E+
Sbjct: 126 ---RHKIVHRDLKPENLLLDDNLNVKIADFGLSN--IMTDGNFLKT-SCGSPNYAAP-EV 178

Query: 683 FSGE 686
            +G+
Sbjct: 179 INGK 182

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 75.2 bits (185), Expect = 2e-14
 Identities = 44/183 (24%), Positives = 74/183 (40%), Gaps = 30/183 (16%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI--ECGMMKRI-RHRNLIKII- 570
           +G G  G V +        + A+K+                E  +  R  +  ++++I+ 
Sbjct: 70  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 122

Query: 571 ---SSCSNDDFKALVLEYMPLGSL-EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
              +  +      +V+E +  G L  +    G+      +   IM  +  A++YLH   S
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---S 179

Query: 627 VPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIF 683
           + I H D+KP N+L      N +  L+DFG AK       SL  T    T  Y+AP E+ 
Sbjct: 180 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTSHNSL--TTPCYTPYYVAP-EVL 235

Query: 684 SGE 686
             E
Sbjct: 236 GPE 238

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 74.7 bits (184), Expect = 2e-14
 Identities = 42/180 (23%), Positives = 75/180 (41%), Gaps = 21/180 (11%)

Query: 519 LIGRGGFGPVY----KDGMEV-AIKVFNLQYGGAFKSFDIECGM-----MKRIRHRNLIK 568
           +IGRG F  V     K   +V A+K+ N       K  ++ C       +     R + +
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWD--MLKRGEVSCFREERDVLVNGDRRWITQ 125

Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVP 628
           +  +  ++++  LV+EY   G L   L      +        + ++  A++ +H    + 
Sbjct: 126 LHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLG 182

Query: 629 IIHCDLKPSNVLLDDNMVAH--LSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGE 686
            +H D+KP N+LLD     H  L+DFG    L  +    +    + T  Y++P EI    
Sbjct: 183 YVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLV-AVGTPDYLSP-EILQAV 238

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 74.2 bits (183), Expect = 2e-14
 Identities = 52/179 (29%), Positives = 85/179 (47%), Gaps = 16/179 (8%)

Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFK-SFDI----ECGMMKRI 561
            R+ + + +G G F  VYK         VAIK   L +    K   +     E  +++ +
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69

Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
            H N+I ++ +  +    +LV ++M    LE  +   + +L        M+     LEYL
Sbjct: 70  SHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 128

Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           H      I+H DLKP+N+LLD+N V  L+DFG+AK     +++   T  + T  Y AP+
Sbjct: 129 H---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPE 182

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 74.9 bits (184), Expect = 3e-14
 Identities = 53/215 (24%), Positives = 90/215 (41%), Gaps = 37/215 (17%)

Query: 492 NMPSVADQRRFTYLEL----FQATNRFSENNLIGRGGFGPVYK-----DGMEVAIK-VFN 541
           NM       +F  +E+    F    R+     IG G  G V           VAIK +  
Sbjct: 38  NMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR 97

Query: 542 LQYGGAFKSFDI------ECGMMKRIRHRNLIKII----SSCSNDDFKA--LVLEYMPLG 589
                 F++         E  +MK + H+N+I ++       + ++F+   LV+E M   
Sbjct: 98  -----PFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-A 151

Query: 590 SLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHL 649
           +L + +      LD  +   ++  +   +++LH   S  IIH DLKPSN+++  +    +
Sbjct: 152 NLCQVIQME---LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKI 205

Query: 650 SDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS 684
            DFG+A+       S   T  + T  Y AP+ I  
Sbjct: 206 LDFGLARTA---GTSFMMTPYVVTRYYRAPEVILG 237

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 70.8 bits (174), Expect = 6e-14
 Identities = 39/166 (23%), Positives = 64/166 (38%), Gaps = 29/166 (17%)

Query: 219 SIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLT 278
            IP  +          + LE N ++   P        L ++DL  N++S   P     L 
Sbjct: 25  EIPTNLPETI----TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLR 80

Query: 279 NLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFS 338
           +L  L L  N +T +P +L               F G        L  L  L L+ N  +
Sbjct: 81  SLNSLVLYGNKITELPKSL---------------FEG--------LFSLQLLLLNANKIN 117

Query: 339 CVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGD-LISLKSLNLSNN 383
           C+       L +L  L L  N+LQ +I       L ++++++L+ N
Sbjct: 118 CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 36/144 (25%), Positives = 55/144 (38%), Gaps = 16/144 (11%)

Query: 36  SIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPS 95
            IP+     +P  I  +          N +  + P        L+ + L +N +S  L  
Sbjct: 25  EIPT----NLPETITEIR------LEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAP 73

Query: 96  SADVRLPNLKELHLWGNNFIGTIPSFIF-NASKLSELGLQKNSFSGSIPN-TFGNLRNLK 153
            A   L +L  L L+GN  I  +P  +F     L  L L  N  +  +    F +L NL 
Sbjct: 74  DAFQGLRSLNSLVLYGNK-ITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLN 131

Query: 154 WLGLNDNYLTSSTPE-LSSLSSLS 176
            L L DN L +      S L ++ 
Sbjct: 132 LLSLYDNKLQTIAKGTFSPLRAIQ 155

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 63.1 bits (154), Expect = 2e-11
 Identities = 30/151 (19%), Positives = 55/151 (36%), Gaps = 27/151 (17%)

Query: 259 LDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLP 318
           + L  N +    P        LR++ L +N ++ +                 + F G   
Sbjct: 37  IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAP---------------DAFQG--- 78

Query: 319 LKIGNLNVLVQLDLSMNNFSCVIPTKI-GGLKDLQYLFLEYNRLQGSIPNSIGD-LISLK 376
                L  L  L L  N  +  +P  +  GL  LQ L L  N++   +       L +L 
Sbjct: 79  -----LRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLN 131

Query: 377 SLNLSNNNLSGTIPISLEKLLDLKDINVSFN 407
            L+L +N L      +   L  ++ ++++ N
Sbjct: 132 LLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 32/173 (18%), Positives = 56/173 (32%), Gaps = 36/173 (20%)

Query: 117 TIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLS 176
            IP+ +       E+ L++N+     P  F   + L+ + L++N ++   P+      L 
Sbjct: 25  EIPTNLPETIT--EIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDA--FQGLR 80

Query: 177 NCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLS 236
           +   L       N +  +       L                             LQLL 
Sbjct: 81  S---LNSLVLYGNKITELPKSLFEGLFS---------------------------LQLLL 110

Query: 237 LEGNQLEGSIPDDL-CRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSN 288
           L  N++   +  D    L  L  L L  NKL          L  ++ ++L  N
Sbjct: 111 LNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 53.1 bits (128), Expect = 6e-08
 Identities = 31/142 (21%), Positives = 47/142 (33%), Gaps = 37/142 (26%)

Query: 21  SSLQTLYLSYNPPSGSIPSFILCEIPHEI-DNLHNMEWMAFSFNKVVGVVPTTIFNVSTL 79
             L+ + LS N          + E+  +    L +                        L
Sbjct: 56  KKLRRIDLSNNQ---------ISELAPDAFQGLRS------------------------L 82

Query: 80  KSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNA-SKLSELGLQKNSF 138
            SL L+ N ++  LP S    L +L+ L L  N  I  +    F     L+ L L  N  
Sbjct: 83  NSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANK-INCLRVDAFQDLHNLNLLSLYDNKL 140

Query: 139 SGSIPNTFGNLRNLKWLGLNDN 160
                 TF  LR ++ + L  N
Sbjct: 141 QTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 22/97 (22%), Positives = 41/97 (42%), Gaps = 13/97 (13%)

Query: 21  SSLQTLYLSYNPPSGSIPSFILCEIPHEI-DNLHNMEWMAFSFNKVVGVVPTTIF-NVST 78
            SL +L L  N          + E+P  + + L +++ +  + NK+  +     F ++  
Sbjct: 80  RSLNSLVLYGNK---------ITELPKSLFEGLFSLQLLLLNANKINCL-RVDAFQDLHN 129

Query: 79  LKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFI 115
           L  L L+ N L   +       L  ++ +HL  N FI
Sbjct: 130 LNLLSLYDNKLQ-TIAKGTFSPLRAIQTMHLAQNPFI 165

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 72.3 bits (178), Expect = 1e-13
 Identities = 52/205 (25%), Positives = 85/205 (41%), Gaps = 48/205 (23%)

Query: 508 FQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI------ECG 556
           +  ++ F   +L+G G +G V        G  VAIK         F           E  
Sbjct: 7   YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE-----PFDKPLFALRTLREIK 61

Query: 557 MMKRIRHRNLIK---IISSCSNDDFKA--LVLEYMPLGSLEKCLYSGNYILD------IF 605
           ++K  +H N+I    I    S ++F    ++ E M    L + + S   + D      I+
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI-STQMLSDDHIQYFIY 119

Query: 606 QGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL 665
           Q L        A++ LH      +IH DLKPSN+L++ N    + DFG+A+ + E     
Sbjct: 120 QTLR-------AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169

Query: 666 TQ--------TQTLATIGYMAPDEI 682
           ++         + +AT  Y AP E+
Sbjct: 170 SEPTGQQSGMVEFVATRWYRAP-EV 193

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 36/158 (22%), Positives = 64/158 (40%), Gaps = 26/158 (16%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI--ECGMMKRI-RHRNLIKII- 570
           +G G  G V +        + A+K+                E  +  R  +  ++++I+ 
Sbjct: 26  LGLGINGKVLQIFNKRTQEKFALKMLQ-------DCPKARREVELHWRASQCPHIVRIVD 78

Query: 571 ---SSCSNDDFKALVLEYMPLGSL-EKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
              +  +      +V+E +  G L  +    G+      +   IM  +  A++YLH   S
Sbjct: 79  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---S 135

Query: 627 VPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEE 661
           + I H D+KP N+L      N +  L+DFG AK    E
Sbjct: 136 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE 173

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 48/168 (28%), Positives = 71/168 (42%), Gaps = 9/168 (5%)

Query: 219 SIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLT 278
           S+P  I   T    + L L+   L          L  L  L+L  N+L         +LT
Sbjct: 28  SVPSGIPADT----EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLT 83

Query: 279 NLRKLYLGSNLLTSIPSTLW-NLKDILHLNLSSNFFTGPLPLKI-GNLNVLVQLDLSMNN 336
            L  L L +N L S+P  ++ +L  +  L L  N     LP  +   L  L +L L+ N 
Sbjct: 84  ELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQ 142

Query: 337 FSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGD-LISLKSLNLSNN 383
              +       L +LQ L L  N+LQ S+P+   D L  L+++ L  N
Sbjct: 143 LQSIPAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 68.6 bits (168), Expect = 5e-13
 Identities = 44/176 (25%), Positives = 74/176 (42%), Gaps = 20/176 (11%)

Query: 18  GNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFN-V 76
           G P+  + L L     + ++              L  + W+   +N++   +   +F+ +
Sbjct: 32  GIPADTEKLDLQSTGLA-TLS-------DATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDL 82

Query: 77  STLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIF-NASKLSELGLQK 135
           + L +L L +N L+  LP      L  L +L+L G N + ++PS +F   +KL EL L  
Sbjct: 83  TELGTLGLANNQLA-SLPLGVFDHLTQLDKLYL-GGNQLKSLPSGVFDRLTKLKELRLNT 140

Query: 136 NSFSGSIPN-TFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNP 190
           N    SIP   F  L NL+ L L+ N L S         +      L+  +   N 
Sbjct: 141 NQLQ-SIPAGAFDKLTNLQTLSLSTNQLQS-----VPHGAFDRLGKLQTITLFGNQ 190

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 44/137 (32%), Positives = 70/137 (51%), Gaps = 8/137 (5%)

Query: 258 QLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWN-LKDILHLNLSSNFFTGP 316
           +LDL    L+    A    LT L  L L  N L ++ + +++ L ++  L L++N     
Sbjct: 39  KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS- 97

Query: 317 LPLKI-GNLNVLVQLDLSMNNFSCVIPTKI-GGLKDLQYLFLEYNRLQGSIPNSIGD-LI 373
           LPL +  +L  L +L L  N     +P+ +   L  L+ L L  N+LQ SIP    D L 
Sbjct: 98  LPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLT 155

Query: 374 SLKSLNLSNNNLSGTIP 390
           +L++L+LS N L  ++P
Sbjct: 156 NLQTLSLSTNQLQ-SVP 171

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 62.8 bits (153), Expect = 5e-11
 Identities = 58/248 (23%), Positives = 81/248 (32%), Gaps = 92/248 (37%)

Query: 69  VPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKL 128
           VP+ I    T + L L S  L+  L  +    L  L  L+L  N  + T+          
Sbjct: 29  VPSGIP-ADT-EKLDLQSTGLA-TLSDATFRGLTKLTWLNLDYNQ-LQTLS--------- 75

Query: 129 SELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSN 188
                            F +L  L  LGL +N L S                        
Sbjct: 76  --------------AGVFDDLTELGTLGLANNQLAS------------------------ 97

Query: 189 NPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPD 248
                 LP                       + + +  L  L      L GNQL+ S+P 
Sbjct: 98  ------LPL---------------------GVFDHLTQLDKL-----YLGGNQLK-SLPS 124

Query: 249 DLC-RLAALFQLDLGGNKLSGFVPACSG---NLTNLRKLYLGSNLLTSIP-STLWNLKDI 303
            +  RL  L +L L  N+L   +PA  G    LTNL+ L L +N L S+P      L  +
Sbjct: 125 GVFDRLTKLKELRLNTNQLQS-IPA--GAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKL 181

Query: 304 LHLNLSSN 311
             + L  N
Sbjct: 182 QTITLFGN 189

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 29/96 (30%), Positives = 51/96 (53%), Gaps = 6/96 (6%)

Query: 329 QLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGD-LISLKSLNLSNNNLSG 387
           +LDL     + +      GL  L +L L+YN+LQ ++   + D L  L +L L+NN L+ 
Sbjct: 39  KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA- 96

Query: 388 TIPISL-EKLLDLKDINVSFNRLEGEIPREGPFRNL 422
           ++P+ + + L  L  + +  N+L+  +P  G F  L
Sbjct: 97  SLPLGVFDHLTQLDKLYLGGNQLK-SLP-SGVFDRL 130

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 44/202 (21%), Positives = 82/202 (40%), Gaps = 40/202 (19%)

Query: 508 FQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI------ECG 556
           F   +R+ +   +G GG G V+          VAIK                     E  
Sbjct: 7   FDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI------VLTDPQSVKHALREIK 60

Query: 557 MMKRIRHRNLIKII------------SSCSNDDFKA--LVLEYMPLGSLEKCLYSGNYIL 602
           +++R+ H N++K+                S  +  +  +V EYM    L   L  G  + 
Sbjct: 61  IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLE 119

Query: 603 DIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEE 661
           +  +    M  +   L+Y+H   S  ++H DLKP+N+ ++ +++V  + DFG+A+ +   
Sbjct: 120 EHAR--LFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPH 174

Query: 662 DQSLTQ-TQTLATIGYMAPDEI 682
                  ++ L T  Y +P  +
Sbjct: 175 YSHKGHLSEGLVTKWYRSP-RL 195

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 70.7 bits (174), Expect = 3e-13
 Identities = 47/178 (26%), Positives = 78/178 (43%), Gaps = 18/178 (10%)

Query: 512 NRFSENNLIGRGGFGPVYK----DGMEVAIKVFNLQYGGAFKS-FDI----ECGMMKRIR 562
            ++ +   +G G +G VYK     G  VA+K   L    A           E  ++K + 
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRL---DAEDEGIPSTAIREISLLKELH 77

Query: 563 HRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
           H N++ +I    ++    LV E+M    L+K L      L   Q    +  +   + + H
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136

Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
                 I+H DLKP N+L++ +    L+DFG+A+      +S   T  + T+ Y APD
Sbjct: 137 ---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--THEVVTLWYRAPD 189

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 71.2 bits (175), Expect = 3e-13
 Identities = 49/193 (25%), Positives = 84/193 (43%), Gaps = 35/193 (18%)

Query: 508 FQATNRFSENNLIGRGGFGPVYK-----DGMEVAIK-VFNLQYGGAFKSFDI------EC 555
           ++    + +   +G G +G V        G +VAIK ++       F+S         E 
Sbjct: 21  WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-----PFQSELFAKRAYREL 75

Query: 556 GMMKRIRHRNLIKII----SSCSNDDFKA--LVLEYMPLGSLEKCLYSGNYILDIFQGLN 609
            ++K +RH N+I ++       + DDF    LV+ +M    L K +       D  Q   
Sbjct: 76  RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMG-TDLGKLMKHEKLGEDRIQ--F 132

Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ 669
           ++  +   L Y+H   +  IIH DLKP N+ ++++    + DFG+A+    E      T 
Sbjct: 133 LVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTG 184

Query: 670 TLATIGYMAPDEI 682
            + T  Y AP E+
Sbjct: 185 YVVTRWYRAP-EV 196

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 70.3 bits (173), Expect = 4e-13
 Identities = 40/175 (22%), Positives = 77/175 (44%), Gaps = 12/175 (6%)

Query: 512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDI-ECGMMKRIRHRN 565
             + + + +G G +  VYK         VA+K   L++        I E  ++K ++H N
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61

Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY 625
           ++ +      +    LV EY+    L++ L     I+++      +  +   L Y H   
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH--- 117

Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
              ++H DLKP N+L+++     L+DFG+A+      ++      + T+ Y  PD
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY--DNEVVTLWYRPPD 170

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 69.1 bits (170), Expect = 6e-13
 Identities = 43/179 (24%), Positives = 78/179 (43%), Gaps = 19/179 (10%)

Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKS-FDI----ECGMMKRI 561
            ++ +   IG G +G V+K         VA+K   L                E  ++K +
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL---DDDDEGVPSSALREICLLKEL 58

Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
           +H+N++++     +D    LV E+     L+K   S N  LD     + +  +   L + 
Sbjct: 59  KHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117

Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           H   S  ++H DLKP N+L++ N    L++FG+A+      +    +  + T+ Y  PD
Sbjct: 118 H---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--SAEVVTLWYRPPD 171

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 70.5 bits (173), Expect = 7e-13
 Identities = 44/192 (22%), Positives = 75/192 (39%), Gaps = 46/192 (23%)

Query: 519 LIGRGGFGPVY----KDGMEV-AIKVFNLQYGGAFKSFDIECGMMKR-----IRHRNLIK 568
           L+G+G FG V     K      A+K+  L+        ++   + +       RH  L  
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKI--LKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212

Query: 569 IISSCSNDDFKALVLEYMPLGSL-----------EK--CLYSGNYILDIFQGLNIMIDVA 615
           +  S    D    V+EY   G L           E     Y                ++ 
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA--------------EIV 258

Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL-ATI 674
           SAL+YLH   +  +++ DLK  N++LD +    ++DFG+ K  +++  +    +T   T 
Sbjct: 259 SALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGTP 313

Query: 675 GYMAPDEIFSGE 686
            Y+AP E+    
Sbjct: 314 EYLAP-EVLEDN 324

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 69.1 bits (170), Expect = 9e-13
 Identities = 49/201 (24%), Positives = 82/201 (40%), Gaps = 61/201 (30%)

Query: 519 LIGRGGFGPVY-------KDGMEV-AIKVFN----LQYGGAFKSFDIECGMMKR-----I 561
           ++G+GG+G V+        +  ++ A+KV      ++      + D      +R     +
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR-----NAKDTAHTKAERNILEEV 78

Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSL-----------EK--CLYSGNYILDIFQGL 608
           +H  ++ +I +        L+LEY+  G L           E   C Y            
Sbjct: 79  KHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA---------- 128

Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAH--LSDFGMAKPLLEEDQSLT 666
               +++ AL +LH      II+ DLKP N++L+     H  L+DFG+ K  + +     
Sbjct: 129 ----EISMALGHLH---QKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTV-- 177

Query: 667 QTQTLA-TIGYMAPDEIFSGE 686
            T T   TI YMAP EI    
Sbjct: 178 -THTFCGTIEYMAP-EILMRS 196

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 70.8 bits (173), Expect = 1e-12
 Identities = 52/193 (26%), Positives = 82/193 (42%), Gaps = 48/193 (24%)

Query: 519 LIGRGGFGPV----YKDGMEV-AIKVFNLQYGGAFKSFDIECGMM-KRI-----RHRNLI 567
           ++G+G FG V     K   E+ A+K+  L+     +  D+EC M+ KR+     +   L 
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405

Query: 568 KIISSCSNDDFKALVLEYMPLGSL-----------EK--CLYSGNYILDIFQGLNIMIDV 614
           ++ S     D    V+EY+  G L           E     Y+               ++
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA--------------EI 451

Query: 615 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-T 673
           A  L +L    S  II+ DLK  NV+LD      ++DFGM K  + +      T+T   T
Sbjct: 452 AIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGT 505

Query: 674 IGYMAPDEIFSGE 686
             Y+AP EI + +
Sbjct: 506 PDYIAP-EIIAYQ 517

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 69.2 bits (170), Expect = 1e-12
 Identities = 44/192 (22%), Positives = 75/192 (39%), Gaps = 47/192 (24%)

Query: 519 LIGRGGFGPV----YKDGMEV-AIKVFNLQYGGAFKSFDIECGMMKR-----IRHRNLIK 568
           L+G+G FG V     K      A+K+  L+        ++   + +       RH  L  
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKI--LRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69

Query: 569 IISSCSNDDFKALVLEYMPLGSL-----------EK--CLYSGNYILDIFQGLNIMIDVA 615
           +  +    D    V+EY   G L           E+    Y                ++ 
Sbjct: 70  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA--------------EIV 115

Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL-ATI 674
           SALEYLH   S  +++ D+K  N++LD +    ++DFG+ K  + +  +    +T   T 
Sbjct: 116 SALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTP 169

Query: 675 GYMAPDEIFSGE 686
            Y+AP E+    
Sbjct: 170 EYLAP-EVLEDN 180

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 69.2 bits (170), Expect = 1e-12
 Identities = 55/193 (28%), Positives = 79/193 (40%), Gaps = 48/193 (24%)

Query: 519 LIGRGGFGPVY----KDGMEV-AIKVFNLQYGGAFKSFDIECGMM-KRI-----RHRNLI 567
           ++G+G FG V     K+  ++ A+KV  L+     +  D+EC M  KRI      H  L 
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFLT 87

Query: 568 KIISSCSNDDFKALVLEYMPLGSL-----------EK--CLYSGNYILDIFQGLNIMIDV 614
           ++       D    V+E++  G L           E     Y+               ++
Sbjct: 88  QLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA--------------EI 133

Query: 615 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL-AT 673
            SAL +LH      II+ DLK  NVLLD      L+DFGM K  +    +   T T   T
Sbjct: 134 ISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGT 187

Query: 674 IGYMAPDEIFSGE 686
             Y+AP EI    
Sbjct: 188 PDYIAP-EILQEM 199

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 68.7 bits (169), Expect = 1e-12
 Identities = 50/195 (25%), Positives = 75/195 (38%), Gaps = 64/195 (32%)

Query: 519 LIGRGGFGPVY----KDGMEV-AIKVFNLQYGGAFKSF-----DIEC-----GMMKRIRH 563
            +G G FG V+    +      A+KV         K        +E       M+  + H
Sbjct: 13  TLGTGSFGRVHLIRSRHNGRYYAMKVLK-------KEIVVRLKQVEHTNDERLMLSIVTH 65

Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSL-----------EK--CLYSGNYILDIFQGLNI 610
             +I++  +  +     ++++Y+  G L                 Y+             
Sbjct: 66  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA------------ 113

Query: 611 MIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAH--LSDFGMAKPLLEEDQSLTQT 668
             +V  ALEYLH   S  II+ DLKP N+LLD N   H  ++DFG AK           T
Sbjct: 114 --EVCLALEYLH---SKDIIYRDLKPENILLDKN--GHIKITDFGFAK------YVPDVT 160

Query: 669 QTL-ATIGYMAPDEI 682
            TL  T  Y+AP E+
Sbjct: 161 YTLCGTPDYIAP-EV 174

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 66.6 bits (163), Expect = 2e-12
 Identities = 33/143 (23%), Positives = 51/143 (35%), Gaps = 12/143 (8%)

Query: 20  PSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTL 79
           P     L L+ N  +    + I          L  +  + FS NK+  +        S +
Sbjct: 31  PQYTAELRLNNNEFTVLEATGIF-------KKLPQLRKINFSNNKITDIEEGAFEGASGV 83

Query: 80  KSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNA-SKLSELGLQKNSF 138
             + L SN L   +       L +LK L L  N  I  + +  F   S +  L L  N  
Sbjct: 84  NEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNR-ITCVGNDSFIGLSSVRLLSLYDNQI 141

Query: 139 SGSIPN-TFGNLRNLKWLGLNDN 160
           + ++    F  L +L  L L  N
Sbjct: 142 T-TVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 60.1 bits (146), Expect = 2e-10
 Identities = 33/153 (21%), Positives = 60/153 (39%), Gaps = 30/153 (19%)

Query: 259 LDLGGNKLSGFVP-ACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPL 317
           L L  N+ +          L  LRK+   +N +T I                   F G  
Sbjct: 37  LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEE---------------GAFEG-- 79

Query: 318 PLKIGNLNVLVQLDLSMNNFSCVIPTKI-GGLKDLQYLFLEYNRLQGSIPNSIGD-LISL 375
                  + + ++ L+ N     +  K+  GL+ L+ L L  NR+   + N     L S+
Sbjct: 80  ------ASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSV 131

Query: 376 KSLNLSNNNLSGTIPI-SLEKLLDLKDINVSFN 407
           + L+L +N ++ T+   + + L  L  +N+  N
Sbjct: 132 RLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 28/160 (17%), Positives = 51/160 (31%), Gaps = 53/160 (33%)

Query: 226 NLTNLILQLLSLEGNQLEGSIPDD-LCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLY 284
            L  L  + ++   N++   I +      + + ++ L  N+L          L +L+ L 
Sbjct: 55  KLPQL--RKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLM 111

Query: 285 LGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTK 344
           L SN +T + +                 F                               
Sbjct: 112 LRSNRITCVGNDS---------------FI------------------------------ 126

Query: 345 IGGLKDLQYLFLEYNRLQGSIPNSIGD-LISLKSLNLSNN 383
             GL  ++ L L  N++  ++     D L SL +LNL  N
Sbjct: 127 --GLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 32/198 (16%), Positives = 62/198 (31%), Gaps = 62/198 (31%)

Query: 69  VPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKL 128
           +P  I        L L++N  +    +    +LP L++++   NN I  I          
Sbjct: 26  IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINF-SNNKITDIE--------- 73

Query: 129 SELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSN 188
                            F     +  + L  N L +   ++     L + K L       
Sbjct: 74  --------------EGAFEGASGVNEILLTSNRLENVQHKM--FKGLESLKTL------- 110

Query: 189 NPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEI-NNLTNLILQLLSLEGNQLEGSIP 247
                                 + +  I+  +  +    L++  ++LLSL  NQ+  ++ 
Sbjct: 111 ---------------------MLRSNRIT-CVGNDSFIGLSS--VRLLSLYDNQIT-TVA 145

Query: 248 DD-LCRLAALFQLDLGGN 264
                 L +L  L+L  N
Sbjct: 146 PGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 47.3 bits (113), Expect = 6e-06
 Identities = 20/96 (20%), Positives = 39/96 (40%), Gaps = 5/96 (5%)

Query: 330 LDLSMNNFSCVIPTKI-GGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGT 388
           L L+ N F+ +  T I   L  L+ +    N++      +      +  + L++N L   
Sbjct: 37  LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-N 95

Query: 389 IPISL-EKLLDLKDINVSFNRLEGEIPREGPFRNLS 423
           +   + + L  LK + +  NR+   +     F  LS
Sbjct: 96  VQHKMFKGLESLKTLMLRSNRIT-CVG-NDSFIGLS 129

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 43.9 bits (104), Expect = 8e-05
 Identities = 20/96 (20%), Positives = 42/96 (43%), Gaps = 13/96 (13%)

Query: 21  SSLQTLYLSYNPPSGSIPSFILCEIPHEI-DNLHNMEWMAFSFNKVVGVVPTTIF-NVST 78
           S +  + L+ N          L  + H++   L +++ +    N++   V    F  +S+
Sbjct: 81  SGVNEILLTSNR---------LENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSS 130

Query: 79  LKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNF 114
           ++ L L+ N ++  +   A   L +L  L+L  N F
Sbjct: 131 VRLLSLYDNQIT-TVAPGAFDTLHSLSTLNLLANPF 165

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 68.4 bits (168), Expect = 2e-12
 Identities = 57/195 (29%), Positives = 84/195 (43%), Gaps = 52/195 (26%)

Query: 519 LIGRGGFGPVY----KDGMEV-AIKVFNLQYGGAFKSFDIECGMMKR------IRHRNLI 567
           +IG+G FG V     K      A+KV  LQ     K  + +  M +R      ++H  L+
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKV--LQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102

Query: 568 KIISSCSNDDFKALVLEYMPLGSL-----------EK--CLYSGNYILDIFQGLNIMIDV 614
            +  S    D    VL+Y+  G L           E     Y+               ++
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA--------------EI 148

Query: 615 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAH--LSDFGMAKPLLEEDQSLTQTQTL- 671
           ASAL YLH   S+ I++ DLKP N+LLD     H  L+DFG+ K  +E + +   T T  
Sbjct: 149 ASALGYLH---SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCKENIEHNST---TSTFC 200

Query: 672 ATIGYMAPDEIFSGE 686
            T  Y+AP E+   +
Sbjct: 201 GTPEYLAP-EVLHKQ 214

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 67.5 bits (166), Expect = 2e-12
 Identities = 42/178 (23%), Positives = 75/178 (42%), Gaps = 18/178 (10%)

Query: 512 NRFSENNLIGRGGFGPVYK----DGMEVAIKVFNLQYGGAFKS-FDI----ECGMMKRIR 562
            ++     IG G +G VYK     G   A+K   L                E  ++K ++
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRL---EKEDEGIPSTTIREISILKELK 58

Query: 563 HRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
           H N++K+           LV E++    L+K L      L+     + ++ + + + Y H
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117

Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
                 ++H DLKP N+L++      ++DFG+A+      +    T  + T+ Y APD
Sbjct: 118 ---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--THEIVTLWYRAPD 170

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 39/196 (19%), Positives = 82/196 (41%), Gaps = 40/196 (20%)

Query: 508 FQATNRFSENNLIGRGGFGPVYK-----DGMEVAIK-VFNLQYGGAFKSFDI------EC 555
                ++     +G+G +G V+K      G  VA+K +F+     AF++         E 
Sbjct: 5   RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD-----AFQNSTDAQRTFREI 59

Query: 556 GMMKRIR-HRNLIKIISSCSNDDFKA--LVLEYMPLGSLEKCLYSGN-------YILDIF 605
            ++  +  H N++ +++    D+ +   LV +YM    L   + +         Y+  ++
Sbjct: 60  MILTELSGHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYV--VY 116

Query: 606 QGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL 665
           Q +         ++YLH   S  ++H D+KPSN+LL+      ++DFG+++  +   +  
Sbjct: 117 QLIK-------VIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166

Query: 666 TQTQTLATIGYMAPDE 681
                         D+
Sbjct: 167 NNIPLSINENTENFDD 182

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 66.6 bits (163), Expect = 3e-12
 Identities = 57/177 (32%), Positives = 87/177 (49%), Gaps = 16/177 (9%)

Query: 213 NCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIP--DDLCRLAALFQLDLGGNKLSGFV 270
           N +   S+   I  L N+  + L+L GN+L   I        L  L  L L GN+L    
Sbjct: 49  NNSDIKSVQG-IQYLPNV--RYLALGGNKLH-DISALK---ELTNLTYLILTGNQLQSLP 101

Query: 271 PACSGNLTNLRKLYLGSNLLTSIPSTLWN-LKDILHLNLSSNFFTGPLPLKI-GNLNVLV 328
                 LTNL++L L  N L S+P  +++ L ++ +LNL+ N     LP  +   L  L 
Sbjct: 102 NGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQS-LPKGVFDKLTNLT 160

Query: 329 QLDLSMNNFSCVIPTKI-GGLKDLQYLFLEYNRLQGSIPNSIGD-LISLKSLNLSNN 383
           +LDLS N     +P  +   L  L+ L L  N+L+ S+P+ + D L SL+ + L +N
Sbjct: 161 ELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 66.2 bits (162), Expect = 5e-12
 Identities = 48/157 (30%), Positives = 71/157 (45%), Gaps = 9/157 (5%)

Query: 232 LQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLT 291
           +  +    + ++         L  +  L LGGNKL   + A    LTNL  L L  N L 
Sbjct: 43  IDQIIANNSDIKSVQGIQ--YLPNVRYLALGGNKLHD-ISALKE-LTNLTYLILTGNQLQ 98

Query: 292 SIPSTLWN-LKDILHLNLSSNFFTGPLPLKIGN-LNVLVQLDLSMNNFSCVIPTKIGGLK 349
           S+P+ +++ L ++  L L  N     LP  + + L  L  L+L+ N    +       L 
Sbjct: 99  SLPNGVFDKLTNLKELVLVENQLQS-LPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLT 157

Query: 350 DLQYLFLEYNRLQGSIPNSIGD-LISLKSLNLSNNNL 385
           +L  L L YN+LQ S+P  + D L  LK L L  N L
Sbjct: 158 NLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQL 193

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 59.3 bits (144), Expect = 1e-09
 Identities = 57/240 (23%), Positives = 93/240 (38%), Gaps = 66/240 (27%)

Query: 75  NVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQ 134
            ++++  +  +++ +   +       LPN++ L L GN  +  I +     + L+ L L 
Sbjct: 39  ELNSIDQIIANNSDIK-SVQGIQ--YLPNVRYLALGGNK-LHDISAL-KELTNLTYLILT 93

Query: 135 KNSFSGSIPNT-FGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGG 193
            N    S+PN  F  L NLK L L +N L S                             
Sbjct: 94  GNQLQ-SLPNGVFDKLTNLKELVLVENQLQS----------------------------- 123

Query: 194 ILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLC-R 252
            LP                     G + +++ NLT L     +L  NQL+ S+P  +  +
Sbjct: 124 -LP--------------------DG-VFDKLTNLTYL-----NLAHNQLQ-SLPKGVFDK 155

Query: 253 LAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLW-NLKDILHLNLSSN 311
           L  L +LDL  N+L          LT L+ L L  N L S+P  ++  L  + ++ L  N
Sbjct: 156 LTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 215

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 43.9 bits (104), Expect = 9e-05
 Identities = 35/144 (24%), Positives = 60/144 (41%), Gaps = 39/144 (27%)

Query: 20  PSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFN-VST 78
            ++L+ L L  N     + S                             +P  +F+ ++ 
Sbjct: 108 LTNLKELVLVEN----QLQS-----------------------------LPDGVFDKLTN 134

Query: 79  LKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNA-SKLSELGLQKNS 137
           L  L L  N L   LP     +L NL EL L  N    ++P  +F+  ++L +L L +N 
Sbjct: 135 LTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQL-QSLPEGVFDKLTQLKDLRLYQNQ 192

Query: 138 FSGSIPN-TFGNLRNLKWLGLNDN 160
              S+P+  F  L +L+++ L+DN
Sbjct: 193 LK-SVPDGVFDRLTSLQYIWLHDN 215

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 67.4 bits (165), Expect = 3e-12
 Identities = 41/158 (25%), Positives = 66/158 (41%), Gaps = 21/158 (13%)

Query: 512 NRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNL 566
             F     IG G FG +           VAIK+  ++         +E    K++   + 
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA--PQLHLEYRFYKQLGSGDG 66

Query: 567 I-KIISSCSNDDFKALVLEYMPLG-SLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFG 624
           I ++        + A+VLE   LG SLE      +    +   L I I + S +EY+H  
Sbjct: 67  IPQVYYFGPCGKYNAMVLEL--LGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH-- 122

Query: 625 YSVPIIHCDLKPSNVLL------DDNMVAHLSDFGMAK 656
            S  +I+ D+KP N L+         ++ H+ DF +AK
Sbjct: 123 -SKNLIYRDVKPENFLIGRPGNKTQQVI-HIIDFALAK 158

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 67.6 bits (166), Expect = 4e-12
 Identities = 54/193 (27%), Positives = 75/193 (38%), Gaps = 48/193 (24%)

Query: 519 LIGRGGFGPV----YKDGMEV-AIKVFNLQYGGAFKSFDIECGMM-KRI-----RHRNLI 567
           +IGRG +  V     K    + A+KV  ++        DI+     K +      H  L+
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKV--VKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 73

Query: 568 KIISSCSNDDFKALVLEYMPLGSL-----------EK--CLYSGNYILDIFQGLNIMIDV 614
            + S    +     V+EY+  G L           E+    YS               ++
Sbjct: 74  GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA--------------EI 119

Query: 615 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL-AT 673
           + AL YLH      II+ DLK  NVLLD      L+D+GM K  L        T T   T
Sbjct: 120 SLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGT 173

Query: 674 IGYMAPDEIFSGE 686
             Y+AP EI  GE
Sbjct: 174 PNYIAP-EILRGE 185

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 67.6 bits (166), Expect = 4e-12
 Identities = 52/193 (26%), Positives = 82/193 (42%), Gaps = 48/193 (24%)

Query: 519 LIGRGGFGPV----YKDGMEV-AIKVFNLQYGGAFKSFDIECGMM-KRI-----RHRNLI 567
           ++G+G FG V     K   E+ A+K+  L+     +  D+EC M+ KR+     +   L 
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84

Query: 568 KIISSCSNDDFKALVLEYMPLGSL-----------EK--CLYSGNYILDIFQGLNIMIDV 614
           ++ S     D    V+EY+  G L           E     Y+               ++
Sbjct: 85  QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAA--------------EI 130

Query: 615 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL-AT 673
           A  L +L    S  II+ DLK  NV+LD      ++DFGM K  + +      T+T   T
Sbjct: 131 AIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGT 184

Query: 674 IGYMAPDEIFSGE 686
             Y+AP EI + +
Sbjct: 185 PDYIAP-EIIAYQ 196

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 67.2 bits (165), Expect = 4e-12
 Identities = 48/201 (23%), Positives = 87/201 (43%), Gaps = 63/201 (31%)

Query: 519 LIGRGGFGPVY-------KDGMEV-AIKVFNLQYGGAFKSF-----DIECGMMKRI---- 561
           ++G+G FG V+        D  ++ A+KV         K+       +   M + I    
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLK-------KATLKVRDRVRTKMERDILVEV 83

Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSL-----------EK--CLYSGNYILDIFQGL 608
            H  ++K+  +   +    L+L+++  G L           E+    Y            
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA---------- 133

Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAH--LSDFGMAKPLLEEDQSLT 666
               ++A AL++LH   S+ II+ DLKP N+LLD+    H  L+DFG++K  ++ ++   
Sbjct: 134 ----ELALALDHLH---SLGIIYRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKK-- 182

Query: 667 QTQTL-ATIGYMAPDEIFSGE 686
              +   T+ YMAP E+ +  
Sbjct: 183 -AYSFCGTVEYMAP-EVVNRR 201

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 67.4 bits (165), Expect = 5e-12
 Identities = 53/193 (27%), Positives = 75/193 (38%), Gaps = 48/193 (24%)

Query: 519 LIGRGGFGPVY----KDGMEV-AIKVFNLQYGGAFKSFDIECGMM-KRI-----RHRNLI 567
           +IGRG +  V     K    + A++V  ++        DI+     K +      H  L+
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRV--VKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116

Query: 568 KIISSCSNDDFKALVLEYMPLGSL-----------EK--CLYSGNYILDIFQGLNIMIDV 614
            + S    +     V+EY+  G L           E+    YS               ++
Sbjct: 117 GLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA--------------EI 162

Query: 615 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL-AT 673
           + AL YLH      II+ DLK  NVLLD      L+D+GM K  L        T T   T
Sbjct: 163 SLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGT 216

Query: 674 IGYMAPDEIFSGE 686
             Y+AP EI  GE
Sbjct: 217 PNYIAP-EILRGE 228

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 66.9 bits (164), Expect = 5e-12
 Identities = 46/192 (23%), Positives = 76/192 (39%), Gaps = 50/192 (26%)

Query: 519 LIGRGGFGPVY----KDGMEV-AIKVFNLQYGGAFKSFDIEC-----GMMKRIRHRNLIK 568
            +G G FG V     K+     A+K+ + Q     K   IE       +++ +    L+K
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQK--VVKLKQIEHTLNEKRILQAVNFPFLVK 105

Query: 569 IISSCSNDDFKALVLEYMPLGSL-------------EKCLYSGNYILDIFQGLNIMIDVA 615
           +  S  ++    +V+EY+  G +                 Y+                + 
Sbjct: 106 LEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAA--------------QIV 151

Query: 616 SALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL-ATI 674
              EYLH   S+ +I+ DLKP N+L+D      ++DFG AK      +   +T TL  T 
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------RVKGRTWTLCGTP 202

Query: 675 GYMAPDEIFSGE 686
             +AP EI   +
Sbjct: 203 EALAP-EIILSK 213

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 66.8 bits (164), Expect = 5e-12
 Identities = 47/184 (25%), Positives = 83/184 (45%), Gaps = 19/184 (10%)

Query: 509 QATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI-ECGMMKRIR 562
            ++++F +   +G G +  VYK      G+ VA+K   L       S  I E  +MK ++
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61

Query: 563 HRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLN------IMIDVAS 616
           H N++++      ++   LV E+M    L+K + S   + +  +GL           +  
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRT-VGNTPRGLELNLVKYFQWQLLQ 119

Query: 617 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGY 676
            L + H      I+H DLKP N+L++      L DFG+A+       +   +  + T+ Y
Sbjct: 120 GLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF--SSEVVTLWY 174

Query: 677 MAPD 680
            APD
Sbjct: 175 RAPD 178

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 66.9 bits (164), Expect = 5e-12
 Identities = 52/195 (26%), Positives = 80/195 (41%), Gaps = 52/195 (26%)

Query: 519 LIGRGGFGPV----YKDGMEV-AIKVFNLQYGGAFKSFDIECGMM-KRI-----RHRNLI 567
           ++G+G FG V    +K   +  AIK   L+        D+EC M+ KR+      H  L 
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81

Query: 568 KIISSCSNDDFKALVLEYMPLGSL-----------EK--CLYSGNYILDIFQGLNIMIDV 614
            +  +    +    V+EY+  G L                 Y+               ++
Sbjct: 82  HMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA--------------EI 127

Query: 615 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAH--LSDFGMAKPLLEEDQSLTQTQTL- 671
              L++LH   S  I++ DLK  N+LLD +   H  ++DFGM K  +  D     T T  
Sbjct: 128 ILGLQFLH---SKGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAK---TNTFC 179

Query: 672 ATIGYMAPDEIFSGE 686
            T  Y+AP EI  G+
Sbjct: 180 GTPDYIAP-EILLGQ 193

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 64.3 bits (157), Expect = 6e-12
 Identities = 43/169 (25%), Positives = 73/169 (43%), Gaps = 26/169 (15%)

Query: 282 KLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQ---LDLSMNNFS 338
           +L+     +  + +TL  LK   HL LS+N        KI +L+ +     L L  N   
Sbjct: 29  ELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-----KISSLSGMENLRILSLGRNLI- 82

Query: 339 CVIPTKIGGL----KDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPIS-L 393
                KI  L      L+ L++ YN++  S+   I  L++L+ L +SNN ++    I  L
Sbjct: 83  ----KKIENLDAVADTLEELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEIDKL 136

Query: 394 EKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMPNLQVL 442
             L  L+D+ ++ N L  +                  E++  +PNL+ L
Sbjct: 137 AALDKLEDLLLAGNPLYNDYKENNATSEYR------IEVVKRLPNLKKL 179

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 59.3 bits (144), Expect = 4e-10
 Identities = 37/150 (24%), Positives = 55/150 (36%), Gaps = 20/150 (13%)

Query: 222 EEINNLTNLILQLLSLEG--NQLEGSIPDDLCRLAALFQLDLGGN---KLSGFVPACSGN 276
           EE  ++     + + L G    +E  +   L  L A   L L  N   K+S         
Sbjct: 15  EERKSVVATEAEKVELHGMIPPIEK-MDATLSTLKACKHLALSTNNIEKISSL-----SG 68

Query: 277 LTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQL---DLS 333
           + NLR L LG NL+  I +       +  L +S N         +  +  LV L    +S
Sbjct: 69  MENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIA-----SLSGIEKLVNLRVLYMS 123

Query: 334 MNNFSCVIP-TKIGGLKDLQYLFLEYNRLQ 362
            N  +      K+  L  L+ L L  N L 
Sbjct: 124 NNKITNWGEIDKLAALDKLEDLLLAGNPLY 153

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 29/117 (24%), Positives = 47/117 (40%), Gaps = 18/117 (15%)

Query: 79  LKSLYLHSNSLSGRLPSSADV----RLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQ 134
            K L L +N++         +     + NL+ L L  N  I  I +    A  L EL + 
Sbjct: 50  CKHLALSTNNIE-------KISSLSGMENLRILSLGRNL-IKKIENLDAVADTLEELWIS 101

Query: 135 KNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPL 191
            N  + S+      L NL+ L +++N +T        +  L+    LE    + NPL
Sbjct: 102 YNQIA-SLSG-IEKLVNLRVLYMSNNKIT----NWGEIDKLAALDKLEDLLLAGNPL 152

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 46.6 bits (111), Expect = 7e-06
 Identities = 40/191 (20%), Positives = 62/191 (32%), Gaps = 50/191 (26%)

Query: 81  SLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSG 140
            L+     +  ++ ++    L   K L L   N I  I S +     L  L L +N    
Sbjct: 29  ELHGMIPPIE-KMDATLS-TLKACKHLAL-STNNIEKI-SSLSGMENLRILSLGRNLIK- 83

Query: 141 SIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIG 200
            I N       L+ L ++ N       +++SLS +     L     SNN +         
Sbjct: 84  KIENLDAVADTLEELWISYN-------QIASLSGIEKLVNLRVLYMSNNKITNW------ 130

Query: 201 NLSQSMEDFWMDNCNISGSIPEEINNLTNLI-LQLLSLEGNQLEGSIPDD---------- 249
                                 EI+ L  L  L+ L L GN L     ++          
Sbjct: 131 ---------------------GEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEV 169

Query: 250 LCRLAALFQLD 260
           + RL  L +LD
Sbjct: 170 VKRLPNLKKLD 180

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 44.7 bits (106), Expect = 3e-05
 Identities = 34/176 (19%), Positives = 56/176 (31%), Gaps = 43/176 (24%)

Query: 130 ELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNN 189
           EL          +  T   L+  K L L+ N        +  +SSLS  + L   S   N
Sbjct: 29  ELHGMIPPIEK-MDATLSTLKACKHLALSTN-------NIEKISSLSGMENLRILSLGRN 80

Query: 190 PLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLI--LQLLSLEGNQLEGSIP 247
            +                              ++I NL  +   L+ L +  NQ+  S+ 
Sbjct: 81  LI------------------------------KKIENLDAVADTLEELWISYNQIA-SL- 108

Query: 248 DDLCRLAALFQLDLGGNKLSGFVPACS-GNLTNLRKLYLGSNLLTSIPSTLWNLKD 302
             + +L  L  L +  NK++ +        L  L  L L  N L +         +
Sbjct: 109 SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSE 164

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 66.7 bits (163), Expect = 8e-12
 Identities = 44/222 (19%), Positives = 83/222 (37%), Gaps = 60/222 (27%)

Query: 511 TNRFSENNLIGRGGFGPVYK-----DGMEVAIK-VFNLQYGGAFKSFDI-ECGMMKRIRH 563
           + ++S    +G G FG V +      G   A+K V           +   E  +MK + H
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDH 59

Query: 564 RNLIKII--------------------------------------SSCSNDDFKALVLEY 585
            N+IK++                                       + S + +  +++EY
Sbjct: 60  VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119

Query: 586 MP--LGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD- 642
           +P  L  + K        + +      +  +  A+ ++H   S+ I H D+KP N+L++ 
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNS 176

Query: 643 DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS 684
            +    L DFG AK L+  + S      + +  Y AP+ +  
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLG 215

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 66.5 bits (163), Expect = 9e-12
 Identities = 48/201 (23%), Positives = 83/201 (41%), Gaps = 59/201 (29%)

Query: 519 LIGRGGFGPVY-------KDGMEV-AIKVFN----LQYGGAFKSFDIECGMM-KRI---- 561
           ++G G +G V+        D  ++ A+KV      +Q     K+   E     +++    
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQ-----KAKTTEHTRTERQVLEHI 115

Query: 562 -RHRNLIKIISSCSNDDFKALVLEYMPLGSL-----------EK--CLYSGNYILDIFQG 607
            +   L+ +  +   +    L+L+Y+  G L           E    +Y G         
Sbjct: 116 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG--------- 166

Query: 608 LNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAH--LSDFGMAKPLLEEDQSL 665
                ++  ALE+LH    + II+ D+K  N+LLD N   H  L+DFG++K  + ++   
Sbjct: 167 -----EIVLALEHLH---KLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETER 216

Query: 666 TQTQTLATIGYMAPDEIFSGE 686
                  TI YMAP +I  G 
Sbjct: 217 AYD-FCGTIEYMAP-DIVRGG 235

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 66.0 bits (161), Expect = 2e-11
 Identities = 39/191 (20%), Positives = 72/191 (37%), Gaps = 36/191 (18%)

Query: 516 ENNLIGRGGFGPVYK-------DGMEVAIKVFNLQYGGAFKSFDI----ECGMMKRIRHR 564
           E   +GRG +G VYK       D  + A+K              +    E  +++ ++H 
Sbjct: 25  EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE------GTGISMSACREIALLRELKHP 78

Query: 565 N---LIKIISSCSNDDFKALVLEYMP--LGSL-----EKCLYSGNYILDIFQGLNIMIDV 614
           N   L K+  S ++     L+ +Y    L  +               L      +++  +
Sbjct: 79  NVISLQKVFLSHADRKV-WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137

Query: 615 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAH----LSDFGMAKPLLEEDQSLTQ-TQ 669
              + YLH   +  ++H DLKP+N+L+           ++D G A+      + L     
Sbjct: 138 LDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 194

Query: 670 TLATIGYMAPD 680
            + T  Y AP+
Sbjct: 195 VVVTFWYRAPE 205

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 65.3 bits (160), Expect = 2e-11
 Identities = 41/169 (24%), Positives = 75/169 (44%), Gaps = 27/169 (15%)

Query: 520 IGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI----ECGMMKRIRHRN---LI 567
           IG+G FG V+K      G +VA+K   ++     + F I    E  +++ ++H N   LI
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLME--NEKEGFPITALREIKILQLLKHENVVNLI 82

Query: 568 KIISSCSNDDFKA-----LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
           +I  + ++   +      LV ++     L   L +      + +   +M  + + L Y+H
Sbjct: 83  EICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 141

Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMA----KPLLEEDQSLTQ 667
                 I+H D+K +NVL+  + V  L+DFG+A         +    T 
Sbjct: 142 ---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 187

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 64.5 bits (158), Expect = 2e-11
 Identities = 43/180 (23%), Positives = 79/180 (43%), Gaps = 20/180 (11%)

Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKS-FDI----ECGMMKRI 561
             F +   IG G +G VYK      G  VA+K   L                E  ++K +
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKEL 59

Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYI-LDIFQGLNIMIDVASALEY 620
            H N++K++     ++   LV E++    L+K + +     + +    + +  +   L +
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118

Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
            H   S  ++H DLKP N+L++      L+DFG+A+      ++   T  + T+ Y AP+
Sbjct: 119 CH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--THEVVTLWYRAPE 173

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 64.4 bits (156), Expect = 3e-11
 Identities = 21/92 (22%), Positives = 32/92 (34%), Gaps = 7/92 (7%)

Query: 101 LPNLKELHLWGNNFIGTIPSFIF-NASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLND 159
             NL EL++     +  +         +L  L + K+      P+ F     L  L L+ 
Sbjct: 30  AENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89

Query: 160 NYLTSSTPELSSLSSLSNCKYLEYFSFSNNPL 191
           N L S + +     SL           S NPL
Sbjct: 90  NALESLSWKTVQGLSLQELV------LSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 58.6 bits (141), Expect = 3e-09
 Identities = 20/96 (20%), Positives = 34/96 (35%), Gaps = 3/96 (3%)

Query: 69  VPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNA-SK 127
               +     L  LY+ +      L       L  L+ L +  +  +  +    F+   +
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG-LRFVAPDAFHFTPR 81

Query: 128 LSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLT 163
           LS L L  N+       T   L +L+ L L+ N L 
Sbjct: 82  LSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 57.1 bits (137), Expect = 9e-09
 Identities = 22/97 (22%), Positives = 30/97 (30%), Gaps = 3/97 (3%)

Query: 219 SIPEEINNLTNLILQLLSLEGNQLEGSIPD-DLCRLAALFQLDLGGNKLSGFVPACSGNL 277
                +    NL    L +E  Q    +   DL  L  L  L +  + L    P      
Sbjct: 22  DSLHHLPGAENL--TELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFT 79

Query: 278 TNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFT 314
             L +L L  N L S+         +  L LS N   
Sbjct: 80  PRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 55.9 bits (134), Expect = 2e-08
 Identities = 24/115 (20%), Positives = 40/115 (34%), Gaps = 6/115 (5%)

Query: 272 ACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLK-IGNLNVLVQL 330
              G+      L    +        L   +++  L + +      L L+ +  L  L  L
Sbjct: 6   CPHGS----SGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNL 61

Query: 331 DLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNL 385
            +  +    V P        L  L L +N L+ S+       +SL+ L LS N L
Sbjct: 62  TIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 52.8 bits (126), Expect = 2e-07
 Identities = 22/97 (22%), Positives = 40/97 (41%), Gaps = 5/97 (5%)

Query: 341 IPTKIGGLKDLQYLFLEYNRLQGSIPN-SIGDLISLKSLNLSNNNLSGTIPISLEKLLDL 399
               + G ++L  L++E  +    +    +  L  L++L +  + L    P +      L
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82

Query: 400 KDINVSFNRLEGEIPREGPFRNLSAES--FKGNELLC 434
             +N+SFN LE  +      + LS +     GN L C
Sbjct: 83  SRLNLSFNALE-SLS-WKTVQGLSLQELVLSGNPLHC 117

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 52.4 bits (125), Expect = 2e-07
 Identities = 19/126 (15%), Positives = 32/126 (25%), Gaps = 33/126 (26%)

Query: 13  ILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTT 72
            L  L    +L  LY+        +                                   
Sbjct: 23  SLHHLPGAENLTELYIENQQHLQHLE------------------LRDLR----------- 53

Query: 73  IFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELG 132
              +  L++L +  + L   +   A    P L  L+L   N + ++         L EL 
Sbjct: 54  --GLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNL-SFNALESLSWKTVQGLSLQELV 109

Query: 133 LQKNSF 138
           L  N  
Sbjct: 110 LSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 52.4 bits (125), Expect = 3e-07
 Identities = 20/93 (21%), Positives = 40/93 (43%), Gaps = 2/93 (2%)

Query: 318 PLKIGNLNVLVQLDLSMNNFSCVIPTK-IGGLKDLQYLFLEYNRLQGSIPNSIGDLISLK 376
              +     L +L +        +  + + GL +L+ L +  + L+   P++      L 
Sbjct: 24  LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83

Query: 377 SLNLSNNNLSGTIPISLEKLLDLKDINVSFNRL 409
            LNLS N L  ++     + L L+++ +S N L
Sbjct: 84  RLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 46.7 bits (110), Expect = 2e-05
 Identities = 16/105 (15%), Positives = 33/105 (31%), Gaps = 10/105 (9%)

Query: 117 TIPSFIFNASKLSELGLQKNSFSGSIPN-TFGNLRNLKWLGLNDNYLTSSTPELSSLSSL 175
                +  A  L+EL ++       +       L  L+ L +  + L    P+     + 
Sbjct: 22  DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPD-----AF 76

Query: 176 SNCKYLEYFSFSNNPLGGILPRAIGNLSQSM----EDFWMDNCNI 216
                L   + S N L  +  + +  LS        +    +C +
Sbjct: 77  HFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCAL 121

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 64.4 bits (157), Expect = 5e-11
 Identities = 33/174 (18%), Positives = 64/174 (36%), Gaps = 35/174 (20%)

Query: 512 NRFSENNLIGRGGFGPVYK-------------DGMEVAIKV-------FNLQ--YGGAFK 549
            ++   +   R   G +Y+                + ++K+       FN Q  +  A K
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101

Query: 550 SFDIECGM-MKRIRHRNLIKIISSCSN-DDFKALVLEYMPLG-SLEKCL-YSGNYILDIF 605
              +     +       +   +    + D ++ LVL    LG SL+  L  S  ++L   
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPS--LGRSLQSALDVSPKHVLSER 159

Query: 606 QGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAK 656
             L +   +  ALE+LH       +H ++   N+ +   D + V  L+ +G A 
Sbjct: 160 SVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQV-TLAGYGFAF 209

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 62.0 bits (151), Expect = 6e-11
 Identities = 51/178 (28%), Positives = 69/178 (38%), Gaps = 40/178 (22%)

Query: 213 NCNISG--SIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFV 270
           +C      S+P  I        Q+L L  NQ+    P     L  L +L LG N+L    
Sbjct: 25  DCRSKRHASVPAGIPTNA----QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALP 80

Query: 271 PACSGNLTNLRKLYLGSNLLTSIPS----TLWNLKDILHLNLSSNFFTGPLPLKIGNLNV 326
                +LT L  L LG+N LT +PS     L +LK    L +  N               
Sbjct: 81  VGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLK---ELFMCCN--------------- 122

Query: 327 LVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGD-LISLKSLNLSNN 383
             +L          +P  I  L  L +L L+ N+L+ SIP+   D L SL    L  N
Sbjct: 123 --KLT--------ELPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLSSLTHAYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 47/186 (25%), Positives = 61/186 (32%), Gaps = 64/186 (34%)

Query: 130 ELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNN 189
            L L  N  +   P  F +L NLK L L  N L +                         
Sbjct: 44  ILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA------------------------- 78

Query: 190 PLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPD- 248
                LP                     G + + +  LT      L L  NQL   +P  
Sbjct: 79  -----LP--------------------VG-VFDSLTQLTV-----LDLGTNQLT-VLPSA 106

Query: 249 --DLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLW-NLKDILH 305
             D  RL  L +L +  NKL+  +P     LT+L  L L  N L SIP   +  L  + H
Sbjct: 107 VFD--RLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTH 163

Query: 306 LNLSSN 311
             L  N
Sbjct: 164 AYLFGN 169

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 44/145 (30%), Positives = 68/145 (46%), Gaps = 14/145 (9%)

Query: 18  GNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVS 77
           G P++ Q LYL  N  +  +        P   D+L N++ +    N++   +P  +F+  
Sbjct: 37  GIPTNAQILYLHDNQIT-KLE-------PGVFDSLINLKELYLGSNQLG-ALPVGVFDSL 87

Query: 78  T-LKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKN 136
           T L  L L +N L+  LPS+   RL +LKEL +  N     +P  I   + L+ L L +N
Sbjct: 88  TQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQN 145

Query: 137 SFSGSIPN-TFGNLRNLKWLGLNDN 160
               SIP+  F  L +L    L  N
Sbjct: 146 QLK-SIPHGAFDRLSSLTHAYLFGN 169

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 63.2 bits (154), Expect = 6e-11
 Identities = 45/162 (27%), Positives = 67/162 (41%), Gaps = 31/162 (19%)

Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKV-------FNLQYGGAFKSFDIECGMMK 559
           NR+     IG G FG +Y       G EVAIK+         L           E  + K
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI---------ESKIYK 59

Query: 560 RIRHRNLI-KIISSCSNDDFKALVLEYMPLG-SLEKCLYSGNYILDIFQGLNIMIDVASA 617
            ++    I  I    +  D+  +V+E   LG SLE      +    +   L +   + S 
Sbjct: 60  MMQGGVGIPTIRWCGAEGDYNVMVMEL--LGPSLEDLFNFCSRKFSLKTVLLLADQMISR 117

Query: 618 LEYLHFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAK 656
           +EY+H   S   IH D+KP N L+       + ++ DFG+AK
Sbjct: 118 IEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 64.9 bits (157), Expect = 8e-11
 Identities = 93/718 (12%), Positives = 193/718 (26%), Gaps = 256/718 (35%)

Query: 7   DFLRGIILSQ-----LGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEI------DNLH-N 54
           D  + I+  +     + +  ++      +         + L     E+      + L  N
Sbjct: 40  DMPKSILSKEEIDHIIMSKDAVSGTLRLF---------WTLLSKQEEMVQKFVEEVLRIN 90

Query: 55  MEWMAFSFNKVVG--VVPTTIFNVSTLKSLYLHSNSLSGRLPSSADV-RLPNLKELHLWG 111
            +++            + T ++ +     LY   N    ++ +  +V RL    +L    
Sbjct: 91  YKFLMSPIKTEQRQPSMMTRMY-IEQRDRLY---ND--NQVFAKYNVSRLQPYLKLR--- 141

Query: 112 NNFIGTIPSFIFNASKLSEL------------GLQKNSFSGSIPNTFGNLRNLKWLGLND 159
                           L EL            G  K   +  +        + K     D
Sbjct: 142 --------------QALLELRPAKNVLIDGVLGSGKTWVALDV------CLSYKVQCKMD 181

Query: 160 N---YLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNI 216
               +L            L NC   E            +   +  L   ++  W    + 
Sbjct: 182 FKIFWLN-----------LKNCNSPE-----------TVLEMLQKLLYQIDPNWTSRSDH 219

Query: 217 SGSIPEEINNLTNLILQLLSLEGNQLEGS--IPDDLCRLAALFQLDLGGNKLSGFVPAC- 273
           S +I   I+++   + +LL  +    E    +  ++    A    +L           C 
Sbjct: 220 SSNIKLRIHSIQAELRRLLKSK--PYENCLLVLLNVQNAKAWNAFNLS----------CK 267

Query: 274 ------SGNLTNLRKLYLGSNLLTSIPS-------TLWNLKDILHLNLSSNFFTGPLPLK 320
                    +T+    +L +   T I         T   +K +L   L        LP +
Sbjct: 268 ILLTTRFKQVTD----FLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQD--LPRE 321

Query: 321 IGNLNVLVQLDLSMNNFSCVIPTKIGG-LKDL-----QYLFLEYNRLQGSIPNSIGDLIS 374
           +   N      LS+          I   ++D       +  +  ++L   I +S+     
Sbjct: 322 VLTTNPRR---LSI----------IAESIRDGLATWDNWKHVNCDKLTTIIESSL----- 363

Query: 375 LKSLNLSNNNLSGTIPISLEKLL-DL----KDINVSFNRLE---GEIPREGP------FR 420
                   N L    P    K+   L       ++    L     ++ +           
Sbjct: 364 --------NVLE---PAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLH 412

Query: 421 NLSAESFKGNELLCGMPNLQVLSCRTKIHHTLGKNDLLIGIVLPLSTIFMMVVVLLILKY 480
             S    +  E    +P++  L  + K+ +    +  ++                    Y
Sbjct: 413 KYSLVEKQPKESTISIPSIY-LELKVKLENEYALHRSIVD------------------HY 453

Query: 481 RKGRKSQLKDVNMPSVADQRRFTY----LELFQATNRFSENNLIGRGGFGPVYKDGMEVA 536
              +     D+ +P   DQ  +++    L+  +   R +         F  V+ D     
Sbjct: 454 NIPKTFDSDDL-IPPYLDQYFYSHIGHHLKNIEHPERMTL--------FRMVFLD----- 499

Query: 537 IKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLY 596
              F       F        + ++IRH +     S    +           L  L+   Y
Sbjct: 500 ---FR------F--------LEQKIRHDSTAWNASGSILNT----------LQQLKF--Y 530

Query: 597 SGNYILDIFQGLNIMIDVASALEYLHF--GYSVPII---HCDL------KPSNVLLDD 643
              YI D       +++       L F       +I   + DL           + ++
Sbjct: 531 K-PYICDNDPKYERLVN-----AILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEE 582

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 54.1 bits (129), Expect = 2e-07
 Identities = 76/553 (13%), Positives = 169/553 (30%), Gaps = 125/553 (22%)

Query: 301 KDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFS-------CVIPTKIGGLKDLQY 353
           KDIL +     F        + N +     D+  +  S        +    + G   L +
Sbjct: 19  KDILSVFED-AF--------VDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFW 69

Query: 354 LFLEYNRLQGSIPNSIGDLIS------LKSLNLSNNNLSGTIPISLEKLLDLKDINVSFN 407
             L     +  +   + +++       +  +       S    + +E+   L + N  F 
Sbjct: 70  TLLSKQ--EEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFA 127

Query: 408 RLEGEIPREGPFRNL--SAESFKGNE--LLCGMPNL--QVL---SCRT-KIHH------- 450
           +    + R  P+  L  +    +  +  L+ G+       +    C + K+         
Sbjct: 128 KYN--VSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIF 185

Query: 451 --TLGKNDLLIGIVLPLSTIFMMVVVLLILKYRKGRKSQLKDVNMPSVADQRRFTYLELF 508
              L   +    ++  L  +   +                 D N  S +D      L + 
Sbjct: 186 WLNLKNCNSPETVLEMLQKLLYQI-----------------DPNWTSRSDHSSNIKLRIH 228

Query: 509 QATNRFSENNLIGRGGFGPVYKDGMEVAIKVFNLQYGGAFKSFDIECGMM---------- 558
                     L+        Y++ + V   + N+Q   A+ +F++ C ++          
Sbjct: 229 SIQAELR--RLL----KSKPYENCLLV---LLNVQNAKAWNAFNLSCKILLTTRFKQVTD 279

Query: 559 ----KRIRHRNLIKIISSCSNDDFKALVLEY--MPLGSL--EKCLYSGN-YILDIFQGLN 609
                   H +L     + + D+ K+L+L+Y       L  E    + N   L I    +
Sbjct: 280 FLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVL--TTNPRRLSII-AES 336

Query: 610 IMIDVASALEYLHFGYS--VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ 667
           I   +A+   + H        II   L   NVL             +          +  
Sbjct: 337 IRDGLATWDNWKHVNCDKLTTIIESSL---NVLEPAEYRKMFDRLSV----FPPSAHIP- 388

Query: 668 TQTLATI-GYMAPDEI--FSGEMR----LKCWVNDSL--LISVMIVVDANLLIREEKHLM 718
           T  L+ I   +   ++     ++     ++    +S   + S+ + +   L      H  
Sbjct: 389 TILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRS 448

Query: 719 TKEQ---PMVRMGTDLSLGQFPASYSISKYLVY-IRELERGKVGITSVAAFPIVHHYL-Y 773
             +    P      DL    +   Y    ++ + ++ +E  +     +  F +V  +L +
Sbjct: 449 IVDHYNIPKTFDSDDLIP-PYLDQY-FYSHIGHHLKNIEHPE----RMTLFRMV--FLDF 500

Query: 774 RTVDYTISSSTFN 786
           R ++  I   +  
Sbjct: 501 RFLEQKIRHDSTA 513

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.9 bits (113), Expect = 1e-05
 Identities = 48/260 (18%), Positives = 76/260 (29%), Gaps = 91/260 (35%)

Query: 4   LTNDFLRGII---LSQLGNPSSLQTLY--LSYNPPSGSIPSFILCEIPHEIDNLHNMEWM 58
           +  D L  II   L+ L  P+  + ++  LS  PPS  IP+ +L            + W 
Sbjct: 350 VNCDKLTTIIESSLNVL-EPAEYRKMFDRLSVFPPSAHIPTILLS-----------LIWF 397

Query: 59  AFSFNKVVGVVPTTIFNVSTLK------SLYLHSNSLSGRLPSSADVRLPNLKELH---- 108
               +  V VV   +   S ++      ++ + S  L  ++       L N   LH    
Sbjct: 398 DVIKS-DVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVK------LENEYALHRSIV 450

Query: 109 ----------LWGN----------NFIG-------------TIP----SFIFNASKLSEL 131
                                   + IG                     F F   K+   
Sbjct: 451 DHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHD 510

Query: 132 GLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSL------------SSLSNCK 179
               N+ SGSI NT   L+  K       Y+  + P+   L             +L   K
Sbjct: 511 STAWNA-SGSILNTLQQLKFYK------PYICDNDPKYERLVNAILDFLPKIEENLICSK 563

Query: 180 YLEYFSFS-NNPLGGILPRA 198
           Y +    +       I   A
Sbjct: 564 YTDLLRIALMAEDEAIFEEA 583

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 63.2 bits (154), Expect = 1e-10
 Identities = 58/349 (16%), Positives = 108/349 (30%), Gaps = 77/349 (22%)

Query: 77  STLKSLYLHSNSLS---GRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGL 133
            ++K + L  N++     R  S       +L+      + F G +   I  A +L    L
Sbjct: 32  DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF-SDIFTGRVKDEIPEALRLLLQAL 90

Query: 134 QKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSS-LSNCKYLEYFSFSNNPLG 192
            K                L  + L+DN    +      L   LS    LE+    NN LG
Sbjct: 91  LKCP-------------KLHTVRLSDNAFGPTA--QEPLIDFLSKHTPLEHLYLHNNGLG 135

Query: 193 GILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEG----SIPD 248
              P+A   +++++++           +           L+ +    N+LE         
Sbjct: 136 ---PQAGAKIARALQE-----------LAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK 181

Query: 249 DLCRLAALFQLDLGGNKLS--GFVPACSGNL---TNLRKLYLGSNLLT-----SIPSTLW 298
                  L  + +  N +   G        L     L+ L L  N  T     ++   L 
Sbjct: 182 TFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK 241

Query: 299 NLKDILHLNLSSNFFTGPLPLKIGN--LNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFL 356
           +  ++  L L+           +       +V     + N              LQ L L
Sbjct: 242 SWPNLRELGLNDC--------LLSARGAAAVVDAFSKLENIG------------LQTLRL 281

Query: 357 EYNRLQGSIPNSIGDLI-----SLKSLNLSNNNLS--GTIPISLEKLLD 398
           +YN ++     ++  +I      L  L L+ N  S    +   + ++  
Sbjct: 282 QYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFS 330

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 54.3 bits (131), Expect = 8e-08
 Identities = 49/328 (14%), Positives = 103/328 (31%), Gaps = 58/328 (17%)

Query: 13  ILSQLGNPSSLQTLYLSYNP--PSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVP 70
           + + L    S++ + LS N      +     L E      +L   E+      +V   +P
Sbjct: 24  VFAVLLEDDSVKEIVLSGNTIGTEAAR---WLSENIASKKDLEIAEFSDIFTGRVKDEIP 80

Query: 71  TTIFNVS-------TLKSLYLHSNSLS---GRLPSSADVRLPNLKELHLWGNNF------ 114
             +  +         L ++ L  N+              +   L+ L+L  N        
Sbjct: 81  EALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGA 140

Query: 115 -------IGTIPSFIFNASKLSELGLQKNSFSG----SIPNTFGNLRNLKWLGLNDNYLT 163
                     +     NA  L  +   +N            TF + R L  + +  N + 
Sbjct: 141 KIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIR 200

Query: 164 SSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNL---SQSMEDFWMDNCNISG-- 218
               E   L  L+ C+ L+     +N    +   A+        ++ +  +++C +S   
Sbjct: 201 PEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARG 260

Query: 219 --SIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGN 276
             ++ +  + L N+ LQ L L+ N++E                      L          
Sbjct: 261 AAAVVDAFSKLENIGLQTLRLQYNEIE----------------LDAVRTLKT---VIDEK 301

Query: 277 LTNLRKLYLGSNLLTSIPSTLWNLKDIL 304
           + +L  L L  N  +     +  ++++ 
Sbjct: 302 MPDLLFLELNGNRFSEEDDVVDEIREVF 329

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 53.6 bits (129), Expect = 2e-07
 Identities = 47/302 (15%), Positives = 100/302 (33%), Gaps = 55/302 (18%)

Query: 150 RNLKWLGLNDNYLTSSTPELSSLSS-LSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMED 208
            +++   L  + +T+   +  S+ + L     ++    S N +G    R +     S   
Sbjct: 4   FSIEGKSLKLDAITTE--DEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIAS--- 58

Query: 209 FWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKL-- 266
                 ++      EI   +++    +  E  +    +   L +   L  + L  N    
Sbjct: 59  ----KKDL------EIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGP 108

Query: 267 ---SGFVPACSGNLTNLRKLYLGSNLLT--------------SIPSTLWNLKDILHLNLS 309
                 +   S + T L  LYL +N L               ++     N   +  +   
Sbjct: 109 TAQEPLIDFLSKH-TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICG 167

Query: 310 SNFFTGP----LPLKIGNLNVLVQLDLSMNNFSCV-IPTKIG-GLKD---LQYLFLEYNR 360
            N               +  +L  + +  N      I   +  GL     L+ L L+ N 
Sbjct: 168 RNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNT 227

Query: 361 L--QG--SIPNSIGDLISLKSLNLSNNNLS--GTIPIS--LEKL--LDLKDINVSFNRLE 410
               G  ++  ++    +L+ L L++  LS  G   +     KL  + L+ + + +N +E
Sbjct: 228 FTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 287

Query: 411 GE 412
            +
Sbjct: 288 LD 289

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 62.6 bits (153), Expect = 1e-10
 Identities = 51/192 (26%), Positives = 81/192 (42%), Gaps = 26/192 (13%)

Query: 508 FQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNL-QYGGAFKSFDI----ECGM 557
             AT+R+     IG G +G VYK      G  VA+K   +   GG      I    E  +
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64

Query: 558 MKRIR---HRN---LIKIISSCSNDDFKA--LVLEYMPLGSLEKCLYSGNYI-LDIFQGL 608
           ++R+    H N   L+ + ++   D      LV E++    L   L       L      
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123

Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQT 668
           ++M      L++LH   +  I+H DLKP N+L+       L+DFG+A+        +  T
Sbjct: 124 DLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIY---SYQMALT 177

Query: 669 QTLATIGYMAPD 680
             + T+ Y AP+
Sbjct: 178 PVVVTLWYRAPE 189

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 62.4 bits (152), Expect = 1e-10
 Identities = 33/158 (20%), Positives = 59/158 (37%), Gaps = 21/158 (13%)

Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNL 566
             +     IG G FG +++     +  +VAIK    +          E    K +     
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 67

Query: 567 I-KIISSCSNDDFKALVLEYMPLG-SLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFG 624
           I  +           LV++   LG SLE  L        +         + + ++ +H  
Sbjct: 68  IPNVYYFGQEGLHNVLVIDL--LGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH-- 123

Query: 625 YSVPIIHCDLKPSNVLL------DDNMVAHLSDFGMAK 656
               +++ D+KP N L+      + NM+ ++ DFGM K
Sbjct: 124 -EKSLVYRDIKPDNFLIGRPNSKNANMI-YVVDFGMVK 159

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 62.2 bits (150), Expect = 2e-10
 Identities = 43/257 (16%), Positives = 76/257 (29%), Gaps = 68/257 (26%)

Query: 498 DQRRFTYLELFQATNRFSENNLIGRGGFGPVYK---DGMEVAIKV--------FNLQYGG 546
            Q+          T +      IG G FG V++   D   VAIK+         N  +  
Sbjct: 6   SQKGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQK 65

Query: 547 AFKSFDIECGMMKRI---------RHRNLIKIISSC------------------------ 573
            F+    E  + K +         R    I + S                          
Sbjct: 66  TFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSA 125

Query: 574 ------SNDDFKALVLEYMPLG-SLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
                   DD   +VLE+   G  LE+       +  +    +I+  + ++L        
Sbjct: 126 NDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEASLR 182

Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL---------LEEDQSLTQTQTLATIGYM 677
               H DL   NVLL    +  L      K              D +L++ +    + + 
Sbjct: 183 --FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFC 240

Query: 678 ---APDEIFSGEMRLKC 691
                +++F+G+   + 
Sbjct: 241 DVSMDEDLFTGDGDYQF 257

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 60.3 bits (147), Expect = 6e-10
 Identities = 44/187 (23%), Positives = 78/187 (41%), Gaps = 31/187 (16%)

Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNL-QYGGAFKSFDI-ECGMMKRIRHR 564
           +R+     +G G +G VYK         VAIK   L           I E  ++K ++HR
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93

Query: 565 NLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLN------IMIDVASAL 618
           N+I++ S   ++    L+ EY     L+K        +D    ++       +  + + +
Sbjct: 94  NIIELKSVIHHNHRLHLIFEYAEN-DLKK-------YMDKNPDVSMRVIKSFLYQLINGV 145

Query: 619 EYLHFGYSVPIIHCDLKPSNVLLDDNMVAH-----LSDFGMAKPLLEEDQSLTQTQTLAT 673
            + H   S   +H DLKP N+LL  +  +      + DFG+A+      +    T  + T
Sbjct: 146 NFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF--THEIIT 200

Query: 674 IGYMAPD 680
           + Y  P+
Sbjct: 201 LWYRPPE 207

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 60.6 bits (147), Expect = 7e-10
 Identities = 34/171 (19%), Positives = 60/171 (35%), Gaps = 43/171 (25%)

Query: 519 LIGRGGFGPVY----------KDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIK 568
            IG+GGFG +Y                 +KV     G  F     E    +R      I+
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLF----TELKFYQRAAKPEQIQ 97

Query: 569 IISS-------------------CSNDDFKALVLEYMPLG-SLEKCLYSGNYILDIFQGL 608
                                   +   ++ ++++    G  L+K   +          L
Sbjct: 98  KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDR--FGSDLQKIYEANAKRFSRKTVL 155

Query: 609 NIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAK 656
            + + +   LEY+H       +H D+K SN+LL   + + V +L D+G+A 
Sbjct: 156 QLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQV-YLVDYGLAY 202

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 60.3 bits (146), Expect = 7e-10
 Identities = 42/241 (17%), Positives = 82/241 (34%), Gaps = 75/241 (31%)

Query: 520 IGRGGFGPVYK----------DGMEVAIKVFNLQYG-GAFKSFDIECGMMKRI-RHRNLI 567
           +GRG FG V +              VA+K+          ++   E  ++  I  H N++
Sbjct: 30  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89

Query: 568 KIISSCSNDDFKALV-LEYMPLGSLEKCL----------------------YSGNYILDI 604
            ++ +C+      +V +E+   G+L   L                      Y G   +D+
Sbjct: 90  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL 149

Query: 605 FQGLNIMI------------------------------DVASALEYLHFGYSV------- 627
            + L+ +                               D  +    + + + V       
Sbjct: 150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL 209

Query: 628 ---PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS 684
                IH DL   N+LL +  V  + DFG+A+ + ++   + +      + +MAP+ IF 
Sbjct: 210 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 269

Query: 685 G 685
            
Sbjct: 270 R 270

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 58.1 bits (141), Expect = 8e-10
 Identities = 34/109 (31%), Positives = 53/109 (48%), Gaps = 6/109 (5%)

Query: 278 TNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKI-GNLNVLVQLDLSMNN 336
            ++ +LYL  N  T +P  L N K +  ++LS+N  +  L  +   N+  L+ L LS N 
Sbjct: 31  RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNR 89

Query: 337 FSCVIPTKI-GGLKDLQYLFLEYNRLQGSIPNSIGD-LISLKSLNLSNN 383
             C IP +   GLK L+ L L  N +   +P    + L +L  L +  N
Sbjct: 90  LRC-IPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 57.3 bits (139), Expect = 1e-09
 Identities = 25/101 (24%), Positives = 47/101 (46%), Gaps = 5/101 (4%)

Query: 213 NCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLC-RLAALFQLDLGGNKLSGFVP 271
           + N    +P+E++N  +L   L+ L  N++  ++ +     +  L  L L  N+L    P
Sbjct: 39  DGNQFTLVPKELSNYKHL--TLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRCIPP 95

Query: 272 ACSGNLTNLRKLYLGSNLLTSIP-STLWNLKDILHLNLSSN 311
                L +LR L L  N ++ +P     +L  + HL + +N
Sbjct: 96  RTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 55.0 bits (133), Expect = 9e-09
 Identities = 28/97 (28%), Positives = 40/97 (41%), Gaps = 12/97 (12%)

Query: 219 SIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLT 278
            +P+ I          L L+GNQ    +P +L     L  +DL  N++S        N+T
Sbjct: 24  VLPKGIPRDV----TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMT 78

Query: 279 NLRKLYLGSNLLTSIPS----TLWNLKDILHLNLSSN 311
            L  L L  N L  IP      L +L+    L+L  N
Sbjct: 79  QLLTLILSYNRLRCIPPRTFDGLKSLR---LLSLHGN 112

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 50.8 bits (122), Expect = 3e-07
 Identities = 32/119 (26%), Positives = 51/119 (42%), Gaps = 14/119 (11%)

Query: 20  PSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIF-NVST 78
           P  +  LYL  N             +P E+ N  ++  +  S N++   +    F N++ 
Sbjct: 30  PRDVTELYLDGNQ---------FTLVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQ 79

Query: 79  LKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIF-NASKLSELGLQKN 136
           L +L L  N L   +P      L +L+ L L GN+ I  +P   F + S LS L +  N
Sbjct: 80  LLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGND-ISVVPEGAFNDLSALSHLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 50.0 bits (120), Expect = 4e-07
 Identities = 31/127 (24%), Positives = 49/127 (38%), Gaps = 16/127 (12%)

Query: 36  SIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPS 95
            +P      IP ++  L+         N+   +VP  + N   L  + L +N +S  L +
Sbjct: 24  VLPK----GIPRDVTELY------LDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSN 71

Query: 96  SADVRLPNLKELHLWGNNFIGTIPSFIFNA-SKLSELGLQKNSFSGSIPN-TFGNLRNLK 153
            +   +  L  L L  N  +  IP   F+    L  L L  N  S  +P   F +L  L 
Sbjct: 72  QSFSNMTQLLTLILSYNR-LRCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALS 129

Query: 154 WLGLNDN 160
            L +  N
Sbjct: 130 HLAIGAN 136

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 40.7 bits (96), Expect = 7e-04
 Identities = 29/106 (27%), Positives = 40/106 (37%), Gaps = 20/106 (18%)

Query: 105 KELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTS 164
            EL+L GN F   +P  + N   L+ + L  N  S     +F N+  L  L L+ N L  
Sbjct: 34  TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC 92

Query: 165 STP----ELSSLSSLS---------------NCKYLEYFSFSNNPL 191
             P     L SL  LS               +   L + +   NPL
Sbjct: 93  IPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPL 138

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 57.3 bits (139), Expect = 1e-09
 Identities = 41/124 (33%), Positives = 55/124 (44%), Gaps = 12/124 (9%)

Query: 69  VPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNA-SK 127
           VPT I   S+   L L SN L   LP     +L  L +L L  N  I ++P  +F+  +K
Sbjct: 22  VPTGIP--SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQ-IQSLPDGVFDKLTK 77

Query: 128 LSELGLQKNSFSGSIPN-TFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSF 186
           L+ L L +N    S+PN  F  L  LK L L+ N L  S P+            L+    
Sbjct: 78  LTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLK-SVPD----GIFDRLTSLQKIWL 131

Query: 187 SNNP 190
             NP
Sbjct: 132 HTNP 135

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 51.1 bits (123), Expect = 1e-07
 Identities = 30/87 (34%), Positives = 44/87 (50%), Gaps = 5/87 (5%)

Query: 227 LTNLILQLLSLEGNQLEGSIPDDLC-RLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYL 285
           LT L    LSL  NQ++ S+PD +  +L  L  L L  NKL          LT L++L L
Sbjct: 51  LTQL--TKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQSLPNGVFDKLTQLKELAL 107

Query: 286 GSNLLTSIPSTLW-NLKDILHLNLSSN 311
            +N L S+P  ++  L  +  + L +N
Sbjct: 108 DTNQLKSVPDGIFDRLTSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 50.3 bits (121), Expect = 3e-07
 Identities = 27/94 (28%), Positives = 41/94 (43%), Gaps = 5/94 (5%)

Query: 219 SIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLT 278
           S+P  I +        L LE N+L+        +L  L +L L  N++          LT
Sbjct: 21  SVPTGIPSSA----TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLT 76

Query: 279 NLRKLYLGSNLLTSIPSTLW-NLKDILHLNLSSN 311
            L  LYL  N L S+P+ ++  L  +  L L +N
Sbjct: 77  KLTILYLHENKLQSLPNGVFDKLTQLKELALDTN 110

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 48.4 bits (116), Expect = 1e-06
 Identities = 36/131 (27%), Positives = 50/131 (38%), Gaps = 35/131 (26%)

Query: 259 LDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPS----TLWNLKDILHLNLSSNFFT 314
           L+L  NKL          LT L KL L  N + S+P      L  L     L L  N   
Sbjct: 33  LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLT---ILYLHEN--- 86

Query: 315 GPLPLKIGNLNVLVQLDLSMNNFSCVIPTKI-GGLKDLQYLFLEYNRLQGSIPNSIGD-L 372
                         +L          +P  +   L  L+ L L+ N+L+ S+P+ I D L
Sbjct: 87  --------------KLQ--------SLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRL 123

Query: 373 ISLKSLNLSNN 383
            SL+ + L  N
Sbjct: 124 TSLQKIWLHTN 134

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 44.9 bits (107), Expect = 2e-05
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 6/96 (6%)

Query: 330 LDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGD-LISLKSLNLSNNNLSGT 388
           L+L  N    +       L  L  L L  N++Q S+P+ + D L  L  L L  N L  +
Sbjct: 33  LELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHENKLQ-S 90

Query: 389 IPISL-EKLLDLKDINVSFNRLEGEIPREGPFRNLS 423
           +P  + +KL  LK++ +  N+L+  +P  G F  L+
Sbjct: 91  LPNGVFDKLTQLKELALDTNQLKS-VPD-GIFDRLT 124

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 40.7 bits (96), Expect = 5e-04
 Identities = 36/146 (24%), Positives = 57/146 (39%), Gaps = 39/146 (26%)

Query: 18  GNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVS 77
           G PSS   L L  N                ++ +L                 P  +F+  
Sbjct: 25  GIPSSATRLELESN----------------KLQSL-----------------PHGVFDKL 51

Query: 78  T-LKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIF-NASKLSELGLQK 135
           T L  L L  N +   LP     +L  L  L+L   N + ++P+ +F   ++L EL L  
Sbjct: 52  TQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYL-HENKLQSLPNGVFDKLTQLKELALDT 109

Query: 136 NSFSGSIPN-TFGNLRNLKWLGLNDN 160
           N    S+P+  F  L +L+ + L+ N
Sbjct: 110 NQLK-SVPDGIFDRLTSLQKIWLHTN 134

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 60.4 bits (146), Expect = 1e-09
 Identities = 41/156 (26%), Positives = 68/156 (43%), Gaps = 17/156 (10%)

Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNL 566
           N+F     IG G FG +Y         EVAIK+ N++          E  + + ++    
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTG 64

Query: 567 I-KIISSCSNDDFKALVLEYMPLG-SLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFG 624
           I  +       D+  LV++   LG SLE      +  L +   L +   + + +E++H  
Sbjct: 65  IPNVRWFGVEGDYNVLVMDL--LGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH-- 120

Query: 625 YSVPIIHCDLKPSNVLLDDNMVAH---LSDFGMAKP 657
            S   +H D+KP N L+     A+   + DFG+AK 
Sbjct: 121 -SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 37/131 (28%), Positives = 59/131 (45%), Gaps = 15/131 (11%)

Query: 36  SIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPS 95
           S+P+     IP +   L          N +  +       +++L  LYL  N L   LP+
Sbjct: 21  SVPT----GIPAQTTYLD------LETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPN 69

Query: 96  SADVRLPNLKELHLWGNNFIGTIPSFIFNA-SKLSELGLQKNSFSGSIPN-TFGNLRNLK 153
               +L +L  L+L  N  + ++P+ +F+  ++L EL L  N    S+P+  F  L  LK
Sbjct: 70  GVFNKLTSLTYLNLSTNQ-LQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLK 127

Query: 154 WLGLNDNYLTS 164
            L L  N L S
Sbjct: 128 DLRLYQNQLKS 138

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 53/179 (29%), Positives = 73/179 (40%), Gaps = 41/179 (22%)

Query: 213 NCNISG--SIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFV 270
            C   G  S+P  I   T      L LE N L+         L +L QL LGGNKL    
Sbjct: 13  ECYSQGRTSVPTGIPAQT----TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLP 68

Query: 271 PACSGNLTNLRKLYLGSNLLTSIPS----TLWNLKDILHLNLSSNFFTGPLPLKIGNLNV 326
                 LT+L  L L +N L S+P+     L  LK    L L++N               
Sbjct: 69  NGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLK---ELALNTN--------------- 110

Query: 327 LVQLDLSMNNFSCVIPTKI-GGLKDLQYLFLEYNRLQGSIPNSIGD-LISLKSLNLSNN 383
             QL          +P  +   L  L+ L L  N+L+ S+P+ + D L SL+ + L +N
Sbjct: 111 --QLQ--------SLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 158

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 33/95 (34%), Positives = 49/95 (51%), Gaps = 4/95 (4%)

Query: 329 QLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGD-LISLKSLNLSNNNLSG 387
            LDL  N+   +       L  L  L+L  N+LQ S+PN + + L SL  LNLS N L  
Sbjct: 32  YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQS 90

Query: 388 TIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNL 422
                 +KL  LK++ ++ N+L+  +P +G F  L
Sbjct: 91  LPNGVFDKLTQLKELALNTNQLQ-SLP-DGVFDKL 123

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 58.6 bits (142), Expect = 3e-09
 Identities = 38/173 (21%), Positives = 70/173 (40%), Gaps = 36/173 (20%)

Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNL 566
           N++     IG GGFG +Y         + A  V  ++Y         E    +R+  ++ 
Sbjct: 37  NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN-GPLFSELKFYQRVAKKDC 95

Query: 567 IKI-------------------ISSCSNDDFKALVLEYMPLG-SLEKCLYSGNYILDIFQ 606
           IK                    ++      ++ +V+E   LG  L+K +   N       
Sbjct: 96  IKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMER--LGIDLQK-ISGQNGTFKKST 152

Query: 607 GLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAK 656
            L + I +   LEY+H       +H D+K +N+LL   + + V +L+D+G++ 
Sbjct: 153 VLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQV-YLADYGLSY 201

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 55.5 bits (134), Expect = 4e-09
 Identities = 24/117 (20%), Positives = 44/117 (37%), Gaps = 6/117 (5%)

Query: 75  NVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQ 134
             + ++ L L +   +            NL+ L L     + ++ +      KL +L L 
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVG-LISVSNLPKL-PKLKKLELS 79

Query: 135 KNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPL 191
           +N   G +      L NL  L L+ N L     ++S+L  L   + L+     N  +
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLK----DISTLEPLKKLECLKSLDLFNCEV 132

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 50.5 bits (121), Expect = 2e-07
 Identities = 36/133 (27%), Positives = 50/133 (37%), Gaps = 25/133 (18%)

Query: 252 RLAALFQLDLGGNKLS-GFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSS 310
             AA+ +L L   K + G +   +    NL  L L +  L S+ S L  L  +  L LS 
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSE 80

Query: 311 NFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIG 370
           N   G L +    L  L  L+LS N         +  +  L+ L                
Sbjct: 81  NRIFGGLDMLAEKLPNLTHLNLSGNK--------LKDISTLEPL---------------K 117

Query: 371 DLISLKSLNLSNN 383
            L  LKSL+L N 
Sbjct: 118 KLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 49.4 bits (118), Expect = 5e-07
 Identities = 28/111 (25%), Positives = 50/111 (45%), Gaps = 7/111 (6%)

Query: 204 QSMEDFWMDNCNISGSIPEEINNLTNLI-LQLLSLEGNQLEGSIPDDLCRLAALFQLDLG 262
            ++ +  +DNC  +    +        + L+ LSL    L  S+  +L +L  L +L+L 
Sbjct: 24  AAVRELVLDNCKSN--DGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELS 79

Query: 263 GNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPS--TLWNLKDILHLNLSSN 311
            N++ G +   +  L NL  L L  N L  I +   L  L+ +  L+L + 
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 44.0 bits (104), Expect = 3e-05
 Identities = 31/137 (22%), Positives = 52/137 (37%), Gaps = 15/137 (10%)

Query: 319 LKIGNLNVLVQLDLSMNNFS-CVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKS 377
           L+      + +L L     +   I        +L++L L    L  S+ N +  L  LK 
Sbjct: 18  LRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKK 75

Query: 378 LNLSNNNLSGTIPISLEKLLDLKDINVSFNRLE--GEIPREGPFRNLSAESFKGNEL--- 432
           L LS N + G + +  EKL +L  +N+S N+L+    +        L +      E+   
Sbjct: 76  LELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNL 135

Query: 433 -------LCGMPNLQVL 442
                     +P L  L
Sbjct: 136 NDYRESVFKLLPQLTYL 152

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 40.9 bits (96), Expect = 4e-04
 Identities = 26/111 (23%), Positives = 40/111 (36%), Gaps = 4/111 (3%)

Query: 299 NLKDILHLNLSSNFFTGPLPLKIG-NLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLE 357
               +  L L +          +      L  L L       V  + +  L  L+ L L 
Sbjct: 22  TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELS 79

Query: 358 YNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPIS-LEKLLDLKDINVSFN 407
            NR+ G +      L +L  LNLS N L     +  L+KL  LK +++   
Sbjct: 80  ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 58.2 bits (141), Expect = 5e-09
 Identities = 50/331 (15%), Positives = 109/331 (32%), Gaps = 51/331 (15%)

Query: 148 NLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGI----LPRAIGNLS 203
               +  L L+ N L S +      +  +    +   + S N LG      L + +  + 
Sbjct: 20  IPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIP 79

Query: 204 QSMEDFWMDNCNISGSIPEEINNL---TNLILQLLSLEGNQLEGSIPDDLCRL-----AA 255
            ++    +    +S    +E+          + +L L  N        +  +      A+
Sbjct: 80  ANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPAS 139

Query: 256 LFQLDLGGNKLS-----GFVPACSGNLTNLRKLYLGSN------------LLTSIPSTLW 298
           +  L+L GN L        +   +    N+  L L  N             L SIP+++ 
Sbjct: 140 ITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASV- 198

Query: 299 NLKDILHLNLSSNFFTGPLPLKIG-----NLNVLVQLDLSMNNFSCVIPTKIGGLKD--- 350
                  L+LS+N        ++        N +V L+L +N         +  LKD   
Sbjct: 199 -----TSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLK 253

Query: 351 -LQYLFLEYNRLQG-------SIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDI 402
            LQ ++L+Y+ ++        ++  +  ++  +  ++ +   +  +  I +  L+     
Sbjct: 254 HLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISNLIRELSG 313

Query: 403 NVSFNRLEGEIPREGPFRNLSAESFKGNELL 433
                 L  +          + E     + L
Sbjct: 314 KADVPSLLNQCLIFAQKHQTNIEDLNIPDEL 344

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 48.5 bits (116), Expect = 4e-06
 Identities = 51/296 (17%), Positives = 96/296 (32%), Gaps = 54/296 (18%)

Query: 77  STLKSLYLHSNSLSGR----LPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELG 132
             + SL L  N+L       L  +      ++  L+L GN+ +G       N+ +L +  
Sbjct: 22  HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNS-LGFK-----NSDELVQ-I 74

Query: 133 LQKNSFSGSIPNTFGNLRNLKWLGLNDNYLT-SSTPELSSLSSLSNCKYLEYFSFSNNPL 191
           L                 N+  L L+ N+L+  S+ EL    +      +       N  
Sbjct: 75  LAAIP------------ANVTSLNLSGNFLSYKSSDELVKTLAAIPFT-ITVLDLGWNDF 121

Query: 192 GG----ILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNL---TNLILQLLSLEGNQLEG 244
                    +A  NL  S+    +   ++     +E+  +       +  L+L GN L  
Sbjct: 122 SSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLAS 181

Query: 245 SIPDDLCRL-----AALFQLDLGGNKL-----SGFVPACSGNLTNLRKLYLGSNLLTS-- 292
               +L +      A++  LDL  N L     +      S    ++  L L  N L    
Sbjct: 182 KNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPS 241

Query: 293 ---IPSTLWNLKDILHLNLSSNFFT--GPLPLK-----IGNLNVLVQLDLSMNNFS 338
              +     +LK +  + L  +          K       N+  ++ +D +     
Sbjct: 242 LENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH 297

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 26/190 (13%), Positives = 60/190 (31%), Gaps = 24/190 (12%)

Query: 77  STLKSLYLHSNSLSGR----LPSSADVRLPNLKELHLWGNNFIGT------IPSFIFNAS 126
           + + SL L  N+L+ +    L         ++  L L   N +G          F    +
Sbjct: 167 ANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDL-SANLLGLKSYAELAYIFSSIPN 225

Query: 127 KLSELGLQKNSFSGS----IPNTFGNLRNLKWLGLNDNYLTSSTPEL--SSLSSLSNCKY 180
            +  L L  N   G     +     +L++L+ + L+ + + + + E   +  ++  N + 
Sbjct: 226 HVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQK 285

Query: 181 LEYFSFSNNPLGG----ILPRAIGNLSQSMEDFWMDNCNI---SGSIPEEINNLTNLILQ 233
           +     +   +       +   I  LS   +   + N  +           +      L+
Sbjct: 286 IILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELR 345

Query: 234 LLSLEGNQLE 243
                   L 
Sbjct: 346 ESIQTCKPLL 355

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 55.4 bits (134), Expect = 6e-09
 Identities = 25/112 (22%), Positives = 37/112 (33%), Gaps = 9/112 (8%)

Query: 276 NLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGN---LNVLVQLDL 332
           N    R+L L    +  I +    L     ++ S N        K+     L  L  L +
Sbjct: 17  NAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR-----KLDGFPLLRRLKTLLV 71

Query: 333 SMNNFSCVIPTKIGGLKDLQYLFLEYNRLQG-SIPNSIGDLISLKSLNLSNN 383
           + N    +       L DL  L L  N L      + +  L SL  L +  N
Sbjct: 72  NNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 51.6 bits (124), Expect = 1e-07
 Identities = 27/128 (21%), Positives = 41/128 (32%), Gaps = 13/128 (10%)

Query: 285 LGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNV----LVQLDLSMNNFSCV 340
           L + L+        N      L+L            I NL         +D S N    +
Sbjct: 4   LTAELIEQAAQ-YTNAVRDRELDLRGYKIP-----VIENLGATLDQFDAIDFSDNEIRKL 57

Query: 341 IPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPIS-LEKLLDL 399
                  L+ L+ L +  NR+          L  L  L L+NN+L     +  L  L  L
Sbjct: 58  --DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSL 115

Query: 400 KDINVSFN 407
             + +  N
Sbjct: 116 TYLCILRN 123

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 50.4 bits (121), Expect = 2e-07
 Identities = 25/117 (21%), Positives = 39/117 (33%), Gaps = 8/117 (6%)

Query: 75  NVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQ 134
           N    + L L    +   +  +    L     +    +N I  +  F     +L  L + 
Sbjct: 17  NAVRDRELDLRGYKIP--VIENLGATLDQFDAIDFS-DNEIRKLDGFPLL-RRLKTLLVN 72

Query: 135 KNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPL 191
            N            L +L  L L +N L     EL  L  L++ K L Y     NP+
Sbjct: 73  NNRICRIGEGLDQALPDLTELILTNNSLV----ELGDLDPLASLKSLTYLCILRNPV 125

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 47.0 bits (112), Expect = 4e-06
 Identities = 21/94 (22%), Positives = 37/94 (39%), Gaps = 6/94 (6%)

Query: 222 EEINNLTNLILQL--LSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTN 279
             I NL   + Q   +    N++   + D    L  L  L +  N++          L +
Sbjct: 32  PVIENLGATLDQFDAIDFSDNEIR-KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89

Query: 280 LRKLYLGSNLLTSIP--STLWNLKDILHLNLSSN 311
           L +L L +N L  +     L +LK + +L +  N
Sbjct: 90  LTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 57.2 bits (139), Expect = 7e-09
 Identities = 45/194 (23%), Positives = 79/194 (40%), Gaps = 34/194 (17%)

Query: 509 QATNRFSENNLIGRGGFGPVYK------DGMEVAIKVFNLQY---GGAFKSFDI----EC 555
           +A  ++     IG G +G V+K       G  VA+K   +Q    G       +    E 
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-----MPLSTIREV 62

Query: 556 GMMKRIR---HRN---LIKIISSCSNDDFKA--LVLEYMPLGSLEKCLYS-GNYILDIFQ 606
            +++ +    H N   L  + +    D      LV E++    L   L       +    
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTET 121

Query: 607 GLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT 666
             ++M  +   L++LH   S  ++H DLKP N+L+  +    L+DFG+A+        + 
Sbjct: 122 IKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMA 175

Query: 667 QTQTLATIGYMAPD 680
            T  + T+ Y AP+
Sbjct: 176 LTSVVVTLWYRAPE 189

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 52.8 bits (127), Expect = 2e-08
 Identities = 24/117 (20%), Positives = 44/117 (37%), Gaps = 6/117 (5%)

Query: 75  NVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQ 134
             S +K L L ++  +             L+ L       + +I + +   +KL +L L 
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVG-LTSI-ANLPKLNKLKKLELS 72

Query: 135 KNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPL 191
            N  SG +        NL  L L+ N +     +LS++  L   + L+     N  +
Sbjct: 73  DNRVSGGLEVLAEKCPNLTHLNLSGNKIK----DLSTIEPLKKLENLKSLDLFNCEV 125

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 50.4 bits (121), Expect = 1e-07
 Identities = 23/119 (19%), Positives = 40/119 (33%), Gaps = 12/119 (10%)

Query: 124 NASKLSELGLQKNSFS-GSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLE 182
             S + EL L  +  + G +         L++L   +  LT       S+++L     L+
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-------SIANLPKLNKLK 67

Query: 183 YFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLI-LQLLSLEGN 240
               S+N + G L         ++    +    I       I  L  L  L+ L L   
Sbjct: 68  KLELSDNRVSGGLEVLAEKC-PNLTHLNLSGNKIKD--LSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 49.7 bits (119), Expect = 3e-07
 Identities = 25/103 (24%), Positives = 44/103 (42%), Gaps = 7/103 (6%)

Query: 212 DNCNISGSIPEEINNLTNLI-LQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFV 270
           DN   +    +          L+ LS     L  SI  +L +L  L +L+L  N++SG +
Sbjct: 25  DNSRSN--EGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSGGL 80

Query: 271 PACSGNLTNLRKLYLGSNLLTSIPS--TLWNLKDILHLNLSSN 311
              +    NL  L L  N +  + +   L  L+++  L+L + 
Sbjct: 81  EVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 47.7 bits (114), Expect = 2e-06
 Identities = 33/133 (24%), Positives = 51/133 (38%), Gaps = 25/133 (18%)

Query: 252 RLAALFQLDLGGNKLS-GFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSS 310
             + + +L L  ++ + G +   +     L  L   +  LTSI + L  L  +  L LS 
Sbjct: 15  TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSD 73

Query: 311 NFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIG 370
           N  +G L +       L  L+LS N        KI  L  ++ L                
Sbjct: 74  NRVSGGLEVLAEKCPNLTHLNLSGN--------KIKDLSTIEPL---------------K 110

Query: 371 DLISLKSLNLSNN 383
            L +LKSL+L N 
Sbjct: 111 KLENLKSLDLFNC 123

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 44.7 bits (106), Expect = 1e-05
 Identities = 31/137 (22%), Positives = 56/137 (40%), Gaps = 15/137 (10%)

Query: 319 LKIGNLNVLVQLDLSMNNFSCV-IPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKS 377
           L+    + + +L L  +  +   +       ++L++L      L  SI N +  L  LK 
Sbjct: 11  LRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKK 68

Query: 378 LNLSNNNLSGTIPISLEKLLDLKDINVSFNRLE--GEIPREGPFRNLSAESFKGNE---- 431
           L LS+N +SG + +  EK  +L  +N+S N+++    I       NL +      E    
Sbjct: 69  LELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNL 128

Query: 432 ------LLCGMPNLQVL 442
                 +   +P L  L
Sbjct: 129 NDYRENVFKLLPQLTYL 145

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 26/110 (23%), Positives = 45/110 (40%), Gaps = 5/110 (4%)

Query: 299 NLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEY 358
           ++K+++  N  SN   G L         L  L       + +    +  L  L+ L L  
Sbjct: 18  DVKELVLDNSRSN--EGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSD 73

Query: 359 NRLQGSIPNSIGDLISLKSLNLSNNNLSG-TIPISLEKLLDLKDINVSFN 407
           NR+ G +        +L  LNLS N +   +    L+KL +LK +++   
Sbjct: 74  NRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 53.5 bits (129), Expect = 3e-08
 Identities = 24/89 (26%), Positives = 39/89 (43%), Gaps = 5/89 (5%)

Query: 225 NNLTNLILQLLSLEGNQLEGSIPDDLC-RLAALFQLDLGGNKLSGFVPACSGNLTNLRKL 283
             L +L    L L+ NQL   I  +     + + +L LG NK+          L  L+ L
Sbjct: 51  GRLPHL--VKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTL 107

Query: 284 YLGSNLLTSIP-STLWNLKDILHLNLSSN 311
            L  N ++ +   +  +L  +  LNL+SN
Sbjct: 108 NLYDNQISCVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 50.4 bits (121), Expect = 4e-07
 Identities = 39/168 (23%), Positives = 60/168 (35%), Gaps = 56/168 (33%)

Query: 219 SIPEEINNLTNLILQLLSLEGNQLEGSIPDD--LCRLAALFQLDLGGNKLSGFVPACSGN 276
            IP +I   T      L L  N+L   I  D    RL  L +L+L  N+L+G  P     
Sbjct: 22  EIPRDIPLHT----TELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEG 76

Query: 277 LTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNN 336
            +++++L LG N +  I + +               F G                     
Sbjct: 77  ASHIQELQLGENKIKEISNKM---------------FLG--------------------- 100

Query: 337 FSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGD-LISLKSLNLSNN 383
                      L  L+ L L  N++   +     + L SL SLNL++N
Sbjct: 101 -----------LHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 48.1 bits (115), Expect = 2e-06
 Identities = 30/103 (29%), Positives = 45/103 (43%), Gaps = 6/103 (5%)

Query: 290 LTSIPSTLWNLKDILHLNLSSNFFTGPLPLKI-GNLNVLVQLDLSMNNFSCVIPTKIGGL 348
           L  IP  +      L LN   N         + G L  LV+L+L  N  + + P    G 
Sbjct: 20  LKEIPRDIPLHTTELLLN--DNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGA 77

Query: 349 KDLQYLFLEYNRLQGSIPNSIGD-LISLKSLNLSNNNLSGTIP 390
             +Q L L  N+++  I N +   L  LK+LNL +N +S  + 
Sbjct: 78  SHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVM 118

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 28/154 (18%), Positives = 51/154 (33%), Gaps = 38/154 (24%)

Query: 69  VPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKL 128
           +P  I        L L+ N L          RLP+L +L L   N +  I          
Sbjct: 23  IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLEL-KRNQLTGIE--------- 70

Query: 129 SELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSN 188
                         PN F    +++ L L +N +            L   K L   +  +
Sbjct: 71  --------------PNAFEGASHIQELQLGENKIK-EISN-KMFLGLHQLKTL---NLYD 111

Query: 189 NPLGGILPRAIGNLSQSMEDFWMDN------CNI 216
           N +  ++P +  +L+ S+    + +      C++
Sbjct: 112 NQISCVMPGSFEHLN-SLTSLNLASNPFNCNCHL 144

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 54.6 bits (132), Expect = 5e-08
 Identities = 37/168 (22%), Positives = 70/168 (41%), Gaps = 41/168 (24%)

Query: 508 FQATNRFSENNLIGRGGFGPVY-----KDGMEVAIKVFNLQYGGAFKSFDI--ECGMMKR 560
           +   + +     +GRG +  V+      +  +V +K+         K   I  E  +++ 
Sbjct: 32  WGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP-----VKKKKIKREIKILEN 86

Query: 561 IR-HRNLIKII----SSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVA 615
           +R   N+I +        S     ALV E++     ++          ++Q L    D+ 
Sbjct: 87  LRGGPNIITLADIVKDPVSRTP--ALVFEHVNNTDFKQ----------LYQTLTDY-DIR 133

Query: 616 S-------ALEYLHFGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMA 655
                   AL+Y H   S+ I+H D+KP NV++D ++    L D+G+A
Sbjct: 134 FYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA 178

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 54.0 bits (130), Expect = 1e-07
 Identities = 39/166 (23%), Positives = 68/166 (40%), Gaps = 33/166 (19%)

Query: 511 TNRFSENNLIGRGGFGPVYK-----DGMEVAIKVF--NLQYGGAFKSFDIECGMMKRIRH 563
             R+    +IG+G FG V K         VA+K+     ++    +    E  +++ +R 
Sbjct: 96  AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRF---HRQAAEEIRILEHLRK 152

Query: 564 R---NLIKIISSCSNDDFKA---LVLEYMPLGSLEKCLYSGNYILDIFQGLN------IM 611
           +   N + +I    N  F+    +  E + + +L + +         FQG +        
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKKNK-----FQGFSLPLVRKFA 206

Query: 612 IDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAH--LSDFGMA 655
             +   L+ LH      IIHCDLKP N+LL     +   + DFG +
Sbjct: 207 HSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 52.4 bits (126), Expect = 3e-07
 Identities = 37/172 (21%), Positives = 65/172 (37%), Gaps = 47/172 (27%)

Query: 519 LIGRGGFGPVY-----KDGMEVAIKVF--NLQYGGAFKSFDIECGMMKRIRHRNLIKIIS 571
            +G G F  V+      +   VA+K+   +  Y    ++ + E  +++R+   +  K  S
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY---TEAAEDEIKLLQRVNDADNTKEDS 82

Query: 572 SCSN------DDFKA---------LVLEYMPLG-SLEKCLYSGNYILDIFQGLN------ 609
             +N      D F           +V E   LG +L   +          +G+       
Sbjct: 83  MGANHILKLLDHFNHKGPNGVHVVMVFE--VLGENLLALIKKYE-----HRGIPLIYVKQ 135

Query: 610 IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAH------LSDFGMA 655
           I   +   L+Y+H      IIH D+KP NVL++            ++D G A
Sbjct: 136 ISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 49.5 bits (119), Expect = 5e-07
 Identities = 35/102 (34%), Positives = 48/102 (47%), Gaps = 7/102 (6%)

Query: 213 NCNISG--SIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFV 270
           +C+     S+P  I   T    Q+L L  NQ+    P    RL  L +LDL  N+L+   
Sbjct: 15  DCSGKSLASVPTGI--PTTT--QVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLP 70

Query: 271 PACSGNLTNLRKLYLGSNLLTSIPSTLW-NLKDILHLNLSSN 311
                 LT L +L L  N L SIP   + NLK + H+ L +N
Sbjct: 71  AGVFDKLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNN 112

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 40.7 bits (96), Expect = 5e-04
 Identities = 28/85 (32%), Positives = 44/85 (51%), Gaps = 12/85 (14%)

Query: 341 IPTKIGGLKDLQYLFLEYNRLQGSIPNSIGD-LISLKSLNLSNNNLSGTIPISL-EKLLD 398
           IPT        Q L+L  N++   +   + D L  L  L+L NN L+  +P  + +KL  
Sbjct: 28  IPT------TTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQ 79

Query: 399 LKDINVSFNRLEGEIPREGPFRNLS 423
           L  ++++ N+L+  IPR G F NL 
Sbjct: 80  LTQLSLNDNQLKS-IPR-GAFDNLK 102

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 40.7 bits (96), Expect = 5e-04
 Identities = 36/128 (28%), Positives = 48/128 (37%), Gaps = 44/128 (34%)

Query: 69  VPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKL 128
           VPT I   +T + LYL+ N ++ +L      RL  L  L L  N              +L
Sbjct: 24  VPTGIP--TTTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNN--------------QL 66

Query: 129 SELGLQKNSFSGSIPN-TFGNLRNLKWLGLNDNYLTSSTPE-----LSSLSSLSNCKYLE 182
           +            +P   F  L  L  L LNDN L  S P      L SL+ +    +L 
Sbjct: 67  T-----------VLPAGVFDKLTQLTQLSLNDNQLK-SIPRGAFDNLKSLTHI----WLL 110

Query: 183 YFSFSNNP 190
                NNP
Sbjct: 111 -----NNP 113

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 49.6 bits (119), Expect = 5e-07
 Identities = 35/102 (34%), Positives = 44/102 (43%), Gaps = 7/102 (6%)

Query: 213 NCNISG--SIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFV 270
           NC      S+P  I   T+   Q L L  NQ+    P     L  L QL    NKL+   
Sbjct: 18  NCQNIRLASVPAGI--PTDK--QRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIP 73

Query: 271 PACSGNLTNLRKLYLGSNLLTSIPSTLW-NLKDILHLNLSSN 311
                 LT L +L L  N L SIP   + NLK + H+ L +N
Sbjct: 74  TGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNN 115

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 41.5 bits (98), Expect = 3e-04
 Identities = 35/128 (27%), Positives = 51/128 (39%), Gaps = 44/128 (34%)

Query: 69  VPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKL 128
           VP  I   +  + L+L++N ++ +L       L NL++L+   N              KL
Sbjct: 27  VPAGIP--TDKQRLWLNNNQIT-KLEPGVFDHLVNLQQLYFNSN--------------KL 69

Query: 129 SELGLQKNSFSGSIPN-TFGNLRNLKWLGLNDNYLTSSTPE-----LSSLSSLSNCKYLE 182
           +           +IP   F  L  L  L LNDN+L  S P      L SL+ +    YL 
Sbjct: 70  T-----------AIPTGVFDKLTQLTQLDLNDNHLK-SIPRGAFDNLKSLTHI----YL- 112

Query: 183 YFSFSNNP 190
                NNP
Sbjct: 113 ----YNNP 116

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 40.3 bits (95), Expect = 7e-04
 Identities = 28/85 (32%), Positives = 46/85 (54%), Gaps = 12/85 (14%)

Query: 341 IPTKIGGLKDLQYLFLEYNRLQGSIPNSIGD-LISLKSLNLSNNNLSGTIPISL-EKLLD 398
           IPT      D Q L+L  N++   +   + D L++L+ L  ++N L+  IP  + +KL  
Sbjct: 31  IPT------DKQRLWLNNNQIT-KLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQ 82

Query: 399 LKDINVSFNRLEGEIPREGPFRNLS 423
           L  ++++ N L+  IPR G F NL 
Sbjct: 83  LTQLDLNDNHLKS-IPR-GAFDNLK 105

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 50.5 bits (121), Expect = 1e-06
 Identities = 41/171 (23%), Positives = 70/171 (40%), Gaps = 41/171 (23%)

Query: 511 TNRFSENNLIGRGGFGPVYK-----DGMEVAIKVF--NLQYGGAFKSFDIECGMMKRIRH 563
            +R+  ++LIG+G FG V K     +   VAIK+      +        IE  +++ +  
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAF---LNQAQIEVRLLELMNK 109

Query: 564 R------NLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDI-----FQGLN--- 609
                   ++ +       +   LV E      L   LY      D+     F+G++   
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFE-----MLSYNLY------DLLRNTNFRGVSLNL 158

Query: 610 ---IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAH--LSDFGMA 655
                  + +AL +L     + IIHCDLKP N+LL +   +   + DFG +
Sbjct: 159 TRKFAQQMCTALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 40/160 (25%), Positives = 62/160 (38%), Gaps = 46/160 (28%)

Query: 511 TNRFSENNLIGRGGFGPVYK-----DGMEVAIKVF--NLQYGGAFKSFDIECGMMKRIRH 563
            N F     +G G FG V       +    A+KV     +Y    +S  IE  ++K+I++
Sbjct: 34  NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKY---TRSAKIEADILKKIQN 90

Query: 564 R-----NLIKIISSCSNDDFKA---LVLEYMPLGSLEKCLYSGNYILDI-----FQGLN- 609
                 N++K         +     L+ E      L   LY      +I     + G + 
Sbjct: 91  DDINNNNIVKYHGKF---MYYDHMCLIFE-----PLGPSLY------EIITRNNYNGFHI 136

Query: 610 -----IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN 644
                  I++  AL YL     + + H DLKP N+LLDD 
Sbjct: 137 EDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDP 173

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 48.9 bits (117), Expect = 4e-06
 Identities = 30/162 (18%), Positives = 58/162 (35%), Gaps = 48/162 (29%)

Query: 511 TNRFSENNLIGRGGFGPVYK------DGMEVAIKVF--NLQYGGAFKSFDIECGMMKRIR 562
             R+     +G G FG V +         +VA+K+     +Y    ++  +E  ++K+I+
Sbjct: 18  QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKY---REAARLEINVLKKIK 74

Query: 563 HR------NLIKIISSCSNDDFKA---LVLEYMPLGSLEKCLYSGNYILDI-----FQGL 608
            +        + +       +F     +  E      L K  +      +      FQ  
Sbjct: 75  EKDKENKFLCVLMSDWF---NFHGHMCIAFE-----LLGKNTF------EFLKENNFQPY 120

Query: 609 N------IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN 644
                  +   +  AL +LH      + H DLKP N+L  ++
Sbjct: 121 PLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNS 159

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 48.0 bits (114), Expect = 9e-06
 Identities = 48/236 (20%), Positives = 80/236 (33%), Gaps = 38/236 (16%)

Query: 511 TNRFSENNLIGRGGFGPVY--KDGME---VAIKVFNLQYGGAFKSFDIECGMMKRIR--- 562
             R+     +G G F  V+   D      VA+KV         ++   E  ++K +R   
Sbjct: 36  NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT-ETALDEIRLLKSVRNSD 94

Query: 563 --HRNLIKIISSCSNDDFK---------ALVLEYMPLG-SLEKCLYSGNYI---LDIFQG 607
               N   ++     DDFK          +V E   LG  L K +   NY    L   + 
Sbjct: 95  PNDPNREMVVQLL--DDFKISGVNGTHICMVFE--VLGHHLLKWIIKSNYQGLPLPCVKK 150

Query: 608 LNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ 667
             I+  V   L+YLH      IIH D+KP N+LL       +++  + +   E  +    
Sbjct: 151 --IIQQVLQGLDYLH--TKCRIIHTDIKPENILL------SVNEQYIRRLAAEATEWQRS 200

Query: 668 TQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEKHLMTKEQP 723
                +   ++     +G   +      +     + + D        KH     Q 
Sbjct: 201 GAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQT 256

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 47.3 bits (113), Expect = 1e-05
 Identities = 28/162 (17%), Positives = 56/162 (34%), Gaps = 48/162 (29%)

Query: 511 TNRFSENNLIGRGGFGPVYK------DGMEVAIKVF--NLQYGGAFKSFDIECGMMKRIR 562
           + R+   + +G G FG V +       G  VA+K+     +Y    ++   E  +++ + 
Sbjct: 13  SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRY---CEAARSEIQVLEHLN 69

Query: 563 HR------NLIKIISSCSNDDFKA---LVLEYMPLGSLEKCLYSGNYILDI-----FQGL 608
                     ++++      +      +V E      L    Y      D      F   
Sbjct: 70  TTDPNSTFRCVQMLEWF---EHHGHICIVFE-----LLGLSTY------DFIKENGFLPF 115

Query: 609 N------IMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN 644
                  +   +  ++ +LH   S  + H DLKP N+L   +
Sbjct: 116 RLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQS 154

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592

 Score = 47.6 bits (113), Expect = 1e-05
 Identities = 56/352 (15%), Positives = 104/352 (29%), Gaps = 46/352 (13%)

Query: 100 RLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLND 159
           R PNL+ L L G            N        + + S          NLR LK +    
Sbjct: 71  RFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEIS---------NNLRQLKSVHFRR 121

Query: 160 NYLTSSTPELSSLSSLSNCKYLEYFSFSN-NPLGGILPRAIGNLSQSMEDFWMDNCNISG 218
             ++     L  L+  +    LE       +        +I    + ++   M+  + S 
Sbjct: 122 MIVSDLD--LDRLAK-ARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSE 178

Query: 219 SIPEEINNLTNLI--LQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGN 276
              + ++ L      L++L+    +     P DL  +A                     N
Sbjct: 179 KDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIAR--------------------N 218

Query: 277 LTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNN 336
             +L  + +G   +  +        ++      S      +P K  NL    +L      
Sbjct: 219 CRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRL--G 276

Query: 337 FSCV----IPTKIGGLKDLQYLFLEYNRLQG-SIPNSIGDLISLKSLNLSNNNLSGTIPI 391
            S +    +P        ++ L L Y  L+       I    +L+ L   N      + +
Sbjct: 277 LSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEV 336

Query: 392 SLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMPNLQVLS 443
             +    LK + +   R   E   E     +S        L  G   L+ ++
Sbjct: 337 LAQYCKQLKRLRIE--RGADEQGMEDEEGLVSQRGLI--ALAQGCQELEYMA 384

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 46.1 bits (108), Expect = 3e-05
 Identities = 35/200 (17%), Positives = 63/200 (31%), Gaps = 22/200 (11%)

Query: 219 SIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCR-LAALFQLDLGGNKLSGFVPACSGNL 277
              E+  +   L    +  E  ++      DL   L A+  L+    K +  +       
Sbjct: 133 ENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPR 192

Query: 278 TNLRKLYLGSNLLTS------IPSTLWNLKDILHLNLSSNFFTGPLP-------LKIGNL 324
            NL+ L + S  L        + S L NL+  L L +    +                  
Sbjct: 193 PNLKSLEIISGGLPDSVVEDILGSDLPNLEK-LVLYVGVEDYGFDGDMNVFRPLFSKDRF 251

Query: 325 NVLVQLDLSMNNFSCVIPTKIGG---LKDLQYLFLEYNRLQGS----IPNSIGDLISLKS 377
             L  L +       V+         L  L+ + +    L       + + +  +  LK 
Sbjct: 252 PNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKF 311

Query: 378 LNLSNNNLSGTIPISLEKLL 397
           +N+  N LS  +   L+K L
Sbjct: 312 INMKYNYLSDEMKKELQKSL 331

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 46.1 bits (108), Expect = 3e-05
 Identities = 26/191 (13%), Positives = 59/191 (30%), Gaps = 22/191 (11%)

Query: 96  SADVRLPNLKELHLWGNNF---------IGTIPSFIFNASKLSELGLQKNSFSGSIPNTF 146
               +  + + L     +F            +   +     L+ L ++  +         
Sbjct: 133 ENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPR 192

Query: 147 GNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQ-- 204
            NL++L+   +    L  S  E    S L N + L  +    +            L    
Sbjct: 193 PNLKSLE---IISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKD 249

Query: 205 ---SMEDFWMDNCNISGSIPEEINNLTNLI-LQLLSLEGNQL--EG--SIPDDLCRLAAL 256
              +++   + +      + E       L  L+ + +    L  EG   + D + ++  L
Sbjct: 250 RFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHL 309

Query: 257 FQLDLGGNKLS 267
             +++  N LS
Sbjct: 310 KFINMKYNYLS 320

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594

 Score = 42.2 bits (99), Expect = 6e-04
 Identities = 42/319 (13%), Positives = 96/319 (30%), Gaps = 60/319 (18%)

Query: 74  FNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGL 133
           + +       +   +     P++   R P ++ + L G                     +
Sbjct: 38  YEIERWCRRKVFIGNCYAVSPATVIRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWI 97

Query: 134 QKNSFSGSIPNTFGNLR--NLKWLGLNDN---YLTSSTPELSSLSSLSNCKYLEYFSFSN 188
           +      ++ +++  L    LK + + D+    +  S      L  LS+C+      FS 
Sbjct: 98  E------AMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLV-LSSCE-----GFST 145

Query: 189 NPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPD 248
           + L      AI    +++++  +   ++       +++  +    L+SL  + L   +  
Sbjct: 146 DGL-----AAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSF 200

Query: 249 DLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYL-GSNLLTSIPSTLWNLKDILHLN 307
               L  L                      NL+ L L  +  L  + + L     +  L 
Sbjct: 201 SA--LERLVT-----------------RCPNLKSLKLNRAVPLEKLATLLQRAPQLEELG 241

Query: 308 LSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPN 367
                                       +    +   + G K+L+ L   ++ +   +P 
Sbjct: 242 TGGYT------------------AEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPA 283

Query: 368 SIGDLISLKSLNLSNNNLS 386
                  L +LNLS   + 
Sbjct: 284 VYSVCSRLTTLNLSYATVQ 302

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	797
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	100.0
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	100.0
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	100.0
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
1o6v_A	466	Internalin A; bacterial infection, extracellular r	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.98
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	99.98
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.98
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.98
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.98
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.98
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.98
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.98
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.98
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.98
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.98
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.98
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.98
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.97
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.97
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.97
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.97
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.97
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.97
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.97
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.97
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.97
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.97
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.97
3uqc_A	286	Probable conserved transmembrane protein; structur	99.97
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.97
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.96
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.96
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.96
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.96
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.96
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.96
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.96
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.96
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.96
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.96
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.96
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.96
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.96
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.96
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.95
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.95
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.95
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.94
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.94
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.94
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	99.94
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.94
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.94
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.93
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.93
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.93
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.93
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.93
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.92
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.92
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.91
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.91
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.91
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.91
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.91
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	99.91
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.9
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.9
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.89
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.89
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.89
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.89
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.88
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.88
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.88
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.87
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.87
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.87
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.85
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.85
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.85
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.85
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.84
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.84
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.83
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.83
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.83
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.83
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.82
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.82
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.81
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.81
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.81
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.8
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.8
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.79
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.79
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	99.79
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.78
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.78
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.78
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.77
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.77
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.76
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.75
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	99.75
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.75
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.73
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.71
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.71
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.71
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.69
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.69
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.69
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.68
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.68
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	99.68
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.66
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.65
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.65
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.61
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.6
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.56
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.54
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.54
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.54
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.54
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.53
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	99.52
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.52
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.38
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.37
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.34
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.33
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.29
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	99.26
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	99.22
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.02
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.92
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.84
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	98.68
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.6
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.55
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.49
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.46
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.45
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.44
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.35
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.28
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.07
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.05
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.98
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.82
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.71
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.66
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.65
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.53
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	97.14
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.06
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.0
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	96.96
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.88
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.85
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.83
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	96.82
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	96.64
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.4
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	95.9
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	95.78
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	95.64
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	95.35
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.07
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	94.77
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	92.79
3mes_A	424	Choline kinase; malaria, structural genomics, stru	90.7
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	82.12
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	81.25

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=4e-56  Score=532.57  Aligned_cols=436  Identities=34%  Similarity=0.514  Sum_probs=368.0

Q ss_pred             CCCCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCcc--------------ccCCCccccCC-CCCCEEEcccCccc
Q 040702            2 PSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFI--------------LCEIPHEIDNL-HNMEWMAFSFNKVV   66 (797)
Q Consensus         2 ~~l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~--------------l~~ip~~~~~l-~~L~~L~ls~N~i~   66 (797)
                      ++|++|.++|.+|..|+.+++|++|||++|++++.+|..-              ...+|..+..+ ++|++|++++|+++
T Consensus       228 L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~  307 (768)
T 3rgz_A          228 LDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFY  307 (768)
T ss_dssp             EECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCCCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEE
T ss_pred             EECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCccccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCC
Confidence            4556666666666666666666666666666665555421              12567776664 88888888888888


Q ss_pred             ccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCC-CCCEEEccCCcCcccCCcc
Q 040702           67 GVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNAS-KLSELGLQKNSFSGSIPNT  145 (797)
Q Consensus        67 ~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~~~~  145 (797)
                      +..|..|+++++|++|+|++|.+++.+|...+..+++|++|+|++|++++.+|..+.+++ +|++|+|++|++++..|..
T Consensus       308 ~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~  387 (768)
T 3rgz_A          308 GAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPN  387 (768)
T ss_dssp             ECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTT
T ss_pred             CccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChh
Confidence            888888888888888888888887778877677888888888888888877888887776 7888888888887777776


Q ss_pred             ccC--CCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChh
Q 040702          146 FGN--LRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEE  223 (797)
Q Consensus       146 f~~--l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~  223 (797)
                      +..  +++|++|+|++|.++...+.     .+.++++|++|++++|++++..|..|..++ +|+.|++++|.+.+.+|..
T Consensus       388 ~~~~~~~~L~~L~L~~n~l~~~~p~-----~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~L~~n~l~~~~p~~  461 (768)
T 3rgz_A          388 LCQNPKNTLQELYLQNNGFTGKIPP-----TLSNCSELVSLHLSFNYLSGTIPSSLGSLS-KLRDLKLWLNMLEGEIPQE  461 (768)
T ss_dssp             TTCSTTCCCCEEECCSSEEEEECCG-----GGGGCTTCCEEECCSSEEESCCCGGGGGCT-TCCEEECCSSCCCSCCCGG
T ss_pred             hhhcccCCccEEECCCCccccccCH-----HHhcCCCCCEEECcCCcccCcccHHHhcCC-CCCEEECCCCcccCcCCHH
Confidence            666  77888888888888755443     377888899999999999988899999887 8999999999999999999


Q ss_pred             hhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCC-CCCCCCCCCCc
Q 040702          224 INNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLT-SIPSTLWNLKD  302 (797)
Q Consensus       224 ~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~  302 (797)
                      +..+++|  ++|++++|++++..|..+..+++|++|+|++|++++..|..++.+++|++|+|++|.++ .+|..+..+++
T Consensus       462 ~~~l~~L--~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~  539 (768)
T 3rgz_A          462 LMYVKTL--ETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRS  539 (768)
T ss_dssp             GGGCTTC--CEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTT
T ss_pred             HcCCCCc--eEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCC
Confidence            9999888  99999999999889999999999999999999999888999999999999999999994 78888888999


Q ss_pred             ccEEEccCCcCCCCCCcc--------------------------------------------------------------
Q 040702          303 ILHLNLSSNFFTGPLPLK--------------------------------------------------------------  320 (797)
Q Consensus       303 L~~L~l~~N~l~~~~~~~--------------------------------------------------------------  320 (797)
                      |+.|++++|.+++.+|..                                                              
T Consensus       540 L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  619 (768)
T 3rgz_A          540 LIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRV  619 (768)
T ss_dssp             CCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCE
T ss_pred             CCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccce
Confidence            999999999888666643                                                              


Q ss_pred             --------ccccccccEEeccCcccccccCccccCCcccceecccCccccCCCChhhhccccCCeeeecCCcCCCCCChh
Q 040702          321 --------IGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPIS  392 (797)
Q Consensus       321 --------~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~  392 (797)
                              ++.+++|+.|||++|++++.+|..|+.+++|+.|+|++|++++.+|..++.+++|++|||++|+++|.+|..
T Consensus       620 ~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~  699 (768)
T 3rgz_A          620 YGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQA  699 (768)
T ss_dssp             EEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGG
T ss_pred             ecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChH
Confidence                    334578999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCeEEccCCcCcccCCCCCCCCCCCcccccCCccccCCCCcccccccccc
Q 040702          393 LEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMPNLQVLSCRTKI  448 (797)
Q Consensus       393 ~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~~~~~~n~~~c~~~~~~~~~~~~~~  448 (797)
                      +.++++|+.|++++|+++|.+|..+.+.++....+.||+.+||.|..   .|....
T Consensus       700 l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~---~C~~~~  752 (768)
T 3rgz_A          700 MSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLP---RCDPSN  752 (768)
T ss_dssp             GGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSC---CCCSCC
T ss_pred             HhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCc---CCCCCc
Confidence            99999999999999999999999999999999999999999998842   686543

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=100.00  E-value=8.5e-52  Score=495.12  Aligned_cols=422  Identities=33%  Similarity=0.487  Sum_probs=339.8

Q ss_pred             CCCCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCE
Q 040702            2 PSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKS   81 (797)
Q Consensus         2 ~~l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~   81 (797)
                      +||++|.+++.+|. |+.+++|++|||++|++++.        +|..+..+++|++|++++|++.+..|..  .+++|++
T Consensus       205 L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~--------~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~  273 (768)
T 3rgz_A          205 LDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGD--------FSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQY  273 (768)
T ss_dssp             EECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSC--------HHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCE
T ss_pred             EECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCc--------ccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCE
Confidence            45666666666665 66666777777776665443        3455667777777777777777666554  6677777


Q ss_pred             EEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCc-cccCCCCCCeeeccCc
Q 040702           82 LYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPN-TFGNLRNLKWLGLNDN  160 (797)
Q Consensus        82 L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~f~~l~~L~~L~L~~N  160 (797)
                      |+|++|++++.+|..++..+++|++|+|++|++++..|..|.++++|++|+|++|++++..|. .|.++++|++|+|++|
T Consensus       274 L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n  353 (768)
T 3rgz_A          274 LSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFN  353 (768)
T ss_dssp             EECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSS
T ss_pred             EECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCC
Confidence            777777777677776665557788888888877777777777777788888888777755554 3777777777777777


Q ss_pred             cCc-CCCCCccccc-------------------cCCC--CCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccc
Q 040702          161 YLT-SSTPELSSLS-------------------SLSN--CKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISG  218 (797)
Q Consensus       161 ~l~-~~~~~~~~~~-------------------~l~~--l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~  218 (797)
                      .++ .++..+..+.                   .+..  +++|++|++++|++.+..|..+.+++ +|+.|++++|.+++
T Consensus       354 ~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~  432 (768)
T 3rgz_A          354 EFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCS-ELVSLHLSFNYLSG  432 (768)
T ss_dssp             EEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCT-TCCEEECCSSEEES
T ss_pred             ccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhcCC-CCCEEECcCCcccC
Confidence            776 3343332211                   1222  67788889999988888888998887 89999999999999


Q ss_pred             cCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCC-CCCCCC
Q 040702          219 SIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLT-SIPSTL  297 (797)
Q Consensus       219 ~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~~  297 (797)
                      .+|..++.+++|  ++|++++|.+.+..|..+..+++|++|++++|++++..|..+.++++|++|+|++|+++ .+|.++
T Consensus       433 ~~p~~l~~l~~L--~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~  510 (768)
T 3rgz_A          433 TIPSSLGSLSKL--RDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWI  510 (768)
T ss_dssp             CCCGGGGGCTTC--CEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGG
T ss_pred             cccHHHhcCCCC--CEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHH
Confidence            999999999988  99999999999999999999999999999999999889999999999999999999995 778888


Q ss_pred             CCCCcccEEEccCCcCCCCCCccccccccccEEeccCcccccccCcc---------------------------------
Q 040702          298 WNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTK---------------------------------  344 (797)
Q Consensus       298 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~---------------------------------  344 (797)
                      ..+++|+.|++++|++++..|..++.+++|+.|++++|++++.+|..                                 
T Consensus       511 ~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  590 (768)
T 3rgz_A          511 GRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGA  590 (768)
T ss_dssp             GGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSS
T ss_pred             hcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccccccccccccccccc
Confidence            89999999999999999999999999999999999999988766643                                 


Q ss_pred             -------------------------------------ccCCcccceecccCccccCCCChhhhccccCCeeeecCCcCCC
Q 040702          345 -------------------------------------IGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSG  387 (797)
Q Consensus       345 -------------------------------------~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  387 (797)
                                                           |..+++|+.|+|++|++++.+|..++.+++|+.|+|++|+++|
T Consensus       591 ~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g  670 (768)
T 3rgz_A          591 GNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISG  670 (768)
T ss_dssp             EEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCS
T ss_pred             ccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCC
Confidence                                                 3345778999999999999999999999999999999999999


Q ss_pred             CCChhhhccCCCCeEEccCCcCcccCCCC-CCCCCCCcccccCCccccCCC
Q 040702          388 TIPISLEKLLDLKDINVSFNRLEGEIPRE-GPFRNLSAESFKGNELLCGMP  437 (797)
Q Consensus       388 ~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~l~~~~~~~n~~~c~~~  437 (797)
                      .+|..+.++++|+.|||++|+++|.+|.. ..++.++.+++++|++.-..|
T Consensus       671 ~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP  721 (768)
T 3rgz_A          671 SIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP  721 (768)
T ss_dssp             CCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECC
T ss_pred             CCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCC
Confidence            99999999999999999999999999875 667889999999998765455

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=1.9e-50  Score=472.18  Aligned_cols=418  Identities=20%  Similarity=0.191  Sum_probs=261.8

Q ss_pred             CCCCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCE
Q 040702            2 PSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKS   81 (797)
Q Consensus         2 ~~l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~   81 (797)
                      +||++|.|+++.+.+|+.+++|++|||++|++++..|.        .|.++++|++|++++|+++++.|.+|.++++|++
T Consensus        38 L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~--------~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~  109 (606)
T 3t6q_A           38 LEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHED--------TFQSQHRLDTLVLTANPLIFMAETALSGPKALKH  109 (606)
T ss_dssp             EECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTT--------TTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCE
T ss_pred             EEccCCccCcCChhHhccCccceEEECCCCccceeChh--------hccCccccCeeeCCCCcccccChhhhcccccccE
Confidence            57889999988888899999999999999987655443        3444455555555555555444444555555555


Q ss_pred             EEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCC------------
Q 040702           82 LYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNL------------  149 (797)
Q Consensus        82 L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l------------  149 (797)
                      |+|++|+++ .++...+..+++|++|+|++|++++..+..+..+++|++|+|++|+|+++.+..|.++            
T Consensus       110 L~L~~n~i~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~  188 (606)
T 3t6q_A          110 LFFIQTGIS-SIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNG  188 (606)
T ss_dssp             EECTTSCCS-CGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTT
T ss_pred             eeccccCcc-cCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhhhcccceeEEecCC
Confidence            555555444 3322333444444444444444443322223334444444444444444444444444            


Q ss_pred             --------------------------------------------------------------------------------
Q 040702          150 --------------------------------------------------------------------------------  149 (797)
Q Consensus       150 --------------------------------------------------------------------------------  149 (797)
                                                                                                      
T Consensus       189 n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~  268 (606)
T 3t6q_A          189 NDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFN  268 (606)
T ss_dssp             CCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSS
T ss_pred             CccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCc
Confidence                                                                                            


Q ss_pred             ---------CCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccC
Q 040702          150 ---------RNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSI  220 (797)
Q Consensus       150 ---------~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~  220 (797)
                               ++|++|+|++|.++.+|..      +..+++|++|++++|++.+..|..+..++ +|+.|++++|.+.+.+
T Consensus       269 ~~~~~~~~l~~L~~L~l~~n~l~~lp~~------l~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~~~~~~  341 (606)
T 3t6q_A          269 ISSNTFHCFSGLQELDLTATHLSELPSG------LVGLSTLKKLVLSANKFENLCQISASNFP-SLTHLSIKGNTKRLEL  341 (606)
T ss_dssp             CCTTTTTTCTTCSEEECTTSCCSCCCSS------CCSCTTCCEEECTTCCCSBGGGGCGGGCT-TCSEEECCSCSSCCBC
T ss_pred             cCHHHhccccCCCEEeccCCccCCCChh------hcccccCCEEECccCCcCcCchhhhhccC-cCCEEECCCCCccccc
Confidence                     4444444444444443332      34444555555555555544444555554 4555555555555333


Q ss_pred             Ch-hhhhhhhhHhhhcccccccccCCC--chhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCC-CC-
Q 040702          221 PE-EINNLTNLILQLLSLEGNQLEGSI--PDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSI-PS-  295 (797)
Q Consensus       221 p~-~~~~l~~L~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l-p~-  295 (797)
                      |. .+..+++|  ++|++++|.+.+..  +..+..+++|++|++++|++.+..|..|..+++|+.|++++|.++.. |. 
T Consensus       342 ~~~~~~~l~~L--~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~  419 (606)
T 3t6q_A          342 GTGCLENLENL--RELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQS  419 (606)
T ss_dssp             CSSTTTTCTTC--CEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCC
T ss_pred             chhhhhccCcC--CEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccch
Confidence            32 35555555  66666666665544  55566666777777777777666666777777777777777777443 32 


Q ss_pred             CCCCCCcccEEEccCCcCCCCCCccccccccccEEeccCcccccc---cCccccCCcccceecccCccccCCCChhhhcc
Q 040702          296 TLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCV---IPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDL  372 (797)
Q Consensus       296 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~---~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  372 (797)
                      .+..+++|+.|++++|.+.+..|..|..+++|++|++++|.+++.   .+..+..+++|++|++++|++++..|..|..+
T Consensus       420 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l  499 (606)
T 3t6q_A          420 PFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSL  499 (606)
T ss_dssp             TTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTC
T ss_pred             hhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccc
Confidence            366677777777777777777777777777788888888777652   23557777788888888888877777778888


Q ss_pred             ccCCeeeecCCcCCCCCChhhhccCCCCeEEccCCcCcccCCCC-CCCCCCCcccccCCccccCCCC
Q 040702          373 ISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPRE-GPFRNLSAESFKGNELLCGMPN  438 (797)
Q Consensus       373 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~l~~~~~~~n~~~c~~~~  438 (797)
                      ++|++|+|++|++++..|..+..+++| .|++++|++++.+|.. ..+..++.+++.+|++.|+|+.
T Consensus       500 ~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~  565 (606)
T 3t6q_A          500 KMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSN  565 (606)
T ss_dssp             TTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGG
T ss_pred             cCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCc
Confidence            888888888888887778888888888 8888888888776653 4466778888889998888764

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=7.2e-50  Score=483.35  Aligned_cols=423  Identities=22%  Similarity=0.208  Sum_probs=329.9

Q ss_pred             CCCCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCE
Q 040702            2 PSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKS   81 (797)
Q Consensus         2 ~~l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~   81 (797)
                      +||++|.|+++.+..|..+++|++|||++|...+.++       |..+.++++|++|+|++|++.++.|.+|.++++|++
T Consensus        29 LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~-------~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  101 (844)
T 3j0a_A           29 LLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTID-------KEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFE  101 (844)
T ss_dssp             EEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEEC-------TTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCC
T ss_pred             EECCCCcCCccChhHCcccccCeEEeCCCCCCccccC-------HHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCE
Confidence            6899999999999999999999999999997433322       677899999999999999999999999999999999


Q ss_pred             EEccCCcCcccCCC-ccccCCCCccEEEccCccccccCC-chhhCCCCCCEEEccCCcCcccCCccccCC--CCCCeeec
Q 040702           82 LYLHSNSLSGRLPS-SADVRLPNLKELHLWGNNFIGTIP-SFIFNASKLSELGLQKNSFSGSIPNTFGNL--RNLKWLGL  157 (797)
Q Consensus        82 L~Ls~N~l~~~l~~-~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l--~~L~~L~L  157 (797)
                      |+|++|.+++.+|. ..|..+++|++|+|++|.+++..+ ..|.++++|++|+|++|+|+++.+..|..+  ++|++|+|
T Consensus       102 L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L  181 (844)
T 3j0a_A          102 LRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSL  181 (844)
T ss_dssp             EECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEE
T ss_pred             eeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEEC
Confidence            99999999865554 467899999999999999987765 579999999999999999999888888877  67777777


Q ss_pred             cCccCcCCCCC-cccc------------------------------------------------------------ccCC
Q 040702          158 NDNYLTSSTPE-LSSL------------------------------------------------------------SSLS  176 (797)
Q Consensus       158 ~~N~l~~~~~~-~~~~------------------------------------------------------------~~l~  176 (797)
                      ++|.++...+. +..+                                                            ..|.
T Consensus       182 ~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~  261 (844)
T 3j0a_A          182 AANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFA  261 (844)
T ss_dssp             CCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTT
T ss_pred             CCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhh
Confidence            77766543221 0000                                                            0011


Q ss_pred             C--CCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCC
Q 040702          177 N--CKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLA  254 (797)
Q Consensus       177 ~--l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~  254 (797)
                      +  .++|+.|++++|.+.+..+..|..++ +|+.|++++|.+.+..|..|.++++|  ++|+|++|.+++..+..|..++
T Consensus       262 ~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~-~L~~L~L~~n~i~~~~~~~~~~l~~L--~~L~Ls~N~l~~~~~~~~~~l~  338 (844)
T 3j0a_A          262 GLARSSVRHLDLSHGFVFSLNSRVFETLK-DLKVLNLAYNKINKIADEAFYGLDNL--QVLNLSYNLLGELYSSNFYGLP  338 (844)
T ss_dssp             TTTTSCCCEEECTTCCCCEECSCCSSSCC-CCCEEEEESCCCCEECTTTTTTCSSC--CEEEEESCCCSCCCSCSCSSCT
T ss_pred             ccccCCccEEECCCCcccccChhhhhcCC-CCCEEECCCCcCCCCChHHhcCCCCC--CEEECCCCCCCccCHHHhcCCC
Confidence            1  25677777777777777777777776 78888888888877777777777777  7888888888777777788888


Q ss_pred             CCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCC-------------------C-------------------
Q 040702          255 ALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPS-------------------T-------------------  296 (797)
Q Consensus       255 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~-------------------~-------------------  296 (797)
                      +|+.|++++|+++.+.+..|.++++|+.|+|++|.++.++.                   .                   
T Consensus       339 ~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~  418 (844)
T 3j0a_A          339 KVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDI  418 (844)
T ss_dssp             TCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTT
T ss_pred             CCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCch
Confidence            88888888888877777777777788877777777765432                   0                   


Q ss_pred             ---CCCCCcccEEEccCCcCCCCCCc-cccccccccEEeccCcccc-----cccCccccCCcccceecccCccccCCCCh
Q 040702          297 ---LWNLKDILHLNLSSNFFTGPLPL-KIGNLNVLVQLDLSMNNFS-----CVIPTKIGGLKDLQYLFLEYNRLQGSIPN  367 (797)
Q Consensus       297 ---~~~l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~-----~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~  367 (797)
                         +..+++|+.|++++|++++..+. .+..+++|+.|++++|.++     +..+..|.++++|+.|+|++|++++..|.
T Consensus       419 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~  498 (844)
T 3j0a_A          419 LYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPG  498 (844)
T ss_dssp             HHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTT
T ss_pred             hhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChh
Confidence               11345555555555555543322 2344566666666666665     33445688889999999999999988888


Q ss_pred             hhhccccCCeeeecCCcCCCCCChhhhccCCCCeEEccCCcCcccCCCCCCCCCCCcccccCCccccCCCC
Q 040702          368 SIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMPN  438 (797)
Q Consensus       368 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~~~~~~n~~~c~~~~  438 (797)
                      .|..+++|+.|+|++|+|++..|..+.  ++|+.|++++|++++.+|..  +..+..+++.+||+.|+|+.
T Consensus       499 ~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~--~~~L~~l~l~~Np~~C~c~~  565 (844)
T 3j0a_A          499 VFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDV--FVSLSVLDITHNKFICECEL  565 (844)
T ss_dssp             SSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCC--CSSCCEEEEEEECCCCSSSC
T ss_pred             HccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhH--hCCcCEEEecCCCccccccc
Confidence            899999999999999999987777766  88999999999999888854  56889999999999999874

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=3.4e-49  Score=461.63  Aligned_cols=421  Identities=21%  Similarity=0.181  Sum_probs=348.0

Q ss_pred             CCCCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCE
Q 040702            2 PSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKS   81 (797)
Q Consensus         2 ~~l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~   81 (797)
                      +||++|.++++.+..|..+++|++|||++|++++..        |..|.++++|++|+|++|+++++.|.+|.++++|++
T Consensus        37 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~--------~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~  108 (606)
T 3vq2_A           37 IDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIE--------DKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLEN  108 (606)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEEC--------TTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCE
T ss_pred             EECCCCCcCEeChhhccCCccCcEEeCCCCcccccC--------HHHhhchhhcCEeECCCCcccccChhhcCCcccCCE
Confidence            689999999999999999999999999999965443        456788999999999999999988999999999999


Q ss_pred             EEccCCcCcccCCCccccCCCCccEEEccCccccc-cCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCC----eee
Q 040702           82 LYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIG-TIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLK----WLG  156 (797)
Q Consensus        82 L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~----~L~  156 (797)
                      |+|++|.++ .++...+.++++|++|+|++|.+++ .+|..|.++++|++|+|++|+++++.+..|..+++|+    +|+
T Consensus       109 L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~  187 (606)
T 3vq2_A          109 LVAVETKLA-SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLD  187 (606)
T ss_dssp             EECTTSCCC-CSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEE
T ss_pred             EEccCCccc-cccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceee
Confidence            999999998 6776667899999999999999986 4689999999999999999999988888888777665    677


Q ss_pred             ccCccCcCCCCCccc-----------------------------------------------------------------
Q 040702          157 LNDNYLTSSTPELSS-----------------------------------------------------------------  171 (797)
Q Consensus       157 L~~N~l~~~~~~~~~-----------------------------------------------------------------  171 (797)
                      +++|.++.+++....                                                                 
T Consensus       188 l~~n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~  267 (606)
T 3vq2_A          188 MSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFR  267 (606)
T ss_dssp             CTTCCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEE
T ss_pred             ccCCCcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhhee
Confidence            777777665543211                                                                 


Q ss_pred             --------------------------------cccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCccccc
Q 040702          172 --------------------------------LSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGS  219 (797)
Q Consensus       172 --------------------------------~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~  219 (797)
                                                      ++.+..+++|+.|++++|++. .+| .+ .++ +|+.|++++|...+.
T Consensus       268 l~~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l~-~lp-~~-~l~-~L~~L~l~~n~~~~~  343 (606)
T 3vq2_A          268 LTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLK-QFP-TL-DLP-FLKSLTLTMNKGSIS  343 (606)
T ss_dssp             ECCCTTCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCCS-SCC-CC-CCS-SCCEEEEESCSSCEE
T ss_pred             ccccccccccccccccCCCCCEEEecCccchhhhhccccccCCEEEcccccCc-ccc-cC-CCC-ccceeeccCCcCccc
Confidence                                            001233344555555555552 333 22 443 555555555543332


Q ss_pred             CChhhhhhhhhHhhhcccccccccCC--CchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCC--
Q 040702          220 IPEEINNLTNLILQLLSLEGNQLEGS--IPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPS--  295 (797)
Q Consensus       220 ~p~~~~~l~~L~L~~L~Ls~N~l~~~--~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~--  295 (797)
                      .  .+..+++|  ++|++++|.+++.  .+..+..+++|++|++++|.+++. |..+..+++|+.|++++|.+..++.  
T Consensus       344 ~--~~~~l~~L--~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~-~~~~~~l~~L~~L~l~~n~l~~~~~~~  418 (606)
T 3vq2_A          344 F--KKVALPSL--SYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIM-SANFMGLEELQHLDFQHSTLKRVTEFS  418 (606)
T ss_dssp             C--CCCCCTTC--CEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEEE-CCCCTTCTTCCEEECTTSEEESTTTTT
T ss_pred             h--hhccCCCC--CEEECcCCccCCCcchhhhhccCCcccEeECCCCccccc-hhhccCCCCCCeeECCCCccCCccChh
Confidence            2  45566777  8899999998866  378899999999999999999864 5889999999999999999976643  


Q ss_pred             CCCCCCcccEEEccCCcCCCCCCccccccccccEEeccCccccc-ccCccccCCcccceecccCccccCCCChhhhcccc
Q 040702          296 TLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSC-VIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLIS  374 (797)
Q Consensus       296 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  374 (797)
                      .+..+++|+.|++++|.+.+..|..|..+++|++|++++|.+++ ..|..|..+++|+.|+|++|++++..|..|..+++
T Consensus       419 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~  498 (606)
T 3vq2_A          419 AFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHR  498 (606)
T ss_dssp             TTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred             hhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhccccc
Confidence            77889999999999999999899999999999999999999997 47899999999999999999999999999999999


Q ss_pred             CCeeeecCCcCCCCCChhhhccCCCCeEEccCCcCcccCCCCCCCC-CCCcccccCCccccCCCCcc
Q 040702          375 LKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFR-NLSAESFKGNELLCGMPNLQ  440 (797)
Q Consensus       375 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~-~l~~~~~~~n~~~c~~~~~~  440 (797)
                      |++|+|++|++++..|..+..+++|+.|++++|+++..++....+. .++.+++.+|++.|+|+..+
T Consensus       499 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~~  565 (606)
T 3vq2_A          499 LQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEHQK  565 (606)
T ss_dssp             CCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSSTTHH
T ss_pred             CCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCccHH
Confidence            9999999999999999999999999999999999997665555554 58999999999999998543

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=2e-48  Score=461.44  Aligned_cols=433  Identities=24%  Similarity=0.288  Sum_probs=292.6

Q ss_pred             CCCCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCcc---------------ccCCCc-cccCCCCCCEEEcccCcc
Q 040702            2 PSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFI---------------LCEIPH-EIDNLHNMEWMAFSFNKV   65 (797)
Q Consensus         2 ~~l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~---------------l~~ip~-~~~~l~~L~~L~ls~N~i   65 (797)
                      +||++|.++++.+..|+.+++|++|||++|++++..|..+               ++.+|. .++++++|++|++++|++
T Consensus        30 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l  109 (680)
T 1ziw_A           30 LNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSI  109 (680)
T ss_dssp             EECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCC
T ss_pred             EECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCcc
Confidence            3556666666555556666666666666666555554432               334444 356666666666666666


Q ss_pred             cccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCcccc--------------------------ccCC
Q 040702           66 VGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFI--------------------------GTIP  119 (797)
Q Consensus        66 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~--------------------------~~~~  119 (797)
                      +++.|..|.++++|++|+|++|.++ .++...+.++++|++|+|++|+++                          +..|
T Consensus       110 ~~~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~  188 (680)
T 1ziw_A          110 QKIKNNPFVKQKNLITLDLSHNGLS-STKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSP  188 (680)
T ss_dssp             CCCCSCTTTTCTTCCEEECCSSCCS-CCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCT
T ss_pred             CccChhHccccCCCCEEECCCCccc-ccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccCh
Confidence            6655556666666666666666665 222233334444444444444433                          2222


Q ss_pred             c---------------------------------------------------hhhCCC--CCCEEEccCCcCcccCCccc
Q 040702          120 S---------------------------------------------------FIFNAS--KLSELGLQKNSFSGSIPNTF  146 (797)
Q Consensus       120 ~---------------------------------------------------~~~~l~--~L~~L~L~~N~l~~~~~~~f  146 (797)
                      .                                                   .|.+++  +|++|+|++|+++++.|.+|
T Consensus       189 ~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~  268 (680)
T 1ziw_A          189 GCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSF  268 (680)
T ss_dssp             TGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTT
T ss_pred             hhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccc
Confidence            2                                                   222222  26666666666666666666


Q ss_pred             cCCCCCCeeeccCccCcCCCCC-cccc----------------------c-----cCCCCCCCcEEEccCCCCCCCCChh
Q 040702          147 GNLRNLKWLGLNDNYLTSSTPE-LSSL----------------------S-----SLSNCKYLEYFSFSNNPLGGILPRA  198 (797)
Q Consensus       147 ~~l~~L~~L~L~~N~l~~~~~~-~~~~----------------------~-----~l~~l~~L~~L~Ls~N~l~~~~~~~  198 (797)
                      .++++|++|+|++|.++..++. +..+                      +     .|..+++|++|++++|++.++.+..
T Consensus       269 ~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~  348 (680)
T 1ziw_A          269 AWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNM  348 (680)
T ss_dssp             TTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTT
T ss_pred             cCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhH
Confidence            6677777777777766654432 1110                      0     3556677777777777777777666


Q ss_pred             hhccccCCcEEEcc----------------------------CCcccccCChhhhhhhhhHhhhcccccccccCCCc-hh
Q 040702          199 IGNLSQSMEDFWMD----------------------------NCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIP-DD  249 (797)
Q Consensus       199 ~~~l~~~L~~L~L~----------------------------~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~-~~  249 (797)
                      |.+++ +|+.|+++                            +|++++..|..|..+++|  ++|++++|.+.+.++ ..
T Consensus       349 ~~~l~-~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L--~~L~L~~N~l~~~~~~~~  425 (680)
T 1ziw_A          349 FTGLI-NLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHL--EVLDLGLNEIGQELTGQE  425 (680)
T ss_dssp             TTTCT-TCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTCTTC--CEEECCSSCCEEECCSGG
T ss_pred             hcccc-CCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCCCCC--CEEeCCCCcCccccCccc
Confidence            66654 45444444                            444445555556666665  666666666654333 55


Q ss_pred             hcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCC---CCCCCCCCCCcccEEEccCCcCCCCCCcccccccc
Q 040702          250 LCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLT---SIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNV  326 (797)
Q Consensus       250 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~---~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~  326 (797)
                      |.++++|++|++++|++.+..+..|..+++|+.|++++|.++   .+|..+..+++|+.|++++|.+++..+..|.++++
T Consensus       426 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~  505 (680)
T 1ziw_A          426 WRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEK  505 (680)
T ss_dssp             GTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred             ccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccc
Confidence            666666666666666666666666667777777777777663   45777888999999999999999888888999999


Q ss_pred             ccEEeccCcccccccC--------ccccCCcccceecccCccccCCCChhhhccccCCeeeecCCcCCCCCChhhhccCC
Q 040702          327 LVQLDLSMNNFSCVIP--------TKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLD  398 (797)
Q Consensus       327 L~~L~Ls~N~l~~~~~--------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  398 (797)
                      |++|++++|++++..+        ..|.++++|+.|+|++|+++...+..|..+++|+.|+|++|++++..+..|..+++
T Consensus       506 L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~  585 (680)
T 1ziw_A          506 LEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVS  585 (680)
T ss_dssp             CCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred             cCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCC
Confidence            9999999999986533        23788999999999999999666667999999999999999999888888899999


Q ss_pred             CCeEEccCCcCcccCCCC-C-CCCCCCcccccCCccccCCCC
Q 040702          399 LKDINVSFNRLEGEIPRE-G-PFRNLSAESFKGNELLCGMPN  438 (797)
Q Consensus       399 L~~L~l~~N~l~~~~p~~-~-~~~~l~~~~~~~n~~~c~~~~  438 (797)
                      |+.|++++|++++.+|.. . .+..+..+++.+|||.|+|+.
T Consensus       586 L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~~  627 (680)
T 1ziw_A          586 LKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES  627 (680)
T ss_dssp             CCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCCC
T ss_pred             CCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCcc
Confidence            999999999999877653 2 467899999999999999985

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=6.6e-49  Score=459.54  Aligned_cols=418  Identities=18%  Similarity=0.268  Sum_probs=259.1

Q ss_pred             CCCCCCCccccCCcCCCCCCCCCEEeCCCCCC------CC------cCCCc-------------cccCCCcccc------
Q 040702            2 PSLTNDFLRGIILSQLGNPSSLQTLYLSYNPP------SG------SIPSF-------------ILCEIPHEID------   50 (797)
Q Consensus         2 ~~l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~------~~------~~p~~-------------~l~~ip~~~~------   50 (797)
                      +||++|.++|.+|++|+.+++|++|||++|.+      .|      .+|..             +...+|..+.      
T Consensus        86 L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l  165 (636)
T 4eco_A           86 LSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDC  165 (636)
T ss_dssp             EECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHH
T ss_pred             EEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHH
Confidence            68999999999999999999999999999975      11      01100             0001111111      


Q ss_pred             -------------CCCCCCEEEc--ccCcccccCCccccCCCCCCEEEccCCcCccc-----------------CCCccc
Q 040702           51 -------------NLHNMEWMAF--SFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGR-----------------LPSSAD   98 (797)
Q Consensus        51 -------------~l~~L~~L~l--s~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~-----------------l~~~~~   98 (797)
                                   ....++.+.+  ..|++++ +|..|+++++|++|+|++|++++.                 +|..+.
T Consensus       166 ~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~  244 (636)
T 4eco_A          166 INSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLK  244 (636)
T ss_dssp             HHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCC
T ss_pred             hhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhh
Confidence                         0011111111  2456666 566666666777777777766643                 555542


Q ss_pred             -cCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCc-Ccc-cCCccccCC------CCCCeeeccCccCcCCCCCc
Q 040702           99 -VRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNS-FSG-SIPNTFGNL------RNLKWLGLNDNYLTSSTPEL  169 (797)
Q Consensus        99 -~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~-~~~~~f~~l------~~L~~L~L~~N~l~~~~~~~  169 (797)
                       .++++|++|+|++|++.+.+|..|.++++|++|+|++|+ +++ ..|..++++      ++|++|+|++|+++.+|.. 
T Consensus       245 ~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~ip~~-  323 (636)
T 4eco_A          245 WDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVE-  323 (636)
T ss_dssp             GGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSSCCCH-
T ss_pred             hcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCCccCch-
Confidence             256667777777766666666666666677777777766 665 556666555      6677777777766655540 


Q ss_pred             cccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhh-hHhhhcccccccccCCCch
Q 040702          170 SSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTN-LILQLLSLEGNQLEGSIPD  248 (797)
Q Consensus       170 ~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~-L~L~~L~Ls~N~l~~~~~~  248 (797)
                         ..+.++++|+.|++++|++.+.+| .|..++ +|+.|++++|.++ .+|..+..+++ |  ++|++++|.++ .+|.
T Consensus       324 ---~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~-~L~~L~L~~N~l~-~lp~~l~~l~~~L--~~L~Ls~N~l~-~lp~  394 (636)
T 4eco_A          324 ---TSLQKMKKLGMLECLYNQLEGKLP-AFGSEI-KLASLNLAYNQIT-EIPANFCGFTEQV--ENLSFAHNKLK-YIPN  394 (636)
T ss_dssp             ---HHHTTCTTCCEEECCSCCCEEECC-CCEEEE-EESEEECCSSEEE-ECCTTSEEECTTC--CEEECCSSCCS-SCCS
T ss_pred             ---hhhccCCCCCEEeCcCCcCccchh-hhCCCC-CCCEEECCCCccc-cccHhhhhhcccC--cEEEccCCcCc-ccch
Confidence               015556666667777776665555 666665 6666777776666 56666666666 6  66677777666 4555


Q ss_pred             hhcCCC--CCcEEEccCCcCcccCCCCcc-------CCccccccccCCCCCCCCCCCCC-CCCcccEEEccCCcCCCCCC
Q 040702          249 DLCRLA--ALFQLDLGGNKLSGFVPACSG-------NLTNLRKLYLGSNLLTSIPSTLW-NLKDILHLNLSSNFFTGPLP  318 (797)
Q Consensus       249 ~~~~l~--~L~~L~Ls~N~l~~~~~~~~~-------~l~~L~~L~L~~N~l~~lp~~~~-~l~~L~~L~l~~N~l~~~~~  318 (797)
                      .+..+.  +|++|++++|++++..|..+.       .+++|++|+|++|.++.+|..++ .+++|+.|++++|.++...+
T Consensus       395 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~  474 (636)
T 4eco_A          395 IFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPK  474 (636)
T ss_dssp             CCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCS
T ss_pred             hhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCH
Confidence            555543  666777777776666666665       56666777777777666666443 36666777777776663333


Q ss_pred             cccccc-------ccccEEeccCcccccccCcccc--CCcccceecccCccccCCCChhhhccccCCeeee------cCC
Q 040702          319 LKIGNL-------NVLVQLDLSMNNFSCVIPTKIG--GLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNL------SNN  383 (797)
Q Consensus       319 ~~~~~l-------~~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L------s~N  383 (797)
                      ..+...       ++|+.|+|++|+++ .+|..+.  .+++|+.|+|++|++++ +|..+..+++|++|+|      ++|
T Consensus       475 ~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N  552 (636)
T 4eco_A          475 NSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGN  552 (636)
T ss_dssp             SSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCC
T ss_pred             HHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccC
Confidence            333322       26667777777666 4455554  66667777777777665 6666666677777766      445


Q ss_pred             cCCCCCChhhhccCCCCeEEccCCcCcccCCCCCCCCCCCcccccCCcccc
Q 040702          384 NLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLC  434 (797)
Q Consensus       384 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~~~~~~n~~~c  434 (797)
                      ++.+.+|..+..+++|+.|++++|++ +.+|.. ..+.++.+++++|++.|
T Consensus       553 ~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~-~~~~L~~L~Ls~N~l~~  601 (636)
T 4eco_A          553 RTLREWPEGITLCPSLTQLQIGSNDI-RKVNEK-ITPNISVLDIKDNPNIS  601 (636)
T ss_dssp             BCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC-CCTTCCEEECCSCTTCE
T ss_pred             cccccChHHHhcCCCCCEEECCCCcC-CccCHh-HhCcCCEEECcCCCCcc
Confidence            66666666666677777777777776 344443 12566666666666655

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=9.2e-49  Score=465.56  Aligned_cols=423  Identities=17%  Similarity=0.176  Sum_probs=308.0

Q ss_pred             CCCCCCCccccCCcCCCCCCCCCEEeC-CCCCCCCcCCCc----------------------------------------
Q 040702            2 PSLTNDFLRGIILSQLGNPSSLQTLYL-SYNPPSGSIPSF----------------------------------------   40 (797)
Q Consensus         2 ~~l~~~~~~~~~~~~~~~l~~L~~LdL-s~N~~~~~~p~~----------------------------------------   40 (797)
                      +||++|.++|.+|++|++|++|++||| ++|.++|..|..                                        
T Consensus       328 L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~  407 (876)
T 4ecn_A          328 LSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDA  407 (876)
T ss_dssp             EECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHH
T ss_pred             EECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHH
Confidence            689999999999999999999999999 999877763321                                        


Q ss_pred             ----------------------------cccCCCccccCCCCCCEEEcccCcccc-----------------cCCcccc-
Q 040702           41 ----------------------------ILCEIPHEIDNLHNMEWMAFSFNKVVG-----------------VVPTTIF-   74 (797)
Q Consensus        41 ----------------------------~l~~ip~~~~~l~~L~~L~ls~N~i~~-----------------~~p~~~~-   74 (797)
                                                  -++.||..++++++|++|+|++|++++                 .+|..++ 
T Consensus       408 l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f  487 (876)
T 4ecn_A          408 INRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSW  487 (876)
T ss_dssp             HHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCG
T ss_pred             hhhCccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhh
Confidence                                        012277788888888888888888887                 3677766 


Q ss_pred             -CCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCcc-ccc-cCCchhhCCC-------CCCEEEccCCcCcccCCc
Q 040702           75 -NVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNN-FIG-TIPSFIFNAS-------KLSELGLQKNSFSGSIPN  144 (797)
Q Consensus        75 -~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~-l~~-~~~~~~~~l~-------~L~~L~L~~N~l~~~~~~  144 (797)
                       ++++|++|+|++|++.+.+|.. +.++++|++|+|++|+ +++ .+|..+..++       +|++|+|++|+|+ .+|.
T Consensus       488 ~~L~~L~~L~Ls~N~l~~~iP~~-l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~  565 (876)
T 4ecn_A          488 SNLKDLTDVELYNCPNMTQLPDF-LYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPA  565 (876)
T ss_dssp             GGCTTCCEEEEESCTTCCSCCGG-GGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCC
T ss_pred             ccCCCCCEEECcCCCCCccChHH-HhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCC
Confidence             8888888888888877777744 4578888888888887 776 6777666555       8888888888888 4555


Q ss_pred             --cccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCCh
Q 040702          145 --TFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPE  222 (797)
Q Consensus       145 --~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~  222 (797)
                        .|.++++|++|+|++|.++.+| .      |..+++|+.|+|++|++. .+|..+..++.+|+.|++++|.++ .+|.
T Consensus       566 ~~~l~~L~~L~~L~Ls~N~l~~lp-~------~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~  636 (876)
T 4ecn_A          566 SASLQKMVKLGLLDCVHNKVRHLE-A------FGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPN  636 (876)
T ss_dssp             HHHHTTCTTCCEEECTTSCCCBCC-C------CCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCS
T ss_pred             hhhhhcCCCCCEEECCCCCcccch-h------hcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCch
Confidence              7888888888888888887655 2      677778888888888888 566677777723888888888887 6677


Q ss_pred             hhhhhhhhHhhhcccccccccCCCchhh---c--CCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCCCC
Q 040702          223 EINNLTNLILQLLSLEGNQLEGSIPDDL---C--RLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTL  297 (797)
Q Consensus       223 ~~~~l~~L~L~~L~Ls~N~l~~~~~~~~---~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~  297 (797)
                      .+..++.-.|+.|+|++|++.+.+|...   .  .+++|+.|+|++|+++.+++..+..+++|+.|+|++|.++.+|..+
T Consensus       637 ~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~  716 (876)
T 4ecn_A          637 IFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENS  716 (876)
T ss_dssp             CCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTS
T ss_pred             hhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHH
Confidence            7666554112788888888876655322   1  2347888888888888554445557788888888888888887765


Q ss_pred             CCC--------CcccEEEccCCcCCCCCCcccc--ccccccEEeccCcccccccCccccCCcccceecccC------ccc
Q 040702          298 WNL--------KDILHLNLSSNFFTGPLPLKIG--NLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEY------NRL  361 (797)
Q Consensus       298 ~~l--------~~L~~L~l~~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~------N~l  361 (797)
                      +..        ++|+.|+|++|+++ .+|..+.  .+++|+.|+|++|++++ +|..+..+++|+.|+|++      |++
T Consensus       717 ~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l  794 (876)
T 4ecn_A          717 LKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRI  794 (876)
T ss_dssp             SSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBC
T ss_pred             hccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccc
Confidence            542        27888888888887 5666665  78888888888888876 577777888888888865      667


Q ss_pred             cCCCChhhhccccCCeeeecCCcCCCCCChhhhccCCCCeEEccCCcCcccCCCC-CCCCCCCcccccCCccc--cCCCC
Q 040702          362 QGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPRE-GPFRNLSAESFKGNELL--CGMPN  438 (797)
Q Consensus       362 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~~~l~~~~~~~n~~~--c~~~~  438 (797)
                      .+.+|..|..+++|+.|+|++|++ +.+|..+.  ++|+.|++++|++....+.. .+........+.+|++.  ++|+.
T Consensus       795 ~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~~I~gC~~  871 (876)
T 4ecn_A          795 LRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRGCDA  871 (876)
T ss_dssp             CCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTSEEESCGG
T ss_pred             cccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCccccCCCCC
Confidence            777888888888888888888888 56676654  57888888888876554322 11112333445555543  36665


Q ss_pred             cc
Q 040702          439 LQ  440 (797)
Q Consensus       439 ~~  440 (797)
                      +.
T Consensus       872 L~  873 (876)
T 4ecn_A          872 LG  873 (876)
T ss_dssp             GC
T ss_pred             cc
Confidence            43

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1e-49  Score=416.61  Aligned_cols=246  Identities=24%  Similarity=0.304  Sum_probs=211.0

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEec---cCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQ---YGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ++|+..+.||+|+||+||++     ++.||||++.+.   .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            67999999999999999975     689999999865   2344578999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      |||+||+|.+++...+ .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.+.....
T Consensus       112 Ey~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          112 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             ecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            9999999999998754 4899999999999999999999   99999999999999999999999999999997754444


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh----------------hhhhcccccchhc
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE----------------KHLMTKEQPMVRM  727 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~l~~~  727 (797)
                      .......+||+.|||||++.+..|+.++|+||+|+..++++.+..++....                .......+++++.
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~  267 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEK  267 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHH
T ss_pred             cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHH
Confidence            444567899999999999999999999999999999877776665543311                1233456788999


Q ss_pred             cccCCCCCCCChHHHHHhHHHHHHHhccccccccccCCcccccceeeeeeeee
Q 040702          728 GTDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYTI  780 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~  780 (797)
                      |+..||++||++.|+...                   ..+++||||++++|+-
T Consensus       268 lL~~dp~~R~t~~e~~~~-------------------~~i~~Hp~F~~idw~~  301 (311)
T 4aw0_A          268 LLVLDATKRLGCEEMEGY-------------------GPLKAHPFFESVTWEN  301 (311)
T ss_dssp             HSCSSGGGSTTSGGGTCH-------------------HHHHTSGGGTTCCCTT
T ss_pred             HccCCHhHCcChHHHcCC-------------------HHHHCCCCcCCCCHHH
Confidence            999999999998876432                   2346899999999974

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.6e-48  Score=446.93  Aligned_cols=420  Identities=21%  Similarity=0.216  Sum_probs=342.1

Q ss_pred             CCCCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCE
Q 040702            2 PSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKS   81 (797)
Q Consensus         2 ~~l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~   81 (797)
                      +||++|.++++.+.+|..+++|++|||++|++++..        |..+.++++|++|++++|+++++.|.+|.++++|++
T Consensus        33 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~--------~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  104 (570)
T 2z63_A           33 LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIE--------DGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQK  104 (570)
T ss_dssp             EECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEEC--------TTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCE
T ss_pred             EEccCCccCccChhHhhCCCCceEEECCCCcCCccC--------cccccCchhCCEEeCcCCcCCccCHhhhcCcccccc
Confidence            689999999999999999999999999999865432        356888999999999999999988999999999999


Q ss_pred             EEccCCcCcccCCCccccCCCCccEEEccCcccccc-CCchhhCCCCCCEEEccCCcCcccCCccccCCCCC----Ceee
Q 040702           82 LYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGT-IPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNL----KWLG  156 (797)
Q Consensus        82 L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L----~~L~  156 (797)
                      |+|++|+++ .++...+..+++|++|+|++|.+++. +|..|.++++|++|++++|+++++.+..|..+++|    +.|+
T Consensus       105 L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~  183 (570)
T 2z63_A          105 LVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD  183 (570)
T ss_dssp             EECTTSCCC-CSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEE
T ss_pred             ccccccccc-cCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcc
Confidence            999999998 77776688999999999999999863 68999999999999999999999989999999998    8999


Q ss_pred             ccCccCcCCCCCcccc----------------------------------------------------------------
Q 040702          157 LNDNYLTSSTPELSSL----------------------------------------------------------------  172 (797)
Q Consensus       157 L~~N~l~~~~~~~~~~----------------------------------------------------------------  172 (797)
                      +++|.++.+++.....                                                                
T Consensus       184 l~~n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~  263 (570)
T 2z63_A          184 LSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR  263 (570)
T ss_dssp             CTTCCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEE
T ss_pred             cCCCCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhh
Confidence            9999998876642100                                                                


Q ss_pred             ------------ccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccc
Q 040702          173 ------------SSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGN  240 (797)
Q Consensus       173 ------------~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N  240 (797)
                                  ..|..+++|+.|++++|.+.. +|..+..+  +|+.|++++|.+. .+|.  ..+++|  +.|++++|
T Consensus       264 l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~-l~~~~~~~--~L~~L~l~~n~~~-~l~~--~~l~~L--~~L~l~~n  335 (570)
T 2z63_A          264 LAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNF--GWQHLELVNCKFG-QFPT--LKLKSL--KRLTFTSN  335 (570)
T ss_dssp             EEETTEEESCSTTTTGGGTTCSEEEEESCEECS-CCBCCSCC--CCSEEEEESCBCS-SCCB--CBCSSC--CEEEEESC
T ss_pred             hhcchhhhhhchhhhcCcCcccEEEecCccchh-hhhhhccC--CccEEeeccCccc-ccCc--cccccc--CEEeCcCC
Confidence                        012223444444444444442 23333333  3444444444444 2222  133333  55555555


Q ss_pred             cccCCCchhhcCCCCCcEEEccCCcCcccC--CCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEccCCcCCCCCC
Q 040702          241 QLEGSIPDDLCRLAALFQLDLGGNKLSGFV--PACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLP  318 (797)
Q Consensus       241 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~  318 (797)
                      .+.+..+.  ..+++|++|++++|++++..  +..+..+++|++|++++|.++.+|..+..+++|+.|++++|.+.+..+
T Consensus       336 ~~~~~~~~--~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~  413 (570)
T 2z63_A          336 KGGNAFSE--VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSE  413 (570)
T ss_dssp             BSCCBCCC--CBCTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESCTT
T ss_pred             cccccccc--ccCCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccccccccCCCCEEEccCCccccccc
Confidence            55443332  56788999999999988664  667888999999999999998888778889999999999999997766


Q ss_pred             -ccccccccccEEeccCcccccccCccccCCcccceecccCcccc-CCCChhhhccccCCeeeecCCcCCCCCChhhhcc
Q 040702          319 -LKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQ-GSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKL  396 (797)
Q Consensus       319 -~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  396 (797)
                       ..+..+++|+.|++++|.+++..|..|.++++|++|++++|+++ +.+|..+..+++|++|++++|++++..|..|..+
T Consensus       414 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l  493 (570)
T 2z63_A          414 FSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSL  493 (570)
T ss_dssp             SCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTC
T ss_pred             hhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcc
Confidence             57899999999999999999999999999999999999999997 5789999999999999999999999999999999


Q ss_pred             CCCCeEEccCCcCcccCCCC-CCCCCCCcccccCCccccCCCCcc
Q 040702          397 LDLKDINVSFNRLEGEIPRE-GPFRNLSAESFKGNELLCGMPNLQ  440 (797)
Q Consensus       397 ~~L~~L~l~~N~l~~~~p~~-~~~~~l~~~~~~~n~~~c~~~~~~  440 (797)
                      ++|+.|++++|++++.+|.. ..+..++.+++.+|++.|+|+...
T Consensus       494 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~~~  538 (570)
T 2z63_A          494 SSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRID  538 (570)
T ss_dssp             TTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTTH
T ss_pred             cCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcchH
Confidence            99999999999999988763 678899999999999999998654

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=100.00  E-value=1.1e-46  Score=440.50  Aligned_cols=402  Identities=25%  Similarity=0.227  Sum_probs=324.7

Q ss_pred             CCCCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCcc---------------ccCC-CccccCCCCCCEEEcccCcc
Q 040702            2 PSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFI---------------LCEI-PHEIDNLHNMEWMAFSFNKV   65 (797)
Q Consensus         2 ~~l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~---------------l~~i-p~~~~~l~~L~~L~ls~N~i   65 (797)
                      +||++|.++++.|.+|+.+++|++|||++|++++..|..+               ++.+ |..+.++++|++|++++|++
T Consensus        62 L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l  141 (606)
T 3t6q_A           62 LDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHI  141 (606)
T ss_dssp             EECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCC
T ss_pred             EECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcc
Confidence            5778888888878888888888888888887766655432               1222 33455555566666666665


Q ss_pred             cccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCcc--EEEc----------------------------------
Q 040702           66 VGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLK--ELHL----------------------------------  109 (797)
Q Consensus        66 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~--~L~L----------------------------------  109 (797)
                      .++.+..+.++++|++|+|++|.++ .++...|..+++|+  +|++                                  
T Consensus       142 ~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~  220 (606)
T 3t6q_A          142 SSIKLPKGFPTEKLKVLDFQNNAIH-YLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFK  220 (606)
T ss_dssp             CCCCCCTTCCCTTCCEEECCSSCCC-EECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHH
T ss_pred             cccCcccccCCcccCEEEcccCccc-ccChhhhhhhcccceeEEecCCCccCccChhHhhhccccccccCCchhHHHHhh
Confidence            5544334444555555555555555 33333333444444  3444                                  


Q ss_pred             -----------------------------------------cCccccccCCchhhCCCCCCEEEccCCcCcccCCccccC
Q 040702          110 -----------------------------------------WGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGN  148 (797)
Q Consensus       110 -----------------------------------------~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~  148 (797)
                                                               ++|.+++..+..|.++++|++|+|++|+++ ..|..|.+
T Consensus       221 ~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~  299 (606)
T 3t6q_A          221 GLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVG  299 (606)
T ss_dssp             HTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCS
T ss_pred             hccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcc
Confidence                                                     444444444445777889999999999999 46778999


Q ss_pred             CCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCC-hhhhccccCCcEEEccCCcccccC--Chhhh
Q 040702          149 LRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILP-RAIGNLSQSMEDFWMDNCNISGSI--PEEIN  225 (797)
Q Consensus       149 l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~~L~~L~L~~n~i~~~~--p~~~~  225 (797)
                      +++|++|+|++|.++.+++.     .+..+++|++|++++|.+.+..| ..+..++ +|+.|++++|.+.+..  +..+.
T Consensus       300 l~~L~~L~l~~n~l~~~~~~-----~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~~  373 (606)
T 3t6q_A          300 LSTLKKLVLSANKFENLCQI-----SASNFPSLTHLSIKGNTKRLELGTGCLENLE-NLRELDLSHDDIETSDCCNLQLR  373 (606)
T ss_dssp             CTTCCEEECTTCCCSBGGGG-----CGGGCTTCSEEECCSCSSCCBCCSSTTTTCT-TCCEEECCSSCCCEEEESTTTTT
T ss_pred             cccCCEEECccCCcCcCchh-----hhhccCcCCEEECCCCCcccccchhhhhccC-cCCEEECCCCccccccCcchhcc
Confidence            99999999999999988664     47889999999999999985554 5588887 8999999999999876  78899


Q ss_pred             hhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCC-CccCCccccccccCCCCCCCC-CCCCCCCCcc
Q 040702          226 NLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPA-CSGNLTNLRKLYLGSNLLTSI-PSTLWNLKDI  303 (797)
Q Consensus       226 ~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~l-p~~~~~l~~L  303 (797)
                      .+++|  ++|++++|.+.+..|..|..+++|++|++++|++.+..+. .+..+++|+.|++++|.++.. |..+..+++|
T Consensus       374 ~l~~L--~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L  451 (606)
T 3t6q_A          374 NLSHL--QSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPAL  451 (606)
T ss_dssp             TCTTC--CEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTC
T ss_pred             cCCCC--CEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCC
Confidence            99998  9999999999999999999999999999999999877654 489999999999999999665 5578889999


Q ss_pred             cEEEccCCcCCCC---CCccccccccccEEeccCcccccccCccccCCcccceecccCccccCCCChhhhccccCCeeee
Q 040702          304 LHLNLSSNFFTGP---LPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNL  380 (797)
Q Consensus       304 ~~L~l~~N~l~~~---~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  380 (797)
                      ++|++++|.+.+.   .+..+..+++|+.|++++|++++..|..|.++++|+.|+|++|++++..|..+..+++| .|+|
T Consensus       452 ~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L  530 (606)
T 3t6q_A          452 QHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNL  530 (606)
T ss_dssp             CEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEEC
T ss_pred             CEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEEC
Confidence            9999999999862   33678999999999999999999999999999999999999999999999999999999 9999


Q ss_pred             cCCcCCCCCChhhhccCCCCeEEccCCcCcccCC
Q 040702          381 SNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIP  414 (797)
Q Consensus       381 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  414 (797)
                      ++|++++.+|..+..+++|+.|++++|++.|..+
T Consensus       531 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~  564 (606)
T 3t6q_A          531 ASNHISIILPSLLPILSQQRTINLRQNPLDCTCS  564 (606)
T ss_dssp             CSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred             cCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence            9999999999999999999999999999998765

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.4e-48  Score=405.73  Aligned_cols=238  Identities=22%  Similarity=0.304  Sum_probs=200.9

Q ss_pred             cCCCccccccccCCcceeec----------ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD----------GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~----------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l  581 (797)
                      ++|...+.||+|+||+||+|          +..||||+++.......++|.+|++++++++|||||+++|+|.+++..|+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            57888899999999999986          46799999986655556789999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCC------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEE
Q 040702          582 VLEYMPLGSLEKCLYSGN------------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHL  649 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~------------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl  649 (797)
                      |||||++|+|.++++..+            ..++|.++..|+.|||+||+|||   +++|+||||||+|||+++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEE
Confidence            999999999999997542            36899999999999999999999   899999999999999999999999


Q ss_pred             EeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccch----------------
Q 040702          650 SDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIR----------------  712 (797)
Q Consensus       650 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~----------------  712 (797)
                      +|||+|+.....+.........||+.|||||.+.++.|+.++||||+|+..++.+. +..++..                
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~  249 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL  249 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCC
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCC
Confidence            99999987654443333445679999999999999999999999999999876653 3333222                


Q ss_pred             -hhhhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          713 -EEKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       713 -~~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                       .+......+.+++..||+.||++|||+.|+.+.|+.+.+.
T Consensus       250 ~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          250 QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence             1112334677899999999999999999999998887654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.4e-47  Score=407.54  Aligned_cols=238  Identities=21%  Similarity=0.302  Sum_probs=194.1

Q ss_pred             cCCCccccccccCCcceeec----------ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD----------GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~----------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l  581 (797)
                      ++|...++||+|+||+||+|          +..||||+++.......++|.+|++++++++|||||+++|+|.+++..|+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            56778899999999999986          47899999976655556789999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcE
Q 040702          582 VLEYMPLGSLEKCLYSGN--------------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVA  647 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~--------------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~  647 (797)
                      |||||++|+|.++++...              .+++|.++..|+.|||+||+|||   +++|+||||||+|||+++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcE
Confidence            999999999999997542              25899999999999999999999   8999999999999999999999


Q ss_pred             EEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccch--------------
Q 040702          648 HLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIR--------------  712 (797)
Q Consensus       648 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~--------------  712 (797)
                      ||+|||+|+.....+........+||+.|||||.+.+..|+.++||||+|+..++.+. +..++..              
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~  277 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR  277 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTC
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence            9999999997654443334456789999999999999999999999999999876654 3332221              


Q ss_pred             ---hhhhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          713 ---EEKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       713 ---~~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                         .+....+.+.++++.||+.||++|||+.||++.|+.+.+.
T Consensus       278 ~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          278 ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence               1112334677899999999999999999999999888664

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=100.00  E-value=1.7e-46  Score=439.12  Aligned_cols=393  Identities=18%  Similarity=0.235  Sum_probs=330.8

Q ss_pred             CCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCccc------c---------------------------
Q 040702           21 SSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVV------G---------------------------   67 (797)
Q Consensus        21 ~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~------~---------------------------   67 (797)
                      ..++.|||++|.++|.+        |.++++|++|++|+|++|++.      +                           
T Consensus        81 ~~V~~L~L~~~~l~g~l--------p~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~  152 (636)
T 4eco_A           81 GRVTGLSLEGFGASGRV--------PDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDY  152 (636)
T ss_dssp             CCEEEEECTTSCCEEEE--------CGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCC
T ss_pred             CCEEEEEecCcccCCcC--------ChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhcc
Confidence            57899999999977664        567899999999999999762      1                           


Q ss_pred             cCCcccc-------------------CCCCCCEEEcc--CCcCcccCCCccccCCCCccEEEccCcccccc---------
Q 040702           68 VVPTTIF-------------------NVSTLKSLYLH--SNSLSGRLPSSADVRLPNLKELHLWGNNFIGT---------  117 (797)
Q Consensus        68 ~~p~~~~-------------------~l~~L~~L~Ls--~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~---------  117 (797)
                      ..|..+.                   ....++.+++.  +|++++ +|.. +.++++|++|+|++|.+++.         
T Consensus       153 ~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~-l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~  230 (636)
T 4eco_A          153 DPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKA-VMRLTKLRQFYMGNSPFVAENICEAWENE  230 (636)
T ss_dssp             CGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGG-GGGCTTCCEEEEESCCCCGGGBSSSCSCT
T ss_pred             CchhhHHHHHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHH-HhcccCCCEEECcCCcccccccccccccc
Confidence            1111111                   11123333333  688986 8886 46899999999999999985         


Q ss_pred             --------CCchhh--CCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCcc-CcC--CCCCccccccCCCCCCCcEE
Q 040702          118 --------IPSFIF--NASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNY-LTS--STPELSSLSSLSNCKYLEYF  184 (797)
Q Consensus       118 --------~~~~~~--~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~-l~~--~~~~~~~~~~l~~l~~L~~L  184 (797)
                              +|..+.  ++++|++|+|++|++.+..|..|+++++|++|+|++|+ ++.  +|..+..+..+..+++|++|
T Consensus       231 ~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L  310 (636)
T 4eco_A          231 NSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQII  310 (636)
T ss_dssp             TSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEE
T ss_pred             ccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEE
Confidence                    899988  99999999999999999999999999999999999998 885  66655444445566899999


Q ss_pred             EccCCCCCCCCCh--hhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCC-CcEEEc
Q 040702          185 SFSNNPLGGILPR--AIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAA-LFQLDL  261 (797)
Q Consensus       185 ~Ls~N~l~~~~~~--~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~-L~~L~L  261 (797)
                      ++++|+++ .+|.  .+++++ +|+.|++++|.++|.+| .++.+++|  ++|++++|+++ .+|..+..+++ |++|++
T Consensus       311 ~L~~n~l~-~ip~~~~l~~l~-~L~~L~L~~N~l~g~ip-~~~~l~~L--~~L~L~~N~l~-~lp~~l~~l~~~L~~L~L  384 (636)
T 4eco_A          311 YIGYNNLK-TFPVETSLQKMK-KLGMLECLYNQLEGKLP-AFGSEIKL--ASLNLAYNQIT-EIPANFCGFTEQVENLSF  384 (636)
T ss_dssp             ECCSSCCS-SCCCHHHHTTCT-TCCEEECCSCCCEEECC-CCEEEEEE--SEEECCSSEEE-ECCTTSEEECTTCCEEEC
T ss_pred             ECCCCcCC-ccCchhhhccCC-CCCEEeCcCCcCccchh-hhCCCCCC--CEEECCCCccc-cccHhhhhhcccCcEEEc
Confidence            99999999 6677  899998 89999999999999999 99999998  99999999999 77888999999 999999


Q ss_pred             cCCcCcccCCCCccCCc--cccccccCCCCCCC-CCCCCC-------CCCcccEEEccCCcCCCCCCccccccccccEEe
Q 040702          262 GGNKLSGFVPACSGNLT--NLRKLYLGSNLLTS-IPSTLW-------NLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLD  331 (797)
Q Consensus       262 s~N~l~~~~~~~~~~l~--~L~~L~L~~N~l~~-lp~~~~-------~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~  331 (797)
                      ++|+++ .+|..+..++  +|+.|++++|.++. +|..+.       .+++|+.|++++|.++...+..+..+++|+.|+
T Consensus       385 s~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~  463 (636)
T 4eco_A          385 AHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSIN  463 (636)
T ss_dssp             CSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEE
T ss_pred             cCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEE
Confidence            999999 5677777655  89999999999954 566676       778999999999999966555677799999999


Q ss_pred             ccCcccccccCccccCCc-------ccceecccCccccCCCChhhh--ccccCCeeeecCCcCCCCCChhhhccCCCCeE
Q 040702          332 LSMNNFSCVIPTKIGGLK-------DLQYLFLEYNRLQGSIPNSIG--DLISLKSLNLSNNNLSGTIPISLEKLLDLKDI  402 (797)
Q Consensus       332 Ls~N~l~~~~~~~~~~l~-------~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  402 (797)
                      +++|+++.+.+..+....       +|+.|+|++|+++ .+|..+.  .+++|+.|+|++|++++ +|..+..+++|+.|
T Consensus       464 Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L  541 (636)
T 4eco_A          464 LMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGF  541 (636)
T ss_dssp             CCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEE
T ss_pred             CCCCCCCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEE
Confidence            999999965555555443       9999999999999 7888887  99999999999999997 89999999999999


Q ss_pred             Ec------cCCcCcccCCCC-CCCCCCCcccccCCcc
Q 040702          403 NV------SFNRLEGEIPRE-GPFRNLSAESFKGNEL  432 (797)
Q Consensus       403 ~l------~~N~l~~~~p~~-~~~~~l~~~~~~~n~~  432 (797)
                      ++      ++|++.+.+|.. ..+..++.+++++|..
T Consensus       542 ~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l  578 (636)
T 4eco_A          542 GIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI  578 (636)
T ss_dssp             ECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC
T ss_pred             ECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC
Confidence            99      567788888764 5688899999999987

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4.4e-47  Score=397.92  Aligned_cols=236  Identities=22%  Similarity=0.316  Sum_probs=192.3

Q ss_pred             hcCCCccccccccCCcceeecc--eEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          511 TNRFSENNLIGRGGFGPVYKDG--MEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~~--~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      .++|...+.||+|+||+||+|.  ..||||+++....  ...++|.+|++++++++|||||+++|++.+ +..|+|||||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~  113 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWC  113 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSSEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcC
Confidence            3577888999999999999973  6799999875432  234679999999999999999999999865 5689999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccc
Q 040702          587 PLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  666 (797)
Q Consensus       587 ~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  666 (797)
                      ++|+|.++++.....+++.++..|+.|||+||+|||   +++|+||||||+|||+++++.+||+|||+|+..........
T Consensus       114 ~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~  190 (307)
T 3omv_A          114 EGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQ  190 (307)
T ss_dssp             SSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---------
T ss_pred             CCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCccee
Confidence            999999999877667999999999999999999999   89999999999999999999999999999987644333334


Q ss_pred             ccccccCccccccccccc---CccchHHHHHHHhhhhhhhhccccccchhh----------------------hhhhccc
Q 040702          667 QTQTLATIGYMAPDEIFS---GEMRLKCWVNDSLLISVMIVVDANLLIREE----------------------KHLMTKE  721 (797)
Q Consensus       667 ~~~~~gt~~y~aPE~~~~---~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~  721 (797)
                      ....+||+.|||||.+..   +.|+.++||||+|+..++.+.+..++....                      .+....+
T Consensus       191 ~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l  270 (307)
T 3omv_A          191 VEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAM  270 (307)
T ss_dssp             ---CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHH
T ss_pred             ecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHH
Confidence            456789999999999863   468999999999999877666555443211                      1122346


Q ss_pred             ccchhccccCCCCCCCChHHHHHhHHHHH
Q 040702          722 QPMVRMGTDLSLGQFPASYSISKYLVYIR  750 (797)
Q Consensus       722 ~~l~~~cl~~dp~~RPs~~~i~~~l~~i~  750 (797)
                      .+++..||+.||++|||+.|+++.++.++
T Consensus       271 ~~li~~cl~~dP~~RPs~~ei~~~Le~l~  299 (307)
T 3omv_A          271 KRLVADCVKKVKEERPLFPQILSSIELLQ  299 (307)
T ss_dssp             HHHHHHHTCSSSTTSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            77899999999999999999999988765

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5.5e-48  Score=403.71  Aligned_cols=243  Identities=21%  Similarity=0.268  Sum_probs=196.3

Q ss_pred             cCCCccccccccCCcceeec--------ceEEEEEEEEecc--CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD--------GMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~--------~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l  581 (797)
                      ++|+..+.||+|+||+||++        ++.||||++++..  ......+.+|++++++++|||||++++++.+++..|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999964        4689999997553  2234578899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCcc
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  661 (797)
                      |||||+||+|.+++...+ .+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus       104 vmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             EECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence            999999999999998755 4899999999999999999999   999999999999999999999999999999865332


Q ss_pred             CccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh----------------hhhcccccch
Q 040702          662 DQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK----------------HLMTKEQPMV  725 (797)
Q Consensus       662 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~l~  725 (797)
                      .  ......+||+.|||||.+.+..|+.++|+||+|+..++++.+..++.....                ...+..++++
T Consensus       180 ~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li  257 (304)
T 3ubd_A          180 E--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLL  257 (304)
T ss_dssp             ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred             C--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence            2  234557899999999999999999999999999998777766655443211                2234567888


Q ss_pred             hccccCCCCCCCChHHHHHhHHHHHHHhccccccccccCCcccccceeeeeeeee
Q 040702          726 RMGTDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYTI  780 (797)
Q Consensus       726 ~~cl~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~  780 (797)
                      +.||+.||++||++..                    ...+++++|+||+++||+-
T Consensus       258 ~~~L~~dP~~R~ta~~--------------------~~~~eil~Hp~f~~idw~~  292 (304)
T 3ubd_A          258 RMLFKRNPANRLGAGP--------------------DGVEEIKRHSFFSTIDWNK  292 (304)
T ss_dssp             HHHTCSSGGGSTTCST--------------------TTHHHHHTSGGGTTCCHHH
T ss_pred             HHHcccCHHHCCCCCc--------------------CCHHHHHcCccccCCCHHH
Confidence            8899999999998532                    1123456899999999974

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5.5e-47  Score=399.15  Aligned_cols=235  Identities=20%  Similarity=0.253  Sum_probs=196.9

Q ss_pred             cCCCccccccccCCcceeecc----------eEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEE
Q 040702          512 NRFSENNLIGRGGFGPVYKDG----------MEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKA  580 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~~----------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~  580 (797)
                      ++++..+.||+|+||+||+|.          +.||||+++.... ...++|.+|+.++++++|||||+++|+|.+++..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            455667899999999999862          6899999975533 33578999999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCC
Q 040702          581 LVLEYMPLGSLEKCLYSGN---------------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM  645 (797)
Q Consensus       581 lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~  645 (797)
                      +|||||++|+|.+++....               ..++|.++.+|+.|||+||+|||   +++||||||||+|||+++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCC
Confidence            9999999999999996532               25899999999999999999999   89999999999999999999


Q ss_pred             cEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccch------------
Q 040702          646 VAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIR------------  712 (797)
Q Consensus       646 ~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~------------  712 (797)
                      .+||+|||+|+.....+........+||+.|||||.+.++.|+.++||||+|+..++.+. +..++..            
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~  262 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN  262 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHT
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            999999999987654444444456789999999999999999999999999999866553 3322222            


Q ss_pred             -----hhhhhhcccccchhccccCCCCCCCChHHHHHhHHHH
Q 040702          713 -----EEKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYI  749 (797)
Q Consensus       713 -----~~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i  749 (797)
                           .+.+....+.+++..||+.||++||++.||++.|+.+
T Consensus       263 ~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          263 RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                 1122334577889999999999999999999988754

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=7.2e-46  Score=425.14  Aligned_cols=410  Identities=21%  Similarity=0.222  Sum_probs=322.8

Q ss_pred             CCCCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCE
Q 040702            2 PSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKS   81 (797)
Q Consensus         2 ~~l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~   81 (797)
                      +|+++|.+++ +|..+.  ++|++|||++|++++..        |..+.++++|++|++++|+++++.|.+|.++++|++
T Consensus         5 l~ls~n~l~~-ip~~~~--~~L~~L~Ls~n~i~~~~--------~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~   73 (520)
T 2z7x_B            5 VDRSKNGLIH-VPKDLS--QKTTILNISQNYISELW--------TSDILSLSKLRILIISHNRIQYLDISVFKFNQELEY   73 (520)
T ss_dssp             EECTTSCCSS-CCCSCC--TTCSEEECCSSCCCCCC--------HHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCE
T ss_pred             EecCCCCccc-cccccc--ccccEEECCCCcccccC--------hhhccccccccEEecCCCccCCcChHHhhcccCCCE
Confidence            6899999996 666565  99999999999965432        357889999999999999999999999999999999


Q ss_pred             EEccCCcCcccCCCccccCCCCccEEEccCccccc-cCCchhhCCCCCCEEEccCCcCcccCCccccCCCCC--Ceeecc
Q 040702           82 LYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIG-TIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNL--KWLGLN  158 (797)
Q Consensus        82 L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L--~~L~L~  158 (797)
                      |+|++|+|+ .+|..   .+++|++|+|++|++++ ..|..|.++++|++|+|++|+|++   ..|.++++|  ++|+|+
T Consensus        74 L~Ls~N~l~-~lp~~---~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~  146 (520)
T 2z7x_B           74 LDLSHNKLV-KISCH---PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLV  146 (520)
T ss_dssp             EECCSSCCC-EEECC---CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEE
T ss_pred             EecCCCcee-ecCcc---ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccccccceeeEEEee
Confidence            999999998 78876   78999999999999987 468999999999999999999986   568888888  999999


Q ss_pred             CccC--cCCCC-Cccccc--------------------cCCCCCCCcEEEccCCC-------CCCCCChhhhccc-----
Q 040702          159 DNYL--TSSTP-ELSSLS--------------------SLSNCKYLEYFSFSNNP-------LGGILPRAIGNLS-----  203 (797)
Q Consensus       159 ~N~l--~~~~~-~~~~~~--------------------~l~~l~~L~~L~Ls~N~-------l~~~~~~~~~~l~-----  203 (797)
                      +|.+  +...+ .+..+.                    .+.++++|+.|++++|.       +.+.+| .+..++     
T Consensus       147 ~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L  225 (520)
T 2z7x_B          147 LGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNL  225 (520)
T ss_dssp             ECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEE
T ss_pred             cccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhc
Confidence            9999  33322 222211                    23456777777777776       332222 344443     


Q ss_pred             ---------------------cCCcEEEccCCcccccCChhh-----hhhhhhHhhhcccccccccCCCchhhcCC---C
Q 040702          204 ---------------------QSMEDFWMDNCNISGSIPEEI-----NNLTNLILQLLSLEGNQLEGSIPDDLCRL---A  254 (797)
Q Consensus       204 ---------------------~~L~~L~L~~n~i~~~~p~~~-----~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l---~  254 (797)
                                           .+|+.|++++|.+++.+|..+     +.+++|  +.+++++|.+ ......+..+   .
T Consensus       226 ~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L--~~l~l~~n~~-~~p~~~~~~~~~~~  302 (520)
T 2z7x_B          226 TLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKAL--SIHQVVSDVF-GFPQSYIYEIFSNM  302 (520)
T ss_dssp             EEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEE--EEEEEEECCC-CSCTHHHHHHHHTC
T ss_pred             cccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCcee--Eeccccccce-ecchhhhhcccccC
Confidence                                 145555555555555555555     555555  5555555555 2222333333   4


Q ss_pred             CCcEEEccCCcCcccCCCCccCCccccccccCCCCCCC-CCCCCCCCCcccEEEccCCcCCC--CCCccccccccccEEe
Q 040702          255 ALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTS-IPSTLWNLKDILHLNLSSNFFTG--PLPLKIGNLNVLVQLD  331 (797)
Q Consensus       255 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-lp~~~~~l~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~L~  331 (797)
                      +|+.|++++|.+....  .+..+++|++|++++|.++. +|..+..+++|+.|++++|++++  ..|..++.+++|++|+
T Consensus       303 ~L~~L~l~~n~l~~~~--~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~  380 (520)
T 2z7x_B          303 NIKNFTVSGTRMVHML--CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLD  380 (520)
T ss_dssp             CCSEEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEE
T ss_pred             ceeEEEcCCCcccccc--chhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEE
Confidence            5777777777765432  23688999999999999966 78889999999999999999996  4557799999999999


Q ss_pred             ccCccccc-ccCccccCCcccceecccCccccCCCChhhhccccCCeeeecCCcCCCCCChhhhccCCCCeEEccCCcCc
Q 040702          332 LSMNNFSC-VIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLE  410 (797)
Q Consensus       332 Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  410 (797)
                      +++|.+++ ..+..+..+++|++|++++|++++..|..+.  ++|+.|+|++|+++ .+|..+..+++|+.|++++|+++
T Consensus       381 Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~  457 (520)
T 2z7x_B          381 ISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK  457 (520)
T ss_dssp             CCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC
T ss_pred             CCCCcCCcccccchhccCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC
Confidence            99999998 4445688999999999999999887776664  79999999999999 78888889999999999999999


Q ss_pred             ccCCC-CCCCCCCCcccccCCccccCCCC
Q 040702          411 GEIPR-EGPFRNLSAESFKGNELLCGMPN  438 (797)
Q Consensus       411 ~~~p~-~~~~~~l~~~~~~~n~~~c~~~~  438 (797)
                      ..++. ...+..++.+++.+|++.|+|+.
T Consensus       458 ~l~~~~~~~l~~L~~L~l~~N~~~c~c~~  486 (520)
T 2z7x_B          458 SVPDGIFDRLTSLQKIWLHTNPWDCSCPR  486 (520)
T ss_dssp             CCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred             ccCHHHhccCCcccEEECcCCCCcccCCc
Confidence            76555 46788899999999999998874

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=100.00  E-value=3.7e-45  Score=427.47  Aligned_cols=390  Identities=19%  Similarity=0.125  Sum_probs=326.3

Q ss_pred             CCCCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCE
Q 040702            2 PSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKS   81 (797)
Q Consensus         2 ~~l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~   81 (797)
                      +||++|.++++.|.+|+.+++|++|||++|++++..        |..++++++|++|++++|+++++.|..|+++++|++
T Consensus        61 L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~--------p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  132 (606)
T 3vq2_A           61 LDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFS--------PGSFSGLTSLENLVAVETKLASLESFPIGQLITLKK  132 (606)
T ss_dssp             EECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCC--------TTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCE
T ss_pred             EeCCCCcccccCHHHhhchhhcCEeECCCCcccccC--------hhhcCCcccCCEEEccCCccccccccccCCCCCCCE
Confidence            689999999999999999999999999999965543        567888889999999999998888788888999999


Q ss_pred             EEccCCcCcc-cCCCccccCCCCccEEEccCccccccCCchhhCCCCCC----EEEccCCcCcccCCcccc---------
Q 040702           82 LYLHSNSLSG-RLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLS----ELGLQKNSFSGSIPNTFG---------  147 (797)
Q Consensus        82 L~Ls~N~l~~-~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~----~L~L~~N~l~~~~~~~f~---------  147 (797)
                      |+|++|.+++ .+|.. +.++++|++|+|++|++++..+..|..+++|+    +|++++|+++++.+..|.         
T Consensus       133 L~L~~n~l~~~~lp~~-~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L  211 (606)
T 3vq2_A          133 LNVAHNFIHSCKLPAY-FSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTL  211 (606)
T ss_dssp             EECCSSCCCCCCCCGG-GGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEE
T ss_pred             EeCCCCcccceechHh-HhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCceeeeeec
Confidence            9999998874 34554 46888999999999888877777666555443    566666666554443332         


Q ss_pred             --------------------------------------------------------------------------------
Q 040702          148 --------------------------------------------------------------------------------  147 (797)
Q Consensus       148 --------------------------------------------------------------------------------  147 (797)
                                                                                                      
T Consensus       212 ~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~  291 (606)
T 3vq2_A          212 RGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMS  291 (606)
T ss_dssp             ESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEE
T ss_pred             cCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccccccCCCCCEEE
Confidence                                                                                            


Q ss_pred             -------------CCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCC
Q 040702          148 -------------NLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNC  214 (797)
Q Consensus       148 -------------~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n  214 (797)
                                   .+++|++|++++|.+..++       .+ .+++|+.|++++|+..+..  .+..++ +|+.|++++|
T Consensus       292 l~~~~~~~l~~l~~~~~L~~L~l~~n~l~~lp-------~~-~l~~L~~L~l~~n~~~~~~--~~~~l~-~L~~L~ls~n  360 (606)
T 3vq2_A          292 LAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFP-------TL-DLPFLKSLTLTMNKGSISF--KKVALP-SLSYLDLSRN  360 (606)
T ss_dssp             EESCCCCCCCCCCTTCCCSEEEEESCCCSSCC-------CC-CCSSCCEEEEESCSSCEEC--CCCCCT-TCCEEECCSS
T ss_pred             ecCccchhhhhccccccCCEEEcccccCcccc-------cC-CCCccceeeccCCcCccch--hhccCC-CCCEEECcCC
Confidence                         2334444444444443333       25 7899999999999655433  566777 8999999999


Q ss_pred             ccccc--CChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCC-CCccCCccccccccCCCCCC
Q 040702          215 NISGS--IPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVP-ACSGNLTNLRKLYLGSNLLT  291 (797)
Q Consensus       215 ~i~~~--~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~  291 (797)
                      .+++.  .|..+..+++|  ++|++++|.+.+ .|..|..+++|+.|++++|++.+..| ..+..+++|++|++++|.++
T Consensus       361 ~l~~~~~~~~~~~~~~~L--~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~  437 (606)
T 3vq2_A          361 ALSFSGCCSYSDLGTNSL--RHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTK  437 (606)
T ss_dssp             CEEEEEECCHHHHCCSCC--CEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCE
T ss_pred             ccCCCcchhhhhccCCcc--cEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCC
Confidence            99977  48899999998  999999999996 55889999999999999999998877 68999999999999999995


Q ss_pred             C-CCCCCCCCCcccEEEccCCcCCC-CCCccccccccccEEeccCcccccccCccccCCcccceecccCccccCCCChhh
Q 040702          292 S-IPSTLWNLKDILHLNLSSNFFTG-PLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSI  369 (797)
Q Consensus       292 ~-lp~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~  369 (797)
                      . .|..+..+++|+.|++++|.+++ ..|..|+.+++|+.|++++|++++..|..|.++++|++|+|++|++++..|..|
T Consensus       438 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  517 (606)
T 3vq2_A          438 IDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHY  517 (606)
T ss_dssp             ECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGT
T ss_pred             ccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHc
Confidence            5 56788899999999999999997 478899999999999999999999999999999999999999999999889999


Q ss_pred             hccccCCeeeecCCcCCCCCChhhhccC-CCCeEEccCCcCcccCCC
Q 040702          370 GDLISLKSLNLSNNNLSGTIPISLEKLL-DLKDINVSFNRLEGEIPR  415 (797)
Q Consensus       370 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~l~~N~l~~~~p~  415 (797)
                      ..+++|++|+|++|+++ .+|..+..++ +|+.|++++|++.|..+.
T Consensus       518 ~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~~  563 (606)
T 3vq2_A          518 NQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICEH  563 (606)
T ss_dssp             TTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSSTT
T ss_pred             cCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCcc
Confidence            99999999999999999 5676799997 699999999999987654

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=100.00  E-value=1e-44  Score=429.58  Aligned_cols=414  Identities=22%  Similarity=0.232  Sum_probs=302.1

Q ss_pred             CCCCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCE
Q 040702            2 PSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKS   81 (797)
Q Consensus         2 ~~l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~   81 (797)
                      +|.+++.++. +|..+.  +++++|||++|++++..        |..+.++++|++|++++|+++++.|.+|.++++|++
T Consensus         9 ~~cs~~~L~~-ip~~~~--~~l~~L~Ls~n~l~~~~--------~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~   77 (680)
T 1ziw_A            9 ADCSHLKLTQ-VPDDLP--TNITVLNLTHNQLRRLP--------AANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKV   77 (680)
T ss_dssp             EECCSSCCSS-CCSCSC--TTCSEEECCSSCCCCCC--------GGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCE
T ss_pred             eECCCCCccc-cccccC--CCCcEEECCCCCCCCcC--------HHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCE
Confidence            4678888865 555453  89999999999965432        235888999999999999999999999999999999


Q ss_pred             EEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCcc
Q 040702           82 LYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNY  161 (797)
Q Consensus        82 L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~  161 (797)
                      |+|++|+++ .+|...|.++++|++|+|++|++++..|..|.++++|++|+|++|+++++.+..|.++++|++|+|++|.
T Consensus        78 L~L~~n~l~-~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~  156 (680)
T 1ziw_A           78 LNLQHNELS-QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNK  156 (680)
T ss_dssp             EECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSC
T ss_pred             EECCCCccC-ccChhhhccCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCc
Confidence            999999998 8888888899999999999999998888899999999999999999999999999999999999999999


Q ss_pred             CcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccc--------------------------cCCcEEEccCCc
Q 040702          162 LTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLS--------------------------QSMEDFWMDNCN  215 (797)
Q Consensus       162 l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~--------------------------~~L~~L~L~~n~  215 (797)
                      ++..++...   .+..+++|+.|++++|++.++.|..|..++                          .+|+.|++++|.
T Consensus       157 l~~~~~~~~---~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~  233 (680)
T 1ziw_A          157 IQALKSEEL---DIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQ  233 (680)
T ss_dssp             CCCBCHHHH---GGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSC
T ss_pred             ccccCHHHh---hccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCc
Confidence            988765421   123457889999999999888887776542                          257778888888


Q ss_pred             ccccCChhhhhhhh--hHhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCC--
Q 040702          216 ISGSIPEEINNLTN--LILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLT--  291 (797)
Q Consensus       216 i~~~~p~~~~~l~~--L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~--  291 (797)
                      +.+..|.+|.+++.  |  ++|++++|++.++.+..|..+++|++|++++|++.+..|..|.++++|+.|++++|...  
T Consensus       234 l~~~~~~~~~~l~~~~L--~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~  311 (680)
T 1ziw_A          234 LSTTSNTTFLGLKWTNL--TMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQS  311 (680)
T ss_dssp             CCEECTTTTGGGGGSCC--CEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC-
T ss_pred             ccccChhHhhccCcCCC--CEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcc
Confidence            88888888887765  6  88888888888888888888888888888888888877777777777777666665432  


Q ss_pred             ----CCCC----CCCCCCcccEEEccCCcCCCCCCccccccccccEEecc----------------------------Cc
Q 040702          292 ----SIPS----TLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLS----------------------------MN  335 (797)
Q Consensus       292 ----~lp~----~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls----------------------------~N  335 (797)
                          .+|.    .+..+++|++|++++|.+++..+..|.++++|++|+++                            +|
T Consensus       312 ~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n  391 (680)
T 1ziw_A          312 ISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKN  391 (680)
T ss_dssp             -----CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTS
T ss_pred             cccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCC
Confidence                2332    44455666666666666665555555555444444443                            44


Q ss_pred             ccccccCccccCCcccceecccCccccCCCC-hhhhccccCCeeeecCCcCCCCCChhhhccCCCCeEEccCCcCc--cc
Q 040702          336 NFSCVIPTKIGGLKDLQYLFLEYNRLQGSIP-NSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLE--GE  412 (797)
Q Consensus       336 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~--~~  412 (797)
                      +++++.|..|..+++|+.|+|++|++.+.+| ..|..+++|++|++++|++++..+..|..+++|+.|++++|.++  +.
T Consensus       392 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~  471 (680)
T 1ziw_A          392 KISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDS  471 (680)
T ss_dssp             CCCEECTTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTC
T ss_pred             CCCeEChhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhcccccccccc
Confidence            4444555556666666666666666654333 45566666666666666665555555555555555555555554  22


Q ss_pred             CCC-CCCCCCCCcccccCCcc
Q 040702          413 IPR-EGPFRNLSAESFKGNEL  432 (797)
Q Consensus       413 ~p~-~~~~~~l~~~~~~~n~~  432 (797)
                      +|. ...+..++.+++++|..
T Consensus       472 ~p~~~~~l~~L~~L~Ls~N~l  492 (680)
T 1ziw_A          472 SPSPFQPLRNLTILDLSNNNI  492 (680)
T ss_dssp             SSCTTTTCTTCCEEECCSSCC
T ss_pred             CCcccccCCCCCEEECCCCCC
Confidence            222 24455566666666643

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.6e-46  Score=396.91  Aligned_cols=226  Identities=21%  Similarity=0.211  Sum_probs=196.7

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      +.|+..++||+|+||+||++     |+.||||+++.......+.+.+|+++|++++|||||+++++|.+++..|+|||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            56999999999999999985     6899999998776666788999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccc
Q 040702          587 PLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  666 (797)
Q Consensus       587 ~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  666 (797)
                      +||+|.+++...  .+++.++..|+.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+.+.....  .
T Consensus       154 ~gg~L~~~l~~~--~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~  226 (346)
T 4fih_A          154 EGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--R  226 (346)
T ss_dssp             TTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--C
T ss_pred             CCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC--c
Confidence            999999999765  3899999999999999999999   99999999999999999999999999999987643322  3


Q ss_pred             ccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh-------------------hhhhcccccchhc
Q 040702          667 QTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE-------------------KHLMTKEQPMVRM  727 (797)
Q Consensus       667 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~l~~~  727 (797)
                      ....+||+.|||||++.+..|+.++||||+|++.++++.+..++....                   .......+++++.
T Consensus       227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~  306 (346)
T 4fih_A          227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR  306 (346)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHH
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHH
Confidence            456789999999999999999999999999999877766655443211                   1223456788999


Q ss_pred             cccCCCCCCCChHHHHH
Q 040702          728 GTDLSLGQFPASYSISK  744 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~  744 (797)
                      ||..||++|||+.|+++
T Consensus       307 ~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          307 LLVRDPAQRATAAELLK  323 (346)
T ss_dssp             HSCSSTTTSCCHHHHTT
T ss_pred             HcCCChhHCcCHHHHhc
Confidence            99999999999887764

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=7.5e-46  Score=428.09  Aligned_cols=411  Identities=22%  Similarity=0.231  Sum_probs=302.4

Q ss_pred             CCCCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCE
Q 040702            2 PSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKS   81 (797)
Q Consensus         2 ~~l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~   81 (797)
                      +||++|.+++..+..|..+++|++|||++|++++..        |..++.+++|++|++++|++++..|..|+++++|++
T Consensus        31 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~--------~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~  102 (549)
T 2z81_A           31 LDLSFNKITYIGHGDLRACANLQVLILKSSRINTIE--------GDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKY  102 (549)
T ss_dssp             EECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEEC--------TTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCE
T ss_pred             EECcCCccCccChhhhhcCCcccEEECCCCCcCccC--------hhhccccccCCEEECCCCccCccCHHHhccCCCCcE
Confidence            577888888887778888888888888888755433        345677778888888888888777777888888888


Q ss_pred             EEccCCcCcccCCCccccCCCCccEEEccCcc-ccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCc
Q 040702           82 LYLHSNSLSGRLPSSADVRLPNLKELHLWGNN-FIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDN  160 (797)
Q Consensus        82 L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N  160 (797)
                      |+|++|.+++.-....+..+++|++|+|++|+ +....+..|.++++|++|+|++|++++..|..|.++++|++|++++|
T Consensus       103 L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n  182 (549)
T 2z81_A          103 LNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLS  182 (549)
T ss_dssp             EECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECS
T ss_pred             EECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccC
Confidence            88888887631112345677888888888887 44344467777888888888888888777777777777777777777


Q ss_pred             cCcCCCCCccccccCCCCCCCcEEEccCCCCCCCC--ChhhhccccCCc----------------------------EEE
Q 040702          161 YLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGIL--PRAIGNLSQSME----------------------------DFW  210 (797)
Q Consensus       161 ~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~--~~~~~~l~~~L~----------------------------~L~  210 (797)
                      .+..++..+     +..+++|++|++++|++.+..  |..+.....+|+                            .++
T Consensus       183 ~~~~~~~~~-----~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~  257 (549)
T 2z81_A          183 ESAFLLEIF-----ADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE  257 (549)
T ss_dssp             BSTTHHHHH-----HHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEE
T ss_pred             cccccchhh-----HhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhccccccc
Confidence            665544321     334667777777777777642  111111111344                            444


Q ss_pred             ccCCcccccC-----------------------------------ChhhhhhhhhHhhhcccccccccCCCchhh-cCCC
Q 040702          211 MDNCNISGSI-----------------------------------PEEINNLTNLILQLLSLEGNQLEGSIPDDL-CRLA  254 (797)
Q Consensus       211 L~~n~i~~~~-----------------------------------p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~-~~l~  254 (797)
                      +++|.+.+..                                   +..+....+|  +.|++++|.+.. +|..+ ..++
T Consensus       258 l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L--~~L~l~~n~l~~-ip~~~~~~l~  334 (549)
T 2z81_A          258 FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKV--KRITVENSKVFL-VPCSFSQHLK  334 (549)
T ss_dssp             EESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTC--CEEEEESSCCCC-CCHHHHHHCT
T ss_pred             cccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccc--eEEEeccCcccc-CCHHHHhcCc
Confidence            4444333210                                   0111222344  788888888874 45444 6799


Q ss_pred             CCcEEEccCCcCcccCC---CCccCCccccccccCCCCCCCCCC---CCCCCCcccEEEccCCcCCCCCCcccccccccc
Q 040702          255 ALFQLDLGGNKLSGFVP---ACSGNLTNLRKLYLGSNLLTSIPS---TLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLV  328 (797)
Q Consensus       255 ~L~~L~Ls~N~l~~~~~---~~~~~l~~L~~L~L~~N~l~~lp~---~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~  328 (797)
                      +|++|++++|++++..|   ..++.+++|++|+|++|.++.+|.   .+..+++|++|++++|+++ .+|..+..+++|+
T Consensus       335 ~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~  413 (549)
T 2z81_A          335 SLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMR  413 (549)
T ss_dssp             TCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCC
T ss_pred             cccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc-cCChhhccccccc
Confidence            99999999999987653   457889999999999999988763   4778999999999999998 5677888999999


Q ss_pred             EEeccCcccccccCccccCCcccceecccCccccCCCChhhhccccCCeeeecCCcCCCCCChhhhccCCCCeEEccCCc
Q 040702          329 QLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNR  408 (797)
Q Consensus       329 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~  408 (797)
                      +|++++|.++.. |..+  .++|++|+|++|++++..    ..+++|++|+|++|+++ .+|. ...+++|+.|++++|+
T Consensus       414 ~L~Ls~N~l~~l-~~~~--~~~L~~L~Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~  484 (549)
T 2z81_A          414 FLNLSSTGIRVV-KTCI--PQTLEVLDVSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQ  484 (549)
T ss_dssp             EEECTTSCCSCC-CTTS--CTTCSEEECCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSC
T ss_pred             EEECCCCCcccc-cchh--cCCceEEECCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCc
Confidence            999999999854 4333  268999999999998643    57899999999999998 5665 4679999999999999


Q ss_pred             CcccCCC-CCCCCCCCcccccCCccccCCCC
Q 040702          409 LEGEIPR-EGPFRNLSAESFKGNELLCGMPN  438 (797)
Q Consensus       409 l~~~~p~-~~~~~~l~~~~~~~n~~~c~~~~  438 (797)
                      +++.+|. ...+..++.+++++|++.|+|+.
T Consensus       485 l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~  515 (549)
T 2z81_A          485 LKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR  515 (549)
T ss_dssp             CCCCCTTGGGGCTTCCEEECCSSCBCCCHHH
T ss_pred             cCCcCHHHHhcCcccCEEEecCCCccCCCcc
Confidence            9998886 46788899999999999998874

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=100.00  E-value=4.9e-45  Score=433.59  Aligned_cols=391  Identities=19%  Similarity=0.285  Sum_probs=338.6

Q ss_pred             CCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEc-ccCccccc-------------------------------
Q 040702           21 SSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAF-SFNKVVGV-------------------------------   68 (797)
Q Consensus        21 ~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~l-s~N~i~~~-------------------------------   68 (797)
                      ..++.|||++|.++|.+        |.++++|++|++|+| ++|++.+.                               
T Consensus       323 ~~V~~L~Ls~~~L~G~i--------p~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~  394 (876)
T 4ecn_A          323 GRVTGLSLAGFGAKGRV--------PDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDY  394 (876)
T ss_dssp             SCEEEEECTTTCCEEEE--------CGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCC
T ss_pred             CCEEEEECccCCCCCcC--------chHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhcc
Confidence            67999999999977664        567899999999999 77765443                               


Q ss_pred             ---------------------------------------------CCccccCCCCCCEEEccCCcCcc------------
Q 040702           69 ---------------------------------------------VPTTIFNVSTLKSLYLHSNSLSG------------   91 (797)
Q Consensus        69 ---------------------------------------------~p~~~~~l~~L~~L~Ls~N~l~~------------   91 (797)
                                                                   +|..|+++++|+.|+|++|+|++            
T Consensus       395 ~~~~~~s~l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~  474 (876)
T 4ecn_A          395 DQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANS  474 (876)
T ss_dssp             CGGGGSCHHHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTS
T ss_pred             CcchhhhHHHHHHhhhCccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCccccccccccc
Confidence                                                         78899999999999999999996            


Q ss_pred             -----cCCCcc-ccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCc-Ccc-cCCccccCCC-------CCCeee
Q 040702           92 -----RLPSSA-DVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNS-FSG-SIPNTFGNLR-------NLKWLG  156 (797)
Q Consensus        92 -----~l~~~~-~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~-~~~~~f~~l~-------~L~~L~  156 (797)
                           .+|..+ |.++++|++|+|++|++.+.+|..|.++++|++|+|++|+ |++ ..|..|.+++       +|++|+
T Consensus       475 n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~  554 (876)
T 4ecn_A          475 DYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFY  554 (876)
T ss_dssp             HHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEE
T ss_pred             ccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEE
Confidence                 288876 5689999999999999999999999999999999999998 987 6787666665       999999


Q ss_pred             ccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhh-hHhhhc
Q 040702          157 LNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTN-LILQLL  235 (797)
Q Consensus       157 L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~-L~L~~L  235 (797)
                      |++|.++.+|..    ..|.++++|+.|+|++|++. .+| .|..++ +|+.|++++|.++ .+|..+..+++ |  ++|
T Consensus       555 Ls~N~L~~ip~~----~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~-~L~~L~Ls~N~l~-~lp~~l~~l~~~L--~~L  624 (876)
T 4ecn_A          555 MGYNNLEEFPAS----ASLQKMVKLGLLDCVHNKVR-HLE-AFGTNV-KLTDLKLDYNQIE-EIPEDFCAFTDQV--EGL  624 (876)
T ss_dssp             CCSSCCCBCCCH----HHHTTCTTCCEEECTTSCCC-BCC-CCCTTS-EESEEECCSSCCS-CCCTTSCEECTTC--CEE
T ss_pred             eeCCcCCccCCh----hhhhcCCCCCEEECCCCCcc-cch-hhcCCC-cceEEECcCCccc-cchHHHhhccccC--CEE
Confidence            999999977750    02778899999999999999 666 888887 8999999999999 89989999998 8  999


Q ss_pred             ccccccccCCCchhhcCCCC--CcEEEccCCcCcccCCCCc---c--CCccccccccCCCCCCCCCCCCC-CCCcccEEE
Q 040702          236 SLEGNQLEGSIPDDLCRLAA--LFQLDLGGNKLSGFVPACS---G--NLTNLRKLYLGSNLLTSIPSTLW-NLKDILHLN  307 (797)
Q Consensus       236 ~Ls~N~l~~~~~~~~~~l~~--L~~L~Ls~N~l~~~~~~~~---~--~l~~L~~L~L~~N~l~~lp~~~~-~l~~L~~L~  307 (797)
                      +|++|.++ .+|..+..+..  |+.|+|++|++.+.+|...   .  .+++|+.|+|++|.++.+|..++ .+++|+.|+
T Consensus       625 ~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~  703 (876)
T 4ecn_A          625 GFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTII  703 (876)
T ss_dssp             ECCSSCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEE
T ss_pred             ECcCCCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEE
Confidence            99999999 67788877654  9999999999998766432   2  34589999999999999998765 789999999


Q ss_pred             ccCCcCCCCCCccccc-------cccccEEeccCcccccccCcccc--CCcccceecccCccccCCCChhhhccccCCee
Q 040702          308 LSSNFFTGPLPLKIGN-------LNVLVQLDLSMNNFSCVIPTKIG--GLKDLQYLFLEYNRLQGSIPNSIGDLISLKSL  378 (797)
Q Consensus       308 l~~N~l~~~~~~~~~~-------l~~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  378 (797)
                      +++|.++...+..+..       +++|+.|+|++|+++ .+|..+.  .+++|+.|+|++|++++ +|..+..+++|+.|
T Consensus       704 Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L  781 (876)
T 4ecn_A          704 LSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAF  781 (876)
T ss_dssp             CCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEE
T ss_pred             CCCCcCCccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEE
Confidence            9999999544444432       349999999999999 5677776  99999999999999997 79899999999999


Q ss_pred             eecC------CcCCCCCChhhhccCCCCeEEccCCcCcccCCCCCCCCCCCcccccCCcccc
Q 040702          379 NLSN------NNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLC  434 (797)
Q Consensus       379 ~Ls~------N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~~~~~~n~~~c  434 (797)
                      +|++      |++.+.+|..+..+++|+.|++++|++ +.+|.. ....++.+++++|++..
T Consensus       782 ~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~-l~~~L~~LdLs~N~l~~  841 (876)
T 4ecn_A          782 GIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEK-LTPQLYILDIADNPNIS  841 (876)
T ss_dssp             ECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSC-CCSSSCEEECCSCTTCE
T ss_pred             ECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHh-hcCCCCEEECCCCCCCc
Confidence            9976      889999999999999999999999999 566664 23689999999998754

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2e-46  Score=398.44  Aligned_cols=230  Identities=19%  Similarity=0.221  Sum_probs=191.1

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCC--cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG--AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      .++|+..+.||+|+||+||++     ++.||||++++....  ..+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence            368999999999999999985     689999999866432  3467899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          584 EYMPLGSLEKCLYSGNY-ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      |||+||+|.+++...+. .+++.+++.|+.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+......
T Consensus       103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            99999999999976543 5789999999999999999999   9999999999999999999999999999999764321


Q ss_pred             ccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh-----------------hhhhcccccch
Q 040702          663 QSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE-----------------KHLMTKEQPMV  725 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~l~  725 (797)
                        ......+||+.|||||++.+..|+.++|+||+|++.++++.+..++....                 ......+++++
T Consensus       180 --~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li  257 (350)
T 4b9d_A          180 --ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLV  257 (350)
T ss_dssp             --HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHH
T ss_pred             --ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHH
Confidence              12345789999999999999999999999999999877766655443211                 12234567899


Q ss_pred             hccccCCCCCCCChHHHHHh
Q 040702          726 RMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       726 ~~cl~~dp~~RPs~~~i~~~  745 (797)
                      +.||+.||++|||+.|+++.
T Consensus       258 ~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          258 SQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             HHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHccCChhHCcCHHHHhcC
Confidence            99999999999999999763

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.7e-46  Score=393.80  Aligned_cols=232  Identities=20%  Similarity=0.225  Sum_probs=193.2

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      .+.|...++||+|+||+||++     ++.||||+++...     ...+|+.++++++|||||++++++.+++..|+||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            356888899999999999985     6899999997542     234799999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCC-cEEEEeecCCccCCccCcc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM-VAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DFGla~~~~~~~~~  664 (797)
                      |+||+|.++++..+ .+++..+..|+.||+.||+|||   +++|+||||||+|||++.+| .+||+|||+|+.+..+...
T Consensus       132 ~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          132 LEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             CTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            99999999998755 4999999999999999999999   99999999999999999987 6999999999876443221


Q ss_pred             ---ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccch-------------------hhhhhhcccc
Q 040702          665 ---LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIR-------------------EEKHLMTKEQ  722 (797)
Q Consensus       665 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~  722 (797)
                         ......+||+.|||||++.+..|+.++||||+|++.++++.+..++..                   .+......+.
T Consensus       208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~  287 (336)
T 4g3f_A          208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTA  287 (336)
T ss_dssp             ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHH
T ss_pred             cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHH
Confidence               122346899999999999999999999999999998776665544322                   1122334567


Q ss_pred             cchhccccCCCCCCCChHHHHHhHHHHHH
Q 040702          723 PMVRMGTDLSLGQFPASYSISKYLVYIRE  751 (797)
Q Consensus       723 ~l~~~cl~~dp~~RPs~~~i~~~l~~i~~  751 (797)
                      ++++.||+.||.+|||+.|+++.+.....
T Consensus       288 ~li~~~L~~dP~~R~sa~el~~~l~~~l~  316 (336)
T 4g3f_A          288 QAIQEGLRKEPVHRASAMELRRKVGKALQ  316 (336)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            88999999999999999999988776543

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.6e-45  Score=398.77  Aligned_cols=226  Identities=21%  Similarity=0.211  Sum_probs=197.0

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      +.|+..+.||+|+||.||++     |+.||||+++.......+.+.+|+.+|++++|||||+++++|.+++..|+|||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56999999999999999985     6899999998776666788999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccc
Q 040702          587 PLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  666 (797)
Q Consensus       587 ~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  666 (797)
                      +||+|.+++....  +++.++..|+.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+.+....  ..
T Consensus       231 ~gG~L~~~i~~~~--l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~--~~  303 (423)
T 4fie_A          231 EGGALTDIVTHTR--MNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PR  303 (423)
T ss_dssp             TTEEHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC--CC
T ss_pred             CCCcHHHHHhccC--CCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC--cc
Confidence            9999999997654  899999999999999999999   9999999999999999999999999999998764332  23


Q ss_pred             ccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh-------------------hhhcccccchhc
Q 040702          667 QTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK-------------------HLMTKEQPMVRM  727 (797)
Q Consensus       667 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~l~~~  727 (797)
                      ....+||+.|||||++.+..|+.++||||+|++.++++.+..++.....                   .....++++++.
T Consensus       304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~  383 (423)
T 4fie_A          304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR  383 (423)
T ss_dssp             BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHH
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHH
Confidence            4567899999999999999999999999999998777766555432111                   123356788999


Q ss_pred             cccCCCCCCCChHHHHH
Q 040702          728 GTDLSLGQFPASYSISK  744 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~  744 (797)
                      ||..||++|||+.|+++
T Consensus       384 ~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          384 LLVRDPAQRATAAELLK  400 (423)
T ss_dssp             HSCSSTTTSCCHHHHTT
T ss_pred             HcCCChhHCcCHHHHhc
Confidence            99999999999887754

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.7e-44  Score=415.86  Aligned_cols=390  Identities=21%  Similarity=0.214  Sum_probs=338.1

Q ss_pred             CCCCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCE
Q 040702            2 PSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKS   81 (797)
Q Consensus         2 ~~l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~   81 (797)
                      +||++|.++++.+..|+.+++|++|||++|++++..        |..+.++++|++|++++|+++++.+..|+++++|++
T Consensus        57 L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~--------~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~  128 (570)
T 2z63_A           57 LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLA--------LGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKE  128 (570)
T ss_dssp             EECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEEC--------TTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCE
T ss_pred             EECCCCcCCccCcccccCchhCCEEeCcCCcCCccC--------HhhhcCccccccccccccccccCCCccccccccccE
Confidence            689999999999999999999999999999965433        356788899999999999998877777889999999


Q ss_pred             EEccCCcCcc-cCCCccccCCCCccEEEccCccccccCCchhhCCCCC----CEEEccCCcCcccCCc------------
Q 040702           82 LYLHSNSLSG-RLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKL----SELGLQKNSFSGSIPN------------  144 (797)
Q Consensus        82 L~Ls~N~l~~-~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L----~~L~L~~N~l~~~~~~------------  144 (797)
                      |+|++|.+++ .+|.. +.++++|++|++++|++++..+..|..+++|    ++|++++|.++++.++            
T Consensus       129 L~L~~n~l~~~~lp~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~~L~~L~l  207 (570)
T 2z63_A          129 LNVAHNLIQSFKLPEY-FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTL  207 (570)
T ss_dssp             EECCSSCCCCCCCCGG-GGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEE
T ss_pred             EecCCCccceecChhh-hcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHHhccCcceeEec
Confidence            9999999874 24544 5688999999999999888777888888777    7888888877665543            


Q ss_pred             ---------------------------------------------------------------------cccCCCCCCee
Q 040702          145 ---------------------------------------------------------------------TFGNLRNLKWL  155 (797)
Q Consensus       145 ---------------------------------------------------------------------~f~~l~~L~~L  155 (797)
                                                                                           .|..+++|++|
T Consensus       208 ~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L  287 (570)
T 2z63_A          208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSF  287 (570)
T ss_dssp             ESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEE
T ss_pred             ccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEE
Confidence                                                                                 34456788888


Q ss_pred             eccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhc
Q 040702          156 GLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLL  235 (797)
Q Consensus       156 ~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L  235 (797)
                      ++++|.++.++..      +..+ +|+.|++++|.+..+..   ..++ +|+.|++++|.+.+..+.  ..+++|  ++|
T Consensus       288 ~l~~~~l~~l~~~------~~~~-~L~~L~l~~n~~~~l~~---~~l~-~L~~L~l~~n~~~~~~~~--~~~~~L--~~L  352 (570)
T 2z63_A          288 SLVSVTIERVKDF------SYNF-GWQHLELVNCKFGQFPT---LKLK-SLKRLTFTSNKGGNAFSE--VDLPSL--EFL  352 (570)
T ss_dssp             EEESCEECSCCBC------CSCC-CCSEEEEESCBCSSCCB---CBCS-SCCEEEEESCBSCCBCCC--CBCTTC--CEE
T ss_pred             EecCccchhhhhh------hccC-CccEEeeccCcccccCc---cccc-ccCEEeCcCCcccccccc--ccCCCC--CEE
Confidence            8888888877654      5566 89999999999995543   3455 899999999999877765  667777  999


Q ss_pred             ccccccccCCC--chhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCC--CCCCCCcccEEEccCC
Q 040702          236 SLEGNQLEGSI--PDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPS--TLWNLKDILHLNLSSN  311 (797)
Q Consensus       236 ~Ls~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~--~~~~l~~L~~L~l~~N  311 (797)
                      ++++|.+++..  +..+..+++|++|++++|.+.+..+. +..+++|+.|++++|.++.++.  .+..+++|+.|++++|
T Consensus       353 ~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n  431 (570)
T 2z63_A          353 DLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT  431 (570)
T ss_dssp             ECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTS
T ss_pred             eCcCCccCccccccccccccCccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCC
Confidence            99999998665  78899999999999999999987665 9999999999999999976643  6778999999999999


Q ss_pred             cCCCCCCccccccccccEEeccCcccc-cccCccccCCcccceecccCccccCCCChhhhccccCCeeeecCCcCCCCCC
Q 040702          312 FFTGPLPLKIGNLNVLVQLDLSMNNFS-CVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIP  390 (797)
Q Consensus       312 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  390 (797)
                      .+.+..|..|.++++|+.|++++|.++ +..|..|..+++|++|++++|++++..|..|..+++|++|++++|++++..|
T Consensus       432 ~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~  511 (570)
T 2z63_A          432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPD  511 (570)
T ss_dssp             CCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred             cccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCH
Confidence            999999999999999999999999997 5789999999999999999999998889999999999999999999999989


Q ss_pred             hhhhccCCCCeEEccCCcCcccCCCC
Q 040702          391 ISLEKLLDLKDINVSFNRLEGEIPRE  416 (797)
Q Consensus       391 ~~~~~l~~L~~L~l~~N~l~~~~p~~  416 (797)
                      ..|..+++|+.|++++|+++|.+|..
T Consensus       512 ~~~~~l~~L~~L~l~~N~~~~~~~~~  537 (570)
T 2z63_A          512 GIFDRLTSLQKIWLHTNPWDCSCPRI  537 (570)
T ss_dssp             TTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred             HHhhcccCCcEEEecCCcccCCCcch
Confidence            99999999999999999999988764

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.8e-45  Score=385.10  Aligned_cols=227  Identities=22%  Similarity=0.311  Sum_probs=176.6

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCC-cchhHHHHHHHhhhccCCceeEeeeeeecCC--------
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCSNDD--------  577 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~--------  577 (797)
                      ++|+..+.||+|+||+||++     ++.||||+++..... ..+.+.+|++++++++|||||+++++|.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            56999999999999999975     689999999865432 3467899999999999999999999987544        


Q ss_pred             ----eEEEEEEccCCCCHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEe
Q 040702          578 ----FKALVLEYMPLGSLEKCLYSGNY--ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSD  651 (797)
Q Consensus       578 ----~~~lv~e~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  651 (797)
                          ..|+|||||++|+|.+++.....  ..++..++.|+.||++||+|||   +++|+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEcc
Confidence                36999999999999999987653  3566778899999999999999   99999999999999999999999999


Q ss_pred             ecCCccCCccCcc----------ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh--------
Q 040702          652 FGMAKPLLEEDQS----------LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE--------  713 (797)
Q Consensus       652 FGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~--------  713 (797)
                      ||+|+........          ...++.+||+.|||||++.+..|+.++|+||+|+..++++. |. ....        
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~-Pf-~~~~~~~~~~~~  239 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-PF-STQMERVRTLTD  239 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS-CC-SSHHHHHHHHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc-CC-CCccHHHHHHHH
Confidence            9999876433211          12244689999999999999999999999999999866553 21 1111        


Q ss_pred             ---------hhhhhcccccchhccccCCCCCCCChHHHH
Q 040702          714 ---------EKHLMTKEQPMVRMGTDLSLGQFPASYSIS  743 (797)
Q Consensus       714 ---------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~  743 (797)
                               ..+..+...++++.|++.||++|||+.|++
T Consensus       240 ~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil  278 (299)
T 4g31_A          240 VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINII  278 (299)
T ss_dssp             HHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             HhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHh
Confidence                     111222345789999999999999987764

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=100.00  E-value=5.6e-44  Score=431.83  Aligned_cols=416  Identities=22%  Similarity=0.198  Sum_probs=323.4

Q ss_pred             CCCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCccc-ccCCccccCCCCCCE
Q 040702            3 SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVV-GVVPTTIFNVSTLKS   81 (797)
Q Consensus         3 ~l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~-~~~p~~~~~l~~L~~   81 (797)
                      |.+++.++++..    .+++|++||||+|++++..        |..+.++++|++|+|++|++. .+.|.+|.++++|++
T Consensus        10 dcs~~~L~~vP~----lp~~l~~LdLs~N~i~~i~--------~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~   77 (844)
T 3j0a_A           10 FYRFCNLTQVPQ----VLNTTERLLLSFNYIRTVT--------ASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRI   77 (844)
T ss_dssp             EESCCCSSCCCS----SCTTCCEEEEESCCCCEEC--------SSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCE
T ss_pred             EccCCCCCCCCC----CCCCcCEEECCCCcCCccC--------hhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCE
Confidence            567778876543    5789999999999966443        567899999999999999554 445899999999999


Q ss_pred             EEccCCcCcccCCCccccCCCCccEEEccCccccccCCch--hhCCCCCCEEEccCCcCcccCC-ccccCCCCCCeeecc
Q 040702           82 LYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSF--IFNASKLSELGLQKNSFSGSIP-NTFGNLRNLKWLGLN  158 (797)
Q Consensus        82 L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~--~~~l~~L~~L~L~~N~l~~~~~-~~f~~l~~L~~L~L~  158 (797)
                      |+|++|+|+ .++...|.++++|++|+|++|.+++..|..  |.++++|++|+|++|.++++.+ ..|+++++|++|+|+
T Consensus        78 L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls  156 (844)
T 3j0a_A           78 LDLGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFS  156 (844)
T ss_dssp             EECTTCCCC-EECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEE
T ss_pred             EECCCCcCc-ccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECC
Confidence            999999998 555566789999999999999999866654  8999999999999999998765 589999999999999


Q ss_pred             CccCcCCCCC-cccc--------------------ccCCCCCC------CcEEEccCCCCCCCCChhhhcc---------
Q 040702          159 DNYLTSSTPE-LSSL--------------------SSLSNCKY------LEYFSFSNNPLGGILPRAIGNL---------  202 (797)
Q Consensus       159 ~N~l~~~~~~-~~~~--------------------~~l~~l~~------L~~L~Ls~N~l~~~~~~~~~~l---------  202 (797)
                      +|.++...+. +..+                    ..+..+++      |+.|++++|.+.+..+..+...         
T Consensus       157 ~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L  236 (844)
T 3j0a_A          157 SNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSL  236 (844)
T ss_dssp             SSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEE
T ss_pred             CCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccce
Confidence            9999876553 1111                    01122222      7777777777665555444321         


Q ss_pred             ----------------------------ccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCC
Q 040702          203 ----------------------------SQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLA  254 (797)
Q Consensus       203 ----------------------------~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~  254 (797)
                                                  ..+++.|++++|.+.+..|..|..+++|  +.|+|++|++.++.+.+|..++
T Consensus       237 ~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L--~~L~L~~n~i~~~~~~~~~~l~  314 (844)
T 3j0a_A          237 ILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDL--KVLNLAYNKINKIADEAFYGLD  314 (844)
T ss_dssp             ECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCC--CEEEEESCCCCEECTTTTTTCS
T ss_pred             ecccccccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCC--CEEECCCCcCCCCChHHhcCCC
Confidence                                        1367888888888888778888888877  8888888888888888888888


Q ss_pred             CCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCC-CCCCCCcccEEEccCCcCCCCCC---------------
Q 040702          255 ALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPS-TLWNLKDILHLNLSSNFFTGPLP---------------  318 (797)
Q Consensus       255 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~-~~~~l~~L~~L~l~~N~l~~~~~---------------  318 (797)
                      +|++|+|++|+++++.|..|.++++|+.|++++|.++.++. .+..+++|+.|++++|.+++...               
T Consensus       315 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~  394 (844)
T 3j0a_A          315 NLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLV  394 (844)
T ss_dssp             SCCEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCC
T ss_pred             CCCEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcc
Confidence            88888888888887778888888888888888888877765 56678888888888887764211               


Q ss_pred             -------------------------ccccccccccEEeccCcccccccCc-cccCCcccceecccCcccc-----CCCCh
Q 040702          319 -------------------------LKIGNLNVLVQLDLSMNNFSCVIPT-KIGGLKDLQYLFLEYNRLQ-----GSIPN  367 (797)
Q Consensus       319 -------------------------~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~l~-----~~~p~  367 (797)
                                               ..+..+++|+.|++++|++++..+. .+..+++|+.|+|++|.++     +..+.
T Consensus       395 ~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~  474 (844)
T 3j0a_A          395 TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWD  474 (844)
T ss_dssp             CCCCCCTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSS
T ss_pred             cccccccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchh
Confidence                                     0122456667777777777654332 3455677778888888776     34456


Q ss_pred             hhhccccCCeeeecCCcCCCCCChhhhccCCCCeEEccCCcCcccCCCCCCCCCCCcccccCCcccc
Q 040702          368 SIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLC  434 (797)
Q Consensus       368 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~~~~~~n~~~c  434 (797)
                      .|..+++|+.|+|++|++++.+|..|..+++|+.|++++|++++.+|.... ..++.+++++|....
T Consensus       475 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~-~~L~~L~Ls~N~l~~  540 (844)
T 3j0a_A          475 VFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP-ANLEILDISRNQLLA  540 (844)
T ss_dssp             CSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC-SCCCEEEEEEECCCC
T ss_pred             hhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh-ccccEEECCCCcCCC
Confidence            688899999999999999999999999999999999999999988776544 788889999887654

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=2.2e-43  Score=414.72  Aligned_cols=422  Identities=20%  Similarity=0.212  Sum_probs=323.8

Q ss_pred             CCCCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCE
Q 040702            2 PSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKS   81 (797)
Q Consensus         2 ~~l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~   81 (797)
                      |||++|.|+++.+.+|..+++|++|||++|+++++.        |..|.++++|++|+|++|+|+++.+.+|.++++|++
T Consensus        57 LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~--------~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~  128 (635)
T 4g8a_A           57 LDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIE--------DGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQK  128 (635)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEEC--------TTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCE
T ss_pred             EEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcC--------hhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCE
Confidence            688888888888888888888888888888855432        235788888888888888888888888888888888


Q ss_pred             EEccCCcCcccCCCccccCCCCccEEEccCcccccc-CCchhhCCCCCCEEEccCCcCcccCCccccCCCCCC----eee
Q 040702           82 LYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGT-IPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLK----WLG  156 (797)
Q Consensus        82 L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~----~L~  156 (797)
                      |+|++|+|+ .+|...|.++++|++|+|++|.++.. .|..+..+++|++|+|++|+|+++.+..|..+++++    .++
T Consensus       129 L~Ls~N~l~-~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~  207 (635)
T 4g8a_A          129 LVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD  207 (635)
T ss_dssp             EECTTSCCC-CSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEE
T ss_pred             EECCCCcCC-CCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhh
Confidence            888888887 77777788888888888888888753 567788888888888888888888888887766554    566


Q ss_pred             ccCccCcCCCCCcccc----------------------------------------------------------------
Q 040702          157 LNDNYLTSSTPELSSL----------------------------------------------------------------  172 (797)
Q Consensus       157 L~~N~l~~~~~~~~~~----------------------------------------------------------------  172 (797)
                      ++.|.++.+++.....                                                                
T Consensus       208 ls~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~  287 (635)
T 4g8a_A          208 LSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR  287 (635)
T ss_dssp             CTTCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEE
T ss_pred             cccCcccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhh
Confidence            7777766554431100                                                                


Q ss_pred             ------------ccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhh----------------
Q 040702          173 ------------SSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEI----------------  224 (797)
Q Consensus       173 ------------~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~----------------  224 (797)
                                  ..+..+.+++.+++.+|.+..+.  .+.... .++.|++.+|.+.+..+..+                
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~--~~~~~~-~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~  364 (635)
T 4g8a_A          288 LAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK--DFSYNF-GWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNA  364 (635)
T ss_dssp             EECCCSCEEECTTTTGGGTTCSEEEEESCEEEECG--GGGSCC-CCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCB
T ss_pred             hhhhcccccchhhhhhhhccccccccccccccccc--ccccch-hhhhhhcccccccCcCcccchhhhhcccccccCCCC
Confidence                        00111112222222222222111  112222 45666666666554333222                


Q ss_pred             ---hhhhhhHhhhcccccccccC--CCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCC-C-CCC
Q 040702          225 ---NNLTNLILQLLSLEGNQLEG--SIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSI-P-STL  297 (797)
Q Consensus       225 ---~~l~~L~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l-p-~~~  297 (797)
                         ..+++|  +.|++++|.+..  ..+..+..+.+|+.|+++.|.+... +..+..+++|+.+++++|..... + ..+
T Consensus       365 ~~~~~l~~L--~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~-~~~~~~l~~L~~l~l~~~~~~~~~~~~~~  441 (635)
T 4g8a_A          365 FSEVDLPSL--EFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITM-SSNFLGLEQLEHLDFQHSNLKQMSEFSVF  441 (635)
T ss_dssp             CCCCBCTTC--CEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEE-CSCCTTCTTCCEEECTTSEEESTTSSCTT
T ss_pred             ccccccccc--ccchhhccccccccccccchhhhhhhhhhhccccccccc-cccccccccccchhhhhcccccccccccc
Confidence               234555  778888887753  3456667777888888888877653 55678899999999998888444 3 356


Q ss_pred             CCCCcccEEEccCCcCCCCCCccccccccccEEeccCccc-ccccCccccCCcccceecccCccccCCCChhhhccccCC
Q 040702          298 WNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNF-SCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLK  376 (797)
Q Consensus       298 ~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l-~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~  376 (797)
                      ..+++++.++++.|.+.+..+..+..++.|+.|++++|.+ ....|..|..+++|++|+|++|++++..|..|.++++|+
T Consensus       442 ~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~  521 (635)
T 4g8a_A          442 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ  521 (635)
T ss_dssp             TTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred             ccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCC
Confidence            7799999999999999999999999999999999999975 456789999999999999999999999999999999999


Q ss_pred             eeeecCCcCCCCCChhhhccCCCCeEEccCCcCcccCCCC-CCC-CCCCcccccCCccccCCCC
Q 040702          377 SLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPRE-GPF-RNLSAESFKGNELLCGMPN  438 (797)
Q Consensus       377 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~~~-~~l~~~~~~~n~~~c~~~~  438 (797)
                      +|+|++|+|++..|..|.++++|+.|++++|++++.+|.. ..+ ..++.+++++|||.|+|..
T Consensus       522 ~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~  585 (635)
T 4g8a_A          522 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH  585 (635)
T ss_dssp             EEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGG
T ss_pred             EEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCc
Confidence            9999999999999999999999999999999999998875 344 6799999999999999874

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=1.1e-43  Score=399.92  Aligned_cols=374  Identities=19%  Similarity=0.214  Sum_probs=269.7

Q ss_pred             CEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCC
Q 040702           24 QTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPN  103 (797)
Q Consensus        24 ~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~  103 (797)
                      +.++.+++.         ++.+|. +.  ++|++|+|++|+++++.|..|.++++|++|+|++|.+.+.++...|.++++
T Consensus        13 ~~~~c~~~~---------l~~lp~-l~--~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~   80 (455)
T 3v47_A           13 YNAICINRG---------LHQVPE-LP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSS   80 (455)
T ss_dssp             TEEECCSSC---------CSSCCC-CC--TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTT
T ss_pred             cccCcCCCC---------cccCCC-CC--CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECccccccccc
Confidence            457777776         445555 32  678888888888888888888888888888888888876777777788888


Q ss_pred             ccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCc--cccCCCCCCeeeccCccCcCCCCCccccccCCCCCCC
Q 040702          104 LKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPN--TFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYL  181 (797)
Q Consensus       104 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~--~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L  181 (797)
                      |++|+|++|++++..|..|.++++|++|+|++|++++..+.  .|.++++|++|+|++|.++.+.+.-    .+.++++|
T Consensus        81 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~----~~~~l~~L  156 (455)
T 3v47_A           81 LIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS----FFLNMRRF  156 (455)
T ss_dssp             CCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCG----GGGGCTTC
T ss_pred             CCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCccc----ccCCCCcc
Confidence            88888888888877788888888888888888888864433  4888888888888888888775531    16677888


Q ss_pred             cEEEccCCCCCCCCChhhhccc-cCCcEEEccCCcccccCChhhh--------hhhhhHhhhcccccccccCCCchhhcC
Q 040702          182 EYFSFSNNPLGGILPRAIGNLS-QSMEDFWMDNCNISGSIPEEIN--------NLTNLILQLLSLEGNQLEGSIPDDLCR  252 (797)
Q Consensus       182 ~~L~Ls~N~l~~~~~~~~~~l~-~~L~~L~L~~n~i~~~~p~~~~--------~l~~L~L~~L~Ls~N~l~~~~~~~~~~  252 (797)
                      ++|++++|++.+..+..+..+. .+++.|++++|.+.+..+..++        .+++|  ++|++++|++.+..|..+..
T Consensus       157 ~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L--~~L~Ls~n~l~~~~~~~~~~  234 (455)
T 3v47_A          157 HVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSI--TTLDLSGNGFKESMAKRFFD  234 (455)
T ss_dssp             CEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEE--EEEECTTSCCCHHHHHHHHH
T ss_pred             cEEeCCCCcccccChhhhhccccccccccccccCcccccchhhcccccccccccccee--eeEecCCCcccccchhhhhc
Confidence            8888888888888887777652 2688888888888765554432        34455  78888888887777776655


Q ss_pred             C---CCCcEEEccCCcCccc----------CCCCccC--CccccccccCCCCCCCC-CCCCCCCCcccEEEccCCcCCCC
Q 040702          253 L---AALFQLDLGGNKLSGF----------VPACSGN--LTNLRKLYLGSNLLTSI-PSTLWNLKDILHLNLSSNFFTGP  316 (797)
Q Consensus       253 l---~~L~~L~Ls~N~l~~~----------~~~~~~~--l~~L~~L~L~~N~l~~l-p~~~~~l~~L~~L~l~~N~l~~~  316 (797)
                      .   ++|+.|++++|.+.+.          .+..+..  .++|+.|++++|.++.+ |..+..+++|++|++++|.+++.
T Consensus       235 ~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~  314 (455)
T 3v47_A          235 AIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKI  314 (455)
T ss_dssp             HTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEE
T ss_pred             cccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCccccc
Confidence            4   7788888887765432          1122222  24677777777777544 44566667777777777777766


Q ss_pred             CCccccccccccEEeccCcccccccCccccCCcccceecccCccccCCCChhhhccccCCeeeecCCcCCCCCChhhhcc
Q 040702          317 LPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKL  396 (797)
Q Consensus       317 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  396 (797)
                      .|..|.++++|+.|++++|.+++..|..|.++++|++|+|++|++++..|..|..+++|++|+|++|++++..+..+..+
T Consensus       315 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  394 (455)
T 3v47_A          315 DDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRL  394 (455)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTC
T ss_pred             ChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccC
Confidence            66667777777777777777766666667777777777777777776666677777777777777777776666666677


Q ss_pred             CCCCeEEccCCcCcccCCC
Q 040702          397 LDLKDINVSFNRLEGEIPR  415 (797)
Q Consensus       397 ~~L~~L~l~~N~l~~~~p~  415 (797)
                      ++|+.|++++|+++|.+|.
T Consensus       395 ~~L~~L~l~~N~l~~~~~~  413 (455)
T 3v47_A          395 TSLQKIWLHTNPWDCSCPR  413 (455)
T ss_dssp             TTCCEEECCSSCBCCCTTT
T ss_pred             CcccEEEccCCCcccCCCc
Confidence            7777777777777766653

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=7.3e-45  Score=374.88  Aligned_cols=225  Identities=21%  Similarity=0.300  Sum_probs=179.4

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ++|+..+.||+|+||+||++     ++.||||++++..   ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            68999999999999999985     6899999997653   233467899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      ||+ +|+|.+++...+ .+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+...... 
T Consensus        93 Ey~-~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-  166 (275)
T 3hyh_A           93 EYA-GNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-  166 (275)
T ss_dssp             ECC-CEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred             eCC-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence            999 679999997765 4999999999999999999999   9999999999999999999999999999998654322 


Q ss_pred             cccccccccCcccccccccccCcc-chHHHHHHHhhhhhhhhccccccchhh----------------hhhhcccccchh
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEM-RLKCWVNDSLLISVMIVVDANLLIREE----------------KHLMTKEQPMVR  726 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~l~~  726 (797)
                        .....+||+.|||||.+.+..| +.++|+||+|+..++++.+..++....                ....+..+++++
T Consensus       167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  244 (275)
T 3hyh_A          167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIK  244 (275)
T ss_dssp             ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHH
T ss_pred             --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence              3345789999999999988776 589999999999877776655543311                122345678999


Q ss_pred             ccccCCCCCCCChHHHHH
Q 040702          727 MGTDLSLGQFPASYSISK  744 (797)
Q Consensus       727 ~cl~~dp~~RPs~~~i~~  744 (797)
                      .|++.||++|||+.|+++
T Consensus       245 ~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          245 RMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             HHSCSSGGGSCCHHHHHH
T ss_pred             HHccCChhHCcCHHHHHc
Confidence            999999999999998875

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.5e-45  Score=392.21  Aligned_cols=249  Identities=20%  Similarity=0.270  Sum_probs=206.0

Q ss_pred             ccCHHHHHHHhcCCCccccccccCCcceeec----------ceEEEEEEEEeccC-CcchhHHHHHHHhhhccC-CceeE
Q 040702          501 RFTYLELFQATNRFSENNLIGRGGFGPVYKD----------GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRH-RNLIK  568 (797)
Q Consensus       501 ~~~~~~l~~~~~~f~~~~~lg~G~~g~Vyk~----------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H-pniv~  568 (797)
                      .++..++....++|+..+.||+|+||+||+|          ++.||||+++.... ...++|.+|++++++++| ||||+
T Consensus        53 p~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~  132 (353)
T 4ase_A           53 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN  132 (353)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence            4555666666789999999999999999985          26799999975533 234679999999999965 99999


Q ss_pred             eeeeeecC-CeEEEEEEccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEc
Q 040702          569 IISSCSND-DFKALVLEYMPLGSLEKCLYSGN---------------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHC  632 (797)
Q Consensus       569 l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHr  632 (797)
                      ++|+|.++ +..|+|||||++|+|.++++...               ..+++.++..|+.|||+||+|||   +++||||
T Consensus       133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHR  209 (353)
T 4ase_A          133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHR  209 (353)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred             EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecC
Confidence            99999764 57899999999999999997532               24899999999999999999999   9999999


Q ss_pred             CCCCCceEEcCCCcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccc
Q 040702          633 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLI  711 (797)
Q Consensus       633 Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~  711 (797)
                      ||||+|||+++++.+||+|||+|+....+.........+||+.|||||.+.++.|+.++||||+|+..++.+. +..++.
T Consensus       210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~  289 (353)
T 4ase_A          210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  289 (353)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999997755544444556789999999999999999999999999999866653 333322


Q ss_pred             hh------------------hhhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          712 RE------------------EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       712 ~~------------------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                      ..                  +....+.+.+++..||+.||++|||+.|+++.|+.+.+.
T Consensus       290 ~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          290 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             TCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence            21                  111233567889999999999999999999999887554

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=100.00  E-value=5.4e-44  Score=412.53  Aligned_cols=391  Identities=20%  Similarity=0.188  Sum_probs=323.2

Q ss_pred             CCCCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCccccc-CCccccCCCCCC
Q 040702            2 PSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGV-VPTTIFNVSTLK   80 (797)
Q Consensus         2 ~~l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~-~p~~~~~l~~L~   80 (797)
                      ++|++|.+++..+.+|+.+++|++|||++|++++..        |..++++++|++|++++|+++++ .|..|.++++|+
T Consensus        55 L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~--------~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~  126 (549)
T 2z81_A           55 LILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLS--------SSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQ  126 (549)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCC--------HHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCC
T ss_pred             EECCCCCcCccChhhccccccCCEEECCCCccCccC--------HHHhccCCCCcEEECCCCcccccchhhhhhccCCcc
Confidence            689999999999999999999999999999965432        23488999999999999999974 578899999999


Q ss_pred             EEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCc
Q 040702           81 SLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDN  160 (797)
Q Consensus        81 ~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N  160 (797)
                      +|+|++|.+.+.+|...|.++++|++|+|++|++++..|..+..+++|++|+++.|.+..+.+..+..+++|++|+|++|
T Consensus       127 ~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n  206 (549)
T 2z81_A          127 TLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDT  206 (549)
T ss_dssp             EEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESC
T ss_pred             EEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCC
Confidence            99999999555888888889999999999999999999999999999999999999998666556678999999999999


Q ss_pred             cCcCCCCCccccccCCCC----------------------------CCCcEEEccCCCCCCC------------------
Q 040702          161 YLTSSTPELSSLSSLSNC----------------------------KYLEYFSFSNNPLGGI------------------  194 (797)
Q Consensus       161 ~l~~~~~~~~~~~~l~~l----------------------------~~L~~L~Ls~N~l~~~------------------  194 (797)
                      +++..+....  .....+                            ++|+.|++++|.+.+.                  
T Consensus       207 ~l~~~~~~~~--~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~  284 (549)
T 2z81_A          207 NLARFQFSPL--PVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVE  284 (549)
T ss_dssp             BCTTCCCCCC--SSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCC
T ss_pred             cccccccccc--chhhhhhcccceeccccccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccc
Confidence            9988631100  011222                            3333333333333221                  


Q ss_pred             -----------------CChhhhccccCCcEEEccCCcccccCChhh-hhhhhhHhhhcccccccccCCCch---hhcCC
Q 040702          195 -----------------LPRAIGNLSQSMEDFWMDNCNISGSIPEEI-NNLTNLILQLLSLEGNQLEGSIPD---DLCRL  253 (797)
Q Consensus       195 -----------------~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~-~~l~~L~L~~L~Ls~N~l~~~~~~---~~~~l  253 (797)
                                       .+..+... .+++.|++++|.+. .+|..+ ..+++|  ++|++++|++.+..|.   .+..+
T Consensus       285 ~L~l~~~~i~~~~~~~~l~~~~~~~-~~L~~L~l~~n~l~-~ip~~~~~~l~~L--~~L~Ls~N~l~~~~~~~~~~~~~l  360 (549)
T 2z81_A          285 TVTIRRLHIPQFYLFYDLSTVYSLL-EKVKRITVENSKVF-LVPCSFSQHLKSL--EFLDLSENLMVEEYLKNSACKGAW  360 (549)
T ss_dssp             EEEEESCBCSCGGGSCCCCHHHHHS-TTCCEEEEESSCCC-CCCHHHHHHCTTC--CEEECCSSCCCHHHHHHHTCTTSS
T ss_pred             cccccccccchhhhcccchhhhhhc-ccceEEEeccCccc-cCCHHHHhcCccc--cEEEccCCccccccccchhhhhcc
Confidence                             01112222 37999999999998 566665 678988  9999999999976643   37789


Q ss_pred             CCCcEEEccCCcCcccCC--CCccCCccccccccCCCCCCCCCCCCCCCCcccEEEccCCcCCCCCCccccccccccEEe
Q 040702          254 AALFQLDLGGNKLSGFVP--ACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLD  331 (797)
Q Consensus       254 ~~L~~L~Ls~N~l~~~~~--~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~  331 (797)
                      ++|++|+|++|+++++.+  ..+..+++|++|++++|+++.+|..+..+++|+.|++++|.++.. |..+  .++|+.|+
T Consensus       361 ~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~~~~L~~L~Ls~N~l~~l-~~~~--~~~L~~L~  437 (549)
T 2z81_A          361 PSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIRVV-KTCI--PQTLEVLD  437 (549)
T ss_dssp             TTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCCCCCSCCCCCTTCCEEECTTSCCSCC-CTTS--CTTCSEEE
T ss_pred             ccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCccCChhhcccccccEEECCCCCcccc-cchh--cCCceEEE
Confidence            999999999999987643  458899999999999999999999999999999999999999853 3333  26899999


Q ss_pred             ccCcccccccCccccCCcccceecccCccccCCCChhhhccccCCeeeecCCcCCCCCChhhhccCCCCeEEccCCcCcc
Q 040702          332 LSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEG  411 (797)
Q Consensus       332 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~  411 (797)
                      +++|++++.+    ..+++|++|+|++|+++ .+|. ...+++|++|+|++|++++.+|..+..+++|+.|++++|++.|
T Consensus       438 Ls~N~l~~~~----~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~  511 (549)
T 2z81_A          438 VSNNNLDSFS----LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDC  511 (549)
T ss_dssp             CCSSCCSCCC----CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCC
T ss_pred             CCCCChhhhc----ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccC
Confidence            9999998653    57899999999999999 5665 5789999999999999999999999999999999999999998


Q ss_pred             cCCC
Q 040702          412 EIPR  415 (797)
Q Consensus       412 ~~p~  415 (797)
                      ..|.
T Consensus       512 ~~~~  515 (549)
T 2z81_A          512 SCPR  515 (549)
T ss_dssp             CHHH
T ss_pred             CCcc
Confidence            8763

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.4e-44  Score=376.14  Aligned_cols=221  Identities=20%  Similarity=0.227  Sum_probs=182.6

Q ss_pred             CccccccccCCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeec----CCeEEEEE
Q 040702          515 SENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSN----DDFKALVL  583 (797)
Q Consensus       515 ~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~----~~~~~lv~  583 (797)
                      +..++||+|+||.||++     +..||||++.....  ...+.|.+|++++++++|||||+++++|.+    ++..|+||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            56678999999999985     58899999976532  234679999999999999999999999865    34689999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC--eEEcCCCCCceEEcC-CCcEEEEeecCCccCCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVP--IIHCDLKPSNVLLDD-NMVAHLSDFGMAKPLLE  660 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~--ivHrDlkp~NIll~~-~~~~kl~DFGla~~~~~  660 (797)
                      |||+||+|.+++.... .+++..+..|+.||+.||+|||   +++  |+||||||+|||++. ++.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            9999999999998754 4899999999999999999999   777  999999999999984 79999999999985422


Q ss_pred             cCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh-------------------hhhhhccc
Q 040702          661 EDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE-------------------EKHLMTKE  721 (797)
Q Consensus       661 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~  721 (797)
                          ......+||+.|||||.+. +.|+.++||||+|+..++++.+..++...                   +....+.+
T Consensus       185 ----~~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  259 (290)
T 3fpq_A          185 ----SFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV  259 (290)
T ss_dssp             ----TSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred             ----CccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHH
Confidence                1335578999999999775 57999999999999987666655544221                   11122356


Q ss_pred             ccchhccccCCCCCCCChHHHHH
Q 040702          722 QPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       722 ~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      +++++.||+.||++|||+.|+++
T Consensus       260 ~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          260 KEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHccCChhHCcCHHHHhc
Confidence            78999999999999999888753

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.1e-44  Score=380.47  Aligned_cols=238  Identities=22%  Similarity=0.235  Sum_probs=183.8

Q ss_pred             cCCCccccccccCCcceeec---ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCC----eEEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD---GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDD----FKALVLE  584 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~---~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~----~~~lv~e  584 (797)
                      ++|...+.||+|+||+||+|   |+.||||+++..... ...+..|+..+.+++|||||+++|+|.+++    ..|+|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E   81 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD   81 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence            46778899999999999996   689999998654321 122344666667889999999999998654    5799999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcc-----CCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCC
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFG-----YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  659 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~-----~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  659 (797)
                      ||++|+|.++++...  ++|..+.+++.|+++||+|||+.     +.++|+||||||+|||+|.++++||+|||+|+...
T Consensus        82 y~~~gsL~~~l~~~~--l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  159 (303)
T 3hmm_A           82 YHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD  159 (303)
T ss_dssp             CCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred             CCCCCcHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence            999999999998764  89999999999999999999932     12399999999999999999999999999998654


Q ss_pred             ccCcc--ccccccccCcccccccccccC------ccchHHHHHHHhhhhhhhhccccccch-------------------
Q 040702          660 EEDQS--LTQTQTLATIGYMAPDEIFSG------EMRLKCWVNDSLLISVMIVVDANLLIR-------------------  712 (797)
Q Consensus       660 ~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~dv~s~~~~~~~~~~~~~~~~~-------------------  712 (797)
                      .....  ......+||+.|||||.+.+.      .++.++||||+|+..++.+....+++.                   
T Consensus       160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~  239 (303)
T 3hmm_A          160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE  239 (303)
T ss_dssp             TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred             CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence            33221  123456899999999988653      578899999999988665543221100                   


Q ss_pred             --------------h-----hhhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          713 --------------E-----EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       713 --------------~-----~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                                    .     ..+....+.++++.||+.||++|||+.|+++.|+++.+.
T Consensus       240 ~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             HHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence                          0     001122456789999999999999999999999887653

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=9.2e-43  Score=402.92  Aligned_cols=412  Identities=19%  Similarity=0.195  Sum_probs=292.5

Q ss_pred             CCCCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCE
Q 040702            2 PSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKS   81 (797)
Q Consensus         2 ~~l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~   81 (797)
                      +|+++|.+++ +|..+.  ++|++|||++|++++..        |..+.++++|++|++++|+|+++.|.+|.++++|++
T Consensus        36 l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~--------~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  104 (562)
T 3a79_B           36 VDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELR--------MPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEY  104 (562)
T ss_dssp             EECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCC--------GGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCE
T ss_pred             EEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccC--------hhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCE
Confidence            5778888886 554443  78888888888854332        246778888888888888888888888888888888


Q ss_pred             EEccCCcCcccCCCccccCCCCccEEEccCcccccc-CCchhhCCCCCCEEEccCCcCcccCCccccCCCCC--Ceeecc
Q 040702           82 LYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGT-IPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNL--KWLGLN  158 (797)
Q Consensus        82 L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L--~~L~L~  158 (797)
                      |+|++|+|+ .+|..   .+++|++|+|++|++++. .|..|.++++|++|+|++|+|+..   .|.++++|  ++|+|+
T Consensus       105 L~Ls~N~l~-~lp~~---~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~  177 (562)
T 3a79_B          105 LDVSHNRLQ-NISCC---PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLD  177 (562)
T ss_dssp             EECTTSCCC-EECSC---CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEE
T ss_pred             EECCCCcCC-ccCcc---ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEee
Confidence            888888887 77766   678888888888888763 357888888888888888888753   45555555  888888


Q ss_pred             CccC--cCCCCC-ccccc--------------------cCCCCCCCcEEEccCCCCCC----CCChhhhccccCCcEEEc
Q 040702          159 DNYL--TSSTPE-LSSLS--------------------SLSNCKYLEYFSFSNNPLGG----ILPRAIGNLSQSMEDFWM  211 (797)
Q Consensus       159 ~N~l--~~~~~~-~~~~~--------------------~l~~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~~L~~L~L  211 (797)
                      +|.+  +...+. +..+.                    .+..+++|+.|++++|+...    .....+..++ .++.|++
T Consensus       178 ~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~-~L~~L~L  256 (562)
T 3a79_B          178 LVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGP-TLLNVTL  256 (562)
T ss_dssp             ESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCS-SCEEEEE
T ss_pred             cccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccC-cceEEEe
Confidence            8888  544332 11111                    12234455555555553110    0011122222 2333333


Q ss_pred             cCCcccccCChhhh---hhhhhHhhhcccccccccCCCchhh----------------------------cC---CCCCc
Q 040702          212 DNCNISGSIPEEIN---NLTNLILQLLSLEGNQLEGSIPDDL----------------------------CR---LAALF  257 (797)
Q Consensus       212 ~~n~i~~~~p~~~~---~l~~L~L~~L~Ls~N~l~~~~~~~~----------------------------~~---l~~L~  257 (797)
                      .++.+.+.....+.   ...+|  ++|++++|.+.+.+|..+                            ..   ..+|+
T Consensus       257 ~~~~l~~~~~~~~~~~~~~~~L--~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~  334 (562)
T 3a79_B          257 QHIETTWKCSVKLFQFFWPRPV--EYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIK  334 (562)
T ss_dssp             EEEEECHHHHHHHHHHHTTSSE--EEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCS
T ss_pred             cCCcCcHHHHHHHHHhhhcccc--cEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcce
Confidence            33222211110000   01122  555555555554444433                            11   14588


Q ss_pred             EEEccCCcCcccCCCCccCCccccccccCCCCCCC-CCCCCCCCCcccEEEccCCcCCCCC--CccccccccccEEeccC
Q 040702          258 QLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTS-IPSTLWNLKDILHLNLSSNFFTGPL--PLKIGNLNVLVQLDLSM  334 (797)
Q Consensus       258 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-lp~~~~~l~~L~~L~l~~N~l~~~~--~~~~~~l~~L~~L~Ls~  334 (797)
                      .|++++|.+....  .+..+++|++|++++|.++. +|..+..+++|+.|++++|++++..  |..|..+++|+.|++++
T Consensus       335 ~L~l~~n~~~~~~--~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~  412 (562)
T 3a79_B          335 MLSISDTPFIHMV--CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSL  412 (562)
T ss_dssp             EEEEESSCCCCCC--CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTT
T ss_pred             EEEccCCCccccc--CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCC
Confidence            8888888876432  23788999999999999966 6788999999999999999999743  46689999999999999


Q ss_pred             ccccc-ccCccccCCcccceecccCccccCCCChhhhccccCCeeeecCCcCCCCCChhhhccCCCCeEEccCCcCcccC
Q 040702          335 NNFSC-VIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEI  413 (797)
Q Consensus       335 N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  413 (797)
                      |.+++ ..+..+..+++|++|++++|++++..|..+.  ++|++|+|++|+++ .+|..+..+++|+.|++++|+++..+
T Consensus       413 N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~  489 (562)
T 3a79_B          413 NSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVP  489 (562)
T ss_dssp             SCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCC
T ss_pred             CcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCC
Confidence            99998 5555688999999999999999877666554  78999999999998 66776779999999999999999766


Q ss_pred             CC-CCCCCCCCcccccCCccccCCCCc
Q 040702          414 PR-EGPFRNLSAESFKGNELLCGMPNL  439 (797)
Q Consensus       414 p~-~~~~~~l~~~~~~~n~~~c~~~~~  439 (797)
                      +. ...+..++.+++.+|++.|+|+..
T Consensus       490 ~~~~~~l~~L~~L~l~~N~~~c~c~~~  516 (562)
T 3a79_B          490 DGVFDRLTSLQYIWLHDNPWDCTCPGI  516 (562)
T ss_dssp             TTSTTTCTTCCCEECCSCCBCCCHHHH
T ss_pred             HHHHhcCCCCCEEEecCCCcCCCcchH
Confidence            65 567888999999999999988743

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=100.00  E-value=4.6e-42  Score=397.04  Aligned_cols=387  Identities=20%  Similarity=0.204  Sum_probs=304.0

Q ss_pred             CCCCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCE
Q 040702            2 PSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKS   81 (797)
Q Consensus         2 ~~l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~   81 (797)
                      +||++|.|+++.+.+|..+++|++|||++|++++..        |+.+..+++|++|++++|+|+.+ |..  .+++|++
T Consensus        57 L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--------~~~~~~l~~L~~L~Ls~N~l~~l-p~~--~l~~L~~  125 (562)
T 3a79_B           57 LSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLD--------FHVFLFNQDLEYLDVSHNRLQNI-SCC--PMASLRH  125 (562)
T ss_dssp             EECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEEC--------TTTTTTCTTCCEEECTTSCCCEE-CSC--CCTTCSE
T ss_pred             EECCCCCccccChhhhccCCCccEEECCCCCCCcCC--------HHHhCCCCCCCEEECCCCcCCcc-Ccc--ccccCCE
Confidence            689999999999999999999999999999966543        45688999999999999999964 544  8999999


Q ss_pred             EEccCCcCcccCCC-ccccCCCCccEEEccCccccccCCchhhCCCCC--CEEEccCCcC--cccCCccccCC-------
Q 040702           82 LYLHSNSLSGRLPS-SADVRLPNLKELHLWGNNFIGTIPSFIFNASKL--SELGLQKNSF--SGSIPNTFGNL-------  149 (797)
Q Consensus        82 L~Ls~N~l~~~l~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L--~~L~L~~N~l--~~~~~~~f~~l-------  149 (797)
                      |+|++|+++ .+|. ..|.++++|++|+|++|++++.   .+..+++|  ++|+|++|++  ++..|..|.++       
T Consensus       126 L~Ls~N~l~-~l~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l  201 (562)
T 3a79_B          126 LDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHL  201 (562)
T ss_dssp             EECCSSCCS-BCCCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEE
T ss_pred             EECCCCCcc-ccCchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCcceEEE
Confidence            999999998 6553 5678999999999999999863   45556666  9999999999  77888777664       


Q ss_pred             -------------------CCCCeeeccCccCc--CCCCCccccccCCCC---------------------------CCC
Q 040702          150 -------------------RNLKWLGLNDNYLT--SSTPELSSLSSLSNC---------------------------KYL  181 (797)
Q Consensus       150 -------------------~~L~~L~L~~N~l~--~~~~~~~~~~~l~~l---------------------------~~L  181 (797)
                                         ++|+.|++++|...  .++..   ...+..+                           ++|
T Consensus       202 ~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~---~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L  278 (562)
T 3a79_B          202 VFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTF---LSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPV  278 (562)
T ss_dssp             EECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHH---HHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSE
T ss_pred             EecCccchhhhhhhcccccceEEEecccccccccchHHHH---HHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccc
Confidence                               46777777776411  00000   0012222                           256


Q ss_pred             cEEEccCCCCCCCCChhh-----hccccCCcEEEccCCcccccCC-hhhhhh-hhhHhhhcccccccccCCCchhhcCCC
Q 040702          182 EYFSFSNNPLGGILPRAI-----GNLSQSMEDFWMDNCNISGSIP-EEINNL-TNLILQLLSLEGNQLEGSIPDDLCRLA  254 (797)
Q Consensus       182 ~~L~Ls~N~l~~~~~~~~-----~~l~~~L~~L~L~~n~i~~~~p-~~~~~l-~~L~L~~L~Ls~N~l~~~~~~~~~~l~  254 (797)
                      ++|++++|++.+.+|..+     ..+. .|+.+++..|.+  .+| ..+..+ ++..+++|++++|.+....  ....++
T Consensus       279 ~~L~l~~n~l~~~ip~~~~~~~~~~L~-~L~~~~~~~~~~--~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~  353 (562)
T 3a79_B          279 EYLNIYNLTITERIDREEFTYSETALK-SLMIEHVKNQVF--LFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPS  353 (562)
T ss_dssp             EEEEEEEEEECSCCCCCCCCCCSCSCC-EEEEEEEEECCC--SSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCC
T ss_pred             cEEEEeccEeeccccchhhhcccccch-heehhhccccee--ecChhhhhhhhccCcceEEEccCCCccccc--CccCCC
Confidence            666777776665555554     3333 444455555555  233 333332 2222489999999986432  126789


Q ss_pred             CCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCC---CCCCCCCcccEEEccCCcCCC-CCCccccccccccEE
Q 040702          255 ALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIP---STLWNLKDILHLNLSSNFFTG-PLPLKIGNLNVLVQL  330 (797)
Q Consensus       255 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp---~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L  330 (797)
                      +|++|++++|++++..|..+.++++|+.|+|++|+++.++   ..+..+++|+.|++++|.+++ ..+..+..+++|++|
T Consensus       354 ~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L  433 (562)
T 3a79_B          354 SFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVL  433 (562)
T ss_dssp             CCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEE
T ss_pred             CceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEE
Confidence            9999999999999989999999999999999999998765   468889999999999999998 445568899999999


Q ss_pred             eccCcccccccCccccCCcccceecccCccccCCCChhhhccccCCeeeecCCcCCCCCChhhhccCCCCeEEccCCcCc
Q 040702          331 DLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLE  410 (797)
Q Consensus       331 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  410 (797)
                      ++++|++++..|..+.  ++|+.|+|++|+++ .+|..+..+++|++|+|++|++++..+..+..+++|+.|++++|++.
T Consensus       434 ~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~~  510 (562)
T 3a79_B          434 NLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNPWD  510 (562)
T ss_dssp             ECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEECCSCCBC
T ss_pred             ECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEecCCCcC
Confidence            9999999877766554  79999999999999 67777779999999999999999554445999999999999999999


Q ss_pred             ccCC
Q 040702          411 GEIP  414 (797)
Q Consensus       411 ~~~p  414 (797)
                      |..+
T Consensus       511 c~c~  514 (562)
T 3a79_B          511 CTCP  514 (562)
T ss_dssp             CCHH
T ss_pred             CCcc
Confidence            8765

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.3e-43  Score=402.09  Aligned_cols=388  Identities=21%  Similarity=0.241  Sum_probs=319.6

Q ss_pred             CCCCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCE
Q 040702            2 PSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKS   81 (797)
Q Consensus         2 ~~l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~   81 (797)
                      +||++|.|++..+..|..+++|++|||++|++++..        |..++++++|++|++++|+|+++ |..  .+++|++
T Consensus        26 L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~--------~~~~~~l~~L~~L~Ls~N~l~~l-p~~--~l~~L~~   94 (520)
T 2z7x_B           26 LNISQNYISELWTSDILSLSKLRILIISHNRIQYLD--------ISVFKFNQELEYLDLSHNKLVKI-SCH--PTVNLKH   94 (520)
T ss_dssp             EECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEE--------GGGGTTCTTCCEEECCSSCCCEE-ECC--CCCCCSE
T ss_pred             EECCCCcccccChhhccccccccEEecCCCccCCcC--------hHHhhcccCCCEEecCCCceeec-Ccc--ccCCccE
Confidence            689999999999999999999999999999965433        56788999999999999999964 544  8999999


Q ss_pred             EEccCCcCcc-cCCCccccCCCCccEEEccCccccccCCchhhCCCCC--CEEEccCCcC--cccCCccccC--------
Q 040702           82 LYLHSNSLSG-RLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKL--SELGLQKNSF--SGSIPNTFGN--------  148 (797)
Q Consensus        82 L~Ls~N~l~~-~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L--~~L~L~~N~l--~~~~~~~f~~--------  148 (797)
                      |+|++|++++ .+|. .|..+++|++|+|++|++++   ..|..+++|  ++|+|++|++  .+..|..|..        
T Consensus        95 L~L~~N~l~~~~~p~-~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l  170 (520)
T 2z7x_B           95 LDLSFNAFDALPICK-EFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHI  170 (520)
T ss_dssp             EECCSSCCSSCCCCG-GGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEE
T ss_pred             EeccCCccccccchh-hhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEE
Confidence            9999999984 2444 45789999999999999986   467778888  9999999999  6666665555        


Q ss_pred             ------------------CCCCCeeeccCcc-------CcCCCCCccccccCC---------------------CCCCCc
Q 040702          149 ------------------LRNLKWLGLNDNY-------LTSSTPELSSLSSLS---------------------NCKYLE  182 (797)
Q Consensus       149 ------------------l~~L~~L~L~~N~-------l~~~~~~~~~~~~l~---------------------~l~~L~  182 (797)
                                        +++|+.|++++|.       +....+.+..+..+.                     ..++|+
T Consensus       171 ~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~  250 (520)
T 2z7x_B          171 VFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVW  250 (520)
T ss_dssp             ECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCS
T ss_pred             EeccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCccc
Confidence                              6677777777775       221111111111111                     134799


Q ss_pred             EEEccCCCCCCCCChhh-----hccccCCcEEEccCCcccccCC-hhhhhh---hhhHhhhcccccccccCCCchhhcCC
Q 040702          183 YFSFSNNPLGGILPRAI-----GNLSQSMEDFWMDNCNISGSIP-EEINNL---TNLILQLLSLEGNQLEGSIPDDLCRL  253 (797)
Q Consensus       183 ~L~Ls~N~l~~~~~~~~-----~~l~~~L~~L~L~~n~i~~~~p-~~~~~l---~~L~L~~L~Ls~N~l~~~~~~~~~~l  253 (797)
                      +|++++|++.+..|..+     ..++ +|+.+++++|.+  .+| ..+..+   .+|  +.|++++|.+....  .+..+
T Consensus       251 ~L~l~~n~l~~~~p~~~~~~~~~~l~-~L~~l~l~~n~~--~~p~~~~~~~~~~~~L--~~L~l~~n~l~~~~--~~~~l  323 (520)
T 2z7x_B          251 YFSISNVKLQGQLDFRDFDYSGTSLK-ALSIHQVVSDVF--GFPQSYIYEIFSNMNI--KNFTVSGTRMVHML--CPSKI  323 (520)
T ss_dssp             EEEEEEEEEESCCCCCCCCCCSCCCC-EEEEEEEEECCC--CSCTHHHHHHHHTCCC--SEEEEESSCCCCCC--CCSSC
T ss_pred             EEEeecccccCccccchhhcccccCc-eeEeccccccce--ecchhhhhcccccCce--eEEEcCCCcccccc--chhhC
Confidence            99999999998888887     7777 899999999999  455 666665   445  99999999987543  12688


Q ss_pred             CCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCC---CCCCCCCCcccEEEccCCcCCCCCC-ccccccccccE
Q 040702          254 AALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSI---PSTLWNLKDILHLNLSSNFFTGPLP-LKIGNLNVLVQ  329 (797)
Q Consensus       254 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l---p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~  329 (797)
                      ++|++|++++|++++..|..+..+++|++|++++|.++.+   |..+..+++|+.|++++|.+++..| ..+..+++|+.
T Consensus       324 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~  403 (520)
T 2z7x_B          324 SPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLS  403 (520)
T ss_dssp             CCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCE
T ss_pred             CcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCE
Confidence            9999999999999998899999999999999999999864   4568889999999999999998455 45889999999


Q ss_pred             EeccCcccccccCccccCCcccceecccCccccCCCChhhhccccCCeeeecCCcCCCCCChhhhccCCCCeEEccCCcC
Q 040702          330 LDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRL  409 (797)
Q Consensus       330 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l  409 (797)
                      |++++|++++..|..+.  ++|+.|+|++|+++ .+|..+..+++|++|+|++|++++..+..+..+++|+.|++++|++
T Consensus       404 L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~  480 (520)
T 2z7x_B          404 LNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW  480 (520)
T ss_dssp             EECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCB
T ss_pred             EECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCC
Confidence            99999999887777664  79999999999999 7888888999999999999999955444599999999999999999


Q ss_pred             cccCC
Q 040702          410 EGEIP  414 (797)
Q Consensus       410 ~~~~p  414 (797)
                      +|..+
T Consensus       481 ~c~c~  485 (520)
T 2z7x_B          481 DCSCP  485 (520)
T ss_dssp             CCCHH
T ss_pred             cccCC
Confidence            98754

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=100.00  E-value=8.5e-42  Score=384.59  Aligned_cols=367  Identities=24%  Similarity=0.262  Sum_probs=304.8

Q ss_pred             CCCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccc-cCCccccCCCCCCE
Q 040702            3 SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVG-VVPTTIFNVSTLKS   81 (797)
Q Consensus         3 ~l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~-~~p~~~~~l~~L~~   81 (797)
                      +.+++.++.+ |.   -.++|++|||++|++++..        |..++++++|++|++++|++.+ +.|..|.++++|++
T Consensus        16 ~c~~~~l~~l-p~---l~~~l~~L~Ls~n~i~~~~--------~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~   83 (455)
T 3v47_A           16 ICINRGLHQV-PE---LPAHVNYVDLSLNSIAELN--------ETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLII   83 (455)
T ss_dssp             ECCSSCCSSC-CC---CCTTCCEEECCSSCCCEEC--------TTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCE
T ss_pred             CcCCCCcccC-CC---CCCccCEEEecCCccCcCC--------hhHhccCccccEEECcCCcccceECcccccccccCCE
Confidence            3455666543 32   3478999999999865433        5568889999999999999874 45678899999999


Q ss_pred             EEccCCcCcccCCCccccCCCCccEEEccCccccccCCch--hhCCCCCCEEEccCCcCcccCCcc-ccCCCCCCeeecc
Q 040702           82 LYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSF--IFNASKLSELGLQKNSFSGSIPNT-FGNLRNLKWLGLN  158 (797)
Q Consensus        82 L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~--~~~l~~L~~L~L~~N~l~~~~~~~-f~~l~~L~~L~L~  158 (797)
                      |+|++|+++ .++...|.++++|++|+|++|++++..+..  |..+++|++|+|++|+|+++.|.. |.++++|++|+|+
T Consensus        84 L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~  162 (455)
T 3v47_A           84 LKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLT  162 (455)
T ss_dssp             EECTTCTTC-EECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECT
T ss_pred             EeCCCCccC-ccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCC
Confidence            999999998 554555678999999999999998754443  888999999999999999887776 8899999999999


Q ss_pred             CccCcCCCCCccccccCCCC--CCCcEEEccCCCCCCCCChhhh--------ccccCCcEEEccCCcccccCChhhhhh-
Q 040702          159 DNYLTSSTPELSSLSSLSNC--KYLEYFSFSNNPLGGILPRAIG--------NLSQSMEDFWMDNCNISGSIPEEINNL-  227 (797)
Q Consensus       159 ~N~l~~~~~~~~~~~~l~~l--~~L~~L~Ls~N~l~~~~~~~~~--------~l~~~L~~L~L~~n~i~~~~p~~~~~l-  227 (797)
                      +|.++...+.     .+..+  .+|+.|++++|.+....+..+.        .++ +|+.|++++|.+.+..|..+... 
T Consensus       163 ~n~l~~~~~~-----~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~-~L~~L~Ls~n~l~~~~~~~~~~~~  236 (455)
T 3v47_A          163 FNKVKSICEE-----DLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNT-SITTLDLSGNGFKESMAKRFFDAI  236 (455)
T ss_dssp             TCCBSCCCTT-----TSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTC-EEEEEECTTSCCCHHHHHHHHHHT
T ss_pred             CCcccccChh-----hhhccccccccccccccCcccccchhhccccccccccccc-eeeeEecCCCcccccchhhhhccc
Confidence            9999887664     23333  6789999999999877654432        334 79999999999998888888765 


Q ss_pred             --hhhHhhhcccccccccCC----------CchhhcC--CCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCC
Q 040702          228 --TNLILQLLSLEGNQLEGS----------IPDDLCR--LAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSI  293 (797)
Q Consensus       228 --~~L~L~~L~Ls~N~l~~~----------~~~~~~~--l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l  293 (797)
                        +++  +.|++++|.+.+.          .+..+..  .++|+.|++++|.+.+..|..+..+++|++|+|++|.++.+
T Consensus       237 ~~~~L--~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~  314 (455)
T 3v47_A          237 AGTKI--QSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKI  314 (455)
T ss_dssp             TTCCE--EEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEE
T ss_pred             cccce--eeEeeccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCccccc
Confidence              555  8889888865432          2223333  36899999999999999999999999999999999999877


Q ss_pred             -CCCCCCCCcccEEEccCCcCCCCCCccccccccccEEeccCcccccccCccccCCcccceecccCccccCCCChhhhcc
Q 040702          294 -PSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDL  372 (797)
Q Consensus       294 -p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  372 (797)
                       |..+.++++|+.|++++|.+++..|..|..+++|++|++++|++++..|..|.++++|++|+|++|++++..+..|..+
T Consensus       315 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l  394 (455)
T 3v47_A          315 DDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRL  394 (455)
T ss_dssp             CTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTC
T ss_pred             ChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHhHhccC
Confidence             4578899999999999999998889999999999999999999999989999999999999999999998777788999


Q ss_pred             ccCCeeeecCCcCCCCCC
Q 040702          373 ISLKSLNLSNNNLSGTIP  390 (797)
Q Consensus       373 ~~L~~L~Ls~N~l~~~~p  390 (797)
                      ++|++|++++|++++..|
T Consensus       395 ~~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          395 TSLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             TTCCEEECCSSCBCCCTT
T ss_pred             CcccEEEccCCCcccCCC
Confidence            999999999999998877

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=9.5e-43  Score=394.96  Aligned_cols=242  Identities=19%  Similarity=0.239  Sum_probs=195.1

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHH---HHHhhhccCCceeEeeeeeecCCeE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIE---CGMMKRIRHRNLIKIISSCSNDDFK  579 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E---~~~l~~l~Hpniv~l~~~~~~~~~~  579 (797)
                      .++|+..+.||+|+||+||++     |+.||||++++..   ......+.+|   +.+++.++|||||+++++|.+++..
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            368999999999999999974     6899999998652   2222334444   5666777899999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCC
Q 040702          580 ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  659 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  659 (797)
                      |+|||||+||+|.+++...+ .+++..+..|+.||+.||+|||   +++||||||||+|||++.+|++||+|||+|+.+.
T Consensus       268 ylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~  343 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  343 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence            99999999999999998755 4899999999999999999999   9999999999999999999999999999998764


Q ss_pred             ccCccccccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchhhhh-------------------hhc
Q 040702          660 EEDQSLTQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIREEKH-------------------LMT  719 (797)
Q Consensus       660 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~~-------------------~~~  719 (797)
                      ..    .....+||+.|||||++.. ..|+.++|+||+|++.++++.+..++......                   ...
T Consensus       344 ~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~  419 (689)
T 3v5w_A          344 KK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP  419 (689)
T ss_dssp             SC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred             CC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCH
Confidence            32    2345789999999999975 47999999999999998877776665432211                   112


Q ss_pred             ccccchhccccCCCCCCCChHHHHHhHHHHHHHhccccccccccCCcccccceeeeeeeee
Q 040702          720 KEQPMVRMGTDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYTI  780 (797)
Q Consensus       720 ~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~  780 (797)
                      ..+++++.|+..||.+|++                    .....+.++++|+||+++||+.
T Consensus       420 ~a~dLI~~lL~~dP~~Rl~--------------------~~~~ga~ei~~HpfF~~idW~~  460 (689)
T 3v5w_A          420 ELRSLLEGLLQRDVNRRLG--------------------CLGRGAQEVKESPFFRSLDWQM  460 (689)
T ss_dssp             HHHHHHHHHTCSCGGGCTT--------------------CSSSTHHHHTTSGGGTTCCHHH
T ss_pred             HHHHHHHHHccCCHhHCCC--------------------CCCCCHHHHhcCccccCCCHHH
Confidence            3445555555555555554                    3344567788999999999974

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.4e-41  Score=379.70  Aligned_cols=345  Identities=21%  Similarity=0.209  Sum_probs=220.0

Q ss_pred             EEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCc
Q 040702           81 SLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDN  160 (797)
Q Consensus        81 ~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N  160 (797)
                      .++.++++++ .+|....   +++++|+|++|+|++..+..|.++++|++|+|++|.|+++.|++|.++++|++|+|++|
T Consensus        15 ~v~c~~~~l~-~ip~~~~---~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n   90 (477)
T 2id5_A           15 AVLCHRKRFV-AVPEGIP---TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN   90 (477)
T ss_dssp             EEECCSCCCS-SCCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             EEEeCCCCcC-cCCCCCC---CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence            3444444443 4443321   34444444444444444444444444444444444444444444444444444444444


Q ss_pred             cCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccc
Q 040702          161 YLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGN  240 (797)
Q Consensus       161 ~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N  240 (797)
                      .++.+++.     .|.++++|++|+|++|++.++.+..|..++ +|+.|++++|.+.+..+..|.++++|  ++|++++|
T Consensus        91 ~l~~~~~~-----~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L--~~L~l~~n  162 (477)
T 2id5_A           91 RLKLIPLG-----VFTGLSNLTKLDISENKIVILLDYMFQDLY-NLKSLEVGDNDLVYISHRAFSGLNSL--EQLTLEKC  162 (477)
T ss_dssp             CCCSCCTT-----SSTTCTTCCEEECTTSCCCEECTTTTTTCT-TCCEEEECCTTCCEECTTSSTTCTTC--CEEEEESC
T ss_pred             cCCccCcc-----cccCCCCCCEEECCCCccccCChhHccccc-cCCEEECCCCccceeChhhccCCCCC--CEEECCCC
Confidence            44444433     144444455555555554444444444444 45555555555555555555555555  66667777


Q ss_pred             cccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCC-CCCCCCCCCCCcccEEEccCCcCCCCCCc
Q 040702          241 QLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLL-TSIPSTLWNLKDILHLNLSSNFFTGPLPL  319 (797)
Q Consensus       241 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l-~~lp~~~~~l~~L~~L~l~~N~l~~~~~~  319 (797)
                      +++++.+..|..+++|+.|+|++|.+.++.+..|..+++|+.|++++|.+ ..+|.......+|+.|++++|.+++..+.
T Consensus       163 ~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~  242 (477)
T 2id5_A          163 NLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYL  242 (477)
T ss_dssp             CCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHH
T ss_pred             cCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHH
Confidence            77666666777777888888888888777777777888888888887765 66676666666888888888888866556


Q ss_pred             cccccccccEEeccCcccccccCccccCCcccceecccCccccCCCChhhhccccCCeeeecCCcCCCCCChhhhccCCC
Q 040702          320 KIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDL  399 (797)
Q Consensus       320 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L  399 (797)
                      .|..+++|+.|+|++|.+++..+..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|++++..+..|..+++|
T Consensus       243 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  322 (477)
T 2id5_A          243 AVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNL  322 (477)
T ss_dssp             HHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGC
T ss_pred             HhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCccc
Confidence            77888888888888888887777778888888888888888887778888888888888888888887777777888888


Q ss_pred             CeEEccCCcCcccCCCCCCCCCCCcccccCCccccCCC
Q 040702          400 KDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMP  437 (797)
Q Consensus       400 ~~L~l~~N~l~~~~p~~~~~~~l~~~~~~~n~~~c~~~  437 (797)
                      +.|++++|++.|..+....+.......+.++...|..|
T Consensus       323 ~~L~l~~N~l~c~c~~~~~~~~~~~~~~~~~~~~C~~p  360 (477)
T 2id5_A          323 ETLILDSNPLACDCRLLWVFRRRWRLNFNRQQPTCATP  360 (477)
T ss_dssp             CEEECCSSCEECSGGGHHHHTTTTSSCCTTCCCBEEES
T ss_pred             CEEEccCCCccCccchHhHHhhhhccccCccCceeCCc
Confidence            88888888887664321111222334556677777655

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.8e-41  Score=366.05  Aligned_cols=190  Identities=21%  Similarity=0.265  Sum_probs=160.7

Q ss_pred             HhcCCCccccccccCCcceeec--------ceEEEEEEEEeccCCcchhHHHHHHHhhhc-cCCceeEeeeeeecCCeEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD--------GMEVAIKVFNLQYGGAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDFKA  580 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~--------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~  580 (797)
                      ..++|++.+.||+|+||+||++        ++.||||.+....  ...++.+|+++++.+ +|||||++++++.+.+..|
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~   96 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV   96 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence            4578999999999999999975        4689999986443  346788999999998 6999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCC-CcEEEEeecCCccCC
Q 040702          581 LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN-MVAHLSDFGMAKPLL  659 (797)
Q Consensus       581 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~DFGla~~~~  659 (797)
                      +||||+++|+|.+++.    .+++.+++.++.|++.||+|||   +++|+||||||+|||++.+ +.+||+|||+|+...
T Consensus        97 lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~  169 (361)
T 4f9c_A           97 IAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH  169 (361)
T ss_dssp             EEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred             EEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence            9999999999999984    3889999999999999999999   9999999999999999876 799999999998553


Q ss_pred             ccCcc--------------------------ccccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhcccc
Q 040702          660 EEDQS--------------------------LTQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDAN  708 (797)
Q Consensus       660 ~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~  708 (797)
                      +....                          ......+||++|||||++.+. .|+.++|+||+|++.++++.+..
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~  245 (361)
T 4f9c_A          170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY  245 (361)
T ss_dssp             TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred             CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence            22110                          112345799999999999875 48999999999999877666543

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=1.2e-39  Score=367.87  Aligned_cols=349  Identities=29%  Similarity=0.433  Sum_probs=305.0

Q ss_pred             CCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCcc
Q 040702           18 GNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSA   97 (797)
Q Consensus        18 ~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~   97 (797)
                      ..+++++.|++++|.+         ..+| .+..+++|++|++++|+++++.|  |.++++|++|+|++|.++ .++.  
T Consensus        43 ~~l~~l~~L~l~~~~i---------~~l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~-~~~~--  107 (466)
T 1o6v_A           43 TDLDQVTTLQADRLGI---------KSID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DITP--  107 (466)
T ss_dssp             HHHHTCCEEECCSSCC---------CCCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCGG--
T ss_pred             hHhccccEEecCCCCC---------ccCc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccc-cChh--
Confidence            3467899999999984         3455 37889999999999999998755  999999999999999998 5554  


Q ss_pred             ccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCC
Q 040702           98 DVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSN  177 (797)
Q Consensus        98 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~  177 (797)
                      +..+++|++|+|++|++++..+  +.++++|++|+|++|+++++.  .+.++++|++|+++ |.+...+       .+.+
T Consensus       108 ~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~--~~~~l~~L~~L~l~-~~~~~~~-------~~~~  175 (466)
T 1o6v_A          108 LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDIS--ALSGLTSLQQLSFG-NQVTDLK-------PLAN  175 (466)
T ss_dssp             GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCG--GGTTCTTCSEEEEE-ESCCCCG-------GGTT
T ss_pred             hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECCCCccCCCh--hhccCCcccEeecC-CcccCch-------hhcc
Confidence            6789999999999999986543  899999999999999999753  59999999999996 5555443       3788


Q ss_pred             CCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCc
Q 040702          178 CKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALF  257 (797)
Q Consensus       178 l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~  257 (797)
                      +++|+.|++++|++..+  ..+..++ +|+.|++++|.+.+..|  ++.+++|  ++|++++|++++.  ..+..+++|+
T Consensus       176 l~~L~~L~l~~n~l~~~--~~l~~l~-~L~~L~l~~n~l~~~~~--~~~l~~L--~~L~l~~n~l~~~--~~l~~l~~L~  246 (466)
T 1o6v_A          176 LTTLERLDISSNKVSDI--SVLAKLT-NLESLIATNNQISDITP--LGILTNL--DELSLNGNQLKDI--GTLASLTNLT  246 (466)
T ss_dssp             CTTCCEEECCSSCCCCC--GGGGGCT-TCSEEECCSSCCCCCGG--GGGCTTC--CEEECCSSCCCCC--GGGGGCTTCS
T ss_pred             CCCCCEEECcCCcCCCC--hhhccCC-CCCEEEecCCccccccc--ccccCCC--CEEECCCCCcccc--hhhhcCCCCC
Confidence            89999999999999876  3477887 89999999999997665  7778888  9999999999864  4688999999


Q ss_pred             EEEccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEccCCcCCCCCCccccccccccEEeccCccc
Q 040702          258 QLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNF  337 (797)
Q Consensus       258 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  337 (797)
                      .|++++|.+++..+  +..+++|+.|++++|.++.++. +..+++|+.|++++|++++..+  +..+++|+.|++++|++
T Consensus       247 ~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l  321 (466)
T 1o6v_A          247 DLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNI  321 (466)
T ss_dssp             EEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCC
T ss_pred             EEECCCCccccchh--hhcCCCCCEEECCCCccCcccc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcC
Confidence            99999999997755  8899999999999999988876 7889999999999999997654  88999999999999999


Q ss_pred             ccccCccccCCcccceecccCccccCCCChhhhccccCCeeeecCCcCCCCCChhhhccCCCCeEEccCCcCcccC
Q 040702          338 SCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEI  413 (797)
Q Consensus       338 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  413 (797)
                      ++..|  +..+++|+.|++++|++++.  ..+..+++|+.|++++|++++..|  +..+++|+.|++++|++++.+
T Consensus       322 ~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~~p  391 (466)
T 1o6v_A          322 SDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAP  391 (466)
T ss_dssp             SCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEECCC
T ss_pred             CCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccCCc
Confidence            98766  78999999999999999865  478999999999999999998877  899999999999999999754

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.9e-41  Score=366.41  Aligned_cols=228  Identities=23%  Similarity=0.265  Sum_probs=186.2

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCC--cchhHHHHHHHhhhccCCceeEeeeeeec------CCe
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG--AFKSFDIECGMMKRIRHRNLIKIISSCSN------DDF  578 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~l~~~~~~------~~~  578 (797)
                      ++|+..+.||+|+||+||++     |+.||||+++.....  ..+.+.+|+++|+.++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999985     689999999755322  24578899999999999999999998754      357


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccC
Q 040702          579 KALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  658 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  658 (797)
                      .|+|||||+ |+|.+++...+ .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.+
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~  208 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGL  208 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred             EEEEEeCCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence            899999996 68999997655 5999999999999999999999   999999999999999999999999999999876


Q ss_pred             CccCc--cccccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccccccchhh-h-------------------
Q 040702          659 LEEDQ--SLTQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANLLIREE-K-------------------  715 (797)
Q Consensus       659 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-~-------------------  715 (797)
                      .....  .......+||+.|||||++.+. .|+.++|+||+|++.++++.+..++.+.. .                   
T Consensus       209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~  288 (398)
T 4b99_A          209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ  288 (398)
T ss_dssp             -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred             ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            43221  1234567899999999998875 46899999999999877666655543211 0                   


Q ss_pred             ---------------------------hhhcccccchhccccCCCCCCCChHHHHH
Q 040702          716 ---------------------------HLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       716 ---------------------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                                 .......++++.|+..||++|||+.|+++
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                                       01223457899999999999999998876

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=100.00  E-value=7.3e-39  Score=376.20  Aligned_cols=398  Identities=20%  Similarity=0.176  Sum_probs=315.9

Q ss_pred             CCCCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCC-ccccCCCCCCEEEcccCcccccCCccccCCCCCC
Q 040702            2 PSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIP-HEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLK   80 (797)
Q Consensus         2 ~~l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip-~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~   80 (797)
                      |||++|.|+++.+.+|.++++|++|||++|+++         .+| ..|.++++|++|+|++|+++++.+..|+++++|+
T Consensus        81 L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~---------~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~  151 (635)
T 4g8a_A           81 LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ---------SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK  151 (635)
T ss_dssp             EECTTCCCCEECTTTTTTCTTCCEEECTTCCCC---------EECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCC
T ss_pred             EECCCCcCCCcChhHhcCCCCCCEEEccCCcCC---------CCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccC
Confidence            689999999999999999999999999999954         344 3578999999999999999998888999999999


Q ss_pred             EEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCC----CEEEccCCcCcccCCccccCCCCCCeee
Q 040702           81 SLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKL----SELGLQKNSFSGSIPNTFGNLRNLKWLG  156 (797)
Q Consensus        81 ~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L----~~L~L~~N~l~~~~~~~f~~l~~L~~L~  156 (797)
                      +|+|++|.+++......+..+++|++|+|++|+|++..+..|..+.++    ..++++.|.++.+.++.+..+ .++.|+
T Consensus       152 ~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~-~~~~l~  230 (635)
T 4g8a_A          152 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLT  230 (635)
T ss_dssp             EEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTC-EEEEEE
T ss_pred             eeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccch-hhhhhh
Confidence            999999999843234556789999999999999998888888766544    468888888876655444322 222222


Q ss_pred             ccCccCc-----------------------------------------------------------CCCCC---------
Q 040702          157 LNDNYLT-----------------------------------------------------------SSTPE---------  168 (797)
Q Consensus       157 L~~N~l~-----------------------------------------------------------~~~~~---------  168 (797)
                      +++|...                                                           .....         
T Consensus       231 l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~  310 (635)
T 4g8a_A          231 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSS  310 (635)
T ss_dssp             EESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSE
T ss_pred             hhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccc
Confidence            2222110                                                           00000         


Q ss_pred             -------ccccccCCCCCCCcEEEccCCCCCCCCChh-------------------hhccccCCcEEEccCCccc--ccC
Q 040702          169 -------LSSLSSLSNCKYLEYFSFSNNPLGGILPRA-------------------IGNLSQSMEDFWMDNCNIS--GSI  220 (797)
Q Consensus       169 -------~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~-------------------~~~l~~~L~~L~L~~n~i~--~~~  220 (797)
                             +.....+.....|+.|++++|.+....+..                   +..++ +|+.|++++|.+.  +..
T Consensus       311 l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~-~L~~L~ls~n~l~~~~~~  389 (635)
T 4g8a_A          311 FSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLP-SLEFLDLSRNGLSFKGCC  389 (635)
T ss_dssp             EEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCT-TCCEEECCSSCCBEEEEC
T ss_pred             ccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCccccccc-ccccchhhcccccccccc
Confidence                   000112333445555555555544332222                   23455 7999999999986  345


Q ss_pred             ChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCC-CCccCCccccccccCCCCCCCC-CCCCC
Q 040702          221 PEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVP-ACSGNLTNLRKLYLGSNLLTSI-PSTLW  298 (797)
Q Consensus       221 p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~l-p~~~~  298 (797)
                      +..+..+.+|  ++|+++.|.+.. .+..+..+++|+.++++.|......+ ..|..+++++.++++.|.+..+ |..+.
T Consensus       390 ~~~~~~~~~L--~~L~~~~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~  466 (635)
T 4g8a_A          390 SQSDFGTISL--KYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN  466 (635)
T ss_dssp             CHHHHSCSCC--CEEECCSCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTT
T ss_pred             ccchhhhhhh--hhhhcccccccc-ccccccccccccchhhhhccccccccccccccccccccccccccccccccccccc
Confidence            6667777777  999999999885 45678889999999999988765544 5788999999999999999665 45667


Q ss_pred             CCCcccEEEccCCcCC-CCCCccccccccccEEeccCcccccccCccccCCcccceecccCccccCCCChhhhccccCCe
Q 040702          299 NLKDILHLNLSSNFFT-GPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKS  377 (797)
Q Consensus       299 ~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~  377 (797)
                      .+++|+.|++++|.+. +..|..|..+++|+.|+|++|+|+++.|..|.++++|++|+|++|+|++..|..|..+++|++
T Consensus       467 ~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~  546 (635)
T 4g8a_A          467 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV  546 (635)
T ss_dssp             TCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCE
T ss_pred             cchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCE
Confidence            7999999999999854 467888999999999999999999999999999999999999999999999999999999999


Q ss_pred             eeecCCcCCCCCChhhhcc-CCCCeEEccCCcCcccC
Q 040702          378 LNLSNNNLSGTIPISLEKL-LDLKDINVSFNRLEGEI  413 (797)
Q Consensus       378 L~Ls~N~l~~~~p~~~~~l-~~L~~L~l~~N~l~~~~  413 (797)
                      |+|++|+|++..|..+..+ ++|+.|++++|++.|..
T Consensus       547 L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C  583 (635)
T 4g8a_A          547 LDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC  583 (635)
T ss_dssp             EECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSG
T ss_pred             EECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccC
Confidence            9999999999999999998 68999999999999864

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.6e-40  Score=380.38  Aligned_cols=228  Identities=18%  Similarity=0.212  Sum_probs=195.2

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      .++|++.+.||+|+||.||++     |+.||||++........+.+.+|+++|+.++|||||++++++.+++..|+||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            368999999999999999974     689999999876544567789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCC--CcEEEEeecCCccCCccCc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN--MVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~--~~~kl~DFGla~~~~~~~~  663 (797)
                      |+||+|.+++......+++.++..++.||+.||+|||   +++|+||||||+|||++.+  +.+||+|||+|+.+.... 
T Consensus       236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~-  311 (573)
T 3uto_A          236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-  311 (573)
T ss_dssp             CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred             cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence            9999999999766667999999999999999999999   9999999999999999854  899999999999764332 


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh--------------------hhhhccccc
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE--------------------KHLMTKEQP  723 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~  723 (797)
                        .....+||+.|||||.+.+..|+.++|+||+|++.++++.+..++....                    .......++
T Consensus       312 --~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~d  389 (573)
T 3uto_A          312 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD  389 (573)
T ss_dssp             --EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHH
T ss_pred             --ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence              3345689999999999999999999999999999866665554433211                    112335578


Q ss_pred             chhccccCCCCCCCChHHHHH
Q 040702          724 MVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       724 l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      +++.||..||.+||++.|+++
T Consensus       390 li~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          390 FIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCChhHCcCHHHHhc
Confidence            899999999999999888754

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=100.00  E-value=5.9e-39  Score=362.06  Aligned_cols=340  Identities=25%  Similarity=0.374  Sum_probs=299.3

Q ss_pred             CCCCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCE
Q 040702            2 PSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKS   81 (797)
Q Consensus         2 ~~l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~   81 (797)
                      ++++++.++.+ + .+..+++|++|||++|++++         +|. +..+++|++|++++|++.++.|  +.++++|++
T Consensus        51 L~l~~~~i~~l-~-~~~~l~~L~~L~Ls~n~l~~---------~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~  116 (466)
T 1o6v_A           51 LQADRLGIKSI-D-GVEYLNNLTQINFSNNQLTD---------ITP-LKNLTKLVDILMNNNQIADITP--LANLTNLTG  116 (466)
T ss_dssp             EECCSSCCCCC-T-TGGGCTTCCEEECCSSCCCC---------CGG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred             EecCCCCCccC-c-chhhhcCCCEEECCCCccCC---------chh-hhccccCCEEECCCCccccChh--hcCCCCCCE
Confidence            46788888764 3 48899999999999999553         444 8899999999999999998766  999999999


Q ss_pred             EEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCcc
Q 040702           82 LYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNY  161 (797)
Q Consensus        82 L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~  161 (797)
                      |+|++|.++ .++.  +..+++|++|+|++|.+.+. + .+..+++|++|+++ |.+.+..+  |.++++|++|++++|.
T Consensus       117 L~L~~n~l~-~~~~--~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~~~--~~~l~~L~~L~l~~n~  188 (466)
T 1o6v_A          117 LTLFNNQIT-DIDP--LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNK  188 (466)
T ss_dssp             EECCSSCCC-CCGG--GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCCGG--GTTCTTCCEEECCSSC
T ss_pred             EECCCCCCC-CChH--HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCchh--hccCCCCCEEECcCCc
Confidence            999999998 6654  67999999999999999854 3 58999999999997 56665543  9999999999999999


Q ss_pred             CcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhccccccc
Q 040702          162 LTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQ  241 (797)
Q Consensus       162 l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~  241 (797)
                      ++.++       .+..+++|++|++++|++.+..|  ++.++ +|+.|++++|.+.+.  ..+..+++|  ++|++++|.
T Consensus       189 l~~~~-------~l~~l~~L~~L~l~~n~l~~~~~--~~~l~-~L~~L~l~~n~l~~~--~~l~~l~~L--~~L~l~~n~  254 (466)
T 1o6v_A          189 VSDIS-------VLAKLTNLESLIATNNQISDITP--LGILT-NLDELSLNGNQLKDI--GTLASLTNL--TDLDLANNQ  254 (466)
T ss_dssp             CCCCG-------GGGGCTTCSEEECCSSCCCCCGG--GGGCT-TCCEEECCSSCCCCC--GGGGGCTTC--SEEECCSSC
T ss_pred             CCCCh-------hhccCCCCCEEEecCCccccccc--ccccC-CCCEEECCCCCcccc--hhhhcCCCC--CEEECCCCc
Confidence            98764       37788999999999999998766  66676 899999999999864  468888888  999999999


Q ss_pred             ccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEccCCcCCCCCCccc
Q 040702          242 LEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKI  321 (797)
Q Consensus       242 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~  321 (797)
                      +.+..+  +..+++|++|++++|.+++..+  +..+++|+.|++++|.++.++. +..+++|+.|++++|.+++..|  +
T Consensus       255 l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~  327 (466)
T 1o6v_A          255 ISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP-ISNLKNLTYLTLYFNNISDISP--V  327 (466)
T ss_dssp             CCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG-GGGCTTCSEEECCSSCCSCCGG--G
T ss_pred             cccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh-hcCCCCCCEEECcCCcCCCchh--h
Confidence            997655  8899999999999999997655  8899999999999999988876 7789999999999999998766  7


Q ss_pred             cccccccEEeccCcccccccCccccCCcccceecccCccccCCCChhhhccccCCeeeecCCcCCCC
Q 040702          322 GNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGT  388 (797)
Q Consensus       322 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  388 (797)
                      ..+++|++|++++|.+++.  ..+..+++|+.|++++|++++..|  +..+++|+.|++++|.+++.
T Consensus       328 ~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~~~  390 (466)
T 1o6v_A          328 SSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNA  390 (466)
T ss_dssp             GGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEECC
T ss_pred             ccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCcccCC
Confidence            8999999999999999976  478999999999999999998777  89999999999999999964

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=2.8e-39  Score=361.76  Aligned_cols=364  Identities=25%  Similarity=0.321  Sum_probs=228.1

Q ss_pred             CCCCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCC-------------CCEEEcccCccccc
Q 040702            2 PSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHN-------------MEWMAFSFNKVVGV   68 (797)
Q Consensus         2 ~~l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~-------------L~~L~ls~N~i~~~   68 (797)
                      +++++|.+ |.+|++++.+++|++|||++|.++|.+        |.+++.+.+             +++|++++|+++++
T Consensus        16 L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~--------p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~l   86 (454)
T 1jl5_A           16 PLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNA--------PPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSL   86 (454)
T ss_dssp             -------------------CCHHHHHHHHHHHHHTS--------CTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCC
T ss_pred             hhcccCch-hhCChhHhcccchhhhhccCCcccccC--------CcccccchhcchhhhhhhhccCCCEEEecCCccccC
Confidence            67889998 889999999999999999999866554        455555554             48888888888774


Q ss_pred             CCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccC
Q 040702           69 VPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGN  148 (797)
Q Consensus        69 ~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~  148 (797)
                       |..   .++|++|++++|.++ .+|..    +++|++|++++|++++. |..   .++|++|+|++|+|++ .| .|++
T Consensus        87 -p~~---~~~L~~L~l~~n~l~-~lp~~----~~~L~~L~l~~n~l~~l-~~~---~~~L~~L~L~~n~l~~-lp-~~~~  151 (454)
T 1jl5_A           87 -PEL---PPHLESLVASCNSLT-ELPEL----PQSLKSLLVDNNNLKAL-SDL---PPLLEYLGVSNNQLEK-LP-ELQN  151 (454)
T ss_dssp             -CSC---CTTCSEEECCSSCCS-SCCCC----CTTCCEEECCSSCCSCC-CSC---CTTCCEEECCSSCCSS-CC-CCTT
T ss_pred             -CCC---cCCCCEEEccCCcCC-ccccc----cCCCcEEECCCCccCcc-cCC---CCCCCEEECcCCCCCC-Cc-ccCC
Confidence             332   367888888888887 47743    37888888888888743 221   2678888888888886 44 5888


Q ss_pred             CCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhh
Q 040702          149 LRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLT  228 (797)
Q Consensus       149 l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~  228 (797)
                      +++|++|++++|+++.++..         .++|++|++++|+++++ | .+.+++ +|+.|++++|.+++ +|...   +
T Consensus       152 l~~L~~L~l~~N~l~~lp~~---------~~~L~~L~L~~n~l~~l-~-~~~~l~-~L~~L~l~~N~l~~-l~~~~---~  215 (454)
T 1jl5_A          152 SSFLKIIDVDNNSLKKLPDL---------PPSLEFIAAGNNQLEEL-P-ELQNLP-FLTAIYADNNSLKK-LPDLP---L  215 (454)
T ss_dssp             CTTCCEEECCSSCCSCCCCC---------CTTCCEEECCSSCCSSC-C-CCTTCT-TCCEEECCSSCCSS-CCCCC---T
T ss_pred             CCCCCEEECCCCcCcccCCC---------cccccEEECcCCcCCcC-c-cccCCC-CCCEEECCCCcCCc-CCCCc---C
Confidence            88888888888888876543         13788888888888864 4 477776 78888888888875 34332   2


Q ss_pred             hhHhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEc
Q 040702          229 NLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNL  308 (797)
Q Consensus       229 ~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l  308 (797)
                      +|  ++|++++|.++ .+| .+..+++|++|++++|+++++ |..   +++|+.|++++|.++.+|..   +++|+.|++
T Consensus       216 ~L--~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~l-~~~---~~~L~~L~l~~N~l~~l~~~---~~~L~~L~l  284 (454)
T 1jl5_A          216 SL--ESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKTL-PDL---PPSLEALNVRDNYLTDLPEL---PQSLTFLDV  284 (454)
T ss_dssp             TC--CEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSSC-CSC---CTTCCEEECCSSCCSCCCCC---CTTCCEEEC
T ss_pred             cc--cEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCcc-ccc---ccccCEEECCCCcccccCcc---cCcCCEEEC
Confidence            44  78888888887 445 377888888888888888764 332   36788888888888777764   367788888


Q ss_pred             cCCcCCCCCCccccccccccEEeccCcccccccCccccCC-cccceecccCccccCCCChhhhccccCCeeeecCCcCCC
Q 040702          309 SSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGL-KDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSG  387 (797)
Q Consensus       309 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~  387 (797)
                      ++|.+++.. ..   .++|+.|++++|++++. +    .+ ++|++|++++|++++ +|..   +++|++|++++|++++
T Consensus       285 s~N~l~~l~-~~---~~~L~~L~l~~N~l~~i-~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~~  351 (454)
T 1jl5_A          285 SENIFSGLS-EL---PPNLYYLNASSNEIRSL-C----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLAE  351 (454)
T ss_dssp             CSSCCSEES-CC---CTTCCEEECCSSCCSEE-C----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC
T ss_pred             cCCccCccc-Cc---CCcCCEEECcCCcCCcc-c----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCcccc
Confidence            888877521 11   14677777777777642 2    22 467777777777764 4433   4667777777777763


Q ss_pred             CCChhhhccCCCCeEEccCCcCcc--cCCCC-CCC-------------CCCCcccccCCccc
Q 040702          388 TIPISLEKLLDLKDINVSFNRLEG--EIPRE-GPF-------------RNLSAESFKGNELL  433 (797)
Q Consensus       388 ~~p~~~~~l~~L~~L~l~~N~l~~--~~p~~-~~~-------------~~l~~~~~~~n~~~  433 (797)
                       +|.   .+++|+.|++++|++++  .+|.. ..+             ..++.+++++|++.
T Consensus       352 -lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~  409 (454)
T 1jl5_A          352 -VPE---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR  409 (454)
T ss_dssp             -CCC---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC-----------------------
T ss_pred             -ccc---hhhhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCC
Confidence             444   35667777777777776  33332 222             45566666666554

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.6e-39  Score=363.14  Aligned_cols=347  Identities=20%  Similarity=0.184  Sum_probs=239.3

Q ss_pred             CEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCC
Q 040702           24 QTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPN  103 (797)
Q Consensus        24 ~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~  103 (797)
                      +.++.++++         ++.+|..+.  ++++.|+|++|+|+++.|..|.++++|++|+|++|.++ .++...|.++++
T Consensus        14 ~~v~c~~~~---------l~~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~-~~~~~~~~~l~~   81 (477)
T 2id5_A           14 RAVLCHRKR---------FVAVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFN   81 (477)
T ss_dssp             TEEECCSCC---------CSSCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCC-EECTTTTTTCTT
T ss_pred             CEEEeCCCC---------cCcCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccC-EeChhhhhCCcc
Confidence            567777776         445555553  46788888888888777778888888888888888887 555555667788


Q ss_pred             ccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcE
Q 040702          104 LKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEY  183 (797)
Q Consensus       104 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~  183 (797)
                      |++|+|++|++++..+..|.++++|++|+|++|+|+++.+..|.++++|++|+|++|.++.+.+.     .|.++++|+.
T Consensus        82 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-----~~~~l~~L~~  156 (477)
T 2id5_A           82 LRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHR-----AFSGLNSLEQ  156 (477)
T ss_dssp             CCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTT-----SSTTCTTCCE
T ss_pred             CCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChh-----hccCCCCCCE
Confidence            88888888887766666677778888888888888777777788888888888888877776654     3677777777


Q ss_pred             EEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccC
Q 040702          184 FSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGG  263 (797)
Q Consensus       184 L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~  263 (797)
                      |+|++|+++++.+..|.+++ +|+.|++++|                          .+.++.+..|..+++|+.|++++
T Consensus       157 L~l~~n~l~~~~~~~l~~l~-~L~~L~l~~n--------------------------~i~~~~~~~~~~l~~L~~L~l~~  209 (477)
T 2id5_A          157 LTLEKCNLTSIPTEALSHLH-GLIVLRLRHL--------------------------NINAIRDYSFKRLYRLKVLEISH  209 (477)
T ss_dssp             EEEESCCCSSCCHHHHTTCT-TCCEEEEESC--------------------------CCCEECTTCSCSCTTCCEEEEEC
T ss_pred             EECCCCcCcccChhHhcccC-CCcEEeCCCC--------------------------cCcEeChhhcccCcccceeeCCC
Confidence            77777777766666666655 4555544444                          44444455566666666677766


Q ss_pred             CcCcccCCCCccCCccccccccCCCCCCCCCC-CCCCCCcccEEEccCCcCCCCCCccccccccccEEeccCcccccccC
Q 040702          264 NKLSGFVPACSGNLTNLRKLYLGSNLLTSIPS-TLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIP  342 (797)
Q Consensus       264 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~  342 (797)
                      |...+..|.......+|+.|+|++|.++.+|. .+..+++|+.|++++|.+++..+..|..+++|+.|+|++|++++..|
T Consensus       210 ~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~  289 (477)
T 2id5_A          210 WPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEP  289 (477)
T ss_dssp             CTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECT
T ss_pred             CccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECH
Confidence            66555555444445577777777777776664 45567777777777777776666667777777777777777777777


Q ss_pred             ccccCCcccceecccCccccCCCChhhhccccCCeeeecCCcCCCCCChhhhccCCCCeEEccCCcCcccCCC
Q 040702          343 TKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPR  415 (797)
Q Consensus       343 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~  415 (797)
                      ..|.++++|+.|+|++|++++..+..|..+++|+.|+|++|.+....+ ...-......+++.++...|..|.
T Consensus       290 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~-~~~~~~~~~~~~~~~~~~~C~~p~  361 (477)
T 2id5_A          290 YAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCR-LLWVFRRRWRLNFNRQQPTCATPE  361 (477)
T ss_dssp             TTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGG-GHHHHTTTTSSCCTTCCCBEEESG
T ss_pred             HHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccc-hHhHHhhhhccccCccCceeCCch
Confidence            777777777777777777776666667777777788887777764322 111122334455666666665553

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=1.9e-38  Score=355.22  Aligned_cols=348  Identities=17%  Similarity=0.157  Sum_probs=278.5

Q ss_pred             CccccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCC
Q 040702            8 FLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSN   87 (797)
Q Consensus         8 ~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N   87 (797)
                      .+.+..+.+++.+++|++|||++|++++         +| ++..+++|++|++++|+++++ |  ++++++|++|+|++|
T Consensus        29 ~~~~~~~~~~~~l~~L~~L~Ls~n~l~~---------~~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N   95 (457)
T 3bz5_A           29 EMQATDTISEEQLATLTSLDCHNSSITD---------MT-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSN   95 (457)
T ss_dssp             TCCTTSEEEHHHHTTCCEEECCSSCCCC---------CT-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSS
T ss_pred             CcCcccccChhHcCCCCEEEccCCCccc---------Ch-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCC
Confidence            3455566678899999999999999554         44 578899999999999999985 4  899999999999999


Q ss_pred             cCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCcc-CcCCC
Q 040702           88 SLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNY-LTSST  166 (797)
Q Consensus        88 ~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~-l~~~~  166 (797)
                      .|+ .+|   +..+++|++|+|++|++++. |  +..+++|++|++++|+|+++   .++++++|++|++++|. +..+ 
T Consensus        96 ~l~-~~~---~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~l---~l~~l~~L~~L~l~~n~~~~~~-  164 (457)
T 3bz5_A           96 KLT-NLD---VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKL-  164 (457)
T ss_dssp             CCS-CCC---CTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSCC---CCTTCTTCCEEECTTCSCCCCC-
T ss_pred             CCc-eee---cCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCcccee---ccccCCcCCEEECCCCCccccc-
Confidence            998 555   67899999999999999864 4  88999999999999999986   28899999999999994 4443 


Q ss_pred             CCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCC
Q 040702          167 PELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSI  246 (797)
Q Consensus       167 ~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~  246 (797)
                             .+..+++|+.|++++|+++++.   +..++ +|+.|++++|.+++.   .++.+++|  ++|++++|+++++ 
T Consensus       165 -------~~~~l~~L~~L~ls~n~l~~l~---l~~l~-~L~~L~l~~N~l~~~---~l~~l~~L--~~L~Ls~N~l~~i-  227 (457)
T 3bz5_A          165 -------DVTPQTQLTTLDCSFNKITELD---VSQNK-LLNRLNCDTNNITKL---DLNQNIQL--TFLDCSSNKLTEI-  227 (457)
T ss_dssp             -------CCTTCTTCCEEECCSSCCCCCC---CTTCT-TCCEEECCSSCCSCC---CCTTCTTC--SEEECCSSCCSCC-
T ss_pred             -------ccccCCcCCEEECCCCccceec---cccCC-CCCEEECcCCcCCee---ccccCCCC--CEEECcCCccccc-
Confidence                   2678899999999999999863   67776 899999999999976   37788888  9999999999974 


Q ss_pred             chhhcCCCCCcEEEccCCcCcccCCCCccCCc-------cccccccCCCCC-CCCCCCCCCCCcccEEEccCCcCCCCCC
Q 040702          247 PDDLCRLAALFQLDLGGNKLSGFVPACSGNLT-------NLRKLYLGSNLL-TSIPSTLWNLKDILHLNLSSNFFTGPLP  318 (797)
Q Consensus       247 ~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-------~L~~L~L~~N~l-~~lp~~~~~l~~L~~L~l~~N~l~~~~~  318 (797)
                      |  +..+++|+.|++++|++++..+..+..++       +|+.|++++|.+ +.+|  +..+++|+.|++++|...+.+|
T Consensus       228 p--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~  303 (457)
T 3bz5_A          228 D--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLD  303 (457)
T ss_dssp             C--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEE
T ss_pred             C--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceec
Confidence            4  88899999999999999987665555444       455666666654 4444  3567888889999887665544


Q ss_pred             c--------cccccccccEEeccCcccccccCccccCCcccceecccCccccCCCChhhhccccCCeeeecCCcCCCCCC
Q 040702          319 L--------KIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIP  390 (797)
Q Consensus       319 ~--------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p  390 (797)
                      .        .+.++++|++|++++|++++. +  +..+++|+.|++++|++++        ++.|..|++++|.++|.  
T Consensus       304 ~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~--  370 (457)
T 3bz5_A          304 CQAAGITELDLSQNPKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE--  370 (457)
T ss_dssp             CTTCCCSCCCCTTCTTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE--
T ss_pred             cCCCcceEechhhcccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec--
Confidence            3        245567788888888888764 2  7778888888888888774        24566777888888765  


Q ss_pred             hhhhccCCCCeEEccCCcCcccCCCC
Q 040702          391 ISLEKLLDLKDINVSFNRLEGEIPRE  416 (797)
Q Consensus       391 ~~~~~l~~L~~L~l~~N~l~~~~p~~  416 (797)
                         ..+..|+.+++++|+++|.+|..
T Consensus       371 ---~~~~~l~~l~l~~N~l~g~ip~~  393 (457)
T 3bz5_A          371 ---GQTITMPKETLTNNSLTIAVSPD  393 (457)
T ss_dssp             ---EEEEECCCBCCBTTBEEEECCTT
T ss_pred             ---ceeeecCccccccCcEEEEcChh
Confidence               35567888899999999888753

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=7.2e-38  Score=344.97  Aligned_cols=335  Identities=20%  Similarity=0.206  Sum_probs=225.2

Q ss_pred             CCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEE
Q 040702           52 LHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSEL  131 (797)
Q Consensus        52 l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  131 (797)
                      ++++++|++++|.+..+.+..|.++++|++|+|++|.++ .++...|..+++|++|+|++|++++..|..|.++++|++|
T Consensus        44 l~~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L  122 (390)
T 3o6n_A           44 LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL  122 (390)
T ss_dssp             GCCCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             cCCceEEEecCCchhhCChhHhcccccCcEEECCCCccc-ccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEE
Confidence            345555555555555544444555555555555555554 4444444455555555555555555445555555555555


Q ss_pred             EccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEc
Q 040702          132 GLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWM  211 (797)
Q Consensus       132 ~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L  211 (797)
                      +|++|+|+.+.+..|.++++|++|+|++|.++.+++.     .|..+++|++|++++|+++++.                
T Consensus       123 ~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~l~~L~~L~l~~n~l~~~~----------------  181 (390)
T 3o6n_A          123 VLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDD-----TFQATTSLQNLQLSSNRLTHVD----------------  181 (390)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTT-----TTSSCTTCCEEECCSSCCSBCC----------------
T ss_pred             ECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChh-----hccCCCCCCEEECCCCcCCccc----------------
Confidence            5555555544444455555555555555555554443     2444555555555555554331                


Q ss_pred             cCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCC
Q 040702          212 DNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLT  291 (797)
Q Consensus       212 ~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  291 (797)
                                  +..+++|  +.|++++|.+.+     +....+|++|++++|.+..+....   .++|+.|++++|.++
T Consensus       182 ------------~~~l~~L--~~L~l~~n~l~~-----~~~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~n~l~  239 (390)
T 3o6n_A          182 ------------LSLIPSL--FHANVSYNLLST-----LAIPIAVEELDASHNSINVVRGPV---NVELTILKLQHNNLT  239 (390)
T ss_dssp             ------------GGGCTTC--SEEECCSSCCSE-----EECCSSCSEEECCSSCCCEEECCC---CSSCCEEECCSSCCC
T ss_pred             ------------ccccccc--ceeecccccccc-----cCCCCcceEEECCCCeeeeccccc---cccccEEECCCCCCc
Confidence                        2223333  566666666553     223457888999999888664332   478999999999998


Q ss_pred             CCCCCCCCCCcccEEEccCCcCCCCCCccccccccccEEeccCcccccccCccccCCcccceecccCccccCCCChhhhc
Q 040702          292 SIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGD  371 (797)
Q Consensus       292 ~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  371 (797)
                      .+ ..+..+++|++|++++|.+++..|..|..+++|+.|++++|++++ +|..+..+++|++|+|++|+++ .+|..+..
T Consensus       240 ~~-~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~  316 (390)
T 3o6n_A          240 DT-AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQ  316 (390)
T ss_dssp             CC-GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHH
T ss_pred             cc-HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccc
Confidence            76 467788999999999999998888999999999999999999986 4666788999999999999998 56778899


Q ss_pred             cccCCeeeecCCcCCCCCChhhhccCCCCeEEccCCcCcccCCCCCCCCCCCcccccCCccccCCC
Q 040702          372 LISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMP  437 (797)
Q Consensus       372 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~~~~~~n~~~c~~~  437 (797)
                      +++|++|+|++|++++. |  +..+++|+.|++++|++++.... ..+..+....+.+++..|.++
T Consensus       317 l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~c~~~  378 (390)
T 3o6n_A          317 FDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKID  378 (390)
T ss_dssp             HTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCSCCCTT
T ss_pred             cCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccchhHH-HHHHHHHhhcccccCceeccc
Confidence            99999999999999855 3  67889999999999999875322 234445555677788888765

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=100.00  E-value=1.1e-37  Score=348.69  Aligned_cols=351  Identities=28%  Similarity=0.331  Sum_probs=272.9

Q ss_pred             CCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCC-------------CEEE
Q 040702           17 LGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTL-------------KSLY   83 (797)
Q Consensus        17 ~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L-------------~~L~   83 (797)
                      --..++|++|++++|.+         .++|++++++++|++|++++|++.+..|..++++.+|             ++|+
T Consensus         7 ~~~~~~L~~L~l~~n~l---------~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~   77 (454)
T 1jl5_A            7 NVSNTFLQEPLRHSSNL---------TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELE   77 (454)
T ss_dssp             ------------------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEE
T ss_pred             ccccccchhhhcccCch---------hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEE
Confidence            34578999999999983         5678899999999999999999999999999999875             9999


Q ss_pred             ccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCc
Q 040702           84 LHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLT  163 (797)
Q Consensus        84 Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~  163 (797)
                      +++|.++ .+|..    .++|++|++++|.+++ +|..   +++|++|++++|+++++...    .++|++|+|++|.++
T Consensus        78 l~~~~l~-~lp~~----~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l~~~----~~~L~~L~L~~n~l~  144 (454)
T 1jl5_A           78 LNNLGLS-SLPEL----PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKALSDL----PPLLEYLGVSNNQLE  144 (454)
T ss_dssp             CTTSCCS-CCCSC----CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCCCSC----CTTCCEEECCSSCCS
T ss_pred             ecCCccc-cCCCC----cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcccCC----CCCCCEEECcCCCCC
Confidence            9999998 67762    4799999999999997 5643   48999999999999975421    279999999999999


Q ss_pred             CCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhccccccccc
Q 040702          164 SSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLE  243 (797)
Q Consensus       164 ~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~  243 (797)
                      .++ .      |.++++|++|++++|+++++ |..+    .+|+.|++++|.+++ +| .++++++|  ++|++++|+++
T Consensus       145 ~lp-~------~~~l~~L~~L~l~~N~l~~l-p~~~----~~L~~L~L~~n~l~~-l~-~~~~l~~L--~~L~l~~N~l~  208 (454)
T 1jl5_A          145 KLP-E------LQNSSFLKIIDVDNNSLKKL-PDLP----PSLEFIAAGNNQLEE-LP-ELQNLPFL--TAIYADNNSLK  208 (454)
T ss_dssp             SCC-C------CTTCTTCCEEECCSSCCSCC-CCCC----TTCCEEECCSSCCSS-CC-CCTTCTTC--CEEECCSSCCS
T ss_pred             CCc-c------cCCCCCCCEEECCCCcCccc-CCCc----ccccEEECcCCcCCc-Cc-cccCCCCC--CEEECCCCcCC
Confidence            866 2      78899999999999999974 4332    389999999999997 56 68999998  99999999999


Q ss_pred             CCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEccCCcCCCCCCccccc
Q 040702          244 GSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGN  323 (797)
Q Consensus       244 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~  323 (797)
                      ++ |..   .++|++|++++|+++. .| .++.+++|++|++++|+++.+|..   +++|+.|++++|++++ +|..   
T Consensus       209 ~l-~~~---~~~L~~L~l~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~l~~~---~~~L~~L~l~~N~l~~-l~~~---  275 (454)
T 1jl5_A          209 KL-PDL---PLSLESIVAGNNILEE-LP-ELQNLPFLTTIYADNNLLKTLPDL---PPSLEALNVRDNYLTD-LPEL---  275 (454)
T ss_dssp             SC-CCC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSCCSC---CTTCCEEECCSSCCSC-CCCC---
T ss_pred             cC-CCC---cCcccEEECcCCcCCc-cc-ccCCCCCCCEEECCCCcCCccccc---ccccCEEECCCCcccc-cCcc---
Confidence            63 332   2589999999999994 45 489999999999999999999864   4789999999999996 4433   


Q ss_pred             cccccEEeccCcccccccCccccCCcccceecccCccccCCCChhhhcc-ccCCeeeecCCcCCCCCChhhhccCCCCeE
Q 040702          324 LNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDL-ISLKSLNLSNNNLSGTIPISLEKLLDLKDI  402 (797)
Q Consensus       324 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  402 (797)
                      .++|+.|++++|++++. |..   .++|+.|++++|++++ ++    .+ ++|++|++++|++++ +|..   +++|+.|
T Consensus       276 ~~~L~~L~ls~N~l~~l-~~~---~~~L~~L~l~~N~l~~-i~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L  342 (454)
T 1jl5_A          276 PQSLTFLDVSENIFSGL-SEL---PPNLYYLNASSNEIRS-LC----DLPPSLEELNVSNNKLIE-LPAL---PPRLERL  342 (454)
T ss_dssp             CTTCCEEECCSSCCSEE-SCC---CTTCCEEECCSSCCSE-EC----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEE
T ss_pred             cCcCCEEECcCCccCcc-cCc---CCcCCEEECcCCcCCc-cc----CCcCcCCEEECCCCcccc-cccc---CCcCCEE
Confidence            37899999999999874 221   2689999999999985 22    23 589999999999996 5543   5899999


Q ss_pred             EccCCcCcccCCCCCCCCCCCcccccCCcccc
Q 040702          403 NVSFNRLEGEIPREGPFRNLSAESFKGNELLC  434 (797)
Q Consensus       403 ~l~~N~l~~~~p~~~~~~~l~~~~~~~n~~~c  434 (797)
                      ++++|+++.. |.  .+..++.+++++|.+.+
T Consensus       343 ~L~~N~l~~l-p~--~l~~L~~L~L~~N~l~~  371 (454)
T 1jl5_A          343 IASFNHLAEV-PE--LPQNLKQLHVEYNPLRE  371 (454)
T ss_dssp             ECCSSCCSCC-CC--CCTTCCEEECCSSCCSS
T ss_pred             ECCCCccccc-cc--hhhhccEEECCCCCCCc
Confidence            9999999964 44  46889999999998766

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=5.1e-38  Score=334.82  Aligned_cols=240  Identities=23%  Similarity=0.282  Sum_probs=201.2

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      .++|...+.||+|+||.||++     +..||+|++........+.+.+|++++++++||||+++++++.+++..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            468999999999999999984     688999998655445567899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      +++|+|.+++......+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.........
T Consensus        89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (310)
T 3s95_A           89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP  165 (310)
T ss_dssp             CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred             cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence            9999999999886667999999999999999999999   9999999999999999999999999999998654332211


Q ss_pred             ------------cccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh-------------------h
Q 040702          666 ------------TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE-------------------E  714 (797)
Q Consensus       666 ------------~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~-------------------~  714 (797)
                                  ......||+.|+|||.+.+..++.++|+|++|+..+..+....+....                   +
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (310)
T 3s95_A          166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCP  245 (310)
T ss_dssp             --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCC
T ss_pred             cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccCC
Confidence                        112467999999999999999999999999999875555333222111                   1


Q ss_pred             hhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHHh
Q 040702          715 KHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRELE  753 (797)
Q Consensus       715 ~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~  753 (797)
                      ......+.++++.|++.||++||++.++.+.++.++..-
T Consensus       246 ~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~  284 (310)
T 3s95_A          246 PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL  284 (310)
T ss_dssp             TTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            233456778999999999999999999999999887653

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=100.00  E-value=4.4e-37  Score=344.19  Aligned_cols=333  Identities=17%  Similarity=0.190  Sum_probs=280.7

Q ss_pred             CCCCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCE
Q 040702            2 PSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKS   81 (797)
Q Consensus         2 ~~l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~   81 (797)
                      +||++|.+++. | .|+.+++|++|||++|++++         +|  ++.+++|++|++++|+++++ |  |+++++|++
T Consensus        47 L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~---------~~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~  110 (457)
T 3bz5_A           47 LDCHNSSITDM-T-GIEKLTGLTKLICTSNNITT---------LD--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTY  110 (457)
T ss_dssp             EECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSC---------CC--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCE
T ss_pred             EEccCCCcccC-h-hhcccCCCCEEEccCCcCCe---------Ec--cccCCCCCEEECcCCCCcee-e--cCCCCcCCE
Confidence            68999999986 4 69999999999999999654         33  78899999999999999985 3  899999999


Q ss_pred             EEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCcc
Q 040702           82 LYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNY  161 (797)
Q Consensus        82 L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~  161 (797)
                      |+|++|+++ .+|   +..+++|++|++++|++++. +  +..+++|++|++++|+..+..  .|..+++|++|++++|+
T Consensus       111 L~L~~N~l~-~l~---~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~  181 (457)
T 3bz5_A          111 LNCDTNKLT-KLD---VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNK  181 (457)
T ss_dssp             EECCSSCCS-CCC---CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSC
T ss_pred             EECCCCcCC-eec---CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCc
Confidence            999999998 565   57899999999999999974 3  889999999999999544333  58899999999999999


Q ss_pred             CcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhccccccc
Q 040702          162 LTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQ  241 (797)
Q Consensus       162 l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~  241 (797)
                      ++.++        +..+++|+.|++++|+++++   .+..++ +|+.|++++|++++ +|  ++.+++|  ++|++++|+
T Consensus       182 l~~l~--------l~~l~~L~~L~l~~N~l~~~---~l~~l~-~L~~L~Ls~N~l~~-ip--~~~l~~L--~~L~l~~N~  244 (457)
T 3bz5_A          182 ITELD--------VSQNKLLNRLNCDTNNITKL---DLNQNI-QLTFLDCSSNKLTE-ID--VTPLTQL--TYFDCSVNP  244 (457)
T ss_dssp             CCCCC--------CTTCTTCCEEECCSSCCSCC---CCTTCT-TCSEEECCSSCCSC-CC--CTTCTTC--SEEECCSSC
T ss_pred             cceec--------cccCCCCCEEECcCCcCCee---ccccCC-CCCEEECcCCcccc-cC--ccccCCC--CEEEeeCCc
Confidence            99864        56788999999999999987   377777 89999999999998 45  7888888  999999999


Q ss_pred             ccCCCchhhcCCC-------CCcEEEccCCcCcccCCCCccCCccccccccCCCCC-CCCCC--------CCCCCCcccE
Q 040702          242 LEGSIPDDLCRLA-------ALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLL-TSIPS--------TLWNLKDILH  305 (797)
Q Consensus       242 l~~~~~~~~~~l~-------~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l-~~lp~--------~~~~l~~L~~  305 (797)
                      +++..+..+..+.       +|+.|++++|.+.+..|  ++.+++|+.|++++|.+ +.+|.        .+.++++|+.
T Consensus       245 l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~  322 (457)
T 3bz5_A          245 LTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLDCQAAGITELDLSQNPKLVY  322 (457)
T ss_dssp             CSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCE
T ss_pred             CCCcCHHHCCCCCEEeccCCCCCEEECCCCccCCccc--ccccccCCEEECCCCcccceeccCCCcceEechhhcccCCE
Confidence            9987765555444       45556666666554444  56789999999999975 44443        3556789999


Q ss_pred             EEccCCcCCCCCCccccccccccEEeccCcccccccCccccCCcccceecccCccccCCCChhhhccccCCeeeecCCcC
Q 040702          306 LNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNL  385 (797)
Q Consensus       306 L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  385 (797)
                      |++++|++++.   .++.+++|+.|++++|++++        ++.|..|++++|.+.|.     +.+..|..+++++|++
T Consensus       323 L~L~~N~l~~l---~l~~l~~L~~L~l~~N~l~~--------l~~L~~L~l~~n~l~g~-----~~~~~l~~l~l~~N~l  386 (457)
T 3bz5_A          323 LYLNNTELTEL---DVSHNTKLKSLSCVNAHIQD--------FSSVGKIPALNNNFEAE-----GQTITMPKETLTNNSL  386 (457)
T ss_dssp             EECTTCCCSCC---CCTTCTTCSEEECCSSCCCB--------CTTGGGSSGGGTSEEEE-----EEEEECCCBCCBTTBE
T ss_pred             EECCCCccccc---ccccCCcCcEEECCCCCCCC--------ccccccccccCCcEEec-----ceeeecCccccccCcE
Confidence            99999999985   38999999999999999985        35788899999999875     4677899999999999


Q ss_pred             CCCCChhhh
Q 040702          386 SGTIPISLE  394 (797)
Q Consensus       386 ~~~~p~~~~  394 (797)
                      +|.+|..+.
T Consensus       387 ~g~ip~~~~  395 (457)
T 3bz5_A          387 TIAVSPDLL  395 (457)
T ss_dssp             EEECCTTCB
T ss_pred             EEEcChhHh
Confidence            999987654

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=344.44  Aligned_cols=246  Identities=21%  Similarity=0.235  Sum_probs=196.8

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhc-cCCceeEeeeeeecCCeEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDFKA  580 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~  580 (797)
                      ..++|+..+.||+|+||.||++     ++.||||++++..   ....+.+.+|.++++.+ +||||+++++++.+.+..|
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            3478999999999999999974     6899999998652   23456788899999988 6999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCc
Q 040702          581 LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  660 (797)
Q Consensus       581 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  660 (797)
                      +||||+++|+|.+++.... .+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+....
T Consensus       101 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~  176 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC  176 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence            9999999999999997654 4899999999999999999999   89999999999999999999999999999985432


Q ss_pred             cCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh----------------hhhcccccc
Q 040702          661 EDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK----------------HLMTKEQPM  724 (797)
Q Consensus       661 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~l  724 (797)
                      ..  ......+||+.|||||.+.+..++.++|+|++|+..++++.+..++.....                .......++
T Consensus       177 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l  254 (353)
T 3txo_A          177 NG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGI  254 (353)
T ss_dssp             -----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             CC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            22  234557899999999999988999999999999998766665554432211                123356678


Q ss_pred             hhccccCCCCCCCChHHHHHhHHHHHHHhccccccccccCCcccccceeeeeeeee
Q 040702          725 VRMGTDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYTI  780 (797)
Q Consensus       725 ~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~  780 (797)
                      ++.|+..||.+||++.                   ....+..+++|+||++++|+.
T Consensus       255 i~~lL~~dP~~R~~~~-------------------~~~~~~~il~hp~f~~~~w~~  291 (353)
T 3txo_A          255 LKSFMTKNPTMRLGSL-------------------TQGGEHAILRHPFFKEIDWAQ  291 (353)
T ss_dssp             HHHHTCSSGGGSTTSG-------------------GGTCTHHHHTSGGGTTCCHHH
T ss_pred             HHHHhhhCHHHccCCc-------------------ccCCHHHHhhCCcccCCCHHH
Confidence            8889999999999852                   112345567788888888864

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=6.3e-38  Score=343.01  Aligned_cols=223  Identities=21%  Similarity=0.206  Sum_probs=188.1

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhc-cCCceeEeeeeeecCCeEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~l  581 (797)
                      .++|+..+.||+|+||.||++     ++.||||++++..   ....+.+.+|..++.++ +||||+++++++.+++..|+
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            468999999999999999974     6899999998663   23346688999999887 89999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCcc
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  661 (797)
                      ||||+++|+|..++...+ .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.....
T Consensus       131 V~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~  206 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  206 (396)
T ss_dssp             EEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence            999999999999997654 4899999999999999999999   999999999999999999999999999999863322


Q ss_pred             CccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh-------------------------hhh
Q 040702          662 DQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE-------------------------EKH  716 (797)
Q Consensus       662 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~-------------------------~~~  716 (797)
                      .  ......+||+.|||||.+.+..++.++|+|++|+..++++.+..++...                         +..
T Consensus       207 ~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~  284 (396)
T 4dc2_A          207 G--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS  284 (396)
T ss_dssp             T--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTT
T ss_pred             C--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCc
Confidence            2  2345678999999999999999999999999999987766665554210                         111


Q ss_pred             hhcccccchhccccCCCCCCCCh
Q 040702          717 LMTKEQPMVRMGTDLSLGQFPAS  739 (797)
Q Consensus       717 ~~~~~~~l~~~cl~~dp~~RPs~  739 (797)
                      ......++++.|+..||.+||++
T Consensus       285 ~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          285 LSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             SCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             CCHHHHHHHHHHhcCCHhHcCCC
Confidence            23355788899999999999986

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.3e-38  Score=339.31  Aligned_cols=250  Identities=30%  Similarity=0.438  Sum_probs=207.4

Q ss_pred             cCHHHHHHHhcCCCccccccccCCcceeec----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCC
Q 040702          502 FTYLELFQATNRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDD  577 (797)
Q Consensus       502 ~~~~~l~~~~~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~  577 (797)
                      +++.++...+++|+..+.||+|+||.||++    ++.||||++........+.+.+|++++++++||||+++++++...+
T Consensus        29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  108 (321)
T 2qkw_B           29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN  108 (321)
T ss_dssp             -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred             ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence            444455567899999999999999999985    6899999987666556678999999999999999999999999999


Q ss_pred             eEEEEEEccCCCCHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecC
Q 040702          578 FKALVLEYMPLGSLEKCLYSGN---YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGM  654 (797)
Q Consensus       578 ~~~lv~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl  654 (797)
                      ..++||||+++|+|.+++....   ..+++..+..++.|+++||+|||   +++|+||||||+||+++.++.+||+|||+
T Consensus       109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  185 (321)
T 2qkw_B          109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGI  185 (321)
T ss_dssp             CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTT
T ss_pred             eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeeccc
Confidence            9999999999999999986543   25899999999999999999999   89999999999999999999999999999


Q ss_pred             CccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccch----------------------
Q 040702          655 AKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIR----------------------  712 (797)
Q Consensus       655 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~----------------------  712 (797)
                      ++...............||+.|+|||.+.++.++.++|+|++|+..++.+.+..++..                      
T Consensus       186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  265 (321)
T 2qkw_B          186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL  265 (321)
T ss_dssp             CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred             ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence            9865433333233455699999999999999999999999999987555443322111                      


Q ss_pred             -----------hhhhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHHhc
Q 040702          713 -----------EEKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRELER  754 (797)
Q Consensus       713 -----------~~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~  754 (797)
                                 ...+....+.++++.|++.||++||++.|+++.++.+.+...
T Consensus       266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~  318 (321)
T 2qkw_B          266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE  318 (321)
T ss_dssp             CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred             HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence                       112223345678889999999999999999999998876643

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=8.3e-38  Score=335.89  Aligned_cols=228  Identities=20%  Similarity=0.234  Sum_probs=190.5

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEec---cCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQ---YGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      .++|+..+.||+|+||.||++     ++.||||++++.   .......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            468999999999999999974     689999999865   234456788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      |||+++|+|.+++...+ .+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++......
T Consensus        84 ~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  159 (337)
T 1o6l_A           84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence            99999999999987654 4899999999999999999999   8999999999999999999999999999998643222


Q ss_pred             ccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh----------------hhhhcccccchh
Q 040702          663 QSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE----------------KHLMTKEQPMVR  726 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~l~~  726 (797)
                        ......+||+.|+|||.+.+..++.++|+|++|+..++.+.+..++....                ........++++
T Consensus       160 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  237 (337)
T 1o6l_A          160 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLA  237 (337)
T ss_dssp             --CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred             --CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence              23355789999999999999999999999999999866665554432211                112335577888


Q ss_pred             ccccCCCCCCC-----ChHHHHH
Q 040702          727 MGTDLSLGQFP-----ASYSISK  744 (797)
Q Consensus       727 ~cl~~dp~~RP-----s~~~i~~  744 (797)
                      .|+..||.+||     ++.|+++
T Consensus       238 ~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          238 GLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             HHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             HHhhcCHHHhcCCCCCCHHHHHc
Confidence            89999999998     5555543

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.9e-37  Score=327.98  Aligned_cols=227  Identities=23%  Similarity=0.314  Sum_probs=195.5

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      .++|...+.||+|+||.||++     ++.||||++........+.+.+|+.++++++||||+++++++..++..|+||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            468999999999999999985     689999999877666667899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      +++|+|.+++....  +++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.......  
T Consensus        99 ~~~~~L~~~~~~~~--~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--  171 (297)
T 3fxz_A           99 LAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--  171 (297)
T ss_dssp             CTTCBHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--
T ss_pred             CCCCCHHHHHhhcC--CCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--
Confidence            99999999998763  899999999999999999999   89999999999999999999999999999986543322  


Q ss_pred             cccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh-------------------hhhhhcccccchh
Q 040702          666 TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE-------------------EKHLMTKEQPMVR  726 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~l~~  726 (797)
                      ......||+.|+|||.+.+..++.++|+|++|+..+..+.+..++...                   +......+.++++
T Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  251 (297)
T 3fxz_A          172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN  251 (297)
T ss_dssp             CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHH
T ss_pred             ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHH
Confidence            334567999999999999999999999999999986665554443221                   1223334678999


Q ss_pred             ccccCCCCCCCChHHHHH
Q 040702          727 MGTDLSLGQFPASYSISK  744 (797)
Q Consensus       727 ~cl~~dp~~RPs~~~i~~  744 (797)
                      .|++.||++||++.|+++
T Consensus       252 ~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          252 RCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             HHSCSSTTTSCCHHHHTT
T ss_pred             HHccCChhHCcCHHHHhh
Confidence            999999999999988864

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=5.3e-37  Score=356.69  Aligned_cols=334  Identities=20%  Similarity=0.204  Sum_probs=225.9

Q ss_pred             CCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeee
Q 040702           77 STLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLG  156 (797)
Q Consensus        77 ~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~  156 (797)
                      ++++.|++++|.++ .+|..+|..+++|++|+|++|.|++..|..|..+++|++|+|++|.|+++.|..|+++++|++|+
T Consensus        51 ~~l~~l~l~~~~l~-~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  129 (597)
T 3oja_B           51 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLV  129 (597)
T ss_dssp             CCCSEEEESSCEES-EECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCceEEEeeCCCCC-CcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEE
Confidence            34455555555554 44444444455555555555555544444555555555555555555555555555555555555


Q ss_pred             ccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcc
Q 040702          157 LNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLS  236 (797)
Q Consensus       157 L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~  236 (797)
                      |++|.|+.+++.+     |.++++|++|+|++|.+.++.|..|..++ +|+.|++++|.+++..   ++.+++|  +.|+
T Consensus       130 L~~n~l~~l~~~~-----~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~N~l~~~~---~~~l~~L--~~L~  198 (597)
T 3oja_B          130 LERNDLSSLPRGI-----FHNTPKLTTLSMSNNNLERIEDDTFQATT-SLQNLQLSSNRLTHVD---LSLIPSL--FHAN  198 (597)
T ss_dssp             CCSSCCCCCCTTT-----TTTCTTCCEEECCSSCCCBCCTTTTTTCT-TCCEEECTTSCCSBCC---GGGCTTC--SEEE
T ss_pred             eeCCCCCCCCHHH-----hccCCCCCEEEeeCCcCCCCChhhhhcCC-cCcEEECcCCCCCCcC---hhhhhhh--hhhh
Confidence            5555555544432     44455555555555555555555555544 4555555555555432   2233344  6667


Q ss_pred             cccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEccCCcCCCC
Q 040702          237 LEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGP  316 (797)
Q Consensus       237 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~  316 (797)
                      +++|.+.+     +....+|+.|++++|.+..+.+..+   ++|+.|+|++|.++.. ..+..+++|+.|++++|.+++.
T Consensus       199 l~~n~l~~-----l~~~~~L~~L~ls~n~l~~~~~~~~---~~L~~L~L~~n~l~~~-~~l~~l~~L~~L~Ls~N~l~~~  269 (597)
T 3oja_B          199 VSYNLLST-----LAIPIAVEELDASHNSINVVRGPVN---VELTILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELEKI  269 (597)
T ss_dssp             CCSSCCSE-----EECCTTCSEEECCSSCCCEEECSCC---SCCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCEE
T ss_pred             cccCcccc-----ccCCchhheeeccCCcccccccccC---CCCCEEECCCCCCCCC-hhhccCCCCCEEECCCCccCCC
Confidence            77776653     2344578899999999886654433   6899999999999775 5678899999999999999988


Q ss_pred             CCccccccccccEEeccCcccccccCccccCCcccceecccCccccCCCChhhhccccCCeeeecCCcCCCCCChhhhcc
Q 040702          317 LPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKL  396 (797)
Q Consensus       317 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  396 (797)
                      .|..|+.+++|+.|+|++|.+++ +|..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|.+++..   +..+
T Consensus       270 ~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~---~~~~  344 (597)
T 3oja_B          270 MYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK---LSTH  344 (597)
T ss_dssp             ESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC---CCTT
T ss_pred             CHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC---hhhc
Confidence            89999999999999999999986 4667788999999999999998 67888999999999999999998653   6678


Q ss_pred             CCCCeEEccCCcCcccCCCCCCCCCCCcccccCCccccCCC
Q 040702          397 LDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMP  437 (797)
Q Consensus       397 ~~L~~L~l~~N~l~~~~p~~~~~~~l~~~~~~~n~~~c~~~  437 (797)
                      ++|+.|++++|+++|.... ..+..+....+.+++..|+.+
T Consensus       345 ~~L~~L~l~~N~~~~~~~~-~~~~~~~~~~~~~~~~~C~~~  384 (597)
T 3oja_B          345 HTLKNLTLSHNDWDCNSLR-ALFRNVARPAVDDADQHCKID  384 (597)
T ss_dssp             CCCSEEECCSSCEEHHHHH-HHTTTCCTTTBCCCCCCCCTT
T ss_pred             CCCCEEEeeCCCCCChhHH-HHHHHHhhhccccccccCCcc
Confidence            8999999999999876432 234455555677888888764

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.4e-38  Score=350.98  Aligned_cols=270  Identities=18%  Similarity=0.204  Sum_probs=201.5

Q ss_pred             CHHHHHHHhcCCCccccccccCCcceeec-----ceEEEEEEEEec---cCCcchhHHHHHHHhhhccCCceeEeeeeee
Q 040702          503 TYLELFQATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQ---YGGAFKSFDIECGMMKRIRHRNLIKIISSCS  574 (797)
Q Consensus       503 ~~~~l~~~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~  574 (797)
                      .+.++...+++|+..+.||+|+||.||++     ++.||||++++.   .......+.+|+.++..++||||++++++|.
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  144 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ  144 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            44555667789999999999999999974     689999999864   2333456899999999999999999999999


Q ss_pred             cCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecC
Q 040702          575 NDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGM  654 (797)
Q Consensus       575 ~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl  654 (797)
                      +++..|+||||+++|+|.+++......+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGl  221 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGS  221 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhh
Confidence            999999999999999999999875556999999999999999999999   99999999999999999999999999999


Q ss_pred             CccCCccCccccccccccCcccccccccc-----cCccchHHHHHHHhhhhhhhhccccccchhh-hhhhcccccchhcc
Q 040702          655 AKPLLEEDQSLTQTQTLATIGYMAPDEIF-----SGEMRLKCWVNDSLLISVMIVVDANLLIREE-KHLMTKEQPMVRMG  728 (797)
Q Consensus       655 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~c  728 (797)
                      |+....... ......+||+.|||||.+.     .+.++.++|+|++|+..++++.+..++.... .+...   .++...
T Consensus       222 a~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~---~i~~~~  297 (437)
T 4aw2_A          222 CLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG---KIMNHK  297 (437)
T ss_dssp             CEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH---HHHTHH
T ss_pred             hhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHH---hhhhcc
Confidence            986643322 2334568999999999987     5678999999999999877776655543322 11111   111110


Q ss_pred             c-cCCCCCCCC-hHHHHHhHHHHHHHhccccccccccCCcccccceeeeeeeeec
Q 040702          729 T-DLSLGQFPA-SYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYTIS  781 (797)
Q Consensus       729 l-~~dp~~RPs-~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~  781 (797)
                      . -.-|...+. ..++.+.++.+-..+..+.+  ...+.++++|+||++++|+..
T Consensus       298 ~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~--r~~~~eil~Hpff~~i~w~~l  350 (437)
T 4aw2_A          298 ERFQFPTQVTDVSENAKDLIRRLICSREHRLG--QNGIEDFKKHPFFSGIDWDNI  350 (437)
T ss_dssp             HHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTT--TTTTHHHHTSGGGTTCCTTTG
T ss_pred             ccccCCcccccCCHHHHHHHHHHhcccccccC--CCCHHHHhCCCccCCCCHHHH
Confidence            0 011221111 13334444433222222221  223556778999999998753

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=7.8e-38  Score=337.05  Aligned_cols=243  Identities=19%  Similarity=0.246  Sum_probs=198.7

Q ss_pred             HHHhcCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhc-cCCceeEeeeeeecCCe
Q 040702          508 FQATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDF  578 (797)
Q Consensus       508 ~~~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~  578 (797)
                      ....++|...+.||+|+||.||++     ++.||||++++..   ....+.+..|..+++.+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            345689999999999999999974     6899999998652   33456788899999887 89999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccC
Q 040702          579 KALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  658 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  658 (797)
                      .|+||||+++|+|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+|+..
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  168 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN  168 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence            999999999999999997654 4899999999999999999999   899999999999999999999999999999864


Q ss_pred             CccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh----------------hhhcccc
Q 040702          659 LEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK----------------HLMTKEQ  722 (797)
Q Consensus       659 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~  722 (797)
                      ....  ......+||+.|+|||.+.+..++.++|+|++|+..++.+.+..++.....                .......
T Consensus       169 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~  246 (345)
T 1xjd_A          169 MLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAK  246 (345)
T ss_dssp             CCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred             ccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHH
Confidence            3222  134557899999999999999999999999999998666655544332111                1223556


Q ss_pred             cchhccccCCCCCCCChHHHHHhHHHHHHHhccccccccccCCcccccceeeeeeeee
Q 040702          723 PMVRMGTDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYTI  780 (797)
Q Consensus       723 ~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~  780 (797)
                      ++++.|+..||++||++.                        ..+++|+||++++|+.
T Consensus       247 ~li~~lL~~dp~~R~~~~------------------------~~i~~hp~f~~~~w~~  280 (345)
T 1xjd_A          247 DLLVKLFVREPEKRLGVR------------------------GDIRQHPLFREINWEE  280 (345)
T ss_dssp             HHHHHHSCSSGGGSBTTB------------------------SCGGGSGGGTTCCHHH
T ss_pred             HHHHHHhcCCHhHcCCCh------------------------HHHHcCccccCCCHHH
Confidence            788888888999888864                        1456677777777753

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1e-37  Score=334.73  Aligned_cols=266  Identities=19%  Similarity=0.208  Sum_probs=210.7

Q ss_pred             cCCCccccccccCCcceeec-----ce----EEEEEEEEecc-CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GM----EVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l  581 (797)
                      ++|...+.||+|+||.||++     +.    .||+|.+.... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            57899999999999999985     22    47888775443 334567889999999999999999999986 456889


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCcc
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  661 (797)
                      ||||+++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        92 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  168 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD  168 (325)
T ss_dssp             EEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred             EEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence            99999999999999876556899999999999999999999   899999999999999999999999999999876544


Q ss_pred             CccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchhh-----------------hhhhccccc
Q 040702          662 DQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIREE-----------------KHLMTKEQP  723 (797)
Q Consensus       662 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~~-----------------~~~~~~~~~  723 (797)
                      ..........||..|+|||.+.++.++.++|+|++|+..+..+. +..++....                 ......+.+
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (325)
T 3kex_A          169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYM  248 (325)
T ss_dssp             TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTTTH
T ss_pred             cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHHHHH
Confidence            43334455678889999999999999999999999999866554 443332211                 112346778


Q ss_pred             chhccccCCCCCCCChHHHHHhHHHHHHHhccccccccccCCcccccceeeeeeeeec
Q 040702          724 MVRMGTDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYTIS  781 (797)
Q Consensus       724 l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~  781 (797)
                      +++.|+..||.+||++.++++.++.+...+............+...++++.+++|+..
T Consensus       249 li~~~l~~dp~~Rps~~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~  306 (325)
T 3kex_A          249 VMVKCWMIDENIRPTFKELANEFTRMARDPPRYLVIKRESGPGIAPGPEPHGLTNKKL  306 (325)
T ss_dssp             HHHHHTCSCTTTSCCHHHHHHHHHHHTTSHHHHBCCCSSSSCCCBCCCCCCC------
T ss_pred             HHHHHcCCChhhCcCHHHHHHHHHHHHhcchhhhccccCCCCCCCCCCccccchhhcc
Confidence            9999999999999999999999999877666555555555666677888888888754

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.7e-37  Score=333.31  Aligned_cols=251  Identities=30%  Similarity=0.403  Sum_probs=208.3

Q ss_pred             cccCccCHHHHHHHhcCCCccccccccCCcceeec----ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeee
Q 040702          497 ADQRRFTYLELFQATNRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIIS  571 (797)
Q Consensus       497 ~~~~~~~~~~l~~~~~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~  571 (797)
                      .....+++.++...+++|...+.||+|+||.||++    ++.||||++..... .....+.+|+++++.++||||+++++
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence            34567899999999999999999999999999984    68899999876532 23457899999999999999999999


Q ss_pred             eeecCCeEEEEEEccCCCCHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEE
Q 040702          572 SCSNDDFKALVLEYMPLGSLEKCLYSGNY---ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAH  648 (797)
Q Consensus       572 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~k  648 (797)
                      ++..++..++||||+++|+|.+++.....   .+++..+..++.|++.||+|||..+..+|+||||||+||+++.++.+|
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence            99999999999999999999999986543   589999999999999999999922222999999999999999999999


Q ss_pred             EEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccch----------------
Q 040702          649 LSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIR----------------  712 (797)
Q Consensus       649 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~----------------  712 (797)
                      |+|||+++....... .......||+.|+|||.+.++.++.++|+|++|+..+..+.+..++..                
T Consensus       175 l~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  253 (326)
T 3uim_A          175 VGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK  253 (326)
T ss_dssp             ECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred             eccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence            999999986643322 233445699999999999999999999999999998666555444321                


Q ss_pred             -------------------hhhhhhcccccchhccccCCCCCCCChHHHHHhHHH
Q 040702          713 -------------------EEKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVY  748 (797)
Q Consensus       713 -------------------~~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~  748 (797)
                                         ........+.+++..|++.||.+||++.|+++.|+.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence                               111223456788889999999999999999998865

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=100.00  E-value=1.2e-36  Score=335.06  Aligned_cols=309  Identities=20%  Similarity=0.235  Sum_probs=236.9

Q ss_pred             CCCCCCEEeCCCCCCCCcCCCccccCCCcc-ccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCcc
Q 040702           19 NPSSLQTLYLSYNPPSGSIPSFILCEIPHE-IDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSA   97 (797)
Q Consensus        19 ~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~-~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~   97 (797)
                      .++++++|++++|.         ++.+|.. +..+++|++|++++|++.++.+..|.++++|++|+|++|.++ .++...
T Consensus        43 ~l~~l~~l~l~~~~---------l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~  112 (390)
T 3o6n_A           43 TLNNQKIVTFKNST---------MRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHV  112 (390)
T ss_dssp             GGCCCSEEEEESCE---------ESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-CCCTTT
T ss_pred             ccCCceEEEecCCc---------hhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCC-cCCHHH
Confidence            46899999999998         5566665 688999999999999999998899999999999999999998 777777


Q ss_pred             ccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCC
Q 040702           98 DVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSN  177 (797)
Q Consensus        98 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~  177 (797)
                      |..+++|++|+|++|+++...+..|.++++|++|+|++|+|+++.+.+|.++++|++|+|++|.++.++        +..
T Consensus       113 ~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~--------~~~  184 (390)
T 3o6n_A          113 FQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVD--------LSL  184 (390)
T ss_dssp             TTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCC--------GGG
T ss_pred             hcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccc--------ccc
Confidence            889999999999999999766667899999999999999999999999999999999999999999874        456


Q ss_pred             CCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCc
Q 040702          178 CKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALF  257 (797)
Q Consensus       178 l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~  257 (797)
                      +++|+.|++++|.+.+..      .+.+++.|++++|.+.......   .++|  ++|++++|.+++.  ..+..+++|+
T Consensus       185 l~~L~~L~l~~n~l~~~~------~~~~L~~L~l~~n~l~~~~~~~---~~~L--~~L~l~~n~l~~~--~~l~~l~~L~  251 (390)
T 3o6n_A          185 IPSLFHANVSYNLLSTLA------IPIAVEELDASHNSINVVRGPV---NVEL--TILKLQHNNLTDT--AWLLNYPGLV  251 (390)
T ss_dssp             CTTCSEEECCSSCCSEEE------CCSSCSEEECCSSCCCEEECCC---CSSC--CEEECCSSCCCCC--GGGGGCTTCS
T ss_pred             ccccceeecccccccccC------CCCcceEEECCCCeeeeccccc---cccc--cEEECCCCCCccc--HHHcCCCCcc
Confidence            788999999999987542      2237888888888887543322   2344  7777777777643  4667777777


Q ss_pred             EEEccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEccCCcCCCCCCccccccccccEEeccCccc
Q 040702          258 QLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNF  337 (797)
Q Consensus       258 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  337 (797)
                      +|++++|.+++..|..|..+++|+.|+|++|.++.+|..+..+++|+.|++++|+++ .+|..+..+++|+.|++++|.+
T Consensus       252 ~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i  330 (390)
T 3o6n_A          252 EVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSI  330 (390)
T ss_dssp             EEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCEEECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCC
T ss_pred             EEECCCCcCCCcChhHccccccCCEEECCCCcCcccCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCcc
Confidence            777777777776677777777777777777777766666656666666666666666 3344455556666666666665


Q ss_pred             ccccCccccCCcccceecccCcccc
Q 040702          338 SCVIPTKIGGLKDLQYLFLEYNRLQ  362 (797)
Q Consensus       338 ~~~~~~~~~~l~~L~~L~Ls~N~l~  362 (797)
                      +...   +..+++|+.|++++|++.
T Consensus       331 ~~~~---~~~~~~L~~L~l~~N~~~  352 (390)
T 3o6n_A          331 VTLK---LSTHHTLKNLTLSHNDWD  352 (390)
T ss_dssp             CCCC---CCTTCCCSEEECCSSCEE
T ss_pred             ceeC---chhhccCCEEEcCCCCcc
Confidence            5331   344445555555555444

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.6e-37  Score=337.23  Aligned_cols=240  Identities=23%  Similarity=0.305  Sum_probs=199.7

Q ss_pred             hcCCCccccccccCCcceeecc------------eEEEEEEEEeccC-CcchhHHHHHHHhhhc-cCCceeEeeeeeecC
Q 040702          511 TNRFSENNLIGRGGFGPVYKDG------------MEVAIKVFNLQYG-GAFKSFDIECGMMKRI-RHRNLIKIISSCSND  576 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~~------------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~  576 (797)
                      .++|...+.||+|+||.||++.            ..||||+++.... ...+.+.+|+++++++ +||||++++++|.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            4789999999999999999752            4699999975432 2346789999999999 899999999999999


Q ss_pred             CeEEEEEEccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEE
Q 040702          577 DFKALVLEYMPLGSLEKCLYSGN---------------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL  641 (797)
Q Consensus       577 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll  641 (797)
                      +..|+||||+++|+|.+++....               ..+++..++.++.||+.||+|||   +++|+||||||+||++
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence            99999999999999999997643               24789999999999999999999   9999999999999999


Q ss_pred             cCCCcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchhh------
Q 040702          642 DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIREE------  714 (797)
Q Consensus       642 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~~------  714 (797)
                      +.++.+||+|||+++...............||+.|+|||.+.+..++.++|+|++|+..++.+. +..++....      
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~  316 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK  316 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            9999999999999986654433333445568899999999999999999999999999866554 333322211      


Q ss_pred             -----------hhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHHh
Q 040702          715 -----------KHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRELE  753 (797)
Q Consensus       715 -----------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~  753 (797)
                                 ......+.++++.||+.||.+||++.|+++.|+.+....
T Consensus       317 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~  366 (370)
T 2psq_A          317 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  366 (370)
T ss_dssp             HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence                       112235667899999999999999999999999987653

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.6e-37  Score=332.81  Aligned_cols=236  Identities=21%  Similarity=0.228  Sum_probs=194.7

Q ss_pred             hcCCCccccccccCCcceeec---ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCC----eEEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD---GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDD----FKALVL  583 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~---~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~----~~~lv~  583 (797)
                      .++|+..+.||+|+||.||++   ++.||||+++.... ....+..|+.++++++||||+++++++....    ..++||
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~  101 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLIT  101 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEECCCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEE
Confidence            478999999999999999986   68999999965432 2345667899999999999999999998754    479999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCC----------CeEEcCCCCCceEEcCCCcEEEEeec
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV----------PIIHCDLKPSNVLLDDNMVAHLSDFG  653 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~----------~ivHrDlkp~NIll~~~~~~kl~DFG  653 (797)
                      ||+++|+|.+++....  +++..+..++.|++.||+|||   +.          +|+||||||+||+++.++.+||+|||
T Consensus       102 e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg  176 (322)
T 3soc_A          102 AFHEKGSLSDFLKANV--VSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG  176 (322)
T ss_dssp             ECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             ecCCCCCHHHHHHhcC--CCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence            9999999999998754  899999999999999999999   87          99999999999999999999999999


Q ss_pred             CCccCCccCccccccccccCccccccccccc-----CccchHHHHHHHhhhhhhhhccccccchhh--------------
Q 040702          654 MAKPLLEEDQSLTQTQTLATIGYMAPDEIFS-----GEMRLKCWVNDSLLISVMIVVDANLLIREE--------------  714 (797)
Q Consensus       654 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------  714 (797)
                      +|+...............||+.|+|||.+.+     ..++.++|+|++|+..++.+.+..++....              
T Consensus       177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  256 (322)
T 3soc_A          177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH  256 (322)
T ss_dssp             TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred             cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence            9987654433333445689999999999876     467789999999999866655433221100              


Q ss_pred             ---h----------------------hhhcccccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          715 ---K----------------------HLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       715 ---~----------------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                         .                      .....+.++++.||+.||++|||+.|+++.|+.+++.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          257 PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence               0                      0111267889999999999999999999999998875

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=9.6e-38  Score=337.44  Aligned_cols=245  Identities=20%  Similarity=0.194  Sum_probs=199.1

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhc-cCCceeEeeeeeecCCeEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDFKA  580 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~  580 (797)
                      ..++|+..+.||+|+||.||++     ++.||||++++..   ....+.+..|..+++.+ +||+|+++++++.+.+..|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            3478999999999999999974     5789999998652   33456788999999988 7999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCc
Q 040702          581 LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  660 (797)
Q Consensus       581 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  660 (797)
                      +||||+++|+|.+++...+ .+++..++.++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+|+....
T Consensus        98 lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            9999999999999997654 4899999999999999999999   89999999999999999999999999999986432


Q ss_pred             cCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh----------------hhhhcccccc
Q 040702          661 EDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE----------------KHLMTKEQPM  724 (797)
Q Consensus       661 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~l  724 (797)
                      ..  ......+||+.|+|||.+.+..++.++|+|++|+..++.+.+..++....                ........++
T Consensus       174 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  251 (353)
T 2i0e_A          174 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAI  251 (353)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             CC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            22  23455789999999999999999999999999999876666555443211                1123355678


Q ss_pred             hhccccCCCCCCCChHHHHHhHHHHHHHhccccccccccCCcccccceeeeeeeee
Q 040702          725 VRMGTDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYTI  780 (797)
Q Consensus       725 ~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~  780 (797)
                      ++.|+..||.+||++.                    +..+.++++|+||++++|+.
T Consensus       252 i~~lL~~dP~~R~~~~--------------------~~~~~~i~~h~~f~~~~w~~  287 (353)
T 2i0e_A          252 CKGLMTKHPGKRLGCG--------------------PEGERDIKEHAFFRYIDWEK  287 (353)
T ss_dssp             HHHHTCSCTTSCTTCS--------------------TTHHHHHHTSGGGTTCCHHH
T ss_pred             HHHHhhcCHHHcCCCC--------------------CCCHHHHhcCccccCCCHHH
Confidence            8889999999998742                    11233445677777777754

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=8.3e-38  Score=337.45  Aligned_cols=224  Identities=21%  Similarity=0.198  Sum_probs=187.8

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCC---cchhHHHHHHHhhhc-cCCceeEeeeeeecCCeEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG---AFKSFDIECGMMKRI-RHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~l  581 (797)
                      .++|+..+.||+|+||.||++     ++.||||++++....   ..+.+.+|..+++++ +||||+++++++.+.+..|+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            368999999999999999974     689999999866432   235678899999988 89999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCcc
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  661 (797)
                      ||||+++|+|.+++.... .+++..++.++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++.....
T Consensus        88 v~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             EECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             EEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            999999999999997654 4899999999999999999999   999999999999999999999999999999864322


Q ss_pred             CccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccch-------------------------hhhh
Q 040702          662 DQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIR-------------------------EEKH  716 (797)
Q Consensus       662 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~-------------------------~~~~  716 (797)
                      .  ......+||+.|+|||.+.+..++.++|+|++|+..++.+.+..++..                         .+..
T Consensus       164 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~  241 (345)
T 3a8x_A          164 G--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS  241 (345)
T ss_dssp             T--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTT
T ss_pred             C--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCC
Confidence            2  234556899999999999999999999999999998666665554421                         0011


Q ss_pred             hhcccccchhccccCCCCCCCChH
Q 040702          717 LMTKEQPMVRMGTDLSLGQFPASY  740 (797)
Q Consensus       717 ~~~~~~~l~~~cl~~dp~~RPs~~  740 (797)
                      ......++++.|+..||.+||++.
T Consensus       242 ~s~~~~~li~~lL~~dP~~R~~~~  265 (345)
T 3a8x_A          242 LSVKAASVLKSFLNKDPKERLGCH  265 (345)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSTTCC
T ss_pred             CCHHHHHHHHHHhcCCHhHCCCCC
Confidence            233556888999999999999863

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.9e-37  Score=336.66  Aligned_cols=222  Identities=22%  Similarity=0.227  Sum_probs=188.0

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      .++|...+.||+|+||.||++     ++.||+|++....   ....+.+.+|+.+++.++|||||++++++.+.+..|+|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            368999999999999999974     6889999997652   33456788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      |||+++|+|.+++.... .+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||+|+......
T Consensus        94 ~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  169 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQNV-HFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET  169 (384)
T ss_dssp             ECCCTTEEHHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence            99999999999998754 4899999999999999999999   9999999999999999999999999999998654322


Q ss_pred             ccccccccccCccccccccccc---CccchHHHHHHHhhhhhhhhccccccch-------------------hhhhhhcc
Q 040702          663 QSLTQTQTLATIGYMAPDEIFS---GEMRLKCWVNDSLLISVMIVVDANLLIR-------------------EEKHLMTK  720 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~dv~s~~~~~~~~~~~~~~~~~-------------------~~~~~~~~  720 (797)
                         .....+||+.|+|||.+..   ..++.++|+|++|+..+..+.+..++..                   .+......
T Consensus       170 ---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~  246 (384)
T 4fr4_A          170 ---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQE  246 (384)
T ss_dssp             ---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHH
T ss_pred             ---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCHH
Confidence               3355789999999999863   4589999999999998766665554421                   11122345


Q ss_pred             cccchhccccCCCCCCCCh
Q 040702          721 EQPMVRMGTDLSLGQFPAS  739 (797)
Q Consensus       721 ~~~l~~~cl~~dp~~RPs~  739 (797)
                      +.++++.|+..||.+||+.
T Consensus       247 ~~~li~~lL~~dP~~R~s~  265 (384)
T 4fr4_A          247 MVSLLKKLLEPNPDQRFSQ  265 (384)
T ss_dssp             HHHHHHHHSCSSGGGSCCS
T ss_pred             HHHHHHHHhcCCHhHhccc
Confidence            6788999999999999983

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.9e-37  Score=341.16  Aligned_cols=202  Identities=23%  Similarity=0.287  Sum_probs=173.3

Q ss_pred             HHHHHHHhcCCCccccccccCCcceeec-----ceEEEEEEEEec---cCCcchhHHHHHHHhhhccCCceeEeeeeeec
Q 040702          504 YLELFQATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQ---YGGAFKSFDIECGMMKRIRHRNLIKIISSCSN  575 (797)
Q Consensus       504 ~~~l~~~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~  575 (797)
                      +.++....++|+..+.||+|+||.||++     ++.||+|++++.   .....+.+.+|+.+++.++|||||++++++.+
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            3445556789999999999999999974     688999999764   23345678899999999999999999999999


Q ss_pred             CCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCC
Q 040702          576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMA  655 (797)
Q Consensus       576 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla  655 (797)
                      ++..|+||||+++|+|.+++....  +++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~~~--~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a  215 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSNYD--VPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTC  215 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEecccee
Confidence            999999999999999999997653  899999999999999999999   899999999999999999999999999999


Q ss_pred             ccCCccCccccccccccCcccccccccccCc----cchHHHHHHHhhhhhhhhccccccc
Q 040702          656 KPLLEEDQSLTQTQTLATIGYMAPDEIFSGE----MRLKCWVNDSLLISVMIVVDANLLI  711 (797)
Q Consensus       656 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~dv~s~~~~~~~~~~~~~~~~  711 (797)
                      +...... .......+||+.|||||.+....    ++.++|+|++|+..++.+.+..++.
T Consensus       216 ~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~  274 (410)
T 3v8s_A          216 MKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY  274 (410)
T ss_dssp             EECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTC
T ss_pred             EeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCC
Confidence            8664332 12334578999999999987655    8899999999999877666655543

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=5.2e-37  Score=332.74  Aligned_cols=227  Identities=20%  Similarity=0.272  Sum_probs=191.9

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCC------cchhHHHHHHHhhhccCCceeEeeeeeecCCeE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG------AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFK  579 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~  579 (797)
                      .++|...+.||+|+||.||++     ++.||||+++.....      ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            468999999999999999984     689999999876432      236789999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCC----cEEEEeecCC
Q 040702          580 ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM----VAHLSDFGMA  655 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~----~~kl~DFGla  655 (797)
                      |+||||+++|+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++    .+||+|||++
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence            99999999999999997654 5899999999999999999999   89999999999999998776    7999999999


Q ss_pred             ccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh--------------------h
Q 040702          656 KPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE--------------------K  715 (797)
Q Consensus       656 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------------~  715 (797)
                      +......   .....+||+.|+|||.+.+..++.++|+|++|+..+..+.+..++....                    .
T Consensus       167 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  243 (361)
T 2yab_A          167 HEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS  243 (361)
T ss_dssp             EECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred             eEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhcc
Confidence            8764322   2345679999999999998899999999999998866555444432211                    1


Q ss_pred             hhhcccccchhccccCCCCCCCChHHHHH
Q 040702          716 HLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       716 ~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      ......+++++.|+..||.+||++.|+++
T Consensus       244 ~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          244 QTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            22335678999999999999999988764

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.6e-37  Score=328.16  Aligned_cols=239  Identities=21%  Similarity=0.286  Sum_probs=193.7

Q ss_pred             hcCCCccccccccCCcceeec----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      .++|+..+.||+|+||.||++    ++.||||+++....  ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            478999999999999999985    58899999975532  224678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      |+++ ++.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  
T Consensus       100 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--  173 (311)
T 3niz_A          100 FMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV--  173 (311)
T ss_dssp             CCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC--
T ss_pred             CCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc--
Confidence            9975 888888776667999999999999999999999   9999999999999999999999999999998653222  


Q ss_pred             ccccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchhhh----------------------------
Q 040702          665 LTQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIREEK----------------------------  715 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~----------------------------  715 (797)
                      .......||+.|+|||.+.+ ..++.++|+|++|+..+..+.+..++.....                            
T Consensus       174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  253 (311)
T 3niz_A          174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW  253 (311)
T ss_dssp             C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred             ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence            22344678999999999876 5689999999999998665554443321100                            


Q ss_pred             ------------------hhhcccccchhccccCCCCCCCChHHHHHhHHHHHHHhccccccccccCCcccccceeeeee
Q 040702          716 ------------------HLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVD  777 (797)
Q Consensus       716 ------------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~  777 (797)
                                        .......++++.|+..||++|||+.|++                         +|+||++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell-------------------------~hp~f~~~~  308 (311)
T 3niz_A          254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAM-------------------------NHPYFKDLD  308 (311)
T ss_dssp             HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHH-------------------------TSGGGTTSC
T ss_pred             hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHh-------------------------cCcccccCC
Confidence                              0112345789999999999999987766                         578888887


Q ss_pred             eee
Q 040702          778 YTI  780 (797)
Q Consensus       778 ~~~  780 (797)
                      ++|
T Consensus       309 ~~i  311 (311)
T 3niz_A          309 PQI  311 (311)
T ss_dssp             TTC
T ss_pred             ccC
Confidence            764

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=5e-37  Score=327.40  Aligned_cols=241  Identities=21%  Similarity=0.224  Sum_probs=196.4

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      .++|+..+.||+|+||.||++     ++.||+|++++..   ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            368999999999999999974     6899999998652   23456788899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      |||+++|+|.+++.... .+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++....  
T Consensus        85 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--  158 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--  158 (318)
T ss_dssp             ECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred             EeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCC--
Confidence            99999999999998765 4899999999999999999999   99999999999999999999999999999986532  


Q ss_pred             ccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh----------------hhhhcccccchh
Q 040702          663 QSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE----------------KHLMTKEQPMVR  726 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~l~~  726 (797)
                         .....+||+.|+|||.+.+..++.++|+|++|+..++.+.+..++....                ......+.++++
T Consensus       159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~  235 (318)
T 1fot_A          159 ---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLS  235 (318)
T ss_dssp             ---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred             ---ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence               2234679999999999999999999999999999866665544432211                112234567788


Q ss_pred             ccccCCCCCCCChHHHHHhHHHHHHHhccccccccccCCcccccceeeeeeeee
Q 040702          727 MGTDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYTI  780 (797)
Q Consensus       727 ~cl~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~  780 (797)
                      .|+..||++||+.                    ....+.++++|+||++++|+.
T Consensus       236 ~lL~~dp~~R~~~--------------------~~~~~~~i~~hp~f~~~~~~~  269 (318)
T 1fot_A          236 RLITRDLSQRLGN--------------------LQNGTEDVKNHPWFKEVVWEK  269 (318)
T ss_dssp             HHTCSCTTTCTTS--------------------STTTTHHHHTSGGGSSCCHHH
T ss_pred             HHhccCHHHcCCC--------------------cCCCHHHHhcCccccCCCHHH
Confidence            8888888888842                    112234455677777777753

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.3e-36  Score=325.39  Aligned_cols=238  Identities=19%  Similarity=0.196  Sum_probs=200.8

Q ss_pred             CccCHHHHHHHhcC----------CCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCC
Q 040702          500 RRFTYLELFQATNR----------FSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHR  564 (797)
Q Consensus       500 ~~~~~~~l~~~~~~----------f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hp  564 (797)
                      ..++++++..+++.          |+..+.||+|+||.||++     ++.||||+++.......+.+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            56888998888864          677789999999999975     689999999877666667899999999999999


Q ss_pred             ceeEeeeeeecCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCC
Q 040702          565 NLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN  644 (797)
Q Consensus       565 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~  644 (797)
                      ||+++++++...+..++||||+++|+|.+++...  .+++..+..++.|++.||+|||   +.+|+||||||+||+++.+
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~  177 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV--RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLD  177 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTT
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCC
Confidence            9999999999999999999999999999998754  4899999999999999999999   8999999999999999999


Q ss_pred             CcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh-----------
Q 040702          645 MVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE-----------  713 (797)
Q Consensus       645 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~-----------  713 (797)
                      +.+||+|||+++.......  ......||+.|+|||.+.++.++.++|+|++|+..+..+.+..++...           
T Consensus       178 ~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~  255 (321)
T 2c30_A          178 GRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRD  255 (321)
T ss_dssp             CCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred             CcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence            9999999999986543221  234567999999999999999999999999999886655544332211           


Q ss_pred             --------hhhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          714 --------EKHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       714 --------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                              .......+.++++.|++.||++||++.|+++
T Consensus       256 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          256 SPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             SSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                    1112334678899999999999999998875

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.9e-37  Score=330.92  Aligned_cols=241  Identities=23%  Similarity=0.292  Sum_probs=196.9

Q ss_pred             cCCCccccccccCCcceeecc--------eEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKDG--------MEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~~--------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      ++|...+.||+|+||.||++.        ..||||+++.... ...+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            578888999999999999752        4599999975532 2346789999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      |||+++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus       129 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  205 (325)
T 3kul_A          129 TEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP  205 (325)
T ss_dssp             EECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred             eeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence            9999999999999876667999999999999999999999   9999999999999999999999999999998764332


Q ss_pred             cc-ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-----------------hhhhhccccc
Q 040702          663 QS-LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-----------------EKHLMTKEQP  723 (797)
Q Consensus       663 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-----------------~~~~~~~~~~  723 (797)
                      .. .......+|+.|+|||.+.+..++.++|+|++|+..+..+. +..++...                 +......+.+
T Consensus       206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  285 (325)
T 3kul_A          206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQ  285 (325)
T ss_dssp             -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHHHHH
Confidence            21 12234457889999999998999999999999999866554 33332211                 1122345678


Q ss_pred             chhccccCCCCCCCChHHHHHhHHHHHHHhcc
Q 040702          724 MVRMGTDLSLGQFPASYSISKYLVYIRELERG  755 (797)
Q Consensus       724 l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~~  755 (797)
                      +++.|++.||++||++.++++.|+.+.+.+..
T Consensus       286 li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~  317 (325)
T 3kul_A          286 LMLDCWHKDRAQRPRFSQIVSVLDALIRSPES  317 (325)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence            99999999999999999999999998765433

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.1e-37  Score=336.22  Aligned_cols=240  Identities=24%  Similarity=0.306  Sum_probs=201.3

Q ss_pred             hcCCCccccccccCCcceeecc------------eEEEEEEEEeccC-CcchhHHHHHHHhhhc-cCCceeEeeeeeecC
Q 040702          511 TNRFSENNLIGRGGFGPVYKDG------------MEVAIKVFNLQYG-GAFKSFDIECGMMKRI-RHRNLIKIISSCSND  576 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~~------------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~  576 (797)
                      .++|...+.||+|+||.||++.            ..||||+++.... ...+.+.+|+++++++ +||||+++++++..+
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            4789999999999999999863            5799999975532 2346788999999999 899999999999999


Q ss_pred             CeEEEEEEccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEE
Q 040702          577 DFKALVLEYMPLGSLEKCLYSGN---------------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL  641 (797)
Q Consensus       577 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll  641 (797)
                      +..++||||+++|+|.+++....               ..+++..++.++.|++.||+|||   +.+|+||||||+||++
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  224 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  224 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEE
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEE
Confidence            99999999999999999997654               24899999999999999999999   8999999999999999


Q ss_pred             cCCCcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchhh------
Q 040702          642 DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIREE------  714 (797)
Q Consensus       642 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~~------  714 (797)
                      +.++.+||+|||+|+...............||+.|+|||.+.+..++.++|+|++|+..+..+. +..++....      
T Consensus       225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~  304 (382)
T 3tt0_A          225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK  304 (382)
T ss_dssp             CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred             cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            9999999999999987654433334445668899999999999999999999999999865554 333322211      


Q ss_pred             -----------hhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHHh
Q 040702          715 -----------KHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRELE  753 (797)
Q Consensus       715 -----------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~  753 (797)
                                 ......+.++++.||+.||++||++.|+++.|+.+....
T Consensus       305 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  354 (382)
T 3tt0_A          305 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT  354 (382)
T ss_dssp             HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             HHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence                       112335678899999999999999999999999987664

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=8.8e-36  Score=322.87  Aligned_cols=305  Identities=28%  Similarity=0.384  Sum_probs=193.2

Q ss_pred             CCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCE
Q 040702           51 NLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSE  130 (797)
Q Consensus        51 ~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  130 (797)
                      .+++|+.|++++|++..+ | .+..+++|++|+|++|+++ .++.  +..+++|++|+|++|.+++.  ..|.++++|++
T Consensus        42 ~l~~L~~L~l~~~~i~~~-~-~~~~~~~L~~L~l~~n~i~-~~~~--~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~~  114 (347)
T 4fmz_A           42 ELESITKLVVAGEKVASI-Q-GIEYLTNLEYLNLNGNQIT-DISP--LSNLVKLTNLYIGTNKITDI--SALQNLTNLRE  114 (347)
T ss_dssp             HHTTCSEEECCSSCCCCC-T-TGGGCTTCCEEECCSSCCC-CCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCSE
T ss_pred             hcccccEEEEeCCccccc-h-hhhhcCCccEEEccCCccc-cchh--hhcCCcCCEEEccCCcccCc--hHHcCCCcCCE
Confidence            445555555555555442 2 2455555555555555554 3333  34555555555555555432  23555555555


Q ss_pred             EEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEE
Q 040702          131 LGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFW  210 (797)
Q Consensus       131 L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~  210 (797)
                      |+|++|+++++.+  +.++++|++|++++|......+      .+..+++|++|++++|.+....+              
T Consensus       115 L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~------~~~~l~~L~~L~l~~~~~~~~~~--------------  172 (347)
T 4fmz_A          115 LYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLS------PLSNMTGLNYLTVTESKVKDVTP--------------  172 (347)
T ss_dssp             EECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCG------GGTTCTTCCEEECCSSCCCCCGG--------------
T ss_pred             EECcCCcccCchh--hccCCceeEEECCCCCCccccc------chhhCCCCcEEEecCCCcCCchh--------------
Confidence            5555555554332  5555555555555553322222      14444555555555555543322              


Q ss_pred             ccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCC
Q 040702          211 MDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLL  290 (797)
Q Consensus       211 L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  290 (797)
                                   +..+++|  ++|++++|.+.+..+  +..+++|+.|++++|.+.+..+  +..+++|++|++++|.+
T Consensus       173 -------------~~~l~~L--~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l  233 (347)
T 4fmz_A          173 -------------IANLTDL--YSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKI  233 (347)
T ss_dssp             -------------GGGCTTC--SEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCC
T ss_pred             -------------hccCCCC--CEEEccCCccccccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCcc
Confidence                         4444444  666666666654332  6677778888888887776544  67777888888888888


Q ss_pred             CCCCCCCCCCCcccEEEccCCcCCCCCCccccccccccEEeccCcccccccCccccCCcccceecccCccccCCCChhhh
Q 040702          291 TSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIG  370 (797)
Q Consensus       291 ~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~  370 (797)
                      +.++. +..+++|++|++++|.+++.  ..+..+++|+.|++++|.+++.  ..+..+++|+.|++++|++++..|..++
T Consensus       234 ~~~~~-~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~  308 (347)
T 4fmz_A          234 TDLSP-LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIG  308 (347)
T ss_dssp             CCCGG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHH
T ss_pred             CCCcc-hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhh
Confidence            77765 66778888888888888753  3577788888888888888764  3577888888888888888877788888


Q ss_pred             ccccCCeeeecCCcCCCCCChhhhccCCCCeEEccCCcCc
Q 040702          371 DLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLE  410 (797)
Q Consensus       371 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~  410 (797)
                      .+++|++|++++|++++..|  +..+++|+.|++++|+++
T Consensus       309 ~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          309 GLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             TCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             ccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            88888888888888887666  778888888888888775

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=4e-37  Score=335.09  Aligned_cols=251  Identities=20%  Similarity=0.274  Sum_probs=206.2

Q ss_pred             cCccCHHHHHHHhcCCCccccccccCCcceeecc----------eEEEEEEEEeccC-CcchhHHHHHHHhhhc-cCCce
Q 040702          499 QRRFTYLELFQATNRFSENNLIGRGGFGPVYKDG----------MEVAIKVFNLQYG-GAFKSFDIECGMMKRI-RHRNL  566 (797)
Q Consensus       499 ~~~~~~~~l~~~~~~f~~~~~lg~G~~g~Vyk~~----------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~Hpni  566 (797)
                      ...+...+.....++|...+.||+|+||.||++.          +.||||+++.... ...+.+.+|+++++++ +||||
T Consensus         9 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpni   88 (359)
T 3vhe_A            9 RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV   88 (359)
T ss_dssp             GSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             hCCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcce
Confidence            3455666666778999999999999999999863          7899999975432 2346789999999999 79999


Q ss_pred             eEeeeeeecCC-eEEEEEEccCCCCHHHHHhcCCC---------------------------------------------
Q 040702          567 IKIISSCSNDD-FKALVLEYMPLGSLEKCLYSGNY---------------------------------------------  600 (797)
Q Consensus       567 v~l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------  600 (797)
                      +++++++.+.+ ..++||||+++|+|.+++.....                                             
T Consensus        89 v~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (359)
T 3vhe_A           89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV  168 (359)
T ss_dssp             CCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred             eeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence            99999998765 48999999999999999976532                                             


Q ss_pred             --------------------CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCc
Q 040702          601 --------------------ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  660 (797)
Q Consensus       601 --------------------~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  660 (797)
                                          .+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  245 (359)
T 3vhe_A          169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK  245 (359)
T ss_dssp             ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred             cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence                                1889999999999999999999   99999999999999999999999999999987654


Q ss_pred             cCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh------------------hhhhhccc
Q 040702          661 EDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE------------------EKHLMTKE  721 (797)
Q Consensus       661 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~------------------~~~~~~~~  721 (797)
                      ...........||+.|+|||.+.+..++.++|+|++|+..+..+. +..++...                  +......+
T Consensus       246 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  325 (359)
T 3vhe_A          246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEM  325 (359)
T ss_dssp             CTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHH
T ss_pred             cccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHH
Confidence            444334455678999999999999999999999999999866653 33332221                  11123357


Q ss_pred             ccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          722 QPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       722 ~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                      .++++.|++.||.+||++.|+++.|+.+.+-
T Consensus       326 ~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          326 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence            7889999999999999999999999987654

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=6e-37  Score=331.22  Aligned_cols=219  Identities=21%  Similarity=0.234  Sum_probs=187.1

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      .++|+..+.||+|+||.||++     ++.||||++++..   ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            368999999999999999974     6899999997653   23456788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      |||+++|+|.+++.... .+++..++.++.||+.||+|||   +++|+||||||+||+++.++.+||+|||+++..... 
T Consensus       120 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-  194 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             EECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence            99999999999998654 3899999999999999999999   999999999999999999999999999999865322 


Q ss_pred             ccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh----------------hhhhhcccccchh
Q 040702          663 QSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE----------------EKHLMTKEQPMVR  726 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~l~~  726 (797)
                          ....+||+.|+|||.+.+..++.++|+|++|+..++.+.+..++...                +......+.++++
T Consensus       195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~  270 (350)
T 1rdq_E          195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR  270 (350)
T ss_dssp             ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHH
T ss_pred             ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence                23467999999999999999999999999999986666554443221                1122345678889


Q ss_pred             ccccCCCCCCCC
Q 040702          727 MGTDLSLGQFPA  738 (797)
Q Consensus       727 ~cl~~dp~~RPs  738 (797)
                      .|+..||.+||+
T Consensus       271 ~lL~~dp~~R~~  282 (350)
T 1rdq_E          271 NLLQVDLTKRFG  282 (350)
T ss_dssp             HHSCSCTTTCTT
T ss_pred             HHhhcCHHhccC
Confidence            999999999997

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=4.8e-37  Score=326.69  Aligned_cols=239  Identities=24%  Similarity=0.290  Sum_probs=191.2

Q ss_pred             HHhcCCCccccccccCCcceeec---ceEEEEEEEEeccCC--cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          509 QATNRFSENNLIGRGGFGPVYKD---GMEVAIKVFNLQYGG--AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       509 ~~~~~f~~~~~lg~G~~g~Vyk~---~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ...++|+..+.||+|+||.||++   +..||||++......  ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT  113 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred             CChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence            34578999999999999999985   689999999765422  2457889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHccCCCC--eEEcCCCCCceEEcCCCcEEEEeecCCccCC
Q 040702          584 EYMPLGSLEKCLYSGNY--ILDIFQGLNIMIDVASALEYLHFGYSVP--IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  659 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~al~yLH~~~~~~--ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  659 (797)
                      ||+++|+|.+++.....  .+++..++.++.|++.||+|||   +.+  |+||||||+||+++.++.+||+|||+++...
T Consensus       114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  190 (309)
T 3p86_A          114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA  190 (309)
T ss_dssp             ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred             ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence            99999999999987543  4899999999999999999999   888  9999999999999999999999999998543


Q ss_pred             ccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh------------------hhhhccc
Q 040702          660 EEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE------------------KHLMTKE  721 (797)
Q Consensus       660 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~------------------~~~~~~~  721 (797)
                      ..  ........||+.|+|||.+.+..++.++|+|++|+..+..+....++....                  ......+
T Consensus       191 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  268 (309)
T 3p86_A          191 ST--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQV  268 (309)
T ss_dssp             -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHH
T ss_pred             cc--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHH
Confidence            22  122345679999999999999999999999999999866655444333211                  1223356


Q ss_pred             ccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          722 QPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       722 ~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                      .++++.|++.||.+||++.++++.|+.+.+-
T Consensus       269 ~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          269 AAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            7899999999999999999999999887543

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.3e-37  Score=326.10  Aligned_cols=238  Identities=20%  Similarity=0.294  Sum_probs=193.3

Q ss_pred             hcCCCccccccccCCcceeec---------ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecC--CeE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD---------GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSND--DFK  579 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~---------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~--~~~  579 (797)
                      .++|+..+.||+|+||.||++         ++.||||++........+.+.+|++++++++||||+++++++...  ...
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            468999999999999999864         588999999765544557889999999999999999999998654  468


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCC
Q 040702          580 ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  659 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  659 (797)
                      ++||||+++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~  165 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  165 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred             EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence            9999999999999999887666899999999999999999999   8999999999999999999999999999998764


Q ss_pred             ccCcc-ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh-------------------------
Q 040702          660 EEDQS-LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE-------------------------  713 (797)
Q Consensus       660 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~-------------------------  713 (797)
                      ..... .......||..|+|||.+.+..++.++|+|++|+..+..+....+....                         
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (295)
T 3ugc_A          166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL  245 (295)
T ss_dssp             ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred             CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH
Confidence            33221 1223445788899999999999999999999999875554432211111                         


Q ss_pred             --------hhhhhcccccchhccccCCCCCCCChHHHHHhHHHHHH
Q 040702          714 --------EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRE  751 (797)
Q Consensus       714 --------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~  751 (797)
                              +......+.++++.||+.||++||++.|+++.++.+.+
T Consensus       246 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~  291 (295)
T 3ugc_A          246 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  291 (295)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence                    11223457789999999999999999999999988764

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=6.3e-37  Score=328.14  Aligned_cols=228  Identities=21%  Similarity=0.248  Sum_probs=193.4

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCC--cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG--AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      .++|...+.||+|+||.||++     ++.||||++......  ..+.+.+|+++++.++||||+++++++...+..|+||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            468999999999999999974     689999999865432  3457889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      ||+++|+|.+++...+ .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...... 
T Consensus        94 e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  168 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-  168 (328)
T ss_dssp             CCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-
T ss_pred             ECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-
Confidence            9999999999997654 3899999999999999999999   9999999999999999999999999999998654322 


Q ss_pred             cccccccccCcccccccccccCccc-hHHHHHHHhhhhhhhhccccccchhhh----------------hhhcccccchh
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMR-LKCWVNDSLLISVMIVVDANLLIREEK----------------HLMTKEQPMVR  726 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~dv~s~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~l~~  726 (797)
                        .....+||+.|+|||.+.+..+. .++|+|++|+..+..+.+..++.....                .......++++
T Consensus       169 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  246 (328)
T 3fe3_A          169 --KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK  246 (328)
T ss_dssp             --GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred             --ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence              33556899999999999888775 899999999998666655544432111                12345678999


Q ss_pred             ccccCCCCCCCChHHHHHh
Q 040702          727 MGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       727 ~cl~~dp~~RPs~~~i~~~  745 (797)
                      .|+..||.+|||+.|+++.
T Consensus       247 ~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          247 RFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             HHCCSSTTTSCCHHHHTTC
T ss_pred             HHCCCChhHCcCHHHHhcC
Confidence            9999999999999998763

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3e-36  Score=320.68  Aligned_cols=249  Identities=27%  Similarity=0.388  Sum_probs=206.4

Q ss_pred             ccCccCHHHHHHHhcCCCcc------ccccccCCcceeec---ceEEEEEEEEecc----CCcchhHHHHHHHhhhccCC
Q 040702          498 DQRRFTYLELFQATNRFSEN------NLIGRGGFGPVYKD---GMEVAIKVFNLQY----GGAFKSFDIECGMMKRIRHR  564 (797)
Q Consensus       498 ~~~~~~~~~l~~~~~~f~~~------~~lg~G~~g~Vyk~---~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~Hp  564 (797)
                      ....|++.++..++++|...      +.||+|+||.||++   ++.||||++....    ....+.+.+|+.++++++||
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   90 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE   90 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence            45689999999999999887      89999999999985   6899999997542    22346788999999999999


Q ss_pred             ceeEeeeeeecCCeEEEEEEccCCCCHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEc
Q 040702          565 NLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSG--NYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD  642 (797)
Q Consensus       565 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~  642 (797)
                      ||+++++++.+.+..++||||+++|+|.+++...  ...+++..+..++.|++.||+|||   +.+|+||||||+||+++
T Consensus        91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nili~  167 (307)
T 2nru_A           91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLD  167 (307)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEC
T ss_pred             CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHHEEEc
Confidence            9999999999999999999999999999998743  235899999999999999999999   89999999999999999


Q ss_pred             CCCcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh--------
Q 040702          643 DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE--------  714 (797)
Q Consensus       643 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------  714 (797)
                      .++.+||+|||+++...............||+.|+|||.+. +.++.++|+|++|+..+..+.+..++....        
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~  246 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI  246 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHT-TEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHH
T ss_pred             CCCcEEEeecccccccccccccccccccCCCcCcCChHHhc-CCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHH
Confidence            99999999999998654433332334567999999999765 568999999999998865555433332211        


Q ss_pred             -----------------------hhhhcccccchhccccCCCCCCCChHHHHHhHHHHH
Q 040702          715 -----------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIR  750 (797)
Q Consensus       715 -----------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~  750 (797)
                                             ......+.++++.|++.||.+||++.++++.|+.+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          247 KEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             HHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             HHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence                                   111234567899999999999999999999998764

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.7e-37  Score=338.28  Aligned_cols=240  Identities=22%  Similarity=0.259  Sum_probs=197.4

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ..++|...+.||+|+||.||++     ++.||||+++.... ...+++.+|++++++++||||+++++++..++..|+||
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  191 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM  191 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence            3468899999999999999974     68899999875422 22457889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      ||+++|+|.+++......+++..+..++.|+++||+|||   +++|+||||||+||+++.++.+||+|||+++.......
T Consensus       192 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY  268 (377)
T ss_dssp             ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred             EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence            999999999999876556899999999999999999999   99999999999999999999999999999986433211


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchhh-----------------hhhhcccccch
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIREE-----------------KHLMTKEQPMV  725 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~~-----------------~~~~~~~~~l~  725 (797)
                      ........+++.|+|||.+..+.++.++|+|++|+..++.+. +..++....                 ......+.+++
T Consensus       269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  348 (377)
T 3cbl_A          269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLM  348 (377)
T ss_dssp             ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            111122346778999999999999999999999999865553 333322211                 11233567889


Q ss_pred             hccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          726 RMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       726 ~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                      +.||+.||++||++.++++.|+.+.+-
T Consensus       349 ~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          349 EQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence            999999999999999999999988654

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=100.00  E-value=2e-35  Score=320.02  Aligned_cols=307  Identities=26%  Similarity=0.410  Sum_probs=241.0

Q ss_pred             CCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCc
Q 040702           17 LGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSS   96 (797)
Q Consensus        17 ~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~   96 (797)
                      +..+++|++|++++|.++         .+| .+..+++|++|++++|+++++.+  |.++++|++|+|++|.++ .+|  
T Consensus        40 ~~~l~~L~~L~l~~~~i~---------~~~-~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~-~~~--  104 (347)
T 4fmz_A           40 QEELESITKLVVAGEKVA---------SIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT-DIS--  104 (347)
T ss_dssp             HHHHTTCSEEECCSSCCC---------CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG--
T ss_pred             chhcccccEEEEeCCccc---------cch-hhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCccc-Cch--
Confidence            567899999999999843         444 38889999999999999998655  999999999999999998 665  


Q ss_pred             cccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCC
Q 040702           97 ADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLS  176 (797)
Q Consensus        97 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~  176 (797)
                      .+..+++|++|+|++|.+++..+  +..+++|++|++++|...... ..+.++++|++|++++|.+...++       +.
T Consensus       105 ~~~~l~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~-~~~~~l~~L~~L~l~~~~~~~~~~-------~~  174 (347)
T 4fmz_A          105 ALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVKDVTP-------IA  174 (347)
T ss_dssp             GGTTCTTCSEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCC-GGGTTCTTCCEEECCSSCCCCCGG-------GG
T ss_pred             HHcCCCcCCEEECcCCcccCchh--hccCCceeEEECCCCCCcccc-cchhhCCCCcEEEecCCCcCCchh-------hc
Confidence            36799999999999999986543  899999999999999765444 449999999999999999987764       67


Q ss_pred             CCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCC
Q 040702          177 NCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAAL  256 (797)
Q Consensus       177 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L  256 (797)
                      .+++|+.|++++|++.++.+  +..++ +|+.|++++|.+.                          +..+  +..+++|
T Consensus       175 ~l~~L~~L~l~~n~l~~~~~--~~~l~-~L~~L~l~~n~l~--------------------------~~~~--~~~~~~L  223 (347)
T 4fmz_A          175 NLTDLYSLSLNYNQIEDISP--LASLT-SLHYFTAYVNQIT--------------------------DITP--VANMTRL  223 (347)
T ss_dssp             GCTTCSEEECTTSCCCCCGG--GGGCT-TCCEEECCSSCCC--------------------------CCGG--GGGCTTC
T ss_pred             cCCCCCEEEccCCccccccc--ccCCC-ccceeecccCCCC--------------------------CCch--hhcCCcC
Confidence            88999999999999986644  55555 5655555555554                          3222  5556677


Q ss_pred             cEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEccCCcCCCCCCccccccccccEEeccCcc
Q 040702          257 FQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNN  336 (797)
Q Consensus       257 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  336 (797)
                      ++|++++|++++..+  +..+++|++|++++|.++.++ .+..+++|+.|++++|.+++.  ..+..+++|+.|++++|.
T Consensus       224 ~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~-~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~  298 (347)
T 4fmz_A          224 NSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDIN-AVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQ  298 (347)
T ss_dssp             CEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSC
T ss_pred             CEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCCh-hHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCc
Confidence            777777777765543  667777777777777776663 466677888888888887754  357778888888888888


Q ss_pred             cccccCccccCCcccceecccCccccCCCChhhhccccCCeeeecCCcCC
Q 040702          337 FSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLS  386 (797)
Q Consensus       337 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~  386 (797)
                      +++..+..|.++++|++|++++|++++..|  +..+++|++|++++|.|+
T Consensus       299 l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~  346 (347)
T 4fmz_A          299 LGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK  346 (347)
T ss_dssp             CCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred             CCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence            887777888888888888888888886655  788888888888888875

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=8e-37  Score=333.59  Aligned_cols=240  Identities=21%  Similarity=0.293  Sum_probs=188.5

Q ss_pred             hcCCCccccccccCCcceeec--------ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD--------GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~--------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l  581 (797)
                      .++|...+.||+|+||.||++        +..||||+++.... ...+++.+|+.++++++||||+++++++.+.+..++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            358999999999999999975        35699999975532 234679999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCcc
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  661 (797)
                      ||||+++|+|.+++......+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus       124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  200 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD  200 (373)
T ss_dssp             EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence            99999999999999877667999999999999999999999   899999999999999999999999999999876433


Q ss_pred             Ccc-ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-----------------hhhhhcccc
Q 040702          662 DQS-LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-----------------EKHLMTKEQ  722 (797)
Q Consensus       662 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-----------------~~~~~~~~~  722 (797)
                      ... .......+|+.|+|||.+....++.++|+|++|+..++.+. +..++...                 +......+.
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~  280 (373)
T 2qol_A          201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALY  280 (373)
T ss_dssp             -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHHH
T ss_pred             CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHH
Confidence            211 11223346788999999999999999999999999865443 33322111                 112234567


Q ss_pred             cchhccccCCCCCCCChHHHHHhHHHHHHHh
Q 040702          723 PMVRMGTDLSLGQFPASYSISKYLVYIRELE  753 (797)
Q Consensus       723 ~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~  753 (797)
                      +++..|++.||++||++.++++.|+.+.+.+
T Consensus       281 ~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          281 QLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             HHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence            8899999999999999999999999986654

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4.2e-37  Score=334.80  Aligned_cols=224  Identities=23%  Similarity=0.234  Sum_probs=179.0

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccC---CcchhHHHHHHH-hhhccCCceeEeeeeeecCCeEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG---GAFKSFDIECGM-MKRIRHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~---~~~~~~~~E~~~-l~~l~Hpniv~l~~~~~~~~~~~l  581 (797)
                      .++|+..+.||+|+||.||++     ++.||||++++...   .....+..|..+ ++.++||||+++++++.+.+..|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            468999999999999999974     58899999986632   233456677776 577899999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCcc
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  661 (797)
                      ||||+++|+|.+++.... .+++..++.++.||+.||+|||   +++|+||||||+||+++.++++||+|||+++.....
T Consensus       117 v~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~  192 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH  192 (373)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred             EEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence            999999999999997654 4889999999999999999999   999999999999999999999999999999864322


Q ss_pred             CccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh----------------hhhhcccccch
Q 040702          662 DQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE----------------KHLMTKEQPMV  725 (797)
Q Consensus       662 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~l~  725 (797)
                      .  ......+||+.|+|||.+.+..++.++|+|++|+..++++.+..++....                ........+++
T Consensus       193 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li  270 (373)
T 2r5t_A          193 N--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLL  270 (373)
T ss_dssp             C--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHH
T ss_pred             C--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Confidence            2  23455789999999999999999999999999999876665554432211                11233456788


Q ss_pred             hccccCCCCCCCChH
Q 040702          726 RMGTDLSLGQFPASY  740 (797)
Q Consensus       726 ~~cl~~dp~~RPs~~  740 (797)
                      +.|+..||.+||++.
T Consensus       271 ~~lL~~dp~~R~~~~  285 (373)
T 2r5t_A          271 EGLLQKDRTKRLGAK  285 (373)
T ss_dssp             HHHTCSSGGGSTTTT
T ss_pred             HHHcccCHHhCCCCC
Confidence            889999999999875

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=8.3e-37  Score=345.78  Aligned_cols=224  Identities=21%  Similarity=0.270  Sum_probs=187.5

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      .++|...+.||+|+||.||++     ++.||||++.+..   ....+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            368999999999999999974     6899999997653   23456788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCC
Q 040702          583 LEYMPLGSLEKCLYSGN---YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  659 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  659 (797)
                      |||++||+|.+++....   ..+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            99999999999987643   25899999999999999999999   9999999999999999999999999999998764


Q ss_pred             ccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh--------------------hhhhc
Q 040702          660 EEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE--------------------KHLMT  719 (797)
Q Consensus       660 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------------~~~~~  719 (797)
                      ....  .....+||+.|||||.+.+..++.++|+|++|+..++.+.+..++....                    .....
T Consensus       341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~  418 (543)
T 3c4z_A          341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSP  418 (543)
T ss_dssp             TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred             CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCH
Confidence            3322  2344689999999999999999999999999999877666555443211                    11233


Q ss_pred             ccccchhccccCCCCCCCCh
Q 040702          720 KEQPMVRMGTDLSLGQFPAS  739 (797)
Q Consensus       720 ~~~~l~~~cl~~dp~~RPs~  739 (797)
                      ...++++.|+..||.+||++
T Consensus       419 ~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          419 ASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             HHHHHHHHHSCSSGGGSCCC
T ss_pred             HHHHHHHHhccCCHhHCCCC
Confidence            45677788888888888864

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.4e-36  Score=316.80  Aligned_cols=236  Identities=22%  Similarity=0.261  Sum_probs=198.5

Q ss_pred             hcCCCccccccccCCcceeec----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          511 TNRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      .++|+..+.||+|+||.||++    +..||||++..... ..+++.+|++++++++||||+++++++.+++..++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            368899999999999999984    57899999975432 3467999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccc
Q 040702          587 PLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  666 (797)
Q Consensus       587 ~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  666 (797)
                      ++|+|.+++......+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++...... ...
T Consensus        88 ~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~  163 (269)
T 4hcu_A           88 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTS  163 (269)
T ss_dssp             TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHS
T ss_pred             CCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccc-ccc
Confidence            999999999877667899999999999999999999   9999999999999999999999999999998654322 122


Q ss_pred             ccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchhh-----------------hhhhcccccchhcc
Q 040702          667 QTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIREE-----------------KHLMTKEQPMVRMG  728 (797)
Q Consensus       667 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~~-----------------~~~~~~~~~l~~~c  728 (797)
                      .....||+.|+|||.+....++.++|+|++|+..+..+. +..++....                 ......+.++++.|
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  243 (269)
T 4hcu_A          164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC  243 (269)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHH
T ss_pred             ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHHH
Confidence            344567889999999998999999999999999866554 333222111                 11233566789999


Q ss_pred             ccCCCCCCCChHHHHHhHHHHHH
Q 040702          729 TDLSLGQFPASYSISKYLVYIRE  751 (797)
Q Consensus       729 l~~dp~~RPs~~~i~~~l~~i~~  751 (797)
                      ++.||++||++.++++.++++.+
T Consensus       244 l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          244 WRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccCCcccCcCHHHHHHHHHHHHH
Confidence            99999999999999999988764

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.5e-37  Score=338.31  Aligned_cols=205  Identities=21%  Similarity=0.282  Sum_probs=175.3

Q ss_pred             cCHHHHHHHhcCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeee
Q 040702          502 FTYLELFQATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSC  573 (797)
Q Consensus       502 ~~~~~l~~~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~  573 (797)
                      +.+.+.....++|+..+.||+|+||.||++     ++.||||++++..   ....+.+.+|..++..++||||+++++++
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  130 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF  130 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            345555566789999999999999999974     6899999997642   23356789999999999999999999999


Q ss_pred             ecCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeec
Q 040702          574 SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFG  653 (797)
Q Consensus       574 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG  653 (797)
                      .+++..|+||||+++|+|.+++...+..+++..++.++.||+.||+|||   +.+|+||||||+|||++.++++||+|||
T Consensus       131 ~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL~DFG  207 (412)
T 2vd5_A          131 QDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFG  207 (412)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             eeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEEeech
Confidence            9999999999999999999999875546899999999999999999999   9999999999999999999999999999


Q ss_pred             CCccCCccCccccccccccCcccccccccc-------cCccchHHHHHHHhhhhhhhhcccccc
Q 040702          654 MAKPLLEEDQSLTQTQTLATIGYMAPDEIF-------SGEMRLKCWVNDSLLISVMIVVDANLL  710 (797)
Q Consensus       654 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~dv~s~~~~~~~~~~~~~~~  710 (797)
                      +++....... ......+||+.|||||.+.       .+.++.++|+|++|+..++.+.+..++
T Consensus       208 la~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf  270 (412)
T 2vd5_A          208 SCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF  270 (412)
T ss_dssp             TCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             hheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCC
Confidence            9987643322 2234468999999999987       467899999999999987766655544

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.3e-37  Score=336.13  Aligned_cols=241  Identities=20%  Similarity=0.239  Sum_probs=197.3

Q ss_pred             hcCCCccccccccCCcceeecc----------eEEEEEEEEecc-CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeE
Q 040702          511 TNRFSENNLIGRGGFGPVYKDG----------MEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFK  579 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~~----------~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~  579 (797)
                      .++|...+.||+|+||.||++.          ..||||+++... ......+.+|+.++++++||||+++++++.+.+..
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            3678999999999999999753          579999986442 22345788999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCC---cEEEE
Q 040702          580 ALVLEYMPLGSLEKCLYSGN------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM---VAHLS  650 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~---~~kl~  650 (797)
                      ++||||+++|+|.+++....      ..+++..++.++.||++||+|||   +++|+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999997543      25899999999999999999999   99999999999999999555   59999


Q ss_pred             eecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh----------------
Q 040702          651 DFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE----------------  713 (797)
Q Consensus       651 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~----------------  713 (797)
                      |||+|+...............||+.|+|||.+.++.++.++|+|++|+..++.+. +..++...                
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~  306 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD  306 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            9999986533333333345678999999999999999999999999999866553 33222211                


Q ss_pred             -hhhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHHhc
Q 040702          714 -EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRELER  754 (797)
Q Consensus       714 -~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~  754 (797)
                       +......+.++++.||+.||++||++.++++.++.+.+.+.
T Consensus       307 ~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~  348 (367)
T 3l9p_A          307 PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  348 (367)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence             11223356789999999999999999999999998876543

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1e-36  Score=327.11  Aligned_cols=242  Identities=19%  Similarity=0.214  Sum_probs=193.9

Q ss_pred             hcCCCccccccccCCcceeecc---------eEEEEEEEEecc-CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKDG---------MEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKA  580 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~~---------~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~  580 (797)
                      .++|+..+.||+|+||.||++.         ..||+|.++... ....+.+.+|+.++++++||||++++++|..++ .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            3679999999999999999852         246888775443 234578999999999999999999999998765 78


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCc
Q 040702          581 LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  660 (797)
Q Consensus       581 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  660 (797)
                      +|+||+++|+|.+++......+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|+....
T Consensus        93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            999999999999999887667999999999999999999999   89999999999999999999999999999987654


Q ss_pred             cCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchhh-----------------hhhhcccc
Q 040702          661 EDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIREE-----------------KHLMTKEQ  722 (797)
Q Consensus       661 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~~-----------------~~~~~~~~  722 (797)
                      ...........||+.|+|||.+.++.++.++|+|++|+..++.+. +..++....                 ......+.
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (327)
T 3poz_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY  249 (327)
T ss_dssp             TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHH
T ss_pred             CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCHHHH
Confidence            433333445567889999999999999999999999999866554 433332211                 11223466


Q ss_pred             cchhccccCCCCCCCChHHHHHhHHHHHHHhccc
Q 040702          723 PMVRMGTDLSLGQFPASYSISKYLVYIRELERGK  756 (797)
Q Consensus       723 ~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~~~  756 (797)
                      ++++.||+.||++||++.++++.++.+...+...
T Consensus       250 ~li~~~l~~~p~~Rps~~ell~~l~~~~~~~~~~  283 (327)
T 3poz_A          250 MIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY  283 (327)
T ss_dssp             HHHHHHTCSCGGGSCCHHHHHHHHHHHHTSHHHH
T ss_pred             HHHHHHcCCChhhCCCHHHHHHHHHHHHhhhhhh
Confidence            7889999999999999999999999887654433

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-36  Score=330.38  Aligned_cols=228  Identities=18%  Similarity=0.260  Sum_probs=193.4

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      .++|+..+.||+|+||.||++     ++.||+|++..........+.+|++++++++||||+++++++.+.+..++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            468999999999999999984     688999999866444456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcC--CCcEEEEeecCCccCCccCc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD--NMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~--~~~~kl~DFGla~~~~~~~~  663 (797)
                      +++|+|.+++......+++..+..++.||+.||+|||   +.+|+||||||+||+++.  ++.+||+|||+++...... 
T Consensus       130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~-  205 (387)
T 1kob_A          130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-  205 (387)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred             CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCc-
Confidence            9999999999876656899999999999999999999   999999999999999974  5789999999998764332 


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh--------------------hhhhccccc
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE--------------------KHLMTKEQP  723 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~  723 (797)
                        ......||+.|+|||.+.+..++.++|+|++|+..+..+.+..++....                    ......+.+
T Consensus       206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  283 (387)
T 1kob_A          206 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD  283 (387)
T ss_dssp             --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred             --ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHH
Confidence              2234579999999999999999999999999999866655544432211                    112335678


Q ss_pred             chhccccCCCCCCCChHHHHH
Q 040702          724 MVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       724 l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      +++.|+..||.+||++.|+++
T Consensus       284 li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          284 FIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHHcCCChhHCcCHHHHhh
Confidence            999999999999999998875

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=100.00  E-value=1.7e-35  Score=344.09  Aligned_cols=314  Identities=19%  Similarity=0.210  Sum_probs=285.2

Q ss_pred             CCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCC
Q 040702          100 RLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCK  179 (797)
Q Consensus       100 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~  179 (797)
                      .+++++.|++++|.+..+.+..|.++++|++|+|++|.|+++.|.+|.++++|++|+|++|.|+.+++.     .|.+++
T Consensus        49 ~l~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~-----~~~~l~  123 (597)
T 3oja_B           49 TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPH-----VFQNVP  123 (597)
T ss_dssp             GGCCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTT-----TTTTCT
T ss_pred             cCCCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHH-----HHcCCC
Confidence            468899999999999988778889999999999999999999999999999999999999999999886     388999


Q ss_pred             CCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEE
Q 040702          180 YLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQL  259 (797)
Q Consensus       180 ~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  259 (797)
                      +|++|+|++|.++++++..|.+++ +|+.|++++|.+++..|..|+++++|  ++|++++|.+++..   +..+++|+.|
T Consensus       124 ~L~~L~L~~n~l~~l~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L--~~L~L~~N~l~~~~---~~~l~~L~~L  197 (597)
T 3oja_B          124 LLTVLVLERNDLSSLPRGIFHNTP-KLTTLSMSNNNLERIEDDTFQATTSL--QNLQLSSNRLTHVD---LSLIPSLFHA  197 (597)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCT-TCCEEECCSSCCCBCCTTTTTTCTTC--CEEECTTSCCSBCC---GGGCTTCSEE
T ss_pred             CCCEEEeeCCCCCCCCHHHhccCC-CCCEEEeeCCcCCCCChhhhhcCCcC--cEEECcCCCCCCcC---hhhhhhhhhh
Confidence            999999999999988888889988 89999999999999999999999998  99999999999764   5567899999


Q ss_pred             EccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEccCCcCCCCCCccccccccccEEeccCccccc
Q 040702          260 DLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSC  339 (797)
Q Consensus       260 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  339 (797)
                      ++++|.++++     ...++|+.|++++|.++.+|..+.  ++|+.|++++|.+++  +..+..+++|+.|+|++|.+++
T Consensus       198 ~l~~n~l~~l-----~~~~~L~~L~ls~n~l~~~~~~~~--~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~  268 (597)
T 3oja_B          198 NVSYNLLSTL-----AIPIAVEELDASHNSINVVRGPVN--VELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEK  268 (597)
T ss_dssp             ECCSSCCSEE-----ECCTTCSEEECCSSCCCEEECSCC--SCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCE
T ss_pred             hcccCccccc-----cCCchhheeeccCCcccccccccC--CCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCC
Confidence            9999999864     344689999999999998877553  689999999999996  4678999999999999999999


Q ss_pred             ccCccccCCcccceecccCccccCCCChhhhccccCCeeeecCCcCCCCCChhhhccCCCCeEEccCCcCcccCCCCCCC
Q 040702          340 VIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPF  419 (797)
Q Consensus       340 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~  419 (797)
                      ..|..|.++++|+.|+|++|++++ +|..+..+++|+.|+|++|.++ .+|..+..+++|+.|++++|++++..  ...+
T Consensus       269 ~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~--~~~~  344 (597)
T 3oja_B          269 IMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK--LSTH  344 (597)
T ss_dssp             EESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC--CCTT
T ss_pred             CCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC--hhhc
Confidence            999999999999999999999995 5777788999999999999999 67888999999999999999998764  4567


Q ss_pred             CCCCcccccCCccccCCC
Q 040702          420 RNLSAESFKGNELLCGMP  437 (797)
Q Consensus       420 ~~l~~~~~~~n~~~c~~~  437 (797)
                      ..+..+++.+|++.|.+.
T Consensus       345 ~~L~~L~l~~N~~~~~~~  362 (597)
T 3oja_B          345 HTLKNLTLSHNDWDCNSL  362 (597)
T ss_dssp             CCCSEEECCSSCEEHHHH
T ss_pred             CCCCEEEeeCCCCCChhH
Confidence            889999999999998753

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.4e-36  Score=344.56  Aligned_cols=222  Identities=21%  Similarity=0.261  Sum_probs=186.8

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      .++|...+.||+|+||.||++     ++.||||++.+..   ......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            467999999999999999974     6899999997652   33456788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCcc
Q 040702          583 LEYMPLGSLEKCLYSGNY-ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  661 (797)
                      |||++||+|.+++..... .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.....
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            999999999999976543 5899999999999999999999   899999999999999999999999999999876433


Q ss_pred             CccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh--------------------hhhhccc
Q 040702          662 DQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE--------------------KHLMTKE  721 (797)
Q Consensus       662 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~  721 (797)
                      .   .....+||+.|||||.+.+..++.++|+|++|+..++.+.+..++....                    .......
T Consensus       340 ~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~  416 (576)
T 2acx_A          340 Q---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQA  416 (576)
T ss_dssp             C---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred             c---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHH
Confidence            2   2344689999999999999999999999999999876666554443211                    1122345


Q ss_pred             ccchhccccCCCCCCCC
Q 040702          722 QPMVRMGTDLSLGQFPA  738 (797)
Q Consensus       722 ~~l~~~cl~~dp~~RPs  738 (797)
                      .++++.|+..||.+||+
T Consensus       417 ~dLI~~lL~~dP~~R~g  433 (576)
T 2acx_A          417 RSLCSQLLCKDPAERLG  433 (576)
T ss_dssp             HHHHHHHTCSSGGGSTT
T ss_pred             HHHHHHhccCCHHHcCC
Confidence            67788888888888884

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=5.5e-37  Score=329.12  Aligned_cols=223  Identities=21%  Similarity=0.287  Sum_probs=176.1

Q ss_pred             hcCCCccccccccCCcceee--------cceEEEEEEEEecc----CCcchhHHHHHHHhhhccCCceeEeeeeeecCCe
Q 040702          511 TNRFSENNLIGRGGFGPVYK--------DGMEVAIKVFNLQY----GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDF  578 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk--------~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~  578 (797)
                      .++|+..+.||+|+||.||+        .++.||||+++...    ......+.+|+.++++++||||+++++++..++.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46899999999999999995        35789999997542    2234567889999999999999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccC
Q 040702          579 KALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  658 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  658 (797)
                      .|+||||+++|+|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++..
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             EEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            999999999999999997654 4889999999999999999999   899999999999999999999999999999854


Q ss_pred             CccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh----------------hhhhcccc
Q 040702          659 LEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE----------------KHLMTKEQ  722 (797)
Q Consensus       659 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~  722 (797)
                      .....  ......||+.|+|||.+.+..++.++|+|++|+..+..+.+..++....                ......+.
T Consensus       172 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~  249 (327)
T 3a62_A          172 IHDGT--VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEAR  249 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHHH
T ss_pred             ccCCc--cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            32221  2345679999999999999999999999999999866665554433211                11233556


Q ss_pred             cchhccccCCCCCCCCh
Q 040702          723 PMVRMGTDLSLGQFPAS  739 (797)
Q Consensus       723 ~l~~~cl~~dp~~RPs~  739 (797)
                      ++++.|+..||.+||++
T Consensus       250 ~li~~~L~~dp~~R~~~  266 (327)
T 3a62_A          250 DLLKKLLKRNAASRLGA  266 (327)
T ss_dssp             HHHHHHSCSCGGGSTTS
T ss_pred             HHHHHHHhcCHhhccCC
Confidence            78888888888888853

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-36  Score=321.90  Aligned_cols=229  Identities=17%  Similarity=0.199  Sum_probs=194.5

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      .++|...+.||+|+||.||++     +..||+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            468999999999999999984     6899999987442 2345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcC--CCcEEEEeecCCccCCccCc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD--NMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~--~~~~kl~DFGla~~~~~~~~  663 (797)
                      +++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.  ++.+||+|||+++...... 
T Consensus        83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~-  158 (321)
T 1tki_A           83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-  158 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-
Confidence            9999999999876656899999999999999999999   999999999999999987  7899999999998764332 


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh--------------------hhhhccccc
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE--------------------KHLMTKEQP  723 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~  723 (797)
                        ......||+.|+|||.+.+..++.++|+|++|+..+..+.+..++....                    ......+.+
T Consensus       159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  236 (321)
T 1tki_A          159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD  236 (321)
T ss_dssp             --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred             --ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHH
Confidence              2344679999999999998889999999999998866555443332111                    123445678


Q ss_pred             chhccccCCCCCCCChHHHHHhH
Q 040702          724 MVRMGTDLSLGQFPASYSISKYL  746 (797)
Q Consensus       724 l~~~cl~~dp~~RPs~~~i~~~l  746 (797)
                      +++.|+..||.+|||+.|+++.-
T Consensus       237 li~~~L~~dp~~Rpt~~e~l~hp  259 (321)
T 1tki_A          237 FVDRLLVKERKSRMTASEALQHP  259 (321)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             HHHHHcCCChhHCcCHHHHhcCh
Confidence            99999999999999999998854

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=7.2e-36  Score=321.14  Aligned_cols=236  Identities=19%  Similarity=0.220  Sum_probs=198.0

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhc-cCCceeEeeeeeecCCeEEEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      .++|...+.||+|+||.||++     ++.||||++....  ..+.+.+|+++++++ +||||+++++++..++..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            367999999999999999975     6899999987553  246799999999999 89999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCc-----EEEEeecCCccCC
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV-----AHLSDFGMAKPLL  659 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~-----~kl~DFGla~~~~  659 (797)
                      |+ +|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.     +||+|||+++...
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            99 89999999876556999999999999999999999   899999999999999998887     9999999998754


Q ss_pred             ccCccc-----cccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh-------------------
Q 040702          660 EEDQSL-----TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK-------------------  715 (797)
Q Consensus       660 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~-------------------  715 (797)
                      ......     ......||+.|+|||.+.+..++.++|+|++|+..++.+.+..++.....                   
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  241 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI  241 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred             cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence            332211     12456899999999999999999999999999998666655444332100                   


Q ss_pred             ----hhhcccccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          716 ----HLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       716 ----~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                          ...+.+.++++.|++.||.+||++.++.+.++.+.+-
T Consensus       242 ~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~  282 (330)
T 2izr_A          242 EVLCENFPEMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR  282 (330)
T ss_dssp             HHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHHhccChHHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence                0022677889999999999999999999999876544

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=9e-37  Score=341.96  Aligned_cols=227  Identities=21%  Similarity=0.231  Sum_probs=179.7

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEec---cCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQ---YGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      .++|+..+.||+|+||.||++     ++.||||+++..   .......+.+|+.+++.++||||+++++++...+..|+|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            468999999999999999974     689999999865   223346778899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCceEEcCCCcEEEEeecCCccCCcc
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS-VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~-~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  661 (797)
                      |||+++|+|.+++.... .+++..+..++.|++.||+|||   + ++|+||||||+|||++.++.+||+|||+|+.....
T Consensus       227 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  302 (446)
T 4ejn_A          227 MEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD  302 (446)
T ss_dssp             ECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred             EeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence            99999999999987654 4899999999999999999999   7 89999999999999999999999999999864322


Q ss_pred             CccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh----------------hhhhcccccch
Q 040702          662 DQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE----------------KHLMTKEQPMV  725 (797)
Q Consensus       662 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~l~  725 (797)
                      .  ......+||+.|||||.+.+..++.++|+|++|+..++.+.+..++....                ......+.+++
T Consensus       303 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li  380 (446)
T 4ejn_A          303 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLL  380 (446)
T ss_dssp             ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred             C--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence            2  23345789999999999999999999999999999866665544432211                12233567888


Q ss_pred             hccccCCCCCCC-----ChHHHH
Q 040702          726 RMGTDLSLGQFP-----ASYSIS  743 (797)
Q Consensus       726 ~~cl~~dp~~RP-----s~~~i~  743 (797)
                      +.|++.||.+||     ++.|++
T Consensus       381 ~~~L~~dP~~R~~~~~~t~~ell  403 (446)
T 4ejn_A          381 SGLLKKDPKQRLGGGSEDAKEIM  403 (446)
T ss_dssp             HHHTCSSTTTSTTCSTTTHHHHH
T ss_pred             HHHcccCHHHhCCCCCCCHHHHH
Confidence            899999999999     655554

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.7e-36  Score=324.65  Aligned_cols=231  Identities=19%  Similarity=0.242  Sum_probs=191.1

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      .++|+..+.||+|+||.||++     ++.||||++..... ...+.+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            468999999999999999985     68899999975532 334678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      |+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.+......
T Consensus        86 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           86 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            999999999887654 4899999999999999999999   999999999999999999999999999999865433333


Q ss_pred             ccccccccCcccccccccccCcc-chHHHHHHHhhhhhhhhccccccchhh-------------------hhhhcccccc
Q 040702          665 LTQTQTLATIGYMAPDEIFSGEM-RLKCWVNDSLLISVMIVVDANLLIREE-------------------KHLMTKEQPM  724 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~dv~s~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~l  724 (797)
                      .......||+.|+|||.+.+..+ +.++|+|++|+..+..+.+..++....                   ......+.++
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL  241 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred             cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHH
Confidence            33445689999999999987776 789999999999866655544432211                   1223355678


Q ss_pred             hhccccCCCCCCCChHHHHHh
Q 040702          725 VRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       725 ~~~cl~~dp~~RPs~~~i~~~  745 (797)
                      ++.|++.||++||++.|+++.
T Consensus       242 i~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          242 LHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTC
T ss_pred             HHHHccCChhhCcCHHHHhhC
Confidence            999999999999999998764

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=4.3e-36  Score=320.84  Aligned_cols=246  Identities=22%  Similarity=0.283  Sum_probs=178.7

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ..++|+..+.||+|+||.||++     ++.||||+++.... ...+.+.+|++++++++||||+++++++..++..|+||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            3568999999999999999975     68999999986543 34567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccC
Q 040702          584 EYMPLGSLEKCLYSGN-----YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  658 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  658 (797)
                      ||++ |+|.+++....     ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            9998 59999886432     24889999999999999999999   899999999999999999999999999999865


Q ss_pred             CccCccccccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccccccchhhh----------------------
Q 040702          659 LEEDQSLTQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANLLIREEK----------------------  715 (797)
Q Consensus       659 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~----------------------  715 (797)
                      .....  ......||+.|+|||.+.+. .++.++|+|++|+..+..+.+..++.....                      
T Consensus       159 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (317)
T 2pmi_A          159 GIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV  236 (317)
T ss_dssp             TSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred             CCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhh
Confidence            32221  23445799999999998764 589999999999988665554443321110                      


Q ss_pred             ----------------------------hhhcccccchhccccCCCCCCCChHHHHHhHHHHHHHhccccccccccCCcc
Q 040702          716 ----------------------------HLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPI  767 (797)
Q Consensus       716 ----------------------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~  767 (797)
                                                  .....+.++++.|+..||++||++.|++                        
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l------------------------  292 (317)
T 2pmi_A          237 TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQAL------------------------  292 (317)
T ss_dssp             GGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHT------------------------
T ss_pred             hhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHh------------------------
Confidence                                        1122455788889999999999976654                        


Q ss_pred             cccceeeeeeeeecccchh
Q 040702          768 VHHYLYRTVDYTISSSTFN  786 (797)
Q Consensus       768 ~~~~~f~~~~~~~~~~~~~  786 (797)
                       +|+||+...|.+..++-|
T Consensus       293 -~hp~f~~~~~~~~~~~~~  310 (317)
T 2pmi_A          293 -HHPWFAEYYHHASMGGSR  310 (317)
T ss_dssp             -TSGGGGGGCC--------
T ss_pred             -CChhhhcccchhhccccc
Confidence             467777777766555443

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.9e-35  Score=311.52  Aligned_cols=236  Identities=15%  Similarity=0.135  Sum_probs=198.9

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhc-cCCceeEeeeeeecCCeEEEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      .++|...+.||+|+||.||++     ++.||||++....  ..+.+.+|+++++++ +|+|++++++++......++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            357999999999999999975     6899999986543  346789999999999 79999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCc-----EEEEeecCCccCC
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV-----AHLSDFGMAKPLL  659 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~-----~kl~DFGla~~~~  659 (797)
                      |+ +++|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.     +||+|||+++...
T Consensus        87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~  162 (298)
T 1csn_A           87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  162 (298)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence            99 89999999876666999999999999999999999   999999999999999987776     9999999998764


Q ss_pred             ccCcc-----ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh--------------------
Q 040702          660 EEDQS-----LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE--------------------  714 (797)
Q Consensus       660 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------------  714 (797)
                      .....     .......||+.|+|||.+.+..++.++|+|++|+..+..+.+..++....                    
T Consensus       163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  242 (298)
T 1csn_A          163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL  242 (298)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred             cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH
Confidence            33221     12345679999999999999999999999999999866555444432210                    


Q ss_pred             ----hhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          715 ----KHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       715 ----~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                          ......+.++++.|++.||++||++.++.+.++.+.+-
T Consensus       243 ~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~  284 (298)
T 1csn_A          243 RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER  284 (298)
T ss_dssp             HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence                12234677899999999999999999999999987653

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=8.6e-36  Score=320.67  Aligned_cols=231  Identities=23%  Similarity=0.310  Sum_probs=186.1

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCC-------
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDD-------  577 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~-------  577 (797)
                      .++|+..+.||+|+||.||++     ++.||||+++.... ...+.+.+|++++++++||||++++++|.+.+       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            468999999999999999974     68899999986543 34578999999999999999999999986543       


Q ss_pred             --------------------------------------------------eEEEEEEccCCCCHHHHHhcCCC--CCCHH
Q 040702          578 --------------------------------------------------FKALVLEYMPLGSLEKCLYSGNY--ILDIF  605 (797)
Q Consensus       578 --------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~--~l~~~  605 (797)
                                                                        ..++||||+++|+|.+++.....  ..++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              37999999999999999987543  45667


Q ss_pred             HHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc----------ccccccccCcc
Q 040702          606 QGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS----------LTQTQTLATIG  675 (797)
Q Consensus       606 ~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~----------~~~~~~~gt~~  675 (797)
                      .++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++........          .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            78999999999999999   999999999999999999999999999999876543211          12244579999


Q ss_pred             cccccccccCccchHHHHHHHhhhhhhhhccccccch---------------hhhhhhcccccchhccccCCCCCCCChH
Q 040702          676 YMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIR---------------EEKHLMTKEQPMVRMGTDLSLGQFPASY  740 (797)
Q Consensus       676 y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~l~~~cl~~dp~~RPs~~  740 (797)
                      |+|||.+.+..++.++|+|++|+..+..+........               ..........++++.|++.||++||++.
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~  321 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEAT  321 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHH
Confidence            9999999999999999999999987555543222111               1112234557889999999999999998


Q ss_pred             HHHH
Q 040702          741 SISK  744 (797)
Q Consensus       741 ~i~~  744 (797)
                      |+++
T Consensus       322 ~~l~  325 (332)
T 3qd2_B          322 DIIE  325 (332)
T ss_dssp             HHHH
T ss_pred             HHhh
Confidence            8874

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.6e-36  Score=322.84  Aligned_cols=228  Identities=23%  Similarity=0.299  Sum_probs=191.8

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      .++|...+.||+|+||.||++     ++.||||++....   ....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            368999999999999999974     5899999997642   23356789999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      |||+ +|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++......
T Consensus        88 ~E~~-~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~  162 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN  162 (336)
T ss_dssp             ECCC-CEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred             EECC-CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence            9999 679988887654 4899999999999999999999   8999999999999999999999999999998654332


Q ss_pred             ccccccccccCcccccccccccCcc-chHHHHHHHhhhhhhhhccccccchh----------------hhhhhcccccch
Q 040702          663 QSLTQTQTLATIGYMAPDEIFSGEM-RLKCWVNDSLLISVMIVVDANLLIRE----------------EKHLMTKEQPMV  725 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~dv~s~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~l~  725 (797)
                         .....+||+.|+|||.+.+..+ +.++|+|++|+..+..+.+..++...                +......+.+++
T Consensus       163 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li  239 (336)
T 3h4j_B          163 ---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLI  239 (336)
T ss_dssp             ---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHH
T ss_pred             ---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHH
Confidence               2345679999999999988776 68999999999986665554433321                112334567899


Q ss_pred             hccccCCCCCCCChHHHHHhH
Q 040702          726 RMGTDLSLGQFPASYSISKYL  746 (797)
Q Consensus       726 ~~cl~~dp~~RPs~~~i~~~l  746 (797)
                      +.|+..||.+|||+.|+++.-
T Consensus       240 ~~~L~~dP~~Rpt~~eil~hp  260 (336)
T 3h4j_B          240 RRMIVADPMQRITIQEIRRDP  260 (336)
T ss_dssp             HTTSCSSGGGSCCHHHHTTCH
T ss_pred             HHHcCCChhHCcCHHHHHhCh
Confidence            999999999999999998753

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-36  Score=328.46  Aligned_cols=241  Identities=23%  Similarity=0.325  Sum_probs=198.0

Q ss_pred             HHhcCCCccccccccCCcceeecc----------eEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCC
Q 040702          509 QATNRFSENNLIGRGGFGPVYKDG----------MEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDD  577 (797)
Q Consensus       509 ~~~~~f~~~~~lg~G~~g~Vyk~~----------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~  577 (797)
                      ...++|...+.||+|+||.||++.          +.||||+++.... ...+.+.+|+.++++++||||+++++++.+.+
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  123 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK  123 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence            346789999999999999999852          7899999975532 23467899999999999999999999999999


Q ss_pred             eEEEEEEccCCCCHHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCC
Q 040702          578 FKALVLEYMPLGSLEKCLYSGN-----------------------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDL  634 (797)
Q Consensus       578 ~~~lv~e~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDl  634 (797)
                      ..|+||||+++|+|.+++....                       ..+++.+++.++.||++||+|||   +++|+||||
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dl  200 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDL  200 (343)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCC
T ss_pred             ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCC
Confidence            9999999999999999997642                       35899999999999999999999   999999999


Q ss_pred             CCCceEEcCCCcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh
Q 040702          635 KPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE  713 (797)
Q Consensus       635 kp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~  713 (797)
                      ||+||+++.++.+||+|||+++...............||+.|+|||.+.++.++.++|+|++|+..+..+. +..++...
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence            99999999999999999999986543332233345678999999999999999999999999999866554 33222211


Q ss_pred             -----------------hhhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          714 -----------------EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       714 -----------------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                                       +......+.++++.|++.||++||++.++++.|+.+.+-
T Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          281 AHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             ChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence                             112233567899999999999999999999999886544

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=4.4e-36  Score=320.36  Aligned_cols=238  Identities=22%  Similarity=0.309  Sum_probs=198.7

Q ss_pred             hcCCCccccccccCCcceeec----------ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD----------GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFK  579 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~----------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~  579 (797)
                      .++|...+.||+|+||.||++          +..||||+++.... ...+.+.+|++++++++||||+++++++.+.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            478999999999999999985          27899999875432 2346788999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCC-----------------------CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCC
Q 040702          580 ALVLEYMPLGSLEKCLYSGNY-----------------------ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKP  636 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~~-----------------------~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp  636 (797)
                      ++||||+++|+|.+++.....                       .+++..++.++.|+++||+|||   +++|+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccch
Confidence            999999999999999976432                       3889999999999999999999   89999999999


Q ss_pred             CceEEcCCCcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh--
Q 040702          637 SNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE--  713 (797)
Q Consensus       637 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~--  713 (797)
                      +||+++.++.+||+|||+++...............+|+.|+|||.+.+..++.++|+|++|+..+..+. +..++...  
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987654433333445568899999999999999999999999999866554 33322211  


Q ss_pred             ---------------hhhhhcccccchhccccCCCCCCCChHHHHHhHHHHHH
Q 040702          714 ---------------EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRE  751 (797)
Q Consensus       714 ---------------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~  751 (797)
                                     +......+.++++.|++.||++||++.++++.++.+..
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          259 ERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             GGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                           11223456789999999999999999999999988754

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=6.7e-36  Score=332.59  Aligned_cols=229  Identities=18%  Similarity=0.264  Sum_probs=191.8

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      ..++|+..+.||+|+||.||++     ++.||+|++.....  ...+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv   88 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI   88 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence            4578999999999999999974     68999999986532  2345788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEc---CCCcEEEEeecCCccCC
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLL  659 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~---~~~~~kl~DFGla~~~~  659 (797)
                      |||+++|+|.+.+.... .+++..+..++.||+.||+|||   +.+|+||||||+||+++   .++.+||+|||+|+...
T Consensus        89 ~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           89 FDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             ECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            99999999999988765 4899999999999999999999   99999999999999998   46789999999998664


Q ss_pred             ccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh--------------------hhhhc
Q 040702          660 EEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE--------------------KHLMT  719 (797)
Q Consensus       660 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------------~~~~~  719 (797)
                      ....  ......||+.|+|||.+.+..++.++|+|++|+..+..+.+..++....                    .....
T Consensus       165 ~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  242 (444)
T 3soa_A          165 GEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP  242 (444)
T ss_dssp             TTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred             CCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCH
Confidence            3322  2345689999999999998899999999999999866555444332111                    12234


Q ss_pred             ccccchhccccCCCCCCCChHHHHH
Q 040702          720 KEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       720 ~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      .+.++++.|++.||++||++.|+++
T Consensus       243 ~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          243 EAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             HHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCCCHHHHhc
Confidence            5678999999999999999999887

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.2e-36  Score=313.76  Aligned_cols=236  Identities=22%  Similarity=0.227  Sum_probs=197.6

Q ss_pred             hcCCCccccccccCCcceeec----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          511 TNRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      .++|+..+.||+|+||.||++    +..||||+++.... ..+++.+|++++++++||||+++++++.+++..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            468999999999999999975    57899999975543 3467899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccc
Q 040702          587 PLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  666 (797)
Q Consensus       587 ~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  666 (797)
                      ++|+|.+++......+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++...... ...
T Consensus        86 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~  161 (268)
T 3sxs_A           86 SNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-YVS  161 (268)
T ss_dssp             TTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-EEE
T ss_pred             CCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhh-hhc
Confidence            999999999876556899999999999999999999   8999999999999999999999999999998654332 222


Q ss_pred             ccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchhh-----------------hhhhcccccchhcc
Q 040702          667 QTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIREE-----------------KHLMTKEQPMVRMG  728 (797)
Q Consensus       667 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~~-----------------~~~~~~~~~l~~~c  728 (797)
                      .....+|+.|+|||.+.+..++.++|+|++|+..+..+. +..++....                 ......+.++++.|
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  241 (268)
T 3sxs_A          162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSC  241 (268)
T ss_dssp             CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHT
T ss_pred             ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHHHHH
Confidence            344557788999999998899999999999998865554 333322111                 11233567899999


Q ss_pred             ccCCCCCCCChHHHHHhHHHHHH
Q 040702          729 TDLSLGQFPASYSISKYLVYIRE  751 (797)
Q Consensus       729 l~~dp~~RPs~~~i~~~l~~i~~  751 (797)
                      ++.||++||++.++++.++.+++
T Consensus       242 l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          242 WHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             TCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             cCCChhhCcCHHHHHHHHHHhhh
Confidence            99999999999999998877643

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-35  Score=318.87  Aligned_cols=227  Identities=20%  Similarity=0.265  Sum_probs=191.6

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCC------cchhHHHHHHHhhhccCCceeEeeeeeecCCeE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG------AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFK  579 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~  579 (797)
                      .++|...+.||+|+||.||++     +..||||+++.....      ..+.+.+|+.++++++||||+++++++.+++..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            467999999999999999984     689999999865322      246789999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCC----cEEEEeecCC
Q 040702          580 ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM----VAHLSDFGMA  655 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~----~~kl~DFGla  655 (797)
                      ++||||+++|+|.+++.... .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++    .+||+|||++
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  165 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  165 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSS-CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCCCHHHHHHhcC-CcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence            99999999999999997654 4899999999999999999999   99999999999999999877    8999999999


Q ss_pred             ccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh--------------------hh
Q 040702          656 KPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE--------------------EK  715 (797)
Q Consensus       656 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~--------------------~~  715 (797)
                      +......   ......||+.|+|||.+....++.++|+|++|+..+..+.+..++...                    ..
T Consensus       166 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  242 (326)
T 2y0a_A          166 HKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS  242 (326)
T ss_dssp             EECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred             eECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccc
Confidence            8664322   234467999999999998889999999999999886655544433211                    11


Q ss_pred             hhhcccccchhccccCCCCCCCChHHHHH
Q 040702          716 HLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       716 ~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      .....+.++++.|+..||++||++.|+++
T Consensus       243 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            22335668899999999999999999876

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3e-36  Score=317.68  Aligned_cols=232  Identities=21%  Similarity=0.256  Sum_probs=195.7

Q ss_pred             hcCCCccccccccCCcceeecc------------eEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCe
Q 040702          511 TNRFSENNLIGRGGFGPVYKDG------------MEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDF  578 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~~------------~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~  578 (797)
                      .++|...+.||+|+||.||++.            ..||+|++........+.+.+|+.++++++||||+++++++.+++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            4689999999999999999852            5699999977665666789999999999999999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCc--------EEEE
Q 040702          579 KALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV--------AHLS  650 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~--------~kl~  650 (797)
                      .++||||+++|+|.+++......+++..+..++.|+++||+|||   +++|+||||||+||+++.++.        +||+
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeec
Confidence            99999999999999999887666899999999999999999999   999999999999999998876        9999


Q ss_pred             eecCCccCCccCccccccccccCccccccccccc-CccchHHHHHHHhhhhhhhhcc-ccccchh---------------
Q 040702          651 DFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVD-ANLLIRE---------------  713 (797)
Q Consensus       651 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~-~~~~~~~---------------  713 (797)
                      |||+++.....      ....||+.|+|||.+.+ ..++.++|+|++|+..+..+.. ..+....               
T Consensus       164 Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~  237 (289)
T 4fvq_A          164 DPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQL  237 (289)
T ss_dssp             CCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC
T ss_pred             cCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCC
Confidence            99999754321      23458999999999987 6789999999999998666552 2222111               


Q ss_pred             hhhhhcccccchhccccCCCCCCCChHHHHHhHHHHHH
Q 040702          714 EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRE  751 (797)
Q Consensus       714 ~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~  751 (797)
                      +......+.++++.|++.||++||++.++++.++.+..
T Consensus       238 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          238 PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            11223467789999999999999999999998877643

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.9e-36  Score=317.50  Aligned_cols=234  Identities=22%  Similarity=0.335  Sum_probs=190.4

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCC---cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG---AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      .++|+..+.||+|+||.||++     +..||+|++......   ..+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            367999999999999999975     588999999765332   235788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      |||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus        90 ~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  165 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS  165 (294)
T ss_dssp             EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred             EeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence            99999999999997654 4899999999999999999999   9999999999999999999999999999998654322


Q ss_pred             ccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh---------------------hhhhccc
Q 040702          663 QSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE---------------------KHLMTKE  721 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~  721 (797)
                       ........||+.|+|||.+.+..++.++|+|++|+..+..+.+..++....                     .+....+
T Consensus       166 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (294)
T 4eqm_A          166 -LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSL  244 (294)
T ss_dssp             ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHH
T ss_pred             -ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHH
Confidence             122344679999999999999999999999999999866655544432211                     1233457


Q ss_pred             ccchhccccCCCCCCC-ChHHHHHhHHHH
Q 040702          722 QPMVRMGTDLSLGQFP-ASYSISKYLVYI  749 (797)
Q Consensus       722 ~~l~~~cl~~dp~~RP-s~~~i~~~l~~i  749 (797)
                      .+++.+|++.||.+|| ++.++.+.++.+
T Consensus       245 ~~li~~~l~~dp~~R~~~~~~l~~~l~~~  273 (294)
T 4eqm_A          245 SNVILRATEKDKANRYKTIQEMKDDLSSV  273 (294)
T ss_dssp             HHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred             HHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence            7899999999999999 778888777654

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.4e-36  Score=322.63  Aligned_cols=240  Identities=20%  Similarity=0.310  Sum_probs=196.8

Q ss_pred             HhcCCCccccccccCCcceeec----------ceEEEEEEEEecc-CCcchhHHHHHHHhhhc-cCCceeEeeeeeecCC
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD----------GMEVAIKVFNLQY-GGAFKSFDIECGMMKRI-RHRNLIKIISSCSNDD  577 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~----------~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~  577 (797)
                      ..++|...+.||+|+||.||++          +..||||+++... ....+.+.+|+.+++++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            4578999999999999999975          2579999997543 33457899999999999 8999999999999999


Q ss_pred             eEEEEEEccCCCCHHHHHhcCCC----------------------CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCC
Q 040702          578 FKALVLEYMPLGSLEKCLYSGNY----------------------ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLK  635 (797)
Q Consensus       578 ~~~lv~e~~~~g~L~~~l~~~~~----------------------~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlk  635 (797)
                      ..++||||+++|+|.+++.....                      .+++..++.++.|++.||+|||   +++|+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCC
Confidence            99999999999999999976542                      3789999999999999999999   8999999999


Q ss_pred             CCceEEcCCCcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-
Q 040702          636 PSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-  713 (797)
Q Consensus       636 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-  713 (797)
                      |+||+++.++.+||+|||+++...............||+.|+|||.+.++.++.++|+|++|+..+..+. +..++... 
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            9999999999999999999987654433333445668899999999999999999999999999866553 33332221 


Q ss_pred             -----------------hhhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          714 -----------------EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       714 -----------------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                                       +......+.++++.|++.||.+||++.++++.++.+...
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  335 (344)
T 1rjb_A          280 VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD  335 (344)
T ss_dssp             CSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             cHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence                             111234567789999999999999999999999876443

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=3.7e-36  Score=351.88  Aligned_cols=246  Identities=20%  Similarity=0.190  Sum_probs=202.3

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEec---cCCcchhHHHHHHHhhhc-cCCceeEeeeeeecCCeEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQ---YGGAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDFKA  580 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~  580 (797)
                      ..++|+..+.||+|+||.||++     ++.||||++++.   .....+.+..|..++..+ +||+|+++++++.+.+..|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            4578999999999999999974     578999999864   234456788899999988 6999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCc
Q 040702          581 LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  660 (797)
Q Consensus       581 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  660 (797)
                      +||||+++|+|.+++...+ .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+....
T Consensus       419 lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             EEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            9999999999999998754 4899999999999999999999   99999999999999999999999999999986432


Q ss_pred             cCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh----------------hhhhcccccc
Q 040702          661 EDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE----------------KHLMTKEQPM  724 (797)
Q Consensus       661 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~l  724 (797)
                      ..  ......+||+.|||||.+.+..|+.++|+|++|+..++++.+..++....                ........++
T Consensus       495 ~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  572 (674)
T 3pfq_A          495 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAI  572 (674)
T ss_dssp             TT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHH
T ss_pred             CC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHH
Confidence            22  23456789999999999999999999999999999877666555443321                1223456678


Q ss_pred             hhccccCCCCCCCChHHHHHhHHHHHHHhccccccccccCCcccccceeeeeeeeec
Q 040702          725 VRMGTDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYTIS  781 (797)
Q Consensus       725 ~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~  781 (797)
                      ++.|+..||++||++.                    +..+.++++|+||++++|+..
T Consensus       573 i~~lL~~dP~~R~~~~--------------------~~~~~ei~~h~ff~~i~w~~l  609 (674)
T 3pfq_A          573 CKGLMTKHPGKRLGCG--------------------PEGERDIKEHAFFRYIDWEKL  609 (674)
T ss_dssp             HHHHSCSSSTTCTTCS--------------------TTHHHHHHSSGGGSSCCHHHH
T ss_pred             HHHHccCCHHHCCCCC--------------------CCcHHHHhcCccccCCCHHHH
Confidence            8888888888888752                    122345567888888888743

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=7.1e-36  Score=328.83  Aligned_cols=231  Identities=15%  Similarity=0.172  Sum_probs=190.4

Q ss_pred             hcCCCcccccccc--CCcceeec-----ceEEEEEEEEeccCC--cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEE
Q 040702          511 TNRFSENNLIGRG--GFGPVYKD-----GMEVAIKVFNLQYGG--AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       511 ~~~f~~~~~lg~G--~~g~Vyk~-----~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l  581 (797)
                      .++|+..+.||+|  +||.||++     ++.||||+++.....  ..+.+.+|+.++++++|||||++++++.+++..|+
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4789999999999  99999974     688999999866432  24578889999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCc
Q 040702          582 VLEYMPLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  660 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  660 (797)
                      ||||+++|+|.+++.... ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||.+.....
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            999999999999997652 35899999999999999999999   99999999999999999999999999999865432


Q ss_pred             cCcc-----ccccccccCccccccccccc--CccchHHHHHHHhhhhhhhhccccccchhh-------------------
Q 040702          661 EDQS-----LTQTQTLATIGYMAPDEIFS--GEMRLKCWVNDSLLISVMIVVDANLLIREE-------------------  714 (797)
Q Consensus       661 ~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-------------------  714 (797)
                      ....     .......||+.|+|||.+.+  ..++.++|+|++|+..+..+.+..++....                   
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT  260 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred             ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence            2111     11233479999999999987  578999999999998866655444432210                   


Q ss_pred             -------------------------------------------hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          715 -------------------------------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       715 -------------------------------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                                                 ......+.++++.|++.||++|||+.|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence                                                       112234567899999999999999999875

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=7.5e-36  Score=318.45  Aligned_cols=239  Identities=21%  Similarity=0.290  Sum_probs=199.7

Q ss_pred             hcCCCccccccccCCcceeec----------ceEEEEEEEEeccC-CcchhHHHHHHHhhhc-cCCceeEeeeeeecCCe
Q 040702          511 TNRFSENNLIGRGGFGPVYKD----------GMEVAIKVFNLQYG-GAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDF  578 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~----------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~  578 (797)
                      .++|...+.||+|+||.||++          +..||||+++.... ...+.+.+|+.+++++ +||||+++++++..++.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            468999999999999999975          37899999975532 2346789999999999 89999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCCC-----------------CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEE
Q 040702          579 KALVLEYMPLGSLEKCLYSGNY-----------------ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL  641 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~~~~-----------------~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll  641 (797)
                      .++||||+++|+|.+++.....                 .+++..++.++.|+++||+|||   +++|+||||||+||++
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEE
Confidence            9999999999999999976542                 3899999999999999999999   8999999999999999


Q ss_pred             cCCCcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-------
Q 040702          642 DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-------  713 (797)
Q Consensus       642 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-------  713 (797)
                      +.++.+||+|||+++...............||+.|+|||.+.+..++.++|+|++|+..+..+. +..++...       
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~  258 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY  258 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHH
Confidence            9999999999999987654433333345568889999999999999999999999998865553 33322211       


Q ss_pred             -----------hhhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          714 -----------EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       714 -----------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                                 +......+.++++.|++.||.+||++.|+++.|+.+...
T Consensus       259 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  308 (313)
T 1t46_A          259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (313)
T ss_dssp             HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence                       112234567899999999999999999999999887553

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=6.6e-36  Score=314.06  Aligned_cols=238  Identities=20%  Similarity=0.245  Sum_probs=196.0

Q ss_pred             HhcCCCccccccccCCcceeec----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      ..++|+..+.||+|+||.||++    +..||||+++.... ..+++.+|++++++++||||+++++++.+.+..++||||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            3578999999999999999974    57899999975532 347799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      +++|+|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++...... ..
T Consensus       101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~  176 (283)
T 3gen_A          101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YT  176 (283)
T ss_dssp             CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-HH
T ss_pred             cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccccc-cc
Confidence            9999999999875556899999999999999999999   9999999999999999999999999999998654322 12


Q ss_pred             cccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-----------------hhhhhcccccchhc
Q 040702          666 TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-----------------EKHLMTKEQPMVRM  727 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-----------------~~~~~~~~~~l~~~  727 (797)
                      ......+|+.|+|||.+....++.++|+|++|+..+..+. +..++...                 +......+.++++.
T Consensus       177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  256 (283)
T 3gen_A          177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS  256 (283)
T ss_dssp             STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHHHHH
Confidence            2334557889999999998999999999999999866553 33332211                 11123356688999


Q ss_pred             cccCCCCCCCChHHHHHhHHHHHHH
Q 040702          728 GTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                      |++.||++||++.++++.++.+.+.
T Consensus       257 ~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          257 CWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             TTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HccCChhHCcCHHHHHHHHHHHhhc
Confidence            9999999999999999999887643

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.7e-35  Score=312.54  Aligned_cols=227  Identities=21%  Similarity=0.261  Sum_probs=184.9

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCC--cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG--AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      ++|+..+.||+|+||.||++     ++.||||+++.....  ..+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57899999999999999985     688999999865432  24678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      |+++ ++.+.+......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--  155 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC--
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc--
Confidence            9976 666666655556999999999999999999999   8999999999999999999999999999998653222  


Q ss_pred             ccccccccCcccccccccccCc-cchHHHHHHHhhhhhhhhccccc-cch-hhh--------------------------
Q 040702          665 LTQTQTLATIGYMAPDEIFSGE-MRLKCWVNDSLLISVMIVVDANL-LIR-EEK--------------------------  715 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~dv~s~~~~~~~~~~~~~~-~~~-~~~--------------------------  715 (797)
                      .......||+.|+|||.+.+.. ++.++|+|++|+..+..+....+ +.. ...                          
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  235 (292)
T 3o0g_A          156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccc
Confidence            2334567899999999998766 79999999999988655532221 111 100                          


Q ss_pred             ------------------hhhcccccchhccccCCCCCCCChHHHHH
Q 040702          716 ------------------HLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       716 ------------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                        .......++++.|++.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence                              11123457899999999999999887763

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=6.1e-36  Score=336.63  Aligned_cols=189  Identities=24%  Similarity=0.343  Sum_probs=148.7

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCC--cchhHHHHHHHhhhccCCceeEeeeeeecC-----Ce
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG--AFKSFDIECGMMKRIRHRNLIKIISSCSND-----DF  578 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~-----~~  578 (797)
                      .++|+..+.||+|+||.||++     ++.||||++......  ..+.+.+|++++++++||||+++++++...     +.
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            468999999999999999975     688999999754322  346788999999999999999999998443     57


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccC
Q 040702          579 KALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  658 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  658 (797)
                      .|+||||+. |+|.+++.... .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+..
T Consensus       132 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFRTPV-YLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             EEEEECCCS-EEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             EEEEEeccc-cchhhhcccCC-CCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence            899999985 69999987654 4899999999999999999999   899999999999999999999999999999875


Q ss_pred             CccCcc-------------------------ccccccccCcccccccccc-cCccchHHHHHHHhhhhhhhh
Q 040702          659 LEEDQS-------------------------LTQTQTLATIGYMAPDEIF-SGEMRLKCWVNDSLLISVMIV  704 (797)
Q Consensus       659 ~~~~~~-------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~~dv~s~~~~~~~~~  704 (797)
                      ......                         ......+||++|||||.+. ...++.++|+|++|++.++.+
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ell  278 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL  278 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHH
Confidence            422110                         1234567899999999874 566999999999999986555

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.3e-36  Score=319.94  Aligned_cols=241  Identities=20%  Similarity=0.235  Sum_probs=190.5

Q ss_pred             hcCCCccccccccCCcceeec-----ce----EEEEEEEEecc-CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GM----EVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKA  580 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~----~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~  580 (797)
                      .++|+..+.||+|+||.||++     ++    .||+|.+.... ....+.+.+|+.++++++||||+++++++..++ .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            368999999999999999985     23    46777765442 334578999999999999999999999998765 78


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCc
Q 040702          581 LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  660 (797)
Q Consensus       581 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  660 (797)
                      +|+||+++|+|.+++......+++..++.++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++....
T Consensus        93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~  169 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence            999999999999999887667999999999999999999999   99999999999999999999999999999987654


Q ss_pred             cCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchhh-----------------hhhhcccc
Q 040702          661 EDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIREE-----------------KHLMTKEQ  722 (797)
Q Consensus       661 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~~-----------------~~~~~~~~  722 (797)
                      ...........||+.|+|||.+.+..++.++|+|++|+..+..+. +..++....                 ......+.
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  249 (327)
T 3lzb_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY  249 (327)
T ss_dssp             ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHH
T ss_pred             ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHH
Confidence            433333445567889999999999999999999999999866554 333332211                 11233567


Q ss_pred             cchhccccCCCCCCCChHHHHHhHHHHHHHhcc
Q 040702          723 PMVRMGTDLSLGQFPASYSISKYLVYIRELERG  755 (797)
Q Consensus       723 ~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~~  755 (797)
                      ++++.|++.||.+||++.|+++.++.+...+..
T Consensus       250 ~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  282 (327)
T 3lzb_A          250 MIMRKCWMIDADSRPKFRELIIEFSKMARDPQR  282 (327)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHHH
T ss_pred             HHHHHHcCCChhHCcCHHHHHHHHHHHHhCcCc
Confidence            889999999999999999999999998765443

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.8e-36  Score=324.10  Aligned_cols=240  Identities=20%  Similarity=0.307  Sum_probs=187.6

Q ss_pred             HHhcCCCccccccccCCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEE
Q 040702          509 QATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       509 ~~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l  581 (797)
                      ...++|...+.||+|+||.||++     ++.||||+++....  ...+.+.+|++++++++||||+++++++.+++..|+
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            34578999999999999999985     68999999975532  224567899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEc-----CCCcEEEEeecCCc
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD-----DNMVAHLSDFGMAK  656 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~-----~~~~~kl~DFGla~  656 (797)
                      ||||+++ +|.+++..... +++..+..++.|++.||+|||   +.+|+||||||+||+++     ..+.+||+|||+++
T Consensus       111 v~e~~~~-~L~~~~~~~~~-~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~  185 (329)
T 3gbz_A          111 IFEYAEN-DLKKYMDKNPD-VSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR  185 (329)
T ss_dssp             EEECCSE-EHHHHHHHCTT-CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred             EEecCCC-CHHHHHhhcCC-CCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence            9999975 99999987654 899999999999999999999   89999999999999994     45569999999998


Q ss_pred             cCCccCccccccccccCcccccccccccCc-cchHHHHHHHhhhhhhhhccccccchhhh-h------------------
Q 040702          657 PLLEEDQSLTQTQTLATIGYMAPDEIFSGE-MRLKCWVNDSLLISVMIVVDANLLIREEK-H------------------  716 (797)
Q Consensus       657 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~dv~s~~~~~~~~~~~~~~~~~~~~-~------------------  716 (797)
                      ......  .......||+.|+|||.+.+.. ++.++|+|++|+..+..+....++..... +                  
T Consensus       186 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  263 (329)
T 3gbz_A          186 AFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP  263 (329)
T ss_dssp             HHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             ccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhh
Confidence            653221  1234457899999999998754 89999999999988665554443322110 0                  


Q ss_pred             ---------------------------hhcccccchhccccCCCCCCCChHHHHHhHHHHHHHhccccccccccCCcccc
Q 040702          717 ---------------------------LMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVH  769 (797)
Q Consensus       717 ---------------------------~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~  769 (797)
                                                 ....+.++++.|++.||++|||+.|++                         +
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l-------------------------~  318 (329)
T 3gbz_A          264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNAL-------------------------E  318 (329)
T ss_dssp             TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHH-------------------------T
T ss_pred             hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHh-------------------------C
Confidence                                       123445789999999999999987764                         6


Q ss_pred             cceeeeeeeee
Q 040702          770 HYLYRTVDYTI  780 (797)
Q Consensus       770 ~~~f~~~~~~~  780 (797)
                      |+||++++|+.
T Consensus       319 hp~f~~~~~~P  329 (329)
T 3gbz_A          319 HPYFSHNDFDP  329 (329)
T ss_dssp             SGGGSSSCSCC
T ss_pred             CcccCCCCCCC
Confidence            89999999974

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=7.5e-36  Score=323.49  Aligned_cols=229  Identities=21%  Similarity=0.308  Sum_probs=190.5

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEecc-----CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY-----GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKA  580 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~  580 (797)
                      .++|+..+.||+|+||.||++     ++.||||+++...     ....+.+.+|+.+++.++||||+++++++.+++..|
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            467999999999999999984     6899999997542     123567899999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCc---EEEEeecC
Q 040702          581 LVLEYMPLGSLEKCLYSG---NYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV---AHLSDFGM  654 (797)
Q Consensus       581 lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~---~kl~DFGl  654 (797)
                      +||||+++|+|.+.+...   ...+++..+..++.||++||+|||   +++|+||||||+||+++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            999999999998877542   235899999999999999999999   999999999999999986654   99999999


Q ss_pred             CccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh-------------------h
Q 040702          655 AKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE-------------------K  715 (797)
Q Consensus       655 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-------------------~  715 (797)
                      ++......  ......+||+.|+|||.+.+..++.++|+|++|++.+..+.+..++....                   .
T Consensus       180 a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~~~~~~~~~  257 (351)
T 3c0i_A          180 AIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQWS  257 (351)
T ss_dssp             CEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred             eeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCCCCCccccc
Confidence            98764322  12345679999999999999999999999999998866555443332211                   1


Q ss_pred             hhhcccccchhccccCCCCCCCChHHHHH
Q 040702          716 HLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       716 ~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      .....+.++++.|+..||++||++.|+++
T Consensus       258 ~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          258 HISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            23345678999999999999999999876

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.5e-35  Score=314.47  Aligned_cols=236  Identities=18%  Similarity=0.286  Sum_probs=193.7

Q ss_pred             cCCCccccccccCCcceeec---------ceEEEEEEEEecc-CCcchhHHHHHHHhhhccCCceeEeeeeeecC--CeE
Q 040702          512 NRFSENNLIGRGGFGPVYKD---------GMEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLIKIISSCSND--DFK  579 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~---------~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~--~~~  579 (797)
                      ++|+..+.||+|+||.||++         ++.||||+++... ....+.+.+|++++++++||||+++++++...  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            56899999999999999863         5899999997553 23457889999999999999999999999876  568


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCC
Q 040702          580 ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  659 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  659 (797)
                      ++||||+++|+|.+++......+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  177 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  177 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence            9999999999999999766556899999999999999999999   9999999999999999999999999999998764


Q ss_pred             ccCcc-ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccch--------------------------
Q 040702          660 EEDQS-LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIR--------------------------  712 (797)
Q Consensus       660 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~--------------------------  712 (797)
                      ..... .......||..|+|||.+.+..++.++|+|++|+..+..+....+...                          
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (302)
T 4e5w_A          178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK  257 (302)
T ss_dssp             TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH
T ss_pred             CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh
Confidence            43321 223445688899999999999999999999999987555543221100                          


Q ss_pred             ------hhhhhhcccccchhccccCCCCCCCChHHHHHhHHHHH
Q 040702          713 ------EEKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIR  750 (797)
Q Consensus       713 ------~~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~  750 (797)
                            .+......+.++++.|++.||.+||++.++++.++.+.
T Consensus       258 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          258 EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence                  01122345778999999999999999999999998763

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=4.7e-36  Score=314.83  Aligned_cols=238  Identities=22%  Similarity=0.263  Sum_probs=184.9

Q ss_pred             hcCCCccccccccCCcceeec--------ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD--------GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~--------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l  581 (797)
                      .++|+..+.||+|+||.||++        +..||||+++.... ...+.+.+|+.++++++||||+++++++. ++..|+
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            468999999999999999975        24699998865432 23467889999999999999999999984 456899


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCcc
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  661 (797)
                      ||||+++|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  169 (281)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCcc
Confidence            99999999999999877666899999999999999999999   899999999999999999999999999999866432


Q ss_pred             CccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-----------------hhhhhccccc
Q 040702          662 DQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-----------------EKHLMTKEQP  723 (797)
Q Consensus       662 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-----------------~~~~~~~~~~  723 (797)
                      .. .......+|+.|+|||.+....++.++|+|++|+..+..+. +..++...                 +......+.+
T Consensus       170 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  248 (281)
T 1mp8_A          170 TY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS  248 (281)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             cc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            21 12234457889999999998899999999999998865553 33222211                 1122335678


Q ss_pred             chhccccCCCCCCCChHHHHHhHHHHHHHh
Q 040702          724 MVRMGTDLSLGQFPASYSISKYLVYIRELE  753 (797)
Q Consensus       724 l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~  753 (797)
                      +++.|++.||++||++.++++.++.+.+..
T Consensus       249 li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  278 (281)
T 1mp8_A          249 LMTKCWAYDPSRRPRFTELKAQLSTILEEE  278 (281)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            899999999999999999999999886654

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.5e-35  Score=314.21  Aligned_cols=234  Identities=23%  Similarity=0.285  Sum_probs=186.2

Q ss_pred             hcCCCccccccccCCcceeec---ceEEEEEEEEeccCCcchhHHHHHHHhhh--ccCCceeEeeeeeec----CCeEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD---GMEVAIKVFNLQYGGAFKSFDIECGMMKR--IRHRNLIKIISSCSN----DDFKAL  581 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~---~~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~Hpniv~l~~~~~~----~~~~~l  581 (797)
                      .++|+..+.||+|+||.||++   ++.||||++...   ..+.+..|.+++..  ++||||+++++++..    ....|+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~l   83 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL   83 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEE
Confidence            468999999999999999986   689999998644   23556677777766  789999999998654    346899


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcc-----CCCCeEEcCCCCCceEEcCCCcEEEEeecCCc
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFG-----YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  656 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~-----~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  656 (797)
                      ||||+++|+|.++++..  .+++..+..++.|++.||+|||..     ++++|+||||||+||+++.++.+||+|||+|+
T Consensus        84 v~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  161 (301)
T 3q4u_A           84 ITHYHEMGSLYDYLQLT--TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV  161 (301)
T ss_dssp             EECCCTTCBHHHHHTTC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ehhhccCCCHHHHHhhc--ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCee
Confidence            99999999999999654  489999999999999999999932     26799999999999999999999999999997


Q ss_pred             cCCccCcc--ccccccccCcccccccccccC------ccchHHHHHHHhhhhhhhhcc----------ccccch------
Q 040702          657 PLLEEDQS--LTQTQTLATIGYMAPDEIFSG------EMRLKCWVNDSLLISVMIVVD----------ANLLIR------  712 (797)
Q Consensus       657 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~dv~s~~~~~~~~~~~----------~~~~~~------  712 (797)
                      ........  .......||+.|+|||.+.+.      .++.++|+|++|+..++.+.+          ..++..      
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~  241 (301)
T 3q4u_A          162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP  241 (301)
T ss_dssp             EEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             ecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCc
Confidence            65332211  112345799999999998876      567899999999988655543          111110      


Q ss_pred             ----------------------hhhhhhcccccchhccccCCCCCCCChHHHHHhHHHH
Q 040702          713 ----------------------EEKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYI  749 (797)
Q Consensus       713 ----------------------~~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i  749 (797)
                                            ........+.++++.||+.||++||++.++++.|+.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          242 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             chhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence                                  0011223467899999999999999999999998875

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.3e-35  Score=317.03  Aligned_cols=230  Identities=20%  Similarity=0.268  Sum_probs=183.7

Q ss_pred             hcCCCcc-ccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhc-cCCceeEeeeeeecCCeEEEEE
Q 040702          511 TNRFSEN-NLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       511 ~~~f~~~-~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      .+.|.+. +.||+|+||.||++     ++.||||+++.......+.+.+|++++.++ +||||+++++++.+++..|+||
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            3567774 78999999999984     689999999876655567899999999985 7999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCc---EEEEeecCCccCCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV---AHLSDFGMAKPLLE  660 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~---~kl~DFGla~~~~~  660 (797)
                      ||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.   +||+|||+++....
T Consensus        91 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  166 (316)
T 2ac3_A           91 EKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL  166 (316)
T ss_dssp             ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred             EcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence            9999999999997654 4899999999999999999999   899999999999999998766   99999999986532


Q ss_pred             cCc-----cccccccccCccccccccccc-----CccchHHHHHHHhhhhhhhhccccccchhh----------------
Q 040702          661 EDQ-----SLTQTQTLATIGYMAPDEIFS-----GEMRLKCWVNDSLLISVMIVVDANLLIREE----------------  714 (797)
Q Consensus       661 ~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------  714 (797)
                      ...     ........||+.|+|||.+..     ..++.++|+|++|+..+..+.+..++....                
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  246 (316)
T 2ac3_A          167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ  246 (316)
T ss_dssp             ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred             CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence            211     111234569999999999875     568899999999999866555444332110                


Q ss_pred             -------------------hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          715 -------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       715 -------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                         ......+.++++.|++.||++||++.|+++
T Consensus       247 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          247 NMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence                               112335678999999999999999888764

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.4e-35  Score=319.47  Aligned_cols=241  Identities=23%  Similarity=0.308  Sum_probs=199.7

Q ss_pred             hcCCCccccccccCCcceeec------------ceEEEEEEEEeccC-CcchhHHHHHHHhhhc-cCCceeEeeeeeecC
Q 040702          511 TNRFSENNLIGRGGFGPVYKD------------GMEVAIKVFNLQYG-GAFKSFDIECGMMKRI-RHRNLIKIISSCSND  576 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~------------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~  576 (797)
                      .++|...+.||+|+||.||++            +..||||+++.... ...+.+.+|+++++++ +||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            478999999999999999975            35799999875432 2346788999999999 899999999999999


Q ss_pred             CeEEEEEEccCCCCHHHHHhcCCC---------------CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEE
Q 040702          577 DFKALVLEYMPLGSLEKCLYSGNY---------------ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL  641 (797)
Q Consensus       577 ~~~~lv~e~~~~g~L~~~l~~~~~---------------~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll  641 (797)
                      +..|+||||+++|+|.+++.....               .+++..++.++.|+++||+|||   +.+|+||||||+||++
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEE
Confidence            999999999999999999976532               3889999999999999999999   8999999999999999


Q ss_pred             cCCCcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchhh------
Q 040702          642 DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIREE------  714 (797)
Q Consensus       642 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~~------  714 (797)
                      +.++.+||+|||+++...............+|+.|+|||.+.+..++.++|+|++|+..+..+. +..++....      
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~  270 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK  270 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHH
Confidence            9999999999999987654333223344567889999999999999999999999999865554 333322111      


Q ss_pred             -----------hhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHHhc
Q 040702          715 -----------KHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRELER  754 (797)
Q Consensus       715 -----------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~  754 (797)
                                 ......+.++++.|++.||.+||++.++++.|+.+.....
T Consensus       271 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          271 LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence                       1123356788999999999999999999999999877643

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=7.1e-36  Score=320.21  Aligned_cols=240  Identities=20%  Similarity=0.297  Sum_probs=183.1

Q ss_pred             HhcCCCccccccccCCcceeecc--------eEEEEEEEEecc--CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKDG--------MEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFK  579 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~~--------~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~  579 (797)
                      ..++|...+.||+|+||.||++.        ..||||+++...  ....+.+.+|++++++++||||+++++++...+..
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            45689999999999999999852        279999987652  33457899999999999999999999999877655


Q ss_pred             ------EEEEEccCCCCHHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEE
Q 040702          580 ------ALVLEYMPLGSLEKCLYSGN-----YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAH  648 (797)
Q Consensus       580 ------~lv~e~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~k  648 (797)
                            ++||||+++|+|.+++....     ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEE
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEE
Confidence                  99999999999999986432     14899999999999999999999   89999999999999999999999


Q ss_pred             EEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh--------------
Q 040702          649 LSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE--------------  713 (797)
Q Consensus       649 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~--------------  713 (797)
                      |+|||+++...............+|+.|+|||.+.+..++.++|+|++|+..+..+. +..++...              
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~  257 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR  257 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC
Confidence            999999987654433333344567889999999999999999999999999866555 33332221              


Q ss_pred             ---hhhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          714 ---EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       714 ---~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                         +......+.++++.|++.||++||++.++.+.++.+...
T Consensus       258 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~  299 (323)
T 3qup_A          258 LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH  299 (323)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence               112334577899999999999999999999999887554

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=3.2e-34  Score=308.52  Aligned_cols=287  Identities=24%  Similarity=0.296  Sum_probs=155.9

Q ss_pred             CCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCC
Q 040702           22 SLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRL  101 (797)
Q Consensus        22 ~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l  101 (797)
                      +++++++++|.         ++.+|..+.  +++++|++++|+++++.|..|.++++|++|+|++|+++ .++...|..+
T Consensus        34 ~l~~l~~~~~~---------l~~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l  101 (332)
T 2ft3_A           34 HLRVVQCSDLG---------LKAVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHEKAFSPL  101 (332)
T ss_dssp             ETTEEECCSSC---------CSSCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-EECGGGSTTC
T ss_pred             cCCEEECCCCC---------ccccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccC-ccCHhHhhCc
Confidence            46666666665         233444442  45666666666666666666666666666666666666 4444445566


Q ss_pred             CCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcC--CCCCccccccCCCCC
Q 040702          102 PNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTS--STPELSSLSSLSNCK  179 (797)
Q Consensus       102 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~--~~~~~~~~~~l~~l~  179 (797)
                      ++|++|+|++|+++ .+|..+.  ++|++|++++|+|+.+.+..|.++++|++|++++|.++.  ..+.     .|..+ 
T Consensus       102 ~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-----~~~~l-  172 (332)
T 2ft3_A          102 RKLQKLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPG-----AFDGL-  172 (332)
T ss_dssp             TTCCEEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTT-----SSCSC-
T ss_pred             CCCCEEECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcc-----cccCC-
Confidence            66666666666665 3333332  566666666666666666666666666666666666653  2221     24444 


Q ss_pred             CCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEE
Q 040702          180 YLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQL  259 (797)
Q Consensus       180 ~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  259 (797)
                      +|+.|++++|+++++.. .+.                           ++|  ++|++++|.+++..+..|..+++|+.|
T Consensus       173 ~L~~L~l~~n~l~~l~~-~~~---------------------------~~L--~~L~l~~n~i~~~~~~~l~~l~~L~~L  222 (332)
T 2ft3_A          173 KLNYLRISEAKLTGIPK-DLP---------------------------ETL--NELHLDHNKIQAIELEDLLRYSKLYRL  222 (332)
T ss_dssp             CCSCCBCCSSBCSSCCS-SSC---------------------------SSC--SCCBCCSSCCCCCCTTSSTTCTTCSCC
T ss_pred             ccCEEECcCCCCCccCc-ccc---------------------------CCC--CEEECCCCcCCccCHHHhcCCCCCCEE
Confidence            56666666666554221 111                           122  555555555555555555555566666


Q ss_pred             EccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEccCCcCCCCCCcccccc------ccccEEecc
Q 040702          260 DLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNL------NVLVQLDLS  333 (797)
Q Consensus       260 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l------~~L~~L~Ls  333 (797)
                      +|++|+++++.+..+..+++|+.|+|++|.++.+|..+..+++|+.|++++|.+++..+..|...      ..|+.|+++
T Consensus       223 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~  302 (332)
T 2ft3_A          223 GLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLF  302 (332)
T ss_dssp             BCCSSCCCCCCTTGGGGCTTCCEEECCSSCCCBCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECC
T ss_pred             ECCCCcCCcCChhHhhCCCCCCEEECCCCcCeecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEee
Confidence            66666665555555555566666666666665555555555555555555555554444444332      334444444


Q ss_pred             Ccccc--cccCccccCCcccceecccCc
Q 040702          334 MNNFS--CVIPTKIGGLKDLQYLFLEYN  359 (797)
Q Consensus       334 ~N~l~--~~~~~~~~~l~~L~~L~Ls~N  359 (797)
                      +|.+.  +..|..|..+++|+.|++++|
T Consensus       303 ~N~~~~~~~~~~~~~~l~~L~~l~l~~n  330 (332)
T 2ft3_A          303 NNPVPYWEVQPATFRCVTDRLAIQFGNY  330 (332)
T ss_dssp             SSSSCGGGSCGGGGTTBCCSTTEEC---
T ss_pred             cCcccccccCcccccccchhhhhhcccc
Confidence            44443  333444444444444444444

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.8e-35  Score=322.49  Aligned_cols=238  Identities=16%  Similarity=0.137  Sum_probs=191.8

Q ss_pred             hcCCCccccccccCCcceeec----------ceEEEEEEEEeccCC-----------cchhHHHHHHHhhhccCCceeEe
Q 040702          511 TNRFSENNLIGRGGFGPVYKD----------GMEVAIKVFNLQYGG-----------AFKSFDIECGMMKRIRHRNLIKI  569 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~----------~~~vAvK~~~~~~~~-----------~~~~~~~E~~~l~~l~Hpniv~l  569 (797)
                      .++|...+.||+|+||.||++          ++.||||++......           ....+..|+..++.++||||+++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~  113 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY  113 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence            468999999999999999986          378999998754311           11234445666777789999999


Q ss_pred             eeeeecC----CeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEc--C
Q 040702          570 ISSCSND----DFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD--D  643 (797)
Q Consensus       570 ~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~--~  643 (797)
                      ++++...    ...|+||||+ +|+|.+++......+++..+..++.||+.||+|||   +.+|+||||||+|||++  .
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESSC
T ss_pred             EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecCC
Confidence            9998764    4589999999 99999999887667999999999999999999999   89999999999999999  8


Q ss_pred             CCcEEEEeecCCccCCccCccc-----cccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh----
Q 040702          644 NMVAHLSDFGMAKPLLEEDQSL-----TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE----  714 (797)
Q Consensus       644 ~~~~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----  714 (797)
                      ++.+||+|||+|+.+.......     ......||+.|||||.+.+..++.++|+|++|+..++.+.+..++....    
T Consensus       190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~  269 (364)
T 3op5_A          190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK  269 (364)
T ss_dssp             TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred             CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence            8999999999998764332211     1234569999999999999899999999999999866665554444210    


Q ss_pred             -----------------------hhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          715 -----------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       715 -----------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                                             ......+.++++.|++.||.+||++.++.+.++.+.+.
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  330 (364)
T 3op5_A          270 YVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA  330 (364)
T ss_dssp             HHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence                                   11134567889999999999999999999999887654

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1e-35  Score=323.46  Aligned_cols=229  Identities=19%  Similarity=0.331  Sum_probs=192.1

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEeccCC--cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG--AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      ..++|...+.||+|+||.||++     +..||||++......  ..+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            3578999999999999999974     689999999865322  345788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCC---cEEEEeecCCccCC
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM---VAHLSDFGMAKPLL  659 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~---~~kl~DFGla~~~~  659 (797)
                      |||+++|+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++   .+||+|||+++...
T Consensus       107 ~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~  182 (362)
T 2bdw_A          107 FDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  182 (362)
T ss_dssp             ECCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred             EecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence            99999999999987654 4899999999999999999999   89999999999999998654   59999999998664


Q ss_pred             ccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh--------------------hhhhc
Q 040702          660 EEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE--------------------KHLMT  719 (797)
Q Consensus       660 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------------~~~~~  719 (797)
                      ...   ......||+.|+|||.+.+..++.++|+|++|+..+..+.+..++....                    .....
T Consensus       183 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  259 (362)
T 2bdw_A          183 DSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP  259 (362)
T ss_dssp             TCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCH
T ss_pred             CCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence            322   2345679999999999998899999999999999866655444332111                    12234


Q ss_pred             ccccchhccccCCCCCCCChHHHHHh
Q 040702          720 KEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       720 ~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                      .+.++++.|+..||++||++.|+++.
T Consensus       260 ~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          260 EAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            56789999999999999999998764

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.3e-35  Score=330.43  Aligned_cols=233  Identities=25%  Similarity=0.303  Sum_probs=193.8

Q ss_pred             HhcCCCccccccccCCcceeec---ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCC-eEEEEEEc
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD---GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDD-FKALVLEY  585 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~---~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~-~~~lv~e~  585 (797)
                      ..++|+..+.||+|+||.||++   ++.||||+++...  ..+.|.+|++++++++||||+++++++...+ ..|+||||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~  268 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY  268 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence            3468889999999999999985   6899999997543  4578999999999999999999999987665 79999999


Q ss_pred             cCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          586 MPLGSLEKCLYSGNY-ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      +++|+|.+++..... .+++..+..++.|+++||+|||   +++|+||||||+|||++.++.+||+|||+++.....   
T Consensus       269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---  342 (450)
T 1k9a_A          269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---  342 (450)
T ss_dssp             CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence            999999999986543 4789999999999999999999   999999999999999999999999999999854221   


Q ss_pred             ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-----------------hhhhhcccccchh
Q 040702          665 LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-----------------EKHLMTKEQPMVR  726 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-----------------~~~~~~~~~~l~~  726 (797)
                        .....+|..|+|||.+.++.++.++|+|++|+..++.+. +..++...                 +......+.++++
T Consensus       343 --~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~  420 (450)
T 1k9a_A          343 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMK  420 (450)
T ss_dssp             ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             --ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHH
Confidence              122367889999999999999999999999998865553 33222211                 1122346678899


Q ss_pred             ccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          727 MGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       727 ~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                      .||+.||++||++.++.+.|+.+...
T Consensus       421 ~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          421 NCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHcCCChhHCcCHHHHHHHHHHHHHh
Confidence            99999999999999999999887653

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.7e-35  Score=313.37  Aligned_cols=227  Identities=22%  Similarity=0.290  Sum_probs=182.9

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccC--------------------------CcchhHHHHHHHhh
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--------------------------GAFKSFDIECGMMK  559 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--------------------------~~~~~~~~E~~~l~  559 (797)
                      .++|...+.||+|+||.||++     ++.||||++.....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            468999999999999999985     68999999975431                          12367889999999


Q ss_pred             hccCCceeEeeeeeec--CCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCC
Q 040702          560 RIRHRNLIKIISSCSN--DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPS  637 (797)
Q Consensus       560 ~l~Hpniv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~  637 (797)
                      +++||||+++++++.+  .+..|+||||+++|+|.++....  .+++..+..++.|+++||+|||   +.+|+||||||+
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~  166 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK--PLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPS  166 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGG
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHH
Confidence            9999999999999986  56899999999999998765433  5899999999999999999999   899999999999


Q ss_pred             ceEEcCCCcEEEEeecCCccCCccCccccccccccCcccccccccccCc---cchHHHHHHHhhhhhhhhccccccchhh
Q 040702          638 NVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGE---MRLKCWVNDSLLISVMIVVDANLLIREE  714 (797)
Q Consensus       638 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~dv~s~~~~~~~~~~~~~~~~~~~  714 (797)
                      ||+++.++.+||+|||+++.......  ......||+.|+|||.+.+..   ++.++|+|++|+..+..+.+..++....
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  244 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER  244 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence            99999999999999999986643321  234567999999999987655   4789999999998866555443332110


Q ss_pred             ------------------hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          715 ------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       715 ------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                        ......+.++++.|++.||++||++.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          245 IMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence                              122345678999999999999999988764

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.3e-35  Score=323.73  Aligned_cols=224  Identities=20%  Similarity=0.308  Sum_probs=184.5

Q ss_pred             CccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccCCC
Q 040702          515 SENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLG  589 (797)
Q Consensus       515 ~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~g  589 (797)
                      ...+.||+|+||.||++     +..||||+++.......+.+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG  171 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            33578999999999984     6899999998765445678999999999999999999999999999999999999999


Q ss_pred             CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEE--cCCCcEEEEeecCCccCCccCccccc
Q 040702          590 SLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL--DDNMVAHLSDFGMAKPLLEEDQSLTQ  667 (797)
Q Consensus       590 ~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll--~~~~~~kl~DFGla~~~~~~~~~~~~  667 (797)
                      +|.+++......+++..+..++.||+.||+|||   +.+|+||||||+||++  +.++.+||+|||+++......   ..
T Consensus       172 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~---~~  245 (373)
T 2x4f_A          172 ELFDRIIDESYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KL  245 (373)
T ss_dssp             EEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC---BC
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc---cc
Confidence            999998776556899999999999999999999   8999999999999999  567899999999998764332   22


Q ss_pred             cccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh--------------------hhhhcccccchhc
Q 040702          668 TQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE--------------------KHLMTKEQPMVRM  727 (797)
Q Consensus       668 ~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~l~~~  727 (797)
                      ....||+.|+|||.+..+.++.++|+|++|+..++.+.+..++....                    ......+.++++.
T Consensus       246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~  325 (373)
T 2x4f_A          246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISK  325 (373)
T ss_dssp             CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHT
T ss_pred             ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHH
Confidence            34579999999999998899999999999998866555444332111                    1223456788999


Q ss_pred             cccCCCCCCCChHHHHH
Q 040702          728 GTDLSLGQFPASYSISK  744 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~  744 (797)
                      |+..||.+||++.|+++
T Consensus       326 ~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          326 LLIKEKSWRISASEALK  342 (373)
T ss_dssp             TSCSSGGGSCCHHHHHH
T ss_pred             HcCCChhhCCCHHHHhc
Confidence            99999999999999987

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=100.00  E-value=4.3e-34  Score=307.52  Aligned_cols=289  Identities=23%  Similarity=0.257  Sum_probs=188.5

Q ss_pred             CCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeee
Q 040702           77 STLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLG  156 (797)
Q Consensus        77 ~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~  156 (797)
                      .+++.+++++|.++ .+|...+   ++|++|+|++|++++..|..|.++++|++|+|++|+|+++.|.+|.++++|++|+
T Consensus        33 c~l~~l~~~~~~l~-~ip~~~~---~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  108 (332)
T 2ft3_A           33 CHLRVVQCSDLGLK-AVPKEIS---PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLY  108 (332)
T ss_dssp             EETTEEECCSSCCS-SCCSCCC---TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEE
T ss_pred             ccCCEEECCCCCcc-ccCCCCC---CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEE
Confidence            36888888888887 7887664   6888999999998887788889999999999999999988888999999999999


Q ss_pred             ccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccc--cCChhhhhhhhhHhhh
Q 040702          157 LNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISG--SIPEEINNLTNLILQL  234 (797)
Q Consensus       157 L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~--~~p~~~~~l~~L~L~~  234 (797)
                      |++|.++.++..+     +   ++|++|++++|++.++.+..|.+++ +|+.|++++|.++.  ..+..+..+ +|  ++
T Consensus       109 L~~n~l~~l~~~~-----~---~~L~~L~l~~n~i~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~~~l-~L--~~  176 (332)
T 2ft3_A          109 ISKNHLVEIPPNL-----P---SSLVELRIHDNRIRKVPKGVFSGLR-NMNCIEMGGNPLENSGFEPGAFDGL-KL--NY  176 (332)
T ss_dssp             CCSSCCCSCCSSC-----C---TTCCEEECCSSCCCCCCSGGGSSCS-SCCEEECCSCCCBGGGSCTTSSCSC-CC--SC
T ss_pred             CCCCcCCccCccc-----c---ccCCEEECCCCccCccCHhHhCCCc-cCCEEECCCCccccCCCCcccccCC-cc--CE
Confidence            9999998887653     2   6789999999999888777888887 78888888887752  445555444 33  56


Q ss_pred             cccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEccCCcCC
Q 040702          235 LSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFT  314 (797)
Q Consensus       235 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~  314 (797)
                      |++++|+++++ |..+.  ++|++|++++|++++..+..|..+++|+.|+|++|.++.+                     
T Consensus       177 L~l~~n~l~~l-~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~---------------------  232 (332)
T 2ft3_A          177 LRISEAKLTGI-PKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMI---------------------  232 (332)
T ss_dssp             CBCCSSBCSSC-CSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCC---------------------
T ss_pred             EECcCCCCCcc-Ccccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcC---------------------
Confidence            66666666542 22222  3555555555555555545555555555555555555444                     


Q ss_pred             CCCCccccccccccEEeccCcccccccCccccCCcccceecccCccccCCCChhhhc------cccCCeeeecCCcCC--
Q 040702          315 GPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGD------LISLKSLNLSNNNLS--  386 (797)
Q Consensus       315 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~------l~~L~~L~Ls~N~l~--  386 (797)
                        .+..|..+++|++|++++|+++ .+|..+..+++|+.|++++|++++..+..|..      ...|+.|++++|.+.  
T Consensus       233 --~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~  309 (332)
T 2ft3_A          233 --ENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYW  309 (332)
T ss_dssp             --CTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGG
T ss_pred             --ChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCccccc
Confidence              3344444444444444444444 33344444445555555555554443333332      245666666666665  


Q ss_pred             CCCChhhhccCCCCeEEccCCc
Q 040702          387 GTIPISLEKLLDLKDINVSFNR  408 (797)
Q Consensus       387 ~~~p~~~~~l~~L~~L~l~~N~  408 (797)
                      +..|..|..+++|+.+++++|+
T Consensus       310 ~~~~~~~~~l~~L~~l~l~~n~  331 (332)
T 2ft3_A          310 EVQPATFRCVTDRLAIQFGNYK  331 (332)
T ss_dssp             GSCGGGGTTBCCSTTEEC----
T ss_pred             ccCcccccccchhhhhhccccc
Confidence            4556666666667777666663

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.7e-35  Score=315.06  Aligned_cols=232  Identities=20%  Similarity=0.230  Sum_probs=191.7

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEecc-CCcchhHHHHHHHhhhccCCceeEeeeeeecCC--eEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDD--FKALV  582 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~--~~~lv  582 (797)
                      .++|...+.||+|+||.||++     ++.||||+++... ....+.+.+|++++++++||||+++++++...+  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            367999999999999999985     6889999997553 234567889999999999999999999988765  78999


Q ss_pred             EEccCCCCHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEE----cCCCcEEEEeecCCc
Q 040702          583 LEYMPLGSLEKCLYSGNY--ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL----DDNMVAHLSDFGMAK  656 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll----~~~~~~kl~DFGla~  656 (797)
                      |||+++|+|.+++.....  .+++..++.++.|+++||+|||   +.+|+||||||+||++    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999976443  3899999999999999999999   9999999999999999    788889999999998


Q ss_pred             cCCccCccccccccccCcccccccccc--------cCccchHHHHHHHhhhhhhhhccccccchh---------------
Q 040702          657 PLLEEDQSLTQTQTLATIGYMAPDEIF--------SGEMRLKCWVNDSLLISVMIVVDANLLIRE---------------  713 (797)
Q Consensus       657 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~---------------  713 (797)
                      ......   ......||+.|+|||.+.        +..++.++|+|++|+..++.+.+..++...               
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  241 (319)
T 4euu_A          165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (319)
T ss_dssp             ECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred             ecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence            764332   223467999999999876        577899999999999986666554443210               


Q ss_pred             ------------------------------hhhhhcccccchhccccCCCCCCCChHHHHHhHHH
Q 040702          714 ------------------------------EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVY  748 (797)
Q Consensus       714 ------------------------------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~  748 (797)
                                                    .......+.++++.|++.||++||++.|+++...+
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d  306 (319)
T 4euu_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD  306 (319)
T ss_dssp             HCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred             CCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence                                          01122355678899999999999999999987654

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=7.7e-36  Score=314.58  Aligned_cols=236  Identities=22%  Similarity=0.298  Sum_probs=182.6

Q ss_pred             hcCCCccccccccCCcceeec--ceEEEEEEEEeccCC--cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          511 TNRFSENNLIGRGGFGPVYKD--GMEVAIKVFNLQYGG--AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~--~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      .++|...+.||+|+||.||++  ...||||+++.....  ..+.+.+|+.++++++||||+++++++ ..+..++||||+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~  101 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWC  101 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECC
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEec
Confidence            468999999999999999986  467999999765432  346789999999999999999999965 445689999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccc
Q 040702          587 PLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  666 (797)
Q Consensus       587 ~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  666 (797)
                      ++++|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++..........
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  178 (289)
T 3og7_A          102 EGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ  178 (289)
T ss_dssp             CEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-------------
T ss_pred             CCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccccccccccc
Confidence            999999999776667999999999999999999999   89999999999999999999999999999986543222223


Q ss_pred             ccccccCcccccccccc---cCccchHHHHHHHhhhhhhhhccccccchhh----------------------hhhhccc
Q 040702          667 QTQTLATIGYMAPDEIF---SGEMRLKCWVNDSLLISVMIVVDANLLIREE----------------------KHLMTKE  721 (797)
Q Consensus       667 ~~~~~gt~~y~aPE~~~---~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~  721 (797)
                      .....||+.|+|||.+.   ...++.++|+|++|+..+..+.+..++....                      ......+
T Consensus       179 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  258 (289)
T 3og7_A          179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM  258 (289)
T ss_dssp             -----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHH
T ss_pred             ccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHH
Confidence            34567999999999886   5678899999999998866555444332210                      1122356


Q ss_pred             ccchhccccCCCCCCCChHHHHHhHHHHH
Q 040702          722 QPMVRMGTDLSLGQFPASYSISKYLVYIR  750 (797)
Q Consensus       722 ~~l~~~cl~~dp~~RPs~~~i~~~l~~i~  750 (797)
                      .++++.|++.||.+||++.++++.|+.+.
T Consensus       259 ~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          259 KRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             HHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            78899999999999999999999887753

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.3e-36  Score=322.61  Aligned_cols=245  Identities=19%  Similarity=0.252  Sum_probs=198.8

Q ss_pred             cCHHHHHHHhcCCCccccccccCCcceeec----------ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEee
Q 040702          502 FTYLELFQATNRFSENNLIGRGGFGPVYKD----------GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKII  570 (797)
Q Consensus       502 ~~~~~l~~~~~~f~~~~~lg~G~~g~Vyk~----------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~  570 (797)
                      +...++....++|...+.||+|+||.||++          +..||||++..... .....+.+|++++++++||||++++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            333444556789999999999999999975          46799999875432 2235688999999999999999999


Q ss_pred             eeeecCCeEEEEEEccCCCCHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEE
Q 040702          571 SSCSNDDFKALVLEYMPLGSLEKCLYSGN---------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL  641 (797)
Q Consensus       571 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll  641 (797)
                      +++.+.+..++||||+++|+|.+++....         ..+++..+..++.|++.||+|||   +++|+||||||+||++
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli  171 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMV  171 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEE
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEE
Confidence            99999999999999999999999986522         24688999999999999999999   8999999999999999


Q ss_pred             cCCCcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-------
Q 040702          642 DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-------  713 (797)
Q Consensus       642 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-------  713 (797)
                      +.++.+||+|||+++...............||+.|+|||.+.++.++.++|+|++|+..+..+. ...++...       
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  251 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR  251 (322)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred             cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHH
Confidence            9999999999999986544333233344567899999999999999999999999998865554 33322211       


Q ss_pred             ----------hhhhhcccccchhccccCCCCCCCChHHHHHhHHHH
Q 040702          714 ----------EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYI  749 (797)
Q Consensus       714 ----------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i  749 (797)
                                +......+.++++.|++.||.+||++.|+++.++.+
T Consensus       252 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~  297 (322)
T 1p4o_A          252 FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  297 (322)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence                      112233567889999999999999999999887654

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=6.5e-34  Score=305.87  Aligned_cols=290  Identities=21%  Similarity=0.237  Sum_probs=197.9

Q ss_pred             CCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccC
Q 040702           21 SSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVR  100 (797)
Q Consensus        21 ~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~  100 (797)
                      .++++++++++.+         +.+|..+.  +++++|++++|+++++.+..|.++++|++|+|++|+++ .++...|..
T Consensus        31 c~l~~l~~~~~~l---------~~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~   98 (330)
T 1xku_A           31 CHLRVVQCSDLGL---------EKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAP   98 (330)
T ss_dssp             EETTEEECTTSCC---------CSCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCC-CBCTTTTTT
T ss_pred             CCCeEEEecCCCc---------cccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCC-eeCHHHhcC
Confidence            3677788887773         34454443  46778888888887777777778888888888888887 454445567


Q ss_pred             CCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcC--CCCCccccccCCCC
Q 040702          101 LPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTS--STPELSSLSSLSNC  178 (797)
Q Consensus       101 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~--~~~~~~~~~~l~~l  178 (797)
                      +++|++|+|++|+++ .+|..+.  ++|++|++++|+|+++.+..|.++++|++|+|++|.++.  ..+.     .|.++
T Consensus        99 l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~-----~~~~l  170 (330)
T 1xku_A           99 LVKLERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENG-----AFQGM  170 (330)
T ss_dssp             CTTCCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTT-----GGGGC
T ss_pred             CCCCCEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChh-----hccCC
Confidence            788888888888777 3444443  678888888888877777777778888888888877764  2222     35667


Q ss_pred             CCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcE
Q 040702          179 KYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQ  258 (797)
Q Consensus       179 ~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  258 (797)
                      ++|++|++++|+++.+... +.   .+|                          ++|++++|++++..+..|..+++|++
T Consensus       171 ~~L~~L~l~~n~l~~l~~~-~~---~~L--------------------------~~L~l~~n~l~~~~~~~~~~l~~L~~  220 (330)
T 1xku_A          171 KKLSYIRIADTNITTIPQG-LP---PSL--------------------------TELHLDGNKITKVDAASLKGLNNLAK  220 (330)
T ss_dssp             TTCCEEECCSSCCCSCCSS-CC---TTC--------------------------SEEECTTSCCCEECTGGGTTCTTCCE
T ss_pred             CCcCEEECCCCccccCCcc-cc---ccC--------------------------CEEECCCCcCCccCHHHhcCCCCCCE
Confidence            7777777777777643221 11   133                          55666666666666677777778888


Q ss_pred             EEccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEccCCcCCCCCCcccccc------ccccEEec
Q 040702          259 LDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNL------NVLVQLDL  332 (797)
Q Consensus       259 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l------~~L~~L~L  332 (797)
                      |+|++|++++..+..+..+++|+.|+|++|.++.+|..+..+++|+.|++++|++++..+..|...      ..++.|++
T Consensus       221 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l  300 (330)
T 1xku_A          221 LGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSL  300 (330)
T ss_dssp             EECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEEC
T ss_pred             EECCCCcCceeChhhccCCCCCCEEECCCCcCccCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEe
Confidence            888888887777777777888888888888888888777777888888888888876666665432      45666666


Q ss_pred             cCccccc--ccCccccCCcccceecccCcc
Q 040702          333 SMNNFSC--VIPTKIGGLKDLQYLFLEYNR  360 (797)
Q Consensus       333 s~N~l~~--~~~~~~~~l~~L~~L~Ls~N~  360 (797)
                      ++|.+..  +.|..|..+.+++.++|++|+
T Consensus       301 ~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          301 FSNPVQYWEIQPSTFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             CSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred             ecCcccccccCccccccccceeEEEecccC
Confidence            6666643  345556666666666666653

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.3e-35  Score=316.13  Aligned_cols=229  Identities=22%  Similarity=0.260  Sum_probs=193.2

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEeccC--------CcchhHHHHHHHhhhccCCceeEeeeeeecC
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--------GAFKSFDIECGMMKRIRHRNLIKIISSCSND  576 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--------~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~  576 (797)
                      ..++|...+.||+|+||.||++     ++.||||+++....        ...+.+.+|+.++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            4578999999999999999985     68999999986532        1335678899999999999999999999999


Q ss_pred             CeEEEEEEccCCC-CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCC
Q 040702          577 DFKALVLEYMPLG-SLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMA  655 (797)
Q Consensus       577 ~~~~lv~e~~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla  655 (797)
                      +..++||||+.+| +|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  177 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSA  177 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence            9999999999777 9999998765 4899999999999999999999   899999999999999999999999999999


Q ss_pred             ccCCccCccccccccccCcccccccccccCcc-chHHHHHHHhhhhhhhhccccccchhhh----------hhhcccccc
Q 040702          656 KPLLEEDQSLTQTQTLATIGYMAPDEIFSGEM-RLKCWVNDSLLISVMIVVDANLLIREEK----------HLMTKEQPM  724 (797)
Q Consensus       656 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~dv~s~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~l  724 (797)
                      +......   ......||+.|+|||.+.+..+ +.++|+|++|+..+..+.+..++.....          .....+.++
T Consensus       178 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~l~~l  254 (335)
T 3dls_A          178 AYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSL  254 (335)
T ss_dssp             EECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTTTCCCCSSCCCHHHHHH
T ss_pred             eECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHhhccCCCcccCHHHHHH
Confidence            8664332   2334679999999999988877 8999999999998666655544433221          123356789


Q ss_pred             hhccccCCCCCCCChHHHHHh
Q 040702          725 VRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       725 ~~~cl~~dp~~RPs~~~i~~~  745 (797)
                      ++.|++.||++||++.++++.
T Consensus       255 i~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          255 VSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHC
T ss_pred             HHHHccCChhhCcCHHHHhcC
Confidence            999999999999999998864

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=4.6e-35  Score=308.29  Aligned_cols=228  Identities=25%  Similarity=0.342  Sum_probs=189.8

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCc-------chhHHHHHHHhhhccCCceeEeeeeeecCCe
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGA-------FKSFDIECGMMKRIRHRNLIKIISSCSNDDF  578 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~-------~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~  578 (797)
                      .++|+..+.||+|+||.||++     ++.||||++.......       .+.+.+|++++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            368999999999999999974     6889999987653322       267889999999999999999999997665 


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC--eEEcCCCCCceEEcCCCc-----EEEEe
Q 040702          579 KALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVP--IIHCDLKPSNVLLDDNMV-----AHLSD  651 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~--ivHrDlkp~NIll~~~~~-----~kl~D  651 (797)
                       ++||||+++|+|.+++......+++..+..++.|++.||+|||   +.+  |+||||||+||+++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             7999999999999999877667999999999999999999999   888  999999999999988776     99999


Q ss_pred             ecCCccCCccCccccccccccCccccccccc--ccCccchHHHHHHHhhhhhhhhccccccchh----------------
Q 040702          652 FGMAKPLLEEDQSLTQTQTLATIGYMAPDEI--FSGEMRLKCWVNDSLLISVMIVVDANLLIRE----------------  713 (797)
Q Consensus       652 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~----------------  713 (797)
                      ||+++....     ......||+.|+|||.+  ....++.++|+|++|+..+..+.+..++...                
T Consensus       173 fg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  247 (287)
T 4f0f_A          173 FGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL  247 (287)
T ss_dssp             CTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred             CCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence            999985422     23446799999999998  4556789999999999886665544443221                


Q ss_pred             ----hhhhhcccccchhccccCCCCCCCChHHHHHhHHH
Q 040702          714 ----EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVY  748 (797)
Q Consensus       714 ----~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~  748 (797)
                          +......+.++++.|++.||++||++.++++.|++
T Consensus       248 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          248 RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence                11223356789999999999999999999998864

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=9.6e-36  Score=318.05  Aligned_cols=249  Identities=20%  Similarity=0.272  Sum_probs=204.3

Q ss_pred             ccCHHHHHHHhcCCCccccccccCCcceeec----------ceEEEEEEEEeccCC-cchhHHHHHHHhhhc-cCCceeE
Q 040702          501 RFTYLELFQATNRFSENNLIGRGGFGPVYKD----------GMEVAIKVFNLQYGG-AFKSFDIECGMMKRI-RHRNLIK  568 (797)
Q Consensus       501 ~~~~~~l~~~~~~f~~~~~lg~G~~g~Vyk~----------~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l-~Hpniv~  568 (797)
                      .+...+.....++|...+.||+|+||.||++          ++.||||+++..... ..+.+.+|+.+++++ +||||++
T Consensus        16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~   95 (316)
T 2xir_A           16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   95 (316)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence            4555555566789999999999999999985          378999999755322 345788999999999 6999999


Q ss_pred             eeeeeecCC-eEEEEEEccCCCCHHHHHhcCCC---------------CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEc
Q 040702          569 IISSCSNDD-FKALVLEYMPLGSLEKCLYSGNY---------------ILDIFQGLNIMIDVASALEYLHFGYSVPIIHC  632 (797)
Q Consensus       569 l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~---------------~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHr  632 (797)
                      +++++...+ ..++||||+++|+|.+++.....               .+++..+..++.|+++||.|||   +.+|+||
T Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~  172 (316)
T 2xir_A           96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHR  172 (316)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred             EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccc
Confidence            999987755 58999999999999999987543               2789999999999999999999   8999999


Q ss_pred             CCCCCceEEcCCCcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccc
Q 040702          633 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLI  711 (797)
Q Consensus       633 Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~  711 (797)
                      ||||+||+++.++.+||+|||+++...............||+.|+|||.+.+..++.++|+|++|+..+..+. +..++.
T Consensus       173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~  252 (316)
T 2xir_A          173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  252 (316)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence            9999999999999999999999987654433333445678999999999999999999999999999865553 333322


Q ss_pred             hh------------------hhhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          712 RE------------------EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       712 ~~------------------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                      ..                  +......+.+++..|++.||.+||++.++++.++.+.+-
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  311 (316)
T 2xir_A          253 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  311 (316)
T ss_dssp             TCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            11                  111233567889999999999999999999999988654

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.5e-35  Score=318.32  Aligned_cols=239  Identities=19%  Similarity=0.229  Sum_probs=196.8

Q ss_pred             hcCCCccccccccCCcceeec---------ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeee--cCCeE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD---------GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS--NDDFK  579 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~---------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~--~~~~~  579 (797)
                      .++|+..+.||+|+||.||++         +..||||++........+.+.+|++++++++||||+++++++.  +.+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            368999999999999999864         4789999997665444567999999999999999999999886  45578


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCC
Q 040702          580 ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  659 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  659 (797)
                      ++||||+++|+|.+++......+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  178 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLP  178 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred             EEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence            9999999999999999875556899999999999999999999   8999999999999999999999999999998764


Q ss_pred             ccCcc-ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh------------------------
Q 040702          660 EEDQS-LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE------------------------  714 (797)
Q Consensus       660 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~------------------------  714 (797)
                      ..... .......||+.|+|||.+.+..++.++|+|++|+..+..+....++....                        
T Consensus       179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (327)
T 3lxl_A          179 LDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE  258 (327)
T ss_dssp             TTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHH
T ss_pred             cCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhh
Confidence            33221 12334568899999999999999999999999998865554333221111                        


Q ss_pred             --------hhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          715 --------KHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       715 --------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                              ......+.++++.|++.||++||++.|+++.|+.+...
T Consensus       259 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  304 (327)
T 3lxl_A          259 EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG  304 (327)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred             cccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence                    11234577899999999999999999999999887544

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.2e-35  Score=312.87  Aligned_cols=227  Identities=22%  Similarity=0.288  Sum_probs=183.3

Q ss_pred             cCCCccccccccCCcceeec----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          512 NRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      ++|...+.||+|+||.||++    ++.||||+++....  ...+.+.+|++++++++||||+++++++..++..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            57899999999999999985    68899999975532  2346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      +++ +|.+++......+++..+..++.|+++||+|||   +++|+||||||+||+++.++.+||+|||+++......  .
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--R  155 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc--c
Confidence            975 999999876566899999999999999999999   8999999999999999999999999999997653221  1


Q ss_pred             cccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccccccchhhh-----------------------------
Q 040702          666 TQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANLLIREEK-----------------------------  715 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~-----------------------------  715 (797)
                      ......||+.|+|||.+.+. .++.++|+|++|+..+..+.+..++.....                             
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence            23445789999999998764 589999999999988665554443322110                             


Q ss_pred             ----------------hhhcccccchhccccCCCCCCCChHHHHH
Q 040702          716 ----------------HLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       716 ----------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                      .......++++.|++.||++||++.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                            01122347899999999999999887753

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.3e-35  Score=314.39  Aligned_cols=227  Identities=21%  Similarity=0.230  Sum_probs=181.5

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCC--cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG--AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      ++|+..+.||+|+||.||++     ++.||||++......  ..+.+.+|++++++++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57999999999999999974     688999998655332  24567899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      |++++++.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....... 
T Consensus        83 ~~~~~~l~~~~~~~~-~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  157 (311)
T 4agu_A           83 YCDHTVLHELDRYQR-GVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD-  157 (311)
T ss_dssp             CCSEEHHHHHHHTSS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             eCCCchHHHHHhhhc-CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc-
Confidence            999999998887654 4899999999999999999999   99999999999999999999999999999986543222 


Q ss_pred             ccccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchhhh----------------------------
Q 040702          665 LTQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIREEK----------------------------  715 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~----------------------------  715 (797)
                       ......||+.|+|||.+.+ ..++.++|+|++|+..+..+.+..++.....                            
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (311)
T 4agu_A          158 -YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF  236 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred             -ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence             2344579999999999876 5679999999999987665554433221110                            


Q ss_pred             -------------------hhhcccccchhccccCCCCCCCChHHHHH
Q 040702          716 -------------------HLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       716 -------------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                         .....+.++++.|++.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence                               11123557899999999999999988874

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.3e-35  Score=309.61  Aligned_cols=229  Identities=22%  Similarity=0.306  Sum_probs=181.7

Q ss_pred             hcCCCccccccccCCcceeec---ceEEEEEEEEeccC----CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD---GMEVAIKVFNLQYG----GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~---~~~vAvK~~~~~~~----~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      .++|+..+.||+|+||.||++   +..||||+++....    ...+.+.+|+++++.++||||+++++++.+++..++||
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            368899999999999999986   68999999875532    22467889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC---eEEcCCCCCceEEcC--------CCcEEEEee
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVP---IIHCDLKPSNVLLDD--------NMVAHLSDF  652 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~---ivHrDlkp~NIll~~--------~~~~kl~DF  652 (797)
                      ||+++++|.+++...  .+++..+..++.|+++||+|||   +.+   |+||||||+||+++.        ++.+||+||
T Consensus        86 e~~~~~~L~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           86 EFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             ECCTTEEHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EcCCCCCHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            999999999998654  4899999999999999999999   777   999999999999985        678999999


Q ss_pred             cCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh------------------
Q 040702          653 GMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE------------------  714 (797)
Q Consensus       653 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~------------------  714 (797)
                      |+++......    .....||+.|+|||.+.+..++.++|+|++|+..+..+....++....                  
T Consensus       161 g~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  236 (271)
T 3dtc_A          161 GLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP  236 (271)
T ss_dssp             CC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCC
T ss_pred             Cccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCC
Confidence            9998653322    234579999999999999999999999999998866555444332211                  


Q ss_pred             hhhhcccccchhccccCCCCCCCChHHHHHhHHH
Q 040702          715 KHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVY  748 (797)
Q Consensus       715 ~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~  748 (797)
                      ......+.++++.|++.||.+||++.|+++.|+.
T Consensus       237 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          237 STCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             cccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence            1223456789999999999999999999998864

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=3.1e-35  Score=319.67  Aligned_cols=228  Identities=21%  Similarity=0.217  Sum_probs=182.3

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      .++|...+.||+|+||.||++     ++.||||++..... ..+.+.+|+.+++.++||||+++++++.+++..|+||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            468999999999999999974     68899999975432 346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCc--EEEEeecCCccCCccCc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV--AHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~--~kl~DFGla~~~~~~~~  663 (797)
                      +++|+|.+++...+ .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.  +||+|||+|+...... 
T Consensus        98 ~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~-  172 (361)
T 3uc3_A           98 ASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-  172 (361)
T ss_dssp             CCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred             CCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC-
Confidence            99999999987654 4899999999999999999999   999999999999999987765  9999999998432221 


Q ss_pred             cccccccccCcccccccccccCccchH-HHHHHHhhhhhhhhccccccchhhh----------------------hhhcc
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLK-CWVNDSLLISVMIVVDANLLIREEK----------------------HLMTK  720 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~dv~s~~~~~~~~~~~~~~~~~~~~----------------------~~~~~  720 (797)
                        ......||+.|+|||.+.+..+..+ +|+|++|+..+..+.+..++.....                      .....
T Consensus       173 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  250 (361)
T 3uc3_A          173 --QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPE  250 (361)
T ss_dssp             ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHH
T ss_pred             --CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHH
Confidence              2344679999999999988887655 8999999998666655544432111                      12335


Q ss_pred             cccchhccccCCCCCCCChHHHHHhH
Q 040702          721 EQPMVRMGTDLSLGQFPASYSISKYL  746 (797)
Q Consensus       721 ~~~l~~~cl~~dp~~RPs~~~i~~~l  746 (797)
                      +.++++.|+..||++|||+.|+++.-
T Consensus       251 ~~~li~~~L~~dP~~Rps~~ell~hp  276 (361)
T 3uc3_A          251 CCHLISRIFVADPATRISIPEIKTHS  276 (361)
T ss_dssp             HHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred             HHHHHHHHccCChhHCcCHHHHHhCc
Confidence            56899999999999999999998753

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.5e-36  Score=321.74  Aligned_cols=227  Identities=20%  Similarity=0.284  Sum_probs=180.5

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      ++|...+.||+|+||.||++     ++.||||+++.... .....+.+|++++++++||||+++++++..++..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57899999999999999985     58899999975532 2234566799999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      ++ |+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......  .
T Consensus        82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~--~  155 (324)
T 3mtl_A           82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--K  155 (324)
T ss_dssp             CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc--c
Confidence            97 5999999877667899999999999999999999   9999999999999999999999999999998553222  1


Q ss_pred             cccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchhhh-----------------------------
Q 040702          666 TQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIREEK-----------------------------  715 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~-----------------------------  715 (797)
                      ......||+.|+|||.+.+ ..++.++|+|++|+..+..+.+..++.....                             
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (324)
T 3mtl_A          156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  235 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred             ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence            2344578999999999876 5689999999999998666555443322110                             


Q ss_pred             -----------------hhhcccccchhccccCCCCCCCChHHHHH
Q 040702          716 -----------------HLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       716 -----------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                       .......++++.|++.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                             11223468999999999999999988875

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.1e-35  Score=313.31  Aligned_cols=225  Identities=20%  Similarity=0.189  Sum_probs=182.3

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCCc--chhHHHHHHHhhhc-cCCceeEeeeeeecCCeEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGA--FKSFDIECGMMKRI-RHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~--~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ++|+..++||+|+||.||++     ++.||||++.......  ...+..|+..+.++ +||||++++++|.+++..|+||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            68999999999999999984     6899999986543322  23455666666655 8999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      ||+ +|+|.+++......+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus       137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-  211 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-  211 (311)
T ss_dssp             ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred             ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC-
Confidence            999 67999988776667999999999999999999999   8999999999999999999999999999998654322 


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccc-cch--------------hhhhhhcccccchhcc
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANL-LIR--------------EEKHLMTKEQPMVRMG  728 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~-~~~--------------~~~~~~~~~~~l~~~c  728 (797)
                        ......||+.|+|||.+.+ .++.++|+|++|+..++.+.+..+ ...              ........+.++++.|
T Consensus       212 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  288 (311)
T 3p1a_A          212 --AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMM  288 (311)
T ss_dssp             -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHHTTTCCCHHHHTTSCHHHHHHHHHH
T ss_pred             --CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHhccCCCcccccCCCHHHHHHHHHH
Confidence              2344569999999998764 789999999999987665544222 111              1222345677899999


Q ss_pred             ccCCCCCCCChHHHHH
Q 040702          729 TDLSLGQFPASYSISK  744 (797)
Q Consensus       729 l~~dp~~RPs~~~i~~  744 (797)
                      ++.||++||++.|+++
T Consensus       289 L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          289 LEPDPKLRATAEALLA  304 (311)
T ss_dssp             SCSSTTTSCCHHHHHT
T ss_pred             cCCChhhCcCHHHHHh
Confidence            9999999999998874

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.7e-35  Score=329.92  Aligned_cols=189  Identities=26%  Similarity=0.360  Sum_probs=158.0

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCC--cchhHHHHHHHhhhccCCceeEeeeeeecC-----Ce
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG--AFKSFDIECGMMKRIRHRNLIKIISSCSND-----DF  578 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~-----~~  578 (797)
                      .++|...+.||+|+||.||++     ++.||||++......  ..+.+.+|++++++++||||+++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            468999999999999999985     689999999754322  346788999999999999999999999766     57


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccC
Q 040702          579 KALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  658 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  658 (797)
                      .|+||||++ |+|.+++.... .+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+..
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~~  179 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTPI-FLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI  179 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEecCC-cCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence            899999996 59999997754 4899999999999999999999   999999999999999999999999999999876


Q ss_pred             CccCcc--------------------ccccccccCccccccccc-ccCccchHHHHHHHhhhhhhhh
Q 040702          659 LEEDQS--------------------LTQTQTLATIGYMAPDEI-FSGEMRLKCWVNDSLLISVMIV  704 (797)
Q Consensus       659 ~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~dv~s~~~~~~~~~  704 (797)
                      ......                    ......+||++|+|||.+ ....++.++|+|++|++.++.+
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell  246 (432)
T 3n9x_A          180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL  246 (432)
T ss_dssp             -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHH
Confidence            432211                    123567899999999986 4566999999999999985555

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=6.2e-36  Score=322.13  Aligned_cols=241  Identities=21%  Similarity=0.304  Sum_probs=198.2

Q ss_pred             HhcCCCccccccccCCcceeecc----------eEEEEEEEEeccC-CcchhHHHHHHHhhhc-cCCceeEeeeeeecCC
Q 040702          510 ATNRFSENNLIGRGGFGPVYKDG----------MEVAIKVFNLQYG-GAFKSFDIECGMMKRI-RHRNLIKIISSCSNDD  577 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~~----------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~  577 (797)
                      ..++|...+.||+|+||.||++.          ..||||.++.... ...+.+.+|+.+++++ +||||+++++++..++
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  123 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG  123 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence            45789999999999999999852          4799999975532 2346788999999999 8999999999999999


Q ss_pred             eEEEEEEccCCCCHHHHHhcC-------------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCC
Q 040702          578 FKALVLEYMPLGSLEKCLYSG-------------NYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN  644 (797)
Q Consensus       578 ~~~lv~e~~~~g~L~~~l~~~-------------~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~  644 (797)
                      ..++||||+++|+|.+++...             ...+++..+..++.|++.||+|||   +.+|+||||||+||+++.+
T Consensus       124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~  200 (333)
T 2i1m_A          124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNG  200 (333)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGG
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECCC
Confidence            999999999999999998653             124789999999999999999999   8999999999999999999


Q ss_pred             CcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh----------
Q 040702          645 MVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE----------  713 (797)
Q Consensus       645 ~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~----------  713 (797)
                      +.+||+|||+++...............||+.|+|||.+.+..++.++|+|++|+..+..+. +..++...          
T Consensus       201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~  280 (333)
T 2i1m_A          201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV  280 (333)
T ss_dssp             GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHH
T ss_pred             CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHH
Confidence            9999999999986644433333344567889999999999999999999999999865553 33222210          


Q ss_pred             --------hhhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHHh
Q 040702          714 --------EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRELE  753 (797)
Q Consensus       714 --------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~  753 (797)
                              +......+.++++.|++.||.+||++.++++.|+.+....
T Consensus       281 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  328 (333)
T 2i1m_A          281 KDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED  328 (333)
T ss_dssp             HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence                    1112335678999999999999999999999998876543

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2e-35  Score=334.74  Aligned_cols=235  Identities=20%  Similarity=0.310  Sum_probs=196.2

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      ...+|...+.||+|+||.||++     +..||||+++... ...++|.+|+.++++++||||++++++|...+..|+|||
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence            3467889999999999999985     5889999987543 235789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          585 YMPLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      |+++|+|.+++.... ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++...... 
T Consensus       297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-  372 (495)
T 1opk_A          297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT-  372 (495)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-
T ss_pred             ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-
Confidence            999999999998643 35899999999999999999999   8999999999999999999999999999998654322 


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-----------------hhhhhcccccch
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-----------------EKHLMTKEQPMV  725 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-----------------~~~~~~~~~~l~  725 (797)
                      ........+|..|+|||.+..+.++.++|||++|+..++.+. +..++...                 +......+.+++
T Consensus       373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  452 (495)
T 1opk_A          373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM  452 (495)
T ss_dssp             EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            222334557889999999999999999999999999865554 32222211                 112234567889


Q ss_pred             hccccCCCCCCCChHHHHHhHHHH
Q 040702          726 RMGTDLSLGQFPASYSISKYLVYI  749 (797)
Q Consensus       726 ~~cl~~dp~~RPs~~~i~~~l~~i  749 (797)
                      +.||+.||++||++.++++.|+.+
T Consensus       453 ~~cl~~dP~~RPs~~el~~~L~~~  476 (495)
T 1opk_A          453 RACWQWNPSDRPSFAEIHQAFETM  476 (495)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHHcCcChhHCcCHHHHHHHHHHH
Confidence            999999999999999999888764

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=5.3e-35  Score=312.59  Aligned_cols=237  Identities=22%  Similarity=0.295  Sum_probs=194.9

Q ss_pred             CCCccccccccCCcceee---------cceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecC--CeEE
Q 040702          513 RFSENNLIGRGGFGPVYK---------DGMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSND--DFKA  580 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk---------~~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~--~~~~  580 (797)
                      .|+..+.||+|+||.||+         .++.||||+++.... ...+.+.+|++++++++||||+++++++.+.  ...+
T Consensus        32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  111 (318)
T 3lxp_A           32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ  111 (318)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred             HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence            348899999999999964         358899999975532 2346789999999999999999999999874  5789


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCc
Q 040702          581 LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  660 (797)
Q Consensus       581 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  660 (797)
                      +||||+++|+|.+++....  +++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus       112 lv~e~~~~~~L~~~l~~~~--~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  186 (318)
T 3lxp_A          112 LVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  186 (318)
T ss_dssp             EEECCCTTCBHHHHGGGSC--CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred             EEEecccCCcHHHHHhhCC--CCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCccccccccc
Confidence            9999999999999997764  899999999999999999999   89999999999999999999999999999987644


Q ss_pred             cCcc-ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh-------------------------
Q 040702          661 EDQS-LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE-------------------------  714 (797)
Q Consensus       661 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-------------------------  714 (797)
                      .... .......||..|+|||.+.+..++.++|+|++|+..+..+....++....                         
T Consensus       187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (318)
T 3lxp_A          187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER  266 (318)
T ss_dssp             TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHT
T ss_pred             cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhc
Confidence            3221 12344568889999999999999999999999999866555433322111                         


Q ss_pred             -------hhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHHhc
Q 040702          715 -------KHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRELER  754 (797)
Q Consensus       715 -------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~  754 (797)
                             ......+.++++.|++.||++||++.|+++.|+.+.+-..
T Consensus       267 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  313 (318)
T 3lxp_A          267 GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ  313 (318)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence                   1123457789999999999999999999999998876544

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.2e-35  Score=307.16  Aligned_cols=236  Identities=22%  Similarity=0.256  Sum_probs=197.9

Q ss_pred             hcCCCccccccccCCcceeec----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          511 TNRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      .++|...+.||+|+||.||++    +..||+|++..... ..+.+.+|++++++++||||+++++++.+++..++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            367899999999999999974    57899999975543 3468999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccc
Q 040702          587 PLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  666 (797)
Q Consensus       587 ~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  666 (797)
                      ++|+|.+++......+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++...... ...
T Consensus        86 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~~  161 (267)
T 3t9t_A           86 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTS  161 (267)
T ss_dssp             TTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HHS
T ss_pred             CCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccccc-ccc
Confidence            999999999877667899999999999999999999   9999999999999999999999999999998653321 112


Q ss_pred             ccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-----------------hhhhhcccccchhcc
Q 040702          667 QTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-----------------EKHLMTKEQPMVRMG  728 (797)
Q Consensus       667 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-----------------~~~~~~~~~~l~~~c  728 (797)
                      .....||+.|+|||.+....++.++|+|++|+..+..+. +..++...                 +......+.++++.|
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~  241 (267)
T 3t9t_A          162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC  241 (267)
T ss_dssp             TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHH
T ss_pred             cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHHHH
Confidence            234567889999999998899999999999998866554 33322211                 111233567889999


Q ss_pred             ccCCCCCCCChHHHHHhHHHHHH
Q 040702          729 TDLSLGQFPASYSISKYLVYIRE  751 (797)
Q Consensus       729 l~~dp~~RPs~~~i~~~l~~i~~  751 (797)
                      ++.||++||++.++++.|+.+.+
T Consensus       242 l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          242 WRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999999988764

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-35  Score=315.80  Aligned_cols=240  Identities=22%  Similarity=0.309  Sum_probs=190.4

Q ss_pred             cCCCccccccccCCcceeecc---------eEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKDG---------MEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~~---------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l  581 (797)
                      ++|...+.||+|+||.||++.         ..||||+++.... .....+.+|+.++++++||||+++++++...+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            467778999999999999852         3599999975432 234578899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCcc
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  661 (797)
                      ||||+++|+|.+++......+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus       124 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  200 (333)
T 1mqb_A          124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  200 (333)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence            99999999999999876667999999999999999999999   899999999999999999999999999999876433


Q ss_pred             Ccc-ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-----------------hhhhhcccc
Q 040702          662 DQS-LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-----------------EKHLMTKEQ  722 (797)
Q Consensus       662 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-----------------~~~~~~~~~  722 (797)
                      ... .......+|+.|+|||.+....++.++|+|++|+..+..+. +..++...                 +......+.
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  280 (333)
T 1mqb_A          201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIY  280 (333)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHH
T ss_pred             cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCHHHH
Confidence            211 12233456889999999998899999999999998865543 33222111                 112234567


Q ss_pred             cchhccccCCCCCCCChHHHHHhHHHHHHHhc
Q 040702          723 PMVRMGTDLSLGQFPASYSISKYLVYIRELER  754 (797)
Q Consensus       723 ~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~  754 (797)
                      ++++.||+.||.+||++.++++.++.+.....
T Consensus       281 ~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  312 (333)
T 1mqb_A          281 QLMMQCWQQERARRPKFADIVSILDKLIRAPD  312 (333)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             HHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence            88999999999999999999999988765533

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.5e-35  Score=315.15  Aligned_cols=239  Identities=20%  Similarity=0.295  Sum_probs=196.9

Q ss_pred             hcCCCccccccccCCcceeec---------ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCC--eE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD---------GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDD--FK  579 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~---------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~--~~  579 (797)
                      .++|+..+.||+|+||.||++         ++.||||++........+.+.+|++++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            357899999999999999964         5889999998665555678999999999999999999999987654  68


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCC
Q 040702          580 ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  659 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  659 (797)
                      ++||||+++|+|.+++......+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  196 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence            9999999999999999887666899999999999999999999   8999999999999999999999999999998764


Q ss_pred             ccCccc-cccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh-------------------------
Q 040702          660 EEDQSL-TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE-------------------------  713 (797)
Q Consensus       660 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~-------------------------  713 (797)
                      ...... ......+|..|+|||.+.+..++.++|+|++|+..+..+....+....                         
T Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (326)
T 2w1i_A          197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL  276 (326)
T ss_dssp             SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred             ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh
Confidence            432211 123345788899999999999999999999999875554432221110                         


Q ss_pred             --------hhhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          714 --------EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       714 --------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                              +......+.++++.|++.||++||++.++++.++.+++.
T Consensus       277 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~  323 (326)
T 2w1i_A          277 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ  323 (326)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence                    111224567899999999999999999999999988654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.9e-35  Score=318.54  Aligned_cols=226  Identities=22%  Similarity=0.284  Sum_probs=174.6

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      ..++|+..+.||+|+||.||++     ++.||||+++...  ..+.+.+|++++++++||||+++++++.+++..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            3578999999999999999984     5789999997553  34678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcC---CCcEEEEeecCCccCCcc
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD---NMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~DFGla~~~~~~  661 (797)
                      |+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.   ++.+||+|||+++.....
T Consensus       129 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  204 (349)
T 2w4o_A          129 LVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ  204 (349)
T ss_dssp             CCCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred             eCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence            999999999997654 4899999999999999999999   899999999999999975   889999999999865322


Q ss_pred             CccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh---------------------hhhhcc
Q 040702          662 DQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE---------------------KHLMTK  720 (797)
Q Consensus       662 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~---------------------~~~~~~  720 (797)
                      .   ......||+.|+|||.+.+..++.++|+|++|+..++.+.+..++....                     ......
T Consensus       205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  281 (349)
T 2w4o_A          205 V---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLN  281 (349)
T ss_dssp             -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred             c---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHH
Confidence            1   2344679999999999998899999999999998866555443322111                     112335


Q ss_pred             cccchhccccCCCCCCCChHHHHH
Q 040702          721 EQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       721 ~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      +.++++.|+..||++||++.|+++
T Consensus       282 ~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          282 AKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHccCChhhCcCHHHHhc
Confidence            667999999999999999988765

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5.7e-35  Score=327.16  Aligned_cols=228  Identities=22%  Similarity=0.292  Sum_probs=192.9

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      .++|...+.||+|+||.||++     ++.||||++....   ....+.+.+|+.+++.++||||+++++++..++..|+|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            368999999999999999975     6899999997652   23346789999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      |||+++|+|.+++...+ .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus        95 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           95 MEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             EECCSSEEHHHHTTSSS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred             EeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence            99999999999997654 4899999999999999999999   9999999999999999999999999999998654322


Q ss_pred             ccccccccccCcccccccccccCcc-chHHHHHHHhhhhhhhhccccccchh----------------hhhhhcccccch
Q 040702          663 QSLTQTQTLATIGYMAPDEIFSGEM-RLKCWVNDSLLISVMIVVDANLLIRE----------------EKHLMTKEQPMV  725 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~dv~s~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~l~  725 (797)
                         .....+||+.|+|||.+.+..+ +.++|+|++|+..+..+.+..++...                +......+.+++
T Consensus       171 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li  247 (476)
T 2y94_A          171 ---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLL  247 (476)
T ss_dssp             ---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHH
T ss_pred             ---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHHH
Confidence               2345679999999999988766 68999999999986665544433221                111234567899


Q ss_pred             hccccCCCCCCCChHHHHHh
Q 040702          726 RMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       726 ~~cl~~dp~~RPs~~~i~~~  745 (797)
                      +.|+..||++||++.|+++.
T Consensus       248 ~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          248 KHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             HHHTCSSTTTSCCHHHHHTC
T ss_pred             HHHcCCCchhCcCHHHHHhC
Confidence            99999999999999999874

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-34  Score=312.80  Aligned_cols=238  Identities=22%  Similarity=0.251  Sum_probs=187.5

Q ss_pred             HHHhcCCCccccccccCCcceeec---ceEEEEEEEEeccCCcchhHHHHHHHhhhc--cCCceeEeeeeeecC----Ce
Q 040702          508 FQATNRFSENNLIGRGGFGPVYKD---GMEVAIKVFNLQYGGAFKSFDIECGMMKRI--RHRNLIKIISSCSND----DF  578 (797)
Q Consensus       508 ~~~~~~f~~~~~lg~G~~g~Vyk~---~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l--~Hpniv~l~~~~~~~----~~  578 (797)
                      ....++|+..+.||+|+||.||++   ++.||||++....   ...+..|.+++...  +||||+++++++...    ..
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  109 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ  109 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred             cccccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence            334578999999999999999985   6899999986442   24455566666554  899999999999877    68


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCC--------CeEEcCCCCCceEEcCCCcEEEE
Q 040702          579 KALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV--------PIIHCDLKPSNVLLDDNMVAHLS  650 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~--------~ivHrDlkp~NIll~~~~~~kl~  650 (797)
                      .|+||||+++|+|.++++...  +++..++.++.|++.||+|||   +.        +|+||||||+||+++.++.+||+
T Consensus       110 ~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~  184 (337)
T 3mdy_A          110 LYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA  184 (337)
T ss_dssp             EEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred             eEEEEeccCCCcHHHHhhccC--CCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence            999999999999999997763  899999999999999999999   77        99999999999999999999999


Q ss_pred             eecCCccCCccCccc--cccccccCcccccccccccCccch------HHHHHHHhhhhhhhhccc----------cccch
Q 040702          651 DFGMAKPLLEEDQSL--TQTQTLATIGYMAPDEIFSGEMRL------KCWVNDSLLISVMIVVDA----------NLLIR  712 (797)
Q Consensus       651 DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~------~~dv~s~~~~~~~~~~~~----------~~~~~  712 (797)
                      |||+++.........  ......||+.|+|||.+.+..+..      ++|+|++|+..++.+.+.          .++..
T Consensus       185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~  264 (337)
T 3mdy_A          185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD  264 (337)
T ss_dssp             CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence            999997654332211  123457999999999987665444      499999999886555431          11110


Q ss_pred             h----------------------------hhhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHHh
Q 040702          713 E----------------------------EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRELE  753 (797)
Q Consensus       713 ~----------------------------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~  753 (797)
                      .                            .......+.++++.||+.||++||++.++++.|+.+.+..
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             hcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            0                            0122234678999999999999999999999999887653

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-34  Score=308.35  Aligned_cols=228  Identities=23%  Similarity=0.317  Sum_probs=185.2

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEeccC-----CcchhHHHHHHHhhhcc---CCceeEeeeeeecC
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG-----GAFKSFDIECGMMKRIR---HRNLIKIISSCSND  576 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~-----~~~~~~~~E~~~l~~l~---Hpniv~l~~~~~~~  576 (797)
                      .+++|+..+.||+|+||.||++     ++.||||+++....     .....+.+|+.++++++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            3679999999999999999975     58999999976532     12356788888888775   99999999999876


Q ss_pred             C-----eEEEEEEccCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEE
Q 040702          577 D-----FKALVLEYMPLGSLEKCLYSGNY-ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLS  650 (797)
Q Consensus       577 ~-----~~~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~  650 (797)
                      .     ..++||||+. |+|.+++..... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEe
Confidence            5     5899999997 599999987653 4899999999999999999999   8999999999999999999999999


Q ss_pred             eecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh---------------
Q 040702          651 DFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK---------------  715 (797)
Q Consensus       651 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~---------------  715 (797)
                      |||+++......   ......||+.|+|||.+.+..++.++|+|++|+..+..+....++.....               
T Consensus       163 Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  239 (308)
T 3g33_A          163 DFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP  239 (308)
T ss_dssp             SCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             eCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            999998653322   23456799999999999999999999999999988666555444322111               


Q ss_pred             ----------------------------hhhcccccchhccccCCCCCCCChHHHHH
Q 040702          716 ----------------------------HLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       716 ----------------------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                                  +....+.++++.|++.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence                                        11223457899999999999999988774

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2.9e-35  Score=306.83  Aligned_cols=230  Identities=17%  Similarity=0.293  Sum_probs=192.5

Q ss_pred             hcCCCccccccccCCcceeec---ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeecC--CeEEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD---GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSND--DFKALVL  583 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~---~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~--~~~~lv~  583 (797)
                      .++|...+.||+|+||.||++   +..||||+++....  ...+.+.+|+.++++++||||+++++++.+.  +..++||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            368999999999999999986   68999999986532  2345789999999999999999999999887  7889999


Q ss_pred             EccCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCC--eEEcCCCCCceEEcCCCcEEEEeecCCccCCc
Q 040702          584 EYMPLGSLEKCLYSGNY-ILDIFQGLNIMIDVASALEYLHFGYSVP--IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  660 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~al~yLH~~~~~~--ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  660 (797)
                      ||+++|+|.+++..... .+++..+..++.|+++||+|||   +.+  |+||||||+||+++.++.++|+|||++.... 
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-  164 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-  164 (271)
T ss_dssp             ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred             cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence            99999999999987654 5899999999999999999999   888  9999999999999999999999999886432 


Q ss_pred             cCccccccccccCcccccccccccCccc---hHHHHHHHhhhhhhhhccccccchh------------------hhhhhc
Q 040702          661 EDQSLTQTQTLATIGYMAPDEIFSGEMR---LKCWVNDSLLISVMIVVDANLLIRE------------------EKHLMT  719 (797)
Q Consensus       661 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~dv~s~~~~~~~~~~~~~~~~~~------------------~~~~~~  719 (797)
                            .....||+.|+|||.+.+..++   .++|+|++|+..++.+.+..++...                  +.....
T Consensus       165 ------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (271)
T 3kmu_A          165 ------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP  238 (271)
T ss_dssp             ------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCH
T ss_pred             ------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCH
Confidence                  2235689999999998876544   4899999999986655554443221                  112234


Q ss_pred             ccccchhccccCCCCCCCChHHHHHhHHHHH
Q 040702          720 KEQPMVRMGTDLSLGQFPASYSISKYLVYIR  750 (797)
Q Consensus       720 ~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~  750 (797)
                      .+.++++.|++.||++||++.++++.++.+.
T Consensus       239 ~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          239 HVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            5678999999999999999999999988764

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-35  Score=321.97  Aligned_cols=238  Identities=20%  Similarity=0.267  Sum_probs=184.5

Q ss_pred             cCCCccccccccCCcceeecc--------eEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeec-CCeEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKDG--------MEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSN-DDFKAL  581 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~~--------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~-~~~~~l  581 (797)
                      ..|...+.||+|+||.||++.        ..||||.++.... ...+++.+|+.++++++||||+++++++.. ++..++
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            356777899999999999752        4689998865432 335679999999999999999999998754 457899


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCcc
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  661 (797)
                      ||||+++|+|.+++......+++..+..++.|+++||+|||   +++|+||||||+||+++.++.+||+|||+++.....
T Consensus       169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  245 (373)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence            99999999999999877667899999999999999999999   899999999999999999999999999999865432


Q ss_pred             Ccc--ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-----------------hhhhhccc
Q 040702          662 DQS--LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-----------------EKHLMTKE  721 (797)
Q Consensus       662 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-----------------~~~~~~~~  721 (797)
                      ...  .......+|+.|+|||.+.+..++.++|+|++|+..++.+. ...++...                 +......+
T Consensus       246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l  325 (373)
T 3c1x_A          246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL  325 (373)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHH
T ss_pred             ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence            211  12234567889999999999999999999999999866554 22222111                 11123456


Q ss_pred             ccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          722 QPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       722 ~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                      .++++.||+.||++||++.|+++.|+.+...
T Consensus       326 ~~li~~cl~~dp~~RPs~~ell~~L~~i~~~  356 (373)
T 3c1x_A          326 YEVMLKCWHPKAEMRPSFSELVSRISAIFST  356 (373)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            7889999999999999999999999887554

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=5.2e-35  Score=315.33  Aligned_cols=244  Identities=24%  Similarity=0.289  Sum_probs=185.7

Q ss_pred             hcCCCccccccccCCcceeec---ceEEEEEEEEeccCCcchhHHHHHHH--hhhccCCceeEeeeeee-----cCCeEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD---GMEVAIKVFNLQYGGAFKSFDIECGM--MKRIRHRNLIKIISSCS-----NDDFKA  580 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~---~~~vAvK~~~~~~~~~~~~~~~E~~~--l~~l~Hpniv~l~~~~~-----~~~~~~  580 (797)
                      .++|+..+.||+|+||.||++   ++.||||++....   ...+..|.++  +..++||||+++++++.     .....+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~   88 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL   88 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence            478999999999999999986   6899999997543   2344445444  45689999999998543     233678


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCC---------CeEEcCCCCCceEEcCCCcEEEEe
Q 040702          581 LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV---------PIIHCDLKPSNVLLDDNMVAHLSD  651 (797)
Q Consensus       581 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~---------~ivHrDlkp~NIll~~~~~~kl~D  651 (797)
                      +||||+++|+|.+++....  .++..+..++.|+++||+|||   +.         +|+||||||+|||++.++.+||+|
T Consensus        89 lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D  163 (336)
T 3g2f_A           89 LVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD  163 (336)
T ss_dssp             EEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred             EEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEee
Confidence            9999999999999998765  588999999999999999999   77         999999999999999999999999


Q ss_pred             ecCCccCCccCc------cccccccccCccccccccccc-------CccchHHHHHHHhhhhhhhhccccc-cchhh---
Q 040702          652 FGMAKPLLEEDQ------SLTQTQTLATIGYMAPDEIFS-------GEMRLKCWVNDSLLISVMIVVDANL-LIREE---  714 (797)
Q Consensus       652 FGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~dv~s~~~~~~~~~~~~~~-~~~~~---  714 (797)
                      ||+++.+.....      ........||+.|+|||.+.+       ..++.++|+|++|+..++.+.+..+ +....   
T Consensus       164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~  243 (336)
T 3g2f_A          164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE  243 (336)
T ss_dssp             CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred             ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence            999986543211      112234579999999999876       4677899999999998655543221 11000   


Q ss_pred             --------------------------------h------hhhcccccchhccccCCCCCCCChHHHHHhHHHHHHHhccc
Q 040702          715 --------------------------------K------HLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRELERGK  756 (797)
Q Consensus       715 --------------------------------~------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~~~  756 (797)
                                                      .      .....+.++++.||+.||++|||+.|+++.|+.+.......
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~  323 (336)
T 3g2f_A          244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN  323 (336)
T ss_dssp             CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred             HHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence                                            0      01124778999999999999999999999999987765555


Q ss_pred             cccccc
Q 040702          757 VGITSV  762 (797)
Q Consensus       757 ~~~~~~  762 (797)
                      .+..+.
T Consensus       324 ~~~~~~  329 (336)
T 3g2f_A          324 KSVSPT  329 (336)
T ss_dssp             ------
T ss_pred             ccCCCc
Confidence            544433

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=5e-35  Score=319.17  Aligned_cols=237  Identities=16%  Similarity=0.178  Sum_probs=194.5

Q ss_pred             HhcCCCccccccccCCcceeec----------ceEEEEEEEEeccCCcchhHHHHHHHhhhcc---CCceeEeeeeeecC
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD----------GMEVAIKVFNLQYGGAFKSFDIECGMMKRIR---HRNLIKIISSCSND  576 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~----------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---Hpniv~l~~~~~~~  576 (797)
                      ..++|...+.||+|+||.||++          ++.||||+++..   ...++..|++++++++   |+||+++++++...
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            3578999999999999999987          478999998643   3467788888888886   99999999999999


Q ss_pred             CeEEEEEEccCCCCHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcC---------
Q 040702          577 DFKALVLEYMPLGSLEKCLYS----GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD---------  643 (797)
Q Consensus       577 ~~~~lv~e~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~---------  643 (797)
                      +..|+||||+++|+|.+++..    ....+++..++.|+.||+.||+|||   +++|+||||||+|||++.         
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~  216 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDED  216 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccccc
Confidence            999999999999999999974    2336999999999999999999999   999999999999999988         


Q ss_pred             --CCcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh------
Q 040702          644 --NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK------  715 (797)
Q Consensus       644 --~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~------  715 (797)
                        ++.+||+|||+|+.+............+||+.|||||.+.+..++.++|+|++|+..++.+.+..++.....      
T Consensus       217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~  296 (365)
T 3e7e_A          217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPE  296 (365)
T ss_dssp             --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEEEC
T ss_pred             cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCceeec
Confidence              899999999999765333333344567899999999999999999999999999998776665543322111      


Q ss_pred             ------hhhcccccchhccccCCCCCCC-ChHHHHHhHHHHHHH
Q 040702          716 ------HLMTKEQPMVRMGTDLSLGQFP-ASYSISKYLVYIREL  752 (797)
Q Consensus       716 ------~~~~~~~~l~~~cl~~dp~~RP-s~~~i~~~l~~i~~~  752 (797)
                            .......+++..|++.+|.+|| ++.++.+.++.+..-
T Consensus       297 ~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          297 GLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             SCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence                  1123456788889999999985 677788777776443

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.6e-35  Score=309.20  Aligned_cols=240  Identities=20%  Similarity=0.280  Sum_probs=194.5

Q ss_pred             HhcCCCccccccccCCcceeecc--------eEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKDG--------MEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKA  580 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~~--------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~  580 (797)
                      ..++|...+.||+|+||.||++.        ..||||.++.... ...+.+.+|+.++++++||||+++++++.++ ..|
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence            35789999999999999999852        4599999875532 2356789999999999999999999998754 568


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCc
Q 040702          581 LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  660 (797)
Q Consensus       581 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  660 (797)
                      +||||+++++|.+++......+++..+..++.|+++||+|||   +++|+||||||+||+++.++.+||+|||+++....
T Consensus        89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  165 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIED  165 (281)
T ss_dssp             EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred             EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence            999999999999999876656899999999999999999999   99999999999999999999999999999986543


Q ss_pred             cCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-----------------hhhhhcccc
Q 040702          661 EDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-----------------EKHLMTKEQ  722 (797)
Q Consensus       661 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-----------------~~~~~~~~~  722 (797)
                      ... .......+|+.|+|||.+.+..++.++|+|++|+..+..+. +..++...                 +......+.
T Consensus       166 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  244 (281)
T 3cc6_A          166 EDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLY  244 (281)
T ss_dssp             --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHHH
T ss_pred             ccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHHH
Confidence            221 12334567889999999988899999999999998866553 33332110                 111233567


Q ss_pred             cchhccccCCCCCCCChHHHHHhHHHHHHHhc
Q 040702          723 PMVRMGTDLSLGQFPASYSISKYLVYIRELER  754 (797)
Q Consensus       723 ~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~  754 (797)
                      ++++.|++.||++||++.|+++.|+.+.+..+
T Consensus       245 ~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  276 (281)
T 3cc6_A          245 TLMTRCWDYDPSDRPRFTELVCSLSDVYQMEK  276 (281)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHccCCchhCcCHHHHHHHHHHHHHhhh
Confidence            89999999999999999999999999877644

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=4.1e-35  Score=314.13  Aligned_cols=219  Identities=19%  Similarity=0.246  Sum_probs=166.2

Q ss_pred             cccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhcc-CCceeEeeeeeecCCeEEEEEEccCCCC
Q 040702          517 NNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIR-HRNLIKIISSCSNDDFKALVLEYMPLGS  590 (797)
Q Consensus       517 ~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~lv~e~~~~g~  590 (797)
                      .+.||+|+||.||++     ++.||||++...   ....+.+|+.+++.+. ||||+++++++.+++..|+||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            478999999999984     688999999754   2467788999999997 9999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCC---cEEEEeecCCccCCccCccccc
Q 040702          591 LEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM---VAHLSDFGMAKPLLEEDQSLTQ  667 (797)
Q Consensus       591 L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~---~~kl~DFGla~~~~~~~~~~~~  667 (797)
                      |.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++   .+||+|||+++.......  ..
T Consensus        93 L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~~  166 (325)
T 3kn6_A           93 LFERIKKKK-HFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PL  166 (325)
T ss_dssp             HHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred             HHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--cc
Confidence            999998765 4899999999999999999999   99999999999999998665   899999999986543222  23


Q ss_pred             cccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh---------------------------hhhhcc
Q 040702          668 TQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE---------------------------KHLMTK  720 (797)
Q Consensus       668 ~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~  720 (797)
                      ...+||+.|+|||.+.+..++.++|+|++|+..+..+.+..++....                           ......
T Consensus       167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  246 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQE  246 (325)
T ss_dssp             -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHH
T ss_pred             cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHH
Confidence            45678999999999999999999999999999866655544433211                           123445


Q ss_pred             cccchhccccCCCCCCCChHHHHH
Q 040702          721 EQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       721 ~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      +.++++.|+..||.+||++.|+++
T Consensus       247 ~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          247 AKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             HHHHHHHHCCCChhHCCCHHHHhc
Confidence            678999999999999999888754

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.2e-35  Score=310.95  Aligned_cols=233  Identities=25%  Similarity=0.335  Sum_probs=186.7

Q ss_pred             hcCCCccccccccCCcceeec---ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccC
Q 040702          511 TNRFSENNLIGRGGFGPVYKD---GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  587 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~---~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~  587 (797)
                      .++|+..+.||+|+||.||++   ++.||||.+...  ...+.+.+|++++++++||||+++++++.+  ..++||||++
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~   82 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE   82 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred             HhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence            367889999999999999985   688999998633  345789999999999999999999999874  4799999999


Q ss_pred             CCCHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCc-EEEEeecCCccCCccCcc
Q 040702          588 LGSLEKCLYSGNY--ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV-AHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       588 ~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~-~kl~DFGla~~~~~~~~~  664 (797)
                      +|+|.+++.....  .+++..++.++.|+++||+|||+.+.++|+||||||+||+++.++. +||+|||+++.....   
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence            9999999987653  4788899999999999999999322289999999999999998886 799999999754321   


Q ss_pred             ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh-------------------hhhhhcccccch
Q 040702          665 LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE-------------------EKHLMTKEQPMV  725 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~l~  725 (797)
                        .....||+.|+|||.+.+..++.++|+|++|+..++.+.+..++...                   .......+.+++
T Consensus       160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  237 (307)
T 2eva_A          160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLM  237 (307)
T ss_dssp             -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHH
T ss_pred             --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccCHHHHHHH
Confidence              23346999999999999889999999999999886665554443211                   011233567889


Q ss_pred             hccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          726 RMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       726 ~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                      +.|++.||++||++.++++.++.+.+.
T Consensus       238 ~~~l~~dp~~Rps~~ell~~L~~~~~~  264 (307)
T 2eva_A          238 TRCWSKDPSQRPSMEEIVKIMTHLMRY  264 (307)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred             HHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence            999999999999999999999887655

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=4.1e-35  Score=310.44  Aligned_cols=239  Identities=21%  Similarity=0.272  Sum_probs=193.4

Q ss_pred             hcCCCccccccccCCcceeecc--------eEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeee-cCCeEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKDG--------MEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCS-NDDFKA  580 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~~--------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~-~~~~~~  580 (797)
                      ..+|...+.||+|+||.||++.        ..||||.+..... ...+.+.+|+.++++++||||+++++++. .++..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            3578888999999999999752        3589998865432 23467889999999999999999999865 456789


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCc
Q 040702          581 LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  660 (797)
Q Consensus       581 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  660 (797)
                      +||||+++|+|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++....
T Consensus       104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            999999999999999876667899999999999999999999   99999999999999999999999999999986643


Q ss_pred             cCc--cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-----------------hhhhhcc
Q 040702          661 EDQ--SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-----------------EKHLMTK  720 (797)
Q Consensus       661 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-----------------~~~~~~~  720 (797)
                      ...  ........||+.|+|||.+.+..++.++|+|++|+..+..+. ...++...                 +......
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP  260 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHH
T ss_pred             cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHH
Confidence            321  122344568889999999999999999999999999865554 22222111                 1112335


Q ss_pred             cccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          721 EQPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       721 ~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                      +.++++.|++.||++||++.++++.++.+...
T Consensus       261 l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  292 (298)
T 3f66_A          261 LYEVMLKCWHPKAEMRPSFSELVSRISAIFST  292 (298)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            67899999999999999999999999887553

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=100.00  E-value=1.2e-33  Score=303.83  Aligned_cols=295  Identities=19%  Similarity=0.220  Sum_probs=187.8

Q ss_pred             CCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeee
Q 040702           77 STLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLG  156 (797)
Q Consensus        77 ~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~  156 (797)
                      .+++.++++++.++ .+|....   ++|++|+|++|++++..+..|.++++|++|+|++|+|+++.|.+|.++++|++|+
T Consensus        31 c~l~~l~~~~~~l~-~lp~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  106 (330)
T 1xku_A           31 CHLRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY  106 (330)
T ss_dssp             EETTEEECTTSCCC-SCCCSCC---TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred             CCCeEEEecCCCcc-ccCccCC---CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEE
Confidence            36788888888887 7776553   6888899999988877777888899999999999999988888999999999999


Q ss_pred             ccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccc--cCChhhhhhhhhHhhh
Q 040702          157 LNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISG--SIPEEINNLTNLILQL  234 (797)
Q Consensus       157 L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~--~~p~~~~~l~~L~L~~  234 (797)
                      |++|.++.++..+     +   ++|+.|++++|++.++.+..|.+++ +|+.|++++|.+..  ..+..+..+++|  ++
T Consensus       107 Ls~n~l~~l~~~~-----~---~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~~~l~~L--~~  175 (330)
T 1xku_A          107 LSKNQLKELPEKM-----P---KTLQELRVHENEITKVRKSVFNGLN-QMIVVELGTNPLKSSGIENGAFQGMKKL--SY  175 (330)
T ss_dssp             CCSSCCSBCCSSC-----C---TTCCEEECCSSCCCBBCHHHHTTCT-TCCEEECCSSCCCGGGBCTTGGGGCTTC--CE
T ss_pred             CCCCcCCccChhh-----c---ccccEEECCCCcccccCHhHhcCCc-cccEEECCCCcCCccCcChhhccCCCCc--CE
Confidence            9999998887653     2   6788999999998888777888877 78888888877753  445555555555  55


Q ss_pred             cccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCC-CCCCCCcccEEEccCCcC
Q 040702          235 LSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPS-TLWNLKDILHLNLSSNFF  313 (797)
Q Consensus       235 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~-~~~~l~~L~~L~l~~N~l  313 (797)
                      |++++|.++.+ |..+.  ++|++|++++|++++..+..|..+++|+.|+|++|.++.++. .+..+++|+.|++++|.+
T Consensus       176 L~l~~n~l~~l-~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l  252 (330)
T 1xku_A          176 IRIADTNITTI-PQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL  252 (330)
T ss_dssp             EECCSSCCCSC-CSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCC
T ss_pred             EECCCCccccC-Ccccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcC
Confidence            55555555532 22221  455555555555555555555555555555555555544433 344444555555555554


Q ss_pred             CCCCCccccccccccEEeccCcccccccCccccCCcccceecccCccccCCCChhhhccccCCeeeecCCcCCC--CCCh
Q 040702          314 TGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSG--TIPI  391 (797)
Q Consensus       314 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~  391 (797)
                      + .+|..+..+++|++|++++|+|+++.+..|....                  .......++.|++++|.+..  ..|.
T Consensus       253 ~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~------------------~~~~~~~l~~l~l~~N~~~~~~i~~~  313 (330)
T 1xku_A          253 V-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPG------------------YNTKKASYSGVSLFSNPVQYWEIQPS  313 (330)
T ss_dssp             S-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSS------------------CCTTSCCCSEEECCSSSSCGGGSCGG
T ss_pred             c-cCChhhccCCCcCEEECCCCcCCccChhhcCCcc------------------cccccccccceEeecCcccccccCcc
Confidence            4 3344444444444444444444444333332210                  00012456666666666642  4556


Q ss_pred             hhhccCCCCeEEccCCc
Q 040702          392 SLEKLLDLKDINVSFNR  408 (797)
Q Consensus       392 ~~~~l~~L~~L~l~~N~  408 (797)
                      .|..+.+++.+++++|+
T Consensus       314 ~f~~~~~l~~l~L~~N~  330 (330)
T 1xku_A          314 TFRCVYVRAAVQLGNYK  330 (330)
T ss_dssp             GGTTCCCGGGEEC----
T ss_pred             ccccccceeEEEecccC
Confidence            66666777777776664

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1e-34  Score=309.73  Aligned_cols=242  Identities=21%  Similarity=0.281  Sum_probs=185.7

Q ss_pred             HHHhcCCCccccccccCCcceeec--------ceEEEEEEEEeccCC--cchhHHHHHHHhhhccCCceeEeeeeeecCC
Q 040702          508 FQATNRFSENNLIGRGGFGPVYKD--------GMEVAIKVFNLQYGG--AFKSFDIECGMMKRIRHRNLIKIISSCSNDD  577 (797)
Q Consensus       508 ~~~~~~f~~~~~lg~G~~g~Vyk~--------~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~  577 (797)
                      ....++|...+.||+|+||.||++        +..||||+++.....  ..+.+.+|+.++++++||||+++++++...+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred             ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence            335578999999999999999974        347999998765322  3467889999999999999999999998765


Q ss_pred             -----eEEEEEEccCCCCHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcE
Q 040702          578 -----FKALVLEYMPLGSLEKCLYS-----GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVA  647 (797)
Q Consensus       578 -----~~~lv~e~~~~g~L~~~l~~-----~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~  647 (797)
                           ..++||||+++|+|.+++..     ....+++..++.++.|+++||.|||   +.+|+||||||+||+++.++.+
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~  186 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTV  186 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCE
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcE
Confidence                 35999999999999999843     2235899999999999999999999   9999999999999999999999


Q ss_pred             EEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-------------
Q 040702          648 HLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-------------  713 (797)
Q Consensus       648 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-------------  713 (797)
                      ||+|||+++...............+++.|+|||.+.+..++.++|+|++|+..+..+. +..++...             
T Consensus       187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  266 (313)
T 3brb_A          187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH  266 (313)
T ss_dssp             EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC
T ss_pred             EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC
Confidence            9999999987644333233344567889999999999999999999999998866555 33222211             


Q ss_pred             ----hhhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          714 ----EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       714 ----~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                          +......+.++++.|+..||.+||++.++++.|+.+.+.
T Consensus       267 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~  309 (313)
T 3brb_A          267 RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES  309 (313)
T ss_dssp             CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                112234577899999999999999999999999887543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.8e-35  Score=316.22  Aligned_cols=226  Identities=19%  Similarity=0.286  Sum_probs=188.0

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhc-cCCceeEeeeeeecCCeEEEEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ..++|+..+.||+|+||.||++     ++.||||+++...    ....+|++++.++ +||||+++++++.+++..|+||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT----CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc----CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            3578999999999999999974     6899999997553    3356788889888 7999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCC----CcEEEEeecCCccCC
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN----MVAHLSDFGMAKPLL  659 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~----~~~kl~DFGla~~~~  659 (797)
                      ||+++|+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+||++.+.    +.+||+|||+++...
T Consensus        96 E~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A           96 ELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             CCCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             eCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            9999999999997665 4899999999999999999999   9999999999999998533    359999999998654


Q ss_pred             ccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh-----------------------hh
Q 040702          660 EEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE-----------------------KH  716 (797)
Q Consensus       660 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-----------------------~~  716 (797)
                      ....  .....+||+.|+|||.+.+..++.++|+|++|+..+..+.+..++....                       ..
T Consensus       172 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  249 (342)
T 2qr7_A          172 AENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS  249 (342)
T ss_dssp             CTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTT
T ss_pred             CCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccccc
Confidence            3322  2345689999999999988889999999999999866665544433210                       12


Q ss_pred             hhcccccchhccccCCCCCCCChHHHHHh
Q 040702          717 LMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       717 ~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                      ....+.++++.|+..||++||++.++++.
T Consensus       250 ~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          250 VSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            23456789999999999999999998874

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.1e-34  Score=310.52  Aligned_cols=227  Identities=20%  Similarity=0.275  Sum_probs=191.7

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCC------cchhHHHHHHHhhhccCCceeEeeeeeecCCeE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG------AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFK  579 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~  579 (797)
                      .++|...+.||+|+||.||++     ++.||||+++.....      ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            467999999999999999984     688999999866432      245789999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCC----cEEEEeecCC
Q 040702          580 ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM----VAHLSDFGMA  655 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~----~~kl~DFGla  655 (797)
                      ++||||+++++|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++    .+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~  166 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKE-SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCS-CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence            99999999999999997654 4899999999999999999999   89999999999999999887    7999999999


Q ss_pred             ccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh--------------------hh
Q 040702          656 KPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE--------------------EK  715 (797)
Q Consensus       656 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~--------------------~~  715 (797)
                      +......   ......||+.|+|||.+.+..++.++|+|++|+..+..+.+..++...                    ..
T Consensus       167 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  243 (321)
T 2a2a_A          167 HEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS  243 (321)
T ss_dssp             EECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred             eecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhc
Confidence            8654322   224457999999999999889999999999999886555544433211                    11


Q ss_pred             hhhcccccchhccccCCCCCCCChHHHHH
Q 040702          716 HLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       716 ~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      .....+.++++.|+..||++||++.|+++
T Consensus       244 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          244 HTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             TCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             ccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            22335678999999999999999988875

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.6e-35  Score=306.22  Aligned_cols=242  Identities=19%  Similarity=0.222  Sum_probs=197.2

Q ss_pred             hcCCCccc-cccccCCcceeec-------ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEE
Q 040702          511 TNRFSENN-LIGRGGFGPVYKD-------GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       511 ~~~f~~~~-~lg~G~~g~Vyk~-------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l  581 (797)
                      .++|...+ .||+|+||.||++       +..||||+++.... ...+.+.+|++++++++||||+++++++ ..+..++
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l   86 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML   86 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence            35666665 9999999999974       46799999976532 2356789999999999999999999999 4556899


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCcc
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  661 (797)
                      ||||+++|+|.+++......+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  163 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  163 (287)
T ss_dssp             EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence            99999999999999776667999999999999999999999   899999999999999999999999999999876433


Q ss_pred             Ccc-ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccch-----------------hhhhhhcccc
Q 040702          662 DQS-LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIR-----------------EEKHLMTKEQ  722 (797)
Q Consensus       662 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~-----------------~~~~~~~~~~  722 (797)
                      ... .......||+.|+|||.+.+..++.++|+|++|+..+..+. +..++..                 .+......+.
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~  243 (287)
T 1u59_A          164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY  243 (287)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHHH
Confidence            221 12233457899999999988899999999999998866553 3333221                 1112334667


Q ss_pred             cchhccccCCCCCCCChHHHHHhHHHHHHHhccc
Q 040702          723 PMVRMGTDLSLGQFPASYSISKYLVYIRELERGK  756 (797)
Q Consensus       723 ~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~~~  756 (797)
                      ++++.|++.||++||++.++++.++.+..-....
T Consensus       244 ~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~  277 (287)
T 1u59_A          244 ALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK  277 (287)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence            7899999999999999999999999986654443

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.3e-35  Score=309.22  Aligned_cols=238  Identities=20%  Similarity=0.233  Sum_probs=192.3

Q ss_pred             HhcCCCccc-cccccCCcceeec-------ceEEEEEEEEeccCC--cchhHHHHHHHhhhccCCceeEeeeeeecCCeE
Q 040702          510 ATNRFSENN-LIGRGGFGPVYKD-------GMEVAIKVFNLQYGG--AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFK  579 (797)
Q Consensus       510 ~~~~f~~~~-~lg~G~~g~Vyk~-------~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~  579 (797)
                      ..++|...+ .||+|+||.||++       ++.||||+++.....  ..+++.+|+++++.++||||+++++++ ..+..
T Consensus        14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~   92 (291)
T 1xbb_A           14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW   92 (291)
T ss_dssp             CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred             cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence            346788877 9999999999986       578999999765322  246789999999999999999999999 56678


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCC
Q 040702          580 ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  659 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  659 (797)
                      ++||||+++++|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        93 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             EEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence            99999999999999998765 4899999999999999999999   8999999999999999999999999999998664


Q ss_pred             ccCcc-ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-----------------hhhhhcc
Q 040702          660 EEDQS-LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-----------------EKHLMTK  720 (797)
Q Consensus       660 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-----------------~~~~~~~  720 (797)
                      ..... .......||+.|+|||.+.+..++.++|+|++|+..+..+. +..++...                 +......
T Consensus       169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (291)
T 1xbb_A          169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPRE  248 (291)
T ss_dssp             TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence            33221 11233457789999999998899999999999998866554 33332221                 1122346


Q ss_pred             cccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          721 EQPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       721 ~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                      +.++++.|++.||.+||++.++++.|+.+-..
T Consensus       249 l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  280 (291)
T 1xbb_A          249 MYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  280 (291)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            77899999999999999999999999887544

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.9e-35  Score=331.69  Aligned_cols=235  Identities=20%  Similarity=0.263  Sum_probs=194.3

Q ss_pred             HHhcCCCccccccccCCcceeec----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          509 QATNRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       509 ~~~~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      ...++|...+.||+|+||.||++    +..||||+++... ...+.|.+|+.++++++||||+++++++. .+..|+|||
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e  262 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE  262 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred             echHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence            34578999999999999999985    5789999997543 34678999999999999999999999986 567899999


Q ss_pred             ccCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          585 YMPLGSLEKCLYSGNY-ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      |+++|+|.+++..... .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++...... 
T Consensus       263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-  338 (454)
T 1qcf_A          263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE-  338 (454)
T ss_dssp             CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-
T ss_pred             ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-
Confidence            9999999999975432 5788999999999999999999   8999999999999999999999999999998654321 


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-----------------hhhhhcccccch
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-----------------EKHLMTKEQPMV  725 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-----------------~~~~~~~~~~l~  725 (797)
                      ........+|..|+|||.+..+.++.++|||++|+..++.+. +..++...                 +......+.+++
T Consensus       339 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li  418 (454)
T 1qcf_A          339 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIM  418 (454)
T ss_dssp             HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHHH
T ss_pred             eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            112234457889999999998999999999999999866554 33332211                 112234567889


Q ss_pred             hccccCCCCCCCChHHHHHhHHHH
Q 040702          726 RMGTDLSLGQFPASYSISKYLVYI  749 (797)
Q Consensus       726 ~~cl~~dp~~RPs~~~i~~~l~~i  749 (797)
                      +.||+.||++||++.++.+.|+.+
T Consensus       419 ~~cl~~dp~~RPt~~~i~~~L~~~  442 (454)
T 1qcf_A          419 MRCWKNRPEERPTFEYIQSVLDDF  442 (454)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHHccCChhHCcCHHHHHHHHHHH
Confidence            999999999999999999888765

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=8.5e-35  Score=304.55  Aligned_cols=227  Identities=22%  Similarity=0.283  Sum_probs=191.9

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      .++|...+.||+|+||.||++     +..||+|.+........+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            468999999999999999985     578999999877666678899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEE---cCCCcEEEEeecCCccCCccC
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll---~~~~~~kl~DFGla~~~~~~~  662 (797)
                      +++++|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||++   +.++.+||+|||++.......
T Consensus        88 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~  163 (277)
T 3f3z_A           88 CTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK  163 (277)
T ss_dssp             CCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred             cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence            99999999887654 4899999999999999999999   9999999999999999   788999999999998654332


Q ss_pred             ccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh--------------------hhhhcccc
Q 040702          663 QSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE--------------------KHLMTKEQ  722 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~  722 (797)
                         ......||+.|+|||.+. +.++.++|+|++|+..+..+....++....                    ......+.
T Consensus       164 ---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (277)
T 3f3z_A          164 ---MMRTKVGTPYYVSPQVLE-GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAE  239 (277)
T ss_dssp             ---CBCCCCSCTTTCCHHHHT-TCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHH
T ss_pred             ---chhccCCCCCccChHHhc-ccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHH
Confidence               234467999999999875 458999999999998765554443322111                    02344677


Q ss_pred             cchhccccCCCCCCCChHHHHHh
Q 040702          723 PMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       723 ~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                      ++++.|++.||++||++.++++.
T Consensus       240 ~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          240 SLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             HHHHHHccCChhhCcCHHHHhcC
Confidence            89999999999999999988764

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=7.8e-35  Score=306.66  Aligned_cols=238  Identities=21%  Similarity=0.303  Sum_probs=199.2

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      ..++|...+.||+|+||.||++     +..||||++.... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            4578999999999999999985     6889999997543 345788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          585 YMPLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      |+++|+|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...... 
T Consensus        90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  165 (288)
T 3kfa_A           90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-  165 (288)
T ss_dssp             CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS-
T ss_pred             cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCc-
Confidence            999999999997643 35899999999999999999999   8999999999999999999999999999998664332 


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-----------------hhhhhcccccch
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-----------------EKHLMTKEQPMV  725 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-----------------~~~~~~~~~~l~  725 (797)
                      ........+|+.|+|||.+.+..++.++|+|++|+..+..+. +..++...                 +......+.+++
T Consensus       166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  245 (288)
T 3kfa_A          166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM  245 (288)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHHHH
Confidence            223344567889999999998999999999999999865554 33222211                 112233567899


Q ss_pred             hccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          726 RMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       726 ~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                      +.|+..||.+||++.++++.++.+...
T Consensus       246 ~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          246 RACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence            999999999999999999999887554

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=5.4e-35  Score=324.32  Aligned_cols=227  Identities=22%  Similarity=0.228  Sum_probs=178.3

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEecc--------CCcchhHHHHHHHhhhccCCceeEeeeeeecC
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY--------GGAFKSFDIECGMMKRIRHRNLIKIISSCSND  576 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~  576 (797)
                      ..++|...+.||+|+||.||++     ++.||||++....        ......+.+|+.++++++||||+++++++.. 
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence            4678999999999999999985     5899999997642        1123468899999999999999999999754 


Q ss_pred             CeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCC---cEEEEeec
Q 040702          577 DFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM---VAHLSDFG  653 (797)
Q Consensus       577 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~---~~kl~DFG  653 (797)
                      +..|+||||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++   .+||+|||
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG  287 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG  287 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSSSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCSS
T ss_pred             CceEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeecc
Confidence            45799999999999999887654 4899999999999999999999   89999999999999997544   59999999


Q ss_pred             CCccCCccCccccccccccCccccccccccc---CccchHHHHHHHhhhhhhhhccccccchh-----------------
Q 040702          654 MAKPLLEEDQSLTQTQTLATIGYMAPDEIFS---GEMRLKCWVNDSLLISVMIVVDANLLIRE-----------------  713 (797)
Q Consensus       654 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~dv~s~~~~~~~~~~~~~~~~~~-----------------  713 (797)
                      +|+......   .....+||+.|+|||.+..   ..++.++|+|++|+..+..+.+..++...                 
T Consensus       288 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~  364 (419)
T 3i6u_A          288 HSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF  364 (419)
T ss_dssp             TTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCC
T ss_pred             cceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCC
Confidence            998764322   2345679999999999863   67889999999999886655544333211                 


Q ss_pred             ----hhhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          714 ----EKHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       714 ----~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                          .......+.++++.|++.||++||++.|+++
T Consensus       365 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          365 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence                0123345678999999999999999988765

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.5e-34  Score=303.99  Aligned_cols=237  Identities=21%  Similarity=0.268  Sum_probs=191.8

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeee-ecCCeEEEEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSC-SNDDFKALVL  583 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~-~~~~~~~lv~  583 (797)
                      ..++|+..+.||+|+||.||++     ++.||||++.....  .+.+.+|+++++.++|++++..++++ ...+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            3578999999999999999975     58999998765533  36789999999999988777666655 6677889999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEE---cCCCcEEEEeecCCccCCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLE  660 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll---~~~~~~kl~DFGla~~~~~  660 (797)
                      ||+ +|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||++   +.++.+||+|||+++....
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  160 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence            999 89999999866556999999999999999999999   9999999999999999   7889999999999986643


Q ss_pred             cCcc-----ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh---------------------
Q 040702          661 EDQS-----LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE---------------------  714 (797)
Q Consensus       661 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~---------------------  714 (797)
                      ....     .......||+.|+|||.+.+..++.++|+|++|+..+..+.+..++....                     
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (296)
T 4hgt_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE  240 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred             cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh
Confidence            3221     12235679999999999999999999999999998866555444332210                     


Q ss_pred             ---hhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          715 ---KHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       715 ---~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                         ......+.++++.|++.||++||++.++++.++.+.+-
T Consensus       241 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~  281 (296)
T 4hgt_A          241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence               11244678899999999999999999999999887654

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=5.9e-35  Score=311.10  Aligned_cols=241  Identities=22%  Similarity=0.295  Sum_probs=187.3

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccC---CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG---GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      .++|...+.||+|+||.||++     +..||||+++....   ...+.+.+|+.++++++||||+++++++...+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            468999999999999999974     68999999975422   2345788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCC
Q 040702          583 LEYMPLGSLEKCLYS---GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  659 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  659 (797)
                      |||+++|+|.+++..   ....+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999999999864   2345899999999999999999999   8999999999999999999999999999998653


Q ss_pred             ccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh--------------------hhhhc
Q 040702          660 EEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE--------------------KHLMT  719 (797)
Q Consensus       660 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------------~~~~~  719 (797)
                      ....  ......||+.|+|||.+.+..++.++|+|++|+..+..+....++....                    .....
T Consensus       188 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (310)
T 2wqm_A          188 SKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSE  265 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCH
T ss_pred             CCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCH
Confidence            3221  2234579999999999999999999999999998755554433322110                    12234


Q ss_pred             ccccchhccccCCCCCCCChHHHHHhHHHHHHHhccc
Q 040702          720 KEQPMVRMGTDLSLGQFPASYSISKYLVYIRELERGK  756 (797)
Q Consensus       720 ~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~~~  756 (797)
                      .+.++++.|++.||++||++.++++.++.++....+.
T Consensus       266 ~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~  302 (310)
T 2wqm_A          266 ELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS  302 (310)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence            5778899999999999999999999999987764443

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.5e-35  Score=315.89  Aligned_cols=230  Identities=20%  Similarity=0.251  Sum_probs=183.4

Q ss_pred             hcCCCccccccccCCcceeec----ceEEEEEEEEeccCC--cchhHHHHHHHhhhccC--CceeEeeeeeecCCeEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGG--AFKSFDIECGMMKRIRH--RNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~H--pniv~l~~~~~~~~~~~lv  582 (797)
                      .++|+..+.||+|+||.||++    ++.||||++......  ..+.+.+|+.++++++|  |||+++++++..++..|+|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            357999999999999999975    688999999865432  24678899999999986  9999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      ||+ .+|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+|||++ ++.+||+|||+++......
T Consensus        88 ~e~-~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           88 MEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             ECC-CSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             EeC-CCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            995 5789999998765 4899999999999999999999   89999999999999997 5789999999998765443


Q ss_pred             ccccccccccCccccccccccc-----------CccchHHHHHHHhhhhhhhhccccccchh------------------
Q 040702          663 QSLTQTQTLATIGYMAPDEIFS-----------GEMRLKCWVNDSLLISVMIVVDANLLIRE------------------  713 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~dv~s~~~~~~~~~~~~~~~~~~------------------  713 (797)
                      .........||+.|+|||.+.+           +.++.++|+|++|+..+..+.+..++...                  
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  241 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE  241 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccC
Confidence            3333445689999999998865           67899999999999986666554443221                  


Q ss_pred             -hhhhhcccccchhccccCCCCCCCChHHHHHhH
Q 040702          714 -EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYL  746 (797)
Q Consensus       714 -~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l  746 (797)
                       +......+.++++.|++.||.+||++.|+++.-
T Consensus       242 ~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp  275 (343)
T 3dbq_A          242 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  275 (343)
T ss_dssp             CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence             011122467899999999999999999998753

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.8e-35  Score=306.00  Aligned_cols=229  Identities=22%  Similarity=0.326  Sum_probs=171.8

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      .++|...+.||+|+||.||++     ++.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            468999999999999999975     5789999997552   23346789999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      |||+++++|.+++......+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||++.......
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence            9999999999999876667899999999999999999999   8999999999999999999999999999998654222


Q ss_pred             ccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh----------------hhhhhcccccchh
Q 040702          663 QSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE----------------EKHLMTKEQPMVR  726 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~l~~  726 (797)
                      .  ......||+.|+|||.+.+..++.++|+|++|+..+..+....++...                +......+.++++
T Consensus       167 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  244 (278)
T 3cok_A          167 E--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIH  244 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHH
T ss_pred             C--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHH
Confidence            1  223457999999999999888999999999999876555444332211                1112335568899


Q ss_pred             ccccCCCCCCCChHHHHH
Q 040702          727 MGTDLSLGQFPASYSISK  744 (797)
Q Consensus       727 ~cl~~dp~~RPs~~~i~~  744 (797)
                      .|++.||++||++.++++
T Consensus       245 ~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          245 QLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             HHSCSSGGGSCCHHHHTT
T ss_pred             HHcccCHhhCCCHHHHhc
Confidence            999999999999888764

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-35  Score=308.90  Aligned_cols=237  Identities=19%  Similarity=0.231  Sum_probs=193.8

Q ss_pred             CCCccccccccCCcceeecc--------eEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeE-EEE
Q 040702          513 RFSENNLIGRGGFGPVYKDG--------MEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFK-ALV  582 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~~--------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~-~lv  582 (797)
                      .|...+.||+|+||.||++.        ..||+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            45667899999999999752        3799999865432 2346788999999999999999999999876654 999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      |||+.+|+|.+++......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus       102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            9999999999999886667899999999999999999999   8999999999999999999999999999998654332


Q ss_pred             c--cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhcc-ccccchh-----------------hhhhhcccc
Q 040702          663 Q--SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVD-ANLLIRE-----------------EKHLMTKEQ  722 (797)
Q Consensus       663 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~-~~~~~~~-----------------~~~~~~~~~  722 (797)
                      .  ........||+.|+|||.+.+..++.++|+|++|+..+..+.. ..++...                 +......+.
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  258 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLY  258 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHH
Confidence            1  1223445688999999999999999999999999988665542 2221111                 111233567


Q ss_pred             cchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          723 PMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       723 ~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                      ++++.|++.||.+||++.++++.++.+...
T Consensus       259 ~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  288 (298)
T 3pls_A          259 QVMQQCWEADPAVRPTFRVLVGEVEQIVSA  288 (298)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            899999999999999999999999887554

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3.7e-35  Score=312.81  Aligned_cols=230  Identities=17%  Similarity=0.296  Sum_probs=180.9

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCc---chhHHHHHHHhhhccCCceeEeeeeeecCC----e
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGA---FKSFDIECGMMKRIRHRNLIKIISSCSNDD----F  578 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~---~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~----~  578 (797)
                      .++|+..+.||+|+||.||++     ++.||||+++......   ...+.+|+.++++++||||+++++++...+    .
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            468999999999999999974     6899999997653322   356889999999999999999999987654    3


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccC
Q 040702          579 KALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  658 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  658 (797)
                      .|+||||+++|+|.+++.... .+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             cEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence            499999999999999997654 4899999999999999999999   899999999999999999999999999999866


Q ss_pred             CccCcc-ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh--------------------hhh
Q 040702          659 LEEDQS-LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE--------------------KHL  717 (797)
Q Consensus       659 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------------~~~  717 (797)
                      ...... .......||+.|+|||.+.+..++.++|+|++|+..+..+.+..++....                    ...
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL  246 (311)
T ss_dssp             ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTC
T ss_pred             cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCC
Confidence            433221 22344579999999999999999999999999999866665544432211                    112


Q ss_pred             hcccccchhccccCCCCCCCChHHHHH
Q 040702          718 MTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       718 ~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      ...+.++++.|++.||++||++.+++.
T Consensus       247 ~~~l~~li~~~l~~dP~~R~~~~~~l~  273 (311)
T 3ork_A          247 SADLDAVVLKALAKNPENRYQTAAEMR  273 (311)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred             CHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence            345678899999999999998766554

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=6.8e-35  Score=305.68  Aligned_cols=229  Identities=22%  Similarity=0.305  Sum_probs=189.7

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l  581 (797)
                      +.++|+..+.||+|+||.||++     +..||||++....   ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            3578999999999999999985     5789999997542   2234678899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCcc
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  661 (797)
                      ||||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++......
T Consensus        87 v~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             EECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             EEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence            999999999999987654 4899999999999999999999   999999999999999999999999999998654322


Q ss_pred             CccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh----------------hhhhcccccch
Q 040702          662 DQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE----------------KHLMTKEQPMV  725 (797)
Q Consensus       662 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~l~  725 (797)
                          ......||+.|+|||.+.+..++.++|+|++|+..+..+.+..++....                ......+.+++
T Consensus       163 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  238 (279)
T 3fdn_A          163 ----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLI  238 (279)
T ss_dssp             ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHH
T ss_pred             ----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHH
Confidence                2234579999999999998889999999999998865555444332211                11233467899


Q ss_pred             hccccCCCCCCCChHHHHHhH
Q 040702          726 RMGTDLSLGQFPASYSISKYL  746 (797)
Q Consensus       726 ~~cl~~dp~~RPs~~~i~~~l  746 (797)
                      +.|++.||.+||++.|+++.-
T Consensus       239 ~~~l~~~p~~Rps~~e~l~h~  259 (279)
T 3fdn_A          239 SRLLKHNPSQRPMLREVLEHP  259 (279)
T ss_dssp             HHHCCSSGGGSCCHHHHHHCH
T ss_pred             HHHhccChhhCCCHHHHhhCc
Confidence            999999999999999999853

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=4.3e-34  Score=302.20  Aligned_cols=236  Identities=21%  Similarity=0.269  Sum_probs=194.7

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeee-ecCCeEEEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSC-SNDDFKALVLE  584 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~-~~~~~~~lv~e  584 (797)
                      .++|...+.||+|+||.||++     ++.||||++.....  .+.+.+|+.+++.++|++++..++++ ...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            468999999999999999975     68999999875533  46789999999999988766666555 56778899999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEE---cCCCcEEEEeecCCccCCcc
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll---~~~~~~kl~DFGla~~~~~~  661 (797)
                      |+ +++|.+++......+++..+..++.|++.||+|||   +++|+||||||+||++   +.++.+||+|||+++.....
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            99 89999999865556999999999999999999999   9999999999999999   48889999999999866433


Q ss_pred             Ccc-----ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh----------------------
Q 040702          662 DQS-----LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE----------------------  714 (797)
Q Consensus       662 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------------  714 (797)
                      ...     .......||+.|+|||.+.+..++.++|+|++|+..+..+.+..++....                      
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV  241 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred             ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHH
Confidence            221     12245679999999999999999999999999999866555544432210                      


Q ss_pred             --hhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          715 --KHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       715 --~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                        ......+.++++.|++.||++||++.++.+.++.+..-
T Consensus       242 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  281 (296)
T 3uzp_A          242 LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence              12234677899999999999999999999999987655

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=5.7e-35  Score=315.77  Aligned_cols=226  Identities=25%  Similarity=0.279  Sum_probs=187.9

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCC---cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG---AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      .+.|...+.||+|+||.||++     ++.||||++......   ..+.+.+|++++++++||||+++++++..++..++|
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  132 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV  132 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence            356889999999999999974     689999999765332   235788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      |||+. |++.+++......+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++....  
T Consensus       133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--  206 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--  206 (348)
T ss_dssp             EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred             EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC--
Confidence            99997 5888888655556899999999999999999999   89999999999999999999999999999986532  


Q ss_pred             ccccccccccCcccccccccc---cCccchHHHHHHHhhhhhhhhccccccchhh------------------hhhhccc
Q 040702          663 QSLTQTQTLATIGYMAPDEIF---SGEMRLKCWVNDSLLISVMIVVDANLLIREE------------------KHLMTKE  721 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~------------------~~~~~~~  721 (797)
                          .....||+.|+|||.+.   .+.++.++|+|++|+..++.+....++....                  ......+
T Consensus       207 ----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  282 (348)
T 1u5q_A          207 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF  282 (348)
T ss_dssp             ----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHH
T ss_pred             ----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHH
Confidence                23457999999999885   5678999999999999866555444322111                  1122346


Q ss_pred             ccchhccccCCCCCCCChHHHHHhH
Q 040702          722 QPMVRMGTDLSLGQFPASYSISKYL  746 (797)
Q Consensus       722 ~~l~~~cl~~dp~~RPs~~~i~~~l  746 (797)
                      .++++.|++.||++||++.++++.-
T Consensus       283 ~~li~~~l~~dP~~Rps~~~ll~h~  307 (348)
T 1u5q_A          283 RNFVDSCLQKIPQDRPTSEVLLKHR  307 (348)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred             HHHHHHHcccChhhCcCHHHHhhCh
Confidence            6899999999999999999988643

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.8e-34  Score=322.18  Aligned_cols=236  Identities=18%  Similarity=0.217  Sum_probs=196.2

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccC-CceeEeeeeeecCCeEEEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRH-RNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H-pniv~l~~~~~~~~~~~lv~e  584 (797)
                      .++|...+.||+|+||.||++     ++.||||++.....  .+++..|+++++.++| ++|+.+..++...+..++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            368999999999999999985     68999998875543  3678999999999986 666677777788889999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEE---cCCCcEEEEeecCCccCCcc
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll---~~~~~~kl~DFGla~~~~~~  661 (797)
                      |+ +++|.+++......+++..++.|+.||+.||+|||   +++|+||||||+|||+   +.++.+||+|||+++.+...
T Consensus        84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            99 89999999876667999999999999999999999   8999999999999999   68899999999999876443


Q ss_pred             Ccc-----ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh----------------------
Q 040702          662 DQS-----LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE----------------------  714 (797)
Q Consensus       662 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------------  714 (797)
                      ...     .......||+.|+|||.+.+..++.++|||++|++.++.+.+..++....                      
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~  239 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA  239 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH
Confidence            221     12235679999999999999999999999999999866665544432210                      


Q ss_pred             --hhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          715 --KHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       715 --~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                        ......+.+++..|++.||++||++.++.+.++.+...
T Consensus       240 l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~  279 (483)
T 3sv0_A          240 LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR  279 (483)
T ss_dssp             HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence              12234677889999999999999999999999887654

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.2e-35  Score=315.42  Aligned_cols=232  Identities=24%  Similarity=0.307  Sum_probs=183.7

Q ss_pred             HHHhcCCCccccccccCCcceeec-----ceEEEEEEEEeccC-----CcchhHHHHHHHhhhccCCceeEeeeeeecCC
Q 040702          508 FQATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG-----GAFKSFDIECGMMKRIRHRNLIKIISSCSNDD  577 (797)
Q Consensus       508 ~~~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~-----~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~  577 (797)
                      ....++|...+.||+|+||.||++     ++.||||+++....     ...+.+.+|++++++++||||+++++++.+.+
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            344678999999999999999985     68899999875422     12357889999999999999999999999999


Q ss_pred             eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCcc
Q 040702          578 FKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  657 (797)
Q Consensus       578 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  657 (797)
                      ..++||||+++ +|.+++......+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence            99999999986 899998876666888999999999999999999   99999999999999999999999999999987


Q ss_pred             CCccCccccccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccccccchhh----------------------
Q 040702          658 LLEEDQSLTQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANLLIREE----------------------  714 (797)
Q Consensus       658 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------------  714 (797)
                      .....  .......||+.|+|||.+.+. .++.++|+|++|+..+..+.+..++....                      
T Consensus       162 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  239 (346)
T 1ua2_A          162 FGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPD  239 (346)
T ss_dssp             TTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSS
T ss_pred             ccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhh
Confidence            64322  223456799999999998764 48999999999998865554433322111                      


Q ss_pred             ----------------------hhhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          715 ----------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       715 ----------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                                            ......+.++++.|+..||++|||+.|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          240 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence                                  1112345679999999999999999998864

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.1e-35  Score=320.22  Aligned_cols=230  Identities=19%  Similarity=0.283  Sum_probs=177.2

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhcc-CCceeEeeeeeecCC--eE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIR-HRNLIKIISSCSNDD--FK  579 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~--~~  579 (797)
                      ..++|+..+.||+|+||.||++     ++.||||++.....  ...+.+.+|+.+++++. ||||+++++++..++  ..
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            4578999999999999999985     68999999865422  23456789999999997 999999999997554  68


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCC
Q 040702          580 ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  659 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  659 (797)
                      |+||||++ |+|.+++...  .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+...
T Consensus        87 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  160 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRAN--ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV  160 (388)
T ss_dssp             EEEEECCS-EEHHHHHHHT--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred             EEEecccC-cCHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence            99999997 5999998775  4889999999999999999999   9999999999999999999999999999998653


Q ss_pred             ccC-------------------ccccccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchhhh----
Q 040702          660 EED-------------------QSLTQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIREEK----  715 (797)
Q Consensus       660 ~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~----  715 (797)
                      ...                   ........+||++|+|||.+.+ ..++.++|+||+|++.++.+.+..++.....    
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~  240 (388)
T 3oz6_A          161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL  240 (388)
T ss_dssp             SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            211                   1112344689999999999886 6789999999999998666655443321100    


Q ss_pred             -----------------------------------------------------------hhhcccccchhccccCCCCCC
Q 040702          716 -----------------------------------------------------------HLMTKEQPMVRMGTDLSLGQF  736 (797)
Q Consensus       716 -----------------------------------------------------------~~~~~~~~l~~~cl~~dp~~R  736 (797)
                                                                                 .......++++.|+..||++|
T Consensus       241 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R  320 (388)
T 3oz6_A          241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR  320 (388)
T ss_dssp             HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence                                                                       122346689999999999999


Q ss_pred             CChHHHHHh
Q 040702          737 PASYSISKY  745 (797)
Q Consensus       737 Ps~~~i~~~  745 (797)
                      ||+.|+++.
T Consensus       321 ~t~~e~l~H  329 (388)
T 3oz6_A          321 ISANDALKH  329 (388)
T ss_dssp             CCHHHHTTS
T ss_pred             CCHHHHhCC
Confidence            999888763

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1e-34  Score=315.00  Aligned_cols=232  Identities=13%  Similarity=0.137  Sum_probs=192.4

Q ss_pred             cCCCccccccccCCcceeec-------------ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeE----------
Q 040702          512 NRFSENNLIGRGGFGPVYKD-------------GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIK----------  568 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-------------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~----------  568 (797)
                      ++|...+.||+|+||.||++             ++.||||++...     +.+.+|++++++++||||++          
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            68999999999999999975             578999998743     57889999999999999988          


Q ss_pred             -----eeeeeec-CCeEEEEEEccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEE
Q 040702          569 -----IISSCSN-DDFKALVLEYMPLGSLEKCLYSG-NYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL  641 (797)
Q Consensus       569 -----l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll  641 (797)
                           +++++.. ++..|+||||+ +|+|.+++... ...+++..++.++.|++.||+|||   +++|+||||||+||++
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl~  192 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFV  192 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEEE
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEE
Confidence                 5666665 67899999999 99999999875 236899999999999999999999   8999999999999999


Q ss_pred             cCCC--cEEEEeecCCccCCccCccc-----cccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh
Q 040702          642 DDNM--VAHLSDFGMAKPLLEEDQSL-----TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE  714 (797)
Q Consensus       642 ~~~~--~~kl~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~  714 (797)
                      +.++  .+||+|||+++.........     ......||+.|+|||.+.+..++.++|+|++|+..+..+.+..++....
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            9998  89999999998765432211     1234579999999999998899999999999999866655544433321


Q ss_pred             --h-------------------------hhhcccccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          715 --K-------------------------HLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       715 --~-------------------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                        .                         .....+.++++.|++.||++||++.++++.|+.+.+.
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  337 (352)
T 2jii_A          273 PNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQD  337 (352)
T ss_dssp             TCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHh
Confidence              0                         1134567889999999999999999999999987655

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.7e-34  Score=303.36  Aligned_cols=233  Identities=23%  Similarity=0.362  Sum_probs=192.4

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeec---------
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN---------  575 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~---------  575 (797)
                      ..++|+..+.||+|+||.||++     ++.||||+++...    +.+.+|++++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            3467999999999999999985     6899999997543    567899999999999999999998854         


Q ss_pred             -------CCeEEEEEEccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcE
Q 040702          576 -------DDFKALVLEYMPLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVA  647 (797)
Q Consensus       576 -------~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~  647 (797)
                             ....++||||+++|+|.+++.... ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCE
Confidence                   345899999999999999997542 35899999999999999999999   8999999999999999999999


Q ss_pred             EEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh------------h
Q 040702          648 HLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE------------K  715 (797)
Q Consensus       648 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~------------~  715 (797)
                      ||+|||+++......   ......||+.|+|||.+.+..++.++|+|++|+..+..+....+.....            .
T Consensus       162 kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T 2a19_B          162 KIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISD  238 (284)
T ss_dssp             EECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHHHHTTCCCT
T ss_pred             EECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHHHhhcccccc
Confidence            999999998764332   2234579999999999998899999999999998755554332221111            1


Q ss_pred             hhhcccccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          716 HLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       716 ~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                      .....+.++++.|++.||.+||++.|+++.++.++.-
T Consensus       239 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~  275 (284)
T 2a19_B          239 IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS  275 (284)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence            1223456889999999999999999999998877544

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.3e-34  Score=304.34  Aligned_cols=228  Identities=19%  Similarity=0.333  Sum_probs=191.2

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCC--cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG--AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      .++|+..+.||+|+||.||++     ++.||+|++......  ..+.+.+|+.++++++||||+++++++..++..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            478999999999999999985     689999999865432  3467889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCc---EEEEeecCCccCCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV---AHLSDFGMAKPLLE  660 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~---~kl~DFGla~~~~~  660 (797)
                      ||+++|+|.+.+.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.   +||+|||++.....
T Consensus        85 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           85 DLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             ecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            9999999988887654 4899999999999999999999   899999999999999986655   99999999976543


Q ss_pred             cCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh--------------------hhhhcc
Q 040702          661 EDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE--------------------KHLMTK  720 (797)
Q Consensus       661 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------------~~~~~~  720 (797)
                      ..   ......||+.|+|||.+.+..++.++|+|++|+..+..+.+..++....                    ......
T Consensus       161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T 3kk8_A          161 SE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPE  237 (284)
T ss_dssp             SC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred             Cc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHH
Confidence            22   2244679999999999999999999999999998865555443321111                    122345


Q ss_pred             cccchhccccCCCCCCCChHHHHHh
Q 040702          721 EQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       721 ~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                      +.++++.|++.||++||++.|+++.
T Consensus       238 ~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          238 AKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             HHHHHHHHcccChhhCCCHHHHhcC
Confidence            6789999999999999999999874

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.9e-34  Score=310.04  Aligned_cols=220  Identities=16%  Similarity=0.239  Sum_probs=182.6

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhcc-CCceeEeeeeeec--CCeEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIR-HRNLIKIISSCSN--DDFKALV  582 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~--~~~~~lv  582 (797)
                      .++|+..+.||+|+||.||++     ++.||||+++..   ..+.+.+|++++++++ ||||+++++++.+  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            368999999999999999985     589999998633   3477899999999997 9999999999987  5678999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCC-cEEEEeecCCccCCcc
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM-VAHLSDFGMAKPLLEE  661 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DFGla~~~~~~  661 (797)
                      |||+++++|.+++..    +++..+..++.|++.||+|||   +.+|+||||||+||+++.++ .+||+|||+|+.....
T Consensus       112 ~e~~~~~~l~~~~~~----~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             EECCCCCCHHHHGGG----CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             EeccCchhHHHHHHh----CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            999999999998853    788899999999999999999   99999999999999999776 8999999999865433


Q ss_pred             CccccccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccch--h-------------------------
Q 040702          662 DQSLTQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIR--E-------------------------  713 (797)
Q Consensus       662 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~--~-------------------------  713 (797)
                      .   ......||+.|+|||.+.+ ..++.++|+|++|+..+..+.+..++..  .                         
T Consensus       185 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  261 (330)
T 3nsz_A          185 Q---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  261 (330)
T ss_dssp             C---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             C---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence            2   2344579999999999877 6689999999999988665554433210  0                         


Q ss_pred             ---------------------------hhhhhcccccchhccccCCCCCCCChHHHH
Q 040702          714 ---------------------------EKHLMTKEQPMVRMGTDLSLGQFPASYSIS  743 (797)
Q Consensus       714 ---------------------------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~  743 (797)
                                                 .......+.++++.|++.||++|||+.|++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l  318 (330)
T 3nsz_A          262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM  318 (330)
T ss_dssp             CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred             cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHh
Confidence                                       000234566799999999999999987775

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.6e-35  Score=320.61  Aligned_cols=234  Identities=21%  Similarity=0.234  Sum_probs=192.7

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEecc-CCcchhHHHHHHHhhhccCCceeEeeeeeecCC--eEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDD--FKALV  582 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~--~~~lv  582 (797)
                      .++|...+.||+|+||.||++     ++.||||+++... ....+.+.+|++++++++||||+++++++...+  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            367999999999999999985     6899999997543 234567889999999999999999999998765  78999


Q ss_pred             EEccCCCCHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEE----cCCCcEEEEeecCCc
Q 040702          583 LEYMPLGSLEKCLYSGNY--ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL----DDNMVAHLSDFGMAK  656 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll----~~~~~~kl~DFGla~  656 (797)
                      |||+++|+|.+++.....  .+++..++.++.|++.||+|||   +.+|+||||||+||++    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999976432  3899999999999999999999   9999999999999999    778889999999998


Q ss_pred             cCCccCccccccccccCccccccccccc--------CccchHHHHHHHhhhhhhhhccccccchhh--------------
Q 040702          657 PLLEEDQSLTQTQTLATIGYMAPDEIFS--------GEMRLKCWVNDSLLISVMIVVDANLLIREE--------------  714 (797)
Q Consensus       657 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------  714 (797)
                      ......   ......||+.|+|||.+..        ..++.++|+|++|+..++.+.+..++....              
T Consensus       165 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  241 (396)
T 4eut_A          165 ELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (396)
T ss_dssp             ECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred             EccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence            664332   2234679999999998865        578899999999999866665544432110              


Q ss_pred             -------------------------------hhhhcccccchhccccCCCCCCCChHHHHHhHHHHH
Q 040702          715 -------------------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIR  750 (797)
Q Consensus       715 -------------------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~  750 (797)
                                                     ......+.++++.|++.||++||++.++.+.++.+.
T Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il  308 (396)
T 4eut_A          242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (396)
T ss_dssp             SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred             CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence                                           122234567889999999999999999988777664

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.5e-34  Score=318.60  Aligned_cols=226  Identities=19%  Similarity=0.241  Sum_probs=179.0

Q ss_pred             hcCCCcc-ccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhh-ccCCceeEeeeeeec----CCeE
Q 040702          511 TNRFSEN-NLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKR-IRHRNLIKIISSCSN----DDFK  579 (797)
Q Consensus       511 ~~~f~~~-~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~-l~Hpniv~l~~~~~~----~~~~  579 (797)
                      .++|... +.||+|+||.||++     ++.||||+++.     ...+.+|+.++.+ .+||||+++++++..    .+..
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            3567665 68999999999974     68899999863     2567789988755 489999999999875    5578


Q ss_pred             EEEEEccCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcC---CCcEEEEeecCC
Q 040702          580 ALVLEYMPLGSLEKCLYSGNY-ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD---NMVAHLSDFGMA  655 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~DFGla  655 (797)
                      |+||||+++|+|.+++..... .+++..+..++.||+.||+|||   +.+|+||||||+|||++.   ++.+||+|||++
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence            999999999999999987542 5899999999999999999999   899999999999999997   789999999999


Q ss_pred             ccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh---------------------
Q 040702          656 KPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE---------------------  714 (797)
Q Consensus       656 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~---------------------  714 (797)
                      +......   .....+||+.|+|||.+.++.++.++|+|++|++.+..+.+..++....                     
T Consensus       212 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~  288 (400)
T 1nxk_A          212 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  288 (400)
T ss_dssp             EECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred             cccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence            8653222   2345679999999999999999999999999999866655444332110                     


Q ss_pred             ---hhhhcccccchhccccCCCCCCCChHHHHHhHH
Q 040702          715 ---KHLMTKEQPMVRMGTDLSLGQFPASYSISKYLV  747 (797)
Q Consensus       715 ---~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~  747 (797)
                         ......+.++++.|+..||++||++.|+++.-.
T Consensus       289 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~  324 (400)
T 1nxk_A          289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW  324 (400)
T ss_dssp             TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence               122345678999999999999999999988543

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4.5e-35  Score=314.52  Aligned_cols=241  Identities=20%  Similarity=0.243  Sum_probs=192.8

Q ss_pred             hcCCCccccccccCCcceeecc----------eEEEEEEEEecc-CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeE
Q 040702          511 TNRFSENNLIGRGGFGPVYKDG----------MEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFK  579 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~~----------~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~  579 (797)
                      .++|...+.||+|+||.||++.          ..||||++.... .....++.+|+.++++++||||+++++++...+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            4789999999999999999853          479999986442 22346788999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcC---CCcEEEE
Q 040702          580 ALVLEYMPLGSLEKCLYSGN------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD---NMVAHLS  650 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~  650 (797)
                      |+||||+++|+|.+++....      ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEEC
Confidence            99999999999999998653      24889999999999999999999   899999999999999984   4469999


Q ss_pred             eecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchhh---------------
Q 040702          651 DFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIREE---------------  714 (797)
Q Consensus       651 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~~---------------  714 (797)
                      |||+++...............||+.|+|||.+.++.++.++|+|++|+..+..+. +..++....               
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~  265 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD  265 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCC
Confidence            9999975433322223344568999999999999999999999999999866553 333222111               


Q ss_pred             --hhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHHhc
Q 040702          715 --KHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRELER  754 (797)
Q Consensus       715 --~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~  754 (797)
                        ......+.++++.|++.||.+||++.++++.++.+...+.
T Consensus       266 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~  307 (327)
T 2yfx_A          266 PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  307 (327)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence              1122356689999999999999999999999988866543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-34  Score=314.11  Aligned_cols=235  Identities=22%  Similarity=0.295  Sum_probs=186.9

Q ss_pred             HHHHhcCCCccccccccCCcceeec-----ceEEEEEEEEecc-----CCcchhHHHHHHHhhhccCCceeEeeeeeecC
Q 040702          507 LFQATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY-----GGAFKSFDIECGMMKRIRHRNLIKIISSCSND  576 (797)
Q Consensus       507 l~~~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~-----~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~  576 (797)
                      +....++|...+.||+|+||.||++     +..||||++....     ....+.+.+|++++++++||||+++++++.+.
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  100 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE  100 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence            3456788999999999999999975     5789999997652     23456889999999999999999999999999


Q ss_pred             CeEEEEEEccCCCCHHHHHhcC---------------------------------------CCCCCHHHHHHHHHHHHHH
Q 040702          577 DFKALVLEYMPLGSLEKCLYSG---------------------------------------NYILDIFQGLNIMIDVASA  617 (797)
Q Consensus       577 ~~~~lv~e~~~~g~L~~~l~~~---------------------------------------~~~l~~~~~~~i~~qi~~a  617 (797)
                      +..++||||+++|+|.+++...                                       ...+++..++.++.|+++|
T Consensus       101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~  180 (345)
T 3hko_A          101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA  180 (345)
T ss_dssp             SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            9999999999999999998521                                       1123567788999999999


Q ss_pred             HHHHHccCCCCeEEcCCCCCceEEcCCC--cEEEEeecCCccCCccCc--cccccccccCccccccccccc--CccchHH
Q 040702          618 LEYLHFGYSVPIIHCDLKPSNVLLDDNM--VAHLSDFGMAKPLLEEDQ--SLTQTQTLATIGYMAPDEIFS--GEMRLKC  691 (797)
Q Consensus       618 l~yLH~~~~~~ivHrDlkp~NIll~~~~--~~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~~  691 (797)
                      |+|||   +.+|+||||||+||+++.++  .+||+|||+++.+.....  ........||+.|+|||.+.+  ..++.++
T Consensus       181 l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          181 LHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            99999   89999999999999998766  899999999986533211  112345679999999999865  6788999


Q ss_pred             HHHHHhhhhhhhhccccccchhh--------------------hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          692 WVNDSLLISVMIVVDANLLIREE--------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       692 dv~s~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      |+|++|+..+..+.+..++....                    ......+.++++.|++.||.+||++.++++
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            99999998866555444432111                    112345678999999999999999988865

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.3e-34  Score=318.19  Aligned_cols=228  Identities=20%  Similarity=0.249  Sum_probs=183.7

Q ss_pred             cCCCccccccccCCcceeec----ceEEEEEEEEeccCC--cchhHHHHHHHhhhcc--CCceeEeeeeeecCCeEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGG--AFKSFDIECGMMKRIR--HRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~--Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ++|...+.||+|+||.||++    ++.||||++......  ..+.+.+|+.++++++  ||||+++++++..++..|+||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            46999999999999999985    688999999865432  3467899999999996  599999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      | +.+++|.+++.... .+++..+..++.||+.||.|||   +.+|+||||||+|||++ ++.+||+|||+++.......
T Consensus       136 E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~  209 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT  209 (390)
T ss_dssp             E-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred             e-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence            9 56789999998765 4888899999999999999999   99999999999999996 57999999999987654333


Q ss_pred             cccccccccCccccccccccc-----------CccchHHHHHHHhhhhhhhhccccccchhh------------------
Q 040702          664 SLTQTQTLATIGYMAPDEIFS-----------GEMRLKCWVNDSLLISVMIVVDANLLIREE------------------  714 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~------------------  714 (797)
                      .......+||+.|||||.+.+           ..++.++|||++|++.++.+.+..++....                  
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~  289 (390)
T 2zmd_A          210 SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF  289 (390)
T ss_dssp             ----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCC
T ss_pred             cccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCC
Confidence            333455689999999998864           468999999999999866665544432210                  


Q ss_pred             -hhhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          715 -KHLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       715 -~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                       ......+.++++.|+..||.+||++.|+++.
T Consensus       290 ~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          290 PDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence             0112246788999999999999999999875

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.3e-34  Score=333.70  Aligned_cols=236  Identities=18%  Similarity=0.222  Sum_probs=189.1

Q ss_pred             CCCccc-cccccCCcceeec-------ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          513 RFSENN-LIGRGGFGPVYKD-------GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       513 ~f~~~~-~lg~G~~g~Vyk~-------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ++...+ .||+|+||.||++       +..||||+++.... ...+++.+|++++++++|||||+++++|.. +..++||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            344444 7999999999975       35799999976532 345789999999999999999999999976 5689999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      ||+++|+|.+++......+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.......
T Consensus       415 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~  491 (613)
T 2ozo_A          415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS  491 (613)
T ss_dssp             ECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred             EeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence            999999999999876667999999999999999999999   89999999999999999999999999999987643322


Q ss_pred             c-ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-----------------hhhhhcccccc
Q 040702          664 S-LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-----------------EKHLMTKEQPM  724 (797)
Q Consensus       664 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-----------------~~~~~~~~~~l  724 (797)
                      . .......+|+.|+|||.+..+.++.++|||++|+..++.+. +..++...                 +......+.++
T Consensus       492 ~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~l  571 (613)
T 2ozo_A          492 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYAL  571 (613)
T ss_dssp             ----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence            1 12223446789999999999999999999999999866553 33332211                 11233466788


Q ss_pred             hhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          725 VRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       725 ~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                      ++.||+.||++||++.++++.|+.+...
T Consensus       572 i~~cl~~dP~~RPs~~~l~~~L~~~~~~  599 (613)
T 2ozo_A          572 MSDCWIYKWEDRPDFLTVEQRMRACYYS  599 (613)
T ss_dssp             HHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             HHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            9999999999999999999999887554

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=7.5e-35  Score=305.33  Aligned_cols=236  Identities=20%  Similarity=0.285  Sum_probs=194.6

Q ss_pred             hcCCCccccccccCCcceeec----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          511 TNRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      .++|+..+.||+|+||.||++    +..||||.++... ...+.+.+|++++++++||||+++++++.. +..++||||+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~   89 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecC
Confidence            468999999999999999985    5789999987543 235789999999999999999999999864 4589999999


Q ss_pred             CCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          587 PLGSLEKCLYSGNY-ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       587 ~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      ++++|.+++..... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...... ..
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~  165 (279)
T 1qpc_A           90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YT  165 (279)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EE
T ss_pred             CCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc-cc
Confidence            99999999875432 4899999999999999999999   9999999999999999999999999999998664322 12


Q ss_pred             cccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-h----------------hhhhcccccchhc
Q 040702          666 TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-E----------------KHLMTKEQPMVRM  727 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-~----------------~~~~~~~~~l~~~  727 (797)
                      ......+|..|+|||.+..+.++.++|+|++|+..+..+. +..++... .                ......+.++++.
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  245 (279)
T 1qpc_A          166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL  245 (279)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHHHHH
Confidence            2234567889999999998999999999999999866554 33322211 1                1123356789999


Q ss_pred             cccCCCCCCCChHHHHHhHHHHHHH
Q 040702          728 GTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                      |++.||++||++.++++.++.+...
T Consensus       246 ~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          246 CWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HhccChhhCCCHHHHHHHHHHHHHh
Confidence            9999999999999999999887654

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.9e-34  Score=301.64  Aligned_cols=231  Identities=19%  Similarity=0.243  Sum_probs=191.6

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ..++|+..+.||+|+||.||++     ++.||||+++.... ...+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            3578999999999999999975     68999999986543 33567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      ||+++++|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||.+........
T Consensus        85 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  160 (276)
T 2yex_A           85 EYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (276)
T ss_dssp             ECCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             EecCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence            9999999999886544 4899999999999999999999   89999999999999999999999999999986543322


Q ss_pred             cccccccccCcccccccccccCcc-chHHHHHHHhhhhhhhhccccccchhh-------------------hhhhccccc
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEM-RLKCWVNDSLLISVMIVVDANLLIREE-------------------KHLMTKEQP  723 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~dv~s~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~  723 (797)
                      ........||+.|+|||.+.+..+ +.++|+|++|+..+..+.+..++....                   ......+.+
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (276)
T 2yex_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA  240 (276)
T ss_dssp             ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHH
T ss_pred             hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHH
Confidence            223345679999999999987765 789999999998865554443322111                   122345668


Q ss_pred             chhccccCCCCCCCChHHHHH
Q 040702          724 MVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       724 l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      +++.|++.||.+||++.|+++
T Consensus       241 li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          241 LLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHHHHCCCCchhCCCHHHHhc
Confidence            899999999999999888764

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.1e-34  Score=313.87  Aligned_cols=233  Identities=18%  Similarity=0.168  Sum_probs=185.6

Q ss_pred             cCCCccccccccCCcceeec--------ceEEEEEEEEeccCC-----------cchhHHHHHHHhhhccCCceeEeeee
Q 040702          512 NRFSENNLIGRGGFGPVYKD--------GMEVAIKVFNLQYGG-----------AFKSFDIECGMMKRIRHRNLIKIISS  572 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~--------~~~vAvK~~~~~~~~-----------~~~~~~~E~~~l~~l~Hpniv~l~~~  572 (797)
                      ++|...+.||+|+||.||++        +..||||++......           ....+.+|+..++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            67999999999999999974        467999998765321           12346778888999999999999999


Q ss_pred             eec----CCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCC--c
Q 040702          573 CSN----DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM--V  646 (797)
Q Consensus       573 ~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~--~  646 (797)
                      +..    .+..|+||||+ +++|.+++...+ .+++..++.++.|++.||+|||   +.+|+||||||+||+++.++  .
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~  191 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQ  191 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTTS
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCCc
Confidence            987    67899999999 999999997655 5899999999999999999999   89999999999999999877  9


Q ss_pred             EEEEeecCCccCCccCcc-----ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh------
Q 040702          647 AHLSDFGMAKPLLEEDQS-----LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK------  715 (797)
Q Consensus       647 ~kl~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~------  715 (797)
                      +||+|||+|+.+......     .......||+.|+|||.+.+..++.++|+|++|+..++.+.+..++.....      
T Consensus       192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~  271 (345)
T 2v62_A          192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ  271 (345)
T ss_dssp             EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred             EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence            999999999876433211     112456799999999999988899999999999998666655554422100      


Q ss_pred             ---------------------hhhcccccchhccccCCCCCCCChHHHHHhHHHH
Q 040702          716 ---------------------HLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYI  749 (797)
Q Consensus       716 ---------------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i  749 (797)
                                           .....+.++++.|+..||++||++.++++.|+.+
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  326 (345)
T 2v62_A          272 TAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH  326 (345)
T ss_dssp             HHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred             HHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence                                 2223677899999999999999999999988653

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.7e-34  Score=308.41  Aligned_cols=235  Identities=24%  Similarity=0.305  Sum_probs=191.3

Q ss_pred             cCCCccccccccCCcceeec-----ce--EEEEEEEEecc-CCcchhHHHHHHHhhhc-cCCceeEeeeeeecCCeEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GM--EVAIKVFNLQY-GGAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~--~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      ++|...+.||+|+||.||++     +.  .||||.++... ....+.+.+|+++++++ +||||+++++++.+.+..|+|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            68999999999999999985     33  45999987542 33457799999999999 899999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcE
Q 040702          583 LEYMPLGSLEKCLYSGN---------------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVA  647 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~  647 (797)
                      |||+++|+|.+++....               ..+++..++.++.|+++||+|||   +++|+||||||+||+++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence            99999999999997654               25899999999999999999999   9999999999999999999999


Q ss_pred             EEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-------------
Q 040702          648 HLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-------------  713 (797)
Q Consensus       648 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-------------  713 (797)
                      ||+|||+++.....   .......+|+.|+|||.+....++.++|+|++|+..+..+. +..++...             
T Consensus       182 kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~  258 (327)
T 1fvr_A          182 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  258 (327)
T ss_dssp             EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred             EEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCC
Confidence            99999999743221   12233457889999999988889999999999999866553 33332211             


Q ss_pred             ----hhhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          714 ----EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       714 ----~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                          +......+.++++.|++.||.+||++.++++.++.+.+-
T Consensus       259 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  301 (327)
T 1fvr_A          259 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  301 (327)
T ss_dssp             CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                112234567899999999999999999999999887654

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4.9e-35  Score=327.99  Aligned_cols=235  Identities=21%  Similarity=0.293  Sum_probs=188.3

Q ss_pred             HhcCCCccccccccCCcceeec----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      ..++|...+.||+|+||.||++    +..||||+++... ...++|.+|++++++++||||+++++++.+ +..|+||||
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            4578899999999999999985    4789999987543 235789999999999999999999999876 678999999


Q ss_pred             cCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          586 MPLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       586 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      +++|+|.+++.... ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++...... .
T Consensus       260 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~  335 (452)
T 1fmk_A          260 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-Y  335 (452)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             hcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc-e
Confidence            99999999997532 34899999999999999999999   9999999999999999999999999999998654322 2


Q ss_pred             ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-----------------hhhhhcccccchh
Q 040702          665 LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-----------------EKHLMTKEQPMVR  726 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-----------------~~~~~~~~~~l~~  726 (797)
                      .......+|..|+|||.+..+.++.++|+|++|+..++.+. +..++...                 +......+.++++
T Consensus       336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~  415 (452)
T 1fmk_A          336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC  415 (452)
T ss_dssp             -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred             ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence            22334557889999999999999999999999999866554 33322211                 1122335678899


Q ss_pred             ccccCCCCCCCChHHHHHhHHHHH
Q 040702          727 MGTDLSLGQFPASYSISKYLVYIR  750 (797)
Q Consensus       727 ~cl~~dp~~RPs~~~i~~~l~~i~  750 (797)
                      .||+.||++||++.++.+.|+.+.
T Consensus       416 ~cl~~dP~~Rpt~~~l~~~L~~~~  439 (452)
T 1fmk_A          416 QCWRKEPEERPTFEYLQAFLEDYF  439 (452)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             HHccCChhhCcCHHHHHHHHHHHh
Confidence            999999999999999998887653

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1e-34  Score=325.75  Aligned_cols=224  Identities=22%  Similarity=0.237  Sum_probs=179.5

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeecC------C
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSND------D  577 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~------~  577 (797)
                      .++|+..+.||+|+||.||++     ++.||||++.....  ...+.+.+|+.+++.++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            478999999999999999975     68999999986532  2346788999999999999999999998654      3


Q ss_pred             eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCcc
Q 040702          578 FKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  657 (797)
Q Consensus       578 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  657 (797)
                      ..|+||||+++ ++.+.+..   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~  213 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred             eEEEEEeCCCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence            57999999976 56666644   3889999999999999999999   89999999999999999999999999999986


Q ss_pred             CCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh----------------------
Q 040702          658 LLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK----------------------  715 (797)
Q Consensus       658 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~----------------------  715 (797)
                      ....   ......+||++|+|||.+.+..|+.++|+|++|++.++.+.+..++.+...                      
T Consensus       214 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~  290 (464)
T 3ttj_A          214 AGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  290 (464)
T ss_dssp             ---C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTS
T ss_pred             cCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHc
Confidence            5332   133457899999999999999999999999999998665544433322100                      


Q ss_pred             ------------------------------------hhhcccccchhccccCCCCCCCChHHHHH
Q 040702          716 ------------------------------------HLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       716 ------------------------------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                                          .......++++.|+..||++|||+.|+++
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                                                00234568999999999999999999886

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.1e-34  Score=302.90  Aligned_cols=227  Identities=22%  Similarity=0.325  Sum_probs=183.8

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      .++|...+.||+|+||.||++     +..||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            368999999999999999974     68999999987643 345788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEE---cCCCcEEEEeecCCccC
Q 040702          585 YMPLGSLEKCLYSG---NYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPL  658 (797)
Q Consensus       585 ~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll---~~~~~~kl~DFGla~~~  658 (797)
                      |+++|+|.+++...   ...+++..+..++.|++.||+|||   +.+|+||||||+||++   +.++.+||+|||+++..
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999988542   235899999999999999999999   9999999999999999   45678999999999865


Q ss_pred             CccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh-------------------hhhc
Q 040702          659 LEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK-------------------HLMT  719 (797)
Q Consensus       659 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~-------------------~~~~  719 (797)
                      ....   ......||+.|+|||.+. +.++.++|+|++|+..+..+.+..++.....                   ....
T Consensus       178 ~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (285)
T 3is5_A          178 KSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTP  253 (285)
T ss_dssp             ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCH
T ss_pred             CCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCH
Confidence            4322   234467999999999874 6789999999999998665554443322111                   1233


Q ss_pred             ccccchhccccCCCCCCCChHHHHH
Q 040702          720 KEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       720 ~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      .+.++++.|++.||++||++.|+++
T Consensus       254 ~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          254 QAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhc
Confidence            5568899999999999999988874

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=6.5e-35  Score=317.76  Aligned_cols=202  Identities=26%  Similarity=0.290  Sum_probs=170.3

Q ss_pred             cCccCHHHHHHHhcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhcc-----CCceeE
Q 040702          499 QRRFTYLELFQATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIR-----HRNLIK  568 (797)
Q Consensus       499 ~~~~~~~~l~~~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----Hpniv~  568 (797)
                      ...+++++-....++|...+.||+|+||.||++     ++.||||+++... ...+.+..|+.+++.++     ||||++
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            344555555556789999999999999999974     5889999986432 22456778999999986     999999


Q ss_pred             eeeeeecCCeEEEEEEccCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcC----
Q 040702          569 IISSCSNDDFKALVLEYMPLGSLEKCLYSGNY-ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD----  643 (797)
Q Consensus       569 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~----  643 (797)
                      +++++...+..|+||||+ +++|.+++..... .+++..+..++.||+.||+|||   +++|+||||||+|||++.    
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~  176 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFE  176 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCC
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEcccccc
Confidence            999999999999999999 8899999986543 5899999999999999999999   999999999999999975    


Q ss_pred             ---------------------CCcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhh
Q 040702          644 ---------------------NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVM  702 (797)
Q Consensus       644 ---------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~  702 (797)
                                           ++.+||+|||+|+.....     .....||+.|+|||.+.+..++.++|+|++|+..+.
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e  251 (360)
T 3llt_A          177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE  251 (360)
T ss_dssp             EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred             ccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence                                 789999999999854321     234679999999999999999999999999999866


Q ss_pred             hhcccccc
Q 040702          703 IVVDANLL  710 (797)
Q Consensus       703 ~~~~~~~~  710 (797)
                      .+.+..++
T Consensus       252 ll~g~~pf  259 (360)
T 3llt_A          252 LYTGSLLF  259 (360)
T ss_dssp             HHHSSCSC
T ss_pred             HHHCCCCC
Confidence            66554443

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.9e-34  Score=308.20  Aligned_cols=237  Identities=19%  Similarity=0.165  Sum_probs=191.5

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeec----CCeEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN----DDFKAL  581 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~----~~~~~l  581 (797)
                      .++|...+.||+|+||.||++     ++.||||++........+.+.+|+++++.++||||+++++++..    ....|+
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            468999999999999999974     68999999977655556788999999999999999999999873    347899


Q ss_pred             EEEccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccC
Q 040702          582 VLEYMPLGSLEKCLYS---GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  658 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  658 (797)
                      ||||+++|+|.+++..   ....+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~  184 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA  184 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence            9999999999999875   3346899999999999999999999   899999999999999999999999999998765


Q ss_pred             CccCccc-------cccccccCcccccccccccCc---cchHHHHHHHhhhhhhhhccccccchhh--------------
Q 040702          659 LEEDQSL-------TQTQTLATIGYMAPDEIFSGE---MRLKCWVNDSLLISVMIVVDANLLIREE--------------  714 (797)
Q Consensus       659 ~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------  714 (797)
                      .......       ......||+.|+|||.+....   ++.++|+|++|+..+..+....++....              
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~  264 (317)
T 2buj_A          185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL  264 (317)
T ss_dssp             CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-
T ss_pred             ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccC
Confidence            3211110       112345799999999887543   6899999999998866655544432211              


Q ss_pred             -----hhhhcccccchhccccCCCCCCCChHHHHHhHHHHH
Q 040702          715 -----KHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIR  750 (797)
Q Consensus       715 -----~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~  750 (797)
                           ......+.++++.|++.||.+||++.++++.++.++
T Consensus       265 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          265 SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence                 112335678999999999999999999999887754

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-35  Score=317.45  Aligned_cols=229  Identities=20%  Similarity=0.231  Sum_probs=184.8

Q ss_pred             hcCCCccccccccCCcceee--------cceEEEEEEEEecc----CCcchhHHHHHHHhhhc-cCCceeEeeeeeecCC
Q 040702          511 TNRFSENNLIGRGGFGPVYK--------DGMEVAIKVFNLQY----GGAFKSFDIECGMMKRI-RHRNLIKIISSCSNDD  577 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk--------~~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~  577 (797)
                      .++|...+.||+|+||.||+        .++.||||+++...    ....+.+.+|+++++++ +||||+++++++..++
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            46899999999999999996        35889999986542    22346677899999999 5999999999999999


Q ss_pred             eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCcc
Q 040702          578 FKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  657 (797)
Q Consensus       578 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  657 (797)
                      ..++||||+++|+|.+++.... .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            9999999999999999997654 4899999999999999999999   89999999999999999999999999999986


Q ss_pred             CCccCccccccccccCccccccccccc--CccchHHHHHHHhhhhhhhhccccccch--------------------hhh
Q 040702          658 LLEEDQSLTQTQTLATIGYMAPDEIFS--GEMRLKCWVNDSLLISVMIVVDANLLIR--------------------EEK  715 (797)
Q Consensus       658 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~dv~s~~~~~~~~~~~~~~~~~--------------------~~~  715 (797)
                      ...... ......+||+.|+|||.+.+  ..++.++|+|++|+..+..+.+..++..                    .+.
T Consensus       209 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  287 (355)
T 1vzo_A          209 FVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ  287 (355)
T ss_dssp             CCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT
T ss_pred             cccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCc
Confidence            543222 22345679999999999885  3478999999999998666555443321                    111


Q ss_pred             hhhcccccchhccccCCCCCCC-----ChHHHHH
Q 040702          716 HLMTKEQPMVRMGTDLSLGQFP-----ASYSISK  744 (797)
Q Consensus       716 ~~~~~~~~l~~~cl~~dp~~RP-----s~~~i~~  744 (797)
                      .....+.++++.|+..||.+||     ++.|+++
T Consensus       288 ~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~  321 (355)
T 1vzo_A          288 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  321 (355)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence            2223456788999999999999     5555544

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.9e-34  Score=310.17  Aligned_cols=228  Identities=23%  Similarity=0.313  Sum_probs=183.9

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCc--chhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGA--FKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~--~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      .++|+..+.||+|+||.||++     ++.||||++.......  .+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            468999999999999999974     6889999987654322  356788999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      ||++++++.++..... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.......
T Consensus       104 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  179 (331)
T 4aaa_A          104 EFVDHTILDDLELFPN-GLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE  179 (331)
T ss_dssp             ECCSEEHHHHHHHSTT-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             ecCCcchHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc
Confidence            9999999988776544 4899999999999999999999   89999999999999999999999999999986543221


Q ss_pred             cccccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccccccchhhh---------------------------
Q 040702          664 SLTQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANLLIREEK---------------------------  715 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~---------------------------  715 (797)
                        ......||+.|+|||.+.+. .++.++|+|++|+..+..+.+..++.....                           
T Consensus       180 --~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (331)
T 4aaa_A          180 --VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV  257 (331)
T ss_dssp             ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred             --ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence              23446799999999998775 689999999999988665555443322110                           


Q ss_pred             --------------------hhhcccccchhccccCCCCCCCChHHHHH
Q 040702          716 --------------------HLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       716 --------------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                          .....+.++++.|++.||++||++.|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                                12334668899999999999999988775

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.5e-34  Score=310.37  Aligned_cols=230  Identities=19%  Similarity=0.237  Sum_probs=185.7

Q ss_pred             HHHhcCCCcc-ccccccCCcceeec-----ceEEEEEEEEeccCC--cchhHHHHHHHhhhcc-CCceeEeeeeeecCCe
Q 040702          508 FQATNRFSEN-NLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG--AFKSFDIECGMMKRIR-HRNLIKIISSCSNDDF  578 (797)
Q Consensus       508 ~~~~~~f~~~-~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~  578 (797)
                      ....++|... +.||+|+||.||++     ++.||||+++.....  ....+.+|+.+++++. ||||+++++++.+.+.
T Consensus        24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~  103 (327)
T 3lm5_A           24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE  103 (327)
T ss_dssp             HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence            3445677776 89999999999985     689999999865432  3467889999999995 6999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcC---CCcEEEEeecC
Q 040702          579 KALVLEYMPLGSLEKCLYSG-NYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD---NMVAHLSDFGM  654 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~DFGl  654 (797)
                      .++||||+++|+|.+++... ...+++..++.++.|++.||+|||   +.+|+||||||+||+++.   ++.+||+|||+
T Consensus       104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~  180 (327)
T 3lm5_A          104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM  180 (327)
T ss_dssp             EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred             EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence            99999999999999988653 236899999999999999999999   899999999999999987   78999999999


Q ss_pred             CccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh--------------------
Q 040702          655 AKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE--------------------  714 (797)
Q Consensus       655 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------------  714 (797)
                      ++......   ......||+.|+|||.+....++.++|+|++|+..+..+....++....                    
T Consensus       181 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  257 (327)
T 3lm5_A          181 SRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETF  257 (327)
T ss_dssp             CEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTT
T ss_pred             ccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhh
Confidence            98654322   2234679999999999999999999999999998866555444332111                    


Q ss_pred             hhhhcccccchhccccCCCCCCCChHHHH
Q 040702          715 KHLMTKEQPMVRMGTDLSLGQFPASYSIS  743 (797)
Q Consensus       715 ~~~~~~~~~l~~~cl~~dp~~RPs~~~i~  743 (797)
                      ......+.++++.|++.||++||++.+++
T Consensus       258 ~~~~~~~~~li~~~L~~dP~~Rpt~~~ll  286 (327)
T 3lm5_A          258 SSVSQLATDFIQSLLVKNPEKRPTAEICL  286 (327)
T ss_dssp             TTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred             cccCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence            11223467789999999999999987775

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=4.8e-34  Score=309.74  Aligned_cols=230  Identities=20%  Similarity=0.267  Sum_probs=185.9

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeec--------
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSN--------  575 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~--------  575 (797)
                      .++|+..+.||+|+||.||++     ++.||||++.....  .....+.+|++++++++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            468999999999999999975     68999999865532  234578899999999999999999999877        


Q ss_pred             CCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCC
Q 040702          576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMA  655 (797)
Q Consensus       576 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla  655 (797)
                      .+..|+||||+++ ++.+.+......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+|
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence            3468999999975 888888776666999999999999999999999   999999999999999999999999999999


Q ss_pred             ccCCccC--ccccccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchhhhh----------------
Q 040702          656 KPLLEED--QSLTQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIREEKH----------------  716 (797)
Q Consensus       656 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~~----------------  716 (797)
                      +......  .........||+.|+|||.+.+ ..++.++|+|++|+..+..+.+..++......                
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  251 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  251 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            8654222  1122345678999999998876 45799999999999886655544433221110                


Q ss_pred             --------------------------------hhcccccchhccccCCCCCCCChHHHHH
Q 040702          717 --------------------------------LMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       717 --------------------------------~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                                      ....+.++++.|++.||++||++.|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence                                            0123557899999999999999988775

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=5.3e-35  Score=306.30  Aligned_cols=232  Identities=25%  Similarity=0.301  Sum_probs=186.7

Q ss_pred             hcCCCccccccccCCcceeec---ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecC-CeEEEEEEcc
Q 040702          511 TNRFSENNLIGRGGFGPVYKD---GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSND-DFKALVLEYM  586 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~---~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~-~~~~lv~e~~  586 (797)
                      .++|+..+.||+|+||.||++   ++.||||+++...  ..+.+.+|++++++++||||+++++++... +..++||||+
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   97 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   97 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             hhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecC
Confidence            478999999999999999985   6899999986443  457899999999999999999999997654 4789999999


Q ss_pred             CCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          587 PLGSLEKCLYSGNY-ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       587 ~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      ++|+|.+++..... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....    
T Consensus        98 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----  170 (278)
T 1byg_A           98 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST----  170 (278)
T ss_dssp             TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             CCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccccccc----
Confidence            99999999976432 3788899999999999999999   899999999999999999999999999999854322    


Q ss_pred             cccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-----------------hhhhhcccccchhc
Q 040702          666 TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-----------------EKHLMTKEQPMVRM  727 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-----------------~~~~~~~~~~l~~~  727 (797)
                       .....+++.|+|||.+.+..++.++|+|++|+..+..+. +..++...                 +......+.++++.
T Consensus       171 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  249 (278)
T 1byg_A          171 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKN  249 (278)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHH
T ss_pred             -ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHH
Confidence             123457889999999998899999999999998865553 33322211                 11223456788999


Q ss_pred             cccCCCCCCCChHHHHHhHHHHHHH
Q 040702          728 GTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                      |++.||++||++.++++.|+.++..
T Consensus       250 ~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          250 CWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HhcCChhhCCCHHHHHHHHHHHHhh
Confidence            9999999999999999999998765

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=5.5e-34  Score=299.38  Aligned_cols=227  Identities=22%  Similarity=0.265  Sum_probs=187.9

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCC------cchhHHHHHHHhhhccCCceeEeeeeeecCCeEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG------AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKA  580 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~  580 (797)
                      ++|...+.||+|+||.||++     ++.||||+++.....      ..+.+.+|+.++++++||||+++++++.+.+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            57999999999999999985     689999999865321      2467899999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCC----cEEEEeecCCc
Q 040702          581 LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM----VAHLSDFGMAK  656 (797)
Q Consensus       581 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~----~~kl~DFGla~  656 (797)
                      +||||+++++|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++    .+||+|||+++
T Consensus        85 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~  160 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH  160 (283)
T ss_dssp             EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred             EEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence            9999999999999997644 4899999999999999999999   89999999999999998877    89999999998


Q ss_pred             cCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh--------------------hhh
Q 040702          657 PLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE--------------------EKH  716 (797)
Q Consensus       657 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~--------------------~~~  716 (797)
                      ......   ......||+.|+|||.+....++.++|+|++|+..+..+....++...                    ...
T Consensus       161 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T 3bhy_A          161 KIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSN  237 (283)
T ss_dssp             ECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTT
T ss_pred             eccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhccc
Confidence            654322   223457999999999998889999999999999875555443332211                    112


Q ss_pred             hhcccccchhccccCCCCCCCChHHHHHh
Q 040702          717 LMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       717 ~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                      ....+.++++.|+..||++||++.++++.
T Consensus       238 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          238 TSELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             CCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             CCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence            23356788999999999999999999874

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=4.7e-34  Score=304.07  Aligned_cols=255  Identities=31%  Similarity=0.494  Sum_probs=224.1

Q ss_pred             CCCcEEEccCCCCCC--CCChhhhccccCCcEEEccC-CcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCC
Q 040702          179 KYLEYFSFSNNPLGG--ILPRAIGNLSQSMEDFWMDN-CNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAA  255 (797)
Q Consensus       179 ~~L~~L~Ls~N~l~~--~~~~~~~~l~~~L~~L~L~~-n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~  255 (797)
                      .+++.|+|++|.+.+  .+|..|.+++ +|+.|++++ |.+.+.+|..|+++++|  ++|+|++|.+++..|..|..+++
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~-~L~~L~L~~~n~l~~~~p~~l~~l~~L--~~L~Ls~n~l~~~~p~~~~~l~~  126 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSSLANLP-YLNFLYIGGINNLVGPIPPAIAKLTQL--HYLYITHTNVSGAIPDFLSQIKT  126 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGGGGCT-TCSEEEEEEETTEESCCCGGGGGCTTC--SEEEEEEECCEEECCGGGGGCTT
T ss_pred             ceEEEEECCCCCccCCcccChhHhCCC-CCCeeeCCCCCcccccCChhHhcCCCC--CEEECcCCeeCCcCCHHHhCCCC
Confidence            457777777777777  6677777776 778888874 77777778888888877  88888888888788888888888


Q ss_pred             CcEEEccCCcCcccCCCCccCCccccccccCCCCCC-CCCCCCCCCC-cccEEEccCCcCCCCCCccccccccccEEecc
Q 040702          256 LFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLT-SIPSTLWNLK-DILHLNLSSNFFTGPLPLKIGNLNVLVQLDLS  333 (797)
Q Consensus       256 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~-~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls  333 (797)
                      |++|+|++|++++..|..+..+++|++|++++|.++ .+|..+..++ +|+.|++++|.+++..|..|..+. |+.|+++
T Consensus       127 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls  205 (313)
T 1ogq_A          127 LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLS  205 (313)
T ss_dssp             CCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECC
T ss_pred             CCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECc
Confidence            888888888888888888888888999999999885 7888888887 899999999999988899999887 9999999


Q ss_pred             CcccccccCccccCCcccceecccCccccCCCChhhhccccCCeeeecCCcCCCCCChhhhccCCCCeEEccCCcCcccC
Q 040702          334 MNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEI  413 (797)
Q Consensus       334 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~  413 (797)
                      +|.+++..|..|..+++|+.|+|++|++++..|. +..+++|++|+|++|++++.+|..+..+++|+.|++++|++++.+
T Consensus       206 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~i  284 (313)
T 1ogq_A          206 RNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI  284 (313)
T ss_dssp             SSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEEC
T ss_pred             CCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccC
Confidence            9999999999999999999999999999976665 888999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCcccccCCccccCCCC
Q 040702          414 PREGPFRNLSAESFKGNELLCGMPN  438 (797)
Q Consensus       414 p~~~~~~~l~~~~~~~n~~~c~~~~  438 (797)
                      |....+..+..+++.+|+++|+.|.
T Consensus       285 p~~~~l~~L~~l~l~~N~~lc~~p~  309 (313)
T 1ogq_A          285 PQGGNLQRFDVSAYANNKCLCGSPL  309 (313)
T ss_dssp             CCSTTGGGSCGGGTCSSSEEESTTS
T ss_pred             CCCccccccChHHhcCCCCccCCCC
Confidence            9988899999999999999999874

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.4e-34  Score=303.95  Aligned_cols=230  Identities=18%  Similarity=0.249  Sum_probs=192.6

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccC---CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG---GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      .++|...+.||+|+||.||++     ++.||+|++.....   ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            468999999999999999984     57899999976532   2346788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      |||+++++|.+++.... .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus        94 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  169 (294)
T 2rku_A           94 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  169 (294)
T ss_dssp             EECCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence            99999999999887654 4899999999999999999999   8999999999999999999999999999998654222


Q ss_pred             ccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh----------------hhhhhcccccchh
Q 040702          663 QSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE----------------EKHLMTKEQPMVR  726 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~l~~  726 (797)
                      .  ......||+.|+|||.+.+..++.++|+|++|+..+..+.+..++...                +......+.++++
T Consensus       170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  247 (294)
T 2rku_A          170 E--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ  247 (294)
T ss_dssp             C--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHH
T ss_pred             c--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHH
Confidence            1  234467999999999998888999999999999886555444433221                1122335678899


Q ss_pred             ccccCCCCCCCChHHHHHhH
Q 040702          727 MGTDLSLGQFPASYSISKYL  746 (797)
Q Consensus       727 ~cl~~dp~~RPs~~~i~~~l  746 (797)
                      .|++.||++||++.|+++.-
T Consensus       248 ~~l~~~p~~Rps~~~ll~~~  267 (294)
T 2rku_A          248 KMLQTDPTARPTINELLNDE  267 (294)
T ss_dssp             HHTCSSGGGSCCGGGGGGSH
T ss_pred             HHcccChhhCcCHHHHhhCh
Confidence            99999999999999998753

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.5e-34  Score=301.45  Aligned_cols=226  Identities=20%  Similarity=0.259  Sum_probs=185.7

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhc-cCCceeEeeeeeecCCeEEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~l  581 (797)
                      ..++|+..+.||+|+||.||++     ++.||||+++....  ....++.+|+..+..+ +||||+++++++.+++..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            3578999999999999999984     68999999986532  2346788899999999 89999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCC--------------
Q 040702          582 VLEYMPLGSLEKCLYSGN---YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN--------------  644 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~--------------  644 (797)
                      ||||+++|+|.+++....   ..+++..++.++.|++.||+|||   +++|+||||||+||+++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            999999999999997542   35899999999999999999999   8999999999999999844              


Q ss_pred             -----CcEEEEeecCCccCCccCccccccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccccccch------
Q 040702          645 -----MVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANLLIR------  712 (797)
Q Consensus       645 -----~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~~~~------  712 (797)
                           ..+||+|||.++.....      ....||+.|+|||.+.+. .++.++|+|++|+..+..+....+...      
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~  239 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE  239 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHH
T ss_pred             ccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHH
Confidence                 47999999999865332      224599999999998766 567899999999988655544433211      


Q ss_pred             --------hhhhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          713 --------EEKHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       713 --------~~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                              .+......+.++++.|++.||++||++.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          240 IRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             HHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                    11123346778999999999999999988865

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.5e-34  Score=304.26  Aligned_cols=227  Identities=19%  Similarity=0.254  Sum_probs=188.5

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      .++|...+.||+|+||.||++     ++.||||+++.......+.+.+|+.++++++||||+++++++.+.+..|+||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            468999999999999999974     689999999866544456789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEE---cCCCcEEEEeecCCccCCccC
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll---~~~~~~kl~DFGla~~~~~~~  662 (797)
                      +++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||++   +.++.+||+|||+++..... 
T Consensus        88 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-  162 (304)
T 2jam_A           88 VSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-  162 (304)
T ss_dssp             CCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred             CCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence            99999999987654 4899999999999999999999   8999999999999999   78889999999999754321 


Q ss_pred             ccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh--------------------hhhhhcccc
Q 040702          663 QSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE--------------------EKHLMTKEQ  722 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~  722 (797)
                         ......||+.|+|||.+.+..++.++|+|++|+..+..+.+..++...                    .......+.
T Consensus       163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  239 (304)
T 2jam_A          163 ---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAK  239 (304)
T ss_dssp             ---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHH
T ss_pred             ---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHH
Confidence               223456999999999999999999999999999876555444332211                    112234567


Q ss_pred             cchhccccCCCCCCCChHHHHHh
Q 040702          723 PMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       723 ~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                      ++++.|+..||++||++.|+++.
T Consensus       240 ~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          240 DFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             HHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHcCCChhHCcCHHHHhcC
Confidence            89999999999999999998874

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.5e-34  Score=304.20  Aligned_cols=228  Identities=22%  Similarity=0.244  Sum_probs=187.4

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      ..++|+..+.||+|+||.||++     ++.||||.+....  ..+.+.+|+.++++++||||+++++++...+..|+|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            3468999999999999999985     6899999997543  35789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      |+++|+|.+++......+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++.......  
T Consensus       105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~--  179 (314)
T 3com_A          105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM--  179 (314)
T ss_dssp             CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB--
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc--
Confidence            99999999999754456899999999999999999999   8999999999999999999999999999998653321  


Q ss_pred             ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh-------------------hhhhhcccccch
Q 040702          665 LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE-------------------EKHLMTKEQPMV  725 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~l~  725 (797)
                      .......||+.|+|||.+.+..++.++|+|++|+..+..+.+..++...                   +......+.+++
T Consensus       180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  259 (314)
T 3com_A          180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFV  259 (314)
T ss_dssp             SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHH
T ss_pred             cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHH
Confidence            1234467999999999999889999999999999876555544333221                   111234567899


Q ss_pred             hccccCCCCCCCChHHHHH
Q 040702          726 RMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       726 ~~cl~~dp~~RPs~~~i~~  744 (797)
                      +.|++.||.+||++.++++
T Consensus       260 ~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          260 KQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             HHHTCSCTTTSCCHHHHTT
T ss_pred             HHHccCChhhCcCHHHHHh
Confidence            9999999999999998876

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.9e-34  Score=305.50  Aligned_cols=234  Identities=19%  Similarity=0.214  Sum_probs=185.2

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCC---cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG---AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      .++|...+.||+|+||.||++     ++.||||++......   ..+.+.+|+.++++++||||+++++++..++..|+|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            478999999999999999985     688999998755322   236788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      |||+++++|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus       113 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  188 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK  188 (309)
T ss_dssp             EECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred             EEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence            99999999999997654 4899999999999999999999   8999999999999999999999999999998654322


Q ss_pred             ccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh-------------------hhhhccccc
Q 040702          663 QSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE-------------------KHLMTKEQP  723 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~  723 (797)
                       ........||+.|+|||.+.+..++.++|+|++|+..+..+.+..++....                   ......+.+
T Consensus       189 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  267 (309)
T 2h34_A          189 -LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDA  267 (309)
T ss_dssp             ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHH
T ss_pred             -cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHHHH
Confidence             122334579999999999998889999999999998866555544432211                   122345678


Q ss_pred             chhccccCCCCCCC-ChHHHHHhHHHH
Q 040702          724 MVRMGTDLSLGQFP-ASYSISKYLVYI  749 (797)
Q Consensus       724 l~~~cl~~dp~~RP-s~~~i~~~l~~i  749 (797)
                      +++.|++.||++|| ++.++++.++..
T Consensus       268 li~~~l~~dP~~Rp~s~~~l~~~l~~~  294 (309)
T 2h34_A          268 VIARGMAKNPEDRYVTCGDLSAAAHAA  294 (309)
T ss_dssp             HHHHHTCSSGGGSCSSHHHHHHHHHHT
T ss_pred             HHHHhccCCHHHHHHhHHHHHHHHHHH
Confidence            89999999999999 899999888765

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=4.3e-34  Score=300.37  Aligned_cols=227  Identities=21%  Similarity=0.270  Sum_probs=191.8

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      .++|...+.||+|+||.||++     +..||||++....   ....+.+.+|++++++++||||+++++++.+.+..|+|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            368999999999999999985     5789999997642   23346789999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      |||+++|+|.+++.... .+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||++...... 
T Consensus        93 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-  167 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-  167 (284)
T ss_dssp             ECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred             EEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence            99999999999997654 4899999999999999999999   999999999999999999999999999999754322 


Q ss_pred             ccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh----------------hhhhhcccccchh
Q 040702          663 QSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE----------------EKHLMTKEQPMVR  726 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~l~~  726 (797)
                         ......||+.|+|||.+.+..++.++|+|++|+..+..+.+..++...                +......+.++++
T Consensus       168 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  244 (284)
T 2vgo_A          168 ---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLIS  244 (284)
T ss_dssp             ---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHH
T ss_pred             ---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHHHHHHH
Confidence               223467999999999999888999999999999886655544433221                1122345678999


Q ss_pred             ccccCCCCCCCChHHHHHh
Q 040702          727 MGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       727 ~cl~~dp~~RPs~~~i~~~  745 (797)
                      .|++.||.+||++.++++.
T Consensus       245 ~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          245 KLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             HHSCSSGGGSCCHHHHHTC
T ss_pred             HHhhcCHhhCCCHHHHhhC
Confidence            9999999999999998874

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.3e-34  Score=315.34  Aligned_cols=227  Identities=20%  Similarity=0.237  Sum_probs=188.6

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      .++|...+.||+|+||.||++     +..||+|+++.... ...+.+.+|+.++++++||||+++++++..++..|+|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            367999999999999999984     68899999986532 234678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCC-CeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV-PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~-~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      |+++|+|.+++.... .+++..+..++.|++.||+|||   +. +|+||||||+||+++.++.+||+|||+++.....  
T Consensus       112 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  185 (360)
T ss_dssp             CCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence            999999999997754 4899999999999999999999   75 8999999999999999999999999999754221  


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh----------------------------
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK----------------------------  715 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~----------------------------  715 (797)
                        ......||+.|+|||.+.+..++.++|+|++|+..+..+.+..++.....                            
T Consensus       186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (360)
T 3eqc_A          186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  263 (360)
T ss_dssp             --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred             --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence              22345799999999999999999999999999988665554433221100                            


Q ss_pred             --------------------------------hhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          716 --------------------------------HLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       716 --------------------------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                                                      .....+.++++.|++.||++|||+.|+++.
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                                            012346688999999999999999998863

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=6e-35  Score=319.84  Aligned_cols=224  Identities=13%  Similarity=0.110  Sum_probs=179.1

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHH---HHhhhccCCceeEee-------ee
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIEC---GMMKRIRHRNLIKII-------SS  572 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~---~~l~~l~Hpniv~l~-------~~  572 (797)
                      .++|...+.||+|+||.||++     ++.||||++....   ....+.+.+|+   +.+++++|||||+++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            467888999999999999974     6899999998542   23457788999   556666899999998       55


Q ss_pred             eecCC-----------------eEEEEEEccCCCCHHHHHhcCCC------CCCHHHHHHHHHHHHHHHHHHHccCCCCe
Q 040702          573 CSNDD-----------------FKALVLEYMPLGSLEKCLYSGNY------ILDIFQGLNIMIDVASALEYLHFGYSVPI  629 (797)
Q Consensus       573 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~------~l~~~~~~~i~~qi~~al~yLH~~~~~~i  629 (797)
                      +..++                 ..|+||||+ +|+|.+++.....      .+++..++.|+.||+.||+|||   +++|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            55443                 278999999 6799999975322      2335788899999999999999   8999


Q ss_pred             EEcCCCCCceEEcCCCcEEEEeecCCccCCccCccccccccccCcccccccccccC-----------ccchHHHHHHHhh
Q 040702          630 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG-----------EMRLKCWVNDSLL  698 (797)
Q Consensus       630 vHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~dv~s~~~  698 (797)
                      +||||||+|||++.++.+||+|||+|+....     ......| +.|+|||.+.+.           .++.++|+|++|+
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            9999999999999999999999999985321     2344567 999999999887           8999999999999


Q ss_pred             hhhhhhccccccchhhh------------hhhcccccchhccccCCCCCCCChHHHHH
Q 040702          699 ISVMIVVDANLLIREEK------------HLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       699 ~~~~~~~~~~~~~~~~~------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      ..++.+.+..++.....            .....+.++++.|++.||++||++.|+++
T Consensus       302 il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHHSSCCC------CCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHHCCCCCcccccccchhhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            98666655544433221            22345678899999999999999999986

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.1e-34  Score=303.84  Aligned_cols=237  Identities=20%  Similarity=0.242  Sum_probs=185.2

Q ss_pred             hcCCCccccccccCCcceeecc--------eEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeE
Q 040702          511 TNRFSENNLIGRGGFGPVYKDG--------MEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFK  579 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~~--------~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~  579 (797)
                      .++|+..+.||+|+||.||++.        ..||||+++...   ....+.+.+|++++++++||||+++++++..++ .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            4689999999999999999852        369999987653   223567889999999999999999999998765 8


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCC
Q 040702          580 ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  659 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  659 (797)
                      ++||||+++|+|.+++......+++..+..++.|+++||+|||   +++|+||||||+||+++.++.+||+|||+++...
T Consensus        96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence            8999999999999999876556899999999999999999999   8999999999999999999999999999998764


Q ss_pred             ccCcc-ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh------------------hhhhhc
Q 040702          660 EEDQS-LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE------------------EKHLMT  719 (797)
Q Consensus       660 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~------------------~~~~~~  719 (797)
                      ..... .......+|..|+|||.+.+..++.++|+|++|+..+..+. +..++...                  +.....
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (291)
T 1u46_A          173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ  252 (291)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred             ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCH
Confidence            33221 12234567889999999998899999999999998866554 33332211                  112234


Q ss_pred             ccccchhccccCCCCCCCChHHHHHhHHHHHH
Q 040702          720 KEQPMVRMGTDLSLGQFPASYSISKYLVYIRE  751 (797)
Q Consensus       720 ~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~  751 (797)
                      .+.++++.|++.||++||++.++++.++.+..
T Consensus       253 ~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          253 DIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence            56789999999999999999999998887644

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=8.9e-34  Score=321.26  Aligned_cols=227  Identities=21%  Similarity=0.322  Sum_probs=188.5

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEecc--CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      .++|...+.||+|+||.||++     ++.||||++....  ......+.+|++++++++||||+++++++.+.+..|+||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            468999999999999999974     6889999997652  334567899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEc---CCCcEEEEeecCCccCCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLE  660 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~---~~~~~kl~DFGla~~~~~  660 (797)
                      ||+++|+|.+.+.... .+++..+..++.|++.||.|||   +.+|+||||||+||+++   .++.+||+|||+++....
T Consensus       101 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  176 (486)
T 3mwu_A          101 ELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (486)
T ss_dssp             CCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred             EcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence            9999999999887654 4899999999999999999999   99999999999999995   456799999999986543


Q ss_pred             cCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh--------------------hhhhcc
Q 040702          661 EDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE--------------------KHLMTK  720 (797)
Q Consensus       661 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------------~~~~~~  720 (797)
                      ..   .....+||+.|+|||.+. +.++.++|+|++|++.+..+.+..++....                    ......
T Consensus       177 ~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  252 (486)
T 3mwu_A          177 NT---KMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDD  252 (486)
T ss_dssp             C-------CCTTGGGGCCGGGGG-SCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHH
T ss_pred             CC---ccCCCcCCCCCCCHHHhC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHH
Confidence            22   234567999999999876 469999999999998866555444332111                    122345


Q ss_pred             cccchhccccCCCCCCCChHHHHHh
Q 040702          721 EQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       721 ~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                      +.++++.|+..||.+|||+.++++.
T Consensus       253 ~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          253 AKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhcC
Confidence            6789999999999999999999874

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.3e-33  Score=305.18  Aligned_cols=241  Identities=22%  Similarity=0.263  Sum_probs=192.9

Q ss_pred             HHHHhcCCCccccccccCCcceeec---ceEEEEEEEEeccCCcchhHHHHHHHhhh--ccCCceeEeeeeeecCC----
Q 040702          507 LFQATNRFSENNLIGRGGFGPVYKD---GMEVAIKVFNLQYGGAFKSFDIECGMMKR--IRHRNLIKIISSCSNDD----  577 (797)
Q Consensus       507 l~~~~~~f~~~~~lg~G~~g~Vyk~---~~~vAvK~~~~~~~~~~~~~~~E~~~l~~--l~Hpniv~l~~~~~~~~----  577 (797)
                      -....++|...+.||+|+||.||++   ++.||||++...   ..+.+.+|++++..  ++||||+++++++...+    
T Consensus        37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~  113 (342)
T 1b6c_B           37 QRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT  113 (342)
T ss_dssp             HHHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred             cccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence            3445678999999999999999985   689999998643   24677889999887  78999999999998876    


Q ss_pred             eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcc-----CCCCeEEcCCCCCceEEcCCCcEEEEee
Q 040702          578 FKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFG-----YSVPIIHCDLKPSNVLLDDNMVAHLSDF  652 (797)
Q Consensus       578 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~-----~~~~ivHrDlkp~NIll~~~~~~kl~DF  652 (797)
                      ..++||||+++|+|.+++....  +++..++.++.|++.||+|||..     ++.+|+||||||+||+++.++.+||+||
T Consensus       114 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  191 (342)
T 1b6c_B          114 QLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  191 (342)
T ss_dssp             CEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred             eeEEEEeecCCCcHHHHHhccC--ccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence            7899999999999999998753  89999999999999999999932     1468999999999999999999999999


Q ss_pred             cCCccCCccCccc--cccccccCcccccccccccC------ccchHHHHHHHhhhhhhhhccc----------cccchh-
Q 040702          653 GMAKPLLEEDQSL--TQTQTLATIGYMAPDEIFSG------EMRLKCWVNDSLLISVMIVVDA----------NLLIRE-  713 (797)
Q Consensus       653 Gla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~dv~s~~~~~~~~~~~~----------~~~~~~-  713 (797)
                      |+++.........  ......||+.|+|||.+.+.      .++.++|+|++|+..++.+...          .++... 
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~  271 (342)
T 1b6c_B          192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  271 (342)
T ss_dssp             TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence            9997654332111  22445799999999988765      4457899999999886555431          111110 


Q ss_pred             ---------------------------hhhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          714 ---------------------------EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       714 ---------------------------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                                                 ..+....+.++++.||+.||++||++.++++.|+.+.+-
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~  337 (342)
T 1b6c_B          272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  337 (342)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             cCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence                                       001122456789999999999999999999999988654

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4.1e-34  Score=311.63  Aligned_cols=236  Identities=17%  Similarity=0.201  Sum_probs=186.4

Q ss_pred             cCHHHHHHHhcCCCccccccccCCcceeec----ceEEEEEEEEeccCCc-----------chhHHHHHHHhhhccCCce
Q 040702          502 FTYLELFQATNRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGGA-----------FKSFDIECGMMKRIRHRNL  566 (797)
Q Consensus       502 ~~~~~l~~~~~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~~-----------~~~~~~E~~~l~~l~Hpni  566 (797)
                      ..+.++....++|...+.||+|+||.||++    +..||||++.......           .+.+.+|++++++++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            346677888899999999999999999985    6899999997653221           2678899999999999999


Q ss_pred             eEeeeeeec-----CCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEE
Q 040702          567 IKIISSCSN-----DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL  641 (797)
Q Consensus       567 v~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll  641 (797)
                      +++++++..     ....|+||||++ |+|.+.+......+++..+..++.|++.||.|||   +.+|+||||||+||++
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNILL  167 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEE
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHEEE
Confidence            999999843     336899999997 5898888877667999999999999999999999   8999999999999999


Q ss_pred             cCCCcEEEEeecCCccCCccCccccccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchhh------
Q 040702          642 DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIREE------  714 (797)
Q Consensus       642 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~------  714 (797)
                      +.++.+||+|||+++......   ......||+.|+|||.+.+ ..++.++|+|++|+..+..+.+..++....      
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~  244 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN  244 (362)
T ss_dssp             CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             cCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            999999999999998543222   2344679999999999877 678999999999999866555444332211      


Q ss_pred             ------------------------------------------hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          715 ------------------------------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       715 ------------------------------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                                                ......+.++++.|++.||++||++.|+++
T Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence                                                      011233668999999999999999998876

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=8.7e-34  Score=301.03  Aligned_cols=230  Identities=24%  Similarity=0.295  Sum_probs=193.8

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEecc-CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      .+.|...+.||+|+||.||++     ++.||||++.... ....+.+.+|+.++++++||||+++++++...+..|+|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            357899999999999999985     6899999998654 3345789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      |+++++|.+++...  .+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++.......  
T Consensus       101 ~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--  173 (303)
T 3a7i_A          101 YLGGGSALDLLEPG--PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--  173 (303)
T ss_dssp             CCTTEEHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB--
T ss_pred             eCCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCccc--
Confidence            99999999998754  4899999999999999999999   8999999999999999999999999999998654322  


Q ss_pred             ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh-----------------hhhhcccccchhc
Q 040702          665 LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE-----------------KHLMTKEQPMVRM  727 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~l~~~  727 (797)
                      .......||+.|+|||.+.+..++.++|+|++|+..+..+....++....                 ......+.++++.
T Consensus       174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  253 (303)
T 3a7i_A          174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA  253 (303)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHH
T ss_pred             cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHH
Confidence            12345679999999999999999999999999998866555444332211                 1122346788999


Q ss_pred             cccCCCCCCCChHHHHHhHH
Q 040702          728 GTDLSLGQFPASYSISKYLV  747 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~~l~  747 (797)
                      |++.||.+||++.++++...
T Consensus       254 ~l~~dp~~Rps~~~ll~~~~  273 (303)
T 3a7i_A          254 CLNKEPSFRPTAKELLKHKF  273 (303)
T ss_dssp             HCCSSGGGSCCHHHHTTCHH
T ss_pred             HcCCChhhCcCHHHHhhChh
Confidence            99999999999999988643

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=8.9e-34  Score=305.62  Aligned_cols=238  Identities=21%  Similarity=0.206  Sum_probs=179.9

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhcc-CCceeEeeeeee--------cC
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIR-HRNLIKIISSCS--------ND  576 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~--------~~  576 (797)
                      ..+|...+.||+|+||.||++     ++.||||++........+.+.+|+.+++++. ||||+++++++.        ..
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            458999999999999999975     5789999997665555678899999999996 999999999984        33


Q ss_pred             CeEEEEEEccCCCCHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHccCCCC--eEEcCCCCCceEEcCCCcEEEEee
Q 040702          577 DFKALVLEYMPLGSLEKCLYS--GNYILDIFQGLNIMIDVASALEYLHFGYSVP--IIHCDLKPSNVLLDDNMVAHLSDF  652 (797)
Q Consensus       577 ~~~~lv~e~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~--ivHrDlkp~NIll~~~~~~kl~DF  652 (797)
                      ...++||||+. |+|.+++..  ....+++..++.++.|++.||+|||   +.+  |+||||||+||+++.++.+||+||
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Df  182 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDF  182 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecC
Confidence            46899999996 699888864  3335899999999999999999999   888  999999999999999999999999


Q ss_pred             cCCccCCccCccc----------cccccccCccccccccc---ccCccchHHHHHHHhhhhhhhhccccccchhh-----
Q 040702          653 GMAKPLLEEDQSL----------TQTQTLATIGYMAPDEI---FSGEMRLKCWVNDSLLISVMIVVDANLLIREE-----  714 (797)
Q Consensus       653 Gla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-----  714 (797)
                      |+++.........          ......||+.|+|||.+   .+..++.++|+|++|+..+..+....++....     
T Consensus       183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~  262 (337)
T 3ll6_A          183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV  262 (337)
T ss_dssp             TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh
Confidence            9998764322111          11245699999999988   56678999999999999866655444432211     


Q ss_pred             ---------hhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          715 ---------KHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       715 ---------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                               ......+.++++.|++.||.+||++.|+++.++.+...
T Consensus       263 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~  309 (337)
T 3ll6_A          263 NGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA  309 (337)
T ss_dssp             ---CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence                     11223567899999999999999999999999988765

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=5.6e-34  Score=323.44  Aligned_cols=227  Identities=20%  Similarity=0.285  Sum_probs=185.2

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEecc--CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      .++|...+.||+|+||.||++     +..||||+++...  ......+.+|+.+++.++||||++++++|.+.+..|+||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            457999999999999999974     5789999998653  234577899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCC---CcEEEEeecCCccCCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN---MVAHLSDFGMAKPLLE  660 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~---~~~kl~DFGla~~~~~  660 (797)
                      ||+++|+|.+.+.... .+++..+..++.||+.||+|||   +.+|+||||||+||+++..   +.+||+|||+|+....
T Consensus       116 e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~  191 (494)
T 3lij_A          116 ECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN  191 (494)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred             ecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence            9999999999887654 4899999999999999999999   8999999999999999764   4599999999986543


Q ss_pred             cCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh--------------------hhhhcc
Q 040702          661 EDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE--------------------KHLMTK  720 (797)
Q Consensus       661 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------------~~~~~~  720 (797)
                      ..   .....+||+.|+|||.+. +.++.++|+|++|+..+..+.+..++....                    ......
T Consensus       192 ~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  267 (494)
T 3lij_A          192 QK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEG  267 (494)
T ss_dssp             TB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHH
T ss_pred             Cc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHH
Confidence            22   234567999999999875 679999999999998866555544332211                    112345


Q ss_pred             cccchhccccCCCCCCCChHHHHHh
Q 040702          721 EQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       721 ~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                      +.++++.|+..||.+|||+.|+++.
T Consensus       268 ~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          268 AKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             HHHHHHHHCCCChhhCccHHHHhcC
Confidence            6789999999999999999999874

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.8e-34  Score=308.28  Aligned_cols=229  Identities=18%  Similarity=0.254  Sum_probs=192.9

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccC---CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG---GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      .++|...+.||+|+||.||++     ++.||+|++.....   ...+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            468999999999999999984     57899999986532   2346788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      |||+++++|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++......
T Consensus       120 ~e~~~~~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  195 (335)
T 2owb_A          120 LELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG  195 (335)
T ss_dssp             ECCCTTCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EecCCCCCHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence            99999999999987654 4899999999999999999999   8999999999999999999999999999998654222


Q ss_pred             ccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh----------------hhhhhcccccchh
Q 040702          663 QSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE----------------EKHLMTKEQPMVR  726 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~l~~  726 (797)
                      .  ......||+.|+|||.+.+..++.++|+|++|+..+..+.+..++...                +......+.++++
T Consensus       196 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  273 (335)
T 2owb_A          196 E--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ  273 (335)
T ss_dssp             C--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHH
T ss_pred             c--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHH
Confidence            1  234467999999999999888999999999999886655544433221                1112234578899


Q ss_pred             ccccCCCCCCCChHHHHHh
Q 040702          727 MGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       727 ~cl~~dp~~RPs~~~i~~~  745 (797)
                      .|++.||++||++.|+++.
T Consensus       274 ~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          274 KMLQTDPTARPTINELLND  292 (335)
T ss_dssp             HHTCSSGGGSCCGGGGGGS
T ss_pred             HHccCChhHCcCHHHHhcC
Confidence            9999999999999999875

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.2e-33  Score=298.62  Aligned_cols=227  Identities=21%  Similarity=0.267  Sum_probs=184.3

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccC
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  587 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~  587 (797)
                      +|.....||+|+||.||++     +..||||.+........+.+.+|+.+++.++||||+++++++...+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            4555569999999999985     57899999987665556789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcC-CCcEEEEeecCCccCCccCcc
Q 040702          588 LGSLEKCLYSGNY--ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD-NMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       588 ~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl~DFGla~~~~~~~~~  664 (797)
                      +++|.+++.....  .+++..+..++.|++.||+|||   +.+|+||||||+||+++. ++.+||+|||+++....... 
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-  178 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-  178 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence            9999999976532  4678889999999999999999   899999999999999987 89999999999986543221 


Q ss_pred             ccccccccCcccccccccccCc--cchHHHHHHHhhhhhhhhccccccchh-------------------hhhhhccccc
Q 040702          665 LTQTQTLATIGYMAPDEIFSGE--MRLKCWVNDSLLISVMIVVDANLLIRE-------------------EKHLMTKEQP  723 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~dv~s~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~  723 (797)
                       ......||+.|+|||.+.++.  ++.++|+|++|+..+..+.+..++...                   +......+.+
T Consensus       179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (295)
T 2clq_A          179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKA  257 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHH
T ss_pred             -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHH
Confidence             234457999999999987654  789999999999886555444333211                   1112335568


Q ss_pred             chhccccCCCCCCCChHHHHH
Q 040702          724 MVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       724 l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      +++.|++.||++||++.++++
T Consensus       258 li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          258 FILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             HHHHTTCSSTTTSCCHHHHHT
T ss_pred             HHHHHccCChhhCCCHHHHhc
Confidence            899999999999999988875

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.7e-34  Score=306.28  Aligned_cols=228  Identities=20%  Similarity=0.264  Sum_probs=183.4

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      .++|+..+.||+|+||.||++     +..||+|++........+.+.+|+++++.++||||+++++++..++..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            468999999999999999985     688999999876656668899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      +++++|.+++......+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++......  ..
T Consensus        98 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~  172 (302)
T 2j7t_A           98 CPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT--LQ  172 (302)
T ss_dssp             CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH--HH
T ss_pred             CCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc--cc
Confidence            9999999998765556899999999999999999999   899999999999999999999999999987643211  11


Q ss_pred             cccccccCcccccccccc-----cCccchHHHHHHHhhhhhhhhccccccchh-------------------hhhhhccc
Q 040702          666 TQTQTLATIGYMAPDEIF-----SGEMRLKCWVNDSLLISVMIVVDANLLIRE-------------------EKHLMTKE  721 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~  721 (797)
                      ......||+.|+|||.+.     ...++.++|+|++|+..+..+....++...                   +......+
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  252 (302)
T 2j7t_A          173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEF  252 (302)
T ss_dssp             C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHH
T ss_pred             ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHH
Confidence            223457999999999884     567889999999999876555444332221                   11223346


Q ss_pred             ccchhccccCCCCCCCChHHHH
Q 040702          722 QPMVRMGTDLSLGQFPASYSIS  743 (797)
Q Consensus       722 ~~l~~~cl~~dp~~RPs~~~i~  743 (797)
                      .++++.|++.||++||++.+++
T Consensus       253 ~~li~~~l~~dp~~Rps~~~ll  274 (302)
T 2j7t_A          253 RDFLKIALDKNPETRPSAAQLL  274 (302)
T ss_dssp             HHHHHHHSCSCTTTSCCHHHHT
T ss_pred             HHHHHHHcccChhhCCCHHHHh
Confidence            7889999999999999987754

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4.7e-34  Score=302.31  Aligned_cols=228  Identities=21%  Similarity=0.277  Sum_probs=188.2

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEeccCC---------cchhHHHHHHHhhhcc-CCceeEeeeeee
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG---------AFKSFDIECGMMKRIR-HRNLIKIISSCS  574 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~---------~~~~~~~E~~~l~~l~-Hpniv~l~~~~~  574 (797)
                      ..++|...+.||+|+||.||++     ++.||||+++.....         ..+.+.+|+++++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            3578999999999999999974     689999999765321         1356788999999996 999999999999


Q ss_pred             cCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecC
Q 040702          575 NDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGM  654 (797)
Q Consensus       575 ~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl  654 (797)
                      ..+..++||||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  170 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGF  170 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cCCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccc
Confidence            9999999999999999999997654 4899999999999999999999   89999999999999999999999999999


Q ss_pred             CccCCccCccccccccccCcccccccccc------cCccchHHHHHHHhhhhhhhhccccccchhh--------------
Q 040702          655 AKPLLEEDQSLTQTQTLATIGYMAPDEIF------SGEMRLKCWVNDSLLISVMIVVDANLLIREE--------------  714 (797)
Q Consensus       655 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------  714 (797)
                      ++......   ......||+.|+|||.+.      ...++.++|+|++|+..+..+.+..++....              
T Consensus       171 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  247 (298)
T 1phk_A          171 SCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ  247 (298)
T ss_dssp             CEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC
T ss_pred             hhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcc
Confidence            98654322   234467999999999875      4568899999999998765554443321110              


Q ss_pred             ------hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          715 ------KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       715 ------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                            ......+.++++.|++.||.+||++.|+++
T Consensus       248 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          248 FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence                  123345778999999999999999877754

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.2e-34  Score=333.26  Aligned_cols=228  Identities=21%  Similarity=0.253  Sum_probs=184.5

Q ss_pred             ccccccCCcceeec-------ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccCC
Q 040702          518 NLIGRGGFGPVYKD-------GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPL  588 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~-------~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~  588 (797)
                      +.||+|+||.||++       ++.||||+++....  ...+++.+|++++++++|||||++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999975       47899999976533  234789999999999999999999999965 458899999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc-ccc
Q 040702          589 GSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS-LTQ  667 (797)
Q Consensus       589 g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~  667 (797)
                      |+|.+++.... .+++..+..|+.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.+...... ...
T Consensus       454 g~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  529 (635)
T 4fl3_A          454 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  529 (635)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred             CCHHHHHhhCC-CCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence            99999997765 4899999999999999999999   899999999999999999999999999999876443321 223


Q ss_pred             cccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchhh-----------------hhhhcccccchhccc
Q 040702          668 TQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIREE-----------------KHLMTKEQPMVRMGT  729 (797)
Q Consensus       668 ~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~~-----------------~~~~~~~~~l~~~cl  729 (797)
                      ....||+.|+|||.+....++.++|||++|+..++.+. +..++....                 ......+.++++.||
T Consensus       530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl  609 (635)
T 4fl3_A          530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCW  609 (635)
T ss_dssp             -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred             cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHc
Confidence            34457889999999999999999999999999866654 333332211                 122335678899999


Q ss_pred             cCCCCCCCChHHHHHhHHHHH
Q 040702          730 DLSLGQFPASYSISKYLVYIR  750 (797)
Q Consensus       730 ~~dp~~RPs~~~i~~~l~~i~  750 (797)
                      +.||++||++.++++.|+.+.
T Consensus       610 ~~dP~~RPs~~~l~~~L~~~~  630 (635)
T 4fl3_A          610 TYDVENRPGFAAVELRLRNYY  630 (635)
T ss_dssp             CSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCHhHCcCHHHHHHHHHHHH
Confidence            999999999999999988764

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.5e-34  Score=311.61  Aligned_cols=226  Identities=19%  Similarity=0.220  Sum_probs=187.6

Q ss_pred             hcCCCccccccccCCcceeec---ceEEEEEEEEeccCCc---c--------------hhHHHHHHHhhhccCCceeEee
Q 040702          511 TNRFSENNLIGRGGFGPVYKD---GMEVAIKVFNLQYGGA---F--------------KSFDIECGMMKRIRHRNLIKII  570 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~---~~~vAvK~~~~~~~~~---~--------------~~~~~E~~~l~~l~Hpniv~l~  570 (797)
                      .++|...+.||+|+||.||++   ++.||||++.......   .              +.+.+|+.++++++||||++++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~  109 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE  109 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred             cCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence            468999999999999999985   7999999998653221   1              7899999999999999999999


Q ss_pred             eeeecCCeEEEEEEccCCCCHHHH------HhcC-CCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCceEEc
Q 040702          571 SSCSNDDFKALVLEYMPLGSLEKC------LYSG-NYILDIFQGLNIMIDVASALEYLHFGYS-VPIIHCDLKPSNVLLD  642 (797)
Q Consensus       571 ~~~~~~~~~~lv~e~~~~g~L~~~------l~~~-~~~l~~~~~~~i~~qi~~al~yLH~~~~-~~ivHrDlkp~NIll~  642 (797)
                      +++.+.+..|+||||+++|+|.++      +... ...+++..++.++.|++.||.|||   + .+|+||||||+||+++
T Consensus       110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Nil~~  186 (348)
T 2pml_X          110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNILMD  186 (348)
T ss_dssp             EEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGEEEC
T ss_pred             EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhEEEc
Confidence            999999999999999999999998      5542 336899999999999999999999   7 9999999999999999


Q ss_pred             CCCcEEEEeecCCccCCccCccccccccccCcccccccccccC-ccch-HHHHHHHhhhhhhhhccccccchhh------
Q 040702          643 DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG-EMRL-KCWVNDSLLISVMIVVDANLLIREE------  714 (797)
Q Consensus       643 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~dv~s~~~~~~~~~~~~~~~~~~~------  714 (797)
                      .++.+||+|||+++.....    ......||+.|+|||.+.+. .++. ++|+|++|+..+..+.+..++....      
T Consensus       187 ~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  262 (348)
T 2pml_X          187 KNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF  262 (348)
T ss_dssp             TTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred             CCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence            9999999999999865332    23456799999999999877 6665 9999999998755554443332110      


Q ss_pred             ------------------------------hhhhcccccchhccccCCCCCCCChHHHH
Q 040702          715 ------------------------------KHLMTKEQPMVRMGTDLSLGQFPASYSIS  743 (797)
Q Consensus       715 ------------------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~  743 (797)
                                                    ......+.++++.|++.||.+||++.|++
T Consensus       263 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l  321 (348)
T 2pml_X          263 NNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDAL  321 (348)
T ss_dssp             HHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred             HHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHh
Confidence                                          12234566889999999999999987776

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4.9e-35  Score=319.91  Aligned_cols=225  Identities=9%  Similarity=0.003  Sum_probs=167.2

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccC---CcchhHHHHHHHhhhc--cCCceeEee-------eee
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG---GAFKSFDIECGMMKRI--RHRNLIKII-------SSC  573 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l--~Hpniv~l~-------~~~  573 (797)
                      ...|...+.||+|+||.||++     ++.||||++.....   ...+.+.+|+.+++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            346889999999999999985     68999999987643   2245677786555555  599988855       343


Q ss_pred             ecC-----------------CeEEEEEEccCCCCHHHHHhcCCCCCCHHHH------HHHHHHHHHHHHHHHccCCCCeE
Q 040702          574 SND-----------------DFKALVLEYMPLGSLEKCLYSGNYILDIFQG------LNIMIDVASALEYLHFGYSVPII  630 (797)
Q Consensus       574 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~------~~i~~qi~~al~yLH~~~~~~iv  630 (797)
                      ..+                 ...|+||||++ |+|.+++......+++..+      ..++.||++||+|||   +++|+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~iv  216 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLV  216 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCc
Confidence            322                 23799999998 8999999864333455555      678899999999999   99999


Q ss_pred             EcCCCCCceEEcCCCcEEEEeecCCccCCccCccccccccccCccccccccccc--CccchHHHHHHHhhhhhhhhcccc
Q 040702          631 HCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS--GEMRLKCWVNDSLLISVMIVVDAN  708 (797)
Q Consensus       631 HrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~dv~s~~~~~~~~~~~~~  708 (797)
                      ||||||+|||++.++.+||+|||+|+.....     .....||+.|+|||.+.+  ..++.++|+|++|+..+..+.+..
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999865321     124567799999999987  679999999999999866555444


Q ss_pred             ccchhh-------------------------hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          709 LLIREE-------------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       709 ~~~~~~-------------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      ++....                         ......+.++++.|++.||++||++.++++
T Consensus       292 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          292 PFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             STTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            333220                         122346678899999999999999877763

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.3e-33  Score=307.40  Aligned_cols=234  Identities=22%  Similarity=0.305  Sum_probs=192.7

Q ss_pred             HHHHHHHhcCCCccccccccCCcceeec-----ceEEEEEEEEeccCC--------cchhHHHHHHHhhhc-cCCceeEe
Q 040702          504 YLELFQATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG--------AFKSFDIECGMMKRI-RHRNLIKI  569 (797)
Q Consensus       504 ~~~l~~~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~--------~~~~~~~E~~~l~~l-~Hpniv~l  569 (797)
                      +.......++|...+.||+|+||.||++     |+.||||+++.....        ..+.+.+|+.+++++ +||||+++
T Consensus        86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~  165 (365)
T 2y7j_A           86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL  165 (365)
T ss_dssp             HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            3344455678999999999999999984     689999999865421        134678899999999 79999999


Q ss_pred             eeeeecCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEE
Q 040702          570 ISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHL  649 (797)
Q Consensus       570 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl  649 (797)
                      ++++...+..|+||||+++|+|.+++.... .+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.+||
T Consensus       166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl  241 (365)
T 2y7j_A          166 IDSYESSSFMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRL  241 (365)
T ss_dssp             EEEEEBSSEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEE
T ss_pred             EEEEeeCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEE
Confidence            999999999999999999999999997654 4899999999999999999999   899999999999999999999999


Q ss_pred             EeecCCccCCccCccccccccccCccccccccccc------CccchHHHHHHHhhhhhhhhccccccchhh---------
Q 040702          650 SDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS------GEMRLKCWVNDSLLISVMIVVDANLLIREE---------  714 (797)
Q Consensus       650 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~---------  714 (797)
                      +|||+++......   ......||+.|+|||.+.+      ..++.++|+|++|+..+..+.+..++....         
T Consensus       242 ~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~  318 (365)
T 2y7j_A          242 SDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIM  318 (365)
T ss_dssp             CCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             EecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            9999998664332   2345679999999998863      358899999999999866665544432211         


Q ss_pred             -----------hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          715 -----------KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       715 -----------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                 ......+.++++.|++.||++||++.++++
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          319 EGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                       112234678999999999999999988875

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=8.4e-34  Score=322.83  Aligned_cols=227  Identities=22%  Similarity=0.315  Sum_probs=187.5

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccC-------------CcchhHHHHHHHhhhccCCceeEeeee
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG-------------GAFKSFDIECGMMKRIRHRNLIKIISS  572 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~-------------~~~~~~~~E~~~l~~l~Hpniv~l~~~  572 (797)
                      .++|...+.||+|+||.||++     +..||||++.....             ...+.+.+|+.++++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            578999999999999999974     58999999975431             224678899999999999999999999


Q ss_pred             eecCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCC---cEEE
Q 040702          573 CSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM---VAHL  649 (797)
Q Consensus       573 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~---~~kl  649 (797)
                      +.+++..|+||||+++|+|.+++.... .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++   .+||
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl  190 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKI  190 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEEE
Confidence            999999999999999999999887654 4899999999999999999999   89999999999999998765   6999


Q ss_pred             EeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh---------------
Q 040702          650 SDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE---------------  714 (797)
Q Consensus       650 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~---------------  714 (797)
                      +|||+|+......   ......||+.|+|||.+. +.++.++|+|++|+..+..+.+..++....               
T Consensus       191 ~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~  266 (504)
T 3q5i_A          191 VDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYF  266 (504)
T ss_dssp             CCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC
T ss_pred             EECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            9999998664322   234567999999999875 579999999999999866655544433211               


Q ss_pred             -----hhhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          715 -----KHLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       715 -----~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                           ......+.++++.|+..||.+|||+.|+++.
T Consensus       267 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          267 DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                 1234467789999999999999999998864

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=5.8e-34  Score=302.07  Aligned_cols=230  Identities=22%  Similarity=0.286  Sum_probs=180.8

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeec---------
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN---------  575 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~---------  575 (797)
                      ..++|+..+.||+|+||.||++     ++.||||+++... ...+.+.+|+.++++++||||+++++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            3568999999999999999975     6899999997543 234678899999999999999999998865         


Q ss_pred             ----CCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEe
Q 040702          576 ----DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSD  651 (797)
Q Consensus       576 ----~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~D  651 (797)
                          .+..|+||||+++|+|.+++......+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEee
Confidence                34689999999999999999876666888999999999999999999   89999999999999999999999999


Q ss_pred             ecCCccCCccCc------------cccccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccccccchh-----
Q 040702          652 FGMAKPLLEEDQ------------SLTQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANLLIRE-----  713 (797)
Q Consensus       652 FGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~~~~~-----  713 (797)
                      ||+++.......            ........||+.|+|||.+.+. .++.++|+|++|+..+..+. +......     
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-p~~~~~~~~~~~  238 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY-PFSTGMERVNIL  238 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS-CCSSHHHHHHHH
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh-ccCCchhHHHHH
Confidence            999986532210            1122345799999999998754 68999999999998755553 2111111     


Q ss_pred             --------------hhhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          714 --------------EKHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       714 --------------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                    +......+.++++.|++.||.+||++.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence                          1111223578999999999999999988874

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=7.9e-34  Score=297.01  Aligned_cols=228  Identities=22%  Similarity=0.285  Sum_probs=182.9

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      .++|...+.||+|+||.||++     ++.||||++....   ....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            368999999999999999975     6899999997652   23356788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      |||+++++|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++.......
T Consensus        90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  165 (276)
T 2h6d_A           90 MEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  165 (276)
T ss_dssp             EECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             EeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence            99999999999997654 3899999999999999999999   8999999999999999999999999999998654322


Q ss_pred             ccccccccccCcccccccccccCcc-chHHHHHHHhhhhhhhhccccccchh----------------hhhhhcccccch
Q 040702          663 QSLTQTQTLATIGYMAPDEIFSGEM-RLKCWVNDSLLISVMIVVDANLLIRE----------------EKHLMTKEQPMV  725 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~dv~s~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~l~  725 (797)
                         ......||+.|+|||.+.+..+ +.++|+|++|+..+..+.+..++...                +......+.+++
T Consensus       166 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  242 (276)
T 2h6d_A          166 ---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLL  242 (276)
T ss_dssp             --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred             ---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHH
Confidence               2234578999999999987765 68999999999886555544433221                111234567889


Q ss_pred             hccccCCCCCCCChHHHHHh
Q 040702          726 RMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       726 ~~cl~~dp~~RPs~~~i~~~  745 (797)
                      +.|++.||++||++.++++.
T Consensus       243 ~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          243 MHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             HHHTCSSGGGSCCHHHHHHS
T ss_pred             HHHccCChhhCCCHHHHHhC
Confidence            99999999999999998874

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.6e-34  Score=330.28  Aligned_cols=234  Identities=21%  Similarity=0.299  Sum_probs=192.9

Q ss_pred             HhcCCCccccccccCCcceeec----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      ..++|...+.||+|+||.||++    +..||||+++.... ..++|.+|++++++++||||+++++++.+ +..|+||||
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~  342 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  342 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence            4578899999999999999985    47899999975542 35789999999999999999999999876 678999999


Q ss_pred             cCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          586 MPLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       586 ~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      +++|+|.+++.... ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++...... .
T Consensus       343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~  418 (535)
T 2h8h_A          343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-Y  418 (535)
T ss_dssp             CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-H
T ss_pred             hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-e
Confidence            99999999997532 34899999999999999999999   9999999999999999999999999999998654321 1


Q ss_pred             ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-----------------hhhhhcccccchh
Q 040702          665 LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-----------------EKHLMTKEQPMVR  726 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-----------------~~~~~~~~~~l~~  726 (797)
                      .......++..|+|||.+..+.++.++|||++|+..++.+. +..++...                 +......+.++++
T Consensus       419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~  498 (535)
T 2h8h_A          419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMC  498 (535)
T ss_dssp             HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence            12234457889999999999999999999999999866655 33222211                 1112234678899


Q ss_pred             ccccCCCCCCCChHHHHHhHHHH
Q 040702          727 MGTDLSLGQFPASYSISKYLVYI  749 (797)
Q Consensus       727 ~cl~~dp~~RPs~~~i~~~l~~i  749 (797)
                      .||+.||++||++.++++.|+.+
T Consensus       499 ~cl~~dP~~RPt~~~l~~~L~~~  521 (535)
T 2h8h_A          499 QCWRKEPEERPTFEYLQAFLEDY  521 (535)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHcCCChhHCcCHHHHHHHHHHH
Confidence            99999999999999999888764

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.9e-34  Score=309.78  Aligned_cols=223  Identities=22%  Similarity=0.262  Sum_probs=179.1

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCC--cchhHHHHHHHhhhccCCceeEeeeeeecCC------
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG--AFKSFDIECGMMKRIRHRNLIKIISSCSNDD------  577 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~------  577 (797)
                      .++|...+.||+|+||.||++     ++.||||++......  ..+.+.+|+++++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            468999999999999999975     689999998654322  2457889999999999999999999997653      


Q ss_pred             eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCcc
Q 040702          578 FKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  657 (797)
Q Consensus       578 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  657 (797)
                      ..|+||||+ +++|.+++...  .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence            469999999 78999999874  3899999999999999999999   99999999999999999999999999999986


Q ss_pred             CCccCccccccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchhh----------------------
Q 040702          658 LLEEDQSLTQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIREE----------------------  714 (797)
Q Consensus       658 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------------  714 (797)
                      ...     .....+||++|+|||.+.+ ..++.++|+|++|+..++.+.+..++....                      
T Consensus       178 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  252 (367)
T 1cm8_A          178 ADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  252 (367)
T ss_dssp             CCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             ccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            532     2344679999999999887 678999999999998866555544332110                      


Q ss_pred             -------------------------hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          715 -------------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       715 -------------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                               ........++++.|+..||.+|||+.|+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          253 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence                                     011234567889999999999999999887

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-33  Score=310.46  Aligned_cols=232  Identities=20%  Similarity=0.286  Sum_probs=182.5

Q ss_pred             HHHhcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecC------
Q 040702          508 FQATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSND------  576 (797)
Q Consensus       508 ~~~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~------  576 (797)
                      ....++|...+.||+|+||.||++     ++.||||++....    ....+|+++++.++||||+++++++...      
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            345678999999999999999985     6899999987543    2334799999999999999999998543      


Q ss_pred             --------------------------------CeEEEEEEccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHH
Q 040702          577 --------------------------------DFKALVLEYMPLGSLEKCLYS---GNYILDIFQGLNIMIDVASALEYL  621 (797)
Q Consensus       577 --------------------------------~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~al~yL  621 (797)
                                                      ...++||||++ |+|.+.+..   ....+++..+..++.|+++||+||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                            34889999998 488777653   334689999999999999999999


Q ss_pred             HccCCCCeEEcCCCCCceEEc-CCCcEEEEeecCCccCCccCccccccccccCcccccccccccCc-cchHHHHHHHhhh
Q 040702          622 HFGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGE-MRLKCWVNDSLLI  699 (797)
Q Consensus       622 H~~~~~~ivHrDlkp~NIll~-~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~dv~s~~~~  699 (797)
                      |   +.+|+||||||+||+++ .++.+||+|||+|+......   ......||+.|+|||.+.+.. ++.++|+|++|+.
T Consensus       158 H---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          158 H---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             H---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             H---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            9   99999999999999998 68899999999998654332   234467899999999987654 8999999999998


Q ss_pred             hhhhhccccccchhh-h--------------------------------------------hhhcccccchhccccCCCC
Q 040702          700 SVMIVVDANLLIREE-K--------------------------------------------HLMTKEQPMVRMGTDLSLG  734 (797)
Q Consensus       700 ~~~~~~~~~~~~~~~-~--------------------------------------------~~~~~~~~l~~~cl~~dp~  734 (797)
                      .+..+.+..++.... .                                            .....+.++++.|+..||.
T Consensus       232 l~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  311 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD  311 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence            866555544433211 0                                            1122366899999999999


Q ss_pred             CCCChHHHHH--hHHHHH
Q 040702          735 QFPASYSISK--YLVYIR  750 (797)
Q Consensus       735 ~RPs~~~i~~--~l~~i~  750 (797)
                      +|||+.|+++  .++.+.
T Consensus       312 ~R~t~~e~l~hp~f~~~~  329 (383)
T 3eb0_A          312 LRINPYEAMAHPFFDHLR  329 (383)
T ss_dssp             GSCCHHHHHTSGGGHHHH
T ss_pred             hCCCHHHHhcCHHHHHHH
Confidence            9999999986  444443

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=4e-34  Score=324.17  Aligned_cols=227  Identities=22%  Similarity=0.330  Sum_probs=190.7

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      .++|...+.||+|+||.||++     ++.||||++....   ....+.+.+|+.++++++||||+++++++.+.+..|+|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            468999999999999999974     6899999997653   23456789999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEE---cCCCcEEEEeecCCccCC
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL---DDNMVAHLSDFGMAKPLL  659 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll---~~~~~~kl~DFGla~~~~  659 (797)
                      |||+.+|+|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||++   +.++.+||+|||+|+...
T Consensus       105 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  180 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE  180 (484)
T ss_dssp             ECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred             EecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence            99999999999987665 4899999999999999999999   8999999999999999   467899999999998654


Q ss_pred             ccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh--------------------hhhhc
Q 040702          660 EEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE--------------------KHLMT  719 (797)
Q Consensus       660 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------------~~~~~  719 (797)
                      ...   ......||+.|+|||.+.+ .++.++|+|++|+..+..+.+..++....                    .....
T Consensus       181 ~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  256 (484)
T 3nyv_A          181 ASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE  256 (484)
T ss_dssp             CCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCH
T ss_pred             ccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCH
Confidence            322   2344679999999998754 79999999999999866555444332211                    12334


Q ss_pred             ccccchhccccCCCCCCCChHHHHHh
Q 040702          720 KEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       720 ~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                      .+.++++.|+..||.+|||+.|+++.
T Consensus       257 ~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          257 SAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhhC
Confidence            56789999999999999999999874

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.4e-33  Score=297.42  Aligned_cols=223  Identities=20%  Similarity=0.224  Sum_probs=182.4

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeec----CCeEEE
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSN----DDFKAL  581 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~----~~~~~l  581 (797)
                      .|...+.||+|+||.||++     +..||+|.+.....  ...+.+.+|+.++++++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            4677889999999999985     57899999986532  234678899999999999999999998865    356899


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC--eEEcCCCCCceEEc-CCCcEEEEeecCCccC
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVP--IIHCDLKPSNVLLD-DNMVAHLSDFGMAKPL  658 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~--ivHrDlkp~NIll~-~~~~~kl~DFGla~~~  658 (797)
                      ||||+++|+|.+++.... .+++..+..++.|++.||+|||   +.+  |+||||||+||+++ .++.+||+|||++...
T Consensus       107 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEecCCCCHHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence            999999999999997654 4899999999999999999999   888  99999999999998 7899999999999754


Q ss_pred             CccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccch-------------------hhhhhhc
Q 040702          659 LEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIR-------------------EEKHLMT  719 (797)
Q Consensus       659 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~-------------------~~~~~~~  719 (797)
                      ...    ......||+.|+|||.+. +.++.++|+|++|+..+..+....++..                   .+.....
T Consensus       183 ~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (290)
T 1t4h_A          183 RAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP  257 (290)
T ss_dssp             CTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred             ccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCH
Confidence            322    233457999999999765 5689999999999988665554433222                   1111223


Q ss_pred             ccccchhccccCCCCCCCChHHHHH
Q 040702          720 KEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       720 ~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      .+.++++.|++.||.+||++.|+++
T Consensus       258 ~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          258 EVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhh
Confidence            5678999999999999999988774

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.2e-33  Score=308.16  Aligned_cols=229  Identities=21%  Similarity=0.225  Sum_probs=186.8

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCC-cchhHHHHHHHhhhccCCceeEeeeeeecC-----CeE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCSND-----DFK  579 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~-----~~~  579 (797)
                      .++|...+.||+|+||.||++     +..||||++...... ..+.+.+|++++++++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            468999999999999999985     588999999754322 236788999999999999999999998755     368


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCC
Q 040702          580 ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  659 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  659 (797)
                      |+||||++ |+|.+++....  +++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus       106 ~iv~e~~~-~~L~~~l~~~~--~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  179 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQH--LSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  179 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEcccC-cCHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence            99999997 59999987653  899999999999999999999   9999999999999999999999999999998664


Q ss_pred             ccCccc-cccccccCcccccccccccCc-cchHHHHHHHhhhhhhhhccccccchhh-----------------------
Q 040702          660 EEDQSL-TQTQTLATIGYMAPDEIFSGE-MRLKCWVNDSLLISVMIVVDANLLIREE-----------------------  714 (797)
Q Consensus       660 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~dv~s~~~~~~~~~~~~~~~~~~~-----------------------  714 (797)
                      ...... ......||+.|+|||.+.++. ++.++|+|++|+..+..+.+..++....                       
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  259 (364)
T 3qyz_A          180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  259 (364)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred             CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            332211 234568999999999876544 8999999999999866555444332110                       


Q ss_pred             ------------------------hhhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          715 ------------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       715 ------------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                                              ......+.++++.|+..||++||++.|+++.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                                    1122346689999999999999999998863

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=8.4e-34  Score=312.21  Aligned_cols=224  Identities=23%  Similarity=0.302  Sum_probs=176.9

Q ss_pred             hcCCCccccccccCCcceeec----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCC------eEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDD------FKA  580 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~------~~~  580 (797)
                      ..+|...+.||+|+||.||++    +..||+|++....    ....+|+++++.++||||+++++++...+      ..+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            357999999999999999975    4569999886443    22347999999999999999999986443      378


Q ss_pred             EEEEccCCCCHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEc-CCCcEEEEeecCCcc
Q 040702          581 LVLEYMPLGSLEKCLY--SGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKP  657 (797)
Q Consensus       581 lv~e~~~~g~L~~~l~--~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~-~~~~~kl~DFGla~~  657 (797)
                      +||||++++.+.....  .....+++..++.++.|++.||+|||   +.+|+||||||+||+++ .++.+||+|||+|+.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            9999998754333321  22335899999999999999999999   99999999999999999 799999999999986


Q ss_pred             CCccCccccccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccccccchhhh---------------------
Q 040702          658 LLEEDQSLTQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANLLIREEK---------------------  715 (797)
Q Consensus       658 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~---------------------  715 (797)
                      .....   ......||+.|+|||.+.+. .++.++|+|++|+..++.+.+..++.....                     
T Consensus       192 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  268 (394)
T 4e7w_A          192 LIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT  268 (394)
T ss_dssp             CCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             ccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            54332   23346789999999998765 589999999999998666655444332110                     


Q ss_pred             ------------------------hhhcccccchhccccCCCCCCCChHHHHH
Q 040702          716 ------------------------HLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       716 ------------------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                              .....+.++++.|+..||.+||++.|+++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence                                    12235668999999999999999988875

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.8e-34  Score=307.18  Aligned_cols=239  Identities=19%  Similarity=0.238  Sum_probs=190.7

Q ss_pred             HhcCCCccccccccCCcceeec--ceEEEEEEEEecc--CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD--GMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~--~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      ..++|+..+.||+|+||.||++  +..||+|+++...  ....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~  110 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSL  110 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESSSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBC
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcCeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeec
Confidence            3578999999999999999986  3579999987553  23346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC---
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED---  662 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~---  662 (797)
                      +++++|.+++...+..+++..+..++.|++.||+|||   +.+|+||||||+||+++ ++.+||+|||+++......   
T Consensus       111 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~  186 (319)
T 2y4i_B          111 CKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGR  186 (319)
T ss_dssp             CCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC---------
T ss_pred             ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCccccccccccc
Confidence            9999999999876656899999999999999999999   89999999999999998 6799999999987543211   


Q ss_pred             ccccccccccCccccccccccc---------CccchHHHHHHHhhhhhhhhccccccchhhh------------------
Q 040702          663 QSLTQTQTLATIGYMAPDEIFS---------GEMRLKCWVNDSLLISVMIVVDANLLIREEK------------------  715 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~------------------  715 (797)
                      .........||+.|+|||.+..         ..++.++|+|++|+..+..+....++.....                  
T Consensus       187 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  266 (319)
T 2y4i_B          187 REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQI  266 (319)
T ss_dssp             -CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCCS
T ss_pred             cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCcC
Confidence            1112234569999999998864         4578999999999987665554443322111                  


Q ss_pred             hhhcccccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          716 HLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       716 ~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                      .....+.++++.|++.||++||++.++++.++.+.+-
T Consensus       267 ~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          267 GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence            1234677899999999999999999999988876554

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1e-33  Score=309.31  Aligned_cols=225  Identities=21%  Similarity=0.230  Sum_probs=177.1

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCC--cchhHHHHHHHhhhccCCceeEeeeeeecCC------
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG--AFKSFDIECGMMKRIRHRNLIKIISSCSNDD------  577 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~------  577 (797)
                      .++|...+.||+|+||.||++     ++.||||++......  ..+.+.+|+.+++.++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            368999999999999999975     689999999865322  2457889999999999999999999997664      


Q ss_pred             eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCcc
Q 040702          578 FKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  657 (797)
Q Consensus       578 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  657 (797)
                      ..|+||||+++ +|.+.+..   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  176 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  176 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred             ceEEEEEcCCC-CHHHHHhh---ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence            78999999975 78888864   3789999999999999999999   89999999999999999999999999999986


Q ss_pred             CCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh-----------------------
Q 040702          658 LLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE-----------------------  714 (797)
Q Consensus       658 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-----------------------  714 (797)
                      .....   ......||+.|+|||.+.+..++.++|+|++|+..+..+.+..++....                       
T Consensus       177 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  253 (371)
T 2xrw_A          177 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL  253 (371)
T ss_dssp             ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred             ccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence            53221   2344679999999999999899999999999998865555443322110                       


Q ss_pred             -----------------------------------hhhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          715 -----------------------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       715 -----------------------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                                                         ......+.++++.|+..||++|||+.|+++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence                                               0012345689999999999999999999874

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.3e-33  Score=329.47  Aligned_cols=237  Identities=22%  Similarity=0.257  Sum_probs=191.5

Q ss_pred             hcCCCccccccccCCcceeec--------ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD--------GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~--------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l  581 (797)
                      .++|...+.||+|+||.||++        +..||||.++.... ...+.+.+|+.++++++||||+++++++. ++..|+
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l  467 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI  467 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence            467888999999999999975        25699998865432 22467899999999999999999999985 456899


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCcc
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  661 (797)
                      ||||+++|+|.+++......+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus       468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~  544 (656)
T 2j0j_A          468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  544 (656)
T ss_dssp             EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-
T ss_pred             EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecCCC
Confidence            99999999999999877666899999999999999999999   899999999999999999999999999999876433


Q ss_pred             CccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-----------------hhhhhccccc
Q 040702          662 DQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-----------------EKHLMTKEQP  723 (797)
Q Consensus       662 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-----------------~~~~~~~~~~  723 (797)
                      . ........||+.|||||.+....++.++|+|++|+..++.+. +..++...                 +......+.+
T Consensus       545 ~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  623 (656)
T 2j0j_A          545 T-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS  623 (656)
T ss_dssp             ----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHHH
T ss_pred             c-ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHH
Confidence            2 222334567889999999998899999999999998866553 33222211                 1122345678


Q ss_pred             chhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          724 MVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       724 l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                      +++.||+.||++||++.++++.|+.+.+.
T Consensus       624 li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          624 LMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            99999999999999999999999987654

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.6e-33  Score=297.55  Aligned_cols=231  Identities=19%  Similarity=0.244  Sum_probs=185.5

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEecc----CCcchhHHHHHHHhhhccCCceeEeeeeee--cCCeE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY----GGAFKSFDIECGMMKRIRHRNLIKIISSCS--NDDFK  579 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~--~~~~~  579 (797)
                      .++|...+.||+|+||.||++     +..||||+++...    ....+.+.+|++++++++||||+++++++.  +.+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            468999999999999999974     5789999997652    234567899999999999999999999984  44578


Q ss_pred             EEEEEccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccC
Q 040702          580 ALVLEYMPLGSLEKCLYSG-NYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  658 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  658 (797)
                      |+||||++++ +.+++... ...+++..+..++.|+++||+|||   +++|+||||||+||+++.++.+||+|||+++..
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            9999999876 76766543 336899999999999999999999   899999999999999999999999999999866


Q ss_pred             CccCccccccccccCcccccccccccCc--cchHHHHHHHhhhhhhhhccccccchhh----------------hhhhcc
Q 040702          659 LEEDQSLTQTQTLATIGYMAPDEIFSGE--MRLKCWVNDSLLISVMIVVDANLLIREE----------------KHLMTK  720 (797)
Q Consensus       659 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------~~~~~~  720 (797)
                      .............||+.|+|||.+.+..  ++.++|+|++|+..+..+.+..++....                ......
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~  239 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPP  239 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHH
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHH
Confidence            4333233334567999999999887543  4789999999998866555544333211                112334


Q ss_pred             cccchhccccCCCCCCCChHHHHHh
Q 040702          721 EQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       721 ~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                      +.++++.|++.||.+||++.|+++.
T Consensus       240 l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          240 LSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHHccCChhhCCCHHHHhcC
Confidence            6789999999999999999999875

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.1e-34  Score=306.89  Aligned_cols=238  Identities=26%  Similarity=0.294  Sum_probs=186.0

Q ss_pred             ccCHHHHHHHhcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhc-cCCceeEeeeeee
Q 040702          501 RFTYLELFQATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRI-RHRNLIKIISSCS  574 (797)
Q Consensus       501 ~~~~~~l~~~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~  574 (797)
                      .+++.++....++|+..+.||+|+||.||++     ++.||||++.... ...+.+.+|+.+++++ +||||+++++++.
T Consensus        13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   91 (326)
T 2x7f_A           13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI   91 (326)
T ss_dssp             ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred             hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence            3444445556789999999999999999984     5799999997553 3357889999999999 7999999999997


Q ss_pred             c------CCeEEEEEEccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcE
Q 040702          575 N------DDFKALVLEYMPLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVA  647 (797)
Q Consensus       575 ~------~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~  647 (797)
                      .      .+..|+||||+++|+|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~  168 (326)
T 2x7f_A           92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEV  168 (326)
T ss_dssp             ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCE
T ss_pred             eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCE
Confidence            6      468899999999999999997653 35899999999999999999999   8999999999999999999999


Q ss_pred             EEEeecCCccCCccCccccccccccCcccccccccc-----cCccchHHHHHHHhhhhhhhhccccccchhh--------
Q 040702          648 HLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIF-----SGEMRLKCWVNDSLLISVMIVVDANLLIREE--------  714 (797)
Q Consensus       648 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------  714 (797)
                      ||+|||++.......  .......||+.|+|||.+.     ...++.++|+|++|+..+..+.+..++....        
T Consensus       169 kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~  246 (326)
T 2x7f_A          169 KLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI  246 (326)
T ss_dssp             EECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred             EEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh
Confidence            999999998653221  1234457999999999887     5668899999999998866555444332211        


Q ss_pred             ----------hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          715 ----------KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       715 ----------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                ......+.++++.|+..||.+||++.++++
T Consensus       247 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          247 PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                      112235678999999999999999998876

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.6e-33  Score=301.72  Aligned_cols=227  Identities=22%  Similarity=0.236  Sum_probs=182.9

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEecc--------CCcchhHHHHHHHhhhccCCceeEeeeeeecC
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY--------GGAFKSFDIECGMMKRIRHRNLIKIISSCSND  576 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~--------~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~  576 (797)
                      ..++|...+.||+|+||.||++     ++.||||++....        ......+.+|++++++++||||+++++++..+
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            3468999999999999999985     5899999986542        12235688999999999999999999998766


Q ss_pred             CeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCc---EEEEeec
Q 040702          577 DFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV---AHLSDFG  653 (797)
Q Consensus       577 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~---~kl~DFG  653 (797)
                      + .|+||||+++|+|.+++.... .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.   +||+|||
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  162 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFG  162 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTTC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred             c-eEEEEecCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence            5 899999999999999887654 4899999999999999999999   899999999999999987654   9999999


Q ss_pred             CCccCCccCccccccccccCcccccccccc---cCccchHHHHHHHhhhhhhhhccccccchh-----------------
Q 040702          654 MAKPLLEEDQSLTQTQTLATIGYMAPDEIF---SGEMRLKCWVNDSLLISVMIVVDANLLIRE-----------------  713 (797)
Q Consensus       654 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~-----------------  713 (797)
                      +++......   ......||+.|+|||.+.   ...++.++|+|++|+..+..+.+..++...                 
T Consensus       163 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (322)
T 2ycf_A          163 HSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNF  239 (322)
T ss_dssp             TCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCC
T ss_pred             cceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcccc
Confidence            998653221   223457999999999874   466889999999999886555544333211                 


Q ss_pred             ----hhhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          714 ----EKHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       714 ----~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                          .......+.++++.|++.||++||++.++++
T Consensus       240 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          240 IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence                1122345678899999999999999999875

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3e-34  Score=300.73  Aligned_cols=231  Identities=20%  Similarity=0.233  Sum_probs=187.1

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeee--cCCeEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCS--NDDFKAL  581 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~--~~~~~~l  581 (797)
                      .++|+..+.||+|+||.||++     ++.||+|++.....  ...+.+.+|+.++++++||||+++++++.  ..+..|+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            468999999999999999984     68899999986532  23467889999999999999999999875  4568999


Q ss_pred             EEEccCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHccCCCC-----eEEcCCCCCceEEcCCCcEEEEeec
Q 040702          582 VLEYMPLGSLEKCLYSG---NYILDIFQGLNIMIDVASALEYLHFGYSVP-----IIHCDLKPSNVLLDDNMVAHLSDFG  653 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~al~yLH~~~~~~-----ivHrDlkp~NIll~~~~~~kl~DFG  653 (797)
                      ||||+++|+|.+++...   ...+++..++.++.|++.||+|||   +.+     |+||||||+||+++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            99999999999998653   224899999999999999999999   777     9999999999999999999999999


Q ss_pred             CCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh-----------------hh
Q 040702          654 MAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE-----------------KH  716 (797)
Q Consensus       654 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-----------------~~  716 (797)
                      +++......  .......||+.|+|||.+.+..++.++|+|++|+..+..+....++....                 ..
T Consensus       162 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~  239 (279)
T 2w5a_A          162 LARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR  239 (279)
T ss_dssp             HHHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred             hheeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcc
Confidence            998653322  12234579999999999998899999999999998865554443322211                 11


Q ss_pred             hhcccccchhccccCCCCCCCChHHHHHhH
Q 040702          717 LMTKEQPMVRMGTDLSLGQFPASYSISKYL  746 (797)
Q Consensus       717 ~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l  746 (797)
                      ....+.++++.|++.||++||++.|+++..
T Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          240 YSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             cCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence            234567899999999999999999998754

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=3.9e-34  Score=303.62  Aligned_cols=232  Identities=21%  Similarity=0.246  Sum_probs=171.7

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEecc-CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ..++|...+.||+|+||.||++     ++.||||++.... ....+++.+|+.++++++||||+++++++...+..++||
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            4578999999999999999985     5889999986543 234567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCc
Q 040702          584 EYMPLGSLEKCLYS-------GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  656 (797)
Q Consensus       584 e~~~~g~L~~~l~~-------~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  656 (797)
                      ||+++|+|.+++..       ....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            99999999999864       2335899999999999999999999   8999999999999999999999999999987


Q ss_pred             cCCccCcc---ccccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchhhh-----------------
Q 040702          657 PLLEEDQS---LTQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIREEK-----------------  715 (797)
Q Consensus       657 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~-----------------  715 (797)
                      ........   .......||+.|+|||.+.+ ..++.++|+|++|+..+..+.+..++.....                 
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  249 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET  249 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccc
Confidence            65432211   12234579999999998875 4588999999999988665554443322110                 


Q ss_pred             ---------hhhcccccchhccccCCCCCCCChHHHHH
Q 040702          716 ---------HLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       716 ---------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                               .....+.++++.|++.||.+||++.++++
T Consensus       250 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             -----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence                     11123567899999999999999988874

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=2e-33  Score=312.49  Aligned_cols=189  Identities=21%  Similarity=0.292  Sum_probs=161.1

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhc------cCCceeEeeeeeecCCeE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRI------RHRNLIKIISSCSNDDFK  579 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l------~Hpniv~l~~~~~~~~~~  579 (797)
                      ..+|+..+.||+|+||.||++     ++.||||+++... ...+.+.+|+++++.+      +|+||+++++++...+..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            357999999999999999985     6899999997432 2235677899888887      477999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCc--EEEEeecCCc
Q 040702          580 ALVLEYMPLGSLEKCLYSGNY-ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV--AHLSDFGMAK  656 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~--~kl~DFGla~  656 (797)
                      ++||||+. ++|.+++..... .+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.  +||+|||+|+
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            99999996 699998876543 5899999999999999999999   899999999999999999887  9999999997


Q ss_pred             cCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccc
Q 040702          657 PLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANL  709 (797)
Q Consensus       657 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~  709 (797)
                      ....     .....+||+.|||||.+.+..++.++|+|++|+..++.+.+..+
T Consensus       251 ~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~p  298 (429)
T 3kvw_A          251 YEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPL  298 (429)
T ss_dssp             ETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             ecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCC
Confidence            5432     22346799999999999999999999999999998665554433

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.1e-33  Score=300.36  Aligned_cols=228  Identities=21%  Similarity=0.276  Sum_probs=178.6

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeee-----------
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS-----------  574 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~-----------  574 (797)
                      .++|...+.||+|+||.||++     ++.||||++........+.+.+|++++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            368999999999999999985     6899999998665455678899999999999999999999874           


Q ss_pred             ---cCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEc-CCCcEEEE
Q 040702          575 ---NDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD-DNMVAHLS  650 (797)
Q Consensus       575 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~-~~~~~kl~  650 (797)
                         +.+..|+||||++ |+|.+++...  .+++..++.++.|++.||+|||   +.+|+||||||+||+++ +++.+||+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQG--PLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             cccccCceeEEeeccC-CCHHHHhhcC--CccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEc
Confidence               3467899999997 5999998754  4889999999999999999999   89999999999999997 56799999


Q ss_pred             eecCCccCCccCc-cccccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchhh--------------
Q 040702          651 DFGMAKPLLEEDQ-SLTQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIREE--------------  714 (797)
Q Consensus       651 DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------  714 (797)
                      |||+++....... ........||..|+|||.+.. ..++.++|+|++|+..+..+.+..++....              
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  243 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV  243 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred             cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            9999986532211 112234568999999998876 678999999999998766555443332111              


Q ss_pred             --------------------------------hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          715 --------------------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       715 --------------------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                                      ......+.++++.|++.||++||++.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             CCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             CchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence                                            112345678999999999999999888864

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-33  Score=314.38  Aligned_cols=228  Identities=19%  Similarity=0.317  Sum_probs=176.2

Q ss_pred             HhcCCCccccccccCCccee-e---cceEEEEEEEEeccCCcchhHHHHHHHhhhc-cCCceeEeeeeeecCCeEEEEEE
Q 040702          510 ATNRFSENNLIGRGGFGPVY-K---DGMEVAIKVFNLQYGGAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vy-k---~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      ...+|...+.||+|+||.|| +   .++.||||++...   ....+.+|+++++.+ +|||||++++++.+.+..|+|||
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E   98 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE---CFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE   98 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTT---TEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence            34578899999999999965 3   3689999998643   234567899999999 79999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcC-----CCcEEEEeecCCccCC
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD-----NMVAHLSDFGMAKPLL  659 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~-----~~~~kl~DFGla~~~~  659 (797)
                      |++ |+|.+++........+..+..++.||++||+|||   +.+|+||||||+||+++.     ...+||+|||+|+...
T Consensus        99 ~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~  174 (432)
T 3p23_A           99 LCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA  174 (432)
T ss_dssp             CCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred             CCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence            996 5999999876654555567889999999999999   899999999999999953     3468899999998764


Q ss_pred             ccCc-cccccccccCcccccccccc---cCccchHHHHHHHhhhhhhhhc-cccccchhhhh------------------
Q 040702          660 EEDQ-SLTQTQTLATIGYMAPDEIF---SGEMRLKCWVNDSLLISVMIVV-DANLLIREEKH------------------  716 (797)
Q Consensus       660 ~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~~~~------------------  716 (797)
                      .... ........||+.|+|||.+.   ...++.++|+|++|+..++.+. +..+++.....                  
T Consensus       175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  254 (432)
T 3p23_A          175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEK  254 (432)
T ss_dssp             -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTC
T ss_pred             CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccc
Confidence            3321 12334567999999999987   4567889999999999866655 44333321111                  


Q ss_pred             -hhcccccchhccccCCCCCCCChHHHHH
Q 040702          717 -LMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       717 -~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                       ......++++.|++.||.+||++.++++
T Consensus       255 ~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          255 HEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             HHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence             1112567999999999999999999874

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=100.00  E-value=4.4e-36  Score=338.51  Aligned_cols=363  Identities=17%  Similarity=0.139  Sum_probs=192.6

Q ss_pred             CCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCccccc----CCccccCCCCCCEEEccCCcCcccCCC
Q 040702           20 PSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGV----VPTTIFNVSTLKSLYLHSNSLSGRLPS   95 (797)
Q Consensus        20 l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~----~p~~~~~l~~L~~L~Ls~N~l~~~l~~   95 (797)
                      +++|++|||++|++++..       ....+..+++|++|++++|+++..    ++..+..+++|++|+|++|.++...+.
T Consensus         2 ~~~l~~L~Ls~~~l~~~~-------~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~   74 (461)
T 1z7x_W            2 SLDIQSLDIQCEELSDAR-------WAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVH   74 (461)
T ss_dssp             CEEEEEEEEESCCCCHHH-------HHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHH
T ss_pred             CccceehhhhhcccCchh-------HHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHH
Confidence            456788888888754321       112256677888888888888742    466677778888888888888643333


Q ss_pred             ccccCCC----CccEEEccCccccc----cCCchhhCCCCCCEEEccCCcCcccCCcccc-----CCCCCCeeeccCccC
Q 040702           96 SADVRLP----NLKELHLWGNNFIG----TIPSFIFNASKLSELGLQKNSFSGSIPNTFG-----NLRNLKWLGLNDNYL  162 (797)
Q Consensus        96 ~~~~~l~----~L~~L~L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~-----~l~~L~~L~L~~N~l  162 (797)
                      .++..++    +|++|+|++|+++.    .++..|..+++|++|+|++|+|+...+..+.     ..++|++|+|++|.+
T Consensus        75 ~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l  154 (461)
T 1z7x_W           75 CVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSL  154 (461)
T ss_dssp             HHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred             HHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCC
Confidence            3344444    68888888888773    4466777777888888888877654443332     245677777777776


Q ss_pred             cCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhc----cccCCcEEEccCCccccc----CChhhhhhhhhHhhh
Q 040702          163 TSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGN----LSQSMEDFWMDNCNISGS----IPEEINNLTNLILQL  234 (797)
Q Consensus       163 ~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~----l~~~L~~L~L~~n~i~~~----~p~~~~~l~~L~L~~  234 (797)
                      +...... -...+..+++|+.|++++|++....+..+..    ...+|+.|++++|.++..    ++..+..+++|  ++
T Consensus       155 ~~~~~~~-l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L--~~  231 (461)
T 1z7x_W          155 SAASCEP-LASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASL--RE  231 (461)
T ss_dssp             BGGGHHH-HHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTC--CE
T ss_pred             CHHHHHH-HHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCc--cE
Confidence            6532110 0012344566777777777665443333332    111566666666665542    23344444444  45


Q ss_pred             cccccccccCCC-----chhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEcc
Q 040702          235 LSLEGNQLEGSI-----PDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLS  309 (797)
Q Consensus       235 L~Ls~N~l~~~~-----~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~  309 (797)
                      |++++|.+.+..     +..+..+++|++|++++|.++......                   ++..+..+++|++|+++
T Consensus       232 L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~-------------------l~~~l~~~~~L~~L~Ls  292 (461)
T 1z7x_W          232 LALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGD-------------------LCRVLRAKESLKELSLA  292 (461)
T ss_dssp             EECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHH-------------------HHHHHHHCTTCCEEECT
T ss_pred             EeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHH-------------------HHHHHhhCCCcceEECC
Confidence            555555444321     111123444555555555444320000                   33333344445555555


Q ss_pred             CCcCCCCCCccccc-----cccccEEeccCcccccc----cCccccCCcccceecccCccccCCCChhhhc-----cccC
Q 040702          310 SNFFTGPLPLKIGN-----LNVLVQLDLSMNNFSCV----IPTKIGGLKDLQYLFLEYNRLQGSIPNSIGD-----LISL  375 (797)
Q Consensus       310 ~N~l~~~~~~~~~~-----l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L  375 (797)
                      +|.+++..+..+..     .++|++|++++|.+++.    ++..+..+++|++|+|++|++++..+..+..     .++|
T Consensus       293 ~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L  372 (461)
T 1z7x_W          293 GNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVL  372 (461)
T ss_dssp             TCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCC
T ss_pred             CCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCce
Confidence            55444322222221     13455555555555433    2333444455555555555554433333332     3455


Q ss_pred             CeeeecCCcCCC----CCChhhhccCCCCeEEccCCcCcc
Q 040702          376 KSLNLSNNNLSG----TIPISLEKLLDLKDINVSFNRLEG  411 (797)
Q Consensus       376 ~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~  411 (797)
                      ++|+|++|.+++    .+|..+..+++|+.|++++|++++
T Consensus       373 ~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~  412 (461)
T 1z7x_W          373 RVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD  412 (461)
T ss_dssp             CEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred             EEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCH
Confidence            555555555553    445555555555555555555543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.9e-33  Score=310.34  Aligned_cols=224  Identities=19%  Similarity=0.215  Sum_probs=181.9

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhcc--------CCceeEeeeeee---
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIR--------HRNLIKIISSCS---  574 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~--------Hpniv~l~~~~~---  574 (797)
                      .++|...+.||+|+||.||++     ++.||||+++... ...+.+.+|+++++.++        ||||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            368999999999999999985     6899999997432 23467889999999996        788999999987   


Q ss_pred             -cCCeEEEEEEccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHccCCC-CeEEcCCCCCceEEcCCC------
Q 040702          575 -NDDFKALVLEYMPLGSLEKCLYSG-NYILDIFQGLNIMIDVASALEYLHFGYSV-PIIHCDLKPSNVLLDDNM------  645 (797)
Q Consensus       575 -~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~yLH~~~~~-~ivHrDlkp~NIll~~~~------  645 (797)
                       .....|+||||+. |++.+.+... ...+++..++.++.||+.||+|||   ++ +|+||||||+|||++.++      
T Consensus       115 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          115 VNGTHICMVFEVLG-HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             TTEEEEEEEECCCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred             CCCceEEEEEeccC-ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhh
Confidence             5568999999994 5666655443 346899999999999999999999   87 999999999999999775      


Q ss_pred             -------------------------------------------cEEEEeecCCccCCccCccccccccccCccccccccc
Q 040702          646 -------------------------------------------VAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI  682 (797)
Q Consensus       646 -------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~  682 (797)
                                                                 .+||+|||+|+.....     .....||+.|+|||.+
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHH
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhh
Confidence                                                       7999999999865322     2345799999999999


Q ss_pred             ccCccchHHHHHHHhhhhhhhhccccccchhh------------------------------------------------
Q 040702          683 FSGEMRLKCWVNDSLLISVMIVVDANLLIREE------------------------------------------------  714 (797)
Q Consensus       683 ~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~------------------------------------------------  714 (797)
                      .+..++.++|+|++|++.++.+.+..++....                                                
T Consensus       266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (397)
T 1wak_A          266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL  345 (397)
T ss_dssp             HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred             cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence            99999999999999999866665544432110                                                


Q ss_pred             ----------------hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          715 ----------------KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       715 ----------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                      ......+.++++.|++.||++|||+.|+++
T Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                            111223568999999999999999988874

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=6.3e-33  Score=297.61  Aligned_cols=228  Identities=22%  Similarity=0.300  Sum_probs=186.0

Q ss_pred             HhcCCCccccccccCCcceeec------ceEEEEEEEEeccC--CcchhHHHHHHHhhhc---cCCceeEeeeeee----
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD------GMEVAIKVFNLQYG--GAFKSFDIECGMMKRI---RHRNLIKIISSCS----  574 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~------~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l---~Hpniv~l~~~~~----  574 (797)
                      +.++|...+.||+|+||.||++      ++.||||+++....  .....+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            4578999999999999999974      57899999976542  2345788899888877   7999999999987    


Q ss_pred             -cCCeEEEEEEccCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEee
Q 040702          575 -NDDFKALVLEYMPLGSLEKCLYSGNY-ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDF  652 (797)
Q Consensus       575 -~~~~~~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF  652 (797)
                       .....++||||++ |+|.+++..... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecC
Confidence             4567899999997 699999876543 5899999999999999999999   899999999999999999999999999


Q ss_pred             cCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh------------------
Q 040702          653 GMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE------------------  714 (797)
Q Consensus       653 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~------------------  714 (797)
                      |+++......   ......||+.|+|||.+.++.++.++|+|++|+..+..+.+..++....                  
T Consensus       165 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (326)
T 1blx_A          165 GLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  241 (326)
T ss_dssp             CSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             cccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence            9998654222   2345679999999999999999999999999998765554443332111                  


Q ss_pred             -------------------------hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          715 -------------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       715 -------------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                               ......+.++++.|++.||++||++.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                                     011223457889999999999999888764

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2.7e-33  Score=304.03  Aligned_cols=229  Identities=21%  Similarity=0.238  Sum_probs=183.5

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecC-----CeE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSND-----DFK  579 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~-----~~~  579 (797)
                      .++|...+.||+|+||.||++     ++.||||++..... .....+.+|++++++++||||+++++++..+     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            468999999999999999985     68899999964432 2245678999999999999999999987654     678


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCC
Q 040702          580 ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  659 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  659 (797)
                      |+||||+. |+|.+++...  .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        90 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVISTQ--MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID  163 (353)
T ss_dssp             EEEECCCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeccC-ccHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence            99999997 5999998775  3899999999999999999999   8999999999999999999999999999998654


Q ss_pred             ccCccc--------cccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchhh----------------
Q 040702          660 EEDQSL--------TQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIREE----------------  714 (797)
Q Consensus       660 ~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------  714 (797)
                      ......        ......||+.|+|||.+.. ..++.++|+|++|+..+..+.+..++....                
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  243 (353)
T 2b9h_A          164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH  243 (353)
T ss_dssp             ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence            321110        1233578999999998765 678999999999998755554443332110                


Q ss_pred             --------------------------------hhhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          715 --------------------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       715 --------------------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                                                      ......+.++++.|++.||++||++.|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                                            1122345678999999999999999998873

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.5e-33  Score=297.22  Aligned_cols=227  Identities=19%  Similarity=0.170  Sum_probs=171.4

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCC-c-chhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG-A-FKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~-~-~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      .++|+..+.||+|+||.||++     ++.||||+++..... . .+.+..+...++.++||||+++++++.+++..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            478999999999999999974     689999999755322 1 233444555578889999999999999999999999


Q ss_pred             EccCCCCHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHccCCC-CeEEcCCCCCceEEcCCCcEEEEeecCCccCC
Q 040702          584 EYMPLGSLEKCLYS---GNYILDIFQGLNIMIDVASALEYLHFGYSV-PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  659 (797)
Q Consensus       584 e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~al~yLH~~~~~-~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  659 (797)
                      ||+++ +|.+++..   ....+++..+..++.|++.||+|||   ++ +|+||||||+||+++.++.+||+|||+++...
T Consensus        86 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99974 88777653   3346899999999999999999999   87 99999999999999999999999999998654


Q ss_pred             ccCccccccccccCccccccccc----ccCccchHHHHHHHhhhhhhhhccccccchh-------------------hhh
Q 040702          660 EEDQSLTQTQTLATIGYMAPDEI----FSGEMRLKCWVNDSLLISVMIVVDANLLIRE-------------------EKH  716 (797)
Q Consensus       660 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~-------------------~~~  716 (797)
                      ...   ......||+.|+|||.+    ....++.++|+|++|+..+..+....++...                   ...
T Consensus       162 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (290)
T 3fme_A          162 DDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADK  238 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTT
T ss_pred             ccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCccccc
Confidence            322   22335799999999986    5667899999999999986655544433210                   012


Q ss_pred             hhcccccchhccccCCCCCCCChHHHHH
Q 040702          717 LMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       717 ~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      ....+.++++.|++.||++||++.|+++
T Consensus       239 ~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          239 FSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            2335678899999999999999999876

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=100.00  E-value=6.5e-33  Score=295.25  Aligned_cols=250  Identities=29%  Similarity=0.422  Sum_probs=142.9

Q ss_pred             CCCCEEEccCCcCcc--cCCCccccCCCCccEEEccC-ccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCC
Q 040702           77 STLKSLYLHSNSLSG--RLPSSADVRLPNLKELHLWG-NNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLK  153 (797)
Q Consensus        77 ~~L~~L~Ls~N~l~~--~l~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~  153 (797)
                      .+++.|+|++|.+++  .+|..+ ..+++|++|+|++ |.+.+.+|..|.++++|++|+|++|+|++..|..|.++++|+
T Consensus        50 ~~l~~L~L~~~~l~~~~~~~~~l-~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~  128 (313)
T 1ogq_A           50 YRVNNLDLSGLNLPKPYPIPSSL-ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV  128 (313)
T ss_dssp             CCEEEEEEECCCCSSCEECCGGG-GGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred             ceEEEEECCCCCccCCcccChhH-hCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCC
Confidence            355566666666654  455432 3555666666653 555555555555556666666666665555555555555555


Q ss_pred             eeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhh
Q 040702          154 WLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQ  233 (797)
Q Consensus       154 ~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~  233 (797)
                      +|+|++|.++...+.     .+..+++|++|++++|++++..|..+..++.+|                          +
T Consensus       129 ~L~Ls~N~l~~~~p~-----~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L--------------------------~  177 (313)
T 1ogq_A          129 TLDFSYNALSGTLPP-----SISSLPNLVGITFDGNRISGAIPDSYGSFSKLF--------------------------T  177 (313)
T ss_dssp             EEECCSSEEESCCCG-----GGGGCTTCCEEECCSSCCEEECCGGGGCCCTTC--------------------------C
T ss_pred             EEeCCCCccCCcCCh-----HHhcCCCCCeEECcCCcccCcCCHHHhhhhhcC--------------------------c
Confidence            555555555533222     244445555555555555444444444443233                          4


Q ss_pred             hcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEccCCcC
Q 040702          234 LLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFF  313 (797)
Q Consensus       234 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l  313 (797)
                      +|++++|++++..|..|..+. |++|++++|++++..|..|..+++|+.|+|++|.++..++.+..+++|++|++++|.+
T Consensus       178 ~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~l~~L~~L~Ls~N~l  256 (313)
T 1ogq_A          178 SMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRI  256 (313)
T ss_dssp             EEECCSSEEEEECCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCC
T ss_pred             EEECcCCeeeccCChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCcccccCCCCEEECcCCcc
Confidence            555555555555555555554 6666666666666556566666666666666666654433455556666666666666


Q ss_pred             CCCCCccccccccccEEeccCcccccccCccccCCcccceecccCcc
Q 040702          314 TGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNR  360 (797)
Q Consensus       314 ~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  360 (797)
                      ++..|..|..+++|+.|++++|++++.+|.. ..+++|+.|++++|+
T Consensus       257 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~  302 (313)
T 1ogq_A          257 YGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK  302 (313)
T ss_dssp             EECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred             cCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence            6666666666666666666666666666654 556666666666665

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=5.6e-33  Score=301.67  Aligned_cols=190  Identities=22%  Similarity=0.266  Sum_probs=159.9

Q ss_pred             hcCCCccccccccCCcceeec------ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCc------eeEeeeeeecCCe
Q 040702          511 TNRFSENNLIGRGGFGPVYKD------GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRN------LIKIISSCSNDDF  578 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpn------iv~l~~~~~~~~~  578 (797)
                      .++|...+.||+|+||.||++      +..||||+++... ...+.+.+|+.++++++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            368999999999999999974      3789999997432 23467888999999998776      9999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEE----------------
Q 040702          579 KALVLEYMPLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL----------------  641 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll----------------  641 (797)
                      .++||||+ ++++.+++.... ..+++..+..++.||+.||+|||   +++|+||||||+||++                
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccccccc
Confidence            99999999 567777766543 36899999999999999999999   9999999999999999                


Q ss_pred             ---cCCCcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhcccccc
Q 040702          642 ---DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLL  710 (797)
Q Consensus       642 ---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~  710 (797)
                         +.++.+||+|||+++.....     .....||+.|+|||.+.+..++.++|+|++|+..++.+.+..++
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf  239 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLF  239 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred             ccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCC
Confidence               56789999999999864322     23457999999999999999999999999999886655554443

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.98  E-value=2.5e-33  Score=310.09  Aligned_cols=228  Identities=18%  Similarity=0.194  Sum_probs=168.3

Q ss_pred             cCCCc-cccccccCCcceeec-------ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeee--cCCeEEE
Q 040702          512 NRFSE-NNLIGRGGFGPVYKD-------GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCS--NDDFKAL  581 (797)
Q Consensus       512 ~~f~~-~~~lg~G~~g~Vyk~-------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~--~~~~~~l  581 (797)
                      +.|.. +++||+|+||.||++       +..||||++....  ....+.+|+.++++++||||+++++++.  .....|+
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            44655 468999999999975       4679999986432  3467889999999999999999999995  4678999


Q ss_pred             EEEccCCCCHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEE----cCCCcEEE
Q 040702          582 VLEYMPLGSLEKCLYSG--------NYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL----DDNMVAHL  649 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~--------~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll----~~~~~~kl  649 (797)
                      ||||+++ +|.+++...        ...+++..++.++.||+.||+|||   +.+|+||||||+|||+    +.++.+||
T Consensus        98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence            9999975 888777521        114899999999999999999999   8999999999999999    67789999


Q ss_pred             EeecCCccCCccCc-cccccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccccccchhhhh-----------
Q 040702          650 SDFGMAKPLLEEDQ-SLTQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANLLIREEKH-----------  716 (797)
Q Consensus       650 ~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~~-----------  716 (797)
                      +|||+|+....... .......+||+.|+|||.+.+. .++.++|+|++|++.+..+.+..++.....+           
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  253 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ  253 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence            99999987643211 1223456799999999999874 4899999999999986666554443211000           


Q ss_pred             ----------------------------------------------------hhcccccchhccccCCCCCCCChHHHHH
Q 040702          717 ----------------------------------------------------LMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       717 ----------------------------------------------------~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                                                          ......++++.|+..||.+|||+.|+++
T Consensus       254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                                                                0234457899999999999999999886


Q ss_pred             h
Q 040702          745 Y  745 (797)
Q Consensus       745 ~  745 (797)
                      .
T Consensus       334 h  334 (405)
T 3rgf_A          334 D  334 (405)
T ss_dssp             S
T ss_pred             C
Confidence            4

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=99.98  E-value=1.4e-35  Score=334.45  Aligned_cols=357  Identities=18%  Similarity=0.131  Sum_probs=249.0

Q ss_pred             CCCCEEEcccCcccccCCcc-ccCCCCCCEEEccCCcCcc----cCCCccccCCCCccEEEccCccccccCCchhh-CCC
Q 040702           53 HNMEWMAFSFNKVVGVVPTT-IFNVSTLKSLYLHSNSLSG----RLPSSADVRLPNLKELHLWGNNFIGTIPSFIF-NAS  126 (797)
Q Consensus        53 ~~L~~L~ls~N~i~~~~p~~-~~~l~~L~~L~Ls~N~l~~----~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~-~l~  126 (797)
                      ++|+.||+++|+++...... +..+++|++|+|++|.++.    .++. .+..+++|++|+|++|.+.+..+..+. .++
T Consensus         3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~-~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~   81 (461)
T 1z7x_W            3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISS-ALRVNPALAELNLRSNELGDVGVHCVLQGLQ   81 (461)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHH-HHHTCTTCCEEECTTCCCHHHHHHHHHHTTC
T ss_pred             ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHH-HHHhCCCcCEEeCCCCcCChHHHHHHHHHHh
Confidence            46788999999987654443 7778899999999998873    1232 345678899999999988765444443 355


Q ss_pred             ----CCCEEEccCCcCcc----cCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCC---
Q 040702          127 ----KLSELGLQKNSFSG----SIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGIL---  195 (797)
Q Consensus       127 ----~L~~L~L~~N~l~~----~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~---  195 (797)
                          +|++|+|++|+|+.    ..+.+|.++++|++|+|++|.++......-.-.-+...++|++|++++|+++...   
T Consensus        82 ~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~  161 (461)
T 1z7x_W           82 TPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEP  161 (461)
T ss_dssp             STTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHH
T ss_pred             hCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHH
Confidence                68999999998884    4477888888888888888888653221000001233567888888888877643   


Q ss_pred             -ChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhh-cCCCCCcEEEccCCcCccc----
Q 040702          196 -PRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDL-CRLAALFQLDLGGNKLSGF----  269 (797)
Q Consensus       196 -~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~----  269 (797)
                       +..+..++ +|+.|++++|.+....+..+..                      .+ ...++|++|++++|.++..    
T Consensus       162 l~~~l~~~~-~L~~L~L~~n~i~~~~~~~l~~----------------------~l~~~~~~L~~L~L~~n~l~~~~~~~  218 (461)
T 1z7x_W          162 LASVLRAKP-DFKELTVSNNDINEAGVRVLCQ----------------------GLKDSPCQLEALKLESCGVTSDNCRD  218 (461)
T ss_dssp             HHHHHHHCT-TCCEEECCSSBCHHHHHHHHHH----------------------HHHHSCCCCCEEECTTSCCBTTHHHH
T ss_pred             HHHHHhhCC-CCCEEECcCCCcchHHHHHHHH----------------------HHhcCCCCceEEEccCCCCcHHHHHH
Confidence             34444445 6677777766665433322221                      01 1244667777777766643    


Q ss_pred             CCCCccCCccccccccCCCCCCCC-----CC-CCCCCCcccEEEccCCcCCCC----CCccccccccccEEeccCccccc
Q 040702          270 VPACSGNLTNLRKLYLGSNLLTSI-----PS-TLWNLKDILHLNLSSNFFTGP----LPLKIGNLNVLVQLDLSMNNFSC  339 (797)
Q Consensus       270 ~~~~~~~l~~L~~L~L~~N~l~~l-----p~-~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~  339 (797)
                      .+..+..+++|++|++++|.++..     .. .+..+++|++|++++|.++..    ++..+..+++|++|++++|.++.
T Consensus       219 l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~  298 (461)
T 1z7x_W          219 LCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGD  298 (461)
T ss_dssp             HHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHH
T ss_pred             HHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCch
Confidence            244555667777777777776442     12 223578899999999998853    46667779999999999999986


Q ss_pred             ccCccccC-----CcccceecccCccccCC----CChhhhccccCCeeeecCCcCCCCCChhhhc-----cCCCCeEEcc
Q 040702          340 VIPTKIGG-----LKDLQYLFLEYNRLQGS----IPNSIGDLISLKSLNLSNNNLSGTIPISLEK-----LLDLKDINVS  405 (797)
Q Consensus       340 ~~~~~~~~-----l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-----l~~L~~L~l~  405 (797)
                      ..+..+..     .++|++|++++|.+++.    ++..+..+++|++|+|++|.+++..+..+..     .++|+.|+++
T Consensus       299 ~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~  378 (461)
T 1z7x_W          299 EGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLA  378 (461)
T ss_dssp             HHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECT
T ss_pred             HHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECC
Confidence            54444432     36999999999999865    4667788899999999999998776666654     6799999999


Q ss_pred             CCcCcc----cCCC-CCCCCCCCcccccCCccc
Q 040702          406 FNRLEG----EIPR-EGPFRNLSAESFKGNELL  433 (797)
Q Consensus       406 ~N~l~~----~~p~-~~~~~~l~~~~~~~n~~~  433 (797)
                      +|++++    .+|. ....+.++.+++.+|+..
T Consensus       379 ~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~  411 (461)
T 1z7x_W          379 DCDVSDSSCSSLAATLLANHSLRELDLSNNCLG  411 (461)
T ss_dssp             TSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCC
T ss_pred             CCCCChhhHHHHHHHHHhCCCccEEECCCCCCC
Confidence            999985    3443 234678888999999753

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.98  E-value=1.1e-33  Score=307.85  Aligned_cols=224  Identities=21%  Similarity=0.265  Sum_probs=167.9

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCC--cchhHHHHHHHhhhccCCceeEeeeeeecC------C
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG--AFKSFDIECGMMKRIRHRNLIKIISSCSND------D  577 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~------~  577 (797)
                      .++|...+.||+|+||.||++     ++.||||++......  ..+.+.+|+++++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            478999999999999999985     689999998654322  346788999999999999999999998654      5


Q ss_pred             eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCcc
Q 040702          578 FKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  657 (797)
Q Consensus       578 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  657 (797)
                      ..|+||||+ +++|.+++...  .+++..+..++.||++||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~  181 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH  181 (367)
T ss_dssp             CCEEEEECC-CEECC-----C--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred             eEEEEeccc-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence            689999999 67999988764  4899999999999999999999   99999999999999999999999999999986


Q ss_pred             CCccCccccccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchhhh---------------------
Q 040702          658 LLEEDQSLTQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIREEK---------------------  715 (797)
Q Consensus       658 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~---------------------  715 (797)
                      ...     ......||+.|+|||.+.+ ..++.++|+|++|+..+..+.+..++.....                     
T Consensus       182 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  256 (367)
T 2fst_X          182 TAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  256 (367)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             ccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            432     2344679999999999877 6789999999999988666555443322110                     


Q ss_pred             --------------------------hhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          716 --------------------------HLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       716 --------------------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                                                .......++++.|+..||.+||++.|+++.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          257 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence                                      012235678999999999999999998864

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.98  E-value=1e-32  Score=300.43  Aligned_cols=234  Identities=20%  Similarity=0.235  Sum_probs=175.1

Q ss_pred             HHHHHHhcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCC--
Q 040702          505 LELFQATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDD--  577 (797)
Q Consensus       505 ~~l~~~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~--  577 (797)
                      .+.....++|...+.||+|+||.||++     +..||||++.... .....+.+|++.++.++||||+++++++...+  
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            445667789999999999999999974     6889999986543 33456778888899999999999999986543  


Q ss_pred             -----eEEEEEEccCCCCHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcC-CCcEE
Q 040702          578 -----FKALVLEYMPLGSLEKCLY---SGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD-NMVAH  648 (797)
Q Consensus       578 -----~~~lv~e~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~-~~~~k  648 (797)
                           ..++||||+++ ++.+.+.   .....+++..+..++.|++.|+.||| .++++|+||||||+||+++. ++.+|
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH-~~~~~ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLH-LPSVNVCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHT-STTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHh-CCCCCeecCcCCHHHEEEeCCCCcEE
Confidence                 27899999986 5554443   23335889999999999999999999 33679999999999999996 89999


Q ss_pred             EEeecCCccCCccCccccccccccCcccccccccccCc-cchHHHHHHHhhhhhhhhccccccchhhhh-----------
Q 040702          649 LSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGE-MRLKCWVNDSLLISVMIVVDANLLIREEKH-----------  716 (797)
Q Consensus       649 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~dv~s~~~~~~~~~~~~~~~~~~~~~-----------  716 (797)
                      |+|||+++......   ......||+.|+|||.+.+.. ++.++|+|++|+..+..+.+..++......           
T Consensus       173 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  249 (360)
T 3e3p_A          173 LCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG  249 (360)
T ss_dssp             ECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             EeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcC
Confidence            99999998764332   233467899999999987655 899999999999986665554443221100           


Q ss_pred             -------------------------------------hhcccccchhccccCCCCCCCChHHHHH
Q 040702          717 -------------------------------------LMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       717 -------------------------------------~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                                           ....+.++++.|++.||.+||++.|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence                                                 1234668999999999999999988875

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.98  E-value=6.2e-33  Score=307.85  Aligned_cols=223  Identities=23%  Similarity=0.347  Sum_probs=177.8

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecC----C--eE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSND----D--FK  579 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~----~--~~  579 (797)
                      ..+|...+.||+|+||.||++     ++.||||++....    ....+|++++++++|||||++++++...    +  ..
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            357899999999999999985     6889999987542    2344799999999999999999988542    2  36


Q ss_pred             EEEEEccCCCCHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCC-CcEEEEeecCC
Q 040702          580 ALVLEYMPLGSLEKCLY---SGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN-MVAHLSDFGMA  655 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~-~~~kl~DFGla  655 (797)
                      ++||||+++ ++.+.+.   .....+++..++.++.||++||+|||   +.+|+||||||+|||++.+ +.+||+|||+|
T Consensus       129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence            799999976 6666554   23346899999999999999999999   9999999999999999955 67899999999


Q ss_pred             ccCCccCccccccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccccccchhh--------------------
Q 040702          656 KPLLEEDQSLTQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANLLIREE--------------------  714 (797)
Q Consensus       656 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------------  714 (797)
                      +......   ......||+.|+|||.+.+. .++.++|+|++|++.++.+.+..++....                    
T Consensus       205 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~  281 (420)
T 1j1b_A          205 KQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI  281 (420)
T ss_dssp             EECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             hhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            8654322   22346799999999998765 68999999999999866665554432211                    


Q ss_pred             -------------------------hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          715 -------------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       715 -------------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                               ........+++++|+..||.+||++.|+++
T Consensus       282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence                                     011234668899999999999999999876

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.98  E-value=8.8e-33  Score=295.56  Aligned_cols=227  Identities=21%  Similarity=0.246  Sum_probs=189.6

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEeccCC------cchhHHHHHHHhhhcc--CCceeEeeeeeecC
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG------AFKSFDIECGMMKRIR--HRNLIKIISSCSND  576 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~--Hpniv~l~~~~~~~  576 (797)
                      ..++|...+.||+|+||.||++     ++.||||+++.....      ..+.+.+|+.++++++  ||||+++++++..+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            4578999999999999999985     689999999866432      2356788999999996  59999999999999


Q ss_pred             CeEEEEEEccCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEc-CCCcEEEEeecC
Q 040702          577 DFKALVLEYMPL-GSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGM  654 (797)
Q Consensus       577 ~~~~lv~e~~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~-~~~~~kl~DFGl  654 (797)
                      +..++||||+.+ ++|.+++.... .+++..++.++.|+++||+|||   +.+|+||||||+||+++ .++.+||+|||+
T Consensus       121 ~~~~lv~e~~~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~  196 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGS  196 (320)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTT
T ss_pred             CcEEEEEEcCCCCccHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCcc
Confidence            999999999976 89999987654 4899999999999999999999   99999999999999999 789999999999


Q ss_pred             CccCCccCccccccccccCcccccccccccCcc-chHHHHHHHhhhhhhhhccccccchhhh----------hhhccccc
Q 040702          655 AKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEM-RLKCWVNDSLLISVMIVVDANLLIREEK----------HLMTKEQP  723 (797)
Q Consensus       655 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~dv~s~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~  723 (797)
                      ++.....    ......||+.|+|||.+.+..+ +.++|+|++|+..++.+.+..++.....          .....+.+
T Consensus       197 ~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  272 (320)
T 3a99_A          197 GALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQH  272 (320)
T ss_dssp             CEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSSCCCHHHHH
T ss_pred             ccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhhcccccccccCCHHHHH
Confidence            9865432    2234579999999999887776 7889999999998666655544433221          22345678


Q ss_pred             chhccccCCCCCCCChHHHHH
Q 040702          724 MVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       724 l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      +++.|++.||++||++.|+++
T Consensus       273 li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          273 LIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHccCChhhCcCHHHHhc
Confidence            999999999999999988764

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.98  E-value=9.3e-33  Score=297.79  Aligned_cols=188  Identities=20%  Similarity=0.282  Sum_probs=160.7

Q ss_pred             hcCCCccccccccCCcceeec------ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCc------eeEeeeeeecCCe
Q 040702          511 TNRFSENNLIGRGGFGPVYKD------GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRN------LIKIISSCSNDDF  578 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpn------iv~l~~~~~~~~~  578 (797)
                      .++|+..+.||+|+||.||++      ++.||||+++... ...+.+.+|+++++.++|++      ++++++++...+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            368999999999999999974      5889999986432 23467889999999997765      9999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcC--------------
Q 040702          579 KALVLEYMPLGSLEKCLYSGNY-ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD--------------  643 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~--------------  643 (797)
                      .++||||+ +++|.+++..... .+++..+..++.|+++||+|||   +++|+||||||+||+++.              
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence            99999999 7899999977653 5889999999999999999999   899999999999999987              


Q ss_pred             -----CCcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhcccc
Q 040702          644 -----NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDAN  708 (797)
Q Consensus       644 -----~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~  708 (797)
                           ++.+||+|||+++.....     .....||+.|+|||.+.+..++.++|+|++|+..++.+.+..
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~  232 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFT  232 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             cccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCC
Confidence                 668999999999864321     234579999999999999899999999999998865554433

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.98  E-value=1.3e-32  Score=301.73  Aligned_cols=192  Identities=24%  Similarity=0.314  Sum_probs=160.3

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhcc-CC-----ceeEeeeeeecCCe
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIR-HR-----NLIKIISSCSNDDF  578 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-Hp-----niv~l~~~~~~~~~  578 (797)
                      ..++|...+.||+|+||.||++     ++.||||+++... ....++..|+++++.++ |+     +|+++++++...+.
T Consensus        52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  130 (382)
T 2vx3_A           52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH  130 (382)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred             eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence            3578999999999999999985     6889999997432 22456778999988885 44     49999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEc--CCCcEEEEeecCC
Q 040702          579 KALVLEYMPLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD--DNMVAHLSDFGMA  655 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~--~~~~~kl~DFGla  655 (797)
                      .|+||||++ |+|.+++.... ..+++..+..++.|++.||.|||. +..+|+||||||+|||++  .++.+||+|||+|
T Consensus       131 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~-~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a  208 (382)
T 2vx3_A          131 LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS  208 (382)
T ss_dssp             EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTS-TTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhcc-CCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence            999999996 59999987754 358999999999999999999992 246899999999999994  5788999999999


Q ss_pred             ccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccc
Q 040702          656 KPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANL  709 (797)
Q Consensus       656 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~  709 (797)
                      +.....     .....||+.|+|||.+.+..++.++|+|++|+..++.+.+..+
T Consensus       209 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p  257 (382)
T 2vx3_A          209 CQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPL  257 (382)
T ss_dssp             EETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             eecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            865322     2346799999999999999999999999999988665554443

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.98  E-value=9.5e-33  Score=294.47  Aligned_cols=231  Identities=20%  Similarity=0.251  Sum_probs=182.2

Q ss_pred             HHhcCCCccccccccCCcceeec----ceEEEEEEEEeccCC--cchhHHHHHHHhhhcc--CCceeEeeeeeecCCeEE
Q 040702          509 QATNRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGG--AFKSFDIECGMMKRIR--HRNLIKIISSCSNDDFKA  580 (797)
Q Consensus       509 ~~~~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~--Hpniv~l~~~~~~~~~~~  580 (797)
                      ...++|...+.||+|+||.||++    ++.||||++......  ..+.+.+|++++++++  ||||+++++++..++..+
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~  104 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  104 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence            34578999999999999999985    688999999765332  3467889999999997  599999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCc
Q 040702          581 LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  660 (797)
Q Consensus       581 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  660 (797)
                      +||| +.+++|.+++.... .+++..+..++.|+++||.|||   +.+|+||||||+||++++ +.+||+|||+++....
T Consensus       105 lv~e-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~  178 (313)
T 3cek_A          105 MVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQP  178 (313)
T ss_dssp             EEEC-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC---
T ss_pred             EEEe-cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccccccccC
Confidence            9999 55789999998765 4899999999999999999999   899999999999999975 8999999999987644


Q ss_pred             cCccccccccccCccccccccccc-----------CccchHHHHHHHhhhhhhhhccccccchh----------------
Q 040702          661 EDQSLTQTQTLATIGYMAPDEIFS-----------GEMRLKCWVNDSLLISVMIVVDANLLIRE----------------  713 (797)
Q Consensus       661 ~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~dv~s~~~~~~~~~~~~~~~~~~----------------  713 (797)
                      ...........||+.|+|||.+..           ..++.++|+|++|+..+..+.+..++...                
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  258 (313)
T 3cek_A          179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE  258 (313)
T ss_dssp             -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSC
T ss_pred             ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccc
Confidence            333223345679999999998865           46889999999999886655544433221                


Q ss_pred             ---hhhhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          714 ---EKHLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       714 ---~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                         +......+.++++.|++.||.+||++.|+++.
T Consensus       259 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          259 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence               01112346788999999999999999998864

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.98  E-value=6.2e-33  Score=303.04  Aligned_cols=223  Identities=20%  Similarity=0.277  Sum_probs=181.9

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCC--cchhHHHHHHHhhhccCCceeEeeeeeecCCeE----
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG--AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFK----  579 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~----  579 (797)
                      .++|...+.||+|+||.||++     ++.||||++......  ..+.+.+|+.+++.++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            468999999999999999985     689999999765332  246788999999999999999999999877654    


Q ss_pred             --EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCcc
Q 040702          580 --ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  657 (797)
Q Consensus       580 --~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  657 (797)
                        |+||||+. |+|.+++..   .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  193 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH  193 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred             eEEEEEcccc-ccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence              99999997 588887743   3899999999999999999999   89999999999999999999999999999985


Q ss_pred             CCccCccccccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchhh----------------------
Q 040702          658 LLEEDQSLTQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIREE----------------------  714 (797)
Q Consensus       658 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------------  714 (797)
                      ...     ......||+.|+|||.+.+ ..++.++|+|++|+..+..+.+..++....                      
T Consensus       194 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  268 (371)
T 4exu_A          194 ADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  268 (371)
T ss_dssp             -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             ccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHH
Confidence            432     2234678999999999887 678999999999998866555444332211                      


Q ss_pred             -------------------------hhhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          715 -------------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       715 -------------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                                               ......+.++++.|++.||++||++.|+++.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          269 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence                                     1123456789999999999999999998763

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.98  E-value=7e-33  Score=295.34  Aligned_cols=231  Identities=23%  Similarity=0.262  Sum_probs=181.4

Q ss_pred             HHHHHhcCCCccccccccCCcceeec-----ceEEEEEEEEeccC------CcchhHHHHHHHhhhc----cCCceeEee
Q 040702          506 ELFQATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG------GAFKSFDIECGMMKRI----RHRNLIKII  570 (797)
Q Consensus       506 ~l~~~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~------~~~~~~~~E~~~l~~l----~Hpniv~l~  570 (797)
                      +.....++|...+.||+|+||.||++     ++.||||+++....      .....+.+|+.++.++    +||||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            34445678999999999999999985     57899999975532      1234567799999999    899999999


Q ss_pred             eeeecCCeEEEEEEc-cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEc-CCCcEE
Q 040702          571 SSCSNDDFKALVLEY-MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD-DNMVAH  648 (797)
Q Consensus       571 ~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~-~~~~~k  648 (797)
                      +++...+..++|||| +.+++|.+++.... .+++..++.++.|+++||+|||   +.+|+||||||+||+++ .++.+|
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEE
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEE
Confidence            999999999999999 78999999997754 4899999999999999999999   89999999999999999 889999


Q ss_pred             EEeecCCccCCccCccccccccccCcccccccccccCcc-chHHHHHHHhhhhhhhhccccccchhh----------hhh
Q 040702          649 LSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEM-RLKCWVNDSLLISVMIVVDANLLIREE----------KHL  717 (797)
Q Consensus       649 l~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~dv~s~~~~~~~~~~~~~~~~~~~----------~~~  717 (797)
                      |+|||+++.....    ......||..|+|||.+.+..+ +.++|+|++|+..+..+.+..++....          ...
T Consensus       181 l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  256 (312)
T 2iwi_A          181 LIDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAELHFPAHV  256 (312)
T ss_dssp             ECCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHTCCCCCTTS
T ss_pred             EEEcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHhhhccCCcccC
Confidence            9999999866432    2234579999999999887766 469999999999866665554443221          123


Q ss_pred             hcccccchhccccCCCCCCCChHHHHH
Q 040702          718 MTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       718 ~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      ...+.++++.|++.||++||++.|+++
T Consensus       257 ~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          257 SPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            345678999999999999999999876

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.98  E-value=1e-32  Score=290.42  Aligned_cols=228  Identities=21%  Similarity=0.316  Sum_probs=187.0

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      ..++|...+.||+|+||.||++     ++.||||++.....  ...+.+.+|++++++++||||+++++++.+.+..++|
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence            3468999999999999999984     68899999976532  3456789999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCC---CcEEEEeecCCccCC
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN---MVAHLSDFGMAKPLL  659 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~---~~~kl~DFGla~~~~  659 (797)
                      |||+++++|.+++.... .+++..+..++.|++.||+|||   +.+|+||||||+||+++.+   +.+||+|||+++...
T Consensus       100 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A          100 GELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             ECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             EEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            99999999999887654 4899999999999999999999   8999999999999999754   479999999998654


Q ss_pred             ccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh--------------------hhhhc
Q 040702          660 EEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE--------------------KHLMT  719 (797)
Q Consensus       660 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------------~~~~~  719 (797)
                      ...   ......||+.|+|||.+. +.++.++|+|++|+..+..+.+..++....                    .....
T Consensus       176 ~~~---~~~~~~~~~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (287)
T 2wei_A          176 QNT---KMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISD  251 (287)
T ss_dssp             CCS---SCSCHHHHHTTCCHHHHT-TCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCH
T ss_pred             CCC---ccccccCcccccChHHhc-CCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCH
Confidence            322   223346899999999875 458999999999998755554433322110                    11233


Q ss_pred             ccccchhccccCCCCCCCChHHHHHh
Q 040702          720 KEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       720 ~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                      .+.++++.|+..||++||++.|+++.
T Consensus       252 ~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          252 DAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHHHcccChhhCcCHHHHhcC
Confidence            56789999999999999999998873

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.97  E-value=1.9e-32  Score=295.00  Aligned_cols=224  Identities=19%  Similarity=0.248  Sum_probs=162.5

Q ss_pred             hcCCCcc-ccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHH-HHhhhccCCceeEeeeeeec----CCeE
Q 040702          511 TNRFSEN-NLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIEC-GMMKRIRHRNLIKIISSCSN----DDFK  579 (797)
Q Consensus       511 ~~~f~~~-~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~-~~l~~l~Hpniv~l~~~~~~----~~~~  579 (797)
                      .++|... +.||+|+||.||++     ++.||||++...     ....+|+ ..++.++||||+++++++..    ....
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            5788885 46999999999975     689999998643     2233333 34566789999999999876    4458


Q ss_pred             EEEEEccCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcC---CCcEEEEeecCC
Q 040702          580 ALVLEYMPLGSLEKCLYSGNY-ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD---NMVAHLSDFGMA  655 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~DFGla  655 (797)
                      ++||||+++|+|.+++..... .+++..++.++.|++.||+|||   +.+|+||||||+||+++.   ++.+||+|||++
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            999999999999999987643 6899999999999999999999   899999999999999976   455999999999


Q ss_pred             ccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh---------------------
Q 040702          656 KPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE---------------------  714 (797)
Q Consensus       656 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~---------------------  714 (797)
                      +.....    ......||+.|+|||.+....++.++|+|++|+..+..+.+..++....                     
T Consensus       179 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  254 (336)
T 3fhr_A          179 KETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPN  254 (336)
T ss_dssp             EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCT
T ss_pred             eecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCc
Confidence            865322    2234578999999999988999999999999998866555444332211                     


Q ss_pred             ---hhhhcccccchhccccCCCCCCCChHHHHHhH
Q 040702          715 ---KHLMTKEQPMVRMGTDLSLGQFPASYSISKYL  746 (797)
Q Consensus       715 ---~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l  746 (797)
                         ......+.++++.|++.||++||++.|+++.-
T Consensus       255 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  289 (336)
T 3fhr_A          255 PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP  289 (336)
T ss_dssp             TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence               12234567899999999999999999998753

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.97  E-value=1.5e-32  Score=294.90  Aligned_cols=228  Identities=20%  Similarity=0.220  Sum_probs=165.0

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccC-CcchhHHHHHH-HhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG-GAFKSFDIECG-MMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~-~~~~~~~~E~~-~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      .++|...+.||+|+||.||++     ++.||||+++.... ....++..|+. +++.++||||+++++++..++..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            368999999999999999974     68999999986532 22345556665 677789999999999999999999999


Q ss_pred             EccCCCCHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHccCCC-CeEEcCCCCCceEEcCCCcEEEEeecCCccC
Q 040702          584 EYMPLGSLEKCLYS----GNYILDIFQGLNIMIDVASALEYLHFGYSV-PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  658 (797)
Q Consensus       584 e~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~al~yLH~~~~~-~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  658 (797)
                      ||+++ +|.+++..    ....+++..+..++.|++.||.|||   +. +|+||||||+||+++.++.+||+|||+++..
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99985 88777753    2335899999999999999999999   87 9999999999999999999999999999865


Q ss_pred             CccCccccccccccCccccccccc----ccCccchHHHHHHHhhhhhhhhccccccchhh--------------------
Q 040702          659 LEEDQSLTQTQTLATIGYMAPDEI----FSGEMRLKCWVNDSLLISVMIVVDANLLIREE--------------------  714 (797)
Q Consensus       659 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------------  714 (797)
                      ....   ......||+.|+|||.+    .+..++.++|+|++|+..+..+.+..++....                    
T Consensus       177 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  253 (327)
T 3aln_A          177 VDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNS  253 (327)
T ss_dssp             --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCC
T ss_pred             cccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCc
Confidence            4322   22334799999999998    45668999999999998866555443332211                    


Q ss_pred             --hhhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          715 --KHLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       715 --~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                        ......+.++++.|++.||++||++.++++.
T Consensus       254 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          254 EEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             SSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             ccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence              0123346688999999999999999999774

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.97  E-value=1.7e-32  Score=300.18  Aligned_cols=225  Identities=17%  Similarity=0.232  Sum_probs=183.6

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhcc-----------CCceeEeeeeee
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIR-----------HRNLIKIISSCS  574 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----------Hpniv~l~~~~~  574 (797)
                      .++|...+.||+|+||.||++     ++.||||++.... ...+.+.+|+.++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            368999999999999999975     6899999987432 22467888999999886           899999999987


Q ss_pred             cCC----eEEEEEEccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCC-CeEEcCCCCCceEEc------
Q 040702          575 NDD----FKALVLEYMPLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSV-PIIHCDLKPSNVLLD------  642 (797)
Q Consensus       575 ~~~----~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~-~ivHrDlkp~NIll~------  642 (797)
                      ..+    ..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||   ++ +|+||||||+||+++      
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCc
Confidence            654    789999999 889999997643 35899999999999999999999   87 999999999999994      


Q ss_pred             CCCcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh--------
Q 040702          643 DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE--------  714 (797)
Q Consensus       643 ~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------  714 (797)
                      ..+.+||+|||+++.....     .....||+.|+|||.+.+..++.++|+|++|+..+..+.+..++....        
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  247 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  247 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             CcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence            4458999999999865322     234579999999999999999999999999999866665544433211        


Q ss_pred             --------------------------------------------------------hhhhcccccchhccccCCCCCCCC
Q 040702          715 --------------------------------------------------------KHLMTKEQPMVRMGTDLSLGQFPA  738 (797)
Q Consensus       715 --------------------------------------------------------~~~~~~~~~l~~~cl~~dp~~RPs  738 (797)
                                                                              ......+.++++.|++.||++||+
T Consensus       248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  327 (373)
T 1q8y_A          248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  327 (373)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence                                                                    122335568999999999999999


Q ss_pred             hHHHHHh
Q 040702          739 SYSISKY  745 (797)
Q Consensus       739 ~~~i~~~  745 (797)
                      +.|+++.
T Consensus       328 ~~ell~h  334 (373)
T 1q8y_A          328 AGGLVNH  334 (373)
T ss_dssp             HHHHHTC
T ss_pred             HHHHhhC
Confidence            9998863

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.97  E-value=1.6e-32  Score=305.78  Aligned_cols=226  Identities=22%  Similarity=0.313  Sum_probs=171.6

Q ss_pred             cCCCccccccccCCcceee----cceEEEEEEEEeccCCcchhHHHHHHHhhhc-cCCceeEeeeeeecCCeEEEEEEcc
Q 040702          512 NRFSENNLIGRGGFGPVYK----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk----~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      +.|...+.||+|+||+||.    .++.||||++....   .+.+.+|+++++++ +||||+++++++.+++..|+||||+
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            3455568899999999974    36899999987542   35678899999987 8999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCC------CCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCC-------------CcE
Q 040702          587 PLGSLEKCLYSGNYI------LDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDN-------------MVA  647 (797)
Q Consensus       587 ~~g~L~~~l~~~~~~------l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~-------------~~~  647 (797)
                      . |+|.+++......      .++..++.++.||+.||+|||   +.+|+||||||+||+++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence            6 6999999865431      122345679999999999999   8999999999999999754             489


Q ss_pred             EEEeecCCccCCccCccc--cccccccCccccccccccc-------CccchHHHHHHHhhhhhhhhc-cccccchh-h--
Q 040702          648 HLSDFGMAKPLLEEDQSL--TQTQTLATIGYMAPDEIFS-------GEMRLKCWVNDSLLISVMIVV-DANLLIRE-E--  714 (797)
Q Consensus       648 kl~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-~--  714 (797)
                      ||+|||+++.........  ......||+.|+|||.+.+       ..++.++|+|++|+..++.+. +..++... .  
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            999999998764432211  1234679999999999865       668999999999999866654 33333211 0  


Q ss_pred             ------------------hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          715 ------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       715 ------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                        ......+.++++.|++.||.+||++.++++
T Consensus       248 ~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence                              011235678999999999999999999876

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.97  E-value=1.5e-32  Score=298.09  Aligned_cols=223  Identities=20%  Similarity=0.280  Sum_probs=180.2

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCC--cchhHHHHHHHhhhccCCceeEeeeeeecCCe-----
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG--AFKSFDIECGMMKRIRHRNLIKIISSCSNDDF-----  578 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~-----  578 (797)
                      .++|...+.||+|+||.||++     ++.||||++......  ..+.+.+|+.+++.++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            367999999999999999985     689999999754322  24578899999999999999999999987654     


Q ss_pred             -EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCcc
Q 040702          579 -KALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  657 (797)
Q Consensus       579 -~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  657 (797)
                       .|+||||++ |+|.+++..   .+++..+..++.|++.||+|||   +++|+||||||+||+++.++.+||+|||+++.
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL---KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             eEEEEecccc-CCHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence             499999997 588877643   3899999999999999999999   89999999999999999999999999999986


Q ss_pred             CCccCccccccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchhh----------------------
Q 040702          658 LLEEDQSLTQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIREE----------------------  714 (797)
Q Consensus       658 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------------  714 (797)
                      ....     .....||+.|+|||.+.+ ..++.++|+|++|+..+..+.+..++....                      
T Consensus       176 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  250 (353)
T 3coi_A          176 ADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK  250 (353)
T ss_dssp             -------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTT
T ss_pred             CCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHH
Confidence            4321     234578999999999876 678999999999998866555444332211                      


Q ss_pred             -------------------------hhhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          715 -------------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       715 -------------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                                               ......+.++++.|+..||++||++.++++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          251 LNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             CSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                                     0123346788999999999999999998763

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.97  E-value=5e-32  Score=309.97  Aligned_cols=237  Identities=23%  Similarity=0.263  Sum_probs=185.9

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEecc-CCcchhHHHHHHHhhhccCCceeEeeeeeec------CCe
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLIKIISSCSN------DDF  578 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~------~~~  578 (797)
                      .++|...+.||+|+||.||++     ++.||||+++... ....+.+.+|++++++++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            378999999999999999974     6889999987542 2234678899999999999999999998765      667


Q ss_pred             EEEEEEccCCCCHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCc---EEEEeec
Q 040702          579 KALVLEYMPLGSLEKCLYSGNY--ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMV---AHLSDFG  653 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~---~kl~DFG  653 (797)
                      .|+||||+++|+|.+++.....  .+++..++.++.|++.||+|||   +.+|+||||||+||+++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcccc
Confidence            8999999999999999986442  5888899999999999999999   899999999999999997664   9999999


Q ss_pred             CCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccch---------------------
Q 040702          654 MAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIR---------------------  712 (797)
Q Consensus       654 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~---------------------  712 (797)
                      +++......   ......||+.|+|||.+.++.++.++|+|++|+..+..+.+..++..                     
T Consensus       170 ~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~  246 (676)
T 3qa8_A          170 YAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV  246 (676)
T ss_dssp             CCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred             ccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence            998764332   23446799999999999999999999999999988666555433311                     


Q ss_pred             -------------------hhhhhhcccccchhccccCCCCCCCChHHHHH--hHHHHHHHh
Q 040702          713 -------------------EEKHLMTKEQPMVRMGTDLSLGQFPASYSISK--YLVYIRELE  753 (797)
Q Consensus       713 -------------------~~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~--~l~~i~~~~  753 (797)
                                         ........+.++++.|+..||++||++.++++  .++.+..+.
T Consensus       247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL  308 (676)
T 3qa8_A          247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL  308 (676)
T ss_dssp             CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred             hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence                               01112345678899999999999999988543  444444443

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.97  E-value=4e-32  Score=290.26  Aligned_cols=228  Identities=19%  Similarity=0.185  Sum_probs=167.3

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCC-c-chhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG-A-FKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~-~-~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      .++|+..+.||+|+||.||++     ++.||||++...... . .+.+..+..+++.++||||+++++++..++..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            468999999999999999985     689999999765322 1 223444555678889999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCC-CeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV-PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~-~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      ||+ ++.+..+.......+++..+..++.|+++||.|||   +. +|+||||||+||+++.++.+||+|||+++......
T Consensus       104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK  179 (318)
T ss_dssp             CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence            999 55776666554446899999999999999999999   75 99999999999999999999999999997654322


Q ss_pred             ccccccccccCcccccccccc-----cCccchHHHHHHHhhhhhhhhccccccchhh--------------------hhh
Q 040702          663 QSLTQTQTLATIGYMAPDEIF-----SGEMRLKCWVNDSLLISVMIVVDANLLIREE--------------------KHL  717 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------------~~~  717 (797)
                         ......||+.|+|||.+.     ...++.++|+|++|+..+..+....++....                    ...
T Consensus       180 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (318)
T 2dyl_A          180 ---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGF  256 (318)
T ss_dssp             ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCC
T ss_pred             ---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCC
Confidence               223457999999999984     4568899999999999866555444332210                    012


Q ss_pred             hcccccchhccccCCCCCCCChHHHHHh
Q 040702          718 MTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       718 ~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                      ...+.++++.|++.||.+||++.++++.
T Consensus       257 ~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          257 SGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            3356788999999999999999998873

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.97  E-value=5.4e-31  Score=285.83  Aligned_cols=278  Identities=17%  Similarity=0.181  Sum_probs=149.3

Q ss_pred             CCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCcccc
Q 040702           20 PSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADV   99 (797)
Q Consensus        20 l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~   99 (797)
                      ++.....|+++|.         ++++|..+.  ++|++|++++|+++++.+..|.++++|++|+|++|+++ .++...|.
T Consensus        30 C~~~~~c~~~~~~---------l~~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~   97 (353)
T 2z80_A           30 CDRNGICKGSSGS---------LNSIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFS   97 (353)
T ss_dssp             ECTTSEEECCSTT---------CSSCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCC-EECTTTTT
T ss_pred             CCCCeEeeCCCCC---------ccccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccC-ccCHhhcC
Confidence            3444445666555         334444433  25566666666665555555556666666666666655 44444445


Q ss_pred             CCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCC-ccccCCCCCCeeeccCc-cCcCCCCCccccccCCC
Q 040702          100 RLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIP-NTFGNLRNLKWLGLNDN-YLTSSTPELSSLSSLSN  177 (797)
Q Consensus       100 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~f~~l~~L~~L~L~~N-~l~~~~~~~~~~~~l~~  177 (797)
                      ++++|++|+|++|++++..+..|.++++|++|+|++|+|+.+.+ ..|.++++|++|++++| .++.+++.     .|.+
T Consensus        98 ~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~-----~~~~  172 (353)
T 2z80_A           98 SLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRK-----DFAG  172 (353)
T ss_dssp             TCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTT-----TTTT
T ss_pred             CCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHH-----HccC
Confidence            55556666666665554433445555555566665555554444 45555555555555555 34444432     2455


Q ss_pred             CCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCc
Q 040702          178 CKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALF  257 (797)
Q Consensus       178 l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~  257 (797)
                      +++|+.|++++|++.+..|..|..++ +|+.|++++|.+.                          ...+..+..+++|+
T Consensus       173 l~~L~~L~l~~n~l~~~~~~~l~~l~-~L~~L~l~~n~l~--------------------------~~~~~~~~~~~~L~  225 (353)
T 2z80_A          173 LTFLEELEIDASDLQSYEPKSLKSIQ-NVSHLILHMKQHI--------------------------LLLEIFVDVTSSVE  225 (353)
T ss_dssp             CCEEEEEEEEETTCCEECTTTTTTCS-EEEEEEEECSCST--------------------------THHHHHHHHTTTEE
T ss_pred             CCCCCEEECCCCCcCccCHHHHhccc-cCCeecCCCCccc--------------------------cchhhhhhhccccc
Confidence            55555555555555555555555544 4555555555443                          22222233345555


Q ss_pred             EEEccCCcCcccCCCCcc---CCccccccccCCCCCC-----CCCCCCCCCCcccEEEccCCcCCCCCCccccccccccE
Q 040702          258 QLDLGGNKLSGFVPACSG---NLTNLRKLYLGSNLLT-----SIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQ  329 (797)
Q Consensus       258 ~L~Ls~N~l~~~~~~~~~---~l~~L~~L~L~~N~l~-----~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~  329 (797)
                      .|++++|.+++..+..+.   ....++.++|++|.++     .+|..+..+++|+.|++++|+++...+..|..+++|++
T Consensus       226 ~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~  305 (353)
T 2z80_A          226 CLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQK  305 (353)
T ss_dssp             EEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred             EEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCE
Confidence            555555555543332221   2233444444444442     35666667777777777777777544444577777778


Q ss_pred             EeccCccccccc
Q 040702          330 LDLSMNNFSCVI  341 (797)
Q Consensus       330 L~Ls~N~l~~~~  341 (797)
                      |++++|++.+..
T Consensus       306 L~L~~N~~~~~~  317 (353)
T 2z80_A          306 IWLHTNPWDCSC  317 (353)
T ss_dssp             EECCSSCBCCCH
T ss_pred             EEeeCCCccCcC
Confidence            888887776543

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.97  E-value=1.6e-31  Score=314.89  Aligned_cols=224  Identities=20%  Similarity=0.257  Sum_probs=178.7

Q ss_pred             cCCCccccccccCCcceeec------ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCe-----E
Q 040702          512 NRFSENNLIGRGGFGPVYKD------GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDF-----K  579 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~-----~  579 (797)
                      ++|.+.+.||+|+||.||++      ++.||||++..... .....+.+|++++++++||||+++++++...+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            68999999999999999974      58899998864422 234578899999999999999999999987655     7


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCC
Q 040702          580 ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL  659 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~  659 (797)
                      |+||||+++++|.+++..   .+++..++.++.||++||.|||   +++|+||||||+||+++.+ .+||+|||+++...
T Consensus       160 ~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~  232 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN  232 (681)
T ss_dssp             EEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred             EEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence            999999999999987755   4899999999999999999999   8999999999999999975 99999999998653


Q ss_pred             ccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccch----------hhhhhhcccccchhccc
Q 040702          660 EEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIR----------EEKHLMTKEQPMVRMGT  729 (797)
Q Consensus       660 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~l~~~cl  729 (797)
                      ..      ....||+.|||||.+.++ ++.++|+|++|++.+..+.+..++..          ........+.++++.|+
T Consensus       233 ~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  305 (681)
T 2pzi_A          233 SF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLLRRAI  305 (681)
T ss_dssp             CC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCCTTCHHHHHCHHHHHHHHHHT
T ss_pred             cC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccccccccccccCHHHHHHHhhhc
Confidence            22      345799999999988665 48999999999987655543322211          11112345678999999


Q ss_pred             cCCCCCCCCh-HHHHHhHHHH
Q 040702          730 DLSLGQFPAS-YSISKYLVYI  749 (797)
Q Consensus       730 ~~dp~~RPs~-~~i~~~l~~i  749 (797)
                      +.||.+||+. .++...+..+
T Consensus       306 ~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          306 DPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             CSSGGGSCSSHHHHHHHHHHH
T ss_pred             cCChhhCCCHHHHHHHHHHHH
Confidence            9999999964 5565555544

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.97  E-value=6.5e-32  Score=291.03  Aligned_cols=178  Identities=19%  Similarity=0.211  Sum_probs=145.4

Q ss_pred             hcCCCccccccccCCcceeec---ceEEEEEEEEeccCC--------cchhHHHHHHHhhhcc---------CCceeEe-
Q 040702          511 TNRFSENNLIGRGGFGPVYKD---GMEVAIKVFNLQYGG--------AFKSFDIECGMMKRIR---------HRNLIKI-  569 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~---~~~vAvK~~~~~~~~--------~~~~~~~E~~~l~~l~---------Hpniv~l-  569 (797)
                      .++|+..+.||+|+||.||++   ++.||||+++.....        ..+.+.+|+.+++.++         ||||+++ 
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~   98 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN   98 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred             cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence            467999999999999999985   689999999876321        2367889999999986         5555554 


Q ss_pred             ----------------eeeeec-------------CCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH
Q 040702          570 ----------------ISSCSN-------------DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEY  620 (797)
Q Consensus       570 ----------------~~~~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~y  620 (797)
                                      ++++.+             ++..|+||||+++|++.+.+..  ..+++..++.++.||+.||+|
T Consensus        99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~~  176 (336)
T 2vuw_A           99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLAV  176 (336)
T ss_dssp             EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHHH
T ss_pred             ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHHH
Confidence                            444443             6789999999999976665544  347999999999999999999


Q ss_pred             HHccCCCCeEEcCCCCCceEEcCCC--------------------cEEEEeecCCccCCccCccccccccccCccccccc
Q 040702          621 LHFGYSVPIIHCDLKPSNVLLDDNM--------------------VAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD  680 (797)
Q Consensus       621 LH~~~~~~ivHrDlkp~NIll~~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE  680 (797)
                      ||+  +++|+||||||+|||++.++                    .+||+|||+|+....       ...+||+.|||||
T Consensus       177 lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE  247 (336)
T 2vuw_A          177 AEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDED  247 (336)
T ss_dssp             HHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSG
T ss_pred             HHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChh
Confidence            992  36899999999999999887                    899999999986532       2347999999999


Q ss_pred             ccccCccchHHHHHHHhhhh
Q 040702          681 EIFSGEMRLKCWVNDSLLIS  700 (797)
Q Consensus       681 ~~~~~~~~~~~dv~s~~~~~  700 (797)
                      .+.+.. +.++|+|+++...
T Consensus       248 ~~~g~~-~~~~Diwsl~~~~  266 (336)
T 2vuw_A          248 LFTGDG-DYQFDIYRLMKKE  266 (336)
T ss_dssp             GGCCCS-SHHHHHHHHHHHH
T ss_pred             hhcCCC-ccceehhhhhCCC
Confidence            987655 8999999987663

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.97  E-value=5.3e-31  Score=285.93  Aligned_cols=280  Identities=20%  Similarity=0.181  Sum_probs=215.4

Q ss_pred             CCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCE
Q 040702           51 NLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSE  130 (797)
Q Consensus        51 ~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  130 (797)
                      .++.....++++|+++. +|..+.  ++|++|+|++|+++ .+|...|.++++|++|+|++|++++..|..|.++++|++
T Consensus        29 ~C~~~~~c~~~~~~l~~-iP~~~~--~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  104 (353)
T 2z80_A           29 SCDRNGICKGSSGSLNS-IPSGLT--EAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEH  104 (353)
T ss_dssp             EECTTSEEECCSTTCSS-CCTTCC--TTCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCE
T ss_pred             CCCCCeEeeCCCCCccc-cccccc--ccCcEEECCCCcCc-ccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCE
Confidence            34555567888888876 454443  47888888888887 667666777888888888888888777777888888888


Q ss_pred             EEccCCcCcccCCccccCCCCCCeeeccCccCcCCCC-CccccccCCCCCCCcEEEccCC-CCCCCCChhhhccccCCcE
Q 040702          131 LGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTP-ELSSLSSLSNCKYLEYFSFSNN-PLGGILPRAIGNLSQSMED  208 (797)
Q Consensus       131 L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~-~~~~~~~l~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~~L~~  208 (797)
                      |+|++|+|+++.+..|.++++|++|+|++|+++.++. .     .|..+++|++|++++| .+..+.+..|.++      
T Consensus       105 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~-----~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l------  173 (353)
T 2z80_A          105 LDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETS-----LFSHLTKLQILRVGNMDTFTKIQRKDFAGL------  173 (353)
T ss_dssp             EECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSC-----SCTTCTTCCEEEEEESSSCCEECTTTTTTC------
T ss_pred             EECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchh-----hhccCCCCcEEECCCCccccccCHHHccCC------
Confidence            8888888887777778888888888888888887765 2     3667777777777777 3554444455444      


Q ss_pred             EEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCC
Q 040702          209 FWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSN  288 (797)
Q Consensus       209 L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  288 (797)
                                         ++|  ++|++++|.+.+..|..|..+++|++|++++|+++...+..+..+++|+.|++++|
T Consensus       174 -------------------~~L--~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n  232 (353)
T 2z80_A          174 -------------------TFL--EELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDT  232 (353)
T ss_dssp             -------------------CEE--EEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESC
T ss_pred             -------------------CCC--CEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCC
Confidence                               444  67777777777777888899999999999999998766556667899999999999


Q ss_pred             CCCCCCC-CC---CCCCcccEEEccCCcCCC----CCCccccccccccEEeccCcccccccCccccCCcccceecccCcc
Q 040702          289 LLTSIPS-TL---WNLKDILHLNLSSNFFTG----PLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNR  360 (797)
Q Consensus       289 ~l~~lp~-~~---~~l~~L~~L~l~~N~l~~----~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  360 (797)
                      .++.++. .+   .....++.+++++|.+.+    .+|..+..+++|+.|++++|+++.+.+..|..+++|++|+|++|+
T Consensus       233 ~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~  312 (353)
T 2z80_A          233 DLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNP  312 (353)
T ss_dssp             BCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             ccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCC
Confidence            9987753 22   235678889999998875    356778899999999999999996655667999999999999999


Q ss_pred             ccCCCC
Q 040702          361 LQGSIP  366 (797)
Q Consensus       361 l~~~~p  366 (797)
                      +.+..|
T Consensus       313 ~~~~~~  318 (353)
T 2z80_A          313 WDCSCP  318 (353)
T ss_dssp             BCCCHH
T ss_pred             ccCcCC
Confidence            986443

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.97  E-value=1.7e-30  Score=272.67  Aligned_cols=207  Identities=12%  Similarity=0.027  Sum_probs=171.1

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCC---cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG---AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ++|...+.||+|+||.||++     ++.||||+++.....   ..+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            67999999999999999985     689999999765432   2367899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      ||+++++|.+++...   ....++.+++.|++.||+|||   +++|+||||||+||+++.++.+||+++           
T Consensus       111 e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~-----------  173 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYP-----------  173 (286)
T ss_dssp             ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSC-----------
T ss_pred             EecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEec-----------
Confidence            999999999999653   355578899999999999999   999999999999999999999998743           


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh-----------------------hhhhcc
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE-----------------------KHLMTK  720 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~  720 (797)
                                 +|++|       ++.++|+|++|+..++.+.+..++....                       ......
T Consensus       174 -----------~~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T 3uqc_A          174 -----------ATMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQ  235 (286)
T ss_dssp             -----------CCCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHH
T ss_pred             -----------cccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHH
Confidence                       34444       6899999999998866655444332211                       123345


Q ss_pred             cccchhccccCCCCCCCChHHHHHhHHHHHHHhc
Q 040702          721 EQPMVRMGTDLSLGQFPASYSISKYLVYIRELER  754 (797)
Q Consensus       721 ~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~  754 (797)
                      +.+++.+|++.||++| |+.|+++.|+.+.....
T Consensus       236 l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~  268 (286)
T 3uqc_A          236 ISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD  268 (286)
T ss_dssp             HHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred             HHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence            6889999999999999 99999999988766543

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.97  E-value=1.6e-30  Score=276.34  Aligned_cols=249  Identities=24%  Similarity=0.269  Sum_probs=162.1

Q ss_pred             CCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCcccccc--CCchhhCCCCCCEEE
Q 040702           55 MEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGT--IPSFIFNASKLSELG  132 (797)
Q Consensus        55 L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~--~~~~~~~l~~L~~L~  132 (797)
                      -+.++++++.++. +|..+.  ++|++|+|++|+++ .+|..+|..+++|++|+|++|+++..  .+..+..+++|++|+
T Consensus         9 ~~~l~c~~~~l~~-ip~~~~--~~l~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~   84 (306)
T 2z66_A            9 GTEIRCNSKGLTS-VPTGIP--SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLD   84 (306)
T ss_dssp             TTEEECCSSCCSS-CCSCCC--TTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEE
T ss_pred             CCEEEcCCCCccc-CCCCCC--CCCCEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEE
Confidence            3578899998876 454443  68999999999998 88888888899999999999998743  367778889999999


Q ss_pred             ccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEcc
Q 040702          133 LQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMD  212 (797)
Q Consensus       133 L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~  212 (797)
                      |++|.++. .|..|.++++|++|+|++|.++.+++.    ..+..+++|++|++++|++.+..+..|..++ +|+.|+++
T Consensus        85 Ls~n~i~~-l~~~~~~l~~L~~L~l~~n~l~~~~~~----~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~  158 (306)
T 2z66_A           85 LSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEF----SVFLSLRNLIYLDISHTHTRVAFNGIFNGLS-SLEVLKMA  158 (306)
T ss_dssp             CCSCSEEE-EEEEEETCTTCCEEECTTSEEESSTTT----TTTTTCTTCCEEECTTSCCEECSTTTTTTCT-TCCEEECT
T ss_pred             CCCCcccc-ChhhcCCCCCCCEEECCCCcccccccc----hhhhhccCCCEEECCCCcCCccchhhcccCc-CCCEEECC
Confidence            99999885 455688899999999999998887651    1367777888888888877766666665554 45555544


Q ss_pred             CCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCC
Q 040702          213 NCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTS  292 (797)
Q Consensus       213 ~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  292 (797)
                      +|.+.+.                         ..|..|..+++|++|++++|++++..|..+..+++|+.|+|++|.++.
T Consensus       159 ~n~l~~~-------------------------~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  213 (306)
T 2z66_A          159 GNSFQEN-------------------------FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFS  213 (306)
T ss_dssp             TCEEGGG-------------------------EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSB
T ss_pred             CCccccc-------------------------cchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCc
Confidence            4444320                         234444555555555555555555555555555555555555555544


Q ss_pred             CCC-CCCCCCcccEEEccCCcCCCCCCccccccc-cccEEeccCcccc
Q 040702          293 IPS-TLWNLKDILHLNLSSNFFTGPLPLKIGNLN-VLVQLDLSMNNFS  338 (797)
Q Consensus       293 lp~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~  338 (797)
                      ++. .+..+++|+.|++++|.+++..|..+..++ +|++|++++|.++
T Consensus       214 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~  261 (306)
T 2z66_A          214 LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA  261 (306)
T ss_dssp             CCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEE
T ss_pred             cChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCee
Confidence            433 333344444444444444444444444442 4444444444443

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.96  E-value=6.7e-30  Score=271.45  Aligned_cols=280  Identities=20%  Similarity=0.252  Sum_probs=206.0

Q ss_pred             CCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccC---CCcccc
Q 040702           23 LQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRL---PSSADV   99 (797)
Q Consensus        23 L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l---~~~~~~   99 (797)
                      -+.++.+++.         ++++|..+.  ++|++|++++|+++.+.+..|.++++|++|+|++|.++ .+   +... .
T Consensus         9 ~~~l~c~~~~---------l~~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~-~   75 (306)
T 2z66_A            9 GTEIRCNSKG---------LTSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLS-FKGCCSQSD-F   75 (306)
T ss_dssp             TTEEECCSSC---------CSSCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-EEEEEEHHH-H
T ss_pred             CCEEEcCCCC---------cccCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccC-cccCccccc-c
Confidence            3689999988         556676554  68999999999999877778999999999999999997 43   3433 4


Q ss_pred             CCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCC-ccccCCCCCCeeeccCccCcCCCCCccccccCCCC
Q 040702          100 RLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIP-NTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNC  178 (797)
Q Consensus       100 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l  178 (797)
                      .+++|++|+|++|.++ .+|..+..+++|++|+|++|+++++.+ ..|.++++|++|+|++|.++...+.     .|..+
T Consensus        76 ~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-----~~~~l  149 (306)
T 2z66_A           76 GTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNG-----IFNGL  149 (306)
T ss_dssp             SCSCCCEEECCSCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTT-----TTTTC
T ss_pred             cccccCEEECCCCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchh-----hcccC
Confidence            7899999999999998 467779999999999999999998776 7899999999999999999988765     48889


Q ss_pred             CCCcEEEccCCCCCC-CCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCc
Q 040702          179 KYLEYFSFSNNPLGG-ILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALF  257 (797)
Q Consensus       179 ~~L~~L~Ls~N~l~~-~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~  257 (797)
                      ++|++|++++|++.+ ..|..+..++ +|+.|++++|.+++.                          .|..|..+++|+
T Consensus       150 ~~L~~L~l~~n~l~~~~~~~~~~~l~-~L~~L~Ls~n~l~~~--------------------------~~~~~~~l~~L~  202 (306)
T 2z66_A          150 SSLEVLKMAGNSFQENFLPDIFTELR-NLTFLDLSQCQLEQL--------------------------SPTAFNSLSSLQ  202 (306)
T ss_dssp             TTCCEEECTTCEEGGGEECSCCTTCT-TCCEEECTTSCCCEE--------------------------CTTTTTTCTTCC
T ss_pred             cCCCEEECCCCccccccchhHHhhCc-CCCEEECCCCCcCCc--------------------------CHHHhcCCCCCC
Confidence            999999999999986 5677777776 566666666655544                          444455555566


Q ss_pred             EEEccCCcCcccCCCCccCCccccccccCCCCCCCC-CCCCCCC-CcccEEEccCCcCCCCCCc--cccccccccEEecc
Q 040702          258 QLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSI-PSTLWNL-KDILHLNLSSNFFTGPLPL--KIGNLNVLVQLDLS  333 (797)
Q Consensus       258 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l-p~~~~~l-~~L~~L~l~~N~l~~~~~~--~~~~l~~L~~L~Ls  333 (797)
                      +|+|++|++++..+..+..+++|+.|+|++|.++.. |..+..+ ++|+.|++++|.++...+.  ....+...+.+.+.
T Consensus       203 ~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~  282 (306)
T 2z66_A          203 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVE  282 (306)
T ss_dssp             EEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSC
T ss_pred             EEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhcc
Confidence            666666666555555555566666666666666433 3345555 3677777777777643221  11223344445556


Q ss_pred             CcccccccCccccCC
Q 040702          334 MNNFSCVIPTKIGGL  348 (797)
Q Consensus       334 ~N~l~~~~~~~~~~l  348 (797)
                      .+.+.+..|..+.+.
T Consensus       283 ~~~~~C~~p~~~~g~  297 (306)
T 2z66_A          283 VERMECATPSDKQGM  297 (306)
T ss_dssp             GGGCBEEESGGGTTC
T ss_pred             ccccccCCchhhCCc
Confidence            667777777666654

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.96  E-value=2.4e-29  Score=282.35  Aligned_cols=246  Identities=22%  Similarity=0.295  Sum_probs=161.7

Q ss_pred             CCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCC
Q 040702           23 LQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLP  102 (797)
Q Consensus        23 L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~  102 (797)
                      ...++.+++.         ++++|..+.  +++++|+|++|+|+++.|..|.++++|+.|+|++|+|+ .++...|.+++
T Consensus        56 ~~~v~c~~~~---------l~~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~-~~~~~~~~~l~  123 (452)
T 3zyi_A           56 FSKVVCTRRG---------LSEVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLA  123 (452)
T ss_dssp             SCEEECCSSC---------CSSCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-EECTTTTTTCT
T ss_pred             CcEEEECCCC---------cCccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccC-CcChhhccCcc
Confidence            3455555554         334444443  35666666666666666666666666666666666665 44545555666


Q ss_pred             CccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccC-ccCcCCCCCccccccCCCCCCC
Q 040702          103 NLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLND-NYLTSSTPELSSLSSLSNCKYL  181 (797)
Q Consensus       103 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~-N~l~~~~~~~~~~~~l~~l~~L  181 (797)
                      +|++|+|++|+|+...+..|.++++|++|+|++|+|+.+.+..|.++++|++|+|++ |.+..++..     .|.++++|
T Consensus       124 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~-----~~~~l~~L  198 (452)
T 3zyi_A          124 SLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEG-----AFEGLFNL  198 (452)
T ss_dssp             TCCEEECCSSCCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTT-----TTTTCTTC
T ss_pred             cCCEEECCCCcCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChh-----hccCCCCC
Confidence            666666666666655555566666666666666666665555666666666666665 444444443     25555566


Q ss_pred             cEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEc
Q 040702          182 EYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDL  261 (797)
Q Consensus       182 ~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  261 (797)
                      ++|+|++|+++++ |                          .+..+++|  ++|+|++|.++++.|..|..+++|+.|+|
T Consensus       199 ~~L~L~~n~l~~~-~--------------------------~~~~l~~L--~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  249 (452)
T 3zyi_A          199 KYLNLGMCNIKDM-P--------------------------NLTPLVGL--EELEMSGNHFPEIRPGSFHGLSSLKKLWV  249 (452)
T ss_dssp             CEEECTTSCCSSC-C--------------------------CCTTCTTC--CEEECTTSCCSEECGGGGTTCTTCCEEEC
T ss_pred             CEEECCCCccccc-c--------------------------cccccccc--cEEECcCCcCcccCcccccCccCCCEEEe
Confidence            6666666655533 1                          23344455  77777777777777888888888888888


Q ss_pred             cCCcCcccCCCCccCCccccccccCCCCCCCCCCC-CCCCCcccEEEccCCcCC
Q 040702          262 GGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPST-LWNLKDILHLNLSSNFFT  314 (797)
Q Consensus       262 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~-~~~l~~L~~L~l~~N~l~  314 (797)
                      ++|+++++.+..|.++++|+.|+|++|+|+.+|.. +..+++|+.|++++|.+.
T Consensus       250 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  303 (452)
T 3zyi_A          250 MNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN  303 (452)
T ss_dssp             TTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred             CCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence            88888888888888888888888888888888764 556888999999998876

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.96  E-value=2.4e-29  Score=281.29  Aligned_cols=246  Identities=23%  Similarity=0.299  Sum_probs=163.8

Q ss_pred             CCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCC
Q 040702           23 LQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLP  102 (797)
Q Consensus        23 L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~  102 (797)
                      ...++.+++.         ++++|..+.  ++++.|+|++|+|+++.+..|.++++|++|+|++|.|+ .++...|.+++
T Consensus        45 ~~~v~c~~~~---------l~~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~-~i~~~~~~~l~  112 (440)
T 3zyj_A           45 FSKVICVRKN---------LREVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLA  112 (440)
T ss_dssp             SCEEECCSCC---------CSSCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCC-EECGGGGTTCS
T ss_pred             CCEEEeCCCC---------cCcCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCC-ccChhhccCCc
Confidence            4455665555         344455443  45666666666666666666666666666666666665 55555555666


Q ss_pred             CccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccC-ccCcCCCCCccccccCCCCCCC
Q 040702          103 NLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLND-NYLTSSTPELSSLSSLSNCKYL  181 (797)
Q Consensus       103 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~-N~l~~~~~~~~~~~~l~~l~~L  181 (797)
                      +|++|+|++|+|+...+..|..+++|++|+|++|+|+.+.+..|.++++|++|+|++ |.+..+++.     .|.++++|
T Consensus       113 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~-----~~~~l~~L  187 (440)
T 3zyj_A          113 NLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEG-----AFEGLSNL  187 (440)
T ss_dssp             SCCEEECCSSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTT-----TTTTCSSC
T ss_pred             cCCEEECCCCcCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcc-----hhhccccc
Confidence            666666666666655555566666666666666666666666666666666666666 344444443     25556666


Q ss_pred             cEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEc
Q 040702          182 EYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDL  261 (797)
Q Consensus       182 ~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  261 (797)
                      ++|+|++|+++.+                          | .+..+++|  ++|+|++|+++++.|..|..+++|+.|+|
T Consensus       188 ~~L~L~~n~l~~~--------------------------~-~~~~l~~L--~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  238 (440)
T 3zyj_A          188 RYLNLAMCNLREI--------------------------P-NLTPLIKL--DELDLSGNHLSAIRPGSFQGLMHLQKLWM  238 (440)
T ss_dssp             CEEECTTSCCSSC--------------------------C-CCTTCSSC--CEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred             CeecCCCCcCccc--------------------------c-ccCCCccc--CEEECCCCccCccChhhhccCccCCEEEC
Confidence            6666666665533                          1 13344444  77777777777777788888888888888


Q ss_pred             cCCcCcccCCCCccCCccccccccCCCCCCCCCCC-CCCCCcccEEEccCCcCC
Q 040702          262 GGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPST-LWNLKDILHLNLSSNFFT  314 (797)
Q Consensus       262 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~-~~~l~~L~~L~l~~N~l~  314 (797)
                      ++|+++++.+..|.++++|+.|+|++|+++.+|.. +..+++|+.|++++|.+.
T Consensus       239 ~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  292 (440)
T 3zyj_A          239 IQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN  292 (440)
T ss_dssp             TTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred             CCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence            88888888888888888888888888888888764 556888899999998876

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.96  E-value=1.1e-30  Score=288.99  Aligned_cols=224  Identities=14%  Similarity=0.096  Sum_probs=169.6

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccC---CcchhHHHHHHHhhhccC-Cce---------------
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG---GAFKSFDIECGMMKRIRH-RNL---------------  566 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~---~~~~~~~~E~~~l~~l~H-pni---------------  566 (797)
                      +..|...+.||+|+||.||++     ++.||||+++....   ...+.+.+|+.+++.++| +|.               
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            456788899999999999985     68999999874432   235789999999999976 221               


Q ss_pred             eEe------eeeeec-----CCeEEEEEEccCCCCHHHHHh------cCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCe
Q 040702          567 IKI------ISSCSN-----DDFKALVLEYMPLGSLEKCLY------SGNYILDIFQGLNIMIDVASALEYLHFGYSVPI  629 (797)
Q Consensus       567 v~l------~~~~~~-----~~~~~lv~e~~~~g~L~~~l~------~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~i  629 (797)
                      +.+      ..++..     ....+++|+++ +++|.+++.      .....+++..+..++.|+++||+|||   +++|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence            111      111111     12457788876 579999884      22335788899999999999999999   9999


Q ss_pred             EEcCCCCCceEEcCCCcEEEEeecCCccCCccCccccccccccCccccccccc----------ccCccchHHHHHHHhhh
Q 040702          630 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI----------FSGEMRLKCWVNDSLLI  699 (797)
Q Consensus       630 vHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~dv~s~~~~  699 (797)
                      +||||||+|||++.++.+||+|||+++.....     ....+| +.|||||.+          ....++.++|+|++|+.
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            99999999999999999999999999865322     344577 999999998          55568999999999999


Q ss_pred             hhhhhccccccchhhh------------hhhcccccchhccccCCCCCCCChHHHHH
Q 040702          700 SVMIVVDANLLIREEK------------HLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       700 ~~~~~~~~~~~~~~~~------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      .++.+....++.....            .....+.++++.|++.||++||++.++++
T Consensus       307 l~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGSCSGGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHCCCCCCCcchhhhHHHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            8666654444332211            23346678899999999999999988865

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.96  E-value=2.2e-29  Score=264.60  Aligned_cols=223  Identities=25%  Similarity=0.317  Sum_probs=104.7

Q ss_pred             CEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccC
Q 040702           56 EWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQK  135 (797)
Q Consensus        56 ~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  135 (797)
                      +.++++++.++.+ |..+  .++|++|+|++|.++ .++...|..+++|++|+|++|.+++..|..|.++++|++|+|++
T Consensus        14 ~~~~c~~~~l~~i-p~~~--~~~l~~L~l~~n~i~-~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   89 (285)
T 1ozn_A           14 VTTSCPQQGLQAV-PVGI--PAASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD   89 (285)
T ss_dssp             CEEECCSSCCSSC-CTTC--CTTCSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred             eEEEcCcCCcccC-CcCC--CCCceEEEeeCCcCC-ccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence            3455555555432 3222  234555555555554 34444444455555555555555444444455555555555555


Q ss_pred             Cc-CcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCC
Q 040702          136 NS-FSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNC  214 (797)
Q Consensus       136 N~-l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n  214 (797)
                      |+ ++.+.+..|.++++|++|+|++|.++.+++.     .|.++++|++|++++|+++++.+..|..+            
T Consensus        90 n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-----~~~~l~~L~~L~l~~n~l~~~~~~~~~~l------------  152 (285)
T 1ozn_A           90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPG-----LFRGLAALQYLYLQDNALQALPDDTFRDL------------  152 (285)
T ss_dssp             CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTT-----TTTTCTTCCEEECCSSCCCCCCTTTTTTC------------
T ss_pred             CCCccccCHHHhcCCcCCCEEECCCCcCCEECHh-----HhhCCcCCCEEECCCCcccccCHhHhccC------------
Confidence            54 4444444444445555555555444444332     23444444444444444443333333332            


Q ss_pred             cccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCC
Q 040702          215 NISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIP  294 (797)
Q Consensus       215 ~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp  294 (797)
                                   ++|  ++|++++|+++++.+..|..+++|++|++++|++++..|..|..+++|+.|++++|.++.+|
T Consensus       153 -------------~~L--~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~  217 (285)
T 1ozn_A          153 -------------GNL--THLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALP  217 (285)
T ss_dssp             -------------TTC--CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred             -------------CCc--cEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCC
Confidence                         222  34444444444344444555555555555555555555555555555555555555554444


Q ss_pred             C-CCCCCCcccEEEccCCcCC
Q 040702          295 S-TLWNLKDILHLNLSSNFFT  314 (797)
Q Consensus       295 ~-~~~~l~~L~~L~l~~N~l~  314 (797)
                      . .+..+++|+.|++++|.+.
T Consensus       218 ~~~~~~l~~L~~L~l~~N~~~  238 (285)
T 1ozn_A          218 TEALAPLRALQYLRLNDNPWV  238 (285)
T ss_dssp             HHHHTTCTTCCEEECCSSCEE
T ss_pred             HHHcccCcccCEEeccCCCcc
Confidence            3 2344444555555555444

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.96  E-value=9.6e-30  Score=269.25  Aligned_cols=204  Identities=19%  Similarity=0.247  Sum_probs=167.5

Q ss_pred             hcCCCcc-ccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHh-hhccCCceeEeeeeeec----CCeE
Q 040702          511 TNRFSEN-NLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMM-KRIRHRNLIKIISSCSN----DDFK  579 (797)
Q Consensus       511 ~~~f~~~-~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l-~~l~Hpniv~l~~~~~~----~~~~  579 (797)
                      .++|... +.||+|+||.||++     ++.||||+++.     ...+.+|+.++ +..+||||+++++++..    ....
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            3567776 78999999999974     68999999863     35678899888 55589999999999876    6678


Q ss_pred             EEEEEccCCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcC---CCcEEEEeecCC
Q 040702          580 ALVLEYMPLGSLEKCLYSGNY-ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD---NMVAHLSDFGMA  655 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~DFGla  655 (797)
                      ++||||+++|+|.+++..... .+++..++.++.|++.||+|||   +.+|+||||||+||+++.   ++.+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            999999999999999987543 6899999999999999999999   999999999999999997   788999999999


Q ss_pred             ccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh---------------------
Q 040702          656 KPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE---------------------  714 (797)
Q Consensus       656 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~---------------------  714 (797)
                      +...                        +..++.++|+|++|+..+..+.+..++....                     
T Consensus       168 ~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  223 (299)
T 3m2w_A          168 KETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  223 (299)
T ss_dssp             EECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCH
T ss_pred             cccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCc
Confidence            7431                        2346789999999999866555444332111                     


Q ss_pred             ---hhhhcccccchhccccCCCCCCCChHHHHHhH
Q 040702          715 ---KHLMTKEQPMVRMGTDLSLGQFPASYSISKYL  746 (797)
Q Consensus       715 ---~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l  746 (797)
                         ......+.++++.|++.||.+||++.|+++.-
T Consensus       224 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp  258 (299)
T 3m2w_A          224 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  258 (299)
T ss_dssp             HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             hhcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence               12344677899999999999999999998753

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.96  E-value=3.1e-28  Score=280.39  Aligned_cols=267  Identities=26%  Similarity=0.295  Sum_probs=153.0

Q ss_pred             CCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEcc
Q 040702           55 MEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQ  134 (797)
Q Consensus        55 L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  134 (797)
                      ++.|++++|+++. +|..+.  ++|+.|+|++|.|+ .+|.    .+++|++|+|++|+|++ +|.   .+++|++|+|+
T Consensus        42 l~~L~ls~n~L~~-lp~~l~--~~L~~L~L~~N~l~-~lp~----~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls  109 (622)
T 3g06_A           42 NAVLNVGESGLTT-LPDCLP--AHITTLVIPDNNLT-SLPA----LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIF  109 (622)
T ss_dssp             CCEEECCSSCCSC-CCSCCC--TTCSEEEECSCCCS-CCCC----CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEEC
T ss_pred             CcEEEecCCCcCc-cChhhC--CCCcEEEecCCCCC-CCCC----cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECc
Confidence            4455555555542 333332  45555555555554 4444    23555555555555542 222   34555555555


Q ss_pred             CCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCC
Q 040702          135 KNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNC  214 (797)
Q Consensus       135 ~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n  214 (797)
                      +|+|+++.+    .+++|++|+|++|+|+.++..         +++|++|+|++|+++++. ..    +.+|+.|+    
T Consensus       110 ~N~l~~l~~----~l~~L~~L~L~~N~l~~lp~~---------l~~L~~L~Ls~N~l~~l~-~~----~~~L~~L~----  167 (622)
T 3g06_A          110 SNPLTHLPA----LPSGLCKLWIFGNQLTSLPVL---------PPGLQELSVSDNQLASLP-AL----PSELCKLW----  167 (622)
T ss_dssp             SCCCCCCCC----CCTTCCEEECCSSCCSCCCCC---------CTTCCEEECCSSCCSCCC-CC----CTTCCEEE----
T ss_pred             CCcCCCCCC----CCCCcCEEECCCCCCCcCCCC---------CCCCCEEECcCCcCCCcC-Cc----cCCCCEEE----
Confidence            555554332    345555555665555554432         245555666666555432 11    11333333    


Q ss_pred             cccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCC
Q 040702          215 NISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIP  294 (797)
Q Consensus       215 ~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp  294 (797)
                                            +++|.++++ |   ..+++|+.|++++|+++++. .   .+++|+.|++++|.++.+|
T Consensus       168 ----------------------L~~N~l~~l-~---~~~~~L~~L~Ls~N~l~~l~-~---~~~~L~~L~L~~N~l~~l~  217 (622)
T 3g06_A          168 ----------------------AYNNQLTSL-P---MLPSGLQELSVSDNQLASLP-T---LPSELYKLWAYNNRLTSLP  217 (622)
T ss_dssp             ----------------------CCSSCCSCC-C---CCCTTCCEEECCSSCCSCCC-C---CCTTCCEEECCSSCCSSCC
T ss_pred             ----------------------CCCCCCCCC-c---ccCCCCcEEECCCCCCCCCC-C---ccchhhEEECcCCcccccC
Confidence                                  333333322 2   23456666666666666432 2   2356777777777777666


Q ss_pred             CCCCCCCcccEEEccCCcCCCCCCccccccccccEEeccCcccccccCccccCCcccceecccCccccCCCChhhhcccc
Q 040702          295 STLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLIS  374 (797)
Q Consensus       295 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~  374 (797)
                      ..   +++|+.|++++|.+++ +|   ..+++|+.|++++|.|+.+ |.   .+++|+.|+|++|+|+ .+|..+..+++
T Consensus       218 ~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~l-p~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~  285 (622)
T 3g06_A          218 AL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTSL-PM---LPSGLLSLSVYRNQLT-RLPESLIHLSS  285 (622)
T ss_dssp             CC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCC-SCCGGGGGSCT
T ss_pred             CC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCcC-Cc---ccccCcEEeCCCCCCC-cCCHHHhhccc
Confidence            43   3667777777777775 33   3456777788888877743 33   4577888888888887 56777888888


Q ss_pred             CCeeeecCCcCCCCCChhhhccC
Q 040702          375 LKSLNLSNNNLSGTIPISLEKLL  397 (797)
Q Consensus       375 L~~L~Ls~N~l~~~~p~~~~~l~  397 (797)
                      |+.|+|++|.+++..|..+..++
T Consensus       286 L~~L~L~~N~l~~~~~~~l~~L~  308 (622)
T 3g06_A          286 ETTVNLEGNPLSERTLQALREIT  308 (622)
T ss_dssp             TCEEECCSCCCCHHHHHHHHHHH
T ss_pred             cCEEEecCCCCCCcCHHHHHhcc
Confidence            88888888888877777776654

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.96  E-value=9.2e-29  Score=276.56  Aligned_cols=248  Identities=22%  Similarity=0.223  Sum_probs=164.6

Q ss_pred             CCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeec
Q 040702           78 TLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGL  157 (797)
Q Consensus        78 ~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L  157 (797)
                      ..+.++.+++.++ .+|..+.   +++++|+|++|+|++..+..|.++++|++|+|++|+|+.+.+++|.++++|++|+|
T Consensus        44 ~~~~v~c~~~~l~-~iP~~~~---~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L  119 (440)
T 3zyj_A           44 QFSKVICVRKNLR-EVPDGIS---TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLEL  119 (440)
T ss_dssp             TSCEEECCSCCCS-SCCSCCC---TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEEC
T ss_pred             CCCEEEeCCCCcC-cCCCCCC---CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEEC
Confidence            4567777777777 7777654   67788888888887777777888888888888888888777788888888888888


Q ss_pred             cCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhccc
Q 040702          158 NDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSL  237 (797)
Q Consensus       158 ~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~L  237 (797)
                      ++|+|+.+++.     .|..+++|++|+|++|++..+.+..|..++ +|+.|++++|+..                    
T Consensus       120 ~~n~l~~~~~~-----~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~-~L~~L~l~~~~~l--------------------  173 (440)
T 3zyj_A          120 FDNRLTTIPNG-----AFVYLSKLKELWLRNNPIESIPSYAFNRIP-SLRRLDLGELKRL--------------------  173 (440)
T ss_dssp             CSSCCSSCCTT-----TSCSCSSCCEEECCSCCCCEECTTTTTTCT-TCCEEECCCCTTC--------------------
T ss_pred             CCCcCCeeCHh-----HhhccccCceeeCCCCcccccCHHHhhhCc-ccCEeCCCCCCCc--------------------
Confidence            88888877765     377777888888888888777666777666 6666666653322                    


Q ss_pred             ccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCC-CCCCCCCCcccEEEccCCcCCCC
Q 040702          238 EGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSI-PSTLWNLKDILHLNLSSNFFTGP  316 (797)
Q Consensus       238 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l-p~~~~~l~~L~~L~l~~N~l~~~  316 (797)
                           ..+.+..|.++++|++|+|++|+++.+ | .+..+++|+.|+|++|.++.+ |..+.++++|+.|++++|++++.
T Consensus       174 -----~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~  246 (440)
T 3zyj_A          174 -----SYISEGAFEGLSNLRYLNLAMCNLREI-P-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVI  246 (440)
T ss_dssp             -----CEECTTTTTTCSSCCEEECTTSCCSSC-C-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEE
T ss_pred             -----ceeCcchhhcccccCeecCCCCcCccc-c-ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEE
Confidence                 112233444555555555555555533 2 245555556666666655544 33555566666666666666655


Q ss_pred             CCccccccccccEEeccCcccccccCccccCCcccceecccCcccc
Q 040702          317 LPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQ  362 (797)
Q Consensus       317 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  362 (797)
                      .+..|.++++|+.|+|++|+++...+..|..+++|+.|+|++|++.
T Consensus       247 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  292 (440)
T 3zyj_A          247 ERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN  292 (440)
T ss_dssp             CTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred             ChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence            5666666666666666666666666666666666666666666654

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.96  E-value=2.6e-29  Score=264.03  Aligned_cols=227  Identities=23%  Similarity=0.286  Sum_probs=189.7

Q ss_pred             CCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccC
Q 040702           21 SSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVR  100 (797)
Q Consensus        21 ~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~  100 (797)
                      ..-+++|.+++.         ++.+|..+  .++|++|++++|+++++.+..|.++++|++|+|++|.++ .++...|..
T Consensus        11 ~~~~~~~c~~~~---------l~~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~-~~~~~~~~~   78 (285)
T 1ozn_A           11 EPKVTTSCPQQG---------LQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTG   78 (285)
T ss_dssp             SSSCEEECCSSC---------CSSCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-EECTTTTTT
T ss_pred             CCCeEEEcCcCC---------cccCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccc-eeCHhhcCC
Confidence            344789999888         44556554  368999999999999988889999999999999999998 665566778


Q ss_pred             CCCccEEEccCcc-ccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCC
Q 040702          101 LPNLKELHLWGNN-FIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCK  179 (797)
Q Consensus       101 l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~  179 (797)
                      +++|++|+|++|. +....|..|..+++|++|+|++|+++++.+..|.++++|++|+|++|.++.+++.     .|..++
T Consensus        79 l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~-----~~~~l~  153 (285)
T 1ozn_A           79 LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDD-----TFRDLG  153 (285)
T ss_dssp             CTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT-----TTTTCT
T ss_pred             ccCCCEEeCCCCCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHh-----HhccCC
Confidence            9999999999997 8877788999999999999999999998899999999999999999999988875     378899


Q ss_pred             CCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEE
Q 040702          180 YLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQL  259 (797)
Q Consensus       180 ~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  259 (797)
                      +|++|++++|+++++.+..|..++ +|+.|++++|.+++..|..|..+++|  ++|++++|.++++.+..|..+++|+.|
T Consensus       154 ~L~~L~l~~n~l~~~~~~~~~~l~-~L~~L~l~~n~l~~~~~~~~~~l~~L--~~L~l~~n~l~~~~~~~~~~l~~L~~L  230 (285)
T 1ozn_A          154 NLTHLFLHGNRISSVPERAFRGLH-SLDRLLLHQNRVAHVHPHAFRDLGRL--MTLYLFANNLSALPTEALAPLRALQYL  230 (285)
T ss_dssp             TCCEEECCSSCCCEECTTTTTTCT-TCCEEECCSSCCCEECTTTTTTCTTC--CEEECCSSCCSCCCHHHHTTCTTCCEE
T ss_pred             CccEEECCCCcccccCHHHhcCcc-ccCEEECCCCcccccCHhHccCcccc--cEeeCCCCcCCcCCHHHcccCcccCEE
Confidence            999999999999988777788877 78888888888887777777777776  777777777776666667777777777


Q ss_pred             EccCCcCc
Q 040702          260 DLGGNKLS  267 (797)
Q Consensus       260 ~Ls~N~l~  267 (797)
                      ++++|.+.
T Consensus       231 ~l~~N~~~  238 (285)
T 1ozn_A          231 RLNDNPWV  238 (285)
T ss_dssp             ECCSSCEE
T ss_pred             eccCCCcc
Confidence            77777765

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.96  E-value=9.1e-29  Score=277.62  Aligned_cols=242  Identities=25%  Similarity=0.259  Sum_probs=198.7

Q ss_pred             CCCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEE
Q 040702            3 SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSL   82 (797)
Q Consensus         3 ~l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L   82 (797)
                      +.+++.++. +|..+  .+++++|||++|++++..        |..+.++++|++|+|++|+|+++.|..|.++++|++|
T Consensus        60 ~c~~~~l~~-iP~~~--~~~l~~L~L~~n~i~~~~--------~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L  128 (452)
T 3zyi_A           60 VCTRRGLSE-VPQGI--PSNTRYLNLMENNIQMIQ--------ADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTL  128 (452)
T ss_dssp             ECCSSCCSS-CCSCC--CTTCSEEECCSSCCCEEC--------TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred             EECCCCcCc-cCCCC--CCCccEEECcCCcCceEC--------HHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEE
Confidence            344555554 44333  479999999999966543        4578899999999999999999999999999999999


Q ss_pred             EccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccC-CcCcccCCccccCCCCCCeeeccCcc
Q 040702           83 YLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQK-NSFSGSIPNTFGNLRNLKWLGLNDNY  161 (797)
Q Consensus        83 ~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~-N~l~~~~~~~f~~l~~L~~L~L~~N~  161 (797)
                      +|++|+|+ .+|...|..+++|++|+|++|+|+.+.+..|.++++|++|+|++ |.+..+.+..|.++++|++|+|++|+
T Consensus       129 ~L~~n~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~  207 (452)
T 3zyi_A          129 ELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCN  207 (452)
T ss_dssp             ECCSSCCS-BCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSC
T ss_pred             ECCCCcCC-ccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCc
Confidence            99999998 88888888999999999999999988888999999999999999 77888888899999999999999999


Q ss_pred             CcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhccccccc
Q 040702          162 LTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQ  241 (797)
Q Consensus       162 l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~  241 (797)
                      ++.++.       +..+++|+.|+|++|++.++.|..|.+++ +|+.|++++|.++                        
T Consensus       208 l~~~~~-------~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~L~~n~l~------------------------  255 (452)
T 3zyi_A          208 IKDMPN-------LTPLVGLEELEMSGNHFPEIRPGSFHGLS-SLKKLWVMNSQVS------------------------  255 (452)
T ss_dssp             CSSCCC-------CTTCTTCCEEECTTSCCSEECGGGGTTCT-TCCEEECTTSCCC------------------------
T ss_pred             cccccc-------ccccccccEEECcCCcCcccCcccccCcc-CCCEEEeCCCcCc------------------------
Confidence            998753       77888999999999999988888887776 5655555555554                        


Q ss_pred             ccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCC
Q 040702          242 LEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLL  290 (797)
Q Consensus       242 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l  290 (797)
                        ++.+..|..+++|+.|+|++|+++++.+..|..+++|+.|+|++|.+
T Consensus       256 --~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~  302 (452)
T 3zyi_A          256 --LIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW  302 (452)
T ss_dssp             --EECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCE
T ss_pred             --eECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCc
Confidence              44555566666777777777777766666667777777777777766

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.96  E-value=2.1e-28  Score=281.90  Aligned_cols=269  Identities=22%  Similarity=0.258  Sum_probs=199.0

Q ss_pred             CCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccC
Q 040702           21 SSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVR  100 (797)
Q Consensus        21 ~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~  100 (797)
                      .++++||+++|.+         +.+|..+.  ++|++|++++|+|+++ |.   .+++|++|+|++|+|+ .+|.    .
T Consensus        40 ~~l~~L~ls~n~L---------~~lp~~l~--~~L~~L~L~~N~l~~l-p~---~l~~L~~L~Ls~N~l~-~lp~----~   99 (622)
T 3g06_A           40 NGNAVLNVGESGL---------TTLPDCLP--AHITTLVIPDNNLTSL-PA---LPPELRTLEVSGNQLT-SLPV----L   99 (622)
T ss_dssp             HCCCEEECCSSCC---------SCCCSCCC--TTCSEEEECSCCCSCC-CC---CCTTCCEEEECSCCCS-CCCC----C
T ss_pred             CCCcEEEecCCCc---------CccChhhC--CCCcEEEecCCCCCCC-CC---cCCCCCEEEcCCCcCC-cCCC----C
Confidence            4689999999994         45566555  7899999999999864 44   5789999999999998 7886    5


Q ss_pred             CCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCC
Q 040702          101 LPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKY  180 (797)
Q Consensus       101 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~  180 (797)
                      +++|++|+|++|+|++. |.   .+++|++|+|++|+|+.+.+    .+++|++|+|++|+++.++..         +++
T Consensus       100 l~~L~~L~Ls~N~l~~l-~~---~l~~L~~L~L~~N~l~~lp~----~l~~L~~L~Ls~N~l~~l~~~---------~~~  162 (622)
T 3g06_A          100 PPGLLELSIFSNPLTHL-PA---LPSGLCKLWIFGNQLTSLPV----LPPGLQELSVSDNQLASLPAL---------PSE  162 (622)
T ss_dssp             CTTCCEEEECSCCCCCC-CC---CCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSCCCCC---------CTT
T ss_pred             CCCCCEEECcCCcCCCC-CC---CCCCcCEEECCCCCCCcCCC----CCCCCCEEECcCCcCCCcCCc---------cCC
Confidence            79999999999999854 44   57899999999999997554    258999999999999987642         367


Q ss_pred             CcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEE
Q 040702          181 LEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLD  260 (797)
Q Consensus       181 L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  260 (797)
                      |+.|++++|+++++.    ..+ .+|+.|++++|.+++ +|.                             .+++|+.|+
T Consensus       163 L~~L~L~~N~l~~l~----~~~-~~L~~L~Ls~N~l~~-l~~-----------------------------~~~~L~~L~  207 (622)
T 3g06_A          163 LCKLWAYNNQLTSLP----MLP-SGLQELSVSDNQLAS-LPT-----------------------------LPSELYKLW  207 (622)
T ss_dssp             CCEEECCSSCCSCCC----CCC-TTCCEEECCSSCCSC-CCC-----------------------------CCTTCCEEE
T ss_pred             CCEEECCCCCCCCCc----ccC-CCCcEEECCCCCCCC-CCC-----------------------------ccchhhEEE
Confidence            999999999999653    222 356666666666553 111                             124566666


Q ss_pred             ccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEccCCcCCCCCCccccccccccEEeccCcccccc
Q 040702          261 LGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCV  340 (797)
Q Consensus       261 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  340 (797)
                      +++|.++.+. .   .+++|+.|+|++|.|+.+|   ..+++|+.|++++|.|+. +|.   .+++|+.|+|++|+|+ .
T Consensus       208 L~~N~l~~l~-~---~~~~L~~L~Ls~N~L~~lp---~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~  275 (622)
T 3g06_A          208 AYNNRLTSLP-A---LPSGLKELIVSGNRLTSLP---VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-R  275 (622)
T ss_dssp             CCSSCCSSCC-C---CCTTCCEEECCSSCCSCCC---CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-S
T ss_pred             CcCCcccccC-C---CCCCCCEEEccCCccCcCC---CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-c
Confidence            6666666432 2   2356777777777777666   334667777777777774 333   4567778888888887 4


Q ss_pred             cCccccCCcccceecccCccccCCCChhhhccc
Q 040702          341 IPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLI  373 (797)
Q Consensus       341 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  373 (797)
                      +|..|.++++|+.|+|++|++++..|..+..++
T Consensus       276 lp~~l~~l~~L~~L~L~~N~l~~~~~~~l~~L~  308 (622)
T 3g06_A          276 LPESLIHLSSETTVNLEGNPLSERTLQALREIT  308 (622)
T ss_dssp             CCGGGGGSCTTCEEECCSCCCCHHHHHHHHHHH
T ss_pred             CCHHHhhccccCEEEecCCCCCCcCHHHHHhcc
Confidence            566777888888888888888777777776665

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.96  E-value=1.1e-30  Score=278.68  Aligned_cols=253  Identities=20%  Similarity=0.180  Sum_probs=118.8

Q ss_pred             EccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccC
Q 040702           83 YLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYL  162 (797)
Q Consensus        83 ~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l  162 (797)
                      +++.+.+. ..+...+..+++|++|+|++|++++..|..|.++++|++|+|++|+|+++.+  |.++++|++|+|++|.+
T Consensus        16 ~ls~~~l~-~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l   92 (317)
T 3o53_A           16 KVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYV   92 (317)
T ss_dssp             SCCTTTHH-HHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEE
T ss_pred             eccccchh-hhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcc
Confidence            34444443 3333333344444444444444444444444445555555555555443332  44555555555555554


Q ss_pred             cCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccc
Q 040702          163 TSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQL  242 (797)
Q Consensus       163 ~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l  242 (797)
                      +.+++          .++|+.|++++|+++++.+..+   + +|+.|++++|.+++..+..+..+++|  ++|++++|.+
T Consensus        93 ~~l~~----------~~~L~~L~l~~n~l~~~~~~~~---~-~L~~L~l~~N~l~~~~~~~~~~l~~L--~~L~Ls~N~l  156 (317)
T 3o53_A           93 QELLV----------GPSIETLHAANNNISRVSCSRG---Q-GKKNIYLANNKITMLRDLDEGCRSRV--QYLDLKLNEI  156 (317)
T ss_dssp             EEEEE----------CTTCCEEECCSSCCSEEEECCC---S-SCEEEECCSSCCCSGGGBCTGGGSSE--EEEECTTSCC
T ss_pred             ccccC----------CCCcCEEECCCCccCCcCcccc---C-CCCEEECCCCCCCCccchhhhccCCC--CEEECCCCCC
Confidence            43321          1345555555555544332221   1 34444444444443333333333333  4444555544


Q ss_pred             cCCCchhhc-CCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEccCCcCCCCCCccc
Q 040702          243 EGSIPDDLC-RLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKI  321 (797)
Q Consensus       243 ~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~  321 (797)
                      ++..+..+. .+++|++|+|++|+++++.+  ...+++|++|+|++|.++.+|..+..+++|+.|++++|.++. +|..+
T Consensus       157 ~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~L~~N~l~~-l~~~~  233 (317)
T 3o53_A          157 DTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVL-IEKAL  233 (317)
T ss_dssp             CEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTSCCCE-ECTTC
T ss_pred             CcccHHHHhhccCcCCEEECCCCcCccccc--ccccccCCEEECCCCcCCcchhhhcccCcccEEECcCCcccc-hhhHh
Confidence            444444442 45556666666666554422  122555555555555555555545555555555555555552 34444


Q ss_pred             cccccccEEeccCcccc-cccCccccCCcccceeccc
Q 040702          322 GNLNVLVQLDLSMNNFS-CVIPTKIGGLKDLQYLFLE  357 (797)
Q Consensus       322 ~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls  357 (797)
                      ..+++|+.|++++|.+. +..|..+..+++|+.|+++
T Consensus       234 ~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~  270 (317)
T 3o53_A          234 RFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (317)
T ss_dssp             CCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHH
T ss_pred             hcCCCCCEEEccCCCccCcCHHHHHhccccceEEECC
Confidence            55555555555555554 3344444555555555554

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.96  E-value=1.8e-30  Score=277.13  Aligned_cols=247  Identities=20%  Similarity=0.140  Sum_probs=157.0

Q ss_pred             CCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCE
Q 040702           51 NLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSE  130 (797)
Q Consensus        51 ~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  130 (797)
                      .+++|++|++++|+++++.|..|.++++|++|+|++|.+++..+   +..+++|++|+|++|++++..     ..++|++
T Consensus        32 ~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~---~~~l~~L~~L~Ls~n~l~~l~-----~~~~L~~  103 (317)
T 3o53_A           32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD---LESLSTLRTLDLNNNYVQELL-----VGPSIET  103 (317)
T ss_dssp             TGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE---ETTCTTCCEEECCSSEEEEEE-----ECTTCCE
T ss_pred             cCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh---hhhcCCCCEEECcCCcccccc-----CCCCcCE
Confidence            34455555555555555555555555555555555555552222   445555555555555554322     1245555


Q ss_pred             EEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEE
Q 040702          131 LGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFW  210 (797)
Q Consensus       131 L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~  210 (797)
                      |++++|+|+++.+..   +++|++|+|++|++                             +++.+..+..++ +|+.|+
T Consensus       104 L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l-----------------------------~~~~~~~~~~l~-~L~~L~  150 (317)
T 3o53_A          104 LHAANNNISRVSCSR---GQGKKNIYLANNKI-----------------------------TMLRDLDEGCRS-RVQYLD  150 (317)
T ss_dssp             EECCSSCCSEEEECC---CSSCEEEECCSSCC-----------------------------CSGGGBCTGGGS-SEEEEE
T ss_pred             EECCCCccCCcCccc---cCCCCEEECCCCCC-----------------------------CCccchhhhccC-CCCEEE
Confidence            555555555443332   23444455555544                             444444444444 455555


Q ss_pred             ccCCcccccCChhhh-hhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCC
Q 040702          211 MDNCNISGSIPEEIN-NLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNL  289 (797)
Q Consensus       211 L~~n~i~~~~p~~~~-~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~  289 (797)
                      +++|.+++..+..+. .+++|  ++|+|++|.+++..  ....+++|++|+|++|+++++.+ .+..+++|+.|+|++|.
T Consensus       151 Ls~N~l~~~~~~~~~~~l~~L--~~L~L~~N~l~~~~--~~~~l~~L~~L~Ls~N~l~~l~~-~~~~l~~L~~L~L~~N~  225 (317)
T 3o53_A          151 LKLNEIDTVNFAELAASSDTL--EHLNLQYNFIYDVK--GQVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNK  225 (317)
T ss_dssp             CTTSCCCEEEGGGGGGGTTTC--CEEECTTSCCCEEE--CCCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSC
T ss_pred             CCCCCCCcccHHHHhhccCcC--CEEECCCCcCcccc--cccccccCCEEECCCCcCCcchh-hhcccCcccEEECcCCc
Confidence            555555544444442 44555  66677777766542  22348899999999999997655 48899999999999999


Q ss_pred             CCCCCCCCCCCCcccEEEccCCcCC-CCCCccccccccccEEeccC-cccccccCc
Q 040702          290 LTSIPSTLWNLKDILHLNLSSNFFT-GPLPLKIGNLNVLVQLDLSM-NNFSCVIPT  343 (797)
Q Consensus       290 l~~lp~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~Ls~-N~l~~~~~~  343 (797)
                      ++.+|..+..+++|+.|++++|.+. +..+..+..+++|+.|++++ +.+++..|.
T Consensus       226 l~~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~  281 (317)
T 3o53_A          226 LVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEE  281 (317)
T ss_dssp             CCEECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred             ccchhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCchh
Confidence            9999999989999999999999998 67778888999999999985 456655444

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.96  E-value=8.2e-29  Score=265.20  Aligned_cols=228  Identities=24%  Similarity=0.309  Sum_probs=137.8

Q ss_pred             CCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCcccc
Q 040702           20 PSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADV   99 (797)
Q Consensus        20 l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~   99 (797)
                      ...+++|||++|+         ++.+|..+..+++|++|+|++|+++ .+|..|+++++|++|+|++|.++ .+|..+ .
T Consensus        80 ~~~l~~L~L~~n~---------l~~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l-~  147 (328)
T 4fcg_A           80 QPGRVALELRSVP---------LPQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASI-A  147 (328)
T ss_dssp             STTCCEEEEESSC---------CSSCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGG-G
T ss_pred             ccceeEEEccCCC---------chhcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHH-h
Confidence            3667777777776         3355666667777777777777777 56777777777777777777776 666553 4


Q ss_pred             CCCCccEEEccCccccccCCchhhC---------CCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCcc
Q 040702          100 RLPNLKELHLWGNNFIGTIPSFIFN---------ASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELS  170 (797)
Q Consensus       100 ~l~~L~~L~L~~N~l~~~~~~~~~~---------l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~  170 (797)
                      .+++|++|+|++|++.+.+|..+..         +++|++|+|++|+|+ ..|..|.++++|++|+|++|.++.+++.  
T Consensus       148 ~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~--  224 (328)
T 4fcg_A          148 SLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPA--  224 (328)
T ss_dssp             GCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGG--
T ss_pred             cCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchh--
Confidence            6777777777777666666665543         555555555555555 3344455555555555555555544432  


Q ss_pred             ccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhh
Q 040702          171 SLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDL  250 (797)
Q Consensus       171 ~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~  250 (797)
                          +..+++|++|+|++|++.+..|..|..                         +++|  ++|++++|.+.+.+|..+
T Consensus       225 ----l~~l~~L~~L~Ls~n~~~~~~p~~~~~-------------------------l~~L--~~L~L~~n~~~~~~p~~~  273 (328)
T 4fcg_A          225 ----IHHLPKLEELDLRGCTALRNYPPIFGG-------------------------RAPL--KRLILKDCSNLLTLPLDI  273 (328)
T ss_dssp             ----GGGCTTCCEEECTTCTTCCBCCCCTTC-------------------------CCCC--CEEECTTCTTCCBCCTTG
T ss_pred             ----hccCCCCCEEECcCCcchhhhHHHhcC-------------------------CCCC--CEEECCCCCchhhcchhh
Confidence                344445555555555555454444444                         4444  555555555555555556


Q ss_pred             cCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCC
Q 040702          251 CRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSI  293 (797)
Q Consensus       251 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l  293 (797)
                      ..+++|++|+|++|.+.+.+|..++.+++|+.+++..|.+..+
T Consensus       274 ~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~~l  316 (328)
T 4fcg_A          274 HRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQL  316 (328)
T ss_dssp             GGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSCC-
T ss_pred             hcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHHHH
Confidence            6666666666666666666666666666666666665555444

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.95  E-value=6.2e-30  Score=272.28  Aligned_cols=250  Identities=22%  Similarity=0.233  Sum_probs=124.1

Q ss_pred             cCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCc-ccCCCccc------cCCCCccEEEccCccccccCCchh
Q 040702           50 DNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLS-GRLPSSAD------VRLPNLKELHLWGNNFIGTIPSFI  122 (797)
Q Consensus        50 ~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~-~~l~~~~~------~~l~~L~~L~L~~N~l~~~~~~~~  122 (797)
                      +..++|+.|++++|++  .+|..+...  |+.|+|++|.++ ..+|...+      .++++|++|+|++|++++..|..+
T Consensus        40 ~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~  115 (312)
T 1wwl_A           40 GGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPL  115 (312)
T ss_dssp             EEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCS
T ss_pred             ccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHH
Confidence            3344455555555555  234433332  555555555552 12222221      134455555555555554444443


Q ss_pred             --hCCCCCCEEEccCCcCcccCCccccCC-----CCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCC
Q 040702          123 --FNASKLSELGLQKNSFSGSIPNTFGNL-----RNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGIL  195 (797)
Q Consensus       123 --~~l~~L~~L~L~~N~l~~~~~~~f~~l-----~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~  195 (797)
                        ..+++|++|+|++|+|+++ |..|.++     ++|++|+|++|+++.+++.     .|..+++|++|+|++|++.+..
T Consensus       116 ~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~-----~~~~l~~L~~L~Ls~N~l~~~~  189 (312)
T 1wwl_A          116 LEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCE-----QVRVFPALSTLDLSDNPELGER  189 (312)
T ss_dssp             SSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTT-----TCCCCSSCCEEECCSCTTCHHH
T ss_pred             HHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHH-----HhccCCCCCEEECCCCCcCcch
Confidence              4455555555555555544 4444444     4555555555555444432     2444444445555444443220


Q ss_pred             ChhhhccccCCcEEEccCCcccccCChhh--hhhhhhHhhhcccccccccC---CCchhhcCCCCCcEEEccCCcCcccC
Q 040702          196 PRAIGNLSQSMEDFWMDNCNISGSIPEEI--NNLTNLILQLLSLEGNQLEG---SIPDDLCRLAALFQLDLGGNKLSGFV  270 (797)
Q Consensus       196 ~~~~~~l~~~L~~L~L~~n~i~~~~p~~~--~~l~~L~L~~L~Ls~N~l~~---~~~~~~~~l~~L~~L~Ls~N~l~~~~  270 (797)
                      +                       .|..+  ..+++|  ++|++++|++++   .....+..+++|++|+|++|++++..
T Consensus       190 ~-----------------------~~~~~~~~~l~~L--~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  244 (312)
T 1wwl_A          190 G-----------------------LISALCPLKFPTL--QVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAA  244 (312)
T ss_dssp             H-----------------------HHHHSCTTSCTTC--CEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSC
T ss_pred             H-----------------------HHHHHHhccCCCC--CEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCccc
Confidence            0                       11111  233333  444444444441   11233445667777777777776655


Q ss_pred             C-CCccCCccccccccCCCCCCCCCCCCCCCCcccEEEccCCcCCCCCCccccccccccEEeccCcccc
Q 040702          271 P-ACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFS  338 (797)
Q Consensus       271 ~-~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  338 (797)
                      | ..+..+++|++|+|++|.|+.+|..+.  ++|+.|++++|++++. |. +..+++|++|++++|+++
T Consensus       245 ~~~~~~~l~~L~~L~Ls~N~l~~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~  309 (312)
T 1wwl_A          245 GAPSCDWPSQLNSLNLSFTGLKQVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFL  309 (312)
T ss_dssp             CCSCCCCCTTCCEEECTTSCCSSCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTT
T ss_pred             chhhhhhcCCCCEEECCCCccChhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCC
Confidence            3 345556667777777777766666554  5666666666666644 33 555556666666666554

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.95  E-value=4.3e-30  Score=273.49  Aligned_cols=252  Identities=20%  Similarity=0.184  Sum_probs=199.7

Q ss_pred             CCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCccc-ccCCcccc-------CCCCCCEEEccCC
Q 040702           16 QLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVV-GVVPTTIF-------NVSTLKSLYLHSN   87 (797)
Q Consensus        16 ~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~-~~~p~~~~-------~l~~L~~L~Ls~N   87 (797)
                      .++...+|++|++++|.+          .+|..+...  |+.|++++|++. ...|..+.       ++++|++|+|++|
T Consensus        38 ~~~~~~~L~~l~l~~n~l----------~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n  105 (312)
T 1wwl_A           38 LYGGGRSLEYLLKRVDTE----------ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENL  105 (312)
T ss_dssp             EEEEEEECTTHHHHCCTT----------CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEE
T ss_pred             EEccCCCceeEeeccccc----------ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCC
Confidence            456778899999999984          456655543  889999999995 44666665       7999999999999


Q ss_pred             cCcccCCCccc-cCCCCccEEEccCccccccCCchhhCC-----CCCCEEEccCCcCcccCCccccCCCCCCeeeccCcc
Q 040702           88 SLSGRLPSSAD-VRLPNLKELHLWGNNFIGTIPSFIFNA-----SKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNY  161 (797)
Q Consensus        88 ~l~~~l~~~~~-~~l~~L~~L~L~~N~l~~~~~~~~~~l-----~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~  161 (797)
                      ++++.+|..+| ..+++|++|+|++|++++. |..+..+     ++|++|+|++|+|+++.+..|.++++|++|+|++|+
T Consensus       106 ~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~  184 (312)
T 1wwl_A          106 EVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNP  184 (312)
T ss_dssp             BCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCT
T ss_pred             cccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCC
Confidence            99988898875 7899999999999999977 8888887     999999999999999999999999999999999999


Q ss_pred             CcCC---CCCccccccCCCCCCCcEEEccCCCCCCCC---ChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhc
Q 040702          162 LTSS---TPELSSLSSLSNCKYLEYFSFSNNPLGGIL---PRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLL  235 (797)
Q Consensus       162 l~~~---~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~---~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L  235 (797)
                      +...   +..+    .+..+++|++|+|++|+++++.   ...+..++ +|                          ++|
T Consensus       185 l~~~~~~~~~~----~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~-~L--------------------------~~L  233 (312)
T 1wwl_A          185 ELGERGLISAL----CPLKFPTLQVLALRNAGMETPSGVCSALAAARV-QL--------------------------QGL  233 (312)
T ss_dssp             TCHHHHHHHHS----CTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTC-CC--------------------------SEE
T ss_pred             cCcchHHHHHH----HhccCCCCCEEECCCCcCcchHHHHHHHHhcCC-CC--------------------------CEE
Confidence            7653   2211    2478899999999999998431   12222333 33                          556


Q ss_pred             ccccccccCCCc-hhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEccCCcCC
Q 040702          236 SLEGNQLEGSIP-DDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFT  314 (797)
Q Consensus       236 ~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~  314 (797)
                      ++++|++++..| ..+..+++|++|+|++|+|+. +|..+.  ++|++|+|++|+|+.+|. +..+++|+.|++++|.++
T Consensus       234 ~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~--~~L~~L~Ls~N~l~~~p~-~~~l~~L~~L~L~~N~l~  309 (312)
T 1wwl_A          234 DLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLP--AKLSVLDLSYNRLDRNPS-PDELPQVGNLSLKGNPFL  309 (312)
T ss_dssp             ECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCSS-CCSSCC--SEEEEEECCSSCCCSCCC-TTTSCEEEEEECTTCTTT
T ss_pred             ECCCCcCCcccchhhhhhcCCCCEEECCCCccCh-hhhhcc--CCceEEECCCCCCCCChh-HhhCCCCCEEeccCCCCC
Confidence            666666665543 345567888899999998884 455554  789999999999988876 778899999999999887


Q ss_pred             C
Q 040702          315 G  315 (797)
Q Consensus       315 ~  315 (797)
                      +
T Consensus       310 ~  310 (312)
T 1wwl_A          310 D  310 (312)
T ss_dssp             C
T ss_pred             C
Confidence            5

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.95  E-value=6.8e-28  Score=258.03  Aligned_cols=235  Identities=21%  Similarity=0.211  Sum_probs=174.5

Q ss_pred             CCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhh
Q 040702          149 LRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLT  228 (797)
Q Consensus       149 l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~  228 (797)
                      .++++.|+|++|.++.+++.      +..+++|++|+|++|.+. .+|..++.++ +|++|++++|.++ .+|..+++++
T Consensus        80 ~~~l~~L~L~~n~l~~lp~~------l~~l~~L~~L~L~~n~l~-~lp~~~~~l~-~L~~L~Ls~n~l~-~lp~~l~~l~  150 (328)
T 4fcg_A           80 QPGRVALELRSVPLPQFPDQ------AFRLSHLQHMTIDAAGLM-ELPDTMQQFA-GLETLTLARNPLR-ALPASIASLN  150 (328)
T ss_dssp             STTCCEEEEESSCCSSCCSC------GGGGTTCSEEEEESSCCC-CCCSCGGGGT-TCSEEEEESCCCC-CCCGGGGGCT
T ss_pred             ccceeEEEccCCCchhcChh------hhhCCCCCEEECCCCCcc-chhHHHhccC-CCCEEECCCCccc-cCcHHHhcCc
Confidence            35677777777777766654      444666777777777776 5555666655 5555555555555 4444444444


Q ss_pred             hhHhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEc
Q 040702          229 NLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNL  308 (797)
Q Consensus       229 ~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l  308 (797)
                      +|  ++|++++|++.+..|..+...               ..+..|.++++|++|+|++|.++.+|..+..+++|++|++
T Consensus       151 ~L--~~L~L~~n~~~~~~p~~~~~~---------------~~~~~~~~l~~L~~L~L~~n~l~~lp~~l~~l~~L~~L~L  213 (328)
T 4fcg_A          151 RL--RELSIRACPELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKI  213 (328)
T ss_dssp             TC--CEEEEEEETTCCCCCSCSEEE---------------C-CCCEEESTTCCEEEEEEECCCCCCGGGGGCTTCCEEEE
T ss_pred             CC--CEEECCCCCCccccChhHhhc---------------cchhhhccCCCCCEEECcCCCcCcchHhhcCCCCCCEEEc
Confidence            44  444444444444444333220               0112244588899999999999888888888889999999


Q ss_pred             cCCcCCCCCCccccccccccEEeccCcccccccCccccCCcccceecccCccccCCCChhhhccccCCeeeecCCcCCCC
Q 040702          309 SSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGT  388 (797)
Q Consensus       309 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  388 (797)
                      ++|.+++ +|..++.+++|++|++++|.+.+.+|..|.++++|++|+|++|++.+.+|..+..+++|++|+|++|++.+.
T Consensus       214 ~~N~l~~-l~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~  292 (328)
T 4fcg_A          214 RNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSR  292 (328)
T ss_dssp             ESSCCCC-CCGGGGGCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCC
T ss_pred             cCCCCCc-CchhhccCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhh
Confidence            9999985 555788899999999999998888899999999999999999998889999999999999999999999999


Q ss_pred             CChhhhccCCCCeEEccCCcCc
Q 040702          389 IPISLEKLLDLKDINVSFNRLE  410 (797)
Q Consensus       389 ~p~~~~~l~~L~~L~l~~N~l~  410 (797)
                      +|..+.++++|+.+++..|.+.
T Consensus       293 iP~~l~~L~~L~~l~l~~~~~~  314 (328)
T 4fcg_A          293 LPSLIAQLPANCIILVPPHLQA  314 (328)
T ss_dssp             CCGGGGGSCTTCEEECCGGGSC
T ss_pred             ccHHHhhccCceEEeCCHHHHH
Confidence            9999999999999999887665

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=1.3e-28  Score=281.69  Aligned_cols=160  Identities=18%  Similarity=0.156  Sum_probs=122.3

Q ss_pred             cceEEEEEEEEeccC----------CcchhHHHHHHHhhhc-cCCceeEeeeeeecCCeEEEEEEccCCCCHHHHHhcCC
Q 040702          531 DGMEVAIKVFNLQYG----------GAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGN  599 (797)
Q Consensus       531 ~~~~vAvK~~~~~~~----------~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~  599 (797)
                      -|+.||||++.+...          ...++|.+|+++|+++ .|+||+++++++++++..||||||++||+|.+.+...+
T Consensus       258 fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~  337 (569)
T 4azs_A          258 FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGE  337 (569)
T ss_dssp             ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTC
T ss_pred             ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCC
Confidence            478899999976521          1235799999999999 69999999999999999999999999999999998765


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccccccccccCcccccc
Q 040702          600 YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP  679 (797)
Q Consensus       600 ~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aP  679 (797)
                      . ++..   +|+.||+.||+|+|   ++|||||||||+|||++.+|.+||+|||+|+......  ......+||+.||||
T Consensus       338 ~-l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~--~~~~t~vGTp~YmAP  408 (569)
T 4azs_A          338 E-IDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC--SWPTNLVQSFFVFVN  408 (569)
T ss_dssp             C-CCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----CCSHHHHHHHHHHHH
T ss_pred             C-CCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC--ccccCceechhhccH
Confidence            3 6653   58999999999999   9999999999999999999999999999998764332  234557899999999


Q ss_pred             cccccCccchHHHHHHHhhhh
Q 040702          680 DEIFSGEMRLKCWVNDSLLIS  700 (797)
Q Consensus       680 E~~~~~~~~~~~dv~s~~~~~  700 (797)
                      |++. +.+...+|+|+.|+..
T Consensus       409 E~l~-g~~~~~~d~~s~g~~~  428 (569)
T 4azs_A          409 ELFA-ENKSWNGFWRSAPVHP  428 (569)
T ss_dssp             HHC------------------
T ss_pred             HHhC-CCCCCcccccccccch
Confidence            9875 4567889999999764

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.94  E-value=3e-28  Score=275.06  Aligned_cols=122  Identities=19%  Similarity=0.157  Sum_probs=82.4

Q ss_pred             hhcccccccccCCCchhhc-CCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEccCC
Q 040702          233 QLLSLEGNQLEGSIPDDLC-RLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSN  311 (797)
Q Consensus       233 ~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N  311 (797)
                      ++|+|++|.+++..|..+. .+++|+.|+|++|.+++..+  ...+++|+.|+|++|.++.+|+.+..+++|+.|++++|
T Consensus       147 ~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~Ls~N  224 (487)
T 3oja_A          147 QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNN  224 (487)
T ss_dssp             EEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECGGGGGGTTCSEEECTTS
T ss_pred             CEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCCCCHhHcCCCCccEEEecCC
Confidence            4445555555444444444 46666666676666665532  23466777777777777777666667777777777777


Q ss_pred             cCCCCCCccccccccccEEeccCcccc-cccCccccCCcccceeccc
Q 040702          312 FFTGPLPLKIGNLNVLVQLDLSMNNFS-CVIPTKIGGLKDLQYLFLE  357 (797)
Q Consensus       312 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls  357 (797)
                      .+++ +|..+..+++|+.|++++|.+. +.+|..+..++.|+.++++
T Consensus       225 ~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~  270 (487)
T 3oja_A          225 KLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (487)
T ss_dssp             CCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred             cCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence            7774 4556777778888888888877 4566778888888888886

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.94  E-value=8.4e-28  Score=271.39  Aligned_cols=235  Identities=20%  Similarity=0.170  Sum_probs=178.1

Q ss_pred             CCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCC
Q 040702          102 PNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYL  181 (797)
Q Consensus       102 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L  181 (797)
                      ++|++|+|++|.+++..|..|..+++|++|+|++|.|++..|  |.++++|++|+|++|.|+.+++          .++|
T Consensus        34 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l~~----------~~~L  101 (487)
T 3oja_A           34 WNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQELLV----------GPSI  101 (487)
T ss_dssp             GGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEEEE----------CTTC
T ss_pred             CCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCCCC----------CCCc
Confidence            366666666666666556666666666666666666665544  6666677777777776665442          1456


Q ss_pred             cEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEc
Q 040702          182 EYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDL  261 (797)
Q Consensus       182 ~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  261 (797)
                      +.|++++|.+.++.+..+                            ++|  ++|+|++|.+++..|..|..+++|+.|+|
T Consensus       102 ~~L~L~~N~l~~~~~~~l----------------------------~~L--~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  151 (487)
T 3oja_A          102 ETLHAANNNISRVSCSRG----------------------------QGK--KNIYLANNKITMLRDLDEGCRSRVQYLDL  151 (487)
T ss_dssp             CEEECCSSCCCCEEECCC----------------------------SSC--EEEECCSSCCCSGGGBCGGGGSSEEEEEC
T ss_pred             CEEECcCCcCCCCCcccc----------------------------CCC--CEEECCCCCCCCCCchhhcCCCCCCEEEC
Confidence            666666666665433221                            122  56666666666667777888899999999


Q ss_pred             cCCcCcccCCCCcc-CCccccccccCCCCCCCCCCCCCCCCcccEEEccCCcCCCCCCccccccccccEEeccCcccccc
Q 040702          262 GGNKLSGFVPACSG-NLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCV  340 (797)
Q Consensus       262 s~N~l~~~~~~~~~-~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  340 (797)
                      ++|.+++..|..+. .+++|+.|+|++|.|+.+|.. ..+++|+.|++++|.+++..| .|..+++|+.|++++|.+++ 
T Consensus       152 s~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~~-~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-  228 (487)
T 3oja_A          152 KLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQ-VVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-  228 (487)
T ss_dssp             TTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECC-CCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-
T ss_pred             CCCCCCCcChHHHhhhCCcccEEecCCCcccccccc-ccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-
Confidence            99999988888776 789999999999999888653 358999999999999997555 48899999999999999996 


Q ss_pred             cCccccCCcccceecccCcccc-CCCChhhhccccCCeeeec
Q 040702          341 IPTKIGGLKDLQYLFLEYNRLQ-GSIPNSIGDLISLKSLNLS  381 (797)
Q Consensus       341 ~~~~~~~l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls  381 (797)
                      +|..+..+++|+.|++++|++. +.+|..+..++.|+.++++
T Consensus       229 lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~  270 (487)
T 3oja_A          229 IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ  270 (487)
T ss_dssp             ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred             cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence            5777889999999999999997 6777888889999999886

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.94  E-value=2.2e-30  Score=301.55  Aligned_cols=305  Identities=13%  Similarity=0.071  Sum_probs=163.0

Q ss_pred             CCCCccEEEccCcccc----ccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccC
Q 040702          100 RLPNLKELHLWGNNFI----GTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSL  175 (797)
Q Consensus       100 ~l~~L~~L~L~~N~l~----~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l  175 (797)
                      .+++|++|+|++|.++    +.++..+.++++|++|+|++|.+.+ .+..+.++++|++|+++.+.......  .....+
T Consensus       190 ~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~--~~~~~l  266 (592)
T 3ogk_B          190 HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGSLNEDIGMP--EKYMNL  266 (592)
T ss_dssp             HCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECBCCCCTTCT--TSSSCC
T ss_pred             cCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccccccccchH--HHHHHh
Confidence            3445555555555543    1222233344555555555555543 23445555555555554322111000  011235


Q ss_pred             CCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCC-hhhhhhhhhHhhhcccccccccCCCchhhcCCC
Q 040702          176 SNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIP-EEINNLTNLILQLLSLEGNQLEGSIPDDLCRLA  254 (797)
Q Consensus       176 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p-~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~  254 (797)
                      ..+++|+.|+++++... ..|..+..++ +|+.|++++|.+++... ..+..+++|  ++|+++++......+..+..++
T Consensus       267 ~~~~~L~~L~l~~~~~~-~l~~~~~~~~-~L~~L~Ls~~~l~~~~~~~~~~~~~~L--~~L~L~~~~~~~~l~~~~~~~~  342 (592)
T 3ogk_B          267 VFPRKLCRLGLSYMGPN-EMPILFPFAA-QIRKLDLLYALLETEDHCTLIQKCPNL--EVLETRNVIGDRGLEVLAQYCK  342 (592)
T ss_dssp             CCCTTCCEEEETTCCTT-TGGGGGGGGG-GCCEEEETTCCCCHHHHHHHHTTCTTC--CEEEEEGGGHHHHHHHHHHHCT
T ss_pred             hccccccccCccccchh-HHHHHHhhcC-CCcEEecCCCcCCHHHHHHHHHhCcCC--CEEeccCccCHHHHHHHHHhCC
Confidence            55666666666665333 3455555555 67777777777654333 234556666  7777773322222333335567


Q ss_pred             CCcEEEcc-----------CCcCcccC-CCCccCCccccccccCCCCCCCC-CCCCCC-CCcccEEEcc----CCcCCCC
Q 040702          255 ALFQLDLG-----------GNKLSGFV-PACSGNLTNLRKLYLGSNLLTSI-PSTLWN-LKDILHLNLS----SNFFTGP  316 (797)
Q Consensus       255 ~L~~L~Ls-----------~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~l-p~~~~~-l~~L~~L~l~----~N~l~~~  316 (797)
                      +|++|+++           .|.++... +..+..+++|++|+++.|.++.- +..+.. +++|+.|+++    .|.+++.
T Consensus       343 ~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~  422 (592)
T 3ogk_B          343 QLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDL  422 (592)
T ss_dssp             TCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSC
T ss_pred             CCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCc
Confidence            77777777           34554321 11233466777777766666432 223332 6677777775    5566643


Q ss_pred             -----CCccccccccccEEeccCc--ccccccCcccc-CCcccceecccCccccC-CCChhhhccccCCeeeecCCcCCC
Q 040702          317 -----LPLKIGNLNVLVQLDLSMN--NFSCVIPTKIG-GLKDLQYLFLEYNRLQG-SIPNSIGDLISLKSLNLSNNNLSG  387 (797)
Q Consensus       317 -----~~~~~~~l~~L~~L~Ls~N--~l~~~~~~~~~-~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~  387 (797)
                           .+..+.++++|++|++++|  .+++..+..+. .+++|++|+|++|++++ .++..+..+++|++|+|++|.+++
T Consensus       423 p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~  502 (592)
T 3ogk_B          423 PLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSE  502 (592)
T ss_dssp             CCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBH
T ss_pred             hHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcH
Confidence                 2222555677777777643  25444333333 36677777777777664 233444667777777777777654


Q ss_pred             C-CChhhhccCCCCeEEccCCcCcc
Q 040702          388 T-IPISLEKLLDLKDINVSFNRLEG  411 (797)
Q Consensus       388 ~-~p~~~~~l~~L~~L~l~~N~l~~  411 (797)
                      . ++..+..+++|+.|++++|+++.
T Consensus       503 ~~~~~~~~~l~~L~~L~ls~n~it~  527 (592)
T 3ogk_B          503 RAIAAAVTKLPSLRYLWVQGYRASM  527 (592)
T ss_dssp             HHHHHHHHHCSSCCEEEEESCBCCT
T ss_pred             HHHHHHHHhcCccCeeECcCCcCCH
Confidence            3 33344567777777777777654

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=99.94  E-value=3.3e-29  Score=291.63  Aligned_cols=408  Identities=14%  Similarity=0.071  Sum_probs=298.3

Q ss_pred             CCcCCCCCCCCCEEeCCCCCCC---CcCCCccccC----CCccccCCCCCCEEEcccCcccccCCccccCC--CCCCEEE
Q 040702           13 ILSQLGNPSSLQTLYLSYNPPS---GSIPSFILCE----IPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNV--STLKSLY   83 (797)
Q Consensus        13 ~~~~~~~l~~L~~LdLs~N~~~---~~~p~~~l~~----ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l--~~L~~L~   83 (797)
                      ++..+..+++|++|+|+++...   +.+|...-..    ++.....+++|++|+|++|.+++..+..+...  .+|++|+
T Consensus        65 ~~~~~~~~~~L~~L~L~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~  144 (592)
T 3ogk_B           65 PDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLK  144 (592)
T ss_dssp             HHHHHHHCTTCSEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEE
T ss_pred             hHHHHHhCCCCeEEEecCCcchhhcccccccccccchHHHHHHHhhCCCCCeEEeeccEecHHHHHHHHHhccccCcEEE
Confidence            3445677888999999986521   1222111000    11112278999999999999988777777664  4599999


Q ss_pred             ccCCc-Ccc-cCCCccccCCCCccEEEccCcccccc----CCchhhCCCCCCEEEccCCcCccc----CCccccCCCCCC
Q 040702           84 LHSNS-LSG-RLPSSADVRLPNLKELHLWGNNFIGT----IPSFIFNASKLSELGLQKNSFSGS----IPNTFGNLRNLK  153 (797)
Q Consensus        84 Ls~N~-l~~-~l~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~f~~l~~L~  153 (797)
                      |++|. ++. .++ .....+++|++|+|++|.+++.    ++..+..+++|++|+|++|.++++    .+..+.++++|+
T Consensus       145 L~~~~~~~~~~l~-~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~  223 (592)
T 3ogk_B          145 LDKCSGFTTDGLL-SIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLV  223 (592)
T ss_dssp             EESCEEEEHHHHH-HHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCC
T ss_pred             CcCCCCcCHHHHH-HHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCc
Confidence            99987 321 111 1224689999999999998765    334567789999999999999844    345567899999


Q ss_pred             eeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCC---CCCChhhhccccCCcEEEccCCcccccCChhhhhhhhh
Q 040702          154 WLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLG---GILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNL  230 (797)
Q Consensus       154 ~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~---~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L  230 (797)
                      +|+|++|.+..++.      .+..+++|+.|+++.+...   ...+..+..++ +|+.|.++++.. +.+|..+..+++|
T Consensus       224 ~L~L~~~~~~~l~~------~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~-~L~~L~l~~~~~-~~l~~~~~~~~~L  295 (592)
T 3ogk_B          224 SVKVGDFEILELVG------FFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPR-KLCRLGLSYMGP-NEMPILFPFAAQI  295 (592)
T ss_dssp             EEECSSCBGGGGHH------HHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCT-TCCEEEETTCCT-TTGGGGGGGGGGC
T ss_pred             EEeccCccHHHHHH------HHhhhhHHHhhcccccccccchHHHHHHhhccc-cccccCccccch-hHHHHHHhhcCCC
Confidence            99999999988663      3677889999999864433   22334555665 899999988643 4677888889988


Q ss_pred             HhhhcccccccccCCCc-hhhcCCCCCcEEEccCCcCcc-cCCCCccCCccccccccC-----------CCCCCC--CCC
Q 040702          231 ILQLLSLEGNQLEGSIP-DDLCRLAALFQLDLGGNKLSG-FVPACSGNLTNLRKLYLG-----------SNLLTS--IPS  295 (797)
Q Consensus       231 ~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~L~-----------~N~l~~--lp~  295 (797)
                        ++|+|++|.+++... ..+..+++|++|+++ |.+.. ..+..+..+++|++|+++           .|.++.  ++.
T Consensus       296 --~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~  372 (592)
T 3ogk_B          296 --RKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIA  372 (592)
T ss_dssp             --CEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHH
T ss_pred             --cEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHH
Confidence              999999999764433 346789999999999 54443 233344678899999999           356643  222


Q ss_pred             CCCCCCcccEEEccCCcCCCCCCccccc-cccccEEecc----Ccccccc-----cCccccCCcccceecccCc--cccC
Q 040702          296 TLWNLKDILHLNLSSNFFTGPLPLKIGN-LNVLVQLDLS----MNNFSCV-----IPTKIGGLKDLQYLFLEYN--RLQG  363 (797)
Q Consensus       296 ~~~~l~~L~~L~l~~N~l~~~~~~~~~~-l~~L~~L~Ls----~N~l~~~-----~~~~~~~l~~L~~L~Ls~N--~l~~  363 (797)
                      ....+++|+.|+++.|.+++..+..+.. +++|+.|+++    .|.+++.     ++..+.++++|+.|+++++  .+++
T Consensus       373 l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~  452 (592)
T 3ogk_B          373 LAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTD  452 (592)
T ss_dssp             HHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCH
T ss_pred             HHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccH
Confidence            2345889999999999998766666665 8899999996    6788753     3344677999999999854  3665


Q ss_pred             CCChhhhc-cccCCeeeecCCcCCC-CCChhhhccCCCCeEEccCCcCcccC-CC-CCCCCCCCcccccCCcc
Q 040702          364 SIPNSIGD-LISLKSLNLSNNNLSG-TIPISLEKLLDLKDINVSFNRLEGEI-PR-EGPFRNLSAESFKGNEL  432 (797)
Q Consensus       364 ~~p~~~~~-l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~-p~-~~~~~~l~~~~~~~n~~  432 (797)
                      ..+..+.. +++|++|+|++|.+++ .++..+..+++|+.|++++|++++.. +. ...++.++.+++++|..
T Consensus       453 ~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~i  525 (592)
T 3ogk_B          453 LGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRA  525 (592)
T ss_dssp             HHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBC
T ss_pred             HHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcC
Confidence            55555554 8899999999999986 34556688999999999999986542 22 13467888999999974

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.94  E-value=1.2e-25  Score=234.79  Aligned_cols=208  Identities=25%  Similarity=0.284  Sum_probs=100.8

Q ss_pred             CCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeec
Q 040702           78 TLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGL  157 (797)
Q Consensus        78 ~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L  157 (797)
                      +|++|+|++|+++ .++...|..+++|++|+|++|++++..+..|.++++|++|+|++|+|+++.+.+|.++++|++|++
T Consensus        29 ~l~~L~ls~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l  107 (276)
T 2z62_A           29 STKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA  107 (276)
T ss_dssp             TCCEEECTTCCCC-EECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred             CccEEECCCCccc-ccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence            3444444444443 333333334444444444444444333444444444444444444444444444455555555555


Q ss_pred             cCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCC-CChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcc
Q 040702          158 NDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGI-LPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLS  236 (797)
Q Consensus       158 ~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~  236 (797)
                      ++|.++.+++.     .+..+++|++|++++|++.+. .|..|..++ +|+.|++++|.+++..+..+..+++|  +.|.
T Consensus       108 ~~n~l~~~~~~-----~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L--~~l~  179 (276)
T 2z62_A          108 VETNLASLENF-----PIGHLKTLKELNVAHNLIQSFKLPEYFSNLT-NLEHLDLSSNKIQSIYCTDLRVLHQM--PLLN  179 (276)
T ss_dssp             TTSCCCCSTTC-----CCTTCTTCCEEECCSSCCCCCCCCGGGGGCT-TCCEEECCSSCCCEECGGGGHHHHTC--TTCC
T ss_pred             CCCCccccCch-----hcccCCCCCEEECcCCccceecCchhhccCC-CCCEEECCCCCCCcCCHHHhhhhhhc--cccc
Confidence            55555444432     244445555555555555443 245555554 55555555555555445555554444  3111


Q ss_pred             cccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCCC-CCCCCcccEEEccCCcCCC
Q 040702          237 LEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPST-LWNLKDILHLNLSSNFFTG  315 (797)
Q Consensus       237 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~-~~~l~~L~~L~l~~N~l~~  315 (797)
                      +                    .|++++|+++++.+..+... +|+.|+|++|.++.+|.. +..+++|+.|++++|.+..
T Consensus       180 l--------------------~L~ls~n~l~~~~~~~~~~~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c  238 (276)
T 2z62_A          180 L--------------------SLDLSLNPMNFIQPGAFKEI-RLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC  238 (276)
T ss_dssp             E--------------------EEECCSSCCCEECTTSSCSC-CEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCC
T ss_pred             e--------------------eeecCCCcccccCccccCCC-cccEEECCCCceeecCHhHhcccccccEEEccCCcccc
Confidence            1                    45555555554444444332 566666666666555543 3446666666666666653

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.94  E-value=6.8e-26  Score=236.70  Aligned_cols=213  Identities=23%  Similarity=0.272  Sum_probs=165.9

Q ss_pred             ccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCch
Q 040702           42 LCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSF  121 (797)
Q Consensus        42 l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~  121 (797)
                      +.++|..+.  ++|++|++++|+++++.+..|.++++|++|+|++|+++ .++...|..+++|++|+|++|++++..+..
T Consensus        19 l~~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~   95 (276)
T 2z62_A           19 FYKIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGA   95 (276)
T ss_dssp             CSSCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCC-EECTTTTTTCTTCCEEECTTCCCCEECTTT
T ss_pred             ccccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCC-ccCHHHccCCcCCCEEECCCCccCccChhh
Confidence            456676664  57999999999999988889999999999999999998 777777889999999999999999888889


Q ss_pred             hhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCC-CCccccccCCCCCCCcEEEccCCCCCCCCChhhh
Q 040702          122 IFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSST-PELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIG  200 (797)
Q Consensus       122 ~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~-~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~  200 (797)
                      |.++++|++|++++|+++++.+..|.++++|++|+|++|.++.+. +.     .|.++++|+.|++++|+++++.+..|.
T Consensus        96 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~-----~~~~l~~L~~L~Ls~N~l~~~~~~~~~  170 (276)
T 2z62_A           96 FSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPE-----YFSNLTNLEHLDLSSNKIQSIYCTDLR  170 (276)
T ss_dssp             TTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCG-----GGGGCTTCCEEECCSSCCCEECGGGGH
T ss_pred             hcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCch-----hhccCCCCCEEECCCCCCCcCCHHHhh
Confidence            999999999999999999888888999999999999999998853 32     377889999999999999988888888


Q ss_pred             ccccCCc----EEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccC
Q 040702          201 NLSQSME----DFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGN  276 (797)
Q Consensus       201 ~l~~~L~----~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  276 (797)
                      .+. +++    .|++++|.+++..+..                          +.. .+|+.|+|++|+++++.+..|..
T Consensus       171 ~l~-~L~~l~l~L~ls~n~l~~~~~~~--------------------------~~~-~~L~~L~L~~n~l~~~~~~~~~~  222 (276)
T 2z62_A          171 VLH-QMPLLNLSLDLSLNPMNFIQPGA--------------------------FKE-IRLKELALDTNQLKSVPDGIFDR  222 (276)
T ss_dssp             HHH-TCTTCCEEEECCSSCCCEECTTS--------------------------SCS-CCEEEEECCSSCCSCCCTTTTTT
T ss_pred             hhh-hccccceeeecCCCcccccCccc--------------------------cCC-CcccEEECCCCceeecCHhHhcc
Confidence            776 565    5556665555433333                          222 24555555555555544444555


Q ss_pred             CccccccccCCCCC
Q 040702          277 LTNLRKLYLGSNLL  290 (797)
Q Consensus       277 l~~L~~L~L~~N~l  290 (797)
                      +++|+.|++++|.+
T Consensus       223 l~~L~~L~l~~N~~  236 (276)
T 2z62_A          223 LTSLQKIWLHTNPW  236 (276)
T ss_dssp             CCSCCEEECCSSCB
T ss_pred             cccccEEEccCCcc
Confidence            55555555555555

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.93  E-value=1.7e-25  Score=232.76  Aligned_cols=203  Identities=24%  Similarity=0.302  Sum_probs=155.3

Q ss_pred             CCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccC
Q 040702           21 SSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVR  100 (797)
Q Consensus        21 ~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~  100 (797)
                      .+.+++|+++|++         +.+|..+.  ++++.|++++|+++++.+.+|.++++|++|+|++|+|+ .+|..+|..
T Consensus        16 ~~~~~l~~~~~~l---------~~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~i~~~~~~~   83 (270)
T 2o6q_A           16 NNKNSVDCSSKKL---------TAIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKE   83 (270)
T ss_dssp             TTTTEEECTTSCC---------SSCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCS-CCCTTTTSS
T ss_pred             CCCCEEEccCCCC---------CccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccC-eeChhhhcC
Confidence            3577888988884         34555444  57888889988888887778888888999999888887 788888888


Q ss_pred             CCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCC
Q 040702          101 LPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKY  180 (797)
Q Consensus       101 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~  180 (797)
                      +++|++|+|++|++++..+..|.++++|++|+|++|+|+.+.+..|.++++|++|+|++|.|+.+++.     .|..+++
T Consensus        84 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-----~~~~l~~  158 (270)
T 2o6q_A           84 LKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKG-----VFDKLTS  158 (270)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT-----TTTTCTT
T ss_pred             CCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHh-----HccCCcc
Confidence            88888888888888877777788888888888888888888888888888888888888888887765     3777788


Q ss_pred             CcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEE
Q 040702          181 LEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLD  260 (797)
Q Consensus       181 L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  260 (797)
                      |+.|+|++|+++++.+..|..++ +|+.|+++                          +|+++++.+..|..+++|+.|+
T Consensus       159 L~~L~L~~n~l~~~~~~~~~~l~-~L~~L~L~--------------------------~N~l~~~~~~~~~~l~~L~~L~  211 (270)
T 2o6q_A          159 LKELRLYNNQLKRVPEGAFDKLT-ELKTLKLD--------------------------NNQLKRVPEGAFDSLEKLKMLQ  211 (270)
T ss_dssp             CCEEECCSSCCSCCCTTTTTTCT-TCCEEECC--------------------------SSCCSCCCTTTTTTCTTCCEEE
T ss_pred             cceeEecCCcCcEeChhHhccCC-CcCEEECC--------------------------CCcCCcCCHHHhccccCCCEEE
Confidence            88888888888877666666665 45554444                          4444444445556666667777


Q ss_pred             ccCCcCc
Q 040702          261 LGGNKLS  267 (797)
Q Consensus       261 Ls~N~l~  267 (797)
                      |++|.+.
T Consensus       212 l~~N~~~  218 (270)
T 2o6q_A          212 LQENPWD  218 (270)
T ss_dssp             CCSSCBC
T ss_pred             ecCCCee
Confidence            7777664

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.93  E-value=1.9e-25  Score=232.61  Aligned_cols=220  Identities=21%  Similarity=0.284  Sum_probs=176.7

Q ss_pred             CCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEc
Q 040702            5 TNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYL   84 (797)
Q Consensus         5 ~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~L   84 (797)
                      .++.+.+.+  .+..+++|+.|++++|.++         .++ .+..+++|++|++++|+++++  ..+.++++|++|+|
T Consensus        27 ~~~~~~~~~--~~~~l~~L~~L~l~~~~i~---------~~~-~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L   92 (272)
T 3rfs_A           27 KKKSVTDAV--TQNELNSIDQIIANNSDIK---------SVQ-GIQYLPNVRYLALGGNKLHDI--SALKELTNLTYLIL   92 (272)
T ss_dssp             TCSCTTSEE--CHHHHTTCCEEECTTSCCC---------CCT-TGGGCTTCCEEECTTSCCCCC--GGGTTCTTCCEEEC
T ss_pred             cCccccccc--ccccccceeeeeeCCCCcc---------ccc-ccccCCCCcEEECCCCCCCCc--hhhcCCCCCCEEEC
Confidence            344444443  3667888999999998843         232 477888999999999998873  47888899999999


Q ss_pred             cCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcC
Q 040702           85 HSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTS  164 (797)
Q Consensus        85 s~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~  164 (797)
                      ++|.++ .++...|..+++|++|+|++|++++..+..|.++++|++|+|++|+|+++.+..|.++++|++|+|++|+++.
T Consensus        93 ~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  171 (272)
T 3rfs_A           93 TGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS  171 (272)
T ss_dssp             TTSCCC-CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred             CCCccC-ccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCc
Confidence            999998 7777777788999999999999987777788889999999999999998888888899999999999999988


Q ss_pred             CCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccC
Q 040702          165 STPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEG  244 (797)
Q Consensus       165 ~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~  244 (797)
                      +++.     .|..+++|+.|++++|+++++.+..|..++ +|+.|++++|.+.+..|       ++  ++|+++.|.+.+
T Consensus       172 ~~~~-----~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~l~~N~~~~~~~-------~l--~~l~~~~n~~~g  236 (272)
T 3rfs_A          172 LPEG-----VFDKLTQLKDLRLYQNQLKSVPDGVFDRLT-SLQYIWLHDNPWDCTCP-------GI--RYLSEWINKHSG  236 (272)
T ss_dssp             CCTT-----TTTTCTTCCEEECCSSCCSCCCTTTTTTCT-TCCEEECCSSCBCCCTT-------TT--HHHHHHHHHTGG
T ss_pred             cCHH-----HhcCCccCCEEECCCCcCCccCHHHHhCCc-CCCEEEccCCCccccCc-------HH--HHHHHHHHhCCC
Confidence            8775     377888899999999999988888888887 78888888888876544       33  777888888887


Q ss_pred             CCchhhcCCC
Q 040702          245 SIPDDLCRLA  254 (797)
Q Consensus       245 ~~~~~~~~l~  254 (797)
                      .+|.+++.+.
T Consensus       237 ~ip~~~~~~~  246 (272)
T 3rfs_A          237 VVRNSAGSVA  246 (272)
T ss_dssp             GBBCTTSCBC
T ss_pred             cccCcccccC
Confidence            7777766554

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.93  E-value=6.2e-25  Score=228.49  Aligned_cols=200  Identities=26%  Similarity=0.300  Sum_probs=103.3

Q ss_pred             CCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeecc
Q 040702           79 LKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLN  158 (797)
Q Consensus        79 L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~  158 (797)
                      .+.+++++|.++ .+|..+.   ++|++|+|++|++++..+..|.++++|++|+|++|+|+.+.+..|.++++|++|+|+
T Consensus        18 ~~~l~~~~~~l~-~ip~~~~---~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~   93 (270)
T 2o6q_A           18 KNSVDCSSKKLT-AIPSNIP---ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT   93 (270)
T ss_dssp             TTEEECTTSCCS-SCCSCCC---TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred             CCEEEccCCCCC-ccCCCCC---CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence            444555555554 4444332   345555555555554444445555555555555555555555555555555555555


Q ss_pred             CccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccc
Q 040702          159 DNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLE  238 (797)
Q Consensus       159 ~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls  238 (797)
                      +|.++.+++.     .|.++++|++|++++|+++++.+..|..++ +|+.                          |+|+
T Consensus        94 ~n~l~~~~~~-----~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~-~L~~--------------------------L~Ls  141 (270)
T 2o6q_A           94 DNKLQALPIG-----VFDQLVNLAELRLDRNQLKSLPPRVFDSLT-KLTY--------------------------LSLG  141 (270)
T ss_dssp             SSCCCCCCTT-----TTTTCSSCCEEECCSSCCCCCCTTTTTTCT-TCCE--------------------------EECC
T ss_pred             CCcCCcCCHh-----HcccccCCCEEECCCCccCeeCHHHhCcCc-CCCE--------------------------EECC
Confidence            5555555443     244455555555555555544444444443 3333                          3333


Q ss_pred             cccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCCC-CCCCCcccEEEccCCcCC
Q 040702          239 GNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPST-LWNLKDILHLNLSSNFFT  314 (797)
Q Consensus       239 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~-~~~l~~L~~L~l~~N~l~  314 (797)
                      +|.++++.+..|..+++|++|+|++|+++++.+..|..+++|+.|+|++|.++.+|.. +..+++|+.|++++|.+.
T Consensus       142 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~  218 (270)
T 2o6q_A          142 YNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWD  218 (270)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             CCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCee
Confidence            3333333334445555555666666666555555555666666666666666555543 445666666666666665

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.93  E-value=6.4e-25  Score=230.52  Aligned_cols=203  Identities=24%  Similarity=0.254  Sum_probs=139.5

Q ss_pred             ccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCC
Q 040702           73 IFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNL  152 (797)
Q Consensus        73 ~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L  152 (797)
                      +.++++++++++++|.++ .+|..++   +++++|+|++|++++..+..|.++++|++|+|++|+|+++.+.  ..+++|
T Consensus         6 ~~~l~~l~~l~~~~~~l~-~ip~~~~---~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L   79 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVL   79 (290)
T ss_dssp             EECSTTCCEEECTTSCCS-SCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTC
T ss_pred             ccccCCccEEECCCCCCC-cCCCCCC---CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcC
Confidence            556777777777777777 6776654   5777888888887777777777788888888888887765443  677778


Q ss_pred             CeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHh
Q 040702          153 KWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLIL  232 (797)
Q Consensus       153 ~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L  232 (797)
                      ++|+|++|.|+.++..      +..+++|++|++++|+|+++.+..|.+++ +|                          
T Consensus        80 ~~L~Ls~N~l~~l~~~------~~~l~~L~~L~l~~N~l~~l~~~~~~~l~-~L--------------------------  126 (290)
T 1p9a_G           80 GTLDLSHNQLQSLPLL------GQTLPALTVLDVSFNRLTSLPLGALRGLG-EL--------------------------  126 (290)
T ss_dssp             CEEECCSSCCSSCCCC------TTTCTTCCEEECCSSCCCCCCSSTTTTCT-TC--------------------------
T ss_pred             CEEECCCCcCCcCchh------hccCCCCCEEECCCCcCcccCHHHHcCCC-CC--------------------------
Confidence            8888888877766653      55666777777777777766555555544 33                          


Q ss_pred             hhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEccCCc
Q 040702          233 QLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNF  312 (797)
Q Consensus       233 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~  312 (797)
                      ++|+|++|+++++.+..|..+++|+.|+|++|+|+.+.+..|..+++|+.|+|++|+|+.+|..++...+|+.|++++|.
T Consensus       127 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~ip~~~~~~~~L~~l~L~~Np  206 (290)
T 1p9a_G          127 QELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNP  206 (290)
T ss_dssp             CEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCC
T ss_pred             CEEECCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCCccChhhcccccCCeEEeCCCC
Confidence            44444445555455555666777777777777777666666677777777777777777777766666666666666665


Q ss_pred             CC
Q 040702          313 FT  314 (797)
Q Consensus       313 l~  314 (797)
                      +.
T Consensus       207 ~~  208 (290)
T 1p9a_G          207 WL  208 (290)
T ss_dssp             BC
T ss_pred             cc
Confidence            54

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.93  E-value=4.7e-25  Score=231.51  Aligned_cols=203  Identities=21%  Similarity=0.244  Sum_probs=168.6

Q ss_pred             CCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCc
Q 040702           17 LGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSS   96 (797)
Q Consensus        17 ~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~   96 (797)
                      +..+++++++++++|.+         +++|..+.  ++++.|++++|+++++.|..|.++++|++|+|++|.|+ .++..
T Consensus         6 ~~~l~~l~~l~~~~~~l---------~~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~   73 (290)
T 1p9a_G            6 VSKVASHLEVNCDKRNL---------TALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD   73 (290)
T ss_dssp             EECSTTCCEEECTTSCC---------SSCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEECC
T ss_pred             ccccCCccEEECCCCCC---------CcCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccC-cccCC
Confidence            67889999999999984         45566554  68999999999999999999999999999999999998 56554


Q ss_pred             cccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCC
Q 040702           97 ADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLS  176 (797)
Q Consensus        97 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~  176 (797)
                        ..+++|++|+|++|+++ .+|..+..+++|++|+|++|+|+++.+++|.++++|++|+|++|+|+.+++..     |.
T Consensus        74 --~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~-----~~  145 (290)
T 1p9a_G           74 --GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGL-----LT  145 (290)
T ss_dssp             --SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTT-----TT
T ss_pred             --CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhh-----cc
Confidence              57899999999999998 67888899999999999999999998999999999999999999999988763     78


Q ss_pred             CCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCC
Q 040702          177 NCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAAL  256 (797)
Q Consensus       177 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L  256 (797)
                      .+++|+.|+|++|+|+++.+..|..++ +|+.|++++|.++                           .+|..+..+.+|
T Consensus       146 ~l~~L~~L~L~~N~l~~l~~~~~~~l~-~L~~L~L~~N~l~---------------------------~ip~~~~~~~~L  197 (290)
T 1p9a_G          146 PTPKLEKLSLANNNLTELPAGLLNGLE-NLDTLLLQENSLY---------------------------TIPKGFFGSHLL  197 (290)
T ss_dssp             TCTTCCEEECTTSCCSCCCTTTTTTCT-TCCEEECCSSCCC---------------------------CCCTTTTTTCCC
T ss_pred             cccCCCEEECCCCcCCccCHHHhcCcC-CCCEEECCCCcCC---------------------------ccChhhcccccC
Confidence            889999999999999988777777776 5666665555554                           234444555567


Q ss_pred             cEEEccCCcCc
Q 040702          257 FQLDLGGNKLS  267 (797)
Q Consensus       257 ~~L~Ls~N~l~  267 (797)
                      +.|+|++|.+.
T Consensus       198 ~~l~L~~Np~~  208 (290)
T 1p9a_G          198 PFAFLHGNPWL  208 (290)
T ss_dssp             SEEECCSCCBC
T ss_pred             CeEEeCCCCcc
Confidence            77777777664

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.92  E-value=6.6e-25  Score=237.35  Aligned_cols=221  Identities=19%  Similarity=0.196  Sum_probs=106.3

Q ss_pred             CCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCC-chhhCCCCCCE-EEccCCcCcccCCccccCCCCCCee
Q 040702           78 TLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIP-SFIFNASKLSE-LGLQKNSFSGSIPNTFGNLRNLKWL  155 (797)
Q Consensus        78 ~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~-L~L~~N~l~~~~~~~f~~l~~L~~L  155 (797)
                      ++++|+|++|+|+ .+|..+|.++++|++|+|++|++.+.+| .+|.++++|++ +.++.|+|+.+.|++|.++++|++|
T Consensus        31 ~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L  109 (350)
T 4ay9_X           31 NAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL  109 (350)
T ss_dssp             TCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEE
T ss_pred             CCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccc
Confidence            4444444444444 4444444444444444444444433222 23444444332 3334455555555555555555555


Q ss_pred             eccCccCcCCCCCccccccCCCCCCCcEEEccC-CCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhh
Q 040702          156 GLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSN-NPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQL  234 (797)
Q Consensus       156 ~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~  234 (797)
                      ++++|+|+.+++.     .+....++..|++.+ |++..+.+..|..+...++.|++++|.|+.+.+..|. ..+|  +.
T Consensus       110 ~l~~n~l~~~~~~-----~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~i~~~~f~-~~~L--~~  181 (350)
T 4ay9_X          110 LISNTGIKHLPDV-----HKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFN-GTQL--DE  181 (350)
T ss_dssp             EEEEECCSSCCCC-----TTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTSST-TEEE--EE
T ss_pred             cccccccccCCch-----hhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccCCChhhcc-ccch--hH
Confidence            5555555554432     133334455555533 3454444444544443444455555444432222222 1222  45


Q ss_pred             cccc-cccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEccC
Q 040702          235 LSLE-GNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSS  310 (797)
Q Consensus       235 L~Ls-~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~  310 (797)
                      |+++ +|.++.+.+++|..+++|++|||++|+|+.+++..|.++++|+.+++  +.++.+|. +..+++|+.+++++
T Consensus       182 l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~~lP~-l~~l~~L~~l~l~~  255 (350)
T 4ay9_X          182 LNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKKLPT-LEKLVALMEASLTY  255 (350)
T ss_dssp             EECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC--TTCCCCCC-TTTCCSCCEEECSC
T ss_pred             HhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC--CCcCcCCC-chhCcChhhCcCCC
Confidence            5554 34555445555666666666666666666655555555555555443  33455552 44455555555543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=6.3e-26  Score=258.18  Aligned_cols=178  Identities=17%  Similarity=0.134  Sum_probs=135.2

Q ss_pred             cCCCccccccccCCcceeec---ceEEEEEEEEeccCC--------cchhHHHHHHHhhhccCCceeEeeeeeecCCeEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD---GMEVAIKVFNLQYGG--------AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKA  580 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~---~~~vAvK~~~~~~~~--------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~  580 (797)
                      ..+...+.||+|+||.||++   +..+|+|........        ..+.+.+|++++++++||||+++..++...+..|
T Consensus       336 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~  415 (540)
T 3en9_A          336 KRKIPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKR  415 (540)
T ss_dssp             ------------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTE
T ss_pred             ccCCCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccE
Confidence            33345679999999999975   578899987543211        1245789999999999999997666666777789


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCc
Q 040702          581 LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  660 (797)
Q Consensus       581 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  660 (797)
                      +||||+++|+|.+++..         +..++.|+++||+|||   +++|+||||||+|||++.  .+||+|||+|+....
T Consensus       416 lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          416 IMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            99999999999999865         4589999999999999   999999999999999998  999999999997644


Q ss_pred             cCccc-----cccccccCccccccccccc--CccchHHHHHHHhhhhhhh
Q 040702          661 EDQSL-----TQTQTLATIGYMAPDEIFS--GEMRLKCWVNDSLLISVMI  703 (797)
Q Consensus       661 ~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~dv~s~~~~~~~~  703 (797)
                      .....     ......||+.|||||.+..  ..|+..+|+|+.....+.+
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~  531 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKD  531 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHH
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHH
Confidence            32211     1245689999999998876  6678888889887665443

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.92  E-value=4e-28  Score=282.59  Aligned_cols=372  Identities=14%  Similarity=0.108  Sum_probs=218.1

Q ss_pred             CCCCCCCEEeCCCCCCCCcCCCccccCCCcccc-CCCCCCEEEcccC-ccccc-CCccccCCCCCCEEEccCCcCcccCC
Q 040702           18 GNPSSLQTLYLSYNPPSGSIPSFILCEIPHEID-NLHNMEWMAFSFN-KVVGV-VPTTIFNVSTLKSLYLHSNSLSGRLP   94 (797)
Q Consensus        18 ~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~-~l~~L~~L~ls~N-~i~~~-~p~~~~~l~~L~~L~Ls~N~l~~~l~   94 (797)
                      ..+++|++|+|++|.+++..+        ..+. .+++|+.|++++| .++.. ++..+.++++|++|+|++|.+++..+
T Consensus       102 ~~~~~L~~L~L~~~~~~~~~~--------~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~  173 (594)
T 2p1m_B          102 SSYTWLEEIRLKRMVVTDDCL--------ELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSG  173 (594)
T ss_dssp             HHCTTCCEEEEESCBCCHHHH--------HHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCG
T ss_pred             HhCCCCCeEEeeCcEEcHHHH--------HHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcch
Confidence            467899999999998654432        2333 5789999999999 55543 44455589999999999999873222


Q ss_pred             C---ccccCCCCccEEEccCcc--ccc-cCCchhhCCCCCCEEEccCC-cCcccCCccccCCCCCCeeeccCcc------
Q 040702           95 S---SADVRLPNLKELHLWGNN--FIG-TIPSFIFNASKLSELGLQKN-SFSGSIPNTFGNLRNLKWLGLNDNY------  161 (797)
Q Consensus        95 ~---~~~~~l~~L~~L~L~~N~--l~~-~~~~~~~~l~~L~~L~L~~N-~l~~~~~~~f~~l~~L~~L~L~~N~------  161 (797)
                      .   .....+++|++|+|++|.  +.. .++..+..+++|++|+|++| .+.+ .+..+..+++|++|+++.+.      
T Consensus       174 ~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~  252 (594)
T 2p1m_B          174 HWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPD  252 (594)
T ss_dssp             GGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHH
T ss_pred             HHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchh
Confidence            1   122367899999999997  321 11222345799999999998 4554 67788899999999965543      


Q ss_pred             -CcCCCCCccccccCCCCCCCcEE-EccCCCCCCCCChhhhccccCCcEEEccCCcccccCCh-hhhhhhhhHhhhcccc
Q 040702          162 -LTSSTPELSSLSSLSNCKYLEYF-SFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPE-EINNLTNLILQLLSLE  238 (797)
Q Consensus       162 -l~~~~~~~~~~~~l~~l~~L~~L-~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~-~~~~l~~L~L~~L~Ls  238 (797)
                       +..++.      .+.++++|+.| .+.+... ...+..+..++ +|+.|++++|.++..... .+..+++|  ++|+++
T Consensus       253 ~~~~l~~------~l~~~~~L~~Ls~~~~~~~-~~l~~~~~~~~-~L~~L~L~~~~l~~~~l~~~~~~~~~L--~~L~l~  322 (594)
T 2p1m_B          253 VYSGLSV------ALSGCKELRCLSGFWDAVP-AYLPAVYSVCS-RLTTLNLSYATVQSYDLVKLLCQCPKL--QRLWVL  322 (594)
T ss_dssp             HHHHHHH------HHHTCTTCCEEECCBTCCG-GGGGGGHHHHT-TCCEEECTTCCCCHHHHHHHHTTCTTC--CEEEEE
T ss_pred             hHHHHHH------HHhcCCCcccccCCcccch-hhHHHHHHhhC-CCCEEEccCCCCCHHHHHHHHhcCCCc--CEEeCc
Confidence             333222      24556666666 3333222 12233333444 677777777665532222 23345555  667776


Q ss_pred             cccccCC-CchhhcCCCCCcEEEccC---------CcCcccCCCCc-cCCccccccccCCCCCCCC-CCCCC-CCCcccE
Q 040702          239 GNQLEGS-IPDDLCRLAALFQLDLGG---------NKLSGFVPACS-GNLTNLRKLYLGSNLLTSI-PSTLW-NLKDILH  305 (797)
Q Consensus       239 ~N~l~~~-~~~~~~~l~~L~~L~Ls~---------N~l~~~~~~~~-~~l~~L~~L~L~~N~l~~l-p~~~~-~l~~L~~  305 (797)
                      +| +... .+.....+++|++|++++         +.+++.....+ .++++|+.|+++.|.++.. +..+. .+++|+.
T Consensus       323 ~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~  401 (594)
T 2p1m_B          323 DY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTR  401 (594)
T ss_dssp             GG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCE
T ss_pred             Cc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcce
Confidence            66 3311 111222466677776632         34432221122 2356677776666666432 11222 3566777


Q ss_pred             EEcc--C----CcCCCCCC-----ccccccccccEEeccCcccccccCccccC-CcccceecccCccccCCCChhh-hcc
Q 040702          306 LNLS--S----NFFTGPLP-----LKIGNLNVLVQLDLSMNNFSCVIPTKIGG-LKDLQYLFLEYNRLQGSIPNSI-GDL  372 (797)
Q Consensus       306 L~l~--~----N~l~~~~~-----~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l  372 (797)
                      |+++  +    |.++....     ..+..+++|+.|++++ .++...+..+.. +++|+.|+|++|.+++..+..+ ..+
T Consensus       402 L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~  480 (594)
T 2p1m_B          402 FRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGC  480 (594)
T ss_dssp             EEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHC
T ss_pred             eEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcC
Confidence            7776  3    44442111     1144566777777766 554443344433 6667777777777655444444 556


Q ss_pred             ccCCeeeecCCcCCCCCCh-hhhccCCCCeEEccCCcCc
Q 040702          373 ISLKSLNLSNNNLSGTIPI-SLEKLLDLKDINVSFNRLE  410 (797)
Q Consensus       373 ~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~  410 (797)
                      ++|++|+|++|.+++.... ....+++|+.|++++|+++
T Consensus       481 ~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~  519 (594)
T 2p1m_B          481 DSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS  519 (594)
T ss_dssp             TTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCB
T ss_pred             CCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCC
Confidence            7777777777777543333 2344667777777777663

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.91  E-value=1.2e-23  Score=216.25  Aligned_cols=183  Identities=21%  Similarity=0.195  Sum_probs=162.1

Q ss_pred             CCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccC
Q 040702           21 SSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVR  100 (797)
Q Consensus        21 ~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~  100 (797)
                      .+.+++|+++|.         ++++|..+.  ++++.|++++|++.++.+..|.++++|++|+|++|+|+ .++...|..
T Consensus        14 ~~~~~l~~~~~~---------l~~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~   81 (251)
T 3m19_A           14 EGKKEVDCQGKS---------LDSVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDD   81 (251)
T ss_dssp             GGGTEEECTTCC---------CSSCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCC-CCCTTTTTT
T ss_pred             CCCeEEecCCCC---------ccccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCC-ccCHhHhcc
Confidence            467889999998         445666655  58999999999999999999999999999999999998 677777789


Q ss_pred             CCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCC
Q 040702          101 LPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKY  180 (797)
Q Consensus       101 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~  180 (797)
                      +++|++|+|++|++++..+..|..+++|++|+|++|+|+++.+..|.++++|++|+|++|+|+.+++.     .|..+++
T Consensus        82 l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-----~~~~l~~  156 (251)
T 3m19_A           82 LTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAG-----AFDKLTN  156 (251)
T ss_dssp             CTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT-----TTTTCTT
T ss_pred             CCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHH-----HcCcCcC
Confidence            99999999999999988888899999999999999999999888999999999999999999998875     4888999


Q ss_pred             CcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCC
Q 040702          181 LEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIP  221 (797)
Q Consensus       181 L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p  221 (797)
                      |+.|+|++|+++++.+..|..++ +|+.|++++|.+.....
T Consensus       157 L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~l~~N~~~c~~~  196 (251)
T 3m19_A          157 LQTLSLSTNQLQSVPHGAFDRLG-KLQTITLFGNQFDCSRC  196 (251)
T ss_dssp             CCEEECCSSCCSCCCTTTTTTCT-TCCEEECCSCCBCTTST
T ss_pred             CCEEECCCCcCCccCHHHHhCCC-CCCEEEeeCCceeCCcc
Confidence            99999999999998888898887 89999999999986533

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.91  E-value=2.4e-24  Score=219.72  Aligned_cols=196  Identities=16%  Similarity=0.222  Sum_probs=110.8

Q ss_pred             CCCEEEcccCcccccCCccccCCCCCCEEEccCCc-CcccCCCccccCCCCccEEEccC-ccccccCCchhhCCCCCCEE
Q 040702           54 NMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNS-LSGRLPSSADVRLPNLKELHLWG-NNFIGTIPSFIFNASKLSEL  131 (797)
Q Consensus        54 ~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~-l~~~l~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L  131 (797)
                      ++++|++++|+++++.+.+|.++++|++|+|++|+ ++ .++...|..+++|++|+|++ |++++..+..|.++++|++|
T Consensus        32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L  110 (239)
T 2xwt_C           32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL  110 (239)
T ss_dssp             TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCC-EECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred             cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcc-eeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence            55566666666655555555555556666665554 54 45555555555555555555 55554444555555555555


Q ss_pred             EccCCcCcccCCccccCCCCCC---eeeccCc-cCcCCCCCccccccCCCCCCCc-EEEccCCCCCCCCChhhhccccCC
Q 040702          132 GLQKNSFSGSIPNTFGNLRNLK---WLGLNDN-YLTSSTPELSSLSSLSNCKYLE-YFSFSNNPLGGILPRAIGNLSQSM  206 (797)
Q Consensus       132 ~L~~N~l~~~~~~~f~~l~~L~---~L~L~~N-~l~~~~~~~~~~~~l~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~~L  206 (797)
                      +|++|+|+++ |. |.++++|+   +|++++| .++.+++.     .|.++++|+ .|++++|+++.+.+..|.      
T Consensus       111 ~l~~n~l~~l-p~-~~~l~~L~~L~~L~l~~N~~l~~i~~~-----~~~~l~~L~~~L~l~~n~l~~i~~~~~~------  177 (239)
T 2xwt_C          111 GIFNTGLKMF-PD-LTKVYSTDIFFILEITDNPYMTSIPVN-----AFQGLCNETLTLKLYNNGFTSVQGYAFN------  177 (239)
T ss_dssp             EEEEECCCSC-CC-CTTCCBCCSEEEEEEESCTTCCEECTT-----TTTTTBSSEEEEECCSCCCCEECTTTTT------
T ss_pred             eCCCCCCccc-cc-cccccccccccEEECCCCcchhhcCcc-----cccchhcceeEEEcCCCCCcccCHhhcC------
Confidence            5555555542 22 55555555   5555555 55554443     244455555 555555555433333332      


Q ss_pred             cEEEccCCcccccCChhhhhhhhhHhhhccccccc-ccCCCchhhcCC-CCCcEEEccCCcCcccCCCCccCCccccccc
Q 040702          207 EDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQ-LEGSIPDDLCRL-AALFQLDLGGNKLSGFVPACSGNLTNLRKLY  284 (797)
Q Consensus       207 ~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~-l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  284 (797)
                                         . ++|  ++|++++|+ ++++.+..|..+ ++|+.|++++|+++++.+.   .+++|+.|+
T Consensus       178 -------------------~-~~L--~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~---~~~~L~~L~  232 (239)
T 2xwt_C          178 -------------------G-TKL--DAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSK---GLEHLKELI  232 (239)
T ss_dssp             -------------------T-CEE--EEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCT---TCTTCSEEE
T ss_pred             -------------------C-CCC--CEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChh---HhccCceee
Confidence                               2 333  666666663 666666677777 7788888888888765444   456677777


Q ss_pred             cCCC
Q 040702          285 LGSN  288 (797)
Q Consensus       285 L~~N  288 (797)
                      ++++
T Consensus       233 l~~~  236 (239)
T 2xwt_C          233 ARNT  236 (239)
T ss_dssp             CTTC
T ss_pred             ccCc
Confidence            7665

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.91  E-value=2.1e-24  Score=224.70  Aligned_cols=227  Identities=22%  Similarity=0.251  Sum_probs=113.3

Q ss_pred             CCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCC
Q 040702          102 PNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYL  181 (797)
Q Consensus       102 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L  181 (797)
                      .++..+++.++.+.+.  ..+..+++|++|++++|.++.+  ..+..+++|++|+|++|.++.++       .+..+++|
T Consensus        19 ~~l~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~~~--~~l~~l~~L~~L~l~~n~l~~~~-------~l~~l~~L   87 (272)
T 3rfs_A           19 AETIKANLKKKSVTDA--VTQNELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKLHDIS-------ALKELTNL   87 (272)
T ss_dssp             HHHHHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECTTSCCCCCG-------GGTTCTTC
T ss_pred             HHHHHHHhcCcccccc--cccccccceeeeeeCCCCcccc--cccccCCCCcEEECCCCCCCCch-------hhcCCCCC
Confidence            4455566666665543  2345566677777777766643  23666666666666666665532       24555566


Q ss_pred             cEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEc
Q 040702          182 EYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDL  261 (797)
Q Consensus       182 ~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L  261 (797)
                      ++|++++|+++++.+..|..++ +|                          ++|++++|++++..+..|..+++|++|++
T Consensus        88 ~~L~L~~n~l~~~~~~~~~~l~-~L--------------------------~~L~L~~n~l~~~~~~~~~~l~~L~~L~L  140 (272)
T 3rfs_A           88 TYLILTGNQLQSLPNGVFDKLT-NL--------------------------KELVLVENQLQSLPDGVFDKLTNLTYLNL  140 (272)
T ss_dssp             CEEECTTSCCCCCCTTTTTTCT-TC--------------------------CEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred             CEEECCCCccCccChhHhcCCc-CC--------------------------CEEECCCCcCCccCHHHhccCCCCCEEEC
Confidence            6666666666555444444433 23                          33333333333333333444444444444


Q ss_pred             cCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEccCCcCCCCCCccccccccccEEeccCccccccc
Q 040702          262 GGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVI  341 (797)
Q Consensus       262 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  341 (797)
                      ++|+++++.+..|..+++|+.|++++|.++.+                       .+..|+.+++|+.|++++|++++..
T Consensus       141 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-----------------------~~~~~~~l~~L~~L~L~~N~l~~~~  197 (272)
T 3rfs_A          141 AHNQLQSLPKGVFDKLTNLTELDLSYNQLQSL-----------------------PEGVFDKLTQLKDLRLYQNQLKSVP  197 (272)
T ss_dssp             CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCC-----------------------CTTTTTTCTTCCEEECCSSCCSCCC
T ss_pred             CCCccCccCHHHhccCccCCEEECCCCCcCcc-----------------------CHHHhcCCccCCEEECCCCcCCccC
Confidence            44444444444444444444444444444433                       3333444444444444444444444


Q ss_pred             CccccCCcccceecccCccccCCCChhhhccccCCeeeecCCcCCCCCChhhhcc
Q 040702          342 PTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKL  396 (797)
Q Consensus       342 ~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l  396 (797)
                      +..|..+++|+.|++++|++.+.       +++|+.|+++.|.++|.+|.+++.+
T Consensus       198 ~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~ip~~~~~~  245 (272)
T 3rfs_A          198 DGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSAGSV  245 (272)
T ss_dssp             TTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGBBCTTSCB
T ss_pred             HHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcccCccccc
Confidence            44444445555555555544422       2345555555555555555554443

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.91  E-value=1.5e-25  Score=243.55  Aligned_cols=227  Identities=18%  Similarity=0.180  Sum_probs=91.4

Q ss_pred             EcccCcccccCCccccCCCCCCEEEccCCcCcccCCC----ccccCCC-CccEEEccCccccccCCchhhCC-----CCC
Q 040702           59 AFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPS----SADVRLP-NLKELHLWGNNFIGTIPSFIFNA-----SKL  128 (797)
Q Consensus        59 ~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~----~~~~~l~-~L~~L~L~~N~l~~~~~~~~~~l-----~~L  128 (797)
                      ++++|++++.+|..+...++|++|+|++|.|+ .++.    ..+..++ +|++|+|++|++++..+..|..+     ++|
T Consensus         4 ~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~-~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L   82 (362)
T 3goz_A            4 KLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLY-SISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV   82 (362)
T ss_dssp             ECCCCTTCCHHHHHHTSCTTCCEEECTTSCGG-GSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred             ccccccchHHHHHHHhCCCCceEEEccCCCCC-hHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence            33444444433333333333444444444443 3322    2233333 44444444444443333333332     444


Q ss_pred             CEEEccCCcCcccCCccccC----C-CCCCeeeccCccCcCCCCCccccccCCC-CCCCcEEEccCCCCCCCCChh----
Q 040702          129 SELGLQKNSFSGSIPNTFGN----L-RNLKWLGLNDNYLTSSTPELSSLSSLSN-CKYLEYFSFSNNPLGGILPRA----  198 (797)
Q Consensus       129 ~~L~L~~N~l~~~~~~~f~~----l-~~L~~L~L~~N~l~~~~~~~~~~~~l~~-l~~L~~L~Ls~N~l~~~~~~~----  198 (797)
                      ++|+|++|+|++..+..+..    + ++|++|+|++|.|+..+.... ...+.. .++|++|+|++|+++...+..    
T Consensus        83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l-~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~  161 (362)
T 3goz_A           83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEF-KQAFSNLPASITSLNLRGNDLGIKSSDELIQI  161 (362)
T ss_dssp             CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHH-HHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred             cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHH-HHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence            44444444444433332222    2 444444444444444332100 000112 134555555555544322222    


Q ss_pred             hhccccCCcEEEccCCcccccCChhhhhh-----hhhHhhhcccccccccCC----CchhhcC-CCCCcEEEccCCcCcc
Q 040702          199 IGNLSQSMEDFWMDNCNISGSIPEEINNL-----TNLILQLLSLEGNQLEGS----IPDDLCR-LAALFQLDLGGNKLSG  268 (797)
Q Consensus       199 ~~~l~~~L~~L~L~~n~i~~~~p~~~~~l-----~~L~L~~L~Ls~N~l~~~----~~~~~~~-l~~L~~L~Ls~N~l~~  268 (797)
                      +...+.+|+.|+|++|.+++..+..+...     ++|  ++|+|++|.+...    ++..+.. .++|++|+|++|.+++
T Consensus       162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L--~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~  239 (362)
T 3goz_A          162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASV--TSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHG  239 (362)
T ss_dssp             HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTC--CEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCC
T ss_pred             HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCC--CEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCc
Confidence            22222245555555555544444333322     233  4444444444432    1222333 2356666666665554


Q ss_pred             cCC----CCccCCccccccccCCCC
Q 040702          269 FVP----ACSGNLTNLRKLYLGSNL  289 (797)
Q Consensus       269 ~~~----~~~~~l~~L~~L~L~~N~  289 (797)
                      ..+    ..+..+++|+.|+|++|.
T Consensus       240 ~~~~~l~~~~~~l~~L~~L~L~~n~  264 (362)
T 3goz_A          240 PSLENLKLLKDSLKHLQTVYLDYDI  264 (362)
T ss_dssp             CCHHHHHHTTTTTTTCSEEEEEHHH
T ss_pred             HHHHHHHHHHhcCCCccEEEeccCC
Confidence            332    122334445555555554

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.91  E-value=3.7e-24  Score=218.41  Aligned_cols=207  Identities=19%  Similarity=0.250  Sum_probs=166.0

Q ss_pred             cccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCcc-ccccCCchhhCCCCCCEEEccC-CcCccc
Q 040702           64 KVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNN-FIGTIPSFIFNASKLSELGLQK-NSFSGS  141 (797)
Q Consensus        64 ~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~-l~~~~~~~~~~l~~L~~L~L~~-N~l~~~  141 (797)
                      +++. +|. +.  ++|++|+|++|+|+ .+|...|..+++|++|+|++|+ ++.+.+..|.++++|++|+|++ |+|+.+
T Consensus        22 ~l~~-ip~-~~--~~l~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i   96 (239)
T 2xwt_C           22 DIQR-IPS-LP--PSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYI   96 (239)
T ss_dssp             SCSS-CCC-CC--TTCCEEEEESCCCS-EECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEE
T ss_pred             Cccc-cCC-CC--CcccEEEEeCCcce-EECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEc
Confidence            3554 455 33  38999999999998 7787778889999999999997 8877777889999999999998 999988


Q ss_pred             CCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCc---EEEccCC-CCCCCCChhhhccccCCcEEEccCCccc
Q 040702          142 IPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLE---YFSFSNN-PLGGILPRAIGNLSQSMEDFWMDNCNIS  217 (797)
Q Consensus       142 ~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~---~L~Ls~N-~l~~~~~~~~~~l~~~L~~L~L~~n~i~  217 (797)
                      .+.+|.++++|++|+|++|.++.++.       |..+++|+   +|++++| +++++.+..|.+++ +|           
T Consensus        97 ~~~~f~~l~~L~~L~l~~n~l~~lp~-------~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~-~L-----------  157 (239)
T 2xwt_C           97 DPDALKELPLLKFLGIFNTGLKMFPD-------LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLC-NE-----------  157 (239)
T ss_dssp             CTTSEECCTTCCEEEEEEECCCSCCC-------CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTB-SS-----------
T ss_pred             CHHHhCCCCCCCEEeCCCCCCccccc-------cccccccccccEEECCCCcchhhcCcccccchh-cc-----------
Confidence            88899999999999999999988664       44555555   8888888 78766666666655 44           


Q ss_pred             ccCChhhhhhhhhHhh-hcccccccccCCCchhhcCCCCCcEEEccCCc-CcccCCCCccCC-ccccccccCCCCCCCCC
Q 040702          218 GSIPEEINNLTNLILQ-LLSLEGNQLEGSIPDDLCRLAALFQLDLGGNK-LSGFVPACSGNL-TNLRKLYLGSNLLTSIP  294 (797)
Q Consensus       218 ~~~p~~~~~l~~L~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l-~~L~~L~L~~N~l~~lp  294 (797)
                                     + +|++++|+++.+.+..|.. ++|+.|++++|+ ++.+.+..|.++ ++|+.|++++|.++.+|
T Consensus       158 ---------------~~~L~l~~n~l~~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~  221 (239)
T 2xwt_C          158 ---------------TLTLKLYNNGFTSVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALP  221 (239)
T ss_dssp             ---------------EEEEECCSCCCCEECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCC
T ss_pred             ---------------eeEEEcCCCCCcccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCC
Confidence                           4 5555556665444555655 899999999995 998888999999 99999999999999998


Q ss_pred             CCCCCCCcccEEEccCCc
Q 040702          295 STLWNLKDILHLNLSSNF  312 (797)
Q Consensus       295 ~~~~~l~~L~~L~l~~N~  312 (797)
                      ..  .+++|+.|+++++.
T Consensus       222 ~~--~~~~L~~L~l~~~~  237 (239)
T 2xwt_C          222 SK--GLEHLKELIARNTW  237 (239)
T ss_dssp             CT--TCTTCSEEECTTC-
T ss_pred             hh--HhccCceeeccCcc
Confidence            76  67899999998763

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=99.91  E-value=5.7e-27  Score=272.83  Aligned_cols=402  Identities=15%  Similarity=0.095  Sum_probs=278.1

Q ss_pred             CCCCCCCCEEeCCCCCCCCcC---CCccccC----CCccccCCCCCCEEEcccCcccccCCcccc-CCCCCCEEEccCC-
Q 040702           17 LGNPSSLQTLYLSYNPPSGSI---PSFILCE----IPHEIDNLHNMEWMAFSFNKVVGVVPTTIF-NVSTLKSLYLHSN-   87 (797)
Q Consensus        17 ~~~l~~L~~LdLs~N~~~~~~---p~~~l~~----ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~-~l~~L~~L~Ls~N-   87 (797)
                      +..+++|++|+|++|.....+   |......    ++.-...+++|+.|+|++|.+++..+..+. ++++|++|+|++| 
T Consensus        62 ~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~  141 (594)
T 2p1m_B           62 IRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCE  141 (594)
T ss_dssp             HHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCE
T ss_pred             HhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcC
Confidence            456788999999998622111   1000000    011134678999999999999887777775 6899999999999 


Q ss_pred             cCcccCCCccccCCCCccEEEccCccccccCCchhh----CCCCCCEEEccCCcCcccCCccc----cCCCCCCeeeccC
Q 040702           88 SLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIF----NASKLSELGLQKNSFSGSIPNTF----GNLRNLKWLGLND  159 (797)
Q Consensus        88 ~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~----~l~~L~~L~L~~N~l~~~~~~~f----~~l~~L~~L~L~~  159 (797)
                      .++..-.......+++|++|+|++|.+++..+..+.    .+++|++|+|++|. ..+....+    .++++|++|+|++
T Consensus       142 ~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~-~~~~~~~l~~l~~~~~~L~~L~L~~  220 (594)
T 2p1m_B          142 GFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA-SEVSFSALERLVTRCPNLKSLKLNR  220 (594)
T ss_dssp             EEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC-SCCCHHHHHHHHHHCTTCCEEECCT
T ss_pred             CCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC-CcCCHHHHHHHHHhCCCCcEEecCC
Confidence            555221223334789999999999998765555444    56799999999997 32333333    4569999999999


Q ss_pred             c-cCcCCCCCccccccCCCCCCCcEEEccCCC-------CCCCCChhhhccccCCcEE-EccCCcccccCChhhhhhhhh
Q 040702          160 N-YLTSSTPELSSLSSLSNCKYLEYFSFSNNP-------LGGILPRAIGNLSQSMEDF-WMDNCNISGSIPEEINNLTNL  230 (797)
Q Consensus       160 N-~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~-------l~~~~~~~~~~l~~~L~~L-~L~~n~i~~~~p~~~~~l~~L  230 (797)
                      | .++.++.      .+..+++|+.|+++.+.       +.+ .+..+.+++ +|+.| .+.+.. ...++..+..+++|
T Consensus       221 ~~~~~~l~~------~~~~~~~L~~L~l~~~~~~~~~~~~~~-l~~~l~~~~-~L~~Ls~~~~~~-~~~l~~~~~~~~~L  291 (594)
T 2p1m_B          221 AVPLEKLAT------LLQRAPQLEELGTGGYTAEVRPDVYSG-LSVALSGCK-ELRCLSGFWDAV-PAYLPAVYSVCSRL  291 (594)
T ss_dssp             TSCHHHHHH------HHHHCTTCSEEECSBCCCCCCHHHHHH-HHHHHHTCT-TCCEEECCBTCC-GGGGGGGHHHHTTC
T ss_pred             CCcHHHHHH------HHhcCCcceEcccccccCccchhhHHH-HHHHHhcCC-CcccccCCcccc-hhhHHHHHHhhCCC
Confidence            8 4444222      25567889999976654       222 234667776 78888 344332 23456666678888


Q ss_pred             HhhhcccccccccCCCc-hhhcCCCCCcEEEccCCcCccc-CCCCccCCccccccccCC---------CCCCCCC-CCC-
Q 040702          231 ILQLLSLEGNQLEGSIP-DDLCRLAALFQLDLGGNKLSGF-VPACSGNLTNLRKLYLGS---------NLLTSIP-STL-  297 (797)
Q Consensus       231 ~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~---------N~l~~lp-~~~-  297 (797)
                        ++|++++|.+++... ..+..+++|++|++++| +... .+.....+++|++|++++         |.++... ..+ 
T Consensus       292 --~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~  368 (594)
T 2p1m_B          292 --TTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVS  368 (594)
T ss_dssp             --CEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHH
T ss_pred             --CEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHH
Confidence              999999999764322 23567899999999998 4422 222233578999999943         4443211 112 


Q ss_pred             CCCCcccEEEccCCcCCCCCCcccc-ccccccEEecc--C----cccccc-----cCccccCCcccceecccCccccCCC
Q 040702          298 WNLKDILHLNLSSNFFTGPLPLKIG-NLNVLVQLDLS--M----NNFSCV-----IPTKIGGLKDLQYLFLEYNRLQGSI  365 (797)
Q Consensus       298 ~~l~~L~~L~l~~N~l~~~~~~~~~-~l~~L~~L~Ls--~----N~l~~~-----~~~~~~~l~~L~~L~Ls~N~l~~~~  365 (797)
                      .++++|+.|.++.|.+++.....+. .+++|+.|+++  +    |.++..     .+..+..+++|+.|+|++ .+++..
T Consensus       369 ~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~  447 (594)
T 2p1m_B          369 MGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKV  447 (594)
T ss_dssp             HHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHH
T ss_pred             HhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHH
Confidence            2478999999999999865555554 58999999999  4    566632     122366789999999988 676655


Q ss_pred             Chhhhc-cccCCeeeecCCcCCCCCChhh-hccCCCCeEEccCCcCcccCCC--CCCCCCCCcccccCCcc
Q 040702          366 PNSIGD-LISLKSLNLSNNNLSGTIPISL-EKLLDLKDINVSFNRLEGEIPR--EGPFRNLSAESFKGNEL  432 (797)
Q Consensus       366 p~~~~~-l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~L~l~~N~l~~~~p~--~~~~~~l~~~~~~~n~~  432 (797)
                      +..+.. +++|+.|+|++|.+++..+..+ ..+++|+.|++++|++++..+.  ...++.++.+++.+|+.
T Consensus       448 ~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~  518 (594)
T 2p1m_B          448 FEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSV  518 (594)
T ss_dssp             HHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCC
T ss_pred             HHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCC
Confidence            566665 8999999999999987666565 7799999999999999644322  23467788888888765

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.90  E-value=1.1e-23  Score=227.64  Aligned_cols=204  Identities=17%  Similarity=0.133  Sum_probs=140.4

Q ss_pred             CEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcc-cCCccccCCCCCCe-eec
Q 040702           80 KSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSG-SIPNTFGNLRNLKW-LGL  157 (797)
Q Consensus        80 ~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~-~~~~~f~~l~~L~~-L~L  157 (797)
                      ++++.++|+|+ .+|..++   +++++|+|++|+|+.+.+.+|.++++|++|+|++|+|.+ +.+++|.++++|+. +.+
T Consensus        12 ~~v~C~~~~Lt-~iP~~l~---~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~   87 (350)
T 4ay9_X           12 RVFLCQESKVT-EIPSDLP---RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE   87 (350)
T ss_dssp             TEEEEESTTCC-SCCTTCC---TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred             CEEEecCCCCC-ccCcCcC---CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence            57888899998 8898764   689999999999997777899999999999999999855 56678999999875 777


Q ss_pred             cCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccC-CcccccCChhhhhhhhhHhhhcc
Q 040702          158 NDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDN-CNISGSIPEEINNLTNLILQLLS  236 (797)
Q Consensus       158 ~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~-n~i~~~~p~~~~~l~~L~L~~L~  236 (797)
                      +.|+|+.++++     .|..+++|++|++++|++..+.+..+.... .+..|++.+ +++....+..|..+... +++|+
T Consensus        88 ~~N~l~~l~~~-----~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~-~l~~l~l~~~~~i~~l~~~~f~~~~~~-l~~L~  160 (350)
T 4ay9_X           88 KANNLLYINPE-----AFQNLPNLQYLLISNTGIKHLPDVHKIHSL-QKVLLDIQDNINIHTIERNSFVGLSFE-SVILW  160 (350)
T ss_dssp             EETTCCEECTT-----SBCCCTTCCEEEEEEECCSSCCCCTTCCBS-SCEEEEEESCTTCCEECTTSSTTSBSS-CEEEE
T ss_pred             cCCcccccCch-----hhhhccccccccccccccccCCchhhcccc-hhhhhhhccccccccccccchhhcchh-hhhhc
Confidence            88999999886     489999999999999999988877776655 566676654 44554444444443321 14445


Q ss_pred             cccccccCCCchhhcCCCCCcEEEcc-CCcCcccCCCCccCCccccccccCCCCCCCCCC
Q 040702          237 LEGNQLEGSIPDDLCRLAALFQLDLG-GNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPS  295 (797)
Q Consensus       237 Ls~N~l~~~~~~~~~~l~~L~~L~Ls-~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~  295 (797)
                      |++|+|+.+.+..|. ..+|++|+++ +|.++.+.+..|.++++|++|+|++|+|+.+|.
T Consensus       161 L~~N~i~~i~~~~f~-~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~  219 (350)
T 4ay9_X          161 LNKNGIQEIHNSAFN-GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPS  219 (350)
T ss_dssp             CCSSCCCEECTTSST-TEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCS
T ss_pred             cccccccCCChhhcc-ccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccCh
Confidence            555555433333332 2344444443 244444444444444555555555555444443

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.90  E-value=2.2e-25  Score=242.37  Aligned_cols=265  Identities=17%  Similarity=0.179  Sum_probs=151.9

Q ss_pred             EEEccCCcCcccCCCccccCCCCccEEEccCccccccCC----chhhCCC-CCCEEEccCCcCcccCCccccCC-----C
Q 040702           81 SLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIP----SFIFNAS-KLSELGLQKNSFSGSIPNTFGNL-----R  150 (797)
Q Consensus        81 ~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~----~~~~~l~-~L~~L~L~~N~l~~~~~~~f~~l-----~  150 (797)
                      .++|++|.+++.+|.. ....++|++|+|++|.+++..+    ..|..++ +|++|+|++|+|++..+..|..+     +
T Consensus         2 ~~~ls~n~~~~~~~~~-~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~   80 (362)
T 3goz_A            2 NYKLTLHPGSNPVEEF-TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPA   80 (362)
T ss_dssp             EEECCCCTTCCHHHHH-HTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCT
T ss_pred             ccccccccchHHHHHH-HhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCC
Confidence            4567778877655543 3344558888888888776655    6667777 78888888888877767666665     7


Q ss_pred             CCCeeeccCccCcCCCCCccccccCCCC-CCCcEEEccCCCCCCCCChhhhcc----ccCCcEEEccCCcccccCChhhh
Q 040702          151 NLKWLGLNDNYLTSSTPELSSLSSLSNC-KYLEYFSFSNNPLGGILPRAIGNL----SQSMEDFWMDNCNISGSIPEEIN  225 (797)
Q Consensus       151 ~L~~L~L~~N~l~~~~~~~~~~~~l~~l-~~L~~L~Ls~N~l~~~~~~~~~~l----~~~L~~L~L~~n~i~~~~p~~~~  225 (797)
                      +|++|+|++|.++...+... ...+..+ ++|++|+|++|+++...+..+...    +.+|++|++++|.++...+..+.
T Consensus        81 ~L~~L~Ls~n~l~~~~~~~l-~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~  159 (362)
T 3goz_A           81 NVTSLNLSGNFLSYKSSDEL-VKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELI  159 (362)
T ss_dssp             TCCEEECCSSCGGGSCHHHH-HHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHH
T ss_pred             CccEEECcCCcCChHHHHHH-HHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHH
Confidence            77777777777776544210 0012333 567777777777766655554432    23566666666655543332221


Q ss_pred             hhhhhHhhhcccccccccCCCchhhcCCC-CCcEEEccCCcCcccCCCCcc----CC-ccccccccCCCCCCC-----CC
Q 040702          226 NLTNLILQLLSLEGNQLEGSIPDDLCRLA-ALFQLDLGGNKLSGFVPACSG----NL-TNLRKLYLGSNLLTS-----IP  294 (797)
Q Consensus       226 ~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~----~l-~~L~~L~L~~N~l~~-----lp  294 (797)
                                            ..+..++ +|++|+|++|++++..+..+.    .+ ++|++|+|++|.++.     ++
T Consensus       160 ----------------------~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~  217 (362)
T 3goz_A          160 ----------------------QILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELA  217 (362)
T ss_dssp             ----------------------HHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHH
T ss_pred             ----------------------HHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHH
Confidence                                  1222333 566666666666544433222    22 356666666666544     34


Q ss_pred             CCCCC-CCcccEEEccCCcCCCCCC----ccccccccccEEeccCcccccc-------cCccccCCcccceecccCcccc
Q 040702          295 STLWN-LKDILHLNLSSNFFTGPLP----LKIGNLNVLVQLDLSMNNFSCV-------IPTKIGGLKDLQYLFLEYNRLQ  362 (797)
Q Consensus       295 ~~~~~-l~~L~~L~l~~N~l~~~~~----~~~~~l~~L~~L~Ls~N~l~~~-------~~~~~~~l~~L~~L~Ls~N~l~  362 (797)
                      ..+.. .++|++|++++|.+++..+    ..+..+++|+.|++++|.+..+       .+..+..+++|+.||+++|++.
T Consensus       218 ~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~  297 (362)
T 3goz_A          218 YIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIH  297 (362)
T ss_dssp             HHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCC
T ss_pred             HHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCC
Confidence            43433 2366666666666664433    2234556666777776664322       2234556666777777777666


Q ss_pred             CCCChhh
Q 040702          363 GSIPNSI  369 (797)
Q Consensus       363 ~~~p~~~  369 (797)
                      ...+..+
T Consensus       298 ~~~~~~~  304 (362)
T 3goz_A          298 PSHSIPI  304 (362)
T ss_dssp             GGGCHHH
T ss_pred             CcchHHH
Confidence            5444333

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.89  E-value=2.4e-23  Score=220.73  Aligned_cols=195  Identities=22%  Similarity=0.332  Sum_probs=122.7

Q ss_pred             CCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCc
Q 040702           17 LGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSS   96 (797)
Q Consensus        17 ~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~   96 (797)
                      +..+++|++|++++|.++         .+| .+..+++|++|++++|+++++.+  +.++++|++|+|++|+++ .++  
T Consensus        37 ~~~l~~L~~L~l~~~~i~---------~l~-~~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n~l~-~~~--  101 (308)
T 1h6u_A           37 QADLDGITTLSAFGTGVT---------TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS--  101 (308)
T ss_dssp             HHHHHTCCEEECTTSCCC---------CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG--
T ss_pred             HHHcCCcCEEEeeCCCcc---------Cch-hhhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCCcCC-Cch--
Confidence            345667777777777632         333 46667777777777777766544  667777777777777776 444  


Q ss_pred             cccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCC
Q 040702           97 ADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLS  176 (797)
Q Consensus        97 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~  176 (797)
                      .+..+++|++|+|++|++++. + .+..+++|++|+|++|+|+++.+  |.++++|++|+|++|.++.+++       +.
T Consensus       102 ~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~-------l~  170 (308)
T 1h6u_A          102 AIAGLQSIKTLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP-------LA  170 (308)
T ss_dssp             GGTTCTTCCEEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG-------GT
T ss_pred             hhcCCCCCCEEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh-------hc
Confidence            345667777777777776643 2 26667777777777777765544  6667777777777776665443       45


Q ss_pred             CCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCC
Q 040702          177 NCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAAL  256 (797)
Q Consensus       177 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L  256 (797)
                      .+++|+.|++++|+++++.+  +..++ +|                          ++|++++|++++..  .+..+++|
T Consensus       171 ~l~~L~~L~l~~n~l~~~~~--l~~l~-~L--------------------------~~L~L~~N~l~~~~--~l~~l~~L  219 (308)
T 1h6u_A          171 NLSKLTTLKADDNKISDISP--LASLP-NL--------------------------IEVHLKNNQISDVS--PLANTSNL  219 (308)
T ss_dssp             TCTTCCEEECCSSCCCCCGG--GGGCT-TC--------------------------CEEECTTSCCCBCG--GGTTCTTC
T ss_pred             CCCCCCEEECCCCccCcChh--hcCCC-CC--------------------------CEEEccCCccCccc--cccCCCCC
Confidence            56666666666666665433  44443 34                          55555555555433  25666777


Q ss_pred             cEEEccCCcCcc
Q 040702          257 FQLDLGGNKLSG  268 (797)
Q Consensus       257 ~~L~Ls~N~l~~  268 (797)
                      +.|+|++|++++
T Consensus       220 ~~L~l~~N~i~~  231 (308)
T 1h6u_A          220 FIVTLTNQTITN  231 (308)
T ss_dssp             CEEEEEEEEEEC
T ss_pred             CEEEccCCeeec
Confidence            777777777764

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.89  E-value=1.3e-23  Score=223.33  Aligned_cols=206  Identities=20%  Similarity=0.170  Sum_probs=118.4

Q ss_pred             CCCCCEEEccCCcCcccCCccc--cCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhcc
Q 040702          125 ASKLSELGLQKNSFSGSIPNTF--GNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNL  202 (797)
Q Consensus       125 l~~L~~L~L~~N~l~~~~~~~f--~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l  202 (797)
                      +++|++|+|++|++++..|..|  .++++|++|+|++|.++...+.+... .+..+++|++|+|++|++.+..+..|..+
T Consensus        90 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~-~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l  168 (310)
T 4glp_A           90 YSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAEL-QQWLKPGLKVLSIAQAHSPAFSCEQVRAF  168 (310)
T ss_dssp             HSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHH-HTTBCSCCCEEEEECCSSCCCCTTSCCCC
T ss_pred             cCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHH-HhhhccCCCEEEeeCCCcchhhHHHhccC
Confidence            3456666666666665555555  56666666666666665533321111 13355566666666666666655666555


Q ss_pred             ccCCcEEEccCCccccc--C--ChhhhhhhhhHhhhcccccccccCCCch---hhcCCCCCcEEEccCCcCcccCCCCcc
Q 040702          203 SQSMEDFWMDNCNISGS--I--PEEINNLTNLILQLLSLEGNQLEGSIPD---DLCRLAALFQLDLGGNKLSGFVPACSG  275 (797)
Q Consensus       203 ~~~L~~L~L~~n~i~~~--~--p~~~~~l~~L~L~~L~Ls~N~l~~~~~~---~~~~l~~L~~L~Ls~N~l~~~~~~~~~  275 (797)
                      + +|+.|++++|++.+.  .  +..+..+++|  ++|+|++|+++...+.   .+..+++|++|||++|++++..|..+.
T Consensus       169 ~-~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L--~~L~Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~  245 (310)
T 4glp_A          169 P-ALTSLDLSDNPGLGERGLMAALCPHKFPAI--QNLALRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAP  245 (310)
T ss_dssp             T-TCCEEECCSCTTCHHHHHHTTSCTTSSCCC--CSCBCCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCS
T ss_pred             C-CCCEEECCCCCCccchhhhHHHhhhcCCCC--CEEECCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHH
Confidence            5 566666666655431  1  1122344555  6677777776522111   245667777777777777776666555


Q ss_pred             CC---ccccccccCCCCCCCCCCCCCCCCcccEEEccCCcCCCCCCccccccccccEEeccCcccc
Q 040702          276 NL---TNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFS  338 (797)
Q Consensus       276 ~l---~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~  338 (797)
                      .+   ++|++|+|++|+|+.+|..+.  ++|+.|++++|++++. |. +..+++|+.|++++|+++
T Consensus       246 ~~~~~~~L~~L~Ls~N~l~~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~  307 (310)
T 4glp_A          246 RCMWSSALNSLNLSFAGLEQVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFL  307 (310)
T ss_dssp             SCCCCTTCCCEECCSSCCCSCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTS
T ss_pred             hccCcCcCCEEECCCCCCCchhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCC
Confidence            55   577777777777777766553  5666666666666643 22 445555555555555554

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.89  E-value=9.5e-24  Score=224.27  Aligned_cols=229  Identities=19%  Similarity=0.153  Sum_probs=149.2

Q ss_pred             CCCEEEcccCcccccCCc---cccCCCCCCEEEccCCcCcccCCCccc-cCCCCccEEEccCccccccCC----chhhCC
Q 040702           54 NMEWMAFSFNKVVGVVPT---TIFNVSTLKSLYLHSNSLSGRLPSSAD-VRLPNLKELHLWGNNFIGTIP----SFIFNA  125 (797)
Q Consensus        54 ~L~~L~ls~N~i~~~~p~---~~~~l~~L~~L~Ls~N~l~~~l~~~~~-~~l~~L~~L~L~~N~l~~~~~----~~~~~l  125 (797)
                      .++.|.++++.+....-.   .+..+++|++|+|++|.+++..|...+ ..+++|++|+|++|.+++..+    ..+..+
T Consensus        65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~  144 (310)
T 4glp_A           65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK  144 (310)
T ss_dssp             CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred             ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence            356667766665431100   122345677777777777755665544 567777777777777775444    344567


Q ss_pred             CCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcC---CCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhcc
Q 040702          126 SKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTS---STPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNL  202 (797)
Q Consensus       126 ~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~---~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l  202 (797)
                      ++|++|+|++|+|.++.+..|.++++|++|+|++|++..   ++...    .+..+++|++|+|++|+++... ..    
T Consensus       145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~----~~~~l~~L~~L~Ls~N~l~~l~-~~----  215 (310)
T 4glp_A          145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAAL----CPHKFPAIQNLALRNTGMETPT-GV----  215 (310)
T ss_dssp             SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTS----CTTSSCCCCSCBCCSSCCCCHH-HH----
T ss_pred             cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHH----hhhcCCCCCEEECCCCCCCchH-HH----
Confidence            777777777777777777777777777777777777643   22111    1345666777777777765321 11    


Q ss_pred             ccCCcEEEccCCcccccCCh-hhhhhhhhHhhhcccccccccCCCchhhcCC---CCCcEEEccCCcCcccCCCCccCCc
Q 040702          203 SQSMEDFWMDNCNISGSIPE-EINNLTNLILQLLSLEGNQLEGSIPDDLCRL---AALFQLDLGGNKLSGFVPACSGNLT  278 (797)
Q Consensus       203 ~~~L~~L~L~~n~i~~~~p~-~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l---~~L~~L~Ls~N~l~~~~~~~~~~l~  278 (797)
                                        +. .+.++++|  ++|+|++|++++..|..+..+   ++|++|+|++|+|+.+ |..+.  +
T Consensus       216 ------------------~~~l~~~l~~L--~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~~l-p~~~~--~  272 (310)
T 4glp_A          216 ------------------CAALAAAGVQP--HSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLEQV-PKGLP--A  272 (310)
T ss_dssp             ------------------HHHHHHHTCCC--SSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCCSC-CSCCC--S
T ss_pred             ------------------HHHHHhcCCCC--CEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCCch-hhhhc--C
Confidence                              01 12344444  677777777776666666555   5888888888888844 55443  7


Q ss_pred             cccccccCCCCCCCCCCCCCCCCcccEEEccCCcCCC
Q 040702          279 NLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTG  315 (797)
Q Consensus       279 ~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~  315 (797)
                      +|+.|+|++|+|+.+|. +..+++|+.|++++|+++.
T Consensus       273 ~L~~L~Ls~N~l~~~~~-~~~l~~L~~L~L~~N~l~~  308 (310)
T 4glp_A          273 KLRVLDLSSNRLNRAPQ-PDELPEVDNLTLDGNPFLV  308 (310)
T ss_dssp             CCSCEECCSCCCCSCCC-TTSCCCCSCEECSSTTTSC
T ss_pred             CCCEEECCCCcCCCCch-hhhCCCccEEECcCCCCCC
Confidence            88888999998888765 6678888899999998873

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.89  E-value=3.9e-24  Score=226.77  Aligned_cols=209  Identities=24%  Similarity=0.362  Sum_probs=123.9

Q ss_pred             EEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCC
Q 040702           57 WMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKN  136 (797)
Q Consensus        57 ~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  136 (797)
                      .+.+..+++.+..  .+..+++|++|++++|.++ .+|.  +..+++|++|+|++|++++..+  +..+++|++|+|++|
T Consensus        23 ~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~-~l~~--~~~l~~L~~L~L~~n~i~~~~~--~~~l~~L~~L~L~~n   95 (308)
T 1h6u_A           23 KIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIEG--VQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGN   95 (308)
T ss_dssp             HHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSC
T ss_pred             HHHhCCCCcCcee--cHHHcCCcCEEEeeCCCcc-Cchh--hhccCCCCEEEccCCcCCCChh--HccCCCCCEEEccCC
Confidence            3344555555432  2345667777777777776 5552  3466777777777777764433  667777777777777


Q ss_pred             cCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcc
Q 040702          137 SFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNI  216 (797)
Q Consensus       137 ~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i  216 (797)
                      +|+++  ..|.++++|++|+|++|.++.+++       +..+++|+.|++++|+++++.+  +..++ +|+.|++++|.+
T Consensus        96 ~l~~~--~~~~~l~~L~~L~l~~n~l~~~~~-------l~~l~~L~~L~l~~n~l~~~~~--l~~l~-~L~~L~l~~n~l  163 (308)
T 1h6u_A           96 PLKNV--SAIAGLQSIKTLDLTSTQITDVTP-------LAGLSNLQVLYLDLNQITNISP--LAGLT-NLQYLSIGNAQV  163 (308)
T ss_dssp             CCSCC--GGGTTCTTCCEEECTTSCCCCCGG-------GTTCTTCCEEECCSSCCCCCGG--GGGCT-TCCEEECCSSCC
T ss_pred             cCCCc--hhhcCCCCCCEEECCCCCCCCchh-------hcCCCCCCEEECCCCccCcCcc--ccCCC-CccEEEccCCcC
Confidence            77654  256777777777777777766532       5566667777777777765433  44444 444444444444


Q ss_pred             cccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCCC
Q 040702          217 SGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPST  296 (797)
Q Consensus       217 ~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~  296 (797)
                      +                          +..+  +..+++|+.|++++|+++++.+  +..+++|+.|+|++|.++.+++ 
T Consensus       164 ~--------------------------~~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~-  212 (308)
T 1h6u_A          164 S--------------------------DLTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP-  212 (308)
T ss_dssp             C--------------------------CCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG-
T ss_pred             C--------------------------CChh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc-
Confidence            3                          2222  4455556666666666654433  5556666666666666655552 


Q ss_pred             CCCCCcccEEEccCCcCCC
Q 040702          297 LWNLKDILHLNLSSNFFTG  315 (797)
Q Consensus       297 ~~~l~~L~~L~l~~N~l~~  315 (797)
                      +..+++|+.|++++|.+++
T Consensus       213 l~~l~~L~~L~l~~N~i~~  231 (308)
T 1h6u_A          213 LANTSNLFIVTLTNQTITN  231 (308)
T ss_dssp             GTTCTTCCEEEEEEEEEEC
T ss_pred             ccCCCCCCEEEccCCeeec
Confidence            5556666666666666653

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.88  E-value=8.2e-25  Score=240.19  Aligned_cols=276  Identities=19%  Similarity=0.222  Sum_probs=180.4

Q ss_pred             cCCchhhCCCCCCEEEccCCcCcccCC----ccccCCCCCCeeeccCccCcCCCCC----cccc-ccCCCCCCCcEEEcc
Q 040702          117 TIPSFIFNASKLSELGLQKNSFSGSIP----NTFGNLRNLKWLGLNDNYLTSSTPE----LSSL-SSLSNCKYLEYFSFS  187 (797)
Q Consensus       117 ~~~~~~~~l~~L~~L~L~~N~l~~~~~----~~f~~l~~L~~L~L~~N~l~~~~~~----~~~~-~~l~~l~~L~~L~Ls  187 (797)
                      .++..+..+++|++|+|++|+|+...+    ..|..+++|++|+|++|.+..+...    +..+ ..|..+++|++|+|+
T Consensus        23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls  102 (386)
T 2ca6_A           23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS  102 (386)
T ss_dssp             TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred             HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence            445566666677777777777665533    2355677777777777655433211    1000 124567788888888


Q ss_pred             CCCCCC----CCChhhhccccCCcEEEccCCcccccCChhhhh-hhhhHhhhcccccccccCCCchhhcCCCCCcEEEcc
Q 040702          188 NNPLGG----ILPRAIGNLSQSMEDFWMDNCNISGSIPEEINN-LTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLG  262 (797)
Q Consensus       188 ~N~l~~----~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~-l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  262 (797)
                      +|+++.    .+|..+..++ +|+.|+|++|.++...+..+.. +..+       ..|.+.+       ..++|++|+|+
T Consensus       103 ~n~l~~~~~~~l~~~l~~~~-~L~~L~L~~n~l~~~~~~~l~~~l~~l-------~~~~~~~-------~~~~L~~L~L~  167 (386)
T 2ca6_A          103 DNAFGPTAQEPLIDFLSKHT-PLEHLYLHNNGLGPQAGAKIARALQEL-------AVNKKAK-------NAPPLRSIICG  167 (386)
T ss_dssp             SCCCCTTTHHHHHHHHHHCT-TCCEEECCSSCCHHHHHHHHHHHHHHH-------HHHHHHH-------TCCCCCEEECC
T ss_pred             CCcCCHHHHHHHHHHHHhCC-CCCEEECcCCCCCHHHHHHHHHHHHHH-------hhhhhcc-------cCCCCcEEECC
Confidence            888876    3566677776 7888888888886544444433 1111       1122221       11677777777


Q ss_pred             CCcCc-ccCC---CCccCCccccccccCCCCCC------CCCCCCCCCCcccEEEccCCcCC----CCCCcccccccccc
Q 040702          263 GNKLS-GFVP---ACSGNLTNLRKLYLGSNLLT------SIPSTLWNLKDILHLNLSSNFFT----GPLPLKIGNLNVLV  328 (797)
Q Consensus       263 ~N~l~-~~~~---~~~~~l~~L~~L~L~~N~l~------~lp~~~~~l~~L~~L~l~~N~l~----~~~~~~~~~l~~L~  328 (797)
                      +|+++ ...+   ..+..+++|++|+|++|.++      -+|..+..+++|+.|+|++|.++    ..+|..+..+++|+
T Consensus       168 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~  247 (386)
T 2ca6_A          168 RNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR  247 (386)
T ss_dssp             SSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCC
T ss_pred             CCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcC
Confidence            77776 2223   34556677778888888776      23446777788888888888885    45666778888888


Q ss_pred             EEeccCcccccc----cCccc--cCCcccceecccCccccC----CCChhh-hccccCCeeeecCCcCCCCCC--hhh-h
Q 040702          329 QLDLSMNNFSCV----IPTKI--GGLKDLQYLFLEYNRLQG----SIPNSI-GDLISLKSLNLSNNNLSGTIP--ISL-E  394 (797)
Q Consensus       329 ~L~Ls~N~l~~~----~~~~~--~~l~~L~~L~Ls~N~l~~----~~p~~~-~~l~~L~~L~Ls~N~l~~~~p--~~~-~  394 (797)
                      .|+|++|.+++.    ++..+  +.+++|+.|+|++|++++    .+|..+ .++++|++|+|++|.+++..+  ..+ .
T Consensus       248 ~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~~~~~l~~  327 (386)
T 2ca6_A          248 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIRE  327 (386)
T ss_dssp             EEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSHHHHHHHH
T ss_pred             EEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchhHHHHHHH
Confidence            888988888765    45555  348889999999999986    477777 668999999999999987764  333 2


Q ss_pred             ccCCCCeEEccCC
Q 040702          395 KLLDLKDINVSFN  407 (797)
Q Consensus       395 ~l~~L~~L~l~~N  407 (797)
                      .+++++.+++..+
T Consensus       328 ~l~~~~~~~l~~~  340 (386)
T 2ca6_A          328 VFSTRGRGELDEL  340 (386)
T ss_dssp             HHHHHTCCEECCC
T ss_pred             HhhhcCcchhhhc
Confidence            3455555555543

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.88  E-value=5.5e-25  Score=241.58  Aligned_cols=251  Identities=16%  Similarity=0.159  Sum_probs=162.7

Q ss_pred             ccCCCccccCCCCCCEEEcccCcccccCCc----cccCCCCCCEEEccCCc---CcccCCCcc------ccCCCCccEEE
Q 040702           42 LCEIPHEIDNLHNMEWMAFSFNKVVGVVPT----TIFNVSTLKSLYLHSNS---LSGRLPSSA------DVRLPNLKELH  108 (797)
Q Consensus        42 l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~----~~~~l~~L~~L~Ls~N~---l~~~l~~~~------~~~l~~L~~L~  108 (797)
                      ...++..+..+++|++|+|++|++....+.    .|..+++|++|+|++|.   +++.+|..+      +..+++|++|+
T Consensus        21 ~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~  100 (386)
T 2ca6_A           21 EKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVR  100 (386)
T ss_dssp             HHTTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEE
T ss_pred             HHHHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEE
Confidence            566777888888899999999998876443    47788899999998864   444455443      35678888888


Q ss_pred             ccCccccc----cCCchhhCCCCCCEEEccCCcCcccCCccccC----C---------CCCCeeeccCccCcCCC-CCcc
Q 040702          109 LWGNNFIG----TIPSFIFNASKLSELGLQKNSFSGSIPNTFGN----L---------RNLKWLGLNDNYLTSST-PELS  170 (797)
Q Consensus       109 L~~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~----l---------~~L~~L~L~~N~l~~~~-~~~~  170 (797)
                      |++|.+++    .+|..+..+++|++|+|++|.|+...+..|..    +         ++|++|+|++|+++... +.+.
T Consensus       101 Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~  180 (386)
T 2ca6_A          101 LSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWA  180 (386)
T ss_dssp             CCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHH
T ss_pred             CCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHH
Confidence            88888876    46667778888888888888887544444433    3         67777777777775221 1000


Q ss_pred             ccccCCCCCCCcEEEccCCCCCC-----CCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCC
Q 040702          171 SLSSLSNCKYLEYFSFSNNPLGG-----ILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGS  245 (797)
Q Consensus       171 ~~~~l~~l~~L~~L~Ls~N~l~~-----~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~  245 (797)
                        ..+..+++|++|++++|+++.     ..+..+..++ +|+.|+|++|.++...                      ...
T Consensus       181 --~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~-~L~~L~Ls~n~l~~~g----------------------~~~  235 (386)
T 2ca6_A          181 --KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQ-ELKVLDLQDNTFTHLG----------------------SSA  235 (386)
T ss_dssp             --HHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCT-TCCEEECCSSCCHHHH----------------------HHH
T ss_pred             --HHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCC-CccEEECcCCCCCcHH----------------------HHH
Confidence              124455566677777766652     1222344443 4444444444443100                      023


Q ss_pred             CchhhcCCCCCcEEEccCCcCccc----CCCCc--cCCccccccccCCCCCCC-----CCCCC-CCCCcccEEEccCCcC
Q 040702          246 IPDDLCRLAALFQLDLGGNKLSGF----VPACS--GNLTNLRKLYLGSNLLTS-----IPSTL-WNLKDILHLNLSSNFF  313 (797)
Q Consensus       246 ~~~~~~~l~~L~~L~Ls~N~l~~~----~~~~~--~~l~~L~~L~L~~N~l~~-----lp~~~-~~l~~L~~L~l~~N~l  313 (797)
                      +|..+..+++|+.|+|++|.+++.    ++..+  +.+++|+.|+|++|.++.     +|..+ .++++|+.|++++|.+
T Consensus       236 l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l  315 (386)
T 2ca6_A          236 LAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF  315 (386)
T ss_dssp             HHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBS
T ss_pred             HHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcC
Confidence            455666677777777777777654    33444  337778888888888866     77666 4478888888888888


Q ss_pred             CCCC
Q 040702          314 TGPL  317 (797)
Q Consensus       314 ~~~~  317 (797)
                      ++..
T Consensus       316 ~~~~  319 (386)
T 2ca6_A          316 SEED  319 (386)
T ss_dssp             CTTS
T ss_pred             Ccch
Confidence            8655

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.88  E-value=1.9e-22  Score=207.18  Aligned_cols=127  Identities=20%  Similarity=0.270  Sum_probs=68.0

Q ss_pred             CCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeecc
Q 040702           79 LKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLN  158 (797)
Q Consensus        79 L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~  158 (797)
                      .++++++++.++ .+|..+.   ++|++|+|++|++++..+..|.++++|++|+|++|+|+++.+..|.++++|++|+|+
T Consensus        16 ~~~l~~~~~~l~-~~p~~~~---~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~   91 (251)
T 3m19_A           16 KKEVDCQGKSLD-SVPSGIP---ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLA   91 (251)
T ss_dssp             GTEEECTTCCCS-SCCSCCC---TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECT
T ss_pred             CeEEecCCCCcc-ccCCCCC---CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECC
Confidence            445555555555 5554432   455555555555555555555555555666666555555555555555566666666


Q ss_pred             CccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCc
Q 040702          159 DNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCN  215 (797)
Q Consensus       159 ~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~  215 (797)
                      +|.++.+++.     .|..+++|++|+|++|+|+++.+..|..++ +|+.|+|++|.
T Consensus        92 ~n~l~~~~~~-----~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~  142 (251)
T 3m19_A           92 NNQLASLPLG-----VFDHLTQLDKLYLGGNQLKSLPSGVFDRLT-KLKELRLNTNQ  142 (251)
T ss_dssp             TSCCCCCCTT-----TTTTCTTCCEEECCSSCCCCCCTTTTTTCT-TCCEEECCSSC
T ss_pred             CCcccccChh-----HhcccCCCCEEEcCCCcCCCcChhHhccCC-cccEEECcCCc
Confidence            6655555543     245555555555555555555444444443 33333333333

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.87  E-value=5.6e-24  Score=228.87  Aligned_cols=252  Identities=16%  Similarity=0.174  Sum_probs=112.6

Q ss_pred             ccEEEccCccccccCCchhhCC--CCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCC-CCCccccccCCCCCC
Q 040702          104 LKELHLWGNNFIGTIPSFIFNA--SKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSS-TPELSSLSSLSNCKY  180 (797)
Q Consensus       104 L~~L~L~~N~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~-~~~~~~~~~l~~l~~  180 (797)
                      ++.|++++|.+.   +..+..+  ++++.|++++|.+.+..+. +..+++|++|+|++|.++.. .+.     .+..+++
T Consensus        49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~-----~~~~~~~  119 (336)
T 2ast_B           49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHG-----ILSQCSK  119 (336)
T ss_dssp             SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHH-----HHTTBCC
T ss_pred             heeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHH-----HHhhCCC
Confidence            556666666554   3344444  5566666666655554443 23455555555555554321 111     1334444


Q ss_pred             CcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCC-CchhhcCCCCCcEE
Q 040702          181 LEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGS-IPDDLCRLAALFQL  259 (797)
Q Consensus       181 L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L  259 (797)
                      |++|+|++|++.+..+..++.++ +|+.|++++|.                         .+++. .+..+..+++|++|
T Consensus       120 L~~L~L~~~~l~~~~~~~l~~~~-~L~~L~L~~~~-------------------------~l~~~~l~~~~~~~~~L~~L  173 (336)
T 2ast_B          120 LQNLSLEGLRLSDPIVNTLAKNS-NLVRLNLSGCS-------------------------GFSEFALQTLLSSCSRLDEL  173 (336)
T ss_dssp             CSEEECTTCBCCHHHHHHHTTCT-TCSEEECTTCB-------------------------SCCHHHHHHHHHHCTTCCEE
T ss_pred             CCEEeCcCcccCHHHHHHHhcCC-CCCEEECCCCC-------------------------CCCHHHHHHHHhcCCCCCEE
Confidence            55555555544433333343333 34333333331                         22211 22233344445555


Q ss_pred             EccCC-cCccc-CCCCccCCc-cccccccCCCCCCCCCCCCCCCCcccEEEccCCcCC-CCCCccccccccccEEeccCc
Q 040702          260 DLGGN-KLSGF-VPACSGNLT-NLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFT-GPLPLKIGNLNVLVQLDLSMN  335 (797)
Q Consensus       260 ~Ls~N-~l~~~-~~~~~~~l~-~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~Ls~N  335 (797)
                      ++++| .+++. .+..+..++ +|++|++++|.+                     .++ +..+..+..+++|+.|++++|
T Consensus       174 ~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~---------------------~~~~~~l~~~~~~~~~L~~L~l~~~  232 (336)
T 2ast_B          174 NLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK---------------------NLQKSDLSTLVRRCPNLVHLDLSDS  232 (336)
T ss_dssp             ECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGG---------------------GSCHHHHHHHHHHCTTCSEEECTTC
T ss_pred             cCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcc---------------------cCCHHHHHHHHhhCCCCCEEeCCCC
Confidence            55555 44432 122233333 444444444321                     222 122333444455555555555


Q ss_pred             c-cccccCccccCCcccceecccCcc-ccCCCChhhhccccCCeeeecCCcCCCCCChhhhcc-CCCCeEEccCCcCccc
Q 040702          336 N-FSCVIPTKIGGLKDLQYLFLEYNR-LQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKL-LDLKDINVSFNRLEGE  412 (797)
Q Consensus       336 ~-l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~l~~N~l~~~  412 (797)
                      . +++..+..+..+++|++|++++|. +.......++.+++|+.|++++| ++   ...+..+ .+++.|++++|++++.
T Consensus       233 ~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~  308 (336)
T 2ast_B          233 VMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTI  308 (336)
T ss_dssp             TTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCT
T ss_pred             CcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCccc
Confidence            5 444444455555555555555553 21111123555566666666666 22   1223333 2255555666666665


Q ss_pred             CCC
Q 040702          413 IPR  415 (797)
Q Consensus       413 ~p~  415 (797)
                      .|.
T Consensus       309 ~~~  311 (336)
T 2ast_B          309 ARP  311 (336)
T ss_dssp             TCS
T ss_pred             cCC
Confidence            553

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.87  E-value=9.6e-24  Score=227.04  Aligned_cols=253  Identities=17%  Similarity=0.198  Sum_probs=123.0

Q ss_pred             CCEEEcccCcccccCCccccCC--CCCCEEEccCCcCcccCCCccccCCCCccEEEccCcccccc-CCchhhCCCCCCEE
Q 040702           55 MEWMAFSFNKVVGVVPTTIFNV--STLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGT-IPSFIFNASKLSEL  131 (797)
Q Consensus        55 L~~L~ls~N~i~~~~p~~~~~l--~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L  131 (797)
                      ++.+++++|++.   |..+..+  ++++.|++++|.+.+..+ ..+ .+++|++|+|++|.+++. ++..+..+++|++|
T Consensus        49 ~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~-~~~-~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L  123 (336)
T 2ast_B           49 WQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLA-EHF-SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL  123 (336)
T ss_dssp             SSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCC-SCC-CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred             heeeccccccCC---HHHHHhhhhccceEEEcCCccccccch-hhc-cCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence            445555555443   3334444  455555555555543222 222 455555555555555433 44445555555555


Q ss_pred             EccCCcCcccCCccccCCCCCCeeeccCc-cCcC--CCCCccccccCCCCCCCcEEEccCC-CCCCC-CChhhhccccCC
Q 040702          132 GLQKNSFSGSIPNTFGNLRNLKWLGLNDN-YLTS--STPELSSLSSLSNCKYLEYFSFSNN-PLGGI-LPRAIGNLSQSM  206 (797)
Q Consensus       132 ~L~~N~l~~~~~~~f~~l~~L~~L~L~~N-~l~~--~~~~~~~~~~l~~l~~L~~L~Ls~N-~l~~~-~~~~~~~l~~~L  206 (797)
                      +|++|++++..+..|..+++|++|+|++| .++.  ++.      .+.++++|++|++++| .+++. .+..+..++.+|
T Consensus       124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~------~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L  197 (336)
T 2ast_B          124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQT------LLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETI  197 (336)
T ss_dssp             ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHH------HHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTC
T ss_pred             eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHH------HHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCC
Confidence            55555555444555555555555555555 3432  111      1333444555555555 44432 233333333234


Q ss_pred             cEEEccCCcccccCChhhhhhhhhHhhhccccccccc-CCCchhhcCCCCCcEEEccCCc-CcccCCCCccCCccccccc
Q 040702          207 EDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLE-GSIPDDLCRLAALFQLDLGGNK-LSGFVPACSGNLTNLRKLY  284 (797)
Q Consensus       207 ~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~  284 (797)
                      +.|++++|.+                        .++ +..+..+..+++|++|++++|. +++..+..+..+++|+.|+
T Consensus       198 ~~L~l~~~~~------------------------~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~  253 (336)
T 2ast_B          198 TQLNLSGYRK------------------------NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLS  253 (336)
T ss_dssp             CEEECCSCGG------------------------GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEE
T ss_pred             CEEEeCCCcc------------------------cCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEee
Confidence            4444444421                        121 1223344445556666666665 4444444555556666666


Q ss_pred             cCCCCCCCCCC---CCCCCCcccEEEccCCcCCCCCCcccccc-ccccEEeccCcccccccCccccC
Q 040702          285 LGSNLLTSIPS---TLWNLKDILHLNLSSNFFTGPLPLKIGNL-NVLVQLDLSMNNFSCVIPTKIGG  347 (797)
Q Consensus       285 L~~N~l~~lp~---~~~~l~~L~~L~l~~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~  347 (797)
                      +++|. ...+.   .+..+++|+.|++++| +.   ...+..+ ..++.|++++|.+++..|..++.
T Consensus       254 l~~~~-~~~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~  315 (336)
T 2ast_B          254 LSRCY-DIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSHFTTIARPTIGN  315 (336)
T ss_dssp             CTTCT-TCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred             CCCCC-CCCHHHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEecccCccccCCcccc
Confidence            66664 11111   3445666777777666 32   1223333 23666667777777776666554

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.87  E-value=8.7e-22  Score=196.17  Aligned_cols=152  Identities=23%  Similarity=0.290  Sum_probs=108.1

Q ss_pred             CEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCC
Q 040702           24 QTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPN  103 (797)
Q Consensus        24 ~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~  103 (797)
                      +.++.+++.         ++++|..+  .++|++|++++|+++++.+..|.++++|++|+|++|+++ .+|...|..+++
T Consensus        10 ~~v~c~~~~---------l~~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~   77 (208)
T 2o6s_A           10 TTVECYSQG---------RTSVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTS   77 (208)
T ss_dssp             TEEECCSSC---------CSSCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CCCTTTTTTCTT
T ss_pred             CEEEecCCC---------ccCCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccC-ccChhhcCCCCC
Confidence            567777776         34445444  246777888888777776667777777888888877777 667666667777


Q ss_pred             ccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcE
Q 040702          104 LKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEY  183 (797)
Q Consensus       104 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~  183 (797)
                      |++|+|++|++++..+..|.++++|++|+|++|+|+++.+..|.++++|++|+|++|.++.+++.     .|..+++|+.
T Consensus        78 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~-----~~~~l~~L~~  152 (208)
T 2o6s_A           78 LTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDG-----VFDRLTSLQY  152 (208)
T ss_dssp             CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT-----TTTTCTTCCE
T ss_pred             cCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHH-----HhccCCCccE
Confidence            77777777777766666677777777777777777777777777777777777777777766654     2566667777


Q ss_pred             EEccCCCCC
Q 040702          184 FSFSNNPLG  192 (797)
Q Consensus       184 L~Ls~N~l~  192 (797)
                      |++++|++.
T Consensus       153 L~l~~N~~~  161 (208)
T 2o6s_A          153 IWLHDNPWD  161 (208)
T ss_dssp             EECCSCCBC
T ss_pred             EEecCCCee
Confidence            777777655

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.85  E-value=9.9e-21  Score=188.49  Aligned_cols=182  Identities=24%  Similarity=0.268  Sum_probs=157.4

Q ss_pred             CCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEcc
Q 040702           55 MEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQ  134 (797)
Q Consensus        55 L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  134 (797)
                      -+.++++++.++.+ |..+  .++|++|+|++|+++ .++...|..+++|++|+|++|++++..+..|..+++|++|+|+
T Consensus         9 ~~~v~c~~~~l~~~-p~~~--~~~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls   84 (208)
T 2o6s_A            9 GTTVECYSQGRTSV-PTGI--PAQTTYLDLETNSLK-SLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLS   84 (208)
T ss_dssp             TTEEECCSSCCSSC-CSCC--CTTCSEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCEEEecCCCccCC-CCCC--CCCCcEEEcCCCccC-cCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECC
Confidence            35788999999864 4443  468999999999998 7888888899999999999999998777788999999999999


Q ss_pred             CCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCC
Q 040702          135 KNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNC  214 (797)
Q Consensus       135 ~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n  214 (797)
                      +|+|+++.+..|.++++|++|+|++|.|+.+++.     .|..+++|+.|++++|+++++.+..|..++ +|+.|++++|
T Consensus        85 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-----~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~-~L~~L~l~~N  158 (208)
T 2o6s_A           85 TNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDG-----VFDKLTQLKDLRLYQNQLKSVPDGVFDRLT-SLQYIWLHDN  158 (208)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT-----TTTTCTTCCEEECCSSCCSCCCTTTTTTCT-TCCEEECCSC
T ss_pred             CCcCCccCHhHhcCccCCCEEEcCCCcCcccCHh-----HhccCCcCCEEECCCCccceeCHHHhccCC-CccEEEecCC
Confidence            9999998888899999999999999999998876     378899999999999999988888888887 8999999999


Q ss_pred             cccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCC
Q 040702          215 NISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAA  255 (797)
Q Consensus       215 ~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~  255 (797)
                      .+.+..|       +|  ++|+++.|++++.+|..++.++.
T Consensus       159 ~~~~~~~-------~l--~~L~~~~n~~~g~ip~~~~~l~~  190 (208)
T 2o6s_A          159 PWDCTCP-------GI--RYLSEWINKHSGVVRNSAGSVAP  190 (208)
T ss_dssp             CBCCCTT-------TT--HHHHHHHHHCTTTBBCTTSSBCT
T ss_pred             CeecCCC-------CH--HHHHHHHHhCCceeeccCccccC
Confidence            8876544       44  88899999999888887776653

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.85  E-value=1e-20  Score=215.09  Aligned_cols=188  Identities=23%  Similarity=0.263  Sum_probs=144.9

Q ss_pred             CCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCC
Q 040702           22 SLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRL  101 (797)
Q Consensus        22 ~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l  101 (797)
                      +|++|||++|.+++         +|..+.  ++|++|+|++|+|+. +|   ..+++|++|+|++|+|+ .+|. + .. 
T Consensus        60 ~L~~L~Ls~n~L~~---------lp~~l~--~~L~~L~Ls~N~l~~-ip---~~l~~L~~L~Ls~N~l~-~ip~-l-~~-  120 (571)
T 3cvr_A           60 QFSELQLNRLNLSS---------LPDNLP--PQITVLEITQNALIS-LP---ELPASLEYLDACDNRLS-TLPE-L-PA-  120 (571)
T ss_dssp             TCSEEECCSSCCSC---------CCSCCC--TTCSEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC-C-CT-
T ss_pred             CccEEEeCCCCCCc---------cCHhHc--CCCCEEECcCCCCcc-cc---cccCCCCEEEccCCCCC-Ccch-h-hc-
Confidence            88899999988654         344332  678899999999885 55   44788999999999998 5777 3 23 


Q ss_pred             CCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCC
Q 040702          102 PNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYL  181 (797)
Q Consensus       102 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L  181 (797)
                       +|++|+|++|+|++ +|.   .+++|++|+|++|+|+++.+    .+++|++|+|++|+|+.++. +      .  ++|
T Consensus       121 -~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~lp~----~l~~L~~L~Ls~N~L~~lp~-l------~--~~L  182 (571)
T 3cvr_A          121 -SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTMLPE----LPTSLEVLSVRNNQLTFLPE-L------P--ESL  182 (571)
T ss_dssp             -TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSCCCC-C------C--TTC
T ss_pred             -CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCcCCC----cCCCcCEEECCCCCCCCcch-h------h--CCC
Confidence             89999999999886 555   57889999999999987543    57889999999999888765 3      2  778


Q ss_pred             cEEEccCCCCCCCCChhhhccccCC-------cEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCC
Q 040702          182 EYFSFSNNPLGGILPRAIGNLSQSM-------EDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLA  254 (797)
Q Consensus       182 ~~L~Ls~N~l~~~~~~~~~~l~~~L-------~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~  254 (797)
                      +.|+|++|+|+.++ . |..   +|       +.|+|++|.|+ .+|..+..+++|  ++|+|++|.+++..|..+..+.
T Consensus       183 ~~L~Ls~N~L~~lp-~-~~~---~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L--~~L~L~~N~l~~~~p~~l~~l~  254 (571)
T 3cvr_A          183 EALDVSTNLLESLP-A-VPV---RNHHSEETEIFFRCRENRIT-HIPENILSLDPT--CTIILEDNPLSSRIRESLSQQT  254 (571)
T ss_dssp             CEEECCSSCCSSCC-C-CC-----------CCEEEECCSSCCC-CCCGGGGGSCTT--EEEECCSSSCCHHHHHHHHHHH
T ss_pred             CEEECcCCCCCchh-h-HHH---hhhcccccceEEecCCCcce-ecCHHHhcCCCC--CEEEeeCCcCCCcCHHHHHHhh
Confidence            89999999988544 3 433   56       88999999988 577777778888  8899999999888888887654

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.85  E-value=5.2e-21  Score=207.55  Aligned_cols=180  Identities=22%  Similarity=0.231  Sum_probs=151.1

Q ss_pred             CEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCcccc-CCCCCCEEEccCCcCcccCCCccccCCC
Q 040702           24 QTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIF-NVSTLKSLYLHSNSLSGRLPSSADVRLP  102 (797)
Q Consensus        24 ~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~-~l~~L~~L~Ls~N~l~~~l~~~~~~~l~  102 (797)
                      +++|+++|+         ++.+|..+.  ..++.|+|++|+|+++.+..|. ++++|+.|+|++|+|+ .++...|..++
T Consensus        21 ~~l~c~~~~---------l~~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~-~i~~~~~~~l~   88 (361)
T 2xot_A           21 NILSCSKQQ---------LPNVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP   88 (361)
T ss_dssp             TEEECCSSC---------CSSCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCC-EECTTTTTTCT
T ss_pred             CEEEeCCCC---------cCccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCC-ccChhhccCCC
Confidence            689999998         445666554  3689999999999998888888 9999999999999998 77877888999


Q ss_pred             CccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCc
Q 040702          103 NLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLE  182 (797)
Q Consensus       103 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~  182 (797)
                      +|++|+|++|+|+...+..|.++++|++|+|++|+|+.+.+.+|.++++|++|+|++|+|+.++...  +..+..+++|+
T Consensus        89 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~--~~~~~~l~~L~  166 (361)
T 2xot_A           89 NLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVEL--IKDGNKLPKLM  166 (361)
T ss_dssp             TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGG--TC----CTTCC
T ss_pred             CCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHH--hcCcccCCcCC
Confidence            9999999999999888888999999999999999999999999999999999999999999988753  11126688999


Q ss_pred             EEEccCCCCCCCCChhhhccccC-CcEEEccCCccc
Q 040702          183 YFSFSNNPLGGILPRAIGNLSQS-MEDFWMDNCNIS  217 (797)
Q Consensus       183 ~L~Ls~N~l~~~~~~~~~~l~~~-L~~L~L~~n~i~  217 (797)
                      .|+|++|+|+.+.+..|..++.. ++.|+|++|.+.
T Consensus       167 ~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~  202 (361)
T 2xot_A          167 LLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE  202 (361)
T ss_dssp             EEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred             EEECCCCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence            99999999998877788777621 467777777776

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.85  E-value=2.5e-22  Score=209.39  Aligned_cols=149  Identities=15%  Similarity=0.123  Sum_probs=117.2

Q ss_pred             HHHHHHHhcCCCccccccccCCcceeec----ceEEEEEEEEeccCC------------------cchhHHHHHHHhhhc
Q 040702          504 YLELFQATNRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGG------------------AFKSFDIECGMMKRI  561 (797)
Q Consensus       504 ~~~l~~~~~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~------------------~~~~~~~E~~~l~~l  561 (797)
                      ...+......|...+.||+|+||.||++    ++.||||+++.....                  ....+.+|+++++++
T Consensus        82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l  161 (282)
T 1zar_A           82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL  161 (282)
T ss_dssp             HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence            3444555566778899999999999985    689999999643211                  234688999999999


Q ss_pred             cCCceeEeeeeeecCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEE
Q 040702          562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL  641 (797)
Q Consensus       562 ~Hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll  641 (797)
                      +  | +++.+++.. +..|+||||++||+|.+ +..       .....++.|+++|++|||   +.+|+||||||+|||+
T Consensus       162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl  226 (282)
T 1zar_A          162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLV  226 (282)
T ss_dssp             T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEE
T ss_pred             c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEE
Confidence            9  4 666665433 45699999999999988 421       134579999999999999   9999999999999999


Q ss_pred             cCCCcEEEEeecCCccCCccCccccccccccCcccccccccc
Q 040702          642 DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIF  683 (797)
Q Consensus       642 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~  683 (797)
                      + ++.+||+|||+|+.               +..|+|||.+.
T Consensus       227 ~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~  252 (282)
T 1zar_A          227 S-EEGIWIIDFPQSVE---------------VGEEGWREILE  252 (282)
T ss_dssp             E-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred             E-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence            9 99999999999973               33478898664

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.84  E-value=2.3e-20  Score=187.32  Aligned_cols=153  Identities=23%  Similarity=0.278  Sum_probs=104.2

Q ss_pred             CEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCC
Q 040702           24 QTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPN  103 (797)
Q Consensus        24 ~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~  103 (797)
                      +.+|+++|.         ++++|..+.  ++++.|++++|+|+++.+..|.++++|+.|+|++|+|+ .++...|.++++
T Consensus        14 ~~v~c~~~~---------l~~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~-~~~~~~~~~l~~   81 (220)
T 2v9t_B           14 NIVDCRGKG---------LTEIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS   81 (220)
T ss_dssp             TEEECTTSC---------CSSCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCC-EECTTTTTTCSS
T ss_pred             CEEEcCCCC---------cCcCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCC-CcCHHHhhCCcC
Confidence            567777776         344555443  46777777777777766667777777777777777776 454455567777


Q ss_pred             ccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcE
Q 040702          104 LKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEY  183 (797)
Q Consensus       104 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~  183 (797)
                      |++|+|++|+|+.+.+..|.++++|++|+|++|+|+++.|.+|.++++|++|+|++|+|+.+++.     .|..+++|+.
T Consensus        82 L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-----~~~~l~~L~~  156 (220)
T 2v9t_B           82 LNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKG-----TFSPLRAIQT  156 (220)
T ss_dssp             CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT-----TTTTCTTCCE
T ss_pred             CCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHH-----HHhCCCCCCE
Confidence            77777777777755555666777777777777777777677777777777777777777766654     2566666677


Q ss_pred             EEccCCCCCC
Q 040702          184 FSFSNNPLGG  193 (797)
Q Consensus       184 L~Ls~N~l~~  193 (797)
                      |+|++|++..
T Consensus       157 L~L~~N~~~c  166 (220)
T 2v9t_B          157 MHLAQNPFIC  166 (220)
T ss_dssp             EECCSSCEEC
T ss_pred             EEeCCCCcCC
Confidence            7777766653

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.84  E-value=1.2e-20  Score=214.59  Aligned_cols=204  Identities=18%  Similarity=0.234  Sum_probs=154.8

Q ss_pred             CCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEc
Q 040702           54 NMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGL  133 (797)
Q Consensus        54 ~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  133 (797)
                      +++.|+|++|++++ +|..+  .++|+.|+|++|+|+ .+| .   .+++|++|+|++|+|++ +|. |.+  +|++|+|
T Consensus        60 ~L~~L~Ls~n~L~~-lp~~l--~~~L~~L~Ls~N~l~-~ip-~---~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~L  127 (571)
T 3cvr_A           60 QFSELQLNRLNLSS-LPDNL--PPQITVLEITQNALI-SLP-E---LPASLEYLDACDNRLST-LPE-LPA--SLKHLDV  127 (571)
T ss_dssp             TCSEEECCSSCCSC-CCSCC--CTTCSEEECCSSCCS-CCC-C---CCTTCCEEECCSSCCSC-CCC-CCT--TCCEEEC
T ss_pred             CccEEEeCCCCCCc-cCHhH--cCCCCEEECcCCCCc-ccc-c---ccCCCCEEEccCCCCCC-cch-hhc--CCCEEEC
Confidence            89999999999988 56555  378999999999998 888 2   46899999999999986 666 655  8999999


Q ss_pred             cCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccC
Q 040702          134 QKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDN  213 (797)
Q Consensus       134 ~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~  213 (797)
                      ++|+|+++.+    .+++|++|+|++|.|+.++.         .+++|+.|+|++|+|+++ |. |.   .+|+.|+|++
T Consensus       128 s~N~l~~lp~----~l~~L~~L~Ls~N~l~~lp~---------~l~~L~~L~Ls~N~L~~l-p~-l~---~~L~~L~Ls~  189 (571)
T 3cvr_A          128 DNNQLTMLPE----LPALLEYINADNNQLTMLPE---------LPTSLEVLSVRNNQLTFL-PE-LP---ESLEALDVST  189 (571)
T ss_dssp             CSSCCSCCCC----CCTTCCEEECCSSCCSCCCC---------CCTTCCEEECCSSCCSCC-CC-CC---TTCCEEECCS
T ss_pred             CCCcCCCCCC----cCccccEEeCCCCccCcCCC---------cCCCcCEEECCCCCCCCc-ch-hh---CCCCEEECcC
Confidence            9999997544    68899999999999988764         357899999999999974 44 54   4899999999


Q ss_pred             CcccccCChhhhhhhhhHh-------hhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccc------
Q 040702          214 CNISGSIPEEINNLTNLIL-------QLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNL------  280 (797)
Q Consensus       214 n~i~~~~p~~~~~l~~L~L-------~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L------  280 (797)
                      |.|+ .+|. +..    .|       ++|+|++|+|+. +|..+..+++|+.|+|++|++++..|..+..++..      
T Consensus       190 N~L~-~lp~-~~~----~L~~~~~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~~~~~~~  262 (571)
T 3cvr_A          190 NLLE-SLPA-VPV----RNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGP  262 (571)
T ss_dssp             SCCS-SCCC-CC------------CCEEEECCSSCCCC-CCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHHSCC---C
T ss_pred             CCCC-chhh-HHH----hhhcccccceEEecCCCccee-cCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhcCccccCC
Confidence            9998 5555 443    24       889999999994 67777779999999999999998887776655432      


Q ss_pred             -cccccCCCCCCCCC
Q 040702          281 -RKLYLGSNLLTSIP  294 (797)
Q Consensus       281 -~~L~L~~N~l~~lp  294 (797)
                       ..+++++|.+..++
T Consensus       263 ~~~~~l~~~~~~~~~  277 (571)
T 3cvr_A          263 RIYFSMSDGQQNTLH  277 (571)
T ss_dssp             EEECCC---------
T ss_pred             eeEEeeccccccccc
Confidence             23455555554443

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.83  E-value=2.6e-20  Score=186.89  Aligned_cols=153  Identities=18%  Similarity=0.227  Sum_probs=95.9

Q ss_pred             CEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCC-ccccCCCCCCEEEccCCcCcccCCCccccCCC
Q 040702           24 QTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVP-TTIFNVSTLKSLYLHSNSLSGRLPSSADVRLP  102 (797)
Q Consensus        24 ~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p-~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~  102 (797)
                      +++|+++|.+         +++|..+.  ..+++|+|++|+|+++.| ..|.++++|++|+|++|+|+ .++...|.+++
T Consensus        14 ~~l~~s~n~l---------~~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~-~i~~~~~~~l~   81 (220)
T 2v70_A           14 TTVDCSNQKL---------NKIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEGAS   81 (220)
T ss_dssp             TEEECCSSCC---------SSCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCC-EECTTTTTTCT
T ss_pred             CEeEeCCCCc---------ccCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCC-EECHHHhCCCC
Confidence            4677777763         33444442  245667777777766543 34666666777777776666 55555556666


Q ss_pred             CccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCc
Q 040702          103 NLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLE  182 (797)
Q Consensus       103 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~  182 (797)
                      +|++|+|++|+|++..+..|.++++|++|+|++|+|+++.|.+|.++++|++|+|++|+|+.+++.     .|..+++|+
T Consensus        82 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-----~~~~l~~L~  156 (220)
T 2v70_A           82 GVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPG-----AFDTLHSLS  156 (220)
T ss_dssp             TCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTT-----TTTTCTTCC
T ss_pred             CCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHH-----HhcCCCCCC
Confidence            666666666666666566666666666666666666666666666666666666666666666543     355666666


Q ss_pred             EEEccCCCCCC
Q 040702          183 YFSFSNNPLGG  193 (797)
Q Consensus       183 ~L~Ls~N~l~~  193 (797)
                      .|+|++|++.+
T Consensus       157 ~L~L~~N~l~c  167 (220)
T 2v70_A          157 TLNLLANPFNC  167 (220)
T ss_dssp             EEECCSCCEEC
T ss_pred             EEEecCcCCcC
Confidence            66666666654

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.83  E-value=1.1e-20  Score=198.41  Aligned_cols=172  Identities=22%  Similarity=0.284  Sum_probs=101.8

Q ss_pred             CCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCc
Q 040702           17 LGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSS   96 (797)
Q Consensus        17 ~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~   96 (797)
                      +..+++|++|++++|.++         .+| .+..+++|++|++++|+++++.+  +.++++|++|+|++|.++ .+|. 
T Consensus        42 ~~~l~~L~~L~l~~~~i~---------~~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~-~~~~-  107 (291)
T 1h6t_A           42 QNELNSIDQIIANNSDIK---------SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK-DLSS-  107 (291)
T ss_dssp             HHHHHTCCEEECTTSCCC---------CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CGGG-
T ss_pred             hhhcCcccEEEccCCCcc---------cCh-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCC-CChh-
Confidence            345666777777776633         232 35566667777777777666444  666666777777777665 4443 


Q ss_pred             cccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCC
Q 040702           97 ADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLS  176 (797)
Q Consensus        97 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~  176 (797)
                       +..+++|++|+|++|++++.  ..+..+++|++|+|++|+|+++  ..|.++++|++|+|++|.++.+++       +.
T Consensus       108 -l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~-------l~  175 (291)
T 1h6t_A          108 -LKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-------LA  175 (291)
T ss_dssp             -GTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-------GT
T ss_pred             -hccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh-------hc
Confidence             44666666666666666643  3466666666666666666654  456666666666666666665543       44


Q ss_pred             CCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCccc
Q 040702          177 NCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNIS  217 (797)
Q Consensus       177 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~  217 (797)
                      .+++|+.|++++|+++.+ + .+..++ +|+.|++++|.+.
T Consensus       176 ~l~~L~~L~L~~N~i~~l-~-~l~~l~-~L~~L~l~~n~i~  213 (291)
T 1h6t_A          176 GLTKLQNLYLSKNHISDL-R-ALAGLK-NLDVLELFSQECL  213 (291)
T ss_dssp             TCTTCCEEECCSSCCCBC-G-GGTTCT-TCSEEEEEEEEEE
T ss_pred             CCCccCEEECCCCcCCCC-h-hhccCC-CCCEEECcCCccc
Confidence            556666666666666543 1 244444 4444444444443

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.83  E-value=3.7e-20  Score=200.86  Aligned_cols=179  Identities=22%  Similarity=0.210  Sum_probs=152.3

Q ss_pred             CCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCcccc-CCCCccEEEccCccccccCCchhhCCCCCCEEEc
Q 040702           55 MEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADV-RLPNLKELHLWGNNFIGTIPSFIFNASKLSELGL  133 (797)
Q Consensus        55 L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~-~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  133 (797)
                      -+.+++++|+++. +|..+.  +.++.|+|++|+|+ .++...|. .+++|++|+|++|+|+++.+..|.++++|++|+|
T Consensus        20 ~~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~-~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~L   95 (361)
T 2xot_A           20 SNILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDL   95 (361)
T ss_dssp             TTEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCC-EECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEEC
T ss_pred             CCEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCC-ccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEEC
Confidence            3689999999987 565543  46899999999998 77777777 8999999999999999888889999999999999


Q ss_pred             cCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhh---hccccCCcEEE
Q 040702          134 QKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAI---GNLSQSMEDFW  210 (797)
Q Consensus       134 ~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~---~~l~~~L~~L~  210 (797)
                      ++|+|+.+.+..|.++++|++|+|++|+|+.+++.     .|.++++|+.|+|++|+|+++.+..|   ..++ +|+.|+
T Consensus        96 s~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~-----~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~-~L~~L~  169 (361)
T 2xot_A           96 SSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRN-----AFEDMAQLQKLYLSQNQISRFPVELIKDGNKLP-KLMLLD  169 (361)
T ss_dssp             CSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTT-----TTTTCTTCCEEECCSSCCCSCCGGGTC----CT-TCCEEE
T ss_pred             CCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHH-----HhCCcccCCEEECCCCcCCeeCHHHhcCcccCC-cCCEEE
Confidence            99999999999999999999999999999988775     48899999999999999998777766   4566 788999


Q ss_pred             ccCCcccccCChhhhhhhhhHhhhccccccccc
Q 040702          211 MDNCNISGSIPEEINNLTNLILQLLSLEGNQLE  243 (797)
Q Consensus       211 L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~  243 (797)
                      |++|+|++..+..+..++.+.++.|+|++|.+.
T Consensus       170 L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~  202 (361)
T 2xot_A          170 LSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE  202 (361)
T ss_dssp             CCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred             CCCCCCCccCHHHhhhccHhhcceEEecCCCcc
Confidence            999988877777788777755577888888776

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.83  E-value=3.4e-20  Score=186.13  Aligned_cols=154  Identities=22%  Similarity=0.223  Sum_probs=138.0

Q ss_pred             CCCCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCE
Q 040702            2 PSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKS   81 (797)
Q Consensus         2 ~~l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~   81 (797)
                      +|+++|.+++ +|..+  ...+++|+|++|++++..|.       ..+..+++|++|+|++|+|+++.+.+|.++++|++
T Consensus        16 l~~s~n~l~~-iP~~~--~~~~~~L~L~~N~l~~~~~~-------~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~   85 (220)
T 2v70_A           16 VDCSNQKLNK-IPEHI--PQYTAELRLNNNEFTVLEAT-------GIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNE   85 (220)
T ss_dssp             EECCSSCCSS-CCSCC--CTTCSEEECCSSCCCEECCC-------CCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred             eEeCCCCccc-CccCC--CCCCCEEEcCCCcCCccCch-------hhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCE
Confidence            5789999987 45544  45679999999997655432       34788999999999999999999999999999999


Q ss_pred             EEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCcc
Q 040702           82 LYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNY  161 (797)
Q Consensus        82 L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~  161 (797)
                      |+|++|+|+ .++...|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|+++.|..|..+++|++|+|++|.
T Consensus        86 L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~  164 (220)
T 2v70_A           86 ILLTSNRLE-NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANP  164 (220)
T ss_dssp             EECCSSCCC-CCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCC
T ss_pred             EECCCCccC-ccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcC
Confidence            999999998 7888888899999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CcCCC
Q 040702          162 LTSST  166 (797)
Q Consensus       162 l~~~~  166 (797)
                      ++...
T Consensus       165 l~c~c  169 (220)
T 2v70_A          165 FNCNC  169 (220)
T ss_dssp             EECSG
T ss_pred             CcCCC
Confidence            98643

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.82  E-value=1.2e-19  Score=183.26  Aligned_cols=154  Identities=23%  Similarity=0.236  Sum_probs=120.3

Q ss_pred             CCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCC
Q 040702           23 LQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLP  102 (797)
Q Consensus        23 L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~  102 (797)
                      -+.+|.+++.         ++++|..+.  ++|++|+|++|+|+++.|..|.++++|++|+|++|+|+ .+|...|..++
T Consensus        21 ~~~v~c~~~~---------l~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~-~i~~~~~~~l~   88 (229)
T 3e6j_A           21 GTTVDCRSKR---------HASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLT   88 (229)
T ss_dssp             TTEEECTTSC---------CSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCT
T ss_pred             CCEeEccCCC---------cCccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCC-CcChhhcccCC
Confidence            4578888887         445565554  67888888888888888888888888888888888886 77777777888


Q ss_pred             CccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCc
Q 040702          103 NLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLE  182 (797)
Q Consensus       103 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~  182 (797)
                      +|++|+|++|+|++..+..|..+++|++|+|++|+|+ .+|..+.++++|++|+|++|+|+.+++.     .|..+++|+
T Consensus        89 ~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~-----~~~~l~~L~  162 (229)
T 3e6j_A           89 QLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHG-----AFDRLSSLT  162 (229)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTT-----TTTTCTTCC
T ss_pred             CcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHH-----HHhCCCCCC
Confidence            8888888888888777777788888888888888888 4466778888888888888888877764     367777788


Q ss_pred             EEEccCCCCCCC
Q 040702          183 YFSFSNNPLGGI  194 (797)
Q Consensus       183 ~L~Ls~N~l~~~  194 (797)
                      .|+|++|++.+.
T Consensus       163 ~L~l~~N~~~c~  174 (229)
T 3e6j_A          163 HAYLFGNPWDCE  174 (229)
T ss_dssp             EEECTTSCBCTT
T ss_pred             EEEeeCCCccCC
Confidence            888888877654

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.82  E-value=3.2e-20  Score=213.54  Aligned_cols=183  Identities=21%  Similarity=0.287  Sum_probs=110.9

Q ss_pred             CCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEE
Q 040702            4 LTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLY   83 (797)
Q Consensus         4 l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~   83 (797)
                      |+++.+.+.++  +..+.+|++|+|++|.++         .+| .+..+++|+.|+|++|+|.++.|  |.++++|+.|+
T Consensus        28 l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~---------~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~   93 (605)
T 1m9s_A           28 LKKKSVTDAVT--QNELNSIDQIIANNSDIK---------SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLF   93 (605)
T ss_dssp             TTCSCTTSEEC--HHHHTTCCCCBCTTCCCC---------CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEE
T ss_pred             ccCCCcccccc--hhcCCCCCEEECcCCCCC---------CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEE
Confidence            34444444433  456667777777777633         233 35666677777777777766544  66677777777


Q ss_pred             ccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCc
Q 040702           84 LHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLT  163 (797)
Q Consensus        84 Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~  163 (797)
                      |++|.|+ .+|  .+..+++|++|+|++|+|.+.  ..+..+++|+.|+|++|+|+++  ..|..+++|+.|+|++|.|+
T Consensus        94 Ls~N~l~-~l~--~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~  166 (605)
T 1m9s_A           94 LDENKIK-DLS--SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS  166 (605)
T ss_dssp             CCSSCCC-CCT--TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCC
T ss_pred             CcCCCCC-CCh--hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCC
Confidence            7777776 444  244666677777777766642  3466666667777766666654  45666666666666666666


Q ss_pred             CCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCccc
Q 040702          164 SSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNIS  217 (797)
Q Consensus       164 ~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~  217 (797)
                      .+++       +..+++|+.|+|++|+|.++  ..+..++ +|+.|+|++|.+.
T Consensus       167 ~~~~-------l~~l~~L~~L~Ls~N~i~~l--~~l~~l~-~L~~L~L~~N~l~  210 (605)
T 1m9s_A          167 DIVP-------LAGLTKLQNLYLSKNHISDL--RALAGLK-NLDVLELFSQECL  210 (605)
T ss_dssp             CCGG-------GTTCTTCCEEECCSSCCCBC--GGGTTCT-TCSEEECCSEEEE
T ss_pred             Cchh-------hccCCCCCEEECcCCCCCCC--hHHccCC-CCCEEEccCCcCc
Confidence            5543       44556666666666666643  2355554 5555555555554

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.81  E-value=1.8e-19  Score=180.81  Aligned_cols=154  Identities=18%  Similarity=0.232  Sum_probs=137.3

Q ss_pred             CCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEcc
Q 040702           55 MEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQ  134 (797)
Q Consensus        55 L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  134 (797)
                      -+.+++++|+++.+ |..+.  ++|+.|+|++|+|+ .++...|..+++|++|+|++|+|++..|..|.++++|++|+|+
T Consensus        13 ~~~v~c~~~~l~~i-P~~l~--~~l~~L~l~~n~i~-~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls   88 (220)
T 2v9t_B           13 NNIVDCRGKGLTEI-PTNLP--ETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLY   88 (220)
T ss_dssp             TTEEECTTSCCSSC-CSSCC--TTCCEEECCSSCCC-EECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECC
T ss_pred             CCEEEcCCCCcCcC-CCccC--cCCCEEECCCCcCC-CcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECC
Confidence            36799999999874 55543  68999999999998 7888788899999999999999998889999999999999999


Q ss_pred             CCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCC
Q 040702          135 KNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNC  214 (797)
Q Consensus       135 ~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n  214 (797)
                      +|+|+.+.+..|.++++|++|+|++|+|+.+++.     .|..+++|+.|+|++|+|+++.+..|..++ +|+.|++++|
T Consensus        89 ~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~-----~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~L~~N  162 (220)
T 2v9t_B           89 GNKITELPKSLFEGLFSLQLLLLNANKINCLRVD-----AFQDLHNLNLLSLYDNKLQTIAKGTFSPLR-AIQTMHLAQN  162 (220)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT-----TTTTCTTCCEEECCSSCCSCCCTTTTTTCT-TCCEEECCSS
T ss_pred             CCcCCccCHhHccCCCCCCEEECCCCCCCEeCHH-----HcCCCCCCCEEECCCCcCCEECHHHHhCCC-CCCEEEeCCC
Confidence            9999998888999999999999999999998876     488899999999999999999888898887 8999999999


Q ss_pred             cccc
Q 040702          215 NISG  218 (797)
Q Consensus       215 ~i~~  218 (797)
                      .+..
T Consensus       163 ~~~c  166 (220)
T 2v9t_B          163 PFIC  166 (220)
T ss_dssp             CEEC
T ss_pred             CcCC
Confidence            8874

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.81  E-value=3.3e-20  Score=194.72  Aligned_cols=142  Identities=21%  Similarity=0.312  Sum_probs=77.4

Q ss_pred             EEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCC
Q 040702           57 WMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKN  136 (797)
Q Consensus        57 ~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  136 (797)
                      .+.+..+.+.++.+  +..+++|+.|++++|.++ .++.  +..+++|++|+|++|++++..+  +..+++|++|+|++|
T Consensus        28 ~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~-~~~~--~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n  100 (291)
T 1h6t_A           28 KDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG--IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDEN  100 (291)
T ss_dssp             HHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCC-CCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred             HHHhcCCCcccccc--hhhcCcccEEEccCCCcc-cChh--HhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCC
Confidence            33445555544322  334566666666666665 4443  3456666666666666664433  666666666666666


Q ss_pred             cCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcc
Q 040702          137 SFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNI  216 (797)
Q Consensus       137 ~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i  216 (797)
                      +|+++.  .|.++++|++|+|++|+++.++       .+..+++|+.|++++|+++++  ..+..++ +|+.|++++|.+
T Consensus       101 ~l~~~~--~l~~l~~L~~L~L~~n~i~~~~-------~l~~l~~L~~L~l~~n~l~~~--~~l~~l~-~L~~L~L~~N~l  168 (291)
T 1h6t_A          101 KVKDLS--SLKDLKKLKSLSLEHNGISDIN-------GLVHLPQLESLYLGNNKITDI--TVLSRLT-KLDTLSLEDNQI  168 (291)
T ss_dssp             CCCCGG--GGTTCTTCCEEECTTSCCCCCG-------GGGGCTTCCEEECCSSCCCCC--GGGGGCT-TCSEEECCSSCC
T ss_pred             cCCCCh--hhccCCCCCEEECCCCcCCCCh-------hhcCCCCCCEEEccCCcCCcc--hhhccCC-CCCEEEccCCcc
Confidence            666432  2666666666666666665542       245556666666666666544  3344443 344444444433


Q ss_pred             c
Q 040702          217 S  217 (797)
Q Consensus       217 ~  217 (797)
                      +
T Consensus       169 ~  169 (291)
T 1h6t_A          169 S  169 (291)
T ss_dssp             C
T ss_pred             c
Confidence            3

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.81  E-value=4.5e-20  Score=212.28  Aligned_cols=190  Identities=23%  Similarity=0.297  Sum_probs=93.4

Q ss_pred             CEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccC
Q 040702           56 EWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQK  135 (797)
Q Consensus        56 ~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  135 (797)
                      ..+.++.+.+..+.+  +..+++|+.|+|++|.|+ .+|.  +..+++|++|+|++|+|++..+  +..+++|+.|+|++
T Consensus        24 ~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~-~l~~--l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~   96 (605)
T 1m9s_A           24 IKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG--IQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDE   96 (605)
T ss_dssp             HHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCC-CCTT--GGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCS
T ss_pred             HHHhccCCCcccccc--hhcCCCCCEEECcCCCCC-CChH--HccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcC
Confidence            334444444444322  334455555555555554 4432  3345555555555555554333  55555555555555


Q ss_pred             CcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCc
Q 040702          136 NSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCN  215 (797)
Q Consensus       136 N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~  215 (797)
                      |+|+++.  .|..+++|++|+|++|.|+.++       .+..+++|+.|+|++|++.++  ..+..++ +|+.|+|++|.
T Consensus        97 N~l~~l~--~l~~l~~L~~L~Ls~N~l~~l~-------~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~-~L~~L~Ls~N~  164 (605)
T 1m9s_A           97 NKIKDLS--SLKDLKKLKSLSLEHNGISDIN-------GLVHLPQLESLYLGNNKITDI--TVLSRLT-KLDTLSLEDNQ  164 (605)
T ss_dssp             SCCCCCT--TSTTCTTCCEEECTTSCCCCCG-------GGGGCTTCSEEECCSSCCCCC--GGGGSCT-TCSEEECCSSC
T ss_pred             CCCCCCh--hhccCCCCCEEEecCCCCCCCc-------cccCCCccCEEECCCCccCCc--hhhcccC-CCCEEECcCCc
Confidence            5555321  3555555555555555555432       144455555555555555543  3344443 44444444444


Q ss_pred             ccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccC
Q 040702          216 ISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFV  270 (797)
Q Consensus       216 i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  270 (797)
                      +.+..|  +..+++|  +.|+|++|+|+++  ..+..+++|+.|+|++|++...+
T Consensus       165 l~~~~~--l~~l~~L--~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p  213 (605)
T 1m9s_A          165 ISDIVP--LAGLTKL--QNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKP  213 (605)
T ss_dssp             CCCCGG--GTTCTTC--CEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCC
T ss_pred             CCCchh--hccCCCC--CEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCc
Confidence            443333  3444444  5555555555533  23555666666666666665443

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.80  E-value=1.9e-20  Score=200.42  Aligned_cols=263  Identities=13%  Similarity=0.067  Sum_probs=161.1

Q ss_pred             CCCCCEEEcccCccc--ccCCccccCCCCCCEEEccCCcCcccCCCccccC--------CCCccEEEccCccccccCCch
Q 040702           52 LHNMEWMAFSFNKVV--GVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVR--------LPNLKELHLWGNNFIGTIPSF  121 (797)
Q Consensus        52 l~~L~~L~ls~N~i~--~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~--------l~~L~~L~L~~N~l~~~~~~~  121 (797)
                      +++|++|||++|+|.  ...+..+   +.++.+.+..|    .+|..+|.+        +++|++|+|.+ +++.+.+.+
T Consensus        48 l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~----~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~a  119 (329)
T 3sb4_A           48 FPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMAN----FVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAA  119 (329)
T ss_dssp             CTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTT----EECTTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTT
T ss_pred             hccCeEEecCcceeEEecCccccc---ccccccccccc----ccCHHHhcccccccccccCCCcEEECCc-cccchhHHH
Confidence            566777777777766  3222222   22444555555    345666666        67777777766 666566666


Q ss_pred             hhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccC----cCCCCCccccccCCCCCCCc-EEEccCCCCCCCCC
Q 040702          122 IFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYL----TSSTPELSSLSSLSNCKYLE-YFSFSNNPLGGILP  196 (797)
Q Consensus       122 ~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l----~~~~~~~~~~~~l~~l~~L~-~L~Ls~N~l~~~~~  196 (797)
                      |.++++|++|+|++|.+..+.+.+|.++.++..+.+..+..    ..+...     .|.++..|+ .+.+....   ..+
T Consensus       120 F~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~-----~f~~~~~L~~~i~~~~~~---~l~  191 (329)
T 3sb4_A          120 FKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHF-----AFIEGEPLETTIQVGAMG---KLE  191 (329)
T ss_dssp             TTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTS-----CEEESCCCEEEEEECTTC---CHH
T ss_pred             hhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccc-----ccccccccceeEEecCCC---cHH
Confidence            66677777777777766666666676666666665555322    111111     233444444 33332211   111


Q ss_pred             hhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhh-cCCCCCcEEEccCCcCcccCCCCcc
Q 040702          197 RAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDL-CRLAALFQLDLGGNKLSGFVPACSG  275 (797)
Q Consensus       197 ~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~Ls~N~l~~~~~~~~~  275 (797)
                      ..+....                     -...++  +.+.+.++-.. .....+ ..+++|+.++|++|+++.+.+.+|.
T Consensus       192 ~~~~~~~---------------------~~~~~~--~~l~~~~~l~~-~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~  247 (329)
T 3sb4_A          192 DEIMKAG---------------------LQPRDI--NFLTIEGKLDN-ADFKLIRDYMPNLVSLDISKTNATTIPDFTFA  247 (329)
T ss_dssp             HHHHHTT---------------------CCGGGC--SEEEEEECCCH-HHHHHHHHHCTTCCEEECTTBCCCEECTTTTT
T ss_pred             HHHhhcc---------------------cCcccc--ceEEEeeeecH-HHHHHHHHhcCCCeEEECCCCCcceecHhhhh
Confidence            1111000                     001111  23333322111 111111 1367888888888888888888888


Q ss_pred             CCccccccccCCCCCCCCCC-CCCCCCccc-EEEccCCcCCCCCCccccccccccEEeccCcccccccCccccCCcccce
Q 040702          276 NLTNLRKLYLGSNLLTSIPS-TLWNLKDIL-HLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQY  353 (797)
Q Consensus       276 ~l~~L~~L~L~~N~l~~lp~-~~~~l~~L~-~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~  353 (797)
                      ++++|+.++|++| ++.|+. +|.++++|+ .+++++ .++.+.+.+|.++++|+.+++++|.++.+.+.+|.++++|+.
T Consensus       248 ~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~  325 (329)
T 3sb4_A          248 QKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKL  325 (329)
T ss_dssp             TCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCE
T ss_pred             CCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhh
Confidence            8888998888887 877866 666788888 888888 777777888999999999999999998888889999999988


Q ss_pred             ecc
Q 040702          354 LFL  356 (797)
Q Consensus       354 L~L  356 (797)
                      ++.
T Consensus       326 ly~  328 (329)
T 3sb4_A          326 IYK  328 (329)
T ss_dssp             EEC
T ss_pred             hcc
Confidence            864

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.80  E-value=1.8e-20  Score=221.08  Aligned_cols=225  Identities=20%  Similarity=0.221  Sum_probs=100.3

Q ss_pred             CCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCcccc
Q 040702           20 PSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADV   99 (797)
Q Consensus        20 l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~   99 (797)
                      .+.++.|+|++|.+... |..++..+  .++.+ ++..++++.|++. +.|..|..+++|+.|+|++|.|. .+|..+| 
T Consensus       172 ~~~~~~l~L~~n~~~~~-~~~~l~~l--~Ls~~-~i~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~-  244 (727)
T 4b8c_D          172 TPLTPKIELFANGKDEA-NQALLQHK--KLSQY-SIDEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIF-  244 (727)
T ss_dssp             -------------------------------------------------------CCCCCCEEECTTSCCS-CCCGGGG-
T ss_pred             CCccceEEeeCCCCCcc-hhhHhhcC--ccCcc-cccCcccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhc-
Confidence            35678888888875432 21111100  00000 1222333344443 45777777888888888888887 7777776 


Q ss_pred             CCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCC
Q 040702          100 RLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCK  179 (797)
Q Consensus       100 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~  179 (797)
                      .+++|++|+|++|.|+ .+|..|.++++|++|+|++|+|+ .+|..|++|++|++|+|++|.|+.+|..      |..++
T Consensus       245 ~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~lp~~------~~~l~  316 (727)
T 4b8c_D          245 KYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVTTLPWE------FGNLC  316 (727)
T ss_dssp             GCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCCCCCSS------TTSCT
T ss_pred             CCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCCccChh------hhcCC
Confidence            6778888888888877 66777777888888888888877 4477777777888888888777776653      66677


Q ss_pred             CCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEE
Q 040702          180 YLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQL  259 (797)
Q Consensus       180 ~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  259 (797)
                      +|+.|+|++|+|.+.+|..+..+.                         .. ...|+|++|.+++.+|..      |..|
T Consensus       317 ~L~~L~L~~N~l~~~~p~~~~~~~-------------------------~~-~~~l~l~~N~l~~~~p~~------l~~l  364 (727)
T 4b8c_D          317 NLQFLGVEGNPLEKQFLKILTEKS-------------------------VT-GLIFYLRDNRPEIPLPHE------RRFI  364 (727)
T ss_dssp             TCCCEECTTSCCCSHHHHHHHHHH-------------------------HH-HHHHHHHHCCCCCCCCCC----------
T ss_pred             CccEEeCCCCccCCCChHHHhhcc-------------------------hh-hhHHhhccCcccCcCccc------ccee
Confidence            777777777777766665554432                         11 134667777776665543      3444


Q ss_pred             EccCC--------cCcccCCCCccCCccccccccCCCCCC
Q 040702          260 DLGGN--------KLSGFVPACSGNLTNLRKLYLGSNLLT  291 (797)
Q Consensus       260 ~Ls~N--------~l~~~~~~~~~~l~~L~~L~L~~N~l~  291 (797)
                      +++.|        .+....+..+..+..++...+++|.+.
T Consensus       365 ~l~~n~~~~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~  404 (727)
T 4b8c_D          365 EINTDGEPQREYDSLQQSTEHLATDLAKRTFTVLSYNTLC  404 (727)
T ss_dssp             -------------------------------------CCC
T ss_pred             EeecccccccccCCccccccchhhcccccceeeeeccccc
Confidence            55555        333344444555666667777777663

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.79  E-value=1.1e-19  Score=187.60  Aligned_cols=163  Identities=18%  Similarity=0.276  Sum_probs=111.3

Q ss_pred             CCCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEE
Q 040702            3 SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSL   82 (797)
Q Consensus         3 ~l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L   82 (797)
                      +|++|.+++..  .+..+++|++|+|++|++         +++| .+..+++|++|++++|+|+++.+  |.++++|+.|
T Consensus        25 ~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i---------~~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L   90 (263)
T 1xeu_A           25 NLGKQSVTDLV--SQKELSGVQNFNGDNSNI---------QSLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL   90 (263)
T ss_dssp             HHTCSCTTSEE--CHHHHTTCSEEECTTSCC---------CCCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred             HhcCCCccccc--chhhcCcCcEEECcCCCc---------ccch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence            45666666554  466777777777777763         3344 56677777777777777776544  7777777777


Q ss_pred             EccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccC
Q 040702           83 YLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYL  162 (797)
Q Consensus        83 ~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l  162 (797)
                      +|++|+++ .+|...+   ++|++|+|++|++++.  ..+..+++|++|+|++|+|+++.  .|..+++|++|+|++|+|
T Consensus        91 ~L~~N~l~-~l~~~~~---~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~~--~l~~l~~L~~L~L~~N~i  162 (263)
T 1xeu_A           91 SVNRNRLK-NLNGIPS---ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSIV--MLGFLSKLEVLDLHGNEI  162 (263)
T ss_dssp             ECCSSCCS-CCTTCCC---SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBCG--GGGGCTTCCEEECTTSCC
T ss_pred             ECCCCccC-CcCcccc---CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCCh--HHccCCCCCEEECCCCcC
Confidence            77777776 5554332   7777777777777653  34677777777777777777652  577777777777777777


Q ss_pred             cCCCCCccccccCCCCCCCcEEEccCCCCCCC
Q 040702          163 TSSTPELSSLSSLSNCKYLEYFSFSNNPLGGI  194 (797)
Q Consensus       163 ~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~  194 (797)
                      +.+ .      .+..+++|+.|++++|++.+.
T Consensus       163 ~~~-~------~l~~l~~L~~L~l~~N~~~~~  187 (263)
T 1xeu_A          163 TNT-G------GLTRLKKVNWIDLTGQKCVNE  187 (263)
T ss_dssp             CBC-T------TSTTCCCCCEEEEEEEEEECC
T ss_pred             cch-H------HhccCCCCCEEeCCCCcccCC
Confidence            766 1      266667777777777776654

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.79  E-value=4.1e-21  Score=219.62  Aligned_cols=166  Identities=28%  Similarity=0.236  Sum_probs=101.4

Q ss_pred             ccccCChhhhhhhhhHhhhcc-cccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCC
Q 040702          216 ISGSIPEEINNLTNLILQLLS-LEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIP  294 (797)
Q Consensus       216 i~~~~p~~~~~l~~L~L~~L~-Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp  294 (797)
                      +.+..|..++++++|  +.|+ ++.|.+.           +|..+.+++|.++.+.+.      .|+.|+|++|.|+.+|
T Consensus       397 ~~~~~~~~l~~l~~L--~~L~~l~~n~~~-----------~L~~l~l~~n~i~~l~~~------~L~~L~Ls~n~l~~lp  457 (567)
T 1dce_A          397 PLLYEKETLQYFSTL--KAVDPMRAAYLD-----------DLRSKFLLENSVLKMEYA------DVRVLHLAHKDLTVLC  457 (567)
T ss_dssp             TGGGHHHHHHHHHHH--HHHCGGGHHHHH-----------HHHHHHHHHHHHHHHHHT------TCSEEECTTSCCSSCC
T ss_pred             cccCCHHHHHHHHhc--ccCcchhhcccc-----------hhhhhhhhcccccccCcc------CceEEEecCCCCCCCc
Confidence            445666777777776  7776 5665543           233445555555543221      3566666666666666


Q ss_pred             CCCCCCCcccEEEccCCcCCCCCCccccccccccEEeccCcccccccCccccCCcccceecccCccccCCC-Chhhhccc
Q 040702          295 STLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSI-PNSIGDLI  373 (797)
Q Consensus       295 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~  373 (797)
                      . +..+++|+.|+|++|.|+ .+|..|+.+++|+.|+|++|+|++ +| .|+++++|+.|+|++|+|++.. |..++.++
T Consensus       458 ~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~  533 (567)
T 1dce_A          458 H-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCP  533 (567)
T ss_dssp             C-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCT
T ss_pred             C-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCC
Confidence            5 666666666666666666 455566666666666666666665 34 5666666666666666666554 66666666


Q ss_pred             cCCeeeecCCcCCCCCCh---hhhccCCCCeEEc
Q 040702          374 SLKSLNLSNNNLSGTIPI---SLEKLLDLKDINV  404 (797)
Q Consensus       374 ~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~l  404 (797)
                      +|+.|+|++|++++.+|.   .+..+++|+.|++
T Consensus       534 ~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l  567 (567)
T 1dce_A          534 RLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT  567 (567)
T ss_dssp             TCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred             CCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence            677777777766655442   2334666666653

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=99.79  E-value=3.8e-20  Score=198.15  Aligned_cols=288  Identities=15%  Similarity=0.115  Sum_probs=203.6

Q ss_pred             CCCCCEEEcccCcccccCCccccC-CCCCCEEEccCCcCcc-cCCCccccCCCCccEEEccCccccccCCchhhC-----
Q 040702           52 LHNMEWMAFSFNKVVGVVPTTIFN-VSTLKSLYLHSNSLSG-RLPSSADVRLPNLKELHLWGNNFIGTIPSFIFN-----  124 (797)
Q Consensus        52 l~~L~~L~ls~N~i~~~~p~~~~~-l~~L~~L~Ls~N~l~~-~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~-----  124 (797)
                      +.+++.|.++++ +....-..+.. +++|+.|||++|+|.. ..+...   ++.+..+.+..|.   +.+.+|.+     
T Consensus        24 ~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~~~~~~~~~---~~~~~~~~~~~~~---I~~~aF~~~~~~~   96 (329)
T 3sb4_A           24 ANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIKMYSGKAGT---YPNGKFYIYMANF---VPAYAFSNVVNGV   96 (329)
T ss_dssp             HHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEECCEEESSSS---SGGGCCEEECTTE---ECTTTTEEEETTE
T ss_pred             hCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeEEecCcccc---ccccccccccccc---cCHHHhccccccc
Confidence            557888888864 22222223333 7889999999999871 112222   3335666776664   44567888     


Q ss_pred             ---CCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCC----CCCCCCCh
Q 040702          125 ---ASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNN----PLGGILPR  197 (797)
Q Consensus       125 ---l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N----~l~~~~~~  197 (797)
                         +++|++|+|.+ .++.+.+.+|.++++|+.|++++|.++.+++.     .|.++.++..+.+..+    ....+...
T Consensus        97 ~~g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~~i~~~-----aF~~~~~l~~l~~~~~~~~~~~~~i~~~  170 (329)
T 3sb4_A           97 TKGKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAPNLLPE-----ALADSVTAIFIPLGSSDAYRFKNRWEHF  170 (329)
T ss_dssp             EEECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCCEECTT-----SSCTTTCEEEECTTCTHHHHTSTTTTTS
T ss_pred             ccccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCccccchh-----hhcCCCceEEecCcchhhhhcccccccc
Confidence               99999999999 88889999999999999999999999888876     4777777777766652    22334444


Q ss_pred             hhhccccCCc-EEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccC
Q 040702          198 AIGNLSQSME-DFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGN  276 (797)
Q Consensus       198 ~~~~l~~~L~-~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~  276 (797)
                      +|.++. .|+ .+.+....          .++..               .........++..+.+.++-...........
T Consensus       171 ~f~~~~-~L~~~i~~~~~~----------~l~~~---------------~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~  224 (329)
T 3sb4_A          171 AFIEGE-PLETTIQVGAMG----------KLEDE---------------IMKAGLQPRDINFLTIEGKLDNADFKLIRDY  224 (329)
T ss_dssp             CEEESC-CCEEEEEECTTC----------CHHHH---------------HHHTTCCGGGCSEEEEEECCCHHHHHHHHHH
T ss_pred             cccccc-ccceeEEecCCC----------cHHHH---------------HhhcccCccccceEEEeeeecHHHHHHHHHh
Confidence            555544 343 23222111          11111               0000112345566666655322111111123


Q ss_pred             CccccccccCCCCCCCCCC-CCCCCCcccEEEccCCcCCCCCCcccccccccc-EEeccCcccccccCccccCCccccee
Q 040702          277 LTNLRKLYLGSNLLTSIPS-TLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLV-QLDLSMNNFSCVIPTKIGGLKDLQYL  354 (797)
Q Consensus       277 l~~L~~L~L~~N~l~~lp~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~~~~~~~l~~L~~L  354 (797)
                      +++|+.++|++|.++.+|. .|.++.+|+.+++++| ++.+.+.+|.++++|+ .+++.+ .++.+.+.+|.++++|+.|
T Consensus       225 ~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l  302 (329)
T 3sb4_A          225 MPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYV  302 (329)
T ss_dssp             CTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEE
T ss_pred             cCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEE
Confidence            7899999999999999987 6778999999999998 8878889999999999 999998 7887889999999999999


Q ss_pred             cccCccccCCCChhhhccccCCeeee
Q 040702          355 FLEYNRLQGSIPNSIGDLISLKSLNL  380 (797)
Q Consensus       355 ~Ls~N~l~~~~p~~~~~l~~L~~L~L  380 (797)
                      ++++|+++...+.+|.++++|+.++.
T Consensus       303 ~l~~n~i~~I~~~aF~~~~~L~~ly~  328 (329)
T 3sb4_A          303 LATGDKITTLGDELFGNGVPSKLIYK  328 (329)
T ss_dssp             EECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred             EeCCCccCccchhhhcCCcchhhhcc
Confidence            99999999888889999999999874

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.78  E-value=1.6e-18  Score=175.11  Aligned_cols=155  Identities=24%  Similarity=0.210  Sum_probs=135.2

Q ss_pred             CCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEcc
Q 040702           55 MEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQ  134 (797)
Q Consensus        55 L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~  134 (797)
                      .+.++++++++..+ |..+.  ++|++|+|++|+|+ .++...|..+++|++|+|++|+|+.+.+..|..+++|++|+|+
T Consensus        21 ~~~v~c~~~~l~~i-p~~~~--~~L~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls   96 (229)
T 3e6j_A           21 GTTVDCRSKRHASV-PAGIP--TNAQILYLHDNQIT-KLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLG   96 (229)
T ss_dssp             TTEEECTTSCCSSC-CSCCC--TTCSEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCEeEccCCCcCcc-CCCCC--CCCCEEEcCCCccC-ccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECC
Confidence            67899999999864 54443  88999999999998 6666677889999999999999987777888999999999999


Q ss_pred             CCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCC
Q 040702          135 KNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNC  214 (797)
Q Consensus       135 ~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n  214 (797)
                      +|+|+++.+..|.++++|++|+|++|+|+.++..      +..+++|+.|+|++|+|+++.+..|..++ +|+.|++++|
T Consensus        97 ~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~lp~~------~~~l~~L~~L~L~~N~l~~~~~~~~~~l~-~L~~L~l~~N  169 (229)
T 3e6j_A           97 TNQLTVLPSAVFDRLVHLKELFMCCNKLTELPRG------IERLTHLTHLALDQNQLKSIPHGAFDRLS-SLTHAYLFGN  169 (229)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCSCCTT------GGGCTTCSEEECCSSCCCCCCTTTTTTCT-TCCEEECTTS
T ss_pred             CCcCCccChhHhCcchhhCeEeccCCcccccCcc------cccCCCCCEEECCCCcCCccCHHHHhCCC-CCCEEEeeCC
Confidence            9999999899999999999999999999988765      67788999999999999988888888887 8999999999


Q ss_pred             cccccC
Q 040702          215 NISGSI  220 (797)
Q Consensus       215 ~i~~~~  220 (797)
                      .+....
T Consensus       170 ~~~c~c  175 (229)
T 3e6j_A          170 PWDCEC  175 (229)
T ss_dssp             CBCTTB
T ss_pred             CccCCc
Confidence            988543

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.78  E-value=7.3e-19  Score=173.26  Aligned_cols=151  Identities=14%  Similarity=0.211  Sum_probs=67.5

Q ss_pred             CCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEE
Q 040702           52 LHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSEL  131 (797)
Q Consensus        52 l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  131 (797)
                      +++|+.|++++|+++. +| .+..+++|++|++++|.++ .++  .+..+++|++|+|++|++++..+..|..+++|++|
T Consensus        43 l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~n~~~-~~~--~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L  117 (197)
T 4ezg_A           43 MNSLTYITLANINVTD-LT-GIEYAHNIKDLTINNIHAT-NYN--PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL  117 (197)
T ss_dssp             HHTCCEEEEESSCCSC-CT-TGGGCTTCSEEEEESCCCS-CCG--GGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEE
T ss_pred             cCCccEEeccCCCccC-hH-HHhcCCCCCEEEccCCCCC-cch--hhhcCCCCCEEEeECCccCcccChhhcCCCCCCEE
Confidence            3444444444444442 22 3444444444444444443 222  22344445555555544444444444444555555


Q ss_pred             EccCCcCcccCCccccCCCCCCeeeccCcc-CcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEE
Q 040702          132 GLQKNSFSGSIPNTFGNLRNLKWLGLNDNY-LTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFW  210 (797)
Q Consensus       132 ~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~-l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~  210 (797)
                      +|++|+|++..+..|.++++|++|+|++|. ++.++       .+..+++|+.|++++|+++++.  .+..++ +|+.|+
T Consensus       118 ~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~-------~l~~l~~L~~L~l~~n~i~~~~--~l~~l~-~L~~L~  187 (197)
T 4ezg_A          118 DISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIM-------PLKTLPELKSLNIQFDGVHDYR--GIEDFP-KLNQLY  187 (197)
T ss_dssp             ECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCG-------GGGGCSSCCEEECTTBCCCCCT--TGGGCS-SCCEEE
T ss_pred             EecCCccCcHhHHHHhhCCCCCEEEccCCCCccccH-------hhcCCCCCCEEECCCCCCcChH--HhccCC-CCCEEE
Confidence            555555544444444455555555555554 43332       1344444555555555544322  344443 455555


Q ss_pred             ccCCccc
Q 040702          211 MDNCNIS  217 (797)
Q Consensus       211 L~~n~i~  217 (797)
                      +++|+|.
T Consensus       188 l~~N~i~  194 (197)
T 4ezg_A          188 AFSQTIG  194 (197)
T ss_dssp             ECBC---
T ss_pred             eeCcccC
Confidence            5555443

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.78  E-value=2.9e-21  Score=220.81  Aligned_cols=216  Identities=18%  Similarity=0.087  Sum_probs=170.5

Q ss_pred             hCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccC-cCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhc
Q 040702          123 FNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYL-TSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGN  201 (797)
Q Consensus       123 ~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l-~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~  201 (797)
                      ...++|+.|+|++|+|+ .+|..++++++|+.|++++|.. ...+.                 .+..+.+.+..|..++.
T Consensus       346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~-----------------ll~~~~~~~~~~~~l~~  407 (567)
T 1dce_A          346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIIL-----------------LMRALDPLLYEKETLQY  407 (567)
T ss_dssp             STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHH-----------------HHHHHCTGGGHHHHHHH
T ss_pred             ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHH-----------------HHHhcccccCCHHHHHH
Confidence            45677888888888887 4577788888888888866642 11100                 01122244567788888


Q ss_pred             cccCCcEEE-ccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccc
Q 040702          202 LSQSMEDFW-MDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNL  280 (797)
Q Consensus       202 l~~~L~~L~-L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L  280 (797)
                      ++ +|+.|+ ++.|.+           .+|  +.+.+++|.+..+.+      ..|+.|+|++|+|+++ |. ++.+++|
T Consensus       408 l~-~L~~L~~l~~n~~-----------~~L--~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~l-p~-~~~l~~L  465 (567)
T 1dce_A          408 FS-TLKAVDPMRAAYL-----------DDL--RSKFLLENSVLKMEY------ADVRVLHLAHKDLTVL-CH-LEQLLLV  465 (567)
T ss_dssp             HH-HHHHHCGGGHHHH-----------HHH--HHHHHHHHHHHHHHH------TTCSEEECTTSCCSSC-CC-GGGGTTC
T ss_pred             HH-hcccCcchhhccc-----------chh--hhhhhhcccccccCc------cCceEEEecCCCCCCC-cC-ccccccC
Confidence            87 788777 555543           344  788889999885433      2489999999999975 55 9999999


Q ss_pred             cccccCCCCCCCCCCCCCCCCcccEEEccCCcCCCCCCccccccccccEEeccCccccccc-CccccCCcccceecccCc
Q 040702          281 RKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVI-PTKIGGLKDLQYLFLEYN  359 (797)
Q Consensus       281 ~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~Ls~N  359 (797)
                      +.|+|++|.|+.+|..+..+++|+.|+|++|.|++ +| .++.+++|+.|+|++|+|++.. |..|+.+++|+.|+|++|
T Consensus       466 ~~L~Ls~N~l~~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N  543 (567)
T 1dce_A          466 THLDLSHNRLRALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN  543 (567)
T ss_dssp             CEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTS
T ss_pred             cEeecCcccccccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCC
Confidence            99999999999999999999999999999999997 56 8999999999999999999887 999999999999999999


Q ss_pred             cccCCCCh---hhhccccCCeeee
Q 040702          360 RLQGSIPN---SIGDLISLKSLNL  380 (797)
Q Consensus       360 ~l~~~~p~---~~~~l~~L~~L~L  380 (797)
                      ++++..|.   .+..+++|+.|++
T Consensus       544 ~l~~~~~~~~~l~~~lp~L~~L~l  567 (567)
T 1dce_A          544 SLCQEEGIQERLAEMLPSVSSILT  567 (567)
T ss_dssp             GGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred             cCCCCccHHHHHHHHCcccCccCC
Confidence            99976553   3455899999875

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.77  E-value=6.4e-19  Score=181.92  Aligned_cols=172  Identities=21%  Similarity=0.257  Sum_probs=147.7

Q ss_pred             hhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccE
Q 040702          226 NLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILH  305 (797)
Q Consensus       226 ~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~  305 (797)
                      .+.++  ..+++++|.++++.  .+..+++|+.|++++|.++.+ + .+..+++|+.|+|++|.++.+|. +..+++|+.
T Consensus        17 ~l~~l--~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~l-~-~l~~l~~L~~L~L~~N~i~~~~~-l~~l~~L~~   89 (263)
T 1xeu_A           17 GLANA--VKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQSL-A-GMQFFTNLKELHLSHNQISDLSP-LKDLTKLEE   89 (263)
T ss_dssp             HHHHH--HHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG-GTTCSSCCE
T ss_pred             HHHHH--HHHHhcCCCccccc--chhhcCcCcEEECcCCCcccc-h-HHhhCCCCCEEECCCCccCCChh-hccCCCCCE
Confidence            45555  78899999998554  678899999999999999865 3 68899999999999999999887 888999999


Q ss_pred             EEccCCcCCCCCCccccccccccEEeccCcccccccCccccCCcccceecccCccccCCCChhhhccccCCeeeecCCcC
Q 040702          306 LNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNL  385 (797)
Q Consensus       306 L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  385 (797)
                      |++++|++++..+  +.. ++|+.|++++|++++.  ..+..+++|+.|+|++|++++. + .+..+++|+.|+|++|++
T Consensus        90 L~L~~N~l~~l~~--~~~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i  162 (263)
T 1xeu_A           90 LSVNRNRLKNLNG--IPS-ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEI  162 (263)
T ss_dssp             EECCSSCCSCCTT--CCC-SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCC
T ss_pred             EECCCCccCCcCc--ccc-CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcC
Confidence            9999999986543  223 8999999999999864  3588999999999999999864 4 689999999999999999


Q ss_pred             CCCCChhhhccCCCCeEEccCCcCcccC
Q 040702          386 SGTIPISLEKLLDLKDINVSFNRLEGEI  413 (797)
Q Consensus       386 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~  413 (797)
                      ++.  ..+..+++|+.|++++|++++.+
T Consensus       163 ~~~--~~l~~l~~L~~L~l~~N~~~~~~  188 (263)
T 1xeu_A          163 TNT--GGLTRLKKVNWIDLTGQKCVNEP  188 (263)
T ss_dssp             CBC--TTSTTCCCCCEEEEEEEEEECCC
T ss_pred             cch--HHhccCCCCCEEeCCCCcccCCc
Confidence            976  67889999999999999998764

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.77  E-value=8.7e-19  Score=172.70  Aligned_cols=155  Identities=16%  Similarity=0.160  Sum_probs=114.2

Q ss_pred             CCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCc
Q 040702           17 LGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSS   96 (797)
Q Consensus        17 ~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~   96 (797)
                      .+.+++|++|++++|.+         +.+| .+..+++|++|++++|++..  +..+.++++|++|+|++|++++..+..
T Consensus        40 ~~~l~~L~~L~l~~n~i---------~~l~-~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~  107 (197)
T 4ezg_A           40 EAQMNSLTYITLANINV---------TDLT-GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPN  107 (197)
T ss_dssp             HHHHHTCCEEEEESSCC---------SCCT-TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCC
T ss_pred             hhhcCCccEEeccCCCc---------cChH-HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChh
Confidence            35667888888888873         3455 57777888888888887754  346778888888888888887444443


Q ss_pred             cccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCc-CcccCCccccCCCCCCeeeccCccCcCCCCCccccccC
Q 040702           97 ADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNS-FSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSL  175 (797)
Q Consensus        97 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l  175 (797)
                       +..+++|++|+|++|++++..+..|..+++|++|+|++|+ ++.+ | .|.++++|++|++++|.++.++.       +
T Consensus       108 -l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~-~-~l~~l~~L~~L~l~~n~i~~~~~-------l  177 (197)
T 4ezg_A          108 -LSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-M-PLKTLPELKSLNIQFDGVHDYRG-------I  177 (197)
T ss_dssp             -CTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCC-G-GGGGCSSCCEEECTTBCCCCCTT-------G
T ss_pred             -hcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcccc-H-hhcCCCCCCEEECCCCCCcChHH-------h
Confidence             4578888888888888887777788888888888888887 6654 3 58888888888888888877652       6


Q ss_pred             CCCCCCcEEEccCCCCCC
Q 040702          176 SNCKYLEYFSFSNNPLGG  193 (797)
Q Consensus       176 ~~l~~L~~L~Ls~N~l~~  193 (797)
                      ..+++|+.|++++|++.+
T Consensus       178 ~~l~~L~~L~l~~N~i~~  195 (197)
T 4ezg_A          178 EDFPKLNQLYAFSQTIGG  195 (197)
T ss_dssp             GGCSSCCEEEECBC----
T ss_pred             ccCCCCCEEEeeCcccCC
Confidence            677788888888888763

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.76  E-value=7.7e-19  Score=207.17  Aligned_cols=222  Identities=21%  Similarity=0.186  Sum_probs=82.8

Q ss_pred             CCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEE
Q 040702           53 HNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELG  132 (797)
Q Consensus        53 ~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  132 (797)
                      +.++.|+|++|.+... +..     .|+.++|++|.|.+               ++++.|.+. ..+..|..+++|+.|+
T Consensus       173 ~~~~~l~L~~n~~~~~-~~~-----~l~~l~Ls~~~i~~---------------~~~~~n~~~-~~~~~~~~l~~L~~L~  230 (727)
T 4b8c_D          173 PLTPKIELFANGKDEA-NQA-----LLQHKKLSQYSIDE---------------DDDIENRMV-MPKDSKYDDQLWHALD  230 (727)
T ss_dssp             -----------------------------------------------------------------------CCCCCCEEE
T ss_pred             CccceEEeeCCCCCcc-hhh-----HhhcCccCcccccC---------------cccccccee-cChhhhccCCCCcEEE
Confidence            4577788888888763 332     34555666665541               122334433 4455555555555555


Q ss_pred             ccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEcc
Q 040702          133 LQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMD  212 (797)
Q Consensus       133 L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~  212 (797)
                      |++|+|..+. ..+.++++|++|+|++|.|+.+|..      |.++++|++|+|++|+|+ .+|..|+.++ +|+.|+|+
T Consensus       231 Ls~n~l~~l~-~~~~~l~~L~~L~Ls~N~l~~lp~~------~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~-~L~~L~L~  301 (727)
T 4b8c_D          231 LSNLQIFNIS-ANIFKYDFLTRLYLNGNSLTELPAE------IKNLSNLRVLDLSHNRLT-SLPAELGSCF-QLKYFYFF  301 (727)
T ss_dssp             CTTSCCSCCC-GGGGGCCSCSCCBCTTSCCSCCCGG------GGGGTTCCEEECTTSCCS-SCCSSGGGGT-TCSEEECC
T ss_pred             CCCCCCCCCC-hhhcCCCCCCEEEeeCCcCcccChh------hhCCCCCCEEeCcCCcCC-ccChhhcCCC-CCCEEECC
Confidence            5555555332 2233555555555555555544432      445555555555555555 3355555555 56666666


Q ss_pred             CCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCC-CCcEEEccCCcCcccCCCCccCCccccccccCCCC--
Q 040702          213 NCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLA-ALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNL--  289 (797)
Q Consensus       213 ~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~--  289 (797)
                      +|.|+ .+|..|+++++|  ++|+|++|.|++.+|..+..+. .+..|+|++|.+++.+|.      .|+.|++++|.  
T Consensus       302 ~N~l~-~lp~~~~~l~~L--~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~------~l~~l~l~~n~~~  372 (727)
T 4b8c_D          302 DNMVT-TLPWEFGNLCNL--QFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLPH------ERRFIEINTDGEP  372 (727)
T ss_dssp             SSCCC-CCCSSTTSCTTC--CCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCCC------C------------
T ss_pred             CCCCC-ccChhhhcCCCc--cEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCcc------ccceeEeeccccc
Confidence            66554 445556666666  7777777777766666665432 123478999999987775      46677777771  


Q ss_pred             ---CCCCCC----CCCCCCcccEEEccCCcCC
Q 040702          290 ---LTSIPS----TLWNLKDILHLNLSSNFFT  314 (797)
Q Consensus       290 ---l~~lp~----~~~~l~~L~~L~l~~N~l~  314 (797)
                         +..++.    .+..+.++....++.|-+.
T Consensus       373 ~~~~~~l~~~~~~~~~~l~~~~~~~ls~Nil~  404 (727)
T 4b8c_D          373 QREYDSLQQSTEHLATDLAKRTFTVLSYNTLC  404 (727)
T ss_dssp             -----------------------------CCC
T ss_pred             ccccCCccccccchhhcccccceeeeeccccc
Confidence               122322    3344555666677777665

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.75  E-value=1.2e-17  Score=182.77  Aligned_cols=263  Identities=12%  Similarity=0.086  Sum_probs=141.6

Q ss_pred             CCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCee
Q 040702           76 VSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWL  155 (797)
Q Consensus        76 l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L  155 (797)
                      ...++.+.+.+ .++ .|+..+|.+. +|+.+.|..| ++.+...+|.+ .+|+++.|.+ .++.+.+.+|.++++|+.+
T Consensus       112 ~~~l~~i~ip~-~i~-~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l  185 (401)
T 4fdw_A          112 LKGYNEIILPN-SVK-SIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKA  185 (401)
T ss_dssp             CSSCSEEECCT-TCC-EECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEE
T ss_pred             cCCccEEEECC-ccC-EehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCee
Confidence            35566666653 354 5666666553 5777776655 55555566666 3577777764 5666666677777777777


Q ss_pred             eccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhc
Q 040702          156 GLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLL  235 (797)
Q Consensus       156 ~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L  235 (797)
                      +|++|.++.++..     .|. ..+|+.+.|..| +..+...+|.+++ +|+.+.+.+| ++.+                
T Consensus       186 ~l~~n~l~~I~~~-----aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~-~L~~l~l~~~-l~~I----------------  240 (401)
T 4fdw_A          186 DLSKTKITKLPAS-----TFV-YAGIEEVLLPVT-LKEIGSQAFLKTS-QLKTIEIPEN-VSTI----------------  240 (401)
T ss_dssp             ECTTSCCSEECTT-----TTT-TCCCSEEECCTT-CCEECTTTTTTCT-TCCCEECCTT-CCEE----------------
T ss_pred             ecCCCcceEechh-----hEe-ecccCEEEeCCc-hheehhhHhhCCC-CCCEEecCCC-ccCc----------------
Confidence            7777777666654     244 356666666633 5556666666655 5555555542 3323                


Q ss_pred             ccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCC-----CCCC-CCCCCCcccEEEcc
Q 040702          236 SLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLT-----SIPS-TLWNLKDILHLNLS  309 (797)
Q Consensus       236 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-----~lp~-~~~~l~~L~~L~l~  309 (797)
                                ...+|.+ .+|+.+++ .|.++.+...+|.++++|+.+++.+|.+.     .++. .|.++++|+.+++.
T Consensus       241 ----------~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~  308 (401)
T 4fdw_A          241 ----------GQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP  308 (401)
T ss_dssp             ----------CTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC
T ss_pred             ----------ccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC
Confidence                      3333333 34444444 22334344444444444444444444433     2332 34445555555555


Q ss_pred             CCcCCCCCCccccccccccEEeccCcccccccCccccCCcccceecccCccccCCCChhhhccc-cCCeeeecCCc
Q 040702          310 SNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLI-SLKSLNLSNNN  384 (797)
Q Consensus       310 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~  384 (797)
                       +.++.+...+|.++++|+.++|..| ++.+.+.+|.++ +|+.+++++|.+....+..|.+++ +++.|++..+.
T Consensus       309 -~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~  381 (401)
T 4fdw_A          309 -ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAES  381 (401)
T ss_dssp             -TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGG
T ss_pred             -CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHH
Confidence             2344444455555555555555333 444445555555 555555555555544445555553 45555555544

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=99.75  E-value=3.6e-17  Score=178.89  Aligned_cols=264  Identities=11%  Similarity=0.105  Sum_probs=165.1

Q ss_pred             CCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEE
Q 040702           53 HNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELG  132 (797)
Q Consensus        53 ~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~  132 (797)
                      ..++.+.+.+ +++.+.+.+|.+. +|+.+.|.+| ++ .|+..+|.+ .+|+.+.+.. .++.+.+.+|.++++|+.++
T Consensus       113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~-~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~  186 (401)
T 4fdw_A          113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LK-SIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKAD  186 (401)
T ss_dssp             SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CC-EECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEE
T ss_pred             CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-cc-EECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeee
Confidence            4445554432 3445555555553 5666665544 44 555555544 3466666653 44545555566666666666


Q ss_pred             ccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEcc
Q 040702          133 LQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMD  212 (797)
Q Consensus       133 L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~  212 (797)
                      |++|+++.+...+|. .++|+.+.|..| ++.++..     .|.++++|+.+++..| ++.+...+|.+ . +|+.+.+ 
T Consensus       187 l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~-----aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~-~L~~i~l-  255 (401)
T 4fdw_A          187 LSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQ-----AFLKTSQLKTIEIPEN-VSTIGQEAFRE-S-GITTVKL-  255 (401)
T ss_dssp             CTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTT-----TTTTCTTCCCEECCTT-CCEECTTTTTT-C-CCSEEEE-
T ss_pred             cCCCcceEechhhEe-ecccCEEEeCCc-hheehhh-----HhhCCCCCCEEecCCC-ccCcccccccc-C-CccEEEe-
Confidence            666666655555555 355666666533 5555443     3555566666666543 44455555555 2 5666665 


Q ss_pred             CCcccccCChhhhhhhhhHhhhccccccccc-----CCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCC
Q 040702          213 NCNISGSIPEEINNLTNLILQLLSLEGNQLE-----GSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGS  287 (797)
Q Consensus       213 ~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~-----~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  287 (797)
                      .+.++.+...+|.++++|  +.+++.+|.+.     .+.+.+|.++++|+.+++. +.++.+...+|.++++|+.++|..
T Consensus       256 p~~i~~I~~~aF~~c~~L--~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~  332 (401)
T 4fdw_A          256 PNGVTNIASRAFYYCPEL--AEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPA  332 (401)
T ss_dssp             ETTCCEECTTTTTTCTTC--CEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECT
T ss_pred             CCCccEEChhHhhCCCCC--CEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECc
Confidence            334454555556666655  66666665554     4667788888888888888 457777788888888888888855


Q ss_pred             CCCCCCCC-CCCCCCcccEEEccCCcCCCCCCccccccc-cccEEeccCcccc
Q 040702          288 NLLTSIPS-TLWNLKDILHLNLSSNFFTGPLPLKIGNLN-VLVQLDLSMNNFS  338 (797)
Q Consensus       288 N~l~~lp~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~l~  338 (797)
                      | ++.++. +|.++ +|+.+++++|.+....+..|.+++ .++.|++..+.+.
T Consensus       333 ~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~  383 (401)
T 4fdw_A          333 N-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE  383 (401)
T ss_dssp             T-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred             c-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence            4 777755 56667 888888888888777777787774 6788888877765

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.75  E-value=8.3e-19  Score=171.99  Aligned_cols=129  Identities=28%  Similarity=0.329  Sum_probs=71.0

Q ss_pred             cEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCCC--CCCCCcccEEEccCCcCCCCCCccccccccccEEeccC
Q 040702          257 FQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPST--LWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSM  334 (797)
Q Consensus       257 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~--~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~  334 (797)
                      +.+++++|.++.+ |..+.  .+|+.|++++|.++.++..  +..+++|+.|++++|.|++..|..|.++++|++|+|++
T Consensus        11 ~~l~~s~~~l~~i-p~~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLKEI-PRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCSSC-CSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcCcC-ccCCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            4556666666533 33222  2555566666666555442  44555555555555555555555555555555555555


Q ss_pred             cccccccCccccCCcccceecccCccccCCCChhhhccccCCeeeecCCcCCCC
Q 040702          335 NNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGT  388 (797)
Q Consensus       335 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  388 (797)
                      |+|++..+..|.++++|++|+|++|++++..|..|..+++|++|+|++|.+++.
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~  141 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN  141 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence            555555555555555555555555555555555555555555555555555543

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.73  E-value=2e-17  Score=162.05  Aligned_cols=131  Identities=26%  Similarity=0.297  Sum_probs=77.4

Q ss_pred             CEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccC
Q 040702           56 EWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQK  135 (797)
Q Consensus        56 ~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  135 (797)
                      +++++++|+++. +|..+..  +|++|+|++|+|++..+...|..+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus        11 ~~l~~s~~~l~~-ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~   87 (192)
T 1w8a_A           11 TTVDCTGRGLKE-IPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCSS-CCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEcCCCCcCc-CccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence            344555555533 2333222  5555666666555222223455566666666666666666566666666666666666


Q ss_pred             CcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCC
Q 040702          136 NSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGI  194 (797)
Q Consensus       136 N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~  194 (797)
                      |+|+++.+.+|.++++|++|+|++|+|+.+.+.     .|..+++|++|+|++|++.+.
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-----~~~~l~~L~~L~L~~N~l~c~  141 (192)
T 1w8a_A           88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPG-----SFEHLNSLTSLNLASNPFNCN  141 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTT-----SSTTCTTCCEEECTTCCBCCS
T ss_pred             CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHH-----HhhcCCCCCEEEeCCCCccCc
Confidence            666666666666666666666666666666554     356666677777777777654

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.71  E-value=7.6e-18  Score=173.32  Aligned_cols=133  Identities=20%  Similarity=0.255  Sum_probs=101.8

Q ss_pred             CCccccccccCCcceeec-----ceE--EEEEEEEeccCCc------------------------chhHHHHHHHhhhcc
Q 040702          514 FSENNLIGRGGFGPVYKD-----GME--VAIKVFNLQYGGA------------------------FKSFDIECGMMKRIR  562 (797)
Q Consensus       514 f~~~~~lg~G~~g~Vyk~-----~~~--vAvK~~~~~~~~~------------------------~~~~~~E~~~l~~l~  562 (797)
                      |+..+.||+|+||.||++     |+.  ||||+++......                        ...+.+|+.++.+++
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            567899999999999974     567  9999975431110                        125788999999999


Q ss_pred             CCce--eEeeeeeecCCeEEEEEEccCC-C----CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCC
Q 040702          563 HRNL--IKIISSCSNDDFKALVLEYMPL-G----SLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLK  635 (797)
Q Consensus       563 Hpni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlk  635 (797)
                      |+++  +.++++    +..++||||+.+ |    +|.+....    .++..+..++.|++.|+.|||.  +.+|+|||||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~--~~givHrDlk  198 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQ--EAELVHADLS  198 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSCS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCCC
Confidence            8864  344432    356899999942 3    77776433    2234567899999999999994  4689999999


Q ss_pred             CCceEEcCCCcEEEEeecCCccC
Q 040702          636 PSNVLLDDNMVAHLSDFGMAKPL  658 (797)
Q Consensus       636 p~NIll~~~~~~kl~DFGla~~~  658 (797)
                      |+|||++.  .++|+|||+|...
T Consensus       199 p~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          199 EYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TTSEEESS--SEEECCCTTCEET
T ss_pred             HHHEEEcC--cEEEEECcccccC
Confidence            99999998  9999999999753

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.71  E-value=5.5e-17  Score=158.97  Aligned_cols=109  Identities=23%  Similarity=0.304  Sum_probs=61.3

Q ss_pred             CCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeec
Q 040702           78 TLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGL  157 (797)
Q Consensus        78 ~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L  157 (797)
                      +|++|+|++|+|+ .+| ..|..+++|++|+|++|+|+++.+..|.++++|++|+|++|+|+++.+.+|.++++|++|+|
T Consensus        32 ~l~~L~L~~n~i~-~ip-~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~L  109 (193)
T 2wfh_A           32 DVTELYLDGNQFT-LVP-KELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSL  109 (193)
T ss_dssp             TCCEEECCSSCCC-SCC-GGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEEC
T ss_pred             CCCEEECCCCcCc-hhH-HHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCccCEeCHHHhCCCCCCCEEEC
Confidence            4555555555554 444 23345555555555555555555555555555555555555555555555666666666666


Q ss_pred             cCccCcCCCCCccccccCCCCCCCcEEEccCCCCCC
Q 040702          158 NDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGG  193 (797)
Q Consensus       158 ~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~  193 (797)
                      ++|.|+.+++.     .|..+++|+.|+|++|++.+
T Consensus       110 ~~N~l~~~~~~-----~~~~l~~L~~L~L~~N~~~C  140 (193)
T 2wfh_A          110 HGNDISVVPEG-----AFNDLSALSHLAIGANPLYC  140 (193)
T ss_dssp             CSSCCCBCCTT-----TTTTCTTCCEEECCSSCEEC
T ss_pred             CCCCCCeeChh-----hhhcCccccEEEeCCCCeec
Confidence            66666655553     25555666666666666553

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.71  E-value=2.7e-17  Score=157.53  Aligned_cols=137  Identities=22%  Similarity=0.271  Sum_probs=69.1

Q ss_pred             CCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCcccc
Q 040702           20 PSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADV   99 (797)
Q Consensus        20 l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~   99 (797)
                      +++|++|+|++|+++.       ..+|..+..+++|++|++++|+++++  ..|..+++|++|+|++|++++.+| ..+.
T Consensus        23 ~~~L~~L~l~~n~l~~-------~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~   92 (168)
T 2ell_A           23 PAAVRELVLDNCKSND-------GKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLD-MLAE   92 (168)
T ss_dssp             TTSCSEEECCSCBCBT-------TBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCC-HHHH
T ss_pred             cccCCEEECCCCCCCh-------hhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHH-HHHh
Confidence            3555666666655320       12334445555555555555555544  445555555555555555552222 2233


Q ss_pred             CCCCccEEEccCccccccCC-chhhCCCCCCEEEccCCcCcccCC---ccccCCCCCCeeeccCccCcCCC
Q 040702          100 RLPNLKELHLWGNNFIGTIP-SFIFNASKLSELGLQKNSFSGSIP---NTFGNLRNLKWLGLNDNYLTSST  166 (797)
Q Consensus       100 ~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~---~~f~~l~~L~~L~L~~N~l~~~~  166 (797)
                      .+++|++|+|++|++++..+ ..+..+++|++|+|++|+|+++.+   ..|..+++|++|++++|.+.+++
T Consensus        93 ~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~  163 (168)
T 2ell_A           93 KLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEAP  163 (168)
T ss_dssp             HCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBCC
T ss_pred             hCCCCCEEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhcc
Confidence            45555555555555553211 445555555555555555554443   34555555555555555555444

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.69  E-value=5e-17  Score=155.61  Aligned_cols=139  Identities=20%  Similarity=0.155  Sum_probs=116.1

Q ss_pred             CCCCCCEEEcccCccc-ccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCC
Q 040702           51 NLHNMEWMAFSFNKVV-GVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLS  129 (797)
Q Consensus        51 ~l~~L~~L~ls~N~i~-~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~  129 (797)
                      ..++|+.|++++|+++ +.+|..+..+++|++|+|++|.|+ .+  ..+..+++|++|+|++|++++.+|..+..+++|+
T Consensus        22 ~~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~-~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~   98 (168)
T 2ell_A           22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLT   98 (168)
T ss_dssp             CTTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCC-CC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCC
T ss_pred             CcccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCC-Ch--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCC
Confidence            3478999999999998 567888899999999999999998 55  4567899999999999999877888888899999


Q ss_pred             EEEccCCcCcccCC-ccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCC
Q 040702          130 ELGLQKNSFSGSIP-NTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGI  194 (797)
Q Consensus       130 ~L~L~~N~l~~~~~-~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~  194 (797)
                      +|+|++|+|+++.. ..|.++++|++|+|++|.++..++..  ...+..+++|++|++++|.+..+
T Consensus        99 ~L~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~--~~~~~~l~~L~~L~l~~n~~~~~  162 (168)
T 2ell_A           99 HLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYR--ESVFKLLPQLTYLDGYDREDQEA  162 (168)
T ss_dssp             EEECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHH--HHHHTTCSSCCEETTEETTSCBC
T ss_pred             EEeccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHH--HHHHHhCccCcEecCCCCChhhc
Confidence            99999999997643 78999999999999999998887610  00267788899999999988744

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.69  E-value=1.7e-17  Score=160.24  Aligned_cols=148  Identities=20%  Similarity=0.249  Sum_probs=106.5

Q ss_pred             CCCCCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCC-CCCCEEEcccCcccccCCccccCCCCC
Q 040702            1 MPSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNL-HNMEWMAFSFNKVVGVVPTTIFNVSTL   79 (797)
Q Consensus         1 ~~~l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l-~~L~~L~ls~N~i~~~~p~~~~~l~~L   79 (797)
                      |+.|+.+.+..  .+++.++++|++|+|++|+++         .+|. +..+ ++|++|++++|+|+++  ..|.++++|
T Consensus         1 m~~lt~~~i~~--~~~~~~~~~L~~L~l~~n~l~---------~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L   66 (176)
T 1a9n_A            1 MVKLTAELIEQ--AAQYTNAVRDRELDLRGYKIP---------VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRL   66 (176)
T ss_dssp             -CCCCHHHHHT--SCEEECTTSCEEEECTTSCCC---------SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSC
T ss_pred             CccccHHHHHH--HHhcCCcCCceEEEeeCCCCc---------hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCC
Confidence            55666666654  345788889999999999854         3333 3333 3888888888888875  577888888


Q ss_pred             CEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCc--hhhCCCCCCEEEccCCcCcccCCc---cccCCCCCCe
Q 040702           80 KSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPS--FIFNASKLSELGLQKNSFSGSIPN---TFGNLRNLKW  154 (797)
Q Consensus        80 ~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~~~---~f~~l~~L~~  154 (797)
                      ++|+|++|+|+ .+|...|..+++|++|+|++|+|+. +|.  .+..+++|++|+|++|.++.+.+.   .+..+++|++
T Consensus        67 ~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~~~~~~~l~~L~~  144 (176)
T 1a9n_A           67 KTLLVNNNRIC-RIGEGLDQALPDLTELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRV  144 (176)
T ss_dssp             CEEECCSSCCC-EECSCHHHHCTTCCEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSE
T ss_pred             CEEECCCCccc-ccCcchhhcCCCCCEEECCCCcCCc-chhhHhhhcCCCCCEEEecCCCCCCcHhHHHHHHHHCCccce
Confidence            88888888887 6776666778888888888888763 444  677777888888888887754333   4777777777


Q ss_pred             eeccCccCcC
Q 040702          155 LGLNDNYLTS  164 (797)
Q Consensus       155 L~L~~N~l~~  164 (797)
                      |++++|.+.+
T Consensus       145 Ld~~~n~~~~  154 (176)
T 1a9n_A          145 LDFQKVKLKE  154 (176)
T ss_dssp             ETTEECCHHH
T ss_pred             eCCCcCCHHH
Confidence            7777776644

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.69  E-value=2e-16  Score=152.88  Aligned_cols=131  Identities=26%  Similarity=0.269  Sum_probs=81.5

Q ss_pred             CEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccC
Q 040702           56 EWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQK  135 (797)
Q Consensus        56 ~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  135 (797)
                      +.+++++|+++.+ |..+  .++|++|++++|+++ .++...|..+++|++|+|++|++++..+..|.++++|++|+|++
T Consensus        10 ~~l~~~~~~l~~~-p~~~--~~~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~   85 (177)
T 2o6r_A           10 TEIRCNSKGLTSV-PTGI--PSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE   85 (177)
T ss_dssp             TEEECCSSCCSSC-CTTC--CTTCSEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CEEEecCCCCccC-CCCC--CCCCcEEEeCCCccc-EeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence            4455555555542 2222  245666666666665 55555555666666666666666655555566666677777777


Q ss_pred             CcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCC
Q 040702          136 NSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGIL  195 (797)
Q Consensus       136 N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~  195 (797)
                      |+|+++.+..|.++++|++|+|++|.++.+++..     |..+++|++|++++|++.+..
T Consensus        86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~-----~~~l~~L~~L~l~~N~~~~~~  140 (177)
T 2o6r_A           86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGI-----FDRLTSLQKIWLHTNPWDCSC  140 (177)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTT-----TTTCTTCCEEECCSSCBCCCH
T ss_pred             CCccccCHHHhhCCcccCEEECcCCcceEeCHHH-----hcCCcccCEEEecCCCeeccC
Confidence            7776666666677777777777777777666542     566677777777777776543

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.68  E-value=1.1e-16  Score=156.70  Aligned_cols=129  Identities=27%  Similarity=0.370  Sum_probs=99.6

Q ss_pred             cccccCCCCCCCCCCCCCCCCcccEEEccCCcCCCCCCccccccccccEEeccCcccccccCccccCCcccceecccCcc
Q 040702          281 RKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNR  360 (797)
Q Consensus       281 ~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  360 (797)
                      +.+++++|.++.+|..+.  ++|+.|++++|.|+ .+|..|..+++|+.|+|++|.|+++.+..|.++++|++|+|++|+
T Consensus        13 ~~l~~~~~~l~~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~   89 (193)
T 2wfh_A           13 TVVRCSNKGLKVLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNR   89 (193)
T ss_dssp             TEEECTTSCCSSCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred             CEEEcCCCCCCcCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCc
Confidence            456777777777776553  57778888888877 455677778888888888888887777778888888888888888


Q ss_pred             ccCCCChhhhccccCCeeeecCCcCCCCCChhhhccCCCCeEEccCCcCccc
Q 040702          361 LQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGE  412 (797)
Q Consensus       361 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~  412 (797)
                      |++..|..|..+++|++|+|++|+|++..+..|..+++|+.|++++|++.|.
T Consensus        90 l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~  141 (193)
T 2wfh_A           90 LRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD  141 (193)
T ss_dssp             CCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred             cCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence            8877777788888888888888888876666788888888888887777653

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.68  E-value=6.1e-16  Score=169.72  Aligned_cols=319  Identities=11%  Similarity=0.063  Sum_probs=214.4

Q ss_pred             cccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCC
Q 040702           64 KVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIP  143 (797)
Q Consensus        64 ~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~  143 (797)
                      +++.+...+|.++++|+.+.|.. .++ .|+..+|.++++|+.++|..+ ++.+...+|.++++|+.+.+..+ +..+..
T Consensus        58 ~VtsIg~~AF~~c~~L~~i~lp~-~i~-~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~-l~~i~~  133 (394)
T 4fs7_A           58 DVVSIGYAAFQGCRKVTEIKIPS-TVR-EIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLM-LKSIGV  133 (394)
T ss_dssp             EEEEECTTTTTTCTTEEEEECCT-TCC-EECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECT
T ss_pred             eEeEhHHHHhhCCCCceEEEeCC-Ccc-CcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCc-eeeecc
Confidence            45666677777777777777764 366 677777777777777777654 55566667777777777766654 445666


Q ss_pred             ccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChh
Q 040702          144 NTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEE  223 (797)
Q Consensus       144 ~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~  223 (797)
                      .+|.+...++.......  ..+...     .|.++++|+.+.+.++ +..+...+|.++. +|+.+.+..+ +.......
T Consensus       134 ~aF~~~~~~~~~~~~~~--~~i~~~-----aF~~c~~L~~i~l~~~-~~~I~~~~F~~c~-~L~~i~l~~~-~~~I~~~~  203 (394)
T 4fs7_A          134 EAFKGCDFKEITIPEGV--TVIGDE-----AFATCESLEYVSLPDS-METLHNGLFSGCG-KLKSIKLPRN-LKIIRDYC  203 (394)
T ss_dssp             TTTTTCCCSEEECCTTC--CEECTT-----TTTTCTTCCEEECCTT-CCEECTTTTTTCT-TCCBCCCCTT-CCEECTTT
T ss_pred             eeeecccccccccCccc--cccchh-----hhcccCCCcEEecCCc-cceeccccccCCC-CceEEEcCCC-ceEeCchh
Confidence            77777654444333222  222222     4777777777777654 3446666676665 6777777655 44455566


Q ss_pred             hhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcc
Q 040702          224 INNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDI  303 (797)
Q Consensus       224 ~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L  303 (797)
                      |.+...|  +.+.+..+...  +.+.+....+|+.+.+..+ ++.+...+|.++..|+.+.+..+...--...+..+..+
T Consensus       204 F~~~~~L--~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~-~~~i~~~~f~~~~~l~~~~~~~~~~~i~~~~F~~~~~l  278 (394)
T 4fs7_A          204 FAECILL--ENMEFPNSLYY--LGDFALSKTGVKNIIIPDS-FTELGKSVFYGCTDLESISIQNNKLRIGGSLFYNCSGL  278 (394)
T ss_dssp             TTTCTTC--CBCCCCTTCCE--ECTTTTTTCCCCEEEECTT-CCEECSSTTTTCSSCCEEEECCTTCEECSCTTTTCTTC
T ss_pred             hcccccc--ceeecCCCceE--eehhhcccCCCceEEECCC-ceecccccccccccceeEEcCCCcceeecccccccccc
Confidence            6666666  66666555433  2233444567888877643 44466677888888888888776543333466677788


Q ss_pred             cEEEccCCcCCCCCCccccccccccEEeccCcccccccCccccCCcccceecccCccccCCCChhhhccccCCeeeecCC
Q 040702          304 LHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNN  383 (797)
Q Consensus       304 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N  383 (797)
                      +.+....+.+.   ...|..+.+|+.+.+..+ ++.+...+|.++.+|+.++|.++ ++.+...+|.++.+|+.+++..|
T Consensus       279 ~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~  353 (394)
T 4fs7_A          279 KKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS  353 (394)
T ss_dssp             CEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT
T ss_pred             ceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc
Confidence            87777666543   346777888888888755 66567778888888888888654 66566778888888888888776


Q ss_pred             cCCCCCChhhhccCCCCeEEccCC
Q 040702          384 NLSGTIPISLEKLLDLKDINVSFN  407 (797)
Q Consensus       384 ~l~~~~p~~~~~l~~L~~L~l~~N  407 (797)
                       ++.+-..+|.++.+|+.+++..+
T Consensus       354 -l~~I~~~aF~~C~~L~~i~lp~~  376 (394)
T 4fs7_A          354 -LRKIGANAFQGCINLKKVELPKR  376 (394)
T ss_dssp             -CCEECTTTBTTCTTCCEEEEEGG
T ss_pred             -ccEehHHHhhCCCCCCEEEECCC
Confidence             76677778888888888888654

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=99.68  E-value=1e-15  Score=167.88  Aligned_cols=327  Identities=14%  Similarity=0.102  Sum_probs=184.6

Q ss_pred             ccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCC
Q 040702           49 IDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKL  128 (797)
Q Consensus        49 ~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L  128 (797)
                      |.++.+|+.+.+.. .++.+...+|.++++|+.++|..+ ++ .++..+|.++++|+.+.+..+ +..+...+|.+...+
T Consensus        67 F~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~-~I~~~aF~~c~~L~~i~~p~~-l~~i~~~aF~~~~~~  142 (394)
T 4fs7_A           67 FQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VK-MIGRCTFSGCYALKSILLPLM-LKSIGVEAFKGCDFK  142 (394)
T ss_dssp             TTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CC-EECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTCCCS
T ss_pred             hhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ce-EccchhhcccccchhhcccCc-eeeecceeeeccccc
Confidence            44455555555542 244444455555555555555433 33 445555555555555444432 333333444443322


Q ss_pred             CEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcE
Q 040702          129 SELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMED  208 (797)
Q Consensus       129 ~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~  208 (797)
                      +....  +.+..+...+|.++++|+.+.+.++ +..+...     .|.++.+|+.+++..| +..+...+|.+.. .|+.
T Consensus       143 ~~~~~--~~~~~i~~~aF~~c~~L~~i~l~~~-~~~I~~~-----~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~-~L~~  212 (394)
T 4fs7_A          143 EITIP--EGVTVIGDEAFATCESLEYVSLPDS-METLHNG-----LFSGCGKLKSIKLPRN-LKIIRDYCFAECI-LLEN  212 (394)
T ss_dssp             EEECC--TTCCEECTTTTTTCTTCCEEECCTT-CCEECTT-----TTTTCTTCCBCCCCTT-CCEECTTTTTTCT-TCCB
T ss_pred             ccccC--ccccccchhhhcccCCCcEEecCCc-cceeccc-----cccCCCCceEEEcCCC-ceEeCchhhcccc-ccce
Confidence            22211  1122233444555555555554433 2223322     2444444554444443 3334444444443 4444


Q ss_pred             EEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCC
Q 040702          209 FWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSN  288 (797)
Q Consensus       209 L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N  288 (797)
                      +.+.++...  +.+.+....+|  +.+.+.. .++.+...+|.....++.+.+..+... +....|..+..++.+....+
T Consensus       213 i~~~~~~~~--i~~~~~~~~~l--~~i~ip~-~~~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~  286 (394)
T 4fs7_A          213 MEFPNSLYY--LGDFALSKTGV--KNIIIPD-SFTELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSV  286 (394)
T ss_dssp             CCCCTTCCE--ECTTTTTTCCC--CEEEECT-TCCEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSS
T ss_pred             eecCCCceE--eehhhcccCCC--ceEEECC-CceecccccccccccceeEEcCCCcce-eeccccccccccceeccCce
Confidence            444333221  11111111222  4444432 233355667778888888888777543 66778888888888877766


Q ss_pred             CCCCCCCCCCCCCcccEEEccCCcCCCCCCccccccccccEEeccCcccccccCccccCCcccceecccCccccCCCChh
Q 040702          289 LLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNS  368 (797)
Q Consensus       289 ~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~  368 (797)
                      .+..  ..+..+.+|+.+.+..+ ++.+...+|.++.+|+.+++..+ ++.+...+|.++.+|+.+.+..| ++.....+
T Consensus       287 ~i~~--~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~a  361 (394)
T 4fs7_A          287 IVPE--KTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANA  361 (394)
T ss_dssp             EECT--TTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTT
T ss_pred             eecc--ccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHH
Confidence            4321  25667888888888765 66566778888899999998754 77677888999999999999877 76677788


Q ss_pred             hhccccCCeeeecCCcCCCCCChhhhccCCCCeE
Q 040702          369 IGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDI  402 (797)
Q Consensus       369 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L  402 (797)
                      |.++.+|+.+++..+ ++ .+..+|.++++|+.+
T Consensus       362 F~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I  393 (394)
T 4fs7_A          362 FQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI  393 (394)
T ss_dssp             BTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred             hhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence            999999999998765 33 335667777777654

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.66  E-value=2.9e-16  Score=151.64  Aligned_cols=133  Identities=26%  Similarity=0.274  Sum_probs=101.0

Q ss_pred             ccccccCCCCCCCCCCCCCCCCcccEEEccCCcCCCCCCccccccccccEEeccCcccccccCccccCCcccceecccCc
Q 040702          280 LRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYN  359 (797)
Q Consensus       280 L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  359 (797)
                      .+.+++++|.++.+|..+.  ++|+.|++++|.+++..+..|..+++|++|++++|.+++..+..|.++++|++|+|++|
T Consensus         9 ~~~l~~~~~~l~~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N   86 (177)
T 2o6r_A            9 GTEIRCNSKGLTSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHEN   86 (177)
T ss_dssp             TTEEECCSSCCSSCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             CCEEEecCCCCccCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCCC
Confidence            4566777777777775443  57777788888777666666777788888888888887776677778888888888888


Q ss_pred             cccCCCChhhhccccCCeeeecCCcCCCCCChhhhccCCCCeEEccCCcCcccCC
Q 040702          360 RLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIP  414 (797)
Q Consensus       360 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  414 (797)
                      ++++..+..|..+++|++|+|++|++++..+..+..+++|+.|++++|++.+.+|
T Consensus        87 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A           87 KLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             CCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             CccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            8887666677788888888888888886666667778888888888888776654

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.65  E-value=1.6e-16  Score=148.70  Aligned_cols=128  Identities=23%  Similarity=0.315  Sum_probs=63.0

Q ss_pred             CCCCCEEeCCCCCCC-CcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccc
Q 040702           20 PSSLQTLYLSYNPPS-GSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSAD   98 (797)
Q Consensus        20 l~~L~~LdLs~N~~~-~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~   98 (797)
                      +++|++|++++|.++ +        .+|..+..+++|++|++++|+++++  ..|.++++|++|+|++|.+++.+|. .+
T Consensus        16 ~~~l~~L~l~~n~l~~~--------~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~-~~   84 (149)
T 2je0_A           16 PSDVKELVLDNSRSNEG--------KLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEV-LA   84 (149)
T ss_dssp             GGGCSEEECTTCBCBTT--------BCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHH-HH
T ss_pred             CccCeEEEccCCcCChh--------HHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHH-Hh
Confidence            355555666655533 1        2333444555555555555555544  4455555555555555555522332 22


Q ss_pred             cCCCCccEEEccCcccccc-CCchhhCCCCCCEEEccCCcCcccCC---ccccCCCCCCeeecc
Q 040702           99 VRLPNLKELHLWGNNFIGT-IPSFIFNASKLSELGLQKNSFSGSIP---NTFGNLRNLKWLGLN  158 (797)
Q Consensus        99 ~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~---~~f~~l~~L~~L~L~  158 (797)
                      ..+++|++|+|++|++++. .+..+..+++|++|++++|+++++.+   ..|..+++|++|+++
T Consensus        85 ~~l~~L~~L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~  148 (149)
T 2je0_A           85 EKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY  148 (149)
T ss_dssp             HHCTTCCEEECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred             hhCCCCCEEECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence            3355555555555555432 22444555555555555555554443   345555555555543

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.65  E-value=1.3e-16  Score=149.32  Aligned_cols=132  Identities=18%  Similarity=0.159  Sum_probs=102.9

Q ss_pred             CCCCCEEEcccCccc-ccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCE
Q 040702           52 LHNMEWMAFSFNKVV-GVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSE  130 (797)
Q Consensus        52 l~~L~~L~ls~N~i~-~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~  130 (797)
                      .++|+.|++++|+++ +.+|..+..+++|+.|+|++|.++ .+  ..+..+++|++|+|++|.+++.+|..+..+++|++
T Consensus        16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~-~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~   92 (149)
T 2je0_A           16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH   92 (149)
T ss_dssp             GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCC-CC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred             CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCC-Cc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence            467889999999988 667888888999999999999988 44  45567888999999999888767777778888888


Q ss_pred             EEccCCcCcccC-CccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccC
Q 040702          131 LGLQKNSFSGSI-PNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSN  188 (797)
Q Consensus       131 L~L~~N~l~~~~-~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~  188 (797)
                      |+|++|+|+++. +..|.++++|++|++++|.++..++..  ...+..+++|+.|++++
T Consensus        93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~~~~l~~L~~L~l~d  149 (149)
T 2je0_A           93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYR--ENVFKLLPQLTYLDGYD  149 (149)
T ss_dssp             EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHH--HHHHHHCTTCCEETTBC
T ss_pred             EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHH--HHHHHHCCCcccccCCC
Confidence            888888888753 477888888888888888888776510  00256667777777763

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.61  E-value=1.3e-16  Score=170.24  Aligned_cols=133  Identities=15%  Similarity=0.167  Sum_probs=92.9

Q ss_pred             CCCccccccccCCcceeec----ceEEEEEEEEeccCC--------------cchhH--------HHHHHHhhhccCCce
Q 040702          513 RFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGG--------------AFKSF--------DIECGMMKRIRHRNL  566 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~--------------~~~~~--------~~E~~~l~~l~Hpni  566 (797)
                      -|.+.+.||+|+||.||++    |+.||||+++.....              .....        .+|...+.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            3889999999999999985    689999998643100              01112        234455555544333


Q ss_pred             eEeeeeeecCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCC-
Q 040702          567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM-  645 (797)
Q Consensus       567 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~-  645 (797)
                      ....-+..  ...++||||++|+++.++..       ......++.|++.|+.|||   ..|||||||||.|||+++++ 
T Consensus       176 ~vp~p~~~--~~~~LVME~i~G~~L~~l~~-------~~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dgd  243 (397)
T 4gyi_A          176 PVPEPIAQ--SRHTIVMSLVDALPMRQVSS-------VPDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEKD  243 (397)
T ss_dssp             SCCCEEEE--ETTEEEEECCSCEEGGGCCC-------CSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEEC
T ss_pred             CCCeeeec--cCceEEEEecCCccHhhhcc-------cHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCCC
Confidence            21111111  12379999999988765421       1234578899999999999   89999999999999998776 


Q ss_pred             ---------cEEEEeecCCcc
Q 040702          646 ---------VAHLSDFGMAKP  657 (797)
Q Consensus       646 ---------~~kl~DFGla~~  657 (797)
                               .+.|+||+-+-.
T Consensus       244 ~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          244 AEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             SSCTTSEEEEEEECCCTTCEE
T ss_pred             cccccccccceEEEEeCCccc
Confidence                     389999997753

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.60  E-value=1.3e-15  Score=147.03  Aligned_cols=136  Identities=17%  Similarity=0.143  Sum_probs=67.1

Q ss_pred             ccCCCCCCEEEcccCcccccCCccccCC-CCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCC
Q 040702           49 IDNLHNMEWMAFSFNKVVGVVPTTIFNV-STLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASK  127 (797)
Q Consensus        49 ~~~l~~L~~L~ls~N~i~~~~p~~~~~l-~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  127 (797)
                      +.++.+|+.|++++|+++.+ |. +..+ ++|++|+|++|.|+ .+  ..+..+++|++|+|++|+|++..+..|..+++
T Consensus        15 ~~~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~-~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~   89 (176)
T 1a9n_A           15 YTNAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIR-KL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD   89 (176)
T ss_dssp             EECTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCC-EE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred             cCCcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCC-cc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence            34455566666666666543 33 3333 25666666666655 33  23345555555555555555444444455555


Q ss_pred             CCEEEccCCcCcccCC-ccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCC
Q 040702          128 LSELGLQKNSFSGSIP-NTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPL  191 (797)
Q Consensus       128 L~~L~L~~N~l~~~~~-~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l  191 (797)
                      |++|+|++|+|+.+.+ ..|.++++|++|+|++|.++..+...  ...+..+++|+.||+++|.+
T Consensus        90 L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~l~~N~i~~~~~~~--~~~~~~l~~L~~Ld~~~n~~  152 (176)
T 1a9n_A           90 LTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYR--LYVIYKVPQVRVLDFQKVKL  152 (176)
T ss_dssp             CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHH--HHHHHHCTTCSEETTEECCH
T ss_pred             CCEEECCCCcCCcchhhHhhhcCCCCCEEEecCCCCCCcHhHH--HHHHHHCCccceeCCCcCCH
Confidence            5555555555543322 24555555555555555555443310  00133344455555554443

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.56  E-value=3.1e-17  Score=161.70  Aligned_cols=167  Identities=17%  Similarity=0.174  Sum_probs=138.8

Q ss_pred             CCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCc
Q 040702           17 LGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSS   96 (797)
Q Consensus        17 ~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~   96 (797)
                      +....+++.++|+.|.++|.+|.  ++.+|..+..+++|++|++++|++++ +| .+.++++|+.|+|++|.|+ .+|..
T Consensus        14 ~~~~~~l~~l~l~~~~l~~~~~~--l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~   88 (198)
T 1ds9_A           14 FEERKSVVATEAEKVELHGMIPP--IEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENL   88 (198)
T ss_dssp             HHHTTCCCCTTCSEEECCBCCTT--CCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSH
T ss_pred             HHhcccccCcchheeEeccccCc--HhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccch
Confidence            45667889999999999988876  77888899999999999999999998 56 8999999999999999998 88864


Q ss_pred             cccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCC-ccccCCCCCCeeeccCccCcCCCCCc-----c
Q 040702           97 ADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIP-NTFGNLRNLKWLGLNDNYLTSSTPEL-----S  170 (797)
Q Consensus        97 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~f~~l~~L~~L~L~~N~l~~~~~~~-----~  170 (797)
                      . ..+++|++|+|++|++++. | .+..+++|++|+|++|+|+.+.+ ..|.++++|++|++++|.++..++.-     .
T Consensus        89 ~-~~~~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~  165 (198)
T 1ds9_A           89 D-AVADTLEELWISYNQIASL-S-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEY  165 (198)
T ss_dssp             H-HHHHHCSEEEEEEEECCCH-H-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHH
T ss_pred             h-hcCCcCCEEECcCCcCCcC-C-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHH
Confidence            4 4678999999999999864 4 68899999999999999997654 67999999999999999997764320     0


Q ss_pred             ccccCCCCCCCcEEEccCCCCCC
Q 040702          171 SLSSLSNCKYLEYFSFSNNPLGG  193 (797)
Q Consensus       171 ~~~~l~~l~~L~~L~Ls~N~l~~  193 (797)
                      ....+..+++|+.||  +|.++.
T Consensus       166 ~~~~~~~l~~L~~Ld--~~~i~~  186 (198)
T 1ds9_A          166 RIEVVKRLPNLKKLD--GMPVDV  186 (198)
T ss_dssp             HHHHHHHCSSCSEEC--CGGGTT
T ss_pred             HHHHHHhCCCcEEEC--CcccCH
Confidence            001256788899887  677664

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.54  E-value=1.1e-13  Score=151.72  Aligned_cols=327  Identities=10%  Similarity=0.109  Sum_probs=154.6

Q ss_pred             ccCCC-CCCEEEcccCcccccCCccccCCCCCCEEEccCCc---CcccCCCccccCCCCccEEEccCccccccCCchhhC
Q 040702           49 IDNLH-NMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNS---LSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFN  124 (797)
Q Consensus        49 ~~~l~-~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~---l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~  124 (797)
                      |.++. .|+.+.+-. .++.+...+|.++++|+.+.++.|.   ++ .|+..+|.++.+|+.+.+..+ ++.+...+|.+
T Consensus        59 F~~~~~~L~sI~iP~-svt~Ig~~AF~~C~~L~~i~~~~n~p~~l~-~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~  135 (394)
T 4gt6_A           59 FCNYKYVLTSVQIPD-TVTEIGSNAFYNCTSLKRVTIQDNKPSCVK-KIGRQAFMFCSELTDIPILDS-VTEIDSEAFHH  135 (394)
T ss_dssp             TTTCCSCCCEEEECT-TCCEECTTTTTTCTTCCEEEEGGGCCCCCC-EECTTTTTTCTTCCBCGGGTT-CSEECTTTTTT
T ss_pred             ccCCCCcCEEEEECC-CeeEEhHHHhhCCccCceEeecCCCCCeee-EechhhchhcccceeeccCCc-cceehhhhhhh
Confidence            44442 355555543 2555555566666666666655542   44 555555555556665555443 34344455555


Q ss_pred             CCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhcccc
Q 040702          125 ASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQ  204 (797)
Q Consensus       125 l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  204 (797)
                      +.+|+.+.+..+ +..+...+|.++.+|+.+.+..+ ++.+...     .|.+ .+|+.+.+..+- ..+...+|.+.. 
T Consensus       136 c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~-----aF~~-~~l~~i~ip~~~-~~i~~~af~~c~-  205 (394)
T 4gt6_A          136 CEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEER-----AFTG-TALTQIHIPAKV-TRIGTNAFSECF-  205 (394)
T ss_dssp             CTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTT-----TTTT-CCCSEEEECTTC-CEECTTTTTTCT-
T ss_pred             hcccccccccce-eeeecccceecccccccccccce-eeEeccc-----cccc-cceeEEEECCcc-cccccchhhhcc-
Confidence            666666666533 33355555666666666555443 3333332     2332 345555554332 223344444443 


Q ss_pred             CCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccc
Q 040702          205 SMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLY  284 (797)
Q Consensus       205 ~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  284 (797)
                      ++.......+.........+             ..+.........+.....+..+.+. +.+..+...+|.++..|+.+.
T Consensus       206 ~l~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~  271 (394)
T 4gt6_A          206 ALSTITSDSESYPAIDNVLY-------------EKSANGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVK  271 (394)
T ss_dssp             TCCEEEECCSSSCBSSSCEE-------------EECTTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEE
T ss_pred             ccceecccccccccccceee-------------cccccccccccccccccccceEEcC-CcceEcccceeeecccccEEe
Confidence            34443333322221000000             0000000000001112223333332 223344455666666666666


Q ss_pred             cCCCCCCCCC-CCCCCCCcccEEEccCCcCCCCCCccccccccccEEeccCcccccccCccccCCcccceecccCccccC
Q 040702          285 LGSNLLTSIP-STLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQG  363 (797)
Q Consensus       285 L~~N~l~~lp-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~  363 (797)
                      +..+.. .+. .+|.++++|+.+.+. +.++.+....|.++.+|+.+++..+ ++.+...+|.++.+|+.+.+..+ ++.
T Consensus       272 lp~~~~-~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~  347 (394)
T 4gt6_A          272 MPDSVV-SIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTK  347 (394)
T ss_dssp             CCTTCC-EECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCB
T ss_pred             cccccc-eecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCE
Confidence            654433 233 245556666666664 3344455556666666666666543 44455566666667776666543 554


Q ss_pred             CCChhhhccccCCeeeecCCcCCCCCChhhhccCCCCeEEccCCcC
Q 040702          364 SIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRL  409 (797)
Q Consensus       364 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l  409 (797)
                      +...+|.++.+|+.+++.+|....   ..+....+|+.+.+..|.+
T Consensus       348 I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~  390 (394)
T 4gt6_A          348 IPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI  390 (394)
T ss_dssp             CCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred             EhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence            555666666677777666664331   3445556666666655543

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.54  E-value=2e-14  Score=137.53  Aligned_cols=105  Identities=22%  Similarity=0.246  Sum_probs=58.9

Q ss_pred             CCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCC
Q 040702           23 LQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLP  102 (797)
Q Consensus        23 L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~  102 (797)
                      .++||+++|.         ++++|..+.  ++|++|+|++|+|+++.|..|.++++|++|+|++|+|+ .+|...|..++
T Consensus        11 ~~~l~~s~n~---------l~~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~f~~l~   78 (170)
T 3g39_A           11 GTTVDCSGKS---------LASVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLT   78 (170)
T ss_dssp             TTEEECTTSC---------CSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCC-CCCTTTTTTCT
T ss_pred             CCEEEeCCCC---------cCccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcC-ccChhhccCCC
Confidence            4566666666         333444442  45666666666666665666666666666666666665 55555555555


Q ss_pred             CccEEEccCccccccCCchhhCCCCCCEEEccCCcCc
Q 040702          103 NLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFS  139 (797)
Q Consensus       103 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  139 (797)
                      +|++|+|++|+|++..+..|..+++|++|+|++|.+.
T Consensus        79 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  115 (170)
T 3g39_A           79 QLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWD  115 (170)
T ss_dssp             TCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred             CCCEEECCCCccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence            5555555555555444444555555555555555544

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.54  E-value=9.8e-17  Score=158.06  Aligned_cols=128  Identities=29%  Similarity=0.293  Sum_probs=76.4

Q ss_pred             hhcccccccccCCCch------hhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEE
Q 040702          233 QLLSLEGNQLEGSIPD------DLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHL  306 (797)
Q Consensus       233 ~~L~Ls~N~l~~~~~~------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L  306 (797)
                      +.++++.+.+.+..|.      .|..+++|++|+|++|++++ +| .+..+++|+.|++++|.++.+|..+..+++|+.|
T Consensus        21 ~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~~l~~~~~~~~~L~~L   98 (198)
T 1ds9_A           21 VATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIKKIENLDAVADTLEEL   98 (198)
T ss_dssp             CCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEECSCSSHHHHHHHCSEE
T ss_pred             cCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcccccchhhcCCcCCEE
Confidence            5666666666665554      66667777777777777765 33 6666666777777766666666555455666666


Q ss_pred             EccCCcCCCCCCccccccccccEEeccCcccccccC-ccccCCcccceecccCccccCC
Q 040702          307 NLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIP-TKIGGLKDLQYLFLEYNRLQGS  364 (797)
Q Consensus       307 ~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~~  364 (797)
                      ++++|.+++ +| .+..+++|+.|++++|+++...+ ..+..+++|++|++++|++.+.
T Consensus        99 ~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~  155 (198)
T 1ds9_A           99 WISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYND  155 (198)
T ss_dssp             EEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHH
T ss_pred             ECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccc
Confidence            666666654 22 35555566666666665554322 3455555555555555555443

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.54  E-value=3e-14  Score=136.37  Aligned_cols=107  Identities=25%  Similarity=0.306  Sum_probs=81.7

Q ss_pred             CCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeecc
Q 040702           79 LKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLN  158 (797)
Q Consensus        79 L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~  158 (797)
                      .+.|++++|.|+ .+|..++   ++|++|+|++|+|++..|..|.++++|++|+|++|+|+++.++.|.++++|++|+|+
T Consensus        11 ~~~l~~s~n~l~-~ip~~~~---~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~   86 (170)
T 3g39_A           11 GTTVDCSGKSLA-SVPTGIP---TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN   86 (170)
T ss_dssp             TTEEECTTSCCS-SCCSCCC---TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred             CCEEEeCCCCcC-ccCccCC---CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence            467777777776 6776553   677888888888877777778888888888888888887777778888888888888


Q ss_pred             CccCcCCCCCccccccCCCCCCCcEEEccCCCCCCC
Q 040702          159 DNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGI  194 (797)
Q Consensus       159 ~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~  194 (797)
                      +|+|+.+++.     .|..+++|++|+|++|++.+.
T Consensus        87 ~N~l~~~~~~-----~~~~l~~L~~L~L~~N~~~c~  117 (170)
T 3g39_A           87 DNQLKSIPRG-----AFDNLKSLTHIWLLNNPWDCA  117 (170)
T ss_dssp             SSCCCCCCTT-----TTTTCTTCCEEECCSSCBCTT
T ss_pred             CCccCEeCHH-----HhcCCCCCCEEEeCCCCCCCC
Confidence            8888877765     367777788888888877654

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.53  E-value=3.9e-14  Score=135.99  Aligned_cols=104  Identities=20%  Similarity=0.295  Sum_probs=56.5

Q ss_pred             CEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCC
Q 040702           24 QTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPN  103 (797)
Q Consensus        24 ~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~  103 (797)
                      +.+|+++|+         ++++|..+.  ++|++|+|++|+|+++.|..|.++++|+.|+|++|+|+ .+|...|..+++
T Consensus        15 ~~l~~~~n~---------l~~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~   82 (174)
T 2r9u_A           15 TLVNCQNIR---------LASVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQ   82 (174)
T ss_dssp             SEEECCSSC---------CSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTT
T ss_pred             cEEEeCCCC---------CCccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCC-ccChhHhCCcch
Confidence            566666666         233444443  45666666666666655666666666666666666665 455555545555


Q ss_pred             ccEEEccCccccccCCchhhCCCCCCEEEccCCcCc
Q 040702          104 LKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFS  139 (797)
Q Consensus       104 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  139 (797)
                      |++|+|++|+|++..+..|..+++|++|+|++|.+.
T Consensus        83 L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~  118 (174)
T 2r9u_A           83 LTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWD  118 (174)
T ss_dssp             CCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred             hhEEECCCCccceeCHHHhccccCCCEEEeCCCCcc
Confidence            555555555555433334444444444444444444

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=99.52  E-value=2.4e-13  Score=148.98  Aligned_cols=333  Identities=12%  Similarity=0.108  Sum_probs=234.6

Q ss_pred             cccCCcCCCCC-CCCCEEeCCCCCCCCcCCCccccCCC-ccccCCCCCCEEEcccCc---ccccCCccccCCCCCCEEEc
Q 040702           10 RGIILSQLGNP-SSLQTLYLSYNPPSGSIPSFILCEIP-HEIDNLHNMEWMAFSFNK---VVGVVPTTIFNVSTLKSLYL   84 (797)
Q Consensus        10 ~~~~~~~~~~l-~~L~~LdLs~N~~~~~~p~~~l~~ip-~~~~~l~~L~~L~ls~N~---i~~~~p~~~~~l~~L~~L~L   84 (797)
                      +.+-..+|.+. .+|+...+-.+          ++.|. .+|.++++|+.+.++.|.   ++.+...+|.+..+|+.+.+
T Consensus        52 t~Ig~~aF~~~~~~L~sI~iP~s----------vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~  121 (394)
T 4gt6_A           52 SKIGDRVFCNYKYVLTSVQIPDT----------VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPI  121 (394)
T ss_dssp             EEECTTTTTTCCSCCCEEEECTT----------CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGG
T ss_pred             eEcCHhhccCCCCcCEEEEECCC----------eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeecc
Confidence            34455678777 45888887543          34454 468999999999998874   88888899999999999988


Q ss_pred             cCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcC
Q 040702           85 HSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTS  164 (797)
Q Consensus        85 s~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~  164 (797)
                      ..+ ++ .++..+|..+.+|+.+.+..+ +..+...+|.+..+|+.+.+..+ ++.+...+|.+ .+|+.+.+..+.. .
T Consensus       122 ~~~-~~-~I~~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~-~  195 (394)
T 4gt6_A          122 LDS-VT-EIDSEAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVT-R  195 (394)
T ss_dssp             GTT-CS-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCC-E
T ss_pred             CCc-cc-eehhhhhhhhcccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEECCccc-c
Confidence            765 65 789999999999999999755 55577889999999999999876 66688899976 6899999876643 3


Q ss_pred             CCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccC
Q 040702          165 STPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEG  244 (797)
Q Consensus       165 ~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~  244 (797)
                      +...     .|.++..|+......+.........+.... .........       +    ....+  ..+.+. +.++.
T Consensus       196 i~~~-----af~~c~~l~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-------~----~~~~~--~~~~ip-~~v~~  255 (394)
T 4gt6_A          196 IGTN-----AFSECFALSTITSDSESYPAIDNVLYEKSA-NGDYALIRY-------P----SQRED--PAFKIP-NGVAR  255 (394)
T ss_dssp             ECTT-----TTTTCTTCCEEEECCSSSCBSSSCEEEECT-TSCEEEEEC-------C----TTCCC--SEEECC-TTEEE
T ss_pred             cccc-----hhhhccccceecccccccccccceeecccc-ccccccccc-------c----ccccc--ceEEcC-CcceE
Confidence            3332     488889999988887766533222222111 111000000       0    00000  122222 33444


Q ss_pred             CCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCC-CCCCCCcccEEEccCCcCCCCCCccccc
Q 040702          245 SIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPS-TLWNLKDILHLNLSSNFFTGPLPLKIGN  323 (797)
Q Consensus       245 ~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~  323 (797)
                      +...+|.++..|+.+.+..+.. .+...+|.++++|+.+.+. +.++.++. +|.++.+|+.+.+..+ ++.+...+|.+
T Consensus       256 i~~~aF~~c~~L~~i~lp~~~~-~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~  332 (394)
T 4gt6_A          256 IETHAFDSCAYLASVKMPDSVV-SIGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAG  332 (394)
T ss_dssp             ECTTTTTTCSSCCEEECCTTCC-EECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT
T ss_pred             cccceeeecccccEEecccccc-eecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhC
Confidence            5667888899999999876654 4677889999999999986 56777876 6667899999999865 66566788999


Q ss_pred             cccccEEeccCcccccccCccccCCcccceecccCccccCCCChhhhccccCCeeeecCCcC
Q 040702          324 LNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNL  385 (797)
Q Consensus       324 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l  385 (797)
                      +.+|+.+.+..+ ++.+...+|.++.+|+.+++.+|....   ..+....+|+.+.+..|.+
T Consensus       333 C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~~  390 (394)
T 4gt6_A          333 CEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGSI  390 (394)
T ss_dssp             CTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC----------
T ss_pred             CCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCCE
Confidence            999999999754 766778899999999999999886542   4677778888888877655

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.52  E-value=5.5e-14  Score=134.99  Aligned_cols=106  Identities=24%  Similarity=0.273  Sum_probs=78.7

Q ss_pred             CEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccC
Q 040702           80 KSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLND  159 (797)
Q Consensus        80 ~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~  159 (797)
                      +.+++++|+++ .+|..++   ++|++|+|++|+|++..|..|.++++|++|+|++|+|+++.+..|.++++|++|+|++
T Consensus        15 ~~l~~~~n~l~-~iP~~~~---~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~   90 (174)
T 2r9u_A           15 TLVNCQNIRLA-SVPAGIP---TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND   90 (174)
T ss_dssp             SEEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             cEEEeCCCCCC-ccCCCcC---CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence            56777777776 6776553   6777777777777777777777777888888888888777777777788888888888


Q ss_pred             ccCcCCCCCccccccCCCCCCCcEEEccCCCCCCC
Q 040702          160 NYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGI  194 (797)
Q Consensus       160 N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~  194 (797)
                      |+|+.+++.     .|..+++|+.|+|++|++...
T Consensus        91 N~l~~l~~~-----~~~~l~~L~~L~L~~N~~~c~  120 (174)
T 2r9u_A           91 NHLKSIPRG-----AFDNLKSLTHIYLYNNPWDCE  120 (174)
T ss_dssp             SCCCCCCTT-----TTTTCTTCSEEECCSSCBCTT
T ss_pred             CccceeCHH-----HhccccCCCEEEeCCCCcccc
Confidence            887777764     266777777777777777643

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.38  E-value=8.2e-15  Score=158.57  Aligned_cols=164  Identities=16%  Similarity=0.112  Sum_probs=86.3

Q ss_pred             CCCCEEEcccCcccccCCccccCC-----CCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhh----
Q 040702           53 HNMEWMAFSFNKVVGVVPTTIFNV-----STLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIF----  123 (797)
Q Consensus        53 ~~L~~L~ls~N~i~~~~p~~~~~l-----~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~----  123 (797)
                      +.|+.|+|++|+++......+...     ++|++|+|++|.|+..-...+...+++|++|+|++|.|++.....+.    
T Consensus        72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~  151 (372)
T 3un9_A           72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL  151 (372)
T ss_dssp             TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred             hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence            456677777777665433333322     56777777777665221222223345677777777776544333332    


Q ss_pred             -CCCCCCEEEccCCcCccc----CCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChh
Q 040702          124 -NASKLSELGLQKNSFSGS----IPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRA  198 (797)
Q Consensus       124 -~l~~L~~L~L~~N~l~~~----~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~  198 (797)
                       ..++|++|+|++|.|+..    .+.++..+++|++|+|++|.|+...... -...+...++|+.|+|++|.|+......
T Consensus       152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~-L~~~L~~~~~L~~L~Ls~N~i~~~g~~~  230 (372)
T 3un9_A          152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLEL-LAAQLDRNRQLQELNVAYNGAGDTAALA  230 (372)
T ss_dssp             STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHH-HHHHGGGCSCCCEEECCSSCCCHHHHHH
T ss_pred             hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHH-HHHHHhcCCCcCeEECCCCCCCHHHHHH
Confidence             345677777777766542    2333455666777777777665432100 0012344556666666666665432222


Q ss_pred             ----hhccccCCcEEEccCCcccc
Q 040702          199 ----IGNLSQSMEDFWMDNCNISG  218 (797)
Q Consensus       199 ----~~~l~~~L~~L~L~~n~i~~  218 (797)
                          +...+ +|++|+|++|.|+.
T Consensus       231 l~~~L~~~~-~L~~L~Ls~N~i~~  253 (372)
T 3un9_A          231 LARAAREHP-SLELLHLYFNELSS  253 (372)
T ss_dssp             HHHHHHHCS-SCCEEECTTSSCCH
T ss_pred             HHHHHHhCC-CCCEEeccCCCCCH
Confidence                22233 45555555555543

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.37  E-value=3.7e-11  Score=130.89  Aligned_cols=313  Identities=11%  Similarity=0.055  Sum_probs=153.6

Q ss_pred             cccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCC
Q 040702           48 EIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASK  127 (797)
Q Consensus        48 ~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~  127 (797)
                      ++....+|+.+.+. ..++.+...+|.++.+|+.++|..+ ++ .|+..+|.+. +|+.+.+..+ ++.+...+|.+ .+
T Consensus        41 ~~~~~~~i~~v~ip-~~vt~Ig~~aF~~C~~L~~I~lp~~-v~-~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~  114 (379)
T 4h09_A           41 WYKDRDRISEVRVN-SGITSIGEANFNSCYNMTKVTVAST-VT-SIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TD  114 (379)
T ss_dssp             TGGGGGGCSEEEEC-TTEEEECTTTTTTCTTCCEEEECTT-CC-EECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CC
T ss_pred             ccccccCCEEEEeC-CCccChHHHHhhCCCCCCEEEeCCc-ce-EechhhhcCC-CCceEECCce-eeEeccceecc-CC
Confidence            34455667777665 3466667777777777777777643 65 6777777665 5666666543 45444555544 36


Q ss_pred             CCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCc
Q 040702          128 LSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSME  207 (797)
Q Consensus       128 L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~  207 (797)
                      |+.+.+..+ +..+...+|.+. +|+...+..+ ++.+...     .|..+..++...+..+.........+. ......
T Consensus       115 L~~i~lp~~-~~~i~~~~F~~~-~l~~~~~~~~-v~~i~~~-----~f~~~~~l~~~~~~~~~~~~~~~~~~~-~~~~~~  185 (379)
T 4h09_A          115 LDDFEFPGA-TTEIGNYIFYNS-SVKRIVIPKS-VTTIKDG-----IGYKAENLEKIEVSSNNKNYVAENYVL-YNKNKT  185 (379)
T ss_dssp             CSEEECCTT-CCEECTTTTTTC-CCCEEEECTT-CCEECSC-----TTTTCTTCCEEEECTTCSSEEEETTEE-EETTSS
T ss_pred             cccccCCCc-cccccccccccc-eeeeeeccce-eeccccc-----hhcccccccccccccccceeeccccee-cccccc
Confidence            777777655 333566666654 4555544433 3333332     356666666666655443311111000 000000


Q ss_pred             EEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCC
Q 040702          208 DFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGS  287 (797)
Q Consensus       208 ~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~  287 (797)
                                  ....+.....+  ..+.+.. ....+...++....+|+.+.+..+ +..+...+|.++..|+.+.+..
T Consensus       186 ------------~~~~~~~~~~~--~~~~~~~-~~~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~  249 (379)
T 4h09_A          186 ------------ILESYPAAKTG--TEFTIPS-TVKTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPK  249 (379)
T ss_dssp             ------------EEEECCTTCCC--SEEECCT-TCCEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECT
T ss_pred             ------------eeccccccccc--ccccccc-ceeEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCC
Confidence                        00000000000  1111111 111123344445555555555433 3334445555555565555554


Q ss_pred             CCCCCCCC-CCCCCCcccEEEccCCcCCCCCCccccccccccEEeccCcccccccCccccCCcccceecccCccccCCCC
Q 040702          288 NLLTSIPS-TLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIP  366 (797)
Q Consensus       288 N~l~~lp~-~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p  366 (797)
                      + ++.+.. .+.++.+|+.+.+..+ +.......|.++.+|+.+.+.++.++.+...+|.++.+|+.+.|..+ ++.+..
T Consensus       250 ~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~  326 (379)
T 4h09_A          250 N-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQV  326 (379)
T ss_dssp             T-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECT
T ss_pred             C-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHH
Confidence            4 444433 3444555555555433 33334445555555555555555555455555555555555555433 443444


Q ss_pred             hhhhccccCCeeeecCCcCCCCCChhhhc
Q 040702          367 NSIGDLISLKSLNLSNNNLSGTIPISLEK  395 (797)
Q Consensus       367 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~  395 (797)
                      .+|.++.+|+.+.+..+ ++.+-..+|.+
T Consensus       327 ~aF~~C~~L~~i~ip~~-v~~I~~~aF~~  354 (379)
T 4h09_A          327 YAFKNCKALSTISYPKS-ITLIESGAFEG  354 (379)
T ss_dssp             TTTTTCTTCCCCCCCTT-CCEECTTTTTT
T ss_pred             HHhhCCCCCCEEEECCc-cCEEchhHhhC
Confidence            45555555555555433 33333344443

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.34  E-value=1.7e-12  Score=139.66  Aligned_cols=132  Identities=19%  Similarity=0.143  Sum_probs=85.8

Q ss_pred             ccccCCC-CCCCCCCCCCCCCcccEEEccC-CcCCCCCCccccccccccEEeccCcccccccCccccCCcccceecccCc
Q 040702          282 KLYLGSN-LLTSIPSTLWNLKDILHLNLSS-NFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYN  359 (797)
Q Consensus       282 ~L~L~~N-~l~~lp~~~~~l~~L~~L~l~~-N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N  359 (797)
                      .++++++ .|+.+|. +..+++|+.|+|++ |.|++..+..|.++++|+.|+|++|+|+++.|..|.++++|+.|+|++|
T Consensus        12 ~v~~~~~n~l~~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N   90 (347)
T 2ifg_A           12 GLRCTRDGALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN   90 (347)
T ss_dssp             CEECCSSCCCTTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSS
T ss_pred             EEEcCCCCCCCccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCCC
Confidence            4566666 6777777 66677777777775 7777666667777777777777777777777777777777777777777


Q ss_pred             cccCCCChhhhccccCCeeeecCCcCCCCCC-hhhhccCCCCeEEccCCcCcccCCC
Q 040702          360 RLQGSIPNSIGDLISLKSLNLSNNNLSGTIP-ISLEKLLDLKDINVSFNRLEGEIPR  415 (797)
Q Consensus       360 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~p~  415 (797)
                      +|++..+..|..++ |+.|+|++|.+...-. .+|..+.......+..+.++|.-|.
T Consensus        91 ~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~C~~~~  146 (347)
T 2ifg_A           91 ALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQG  146 (347)
T ss_dssp             CCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSS
T ss_pred             ccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCCCCCCh
Confidence            77765555555555 7777777777764322 2343333333334445566665554

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.33  E-value=2.3e-12  Score=138.60  Aligned_cols=94  Identities=18%  Similarity=0.142  Sum_probs=51.9

Q ss_pred             cCCCccccCCCCCCEEEccc-CcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCch
Q 040702           43 CEIPHEIDNLHNMEWMAFSF-NKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSF  121 (797)
Q Consensus        43 ~~ip~~~~~l~~L~~L~ls~-N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~  121 (797)
                      +.||. +..+++|+.|+|++ |+|.++.|..|.++++|+.|+|++|+|+ .++...|..+++|++|+|++|+|+++.+..
T Consensus        22 ~~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~   99 (347)
T 2ifg_A           22 DSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLSRLNLSFNALESLSWKT   99 (347)
T ss_dssp             TTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCC-EECTTGGGSCSCCCEEECCSSCCSCCCSTT
T ss_pred             CccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccc-eeCHHHhcCCcCCCEEeCCCCccceeCHHH
Confidence            34455 55555666666653 6666555555666666666666666665 444444555555555555555555444444


Q ss_pred             hhCCCCCCEEEccCCcCc
Q 040702          122 IFNASKLSELGLQKNSFS  139 (797)
Q Consensus       122 ~~~l~~L~~L~L~~N~l~  139 (797)
                      |..++ |+.|+|++|.|.
T Consensus       100 ~~~~~-L~~l~l~~N~~~  116 (347)
T 2ifg_A          100 VQGLS-LQELVLSGNPLH  116 (347)
T ss_dssp             TCSCC-CCEEECCSSCCC
T ss_pred             cccCC-ceEEEeeCCCcc
Confidence            44443 555555555554

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.29  E-value=8.8e-12  Score=128.37  Aligned_cols=143  Identities=17%  Similarity=0.138  Sum_probs=114.1

Q ss_pred             HHHhcCCCccccccccCCcceeec---ceEEEEEEEEeccCCcchhHHHHHHHhhhcc-CCceeEeeeeeecCCeEEEEE
Q 040702          508 FQATNRFSENNLIGRGGFGPVYKD---GMEVAIKVFNLQYGGAFKSFDIECGMMKRIR-HRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       508 ~~~~~~f~~~~~lg~G~~g~Vyk~---~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      .....+|......+.|+.+.||+.   +..+++|+...........+.+|+++++.+. +..++++++++...+..|+||
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~   89 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM   89 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence            445567888888898999999973   5899999987643334467999999999985 678889999999889999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcc---------------------------------------
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFG---------------------------------------  624 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~---------------------------------------  624 (797)
                      ||++|.++.+....      ......++.+++++++.||..                                       
T Consensus        90 e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T 3tm0_A           90 SEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             ECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred             EecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence            99999999876321      123347889999999999951                                       


Q ss_pred             -----------------CCCCeEEcCCCCCceEEcCCCcEEEEeecCCc
Q 040702          625 -----------------YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  656 (797)
Q Consensus       625 -----------------~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  656 (797)
                                       ....++|+|++|.||+++++..+.|+||+.+.
T Consensus       164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                             01458999999999999876666799999886

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=99.26  E-value=1.1e-10  Score=127.00  Aligned_cols=303  Identities=12%  Similarity=0.078  Sum_probs=220.1

Q ss_pred             ccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCC
Q 040702           71 TTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLR  150 (797)
Q Consensus        71 ~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~  150 (797)
                      .++....+|+.+.+.. .++ .|+..+|.++.+|+.++|..+ ++.+...+|.+. +|+.+.+..+ ++.+...+|.+. 
T Consensus        40 ~~~~~~~~i~~v~ip~-~vt-~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~~-  113 (379)
T 4h09_A           40 PWYKDRDRISEVRVNS-GIT-SIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQGT-  113 (379)
T ss_dssp             TTGGGGGGCSEEEECT-TEE-EECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTTC-
T ss_pred             cccccccCCEEEEeCC-Ccc-ChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceeccC-
Confidence            3566677899999864 576 899999999999999999754 776777888876 7888888754 676888889875 


Q ss_pred             CCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhh
Q 040702          151 NLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNL  230 (797)
Q Consensus       151 ~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L  230 (797)
                      +|+.+.+..+ ++.+...     .|.+. +|+...+.. .+..+...+|.... .++...+..+........        
T Consensus       114 ~L~~i~lp~~-~~~i~~~-----~F~~~-~l~~~~~~~-~v~~i~~~~f~~~~-~l~~~~~~~~~~~~~~~~--------  176 (379)
T 4h09_A          114 DLDDFEFPGA-TTEIGNY-----IFYNS-SVKRIVIPK-SVTTIKDGIGYKAE-NLEKIEVSSNNKNYVAEN--------  176 (379)
T ss_dssp             CCSEEECCTT-CCEECTT-----TTTTC-CCCEEEECT-TCCEECSCTTTTCT-TCCEEEECTTCSSEEEET--------
T ss_pred             CcccccCCCc-ccccccc-----ccccc-eeeeeeccc-eeeccccchhcccc-cccccccccccceeeccc--------
Confidence            8999999765 4444443     25544 566666654 35556666777665 677666655443311110        


Q ss_pred             HhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCC-CCCCCCcccEEEcc
Q 040702          231 ILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPS-TLWNLKDILHLNLS  309 (797)
Q Consensus       231 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~-~~~~l~~L~~L~l~  309 (797)
                           ....+... .....+.....+..+.+..+. .......+....+|+.+.+..+ +..+.. .+.++..|+.+.+.
T Consensus       177 -----~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~-~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp  248 (379)
T 4h09_A          177 -----YVLYNKNK-TILESYPAAKTGTEFTIPSTV-KTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIP  248 (379)
T ss_dssp             -----TEEEETTS-SEEEECCTTCCCSEEECCTTC-CEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEEC
T ss_pred             -----ceeccccc-ceeccccccccccccccccce-eEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcC
Confidence                 00111111 233445556667777665543 3356677888889999988765 555544 67788999999998


Q ss_pred             CCcCCCCCCccccccccccEEeccCcccccccCccccCCcccceecccCccccCCCChhhhccccCCeeeecCCcCCCCC
Q 040702          310 SNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTI  389 (797)
Q Consensus       310 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~  389 (797)
                      .+ ++.+....|.++.+|+.+.+..+ ++.+...+|.++.+|+.+.+.++.++.+...+|.++.+|+.++|..+ ++.+-
T Consensus       249 ~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~  325 (379)
T 4h09_A          249 KN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQ  325 (379)
T ss_dssp             TT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEEC
T ss_pred             CC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcCcc-ccEEH
Confidence            76 66567788999999999999754 66577789999999999999999998777889999999999999765 77677


Q ss_pred             ChhhhccCCCCeEEccCC
Q 040702          390 PISLEKLLDLKDINVSFN  407 (797)
Q Consensus       390 p~~~~~l~~L~~L~l~~N  407 (797)
                      ..+|.++.+|+.+.+..+
T Consensus       326 ~~aF~~C~~L~~i~ip~~  343 (379)
T 4h09_A          326 VYAFKNCKALSTISYPKS  343 (379)
T ss_dssp             TTTTTTCTTCCCCCCCTT
T ss_pred             HHHhhCCCCCCEEEECCc
Confidence            889999999999988654

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=99.22  E-value=3.8e-13  Score=145.46  Aligned_cols=159  Identities=20%  Similarity=0.203  Sum_probs=106.2

Q ss_pred             CCCCcEEEccCCcCcccCCCCccC-----CccccccccCCCCCCCC-CCCC-CCCCcccEEEccCCcCCCCCCcccc---
Q 040702          253 LAALFQLDLGGNKLSGFVPACSGN-----LTNLRKLYLGSNLLTSI-PSTL-WNLKDILHLNLSSNFFTGPLPLKIG---  322 (797)
Q Consensus       253 l~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~l-p~~~-~~l~~L~~L~l~~N~l~~~~~~~~~---  322 (797)
                      ++.|+.|+|++|.++......+..     .++|+.|+|++|.++.. ...+ ..+++|+.|+|++|.++......+.   
T Consensus        71 ~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L  150 (372)
T 3un9_A           71 LSSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL  150 (372)
T ss_dssp             HTTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred             HhhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence            346777777777776443332222     25777778887777432 1122 2356788888888888644333332   


Q ss_pred             --ccccccEEeccCcccccc----cCccccCCcccceecccCccccCC----CChhhhccccCCeeeecCCcCCCC----
Q 040702          323 --NLNVLVQLDLSMNNFSCV----IPTKIGGLKDLQYLFLEYNRLQGS----IPNSIGDLISLKSLNLSNNNLSGT----  388 (797)
Q Consensus       323 --~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----  388 (797)
                        ..++|++|+|++|.|+..    ++..+..+++|++|+|++|+|.+.    ++..+...++|++|+|++|.|+..    
T Consensus       151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~  230 (372)
T 3un9_A          151 LHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALA  230 (372)
T ss_dssp             HSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHH
T ss_pred             HhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHH
Confidence              346788888888888643    334456778888899988888743    245566778899999999988753    


Q ss_pred             CChhhhccCCCCeEEccCCcCcc
Q 040702          389 IPISLEKLLDLKDINVSFNRLEG  411 (797)
Q Consensus       389 ~p~~~~~l~~L~~L~l~~N~l~~  411 (797)
                      ++..+...++|+.|+|++|+++.
T Consensus       231 l~~~L~~~~~L~~L~Ls~N~i~~  253 (372)
T 3un9_A          231 LARAAREHPSLELLHLYFNELSS  253 (372)
T ss_dssp             HHHHHHHCSSCCEEECTTSSCCH
T ss_pred             HHHHHHhCCCCCEEeccCCCCCH
Confidence            33445567889999999998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.02  E-value=3.1e-10  Score=116.41  Aligned_cols=134  Identities=13%  Similarity=0.074  Sum_probs=98.1

Q ss_pred             cCCCccccccccCCcceeec----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCc--eeEeeeeeecCCeEEEEEEc
Q 040702          512 NRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRN--LIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpn--iv~l~~~~~~~~~~~lv~e~  585 (797)
                      .+|......+.|..+.||+.    |..+++|+....   ....+..|+.+++.+.+.+  +++++++...++..++||||
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~   96 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   96 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence            34544333345566899973    467999987543   3367889999999996544  56788888888889999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccC----------------------------------------
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY----------------------------------------  625 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~----------------------------------------  625 (797)
                      ++|.++.  ...    .+   ...++.++++.+..||...                                        
T Consensus        97 i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (264)
T 1nd4_A           97 VPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP  167 (264)
T ss_dssp             CSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred             cCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence            9998874  211    12   2357788888889888321                                        


Q ss_pred             ---------------CCCeEEcCCCCCceEEcCCCcEEEEeecCCcc
Q 040702          626 ---------------SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  657 (797)
Q Consensus       626 ---------------~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  657 (797)
                                     ...++|+|++|.||++++++.+.|+|||.+..
T Consensus       168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                           11299999999999998876677999999863

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.92  E-value=1.5e-09  Score=117.12  Aligned_cols=139  Identities=12%  Similarity=0.143  Sum_probs=103.9

Q ss_pred             ccccccccCCcceeec---ceEEEEEEEE--ecc-CCcchhHHHHHHHhhhcc--CCceeEeeeeeecC---CeEEEEEE
Q 040702          516 ENNLIGRGGFGPVYKD---GMEVAIKVFN--LQY-GGAFKSFDIECGMMKRIR--HRNLIKIISSCSND---DFKALVLE  584 (797)
Q Consensus       516 ~~~~lg~G~~g~Vyk~---~~~vAvK~~~--~~~-~~~~~~~~~E~~~l~~l~--Hpniv~l~~~~~~~---~~~~lv~e  584 (797)
                      ..+.++.|.++.||+.   +..+++|+..  ... ......+.+|+.+++.+.  +..++++++++.+.   +..|+|||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             eEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            4578899999999973   5778888775  332 122467889999999997  45688899988776   45899999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccC---------------------------------------
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY---------------------------------------  625 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~---------------------------------------  625 (797)
                      |++|..+.+..   ...++..+...++.+++++|..||...                                       
T Consensus       122 ~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (359)
T 3dxp_A          122 FVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD  198 (359)
T ss_dssp             CCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred             ecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence            99987764311   113677788899999999999999420                                       


Q ss_pred             ----------------CCCeEEcCCCCCceEEcCCCc--EEEEeecCCcc
Q 040702          626 ----------------SVPIIHCDLKPSNVLLDDNMV--AHLSDFGMAKP  657 (797)
Q Consensus       626 ----------------~~~ivHrDlkp~NIll~~~~~--~kl~DFGla~~  657 (797)
                                      ...++|+|++|.||+++.++.  +.|+||+.+..
T Consensus       199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                            257999999999999997653  68999999874

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.84  E-value=1.1e-09  Score=117.20  Aligned_cols=43  Identities=16%  Similarity=0.051  Sum_probs=19.4

Q ss_pred             CCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccC
Q 040702           21 SSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFN   63 (797)
Q Consensus        21 ~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N   63 (797)
                      ..++.|.+......|......+..+..++..+++|+.|.+..+
T Consensus       107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~  149 (362)
T 2ra8_A          107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDI  149 (362)
T ss_dssp             GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCC
T ss_pred             hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCc
Confidence            3455666654433210000112233344555666777766543

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=98.68  E-value=5e-09  Score=112.14  Aligned_cols=159  Identities=16%  Similarity=0.113  Sum_probs=70.3

Q ss_pred             hhhhhhhhHhhhccccccccc---------CCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCC
Q 040702          223 EINNLTNLILQLLSLEGNQLE---------GSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSI  293 (797)
Q Consensus       223 ~~~~l~~L~L~~L~Ls~N~l~---------~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l  293 (797)
                      ++..+++|  +.|.+..+...         +.+...+..+++|+.|+|++|.-... +. +. +++|+.|+|..|.++.-
T Consensus       134 s~~~l~~L--~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l~l-~~-~~-~~~L~~L~L~~~~l~~~  208 (362)
T 2ra8_A          134 NKEKFAHF--EGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSI-GK-KP-RPNLKSLEIISGGLPDS  208 (362)
T ss_dssp             THHHHTTC--SEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTCBC-CS-CB-CTTCSEEEEECSBCCHH
T ss_pred             hhhhcchh--hheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCcee-cc-cc-CCCCcEEEEecCCCChH
Confidence            34455665  67766554321         11334445566777777766621111 11 22 55666666666555321


Q ss_pred             C-CCC--CCCCcccEEEccC--CcCCCCC-----Cccc--cccccccEEeccCcccccccCccc---cCCcccceecccC
Q 040702          294 P-STL--WNLKDILHLNLSS--NFFTGPL-----PLKI--GNLNVLVQLDLSMNNFSCVIPTKI---GGLKDLQYLFLEY  358 (797)
Q Consensus       294 p-~~~--~~l~~L~~L~l~~--N~l~~~~-----~~~~--~~l~~L~~L~Ls~N~l~~~~~~~~---~~l~~L~~L~Ls~  358 (797)
                      . ..+  ..+++|+.|+|+.  |...+..     ...+  ..+++|+.|+|++|.+....+..+   ..+++|++|+|+.
T Consensus       209 ~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~  288 (362)
T 2ra8_A          209 VVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISA  288 (362)
T ss_dssp             HHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCS
T ss_pred             HHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCC
Confidence            0 111  1355666665532  1111100     0011  124555555555555543221111   1344555555555


Q ss_pred             ccccCC----CChhhhccccCCeeeecCCcCC
Q 040702          359 NRLQGS----IPNSIGDLISLKSLNLSNNNLS  386 (797)
Q Consensus       359 N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~  386 (797)
                      |.+.+.    ++..+..+++|+.|+|++|.++
T Consensus       289 n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~  320 (362)
T 2ra8_A          289 GVLTDEGARLLLDHVDKIKHLKFINMKYNYLS  320 (362)
T ss_dssp             SCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred             CCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence            555432    1222234455555555555554

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.55  E-value=7.7e-08  Score=100.99  Aligned_cols=136  Identities=20%  Similarity=0.193  Sum_probs=101.1

Q ss_pred             cccccccCCcceeecceEEEEEEEEeccCCcchhHHHHHHHhhhcc-CCc--eeEeeeeeecCC---eEEEEEEccCCCC
Q 040702          517 NNLIGRGGFGPVYKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIR-HRN--LIKIISSCSNDD---FKALVLEYMPLGS  590 (797)
Q Consensus       517 ~~~lg~G~~g~Vyk~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-Hpn--iv~l~~~~~~~~---~~~lv~e~~~~g~  590 (797)
                      .+.++.|....||+.+..+++|+....  .....+.+|+++++.+. +..  +.+++......+   ..|+|||+++|.+
T Consensus        25 i~~~~~G~~n~v~~v~~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~  102 (304)
T 3sg8_A           25 IEISGEGNDCIAYEINRDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVP  102 (304)
T ss_dssp             CCEEEECSSEEEEESTTSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEE
T ss_pred             eEecCCCCcceEEEECCEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeE
Confidence            456899999999998888999986533  23467889999998883 332  445555544333   4589999999988


Q ss_pred             HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcc----------------------------------------------
Q 040702          591 LEKCLYSGNYILDIFQGLNIMIDVASALEYLHFG----------------------------------------------  624 (797)
Q Consensus       591 L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~----------------------------------------------  624 (797)
                      +.+....   .++..++..++.++++.++.||..                                              
T Consensus       103 l~~~~~~---~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  179 (304)
T 3sg8_A          103 LTPLLLN---NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRD  179 (304)
T ss_dssp             CCHHHHH---TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHH
T ss_pred             CCccccc---cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHH
Confidence            8654332   256777788888999988888841                                              


Q ss_pred             ---------CCCCeEEcCCCCCceEEcC--CCcEEEEeecCCcc
Q 040702          625 ---------YSVPIIHCDLKPSNVLLDD--NMVAHLSDFGMAKP  657 (797)
Q Consensus       625 ---------~~~~ivHrDlkp~NIll~~--~~~~kl~DFGla~~  657 (797)
                               ....++|+|++|.||++++  ...+.|+||+.+..
T Consensus       180 ~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~  223 (304)
T 3sg8_A          180 ILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI  223 (304)
T ss_dssp             HHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred             HHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence                     0135899999999999998  55688999999874

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.49  E-value=2.2e-08  Score=101.56  Aligned_cols=63  Identities=25%  Similarity=0.390  Sum_probs=36.3

Q ss_pred             CCCCccEEEccCccccc--cCCchhhCCCCCCEEEccCCcCcccCCccccCCC--CCCeeeccCccCcC
Q 040702          100 RLPNLKELHLWGNNFIG--TIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLR--NLKWLGLNDNYLTS  164 (797)
Q Consensus       100 ~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~--~L~~L~L~~N~l~~  164 (797)
                      ++++|++|+|++|+|++  .+|..+..+++|+.|+|++|+|+++  ..+..++  +|++|+|++|.+..
T Consensus       168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~  234 (267)
T 3rw6_A          168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCD  234 (267)
T ss_dssp             HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGG
T ss_pred             hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCcc
Confidence            45566666666666654  2334555666666666666666654  2233333  66666666666654

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.46  E-value=2.2e-08  Score=96.73  Aligned_cols=116  Identities=14%  Similarity=0.107  Sum_probs=71.4

Q ss_pred             cccCCCCCCEEEcccC-ccccc----CCccccCCCCCCEEEccCCcCccc----CCCccccCCCCccEEEccCcccccc-
Q 040702           48 EIDNLHNMEWMAFSFN-KVVGV----VPTTIFNVSTLKSLYLHSNSLSGR----LPSSADVRLPNLKELHLWGNNFIGT-  117 (797)
Q Consensus        48 ~~~~l~~L~~L~ls~N-~i~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----l~~~~~~~l~~L~~L~L~~N~l~~~-  117 (797)
                      .+...++|+.|+|++| +|...    +...+...++|++|+|++|.|...    +.. .+...++|++|+|++|.|.+. 
T Consensus        31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~-~L~~n~~L~~L~L~~N~i~~~g  109 (185)
T 1io0_A           31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAE-MLKVNNTLKSLNVESNFISGSG  109 (185)
T ss_dssp             HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHH-HHHHCSSCCEEECCSSCCCHHH
T ss_pred             HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHH-HHHhCCCcCEEECcCCcCCHHH
Confidence            3555666777777776 66532    334455566777777777777521    111 122346677777777777643 


Q ss_pred             ---CCchhhCCCCCCEEEc--cCCcCcccC----CccccCCCCCCeeeccCccCcC
Q 040702          118 ---IPSFIFNASKLSELGL--QKNSFSGSI----PNTFGNLRNLKWLGLNDNYLTS  164 (797)
Q Consensus       118 ---~~~~~~~l~~L~~L~L--~~N~l~~~~----~~~f~~l~~L~~L~L~~N~l~~  164 (797)
                         +...+...+.|++|+|  ++|.|+...    ..++...++|++|+|++|.+..
T Consensus       110 ~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~~  165 (185)
T 1io0_A          110 ILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQGP  165 (185)
T ss_dssp             HHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHHH
T ss_pred             HHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCCh
Confidence               3445566677888888  778777432    3344555778888888887653

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.45  E-value=2.9e-08  Score=100.73  Aligned_cols=99  Identities=24%  Similarity=0.193  Sum_probs=66.7

Q ss_pred             CCCccccCCCCccE--EEccCcccc---ccCCchhhCCCCCCEEEccCCcCcccC--CccccCCCCCCeeeccCccCcCC
Q 040702           93 LPSSADVRLPNLKE--LHLWGNNFI---GTIPSFIFNASKLSELGLQKNSFSGSI--PNTFGNLRNLKWLGLNDNYLTSS  165 (797)
Q Consensus        93 l~~~~~~~l~~L~~--L~L~~N~l~---~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~f~~l~~L~~L~L~~N~l~~~  165 (797)
                      ++-+.+...+.|+.  ++++.|...   ...+....++++|++|+|++|+|+++.  |..+..+++|+.|+|++|+|+++
T Consensus       132 LdLs~l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~  211 (267)
T 3rw6_A          132 LDLKGLRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE  211 (267)
T ss_dssp             EECTTGGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG
T ss_pred             cCHHHcCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc
Confidence            33333444555665  677777543   222223356889999999999998754  46778899999999999999876


Q ss_pred             CCCccccccCCCCCCCcEEEccCCCCCCCCC
Q 040702          166 TPELSSLSSLSNCKYLEYFSFSNNPLGGILP  196 (797)
Q Consensus       166 ~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~  196 (797)
                      . +   +..+..+ +|+.|+|++|++.+..|
T Consensus       212 ~-~---l~~l~~l-~L~~L~L~~Npl~~~~~  237 (267)
T 3rw6_A          212 R-E---LDKIKGL-KLEELWLDGNSLCDTFR  237 (267)
T ss_dssp             G-G---GGGGTTS-CCSEEECTTSTTGGGCS
T ss_pred             h-h---hhhcccC-CcceEEccCCcCccccC
Confidence            2 2   2234444 78888888888875444

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.44  E-value=2.5e-08  Score=96.30  Aligned_cols=123  Identities=15%  Similarity=0.139  Sum_probs=87.6

Q ss_pred             cCCccccCCCCCCEEEccCC-cCccc----CCCccccCCCCccEEEccCcccccc----CCchhhCCCCCCEEEccCCcC
Q 040702           68 VVPTTIFNVSTLKSLYLHSN-SLSGR----LPSSADVRLPNLKELHLWGNNFIGT----IPSFIFNASKLSELGLQKNSF  138 (797)
Q Consensus        68 ~~p~~~~~l~~L~~L~Ls~N-~l~~~----l~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l  138 (797)
                      .+...+...++|++|+|++| .|...    +.. .+...++|++|+|++|.|...    +...+...+.|++|+|++|.|
T Consensus        27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~-~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i  105 (185)
T 1io0_A           27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAE-ALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFI  105 (185)
T ss_dssp             HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHH-HHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCC
T ss_pred             HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHH-HHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcC
Confidence            34556777889999999999 88621    111 224568899999999998753    234555668899999999999


Q ss_pred             ccc----CCccccCCCCCCeeec--cCccCcCCCCCccccccCCCCCCCcEEEccCCCCC
Q 040702          139 SGS----IPNTFGNLRNLKWLGL--NDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLG  192 (797)
Q Consensus       139 ~~~----~~~~f~~l~~L~~L~L--~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~  192 (797)
                      +..    +..++...++|++|+|  ++|.|+...... -...+...++|++|+|++|.+.
T Consensus       106 ~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~-l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          106 SGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEME-IANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             CHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHH-HHHHHHHCSSCCEEECCCSSHH
T ss_pred             CHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHH-HHHHHHhCCCcCEEeccCCCCC
Confidence            854    3556777788999999  889887632210 0012455678999999999875

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.35  E-value=8.8e-07  Score=92.84  Aligned_cols=136  Identities=15%  Similarity=0.063  Sum_probs=95.9

Q ss_pred             cccccccCCcceeecceEEEEEEEEeccCCcchhHHHHHHHhhhccCC---ceeEeeeeee-cCCeEEEEEEccCCCCHH
Q 040702          517 NNLIGRGGFGPVYKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHR---NLIKIISSCS-NDDFKALVLEYMPLGSLE  592 (797)
Q Consensus       517 ~~~lg~G~~g~Vyk~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hp---niv~l~~~~~-~~~~~~lv~e~~~~g~L~  592 (797)
                      .+.++.|....||+-+..+++|+.+.  ......+.+|+++++.+.+.   .+.+.+.++. ..+..++||||++|.++.
T Consensus        24 v~~l~~G~~n~v~~vg~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~  101 (306)
T 3tdw_A           24 VESLGEGFRNYAILVNGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILG  101 (306)
T ss_dssp             EEEEEECSSEEEEEETTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECH
T ss_pred             eeecCCCcceeEEEECCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECc
Confidence            45678888889999888899998532  12346788999999999742   3667777764 455678999999998876


Q ss_pred             HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcc------------------------------------------------
Q 040702          593 KCLYSGNYILDIFQGLNIMIDVASALEYLHFG------------------------------------------------  624 (797)
Q Consensus       593 ~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~------------------------------------------------  624 (797)
                      +.....   ++..+...++.++++.++.||..                                                
T Consensus       102 ~~~~~~---l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~  178 (306)
T 3tdw_A          102 EDGMAV---LPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQS  178 (306)
T ss_dssp             HHHHTT---SCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHH
T ss_pred             hhhhhh---CCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHH
Confidence            532211   34445555566666666666521                                                


Q ss_pred             ---------CCCCeEEcCCCCCceEEcC---CCc-EEEEeecCCcc
Q 040702          625 ---------YSVPIIHCDLKPSNVLLDD---NMV-AHLSDFGMAKP  657 (797)
Q Consensus       625 ---------~~~~ivHrDlkp~NIll~~---~~~-~kl~DFGla~~  657 (797)
                               ....++|+|++|.||+++.   ++. +.|+||+.+..
T Consensus       179 ~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          179 YMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                     1345799999999999987   455 48999998874

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.28  E-value=3.3e-06  Score=86.72  Aligned_cols=131  Identities=19%  Similarity=0.109  Sum_probs=96.8

Q ss_pred             cccccCCc-ceee-----cceEEEEEEEEeccCCcchhHHHHHHHhhhcc-CCceeEeeeeeecCCeEEEEEEccCCCCH
Q 040702          519 LIGRGGFG-PVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIR-HRNLIKIISSCSNDDFKALVLEYMPLGSL  591 (797)
Q Consensus       519 ~lg~G~~g-~Vyk-----~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~lv~e~~~~g~L  591 (797)
                      .+..|..| .||+     ++..+++|+-...   ...++.+|...|+.+. +--+.++++++.+++..|+|||+++|.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            44556555 5886     3567899986643   2457888999998884 33477889999999999999999999888


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcc-----------------------------------------------
Q 040702          592 EKCLYSGNYILDIFQGLNIMIDVASALEYLHFG-----------------------------------------------  624 (797)
Q Consensus       592 ~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~-----------------------------------------------  624 (797)
                      .+......     .....++.+++..++.||..                                               
T Consensus       108 ~~~~~~~~-----~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (272)
T 4gkh_A          108 FQVLEEYP-----DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE  182 (272)
T ss_dssp             HHHHHHCG-----GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred             cccccCCH-----HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence            77654321     23345677778888888831                                               


Q ss_pred             --------CCCCeEEcCCCCCceEEcCCCcEEEEeecCCcc
Q 040702          625 --------YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  657 (797)
Q Consensus       625 --------~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  657 (797)
                              ....++|+|+.+.||++++++.+-|+||+.+..
T Consensus       183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                    012379999999999999887778999998863

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.98  E-value=8.3e-06  Score=87.44  Aligned_cols=76  Identities=5%  Similarity=-0.062  Sum_probs=53.5

Q ss_pred             cccc-cccCCcceeec-----------ceEEEEEEEEecc---CCcchhHHHHHHHhhhcc-C--CceeEeeeeeecC--
Q 040702          517 NNLI-GRGGFGPVYKD-----------GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIR-H--RNLIKIISSCSND--  576 (797)
Q Consensus       517 ~~~l-g~G~~g~Vyk~-----------~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~-H--pniv~l~~~~~~~--  576 (797)
                      .+.| +.|....+|+-           +..+++|+.....   ......+.+|+.+++.+. +  -.+.++++++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3566 77888888862           5678888765433   112367889999999885 3  3577888887665  


Q ss_pred             -CeEEEEEEccCCCCHH
Q 040702          577 -DFKALVLEYMPLGSLE  592 (797)
Q Consensus       577 -~~~~lv~e~~~~g~L~  592 (797)
                       +..++||||++|..+.
T Consensus       105 ~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TSSCEEEEECCCCBCCC
T ss_pred             cCCceEEEEecCCCChh
Confidence             3578999999886543

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.82  E-value=6.3e-06  Score=77.43  Aligned_cols=83  Identities=11%  Similarity=0.138  Sum_probs=40.7

Q ss_pred             CccEEEccCccccccCCchhhCCCCCCEEEccCCc-CcccCCccccCC----CCCCeeeccCcc-CcCCCCCccccccCC
Q 040702          103 NLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNS-FSGSIPNTFGNL----RNLKWLGLNDNY-LTSSTPELSSLSSLS  176 (797)
Q Consensus       103 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~-l~~~~~~~f~~l----~~L~~L~L~~N~-l~~~~~~~~~~~~l~  176 (797)
                      +|++|||+++.|+..--..+.++++|++|+|++|. |+...-..+..+    ++|++|+|++|. |+...-     ..+.
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl-----~~L~  136 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGI-----IALH  136 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHH-----HHGG
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHH-----HHHh
Confidence            45555555555444333444555555555555553 443222333333    246666666653 443221     1244


Q ss_pred             CCCCCcEEEccCCC
Q 040702          177 NCKYLEYFSFSNNP  190 (797)
Q Consensus       177 ~l~~L~~L~Ls~N~  190 (797)
                      .+++|++|+++++.
T Consensus       137 ~~~~L~~L~L~~c~  150 (176)
T 3e4g_A          137 HFRNLKYLFLSDLP  150 (176)
T ss_dssp             GCTTCCEEEEESCT
T ss_pred             cCCCCCEEECCCCC
Confidence            55666666666654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.71  E-value=7.5e-05  Score=79.32  Aligned_cols=136  Identities=15%  Similarity=0.079  Sum_probs=78.4

Q ss_pred             ccccccCCcceeec---ceEEEEEEEEeccCCcchhHHHHHHHhhhccC--CceeEeee------eeecCCeEEEEEEcc
Q 040702          518 NLIGRGGFGPVYKD---GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRH--RNLIKIIS------SCSNDDFKALVLEYM  586 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~---~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H--pniv~l~~------~~~~~~~~~lv~e~~  586 (797)
                      +.++.|..+.||+.   +..+++|+....    ...+..|+.+++.+..  -.+++++.      +....+..++||||+
T Consensus        38 ~~l~gG~~n~~~~v~~~~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i  113 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI  113 (346)
T ss_dssp             EECC----CEEEEEEETTEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred             eeccccccCcEEEEEeCCCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence            45666778889973   356899988642    2445556666666641  12344443      123466789999999


Q ss_pred             CCCCHH-----H---------HHhc--C----CC-------CCCHHHH-------------------------------H
Q 040702          587 PLGSLE-----K---------CLYS--G----NY-------ILDIFQG-------------------------------L  608 (797)
Q Consensus       587 ~~g~L~-----~---------~l~~--~----~~-------~l~~~~~-------------------------------~  608 (797)
                      +|..+.     .         .++.  .    ..       .-.|...                               .
T Consensus       114 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  193 (346)
T 2q83_A          114 EGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEID  193 (346)
T ss_dssp             CCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHH
T ss_pred             cCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHH
Confidence            986431     0         1111  0    00       0122211                               0


Q ss_pred             HHHHHHHHHHHHHHc----------cCCCCeEEcCCCCCceEEcCCCcEEEEeecCCcc
Q 040702          609 NIMIDVASALEYLHF----------GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  657 (797)
Q Consensus       609 ~i~~qi~~al~yLH~----------~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  657 (797)
                      .+..++..++++|+.          .....++|+|+++.||+++.++.+.|+||+.+..
T Consensus       194 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          194 GFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            111223345666652          0257899999999999998888999999998863

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.66  E-value=0.0001  Score=80.07  Aligned_cols=71  Identities=17%  Similarity=0.132  Sum_probs=48.6

Q ss_pred             cccccccCCcceeec-----ceEEEEEEEEeccC-------CcchhHHHHHHHhhhccC--C-ceeEeeeeeecCCeEEE
Q 040702          517 NNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG-------GAFKSFDIECGMMKRIRH--R-NLIKIISSCSNDDFKAL  581 (797)
Q Consensus       517 ~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~-------~~~~~~~~E~~~l~~l~H--p-niv~l~~~~~~~~~~~l  581 (797)
                      .+.+|.|.++.||+.     ++.|+||.......       ...+.+..|.++++.+..  | .+++++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            467899999999985     36799998653211       124567889999988742  3 44566654  3445689


Q ss_pred             EEEccCCC
Q 040702          582 VLEYMPLG  589 (797)
Q Consensus       582 v~e~~~~g  589 (797)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999763

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.65  E-value=2.2e-05  Score=73.71  Aligned_cols=83  Identities=12%  Similarity=0.034  Sum_probs=41.2

Q ss_pred             CcccEEEccCCcCCCCCCccccccccccEEeccCcc-cccccCccccCC----cccceecccCcc-ccCCCChhhhcccc
Q 040702          301 KDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNN-FSCVIPTKIGGL----KDLQYLFLEYNR-LQGSIPNSIGDLIS  374 (797)
Q Consensus       301 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l~~  374 (797)
                      .+|++||++++.++..--..+.++++|+.|+|++|. |+...-..+..+    ++|++|+|+++. +++.--..+..+++
T Consensus        61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~  140 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN  140 (176)
T ss_dssp             CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred             ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence            356666666666654333344555666666666653 443322233332    245555555543 44333334444555


Q ss_pred             CCeeeecCC
Q 040702          375 LKSLNLSNN  383 (797)
Q Consensus       375 L~~L~Ls~N  383 (797)
                      |++|+|+++
T Consensus       141 L~~L~L~~c  149 (176)
T 3e4g_A          141 LKYLFLSDL  149 (176)
T ss_dssp             CCEEEEESC
T ss_pred             CCEEECCCC
Confidence            555555554

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.53  E-value=0.00024  Score=74.05  Aligned_cols=134  Identities=13%  Similarity=0.079  Sum_probs=89.7

Q ss_pred             ccccccccCCcceee---cceEEEEEEEEeccCCcchhHHHHHHHhhhcc---CCceeEeeeeeecCCeEEEEEEccCCC
Q 040702          516 ENNLIGRGGFGPVYK---DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIR---HRNLIKIISSCSNDDFKALVLEYMPLG  589 (797)
Q Consensus       516 ~~~~lg~G~~g~Vyk---~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~---Hpniv~l~~~~~~~~~~~lv~e~~~~g  589 (797)
                      ..+.++.|....+|+   ++..+++|+....   ....+..|++.|+.+.   ...++++++++...+..++||||+++.
T Consensus        40 ~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLINDEVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEEECCSSSSEEEEEESSSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eeEEeCCccceeeeEEEECCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            346789999999997   3578899987643   2467889999998884   357888999888888999999999987


Q ss_pred             CHH--------H---HHhcCCC---------------------CCCHHHHH---HHHH----------------HHHHHH
Q 040702          590 SLE--------K---CLYSGNY---------------------ILDIFQGL---NIMI----------------DVASAL  618 (797)
Q Consensus       590 ~L~--------~---~l~~~~~---------------------~l~~~~~~---~i~~----------------qi~~al  618 (797)
                      .+.        +   .++....                     .-+|....   ++..                ++...+
T Consensus       117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l  196 (312)
T 3jr1_A          117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV  196 (312)
T ss_dssp             CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence            541        1   1222110                     01344321   1111                111111


Q ss_pred             -HHHH-ccCCCCeEEcCCCCCceEEcCCCcEEEEeec
Q 040702          619 -EYLH-FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFG  653 (797)
Q Consensus       619 -~yLH-~~~~~~ivHrDlkp~NIll~~~~~~kl~DFG  653 (797)
                       ..|. ......++|+|+.+.|++++.++ +.|+||+
T Consensus       197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence             2332 12256799999999999999887 8899984

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=97.14  E-value=0.00013  Score=69.84  Aligned_cols=119  Identities=10%  Similarity=0.083  Sum_probs=61.3

Q ss_pred             ccCCCCCCEEEccCC-cCcc----cCCCccccCCCCccEEEccCccccccC----CchhhCCCCCCEEEccCCcCcccC-
Q 040702           73 IFNVSTLKSLYLHSN-SLSG----RLPSSADVRLPNLKELHLWGNNFIGTI----PSFIFNASKLSELGLQKNSFSGSI-  142 (797)
Q Consensus        73 ~~~l~~L~~L~Ls~N-~l~~----~l~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~-  142 (797)
                      +.+-+.|++|+|++| +|..    .+-. +...-+.|++|+|++|+|.+..    ...+..-+.|++|+|++|+|.... 
T Consensus        37 l~~n~~L~~L~L~~nn~igd~ga~~la~-aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga  115 (197)
T 1pgv_A           37 REDDTDLKEVNINNMKRVSKERIRSLIE-AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELL  115 (197)
T ss_dssp             HTTCSSCCEEECTTCCSSCHHHHHHHHH-HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHH
T ss_pred             HhcCCCccEEECCCCCCCCHHHHHHHHH-HHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHH
Confidence            344456666666654 5531    0111 1123456666666666665322    233445566777777777776332 


Q ss_pred             ---CccccCCCCCCeeeccCccCcCCCCCc--cccccCCCCCCCcEEEccCCCCC
Q 040702          143 ---PNTFGNLRNLKWLGLNDNYLTSSTPEL--SSLSSLSNCKYLEYFSFSNNPLG  192 (797)
Q Consensus       143 ---~~~f~~l~~L~~L~L~~N~l~~~~~~~--~~~~~l~~l~~L~~L~Ls~N~l~  192 (797)
                         ..++..-+.|++|+|++|....+....  .-...+..-+.|+.|+++.|.+.
T Consensus       116 ~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g  170 (197)
T 1pgv_A          116 ARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME  170 (197)
T ss_dssp             HHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred             HHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence               223444456777777755331111110  00012445567888888877654

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.06  E-value=0.00069  Score=60.51  Aligned_cols=37  Identities=24%  Similarity=0.251  Sum_probs=19.5

Q ss_pred             CCCEEEccCCcCcccCCccccCCCCCCeeeccCccCc
Q 040702          127 KLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLT  163 (797)
Q Consensus       127 ~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~  163 (797)
                      +|++|+|++|+|+.+.+++|..+++|++|+|++|.+.
T Consensus        32 ~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           32 DTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             TCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             CCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            3455555555555555555555555555555555443

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.00  E-value=0.001  Score=59.36  Aligned_cols=56  Identities=25%  Similarity=0.328  Sum_probs=35.6

Q ss_pred             EEEcccCccc-ccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCcccc
Q 040702           57 WMAFSFNKVV-GVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFI  115 (797)
Q Consensus        57 ~L~ls~N~i~-~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~  115 (797)
                      .++.++++++ ..+|..+  -++|+.|+|++|+|+ .+|..+|..+++|++|+|++|.+.
T Consensus        12 ~v~Cs~~~L~~~~vP~~l--p~~l~~L~Ls~N~l~-~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAF--PVDTTELVLTGNNLT-ALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             EEECCSSCCCTTTSCSCC--CTTCSEEECTTSCCS-SCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             EEEeCCCCCccccCCCCC--CcCCCEEECCCCcCC-ccChhhhhhccccCEEEecCCCee
Confidence            5666666665 1234332  135777777777776 777777777777777777777653

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=96.96  E-value=0.00018  Score=68.84  Aligned_cols=112  Identities=10%  Similarity=0.115  Sum_probs=66.7

Q ss_pred             cCCCCCCEEEcccC-ccccc----CCccccCCCCCCEEEccCCcCcccCCCc----cccCCCCccEEEccCccccccC--
Q 040702           50 DNLHNMEWMAFSFN-KVVGV----VPTTIFNVSTLKSLYLHSNSLSGRLPSS----ADVRLPNLKELHLWGNNFIGTI--  118 (797)
Q Consensus        50 ~~l~~L~~L~ls~N-~i~~~----~p~~~~~l~~L~~L~Ls~N~l~~~l~~~----~~~~l~~L~~L~L~~N~l~~~~--  118 (797)
                      .+-+.|+.|+|++| +|...    +-.++..-+.|+.|+|++|+|. .-...    +...-+.|++|+|++|.|.+.-  
T Consensus        38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~ig-d~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~  116 (197)
T 1pgv_A           38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAIS-DSEARGLIELIETSPSLRVLNVESNFLTPELLA  116 (197)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCB-HHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred             hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCC-hHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence            34456777777764 66432    3345555667788888888775 21111    1123467888888888876432  


Q ss_pred             --CchhhCCCCCCEEEccCCc---Cccc----CCccccCCCCCCeeeccCccC
Q 040702          119 --PSFIFNASKLSELGLQKNS---FSGS----IPNTFGNLRNLKWLGLNDNYL  162 (797)
Q Consensus       119 --~~~~~~l~~L~~L~L~~N~---l~~~----~~~~f~~l~~L~~L~L~~N~l  162 (797)
                        ..++..-+.|++|+|++|.   |...    +..++..-+.|+.|+++.|.+
T Consensus       117 ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~  169 (197)
T 1pgv_A          117 RLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM  169 (197)
T ss_dssp             HHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred             HHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence              2344455668888887653   3321    233455567788888877754

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.88  E-value=0.0026  Score=66.03  Aligned_cols=128  Identities=12%  Similarity=0.088  Sum_probs=76.7

Q ss_pred             ccccccccCCcceeecceEEEEEEEEeccCCcchhHHHHHHHhhhccCCce-eEeeeeeecCCeEEEEEEcc-CCCCHHH
Q 040702          516 ENNLIGRGGFGPVYKDGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNL-IKIISSCSNDDFKALVLEYM-PLGSLEK  593 (797)
Q Consensus       516 ~~~~lg~G~~g~Vyk~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpni-v~l~~~~~~~~~~~lv~e~~-~~g~L~~  593 (797)
                      ..+.++.|....+|+- ..+++|+....... .....+|+.+++.+....+ .++++++  ++..++|+||+ +|.++..
T Consensus        22 ~i~~l~gG~tN~~~~~-~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~l~~   97 (301)
T 3dxq_A           22 GPLERLGGLTNLVFRA-GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQTMSP   97 (301)
T ss_dssp             SCEEEESCSSEEEEEE-TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEECCH
T ss_pred             ceeEcCCcccccccee-eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCccCCH
Confidence            3678888999999988 77888887654222 2344678888887752222 4555543  33357899999 5544321


Q ss_pred             H-HhcCCCCCCHHHHHHHHHHHHHHHHHHHc-------------------------------------------------
Q 040702          594 C-LYSGNYILDIFQGLNIMIDVASALEYLHF-------------------------------------------------  623 (797)
Q Consensus       594 ~-l~~~~~~l~~~~~~~i~~qi~~al~yLH~-------------------------------------------------  623 (797)
                      . +..         +..++.++++.|+-+|.                                                 
T Consensus        98 ~~~~~---------~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~  168 (301)
T 3dxq_A           98 EKFKT---------RPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAA  168 (301)
T ss_dssp             HHHHH---------STTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHS
T ss_pred             hhHhh---------hHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHh
Confidence            0 000         00112222222222221                                                 


Q ss_pred             -cCCCCeEEcCCCCCceEEcCCCcEEEEeecCCcc
Q 040702          624 -GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  657 (797)
Q Consensus       624 -~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  657 (797)
                       .....++|+|+.+.||+ ..++.+.++||..+..
T Consensus       169 ~~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          169 HPLPLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             SCCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             cCCCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence             12345899999999999 5667889999998864

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.85  E-value=0.0034  Score=65.75  Aligned_cols=155  Identities=15%  Similarity=0.151  Sum_probs=87.7

Q ss_pred             ccCHHHHHHHhcCCCc-----cccccccCCcceeec---ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCc--eeEee
Q 040702          501 RFTYLELFQATNRFSE-----NNLIGRGGFGPVYKD---GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRN--LIKII  570 (797)
Q Consensus       501 ~~~~~~l~~~~~~f~~-----~~~lg~G~~g~Vyk~---~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpn--iv~l~  570 (797)
                      .++.+++......|..     .+.++.|....+|+-   +..+++|+....  .....+..|+.+++.+....  +.+++
T Consensus         6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~   83 (322)
T 2ppq_A            6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL   83 (322)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCccEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence            4556666666666754     245666777888872   347889988653  12356777888888775222  33444


Q ss_pred             ee------eecCCeEEEEEEccCCCCHH-----HH---------HhcC--C--CC----C---CHHHHHH----------
Q 040702          571 SS------CSNDDFKALVLEYMPLGSLE-----KC---------LYSG--N--YI----L---DIFQGLN----------  609 (797)
Q Consensus       571 ~~------~~~~~~~~lv~e~~~~g~L~-----~~---------l~~~--~--~~----l---~~~~~~~----------  609 (797)
                      ..      ....+..+++|+|++|..+.     .+         ++..  .  ..    .   .|.....          
T Consensus        84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~  163 (322)
T 2ppq_A           84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  163 (322)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence            22      12345678999999875421     10         1110  0  00    0   1221100          


Q ss_pred             --HHHHHHHHHHHHHcc----CCCCeEEcCCCCCceEEcCCCcEEEEeecCCcc
Q 040702          610 --IMIDVASALEYLHFG----YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  657 (797)
Q Consensus       610 --i~~qi~~al~yLH~~----~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  657 (797)
                        +...+.+.+++++..    ...+++|+|+.+.||++++++.+.|+||+.+..
T Consensus       164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence              001134445555421    245799999999999999876668999998863

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.83  E-value=0.0028  Score=66.73  Aligned_cols=135  Identities=11%  Similarity=0.045  Sum_probs=71.2

Q ss_pred             ccccccCCcc-eee---c-ceEEEEEEEEeccCCcchhHHHHHHHhhhccC--CceeEeeeeeecCCeEEEEEEccCCCC
Q 040702          518 NLIGRGGFGP-VYK---D-GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRH--RNLIKIISSCSNDDFKALVLEYMPLGS  590 (797)
Q Consensus       518 ~~lg~G~~g~-Vyk---~-~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H--pniv~l~~~~~~~~~~~lv~e~~~~g~  590 (797)
                      +.++.|+... +|+   + +..+++|......   ...+..|+.+++.+..  -.+++++.+....+  ++|||++.+..
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~   98 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL   98 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence            4565554443 554   2 5667776543221   1455667888777742  23556666644333  78999997766


Q ss_pred             HHHHHhcCC-------------------------CCCCHHHHH-------HH-------------HHHHHHHHHHHH---
Q 040702          591 LEKCLYSGN-------------------------YILDIFQGL-------NI-------------MIDVASALEYLH---  622 (797)
Q Consensus       591 L~~~l~~~~-------------------------~~l~~~~~~-------~i-------------~~qi~~al~yLH---  622 (797)
                      +.+.+....                         ..++.....       .+             ...+...++.+.   
T Consensus        99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~  178 (333)
T 3csv_A           99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ  178 (333)
T ss_dssp             HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence            654432210                         011111100       00             001111222221   


Q ss_pred             ccCCCCeEEcCCCCCceEEcCC----CcEEEEeecCCcc
Q 040702          623 FGYSVPIIHCDLKPSNVLLDDN----MVAHLSDFGMAKP  657 (797)
Q Consensus       623 ~~~~~~ivHrDlkp~NIll~~~----~~~kl~DFGla~~  657 (797)
                      ......++|+|+.+.||+++.+    +.+.|+||+.+..
T Consensus       179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            1125689999999999999874    6899999999874

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=96.82  E-value=0.0021  Score=70.18  Aligned_cols=31  Identities=19%  Similarity=0.317  Sum_probs=28.2

Q ss_pred             CCCeEEcCCCCCceEEcCCCcEEEEeecCCcc
Q 040702          626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  657 (797)
Q Consensus       626 ~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  657 (797)
                      ...++|+|++|.|||++.++ ++++||+.+..
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            77899999999999998776 99999999874

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=96.64  E-value=0.0061  Score=62.69  Aligned_cols=74  Identities=12%  Similarity=0.084  Sum_probs=52.1

Q ss_pred             CCCccccccccCCcceee----cceEEEEEEEEeccCCcchhHHHHHHHhhhcc-C--CceeEeeeeeecCCeEEEEEEc
Q 040702          513 RFSENNLIGRGGFGPVYK----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIR-H--RNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk----~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-H--pniv~l~~~~~~~~~~~lv~e~  585 (797)
                      .....+.+|.|..+.||+    +|+.|.+|+-..........|..|++.|+.+. .  --+++++++.    ..++||||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~   91 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW   91 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence            345567889999999998    47899999865443333457889999999884 2  2344555542    24789999


Q ss_pred             cCCCC
Q 040702          586 MPLGS  590 (797)
Q Consensus       586 ~~~g~  590 (797)
                      ++++.
T Consensus        92 l~~~~   96 (288)
T 3f7w_A           92 VDERP   96 (288)
T ss_dssp             CCCCC
T ss_pred             ecccC
Confidence            98764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.40  E-value=0.023  Score=59.41  Aligned_cols=154  Identities=10%  Similarity=0.064  Sum_probs=86.7

Q ss_pred             CccCHHHHHHHhcCCCc-----cccccccCCcceeec----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCC--ceeE
Q 040702          500 RRFTYLELFQATNRFSE-----NNLIGRGGFGPVYKD----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHR--NLIK  568 (797)
Q Consensus       500 ~~~~~~~l~~~~~~f~~-----~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hp--niv~  568 (797)
                      ...+.+++......|..     ...++ |....||+-    |+.+++|+.+... .....+..|..+++.+...  .+++
T Consensus         9 ~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~   86 (328)
T 1zyl_A            9 QTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAA   86 (328)
T ss_dssp             CCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCC
T ss_pred             CCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecc
Confidence            34555556555555532     24566 777888972    4579999986432 2345677788888887522  2444


Q ss_pred             eeee-----eecCCeEEEEEEccCCCCHH-----HH---------Hhc----CC----CCCCHHHH----HHH-------
Q 040702          569 IISS-----CSNDDFKALVLEYMPLGSLE-----KC---------LYS----GN----YILDIFQG----LNI-------  610 (797)
Q Consensus       569 l~~~-----~~~~~~~~lv~e~~~~g~L~-----~~---------l~~----~~----~~l~~~~~----~~i-------  610 (797)
                      ++..     ....+..++||||++|..+.     ..         ++.    ..    ...++...    ..+       
T Consensus        87 ~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  166 (328)
T 1zyl_A           87 PVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLI  166 (328)
T ss_dssp             CCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSS
T ss_pred             eeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcC
Confidence            4443     22345678999999874321     11         111    00    01222111    001       


Q ss_pred             --------HHHHHHHHHHHHc----cCCCCeEEcCCCCCceEEcCCCcEEEEeecCCcc
Q 040702          611 --------MIDVASALEYLHF----GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  657 (797)
Q Consensus       611 --------~~qi~~al~yLH~----~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  657 (797)
                              ...+...++.+..    .....++|+|+++.||+++ + .+.|+||+.+..
T Consensus       167 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          167 PSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             CHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                    0111112222221    1256689999999999999 4 899999998863

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=95.90  E-value=0.0048  Score=67.43  Aligned_cols=67  Identities=18%  Similarity=0.183  Sum_probs=43.8

Q ss_pred             ccccccCCcceeec------------ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCce-eEeeeeeecCCeEEEEEE
Q 040702          518 NLIGRGGFGPVYKD------------GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNL-IKIISSCSNDDFKALVLE  584 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~------------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpni-v~l~~~~~~~~~~~lv~e  584 (797)
                      +.|+.|....||+.            +..|++|+....  .....+..|..+++.+...++ +++++.+.+    .+|||
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e  152 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  152 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence            56777777888862            257888887321  111566689999988853333 566666542    38999


Q ss_pred             ccCCCC
Q 040702          585 YMPLGS  590 (797)
Q Consensus       585 ~~~~g~  590 (797)
                      |++|.+
T Consensus       153 ~l~G~~  158 (429)
T 1nw1_A          153 YIPSRP  158 (429)
T ss_dssp             CCCEEE
T ss_pred             EeCCcc
Confidence            998643

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=95.78  E-value=0.014  Score=64.09  Aligned_cols=69  Identities=14%  Similarity=0.114  Sum_probs=42.8

Q ss_pred             cccccccCCcceeec---c--eEEEEEEEEeccCCcchhHHHHHHHhhhccCCce-eEeeeeeecCCeEEEEEEccCCCC
Q 040702          517 NNLIGRGGFGPVYKD---G--MEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNL-IKIISSCSNDDFKALVLEYMPLGS  590 (797)
Q Consensus       517 ~~~lg~G~~g~Vyk~---~--~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpni-v~l~~~~~~~~~~~lv~e~~~~g~  590 (797)
                      .+.|+.|-...+|+-   +  ..|++|+....... .-+-.+|..+++.+...++ +++++++.  +  ..||||++|.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            356777777888872   2  77888877433221 1223689999998864333 56777663  2  25999998743

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=95.64  E-value=0.027  Score=60.07  Aligned_cols=135  Identities=14%  Similarity=0.130  Sum_probs=77.8

Q ss_pred             ccccccCCcceeec------------ceEEEEEEEEeccCCcchhHHHHHHHhhhcc-CCceeEeeeeeecCCeEEEEEE
Q 040702          518 NLIGRGGFGPVYKD------------GMEVAIKVFNLQYGGAFKSFDIECGMMKRIR-HRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~------------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      +.+..|-...+|+-            +..|++|+..... .....+.+|.++++.+. +.-..++++++.+    .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            45656666777762            2578888753221 23456678999998885 3223566666643    28999


Q ss_pred             ccCCCCHHH--------------H---HhcCC----CCCC--HHHHHHHHHHHHH-------------------HHHHHH
Q 040702          585 YMPLGSLEK--------------C---LYSGN----YILD--IFQGLNIMIDVAS-------------------ALEYLH  622 (797)
Q Consensus       585 ~~~~g~L~~--------------~---l~~~~----~~l~--~~~~~~i~~qi~~-------------------al~yLH  622 (797)
                      |++|.++..              .   ++...    ....  +.+..++..++..                   .+..|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            998754421              1   12211    1112  3444555544322                   223332


Q ss_pred             ----c-cCCCCeEEcCCCCCceEEcCC----CcEEEEeecCCcc
Q 040702          623 ----F-GYSVPIIHCDLKPSNVLLDDN----MVAHLSDFGMAKP  657 (797)
Q Consensus       623 ----~-~~~~~ivHrDlkp~NIll~~~----~~~kl~DFGla~~  657 (797)
                          . .....++|+|+.+.||+++.+    +.+.++||..|..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                1 124568999999999999876    7899999998863

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=95.35  E-value=0.015  Score=62.16  Aligned_cols=68  Identities=9%  Similarity=0.125  Sum_probs=39.5

Q ss_pred             ccccccCCcceeec---c----------eEEEEEEEEeccCCcchhHHHHHHHhhhccCCc-eeEeeeeeecCCeEEEEE
Q 040702          518 NLIGRGGFGPVYKD---G----------MEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRN-LIKIISSCSNDDFKALVL  583 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~---~----------~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpn-iv~l~~~~~~~~~~~lv~  583 (797)
                      +.++.|....+|+-   +          ..+++|+...... .......|.++++.+...+ ++++++..  .  .++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence            46677777788862   1          5788887643321 1223467888888885333 44666544  2  36899


Q ss_pred             EccCCCC
Q 040702          584 EYMPLGS  590 (797)
Q Consensus       584 e~~~~g~  590 (797)
                      ||++|..
T Consensus       114 e~i~G~~  120 (369)
T 3c5i_A          114 EWLYGDP  120 (369)
T ss_dssp             ECCCSEE
T ss_pred             EEecCCc
Confidence            9998753

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.07  E-value=0.079  Score=55.69  Aligned_cols=32  Identities=19%  Similarity=0.293  Sum_probs=28.3

Q ss_pred             CCCeEEcCCCCCceEEcCCCcEEEEeecCCcc
Q 040702          626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  657 (797)
Q Consensus       626 ~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  657 (797)
                      ...++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            45799999999999999888899999988764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=94.77  E-value=0.095  Score=50.30  Aligned_cols=138  Identities=12%  Similarity=0.021  Sum_probs=90.1

Q ss_pred             CHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccccccc
Q 040702          590 SLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQ  669 (797)
Q Consensus       590 ~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~  669 (797)
                      +|.+++...+.++++.++|.++.|.+.+|.-.-.  .+.-..+=+-|..|++..+|.+.+.+ +.+.             
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------   97 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------   97 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc-------------
Confidence            8999999888889999999999999999887620  11111233446889999999887653 1111             


Q ss_pred             cccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhhhhhcccccchhccccC------------------
Q 040702          670 TLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEKHLMTKEQPMVRMGTDL------------------  731 (797)
Q Consensus       670 ~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~------------------  731 (797)
                       .....+.|||... ...+.+.-|+++|...+. ..|..+....+.+..+.+..++..|...                  
T Consensus        98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~-ALDygL~e~eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~  174 (229)
T 2yle_A           98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYK-ALDYGLKENEERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGL  174 (229)
T ss_dssp             ----------CCSS-SSSCHHHHHHHHHHHHHH-HHTTTCCTTEEECCCHHHHHHHHHHTTCCC----------------
T ss_pred             -ccccCCCChhhcc-ccchHHHHHHHHHHHHHH-HhhcCCCcccchhhCHHHHHHHHHHHhccccccccccccccccccc
Confidence             1122466887663 345688899999988643 3466666667777777777778777654                  


Q ss_pred             -------CCCCCCChHHHHHhH
Q 040702          732 -------SLGQFPASYSISKYL  746 (797)
Q Consensus       732 -------dp~~RPs~~~i~~~l  746 (797)
                             .+..|++.++|++..
T Consensus       175 ~d~~~~~~~~~~~sl~~Vi~~C  196 (229)
T 2yle_A          175 GDEDEKRKISAIRSYRDVMKLC  196 (229)
T ss_dssp             ----CCSCCCCCCSHHHHHHHH
T ss_pred             ccccccccccCcCCHHHHHHHH
Confidence                   235777877777654

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=90.70  E-value=0.6  Score=50.39  Aligned_cols=31  Identities=23%  Similarity=0.342  Sum_probs=27.2

Q ss_pred             CCCeEEcCCCCCceEEcCCCcEEEEeecCCcc
Q 040702          626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  657 (797)
Q Consensus       626 ~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  657 (797)
                      ...++|+|+.+.||+ +.++.+.++||..|..
T Consensus       261 ~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          261 SLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             CEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             CceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            346899999999999 8888999999998874

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=82.12  E-value=0.43  Score=32.67  Aligned_cols=17  Identities=18%  Similarity=0.217  Sum_probs=7.2

Q ss_pred             HHHHHHHHHhhhhcCcc
Q 040702          469 FMMVVVLLILKYRKGRK  485 (797)
Q Consensus       469 ~~~~~~~~~~~~r~~r~  485 (797)
                      ++++++.++++.||++.
T Consensus        24 ~~ii~~~~~~~~RRr~~   40 (44)
T 2ks1_B           24 LLVVALGIGLFMRRRHI   40 (44)
T ss_dssp             HHHHHHHHHHHHHTTTC
T ss_pred             HHHHHHHHHHHhhhhHh
Confidence            33344444444444433

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=81.25  E-value=0.32  Score=33.25  Aligned_cols=19  Identities=16%  Similarity=0.258  Sum_probs=8.4

Q ss_pred             hHHHHHHHHHhhhhcCccc
Q 040702          468 IFMMVVVLLILKYRKGRKS  486 (797)
Q Consensus       468 ~~~~~~~~~~~~~r~~r~~  486 (797)
                      +++++++.++++.||++++
T Consensus        22 ~v~ii~~~~~~~~RRRr~~   40 (44)
T 2l2t_A           22 ILVIVGLTFAVYVRRKSIK   40 (44)
T ss_dssp             HHHHHHHHHHHHHHTTCSS
T ss_pred             HHHHHHHHHHHHhhhhhhh
Confidence            3334444444444444433

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	797
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-41
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-41
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	8e-40
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	7e-39
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-38
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	8e-38
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-37
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-36
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-36
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	7e-36
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	8e-36
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-35
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-35
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-35
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	4e-35
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-35
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-34
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-34
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-34
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-34
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	6e-34
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	7e-34
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-33
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-33
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-33
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-33
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-32
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-32
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	7e-32
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-31
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	6e-31
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	7e-31
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	7e-31
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	3e-30
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	5e-30
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-29
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-29
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-28
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-28
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-28
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	9e-28
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-27
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-27
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-27
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-26
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-26
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-26
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-26
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	6e-26
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-25
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-25
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-25
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	9e-25
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-24
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-24
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-23
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	6e-20
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-17
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	8e-17
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-16
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	3e-09
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	6e-05
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-23
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	6e-23
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-22
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	2e-20
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-17
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	6e-12
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-22
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-21
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-20
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-20
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-19
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-18
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	5e-18
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-17
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	5e-14
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-11
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	8e-05
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-04
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-17
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-14
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	5e-13
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-09
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	8e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-10
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-10
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	0.004
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-09
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	4e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	5e-06
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	1e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	9e-09
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	7e-08
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	4e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	7e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-04
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.002
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	1e-06
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	3e-04
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.002
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	1e-06
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	4e-05
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	2e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	6e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.003
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	2e-06
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	4e-06
d1w8aa_	192	c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga	5e-04
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-06
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	4e-06
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	3e-04
d1a9na_	162	c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom	0.004
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	6e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	7e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-04
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-04
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	1e-05
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	1e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	3e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	5e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.001
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	2e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	3e-04
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	0.002
d1m9la_	198	c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree	5e-04

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 1e-41
 Identities = 47/179 (26%), Positives = 85/179 (47%), Gaps = 8/179 (4%)

Query: 512 NRFSENNLIGRGGFGPVYK--DGMEVAIKVFNLQYGGA--FKSFDIECGMMKRIRHRNLI 567
            + +    IG G FG VYK     +VA+K+ N+        ++F  E G++++ RH N++
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67

Query: 568 KIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
             +   +     A+V ++    SL   L+      ++ + ++I    A  ++YLH     
Sbjct: 68  LFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK--- 123

Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGE 686
            IIH DLK +N+ L +++   + DFG+A        S    Q   +I +MAP+ I   +
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  150 bits (380), Expect = 4e-41
 Identities = 50/211 (23%), Positives = 91/211 (43%), Gaps = 24/211 (11%)

Query: 502 FTYLELFQATNRFSEN---------NLIGRGGFGPVYK--------DGMEVAIKVFNLQY 544
           FT+ +  +A   F++           +IG G FG V            + VAIK     Y
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 545 G-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILD 603
                + F  E  +M +  H N+I +    +      ++ E+M  GSL+  L   +    
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 126

Query: 604 IFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ 663
           + Q + ++  +A+ ++YL     +  +H DL   N+L++ N+V  +SDFG+++ L ++  
Sbjct: 127 VIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 183

Query: 664 SLTQTQTL---ATIGYMAPDEIFSGEMRLKC 691
             T T  L     I + AP+ I   +     
Sbjct: 184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSAS 214

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (368), Expect = 8e-40
 Identities = 45/187 (24%), Positives = 88/187 (47%), Gaps = 11/187 (5%)

Query: 512 NRFSENNLIGRGGFGPVYK----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLI 567
                   +G G FG V+        +VA+K           +F  E  +MK+++H+ L+
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLV 71

Query: 568 KIISSCSNDDFKALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFGYS 626
           ++ +  + +    ++ EYM  GSL   L +     L I + L++   +A  + ++     
Sbjct: 72  RLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---E 127

Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGE 686
              IH DL+ +N+L+ D +   ++DFG+A+ L+E+++   +      I + AP+ I  G 
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLAR-LIEDNEYTAREGAKFPIKWTAPEAINYGT 186

Query: 687 MRLKCWV 693
             +K  V
Sbjct: 187 FTIKSDV 193

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 7e-39
 Identities = 45/188 (23%), Positives = 84/188 (44%), Gaps = 16/188 (8%)

Query: 505 LELFQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKS-FDIECGMM 558
           +EL    + F + + +G G  G V+K      G+ +A K+ +L+   A ++    E  ++
Sbjct: 1   MEL--KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 58

Query: 559 KRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASAL 618
                  ++    +  +D   ++ +E+M  GSL++ L      +       + I V   L
Sbjct: 59  HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-IPEQILGKVSIAVIKGL 117

Query: 619 EYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 678
            YL   +   I+H D+KPSN+L++      L DFG++  L++          + T  YM+
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMS 171

Query: 679 PDEIFSGE 686
           P E   G 
Sbjct: 172 P-ERLQGT 178

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 1e-38
 Identities = 45/196 (22%), Positives = 81/196 (41%), Gaps = 14/196 (7%)

Query: 506 ELFQATNRFS-ENNLIGRGGFGPVYK-------DGMEVAIKVFNLQYG-GAFKSFDIECG 556
           +LF   +     +  +G G FG V +         ++VAIKV          +    E  
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 557 MMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVAS 616
           +M ++ +  ++++I  C  +    LV+E    G L K L      + +     ++  V+ 
Sbjct: 62  IMHQLDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120

Query: 617 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIG 675
            ++YL        +H DL   NVLL +   A +SDFG++K L  +D   T        + 
Sbjct: 121 GMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177

Query: 676 YMAPDEIFSGEMRLKC 691
           + AP+ I   +   + 
Sbjct: 178 WYAPECINFRKFSSRS 193

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  141 bits (356), Expect = 8e-38
 Identities = 46/182 (25%), Positives = 72/182 (39%), Gaps = 18/182 (9%)

Query: 511 TNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNL---QYGGAFKSFDIECGMMKRIR 562
              FS+   IG G FG VY      +   VAIK  +    Q    ++    E   ++++R
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 563 HRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
           H N I+       +    LV+EY    + +         L   +   +       L YLH
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLH 132

Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              S  +IH D+K  N+LL +  +  L DFG A  +            + T  +MAP+ I
Sbjct: 133 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAPEVI 183

Query: 683 FS 684
            +
Sbjct: 184 LA 185

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 3e-37
 Identities = 40/178 (22%), Positives = 75/178 (42%), Gaps = 10/178 (5%)

Query: 518 NLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISS 572
             +G G FG VYK       +  A KV + +     + + +E  ++    H N++K++ +
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 573 CSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHC 632
              ++   +++E+   G+++  +      L   Q   +      AL YLH      IIH 
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHR 134

Query: 633 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLK 690
           DLK  N+L   +    L+DFG++       Q         T  +MAP+ +     + +
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAPEVVMCETSKDR 190

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (346), Expect = 2e-36
 Identities = 50/250 (20%), Positives = 94/250 (37%), Gaps = 47/250 (18%)

Query: 485 KSQLKDVNMPSVADQRRFTYLELFQAT---------NRFSENNLIGRGGFGPVYK----- 530
           +SQL+ V +   +D   + Y++  +                  ++G G FG V       
Sbjct: 2   ESQLQMVQVTGSSDNE-YFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYG 60

Query: 531 -----DGMEVAIKVFNLQYG-GAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDFKALVL 583
                  ++VA+K+   +      ++   E  MM ++  H N++ ++ +C+      L+ 
Sbjct: 61  ISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIF 120

Query: 584 EYMPLGSLEKCLYSGN----------------------YILDIFQGLNIMIDVASALEYL 621
           EY   G L   L S                         +L     L     VA  +E+L
Sbjct: 121 EYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL 180

Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDE 681
                   +H DL   NVL+    V  + DFG+A+ ++ +   + +      + +MAP+ 
Sbjct: 181 E---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPES 237

Query: 682 IFSGEMRLKC 691
           +F G   +K 
Sbjct: 238 LFEGIYTIKS 247

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 4e-36
 Identities = 40/182 (21%), Positives = 75/182 (41%), Gaps = 10/182 (5%)

Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRN 565
             +     +G G +G V           VA+K+ +++      ++   E  + K + H N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY 625
           ++K        + + L LEY   G L   +   +  +           + + + YLH   
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLH--- 120

Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG 685
            + I H D+KP N+LLD+     +SDFG+A      ++     +   T+ Y+AP+ +   
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180

Query: 686 EM 687
           E 
Sbjct: 181 EF 182

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  135 bits (340), Expect = 7e-36
 Identities = 44/186 (23%), Positives = 83/186 (44%), Gaps = 11/186 (5%)

Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNL 566
              +  + +G G +G VY+       + VA+K          + F  E  +MK I+H NL
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNL 75

Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLY-SGNYILDIFQGLNIMIDVASALEYLHFGY 625
           ++++  C+ +    ++ E+M  G+L   L       +     L +   ++SA+EYL    
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 132

Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG 685
               IH DL   N L+ +N +  ++DFG+++ L+  D           I + AP+ +   
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYN 191

Query: 686 EMRLKC 691
           +  +K 
Sbjct: 192 KFSIKS 197

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 8e-36
 Identities = 43/182 (23%), Positives = 75/182 (41%), Gaps = 9/182 (4%)

Query: 514 FSENNLIGRGGFGPVYK----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKI 569
            +    +G G FG V         +VAIK+           F  E  +M  + H  L+++
Sbjct: 6   LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQL 64

Query: 570 ISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPI 629
              C+      ++ EYM  G L   L    +     Q L +  DV  A+EYL        
Sbjct: 65  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QF 121

Query: 630 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRL 689
           +H DL   N L++D  V  +SDFG+++  + +D+  +   +   + +  P+ +   +   
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 180

Query: 690 KC 691
           K 
Sbjct: 181 KS 182

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 1e-35
 Identities = 47/184 (25%), Positives = 77/184 (41%), Gaps = 9/184 (4%)

Query: 512 NRFSENNLIGRGGFGPVYK----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLI 567
           +  +    IG G FG V+     +  +VAIK          + F  E  +M ++ H  L+
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLV 63

Query: 568 KIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
           ++   C       LV E+M  G L   L +   +      L + +DV   + YL      
Sbjct: 64  QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EA 120

Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEM 687
            +IH DL   N L+ +N V  +SDFGM +  + +DQ  + T T   + + +P+       
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179

Query: 688 RLKC 691
             K 
Sbjct: 180 SSKS 183

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 1e-35
 Identities = 47/185 (25%), Positives = 87/185 (47%), Gaps = 11/185 (5%)

Query: 512 NRFSENNLIGRGGFGPVYK----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLI 567
                   +G+G FG V+         VAIK          ++F  E  +MK++RH  L+
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLV 75

Query: 568 KIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIF-QGLNIMIDVASALEYLHFGYS 626
           ++ +  S +    +V EYM  GSL   L           Q +++   +AS + Y+     
Sbjct: 76  QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER--- 131

Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGE 686
           +  +H DL+ +N+L+ +N+V  ++DFG+A+ L+E+++   +      I + AP+    G 
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLAR-LIEDNEYTARQGAKFPIKWTAPEAALYGR 190

Query: 687 MRLKC 691
             +K 
Sbjct: 191 FTIKS 195

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 2e-35
 Identities = 43/186 (23%), Positives = 78/186 (41%), Gaps = 15/186 (8%)

Query: 516 ENNLIGRGGFGPVYK-------DGMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNL 566
           E+  +G G FG V K           VA+K+   +            E  +M+++ +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
           +++I  C  + +  LV+E   LG L K L    + +     + ++  V+  ++YL     
Sbjct: 71  VRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGMKYLEES-- 126

Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGYMAPDEIFSG 685
              +H DL   NVLL     A +SDFG++K L  ++            + + AP+ I   
Sbjct: 127 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185

Query: 686 EMRLKC 691
           +   K 
Sbjct: 186 KFSSKS 191

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 4e-35
 Identities = 53/180 (29%), Positives = 82/180 (45%), Gaps = 15/180 (8%)

Query: 512 NRFSENNLIGRGGFGPVYK---DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIK 568
                   IG+G FG V      G +VA+K          ++F  E  +M ++RH NL++
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQ 64

Query: 569 IISSCSNDDFK-ALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFGYS 626
           ++     +     +V EYM  GSL   L S G  +L     L   +DV  A+EYL     
Sbjct: 65  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---G 121

Query: 627 VPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGE 686
              +H DL   NVL+ ++ VA +SDFG+ K     + S TQ      + + AP+ +   +
Sbjct: 122 NNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKK 176

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 5e-35
 Identities = 49/191 (25%), Positives = 90/191 (47%), Gaps = 14/191 (7%)

Query: 512 NRFSENNLIGRGGFGPVYK---------DGMEVAIKVFNLQYG-GAFKSFDIECGMMKRI 561
           +  +   +IG G FG VYK           + VAIK     Y       F  E G+M + 
Sbjct: 7   SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66

Query: 562 RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYL 621
            H N+I++    S      ++ EYM  G+L+K L   +    + Q + ++  +A+ ++YL
Sbjct: 67  SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126

Query: 622 HFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE-DQSLTQTQTLATIGYMAPD 680
               ++  +H DL   N+L++ N+V  +SDFG+++ L ++ + + T +     I + AP+
Sbjct: 127 A---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183

Query: 681 EIFSGEMRLKC 691
            I   +     
Sbjct: 184 AISYRKFTSAS 194

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 1e-34
 Identities = 45/211 (21%), Positives = 80/211 (37%), Gaps = 32/211 (15%)

Query: 512 NRFSENNLIGRGGFGPVYK----------DGMEVAIKVFNLQYG-GAFKSFDIECGMMKR 560
           NR S    +G G FG V +            M VA+K+          ++   E  ++  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 561 I-RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLY-----------------SGNYIL 602
           +  H N++ ++ +C+      ++ EY   G L   L                       L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 603 DIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED 662
           D+   L+    VA  + +L    S   IH DL   N+LL    +  + DFG+A+ +  + 
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 663 QSLTQTQTLATIGYMAPDEIFSGEMRLKCWV 693
             + +      + +MAP+ IF+     +  V
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDV 230

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  131 bits (330), Expect = 2e-34
 Identities = 49/207 (23%), Positives = 77/207 (37%), Gaps = 37/207 (17%)

Query: 512 NRFSENNLIGRGGFGPVYK----------DGMEVAIKVFNLQYGGAF-KSFDIECGMMKR 560
           N       IG G FG V++              VA+K+   +        F  E  +M  
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 561 IRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYS----------------------- 597
             + N++K++  C+      L+ EYM  G L + L S                       
Sbjct: 73  FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132

Query: 598 GNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP 657
           G   L   + L I   VA+ + YL        +H DL   N L+ +NMV  ++DFG+++ 
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189

Query: 658 LLEEDQSLTQTQTLATIGYMAPDEIFS 684
           +   D           I +M P+ IF 
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFY 216

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  132 bits (333), Expect = 3e-34
 Identities = 39/182 (21%), Positives = 74/182 (40%), Gaps = 14/182 (7%)

Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNL 566
           + +  +  +G G FG V++      G   A K     +    ++   E   M  +RH  L
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85

Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
           + +  +  +D+   ++ E+M  G L + +   +  +   + +  M  V   L ++H    
Sbjct: 86  VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---E 142

Query: 627 VPIIHCDLKPSNVLL--DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS 684
              +H DLKP N++     +    L DFG+   L  +      T T     + AP E+  
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTA---EFAAP-EVAE 198

Query: 685 GE 686
           G+
Sbjct: 199 GK 200

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 4e-34
 Identities = 49/181 (27%), Positives = 79/181 (43%), Gaps = 12/181 (6%)

Query: 511 TNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRN 565
             +++    IG+G  G VY       G EVAI+  NLQ     +    E  +M+  ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY 625
           ++  + S    D   +V+EY+  GSL   +       D  Q   +  +   ALE+LH   
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM--DEGQIAAVCRECLQALEFLH--- 133

Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG 685
           S  +IH D+K  N+LL  +    L+DFG    +  E    +      T  +MAP+ +   
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG--TPYWMAPEVVTRK 191

Query: 686 E 686
            
Sbjct: 192 A 192

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (324), Expect = 6e-34
 Identities = 50/184 (27%), Positives = 82/184 (44%), Gaps = 17/184 (9%)

Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFN---LQYGGAFKSFDIECGMMKRIRH 563
             F     +G+G FG VY          +A+KV     L+  G       E  +   +RH
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65

Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHF 623
            N++++     +     L+LEY PLG++ + L   +   D  +    + ++A+AL Y H 
Sbjct: 66  PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH- 123

Query: 624 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIF 683
             S  +IH D+KP N+LL       ++DFG +        S  +T    T+ Y+ P E+ 
Sbjct: 124 --SKRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPP-EMI 176

Query: 684 SGEM 687
            G M
Sbjct: 177 EGRM 180

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (325), Expect = 7e-34
 Identities = 50/182 (27%), Positives = 78/182 (42%), Gaps = 13/182 (7%)

Query: 513 RFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYG---GAFKSFDIECGMMKRIRHR 564
            F    ++G G F  V          E AIK+   ++            E  +M R+ H 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 565 NLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFG 624
             +K+  +  +D+     L Y   G L K +       D         ++ SALEYLH  
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYTAEIVSALEYLH-- 125

Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS 684
               IIH DLKP N+LL+++M   ++DFG AK L  E +       + T  Y++P E+ +
Sbjct: 126 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP-ELLT 183

Query: 685 GE 686
            +
Sbjct: 184 EK 185

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (324), Expect = 1e-33
 Identities = 49/185 (26%), Positives = 84/185 (45%), Gaps = 18/185 (9%)

Query: 520 IGRGGFGPVYK---DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSND 576
           IG+G FG V++    G EVA+K+F+ +   ++   + E      +RH N++  I++ + D
Sbjct: 11  IGKGRFGEVWRGKWRGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNKD 69

Query: 577 DFKA----LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH-----FGYSV 627
           +       LV +Y   GSL   L    Y + +   + + +  AS L +LH          
Sbjct: 70  NGTWTQLWLVSDYHEHGSLFDYLN--RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 127

Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT--QTQTLATIGYMAPDEIFSG 685
            I H DLK  N+L+  N    ++D G+A        ++       + T  YMAP E+   
Sbjct: 128 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP-EVLDD 186

Query: 686 EMRLK 690
            + +K
Sbjct: 187 SINMK 191

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 2e-33
 Identities = 46/183 (25%), Positives = 74/183 (40%), Gaps = 17/183 (9%)

Query: 518 NLIGRGGFGPVYK-----DGMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKII 570
             IG G +G   K     DG  +  K  +         +    E  +++ ++H N+++  
Sbjct: 10  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69

Query: 571 SSC--SNDDFKALVLEYMPLGSLEKCLYSG---NYILDIFQGLNIMIDVASALEYLH--F 623
                  +    +V+EY   G L   +  G      LD    L +M  +  AL+  H   
Sbjct: 70  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129

Query: 624 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIF 683
                ++H DLKP+NV LD      L DFG+A+ +L  D S  +     T  YM+P E  
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKAFV-GTPYYMSP-EQM 186

Query: 684 SGE 686
           +  
Sbjct: 187 NRM 189

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 2e-33
 Identities = 48/192 (25%), Positives = 79/192 (41%), Gaps = 20/192 (10%)

Query: 513 RFSE-NNLIGRGGFGPVYK-----DGMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHR 564
           RF + +  IGRG F  VYK       +EVA      +       + F  E  M+K ++H 
Sbjct: 9   RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68

Query: 565 NLIKIISSC----SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEY 620
           N+++   S            LV E M  G+L+  L     ++ I    +    +   L++
Sbjct: 69  NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQF 127

Query: 621 LHFGYSVPIIHCDLKPSNVLLDD-NMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAP 679
           LH   + PIIH DLK  N+ +        + D G+A     +  S  +   + T  +MAP
Sbjct: 128 LHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT---LKRASFAKA-VIGTPEFMAP 182

Query: 680 DEIFSGEMRLKC 691
            E++  +     
Sbjct: 183 -EMYEEKYDESV 193

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  129 bits (325), Expect = 3e-33
 Identities = 40/182 (21%), Positives = 76/182 (41%), Gaps = 13/182 (7%)

Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNL 566
           + +     +G G FG V++      G     K  N  Y     +   E  +M ++ H  L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
           I +  +  +     L+LE++  G L   + + +Y +   + +N M      L+++H    
Sbjct: 89  INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---E 145

Query: 627 VPIIHCDLKPSNVLLD--DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS 684
             I+H D+KP N++ +        + DFG+A  L  ++       T AT  + AP+ +  
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDR 202

Query: 685 GE 686
             
Sbjct: 203 EP 204

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (313), Expect = 2e-32
 Identities = 46/189 (24%), Positives = 80/189 (42%), Gaps = 14/189 (7%)

Query: 512 NRFSENNLIGRGGFGPVYK--------DGMEVAIKVFNLQYGGAFKS-FDIECGMMKRIR 562
            R      IG G FG V++          + VAIK        + +  F  E   M++  
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 563 HRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
           H +++K+I   + ++   +++E   LG L   L    Y LD+   +     +++AL YL 
Sbjct: 67  HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125

Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              S   +H D+   NVL+  N    L DFG+++  +E+      ++    I +MAP+ I
Sbjct: 126 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESI 181

Query: 683 FSGEMRLKC 691
                    
Sbjct: 182 NFRRFTSAS 190

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 3e-32
 Identities = 46/197 (23%), Positives = 79/197 (40%), Gaps = 15/197 (7%)

Query: 505 LELFQATNRFSENNLIGRGGFGPVYK---------DGMEVAIKVFNL-QYGGAFKSFDIE 554
           L + + T  F +  ++G G FG VYK           + VAIK         A K    E
Sbjct: 3   LRILKETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDE 61

Query: 555 CGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDV 614
             +M  + + ++ +++  C     + L+ + MP G L   +      +     LN  + +
Sbjct: 62  AYVMASVDNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120

Query: 615 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI 674
           A  + YL       ++H DL   NVL+       ++DFG+AK L  E++          I
Sbjct: 121 AKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177

Query: 675 GYMAPDEIFSGEMRLKC 691
            +MA + I       + 
Sbjct: 178 KWMALESILHRIYTHQS 194

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 7e-32
 Identities = 46/184 (25%), Positives = 69/184 (37%), Gaps = 16/184 (8%)

Query: 520 IGRGGFGPVYK--------DGMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIK 568
           +G G FG V +          + VA+K           A   F  E   M  + HRNLI+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75

Query: 569 IISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVP 628
           +         K +V E  PLGSL   L        +       + VA  + YL    S  
Sbjct: 76  LYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 131

Query: 629 IIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE-EDQSLTQTQTLATIGYMAPDEIFSGEM 687
            IH DL   N+LL    +  + DFG+ + L + +D  + Q        + AP+ + +   
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191

Query: 688 RLKC 691
               
Sbjct: 192 SHAS 195

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  120 bits (302), Expect = 5e-31
 Identities = 38/189 (20%), Positives = 82/189 (43%), Gaps = 17/189 (8%)

Query: 511 TNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYG---GAFKSFDIECGMMKRIR 562
           ++R+    ++G GG   V+         +VA+KV           +  F  E      + 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 563 HRNLIKIISSCSNDDFKA----LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASAL 618
           H  ++ +  +   +        +V+EY+   +L   +++    +   + + ++ D   AL
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQAL 124

Query: 619 EYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLA-TIGYM 677
            + H      IIH D+KP+N+++       + DFG+A+ + +   S+TQT  +  T  Y+
Sbjct: 125 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181

Query: 678 APDEIFSGE 686
           +P++     
Sbjct: 182 SPEQARGDS 190

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 6e-31
 Identities = 47/210 (22%), Positives = 85/210 (40%), Gaps = 17/210 (8%)

Query: 494 PSVADQRRFTYLELFQATNRFSENNLIGRGGFGPVYK--------DGMEVAIKVFNLQYG 545
           P +    +   +        F+E  +IGRG FG VY           +  A+K  N    
Sbjct: 11  PELVQAVQHVVIGPSSLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD 68

Query: 546 -GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKA-LVLEYMPLGSLEKCLYSGNYILD 603
            G    F  E  +MK   H N++ ++  C   +    +VL YM  G L   + +  +   
Sbjct: 69  IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPT 128

Query: 604 IFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL--EE 661
           +   +   + VA  +++L        +H DL   N +LD+     ++DFG+A+ +   E 
Sbjct: 129 VKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185

Query: 662 DQSLTQTQTLATIGYMAPDEIFSGEMRLKC 691
           D    +T     + +MA + + + +   K 
Sbjct: 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKS 215

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 7e-31
 Identities = 48/204 (23%), Positives = 84/204 (41%), Gaps = 30/204 (14%)

Query: 512 NRFSENNLIGRGGFGPVYK-------DGMEVAIKVFNLQY-GGAFKSFDIECGMMKRI-R 562
           N     ++IG G FG V K         M+ AIK           + F  E  ++ ++  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 563 HRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYI---------------LDIFQG 607
           H N+I ++ +C +  +  L +EY P G+L   L     +               L   Q 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 608 LNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ 667
           L+   DVA  ++YL        IH DL   N+L+ +N VA ++DFG+++    ++  + +
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 183

Query: 668 TQTLATIGYMAPDEIFSGEMRLKC 691
           T     + +MA + +         
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNS 207

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 7e-31
 Identities = 39/200 (19%), Positives = 79/200 (39%), Gaps = 23/200 (11%)

Query: 512 NRFSENNLIGRGGFGPVYK----------DGMEVAIKVFNLQYG-GAFKSFDIECGMMKR 560
            + + +  +G+G FG VY+              VAIK  N          F  E  +MK 
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 561 IRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYI---------LDIFQGLNIM 611
               ++++++   S      +++E M  G L+  L S               + + + + 
Sbjct: 80  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 612 IDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTL 671
            ++A  + YL+   +   +H DL   N ++ ++    + DFGM + + E D      + L
Sbjct: 140 GEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196

Query: 672 ATIGYMAPDEIFSGEMRLKC 691
             + +M+P+ +  G      
Sbjct: 197 LPVRWMSPESLKDGVFTTYS 216

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  120 bits (303), Expect = 3e-30
 Identities = 45/186 (24%), Positives = 80/186 (43%), Gaps = 19/186 (10%)

Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNL------QYGGAFKSFDIECGMMKR 560
           N FS + +IGRGGFG VY       G   A+K  +       Q      +  I   ++  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 561 IRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEY 620
                ++ +  +    D  + +L+ M  G L   L       +         ++   LE+
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-DMRFYAAEIILGLEH 122

Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPD 680
           +H   +  +++ DLKP+N+LLD++    +SD G+A    ++        ++ T GYMAP+
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPE 175

Query: 681 EIFSGE 686
            +  G 
Sbjct: 176 VLQKGV 181

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 5e-30
 Identities = 46/191 (24%), Positives = 84/191 (43%), Gaps = 12/191 (6%)

Query: 506 ELFQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFN-LQYGGAFKSFDIECGMMK 559
           ++F    R++  + IG G +G V       + + VAIK  +  ++    +    E  ++ 
Sbjct: 2   QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61

Query: 560 RIRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYS--GNYILDIFQGLNIMIDVASA 617
           R RH N+I I         + +   Y+    +   LY       L        +  +   
Sbjct: 62  RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRG 121

Query: 618 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLL-EEDQSLTQTQTLATIGY 676
           L+Y+H   S  ++H DLKPSN+LL+      + DFG+A+    + D +   T+ +AT  Y
Sbjct: 122 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178

Query: 677 MAPDEIFSGEM 687
            AP+ + + + 
Sbjct: 179 RAPEIMLNSKG 189

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  117 bits (293), Expect = 2e-29
 Identities = 45/182 (24%), Positives = 77/182 (42%), Gaps = 17/182 (9%)

Query: 518 NLIGRGGFGPVYK-----DGMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKI 569
             +G G FG V+      +G   A+KV   +        +  + E  M+  + H  +I++
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 570 ISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPI 629
             +  +     ++++Y+  G     L   +             +V  ALEYLH   S  I
Sbjct: 70  WGTFQDAQQIFMIMDYIE-GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH---SKDI 125

Query: 630 IHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRL 689
           I+ DLKP N+LLD N    ++DFG AK + +   +L       T  Y+AP+ + +     
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCG-----TPDYIAPEVVSTKPYNK 180

Query: 690 KC 691
             
Sbjct: 181 SI 182

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  116 bits (292), Expect = 3e-29
 Identities = 37/182 (20%), Positives = 71/182 (39%), Gaps = 10/182 (5%)

Query: 511 TNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHR 564
            + +   +++G G F  V           VAIK    +   G   S + E  ++ +I+H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 565 NLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFG 624
           N++ +     +     L+++ +  G L   +    +         ++  V  A++YLH  
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLHDL 126

Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS 684
             V             LD++    +SDFG++K    ED     +    T GY+AP+ +  
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTACGTPGYVAPEVLAQ 183

Query: 685 GE 686
             
Sbjct: 184 KP 185

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  114 bits (285), Expect = 1e-28
 Identities = 51/190 (26%), Positives = 85/190 (44%), Gaps = 23/190 (12%)

Query: 513 RFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI---------ECGMM 558
            +    ++GRG    V +        E A+K+ ++  GG+F + ++         E  ++
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 559 KRIR-HRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASA 617
           +++  H N+I++  +   + F  LV + M  G L   L      L   +   IM  +   
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEV 122

Query: 618 LEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 677
           +  LH    + I+H DLKP N+LLDD+M   L+DFG +  L   D      +   T  Y+
Sbjct: 123 ICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTPSYL 176

Query: 678 APDEIFSGEM 687
           AP EI    M
Sbjct: 177 AP-EIIECSM 185

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 1e-28
 Identities = 52/176 (29%), Positives = 84/176 (47%), Gaps = 16/176 (9%)

Query: 518 NLIGRGGFGPVYK-----DGMEVAIKVFNLQY-----GGAFKSFDIECGMMKRIRHRNLI 567
           + +G G F  VYK         VAIK   L +      G  ++   E  +++ + H N+I
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 568 KIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV 627
            ++ +  +    +LV ++M    LE  +   + +L        M+     LEYLH     
Sbjct: 64  GLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QH 119

Query: 628 PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIF 683
            I+H DLKP+N+LLD+N V  L+DFG+AK     ++    T  + T  Y AP+ +F
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELLF 173

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 1e-28
 Identities = 45/250 (18%), Positives = 89/250 (35%), Gaps = 32/250 (12%)

Query: 512 NRFSENNLIGRGGFGPVYK----------DGMEVAIKVFNLQYG-GAFKSFDIECGMMKR 560
           +R      +GRG FG V +              VA+K+          ++   E  ++  
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 561 IRHRNLIKII--SSCSNDDFKALVLEYMPLGSLEKCLYSGNY---------------ILD 603
           I H   +  +  +         +++E+   G+L   L S                   L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 604 IFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ 663
           +   +     VA  +E+L    S   IH DL   N+LL +  V  + DFG+A+ + ++  
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEKHLMTKEQP 723
            + +      + +MAP+ IF     ++  V  S  + +  +            +  +   
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVW-SFGVLLWEIFSLGASPYPGVKIDEEFCR 248

Query: 724 MVRMGTDLSL 733
            ++ GT +  
Sbjct: 249 RLKEGTRMRA 258

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 9e-28
 Identities = 36/193 (18%), Positives = 78/193 (40%), Gaps = 17/193 (8%)

Query: 506 ELFQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKR 560
           EL++   ++     +GRG FG V++            K   ++ G        E  ++  
Sbjct: 2   ELYE---KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNI 57

Query: 561 IRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEY 620
            RHRN++ +  S  + +   ++ E++    + + + +  + L+  + ++ +  V  AL++
Sbjct: 58  ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQF 117

Query: 621 LHFGYSVPIIHCDLKPSNVLLD--DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 678
           LH   S  I H D++P N++     +    + +FG A+ L                 Y A
Sbjct: 118 LH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL---KPGDNFRLLFTAPEYYA 171

Query: 679 PDEIFSGEMRLKC 691
           P+      +    
Sbjct: 172 PEVHQHDVVSTAT 184

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 2e-27
 Identities = 49/209 (23%), Positives = 84/209 (40%), Gaps = 32/209 (15%)

Query: 512 NRFSENNLIGRGGFGPVYK------------DGMEVAIKVFNLQYG-GAFKSFDIECGMM 558
           +R      +G G FG V                 +VA+K+               E  MM
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 559 KRI-RHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCL---------------YSGNYIL 602
           K I +H+N+I ++ +C+ D    +++EY   G+L + L               ++    L
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 603 DIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED 662
                ++    VA  +EYL    S   IH DL   NVL+ ++ V  ++DFG+A+ +   D
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 663 QSLTQTQTLATIGYMAPDEIFSGEMRLKC 691
                T     + +MAP+ +F      + 
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQS 218

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (277), Expect = 4e-27
 Identities = 50/187 (26%), Positives = 85/187 (45%), Gaps = 24/187 (12%)

Query: 513 RFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLI 567
            +++  +IG G FG VY+      G  VAIK          +  + E  +M+++ H N++
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76

Query: 568 KIISSC------SNDDFKALVLEYMPLGSLEKCLY--SGNYILDIFQGLNIMIDVASALE 619
           ++           ++ +  LVL+Y+P        +       L +      M  +  +L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136

Query: 620 YLHFGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 678
           Y+H   S  I H D+KP N+LLD D  V  L DFG AK L+  + +++    + +  Y A
Sbjct: 137 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS---YICSRYYRA 190

Query: 679 PDEIFSG 685
           P+ IF  
Sbjct: 191 PELIFGA 197

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  109 bits (273), Expect = 5e-27
 Identities = 43/181 (23%), Positives = 80/181 (44%), Gaps = 12/181 (6%)

Query: 512 NRFSENNLIGRGGFGPVYK----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRN 565
            ++     IG G +G VYK     G   A+K   L  +  G   +   E  ++K ++H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY 625
           ++K+           LV E++    L+K L      L+     + ++ + + + Y H   
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--- 117

Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG 685
              ++H DLKP N+L++      ++DFG+A+      +    T  + T+ Y APD +   
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGS 175

Query: 686 E 686
           +
Sbjct: 176 K 176

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 1e-26
 Identities = 40/189 (21%), Positives = 72/189 (38%), Gaps = 15/189 (7%)

Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDI----ECGMMKRIR 562
             F  + ++G+G FG V+           AIK             +     +  +     
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 563 HRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLH 622
           H  L  +  +    +    V+EY+  G L   + S +   D+ +      ++   L++LH
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAAEIILGLQFLH 120

Query: 623 FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
              S  I++ DLK  N+LLD +    ++DFGM K  +  D          T  Y+AP+ +
Sbjct: 121 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAPEIL 175

Query: 683 FSGEMRLKC 691
              +     
Sbjct: 176 LGQKYNHSV 184

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 3e-26
 Identities = 44/181 (24%), Positives = 81/181 (44%), Gaps = 12/181 (6%)

Query: 513 RFSENNLIGRGGFGPVYK-----DGMEVAIKVFNL--QYGGAFKSFDIECGMMKRIRHRN 565
            F +   IG G +G VYK      G  VA+K   L  +  G   +   E  ++K + H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 566 LIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY 625
           ++K++     ++   LV E++     +    S    + +    + +  +   L + H   
Sbjct: 63  IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 119

Query: 626 SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSG 685
           S  ++H DLKP N+L++      L+DFG+A+      +  T T  + T+ Y AP+ +   
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAPEILLGC 177

Query: 686 E 686
           +
Sbjct: 178 K 178

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 3e-26
 Identities = 42/182 (23%), Positives = 73/182 (40%), Gaps = 26/182 (14%)

Query: 519 LIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRI-RHRNLIKIISS 572
           ++G G  G V +        + A+K+              E  +  R  +  ++++I+  
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 73

Query: 573 C----SNDDFKALVLEYMPLGSLEKCLYS-GNYILDIFQGLNIMIDVASALEYLHFGYSV 627
                +      +V+E +  G L   +   G+      +   IM  +  A++YLH   S+
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SI 130

Query: 628 PIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS 684
            I H D+KP N+L      N +  L+DFG AK     +   T      T  Y+AP E+  
Sbjct: 131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY---TPYYVAP-EVLG 186

Query: 685 GE 686
            E
Sbjct: 187 PE 188

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  107 bits (267), Expect = 4e-26
 Identities = 47/194 (24%), Positives = 75/194 (38%), Gaps = 20/194 (10%)

Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNL 566
           NR+     IG G FG +Y       G EVAIK+  ++         IE  + K ++    
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVG 64

Query: 567 IKIISSC-SNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGY 625
           I  I  C +  D+  +V+E +   SLE      +    +   L +   + S +EY+H   
Sbjct: 65  IPTIRWCGAEGDYNVMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH--- 120

Query: 626 SVPIIHCDLKPSNVL---LDDNMVAHLSDFGMAKPLLEED-----QSLTQTQTLATIGYM 677
           S   IH D+KP N L        + ++ DFG+AK   +                 T  Y 
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 180

Query: 678 APDEIFSGEMRLKC 691
           + +     E   + 
Sbjct: 181 SINTHLGIEQSRRD 194

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (264), Expect = 6e-26
 Identities = 40/189 (21%), Positives = 68/189 (35%), Gaps = 22/189 (11%)

Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAF------KSFDIECGMMKR 560
           +++    L+G GGFG VY      D + VAIK         +          +E  ++K+
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 561 IR--HRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASAL 618
           +      +I+++      D   L+LE            +    L      +    V  A+
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123

Query: 619 EYLHFGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYM 677
            + H   +  ++H D+K  N+L+D +     L DFG    L +       T    T  Y 
Sbjct: 124 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYS 176

Query: 678 APDEIFSGE 686
            P E     
Sbjct: 177 PP-EWIRYH 184

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 2e-25
 Identities = 46/197 (23%), Positives = 80/197 (40%), Gaps = 22/197 (11%)

Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQY------GGAFKSFDIECGMMKR 560
           + +     +G G F  V K      G++ A K    +       G + +  + E  ++K 
Sbjct: 10  DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69

Query: 561 IRHRNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEY 620
           I+H N+I +     N     L+LE +  G L   L      L   +    +  + + + Y
Sbjct: 70  IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTEEEATEFLKQILNGVYY 128

Query: 621 LHFGYSVPIIHCDLKPSNVLLDDNMVA----HLSDFGMAKPLLEEDQSLTQTQTLATIGY 676
           LH   S+ I H DLKP N++L D  V      + DFG+A  +   D          T  +
Sbjct: 129 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFGNEFKNIFGTPEF 182

Query: 677 MAPDEIFSGEMRLKCWV 693
           +AP+ +    + L+  +
Sbjct: 183 VAPEIVNYEPLGLEADM 199

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 2e-25
 Identities = 44/198 (22%), Positives = 80/198 (40%), Gaps = 22/198 (11%)

Query: 510 ATNRFSENNLIGRGGFGPVYK------DGMEVAIKVFNLQYG--GAFKSFDIECGMMKRI 561
           A  ++     IG G +G V+K       G  VA+K   +Q G  G   S   E  +++ +
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 562 ---RHRNLIKIISSCSNDDFKA-----LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMID 613
               H N++++   C+           LV E++               +      ++M  
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 614 VASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLAT 673
           +   L++LH   S  ++H DLKP N+L+  +    L+DFG+A+        +  T  + T
Sbjct: 125 LLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVT 178

Query: 674 IGYMAPDEIFSGEMRLKC 691
           + Y AP+ +         
Sbjct: 179 LWYRAPEVLLQSSYATPV 196

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (261), Expect = 2e-25
 Identities = 40/183 (21%), Positives = 79/183 (43%), Gaps = 13/183 (7%)

Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHR 564
            ++ +   IG G +G V+K         VA+K   L     G   S   E  ++K ++H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 565 NLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFG 624
           N++++     +D    LV E+      +        + D     + +  +   L + H  
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCHS- 119

Query: 625 YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFS 684
               ++H DLKP N+L++ N    L++FG+A+      +    +  + T+ Y  PD +F 
Sbjct: 120 --RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFG 175

Query: 685 GEM 687
            ++
Sbjct: 176 AKL 178

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (259), Expect = 9e-25
 Identities = 44/183 (24%), Positives = 77/183 (42%), Gaps = 14/183 (7%)

Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGA---FKSFDIECGMMKRIRH 563
           N F    L+G+G FG V        G   A+K+   +   A         E  +++  RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHF 623
             L  +  +    D    V+EY   G L   L     +    +      ++ SALEYLH 
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLH- 122

Query: 624 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIF 683
             S  +++ D+K  N++LD +    ++DFG+ K  + +  ++       T  Y+AP+ + 
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPEVLE 178

Query: 684 SGE 686
             +
Sbjct: 179 DND 181

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (256), Expect = 1e-24
 Identities = 41/191 (21%), Positives = 80/191 (41%), Gaps = 21/191 (10%)

Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHR 564
           +++ +   IG+G FG V+K      G +VA+K   ++    G   +   E  +++ ++H 
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 565 NLIKIISSCSNDDFKA--------LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVAS 616
           N++ +I  C               LV ++                  + +   +M  + +
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK-FTLSEIKRVMQMLLN 128

Query: 617 ALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQT--LATI 674
            L Y+H      I+H D+K +NVL+  + V  L+DFG+A+       S     T  + T+
Sbjct: 129 GLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185

Query: 675 GYMAPDEIFSG 685
            Y  P+ +   
Sbjct: 186 WYRPPELLLGE 196

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  102 bits (255), Expect = 4e-24
 Identities = 43/188 (22%), Positives = 74/188 (39%), Gaps = 17/188 (9%)

Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRH 563
           ++F     +G G FG V        G   A+K+ + Q        +    E  +++ +  
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHF 623
             L+K+  S  ++    +V+EY+  G +   L                  +    EYLH 
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-FSEPHARFYAAQIVLTFEYLH- 158

Query: 624 GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIF 683
             S+ +I+ DLKP N+L+D      ++DFG AK +     +L       T   +AP+ I 
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG-----TPEALAPEIIL 211

Query: 684 SGEMRLKC 691
           S       
Sbjct: 212 SKGYNKAV 219

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 99.0 bits (245), Expect = 3e-23
 Identities = 56/288 (19%), Positives = 96/288 (33%), Gaps = 22/288 (7%)

Query: 102 PNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNY 161
           P+   L L  N           N   L  L L  N  S   P  F  L  L+ L L+ N 
Sbjct: 31  PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90

Query: 162 LTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSME-DFWMDNCNISGSI 220
           L     ++         K L+      N +  +       L+Q +  +   +    SG  
Sbjct: 91  LKELPEKM--------PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIE 142

Query: 221 PEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNL 280
                 +  L    ++     +  +IP  L    +L +L L GNK++    A    L NL
Sbjct: 143 NGAFQGMKKLSYIRIA--DTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNL 197

Query: 281 RKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCV 340
            KL L  N ++++ +        L     +N     +P  + +   +  + L  NN S +
Sbjct: 198 AKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAI 257

Query: 341 ------IPTKIGGLKDLQYLFLEYNRLQGS--IPNSIGDLISLKSLNL 380
                  P           + L  N +Q     P++   +    ++ L
Sbjct: 258 GSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 89.3 bits (220), Expect = 6e-20
 Identities = 62/290 (21%), Positives = 106/290 (36%), Gaps = 24/290 (8%)

Query: 141 SIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIG 200
            +P       +   L L +N +T             N K L      NN +  I P A  
Sbjct: 24  KVPKDLP--PDTALLDLQNNKITEIKD-----GDFKNLKNLHTLILINNKISKISPGAFA 76

Query: 201 NLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLD 260
            L   +E  ++    +   +PE++       LQ L +  N++          L  +  ++
Sbjct: 77  PLV-KLERLYLSKNQLK-ELPEKMPK----TLQELRVHENEITKVRKSVFNGLNQMIVVE 130

Query: 261 LGG--NKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLP 318
           LG    K SG        +  L  + +    +T+IP  L     +  L+L  N  T    
Sbjct: 131 LGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGL--PPSLTELHLDGNKITKVDA 188

Query: 319 LKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSL 378
             +  LN L +L LS N+ S V    +     L+ L L  N+L   +P  + D   ++ +
Sbjct: 189 ASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVV 247

Query: 379 NLSNNNLSG------TIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNL 422
            L NNN+S         P    K      +++  N ++    +   FR +
Sbjct: 248 YLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCV 297

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 82.0 bits (201), Expect = 1e-17
 Identities = 49/220 (22%), Positives = 83/220 (37%), Gaps = 7/220 (3%)

Query: 219 SIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLT 278
            +P+++         LL L+ N++      D   L  L  L L  NK+S   P     L 
Sbjct: 24  KVPKDLPPD----TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLV 79

Query: 279 NLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFS 338
            L +LYL  N L  +P  +      L ++ +             N  ++V+L  +    S
Sbjct: 80  KLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS 139

Query: 339 CVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLD 398
            +      G+K L Y+ +    +  +IP  +    SL  L+L  N ++     SL+ L +
Sbjct: 140 GIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNN 196

Query: 399 LKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMPN 438
           L  + +SFN +               E    N  L  +P 
Sbjct: 197 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPG 236

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 79.7 bits (195), Expect = 8e-17
 Identities = 51/298 (17%), Positives = 92/298 (30%), Gaps = 31/298 (10%)

Query: 20  PSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTL 79
           P     L L  N  +             +  NL N+  +    NK+  + P     +  L
Sbjct: 30  PPDTALLDLQNNKITEIKDG--------DFKNLKNLHTLILINNKISKISPGAFAPLVKL 81

Query: 80  KSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFS 139
           + LYL  N L   LP      L  L+           ++ + +     + ELG      S
Sbjct: 82  ERLYLSKNQLKE-LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSS 139

Query: 140 GSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAI 199
           G     F  ++ L ++ + D  +T+    L           L       N +  +   ++
Sbjct: 140 GIENGAFQGMKKLSYIRIADTNITTIPQGL--------PPSLTELHLDGNKITKVDAASL 191

Query: 200 GNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQL 259
             L+   +   +   +IS      + N  +L         N     +P  L     +  +
Sbjct: 192 KGLNNLAK-LGLSFNSISAVDNGSLANTPHLR---ELHLNNNKLVKVPGGLADHKYIQVV 247

Query: 260 DLGGNKLSGF------VPACSGNLTNLRKLYLGSNLLTSI---PSTLWNLKDILHLNL 308
            L  N +S         P  +    +   + L SN +      PST   +     + L
Sbjct: 248 YLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 79.7 bits (195), Expect = 1e-16
 Identities = 58/277 (20%), Positives = 105/277 (37%), Gaps = 23/277 (8%)

Query: 42  LCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRL 101
           L ++P ++    +   +    NK+  +      N+  L +L L +N +S   P +    L
Sbjct: 22  LEKVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFA-PL 78

Query: 102 PNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNY 161
             L+ L+L  N  +  +P  +    +  EL + +N  +    + F  L  +  + L  N 
Sbjct: 79  VKLERLYLSKNQ-LKELPEKMPKTLQ--ELRVHENEITKVRKSVFNGLNQMIVVELGTNP 135

Query: 162 LTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIP 221
           L SS  E  +   +     L Y   ++  +  I       L  S+ +  +D   I+    
Sbjct: 136 LKSSGIENGAFQGMKK---LSYIRIADTNITTIPQ----GLPPSLTELHLDGNKITKVDA 188

Query: 222 EEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLR 281
             +  L N  L  L L  N +       L     L +L L  NKL   VP    +   ++
Sbjct: 189 ASLKGLNN--LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQ 245

Query: 282 KLYLGSNLLTSIPST-------LWNLKDILHLNLSSN 311
            +YL +N +++I S                 ++L SN
Sbjct: 246 VVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSN 282

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 57.0 bits (136), Expect = 3e-09
 Identities = 51/242 (21%), Positives = 86/242 (35%), Gaps = 21/242 (8%)

Query: 3   SLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSF 62
            L N+ +  I          L+ LYLS N          L E+P ++        +  + 
Sbjct: 61  ILINNKISKISPGAFAPLVKLERLYLSKNQ---------LKELPEKMPKTLQELRVHENE 111

Query: 63  NKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFI 122
              V        N   +  L  +    SG    +    +  L  + +   N I TIP  +
Sbjct: 112 ITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQ-GMKKLSYIRIADTN-ITTIPQGL 169

Query: 123 FNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLE 182
                L+EL L  N  +     +   L NL  LGL+ N +++         SL+N  +L 
Sbjct: 170 P--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDN-----GSLANTPHLR 222

Query: 183 YFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQL 242
               +NN L  + P  + +  + ++  ++ N NIS +I            +  S  G  L
Sbjct: 223 ELHLNNNKLVKV-PGGLADH-KYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSL 279

Query: 243 EG 244
             
Sbjct: 280 FS 281

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 43.5 bits (101), Expect = 6e-05
 Identities = 35/179 (19%), Positives = 62/179 (34%), Gaps = 30/179 (16%)

Query: 1   MPSLTNDFLRGIILSQL--GNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWM 58
           M  L+   +    ++ +  G P SL  L+L  N         I       +  L+N+  +
Sbjct: 149 MKKLSYIRIADTNITTIPQGLPPSLTELHLDGNK--------ITKVDAASLKGLNNLAKL 200

Query: 59  AFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTI 118
             SFN +  V   ++ N   L+ L+L++N L       AD     ++ ++L  NN I  I
Sbjct: 201 GLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLAD--HKYIQVVYLHNNN-ISAI 257

Query: 119 PSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSN 177
            S  F                   P       +   + L  N +     + S+   +  
Sbjct: 258 GSNDF-----------------CPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYV 299

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 98.3 bits (244), Expect = 4e-23
 Identities = 31/190 (16%), Positives = 61/190 (32%), Gaps = 20/190 (10%)

Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNL 566
             +     IG G FG +++     +  +VAIK    +          E    K +     
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62

Query: 567 IKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYS 626
           I  +     +    +++  +   SLE  L        +         + + ++ +H    
Sbjct: 63  IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---E 119

Query: 627 VPIIHCDLKPSNVLLDDNMVAH-----LSDFGMAKPLLEEDQSLTQ-----TQTLATIGY 676
             +++ D+KP N L+      +     + DFGM K   +                 T  Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179

Query: 677 MAPDEIFSGE 686
           M+ +     E
Sbjct: 180 MSINTHLGRE 189

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.7 bits (245), Expect = 6e-23
 Identities = 44/199 (22%), Positives = 81/199 (40%), Gaps = 22/199 (11%)

Query: 502 FTYLELFQAT----NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQY--GGAFKS 550
           F   E+ +        + +   +G G +G V        G +VAIK     +      K 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 551 FDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY---MPLGSLEKCLYSGNYILDIFQG 607
              E  ++K +RH N+I ++   + D+      ++   MP    +      +  L   + 
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123

Query: 608 LNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ 667
             ++  +   L Y+H   +  IIH DLKP N+ ++++    + DFG+A+    E      
Sbjct: 124 QFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----M 175

Query: 668 TQTLATIGYMAPDEIFSGE 686
           T  + T  Y AP+ I +  
Sbjct: 176 TGYVVTRWYRAPEVILNWM 194

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 97.8 bits (242), Expect = 2e-22
 Identities = 80/385 (20%), Positives = 139/385 (36%), Gaps = 47/385 (12%)

Query: 50  DNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHL 109
             L            V   V  T  ++  + +L      +           L NL +++ 
Sbjct: 19  TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS---IDGVEYLNNLTQINF 73

Query: 110 WGNNFIGTIPSFIFNASKLSELGL----------QKNSFSGSIPNTFGNLRNLKWLGLND 159
             N      P  + N +KL ++ +            N  + +    F N         N 
Sbjct: 74  SNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNL 131

Query: 160 NYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGS 219
             L       +++S +S    L      +        + + NL+         N     S
Sbjct: 132 TNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDIS 191

Query: 220 IPEEI----------NNLTNLI-------LQLLSLEGNQLEGSIPDDLCRLAALFQLDLG 262
           +  ++          N ++++        L  LSL GNQL+      L  L  L  LDL 
Sbjct: 192 VLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249

Query: 263 GNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIG 322
            N++S   P     LT L +L LG+N +++I   L  L  + +L L+ N      P  I 
Sbjct: 250 NNQISNLAP--LSGLTKLTELKLGANQISNISP-LAGLTALTNLELNENQLEDISP--IS 304

Query: 323 NLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSN 382
           NL  L  L L  NN S + P  +  L  LQ LF   N++     +S+ +L ++  L+  +
Sbjct: 305 NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGH 360

Query: 383 NNLSGTIPISLEKLLDLKDINVSFN 407
           N +S   P++   L  +  + ++  
Sbjct: 361 NQISDLTPLA--NLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 91.6 bits (226), Expect = 2e-20
 Identities = 74/365 (20%), Positives = 135/365 (36%), Gaps = 41/365 (11%)

Query: 75  NVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQ 134
            ++      L   +++  +  +    L  +  L       I +I   +   + L+++   
Sbjct: 20  ALAEKMKTVLGKTNVTDTVSQTD---LDQVTTLQADRLG-IKSI-DGVEYLNNLTQINFS 74

Query: 135 KNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGI 194
            N  +   P    NL  L  + +N+N +   TP  +  +      +    +  +      
Sbjct: 75  NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132

Query: 195 LPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLI-----LQLLSLEGNQLEGSIPDD 249
               +   S ++ D    +   S       N +T+L        L  L+ +  + S    
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192

Query: 250 LCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLS 309
           L +L  L  L    N++S   P     LTNL +L L  N L  I + L +L ++  L+L+
Sbjct: 193 LAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKDIGT-LASLTNLTDLDLA 249

Query: 310 SNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIP--------------------TKIGGLK 349
           +N  +   PL    L  L +L L  N  S + P                    + I  LK
Sbjct: 250 NNQISNLAPL--SGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLK 307

Query: 350 DLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRL 409
           +L YL L +N +    P  +  L  L+ L  +NN +S     SL  L ++  ++   N++
Sbjct: 308 NLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQI 363

Query: 410 EGEIP 414
               P
Sbjct: 364 SDLTP 368

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 81.6 bits (200), Expect = 4e-17
 Identities = 68/348 (19%), Positives = 109/348 (31%), Gaps = 73/348 (20%)

Query: 14  LSQLGNPSSLQTLYLSYNPPSGSIPSFIL------------------------------- 42
           +  +   ++L  +  S N  +   P   L                               
Sbjct: 59  IDGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLF 118

Query: 43  -------------------CEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLY 83
                                  + I ++  +  +        G   T +  ++ L +L 
Sbjct: 119 NNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLE 178

Query: 84  LHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIP 143
               S +     S   +L NL+ L    N      P  I   + L EL L  N       
Sbjct: 179 RLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--I 234

Query: 144 NTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLS 203
            T  +L NL  L L +N       ++S+L+ LS    L       N +  I P  +  L+
Sbjct: 235 GTLASLTNLTDLDLANN-------QISNLAPLSGLTKLTELKLGANQISNISP--LAGLT 285

Query: 204 QSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGG 263
                   +N     S    + NLT      L+L  N +    P  +  L  L +L    
Sbjct: 286 ALTNLELNENQLEDISPISNLKNLT-----YLTLYFNNISDISP--VSSLTKLQRLFFAN 338

Query: 264 NKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSN 311
           NK+S    +   NLTN+  L  G N ++ +   L NL  I  L L+  
Sbjct: 339 NKVSD--VSSLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 65.8 bits (159), Expect = 6e-12
 Identities = 65/379 (17%), Positives = 124/379 (32%), Gaps = 78/379 (20%)

Query: 124 NASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEY 183
             ++  +  L K + + ++  +  +L  +  L  +          + S+  +     L  
Sbjct: 20  ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRL-------GIKSIDGVEYLNNLTQ 70

Query: 184 FSFSNNPLGGILPRAIGNLSQ----------------------------SMEDFWMDNCN 215
            +FSNN L  I P  + NL++                                    +  
Sbjct: 71  INFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPL 128

Query: 216 ISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKL------SGF 269
            + +    +   +N I  + +L G      +             +L   +          
Sbjct: 129 KNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVS 188

Query: 270 VPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQ 329
             +    LTNL  L   +N ++ I      L ++  L+L+ N       L   +L  L  
Sbjct: 189 DISVLAKLTNLESLIATNNQISDITPL-GILTNLDELSLNGNQLKDIGTL--ASLTNLTD 245

Query: 330 LDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIP--------------------NSI 369
           LDL+ N  S + P  + GL  L  L L  N++    P                    + I
Sbjct: 246 LDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPI 303

Query: 370 GDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKG 429
            +L +L  L L  NN+S   P+S   L  L+ +  + N++   +       N++  S   
Sbjct: 304 SNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGH 360

Query: 430 NEL-----LCGMPNLQVLS 443
           N++     L  +  +  L 
Sbjct: 361 NQISDLTPLANLTRITQLG 379

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 96.4 bits (239), Expect = 3e-22
 Identities = 36/182 (19%), Positives = 78/182 (42%), Gaps = 22/182 (12%)

Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIR-HRN 565
           + +     +GRG +  V++     +  +V +K+         K    E  +++ +R   N
Sbjct: 35  DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91

Query: 566 LIKIISSCSNDDFK--ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHF 623
           +I +     +   +  ALV E++     ++   +    L  +     M ++  AL+Y H 
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYCH- 146

Query: 624 GYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEI 682
             S+ I+H D+KP NV++D ++    L D+G+A+              +A+  +  P+ +
Sbjct: 147 --SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELL 201

Query: 683 FS 684
             
Sbjct: 202 VD 203

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.5 bits (234), Expect = 1e-21
 Identities = 45/188 (23%), Positives = 78/188 (41%), Gaps = 18/188 (9%)

Query: 512 NRFSENNLIGRGGFGPVYK--------DGMEVAIKVFN----LQYGGAFKSFDIECGMMK 559
             F    ++G G +G V+          G   A+KV      +Q     +    E  +++
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 560 RIRHR-NLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASAL 618
            IR    L+ +  +   +    L+L+Y+  G L   L       +      + I V   +
Sbjct: 84  HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE----HEVQIYVGEIV 139

Query: 619 EYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMA 678
             L   + + II+ D+K  N+LLD N    L+DFG++K  + ++          TI YMA
Sbjct: 140 LALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEYMA 198

Query: 679 PDEIFSGE 686
           PD +  G+
Sbjct: 199 PDIVRGGD 206

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.5 bits (226), Expect = 2e-20
 Identities = 46/197 (23%), Positives = 76/197 (38%), Gaps = 23/197 (11%)

Query: 508 FQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQY--GGAFKSFDIECGMMKR 560
           F    R+     IG G  G V           VAIK  +  +      K    E  +MK 
Sbjct: 13  FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC 72

Query: 561 IRHRNLIKIISSCSNDDFK------ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDV 614
           + H+N+I +++  +            LV+E M     +          D  +   ++  +
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL----DHERMSYLLYQM 128

Query: 615 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI 674
              +++LH   S  IIH DLKPSN+++  +    + DFG+A+       S   T  + T 
Sbjct: 129 LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTR 182

Query: 675 GYMAPDEIFSGEMRLKC 691
            Y AP+ I     +   
Sbjct: 183 YYRAPEVILGMGYKENV 199

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.7 bits (224), Expect = 4e-20
 Identities = 40/193 (20%), Positives = 82/193 (42%), Gaps = 22/193 (11%)

Query: 507 LFQATNRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQY--GGAFKSFDIECGMMK 559
           +++   R+   + +G G +G V        G+ VA+K  +  +      K    E  ++K
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 72

Query: 560 RIRHRNLIKIISSCS-----NDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDV 614
            ++H N+I ++   +      +     ++ ++    L   +      L       ++  +
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI 130

Query: 615 ASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATI 674
              L+Y+H   S  IIH DLKPSN+ ++++    + DFG+A+           T  +AT 
Sbjct: 131 LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT-----DDEMTGYVATR 182

Query: 675 GYMAPDEIFSGEM 687
            Y AP+ + +   
Sbjct: 183 WYRAPEIMLNWMH 195

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 88.6 bits (218), Expect = 2e-19
 Identities = 45/247 (18%), Positives = 89/247 (36%), Gaps = 25/247 (10%)

Query: 512 NRFSENNLIGRGGFGPVYK-----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNL 566
            R+     +G G F  V+      +   VA+K+         ++ + E  +++R+   + 
Sbjct: 13  ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT-EAAEDEIKLLQRVNDADN 71

Query: 567 IKIISSCSNDDFK---------------ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIM 611
            K  S  +N   K                +V E +    L       +  + +     I 
Sbjct: 72  TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131

Query: 612 IDVASALEYLHFGYSVPIIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLEEDQSLTQTQT 670
             +   L+Y+H      IIH D+KP NVL++  +   +L    +A            T +
Sbjct: 132 KQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 189

Query: 671 LATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEKHLMTKEQPMVRMGTD 730
           + T  Y +P+ +          +  +  +   ++    L   +E H  TK+   +    +
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249

Query: 731 LSLGQFP 737
           L LG+ P
Sbjct: 250 L-LGELP 255

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 81.8 bits (201), Expect = 2e-18
 Identities = 25/163 (15%), Positives = 51/163 (31%), Gaps = 30/163 (18%)

Query: 518 NLIGRGGFGPVYK----DGMEVAIKVFNL----------QYGGAFKSFDIECGMMKRIRH 563
            L+G G    V+        E  +K   +          +       F +      R   
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 564 RNLIKIISSCSNDDF----KALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALE 619
           R L K+        +     A+++E +    L +          +     ++  +   + 
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV--------RVENPDEVLDMILEEVA 117

Query: 620 YLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED 662
             +      I+H DL   NVL+ +  +  + DF  +  + EE 
Sbjct: 118 KFY---HRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEG 156

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.9 bits (203), Expect = 5e-18
 Identities = 62/272 (22%), Positives = 99/272 (36%), Gaps = 14/272 (5%)

Query: 141 SIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIG 200
           ++P         + + L+ N ++          S   C+ L      +N L  I   A  
Sbjct: 25  AVPVGIP--AASQRIFLHGNRISHVPAA-----SFRACRNLTILWLHSNVLARIDAAAFT 77

Query: 201 NLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLD 260
            L+   +    DN  +    P   + L  L    L L+   L+   P     LAAL  L 
Sbjct: 78  GLALLEQLDLSDNAQLRSVDPATFHGLGRL--HTLHLDRCGLQELGPGLFRGLAALQYLY 135

Query: 261 LGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIP-STLWNLKDILHLNLSSNFFTGPLPL 319
           L  N L         +L NL  L+L  N ++S+P      L  +  L L  N      P 
Sbjct: 136 LQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPH 195

Query: 320 KIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLN 379
              +L  L+ L L  NN S +    +  L+ LQYL L  N               L+   
Sbjct: 196 AFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFR 254

Query: 380 LSNNNLSGTIPISLEKLLDLKDINVSFNRLEG 411
            S++ +  ++P   ++L       ++ N L+G
Sbjct: 255 GSSSEVPCSLP---QRLAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.4 bits (199), Expect = 2e-17
 Identities = 58/271 (21%), Positives = 93/271 (34%), Gaps = 15/271 (5%)

Query: 69  VPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKL 128
           VP  I   +  + ++LH N +S  +P+++     NL  L L  N       +     + L
Sbjct: 26  VPVGIP--AASQRIFLHGNRISH-VPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 129 SELGLQKNSFSGSI-PNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFS 187
            +L L  N+   S+ P TF  L  L  L L+   L    P L           L+Y    
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFR-----GLAALQYLYLQ 137

Query: 188 NNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIP 247
           +N L  +      +   ++   ++    IS         L +L    L L  N++    P
Sbjct: 138 DNALQALPDDTFRD-LGNLTHLFLHGNRISSVPERAFRGLHSL--DRLLLHQNRVAHVHP 194

Query: 248 DDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLN 307
                L  L  L L  N LS         L  L+ L L  N              +    
Sbjct: 195 HAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFR 254

Query: 308 LSSNFFTGPLPLKIGNLNVLVQLDLSMNNFS 338
            SS+     LP ++   ++     L+ N+  
Sbjct: 255 GSSSEVPCSLPQRLAGRDL---KRLAANDLQ 282

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.4 bits (173), Expect = 5e-14
 Identities = 51/276 (18%), Positives = 87/276 (31%), Gaps = 28/276 (10%)

Query: 20  PSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTL 79
           P++ Q ++L  N  S    +              N+  +    N +  +       ++ L
Sbjct: 31  PAASQRIFLHGNRISHVPAA--------SFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 80  KSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFS 139
           + L L  N+    +  +    L  L  LHL         P      + L  L LQ N+  
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142

Query: 140 GSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAI 199
               +TF +L NL  L L+ N ++S         +      L+      N +  + P A 
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPER-----AFRGLHSLDRLLLHQNRVAHVHPHAF 197

Query: 200 GNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQ- 258
            +L + M  +   N   +              LQ L L  N          CR   L+  
Sbjct: 198 RDLGRLMTLYLFANNLSALPTEALAPLRA---LQYLRLNDNPWVCD-----CRARPLWAW 249

Query: 259 ---LDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLT 291
                   +++   +P     L       L +N L 
Sbjct: 250 LQKFRGSSSEVPCSLPQ---RLAGRDLKRLAANDLQ 282

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.3 bits (152), Expect = 2e-11
 Identities = 44/257 (17%), Positives = 69/257 (26%), Gaps = 30/257 (11%)

Query: 201 NLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLD 260
            +  + +  ++    IS           NL +  L                         
Sbjct: 29  GIPAASQRIFLHGNRISHVPAASFRACRNLTILWLH-SNVLARIDAAAFTGLALLEQLDL 87

Query: 261 LGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHL-NLSSNFFTGPLPL 319
               +L    PA    L  L  L+L    L  +   L+     L    L  N        
Sbjct: 88  SDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDD 147

Query: 320 KIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLI------ 373
              +L  L  L L  N  S V      GL  L  L L  NR+    P++  DL       
Sbjct: 148 TFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLY 207

Query: 374 ------------------SLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIP- 414
                             +L+ L L++N               L+    S + +   +P 
Sbjct: 208 LFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQ 266

Query: 415 --REGPFRNLSAESFKG 429
                  + L+A   +G
Sbjct: 267 RLAGRDLKRLAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.9 bits (99), Expect = 8e-05
 Identities = 18/137 (13%), Positives = 37/137 (27%), Gaps = 13/137 (9%)

Query: 4   LTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFN 63
           L  + +  +         SL  L L  N  +   P             L  +  +    N
Sbjct: 160 LHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRD--------LGRLMTLYLFAN 211

Query: 64  KVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIF 123
            +  +    +  +  L+ L L+ N       +        L++     +    ++P  + 
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDNPWVCDCRARP--LWAWLQKFRGSSSEVPCSLPQRLA 269

Query: 124 NASKLSELGLQKNSFSG 140
                    L  N   G
Sbjct: 270 GRDLKR---LAANDLQG 283

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.7 bits (96), Expect = 2e-04
 Identities = 32/189 (16%), Positives = 53/189 (28%), Gaps = 3/189 (1%)

Query: 271 PACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQL 330
            AC                L ++P  +        + L  N  +            L  L
Sbjct: 4   GACVCYNEPKVTTSCPQQGLQAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTIL 61

Query: 331 DLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSI-PNSIGDLISLKSLNLSNNNLSGTI 389
            L  N  + +      GL  L+ L L  N    S+ P +   L  L +L+L    L    
Sbjct: 62  WLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELG 121

Query: 390 PISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMPNLQVLSCRTKIH 449
           P     L  L+ + +  N L+                F     +  +P        +   
Sbjct: 122 PGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDR 181

Query: 450 HTLGKNDLL 458
             L +N + 
Sbjct: 182 LLLHQNRVA 190

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 82.5 bits (202), Expect = 1e-17
 Identities = 62/267 (23%), Positives = 103/267 (38%), Gaps = 4/267 (1%)

Query: 173 SSLSNCKYLEYFSFSNNPLGGI--LPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNL 230
            + +    +     S   L     +P ++ NL      +     N+ G IP  I  LT L
Sbjct: 44  DTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQL 103

Query: 231 ILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLL 290
               ++     + G+IPD L ++  L  LD   N LSG +P    +L NL  +    N +
Sbjct: 104 HYLYIT--HTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI 161

Query: 291 TSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKD 350
           +      +     L  +++ +       +     N+ +       N      + + G   
Sbjct: 162 SGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDK 221

Query: 351 LQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLE 410
                             +G   +L  L+L NN + GT+P  L +L  L  +NVSFN L 
Sbjct: 222 NTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281

Query: 411 GEIPREGPFRNLSAESFKGNELLCGMP 437
           GEIP+ G  +     ++  N+ LCG P
Sbjct: 282 GEIPQGGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 72.5 bits (176), Expect = 2e-14
 Identities = 54/271 (19%), Positives = 96/271 (35%), Gaps = 10/271 (3%)

Query: 124 NASKLSELGLQKNSFSG--SIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYL 181
              +++ L L   +      IP++  NL  L +L +                +++    L
Sbjct: 48  QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP----PAIAKLTQL 103

Query: 182 EYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQ 241
            Y   ++            +  +++         +SG++P  I++L NL+    + +GN+
Sbjct: 104 HYLYITHTN-VSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI--TFDGNR 160

Query: 242 LEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLK 301
           + G+IPD     + LF                +    NL  + L  N+L    S L+   
Sbjct: 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSD 220

Query: 302 DILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRL 361
                   +         K+G    L  LDL  N     +P  +  LK L  L + +N L
Sbjct: 221 KNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL 280

Query: 362 QGSIPNSIGDLISLKSLNLSNNNLSGTIPIS 392
            G IP   G+L        +NN      P+ 
Sbjct: 281 CGEIP-QGGNLQRFDVSAYANNKCLCGSPLP 310

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 68.6 bits (166), Expect = 5e-13
 Identities = 59/275 (21%), Positives = 99/275 (36%), Gaps = 27/275 (9%)

Query: 67  GVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADV-RLPNLKELHLWGN-NFIGTIPSFIFN 124
           GV+  T      + +L L   +L    P  + +  LP L  L++ G  N +G IP  I  
Sbjct: 40  GVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAK 99

Query: 125 ASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYF 184
            ++L  L +   + SG+IP+    ++ L  L  + N L+ + P      S+S+   L   
Sbjct: 100 LTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLP-----PSISSLPNLVGI 154

Query: 185 SFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLIL------------ 232
           +F  N + G +P + G+ S+      +    ++G IP    NL    +            
Sbjct: 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDAS 214

Query: 233 --------QLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLY 284
                                    +     L  LDL  N++ G +P     L  L  L 
Sbjct: 215 VLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLN 274

Query: 285 LGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPL 319
           +  N L        NL+       ++N      PL
Sbjct: 275 VSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPL 309

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 58.2 bits (139), Expect = 1e-09
 Identities = 53/285 (18%), Positives = 92/285 (32%), Gaps = 54/285 (18%)

Query: 10  RGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFN-KVVGV 68
            G++         +  L LS        P      IP  + NL  + ++       +VG 
Sbjct: 39  LGVLCDTDTQTYRVNNLDLSGLNLPKPYP------IPSSLANLPYLNFLYIGGINNLVGP 92

Query: 69  VPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKL 128
           +P  I  ++ L  LY+   +           ++  L  L    N   GT+P  I +   L
Sbjct: 93  IPPAIAKLTQLHYLYITHTN-VSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNL 151

Query: 129 SELGLQKNSFSGSIPNTFGNLRNLK-WLGLNDNYLTSSTPELSSLSSLSNC--------- 178
             +    N  SG+IP+++G+   L   + ++ N LT   P   +  +L+           
Sbjct: 152 VGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEG 211

Query: 179 --------------------------------KYLEYFSFSNNPLGGILPRAIGNLSQSM 206
                                           K L      NN + G LP+ +  L   +
Sbjct: 212 DASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLK-FL 270

Query: 207 EDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLC 251
               +   N+ G IP+   NL      + +   N+     P   C
Sbjct: 271 HSLNVSFNNLCGEIPQ-GGNLQRF--DVSAYANNKCLCGSPLPAC 312

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 40.1 bits (92), Expect = 8e-04
 Identities = 16/61 (26%), Positives = 26/61 (42%), Gaps = 9/61 (14%)

Query: 4   LTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFN 63
           L N+ + G +   L     L +L +S+N   G IP         +  NL   +  A++ N
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP---------QGGNLQRFDVSAYANN 301

Query: 64  K 64
           K
Sbjct: 302 K 302

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.1 bits (144), Expect = 2e-10
 Identities = 38/214 (17%), Positives = 66/214 (30%), Gaps = 14/214 (6%)

Query: 100 RLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLND 159
           ++ +  E++    N    +P  +      + L L +N        T      L  L L+ 
Sbjct: 8   KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLD- 63

Query: 160 NYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGS 219
               +      +L  L           S           +G    ++    +    ++  
Sbjct: 64  RAELTKLQVDGTLPVLGTLDLSHNQLQSLPL--------LGQTLPALTVLDVSFNRLTSL 115

Query: 220 IPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTN 279
               +  L  L      L+GN+L+   P  L     L +L L  N L+         L N
Sbjct: 116 PLGALRGLGELQEL--YLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLEN 173

Query: 280 LRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFF 313
           L  L L  N L +IP   +    +    L  N +
Sbjct: 174 LDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.3 bits (142), Expect = 3e-10
 Identities = 48/199 (24%), Positives = 70/199 (35%), Gaps = 9/199 (4%)

Query: 213 NCNISG--SIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFV 270
           NC+     ++P ++         +L L  N L       L     L QL+L   +     
Sbjct: 16  NCDKRNLTALPPDLPKD----TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAE--LTK 69

Query: 271 PACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQL 330
               G L  L  L L  N L S+P     L  +  L++S N  T      +  L  L +L
Sbjct: 70  LQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQEL 129

Query: 331 DLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIP 390
            L  N    + P  +     L+ L L  N L       +  L +L +L L  N+L  TIP
Sbjct: 130 YLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIP 188

Query: 391 ISLEKLLDLKDINVSFNRL 409
                   L    +  N  
Sbjct: 189 KGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.6 bits (114), Expect = 1e-06
 Identities = 53/212 (25%), Positives = 83/212 (39%), Gaps = 7/212 (3%)

Query: 223 EINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRK 282
           E++ + + +   ++ +   L  ++P DL +      L L  N L  F  A     T L +
Sbjct: 5   EVSKVASHLE--VNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQ 59

Query: 283 LYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIP 342
           L L      +       L   L     S+     LPL    L  L  LD+S N  + +  
Sbjct: 60  LNL-DRAELTKLQVDGTLPV-LGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPL 117

Query: 343 TKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDI 402
             + GL +LQ L+L+ N L+   P  +     L+ L+L+NNNL+      L  L +L  +
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177

Query: 403 NVSFNRLEGEIPREGPFRNLSAESFKGNELLC 434
            +  N L            L      GN  LC
Sbjct: 178 LLQENSLYTIPKGFFGSHLLPFAFLHGNPWLC 209

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.1 bits (105), Expect = 2e-05
 Identities = 35/186 (18%), Positives = 55/186 (29%), Gaps = 22/186 (11%)

Query: 20  PSSLQTLYLSYNPPSGSIPSFIL--------------CEIPHEIDNLHNMEWMAFSFNKV 65
           P     L+LS N       + ++                       L  +  +  S N++
Sbjct: 30  PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQL 89

Query: 66  VGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNA 125
             +        +        +   S  LP  A   L  L+EL+L GN      P  +   
Sbjct: 90  QSLPLLGQTLPALTVLDVSFNRLTS--LPLGALRGLGELQELYLKGNELKTLPPGLLTPT 147

Query: 126 SKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFS 185
            KL +L L  N+ +         L NL  L L +N L +                L +  
Sbjct: 148 PKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHL------LPFAF 201

Query: 186 FSNNPL 191
              NP 
Sbjct: 202 LHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.7 bits (104), Expect = 2e-05
 Identities = 16/70 (22%), Positives = 26/70 (37%), Gaps = 3/70 (4%)

Query: 271 PACS-GNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQ 329
           P C    + +  ++      LT++P  L   KD   L+LS N         +     L Q
Sbjct: 2   PICEVSKVASHLEVNCDKRNLTALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQ 59

Query: 330 LDLSMNNFSC 339
           L+L     + 
Sbjct: 60  LNLDRAELTK 69

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.8 bits (86), Expect = 0.004
 Identities = 14/76 (18%), Positives = 28/76 (36%), Gaps = 2/76 (2%)

Query: 40  FILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADV 99
            +    P  +     +E ++ + N +  +    +  +  L +L L  NSL   +P     
Sbjct: 135 ELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGF-F 192

Query: 100 RLPNLKELHLWGNNFI 115
               L    L GN ++
Sbjct: 193 GSHLLPFAFLHGNPWL 208

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 57.1 bits (136), Expect = 3e-09
 Identities = 49/311 (15%), Positives = 89/311 (28%), Gaps = 20/311 (6%)

Query: 20  PSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTL 79
           P  L++L  S N          L E+P    +L ++     +   +  + P   +   + 
Sbjct: 57  PPHLESLVASCNS---------LTELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSN 107

Query: 80  KSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFS 139
             L       +       DV   +LK+L     +                   L   +  
Sbjct: 108 NQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAI 167

Query: 140 GSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSN--CKYLEYFSFSNNPLGGILPR 197
            +  N+   L +L     +     +   EL  L +L      Y +       P       
Sbjct: 168 YADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLE 227

Query: 198 AIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALF 257
           A+      + D      +++     E        L       N     I        +L 
Sbjct: 228 ALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLE 287

Query: 258 QLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTG-- 315
           +L++  NKL             L +L    N L  +P    NLK    L++  N      
Sbjct: 288 ELNVSNNKLIEL----PALPPRLERLIASFNHLAEVPELPQNLK---QLHVEYNPLREFP 340

Query: 316 PLPLKIGNLNV 326
            +P  + +L +
Sbjct: 341 DIPESVEDLRM 351

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 53.7 bits (127), Expect = 4e-08
 Identities = 50/326 (15%), Positives = 91/326 (27%), Gaps = 19/326 (5%)

Query: 79  LKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSF 138
              L L++  LS  LP       P+L+ L    N+ +  +P    +   L        + 
Sbjct: 40  AHELELNNLGLS-SLPEL----PPHLESLVASCNS-LTELPELPQSLKSLLVDNNNLKAL 93

Query: 139 SGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNP----LGGI 194
           S   P       +   L        SS  ++  + + S  K  +                
Sbjct: 94  SDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLE 153

Query: 195 LPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLA 254
               + NL      +  +N                    +L              +    
Sbjct: 154 ELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADN 213

Query: 255 ALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFT 314
            L +           +      LT+L +L      L    +    L ++       N  +
Sbjct: 214 NLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASS 273

Query: 315 GPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLIS 374
             +         L +L++S N     +P        L+ L   +N L   +P       +
Sbjct: 274 NEIRSLCDLPPSLEELNVSNNKLIE-LP---ALPPRLERLIASFNHLA-EVPELPQ---N 325

Query: 375 LKSLNLSNNNLSGTIPISLEKLLDLK 400
           LK L++  N L    P   E + DL+
Sbjct: 326 LKQLHVEYNPLR-EFPDIPESVEDLR 350

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 47.1 bits (110), Expect = 5e-06
 Identities = 21/119 (17%), Positives = 44/119 (36%), Gaps = 35/119 (29%)

Query: 264 NKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGN 323
           N  S  + +      +L +L + +N L  +P+    L+                      
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLIELPALPPRLE---------------------- 307

Query: 324 LNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSN 382
                +L  S N+ + V        ++L+ L +EYN L+   P+      S++ L +++
Sbjct: 308 -----RLIASFNHLAEVPEL----PQNLKQLHVEYNPLR-EFPDIPE---SVEDLRMNS 353

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 42.5 bits (98), Expect = 1e-04
 Identities = 59/350 (16%), Positives = 102/350 (29%), Gaps = 38/350 (10%)

Query: 98  DVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGL 157
           D       EL L  N  + ++P    +   L  L    NS +  +P    +L++L     
Sbjct: 34  DCLDRQAHELEL-NNLGLSSLPELPPH---LESLVASCNSLT-ELPELPQSLKSLLVDNN 88

Query: 158 NDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNIS 217
           N   L+   P L                           + I   + S++       ++ 
Sbjct: 89  NLKALSDLPPLLEY-----LGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLE 143

Query: 218 GSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNL 277
                         LQ L         +          L    +              NL
Sbjct: 144 FIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNL 203

Query: 278 TNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNF 337
             L  +Y  +NLL ++P    +L+ +   +                             F
Sbjct: 204 PFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPE---------------LPQSLTF 248

Query: 338 SCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLL 397
             V      GL +L       N     I +      SL+ LN+SNN L   +P    +  
Sbjct: 249 LDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR-- 305

Query: 398 DLKDINVSFNRLEGEIPREGPFRNLSAESFKGN------ELLCGMPNLQV 441
            L+ +  SFN L  E+P     +NL     + N      ++   + +L++
Sbjct: 306 -LERLIASFNHLA-EVPEL--PQNLKQLHVEYNPLREFPDIPESVEDLRM 351

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 52.0 bits (124), Expect = 9e-09
 Identities = 33/108 (30%), Positives = 41/108 (37%), Gaps = 5/108 (4%)

Query: 281 RKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCV 340
           R L+L    LT +   L  L  + HL+LS N      P  +  L  L  L  S N    V
Sbjct: 1   RVLHLAHKDLTVLCH-LEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENV 58

Query: 341 IPTKIGGLKDLQYLFLEYNRLQG-SIPNSIGDLISLKSLNLSNNNLSG 387
                     LQ L L  NRLQ  +    +     L  LNL  N+L  
Sbjct: 59  DGVANL--PRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 49.3 bits (117), Expect = 7e-08
 Identities = 27/118 (22%), Positives = 38/118 (32%), Gaps = 6/118 (5%)

Query: 259 LDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLP 318
           L L    L+  V      L  +  L L  N L ++P  L  L+ +  L  S N       
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60

Query: 319 LKIGNLNVLVQLDLSMNNFSCV-IPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISL 375
             + NL  L +L L  N          +     L  L L+ N L          L  +
Sbjct: 61  --VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 41.6 bits (97), Expect = 4e-05
 Identities = 28/108 (25%), Positives = 45/108 (41%), Gaps = 6/108 (5%)

Query: 306 LNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSI 365
           L+L+    T    L    L ++  LDLS N    + P  +  L+ L+ L  + +      
Sbjct: 3   LHLAHKDLTVLCHL--EQLLLVTHLDLSHNRLRALPPA-LAALRCLEVL--QASDNALEN 57

Query: 366 PNSIGDLISLKSLNLSNNNLSGTIPI-SLEKLLDLKDINVSFNRLEGE 412
            + + +L  L+ L L NN L  +  I  L     L  +N+  N L  E
Sbjct: 58  VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.9 bits (95), Expect = 7e-05
 Identities = 21/104 (20%), Positives = 32/104 (30%), Gaps = 11/104 (10%)

Query: 13  ILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTT 72
           +L  L     +  L LS+N      P+         +    N                  
Sbjct: 12  VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN-----------VDG 60

Query: 73  IFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIG 116
           + N+  L+ L L +N L         V  P L  L+L GN+   
Sbjct: 61  VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 40.5 bits (94), Expect = 1e-04
 Identities = 23/127 (18%), Positives = 44/127 (34%), Gaps = 13/127 (10%)

Query: 131 LGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNP 190
           L L     +  +      L  +  L L+ N L +  P L++L  L   +  +    + + 
Sbjct: 3   LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60

Query: 191 LGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDL 250
           +  +       L         +N     +  + + +     L LL+L+GN L        
Sbjct: 61  VANLPRLQELLLC--------NNRLQQSAAIQPLVSCPR--LVLLNLQGNSLCQ-EEGIQ 109

Query: 251 CRLAALF 257
            RLA + 
Sbjct: 110 ERLAEML 116

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 37.0 bits (85), Expect = 0.002
 Identities = 25/138 (18%), Positives = 38/138 (27%), Gaps = 31/138 (22%)

Query: 168 ELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNL 227
           +L+ L  L     + +   S+N L  + P A+  L         DN              
Sbjct: 9   DLTVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALE----------- 56

Query: 228 TNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGF-VPACSGNLTNLRKLYLG 286
                               D +  L  L +L L  N+L          +   L  L L 
Sbjct: 57  ------------------NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQ 98

Query: 287 SNLLTSIPSTLWNLKDIL 304
            N L         L ++L
Sbjct: 99  GNSLCQEEGIQERLAEML 116

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 48.1 bits (113), Expect = 1e-06
 Identities = 30/191 (15%), Positives = 62/191 (32%), Gaps = 7/191 (3%)

Query: 124 NASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTP--ELSSLSS--LSNCK 179
             ++  +  L+K S + ++      L ++  +  N++ + S      L +++   L+  K
Sbjct: 22  AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNK 79

Query: 180 YLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEG 239
             +    +N    G L      +        +            I+++  L+        
Sbjct: 80  LTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESL 139

Query: 240 NQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWN 299
                 I D            L               LT L+ LYL  N ++ + + L  
Sbjct: 140 YLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDLRA-LAG 198

Query: 300 LKDILHLNLSS 310
           LK++  L L S
Sbjct: 199 LKNLDVLELFS 209

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.4 bits (93), Expect = 3e-04
 Identities = 32/209 (15%), Positives = 60/209 (28%), Gaps = 31/209 (14%)

Query: 219 SIPEEIN------NLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPA 272
           ++P  I            I   L      +  ++  +   L ++ Q+    + +      
Sbjct: 9   TVPTPIKQIFSDDAFAETIKDNLKK--KSVTDAVTQN--ELNSIDQIIANNSDIKSVQGI 64

Query: 273 CSGNLTNLRKLYLGSNLLT----------------SIPSTLWNLKDILHLNLSSNFFTGP 316
               L N+ KL+L  N LT                                L S      
Sbjct: 65  --QYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHN 122

Query: 317 LPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLK 376
               I  L  L QL+      + +    +             +     I   +  L  L+
Sbjct: 123 GISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQ 181

Query: 377 SLNLSNNNLSGTIPISLEKLLDLKDINVS 405
           +L LS N++S  +  +L  L +L  + + 
Sbjct: 182 NLYLSKNHIS-DLR-ALAGLKNLDVLELF 208

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 38.1 bits (87), Expect = 0.002
 Identities = 36/179 (20%), Positives = 58/179 (32%), Gaps = 15/179 (8%)

Query: 204 QSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGG 263
            S++    +N +I       I  L N+    L L GN+L          LA L  L    
Sbjct: 46  NSIDQIIANNSDIKSVQG--IQYLPNV--TKLFLNGNKLTDI-----KPLANLKNLGWLF 96

Query: 264 NKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGN 323
              +      S       K     +   S  + L +L  +  L L +N  T    L    
Sbjct: 97  LDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLT 156

Query: 324 LNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSN 382
               +     + +        + GL  LQ L+L  N +      ++  L +L  L L +
Sbjct: 157 KLDTLS----LEDNQISDIVPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 49.1 bits (115), Expect = 1e-06
 Identities = 41/340 (12%), Positives = 91/340 (26%), Gaps = 30/340 (8%)

Query: 106 ELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSG----SIPNTFGNLRNLKWLGLNDNY 161
           +L         ++ + +     + E+ L  N+        +     + ++L+    +D +
Sbjct: 11  KLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIF 70

Query: 162 LTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIP 221
                 E+         + L         L  +          + E         +    
Sbjct: 71  TGRVKDEIPE-----ALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEH 125

Query: 222 EEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLR 281
             ++N          +     E ++         L  +  G N+L              +
Sbjct: 126 LYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLE-----NGSMKEWAK 180

Query: 282 KLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVI 341
                  L T                   +     L        + +Q +   +  S  +
Sbjct: 181 TFQSHRLLHTVKMVQNGI-----RPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSAL 235

Query: 342 PTKIGGLKDLQYLFLEYNRLQGSIPNSIGD------LISLKSLNLSNNNLSGTIPISL-- 393
              +    +L+ L L    L      ++ D       I L++L L  N +      +L  
Sbjct: 236 AIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKT 295

Query: 394 ---EKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGN 430
              EK+ DL  + ++ NR   E       R + +   +G 
Sbjct: 296 VIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGE 335

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 44.5 bits (103), Expect = 4e-05
 Identities = 41/318 (12%), Positives = 86/318 (27%), Gaps = 22/318 (6%)

Query: 13  ILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTT 72
           + + L    S++ + LS N    +I +     +   I +  ++E   FS      V    
Sbjct: 23  VFAVLLEDDSVKEIVLSGN----TIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEI 78

Query: 73  IFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELG 132
              +  L    L    L     S         + L  + +        ++ N     + G
Sbjct: 79  PEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAG 138

Query: 133 L--QKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSS-----LSSLSNCKYLEYFS 185
               +     ++     N   L+ +    N L + + +  +        L   K ++   
Sbjct: 139 AKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGI 198

Query: 186 FSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGS 245
                   +L          + D   +     GS    I   +   L+ L L    L   
Sbjct: 199 RPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR 258

Query: 246 IPDDL------CRLAALFQLDLGGNKLSG-----FVPACSGNLTNLRKLYLGSNLLTSIP 294
               +           L  L L  N++               + +L  L L  N  +   
Sbjct: 259 GAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 318

Query: 295 STLWNLKDILHLNLSSNF 312
             +  ++++         
Sbjct: 319 DVVDEIREVFSTRGRGEL 336

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 47.7 bits (112), Expect = 2e-06
 Identities = 34/234 (14%), Positives = 75/234 (32%), Gaps = 25/234 (10%)

Query: 124 NASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEY 183
             +   ++   K++ + ++  T  +L  +  L      +T+       +  +     L  
Sbjct: 17  ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-------IEGVQYLNNLIG 67

Query: 184 FSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLE 243
               +N +       + NL++  E     N   + S    + ++  L            +
Sbjct: 68  LELKDNQI--TDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLD-------LTSTQ 118

Query: 244 GSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDI 303
            +    L  L+ L  L L  N+++   P           +        +  + L  L  +
Sbjct: 119 ITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTL 178

Query: 304 LHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLE 357
                  N  +   PL   +L  L+++ L  N  S V P  +    +L  + L 
Sbjct: 179 KA---DDNKISDISPL--ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.6 bits (96), Expect = 2e-04
 Identities = 15/62 (24%), Positives = 29/62 (46%), Gaps = 4/62 (6%)

Query: 321 IGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNL 380
           + NL+ L  L    N  S + P  +  L +L  + L+ N++    P  + +  +L  + L
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224

Query: 381 SN 382
           +N
Sbjct: 225 TN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.0 bits (92), Expect = 5e-04
 Identities = 30/180 (16%), Positives = 55/180 (30%), Gaps = 14/180 (7%)

Query: 14  LSQLGNPSSLQTLYLSYN-----PPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGV 68
           +  +   ++L  L L  N      P  ++      E+        +      S   +   
Sbjct: 56  IEGVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLT 115

Query: 69  VPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKL 128
                          L    L     ++           +L   N   +  + + N SKL
Sbjct: 116 STQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKL 175

Query: 129 SELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSN 188
           + L    N  S   P    +L NL  + L +N       ++S +S L+N   L   + +N
Sbjct: 176 TTLKADDNKISDISP--LASLPNLIEVHLKNN-------QISDVSPLANTSNLFIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 39.6 bits (91), Expect = 6e-04
 Identities = 17/73 (23%), Positives = 31/73 (42%), Gaps = 4/73 (5%)

Query: 333 SMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPIS 392
           S+ N      T +  L  L  L  + N++    P  +  L +L  ++L NN +S   P  
Sbjct: 157 SIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP-- 212

Query: 393 LEKLLDLKDINVS 405
           L    +L  + ++
Sbjct: 213 LANTSNLFIVTLT 225

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.003
 Identities = 36/236 (15%), Positives = 70/236 (29%), Gaps = 63/236 (26%)

Query: 246 IPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILH 305
            PD    LA   ++  G + ++  V     +L  +  L      +T+I   +  L +++ 
Sbjct: 13  FPDP--ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIEG-VQYLNNLIG 67

Query: 306 LNLSSNFFTGPLPLKIGNLNVLVQLDLSM------------------------------- 334
           L L  N  T   PLK       ++L  +                                
Sbjct: 68  LELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAG 127

Query: 335 -------NNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSG 387
                        I             +L     Q S    + +L  L +L   +N +S 
Sbjct: 128 LSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD 187

Query: 388 TIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMPNLQVLS 443
             P++   L +L ++++  N++    P                  L    NL +++
Sbjct: 188 ISPLA--SLPNLIEVHLKNNQISDVSP------------------LANTSNLFIVT 223

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 47.1 bits (110), Expect = 2e-06
 Identities = 26/169 (15%), Positives = 54/169 (31%), Gaps = 22/169 (13%)

Query: 20  PSSLQTLYLSYNPPSGSIP-----------------SFILCEIPHEIDNLHNMEWMAFSF 62
           P     L L+ N                        + +    P+  +   +++ +    
Sbjct: 28  PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87

Query: 63  NKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFI 122
           NK+  +       +  LK+L L+ N +S  +   +   L +L  L+L  N F        
Sbjct: 88  NKIKEISNKMFLGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSLNLASNPFNCNCHLAW 146

Query: 123 FNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSS 171
           F    L +  L   +     P+    +R+++   L  +    S+     
Sbjct: 147 FA-EWLRKKSLNGGAARCGAPS---KVRDVQIKDLPHSEFKCSSENSEG 191

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 46.0 bits (107), Expect = 4e-06
 Identities = 31/162 (19%), Positives = 57/162 (35%), Gaps = 5/162 (3%)

Query: 181 LEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGN 240
                 ++N LG I    +      +    +    ++G  P          +Q L L  N
Sbjct: 31  TTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEG--ASHIQELQLGEN 88

Query: 241 QLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNL 300
           +++         L  L  L+L  N++S  +P    +L +L  L L SN         W  
Sbjct: 89  KIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFA 148

Query: 301 KDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIP 342
           + +   +L+        P K+ ++ +    DL  + F C   
Sbjct: 149 EWLRKKSLNGGAARCGAPSKVRDVQI---KDLPHSEFKCSSE 187

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 39.8 bits (91), Expect = 5e-04
 Identities = 18/100 (18%), Positives = 35/100 (35%), Gaps = 3/100 (3%)

Query: 271 PACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQL 330
                 L  L+ L L  N ++ +    +   + L     ++               L + 
Sbjct: 95  NKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKK 154

Query: 331 DLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIG 370
            L+     C  P+K   ++D+Q   L ++  + S  NS G
Sbjct: 155 SLNGGAARCGAPSK---VRDVQIKDLPHSEFKCSSENSEG 191

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.8 bits (112), Expect = 2e-06
 Identities = 36/272 (13%), Positives = 79/272 (29%), Gaps = 19/272 (6%)

Query: 131 LGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNP 190
           L L   +     P+  G L +   +           P     S       +++   SN+ 
Sbjct: 5   LDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFR----VQHMDLSNSV 57

Query: 191 LGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDL 250
           +       I +    +++  ++   +S  I   +   +NL+   LS      E ++   L
Sbjct: 58  IEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLL 117

Query: 251 CRLAALFQLDLGGNKLSGFVPAC--------SGNLTNLRKLYLGSNLLTSIPSTLWNLKD 302
              + L +L+L                    +    NL                      
Sbjct: 118 SSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNL 177

Query: 303 ILHLNLSSNFFTGPLPLKIGNLNVLVQLDLS-MNNFSCVIPTKIGGLKDLQYLFLEYNRL 361
           +      S         +   LN L  L LS   +       ++G +  L+ L +     
Sbjct: 178 VHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVP 237

Query: 362 QGSIPNSIGDLISLKSLNLSNNNLSGTIPISL 393
            G++        +L  L ++ ++ +     ++
Sbjct: 238 DGTLQLLKE---ALPHLQINCSHFTTIARPTI 266

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.3 bits (106), Expect = 4e-06
 Identities = 23/149 (15%), Positives = 45/149 (30%), Gaps = 10/149 (6%)

Query: 113 NFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSL 172
             I     +  NA +  EL L+       I N    L     +  +DN +         L
Sbjct: 6   ELIEQAAQYT-NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-------KL 56

Query: 173 SSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLIL 232
                 + L+    +NN +  I       L    E    +N  +     + + +L +L  
Sbjct: 57  DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTY 116

Query: 233 QLLS-LEGNQLEGSIPDDLCRLAALFQLD 260
             +        +      + ++  +  LD
Sbjct: 117 LCILRNPVTNKKHYRLYVIYKVPQVRVLD 145

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.9 bits (92), Expect = 3e-04
 Identities = 19/86 (22%), Positives = 27/86 (31%), Gaps = 2/86 (2%)

Query: 276 NLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMN 335
           N    R+L L    +  I +    L     ++ S N            L  L  L ++ N
Sbjct: 16  NAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDG--FPLLRRLKTLLVNNN 73

Query: 336 NFSCVIPTKIGGLKDLQYLFLEYNRL 361
               +       L DL  L L  N L
Sbjct: 74  RICRIGEGLDQALPDLTELILTNNSL 99

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.8 bits (84), Expect = 0.004
 Identities = 22/130 (16%), Positives = 44/130 (33%), Gaps = 6/130 (4%)

Query: 256 LFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTG 315
             +LDL G K+   +      L     +    N +  +      L+ +  L +++N    
Sbjct: 20  DRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGF-PLLRRLKTLLVNNNRICR 77

Query: 316 PLPLKIGNLNVLVQLDLSMNNFSCV-IPTKIGGLKDLQYLFLE---YNRLQGSIPNSIGD 371
                   L  L +L L+ N+   +     +  LK L YL +        +      I  
Sbjct: 78  IGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYK 137

Query: 372 LISLKSLNLS 381
           +  ++ L+  
Sbjct: 138 VPQVRVLDFQ 147

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.3 bits (110), Expect = 6e-06
 Identities = 17/94 (18%), Positives = 35/94 (37%), Gaps = 6/94 (6%)

Query: 323 NLNVLVQLDLSMNNFSCVIPTKI-GGLKDLQYLFLEYNRLQG----SIPNSIGDLISLKS 377
           +L+ +  LD+     S     ++   L+  Q + L+   L       I +++    +L  
Sbjct: 1   SLD-IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59

Query: 378 LNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEG 411
           LNL +N L       + + L      +    L+ 
Sbjct: 60  LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.9 bits (109), Expect = 7e-06
 Identities = 17/87 (19%), Positives = 31/87 (35%), Gaps = 9/87 (10%)

Query: 323 NLNVLVQLDLSMNNFSCV----IPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLI----- 373
             +VL  L L+  + S      +   +     L+ L L  N L  +    + + +     
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 374 SLKSLNLSNNNLSGTIPISLEKLLDLK 400
            L+ L L +   S  +   L+ L   K
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDK 453

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.0 bits (104), Expect = 3e-05
 Identities = 15/92 (16%), Positives = 28/92 (30%), Gaps = 9/92 (9%)

Query: 79  LKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNF----IGTIPSFIFNASKLSELGLQ 134
           ++SL +    LS    +     L   + + L            I S +     L+EL L+
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 135 KNSFSGSIPNTFG-----NLRNLKWLGLNDNY 161
            N       +            ++ L L +  
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (102), Expect = 4e-05
 Identities = 17/102 (16%), Positives = 27/102 (26%), Gaps = 4/102 (3%)

Query: 108 HLWGNNFIGTIPSFIFNASKLSELGLQKNSFSG----SIPNTFGNLRNLKWLGLNDNYLT 163
            L                S L  L L     S     S+  T     +L+ L L++N L 
Sbjct: 351 RLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 410

Query: 164 SSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQS 205
            +       S       LE     +      +   +  L + 
Sbjct: 411 DAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKD 452

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.2 bits (102), Expect = 4e-05
 Identities = 16/79 (20%), Positives = 31/79 (39%), Gaps = 2/79 (2%)

Query: 128 LSELGLQKNSFSGS-IPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSF 186
           +  L +Q    S +        L+  + + L+D  LT +  +  S S+L     L   + 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDIS-SALRVNPALAELNL 62

Query: 187 SNNPLGGILPRAIGNLSQS 205
            +N LG +    +    Q+
Sbjct: 63  RSNELGDVGVHCVLQGLQT 81

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.0 bits (99), Expect = 1e-04
 Identities = 18/92 (19%), Positives = 27/92 (29%), Gaps = 11/92 (11%)

Query: 259 LDLGGNKLSGF-VPACSGNLTNLRKLYLGSNLLT-----SIPSTLWNLKDILHLNLSSNF 312
           LD+   +LS          L   + + L    LT      I S L     +  LNL SN 
Sbjct: 7   LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66

Query: 313 FTGPLPLKIG-----NLNVLVQLDLSMNNFSC 339
                   +          + +L L     + 
Sbjct: 67  LGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTG 98

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 1e-04
 Identities = 20/102 (19%), Positives = 38/102 (37%), Gaps = 21/102 (20%)

Query: 351 LQYLFLEYNRLQG----SIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLD-----LKD 401
           L+ L+L    +      S+  ++    SL+ L+LSNN L     + L + +      L+ 
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430

Query: 402 INVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMPNLQVLS 443
           + +       E+                  L    P+L+V+S
Sbjct: 431 LVLYDIYWSEEMEDR------------LQALEKDKPSLRVIS 460

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.7 bits (98), Expect = 1e-04
 Identities = 18/89 (20%), Positives = 35/89 (39%), Gaps = 10/89 (11%)

Query: 271 PACSGNLTNLRKLYLGSNLLT-----SIPSTLWNLKDILHLNLSSNFFTGPLPLKIG--- 322
                  + LR L+L    ++     S+ +TL     +  L+LS+N       L++    
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421

Query: 323 --NLNVLVQLDLSMNNFSCVIPTKIGGLK 349
                +L QL L    +S  +  ++  L+
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALE 450

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.1 bits (94), Expect = 4e-04
 Identities = 17/87 (19%), Positives = 30/87 (34%), Gaps = 8/87 (9%)

Query: 75  NVSTLKSLYLHSNSLSGRLPS---SADVRLPNLKELHLWGNNFIGTIPSFIFNA-----S 126
             S L+ L+L    +S    S   +  +   +L+EL L  N         +  +      
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426

Query: 127 KLSELGLQKNSFSGSIPNTFGNLRNLK 153
            L +L L    +S  + +    L   K
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDK 453

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.4 bits (104), Expect = 1e-05
 Identities = 25/133 (18%), Positives = 46/133 (34%), Gaps = 5/133 (3%)

Query: 237 LEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPST 296
           L+  Q+E  +   + +     Q  L    L                L   S++  ++   
Sbjct: 4   LKPEQVE-QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAATLRII 60

Query: 297 LWNLKDILHLNLSSNFFTG--PLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYL 354
             N+ ++L LNLS+N       +   +     L  L+LS N               L+ L
Sbjct: 61  EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEEL 120

Query: 355 FLEYNRLQGSIPN 367
           +L+ N L  +  +
Sbjct: 121 WLDGNSLSDTFRD 133

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.0 bits (103), Expect = 1e-05
 Identities = 29/160 (18%), Positives = 53/160 (33%), Gaps = 14/160 (8%)

Query: 285 LGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTK 344
           L    +  +   +    D     L          L     N+ V L+   ++ +  +   
Sbjct: 4   LKPEQVEQLKLIMSKRYDGSQQALDLKGLRSDPDLV--AQNIDVVLNRR-SSMAATLRII 60

Query: 345 IGGLKDLQYLFLEYNRLQG--SIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDI 402
              + +L  L L  NRL     + + +    +LK LNLS N L     +   K L L+++
Sbjct: 61  EENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEEL 120

Query: 403 NVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMPNLQVL 442
            +  N L      +  +          + +    P L  L
Sbjct: 121 WLDGNSLSDTFRDQSTYI---------SAIRERFPKLLRL 151

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.1 bits (102), Expect = 3e-05
 Identities = 32/228 (14%), Positives = 62/228 (27%), Gaps = 11/228 (4%)

Query: 69  VPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKL 128
           +P+ +        L      L   +   A     +L+++ +  N+ +  I + +F+    
Sbjct: 23  IPSDLP--RNAIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 79

Query: 129 SELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSN 188
                          N             N  YL  S   +  L  +     L+      
Sbjct: 80  -----LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDI 134

Query: 189 NPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPD 248
                I      +      +  +   N +G             L  L+L  N     +P+
Sbjct: 135 QDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPN 194

Query: 249 D-LCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPS 295
           D     +    LD+   ++         NL  LR        L  +P+
Sbjct: 195 DVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLKKLPT 240

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.3 bits (92), Expect = 5e-04
 Identities = 11/79 (13%), Positives = 21/79 (26%)

Query: 305 HLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGS 364
            L L+ N              +        NN   +      G      L +   R+   
Sbjct: 157 ILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSL 216

Query: 365 IPNSIGDLISLKSLNLSNN 383
               + +L  L++ +  N 
Sbjct: 217 PSYGLENLKKLRARSTYNL 235

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.1 bits (89), Expect = 0.001
 Identities = 24/221 (10%), Positives = 52/221 (23%), Gaps = 23/221 (10%)

Query: 112 NNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSS 171
            + +  IPS +       EL              F    +L+ + ++ N +         
Sbjct: 17  ESKVTEIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVF 74

Query: 172 LSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGS------------ 219
            +     +     + +   +     + + NL   +                         
Sbjct: 75  SNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDI 134

Query: 220 --------IPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVP 271
                   I        +    +L L  N ++                    N L     
Sbjct: 135 QDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPN 194

Query: 272 ACSGNLTNLRKLYLGSNLLTSIPS-TLWNLKDILHLNLSSN 311
                 +    L +    + S+PS  L NLK +   +  + 
Sbjct: 195 DVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.8 bits (94), Expect = 2e-04
 Identities = 32/190 (16%), Positives = 69/190 (36%), Gaps = 20/190 (10%)

Query: 124 NASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEY 183
             ++  +  L K + + ++  +  +L  +  L  +   + S    +  +  L+N   + +
Sbjct: 16  ALAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS----IDGVEYLNNLTQINF 69

Query: 184 --------FSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNL--TNLILQ 233
                       N      +      ++       + N         +I ++     +  
Sbjct: 70  SNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 129

Query: 234 LLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSI 293
           L  LE +    S    L  L +L QL+   N+++   P    NLT L +L + SN ++ I
Sbjct: 130 LNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPL--ANLTTLERLDISSNKVSDI 187

Query: 294 P--STLWNLK 301
              + L NL+
Sbjct: 188 SVLAKLTNLE 197

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.2 bits (92), Expect = 3e-04
 Identities = 30/165 (18%), Positives = 51/165 (30%), Gaps = 19/165 (11%)

Query: 278 TNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKI-GNLNVLVQLDLSMNN 336
                L    +        L   +++  L + +      L L+    L  L  L +  + 
Sbjct: 8   HGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSG 67

Query: 337 FSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPIS-LEK 395
              V P        L  L L +N L+ S+       +SL+ L LS N L  +  +  L++
Sbjct: 68  LRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQR 126

Query: 396 LLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMPNLQ 440
             +     V   +L+                      L  MPN  
Sbjct: 127 WEEEGLGGVPEQKLQCHGQGP----------------LAHMPNAS 155

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.5 bits (85), Expect = 0.002
 Identities = 23/132 (17%), Positives = 46/132 (34%), Gaps = 2/132 (1%)

Query: 327 LVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIP-NSIGDLISLKSLNLSNNNL 385
              L  + +         + G ++L  L++E  +    +    +  L  L++L +  + L
Sbjct: 10  SSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL 68

Query: 386 SGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELLCGMPNLQVLSCR 445
               P +      L  +N+SFN LE    +     +L      GN L C      +    
Sbjct: 69  RFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWE 128

Query: 446 TKIHHTLGKNDL 457
            +    + +  L
Sbjct: 129 EEGLGGVPEQKL 140

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

 Score = 39.7 bits (91), Expect = 5e-04
 Identities = 27/171 (15%), Positives = 53/171 (30%), Gaps = 3/171 (1%)

Query: 91  GRLPSSADVRLPNLKELHLWGN-NFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNL 149
                   V     +++ L G    I  + + +        L L  N+    I +    +
Sbjct: 12  RIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KISS-LSGM 69

Query: 150 RNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDF 209
            NL+ L L  N +       +   +L           S + +  ++   +  +S +    
Sbjct: 70  ENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIASLSGIEKLVNLRVLYMSNNKITN 129

Query: 210 WMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLD 260
           W +   ++     E   L    L     E N       + + RL  L +LD
Sbjct: 130 WGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	797
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.97
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.97
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.96
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.96
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.96
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.95
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.95
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.93
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.93
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.91
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.91
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.88
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	99.86
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.85
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.84
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	99.81
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.8
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.8
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.8
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.79
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.79
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.78
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.76
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	99.74
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.74
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.73
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.65
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.6
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.6
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.55
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.51
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.5
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	99.49
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.48
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	99.48
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.45
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.42
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.38
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.7
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.51
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.45
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.75
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.66
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.58
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.14
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.89
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.7
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	95.43
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.26
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	93.53

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-47  Score=393.31  Aligned_cols=246  Identities=24%  Similarity=0.302  Sum_probs=204.4

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ++|+..+.||+|+||+||++     ++.||||++++..   ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            67999999999999999975     6899999998642   344567999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      ||+++|+|.+++...+ .+++..++.++.|++.||+|||   +++|+||||||+|||+++++.+||+|||+|+.+.....
T Consensus        88 Ey~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~  163 (288)
T d1uu3a_          88 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  163 (288)
T ss_dssp             CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             EccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence            9999999999887655 4899999999999999999999   99999999999999999999999999999987654433


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh----------------hhhhhcccccchhc
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE----------------EKHLMTKEQPMVRM  727 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~l~~~  727 (797)
                      .......+||+.|||||.+.+..|+.++|+||+|+..++++.+..++...                +.......+++++.
T Consensus       164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  243 (288)
T d1uu3a_         164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK  243 (288)
T ss_dssp             ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHT
T ss_pred             ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence            33445578999999999999999999999999999987666655544321                11233456778999


Q ss_pred             cccCCCCCCCChHHHHHhHHHHHHHhccccccccccCCcccccceeeeeeeee
Q 040702          728 GTDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYTI  780 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~  780 (797)
                      |++.||++|||+.|+...                   ..+++||||++++|+-
T Consensus       244 ~L~~dP~~R~t~~e~~~~-------------------~~i~~Hpff~~i~w~~  277 (288)
T d1uu3a_         244 LLVLDATKRLGCEEMEGY-------------------GPLKAHPFFESVTWEN  277 (288)
T ss_dssp             TSCSSGGGSTTSGGGTCH-------------------HHHHTSGGGTTCCCTT
T ss_pred             HccCCHhHCcCHHHHcCC-------------------HHHHcCCccCCCCHHH
Confidence            999999999999887532                   2346789999999973

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-45  Score=378.11  Aligned_cols=237  Identities=21%  Similarity=0.292  Sum_probs=192.9

Q ss_pred             hcCCCccccccccCCcceeec--ceEEEEEEEEecc--CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          511 TNRFSENNLIGRGGFGPVYKD--GMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~--~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      .++|...+.||+|+||+||+|  +..||||+++...  ....+.|.+|++++++++|||||++++++.+ +..++|||||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~   85 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWC   85 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESSSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             cccEEEEEEEeeCCCcEEEEEEECCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecC
Confidence            468999999999999999996  3579999997553  3345789999999999999999999998765 4679999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccc
Q 040702          587 PLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  666 (797)
Q Consensus       587 ~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  666 (797)
                      ++|+|.+++...+..+++..+..++.||++||+|||   +++|+||||||+|||++.++.+||+|||+|+..........
T Consensus        86 ~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~  162 (276)
T d1uwha_          86 EGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ  162 (276)
T ss_dssp             CEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC---------
T ss_pred             CCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCccc
Confidence            999999999876667999999999999999999999   89999999999999999999999999999987654433334


Q ss_pred             ccccccCccccccccccc---CccchHHHHHHHhhhhhhhhccccccchhh----------------------hhhhccc
Q 040702          667 QTQTLATIGYMAPDEIFS---GEMRLKCWVNDSLLISVMIVVDANLLIREE----------------------KHLMTKE  721 (797)
Q Consensus       667 ~~~~~gt~~y~aPE~~~~---~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~  721 (797)
                      .....||+.|||||.+..   +.|+.++||||+|+..++.+.+..++....                      ....+.+
T Consensus       163 ~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l  242 (276)
T d1uwha_         163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM  242 (276)
T ss_dssp             ---CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHH
T ss_pred             ccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHH
Confidence            456789999999999863   458999999999999866665544432211                      1122356


Q ss_pred             ccchhccccCCCCCCCChHHHHHhHHHHHH
Q 040702          722 QPMVRMGTDLSLGQFPASYSISKYLVYIRE  751 (797)
Q Consensus       722 ~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~  751 (797)
                      .+++..||+.||++|||+.|+++.|+.+++
T Consensus       243 ~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         243 KRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            788999999999999999999999988765

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-45  Score=377.09  Aligned_cols=229  Identities=19%  Similarity=0.238  Sum_probs=191.3

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEecc-CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      .++|+..+.||+|+||+||++     ++.||||+++... ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            468999999999999999975     6899999997653 2345689999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      |+++|+|.+++.... .+++.++..++.|+++||+|||   +++|+||||||+|||+++++.+||+|||+|+........
T Consensus        84 y~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          84 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             ccCCCcHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            999999999987654 5999999999999999999999   999999999999999999999999999999876544333


Q ss_pred             ccccccccCcccccccccccCcc-chHHHHHHHhhhhhhhhccccccchhh-------------------hhhhcccccc
Q 040702          665 LTQTQTLATIGYMAPDEIFSGEM-RLKCWVNDSLLISVMIVVDANLLIREE-------------------KHLMTKEQPM  724 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~dv~s~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~l  724 (797)
                      ......+||+.|||||.+.+..+ +.++|+||+|+..++.+.+..++....                   ........++
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  239 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL  239 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHH
Confidence            34456789999999999988776 678999999999876666544432211                   1223455688


Q ss_pred             hhccccCCCCCCCChHHHH
Q 040702          725 VRMGTDLSLGQFPASYSIS  743 (797)
Q Consensus       725 ~~~cl~~dp~~RPs~~~i~  743 (797)
                      ++.|++.||++|||+.|++
T Consensus       240 i~~~L~~dP~~R~t~~eil  258 (271)
T d1nvra_         240 LHKILVENPSARITIPDIK  258 (271)
T ss_dssp             HHHHSCSSTTTSCCHHHHT
T ss_pred             HHHHcCCChhHCcCHHHHh
Confidence            9999999999999988864

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-44  Score=375.46  Aligned_cols=225  Identities=24%  Similarity=0.318  Sum_probs=195.0

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      ++|+..+.||+|+||.||++     ++.||||+++.......+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            47999999999999999985     6899999998776666678999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccc
Q 040702          587 PLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  666 (797)
Q Consensus       587 ~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  666 (797)
                      ++|+|.+++...  .+++.++..++.||+.||+|||   +++|+||||||+|||++.++++||+|||+|+.+.....  .
T Consensus       100 ~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~  172 (293)
T d1yhwa1         100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--K  172 (293)
T ss_dssp             TTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--C
T ss_pred             CCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc--c
Confidence            999999988765  3899999999999999999999   99999999999999999999999999999987643322  3


Q ss_pred             ccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh-------------------hhhhhcccccchhc
Q 040702          667 QTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE-------------------EKHLMTKEQPMVRM  727 (797)
Q Consensus       667 ~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~l~~~  727 (797)
                      ....+||+.|||||.+.++.|+.++|+||+|+..+.++.+..++...                   +......++++++.
T Consensus       173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  252 (293)
T d1yhwa1         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR  252 (293)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHH
T ss_pred             ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHH
Confidence            45568999999999999999999999999999987666555443221                   11223457788999


Q ss_pred             cccCCCCCCCChHHHH
Q 040702          728 GTDLSLGQFPASYSIS  743 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~  743 (797)
                      |++.||++|||+.|++
T Consensus       253 ~L~~dP~~R~s~~eil  268 (293)
T d1yhwa1         253 CLDMDVEKRGSAKELL  268 (293)
T ss_dssp             HTCSSTTTSCCHHHHT
T ss_pred             HccCChhHCcCHHHHh
Confidence            9999999999988864

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-45  Score=374.62  Aligned_cols=235  Identities=23%  Similarity=0.266  Sum_probs=190.2

Q ss_pred             cCCCccccccccCCcceeec----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccC
Q 040702          512 NRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  587 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~  587 (797)
                      ++|+..+.||+|+||.||++    ++.||||+++... ...++|.+|++++++++|||||+++|+|..++..|+||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            57888999999999999985    5789999987543 345789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccccc
Q 040702          588 LGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ  667 (797)
Q Consensus       588 ~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  667 (797)
                      +|+|.+++......+++..+..++.|||+||+|||   +++|+||||||+|||++.++.+||+|||+|+....... ...
T Consensus        84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~  159 (263)
T d1sm2a_          84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSS  159 (263)
T ss_dssp             TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred             CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCc-eee
Confidence            99999999877667899999999999999999999   89999999999999999999999999999987643322 223


Q ss_pred             cccccCcccccccccccCccchHHHHHHHhhhhhhhhcc-ccccchh-----------------hhhhhcccccchhccc
Q 040702          668 TQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVD-ANLLIRE-----------------EKHLMTKEQPMVRMGT  729 (797)
Q Consensus       668 ~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~-~~~~~~~-----------------~~~~~~~~~~l~~~cl  729 (797)
                      ....||+.|||||.+.++.|+.++||||+|+..++.+.. ..++...                 +......+.++++.||
T Consensus       160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl  239 (263)
T d1sm2a_         160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCW  239 (263)
T ss_dssp             -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHT
T ss_pred             cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHc
Confidence            446799999999999999999999999999998665542 2222211                 1112345678899999


Q ss_pred             cCCCCCCCChHHHHHhHHHHHH
Q 040702          730 DLSLGQFPASYSISKYLVYIRE  751 (797)
Q Consensus       730 ~~dp~~RPs~~~i~~~l~~i~~  751 (797)
                      +.||++||+++|+++.|+++.+
T Consensus       240 ~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         240 KERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             CSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCCHhHCcCHHHHHHHHHHHHh
Confidence            9999999999999999998865

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.5e-45  Score=381.66  Aligned_cols=249  Identities=20%  Similarity=0.268  Sum_probs=192.2

Q ss_pred             cCHHHHHHHhc---------CCCccccccccCCcceeecc--------eEEEEEEEEeccC-CcchhHHHHHHHhhhccC
Q 040702          502 FTYLELFQATN---------RFSENNLIGRGGFGPVYKDG--------MEVAIKVFNLQYG-GAFKSFDIECGMMKRIRH  563 (797)
Q Consensus       502 ~~~~~l~~~~~---------~f~~~~~lg~G~~g~Vyk~~--------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~H  563 (797)
                      +|++++.+++.         +|+..+.||+|+||+||+|.        ..||||.+..... ...++|.+|++++++++|
T Consensus         7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H   86 (299)
T d1jpaa_           7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH   86 (299)
T ss_dssp             GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred             CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence            45555555554         44556899999999999863        2588888765432 234679999999999999


Q ss_pred             CceeEeeeeeecCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcC
Q 040702          564 RNLIKIISSCSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD  643 (797)
Q Consensus       564 pniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~  643 (797)
                      ||||+++|+|.+++..|+|||||++|+|.+++......+++.++..++.|||+||+|||   +++|+||||||+|||++.
T Consensus        87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~  163 (299)
T d1jpaa_          87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNS  163 (299)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECT
T ss_pred             CCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECC
Confidence            99999999999999999999999999999999877667999999999999999999999   899999999999999999


Q ss_pred             CCcEEEEeecCCccCCccCccc---cccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-h----
Q 040702          644 NMVAHLSDFGMAKPLLEEDQSL---TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-E----  714 (797)
Q Consensus       644 ~~~~kl~DFGla~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-~----  714 (797)
                      ++.+||+|||+|+.........   ......||+.|||||.+.++.++.++||||+|+..++.+. +..++... .    
T Consensus       164 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~  243 (299)
T d1jpaa_         164 NLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI  243 (299)
T ss_dssp             TCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred             CCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9999999999998764432221   2233568999999999999999999999999999866553 33332221 1    


Q ss_pred             ------------hhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHHh
Q 040702          715 ------------KHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRELE  753 (797)
Q Consensus       715 ------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~  753 (797)
                                  .+....+.++++.||+.||++||++.|+++.|+++.+.+
T Consensus       244 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p  294 (299)
T d1jpaa_         244 NAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP  294 (299)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             HHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence                        122345678899999999999999999999998876543

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-44  Score=377.11  Aligned_cols=235  Identities=20%  Similarity=0.304  Sum_probs=197.9

Q ss_pred             HhcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          510 ATNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       510 ~~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      ..++|+..+.||+|+||+||++     ++.||||+++... ...++|.+|++++++++|||||+++|+|.+++..|+|||
T Consensus        15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E   93 (287)
T d1opja_          15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   93 (287)
T ss_dssp             CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence            3568999999999999999985     6889999986543 345789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          585 YMPLGSLEKCLYSG-NYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       585 ~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      ||++|+|.+++... ...+++..+..++.||++||+|||   +++|+||||||+|||++.++.+||+|||+|+...... 
T Consensus        94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~-  169 (287)
T d1opja_          94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT-  169 (287)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS-
T ss_pred             cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCCC-
Confidence            99999999998754 346899999999999999999999   8999999999999999999999999999998764332 


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhcc-ccccchh-----------------hhhhhcccccch
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVD-ANLLIRE-----------------EKHLMTKEQPMV  725 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~-~~~~~~~-----------------~~~~~~~~~~l~  725 (797)
                      ........||+.|||||.+.++.|+.++||||+|+..++.+.. .++....                 +......+.+++
T Consensus       170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li  249 (287)
T d1opja_         170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELM  249 (287)
T ss_dssp             SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred             ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHH
Confidence            2233445689999999999999999999999999988665542 2222211                 112334677889


Q ss_pred             hccccCCCCCCCChHHHHHhHHHH
Q 040702          726 RMGTDLSLGQFPASYSISKYLVYI  749 (797)
Q Consensus       726 ~~cl~~dp~~RPs~~~i~~~l~~i  749 (797)
                      +.||+.||++|||+.|+.+.|+.+
T Consensus       250 ~~cl~~dP~~Rps~~ei~~~L~~~  273 (287)
T d1opja_         250 RACWQWNPSDRPSFAEIHQAFETM  273 (287)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             HHHcCCCHhHCcCHHHHHHHHHHH
Confidence            999999999999999998887765

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-44  Score=373.71  Aligned_cols=227  Identities=18%  Similarity=0.229  Sum_probs=192.8

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      +.|+..+.||+|+||.||++     +..||||+++.......+.+.+|++++++++|||||++++++.+++..|+|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            56899999999999999985     5789999998776666788999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcccc
Q 040702          587 PLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLT  666 (797)
Q Consensus       587 ~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~  666 (797)
                      ++|+|.+++......+++.++..++.||++||+|||   +++|+||||||+|||++.++.+||+|||+|+.....  ...
T Consensus        92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~  166 (288)
T d2jfla1          92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQR  166 (288)
T ss_dssp             TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HHH
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCC--ccc
Confidence            999999998765556999999999999999999999   999999999999999999999999999999864322  112


Q ss_pred             ccccccCcccccccccc-----cCccchHHHHHHHhhhhhhhhccccccchh-------------------hhhhhcccc
Q 040702          667 QTQTLATIGYMAPDEIF-----SGEMRLKCWVNDSLLISVMIVVDANLLIRE-------------------EKHLMTKEQ  722 (797)
Q Consensus       667 ~~~~~gt~~y~aPE~~~-----~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~  722 (797)
                      .....||+.|||||.+.     ...|+.++||||+|+..++++.+..++...                   +......+.
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~  246 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK  246 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred             ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHH
Confidence            34578999999999884     456889999999999986666554443221                   112234567


Q ss_pred             cchhccccCCCCCCCChHHHH
Q 040702          723 PMVRMGTDLSLGQFPASYSIS  743 (797)
Q Consensus       723 ~l~~~cl~~dp~~RPs~~~i~  743 (797)
                      ++++.||+.||++|||+.|++
T Consensus       247 ~li~~~L~~dp~~R~t~~ell  267 (288)
T d2jfla1         247 DFLKKCLEKNVDARWTTSQLL  267 (288)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHT
T ss_pred             HHHHHHccCChhHCcCHHHHh
Confidence            889999999999999988764

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-44  Score=368.30  Aligned_cols=225  Identities=22%  Similarity=0.313  Sum_probs=193.7

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEec---cCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQ---YGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ++|+..+.||+|+||.||++     ++.||||++.+.   .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999974     689999999754   2334567899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      |||++|+|.+++.... .+++..+..++.||++||+|||   +++|+||||||+|||++.++.+||+|||+|+.....  
T Consensus        86 Ey~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--  159 (263)
T ss_dssp             ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--
T ss_pred             eecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCC--
Confidence            9999999999997654 4899999999999999999999   999999999999999999999999999999865432  


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh----------------hhhhcccccchhc
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE----------------KHLMTKEQPMVRM  727 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~l~~~  727 (797)
                        ......||+.|||||.+.+..++.++|+||+|+..++.+.+..++....                ....+.++++++.
T Consensus       160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  237 (263)
T d2j4za1         160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISR  237 (263)
T ss_dssp             --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred             --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence              2345679999999999999999999999999999876666554443211                1123456789999


Q ss_pred             cccCCCCCCCChHHHHH
Q 040702          728 GTDLSLGQFPASYSISK  744 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~  744 (797)
                      |++.||++|||+.|+++
T Consensus       238 ~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         238 LLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             HTCSSGGGSCCHHHHHT
T ss_pred             HccCCHhHCcCHHHHHc
Confidence            99999999999999875

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-44  Score=381.52  Aligned_cols=222  Identities=21%  Similarity=0.238  Sum_probs=190.2

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEec---cCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQ---YGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      .++|+..+.||+|+||.||++     ++.||||++++.   .....+.+.+|++++++++|||||++++++.+++..|+|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            368999999999999999974     689999999865   234457789999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      ||||+||+|.+++...+ .+++..++.++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+......
T Consensus        84 ~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          84 MEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             eeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence            99999999999988765 4899999999999999999999   9999999999999999999999999999998654322


Q ss_pred             ccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh----------------hhhhcccccchh
Q 040702          663 QSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE----------------KHLMTKEQPMVR  726 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~l~~  726 (797)
                        ......+||+.|||||.+.+..|+.++|+||+|+..++++.+..++....                .......+++++
T Consensus       160 --~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~  237 (337)
T d1o6la_         160 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLA  237 (337)
T ss_dssp             --CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred             --cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHH
Confidence              23456789999999999999999999999999999877666554433211                123345678888


Q ss_pred             ccccCCCCCCCC
Q 040702          727 MGTDLSLGQFPA  738 (797)
Q Consensus       727 ~cl~~dp~~RPs  738 (797)
                      .|++.||.+||+
T Consensus       238 ~~L~~dP~~R~~  249 (337)
T d1o6la_         238 GLLKKDPKQRLG  249 (337)
T ss_dssp             HHTCSSTTTSTT
T ss_pred             hhccCCchhhcc
Confidence            899999999996

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-43  Score=368.82  Aligned_cols=240  Identities=22%  Similarity=0.309  Sum_probs=193.3

Q ss_pred             cCCCccccccccCCcceeecc---------eEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKDG---------MEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~~---------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l  581 (797)
                      +.|+..+.||+|+||.||+|.         ..||||+++.... ....+|.+|++++++++|||||+++|++.+.+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            568888999999999999862         4799999975432 234578999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCcc
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  661 (797)
                      ||||+.+|++.+++......+++.++..++.||+.|++|||   +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus        87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  163 (283)
T d1mqba_          87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  163 (283)
T ss_dssp             EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             EEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence            99999999999988877667999999999999999999999   999999999999999999999999999999876443


Q ss_pred             Cc-cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhcc-ccccch-----------------hhhhhhcccc
Q 040702          662 DQ-SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVD-ANLLIR-----------------EEKHLMTKEQ  722 (797)
Q Consensus       662 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~-~~~~~~-----------------~~~~~~~~~~  722 (797)
                      .. ........||+.|||||.+.++.++.++||||+|+..++.+.. .++...                 .+.+....+.
T Consensus       164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~  243 (283)
T d1mqba_         164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIY  243 (283)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHH
T ss_pred             CccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHHH
Confidence            22 1223445789999999999999999999999999998665432 222211                 1112334678


Q ss_pred             cchhccccCCCCCCCChHHHHHhHHHHHHHhc
Q 040702          723 PMVRMGTDLSLGQFPASYSISKYLVYIRELER  754 (797)
Q Consensus       723 ~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~  754 (797)
                      ++++.||+.||++||++.|+++.|+.+.+.+.
T Consensus       244 ~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~  275 (283)
T d1mqba_         244 QLMMQCWQQERARRPKFADIVSILDKLIRAPD  275 (283)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             HHHHHHCcCCHhHCcCHHHHHHHHHHHhhCcc
Confidence            89999999999999999999999988876543

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-43  Score=366.73  Aligned_cols=233  Identities=21%  Similarity=0.299  Sum_probs=194.2

Q ss_pred             hcCCCccccccccCCcceeec----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          511 TNRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      .++|+..+.||+|+||.||+|    +..||||+++... ...++|.+|++++++++|||||+++|++.+ +..|+||||+
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            468889999999999999985    5789999997543 345789999999999999999999998865 4579999999


Q ss_pred             CCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          587 PLGSLEKCLYSGNY-ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       587 ~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      ++|+|.+++..... .+++..+.+|+.||++||+|||   +++|+||||||+|||+++++.+||+|||+|+...... ..
T Consensus        90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~~  165 (272)
T d1qpca_          90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YT  165 (272)
T ss_dssp             TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-EE
T ss_pred             CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCc-cc
Confidence            99999998755432 5899999999999999999999   8999999999999999999999999999998764332 22


Q ss_pred             cccccccCcccccccccccCccchHHHHHHHhhhhhhhhccc-cccch-----------------hhhhhhcccccchhc
Q 040702          666 TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDA-NLLIR-----------------EEKHLMTKEQPMVRM  727 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~-~~~~~-----------------~~~~~~~~~~~l~~~  727 (797)
                      ......||+.|||||.+..+.++.++||||+|+..++.+... .+...                 .+......+.++++.
T Consensus       166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~  245 (272)
T d1qpca_         166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL  245 (272)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred             cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHHH
Confidence            334567999999999999999999999999999986665432 22211                 111233467889999


Q ss_pred             cccCCCCCCCChHHHHHhHHHH
Q 040702          728 GTDLSLGQFPASYSISKYLVYI  749 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~~l~~i  749 (797)
                      ||+.||++|||+.|+++.|+.+
T Consensus       246 cl~~~P~~Rpt~~ei~~~L~~~  267 (272)
T d1qpca_         246 CWKERPEDRPTFDYLRSVLEDF  267 (272)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HcCCCHhHCcCHHHHHHHhhhh
Confidence            9999999999999999988775

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-43  Score=366.69  Aligned_cols=237  Identities=19%  Similarity=0.230  Sum_probs=195.1

Q ss_pred             hcCCCccc-cccccCCcceeec-------ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEE
Q 040702          511 TNRFSENN-LIGRGGFGPVYKD-------GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       511 ~~~f~~~~-~lg~G~~g~Vyk~-------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l  581 (797)
                      .++|...+ +||+|+||.||+|       +..||||+++.... ...++|.+|++++++++|||||+++|++.+ +..|+
T Consensus         7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l   85 (285)
T d1u59a_           7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML   85 (285)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence            35666667 4999999999986       24799999975533 235689999999999999999999999875 45799


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCcc
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  661 (797)
                      ||||+++|+|.+++...+..+++..+..++.||++||+|||   +++|+||||||+||+++.++.+||+|||+|+.....
T Consensus        86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence            99999999999998776667999999999999999999999   899999999999999999999999999999876543


Q ss_pred             Ccc-ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-----------------hhhhhcccc
Q 040702          662 DQS-LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-----------------EKHLMTKEQ  722 (797)
Q Consensus       662 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-----------------~~~~~~~~~  722 (797)
                      ... .......||+.|||||.+..+.++.++||||+|+..++.+. +..++...                 +......+.
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~  242 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY  242 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence            322 22344578999999999999999999999999999866543 33322211                 112234567


Q ss_pred             cchhccccCCCCCCCChHHHHHhHHHHHH
Q 040702          723 PMVRMGTDLSLGQFPASYSISKYLVYIRE  751 (797)
Q Consensus       723 ~l~~~cl~~dp~~RPs~~~i~~~l~~i~~  751 (797)
                      ++++.||+.||++||++.++.+.|+.+..
T Consensus       243 ~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         243 ALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            89999999999999999999999887643

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-43  Score=360.45  Aligned_cols=232  Identities=21%  Similarity=0.250  Sum_probs=198.4

Q ss_pred             cCCCccccccccCCcceeec----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccC
Q 040702          512 NRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMP  587 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~  587 (797)
                      ++|+..++||+|+||+||+|    ++.||||+++.... ..++|.+|++++++++||||++++|+|.+++..++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            58999999999999999985    57999999986543 35789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccccc
Q 040702          588 LGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQ  667 (797)
Q Consensus       588 ~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~  667 (797)
                      +|++.+++......+++..+.+++.|+++||+|||   +++|+||||||+||+++.++.+||+|||+|+...... ....
T Consensus        83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-~~~~  158 (258)
T d1k2pa_          83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTSS  158 (258)
T ss_dssp             TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-CCCC
T ss_pred             CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCC-ceee
Confidence            99999998777667899999999999999999999   8999999999999999999999999999998664432 2234


Q ss_pred             cccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchhhh-----------------hhhcccccchhccc
Q 040702          668 TQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIREEK-----------------HLMTKEQPMVRMGT  729 (797)
Q Consensus       668 ~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~~~-----------------~~~~~~~~l~~~cl  729 (797)
                      ....||+.|||||.+..+.++.++||||+|+..++.+. +..++.....                 .....++++++.||
T Consensus       159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl  238 (258)
T d1k2pa_         159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCW  238 (258)
T ss_dssp             CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTT
T ss_pred             cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHHc
Confidence            45679999999999999999999999999999866553 3333332111                 12335778999999


Q ss_pred             cCCCCCCCChHHHHHhHHH
Q 040702          730 DLSLGQFPASYSISKYLVY  748 (797)
Q Consensus       730 ~~dp~~RPs~~~i~~~l~~  748 (797)
                      +.||++|||+.++++.|.+
T Consensus       239 ~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         239 HEKADERPTFKILLSNILD  257 (258)
T ss_dssp             CSSGGGSCCHHHHHHHHHC
T ss_pred             cCCHhHCcCHHHHHHHhhC
Confidence            9999999999999987743

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.6e-43  Score=372.94  Aligned_cols=239  Identities=21%  Similarity=0.227  Sum_probs=198.1

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEec---cCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQ---YGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ++|+..+.||+|+||+||++     |+.||||++++.   .....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            57999999999999999974     689999999864   2334578899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      |||+||++..++..... +++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.....  
T Consensus        84 E~~~gg~l~~~~~~~~~-~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQR-FPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTSS-CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred             eecCCcccccccccccc-ccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence            99999999999887664 788899999999999999999   999999999999999999999999999999876432  


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh----------------hhhhcccccchhc
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE----------------KHLMTKEQPMVRM  727 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~l~~~  727 (797)
                         ....+||+.|||||.+.+..|+.++|+||+|+..++++.+..++....                ......+.++++.
T Consensus       158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  234 (316)
T d1fota_         158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR  234 (316)
T ss_dssp             ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence               234689999999999999899999999999999877666655443211                1123356677788


Q ss_pred             cccCCCCCCCChHHHHHhHHHHHHHhccccccccccCCcccccceeeeeeee
Q 040702          728 GTDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYT  779 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~  779 (797)
                      |+..||.+||+.                    ....+..+++||||++++|+
T Consensus       235 ~L~~dp~~R~~~--------------------~r~t~~~il~Hp~f~~i~~~  266 (316)
T d1fota_         235 LITRDLSQRLGN--------------------LQNGTEDVKNHPWFKEVVWE  266 (316)
T ss_dssp             HTCSCTTTCTTS--------------------STTTTHHHHTSGGGSSCCHH
T ss_pred             HhhhCHHhcccc--------------------chhhHHHHHcCcccccCCHH
Confidence            888888888631                    12234456677777777776

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-44  Score=378.35  Aligned_cols=226  Identities=20%  Similarity=0.241  Sum_probs=190.2

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      .++|+..+.||+|+||.||++     ++.||||+++.... ...+.+.+|+.++++++|||||+++++|.+++..|+|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            578999999999999999984     68999999986533 334678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCC-CeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSV-PIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~-~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      |+++|+|.+++.+.+ .+++..+..++.|+++||.|||   ++ +|+||||||+|||++.++.+||+|||+|+...+.  
T Consensus        85 y~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--  158 (322)
T d1s9ja_          85 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  158 (322)
T ss_dssp             CCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             cCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence            999999999997654 4899999999999999999999   64 8999999999999999999999999999865322  


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh----------------------------
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK----------------------------  715 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~----------------------------  715 (797)
                        .....+||+.|||||++.+..|+.++|+||+|+..++++.+..++.....                            
T Consensus       159 --~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (322)
T d1s9ja_         159 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  236 (322)
T ss_dssp             --TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred             --ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence              23456899999999999999999999999999998766655433321000                            


Q ss_pred             --------------------------------hhhcccccchhccccCCCCCCCChHHHHH
Q 040702          716 --------------------------------HLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       716 --------------------------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                                      .......++++.|+..||.+|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                                            01124567899999999999999988875

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-43  Score=366.90  Aligned_cols=226  Identities=20%  Similarity=0.264  Sum_probs=191.2

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCC------cchhHHHHHHHhhhccCCceeEeeeeeecCCeE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG------AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFK  579 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~  579 (797)
                      .++|+..+.||+|+||+||++     |+.||||++++....      ..+.+.+|++++++++|||||++++++.+++..
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            367999999999999999984     689999999865321      246789999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCC----cEEEEeecCC
Q 040702          580 ALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM----VAHLSDFGMA  655 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~----~~kl~DFGla  655 (797)
                      |+|||||++|+|.+++...+ .+++..++.++.|+++||+|||   +.+|+||||||+||+++.++    .+|++|||+|
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a  164 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  164 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhh
Confidence            99999999999999997755 4899999999999999999999   99999999999999998776    5999999999


Q ss_pred             ccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh--------------------hh
Q 040702          656 KPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE--------------------EK  715 (797)
Q Consensus       656 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~--------------------~~  715 (797)
                      +......   ......||+.|||||.+.+..++.++||||+|+..++++....++...                    ..
T Consensus       165 ~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  241 (293)
T d1jksa_         165 HKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS  241 (293)
T ss_dssp             EECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred             hhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcC
Confidence            8764332   234567999999999999999999999999999986666554443321                    11


Q ss_pred             hhhcccccchhccccCCCCCCCChHHHH
Q 040702          716 HLMTKEQPMVRMGTDLSLGQFPASYSIS  743 (797)
Q Consensus       716 ~~~~~~~~l~~~cl~~dp~~RPs~~~i~  743 (797)
                      .......++++.|++.||++|||+.|++
T Consensus       242 ~~s~~~~~li~~~L~~dP~~R~s~~eil  269 (293)
T d1jksa_         242 NTSALAKDFIRRLLVKDPKKRMTIQDSL  269 (293)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence            2233567899999999999999988774

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-43  Score=373.54  Aligned_cols=234  Identities=21%  Similarity=0.327  Sum_probs=194.5

Q ss_pred             hcCCCccccccccCCcceeecc----------eEEEEEEEEecc-CCcchhHHHHHHHhhhc-cCCceeEeeeeeecCCe
Q 040702          511 TNRFSENNLIGRGGFGPVYKDG----------MEVAIKVFNLQY-GGAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDF  578 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~~----------~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~  578 (797)
                      .++|+..+.||+|+||+||++.          ..||||.+.... ......+.+|+.+++++ +|||||+++++|.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            3689999999999999999862          369999986543 33456899999999998 89999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCCC----------------------CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCC
Q 040702          579 KALVLEYMPLGSLEKCLYSGNY----------------------ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKP  636 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~~~~----------------------~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp  636 (797)
                      .|+|||||++|+|.++++....                      .+++..++.++.||++||+|||   +++|+||||||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp  192 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAA  192 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCch
Confidence            9999999999999999976532                      4789999999999999999999   89999999999


Q ss_pred             CceEEcCCCcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchhh-
Q 040702          637 SNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIREE-  714 (797)
Q Consensus       637 ~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~~-  714 (797)
                      +||+++.++.+||+|||+|+...............||+.|||||.+.++.++.++||||+|+..++.+. +..++.... 
T Consensus       193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~  272 (325)
T d1rjba_         193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  272 (325)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987655444334455678999999999999999999999999999876553 333322211 


Q ss_pred             -----------------hhhhcccccchhccccCCCCCCCChHHHHHhHH
Q 040702          715 -----------------KHLMTKEQPMVRMGTDLSLGQFPASYSISKYLV  747 (797)
Q Consensus       715 -----------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~  747 (797)
                                       ......+.++++.||+.||++|||++||++.|.
T Consensus       273 ~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         273 DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence                             122345778999999999999999999998874

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-43  Score=362.51  Aligned_cols=227  Identities=21%  Similarity=0.255  Sum_probs=184.5

Q ss_pred             ccccccCCcceeec-------ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEccCC
Q 040702          518 NLIGRGGFGPVYKD-------GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYMPL  588 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~-------~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~~~  588 (797)
                      ++||+|+||.||+|       ++.||||+++....  ...++|.+|++++++++|||||+++|+|..+ ..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCC
Confidence            57999999999985       36799999965432  2346799999999999999999999999654 57899999999


Q ss_pred             CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc-ccc
Q 040702          589 GSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS-LTQ  667 (797)
Q Consensus       589 g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~-~~~  667 (797)
                      |+|.+++.... .+++..+..++.||++||+|||   +++|+||||||+|||++.++.+||+|||+|+........ ...
T Consensus        92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             CcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence            99999998765 4899999999999999999999   899999999999999999999999999999876443322 223


Q ss_pred             cccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-----------------hhhhhcccccchhccc
Q 040702          668 TQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-----------------EKHLMTKEQPMVRMGT  729 (797)
Q Consensus       668 ~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-----------------~~~~~~~~~~l~~~cl  729 (797)
                      ....||+.|||||.+.++.++.++||||+|+..++.+. +..++...                 +......+.++++.||
T Consensus       168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl  247 (277)
T d1xbba_         168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCW  247 (277)
T ss_dssp             ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred             cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHc
Confidence            44579999999999999999999999999999866553 33332221                 1122345678899999


Q ss_pred             cCCCCCCCChHHHHHhHHHH
Q 040702          730 DLSLGQFPASYSISKYLVYI  749 (797)
Q Consensus       730 ~~dp~~RPs~~~i~~~l~~i  749 (797)
                      +.||++||++.++.+.|+.+
T Consensus       248 ~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         248 TYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             CSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCHhHCcCHHHHHHHhhCH
Confidence            99999999999999887764

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-44  Score=366.66  Aligned_cols=232  Identities=20%  Similarity=0.232  Sum_probs=178.8

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCC--cchhHHHHHHHhhhccCCceeEeeeeeec--CCeEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG--AFKSFDIECGMMKRIRHRNLIKIISSCSN--DDFKAL  581 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~l~~~~~~--~~~~~l  581 (797)
                      .++|+..+.||+|+||+||++     |+.||||.++.....  ..+.+.+|++++++++|||||++++++.+  ++..|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            368999999999999999985     688999999766432  34568899999999999999999999865  456899


Q ss_pred             EEEccCCCCHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHccC--CCCeEEcCCCCCceEEcCCCcEEEEeecCCc
Q 040702          582 VLEYMPLGSLEKCLYSG---NYILDIFQGLNIMIDVASALEYLHFGY--SVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  656 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~al~yLH~~~--~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  656 (797)
                      |||||++|+|.+++...   ...+++..++.++.|++.||+|||+..  ..+|+||||||+|||++.++.+||+|||+|+
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            99999999999998642   235899999999999999999999311  1349999999999999999999999999998


Q ss_pred             cCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh-----------------hhhhc
Q 040702          657 PLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE-----------------KHLMT  719 (797)
Q Consensus       657 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-----------------~~~~~  719 (797)
                      .......  .....+||+.|||||.+.+..|+.++||||+|+..++.+.+..++....                 .....
T Consensus       163 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~s~  240 (269)
T d2java1         163 ILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD  240 (269)
T ss_dssp             HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCH
T ss_pred             ecccCCC--ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcccCH
Confidence            7643322  3345789999999999999999999999999999866665544332211                 12234


Q ss_pred             ccccchhccccCCCCCCCChHHHHH
Q 040702          720 KEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       720 ~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      .+.+++++|++.||.+|||+.|+++
T Consensus       241 ~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         241 ELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHh
Confidence            6778899999999999999998864

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5.1e-43  Score=374.22  Aligned_cols=228  Identities=18%  Similarity=0.260  Sum_probs=195.7

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      .++|+..+.||+|+||.||++     ++.||||+++.......+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            357999999999999999974     689999999876544456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEc--CCCcEEEEeecCCccCCccCc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD--DNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~--~~~~~kl~DFGla~~~~~~~~  663 (797)
                      |+||+|.+++......+++.+++.|+.||+.||+|||   +++|+||||||+|||++  .++.+||+|||+|+...... 
T Consensus       108 ~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~-  183 (352)
T d1koba_         108 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-  183 (352)
T ss_dssp             CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred             CCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence            9999999988776667999999999999999999999   99999999999999998  67899999999998764332 


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh--------------------hhhhccccc
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE--------------------KHLMTKEQP  723 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~  723 (797)
                        ......||+.|||||.+.+..++.++|+||+|++.++++.+..++....                    ......+.+
T Consensus       184 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  261 (352)
T d1koba_         184 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD  261 (352)
T ss_dssp             --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred             --ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence              2345679999999999999999999999999999876666554433211                    112335678


Q ss_pred             chhccccCCCCCCCChHHHHH
Q 040702          724 MVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       724 l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      +++.|++.||.+|||+.|+++
T Consensus       262 li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         262 FIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHHccCChhHCcCHHHHhc
Confidence            899999999999999988864

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.2e-42  Score=371.10  Aligned_cols=228  Identities=18%  Similarity=0.212  Sum_probs=195.3

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      -++|++.+.||+|+||.||++     |+.||||++........+.+.+|+.++++++|||||++++++.+++..|+||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            358999999999999999984     689999999766555567889999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEc--CCCcEEEEeecCCccCCccCc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD--DNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~--~~~~~kl~DFGla~~~~~~~~  663 (797)
                      |+||+|.+++......+++..+..|+.||+.||+|||   +++|+||||||+|||++  .++.+||+|||+|+...... 
T Consensus       105 ~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~-  180 (350)
T d1koaa2         105 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-  180 (350)
T ss_dssp             CCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-
T ss_pred             CCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc-
Confidence            9999999999766667999999999999999999999   99999999999999996  46789999999998764332 


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh--------------------hhhhccccc
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE--------------------KHLMTKEQP  723 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~  723 (797)
                        ......||+.|||||++.+..|+.++|+||+|++.++++.+..++....                    .......++
T Consensus       181 --~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  258 (350)
T d1koaa2         181 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD  258 (350)
T ss_dssp             --CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHH
T ss_pred             --ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence              3345689999999999999999999999999999876665554433211                    112335567


Q ss_pred             chhccccCCCCCCCChHHHHH
Q 040702          724 MVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       724 l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      ++++|+..||++|||+.|+++
T Consensus       259 li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         259 FIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             HHHHHCCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCChhHCcCHHHHhc
Confidence            899999999999999998876

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.2e-43  Score=365.97  Aligned_cols=227  Identities=19%  Similarity=0.265  Sum_probs=177.0

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      .+.|+..+.||+|+||+||++     ++.||||++..... ...+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            367999999999999999984     68899999986542 334678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEc---CCCcEEEEeecCCccCCcc
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~---~~~~~kl~DFGla~~~~~~  661 (797)
                      ||+||+|.+++...+ .+++..+..++.||+.||+|||   +++|+||||||+||++.   +++.+||+|||+|+.....
T Consensus        88 ~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_          88 LVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             CCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             ccCCCcHHHhhhccc-CCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence            999999999997754 4999999999999999999999   99999999999999994   5789999999999865332


Q ss_pred             CccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh--------------------hhhhccc
Q 040702          662 DQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE--------------------KHLMTKE  721 (797)
Q Consensus       662 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~  721 (797)
                      .   .....+||+.|||||.+.+..|+.++|+||+|+..++++.+..++....                    .+..+.+
T Consensus       164 ~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  240 (307)
T d1a06a_         164 S---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA  240 (307)
T ss_dssp             ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHH
T ss_pred             C---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHH
Confidence            2   2345689999999999999999999999999999866665554433211                    1223456


Q ss_pred             ccchhccccCCCCCCCChHHHHH
Q 040702          722 QPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       722 ~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      .++++.|++.||++|||+.|+++
T Consensus       241 ~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         241 KDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHccCCHhHCcCHHHHhc
Confidence            78999999999999999998875

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.8e-43  Score=365.39  Aligned_cols=223  Identities=24%  Similarity=0.269  Sum_probs=188.4

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCC---cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG---AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      +.|+..+.||+|+||.||++     ++.||||+++.....   ..+.+.+|++++++++|||||++++++.+++..|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            45999999999999999985     688999999865432   2356889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      |||++|++..+..... .+++.++..++.||++||.|||   +++|+||||||+|||++.++.+||+|||+|+....   
T Consensus        95 E~~~~g~l~~~~~~~~-~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---  167 (309)
T ss_dssp             ECCSEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred             EecCCCchHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC---
Confidence            9999999987766554 5899999999999999999999   99999999999999999999999999999986532   


Q ss_pred             cccccccccCccccccccccc---CccchHHHHHHHhhhhhhhhccccccchhh------------------hhhhcccc
Q 040702          664 SLTQTQTLATIGYMAPDEIFS---GEMRLKCWVNDSLLISVMIVVDANLLIREE------------------KHLMTKEQ  722 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~  722 (797)
                         .....||+.|||||++.+   +.|+.++||||+|+..++.+.+..++....                  ......+.
T Consensus       168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~  244 (309)
T d1u5ra_         168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFR  244 (309)
T ss_dssp             ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHH
T ss_pred             ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence               234679999999999863   568999999999999866665544432211                  11234667


Q ss_pred             cchhccccCCCCCCCChHHHHH
Q 040702          723 PMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       723 ~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      ++++.||+.||.+|||+.|+++
T Consensus       245 ~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         245 NFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHCcCChhHCcCHHHHHh
Confidence            8999999999999999999875

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=5.6e-43  Score=375.98  Aligned_cols=240  Identities=20%  Similarity=0.255  Sum_probs=193.3

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHH---HHHhhhccCCceeEeeeeeecCCeEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIE---CGMMKRIRHRNLIKIISSCSNDDFKA  580 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E---~~~l~~l~Hpniv~l~~~~~~~~~~~  580 (797)
                      ++|++.+.||+|+||.||++     |+.||||++.+..   ......+.+|   +++++.++|||||++++++.+++..|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            68999999999999999974     6899999997542   1222334444   66677778999999999999999999


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCc
Q 040702          581 LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  660 (797)
Q Consensus       581 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  660 (797)
                      +||||+++|+|.+++.... .+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+....
T Consensus        84 ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~  159 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  159 (364)
T ss_dssp             EEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred             EEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence            9999999999999997655 4889999999999999999999   99999999999999999999999999999986643


Q ss_pred             cCccccccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccccccchhh-------------------hhhhcc
Q 040702          661 EDQSLTQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANLLIREE-------------------KHLMTK  720 (797)
Q Consensus       661 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-------------------~~~~~~  720 (797)
                      .    .....+||+.|||||++..+ .|+.++|+||+|++.++++.+..++....                   ....+.
T Consensus       160 ~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  235 (364)
T d1omwa3         160 K----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE  235 (364)
T ss_dssp             S----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHH
T ss_pred             C----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHH
Confidence            2    23456899999999999754 58999999999999877766655543211                   112335


Q ss_pred             cccchhccccCCCCCCCChHHHHHhHHHHHHHhccccccccccCCcccccceeeeeeee
Q 040702          721 EQPMVRMGTDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVDYT  779 (797)
Q Consensus       721 ~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~  779 (797)
                      +.++++.|++.||++||+..+                    ..+.++++|+||++++|+
T Consensus       236 ~~~li~~~L~~dP~~R~t~~~--------------------~~a~eil~Hp~f~~i~~~  274 (364)
T d1omwa3         236 LRSLLEGLLQRDVNRRLGCLG--------------------RGAQEVKESPFFRSLDWQ  274 (364)
T ss_dssp             HHHHHHHHTCSSTTTSTTTSS--------------------STHHHHHTSGGGTTCCHH
T ss_pred             HHHHHHHHcccCHHHhCCCcc--------------------cCHHHHHcCccccCCCHH
Confidence            678889999999999998411                    223455667777777765

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-42  Score=355.90  Aligned_cols=221  Identities=20%  Similarity=0.229  Sum_probs=181.7

Q ss_pred             CccccccccCCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeec----CCeEEEEE
Q 040702          515 SENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSN----DDFKALVL  583 (797)
Q Consensus       515 ~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~----~~~~~lv~  583 (797)
                      +..++||+|+||+||++     +..||||.+.....  ...+.+.+|++++++++|||||++++++.+    +...|+||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            56678999999999985     57899999986532  234678999999999999999999999865    34689999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCC--eEEcCCCCCceEEc-CCCcEEEEeecCCccCCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVP--IIHCDLKPSNVLLD-DNMVAHLSDFGMAKPLLE  660 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~--ivHrDlkp~NIll~-~~~~~kl~DFGla~~~~~  660 (797)
                      ||+++|+|.+++.... .+++..++.++.||++||+|||   +++  |+||||||+|||++ +++.+||+|||+|+....
T Consensus        92 E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            9999999999997654 4899999999999999999999   777  99999999999996 578999999999985422


Q ss_pred             cCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh-------------------hhhhhccc
Q 040702          661 EDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE-------------------EKHLMTKE  721 (797)
Q Consensus       661 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~  721 (797)
                      .    .....+||+.|||||.+. +.++.++||||+|+..++++.+..++...                   +....+.+
T Consensus       168 ~----~~~~~~GT~~Y~aPE~~~-~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  242 (270)
T d1t4ha_         168 S----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEV  242 (270)
T ss_dssp             T----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHH
T ss_pred             C----ccCCcccCccccCHHHhC-CCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHH
Confidence            1    234568999999999775 56999999999999986666554443221                   11123356


Q ss_pred             ccchhccccCCCCCCCChHHHHH
Q 040702          722 QPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       722 ~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                      +++++.|++.||++|||+.|+++
T Consensus       243 ~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         243 KEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHccCCHhHCcCHHHHhC
Confidence            78999999999999999988853

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.6e-42  Score=368.76  Aligned_cols=217  Identities=21%  Similarity=0.240  Sum_probs=186.9

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVL  583 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~  583 (797)
                      ++|+..+.||+|+||.||++     |+.||||++.+..   ....+.+.+|+++++.++|||||++++++.+.+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            58999999999999999974     6899999997542   334567899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCc
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~  663 (797)
                      ||+.+|+|.+++...+ .+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+.....  
T Consensus       121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred             ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence            9999999999987655 4899999999999999999999   999999999999999999999999999999876322  


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh----------------hhhcccccchhc
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK----------------HLMTKEQPMVRM  727 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~l~~~  727 (797)
                         .....||+.|||||++.+..|+.++|+||+|+..+.++.+..++.....                .....+.++++.
T Consensus       195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  271 (350)
T d1rdqe_         195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRN  271 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHH
T ss_pred             ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHH
Confidence               2346799999999999999999999999999998776666554433211                233467788888


Q ss_pred             cccCCCCCCC
Q 040702          728 GTDLSLGQFP  737 (797)
Q Consensus       728 cl~~dp~~RP  737 (797)
                      |+..||.+|+
T Consensus       272 ~L~~dP~kR~  281 (350)
T d1rdqe_         272 LLQVDLTKRF  281 (350)
T ss_dssp             HSCSCTTTCT
T ss_pred             HhhhCHHhcc
Confidence            9999999885

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-42  Score=364.93  Aligned_cols=225  Identities=19%  Similarity=0.253  Sum_probs=189.3

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEecc---CCcchhHHHHHHHhh-hccCCceeEeeeeeecCCeEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY---GGAFKSFDIECGMMK-RIRHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~---~~~~~~~~~E~~~l~-~l~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      ++|...+.||+|+||+||++     ++.||||++++..   ....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57999999999999999974     6999999998652   334556777877765 68999999999999999999999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccC
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~  662 (797)
                      |||+++|+|.+++.... .+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+......
T Consensus        82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~  157 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  157 (320)
T ss_dssp             EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhccccc
Confidence            99999999999997755 4899999999999999999999   9999999999999999999999999999998654322


Q ss_pred             ccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh----------------hhhhcccccchh
Q 040702          663 QSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE----------------KHLMTKEQPMVR  726 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~l~~  726 (797)
                        .......||+.|||||++.++.|+.++|+||+|+..++++.+..++....                ........++++
T Consensus       158 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~  235 (320)
T d1xjda_         158 --AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLV  235 (320)
T ss_dssp             --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred             --ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence              23345689999999999999999999999999999877666655443211                112346677888


Q ss_pred             ccccCCCCCCCChH-HH
Q 040702          727 MGTDLSLGQFPASY-SI  742 (797)
Q Consensus       727 ~cl~~dp~~RPs~~-~i  742 (797)
                      +|+..||.+||++. ++
T Consensus       236 ~~L~~dP~~R~s~~~~l  252 (320)
T d1xjda_         236 KLFVREPEKRLGVRGDI  252 (320)
T ss_dssp             HHSCSSGGGSBTTBSCG
T ss_pred             HhcccCCCCCcCHHHHH
Confidence            99999999999874 44

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-42  Score=364.22  Aligned_cols=238  Identities=19%  Similarity=0.216  Sum_probs=194.1

Q ss_pred             cCCCccccccccCCcceeecc---------eEEEEEEEEec-cCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKDG---------MEVAIKVFNLQ-YGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~~---------~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l  581 (797)
                      .+|+..+.||+|+||+||+|.         ..||||.++.. .....++|.+|++++++++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            469999999999999999862         36899988654 234457899999999999999999999999875 4678


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCcc
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  661 (797)
                      +|||+.+|+|.+++......+++..+++++.|||+||+|||   +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus        88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~  164 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  164 (317)
T ss_dssp             EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred             EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceecccc
Confidence            89999999999998887777999999999999999999999   899999999999999999999999999999876554


Q ss_pred             CccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchhh-----------------hhhhccccc
Q 040702          662 DQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIREE-----------------KHLMTKEQP  723 (797)
Q Consensus       662 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~~-----------------~~~~~~~~~  723 (797)
                      ..........||+.|||||.+.++.++.++||||+|+..++.+. +..++....                 ......+.+
T Consensus       165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~  244 (317)
T d1xkka_         165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM  244 (317)
T ss_dssp             CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHH
T ss_pred             cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence            44444455679999999999999999999999999999866553 333332211                 122345678


Q ss_pred             chhccccCCCCCCCChHHHHHhHHHHHHHh
Q 040702          724 MVRMGTDLSLGQFPASYSISKYLVYIRELE  753 (797)
Q Consensus       724 l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~  753 (797)
                      +++.||+.||.+|||+.|+++.++.+.+.+
T Consensus       245 li~~cl~~dP~~RPs~~eil~~l~~~~~~~  274 (317)
T d1xkka_         245 IMVKCWMIDADSRPKFRELIIEFSKMARDP  274 (317)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHSH
T ss_pred             HHHHhCCCChhhCcCHHHHHHHHHHHHhCh
Confidence            899999999999999999999988876544

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-42  Score=365.43  Aligned_cols=241  Identities=23%  Similarity=0.313  Sum_probs=199.1

Q ss_pred             HHHHhcCCCccccccccCCcceeec----------ceEEEEEEEEeccCC-cchhHHHHHHHhhhccCCceeEeeeeeec
Q 040702          507 LFQATNRFSENNLIGRGGFGPVYKD----------GMEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCSN  575 (797)
Q Consensus       507 l~~~~~~f~~~~~lg~G~~g~Vyk~----------~~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~Hpniv~l~~~~~~  575 (797)
                      ++-..++|+..+.||+|+||.||+|          ++.||||+++..... ..++|.+|++++++++||||++++++|..
T Consensus         8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~   87 (301)
T d1lufa_           8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV   87 (301)
T ss_dssp             TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence            3334678999999999999999986          268999998754332 34679999999999999999999999999


Q ss_pred             CCeEEEEEEccCCCCHHHHHhcCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEc
Q 040702          576 DDFKALVLEYMPLGSLEKCLYSGN-----------------------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHC  632 (797)
Q Consensus       576 ~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHr  632 (797)
                      .+..++||||+++|+|.++++...                       ..+++..+..|+.|++.||+|||   +++|+||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHr  164 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHR  164 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEee
Confidence            999999999999999999986432                       14789999999999999999999   9999999


Q ss_pred             CCCCCceEEcCCCcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccc--ccc
Q 040702          633 DLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDA--NLL  710 (797)
Q Consensus       633 Dlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~--~~~  710 (797)
                      ||||+|||+|.++.+||+|||+|+...+...........||+.|||||.+.+..|+.++||||+|+..++.+...  ++.
T Consensus       165 DlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~  244 (301)
T d1lufa_         165 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY  244 (301)
T ss_dssp             CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             EEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCC
Confidence            999999999999999999999998765444444445677999999999999999999999999999986554432  222


Q ss_pred             chh----------------hhhhhcccccchhccccCCCCCCCChHHHHHhHHHHH
Q 040702          711 IRE----------------EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIR  750 (797)
Q Consensus       711 ~~~----------------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~  750 (797)
                      +..                +......+.++++.||+.||++|||+.||++.|++|.
T Consensus       245 ~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         245 GMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            111                1123346778999999999999999999999988763

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-42  Score=356.60  Aligned_cols=238  Identities=22%  Similarity=0.255  Sum_probs=186.1

Q ss_pred             hcCCCccccccccCCcceeecc--------eEEEEEEEEeccCC-cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKDG--------MEVAIKVFNLQYGG-AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~~--------~~vAvK~~~~~~~~-~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~l  581 (797)
                      .++|+..+.||+|+||.||+|.        ..||||.++..... ..+.+.+|++++++++|||||+++|++. ++..|+
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            3689999999999999999862        46888887644322 3467999999999999999999999986 467899


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCcc
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEE  661 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~  661 (797)
                      ||||+++|++.+++......+++..++.++.||++||+|||   +++|+||||||+||+++.++.+||+|||+|+.....
T Consensus        85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~  161 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS  161 (273)
T ss_dssp             EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred             EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCC
Confidence            99999999999998777667999999999999999999999   999999999999999999999999999999865432


Q ss_pred             CccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-----------------hhhhhccccc
Q 040702          662 DQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-----------------EKHLMTKEQP  723 (797)
Q Consensus       662 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-----------------~~~~~~~~~~  723 (797)
                      . ........||+.|||||.+.++.++.++||||+|+..++.+. +..++...                 +......+.+
T Consensus       162 ~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  240 (273)
T d1mp8a_         162 T-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS  240 (273)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             c-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            2 223345678999999999999999999999999999865543 22222211                 1123346778


Q ss_pred             chhccccCCCCCCCChHHHHHhHHHHHHHh
Q 040702          724 MVRMGTDLSLGQFPASYSISKYLVYIRELE  753 (797)
Q Consensus       724 l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~  753 (797)
                      +++.||+.||++|||+.|+++.|+.+.+.+
T Consensus       241 li~~cl~~dp~~Rps~~ei~~~L~~i~~~~  270 (273)
T d1mp8a_         241 LMTKCWAYDPSRRPRFTELKAQLSTILEEE  270 (273)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            999999999999999999999998876553

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-42  Score=359.98  Aligned_cols=245  Identities=20%  Similarity=0.267  Sum_probs=190.9

Q ss_pred             HHHHHHHhcCCCccccccccCCcceeec----------ceEEEEEEEEeccC-CcchhHHHHHHHhhhc-cCCceeEeee
Q 040702          504 YLELFQATNRFSENNLIGRGGFGPVYKD----------GMEVAIKVFNLQYG-GAFKSFDIECGMMKRI-RHRNLIKIIS  571 (797)
Q Consensus       504 ~~~l~~~~~~f~~~~~lg~G~~g~Vyk~----------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~Hpniv~l~~  571 (797)
                      ..++....++|+..+.||+|+||.||+|          ++.||||+++.... ...+.+.+|...+.++ +|||||.+++
T Consensus         5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~   84 (299)
T d1ywna1           5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG   84 (299)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence            3333334578999999999999999985          36899999875432 2346788888888887 6899999999


Q ss_pred             eeecC-CeEEEEEEccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCC
Q 040702          572 SCSND-DFKALVLEYMPLGSLEKCLYSGN---------------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLK  635 (797)
Q Consensus       572 ~~~~~-~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlk  635 (797)
                      ++..+ +..++|||||++|+|.++++...               ..+++.++..++.||++||+|||   +++|+|||||
T Consensus        85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlK  161 (299)
T d1ywna1          85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLA  161 (299)
T ss_dssp             EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCC
T ss_pred             eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCC
Confidence            98765 46899999999999999997542               24889999999999999999999   9999999999


Q ss_pred             CCceEEcCCCcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhcc-ccccchh-
Q 040702          636 PSNVLLDDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVD-ANLLIRE-  713 (797)
Q Consensus       636 p~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~-~~~~~~~-  713 (797)
                      |+|||+++++.+||+|||+|+...............||+.|||||.+.++.++.++||||+|+..++.+.. ..++... 
T Consensus       162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~  241 (299)
T d1ywna1         162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  241 (299)
T ss_dssp             GGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999999876554444445567899999999999999999999999999998665432 2222211 


Q ss_pred             -----------------hhhhhcccccchhccccCCCCCCCChHHHHHhHHHHHH
Q 040702          714 -----------------EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRE  751 (797)
Q Consensus       714 -----------------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~  751 (797)
                                       +....+.+.++++.||+.||++|||+.|+++.|+.+.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         242 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             CSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence                             11223457789999999999999999999999988754

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-42  Score=356.30  Aligned_cols=233  Identities=21%  Similarity=0.309  Sum_probs=186.8

Q ss_pred             hcCCCccccccccCCcceeec----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEcc
Q 040702          511 TNRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEYM  586 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~~  586 (797)
                      .++|+..+.||+|+||+||+|    +..||||+++... ...+.|.+|+.++++++|||||+++|+|.+ +..|+||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            368999999999999999986    4689999986443 345789999999999999999999999855 5678999999


Q ss_pred             CCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          587 PLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       587 ~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      ++|++..++.... ..+++.+++.++.||+.||+|||   +.+|+||||||+|||+|.++.+||+|||+|+...+.. ..
T Consensus        94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~~  169 (285)
T d1fmka3          94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YT  169 (285)
T ss_dssp             TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred             CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCC-ce
Confidence            9999998886532 35899999999999999999999   8999999999999999999999999999998664332 22


Q ss_pred             cccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccc-cch-----------------hhhhhhcccccchhc
Q 040702          666 TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANL-LIR-----------------EEKHLMTKEQPMVRM  727 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~-~~~-----------------~~~~~~~~~~~l~~~  727 (797)
                      ......||+.|||||.+..+.++.++||||+|+..++.+....+ ...                 .+......+.+++..
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~  249 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ  249 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHH
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHHH
Confidence            33446799999999999999999999999999988655542211 111                 112233467789999


Q ss_pred             cccCCCCCCCChHHHHHhHHHH
Q 040702          728 GTDLSLGQFPASYSISKYLVYI  749 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~~l~~i  749 (797)
                      ||+.||++||++.+|.+.|+.+
T Consensus       250 cl~~dP~~Rps~~~i~~~L~~~  271 (285)
T d1fmka3         250 CWRKEPEERPTFEYLQAFLEDY  271 (285)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHTT
T ss_pred             HcccCHhHCcCHHHHHHHHhhh
Confidence            9999999999999998877653

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-42  Score=351.47  Aligned_cols=232  Identities=25%  Similarity=0.305  Sum_probs=187.6

Q ss_pred             hcCCCccccccccCCcceeec---ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeec-CCeEEEEEEcc
Q 040702          511 TNRFSENNLIGRGGFGPVYKD---GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSN-DDFKALVLEYM  586 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~---~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~-~~~~~lv~e~~  586 (797)
                      .++|+..+.||+|+||.||++   +..||||+++..  ...+++.+|++++++++||||++++|+|.+ .+..|+||||+
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            367888999999999999986   688999999644  345789999999999999999999999865 45689999999


Q ss_pred             CCCCHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          587 PLGSLEKCLYSGNY-ILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       587 ~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      ++|+|.+++..... .+++..+++|+.||+.||.|||   +.+|+||||||+||+++.++.+|++|||+++....     
T Consensus        84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~-----  155 (262)
T d1byga_          84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-----  155 (262)
T ss_dssp             TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCC-----
Confidence            99999999976432 5899999999999999999999   89999999999999999999999999999986432     


Q ss_pred             cccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchhh-----------------hhhhcccccchhc
Q 040702          666 TQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIREE-----------------KHLMTKEQPMVRM  727 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~~-----------------~~~~~~~~~l~~~  727 (797)
                      ......+|+.|||||.+.++.++.++||||+|+..++.+. +..++....                 ....+.+.++++.
T Consensus       156 ~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~  235 (262)
T d1byga_         156 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKN  235 (262)
T ss_dssp             ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHH
T ss_pred             CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHH
Confidence            2233568999999999999999999999999998866553 232222111                 1223467889999


Q ss_pred             cccCCCCCCCChHHHHHhHHHHHHH
Q 040702          728 GTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       728 cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                      ||+.||.+|||+.++++.|++++..
T Consensus       236 cl~~dP~~Rps~~~l~~~L~~i~~~  260 (262)
T d1byga_         236 CWHLDAAMRPSFLQLREQLEHIKTH  260 (262)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HcccCHhHCcCHHHHHHHHHHHHhC
Confidence            9999999999999999999988754

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-41  Score=356.26  Aligned_cols=254  Identities=23%  Similarity=0.291  Sum_probs=201.4

Q ss_pred             cCCCccccccccCCcceeecc-------eEEEEEEEEec-cCCcchhHHHHHHHhhhc-cCCceeEeeeeeecCCeEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKDG-------MEVAIKVFNLQ-YGGAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDFKALV  582 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~~-------~~vAvK~~~~~-~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~~~lv  582 (797)
                      ++|+..+.||+|+||+||+|.       ..||||.++.. .....++|.+|+++++++ +|||||+++|+|.+++..|+|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            688899999999999999852       35888888644 334567899999999999 799999999999999999999


Q ss_pred             EEccCCCCHHHHHhcC---------------CCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcE
Q 040702          583 LEYMPLGSLEKCLYSG---------------NYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVA  647 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~  647 (797)
                      |||+++|+|.++++..               ...+++..+.+++.|||.|+.|+|   +++|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCce
Confidence            9999999999999754               236899999999999999999999   9999999999999999999999


Q ss_pred             EEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccc-cccchh-------------
Q 040702          648 HLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDA-NLLIRE-------------  713 (797)
Q Consensus       648 kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~-~~~~~~-------------  713 (797)
                      ||+|||+|+......   ......||..|+|||.+.++.++.++||||+|+..++.+... .++...             
T Consensus       167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~  243 (309)
T d1fvra_         167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  243 (309)
T ss_dssp             EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred             EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Confidence            999999998653322   223456999999999999999999999999999986655432 222211             


Q ss_pred             ----hhhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHHhccccccccccCCcccccceeeeee
Q 040702          714 ----EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPIVHHYLYRTVD  777 (797)
Q Consensus       714 ----~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~f~~~~  777 (797)
                          +......+.+++++||+.||++||++.|+++.|+.+.+.....+      .....+.+.|.++|
T Consensus       244 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~~~------~~~~~e~~~~~~~~  305 (309)
T d1fvra_         244 RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYV------NTTLYEKFTYAGID  305 (309)
T ss_dssp             CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSB------CCBCTTCCCCCCCC
T ss_pred             CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcCCC------CCchhhcccccCCC
Confidence                11233467889999999999999999999999988865432222      22344566666655

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-41  Score=351.76  Aligned_cols=234  Identities=21%  Similarity=0.239  Sum_probs=184.9

Q ss_pred             cCCCccccccccCCcceeecc--------eEEEEEEEEecc---CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEE
Q 040702          512 NRFSENNLIGRGGFGPVYKDG--------MEVAIKVFNLQY---GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKA  580 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~~--------~~vAvK~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~  580 (797)
                      ++|+..+.||+|+||.||+|.        ..||||++++..   ....++|.+|++++++++|||||+++|+|.++ ..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence            679999999999999999862        479999987653   22346899999999999999999999999764 578


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCc
Q 040702          581 LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  660 (797)
Q Consensus       581 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  660 (797)
                      +||||+++|++.+.+......+++..+..++.|||+||+|||   +++|+||||||+||+++.++.+||+|||+++....
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            999999999999988776667999999999999999999999   89999999999999999999999999999997644


Q ss_pred             cCcc-ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh------------------hhhhhcc
Q 040702          661 EDQS-LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE------------------EKHLMTK  720 (797)
Q Consensus       661 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~------------------~~~~~~~  720 (797)
                      .... .......||..|||||.+.++.++.++||||+|+..++.+. +..++...                  +......
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  243 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD  243 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHH
T ss_pred             CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHH
Confidence            3322 22344568889999999999999999999999998866553 33332211                  1123346


Q ss_pred             cccchhccccCCCCCCCChHHHHHhHHHH
Q 040702          721 EQPMVRMGTDLSLGQFPASYSISKYLVYI  749 (797)
Q Consensus       721 ~~~l~~~cl~~dp~~RPs~~~i~~~l~~i  749 (797)
                      +.++++.||+.||++|||+.|+.+.|++.
T Consensus       244 l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         244 IYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            77889999999999999999999888764

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=9.5e-41  Score=344.78  Aligned_cols=224  Identities=22%  Similarity=0.296  Sum_probs=188.2

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCCc---------chhHHHHHHHhhhcc-CCceeEeeeeeecC
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGA---------FKSFDIECGMMKRIR-HRNLIKIISSCSND  576 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~---------~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~  576 (797)
                      ++|+..+.||+|+||+||++     ++.||||++++.....         .+.+.+|+.++++++ |||||++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            68999999999999999984     6899999998664321         235889999999997 99999999999999


Q ss_pred             CeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCc
Q 040702          577 DFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  656 (797)
Q Consensus       577 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  656 (797)
                      +..|+|||||++|+|.+++.... .+++.+++.++.||++||+|||   +++|+||||||+||+++.++.+||+|||+|+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~  158 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSC  158 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             cceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchhee
Confidence            99999999999999999997655 4899999999999999999999   9999999999999999999999999999998


Q ss_pred             cCCccCccccccccccCccccccccccc------CccchHHHHHHHhhhhhhhhccccccchhh----------------
Q 040702          657 PLLEEDQSLTQTQTLATIGYMAPDEIFS------GEMRLKCWVNDSLLISVMIVVDANLLIREE----------------  714 (797)
Q Consensus       657 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~----------------  714 (797)
                      ......   ......||+.|+|||.+..      ..++.++|+||+|+..+.++.+..++....                
T Consensus       159 ~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~  235 (277)
T d1phka_         159 QLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG  235 (277)
T ss_dssp             ECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             EccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence            764322   3345789999999998753      346889999999999866555443332211                


Q ss_pred             ----hhhhcccccchhccccCCCCCCCChHHH
Q 040702          715 ----KHLMTKEQPMVRMGTDLSLGQFPASYSI  742 (797)
Q Consensus       715 ----~~~~~~~~~l~~~cl~~dp~~RPs~~~i  742 (797)
                          ....+.+.++++.|++.||.+||++.|+
T Consensus       236 ~~~~~~~s~~~~~li~~~L~~~p~~R~s~~ei  267 (277)
T d1phka_         236 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA  267 (277)
T ss_dssp             TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             CcccccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence                1233456788999999999999998876

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-40  Score=352.07  Aligned_cols=228  Identities=16%  Similarity=0.200  Sum_probs=193.7

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      .++|.+.+.||+|+||+||++     ++.||||+++.... ....+.+|+++|++++|||||++++++.+++..|+||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            367999999999999999974     68999999976532 235688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcC--CCcEEEEeecCCccCCccCc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD--NMVAHLSDFGMAKPLLEEDQ  663 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~--~~~~kl~DFGla~~~~~~~~  663 (797)
                      |+||+|.+++...+..+++.+++.|+.||++||+|||   +++|+||||||+|||++.  ...+||+|||+++...... 
T Consensus        83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~-  158 (321)
T d1tkia_          83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-  158 (321)
T ss_dssp             CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccCC-
Confidence            9999999999877656999999999999999999999   999999999999999985  4589999999998653322 


Q ss_pred             cccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh--------------------hhhccccc
Q 040702          664 SLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK--------------------HLMTKEQP  723 (797)
Q Consensus       664 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~  723 (797)
                        ......||+.|||||.+.+..|+.++|+||+|+..+.++.+..++.....                    ......++
T Consensus       159 --~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  236 (321)
T d1tkia_         159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD  236 (321)
T ss_dssp             --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred             --cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHH
Confidence              23446799999999999999999999999999998766665554332111                    12334678


Q ss_pred             chhccccCCCCCCCChHHHHHh
Q 040702          724 MVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       724 l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                      +++.|+..||.+|||+.|+++.
T Consensus       237 li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         237 FVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHccCChhHCcCHHHHhcC
Confidence            9999999999999999999874

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-41  Score=350.95  Aligned_cols=238  Identities=24%  Similarity=0.303  Sum_probs=195.4

Q ss_pred             hcCCCccccccccCCcceeecc------------eEEEEEEEEeccC-CcchhHHHHHHHhhhc-cCCceeEeeeeeecC
Q 040702          511 TNRFSENNLIGRGGFGPVYKDG------------MEVAIKVFNLQYG-GAFKSFDIECGMMKRI-RHRNLIKIISSCSND  576 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~~------------~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~  576 (797)
                      .++|...+.||+|+||.||++.            ..||||+++.... ....++.+|+..+.++ +|||||+++++|.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            4689999999999999999852            4799999976543 2346788999999998 799999999999999


Q ss_pred             CeEEEEEEccCCCCHHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEE
Q 040702          577 DFKALVLEYMPLGSLEKCLYSGN---------------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL  641 (797)
Q Consensus       577 ~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll  641 (797)
                      +..++||||+++|+|.+++....               ..+++.+++.++.||+.||+|||   +++|+||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceee
Confidence            99999999999999999997553               24899999999999999999999   9999999999999999


Q ss_pred             cCCCcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchhh------
Q 040702          642 DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIREE------  714 (797)
Q Consensus       642 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~~------  714 (797)
                      +.++.+||+|||+++...............||+.|||||.+.++.|+.++|+||+|+..++.+. +..++....      
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~  248 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK  248 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH
Confidence            9999999999999997655444444455679999999999999999999999999998865543 233222211      


Q ss_pred             -----------hhhhcccccchhccccCCCCCCCChHHHHHhHHHHHH
Q 040702          715 -----------KHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRE  751 (797)
Q Consensus       715 -----------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~  751 (797)
                                 ......+.+++++||+.||++|||+.|+++.|+++..
T Consensus       249 ~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         249 LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             HHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence                       1223467889999999999999999999999988754

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-40  Score=350.01  Aligned_cols=232  Identities=20%  Similarity=0.280  Sum_probs=192.2

Q ss_pred             cccccccCCcceeecc--------eEEEEEEEEecc-CCcchhHHHHHHHhhhccCCceeEeeeeeec-CCeEEEEEEcc
Q 040702          517 NNLIGRGGFGPVYKDG--------MEVAIKVFNLQY-GGAFKSFDIECGMMKRIRHRNLIKIISSCSN-DDFKALVLEYM  586 (797)
Q Consensus       517 ~~~lg~G~~g~Vyk~~--------~~vAvK~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~-~~~~~lv~e~~  586 (797)
                      .++||+|+||+||+|.        ..||||+++... ....++|.+|++++++++|||||+++|++.+ ++..++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            4689999999999862        368999997532 2335789999999999999999999999875 46899999999


Q ss_pred             CCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc--
Q 040702          587 PLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS--  664 (797)
Q Consensus       587 ~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~--  664 (797)
                      ++|+|.+++.......++..+.+++.|++.||.|+|   +++|+||||||+|||+++++.+||+|||+++........  
T Consensus       112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            999999999887777889999999999999999999   999999999999999999999999999999876433221  


Q ss_pred             ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccc-hh-----------------hhhhhcccccchh
Q 040702          665 LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLI-RE-----------------EKHLMTKEQPMVR  726 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~-~~-----------------~~~~~~~~~~l~~  726 (797)
                      .......||+.|+|||.+..+.++.++||||+|+..++.+....++. ..                 +......+.+++.
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~  268 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML  268 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHH
Confidence            12334578999999999999999999999999999866654332221 11                 1122346788999


Q ss_pred             ccccCCCCCCCChHHHHHhHHHHHH
Q 040702          727 MGTDLSLGQFPASYSISKYLVYIRE  751 (797)
Q Consensus       727 ~cl~~dp~~RPs~~~i~~~l~~i~~  751 (797)
                      .||+.||++||++.||++.|+.+..
T Consensus       269 ~cl~~dP~~RPs~~ei~~~L~~i~~  293 (311)
T d1r0pa_         269 KCWHPKAEMRPSFSELVSRISAIFS  293 (311)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            9999999999999999999888754

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=8.9e-41  Score=346.74  Aligned_cols=235  Identities=17%  Similarity=0.294  Sum_probs=187.8

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCC---cchhHHHHHHHhhhccCCceeEeeeeeecCC----e
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG---AFKSFDIECGMMKRIRHRNLIKIISSCSNDD----F  578 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~---~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~----~  578 (797)
                      .++|++.+.||+|+||.||++     ++.||||+++.....   ..+.+.+|++++++++|||||++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            367999999999999999985     689999999865432   2357899999999999999999999987654    4


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccC
Q 040702          579 KALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  658 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  658 (797)
                      .|+||||++||+|.+++...+ .+++.++..++.||++||+|||   +++|+||||||+|||++.++..+++|||.++..
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             EEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhh
Confidence            899999999999999887655 4899999999999999999999   999999999999999999999999999998765


Q ss_pred             CccC-ccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh--------------------hhh
Q 040702          659 LEED-QSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE--------------------KHL  717 (797)
Q Consensus       659 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------------~~~  717 (797)
                      .... ........+||+.|||||++.+..++.++|+||+|++.++++.+..++....                    ...
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL  241 (277)
T ss_dssp             C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSC
T ss_pred             ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCC
Confidence            3322 2223455689999999999999999999999999999877666555433211                    122


Q ss_pred             hcccccchhccccCCCCCCC-ChHHHHHhHHHH
Q 040702          718 MTKEQPMVRMGTDLSLGQFP-ASYSISKYLVYI  749 (797)
Q Consensus       718 ~~~~~~l~~~cl~~dp~~RP-s~~~i~~~l~~i  749 (797)
                      ...+.+++++|++.||++|| +++++.+.+.++
T Consensus       242 s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         242 SADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence            34577899999999999999 788888776655

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-40  Score=351.18  Aligned_cols=236  Identities=21%  Similarity=0.305  Sum_probs=199.3

Q ss_pred             hcCCCccccccccCCcceeec----------ceEEEEEEEEeccC-CcchhHHHHHHHhhhc-cCCceeEeeeeeecCCe
Q 040702          511 TNRFSENNLIGRGGFGPVYKD----------GMEVAIKVFNLQYG-GAFKSFDIECGMMKRI-RHRNLIKIISSCSNDDF  578 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~----------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~~~~  578 (797)
                      .++|+..+.||+|+||.||+|          ++.||||+++.... ....++.+|+.+++++ +|||||+++|+|.+++.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            468999999999999999985          26899999976533 2345789999999999 69999999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCC-----------------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEE
Q 040702          579 KALVLEYMPLGSLEKCLYSGN-----------------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLL  641 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~~~-----------------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll  641 (797)
                      .|+|||||++|+|.+++....                 ..+++..+..++.||++|++|||   +++|+||||||+||++
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccccc
Confidence            999999999999999987543                 15889999999999999999999   9999999999999999


Q ss_pred             cCCCcEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc-cccccchh-------
Q 040702          642 DDNMVAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV-DANLLIRE-------  713 (797)
Q Consensus       642 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~-~~~~~~~~-------  713 (797)
                      +.++.+|++|||+++...............||+.|||||.+.++.++.++||||+|+..++.+. +.++....       
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~  258 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY  258 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            9999999999999997765544445566789999999999999999999999999999865553 22222111       


Q ss_pred             -----------hhhhhcccccchhccccCCCCCCCChHHHHHhHHHH
Q 040702          714 -----------EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYI  749 (797)
Q Consensus       714 -----------~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i  749 (797)
                                 +......+.+++..||+.||++|||+.|+++.|+++
T Consensus       259 ~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence                       112334677899999999999999999999999875

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-40  Score=346.42  Aligned_cols=236  Identities=23%  Similarity=0.257  Sum_probs=184.5

Q ss_pred             cCCCccccccccCCcceeec---ceEEEEEEEEeccCCcchhHHH--HHHHhhhccCCceeEeeeeeecCC----eEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD---GMEVAIKVFNLQYGGAFKSFDI--ECGMMKRIRHRNLIKIISSCSNDD----FKALV  582 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~---~~~vAvK~~~~~~~~~~~~~~~--E~~~l~~l~Hpniv~l~~~~~~~~----~~~lv  582 (797)
                      ++|...+.||+|+||.||+|   |+.||||+++...   .+.+.+  |+..+.+++|||||+++++|.+++    ..|+|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence            46777899999999999986   6899999986442   233444  555566789999999999998654    68999


Q ss_pred             EEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcc-----CCCCeEEcCCCCCceEEcCCCcEEEEeecCCcc
Q 040702          583 LEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFG-----YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  657 (797)
Q Consensus       583 ~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~-----~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  657 (797)
                      ||||++|+|.++++...  ++|..+.+++.|+|.|+.|+|+.     ++++|+||||||+|||++.++.+||+|||+++.
T Consensus        80 ~Ey~~~g~L~~~l~~~~--l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~  157 (303)
T d1vjya_          80 SDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             EECCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EecccCCCHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence            99999999999998764  89999999999999999999932     246999999999999999999999999999987


Q ss_pred             CCccCcc--ccccccccCcccccccccccC------ccchHHHHHHHhhhhhhhhccccccch-----------------
Q 040702          658 LLEEDQS--LTQTQTLATIGYMAPDEIFSG------EMRLKCWVNDSLLISVMIVVDANLLIR-----------------  712 (797)
Q Consensus       658 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~dv~s~~~~~~~~~~~~~~~~~-----------------  712 (797)
                      .......  .......||+.|||||.+...      .++.++||||+|+..++.+....++..                 
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence            6433221  123456899999999987643      378899999999987555443322110                 


Q ss_pred             ---------------------hhhhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHH
Q 040702          713 ---------------------EEKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIREL  752 (797)
Q Consensus       713 ---------------------~~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~  752 (797)
                                           ........+.++++.||+.||++|||+.|+++.|+++.+.
T Consensus       238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence                                 0001122366889999999999999999999999988755

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-40  Score=349.25  Aligned_cols=224  Identities=20%  Similarity=0.254  Sum_probs=186.2

Q ss_pred             hcCCCccc-cccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhc-cCCceeEeeeeeec----CCeE
Q 040702          511 TNRFSENN-LIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRI-RHRNLIKIISSCSN----DDFK  579 (797)
Q Consensus       511 ~~~f~~~~-~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~l~~~~~~----~~~~  579 (797)
                      .++|.+.. .||+|+||.||++     ++.||||+++.     .+.+.+|++++.++ +|||||+++++|.+    ....
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            36788764 6999999999985     58999999863     36688899987665 89999999999875    3568


Q ss_pred             EEEEEccCCCCHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcC---CCcEEEEeecCC
Q 040702          580 ALVLEYMPLGSLEKCLYSGN-YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD---NMVAHLSDFGMA  655 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~---~~~~kl~DFGla  655 (797)
                      |+|||||+||+|.+++.... ..+++.+++.|+.||+.||+|||   +.+|+||||||+|||++.   .+.+||+|||+|
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccccccccee
Confidence            99999999999999998653 36999999999999999999999   999999999999999985   467999999999


Q ss_pred             ccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh---------------------
Q 040702          656 KPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE---------------------  714 (797)
Q Consensus       656 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~---------------------  714 (797)
                      +......   .....+||+.|||||.+.+..|+.++|+||+|+..+..+.+..++....                     
T Consensus       162 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~  238 (335)
T d2ozaa1         162 KETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  238 (335)
T ss_dssp             EECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCT
T ss_pred             eeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence            8764332   2345689999999999999999999999999999876665544432211                     


Q ss_pred             ---hhhhcccccchhccccCCCCCCCChHHHHHh
Q 040702          715 ---KHLMTKEQPMVRMGTDLSLGQFPASYSISKY  745 (797)
Q Consensus       715 ---~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~  745 (797)
                         ....+.+.++++.|+..||++|||+.|+++.
T Consensus       239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             cccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence               1233456789999999999999999998774

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-40  Score=349.71  Aligned_cols=235  Identities=20%  Similarity=0.267  Sum_probs=195.3

Q ss_pred             hcCCCccccccccCCcceeec----------ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCCeE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD----------GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFK  579 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~----------~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~  579 (797)
                      .++|...+.||+|+||.||+|          ++.||||+++.... .....|.+|+.++++++|||||+++|+|..++..
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            478899999999999999975          36899999875432 2335689999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEE
Q 040702          580 ALVLEYMPLGSLEKCLYSGN---------YILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLS  650 (797)
Q Consensus       580 ~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~  650 (797)
                      ++||||+++|+|.+++....         ..+++..+.+++.|+|+||.|||   +++|+||||||+|||+++++++||+
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~  175 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIG  175 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEe
Confidence            99999999999999886421         24688999999999999999999   8999999999999999999999999


Q ss_pred             eecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccc-cccchh----------------
Q 040702          651 DFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDA-NLLIRE----------------  713 (797)
Q Consensus       651 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~-~~~~~~----------------  713 (797)
                      |||+|+...............||+.|||||.+.++.++.++|+||+|+..++.+... .++...                
T Consensus       176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~  255 (308)
T d1p4oa_         176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD  255 (308)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred             ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCC
Confidence            999998765554444455567999999999999999999999999999875554332 222111                


Q ss_pred             -hhhhhcccccchhccccCCCCCCCChHHHHHhHHH
Q 040702          714 -EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVY  748 (797)
Q Consensus       714 -~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~  748 (797)
                       +......+.+++..||+.||++|||+.++++.|+.
T Consensus       256 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~  291 (308)
T d1p4oa_         256 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  291 (308)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGG
T ss_pred             CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence             11223467888999999999999999999987754

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-40  Score=347.82  Aligned_cols=223  Identities=23%  Similarity=0.274  Sum_probs=179.0

Q ss_pred             ccccccccCCcceeec-----ceEEEEEEEEeccCC-----cchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          516 ENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG-----AFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       516 ~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~-----~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      ..++||+|+||+||++     ++.||||+++.....     ..+.+.+|+.++++++|||||++++++.+++..|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            4578999999999974     689999998755321     235789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      +.++++..+... ...+++..+..++.||++||+|||   +++|+||||||+|||++.++.+||+|||+|+.......  
T Consensus        82 ~~~~~~~~~~~~-~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~--  155 (299)
T d1ua2a_          82 METDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--  155 (299)
T ss_dssp             CSEEHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--
T ss_pred             hcchHHhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCcc--
Confidence            998776665543 345888899999999999999999   99999999999999999999999999999986643322  


Q ss_pred             cccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccccccchh-hh----------------------------
Q 040702          666 TQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANLLIRE-EK----------------------------  715 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~~~~~-~~----------------------------  715 (797)
                      .....+||+.|||||.+..+ .|+.++|+||+|+..++++.+..++... ..                            
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV  235 (299)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred             cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh
Confidence            33456899999999998755 5799999999999986666554443211 10                            


Q ss_pred             ---------------hhhcccccchhccccCCCCCCCChHHHHH
Q 040702          716 ---------------HLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       716 ---------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                     .......++++.|+..||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence                           11224556899999999999999988764

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-40  Score=345.59  Aligned_cols=227  Identities=21%  Similarity=0.279  Sum_probs=185.0

Q ss_pred             hcCCCccccccccCCcceeec------ceEEEEEEEEeccC--CcchhHHHHHHHhhhc---cCCceeEeeeeeec----
Q 040702          511 TNRFSENNLIGRGGFGPVYKD------GMEVAIKVFNLQYG--GAFKSFDIECGMMKRI---RHRNLIKIISSCSN----  575 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~------~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l---~Hpniv~l~~~~~~----  575 (797)
                      .++|++.+.||+|+||+||++      ++.||||+++....  .....+.+|+.+++.+   +||||++++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            478999999999999999974      46799999976532  3345788898888776   79999999999853    


Q ss_pred             -CCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecC
Q 040702          576 -DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGM  654 (797)
Q Consensus       576 -~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGl  654 (797)
                       ....+++|||+++|.+..........+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg~  162 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGL  162 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchhh
Confidence             34689999999988776666555557899999999999999999999   99999999999999999999999999999


Q ss_pred             CccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhhh-------------------
Q 040702          655 AKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREEK-------------------  715 (797)
Q Consensus       655 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~-------------------  715 (797)
                      ++.....   .......||+.|||||.+.+..|+.++|+||+|+..++.+.+..++.....                   
T Consensus       163 ~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  239 (305)
T d1blxa_         163 ARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  239 (305)
T ss_dssp             CCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             hhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence            9865332   234567899999999999999999999999999998666655544322110                   


Q ss_pred             ------------------------hhhcccccchhccccCCCCCCCChHHHH
Q 040702          716 ------------------------HLMTKEQPMVRMGTDLSLGQFPASYSIS  743 (797)
Q Consensus       716 ------------------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~  743 (797)
                                              ...+...++++.|++.||++|||+.|++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L  291 (305)
T d1blxa_         240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL  291 (305)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence                                    1112345689999999999999988764

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-40  Score=339.96  Aligned_cols=224  Identities=21%  Similarity=0.241  Sum_probs=187.2

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCC------cchhHHHHHHHhhhcc--CCceeEeeeeeecCCe
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG------AFKSFDIECGMMKRIR--HRNLIKIISSCSNDDF  578 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~------~~~~~~~E~~~l~~l~--Hpniv~l~~~~~~~~~  578 (797)
                      ++|++.+.||+|+||.||++     ++.||||++++....      ...++.+|+.++++++  |||||++++++.+++.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            57999999999999999974     689999999865321      2345778999999996  8999999999999999


Q ss_pred             EEEEEEccCC-CCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcC-CCcEEEEeecCCc
Q 040702          579 KALVLEYMPL-GSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD-NMVAHLSDFGMAK  656 (797)
Q Consensus       579 ~~lv~e~~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~-~~~~kl~DFGla~  656 (797)
                      .|+||||+.+ +++.+++.... .+++.+++.++.||++||+|||   +++|+||||||+|||++. ++.+||+|||+|+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~  159 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGA  159 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEEEeccCcchHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECccccce
Confidence            9999999976 68888876654 4899999999999999999999   999999999999999985 4799999999998


Q ss_pred             cCCccCccccccccccCcccccccccccCcc-chHHHHHHHhhhhhhhhccccccchhhh----------hhhcccccch
Q 040702          657 PLLEEDQSLTQTQTLATIGYMAPDEIFSGEM-RLKCWVNDSLLISVMIVVDANLLIREEK----------HLMTKEQPMV  725 (797)
Q Consensus       657 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~dv~s~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~l~  725 (797)
                      .....    ..+...||+.|||||.+.+..+ +.++|+||+|+..++.+.+..++.....          .....+.+++
T Consensus       160 ~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~~~~~~~~~~~s~~~~~li  235 (273)
T d1xwsa_         160 LLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLI  235 (273)
T ss_dssp             ECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSSCCCHHHHHHH
T ss_pred             ecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHHhhcccCCCCCCCHHHHHHH
Confidence            65322    2345789999999999987765 6779999999998777766655544321          2345677899


Q ss_pred             hccccCCCCCCCChHHHH
Q 040702          726 RMGTDLSLGQFPASYSIS  743 (797)
Q Consensus       726 ~~cl~~dp~~RPs~~~i~  743 (797)
                      +.|+..||++|||+.|++
T Consensus       236 ~~~L~~dp~~R~s~~eil  253 (273)
T d1xwsa_         236 RWCLALRPSDRPTFEEIQ  253 (273)
T ss_dssp             HHHTCSSGGGSCCHHHHH
T ss_pred             HHHccCCHhHCcCHHHHh
Confidence            999999999999988875

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-40  Score=344.02  Aligned_cols=228  Identities=21%  Similarity=0.264  Sum_probs=184.3

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEecc--CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      ++|+..+.||+|+||.||++     ++.||||+++...  ....+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            58999999999999999985     6899999996553  2335789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      |+.++.+..........+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+|+......  
T Consensus        82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~--  156 (298)
T d1gz8a_          82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV--  156 (298)
T ss_dssp             CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS--
T ss_pred             ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCc--
Confidence            99765444443444446999999999999999999999   9999999999999999999999999999998654322  


Q ss_pred             ccccccccCcccccccccccCc-cchHHHHHHHhhhhhhhhccccccchhh-h---------------------------
Q 040702          665 LTQTQTLATIGYMAPDEIFSGE-MRLKCWVNDSLLISVMIVVDANLLIREE-K---------------------------  715 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~dv~s~~~~~~~~~~~~~~~~~~~-~---------------------------  715 (797)
                      .......||+.|+|||.+.... ++.++|+||+|+..++++.+..++.... .                           
T Consensus       157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (298)
T d1gz8a_         157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY  236 (298)
T ss_dssp             BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence            2344568999999999887766 4799999999999876665544432110 0                           


Q ss_pred             -----------------hhhcccccchhccccCCCCCCCChHHHHH
Q 040702          716 -----------------HLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       716 -----------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                       .......++++.|+..||.+|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence                             01123457899999999999999998763

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=7.8e-39  Score=333.94  Aligned_cols=226  Identities=20%  Similarity=0.258  Sum_probs=182.4

Q ss_pred             cCCCccccccccCCcceeec----ceEEEEEEEEecc--CCcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEEc
Q 040702          512 NRFSENNLIGRGGFGPVYKD----GMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e~  585 (797)
                      ++|+..++||+|+||.||++    ++.||||+++...  ....+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            58999999999999999985    5889999997653  23357899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCccc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQSL  665 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~~  665 (797)
                      +.++.+..+.... ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+|++|||.|.......  .
T Consensus        82 ~~~~~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~--~  155 (286)
T d1ob3a_          82 LDQDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--R  155 (286)
T ss_dssp             CSEEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             ehhhhHHHHHhhc-CCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCc--c
Confidence            9887666665544 45999999999999999999999   8999999999999999999999999999998653322  2


Q ss_pred             cccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccccccchhh-h----------------------------
Q 040702          666 TQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANLLIREE-K----------------------------  715 (797)
Q Consensus       666 ~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-~----------------------------  715 (797)
                      ......|++.|+|||.+.+. .++.++|+||+|+..++.+.+..++.... .                            
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T d1ob3a_         156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcc
Confidence            33445799999999998765 46899999999999866665544432110 0                            


Q ss_pred             ----------------hhhcccccchhccccCCCCCCCChHHHH
Q 040702          716 ----------------HLMTKEQPMVRMGTDLSLGQFPASYSIS  743 (797)
Q Consensus       716 ----------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~  743 (797)
                                      .......++++.|+..||++|||+.|++
T Consensus       236 ~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell  279 (286)
T d1ob3a_         236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL  279 (286)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred             cccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence                            0112335789999999999999998876

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.8e-38  Score=338.08  Aligned_cols=230  Identities=17%  Similarity=0.233  Sum_probs=185.9

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhcc-CCceeEeeeeeecC--CeEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIR-HRNLIKIISSCSND--DFKALVL  583 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~--~~~~lv~  583 (797)
                      ++|++.++||+|+||+||++     ++.||||+++..   ..+++.+|+.+|+.++ ||||+++++++...  ...++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            68999999999999999985     689999998643   3467899999999995 99999999998744  4689999


Q ss_pred             EccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCC-cEEEEeecCCccCCccC
Q 040702          584 EYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM-VAHLSDFGMAKPLLEED  662 (797)
Q Consensus       584 e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DFGla~~~~~~~  662 (797)
                      ||+++|+|..+.    ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++ .+||+|||+|+......
T Consensus       112 e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         112 EHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             ECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             eecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            999999987653    24899999999999999999999   99999999999999998655 69999999998654332


Q ss_pred             ccccccccccCcccccccccccCc-cchHHHHHHHhhhhhhhhccccccchhh---------------------------
Q 040702          663 QSLTQTQTLATIGYMAPDEIFSGE-MRLKCWVNDSLLISVMIVVDANLLIREE---------------------------  714 (797)
Q Consensus       663 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~dv~s~~~~~~~~~~~~~~~~~~~---------------------------  714 (797)
                         .....+||+.|+|||.+.+.. ++.++|+|++|+..++.+.+..++....                           
T Consensus       185 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  261 (328)
T d3bqca1         185 ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  261 (328)
T ss_dssp             ---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             ---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence               234567999999999987654 7999999999998755444433221100                           


Q ss_pred             ---------------------------hhhhcccccchhccccCCCCCCCChHHHHHhHHHHHHHhccccccccccCCcc
Q 040702          715 ---------------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIRELERGKVGITSVAAFPI  767 (797)
Q Consensus       715 ---------------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~~~~~~~~~~~~~~~~~~  767 (797)
                                                 ....+...++++.|+..||.+|||++|+                         
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~-------------------------  316 (328)
T d3bqca1         262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA-------------------------  316 (328)
T ss_dssp             CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHH-------------------------
T ss_pred             ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHH-------------------------
Confidence                                       0011234568889999999999997665                         


Q ss_pred             cccceeeeeeee
Q 040702          768 VHHYLYRTVDYT  779 (797)
Q Consensus       768 ~~~~~f~~~~~~  779 (797)
                      ++||||++|.||
T Consensus       317 L~Hp~F~~v~~~  328 (328)
T d3bqca1         317 MEHPYFYTVVKD  328 (328)
T ss_dssp             HTSGGGTTSCCC
T ss_pred             hcCcccCCCCCC
Confidence            459999999997

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-39  Score=337.94  Aligned_cols=222  Identities=21%  Similarity=0.255  Sum_probs=183.1

Q ss_pred             cCCCccccccccCCcceeec--------ceEEEEEEEEecc----CCcchhHHHHHHHhhhccC-CceeEeeeeeecCCe
Q 040702          512 NRFSENNLIGRGGFGPVYKD--------GMEVAIKVFNLQY----GGAFKSFDIECGMMKRIRH-RNLIKIISSCSNDDF  578 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~--------~~~vAvK~~~~~~----~~~~~~~~~E~~~l~~l~H-pniv~l~~~~~~~~~  578 (797)
                      ++|+..+.||+|+||+||++        |+.||||++++..    ....+.+.+|++++++++| |||+++++++.+.+.
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            67999999999999999984        5789999986542    2335678899999999977 899999999999999


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccC
Q 040702          579 KALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  658 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  658 (797)
                      .++||||+.+|+|.+++...+. +++..+..++.|++.|++|+|   +.+|+||||||+||+++.++.+||+|||+|+.+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~-~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~  179 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  179 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSC-CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred             eeeeeecccccHHHHHHHhccc-ccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence            9999999999999999977654 678899999999999999999   999999999999999999999999999999876


Q ss_pred             CccCccccccccccCcccccccccccC--ccchHHHHHHHhhhhhhhhccccccchhh--------------------hh
Q 040702          659 LEEDQSLTQTQTLATIGYMAPDEIFSG--EMRLKCWVNDSLLISVMIVVDANLLIREE--------------------KH  716 (797)
Q Consensus       659 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~dv~s~~~~~~~~~~~~~~~~~~~--------------------~~  716 (797)
                      ..... .......||+.|+|||.+...  .++.++||||+|+..++++.+..++....                    ..
T Consensus       180 ~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~  258 (322)
T d1vzoa_         180 VADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE  258 (322)
T ss_dssp             CGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTT
T ss_pred             ccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCccc
Confidence            43322 233456799999999999765  36789999999999876665554432211                    12


Q ss_pred             hhcccccchhccccCCCCCCCC
Q 040702          717 LMTKEQPMVRMGTDLSLGQFPA  738 (797)
Q Consensus       717 ~~~~~~~l~~~cl~~dp~~RPs  738 (797)
                      ....+.+++++|+++||.+||+
T Consensus       259 ~s~~~~~li~~~l~~dP~~R~s  280 (322)
T d1vzoa_         259 MSALAKDLIQRLLMKDPKKRLG  280 (322)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTT
T ss_pred             CCHHHHHHHHHHcccCHHHcCC
Confidence            3335667888899999999986

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-38  Score=338.09  Aligned_cols=223  Identities=22%  Similarity=0.262  Sum_probs=178.3

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCC--cchhHHHHHHHhhhccCCceeEeeeeeecCC------
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG--AFKSFDIECGMMKRIRHRNLIKIISSCSNDD------  577 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~------  577 (797)
                      .++|+..+.||+|+||.||++     ++.||||+++.....  ..+.+.+|+++|++++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            468999999999999999985     688999999754322  2457889999999999999999999997654      


Q ss_pred             eEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCcc
Q 040702          578 FKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  657 (797)
Q Consensus       578 ~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  657 (797)
                      ..|+||||+ ++++..+.+..  .+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+|++|||+|+.
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecc-cccHHHHHHhc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccccccccceec
Confidence            579999999 56888887655  3899999999999999999999   99999999999999999999999999999986


Q ss_pred             CCccCccccccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccccccchhhh---------------------
Q 040702          658 LLEEDQSLTQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANLLIREEK---------------------  715 (797)
Q Consensus       658 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~---------------------  715 (797)
                      ...     ..+...||+.|||||.+.+. .++.++|+||+|+..+..+.+..++.....                     
T Consensus       171 ~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (346)
T d1cm8a_         171 ADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  245 (346)
T ss_dssp             CCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             cCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence            532     23456799999999998864 468999999999998666655444322100                     


Q ss_pred             --------------------------hhhcccccchhccccCCCCCCCChHHHHH
Q 040702          716 --------------------------HLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       716 --------------------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                                .......++++.|+..||.+|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         246 LQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                                      01123457889999999999999999986

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-37  Score=332.77  Aligned_cols=229  Identities=20%  Similarity=0.206  Sum_probs=181.7

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccC-CcchhHHHHHHHhhhccCCceeEeeeeeecCC----eEE
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG-GAFKSFDIECGMMKRIRHRNLIKIISSCSNDD----FKA  580 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~----~~~  580 (797)
                      +.+|...+.||+|+||.||++     ++.||||++++... ...+.+.+|+++|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            457999999999999999985     68999999975432 23467889999999999999999999987653    234


Q ss_pred             EEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCc
Q 040702          581 LVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLE  660 (797)
Q Consensus       581 lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~  660 (797)
                      ++++|+.+|+|.+++....  +++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+|+....
T Consensus        87 ~l~~~~~~g~L~~~l~~~~--l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             EEEEECCCEEHHHHHHHCC--CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             EEEEeecCCchhhhhhcCC--CCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence            4455667899999997653  899999999999999999999   99999999999999999999999999999986543


Q ss_pred             cCcc-ccccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchhhh-----------------------
Q 040702          661 EDQS-LTQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIREEK-----------------------  715 (797)
Q Consensus       661 ~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~-----------------------  715 (797)
                      .... ......+||+.|+|||.+.. ..++.++|+||+|+..+.++.+..++.....                       
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII  241 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence            3221 22355679999999999855 4578999999999998776665444321100                       


Q ss_pred             ------------------------hhhcccccchhccccCCCCCCCChHHHHH
Q 040702          716 ------------------------HLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       716 ------------------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                              .......++++.|+..||.+|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                                    11123568999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.3e-37  Score=321.04  Aligned_cols=233  Identities=21%  Similarity=0.247  Sum_probs=187.6

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCce-eEeeeeeecCCeEEEEEEc
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNL-IKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpni-v~l~~~~~~~~~~~lv~e~  585 (797)
                      ++|+..+.||+|+||+||++     ++.||||++.....  .+++..|+++++.++|+++ +.+.+++.+.+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            46999999999999999985     68999999876543  3678999999999987664 5555666778899999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEc---CCCcEEEEeecCCccCCccC
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLD---DNMVAHLSDFGMAKPLLEED  662 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~---~~~~~kl~DFGla~~~~~~~  662 (797)
                      + +|++.+.+......+++..+..++.|++.||+|||   +++|+||||||+|||++   .+..+|++|||+|+......
T Consensus        85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~  160 (299)
T d1ckia_          85 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  160 (299)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred             c-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence            9 55777777666667999999999999999999999   99999999999999986   45579999999998764332


Q ss_pred             cc-----ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh-----------------------
Q 040702          663 QS-----LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE-----------------------  714 (797)
Q Consensus       663 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~-----------------------  714 (797)
                      ..     .......||+.|||||.+.+..++.++|+||+|+..++.+.+..++....                       
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (299)
T d1ckia_         161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL  240 (299)
T ss_dssp             TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHH
T ss_pred             cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHh
Confidence            21     12345679999999999999999999999999998866655444332110                       


Q ss_pred             -hhhhcccccchhccccCCCCCCCChHHHHHhHHHHH
Q 040702          715 -KHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIR  750 (797)
Q Consensus       715 -~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~  750 (797)
                       ......+.++++.|++.||++||++.++.+.|+.+.
T Consensus       241 ~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~  277 (299)
T d1ckia_         241 CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  277 (299)
T ss_dssp             TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred             ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence             112234678899999999999999999998888764

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-37  Score=327.98  Aligned_cols=230  Identities=20%  Similarity=0.254  Sum_probs=179.9

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEecc--CCcchhHHHHHHHhhhccCCceeEeeeeeec--------
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQY--GGAFKSFDIECGMMKRIRHRNLIKIISSCSN--------  575 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~--------  575 (797)
                      .++|++.+.||+|+||+||++     ++.||||++....  ....+++.+|++++++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            478999999999999999985     5899999986552  3345778999999999999999999998855        


Q ss_pred             CCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCC
Q 040702          576 DDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMA  655 (797)
Q Consensus       576 ~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla  655 (797)
                      .+..|+||||++++.+.... .....++...++.++.|+++||.|||   +++|+||||||+|||++.++.+||+|||+|
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeeccee
Confidence            34589999999876665443 43445899999999999999999999   999999999999999999999999999999


Q ss_pred             ccCCccCcc--ccccccccCcccccccccccC-ccchHHHHHHHhhhhhhhhccccccchhhh-h---------------
Q 040702          656 KPLLEEDQS--LTQTQTLATIGYMAPDEIFSG-EMRLKCWVNDSLLISVMIVVDANLLIREEK-H---------------  716 (797)
Q Consensus       656 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~-~---------------  716 (797)
                      +........  ......+||+.|+|||++... .++.++|+||+|+..++.+.+..++..... +               
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  244 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  244 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence            765432211  123445799999999998765 689999999999998666655544332110 0               


Q ss_pred             --------------------------------hhcccccchhccccCCCCCCCChHHHHH
Q 040702          717 --------------------------------LMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       717 --------------------------------~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                                      ......+++.+|+..||++|||+.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence                                            0112345789999999999999998874

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.2e-36  Score=317.66  Aligned_cols=233  Identities=15%  Similarity=0.135  Sum_probs=193.4

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccC-CceeEeeeeeecCCeEEEEEEc
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRH-RNLIKIISSCSNDDFKALVLEY  585 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H-pniv~l~~~~~~~~~~~lv~e~  585 (797)
                      ++|++.+.||+|+||+||++     ++.||||++....  ..+.+.+|+++++.++| +||+.+++++..+...++||||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence            57999999999999999985     6899999986553  34678899999999975 8999999999999999999999


Q ss_pred             cCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcC-----CCcEEEEeecCCccCCc
Q 040702          586 MPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDD-----NMVAHLSDFGMAKPLLE  660 (797)
Q Consensus       586 ~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~-----~~~~kl~DFGla~~~~~  660 (797)
                      + +|+|.+++......+++..+..++.|++.||+|||   +++|+||||||+||+++.     ++.+||+|||+|+....
T Consensus        83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~  158 (293)
T d1csna_          83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD  158 (293)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred             c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEccc
Confidence            9 68999999877667999999999999999999999   999999999999999974     57899999999987643


Q ss_pred             cCcc-----ccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchh----------------------
Q 040702          661 EDQS-----LTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIRE----------------------  713 (797)
Q Consensus       661 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~----------------------  713 (797)
                      ....     ......+||+.|||||.+.+..++.++|+||+|+..++.+.+..++...                      
T Consensus       159 ~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (293)
T d1csna_         159 PVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR  238 (293)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH
T ss_pred             CccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChH
Confidence            3211     1234567999999999999999999999999999986665544433210                      


Q ss_pred             --hhhhhcccccchhccccCCCCCCCChHHHHHhHHHHH
Q 040702          714 --EKHLMTKEQPMVRMGTDLSLGQFPASYSISKYLVYIR  750 (797)
Q Consensus       714 --~~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~~l~~i~  750 (797)
                        .....+.+.+++..|+..+|++||++..+.+.++++.
T Consensus       239 ~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~  277 (293)
T d1csna_         239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  277 (293)
T ss_dssp             HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence              0112235677888899999999999999988887764

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-37  Score=330.29  Aligned_cols=222  Identities=23%  Similarity=0.326  Sum_probs=177.1

Q ss_pred             CCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhccCCceeEeeeeeecC------CeEEE
Q 040702          513 RFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNLIKIISSCSND------DFKAL  581 (797)
Q Consensus       513 ~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~------~~~~l  581 (797)
                      +|...++||+|+||+||++     ++.||||+++...    ....+|++++++++||||++++++|...      ...|+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            6888899999999999974     6899999997543    2334799999999999999999998543      35789


Q ss_pred             EEEccCCCCHHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCC-cEEEEeecCCccC
Q 040702          582 VLEYMPLGSLEKCLY--SGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNM-VAHLSDFGMAKPL  658 (797)
Q Consensus       582 v~e~~~~g~L~~~l~--~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~-~~kl~DFGla~~~  658 (797)
                      |||||++|....+..  .....+++.+++.++.||+.||+|||   +++|+||||||+|||++.++ .+||+|||+|+..
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            999998764443332  23336899999999999999999999   99999999999999999775 8999999999866


Q ss_pred             CccCccccccccccCccccccccccc-CccchHHHHHHHhhhhhhhhccccccchhhh----------------------
Q 040702          659 LEEDQSLTQTQTLATIGYMAPDEIFS-GEMRLKCWVNDSLLISVMIVVDANLLIREEK----------------------  715 (797)
Q Consensus       659 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~~----------------------  715 (797)
                      ....   .....+||+.|+|||++.+ ..++.++|+||+|+..++.+.+..++.....                      
T Consensus       174 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  250 (350)
T d1q5ka_         174 VRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM  250 (350)
T ss_dssp             CTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             cCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence            4332   2344679999999998875 4689999999999998666655544321110                      


Q ss_pred             -----------------------hhhcccccchhccccCCCCCCCChHHHHH
Q 040702          716 -----------------------HLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       716 -----------------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                             ...+...+++++|+..||++|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                                   11223457889999999999999999886

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-36  Score=318.32  Aligned_cols=226  Identities=20%  Similarity=0.253  Sum_probs=184.8

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccC--CcchhHHHHHHHhhhccCCceeEeeeeeecCCeEEEEEE
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYG--GAFKSFDIECGMMKRIRHRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~--~~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      ++|+..+.||+|+||+||++     ++.||||+++....  ...+++.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57999999999999999985     58899999976543  235688999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccCCccCcc
Q 040702          585 YMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPLLEEDQS  664 (797)
Q Consensus       585 ~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~~~~~~~  664 (797)
                      ++.++++..++...+ .+++..+..++.|+++||+|||   +++|+||||||+|||++.++.+||+|||.|+....... 
T Consensus        82 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-  156 (292)
T d1unla_          82 FCDQDLKKYFDSCNG-DLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-  156 (292)
T ss_dssp             CCSEEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS-
T ss_pred             ecccccccccccccc-ccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCc-
Confidence            999999888776554 4899999999999999999999   89999999999999999999999999999987643322 


Q ss_pred             ccccccccCcccccccccccCc-cchHHHHHHHhhhhhhhhcccccc-c-hhhh--------------------------
Q 040702          665 LTQTQTLATIGYMAPDEIFSGE-MRLKCWVNDSLLISVMIVVDANLL-I-REEK--------------------------  715 (797)
Q Consensus       665 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~dv~s~~~~~~~~~~~~~~~-~-~~~~--------------------------  715 (797)
                       ......+++.|+|||.+.... ++.++|+||+|+..++.+.+..++ . ....                          
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (292)
T d1unla_         157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD  235 (292)
T ss_dssp             -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTT
T ss_pred             -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccc
Confidence             233456788999999887665 689999999999986655443321 1 1000                          


Q ss_pred             ------------------hhhcccccchhccccCCCCCCCChHHHH
Q 040702          716 ------------------HLMTKEQPMVRMGTDLSLGQFPASYSIS  743 (797)
Q Consensus       716 ------------------~~~~~~~~l~~~cl~~dp~~RPs~~~i~  743 (797)
                                        ...+...++++.|++.||.+|||+.|++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L  281 (292)
T d1unla_         236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL  281 (292)
T ss_dssp             CCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred             ccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence                              0011334678889999999999987765

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-36  Score=322.13  Aligned_cols=223  Identities=22%  Similarity=0.241  Sum_probs=172.5

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCC--cchhHHHHHHHhhhccCCceeEeeeeeec------CCe
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG--AFKSFDIECGMMKRIRHRNLIKIISSCSN------DDF  578 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~l~~~~~~------~~~  578 (797)
                      ++|++.++||+|+||+||++     |+.||||+++.....  ..+++.+|+.++++++|||||+++++|..      ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            67999999999999999984     799999999865432  23568899999999999999999999864      357


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccC
Q 040702          579 KALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  658 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  658 (797)
                      .|+||||+.++ +.+.+..   .+++..++.++.||+.||+|||   +.||+||||||+|||++.++.+|++|||+++..
T Consensus        97 ~~iv~Ey~~~~-l~~~~~~---~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~  169 (355)
T d2b1pa1          97 VYLVMELMDAN-LCQVIQM---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_dssp             EEEEEECCSEE-HHHHHTS---CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             eEEEEeccchH-HHHhhhc---CCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhcc
Confidence            89999999765 4444433   3799999999999999999999   999999999999999999999999999998865


Q ss_pred             CccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhccccccchhh------------------------
Q 040702          659 LEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVVDANLLIREE------------------------  714 (797)
Q Consensus       659 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~~~~~~~~~~------------------------  714 (797)
                      ...   ......+||+.|+|||.+.+..++.++|+||+|+..+..+.+..++....                        
T Consensus       170 ~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  246 (355)
T d2b1pa1         170 GTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_dssp             --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred             ccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence            332   23355679999999999999999999999999999866555544432100                        


Q ss_pred             ----------------------------------hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          715 ----------------------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       715 ----------------------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                                        ........+++++|+..||++|||++|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                                              011223467899999999999999999875

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-36  Score=322.90  Aligned_cols=224  Identities=19%  Similarity=0.241  Sum_probs=180.1

Q ss_pred             hcCCCccccccccCCcceeec-----ceEEEEEEEEeccCC--cchhHHHHHHHhhhccCCceeEeeeeeecC-----Ce
Q 040702          511 TNRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGG--AFKSFDIECGMMKRIRHRNLIKIISSCSND-----DF  578 (797)
Q Consensus       511 ~~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~--~~~~~~~E~~~l~~l~Hpniv~l~~~~~~~-----~~  578 (797)
                      .++|+..+.||+|+||+||++     ++.||||+++.....  ..+.+.+|++++++++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            568999999999999999985     689999999765432  245788999999999999999999998643     23


Q ss_pred             EEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCccC
Q 040702          579 KALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKPL  658 (797)
Q Consensus       579 ~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~~  658 (797)
                      .+++|||+.+|+|.+++..+  .+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+|++|||+|...
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             eEEEEEeecCCchhhhcccc--cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhccc
Confidence            46667778899999998654  4899999999999999999999   999999999999999999999999999999754


Q ss_pred             CccCccccccccccCcccccccccccCc-cchHHHHHHHhhhhhhhhccccccchhh-----------------------
Q 040702          659 LEEDQSLTQTQTLATIGYMAPDEIFSGE-MRLKCWVNDSLLISVMIVVDANLLIREE-----------------------  714 (797)
Q Consensus       659 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~dv~s~~~~~~~~~~~~~~~~~~~-----------------------  714 (797)
                      ..     ......||+.|+|||.+.+.. ++.++|+||+|+..+..+.+..++....                       
T Consensus       172 ~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~  246 (348)
T d2gfsa1         172 DD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI  246 (348)
T ss_dssp             TG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred             Cc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhc
Confidence            32     234567999999999877654 5899999999999876666554432110                       


Q ss_pred             ------------------------hhhhcccccchhccccCCCCCCCChHHHHH
Q 040702          715 ------------------------KHLMTKEQPMVRMGTDLSLGQFPASYSISK  744 (797)
Q Consensus       715 ------------------------~~~~~~~~~l~~~cl~~dp~~RPs~~~i~~  744 (797)
                                              ........++++.|+..||.+|||+.|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             CCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence                                    011223467899999999999999999886

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.97  E-value=4.2e-30  Score=279.50  Aligned_cols=355  Identities=27%  Similarity=0.371  Sum_probs=255.3

Q ss_pred             CCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEE
Q 040702            4 LTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLY   83 (797)
Q Consensus         4 l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~   83 (797)
                      +..+.+.+.+.  ...+.+|++|++++|.++         ++ +++..+++|++|+|++|+|+++.|  |.++++|++|+
T Consensus        29 l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~---------~l-~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~   94 (384)
T d2omza2          29 LGKTNVTDTVS--QTDLDQVTTLQADRLGIK---------SI-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDIL   94 (384)
T ss_dssp             TTCSSTTSEEC--HHHHTTCCEEECCSSCCC---------CC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred             hCCCCCCCccC--HHHhCCCCEEECCCCCCC---------Cc-cccccCCCCCEEeCcCCcCCCCcc--ccCCccccccc
Confidence            34444555443  345677888888888743         33 357778888888888888887543  78888888888


Q ss_pred             ccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCc
Q 040702           84 LHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLT  163 (797)
Q Consensus        84 Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~  163 (797)
                      +++|+|+ .++.  +..+++|+.|++++|.+++..  .......+..+....|.+..+.+..................+.
T Consensus        95 L~~n~i~-~i~~--l~~l~~L~~L~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  169 (384)
T d2omza2          95 MNNNQIA-DITP--LANLTNLTGLTLFNNQITDID--PLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLK  169 (384)
T ss_dssp             CCSSCCC-CCGG--GTTCTTCCEEECCSSCCCCCG--GGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCG
T ss_pred             ccccccc-cccc--ccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccchhh
Confidence            8888887 4543  457888888888888876543  2445667777777777777555444433333333333222222


Q ss_pred             CCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhccccccccc
Q 040702          164 SSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLE  243 (797)
Q Consensus       164 ~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~  243 (797)
                                .+...+.........|....  ...+..++ +++.+++++|.+++..|  +...++|  ++|++++|+++
T Consensus       170 ----------~~~~~~~~~~~~~~~~~~~~--~~~~~~l~-~~~~l~l~~n~i~~~~~--~~~~~~L--~~L~l~~n~l~  232 (384)
T d2omza2         170 ----------PLANLTTLERLDISSNKVSD--ISVLAKLT-NLESLIATNNQISDITP--LGILTNL--DELSLNGNQLK  232 (384)
T ss_dssp             ----------GGTTCTTCCEEECCSSCCCC--CGGGGGCT-TCSEEECCSSCCCCCGG--GGGCTTC--CEEECCSSCCC
T ss_pred             ----------hhcccccccccccccccccc--cccccccc-ccceeeccCCccCCCCc--ccccCCC--CEEECCCCCCC
Confidence                      23344455566666665542  34556665 78888888888876544  3445566  88888888887


Q ss_pred             CCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEccCCcCCCCCCccccc
Q 040702          244 GSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGN  323 (797)
Q Consensus       244 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~  323 (797)
                      ..  +.+..+++|+.|++++|++++..+  +..+++|+.|++++|.++.+++ +..++.++.+++++|.+.+.  ..+..
T Consensus       233 ~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~-~~~~~~l~~l~~~~n~l~~~--~~~~~  305 (384)
T d2omza2         233 DI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-LAGLTALTNLELNENQLEDI--SPISN  305 (384)
T ss_dssp             CC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCC--GGGGG
T ss_pred             Cc--chhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCc-cccccccccccccccccccc--cccch
Confidence            43  467788899999999999886543  7788899999999999887764 66788888999999988753  35778


Q ss_pred             cccccEEeccCcccccccCccccCCcccceecccCccccCCCChhhhccccCCeeeecCCcCCCCCChhhhccCCCCeEE
Q 040702          324 LNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDIN  403 (797)
Q Consensus       324 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~  403 (797)
                      +++++.|++++|++++..  .+..+++|++|++++|++++ ++ .++++++|++|++++|++++..|  +.++++|+.|+
T Consensus       306 ~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~  379 (384)
T d2omza2         306 LKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLG  379 (384)
T ss_dssp             CTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEE
T ss_pred             hcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEee
Confidence            888999999999998754  37788899999999999884 34 68889999999999999987655  88889999999


Q ss_pred             ccCC
Q 040702          404 VSFN  407 (797)
Q Consensus       404 l~~N  407 (797)
                      +++|
T Consensus       380 L~~N  383 (384)
T d2omza2         380 LNDQ  383 (384)
T ss_dssp             CCCE
T ss_pred             CCCC
Confidence            9887

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.97  E-value=3.3e-32  Score=293.91  Aligned_cols=185  Identities=19%  Similarity=0.278  Sum_probs=146.2

Q ss_pred             cCCCccccccccCCcceeec-----ceEEEEEEEEeccCCcchhHHHHHHHhhhcc-----------CCceeEeeeeeec
Q 040702          512 NRFSENNLIGRGGFGPVYKD-----GMEVAIKVFNLQYGGAFKSFDIECGMMKRIR-----------HRNLIKIISSCSN  575 (797)
Q Consensus       512 ~~f~~~~~lg~G~~g~Vyk~-----~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-----------Hpniv~l~~~~~~  575 (797)
                      ++|+++++||+|+||.||++     |+.||||+++.... ..+.+.+|+.+++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            45999999999999999985     68999999975432 2356788999888875           5789999998764


Q ss_pred             --CCeEEEEEEccCCCC-HHHHH-hcCCCCCCHHHHHHHHHHHHHHHHHHHccCC-CCeEEcCCCCCceEEcCCC-----
Q 040702          576 --DDFKALVLEYMPLGS-LEKCL-YSGNYILDIFQGLNIMIDVASALEYLHFGYS-VPIIHCDLKPSNVLLDDNM-----  645 (797)
Q Consensus       576 --~~~~~lv~e~~~~g~-L~~~l-~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~-~~ivHrDlkp~NIll~~~~-----  645 (797)
                        ....+++|+++..+. ..... ......+++..+..++.||+.|++|||   + .+|+||||||+|||++.++     
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh---~~~~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHh---hhcCcccccCChhHeeeeccCccccc
Confidence              346667777665443 22222 233346889999999999999999999   5 7899999999999998654     


Q ss_pred             -cEEEEeecCCccCCccCccccccccccCcccccccccccCccchHHHHHHHhhhhhhhhc
Q 040702          646 -VAHLSDFGMAKPLLEEDQSLTQTQTLATIGYMAPDEIFSGEMRLKCWVNDSLLISVMIVV  705 (797)
Q Consensus       646 -~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~dv~s~~~~~~~~~~  705 (797)
                       .+|++|||.|+....     .....+||+.|+|||.+....++.++|+||+|++.++.+.
T Consensus       169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  224 (362)
T d1q8ya_         169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT  224 (362)
T ss_dssp             EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHH
T ss_pred             ceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHH
Confidence             499999999985432     2244679999999999999999999999999998754443

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.96  E-value=2.7e-30  Score=272.87  Aligned_cols=254  Identities=31%  Similarity=0.498  Sum_probs=224.4

Q ss_pred             CCcEEEccCCCCCCC--CChhhhccccCCcEEEccC-CcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCC
Q 040702          180 YLEYFSFSNNPLGGI--LPRAIGNLSQSMEDFWMDN-CNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAAL  256 (797)
Q Consensus       180 ~L~~L~Ls~N~l~~~--~~~~~~~l~~~L~~L~L~~-n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L  256 (797)
                      +++.|+|++|.+.+.  +|..+++++ +|++|+|++ |.++|.+|..|+++++|  ++|+|++|++.+..+..+..+..|
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l~~L~-~L~~L~Ls~~N~l~g~iP~~i~~L~~L--~~L~Ls~N~l~~~~~~~~~~~~~L  127 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSLANLP-YLNFLYIGGINNLVGPIPPAIAKLTQL--HYLYITHTNVSGAIPDFLSQIKTL  127 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGGGGCT-TCSEEEEEEETTEESCCCGGGGGCTTC--SEEEEEEECCEEECCGGGGGCTTC
T ss_pred             EEEEEECCCCCCCCCCCCChHHhcCc-ccccccccccccccccccccccccccc--chhhhccccccccccccccchhhh
Confidence            577778888877763  577888887 788888876 77888888888888888  889999999988888888889999


Q ss_pred             cEEEccCCcCcccCCCCccCCccccccccCCCCC-CCCCCCCCCCCcc-cEEEccCCcCCCCCCccccccccccEEeccC
Q 040702          257 FQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLL-TSIPSTLWNLKDI-LHLNLSSNFFTGPLPLKIGNLNVLVQLDLSM  334 (797)
Q Consensus       257 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l-~~lp~~~~~l~~L-~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~  334 (797)
                      +.+++++|.+.+..|..+..++.|+.+++++|.+ ..+|..+..+.++ +.+++++|++++..|..+..+..+ .+++++
T Consensus       128 ~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~  206 (313)
T d1ogqa_         128 VTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSR  206 (313)
T ss_dssp             CEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCS
T ss_pred             cccccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccc
Confidence            9999999998888888999999999999999998 4788888877775 889999999998888888887654 799999


Q ss_pred             cccccccCccccCCcccceecccCccccCCCChhhhccccCCeeeecCCcCCCCCChhhhccCCCCeEEccCCcCcccCC
Q 040702          335 NNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIP  414 (797)
Q Consensus       335 N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p  414 (797)
                      |.+.+.+|..+..+++|+.+++++|.+.+.+| .++.+++|+.|+|++|+++|.+|..|.++++|+.|+|++|+++|.+|
T Consensus       207 ~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP  285 (313)
T d1ogqa_         207 NMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP  285 (313)
T ss_dssp             SEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC
T ss_pred             cccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCC
Confidence            99999999999999999999999999987654 68889999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCcccccCCccccCCCC
Q 040702          415 REGPFRNLSAESFKGNELLCGMPN  438 (797)
Q Consensus       415 ~~~~~~~l~~~~~~~n~~~c~~~~  438 (797)
                      ..+.+..++.+++.+|+.+||.|.
T Consensus       286 ~~~~L~~L~~l~l~~N~~l~g~pl  309 (313)
T d1ogqa_         286 QGGNLQRFDVSAYANNKCLCGSPL  309 (313)
T ss_dssp             CSTTGGGSCGGGTCSSSEEESTTS
T ss_pred             CcccCCCCCHHHhCCCccccCCCC
Confidence            888889999999999999999874

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.96  E-value=8.6e-29  Score=268.99  Aligned_cols=336  Identities=24%  Similarity=0.338  Sum_probs=260.3

Q ss_pred             CCCCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCE
Q 040702            2 PSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKS   81 (797)
Q Consensus         2 ~~l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~   81 (797)
                      ++++++.|+.+  +.++.+++|++|||++|++++         +| .++++++|++|++++|++.++.|  +.++++|+.
T Consensus        49 L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~---------l~-~l~~L~~L~~L~L~~n~i~~i~~--l~~l~~L~~  114 (384)
T d2omza2          49 LQADRLGIKSI--DGVEYLNNLTQINFSNNQLTD---------IT-PLKNLTKLVDILMNNNQIADITP--LANLTNLTG  114 (384)
T ss_dssp             EECCSSCCCCC--TTGGGCTTCCEEECCSSCCCC---------CG-GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred             EECCCCCCCCc--cccccCCCCCEEeCcCCcCCC---------Cc-cccCCcccccccccccccccccc--ccccccccc
Confidence            57888988865  458899999999999999554         44 38899999999999999998654  889999999


Q ss_pred             EEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCcc
Q 040702           82 LYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNY  161 (797)
Q Consensus        82 L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~  161 (797)
                      |++++|.++ .++..  .....+..+....|.+....+..................+     ..+...+.........|.
T Consensus       115 L~~~~~~~~-~~~~~--~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~  186 (384)
T d2omza2         115 LTLFNNQIT-DIDPL--KNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDL-----KPLANLTTLERLDISSNK  186 (384)
T ss_dssp             EECCSSCCC-CCGGG--TTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCC-----GGGTTCTTCCEEECCSSC
T ss_pred             ccccccccc-ccccc--cccccccccccccccccccccccccccccccccccccchh-----hhhccccccccccccccc
Confidence            999999998 54443  3567888999999988754443333333333333332222     335556666666666665


Q ss_pred             CcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhccccccc
Q 040702          162 LTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQ  241 (797)
Q Consensus       162 l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~  241 (797)
                      .....       .+..+++++.+++++|.++++.|  +...+ +|+.|++++|.++.  +..+..+++|  +.|++++|.
T Consensus       187 ~~~~~-------~~~~l~~~~~l~l~~n~i~~~~~--~~~~~-~L~~L~l~~n~l~~--~~~l~~l~~L--~~L~l~~n~  252 (384)
T d2omza2         187 VSDIS-------VLAKLTNLESLIATNNQISDITP--LGILT-NLDELSLNGNQLKD--IGTLASLTNL--TDLDLANNQ  252 (384)
T ss_dssp             CCCCG-------GGGGCTTCSEEECCSSCCCCCGG--GGGCT-TCCEEECCSSCCCC--CGGGGGCTTC--SEEECCSSC
T ss_pred             ccccc-------ccccccccceeeccCCccCCCCc--ccccC-CCCEEECCCCCCCC--cchhhccccc--chhccccCc
Confidence            54432       25667788888888888887654  33344 78888888888874  3467777777  889999999


Q ss_pred             ccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEccCCcCCCCCCccc
Q 040702          242 LEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKI  321 (797)
Q Consensus       242 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~  321 (797)
                      +++..  .+..+++|++|++++|++++..  .+..++.++.++++.|.++.++ .+..+++++.|++++|++++..  .+
T Consensus       253 l~~~~--~~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~~-~~~~~~~l~~L~ls~n~l~~l~--~l  325 (384)
T d2omza2         253 ISNLA--PLSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDIS-PISNLKNLTYLTLYFNNISDIS--PV  325 (384)
T ss_dssp             CCCCG--GGTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCCG-GGGGCTTCSEEECCSSCCSCCG--GG
T ss_pred             cCCCC--cccccccCCEeeccCcccCCCC--cccccccccccccccccccccc-ccchhcccCeEECCCCCCCCCc--cc
Confidence            88654  3788899999999999998654  3778899999999999998765 4777899999999999999754  38


Q ss_pred             cccccccEEeccCcccccccCccccCCcccceecccCccccCCCChhhhccccCCeeeecCCc
Q 040702          322 GNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNN  384 (797)
Q Consensus       322 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~  384 (797)
                      ..+++|++|++++|+|+++ + .+.++++|++|++++|++++..|  +.++++|+.|+|++|.
T Consensus       326 ~~l~~L~~L~L~~n~l~~l-~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~Na  384 (384)
T d2omza2         326 SSLTKLQRLFFANNKVSDV-S-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA  384 (384)
T ss_dssp             GGCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCEE
T ss_pred             ccCCCCCEEECCCCCCCCC-h-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCCCCc
Confidence            8899999999999999853 3 58999999999999999997654  8999999999999984

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.96  E-value=6.9e-30  Score=269.68  Aligned_cols=249  Identities=30%  Similarity=0.436  Sum_probs=137.6

Q ss_pred             CCCEEEccCCcCcc--cCCCccccCCCCccEEEccC-ccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCe
Q 040702           78 TLKSLYLHSNSLSG--RLPSSADVRLPNLKELHLWG-NNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKW  154 (797)
Q Consensus        78 ~L~~L~Ls~N~l~~--~l~~~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~  154 (797)
                      +++.|+|++|.++|  .+|..+ .++++|++|+|++ |++++.+|..|.++++|++|+|++|+|.++.+..|..+.+|++
T Consensus        51 ~v~~L~L~~~~l~g~~~lp~~l-~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~  129 (313)
T d1ogqa_          51 RVNNLDLSGLNLPKPYPIPSSL-ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT  129 (313)
T ss_dssp             CEEEEEEECCCCSSCEECCGGG-GGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred             EEEEEECCCCCCCCCCCCChHH-hcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence            45555555555544  234433 2455555555544 4455455555555555555555555555555555555555555


Q ss_pred             eeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhh
Q 040702          155 LGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQL  234 (797)
Q Consensus       155 L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~  234 (797)
                      +++++|.+                             .+..|..+.+++ .++.+++++|.+.+.+|..+..+..+ ++.
T Consensus       130 l~l~~N~~-----------------------------~~~~p~~l~~l~-~L~~l~l~~n~l~~~ip~~~~~l~~l-~~~  178 (313)
T d1ogqa_         130 LDFSYNAL-----------------------------SGTLPPSISSLP-NLVGITFDGNRISGAIPDSYGSFSKL-FTS  178 (313)
T ss_dssp             EECCSSEE-----------------------------ESCCCGGGGGCT-TCCEEECCSSCCEEECCGGGGCCCTT-CCE
T ss_pred             cccccccc-----------------------------cccCchhhccCc-ccceeecccccccccccccccccccc-ccc
Confidence            55555544                             444444444444 44444444444444444444444333 244


Q ss_pred             cccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEccCCcCC
Q 040702          235 LSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFT  314 (797)
Q Consensus       235 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~  314 (797)
                      +++++|++++..|..+..+..+ .++++.|...+..|..+..+++++.+++++|.+...+..+..+++|+.|++++|+++
T Consensus       179 l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~  257 (313)
T d1ogqa_         179 MTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIY  257 (313)
T ss_dssp             EECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCE
T ss_pred             cccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccCccCeec
Confidence            5555566655555555555433 566666666666666666666666666666666544445555666666666666666


Q ss_pred             CCCCccccccccccEEeccCcccccccCccccCCcccceecccCcc
Q 040702          315 GPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNR  360 (797)
Q Consensus       315 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~  360 (797)
                      +.+|..|+++++|++|+|++|+|+|.+|. ++.+++|+.+++++|+
T Consensus       258 g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~  302 (313)
T d1ogqa_         258 GTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK  302 (313)
T ss_dssp             ECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred             ccCChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCc
Confidence            66666666666666666666666665553 4556666666666665

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.95  E-value=2.7e-27  Score=248.59  Aligned_cols=282  Identities=22%  Similarity=0.257  Sum_probs=161.2

Q ss_pred             CCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCC
Q 040702           23 LQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLP  102 (797)
Q Consensus        23 L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~  102 (797)
                      ++.+|=+++.         ++++|..+.  +++++|+|++|+|+.+.+.+|.++++|++|++++|.+. .++...|.+++
T Consensus        12 ~~~~~C~~~~---------L~~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~-~i~~~~f~~l~   79 (305)
T d1xkua_          12 LRVVQCSDLG---------LEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLV   79 (305)
T ss_dssp             TTEEECTTSC---------CCSCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCC-CBCTTTTTTCT
T ss_pred             CCEEEecCCC---------CCccCCCCC--CCCCEEECcCCcCCCcChhHhhcccccccccccccccc-ccchhhhhCCC
Confidence            4455555555         344455443  45666777777666655556666667777777777666 55555566666


Q ss_pred             CccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCc
Q 040702          103 NLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLE  182 (797)
Q Consensus       103 ~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~  182 (797)
                      +|++|++++|+++. +|..+  ...|+.|++++|.+..+.+..|.....+..++...|.........   ..|..+++|+
T Consensus        80 ~L~~L~l~~n~l~~-l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~---~~~~~l~~L~  153 (305)
T d1xkua_          80 KLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIEN---GAFQGMKKLS  153 (305)
T ss_dssp             TCCEEECCSSCCSB-CCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCT---TGGGGCTTCC
T ss_pred             ccCEecccCCccCc-Cccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCc---cccccccccC
Confidence            77777777766663 33322  345666666677666666666666666666666666544332211   1355556666


Q ss_pred             EEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEcc
Q 040702          183 YFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLG  262 (797)
Q Consensus       183 ~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  262 (797)
                      .+++++|.+..+....    ..++                          +.|++++|......+..|..++.++.|+++
T Consensus       154 ~l~l~~n~l~~l~~~~----~~~L--------------------------~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s  203 (305)
T d1xkua_         154 YIRIADTNITTIPQGL----PPSL--------------------------TELHLDGNKITKVDAASLKGLNNLAKLGLS  203 (305)
T ss_dssp             EEECCSSCCCSCCSSC----CTTC--------------------------SEEECTTSCCCEECTGGGTTCTTCCEEECC
T ss_pred             ccccccCCccccCccc----CCcc--------------------------CEEECCCCcCCCCChhHhhccccccccccc
Confidence            6666666665332211    1133                          444444444444455555566666666666


Q ss_pred             CCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEccCCcCCCCCCccc------cccccccEEeccCcc
Q 040702          263 GNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKI------GNLNVLVQLDLSMNN  336 (797)
Q Consensus       263 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~------~~l~~L~~L~Ls~N~  336 (797)
                      +|.+.++.+..+.++++|++|+|++|.|+++|.++..+++|++|++++|+|+.+....|      ..+.+|+.|+|++|.
T Consensus       204 ~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~  283 (305)
T d1xkua_         204 FNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNP  283 (305)
T ss_dssp             SSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSS
T ss_pred             cccccccccccccccccceeeecccccccccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCc
Confidence            66666666666666666666666666666666666666666666666666664433332      234556666666665


Q ss_pred             cc--cccCccccCCcccc
Q 040702          337 FS--CVIPTKIGGLKDLQ  352 (797)
Q Consensus       337 l~--~~~~~~~~~l~~L~  352 (797)
                      ++  .+.|.+|..+....
T Consensus       284 ~~~~~~~~~~f~~~~~~~  301 (305)
T d1xkua_         284 VQYWEIQPSTFRCVYVRA  301 (305)
T ss_dssp             SCGGGSCGGGGTTCCCGG
T ss_pred             CccCcCCHhHhcccccCc
Confidence            53  23444554444333

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.95  E-value=3.1e-27  Score=248.14  Aligned_cols=284  Identities=19%  Similarity=0.216  Sum_probs=167.3

Q ss_pred             CCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeec
Q 040702           78 TLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGL  157 (797)
Q Consensus        78 ~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L  157 (797)
                      ..+.+|-++++++ .+|..++   +++++|+|++|+|+.+.+.+|.++++|++|++++|.+..+.|++|.++++|++|++
T Consensus        11 ~~~~~~C~~~~L~-~lP~~l~---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l   86 (305)
T d1xkua_          11 HLRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYL   86 (305)
T ss_dssp             ETTEEECTTSCCC-SCCCSCC---TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred             cCCEEEecCCCCC-ccCCCCC---CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecc
Confidence            4566677777776 6776553   56777777777777665667777888888888888888777788888888888888


Q ss_pred             cCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhccc
Q 040702          158 NDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSL  237 (797)
Q Consensus       158 ~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~L  237 (797)
                      ++|+|+.++...        ...++.|++++|.+.++.+..+.... ....++...|.....                  
T Consensus        87 ~~n~l~~l~~~~--------~~~l~~L~~~~n~l~~l~~~~~~~~~-~~~~l~~~~n~~~~~------------------  139 (305)
T d1xkua_          87 SKNQLKELPEKM--------PKTLQELRVHENEITKVRKSVFNGLN-QMIVVELGTNPLKSS------------------  139 (305)
T ss_dssp             CSSCCSBCCSSC--------CTTCCEEECCSSCCCBBCHHHHTTCT-TCCEEECCSSCCCGG------------------
T ss_pred             cCCccCcCccch--------hhhhhhhhccccchhhhhhhhhhccc-ccccccccccccccc------------------
Confidence            888888776542        24677888888888877666665554 455666655543211                  


Q ss_pred             ccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCC-CCCCCCCCcccEEEccCCcCCCC
Q 040702          238 EGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSI-PSTLWNLKDILHLNLSSNFFTGP  316 (797)
Q Consensus       238 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l-p~~~~~l~~L~~L~l~~N~l~~~  316 (797)
                            ...+..|..+++|+.+++++|.+..+...   ..++|+.|++++|.+... +..+.+++.++.|++++|.+.+.
T Consensus       140 ------~~~~~~~~~l~~L~~l~l~~n~l~~l~~~---~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~  210 (305)
T d1xkua_         140 ------GIENGAFQGMKKLSYIRIADTNITTIPQG---LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAV  210 (305)
T ss_dssp             ------GBCTTGGGGCTTCCEEECCSSCCCSCCSS---CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEE
T ss_pred             ------CCCccccccccccCccccccCCccccCcc---cCCccCEEECCCCcCCCCChhHhhcccccccccccccccccc
Confidence                  11223344444455555555554432211   124455555555554332 23444455555555555555555


Q ss_pred             CCccccccccccEEeccCcccccccCccccCCcccceecccCccccCCCChh------hhccccCCeeeecCCcCC--CC
Q 040702          317 LPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNS------IGDLISLKSLNLSNNNLS--GT  388 (797)
Q Consensus       317 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~------~~~l~~L~~L~Ls~N~l~--~~  388 (797)
                      .+..|.++++|++|+|++|+|+. +|..|..+++|++|+|++|+|+......      +..+.+|+.|+|++|.++  ..
T Consensus       211 ~~~~~~~l~~L~~L~L~~N~L~~-lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~  289 (305)
T d1xkua_         211 DNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEI  289 (305)
T ss_dssp             CTTTGGGSTTCCEEECCSSCCSS-CCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGS
T ss_pred             ccccccccccceeeecccccccc-cccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcC
Confidence            55555555555555555555552 3445555555666666555555332222      234566777777777664  34


Q ss_pred             CChhhhccCCCCeE
Q 040702          389 IPISLEKLLDLKDI  402 (797)
Q Consensus       389 ~p~~~~~l~~L~~L  402 (797)
                      .|.+|..+.....+
T Consensus       290 ~~~~f~~~~~~~~~  303 (305)
T d1xkua_         290 QPSTFRCVYVRAAV  303 (305)
T ss_dssp             CGGGGTTCCCGGGE
T ss_pred             CHhHhcccccCccc
Confidence            55555555444443

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=3e-26  Score=237.80  Aligned_cols=222  Identities=24%  Similarity=0.309  Sum_probs=129.9

Q ss_pred             EEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEc-cC
Q 040702           57 WMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGL-QK  135 (797)
Q Consensus        57 ~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L-~~  135 (797)
                      .++.++++++. +|..+.  +++++|+|++|+|+ .+|...|.++++|++|++++|++..+.+..+.+++.++.+.. ..
T Consensus        15 ~v~c~~~~L~~-iP~~ip--~~~~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~   90 (284)
T d1ozna_          15 TTSCPQQGLQA-VPVGIP--AASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN   90 (284)
T ss_dssp             EEECCSSCCSS-CCTTCC--TTCSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred             EEEcCCCCCCc-cCCCCC--CCCCEEECcCCcCC-CCCHHHhhccccccccccccccccccccccccccccccccccccc
Confidence            45666666664 344332  45677777777776 666666666777777777777776666666666666666654 35


Q ss_pred             CcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCc
Q 040702          136 NSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCN  215 (797)
Q Consensus       136 N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~  215 (797)
                      |.++.+.+.+|.++++|++|++++|.+..++..     .+...++|+.+++++|+++++.+.+|..++ +|         
T Consensus        91 ~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~-----~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~-~L---------  155 (284)
T d1ozna_          91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPG-----LFRGLAALQYLYLQDNALQALPDDTFRDLG-NL---------  155 (284)
T ss_dssp             TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTT-----TTTTCTTCCEEECCSSCCCCCCTTTTTTCT-TC---------
T ss_pred             cccccccchhhcccccCCEEecCCccccccccc-----ccchhcccchhhhccccccccChhHhcccc-ch---------
Confidence            556666666666666677776666666655543     255555666666666666555544444433 23         


Q ss_pred             ccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCC
Q 040702          216 ISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPS  295 (797)
Q Consensus       216 i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~  295 (797)
                                       +.|++++|+++++.+.+|.++++|+.+++++|+++++.|..|.++++|++|++++|.+..++.
T Consensus       156 -----------------~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~  218 (284)
T d1ozna_         156 -----------------THLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPT  218 (284)
T ss_dssp             -----------------CEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCH
T ss_pred             -----------------hhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccc
Confidence                             344444444444455555555666666666666665555555555555555555555544443


Q ss_pred             -CCCCCCcccEEEccCCcCC
Q 040702          296 -TLWNLKDILHLNLSSNFFT  314 (797)
Q Consensus       296 -~~~~l~~L~~L~l~~N~l~  314 (797)
                       .+..+++|+.|++++|.+.
T Consensus       219 ~~~~~~~~L~~L~l~~N~l~  238 (284)
T d1ozna_         219 EALAPLRALQYLRLNDNPWV  238 (284)
T ss_dssp             HHHTTCTTCCEEECCSSCEE
T ss_pred             cccccccccCEEEecCCCCC
Confidence             3444555555555555554

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=2.7e-26  Score=238.17  Aligned_cols=224  Identities=23%  Similarity=0.291  Sum_probs=192.2

Q ss_pred             CEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCC
Q 040702           24 QTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPN  103 (797)
Q Consensus        24 ~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~  103 (797)
                      ...+.++++         ++++|..+.  +++++|+|++|+|+++.+.+|.++++|++|++++|+|. .++...+..++.
T Consensus        14 ~~v~c~~~~---------L~~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~-~i~~~~~~~~~~   81 (284)
T d1ozna_          14 VTTSCPQQG---------LQAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLAL   81 (284)
T ss_dssp             CEEECCSSC---------CSSCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC-EECTTTTTTCTT
T ss_pred             eEEEcCCCC---------CCccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccc-cccccccccccc
Confidence            456777776         556666554  57899999999999988889999999999999999998 788888888999


Q ss_pred             ccEEEcc-CccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCc
Q 040702          104 LKELHLW-GNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLE  182 (797)
Q Consensus       104 L~~L~L~-~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~  182 (797)
                      ++.++.. .|.++...+..|.++++|++|+|++|.+..+.+..+..+++|+.+++++|.|+.++++     .|..+++|+
T Consensus        82 ~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~-----~f~~~~~L~  156 (284)
T d1ozna_          82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDD-----TFRDLGNLT  156 (284)
T ss_dssp             CCEEECCSCTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTT-----TTTTCTTCC
T ss_pred             ccccccccccccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChh-----Hhccccchh
Confidence            9998775 5677777788999999999999999999988889999999999999999999999876     488889999


Q ss_pred             EEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEcc
Q 040702          183 YFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLG  262 (797)
Q Consensus       183 ~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls  262 (797)
                      .|++++|+++++.+.+|.+++ +|+.+++++|++++..|..|.++++|  ++|++++|++.++.+++|..+++|++|+|+
T Consensus       157 ~L~l~~N~l~~l~~~~f~~l~-~L~~l~l~~N~l~~i~~~~f~~l~~L--~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~  233 (284)
T d1ozna_         157 HLFLHGNRISSVPERAFRGLH-SLDRLLLHQNRVAHVHPHAFRDLGRL--MTLYLFANNLSALPTEALAPLRALQYLRLN  233 (284)
T ss_dssp             EEECCSSCCCEECTTTTTTCT-TCCEEECCSSCCCEECTTTTTTCTTC--CEEECCSSCCSCCCHHHHTTCTTCCEEECC
T ss_pred             hcccccCcccccchhhhcccc-ccchhhhhhccccccChhHhhhhhhc--ccccccccccccccccccccccccCEEEec
Confidence            999999999999899998887 88888888888888888888888777  788888888887777788888888888888


Q ss_pred             CCcCc
Q 040702          263 GNKLS  267 (797)
Q Consensus       263 ~N~l~  267 (797)
                      +|.+.
T Consensus       234 ~N~l~  238 (284)
T d1ozna_         234 DNPWV  238 (284)
T ss_dssp             SSCEE
T ss_pred             CCCCC
Confidence            88775

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=3.1e-24  Score=220.02  Aligned_cols=202  Identities=24%  Similarity=0.242  Sum_probs=147.8

Q ss_pred             cCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCC
Q 040702           74 FNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLK  153 (797)
Q Consensus        74 ~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~  153 (797)
                      .+...+.+.+.+++.|+ .+|..+.   ++|++|+|++|+|+++.+.+|.++++|++|+|++|+|+.+.  .+..+++|+
T Consensus         7 ~~~~~~~~v~C~~~~L~-~iP~~lp---~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~--~~~~l~~L~   80 (266)
T d1p9ag_           7 SKVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ--VDGTLPVLG   80 (266)
T ss_dssp             ECSTTCCEEECTTSCCS-SCCSCCC---TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEE--CCSCCTTCC
T ss_pred             cccCCCeEEEccCCCCC-eeCcCcC---cCCCEEECcCCcCCCcCHHHhhccccccccccccccccccc--ccccccccc
Confidence            45566777888888888 7887653   57888888888888777778888888888888888888653  356788888


Q ss_pred             eeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhh
Q 040702          154 WLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQ  233 (797)
Q Consensus       154 ~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~  233 (797)
                      +|+|++|+++..+..      +.++++|+.|++++|.+.++.+..+..+. ++                          +
T Consensus        81 ~L~Ls~N~l~~~~~~------~~~l~~L~~L~l~~~~~~~~~~~~~~~l~-~l--------------------------~  127 (266)
T d1p9ag_          81 TLDLSHNQLQSLPLL------GQTLPALTVLDVSFNRLTSLPLGALRGLG-EL--------------------------Q  127 (266)
T ss_dssp             EEECCSSCCSSCCCC------TTTCTTCCEEECCSSCCCCCCSSTTTTCT-TC--------------------------C
T ss_pred             ccccccccccccccc------cccccccccccccccccceeecccccccc-cc--------------------------c
Confidence            888888888776553      66677777888877777766555554443 33                          4


Q ss_pred             hcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEccCCcC
Q 040702          234 LLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFF  313 (797)
Q Consensus       234 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l  313 (797)
                      +|++++|.++.+.+..+..+++++.|++++|+++++.+..|..+++|++|+|++|+|+.+|..++.+++|+.|+|++|.+
T Consensus       128 ~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~~lp~~~~~~~~L~~L~L~~Np~  207 (266)
T d1p9ag_         128 ELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPW  207 (266)
T ss_dssp             EEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCCCSEEECCSCCB
T ss_pred             cccccccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCcccChhHCCCCCCCEEEecCCCC
Confidence            55555555555666667777778888888888877777777777888888888888877777777777777777666665


Q ss_pred             C
Q 040702          314 T  314 (797)
Q Consensus       314 ~  314 (797)
                      .
T Consensus       208 ~  208 (266)
T d1p9ag_         208 L  208 (266)
T ss_dssp             C
T ss_pred             C
Confidence            4

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=4.3e-24  Score=218.99  Aligned_cols=202  Identities=22%  Similarity=0.260  Sum_probs=149.5

Q ss_pred             CCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCcc
Q 040702           18 GNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSA   97 (797)
Q Consensus        18 ~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~   97 (797)
                      ...+++...|.+++.         +++||+.+.  +++++|+|++|+|+++.+.+|.++++|++|+|++|+|+ .+|.  
T Consensus         7 ~~~~~~~~v~C~~~~---------L~~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~--   72 (266)
T d1p9ag_           7 SKVASHLEVNCDKRN---------LTALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV--   72 (266)
T ss_dssp             ECSTTCCEEECTTSC---------CSSCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC--
T ss_pred             cccCCCeEEEccCCC---------CCeeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc--
Confidence            345666777888887         445565554  47888888888888877788888888888888888887 6664  


Q ss_pred             ccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCC
Q 040702           98 DVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSN  177 (797)
Q Consensus        98 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~  177 (797)
                      +..+++|++|+|++|+++ ..+..+.++++|+.|++++|.+..+.+..+..+.++++|++++|.++.+++..     +..
T Consensus        73 ~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~-----~~~  146 (266)
T d1p9ag_          73 DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGL-----LTP  146 (266)
T ss_dssp             CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTT-----TTT
T ss_pred             cccccccccccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceecccc-----ccc
Confidence            346888888888888887 45667788888888888888888888888888888888888888888887753     677


Q ss_pred             CCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCc
Q 040702          178 CKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALF  257 (797)
Q Consensus       178 l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~  257 (797)
                      +++|+.|++++|+++++.+..|..++ +|+.|+|++|+|+                           .+|+.+..+++|+
T Consensus       147 l~~l~~l~l~~N~l~~~~~~~~~~l~-~L~~L~Ls~N~L~---------------------------~lp~~~~~~~~L~  198 (266)
T d1p9ag_         147 TPKLEKLSLANNNLTELPAGLLNGLE-NLDTLLLQENSLY---------------------------TIPKGFFGSHLLP  198 (266)
T ss_dssp             CTTCCEEECTTSCCSCCCTTTTTTCT-TCCEEECCSSCCC---------------------------CCCTTTTTTCCCS
T ss_pred             cccchhcccccccccccCcccccccc-ccceeecccCCCc---------------------------ccChhHCCCCCCC
Confidence            77888888888888877777776665 5555555555544                           3344444556666


Q ss_pred             EEEccCCcCc
Q 040702          258 QLDLGGNKLS  267 (797)
Q Consensus       258 ~L~Ls~N~l~  267 (797)
                      .|+|++|.+.
T Consensus       199 ~L~L~~Np~~  208 (266)
T d1p9ag_         199 FAFLHGNPWL  208 (266)
T ss_dssp             EEECCSCCBC
T ss_pred             EEEecCCCCC
Confidence            6666666553

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.88  E-value=5.3e-21  Score=204.02  Aligned_cols=302  Identities=25%  Similarity=0.291  Sum_probs=171.3

Q ss_pred             CCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccC
Q 040702           21 SSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVR  100 (797)
Q Consensus        21 ~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~  100 (797)
                      .++++||||+|.+         +++|+.   +++|++|++++|+|+. +|..   +.+|+.|++++|+++ .++.-    
T Consensus        38 ~~l~~LdLs~~~L---------~~lp~~---~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~l~~n~l~-~l~~l----   96 (353)
T d1jl5a_          38 RQAHELELNNLGL---------SSLPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLK-ALSDL----   96 (353)
T ss_dssp             HTCSEEECTTSCC---------SCCCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCS-CCCSC----
T ss_pred             cCCCEEEeCCCCC---------CCCCCC---CCCCCEEECCCCCCcc-cccc---hhhhhhhhhhhcccc-hhhhh----
Confidence            3577777777763         344532   3467777777777774 4544   346777777777776 55431    


Q ss_pred             CCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCC
Q 040702          101 LPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKY  180 (797)
Q Consensus       101 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~  180 (797)
                      .+.|++|+|++|.+.. +|. +..+++|++|++++|.+.....    ....+..|.+.++......       .+..++.
T Consensus        97 p~~L~~L~L~~n~l~~-lp~-~~~l~~L~~L~l~~~~~~~~~~----~~~~l~~l~~~~~~~~~~~-------~l~~l~~  163 (353)
T d1jl5a_          97 PPLLEYLGVSNNQLEK-LPE-LQNSSFLKIIDVDNNSLKKLPD----LPPSLEFIAAGNNQLEELP-------ELQNLPF  163 (353)
T ss_dssp             CTTCCEEECCSSCCSS-CCC-CTTCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSSCC-------CCTTCTT
T ss_pred             cccccccccccccccc-ccc-hhhhccceeecccccccccccc----ccccccchhhccccccccc-------ccccccc
Confidence            2457777777777763 343 4567777777777777663322    2345556666655554432       2555666


Q ss_pred             CcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEE
Q 040702          181 LEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLD  260 (797)
Q Consensus       181 L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  260 (797)
                      ++.|++++|.+.......     ...                          +.+..+++.+. ..+ .+..++.|+.++
T Consensus       164 l~~L~l~~n~~~~~~~~~-----~~~--------------------------~~l~~~~~~~~-~~~-~~~~l~~L~~l~  210 (353)
T d1jl5a_         164 LTAIYADNNSLKKLPDLP-----LSL--------------------------ESIVAGNNILE-ELP-ELQNLPFLTTIY  210 (353)
T ss_dssp             CCEEECCSSCCSSCCCCC-----TTC--------------------------CEEECCSSCCS-SCC-CCTTCTTCCEEE
T ss_pred             ceeccccccccccccccc-----ccc--------------------------ccccccccccc-ccc-cccccccccccc
Confidence            667777766665332111     112                          22333333333 122 245566777777


Q ss_pred             ccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEccCCcCCCCCCccccccccccEEeccCcccccc
Q 040702          261 LGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCV  340 (797)
Q Consensus       261 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~  340 (797)
                      +++|..... +.   ...++..+.+.+|.+...+..   ...+...++..|.+.+...    -.......++..|.+.+.
T Consensus       211 l~~n~~~~~-~~---~~~~l~~~~~~~~~~~~~~~~---~~~l~~~~~~~~~~~~l~~----l~~~~~~~~~~~~~~~~~  279 (353)
T d1jl5a_         211 ADNNLLKTL-PD---LPPSLEALNVRDNYLTDLPEL---PQSLTFLDVSENIFSGLSE----LPPNLYYLNASSNEIRSL  279 (353)
T ss_dssp             CCSSCCSSC-CS---CCTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCSEESC----CCTTCCEEECCSSCCSEE
T ss_pred             ccccccccc-cc---ccccccccccccccccccccc---ccccccccccccccccccc----ccchhcccccccCccccc
Confidence            777766532 22   234566666777766555433   2345555555555542211    012334556666665532


Q ss_pred             cCccccCCcccceecccCccccCCCChhhhccccCCeeeecCCcCCCCCChhhhccCCCCeEEccCCcCccc
Q 040702          341 IPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGE  412 (797)
Q Consensus       341 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~  412 (797)
                          ...+++|++|+|++|+|+ .+|.   .+++|+.|+|++|+|+ .+|..   +.+|+.|++++|+++..
T Consensus       280 ----~~~~~~L~~L~Ls~N~l~-~lp~---~~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~~l  339 (353)
T d1jl5a_         280 ----CDLPPSLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLREF  339 (353)
T ss_dssp             ----CCCCTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSSC
T ss_pred             ----cccCCCCCEEECCCCccC-cccc---ccCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCCCC
Confidence                233567777777777777 4553   2467777777777777 44532   45677788888877643

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=99.86  E-value=2.2e-20  Score=199.08  Aligned_cols=299  Identities=27%  Similarity=0.290  Sum_probs=195.9

Q ss_pred             CCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEc
Q 040702           54 NMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGL  133 (797)
Q Consensus        54 ~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L  133 (797)
                      +++.|||++|.++. +|+.   .++|++|+|++|+|+ .+|..    +.+|++|++++|+++. ++..   .+.|++|+|
T Consensus        39 ~l~~LdLs~~~L~~-lp~~---~~~L~~L~Ls~N~l~-~lp~~----~~~L~~L~l~~n~l~~-l~~l---p~~L~~L~L  105 (353)
T d1jl5a_          39 QAHELELNNLGLSS-LPEL---PPHLESLVASCNSLT-ELPEL----PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGV  105 (353)
T ss_dssp             TCSEEECTTSCCSC-CCSC---CTTCSEEECCSSCCS-SCCCC----CTTCCEEECCSSCCSC-CCSC---CTTCCEEEC
T ss_pred             CCCEEEeCCCCCCC-CCCC---CCCCCEEECCCCCCc-ccccc----hhhhhhhhhhhcccch-hhhh---ccccccccc
Confidence            57788888888765 4543   467788888888887 77753    3577788888877763 2321   235777777


Q ss_pred             cCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccC
Q 040702          134 QKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDN  213 (797)
Q Consensus       134 ~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~  213 (797)
                      ++|+|+.+.  .+..+++|++|++++|.++..+..         ...+..+.+..+.....  ..+..+           
T Consensus       106 ~~n~l~~lp--~~~~l~~L~~L~l~~~~~~~~~~~---------~~~l~~l~~~~~~~~~~--~~l~~l-----------  161 (353)
T d1jl5a_         106 SNNQLEKLP--ELQNSSFLKIIDVDNNSLKKLPDL---------PPSLEFIAAGNNQLEEL--PELQNL-----------  161 (353)
T ss_dssp             CSSCCSSCC--CCTTCTTCCEEECCSSCCSCCCCC---------CTTCCEEECCSSCCSSC--CCCTTC-----------
T ss_pred             ccccccccc--chhhhccceeeccccccccccccc---------cccccchhhcccccccc--cccccc-----------
Confidence            777777543  256677777777777777655432         23455555555544321  222222           


Q ss_pred             CcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCC
Q 040702          214 CNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSI  293 (797)
Q Consensus       214 n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l  293 (797)
                                    +.+  +.|++++|.+.....    .....+.+..+.+.+...  ..+..++.|+.+++++|....+
T Consensus       162 --------------~~l--~~L~l~~n~~~~~~~----~~~~~~~l~~~~~~~~~~--~~~~~l~~L~~l~l~~n~~~~~  219 (353)
T d1jl5a_         162 --------------PFL--TAIYADNNSLKKLPD----LPLSLESIVAGNNILEEL--PELQNLPFLTTIYADNNLLKTL  219 (353)
T ss_dssp             --------------TTC--CEEECCSSCCSSCCC----CCTTCCEEECCSSCCSSC--CCCTTCTTCCEEECCSSCCSSC
T ss_pred             --------------ccc--eeccccccccccccc----cccccccccccccccccc--cccccccccccccccccccccc
Confidence                          223  556666666553221    123345677777777633  3467889999999999999887


Q ss_pred             CCCCCCCCcccEEEccCCcCCCCCCccccccccccEEeccCcccccccCccccCCcccceecccCccccCCCChhhhccc
Q 040702          294 PSTLWNLKDILHLNLSSNFFTGPLPLKIGNLNVLVQLDLSMNNFSCVIPTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLI  373 (797)
Q Consensus       294 p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~  373 (797)
                      |..   ..++..+.+.+|.+... +.   ....+...++..|.+.+.. .   -.......++..|.+.+.    ...++
T Consensus       220 ~~~---~~~l~~~~~~~~~~~~~-~~---~~~~l~~~~~~~~~~~~l~-~---l~~~~~~~~~~~~~~~~~----~~~~~  284 (353)
T d1jl5a_         220 PDL---PPSLEALNVRDNYLTDL-PE---LPQSLTFLDVSENIFSGLS-E---LPPNLYYLNASSNEIRSL----CDLPP  284 (353)
T ss_dssp             CSC---CTTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSEES-C---CCTTCCEEECCSSCCSEE----CCCCT
T ss_pred             ccc---ccccccccccccccccc-cc---ccccccccccccccccccc-c---ccchhcccccccCccccc----cccCC
Confidence            754   35678888999988743 22   2345677777777765431 1   113455677777776632    23467


Q ss_pred             cCCeeeecCCcCCCCCChhhhccCCCCeEEccCCcCcccCCCCCCCCCCCcccccCCccc
Q 040702          374 SLKSLNLSNNNLSGTIPISLEKLLDLKDINVSFNRLEGEIPREGPFRNLSAESFKGNELL  433 (797)
Q Consensus       374 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~l~~~~~~~n~~~  433 (797)
                      +|++|+|++|+|+ .+|.   .+++|+.|++++|+++.. |.  ...+++.+++++|+..
T Consensus       285 ~L~~L~Ls~N~l~-~lp~---~~~~L~~L~L~~N~L~~l-~~--~~~~L~~L~L~~N~L~  337 (353)
T d1jl5a_         285 SLEELNVSNNKLI-ELPA---LPPRLERLIASFNHLAEV-PE--LPQNLKQLHVEYNPLR  337 (353)
T ss_dssp             TCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSCC-CC--CCTTCCEEECCSSCCS
T ss_pred             CCCEEECCCCccC-cccc---ccCCCCEEECCCCcCCcc-cc--ccCCCCEEECcCCcCC
Confidence            8999999999998 5664   367899999999999854 43  2457889999999865

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.85  E-value=3e-21  Score=194.69  Aligned_cols=227  Identities=19%  Similarity=0.191  Sum_probs=132.6

Q ss_pred             CEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCcccccc-CCchhhCCCCCCEEEcc
Q 040702           56 EWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGT-IPSFIFNASKLSELGLQ  134 (797)
Q Consensus        56 ~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~  134 (797)
                      +.++.++++++. +|..+.  +++++|+|++|+|+ .+|..+|.++++|++|+|++|.+... .+..|.+++++++|.+.
T Consensus        11 ~~i~c~~~~l~~-iP~~l~--~~l~~L~Ls~n~i~-~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~   86 (242)
T d1xwdc1          11 RVFLCQESKVTE-IPSDLP--RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE   86 (242)
T ss_dssp             SEEEEESCSCSS-CCSCSC--SCCSEEEEESCCCC-EECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred             CEEEEeCCCCCC-cCCCCC--CCCCEEECcCCcCC-ccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence            344555555543 232221  34555555555554 55555555555555555555555432 23345555555555543


Q ss_pred             -CCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccC
Q 040702          135 -KNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDN  213 (797)
Q Consensus       135 -~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~  213 (797)
                       .|++..+.++.|.++++|++|++++|.++..++.    ..+..+..+..+..+++++..+.+..|.+++..++.|++++
T Consensus        87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~----~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~  162 (242)
T d1xwdc1          87 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDV----HKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNK  162 (242)
T ss_dssp             CCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCC----TTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCS
T ss_pred             ccccccccccccccccccccccccchhhhcccccc----cccccccccccccccccccccccccccccccccceeeeccc
Confidence             2455555556666666666666666666554331    12344555555566666666665666665555566666666


Q ss_pred             CcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCC
Q 040702          214 CNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSI  293 (797)
Q Consensus       214 n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l  293 (797)
                      |.++...+..+.. .++ .+.+++++|+++.+.++.|.++++|++|+|++|+|+.+.+..|.++++|+.+++.+  +..+
T Consensus       163 n~l~~i~~~~~~~-~~l-~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~--l~~l  238 (242)
T d1xwdc1         163 NGIQEIHNCAFNG-TQL-DELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN--LKKL  238 (242)
T ss_dssp             SCCCEECTTTTTT-CCE-EEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES--SSCS
T ss_pred             ccccccccccccc-hhh-hccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC--CCcC
Confidence            6666444443332 222 14456777788766677788888888888888888877777788888888877643  4455


Q ss_pred             C
Q 040702          294 P  294 (797)
Q Consensus       294 p  294 (797)
                      |
T Consensus       239 p  239 (242)
T d1xwdc1         239 P  239 (242)
T ss_dssp             C
T ss_pred             C
Confidence            5

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.84  E-value=2.3e-22  Score=194.89  Aligned_cols=159  Identities=18%  Similarity=0.195  Sum_probs=115.1

Q ss_pred             CccccccccCCcceeec----ceEEEEEEEEeccCC------------------cchhHHHHHHHhhhccCCceeEeeee
Q 040702          515 SENNLIGRGGFGPVYKD----GMEVAIKVFNLQYGG------------------AFKSFDIECGMMKRIRHRNLIKIISS  572 (797)
Q Consensus       515 ~~~~~lg~G~~g~Vyk~----~~~vAvK~~~~~~~~------------------~~~~~~~E~~~l~~l~Hpniv~l~~~  572 (797)
                      .++++||+|+||.||++    |+.||||+++.....                  ....+..|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            45789999999999985    689999987643110                  01234568888999999999988766


Q ss_pred             eecCCeEEEEEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHccCCCCeEEcCCCCCceEEcCCCcEEEEee
Q 040702          573 CSNDDFKALVLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFGYSVPIIHCDLKPSNVLLDDNMVAHLSDF  652 (797)
Q Consensus       573 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~~~~~ivHrDlkp~NIll~~~~~~kl~DF  652 (797)
                      ..    .++||||++++...+        ++...+..++.|+++|++|||   +++|+||||||+|||++++ .++|+||
T Consensus        83 ~~----~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~liDF  146 (191)
T d1zara2          83 EG----NAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIIDF  146 (191)
T ss_dssp             ET----TEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred             cC----CEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEEEC
Confidence            32    379999998765432        344456789999999999999   9999999999999999965 5899999


Q ss_pred             cCCccCCccCccccccccccCccccc--cc---ccccCccchHHHHHHHhhh
Q 040702          653 GMAKPLLEEDQSLTQTQTLATIGYMA--PD---EIFSGEMRLKCWVNDSLLI  699 (797)
Q Consensus       653 Gla~~~~~~~~~~~~~~~~gt~~y~a--PE---~~~~~~~~~~~dv~s~~~~  699 (797)
                      |.|+....+...          .|..  .+   .++...|..++|+|++...
T Consensus       147 G~a~~~~~~~~~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         147 PQSVEVGEEGWR----------EILERDVRNIITYFSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             TTCEETTSTTHH----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHH
T ss_pred             CCcccCCCCCcH----------HHHHHHHHHHHHHHcCCCCCcccHHHHHHH
Confidence            999754322110          1111  00   1234667888899988643

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.81  E-value=2e-20  Score=188.56  Aligned_cols=221  Identities=14%  Similarity=0.118  Sum_probs=174.7

Q ss_pred             CEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCC
Q 040702           24 QTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPN  103 (797)
Q Consensus        24 ~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~  103 (797)
                      ++++.+++.         ++++|+.+.  +++++|++++|+|+.+.+.+|.++++|++|+|++|.+...++...|.++++
T Consensus        11 ~~i~c~~~~---------l~~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~   79 (242)
T d1xwdc1          11 RVFLCQESK---------VTEIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK   79 (242)
T ss_dssp             SEEEEESCS---------CSSCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTT
T ss_pred             CEEEEeCCC---------CCCcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccc
Confidence            677888776         455666553  478999999999998888889999999999999999876788888889999


Q ss_pred             ccEEEccC-ccccccCCchhhCCCCCCEEEccCCcCcccCCc-cccCCCCCCeeeccCccCcCCCCCccccccCCCCC-C
Q 040702          104 LKELHLWG-NNFIGTIPSFIFNASKLSELGLQKNSFSGSIPN-TFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCK-Y  180 (797)
Q Consensus       104 L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~-~  180 (797)
                      +++|++.. |++....+..|.++++|++|++++|++....+. .+..++.+..+..+++.+..++..     .|.+++ .
T Consensus        80 l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~-----~~~~~~~~  154 (242)
T d1xwdc1          80 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERN-----SFVGLSFE  154 (242)
T ss_dssp             CCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTT-----SSTTSBSS
T ss_pred             cccccccccccccccccccccccccccccccchhhhccccccccccccccccccccccccccccccc-----cccccccc
Confidence            99998864 678878888899999999999999999865443 345567777778888888887765     355554 7


Q ss_pred             CcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEE
Q 040702          181 LEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLD  260 (797)
Q Consensus       181 L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  260 (797)
                      ++.|++++|+++.+.+..|.. +...+.+++++|+++...+..|.++++|  ++|++++|+|+.+.+..|.++++|+.++
T Consensus       155 l~~L~l~~n~l~~i~~~~~~~-~~l~~~~~l~~n~l~~l~~~~f~~l~~L--~~L~Ls~N~l~~l~~~~~~~l~~L~~l~  231 (242)
T d1xwdc1         155 SVILWLNKNGIQEIHNCAFNG-TQLDELNLSDNNNLEELPNDVFHGASGP--VILDISRTRIHSLPSYGLENLKKLRARS  231 (242)
T ss_dssp             CEEEECCSSCCCEECTTTTTT-CCEEEEECTTCTTCCCCCTTTTTTSCCC--SEEECTTSCCCCCCSSSCTTCCEEESSS
T ss_pred             ceeeecccccccccccccccc-hhhhccccccccccccccHHHhcCCCCC--CEEECCCCcCCccCHHHHcCCcccccCc
Confidence            888999999999777666654 3233444678888887666778889988  9999999999987777788888887776


Q ss_pred             ccC
Q 040702          261 LGG  263 (797)
Q Consensus       261 Ls~  263 (797)
                      +.+
T Consensus       232 ~~~  234 (242)
T d1xwdc1         232 TYN  234 (242)
T ss_dssp             EES
T ss_pred             CCC
Confidence            644

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.80  E-value=6.2e-20  Score=177.62  Aligned_cols=131  Identities=26%  Similarity=0.299  Sum_probs=83.6

Q ss_pred             CEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccC
Q 040702           56 EWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQK  135 (797)
Q Consensus        56 ~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~  135 (797)
                      +++++++|+++. +|..+.  +++++|+|++|+|++.++...|.++++|++|+|++|++....+..|..+++|++|+|++
T Consensus        11 ~~v~Cs~~~L~~-iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~   87 (192)
T d1w8aa_          11 TTVDCTGRGLKE-IPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE   87 (192)
T ss_dssp             TEEECTTSCCSS-CCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred             CEEEEeCCCcCc-cCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeecc
Confidence            355555555554 233331  45666666666665445566666666666666666666666666666666777777777


Q ss_pred             CcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCC
Q 040702          136 NSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGI  194 (797)
Q Consensus       136 N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~  194 (797)
                      |+|+.+.+++|.++++|++|+|++|+|+.++++     .|.++++|++|+|++|++...
T Consensus        88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~-----~f~~l~~L~~l~L~~N~~~~~  141 (192)
T d1w8aa_          88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPG-----SFEHLNSLTSLNLASNPFNCN  141 (192)
T ss_dssp             CCCCEECSSSSTTCTTCCEEECCSSCCCEECTT-----SSTTCTTCCEEECTTCCBCCS
T ss_pred             ccccccCHHHHhCCCcccccccCCccccccCHH-----HhcCCcccccccccccccccc
Confidence            777766666777777777777777777766665     366666677777777666543

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.80  E-value=2.6e-22  Score=222.31  Aligned_cols=381  Identities=18%  Similarity=0.132  Sum_probs=224.7

Q ss_pred             CCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccc----cCCccccCCCCCCEEEccCCcCcc----c
Q 040702           21 SSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVG----VVPTTIFNVSTLKSLYLHSNSLSG----R   92 (797)
Q Consensus        21 ~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~----~~p~~~~~l~~L~~L~Ls~N~l~~----~   92 (797)
                      .+|++||+|+|++++.-       +.+-+..++++++|+|++|+|+.    .+..++...++|++|||++|.|+.    .
T Consensus         2 ~~l~~ld~~~~~i~~~~-------~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~   74 (460)
T d1z7xw1           2 LDIQSLDIQCEELSDAR-------WAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHC   74 (460)
T ss_dssp             EEEEEEEEESCCCCHHH-------HHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHH
T ss_pred             CCCCEEEeeCCcCChHH-------HHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHH
Confidence            36889999999976431       12235567889999999999874    245567888999999999999862    1


Q ss_pred             CCCccccCCCCccEEEccCcccccc----CCchhhCCCCCCEEEccCCcCcccCCcccc-----CCCCCCeeeccCccCc
Q 040702           93 LPSSADVRLPNLKELHLWGNNFIGT----IPSFIFNASKLSELGLQKNSFSGSIPNTFG-----NLRNLKWLGLNDNYLT  163 (797)
Q Consensus        93 l~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~-----~l~~L~~L~L~~N~l~  163 (797)
                      +.........+|++|+|++|++++.    ++..+..+++|++|+|++|.|+......+.     ..............+.
T Consensus        75 l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~  154 (460)
T d1z7xw1          75 VLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLS  154 (460)
T ss_dssp             HHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCB
T ss_pred             HHHHHhcCCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccc
Confidence            2222222345799999999998753    345677788999999999988754333222     1112233333333322


Q ss_pred             CCCCCccccccCCCCCCCcEEEccCCCCCCCC----ChhhhccccCCcEEEccCCcccccCC----hhhhhhhhhHhhhc
Q 040702          164 SSTPELSSLSSLSNCKYLEYFSFSNNPLGGIL----PRAIGNLSQSMEDFWMDNCNISGSIP----EEINNLTNLILQLL  235 (797)
Q Consensus       164 ~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~~L~~L~L~~n~i~~~~p----~~~~~l~~L~L~~L  235 (797)
                      ..... .....+.....++.++++++.+....    ...+...+.....+.+..+.+.....    ..+...+.+  +.+
T Consensus       155 ~~~~~-~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~--~~l  231 (460)
T d1z7xw1         155 AASCE-PLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASL--REL  231 (460)
T ss_dssp             GGGHH-HHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTC--CEE
T ss_pred             hhhhc-ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccc--ccc
Confidence            11100 00112334566777888877654211    11122222245667777766542211    112223333  667


Q ss_pred             ccccccccC-----CCchhhcCCCCCcEEEccCCcCcccC----CCCccCCccccccccCCCCCCCC-----CCCC-CCC
Q 040702          236 SLEGNQLEG-----SIPDDLCRLAALFQLDLGGNKLSGFV----PACSGNLTNLRKLYLGSNLLTSI-----PSTL-WNL  300 (797)
Q Consensus       236 ~Ls~N~l~~-----~~~~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~l-----p~~~-~~l  300 (797)
                      ++++|.+..     .....+.....++.+++++|.+....    ...+...+.++.+++++|.++..     ...+ ...
T Consensus       232 ~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~  311 (460)
T d1z7xw1         232 ALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPG  311 (460)
T ss_dssp             ECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTT
T ss_pred             chhhccccccccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhccccccc
Confidence            777776542     12233344667888888888775332    12234566778888888877421     1111 123


Q ss_pred             CcccEEEccCCcCCCCCCccc----cccccccEEeccCcccccc----cCcccc-CCcccceecccCccccCC----CCh
Q 040702          301 KDILHLNLSSNFFTGPLPLKI----GNLNVLVQLDLSMNNFSCV----IPTKIG-GLKDLQYLFLEYNRLQGS----IPN  367 (797)
Q Consensus       301 ~~L~~L~l~~N~l~~~~~~~~----~~l~~L~~L~Ls~N~l~~~----~~~~~~-~l~~L~~L~Ls~N~l~~~----~p~  367 (797)
                      ..|+.+++++|.++......+    ....+|++|+|++|.++..    ++..+. ..+.|++|+|++|+++..    ++.
T Consensus       312 ~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~  391 (460)
T d1z7xw1         312 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAA  391 (460)
T ss_dssp             CCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred             cccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHH
Confidence            567888888887764433323    3345788888888887642    222232 356688888888887642    334


Q ss_pred             hhhccccCCeeeecCCcCCCCCChhhh-----ccCCCCeEEccCCcCcc
Q 040702          368 SIGDLISLKSLNLSNNNLSGTIPISLE-----KLLDLKDINVSFNRLEG  411 (797)
Q Consensus       368 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~l~~N~l~~  411 (797)
                      .+..+++|++|+|++|+|+......+.     +...|+.|++++|.+..
T Consensus       392 ~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~  440 (460)
T d1z7xw1         392 TLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE  440 (460)
T ss_dssp             HHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred             HHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCH
Confidence            456667888888888887653333332     23367788888777653

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.80  E-value=2e-20  Score=186.53  Aligned_cols=208  Identities=24%  Similarity=0.320  Sum_probs=125.6

Q ss_pred             CCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEE
Q 040702           52 LHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSEL  131 (797)
Q Consensus        52 l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  131 (797)
                      +.++..++++.+++++..  .+..+.+|+.|++++|.|+ .++.  +.++++|++|++++|++++..|  +..+++|+++
T Consensus        18 l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~-~l~~--l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l   90 (227)
T d1h6ua2          18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIEG--VQYLNNLIGLELKDNQITDLAP--LKNLTKITEL   90 (227)
T ss_dssp             HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEE
T ss_pred             HHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCC-cchh--HhcCCCCcEeecCCceeecccc--cccccccccc
Confidence            334444566666666543  3455667777777777776 5542  3467777777777777765433  6677777777


Q ss_pred             EccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEc
Q 040702          132 GLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWM  211 (797)
Q Consensus       132 ~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L  211 (797)
                      ++++|.++.+  ..|.++++|+++++++|......+       +...+.++.+.++++.+....  .+...+ +|+.|++
T Consensus        91 ~~~~n~~~~i--~~l~~l~~L~~l~l~~~~~~~~~~-------~~~~~~~~~l~~~~~~~~~~~--~~~~~~-~L~~L~l  158 (227)
T d1h6ua2          91 ELSGNPLKNV--SAIAGLQSIKTLDLTSTQITDVTP-------LAGLSNLQVLYLDLNQITNIS--PLAGLT-NLQYLSI  158 (227)
T ss_dssp             ECCSCCCSCC--GGGTTCTTCCEEECTTSCCCCCGG-------GTTCTTCCEEECCSSCCCCCG--GGGGCT-TCCEEEC
T ss_pred             cccccccccc--ccccccccccccccccccccccch-------hccccchhhhhchhhhhchhh--hhcccc-ccccccc
Confidence            7777777644  246677777777777776655432       445566666666666665332  233333 4444444


Q ss_pred             cCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCC
Q 040702          212 DNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLT  291 (797)
Q Consensus       212 ~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  291 (797)
                      ++                          |.+...  ..+..+++|++|+|++|+++++.  .++++++|++|+|++|+++
T Consensus       159 ~~--------------------------n~~~~~--~~l~~l~~L~~L~Ls~n~l~~l~--~l~~l~~L~~L~Ls~N~lt  208 (227)
T d1h6ua2         159 GN--------------------------AQVSDL--TPLANLSKLTTLKADDNKISDIS--PLASLPNLIEVHLKNNQIS  208 (227)
T ss_dssp             CS--------------------------SCCCCC--GGGTTCTTCCEEECCSSCCCCCG--GGGGCTTCCEEECTTSCCC
T ss_pred             cc--------------------------cccccc--hhhcccccceecccCCCccCCCh--hhcCCCCCCEEECcCCcCC
Confidence            44                          444322  22555666666666666666532  2566666777777777766


Q ss_pred             CCCCCCCCCCcccEEEcc
Q 040702          292 SIPSTLWNLKDILHLNLS  309 (797)
Q Consensus       292 ~lp~~~~~l~~L~~L~l~  309 (797)
                      ++++ +.++++|+.|+++
T Consensus       209 ~i~~-l~~l~~L~~L~ls  225 (227)
T d1h6ua2         209 DVSP-LANTSNLFIVTLT  225 (227)
T ss_dssp             BCGG-GTTCTTCCEEEEE
T ss_pred             CCcc-cccCCCCCEEEee
Confidence            6653 5566677777665

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.79  E-value=2.9e-19  Score=172.81  Aligned_cols=172  Identities=17%  Similarity=0.224  Sum_probs=139.2

Q ss_pred             CCEEEccCCcCcccCCCccccCCCCccEEEccCccccc-cCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeec
Q 040702           79 LKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIG-TIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGL  157 (797)
Q Consensus        79 L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L  157 (797)
                      .++++.++|+++ .+|..++   +++++|+|++|+|+. ..+..|.++++|++|+|++|++..+.+++|.++++|++|+|
T Consensus        10 ~~~v~Cs~~~L~-~iP~~lp---~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~L   85 (192)
T d1w8aa_          10 GTTVDCTGRGLK-EIPRDIP---LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQL   85 (192)
T ss_dssp             TTEEECTTSCCS-SCCSCCC---TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEEC
T ss_pred             CCEEEEeCCCcC-ccCCCCC---CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeee
Confidence            468999999999 9998775   789999999999976 44678899999999999999999999999999999999999


Q ss_pred             cCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhccc
Q 040702          158 NDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSL  237 (797)
Q Consensus       158 ~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~L  237 (797)
                      ++|+|+.++++     .|.++++|++|+|++|+|+++.+++|..++ +|++|+|++|.+....... .-...+  +.+.+
T Consensus        86 s~N~l~~l~~~-----~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~-~L~~l~L~~N~~~~~~~~~-~~~~~l--~~~~l  156 (192)
T d1w8aa_          86 GENKIKEISNK-----MFLGLHQLKTLNLYDNQISCVMPGSFEHLN-SLTSLNLASNPFNCNCHLA-WFAEWL--RKKSL  156 (192)
T ss_dssp             CSCCCCEECSS-----SSTTCTTCCEEECCSSCCCEECTTSSTTCT-TCCEEECTTCCBCCSGGGH-HHHHHH--HHHCC
T ss_pred             ccccccccCHH-----HHhCCCcccccccCCccccccCHHHhcCCc-ccccccccccccccccchH-HHhhhh--hhhcc
Confidence            99999999987     499999999999999999999999999998 8999999999987543321 112223  66666


Q ss_pred             ccccccCCCchhhcCCCCCcEEEccCCcC
Q 040702          238 EGNQLEGSIPDDLCRLAALFQLDLGGNKL  266 (797)
Q Consensus       238 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  266 (797)
                      ..|.++...|..+   ..++.++|+.|.+
T Consensus       157 ~~~~~~c~~p~~l---~~~~l~~L~~n~l  182 (192)
T d1w8aa_         157 NGGAARCGAPSKV---RDVQIKDLPHSEF  182 (192)
T ss_dssp             SGGGCBBCSSTTT---TTSBGGGSCTTTC
T ss_pred             cCCCeEeCCChhh---cCCEeeecCHhhC
Confidence            6666664444332   2333444555544

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.79  E-value=2.1e-19  Score=179.06  Aligned_cols=200  Identities=21%  Similarity=0.299  Sum_probs=110.2

Q ss_pred             CCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEE
Q 040702            4 LTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLY   83 (797)
Q Consensus         4 l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~   83 (797)
                      |+++.+.+.+  .+..+.+|++|++++|.+         +++ +++..+++|+.|++++|+++++.|  |.++++|+.|+
T Consensus        26 l~~~~~~d~~--~~~~l~~L~~L~l~~~~i---------~~l-~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~   91 (227)
T d1h6ua2          26 AGKSNVTDTV--TQADLDGITTLSAFGTGV---------TTI-EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELE   91 (227)
T ss_dssp             TTCSSTTSEE--CHHHHHTCCEEECTTSCC---------CCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEE
T ss_pred             hCCCCcCCcC--CHHHcCCcCEEECCCCCC---------Ccc-hhHhcCCCCcEeecCCceeecccc--ccccccccccc
Confidence            4444444433  245556666666666653         233 235566666666666666665433  56666666666


Q ss_pred             ccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCc
Q 040702           84 LHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLT  163 (797)
Q Consensus        84 Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~  163 (797)
                      +++|.++ .++.  +..+++|++|++++|...+.  ..+...+.++.+.++++.+...  ..+.++++|++|++++|.++
T Consensus        92 ~~~n~~~-~i~~--l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~  164 (227)
T d1h6ua2          92 LSGNPLK-NVSA--IAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVS  164 (227)
T ss_dssp             CCSCCCS-CCGG--GTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCC
T ss_pred             ccccccc-cccc--cccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccc
Confidence            6666665 4432  33566666666666655432  2345556666666666665532  23555566666666666555


Q ss_pred             CCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhccccccccc
Q 040702          164 SSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLE  243 (797)
Q Consensus       164 ~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~  243 (797)
                      ...+       +.++++|+.|+|++|+++++.  .++++                         ++|  ++|+|++|+++
T Consensus       165 ~~~~-------l~~l~~L~~L~Ls~n~l~~l~--~l~~l-------------------------~~L--~~L~Ls~N~lt  208 (227)
T d1h6ua2         165 DLTP-------LANLSKLTTLKADDNKISDIS--PLASL-------------------------PNL--IEVHLKNNQIS  208 (227)
T ss_dssp             CCGG-------GTTCTTCCEEECCSSCCCCCG--GGGGC-------------------------TTC--CEEECTTSCCC
T ss_pred             cchh-------hcccccceecccCCCccCCCh--hhcCC-------------------------CCC--CEEECcCCcCC
Confidence            4322       445556666666666655432  24444                         444  55555555555


Q ss_pred             CCCchhhcCCCCCcEEEcc
Q 040702          244 GSIPDDLCRLAALFQLDLG  262 (797)
Q Consensus       244 ~~~~~~~~~l~~L~~L~Ls  262 (797)
                      ++.  .+..+++|+.|+++
T Consensus       209 ~i~--~l~~l~~L~~L~ls  225 (227)
T d1h6ua2         209 DVS--PLANTSNLFIVTLT  225 (227)
T ss_dssp             BCG--GGTTCTTCCEEEEE
T ss_pred             CCc--ccccCCCCCEEEee
Confidence            432  25666777777765

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.78  E-value=6.9e-19  Score=171.22  Aligned_cols=175  Identities=23%  Similarity=0.368  Sum_probs=131.5

Q ss_pred             CCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEE
Q 040702            4 LTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLY   83 (797)
Q Consensus         4 l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~   83 (797)
                      ++.+.+++.+.  ...+.++++|++++|.++         ++ +++..+++|++|++++|+++++.|  +.++++|++|+
T Consensus        25 l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~---------~l-~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~   90 (199)
T d2omxa2          25 LGKTNVTDTVS--QTDLDQVTTLQADRLGIK---------SI-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDIL   90 (199)
T ss_dssp             TTCSSTTSEEC--HHHHTTCCEEECTTSCCC---------CC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred             hCCCCCCCccC--HHHhcCCCEEECCCCCCC---------Cc-cccccCCCcCcCccccccccCccc--ccCCccccccc
Confidence            45555555543  346788889999988843         33 247788889999999998887544  88888899999


Q ss_pred             ccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCc
Q 040702           84 LHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLT  163 (797)
Q Consensus        84 Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~  163 (797)
                      +++|.+. .++.  +.++++|++|++++|.+...  ..+..+++|+.|++++|++..+  ..|..+++|++|++++|+++
T Consensus        91 l~~n~~~-~~~~--l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~~--~~l~~~~~L~~L~l~~n~l~  163 (199)
T d2omxa2          91 MNNNQIA-DITP--LANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVT  163 (199)
T ss_dssp             CCSSCCC-CCGG--GTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCC
T ss_pred             ccccccc-cccc--cccccccccccccccccccc--cccchhhhhHHhhhhhhhhccc--cccccccccccccccccccc
Confidence            9988887 5553  56788888999888887643  4577888888888888888754  35888888888888888888


Q ss_pred             CCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEE
Q 040702          164 SSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDF  209 (797)
Q Consensus       164 ~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L  209 (797)
                      .+++       +.++++|++|++++|+++.+  +.+++++ +|+.|
T Consensus       164 ~l~~-------l~~l~~L~~L~ls~N~i~~i--~~l~~L~-~L~~L  199 (199)
T d2omxa2         164 DLKP-------LANLTTLERLDISSNKVSDI--SVLAKLT-NLESL  199 (199)
T ss_dssp             CCGG-------GTTCTTCCEEECCSSCCCCC--GGGGGCT-TCSEE
T ss_pred             CCcc-------ccCCCCCCEEECCCCCCCCC--ccccCCC-CCCcC
Confidence            7643       67788888888888888764  2466665 56654

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.76  E-value=2.5e-18  Score=168.72  Aligned_cols=165  Identities=22%  Similarity=0.302  Sum_probs=96.9

Q ss_pred             CCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccc
Q 040702           19 NPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSAD   98 (797)
Q Consensus        19 ~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~   98 (797)
                      .+.+|++|++++|.+++         ++ .+..+++|++|++++|+|+++.|  +.++++|++|++++|+|+ .+|.  +
T Consensus        44 ~L~~L~~L~l~~~~i~~---------l~-~l~~l~~L~~L~L~~n~i~~l~~--~~~l~~L~~L~l~~n~i~-~l~~--l  108 (210)
T d1h6ta2          44 ELNSIDQIIANNSDIKS---------VQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK-DLSS--L  108 (210)
T ss_dssp             HHHTCCEEECTTSCCCC---------CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CGGG--G
T ss_pred             HhcCccEEECcCCCCCC---------ch-hHhhCCCCCEEeCCCccccCccc--cccCcccccccccccccc-cccc--c
Confidence            35566666666666332         22 35556666666666666665432  456666666666666665 4442  3


Q ss_pred             cCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCC
Q 040702           99 VRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNC  178 (797)
Q Consensus        99 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l  178 (797)
                      ..+++|+.|++++|.+..  ...+..+++|+.+++++|.++..  ..+..+++|+++++++|+++++++       +.++
T Consensus       109 ~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~i~~-------l~~l  177 (210)
T d1h6ta2         109 KDLKKLKSLSLEHNGISD--INGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP-------LAGL  177 (210)
T ss_dssp             TTCTTCCEEECTTSCCCC--CGGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-------GTTC
T ss_pred             cccccccccccccccccc--ccccccccccccccccccccccc--cccccccccccccccccccccccc-------ccCC
Confidence            456666666666666542  23456666666666666666532  345566666666666666655432       4556


Q ss_pred             CCCcEEEccCCCCCCCCChhhhccccCCcEEEcc
Q 040702          179 KYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMD  212 (797)
Q Consensus       179 ~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~  212 (797)
                      ++|+.|+|++|+|+.+ + .+.+++ +|+.|+|+
T Consensus       178 ~~L~~L~Ls~N~i~~l-~-~l~~l~-~L~~L~Ls  208 (210)
T d1h6ta2         178 TKLQNLYLSKNHISDL-R-ALAGLK-NLDVLELF  208 (210)
T ss_dssp             TTCCEEECCSSCCCBC-G-GGTTCT-TCSEEEEE
T ss_pred             CCCCEEECCCCCCCCC-h-hhcCCC-CCCEEEcc
Confidence            6666666666666543 2 355555 56665554

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.74  E-value=9.4e-21  Score=209.63  Aligned_cols=378  Identities=19%  Similarity=0.162  Sum_probs=243.4

Q ss_pred             CCCEEEcccCcccccC-CccccCCCCCCEEEccCCcCcc----cCCCccccCCCCccEEEccCccccccCC----chhh-
Q 040702           54 NMEWMAFSFNKVVGVV-PTTIFNVSTLKSLYLHSNSLSG----RLPSSADVRLPNLKELHLWGNNFIGTIP----SFIF-  123 (797)
Q Consensus        54 ~L~~L~ls~N~i~~~~-p~~~~~l~~L~~L~Ls~N~l~~----~l~~~~~~~l~~L~~L~L~~N~l~~~~~----~~~~-  123 (797)
                      +|+.||+++|++++.. ...+..++++++|+|++|.|+.    .+.. ++..+++|++|||++|+|+....    ..+. 
T Consensus         3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~-~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~   81 (460)
T d1z7xw1           3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISS-ALRVNPALAELNLRSNELGDVGVHCVLQGLQT   81 (460)
T ss_dssp             EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHH-HHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHH-HHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence            6899999999998642 3445668999999999999972    1222 23578999999999999864322    2222 


Q ss_pred             CCCCCCEEEccCCcCccc----CCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCC---
Q 040702          124 NASKLSELGLQKNSFSGS----IPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILP---  196 (797)
Q Consensus       124 ~l~~L~~L~L~~N~l~~~----~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~---  196 (797)
                      ...+|++|+|++|+|+..    .+.++..+++|++|+|++|.|+........-.-................+.....   
T Consensus        82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  161 (460)
T d1z7xw1          82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL  161 (460)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred             CCCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccc
Confidence            235799999999999854    3567888999999999999987532211000001122234455555544432211   


Q ss_pred             -hhhhccccCCcEEEccCCcccccCChhhhh-hhh--hHhhhcccccccccCCC----chhhcCCCCCcEEEccCCcCcc
Q 040702          197 -RAIGNLSQSMEDFWMDNCNISGSIPEEINN-LTN--LILQLLSLEGNQLEGSI----PDDLCRLAALFQLDLGGNKLSG  268 (797)
Q Consensus       197 -~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~-l~~--L~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~Ls~N~l~~  268 (797)
                       ..+.... .++.++++++.+....-..+.. +..  .....+++..+.+....    ...+.....++.+++++|.+..
T Consensus       162 ~~~l~~~~-~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~  240 (460)
T d1z7xw1         162 ASVLRAKP-DFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGD  240 (460)
T ss_dssp             HHHHHHCT-TCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHH
T ss_pred             cccccccc-ccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccc
Confidence             1122233 6888888887765321111111 110  11244566666554221    1234557889999999998743


Q ss_pred             c-----CCCCccCCccccccccCCCCCCCCC-----CCCCCCCcccEEEccCCcCCCCCCccc-----cccccccEEecc
Q 040702          269 F-----VPACSGNLTNLRKLYLGSNLLTSIP-----STLWNLKDILHLNLSSNFFTGPLPLKI-----GNLNVLVQLDLS  333 (797)
Q Consensus       269 ~-----~~~~~~~l~~L~~L~L~~N~l~~lp-----~~~~~l~~L~~L~l~~N~l~~~~~~~~-----~~l~~L~~L~Ls  333 (797)
                      .     .+........++.+++++|.+...+     ..+...+.+..+++++|.++......+     .....|+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~  320 (460)
T d1z7xw1         241 VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVK  320 (460)
T ss_dssp             HHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECT
T ss_pred             cccchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccccc
Confidence            2     2233455678999999999986432     234457889999999999864222221     234579999999


Q ss_pred             CcccccccCc----cccCCcccceecccCccccCCC----Chhhh-ccccCCeeeecCCcCCCC----CChhhhccCCCC
Q 040702          334 MNNFSCVIPT----KIGGLKDLQYLFLEYNRLQGSI----PNSIG-DLISLKSLNLSNNNLSGT----IPISLEKLLDLK  400 (797)
Q Consensus       334 ~N~l~~~~~~----~~~~l~~L~~L~Ls~N~l~~~~----p~~~~-~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~  400 (797)
                      +|.++.....    .+....+|++|+|++|++++..    +..+. ..+.|++|+|++|.|+..    ++..+..+++|+
T Consensus       321 ~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~  400 (460)
T d1z7xw1         321 SCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLR  400 (460)
T ss_dssp             TSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCC
T ss_pred             ccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCC
Confidence            9998755333    3345678999999999987532    23333 456799999999999753    455677789999


Q ss_pred             eEEccCCcCcccCCC------CCCCCCCCcccccCCccc
Q 040702          401 DINVSFNRLEGEIPR------EGPFRNLSAESFKGNELL  433 (797)
Q Consensus       401 ~L~l~~N~l~~~~p~------~~~~~~l~~~~~~~n~~~  433 (797)
                      .|++++|+++.....      ......++.+.+.+|.+.
T Consensus       401 ~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~  439 (460)
T d1z7xw1         401 ELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWS  439 (460)
T ss_dssp             EEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCC
T ss_pred             EEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCC
Confidence            999999998743111      012224566666666553

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.74  E-value=3.5e-18  Score=167.59  Aligned_cols=180  Identities=26%  Similarity=0.377  Sum_probs=93.0

Q ss_pred             EEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCcc
Q 040702           82 LYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNY  161 (797)
Q Consensus        82 L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~  161 (797)
                      .+++++.+++.++.   ..+.+|++|++++|.++...  .+..+++|++|+|++|+|+++.+  ++++++|++|++++|+
T Consensus        29 ~~l~~~~~~~~~~~---~~L~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~L~~n~i~~l~~--~~~l~~L~~L~l~~n~  101 (210)
T d1h6ta2          29 DNLKKKSVTDAVTQ---NELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENK  101 (210)
T ss_dssp             HHTTCSCTTSEECH---HHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSC
T ss_pred             HHhCcCccCCccCH---HHhcCccEEECcCCCCCCch--hHhhCCCCCEEeCCCccccCccc--cccCcccccccccccc
Confidence            34555555533332   13456677777777666432  35666677777777777665432  5666667777776666


Q ss_pred             CcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhccccccc
Q 040702          162 LTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQ  241 (797)
Q Consensus       162 l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~  241 (797)
                      |+.++       .+.++++|+.|++++|.+..+  ..+..++ .++.+++++|.                          
T Consensus       102 i~~l~-------~l~~l~~L~~L~l~~~~~~~~--~~l~~l~-~l~~l~~~~n~--------------------------  145 (210)
T d1h6ta2         102 VKDLS-------SLKDLKKLKSLSLEHNGISDI--NGLVHLP-QLESLYLGNNK--------------------------  145 (210)
T ss_dssp             CCCGG-------GGTTCTTCCEEECTTSCCCCC--GGGGGCT-TCCEEECCSSC--------------------------
T ss_pred             ccccc-------ccccccccccccccccccccc--ccccccc-ccccccccccc--------------------------
Confidence            66543       255566666666666665432  2333333 34444333333                          


Q ss_pred             ccCCCchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEcc
Q 040702          242 LEGSIPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLS  309 (797)
Q Consensus       242 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~  309 (797)
                      +++  +..+..+++|+++++++|+++++.  .+.++++|+.|+|++|+|+++| .+.++++|++|+|+
T Consensus       146 l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~l~~l~~L~~L~Ls~N~i~~l~-~l~~l~~L~~L~Ls  208 (210)
T d1h6ta2         146 ITD--ITVLSRLTKLDTLSLEDNQISDIV--PLAGLTKLQNLYLSKNHISDLR-ALAGLKNLDVLELF  208 (210)
T ss_dssp             CCC--CGGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCBCG-GGTTCTTCSEEEEE
T ss_pred             ccc--cccccccccccccccccccccccc--cccCCCCCCEEECCCCCCCCCh-hhcCCCCCCEEEcc
Confidence            331  122334445555555555554332  1444555555555555554443 24444444444443

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.73  E-value=9.4e-18  Score=163.04  Aligned_cols=141  Identities=21%  Similarity=0.320  Sum_probs=75.1

Q ss_pred             EEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCC
Q 040702           57 WMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKN  136 (797)
Q Consensus        57 ~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N  136 (797)
                      .+.++.+++++..+  ...+.++++|++++|.|+ .++.  +..+++|++|+|++|++++..|  +.++++|++|++++|
T Consensus        22 ~~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~-~l~~--l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n   94 (199)
T d2omxa2          22 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDG--VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNN   94 (199)
T ss_dssp             HHHTTCSSTTSEEC--HHHHTTCCEEECTTSCCC-CCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred             HHHhCCCCCCCccC--HHHhcCCCEEECCCCCCC-Cccc--cccCCCcCcCccccccccCccc--ccCCccccccccccc
Confidence            33455555554332  234556666666666665 4432  2345666666666666654322  566666666666666


Q ss_pred             cCcccCCccccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCCChhhhccccCCcEEEccCCcc
Q 040702          137 SFSGSIPNTFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGILPRAIGNLSQSMEDFWMDNCNI  216 (797)
Q Consensus       137 ~l~~~~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~~L~~L~L~~n~i  216 (797)
                      .+..+.  .|.++++|+.|++++|.+....+       +..+++|+.|++++|++..+  ..+..++ +++.|++.+|++
T Consensus        95 ~~~~~~--~l~~l~~L~~L~l~~~~~~~~~~-------~~~l~~L~~L~l~~n~l~~~--~~l~~~~-~L~~L~l~~n~l  162 (199)
T d2omxa2          95 QIADIT--PLANLTNLTGLTLFNNQITDIDP-------LKNLTNLNRLELSSNTISDI--SALSGLT-SLQQLNFSSNQV  162 (199)
T ss_dssp             CCCCCG--GGTTCTTCSEEECCSSCCCCCGG-------GTTCTTCSEEECCSSCCCCC--GGGTTCT-TCSEEECCSSCC
T ss_pred             cccccc--ccccccccccccccccccccccc-------cchhhhhHHhhhhhhhhccc--ccccccc-cccccccccccc
Confidence            665432  25666666666666666554432       44555666666666665532  2243333 344444444433

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.65  E-value=7.8e-17  Score=150.27  Aligned_cols=129  Identities=20%  Similarity=0.208  Sum_probs=67.5

Q ss_pred             CCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCC
Q 040702           16 QLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPS   95 (797)
Q Consensus        16 ~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~   95 (797)
                      +|.++..+++|||++|+         ++.||..+..+++|++|+|++|+|+.+  +.|..+++|++|+|++|+|+ .++.
T Consensus        13 ~~~n~~~lr~L~L~~n~---------I~~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~-~l~~   80 (162)
T d1a9na_          13 QYTNAVRDRELDLRGYK---------IPVIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRIC-RIGE   80 (162)
T ss_dssp             EEECTTSCEEEECTTSC---------CCSCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCC-EECS
T ss_pred             hccCcCcCcEEECCCCC---------CCccCccccccccCCEEECCCCCCCcc--CCcccCcchhhhhccccccc-CCCc
Confidence            35566666666666666         233343345555666666666666554  23555566666666666665 5555


Q ss_pred             ccccCCCCccEEEccCccccccCC-chhhCCCCCCEEEccCCcCcccC---CccccCCCCCCeee
Q 040702           96 SADVRLPNLKELHLWGNNFIGTIP-SFIFNASKLSELGLQKNSFSGSI---PNTFGNLRNLKWLG  156 (797)
Q Consensus        96 ~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~---~~~f~~l~~L~~L~  156 (797)
                      ..+..+++|++|+|++|+|+.... ..+..+++|++|++++|.++...   +..+..+++|++||
T Consensus        81 ~~~~~l~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD  145 (162)
T d1a9na_          81 GLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD  145 (162)
T ss_dssp             CHHHHCTTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred             cccccccccccceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence            555455555555555555543211 23445555555555555554322   12344444555444

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.60  E-value=4.7e-16  Score=144.88  Aligned_cols=129  Identities=17%  Similarity=0.118  Sum_probs=61.6

Q ss_pred             ccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCCccccCCCCC
Q 040702           73 IFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNL  152 (797)
Q Consensus        73 ~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L  152 (797)
                      |.+..++++|+|++|+|+ .+|. .+..+++|++|+|++|+|+..  +.|..+++|++|+|++|+|+.+.++.|.++++|
T Consensus        14 ~~n~~~lr~L~L~~n~I~-~i~~-~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L   89 (162)
T d1a9na_          14 YTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   89 (162)
T ss_dssp             EECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             ccCcCcCcEEECCCCCCC-ccCc-cccccccCCEEECCCCCCCcc--CCcccCcchhhhhcccccccCCCcccccccccc
Confidence            344444555555555554 4432 233445555555555555432  124445555555555555555444445555555


Q ss_pred             CeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCCC---ChhhhccccCCcEEE
Q 040702          153 KWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGIL---PRAIGNLSQSMEDFW  210 (797)
Q Consensus       153 ~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~~---~~~~~~l~~~L~~L~  210 (797)
                      ++|+|++|+|++++.    +..+..+++|++|++++|+++...   +..+..+| +|+.|+
T Consensus        90 ~~L~L~~N~i~~~~~----l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp-~L~~LD  145 (162)
T d1a9na_          90 TELILTNNSLVELGD----LDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVP-QVRVLD  145 (162)
T ss_dssp             CEEECCSCCCCCGGG----GGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCT-TCSEET
T ss_pred             ccceecccccccccc----ccccccccccchhhcCCCccccccchHHHHHHHCC-CcCeeC
Confidence            555555555544321    112444555555555555554332   12344554 555554

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.60  E-value=1.9e-15  Score=133.83  Aligned_cols=87  Identities=24%  Similarity=0.375  Sum_probs=41.4

Q ss_pred             ccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCccccccCC-chhhCCCC
Q 040702           49 IDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGTIP-SFIFNASK  127 (797)
Q Consensus        49 ~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~  127 (797)
                      +..+++|++|++++|+|++ +|..|+.+++|+.|++++|.|+ .+|.  +..+++|++|++++|+|+.... ..+..+++
T Consensus        16 l~~l~~L~~L~ls~N~l~~-lp~~~~~l~~L~~L~l~~N~i~-~l~~--~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~   91 (124)
T d1dcea3          16 LEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NVDG--VANLPRLQELLLCNNRLQQSAAIQPLVSCPR   91 (124)
T ss_dssp             GGGGTTCCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCC-CCGG--GTTCSSCCEEECCSSCCCSSSTTGGGGGCTT
T ss_pred             cccCCCCCEEECCCCccCc-chhhhhhhhccccccccccccc-ccCc--cccccccCeEECCCCccCCCCCchhhcCCCC
Confidence            4455555555555555543 3444555555555555555554 3332  3344555555555555443221 23444444


Q ss_pred             CCEEEccCCcCc
Q 040702          128 LSELGLQKNSFS  139 (797)
Q Consensus       128 L~~L~L~~N~l~  139 (797)
                      |++|++++|+|+
T Consensus        92 L~~L~l~~N~i~  103 (124)
T d1dcea3          92 LVLLNLQGNSLC  103 (124)
T ss_dssp             CCEEECTTSGGG
T ss_pred             CCEEECCCCcCC
Confidence            444444444443

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.55  E-value=5.4e-15  Score=130.77  Aligned_cols=117  Identities=24%  Similarity=0.242  Sum_probs=97.4

Q ss_pred             CCCCCCCCccccCCcCCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCC
Q 040702            1 MPSLTNDFLRGIILSQLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLK   80 (797)
Q Consensus         1 ~~~l~~~~~~~~~~~~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~   80 (797)
                      ++||++|.|+...  .++.+++|++||||+|+         ++++|..++.+++|++|++++|+|+++ | .|.++++|+
T Consensus         2 ~L~Ls~n~l~~l~--~l~~l~~L~~L~ls~N~---------l~~lp~~~~~l~~L~~L~l~~N~i~~l-~-~~~~l~~L~   68 (124)
T d1dcea3           2 VLHLAHKDLTVLC--HLEQLLLVTHLDLSHNR---------LRALPPALAALRCLEVLQASDNALENV-D-GVANLPRLQ   68 (124)
T ss_dssp             EEECTTSCCSSCC--CGGGGTTCCEEECCSSC---------CCCCCGGGGGCTTCCEEECCSSCCCCC-G-GGTTCSSCC
T ss_pred             EEEcCCCCCCCCc--ccccCCCCCEEECCCCc---------cCcchhhhhhhhccccccccccccccc-C-ccccccccC
Confidence            3799999998553  49999999999999999         556788899999999999999999975 4 599999999


Q ss_pred             EEEccCCcCcccCCC-ccccCCCCccEEEccCccccccC---CchhhCCCCCCEE
Q 040702           81 SLYLHSNSLSGRLPS-SADVRLPNLKELHLWGNNFIGTI---PSFIFNASKLSEL  131 (797)
Q Consensus        81 ~L~Ls~N~l~~~l~~-~~~~~l~~L~~L~L~~N~l~~~~---~~~~~~l~~L~~L  131 (797)
                      +|++++|+|+ .+|. ..+..+++|++|++++|+++...   ...+..+++|+.|
T Consensus        69 ~L~l~~N~i~-~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L  122 (124)
T d1dcea3          69 ELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI  122 (124)
T ss_dssp             EEECCSSCCC-SSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred             eEECCCCccC-CCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence            9999999998 6664 55678999999999999997432   2334456777665

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.51  E-value=1.4e-15  Score=156.17  Aligned_cols=127  Identities=16%  Similarity=0.100  Sum_probs=74.1

Q ss_pred             CEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCC
Q 040702           24 QTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPN  103 (797)
Q Consensus        24 ~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~  103 (797)
                      ++|||+++.+.+.+...+       +.  .....+.++...+..... ......+|++|||+++.++.......+.++++
T Consensus         3 ~~lDLs~~~l~~~~l~~l-------~~--~~~~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~   72 (284)
T d2astb2           3 QTLDLTGKNLHPDVTGRL-------LS--QGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSK   72 (284)
T ss_dssp             SEEECTTCBCCHHHHHHH-------HH--TTCSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCC
T ss_pred             CEEECCCCCCCchHHHHH-------Hh--ccceEeeccccccccchh-hhccCCCCCEEECCCCccCHHHHHHHHHhCCC
Confidence            578888876432211111       11  134566666666554322 23344577888888777763323344567777


Q ss_pred             ccEEEccCccccccCCchhhCCCCCCEEEccCC-cCcccC-CccccCCCCCCeeeccCc
Q 040702          104 LKELHLWGNNFIGTIPSFIFNASKLSELGLQKN-SFSGSI-PNTFGNLRNLKWLGLNDN  160 (797)
Q Consensus       104 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N-~l~~~~-~~~f~~l~~L~~L~L~~N  160 (797)
                      |++|+|++|.+++..+..+..+++|++|+|+++ .++... ...+.++++|++|+++++
T Consensus        73 L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c  131 (284)
T d2astb2          73 LQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWC  131 (284)
T ss_dssp             CSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCC
T ss_pred             cccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccc
Confidence            777777777777666667777777777777774 454221 122345667777777664

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.50  E-value=1.7e-15  Score=160.40  Aligned_cols=205  Identities=18%  Similarity=0.241  Sum_probs=99.6

Q ss_pred             chhhCCCCCCEEEccCCcCccc----CCccccCCCCCCeeeccCccCcCCCCCc----c-ccccCCCCCCCcEEEccCCC
Q 040702          120 SFIFNASKLSELGLQKNSFSGS----IPNTFGNLRNLKWLGLNDNYLTSSTPEL----S-SLSSLSNCKYLEYFSFSNNP  190 (797)
Q Consensus       120 ~~~~~l~~L~~L~L~~N~l~~~----~~~~f~~l~~L~~L~L~~N~l~~~~~~~----~-~~~~l~~l~~L~~L~Ls~N~  190 (797)
                      ..+.....|++|+|++|.|...    ....+...++|+.|+++++.........    . -...+..+++|+.|+|++|.
T Consensus        25 ~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~  104 (344)
T d2ca6a1          25 AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNA  104 (344)
T ss_dssp             HHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCC
T ss_pred             HHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccc
Confidence            3444455555555555555422    1223445556666666655443322110    0 01224556677778888887


Q ss_pred             CCCCCCh----hhhccccCCcEEEccCCcccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccCCcC
Q 040702          191 LGGILPR----AIGNLSQSMEDFWMDNCNISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGNKL  266 (797)
Q Consensus       191 l~~~~~~----~~~~l~~~L~~L~L~~n~i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l  266 (797)
                      +......    .+...+ +|+.|++++|.+.......+..  .+  ..+...         ......+.|+.+++++|.+
T Consensus       105 i~~~~~~~l~~~l~~~~-~L~~L~l~~n~l~~~~~~~l~~--~l--~~~~~~---------~~~~~~~~L~~l~l~~n~i  170 (344)
T d2ca6a1         105 FGPTAQEPLIDFLSKHT-PLEHLYLHNNGLGPQAGAKIAR--AL--QELAVN---------KKAKNAPPLRSIICGRNRL  170 (344)
T ss_dssp             CCTTTHHHHHHHHHHCT-TCCEEECCSSCCHHHHHHHHHH--HH--HHHHHH---------HHHHTCCCCCEEECCSSCC
T ss_pred             cccccccchhhhhcccc-cchheecccccccccccccccc--cc--cccccc---------cccccCcccceeecccccc
Confidence            7654322    233444 6888888887765322222211  01  111111         1123455777888888877


Q ss_pred             cccCC----CCccCCccccccccCCCCCCC------CCCCCCCCCcccEEEccCCcCCCC----CCccccccccccEEec
Q 040702          267 SGFVP----ACSGNLTNLRKLYLGSNLLTS------IPSTLWNLKDILHLNLSSNFFTGP----LPLKIGNLNVLVQLDL  332 (797)
Q Consensus       267 ~~~~~----~~~~~l~~L~~L~L~~N~l~~------lp~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~L  332 (797)
                      +....    ..+...+.|+.|+|++|.++.      +...+...++|+.|++++|.++..    +...+...++|++|+|
T Consensus       171 ~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~L  250 (344)
T d2ca6a1         171 ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGL  250 (344)
T ss_dssp             TGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEEC
T ss_pred             cccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhh
Confidence            53211    123344566666666666542      122333445555555555555321    1122334445555555


Q ss_pred             cCcccc
Q 040702          333 SMNNFS  338 (797)
Q Consensus       333 s~N~l~  338 (797)
                      ++|.|+
T Consensus       251 s~n~i~  256 (344)
T d2ca6a1         251 NDCLLS  256 (344)
T ss_dssp             TTCCCC
T ss_pred             hcCccC
Confidence            555554

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.49  E-value=5.5e-16  Score=164.30  Aligned_cols=249  Identities=18%  Similarity=0.187  Sum_probs=119.1

Q ss_pred             CCCCCCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCccccc----------CCccccCCCCCCEEEcc
Q 040702           16 QLGNPSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGV----------VPTTIFNVSTLKSLYLH   85 (797)
Q Consensus        16 ~~~~l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~----------~p~~~~~l~~L~~L~Ls   85 (797)
                      ++...++|+.|+|++|++...    -...+-+.+...++|+.|+++++.....          +...+...++|+.|+|+
T Consensus        26 ~L~~~~~l~~L~Ls~n~i~~~----~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~  101 (344)
T d2ca6a1          26 VLLEDDSVKEIVLSGNTIGTE----AARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS  101 (344)
T ss_dssp             HHHHCSCCCEEECTTSEECHH----HHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred             HHhhCCCCCEEECcCCcCCHH----HHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccc
Confidence            345566677777776653211    1122223455566666666665543321          12234445666666666


Q ss_pred             CCcCccc----CCCccccCCCCccEEEccCccccccCCch-------------hhCCCCCCEEEccCCcCcccC----Cc
Q 040702           86 SNSLSGR----LPSSADVRLPNLKELHLWGNNFIGTIPSF-------------IFNASKLSELGLQKNSFSGSI----PN  144 (797)
Q Consensus        86 ~N~l~~~----l~~~~~~~l~~L~~L~L~~N~l~~~~~~~-------------~~~l~~L~~L~L~~N~l~~~~----~~  144 (797)
                      +|.++..    +.. .+...++|++|++++|.+.......             ....+.|+.|.+++|+++...    ..
T Consensus       102 ~n~i~~~~~~~l~~-~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~  180 (344)
T d2ca6a1         102 DNAFGPTAQEPLID-FLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK  180 (344)
T ss_dssp             SCCCCTTTHHHHHH-HHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHH
T ss_pred             ccccccccccchhh-hhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccc
Confidence            6666521    111 1123566666666666653211111             123455666666666655221    22


Q ss_pred             cccCCCCCCeeeccCccCcCCCCCccccccCCCCCCCcEEEccCCCCCCC----CChhhhccccCCcEEEccCCcccccC
Q 040702          145 TFGNLRNLKWLGLNDNYLTSSTPELSSLSSLSNCKYLEYFSFSNNPLGGI----LPRAIGNLSQSMEDFWMDNCNISGSI  220 (797)
Q Consensus       145 ~f~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~~L~~L~L~~n~i~~~~  220 (797)
                      .+...+.|+.|+|++|.|+.......-...+..+++|+.|+|++|.++..    +...+...+ +|+.|++++|.|+...
T Consensus       181 ~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~-~L~~L~Ls~n~i~~~g  259 (344)
T d2ca6a1         181 TFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWP-NLRELGLNDCLLSARG  259 (344)
T ss_dssp             HHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCT-TCCEEECTTCCCCHHH
T ss_pred             hhhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccc-cchhhhhhcCccCchh
Confidence            33445566666666666543110000001244555666666666665422    112233333 4555555555554322


Q ss_pred             ChhhhhhhhhHhhhcccccccccCCCchhhc--CCCCCcEEEccCCcCcccCC----CCc-cCCccccccccCCCCCCC
Q 040702          221 PEEINNLTNLILQLLSLEGNQLEGSIPDDLC--RLAALFQLDLGGNKLSGFVP----ACS-GNLTNLRKLYLGSNLLTS  292 (797)
Q Consensus       221 p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~--~l~~L~~L~Ls~N~l~~~~~----~~~-~~l~~L~~L~L~~N~l~~  292 (797)
                      ...+.                      ..+.  ....|++|++++|+|+....    ..+ .+.++|+.|+|++|.+..
T Consensus       260 ~~~l~----------------------~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~  316 (344)
T d2ca6a1         260 AAAVV----------------------DAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE  316 (344)
T ss_dssp             HHHHH----------------------HHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred             hHHHH----------------------HHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence            21111                      1121  12457777777777653211    112 135567777777777754

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.48  E-value=2.9e-16  Score=151.66  Aligned_cols=136  Identities=20%  Similarity=0.205  Sum_probs=103.7

Q ss_pred             CCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCcccc
Q 040702           20 PSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADV   99 (797)
Q Consensus        20 l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~   99 (797)
                      ...++.++++++.     |.  ++.+|..+..+++|++|+|++|+|+.+ + .|.++++|+.|+|++|+|+ .+|.. +.
T Consensus        22 ~~~~~~~~l~~~~-----~~--i~~l~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~-~i~~~-~~   90 (198)
T d1m9la_          22 ATEAEKVELHGMI-----PP--IEKMDATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIK-KIENL-DA   90 (198)
T ss_dssp             CTTCSCEECCBCC-----TT--CCCCHHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEEC-SCSSH-HH
T ss_pred             ccccceeeeeccc-----Cc--hhhhhhHHhcccccceeECcccCCCCc-c-cccCCccccChhhcccccc-ccccc-cc
Confidence            4455667776542     32  567778888899999999999999875 3 4888899999999999987 77643 33


Q ss_pred             CCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcCcccCC-ccccCCCCCCeeeccCccCcCCCCC
Q 040702          100 RLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSFSGSIP-NTFGNLRNLKWLGLNDNYLTSSTPE  168 (797)
Q Consensus       100 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~f~~l~~L~~L~L~~N~l~~~~~~  168 (797)
                      .+++|++|++++|+|+..  ..+..+++|++|+|++|+|+.+.. ..|..+++|++|+|++|++....+.
T Consensus        91 ~~~~L~~L~l~~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~  158 (198)
T d1m9la_          91 VADTLEELWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE  158 (198)
T ss_dssp             HHHHCCEEECSEEECCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCT
T ss_pred             cccccccccccccccccc--ccccccccccccccccchhccccccccccCCCccceeecCCCccccCccc
Confidence            456788999999988754  357788888999999988886543 5688888888888888888765543

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.48  E-value=4.3e-15  Score=152.43  Aligned_cols=256  Identities=16%  Similarity=0.170  Sum_probs=148.0

Q ss_pred             CEEEcccCcccccCCccccCCCCCCEEEccCCcCcccCCCccccCCCCccEEEccCcccccc-CCchhhCCCCCCEEEcc
Q 040702           56 EWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSADVRLPNLKELHLWGNNFIGT-IPSFIFNASKLSELGLQ  134 (797)
Q Consensus        56 ~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~l~~L~~L~L~  134 (797)
                      +.+||+++.+.......+.. ..+..+.+++..+. ......+ ...+|++|||++|.+++. ++..+..+++|++|+|+
T Consensus         3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~-~~~~~~~-~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~   79 (284)
T d2astb2           3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMD-QPLAEHF-SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLE   79 (284)
T ss_dssp             SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEEC-SCCCSCC-CCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECT
T ss_pred             CEEECCCCCCCchHHHHHHh-ccceEeeccccccc-cchhhhc-cCCCCCEEECCCCccCHHHHHHHHHhCCCccccccc
Confidence            47899988875322222211 24667778777765 3222222 567899999999988744 34557789999999999


Q ss_pred             CCcCcccCCccccCCCCCCeeeccCc-cCcCCCCCccccccCCCCCCCcEEEccCCC-CCCC-CChhhhccccCCcEEEc
Q 040702          135 KNSFSGSIPNTFGNLRNLKWLGLNDN-YLTSSTPELSSLSSLSNCKYLEYFSFSNNP-LGGI-LPRAIGNLSQSMEDFWM  211 (797)
Q Consensus       135 ~N~l~~~~~~~f~~l~~L~~L~L~~N-~l~~~~~~~~~~~~l~~l~~L~~L~Ls~N~-l~~~-~~~~~~~l~~~L~~L~L  211 (797)
                      +|.+....+..+..+++|++|+|+++ .++.....  .  -+.++++|++|+++++. ++.. ....+....++|+.|++
T Consensus        80 ~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~--~--l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l  155 (284)
T d2astb2          80 GLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQ--T--LLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNL  155 (284)
T ss_dssp             TCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHH--H--HHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEEC
T ss_pred             ccCCCcHHHHHHhcCCCCcCccccccccccccccc--h--hhHHHHhccccccccccccccccchhhhcccccccchhhh
Confidence            99998877888999999999999995 55532110  0  13467889999999863 4321 12334444457888888


Q ss_pred             cCCc--ccccCChhhhhhhhhHhhhcccccccccCCCchhhcCCCCCcEEEccCC-cCcccCCCCccCCccccccccCCC
Q 040702          212 DNCN--ISGSIPEEINNLTNLILQLLSLEGNQLEGSIPDDLCRLAALFQLDLGGN-KLSGFVPACSGNLTNLRKLYLGSN  288 (797)
Q Consensus       212 ~~n~--i~~~~p~~~~~l~~L~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~L~~N  288 (797)
                      +++.  ++..   .+                      ...+..+++|++|++++| .+++.....+..+++|++|+|+++
T Consensus       156 ~~~~~~i~~~---~l----------------------~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C  210 (284)
T d2astb2         156 SGYRKNLQKS---DL----------------------STLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRC  210 (284)
T ss_dssp             CSCGGGSCHH---HH----------------------HHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTC
T ss_pred             cccccccccc---cc----------------------cccccccccccccccccccCCCchhhhhhcccCcCCEEECCCC
Confidence            7642  2211   01                      011223455556666553 344444445555556666666653


Q ss_pred             -CCCC-CCCCCCCCCcccEEEccCCcCCCCCCcccccc-ccccEEeccCcccccccCccccC
Q 040702          289 -LLTS-IPSTLWNLKDILHLNLSSNFFTGPLPLKIGNL-NVLVQLDLSMNNFSCVIPTKIGG  347 (797)
Q Consensus       289 -~l~~-lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l-~~L~~L~Ls~N~l~~~~~~~~~~  347 (797)
                       .++. -...+..+++|+.|+++++ ++.   ..+..+ ..+..|.+..+.++.+.+..++.
T Consensus       211 ~~i~~~~l~~L~~~~~L~~L~l~~~-~~d---~~l~~l~~~lp~L~i~~~~ls~~~~~~~~~  268 (284)
T d2astb2         211 YDIIPETLLELGEIPTLKTLQVFGI-VPD---GTLQLLKEALPHLQINCSHFTTIARPTIGN  268 (284)
T ss_dssp             TTCCGGGGGGGGGCTTCCEEECTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred             CCCChHHHHHHhcCCCCCEEeeeCC-CCH---HHHHHHHHhCccccccCccCCCCCCCccCc
Confidence             3321 1223445666677776665 221   111111 12333445566666554444443

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.45  E-value=2.1e-13  Score=125.68  Aligned_cols=108  Identities=17%  Similarity=0.126  Sum_probs=54.1

Q ss_pred             CCCCCEEeCCCCCCCCcCCCccccCCCccccCCCCCCEEEcccC-cccccCCccccCCCCCCEEEccCCcCcccCCCccc
Q 040702           20 PSSLQTLYLSYNPPSGSIPSFILCEIPHEIDNLHNMEWMAFSFN-KVVGVVPTTIFNVSTLKSLYLHSNSLSGRLPSSAD   98 (797)
Q Consensus        20 l~~L~~LdLs~N~~~~~~p~~~l~~ip~~~~~l~~L~~L~ls~N-~i~~~~p~~~~~l~~L~~L~Ls~N~l~~~l~~~~~   98 (797)
                      ......++.+++.         +.++|..+..+++|+.|++++| .|+.+.+.+|.++++|+.|+|++|+|+ .++..+|
T Consensus         7 c~~~~~l~c~~~~---------~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~-~i~~~~f   76 (156)
T d2ifga3           7 PHGSSGLRCTRDG---------ALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAF   76 (156)
T ss_dssp             CSSSSCEECCSSC---------CCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCC-EECTTGG
T ss_pred             cCCCCeEEecCCC---------CccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccC-Ccccccc
Confidence            3344455555555         3334445555555555555433 355555555555555555555555554 4555555


Q ss_pred             cCCCCccEEEccCccccccCCchhhCCCCCCEEEccCCcC
Q 040702           99 VRLPNLKELHLWGNNFIGTIPSFIFNASKLSELGLQKNSF  138 (797)
Q Consensus        99 ~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l  138 (797)
                      ..+++|++|+|++|+|+.+.++.|.. .+|++|+|++|.+
T Consensus        77 ~~l~~L~~L~Ls~N~l~~l~~~~~~~-~~l~~L~L~~Np~  115 (156)
T d2ifga3          77 HFTPRLSRLNLSFNALESLSWKTVQG-LSLQELVLSGNPL  115 (156)
T ss_dssp             GSCSCCCEEECCSSCCSCCCSTTTCS-CCCCEEECCSSCC
T ss_pred             cccccccceeccCCCCcccChhhhcc-ccccccccCCCcc
Confidence            55555555555555555333333322 2455555555544

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.42  E-value=1.2e-13  Score=127.49  Aligned_cols=108  Identities=20%  Similarity=0.203  Sum_probs=76.3

Q ss_pred             CCCCEEEcccCcccccCCccccCCCCCCEEEccCC-cCcccCCCccccCCCCccEEEccCccccccCCchhhCCCCCCEE
Q 040702           53 HNMEWMAFSFNKVVGVVPTTIFNVSTLKSLYLHSN-SLSGRLPSSADVRLPNLKELHLWGNNFIGTIPSFIFNASKLSEL  131 (797)
Q Consensus        53 ~~L~~L~ls~N~i~~~~p~~~~~l~~L~~L~Ls~N-~l~~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  131 (797)
                      ...+.++++++++.. .|..+.++++|++|++++| .|+ .++...|.++++|++|+|++|+|+.+.+.+|..+++|++|
T Consensus         8 ~~~~~l~c~~~~~~~-~p~~l~~l~~l~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L   85 (156)
T d2ifga3           8 HGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQ-HLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL   85 (156)
T ss_dssp             SSSSCEECCSSCCCT-TTTTSCSCSCCSEEECCSCSSCC-EECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE
T ss_pred             CCCCeEEecCCCCcc-CcccccCccccCeeecCCCcccc-ccCchhhccccccCcceeeccccCCcccccccccccccce
Confidence            345567777777765 4666777777777777655 466 6777777777777777777777776667777777777777


Q ss_pred             EccCCcCcccCCccccCCCCCCeeeccCccCc
Q 040702          132 GLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLT  163 (797)
Q Consensus       132 ~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~  163 (797)
                      +|++|+|+.+.++.|..+ +|+.|+|++|.+.
T Consensus        86 ~Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~  116 (156)
T d2ifga3          86 NLSFNALESLSWKTVQGL-SLQELVLSGNPLH  116 (156)
T ss_dssp             ECCSSCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred             eccCCCCcccChhhhccc-cccccccCCCccc
Confidence            777777776666666655 5777777777664

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.38  E-value=4.7e-15  Score=143.02  Aligned_cols=114  Identities=27%  Similarity=0.248  Sum_probs=71.1

Q ss_pred             CchhhcCCCCCcEEEccCCcCcccCCCCccCCccccccccCCCCCCCCCCCCCCCCcccEEEccCCcCCCCCCccccccc
Q 040702          246 IPDDLCRLAALFQLDLGGNKLSGFVPACSGNLTNLRKLYLGSNLLTSIPSTLWNLKDILHLNLSSNFFTGPLPLKIGNLN  325 (797)
Q Consensus       246 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~lp~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~  325 (797)
                      .+.++..+++|++|+|++|+|+.+ + .+.++++|+.|+|++|.|+.+|.....+++|+.|++++|.++..  ..+..++
T Consensus        40 l~~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~  115 (198)
T d1m9la_          40 MDATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIASL--SGIEKLV  115 (198)
T ss_dssp             CHHHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEECSCSSHHHHHHHCCEEECSEEECCCH--HHHHHHH
T ss_pred             hhhHHhcccccceeECcccCCCCc-c-cccCCccccChhhccccccccccccccccccccccccccccccc--ccccccc
Confidence            445666677777777777777654 2 46667777777777777776665444455666777777766642  2355666


Q ss_pred             cccEEeccCcccccccC-ccccCCcccceecccCccccC
Q 040702          326 VLVQLDLSMNNFSCVIP-TKIGGLKDLQYLFLEYNRLQG  363 (797)
Q Consensus       326 ~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~l~~  363 (797)
                      +|+.|++++|+|+.... ..+..+++|+.|+|++|++..
T Consensus       116 ~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~  154 (198)
T d1m9la_         116 NLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN  154 (198)
T ss_dssp             HSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred             cccccccccchhccccccccccCCCccceeecCCCcccc
Confidence            66666666666654322 345666666666666666543

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.70  E-value=5.5e-10  Score=103.08  Aligned_cols=65  Identities=25%  Similarity=0.212  Sum_probs=31.0

Q ss_pred             CCCccEEEccCccccccC--CchhhCCCCCCEEEccCCcCcccCCccccCCCCCCeeeccCccCcCC
Q 040702          101 LPNLKELHLWGNNFIGTI--PSFIFNASKLSELGLQKNSFSGSIPNTFGNLRNLKWLGLNDNYLTSS  165 (797)
Q Consensus       101 l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~f~~l~~L~~L~L~~N~l~~~  165 (797)
                      +++|++|+|++|+|+...  +..+..+++|+.|+|++|+|+.+.+-.+.+..+|+.|+|++|.++..
T Consensus        64 ~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~  130 (162)
T d1koha1          64 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDT  130 (162)
T ss_dssp             CTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSS
T ss_pred             CCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcC
Confidence            444444444444444221  23344455555555555555544443333444555555555555543

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.51  E-value=2.9e-09  Score=98.06  Aligned_cols=65  Identities=26%  Similarity=0.231  Sum_probs=28.4

Q ss_pred             cccccEEeccCccccccc--CccccCCcccceecccCccccCCCChhhhccccCCeeeecCCcCCCC
Q 040702          324 LNVLVQLDLSMNNFSCVI--PTKIGGLKDLQYLFLEYNRLQGSIPNSIGDLISLKSLNLSNNNLSGT  388 (797)
Q Consensus       324 l~~L~~L~Ls~N~l~~~~--~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~  388 (797)
                      ++.|++|+|++|+|+.+.  +..+..+++|+.|+|++|+++...+-.+....+|+.|++++|.++..
T Consensus        64 ~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~  130 (162)
T d1koha1          64 IPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDT  130 (162)
T ss_dssp             CTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSS
T ss_pred             CCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcC
Confidence            344444444444444321  22334445555555555555433222222333455555555555443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.45  E-value=4.3e-07  Score=90.43  Aligned_cols=146  Identities=18%  Similarity=0.177  Sum_probs=104.5

Q ss_pred             HHHHHhcCCCccccccccCCcceee---cceEEEEEEEEeccCCcchhHHHHHHHhhhcc-CCceeEeeeeeecCCeEEE
Q 040702          506 ELFQATNRFSENNLIGRGGFGPVYK---DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIR-HRNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       506 ~l~~~~~~f~~~~~lg~G~~g~Vyk---~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~l  581 (797)
                      ++...-+.|...+..+-++.+.||+   +++.+++|+...........+.+|...+..+. +--+.++++++..++..++
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l   87 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence            4555556676655544444567897   35778899887666555667889999988774 4446788888888899999


Q ss_pred             EEEccCCCCHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHcc-------------------------------------
Q 040702          582 VLEYMPLGSLEKCLYSGNYILDIFQGLNIMIDVASALEYLHFG-------------------------------------  624 (797)
Q Consensus       582 v~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~~-------------------------------------  624 (797)
                      ||++++|.++.+......      ....++.++++.++.||..                                     
T Consensus        88 v~~~l~G~~~~~~~~~~~------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (263)
T d1j7la_          88 LMSEADGVLCSEEYEDEQ------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED  161 (263)
T ss_dssp             EEECCSSEEHHHHTTTCS------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred             EEEecccccccccccccc------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccc
Confidence            999999988866543221      2334566677777777731                                     


Q ss_pred             -------------------CCCCeEEcCCCCCceEEcCCCcEEEEeecCCcc
Q 040702          625 -------------------YSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  657 (797)
Q Consensus       625 -------------------~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  657 (797)
                                         ....++|+|+.|.||++++++.+-|+||+.+..
T Consensus       162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                               012378999999999999876677999998873

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.75  E-value=2.1e-05  Score=77.34  Aligned_cols=126  Identities=16%  Similarity=0.148  Sum_probs=83.3

Q ss_pred             cccccCC-cceee----cceEEEEEEEEeccCCcchhHHHHHHHhhhccC--CceeEeeeeeecCCeEEEEEEccCCCCH
Q 040702          519 LIGRGGF-GPVYK----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRH--RNLIKIISSCSNDDFKALVLEYMPLGSL  591 (797)
Q Consensus       519 ~lg~G~~-g~Vyk----~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~H--pniv~l~~~~~~~~~~~lv~e~~~~g~L  591 (797)
                      .+..|.. +.||+    ++..+++|.....   ....+..|...++.+..  -.+.+++++..+++..++||||++|.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4455543 56886    4567888876533   23567889988887753  3367788888888899999999988654


Q ss_pred             HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHc------------------------------------------------
Q 040702          592 EKCLYSGNYILDIFQGLNIMIDVASALEYLHF------------------------------------------------  623 (797)
Q Consensus       592 ~~~l~~~~~~l~~~~~~~i~~qi~~al~yLH~------------------------------------------------  623 (797)
                      .+.      ....   ...+.++++.++-||.                                                
T Consensus        94 ~~~------~~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (255)
T d1nd4a_          94 LSS------HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR  164 (255)
T ss_dssp             TTS------CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred             ccc------cccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence            321      0111   1122334444444441                                                


Q ss_pred             -------cCCCCeEEcCCCCCceEEcCCCcEEEEeecCCc
Q 040702          624 -------GYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAK  656 (797)
Q Consensus       624 -------~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~  656 (797)
                             .....++|+|+.|.|||++++..+-|+||+.+.
T Consensus       165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                   012247999999999999987667899999886

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.66  E-value=4.6e-06  Score=76.41  Aligned_cols=61  Identities=13%  Similarity=0.097  Sum_probs=30.7

Q ss_pred             CCCccEEEccCccccccC----CchhhCCCCCCEEEccCCcCccc-------CCccccCCCCCCeeeccCcc
Q 040702          101 LPNLKELHLWGNNFIGTI----PSFIFNASKLSELGLQKNSFSGS-------IPNTFGNLRNLKWLGLNDNY  161 (797)
Q Consensus       101 l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~-------~~~~f~~l~~L~~L~L~~N~  161 (797)
                      .+.|++|+|++|.|+...    -.++...+.|++|+|++|++..+       +..++..-+.|+.|+++.+.
T Consensus        71 n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~  142 (167)
T d1pgva_          71 SPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS  142 (167)
T ss_dssp             CSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred             cccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence            345555555555554321    12334445566666666654432       12334445566666665543

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.58  E-value=1.4e-05  Score=73.03  Aligned_cols=92  Identities=8%  Similarity=0.089  Sum_probs=57.4

Q ss_pred             CCCCccEEEccCcccccc----CCchhhCCCCCCEEEccCCcCcccC----CccccCCCCCCeeeccCccCcCCCCCc-c
Q 040702          100 RLPNLKELHLWGNNFIGT----IPSFIFNASKLSELGLQKNSFSGSI----PNTFGNLRNLKWLGLNDNYLTSSTPEL-S  170 (797)
Q Consensus       100 ~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~~----~~~f~~l~~L~~L~L~~N~l~~~~~~~-~  170 (797)
                      ..+.|++|+|++|.+...    +...+...+.|++|+|++|.|+...    ..++..-+.|++|+|++|.+..+..+. .
T Consensus        42 ~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~  121 (167)
T d1pgva_          42 NSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEM  121 (167)
T ss_dssp             TCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHH
T ss_pred             hCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHH
Confidence            445666777776666532    2234555678888888888887432    234566677888888888776554221 0


Q ss_pred             c-cccCCCCCCCcEEEccCCCC
Q 040702          171 S-LSSLSNCKYLEYFSFSNNPL  191 (797)
Q Consensus       171 ~-~~~l~~l~~L~~L~Ls~N~l  191 (797)
                      . ...+...+.|+.|+++++..
T Consensus       122 ~l~~~L~~n~sL~~l~l~~~~~  143 (167)
T d1pgva_         122 DMMMAIEENESLLRVGISFASM  143 (167)
T ss_dssp             HHHHHHHHCSSCCEEECCCCCH
T ss_pred             HHHHHHHhCCCccEeeCcCCCc
Confidence            0 11244567788888877643

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.14  E-value=0.00041  Score=72.41  Aligned_cols=72  Identities=18%  Similarity=0.181  Sum_probs=47.6

Q ss_pred             cccccccCCcceee-----cceEEEEEEEEecc-------CCcchhHHHHHHHhhhcc-C--CceeEeeeeeecCCeEEE
Q 040702          517 NNLIGRGGFGPVYK-----DGMEVAIKVFNLQY-------GGAFKSFDIECGMMKRIR-H--RNLIKIISSCSNDDFKAL  581 (797)
Q Consensus       517 ~~~lg~G~~g~Vyk-----~~~~vAvK~~~~~~-------~~~~~~~~~E~~~l~~l~-H--pniv~l~~~~~~~~~~~l  581 (797)
                      .+.||.|....||+     +++.|+||.-....       ....++...|.+.++.+. +  ..+++++.+  +++..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            35789999999997     35689999764321       112345667888887763 2  356666655  4455679


Q ss_pred             EEEccCCCC
Q 040702          582 VLEYMPLGS  590 (797)
Q Consensus       582 v~e~~~~g~  590 (797)
                      |||++++..
T Consensus       109 vmE~L~~~~  117 (392)
T d2pula1         109 VMEDLSHLK  117 (392)
T ss_dssp             EECCCTTSE
T ss_pred             EEeccCCcc
Confidence            999997643

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.89  E-value=8.6e-05  Score=67.52  Aligned_cols=61  Identities=21%  Similarity=0.243  Sum_probs=28.8

Q ss_pred             CCCccEEEccCcccccc----CCchhhCCCCCCEEEc--cCCcCcc----cCCccccCCCCCCeeeccCcc
Q 040702          101 LPNLKELHLWGNNFIGT----IPSFIFNASKLSELGL--QKNSFSG----SIPNTFGNLRNLKWLGLNDNY  161 (797)
Q Consensus       101 l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~L--~~N~l~~----~~~~~f~~l~~L~~L~L~~N~  161 (797)
                      .+.++.|++++|.+...    +...+...++|+.++|  ++|.+..    .+..++...++|+.|+++.+.
T Consensus        73 ~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~  143 (166)
T d1io0a_          73 NNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ  143 (166)
T ss_dssp             CSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred             cccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCC
Confidence            34555555555554321    1233444555555443  3444442    123344455666666665543

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.70  E-value=0.00018  Score=65.26  Aligned_cols=86  Identities=19%  Similarity=0.189  Sum_probs=44.7

Q ss_pred             ccccccEEeccCcccccc----cCccccCCcccceecccCccccCC----CChhhhccccCCeeee--cCCcCCC----C
Q 040702          323 NLNVLVQLDLSMNNFSCV----IPTKIGGLKDLQYLFLEYNRLQGS----IPNSIGDLISLKSLNL--SNNNLSG----T  388 (797)
Q Consensus       323 ~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L--s~N~l~~----~  388 (797)
                      ..+.|++|++++|.++..    +...+...++++.+++++|.+...    +-..+...++|+.++|  ++|.+..    .
T Consensus        44 ~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~  123 (166)
T d1io0a_          44 TNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEME  123 (166)
T ss_dssp             TCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHH
T ss_pred             cCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHH
Confidence            445555666666555432    112333445666666666665432    2234455566665333  4555543    2


Q ss_pred             CChhhhccCCCCeEEccCCc
Q 040702          389 IPISLEKLLDLKDINVSFNR  408 (797)
Q Consensus       389 ~p~~~~~l~~L~~L~l~~N~  408 (797)
                      +...+...++|+.|+++.|.
T Consensus       124 La~~L~~n~~L~~L~l~~~~  143 (166)
T d1io0a_         124 IANMLEKNTTLLKFGYHFTQ  143 (166)
T ss_dssp             HHHHHHHCSSCCEEECCCSS
T ss_pred             HHHHHHhCCCcCEEeCcCCC
Confidence            33445566777777776554

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=95.43  E-value=0.025  Score=56.62  Aligned_cols=129  Identities=12%  Similarity=0.153  Sum_probs=72.6

Q ss_pred             cceee----cceEEEEEEEEeccCCcchhHHHHHHHhhhccCCce--eEee-----eeeecCCeEEEEEEccCCCCH---
Q 040702          526 GPVYK----DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNL--IKII-----SSCSNDDFKALVLEYMPLGSL---  591 (797)
Q Consensus       526 g~Vyk----~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpni--v~l~-----~~~~~~~~~~lv~e~~~~g~L---  591 (797)
                      -.||+    +|..|++|+.+... ...+++..|...+..+....+  +...     ..+...+..+.++++++|..+   
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            36886    46789999987553 235678889988888753222  1111     123445678899999976422   


Q ss_pred             --HHH------H-------hcC----CCCCCHH-------------------HHHHHHHHHHHHHHHHH----ccCCCCe
Q 040702          592 --EKC------L-------YSG----NYILDIF-------------------QGLNIMIDVASALEYLH----FGYSVPI  629 (797)
Q Consensus       592 --~~~------l-------~~~----~~~l~~~-------------------~~~~i~~qi~~al~yLH----~~~~~~i  629 (797)
                        ..+      +       ...    +...++.                   ....+...+...++.+.    .....++
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence              111      0       100    0111111                   01111112222222322    1224678


Q ss_pred             EEcCCCCCceEEcCCCcEEEEeecCCcc
Q 040702          630 IHCDLKPSNVLLDDNMVAHLSDFGMAKP  657 (797)
Q Consensus       630 vHrDlkp~NIll~~~~~~kl~DFGla~~  657 (797)
                      +|+|+.+.|||++++  ..++||+-++.
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999744  45899998873

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.26  E-value=0.023  Score=56.57  Aligned_cols=154  Identities=15%  Similarity=0.117  Sum_probs=82.6

Q ss_pred             cCHHHHHHHhcCCCcccccc-----ccCCcceee---cceEEEEEEEEeccCCcchhHHHHHHHhhhccCCce--eEeee
Q 040702          502 FTYLELFQATNRFSENNLIG-----RGGFGPVYK---DGMEVAIKVFNLQYGGAFKSFDIECGMMKRIRHRNL--IKIIS  571 (797)
Q Consensus       502 ~~~~~l~~~~~~f~~~~~lg-----~G~~g~Vyk---~~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~Hpni--v~l~~  571 (797)
                      .+-+|+.....+|..++...     .|---..|+   .+..+++|+.....  ..+++..|++++..+...++  +....
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~   80 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLP   80 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCcEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccce
Confidence            46678888888887754443     333344565   34668999886442  23566667778877753322  11111


Q ss_pred             ------eeecCCeEEEEEEccCCCCHH-----HH---------Hhc----C--CC--CCCHH------------------
Q 040702          572 ------SCSNDDFKALVLEYMPLGSLE-----KC---------LYS----G--NY--ILDIF------------------  605 (797)
Q Consensus       572 ------~~~~~~~~~lv~e~~~~g~L~-----~~---------l~~----~--~~--~l~~~------------------  605 (797)
                            +..-.+..+.++.+..+....     ..         ++.    .  ..  .....                  
T Consensus        81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (316)
T d2ppqa1          81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK  160 (316)
T ss_dssp             BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred             ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence                  122344566777777653221     10         000    0  00  00000                  


Q ss_pred             HHHHHHHHHHHHHHHHH-ccCCCCeEEcCCCCCceEEcCCCcEEEEeecCCcc
Q 040702          606 QGLNIMIDVASALEYLH-FGYSVPIIHCDLKPSNVLLDDNMVAHLSDFGMAKP  657 (797)
Q Consensus       606 ~~~~i~~qi~~al~yLH-~~~~~~ivHrDlkp~NIll~~~~~~kl~DFGla~~  657 (797)
                      .....+......+...+ .....+++|+|+.+.||+++++...-|+||+.+..
T Consensus       161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence            01111222222222222 12367899999999999999887778999999863

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=93.53  E-value=0.043  Score=56.52  Aligned_cols=68  Identities=16%  Similarity=0.123  Sum_probs=41.7

Q ss_pred             ccccccCCcceeec------------ceEEEEEEEEeccCCcchhHHHHHHHhhhcc-CCceeEeeeeeecCCeEEEEEE
Q 040702          518 NLIGRGGFGPVYKD------------GMEVAIKVFNLQYGGAFKSFDIECGMMKRIR-HRNLIKIISSCSNDDFKALVLE  584 (797)
Q Consensus       518 ~~lg~G~~g~Vyk~------------~~~vAvK~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~l~~~~~~~~~~~lv~e  584 (797)
                      +.|+.|-.-.+|+-            ...|.+++.. ... ......+|..+++.+. +.-.+++++++.+    .+|||
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE-TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            45666666667752            1345555543 222 2345567999988885 4334577777643    68999


Q ss_pred             ccCCCCH
Q 040702          585 YMPLGSL  591 (797)
Q Consensus       585 ~~~~g~L  591 (797)
                      |++|..+
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987543